Protein	Entry Name	Protein names	Gene Names	Organism	Gene Ontology (biological process)	Gene Ontology (cellular component)	Gene Ontology (GO)	Gene Ontology (molecular function)	Gene Ontology IDs	Peptide	ID Score	t-test p	ANOVA p	Mass stdev (Da)	MH+ (Da)	CL-6_At_IC50_48H_1 Int (Treated)	CL-6_At_IC50_48H_2 Int (Treated)	CL-6_At_IC50_48H_3 Int (Treated)	CL-6_Be_IC50_48H_1 Int (Treated)	CL-6_Be_IC50_48H_2 Int (Treated)	CL-6_Be_IC50_48H_3 Int (Treated)	CL-6_Cis_IC50_48H_1 Int (Treated)	CL-6_Cis_IC50_48H_2 Int (Treated)	CL-6_Cis_IC50_48H_3 Int (Treated)	CL-6_Con_48H_1 Int (Treated)	CL-6_Con_48H_2 Int (Treated)	CL-6_Con_48H_3 Int (Treated)	H1_At_IC50_48H_1 Int (Treated)	H1_At_IC50_48H_2 Int (Treated)	H1_At_IC50_48H_3 Int (Treated)	H1_Be_IC50_48H_1 Int (Treated)	H1_Be_IC50_48H_2 Int (Treated)	H1_Be_IC50_48H_3 Int (Treated)	H1_Cis_IC50_48H_1 Int (Treated)	H1_Cis_IC50_48H_2 Int (Treated)	H1_Cis_IC50_48H_3 Int (Treated)	H1_Con_48H_1 Int (Treated)	H1_Con_48H_2 Int (Treated)	H1_Con_48H_3 Int (Treated)	H28_At_IC50_48H_1 Int (Treated)	H28_At_IC50_48H_2 Int (Treated)	H28_At_IC50_48H_3 Int (Treated)	H28_Be_IC50_48H_1 Int (Treated)	H28_Be_IC50_48H_2 Int (Treated)	H28_Be_IC50_48H_3 Int (Treated)	H28_Cis_IC50_48H_1 Int (Treated)	H28_Cis_IC50_48H_2 Int (Treated)	H28_Cis_IC50_48H_3 Int (Treated)	H28_Con_48H_1 Int (Treated)	H28_Con_48H_2 Int (Treated)	H28_Con_48H_3 Int (Treated)	MM_At_IC50_48H_1 Int (Treated)	MM_At_IC50_48H_2 Int (Treated)	MM_At_IC50_48H_3 Int (Treated)	MM_Be_IC50_48H_1 Int (Treated)	MM_Be_IC50_48H_2 Int (Treated)	MM_Be_IC50_48H_3 Int (Treated)	MM_Cis_IC50_48H_1 Int (Treated)	MM_Cis_IC50_48H_2 Int (Treated)	MM_Cis_IC50_48H_3 Int (Treated)	MM_Con_48H_1 Int (Treated)	MM_Con_48H_2 Int (Treated)	MM_Con_48H_3 Int (Treated)
A0A075B6H8	KVD42_HUMAN	Probable non-functional immunoglobulin kappa variable 1D-42	IGKV1D-42	Homo sapiens (Human)	adaptive immune response [GO:0002250]; immune response [GO:0006955]	extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955]		GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814	LFLYDAK	24.37000084	0.071557552	0.071557552	0.228456734	869.628711	21.64623	20.0522	21.8862	17.6509	21.64098	20.59927	21.4979	20.24441	20.59386	19.01935	19.13633	19.67433	16.47503	19.42245	19.24078	17.90765	19.89952	19.73788	18.94317	20.07795	20.42299	20.69888	21.53416	17.04043	17.87765	16.87661	21.04861	20.56597	16.86357	18.08978	21.01823	21.14725	18.26523	17.66837	22.8144	22.60235	19.49175	20.76726	20.80444	19.19472	19.45126	19.23502	20.65693	17.36163	19.41331	19.1243	20.70876	21.39997
A0A075B6H9	LV469_HUMAN	Immunoglobulin lambda variable 4-69	IGLV4-69	Homo sapiens (Human)	adaptive immune response [GO:0002250]; immune response [GO:0006955]	extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955]		GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814	GDGIPDRFSGSSSGAER	8.390000343	1	1	0.368067067	1694.585779	0	0	0	0	19.73129	16.42811	19.29702	0	16.57303	0	15.04896	0	0	0	0	0	0	0	0	17.46457	0	0	18.53952	0	0	15.55444	0	0	0	0	0	0	0	16.2664	0	0	0	15.58443	0	0	16.72564	0	0	17.83849	13.47725	0	0	0
A0A075B6K6	LV403_HUMAN	Immunoglobulin lambda variable 4-3	IGLV4-3	Homo sapiens (Human)	adaptive immune response [GO:0002250]; immune response [GO:0006955]	extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955]		GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814	FMGSSSGADR	5.050000191	1	1	2.34E-13	1030.769835	13.78132	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.05894	0	14.75298	0	14.90235	0	0	0	0
A0A075B6N3	TVBX1_HUMAN	T cell receptor beta variable 24-1	TRBV24-1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]		GO:0002250; GO:0005886; GO:0007166; GO:0042101	IMLECSQTK	17.89999962	0.475976467	0.475976467	0.168583516	1126.625705	15.17472	17.98288	0	16.10632	17.58204	0	17.12323	16.64281	18.10911	14.98534	16.34451	18.18324	18.24227	16.32366	16.14259	16.98832	0	18.01536	17.72434	18.02401	17.16746	17.0089	15.55462	0	16.20205	14.78658	16.90717	18.90685	17.38889	18.00222	17.75632	16.01003	0	17.30893	0	17.27155	16.64755	16.48514	13.99759	0	14.9818	14.83847	13.23377	15.62104	15.86105	15.18348	16.3019	16.89981
A0A075B6Q5	HV364_HUMAN	Immunoglobulin heavy variable 3-64	IGHV3-64	Homo sapiens (Human)	"B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]"	"external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]"	"external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]"	antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]	GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871	NTLYLQMGSLR	1.429999948	0.306500316	0.306500316	0.117978205	1311.459414	9.060524	0	0	12.68666	13.91978	13.37519	0	0	5.87016	0	14.12384	0	0	14.21905	0	0	10.87975	0	0	0	13.48172	0	0	0	0	0	0	11.92087	0	0	0	14.55521	14.68683	14.965	13.67695	0	0	0	0	0	0	0	0	0	0	0	0	14.78059
A0A075B6T8	TVA91_HUMAN	T cell receptor alpha variable 9-1	TRAV9-1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; immune response [GO:0006955]	extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]	extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955]		GO:0002250; GO:0005615; GO:0006955; GO:0042101	AMKANDK	2.940000057	1	1	1.26E-12	778.4032666	13.26588	15.96695	0	0	0	0	13.42712	13.29259	14.50752	14.5424	0	0	12.70947	16.41684	0	0	12.88537	0	16.26969	15.92024	0	12.95955	0	16.15465	17.59007	12.26218	0	14.26349	0	15.32093	0	0	0	0	0	0	0	0	0	0	14.54537	0	0	0	0	0	0	0
A0A075B734	AQP7B_HUMAN	Aquaporin-7B	AQP7B	Homo sapiens (Human)	glycerol transport [GO:0015793]; water transport [GO:0006833]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; glycerol transport [GO:0015793]; water transport [GO:0006833]	glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]	GO:0005886; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323	EFLAEFMSTYVMMVFGLGSVAHMVLNK	5.099999905	1	1	9.18E-13	3068.436444	12.22598	15.70933	0	13.2305	0	0	0	14.77114	0	0	14.37452	11.81041	0	13.97769	13.01003	13.50388	0	12.82319	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0A087WT03	TVAZ1_HUMAN	T cell receptor alpha variable 26-1	TRAV26-1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; response to bacterium [GO:0009617]	T cell receptor complex [GO:0042101]	T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617]		GO:0002250; GO:0009617; GO:0042101	KSSTLILPHATLR	15.32999992	0.794895649	0.794895649	0.192997929	1437.017707	0	0	0	16.5432	14.66361	15.54466	0	0	13.14546	0	0	0	0	17.1876	14.71933	18.15221	16.84141	16.32027	15.75632	16.47634	0	0	0	20.6021	12.82784	13.77427	0	0	15.78329	0	0	13.65058	14.79711	16.17391	16.70931	0	0	0	15.9001	15.55293	0	0	0	10.29063	0	13.46677	0	16.6826
A0A087WXM9	MEIKN_HUMAN	Meiosis-specific kinetochore protein	MEIKIN	Homo sapiens (Human)	"female meiosis chromosome segregation [GO:0016321]; homologous chromosome segregation [GO:0045143]; male meiosis chromosome segregation [GO:0007060]; meiotic sister chromatid cohesion involved in meiosis I [GO:0010789]; meiotic sister chromatid cohesion, centromeric [GO:0051754]"	"condensed chromosome, centromeric region [GO:0000779]; kinetochore [GO:0000776]"	"condensed chromosome, centromeric region [GO:0000779]; kinetochore [GO:0000776]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome segregation [GO:0045143]; male meiosis chromosome segregation [GO:0007060]; meiotic sister chromatid cohesion involved in meiosis I [GO:0010789]; meiotic sister chromatid cohesion, centromeric [GO:0051754]"		GO:0000776; GO:0000779; GO:0007060; GO:0010789; GO:0016321; GO:0045143; GO:0051754	AEAPPGSKR	2.24000001	1	1	0.089292502	913.0437284	0	13.28581	0	15.84056	0	0	0	0	0	0	11.83284	0	0	0	0	0	0	0	14.70615	0	0	0	13.02336	0	0	0	0	0	0	0	0	0	15.55362	0	16.55079	0	0	0	0	16.13371	0	0	15.34299	0	16.37996	0	15.56491	0
A0A096LP49	CC187_HUMAN	Coiled-coil domain-containing protein 187	CCDC187	Homo sapiens (Human)	microtubule anchoring [GO:0034453]	centrosome [GO:0005813]	centrosome [GO:0005813]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453]	microtubule binding [GO:0008017]	GO:0005813; GO:0008017; GO:0034453	KHSSLER	7.019999981	0.437560856	0.437560856	0.119893942	854.9978388	0	13.80211	11.51705	10.52457	0	0	0	15.92488	16.03395	14.20517	13.03014	10.48182	0	13.87414	0	13.96162	15.0809	15.52613	15.15233	0	14.20962	0	0	13.43023	11.77357	0	13.50991	9.805283	15.47985	12.46255	0	0	0	0	0	14.73371	13.95936	16.36157	0	15.26657	16.02102	13.58633	0	14.15129	15.73996	20.74608	15.41332	0
A0A0A0MT70	TJB26_HUMAN	T cell receptor beta joining 2-6	TRBJ2-6	Homo sapiens (Human)	adaptive immune response [GO:0002250]	T cell receptor complex [GO:0042101]	T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]		GO:0002250; GO:0042101	SGANVLTFGAGSR	5.289999962	1	1	0.399330768	1236.010591	0	15.65499	0	0	0	15.70907	0	13.61583	0	0	0	15.75462	16.49031	15.41873	0	0	14.60952	0	16.93247	17.17634	16.95579	0	18.51935	0	16.10198	0	16.31601	0	15.91788	0	0	15.83686	12.93281	16.31886	13.51013	14.6957	17.67667	0	15.34867	17.14057	15.87983	0	16.77785	16.31483	16.16371	0	14.88011	0
A0A0A0MT76	LJ01_HUMAN	Immunoglobulin lambda joining 1	IGLJ1	Homo sapiens (Human)	adaptive immune response [GO:0002250]	extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]		GO:0002250; GO:0005576; GO:0005886; GO:0019814	PSRLLLQPSPQR	10.36999989	1	1	0.291884448	1391.373849	0	17.71631	0	17.97672	16.41693	0	0	15.53742	16.87038	0	0	0	16.55369	18.14617	0	17.07927	17.10059	0	0	17.06502	0	16.55093	0	16.13684	0	0	18.91255	0	0	17.93771	0	17.02039	17.32839	0	0	16.14369	14.47236	16.61056	15.07771	17.02779	0	17.05231	0	0	0	15.47496	0	0
A0A0A6YYG2	TVB66_HUMAN	T cell receptor beta variable 6-6	TRBV6-6	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]		GO:0002250; GO:0005886; GO:0007166; GO:0042101	QDPGMGLK	2.970000029	1	1	0.216532752	862.2232079	15.6796	16.06748	11.94439	15.93913	14.57959	0	15.46225	16.56015	0	16.97581	16.5603	13.17416	11.67649	12.76871	14.95532	17.5487	16.50615	0	15.49118	13.89219	16.08684	15.87949	13.8577	12.7543	16.9733	16.83586	16.76709	16.88589	0	0	0	0	0	0	0	0	0	16.31571	0	0	0	16.0597	12.55345	16.09956	0	0	13.50765	0
A0A0A6YYK1	TVA81_HUMAN	T cell receptor alpha variable 8-1	TRAV8-1	Homo sapiens (Human)	adaptive immune response [GO:0002250]	T cell receptor complex [GO:0042101]	T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]		GO:0002250; GO:0042101	GFEAEFIK	6.949999809	0.80369705	0.80369705	0.289877739	941.4805857	17.31528	18.95153	17.35146	0	0	18.26528	21.11233	16.9043	0	0	0	20.60886	0	0	0	0	0	0	0	20.35552	0	0	0	0	19.16219	0	20.92017	0	0	0	0	0	0	20.28402	0	22.28551	18.40125	0	19.13448	0	0	0	0	0	0	0	0	21.66039
A0A0A6YYK7	TVA19_HUMAN	T cell receptor alpha variable 19 (T-cell receptor alpha chain V region HPB-MLT)	TRAV19	Homo sapiens (Human)	adaptive immune response [GO:0002250]; immune response [GO:0006955]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; MHC protein binding [GO:0042287]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; immune response [GO:0006955]	MHC protein binding [GO:0042287]; peptide antigen binding [GO:0042605]	GO:0002250; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0042101; GO:0042287; GO:0042605	MLTASLLRAVIASICVVSSMAQK	6.380000114	0.740108967	0.740108967	0.160923922	2448.98373	0	14.53004	15.98022	0	0	14.92149	14.73615	14.20071	12.71594	0	14.47454	0	0	0	15.26704	0	0	0	0	0	13.20204	0	0	0	13.73779	14.51525	0	0	16.24695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.85388	13.39319
A0A0B4J244	TVA3_HUMAN	T cell receptor alpha variable 3	TRAV3	Homo sapiens (Human)	adaptive immune response [GO:0002250]	T cell receptor complex [GO:0042101]	T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]		GO:0002250; GO:0042101	YITGDNLVK	6.119999886	1	1	0.159960829	1023.705375	0	0	14.81592	15.35963	13.74206	14.14707	0	0	0	0	17.98377	14.62292	0	15.97549	12.83415	18.01757	0	0	0	0	13.85087	17.0633	0	0	0	0	0	14.93284	16.35006	16.11487	0	0	0	0	0	0	16.66104	0	0	0	0	0	0	0	14.55986	15.45945	0	0
A0A0B4J245	TVAL1_HUMAN	T cell receptor alpha variable 12-1	TRAV12-1	Homo sapiens (Human)	adaptive immune response [GO:0002250]	T cell receptor complex [GO:0042101]	T cell receptor complex [GO:0042101]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]	peptide antigen binding [GO:0042605]	GO:0002250; GO:0042101; GO:0042605	LSDSATYLCVVN	2.400000095	1	1	0.383234902	1339.099378	8.912585	0	0	0	0	0	0	17.30127	0	0	0	18.39091	0	0	16.66385	0	0	0	0	0	0	0	0	0	0	0	17.33781	0	0	18.39479	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0A0B4J275	TVA17_HUMAN	T cell receptor alpha variable 17	TRAV17	Homo sapiens (Human)	adaptive immune response [GO:0002250]; response to bacterium [GO:0009617]	T cell receptor complex [GO:0042101]	T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617]		GO:0002250; GO:0009617; GO:0042101	HSGRLR	3.930000067	1	1	0.167712313	724.634184	12.93529	12.84595	16.0878	0	0	15.19389	0	0	0	16.06493	0	0	15.53406	0	0	0	0	14.33597	15.00068	0	0	0	15.49386	0	0	16.05779	0	15.73878	0	15.21325	0	0	0	0	0	0	0	15.6593	0	0	0	15.80647	0	0	0	0	0	0
A0A0B4J2D5	GAL3B_HUMAN	"Putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (Keio novel protein-I, KNP-I) (Protein GT335) (Protein HES1)"	GATD3B HES1 KNPI	Homo sapiens (Human)		mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739	ALVASR	3.24000001	1	1	0.279131797	615.8663195	17.25788	0	0	0	0	15.06597	0	0	0	0	0	0	0	0	0	0	0	18.25498	0	0	0	0	0	16.61792	0	0	0	0	16.75659	17.06737	0	0	16.77279	0	0	16.59754	0	0	0	0	0	0	0	17.34511	0	0	0	0
A0A0B4J2F2	SIK1B_HUMAN	"Putative serine/threonine-protein kinase SIK1B, EC 2.7.11.1 (Salt-inducible kinase 1B)"	SIK1B	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0042149; GO:0106310	DLKTENLLLDGNMDIK	12.46000004	0.184359401	0.184359401	0.157051548	1849.021486	18.47694	18.89428	16.97727	16.6909	19.95492	0	18.96277	17.71387	18.0137	0	15.4078	15.75298	12.72653	14.57564	0	0	15.62177	14.57513	15.91248	18.08393	16.50352	18.87099	19.56444	0	17.6704	16.45832	16.1681	15.96543	17.17275	0	0	17.95897	18.87261	18.98806	15.26113	16.33666	17.91321	13.41667	0	16.32516	16.48319	0	17.88528	13.56879	14.77412	15.223	17.23982	13.52185
A0A0C4DH59	TVB54_HUMAN	T cell receptor beta variable 5-4	TRBV5-4	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]		GO:0002250; GO:0005886; GO:0007166; GO:0042101	MGPGLLCWALLCLLGAGSVETGVTQSPTHLIK	5.639999866	1	1	4.12E-12	3378.661298	0	13.65377	0	0	0	0	0	12.93475	12.07225	0	0	0	0	13.71106	0	10.09464	10.87386	0	12.61771	0	14.19408	0	0	0	0	14.8701	0	0	14.20888	12.88381	0	11.98856	12.35489	0	13.75756	0	0	0	0	0	0	0	0	0	0	0	0	8.104225
A0A0G2JMD5	PRA33_HUMAN	PRAME family member 33	PRAMEF33	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"		GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892	AELMRTLR	2.609999895	0.403098941	0.403098941	0.287418496	1004.541916	18.02785	0	17.98856	15.13338	0	0	0	0	0	0	0	0	17.7372	0	0	0	0	0	0	17.95583	0	0	0	0	17.65693	17.70115	18.78174	0	16.59295	18.00037	0	0	0	17.39633	0	17.38418	17.6647	0	19.14984	0	0	0	17.05396	0	16.99338	0	18.22322	0
A0A0J9YXQ4	PMA6E_HUMAN	Paraneoplastic antigen Ma6E	PNMA6E	Homo sapiens (Human)						MALAMLR	7.03000021	1	1	0.146843127	806.5132688	15.10427	14.1663	0	12.38203	0	0	13.78292	15.97199	11.41602	15.62612	0	0	0	13.4484	0	15.14487	13.93498	15.28738	14.18191	15.28018	15.28953	0	0	13.56683	0	14.8507	0	0	0	0	0	0	0	0	0	0	0	16.7679	0	0	0	0	0	16.33879	0	0	0	0
A0A0U1RQE8	GLYLB_HUMAN	"Putative glycine N-acyltransferase-like protein 1B, EC 2.3.1.68"	GLYATL1B	Homo sapiens (Human)	glutamine metabolic process [GO:0006541]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]; glutamine metabolic process [GO:0006541]	glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]	GO:0005739; GO:0006541; GO:0016410; GO:0047946; GO:0047961	GNGTRLIMR	3.079999924	1	1	4.62E-13	1036.307871	14.44042	16.05533	0	0	0	0	0	15.77727	0	0	0	0	0	13.66144	10.8216	16.60048	0	12.79409	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0A0U1RQF7	DP2NB_HUMAN	DPEP2 neighbor protein	DPEP2NB	Homo sapiens (Human)						LEHRGR	4.489999771	1	1	0.165763151	768.3250375	16.36869	0	13.89921	13.02439	13.73059	0	0	0	0	0	0	0	0	14.52973	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.23235	0	0	0	0	17.21656	15.11909	0	15.38391	0	0	0	0	0	0
A0A1B0GTH6	CS2IP_HUMAN	Casein kinase II subunit alpha'-interacting protein	CSNKA2IP	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634	ALNSHLLHSK	8.630000114	1	1	0.105846545	1120.915692	13.95681	0	14.93005	0	12.4981	0	0	0	0	0	0	0	0	0	0	0	0	0	13.65262	0	0	0	0	0	0	0	0	14.31399	0	12.05636	11.25556	14.80235	0	0	0	0	14.55965	0	13.43823	0	0	0	0	0	0	0	0	13.55156
A0A1B0GTL2	CT204_HUMAN	Uncharacterized protein C20orf204	C20orf204 PRR17	Homo sapiens (Human)						AIIFEDLQAAVK	14.85000038	0.969998598	0.969998598	0.303561576	1316.668053	16.34032	14.50381	13.24805	13.18492	0	0	0	0	0	0	0	13.25496	0	0	16.50522	0	0	0	0	0	0	0	0	0	14.79501	0	0	14.92364	16.80945	13.88101	15.72026	0	0	0	13.29783	0	16.09739	0	15.97492	0	15.58179	0	16.50529	13.87868	0	0	0	0
A0A1B0GTR0	EDD13_HUMAN	Epididymal protein 13	EDDM13	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	GIIGLMSRLSPDGLR	3.519999981	1	1	0.134866714	1600.533585	13.74989	0	0	12.86152	14.3574	14.86762	0	0	11.80948	0	0	13.84938	0	11.90793	14.131	14.79652	0	0	0	13.24816	0	0	15.95354	0	0	0	0	15.43361	13.42155	0	0	14.53497	0	0	0	0	0	0	0	15.85892	0	0	0	0	0	0	0	12.54606
A0A1B0GTS1	HSFX4_HUMAN	"Heat shock transcription factor, X-linked member 4"	HSFX4	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357	RSGMWSK	10.68000031	1	1	0.288671765	852.0299571	16.50269	0	0	16.23537	15.69562	16.6114	0	0	16.95567	16.57748	16.25927	15.97013	15.10328	15.58161	15.234	15.35272	16.21844	15.22075	15.9055	16.38883	15.68346	16.64479	16.2198	15.40606	15.5218	15.09609	15.33815	0	0	0	15.17863	16.62123	17.10434	0	15.71459	0	0	15.46644	0	15.54253	0	15.80466	15.39208	15.2614	0	0	13.83717	14.92
A0A1B0GTU1	ZC11B_HUMAN	Zinc finger CCCH domain-containing protein 11B	ZC3H11B ZC3HDC11B	Homo sapiens (Human)	poly(A)+ mRNA export from nucleus [GO:0016973]		metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]	GO:0003729; GO:0016973; GO:0046872	FSTGGDSDPPLKR	8.460000038	1	1	0.241422209	1375.894883	16.79601	16.30721	0	17.94261	0	0	15.21251	0	0	15.88601	17.05897	0	0	16.68594	14.9455	0	0	0	0	0	0	0	0	0	17.2684	0	17.10295	16.63487	0	0	0	0	0	0	0	0	0	0	0	0	17.69074	0	0	0	16.08344	0	16.62933	16.99779
A0A1B0GUC4	MYCOS_HUMAN	Myocilin opposite strand protein	MYOCOS	Homo sapiens (Human)						KEIITQK	13.47000027	1	1	0.095433744	857.9521838	16.06932	0	15.48274	0	16.24685	15.34732	16.11278	16.54274	0	15.94175	0	0	0	0	0	13.58644	0	15.17897	0	0	0	15.38984	13.59925	16.00799	0	0	0	0	0	0	0	14.65157	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0A1B0GUX0	VAFNB_HUMAN	Protein ATP6V1FNB (ATP6V1F neighbor gene protein)	ATP6V1FNB	Homo sapiens (Human)						AKAAAR	6.050000191	0.170020953	0.170020953	0.325214289	586.7426216	13.32893	14.4895	0	15.88761	0	0	15.90822	0	14.92009	0	0	0	0	0	16.15252	0	0	15.98613	0	16.5213	0	0	0	0	17.17003	14.52213	15.35852	0	16.73079	15.18489	15.90641	16.35324	0	17.03706	16.31363	17.04911	0	15.97466	18.935	17.99183	18.62687	17.42075	15.59811	0	17.09733	18.46972	15.92778	18.36929
A0A1B0GV03	GG6L7_HUMAN	Golgin subfamily A member 6-like protein 7	GOLGA6L7	Homo sapiens (Human)		cis-Golgi network [GO:0005801]	cis-Golgi network [GO:0005801]		GO:0005801	NIITNK	31.07999992	0.483861148	0.483861148	0.131711466	701.5100608	16.83397	15.28703	16.5709	15.91906	17.26972	16.43619	17.18457	17.05134	17.05064	16.71106	16.77982	16.82739	17.50163	17.04063	16.07435	16.40156	16.56947	17.1222	17.05356	16.45135	16.88564	17.02538	17.06313	16.81943	15.96713	17.08744	16.9814	16.63728	16.99631	16.66393	17.10132	16.32806	0	17.06775	16.68924	16.36654	16.62769	17.72159	16.53166	16.86913	16.28298	16.7311	16.48602	0	15.78171	0	16.91994	16.20784
A0A1B0GV85	RELD1_HUMAN	Reelin domain-containing protein 1	REELD1	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	IESSVVSQQTHSSAHSDDRMEPR	4.019999981	0.530567467	0.530567467	0.343308121	2597.360187	14.09089	0	11.94906	11.62811	14.75164	0	0	13.33484	14.29928	0	0	14.65078	0	0	14.94292	0	0	0	0	0	0	0	15.45953	0	11.30305	0	0	0	0	0	0	0	0	17.02591	12.92222	0	0	0	0	0	16.26803	0	0	0	0	0	0	0
A0A1B0GVH7	IQCM_HUMAN	IQ domain-containing protein M	IQCM	Homo sapiens (Human)						FMITPK	1.769999981	1	1	0.040733482	751.4879726	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0A1B0GWB2	PRT1B_HUMAN	Proline rich transmembrane protein 1B	PRRT1B IFITMD8	Homo sapiens (Human)		integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021	GGGSPATPEDPR	9.479999542	1	1	0.523262455	1140.387652	0	0	0	0	0	0	0	0	16.72113	0	0	0	0	0	0	0	17.49733	0	0	0	0	0	0	0	0	0	17.63986	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0A1W2PQ73	ERFL_HUMAN	ETS domain-containing transcription factor ERF-like (ETS repressor factor-like)	ERFL	Homo sapiens (Human)	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565	ILHKTK	6.199999809	1	1	0.23394632	740.2095611	14.11272	14.34604	15.29432	12.60273	15.07954	13.59479	14.01077	15.5678	12.77453	14.09515	0	12.70292	15.21424	14.86155	14.29532	17.48266	14.07623	16.76918	0	17.60127	0	13.94049	16.73026	16.05184	0	0	0	15.82565	15.36662	14.47931	15.28387	17.18574	16.84206	0	16.68138	0	0	0	0	16.4021	14.81617	17.12266	15.66174	0	0	15.27703	0	0
A0A1W2PR19	GSTT4_HUMAN	"Glutathione S-transferase theta-4, EC 2.5.1.18 (GST class-theta-4) (Glutathione S-transferase theta pseudogene 1)"	GSTT4 GSTTP1	Homo sapiens (Human)	glutathione metabolic process [GO:0006749]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]	glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005737; GO:0006749	MQVELNIGSGLFREAHDR	7.46999979	1	1	1.16E-05	2087.811421	14.15949	0	13.93417	13.63715	0	14.11008	12.62753	0	0	0	0	0	0	0	15.2983	0	0	11.15787	14.94099	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0A286YFK9	SIM38_HUMAN	Small integral membrane protein 38	SMIM38	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	MTSWPGGSFGPDPLLALLVVILLAR	5.400000095	1	1	4.11E-12	2638.666841	0	0	10.6798	0	14.72484	11.19123	12.88426	0	0	0	0	12.44607	0	0	0	0	0	0	0	0	12.05944	0	0	0	0	0	0	0	0	0	0	0	0	0	8.355204	0	0	0	0	0	0	0	0	0	0	0	13.03106	0
A0A2R8Y4L2	RA1L3_HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 3 (Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48)	HNRNPA1L3 HNRNPA1P48	Homo sapiens (Human)	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0008380	EDSQRPDAHLTVKK	11.26000023	1	1	0.26104089	1623.882969	0	0	0	0	0	0	0	0	0	0	16.1776	0	0	0	16.75804	16.72734	0	15.77103	0	13.24445	0	0	16.15849	16.29436	15.76981	16.31982	15.38489	0	0	16.44228	0	0	16.50652	0	16.63624	17.0231	0	16.13352	0	16.87136	15.79743	15.95917	0	16.94423	0	0	0	0
A0A2R8YFL7	OSP4A_HUMAN	Oocyte-secreted protein 4A	OOSP4A	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	FPIILVMRGR	14.43999958	1	1	0.337170658	1200.774712	19.42735	18.26384	18.61649	0	18.0808	16.89554	19.49302	19.06624	19.25736	20.84856	19.13237	18.29263	19.47899	0	0	0	0	0	0	0	18.38701	0	0	0	0	0	0	17.73785	0	18.7382	0	20.06343	0	0	20.11976	0	0	18.6093	0	0	0	0	18.37743	19.77451	0	0	0	18.2108
A0A3B3IU63	H2AL3_HUMAN	"Histone H2A-like 3, H2A.L.3"	H2AL3 H2AL1RP	Homo sapiens (Human)		nucleosome [GO:0000786]; nucleus [GO:0005634]	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982	EEEMVVLVVMGGRR	4.650000095	1	1	0.211250511	1635.213693	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.49181	0	0	0	0	0	0	15.14701	0	0	12.69366	13.7252	0	0	0	0	13.80559	0	0	17.39083	13.73381	0	0	15.95369	0	13.38857	17.06858	0	0	10.11093
A0A494C0Y3	F246A_HUMAN	Protein FAM246A	FAM246A	Homo sapiens (Human)						KMPVPPGAPQGGGD	8.800000191	0.278048038	0.278048038	0.299873158	1323.787819	17.4385	0	13.51969	0	0	15.31807	0	13.16129	0	0	0	0	0	0	0	14.90479	0	13.2731	0	0	0	0	0	0	0	13.68831	14.3947	0	0	0	14.66708	0	0	0	12.9426	15.95532	0	0	15.07131	0	0	0	0	0	0	0	16.91343	0
A0A597	TVB55_HUMAN	T cell receptor beta variable 5-5	TRBV5-5 TCRBV5S3A2T	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]		GO:0002250; GO:0005886; GO:0007166; GO:0042101	CSPISGHK	11.53999996	0.788945615	0.788945615	0.292939921	886.1452753	16.53169	16.35268	16.01501	15.95975	13.76126	14.53726	20.17412	17.96677	0	0	17.71358	16.95346	18.46956	0	16.8812	0	0	17.82322	16.94129	18.76507	0	18.92608	0	0	16.90764	18.32623	0	18.49108	0	0	19.52093	0	18.59827	0	20.18725	16.82437	17.90053	17.7225	19.67634	17.9172	18.70712	18.72974	16.78627	0	17.17003	17.37785	17.37678	0
A0A5B0	TVB14_HUMAN	T cell receptor beta variable 14	TRBV14 TCRBV14S1 TCRBV16S1A1N1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]		GO:0002250; GO:0005886; GO:0007166; GO:0042101	MVSRLLSLVSLCLLGAK	3.029999971	1	1	0.281524603	1876.781226	15.08823	13.57381	13.66719	12.56986	14.12491	0	0	15.35092	17.04025	10.95154	13.07969	14.81857	0	0	0	0	0	0	0	0	0	0	0	0	14.96665	15.8278	0	0	0	15.78165	18.18351	0	0	0	15.53665	0	15.81837	0	0	14.97909	0	0	0	0	0	0	0	0
A0A6I8PU40	TUG1_HUMAN	Taurine up-regulated 1 protein	TUG1	Homo sapiens (Human)						MARPPPLPGLVGR	7.079999924	0.166711196	0.166711196	0.080164934	1360.300755	0	0	12.44546	0	12.87915	0	0	0	14.49553	0	0	0	0	0	0	0	0	0	15.23122	0	15.96805	0	9.430932	0	0	0	6.840987	0	0	0	12.40392	12.4472	0	0	0	0	9.557524	0	0	0	0	0	0	0	0	0	0	16.06664
A0AV96	RBM47_HUMAN	RNA-binding protein 47 (RNA-binding motif protein 47)	RBM47	Homo sapiens (Human)	cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244]	nucleus [GO:0005634]	nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0002244; GO:0003723; GO:0003729; GO:0005634; GO:0016554	MTAEDSTAAMSSDSAAGSSAK	3.960000038	0.39916116	0.39916116	0.283608123	1993.88282	20.30738	0	0	0	0	17.42152	17.65883	0	0	18.19792	16.97724	0	20.44456	15.30211	15.60723	0	0	0	15.08804	13.00573	0	0	15.36015	16.19187	17.04393	0	17.28209	0	0	0	0	17.09189	0	0	0	0	0	0	0	0	14.44423	15.92008	19.01426	0	0	15.49458	0	14.1361
A0AVF1	IFT56_HUMAN	"Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26, TPR repeat protein 26)"	TTC26 IFT56	Homo sapiens (Human)	axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]	intraciliary transport particle B binding [GO:0120170]	GO:0005813; GO:0005929; GO:0007224; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0061512; GO:0097542; GO:0097546; GO:0120170; GO:1905198	GACVGIFQMIIAGR	6.570000172	1	1	0.163981689	1508.397049	17.93381	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0AVI2	FR1L5_HUMAN	Fer-1-like protein 5	FER1L5	Homo sapiens (Human)	macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; myoblast fusion [GO:0007520]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; T-tubule [GO:0030315]	cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; T-tubule [GO:0030315]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; myoblast fusion [GO:0007520]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]	GO:0001778; GO:0002280; GO:0002281; GO:0005509; GO:0005544; GO:0006906; GO:0007009; GO:0007520; GO:0016021; GO:0030315; GO:0031410; GO:0033292; GO:0050765; GO:0061025	FKLQSFEPK	3.279999971	1	1	0.104177819	1123.026353	13.67752	13.88709	12.69868	15.90339	15.91791	11.96688	16.43657	15.36925	16.98139	16.07112	14.46484	13.98918	12.9353	13.73331	0	17.54781	13.13434	0	0	0	0	0	0	0	0	0	0	14.40839	0	0	16.67804	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A0AVI4	TM129_HUMAN	"E3 ubiquitin-protein ligase TM129, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TM129)"	TMEM129	Homo sapiens (Human)	"protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0016567; GO:0030433; GO:0030970; GO:0046872; GO:0061630	VHVAQQQDVHLTVTESR	4.739999771	1	1	0.306957495	1945.964821	0	0	0	13.87542	0	0	14.14433	15.67191	0	14.17662	0	15.26043	13.80208	0	14.53329	0	0	0	13.59004	0	12.16041	0	0	0	0	15.16094	0	0	0	0	0	0	16.89958	0	0	0	0	0	0	15.19453	12.67785	14.85602	0	0	0	0	0	0
A0AVK6	E2F8_HUMAN	"Transcription factor E2F8, E2F-8"	E2F8	Homo sapiens (Human)	cell cycle comprising mitosis without cytokinesis [GO:0033301]; cell population proliferation [GO:0008283]; chorionic trophoblast cell differentiation [GO:0060718]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell cycle comprising mitosis without cytokinesis [GO:0033301]; cell population proliferation [GO:0008283]; chorionic trophoblast cell differentiation [GO:0060718]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0008283; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837	ASMLEDSGSK	15.35999966	0.139118508	0.139118508	0.384726886	1041.214532	20.53287	19.1913	21.85538	0	0	17.54938	0	0	0	21.13665	17.12039	0	0	19.5743	0	0	0	21.63953	20.79122	20.06883	18.77578	19.93984	18.49837	19.67203	0	15.62886	0	19.8345	20.28217	19.7287	19.26091	0	0	0	19.7812	0	17.63366	18.71237	19.38963	0	0	0	0	19.7995	19.49987	18.52453	0	0
A0AVT1	UBA6_HUMAN	"Ubiquitin-like modifier-activating enzyme 6, Ubiquitin-activating enzyme 6, EC 6.2.1.45 (Monocyte protein 4, MOP-4) (Ubiquitin-activating enzyme E1-like protein 2, E1-L2)"	UBA6 MOP4 UBE1L2	Homo sapiens (Human)	amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0032446; GO:0060996	LVKPTTEKK	4.96999979	0.8183496	0.8183496	0.214377868	1044.559942	16.16804	16.35231	15.76476	15.21173	15.5418	15.212	16.65087	16.64712	16.58238	0	15.96074	17.30331	16.09184	16.08931	14.85091	16.81007	15.42741	14.79538	17.35321	0	0	17.00586	17.22384	14.56826	0	16.86677	0	15.89811	16.46039	16.23279	17.375	0	0	15.71182	16.34906	16.13327	16.7453	0	0	15.97852	0	0	0	16.43195	0	15.80832	0	0
A0FGR8	ESYT2_HUMAN	"Extended synaptotagmin-2, E-Syt2 (Chr2Syt)"	ESYT2 FAM62B KIAA1228	Homo sapiens (Human)	endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]	GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0016020; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0045296; GO:0061817; GO:0140268	NLPSGK	7.760000229	1	1	0.21725766	613.6515677	11.62361	14.12875	14.47861	0	0	0	14.05219	0	0	0	0	15.32149	0	14.98195	14.34821	0	0	0	0	0	0	0	0	0	0	14.41327	0	15.86929	16.11488	11.20796	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.47516
A0JNW5	UH1BL_HUMAN	UHRF1-binding protein 1-like (Syntaxin-6 Habc-interacting protein of 164 kDa)	UHRF1BP1L KIAA0701 SHIP164	Homo sapiens (Human)		cytosol [GO:0005829]; early endosome [GO:0005769]	cytosol [GO:0005829]; early endosome [GO:0005769]; GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803]	GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803]	GO:0005769; GO:0005829; GO:0042803; GO:0062069	GRPISFVDSFPLSIWICQPTRYAESQK	2.019999981	1	1	0	3181.4221	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.98676	0	0	0	0	0	0	0	18.11209	0
A0MZ66	SHOT1_HUMAN	Shootin-1 (Shootin1)	SHTN1 KIAA1598	Homo sapiens (Human)	"actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]"	axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	"axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]"	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]	GO:0005737; GO:0005874; GO:0005875; GO:0006930; GO:0007265; GO:0007409; GO:0015630; GO:0019894; GO:0030027; GO:0030175; GO:0030424; GO:0030426; GO:0031252; GO:0032488; GO:0038007; GO:0042802; GO:0043204; GO:0044295; GO:0045296; GO:0045773; GO:0048471; GO:0048812; GO:0051015; GO:0060327; GO:0061163; GO:0061573; GO:2000114; GO:2001224	TKPESSK	2.579999924	1	1	0.207731751	776.5435593	16.17865	0	0	12.99955	0	13.53806	0	15.25147	15.3333	15.66459	14.68516	0	15.55389	0	0	13.05081	14.21447	0	16.69025	16.51513	0	0	0	11.70894	16.37174	0	15.73931	0	15.87999	0	0	0	16.32718	14.84394	14.83057	0	17.57141	16.12551	0	15.55762	0	0	0	16.38338	16.20442	15.45835	15.78212	16.2693
A0PJE2	DHR12_HUMAN	"Dehydrogenase/reductase SDR family member 12, EC 1.1.-.- (Short-chain dehydrogenase/reductase family 40C member 1, Protein SDR40C1)"	DHRS12 SDR40C1	Homo sapiens (Human)			oxidoreductase activity [GO:0016491]	oxidoreductase activity [GO:0016491]	GO:0016491	GGTVHLVCR	6.239999771	0.141194582	0.141194582	0.073759601	998.7693636	0	14.37627	0	0	10.8982	12.77629	0	16.3408	0	0	14.9335	16.8084	16.6728	0	0	0	0	0	0	0	13.25226	0	15.34347	13.54346	0	13.01444	15.85836	0	11.88207	13.20293	16.98132	0	17.25992	10.48965	17.11856	0	0	16.69226	15.63989	11.76221	0	15.51622	14.99971	0	0	0	16.60812	0
A0PJY2	FEZF1_HUMAN	Fez family zinc finger protein 1 (Zinc finger protein 312B)	FEZF1 FEZ ZNF312B	Homo sapiens (Human)	"axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; negative regulation of cell population proliferation [GO:0008285]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; negative regulation of cell population proliferation [GO:0008285]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0001764; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0007411; GO:0008285; GO:0021772; GO:0021797; GO:0043697; GO:0045666; GO:0045893; GO:0046872; GO:0050767	MLATAPARGNMMSTSKPLAFSIER	4.599999905	0.043800537	0.043800537	4.57E-12	2595.987185	0	0	0	0	0	0	14.14896	15.42412	15.27211	0	0	14.70186	0	15.935	15.20076	0	0	14.81726	14.4857	16.23131	0	16.64932	0	0	0	0	0	13.57942	15.15738	13.60692	0	16.11164	15.55439	16.17552	0	14.50152	17.64597	15.24478	0	0	0	16.3608	0	15.82014	0	0	0	0
A1A4S6	RHG10_HUMAN	Rho GTPase-activating protein 10 (GTPase regulator associated with focal adhesion kinase 2) (Graf-related protein 2) (Rho-type GTPase-activating protein 10)	ARHGAP10 GRAF2	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471; GO:0051056	LPEKNK	8.460000038	1	1	0.069019695	728.3432217	0	0	0	0	15.29021	0	12.56044	15.90259	14.58674	15.08676	17.32024	15.82417	0	0	13.74117	0	0	15.48609	14.9646	0	17.00255	0	0	0	14.97877	0	0	0	15.98325	0	0	0	0	0	0	0	16.17976	0	0	0	15.777	15.65291	15.01882	0	0	0	0	0
A1A4V9	CF119_HUMAN	Cilia- and flagella-associated protein 119 (Coiled-coil domain-containing protein 189)	CFAP119 C16orf93 CCDC189	Homo sapiens (Human)		acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228]		GO:0001669; GO:0005737; GO:0097228	TQWTTAAAAK	8.300000191	1	1	0.216882662	1048.038001	0	0	15.4015	14.1413	15.06614	0	0	0	0	0	15.42415	0	15.61818	0	14.64054	15.67482	16.39258	15.20983	0	0	0	0	0	0	14.77094	0	15.04083	15.48927	0	0	0	12.14623	0	0	15.93377	15.64406	16.09449	16.36305	13.47864	14.43302	0	10.31929	0	0	0	16.05728	0	0
A1A4Y4	IRGM_HUMAN	"Immunity-related GTPase family M protein, EC 3.6.5.- (Immunity-related GTPase family M protein 1) (Interferon-inducible protein 1) (LPS-stimulated RAW 264.7 macrophage protein 47 homolog, LRG-47)"	IRGM IFI1 IRGM1 LRG47	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein destabilization [GO:0031648]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]	autophagosome membrane [GO:0000421]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]	autophagosome membrane [GO:0000421]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; BH3 domain binding [GO:0051434]; CARD domain binding [GO:0050700]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; autophagosome assembly [GO:0000045]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein destabilization [GO:0031648]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]	BH3 domain binding [GO:0051434]; CARD domain binding [GO:0050700]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]	GO:0000045; GO:0000139; GO:0000421; GO:0001891; GO:0001934; GO:0003924; GO:0005525; GO:0005739; GO:0005789; GO:0005794; GO:0005829; GO:0006952; GO:0006954; GO:0010508; GO:0010800; GO:0019901; GO:0030670; GO:0031648; GO:0033138; GO:0035458; GO:0042742; GO:0042995; GO:0043254; GO:0043539; GO:0045087; GO:0050700; GO:0050821; GO:0050829; GO:0051434; GO:0060335; GO:0061635; GO:0061739; GO:0061762; GO:0070431; GO:0071222; GO:0071902; GO:0098586; GO:1901098	ERVCEY	7.019999981	1	1	0.195906937	856.2720582	15.41917	0	0	0	0	0	14.01679	17.26504	14.55412	15.41395	13.9539	14.75052	0	0	0	15.03497	12.05373	0	0	13.40378	0	15.0405	14.33577	14.84498	0	0	0	0	0	0	0	16.21088	15.02711	0	0	0	0	0	0	0	0	16.13582	16.05422	0	15.5595	0	15.63367	0
A1A519	F170A_HUMAN	Protein FAM170A (Zinc finger domain-containing protein) (Zinc finger protein ZNFD)	FAM170A ZNFD	Homo sapiens (Human)	"fertilization [GO:0009566]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; fertilization [GO:0009566]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006366; GO:0009566; GO:0045893; GO:0046872	TESDSLPGSPTVEDTPRAK	3.00999999	1	1	0.341590115	1986.948098	12.58829	0	0	0	0	0	14.81105	0	13.02555	14.9859	16.76876	14.41865	0	15.98766	11.02969	15.46556	13.79746	0	0	0	0	0	0	0	0	0	0	0	0	14.88865	15.87484	0	0	0	0	0	16.01026	16.13263	0	0	0	0	0	0	15.79629	0	15.26178	0
A1A5B4	ANO9_HUMAN	Anoctamin-9 (Transmembrane protein 16J) (Tumor protein p53-inducible protein 5) (p53-induced gene 5 protein)	ANO9 PIG5 TMEM16J TP53I5	Homo sapiens (Human)	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; lipid metabolic process [GO:0006629]; negative regulation of intracellular calcium activated chloride channel activity [GO:1902939]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; lipid metabolic process [GO:0006629]; negative regulation of intracellular calcium activated chloride channel activity [GO:1902939]; transmembrane transport [GO:0055085]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]	GO:0005229; GO:0005254; GO:0005886; GO:0006629; GO:0006821; GO:0016021; GO:0017128; GO:0034220; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476; GO:1902939	ASESGHLPR	9.649999619	0.103742748	0.103742748	0.131948129	952.9971069	14.64713	15.48471	0	16.55801	11.41907	0	15.73203	12.69911	12.38479	17.24275	0	0	0	16.68717	0	13.85273	18.74382	0	13.18059	14.6723	0	0	14.90468	15.03047	0	17.5304	19.48743	0	15.45189	15.82766	0	17.55774	18.16264	17.60257	17.28562	0	16.43819	0	12.03165	15.55299	0	13.71249	0	0	0	17.41799	0	0
A1A5C7	S22AN_HUMAN	Solute carrier family 22 member 23	SLC22A23 C6orf85	Homo sapiens (Human)	ion transport [GO:0006811]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	EAAGGGPGR	3.289999962	1	1	0.187726706	772.2212356	17.609	15.26154	15.36445	0	0	0	11.20128	14.43276	15.0811	14.68434	12.1776	16.57094	0	0	0	0	15.69902	0	0	11.7747	17.11883	0	0	0	14.44093	15.86691	15.61179	0	0	15.90651	0	0	0	17.74158	16.25851	16.02075	0	0	0	14.32741	16.41571	0	0	0	0	17.18114	15.41113	0
A1A5D9	BICL2_HUMAN	"BICD family-like cargo adapter 2 (Bicaudal D-related protein 2, BICD-related protein 2, BICDR-2) (Coiled-coil domain-containing protein 64B)"	BICDL2 BICDR2 CCDC64B	Homo sapiens (Human)	Golgi to secretory granule transport [GO:0055107]; vesicle transport along microtubule [GO:0047496]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; small GTPase binding [GO:0031267]; Golgi to secretory granule transport [GO:0055107]; vesicle transport along microtubule [GO:0047496]	small GTPase binding [GO:0031267]	GO:0005737; GO:0031267; GO:0047496; GO:0055107	AAPRFSLR	7.289999962	1	1	0.216361344	916.840243	13.2343	14.34038	16.01102	11.69506	14.6019	15.20889	14.06999	11.23213	13.25799	12.26713	13.95313	13.44678	13.75116	14.83457	13.40174	14.78572	14.37244	13.44248	14.62726	11.97396	16.84541	15.60681	16.5541	16.04742	13.63741	15.29631	16.17095	15.54323	15.97823	14.4657	14.52387	0	0	0	0	15.22314	15.83916	0	0	15.98908	13.4717	14.43016	0	15.71654	0	15.26762	15.35742	0
A1IGU5	ARH37_HUMAN	Rho guanine nucleotide exchange factor 37	ARHGEF37	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005737	EVASK	3.170000076	1	1	0.221867878	533.9811317	0	0	15.92806	0	0	14.96478	0	0	0	0	0	15.98636	14.50737	0	14.74123	0	0	0	0	14.05705	0	14.07697	0	0	0	15.49493	14.46897	15.74992	14.39499	14.26431	0	0	0	0	0	0	0	0	16.68985	12.16486	15.49042	14.04573	14.96758	15.83628	15.77877	0	0	0
A1KZ92	PXDNL_HUMAN	"Probable oxidoreductase PXDNL, EC 1.-.-.- (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1, PRM1) (Vascular peroxidase 2)"	PXDNL VPO2	Homo sapiens (Human)	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; endonuclease activity [GO:0004519]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	endonuclease activity [GO:0004519]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004519; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0020037; GO:0042744; GO:0046872	AVTQESQK	5.050000191	0.356054187	0.356054187	0.073954417	890.2437849	14.0408	0	14.92086	14.91299	12.74744	13.9752	0	17.90471	13.72242	16.94635	16.43443	15.30259	15.09041	13.02516	14.49236	12.62373	0	15.85438	17.47575	13.91529	14.73457	14.75422	0	17.80371	17.93377	13.37703	0	0	15.62978	14.92733	13.65912	16.57411	0	0	15.9368	0	16.40602	17.36977	14.96469	15.57284	0	12.95099	12.8469	12.06086	14.67761	16.57378	15.49675	15.67131
A1L020	MEX3A_HUMAN	RNA-binding protein MEX3A (RING finger and KH domain-containing protein 4)	MEX3A RKHD4	Homo sapiens (Human)		cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005634; GO:0005829; GO:0046872	DPVFEITGAPGNVER	3.650000095	0.354120851	0.354120851	0.312956575	1601.994673	10.47255	13.44928	0	14.73938	13.51907	0	15.01794	13.32119	11.44918	13.67868	13.34129	12.90446	0	0	0	0	0	0	15.34689	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.98869	16.67191	0	16.47955	15.84753	0	13.8876	0	15.90488	0	0	0
A1L168	CT202_HUMAN	Uncharacterized protein C20orf202	C20orf202	Homo sapiens (Human)						ARAGSEGR	10.46000004	1	1	0.033932582	803.7330177	0	0	12.88437	0	14.81778	0	9.712662	16.74325	0	16.24887	15.87282	14.60371	0	0	14.69112	15.02308	14.50853	13.95179	0	0	0	0	0	15.76247	0	15.56892	0	0	0	0	15.77053	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A1L188	NDUF8_HUMAN	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8	NDUFAF8 C17orf89	Homo sapiens (Human)	mitochondrial respiratory chain complex I assembly [GO:0032981]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]		GO:0005739; GO:0032981	LAACGAEAAAYGR	14.77000046	1	1	0.992143861	1283.510197	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.79205	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A1L190	SYCE3_HUMAN	"Synaptonemal complex central element protein 3 (Testis highly expressed gene 2 protein, THEG-2)"	SYCE3 C22orf41 THEG2	Homo sapiens (Human)	cell division [GO:0051301]; positive regulation of apoptotic process [GO:0043065]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]	central element [GO:0000801]; chromosome [GO:0005694]; nucleus [GO:0005634]	central element [GO:0000801]; chromosome [GO:0005694]; nucleus [GO:0005634]; cell division [GO:0051301]; positive regulation of apoptotic process [GO:0043065]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]		GO:0000801; GO:0005634; GO:0005694; GO:0007130; GO:0007131; GO:0007283; GO:0043065; GO:0051301	NYDNMLKMLSDLNK	3.950000048	1	1	0.162791612	1731.174911	16.13183	0	0	0	0	14.72727	17.45775	0	13.5606	14.9889	0	16.301	0	0	0	0	0	0	0	0	13.73249	0	0	0	0	17.59337	0	0	0	0	0	0	0	0	0	0	0	0	0	14.38114	0	0	0	0	0	0	0	0
A1L390	PKHG3_HUMAN	"Pleckstrin homology domain-containing family G member 3, PH domain-containing family G member 3"	PLEKHG3 KIAA0599	Homo sapiens (Human)	regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]	cytosol [GO:0005829]; actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114]; regulation of small GTPase mediated signal transduction [GO:0051056]	actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0003779; GO:0005085; GO:0005829; GO:0030334; GO:0051056; GO:2000114	GPLSPFNSRAAAGPAHHK	3.579999924	1	1	0.266146251	1815.352403	0	0	15.31778	0	0	0	0	0	0	0	17.12459	0	0	0	0	0	0	0	0	0	16.11651	0	0	0	0	19.28222	0	17.51709	0	0	0	0	0	0	0	0	16.4879	0	0	0	0	0	0	0	0	0	0	0
A1L4H1	SRCRL_HUMAN	"Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D (Soluble scavenger protein with 5 SRCR domains, SSc5D)"	SSC5D	Homo sapiens (Human)	defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; negative regulation of interleukin-8 production [GO:0032717]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; negative regulation of interleukin-8 production [GO:0032717]	extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]	GO:0001968; GO:0005044; GO:0005615; GO:0005737; GO:0006952; GO:0016020; GO:0031012; GO:0032717; GO:0042494; GO:0043236; GO:0045087; GO:0050829; GO:0050830; GO:0050840; GO:0062023	GNEGQLGLCHHRGWK	6.210000038	0.595434546	0.595434546	0.344433963	1742.580537	0	0	17.62888	0	0	0	0	0	18.0416	18.79328	0	0	16.75109	0	18.56538	18.45011	0	0	0	0	0	0	0	0	0	19.21157	0	0	0	0	17.01679	0	18.41089	0	0	0	0	0	0	0	0	0	0	16.57303	20.50018	0	14.95892	0
A1L4Q6	YK033_HUMAN	Putative uncharacterized protein FLJ41423		Homo sapiens (Human)						ESANIY	9.619999886	1	1	3.45E-13	696.2469346	16.24293	16.65793	17.27474	0	0	0	15.80423	0	0	15.83362	15.77911	14.25722	0	15.61471	0	0	0	0	0	0	0	0	0	0	0	0	16.65487	0	16.3921	0	0	16.21854	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.77762	0
A1X283	SPD2B_HUMAN	SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains)	SH3PXD2B FAD49 KIAA1295 TKS4	Homo sapiens (Human)	adipose tissue development [GO:0060612]; bone development [GO:0060348]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; podosome assembly [GO:0071800]; protein localization to membrane [GO:0072657]; skeletal system development [GO:0001501]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]	"cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; adipose tissue development [GO:0060612]; bone development [GO:0060348]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; podosome assembly [GO:0071800]; protein localization to membrane [GO:0072657]; skeletal system development [GO:0001501]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]"	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176]"	GO:0001501; GO:0001654; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0016176; GO:0022617; GO:0030054; GO:0030154; GO:0032266; GO:0042169; GO:0042554; GO:0042995; GO:0060348; GO:0060612; GO:0071800; GO:0072657; GO:0080025	DMTIPR	12.80000019	0.173970878	0.173970878	0.296247148	747.8044759	13.11675	16.39484	14.64177	0	0	0	0	18.75586	0	18.49334	0	0	0	16.65737	16.93879	0	0	0	0	0	0	17.71305	16.46326	16.96548	18.36288	0	18.01908	0	0	0	19.797	0	0	0	17.06437	0	17.94978	0	0	0	0	16.54335	0	17.20559	0	17.33347	17.74364	0
A1XBS5	CBAR1_HUMAN	CBY1-interacting BAR domain-containing protein 1	CIBAR1 FAM92A FAM92A1	Homo sapiens (Human)	cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; limb morphogenesis [GO:0035108]; membrane organization [GO:0061024]; membrane tubulation [GO:0097749]; positive regulation of smoothened signaling pathway [GO:0045880]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; limb morphogenesis [GO:0035108]; membrane organization [GO:0061024]; membrane tubulation [GO:0097749]; positive regulation of smoothened signaling pathway [GO:0045880]	phospholipid binding [GO:0005543]	GO:0005543; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0007007; GO:0019898; GO:0030061; GO:0035108; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0061024; GO:0097546; GO:0097749	AAMDASRTSR	4.800000191	0.223158553	0.223158553	0.081356608	1078.24722	14.72463	15.2528	0	0	13.59716	14.73238	0	0	13.82918	16.22142	13.63335	0	0	16.37616	13.59553	14.29156	17.36684	13.01326	0	0	0	0	16.02608	13.47409	11.90752	16.9252	15.89842	14.83307	15.56887	13.4733	14.39057	14.87474	13.19381	14.53525	13.90917	0	14.61327	12.68223	11.33176	0	14.76627	17.04876	14.39242	16.00519	13.63347	0	12.249	14.4413
A1Z1Q3	MACD2_HUMAN	"ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2, EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2, EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2, EC 3.2.2.-)"	MACROD2 C20orf133	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]"	"ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]"	GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293	GHINGSHK	2.25	1	1	0.315675442	849.0555487	0	0	14.69435	14.62041	14.97582	0	0	0	11.30677	14.35029	0	13.05004	14.96369	13.14739	0	0	0	0	0	0	0	0	15.66665	0	0	0	0	0	0	0	0	15.39559	0	0	0	0	0	0	0	0	0	0	0	15.18622	0	0	0	0
A2A288	ZC12D_HUMAN	"Probable ribonuclease ZC3H12D, EC 3.1.-.- (MCP-induced protein 4) (Transformed follicular lymphoma) (Zinc finger CCCH domain-containing protein 12D) (p34)"	ZC3H12D C6orf95 MCPIP4 TFL	Homo sapiens (Human)	"3'-UTR-mediated mRNA destabilization [GO:0061158]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]	GO:0000932; GO:0003729; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0006402; GO:0030308; GO:0036464; GO:0046872; GO:0061158; GO:0090502; GO:2000134	ETFSCR	9.760000229	1	1	0.239426734	799.1964933	0	0	0	0	0	0	0	0	17.63989	0	0	0	16.61049	0	0	0	0	0	0	0	14.94452	0	0	0	0	17.45639	0	0	16.18031	0	0	0	0	0	0	0	20.2841	0	0	0	0	0	0	0	0	0	0	0
A2A2Y4	FRMD3_HUMAN	"FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1, 4.1O)"	FRMD3 EPB41L4O	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]	cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeletal protein binding [GO:0008092]	GO:0005856; GO:0008092; GO:0016021; GO:0031032	TFYVIGTQK	2.920000076	1	1	0.163749147	1052.790821	14.94924	0	13.07766	0	0	14.89362	16.24947	13.15609	14.95382	0	0	15.0786	0	0	13.29253	0	0	15.34901	0	0	0	15.03237	0	0	0	0	15.86803	0	0	0	0	0	0	0	14.95685	0	0	0	0	0	0	0	0	0	0	0	0	0
A2A2Z9	AN18B_HUMAN	Ankyrin repeat domain-containing protein 18B	ANKRD18B	Homo sapiens (Human)						EAVSSK	18.92000008	0.933404326	0.933404326	0.130946108	620.5477314	18.60105	0	14.8748	16.15679	0	16.27979	0	15.82138	0	0	0	15.57333	0	15.91129	0	15.06371	14.98931	0	0	17.02697	15.40057	0	0	15.91025	16.75596	0	0	14.98564	0	0	17.03986	14.55133	16.13035	16.07901	16.49483	16.16995	18.3714	16.92358	16.72208	0	0	0	16.36114	0	14.67857	0	0	0
A2A3K4	PTPC1_HUMAN	"Protein tyrosine phosphatase domain-containing protein 1, EC 3.1.3.-"	PTPDC1 PTP9Q22	Homo sapiens (Human)	cilium assembly [GO:0060271]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cilium assembly [GO:0060271]	protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0004725; GO:0005654; GO:0005737; GO:0008138; GO:0060271	MTKDGPKPGL	6.679999828	1	1	0.182569943	1038.447317	0	13.88665	13.60469	15.42124	14.95466	13.03576	0	0	13.08156	0	0	0	12.72188	0	16.59147	0	0	0	0	13.81463	14.20037	0	0	0	16.39108	0	0	0	0	0	0	0	15.60198	0	0	0	0	16.48638	0	0	0	0	0	15.42942	0	0	0	0
A2A3L6	TTC24_HUMAN	"Tetratricopeptide repeat protein 24, TPR repeat protein 24"	TTC24	Homo sapiens (Human)						AGSSTAGVQHR	3.599999905	0.881621897	0.881621897	0.231626609	1071.336022	0	16.4122	9.497762	16.01972	0	0	12.63236	15.56734	14.46931	12.09472	16.59638	14.74228	0	15.14677	0	0	0	17.38365	0	0	0	0	16.04472	15.54009	17.74489	17.17655	15.62541	13.99676	13.15039	15.414	17.60344	15.85631	0	0	0	0	0	0	17.37563	0	0	15.63522	0	0	0	14.06132	13.63074	0
A2A3N6	PIPSL_HUMAN	"Putative PIP5K1A and PSMD4-like protein, PIP5K1A-PSMD4"	PIPSL PSMD4P2	Homo sapiens (Human)	phosphatidylinositol phosphate biosynthetic process [GO:0046854]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]	1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]	GO:0005737; GO:0005886; GO:0016308; GO:0046854	ILSKLHTVQPK	4.639999866	1	1	0.295428492	1261.099857	14.57419	0	13.05337	0	17.68271	0	0	0	0	0	14.62811	0	0	0	0	14.06872	15.96474	0	16.92558	0	0	0	0	0	0	0	0	0	0	0	0	0	15.04564	0	0	14.39993	0	0	0	0	0	0	0	0	0	0	0	0
A2AJT9	BCLA3_HUMAN	BCLAF1 and THRAP3 family member 3	BCLAF3 CXorf23	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]	mediator complex [GO:0016592]; mitochondrion [GO:0005739]	mediator complex [GO:0016592]; mitochondrion [GO:0005739]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]	DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0005739; GO:0016592; GO:0045944	IDMSLAELQSK	4.179999828	1	1	4.63E-13	1250.444382	14.38478	18.85734	16.74693	15.54262	16.83746	16.75899	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A2CJ06	DYTN_HUMAN	Dystrotelin	DYTN	Homo sapiens (Human)	synaptic signaling [GO:0099536]	plasma membrane [GO:0005886]; synapse [GO:0045202]	plasma membrane [GO:0005886]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; synaptic signaling [GO:0099536]	zinc ion binding [GO:0008270]	GO:0005886; GO:0008270; GO:0045202; GO:0099536	HSLSVQQLSQALQELFQK	2.309999943	1	1	0	2085.198735	14.129	15.3726	16.26562	12.38431	0	13.48889	13.85357	0	13.40771	15.64775	15.7579	15.1812	0	0	14.01474	14.64751	14.0282	13.89776	14.30857	0	15.33645	0	13.48514	14.20953	0	0	0	0	0	0	0	0	0	0	15.82677	0	0	0	0	0	0	0	0	0	14.75678	0	0	0
A2PYH4	HFM1_HUMAN	"Probable ATP-dependent DNA helicase HFM1, EC 3.6.4.12 (SEC63 domain-containing protein 1)"	HFM1 SEC3D1	Homo sapiens (Human)	resolution of meiotic recombination intermediates [GO:0000712]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]; resolution of meiotic recombination intermediates [GO:0000712]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]	GO:0000712; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0016887	MDEGVNFKPTEAGR	1.169999957	1	1	0.277729485	1567.072827	17.11378	11.68988	15.03869	16.60143	16.06363	0	0	16.30864	0	0	0	0	16.15615	0	0	0	0	0	0	0	0	0	0	0	15.24074	0	0	0	0	0	0	15.00545	0	0	0	0	18.61054	0	0	0	0	0	0	0	0	16.79811	16.60444	16.68566
A2RRH5	WDR27_HUMAN	WD repeat-containing protein 27	WDR27	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	GHHQPITAMAFGNK	3.609999895	1	1	0.679789982	1522.988092	0	0	17.25338	0	0	0	17.37022	0	17.70864	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.33973	0	0	19.44685	0	0	0	0	0	0	0	0
A2RTX5	SYTC2_HUMAN	"Threonine--tRNA ligase 2, cytoplasmic, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase protein 3)"	TARS3 TARSL2	Homo sapiens (Human)	threonyl-tRNA aminoacylation [GO:0006435]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435]	ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]	GO:0004829; GO:0005524; GO:0005634; GO:0005737; GO:0006435	DTFALKPMNCPGHCLMFAHRPR	2.440000057	1	1	0	2671.164125	17.05153	0	14.25645	15.50331	15.20101	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A2RTY3	HEAT9_HUMAN	Protein HEATR9 (HEAT repeat-containing protein 9)	HEATR9 C17orf66	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]		hematopoietic progenitor cell differentiation [GO:0002244]		GO:0002244	AMAPVHLPLSCYQMPK	3.369999886	1	1	0.649516581	1860.785451	0	0	0	0	0	0	0	0	17.35979	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.49438	0	0	17.84462	0	0	18.13969	0	0	0	18.22131	0	0	0	17.04865	0	0	0	0	0	16.97823	0
A2RU54	HMX2_HUMAN	Homeobox protein HMX2 (Homeobox protein H6 family member 2)	HMX2	Homo sapiens (Human)	"brain development [GO:0007420]; cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007420; GO:0008284; GO:0030154; GO:0042472; GO:0048026; GO:1990837	GSGGSGPGGLER	7.119999886	0.597261727	0.597261727	0.137885066	1031.433307	0	0	0	0	0	15.25308	0	0	16.02114	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A2RU67	F234B_HUMAN	Protein FAM234B	FAM234B KIAA1467	Homo sapiens (Human)		cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005794; GO:0005856; GO:0016021	DVLLSFVMSR	1.220000029	1	1	0.336080741	1165.89294	15.62966	14.25131	15.85483	13.93993	15.99237	16.14038	14.16025	15.06665	15.50449	0	15.48071	15.29204	14.10013	13.48032	14.96067	16.01269	15.82813	0	13.58026	16.49452	0	0	0	0	15.57507	0	0	0	15.21219	0	16.84938	15.61596	0	0	14.25956	0	15.25188	0	0	12.85561	16.90848	16.05303	0	0	16.86896	0	14.58844	0
A2RUB1	MEIOC_HUMAN	Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein)	MEIOC C17orf104	Homo sapiens (Human)	"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]"		GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192	CQDDRDVFALASAIK	3.420000076	1	1	0.040452894	1707.648323	12.58715	13.10491	0	14.18598	0	0	0	0	0	0	0	0	0	0	15.50965	12.30912	0	0	0	0	16.75012	0	0	15.01406	0	0	0	0	0	0	13.90594	0	0	14.90679	0	15.7295	0	0	0	0	0	0	16.41993	0	0	0	0	0
A2RUB6	CCD66_HUMAN	Coiled-coil domain-containing protein 66	CCDC66	Homo sapiens (Human)	cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; microtubule bundle formation [GO:0001578]; regulation of protein localization to cilium [GO:1903564]; retina homeostasis [GO:0001895]	cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; microtubule bundle formation [GO:0001578]; regulation of protein localization to cilium [GO:1903564]; retina homeostasis [GO:0001895]	microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]	GO:0001578; GO:0001750; GO:0001895; GO:0001917; GO:0005813; GO:0005829; GO:0005874; GO:0005929; GO:0008017; GO:0030054; GO:0034451; GO:0036064; GO:0042803; GO:0050908; GO:0060271; GO:0090543; GO:1903564	NLGVDTIQMEYNASNISNSR	1.450000048	1	1	1.37E-12	2226.33067	14.14869	12.90715	14.09523	0	0	0	0	0	0	0	0	0	9.897771	14.65409	12.8778	13.15175	8.550488	0	0	0	0	13.318	16.03625	15.84624	0	10.65304	0	14.40549	10.57791	14.73013	12.98808	13.83479	0	15.30573	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A2RUR9	C144A_HUMAN	Coiled-coil domain-containing protein 144A	CCDC144A KIAA0565	Homo sapiens (Human)						GKAEWHK	3.789999962	0.876722813	0.876722813	0.232512896	854.9397215	15.04631	15.56561	13.54498	15.56741	14.78235	15.29297	0	12.61272	17.045	16.46	16.76396	15.62321	17.14299	12.7879	0	14.3066	0	15.11341	0	0	0	15.37281	0	15.9348	16.50292	0	16.21767	0	0	0	17.29086	0	16.3486	0	0	0	15.87206	0	15.85531	0	14.72565	0	0	0	15.38492	0	15.6109	0
A2RUS2	DEND3_HUMAN	DENN domain-containing protein 3	DENND3 KIAA0870	Homo sapiens (Human)	cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333]; regulation of Rab protein signal transduction [GO:0032483]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333]; regulation of Rab protein signal transduction [GO:0032483]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0008333; GO:0031410; GO:0032483; GO:0044257	IAMTQKR	4.070000172	0.09183459	0.09183459	0.176154706	864.4831548	15.71687	15.84959	13.86378	0	0	0	0	14.05564	15.60273	0	14.09729	0	13.86272	14.35436	15.86283	14.8033	16.1027	0	0	17.12431	15.06397	0	15.63677	15.86743	14.30638	16.14124	13.34039	0	16.02427	14.45053	14.81764	15.82389	16.44383	14.22467	15.55572	15.74066	14.38484	0	15.05089	14.52005	13.78495	0	14.90937	14.23931	15.18496	0	13.22106	0
A2VDJ0	T131L_HUMAN	Transmembrane protein 131-like	TMEM131L KIAA0922	Homo sapiens (Human)	negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; Wnt signaling pathway [GO:0016055]		GO:0005737; GO:0005783; GO:0005886; GO:0016020; GO:0016021; GO:0016055; GO:0033088; GO:0090090	LQMSIMVTMENFSK	8.960000038	1	1	0	1673.657861	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A2VEC9	SSPO_HUMAN	SCO-spondin (SCO-spondin pseudogene)	SSPOP KIAA2036 SSPO	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	peptidase inhibitor activity [GO:0030414]	GO:0005615; GO:0007155; GO:0007399; GO:0030154; GO:0030414; GO:0031012	GARAGAPCTR	5.239999771	0.638375401	0.638375401	0.20472217	1017.432011	14.55138	14.79624	0	14.89462	0	13.48416	13.86053	14.85557	0	15.5678	14.174	0	10.74764	0	16.62433	14.66051	12.65626	14.61222	0	0	14.78513	0	0	16.39954	0	12.57714	0	12.96221	13.8604	10.1062	17.42828	14.91265	16.05124	0	15.12681	14.27699	0	6.747334	15.3864	0	0	12.29297	14.18039	13.74603	13.33945	15.2736	14.46881	0
A3KMH1	VWA8_HUMAN	"von Willebrand factor A domain-containing protein 8 (PEX7-binding protein 2, P7BP2)"	VWA8 KIAA0564	Homo sapiens (Human)		cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005737; GO:0005739; GO:0005777; GO:0016887	FPTEGLSSVVR	8.539999962	1	1	0.22658992	1195.321136	16.07634	15.09169	0	0	0	0	0	0	12.29649	0	0	0	0	0	0	15.61897	0	0	0	0	16.06481	0	16.82323	0	0	0	0	0	0	0	0	0	0	0	0	0	16.52833	0	0	0	0	0	0	0	0	0	0	15.07829
A3KN83	SBNO1_HUMAN	"Protein strawberry notch homolog 1 (Monocyte protein 3, MOP-3)"	SBNO1 MOP3	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0005634; GO:0006355; GO:0031490; GO:0042393	KTAILVK	1.580000043	1	1	0.198866197	772.1208584	12.42166	14.58728	15.67041	12.49575	14.03249	0	14.79762	0	13.78198	0	14.91012	0	14.73385	15.43872	14.68081	0	0	0	0	17.26287	0	16.05584	0	0	0	0	0	0	0	0	0	16.44856	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.12636	0
A4D0V7	CPED1_HUMAN	Cadherin-like and PC-esterase domain-containing protein 1	CPED1 C7orf58 UNQ9432/PRO34713	Homo sapiens (Human)		endoplasmic reticulum [GO:0005783]	endoplasmic reticulum [GO:0005783]		GO:0005783	EAIGK	5.820000172	1	1	0.287236655	517.0019511	17.08821	16.05812	15.20866	0	15.47127	16.41848	16.13487	0	0	0	0	0	0	15.14401	0	16.41259	15.82397	14.76059	15.76425	16.35854	0	17.85095	16.51053	14.81077	15.8417	16.32357	16.10883	15.28972	0	0	15.65664	17.2399	0	15.3346	0	15.68129	0	0	0	16.38108	0	0	16.38554	17.84478	0	16.88498	0	16.84349
A4D1E1	Z804B_HUMAN	Zinc finger protein 804B	ZNF804B	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005634; GO:0046872	SPIYKTK	1.309999943	1	1	0.105509489	836.0512942	13.82108	0	0	11.48855	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.91313	14.28906	0	0	0	0	15.28721	0	0	0	0	15.89584	0	0	0	0	0	0	0	0	0
A4D1E9	GTPBA_HUMAN	"GTP-binding protein 10 (Protein obg homolog 2, ObgH2)"	GTPBP10 OBGH2 UG0751c10	Homo sapiens (Human)	ribosome biogenesis [GO:0042254]	chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254	GGSGGMGYPRLGGEGGK	5.849999905	1	1	0.222490103	1553.380233	0	0	14.88856	15.60253	11.63617	0	0	0	16.2739	0	13.59825	0	0	14.58985	12.68711	14.92707	14.42796	0	0	0	0	0	0	0	0	13.07572	0	0	0	0	0	0	0	0	0	0	0	15.88263	0	0	0	12.44697	0	0	14.20335	0	0	0
A4D1F6	LRRD1_HUMAN	Leucine-rich repeat and death domain-containing protein 1	LRRD1	Homo sapiens (Human)	positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]		positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]		GO:0007165; GO:0046579	HIPDTLPSLKTLR	5.599999905	1	1	4.59E-13	1492.01281	14.82571	12.33939	0	0	15.20228	0	12.92282	12.74814	0	0	10.40572	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.17306	0	0	0	0	0
A4D1P6	WDR91_HUMAN	WD repeat-containing protein 91	WDR91 HSPC049	Homo sapiens (Human)	early endosome to late endosome transport [GO:0045022]; regulation of cellular protein catabolic process [GO:1903362]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; early endosome to late endosome transport [GO:0045022]; regulation of cellular protein catabolic process [GO:1903362]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]	phosphatidylinositol 3-kinase regulator activity [GO:0035014]	GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022; GO:1903362	GMNQVPGR	2.529999971	0.417136431	0.417136431	0.273371809	859.4693061	17.87317	0	0	0	0	0	0	0	0	0	0	0	0	0	17.13094	0	0	17.48935	0	0	0	0	16.56307	0	0	0	0	0	17.06807	16.66547	0	18.77993	0	0	16.79729	0	0	17.75278	0	0	17.72512	17.58302	0	0	16.67068	16.69569	0	0
A4D1S5	RAB19_HUMAN	Ras-related protein Rab-19	RAB19 RAB19B	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intracellular protein transport [GO:0006886]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000045; GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0012505; GO:0070062	RHVLFEDACTLAEK	28.59000015	0.404630452	0.404630452	0.291351155	1689.667792	0	0	0	20.14655	0	16.31305	0	16.74882	0	0	0	16.18052	17.9653	17.40619	0	0	16.70611	16.6448	0	15.72795	0	14.67858	0	18.69217	0	17.60491	0	14.53005	0	16.89556	18.20737	20.01436	0	18.22992	18.23231	17.8273	0	17.953	0	16.00717	18.16534	0	17.53359	17.401	0	19.0449	0	18.66321
A4D263	SPT48_HUMAN	Spermatogenesis-associated protein 48	SPATA48 C7orf72	Homo sapiens (Human)	spermatogenesis [GO:0007283]		spermatogenesis [GO:0007283]		GO:0007283	DVEIQDTPGKISISK	3.680000067	0.074209221	0.074209221	0.232088804	1628.267272	16.55417	0	0	0	17.49959	0	0	0	0	0	0	17.33026	0	0	0	0	0	0	17.35664	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.27582	0	0	0	0	0	0
A4D2B8	PM2P1_HUMAN	"Putative postmeiotic segregation increased 2-like protein 1 (PMS2-related protein 2) (Postmeiotic segregation increased 2-like protein 13) (Postmeiotic segregation increased 2-like protein 6) (Postmeiotic segregation increased 2-like protein 8) (Postmeiotic segregation increased protein 3, hPMS3) (Postmeiotic segregation increased protein 8) (Putative postmeiotic segregation increased 2 pseudogene 1)"	PMS2P1 PMS2L1 PMS2L13 PMS2L6 PMS2L8 PMS3 PMS8 PMSR2	Homo sapiens (Human)	mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446]	mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]	mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446]	ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301]	GO:0006298; GO:0016301; GO:0016446; GO:0016887; GO:0032300; GO:0032389	SEVGGGAPR	2.829999924	0.834037304	0.834037304	0.235532583	829.2687629	15.29897	16.68394	0	0	13.63073	14.87466	15.76802	16.19801	0	0	15.32012	0	16.08125	0	0	14.56449	0	0	15.28524	0	0	0	15.08109	15.07758	0	0	0	0	0	14.54103	0	0	0	15.9169	0	17.14006	0	16.09706	0	14.71037	0	0	0	0	0	16.28759	0	0
A4D2P6	GRD2I_HUMAN	"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)"	GRID2IP	Homo sapiens (Human)	long-term synaptic depression [GO:0060292]	postsynaptic membrane [GO:0045211]	postsynaptic membrane [GO:0045211]; long-term synaptic depression [GO:0060292]		GO:0045211; GO:0060292	ATTSEAFFGIFAEFMSKFER	8.43999958	1	1	2.29E-12	2313.392658	16.07089	15.36391	12.57669	14.33297	15.05175	15.22934	16.13798	14.4837	0	16.67843	11.68079	0	0	13.45268	0	14.85665	9.521667	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A4FU69	EFCB5_HUMAN	EF-hand calcium-binding domain-containing protein 5	EFCAB5	Homo sapiens (Human)			calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509	KISPGSIK	8.579999924	0.385222942	0.385222942	0.03139131	828.7492887	16.15382	16.25993	0	0	14.34909	15.01973	15.93755	0	0	18.20004	17.05896	13.89557	16.34796	0	11.08772	16.33194	0	0	17.48443	12.38068	18.29078	16.24703	15.07605	17.95971	17.9354	12.55374	14.03183	15.03114	12.28202	16.51721	16.1372	12.94692	10.26539	13.62469	15.26642	15.29569	0	0	10.33897	15.68813	15.51547	17.60641	15.30939	17.00941	16.23721	17.18212	15.00304	16.13425
A4GXA9	EME2_HUMAN	"Probable crossover junction endonuclease EME2, EC 3.1.22.-"	EME2	Homo sapiens (Human)	double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]	endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]	endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]	DNA binding [GO:0003677]; endonuclease activity [GO:0004519]	GO:0000712; GO:0003677; GO:0004519; GO:0006302; GO:0031297; GO:0031573; GO:0043596; GO:0048476; GO:1905347	WAAGEPVAR	3.339999914	1	1	0.119815954	954.3025956	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A4UGR9	XIRP2_HUMAN	Xin actin-binding repeat-containing protein 2 (Beta-xin) (Cardiomyopathy-associated protein 3) (Xeplin)	XIRP2 CMYA3	Homo sapiens (Human)	actin filament organization [GO:0007015]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell junction organization [GO:0045216]; ventricular septum development [GO:0003281]	cell junction [GO:0030054]; Z disc [GO:0030018]	cell junction [GO:0030054]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; actin filament organization [GO:0007015]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell junction organization [GO:0045216]; ventricular septum development [GO:0003281]	actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]	GO:0003281; GO:0007015; GO:0030018; GO:0030054; GO:0045216; GO:0051015; GO:0051393; GO:0055008	EERLITER	15.11999989	0.418958783	0.418958783	0.498726453	1046.092176	0	13.73549	16.02201	16.21125	14.42351	0	16.20896	0	14.48185	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.14392	0	0	15.43065	0	0	0	0	0	16.82963	0	15.52787	0	17.18098
A5A3E0	POTEF_HUMAN	POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein)	POTEF A26C1B	Homo sapiens (Human)	retina homeostasis [GO:0001895]	blood microparticle [GO:0072562]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	blood microparticle [GO:0072562]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; retina homeostasis [GO:0001895]		GO:0001895; GO:0005615; GO:0005938; GO:0070062; GO:0072562	SNVGTSGDHDDSAMKTLR	5.039999962	1	1	0.453044584	1906.693963	14.78692	0	0	0	0	10.43051	0	14.66862	17.43164	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.29663	17.96177	14.42498	15.41258	0	18.94739	0	0	0	0	0	0	18.57545	0	0	0	0	0	0	0	0	17.49229	0
A5D6W6	FITM1_HUMAN	Fat storage-inducing transmembrane protein 1 (Fat-inducing protein 1)	FITM1 FIT1	Homo sapiens (Human)	lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]	diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129]	GO:0005789; GO:0008654; GO:0010890; GO:0017129; GO:0019915; GO:0019992; GO:0030176; GO:0034389; GO:0140042	MERGPVVGAGLGAGAR	6.53000021	1	1	9.17E-13	1513.977997	0	16.15307	0	0	15.85686	0	16.07098	0	0	0	15.69206	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.7347	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A5D8T8	CL18A_HUMAN	C-type lectin domain family 18 member A (Mannose receptor-like protein 2)	CLEC18A MRLP2	Homo sapiens (Human)		endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; polysaccharide binding [GO:0030247]	polysaccharide binding [GO:0030247]	GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0030247	TAKDSFR	5.360000134	0.612585425	0.612585425	0.210272245	823.5136237	0	16.88645	13.1903	0	0	0	15.4644	0	0	0	0	0	14.18511	0	0	0	6.391411	0	0	0	0	0	0	0	0	0	0	17.4243	0	0	15.42082	14.13507	0	0	0	0	0	15.92718	0	0	0	0	15.81668	0	16.85639	0	0	14.11484
A5D8W1	CFA69_HUMAN	Cilia- and flagella-associated protein 69	CFAP69 C7orf63	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288]	cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]	cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288]		GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834	IVDAPK	11.28999996	3.28E-06	3.28E-06	0.259212823	642.6028012	19.5391	0	0	0	19.19231	0	18.44085	0	0	0	0	20.1252	0	19.79497	0	0	16.37245	0	0	0	18.00965	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.8352	0	0	0	0	0
A5LHX3	PSB11_HUMAN	"Proteasome subunit beta type-11, EC 3.4.25.1 (Proteasome subunit beta-5t)"	PSMB11	Homo sapiens (Human)	"CD8-positive, alpha-beta T cell differentiation [GO:0043374]; proteasomal protein catabolic process [GO:0010498]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; proteasomal protein catabolic process [GO:0010498]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077]"	endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]	GO:0004175; GO:0004298; GO:0005634; GO:0005829; GO:0005839; GO:0006508; GO:0008233; GO:0010498; GO:0019774; GO:0033077; GO:0043374	EGQLPSVASAAKLLSAMMSQYR	11.61999989	1	1	0.15259578	2339.109035	0	0	0	14.5877	0	0	0	0	0	0	14.00464	0	0	0	0	0	15.73302	0	0	13.30179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.62385	17.53146	0	0	0	0	0	0	15.75602	0	0	0
A5PKW4	PSD1_HUMAN	"PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6, Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1)"	PSD EFA6 EFA6A KIAA2011 PSD1 TYL	Homo sapiens (Human)	neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]; signal transduction [GO:0007165]	"cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]"	"cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]; signal transduction [GO:0007165]"	guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]	GO:0005085; GO:0005543; GO:0007165; GO:0031175; GO:0032012; GO:0032154; GO:0032587; GO:0043197; GO:0098999; GO:0099092	MAQGAMRFCSEGDCAISPPR	1.950000048	0.129846215	0.129846215	0.08825089	2255.850054	0	0	12.13918	0	0	14.43622	0	0	0	0	0	0	0	0	16.43236	0	0	15.26328	12.11428	0	0	16.32874	0	0	15.87916	15.60594	0	0	0	0	10.00245	0	9.173341	14.76906	0	14.03612	0	16.05043	14.6901	0	0	13.01936	0	14.43223	15.07931	15.7064	16.25441	11.59948
A5PL33	KRBA1_HUMAN	Protein KRBA1	KRBA1 KIAA1862	Homo sapiens (Human)						DRLPSCKPPVPLSPCPGGTPAGSSGGSPGEDPR	3.970000029	0.327950239	0.327950239	0.20541693	3286.766514	11.97119	11.94875	14.29877	10.70786	14.16468	12.38512	14.9887	0	14.12791	0	0	0	13.84998	15.11408	9.74111	12.75795	0	10.79569	0	0	12.8241	0	14.86454	0	0	0	15.5733	0	0	0	0	0	0	0	0	0	13.10199	0	0	0	0	14.49438	11.64499	0	0	0	0	0
A5PLK6	RGSL_HUMAN	Regulator of G-protein signaling protein-like	RGSL1 RGSL RGSL2	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	AYNENDVILMR	18.28000069	1	1	0.276721652	1354.062878	0	15.18328	0	0	14.16842	0	15.02793	16.23873	15.69255	14.86456	0	14.7757	0	16.44631	0	0	0	16.37741	0	0	0	0	0	0	0	0	0	0	16.70001	0	15.74943	14.95686	0	0	0	0	0	0	0	0	0	0	0	14.59141	17.10958	0	16.88474	0
A5PLN7	F149A_HUMAN	Protein FAM149A	FAM149A MST119	Homo sapiens (Human)						GTKLPTGVDHMASPLVQTSR	4.71999979	0.18483229	0.18483229	0.03254032	2112.074792	17.45589	0	0	14.79785	0	12.43161	0	11.6957	0	17.05522	14.44657	14.77157	13.71362	0	0	0	14.13009	0	13.84398	0	9.567242	12.42859	15.09862	13.95151	13.55552	0	0	0	0	0	13.14496	0	13.30974	0	16.92702	14.62048	0	0	12.81207	16.11081	0	0	9.996795	0	0	0	0	0
A5YKK6	CNOT1_HUMAN	"CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog, NOT1H, hNOT1)"	CNOT1 CDC39 KIAA1007 NOT1 AD-005	Homo sapiens (Human)	"gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]	"CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]"	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; RNA binding [GO:0003723]	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036	EVFNCMLR	13.01000023	0.491984665	0.491984665	0.440207153	1085.375179	0	12.08351	0	0	0	0	0	0	0	15.85774	14.68942	0	0	0	0	15.93413	15.31248	16.70503	0	0	17.37124	15.69591	0	0	0	0	16.59997	12.29599	13.94083	0	16.75309	12.77501	0	0	15.03387	0	16.47886	17.37698	16.90693	15.72329	0	14.94792	14.8309	15.03824	16.0463	0	15.96192	17.35508
A6H8Y1	BDP1_HUMAN	"Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150, TFIIIB150) (Transcription factor-like nuclear regulator)"	BDP1 KIAA1241 KIAA1689 TFNR	Homo sapiens (Human)	RNA polymerase III preinitiation complex assembly [GO:0070898]	nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126]	nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126]; TFIIIC-class transcription factor complex binding [GO:0001156]; RNA polymerase III preinitiation complex assembly [GO:0070898]	TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0000126; GO:0001156; GO:0005654; GO:0070898	ASKAMLVTLR	2.470000029	1	1	0.118960254	1105.284116	0	0	12.0338	0	0	0	15.38154	0	15.06787	11.67674	13.83973	14.01835	13.7204	14.54226	0	16.34611	0	0	0	14.02608	0	0	0	15.11552	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NC05	YD286_HUMAN	Glutaredoxin-like protein C5orf63	C5orf63	Homo sapiens (Human)						DQKLPGTR	3.74000001	1	1	0.130294261	915.4522733	0	0	15.01904	10.75215	15.7813	0	14.29571	0	0	0	0	15.62305	0	0	15.64885	14.76607	0	0	0	0	15.94289	14.03293	15.52552	0	15.58121	0	15.07873	14.16326	16.21444	0	16.10467	0	12.85656	0	0	14.72432	11.48339	16.63829	0	0	0	13.8671	0	0	0	14.88493	0	14.56554
A6NC86	PINLY_HUMAN	phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein	PINLYP	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; phospholipase inhibitor activity [GO:0004859]	phospholipase inhibitor activity [GO:0004859]	GO:0004859; GO:0005576	DTCVLLVGK	8.020000458	1	1	0.416944302	1002.044256	14.19478	15.918	14.76458	15.05698	13.40218	12.11881	15.47089	14.61548	15.51632	15.46164	0	13.89104	14.95157	0	13.02827	15.79583	0	0	15.73341	0	0	0	0	0	0	15.01246	0	0	0	0	0	15.81392	15.67126	16.31782	0	15.68131	17.1546	17.06203	0	0	0	0	16.30454	15.50508	0	0	0	0
A6NC98	CC88B_HUMAN	"Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3, HkRP3)"	CCDC88B BRLZ	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; defense response to protozoan [GO:0042832]; positive regulation of cytokine production [GO:0001819]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; defense response to protozoan [GO:0042832]; positive regulation of cytokine production [GO:0001819]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]	dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]	GO:0001819; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0008017; GO:0016020; GO:0030705; GO:0031122; GO:0042102; GO:0042832; GO:0050870; GO:0051959	EALQAELEK	14.06000042	0.206523404	0.206523404	0.444928018	1032.124083	16.91401	0	0	0	0	0	0	0	0	0	0	0	0	16.96221	17.85966	17.22795	0	0	0	0	19.98166	0	0	0	0	15.9545	0	0	0	0	0	14.59222	14.34204	0	0	0	20.54925	0	0	20.17632	17.85209	17.04419	20.22662	0	0	18.07341	20.54432	0
A6NCF6	MA13P_HUMAN	Putative MAGE domain-containing protein MAGEA13P	MAGEA13P	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005634	KDPGASQALMLEK	6.46999979	1	1	0.584979251	1403.669119	0	0	0	18.35332	0	0	0	17.96779	19.16787	0	0	0	0	0	0	0	0	0	0	0	0	18.55125	0	0	0	18.0632	0	19.35016	0	0	0	0	0	0	0	19.97063	0	0	0	0	0	0	0	0	0	0	18.15805	0
A6NCI4	VWA3A_HUMAN	von Willebrand factor A domain-containing protein 3A	VWA3A	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	AAGGRFHWFGDTGIYESDDINSIMSEMEK	4.929999828	1	1	3.65E-12	3264.18067	11.373	15.74816	14.32364	13.75675	13.74549	13.36641	0	11.55239	15.63938	0	0	13.32688	12.9427	14.31734	0	12.69025	12.33285	0	13.57477	14.97295	12.60282	13.44182	0	10.94248	14.82092	12.27582	12.99084	0	10.9224	0	0	0	0	0	0	0	0	0	0	0	14.47289	0	0	0	14.6702	0	0	0
A6NCI8	CB078_HUMAN	Uncharacterized protein C2orf78	C2orf78	Homo sapiens (Human)						QTIPNMK	6.840000153	1	1	0.205616858	848.1009329	0	16.12711	0	16.72078	0	0	8.892937	0	15.52646	0	15.77313	16.04332	15.81746	13.14435	0	14.20901	15.95267	14.79804	0	0	0	0	14.40567	0	0	14.81934	16.92329	15.72267	0	15.05703	15.80737	15.77765	17.08533	15.4363	0	0	15.50784	11.47069	0	15.2218	16.4729	13.74488	0	0	0	0	0	16.39422
A6NCJ1	CS071_HUMAN	Uncharacterized protein C19orf71	C19orf71	Homo sapiens (Human)						APASPFR	8.909999847	1	1	0.204184614	745.5926166	0	0	0	0	14.08391	0	0	0	0	0	0	16.31923	0	0	0	0	0	0	16.09463	0	0	0	15.5645	0	0	16.15246	16.20765	0	0	0	15.38224	0	0	0	0	0	15.80857	16.29938	16.69851	15.91622	0	0	0	0	0	0	0	16.54715
A6NCL7	AN33B_HUMAN	Ankyrin repeat domain-containing protein 33B	ANKRD33B	Homo sapiens (Human)						GPAAPAPR	6.25	0.001602429	0.001602429	0.274427389	737.2079293	0	0	0	0	0	0	18.04311	18.82317	0	16.84519	0	0	0	17.73303	0	0	17.30227	16.95893	0	17.54138	0	0	0	17.25422	0	0	0	0	0	0	0	0	0	0	0	0	18.52177	0	0	17.51339	17.87036	18.33102	0	0	0	17.23221	17.63046	0
A6NCM1	IQCAL_HUMAN	IQ and AAA domain-containing protein 1-like (IQ and AAA domain-containing protein 1 pseudogene 1)	IQCA1L IQCA1P1	Homo sapiens (Human)			ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0016887	LGSPDIHIMAPLIRSILLVGPSGMGK	10.92000008	0.822773337	0.822773337	2.28E-12	2671.378585	15.22675	0	14.82195	0	0	15.54996	15.6291	0	0	0	0	12.92498	0	0	12.90179	0	0	14.2633	0	11.06259	14.53791	0	17.6562	0	14.1379	0	0	0	14.06245	0	16.34708	14.72296	13.8017	15.84036	11.33865	0	0	0	0	15.18003	15.02554	12.28013	0	13.54225	0	15.73142	0	15.42196
A6NCN8	TEX52_HUMAN	Testis-expressed protein 52	TEX52	Homo sapiens (Human)						TALPLHHLSKAQASK	1.220000029	1	1	0.34018531	1602.581964	0	16.2457	13.7189	9.963675	0	13.29748	0	11.63246	0	0	0	0	0	15.53591	0	0	15.68023	0	0	14.53962	15.98743	0	0	0	0	15.96838	0	16.96057	16.53927	0	16.86054	16.85925	0	0	0	0	16.08376	17.21077	16.04863	0	0	0	0	0	17.07965	16.28237	17.4778	17.31345
A6ND01	JUNO_HUMAN	"Sperm-egg fusion protein Juno (Folate receptor 4) (Folate receptor delta, FR-delta) (IZUMO1 receptor protein JUNO)"	IZUMO1R FOLR4 JUNO	Homo sapiens (Human)	cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]	anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]	signaling receptor activity [GO:0038023]	GO:0005576; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0031362; GO:0035036; GO:0038023	TWSNSFKASPER	3.609999895	1	1	0.305944376	1409.902868	0	16.65598	12.60202	0	0	12.89356	15.70383	0	0	0	17.0282	0	14.5786	0	0	0	0	0	15.41854	0	0	0	0	0	0	0	0	0	0	0	0	17.18018	17.4901	0	0	0	0	0	0	0	0	0	15.56573	0	0	0	0	0
A6NDP7	MADL2_HUMAN	Myeloid-associated differentiation marker-like protein 2	MYADML2	Homo sapiens (Human)		cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]		GO:0005737; GO:0016021	IRFVPSL	10.97000027	0.365692616	0.365692616	0.177152561	834.2530169	0	12.80175	18.35208	0	16.88607	16.70647	14.21293	0	17.35662	17.28076	10.90223	17.82813	15.4791	17.57601	13.14615	0	17.97634	15.98619	15.25202	19.6638	0	18.2796	19.74982	17.72673	17.10288	17.74899	16.72275	0	17.31647	0	0	0	15.47312	0	11.89679	0	17.27362	17.12558	0	14.73199	17.86749	18.5999	18.92771	0	17.32535	16.00061	0	17.87756
A6NDY0	EPAB2_HUMAN	"Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein 2, ePABP-2, ePABP2 (Embryonic poly(A)-binding protein type II) (Poly(A)-binding protein nuclear-like 1)"	PABPN1L EPABP2 PABPNL1	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005737	GKFSPWFSPY	4.630000114	1	1	0.13544601	1218.050193	0	0	0	15.94089	0	0	0	13.00468	0	0	0	0	0	0	0	10.54389	0	0	13.41373	14.23388	0	0	0	0	14.83945	13.75001	0	15.73455	0	0	0	0	0	13.23706	0	15.14742	0	0	15.85877	0	0	0	0	14.71087	15.1961	0	10.56148	0
A6NDY2	F90AA_HUMAN	Putative protein FAM90A10	FAM90A10 FAM90A10P	Homo sapiens (Human)						APVGPR	1.389999986	1	1	0.077519498	596.5026604	0	0	15.41751	15.40924	0	14.26888	0	0	0	0	14.58484	15.6061	15.33858	15.80271	14.28277	0	0	0	16.47534	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.91279	0	14.54059	0	0	0
A6NE02	BTBDH_HUMAN	BTB/POZ domain-containing protein 17 (Galectin-3-binding protein-like)	BTBD17	Homo sapiens (Human)	negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]	extracellular region [GO:0005576]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; plasma membrane [GO:0005886]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]		GO:0005576; GO:0005886; GO:0009615; GO:0045071	QGNASDVVLR	3.789999962	1	1	0.123455304	1058.123206	15.77696	0	0	0	0	0	15.36907	0	0	13.85662	0	0	15.74419	13.89407	0	14.14404	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NE52	WDR97_HUMAN	WD repeat-containing protein 97	WDR97 KIAA1875	Homo sapiens (Human)						SVAQDPVGGRFVVLDGAGR	4.28000021	1	1	0.085942854	1900.356549	0	0	14.7492	0	0	0	0	0	15.70518	0	0	16.57046	0	15.58225	0	14.90551	14.27936	0	0	0	0	14.86034	14.01698	0	14.83394	0	15.22446	15.84018	0	0	15.74836	14.94934	13.801	14.76654	13.45514	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NEC2	PSAL_HUMAN	"Puromycin-sensitive aminopeptidase-like protein, EC 3.4.11.-"	NPEPPSL1	Homo sapiens (Human)	peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062	GFYRSK	6.150000095	1	1	0.29426593	756.2790005	14.64095	0	0	0	0	11.99135	0	0	15.32945	0	17.31767	16.12857	0	15.19267	0	0	16.31633	15.77901	16.91298	0	16.95812	0	0	0	16.84218	17.72844	17.10288	0	16.21663	0	16.69281	15.98157	17.10298	0	16.99549	16.09877	16.68344	18.09039	17.76793	17.19668	16.38612	18.08032	17.61083	17.04924	16.61311	0	17.08447	17.63517
A6NEH8	ZNAS2_HUMAN	Putative uncharacterized protein encoded by ZNF503-AS2 (ZNF503 antisense RNA 2)	ZNF503-AS2 C10orf41 NCRNA00245	Homo sapiens (Human)						FPNRGSR	1.850000024	1	1	0.24809365	834.6639463	18.04011	0	16.76226	17.13018	18.6521	0	12.29274	19.04936	0	13.53337	18.64284	15.91904	0	0	15.55896	0	0	0	14.87118	17.62263	0	0	0	18.94899	0	0	17.60954	18.30499	0	0	0	0	18.83413	0	0	0	0	0	0	17.27114	0	16.31528	0	17.29604	17.07332	0	0	0
A6NEK1	ARRD5_HUMAN	Arrestin domain-containing protein 5	ARRDC5	Homo sapiens (Human)	protein transport [GO:0015031]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; protein transport [GO:0015031]	ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0015031; GO:0031625; GO:1990756	MYLLVQGTSTFHK	2.529999971	0.714279592	0.714279592	6.85E-13	1524.451278	15.44876	0	14.94745	14.06031	0	0	13.94384	14.22205	14.56398	0	0	0	16.33589	0	0	0	0	12.19566	14.31923	8.837253	0	0	8.63546	0	15.96303	13.76211	14.75824	0	18.41664	0	12.31331	17.30546	14.84672	0	15.35224	0	16.03471	14.50556	0	14.3132	11.00413	0	0	0	15.44419	15.27116	0	16.48672
A6NES4	MRO2A_HUMAN	Maestro heat-like repeat-containing protein family member 2A (HEAT repeat-containing protein 7B1)	MROH2A HEATR7B1	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	ADIWR	13.47000027	1	1	0.224700003	661.3365476	14.45971	16.26855	15.91803	15.5241	14.20146	0	0	0	16.43067	15.28062	14.47005	0	0	0	15.59471	0	0	15.16402	17.00838	17.09415	16.70652	19.8118	0	0	15.76383	16.36767	0	0	15.73824	13.72847	15.92826	14.71594	15.63544	16.32891	14.46961	16.76804	16.99083	17.14587	16.36241	14.48378	15.80377	14.2672	15.69209	16.22974	16.65709	0	16.93547	17.74902
A6NEY8	PRXD1_HUMAN	Putative prolyl-tRNA synthetase associated domain-containing protein 1 (PrdX deacylase domain-containing protein 1) (Prolyl-tRNA synthetase associated domain-containing protein 1 pseudogene)	PRORSD1P NCRNA00117 PRDXDD1P	Homo sapiens (Human)			aminoacyl-tRNA editing activity [GO:0002161]	aminoacyl-tRNA editing activity [GO:0002161]	GO:0002161	QLGVGSGNLRFADETAMLEK	4.170000076	0.295171976	0.295171976	3.65E-12	2152.786498	18.48824	12.11593	0	0	13.7569	0	0	13.42914	15.85667	0	14.75455	0	14.19603	10.02973	15.16952	0	0	17.91135	16.00726	15.24328	13.48152	12.34402	14.73591	13.60906	0	0	16.61345	16.8823	14.57272	16.05225	0	16.71804	0	14.56445	0	0	12.1085	14.70731	16.62759	15.62937	17.08555	12.59089	17.5443	13.52262	14.77637	15.76992	13.06477	16.31468
A6NF34	ANTRL_HUMAN	Anthrax toxin receptor-like	ANTXRL	Homo sapiens (Human)	toxin transport [GO:1901998]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; toxin transport [GO:1901998]	metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0009986; GO:0016021; GO:0046872; GO:1901998	STIDALTSK	2.369999886	0.28905046	0.28905046	0.118465538	935.6743648	12.83895	15.93635	16.7372	12.91868	0	15.40761	14.65209	11.18455	0	17.74857	15.26668	13.79373	0	0	14.25831	0	15.67329	13.77489	13.08568	13.47971	14.17386	16.49714	15.67798	15.57155	15.56739	16.24611	16.7397	0	0	13.04379	15.35431	16.84613	18.95233	17.34822	0	13.19746	15.72761	0	17.84924	0	14.41444	13.39118	11.69344	0	0	16.16286	14.22765	16.4637
A6NF36	CC182_HUMAN	Coiled-coil domain-containing protein 182	CCDC182	Homo sapiens (Human)	female gonad development [GO:0008585]		female gonad development [GO:0008585]		GO:0008585	EPLYQAGSILMTVNTLQGKK	4.159999847	1	1	0.157411456	2206.907254	14.08992	0	0	0	0	12.46746	14.9976	13.80173	0	0	11.61125	0	0	0	3.969814	0	0	0	0	0	0	0	0	0	0	15.91614	0	15.26467	0	13.65665	0	0	15.29781	15.63002	13.01653	12.3164	13.80922	0	0	15.72494	12.42688	0	0	0	0	0	0	0
A6NFA1	TIKI2_HUMAN	"Metalloprotease TIKI2, EC 3.4.-.- (Heart, kidney and adipose-enriched transmembrane protein homolog) (TRAB domain-containing protein 2B)"	TRABD2B HKAT TIKI2	Homo sapiens (Human)	negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein oxidation [GO:1904808]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]	integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein oxidation [GO:1904808]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147]	GO:0004222; GO:0005887; GO:0006508; GO:0016020; GO:0016055; GO:0017147; GO:0030178; GO:0031301; GO:0031334; GO:0046872; GO:1904808	MHAALAGPLLAALLATAR	4.78000021	0.528041959	0.528041959	0.236187625	1771.917428	13.05035	0	0	0	0	0	0	0	16.2041	0	0	0	15.69674	0	0	0	0	0	0	0	0	16.44401	14.14264	0	0	0	0	14.95897	15.69388	0	0	15.9507	17.43186	15.2919	15.56893	16.02525	16.43519	15.76684	0	0	0	16.49921	16.44267	17.32306	14.74169	16.30256	0	17.34912
A6NFD8	HELT_HUMAN	Hairy and enhancer of split-related protein HELT (HES/HEY-like transcription factor)	HELT	Homo sapiens (Human)	anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; GABAergic neuron differentiation in basal ganglia [GO:0021858]; gene expression [GO:0010467]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; suckling behavior [GO:0001967]	chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; GABAergic neuron differentiation in basal ganglia [GO:0021858]; gene expression [GO:0010467]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; suckling behavior [GO:0001967]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005667; GO:0006357; GO:0007417; GO:0009791; GO:0009952; GO:0010259; GO:0010467; GO:0021858; GO:0035264; GO:0042802; GO:0045944; GO:0046983; GO:0050767	TPVSHK	6.28000021	0.271929711	0.271929711	0.326488536	669.1814404	16.34898	15.94027	16.36037	14.92293	16.25465	15.59733	0	15.00673	0	0	16.16191	0	14.81956	15.20446	15.381	0	16.66031	16.20881	17.06271	16.95613	17.54427	0	17.26316	15.79053	16.49491	0	0	17.23001	16.54532	0	16.15997	15.44522	16.70394	17.05841	15.8297	15.88077	17.02942	17.03325	16.91501	15.08615	17.26134	16.94662	17.86375	17.2662	16.51764	16.93951	15.87995	16.10162
A6NFI3	ZN316_HUMAN	Zinc finger protein 316	ZNF316	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	RIHTGERPYR	5.170000076	1	1	0.324888159	1286.062284	0	0	13.8093	0	0	16.48435	16.82043	14.72773	0	16.5219	0	12.92408	0	0	0	0	0	0	15.30971	13.45018	0	0	16.28963	14.51227	16.06119	0	17.77072	0	0	0	15.95783	14.56083	14.93684	0	15.87707	16.32074	0	0	15.21874	16.9892	16.40624	16.88503	16.05961	16.27923	13.77745	15.75341	16.95319	15.62908
A6NFK2	GRCR2_HUMAN	Glutaredoxin domain-containing cysteine-rich protein 2 (GRXCR1-like protein) (Glutaredoxin domain-containing cysteine-rich protein 1-like protein)	GRXCR2	Homo sapiens (Human)	auditory receptor cell stereocilium organization [GO:0060088]; protein localization to organelle [GO:0033365]; sensory perception of sound [GO:0007605]	microvillus [GO:0005902]; stereocilium base [GO:0120044]; stereocilium shaft [GO:0120043]	microvillus [GO:0005902]; stereocilium base [GO:0120044]; stereocilium shaft [GO:0120043]; auditory receptor cell stereocilium organization [GO:0060088]; protein localization to organelle [GO:0033365]; sensory perception of sound [GO:0007605]		GO:0005902; GO:0007605; GO:0033365; GO:0060088; GO:0120043; GO:0120044	FSMLANRFK	4.860000134	0.571826398	0.571826398	0.216078399	1113.387765	15.37451	14.68876	13.94375	15.61799	0	12.86274	14.02938	9.686299	0	0	0	11.44161	0	0	0	0	14.86973	0	14.52177	0	15.24171	18.71258	0	0	15.34633	0	16.72973	13.74075	0	0	0	12.14712	0	0	15.55556	0	17.39617	14.05769	16.54137	0	0	0	15.69469	0	13.72179	14.88262	14.87121	12.26993
A6NFR6	CE060_HUMAN	Uncharacterized protein C5orf60	C5orf60	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	APLAPLASMPSSVPK	4.519999981	1	1	0.116591205	1482.449846	14.88427	11.80706	14.73629	8.001613	14.45083	0	14.79213	13.35834	14.536	14.66378	13.22457	12.46414	12.00372	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NGA9	TM202_HUMAN	Transmembrane protein 202	TMEM202	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021	SPACDENVTVIPTERSR	5.659999847	1	1	0.630531961	1931.789236	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.25862	0	0	0	18.18316	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.34107	0	0	0	0	0	0	0
A6NGB9	WIPF3_HUMAN	WAS/WASL-interacting protein family member 3 (Corticosteroids and regional expression protein 16 homolog)	WIPF3 CR16	Homo sapiens (Human)	actin filament-based movement [GO:0030048]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	actin filament [GO:0005884]; cytosol [GO:0005829]	actin filament [GO:0005884]; cytosol [GO:0005829]; actin binding [GO:0003779]; SH3 domain binding [GO:0017124]; actin filament-based movement [GO:0030048]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	actin binding [GO:0003779]; SH3 domain binding [GO:0017124]	GO:0003779; GO:0005829; GO:0005884; GO:0007283; GO:0017124; GO:0030048; GO:0030154	TGQGPGSR	7.670000076	0.911209524	0.911209524	0.238552464	758.6145102	16.12936	0	15.79226	15.76827	15.89742	14.9133	18.17071	15.40642	0	17.12739	16.48768	0	14.68012	14.65508	14.86737	15.70498	0	15.25219	15.37551	15.47293	14.87803	16.04432	16.50026	17.03013	15.36241	15.6616	15.70412	13.78339	15.52342	15.95978	0	0	15.87071	0	15.41641	16.2577	16.96591	0	0	16.50342	17.45632	16.74347	16.0907	16.87497	15.6168	0	17.40216	16.99838
A6NGD5	ZSA5C_HUMAN	Zinc finger and SCAN domain-containing protein 5C (Zinc finger and SCAN domain-containing protein 5C pseudogene)	ZSCAN5C ZSCAN5CP	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	RSKPDATSISQEEPQGEATPVGNR	6.139999866	1	1	0.300995852	2555.822121	0	19.78409	0	0	0	0	20.79683	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.03997	20.85449	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NGG3	CI092_HUMAN	Putative uncharacterized protein C9orf92	C9orf92	Homo sapiens (Human)						EREEDR	11.98999977	0.002033737	0.002033737	0.277018917	834.0424014	0	0	0	0	0	0	0	16.32362	20.24248	0	0	0	16.53023	0	0	0	17.17763	0	0	0	0	0	0	17.43179	0	0	0	0	0	0	0	17.91792	18.48461	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.65064
A6NGG8	PCARE_HUMAN	Photoreceptor cilium actin regulator	PCARE C2orf71	Homo sapiens (Human)	photoreceptor cell outer segment organization [GO:0035845]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cilium [GO:0005929]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	cilium [GO:0005929]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		GO:0001750; GO:0001917; GO:0005929; GO:0007601; GO:0035845; GO:0050896; GO:1903546	DSEDSQAVIAK	6.639999866	0.036188852	0.036188852	0.116134994	1164.570868	13.68148	15.54298	0	0	0	0	0	0	15.84185	0	0	0	0	0	13.27296	0	14.91443	10.74217	15.15989	0	0	0	0	13.39048	13.97638	9.073506	15.22666	13.84318	12.21849	0	10.01435	12.73564	15.64744	13.87571	14.60523	15.06625	15.09261	15.72502	0	11.14118	0	0	14.55675	0	0	0	13.06005	16.0946
A6NGH8	ANR61_HUMAN	Ankyrin repeat domain-containing protein 61	ANKRD61	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	LLYHTYPLRMTNNQGILPAGIMLPEFR	3.920000076	0.390853375	0.390853375	3.20E-12	3174.733031	13.73361	13.08601	0	0	14.33831	0	0	14.3022	13.58686	0	14.16114	13.03666	13.78443	13.37978	9.598159	14.07624	0	15.33109	13.56759	12.01568	0	0	15.68312	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.33339	0	0	0	13.94123	0	0	0
A6NGN9	IGLO5_HUMAN	IgLON family member 5	IGLON5	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	PPPAPGAR	6.389999866	0.45114249	0.45114249	0.035068712	758.670308	13.40221	11.17871	0	0	0	0	16.18523	16.58502	15.25533	15.77759	0	14.39508	15.29125	16.63178	11.83546	16.58999	13.67679	11.31449	17.41049	16.23677	16.03644	15.40645	15.92556	14.6126	15.9337	0	11.37058	13.64265	12.35784	0	18.39113	15.62112	15.7078	17.4134	16.22804	13.92113	13.88873	15.92842	0	16.41588	14.14283	13.61153	14.33328	0	13.89726	17.56127	13.00661	16.7971
A6NGR9	MROH6_HUMAN	Maestro heat-like repeat-containing protein family member 6	MROH6 C8orf73	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	AREAPVGALTLTALTEGIR	7.25	1	1	0.056581669	1942.71621	11.43835	14.35524	0	0	0	0	0	0	0	0	0	0	0	0	0	14.65269	0	0	14.12078	0	0	0	15.93973	0	0	0	15.06632	0	0	0	0	0	0	0	0	0	16.83672	0	0	14.50384	10.54106	0	13.66988	0	0	0	0	0
A6NGU5	GGT3_HUMAN	"Putative glutathione hydrolase 3 proenzyme, EC 3.4.19.13 (Gamma-glutamyltransferase 3) (Putative gamma-glutamyltranspeptidase 3, GGT 3, EC 2.3.2.2) [Cleaved into: Putative glutathione hydrolase 3 heavy chain; Putative glutathione hydrolase 3 light chain ]"	GGT3P GGT3	Homo sapiens (Human)	glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]	glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]	GO:0002682; GO:0005886; GO:0006750; GO:0006751; GO:0016021; GO:0031179; GO:0036374; GO:0050727; GO:0070062; GO:0102953; GO:0103068; GO:1901750	LSGPVLALILNILK	6.349999905	1	1	0.18879711	1464.588065	16.07313	16.7072	17.8468	0	14.82757	17.34107	16.84139	0	0	13.90164	9.338567	15.41389	0	0	18.12862	17.61846	0	15.35474	13.82635	0	15.88534	0	19.15617	0	16.2268	0	17.46372	0	14.26591	16.66365	12.74482	0	0	0	16.46486	17.00314	19.8802	15.3933	0	0	0	16.08538	0	15.10053	0	0	0	16.1133
A6NGY3	CE052_HUMAN	Uncharacterized protein C5orf52	C5orf52	Homo sapiens (Human)						IYEMEVSALEK	1.149999976	1	1	0.183683281	1312.247269	13.4742	0	0	0	20.02426	0	0	0	13.38733	0	0	0	0	0	0	0	15.78272	0	0	0	0	0	0	0	0	0	12.37267	0	0	0	0	14.65098	0	0	0	0	0	14.97173	15.99218	0	0	0	0	0	0	0	0	0
A6NH52	TV23A_HUMAN	Golgi apparatus membrane protein TVP23 homolog A	TVP23A FAM18A	Homo sapiens (Human)	protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]	integral component of Golgi membrane [GO:0030173]	integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]		GO:0009306; GO:0016192; GO:0030173	MGGNSDIGK	15.81000042	1	1	0.154513165	893.7344673	16.8981	0	12.51318	14.72141	15.46898	15.85311	0	19.04416	0	16.79354	0	0	17.75088	17.37874	16.42198	15.01741	13.90992	14.92272	0	16.40855	19.92155	16.91393	16.89638	8.950906	16.35875	0	15.85625	0	13.69791	0	12.52379	18.24918	16.38276	0	0	0	18.6325	0	16.09311	16.61481	17.22916	0	16.49071	0	17.32894	16.90701	18.46775	12.70372
A6NHC0	CAN8_HUMAN	"Calpain-8, EC 3.4.22.53 (New calpain 2, nCL-2) (Stomach-specific M-type calpain)"	CAPN8 NCL2	Homo sapiens (Human)	digestion [GO:0007586]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508]	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005509; GO:0005737; GO:0005794; GO:0006508; GO:0007586	KVEDGEFWMSLSDFVR	3.5	0.531476021	0.531476021	0.280623634	1959.757665	15.39432	9.822526	15.32483	15.976	0	15.97611	15.61058	8.742809	0	12.92667	15.00256	17.86019	0	15.62682	0	16.3649	15.72269	0	0	16.6858	0	15.70775	16.93231	0	0	0	16.7524	13.45183	9.88632	0	0	16.44839	13.01796	16.62976	0	0	17.88303	14.6489	18.135	0	0	17.6972	0	15.29562	16.77663	18.52316	16.29017	18.41441
A6NHJ4	ZN860_HUMAN	Zinc finger protein 860	ZNF860	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	GKVFS	2.50999999	1	1	0.305932098	536.7341492	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.07412	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.82202	0
A6NHM9	MOXD2_HUMAN	"Putative DBH-like monooxygenase protein 2, EC 1.14.17.- (DBH-like monooxygenase protein 2 pseudogene)"	MOXD2P MOXD2	Homo sapiens (Human)	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]	extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]	extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]	copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]	GO:0004500; GO:0005507; GO:0005615; GO:0006589; GO:0030667; GO:0042420; GO:0042421	MAHDLLFR	10.64999962	1	1	0.231167748	1017.579229	0	12.30584	13.95835	13.91008	0	14.97881	0	0	10.50418	15.63346	16.92332	16.69798	16.16687	16.22178	16.1029	0	16.26851	0	0	15.27184	0	14.84738	0	14.40937	16.389	16.25609	0	15.53585	0	0	16.50757	0	16.18898	0	0	16.30519	0	0	17.34331	0	15.96385	0	0	15.72647	0	14.66929	0	15.61595
A6NHQ2	FBLL1_HUMAN	"rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1, EC 2.1.1.- (Protein-glutamine methyltransferase)"	FBLL1	Homo sapiens (Human)	blastocyst hatching [GO:0001835]; box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167]	box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; blastocyst hatching [GO:0001835]; box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167]	histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]	GO:0000494; GO:0001650; GO:0001835; GO:0003723; GO:0005654; GO:0005730; GO:0008649; GO:0015030; GO:0031167; GO:0031428; GO:0032040; GO:1990258; GO:1990259	KGAMVVSVEPHR	9.020000458	1	1	0.126883316	1311.46028	0	0	0	0	0	0	0	0	0	16.38245	0	0	13.32291	10.48627	11.4681	0	14.89049	0	0	0	0	15.40073	16.47293	0	12.38953	15.94825	14.86344	13.17969	12.51565	15.2639	0	14.37252	15.05433	15.20625	0	15.18159	5.982559	0	15.49589	0	15.60969	14.63289	0	0	15.19263	0	0	0
A6NHR9	SMHD1_HUMAN	"Structural maintenance of chromosomes flexible hinge domain-containing protein 1, SMC hinge domain-containing protein 1, EC 3.6.1.-"	SMCHD1 KIAA0650	Homo sapiens (Human)	dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]	Barr body [GO:0001740]; site of double-strand break [GO:0035861]	Barr body [GO:0001740]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]	GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0009048; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0060820; GO:2000042; GO:2001034	MAAADGGGPGGASVGTEEDGGGVGHR	3.059999943	1	1	0.295489641	2285.701211	18.0589	0	15.265	14.08399	16.89871	12.6728	0	12.976	0	0	16.0569	12.97826	15.00131	0	0	12.43481	0	0	0	0	0	0	0	0	14.84519	15.05003	14.0864	0	0	0	0	16.60453	17.8031	0	15.33174	15.93141	14.53637	0	0	0	14.02045	13.98691	14.75921	0	15.37379	0	0	0
A6NHX0	CAST2_HUMAN	Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2)	CASTOR2 GATSL1 GATSL2	Homo sapiens (Human)	cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531]	cytosol [GO:0005829]	cytosol [GO:0005829]; identical protein binding [GO:0042802]; cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531]	identical protein binding [GO:0042802]	GO:0005829; GO:0042802; GO:1902531; GO:1903577; GO:1904262	DPMATGDDCGHIR	4.309999943	1	1	0.240232947	1447.651637	13.69521	0	0	0	14.50044	0	0	12.5871	0	0	0	0	0	13.10117	0	0	15.41803	0	0	0	12.68604	16.63072	0	0	0	0	0	0	0	14.86612	0	0	16.96027	0	0	0	0	16.10102	0	0	0	0	0	0	0	16.42346	0	0
A6NHZ5	LR14B_HUMAN	Leucine-rich repeat-containing protein 14B	LRRC14B	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	LASLTLPTK	9.100000381	0.874740779	0.874740779	0.305596782	944.0800019	0	0	0	0	0	16.62207	0	16.19434	0	0	0	0	0	0	0	0	15.99189	0	16.95985	0	0	15.94781	0	0	0	0	0	17.13941	0	0	0	0	17.74725	0	0	0	0	19.02107	0	0	0	16.2757	0	0	15.68833	17.1519	0	0
A6NI28	RHG42_HUMAN	Rho GTPase-activating protein 42 (Rho GTPase-activating protein 10-like) (Rho-type GTPase-activating protein 42)	ARHGAP42 GRAF3 TMEM133	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0003085; GO:0005096; GO:0007165; GO:0035024; GO:0090630; GO:1904694	ASPNPDLPPK	5.110000134	1	1	0.090714886	1035.652778	0	0	0	14.606	17.0122	0	0	15.39291	0	0	0	0	13.83324	0	0	0	0	0	0	0	0	0	0	15.89607	0	0	0	0	0	0	0	0	0	0	18.32725	0	17.43871	0	0	16.62137	17.41533	0	0	0	0	0	0	0
A6NI56	CC154_HUMAN	Coiled-coil domain-containing protein 154	CCDC154 C16orf29	Homo sapiens (Human)	bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691]	early endosome [GO:0005769]	early endosome [GO:0005769]; bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691]		GO:0005769; GO:0035630; GO:0042475; GO:0044691; GO:0045453	LATFQNQIMKLENCVQANK	1.909999967	1	1	0.079354566	2266.33871	0	12.8706	13.36416	14.21023	0	0	0	14.92997	0	16.0622	0	13.02003	0	0	15.33813	13.44102	0	0	0	0	12.45846	0	0	0	0	0	0	0	0	0	0	15.7362	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NI61	MYMK_HUMAN	Protein myomaker (Myoblast fusion maker) (Transmembrane protein 226) (Transmembrane protein 8C)	MYMK TMEM226 TMEM8C	Homo sapiens (Human)	muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; positive regulation of skeletal muscle hypertrophy [GO:1904206]	integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; positive regulation of skeletal muscle hypertrophy [GO:1904206]		GO:0005886; GO:0005887; GO:0007517; GO:0007520; GO:0014905; GO:0030173; GO:0045026; GO:1904206	SVYTQQIGPGLCFGALALMLR	5.239999771	1	1	0.182902011	2310.71254	0	0	0	14.21814	0	12.2346	0	10.84514	0	0	0	0	0	0	0	7.346667	11.79947	0	14.79148	12.92949	0	12.01816	0	0	14.75929	9.270823	14.52136	11.78501	0	13.93706	0	0	0	0	0	0	0	13.87559	0	0	0	0	0	0	0	0	0	0
A6NI79	CCD69_HUMAN	Coiled-coil domain-containing protein 69	CCDC69	Homo sapiens (Human)	spindle midzone assembly [GO:0051255]	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; microtubule binding [GO:0008017]; spindle midzone assembly [GO:0051255]	microtubule binding [GO:0008017]	GO:0005634; GO:0005737; GO:0008017; GO:0030496; GO:0051233; GO:0051255	EELLYR	15.85999966	1	1	0.23614391	822.7514714	17.89351	18.94248	17.91238	0	17.47401	16.95325	18.2537	0	0	0	17.12496	16.95418	17.08039	19.40579	0	0	15.32041	0	17.21929	0	18.05299	15.45737	18.87165	17.25289	17.09713	0	18.55412	16.87146	16.80698	0	0	18.5302	0	17.62026	18.83237	16.50797	0	0	18.47221	18.56132	16.04271	16.9259	0	17.90429	17.25402	17.38867	18.59632	15.55598
A6NI87	CBY3_HUMAN	Protein chibby homolog 3	CBY3	Homo sapiens (Human)						AGASAGVLMIQPCALDSQ	4.449999809	0.18774645	0.18774645	0.133376444	1804.454566	0	11.72093	13.51187	0	0	0	10.86889	14.38093	0	11.85941	0	15.53413	16.40351	15.64139	0	15.35742	14.26563	13.5071	0	14.67179	0	0	14.18488	0	0	15.49928	0	0	16.83127	15.77624	16.84941	18.44851	17.16267	0	0	0	0	0	0	0	0	0	15.26409	0	15.07863	14.8518	0	16.46106
A6NJ64	NPIB2_HUMAN	Putative nuclear pore complex-interacting protein family member B2	NPIPB2	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	LDMKEIHTYMK	2.430000067	1	1	0.244597318	1441.550557	16.47516	0	9.869954	0	0	8.959558	12.76438	13.02058	0	15.58935	0	11.51908	15.83286	13.79803	11.17082	0	0	12.66484	12.83757	0	17.17779	0	15.10731	0	13.73958	14.80863	0	13.92004	0	0	15.20296	14.18719	0	0	0	0	0	0	0	15.86254	14.02498	0	12.64555	13.71625	0	0	15.19798	0
A6NJ69	IGIP_HUMAN	IgA-inducing protein homolog	IGIP C5orf53	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	SVSGCNITIFAVMFSHLSAGK	4.630000114	0.18778877	0.18778877	3.66E-12	2243.209026	13.45923	14.53396	9.382403	11.94414	16.4428	14.08867	13.98212	0	0	0	15.34062	14.30698	0	0	0	12.45238	0	0	0	0	0	0	0	14.70051	0	13.5036	14.46098	0	0	0	0	0	0	0	0	0	0	0	0	16.21107	0	0	0	0	0	0	0	0
A6NJG2	SWAHD_HUMAN	Ankyrin repeat domain-containing protein SOWAHD (Ankyrin repeat domain-containing protein 58) (Protein sosondowah homolog D)	SOWAHD ANKRD58	Homo sapiens (Human)						VLVGALGADATR	7.730000019	1	1	0.16131224	1142.496361	13.84552	15.41268	0	12.23874	14.61531	11.63215	14.51576	0	11.5712	0	0	10.6287	17.07598	0	0	10.10308	10.90032	12.19395	14.88807	14.45821	11.43402	12.29766	14.38052	14.79756	16.26825	13.72962	0	0	0	0	0	0	0	0	0	0	14.11189	0	0	0	15.85854	0	13.36125	0	0	0	0	0
A6NK02	TRI75_HUMAN	Tripartite motif-containing protein 75	TRIM75 TRIM75P	Homo sapiens (Human)	female meiosis I [GO:0007144]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; female meiosis I [GO:0007144]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005615; GO:0005737; GO:0007144; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630	DSLPTK	6.940000057	1	1	0.064887904	657.3279148	15.81705	0	14.96314	14.29372	12.31009	14.3701	15.372	0	14.26968	16.37271	15.66344	16.13566	13.88389	16.2515	14.17327	13.85098	0	0	15.46925	14.64816	15.00218	0	0	0	0	16.76494	0	0	0	0	0	0	0	0	0	17.20242	0	0	0	0	0	15.58654	14.15121	17.32222	0	0	0	0
A6NK53	ZN233_HUMAN	Zinc finger protein 233	ZNF233	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	GFSKASNLQAHQR	3.50999999	1	1	2.29E-13	1442.999043	14.75001	15.26125	16.00267	13.7021	15.40364	9.542855	13.83283	0	15.90287	14.14163	15.70977	12.73251	15.03004	15.16771	13.80625	0	12.43264	0	13.6561	13.09464	14.71677	0	0	0	13.68413	0	16.06689	0	0	0	0	0	0	0	0	0	16.55699	0	0	0	0	0	0	0	0	0	15.00323	0
A6NK59	ASB14_HUMAN	"Ankyrin repeat and SOCS box protein 14, ASB-14"	ASB14	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]	cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		GO:0005829; GO:0016567; GO:0035556	AYVLYK	9.010000229	0.00958709	0.00958709	0.243274495	756.3443885	17.65928	18.78673	17.6032	18.42449	16.92314	18.63933	17.78305	17.59436	0	17.88108	0	15.66817	16.79411	15.97125	18.73194	17.79313	19.07147	18.65462	17.96469	18.32144	0	19.02752	0	18.9659	0	18.19045	0	18.30632	0	18.39302	0	19.34075	16.29834	19.40165	18.34187	0	0	17.83198	18.2522	18.2335	17.86012	0	16.41648	19.59172	15.98297	17.98932	16.98361	15.33276
A6NK97	S22AK_HUMAN	Solute carrier family 22 member 20 (Organic anion transporter 6) (Solute carrier family 22 member 20 pseudogene)	SLC22A20P OAT6 SLC22A20	Homo sapiens (Human)	ion transport [GO:0006811]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]	transmembrane transporter activity [GO:0022857]	GO:0006811; GO:0016021; GO:0022857	MAFTDLLDALGSMGR	1.299999952	0.81335777	0.81335777	0.316861964	1613.920432	0	0	0	0	17.06168	15.00141	0	13.48073	0	0	0	0	0	0	0	15.65891	16.10941	16.30774	0	14.19677	0	0	0	0	0	0	13.10942	0	0	15.34774	0	15.47224	0	16.95781	0	0	0	0	0	0	14.28583	19.48806	0	0	15.78668	0	0	0
A6NKF1	SAC31_HUMAN	SAC3 domain-containing protein 1 (SAC3 homology domain-containing protein 1)	SAC3D1 SHD1	Homo sapiens (Human)	cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225]		GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0051225; GO:0051298; GO:0051301	GAGPHPR	3.599999905	1	1	0.099224093	690.419039	0	0	0	0	0	16.99472	0	0	0	0	17.92665	15.30628	17.22393	15.3583	0	0	0	17.62747	0	0	0	0	17.99965	0	0	0	0	0	0	0	16.21866	17.35087	13.91085	16.78338	17.0745	0	0	15.06979	0	0	13.69418	0	0	17.08568	0	0	16.79895	15.10742
A6NKF2	ARI3C_HUMAN	"AT-rich interactive domain-containing protein 3C, ARID domain-containing protein 3C"	ARID3C	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0045121; GO:0045944	RAVLMGPMDPPRPCMPPSFLPR	6.260000229	0.084644638	0.084644638	5.93E-12	2539.10635	17.25344	0	16.94152	0	15.852	11.96586	0	17.6082	0	14.84562	0	0	15.99481	18.33127	0	0	0	15.65329	18.6798	0	0	0	16.49845	0	14.04303	10.80148	10.57835	17.75038	16.96005	0	0	0	0	0	0	14.41663	16.51561	0	8.698325	0	15.16104	0	0	0	0	0	14.78382	14.15725
A6NKF7	TM88B_HUMAN	Transmembrane protein 88B	TMEM88B	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]	PDZ domain binding [GO:0030165]	GO:0005886; GO:0016021; GO:0030165	ETEEEEGGGGASDTAPMLPR	2.900000095	1	1	0.409065196	2032.545097	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.128	0	0	0	0	0	0	0	0	0	0	0	0	0	17.71665	0	0	0	0	0	0	0	0	0
A6NKG5	RTL1_HUMAN	Retrotransposon-like protein 1 (Mammalian retrotransposon derived protein 1) (Paternally expressed gene 11 protein) (Retrotransposon-derived protein PEG11)	RTL1 MAR1 MART1 PEG11	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	HFSGDR	1.529999971	1	1	0.246041306	714.9606654	17.31387	18.19743	17.36012	17.7777	18.55218	18.10135	0	17.79101	0	0	0	0	0	17.85491	0	0	0	0	17.98983	0	0	0	0	0	0	18.91643	0	0	0	0	21.04657	0	20.73985	0	0	0	0	0	0	0	0	0	0	0	16.37695	0	0	0
A6NKL6	T200C_HUMAN	Transmembrane protein 200C (Transmembrane protein TTMA) (Two transmembrane domain-containing family member A)	TMEM200C TTMA	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	GELDLSMTNLRGAEGSMR	7.449999809	1	1	0.19068789	1953.15405	15.4157	14.7561	14.19824	14.00038	11.85997	13.68032	13.86381	0	15.84501	14.73103	14.73619	0	12.15687	14.94042	0	15.31291	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NKT7	RGPD3_HUMAN	RanBP2-like and GRIP domain-containing protein 3	RGPD3 RGP3	Homo sapiens (Human)	NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790]		GO:0005643; GO:0005737; GO:0006607; GO:0050790	KAVPGNSAK	14.03999996	1	1	0.28754713	872.4455256	12.28752	13.09536	14.08018	15.23678	14.06549	0	13.42956	15.26099	0	16.06383	0	14.29805	12.63245	15.09175	13.9567	14.75269	15.34001	16.2724	0	0	0	0	0	14.71582	13.94269	13.12376	15.02169	0	0	0	15.95763	0	0	0	0	16.53481	15.53598	0	0	0	0	0	0	16.07529	0	0	0	0
A6NKX1	F223B_HUMAN	Protein FAM223B	FAM223B CXorf52B LINC00204B	Homo sapiens (Human)						VQQSTDER	7.889999866	1	1	0.047613185	961.3952435	15.00429	14.55922	0	11.74786	0	0	0	14.62044	14.5274	15.01953	0	0	0	0	0	0	13.03954	12.09249	0	15.66461	0	0	0	0	0	0	0	0	0	14.8748	14.99632	0	0	0	0	0	0	14.9322	0	0	0	0	13.85126	0	0	0	0	0
A6NL08	O6C75_HUMAN	Olfactory receptor 6C75	OR6C75	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	TILKIPSMSQR	12.85000038	1	1	9.18E-13	1273.860076	0	15.07517	0	0	14.04234	0	0	0	16.19409	0	0	0	0	0	0	0	14.61438	0	14.72692	0	0	0	0	0	0	0	15.10963	16.78924	17.25897	0	15.17578	0	0	0	0	0	0	0	0	0	17.04756	0	0	0	0	0	0	13.53754
A6NL82	F183A_HUMAN	Protein FAM183A	FAM183A	Homo sapiens (Human)		ciliary base [GO:0097546]	ciliary base [GO:0097546]		GO:0097546	MAGHPKEK	21.60000038	0.543300331	0.543300331	0.151873563	913.7572308	15.80791	0	16.66401	0	15.03921	12.05553	17.1488	0	0	15.23069	0	0	0	0	0	0	0	13.55301	18.88909	0	0	0	14.96313	14.0987	0	16.74742	0	17.32383	0	0	0	0	15.62123	0	0	0	0	0	0	0	0	0	16.72976	0	0	0	0	0
A6NLJ0	C2C4B_HUMAN	C2 calcium-dependent domain-containing protein 4B (Nuclear-localized factor 2) (Protein FAM148B)	C2CD4B FAM148B NLF2	Homo sapiens (Human)	positive regulation of acute inflammatory response [GO:0002675]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528]	nucleus [GO:0005634]	nucleus [GO:0005634]; positive regulation of acute inflammatory response [GO:0002675]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528]		GO:0002528; GO:0002675; GO:0005634; GO:0030155	VPDGLLSR	1.629999995	1	1	0.144104012	860.2533789	0	15.28848	0	14.88824	14.90303	0	0	0	0	0	15.44815	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.78901	0	0	0	0	16.67914	0	0	0	0	0	0	0	0	0	16.68928
A6NLU0	RFPLA_HUMAN	Ret finger protein-like 4A (RING finger protein 210)	RFPL4A RFPL4 RNF210	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription, DNA-templated [GO:0045893]"	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000785; GO:0004842; GO:0005654; GO:0005737; GO:0045893; GO:0046872	SVLTMNPR	8.31000042	1	1	0.294970385	934.1757913	16.08959	0	0	0	0	0	0	0	0	0	0	0	16.62927	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.54253	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NM11	L37A2_HUMAN	Leucine-rich repeat-containing protein 37A2	LRRC37A2	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	GCSSRR	5.960000038	0.418213308	0.418213308	0.154687964	723.4384197	16.95854	20.622	16.5195	18.71738	19.90348	19.95682	18.2445	18.85066	17.67771	19.50007	19.41746	14.78518	19.63395	20.39276	19.82657	18.45323	19.56595	16.23107	16.75886	17.1794	20.12215	17.58594	19.86364	19.26075	16.46077	17.37009	10.7288	18.51233	17.59011	16.84392	0	19.33746	15.35647	14.53152	15.62415	16.19204	18.14552	19.89928	16.3945	16.82336	19.95222	20.56967	15.61308	17.71212	18.8018	17.27912	14.36307	14.53484
A6NM36	LRC30_HUMAN	Leucine-rich repeat-containing protein 30	LRRC30	Homo sapiens (Human)	signal transduction [GO:0007165]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005737; GO:0007165; GO:0043231	LNLSNNFFAHIPMCVFSLK	5.320000172	1	1	0.127374262	2268.688552	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.09947	0	0	0	0	13.39608	12.83401	0	0	0	0	0	0	0	0	0	0	0	14.99349	0	14.01901	0	0	0	13.83962	0	0	0	0	13.1082	0	13.14615
A6NM43	TCPQL_HUMAN	Putative T-complex protein 1 subunit theta-like 1	CCT8L1P CCT8L1	Homo sapiens (Human)	protein folding [GO:0006457]	chaperonin-containing T-complex [GO:0005832]	chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082	KILGMNN	14.55000019	1	1	0.52322678	804.200826	0	0	0	0	17.17464	0	0	0	17.06526	0	0	0	0	0	0	0	0	0	17.61053	0	0	0	0	0	0	0	0	0	0	17.34909	0	0	0	0	0	0	17.30542	17.8775	0	0	0	0	0	19.77905	0	0	0	0
A6NM62	LRC53_HUMAN	Leucine-rich repeat-containing protein 53	LRRC53	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021	LNLHPFRK	4.489999771	1	1	0.10708995	1024.98504	16.40051	0	0	0	0	15.30961	14.0708	0	16.38584	15.48222	14.51073	15.35266	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.0237	0	0	0	0	0	0	0	0	0	16.22335	0	0	14.69004	0	15.8463	0	0
A6NMB1	SIG16_HUMAN	"Sialic acid-binding Ig-like lectin 16, Siglec-16 (Siglec-P16)"	SIGLEC16 SIGLECP16	Homo sapiens (Human)	cell adhesion [GO:0007155]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of interleukin-6 production [GO:0032755]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of interleukin-6 production [GO:0032755]	carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]	GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0032755; GO:0033691; GO:1900426	SGPMTGVVLVAVGEVAMK	3.880000114	0.56840682	0.56840682	0.599646451	1741.679141	0	17.69731	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A6NMB9	FIGL2_HUMAN	Fidgetin-like protein 2	FIGNL2	Homo sapiens (Human)			ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]	GO:0005524; GO:0008568; GO:0016887	LELPPGGRQR	10.61999989	1	1	0.447750943	1121.852224	16.76825	0	0	0	0	17.39561	16.7497	0	0	0	0	0	17.95155	0	0	16.63929	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.83438	0	17.41906	0	0	0	0	0	0	0	0	16.1085	0	0	16.5084
A6NMD0	IFM10_HUMAN	"Interferon-induced transmembrane protein 10 (Dispanin subfamily A member 3, DSPA3)"	IFITM10	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021	TDSVRAAGAPPACK	4.329999924	1	1	0.302976525	1401.172611	15.77063	0	0	0	0	0	0	0	15.31268	0	15.13899	0	16.18985	0	16.2371	0	0	0	0	0	0	0	0	0	16.08424	0	0	16.9141	0	0	0	0	15.5675	0	0	0	16.32629	16.6202	0	13.19456	0	0	0	0	0	0	0	0
A6NMK8	INY2B_HUMAN	Protein INSYN2B (Inhibitory synaptic factor family member 2B)	INSYN2B C5orf57 FAM196B	Homo sapiens (Human)						AGGFR	5.360000134	1	1	0.108657675	506.5643091	0	0	15.51435	11.41242	0	15.03564	0	0	0	15.52422	0	0	15.98796	16.04812	0	14.90088	0	0	0	0	0	0	0	0	0	17.08421	0	0	0	16.45942	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.25703	17.8687	0
A6NMZ5	O4C45_HUMAN	Olfactory receptor 4C45	OR4C45	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	LWKQIMTTDDK	7.320000172	1	1	0.315755206	1396.478585	0	0	0	0	0	0	16.82777	0	0	0	0	15.45922	14.40808	0	0	0	0	17.59302	0	0	14.27705	0	0	0	0	14.13585	0	0	0	0	18.18806	0	0	0	0	0	0	0	0	19.4381	0	0	0	16.0326	0	0	16.83124	0
A6NMZ7	CO6A6_HUMAN	Collagen alpha-6(VI) chain	COL6A6	Homo sapiens (Human)	cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]		GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0062023	GCYGTKGPK	4.429999828	1	1	0.104956136	967.7027527	13.96528	0	16.15127	0	0	0	0	15.72764	0	0	0	0	0	0	0	15.51285	16.32333	0	0	0	15.84782	0	0	0	16.49474	15.40496	17.35599	14.80566	16.9556	16.46052	0	16.26678	15.24283	0	0	16.44913	14.09943	15.01088	14.86167	15.32024	0	15.66043	0	0	0	0	0	0
A6NN90	CB081_HUMAN	Uncharacterized protein C2orf81	C2orf81	Homo sapiens (Human)						GSQEQMESWEPSPQLR	5.849999905	1	1	0.159661126	1905.330978	11.22252	16.28034	0	13.16123	0	0	0	0	15.73829	0	0	16.0998	0	0	0	0	16.91754	13.31985	0	0	0	15.28199	0	0	0	12.9214	0	0	11.71268	0	0	0	0	0	0	13.28675	0	0	12.58552	0	0	0	0	12.61761	11.54067	0	0	0
A6NND4	O2AT4_HUMAN	Olfactory receptor 2AT4 (Olfactory receptor OR11-265)	OR2AT4	Homo sapiens (Human)	positive regulation of ERK1 and ERK2 cascade [GO:0070374]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021; GO:0070374	DVKAAITK	5.730000019	1	1	0.236259155	845.4590408	15.69376	0	0	14.51362	0	0	0	15.83445	0	15.41969	16.19569	0	16.45126	0	0	16.05379	0	17.17084	17.35351	17.80995	16.72907	16.14247	16.43472	16.94261	16.50094	16.37276	16.94048	16.70268	17.35402	0	16.57951	17.294	16.61424	16.71093	16.6969	17.88512	18.17544	17.08605	17.53527	16.5612	16.89812	17.0846	17.38247	17.64527	17.33999	17.15705	17.76428	16.35702
A6NNE9	MARHB_HUMAN	"E3 ubiquitin-protein ligase MARCHF11, EC 2.3.2.27 (Membrane-associated RING finger protein 11) (Membrane-associated RING-CH protein XI, MARCH-XI) (RING-type E3 ubiquitin transferase MARCHF11)"	MARCHF11 MARCH11	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]	cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]	transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0008270; GO:0016021; GO:0016567; GO:0016740; GO:0030659	MSFEGGHGGSRCR	2.140000105	1	1	0.538382063	1437.724722	0	0	0	0	0	0	0	0	0	17.70264	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.8834	0	0	0	0	0	0	0	0	0	18.80855	0	0	0	0	0	18.5671	0	0	0	0	0	0
A6NNM8	TTL13_HUMAN	"Tubulin polyglutamylase TTLL13, EC 6.3.2.- (Tubulin tyrosine ligase like 13) (Tubulin tyrosine ligase-like family member 13 pseudogene) (Tubulin--tyrosine ligase-like protein 13)"	TTLL13 TTLL13P	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]	cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0070740	ILGALPSMNAAIPHVPR	1.830000043	1	1	0.101942383	1772.374748	0	16.65584	15.19899	0	0	12.02905	14.27851	10.94272	16.00018	14.13475	0	13.41682	15.12147	16.23115	0	0	0	13.17291	14.96605	0	16.52369	15.19938	17.71478	0	12.84429	0	0	0	0	17.42154	18.2624	17.33619	0	15.34679	16.92451	0	17.79922	18.06819	0	12.46286	14.78644	13.21238	13.85653	13.58379	16.81522	16.20684	14.92436	0
A6NNP5	CC169_HUMAN	Coiled-coil domain-containing protein 169	CCDC169 C13orf38	Homo sapiens (Human)						NYNFDGVSTNRLK	17.40999985	0.437543631	0.437543631	0.421350162	1527.767572	20.81647	20.19181	18.30093	18.5411	20.28053	19.87323	0	18.0879	18.35152	20.91182	18.11526	18.46912	0	18.76184	0	0	18.41281	0	0	0	17.1276	19.30502	19.42475	18.93844	19.07434	0	19.07977	19.50253	18.69938	19.85841	20.08928	0	0	19.12959	18.01104	20.22437	0	0	18.77674	18.28943	0	0	20.15217	18.5614	0	19.92559	20.15763	0
A6NNV3	SPD16_HUMAN	Putative speedy protein E16	SPDYE16	Homo sapiens (Human)	positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]		protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]	protein kinase binding [GO:0019901]	GO:0019901; GO:0045737	SRIPLVR	8.640000343	0.000847901	0.000847901	0.259489582	840.3028808	0	0	18.62731	0	17.83776	0	0	0	0	0	0	19.44676	0	0	0	0	0	0	18.78464	0	0	0	0	0	0	17.63013	17.05085	0	0	0	19.39608	0	0	16.73845	0	0	0	0	0	0	0	22.86359	0	0	0	0	0	0
A6NNW6	ENO4_HUMAN	"Enolase 4, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase)"	ENO4 C10orf134	Homo sapiens (Human)	cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; glycolytic process [GO:0006096]	phosphopyruvate hydratase complex [GO:0000015]; sperm principal piece [GO:0097228]	phosphopyruvate hydratase complex [GO:0000015]; sperm principal piece [GO:0097228]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; glycolytic process [GO:0006096]	magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]	GO:0000015; GO:0000287; GO:0004634; GO:0006096; GO:0030317; GO:0044782; GO:0097228	GHDGSKR	1.559999943	1	1	0.20516305	756.6520549	0	13.46529	16.87726	0	16.31339	0	14.32914	14.7452	0	0	16.44144	15.09791	0	0	0	0	0	15.8333	0	0	0	14.35175	13.35408	13.95345	15.24392	11.15721	15.6381	13.52946	15.70572	16.33386	0	16.09606	14.93503	0	0	0	0	0	0	0	0	16.30914	0	0	17.7718	0	0	0
A6PVC2	TTLL8_HUMAN	"Protein monoglycylase TTLL8, EC 6.3.2.- (Tubulin--tyrosine ligase-like protein 8)"	TTLL8	Homo sapiens (Human)	cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094]	axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]	"axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094]"	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]"	GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0030317; GO:0036126; GO:0046872; GO:0060271; GO:0070735; GO:0070736	GEGTVCSR	3.619999886	1	1	0.007293384	865.7789399	16.46485	15.0116	12.18007	15.59911	0	14.88291	0	0	13.41294	0	10.60265	0	0	0	0	14.80171	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.69156	0	0	0	0	0	0	0	0
A6PVS8	LRIQ3_HUMAN	Leucine-rich repeat and IQ domain-containing protein 3 (Leucine-rich repeat-containing protein 44)	LRRIQ3 LRRC44	Homo sapiens (Human)						HLIQKGQESEDEIVDEK	2.650000095	1	1	0.292705129	2001.240873	0	11.75035	14.69561	12.35254	13.93512	14.001	16.90533	12.35384	11.38982	0	0	13.79632	0	0	0	15.44905	15.79553	0	13.89031	13.76812	16.09771	0	14.87069	15.39158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38351	0	0	0	0	0
A6QL64	AN36A_HUMAN	Ankyrin repeat domain-containing protein 36A	ANKRD36 ANKRD36A KIAA1641 UNQ2430/PRO499	Homo sapiens (Human)						SIKDVLPPVEEAVDR	5.460000038	1	1	0.319988904	1667.4768	10.71028	15.57297	13.02551	11.68629	15.1703	0	0	14.58538	0	0	0	0	0	15.3205	16.42032	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.2125	0	0	0	0	0	0	0	0	0	0	0	0	15.43061	0	0	0
A7E2U8	CD047_HUMAN	UPF0602 protein C4orf47	C4orf47 Chr4_1746	Homo sapiens (Human)		9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]	9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]		GO:0005813; GO:0005881; GO:0097731	KPGGMK	5.170000076	0.557560146	0.557560146	0.137884585	635.4432163	17.35242	13.24976	17.27386	0	14.56081	13.66424	15.78299	16.45925	15.33098	0	0	12.88462	13.85195	16.64273	15.84798	15.88284	0	17.86852	14.31122	15.98867	17.09148	0	16.55734	17.14196	18.53606	16.48217	16.07956	15.76974	16.31755	17.81333	15.74594	16.7124	12.97432	0	18.32071	17.54583	16.82939	14.94774	18.15062	6.274051	12.94092	18.29181	18.29403	0	0	16.91813	16.77324	14.56598
A7E2V4	ZSWM8_HUMAN	Zinc finger SWIM domain-containing protein 8	ZSWIM8 KIAA0913	Homo sapiens (Human)	positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270]; positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	ubiquitin ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:1990756; GO:2000627	GDQLFR	9.840000153	1	1	1.15E-13	735.4136993	15.0207	0	0	13.1315	13.89054	0	14.66642	15.08043	15.2382	14.64215	0	0	0	0	13.18597	15.66894	15.72973	15.91786	0	0	16.19953	0	0	0	0	0	0	15.46005	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A7E2Y1	MYH7B_HUMAN	"Myosin-7B (Antigen MLAA-21) (Myosin cardiac muscle beta chain) (Myosin heavy chain 7B, cardiac muscle beta isoform) (Slow A MYH14)"	MYH7B KIAA1512	Homo sapiens (Human)		membrane [GO:0016020]; myosin complex [GO:0016459]; myosin filament [GO:0032982]	membrane [GO:0016020]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]	GO:0003774; GO:0005524; GO:0016020; GO:0016459; GO:0032982; GO:0051015	ATSAAAALDK	1.940000057	1	1	0.14198572	916.1001731	13.18285	0	0	15.66657	12.01038	0	0	0	0	0	0	15.71671	14.57937	0	0	0	0	0	0	0	0	0	0	0	0	0	14.82034	0	12.35989	14.87512	0	15.50171	15.58471	0	0	13.83912	0	0	0	14.6563	0	0	13.10841	0	0	0	0	0
A7KAX9	RHG32_HUMAN	Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP)	ARHGAP32 GRIT KIAA0712 RICS	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981]	GO:0000139; GO:0001650; GO:0005096; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0005938; GO:0007264; GO:0010008; GO:0014069; GO:0015629; GO:0043197; GO:0051056; GO:1901981	RVQSLHAPPSSMIR	5.789999962	0.74778223	0.74778223	0.196696517	1593.673962	16.13587	13.35551	13.18627	13.98538	10.79648	11.57813	13.44561	0	15.42847	0	14.28789	13.49413	0	15.27291	0	15.55762	0	0	0	0	0	0	0	0	0	0	0	0	15.13624	0	0	0	0	0	0	16.18508	0	0	17.18939	0	0	0	0	0	16.69177	0	0	0
A7MCY6	TBKB1_HUMAN	"TANK-binding kinase 1-binding protein 1, TBK1-binding protein 1"	TBKBP1 KIAA0775 SINTBAD	Homo sapiens (Human)	defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; serine/threonine protein kinase complex [GO:1902554]	cytoplasm [GO:0005737]; serine/threonine protein kinase complex [GO:1902554]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; type I interferon signaling pathway [GO:0060337]	metal ion binding [GO:0046872]	GO:0005737; GO:0007249; GO:0046872; GO:0051607; GO:0060337; GO:1902554	EEQLQAECERLQGELK	9.210000038	1	1	0.239569088	1958.123321	0	15.8402	0	14.26083	15.89763	16.05944	15.53707	15.5389	14.86868	16.37477	0	14.39667	14.82089	0	0	15.01126	0	0	13.70334	0	0	0	0	12.8586	0	0	0	0	0	0	0	0	0	15.34401	0	0	15.74612	0	0	16.96669	16.58638	15.58557	0	0	0	0	0	0
A7MD48	SRRM4_HUMAN	"Serine/arginine repetitive matrix protein 4 (Medulloblastoma antigen MU-MB-2.76) (Neural-specific serine/arginine repetitive splicing factor of 100 kDa, Neural-specific SR-related protein of 100 kDa, nSR100)"	SRRM4 KIAA1853	Homo sapiens (Human)	"cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]"	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0007399; GO:0007605; GO:0008380; GO:0030154; GO:0042551; GO:0042802; GO:0043484	HSSSSPK	8.68999958	0.199486211	0.199486211	0.190218537	728.4094302	16.19295	13.27843	11.79343	15.28836	16.91274	15.25141	16.99738	0	0	0	16.3388	14.95018	15.65094	0	14.1534	15.48838	15.20038	16.20009	0	15.69318	15.8411	16.49236	0	16.32323	0	0	0	0	15.9259	16.55659	0	15.7179	0	0	0	0	17.12029	16.98295	16.90186	0	16.51771	15.86891	0	14.68594	0	16.7815	16.18382	16.14394
A8CG34	P121C_HUMAN	"Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2, POM121-2) (Pore membrane protein of 121 kDa C)"	POM121C	Homo sapiens (Human)	mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]	nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0005654; GO:0005789; GO:0006405; GO:0006606; GO:0008139; GO:0016021; GO:0017056; GO:0031965; GO:0051028	TPGAR	4.670000076	0.237445757	0.237445757	0.124288022	503.3057347	17.80769	17.33911	17.773	16.46933	16.69178	17.70774	16.84324	16.31071	17.13358	17.03083	16.99332	17.24191	17.11797	17.24459	16.94855	16.06798	16.39974	16.92832	17.02542	17.67012	18.10725	17.11376	16.51	17.06891	17.18429	16.67183	15.43028	16.36882	17.07314	15.98783	17.51123	17.21975	16.95802	17.91326	17.34354	17.44282	16.9393	18.06917	17.5954	18.41825	17.33569	18.13255	17.65428	18.63677	18.481	17.01978	18.70885	17.749
A8K0R7	ZN839_HUMAN	Zinc finger protein 839 (Renal carcinoma antigen NY-REN-50)	ZNF839 C14orf131	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	HTEKLK	3.230000019	1	1	0.093593294	757.7809385	14.39316	0	14.5549	15.1861	14.33936	15.68541	14.03152	15.23098	12.29083	16.06975	14.56481	10.7451	17.23968	0	17.98901	14.90902	14.16247	15.42825	0	17.3498	18.00306	0	0	0	15.7255	0	0	15.30432	14.98642	13.75045	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A8K2U0	A2ML1_HUMAN	Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9)	A2ML1 CPAMD9	Homo sapiens (Human)	regulation of endopeptidase activity [GO:0052548]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of endopeptidase activity [GO:0052548]	endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0030414; GO:0052548; GO:0070062	HLNSKK	8.039999962	0.411370933	0.411370933	0.098409901	723.7376555	14.49894	0	0	17.88715	0	0	16.58449	11.65512	16.03821	16.51224	17.22616	15.15872	14.93578	13.25026	14.29797	16.37251	16.11913	0	14.58251	15.4264	15.53324	0	15.72644	18.68518	16.83887	15.25827	0	17.178	0	16.59906	0	15.39421	15.19876	14.52864	0	0	11.45699	17.47449	0	16.1383	15.75655	0	0	0	0	0	15.41927	0
A8K7I4	CLCA1_HUMAN	"Calcium-activated chloride channel regulator 1, EC 3.4.-.- (Calcium-activated chloride channel family member 1, hCLCA1) (Calcium-activated chloride channel protein 1, CaCC-1, hCaCC-1)"	CLCA1 CACC1	Homo sapiens (Human)	calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005229; GO:0005254; GO:0005615; GO:0005886; GO:0005887; GO:0005902; GO:0006816; GO:0006821; GO:0034220; GO:0042589; GO:0046872; GO:0071456	CQGGSCYTKR	3.460000038	0.413916916	0.413916916	0.214213316	1216.284564	14.9863	13.39219	0	15.36018	11.77154	10.63418	0	0	0	0	0	12.13058	0	0	0	0	0	13.06072	0	15.20882	0	0	0	0	15.99153	14.27294	0	0	14.50792	0	0	0	0	0	14.58481	0	0	0	0	15.41395	15.50573	13.9612	14.9419	0	0	0	15.80916	0
A8K855	EFCB7_HUMAN	EF-hand calcium-binding domain-containing protein 7	EFCAB7 KIAA1799	Homo sapiens (Human)	positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]; calcium ion binding [GO:0005509]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005929; GO:0019898; GO:0042307; GO:0045944; GO:0060170; GO:0098797; GO:1903569	TSGEK	5.090000153	1	1	0.246533785	521.2987877	18.01108	19.40057	18.23641	0	0	0	0	0	20.76629	0	18.20618	22.01989	0	0	18.68808	0	0	18.49728	0	0	0	0	18.01624	0	0	20.68946	21.46566	0	0	0	18.26043	0	21.81269	21.04548	0	0	0	0	0	0	0	0	0	0	0	0	0	18.14344
A8K8P3	SFI1_HUMAN	"Protein SFI1 homolog, hSFI1"	SFI1 KIAA0542	Homo sapiens (Human)		centriole [GO:0005814]; cytosol [GO:0005829]	centriole [GO:0005814]; cytosol [GO:0005829]; phosphatase binding [GO:0019902]	phosphatase binding [GO:0019902]	GO:0005814; GO:0005829; GO:0019902	LLRFAASMK	9.010000229	0.170891523	0.170891523	0.164691039	1052.102059	15.86638	15.4623	0	0	15.36777	0	18.54129	0	14.45174	18.43439	0	0	12.96709	0	0	0	11.27018	0	0	13.99021	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.37579	0	0	16.29758	0	0	0	15.86384	0	0	0	0
A8K979	ERI2_HUMAN	"ERI1 exoribonuclease 2, EC 3.1.-.- (Exonuclease domain-containing protein 1)"	ERI2 EXOD1 KIAA1504	Homo sapiens (Human)	"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]"		"3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]"	3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0000175; GO:0000467; GO:0003676; GO:0008270	NTALLAWK	1.75	0.731054664	0.731054664	0.157303916	914.8871781	14.91747	16.11979	0	0	0	0	0	0	0	15.26614	0	15.92985	0	0	0	17.51879	0	0	0	0	0	0	13.79035	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A8MPP1	D11L8_HUMAN	"Putative ATP-dependent RNA helicase DDX11-like protein 8, EC 3.6.4.13 (DEAD/H box protein 11-like 8)"	DDX11L8	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; establishment of sister chromatid cohesion [GO:0034085]; nucleobase-containing compound metabolic process [GO:0006139]	nucleolus [GO:0005730]; nucleus [GO:0005634]	nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; establishment of sister chromatid cohesion [GO:0034085]; nucleobase-containing compound metabolic process [GO:0006139]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006139; GO:0016887; GO:0032508; GO:0034085	VASGHR	2.019999981	1	1	0.199477385	624.8255099	0	0	0	16.44438	0	0	0	0	0	0	0	15.25508	0	0	15.82826	0	0	0	16.24743	0	0	0	0	0	0	0	0	0	0	0	0	15.56609	0	0	0	0	15.85398	0	0	0	0	16.09612	0	0	0	0	0	15.91863
A8MPS7	YDJC_HUMAN	"Carbohydrate deacetylase, EC 3.5.1.-"	YDJC	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]		deacetylase activity [GO:0019213]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975]	deacetylase activity [GO:0019213]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005975; GO:0019213	MGFREAVAAGDVDLPQVR	5.730000019	1	1	0.237686944	1930.59664	0	0	0	0	0	0	0	15.09376	0	0	0	14.13453	0	0	0	0	16.16768	0	0	0	0	0	0	14.71513	0	0	13.36004	0	0	0	0	15.05707	15.14271	13.6317	0	0	0	0	0	14.10494	0	0	0	0	0	0	0	11.29742
A8MTJ6	FOXI3_HUMAN	Forkhead box protein I3	FOXI3	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154	EDLMKMVRPPYSYSALIAMAIQSAPER	6.889999866	1	1	0.134503195	3084.556081	12.48471	13.94353	15.04355	13.15549	0	0	13.60149	0	0	10.79354	11.06572	0	0	11.71951	0	0	0	0	0	0	13.99142	11.91252	0	0	0	14.65503	0	13.84461	0	0	0	0	12.46975	13.45487	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A8MTL0	IQCF5_HUMAN	IQ domain-containing protein F5	IQCF5	Homo sapiens (Human)			calmodulin binding [GO:0005516]	calmodulin binding [GO:0005516]	GO:0005516	MVLEFYVQQEWAAVR	3.549999952	1	1	0.340750934	1884.394508	0	15.81152	0	0	0	15.89797	0	15.85795	15.87925	0	0	0	0	12.56013	0	0	0	0	0	0	0	0	0	0	15.82014	0	0	0	0	14.75209	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.75876	0	0
A8MU46	SMTL1_HUMAN	Smoothelin-like protein 1	SMTNL1	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]"	contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	"contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]"	calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523]	GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0005815; GO:0008157; GO:0009410; GO:0014823; GO:0018105; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0042310; GO:0043292; GO:0043621; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718	AINEGPPTESGK	7.610000134	0.057625175	0.057625175	0.080005734	1199.715996	12.99177	14.77913	12.88365	14.29382	0	0	0	0	9.926513	14.2912	15.7684	14.71598	0	13.41463	0	0	0	14.65596	14.76629	13.43552	0	0	0	14.9085	15.30887	18.81731	0	0	0	10.43767	0	15.39849	0	0	0	15.37316	0	15.62709	12.42896	17.0455	0	17.04323	0	0	0	12.08652	18.82562	0
A8MUU9	YV023_HUMAN	Putative uncharacterized protein ENSP00000383309		Homo sapiens (Human)						TPPGTWLRR	11.72999954	1	1	1.37E-12	1082.494071	13.60544	11.49234	14.90796	0	0	14.17211	0	0	17.46067	0	15.29966	13.70545	14.82764	0	14.24253	11.99125	0	14.36895	0	10.1913	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.35722	0	0	0	0	0	0
A8MUV8	ZN727_HUMAN	Putative zinc finger protein 727 (Zinc finger protein 727 pseudogene)	ZNF727 ZNF727P	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	CCSDLTK	4.650000095	1	1	0.297318338	883.8223496	18.98478	0	18.44737	0	0	17.00334	0	18.26428	18.79536	16.84552	0	17.03394	16.56243	17.7524	0	17.46215	0	16.7175	0	18.01274	0	18.60244	0	0	0	0	0	0	17.60155	16.25384	0	0	0	0	19.20128	0	0	18.15595	0	0	0	16.10552	16.52984	18.98223	0	0	18.44995	18.49893
A8MUZ8	Z705G_HUMAN	Putative zinc finger protein 705G	ZNF705G	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	HEKTHTGQRPYK	1.769999981	1	1	0.233835679	1482.121349	0	12.77836	0	0	13.59828	13.5919	0	0	0	13.98633	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.92844	13.73477	11.82531	0	0	0	0	0	0	0	16.75386	0	0	0	0	0
A8MV57	MPTX_HUMAN	Putative mucosal pentraxin homolog	MPTX1 MPTX	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	EMCDSCYSGSLLNR	3.569999933	1	1	0.345193123	1706.800046	15.12624	0	17.78162	0	0	0	0	0	0	0	0	18.11386	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A8MV72	YH009_HUMAN	Putative UPF0607 protein ENSP00000382826		Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]	calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]	GO:0005509; GO:0005615; GO:0005737; GO:0048306	GGSCL	3.230000019	0.523002744	0.523002744	0.080664745	493.2541033	0	12.91605	13.733	0	15.36574	15.13963	13.13298	0	16.3742	0	14.92917	12.19743	10.89658	12.31881	0	15.99285	0	0	13.92837	0	0	14.48902	14.14401	16.17828	16.60992	18.14947	16.2627	14.13033	0	17.46496	15.14753	0	14.826	16.27804	0	14.18262	15.03851	16.14977	0	15.94082	17.3613	17.03944	18.48271	16.76407	17.03022	17.13697	0	16.00483
A8MV81	HIG1C_HUMAN	HIG1 domain family member 1C	HIGD1C UBIE UBIE2	Homo sapiens (Human)	mitochondrial respirasome assembly [GO:0097250]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; mitochondrial respirasome assembly [GO:0097250]		GO:0005739; GO:0016021; GO:0097250	DQKMSIHLIHMR	2.089999914	1	1	0.505717926	1524.444022	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.21774	0	0	0	0	0	0
A8MVJ9	HPF1L_HUMAN	Putative histone PARylation factor 1-like		Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]	nucleus [GO:0005634]	nucleus [GO:0005634]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835]	histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]	GO:0005634; GO:0006974; GO:0010835; GO:0018312; GO:0042393; GO:0072572	KENIDQFAA	4.400000095	1	1	0.173170815	1036.566674	0	15.18146	14.49693	14.66152	13.35338	12.82789	0	15.06816	13.86872	12.16411	0	0	15.05923	14.18213	14.17702	15.25192	15.24458	0	14.56481	14.86366	14.45016	0	0	14.69137	0	0	15.07993	0	0	16.40134	15.93204	0	0	0	0	0	0	0	0	0	0	15.80039	0	0	0	0	0	0
A8MVM7	YD021_HUMAN	Putative uncharacterized protein ENSP00000382790		Homo sapiens (Human)						ITEMSTKR	6.980000019	1	1	0.184102011	981.690262	12.99352	9.521925	0	15.03232	13.08499	0	0	0	17.54566	0	0	14.61354	0	13.44337	13.07707	15.26935	14.29796	0	16.69815	0	0	0	14.45055	14.63776	0	14.58797	0	0	0	14.75297	14.5741	0	0	0	14.68057	0	15.52816	0	0	0	14.80938	0	14.72747	0	0	0	0	14.97455
A8MVX0	ARG33_HUMAN	Rho guanine nucleotide exchange factor 33	ARHGEF33	Homo sapiens (Human)			guanyl-nucleotide exchange factor activity [GO:0005085]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085	CSMEEK	3.25999999	1	1	0.251029482	799.1231893	0	0	0	15.04182	0	0	0	0	15.4764	0	0	0	0	15.63541	0	0	0	0	0	14.60648	0	0	0	0	16.7385	0	17.04939	17.05793	0	0	16.95313	16.95244	17.27767	0	16.4308	0	17.18531	0	17.41784	16.97383	0	16.82131	0	16.36526	0	0	17.11696	0
A8MW92	P20L1_HUMAN	PHD finger protein 20-like protein 1	PHF20L1 CGI-72	Homo sapiens (Human)	histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357]	NSL complex [GO:0044545]	NSL complex [GO:0044545]; metal ion binding [GO:0046872]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]	GO:0006357; GO:0016573; GO:0044545; GO:0046872	LATLPMPDDSVEKVSSPSPATDGK	2.339999914	1	1	0.019687844	2441.316662	0	0	0	18.21854	18.73617	0	17.59583	0	0	0	0	0	0	0	16.75614	0	0	0	17.48723	19.49942	0	18.22409	0	18.47176	0	16.67137	0	15.74666	0	0	0	19.34301	0	12.73776	0	0	0	0	0	0	0	0	0	17.33967	0	0	0	0
A8MWE9	EFCB8_HUMAN	EF-hand calcium-binding domain-containing protein 8	EFCAB8	Homo sapiens (Human)			calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509	KVLSSVSDEMLK	3.289999962	0.003906346	0.003906346	0	1335.509876	0	0	0	0	17.7226	0	0	0	0	0	0	0	0	0	0	15.42758	15.91125	0	0	0	0	0	0	0	0	16.2373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A8MWK0	FS2P1_HUMAN	"Putative fatty acid desaturase 2-like protein FADS2B (Fatty acid desaturase 2 pseudogene 1) (Fatty acid desaturase 2B, pseudogene)"	FADS2B FADS2P1	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636]"	"metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]"	GO:0005789; GO:0006629; GO:0006636; GO:0016021; GO:0016717; GO:0046872	CGDNGSIVGR	5.039999962	1	1	0.152062349	1029.131793	18.9048	14.84278	14.62104	13.28255	14.29578	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.8116	0	0	15.32494	15.34048	0	0	17.79429	0	0	0	0	0	0	0	0	0	0	0	0	0	14.88599	14.82086
A8MWL7	TM14D_HUMAN	Transmembrane protein 14DP	TMEM14DP TMEM14D	Homo sapiens (Human)	regulation of heme biosynthetic process [GO:0070453]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; regulation of heme biosynthetic process [GO:0070453]		GO:0016021; GO:0031966; GO:0070453	MLMTSD	23.98999977	0.667627335	0.667627335	0.189767967	695.4342922	17.94663	15.71597	16.89378	0	14.93939	17.43387	19.3083	18.88523	16.88769	18.11197	14.84995	0	18.41329	16.87909	19.74252	14.22065	16.10902	15.36034	16.91725	0	0	17.38791	16.5654	0	16.85278	0	17.64955	17.36786	18.02353	0	0	17.90414	13.50674	18.93943	17.69135	18.14107	19.57856	19.51551	16.61336	0	0	17.70204	18.1297	0	15.99759	0	15.9326	19.51459
A8MWP4	YU008_HUMAN	Putative uncharacterized protein ENSP00000401716		Homo sapiens (Human)						MQRPHRR	10.10999966	0.310438871	0.310438871	0.145537888	996.6907715	16.9416	0	12.21616	0	0	0	0	0	14.9517	16.20563	0	0	0	0	0	0	14.68292	13.51441	13.81557	0	15.84421	13.18706	0	0	0	0	0	0	0	0	15.7929	0	0	11.73873	0	0	0	0	0	12.56256	0	0	0	15.79223	0	0	0	0
A8MX76	CAN14_HUMAN	"Calpain-14, EC 3.4.22.- (Calcium-activated neutral proteinase 14, CANP 14)"	CAPN14	Homo sapiens (Human)	proteolysis [GO:0006508]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005509; GO:0005737; GO:0006508	STAGGQR	7.179999828	0.473042786	0.473042786	0.25207661	675.2373704	15.81402	0	0	0	15.92972	13.19718	0	0	0	16.31864	15.28395	0	14.44884	14.64218	15.87647	0	15.1606	0	16.29954	0	15.78784	0	0	14.76652	15.66346	15.62674	16.38638	14.05869	15.28673	0	0	17.25929	0	0	15.95568	0	0	16.96168	0	16.08101	15.49342	15.42988	16.30087	16.7546	15.97473	0	0	16.98329
A8MX80	YM017_HUMAN	Putative UPF0607 protein ENSP00000383144		Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]	calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]	GO:0005509; GO:0005615; GO:0005737; GO:0048306	SSPPKAAGHR	8.81000042	0.069837257	0.069837257	0.221407474	1008.140753	0	14.18547	0	0	0	0	15.34732	0	0	15.90519	13.45665	15.68507	0	15.37497	14.71833	13.79132	15.14171	0	15.7948	15.39859	0	16.03665	15.66323	0	15.75575	15.32588	15.88371	14.85542	14.43918	7.348936	15.41473	15.24427	13.91328	14.10241	14.58752	10.84809	13.28681	0	15.11322	15.17089	0	0	13.89817	13.37588	14.1907	16.63729	12.28941	15.32813
A8MXD5	GRCR1_HUMAN	Glutaredoxin domain-containing cysteine-rich protein 1	GRXCR1 DFNB25	Homo sapiens (Human)	inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118]	kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420]	kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420]; glutathione oxidoreductase activity [GO:0097573]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118]	glutathione oxidoreductase activity [GO:0097573]	GO:0005902; GO:0007605; GO:0032420; GO:0042491; GO:0048563; GO:0060091; GO:0060118; GO:0060119; GO:0060122; GO:0097573	AASEK	2.920000076	1	1	0.293896643	505.5114523	0	0	0	0	0	0	22.25716	0	0	0	0	0	19.47866	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A8MXQ7	IQAK1_HUMAN	IQ motif and ankyrin repeat domain-containing protein 1	IQANK1	Homo sapiens (Human)	regulation of barbed-end actin filament capping [GO:2000812]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of barbed-end actin filament capping [GO:2000812]		GO:0005634; GO:0005737; GO:2000812	VQLPGTGL	3.809999943	0.757439613	0.757439613	0.201993267	784.4663009	16.85389	13.29934	15.58384	0	14.81746	15.27343	0	14.5367	13.91554	15.39001	14.52469	16.02802	16.02366	0	15.25764	14.42069	15.56131	14.30122	14.03847	0	14.99207	0	0	16.12471	16.25089	0	14.14309	14.37893	12.77448	15.26876	17.00437	11.56319	16.51388	15.63001	15.4356	15.01022	14.80868	15.61228	15.62505	15.26303	14.44688	13.53865	0	11.77335	0	16.51418	16.23758	14.12481
A8MXT2	MAGBH_HUMAN	Melanoma-associated antigen B17	MAGEB17	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005634	GQKGESPNSFHGPSSSESTGR	3.809999943	0.872695744	0.872695744	2.75E-12	2130.623872	0	17.41832	0	0	13.27559	14.86854	12.85178	0	12.15191	0	0	0	11.25237	0	0	11.37344	0	0	0	0	0	0	0	0	15.324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.13609	0	0	14.8701	0	0	0
A8MXV4	NUD19_HUMAN	"Acyl-coenzyme A diphosphatase NUDT19, EC 3.6.1.- (Nucleoside diphosphate-linked moiety X motif 19, Nudix motif 19)"	NUDT19	Homo sapiens (Human)	butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; fatty acid catabolic process [GO:0009062]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; fatty acid catabolic process [GO:0009062]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289]	acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005782; GO:0005829; GO:0009062; GO:0010945; GO:0015938; GO:0036114; GO:0044580; GO:0106399; GO:1901289; GO:1902858; GO:2001294	SSSLRPGPSR	19.15999985	1	1	0.276387995	1042.324056	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.26333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.8112
A8MXV6	CD15L_HUMAN	CMT1A duplicated region transcript 15 protein-like protein	CDRT15L2	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	EGVTSTAPASR	4.829999924	1	1	0.262085685	1076.85537	0	13.99986	0	0	0	14.10885	15.33149	0	0	14.21805	0	0	14.64306	14.95335	0	0	0	0	0	16.48425	15.96589	17.91334	14.45702	13.59291	0	14.91214	0	0	0	0	17.27899	16.18621	0	0	0	0	0	0	0	0	0	0	0	14.55563	0	14.60387	0	0
A8MYA2	CX049_HUMAN	Uncharacterized protein CXorf49	CXorf49; CXorf49B	Homo sapiens (Human)						AQLPTHRPGLPR	1.539999962	1	1	0.451768955	1343.902032	0	0	0	0	0	17.27648	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.60457	0
A8MYJ7	TTC34_HUMAN	"Tetratricopeptide repeat protein 34, TPR repeat protein 34"	TTC34	Homo sapiens (Human)						APTARMFLLR	6.019999981	1	1	0.01740053	1190.796033	0	13.90183	0	0	15.7825	0	8.454234	0	12.97187	11.7655	0	0	0	0	14.85208	0	0	0	0	13.75823	0	0	0	0	0	0	0	0	0	10.82461	0	12.01956	0	0	0	0	0	0	0	11.89629	0	0	0	0	0	0	0	0
A8MYU2	KCNU1_HUMAN	"Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3)"	KCNU1 KCNMA3 KCNMC1 SLO3	Homo sapiens (Human)	regulation of ion transmembrane transport [GO:0034765]; reproductive process [GO:0022414]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765]; reproductive process [GO:0022414]	potassium channel activity [GO:0005267]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005267; GO:0005886; GO:0016021; GO:0022414; GO:0034765	IIIQILQSHNKVYLPK	2.690000057	1	1	0.306429912	1908.276229	15.96108	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.44525	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
A8MYZ6	FOXO6_HUMAN	Forkhead box protein O6	FOXO6	Homo sapiens (Human)	memory [GO:0007613]; positive regulation of dendritic spine development [GO:0060999]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; memory [GO:0007613]; positive regulation of dendritic spine development [GO:0060999]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007613; GO:0060999	ATAPAMAPAPPLGAEVGPLR	6.739999771	1	1	0.325543885	1904.352639	16.14437	14.60539	0	19.72446	0	19.56057	0	0	0	0	0	19.93134	0	0	18.56357	0	20.37325	20.14636	0	0	0	0	0	0	0	0	0	0	0	19.35155	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.1719	0
A8MZ25	YQ037_HUMAN	Putative uncharacterized protein FLJ38767		Homo sapiens (Human)						RRPPGSPCSIR	7.019999981	1	1	0.190244728	1279.087408	15.24026	0	0	13.58455	0	0	0	0	0	0	0	0	0	0	0	15.91809	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.76629	0	0	0	16.1937	0	0	0	0
A8MZF0	PRR33_HUMAN	Proline-rich protein 33	PRR33 C11orf89	Homo sapiens (Human)						MSVAEAQGR	9.460000038	0.488035977	0.488035977	0.28562548	963.0587219	18.66991	0	0	0	16.82452	0	18.36049	0	18.7063	18.47109	0	18.47457	0	0	0	0	0	16.97839	0	18.45128	0	17.15357	0	0	17.52265	18.5714	0	0	17.2479	17.20827	0	0	0	0	0	0	0	0	19.7467	19.0424	0	17.67477	0	0	17.09769	0	16.78261	18.31917
A8MZH6	OOSP1_HUMAN	Putative oocyte-secreted protein 1 homolog	OOSP1	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	MKTILGFK	10.27000046	1	1	0.041341096	936.6953839	18.65971	0	14.3452	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.86841	0	0	0	0	0	0	16.54938	15.26657	0
A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	COL6A5 COL29A1 VWA4	Homo sapiens (Human)	cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0030198; GO:0062023	DVGNAMR	2.25999999	1	1	0.2568901	778.941149	12.19299	14.7059	14.18211	0	14.59613	15.24191	13.14065	14.76013	15.83682	0	0	15.14886	14.83881	15.34063	14.13285	14.93702	0	0	0	0	0	0	0	16.01489	0	0	0	0	0	0	15.44378	16.21027	0	0	0	0	0	0	15.68051	14.30122	15.85719	16.18436	0	15.71731	0	0	0	0
A9YTQ3	AHRR_HUMAN	"Aryl hydrocarbon receptor repressor, AhR repressor, AhRR (Class E basic helix-loop-helix protein 77, bHLHe77)"	AHRR BHLHE77 KIAA1234	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]; xenobiotic metabolic process [GO:0006805]	aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]; regulation of transcription by RNA polymerase II [GO:0006357]; xenobiotic metabolic process [GO:0006805]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000981; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006805; GO:0034751; GO:0046983	AAEAAPVVK	12.98999977	0.187505662	0.187505662	0.272362812	854.586077	16.73652	19.89082	17.6467	19.87631	17.83966	20.64673	0	18.47711	0	0	0	0	17.05109	17.33592	0	0	20.7576	0	19.50392	0	0	0	0	0	18.59581	0	0	18.93509	0	0	0	21.56477	18.18447	0	0	18.02846	18.46255	0	0	19.26715	0	0	0	0	0	0	18.94339	0
A9Z1Z3	FR1L4_HUMAN	Fer-1-like protein 4	FER1L4 C20orf124	Homo sapiens (Human)	plasma membrane organization [GO:0007009]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; plasma membrane organization [GO:0007009]	metal ion binding [GO:0046872]	GO:0007009; GO:0016021; GO:0046872	IYNRSLK	4.340000153	0.456995457	0.456995457	0.173029075	894.6971486	15.85351	0	12.14242	0	14.25548	0	0	0	13.77178	15.46727	15.01971	0	15.13906	13.72229	16.07702	16.8821	0	16.34906	15.55648	16.87642	15.20369	16.53872	16.22102	14.34137	17.02489	0	12.08578	13.85684	0	0	15.30282	16.09288	0	0	16.44075	14.44934	16.73228	15.6455	14.85677	14.96471	0	15.80409	15.81621	14.63195	15.46399	16.56046	14.17276	15.32274
B0I1T2	MYO1G_HUMAN	"Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2, mHag HA-2 ]"	MYO1G HA2	Homo sapiens (Human)	actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]"	"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117	VAAMGALQGLR	7.960000038	1	1	0.265829394	1102.084338	0	0	0	0	0	0	0	0	0	0	0	0	0	15.71807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.26256	0	16.57596	0	0	0	0	0	0	17.53608	16.02821	0	0	0
B1AJZ9	FHAD1_HUMAN	"Forkhead-associated domain-containing protein 1, FHA domain-containing protein 1"	FHAD1 KIAA1937	Homo sapiens (Human)						LSDALAMVEETQKTK	1.00999999	1	1	0.291655776	1680.369358	17.0944	0	0	0	0	0	18.5174	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B1AK76	SNUFL_HUMAN	Putative SNURF-like protein	SNURFL CXorf19	Homo sapiens (Human)		nuclear speck [GO:0016607]	nuclear speck [GO:0016607]		GO:0016607	WTTEQHMPEVEVQVK	3.269999981	0.842364252	0.842364252	0.325770371	1856.616119	0	0	0	0	0	0	15.00366	0	0	0	0	0	0	11.67856	0	0	0	0	0	15.80612	16.64711	0	0	13.93713	0	15.07658	0	16.14545	16.64775	0	17.13958	0	0	16.04217	0	16.67458	0	13.91849	0	0	0	0	15.64743	14.38169	13.95515	0	0	16.53022
B1ANS9	WDR64_HUMAN	WD repeat-containing protein 64	WDR64	Homo sapiens (Human)						INDILFLFR	7.159999847	1	1	0.293556041	1148.367752	0	17.86071	14.44305	0	0	0	0	0	0	0	0	0	0	15.86362	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.26401	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B1ANY3	F220P_HUMAN	Putative protein FAM220BP (Protein FAM220B pseudogene)	FAM220BP C9orf51	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; protein dephosphorylation [GO:0006470]	nucleus [GO:0005634]	nucleus [GO:0005634]; STAT family protein binding [GO:0097677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein dephosphorylation [GO:0006470]	STAT family protein binding [GO:0097677]	GO:0000122; GO:0005634; GO:0006470; GO:0097677	ATHGHRGQCPK	1.909999967	0.671806455	0.671806455	0.160200991	1249.826053	0	0	14.1514	15.24561	11.86856	14.70872	0	0	14.76673	0	13.21822	0	0	14.55689	0	15.54124	0	0	0	0	0	0	0	13.94771	0	0	15.0459	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B2CW77	KILIN_HUMAN	Killin	KLLN	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell cycle [GO:0007049]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]	DNA binding [GO:0003677]	GO:0003677; GO:0005654; GO:0005730; GO:0006915; GO:0007049	VSLVGELSK	10.5	0.436375946	0.436375946	0.181742731	932.68241	15.3178	16.93025	15.75559	14.54565	0	0	17.77659	0	0	0	0	15.2254	0	0	15.4476	15.91455	16.36679	15.85377	15.61077	15.6075	0	15.98777	13.83082	14.68492	0	16.8696	0	17.92355	0	0	0	15.8691	0	0	17.79037	15.51885	15.51507	0	16.62531	17.8273	16.41892	0	15.16316	16.6485	0	0	18.02616	0
B2RTY4	MYO9A_HUMAN	Unconventional myosin-IXa (Unconventional myosin-9a)	MYO9A MYR7	Homo sapiens (Human)	cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601]	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461]	axonal growth cone [GO:0044295]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601]	actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0003774; GO:0003779; GO:0005096; GO:0005524; GO:0005829; GO:0007601; GO:0016021; GO:0016461; GO:0034329; GO:0035556; GO:0043547; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0051056; GO:0150011	AHGILTR	10.64999962	1	1	0.0976284	767.3653576	16.58578	0	14.22322	0	0	0	16.74161	0	0	0	0	0	0	0	0	15.38086	16.22908	15.27343	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.56169	0	0	0	0	0	0	20.69524	0	0	0
B2RXF0	T229A_HUMAN	Transmembrane protein 229A	TMEM229A	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	RPRGPR	6.460000038	1	1	0.276620455	738.0644528	0	0	17.04145	0	0	0	18.70285	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.54564	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.053
B2RXH4	BTBDI_HUMAN	BTB/POZ domain-containing protein 18	BTBD18	Homo sapiens (Human)	cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	nucleus [GO:0005634]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spermatogenesis [GO:0007283]		GO:0005634; GO:0007141; GO:0007283; GO:0010529; GO:0030154; GO:0032968; GO:1990511	CSPASPK	5.130000114	1	1	0.175333501	747.1731265	0	15.09279	0	0	0	0	0	0	16.12498	0	0	0	13.5073	0	0	0	0	0	0	0	0	16.41784	0	0	0	13.26178	0	0	13.52772	14.78118	0	0	0	15.84263	0	0	0	0	0	0	0	16.4385	0	0	0	13.43506	15.87707	16.74372
B3KS81	SRRM5_HUMAN	Serine/arginine repetitive matrix protein 5	SRRM5 ZNF576	Homo sapiens (Human)						MSSPKR	5.199999809	1	1	0.135178646	706.1818411	13.9629	16.10505	0	14.34635	15.14155	16.03701	0	0	12.32535	14.21977	14.19635	14.20957	0	0	0	0	15.32471	14.30901	0	0	0	0	0	0	0	0	0	15.51764	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.97466	13.29814	0	13.51952
B4DJY2	TM233_HUMAN	"Transmembrane protein 233 (Dispanin subfamily B member 2, DSPB2) (Interferon-induced transmembrane domain-containing protein D2)"	TMEM233 IFITMD2	Homo sapiens (Human)		integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021	MSQYAPSPDFKR	10.93999958	1	1	2.29E-13	1426.220523	0	0	15.49832	14.55392	10.968	13.82596	13.62546	14.80719	14.82168	15.06226	0	0	13.69789	16.00121	0	13.02658	0	14.11577	15.05195	14.07089	0	12.40761	0	14.27191	0	0	0	16.17018	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B4DU55	ZN879_HUMAN	Zinc finger protein 879	ZNF879	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	VLVTIKK	1.50999999	1	1	0.006325461	800.5875407	14.3726	15.16742	17.04964	15.91277	0	13.52566	0	15.28849	0	12.96662	0	0	0	0	0	15.06892	0	0	0	0	14.84819	0	0	0	0	0	17.02886	0	0	0	0	0	0	0	0	0	16.46584	0	0	0	0	0	0	0	0	0	0	0
B4DX44	ZN736_HUMAN	Zinc finger protein 736	ZNF736	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	MGVLTFR	10.21000004	0.384276152	0.384276152	0.268927203	839.110827	0	19.56952	18.53477	0	0	0	0	19.06967	0	0	0	18.24248	0	0	0	0	0	18.16386	0	0	0	18.16388	0	0	18.70938	0	0	0	0	0	0	0	0	0	0	19.07214	0	0	0	0	18.16676	0	0	0	18.08762	0	0	17.44781
B4DXR9	ZN732_HUMAN	Zinc finger protein 732	ZNF732	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	IITSSSNVAK	2.519999981	0.13596414	0.13596414	0.123506802	1020.821691	13.79378	0	17.11325	11.81877	0	0	0	0	0	0	16.10498	18.73048	0	0	17.78038	0	12.4439	15.1705	0	19.17451	15.78848	19.53604	16.57377	0	0	0	14.90598	0	13.58291	0	0	0	0	0	16.00069	15.74075	16.53665	0	13.88408	0	0	17.51488	0	0	16.97536	0	14.7365	0
B4DYI2	S31C2_HUMAN	Putative spermatogenesis-associated protein 31C2 (Protein FAM75C2)	SPATA31C2 FAM75C2	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		GO:0007283; GO:0016021; GO:0030154	AHMSR	5.329999924	1	1	0.166422401	600.7524371	13.4355	15.08422	0	15.17001	14.82476	0	0	0	0	14.12435	0	0	0	15.91967	16.15942	13.80182	0	0	0	0	0	0	0	0	14.7833	15.75014	16.50393	0	0	0	0	14.13502	0	13.86219	15.1557	17.1139	15.67443	11.97679	0	13.16506	15.47616	12.95512	16.10972	0	0	16.89958	13.2059	0
B5MCN3	S14L6_HUMAN	Putative SEC14-like protein 6	SEC14L6	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	KHMEFR	10.18000031	1	1	0.058351916	865.4430573	14.00616	11.20098	14.76248	13.01821	12.90546	13.09848	14.01094	15.38064	13.72469	14.38373	13.65662	0	0	0	15.75547	0	15.07015	15.4594	0	0	16.31496	0	15.67237	0	0	0	0	0	0	0	0	16.37636	14.27115	15.12105	0	0	13.81124	0	0	0	14.69974	0	0	0	0	0	0	0
B5MCY1	TDR15_HUMAN	Tudor domain-containing protein 15	TDRD15	Homo sapiens (Human)	P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]	P granule [GO:0043186]	P granule [GO:0043186]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]		GO:0030719; GO:0034587; GO:0043186	CVINELLK	13.06000042	1	1	0.160874788	988.5894457	16.54487	15.7683	0	0	14.64146	14.63276	14.10653	0	15.10745	16.01173	13.64132	13.32952	15.83792	0	0	0	14.60814	15.26214	0	16.65845	0	0	13.24661	0	0	15.54405	0	0	14.71586	15.83034	15.73661	15.38184	16.33241	15.79185	14.94894	15.41982	0	14.08519	16.27463	15.26725	13.13932	14.54897	14.34688	13.0474	13.11284	15.94271	14.73252	16.20389
B7Z6K7	ZN814_HUMAN	Zinc finger protein 814	ZNF814	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	MAAAATLR	5.320000172	1	1	0.183426706	823.3572443	0	12.62788	0	0	15.85091	0	13.44099	0	14.15202	15.66989	15.71503	0	0	12.97581	0	0	0	0	0	0	15.46989	0	15.48351	0	0	0	0	0	0	0	0	0	15.91633	0	0	0	0	0	0	0	0	15.72369	0	0	0	0	0	0
B8ZZ34	SHSA8_HUMAN	Protein shisa-8 (Shisa family member 8)	SHISA8 C22orf17	Homo sapiens (Human)	regulation of AMPA receptor activity [GO:2000311]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	AMPA glutamate receptor complex [GO:0032281]; dendritic spine membrane [GO:0032591]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]	AMPA glutamate receptor complex [GO:0032281]; dendritic spine membrane [GO:0032591]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; regulation of AMPA receptor activity [GO:2000311]; regulation of short-term neuronal synaptic plasticity [GO:0048172]		GO:0014069; GO:0032281; GO:0032591; GO:0045211; GO:0048172; GO:2000311	RPGHAAR	3.390000105	0.27661851	0.27661851	0.168255487	763.6804049	0	0	0	0	0	0	0	0	0	0	15.96923	0	16.19128	15.15326	0	0	15.38835	14.71342	0	17.60282	17.14236	0	0	0	17.11274	15.11808	15.43625	15.73724	0	16.97348	0	0	15.19088	15.87891	0	17.1264	0	16.13137	0	16.90553	16.27064	0	12.11782	15.08479	12.76208	13.92836	16.77943	15.66102
C9J202	AG1L2_HUMAN	"Putative glycosyltransferase ALG1L2, EC 2.4.1.-"	ALG1L2	Homo sapiens (Human)	protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]	endoplasmic reticulum [GO:0005783]; mannosyltransferase activity [GO:0000030]; protein glycosylation [GO:0006486]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005783; GO:0006486	LFMKLGSTHSPFR	16.89999962	1	1	2.29E-12	1521.479804	11.97311	10.54168	12.4099	15.60733	13.69658	13.51182	0	14.14555	15.17073	13.55566	15.08961	0	14.67935	0	15.65353	14.95895	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
C9JC47	F157A_HUMAN	Putative protein FAM157A	FAM157A	Homo sapiens (Human)						LLHDLHLLAFAMKR	4.110000134	1	1	0.228129663	1689.375362	0	14.63119	18.24395	0	14.44509	13.90382	0	0	0	13.41615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.73071	0	0	0	0	0	0	14.64445	0	0	13.60144	0	0	0	0	15.79546	12.57528	12.92678	0
C9JE40	PATL2_HUMAN	"Protein PAT1 homolog 2 (PAT1-like protein 2) (Protein PAT1 homolog a, Pat1a, hPat1a)"	PATL2	Homo sapiens (Human)	deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]	RNA binding [GO:0003723]	GO:0000290; GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0017148; GO:0033962	IEGSLGQVAVSTCFSPRR	4.28000021	0.935141027	0.935141027	1.60E-12	1964.609473	11.26358	0	0	0	0	17.2906	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.44885	0	0	0	0	0	0	0	0	0	0	13.19535	0	0	0	14.8287	15.70132	0	0	0	0	0	0	0	15.41055	0
C9JFL3	PHGR1_HUMAN	"Proline, histidine and glycine-rich protein 1"	PHGR1	Homo sapiens (Human)						MDPGPK	3.160000086	1	1	0.156651612	659.3036768	0	14.65966	12.30713	15.5944	15.61623	15.3323	15.23091	14.65582	14.94799	0	16.82157	14.32579	0	16.0083	15.94185	0	0	16.5772	0	0	0	15.40507	0	0	0	0	17.16405	0	0	0	0	0	0	0	0	0	18.84476	0	0	16.9135	16.05897	0	0	0	0	0	0	0
C9JG80	NPIB4_HUMAN	Nuclear pore complex-interacting protein family member B4	NPIPB4	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]		GO:0005654; GO:0016021	IVLKDVITLR	3.369999886	0.405865312	0.405865312	0.127833311	1170.55398	14.97401	13.50214	14.85151	0	15.60268	12.58023	12.18366	0	0	0	0	0	0	0	15.94745	0	0	0	0	0	0	0	0	0	14.8491	13.31447	0	15.03928	15.94612	0	14.75391	0	0	0	15.89881	12.82713	11.76991	0	15.23426	14.18756	0	0	0	0	0	0	0	15.62924
C9JLR9	ZFTA_HUMAN	"Zinc finger translocation-associated protein, ZFTA"	ZFTA C11orf95	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]"		"negative regulation of transcription, DNA-templated [GO:0045892]"		GO:0045892	HPGSTR	4.809999943	1	1	0.268273082	654.8169365	0	0	0	0	0	0	0	0	0	0	17.16449	0	0	0	16.10575	0	0	0	0	0	0	0	0	0	0	17.88139	16.23009	0	0	0	17.30219	0	0	17.55269	0	16.93744	0	0	18.40853	17.84645	17.91563	0	17.20213	0	17.91995	0	0	16.52097
C9JLW8	MCRI1_HUMAN	Mapk-regulated corepressor-interacting protein 1 (Granulin-2) (Protein FAM195B)	MCRIP1 FAM195B GRAN2	Homo sapiens (Human)	regulation of epithelial to mesenchymal transition [GO:0010717]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; regulation of epithelial to mesenchymal transition [GO:0010717]		GO:0005634; GO:0005737; GO:0010494; GO:0010717	MTSSPVSR	5.909999847	0.109363556	0.109363556	0.256785414	863.5061727	13.76018	0	0	0	0	14.35109	14.85276	16.17062	13.44124	15.4996	16.7567	14.41747	14.64718	0	0	14.84052	16.5381	0	15.62191	15.04944	0	0	0	0	16.82162	0	0	14.96151	17.09737	0	16.23767	15.1698	0	15.63328	0	0	16.06742	0	15.66888	0	16.0302	0	0	15.73091	15.91211	0	15.79828	0
C9JSJ3	MEIOS_HUMAN	Meiosis initiator protein (Basic helix-loop-helix and HMG box domain-containing protein 1)	MEIOSIN BHMG1	Homo sapiens (Human)	activation of meiosis [GO:0090427]; cellular response to retinoic acid [GO:0071300]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; activation of meiosis [GO:0090427]; cellular response to retinoic acid [GO:0071300]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]	GO:0003677; GO:0005634; GO:0006357; GO:0007283; GO:0046983; GO:0048477; GO:0051321; GO:0071300; GO:0090427	LVAPSPDQK	12.07999992	0.592900276	0.592900276	0.253287326	957.2308289	17.17056	15.73532	0	0	14.66075	15.00465	17.17403	12.547	0	17.12938	15.57493	16.59165	0	15.77838	15.222	17.33992	0	15.62588	18.11752	15.28449	15.62919	0	16.53417	0	16.90676	16.04065	0	14.05944	0	15.25313	0	0	0	0	0	15.1596	0	0	16.17325	15.57254	15.78621	16.0896	14.95104	0	13.90638	15.17494	16.14666	15.69114
C9JTQ0	ANR63_HUMAN	Ankyrin repeat domain-containing protein 63	ANKRD63	Homo sapiens (Human)						AGALMALPNSPQSSGTGRWR	4.170000076	1	1	0.212185938	2072.162804	15.43412	0	15.09516	14.92042	14.19509	11.75319	13.7991	13.19721	15.19233	0	0	0	18.62179	13.5849	13.63235	14.57738	12.68504	13.83023	0	0	0	0	0	0	0	0	0	15.47923	14.23777	0	0	18.99227	0	0	0	0	0	0	0	0	0	14.76614	0	0	0	0	0	0
D6REC4	CFA99_HUMAN	Cilia- and flagella-associated protein 99	CFAP99	Homo sapiens (Human)		motile cilium [GO:0031514]	motile cilium [GO:0031514]		GO:0031514	SQELQNMVEQISLCRAAMGR	4.760000229	1	1	4.75E-13	2337.182431	15.69101	16.08255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.17039	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
D6RIA3	CD054_HUMAN	Uncharacterized protein C4orf54 (Familial obliterative portal venopathy)	C4orf54 FOPV	Homo sapiens (Human)						CGGVGARVEQSLLR	8.760000229	1	1	0.10242558	1501.413041	16.13451	14.5952	15.16457	14.42826	14.721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.71698	0	0	18.17782	17.78126	0	0	0	0	0	0	0	0	0	15.35457	15.6635	16.27022	13.13527	0	0	14.08662	14.16387	0	0	0	0	0	0	0
E0CX11	STMP1_HUMAN	Short transmembrane mitochondrial protein 1	STMP1 C7orf73	Homo sapiens (Human)	innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]	integral component of membrane [GO:0016021]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrial respirasome [GO:0005746]	integral component of membrane [GO:0016021]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrial respirasome [GO:0005746]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]		GO:0005741; GO:0005746; GO:0005758; GO:0016021; GO:0032731; GO:0045087; GO:1900227	KKPPSA	7.090000153	1	1	0.1784212	625.5715836	0	0	0	0	0	0	16.19776	0	0	0	0	15.54981	0	0	0	0	0	15.48446	0	0	0	0	14.63723	0	0	0	0	0	0	16.6974	11.45936	0	15.3932	0	0	14.72408	16.78817	0	16.89448	16.03211	15.71869	15.17562	0	0	14.52774	15.3164	0	17.22509
E2RYF7	PBMU2_HUMAN	Protein PBMUCL2 (HLA complex group 22) (Panbronchiolitis-related mucin-like protein 2)	HCG22 G2 PBMUCL2	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	HPETSPKDSR	2.609999895	0.555025756	0.555025756	0.194692481	1155.009894	0	15.76507	16.38496	13.4113	12.77634	0	17.36287	13.10346	0	6.495792	13.91647	0	13.99342	0	0	13.37587	15.28735	0	0	0	0	0	0	0	13.82242	0	0	0	0	0	16.27202	16.24246	0	16.00317	0	0	14.40765	16.35238	0	0	0	0	0	0	15.56781	0	0	0
E7EW31	PROB1_HUMAN	Proline-rich basic protein 1	PROB1 C5orf65	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	QTPNGAVR	13.67000008	1	1	0.180065555	841.7534231	0	0	0	13.60468	13.44915	15.16678	0	0	15.42231	0	0	14.39487	0	13.65544	0	15.05477	0	0	0	0	0	0	0	0	16.06685	0	0	0	0	0	0	0	0	0	0	0	0	0	16.74075	0	14.83423	0	0	0	0	0	0	0
E9PAV3	NACAM_HUMAN	"Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form, skNAC)"	NACA	Homo sapiens (Human)	protein targeting to membrane [GO:0006612]	cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; DNA binding [GO:0003677]; unfolded protein binding [GO:0051082]; protein targeting to membrane [GO:0006612]	DNA binding [GO:0003677]; unfolded protein binding [GO:0051082]	GO:0003677; GO:0005634; GO:0005737; GO:0005854; GO:0006612; GO:0051082	ATPAPK	1.159999967	1	1	2.32E-13	582.3201276	0	0	15.16197	0	15.22248	14.0537	0	0	0	0	0	0	0	0	0	0	0	16.21466	0	0	14.36129	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
F2Z333	FND10_HUMAN	Fibronectin type III domain-containing protein 10	FNDC10 C1orf233	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	CQAPGCVLHAPAGR	4.820000172	1	1	0.046617951	1493.359918	0	15.33988	16.80939	0	0	0	13.04389	14.77962	16.55042	0	16.27346	0	0	16.78884	0	14.43437	0	0	0	0	16.37748	0	15.80502	0	14.09096	0	0	0	0	0	0	16.48192	0	0	0	16.29908	0	0	0	0	0	0	0	0	0	0	14.81933	0
F5H4B4	F227A_HUMAN	Protein FAM227A	FAM227A	Homo sapiens (Human)						NTMVKTVR	4.78000021	0.261385798	0.261385798	0.07866374	949.5580959	13.82972	18.52146	16.22859	12.00903	15.80268	0	16.15348	0	15.05668	17.32737	11.45792	13.16015	15.90287	18.65122	0	0	0	0	17.18691	0	0	0	0	18.06952	0	12.18245	11.23981	0	16.65186	0	18.03011	17.68431	15.99675	16.66761	19.11968	0	17.26723	0	18.60828	0	0	0	16.85963	0	0	0	17.18904	16.39004
H3BQB6	STMD1_HUMAN	Stathmin domain-containing protein 1	STMND1	Homo sapiens (Human)	microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110]	tubulin binding [GO:0015631]	GO:0005737; GO:0007019; GO:0015631; GO:0031110; GO:0031175; GO:0043005	NESDESFGVVESDMSYNQADDIVY	3.00999999	0.461228997	0.461228997	0.144947031	2713.611212	0	14.22546	0	0	0	15.30017	16.55318	0	15.75674	0	15.4102	0	0	0	0	17.97049	0	15.94576	0	0	0	0	13.29068	0	0	13.29333	0	0	16.01608	0	0	0	13.4585	0	15.4236	16.47642	10.69549	0	15.2029	0	13.25891	0	16.82322	17.64703	15.27399	14.78876	0	0
H3BUK9	POTB2_HUMAN	POTE ankyrin domain family member B2	POTEB2	Homo sapiens (Human)						SKMGK	5.440000057	0.67397511	0.67397511	0.187879964	569.5609078	15.02011	16.02617	16.46111	14.96296	0	13.56588	15.78342	0	16.60354	15.50198	0	15.89301	0	18.37539	15.9451	0	16.88955	0	0	15.44577	0	15.51237	0	0	0	0	15.58035	16.7799	17.01105	15.44389	16.2094	16.65302	16.92114	17.98758	0	17.11936	16.92123	15.85303	13.37079	16.61022	14.96972	13.99649	14.74653	17.1727	17.53562	14.09396	16.43849	16.47058
H7BZ55	CRCC2_HUMAN	Ciliary rootlet coiled-coil protein 2	CROCC2	Homo sapiens (Human)						LQDLTAQHQR	8.43999958	0.26390481	0.26390481	0.03616398	1212.288969	0	12.1494	0	0	15.82233	18.37015	0	18.02109	15.00543	0	0	16.10084	16.13262	0	13.51447	0	0	15.81538	14.10064	0	0	0	0	0	0	0	16.18358	0	0	0	15.14713	15.87723	14.24022	0	0	0	15.7796	0	14.67104	15.11001	0	0	0	0	16.07507	0	0	11.16306
I3L1E1	CS084_HUMAN	Uncharacterized protein C19orf84	C19orf84	Homo sapiens (Human)						AGGPGAGPR	9.550000191	1	1	0.224585676	740.8715107	14.99526	0	14.50825	14.58784	15.01895	12.2464	11.2677	15.43714	16.15465	0	16.1449	15.31467	0	15.27868	14.52283	0	15.68758	16.28709	15.78174	15.6452	16.01669	14.95722	0	15.32359	15.15784	15.13752	15.17118	0	0	0	0	0	0	0	0	0	0	0	0	14.70569	0	0	0	0	16.04534	16.0254	12.76351	0
I3L273	GFY_HUMAN	"Golgi-associated olfactory signaling regulator (Golgi protein in olfactory neurons, Goofy)"	GFY	Homo sapiens (Human)	non-motile cilium assembly [GO:1905515]; protein localization to non-motile cilium [GO:0097499]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]	integral component of Golgi membrane [GO:0030173]	integral component of Golgi membrane [GO:0030173]; non-motile cilium assembly [GO:1905515]; protein localization to non-motile cilium [GO:0097499]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]		GO:0007608; GO:0030173; GO:0050896; GO:0097499; GO:1905515	ILFLVFLLAGLRSK	6.550000191	1	1	0.743956847	1591.132336	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.0183	0	0	18.77842	0	0	19.238	21.15271	0	0	0	0	0	0	0	0	17.78506	0	0	0	18.77407	0
I3L3R5	CCER2_HUMAN	Coiled-coil domain-containing glutamate-rich protein 2	CCER2	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	GLLLGDFKK	9.550000191	1	1	0.243610897	991.2066748	18.03013	16.54506	16.70194	12.20334	0	0	14.30926	12.32254	0	16.52388	18.51251	13.18514	0	15.87422	0	15.46406	15.93573	16.49964	0	0	14.6188	15.59449	0	17.41984	12.90324	15.53857	17.61341	0	0	13.47192	16.39197	0	16.96868	15.42562	15.95778	15.78057	16.26863	16.18563	14.1242	0	14.61005	15.3356	16.14559	0	0	11.70432	0	0
K9M1U5	IFNL4_HUMAN	"Interferon lambda-4, IFN-lambda-4"	IFNL4	Homo sapiens (Human)	cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]; type III interferon signaling pathway [GO:0038196]; tyrosine phosphorylation of STAT protein [GO:0007260]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]; type III interferon signaling pathway [GO:0038196]; tyrosine phosphorylation of STAT protein [GO:0007260]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005125; GO:0005615; GO:0005737; GO:0007260; GO:0038196; GO:0045087; GO:0050778; GO:0051607; GO:0098586	HVARGIADAQAVLSGLHR	1.5	1	1	0.205335605	1869.900972	16.32093	0	13.60682	0	14.79958	0	0	0	0	0	0	0	0	0	0	7.780131	0	0	0	14.43861	14.35328	0	0	0	13.01668	0	0	0	0	0	0	0	0	0	14.19002	0	0	0	0	0	0	0	0	0	0	0	0	15.35789
M0R2J8	DCDC1_HUMAN	Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein)	DCDC1 DCDC5 KIAA1493	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412]	cytoplasm [GO:0005737]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]	cytoplasm [GO:0005737]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412]	carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017]	GO:0005737; GO:0005874; GO:0007049; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412	IIAYKNGDGYR	5.889999866	0.587402761	0.587402761	0.073720577	1269.370324	15.98518	16.08079	14.11898	0	14.33364	0	0	0	14.43592	0	15.91024	0	11.79772	0	0	14.24109	16.96497	0	16.70971	15.60536	0	12.9879	13.69315	0	16.71145	16.4177	0	0	17.36575	14.59879	15.56874	0	0	16.19205	16.07223	0	0	16.56917	0	14.67477	0	16.56323	0	13.67088	16.23017	0	0	13.70578
O00139	KIF2A_HUMAN	"Kinesin-like protein KIF2A (Kinesin-2, hK2)"	KIF2A KIF2 KNS2	Homo sapiens (Human)	cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0120103	VFDLLNR	11.68000031	0.353221893	0.353221893	0.171822066	875.4033168	12.00262	16.96215	17.03913	14.1857	14.79123	15.77995	17.22705	17.0036	15.69772	16.95921	16.61612	17.01002	16.23724	0	17.1967	15.94943	16.69982	17.65473	15.80037	17.3301	18.24539	0	17.04747	0	17.51823	11.34901	16.74074	16.85944	15.29171	17.02824	0	18.71826	17.43613	0	0	15.53623	12.17228	16.73928	17.67039	0	11.32285	0	17.82804	0	16.79438	17.38323	14.43795	16.70051
O00141	SGK1_HUMAN	"Serine/threonine-protein kinase Sgk1, EC 2.7.11.1 (Serum/glucocorticoid-regulated kinase 1)"	SGK1 SGK	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045	GMVAILIAFMK	5.619999886	1	1	2.29E-13	1210.326062	15.56125	13.70375	0	0	12.95663	0	0	0	0	0	0	0	15.19882	0	0	0	0	0	0	0	0	0	10.86526	0	11.78705	0	14.34595	13.86566	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00148	DX39A_HUMAN	"ATP-dependent RNA helicase DDX39A, EC 3.6.4.13 (DEAD box protein 39) (Nuclear RNA helicase URH49)"	DDX39A DDX39	Homo sapiens (Human)	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0042802	FSKYMPSVK	7.989999771	1	1	6.94E-13	1085.703507	15.30521	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.13482	0	0	0	0	0	0	14.78332	16.05974	0	16.68917	15.87128	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00154	BACH_HUMAN	"Cytosolic acyl coenzyme A thioester hydrolase, EC 3.1.2.2 (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase, BACH, hBACH) (CTE-IIa, CTE-II) (Long chain acyl-CoA thioester hydrolase)"	ACOT7 BACH	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; protein homodimerization activity [GO:0042803]; acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; protein homodimerization activity [GO:0042803]	GO:0000062; GO:0005654; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0015937; GO:0016290; GO:0036042; GO:0036114; GO:0036116; GO:0042803; GO:0047617; GO:0051792; GO:0052689; GO:0070062; GO:0102991; GO:1900535	QGHAEPQP	4.829999924	1	1	0.270068385	864.2105595	0	0	0	16.6787	0	0	18.65662	0	15.1373	17.42157	15.31814	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.55472	0	0	0	0	18.44734	0	0	0	18.01311	0	19.0041	0	14.12701	0	0	0	0	0	0	0	0	0
O00159	MYO1C_HUMAN	"Unconventional myosin-Ic (Myosin I beta, MMI-beta, MMIb)"	MYO1C	Homo sapiens (Human)	actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; chromatin remodeling [GO:0006338]; mRNA transport [GO:0051028]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of histone acetylation [GO:0035066]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein targeting to membrane [GO:0006612]; regulation of bicellular tight junction assembly [GO:2000810]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; B-WICH complex [GO:0110016]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nuclear body [GO:0016604]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; B-WICH complex [GO:0110016]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nuclear body [GO:0016604]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; chromatin remodeling [GO:0006338]; mRNA transport [GO:0051028]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of histone acetylation [GO:0035066]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein targeting to membrane [GO:0006612]; regulation of bicellular tight junction assembly [GO:2000810]; vesicle transport along actin filament [GO:0030050]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]	GO:0000146; GO:0001726; GO:0005102; GO:0005516; GO:0005524; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0006338; GO:0006612; GO:0007015; GO:0008022; GO:0009925; GO:0015629; GO:0016020; GO:0016328; GO:0016461; GO:0016604; GO:0030050; GO:0030335; GO:0030659; GO:0031267; GO:0031941; GO:0031982; GO:0035066; GO:0038089; GO:0045121; GO:0045335; GO:0045943; GO:0045944; GO:0045945; GO:0051015; GO:0051028; GO:0060171; GO:0070062; GO:0071346; GO:0090314; GO:0110016; GO:1900078; GO:1900748; GO:2000810	GAPVGGHILSYLLEKSR	3.670000076	1	1	0.20229813	1796.027518	10.31167	11.79446	0	12.98747	14.02982	13.37939	14.33855	14.19945	14.37288	15.54213	14.3027	15.10774	0	0	14.69662	15.30165	0	0	14.92089	0	0	0	14.14142	0	0	14.85226	0	0	0	0	0	0	0	0	0	0	15.30347	0	0	0	16.02224	15.24746	14.50504	0	10.06779	0	0	0
O00160	MYO1F_HUMAN	Unconventional myosin-If (Myosin-Ie)	MYO1F	Homo sapiens (Human)	actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016461; GO:0030050; GO:0031982; GO:0051015	GGPLPLEIMSGGGTHRPPR	6.869999886	1	1	0.267892072	1944.00158	0	0	16.54501	0	0	0	0	0	9.53164	0	13.9374	0	0	0	0	0	0	0	0	0	17.36544	0	0	0	18.1479	0	0	0	0	0	18.65173	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00170	AIP_HUMAN	"AH receptor-interacting protein, AIP (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2, XAP-2) (Immunophilin homolog ARA9)"	AIP XAP2	Homo sapiens (Human)	negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805]	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805]	aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]	GO:0003713; GO:0003755; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0010738; GO:0016020; GO:0017162; GO:0022417; GO:0034751; GO:0036004; GO:0051082; GO:0051344	YYDAIACLK	5.289999962	0.180140346	0.180140346	1.60E-12	1113.519601	15.53857	0	0	0	0	16.41619	0	0	0	0	0	15.47803	16.03232	13.25015	0	16.57086	15.58734	0	0	0	14.07214	0	14.78222	0	15.38083	0	12.17991	0	15.40477	0	0	13.11879	0	0	0	9.065432	0	12.01885	0	0	14.51038	16.53358	0	0	0	0	0	0
O00178	GTPB1_HUMAN	"GTP-binding protein 1, G-protein 1, GP-1, GP1"	GTPBP1	Homo sapiens (Human)	GTP metabolic process [GO:0046039]; immune response [GO:0006955]; positive regulation of mRNA catabolic process [GO:0061014]; signal transduction [GO:0007165]; translational elongation [GO:0006414]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; membrane [GO:0016020]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; immune response [GO:0006955]; positive regulation of mRNA catabolic process [GO:0061014]; signal transduction [GO:0007165]; translational elongation [GO:0006414]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0000177; GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0006955; GO:0007165; GO:0016020; GO:0046039; GO:0061014	AVGTITK	14.81000042	0.621101618	0.621101618	0.24882573	688.6110051	14.8488	12.22919	14.90923	16.3656	0	13.04049	14.39971	14.39275	14.67741	14.42249	15.53763	16.17966	0	14.84977	15.78349	13.98285	15.61504	0	15.90352	15.36883	16.60002	16.86668	15.67124	0	0	15.81663	16.01344	0	16.12266	0	15.83236	0	0	16.05366	0	0	16.95642	16.52689	16.96212	16.11931	16.15039	16.41503	17.12693	16.86363	16.17174	15.90956	0	0
O00180	KCNK1_HUMAN	Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1)	KCNK1 HOHO1 KCNO1 TWIK1	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725]; stabilization of membrane potential [GO:0030322]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725]; stabilization of membrane potential [GO:0030322]	identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]	GO:0005242; GO:0005267; GO:0005272; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0016324; GO:0022841; GO:0030322; GO:0030425; GO:0031526; GO:0034705; GO:0035094; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0055037; GO:0060075; GO:0071805; GO:0097060; GO:1902937	MLQSLAGSSCVRLVER	4.739999771	1	1	0.126163133	1807.046199	15.55945	0	15.79765	0	0	16.13103	14.83358	10.58854	0	13.95426	0	0	0	0	0	15.55377	0	14.22851	0	0	0	0	0	0	16.77666	0	0	0	0	0	0	0	0	15.79691	0	0	0	14.60153	15.25317	0	0	0	0	0	14.90511	15.48416	0	0
O00186	STXB3_HUMAN	"Syntaxin-binding protein 3 (Platelet Sec1 protein, PSP) (Protein unc-18 homolog 3, Unc18-3) (Protein unc-18 homolog C, Unc-18C)"	STXBP3	Homo sapiens (Human)	brain development [GO:0007420]; cellular glucose homeostasis [GO:0001678]; cellular response to interferon-gamma [GO:0071346]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of glucose import [GO:0046325]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; protein to membrane docking [GO:0022615]; response to insulin [GO:0032868]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; brain development [GO:0007420]; cellular glucose homeostasis [GO:0001678]; cellular response to interferon-gamma [GO:0071346]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of glucose import [GO:0046325]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; protein to membrane docking [GO:0022615]; response to insulin [GO:0032868]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]	protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]	GO:0001678; GO:0005829; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0007420; GO:0016192; GO:0016323; GO:0016324; GO:0017075; GO:0019905; GO:0022615; GO:0030073; GO:0030141; GO:0031091; GO:0032868; GO:0042581; GO:0043312; GO:0044877; GO:0045335; GO:0045955; GO:0046325; GO:0070062; GO:0070527; GO:0070820; GO:0071346; GO:0098793	DSMRVLLPVLLNK	8.569999695	1	1	0.031778517	1497.023737	0	13.0824	0	15.56906	11.96084	15.81355	0	14.20982	11.90739	16.46879	14.53099	0	15.09154	0	0	14.66994	15.23671	13.06165	15.06533	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.65764	0	0	0	0	0	0	0	0	0	0	13.28499	0	0	0
O00192	ARVC_HUMAN	Armadillo repeat protein deleted in velo-cardio-facial syndrome	ARVCF	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]	cadherin binding [GO:0045296]	GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0016339; GO:0045296; GO:0098609	DTDNKSVENCVCIMR	3.970000029	1	1	0.210689713	1841.923712	18.2161	15.43733	15.62473	15.92547	14.06285	0	0	0	0	0	0	0	0	0	0	0	0	0	15.54009	0	0	17.09489	0	0	16.51821	0	0	0	16.40634	0	0	17.65562	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00203	AP3B1_HUMAN	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	AP3B1 ADTB3A	Homo sapiens (Human)	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular protein modification process [GO:0006464]; cellular zinc ion homeostasis [GO:0006882]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular protein modification process [GO:0006464]; cellular zinc ion homeostasis [GO:0006882]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]"	GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]	GO:0000902; GO:0002224; GO:0002244; GO:0003016; GO:0005739; GO:0005765; GO:0005769; GO:0005794; GO:0006464; GO:0006622; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016020; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0035654; GO:0042789; GO:0045202; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0090152; GO:0098773; GO:1903232; GO:1904115	NVASK	4.329999924	0.238989323	0.238989323	0.177553274	517.460424	15.46754	16.2982	15.64047	16.11605	15.89166	15.12562	0	15.83202	15.76381	16.62891	15.32364	14.67647	15.97381	15.31702	15.58163	0	0	15.95313	0	15.67075	17.26936	16.72592	14.13854	0	15.06664	16.74833	13.32704	15.34867	15.45243	16.77488	15.04651	14.36251	15.41927	16.59249	0	17.61842	13.42041	15.79257	16.95919	16.21643	16.23551	15.1652	15.64684	15.78689	17.85021	16.42659	17.00638	14.72944
O00204	ST2B1_HUMAN	"Sulfotransferase 2B1, EC 2.8.2.2 (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1, ST2B1)"	SULT2B1 HSST2	Homo sapiens (Human)	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; alcohol sulfotransferase activity [GO:0004027]; cholesterol binding [GO:0015485]; nucleic acid binding [GO:0003676]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]	alcohol sulfotransferase activity [GO:0004027]; cholesterol binding [GO:0015485]; nucleic acid binding [GO:0003676]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]	GO:0003676; GO:0004027; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0008146; GO:0008202; GO:0008203; GO:0008285; GO:0015485; GO:0043231; GO:0045606; GO:0050294; GO:0050427; GO:0051923; GO:0070062; GO:1990239	SVPIWER	7.579999924	1	1	3.48E-13	887.7126807	0	0	14.75476	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.16834	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00206	TLR4_HUMAN	Toll-like receptor 4 (hToll) (CD antigen CD284)	TLR4	Homo sapiens (Human)	activation of innate immune response [GO:0002218]; astrocyte development [GO:0014002]; B cell proliferation involved in immune response [GO:0002322]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; detection of fungus [GO:0016046]; detection of lipopolysaccharide [GO:0032497]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intestinal epithelial structure maintenance [GO:0060729]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide production involved in inflammatory response [GO:0002537]; phagocytosis [GO:0006909]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of platelet activation [GO:0010572]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of dendritic cell cytokine production [GO:0002730]; response to lipopolysaccharide [GO:0032496]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; wound healing involved in inflammatory response [GO:0002246]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; activation of innate immune response [GO:0002218]; astrocyte development [GO:0014002]; B cell proliferation involved in immune response [GO:0002322]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; detection of fungus [GO:0016046]; detection of lipopolysaccharide [GO:0032497]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intestinal epithelial structure maintenance [GO:0060729]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide production involved in inflammatory response [GO:0002537]; phagocytosis [GO:0006909]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of platelet activation [GO:0010572]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of dendritic cell cytokine production [GO:0002730]; response to lipopolysaccharide [GO:0032496]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; wound healing involved in inflammatory response [GO:0002246]"	"amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]"	GO:0001530; GO:0001540; GO:0001726; GO:0001875; GO:0001891; GO:0002218; GO:0002224; GO:0002246; GO:0002322; GO:0002537; GO:0002730; GO:0002755; GO:0004888; GO:0005102; GO:0005737; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0006909; GO:0006954; GO:0006955; GO:0007252; GO:0009897; GO:0009986; GO:0010008; GO:0010572; GO:0010628; GO:0014002; GO:0014911; GO:0016046; GO:0030890; GO:0031226; GO:0031663; GO:0032496; GO:0032497; GO:0032689; GO:0032700; GO:0032707; GO:0032715; GO:0032720; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032732; GO:0032733; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034142; GO:0035666; GO:0036120; GO:0038023; GO:0042088; GO:0042116; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043406; GO:0045087; GO:0045348; GO:0045429; GO:0045671; GO:0045944; GO:0046330; GO:0046696; GO:0046982; GO:0048471; GO:0048661; GO:0050135; GO:0050729; GO:0050829; GO:0051092; GO:0051770; GO:0060729; GO:0060907; GO:0061809; GO:0070373; GO:0070374; GO:0070430; GO:0070434; GO:0071222; GO:0071223; GO:0071260; GO:0071346; GO:0120163; GO:0140052; GO:1900017; GO:1900227; GO:1901224; GO:1903223; GO:1903428; GO:1903974; GO:1904466; GO:1904646; GO:2000343	QLLVEVERMECATPSDK	8.350000381	8.57E-14	8.57E-14	0.393537204	2020.016843	0	21.19452	0	0	18.87743	0	19.87898	0	20.16467	0	0	0	0	0	0	20.60444	18.33227	19.98153	19.92783	0	0	0	19.76852	0	0	0	0	19.69718	19.34605	18.63577	19.78214	20.37832	0	0	0	20.80347	20.27196	0	17.89494	0	0	0	0	20.21715	0	19.60649	0	0
O00213	APBB1_HUMAN	Amyloid beta precursor protein binding family B member 1 (Amyloid-beta A4 precursor protein-binding family B member 1) (Protein Fe65)	APBB1 FE65 RIR	Homo sapiens (Human)	"apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H4 acetylation [GO:0043967]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]"	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle receptor binding [GO:0050750]; proline-rich region binding [GO:0070064]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H4 acetylation [GO:0043967]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]"	amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle receptor binding [GO:0050750]; proline-rich region binding [GO:0070064]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0001540; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005886; GO:0006325; GO:0006355; GO:0006915; GO:0006939; GO:0006974; GO:0007165; GO:0007409; GO:0016607; GO:0030027; GO:0030426; GO:0031625; GO:0042393; GO:0043065; GO:0043967; GO:0045202; GO:0045893; GO:0045944; GO:0050714; GO:0050750; GO:0070064; GO:1902807	DLRSAMGEGGGPEPGPANAK	7.139999866	1	1	0.131615303	1925.395814	0	0	12.75835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00220	TR10A_HUMAN	"Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1, TRAIL receptor 1, TRAIL-R1) (CD antigen CD261)"	TNFRSF10A APO2 DR4 TRAILR1	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]; TRAIL-activated apoptotic signaling pathway [GO:0036462]	cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]; TRAIL-activated apoptotic signaling pathway [GO:0036462]	death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]	GO:0002020; GO:0005035; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0007250; GO:0008625; GO:0009986; GO:0016021; GO:0036462; GO:0038023; GO:0042802; GO:0043065; GO:0045121; GO:0045569; GO:0071260; GO:0097191	NASIHTLLDALER	6.989999771	1	1	0.219047378	1452.820862	14.95249	14.27425	13.78795	15.0244	10.83824	13.53856	16.00001	12.52439	0	0	12.72805	13.05299	0	0	14.43874	0	13.10048	0	0	0	14.56362	0	15.11483	0	0	16.37025	0	0	0	0	0	0	0	0	0	0	15.95369	0	0	0	0	15.3258	0	0	0	14.33625	0	0
O00221	IKBE_HUMAN	"NF-kappa-B inhibitor epsilon, NF-kappa-BIE (I-kappa-B-epsilon, IkB-E, IkB-epsilon, IkappaBepsilon)"	NFKBIE IKBE	Homo sapiens (Human)	cytoplasmic sequestering of transcription factor [GO:0042994]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; cytoplasmic sequestering of transcription factor [GO:0042994]		GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0042994	GLMGISSTLCKAGADSLLR	8.340000153	1	1	0.223541712	1949.631608	16.27453	0	13.1949	0	0	17.52419	0	0	0	9.893821	14.5244	0	0	0	0	0	15.42982	0	0	0	12.39712	0	0	0	12.15371	14.34466	17.00012	14.69992	13.70677	13.58666	15.71591	0	0	0	0	0	0	0	0	17.32947	0	0	0	0	0	0	0	0
O00222	GRM8_HUMAN	"Metabotropic glutamate receptor 8, mGluR8"	GRM8 GPRC1H MGLUR8	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]"	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]	GO:0001640; GO:0001642; GO:0004930; GO:0005886; GO:0005887; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966	GVPCGELK	3.690000057	1	1	0.133856436	859.7695588	15.72345	16.62028	0	13.90034	16.7173	14.40059	14.38456	14.90844	14.3217	12.96192	0	0	0	13.39127	0	14.65187	0	14.26662	15.12826	14.76897	0	0	0	15.65148	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.18018	0	0	0
O00232	PSD12_HUMAN	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)	PSMD12	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"		GO:0000502; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0008541; GO:0016020; GO:0022624; GO:0031595; GO:0034774; GO:0043161; GO:0070062; GO:1904813	ERVEFILEQMR	12.86999989	1	1	0.274400472	1466.772532	16.91719	14.16152	15.80352	15.65745	14.14367	14.77599	16.04349	16.04186	14.19428	15.2393	0	0	0	13.45751	0	0	16.40246	0	0	0	15.01742	0	15.65391	16.5185	0	16.66886	0	13.58035	13.38076	0	16.44703	14.22678	0	17.0756	0	0	0	15.93928	0	0	0	0	0	0	0	0	0	13.93518
O00253	AGRP_HUMAN	Agouti-related protein	AGRP AGRT ART	Homo sapiens (Human)	adult feeding behavior [GO:0008343]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; hormone-mediated signaling pathway [GO:0009755]; long-day photoperiodism [GO:0048571]; maternal process involved in female pregnancy [GO:0060135]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]; regulation of feeding behavior [GO:0060259]; response to insulin [GO:0032868]	extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; neuronal cell body [GO:0043025]	extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; neuronal cell body [GO:0043025]; melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]; adult feeding behavior [GO:0008343]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; hormone-mediated signaling pathway [GO:0009755]; long-day photoperiodism [GO:0048571]; maternal process involved in female pregnancy [GO:0060135]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]; regulation of feeding behavior [GO:0060259]; response to insulin [GO:0032868]	melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]	GO:0005102; GO:0005184; GO:0005615; GO:0005796; GO:0007218; GO:0007623; GO:0007631; GO:0008343; GO:0009755; GO:0031779; GO:0032868; GO:0042755; GO:0043025; GO:0048571; GO:0060135; GO:0060259; GO:0070996; GO:2000253	GAQMGLAPMEGIR	10.19999981	1	1	2.07E-12	1330.037154	13.73989	0	0	0	0	0	0	0	14.56726	0	0	0	0	11.93669	11.66777	12.39159	15.85519	13.8901	13.46859	0	0	15.36574	0	0	14.74302	0	0	0	0	13.85157	15.56844	0	16.15585	14.98752	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00264	PGRC1_HUMAN	"Membrane-associated progesterone receptor component 1, mPR (Dap1) (IZA)"	PGRMC1 HPR6.6 PGRMC	Homo sapiens (Human)	associative learning [GO:0008306]; axon guidance [GO:0007411]; heme biosynthetic process [GO:0006783]; memory [GO:0007613]; modification of synaptic structure [GO:0099563]; negative regulation of synapse organization [GO:1905809]; positive regulation of protein localization to plasma membrane [GO:1903078]	cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202]	cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; associative learning [GO:0008306]; axon guidance [GO:0007411]; heme biosynthetic process [GO:0006783]; memory [GO:0007613]; modification of synaptic structure [GO:0099563]; negative regulation of synapse organization [GO:1905809]; positive regulation of protein localization to plasma membrane [GO:1903078]	amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]	GO:0001540; GO:0005496; GO:0005741; GO:0005783; GO:0005886; GO:0005887; GO:0006783; GO:0007411; GO:0007613; GO:0008306; GO:0012505; GO:0016020; GO:0020037; GO:0030868; GO:0035579; GO:0042803; GO:0043005; GO:0043025; GO:0044297; GO:0045202; GO:0046872; GO:0099563; GO:1903078; GO:1905809	FDGVQDPRILMAINGK	4.21999979	1	1	0.189131468	1773.605649	17.90118	16.86726	0	13.16945	15.21109	0	0	0	0	0	0	12.9439	13.3727	14.01603	0	0	0	0	14.47084	14.34773	8.563233	0	0	0	0	0	0	14.55915	16.7504	0	0	0	0	0	0	0	0	0	0	15.05481	0	0	0	0	0	0	0	0
O00267	SPT5H_HUMAN	"Transcription elongation factor SPT5, hSPT5 (DRB sensitivity-inducing factor 160 kDa subunit, DSIF p160) (DRB sensitivity-inducing factor large subunit, DSIF large subunit) (Tat-cotransactivator 1 protein, Tat-CT1 protein)"	SUPT5H SPT5 SPT5H	Homo sapiens (Human)	"negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]	GO:0000122; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006368; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:1900364	EMTDVLKVVK	7.099999905	1	1	0.590780459	1179.539869	18.66715	20.27252	13.83717	19.28534	0	0	18.90516	0	0	0	18.75611	0	0	0	0	0	18.26576	17.15526	17.15665	0	0	0	0	0	19.28597	0	0	20.09959	16.51972	17.15069	0	0	0	0	0	18.925	0	19.67914	20.96885	19.3659	17.00131	0	0	0	18.12925	0	17.9831	16.88346
O00273	DFFA_HUMAN	"DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit, DFF-45) (Inhibitor of CAD, ICAD)"	DFFA DFF1 DFF45 H13	Homo sapiens (Human)	apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; thymocyte apoptotic process [GO:0070242]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; deoxyribonuclease inhibitor activity [GO:0060703]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; thymocyte apoptotic process [GO:0070242]	deoxyribonuclease inhibitor activity [GO:0060703]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]	GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006309; GO:0019904; GO:0032076; GO:0032991; GO:0042981; GO:0043065; GO:0044183; GO:0060703; GO:0061077; GO:0070242; GO:1900118; GO:1902511	AAFGEEVDAVDTGISR	2.720000029	1	1	1.15E-12	1637.858142	0	15.55841	13.92522	0	0	14.07355	0	0	0	0	0	0	0	0	0	15.08989	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.92252	17.81608	0	0	16.58418	0	0	0	0	0	0	0
O00287	RFXAP_HUMAN	"Regulatory factor X-associated protein, RFX-associated protein (RFX DNA-binding complex 36 kDa subunit)"	RFXAP	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0006357; GO:0016607; GO:0045944; GO:0090575	SDQALNCGGTASTGSAGNVK	4.639999866	1	1	1.83E-12	1889.983154	0	0	14.16987	13.9832	0	5.903064	14.7859	14.57366	13.51518	14.7153	13.73996	15.31323	14.25148	12.51711	14.06776	15.38049	0	12.24554	0	16.19258	0	0	15.51787	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00291	HIP1_HUMAN	"Huntingtin-interacting protein 1, HIP-1 (Huntingtin-interacting protein I, HIP-I)"	HIP1	Homo sapiens (Human)	actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]	clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]	"clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]"	"actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]"	GO:0005154; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0006897; GO:0006915; GO:0006919; GO:0007015; GO:0016020; GO:0030100; GO:0030136; GO:0030154; GO:0030276; GO:0030665; GO:0031234; GO:0032051; GO:0032266; GO:0035091; GO:0035254; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0051897; GO:0072583; GO:0080025; GO:0097190; GO:0098793; GO:0098794; GO:0098888; GO:0098890; GO:0098978; GO:0099637; GO:2000588	ILGCCTSLMQAIQVLIVASK	2.140000105	0.35182783	0.35182783	1.83E-12	2221.611881	14.42579	0	13.24915	10.5352	13.39967	0	0	14.2919	0	0	0	0	0	0	0	9.196941	0	0	0	16.40598	0	0	0	0	12.71502	15.34119	10.2769	0	0	0	0	0	0	0	0	0	0	12.76293	0	0	0	0	0	0	11.19068	0	11.82181	12.08254
O00294	TULP1_HUMAN	Tubby-related protein 1 (Tubby-like protein 1)	TULP1 TUBL1	Homo sapiens (Human)	"dendrite development [GO:0016358]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]"	axon terminus [GO:0043679]; cell projection [GO:0042995]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"axon terminus [GO:0043679]; cell projection [GO:0042995]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; dendrite development [GO:0016358]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]"	"actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0001750; GO:0001895; GO:0001917; GO:0005546; GO:0005576; GO:0005829; GO:0005886; GO:0005929; GO:0006910; GO:0007601; GO:0016358; GO:0042462; GO:0042995; GO:0043679; GO:0045202; GO:0045494; GO:0050766; GO:0050908; GO:0051015; GO:0060041; GO:0061512; GO:1903546	NASDGLLVR	4.010000229	1	1	0.123490375	942.7301879	13.74056	16.77173	0	12.60009	0	0	12.58529	15.86913	15.25888	0	15.42999	14.86524	0	7.948943	13.79678	14.80486	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00295	TULP2_HUMAN	"Tubby-related protein 2 (Cancer/testis antigen 65, CT65) (Tubby-like protein 2)"	TULP2 TUBL2	Homo sapiens (Human)	protein localization to cilium [GO:0061512]; visual perception [GO:0007601]	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; protein-containing complex binding [GO:0044877]; protein localization to cilium [GO:0061512]; visual perception [GO:0007601]	protein-containing complex binding [GO:0044877]	GO:0005576; GO:0005737; GO:0005929; GO:0007601; GO:0044877; GO:0061512	SQDNDTLMR	6.429999828	1	1	0	1094.419018	0	19.02418	0	0	0	0	0	0	0	17.6817	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00303	EIF3F_HUMAN	"Eukaryotic translation initiation factor 3 subunit F, eIF3f (Deubiquitinating enzyme eIF3f, EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47)"	EIF3F EIF3S5	Homo sapiens (Human)	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413]	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; identical protein binding [GO:0042802]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; thiol-dependent deubiquitinase [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413]"	identical protein binding [GO:0042802]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; thiol-dependent deubiquitinase [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003743; GO:0004843; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0016579; GO:0031369; GO:0033290; GO:0042802; GO:0070122; GO:0071541; GO:0075522; GO:0140492	MSIKAYVSTLMGVPGR	1.879999995	0.002492317	0.002492317	0.585575333	1726.410851	0	0	0	0	0	0	0	18.81077	0	0	0	0	0	0	0	0	16.41862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00305	CACB4_HUMAN	"Voltage-dependent L-type calcium channel subunit beta-4, CAB4 (Calcium channel voltage-dependent subunit beta 4)"	CACNB4 CACNLB4	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; regulation of voltage-gated calcium channel activity [GO:1901385]	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; regulation of voltage-gated calcium channel activity [GO:1901385]	voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005829; GO:0005886; GO:0005891; GO:0007268; GO:0007528; GO:0009898; GO:0045202; GO:1901385	AIIERSNTR	3.180000067	1	1	0.134443859	1058.577251	0	16.96065	0	0	14.65739	14.21253	12.68916	0	0	0	15.78741	0	0	0	0	0	0	0	0	0	10.27071	0	0	0	0	0	15.73367	15.67025	16.56864	15.12177	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.64117	0	0
O00311	CDC7_HUMAN	"Cell division cycle 7-related protein kinase, CDC7-related kinase, HsCdc7, huCdc7, EC 2.7.11.1"	CDC7 CDC7L1	Homo sapiens (Human)	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0072686; GO:0106310	VMNSAVMRK	7.960000038	1	1	2.35E-13	1048.156484	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00327	BMAL1_HUMAN	"Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5, bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3)"	ARNTL BHLHE5 BMAL1 MOP3 PASD3	Homo sapiens (Human)	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"	aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]	"aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]"	"aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0034751; GO:0042634; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:0120163; GO:0140297; GO:1901985; GO:1990513; GO:1990837; GO:2000074; GO:2000323; GO:2000772; GO:2001016	LTVLRMAVQHMK	5.050000191	1	1	0.305603192	1458.547637	11.36463	0	0	0	0	0	0	0	13.68764	0	0	14.44903	0	12.96122	0	0	15.78781	16.59244	0	17.06462	0	0	0	14.9326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59561	0	0	0	0	0	0	15.87621
O00329	PK3CD_HUMAN	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, PI3-kinase subunit delta, PI3K-delta, PI3Kdelta, PtdIns-3-kinase subunit delta, EC 2.7.1.137, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta, PtdIns-3-kinase subunit p110-delta, p110delta)"	PIK3CD	Homo sapiens (Human)	adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]"	GO:0001779; GO:0001819; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006468; GO:0006954; GO:0006955; GO:0007165; GO:0010595; GO:0010628; GO:0010818; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030101; GO:0030183; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278	ALANRK	6.179999828	1	1	0.220974081	670.77637	16.80622	16.87674	15.26391	13.63978	11.85134	14.68859	13.31382	13.64626	0	13.6489	15.83321	10.69389	0	0	0	16.65134	14.90107	0	16.38121	15.21662	0	15.91152	0	0	0	0	0	15.25288	0	0	0	0	17.17681	0	0	0	0	16.78572	16.39722	0	16.83366	16.76987	0	0	16.66765	17.00731	0	0
O00337	S28A1_HUMAN	"Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1, CNT 1, hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1)"	SLC28A1 CNT1	Homo sapiens (Human)	azole transmembrane transport [GO:0045117]; cytidine transport [GO:0015861]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transport [GO:0015855]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862]	brush border membrane [GO:0031526]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	brush border membrane [GO:0031526]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; azole transmembrane transporter activity [GO:1901474]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]; azole transmembrane transport [GO:0045117]; cytidine transport [GO:0015861]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transport [GO:0015855]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862]	azole transmembrane transporter activity [GO:1901474]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]	GO:0005337; GO:0005345; GO:0005415; GO:0005829; GO:0005886; GO:0005887; GO:0006139; GO:0015212; GO:0015213; GO:0015293; GO:0015389; GO:0015855; GO:0015858; GO:0015861; GO:0015862; GO:0016020; GO:0016607; GO:0031526; GO:0045117; GO:0072531; GO:1901474; GO:1901642; GO:1904823	KSDFSQIVLR	3.25999999	1	1	0.128870576	1193.418573	14.92157	0	15.84768	0	0	11.07438	0	14.79726	0	0	0	14.7531	0	0	15.85818	0	0	0	0	0	0	0	14.48679	0	0	0	0	13.6743	11.97793	13.92096	16.79162	14.20227	14.72992	16.04855	0	0	0	0	0	0	14.01908	0	0	0	0	0	0	0
O00338	ST1C2_HUMAN	"Sulfotransferase 1C2, ST1C2, EC 2.8.2.1 (Sulfotransferase 1C1, SULT1C#1) (humSULTC2)"	SULT1C2 SULT1C1	Homo sapiens (Human)	amine metabolic process [GO:0009308]; sulfation [GO:0051923]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; amine metabolic process [GO:0009308]; sulfation [GO:0051923]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923	AKAMPSPR	2.25999999	0.300388038	0.300388038	0.067967333	858.807776	16.1296	13.37642	0	15.10175	15.81314	17.17315	0	12.85526	0	18.13366	13.25097	15.81587	15.2135	17.23069	15.21337	0	12.84164	0	16.07981	12.79233	0	18.01368	0	0	15.67172	15.97585	13.7564	11.93983	0	0	11.58087	16.97626	0	0	17.41606	15.77401	17.78775	14.73256	0	0	0	14.75142	0	15.82186	16.67002	13.71595	16.3027	16.23866
O00358	FOXE1_HUMAN	"Forkhead box protein E1 (Forkhead box protein E2) (Forkhead-related protein FKHL15) (HFKH4) (HNF-3/fork head-like protein 5, HFKL5) (Thyroid transcription factor 2, TTF-2)"	FOXE1 FKHL15 FOXE2 TITF2 TTF2	Homo sapiens (Human)	"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cranial skeletal system development [GO:1904888]; embryonic organ morphogenesis [GO:0048562]; hair follicle morphogenesis [GO:0031069]; hard palate development [GO:0060022]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pharynx development [GO:0060465]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cranial skeletal system development [GO:1904888]; embryonic organ morphogenesis [GO:0048562]; hair follicle morphogenesis [GO:0031069]; hard palate development [GO:0060022]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pharynx development [GO:0060465]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0006590; GO:0009653; GO:0016477; GO:0030154; GO:0030878; GO:0031069; GO:0043565; GO:0045892; GO:0045893; GO:0048538; GO:0048562; GO:0060022; GO:0060023; GO:0060465; GO:1904888; GO:1990837	HAAAYPGGIDRFVSAM	3.220000029	0.738720834	0.738720834	0.345340219	1662.614775	16.39432	0	0	0	0	0	17.67712	0	12.1154	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.70716	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00370	LORF2_HUMAN	"LINE-1 retrotransposable element ORF2 protein, ORF2p [Includes: Reverse transcriptase, EC 2.7.7.49; Endonuclease, EC 3.1.21.- ]"		Homo sapiens (Human)	"DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"		"metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]"	metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]	GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305	CSSSLAIREMQIK	2.109999895	1	1	0.198138188	1523.018748	0	15.66307	17.6998	0	0	0	0	0	0	0	0	0	0	16.08365	0	0	0	0	0	0	19.32015	0	0	0	0	0	16.46365	0	0	0	0	0	16.50006	0	0	0	0	0	0	16.31507	0	0	0	0	0	0	0	0
O00401	WASL_HUMAN	"Neural Wiskott-Aldrich syndrome protein, N-WASP"	WASL	Homo sapiens (Human)	actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; cell division [GO:0051301]; dendritic spine morphogenesis [GO:0060997]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of membrane tubulation [GO:1903526]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; protein-containing complex localization [GO:0031503]; regulation of protein localization [GO:0032880]; response to bacterium [GO:0009617]; spindle localization [GO:0051653]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050]	actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; cell division [GO:0051301]; dendritic spine morphogenesis [GO:0060997]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of membrane tubulation [GO:1903526]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; protein-containing complex localization [GO:0031503]; regulation of protein localization [GO:0032880]; response to bacterium [GO:0009617]; spindle localization [GO:0051653]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050]	actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]	GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0006900; GO:0008154; GO:0009617; GO:0015629; GO:0016050; GO:0030027; GO:0030041; GO:0030048; GO:0030050; GO:0030478; GO:0030666; GO:0030695; GO:0031410; GO:0031503; GO:0032880; GO:0045944; GO:0051301; GO:0051491; GO:0051653; GO:0060997; GO:0065003; GO:0070062; GO:1903526; GO:2000370; GO:2000402; GO:2000601	EGAQLKK	11.23999977	1	1	0.137983569	770.8022828	15.21428	0	0	0	0	0	0	0	0	0	0	10.47215	0	16.63807	0	0	0	0	17.26229	0	0	0	0	0	0	0	16.93019	15.88958	0	0	0	0	15.34296	0	16.07715	0	0	0	0	14.91993	0	0	0	0	0	0	0	0
O00408	PDE2A_HUMAN	"cGMP-dependent 3',5'-cyclic phosphodiesterase, EC 3.1.4.17 (Cyclic GMP-stimulated phosphodiesterase, CGS-PDE, cGSPDE)"	PDE2A	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004114; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:1904613	MLDLMR	22.03000069	1	1	0.181801022	796.4955852	15.09643	0	0	14.55461	0	0	14.57587	0	0	0	15.36293	0	0	0	0	0	15.97704	0	0	0	0	16.96246	0	0	0	0	16.41795	0	0	0	0	0	0	0	0	0	0	0	0	15.50438	0	0	0	0	0	0	0	0
O00409	FOXN3_HUMAN	Forkhead box protein N3 (Checkpoint suppressor 1)	FOXN3 C14orf116 CHES1	Homo sapiens (Human)	"craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]"	GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006355; GO:0007095; GO:0008022; GO:0045892; GO:0097094	VPSDTLPLK	10.81000042	0.131710693	0.131710693	0.124980654	970.7043525	0	0	0	0	15.23435	0	0	16.03243	0	0	0	11.17806	0	0	0	0	0	14.72951	15.16589	13.23753	0	0	0	0	0	0	0	0	13.1345	0	0	20.92886	0	0	12.99701	0	0	0	0	0	0	0	15.41562	0	0	0	0	0
O00410	IPO5_HUMAN	"Importin-5, Imp5 (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5, RanBP5)"	IPO5 KPNB3 RANBP5	Homo sapiens (Human)	cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005730; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0016020; GO:0031267; GO:0042307; GO:0045736; GO:0061608; GO:0071230	MCKILGK	3.799999952	1	1	0.253228742	865.1013475	0	16.71713	15.37008	17.40905	16.66593	0	0	0	16.77967	17.83079	16.59758	0	0	0	14.92259	18.81276	0	0	16.60087	15.4937	0	0	16.58571	0	0	0	0	0	0	0	0	18.71075	0	15.43743	0	0	0	0	16.3037	16.49077	0	0	15.9316	0	0	15.82148	0	0
O00418	EF2K_HUMAN	"Eukaryotic elongation factor 2 kinase, eEF-2 kinase, eEF-2K, EC 2.7.11.20 (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)"	EEF2K	Homo sapiens (Human)	cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]"	"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]"	GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637	ADEDLIFR	23.90999985	0.55025202	0.55025202	0.098990958	978.9682765	17.20641	17.78405	0	0	17.68943	0	0	0	16.35121	0	0	0	16.4497	14.78074	0	0	0	0	16.15781	0	14.69864	0	0	0	0	0	15.28269	12.82498	15.7629	0	16.32091	0	0	0	15.40284	0	13.44742	15.6	0	0	0	0	0	12.58697	0	0	0	0
O00421	CCRL2_HUMAN	C-C chemokine receptor-like 2 (Chemokine receptor CCR11) (Chemokine receptor X) (Putative MCP-1 chemokine receptor)	CCRL2 CCR11 CCR6 CKRX CRAM HCR	Homo sapiens (Human)	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR chemokine receptor binding [GO:0048020]; chemokine receptor activity [GO:0004950]; chemokine receptor binding [GO:0042379]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR chemokine receptor binding [GO:0048020]; chemokine receptor activity [GO:0004950]; chemokine receptor binding [GO:0042379]	GO:0004950; GO:0005737; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0042379; GO:0048020; GO:0060326	GQSAQGTSR	7.510000229	0.980207384	0.980207384	0.264790542	891.7929339	0	19.03721	0	17.85033	0	0	18.76422	18.87712	17.95175	16.44546	18.29036	0	0	0	16.89197	0	0	19.04133	0	0	0	0	0	17.69968	0	18.77356	19.66808	0	0	16.79681	20.48009	18.51555	19.92168	18.38333	19.01929	0	17.72373	19.98212	0	0	0	0	0	0	0	0	18.66643	16.84131
O00425	IF2B3_HUMAN	"Insulin-like growth factor 2 mRNA-binding protein 3, IGF2 mRNA-binding protein 3, IMP-3 (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer, hKOC) (VICKZ family member 3)"	IGF2BP3 IMP3 KOC1 VICKZ3	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; translation [GO:0006412]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]	GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0007399; GO:0009653; GO:0010468; GO:0010494; GO:0017148; GO:0045182; GO:0048027; GO:0051028; GO:0051252; GO:0070934; GO:1990247	GNVETCAK	3.279999971	0.348270267	0.348270267	0.202484742	878.1930368	17.18781	14.76116	10.96366	15.99415	15.17086	0	0	0	15.32384	0	0	0	0	0	0	0	16.0691	0	0	0	0	17.15408	0	0	0	0	14.68072	0	0	0	0	0	0	0	15.06015	0	0	0	0	16.94036	0	0	0	0	0	0	0	0
O00429	DNM1L_HUMAN	"Dynamin-1-like protein, EC 3.6.5.5 (Dnm1p/Vps1p-like protein, DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less, Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV, HdynIV) (Dynamin-related protein 1)"	DNM1L DLP1 DRP1	Homo sapiens (Human)	calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]	brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511]	GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]	GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244	EALIPVINK	14.84000015	1	1	0.444000862	996.8530544	0	18.48539	19.17172	0	18.6218	0	15.70031	0	0	0	0	16.50583	14.99936	17.05371	0	0	0	17.82059	0	0	17.64733	0	0	18.29326	0	0	0	19.39197	0	0	0	18.97317	0	19.09246	0	19.81912	0	0	18.80202	0	19.64375	0	0	18.94032	0	0	17.75221	19.55021
O00442	RTCA_HUMAN	"RNA 3'-terminal phosphate cyclase, RNA cyclase, RNA-3'-phosphate cyclase, EC 6.5.1.4 (RNA terminal phosphate cyclase domain-containing protein 1, RTC domain-containing protein 1)"	RTCA RPC RPC1 RTC1 RTCD1	Homo sapiens (Human)	RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-3'-phosphate cyclase activity [GO:0003963]; RNA processing [GO:0006396]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-3'-phosphate cyclase activity [GO:0003963]	GO:0003723; GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396	RGVNADK	2.420000076	0.471393734	0.471393734	0.220627824	760.7028812	15.12769	0	0	14.61098	14.84763	0	0	0	0	0	0	0	0	15.042	0	13.86116	14.20007	10.32174	15.79209	0	0	17.00637	14.47147	0	0	17.62199	12.90962	15.41067	0	0	0	14.8242	0	0	0	0	0	0	0	0	16.21095	0	16.67558	16.68554	0	0	0	14.25653
O00443	P3C2A_HUMAN	"Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha, PI3K-C2-alpha, PtdIns-3-kinase C2 subunit alpha, EC 2.7.1.137, EC 2.7.1.153, EC 2.7.1.154 (Phosphoinositide 3-kinase-C2-alpha)"	PIK3C2A	Homo sapiens (Human)	cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829]	clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]	"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; clathrin binding [GO:0030276]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829]"	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; clathrin binding [GO:0030276]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]"	GO:0005524; GO:0005654; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0006887; GO:0006897; GO:0007173; GO:0008286; GO:0010508; GO:0014065; GO:0014829; GO:0016020; GO:0016303; GO:0016477; GO:0030136; GO:0030276; GO:0031982; GO:0035004; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0046854; GO:0046934; GO:0048008; GO:0048015; GO:0048268; GO:0052742; GO:0052812; GO:0061024; GO:0070062; GO:0090050	GFELSSSTR	6.099999905	0.268018246	0.268018246	0.053368337	982.9327094	0	12.91605	16.43145	0	11.92314	13.54846	0	0	13.76107	0	0	0	0	17.2318	16.72711	0	17.70109	14.63435	0	16.17815	0	0	0	16.94112	0	15.02528	15.8373	0	0	15.58172	0	17.79543	0	0	15.57256	0	0	18.50761	16.31294	15.94082	13.86921	15.91427	16.99833	0	14.2276	16.16514	17.57127	13.41591
O00444	PLK4_HUMAN	"Serine/threonine-protein kinase PLK4, EC 2.7.11.21 (Polo-like kinase 4, PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak)"	PLK4 SAK STK18	Homo sapiens (Human)	centriole replication [GO:0007099]; cilium assembly [GO:0060271]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; trophoblast giant cell differentiation [GO:0060707]	centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; spindle pole [GO:0000922]; XY body [GO:0001741]	centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; spindle pole [GO:0000922]; XY body [GO:0001741]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; trophoblast giant cell differentiation [GO:0060707]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000278; GO:0000922; GO:0001741; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0007099; GO:0032154; GO:0032465; GO:0042802; GO:0046601; GO:0060271; GO:0060707; GO:0098535; GO:0098536; GO:0106310; GO:0120098; GO:0120099	KPGSTSSPK	1.450000048	1	1	3.47E-13	886.499863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.52293	0	0	0	0	0	0	15.24308	15.89809	14.68089	0	17.91027	0	0	0	17.34912
O00445	SYT5_HUMAN	"Synaptotagmin-5 (Synaptotagmin V, SytV)"	SYT5	Homo sapiens (Human)	calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of neuronal dense core vesicle membrane [GO:0099066]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proximal neuron projection [GO:1990769]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]	"axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of neuronal dense core vesicle membrane [GO:0099066]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proximal neuron projection [GO:1990769]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]"	"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0043025; GO:0046982; GO:0048471; GO:0048488; GO:0048791; GO:0055038; GO:0070382; GO:0071277; GO:0099066; GO:1990769	HWADMLANPR	7.340000153	0.574057281	0.574057281	0.431068554	1210.292773	15.25759	0	0	0	0	0	0	14.36854	0	0	0	14.65104	16.09007	16.02043	0	0	16.14711	17.54984	17.4228	0	15.92667	16.56971	0	0	16.71971	0	15.65312	15.01154	0	16.41388	15.1424	0	15.08543	16.15747	15.71206	14.60891	17.81074	0	17.55782	16.58578	0	17.11374	16.63624	12.76895	14.51143	0	8.465112	0
O00458	IFRD1_HUMAN	Interferon-related developmental regulator 1 (Nerve growth factor-inducible protein PC4)	IFRD1	Homo sapiens (Human)	myoblast fate determination [GO:0007518]	nucleus [GO:0005634]	nucleus [GO:0005634]; myoblast fate determination [GO:0007518]		GO:0005634; GO:0007518	RMTLTDSIER	7.03000021	1	1	0.333278672	1222.074045	12.32499	0	0	10.6836	12.97581	14.78909	0	14.73382	14.53857	14.94663	14.62455	10.53535	0	0	0	0	13.85395	14.76491	0	0	15.29026	16.40654	14.03389	0	15.58552	0	0	0	0	0	15.77171	0	0	0	16.59233	15.5068	0	0	15.96403	0	0	0	0	0	16.30803	15.47469	0	0
O00461	GOLI4_HUMAN	"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis, GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa, Golgi phosphoprotein of 130 kDa)"	GOLIM4 GIMPC GOLPH4 GPP130	Homo sapiens (Human)		cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]	cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]		GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0016021; GO:0030133; GO:0030139; GO:0032580	EMALQR	7.440000057	1	1	0.277744773	764.7540117	19.12728	0	0	0	18.24439	0	18.25914	0	0	14.35629	17.21591	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.03095	0	0	0	18.50784	0	0	0	0	20.14166	0	0	0	17.91889	20.33907	0	0	18.12326	0	19.63968
O00463	TRAF5_HUMAN	TNF receptor-associated factor 5 (RING finger protein 84)	TRAF5 RNF84	Homo sapiens (Human)	apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]	CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0046330; GO:0048255; GO:0051091; GO:0051092; GO:0070534; GO:0097400	ITLLENNDQR	5.489999771	1	1	0.18595217	1211.743934	14.64656	0	15.92587	15.55688	12.30967	0	12.81726	0	0	0	12.79794	0	0	12.9633	11.74285	0	0	0	0	0	14.04538	0	0	0	0	15.67109	13.79379	0	14.13107	0	0	0	0	0	0	0	0	0	0	15.88869	0	0	15.97422	0	14.07406	0	15.00443	0
O00469	PLOD2_HUMAN	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2, EC 1.14.11.4 (Lysyl hydroxylase 2, LH2)"	PLOD2	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; cellular protein modification process [GO:0006464]; hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001666; GO:0005506; GO:0005783; GO:0005789; GO:0006464; GO:0008475; GO:0017185; GO:0030867; GO:0031418; GO:0046947; GO:0070062	NMGMDFCR	4.039999962	1	1	0.237481239	1061.749641	15.24443	15.21501	12.71468	13.05494	12.70472	15.62117	14.85188	15.39138	0	15.55735	15.84465	13.21709	0	0	0	0	0	0	0	7.84746	0	16.76136	0	0	0	15.95847	0	0	15.03936	0	0	0	0	0	0	0	0	14.98586	15.82679	0	0	15.4957	14.93036	13.99873	0	0	0	0
O00470	MEIS1_HUMAN	Homeobox protein Meis1	MEIS1	Homo sapiens (Human)	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005667; GO:0006357; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0045638; GO:0045665; GO:0045944; GO:0060216	APGPMSGMGMNMGMEGQWHYM	16.45000076	1	1	0.637305177	2364.967341	0	0	0	0	0	20.48012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00472	ELL2_HUMAN	RNA polymerase II elongation factor ELL2	ELL2	Homo sapiens (Human)	positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368]	euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cis-regulatory region sequence-specific DNA binding [GO:0000987]	GO:0000791; GO:0000987; GO:0005654; GO:0006368; GO:0008023; GO:0032968; GO:0042795	EEEIAK	8.510000229	0.319270104	0.319270104	0.09882162	718.8783952	0	15.59639	15.59768	17.48656	0	17.04829	0	17.83943	14.78499	16.99869	16.05657	14.91974	16.55613	0	0	17.41213	16.54585	9.964637	13.55142	0	16.2334	18.46816	0	16.24476	16.20638	0	16.90587	7.340604	16.48461	0	0	17.89515	16.38317	0	0	15.65542	0	15.36171	17.87598	14.43126	13.48153	15.78372	17.35266	0	17.35425	15.71023	12.90194	16.82808
O00476	NPT4_HUMAN	Sodium-dependent phosphate transport protein 4 (Na(+)/PI cotransporter 4) (Sodium/phosphate cotransporter 4) (Solute carrier family 17 member 3)	SLC17A3 NPT4	Homo sapiens (Human)	anion transport [GO:0006820]; glucose-6-phosphate transport [GO:0015760]; ion transmembrane transport [GO:0034220]; organic anion transport [GO:0015711]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; voltage-gated anion channel activity [GO:0008308]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transport [GO:0006820]; glucose-6-phosphate transport [GO:0015760]; ion transmembrane transport [GO:0034220]; organic anion transport [GO:0015711]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; voltage-gated anion channel activity [GO:0008308]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005436; GO:0005737; GO:0005764; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006817; GO:0006820; GO:0008308; GO:0008514; GO:0015136; GO:0015143; GO:0015562; GO:0015711; GO:0015739; GO:0015747; GO:0015760; GO:0016021; GO:0016324; GO:0019534; GO:0022857; GO:0031526; GO:0034220; GO:0042910; GO:0046415; GO:0048471; GO:1990961	QPLPIK	3.170000076	1	1	0.273400077	694.6193661	0	0	0	0	0	0	17.87106	17.45217	0	0	0	0	0	17.51714	0	0	0	0	0	17.07123	0	0	0	18.17664	18.66448	0	18.78014	16.81441	18.23767	17.2976	0	18.50764	19.08797	0	0	0	18.76561	0	0	0	0	0	0	0	0	0	18.90076	0
O00499	BIN1_HUMAN	Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1)	BIN1 AMPHL	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292]	actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]	GO:0000122; GO:0002020; GO:0005543; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0006997; GO:0007010; GO:0008021; GO:0008333; GO:0010564; GO:0015629; GO:0016020; GO:0019828; GO:0030018; GO:0030276; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0031674; GO:0031982; GO:0033268; GO:0033292; GO:0042802; GO:0043065; GO:0043194; GO:0043196; GO:0043547; GO:0043679; GO:0044300; GO:0045664; GO:0045807; GO:0048156; GO:0048488; GO:0048711; GO:0051015; GO:0051020; GO:0051087; GO:0051647; GO:0060987; GO:0060988; GO:0070063; GO:0086091; GO:0090571; GO:0098850; GO:0098978; GO:1901380; GO:1902430; GO:1902960; GO:1903946; GO:1904878	AEMGSK	3.920000076	1	1	0.064303517	637.7694899	0	0	0	0	0	0	0	0	0	0	20.12435	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.24329	0	0	0	0	0	0	0	0	19.27542	0	0	0	0	0	0	0	0	0	18.34939	0	0	0
O00507	USP9Y_HUMAN	"Probable ubiquitin carboxyl-terminal hydrolase FAF-Y, EC 3.4.19.12 (Deubiquitinating enzyme FAF-Y) (Fat facets protein-related, Y-linked) (Ubiquitin thioesterase FAF-Y) (Ubiquitin-specific protease 9, Y chromosome) (Ubiquitin-specific-processing protease FAF-Y)"	USP9Y DFFRY	Homo sapiens (Human)	BMP signaling pathway [GO:0030509]; cell migration [GO:0016477]; protein deubiquitination [GO:0016579]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent deubiquitinase [GO:0004843]; BMP signaling pathway [GO:0030509]; cell migration [GO:0016477]; protein deubiquitination [GO:0016579]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007179; GO:0007283; GO:0008234; GO:0016477; GO:0016579; GO:0030509; GO:0070410	HLSLIVR	15.77999973	1	1	0.236992396	838.4899327	17.58709	15.98254	17.04202	17.16526	17.60547	16.3837	17.76296	17.53493	17.20712	0	18.17069	18.40915	15.61254	0	16.95056	18.31675	17.5645	0	0	0	16.82633	16.04599	19.14421	17.77895	18.88412	18.09822	17.3612	16.13314	0	16.25711	20.15995	17.25145	19.3527	15.82341	19.54708	18.12044	18.43251	18.4158	18.44605	14.549	12.59245	16.43065	14.65666	11.8442	18.35008	18.13763	17.31558	17.73831
O00512	BCL9_HUMAN	"B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, Bcl-9 (Protein legless homolog)"	BCL9	Homo sapiens (Human)	canonical Wnt signaling pathway [GO:0060070]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019]	beta-catenin-TCF complex [GO:1990907]; cis-Golgi network [GO:0005801]; nucleoplasm [GO:0005654]	beta-catenin-TCF complex [GO:1990907]; cis-Golgi network [GO:0005801]; nucleoplasm [GO:0005654]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019]	beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005654; GO:0005801; GO:0008013; GO:0014908; GO:0035019; GO:0035914; GO:0045944; GO:0060070; GO:1990907	TVASSDDDSPPAR	13.43000031	1	1	0.393072144	1318.442906	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00515	LAD1_HUMAN	"Ladinin-1, Lad-1 (Linear IgA disease antigen, LADA)"	LAD1 LAD	Homo sapiens (Human)		actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; extracellular exosome [GO:0070062]	actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]	cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005604; GO:0015629; GO:0045296; GO:0070062	LVSEKASIFEK	5.460000038	0.166837543	0.166837543	0.090654811	1251.168679	16.61339	0	17.32008	0	0	16.36827	0	0	17.51144	15.7724	0	0	0	9.981988	0	0	0	0	0	14.1686	15.52642	14.76182	0	11.97532	0	0	0	0	0	0	0	14.54497	0	0	15.4491	17.56635	17.97546	16.89025	18.02919	0	13.31018	0	17.96703	0	15.2899	16.24993	13.69292	17.24608
O00519	FAAH1_HUMAN	"Fatty-acid amide hydrolase 1, EC 3.5.1.99 (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase, EC 3.1.1.-) (Oleamide hydrolase 1)"	FAAH FAAH1	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907]	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]	cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; identical protein binding [GO:0042802]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907]	acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; identical protein binding [GO:0042802]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543]	GO:0004040; GO:0005543; GO:0005789; GO:0005856; GO:0009062; GO:0016021; GO:0017064; GO:0019369; GO:0031090; GO:0042802; GO:0045907; GO:0047372; GO:0052651; GO:0102077; GO:0103073	ALDLDVVLTPMLAPALDLNAPGR	2.50999999	0.677473068	0.677473068	0.123633767	2390.159303	4.331267	0	15.43235	13.84822	17.50803	16.28068	0	16.69623	0	15.04559	14.97692	0	0	0	14.3314	16.76143	0	12.48855	14.86405	0	0	0	0	0	0	16.36421	0	0	14.31696	17.28601	15.57938	0	0	16.04065	16.27653	16.32943	15.19218	17.0165	0	10.87864	11.63906	12.79573	12.36217	0	13.57855	0	0	16.0542
O00534	VMA5A_HUMAN	"von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1, BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)"	VWA5A BCSC1 LOH11CR2A	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	ALHSDRPPSASQPR	6.610000134	0.628212154	0.628212154	0.253028738	1517.350826	15.43824	12.86225	15.0976	14.5225	11.97785	13.04985	0	6.650084	11.45924	0	0	14.6343	17.16837	10.57242	15.85292	0	0	0	13.70105	0	16.21036	0	0	0	15.97557	0	14.79095	0	0	16.25119	0	0	0	0	0	0	0	0	0	15.8172	0	0	16.00641	0	0	0	14.03588	14.4546
O00555	CAC1A_HUMAN	"Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I, BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)"	CACNA1A CACH4 CACN3 CACNL1A4	Homo sapiens (Human)	calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell death [GO:0008219]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; amyloid-beta binding [GO:0001540]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; syntaxin binding [GO:0019905]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell death [GO:0008219]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645]	amyloid-beta binding [GO:0001540]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; syntaxin binding [GO:0019905]; voltage-gated calcium channel activity [GO:0005245]	GO:0001540; GO:0005245; GO:0005634; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0007204; GO:0007268; GO:0008219; GO:0008331; GO:0016021; GO:0019905; GO:0034765; GO:0042995; GO:0043025; GO:0045202; GO:0046872; GO:0050804; GO:0070509; GO:0070588; GO:1904645; GO:1904646	AATSGPR	10.14000034	0.678128123	0.678128123	0.213759727	658.1012329	16.37658	15.12092	0	0	0	0	14.65313	0	0	0	13.9101	0	0	0	14.55513	0	14.51665	0	0	0	0	0	0	0	0	0	16.30307	16.21686	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00560	SDCB1_HUMAN	"Syntenin-1 (Melanoma differentiation-associated protein 9, MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18, TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)"	SDCBP MDA9 SYCL	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]"	adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]"	"cell adhesion molecule binding [GO:0050839]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]"	GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0044877; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046875; GO:0046982; GO:0047485; GO:0050839; GO:0070062; GO:0072562; GO:0099054; GO:1903543; GO:1903553; GO:1903561	ITMTIR	15.23999977	0.532063901	0.532063901	0.2527052	734.3027135	18.82103	0	0	18.54863	18.62079	19.53704	19.8826	17.87351	19.23478	17.24596	0	19.69775	0	16.91349	0	19.46084	20.36361	18.21181	17.31793	0	19.12747	19.83228	18.38363	21.00142	18.45802	20.7625	20.40494	0	17.97327	0	21.23631	0	20.36016	19.8766	0	20.37571	0	19.29465	19.093	0	0	0	19.20926	0	19.63758	19.66373	19.71293	19.48073
O00562	PITM1_HUMAN	"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1, PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2, NIR-2)"	PITPNM1 DRES9 NIR2 PITPNM	Homo sapiens (Human)	brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]	cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031]	calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]	GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0043231; GO:0044297; GO:0070300	AEEDPR	7.599999905	1	1	0.309649411	716.8634825	10.46046	15.01055	0	0	17.21028	14.76784	0	14.70013	0	14.59589	11.48941	0	0	0	0	0	15.847	0	15.51332	0	13.92382	14.55747	0	15.65259	0	0	0	16.5378	0	16.19636	0	0	0	17.20495	0	0	0	0	15.58903	0	0	16.00454	0	16.0107	0	18.06575	0	0
O00566	MPP10_HUMAN	U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10)	MPHOSPH10 MPP10	Homo sapiens (Human)	"RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]"	chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]	"chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364]"	RNA binding [GO:0003723]	GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006364; GO:0006396; GO:0008380; GO:0032040; GO:0034457	AGDIKTAAEK	3.74000001	1	1	3.47E-13	1003.324148	0	0	0	0	0	13.14116	0	0	0	0	0	0	15.56334	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41971	0	0	0	0	0	0	0	0	0	10.51722	0	0	0	0	0	0	0	0	0	0	0
O00584	RNT2_HUMAN	"Ribonuclease T2, EC 4.6.1.19 (Ribonuclease 6)"	RNASET2 RNASE6PL	Homo sapiens (Human)	innate immune response [GO:0045087]; RNA catabolic process [GO:0006401]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; endoribonuclease activity [GO:0004521]; ribonuclease activity [GO:0004540]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]; innate immune response [GO:0045087]; RNA catabolic process [GO:0006401]	endoribonuclease activity [GO:0004521]; ribonuclease activity [GO:0004540]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]	GO:0003723; GO:0004521; GO:0004540; GO:0005576; GO:0005615; GO:0005758; GO:0005764; GO:0005788; GO:0006401; GO:0033897; GO:0035578; GO:0043202; GO:0045087; GO:0070062	ELDLNSVLLK	22.98999977	1	1	0.517903374	1142.581489	21.78831	21.20475	18.43661	21.20671	19.53537	21.56603	0	0	22.70964	19.33839	0	19.90462	0	19.98342	0	21.91418	0	21.08686	20.27302	0	0	0	21.35793	21.15285	22.24054	0	22.01954	0	0	19.51396	22.78563	22.8333	22.31785	0	22.6173	21.56785	22.29215	21.56297	22.71542	0	20.84871	21.77607	17.9966	21.11698	21.525	21.03476	21.6212	19.90352
O00585	CCL21_HUMAN	"C-C motif chemokine 21 (6Ckine) (Beta-chemokine exodus-2) (Secondary lymphoid-tissue chemokine, SLC) (Small-inducible cytokine A21)"	CCL21 SCYA21 UNQ784/PRO1600	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; cellular response to chemokine [GO:1990869]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; dendritic cell dendrite assembly [GO:0097026]; eosinophil chemotaxis [GO:0048245]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mesangial cell-matrix adhesion [GO:0035759]; monocyte chemotaxis [GO:0002548]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell dendrite assembly [GO:2000548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; release of sequestered calcium ion into cytosol [GO:0051209]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR7 chemokine receptor binding [GO:0031732]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; cellular response to chemokine [GO:1990869]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; dendritic cell dendrite assembly [GO:0097026]; eosinophil chemotaxis [GO:0048245]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mesangial cell-matrix adhesion [GO:0035759]; monocyte chemotaxis [GO:0002548]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell dendrite assembly [GO:2000548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; release of sequestered calcium ion into cytosol [GO:0051209]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]	CCR chemokine receptor binding [GO:0048020]; CCR7 chemokine receptor binding [GO:0031732]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]	GO:0001768; GO:0001771; GO:0001954; GO:0002407; GO:0002548; GO:0002606; GO:0005576; GO:0005615; GO:0006954; GO:0006955; GO:0007186; GO:0007267; GO:0008009; GO:0010560; GO:0010820; GO:0030593; GO:0030838; GO:0031274; GO:0031295; GO:0031529; GO:0031640; GO:0031732; GO:0033630; GO:0034695; GO:0035759; GO:0038116; GO:0042379; GO:0043123; GO:0043547; GO:0043552; GO:0045860; GO:0046330; GO:0048020; GO:0048245; GO:0048247; GO:0048260; GO:0048469; GO:0050921; GO:0051209; GO:0051491; GO:0051897; GO:0060326; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0090023; GO:0090630; GO:0097026; GO:1903237; GO:1990869; GO:2000147; GO:2000406; GO:2000529; GO:2000548; GO:2000669	GSKGCK	7.409999847	1	1	0.202321686	635.5808985	14.71807	13.21489	0	15.66829	0	0	5.621708	0	0	0	0	0	0	0	0	12.44898	0	0	0	0	15.45571	15.41253	0	0	0	0	0	0	0	15.36848	0	0	0	0	0	0	0	0	16.34992	17.64605	16.02438	0	0	16.74599	0	0	0	0
O00602	FCN1_HUMAN	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	FCN1 FCNM	Homo sapiens (Human)	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]"	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]	"collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]"	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1903028; GO:1904813; GO:1905370	ELSGATMARGLAVLLVLFLHIK	1.899999976	0.28522709	0.28522709	0.223633765	2352.351841	0	0	16.73434	16.52884	0	9.849591	0	0	14.77188	17.20222	0	0	18.4456	0	0	15.08092	12.16146	13.43568	0	0	13.4147	16.91546	0	14.29394	16.91392	16.73373	16.35991	14.35231	14.68512	15.89976	17.29576	0	19.2522	0	0	0	15.53997	0	18.48368	0	0	0	0	16.3546	13.70851	11.17614	16.07465	17.02545
O00635	TRI38_HUMAN	"E3 ubiquitin-protein ligase TRIM38, EC 2.3.2.27 (RING finger protein 15) (Tripartite motif-containing protein 38) (Zinc finger protein RoRet)"	TRIM38 RNF15 RORET	Homo sapiens (Human)	innate immune response [GO:0045087]; negative regulation of defense response to virus [GO:0050687]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of viral entry into host cell [GO:0046598]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of interferon-beta production [GO:0032648]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of defense response to virus [GO:0050687]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of viral entry into host cell [GO:0046598]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of interferon-beta production [GO:0032648]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]	protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003713; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032648; GO:0032880; GO:0042803; GO:0043123; GO:0043161; GO:0045070; GO:0045087; GO:0046596; GO:0046598; GO:0050687; GO:0051091; GO:0051092; GO:0061630; GO:0070936	QLGSLIEALK	9.539999962	1	1	0.204084555	1071.962696	0	0	12.28897	14.33201	11.56109	14.43266	0	0	16.30169	0	0	0	13.84788	10.55819	14.63893	16.47319	0	0	0	0	17.83798	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.70601	0	0	0	0	0	0	14.89385	0	0	0
O00744	WN10B_HUMAN	Protein Wnt-10b (Protein Wnt-12)	WNT10B WNT12	Homo sapiens (Human)	bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to cAMP [GO:0071320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fungiform papilla development [GO:0061196]; G2/M transition of mitotic cell cycle [GO:0000086]; hematopoietic stem cell proliferation [GO:0071425]; lipid metabolic process [GO:0006629]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of timing of anagen [GO:0051885]; protein stabilization [GO:0050821]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of skeletal muscle tissue development [GO:0048641]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to cAMP [GO:0071320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fungiform papilla development [GO:0061196]; G2/M transition of mitotic cell cycle [GO:0000086]; hematopoietic stem cell proliferation [GO:0071425]; lipid metabolic process [GO:0006629]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of timing of anagen [GO:0051885]; protein stabilization [GO:0050821]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of skeletal muscle tissue development [GO:0048641]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	GO:0000086; GO:0000122; GO:0002062; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0006629; GO:0007224; GO:0008284; GO:0010971; GO:0014835; GO:0030182; GO:0030501; GO:0030858; GO:0032434; GO:0043065; GO:0045165; GO:0045599; GO:0045669; GO:0045899; GO:0048018; GO:0048641; GO:0048741; GO:0050680; GO:0050821; GO:0050909; GO:0051091; GO:0051885; GO:0060070; GO:0060346; GO:0061196; GO:0071300; GO:0071320; GO:0071374; GO:0071425; GO:0090263; GO:0120163	VGRQVVTENLK	7.039999962	1	1	4.59E-13	1236.754629	9.872536	13.68983	13.31028	15.1605	0	13.81369	14.00936	14.95056	11.22524	14.08607	11.13073	12.40613	14.68029	13.04	0	0	0	0	0	0	0	16.24869	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O00750	P3C2B_HUMAN	"Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, PI3K-C2-beta, PtdIns-3-kinase C2 subunit beta, EC 2.7.1.137, EC 2.7.1.154 (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)"	PIK3C2B	Homo sapiens (Human)	cell migration [GO:0016477]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; cell migration [GO:0016477]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]	GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0046854; GO:0048015; GO:0052742	NATPGKNR	30.65999985	1.01E-13	1.01E-13	0.303825179	856.5285518	21.13205	21.34426	0	20.77418	21.15561	20.21562	0	20.15542	20.91036	18.33824	20.51941	18.27427	20.91568	21.22787	20.64451	0	21.66576	21.12057	20.72895	20.42331	21.47891	19.86515	0	21.21497	0	21.63684	0	21.80563	19.94615	0	0	20.70724	0	20.65885	21.25259	0	21.74147	0	0	0	20.51766	22.49019	0	20.73426	21.96363	21.47266	0	17.15781
O00755	WNT7A_HUMAN	Protein Wnt-7a	WNT7A	Homo sapiens (Human)	"angiogenesis [GO:0001525]; asymmetric protein localization involved in cell fate determination [GO:0045167]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of cell polarity [GO:0030010]; excitatory synapse assembly [GO:1904861]; lens fiber cell development [GO:0070307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; oviduct development [GO:0060066]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein localization to presynapse [GO:1905386]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; regulation of axon diameter [GO:0031133]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; sex differentiation [GO:0007548]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synaptic vesicle recycling [GO:0036465]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]"	cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]	"cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; asymmetric protein localization involved in cell fate determination [GO:0045167]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of cell polarity [GO:0030010]; excitatory synapse assembly [GO:1904861]; lens fiber cell development [GO:0070307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; oviduct development [GO:0060066]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein localization to presynapse [GO:1905386]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; regulation of axon diameter [GO:0031133]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; sex differentiation [GO:0007548]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synaptic vesicle recycling [GO:0036465]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]"	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]	GO:0000578; GO:0001502; GO:0001525; GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007269; GO:0007409; GO:0007548; GO:0009953; GO:0009986; GO:0010595; GO:0010628; GO:0014719; GO:0014834; GO:0021707; GO:0021846; GO:0022009; GO:0030010; GO:0030182; GO:0030666; GO:0031012; GO:0031133; GO:0032270; GO:0032355; GO:0035019; GO:0035115; GO:0035116; GO:0035313; GO:0036465; GO:0042733; GO:0043066; GO:0043627; GO:0045165; GO:0045167; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048103; GO:0048864; GO:0050768; GO:0051965; GO:0060054; GO:0060066; GO:0060070; GO:0060071; GO:0060997; GO:0061038; GO:0062009; GO:0070062; GO:0070307; GO:0071560; GO:0098685; GO:0098793; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:1904861; GO:1904891; GO:1905386; GO:1905606; GO:2000300; GO:2000463	YNEAVHVEPVR	10.14000034	0.076022513	0.076022513	0.148682737	1312.419709	14.3535	14.138	15.92874	14.55193	0	0	12.79069	0	12.21511	8.345362	12.53487	13.33297	16.98428	13.21966	17.09793	0	0	0	0	18.20607	0	0	15.58489	0	15.06491	0	16.81833	0	0	0	18.1032	16.02301	14.46701	0	0	19.11282	14.89938	12.96476	13.93995	12.37242	16.04395	15.31719	0	16.8769	0	10.31091	0	13.64348
O00763	ACACB_HUMAN	"Acetyl-CoA carboxylase 2, EC 6.4.1.2 (ACC-beta)"	ACACB ACC2 ACCB	Homo sapiens (Human)	acetyl-CoA metabolic process [GO:0006084]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; positive regulation of heart growth [GO:0060421]; positive regulation of lipid storage [GO:0010884]; protein homotetramerization [GO:0051289]; regulation of glucose metabolic process [GO:0010906]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; acetyl-CoA metabolic process [GO:0006084]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; positive regulation of heart growth [GO:0060421]; positive regulation of lipid storage [GO:0010884]; protein homotetramerization [GO:0051289]; regulation of glucose metabolic process [GO:0010906]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003989; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006084; GO:0006633; GO:0009374; GO:0009410; GO:0010629; GO:0010884; GO:0010906; GO:0014070; GO:0031667; GO:0031999; GO:0042802; GO:0043086; GO:0046872; GO:0051289; GO:0060421; GO:0097009; GO:2001295	DTPLFSEAR	7.550000191	1	1	0.194614435	1034.953365	0	15.65044	14.60257	13.68435	0	0	0	0	0	0	0	0	0	0	0	0	14.75838	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.14487	16.54521	0	0	0	0	0	0	15.96673	0	0
O00767	SCD_HUMAN	"Stearoyl-CoA desaturase, hSCD1, EC 1.14.19.1 (Acyl-CoA desaturase) (Delta(9)-desaturase, Delta-9 desaturase) (Fatty acid desaturase)"	SCD FADS5 SCD1 SCDOS	Homo sapiens (Human)	monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768]; monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636]	iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768]	GO:0004768; GO:0005506; GO:0005730; GO:0005783; GO:0005789; GO:0006636; GO:0016020; GO:0016021; GO:0016491; GO:0030176; GO:0032896; GO:0070542; GO:0120162; GO:1903966	EGPSPK	4.860000134	0.099383086	0.099383086	0.241622521	614.1540303	0	15.80885	13.47813	0	14.11117	16.41869	0	14.34826	15.22426	17.31198	0	0	16.08559	15.16491	15.74801	0	0	0	0	15.37431	15.29249	16.56586	14.63167	0	15.33795	0	15.6803	0	0	0	0	0	16.04986	15.47443	0	0	0	0	16.27755	15.51446	0	0	16.14615	16.11819	17.39661	0	15.91419	0
O14490	DLGP1_HUMAN	"Disks large-associated protein 1, DAP-1 (Guanylate kinase-associated protein, hGKAP) (PSD-95/SAP90-binding protein 1) (SAP90/PSD-95-associated protein 1, SAPAP1)"	DLGAP1 DAP1 GKAP	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]	glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877]	GO:0005886; GO:0007268; GO:0014069; GO:0044877; GO:0060090; GO:0098962; GO:0098978; GO:0099572	ASVNMDQAMVKSESCQQER	4.590000153	1	1	0.309314307	2214.51873	0	15.02167	0	13.89495	15.40328	10.50352	0	0	14.87685	0	0	0	11.99572	14.59571	14.05578	14.40719	0	0	0	14.87641	0	14.55373	14.70306	14.21396	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14493	CLD4_HUMAN	"Claudin-4 (Clostridium perfringens enterotoxin receptor, CPE-R, CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein)"	CLDN4 CPER CPETR1 WBSCR8	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; chloride transport [GO:0006821]; circadian rhythm [GO:0007623]; establishment of skin barrier [GO:0061436]; female pregnancy [GO:0007565]; positive regulation of cell migration [GO:0030335]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of wound healing [GO:0090303]; regulation of cell morphogenesis [GO:0022604]; renal absorption [GO:0070293]; response to progesterone [GO:0032570]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basal plasma membrane [GO:0009925]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; tight junction [GO:0070160]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basal plasma membrane [GO:0009925]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; transmembrane signaling receptor activity [GO:0004888]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; chloride transport [GO:0006821]; circadian rhythm [GO:0007623]; establishment of skin barrier [GO:0061436]; female pregnancy [GO:0007565]; positive regulation of cell migration [GO:0030335]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of wound healing [GO:0090303]; regulation of cell morphogenesis [GO:0022604]; renal absorption [GO:0070293]; response to progesterone [GO:0032570]	chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005198; GO:0005254; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0006821; GO:0007155; GO:0007565; GO:0007623; GO:0009925; GO:0016324; GO:0016327; GO:0016328; GO:0016338; GO:0022604; GO:0030335; GO:0032570; GO:0034707; GO:0042802; GO:0061436; GO:0070160; GO:0070293; GO:0070830; GO:0090303; GO:1905050	MASMGLQVMGIALAVLGWLAVMLCCALPMWR	7.769999981	1	1	3.66E-12	3450.089467	16.19439	15.36708	16.85779	16.02741	15.49375	15.7988	0	16.53617	1.099677	0	15.59195	15.83602	0	15.74536	0	14.85373	15.99645	0	16.35057	12.45497	0	14.78439	12.34931	0	0	15.48098	17.40473	17.8353	0	19.16144	0	17.59559	18.04094	0	18.07389	0	0	0	18.87499	0	16.99924	0	18.32379	0	18.2695	0	18.48329	0
O14497	ARI1A_HUMAN	"AT-rich interactive domain-containing protein 1A, ARID domain-containing protein 1A (B120) (BRG1-associated factor 250, BAF250) (BRG1-associated factor 250a, BAF250A) (Osa homolog 1, hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)"	ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1	Homo sapiens (Human)	"androgen receptor signaling pathway [GO:0030521]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular estrogen receptor signaling pathway [GO:0030520]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; nucleosome mobilization [GO:0042766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	"bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular estrogen receptor signaling pathway [GO:0030520]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; nucleosome mobilization [GO:0042766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713]	GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0030520; GO:0030521; GO:0035060; GO:0042766; GO:0042921; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819	GPADMASQCWGAAAAAAAAAAASGGAQQR	8.829999924	1	1	9.24E-13	2646.389008	0	7.596388	11.73634	14.27954	13.16158	14.95813	14.19263	0	17.08187	14.28903	14.39289	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14503	BHE40_HUMAN	"Class E basic helix-loop-helix protein 40, bHLHe40 (Class B basic helix-loop-helix protein 2, bHLHb2) (Differentially expressed in chondrocytes protein 1, DEC1) (Enhancer-of-split and hairy-related protein 2, SHARP-2) (Stimulated by retinoic acid gene 13 protein)"	BHLHE40 BHLHB2 DEC1 SHARP2 STRA13	Homo sapiens (Human)	"anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; MRF binding [GO:0043426]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; MRF binding [GO:0043426]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007623; GO:0009952; GO:0016604; GO:0019904; GO:0032922; GO:0042752; GO:0042803; GO:0043153; GO:0043425; GO:0043426; GO:0043433; GO:0045892; GO:0046982; GO:0050767; GO:0061629; GO:0070888; GO:1990837	ERIPSAQPPPACLPK	7.090000153	1	1	0.188046467	1659.063828	0	15.45123	14.33004	0	15.78889	13.72799	12.0174	13.53481	15.69904	0	0	15.09085	14.38599	0	11.49308	0	0	14.95923	0	0	0	0	0	0	0	0	16.02803	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.82862	0	0	0
O14508	SOCS2_HUMAN	"Suppressor of cytokine signaling 2, SOCS-2 (Cytokine-inducible SH2 protein 2, CIS-2) (STAT-induced STAT inhibitor 2, SSI-2)"	SOCS2 CIS2 SSI2 STATI2	Homo sapiens (Human)	cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]; cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]	GO:0001558; GO:0005131; GO:0005159; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0007595; GO:0008269; GO:0009966; GO:0016567; GO:0032355; GO:0032870; GO:0035556; GO:0040015; GO:0043066; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060749	MTLRCLEPSGNGGEGTR	9.539999962	1	1	1.37E-12	1845.467466	14.97112	14.50174	0	0	11.45103	12.75982	14.22014	0	0	0	0	13.96096	0	13.97618	13.12996	0	13.50985	0	0	0	15.59931	13.12874	0	14.64896	15.94505	14.23626	14.63883	12.06101	0	15.40094	14.18449	14.7713	14.80919	0	14.99506	14.15899	14.87656	0	17.28339	15.61452	0	14.46611	0	11.87107	0	0	0	13.75199
O14511	NRG2_HUMAN	"Pro-neuregulin-2, membrane-bound isoform, Pro-NRG2 [Cleaved into: Neuregulin-2, NRG-2 (Divergent of neuregulin-1, DON-1) (Neural- and thymus-derived activator for ERBB kinases, NTAK) ]"	NRG2 NTAK	Homo sapiens (Human)	animal organ development [GO:0048513]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; signal transduction [GO:0007165]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; animal organ development [GO:0048513]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; signal transduction [GO:0007165]	growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0007165; GO:0007399; GO:0008083; GO:0016021; GO:0035556; GO:0048513	QDSAPL	10.48999977	0.741565943	0.741565943	0.153002364	631.4374979	14.73052	0	0	15.71772	15.53278	0	15.85785	0	0	15.00972	14.7567	14.62887	14.64569	11.98234	15.08291	0	0	15.07671	15.98388	0	0	0	0	0	0	0	0	0	0	0	0	0	16.72988	0	0	0	0	0	0	0	0	0	0	15.21275	16.6544	0	0	0
O14512	SOCS7_HUMAN	"Suppressor of cytokine signaling 7, SOCS-7 (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4, NAP-4)"	SOCS7 NAP4 SOCS6	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005829; GO:0005886; GO:0005942; GO:0009968; GO:0016567; GO:0017124; GO:0035556; GO:0040008; GO:0046854; GO:0046935	FSNVK	7.380000114	0.315152705	0.315152705	0.251789452	597.5982384	0	0	11.79148	0	0	13.6045	14.92237	15.39913	0	16.49414	15.51719	0	0	15.40145	15.73659	14.44295	16.20745	13.92628	0	0	15.81333	16.48515	15.34105	0	0	15.70584	0	16.86005	0	0	0	15.36626	15.19846	16.22771	14.75263	0	0	0	16.78482	0	15.74396	16.5165	0	14.97441	15.28129	0	14.75963	0
O14513	NCKP5_HUMAN	"Nck-associated protein 5, NAP-5 (Peripheral clock protein)"	NCKAP5 ERIH NAP5	Homo sapiens (Human)	microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]	microtubule plus-end [GO:0035371]	microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]		GO:0001578; GO:0007019; GO:0035371	DCMNSNEGIYSPGIKSSSLK	4.059999943	1	1	1.83E-12	2187.047358	16.74431	0	0	17.71351	0	16.51908	0	16.20151	10.12877	0	0	0	0	0	0	17.21291	16.75215	0	0	0	16.63006	0	14.59865	0	16.44394	18.18232	16.93465	0	0	0	17.39406	16.27799	0	17.04238	15.72402	0	0	0	13.49144	0	0	0	16.55587	0	0	15.19362	0	0
O14514	AGRB1_HUMAN	"Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40, Vstat40; Vasculostatin-120, Vstat120 ]"	ADGRB1 BAI1	Homo sapiens (Human)	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"	cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	"cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"	G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]	GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428	ETPAGEVAAVR	10.73999977	0.188160151	0.188160151	0.056514696	1100.320307	0	0	0	0	0	0	16.94914	0	16.41924	0	15.18721	0	0	14.5293	13.14926	16.25913	0	0	0	0	0	0	9.117539	10.25211	0	17.58468	15.36675	14.76282	0	0	0	0	0	0	0	16.3493	0	17.18118	0	12.82377	0	0	15.78805	0	0	11.60869	0	15.23491
O14523	C2C2L_HUMAN	"Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like, C2CD2-like) (Transmembrane protein 24)"	C2CD2L KIAA0285 TMEM24 DLNB23	Homo sapiens (Human)	positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]	GO:0005789; GO:0005886; GO:0008526; GO:0016021; GO:0032541; GO:0035091; GO:0035774; GO:0043559; GO:0140268	ANGNPSPQL	8.590000153	1	1	0.258381927	896.9884376	0	0	0	14.86309	16.30898	15.70769	15.18448	0	0	15.8253	0	16.33657	0	0	0	13.49828	0	0	15.77558	0	0	16.73301	0	0	0	0	17.0057	15.19854	0	15.37036	0	0	0	0	0	0	16.82423	0	0	17.18684	15.57426	0	0	0	0	15.74939	0	0
O14524	NEMP1_HUMAN	Nuclear envelope integral membrane protein 1	NEMP1 KIAA0286 TMEM194 TMEM194A	Homo sapiens (Human)	nuclear membrane organization [GO:0071763]	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane organization [GO:0071763]		GO:0005635; GO:0005637; GO:0016021; GO:0071763	VNSSR	1.840000033	0.584812105	0.584812105	0.267105849	560.7272584	16.6332	0	14.6605	0	15.13057	0	13.5942	0	0	0	0	0	16.48602	14.60343	15.4315	16.64177	0	12.78146	0	15.2107	16.76204	0	15.91323	0	15.11692	16.33239	0	0	0	0	15.03864	0	0	15.27255	0	0	0	15.21038	16.08548	0	0	0	15.9334	16.26092	0	0	15.70534	0
O14526	FCHO1_HUMAN	F-BAR domain only protein 1	FCHO1 KIAA0290	Homo sapiens (Human)	clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; positive regulation of T cell activation [GO:0050870]; T cell receptor signaling pathway [GO:0050852]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; AP-2 adaptor complex binding [GO:0035612]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; positive regulation of T cell activation [GO:0050870]; T cell receptor signaling pathway [GO:0050852]	AP-2 adaptor complex binding [GO:0035612]	GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0035612; GO:0048268; GO:0050852; GO:0050870; GO:0072583	CMDQERLR	6.349999905	0.666711032	0.666711032	0.189825456	1112.645427	15.83818	14.57764	12.81852	11.19155	13.65053	15.81929	5.138642	0	15.09659	13.04326	15.08054	12.27858	0	16.26214	0	0	14.87816	15.21889	0	0	9.304179	14.86781	14.83655	15.68002	0	0	0	0	0	0	0	0	14.43886	13.9545	0	15.47462	0	16.11001	16.51449	14.25609	0	0	0	0	0	14.86856	0	0
O14529	CUX2_HUMAN	Homeobox protein cut-like 2 (Homeobox protein cux-2)	CUX2 CUTL2 KIAA0293	Homo sapiens (Human)	cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]	chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007614; GO:0010628; GO:0043565; GO:0050775; GO:0050890; GO:0051965; GO:0061003; GO:0070062; GO:0071310; GO:1990837; GO:2000463	LQAQSDYEEIKTELSILK	12.75	0.490357816	0.490357816	0	2109.02315	17.18218	15.88662	13.35147	17.19756	18.29125	15.50123	15.58334	14.69422	15.77594	13.66889	17.08976	0	14.20916	18.39976	12.92994	16.38107	0	17.61418	0	15.98763	16.3229	15.19886	17.6756	15.35452	17.35814	16.22775	17.61456	0	14.43261	14.73158	0	0	15.46339	11.63719	14.23781	14.52361	10.6352	14.96693	15.16163	16.56287	7.444667	14.6232	14.7164	14.51654	15.24195	9.9153	16.19323	16.68521
O14531	DPYL4_HUMAN	"Dihydropyrimidinase-related protein 4, DRP-4 (Collapsin response mediator protein 3, CRMP-3) (UNC33-like phosphoprotein 4, ULIP-4)"	DPYSL4 CRMP3 ULIP4	Homo sapiens (Human)	nervous system development [GO:0007399]; neuron death [GO:0070997]; neuron projection guidance [GO:0097485]	cytosol [GO:0005829]	"cytosol [GO:0005829]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nervous system development [GO:0007399]; neuron death [GO:0070997]; neuron projection guidance [GO:0097485]"	"filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]"	GO:0005829; GO:0007399; GO:0016810; GO:0031005; GO:0070997; GO:0097485	EELEALVK	6.269999981	1	1	0.233755686	931.330982	0	0	17.72443	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14543	SOCS3_HUMAN	"Suppressor of cytokine signaling 3, SOCS-3 (Cytokine-inducible SH2 protein 3, CIS-3) (STAT-induced STAT inhibitor 3, SSI-3)"	SOCS3 CIS3 SSI3	Homo sapiens (Human)	branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to leukemia inhibitory factor [GO:1990830]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; placenta blood vessel development [GO:0060674]; positive regulation of cell differentiation [GO:0045597]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]	cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]	cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]; protein kinase inhibitor activity [GO:0004860]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to leukemia inhibitory factor [GO:1990830]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; placenta blood vessel development [GO:0060674]; positive regulation of cell differentiation [GO:0045597]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]; protein kinase inhibitor activity [GO:0004860]	GO:0001784; GO:0004860; GO:0005829; GO:0005942; GO:0007259; GO:0016567; GO:0035556; GO:0040008; GO:0042532; GO:0043066; GO:0045597; GO:0046426; GO:0046627; GO:0046854; GO:0046935; GO:0050728; GO:0060670; GO:0060674; GO:0060707; GO:0060708; GO:1990830	LKTFSSK	16.23999977	1	1	0.213544426	809.7753874	16.62378	0	16.54188	16.49161	0	16.28907	0	0	15.0118	0	0	0	15.1447	16.5722	15.80611	0	15.52455	15.5157	0	17.57922	0	0	0	16.32943	0	14.60163	0	16.47355	16.40689	15.47446	15.10866	14.62148	17.15661	14.64241	16.84833	14.79926	16.6018	16.32019	0	0	15.96355	15.90591	15.31151	0	0	16.02043	0	16.56499
O14545	TRAD1_HUMAN	TRAF-type zinc finger domain-containing protein 1 (Protein FLN29)	TRAFD1 FLN29	Homo sapiens (Human)	negative regulation of innate immune response [GO:0045824]		metal ion binding [GO:0046872]; negative regulation of innate immune response [GO:0045824]	metal ion binding [GO:0046872]	GO:0045824; GO:0046872	TAKAKPSK	2.730000019	1	1	0.233854712	832.3200889	14.08746	16.19427	16.24651	0	0	13.4864	0	0	0	14.7628	14.24039	0	0	14.62055	0	15.99216	0	0	0	0	0	0	0	0	17.14467	16.13391	0	0	15.14307	15.18414	15.43303	15.95569	14.73758	16.98397	15.49451	0	0	15.40472	15.17507	15.50631	15.79979	0	14.8864	9.218837	12.49239	15.77392	15.62003	16.51428
O14556	G3PT_HUMAN	"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific, EC 1.2.1.12 (Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2, GAPDH-2) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase)"	GAPDHS GAPD2 GAPDH2 GAPDS HSD-35 HSD35	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; positive regulation of glycolytic process [GO:0045821]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; flagellated sperm motility [GO:0030317]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; positive regulation of glycolytic process [GO:0045821]	glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]	GO:0004365; GO:0005634; GO:0005829; GO:0006006; GO:0006096; GO:0030317; GO:0045821; GO:0050661; GO:0051287	MVSVARELTVGINGFGR	3.049999952	1	1	0.344147555	1806.549238	15.73051	0	0	0	16.4601	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.94416	0	0	0	16.32204	0	16.21877	16.13039	0	13.85291	12.11194	14.01633	15.47871	13.36612	16.69628	16.49944	15.24729	0	17.31608	0	0	0	0	0	0	0	0	0
O14561	ACPM_HUMAN	"Acyl carrier protein, mitochondrial, ACP (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)"	NDUFAB1	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; fatty acid biosynthetic process [GO:0006633]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein lipoylation [GO:0009249]"	iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; calcium ion binding [GO:0005509]; fatty acid binding [GO:0005504]; aerobic respiration [GO:0009060]; fatty acid biosynthetic process [GO:0006633]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein lipoylation [GO:0009249]"	acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; calcium ion binding [GO:0005509]; fatty acid binding [GO:0005504]	GO:0000035; GO:0000036; GO:0005504; GO:0005509; GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006633; GO:0009060; GO:0009249; GO:0016226; GO:0031966; GO:0032981; GO:0042776; GO:1990229	LGTLQPALVLAQVPGR	3.900000095	0.190754563	0.190754563	0.533757724	1632.76371	17.25115	17.81102	17.49161	0	0	0	0	0	0	0	17.07366	0	0	0	0	17.80625	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.32694	0	17.35365	0	0	0	0
O14569	C56D2_HUMAN	"Transmembrane reductase CYB561D2, EC 7.2.1.3 (Cytochrome b561 domain-containing protein 2) (Putative tumor suppressor protein 101F6)"	CYB561D2 101F6 LUCA12.2	Homo sapiens (Human)	ascorbate homeostasis [GO:0140576]	cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]	cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575]; ascorbate homeostasis [GO:0140576]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575]	GO:0005783; GO:0005789; GO:0016021; GO:0016491; GO:0020037; GO:0030659; GO:0031982; GO:0046872; GO:0140571; GO:0140575; GO:0140576	AHLVTR	8.920000076	0.498540759	0.498540759	0.12761397	694.7561198	16.06444	14.82243	14.32617	16.23553	14.58881	16.93612	14.96708	16.44998	12.2565	18.29612	15.4993	17.0289	11.19785	16.26379	17.84797	0	13.77124	15.92036	0	14.44485	16.58789	14.72681	18.46108	15.07294	0	14.70388	0	17.93268	12.93933	16.31831	0	18.21164	12.51938	13.71993	17.63481	17.18486	16.80947	15.1131	13.38798	0	17.47549	0	16.43697	17.56435	16.78901	17.88197	14.60775	16.42794
O14578	CTRO_HUMAN	"Citron Rho-interacting kinase, CRIK, EC 2.7.11.1 (Serine/threonine-protein kinase 21)"	CIT CRIK KIAA0949 STK21	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; transcription coactivator binding [GO:0001223]; actomyosin structure organization [GO:0031032]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; transcription coactivator binding [GO:0001223]	GO:0000086; GO:0000278; GO:0000281; GO:0001223; GO:0001889; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007030; GO:0008064; GO:0016020; GO:0017124; GO:0018107; GO:0019901; GO:0030165; GO:0030291; GO:0030496; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035331; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110; GO:0106310	AMINAMDSK	5.179999828	1	1	0.108241718	997.7710946	0	14.41	13.17558	0	0	0	0	15.91838	0	0	0	0	0	0	0	0	0	0	0	0	15.70533	0	0	0	14.7286	0	12.05618	0	0	0	0	0	0	0	0	0	0	0	16.91538	0	0	0	14.52387	0	16.61561	0	11.92902	0
O14579	COPE_HUMAN	"Coatomer subunit epsilon (Epsilon-coat protein, Epsilon-COP)"	COPE	Homo sapiens (Human)	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030133; GO:0099612	LVLQYAPSA	7.550000191	1	1	0.074011283	961.8429023	16.05608	16.91359	12.51902	0	14.52394	0	14.71446	15.0056	15.54008	0	0	0	14.86924	14.86263	14.16191	0	14.59427	15.42366	0	14.07352	0	14.39466	14.46529	0	15.68591	11.50707	0	0	0	13.39549	16.14316	0	13.77695	0	13.88766	0	16.72019	0	0	0	12.56732	0	0	0	0	0	0	0
O14594	NCAN_HUMAN	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3 NEUR	Homo sapiens (Human)	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]	GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0043202	SYGRR	7.75	0.736498415	0.736498415	0.210246405	639.5527815	14.34443	14.83541	14.36659	13.70527	12.65812	15.60467	15.63663	0	15.07354	15.77296	0	17.11805	16.4652	15.2395	0	16.81584	16.4497	15.87391	15.58937	15.66906	16.49652	0	16.44688	15.68244	17.15679	0	15.83237	16.58797	17.52175	17.71603	17.50332	17.38059	15.60099	15.20002	17.21203	16.00872	16.7832	17.67135	17.0846	19.49878	17.3592	19.76932	14.72139	16.90001	17.70958	15.30663	19.98994	16.92643
O14595	CTDS2_HUMAN	"Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2, EC 3.1.3.16 (Nuclear LIM interactor-interacting factor 2, NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2, SCP2)"	CTDSP2 NIF2 OS4 SCP2	Homo sapiens (Human)	negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470]	metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]	GO:0001933; GO:0004721; GO:0005654; GO:0006470; GO:0008420; GO:0046872; GO:2000134	MEHGSIITQARR	9.600000381	1	1	6.85E-13	1398.229145	15.92812	16.03851	0	15.37467	13.24969	0	14.06446	0	15.16101	0	15.61365	15.79934	15.05369	0	0	15.91559	15.33242	15.7869	14.12844	0	14.45596	0	15.37837	0	0	0	0	15.25469	16.83555	15.86154	0	0	0	0	0	0	0	0	0	16.49201	0	16.15591	17.35739	0	17.14277	0	0	0
O14602	IF1AY_HUMAN	"Eukaryotic translation initiation factor 1A, Y-chromosomal, eIF-1A Y isoform (Eukaryotic translation initiation factor 4C, eIF-4C)"	EIF1AY	Homo sapiens (Human)	translational initiation [GO:0006413]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]	translation initiation factor activity [GO:0003743]	GO:0003743; GO:0005737; GO:0006413	ADVILK	2.910000086	0.247363597	0.247363597	0.194678944	659.4048134	13.41339	14.85454	0	16.43733	0	15.99214	14.99567	0	14.25443	0	0	0	14.89021	16.75944	15.51672	0	0	0	16.22423	14.93724	16.10446	16.45049	0	0	15.59689	16.85415	15.9265	14.6106	12.97475	15.34529	0	16.38632	0	16.77505	0	16.14493	16.28544	17.55239	15.76827	16.26807	16.01315	15.83439	0	14.60109	15.76532	15.76338	0	16.59801
O14604	TYB4Y_HUMAN	"Thymosin beta-4, Y-chromosomal"	TMSB4Y TB4Y	Homo sapiens (Human)	actin filament organization [GO:0007015]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007015; GO:0008064; GO:0030334; GO:0042989	ETIEQERQAGES	8.960000038	1	1	2.06E-12	1378.566415	15.18268	14.49883	14.17547	0	13.82112	15.65028	14.81634	15.0339	0	0	0	13.24004	15.64382	0	0	15.40712	14.21227	0	15.35127	0	13.65303	0	15.05755	13.84364	0	13.35338	14.24041	14.98613	15.70764	0	14.57189	14.96311	0	14.67459	14.89754	15.47638	15.08148	15.32212	0	15.457	15.56655	15.57303	0	0	0	14.38483	0	0
O14607	UTY_HUMAN	"Histone demethylase UTY, EC 1.14.11.68 (Ubiquitously-transcribed TPR protein on the Y chromosome) (Ubiquitously-transcribed Y chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase UTY)"	UTY KDM6C	Homo sapiens (Human)	chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; regulation of gene expression [GO:0010468]	MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]	MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; regulation of gene expression [GO:0010468]	chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005654; GO:0006325; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0044666; GO:0046872; GO:0071557; GO:0071558	QLSNSAQGLHK	4.53000021	0.534331739	0.534331739	0.410600216	1181.23127	0	13.78	0	14.94413	17.18978	14.70121	16.21768	13.64524	15.66832	0	0	0	0	15.90502	0	0	0	16.40574	0	0	16.04032	0	16.53225	0	0	0	0	0	16.83033	16.61719	0	16.39774	0	0	0	17.56789	0	0	0	0	16.69213	15.97689	16.61813	0	0	16.74448	16.38675	17.51823
O14617	AP3D1_HUMAN	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin)	AP3D1 PRO0039	Homo sapiens (Human)	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]"		GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0016183; GO:0016192; GO:0030123; GO:0032438; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:1903232; GO:1904115	NLMEIVKK	14.75	1	1	0.482495863	989.4797071	0	0	0	0	0	17.06788	16.87895	0	0	18.35517	17.34106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.62131	0	17.21741	17.71725	0	0	0	18.57602	19.79125	0	20.63439	20.68195	0	0	17.06045	18.04653	17.26596	0	0	0	0
O14641	DVL2_HUMAN	"Segment polarity protein dishevelled homolog DVL-2, Dishevelled-2 (DSH homolog 2)"	DVL2	Homo sapiens (Human)	"canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cellular protein localization [GO:0034613]; cochlea morphogenesis [GO:0090103]; convergent extension involved in neural plate elongation [GO:0022007]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	aggresome [GO:0016235]; apical part of cell [GO:0045177]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"aggresome [GO:0016235]; apical part of cell [GO:0045177]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cellular protein localization [GO:0034613]; cochlea morphogenesis [GO:0090103]; convergent extension involved in neural plate elongation [GO:0022007]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]	GO:0001843; GO:0001934; GO:0003151; GO:0005109; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0007379; GO:0007507; GO:0016235; GO:0016328; GO:0016604; GO:0019901; GO:0019904; GO:0022007; GO:0030674; GO:0031267; GO:0031410; GO:0034613; GO:0035556; GO:0035567; GO:0042802; GO:0043507; GO:0043547; GO:0043621; GO:0044340; GO:0045177; GO:0045334; GO:0045944; GO:0051091; GO:0060070; GO:0060071; GO:0061098; GO:0090103; GO:0090179; GO:0150012	KYASGLLK	3.190000057	0.459020495	0.459020495	0.273110675	880.5444111	16.91153	14.14913	14.22748	17.81083	17.75659	0	18.18117	17.89677	16.55271	16.53329	0	0	0	17.58384	0	18.14618	0	0	16.38423	17.50613	0	0	0	0	0	0	0	18.20872	0	18.09939	0	18.0854	17.97494	0	0	0	17.13878	0	0	18.14507	0	0	16.71308	18.85666	0	0	0	18.16607
O14646	CHD1_HUMAN	"Chromodomain-helicase-DNA-binding protein 1, CHD-1, EC 3.6.4.12 (ATP-dependent helicase CHD1)"	CHD1	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; positive regulation by host of viral transcription [GO:0043923]	cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; methylated histone binding [GO:0035064]; chromatin remodeling [GO:0006338]; positive regulation by host of viral transcription [GO:0043923]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; methylated histone binding [GO:0035064]	GO:0000228; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0016887; GO:0035064; GO:0043923; GO:0140658	QISFNGSEGR	9.239999771	1	1	0.316061354	1093.808824	15.91791	0	0	0	0	16.17569	0	17.00676	15.81495	0	15.71581	0	0	0	0	16.81934	0	0	0	0	16.05244	0	0	16.92271	0	0	0	0	16.76502	0	0	0	0	17.92571	16.9678	0	0	0	0	16.36063	17.02054	0	0	0	0	16.73927	0	0
O14647	CHD2_HUMAN	"Chromodomain-helicase-DNA-binding protein 2, CHD-2, EC 3.6.4.12 (ATP-dependent helicase CHD2)"	CHD2	Homo sapiens (Human)	muscle organ development [GO:0007517]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; muscle organ development [GO:0007517]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0007517; GO:0016887; GO:0042393; GO:0140658	DHHYGDR	6.099999905	1	1	0.146121551	899.4522938	0	13.41608	12.08743	12.42846	10.98484	9.984545	11.47767	12.48104	14.1619	15.0056	0	15.5046	15.2847	0	0	0	0	0	0	0	0	0	15.47599	0	0	0	0	0	0	0	0	0	0	0	0	0	16.10944	0	0	0	0	0	0	14.27041	0	0	15.30148	0
O14654	IRS4_HUMAN	"Insulin receptor substrate 4, IRS-4 (160 kDa phosphotyrosine protein, py160) (Phosphoprotein of 160 kDa, pp160)"	IRS4	Homo sapiens (Human)	insulin receptor signaling pathway [GO:0008286]; signal transduction [GO:0007165]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; insulin receptor signaling pathway [GO:0008286]; signal transduction [GO:0007165]	insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]	GO:0005158; GO:0005829; GO:0005886; GO:0007165; GO:0008286; GO:0043548	GSGSGK	7.409999847	1	1	0.097720325	493.181911	14.91267	0	15.11098	14.82937	0	0	16.65935	0	0	0	0	0	0	0	0	15.64039	0	13.3463	0	0	15.77437	0	0	0	0	0	0	0	0	15.31891	0	10.77242	0	0	13.76133	0	0	0	0	0	0	16.15417	0	0	0	0	0	0
O14656	TOR1A_HUMAN	"Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A, EC 3.6.4.-) (Torsin family 1 member A)"	TOR1A DQ2 DYT1 TA TORA	Homo sapiens (Human)	"cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ER-associated misfolded protein catabolic process [GO:0071712]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; organelle organization [GO:0006996]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; response to oxidative stress [GO:0006979]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]"	cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]	"cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082]; cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ER-associated misfolded protein catabolic process [GO:0071712]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; organelle organization [GO:0006996]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; response to oxidative stress [GO:0006979]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082]	GO:0000338; GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0005829; GO:0005856; GO:0006979; GO:0006996; GO:0006998; GO:0007155; GO:0008021; GO:0008092; GO:0016020; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0042406; GO:0042802; GO:0043231; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051082; GO:0051085; GO:0051584; GO:0051787; GO:0061077; GO:0070062; GO:0071712; GO:0071763; GO:0140662; GO:1900244; GO:2000008	VEMQSR	1.049999952	0.823913932	0.823913932	0.10505564	766.013228	14.8981	0	0	15.5287	14.02736	0	15.06763	0	0	0	16.15542	14.01803	16.47037	15.99454	12.22339	0	0	0	0	0	0	0	0	0	14.78174	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.67011	0
O14672	ADA10_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 10, ADAM 10, EC 3.4.24.81 (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)"	ADAM10 KUZ MADM	Homo sapiens (Human)	adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]	adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998]	endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005102; GO:0005178; GO:0005634; GO:0005737; GO:0005788; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0005925; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007229; GO:0007267; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0017124; GO:0019901; GO:0022617; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0035579; GO:0042117; GO:0042803; GO:0042987; GO:0043231; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070062; GO:0070821; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	LVDADGPLAR	2.049999952	1	1	0.127131666	1028.284462	0	10.71118	14.58636	0	0	0	15.51675	0	0	0	0	17.11749	12.18287	14.77831	0	0	0	14.7805	14.69461	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53002	15.71586	0	0	0	0	0	0	0	0	14.53034	0
O14678	ABCD4_HUMAN	"Lysosomal cobalamin transporter ABCD4, EC 7.6.2.8 (ATP-binding cassette sub-family D member 4) (PMP70-related protein, P70R) (Peroxisomal membrane protein 1-like, PXMP1-L) (Peroxisomal membrane protein 69, PMP69)"	ABCD4 PXMP1L	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760]	ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]	GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016021; GO:0042626; GO:0042760; GO:0043190; GO:0055085; GO:1990830	MAVAGPAPGAGARPRLDLQFLQR	3.950000048	1	1	0.01470092	2407.776016	12.73292	0	10.27198	12.43763	0	13.46728	0	13.57124	0	0	0	0	0	12.34875	0	13.63564	12.46084	12.12621	0	0	13.01749	13.1017	14.11455	0	0	0	6.511513	0	10.47975	0	0	0	0	15.12463	14.01995	0	0	0	0	0	0	0	13.2589	14.75393	0	0	0	0
O14681	EI24_HUMAN	Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein)	EI24 PIG8	Homo sapiens (Human)	apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; importin-alpha family protein binding [GO:0061676]; apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308]	importin-alpha family protein binding [GO:0061676]	GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0016236; GO:0030308; GO:0031965; GO:0061676	AQSIER	13.55000019	1	1	0.23892343	703.8516949	16.55875	0	18.29505	16.16787	0	0	0	14.93046	0	18.00955	0	0	0	0	0	14.78807	0	16.71262	16.78359	18.12405	0	0	17.30732	14.85532	17.32192	16.26406	17.37097	0	0	0	17.73485	11.32346	16.13949	13.98403	16.41884	17.57546	18.58925	0	16.90417	14.07241	0	16.52768	17.21473	16.85926	16.09399	0	15.92882	0
O14686	KMT2D_HUMAN	"Histone-lysine N-methyltransferase 2D, Lysine N-methyltransferase 2D, EC 2.1.1.364 (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)"	KMT2D ALR MLL2 MLL4	Homo sapiens (Human)	"beta-catenin-TCF complex assembly [GO:1904837]; heterochromatin assembly [GO:0031507]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to estrogen [GO:0043627]"	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; beta-catenin-TCF complex assembly [GO:1904837]; heterochromatin assembly [GO:0031507]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to estrogen [GO:0043627]"	DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]	GO:0000976; GO:0001555; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0008284; GO:0031507; GO:0033148; GO:0035097; GO:0042393; GO:0042800; GO:0043627; GO:0044648; GO:0044666; GO:0045944; GO:0046872; GO:0048477; GO:0051568; GO:0080182; GO:0097692; GO:1904837	APLTPR	3.25999999	1	1	0.256680516	652.0856389	0	0	0	16.32232	0	15.87137	0	0	0	0	0	0	15.51755	0	17.4717	0	0	0	0	0	17.85078	0	0	14.39079	0	0	18.36729	0	0	0	18.5005	0	19.40975	0	16.60804	0	0	0	0	13.95409	16.56528	17.43292	0	15.1778	0	16.1813	0	15.02058
O14709	ZN197_HUMAN	Zinc finger protein 197 (Zinc finger protein with KRAB and SCAN domains 9) (ZnF20) (pVHL-associated KRAB domain-containing protein)	ZNF197 ZKSCAN9 ZNF166	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	ADSHK	11.32999992	0.224395275	0.224395275	0.262331231	556.7397133	16.15743	0	15.20981	0	15.76011	0	13.8822	0	16.50813	15.46698	0	15.45143	0	16.08336	16.55807	14.33849	14.73583	0	0	0	16.98545	16.97297	17.72402	16.82592	0	15.57876	0	16.33559	16.03805	0	16.52241	0	0	14.17978	16.56917	18.03635	17.18565	0	16.82826	16.05954	0	18.27845	17.50537	16.43283	17.15276	17.17295	15.40453	15.51558
O14727	APAF_HUMAN	"Apoptotic protease-activating factor 1, APAF-1"	APAF1 KIAA0413	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to G1 DNA damage checkpoint signaling [GO:0072432]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]	apoptosome [GO:0043293]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]	apoptosome [GO:0043293]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to G1 DNA damage checkpoint signaling [GO:0072432]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]	GO:0000166; GO:0001666; GO:0001822; GO:0001843; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0006915; GO:0006919; GO:0007399; GO:0007568; GO:0007584; GO:0008635; GO:0008656; GO:0010659; GO:0030154; GO:0030900; GO:0031072; GO:0032991; GO:0034774; GO:0042802; GO:0042981; GO:0043065; GO:0043293; GO:0043531; GO:0051402; GO:0070059; GO:0070062; GO:0071560; GO:0072432; GO:0097193; GO:0097202; GO:1902510; GO:1904813; GO:2001235	AAMLIK	7.400000095	1	1	0.273234284	646.6082459	15.56982	17.41143	0	0	17.521	0	0	18.16018	16.68698	16.74128	0	0	0	0	17.08842	0	0	0	18.01799	0	16.57631	0	0	0	17.18473	0	18.07068	0	0	17.4736	0	18.26494	18.07485	0	0	0	17.38952	18.68514	0	0	17.92917	0	0	16.84522	0	0	16.42943	0
O14730	RIOK3_HUMAN	"Serine/threonine-protein kinase RIO3, EC 2.7.11.1 (RIO kinase 3) (sudD homolog)"	RIOK3 SUDD	Homo sapiens (Human)	cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]"	"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]"	ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:0106310; GO:1990786	HILVMSFIGHDQVPAPKLK	7.980000019	0.710289776	0.710289776	0.092514785	2141.938464	15.66476	14.45242	14.09308	12.98102	13.65115	0	0	13.83075	0	0	0	0	14.35608	14.06945	14.91813	14.98682	16.66809	15.50206	0	16.44425	0	14.5609	16.09209	0	0	14.22888	13.93171	14.608	13.16695	13.05458	15.5223	0	7.99588	13.88704	14.581	0	14.37463	15.76814	14.6512	0	12.83642	0	13.60604	0	0	0	0	14.83955
O14732	IMPA2_HUMAN	"Inositol monophosphatase 2, IMP 2, IMPase 2, EC 3.1.3.25 (Inositol-1(or 4)-monophosphatase 2) (Myo-inositol monophosphatase A2)"	IMPA2 IMP.18P	Homo sapiens (Human)	inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; response to lithium ion [GO:0010226]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; response to lithium ion [GO:0010226]; signal transduction [GO:0007165]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]	GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006796; GO:0007165; GO:0008934; GO:0010226; GO:0042803; GO:0046854; GO:0046855; GO:0046872; GO:0052832; GO:0052833	ALVLTEIGPKR	5.019999981	1	1	9.17E-13	1197.858313	0	14.27251	0	0	0	0	14.07657	11.96147	0	0	0	0	0	0	0	14.34935	0	0	0	0	0	0	0	0	0	14.88564	16.58905	0	0	15.56227	16.57823	0	0	0	0	0	0	0	0	0	15.90929	0	14.50808	0	15.33032	0	0	15.82092
O14735	CDIPT_HUMAN	"CDP-diacylglycerol--inositol 3-phosphatidyltransferase, EC 2.7.8.11 (Phosphatidylinositol synthase, PI synthase, PtdIns synthase)"	CDIPT PIS PIS1	Homo sapiens (Human)	CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]	alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341	MGLWVTAPIALLKSLISVIHLITAAR	2.609999895	1	1	0.308504173	2803.019293	0	15.76748	16.14364	0	0	0	0	0	15.52724	0	0	0	0	0	0	0	0	0	0	14.61567	0	0	0	14.84427	0	0	14.21379	0	0	0	0	16.22663	0	0	0	0	14.71427	0	0	0	0	0	0	0	0	0	0	0
O14737	PDCD5_HUMAN	"Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19, Protein TFAR19)"	PDCD5 TFAR19	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]	acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]	GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008201; GO:0008285; GO:0010628; GO:0010698; GO:0043065; GO:0043280; GO:0048487; GO:0070062; GO:0071560; GO:0090200; GO:1903638; GO:1903645	KVSQQTEK	10.81999969	1	1	0.251513098	947.3063236	14.07847	0	14.15162	14.24353	15.05492	14.75602	0	15.38773	15.77042	13.73464	13.88741	0	0	14.99366	12.93161	15.38428	15.27858	0	0	0	0	0	0	0	0	0	16.05072	0	15.73148	15.30245	16.39068	14.95815	0	15.13864	0	0	0	0	16.51102	0	14.97339	0	0	0	0	0	0	0
O14744	ANM5_HUMAN	"Protein arginine N-methyltransferase 5, PRMT5, EC 2.1.1.320 (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog, SKB1 homolog, SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed ]"	PRMT5 HRMT1L5 IBP72 JBP1 SKB1	Homo sapiens (Human)	"chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]"	E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]	GO:0000387; GO:0000785; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0007088; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0045596; GO:0046982; GO:0048026; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:0097421; GO:1901796; GO:1904992	SYTIGL	21.45000076	1	1	0.151916278	654.2614779	0	15.63369	15.60949	0	14.63473	15.13836	0	16.11291	13.61467	16.29671	14.17203	15.21832	15.26619	15.99273	0	13.19631	14.66062	14.72913	0	0	0	0	0	15.23389	16.5117	0	15.47232	0	0	0	0	0	0	0	0	17.00983	17.22531	17.2425	0	0	0	0	14.87825	0	0	0	0	18.698
O14745	NHRF1_HUMAN	"Na(+)/H(+) exchange regulatory cofactor NHE-RF1, NHERF-1 (Ezrin-radixin-moesin-binding phosphoprotein 50, EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)"	SLC9A3R1 NHERF NHERF1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gamma-aminobutyric acid import [GO:0051939]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; import across plasma membrane [GO:0098739]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; morphogenesis of an epithelium [GO:0002009]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of protein kinase activity [GO:0045859]; regulation of renal phosphate excretion [GO:1903402]; regulation of sodium:proton antiporter activity [GO:0032415]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; transport across blood-brain barrier [GO:0150104]; Wnt signaling pathway [GO:0016055]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane protein complex [GO:0098797]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane protein complex [GO:0098797]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein N-terminus binding [GO:0047485]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; gamma-aminobutyric acid import [GO:0051939]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; import across plasma membrane [GO:0098739]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; morphogenesis of an epithelium [GO:0002009]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of protein kinase activity [GO:0045859]; regulation of renal phosphate excretion [GO:1903402]; regulation of sodium:proton antiporter activity [GO:0032415]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; transport across blood-brain barrier [GO:0150104]; Wnt signaling pathway [GO:0016055]	beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein N-terminus binding [GO:0047485]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800]	GO:0001726; GO:0002009; GO:0003096; GO:0005102; GO:0005737; GO:0005902; GO:0007009; GO:0007097; GO:0007191; GO:0007605; GO:0008013; GO:0008285; GO:0008360; GO:0008361; GO:0010642; GO:0012505; GO:0014067; GO:0015185; GO:0015629; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0019902; GO:0022612; GO:0030033; GO:0030036; GO:0030165; GO:0030175; GO:0030336; GO:0030643; GO:0031526; GO:0031528; GO:0031698; GO:0031799; GO:0031800; GO:0031982; GO:0032415; GO:0032416; GO:0032426; GO:0032782; GO:0034635; GO:0034767; GO:0042802; GO:0043495; GO:0043621; GO:0044782; GO:0044877; GO:0045121; GO:0045159; GO:0045198; GO:0045199; GO:0045859; GO:0045930; GO:0047485; GO:0048471; GO:0050780; GO:0051683; GO:0051898; GO:0051939; GO:0060088; GO:0060158; GO:0065003; GO:0070062; GO:0070293; GO:0070373; GO:0070851; GO:0071944; GO:0072659; GO:0090090; GO:0090660; GO:0097225; GO:0097291; GO:0098739; GO:0098797; GO:0150104; GO:1903402; GO:2001244	AALNAVR	3.460000038	1	1	0.253389254	713.576045	0	0	0	0	0	0	0	0	0	0	0	0	17.50124	0	0	0	0	16.42406	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.92278	0	0	0	0	0	0	0	0	0	0	0	0	0
O14753	OVOL1_HUMAN	"Putative transcription factor Ovo-like 1, hOvo1"	OVOL1	Homo sapiens (Human)	"epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]; spermatogenesis [GO:0007283]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; kidney development [GO:0001822]; mesoderm development [GO:0007498]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]; spermatogenesis [GO:0007283]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001227; GO:0001822; GO:0005634; GO:0006357; GO:0007283; GO:0007498; GO:0009913; GO:0043588; GO:0046872; GO:0051729; GO:1901994; GO:1990837; GO:2000647	MLNRHMK	8	1	1	0.214247799	945.348445	14.52173	14.64387	12.56313	13.60828	14.20403	14.03946	14.36775	14.51822	15.28772	16.46427	0	0	14.96816	15.30039	13.18878	0	14.69928	0	14.64285	12.41294	0	15.20694	16.29953	0	15.84531	16.2778	0	0	0	15.05933	0	0	0	0	0	0	14.75454	0	0	15.61066	0	0	0	14.44848	15.25425	13.69957	0	14.90886
O14756	H17B6_HUMAN	"17-beta-hydroxysteroid dehydrogenase type 6, 17-beta-HSD 6, 17-beta-HSD6, EC 1.1.1.105, EC 1.1.1.209, EC 1.1.1.239, EC 1.1.1.53, EC 1.1.1.62 (3-alpha->beta-hydroxysteroid epimerase, 3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 6)"	HSD17B6 RODH SDR9C6	Homo sapiens (Human)	androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; brexanolone catabolic process [GO:0062175]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]	"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; catalytic activity [GO:0003824]; electron transfer activity [GO:0009055]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; brexanolone catabolic process [GO:0062175]"	"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; catalytic activity [GO:0003824]; electron transfer activity [GO:0009055]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0003824; GO:0004745; GO:0005783; GO:0006702; GO:0006710; GO:0009055; GO:0016491; GO:0031901; GO:0044594; GO:0047023; GO:0047024; GO:0047035; GO:0047044; GO:0047045; GO:0062175; GO:0072582	SWPKPAQAV	6.440000057	1	1	0.296335388	982.117266	15.52638	0	17.12376	16.37579	14.85342	0	16.59102	17.61388	15.39293	14.75392	16.60122	16.28309	17.33503	0	15.0816	16.35392	15.92692	16.15844	0	17.54195	0	15.24035	0	16.48307	14.63619	15.28267	15.92862	15.76519	16.38293	15.17145	15.17979	16.73834	14.4114	15.32593	15.84581	16.07182	16.3902	0	15.84058	15.03396	15.95392	17.12095	14.49419	13.68033	15.86601	16.1943	14.80463	14.39173
O14763	TR10B_HUMAN	"Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2) (CD antigen CD262)"	TNFRSF10B DR5 KILLER TRAILR2 TRICK2 ZTNFR9 UNQ160/PRO186	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]; TRAIL-activated apoptotic signaling pathway [GO:0036462]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; TRAIL receptor activity [GO:0036463]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]; TRAIL-activated apoptotic signaling pathway [GO:0036462]	signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; TRAIL receptor activity [GO:0036463]	GO:0002357; GO:0005886; GO:0006915; GO:0007166; GO:0007250; GO:0008625; GO:0009986; GO:0016021; GO:0034976; GO:0036462; GO:0036463; GO:0038023; GO:0042981; GO:0043065; GO:0043123; GO:0045569; GO:0070059; GO:0071260	AAPQQKR	9.029999733	0.862503946	0.862503946	0.26045012	798.7604284	12.3848	17.47766	15.92772	14.26651	0	0	16.26054	15.8083	0	0	0	0	15.7987	0	0	16.62406	15.15395	16.29742	0	15.55695	17.34173	16.69758	0	0	17.02263	0	17.594	16.54575	0	14.44403	16.15686	15.09751	15.97108	16.92865	17.53212	15.5894	16.45545	16.87975	16.2366	15.81062	15.56059	17.01416	17.07112	17.21495	14.94681	16.32491	16.79423	0
O14770	MEIS2_HUMAN	Homeobox protein Meis2 (Meis1-related protein 1)	MEIS2 MRG1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; visual learning [GO:0008542]	chromatin [GO:0000785]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"chromatin [GO:0000785]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; visual learning [GO:0008542]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003677; GO:0005634; GO:0006357; GO:0007420; GO:0008134; GO:0008284; GO:0008542; GO:0009612; GO:0009880; GO:0009887; GO:0031016; GO:0043565; GO:0045638; GO:0045931; GO:0045944; GO:0048471; GO:0070848; GO:0110024; GO:1990837	DAIYGHPLFPLLALVFEK	3.289999962	0.137013882	0.137013882	0.026509494	2043.919298	0	16.64523	16.50517	8.217234	0	11.78785	15.32771	14.53004	0	0	15.94037	13.89305	15.40292	16.31079	13.81393	0	15.31633	13.55454	0	0	11.83891	15.53167	15.76831	18.69153	0	15.13154	0	14.48786	0	0	12.59177	12.49111	0	16.31875	0	0	0	13.02229	9.952018	12.20403	0	12.73812	16.51801	13.99798	12.12747	14.91283	0	0
O14773	TPP1_HUMAN	"Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)"	TPP1 CLN2 GIG1 UNQ267/PRO304	Homo sapiens (Human)	"bone resorption [GO:0045453]; central nervous system development [GO:0007417]; epithelial cell differentiation [GO:0030855]; lipid metabolic process [GO:0006629]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]"	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; recycling endosome [GO:0055037]	"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240]; bone resorption [GO:0045453]; central nervous system development [GO:0007417]; epithelial cell differentiation [GO:0030855]; lipid metabolic process [GO:0006629]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]"	endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240]	GO:0004175; GO:0004252; GO:0005764; GO:0005794; GO:0006508; GO:0006629; GO:0007040; GO:0007399; GO:0007417; GO:0008233; GO:0008236; GO:0008240; GO:0030163; GO:0030855; GO:0035727; GO:0042277; GO:0042470; GO:0043171; GO:0043202; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070062; GO:0070198; GO:0120146; GO:1905146	VVGQQGRGR	6.75	0.714219928	0.714219928	0.118268457	957.2572081	0	15.39825	15.1432	12.33672	12.01147	13.46816	0	14.94582	0	0	15.19192	0	0	14.09596	10.9705	0	0	0	0	0	16.13817	13.05629	0	0	0	14.79962	14.88382	15.98084	0	13.20731	0	14.6333	15.75219	0	0	0	18.37387	0	0	0	13.5689	0	14.7839	13.31815	14.40352	0	12.05264	16.11215
O14775	GNB5_HUMAN	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	GNB5	Homo sapiens (Human)	dark adaptation [GO:1990603]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; presynapse [GO:0098793]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; presynapse [GO:0098793]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; signaling receptor complex adaptor activity [GO:0030159]; dark adaptation [GO:1990603]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; signaling receptor complex adaptor activity [GO:0030159]	GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0007165; GO:0007186; GO:0007212; GO:0030159; GO:0031682; GO:0036367; GO:0043547; GO:0051087; GO:0098793; GO:1901386; GO:1902773; GO:1990603	NENMAAKK	5.619999886	1	1	0.215774735	921.1024929	16.8893	0	16.76293	0	0	0	18.58493	0	0	0	0	0	17.17023	0	0	0	0	0	17.18195	0	0	0	0	0	0	0	18.85429	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.1958	0	0	0	0	0
O14777	NDC80_HUMAN	"Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1, HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC)"	NDC80 HEC HEC1 KNTC2	Homo sapiens (Human)	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057]	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]"	"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057]"	cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]	GO:0000070; GO:0000132; GO:0000278; GO:0000775; GO:0000776; GO:0000940; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0007094; GO:0008315; GO:0008608; GO:0016020; GO:0030332; GO:0031262; GO:0031617; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483; GO:1905342	LLEMVATHVGSVEK	4.420000076	0.811845005	0.811845005	0.089699055	1530.039451	0	0	11.9941	11.65082	13.59925	15.73089	14.47589	0	14.16175	14.55112	14.72453	14.30738	0	0	0	14.51187	0	0	0	0	15.5964	15.64513	0	15.98587	0	0	0	15.39732	12.50303	13.88547	0	16.28106	12.50425	15.18821	13.71782	0	14.30802	0	15.63455	0	15.69945	0	13.25271	0	0	0	14.44901	0
O14787	TNPO2_HUMAN	Transportin-2 (Karyopherin beta-2b)	TNPO2	Homo sapiens (Human)	protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267]	GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0031267; GO:0061608	ATIGILITTIASK	5.050000191	1	1	0.147188415	1302.584851	0	0	0	0	0	0	0	0	0	10.10963	14.17883	0	0	14.33995	0	0	14.66319	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14788	TNF11_HUMAN	"Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor, ODF) (Osteoprotegerin ligand, OPGL) (Receptor activator of nuclear factor kappa-B ligand, RANKL) (TNF-related activation-induced cytokine, TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form ]"	TNFSF11 OPGL RANKL TRANCE	Homo sapiens (Human)	bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]	GO:0001503; GO:0002158; GO:0002548; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006955; GO:0010628; GO:0019221; GO:0019722; GO:0030316; GO:0032813; GO:0033209; GO:0033598; GO:0034112; GO:0036035; GO:0038001; GO:0042802; GO:0043123; GO:0043406; GO:0044691; GO:0045453; GO:0045672; GO:0045780; GO:0045944; GO:0046330; GO:0050870; GO:0051091; GO:0051092; GO:0051466; GO:0051897; GO:0055074; GO:0060749; GO:0070371; GO:0071812; GO:0071847; GO:0071848; GO:1902533; GO:1904616; GO:1990830; GO:2001206	TSIKIPSSHTLMK	13.06000042	1	1	0.113134867	1459.317754	13.25246	0	14.67765	0	0	12.86303	0	0	13.32166	0	0	14.47483	14.89518	14.98804	15.57764	0	16.27612	16.27543	0	0	10.9872	0	17.89247	16.40799	16.02825	0	12.59468	12.89849	14.38302	13.85096	15.04718	14.76745	0	0	12.88588	15.07419	15.54259	10.70666	12.49782	16.04777	0	0	11.96052	0	0	0	0	0
O14793	GDF8_HUMAN	"Growth/differentiation factor 8, GDF-8 (Myostatin)"	MSTN GDF8	Homo sapiens (Human)	"cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005125; GO:0005615; GO:0005737; GO:0007179; GO:0007517; GO:0008083; GO:0008201; GO:0009408; GO:0009629; GO:0010592; GO:0010759; GO:0010862; GO:0014732; GO:0014741; GO:0014839; GO:0014850; GO:0022602; GO:0033574; GO:0033673; GO:0042802; GO:0042803; GO:0043627; GO:0045471; GO:0045662; GO:0045893; GO:0046627; GO:0046716; GO:0048632; GO:0051602; GO:0051898; GO:0060395; GO:0071549; GO:1902723; GO:1902725; GO:2000818	DGTRYTGIR	3.549999952	1	1	0.037209828	1039.593742	0	16.18909	0	15.74803	0	0	0	0	0	0	15.81128	0	15.09935	0	14.85325	14.09919	14.97758	15.40808	0	0	0	0	0	14.14932	16.38879	0	13.19778	0	0	0	0	14.18602	14.89528	0	15.19229	0	14.88749	12.08074	0	0	0	0	0	0	0	0	0	0
O14795	UN13B_HUMAN	"Protein unc-13 homolog B (Munc13-2, munc13)"	UNC13B UNC13	Homo sapiens (Human)	"acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]	GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007528; GO:0010808; GO:0016020; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030672; GO:0030742; GO:0031267; GO:0031594; GO:0035249; GO:0042734; GO:0043065; GO:0043195; GO:0048786; GO:0050714; GO:0060478; GO:0061789; GO:0071333; GO:0097151; GO:0098831; GO:0099011; GO:0099525	QMADILGQVR	12.97999954	1	1	0.416798551	1129.403487	20.08234	0	0	0	0	0	0	0	0	0	19.99046	0	0	0	0	0	0	0	0	0	17.7303	0	0	0	0	0	0	0	0	0	0	0	0	0	20.68077	21.30623	21.90507	0	0	0	0	19.74857	20.40635	0	18.46012	0	0	0
O14802	RPC1_HUMAN	"DNA-directed RNA polymerase III subunit RPC1, RNA polymerase III subunit C1, EC 2.7.7.6 (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit, RPC155) (RNA polymerase III subunit C160)"	POLR3A	Homo sapiens (Human)	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0016020; GO:0032728; GO:0045087; GO:0046872; GO:0051607	ENSKSSMYYVLQFLK	4.929999828	1	1	0.067876892	1853.53914	14.2162	16.4998	0	0	12.51702	14.5661	13.81466	15.86137	0	12.88167	0	0	0	13.3084	0	0	0	11.48652	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14804	TAAR5_HUMAN	"Trace amine-associated receptor 5, TaR-5, Trace amine receptor 5, hTaar5 (Putative neurotransmitter receptor)"	TAAR5 PNR	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; trimethylamine receptor activity [GO:1990081]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165]	G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; trimethylamine receptor activity [GO:1990081]	GO:0001594; GO:0004930; GO:0005887; GO:0007165; GO:0007186; GO:0007606; GO:1990081	SLAGAAKHER	8.369999886	0.150486007	0.150486007	0.264101688	1039.330414	14.57601	0	13.6401	15.08192	13.77209	14.96989	0	15.79774	13.29054	15.91723	16.06165	15.67505	15.8921	0	0	14.95989	0	0	0	0	15.00502	17.18785	15.89871	16.0067	0	14.45125	16.17043	0	0	0	16.65883	0	15.95022	16.42551	0	14.77654	0	14.55394	16.94916	0	0	0	0	0	0	0	14.87793	16.22854
O14807	RASM_HUMAN	"Ras-related protein M-Ras, EC 3.6.5.2 (Ras-related protein R-Ras3)"	MRAS RRAS3	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265]	G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]	GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003; GO:0030036; GO:0030742; GO:1990830	ATGTHK	4	1	1	0.132529429	613.6280515	0	0	0	0	14.07323	0	0	0	15.02262	0	0	0	0	0	0	13.5927	0	0	0	0	0	13.76043	0	0	0	0	0	0	0	0	16.76812	16.30428	0	0	0	0	16.5757	15.73945	0	13.3941	0	0	0	0	0	0	15.5632	16.51237
O14818	PSA7_HUMAN	Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7 HSPC	Homo sapiens (Human)	proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; identical protein binding [GO:0042802]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	identical protein binding [GO:0042802]	GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0042802; GO:0043161; GO:0070062; GO:0098794	ANAIGRGAK	5.539999962	1	1	0.094301311	857.7920541	0	14.82851	0	14.12403	13.94206	14.98947	14.67437	13.203	14.71291	9.371721	11.96865	15.47465	0	0	0	14.75323	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.33025	0	0	0	17.60322	0	0	14.3322	0	0	0	0	0	0	0	0
O14827	RGRF2_HUMAN	"Ras-specific guanine nucleotide-releasing factor 2, Ras-GRF2 (Ras guanine nucleotide exchange factor 2)"	RASGRF2 GRF2	Homo sapiens (Human)	long-term synaptic potentiation [GO:0060291]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to endoplasmic reticulum stress [GO:0034976]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085]; long-term synaptic potentiation [GO:0060291]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to endoplasmic reticulum stress [GO:0034976]	calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005516; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0007265; GO:0034976; GO:0035023; GO:0043547; GO:0051056; GO:0060291; GO:2000310	FSSPPPLAVSRTSSPVR	4.929999828	1	1	0.027814471	1784.245324	14.99946	14.16458	0	0	0	0	0	0	0	0	0	16.23359	0	0	0	14.52186	0	0	0	0	0	0	16.75277	0	16.78073	0	0	0	0	0	0	0	0	0	0	0	0	14.56891	0	0	15.34281	15.06284	0	13.06131	14.79854	0	0	0
O14829	PPE1_HUMAN	"Serine/threonine-protein phosphatase with EF-hands 1, PPEF-1, EC 3.1.3.16 (Protein phosphatase with EF calcium-binding domain, PPEF) (Serine/threonine-protein phosphatase 7, PP7)"	PPEF1 PPEF PPP7C	Homo sapiens (Human)	detection of stimulus involved in sensory perception [GO:0050906]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; detection of stimulus involved in sensory perception [GO:0050906]; protein dephosphorylation [GO:0006470]	calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0030145; GO:0050906	VLKQMPNFTHIQTSPSK	5.420000076	1	1	0.230072315	1956.110324	15.3809	16.24891	0	0	0	15.338	0	13.48491	0	0	0	0	0	0	0	14.04748	0	15.6711	0	13.02204	0	0	0	16.22666	0	0	0	15.3012	0	15.3995	0	15.61843	16.68613	15.42631	12.92422	14.67202	13.26053	0	15.24528	0	13.73046	0	12.88416	13.3542	0	15.14105	11.84952	15.96208
O14830	PPE2_HUMAN	"Serine/threonine-protein phosphatase with EF-hands 2, PPEF-2, EC 3.1.3.16"	PPEF2	Homo sapiens (Human)	detection of stimulus involved in sensory perception [GO:0050906]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; protein dephosphorylation [GO:0006470]; regulation of JUN kinase activity [GO:0043506]; regulation of MAP kinase activity [GO:0043405]; visual perception [GO:0007601]	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine phosphatase activity [GO:0004722]; detection of stimulus involved in sensory perception [GO:0050906]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; protein dephosphorylation [GO:0006470]; regulation of JUN kinase activity [GO:0043506]; regulation of MAP kinase activity [GO:0043405]; visual perception [GO:0007601]	calcium ion binding [GO:0005509]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0001750; GO:0001917; GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0007601; GO:0010801; GO:0030145; GO:0030544; GO:0031435; GO:0043405; GO:0043409; GO:0043506; GO:0050906; GO:0051879	DSGCSSPGAH	5.039999962	1	1	0.035858722	971.9613357	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.6579	15.79092	16.64465	0	0	0	0	0	0	0	0	15.34137	0	0	0	13.57458	14.83089	0	0	0	0	0	0	0	0	0	0	0	0	11.53174	0	0	0
O14841	OPLA_HUMAN	"5-oxoprolinase, EC 3.5.2.9 (5-oxo-L-prolinase, 5-OPase) (Pyroglutamase)"	OPLAH	Homo sapiens (Human)	glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]	cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749]	5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802	FMSIAEQMGR	2.529999971	0.487041175	0.487041175	0.204547604	1200.993218	13.60616	14.83504	0	10.67524	14.40523	14.6316	0	13.54871	13.62349	12.31546	0	15.08242	14.62003	10.95295	13.83935	0	0	0	0	0	0	0	0	14.47564	14.09199	0	0	0	14.05352	0	0	0	0	0	0	14.12132	0	0	0	13.58746	0	0	0	0	0	0	0	0
O14896	IRF6_HUMAN	"Interferon regulatory factor 6, IRF-6"	IRF6	Homo sapiens (Human)	"cell development [GO:0048468]; cranial skeletal system development [GO:1904888]; immune system process [GO:0002376]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]"	cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; cranial skeletal system development [GO:1904888]; immune system process [GO:0002376]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0008285; GO:0030054; GO:0030216; GO:0043565; GO:0043616; GO:0045893; GO:0045944; GO:0048468; GO:0060021; GO:0060173; GO:0060644; GO:0070062; GO:1904888; GO:1990837	EFNLMYDGTKEVPMNPVK	4.139999866	1	1	0.122324911	2129.107654	16.26299	15.55081	12.44605	14.77227	17.13879	0	14.51726	0	12.65894	14.58414	12.95522	16.20637	0	10.5372	0	0	13.84539	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14908	GIPC1_HUMAN	"PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2, TIP-2)"	GIPC1 C19orf3 GIPC RGS19IP1	Homo sapiens (Human)	cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]	GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005938; GO:0006605; GO:0007186; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0045296; GO:0048023; GO:0048167; GO:0070062; GO:0098685; GO:0098761; GO:0098978; GO:2000300	LTEPR	14.89999962	0.654231608	0.654231608	0.216719528	615.0803111	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.80651	0	0	0	0	0	0	0	0	0	0	18.37616	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14910	LIN7A_HUMAN	"Protein lin-7 homolog A, Lin-7A, hLin-7 (Mammalian lin-seven protein 1, MALS-1) (Tax interaction protein 33, TIP-33) (Vertebrate lin-7 homolog 1, Veli-1)"	LIN7A MALS1 VELI1	Homo sapiens (Human)	exocytosis [GO:0006887]; inner ear development [GO:0048839]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; synaptic vesicle transport [GO:0048489]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; exocytosis [GO:0006887]; inner ear development [GO:0048839]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; synaptic vesicle transport [GO:0048489]	L27 domain binding [GO:0097016]	GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0015031; GO:0016323; GO:0045199; GO:0045202; GO:0048489; GO:0048839; GO:0065003; GO:0070062; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361	IIPGGVAER	8.06000042	1	1	0.224099153	912.6255108	0	0	0	0	0	0	0	0	0	0	0	0	0	17.90226	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59542	0	0	0	0	0	0	0	0	17.58788	0	0	0	0	0	0	16.22359	0	18.25943	0	0
O14917	PCD17_HUMAN	Protocadherin-17 (Protocadherin-68)	PCDH17 PCDH68 PCH68	Homo sapiens (Human)	adult behavior [GO:0030534]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of synaptic transmission [GO:0050805]; presynaptic active zone assembly [GO:1904071]; regulation of synaptic vesicle clustering [GO:2000807]; synaptic membrane adhesion [GO:0099560]	GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]	GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; calcium ion binding [GO:0005509]; adult behavior [GO:0030534]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of synaptic transmission [GO:0050805]; presynaptic active zone assembly [GO:1904071]; regulation of synaptic vesicle clustering [GO:2000807]; synaptic membrane adhesion [GO:0099560]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030534; GO:0050805; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099560; GO:1904071; GO:2000807	ASRDSSEMGAVLEQLDHPNR	14.05000019	1	1	0.354164998	2211.12417	10.88674	0	0	18.32255	16.45782	19.17301	19.76255	20.59349	19.91846	18.1769	20.32371	19.80395	0	0	20.26183	18.50306	21.24216	18.75481	17.75026	0	0	0	20.68916	0	21.43045	20.36026	20.88712	18.83979	20.45561	20.07924	0	20.20408	20.39018	0	0	22.13761	20.96746	20.4252	0	20.47426	18.51792	0	0	0	0	18.33467	0	0
O14921	RGS13_HUMAN	"Regulator of G-protein signaling 13, RGS13"	RGS13	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]	GTPase activity [GO:0003924]	GO:0003924; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0045744	EINIDSSTR	17.28000069	1	1	0.042667301	1034.231583	0	0	0	0	0	15.34278	15.10433	0	0	0	0	16.28046	15.14887	15.52357	0	13.77986	12.96741	0	16.00449	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.4748	0	0	0	16.11532	0	0	0	0	16.59417	0	0	0
O14924	RGS12_HUMAN	"Regulator of G-protein signaling 12, RGS12"	RGS12	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase regulator activity [GO:0030695]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase regulator activity [GO:0030695]	GO:0000794; GO:0003924; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0016363; GO:0030425; GO:0030695; GO:0045202	APHPDMFKEQQLQIFNLMK	9.539999962	0.020274824	0.020274824	0.484114545	2315.94414	16.49572	0	19.91901	0	0	0	20.11088	17.55173	0	0	0	17.33463	16.93879	0	17.14439	16.99377	0	0	17.25721	19.02551	18.67926	18.85091	0	0	19.54158	20.15842	19.32041	19.32259	0	0	0	0	19.88191	18.61206	18.69757	17.14006	0	19.46862	0	18.41794	0	0	0	19.61601	18.34893	0	0	0
O14925	TIM23_HUMAN	Mitochondrial import inner membrane translocase subunit Tim23	TIMM23 TIM23	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; protein transmembrane transporter activity [GO:0008320]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	protein transmembrane transporter activity [GO:0008320]	GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0006626; GO:0006886; GO:0008320; GO:0030150; GO:0031305	NVQILNMVTR	3.380000114	0.093565606	0.093565606	0.070969175	1200.764682	12.5419	11.1987	0	15.21565	0	10.97824	14.74106	0	0	0	13.31653	12.64579	10.66948	0	11.39995	0	0	16.38823	16.38382	0	0	12.79117	14.91397	0	0	0	0	15.68367	0	13.05015	0	15.71258	0	0	16.08694	0	15.05304	13.95735	0	16.44361	0	16.35133	11.59984	0	0	12.65922	14.92057	16.1786
O14926	FSCN2_HUMAN	Fascin-2 (Retinal fascin)	FSCN2	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; anatomical structure morphogenesis [GO:0009653]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; visual perception [GO:0007601]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; anatomical structure morphogenesis [GO:0009653]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; visual perception [GO:0007601]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003779; GO:0005737; GO:0007163; GO:0007601; GO:0009653; GO:0015629; GO:0016477; GO:0030036; GO:0030674; GO:0032420; GO:0042462; GO:0051015; GO:0051017	ASNGRYVCMK	2.420000076	1	1	0.218781327	1202.288189	16.08325	0	13.03569	0	0	0	0	0	0	0	0	0	0	0	0	0	14.5743	0	0	0	0	0	0	0	16.3052	0	0	0	0	0	0	0	0	0	0	15.14756	0	0	14.85294	0	15.78922	0	0	14.68018	0	13.87926	0	0
O14929	HAT1_HUMAN	"Histone acetyltransferase type B catalytic subunit, EC 2.3.1.48 (Histone acetyltransferase 1)"	HAT1 KAT1	Homo sapiens (Human)	DNA packaging [GO:0006323]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; subtelomeric heterochromatin assembly [GO:0031509]	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; DNA packaging [GO:0006323]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; subtelomeric heterochromatin assembly [GO:0031509]"	H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]	GO:0000781; GO:0000785; GO:0004402; GO:0005634; GO:0005654; GO:0005739; GO:0006323; GO:0006335; GO:0006336; GO:0006475; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043967	VSQMLILTPFQGQGHGAQLLETVHR	3.690000057	0.234249353	0.234249353	0.02951509	2760.515345	0	0	15.6603	0	0	3.899829	0	0	9.664045	14.27759	14.87811	0	0	12.40782	0	0	0	12.38828	15.24099	15.15021	0	0	15.02537	0	0	16.72958	16.67783	15.06266	16.29073	16.32037	0	18.32627	0	0	0	0	12.69567	0	0	0	0	0	0	0	13.73225	0	0	0
O14936	CSKP_HUMAN	"Peripheral plasma membrane protein CASK, hCASK, EC 2.7.11.1 (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog)"	CASK LIN2	Homo sapiens (Human)	calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; cellular protein localization [GO:0034613]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300]	actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor binding [GO:0005102]; calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; cellular protein localization [GO:0034613]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor binding [GO:0005102]	GO:0001953; GO:0004385; GO:0004674; GO:0004712; GO:0005102; GO:0005516; GO:0005524; GO:0005604; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007155; GO:0010839; GO:0015629; GO:0016323; GO:0016363; GO:0031982; GO:0034613; GO:0042043; GO:0042734; GO:0045944; GO:0046928; GO:0060170; GO:0061045; GO:0070509; GO:0090280; GO:0090288; GO:0098685; GO:0106310; GO:2000300	ERLFEGIIK	2.400000095	1	1	0.194832464	1105.558741	14.2783	0	0	15.97521	14.27017	0	14.3917	15.16362	0	14.7087	0	14.80795	0	14.2647	11.62375	15.52733	0	0	0	0	0	15.09226	0	0	0	15.00028	0	0	0	15.59512	0	0	16.01253	16.33894	0	0	0	0	15.99061	0	0	0	0	0	0	0	0	0
O14939	PLD2_HUMAN	"Phospholipase D2, PLD 2, hPLD2, EC 3.1.4.4 (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2)"	PLD2	Homo sapiens (Human)	cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle recycling [GO:0036465]	endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol lipid-mediated signaling [GO:0048017]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle recycling [GO:0036465]	N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]	GO:0004630; GO:0005789; GO:0005886; GO:0006654; GO:0007010; GO:0007264; GO:0016042; GO:0035091; GO:0036465; GO:0038096; GO:0048017; GO:0048870; GO:0070290; GO:0098793	AAMGTAWR	2.180000067	1	1	0.093757388	862.2904007	15.98605	14.15337	11.35537	0	0	0	0	0	0	0	0	0	0	0	0	15.56886	16.27518	0	0	0	0	0	0	0	0	15.20647	0	0	0	0	0	0	0	13.69475	0	0	0	0	0	0	0	0	0	0	0	0	14.92425	0
O14948	TFEC_HUMAN	"Transcription factor EC, TFE-C (Class E basic helix-loop-helix protein 34, bHLHe34) (Transcription factor EC-like, hTFEC-L)"	TFEC BHLHE34 TCFEC TFECL	Homo sapiens (Human)	cellular response to heat [GO:0034605]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to heat [GO:0034605]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0034605; GO:0045944; GO:0046983; GO:1990837	EITETDTR	7.260000229	1	1	1.03E-12	964.2315849	13.09254	15.1013	0	15.4388	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.56267	13.5759	0	0	17.50735	0	0	15.54272	15.34091	0	0	13.8638	0	0	0	0
O14957	QCR10_HUMAN	Cytochrome b-c1 complex subunit 10 (Complex III subunit 10) (Complex III subunit XI) (Ubiquinol-cytochrome c reductase complex 6.4 kDa protein)	UQCR11 UQCR	Homo sapiens (Human)	"cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; electron transfer activity [GO:0009055]; cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	electron transfer activity [GO:0009055]	GO:0005743; GO:0005750; GO:0006091; GO:0006122; GO:0009055; GO:0045333	MVTRFLGPR	3.279999971	1	1	4.63E-13	1093.155717	0	0	0	0	0	4.575037	12.90581	0	0	0	0	0	14.06187	0	0	0	0	16.82352	0	0	0	0	0	0	0	0	13.46387	0	0	0	0	0	0	14.87165	17.90262	0	0	0	0	0	0	0	0	0	0	0	13.83382	0
O14960	LECT2_HUMAN	"Leukocyte cell-derived chemotaxin-2, LECT-2, hLECT2"	LECT2	Homo sapiens (Human)	chemotaxis [GO:0006935]; skeletal system development [GO:0001501]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chemotaxis [GO:0006935]; skeletal system development [GO:0001501]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0001501; GO:0005615; GO:0005737; GO:0005829; GO:0006935; GO:0042802; GO:0043231; GO:0046872	NAINNGVR	6.619999886	1	1	0.452866276	856.6188684	0	14.68327	0	15.18509	0	0	16.60981	15.36063	15.34437	0	0	16.14972	16.06203	0	14.93557	14.92962	14.53424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.86082	0	0	0	0	0	0	16.97565	0	0
O14964	HGS_HUMAN	Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110)	HGS HRS	Homo sapiens (Human)	endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; phagocytic vesicle lumen [GO:0097013]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; phagocytic vesicle lumen [GO:0097013]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165]	metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0008285; GO:0010324; GO:0010628; GO:0010642; GO:0016197; GO:0016236; GO:0016525; GO:0019904; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0035091; GO:0036258; GO:0042176; GO:0043130; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0070062; GO:0072657; GO:0097013; GO:1903543	STYTSYPK	1.309999943	1	1	0.252377529	948.3771145	15.23027	13.44882	0	14.84537	0	15.29695	0	17.11102	0	0	0	0	16.30099	15.07889	14.21327	15.86897	15.84552	0	15.68757	0	0	15.03126	0	0	17.15466	0	15.96174	16.08163	0	15.94398	0	16.01071	15.18957	11.3169	12.17071	15.22404	16.4504	14.86102	0	15.66552	15.90314	10.11611	15.45657	15.26217	15.73357	15.59859	15.40114	14.85431
O14965	AURKA_HUMAN	"Aurora kinase A, EC 2.7.11.1 (Aurora 2) (Aurora/IPL1-related kinase 1, ARK-1, Aurora-related kinase 1, hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)"	AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6	Homo sapiens (Human)	anterior/posterior axis specification [GO:0009948]; cell division [GO:0051301]; centrosome localization [GO:0051642]; G2/M transition of mitotic cell cycle [GO:0000086]; liver regeneration [GO:0097421]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autophosphorylation [GO:0046777]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]	axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cilium [GO:0005929]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]	axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cilium [GO:0005929]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; anterior/posterior axis specification [GO:0009948]; cell division [GO:0051301]; centrosome localization [GO:0051642]; G2/M transition of mitotic cell cycle [GO:0000086]; liver regeneration [GO:0097421]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autophosphorylation [GO:0046777]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]	ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]	GO:0000086; GO:0000278; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005929; GO:0006468; GO:0007051; GO:0007052; GO:0007057; GO:0007100; GO:0009611; GO:0009948; GO:0010389; GO:0010629; GO:0015630; GO:0018105; GO:0019901; GO:0030496; GO:0031616; GO:0031625; GO:0031647; GO:0032091; GO:0032133; GO:0032436; GO:0032465; GO:0035174; GO:0042585; GO:0043066; GO:0043203; GO:0045120; GO:0045840; GO:0046605; GO:0046777; GO:0046982; GO:0048471; GO:0051233; GO:0051301; GO:0051642; GO:0071539; GO:0072686; GO:0072687; GO:0090141; GO:0097421; GO:0097431; GO:0106310; GO:1900195; GO:1901796; GO:1990138	DIKPENLLLGSAGELK	34.79999924	1	1	0.512305827	1697.662726	0	0	0	17.91612	0	0	0	0	18.88985	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.93819	0	0	0	0	0	0	0	0	0	17.24558	0	0	16.84555	0	0	17.12123
O14966	RAB7L_HUMAN	Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29)	RAB29 RAB7L1	Homo sapiens (Human)	"cell differentiation [GO:0030154]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; toxin transport [GO:1901998]; viral RNA genome replication [GO:0039694]"	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]	"cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267]; cell differentiation [GO:0030154]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; toxin transport [GO:1901998]; viral RNA genome replication [GO:0039694]"	dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267]	GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0032438; GO:0039694; GO:0042110; GO:0042147; GO:0042470; GO:0043231; GO:0048471; GO:0050862; GO:0055037; GO:0070062; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1901214; GO:1901998; GO:1903441; GO:1905279	ENKNINEAMR	6.829999924	1	1	0.085899029	1220.147281	14.75628	15.47869	14.91887	15.64879	15.02307	0	0	0	0	0	0	0	0	0	15.408	0	0	0	0	0	15.94353	15.52726	14.07133	12.17444	0	0	0	16.41058	0	0	0	0	0	0	0	0	15.73563	0	16.88921	15.56017	0	13.38006	0	0	0	0	0	15.11903
O14974	MYPT1_HUMAN	"Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1, Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit)"	PPP1R12A MBS MYPT1	Homo sapiens (Human)	cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165]	A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]	A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165]	14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000776; GO:0004857; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0006470; GO:0007098; GO:0007165; GO:0015629; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0035508; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0071466; GO:0071889; GO:0072357	EKDTAGVTR	4.130000114	0.44173345	0.44173345	0.217894376	975.8763651	17.14133	13.61846	0	0	16.44738	0	0	0	0	0	13.68057	0	0	15.37753	0	0	0	0	15.8537	0	0	0	15.92643	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97719	13.30627	0	0	0	0	0	0	0
O14976	GAK_HUMAN	"Cyclin-G-associated kinase, EC 2.7.11.1"	GAK	Homo sapiens (Human)	cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006898; GO:0007029; GO:0007030; GO:0007049; GO:0010977; GO:0016020; GO:0016191; GO:0030276; GO:0030332; GO:0031982; GO:0034067; GO:0043231; GO:0048471; GO:0051085; GO:0051087; GO:0072318; GO:0072583; GO:0072659; GO:0090160; GO:0098793; GO:0106310; GO:1905224	TATTPK	2.589999914	1	1	0.168018063	620.9217237	15.86209	16.65461	15.54191	0	15.03029	14.7343	12.5148	0	15.62308	0	0	0	0	15.77511	16.12083	0	16.43155	0	16.21894	0	0	0	0	0	0	0	15.19322	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.2859	0	0	0	0	0
O14978	ZN263_HUMAN	Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12)	ZNF263 FPM315 ZKSCAN12	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0045944; GO:0046872; GO:1990837	IHAAER	13.01000023	0.399743289	0.399743289	0.18401473	696.4345212	20.40657	18.3521	19.86172	0	19.25328	18.36985	19.13587	18.14535	18.22901	0	17.16292	18.85079	19.65932	18.42689	18.95686	19.09647	19.8549	17.61267	19.61818	19.74513	17.42346	18.27812	18.1022	18.58487	18.92864	15.25349	18.87081	19.3871	19.03584	17.89489	19.69256	18.99056	0	19.47423	18.35062	19.21671	19.89932	19.00194	19.39216	20.10649	16.53679	20.42799	20.22455	19.77448	18.58436	20.16913	19.34588	19.51196
O14979	HNRDL_HUMAN	"Heterogeneous nuclear ribonucleoprotein D-like, hnRNP D-like, hnRNP DL (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1)"	HNRNPDL HNRPDL JKTBP	Homo sapiens (Human)	regulation of gene expression [GO:0010468]; RNA processing [GO:0006396]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; regulation of gene expression [GO:0010468]; RNA processing [GO:0006396]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0003677; GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008143; GO:0010468; GO:0034046	SLSHWRPRPPRQLAPLLPSLAPSSAR	3.24000001	1	1	2.75E-12	2891.125458	0	0	0	0	15.72757	15.44383	0	0	14.34873	17.60121	0	13.32297	0	0	0	0	0	13.13057	14.27686	0	0	0	0	0	0	16.157	0	0	0	0	0	15.71152	0	0	0	0	14.34612	0	0	12.06478	14.13484	0	0	10.60455	10.65926	0	0	11.10069
O14980	XPO1_HUMAN	"Exportin-1, Exp1 (Chromosome region maintenance 1 protein homolog)"	XPO1 CRM1	Homo sapiens (Human)	mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]	nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	GO:0000054; GO:0000055; GO:0000056; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0010824; GO:0015030; GO:0016020; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0043231; GO:0046825; GO:0051028; GO:1990904	DPETVKQLGSILK	3.25	1	1	0.138893067	1428.058834	14.95856	0	0	15.79084	0	14.17459	14.25481	0	13.57927	15.01702	0	14.92146	0	9.718562	14.65279	0	0	14.2914	0	0	0	0	0	0	0	0	0	0	0	0	15.02999	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14981	BTAF1_HUMAN	"TATA-binding protein-associated factor 172, EC 3.6.4.- (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172, TAF-172)"	BTAF1 TAF172	Homo sapiens (Human)	"negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TBP-class protein binding [GO:0017025]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TBP-class protein binding [GO:0017025]; transcription coregulator activity [GO:0003712]"	GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0016887; GO:0017025; GO:0035562; GO:0043231; GO:0045892; GO:0140658	ADTSTSGKASMK	1.870000005	1	1	0.022613207	1184.002488	13.90174	12.67956	11.63376	0	0	0	0	0	11.96711	0	0	0	0	0	0	0	0	0	0	15.16772	0	0	12.74799	0	14.64874	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O14983	AT2A1_HUMAN	"Sarcoplasmic/endoplasmic reticulum calcium ATPase 1, SERCA1, SR Ca(2+)-ATPase 1, EC 7.2.2.10 (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)"	ATP2A1	Homo sapiens (Human)	apoptotic mitochondrial changes [GO:0008637]; calcium ion import [GO:0070509]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; maintenance of mitochondrion location [GO:0051659]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of calcium ion import into sarcoplasmic reticulum [GO:1902082]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cardiac conduction [GO:1903779]; regulation of striated muscle contraction [GO:0006942]; relaxation of skeletal muscle [GO:0090076]; response to endoplasmic reticulum stress [GO:0034976]	calcium channel complex [GO:0034704]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]	calcium channel complex [GO:0034704]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium-dependent ATPase activity [GO:0030899]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; protein homodimerization activity [GO:0042803]; apoptotic mitochondrial changes [GO:0008637]; calcium ion import [GO:0070509]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; maintenance of mitochondrion location [GO:0051659]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of calcium ion import into sarcoplasmic reticulum [GO:1902082]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cardiac conduction [GO:1903779]; regulation of striated muscle contraction [GO:0006942]; relaxation of skeletal muscle [GO:0090076]; response to endoplasmic reticulum stress [GO:0034976]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium-dependent ATPase activity [GO:0030899]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; protein homodimerization activity [GO:0042803]	GO:0005388; GO:0005509; GO:0005524; GO:0005739; GO:0005789; GO:0005793; GO:0006816; GO:0006874; GO:0006942; GO:0008637; GO:0015662; GO:0016020; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031095; GO:0031448; GO:0031673; GO:0031674; GO:0032470; GO:0032471; GO:0033017; GO:0034220; GO:0034704; GO:0034976; GO:0042803; GO:0045988; GO:0048471; GO:0051561; GO:0051659; GO:0070059; GO:0070509; GO:0070588; GO:0090076; GO:0106134; GO:1901896; GO:1902082; GO:1903779; GO:1990036	KAEIGIAMGSGTAVAK	5.150000095	1	1	0.120978252	1519.148598	0	0	0	0	0	0	0	0	0	0	0	15.19678	0	0	0	0	0	0	0	17.06404	0	0	0	0	0	15.01392	15.12673	0	16.49026	0	0	0	0	0	14.67861	0	0	15.70406	0	0	0	0	0	0	0	0	0	0
O14986	PI51B_HUMAN	"Phosphatidylinositol 4-phosphate 5-kinase type-1 beta, PIP5K1-beta, PtdIns(4)P-5-kinase 1 beta, EC 2.7.1.68 (Phosphatidylinositol 4-phosphate 5-kinase type I beta, PIP5KIbeta) (Protein STM-7) (Type I phosphatidylinositol 4-phosphate 5-kinase beta)"	PIP5K1B STM7	Homo sapiens (Human)	phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; uropod [GO:0001931]	"cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; uropod [GO:0001931]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]"	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]"	GO:0000285; GO:0001931; GO:0005524; GO:0005829; GO:0005886; GO:0006661; GO:0012505; GO:0014066; GO:0016308; GO:0046854; GO:0052810; GO:0052812	IVVMNNVLPRSMR	12.01000023	0.110251285	0.110251285	0.20589355	1547.270294	0	0	0	13.90166	0	0	0	18.05929	0	16.71516	13.66895	0	0	0	13.43253	0	0	13.67882	15.211	19.43177	16.21918	16.29898	14.81477	15.30824	0	0	15.59681	0	0	0	10.30793	0	0	17.36542	0	0	0	0	0	9.865146	0	17.93587	0	0	0	17.0595	0	0
O15013	ARHGA_HUMAN	Rho guanine nucleotide exchange factor 10	ARHGEF10 KIAA0294	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	centrosome [GO:0005813]; cytosol [GO:0005829]	centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]	GO:0005085; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051056; GO:0051298; GO:0051496; GO:0090307; GO:0090630	HPLLVGHMPVMVAKQQEFK	8.590000153	1	1	0.152183957	2220.1944	0	13.76626	17.82461	0	0	13.12868	0	0	14.76188	0	0	15.40718	0	0	0	12.24699	0	0	12.88645	13.65037	0	13.16159	15.47832	15.30047	13.67518	0	0	12.38763	0	10.3813	0	11.29455	0	0	0	0	16.35453	0	0	0	12.35139	0	0	0	0	0	0	0
O15014	ZN609_HUMAN	Zinc finger protein 609	ZNF609 KIAA0295	Homo sapiens (Human)	muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]	GO:0005634; GO:0005654; GO:0006357; GO:0007517; GO:0045944; GO:0046872; GO:1990841; GO:2000291; GO:2001224	ASPSVTCK	6.349999905	0.511219859	0.511219859	0.182614883	851.3584333	15.82966	0	14.85908	15.72448	0	0	0	0	0	0	16.03522	0	0	0	0	0	0	15.36615	0	0	15.54871	0	16.95463	0	16.6934	0	0	15.96716	15.74632	15.09403	16.804	0	0	15.58932	0	16.16356	16.02058	14.11458	15.50374	15.08449	0	16.40375	0	14.78451	0	15.4313	14.78425	16.45681
O15015	ZN646_HUMAN	Zinc finger protein 646	ZNF646 KIAA0296	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	EHEETER	2.640000105	1	1	0.270265354	928.4282214	13.30274	14.52949	15.34029	14.45771	0	0	13.8896	0	0	16.15674	16.34854	0	0	15.90684	0	16.55661	15.93313	0	0	13.68897	16.10879	15.13974	0	17.35242	15.96324	15.91466	0	0	0	15.42731	16.63506	13.65837	15.86932	0	16.30872	15.63881	17.55323	15.40808	16.57233	16.63441	16.51008	14.75688	15.55987	0	16.8587	15.9707	16.18678	16.02841
O15018	PDZD2_HUMAN	PDZ domain-containing protein 2 (Activated in prostate cancer protein) (PDZ domain-containing protein 3) [Cleaved into: Processed PDZ domain-containing protein 2 ]	PDZD2 AIPC KIAA0300 PDZK3	Homo sapiens (Human)	cell adhesion [GO:0007155]	cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]		GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0007155; GO:0034451; GO:0043231	ACPGGSGPK	5.539999962	1	1	0.029477763	831.5636052	13.80496	0	15.1474	0	0	0	0	0	0	0	0	0	0	0	0	17.1222	0	0	0	0	13.64785	0	0	0	15.61387	0	0	14.78735	0	12.11372	0	0	15.10912	16.61201	14.45176	0	0	0	0	0	0	14.94328	17.70645	0	0	0	0	16.33514
O15020	SPTN2_HUMAN	"Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)"	SPTBN2 KIAA0302 SCA5	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192]	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091]	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of synapse [GO:0098918]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of synapse [GO:0098918]	GO:0003779; GO:0005200; GO:0005543; GO:0005615; GO:0005829; GO:0005886; GO:0007416; GO:0008091; GO:0016192; GO:0016324; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099173; GO:0099189	ALCQPMR	14.36999989	0.730427384	0.730427384	0.140485877	890.8383907	16.5076	14.78015	15.3996	0	0	0	18.1994	16.98863	18.18948	16.67043	13.74938	16.30929	16.35932	15.10673	17.39946	15.12089	14.76381	14.03816	15.14897	14.70478	15.57601	15.57785	14.591	13.57064	0	17.19437	0	0	16.48693	0	0	13.65349	17.69286	11.69011	0	18.01721	15.32862	17.30468	17.00177	12.21515	15.55137	15.93284	17.19277	0	0	17.45574	14.80062	17.63492
O15021	MAST4_HUMAN	"Microtubule-associated serine/threonine-protein kinase 4, EC 2.7.11.1"	MAST4 KIAA0303	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0007010; GO:0018105; GO:0035556; GO:0106310	AQPAGEGR	8.170000076	0.040305883	0.040305883	0.171780885	784.5151274	19.27306	19.56392	18.66077	17.55964	18.94114	19.53731	0	19.84323	18.04117	18.43475	18.87459	17.26574	18.08271	18.65037	17.86458	19.75242	17.99412	19.3357	17.15805	17.15957	16.66817	18.69809	18.04125	18.38049	17.88286	17.39596	19.31505	18.4717	17.964	17.64349	18.37429	19.84427	19.38721	19.66305	17.78342	17.97412	18.89061	17.09105	18.35793	19.86039	19.34194	17.5828	19.30997	18.44151	16.89219	19.483	19.13194	19.76852
O15031	PLXB2_HUMAN	Plexin-B2 (MM1)	PLXNB2 KIAA0315	Homo sapiens (Human)	brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	semaphorin receptor activity [GO:0017154]	GO:0001843; GO:0001932; GO:0002116; GO:0005887; GO:0007156; GO:0007162; GO:0007405; GO:0007420; GO:0008360; GO:0009986; GO:0010976; GO:0017154; GO:0030334; GO:0043087; GO:0045727; GO:0050772; GO:0070062; GO:0071526; GO:1902287; GO:1904861; GO:2001222	LDFFR	9.920000076	1	1	0.006557438	697.4862361	16.5322	0	13.62463	0	0	0	0	15.80293	0	16.16179	0	0	0	15.48138	14.08938	14.54604	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.61618	0	0	0	14.67797	0	0	0
O15033	AREL1_HUMAN	"Apoptosis-resistant E3 ubiquitin protein ligase 1, EC 2.3.2.26 (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1)"	AREL1 KIAA0317	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0043161; GO:0045732; GO:0050727; GO:0061630; GO:0070979; GO:1990390	NILAATFIR	31.51000023	0.5119735	0.5119735	0.192709528	1018.817472	0	23.25633	23.23368	22.9516	23.42415	0	23.67563	23.63641	23.07737	23.52547	23.41607	23.5331	0	23.21442	23.9377	0	22.79897	23.1791	23.69203	23.57753	22.87979	0	22.62503	0	23.4627	22.77835	22.90751	22.66498	23.33383	23.87338	22.43918	22.95996	22.85394	0	23.49371	22.70958	23.24325	21.5121	22.94946	23.2932	23.33856	0	0	0	23.08609	23.3912	21.85838	23.57824
O15034	RIMB2_HUMAN	"RIMS-binding protein 2, RIM-BP2"	RIMBP2 KIAA0318 RBP2	Homo sapiens (Human)	neuromuscular synaptic transmission [GO:0007274]	plasma membrane [GO:0005886]; synapse [GO:0045202]	plasma membrane [GO:0005886]; synapse [GO:0045202]; neuromuscular synaptic transmission [GO:0007274]		GO:0005886; GO:0007274; GO:0045202	ILPQPQGTPVSTTVAKAMAR	4.190000057	1	1	0.173185559	2082.695074	14.43005	14.77633	0	14.01116	0	14.62606	0	11.67782	14.76643	0	0	15.2964	13.4635	13.6925	0	13.53814	13.76298	11.51079	0	17.91681	0	14.53131	0	12.81088	15.19551	15.22981	15.46284	0	0	14.09722	16.23503	0	0	0	0	0	12.81429	0	0	14.86756	0	0	0	0	0	0	0	0
O15037	KHNYN_HUMAN	Protein KHNYN (KH and NYN domain-containing protein)	KHNYN KIAA0323	Homo sapiens (Human)	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]	"cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729]	GO:0003729; GO:0004521; GO:0005634; GO:0036464; GO:0090502	EVALRPQSVGGGARESAPLK	3.480000019	1	1	0.282409054	2022.08197	14.87389	0	14.50207	10.92695	0	0	13.00785	13.40366	0	0	0	12.88212	0	0	0	13.27262	0	12.93414	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15040	TCPR2_HUMAN	Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297)	TECPR2 KIAA0297 KIAA0329	Homo sapiens (Human)	autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527]		GO:0005737; GO:0006914; GO:0032527	GSQPLSQR	8.550000191	0.492681742	0.492681742	0.201739662	872.8759932	18.5183	15.9908	16.09661	14.21253	17.99004	15.65198	17.26524	13.81575	17.52423	0	17.44747	16.4316	0	12.93354	0	0	0	15.96965	17.44318	15.48891	0	0	18.2934	16.28062	17.03501	16.00528	17.14004	0	17.20849	14.19515	18.9902	16.22195	0	17.9989	0	0	18.07921	0	0	16.18612	0	0	0	17.05047	0	16.62501	15.76596	17.79618
O15042	SR140_HUMAN	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2SURP KIAA0332 SR140	Homo sapiens (Human)	RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006396	EINNPMFR	6.079999924	1	1	0.118428506	1037.206678	0	0	15.369	0	15.41006	14.22077	0	0	0	16.026	18.44481	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.93234	0	0	0	0	0	0	0	0	0
O15047	SET1A_HUMAN	"Histone-lysine N-methyltransferase SETD1A, EC 2.1.1.364 (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A, hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1)"	SETD1A KIAA0339 KMT2F SET1 SET1A	Homo sapiens (Human)	brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; regulation of chromatin organization [GO:1902275]; regulation of hematopoietic stem cell differentiation [GO:1902036]	chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; regulation of chromatin organization [GO:1902275]; regulation of hematopoietic stem cell differentiation [GO:1902036]	beta-catenin binding [GO:0008013]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]	GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006974; GO:0007420; GO:0008013; GO:0016607; GO:0035097; GO:0042800; GO:0044648; GO:0048188; GO:0051568; GO:0061629; GO:0080182; GO:0097692; GO:1902036; GO:1902275	APRGVER	3.339999914	1	1	6.89E-13	782.0435031	0	13.00056	14.01831	0	0	12.45655	15.59822	14.04156	15.27261	0	11.28421	15.26782	0	14.16477	0	0	14.567	11.76493	17.02891	0	0	0	0	16.16926	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15049	N4BP3_HUMAN	"NEDD4-binding protein 3, N4BP3"	N4BP3 KIAA0341	Homo sapiens (Human)	nervous system development [GO:0007399]	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; nervous system development [GO:0007399]		GO:0007399; GO:0030424; GO:0030425; GO:0031410	LHEVTQKAER	1.919999957	0.341590196	0.341590196	0.054564111	1209.869893	0	13.01036	0	0	0	0	11.14948	18.02109	10.14704	0	0	0	0	0	13.03833	17.07924	13.01895	0	14.10064	0	0	0	0	0	0	15.69526	16.1969	0	14.57776	0	15.14713	0	0	14.43515	0	0	15.38099	0	0	0	0	0	0	0	0	0	0	11.16306
O15050	TRNK1_HUMAN	TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)	TRANK1 KIAA0342 LBA1	Homo sapiens (Human)						EGKDAR	4.090000153	1	1	0.187820609	674.7317765	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.85184	0	0	0	0	0	0	0	0	0	0	0	0	0	15.39633	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15054	KDM6B_HUMAN	"Lysine-specific demethylase 6B, EC 1.14.11.68 (JmjC domain-containing protein 3) (Jumonji domain-containing protein 3) (Lysine demethylase 6B) ([histone H3]-trimethyl-L-lysine(27) demethylase 6B)"	KDM6B JMJD3 KIAA0346	Homo sapiens (Human)	cardiac muscle cell differentiation [GO:0055007]; cell fate commitment [GO:0045165]; cellular response to hydrogen peroxide [GO:0070301]; chromatin remodeling [GO:0006338]; endothelial cell differentiation [GO:0045446]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; inflammatory response [GO:0006954]; mesodermal cell differentiation [GO:0048333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cardiac muscle cell differentiation [GO:0055007]; cell fate commitment [GO:0045165]; cellular response to hydrogen peroxide [GO:0070301]; chromatin remodeling [GO:0006338]; endothelial cell differentiation [GO:0045446]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; inflammatory response [GO:0006954]; mesodermal cell differentiation [GO:0048333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0006954; GO:0007507; GO:0008013; GO:0010468; GO:0031490; GO:0032452; GO:0044666; GO:0045165; GO:0045446; GO:0045944; GO:0046872; GO:0048333; GO:0055007; GO:0070301; GO:0071557; GO:0071558; GO:0120162	NHHIIK	5.289999962	1	1	0.272921502	762.7751207	12.66769	13.86113	15.58907	15.75794	0	0	0	0	17.25142	14.85414	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.741	0	0	0	0	0	0	0	0	0	15.53057	0	0	0	0	0	0	0
O15055	PER2_HUMAN	"Period circadian protein homolog 2, hPER2 (Circadian clock protein PERIOD 2)"	PER2 KIAA0347	Homo sapiens (Human)	"circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; fatty acid metabolic process [GO:0006631]; gluconeogenesis [GO:0006094]; glycogen biosynthetic process [GO:0005978]; histone H3 deacetylation [GO:0070932]; lactate biosynthetic process [GO:0019249]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of vasoconstriction [GO:0019229]; response to ischemia [GO:0002931]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; fatty acid metabolic process [GO:0006631]; gluconeogenesis [GO:0006094]; glycogen biosynthetic process [GO:0005978]; histone H3 deacetylation [GO:0070932]; lactate biosynthetic process [GO:0019249]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of vasoconstriction [GO:0019229]; response to ischemia [GO:0002931]; white fat cell differentiation [GO:0050872]"	transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222]	GO:0000122; GO:0000976; GO:0001222; GO:0002931; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005978; GO:0006094; GO:0006631; GO:0007623; GO:0019229; GO:0019249; GO:0031397; GO:0032922; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0048471; GO:0050767; GO:0050796; GO:0050872; GO:0051726; GO:0051946; GO:0070345; GO:0070932; GO:0097167; GO:0120162; GO:2000678	ATPPSAMGR	3.119999886	1	1	0.064158556	899.7276193	13.00663	15.52344	13.6516	0	12.85944	16.70265	14.08972	14.43258	14.90637	0	16.34136	0	16.36598	0	0	12.63015	0	14.92491	0	16.45518	0	0	0	0	0	0	0	15.10969	0	15.0587	17.2086	0	0	0	0	0	0	0	0	0	15.03738	0	14.48347	0	0	0	0	0
O15061	SYNEM_HUMAN	Synemin (Desmuslin)	SYNM DMN KIAA0353 SYN	Homo sapiens (Human)	fast-twitch skeletal muscle fiber contraction [GO:0031443]; intermediate filament cytoskeleton organization [GO:0045104]	adherens junction [GO:0005912]; costamere [GO:0043034]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neurofilament cytoskeleton [GO:0060053]; sarcolemma [GO:0042383]	adherens junction [GO:0005912]; costamere [GO:0043034]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neurofilament cytoskeleton [GO:0060053]; sarcolemma [GO:0042383]; intermediate filament binding [GO:0019215]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; fast-twitch skeletal muscle fiber contraction [GO:0031443]; intermediate filament cytoskeleton organization [GO:0045104]	intermediate filament binding [GO:0019215]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]	GO:0005200; GO:0005882; GO:0005912; GO:0008307; GO:0017166; GO:0019215; GO:0031443; GO:0042383; GO:0043034; GO:0045104; GO:0045111; GO:0060053	ATLTLAMADWLR	6.860000134	0.951217413	0.951217413	0.169832797	1377.830335	13.42498	15.56323	15.42476	0	12.6244	13.03525	13.92643	0	14.75829	15.59452	0	0	13.82122	13.54655	14.48781	13.82545	0	0	0	0	0	0	0	0	0	12.46196	16.65806	0	0	0	0	0	0	0	0	0	15.77121	0	0	0	0	0	0	14.44602	0	0	0	0
O15063	GRRE1_HUMAN	"Granule associated Rac and RHOG effector protein 1, GARRE1"	GARRE1 KIAA0355	Homo sapiens (Human)	Rac protein signal transduction [GO:0016601]	cytosol [GO:0005829]; P-body [GO:0000932]	cytosol [GO:0005829]; P-body [GO:0000932]; CCR4-NOT complex binding [GO:1905762]; small GTPase binding [GO:0031267]; Rac protein signal transduction [GO:0016601]	CCR4-NOT complex binding [GO:1905762]; small GTPase binding [GO:0031267]	GO:0000932; GO:0005829; GO:0016601; GO:0031267; GO:1905762	AKMPGNIDTR	5.380000114	1	1	0.328841488	1102.730654	13.38451	14.13926	15.76273	15.12584	15.30345	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.58665	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15068	MCF2L_HUMAN	Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein)	MCF2L KIAA0362 OST	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091]	GO:0005085; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0012505; GO:0019898; GO:0031234; GO:0035025; GO:0035091; GO:0035556; GO:0051056	DLASFEEK	1.5	0.593777895	0.593777895	0.295232448	938.1531062	18.18723	16.26214	16.63832	0	17.89246	0	0	0	0	0	0	0	0	17.51221	0	19.97723	0	18.3784	0	0	0	0	0	18.12303	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38443	17.62931	0	0	0	0	0	17.27463	0
O15072	ATS3_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 3, ADAM-TS 3, ADAM-TS3, ADAMTS-3, EC 3.4.24.- (Procollagen II N-proteinase, PC II-NP) (Procollagen II amino propeptide-processing enzyme)"	ADAMTS3 KIAA0366	Homo sapiens (Human)	collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]	endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748	CHLYCQSKETGDVAYMK	3.779999971	1	1	9.23E-13	2091.098488	15.56141	0	0	0	0	0	0	15.5688	0	0	0	12.75685	0	0	0	12.74372	0	0	0	0	0	0	0	14.88447	0	13.1187	0	14.98378	0	0	0	0	0	15.58511	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15078	CE290_HUMAN	"Centrosomal protein of 290 kDa, Cep290 (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87, CT87) (Nephrocystin-6) (Tumor antigen se2-2)"	CEP290 BBS14 KIAA0373 NPHP6	Homo sapiens (Human)	"camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]"	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]	"centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]"	identical protein binding [GO:0042802]	GO:0001822; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043010; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:1905349; GO:1905515	IEGIR	5.269999981	1	1	0.124045097	586.3354429	0	0	0	0	0	0	0	15.181	0	0	16.07056	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.76625	0	0	16.84035	17.37862	0	0	0	17.39472	0	16.79204	17.02076	16.43798	0	0	0	0	0	0	0	0
O15079	SNPH_HUMAN	Syntaphilin	SNPH KIAA0374	Homo sapiens (Human)	neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; synaptic vesicle docking [GO:0016081]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; presynapse [GO:0098793]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; presynapse [GO:0098793]; syntaxin-1 binding [GO:0017075]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; synaptic vesicle docking [GO:0016081]	syntaxin-1 binding [GO:0017075]	GO:0005737; GO:0005739; GO:0005881; GO:0007269; GO:0016021; GO:0016081; GO:0017075; GO:0030182; GO:0043005; GO:0098793	MAMSLPGSR	1.480000019	1	1	0.214467943	982.1843315	0	0	16.43212	15.26607	0	0	0	0	0	0	0	0	0	0	12.74895	15.13484	0	0	0	12.40544	0	15.09181	0	0	14.10425	15.58794	15.37456	0	15.12483	0	0	0	15.91399	0	14.81258	0	16.7423	0	12.18939	11.39345	12.39476	10.8994	0	0	0	0	0	0
O15083	ERC2_HUMAN	ERC protein 2	ERC2 KIAA0378	Homo sapiens (Human)	maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; regulation of synaptic plasticity [GO:0048167]; synaptic vesicle priming [GO:0016082]	cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]	cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; structural constituent of presynaptic active zone [GO:0098882]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; regulation of synaptic plasticity [GO:0048167]; synaptic vesicle priming [GO:0016082]	structural constituent of presynaptic active zone [GO:0098882]	GO:0007274; GO:0016082; GO:0030426; GO:0042734; GO:0048167; GO:0048786; GO:0048788; GO:0048790; GO:0098882; GO:0098978; GO:0098982	DTKIASLER	2.5	1	1	0.211689512	1027.895398	0	16.04982	0	0	15.60961	13.88433	16.30632	0	15.62527	18.57835	0	0	0	0	0	0	15.67217	0	0	0	0	0	15.32574	0	0	0	15.80263	0	0	0	0	17.38624	16.26384	0	0	0	15.41261	16.09188	0	0	0	0	0	0	0	0	0	15.8909
O15084	ANR28_HUMAN	"Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, PP6-ARS-A, Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K, PITK)"	ANKRD28 KIAA0379	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005829	CLEYLLR	7.21999979	1	1	3.46E-13	967.4264294	0	15.77199	0	0	0	0	0	0	13.49343	0	15.31483	0	0	0	0	0	0	0	0	0	0	0	16.41035	0	9.912271	0	0	0	0	0	0	0	13.0878	0	15.57917	0	0	0	0	15.80381	0	0	14.03314	0	0	0	16.50372	0
O15085	ARHGB_HUMAN	Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF)	ARHGEF11 KIAA0380	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]"	G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001558; GO:0001664; GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006941; GO:0007186; GO:0007266; GO:0030010; GO:0030036; GO:0045893; GO:0051056	IPEMLQAEIDSRLR	9.670000076	1	1	0.231424653	1687.476607	13.326	14.42645	15.86352	14.70663	0	14.19469	15.87514	14.95053	15.75362	0	16.30752	0	0	0	0	0	0	0	0	14.98315	0	15.73212	0	0	0	0	14.56777	12.49479	0	0	0	0	0	0	0	0	14.94603	0	0	0	0	0	0	0	0	0	0	0
O15091	MRPP3_HUMAN	"Mitochondrial ribonuclease P catalytic subunit, EC 3.1.26.5 (Mitochondrial ribonuclease P protein 3, Mitochondrial RNase P protein 3) (Protein only RNase P catalytic subunit)"	PRORP KIAA0391 MRPP3	Homo sapiens (Human)	mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682]	mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526]; mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682]	metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526]	GO:0001682; GO:0004526; GO:0005654; GO:0005739; GO:0005759; GO:0030678; GO:0046872; GO:0097745	ERSQMNSQTEDHALAPVR	1.419999957	1	1	0.461238791	2085.280171	0	13.90985	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.27648	0	0	0	0	0	0	0	0	0	17.74255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15117	FYB1_HUMAN	"FYN-binding protein 1 (Adhesion and degranulation promoting adaptor protein, ADAP) (FYB-120/130, p120/p130) (FYN-T-binding protein) (SLAP-130) (SLP-76-associated phosphoprotein)"	FYB1 FYB SLAP130	Homo sapiens (Human)	immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852]	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852]	lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005634; GO:0005829; GO:0005886; GO:0006955; GO:0007229; GO:0008289; GO:0015629; GO:0030054; GO:0032991; GO:0044877; GO:0050852; GO:0072659	FGTPASLTTRDPEAK	6.28000021	0.29077208	0.29077208	0.558846372	1591.43603	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.21208	17.19236	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15119	TBX3_HUMAN	"T-box transcription factor TBX3, T-box protein 3"	TBX3	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification, embryo [GO:0008595]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; blood vessel development [GO:0001568]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cardiac chamber development [GO:0003205]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell fate commitment [GO:0060923]; cell aging [GO:0007569]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion formation [GO:0003272]; female genitalia development [GO:0030540]; follicle-stimulating hormone secretion [GO:0046884]; forelimb morphogenesis [GO:0035136]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; limbic system development [GO:0021761]; luteinizing hormone secretion [GO:0032275]; male genitalia development [GO:0030539]; mammary gland development [GO:0030879]; mammary placode formation [GO:0060596]; mesoderm morphogenesis [GO:0048332]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; semicircular canal morphogenesis [GO:0048752]; sinoatrial node cell development [GO:0060931]; skeletal system development [GO:0001501]; smooth muscle cell differentiation [GO:0051145]; specification of animal organ position [GO:0010159]; stem cell population maintenance [GO:0019827]; ureteric peristalsis [GO:0072105]; ventricular septum morphogenesis [GO:0060412]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification, embryo [GO:0008595]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; blood vessel development [GO:0001568]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cardiac chamber development [GO:0003205]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell fate commitment [GO:0060923]; cell aging [GO:0007569]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion formation [GO:0003272]; female genitalia development [GO:0030540]; follicle-stimulating hormone secretion [GO:0046884]; forelimb morphogenesis [GO:0035136]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; limbic system development [GO:0021761]; luteinizing hormone secretion [GO:0032275]; male genitalia development [GO:0030539]; mammary gland development [GO:0030879]; mammary placode formation [GO:0060596]; mesoderm morphogenesis [GO:0048332]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; semicircular canal morphogenesis [GO:0048752]; sinoatrial node cell development [GO:0060931]; skeletal system development [GO:0001501]; smooth muscle cell differentiation [GO:0051145]; specification of animal organ position [GO:0010159]; stem cell population maintenance [GO:0019827]; ureteric peristalsis [GO:0072105]; ventricular septum morphogenesis [GO:0060412]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001501; GO:0001568; GO:0001701; GO:0001708; GO:0001947; GO:0003151; GO:0003167; GO:0003205; GO:0003272; GO:0005634; GO:0006357; GO:0007417; GO:0007569; GO:0008284; GO:0008595; GO:0009887; GO:0010159; GO:0019827; GO:0021761; GO:0030539; GO:0030540; GO:0030857; GO:0030879; GO:0032275; GO:0035115; GO:0035116; GO:0035136; GO:0036302; GO:0042733; GO:0043066; GO:0043565; GO:0045662; GO:0045787; GO:0045892; GO:0045944; GO:0046884; GO:0048332; GO:0048752; GO:0051145; GO:0060021; GO:0060317; GO:0060412; GO:0060444; GO:0060596; GO:0060923; GO:0060931; GO:0061629; GO:0072105; GO:0090398; GO:1905072; GO:1905222; GO:1990837; GO:2000137; GO:2000648	ADPEMPKR	11.94999981	1	1	0.180381446	944.4524244	0	13.69415	16.87652	15.93387	16.34293	0	0	0	0	0	15.4762	17.68212	16.89563	0	14.00434	15.24686	0	0	16.7111	0	17.19884	0	18.08763	15.28755	16.31744	0	16.11198	17.50336	12.01231	0	18.79472	18.54361	0	16.96157	14.81526	0	17.36746	18.60876	0	18.22502	15.42233	15.30513	16.36725	15.72515	16.87314	18.07967	0	16.85513
O15123	ANGP2_HUMAN	"Angiopoietin-2, ANG-2"	ANGPT2	Homo sapiens (Human)	angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]	metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0001666; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0007165; GO:0007281; GO:0009314; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0050928; GO:0060135; GO:0062023; GO:0071363; GO:0072012	KVLAMEDK	6.820000172	1	1	3.47E-13	950.5852017	13.60481	0	15.53179	13.10936	0	0	0	0	0	15.42643	0	0	0	13.68477	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15144	ARPC2_HUMAN	"Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit, p34-ARC)"	ARPC2 ARC34 PRO2446	Homo sapiens (Human)	actin filament polymerization [GO:0030041]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]	actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; muscle cell projection membrane [GO:0036195]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; muscle cell projection membrane [GO:0036195]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]	actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]	GO:0003779; GO:0005200; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005885; GO:0005925; GO:0010592; GO:0015629; GO:0030027; GO:0030041; GO:0030838; GO:0034314; GO:0035861; GO:0036195; GO:0043005; GO:0070062; GO:0070358; GO:0098978; GO:1900026	VMVSISLK	8.010000229	0.065821409	0.065821409	0.181142956	892.4345895	14.76668	15.76602	13.96433	16.0195	14.13921	0	15.51017	0	15.85509	16.02126	10.55269	14.79976	0	0	0	14.71897	14.82035	0	0	14.09484	0	15.99235	0	0	0	0	0	0	14.55521	16.19252	0	16.4533	0	0	0	0	0	0	0	17.04487	15.26231	0	0	16.11094	0	14.2478	0	15.49163
O15146	MUSK_HUMAN	"Muscle, skeletal receptor tyrosine-protein kinase, EC 2.7.10.1 (Muscle-specific tyrosine-protein kinase receptor, MuSK, Muscle-specific kinase receptor)"	MUSK	Homo sapiens (Human)	cell differentiation [GO:0030154]; memory [GO:0007613]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]	integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; memory [GO:0007613]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005518; GO:0005524; GO:0005887; GO:0007169; GO:0007528; GO:0007613; GO:0008582; GO:0010628; GO:0030154; GO:0031594; GO:0033674; GO:0038062; GO:0043235; GO:0045211; GO:0046777; GO:0046872; GO:0071340; GO:2000541	ILERMCER	6.460000038	1	1	0.014802533	1107.679023	13.02212	13.9124	0	17.03053	0	15.2605	13.84438	0	15.15203	14.58512	13.23148	14.58086	16.74486	13.44777	0	0	12.93763	0	14.17375	0	0	0	13.19692	15.0714	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15151	MDM4_HUMAN	Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4)	MDM4 MDMX	Homo sapiens (Human)	"atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular septum development [GO:0003281]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]; atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular septum development [GO:0003281]"	enzyme binding [GO:0019899]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]	GO:0000122; GO:0002039; GO:0003170; GO:0003181; GO:0003203; GO:0003281; GO:0003283; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0008285; GO:0017053; GO:0019899; GO:0030330; GO:0042177; GO:0043066; GO:0045892; GO:0050821; GO:0051726; GO:0065003; GO:0071456	EVMHYLGQYIMVK	2.220000029	1	1	0.144405311	1642.191192	0	12.97646	15.27389	15.77648	0	0	0	0	14.97755	0	0	0	0	0	0	14.84622	0	0	0	0	0	0	0	0	0	0	15.54428	0	0	14.91056	0	15.9226	0	16.53016	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15165	LRAD4_HUMAN	Low-density lipoprotein receptor class A domain-containing protein 4	LDLRAD4 C18orf1	Homo sapiens (Human)	negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; R-SMAD binding [GO:0070412]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	R-SMAD binding [GO:0070412]	GO:0000139; GO:0010719; GO:0010991; GO:0016021; GO:0030336; GO:0030512; GO:0031901; GO:0043231; GO:0060394; GO:0070412	MEGPPPTYSEVMGHHPGASFLHHQR	3.630000114	1	1	3.20E-12	2815.816725	15.01066	13.88473	0	0	0	0	14.15879	0	14.8345	0	0	14.53511	0	0	0	11.53617	0	13.55048	0	0	0	0	14.27415	0	0	13.17532	0	0	15.31962	13.53693	0	16.42554	12.59192	7.436532	15.00756	0	0	13.58964	0	10.69519	0	9.757152	0	13.78483	0	15.8966	0	14.60941
O15169	AXIN1_HUMAN	"Axin-1 (Axis inhibition protein 1, hAxin)"	AXIN1 AXIN	Homo sapiens (Human)	"activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; canonical Wnt signaling pathway [GO:0060070]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; genomic imprinting [GO:0071514]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605]"	beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Wnt signalosome [GO:1990909]	"beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Wnt signalosome [GO:1990909]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; canonical Wnt signaling pathway [GO:0060070]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; genomic imprinting [GO:0071514]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605]"	armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0001701; GO:0001934; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0008022; GO:0009950; GO:0010800; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030159; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032147; GO:0032436; GO:0033138; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043507; GO:0043621; GO:0045599; GO:0045732; GO:0045893; GO:0046330; GO:0046332; GO:0048320; GO:0048471; GO:0051248; GO:0051443; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071514; GO:0071944; GO:0090090; GO:1990909; GO:2000060	LARAIYR	8.100000381	1	1	0.129891584	861.7952947	14.19942	0	15.19648	0	0	0	0	0	0	0	0	0	0	15.95433	0	0	15.92217	0	0	0	0	0	17.05788	0	0	0	0	16.085	0	16.22511	0	0	15.12866	0	15.35563	16.78781	15.96245	16.15786	0	15.42239	0	14.46353	15.07743	10.44264	15.84524	14.27524	0	15.60615
O15195	VILL_HUMAN	Villin-like protein	VILL	Homo sapiens (Human)	actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]"	"actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]"	GO:0005200; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0051014; GO:0051015; GO:0051016	MSSLQERK	43.61000061	0.398376167	0.398376167	0.269080466	979.9367401	0	15.61717	15.51733	15.94039	14.53151	15.13476	6.977369	0	0	11.42257	0	16.30615	16.85944	14.16315	14.94703	16.39001	16.47871	0	0	15.0999	0	0	0	18.15993	0	0	0	16.65211	0	14.31684	0	18.26432	0	18.66237	0	0	16.42249	0	16.00071	0	0	18.33766	13.93958	14.91585	0	0	17.61114	18.08381
O15197	EPHB6_HUMAN	Ephrin type-B receptor 6 (HEP) (Tyrosine-protein kinase-defective receptor EPH-6)	EPHB6	Homo sapiens (Human)	axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0021952; GO:0033674; GO:0038023; GO:0043005; GO:0043235	QREGQFSSLQLVAMQR	2.789999962	1	1	0.293152491	1878.638504	14.55719	11.57777	0	0	0	0	0	14.53627	0	0	0	0	11.95311	0	0	14.11458	0	0	11.14618	0	0	0	0	14.65338	14.60921	0	0	15.59267	14.40655	14.56232	16.35879	11.08268	13.2631	14.20315	0	14.44465	0	15.07991	0	0	0	0	0	0	0	0	0	0
O15198	SMAD9_HUMAN	"Mothers against decapentaplegic homolog 9, MAD homolog 9, Mothers against DPP homolog 9 (Madh6) (SMAD family member 9, SMAD 9, Smad9)"	SMAD9 MADH6 MADH9 SMAD8	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007179; GO:0009653; GO:0030154; GO:0030509; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144; GO:0071773; GO:1901522	ALSCPGQPSK	3.960000038	1	1	0.205644592	1044.033334	0	15.52471	13.62768	15.42512	12.82055	13.86432	15.17439	0	13.74315	14.89982	15.85534	14.54665	14.365	0	0	13.69301	14.7956	0	14.728	0	14.87418	0	0	0	0	0	0	0	0	0	14.5902	0	0	0	13.51087	14.02732	0	0	0	0	0	0	0	0	16.48091	0	14.85788	0
O15212	PFD6_HUMAN	Prefoldin subunit 6 (Protein Ke2)	PFDN6 HKE2 PFD6	Homo sapiens (Human)	chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0001540; GO:0005737; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:0051131; GO:0101031; GO:1905907; GO:1990062	EELALLDGSNVVFK	1.220000029	1	1	0.324783357	1538.351593	16.65712	0	14.91391	0	0	17.1206	0	0	11.63613	14.68285	12.70016	15.49307	0	10.67757	0	0	14.69653	13.50321	0	0	0	0	0	0	15.85445	0	15.8954	0	0	0	0	15.68131	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15226	NKRF_HUMAN	"NF-kappa-B-repressing factor, NFkB-repressing factor, NRF (Protein ITBA4)"	NKRF ITBA4 NRF	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	"ATPase activator activity [GO:0001671]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0001671; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944	EDLLDQLKQEGQVGHYELVMPQAN	7.53000021	1	1	0.092992955	2771.231979	17.01507	0	0	0	0	14.58958	10.42568	12.75475	13.90224	0	0	0	0	0	15.60972	0	0	0	0	17.84559	14.91382	0	0	17.8938	17.5346	18.06463	0	17.95293	16.28067	0	14.54827	17.6923	17.498	0	11.01731	0	0	17.40051	18.54894	0	13.08979	15.56948	15.84544	12.28627	14.46452	15.27346	0	15.93092
O15228	GNPAT_HUMAN	"Dihydroxyacetone phosphate acyltransferase, DAP-AT, DHAP-AT, EC 2.3.1.42 (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)"	GNPAT DAPAT DHAPAT	Homo sapiens (Human)	cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]	glycerone-phosphate O-acyltransferase activity [GO:0016287]	GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006631; GO:0006654; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0009410; GO:0016020; GO:0016287; GO:0021587; GO:0030913; GO:0031966; GO:0042594; GO:0061024; GO:0070542	ESTTGLLKAR	5.170000076	0.950046241	0.950046241	0.185555107	1076.885636	0	0	0	0	0	0	6.419886	13.95757	19.20751	0	0	0	15.08895	0	0	0	0	15.57394	0	0	0	0	0	14.3098	0	0	0	0	15.1127	0	0	0	0	16.27362	13.83889	0	0	0	0	0	0	0	15.30527	0	14.30228	0	0	0
O15229	KMO_HUMAN	"Kynurenine 3-monooxygenase, EC 1.14.13.9 (Kynurenine 3-hydroxylase)"	KMO	Homo sapiens (Human)	"'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; aging [GO:0007568]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]; tryptophan catabolic process [GO:0006569]"	cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	"cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; aging [GO:0007568]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]; tryptophan catabolic process [GO:0006569]"	FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]	GO:0004502; GO:0005615; GO:0005741; GO:0005829; GO:0006569; GO:0007568; GO:0009651; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1901216; GO:1903296	LLVQDFFLLPAQPMISVK	5.110000134	1	1	0.282417276	2076.182065	0	0	14.51062	18.89252	0	0	0	0	0	0	0	0	18.1534	17.28112	0	0	0	0	0	0	0	0	0	0	17.88128	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15230	LAMA5_HUMAN	Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha)	LAMA5 KIAA0533 KIAA1907	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]	GO:0001658; GO:0001738; GO:0001755; GO:0001942; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005610; GO:0005615; GO:0005634; GO:0007229; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0016331; GO:0016477; GO:0030155; GO:0030324; GO:0030334; GO:0031594; GO:0034446; GO:0042127; GO:0042475; GO:0043083; GO:0043259; GO:0043260; GO:0045995; GO:0060271; GO:0060445; GO:0062023; GO:0070062; GO:0072659; GO:0098609	FLRTNTLLGHLMGK	3.640000105	0.989015222	0.989015222	0.279300876	1616.265201	15.37906	16.35367	0	0	0	0	16.39669	16.47291	15.2834	0	0	15.04685	0	0	0	0	0	0	0	0	0	0	0	0	0	16.67909	0	0	0	0	0	15.57852	0	0	15.29496	0	15.80204	16.56296	15.8983	15.6715	0	16.19127	13.92624	17.21949	0	0	0	0
O15232	MATN3_HUMAN	Matrilin-3	MATN3	Homo sapiens (Human)	cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0001501; GO:0005201; GO:0005509; GO:0005576; GO:0005788; GO:0030198; GO:0031012; GO:0051216; GO:0062023; GO:0120216	MPRPAPARR	2.710000038	1	1	0.261465519	1053.047785	13.15472	16.27057	12.46343	0	0	16.86395	16.07216	15.5123	0	15.39016	14.31798	0	11.7736	0	15.38265	14.6136	15.09474	15.80946	15.31417	15.22546	0	15.30614	16.00441	0	0	15.29121	14.32361	0	15.53333	0	0	16.598	0	0	14.95634	0	0	0	0	0	0	0	16.15832	0	0	0	14.7562	0
O15234	CASC3_HUMAN	"Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein, MLN 51) (Protein barentsz, Btz)"	CASC3 MLN51	Homo sapiens (Human)	"intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]"	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006]	"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]"	enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]	GO:0000184; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006406; GO:0006417; GO:0008298; GO:0010494; GO:0016607; GO:0019899; GO:0030425; GO:0031625; GO:0031965; GO:0035145; GO:0042802; GO:0048471; GO:0071006; GO:2000622	LEQTSVR	3.609999895	0.325480223	0.325480223	0.030486707	832.0953045	0	15.2434	14.62916	17.03673	0	16.1223	15.02274	16.87813	16.03407	0	17.4684	0	0	0	0	14.88164	13.96294	13.7803	14.36404	0	16.44811	0	13.24738	0	14.72756	15.08093	14.72714	0	12.32329	0	16.95451	18.17325	16.16393	0	16.16044	9.291677	16.2049	14.98614	0	16.67838	14.13862	14.11161	14.71037	0	13.13335	14.17219	17.10692	12.53042
O15244	S22A2_HUMAN	"Solute carrier family 22 member 2 (Organic cation transporter 2, hOCT2)"	SLC22A2 OCT2	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amine transport [GO:0015837]; amino acid import across plasma membrane [GO:0089718]; body fluid secretion [GO:0007589]; choline transport [GO:0015871]; dopamine uptake [GO:0090494]; export across plasma membrane [GO:0140115]; histamine uptake [GO:0051615]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic cation transport [GO:0015695]; positive regulation of gene expression [GO:0010628]; purine-containing compound transmembrane transport [GO:0072530]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; choline transmembrane transporter activity [GO:0015220]; efflux transmembrane transporter activity [GO:0015562]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amine transport [GO:0015837]; amino acid import across plasma membrane [GO:0089718]; body fluid secretion [GO:0007589]; choline transport [GO:0015871]; dopamine uptake [GO:0090494]; export across plasma membrane [GO:0140115]; histamine uptake [GO:0051615]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic cation transport [GO:0015695]; positive regulation of gene expression [GO:0010628]; purine-containing compound transmembrane transport [GO:0072530]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	amine transmembrane transporter activity [GO:0005275]; choline transmembrane transporter activity [GO:0015220]; efflux transmembrane transporter activity [GO:0015562]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005275; GO:0005326; GO:0005886; GO:0005887; GO:0006836; GO:0006919; GO:0007589; GO:0008504; GO:0010628; GO:0015101; GO:0015179; GO:0015214; GO:0015220; GO:0015562; GO:0015695; GO:0015837; GO:0015871; GO:0016020; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0061459; GO:0070062; GO:0072530; GO:0089718; GO:0090494; GO:0097638; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1902475; GO:1990962	NAEAMRIIK	10.01000023	1	1	0.203004889	1061.535651	0	0	0	0	0	0	0	0	0	0	0	13.86181	12.52383	11.89957	14.01733	0	15.29246	0	0	13.507	0	16.61526	19.48237	0	15.94681	16.53293	16.09644	0	14.27728	14.04195	15.79534	15.22715	14.54807	0	0	12.24032	16.50097	0	0	16.73567	15.16463	16.65774	0	16.68935	0	0	0	0
O15245	S22A1_HUMAN	"Solute carrier family 22 member 1 (Organic cation transporter 1, hOCT1)"	SLC22A1 OCT1	Homo sapiens (Human)	dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; purine-containing compound transmembrane transport [GO:0072530]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; purine-containing compound transmembrane transport [GO:0072530]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005277; GO:0005326; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0008504; GO:0008513; GO:0010248; GO:0015101; GO:0015214; GO:0015651; GO:0015695; GO:0015697; GO:0015874; GO:0016020; GO:0016323; GO:0016324; GO:0019534; GO:0042802; GO:0042908; GO:0042910; GO:0048241; GO:0051610; GO:0072530; GO:0090494; GO:0098793; GO:0150104; GO:1901998; GO:1990962	ENTIYLKVQTSEPSGT	2.880000114	1	1	0.384958453	1767.486971	0	0	0	0	0	0	13.24591	0	0	0	0	0	16.80935	0	0	0	15.71542	0	0	17.08609	16.76808	0	0	14.40754	0	0	16.94998	16.28912	0	0	16.07388	17.23083	0	16.41421	16.09392	15.14224	14.16355	16.03527	0	0	16.26232	17.4971	15.27627	0	15.28801	16.95454	0	0
O15254	ACOX3_HUMAN	"Peroxisomal acyl-coenzyme A oxidase 3, EC 1.3.3.6 (Branched-chain acyl-CoA oxidase, BRCACox) (Pristanoyl-CoA oxidase)"	ACOX3 BRCOX PRCOX	Homo sapiens (Human)	fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]	GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949	TLLPMPGVMVGDIGKK	6.71999979	1	1	0.267264016	1687.018587	14.30455	15.9826	13.72539	0	0	14.91615	14.27688	0	13.99604	15.72825	17.59034	11.27848	0	0	0	0	0	15.03248	0	0	0	13.97748	0	0	16.07911	0	0	0	0	0	15.3549	15.73909	14.86115	0	0	15.78427	16.43932	0	0	14.52174	0	0	0	0	13.89024	0	0	15.32149
O15259	NPHP1_HUMAN	Nephrocystin-1 (Juvenile nephronophthisis 1 protein)	NPHP1 NPH1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0005912; GO:0005923; GO:0005929; GO:0007165; GO:0007632; GO:0016020; GO:0030030; GO:0030036; GO:0031514; GO:0032391; GO:0048515; GO:0060041; GO:0090251; GO:0098609; GO:1903348	GEILLVIEK	18.64999962	0.40988335	0.40988335	0.138169081	1013.48069	17.89032	15.22677	13.50321	16.24968	0	16.63987	15.16716	16.32401	17.32059	16.71324	15.98803	0	0	0	0	14.728	13.47423	16.86344	15.16333	15.68189	0	18.18492	0	14.67311	18.27066	0	0	0	16.09599	15.54769	15.30102	0	16.86604	16.49009	12.56824	0	17.4556	15.82305	15.36716	17.98871	0	16.45816	14.72075	16.67631	16.70975	16.62947	16.18042	0
O15260	SURF4_HUMAN	Surfeit locus protein 4	SURF4 SURF-4	Homo sapiens (Human)	Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; positive regulation of organelle organization [GO:0010638]; regulation of lipid transport [GO:0032368]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; cargo receptor activity [GO:0038024]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; positive regulation of organelle organization [GO:0010638]; regulation of lipid transport [GO:0032368]	cargo receptor activity [GO:0038024]	GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0010638; GO:0016021; GO:0030133; GO:0031965; GO:0032368; GO:0033116; GO:0035577; GO:0038024; GO:0042953; GO:0055088	LCLISTFLEDGIR	17.20999908	0.290019244	0.290019244	0.274752994	1537.975981	20.85109	19.56081	15.87712	20.93118	21.04054	14.35049	0	21.55739	21.1141	22.1853	21.00267	21.32844	19.88191	20.25142	0	0	17.85649	19.2045	18.71032	17.74873	20.36683	20.28699	20.52167	20.56569	0	20.66944	21.28264	0	20.05079	21.52136	0	21.51088	20.47287	20.87705	22.81715	0	0	22.21368	0	18.75314	19.05585	0	21.56248	18.22834	0	21.44294	19.66996	20.53724
O15264	MK13_HUMAN	"Mitogen-activated protein kinase 13, MAP kinase 13, MAPK 13, EC 2.7.11.24 (Mitogen-activated protein kinase p38 delta, MAP kinase p38 delta) (Stress-activated protein kinase 4)"	MAPK13 PRKM13 SAPK4	Homo sapiens (Human)	cell cycle [GO:0007049]; cellular response to anisomycin [GO:0072740]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to sodium arsenite [GO:1903936]; cellular response to sorbitol [GO:0072709]; cellular response to UV [GO:0034644]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; response to osmotic stress [GO:0006970]; stress-activated MAPK cascade [GO:0051403]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; cellular response to anisomycin [GO:0072740]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to sodium arsenite [GO:1903936]; cellular response to sorbitol [GO:0072709]; cellular response to UV [GO:0034644]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; response to osmotic stress [GO:0006970]; stress-activated MAPK cascade [GO:0051403]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006970; GO:0007049; GO:0018105; GO:0032755; GO:0034644; GO:0035556; GO:0050729; GO:0051403; GO:0070301; GO:0071347; GO:0072709; GO:0072740; GO:0106310; GO:1903936	EIVNFSPIAR	4.239999771	1	1	0.180383516	1146.516919	0	0	18.37134	0	0	0	0	0	0	0	0	0	0	0	18.05322	0	0	0	0	0	12.00581	0	0	0	0	17.59426	0	0	0	0	0	0	19.52696	0	0	0	0	0	0	0	0	0	0	16.51621	0	17.82824	0	0
O15265	ATX7_HUMAN	Ataxin-7 (Spinocerebellar ataxia type 7 protein)	ATXN7 SCA7	Homo sapiens (Human)	"histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of microtubule depolymerization [GO:0007026]; nucleus organization [GO:0006997]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]"	cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]	"cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of microtubule depolymerization [GO:0007026]; nucleus organization [GO:0006997]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]"		GO:0000124; GO:0000226; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006282; GO:0006357; GO:0006997; GO:0007026; GO:0007601; GO:0015630; GO:0016363; GO:0016578; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893	RAVQGR	6.96999979	1	1	0.14517814	686.0599168	0	13.68218	13.36774	15.20522	14.81213	14.50258	0	0	0	15.0655	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15270	SPTC2_HUMAN	"Serine palmitoyltransferase 2, EC 2.3.1.50 (Long chain base biosynthesis protein 2, LCB 2) (Long chain base biosynthesis protein 2a, LCB2a) (Serine-palmitoyl-CoA transferase 2, SPT 2)"	SPTLC2 KIAA0526 LCB2	Homo sapiens (Human)	adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]	pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]	GO:0004758; GO:0005789; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504	EILDTALK	3.109999895	1	1	2.28E-12	903.3923161	14.90944	15.2122	15.51495	15.25806	14.1106	14.1174	14.91585	14.04394	12.40249	15.27536	0	15.3769	15.22239	14.28402	0	14.38975	15.43491	0	15.79963	0	0	15.24235	16.58578	0	0	15.66855	0	13.43151	14.56101	12.58721	0	0	0	0	0	0	0	0	0	0	0	0	15.79662	0	0	0	0	0
O15273	TELT_HUMAN	Telethonin (Titin cap protein)	TCAP	Homo sapiens (Human)	adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of mechanical stimulus [GO:0050982]; detection of muscle stretch [GO:0035995]; otic vesicle formation [GO:0030916]; protein-containing complex assembly [GO:0065003]; response to muscle stretch [GO:0035994]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]	cytosol [GO:0005829]; I band [GO:0031674]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018]	cytosol [GO:0005829]; I band [GO:0031674]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018]; BMP binding [GO:0036122]; FATZ binding [GO:0051373]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; transmembrane transporter binding [GO:0044325]; adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of mechanical stimulus [GO:0050982]; detection of muscle stretch [GO:0035995]; otic vesicle formation [GO:0030916]; protein-containing complex assembly [GO:0065003]; response to muscle stretch [GO:0035994]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]	BMP binding [GO:0036122]; FATZ binding [GO:0051373]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; transmembrane transporter binding [GO:0044325]	GO:0001756; GO:0003009; GO:0003300; GO:0005829; GO:0007512; GO:0008307; GO:0014898; GO:0030018; GO:0030240; GO:0030241; GO:0030674; GO:0030916; GO:0031432; GO:0031674; GO:0035994; GO:0035995; GO:0036122; GO:0044325; GO:0045214; GO:0048769; GO:0050982; GO:0051373; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0065003; GO:0070080; GO:1990733	MGILGRGLQEYQLPYQR	2.849999905	1	1	2.06E-12	2038.625218	0	14.04072	14.43222	12.74542	14.30563	12.60112	0	0	13.9158	10.41751	15.11886	15.14162	15.19604	14.301	14.66514	17.11824	0	0	12.85517	13.06451	0	0	13.80727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15294	OGT1_HUMAN	"UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, EC 2.4.1.255 (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit, OGT)"	OGT	Homo sapiens (Human)	"apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; hemopoiesis [GO:0030097]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitophagy [GO:0000423]; negative regulation of cell migration [GO:0030336]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of proteolysis [GO:0045862]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of necroptotic process [GO:0060544]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]"	cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]	"cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; hemopoiesis [GO:0030097]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitophagy [GO:0000423]; negative regulation of cell migration [GO:0030336]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of proteolysis [GO:0045862]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of necroptotic process [GO:0060544]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]"	"acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]"	GO:0000122; GO:0000123; GO:0000423; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016262; GO:0016485; GO:0016580; GO:0017122; GO:0030097; GO:0030336; GO:0030512; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045862; GO:0045893; GO:0045944; GO:0046626; GO:0048015; GO:0051571; GO:0060544; GO:0061087; GO:0080182; GO:0097363; GO:0120162; GO:1900095; GO:1902455; GO:1902459	DSGNIPEAIASYR	3.619999886	1	1	9.18E-13	1391.852775	13.0995	15.78535	0	13.80502	15.59586	14.21047	15.0211	0	0	15.73612	13.1874	16.11747	0	0	13.73759	0	12.96572	15.75078	15.42447	13.48707	0	15.99859	14.29502	15.11833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15318	RPC7_HUMAN	"DNA-directed RNA polymerase III subunit RPC7, RNA polymerase III subunit C7 (DNA-directed RNA polymerase III subunit G) (RNA polymerase III 32 kDa apha subunit, RPC32-alpha) (RNA polymerase III 32 kDa subunit, RPC32)"	POLR3G	Homo sapiens (Human)	cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383]	chromatin binding [GO:0003682]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0008283; GO:0016604; GO:0032728; GO:0045087; GO:0045089; GO:0051607	GTPLTNTEDVLK	1.809999943	1	1	0.149788205	1288.288636	0	9.289728	0	11.1768	14.11323	0	14.95819	13.5876	0	11.49366	13.27671	0	15.10341	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.95478	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15327	INP4B_HUMAN	"Inositol polyphosphate 4-phosphatase type II (Type II inositol 3,4-bisphosphate 4-phosphatase, EC 3.1.3.66)"	INPP4B	Homo sapiens (Human)	inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165]"	"inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"	GO:0005737; GO:0005829; GO:0006661; GO:0007165; GO:0016316; GO:0017161; GO:0034597; GO:0043647; GO:0046855; GO:0046856; GO:0052828	ALDCMR	10.43000031	0.562511384	0.562511384	0.062264609	780.5901605	9.460384	17.05987	10.36178	12.06179	9.711795	12.2591	13.34803	0	0	0	11.58217	15.40659	17.36494	0	0	16.89233	0	0	17.10109	14.27547	0	15.45139	13.83628	14.58164	15.01495	0	19.34117	15.60542	0	19.49568	14.57895	12.19416	18.83585	0	13.94812	14.68251	17.28708	16.31417	16.25655	19.04818	14.7513	14.59849	0	12.1249	17.69719	15.75807	14.82156	0
O15335	CHAD_HUMAN	Chondroadherin (Cartilage leucine-rich protein)	CHAD SLRR4A	Homo sapiens (Human)	bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155]		GO:0005615; GO:0031012; GO:0060348; GO:1900155	EVAAGAFR	8.380000114	0.490468502	0.490468502	0.221258973	820.5662472	16.52146	0	15.91952	15.59252	15.9735	0	0	15.26036	0	15.39909	16.1157	0	16.61778	15.51689	15.75609	14.86404	0	16.90016	0	0	0	0	0	15.99813	16.48714	15.60543	15.74655	0	14.70039	16.15902	16.82228	16.28	16.60231	16.46761	16.78932	16.37902	17.07673	16.49103	16.03826	0	15.6561	16.1532	17.1778	15.89518	16.06469	15.72091	12.13734	15.87421
O15344	TRI18_HUMAN	"E3 ubiquitin-protein ligase Midline-1, EC 2.3.2.27 (Midin) (Putative transcription factor XPRF) (RING finger protein 59) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18)"	MID1 FXY RNF59 TRIM18 XPRF	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]	enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000226; GO:0005794; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0007026; GO:0007389; GO:0008017; GO:0008270; GO:0016740; GO:0019899; GO:0031625; GO:0032874; GO:0034451; GO:0035372; GO:0042802; GO:0042803; GO:0051219	EGKVMR	9.729999542	1	1	0.260133792	733.129236	14.78431	14.92793	15.04932	0	18.04306	15.80956	15.30549	16.37719	15.53503	0	0	0	0	0	0	15.91574	16.10479	15.15448	0	0	16.29637	16.09533	17.42967	17.49795	0	0	15.87487	16.19344	15.46925	14.85437	16.39279	0	14.0479	15.47559	16.72143	15.81553	16.40516	15.94929	16.55217	16.32195	0	0	0	15.8513	16.56915	16.93146	16.97061	15.50327
O15347	HMGB3_HUMAN	"High mobility group protein B3 (High mobility group protein 2a, HMG-2a) (High mobility group protein 4, HMG-4)"	HMGB3 HMG2A HMG4	Homo sapiens (Human)	DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]"	GO:0000400; GO:0003690; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0006310; GO:0006357; GO:0008301; GO:0032392; GO:0045087; GO:0045578; GO:0045638	IKSTNPGISIGDVAK	4.460000038	1	1	0.28015276	1500.772838	0	0	15.95876	13.56125	15.73252	0	0	16.85008	15.46811	13.36583	14.9427	0	0	0	14.47517	11.97991	14.3801	13.90476	15.46994	0	0	0	14.79426	16.21254	0	0	16.32355	14.45216	12.97135	0	16.59434	0	0	16.19878	14.55409	0	13.91572	0	0	15.53561	0	0	0	0	13.82742	14.54683	15.28061	14.40596
O15354	GPR37_HUMAN	"Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1, ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor, PAELR)"	GPR37	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; dendrite development [GO:0016358]; dopamine biosynthetic process [GO:0042416]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuropeptide signaling pathway [GO:0007218]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; ubiquitin ligase complex [GO:0000151]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; ubiquitin ligase complex [GO:0000151]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; dendrite development [GO:0016358]; dopamine biosynthetic process [GO:0042416]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuropeptide signaling pathway [GO:0007218]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625]	GO:0000151; GO:0004930; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007218; GO:0008188; GO:0008528; GO:0009986; GO:0016358; GO:0030165; GO:0030544; GO:0031072; GO:0031625; GO:0031987; GO:0036505; GO:0042277; GO:0042416; GO:0042923; GO:0043235; GO:0043410; GO:0045202; GO:0045964; GO:1903206	GRDAWGPGNSAR	12.31999969	1	1	0.170126538	1244.257031	0	0	0	0	0	14.62771	0	13.39764	0	0	0	0	0	0	14.45882	0	15.53598	15.46216	0	0	0	17.15489	17.24225	16.70264	0	15.48002	0	13.58987	0	14.70662	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.15658	0	0
O15357	SHIP2_HUMAN	"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2, EC 3.1.3.86 (Inositol polyphosphate phosphatase-like protein 1, INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2, SH2 domain-containing inositol phosphatase 2, SHIP-2)"	INPPL1 SHIP2	Homo sapiens (Human)	actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178]"	"actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]"	GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006006; GO:0006661; GO:0006897; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0034485; GO:0042169; GO:0046856; GO:0097178	APSVSRGSQEPR	2.829999924	1	1	0.390669128	1271.065094	0	17.41	0	0	0	20.93386	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.21771	0	0	0	0	0	0	18.12141	0	0	0	0	17.40905	0	0	0	0	0	0	0
O15360	FANCA_HUMAN	"Fanconi anemia group A protein, Protein FACA"	FANCA FAA FACA FANCH	Homo sapiens (Human)	DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein monoubiquitination [GO:0006513]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein monoubiquitination [GO:0006513]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]		GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0042127; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:2000348	ELLMYK	5.349999905	1	1	0.2105933	796.974895	0	0	0	0	14.31782	0	0	15.41151	0	0	0	0	0	0	16.02747	0	0	0	0	0	17.47943	0	0	0	0	17.00019	17.22852	0	0	0	17.00293	0	16.48207	15.27901	0	0	0	16.53325	16.9737	16.25363	17.09814	16.15314	0	0	0	0	0	0
O15371	EIF3D_HUMAN	"Eukaryotic translation initiation factor 3 subunit D, eIF3d (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)"	EIF3D EIF3S7	Homo sapiens (Human)	cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416	GDRLGK	1.429999948	1	1	0.229144573	645.6302864	16.1855	17.63164	0	0	17.06564	0	18.06131	0	0	0	0	0	0	16.08117	0	0	17.10004	0	16.99284	0	0	0	0	0	0	0	0	0	16.43432	0	0	0	19.53306	0	18.58422	0	0	0	0	0	0	0	0	0	0	0	17.63459	16.4528
O15372	EIF3H_HUMAN	"Eukaryotic translation initiation factor 3 subunit H, eIF3h (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)"	EIF3H EIF3S3	Homo sapiens (Human)	formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0008237; GO:0016020; GO:0016282; GO:0032435; GO:0033290; GO:0042788; GO:0070062; GO:0070122; GO:0071541; GO:0140492	NLQLLMDR	2.460000038	1	1	0.27798058	1018.70344	16.9471	0	16.1824	0	17.32854	0	16.90108	0	18.33026	0	0	16.30099	18.28776	0	0	0	0	17.28244	17.4924	0	0	0	0	0	17.88433	17.02675	0	0	0	0	0	0	0	0	0	18.58373	0	0	0	0	0	0	0	0	0	0	0	18.41234
O15389	SIGL5_HUMAN	"Sialic acid-binding Ig-like lectin 5, Siglec-5 (CD33 antigen-like 2) (Obesity-binding protein 2, OB-BP2, OB-binding protein 2) (CD antigen CD170)"	SIGLEC5 CD33L2 OBBP2	Homo sapiens (Human)	cell adhesion [GO:0007155]	ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]	ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]	carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]	GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0030667; GO:0033691; GO:0070821; GO:0101003	MDDEDPIMGTITSGSRK	3.630000114	1	1	0.424730485	1853.911163	0	15.6898	0	0	0	14.0174	0	16.10291	0	0	16.09023	16.40077	13.6812	0	15.885	16.50189	0	0	15.30954	15.27784	0	0	0	16.64359	15.71471	15.47457	16.07717	0	16.19224	0	0	16.88643	0	0	0	0	16.68714	15.267	17.27769	0	15.87643	16.28296	0	0	15.81431	16.61675	16.02523	16.04427
O15394	NCAM2_HUMAN	"Neural cell adhesion molecule 2, N-CAM-2, NCAM-2"	NCAM2 NCAM21	Homo sapiens (Human)	axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608]	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]	axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608]	identical protein binding [GO:0042802]	GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802; GO:0043005	VELSVGESK	5.889999866	1	1	0.121566217	947.3773275	0	0	0	0	0	13.9094	0	0	0	0	0	0	12.68281	0	14.87368	0	0	0	0	0	16.58603	0	13.56981	0	0	0	16.46396	13.81838	13.97117	0	0	0	0	14.92542	0	0	0	0	0	0	0	0	0	0	0	0	0	14.91016
O15397	IPO8_HUMAN	"Importin-8, Imp8 (Ran-binding protein 8, RanBP8)"	IPO8 RANBP8	Homo sapiens (Human)	protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]	small GTPase binding [GO:0031267]	GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0031267	EMPVKVEAALALQSLISNQIQAK	6.559999943	1	1	7.76E-12	2481.098183	0	15.15928	0	18.5562	0	0	16.42798	0	0	16.1281	15.06062	15.64143	8.897476	18.37145	16.73601	17.48012	16.91705	18.11189	16.05931	0	16.37866	16.62674	0	0	15.16635	14.94517	0	14.79557	15.81492	14.73134	16.84702	17.89305	17.25555	0	15.42924	15.95923	16.77036	0	0	16.16817	15.43726	15.74526	14.35792	0	15.4686	11.88648	8.993093	0
O15399	NMDE4_HUMAN	"Glutamate receptor ionotropic, NMDA 2D, GluN2D (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D, NMDAR2D, NR2D)"	GRIN2D GluN2D NMDAR2D	Homo sapiens (Human)	"adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]"	endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]	"endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]"	glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0001964; GO:0004970; GO:0004972; GO:0005789; GO:0005886; GO:0005887; GO:0007420; GO:0008344; GO:0015276; GO:0016595; GO:0017146; GO:0022849; GO:0035249; GO:0038023; GO:0042165; GO:0045211; GO:0048167; GO:0048168; GO:0051930; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098686; GO:0098839; GO:0098976; GO:0098978; GO:0099061; GO:1904062; GO:1904315; GO:2000463	LGPAVAAAVR	6.599999905	0.349992782	0.349992782	0.048853141	921.5918622	16.39797	10.59164	15.65445	0	14.295	0	0	16.17143	15.95562	18.13791	16.95287	0	0	13.84907	16.05552	0	15.50091	0	0	16.09552	13.43762	0	0	17.5227	0	16.40137	15.97326	16.09762	17.71233	15.36506	15.57105	0	0	15.36135	0	17.64529	17.63214	15.31856	0	0	17.77379	14.86863	16.61599	11.5903	17.09178	0	16.01385	18.1824
O15400	STX7_HUMAN	Syntaxin-7	STX7	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]	azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076	QLEADIMDINEIFK	15.07999992	1	1	1.15E-12	1700.084647	0	0	0	0	0	0	0	0	16.3852	0	0	0	0	0	0	15.34359	15.48554	13.6844	0	15.50733	14.58149	0	0	0	15.53155	13.18885	0	15.94487	14.12446	0	0	0	14.4806	0	15.51048	0	0	0	0	0	0	0	0	0	0	0	0	0
O15403	MOT7_HUMAN	"Monocarboxylate transporter 7, MCT 7 (Monocarboxylate transporter 6, MCT 6) (Solute carrier family 16 member 6)"	SLC16A6 MCT6 MCT7	Homo sapiens (Human)	monocarboxylic acid transport [GO:0015718]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]	monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020; GO:0016021	ADMQQVLVKTSPRPSEK	9.949999809	1	1	0.021754589	1929.922607	0	0	0	0	0	0	0	15.74327	0	0	0	0	13.24234	13.61582	0	0	12.28725	14.79596	0	0	0	0	0	0	0	0	0	0	0	0	14.57506	14.16022	0	12.57646	15.94074	0	0	0	0	0	0	0	0	0	0	0	0	0
O15405	TOX3_HUMAN	TOX high mobility group box family member 3 (CAG trinucleotide repeat-containing gene F9 protein) (Trinucleotide repeat-containing gene 9 protein)	TOX3 CAGF9 TNRC9	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]	GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0031490; GO:0042803; GO:0042981; GO:0043524; GO:0045944; GO:0051219	RAAPDSGK	5.849999905	0.655496955	0.655496955	0.213993935	802.1486457	0	13.19718	0	0	0	0	0	7.83494	0	0	0	0	0	0	0	0	0	0	14.71251	9.828471	0	0	0	0	14.30606	0	0	11.18871	0	14.42998	0	0	0	0	0	13.65304	0	0	15.59849	13.35832	12.87185	0	0	0	0	15.39743	0	13.97411
O15417	TNC18_HUMAN	Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein)	TNRC18 CAGL79 KIAA1856	Homo sapiens (Human)		cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]	chromatin binding [GO:0003682]	GO:0003682; GO:0005654; GO:0005739; GO:0005829; GO:0031965	DPERPESAKAFGR	6.010000229	0.530795336	0.530795336	0.19049772	1460.313986	13.98217	16.41012	15.20631	0	17.38882	17.55534	17.12584	16.48061	12.70102	14.21819	16.60321	16.66111	13.37403	15.29584	15.27563	16.16873	12.80828	16.54689	13.81322	0	16.18708	16.35868	16.18598	16.6251	17.1592	16.33305	14.91404	14.09502	16.80513	17.13561	0	16.34776	16.75132	16.87029	15.87041	16.68267	15.19489	0	16.70588	0	16.32676	14.8986	0	14.76365	0	16.30156	14.21209	16.06015
O15438	MRP3_HUMAN	"ATP-binding cassette sub-family C member 3, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D, MOAT-D) (Multidrug resistance-associated protein 3)"	ABCC3 CMOAT2 MLP2 MRP3	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; glucuronoside transmembrane transporter activity [GO:0015164]; icosanoid transmembrane transporter activity [GO:0071714]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]	ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; glucuronoside transmembrane transporter activity [GO:0015164]; icosanoid transmembrane transporter activity [GO:0071714]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015164; GO:0015431; GO:0015432; GO:0015721; GO:0016020; GO:0016323; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0071714; GO:0071716; GO:0150104	IKLMSEILNGIK	12.64999962	1	1	0.352883141	1373.450469	7.923088	0	15.44908	0	0	12.3572	0	0	0	15.98804	0	0	14.98627	0	0	0	0	0	0	0	0	13.86509	0	0	0	0	15.9848	0	0	0	13.33047	15.09522	0	13.35486	14.75531	0	13.15508	0	0	14.97932	0	15.3174	0	0	0	0	16.65029	0
O15439	MRP4_HUMAN	"ATP-binding cassette sub-family C member 4, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B, MOAT-B) (Multidrug resistance-associated protein 4)"	ABCC4 MOATB MRP4	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]	15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104	KNQILIIDEATANVDPR	6.28000021	0.390462697	0.390462697	0.128763309	1909.151924	0	15.27458	13.61073	14.59124	0	0	14.47397	0	0	14.2864	14.33366	14.34332	15.31404	0	0	13.8259	0	0	0	0	0	0	15.16936	0	15.04821	14.97716	0	14.95943	0	0	0	0	0	0	14.06671	0	0	0	0	17.56853	16.32352	0	0	0	14.34721	0	14.43603	13.63051
O15440	MRP5_HUMAN	"ATP-binding cassette sub-family C member 5, EC 7.6.2.-, EC 7.6.2.2 (Multi-specific organic anion transporter C, MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11)"	ABCC5 MRP5	Homo sapiens (Human)	cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910]; cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005796; GO:0005886; GO:0005887; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0150104	MKDIDIGK	3.410000086	1	1	0.246491193	919.0410634	18.02553	17.78318	17.15724	15.4206	16.04846	15.82387	13.87733	16.11765	14.05851	14.70566	15.53793	6.88494	16.32781	16.33901	17.68391	15.98952	16.43542	15.11687	15.79309	17.16657	0	0	0	0	16.63121	0	0	17.36452	15.22741	16.57689	0	19.02964	17.67701	0	18.27371	0	0	17.44823	0	17.4908	0	15.93302	0	0	0	16.77122	15.27802	16.51964
O15455	TLR3_HUMAN	Toll-like receptor 3 (CD antigen CD283)	TLR3	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to mechanical stimulus [GO:0071260]; cellular response to virus [GO:0098586]; cellular response to xenobiotic stimulus [GO:0071466]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; I-kappaB phosphorylation [GO:0007252]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic signaling pathway [GO:0097527]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type III interferon production [GO:0034346]; regulation of dendritic cell cytokine production [GO:0002730]; response to dsRNA [GO:0043331]; response to exogenous dsRNA [GO:0043330]; signal transduction [GO:0007165]; toll-like receptor 3 signaling pathway [GO:0034138]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; NAD+ nucleosidase activity [GO:0003953]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to mechanical stimulus [GO:0071260]; cellular response to virus [GO:0098586]; cellular response to xenobiotic stimulus [GO:0071466]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; I-kappaB phosphorylation [GO:0007252]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic signaling pathway [GO:0097527]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type III interferon production [GO:0034346]; regulation of dendritic cell cytokine production [GO:0002730]; response to dsRNA [GO:0043331]; response to exogenous dsRNA [GO:0043330]; signal transduction [GO:0007165]; toll-like receptor 3 signaling pathway [GO:0034138]	double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; NAD+ nucleosidase activity [GO:0003953]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	GO:0000139; GO:0001774; GO:0002730; GO:0002756; GO:0003725; GO:0003953; GO:0004888; GO:0005615; GO:0005737; GO:0005765; GO:0005769; GO:0005789; GO:0005887; GO:0006972; GO:0007165; GO:0007250; GO:0007252; GO:0007254; GO:0008584; GO:0009597; GO:0010008; GO:0010628; GO:0016020; GO:0031012; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034123; GO:0034138; GO:0034346; GO:0035458; GO:0036020; GO:0038023; GO:0042742; GO:0042802; GO:0043065; GO:0043123; GO:0043330; GO:0043331; GO:0045087; GO:0045671; GO:0045766; GO:0045944; GO:0046330; GO:0050729; GO:0051092; GO:0051607; GO:0071260; GO:0071346; GO:0071360; GO:0071466; GO:0097191; GO:0097527; GO:0098586; GO:1901224	EFSPGCFHAIGR	13.21000004	1	1	0.614598072	1376.183751	15.05826	0	18.7995	0	0	0	0	0	18.92323	0	18.61466	19.51524	0	0	0	0	0	17.41449	0	15.57502	0	0	0	0	0	0	0	0	0	0	0	18.74418	0	0	0	17.61377	0	0	0	0	0	0	0	17.78082	0	0	0	0
O15479	MAGB2_HUMAN	"Melanoma-associated antigen B2 (Cancer/testis antigen 3.2, CT3.2) (DSS-AHC critical interval MAGE superfamily 6, DAM6) (MAGE XP-2 antigen) (MAGE-B2 antigen)"	MAGEB2	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005634	NASSSQASTSTK	4.920000076	0.435498178	0.435498178	0.156665257	1167.813663	15.61548	16.58255	0	0	0	15.69035	16.6361	0	14.01378	0	16.21885	0	0	13.01258	16.44201	14.44998	16.06748	14.99491	15.0581	0	15.52042	14.28108	17.05675	16.39079	18.15202	17.38051	13.34619	16.44114	16.6543	11.13592	15.04463	0	15.51369	16.12979	0	0	14.74602	14.63281	0	10.02972	16.01757	14.73983	15.46028	11.00599	19.96908	0	0	0
O15480	MAGB3_HUMAN	Melanoma-associated antigen B3 (MAGE-B3 antigen)	MAGEB3	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005634	DSYVLVSK	4.039999962	0.138301611	0.138301611	0.287490675	910.6365814	15.12679	17.94243	0	0	19.02902	0	0	17.82036	0	0	18.84931	0	18.12659	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.2903	18.01683	18.69826	0	0	0	0	0	0	0	0	17.79465	0	0	16.72214	18.0348
O15481	MAGB4_HUMAN	Melanoma-associated antigen B4 (MAGE-B4 antigen)	MAGEB4	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005634; GO:0005737	GTTAMTSAYSRATSSSSSQPM	1.870000005	0.338299572	0.338299572	0.03332142	2135.410905	15.49263	0	0	0	14.18037	0	0	0	0	0	11.98514	0	0	0	0	11.46367	0	0	0	11.91852	0	0	0	0	14.27693	0	0	0	0	14.43261	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.47049	0	0	0
O15484	CAN5_HUMAN	"Calpain-5, EC 3.4.22.- (Calpain htra-3) (New calpain 3, nCL-3)"	CAPN5 NCL3	Homo sapiens (Human)	proteolysis [GO:0006508]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0045202; GO:0070062	GGLISASIK	10.10999966	0.957497001	0.957497001	0.003040548	846.9974008	15.50256	0	14.75651	17.58642	16.52009	15.35529	12.54468	0	16.04626	16.60254	0	16.33461	16.44858	0	0	10.9018	0	15.14894	15.36497	10.70012	15.84267	0	15.81837	0	0	0	15.82628	0	9.989807	16.32965	15.23645	8.61661	16.71027	16.49691	0	17.47366	17.76639	18.13937	0	0	14.6869	0	14.63735	0	12.16928	15.55894	14.8484	14.13794
O15496	PA2GX_HUMAN	"Group 10 secretory phospholipase A2, EC 3.1.1.4 (Group X secretory phospholipase A2, GX sPLA2, sPLA2-X) (Phosphatidylcholine 2-acylhydrolase 10)"	PLA2G10	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; defense response to virus [GO:0051607]; erythrocyte maturation [GO:0043249]; fertilization [GO:0009566]; hair follicle morphogenesis [GO:0031069]; intestinal stem cell homeostasis [GO:0036335]; low-density lipoprotein particle remodeling [GO:0034374]; lysophospholipid transport [GO:0051977]; macrophage activation [GO:0042116]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of inflammatory response [GO:0050728]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; platelet activating factor catabolic process [GO:0062234]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; prostaglandin biosynthetic process [GO:0001516]; regulation of macrophage activation [GO:0043030]	acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]	acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; defense response to virus [GO:0051607]; erythrocyte maturation [GO:0043249]; fertilization [GO:0009566]; hair follicle morphogenesis [GO:0031069]; intestinal stem cell homeostasis [GO:0036335]; low-density lipoprotein particle remodeling [GO:0034374]; lysophospholipid transport [GO:0051977]; macrophage activation [GO:0042116]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of inflammatory response [GO:0050728]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; platelet activating factor catabolic process [GO:0062234]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; prostaglandin biosynthetic process [GO:0001516]; regulation of macrophage activation [GO:0043030]	1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; phospholipid binding [GO:0005543]	GO:0001516; GO:0001669; GO:0002532; GO:0003847; GO:0004620; GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0006644; GO:0006658; GO:0007411; GO:0009566; GO:0010744; GO:0010884; GO:0019369; GO:0031069; GO:0032270; GO:0032308; GO:0034374; GO:0034638; GO:0036335; GO:0042116; GO:0042632; GO:0043030; GO:0043249; GO:0043433; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0047498; GO:0050482; GO:0050728; GO:0051607; GO:0051977; GO:0062234; GO:0090238; GO:0090370; GO:1900016; GO:1990830; GO:2000344	TPIAYMK	8.779999733	0.176138163	0.176138163	0.20588811	823.4621112	17.75793	18.13396	17.07589	16.97842	17.10462	0	15.74959	16.01594	0	17.66606	15.45785	17.22174	17.30291	14.36859	15.74728	0	16.67842	16.52042	16.07638	0	0	18.54281	17.14178	16.45478	17.55629	16.17154	17.83739	17.50755	17.10309	16.55093	15.88412	17.77264	17.31207	17.18448	17.28154	16.80043	18.11469	18.75425	18.5656	0	16.83318	0	17.97034	17.86703	17.58498	16.09815	16.60021	17.87598
O15511	ARPC5_HUMAN	"Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit, p16-ARC)"	ARPC5 ARC16	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; regulation of actin filament polymerization [GO:0030833]; smooth muscle cell migration [GO:0014909]	actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]	actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; regulation of actin filament polymerization [GO:0030833]; smooth muscle cell migration [GO:0014909]	actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]	GO:0003779; GO:0005200; GO:0005576; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005885; GO:0005925; GO:0014909; GO:0015629; GO:0016477; GO:0021769; GO:0030011; GO:0030027; GO:0030036; GO:0030426; GO:0030833; GO:0034314; GO:0034774; GO:0035861; GO:0051639; GO:0061842; GO:0070062; GO:0097581; GO:1904813	NTVSSAR	5.210000038	0.189689785	0.189689785	0.243936931	736.2873669	0	0	15.56444	0	15.38382	15.90054	16.32716	15.79363	15.5886	15.67292	15.56643	15.59099	14.82389	15.42945	13.76572	14.96533	0	0	15.68667	15.18073	0	15.10871	0	15.67142	15.31309	0	0	15.90224	14.18857	0	16.50406	15.44294	0	0	0	16.86691	0	0	0	16.02092	0	0	17.75592	15.87163	0	16.57904	0	15.69392
O15525	MAFG_HUMAN	Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF)	MAFG	Homo sapiens (Human)	adult behavior [GO:0030534]; in utero embryonic development [GO:0001701]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult behavior [GO:0030534]; in utero embryonic development [GO:0001701]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030534; GO:0030641; GO:0042127; GO:0042802; GO:0045604; GO:0046982; GO:0090575; GO:1990837	GNKALK	13.21000004	0.27644974	0.27644974	0.318756006	631.1753904	0	0	15.19633	0	0	0	15.95912	15.0591	0	0	0	14.87547	17.33202	15.02668	16.20948	0	17.0689	16.23608	17.6101	16.64802	18.16687	16.03869	17.27476	0	17.08061	17.14074	16.1111	15.99841	16.31358	0	17.62405	0	16.35506	0	17.297	16.91824	0	17.63564	16.93636	19.00916	0	0	16.87423	17.15308	17.21831	0	15.97399	17.93906
O15533	TPSN_HUMAN	"Tapasin, TPN, TPSN (NGS-17) (TAP-associated protein) (TAP-binding protein)"	TAPBP NGS17 TAPA	Homo sapiens (Human)	"antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; immune response [GO:0006955]; MHC class I protein complex assembly [GO:0002397]; MHC class Ib protein complex assembly [GO:0002398]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide antigen stabilization [GO:0050823]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of immune response [GO:0050776]; regulation of protein complex stability [GO:0061635]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; Tapasin-ERp57 complex [GO:0061779]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; Tapasin-ERp57 complex [GO:0061779]; ABC-type peptide antigen transporter activity [GO:0015433]; antigen binding [GO:0003823]; MHC class I protein binding [GO:0042288]; peptide antigen binding [GO:0042605]; TAP complex binding [GO:0062061]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; unfolded protein binding [GO:0051082]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; immune response [GO:0006955]; MHC class I protein complex assembly [GO:0002397]; MHC class Ib protein complex assembly [GO:0002398]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide antigen stabilization [GO:0050823]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of immune response [GO:0050776]; regulation of protein complex stability [GO:0061635]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	ABC-type peptide antigen transporter activity [GO:0015433]; antigen binding [GO:0003823]; MHC class I protein binding [GO:0042288]; peptide antigen binding [GO:0042605]; TAP complex binding [GO:0062061]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; unfolded protein binding [GO:0051082]	GO:0000139; GO:0002397; GO:0002398; GO:0002502; GO:0003823; GO:0005783; GO:0005789; GO:0006890; GO:0006955; GO:0010468; GO:0015433; GO:0016021; GO:0019885; GO:0030670; GO:0033116; GO:0042288; GO:0042605; GO:0042824; GO:0046978; GO:0046979; GO:0050776; GO:0050823; GO:0051082; GO:0061635; GO:0061779; GO:0062061; GO:0065003; GO:0071556	VSLMPATLAR	8.960000038	1	1	0.244319912	1074.254504	0	13.88542	16.84999	15.26627	13.71968	14.16991	0	15.45591	0	0	0	15.78758	0	12.9804	14.93093	0	15.82001	14.53365	0	16.50959	0	0	0	0	0	0	0	0	15.68169	14.94055	0	15.54673	0	14.23879	0	0	0	0	0	0	0	0	0	0	0	14.12334	0	0
O15534	PER1_HUMAN	"Period circadian protein homolog 1, hPER1 (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui)"	PER1 KIAA0482 PER RIGUI	Homo sapiens (Human)	"circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; histone H3 acetylation [GO:0043966]; histone H3 deacetylation [GO:0070932]; histone H4 acetylation [GO:0043967]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of circadian rhythm [GO:0042752]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of hair cycle [GO:0042634]; regulation of p38MAPK cascade [GO:1900744]; regulation of sodium ion transport [GO:0002028]; response to cAMP [GO:0051591]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; histone H3 acetylation [GO:0043966]; histone H3 deacetylation [GO:0070932]; histone H4 acetylation [GO:0043967]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of circadian rhythm [GO:0042752]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of hair cycle [GO:0042634]; regulation of p38MAPK cascade [GO:1900744]; regulation of sodium ion transport [GO:0002028]; response to cAMP [GO:0051591]"	chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0000976; GO:0000978; GO:0001222; GO:0002028; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007623; GO:0009649; GO:0010608; GO:0019900; GO:0031490; GO:0031625; GO:0032922; GO:0042634; GO:0042752; GO:0043124; GO:0043153; GO:0043966; GO:0043967; GO:0045892; GO:0045944; GO:0046329; GO:0051591; GO:0070888; GO:0070932; GO:0097167; GO:0140297; GO:1900015; GO:1900744; GO:2000323	YLESCNLPSTTKR	11.81000042	0.190285146	0.190285146	0.200054147	1568.150003	19.27306	16.96248	0	12.81466	0	17.08595	0	15.15396	15.0528	15.59995	15.54311	14.51448	12.14191	18.56484	0	12.10723	16.43149	0	14.856	17.31697	14.57711	15.4294	16.35432	0	18.27936	14.8522	15.22541	17.03457	16.22421	0	0	16.41118	17.50413	14.21413	17.52607	16.29816	16.55318	0	17.38725	0	14.89523	16.65759	17.91297	0	14.79668	16.64571	0	16.39651
O15535	ZSC9_HUMAN	Zinc finger and SCAN domain-containing protein 9 (Cell proliferation-inducing gene 12 protein) (PRD51) (Zinc finger protein 193)	ZSCAN9 ZNF193 PIG12	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	IHTVAELV	2.529999971	1	1	1.15E-13	884.0187077	15.93743	0	15.72105	0	14.51162	0	0	0	0	0	14.98305	0	0	15.05406	0	15.23734	0	0	0	0	0	0	0	0	15.55538	0	0	0	0	0	0	0	0	0	0	16.40819	0	0	0	0	0	0	0	0	0	0	14.32078	0
O15550	KDM6A_HUMAN	"Lysine-specific demethylase 6A, EC 1.14.11.68 (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)"	KDM6A UTX	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; histone H3-K4 methylation [GO:0051568]; regulation of gene expression [GO:0010468]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; histone H3-K4 methylation [GO:0051568]; regulation of gene expression [GO:0010468]	chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0051568; GO:0071557; GO:0071558	CYLNATR	11.07999992	1	1	0.272010422	898.0041733	11.39954	19.06863	16.20892	0	18.18879	17.11539	0	0	0	17.27563	0	0	17.69824	18.01666	0	0	0	19.83679	0	0	0	0	0	0	18.06953	0	0	17.39367	0	18.718	19.03572	0	0	0	0	19.13645	0	0	18.57908	0	17.89629	18.11236	17.64997	0	0	0	18.0356	0
O15552	FFAR2_HUMAN	Free fatty acid receptor 2 (G-protein coupled receptor 43)	FFAR2 FFA2 GPCR43 GPR43	Homo sapiens (Human)	cell surface pattern recognition receptor signaling pathway [GO:0002752]; cellular response to fatty acid [GO:0071398]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipid storage [GO:0019915]; mucosal immune response [GO:0002385]; positive regulation of acute inflammatory response to non-antigenic stimulus [GO:0002879]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-8 production [GO:0032757]; regulation of acute inflammatory response [GO:0002673]; regulation of peptide hormone secretion [GO:0090276]	cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; cellular response to fatty acid [GO:0071398]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipid storage [GO:0019915]; mucosal immune response [GO:0002385]; positive regulation of acute inflammatory response to non-antigenic stimulus [GO:0002879]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-8 production [GO:0032757]; regulation of acute inflammatory response [GO:0002673]; regulation of peptide hormone secretion [GO:0090276]	G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]	GO:0002232; GO:0002385; GO:0002673; GO:0002720; GO:0002752; GO:0002879; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008289; GO:0019915; GO:0032722; GO:0032757; GO:0042593; GO:0042995; GO:0045444; GO:0071398; GO:0090276	IIEAASNFR	2.339999914	1	1	0.203980251	1021.078739	9.55902	0	14.41514	12.06795	11.40119	15.03953	14.43544	15.64426	12.84065	0	14.38358	14.78018	0	0	0	14.43023	0	16.42839	0	0	0	0	0	0	0	0	0	0	0	0	0	15.58703	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O15553	MEFV_HUMAN	Pyrin (Marenostrin)	MEFV MEF TRIM20	Homo sapiens (Human)	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; protein ubiquitination [GO:0016567]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; regulation of gene expression [GO:0010468]; regulation of interleukin-1 beta production [GO:0032651]; response to interferon-gamma [GO:0034341]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; protein ubiquitination [GO:0016567]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; regulation of gene expression [GO:0010468]; regulation of interleukin-1 beta production [GO:0032651]; response to interferon-gamma [GO:0034341]	actin binding [GO:0003779]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0001726; GO:0002221; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005829; GO:0005874; GO:0005875; GO:0006954; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0030027; GO:0031410; GO:0032651; GO:0032691; GO:0032695; GO:0032731; GO:0034341; GO:0042802; GO:0045087; GO:0050728; GO:0061630; GO:0061702; GO:0070269; GO:0071641; GO:1900016; GO:1900226; GO:1904270; GO:2001056	LPDGPQRFDSCIIVLGSPSFLSGR	1.49000001	1	1	0.129133673	2617.546513	10.85968	0	13.0487	0	0	12.89272	0	0	0	0	0	0	0	0	0	0	12.20822	12.21686	0	0	0	0	0	6.623271	11.22503	0	0	0	10.10219	0	0	13.09904	0	0	0	0	0	0	0	0	0	0	0	0	13.92434	0	0	0
O43143	DHX15_HUMAN	"ATP-dependent RNA helicase DHX15, EC 3.6.4.13 (ATP-dependent RNA helicase #46) (DEAH box protein 15) (Splicing factor Prp43, hPrp43)"	DHX15 DBP1 DDX15	Homo sapiens (Human)	antiviral innate immune response [GO:0140374]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; antiviral innate immune response [GO:0140374]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0016887; GO:0043123; GO:0043279; GO:0051607; GO:0140374	AGRTRPGK	7.929999828	1	1	0.031143526	842.655321	15.89936	14.87512	13.95961	14.80078	15.57828	14.50412	0	0	0	0	0	0	0	18.20011	0	0	16.50632	0	0	0	0	16.99747	0	15.91147	0	0	0	0	0	0	0	0	16.6701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43147	SGSM2_HUMAN	Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)	SGSM2 KIAA0397 RUTBC1	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547]	cytoplasm [GO:0005737]; melanosome [GO:0042470]	cytoplasm [GO:0005737]; melanosome [GO:0042470]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547]	GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]	GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630	GPPTR	9.100000381	1	1	0.006600381	525.376963	0	0	0	0	0	0	0	0	0	0	0	0	14.01114	15.82318	0	0	0	14.81156	0	0	15.44703	14.77709	11.24893	15.80491	0	0	15.34458	0	11.96674	0	14.96245	15.75987	13.50803	0	11.62275	0	0	0	0	0	0	0	0	0	0	0	0	0
O43149	ZZEF1_HUMAN	Zinc finger ZZ-type and EF-hand domain-containing protein 1	ZZEF1 KIAA0399	Homo sapiens (Human)			calcium ion binding [GO:0005509]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	calcium ion binding [GO:0005509]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0003713; GO:0005509; GO:0008270; GO:0035064; GO:0070577	AHGFEEIR	5.650000095	0.752023458	0.752023458	0.209636774	958.6689645	14.77397	14.9971	0	11.67432	13.80309	15.32496	13.84594	14.19135	14.59759	14.85997	14.75212	15.66865	15.82621	16.53915	0	13.25379	13.71272	0	0	15.56799	16.24747	14.49812	14.93728	13.73161	0	0	0	0	16.55276	0	0	17.16505	0	17.52389	14.71787	0	16.1746	15.90598	0	15.51102	0	0	15.65466	14.9821	0	0	16.56586	0
O43150	ASAP2_HUMAN	"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3, PAG3) (Pyk2 C-terminus-associated protein, PAP)"	ASAP2 DDEF2 KIAA0400	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]	Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886]	Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of GTPase activity [GO:0043547]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005886; GO:0032580; GO:0043547; GO:0046872	ASIEIANESGETPLDIAK	6.860000134	1	1	9.18E-13	1858.793339	12.4434	0	0	13.6439	15.59823	0	0	0	0	0	0	15.96949	0	0	0	0	15.29577	0	15.84789	0	0	0	16.45231	16.21203	0	0	0	0	0	0	0	0	0	0	14.15382	16.27563	14.60667	15.95074	0	0	0	0	0	14.14834	0	0	0	0
O43151	TET3_HUMAN	"Methylcytosine dioxygenase TET3, EC 1.14.11.n2"	TET3 KIAA0401	Homo sapiens (Human)	5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; DNA demethylation of male pronucleus [GO:0044727]; histone H3-K4 trimethylation [GO:0080182]; oxidative demethylation [GO:0070989]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; DNA demethylation of male pronucleus [GO:0044727]; histone H3-K4 trimethylation [GO:0080182]; oxidative demethylation [GO:0070989]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]	methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]	GO:0001939; GO:0001940; GO:0005634; GO:0005694; GO:0005737; GO:0006211; GO:0006325; GO:0006493; GO:0008270; GO:0008327; GO:0044727; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0080182	RPEALPTKPK	5.929999828	1	1	0.276691385	1137.381639	16.78506	15.11553	14.21703	0	0	0	0	0	0	0	0	0	0	15.75515	0	15.93733	0	0	0	0	0	0	0	0	0	0	0	0	0	14.9421	14.50603	0	0	0	16.1559	15.97853	13.07694	0	15.11524	14.70972	10.00475	0	0	0	0	0	0	0
O43155	FLRT2_HUMAN	Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2)	FLRT2 KIAA0405 UNQ232/PRO265	Homo sapiens (Human)	axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222]	cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein-macromolecule adaptor activity [GO:0030674]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222]	chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003007; GO:0005104; GO:0005615; GO:0005789; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007411; GO:0008543; GO:0030674; GO:0031012; GO:0043005; GO:0045202; GO:0045499; GO:0051965; GO:0061343; GO:0070062; GO:0071711; GO:2001222	LKEFSIVR	11.43999958	1	1	0.187238597	990.7875066	16.63689	13.3238	0	15.40168	0	11.52739	0	18.95699	15.29559	0	0	0	0	0	0	0	0	0	0	14.15723	0	0	0	0	15.09721	0	14.62185	0	0	15.48983	16.62974	16.14628	15.80649	16.29312	0	16.36708	16.09037	15.5724	15.39757	13.3133	14.83852	0	0	0	0	0	0	0
O43159	RRP8_HUMAN	"Ribosomal RNA-processing protein 8, EC 2.1.1.- (Cerebral protein 1) (Nucleomethylin)"	RRP8 KIAA0409 NML hucep-1	Homo sapiens (Human)	"cellular response to glucose starvation [GO:0042149]; energy homeostasis [GO:0097009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; rDNA heterochromatin assembly [GO:0000183]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]"	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]	"chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to glucose starvation [GO:0042149]; energy homeostasis [GO:0097009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; rDNA heterochromatin assembly [GO:0000183]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]"	methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0000183; GO:0003723; GO:0005654; GO:0005677; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0008757; GO:0031062; GO:0031065; GO:0032259; GO:0033553; GO:0035064; GO:0042149; GO:0045786; GO:0045892; GO:0046015; GO:0061773; GO:0072332; GO:0097009; GO:1903450	KASFASASAEVGK	8.199999809	1	1	0.277471652	1251.597145	16.43885	0	13.06967	12.52042	14.68416	11.71718	14.39573	12.86594	15.34315	14.62581	0	9.938841	0	0	0	0	0	0	0	0	0	0	0	0	16.71288	0	16.01549	0	13.85731	13.6416	15.50067	16.12932	0	0	12.99439	16.67903	16.03171	0	0	0	16.52589	0	16.67426	17.63954	0	14.38759	0	16.76105
O43164	PJA2_HUMAN	"E3 ubiquitin-protein ligase Praja-2, Praja2, EC 2.3.2.27 (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2)"	PJA2 KIAA0438 RNF131	Homo sapiens (Human)	hippo signaling [GO:0035329]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; protein ubiquitination [GO:0016567]; regulation of macrophage activation [GO:0043030]; regulation of protein kinase A signaling [GO:0010738]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin-protein transferase activity [GO:0004842]; hippo signaling [GO:0035329]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; protein ubiquitination [GO:0016567]; regulation of macrophage activation [GO:0043030]; regulation of protein kinase A signaling [GO:0010738]	metal ion binding [GO:0046872]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0004842; GO:0005737; GO:0005789; GO:0005886; GO:0006954; GO:0007616; GO:0010738; GO:0014069; GO:0016567; GO:0034137; GO:0034236; GO:0034237; GO:0035329; GO:0043030; GO:0045087; GO:0045111; GO:0046330; GO:0046872; GO:1900745	SGTCPVCRR	1.419999957	1	1	0.075146389	1093.04468	0	0	0	0	0	0	12.37718	0	0	15.8025	0	15.5826	0	0	0	14.10899	0	0	0	0	0	0	0	0	0	0	0	0	0	13.34452	0	0	0	0	0	0	0	0	0	15.3699	0	0	0	0	0	0	0	0
O43166	SI1L1_HUMAN	"Signal-induced proliferation-associated 1-like protein 1, SIPA1-like protein 1 (High-risk human papilloma viruses E6 oncoproteins targeted protein 1, E6-targeted protein 1)"	SIPA1L1 E6TP1 KIAA0440	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]	ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005886; GO:0014069; GO:0015629; GO:0031532; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0048814; GO:0050770; GO:0051056; GO:0061001; GO:0090630	GPHSPQVPSQVQSPMTSRLNAGK	3.029999971	1	1	0	2402.725312	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43167	ZBT24_HUMAN	Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450)	ZBTB24 KIAA0441 ZNF450	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0002244; GO:0003700; GO:0005634; GO:0006357; GO:0046872	EESEPTCEPSREEEMPVEK	1.929999948	1	1	0.095038829	2304.755668	0	0	0	0	16.64758	17.13	15.5771	0	0	15.68042	0	0	15.04923	13.85624	14.77445	0	17.73066	0	0	0	0	15.47541	15.81857	16.35167	13.6945	16.20967	0	0	15.60358	16.48184	0	15.77368	0	0	0	0	0	0	18.4057	0	0	0	0	0	0	16.64661	0	15.09409
O43169	CYB5B_HUMAN	Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform)	CYB5B CYB5M OMB5	Homo sapiens (Human)	nitric oxide biosynthetic process [GO:0006809]; response to oxidative stress [GO:0006979]; xenobiotic metabolic process [GO:0006805]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nitric-oxide synthase complex [GO:1903958]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nitric-oxide synthase complex [GO:1903958]; enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide biosynthetic process [GO:0006809]; response to oxidative stress [GO:0006979]; xenobiotic metabolic process [GO:0006805]	enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0005741; GO:0006805; GO:0006809; GO:0006979; GO:0008047; GO:0016020; GO:0016021; GO:0020037; GO:0043231; GO:0046872; GO:1903958	EMLKQYYIGDIHPSDLKPESGSK	4.059999943	1	1	2.76E-12	2634.882339	0	0	15.31357	0	0	0	0	14.54497	0	0	0	13.5252	16.3252	0	0	14.81504	0	0	0	15.58403	0	14.95794	16.92627	0	0	0	0	0	14.83452	0	0	0	16.81448	14.13152	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43173	SIA8C_HUMAN	"Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase, EC 2.4.99.- (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sialyltransferase 8C, SIAT8-C) (Sialyltransferase St8Sia III, ST8SiaIII)"	ST8SIA3 SIAT8C	Homo sapiens (Human)	ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialic acid binding [GO:0033691]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]"	"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialic acid binding [GO:0033691]; sialyltransferase activity [GO:0008373]"	GO:0000139; GO:0001574; GO:0003828; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009100; GO:0009311; GO:0016021; GO:0033691; GO:0042802; GO:1990743	HLSPKR	5.889999866	0.956252396	0.956252396	0.292272527	737.9198591	14.48168	16.52718	15.83705	15.00667	15.00935	0	15.36726	15.44427	15.58404	15.96086	15.84024	15.31009	15.60454	17.062	16.7579	15.5278	14.85311	0	15.87769	17.71569	15.75927	15.88832	15.91684	16.40949	16.6783	0	16.40366	16.40569	0	16.26365	16.87518	16.5648	18.11867	16.29459	16.84838	16.04241	17.07843	17.81235	0	16.43097	17.38752	17.4342	0	16.86926	16.31986	15.63465	18.12861	15.61228
O43175	SERA_HUMAN	"D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)"	PHGDH PGDH3	Homo sapiens (Human)	brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]	electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0005829; GO:0006541; GO:0006544; GO:0006564; GO:0006566; GO:0007420; GO:0009055; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0030060; GO:0031175; GO:0051287; GO:0070062; GO:0070314	EVATRMQSFGMK	2.099999905	1	1	0.204973904	1383.818352	14.29617	13.94989	0	0	13.86537	14.35165	15.12046	13.82404	15.53656	0	0	12.76694	0	0	0	16.00018	0	0	15.6225	0	16.33459	0	14.76761	15.34952	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.2864	0	0	0	0	0	16.25902	0
O43181	NDUS4_HUMAN	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa, CI-18 kDa) (Complex I-AQDQ, CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)"	NDUFS4	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]"	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0001932; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007420; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0045333; GO:0048146; GO:0051591; GO:0072593	KVPKPK	5.630000114	1	1	0.159082261	695.7676688	0	0	0	0	14.66166	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.87669	0	0	0	0	0	0	0	0	0	0	15.49522	0	0	0	0	0	0	0	0	0	0	17.67031	0	0	0	0	0
O43182	RHG06_HUMAN	Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1)	ARHGAP6 RHOGAP6	Homo sapiens (Human)	actin filament polymerization [GO:0030041]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]; actin filament polymerization [GO:0030041]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]	GO:0005096; GO:0005737; GO:0005829; GO:0005884; GO:0007202; GO:0007266; GO:0010518; GO:0015629; GO:0016004; GO:0017124; GO:0030041; GO:0043274; GO:0043547; GO:0048041; GO:0051056; GO:0051497; GO:0051895	MSAQSLLHSVFSCSSPASSSAASAKGFSK	4.349999905	0.843576968	0.843576968	0.214626547	2916.793388	0	0	0	11.93701	12.4088	13.48795	12.18332	12.68999	14.65794	0	14.47567	10.97717	14.27639	0	14.49056	0	0	0	13.59004	10.87872	14.13859	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.35231	12.2464	13.95183	0	0	0	0	14.14674	0
O43186	CRX_HUMAN	Cone-rod homeobox protein	CRX CORD2	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"	chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"	"DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007399; GO:0007601; GO:0009887; GO:0016922; GO:0030154; GO:0043522; GO:0045944; GO:0050896; GO:0061629; GO:0090575; GO:1990837	DQSAWK	4.019999981	1	1	0.145494182	734.8412575	0	13.05448	14.3373	0	0	0	12.89115	0	0	15.72743	0	15.89223	0	15.19276	0	0	0	0	0	0	15.03907	0	0	0	0	0	0	0	15.2454	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.47024	0	0	0
O43189	PHF1_HUMAN	"PHD finger protein 1, Protein PHF1, hPHF1 (Polycomb-like protein 1, hPCl1)"	PHF1 PCL1	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription corepressor binding [GO:0001222]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription corepressor binding [GO:0001222]	GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006325; GO:0006355; GO:0006974; GO:0035064; GO:0035861; GO:0042802; GO:0046872; GO:0061086; GO:0061087; GO:1990226	GERSSR	7.909999847	0.683127284	0.683127284	0.296742507	689.9184794	17.56576	0	15.82355	0	18.06991	0	18.2412	0	17.12964	0	0	0	16.67228	0	0	17.22844	0	0	0	17.0093	18.60159	0	16.64654	16.50495	0	0	0	16.6772	0	0	0	0	18.40991	0	0	0	0	0	0	17.49708	17.19808	0	0	0	0	0	0	0
O43193	MTLR_HUMAN	Motilin receptor (G-protein coupled receptor 38)	MLNR GPR38 MTLR MTLR1	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]	GO:0004930; GO:0005829; GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0042562	GPAASGR	1.950000048	0.446426451	0.446426451	0.207088377	611.9980808	0	0	9.064896	0	13.24971	15.20622	0	0	0	0	0	13.68223	0	15.11253	15.60433	0	16.82965	0	17.11048	0	15.42619	0	14.2991	0	0	16.53294	0	14.68015	14.07413	0	16.5255	17.09657	0	0	11.92419	0	0	0	0	0	14.75263	16.16658	0	0	0	0	16.30194	17.56593
O43194	GPR39_HUMAN	G-protein coupled receptor 39	GPR39	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872]	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0046872	IMAAAKPK	5.679999828	1	1	0.240957828	829.7418969	0	16.92216	16.57062	15.64266	16.48235	17.11265	15.945	15.4711	14.30342	0	16.95798	0	0	16.02213	14.87031	0	0	14.87518	16.49274	13.4347	0	0	0	16.77255	17.54611	0	0	15.8699	0	15.44048	16.1048	0	17.99419	0	17.62296	17.64329	15.21535	15.2501	0	15.7906	17.58471	0	14.42084	0	0	0	16.36486	0
O43236	SEPT4_HUMAN	"Septin-4 (Bradeion beta) (Brain protein H5) (CE5B3 beta) (Cell division control-related protein 2, hCDCREL-2) (Peanut-like protein 2)"	SEPTIN4 C17orf47 PNUTL2 SEP4 SEPT4 hucep-7	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; hematopoietic stem cell homeostasis [GO:0061484]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatid differentiation [GO:0048515]	axon [GO:0030424]; cell division site [GO:0032153]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021]	axon [GO:0030424]; cell division site [GO:0032153]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; apoptotic process [GO:0006915]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; hematopoietic stem cell homeostasis [GO:0061484]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatid differentiation [GO:0048515]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]	GO:0000287; GO:0001764; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005940; GO:0006915; GO:0008021; GO:0015630; GO:0017157; GO:0030317; GO:0030424; GO:0030425; GO:0031105; GO:0031398; GO:0032153; GO:0034613; GO:0042802; GO:0042981; GO:0043065; GO:0043204; GO:0048515; GO:0060090; GO:0061484; GO:0061640; GO:0097227; GO:2001244	GFDFTLMVAGESGLGKSTLVNSLFLTDLYR	2.190000057	1	1	9.16E-13	3266.481982	0	0	0	0	13.75262	0	0	0	0	0	0	0	8.916475	13.74577	0	0	0	0	0	0	12.60282	10.41366	0	0	0	12.95335	13.5922	12.29247	12.5867	12.00354	0	0	15.74401	0	0	15.40492	0	0	12.88658	0	0	0	16.06451	0	0	0	0	11.34752
O43237	DC1L2_HUMAN	"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic, LIC-2) (LIC53/55)"	DYNC1LI2 DNCLI2 LIC2	Homo sapiens (Human)	cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule [GO:0005874]	centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]	GO:0000226; GO:0000776; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0007018; GO:0016020; GO:0030286; GO:0042802; GO:0045504; GO:0051642; GO:1990090	MAPVGVEKK	5.679999828	0.80584538	0.80584538	0.149045483	960.0367042	15.76645	15.07056	16.54185	0	15.55559	14.36673	16.9939	0	14.74192	0	0	15.93342	0	13.32339	0	0	0	0	0	0	0	0	0	16.19798	0	0	16.22311	0	0	0	0	0	0	0	14.68327	0	17.03496	0	0	0	0	0	0	14.77712	0	0	0	0
O43242	PSMD3_HUMAN	26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58)	PSMD3	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]"	enzyme regulator activity [GO:0030234]	GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813	TGNLAK	3.420000076	1	1	0.180982579	603.3458685	0	14.76201	0	16.07053	0	0	0	14.13618	0	15.93445	16.24239	10.85885	0	0	0	16.09306	0	0	16.77454	16.39536	16.93442	14.72345	15.85561	16.10846	0	0	0	0	0	0	0	0	15.23909	0	0	0	17.08734	0	16.11514	15.75771	0	0	0	0	0	16.39724	0	0
O43252	PAPS1_HUMAN	"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1, PAPS synthase 1, PAPSS 1 (Sulfurylase kinase 1, SK 1, SK1) [Includes: Sulfate adenylyltransferase, EC 2.7.7.4 (ATP-sulfurylase) (Sulfate adenylate transferase, SAT); Adenylyl-sulfate kinase, EC 2.7.1.25 (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase) ]"	PAPSS1 ATPSK1 PAPSS	Homo sapiens (Human)	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103]	cytosol [GO:0005829]	cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103]	adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]	GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016779; GO:0042803; GO:0050428	DPAGMPHPETGK	8.260000229	0.824322462	0.824322462	0.538179364	1251.841972	0	0	0	0	0	0	0	0	0	0	0	0	0	18.27514	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.97697	0	0	0	0	0	0	0	0	0	0	0	0	0
O43280	TREA_HUMAN	"Trehalase, EC 3.2.1.28 (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)"	TREH TREA	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]; trehalose metabolic process [GO:0005991]	anchored component of membrane [GO:0031225]; anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]	"anchored component of membrane [GO:0031225]; anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; alpha,alpha-trehalase activity [GO:0004555]; animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]; trehalose metabolic process [GO:0005991]"	"alpha,alpha-trehalase activity [GO:0004555]"	GO:0004555; GO:0005991; GO:0005993; GO:0009887; GO:0031225; GO:0046658; GO:0070062	EFYPSNLTPLWAGCFSDPGVADK	3.289999962	1	1	0.360377945	2571.148993	0	0	19.73826	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43283	M3K13_HUMAN	"Mitogen-activated protein kinase kinase kinase 13, EC 2.7.11.25 (Leucine zipper-bearing kinase) (Mixed lineage kinase, MLK)"	MAP3K13 LZK	Homo sapiens (Human)	JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon extension [GO:0045773]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; IkappaB kinase complex binding [GO:0106137]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon extension [GO:0045773]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; IkappaB kinase complex binding [GO:0106137]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0007254; GO:0014042; GO:0016020; GO:0018105; GO:0019899; GO:0019901; GO:0042802; GO:0042803; GO:0043507; GO:0043539; GO:0045773; GO:0046777; GO:0046872; GO:0051092; GO:0051403; GO:0106137; GO:0106310; GO:0150012; GO:1905492	LNMHGQDIATCANNLRYFGPAAALR	2.599999905	1	1	0.050547203	2791.20874	16.64968	0	13.90657	10.32062	0	1.805341	13.15372	0	12.43402	14.06638	15.50931	0	0	0	0	0	0	15.19167	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43290	SNUT1_HUMAN	"U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog, hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1, SART-1, hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1)"	SART1	Homo sapiens (Human)	"maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]"	RNA binding [GO:0003723]	GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013	GGERGSGR	4.179999828	1	1	0.157343582	774.7092666	0	16.94056	0	0	0	15.88747	0	0	14.84278	0	0	13.21949	16.4723	0	0	0	0	0	0	15.82402	0	0	17.28893	0	16.78009	15.87741	0	0	0	0	0	0	0	0	16.16662	0	0	16.51187	0	15.43096	0	14.77467	15.80947	15.73367	0	0	0	0
O43292	GPAA1_HUMAN	"Glycosylphosphatidylinositol anchor attachment 1 protein, GPI anchor attachment protein 1 (GAA1 protein homolog, hGAA1)"	GPAA1 GAA1	Homo sapiens (Human)	attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]	centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; mitochondrion [GO:0005739]	centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; tubulin binding [GO:0015631]; attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]	tubulin binding [GO:0015631]	GO:0005739; GO:0005783; GO:0005789; GO:0005813; GO:0005829; GO:0006508; GO:0006621; GO:0015631; GO:0016020; GO:0016255; GO:0042765; GO:0065003	MGLLSDPVR	4.980000019	0.349418849	0.349418849	0.133638352	1002.584116	18.25293	21.27072	21.60756	20.72875	20.7508	19.65495	20.12867	20.36335	20.08645	16.36798	17.74001	20.27369	19.71354	20.5412	19.96126	18.19598	20.80067	20.99699	18.29231	19.53103	19.06844	21.17759	21.39273	20.73176	20.89864	21.80748	20.4101	17.81061	19.82444	20.16372	22.03033	17.49508	22.15899	21.58164	21.18248	22.34742	21.16976	20.08389	21.11162	20.11309	20.07507	18.57609	21.2501	16.6614	20.7702	19.91181	21.13827	21.55144
O43293	DAPK3_HUMAN	"Death-associated protein kinase 3, DAP kinase 3, EC 2.7.11.1 (DAP-like kinase, Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase, ZIP-kinase)"	DAPK3 ZIPK	Homo sapiens (Human)	"apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]"	ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006355; GO:0006468; GO:0006915; GO:0006940; GO:0007088; GO:0007346; GO:0008140; GO:0008360; GO:0010506; GO:0016605; GO:0017148; GO:0030335; GO:0031267; GO:0035556; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043519; GO:0043522; GO:0046777; GO:0051893; GO:0071346; GO:0090263; GO:0097190; GO:0106310; GO:2000145; GO:2000249	GALLGTSGLK	2.589999914	1	1	5.75E-13	916.6167375	14.29449	0	0	0	14.88687	13.51054	0	12.88331	0	0	0	0	0	0	0	15.02951	14.12628	0	0	15.30875	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43295	SRGP3_HUMAN	"SLIT-ROBO Rho GTPase-activating protein 3, srGAP3 (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein, WRP)"	SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2	Homo sapiens (Human)	negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0051056	ALSEGHSMR	5.809999943	1	1	0	1001.55653	15.34612	0	0	0	0	15.60965	0	0	0	16.29915	0	0	0	13.55688	13.4957	0	0	0	0	0	19.16941	0	0	0	13.3991	0	0	0	16.28107	0	0	15.08225	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.55748	0
O43296	ZN264_HUMAN	Zinc finger protein 264	ZNF264 KIAA0412	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	KSYLTQHQR	7.059999943	0.272238076	0.272238076	0.093214368	1161.465375	16.97189	11.77663	0	0	17.24657	0	14.48871	11.9567	11.19223	16.23432	15.07542	17.20473	15.36204	0	0	0	14.29126	0	0	15.00933	0	15.17839	0	15.37925	0	16.46021	0	9.820282	0	14.16333	16.7302	14.52782	12.55694	16.44681	0	11.62476	16.40795	0	0	15.90272	14.83889	16.60697	15.45569	15.02003	12.09887	16.71725	0	0
O43299	AP5Z1_HUMAN	"AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit, Zeta5)"	AP5Z1 KIAA0415 SPG48	Homo sapiens (Human)	double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0005770; GO:0015031; GO:0016192; GO:0016197; GO:0016607; GO:0030119; GO:0044599	LLPPRER	4.949999809	1	1	0.267560746	879.0995743	0	0	13.04974	0	14.69578	15.93789	15.5597	12.15044	0	0	13.44099	0	15.66321	0	0	15.75332	0	13.15115	0	0	0	0	0	0	0	17.15502	0	0	0	0	13.24556	14.91493	0	0	12.67592	0	0	14.95014	13.66434	14.27819	0	14.67928	0	0	0	15.60666	0	0
O43300	LRRT2_HUMAN	Leucine-rich repeat transmembrane neuronal protein 2 (Leucine-rich repeat neuronal 2 protein)	LRRTM2 KIAA0416 LRRN2	Homo sapiens (Human)	long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; synapse organization [GO:0050808]	excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; Schaffer collateral - CA1 synapse [GO:0098685]	excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; Schaffer collateral - CA1 synapse [GO:0098685]; neurexin family protein binding [GO:0042043]; long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; synapse organization [GO:0050808]	neurexin family protein binding [GO:0042043]	GO:0002091; GO:0005615; GO:0042043; GO:0050808; GO:0051965; GO:0060076; GO:0060291; GO:0098685; GO:0098686; GO:0098978; GO:0098982; GO:0099060; GO:0099061; GO:0099151	ELILSSNK	28.45000076	0.560273528	0.560273528	0.093451081	902.0706276	16.62375	15.70439	16.07394	16.81268	0	18.10869	0	0	13.84158	13.0147	10.36847	20.08503	0	15.04723	0	11.30311	0	0	0	0	17.28218	16.90098	16.29694	0	17.53584	15.92702	0	0	0	14.37167	13.75623	16.32254	17.41619	11.91261	11.8635	0	0	16.9794	17.04774	0	16.57686	0	17.22099	13.8505	17.97707	14.51178	14.29744	14.55927
O43301	HS12A_HUMAN	Heat shock 70 kDa protein 12A	HSPA12A KIAA0417	Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524; GO:0005634; GO:0005737; GO:0070062	ADKEAGGSDGPR	8.039999962	0.801411986	0.801411986	0.304276496	1159.292244	0	13.54697	14.37933	0	0	0	0	0	0	0	0	0	0	14.02738	0	0	0	11.21848	0	0	0	0	0	0	0	15.99559	16.4919	0	0	0	0	15.0668	0	0	0	16.27467	16.86546	0	0	12.14233	15.63609	0	0	0	16.28171	0	0	16.09657
O43304	S14L5_HUMAN	SEC14-like protein 5	SEC14L5 KIAA0420	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	STLGPALEAVSMDGDK	2.130000114	0.276589364	0.276589364	0.180170792	1606.221556	0	14.36848	14.87365	0	0	13.84024	0	0	14.03124	0	0	0	0	10.13429	0	15.00919	0	13.52993	0	0	0	17.01826	15.31023	15.3331	0	0	7.037933	12.34538	0	0	16.3727	12.83023	12.96854	14.25443	0	12.82453	15.52296	0	0	0	0	14.09486	13.93894	0	13.44045	0	0	16.1602
O43306	ADCY6_HUMAN	"Adenylate cyclase type 6, EC 4.6.1.1 (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase)"	ADCY6 KIAA0422	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; blood vessel diameter maintenance [GO:0097746]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; intracellular signal transduction [GO:0035556]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; renal water homeostasis [GO:0003091]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; blood vessel diameter maintenance [GO:0097746]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; intracellular signal transduction [GO:0035556]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; renal water homeostasis [GO:0003091]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]	GO:0003091; GO:0004016; GO:0005080; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007193; GO:0007212; GO:0010977; GO:0016020; GO:0019901; GO:0031226; GO:0032420; GO:0035556; GO:0035811; GO:0046872; GO:0071380; GO:0071870; GO:0097746; GO:1904117; GO:1904322	LLLSVLPQHVAMEMKEDINTK	9.43999958	1	1	1.38E-12	2445.886894	16.82049	14.48492	0	0	0	15.83586	15.08384	16.71742	14.44298	0	0	0	0	0	13.01979	16.12863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.53851	0	0	0	0	0	0	0	0	0	0	0
O43307	ARHG9_HUMAN	Rho guanine nucleotide exchange factor 9 (Collybistin) (PEM-2 homolog) (Rac/Cdc42 guanine nucleotide exchange factor 9)	ARHGEF9 ARHDH9 KIAA0424	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; postsynaptic density [GO:0014069]	cytosol [GO:0005829]; postsynaptic density [GO:0014069]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0014069; GO:0051056	DDDFNVSMKNAFK	7.059999943	1	1	0.441736102	1547.33403	0	0	16.87155	0	0	0	0	17.29569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.16549	19.30237	19.0436	0	0	20.5246	0	0	19.13106	19.65758	0	0	0	0	0	0	0	0	0
O43309	ZSC12_HUMAN	Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 305) (Zinc finger protein 96)	ZSCAN12 KIAA0426 ZNF305 ZNF96	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	FENDMSK	3.720000029	1	1	0.175075571	870.8097164	13.69757	0	11.30272	0	0	0	16.30284	15.6389	0	0	0	0	0	0	0	15.96495	0	14.00221	0	0	0	0	16.65493	16.35899	15.33569	0	14.82851	15.32136	0	0	16.25493	14.86732	15.79623	0	14.7231	0	16.23605	0	0	0	0	0	0	0	0	0	0	14.8025
O43310	CTIF_HUMAN	CBP80/20-dependent translation initiation factor	CTIF KIAA0427	Homo sapiens (Human)	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]"	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	"cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]"	RNA binding [GO:0003723]; translation activator activity [GO:0008494]	GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0048471	LCDKMALFMVEGTK	4.659999847	1	1	0.22655611	1658.401777	0	0	16.44906	0	0	0	0	15.11773	16.16238	0	0	0	0	0	15.29875	17.66901	0	15.48073	0	0	0	0	0	0	14.26237	14.64353	0	0	0	0	0	0	0	15.99387	0	15.6424	14.87004	14.03424	0	15.76282	13.86802	14.06125	13.86347	0	0	0	0	0
O43314	VIP2_HUMAN	"Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, EC 2.7.4.24 (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2, hsVIP2)"	PPIP5K2 HISPPD1 KIAA0433 VIP2	Homo sapiens (Human)	inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]	cytosol [GO:0005829]	"cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605]"	"5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]"	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092	LEQLKTVLEMYGHFSGINR	3.109999895	0.47867918	0.47867918	0.214635746	2249.596451	13.87462	13.73974	0	12.73558	13.67628	0	0	0	0	0	0	0	0	0	0	0	10.87386	0	14.08424	0	0	0	14.99227	0	0	14.46139	0	0	0	0	0	0	0	0	13.94451	12.12573	14.57868	13.19307	0	0	13.06094	16.50627	0	0	0	0	0	0
O43315	AQP9_HUMAN	"Aquaporin-9, AQP-9 (Aquaglyceroporin-9) (Small solute channel 1)"	AQP9 SSC1	Homo sapiens (Human)	amine transport [GO:0015837]; canalicular bile acid transport [GO:0015722]; cellular response to cAMP [GO:0071320]; glycerol transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; amine transport [GO:0015837]; canalicular bile acid transport [GO:0015722]; cellular response to cAMP [GO:0071320]; glycerol transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833]	glycerol channel activity [GO:0015254]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]	GO:0005345; GO:0005350; GO:0005886; GO:0005887; GO:0006833; GO:0006863; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015722; GO:0015793; GO:0015837; GO:0015855; GO:0016323; GO:0043231; GO:0071320; GO:0071918	NLGAPR	2.660000086	1	1	0.125597571	626.6105572	14.38596	15.06512	15.74881	0	0	0	0	0	0	0	0	0	0	0	15.26916	0	0	0	0	16.52904	16.88043	0	0	16.69844	0	0	0	0	0	0	0	0	0	0	0	0	17.73796	0	17.53546	0	0	0	0	16.4991	0	0	0	0
O43318	M3K7_HUMAN	"Mitogen-activated protein kinase kinase kinase 7, EC 2.7.11.25 (Transforming growth factor-beta-activated kinase 1, TGF-beta-activated kinase 1)"	MAP3K7 TAK1	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; anoikis [GO:0043276]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; histone H3 acetylation [GO:0043966]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; p38MAPK cascade [GO:0038066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta receptor signaling pathway [GO:0007179]	ATAC complex [GO:0140672]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATAC complex [GO:0140672]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; anoikis [GO:0043276]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; histone H3 acetylation [GO:0043966]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; p38MAPK cascade [GO:0038066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta receptor signaling pathway [GO:0007179]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0000165; GO:0000287; GO:0002223; GO:0002726; GO:0002753; GO:0002755; GO:0004672; GO:0004674; GO:0004707; GO:0004709; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007179; GO:0007249; GO:0007250; GO:0007252; GO:0007254; GO:0008349; GO:0010008; GO:0016239; GO:0030971; GO:0032743; GO:0038066; GO:0038095; GO:0042802; GO:0043123; GO:0043276; GO:0043507; GO:0043966; GO:0050852; GO:0051092; GO:0051403; GO:0070423; GO:0070498; GO:0097110; GO:0106310; GO:0140672	LVQEHK	10.38000011	0.55259037	0.55259037	0.058590589	754.1426538	0	13.53596	17.0439	14.15106	0	15.4538	12.60518	12.94899	12.90249	15.19285	15.80867	17.01896	15.79395	14.77338	16.65628	14.14119	11.63637	0	14.51254	0	15.39897	15.22197	0	16.2285	16.65862	16.04081	15.2745	15.95973	12.60035	0	15.63672	13.79841	0	15.88714	0	0	16.74842	0	15.80618	11.41227	0	14.5142	14.38088	0	17.42865	16.7865	17.08179	16.31021
O43323	DHH_HUMAN	"Desert hedgehog protein, DHH (HHG-3) [Cleaved into: Desert hedgehog protein N-product; Desert hedgehog protein C-product ]"	DHH	Homo sapiens (Human)	cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]	calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0001649; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0007286; GO:0008233; GO:0008270; GO:0010468; GO:0016540; GO:0030238; GO:0032355; GO:0033327; GO:0042552; GO:0043627; GO:0050810	VARGSER	5.409999847	1	1	0.113475551	772.0860283	14.35355	14.15082	16.24137	0	0	13.50766	16.09686	13.01793	10.77884	0	0	0	14.34428	0	0	0	0	0	0	0	12.85251	0	0	0	0	0	0	13.56611	0	0	0	0	0	0	15.95913	0	0	0	0	0	0	0	0	0	14.94415	0	0	0
O43324	MCA3_HUMAN	Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18)	EEF1E1 AIMP3 P18	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412]"	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412]"		GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0008285; GO:0017101; GO:0043065; GO:0043517; GO:1990830; GO:2000774; GO:2001235	AAAAELSLLEKSLGLSK	3.789999962	1	1	2.41E-13	1700.280177	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43353	RIPK2_HUMAN	"Receptor-interacting serine/threonine-protein kinase 2, EC 2.7.11.1 (CARD-containing interleukin-1 beta-converting enzyme-associated kinase, CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2, RIP-2) (Tyrosine-protein kinase RIPK2, EC 2.7.10.2)"	RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity [GO:0097202]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to peptidoglycan [GO:0071224]; defense response to Gram-positive bacterium [GO:0050830]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation [GO:0033091]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; response to exogenous dsRNA [GO:0043330]; response to interleukin-1 [GO:0070555]; response to interleukin-12 [GO:0070671]; response to interleukin-18 [GO:0070673]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; LIM domain binding [GO:0030274]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor binding [GO:0005102]; activation of cysteine-type endopeptidase activity [GO:0097202]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to peptidoglycan [GO:0071224]; defense response to Gram-positive bacterium [GO:0050830]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation [GO:0033091]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; response to exogenous dsRNA [GO:0043330]; response to interleukin-1 [GO:0070555]; response to interleukin-12 [GO:0070671]; response to interleukin-18 [GO:0070673]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]	ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; LIM domain binding [GO:0030274]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor binding [GO:0005102]	GO:0001961; GO:0002250; GO:0002827; GO:0004672; GO:0004674; GO:0004706; GO:0004712; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006915; GO:0006954; GO:0007165; GO:0007249; GO:0010800; GO:0010942; GO:0030274; GO:0031398; GO:0031663; GO:0031982; GO:0032092; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032735; GO:0032743; GO:0032755; GO:0032760; GO:0032991; GO:0033091; GO:0033138; GO:0034134; GO:0034142; GO:0042098; GO:0042802; GO:0042803; GO:0043065; GO:0043123; GO:0043330; GO:0045087; GO:0045627; GO:0045944; GO:0046330; GO:0046641; GO:0050700; GO:0050731; GO:0050830; GO:0050852; GO:0051092; GO:0070374; GO:0070427; GO:0070431; GO:0070555; GO:0070671; GO:0070673; GO:0071223; GO:0071224; GO:0071225; GO:0089720; GO:0097202; GO:0106310; GO:1904417	MISLIESGWAQNPDERPSFLK	3.579999924	1	1	0.188401847	2433.76513	0	0	0	15.47941	0	0	13.84332	0	0	0	0	0	0	15.1488	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43361	ZN749_HUMAN	Zinc finger protein 749	ZNF749	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	FFLDSYK	1.940000057	1	1	0.160215389	919.5298944	13.75977	15.7069	11.77836	0	0	0	0	14.23256	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95975	0	0	0	0	0	0	0	0	0	0	14.65647	15.25001	0	15.84064	0	13.62415	0	15.75951	16.75384	0	12.52293	0	0	0	0
O43374	RASL2_HUMAN	Ras GTPase-activating protein 4 (Calcium-promoted Ras inactivator) (Ras p21 protein activator 4) (RasGAP-activating-like protein 2)	RASA4 CAPRI GAPL KIAA0538	Homo sapiens (Human)	cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046580; GO:0046872; GO:0071277	FFSPAIMSPK	2.839999914	1	1	0.089314525	1140.147137	17.72078	14.33851	16.74551	0	0	13.96816	0	16.76007	14.63013	17.72182	17.09361	17.40055	11.69083	17.37738	0	0	11.49245	15.54012	0	15.40409	0	16.39508	17.61652	0	17.00144	0	0	13.57748	16.80382	18.24316	0	16.37763	0	15.22887	15.95517	0	17.01688	0	14.98632	0	0	14.75848	15.47054	13.54996	0	17.29334	16.22447	0
O43379	WDR62_HUMAN	WD repeat-containing protein 62	WDR62 C19orf14	Homo sapiens (Human)	centriole replication [GO:0007099]; cerebral cortex development [GO:0021987]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; regulation of centrosome cycle [GO:0046605]; regulation of neuron differentiation [GO:0045664]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; centriole replication [GO:0007099]; cerebral cortex development [GO:0021987]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; regulation of centrosome cycle [GO:0046605]; regulation of neuron differentiation [GO:0045664]		GO:0000922; GO:0002052; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0007052; GO:0007099; GO:0021987; GO:0022008; GO:0034451; GO:0045664; GO:0046605; GO:2001224	GSENGTPMDVK	7.710000038	1	1	0.062119933	1148.521465	0	0	19.00346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43390	HNRPR_HUMAN	"Heterogeneous nuclear ribonucleoprotein R, hnRNP R"	HNRNPR HNRPR	Homo sapiens (Human)	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	"catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0071013; GO:1990904	AMDEMNGK	2.910000086	0.189487889	0.189487889	0.226689839	893.9756294	17.53418	0	0	18.86359	0	0	17.91515	0	0	0	0	0	17.97813	0	0	0	17.1017	16.11665	0	16.84552	0	0	0	17.87862	0	0	0	0	0	0	0	17.28425	0	0	0	0	17.85674	0	0	17.18675	0	16.72569	0	0	0	0	17.45153	0
O43395	PRPF3_HUMAN	"U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3, hPrp3) (U4/U6 snRNP 90 kDa protein)"	PRPF3 HPRP3 PRP3	Homo sapiens (Human)	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	"Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006397; GO:0008380; GO:0015030; GO:0016607; GO:0042802; GO:0046540; GO:0071005	EVFGDDSEISKESSGVK	5.809999943	1	1	0.302609115	1812.281014	0	0	0	0	15.19239	15.59358	0	0	0	0	0	14.28088	0	0	0	16.53739	0	0	0	0	0	0	0	0	0	0	0	0	15.04116	0	0	0	0	0	0	0	0	0	0	0	13.54373	13.57573	0	0	0	0	0	15.24194
O43405	COCH_HUMAN	Cochlin (COCH-5B2)	COCH COCH5B2 UNQ257/PRO294	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; collagen binding [GO:0005518]; defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]	collagen binding [GO:0005518]	GO:0005518; GO:0005576; GO:0007605; GO:0008360; GO:0042742; GO:0045089; GO:0062023	GGNSNTGKALK	8.420000076	0.509843767	0.509843767	0.174470165	1045.731459	15.70554	16.08095	14.99634	0	15.63339	16.21146	0	0	0	0	0	14.93519	0	0	0	0	0	0	15.17583	15.94562	0	0	0	0	0	0	15.51169	14.64747	0	0	14.55503	0	0	0	15.186	13.64054	0	0	16.93161	14.7374	14.1005	15.17469	10.45848	15.72363	14.1818	0	16.7676	16.08975
O43432	IF4G3_HUMAN	"Eukaryotic translation initiation factor 4 gamma 3, eIF-4-gamma 3, eIF-4G 3, eIF4G 3 (eIF-4-gamma II, eIF4GII)"	EIF4G3	Homo sapiens (Human)	regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]	"cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006413; GO:0006446; GO:0008135; GO:0016281	EDVHLK	6.75	1	1	0.307276148	740.1298239	0	0	0	0	0	0	0	0	19.25898	0	0	0	0	16.21784	16.88195	16.97383	0	18.84251	0	19.39536	16.24288	0	17.70071	15.97441	0	0	0	0	0	0	0	0	0	0	19.05836	0	0	18.3603	0	17.73836	16.74288	0	19.36672	0	0	0	0	18.67756
O43439	MTG8R_HUMAN	Protein CBFA2T2 (ETO homologous on chromosome 20) (MTG8-like protein) (MTG8-related protein 1) (Myeloid translocation-related protein 1) (p85)	CBFA2T2 EHT MTGR1	Homo sapiens (Human)	"intestinal epithelial cell differentiation [GO:0060575]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron projection development [GO:0010976]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron projection development [GO:0010976]; transcription, DNA-templated [GO:0006351]"	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0006351; GO:0010976; GO:0010977; GO:0045746; GO:0045892; GO:0046872; GO:0060575	KTGTELVSR	3.319999933	1	1	0.01398252	987.7677825	18.18032	0	13.22972	0	0	14.12597	14.74979	0	14.73609	15.12789	14.48177	0	14.55486	0	0	0	0	14.79576	0	0	0	0	0	13.96218	0	0	0	0	0	0	0	0	0	0	0	16.7381	0	0	0	0	0	0	0	0	14.6966	0	15.24536	16.31724
O43448	KCAB3_HUMAN	Voltage-gated potassium channel subunit beta-3 (K(+) channel subunit beta-3) (Kv-beta-3)	KCNAB3 KCNA3B	Homo sapiens (Human)	potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379]	aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]	GO:0004033; GO:0005249; GO:0005737; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0044325; GO:1901379	ESTGRGTGMK	6.96999979	1	1	0.105146634	1038.845301	0	14.47272	0	12.97757	15.25991	15.59932	0	0	15.02752	0	0	0	0	0	0	0	14.4066	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.7971	0	15.8834	0	0	0	0	0	16.22038
O43451	MGA_HUMAN	"Maltase-glucoamylase (Alpha-1,4-glucosidase, EC 3.2.1.20)"	MGAM MGA MGAML	Homo sapiens (Human)	dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	"apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983]"	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0000025; GO:0003824; GO:0004339; GO:0004553; GO:0004558; GO:0005886; GO:0005983; GO:0016021; GO:0016324; GO:0030246; GO:0032450; GO:0070062; GO:0070821; GO:0101003; GO:1901027	RQDPVSWDVAFVNISR	3.019999981	1	1	0.239306957	1888.301139	0	0	13.55277	12.25347	0	0	0	0	0	0	15.21695	0	14.68147	0	14.74063	0	0	0	0	0	0	0	0	0	0	13.54939	0	0	15.45439	0	0	0	0	0	17.16686	0	14.43144	16.4907	16.26851	14.34995	0	0	0	13.63832	15.33014	0	0	13.9533
O43474	KLF4_HUMAN	Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor)	KLF4 EZF GKLF	Homo sapiens (Human)	"canonical Wnt signaling pathway [GO:0060070]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; defense response to tumor cell [GO:0002357]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]"	chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; canonical Wnt signaling pathway [GO:0060070]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; defense response to tumor cell [GO:0002357]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]"	"beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001010; GO:0001228; GO:0002357; GO:0003700; GO:0005654; GO:0005667; GO:0005829; GO:0006351; GO:0006357; GO:0007500; GO:0008013; GO:0008270; GO:0008285; GO:0009913; GO:0010628; GO:0010629; GO:0015630; GO:0016525; GO:0019827; GO:0031077; GO:0032088; GO:0032270; GO:0032526; GO:0032717; GO:0034115; GO:0035166; GO:0043154; GO:0045429; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046985; GO:0048679; GO:0048730; GO:0050728; GO:0051247; GO:0051973; GO:0060070; GO:0060761; GO:0061629; GO:0071363; GO:0071499; GO:0090051; GO:0120222; GO:1902895; GO:1903672; GO:1904798; GO:1904998; GO:1990830; GO:1990837; GO:1990841; GO:2000134; GO:2000342	EELSHMK	9.090000153	0.615238547	0.615238547	0.188300882	886.5806855	0	16.3984	15.32354	0	16.01153	0	12.90257	0	0	0	0	0	14.89463	13.81787	0	12.82414	0	14.64256	0	0	0	15.31341	0	15.66037	15.53913	0	0	0	15.05928	0	13.68746	13.8492	12.13611	0	0	0	0	0	14.6891	0	0	0	0	16.61148	16.84556	0	0	0
O43482	MS18B_HUMAN	"Protein Mis18-beta (Cancer/testis antigen 86, CT86) (Opa-interacting protein 5, OIP-5)"	OIP5 MIS18B	Homo sapiens (Human)	cell communication [GO:0007154]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]	"Cajal body [GO:0015030]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"Cajal body [GO:0015030]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]"	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0007049; GO:0007059; GO:0007154; GO:0010369; GO:0015030; GO:0016607; GO:0034080; GO:0042802; GO:0043231; GO:0046872; GO:0051301	SLGAVVFSR	4.130000114	0.648678958	0.648678958	0.198136548	936.7148433	17.03872	16.78867	14.48546	0	0	0	0	15.46214	15.44256	0	16.61874	0	0	15.5626	0	14.99711	0	16.40187	15.89422	15.39092	0	0	0	17.18865	16.74437	0	0	15.1843	16.79996	16.46474	16.5741	16.22759	14.79327	15.39781	15.16852	15.49989	15.33451	15.1262	16.7016	14.51889	15.61566	15.25298	15.03134	15.47668	13.12193	15.79973	0	0
O43491	E41L2_HUMAN	"Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1, 4.1G)"	EPB41L2	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778]	actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007049; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778	GDAEEMAQKK	2.269999981	1	1	0.095727326	1122.97467	0	0	13.00041	9.739493	0	13.71994	0	0	0	7.567513	14.59608	14.90706	0	0	0	0	15.18366	14.96883	14.4831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.24922	14.72495	0	0	0	15.51774	16.70252	0	0	0	0	0
O43493	TGON2_HUMAN	"Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46, TGN38 homolog, hTGN46) (Trans-Golgi network glycoprotein 48, hTGN48) (Trans-Golgi network glycoprotein 51, hTGN51) (Trans-Golgi network protein 2)"	TGOLN2 TGN46 TGN51	Homo sapiens (Human)		clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]	clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]		GO:0005654; GO:0005768; GO:0005788; GO:0005794; GO:0005802; GO:0005886; GO:0016021; GO:0030133; GO:0030140; GO:0030669	DGSNK	5.75	0.984853864	0.984853864	0.141056055	519.1722332	0	15.76082	16.78333	0	15.89648	0	15.13089	0	16.39194	0	16.2205	16.87377	14.68895	0	0	0	16.83316	0	0	0	0	0	0	0	0	16.80953	16.29868	0	15.46523	16.3495	14.58155	14.21235	0	15.43374	16.63578	0	16.40172	0	0	0	15.73415	0	0	0	17.82989	15.99168	0	0
O43497	CAC1G_HUMAN	Voltage-dependent T-type calcium channel subunit alpha-1G (Cav3.1c) (NBR13) (Voltage-gated calcium channel subunit alpha Cav3.1)	CACNA1G KIAA1123	Homo sapiens (Human)	AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cardiac muscle cell action potential involved in contraction [GO:0086002]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]; sinoatrial node development [GO:0003163]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]	cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; voltage-gated sodium channel activity [GO:0005248]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cardiac muscle cell action potential involved in contraction [GO:0086002]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]; sinoatrial node development [GO:0003163]	low voltage-gated calcium channel activity [GO:0008332]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0003163; GO:0005248; GO:0005737; GO:0005886; GO:0005891; GO:0007268; GO:0008332; GO:0010045; GO:0019228; GO:0034765; GO:0042391; GO:0043005; GO:0045202; GO:0045956; GO:0060371; GO:0070509; GO:0070588; GO:0086002; GO:0086010; GO:0086015; GO:0086016; GO:0086018; GO:0086027; GO:0086045; GO:0086046; GO:0086056; GO:0086059; GO:0086091; GO:0097110	DPLASGPPDSMAASPSPKK	8.529999733	1	1	0.127540982	1869.37336	0	14.56829	10.11247	0	15.07613	0	12.29311	15.7609	13.58297	0	15.14386	15.6763	0	0	0	14.04909	14.44954	14.57672	14.66674	0	14.80722	0	0	15.10332	0	15.30925	0	15.06347	13.64647	0	16.44767	13.28425	0	13.29845	11.60527	15.21036	14.11413	16.03647	0	15.03993	0	15.2657	0	11.30381	0	0	0	0
O43506	ADA20_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 20, ADAM 20, EC 3.4.24.-"	ADAM20	Homo sapiens (Human)	male gonad development [GO:0008584]; single fertilization [GO:0007338]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; male gonad development [GO:0008584]; single fertilization [GO:0007338]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005886; GO:0007338; GO:0008237; GO:0008584; GO:0009897; GO:0016021; GO:0046872; GO:1990913	NNMEGLNVMGK	6.989999771	0.445103437	0.445103437	0.147465839	1238.218361	11.52253	0	14.61371	0	13.9029	12.65489	0	0	0	14.31536	13.0883	0	17.62201	14.33623	0	0	0	0	17.13858	17.3556	0	12.63511	17.70138	18.52125	0	19.02509	0	14.76426	0	16.56131	0	0	16.54133	16.80179	18.38108	0	17.30192	18.14118	15.86815	0	14.95051	17.75931	18.1471	0	16.09219	16.9364	0	16.94476
O43511	S26A4_HUMAN	Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4)	SLC26A4 PDS	Homo sapiens (Human)	inorganic anion transport [GO:0015698]; ion transport [GO:0006811]; regulation of pH [GO:0006885]; regulation of protein localization [GO:0032880]; sensory perception of sound [GO:0007605]; sulfate transport [GO:0008272]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; iodide transmembrane transporter activity [GO:0015111]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; inorganic anion transport [GO:0015698]; ion transport [GO:0006811]; regulation of pH [GO:0006885]; regulation of protein localization [GO:0032880]; sensory perception of sound [GO:0007605]; sulfate transport [GO:0008272]	anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; iodide transmembrane transporter activity [GO:0015111]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005886; GO:0005887; GO:0006811; GO:0006885; GO:0007605; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015111; GO:0015116; GO:0015301; GO:0015698; GO:0016021; GO:0016324; GO:0019531; GO:0031526; GO:0032880; GO:0070062	STKNYK	4.28000021	1	1	3.45E-13	741.0128851	10.51452	16.19779	0	0	0	0	14.68788	15.99102	13.20739	14.23024	13.55799	0	14.5931	14.93361	14.72432	0	0	0	0	0	0	0	0	0	15.62073	13.60327	0	0	0	14.07716	0	15.02544	0	0	0	0	0	0	0	0	0	0	16.6221	0	0	0	0	0
O43520	AT8B1_HUMAN	"Phospholipid-transporting ATPase IC, EC 7.6.2.1 (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1)"	ATP8B1 ATPIC FIC1 PFIC	Homo sapiens (Human)	"apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of chloride transport [GO:2001225]; regulation of microvillus assembly [GO:0032534]; regulation of plasma membrane organization [GO:1903729]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]; xenobiotic transmembrane transport [GO:0006855]"	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; trans-Golgi network [GO:0005802]	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of chloride transport [GO:2001225]; regulation of microvillus assembly [GO:0032534]; regulation of plasma membrane organization [GO:1903729]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]; xenobiotic transmembrane transport [GO:0006855]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]	GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006855; GO:0007030; GO:0007605; GO:0008206; GO:0015721; GO:0016324; GO:0016604; GO:0016887; GO:0021650; GO:0032420; GO:0032534; GO:0034220; GO:0045176; GO:0045332; GO:0045892; GO:0060119; GO:0090554; GO:0090556; GO:0140326; GO:0140345; GO:0140346; GO:1901612; GO:1903729; GO:1990531; GO:2001225	RGVSTR	7.980000019	1	1	0.203605115	672.5137481	0	0	0	0	0	0	0	0	0	0	19.78334	0	0	0	0	0	0	0	19.18944	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.26756	0	0	0	0	0	0	0	0	19.95172
O43525	KCNQ3_HUMAN	Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3)	KCNQ3	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; membrane hyperpolarization [GO:0060081]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]	axon initial segment [GO:0043194]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]	axon initial segment [GO:0043194]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; membrane hyperpolarization [GO:0060081]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]	calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0008076; GO:0009986; GO:0016021; GO:0033268; GO:0034765; GO:0043194; GO:0045202; GO:0060081; GO:0071805	DEGQRR	4.400000095	1	1	6.91E-13	759.7326008	9.399611	14.84465	0	12.92709	0	14.10352	13.49276	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43526	KCNQ2_HUMAN	Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2)	KCNQ2	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]	axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]	axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]	ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0007399; GO:0008076; GO:0016021; GO:0030506; GO:0033268; GO:0034765; GO:0043194; GO:0045202; GO:0071805	DPPPEPSPSKGSPCR	2.50999999	1	1	0.159208969	1607.197717	15.41797	12.91316	13.9165	15.84353	13.8451	0	0	15.31834	12.21897	0	15.4433	0	0	0	0	0	15.45423	14.7923	0	0	0	0	17.95432	0	14.32123	15.01976	0	0	0	0	13.08263	13.77883	14.62951	0	13.42262	0	0	17.81685	0	0	0	0	0	0	16.21626	0	0	0
O43541	SMAD6_HUMAN	"Mothers against decapentaplegic homolog 6, MAD homolog 6, Mothers against DPP homolog 6 (SMAD family member 6, SMAD 6, Smad6, hSMAD6)"	SMAD6 MADH6	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; fat cell differentiation [GO:0045444]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of miRNA transcription [GO:1902895]; pulmonary valve morphogenesis [GO:0003184]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; heteromeric SMAD protein complex [GO:0071144]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; heteromeric SMAD protein complex [GO:0071144]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; fat cell differentiation [GO:0045444]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of miRNA transcription [GO:1902895]; pulmonary valve morphogenesis [GO:0003184]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352]	chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]	GO:0000785; GO:0000976; GO:0001657; GO:0003148; GO:0003180; GO:0003183; GO:0003184; GO:0003281; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0007179; GO:0007352; GO:0008285; GO:0009653; GO:0010991; GO:0016604; GO:0030154; GO:0030279; GO:0030509; GO:0030512; GO:0030514; GO:0031589; GO:0031625; GO:0032496; GO:0032991; GO:0034616; GO:0034713; GO:0035904; GO:0042802; GO:0043066; GO:0043627; GO:0045444; GO:0045668; GO:0046872; GO:0060394; GO:0060395; GO:0060976; GO:0070410; GO:0070411; GO:0070412; GO:0070698; GO:0071144; GO:0140416; GO:1902895	SRVVPDR	7.170000076	1	1	5.73E-13	829.3533434	14.19698	13.17544	13.05238	12.88123	13.49196	12.73568	15.86128	14.54033	16.2899	14.679	15.53139	16.19193	0	0	15.58407	0	14.37081	13.60194	0	13.73199	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43543	XRCC2_HUMAN	DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2)	XRCC2	Homo sapiens (Human)	centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756]; strand invasion [GO:0042148]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756]; strand invasion [GO:0042148]"	"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]"	GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0008094; GO:0010165; GO:0010332; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:2000269	LVNDYR	10.60000038	0.452554345	0.452554345	0.149075952	778.5647762	0	0	0	0	0	0	0	0	15.81284	16.22133	0	15.45572	0	16.77288	15.90839	16.37576	14.85854	16.67614	16.78732	17.83407	0	14.26119	16.93975	0	16.03938	16.04826	16.06321	0	14.21819	15.67009	12.84926	13.81692	17.1384	16.54808	16.3719	15.09365	15.57459	16.96749	15.88608	14.90227	16.70519	17.55615	14.38346	15.44715	16.06044	16.59012	16.5981	15.29482
O43556	SGCE_HUMAN	"Epsilon-sarcoglycan, Epsilon-SG"	SGCE ESG UNQ433/PRO840	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]; muscle organ development [GO:0007517]	cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dystrophin-associated glycoprotein complex [GO:0016010]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]	cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dystrophin-associated glycoprotein complex [GO:0016010]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cell-matrix adhesion [GO:0007160]; muscle organ development [GO:0007517]		GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0007160; GO:0007517; GO:0016010; GO:0016012; GO:0032590; GO:0042383	EGVYVMVGADVPFSSCLR	2.440000057	1	1	0.122795023	2002.045921	0	16.8326	0	0	0	0	0	0	13.88974	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88102	0	0	0	0	0	0	0	16.41735	0	0	0	0	0	0	0	0	14.43823	0	0	0	0	0	0	0
O43566	RGS14_HUMAN	"Regulator of G-protein signaling 14, RGS14"	RGS14	Homo sapiens (Human)	cell division [GO:0051301]; chromosome segregation [GO:0007059]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic cell cycle [GO:0000278]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of synaptic plasticity [GO:0031914]; nucleocytoplasmic transport [GO:0006913]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neurogenesis [GO:0050769]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to oxidative stress [GO:0006979]; spindle organization [GO:0007051]; visual learning [GO:0008542]; zygote asymmetric cell division [GO:0010070]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; spindle [GO:0005819]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; spindle [GO:0005819]; spindle pole [GO:0000922]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic cell cycle [GO:0000278]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of synaptic plasticity [GO:0031914]; nucleocytoplasmic transport [GO:0006913]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neurogenesis [GO:0050769]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to oxidative stress [GO:0006979]; spindle organization [GO:0007051]; visual learning [GO:0008542]; zygote asymmetric cell division [GO:0010070]	G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000278; GO:0000922; GO:0001965; GO:0003924; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005886; GO:0006913; GO:0006979; GO:0007051; GO:0007059; GO:0007186; GO:0007612; GO:0007616; GO:0008017; GO:0008277; GO:0008542; GO:0010070; GO:0014069; GO:0016604; GO:0016605; GO:0019901; GO:0030159; GO:0030425; GO:0031914; GO:0032794; GO:0035556; GO:0043197; GO:0043407; GO:0043547; GO:0043620; GO:0045744; GO:0048008; GO:0050769; GO:0051301; GO:0060291; GO:0070373; GO:0098978	EPGSSR	10.43999958	1	1	0.230366347	632.7140715	0	0	0	0	0	0	17.23192	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43572	AKA10_HUMAN	"A-kinase anchor protein 10, mitochondrial, AKAP-10 (Dual specificity A kinase-anchoring protein 2, D-AKAP-2) (Protein kinase A-anchoring protein 10, PRKA10)"	AKAP10	Homo sapiens (Human)	protein localization [GO:0008104]; signal transduction [GO:0007165]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase A binding [GO:0051018]; protein localization [GO:0008104]; signal transduction [GO:0007165]	protein kinase A binding [GO:0051018]	GO:0005739; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0032991; GO:0051018	MRGAGPSPR	4.929999828	1	1	0.075282244	943.4601275	16.02644	0	0	0	0	0	0	14.28841	14.40173	14.15529	0	0	0	0	0	0	0	0	0	0	16.16434	0	12.25083	0	17.79779	0	0	9.834078	0	0	0	16.37372	0	0	13.98802	0	0	0	0	0	0	0	0	0	0	0	0	0
O43581	SYT7_HUMAN	"Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII, SytVII)"	SYT7 PCANAP7	Homo sapiens (Human)	calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]	cell projection [GO:0042995]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	"cell projection [GO:0042995]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]"	"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"	GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042995; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098686; GO:0099056; GO:1990926; GO:1990927	MYRDPEAASPGAPSR	6.710000038	1	1	0.474763716	1620.593987	13.63012	0	0	16.81531	0	15.0532	0	0	0	15.93204	15.63457	0	0	0	0	0	0	0	0	15.70985	0	0	0	0	0	0	16.1026	0	0	15.6322	0	15.90511	16.31437	0	0	0	15.90172	0	0	0	15.25281	0	15.33502	0	0	0	0	16.66991
O43583	DENR_HUMAN	"Density-regulated protein, DRP (Protein DRP1) (Smooth muscle cell-associated protein 3, SMAP-3)"	DENR DRP1 H14	Homo sapiens (Human)	formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188]		mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188]	mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]	GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0032790; GO:0075522	LTVENSPK	19.57999992	1	1	0.0347395	887.6613884	15.26298	15.80224	14.83686	0	15.33896	14.68073	15.13165	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.58005	0	0	0	0	0	0	0	0	0	15.76099	14.27789	0	0	0	0	0	14.16365	0	0	15.18673	0	0	0
O43586	PPIP1_HUMAN	"Proline-serine-threonine phosphatase-interacting protein 1, PEST phosphatase-interacting protein 1 (CD2-binding protein 1) (H-PIP)"	PSTPIP1 CD2BP1	Homo sapiens (Human)	actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165]	actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]	actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165]	actin filament binding [GO:0051015]; identical protein binding [GO:0042802]	GO:0001931; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0030041; GO:0032154; GO:0042802; GO:0045087; GO:0048471; GO:0051015	ISANGHQKQVEK	9.329999924	1	1	0.233387477	1337.898766	15.12219	12.23116	15.14882	0	14.78305	0	0	0	0	0	0	11.02356	0	0	0	0	0	0	15.68137	0	15.48345	0	0	0	0	16.75913	15.02224	14.24553	14.06454	14.77127	0	0	16.938	14.36816	16.26421	15.45364	11.70295	0	0	14.85868	0	0	15.09943	12.70808	15.85661	0	0	0
O43592	XPOT_HUMAN	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]; intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]	GO:0000049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0006886; GO:0016363; GO:0031267; GO:0071528	TYSDDHVK	10.35000038	0.482737303	0.482737303	0.260012619	965.3155894	0	12.2953	14.64454	0	13.16888	12.97119	14.42924	12.58546	9.607173	13.98454	13.62369	12.97457	14.97588	10.37961	14.17113	15.35649	0	16.77058	0	0	0	0	0	15.61421	0	16.08657	13.95186	0	0	0	0	0	13.9842	0	0	0	0	0	0	0	0	14.78267	14.9954	0	0	0	15.33005	0
O43593	HAIR_HUMAN	"Lysine-specific demethylase hairless, EC 1.14.11.65 ([histone H3]-dimethyl-L-lysine(9) demethylase hairless)"	HR	Homo sapiens (Human)	histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0140683	AGPGLR	9.130000114	1	1	0.29456799	571.1489046	19.93326	0	0	0	0	0	20.28047	19.89564	17.91097	19.18279	0	0	0	0	0	0	0	0	0	0	17.85825	0	0	0	0	0	0	0	0	16.63855	0	18.09519	0	0	0	0	0	0	0	0	0	0	0	0	17.74084	0	0	18.38439
O43602	DCX_HUMAN	"Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X, Lis-X)"	DCX DBCN LISX	Homo sapiens (Human)	axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; photoreceptor cell development [GO:0042461]; retina development in camera-type eye [GO:0060041]	axoneme [GO:0005930]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]	axoneme [GO:0005930]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; photoreceptor cell development [GO:0042461]; retina development in camera-type eye [GO:0060041]	microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]	GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0005930; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035082; GO:0035556; GO:0042461; GO:0043005; GO:0060041	GNPSATAGPKASPTPQK	3.700000048	1	1	0.161330856	1607.547792	14.35087	0	0	14.23698	0	13.42505	15.38132	0	0	15.12665	13.23539	12.04555	0	0	0	12.18545	0	0	0	0	0	0	0	0	0	0	0	12.56407	0	0	0	0	0	0	0	0	17.93676	15.9216	0	0	0	0	0	0	0	0	0	0
O43612	OREX_HUMAN	"Orexin (Hypocretin, Hcrt) [Cleaved into: Orexin-A (Hypocretin-1, Hcrt1); Orexin-B (Hypocretin-2, Hcrt2) ]"	HCRT OX PPORX PPOX	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; negative regulation of DNA replication [GO:0008156]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transmission of nerve impulse [GO:0051971]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of neurotransmitter secretion [GO:0046928]; response to starvation [GO:0042594]; sleep [GO:0030431]; temperature homeostasis [GO:0001659]	extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]	extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; neuropeptide hormone activity [GO:0005184]; type 1 hypocretin receptor binding [GO:0031771]; type 2 hypocretin receptor binding [GO:0031772]; chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; negative regulation of DNA replication [GO:0008156]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transmission of nerve impulse [GO:0051971]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of neurotransmitter secretion [GO:0046928]; response to starvation [GO:0042594]; sleep [GO:0030431]; temperature homeostasis [GO:0001659]	neuropeptide hormone activity [GO:0005184]; type 1 hypocretin receptor binding [GO:0031771]; type 2 hypocretin receptor binding [GO:0031772]	GO:0001659; GO:0005184; GO:0005576; GO:0005791; GO:0007200; GO:0007204; GO:0007205; GO:0007218; GO:0007268; GO:0008021; GO:0008156; GO:0030141; GO:0030431; GO:0031771; GO:0031772; GO:0042594; GO:0042755; GO:0043267; GO:0046928; GO:0048471; GO:0051928; GO:0051970; GO:0051971; GO:0060079; GO:0098794; GO:0120162	RSGPPGLQGR	6.739999771	1	1	0.259440423	1025.739173	13.55964	15.85935	14.75692	0	13.90562	14.80456	12.43056	14.75383	0	15.38311	0	16.46739	0	13.23246	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.52866	0	16.54594	0	0	0	0	0	0	0	0	0	0	0
O43615	TIM44_HUMAN	Mitochondrial import inner membrane translocase subunit TIM44	TIMM44 MIMT44 TIM44	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]	GO:0001650; GO:0005524; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0006626; GO:0006886; GO:0030150; GO:0051087	QELAKNK	8.369999886	1	1	0.031203162	831.2185433	15.41744	0	15.34326	0	0	14.46327	0	14.67012	0	0	0	0	14.48361	0	14.38122	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43660	PLRG1_HUMAN	Pleiotropic regulator 1	PLRG1	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"	catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]"		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:1900087	MVEEVQK	13.35000038	1	1	0.239810056	879.2736047	15.7889	16.33481	14.66763	16.10019	14.22744	14.1142	14.60601	0	14.35164	14.69936	14.2265	13.98705	15.43825	13.59309	0	0	14.48235	0	0	0	15.24201	0	15.23228	15.52322	15.58165	14.33094	15.48485	15.20219	0	0	13.5252	0	16.78729	0	14.46404	0	0	17.25365	17.55882	16.11183	0	16.01565	0	14.49436	0	15.40236	15.43806	15.54036
O43663	PRC1_HUMAN	Protein regulator of cytokinesis 1	PRC1	Homo sapiens (Human)	cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465]	chromosome [GO:0005694]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]	chromosome [GO:0005694]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465]	identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]	GO:0000022; GO:0000226; GO:0000922; GO:0001578; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051256; GO:0051301; GO:0070938; GO:1990023	ELWDR	5.429999828	1	1	0.12295942	718.2810203	0	0	15.24594	0	0	12.78396	12.74424	0	0	0	0	13.58067	0	16.64998	0	0	0	0	0	15.11074	16.23013	0	0	0	16.88216	0	0	0	0	15.08048	0	16.49923	15.08403	13.07125	0	0	0	0	0	15.28959	0	14.47337	0	0	0	0	0	0
O43665	RGS10_HUMAN	"Regulator of G-protein signaling 10, RGS10"	RGS10	Homo sapiens (Human)	G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0001965; GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0007213; GO:0008277; GO:0009968; GO:0043547; GO:0045202	AKEIYMTFLSSK	18.47999954	1	1	0.234658376	1434.002174	0	0	0	0	0	0	21.8411	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43670	ZN207_HUMAN	"BUB3-interacting and GLEBS motif-containing protein ZNF207, BuGZ, hBuGZ (Zinc finger protein 207)"	ZNF207 BUGZ	Homo sapiens (Human)	attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]	cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]	cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]	DNA binding [GO:0003677]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]	GO:0000070; GO:0000776; GO:0001578; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008201; GO:0008608; GO:0046785; GO:0046872; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047	LIHPDEDISLEERR	3.769999981	1	1	0.466503176	1720.464759	18.77962	19.68698	16.9282	0	18.55889	0	17.7321	0	0	0	0	0	0	16.58651	0	0	0	0	0	16.37384	0	0	0	0	0	0	0	18.39087	0	0	0	0	0	0	0	18.62729	0	0	0	0	0	0	0	0	0	0	0	0
O43674	NDUB5_HUMAN	"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH, CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)"	NDUFB5	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776	ATPDN	1.970000029	1	1	0.023587874	516.2956423	15.07592	14.79257	15.14365	13.97571	14.99534	0	14.39233	0	14.46272	15.88669	0	13.61199	0	15.46542	15.15793	0	0	15.37998	0	16.75373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43678	NDUA2_HUMAN	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8, CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit)"	NDUFA2	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; blastocyst hatching [GO:0001835]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]	"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; blastocyst hatching [GO:0001835]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0001835; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776	MAAAAASR	2.400000095	1	1	0.252608389	749.096401	16.27197	15.27644	14.87947	15.13073	15.90474	15.04937	0	16.1595	15.31376	15.02157	14.48252	0	14.23354	15.61362	0	16.00087	15.25235	14.79948	15.42783	15.85784	15.62981	15.29647	15.30779	14.87395	16.7478	0	16.73069	15.79003	0	0	0	15.93653	15.44868	16.09114	15.65822	0	16.3364	0	15.71076	0	0	16.0428	14.74444	15.62738	15.03481	14.37518	15.87192	15.30022
O43681	GET3_HUMAN	"ATPase GET3, EC 3.6.-.- (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I)"	GET3 ARSA ASNA1 TRC40	Homo sapiens (Human)	posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; arsenite transmembrane transporter activity [GO:0015105]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	arsenite transmembrane transporter activity [GO:0015105]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]	GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0006620; GO:0015105; GO:0016887; GO:0043529; GO:0045048; GO:0046872; GO:0070062; GO:0071816	LPLLPHEVR	6.260000229	0.121034898	0.121034898	0.094905354	1074.161333	0	12.99607	14.43421	11.14042	14.38557	14.58475	17.36693	0	0	17.55083	14.299	13.94924	0	0	0	17.46437	14.56044	0	16.1258	13.46088	8.496955	0	17.85722	12.71633	0	0	0	0	0	15.84811	16.85827	15.69555	0	0	13.39723	0	14.57083	0	14.91777	16.02111	0	0	0	0	14.35501	15.6046	0	17.76896
O43683	BUB1_HUMAN	"Mitotic checkpoint serine/threonine-protein kinase BUB1, hBUB1, EC 2.7.11.1 (BUB1A)"	BUB1 BUB1L	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]"	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]"	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000776; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007063; GO:0007094; GO:0008283; GO:0016020; GO:0043231; GO:0051301; GO:0051754; GO:0051983; GO:0106310	ESNMER	1.919999957	0.95574218	0.95574218	0.191110174	764.5859854	0	0	0	14.97826	0	0	14.51091	14.28504	16.50333	0	15.53323	0	0	0	14.36929	0	0	0	15.90453	0	15.88176	15.80243	0	0	16.24696	0	15.13498	15.90949	16.38145	15.66694	0	16.31989	16.27239	17.09515	16.93368	0	0	16.00452	15.59942	17.59213	15.15209	16.08491	0	15.57392	16.39655	15.82409	16.00289	15.49445
O43699	SIGL6_HUMAN	"Sialic acid-binding Ig-like lectin 6, Siglec-6 (CD33 antigen-like 1) (CDw327) (Obesity-binding protein 1, OB-BP1) (CD antigen CD327)"	SIGLEC6 CD33L CD33L1 OBBP1	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]	carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]	GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0007267; GO:0016020; GO:0030246; GO:0033691	AAQPVQNTDDVNPVMVSGSR	1.75999999	1	1	0.176792861	2085.884779	0	15.33999	0	0	0	13.70423	13.51879	0	15.31705	0	15.13332	14.73169	0	0	15.25981	0	0	0	0	0	0	0	0	0	14.31629	14.54435	0	0	0	12.82429	0	0	0	0	0	0	14.00887	0	0	0	0	0	13.67139	0	0	0	0	0
O43708	MAAI_HUMAN	"Maleylacetoacetate isomerase, MAAI, EC 5.2.1.2 (GSTZ1-1) (Glutathione S-transferase zeta 1, EC 2.5.1.18)"	GSTZ1 MAAI	Homo sapiens (Human)	glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005829; GO:0006559; GO:0006572; GO:0006749; GO:0016034; GO:0042802; GO:0042803	LLPQDPK	9.68999958	1	1	0.252069332	807.0407794	17.3201	17.18237	16.89688	19.56549	7.418602	16.49338	13.21715	16.17169	16.12848	16.7362	14.24896	14.51323	13.67541	14.89688	15.20047	15.48112	16.8606	14.07115	0	14.39018	16.45779	17.10646	14.5052	0	16.35653	0	0	0	16.46657	15.57635	17.50694	15.52774	17.09216	16.61894	18.00121	0	0	0	0	16.53523	0	17.06675	0	0	15.39717	16.61809	16.67137	16.51484
O43709	BUD23_HUMAN	"Probable 18S rRNA (guanine-N(7))-methyltransferase, EC 2.1.1.- (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)"	BUD23 MERM1 WBSCR22 HUSSY-03 PP3381	Homo sapiens (Human)	chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]	methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]	GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0016435; GO:0046982; GO:0048471; GO:0070476; GO:2000234	MASRGR	3.569999933	1	1	0.277390974	692.839526	0	0	15.93298	0	16.33482	0	0	0	0	0	0	0	0	0	16.82783	17.11085	16.77365	15.03184	16.13738	17.71267	17.0235	15.79024	16.31507	0	0	0	15.74033	16.79233	0	0	0	0	0	0	0	0	0	17.83688	17.79201	17.58083	15.87263	16.9611	17.505	16.78896	16.16827	17.60799	16.94173	18.04252
O43716	GATC_HUMAN	"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial, Glu-AdT subunit C, EC 6.3.5.- (Protein 15E1.2)"	GATC 15E1.2	Homo sapiens (Human)	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681	APLGGR	14.82999992	1	1	0.289839041	569.99029	17.74956	0	0	0	18.64135	0	0	0	0	0	0	0	17.13118	0	0	0	0	0	0	0	0	0	17.14826	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.87115	0	0
O43719	HTSF1_HUMAN	"HIV Tat-specific factor 1, Tat-SF1"	HTATSF1	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]"	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0006357; GO:0019079; GO:0032784	ESEEGCPK	11.76000023	1	1	0.17661347	936.4197072	15.58771	0	0	0	0	0	0	0	0	0	11.5025	0	15.07879	0	0	0	0	14.84014	0	0	0	0	0	0	14.80994	0	0	14.26202	0	0	0	15.28999	0	11.60004	0	0	0	0	0	0	0	0	0	0	15.24921	0	0	0
O43734	CIKS_HUMAN	"E3 ubiquitin ligase TRAF3IP2, EC 2.3.2.27 (Adapter protein CIKS) (Connection to IKK and SAPK/JNK) (E3 ubiquitin-protein ligase CIKS) (Nuclear factor NF-kappa-B activator 1, ACT1) (TRAF3-interacting protein 2)"	TRAF3IP2 C6orf2 C6orf4 C6orf5 C6orf6	Homo sapiens (Human)	B cell affinity maturation [GO:0002344]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; CD40 signaling pathway [GO:0023035]; eosinophil homeostasis [GO:1990959]; eosinophil mediated immunity [GO:0002447]; establishment of T cell polarity [GO:0001768]; heart development [GO:0007507]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; leukocyte activation involved in inflammatory response [GO:0002269]; lymph node development [GO:0048535]; mRNA stabilization [GO:0048255]; mucus secretion [GO:0070254]; neutrophil activation [GO:0042119]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein import into nucleus [GO:0006606]; protein K63-linked ubiquitination [GO:0070534]; protein localization to P-body [GO:0110012]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; skin development [GO:0043588]; spleen development [GO:0048536]; T cell differentiation [GO:0030217]; T-helper 17 type immune response [GO:0072538]; transitional two stage B cell differentiation [GO:0002334]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type 2 immune response [GO:0042092]	cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]	cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; B cell affinity maturation [GO:0002344]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; CD40 signaling pathway [GO:0023035]; eosinophil homeostasis [GO:1990959]; eosinophil mediated immunity [GO:0002447]; establishment of T cell polarity [GO:0001768]; heart development [GO:0007507]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; leukocyte activation involved in inflammatory response [GO:0002269]; lymph node development [GO:0048535]; mRNA stabilization [GO:0048255]; mucus secretion [GO:0070254]; neutrophil activation [GO:0042119]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein import into nucleus [GO:0006606]; protein K63-linked ubiquitination [GO:0070534]; protein localization to P-body [GO:0110012]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; skin development [GO:0043588]; spleen development [GO:0048536]; T cell differentiation [GO:0030217]; T-helper 17 type immune response [GO:0072538]; transitional two stage B cell differentiation [GO:0002334]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type 2 immune response [GO:0042092]	signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]	GO:0001768; GO:0001782; GO:0001783; GO:0001822; GO:0002230; GO:0002269; GO:0002334; GO:0002344; GO:0002447; GO:0005102; GO:0005634; GO:0006606; GO:0006954; GO:0006959; GO:0007507; GO:0009410; GO:0023019; GO:0023035; GO:0030217; GO:0031410; GO:0033209; GO:0035556; GO:0038173; GO:0042092; GO:0042119; GO:0043123; GO:0043588; GO:0048255; GO:0048535; GO:0048536; GO:0061630; GO:0070254; GO:0070534; GO:0072538; GO:0097400; GO:0110012; GO:1990959	GIDIIKWMER	6.320000172	0.338415802	0.338415802	0.330983528	1261.009151	16.25166	15.74552	14.33695	0	13.75923	0	16.00234	13.35313	0	14.48971	0	0	0	14.45245	0	0	16.83025	0	0	0	0	0	0	0	13.16805	0	14.66177	0	15.71749	16.69736	0	0	0	16.20415	17.07791	0	0	0	0	0	15.55864	0	0	0	17.24908	0	16.24161	0
O43745	CHP2_HUMAN	Calcineurin B homologous protein 2 (Hepatocellular carcinoma-associated antigen 520)	CHP2 HCA520	Homo sapiens (Human)	cellular response to calcium ion [GO:0071277]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cellular response to calcium ion [GO:0071277]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0008284; GO:0010922; GO:0015031; GO:0042307; GO:0045944; GO:0070886; GO:0071277	VDFPGFVR	4.869999886	1	1	0.283299221	936.7316094	17.61743	0	16.90977	15.90436	0	0	0	0	0	17.56735	17.12075	0	18.2495	0	0	0	0	0	15.23318	0	0	0	17.27368	0	16.97221	17.6269	17.14702	0	19.37596	15.90232	0	0	0	18.46367	0	18.073	17.25426	18.02	0	0	0	18.44424	0	0	0	0	0	0
O43747	AP1G1_HUMAN	AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1)	AP1G1 ADTG CLAPG1	Homo sapiens (Human)	basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]	AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267]; basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267]	GO:0000139; GO:0005737; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0006896; GO:0006898; GO:0016020; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0031267; GO:0032438; GO:0032588; GO:0035615; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0048471; GO:0055037; GO:0060155; GO:0090160; GO:0110010; GO:0140312; GO:1903232	LTYNHK	3.630000114	0.859953821	0.859953821	0.208676518	777.1473111	0	0	0	15.94237	14.90492	13.35592	0	14.95434	13.399	16.03943	14.93839	0	14.3291	0	0	0	15.83042	13.6548	12.73079	15.71919	15.71774	15.33337	0	0	0	0	0	0	0	0	0	0	15.96559	0	0	15.46097	15.23774	0	0	0	0	0	15.16861	15.62386	0	0	0	0
O43752	STX6_HUMAN	Syntaxin-6	STX6	Homo sapiens (Human)	"endocytic recycling [GO:0032456]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; endocytic recycling [GO:0032456]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]"	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000149; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0016189; GO:0019905; GO:0030136; GO:0030285; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048278; GO:0048471; GO:0090161	AVNTAQGLFQR	4.599999905	1	1	0.145483732	1205.19875	0	0	0	0	0	0	0	0	0	0	0	0	0	15.40184	0	0	0	0	0	0	0	0	0	0	15.85107	0	0	0	13.83343	14.83237	0	16.42737	16.30441	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O43759	SNG1_HUMAN	Synaptogyrin-1	SYNGR1	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; protein targeting [GO:0006605]; regulated exocytosis [GO:0045055]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle membrane organization [GO:0048499]	azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; cellular response to leukemia inhibitory factor [GO:1990830]; protein targeting [GO:0006605]; regulated exocytosis [GO:0045055]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle membrane organization [GO:0048499]		GO:0005886; GO:0006605; GO:0016021; GO:0030285; GO:0030672; GO:0031594; GO:0035577; GO:0042470; GO:0045055; GO:0048169; GO:0048172; GO:0048499; GO:1990830	EGGAYGAGK	7.289999962	0.936530173	0.936530173	0.18410522	808.6963994	0	0	15.33475	0	0	0	14.01228	0	0	0	0	0	0	0	15.3491	15.66115	0	0	0	0	0	0	14.21199	0	17.07828	0	0	0	0	16.25061	0	16.76028	15.0236	16.1848	15.71457	0	16.87255	16.41647	16.87006	16.45956	15.97751	0	17.47375	0	16.15096	14.92489	14.61141	16.71742
O43760	SNG2_HUMAN	Synaptogyrin-2 (Cellugyrin)	SYNGR2 UNQ352/PRO615	Homo sapiens (Human)	regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499]		GO:0005811; GO:0016021; GO:0030672; GO:0031594; GO:0045055; GO:0048499; GO:0070062	FLTQPQVVAR	7.050000191	1	1	9.20E-13	1158.713052	0	0	0	0	0	0	0	14.56998	0	0	0	0	15.92401	0	0	0	0	0	0	0	0	0	14.86253	0	0	0	15.5507	0	0	0	17.18118	16.48271	17.49521	18.34474	0	0	0	0	0	0	0	0	0	0	0	0	17.6539	0
O43776	SYNC_HUMAN	"Asparagine--tRNA ligase, cytoplasmic, EC 6.1.1.22 (Asparaginyl-tRNA synthetase, AsnRS) (Asparaginyl-tRNA synthetase 1)"	NARS1 NARS NRS	Homo sapiens (Human)	asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418]	asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]	GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006421; GO:0016477; GO:0021987; GO:0031728; GO:0046983; GO:0070062	TGLKALMTVGK	6.739999771	0.170800298	0.170800298	0.134713756	1122.617676	15.05499	15.09775	13.00576	0	0	0	0	0	12.24401	0	0	0	0	0	0	15.97831	0	0	0	0	11.99946	0	14.44255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.32948
O43805	SSNA1_HUMAN	Sjoegren syndrome nuclear autoantigen 1 (Nuclear autoantigen of 14 kDa)	SSNA1 NA14	Homo sapiens (Human)	ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; intraciliary transport [GO:0042073]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; intraciliary transport [GO:0042073]	identical protein binding [GO:0042802]	GO:0005634; GO:0005813; GO:0005829; GO:0036064; GO:0042073; GO:0042802; GO:0060830	NEFDRTIAETEAAYLK	3.980000019	0.739904284	0.739904284	0.12645614	1870.652259	0	12.81099	0	0	0	0	0	0	14.16224	16.95899	16.16213	14.22294	0	14.47674	12.948	13.56827	13.31102	11.7283	12.32803	16.1803	14.32951	15.57951	17.93544	14.52419	0	9.942039	14.58248	15.51578	0	0	0	14.88339	0	14.68676	14.78848	0	12.03296	17.84394	0	16.147	0	15.13337	0	15.85122	0	13.8331	14.99833	0
O43815	STRN_HUMAN	Striatin	STRN	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; dendrite development [GO:0016358]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; Wnt signaling pathway [GO:0016055]	bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]	bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; estrogen receptor binding [GO:0030331]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; bicellular tight junction assembly [GO:0070830]; dendrite development [GO:0016358]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; Wnt signaling pathway [GO:0016055]	armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; estrogen receptor binding [GO:0030331]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]	GO:0005516; GO:0005829; GO:0005923; GO:0007626; GO:0008285; GO:0014069; GO:0016020; GO:0016055; GO:0016358; GO:0030331; GO:0030425; GO:0043025; GO:0043197; GO:0044877; GO:0045211; GO:0051721; GO:0070016; GO:0070830; GO:0090443	ALPDSGEDR	6.679999828	0.790386975	0.790386975	0.219512512	959.6924786	16.27042	16.39691	14.80973	14.18451	16.74428	14.18	9.694174	9.701148	15.34137	0	14.83687	16.32567	12.67557	15.90082	11.62475	14.74027	14.72068	12.56443	14.64737	0	14.98999	15.57944	15.60837	15.89472	16.098	0	15.08633	15.78876	15.76564	15.7216	0	15.62416	14.73366	0	15.61467	16.60618	15.8271	16.50674	0	0	15.37141	15.57044	0	0	15.33	0	0	16.80862
O43823	AKAP8_HUMAN	"A-kinase anchor protein 8, AKAP-8 (A-kinase anchor protein 95 kDa, AKAP 95)"	AKAP8 AKAP95	Homo sapiens (Human)	cell cycle G2/M phase transition [GO:0044839]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; innate immune response [GO:0045087]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of histone deacetylation [GO:0031065]; protein transport [GO:0015031]; regulation of histone phosphorylation [GO:0033127]; signal transduction [GO:0007165]	condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell cycle G2/M phase transition [GO:0044839]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; innate immune response [GO:0045087]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of histone deacetylation [GO:0031065]; protein transport [GO:0015031]; regulation of histone phosphorylation [GO:0033127]; signal transduction [GO:0007165]	double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000278; GO:0000793; GO:0001939; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005794; GO:0007076; GO:0007165; GO:0008270; GO:0015031; GO:0016020; GO:0016363; GO:0031065; GO:0032720; GO:0033127; GO:0034237; GO:0042826; GO:0044839; GO:0045087; GO:0051059; GO:0071222; GO:0071380	GSLDGFMR	1.110000014	0.22147581	0.22147581	0.266772985	898.3666127	14.82833	18.62216	17.10785	7.841171	16.7046	0	17.40549	18.14106	18.88984	0	14.32496	0	18.79258	18.05724	0	0	19.40561	19.48734	0	19.20859	17.30047	0	18.48589	17.3151	0	19.18806	0	18.5122	19.64017	17.8916	19.66214	19.19155	0	20.03921	20.30349	19.20468	20.54918	0	19.9728	0	19.09315	0	17.80789	18.5982	18.23128	16.16962	19.1846	0
O43824	GTPB6_HUMAN	Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like)	GTPBP6 PGPL	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]	GO:0005525; GO:0005737; GO:0043022; GO:0046872	TTLIKALTGDAAIQPR	4.079999924	0.46577391	0.46577391	0.107714017	1669.014777	0	10.86302	0	0	0	14.41403	0	0	11.25807	8.052399	17.54647	0	15.11094	0	18.47178	0	0	14.60522	0	17.16208	16.0298	15.5079	14.41501	16.72746	15.34827	0	0	13.50337	0	0	16.17753	14.55299	0	0	15.10547	0	0	14.93301	14.96726	0	0	0	15.01726	11.00821	14.30993	16.41375	0	0
O43829	ZBT14_HUMAN	"Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog, Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog, ZF5, Zfp-5, hZF5)"	ZBTB14 ZFP161 ZNF478	Homo sapiens (Human)	"cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001822; GO:0003170; GO:0003279; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0016235; GO:0043565; GO:0045892; GO:0046872; GO:0060976; GO:1990837	GFTTQAHLK	13.38000011	1	1	0.186793566	1001.624275	17.57556	0	18.15132	0	0	0	0	0	0	0	0	0	21.3012	0	0	0	22.05466	0	0	15.44967	0	0	0	0	0	0	0	0	20.68055	0	0	21.10368	20.38503	21.6057	0	0	0	0	0	0	21.69175	0	22.31178	0	0	21.37951	21.90545	0
O43837	IDH3B_HUMAN	"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)"	IDH3B	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]	electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0009055; GO:0051287	GKVTAVHK	4.489999771	0.33127889	0.33127889	0.131464071	840.1217765	17.76889	16.08018	16.33555	17.01414	16.50688	0	14.91306	15.00395	17.39401	16.77655	16.65839	17.08999	13.16063	0	13.53871	14.31717	0	16.57442	14.10652	13.88972	8.407882	0	17.01545	0	16.83172	14.84048	16.26383	0	15.66607	15.03509	0	15.74693	15.05686	0	15.34929	15.2345	15.38239	16.36583	0	13.04905	14.92143	15.31649	15.45711	13.30102	16.00698	16.34115	16.2063	15.19503
O43852	CALU_HUMAN	Calumenin (Crocalbin) (IEF SSP 9302)	CALU	Homo sapiens (Human)		endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016020; GO:0033018; GO:0042470	IVSKIDGDK	6.630000114	6.83E-06	6.83E-06	0.19452659	974.3871568	0	0	0	0	0	0	0	0	0	0	0	14.48489	0	0	15.93804	15.43248	0	0	0	0	0	0	0	16.40799	0	0	0	13.37719	0	13.85096	0	13.84098	14.87493	0	0	14.38251	0	0	0	14.64372	0	0	13.35024	0	0	0	0	0
O43861	ATP9B_HUMAN	"Probable phospholipid-transporting ATPase IIB, EC 7.6.2.1 (ATPase class II type 9B)"	ATP9B ATPIIB NEO1L HUSSY-20	Homo sapiens (Human)	"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	"endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0016887; GO:0045332; GO:0048471; GO:0140326	MGVIVRDESTAEITFYMK	8.770000458	0.698103964	0.698103964	0.071467797	2122.485583	16.20293	0	0	14.29011	15.65414	14.14035	0	12.58654	14.17625	0	15.15651	14.27813	16.68008	0	17.31408	0	16.20034	15.21206	16.43699	17.19661	0	0	0	0	0	0	0	15.02088	0	0	14.75254	0	16.17212	0	16.13102	0	17.39771	16.75373	0	0	0	0	17.42174	0	0	0	0	0
O43865	SAHH2_HUMAN	"S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3), IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2, AdoHcyase 2)"	AHCYL1 DCAL IRBIT XPVKONA	Homo sapiens (Human)	angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005789; GO:0005829; GO:0006378; GO:0006611; GO:0006730; GO:0006915; GO:0010765; GO:0016324; GO:0031440; GO:0032412; GO:0033353; GO:0038166; GO:0042045; GO:0042802; GO:0044070; GO:0044233; GO:0051592; GO:0070062; GO:1990456	QIQFADDMQEFTK	5.139999866	0.568097711	0.568097711	0.326675739	1597.768578	16.28783	0	13.4781	15.52088	13.32338	10.66785	12.27059	9.608549	14.75501	13.68508	16.3181	13.67181	0	15.97171	0	0	0	0	14.96722	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.89625	0	17.06232	16.68005	0	0	0	0	15.02041	0	0	0
O43866	CD5L_HUMAN	"CD5 antigen-like (Apoptosis inhibitor expressed by macrophages, hAIM) (CT-2) (IgM-associated peptide) (SP-alpha)"	CD5L API6 UNQ203/PRO229	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; positive regulation of complement-dependent cytotoxicity [GO:1903661]; regulation of complement activation [GO:0030449]; zymogen activation [GO:0031638]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; positive regulation of complement-dependent cytotoxicity [GO:1903661]; regulation of complement activation [GO:0030449]; zymogen activation [GO:0031638]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0002376; GO:0004252; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006915; GO:0006954; GO:0006968; GO:0009986; GO:0030449; GO:0031638; GO:0072562; GO:1903661	LEVLHK	2.059999943	0.335885644	0.335885644	0.104349739	737.8116526	17.83818	17.921	15.75116	14.07303	0	15.00176	17.18923	17.90635	0	17.88688	18.70919	0	0	17.92525	0	18.39694	18.2985	0	0	0	15.95187	0	0	18.01166	16.87106	18.21637	15.62543	16.47536	0	0	16.19937	18.69125	0	16.22764	0	0	17.51018	17.885	0	0	17.68965	12.21318	17.61001	17.09331	17.06283	0	0	14.48848
O43869	OR2T1_HUMAN	"Olfactory receptor 2T1 (Olfactory receptor 1-25, OR1-25) (Olfactory receptor OR1-61)"	OR2T1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	VSGGVF	8.229999542	0.55811888	0.55811888	0.189993688	564.3834467	20.31244	17.43404	20.50848	17.03536	20.01251	18.12029	17.17549	18.12005	19.20762	0	17.47295	19.08419	18.88878	19.35103	19.32191	0	0	17.00667	0	17.06811	18.71906	18.24461	0	20.00667	18.83914	18.66202	19.51464	0	18.02594	17.95066	18.3586	18.32024	17.32155	0	0	0	0	19.88146	17.61951	17.64716	0	19.0651	18.37883	18.68205	17.48996	20.16801	18.53598	18.27534
O43895	XPP2_HUMAN	"Xaa-Pro aminopeptidase 2, EC 3.4.11.9 (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P, Membrane-bound APP, Membrane-bound AmP, mAmP) (X-Pro aminopeptidase 2)"	XPNPEP2	Homo sapiens (Human)		anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0004177; GO:0005576; GO:0005886; GO:0016020; GO:0031225; GO:0046872; GO:0070006; GO:0070062	GMFTSIEPGYYK	13.11999989	0.883126497	0.883126497	0.020883842	1408.698072	15.06866	16.5865	0	0	15.01208	0	0	13.83673	0	0	0	14.80815	0	16.09813	14.51606	15.58428	0	15.19122	0	15.62647	0	16.30597	0	0	0	16.90318	17.13181	15.59894	15.76029	0	16.92961	0	17.5398	0	0	17.52857	14.52518	14.46431	0	15.0708	0	16.13535	0	16.31459	0	0	0	15.33926
O43896	KIF1C_HUMAN	Kinesin-like protein KIF1C	KIF1C KIAA0706	Homo sapiens (Human)	"anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	"axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; RNA binding [GO:0003723]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; RNA binding [GO:0003723]	GO:0003723; GO:0003774; GO:0003777; GO:0005524; GO:0005783; GO:0005794; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0030705; GO:1904115; GO:1990048; GO:1990049	AHIDK	6.110000134	0.022612879	0.022612879	0.242364898	584.2783374	0	16.99689	0	15.60531	16.39921	0	15.4116	15.1493	0	13.96374	0	15.72891	0	0	17.1249	0	0	0	18.80298	15.87636	16.99926	0	15.87039	17.35667	0	0	18.48751	0	15.56231	0	0	0	0	16.48739	0	0	17.45511	16.90565	16.68958	0	0	17.53075	0	16.31273	16.62114	17.50409	14.08679	16.7629
O43897	TLL1_HUMAN	"Tolloid-like protein 1, EC 3.4.24.-"	TLL1 TLL	Homo sapiens (Human)	cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; skeletal system development [GO:0001501]	calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0001501; GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0008270; GO:0030154; GO:0030199	AATSRTER	5.320000172	0.964767635	0.964767635	0.208672072	892.5762781	15.5596	16.19352	16.65104	16.02992	0	16.34906	16.5033	15.76219	14.28311	0	13.64804	0	17.28829	0	0	0	14.78285	17.45197	14.60531	0	15.08939	0	0	0	16.788	0	12.40299	15.32829	0	0	0	17.72032	0	16.62109	0	0	16.15633	0	0	0	16.10727	0	15.87029	0	0	0	0	0
O43900	PRIC3_HUMAN	"Prickle planar cell polarity protein 3 (LIM domain only protein 6, LMO-6) (Prickle-like protein 3, Pk3) (Triple LIM domain protein 6)"	PRICKLE3 LMO6	Homo sapiens (Human)	cell projection organization [GO:0030030]	mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; cell projection organization [GO:0030030]	zinc ion binding [GO:0008270]	GO:0005739; GO:0005886; GO:0008270; GO:0030030	AGMPR	1.370000005	0.304892719	0.304892719	0.144305379	542.9527476	0	16.38928	14.02383	16.59074	13.71425	12.45979	13.91799	14.85565	13.8751	14.81834	17.02283	15.58301	19.38408	20.22033	20.56129	19.82896	0	0	19.96281	20.61783	19.86742	19.08745	19.16623	18.26249	18.00899	19.85813	19.13448	19.73786	0	18.98204	0	17.25458	19.31006	0	20.39989	16.7571	18.39067	0	0	0	17.34646	18.32274	20.83205	20.52209	19.9887	20.87863	16.48299	0
O43914	TYOBP_HUMAN	"TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein, KAR-associated protein)"	TYROBP DAP12 KARAP	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; apoptotic cell clearance [GO:0043277]; apoptotic signaling pathway [GO:0097190]; cellular defense response [GO:0006968]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; microglial cell activation involved in immune response [GO:0002282]; myeloid leukocyte activation [GO:0002274]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of transforming growth factor beta1 production [GO:0032911]; neutrophil activation involved in immune response [GO:0002283]; osteoclast differentiation [GO:0030316]; positive regulation of gene expression [GO:0010628]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast development [GO:2001206]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; protein stabilization [GO:0050821]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stimulatory killer cell immunoglobulin-like receptor signaling pathway [GO:0002222]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; apoptotic cell clearance [GO:0043277]; apoptotic signaling pathway [GO:0097190]; cellular defense response [GO:0006968]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; microglial cell activation involved in immune response [GO:0002282]; myeloid leukocyte activation [GO:0002274]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of transforming growth factor beta1 production [GO:0032911]; neutrophil activation involved in immune response [GO:0002283]; osteoclast differentiation [GO:0030316]; positive regulation of gene expression [GO:0010628]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast development [GO:2001206]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; protein stabilization [GO:0050821]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stimulatory killer cell immunoglobulin-like receptor signaling pathway [GO:0002222]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0002222; GO:0002223; GO:0002274; GO:0002282; GO:0002283; GO:0005102; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0009986; GO:0010628; GO:0016021; GO:0030036; GO:0030316; GO:0030667; GO:0030889; GO:0030900; GO:0032693; GO:0032731; GO:0032755; GO:0032760; GO:0032816; GO:0032911; GO:0032930; GO:0034241; GO:0035556; GO:0042802; GO:0042803; GO:0043277; GO:0046872; GO:0048678; GO:0050821; GO:0097190; GO:0110090; GO:1900272; GO:1901216; GO:1902685; GO:1904151; GO:2000010; GO:2001206	GAAEAATRK	1.799999952	1	1	0.257903755	875.0795575	21.0717	0	0	0	0	0	0	0	0	17.73616	0	0	0	0	0	18.75222	0	0	0	0	0	0	0	17.89643	0	0	0	16.99938	0	0	0	19.16682	19.91987	0	0	0	19.24199	0	0	18.72393	0	0	0	19.80474	0	0	0	0
O43916	CHST1_HUMAN	"Carbohydrate sulfotransferase 1 (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1, GST-1) (Keratan sulfate Gal-6 sulfotransferase, KS6ST, KSGal6ST, KSST, EC 2.8.2.21)"	CHST1	Homo sapiens (Human)	galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790]	keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0042339; GO:0045130	WIQNNTRGDPTLGK	9.430000305	0.787651539	0.787651539	2.29E-13	1600.043377	14.01777	15.7154	12.42846	16.48348	0	0	0	14.4833	13.31564	0	0	0	14.28503	0	0	12.17921	0	14.96486	0	0	0	0	17.03395	0	16.13615	13.73615	0	15.24824	0	0	13.00745	0	0	0	13.50021	11.48364	0	0	0	0	0	0	0	0	0	18.49314	16.1969	0
O43918	AIRE_HUMAN	"Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)"	AIRE APECED	Homo sapiens (Human)	"central tolerance induction to self antigen [GO:0002509]; humoral immune response [GO:0006959]; immune response [GO:0006955]; negative thymic T cell selection [GO:0045060]; peripheral T cell tolerance induction [GO:0002458]; positive regulation of chemokine production [GO:0032722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of thymocyte migration [GO:2000410]; regulation of transcription, DNA-templated [GO:0006355]; thymus epithelium morphogenesis [GO:0097536]"	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; central tolerance induction to self antigen [GO:0002509]; humoral immune response [GO:0006959]; immune response [GO:0006955]; negative thymic T cell selection [GO:0045060]; peripheral T cell tolerance induction [GO:0002458]; positive regulation of chemokine production [GO:0032722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of thymocyte migration [GO:2000410]; regulation of transcription, DNA-templated [GO:0006355]; thymus epithelium morphogenesis [GO:0097536]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]	GO:0000977; GO:0002458; GO:0002509; GO:0003682; GO:0005634; GO:0005737; GO:0006355; GO:0006955; GO:0006959; GO:0008270; GO:0016604; GO:0032722; GO:0042393; GO:0042802; GO:0045060; GO:0045182; GO:0045893; GO:0045944; GO:0097536; GO:2000410	FQETLHLK	12.46000004	1	1	0.290201779	1016.406292	15.74533	0	0	0	0	0	17.18692	0	0	0	0	0	0	0	0	0	0	0	15.20243	16.07657	0	17.10107	0	18.49527	17.21133	0	18.64407	0	0	0	0	17.99011	0	0	19.04169	0	0	18.26614	0	0	0	0	0	0	0	0	0	0
O43933	PEX1_HUMAN	Peroxisome biogenesis factor 1 (Peroxin-1) (Peroxisome biogenesis disorder protein 1)	PEX1	Homo sapiens (Human)	microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]	GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016887; GO:0044877; GO:0060152; GO:0070062	ADAEYK	7.449999809	1	1	0.205401795	694.3258015	0	15.74242	0	15.76447	0	15.91028	15.9363	15.65662	11.47879	15.39929	14.60654	16.34124	14.17435	15.00838	15.29873	15.97776	15.64039	15.50814	0	13.24864	15.06922	16.90087	0	15.33638	15.18728	0	0	0	15.50143	0	0	0	0	16.1063	0	0	0	16.23539	0	0	15.94455	16.23809	16.28682	0	0	0	16.50467	15.3843
O60218	AK1BA_HUMAN	"Aldo-keto reductase family 1 member B10, EC 1.1.1.300, EC 1.1.1.54 (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein, ARP, hARP) (Small intestine reductase, SI reductase)"	AKR1B10 AKR1B11	Homo sapiens (Human)	cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523]	cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523]	alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0004032; GO:0004033; GO:0005576; GO:0005739; GO:0005764; GO:0005829; GO:0008106; GO:0016488; GO:0044597; GO:0044598; GO:0045550; GO:0047655; GO:0047718; GO:0052650; GO:0110095	SPLGKVK	10.64999962	1	1	0.261005655	729.459574	0	0	0	0	0	0	0	0	0	17.73768	0	0	0	0	20.23812	0	18.06125	0	0	0	0	0	0	0	0	18.60815	18.77272	0	0	0	0	17.93153	18.20072	0	0	0	0	0	0	0	0	20.15387	0	0	0	0	0	0
O60224	SSX4_HUMAN	"Protein SSX4 (Cancer/testis antigen 5.4, CT5.4)"	SSX4 SSX4A; SSX4B	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]"		GO:0005634; GO:0006355	MKSSEK	1.659999967	1	1	0.023048042	724.4119122	14.29916	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.913	0	0	0	0	12.95245	0	0	0	0	0	0	0	0	0	0	0	0	16.48353	0	0	0	0	0	0	0
O60229	KALRN_HUMAN	"Kalirin, EC 2.7.11.1 (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)"	KALRN DUET DUO HAPIP TRAD	Homo sapiens (Human)	axon guidance [GO:0007411]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0007417; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310	SNHDRIR	1.929999948	1	1	0.096210329	896.3277641	15.83262	0	0	9.650012	14.94958	13.74132	15.58596	16.10223	14.31553	14.93037	15.24212	16.75343	15.35526	0	14.79129	14.8038	0	13.20615	15.46735	14.17516	0	0	0	15.82713	14.95613	0	0	13.01309	0	0	0	0	0	14.96852	0	0	0	0	14.9151	0	0	0	14.01562	0	0	0	0	0
O60231	DHX16_HUMAN	"Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, EC 3.6.4.13 (ATP-dependent RNA helicase #3) (DEAH-box protein 16)"	DHX16 DBP2 DDX16 KIAA0577 PRP2	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0008380; GO:0016887; GO:0071005	AMVPELRK	4.300000191	1	1	0.064221264	959.299432	10.45708	0	14.64374	13.94714	0	14.50504	14.03227	0	0	15.26488	10.56864	0	0	0	14.00868	9.716218	0	14.68287	0	14.12133	13.76963	0	14.11003	14.67099	0	0	0	0	0	16.50801	15.06682	0	13.75994	14.69456	13.90679	0	0	11.37196	16.34191	0	0	0	0	14.06413	0	0	0	0
O60237	MYPT2_HUMAN	"Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2, Myosin phosphatase target subunit 2)"	PPP1R12B MYPT2	Homo sapiens (Human)	regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165]	A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018]	A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018]; enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165]	enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]	GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006937; GO:0007165; GO:0008047; GO:0019208; GO:0019901; GO:0030018; GO:0031672	ESAVNLVR	13.72000027	0.207639173	0.207639173	0.242982138	890.1551948	16.87044	16.38978	17.26982	0	15.01155	15.14776	13.98651	0	14.04904	0	12.27768	14.79823	14.40732	0	0	14.54464	15.09974	16.08262	0	12.71046	15.00783	16.55606	15.91724	16.84187	17.09224	14.87138	16.19681	0	17.39563	16.28883	17.59173	15.66178	16.98611	15.12746	14.69893	15.72535	0	17.77598	17.44364	0	17.7727	0	16.56362	15.38357	17.56139	15.11413	11.40187	15.71522
O60238	BNI3L_HUMAN	"BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X, NIP3L)"	BNIP3L BNIP3A BNIP3H NIX	Homo sapiens (Human)	cellular response to hypoxia [GO:0071456]; defense response to virus [GO:0051607]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; positive regulation of apoptotic process [GO:0043065]; positive regulation of macroautophagy [GO:0016239]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of programmed cell death [GO:0043067]; regulation of protein targeting to mitochondrion [GO:1903214]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; cellular response to hypoxia [GO:0071456]; defense response to virus [GO:0051607]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; positive regulation of apoptotic process [GO:0043065]; positive regulation of macroautophagy [GO:0016239]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of programmed cell death [GO:0043067]; regulation of protein targeting to mitochondrion [GO:1903214]	identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]	GO:0005521; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005783; GO:0016021; GO:0016239; GO:0016607; GO:0031224; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043067; GO:0051607; GO:0060548; GO:0071456; GO:0097345; GO:1903146; GO:1903214	SVSLSMR	3.220000029	1	1	0.042954314	795.6380721	0	16.02369	0	13.76736	13.87385	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.8461	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.34846	0	0	0	0	0	0
O60239	3BP5_HUMAN	"SH3 domain-binding protein 5, SH3BP-5 (SH3 domain-binding protein that preferentially associates with BTK)"	SH3BP5 SAB	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]; signal transduction [GO:0007165]	guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124]	GO:0004860; GO:0005085; GO:0005654; GO:0005737; GO:0005739; GO:0007165; GO:0016604; GO:0017124; GO:0030659; GO:0035556; GO:0061099	KTVDDLQAK	5.46999979	0.905980349	0.905980349	0.274126833	1018.15967	14.69395	15.21305	15.98914	15.43342	14.73766	0	0	0	0	0	0	0	14.84958	15.05449	0	0	0	0	0	16.11844	0	0	0	0	16.18736	13.74058	16.23199	14.51627	16.69464	16.84091	13.93678	15.92074	12.51901	15.87371	16.60012	15.57032	16.32975	15.75767	15.66352	0	12.96305	14.34725	12.06827	16.31507	13.79856	15.92564	0	14.17851
O60240	PLIN1_HUMAN	Perilipin-1 (Lipid droplet-associated protein)	PLIN1 PERI PLIN	Homo sapiens (Human)	cellular response to cold [GO:0070417]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; lipid binding [GO:0008289]; cellular response to cold [GO:0070417]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]	lipid binding [GO:0008289]	GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0008289; GO:0016042; GO:0070417	GLLGGVAHTLQK	4.269999981	1	1	0.127727038	1194.605952	0	0	0	14.31119	0	0	0	14.65109	0	0	15.00254	0	0	0	0	14.61093	0	0	15.90967	0	0	0	0	0	16.13458	0	0	0	14.1449	0	12.50866	0	9.341031	14.09727	11.45599	0	11.10951	11.60085	14.25277	12.9389	0	13.36846	13.90216	13.387	0	0	0	0
O60241	AGRB2_HUMAN	Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2)	ADGRB2 BAI2	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016021; GO:0016525; GO:0033173	QVPEPGERSR	3.190000057	1	1	0.258753044	1154.669616	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60242	AGRB3_HUMAN	Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3)	ADGRB3 BAI3 KIAA0550	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]	G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]	GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558	VPQEQADAAK	4.309999943	0.322763324	0.322763324	0.206161811	1057.58179	0	0	0	18.04933	15.40778	14.85468	0	13.65907	15.18337	16.37898	16.07891	16.49507	0	14.73378	10.7362	14.26782	15.76468	0	15.50795	14.20129	0	0	0	0	0	0	0	0	0	0	14.73382	0	17.7337	0	16.18991	15.76015	15.25433	0	16.52269	0	0	17.52535	0	15.33587	15.17894	0	0	19.14625
O60243	H6ST1_HUMAN	"Heparan-sulfate 6-O-sulfotransferase 1, HS6ST-1, EC 2.8.2.-"	HS6ST1 HS6ST	Homo sapiens (Human)	"angiogenesis [GO:0001525]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; labyrinthine layer blood vessel development [GO:0060716]; lung alveolus development [GO:0048286]; neuron development [GO:0048666]"	Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]	"Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; sulfotransferase activity [GO:0008146]; angiogenesis [GO:0001525]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; labyrinthine layer blood vessel development [GO:0060716]; lung alveolus development [GO:0048286]; neuron development [GO:0048666]"	heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001525; GO:0005887; GO:0006024; GO:0008146; GO:0015015; GO:0017095; GO:0048286; GO:0048666; GO:0060716	APPDDLDLFPTPDPHYEKK	2.230000019	1	1	0.315728465	2195.115352	0	12.51659	0	12.67045	14.27713	0	9.751763	7.473829	12.97459	14.11887	15.47773	12.62955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.11606	0	0	0	0	0	0	0	0
O60244	MED14_HUMAN	"Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component, ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2, CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog, hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component, Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component, DRIP150)"	MED14 ARC150 CRSP2 CXorf4 DRIP150 EXLM1 RGR1 TRAP170	Homo sapiens (Human)	"positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]"	nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]	GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0019827; GO:0030374; GO:0032968; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847	DALVHAR	2.849999905	1	1	0.160598969	781.3165033	14.72286	0	0	13.93951	15.637	11.71323	13.88212	0	15.19011	0	0	0	14.48922	14.243	0	14.36896	13.46894	15.87581	0	0	0	0	0	0	0	21.22992	9.568571	14.33309	0	17.41147	19.96519	18.62308	18.65901	0	4.053926	15.27439	0	0	0	17.91778	0	0	0	16.1635	17.03575	0	0	0
O60245	PCDH7_HUMAN	"Protocadherin-7 (Brain-heart protocadherin, BH-Pcdh)"	PCDH7 BHPCDH	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0031092	AGAADSAPYPGGGGNGASGGGSGGSK	1.779999971	1	1	0.284436584	2062.701749	12.85704	13.37835	15.34026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60256	KPRB_HUMAN	"Phosphoribosyl pyrophosphate synthase-associated protein 2, PRPP synthase-associated protein 2 (41 kDa phosphoribosypyrophosphate synthetase-associated protein, PAP41)"	PRPSAP2	Homo sapiens (Human)	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide biosynthetic process [GO:0006164]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]	cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide biosynthetic process [GO:0006164]	enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]	GO:0000287; GO:0002189; GO:0004749; GO:0004857; GO:0005737; GO:0006015; GO:0006139; GO:0006164; GO:0042802; GO:0060348	HSPPMVRSVAAIHPSLEIPMLIPK	2.369999886	0.735162199	0.735162199	0.250675601	2636.026175	0	11.292	14.38057	13.90185	13.88535	13.61073	10.86302	14.91321	0	14.09115	14.48259	10.55045	0	0	14.14503	11.96152	0	0	0	0	0	0	0	0	14.80537	16.32711	0	13.55108	14.2824	13.60607	0	0	0	0	0	0	0	0	0	0	15.03414	0	0	0	0	0	11.84918	0
O60258	FGF17_HUMAN	"Fibroblast growth factor 17, FGF-17"	FGF17 UNQ161/PRO187	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]	GO:0001934; GO:0005104; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0030154; GO:0030334	RPQPLT	4.099999905	1	1	0.285284697	712.3952768	0	0	16.72355	0	0	0	0	0	0	0	0	17.96393	0	0	0	0	0	17.08243	0	15.74167	16.44284	0	17.15719	16.63682	0	0	0	0	0	0	17.50004	0	0	0	16.53244	0	0	0	0	0	0	0	17.53004	0	16.36903	16.77454	0	17.79363
O60260	PRKN_HUMAN	"E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)"	PRKN PARK2	Homo sapiens (Human)	"adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; amyloid fibril formation [GO:1990000]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]"	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]	"aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; amyloid fibril formation [GO:1990000]; autophagy of mitochondrion [GO:0000422]; cellular protein catabolic process [GO:0044257]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]"	actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0001664; GO:0001933; GO:0001964; GO:0003714; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007417; GO:0007612; GO:0008013; GO:0008270; GO:0008344; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010906; GO:0010994; GO:0014059; GO:0014069; GO:0015631; GO:0016235; GO:0016236; GO:0016567; GO:0016579; GO:0016607; GO:0017124; GO:0019899; GO:0019900; GO:0019901; GO:0030165; GO:0030544; GO:0031072; GO:0031396; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032368; GO:0032436; GO:0033132; GO:0034620; GO:0034976; GO:0035249; GO:0035519; GO:0036503; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043123; GO:0043130; GO:0043161; GO:0043274; GO:0043388; GO:0043524; GO:0044257; GO:0044314; GO:0044828; GO:0044877; GO:0045732; GO:0045944; GO:0046329; GO:0046676; GO:0048471; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051865; GO:0051881; GO:0055069; GO:0060548; GO:0060828; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0071287; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0097237; GO:0097413; GO:0097602; GO:0098779; GO:0098793; GO:0099074; GO:1900407; GO:1901215; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1902803; GO:1903202; GO:1903214; GO:1903265; GO:1903351; GO:1903377; GO:1903382; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1905281; GO:1905366; GO:1905477; GO:1990000; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378	NGGCMHMK	2.349999905	0.945734203	0.945734203	0.17175854	966.1416104	18.44514	16.36963	0	14.53996	13.53463	14.58385	0	0	0	13.5286	16.60687	17.44112	17.11793	18.9579	0	0	15.74681	17.5751	14.11408	16.83443	14.92833	14.73752	17.25982	15.49524	0	16.95727	15.52599	15.46789	0	17.17759	0	13.45565	16.36669	16.82151	0	10.47229	0	17.2025	15.94057	13.87146	13.76556	11.77818	15.42112	14.91708	0	17.86073	17.04636	0
O60264	SMCA5_HUMAN	"SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5, EC 3.6.4.- (Sucrose nonfermenting protein 2 homolog, hSNF2H)"	SMARCA5 SNF2H WCRF135	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; histone H2A phosphorylation [GO:1990164]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of DNA replication [GO:0045740]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin assembly [GO:0000183]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CHRAC [GO:0008623]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; WICH complex [GO:0090535]	"ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CHRAC [GO:0008623]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; WICH complex [GO:0090535]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; histone H2A phosphorylation [GO:1990164]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of DNA replication [GO:0045740]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin assembly [GO:0000183]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]"	GO:0000183; GO:0000793; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005730; GO:0006275; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0006357; GO:0008094; GO:0008623; GO:0016479; GO:0016584; GO:0016589; GO:0016590; GO:0016887; GO:0031062; GO:0031065; GO:0031213; GO:0031491; GO:0031497; GO:0035066; GO:0042766; GO:0044030; GO:0045740; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0090536; GO:0110016; GO:0140658; GO:1905213; GO:1990164; GO:1990830; GO:2001020	MDGAPDGRGR	8.729999542	1	1	0.302617361	1031.930148	0	0	16.68752	16.36758	0	0	0	0	0	0	0	0	17.43096	0	0	0	0	15.91652	0	0	0	0	16.62777	0	16.17232	0	17.60766	0	0	0	0	0	0	0	0	15.9574	0	17.07339	0	15.85577	0	0	0	0	0	0	0	15.5444
O60266	ADCY3_HUMAN	"Adenylate cyclase type 3, EC 4.6.1.1 (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III, AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3, AC3)"	ADCY3 KIAA0511	Homo sapiens (Human)	acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0016021; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322	MEAGGIPGR	7.25	1	1	0.153982291	888.4968524	14.1506	14.17878	15.71017	17.67494	15.44779	14.33628	0	0	14.78732	0	15.08121	13.21665	0	0	14.25837	13.90809	12.22533	15.03486	0	0	0	16.27827	0	11.12125	0	0	0	0	0	0	0	16.21524	0	0	0	0	0	0	0	16.03258	14.6638	0	0	0	0	0	14.77881	0
O60269	GRIN2_HUMAN	"G protein-regulated inducer of neurite outgrowth 2, GRIN2"	GPRIN2 KIAA0514	Homo sapiens (Human)	neuron projection development [GO:0031175]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; neuron projection development [GO:0031175]		GO:0005886; GO:0031175	ASGPK	1.159999967	0.390263587	0.390263587	0.104373623	459.2231284	0	16.66046	16.94385	15.71316	0	0	0	16.71361	16.12259	15.76031	0	14.91189	0	14.90512	0	0	14.78656	17.10488	0	0	0	17.59696	14.67901	0	15.29928	0	0	16.73352	0	0	15.66517	14.94669	0	16.97107	0	17.78596	16.58032	16.63698	0	0	15.89715	16.68367	0	17.48622	16.76223	17.31313	0	17.10463
O60271	JIP4_HUMAN	"C-Jun-amino-terminal kinase-interacting protein 4, JIP-4, JNK-interacting protein 4 (Cancer/testis antigen 89, CT89) (Human lung cancer oncogene 6 protein, HLC-6) (JNK-associated leucine-zipper protein, JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis, PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1)"	SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6	Homo sapiens (Human)	"lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]"	acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]	"acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]"	identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0001669; GO:0001933; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0045665; GO:0045666; GO:0048471; GO:0051146; GO:0070062; GO:1903860	NVSTGSAENEEK	4.670000076	1	1	0.099961978	1265.469509	17.02416	0	9.214664	0	13.03149	0	12.94541	10.60781	13.5786	0	0	17.45266	0	0	13.61839	0	0	0	0	0	0	0	0	0	0	0	0	14.49535	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60279	SUSD5_HUMAN	Sushi domain-containing protein 5	SUSD5 KIAA0527	Homo sapiens (Human)	cell adhesion [GO:0007155]; Notch signaling pathway [GO:0007219]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; Notch signaling pathway [GO:0007219]	hyaluronic acid binding [GO:0005540]	GO:0005540; GO:0007155; GO:0007219; GO:0016021	LNVGQRQAR	4.389999866	0.522687674	0.522687674	0.225232878	1043.086357	12.88893	14.41576	13.56848	14.0115	14.28381	11.62116	0	16.22293	0	16.55139	15.03475	0	0	14.07328	15.24303	15.39795	10.7377	12.37096	0	14.71212	14.72758	0	0	0	0	15.14115	15.93232	14.8009	15.10949	0	13.79235	0	14.71879	16.9079	0	0	0	0	14.83173	0	0	0	0	14.3941	0	15.29832	13.44578	14.69261
O60281	ZN292_HUMAN	Zinc finger protein 292	ZNF292 KIAA0530	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872	ETSEQEGAK	3.019999981	1	1	0.208506701	977.1939563	15.20924	10.33167	12.7505	0	0	14.71691	16.41878	9.88747	16.65426	0	0	0	15.18541	0	0	0	0	13.03473	0	0	0	16.20358	0	0	0	0	0	15.17196	0	0	0	17.51182	0	0	0	16.34579	0	15.85377	0	0	15.72202	16.75607	0	0	0	0	0	14.97904
O60282	KIF5C_HUMAN	Kinesin heavy chain isoform 5C (Kinesin heavy chain neuron-specific 2)	KIF5C KIAA0531 NKHC2	Homo sapiens (Human)	anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; motor neuron axon guidance [GO:0008045]; mRNA transport [GO:0051028]; organelle organization [GO:0006996]; synaptic vesicle transport [GO:0048489]	axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; ciliary rootlet [GO:0035253]; dendrite cytoplasm [GO:0032839]; distal axon [GO:0150034]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]	axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; ciliary rootlet [GO:0035253]; dendrite cytoplasm [GO:0032839]; distal axon [GO:0150034]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; motor neuron axon guidance [GO:0008045]; mRNA transport [GO:0051028]; organelle organization [GO:0006996]; synaptic vesicle transport [GO:0048489]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0006996; GO:0007018; GO:0007411; GO:0008017; GO:0008045; GO:0008574; GO:0016887; GO:0030705; GO:0032839; GO:0035253; GO:0043025; GO:0044295; GO:0048489; GO:0051028; GO:0098971; GO:0099641; GO:0150034; GO:1904115	FRPLNEAEILRGDK	9.970000267	0.186404139	0.186404139	0.121854208	1657.296978	0	16.10634	12.91559	16.16386	14.52226	0	16.44418	13.54915	0	0	15.78902	16.93517	0	12.05081	13.62101	16.35295	16.55179	16.15876	15.37861	16.84254	14.31749	15.19529	0	0	14.01444	13.68458	11.81966	17.11671	14.72103	0	17.96137	15.14838	18.83866	17.04593	15.80856	19.62071	18.67973	0	14.50713	16.16817	14.08224	12.05607	14.72201	0	0	17.27669	13.37233	0
O60284	ST18_HUMAN	Suppression of tumorigenicity 18 protein (Zinc finger protein 387)	ST18 KIAA0535 ZNF387	Homo sapiens (Human)	interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	chromatin [GO:0000785]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	"chromatin [GO:0000785]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0008285; GO:0032993; GO:0033209; GO:0045944; GO:0070102; GO:0070498; GO:2001269	HSPRPEK	12.11999989	1	1	0.039434466	850.2978293	17.24841	14.21684	16.23031	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60285	NUAK1_HUMAN	"NUAK family SNF1-like kinase 1, EC 2.7.11.1 (AMPK-related protein kinase 5, ARK5) (Omphalocele kinase 1)"	NUAK1 ARK5 KIAA0537 OMPHK1	Homo sapiens (Human)	cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001650; GO:0002039; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0042149; GO:0046872; GO:0106310; GO:1901796; GO:2000772	EPTQPSDARGLIR	12.13000011	1	1	0.549207365	1439.627314	20.91192	0	18.27113	10.41054	0	18.32878	0	0	21.36036	0	0	0	19.49704	0	17.67868	0	0	20.21341	0	17.59207	0	17.09259	0	0	21.99384	20.47312	19.84313	0	0	0	22.88571	20.86169	20.14859	18.84495	21.19109	22.07874	20.55329	21.42519	0	20.13353	17.8151	18.56993	0	20.89545	19.76327	0	19.46394	17.67647
O60287	NPA1P_HUMAN	Nucleolar pre-ribosomal-associated protein 1 (Nucleolar protein 254 kDa) (URB1 ribosome biogenesis 1 homolog)	URB1 C21orf108 KIAA0539 NOP254 NPA1	Homo sapiens (Human)	"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	fibrillar center [GO:0001650]; nucleolus [GO:0005730]	"fibrillar center [GO:0001650]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	RNA binding [GO:0003723]	GO:0000463; GO:0000466; GO:0001650; GO:0003723; GO:0005730	ILLLLR	15.55000019	0.58832109	0.58832109	0.123479173	739.4278739	0	13.51706	18.72025	16.63359	11.05665	0	13.76748	15.10843	15.26462	16.64706	17.28845	0	15.37486	0	17.17155	0	16.38608	0	0	17.4727	15.59998	17.05975	0	18.3353	0	17.60824	0	19.14389	17.90871	0	16.74245	17.11243	17.66873	17.95271	17.43554	17.48564	15.7552	0	19.03471	18.57033	17.71492	0	13.41756	16.93339	16.44833	16.67955	14.82115	16.97845
O60290	ZN862_HUMAN	Zinc finger protein 862	ZNF862 KIAA0543	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"	metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]	GO:0005634; GO:0006355; GO:0046872; GO:0046983	ELCGSNK	11.89999962	1	1	0	806.7452555	14.12053	0	15.26426	0	14.74147	0	0	0	15.68282	0	0	0	11.45425	0	0	0	0	0	0	0	0	14.56156	0	0	0	0	12.50245	0	0	13.04139	0	0	0	0	14.79412	0	0	0	0	0	0	0	0	0	0	0	0	0
O60291	MGRN1_HUMAN	"E3 ubiquitin-protein ligase MGRN1, EC 2.3.2.27 (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1)"	MGRN1 KIAA0544 RNF156	Homo sapiens (Human)	endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006513; GO:0008333; GO:0016020; GO:0016567; GO:0043231; GO:0043951; GO:0045744; GO:0045879; GO:0046872; GO:0061630; GO:0070062	MGSILSR	5.389999866	1	1	0.155653817	762.5834749	14.33908	0	15.30936	0	0	15.74456	0	0	0	14.86596	0	14.86185	0	0	14.94874	0	16.30028	13.43823	0	0	0	0	0	0	16.73237	0	0	15.13758	17.02816	0	16.56115	0	17.04488	0	0	16.77103	0	0	16.42523	17.39716	0	14.45715	0	0	0	0	0	0
O60292	SI1L3_HUMAN	"Signal-induced proliferation-associated 1-like protein 3, SIPA1-like protein 3 (SPA-1-like protein 3)"	SIPA1L3 KIAA0545 SPAL3	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cytoskeleton organization [GO:0007010]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell polarity [GO:0090162]; eye development [GO:0001654]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of small GTPase mediated signal transduction [GO:0051056]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; tricellular tight junction [GO:0061689]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; tricellular tight junction [GO:0061689]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cytoskeleton organization [GO:0007010]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell polarity [GO:0090162]; eye development [GO:0001654]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of small GTPase mediated signal transduction [GO:0051056]	GTPase activator activity [GO:0005096]	GO:0001654; GO:0001725; GO:0002244; GO:0003382; GO:0005096; GO:0005615; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0007010; GO:0016324; GO:0045177; GO:0051056; GO:0061689; GO:0090162; GO:0090630	LGPVAVSIKR	6.440000057	1	1	0.123121443	1040.533321	0	8.037623	0	14.68454	14.09357	14.63361	0	0	15.16169	0	0	14.51543	0	0	0	0	0	0	0	0	0	0	0	15.90231	0	0	0	13.75004	0	0	0	0	0	0	15.85821	14.18948	0	14.1439	14.71256	14.18325	15.84049	15.05086	0	15.18752	0	13.34246	0	0
O60293	ZC3H1_HUMAN	Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)	ZFC3H1 CCDC131 KIAA0546 PSRC2	Homo sapiens (Human)	RNA processing [GO:0006396]	exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634]	exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA processing [GO:0006396]	metal ion binding [GO:0046872]	GO:0000178; GO:0005615; GO:0005634; GO:0006396; GO:0046872	GRPYR	1	1	1	0.088157403	650.5976975	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.38615	17.39412	0	0	0	0	0	16.8225	0	0	0	0	15.09565	0	0	0	15.68856	0	0	0	0	0	0	0	0	0	16.50315	15.31035	15.72869
O60299	LZTS3_HUMAN	"Leucine zipper putative tumor suppressor 3 (ProSAP-interacting protein 1, ProSAPiP1)"	LZTS3 KIAA0552 PROSAPIP1	Homo sapiens (Human)	regulation of dendritic spine morphogenesis [GO:0061001]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; regulation of dendritic spine morphogenesis [GO:0061001]		GO:0005737; GO:0005856; GO:0014069; GO:0043197; GO:0045202; GO:0061001	KAWTPSR	5.53000021	1	1	0.112760815	842.5748017	0	0	15.43531	0	0	14.29455	15.09098	14.39333	0	0	0	0	18.44252	0	18.00451	15.70631	0	14.89887	14.54983	0	16.35867	0	0	17.47319	16.08683	0	0	0	14.23189	0	0	14.75163	14.77523	0	12.9827	0	0	0	0	0	0	0	0	0	0	0	0	15.80878
O60303	KATIP_HUMAN	Katanin-interacting protein	KATNIP KIAA0556	Homo sapiens (Human)	cerebrospinal fluid circulation [GO:0090660]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; cerebrospinal fluid circulation [GO:0090660]		GO:0005615; GO:0005737; GO:0005856; GO:0042995; GO:0090660	DPVQLR	8.770000458	0.231413931	0.231413931	0.203013597	728.3957873	16.12498	16.50317	15.21161	13.85765	14.6629	13.50063	0	15.18169	14.93798	15.32606	15.73713	14.36272	15.5768	15.69021	16.37563	16.30102	16.5701	17.13333	17.28348	17.52911	16.07693	16.38355	0	17.58305	0	0	0	16.61689	15.58738	16.15309	16.9521	15.76653	16.17496	0	16.22623	17.15845	17.31274	16.8989	0	16.04983	17.33106	17.61689	16.22507	16.88287	17.49923	0	17.45035	15.95718
O60306	AQR_HUMAN	"RNA helicase aquarius, EC 3.6.4.13 (Intron-binding protein of 160 kDa, IBP160)"	AQR KIAA0560	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mRNA splicing, via spliceosome [GO:0000398]"	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013	GCEIQGMLDDK	7.170000076	0.545821309	0.545821309	0.130280905	1265.810255	0	0	0	0	0	0	0	14.89685	0	0	0	13.75842	11.88462	0	0	0	0	0	0	12.62842	15.61145	0	0	0	8.946012	0	0	11.63503	0	0	0	10.11199	6.668715	13.3826	0	0	16.12446	15.76057	16.76237	0	12.02031	14.84233	0	12.26306	13.48401	14.56813	15.14453	15.00044
O60307	MAST3_HUMAN	"Microtubule-associated serine/threonine-protein kinase 3, EC 2.7.11.1"	MAST3 KIAA0561	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0007010; GO:0018105; GO:0035556; GO:0106310	ATGTFDNEIVMMNHVYR	5.579999924	1	1	0	2014.02924	0	13.58938	14.80442	13.60526	14.32813	0	0	0	0	14.58097	14.54384	0	11.02924	0	13.35392	12.89621	16.13214	0	0	9.087442	0	0	0	0	16.2155	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60308	CE104_HUMAN	"Centrosomal protein of 104 kDa, Cep104"	CEP104 KIAA0562	Homo sapiens (Human)		centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]	centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596]	glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596]	GO:0000922; GO:0005737; GO:0005814; GO:0005929; GO:0016594; GO:0016595; GO:0016596	AIKDIVTSVFQASLK	4.260000229	1	1	2.31E-13	1616.837117	0	0	0	0	0	0	0	0	0	0	0	14.9545	0	0	0	0	0	0	0	0	0	16.01457	0	0	0	0	0	0	0	0	17.08253	15.48234	15.42561	0	0	16.92213	0	0	0	0	0	0	0	0	0	0	0	0
O60309	L37A3_HUMAN	Leucine-rich repeat-containing protein 37A3	LRRC37A3 KIAA0563	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	MTHRTPK	3.779999971	0.44133994	0.44133994	0.25750833	866.6319448	17.04724	16.16383	14.34006	15.07403	13.13991	0	14.90201	14.84222	14.60161	15.76797	16.38921	0	0	12.95277	0	15.95897	14.2222	14.04389	16.05366	0	15.17391	15.62183	15.25848	16.35763	15.32992	0	16.11583	13.83046	16.73883	16.38956	17.02114	17.01679	18.08357	0	16.34982	0	16.21381	15.60756	0	16.54653	15.2346	15.31838	0	15.41349	14.9877	0	0	0
O60312	AT10A_HUMAN	"Phospholipid-transporting ATPase VA, EC 7.6.2.1 (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A)"	ATP10A ATP10C ATPVA ATPVC KIAA0566	Homo sapiens (Human)	ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of membrane tubulation [GO:1903527]; regulation of cell shape [GO:0008360]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of membrane tubulation [GO:1903527]; regulation of cell shape [GO:0008360]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0008360; GO:0016021; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:0140351; GO:1903527; GO:1990531	DITPDPK	2.599999905	0.158693731	0.158693731	0.254546216	784.5133254	0	0	0	0	0	0	0	0	17.83199	0	0	0	0	0	0	0	0	18.16626	17.89934	0	15.38526	0	17.19304	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.12571	0	0	0	0	10.41656	0	19.14738	0	0
O60315	ZEB2_HUMAN	"Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1, SMADIP1) (Zinc finger homeobox protein 1b)"	ZEB2 KIAA0569 SIP1 ZFHX1B ZFX1B HRIHFB2411	Homo sapiens (Human)	anatomical structure development [GO:0048856]; developmental pigmentation [GO:0048066]; melanocyte migration [GO:0097324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of melanosome organization [GO:1903056]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure development [GO:0048856]; developmental pigmentation [GO:0048066]; melanocyte migration [GO:0097324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of melanosome organization [GO:1903056]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007399; GO:0019208; GO:0030511; GO:0043565; GO:0045636; GO:0045944; GO:0046872; GO:0048023; GO:0048066; GO:0048856; GO:0090263; GO:0097324; GO:1903056	QPIMADGPR	8.630000114	1	1	0.333393285	1000.435016	0	14.46987	0	13.47252	0	13.23377	0	14.48715	10.55099	0	13.49533	14.45949	14.96795	14.32698	14.6066	14.07537	13.77893	13.05316	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.87724	16.11135	0	0	0	0	15.3106	0	0	16.34675	0	15.76517
O60318	GANP_HUMAN	"Germinal-center associated nuclear protein, GANP, EC 2.3.1.48 (80 kDa MCM3-associated protein) (MCM3 acetylating protein, MCM3AP, EC 2.3.1.-) (MCM3 acetyltransferase)"	MCM3AP GANP KIAA0572 MAP80	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]; mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446]	chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390	MLLFR	21.38999939	0.761482418	0.761482418	0.136589514	679.5454426	17.70897	17.62908	17.36412	18.16676	17.22811	18.85401	18.06977	17.34588	18.50879	17.7063	17.75459	18.0329	18.32584	17.7526	17.69855	17.45062	17.64707	17.82034	18.2979	17.88157	18.19732	18.50655	18.28091	17.91257	17.97695	17.89352	17.99623	17.70146	17.89026	18.46236	18.07596	17.8834	17.58084	18.51115	18.4824	17.98999	18.14032	18.34851	18.1123	18.75905	18.10162	18.03333	17.20244	17.94119	17.80549	18.35632	18.66208	18.27811
O60320	F1891_HUMAN	Protein FAM189A1 (Transmembrane protein 228)	FAM189A1 KIAA0574 TMEM228	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	PPAGGPR	9.130000114	1	1	0.265701618	648.8936631	0	0	0	0	0	0	0	16.10224	15.66937	0	0	0	0	16.7436	0	0	0	0	0	0	0	0	16.90832	17.1454	0	0	0	0	0	16.06814	16.33872	16.7381	16.91138	16.3142	0	16.68245	0	0	0	0	16.62906	0	0	15.15876	15.5918	0	15.92899	0
O60330	PCDGC_HUMAN	"Protocadherin gamma-A12, PCDH-gamma-A12 (Cadherin-21) (Fibroblast cadherin-3)"	PCDHGA12 CDH21 FIB3 KIAA0588 UNQ371/PRO707	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]	cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0005911; GO:0007155; GO:0007156	VGDISRDLGLEPR	17.81999969	1	1	0.416338641	1426.049251	17.46348	15.15136	0	0	0	0	17.47072	0	0	0	0	17.51696	17.24109	16.18274	0	0	0	0	0	0	0	0	0	0	0	17.44557	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.74809	0	0	0	0	0	0	0
O60331	PI51C_HUMAN	"Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma, PIP5K1gamma, PtdIns(4)P-5-kinase 1 gamma, EC 2.7.1.68 (Type I phosphatidylinositol 4-phosphate 5-kinase gamma)"	PIP5K1C KIAA0589	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]	adherens junction [GO:0005912]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931]	"adherens junction [GO:0005912]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]"	"1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]"	GO:0001891; GO:0001931; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0006661; GO:0006909; GO:0010008; GO:0014066; GO:0016079; GO:0016308; GO:0030036; GO:0030593; GO:0032587; GO:0034333; GO:0046854; GO:0048488; GO:0052812; GO:0061024; GO:0072583; GO:0098609; GO:0098793	ALYSTAMESIQGGAAR	2.089999914	1	1	0.409867428	1643.003184	16.0734	0	0	0	0	14.30909	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38453	0	0	16.21261	0	0	0	0	0	0	0	0	15.58255	0	0	16.34874	0	0	0	0	0	0	0	0	0	0	0	0
O60333	KIF1B_HUMAN	"Kinesin-like protein KIF1B, Klp"	KIF1B KIAA0591 KIAA1448	Homo sapiens (Human)	anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0003777; GO:0005524; GO:0005739; GO:0005871; GO:0005874; GO:0005875; GO:0006915; GO:0007018; GO:0007270; GO:0007274; GO:0008017; GO:0008021; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030659; GO:0030705; GO:0031410; GO:0043005; GO:1904115	HRGVLLQALNDK	13.85000038	1	1	2.40E-13	1363.917685	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60336	MABP1_HUMAN	"Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1, JNKBP-1)"	MAPKBP1 JNKBP1 KIAA0596	Homo sapiens (Human)	negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]		GO:0005654; GO:0005730; GO:0005737; GO:0032717; GO:0043124; GO:0097431; GO:1900425	SGLVAYPAGCVVVLFNPR	4.480000019	1	1	0.214827433	1919.550691	0	0	0	0	15.09418	15.29874	13.43302	13.19148	0	0	0	0	0	13.32339	0	0	0	0	0	0	0	0	17.00327	0	0	0	0	13.82265	0	0	0	0	0	0	0	0	0	0	0	0	17.88777	0	14.44934	0	0	0	0	0
O60343	TBCD4_HUMAN	"TBC1 domain family member 4 (Akt substrate of 160 kDa, AS160)"	TBC1D4 AS160 KIAA0603	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; vesicle [GO:0031982]	cytosol [GO:0005829]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869; GO:0090630	AQGVR	1.289999962	1	1	0.198435342	531.2025866	0	15.85342	14.88703	15.79854	15.70372	0	16.21835	16.0367	16.19145	14.94733	15.67666	0	13.43566	16.2746	15.9632	15.70737	0	0	16.52365	15.43022	15.05829	16.77414	0	16.57542	15.05172	0	0	0	0	0	0	16.65959	0	0	0	16.95807	0	15.9729	0	0	0	0	17.00478	0	0	0	14.39096	0
O60346	PHLP1_HUMAN	"PH domain leucine-rich repeat-containing protein phosphatase 1, EC 3.1.3.16 (Pleckstrin homology domain-containing family E member 1, PH domain-containing family E member 1) (Suprachiasmatic nucleus circadian oscillatory protein, hSCOP)"	PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP	Homo sapiens (Human)	apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of T cell anergy [GO:0002667]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of T cell anergy [GO:0002667]; signal transduction [GO:0007165]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0002667; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0009649; GO:0042981; GO:0043231; GO:0043408; GO:0046328; GO:0046872; GO:0051898; GO:1900744	AGGAGRR	8.359999657	1	1	0.152940891	643.4336534	15.86902	15.37991	0	15.01229	15.10919	0	0	15.09921	15.57454	15.99169	15.48458	15.36482	0	0	13.67786	0	15.65279	16.49781	15.73911	16.09443	15.08927	15.80442	0	15.58251	16.28521	15.35865	14.36119	0	0	15.98232	0	16.12987	0	16.23325	0	16.22107	0	0	0	16.1883	16.07073	15.63276	17.23042	0	16.19312	16.28963	16.18175	16.24923
O60391	NMD3B_HUMAN	"Glutamate receptor ionotropic, NMDA 3B, GluN3B (N-methyl-D-aspartate receptor subtype 3B, NMDAR3B, NR3B)"	GRIN3B	Homo sapiens (Human)	ionotropic glutamate receptor signaling pathway [GO:0035235]; protein insertion into membrane [GO:0051205]; regulation of calcium ion transport [GO:0051924]	neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; glycine binding [GO:0016594]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; ionotropic glutamate receptor signaling pathway [GO:0035235]; protein insertion into membrane [GO:0051205]; regulation of calcium ion transport [GO:0051924]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; glycine binding [GO:0016594]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]	GO:0004970; GO:0005261; GO:0005262; GO:0005886; GO:0015276; GO:0016594; GO:0017146; GO:0030594; GO:0035235; GO:0038023; GO:0042165; GO:0043025; GO:0045211; GO:0051205; GO:0051924	DPASLTR	8.770000458	1	1	0.140666999	759.8843724	0	16.01496	0	15.92198	0	0	0	13.907	14.15017	0	13.70136	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.75	0	0	13.72334	0	0	14.66832	0	0	0	0	0	15.90212	0	0	0	0	15.7875	15.49828	0	14.67717	16.32146	15.58307
O60422	ONEC3_HUMAN	"One cut domain family member 3 (One cut homeobox 3) (Transcription factor ONECUT-3, OC-3)"	ONECUT3	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:1990837	SAAAQHR	16.72999954	0.522123933	0.522123933	0.251473197	740.6808906	0	15.27621	16.90316	15.87054	11.04397	14.97182	0	14.59118	16.18546	15.6043	0	0	0	14.61765	13.0492	13.22625	13.01399	15.45156	0	16.96648	0	17.19681	16.57409	0	0	0	0	14.90231	14.67803	16.20478	17.32618	0	15.98577	0	16.25269	16.61954	15.58902	0	0	15.34128	0	15.11716	16.49322	0	0	0	15.76485	0
O60423	AT8B3_HUMAN	"Phospholipid-transporting ATPase IK, EC 7.6.2.1 (ATPase class I type 8B member 3)"	ATP8B3 ATP1K FOS37502_2	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]	acrosomal membrane [GO:0002080]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	acrosomal membrane [GO:0002080]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556]; binding of sperm to zona pellucida [GO:0007339]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556]	GO:0000287; GO:0002080; GO:0005524; GO:0005789; GO:0005802; GO:0005886; GO:0007030; GO:0007339; GO:0016020; GO:0016021; GO:0016887; GO:0045332; GO:0090556; GO:0140326; GO:1990531	AGMGDSPGRGAPER	4.360000134	1	1	0.125424541	1366.707691	14.35757	12.44349	12.94516	0	14.53329	14.29779	14.09371	13.25087	0	15.58235	15.35549	12.61947	14.64039	13.82441	0	15.99336	0	0	0	12.59653	0	0	0	0	15.29384	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60427	FADS1_HUMAN	"Acyl-CoA (8-3)-desaturase, EC 1.14.19.44 (Delta(5) fatty acid desaturase, D5D, Delta(5) desaturase, Delta-5 desaturase) (Fatty acid desaturase 1)"	FADS1 FADSD5	Homo sapiens (Human)	"alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of transcription, DNA-templated [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA delta5-desaturase activity [GO:0062076]; C-5 sterol desaturase activity [GO:0000248]; linoleoyl-CoA desaturase activity [GO:0016213]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of transcription, DNA-templated [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636]"	"acyl-CoA delta5-desaturase activity [GO:0062076]; C-5 sterol desaturase activity [GO:0000248]; linoleoyl-CoA desaturase activity [GO:0016213]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]"	GO:0000248; GO:0005739; GO:0005789; GO:0006355; GO:0006629; GO:0006636; GO:0007267; GO:0008654; GO:0009267; GO:0016020; GO:0016021; GO:0016213; GO:0016491; GO:0016717; GO:0036109; GO:0042759; GO:0043231; GO:0043651; GO:0045485; GO:0045595; GO:0046456; GO:0062076	ATVERMGLMK	8.079999924	1	1	0.102063264	1152.245847	14.8468	16.14463	15.92679	0	14.8464	0	0	0	0	14.74288	0	15.23151	0	0	0	0	0	0	0	0	0	0	0	0	0	15.68882	0	0	0	0	0	0	0	0	0	0	13.23566	0	0	0	0	0	0	0	0	0	0	0
O60437	PEPL_HUMAN	Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein)	PPL KIAA0568	Homo sapiens (Human)	intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060]	cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0001533; GO:0005198; GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0009612; GO:0016020; GO:0030057; GO:0031424; GO:0042060; GO:0045104; GO:0045296; GO:0070062	TDPEMEK	2.269999981	1	1	0.244588189	863.7513409	0	13.9395	16.96187	15.7331	15.32365	15.10532	15.35079	12.53404	0	15.99843	15.72562	15.83679	16.22964	12.46217	0	14.88624	14.87367	14.64089	15.63908	14.38785	0	0	15.01109	0	0	16.14483	15.89063	15.49397	17.0788	0	0	16.96365	0	0	15.96861	16.3872	15.71007	0	17.56654	14.30146	15.88774	14.46511	15.44505	0	0	14.61797	15.71469	16.03687
O60443	GSDME_HUMAN	"Gasdermin-E (Inversely correlated with estrogen receptor expression 1, ICERE-1) (Non-syndromic hearing impairment protein 5) [Cleaved into: Gasdermin-E, N-terminal, GSDME-NT; Gasdermin-E, C-terminal, GSDME-CT ]"	GSDME DFNA5 ICERE1	Homo sapiens (Human)	cell death [GO:0008219]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; inner ear receptor cell differentiation [GO:0060113]; necrotic cell death [GO:0070265]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of immune response to tumor cell [GO:0002839]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of MAPK cascade [GO:0043410]; pyroptosis [GO:0070269]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cardiolipin binding [GO:1901612]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; wide pore channel activity [GO:0022829]; cell death [GO:0008219]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; inner ear receptor cell differentiation [GO:0060113]; necrotic cell death [GO:0070265]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of immune response to tumor cell [GO:0002839]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of MAPK cascade [GO:0043410]; pyroptosis [GO:0070269]; sensory perception of sound [GO:0007605]"	"cardiolipin binding [GO:1901612]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; wide pore channel activity [GO:0022829]"	GO:0002839; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0007605; GO:0008219; GO:0008285; GO:0016020; GO:0016021; GO:0022829; GO:0043410; GO:0060113; GO:0070265; GO:0070269; GO:0071356; GO:0098586; GO:0140507; GO:1901612; GO:2001244	FGIVQRLFASADISLER	7.349999905	0.6743325	0.6743325	0.405745236	1921.559453	11.7796	16.72242	0	11.83307	16.79775	0	13.13766	12.64322	14.06766	0	0	16.14236	0	0	11.78494	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.83596	0	0	0	0	0	0	0	15.06649	15.71255	14.78135	0	0	0	0	0	0
O60447	EVI5_HUMAN	"Ecotropic viral integration site 5 protein homolog, EVI-5 (Neuroblastoma stage 4S gene protein)"	EVI5 NB4S	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]	"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]"	GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]	GO:0005096; GO:0005634; GO:0005815; GO:0005819; GO:0005829; GO:0007049; GO:0031267; GO:0042147; GO:0043547; GO:0051301; GO:0090630	SVNGSRR	5.260000229	1	1	0.247575883	775.9609058	15.36504	14.83748	0	14.63541	14.59777	14.80768	14.45245	14.98513	0	15.76093	0	0	15.76866	0	0	0	0	0	16.52027	0	0	0	0	0	0	15.19403	0	0	0	0	0	0	0	0	14.79075	0	0	0	0	0	0	0	0	0	15.12213	0	0	0
O60449	LY75_HUMAN	"Lymphocyte antigen 75, Ly-75 (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205)"	LY75 CD205 CLEC13B	Homo sapiens (Human)	endocytosis [GO:0006897]; immune response [GO:0006955]; inflammatory response [GO:0006954]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; endocytosis [GO:0006897]; immune response [GO:0006955]; inflammatory response [GO:0006954]	carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]	GO:0005887; GO:0006897; GO:0006954; GO:0006955; GO:0009897; GO:0030246; GO:0038023; GO:0070062	NKIANISGDGQK	13.23999977	1	1	0.393463633	1245.183309	17.27653	0	0	14.65369	15.06248	14.43027	0	0	0	0	15.53436	0	0	0	0	0	0	0	15.61327	14.01029	0	0	14.0968	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60469	DSCAM_HUMAN	Down syndrome cell adhesion molecule (CHD2)	DSCAM	Homo sapiens (Human)	axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	cell-cell adhesion mediator activity [GO:0098632]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]	GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007162; GO:0007399; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0016020; GO:0030424; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:0098632; GO:1990782; GO:1990890	AAAASASMVFVSWLPPLK	4.949999809	1	1	0.380361069	1846.426426	12.94864	0	0	0	14.93667	16.29964	0	12.59522	0	0	15.75184	18.01704	15.98976	15.8216	12.72793	0	15.26579	13.55974	15.24097	0	0	0	0	0	0	0	0	0	0	0	0	16.60089	0	0	0	0	0	0	0	14.1727	10.15639	14.24526	0	0	0	0	0	0
O60476	MA1A2_HUMAN	"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB, EC 3.2.1.113 (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB, Alpha-1,2-mannosidase IB)"	MAN1A2 MAN1B	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]"	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0016021; GO:0048286; GO:0070062; GO:1904381	ALEEAKEK	8.880000114	0.283158332	0.283158332	0.174996916	918.5623177	17.07905	15.39431	0	16.43839	0	0	0	0	0	0	0	0	0	0	0	0	0	15.86161	17.92239	0	11.76169	16.54592	0	13.94078	0	15.66376	16.34274	15.22262	0	0	16.83555	16.48785	0	0	0	0	16.16978	0	0	13.37924	15.22687	16.13531	0	15.63855	15.70971	0	15.73032	0
O60486	PLXC1_HUMAN	Plexin-C1 (Virus-encoded semaphorin protein receptor) (CD antigen CD232)	PLXNC1 VESPR	Homo sapiens (Human)	cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	semaphorin receptor activity [GO:0017154]; signaling receptor binding [GO:0005102]	GO:0002116; GO:0005102; GO:0005886; GO:0005887; GO:0007155; GO:0007162; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:1902287	EAPTNK	2.700000048	0.881744742	0.881744742	0.286712326	659.9285757	0	17.40283	19.64976	0	0	0	19.17943	18.56048	0	19.02888	19.93943	18.11458	0	17.72146	20.04136	17.45821	18.34637	20.18554	0	0	19.71668	0	20.60688	0	19.3079	0	0	0	0	0	20.36438	0	18.45121	0	0	20.14319	18.35943	0	19.2847	19.45278	0	0	18.53109	17.68672	0	19.57014	19.25042	18.94706
O60493	SNX3_HUMAN	Sorting nexin-3 (Protein SDP3)	SNX3	Homo sapiens (Human)	endocytic recycling [GO:0032456]; intralumenal vesicle formation [GO:0070676]; late endosome to Golgi transport [GO:0034499]; membrane invagination [GO:0010324]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein transport [GO:0051224]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of neuron projection development [GO:0010976]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111]; response to bacterium [GO:0009617]	clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; retromer complex [GO:0030904]	"clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; retromer complex [GO:0030904]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein phosphatase binding [GO:0019903]; retromer complex binding [GO:1905394]; endocytic recycling [GO:0032456]; intralumenal vesicle formation [GO:0070676]; late endosome to Golgi transport [GO:0034499]; membrane invagination [GO:0010324]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein transport [GO:0051224]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of neuron projection development [GO:0010976]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111]; response to bacterium [GO:0009617]"	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein phosphatase binding [GO:0019903]; retromer complex binding [GO:1905394]"	GO:0005737; GO:0005769; GO:0005829; GO:0009617; GO:0010008; GO:0010314; GO:0010324; GO:0010976; GO:0015031; GO:0019903; GO:0022615; GO:0030111; GO:0030136; GO:0030904; GO:0031901; GO:0032009; GO:0032266; GO:0032456; GO:0034499; GO:0042177; GO:0046597; GO:0050765; GO:0051224; GO:0070062; GO:0070273; GO:0070676; GO:0080025; GO:1905394; GO:2000642	SYTPSK	3.24000001	1	1	0.083133436	683.5035418	15.68916	13.9792	15.79769	14.92684	14.66884	0	0	0	13.02199	16.54226	0	13.98717	15.01997	14.82906	0	14.70625	13.75727	16.08719	15.9453	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.39377	15.76543	15.70986	0	18.11425	0	0	0	0	0	0	16.66623	0	16.31873	0
O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	CUBN IFCR	Homo sapiens (Human)	cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894]	calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0070062	EIPGPIRSTGEYMFIR	4.5	0.702266693	0.702266693	5.25E-12	1862.726586	15.46667	14.63396	10.41055	0	14.37886	9.99654	14.15049	0	13.54955	12.70105	0	11.18372	0	14.0308	13.24596	12.20199	0	14.23062	14.69658	13.97566	0	0	0	0	14.73129	15.09837	0	12.37581	12.39298	14.6299	0	0	0	0	0	0	0	15.90724	0	14.52033	16.2522	0	15.49975	15.72801	12.97852	0	14.8556	12.07304
O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	NPHS1 NPHN	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; skeletal muscle tissue development [GO:0007519]; slit diaphragm assembly [GO:0036060]	cell projection [GO:0042995]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]	cell projection [GO:0042995]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; skeletal muscle tissue development [GO:0007519]; slit diaphragm assembly [GO:0036060]	cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022]	GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007254; GO:0007519; GO:0007520; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0036060; GO:0042995; GO:0050839; GO:0070062; GO:0072015; GO:0098609	VTPRSSDNR	6.019999981	0.844905496	0.844905496	0.21452695	1030.335014	0	0	14.45766	0	0	0	15.72089	0	0	0	15.95	0	0	0	0	0	15.38398	14.65753	14.21531	0	0	0	15.63198	17.10379	0	0	0	0	0	0	0	13.64901	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60502	OGA_HUMAN	"Protein O-GlcNAcase, OGA, EC 3.2.1.169 (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase, NCOAT)"	OGA HEXC KIAA0679 MEA5 MGEA5	Homo sapiens (Human)	glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0016020; GO:0016231; GO:0102166; GO:0102167; GO:0102571	EIPVESIEEVSK	8.340000153	1	1	0.434330623	1357.581099	0	0	0	15.7106	0	0	0	0	0	0	19.71631	0	0	0	18.07439	0	0	0	0	0	0	0	18.88243	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.29278	0	0	0	0	0	0	0	0	0
O60503	ADCY9_HUMAN	"Adenylate cyclase type 9, EC 4.6.1.1 (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX, ACIX) (Adenylyl cyclase 9, AC9)"	ADCY9 KIAA0520	Homo sapiens (Human)	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165]	axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]	GO:0001701; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007165; GO:0007189; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0046872; GO:0071880	GKGQMK	1.809999943	0.190380886	0.190380886	0.082596976	663.5445522	0	0	15.49244	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.08104	16.71749	17.54272	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60506	HNRPQ_HUMAN	"Heterogeneous nuclear ribonucleoprotein Q, hnRNP Q (Glycine- and tyrosine-rich RNA-binding protein, GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)"	SYNCRIP HNRPQ NSAP1	Homo sapiens (Human)	"cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006396; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0045293; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990904; GO:2000623; GO:2000767	SGKHIGVCISVANNR	3.559999943	1	1	0.125935844	1611.18171	14.38418	0	13.19194	13.48033	13.99633	0	12.44483	13.02727	0	0	0	0	0	0	0	0	12.10294	14.18446	0	0	0	0	0	0	0	0	0	14.25699	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60507	TPST1_HUMAN	"Protein-tyrosine sulfotransferase 1, EC 2.8.2.20 (Tyrosylprotein sulfotransferase 1, TPST-1)"	TPST1	Homo sapiens (Human)	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inflammatory response [GO:0006954]; peptidyl-tyrosine sulfation [GO:0006478]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inflammatory response [GO:0006954]; peptidyl-tyrosine sulfation [GO:0006478]	protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0005794; GO:0006478; GO:0006954; GO:0008146; GO:0008476; GO:0016020; GO:0030173; GO:0042803; GO:0050427	DMPLIFIGGVPRSGTTLMR	2.859999895	1	1	0.254549278	2077.995272	0	12.42503	0	0	13.7895	0	14.40702	0	0	0	0	0	0	0	13.82531	13.56221	0	0	0	0	14.20657	0	0	0	0	0	0	0	0	0	15.30257	0	0	0	12.91218	0	0	0	0	0	16.13897	0	0	0	0	0	0	0
O60508	PRP17_HUMAN	"Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3, Ehb3) (PRP17 homolog, hPRP17)"	CDC40 EHB3 PRP17 PRPF17	Homo sapiens (Human)	"embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0016607; GO:0071007; GO:0071013; GO:1990403	CPLPAADSLMHLTK	3.700000048	0.570855916	0.570855916	0.190817408	1553.194048	0	15.10069	0	0	14.60929	13.18651	0	0	15.52157	0	0	15.4471	14.5775	15.02001	15.23957	15.20554	0	14.76059	15.86868	0	0	0	0	0	14.61355	0	15.13721	16.08528	12.43744	15.33241	16.1482	0	0	0	0	0	13.74508	16.56169	0	14.86573	14.65246	0	0	15.13434	14.33777	0	0	0
O60518	RNBP6_HUMAN	"Ran-binding protein 6, RanBP6"	RANBP6	Homo sapiens (Human)	protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein import into nucleus [GO:0006606]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0061608	QLALEVIVTLSETATPMLK	1.480000019	0.258883864	0.258883864	0.09749017	2072.859564	0	0	0	15.34391	0	14.67745	0	0	16.27315	0	14.35789	9.802708	0	0	12.24262	15.33237	16.03697	0	0	0	13.64725	17.86237	16.8525	18.57428	12.96189	14.08492	13.56858	16.31085	14.15738	17.00542	0	15.25268	18.89826	0	16.49797	12.47334	14.18101	0	13.90525	12.02703	0	13.74859	15.33298	0	0	0	0	14.87034
O60519	CRBL2_HUMAN	cAMP-responsive element-binding protein-like 2	CREBL2	Homo sapiens (Human)	"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucose import [GO:0046326]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000785; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0007049; GO:0007165; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821	ALLTGEEQNK	6.170000076	0.420781314	0.420781314	0.171175228	1102.54726	18.0031	16.20366	14.44203	15.8325	0	12.01534	13.70659	0	13.721	0	0	0	14.00553	0	0	13.0538	0	15.66538	12.04747	16.31729	0	0	15.89283	0	0	0	0	14.82687	0	16.10436	0	17.28112	0	0	15.90737	16.45184	14.81942	16.58389	12.89935	14.78832	0	0	0	0	0	15.99037	14.90761	0
O60522	TDRD6_HUMAN	"Tudor domain-containing protein 6 (Antigen NY-CO-45) (Cancer/testis antigen 41.2, CT41.2)"	TDRD6	Homo sapiens (Human)	P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]		GO:0005737; GO:0007283; GO:0030719; GO:0033391; GO:0034587; GO:0043186	VKAQAFR	5.800000191	1	1	0.162246586	818.3895124	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.46239	0	0	0	0	0	0	18.17686	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60543	CIDEA_HUMAN	Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A)	CIDEA	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular response to cold [GO:0070417]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular response to cold [GO:0070417]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659]	protein homodimerization activity [GO:0042803]	GO:0001659; GO:0001818; GO:0005634; GO:0005737; GO:0005739; GO:0005740; GO:0005811; GO:0005829; GO:0006629; GO:0006915; GO:0008219; GO:0010890; GO:0019915; GO:0030512; GO:0032720; GO:0035634; GO:0042803; GO:0042981; GO:0050995; GO:0070417; GO:0120163; GO:1900118; GO:1902510	RGVMASSLQELISK	6.559999943	1	1	0.424599811	1532.905369	0	0	0	0	0	0	0	0	0	0	17.83504	0	0	0	0	0	0	0	0	0	0	0	18.49693	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.87543	0	0	0	0	0	0
O60547	GMDS_HUMAN	"GDP-mannose 4,6 dehydratase, EC 4.2.1.47 (GDP-D-mannose dehydratase, GMD)"	GMDS	Homo sapiens (Human)	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]"	"GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]"	GO:0005737; GO:0005829; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070062; GO:0070401	CPSARGSGDGEMGKPR	8.220000267	1	1	0.464911381	1662.233348	16.23016	16.40798	16.80152	15.41889	16.40232	0	14.46809	0	0	16.66509	0	16.85359	0	0	14.14381	0	14.95502	0	0	17.1542	0	16.24874	0	0	0	0	0	0	0	0	0	0	0	0	16.1942	0	0	0	0	0	0	0	0	0	0	0	0	0
O60568	PLOD3_HUMAN	"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3, EC 1.14.11.4 (Lysyl hydroxylase 3, LH3); Procollagen glycosyltransferase, EC 2.4.1.50, EC 2.4.1.66 (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase) ]"	PLOD3	Homo sapiens (Human)	basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070062; GO:0070831	FLNSGGFIGFATTIHQIVRQWK	1.299999952	1	1	0.030465749	2519.43039	0	0	0	0	0	12.65356	13.47838	0	0	0	0	8.284667	0	10.57982	0	10.01978	0	0	15.93799	11.78838	0	0	0	17.391	0	0	0	0	0	13.20873	0	0	0	0	13.23029	0	0	13.28764	0	0	13.02637	0	0	0	11.97892	0	16.25151	0
O60583	CCNT2_HUMAN	"Cyclin-T2, CycT2"	CCNT2	Homo sapiens (Human)	"cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]"	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]"	7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]	GO:0000079; GO:0001223; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006366; GO:0006468; GO:0007049; GO:0007519; GO:0008024; GO:0016538; GO:0019085; GO:0019086; GO:0019901; GO:0032786; GO:0032968; GO:0045944; GO:0048471; GO:0051147; GO:0051301; GO:0061575; GO:0070063; GO:0097322	EELKMK	8.069999695	0.23895067	0.23895067	0.223146752	777.2906281	16.31019	17.52926	15.99712	15.265	15.80839	14.64186	0	14.86717	0	15.70638	16.05734	0	0	0	17.04615	16.40504	0	0	0	0	0	16.57802	16.21435	16.20788	0	0	0	14.69739	0	15.63562	16.80952	15.56204	15.73886	15.70304	0	16.97383	16.59743	0	17.56544	16.45221	16.58646	17.31882	16.71512	16.42444	0	16.56488	15.79491	13.0917
O60609	GFRA3_HUMAN	"GDNF family receptor alpha-3, GDNF receptor alpha-3, GDNFR-alpha-3, GFR-alpha-3"	GFRA3 UNQ339/PRO538/PRO3664	Homo sapiens (Human)	nervous system development [GO:0007399]; neuron migration [GO:0001764]; peripheral nervous system development [GO:0007422]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; axon guidance receptor activity [GO:0008046]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; peripheral nervous system development [GO:0007422]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]	axon guidance receptor activity [GO:0008046]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]	GO:0001764; GO:0005102; GO:0005829; GO:0005886; GO:0007165; GO:0007399; GO:0007422; GO:0008046; GO:0009897; GO:0016167; GO:0019898; GO:0031225; GO:0038023; GO:0043235; GO:0048485	NSSLIGCMCHRR	6.5	1	1	0.02458107	1507.09936	15.89022	16.85502	15.64046	0	0	0	0	0	0	0	0	0	0	16.9821	0	0	0	0	0	0	17.35478	16.85527	18.30596	0	0	0	0	15.23193	0	16.11408	16.84935	15.13572	16.35583	16.64392	15.36594	0	0	0	0	0	0	0	0	0	0	0	0	0
O60610	DIAP1_HUMAN	"Protein diaphanous homolog 1 (Diaphanous-related formin-1, DRF1)"	DIAPH1 DIAP1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605]	actin binding [GO:0003779]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]	GO:0003723; GO:0003779; GO:0005102; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0007010; GO:0007605; GO:0008360; GO:0030036; GO:0030041; GO:0030335; GO:0030667; GO:0031267; GO:0032587; GO:0032886; GO:0035372; GO:0044325; GO:0051279; GO:0051493; GO:0071420; GO:0072686; GO:0101003	DIIIK	2.630000114	1	1	0.26718018	600.7946452	17.89818	17.08964	17.60872	0	0	18.66567	16.97623	0	16.07157	14.77578	16.74756	0	0	17.82316	15.31099	0	0	18.35122	18.36093	18.43656	0	17.77896	0	0	0	18.80688	0	18.35203	17.35749	18.17129	18.74357	18.40247	0	0	0	0	0	0	0	0	17.41481	19.49228	16.88393	0	0	0	16.88752	18.37532
O60613	SEP15_HUMAN	Selenoprotein F (15 kDa selenoprotein)	SELENOF SEP15	Homo sapiens (Human)	'de novo' posttranslational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092]	endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity [GO:0016491]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; 'de novo' posttranslational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092]	oxidoreductase activity [GO:0016491]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]	GO:0005788; GO:0008379; GO:0008430; GO:0016491; GO:0035092; GO:0051084	YVRGSDPVLK	5.699999809	0.228814974	0.228814974	0.202293453	1135.019478	0	0	0	9.644976	15.19868	0	0	0	0	0	0	17.18195	0	16.40584	14.62264	0	14.55899	0	0	0	0	0	13.5062	0	16.64129	0	0	14.27658	0	15.56437	0	9.377136	0	16.12958	15.20148	0	11.54583	13.96203	16.13628	15.33953	14.84244	14.92847	14.93687	15.47251	13.6577	0	0	14.91114
O60641	AP180_HUMAN	Clathrin coat assembly protein AP180 (91 kDa synaptosomal-associated protein) (Clathrin coat-associated protein AP180) (Phosphoprotein F1-20)	SNAP91 KIAA0656	Homo sapiens (Human)	clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; protein transport [GO:0015031]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; vesicle budding from membrane [GO:0006900]	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; synaptic vesicle [GO:0008021]	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; protein transport [GO:0015031]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; vesicle budding from membrane [GO:0006900]"	"1-phosphatidylinositol binding [GO:0005545]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]"	GO:0000149; GO:0005545; GO:0005546; GO:0005905; GO:0006900; GO:0008021; GO:0015031; GO:0016185; GO:0019901; GO:0030136; GO:0032050; GO:0048268; GO:0072583; GO:0098894; GO:2000369	DPLADLNIK	12.02000046	0.093819223	0.093819223	0.080425024	999.0994878	0	0	17.64325	17.03906	16.68241	0	20.10499	17.2747	14.5332	16.87123	0	0	17.41911	0	0	17.2082	0	0	0	0	0	16.89438	0	19.41174	15.2016	12.77352	16.48398	0	16.13371	0	0	0	0	0	0	0	0	15.20822	15.98217	0	17.0246	0	17.10091	0	15.63012	0	17.32868	0
O60645	EXOC3_HUMAN	Exocyst complex component 3 (Exocyst complex component Sec6)	EXOC3 SEC6 SEC6L1	Homo sapiens (Human)	exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	cytosol [GO:0005829]; exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]	cytosol [GO:0005829]; exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]; cadherin binding [GO:0045296]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	cadherin binding [GO:0045296]; SNARE binding [GO:0000149]	GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0005829; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0045296; GO:0048471; GO:0051601; GO:0090148; GO:0090522	ASVEAR	9.130000114	1	1	0.195419851	632.3955852	15.69341	16.03429	16.40523	15.1382	14.18299	15.55101	15.3374	16.01533	15.06921	16.82713	14.86575	16.02097	15.09634	0	15.47547	13.17824	15.83093	14.95545	15.63729	15.80429	15.75506	16.04069	14.68213	15.15714	17.2303	16.87971	16.10449	15.60308	14.7756	16.25193	15.97481	16.49019	16.78343	14.15897	15.27603	16.7485	17.32154	16.09436	17.56102	16.13954	0	16.82864	16.60345	0	16.48893	16.38304	16.68734	0
O60658	PDE8A_HUMAN	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A, EC 3.1.4.53"	PDE8A	Homo sapiens (Human)	"cAMP catabolic process [GO:0006198]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell death [GO:0060548]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell death [GO:0060548]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]"	GO:0001934; GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0006355; GO:0007165; GO:0019900; GO:0046872; GO:0047555; GO:0060548; GO:0070062; GO:0070374; GO:0071364; GO:1903206	EWQGIYYAKK	3.650000095	0.110413276	0.110413276	2.29E-13	1286.097403	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.51252	14.91313	0	12.68237	11.95002	17.69429	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60664	PLIN3_HUMAN	"Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein, 47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17, PP17)"	PLIN3 M6PRBP1 TIP47	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; positive regulation of sequestering of triglyceride [GO:0010890]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]; transport vesicle [GO:0030133]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; positive regulation of sequestering of triglyceride [GO:0010890]; vesicle-mediated transport [GO:0016192]	cadherin binding [GO:0045296]	GO:0005737; GO:0005768; GO:0005794; GO:0005811; GO:0005829; GO:0010008; GO:0010890; GO:0016020; GO:0016192; GO:0019915; GO:0030133; GO:0042149; GO:0045296; GO:1905691	QEQSYFVRLGSLSER	5.409999847	1	1	0.331989497	1799.730112	13.47632	13.95704	0	0	0	0	0	0	0	0	0	13.21819	0	0	0	0	0	14.95781	0	0	0	16.32344	16.10839	0	15.99672	0	15.38814	0	0	15.71193	0	15.05306	0	17.28533	0	15.54736	14.32541	14.92833	0	0	0	13.15853	0	0	13.34613	14.86641	14.67205	17.31009
O60673	REV3L_HUMAN	"DNA polymerase zeta catalytic subunit, EC 2.7.7.7 (Protein reversionless 3-like, REV3-like, hREV3)"	REV3L POLZ REV3	Homo sapiens (Human)	DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]"	GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005730; GO:0006261; GO:0016035; GO:0042276; GO:0046872; GO:0051539	EEMELSLVMSQR	5.579999924	0.438681245	0.438681245	1.83E-12	1482.619331	0	0	0	0	0	7.495123	0	0	0	0	0	0	0	0	12.68721	0	0	0	0	0	0	0	0	7.190049	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60674	JAK2_HUMAN	"Tyrosine-protein kinase JAK2, EC 2.7.10.2 (Janus kinase 2, JAK-2)"	JAK2	Homo sapiens (Human)	actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell differentiation [GO:0030154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-3 [GO:0036016]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; chromatin organization [GO:0006325]; collagen-activated signaling pathway [GO:0038065]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histone H3-Y41 phosphorylation [GO:0035409]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of heart contraction [GO:0045822]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of platelet activation [GO:0010572]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; post-embryonic hemopoiesis [GO:0035166]; postsynapse to nucleus signaling pathway [GO:0099527]; programmed cell death induced by symbiont [GO:0034050]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to amine [GO:0014075]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; tyrosine phosphorylation of STAT protein [GO:0007260]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone kinase activity (H3-Y41 specific) [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702]; actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell differentiation [GO:0030154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-3 [GO:0036016]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; chromatin organization [GO:0006325]; collagen-activated signaling pathway [GO:0038065]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; histone H3-Y41 phosphorylation [GO:0035409]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of heart contraction [GO:0045822]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of platelet activation [GO:0010572]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; post-embryonic hemopoiesis [GO:0035166]; postsynapse to nucleus signaling pathway [GO:0099527]; programmed cell death induced by symbiont [GO:0034050]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to amine [GO:0014075]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; tyrosine phosphorylation of STAT protein [GO:0007260]	acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone kinase activity (H3-Y41 specific) [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702]	GO:0000791; GO:0001774; GO:0002250; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005131; GO:0005143; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006325; GO:0006468; GO:0006915; GO:0006919; GO:0006955; GO:0007165; GO:0007167; GO:0007186; GO:0007204; GO:0007259; GO:0007260; GO:0007498; GO:0008022; GO:0008285; GO:0008631; GO:0010572; GO:0010667; GO:0010811; GO:0014068; GO:0014075; GO:0018108; GO:0019221; GO:0019901; GO:0020037; GO:0022408; GO:0030041; GO:0030154; GO:0030218; GO:0030335; GO:0030526; GO:0031103; GO:0031702; GO:0031904; GO:0031959; GO:0032024; GO:0032496; GO:0032516; GO:0032729; GO:0032731; GO:0032740; GO:0032760; GO:0032819; GO:0033130; GO:0033194; GO:0033209; GO:0034050; GO:0034612; GO:0035166; GO:0035401; GO:0035409; GO:0035556; GO:0035722; GO:0036016; GO:0038065; GO:0038157; GO:0042022; GO:0042102; GO:0042169; GO:0042307; GO:0042393; GO:0042531; GO:0042802; GO:0042976; GO:0042981; GO:0043388; GO:0043392; GO:0043410; GO:0043524; GO:0043548; GO:0043560; GO:0045121; GO:0045348; GO:0045428; GO:0045429; GO:0045597; GO:0045822; GO:0045944; GO:0046425; GO:0046427; GO:0046677; GO:0046777; GO:0046872; GO:0048008; GO:0050727; GO:0050729; GO:0050731; GO:0050804; GO:0051091; GO:0051142; GO:0051428; GO:0051770; GO:0060333; GO:0060391; GO:0060396; GO:0060397; GO:0060399; GO:0061180; GO:0070102; GO:0070665; GO:0070671; GO:0070757; GO:0071222; GO:0071549; GO:0072536; GO:0097191; GO:0097296; GO:0098586; GO:0098794; GO:0098978; GO:0099527; GO:0120162; GO:1901731; GO:1902728; GO:1904037; GO:1904707; GO:2000273; GO:2000318; GO:2001235	DLALR	4.639999866	1	1	0.053883926	588.4007072	16.1114	0	0	14.67409	0	14.99407	0	0	0	0	12.09486	0	0	15.50304	15.23186	0	14.5294	0	14.77968	0	0	0	0	14.89298	16.19995	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.44678	0	0	0
O60675	MAFK_HUMAN	Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit)	MAFK	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0043565	VATTSVITIVK	13.18000031	1	1	0.39938745	1132.220514	0	0	0	0	0	0	0	0	0	0	20.02843	0	18.17467	0	0	0	0	0	0	0	0	0	19.31355	0	0	0	0	0	0	0	17.92059	0	20.50251	0	0	0	16.28675	0	0	0	0	18.6897	18.15027	18.85387	0	19.13256	0	0
O60682	MUSC_HUMAN	"Musculin (Activated B-cell factor 1, ABF-1) (Class A basic helix-loop-helix protein 22, bHLHa22)"	MSC ABF1 BHLHA22	Homo sapiens (Human)	"branchiomeric skeletal muscle development [GO:0014707]; cardiac conduction system development [GO:0003161]; cellular response to leukemia inhibitory factor [GO:1990830]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; branchiomeric skeletal muscle development [GO:0014707]; cardiac conduction system development [GO:0003161]; cellular response to leukemia inhibitory factor [GO:1990830]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003161; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007519; GO:0014707; GO:0032502; GO:0046983; GO:0060021; GO:0060539; GO:1990830; GO:1990837	GSAAECK	3.170000076	0.139379069	0.139379069	0.26867383	723.1633507	14.90873	0	15.69194	15.65914	14.0853	0	14.38671	14.14754	16.49289	0	0	0	0	14.11773	14.85201	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59223	15.47168	0	16.36963	0	16.09594	16.4212	0	0	16.31489	16.70695	16.14474	0	15.24336	0	16.87694	15.63457	0
O60684	IMA7_HUMAN	Importin subunit alpha-7 (Karyopherin subunit alpha-6)	KPNA6 IPOA7	Homo sapiens (Human)	entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; viral genome replication [GO:0019079]	cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; viral genome replication [GO:0019079]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0005634; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0016020; GO:0019079; GO:0042564; GO:0043657; GO:0045944; GO:0060135; GO:0061608; GO:0075506; GO:1900017; GO:1903902	ETMASPGK	10.43000031	0.510888696	0.510888696	0.024864321	819.3127109	0	0	0	12.8696	16.11699	0	18.32564	16.31234	0	16.59958	16.71062	17.28958	15.00282	17.40351	0	14.72446	7.274551	16.4774	15.79682	15.45026	16.39169	17.17505	17.71128	0	15.26839	17.73057	15.64929	14.44348	17.68791	0	18.95992	19.11745	19.7212	16.94252	12.13071	16.08864	0	16.64324	18.25021	17.84248	18.22358	0	15.04654	16.09251	0	17.17299	14.10869	0
O60687	SRPX2_HUMAN	Sushi repeat-containing protein SRPX2 (Sushi-repeat protein upregulated in leukemia)	SRPX2 SRPUL	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of synapse assembly [GO:0051965]; regulation of phosphorylation [GO:0042325]; vocalization behavior [GO:0071625]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; synaptic membrane [GO:0097060]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; synaptic membrane [GO:0097060]; hepatocyte growth factor binding [GO:0036458]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of synapse assembly [GO:0051965]; regulation of phosphorylation [GO:0042325]; vocalization behavior [GO:0071625]	hepatocyte growth factor binding [GO:0036458]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0005102; GO:0005615; GO:0005737; GO:0009986; GO:0036458; GO:0042325; GO:0042802; GO:0048870; GO:0051965; GO:0060076; GO:0062023; GO:0071625; GO:0090050; GO:0097060; GO:0098609	SRICMEDGR	4.159999847	1	1	0.176577884	1139.6992	0	15.54374	0	0	0	0	0	0	15.10627	0	0	0	0	0	14.96368	0	0	13.39198	0	0	0	0	0	0	0	0	0	0	0	0	0	12.78985	0	0	0	0	0	16.37015	0	15.84938	0	0	0	0	0	0	0	0
O60688	YPEL1_HUMAN	Protein yippee-like 1	YPEL1 FKSG3	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005634; GO:0046872	FIIELAHMIK	27.95999908	0.905953348	0.905953348	0.427351719	1214.054497	0	0	0	0	0	0	0	0	0	17.03094	18.605	18.62664	0	0	0	0	17.45475	0	16.46379	0	0	19.89058	0	0	0	0	0	0	18.15662	0	20.50683	0	19.27645	0	19.32826	0	0	0	18.9558	0	0	0	0	18.4251	18.36935	19.16946	0	17.86136
O60701	UGDH_HUMAN	"UDP-glucose 6-dehydrogenase, UDP-Glc dehydrogenase, UDP-GlcDH, UDPGDH, EC 1.1.1.22"	UGDH	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065]	identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]	GO:0001702; GO:0003979; GO:0005634; GO:0005654; GO:0005829; GO:0005975; GO:0006024; GO:0006065; GO:0015012; GO:0030206; GO:0034214; GO:0042802; GO:0048666; GO:0051287; GO:0070062	TYGMGK	7.349999905	0.589581013	0.589581013	0.224931305	672.3732001	0	18.64349	0	0	0	15.63089	0	17.12334	0	16.7827	0	0	0	0	0	17.14176	0	17.87905	16.94726	0	0	16.85476	0	0	0	19.44897	17.6309	18.73806	0	0	19.67859	0	0	0	0	17.92863	0	0	0	0	17.48562	17.1772	0	0	0	17.87509	0	17.60662
O60704	TPST2_HUMAN	"Protein-tyrosine sulfotransferase 2, EC 2.8.2.20 (Tyrosylprotein sulfotransferase 2, TPST-2)"	TPST2	Homo sapiens (Human)	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478]	protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0005783; GO:0005794; GO:0006478; GO:0008146; GO:0008476; GO:0016021; GO:0042803; GO:0050427	ASVHSMITR	3.789999962	1	1	0.083584228	1018.35213	14.64497	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60732	MAGC1_HUMAN	"Melanoma-associated antigen C1 (Cancer/testis antigen 7.1, CT7.1) (MAGE-C1 antigen)"	MAGEC1	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005634	AHSEVIK	3.980000019	0.722587883	0.722587883	0.225355969	783.9697763	0	15.75817	15.09591	14.3432	17.07986	0	15.90127	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.91291	0	0	0	0	0	0	0	0	0	15.34444	0	0	16.42739	16.70231	0	0	15.8821	0	0	0	0	0	0	0	0
O60733	PLPL9_HUMAN	"85/88 kDa calcium-independent phospholipase A2, CaI-PLA2, EC 3.1.1.4 (2-lysophosphatidylcholine acylhydrolase, EC 3.1.1.5) (Group VI phospholipase A2, GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta, iPLA2-beta) (Palmitoyl-CoA hydrolase, EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9, PNPLA9)"	PLA2G6 PLPLA9	Homo sapiens (Human)	"antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]; vasodilation [GO:0042311]"	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	"centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]; vasodilation [GO:0042311]"	1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]	GO:0001934; GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016021; GO:0016290; GO:0016787; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0032049; GO:0034451; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0038096; GO:0042311; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0102545; GO:0102991; GO:1901339; GO:2000304	TWDCVLVNPR	1.889999986	1	1	0.434639338	1259.761122	0	0	0	0	0	16.9854	0	0	0	0	0	17.98562	0	0	0	0	17.795	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.01704	0	0	0	0	16.84024	0	0	0	0	0	0	0
O60741	HCN1_HUMAN	"Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1, BCNG-1)"	HCN1 BCNG1	Homo sapiens (Human)	"apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]"	axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]"	cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]	GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005267; GO:0005886; GO:0005887; GO:0022843; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0045176; GO:0046549; GO:0051289; GO:0051967; GO:0071320; GO:0071805; GO:0086091; GO:0098855; GO:0098907; GO:2001257	ASATGAGPAAAEK	6.980000019	1	1	0.37883801	1102.256649	13.7437	12.4394	13.97256	0	15.31078	14.80099	0	0	0	0	0	0	15.42156	15.86742	16.92643	0	0	0	16.62759	14.9538	17.15545	14.76752	16.18642	0	14.79459	15.63528	17.04463	0	15.19141	0	0	0	15.57989	0	15.64305	15.86841	14.1326	14.53246	13.87477	14.89981	15.4853	15.46393	15.96573	17.39518	15.78032	13.79837	0	16.63667
O60749	SNX2_HUMAN	"Sorting nexin-2 (Transformation-related gene 9 protein, TRG-9)"	SNX2 TRG9	Homo sapiens (Human)	"early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]"	cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]	GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0045296; GO:0046982; GO:0072673; GO:1990459; GO:1990460	LIAAVKGVFDHR	11.44999981	0.674729049	0.674729049	0.469971304	1324.160842	0	17.83094	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.7819	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60762	DPM1_HUMAN	"Dolichol-phosphate mannosyltransferase subunit 1, EC 2.4.1.83 (Dolichol-phosphate mannose synthase subunit 1, DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1, MPD synthase subunit 1)"	DPM1	Homo sapiens (Human)	dolichol metabolic process [GO:0019348]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269]	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]	dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537]; dolichol metabolic process [GO:0019348]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269]	alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537]	GO:0004169; GO:0004582; GO:0005537; GO:0005634; GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0019348; GO:0019673; GO:0033185; GO:0035268; GO:0035269; GO:0043178	DVAEQLEK	1.029999971	1	1	0.057486887	931.9816625	15.96916	0	13.62709	14.0098	15.22707	0	0	14.12544	12.88586	15.38647	14.87156	16.02223	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60779	S19A2_HUMAN	"Thiamine transporter 1, ThTr-1, ThTr1 (Solute carrier family 19 member 2) (Thiamine carrier 1, TC1)"	SLC19A2 THT1 TRMA	Homo sapiens (Human)	thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085]	folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]	GO:0005886; GO:0008517; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934	AAAAAATVLLR	10.35000038	1	1	0.057030454	1027.206128	12.9896	10.33065	12.55296	15.34327	11.10246	13.72221	15.19011	14.05497	0	17.34326	15.88637	15.35354	0	0	13.712	0	15.46373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.83243	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60810	PRAM4_HUMAN	PRAME family member 4	PRAMEF4	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"		GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892	LILSHMDVSR	6.360000134	1	1	0.391405684	1171.021311	13.15458	15.12138	13.67633	0	0	0	0	15.22986	0	15.05995	0	0	0	0	0	0	0	14.60766	0	0	0	0	0	0	16.59107	0	0	15.93739	0	0	15.57243	0	15.49219	0	0	14.84989	16.65669	0	0	0	16.52881	17.47952	15.91368	0	0	0	14.82326	0
O60812	HNRC1_HUMAN	"Heterogeneous nuclear ribonucleoprotein C-like 1, hnRNP C-like-1 (hnRNP core protein C-like 1)"	HNRNPCL1 HNRPCL1	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0042802	NAKSEEEQSSSSMK	5.690000057	1	1	0.119151626	1540.379781	15.42268	0	14.09519	0	0	11.0832	0	14.36855	0	0	0	15.30454	15.94858	0	0	13.44514	0	0	14.78016	13.4189	0	0	0	17.03359	0	12.52805	11.44369	15.63526	0	0	16.03877	15.7264	15.54927	0	12.6187	13.04527	0	17.77517	0	0	14.44881	0	0	0	0	0	0	0
O60825	F262_HUMAN	"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2, 6PF-2-K/Fru-2,6-P2ase 2, PFK/FBPase 2 (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase, EC 2.7.1.105; Fructose-2,6-bisphosphatase, EC 3.1.3.46 ]"	PFKFB2	Homo sapiens (Human)	"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]"	"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]"	GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006007; GO:0006089; GO:0006096; GO:0009749; GO:0019901; GO:0032024; GO:0033133	GADELPYLR	9.260000229	0.400620341	0.400620341	0.264176592	1035.86165	16.11839	0	16.03614	0	0	0	15.56782	0	0	15.09406	15.53894	15.76505	0	15.17423	0	0	17.44337	0	0	15.2033	0	16.69889	16.28683	15.74537	17.37486	17.0695	15.90988	15.3427	14.76737	0	16.31141	19.547	0	16.06139	15.48633	0	16.8328	0	19.17905	17.53177	17.62906	16.0107	16.17966	15.66902	0	17.62247	0	18.16463
O60826	CCD22_HUMAN	Coiled-coil domain-containing protein 22	CCDC22 CXorf37 JM1	Homo sapiens (Human)	cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; cullin family protein binding [GO:0097602]; cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031]	cullin family protein binding [GO:0097602]	GO:0005654; GO:0005768; GO:0005829; GO:0006878; GO:0006893; GO:0007253; GO:0015031; GO:0032456; GO:0043123; GO:0043124; GO:0097602; GO:2000060	DLEEQIETELGK	7.119999886	1	1	0	1404.692385	0	0	0	0	0	12.56321	0	13.33228	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60828	PQBP1_HUMAN	"Polyglutamine-binding protein 1, PQBP-1 (38 kDa nuclear protein containing a WW domain, Npw38) (Polyglutamine tract-binding protein 1)"	PQBP1 NPW38 JM26	Homo sapiens (Human)	"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; transcription coactivator activity [GO:0003713]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0002218; GO:0002230; GO:0003677; GO:0003690; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010494; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598	SHDKSDR	13.13000011	1	1	0	843.2385806	18.69223	16.6876	16.70491	0	17.70698	15.58135	13.96627	17.24774	15.65697	0	17.33406	18.74882	18.03253	16.37938	14.04977	15.84711	0	15.67177	17.07737	0	0	18.72523	17.59243	17.76623	16.80793	17.5395	0	14.73432	0	0	18.92396	0	17.9999	17.25077	0	16.07895	18.59549	18.62514	17.49046	18.05993	16.84643	18.38041	15.47631	0	17.89931	13.27523	16.58856	16.11887
O60829	PAGE4_HUMAN	"P antigen family member 4, PAGE-4 (G antigen family C member 1) (PAGE-1)"	PAGE4 GAGEC1 JM27	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; regulation of stress-activated MAPK cascade [GO:0032872]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; regulation of stress-activated MAPK cascade [GO:0032872]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]	GO:0003677; GO:0003713; GO:0005634; GO:0005737; GO:0005739; GO:0006979; GO:0032872; GO:0042594; GO:0043066; GO:1903202; GO:1903427	SERGDGSDVK	9.930000305	1	1	0.284341668	1049.653758	0	16.71794	12.07646	14.59363	0	0	0	16.45786	14.74446	13.67487	15.77074	15.45759	16.093	14.31304	0	0	0	0	17.16703	16.76367	16.35575	0	15.58543	16.47604	14.99255	16.95187	0	0	0	17.17751	0	16.97923	0	0	0	0	0	18.19276	16.45623	13.71319	19.05403	16.21833	15.68831	18.59068	16.35923	18.57075	0	18.41467
O60832	DKC1_HUMAN	"H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)"	DKC1 NOLA4	Homo sapiens (Human)	box H/ACA RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004]	box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004]	box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]	GO:0000455; GO:0000495; GO:0001650; GO:0003720; GO:0003723; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005737; GO:0006364; GO:0006396; GO:0007004; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:0032212; GO:0034513; GO:0051973; GO:0070034; GO:0072589; GO:0090661; GO:0090666; GO:0090669; GO:1904851; GO:1904871; GO:1904872; GO:1904874; GO:1990481	IMLPGVLRYEDGIEVNQEIVVITTK	7.010000229	0.194230974	0.194230974	8.21E-12	2846.713675	15.31782	0	0	0	0	0	13.05631	0	14.06205	15.16885	0	0	14.57654	0	0	16.11536	0	0	0	14.25673	0	17.63705	20.58016	0	0	0	17.64059	16.63436	13.40538	0	16.13972	0	15.60945	0	0	15.43784	0	0	0	19.88792	0	0	0	0	0	0	13.32164	0
O60840	CAC1F_HUMAN	Voltage-dependent L-type calcium channel subunit alpha-1F (Voltage-gated calcium channel subunit alpha Cav1.4)	CACNA1F CACNAF1	Homo sapiens (Human)	calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; regulation of ion transmembrane transport [GO:0034765]; visual perception [GO:0007601]	integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; voltage-gated calcium channel complex [GO:0005891]	integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; voltage-gated calcium channel complex [GO:0005891]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; regulation of ion transmembrane transport [GO:0034765]; visual perception [GO:0007601]	high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]	GO:0001750; GO:0005245; GO:0005891; GO:0006816; GO:0007601; GO:0008331; GO:0016021; GO:0034765; GO:0043204; GO:0046872; GO:0050908; GO:0070509; GO:1901386	QQMEEDLR	5.610000134	1	1	0.302322747	1049.427662	13.54902	15.57097	15.69514	0	0	16.15471	16.31911	0	0	15.31433	0	12.17576	0	14.76146	0	0	0	0	0	0	0	0	11.24893	0	10.31269	0	14.4422	0	10.98729	0	0	0	13.92736	0	0	0	15.17438	13.3442	0	0	15.78556	14.35785	15.30378	0	15.53778	0	0	0
O60841	IF2P_HUMAN	"Eukaryotic translation initiation factor 5B, eIF-5B, EC 3.6.5.3 (Translation initiation factor IF-2)"	EIF5B IF2 KIAA0741	Homo sapiens (Human)	regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006446; GO:0046872	EGKLLTK	21.04999924	0.340209901	0.340209901	0.30843131	788.8583196	18.38836	16.80778	0	0	18.87919	17.11241	16.03661	17.15368	0	17.80925	16.96802	18.07917	16.65512	17.81236	16.33648	16.2385	17.18726	17.39054	16.44243	0	0	17.48661	17.70848	18.29991	18.40378	17.6841	18.17021	17.09912	16.63603	0	0	18.67144	0	18.50903	0	16.38588	0	19.91498	0	17.70854	19.37794	0	0	16.4501	0	0	0	17.90057
O60861	GAS7_HUMAN	"Growth arrest-specific protein 7, GAS-7"	GAS7 KIAA0394	Homo sapiens (Human)	actin filament polymerization [GO:0030041]; neuron projection morphogenesis [GO:0048812]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; neuron projection morphogenesis [GO:0048812]	actin filament binding [GO:0051015]; identical protein binding [GO:0042802]	GO:0005737; GO:0005884; GO:0005886; GO:0030041; GO:0042802; GO:0048812; GO:0051015	STQAGDDLMR	4.159999847	1	1	0.207666845	1093.993828	14.7831	0	0	0	0	16.42466	0	0	0	0	0	15.17888	0	0	0	17.15382	0	0	0	0	0	0	16.78196	0	0	0	0	14.49679	17.34	16.55689	0	0	0	0	0	0	17.8716	0	0	0	0	0	0	0	0	0	0	0
O60870	KIN17_HUMAN	"DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein homolog)"	KIN BTCD KIN17	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003677; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0016363; GO:0032991; GO:0043231; GO:0046872	YTAVVK	1.269999981	1	1	0.244909616	680.6997842	21.89902	0	0	0	16.19832	17.92914	0	0	0	17.09465	0	0	0	0	19.47512	0	0	0	0	0	16.30337	0	0	0	0	0	0	16.65055	0	0	0	0	0	0	0	0	0	0	18.34251	0	0	15.18	16.24664	0	16.12589	17.74884	17.20664	0
O60882	MMP20_HUMAN	"Matrix metalloproteinase-20, MMP-20, EC 3.4.24.- (Enamel metalloproteinase) (Enamelysin)"	MMP20	Homo sapiens (Human)	amelogenesis [GO:0097186]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of enamel mineralization [GO:0070173]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; amelogenesis [GO:0097186]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of enamel mineralization [GO:0070173]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030163; GO:0030198; GO:0030574; GO:0031012; GO:0070173; GO:0097186	MKVLPASGLAVFLIMALK	2.339999914	1	1	0.483109642	1933.046393	0	18.05865	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.39401	0	0	0	0	0	0	17.30836	0	0	0	0	0	17.09896	17.80971	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60883	G37L1_HUMAN	"G-protein coupled receptor 37-like 1 (Endothelin B receptor-like protein 2, ETBR-LP-2)"	GPR37L1 ETBRLP2	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of MAPK cascade [GO:0043410]	ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of MAPK cascade [GO:0043410]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]	GO:0003085; GO:0004930; GO:0005886; GO:0007193; GO:0008528; GO:0016021; GO:0021940; GO:0036505; GO:0042277; GO:0043235; GO:0043410; GO:0045665; GO:0045879; GO:0048712; GO:0060170; GO:1903206	GNLTGAPGQR	9.229999542	1	1	0.082549211	971.8080662	14.75955	0	14.07033	13.43573	0	14.18811	0	0	0	0	0	12.81299	0	0	0	14.75882	14.1401	0	0	15.30531	0	0	15.78483	0	0	0	0	0	0	0	0	0	16.26395	0	0	0	0	14.56518	0	0	12.10817	0	0	0	0	14.85816	13.28993	0
O60884	DNJA2_HUMAN	"DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3, Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14)"	DNAJA2 CPR3 HIRIP4	Homo sapiens (Human)	positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408]	ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005524; GO:0005829; GO:0008284; GO:0009408; GO:0016020; GO:0030544; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0070062	MANVADTK	4.079999924	1	1	0.100018907	850.1785351	14.5115	15.57427	0	11.9278	14.36881	15.41878	11.90189	0	12.94463	0	14.0742	0	14.69132	15.18984	15.11943	13.40289	15.8111	14.42967	15.64597	13.35052	0	0	0	15.56225	14.35743	0	0	14.94297	14.11997	14.85228	0	0	0	0	0	0	15.24742	15.13925	0	15.90862	0	14.83504	14.79838	0	0	0	0	0
O60885	BRD4_HUMAN	Bromodomain-containing protein 4 (Protein HUNK1)	BRD4 HUNK1	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; lysine-acetylated histone binding [GO:0070577]; P-TEFb complex binding [GO:0106140]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; lysine-acetylated histone binding [GO:0070577]; P-TEFb complex binding [GO:0106140]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000083; GO:0000785; GO:0000794; GO:0002039; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0006338; GO:0006355; GO:0006974; GO:0008353; GO:0010971; GO:0019899; GO:0032968; GO:0043123; GO:0043922; GO:0045893; GO:0045944; GO:0050727; GO:0070577; GO:0099122; GO:0106140; GO:1901407; GO:2000002; GO:2001255	CKPMSYEEKR	4.429999828	1	1	0.392405526	1342.694276	14.57503	14.82707	0	0	0	0	15.16805	15.16541	0	0	0	0	0	15.8092	0	15.09611	14.97793	0	16.64507	15.8505	17.2021	15.37944	16.05191	0	0	0	14.30381	0	15.47787	0	16.2122	0	0	0	16.64998	16.913	17.11872	17.2944	15.70005	15.70603	16.55825	0	17.10402	16.58277	0	0	17.15546	17.20521
O60890	OPHN1_HUMAN	Oligophrenin-1	OPHN1	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell junction assembly [GO:0034329]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cerebellar granule cell differentiation [GO:0021707]; cerebral cortex neuron differentiation [GO:0021895]; establishment of epithelial cell apical/basal polarity [GO:0045198]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of proteasomal protein catabolic process [GO:1901799]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; synaptic vesicle endocytosis [GO:0048488]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; terminal bouton [GO:0043195]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; terminal bouton [GO:0043195]; actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; ionotropic glutamate receptor binding [GO:0035255]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell junction assembly [GO:0034329]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cerebellar granule cell differentiation [GO:0021707]; cerebral cortex neuron differentiation [GO:0021895]; establishment of epithelial cell apical/basal polarity [GO:0045198]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of proteasomal protein catabolic process [GO:1901799]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; synaptic vesicle endocytosis [GO:0048488]"	actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; ionotropic glutamate receptor binding [GO:0035255]; phospholipid binding [GO:0005543]	GO:0003779; GO:0005096; GO:0005543; GO:0005737; GO:0006930; GO:0007165; GO:0007399; GO:0007411; GO:0015629; GO:0021707; GO:0021895; GO:0030036; GO:0030100; GO:0030182; GO:0031175; GO:0034329; GO:0035023; GO:0035255; GO:0043195; GO:0043197; GO:0045198; GO:0048488; GO:0048667; GO:0051966; GO:0098880; GO:0098978; GO:0099149; GO:1901799	EQIGFTK	15.27000046	0.441873461	0.441873461	0.157149161	824.8276347	15.61212	17.07833	17.11337	0	14.7989	16.84261	15.58962	0	16.41465	0	0	0	15.84619	12.68274	0	0	14.68063	16.73906	17.21713	0	15.73485	16.32554	15.99221	0	16.90575	0	17.45979	16.33447	16.80698	18.52041	17.12556	0	0	14.88091	0	14.84136	15.79681	15.16083	0	17.84276	17.04896	16.91748	0	0	0	16.57896	17.52863	15.38844
O60895	RAMP2_HUMAN	"Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2, CRLR activity-modifying protein 2)"	RAMP2	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adherens junction assembly [GO:0034333]; adrenomedullin receptor signaling pathway [GO:1990410]; amylin receptor signaling pathway [GO:0097647]; angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; bicellular tight junction assembly [GO:0070830]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of vascular permeability [GO:0043116]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; sprouting angiogenesis [GO:0002040]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]	adrenomedullin receptor complex [GO:1903143]; amylin receptor complex 2 [GO:0150057]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	adrenomedullin receptor complex [GO:1903143]; amylin receptor complex 2 [GO:0150057]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; coreceptor activity [GO:0015026]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adherens junction assembly [GO:0034333]; adrenomedullin receptor signaling pathway [GO:1990410]; amylin receptor signaling pathway [GO:0097647]; angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; bicellular tight junction assembly [GO:0070830]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of vascular permeability [GO:0043116]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; sprouting angiogenesis [GO:0002040]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]	adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; coreceptor activity [GO:0015026]	GO:0001525; GO:0001570; GO:0001605; GO:0002040; GO:0005737; GO:0005764; GO:0005886; GO:0005887; GO:0005905; GO:0006816; GO:0006886; GO:0007186; GO:0007189; GO:0007507; GO:0008217; GO:0008277; GO:0009986; GO:0010628; GO:0015026; GO:0015031; GO:0031623; GO:0032870; GO:0034333; GO:0035924; GO:0043116; GO:0043235; GO:0045766; GO:0070830; GO:0070831; GO:0072659; GO:0097084; GO:0097647; GO:0150057; GO:1903143; GO:1990409; GO:1990410; GO:2000352; GO:2001214	AGGPR	2.730000019	1.06E-06	1.06E-06	0.284674503	456.4261938	0	0	17.85485	16.52012	18.24219	0	17.93383	0	18.80431	17.48508	0	18.57672	16.12234	0	17.52474	0	0	18.67604	18.02573	0	0	16.44962	18.40317	0	20.47599	0	0	17.93442	0	0	0	0	17.34273	0	0	0	18.75516	0	0	18.458	0	19.07929	16.80759	0	0	17.2596	0	0
O60906	NSMA_HUMAN	"Sphingomyelin phosphodiesterase 2, EC 3.1.4.12 (Lyso-platelet-activating factor-phospholipase C, Lyso-PAF-PLC) (Neutral sphingomyelinase, N-SMase, nSMase, nSMase1)"	SMPD2	Homo sapiens (Human)	ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]	caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]	metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]	GO:0004620; GO:0004767; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006684; GO:0006685; GO:0008081; GO:0016020; GO:0030149; GO:0046513; GO:0046872; GO:0071944	DFKGSEEGNTMVPK	6.340000153	0.650607526	0.650607526	0.334287078	1554.457594	17.16592	16.84054	0	0	0	0	0	0	14.89245	18.33261	15.02142	0	0	0	0	16.40504	16.3308	14.7519	0	14.81423	0	0	15.66675	15.96956	0	0	0	0	15.21462	0	0	0	0	0	16.01166	0	13.95501	14.18423	16.51502	0	15.98566	0	0	16.69743	15.70929	17.0075	0	0
O60911	CATL2_HUMAN	"Cathepsin L2, EC 3.4.22.43 (Cathepsin U) (Cathepsin V)"	CTSV CATL2 CTSL2 CTSU UNQ268/PRO305	Homo sapiens (Human)	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; proteolysis involved in cellular protein catabolic process [GO:0051603]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; serine-type endopeptidase activity [GO:0004252]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; serine-type endopeptidase activity [GO:0004252]	GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005764; GO:0006955; GO:0008234; GO:0019886; GO:0022617; GO:0043202; GO:0051603	AVWEKNMK	6.429999828	1	1	0.000256547	1007.44096	14.70299	14.98465	11.20345	0	0	14.2291	0	14.12308	0	0	0	0	0	14.84182	0	16.39554	8.906175	0	0	0	0	16.75235	0	13.75039	13.36704	0	0	13.2721	0	0	15.32978	0	16.11017	11.8057	15.24962	0	0	0	0	0	16.39411	0	0	0	0	0	0	0
O60934	NBN_HUMAN	Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1)	NBN NBS NBS1 P95	Homo sapiens (Human)	"blastocyst growth [GO:0001832]; cell population proliferation [GO:0008283]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; neuromuscular process controlling balance [GO:0050885]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell cycle [GO:0051726]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]"	"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; protein N-terminus binding [GO:0047485]; blastocyst growth [GO:0001832]; cell population proliferation [GO:0008283]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; neuromuscular process controlling balance [GO:0050885]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell cycle [GO:0051726]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]"	damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; protein N-terminus binding [GO:0047485]	GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001832; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005730; GO:0005829; GO:0006302; GO:0007095; GO:0008283; GO:0016605; GO:0030174; GO:0030330; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042405; GO:0044818; GO:0045190; GO:0047485; GO:0050885; GO:0051321; GO:0051726; GO:0070533; GO:0090656; GO:0090737; GO:0097193; GO:0098687; GO:0110025; GO:0140297; GO:1904354	MLSQDAPTVKESCK	8.130000114	0.72520262	0.72520262	2.05E-12	1593.200613	15.90597	10.7463	0	0	12.44012	9.253762	14.90588	0	11.23092	14.98129	0	0	16.62964	16.73357	18.52665	0	16.94907	0	0	0	0	17.25167	15.29165	0	17.83782	16.40288	16.23449	16.45026	0	17.03334	15.26878	16.51129	16.99744	17.35136	18.03812	17.88987	0	0	18.64939	18.35637	17.71181	17.38432	0	12.81468	17.79328	0	18.6794	0
O60936	NOL3_HUMAN	"Nucleolar protein 3 (Apoptosis repressor with CARD) (Muscle-enriched cytoplasmic protein, Myp) (Nucleolar protein of 30 kDa, Nop30)"	NOL3 ARC NOP	Homo sapiens (Human)	blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; intrinsic apoptotic signaling pathway [GO:0097193]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein complex oligomerization [GO:0051259]; regulation of NIK/NF-kappaB signaling [GO:1901222]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to hypoxia [GO:0001666]; response to injury involved in regulation of muscle adaptation [GO:0014876]; response to ischemia [GO:0002931]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; sarcoplasmic reticulum [GO:0016529]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; intrinsic apoptotic signaling pathway [GO:0097193]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein complex oligomerization [GO:0051259]; regulation of NIK/NF-kappaB signaling [GO:1901222]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to hypoxia [GO:0001666]; response to injury involved in regulation of muscle adaptation [GO:0014876]; response to ischemia [GO:0002931]; RNA splicing [GO:0008380]	calcium ion binding [GO:0005509]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0001666; GO:0001974; GO:0002931; GO:0003723; GO:0005123; GO:0005509; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006376; GO:0008380; GO:0010659; GO:0010667; GO:0010804; GO:0014736; GO:0014808; GO:0014876; GO:0016020; GO:0016529; GO:0035877; GO:0042802; GO:0043027; GO:0043066; GO:0051259; GO:0060547; GO:0089720; GO:0090201; GO:0097193; GO:1901222; GO:1902109; GO:1902176; GO:1903298; GO:1990001; GO:2001237; GO:2001243	MGNAQERPSETIDRER	3.529999971	1	1	0.237770501	1904.318112	11.66569	14.25909	13.77642	15.2991	16.14576	15.97582	0	14.29284	13.52453	0	15.5054	0	0	0	0	15.88675	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O60941	DTNB_HUMAN	"Dystrobrevin beta, DTN-B (Beta-dystrobrevin)"	DTNB	Homo sapiens (Human)	neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536]	basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536]	zinc ion binding [GO:0008270]	GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0099536	IMLNMFLDTMMADPPPQCLVWLPLMHR	3.190000057	0.007895735	0.007895735	0.238115591	3287.464933	0	14.27348	12.40735	10.55271	0	0	12.10709	13.13295	0	0	0	0	0	0	13.27416	0	0	0	0	0	12.02752	0	13.12917	0	13.66192	0	12.20624	0	14.61468	9.242579	19.18259	0	0	0	0	0	0	17.64389	0	0	0	0	0	0	0	0	13.0491	14.69552
O75019	LIRA1_HUMAN	"Leukocyte immunoglobulin-like receptor subfamily A member 1 (CD85 antigen-like family member I) (Leukocyte immunoglobulin-like receptor 6, LIR-6) (CD antigen CD85i)"	LILRA1 LIR6	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; inhibitory MHC class I receptor activity [GO:0032396]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]	antigen binding [GO:0003823]; inhibitory MHC class I receptor activity [GO:0032396]; transmembrane signaling receptor activity [GO:0004888]	GO:0002250; GO:0003823; GO:0004888; GO:0005886; GO:0006952; GO:0007166; GO:0016021; GO:0019221; GO:0032396	KTAPWITR	16.38999939	0.572959781	0.572959781	0.177844336	971.5802613	14.65675	14.76575	0	0	15.66898	0	14.83569	0	0	0	0	0	16.62265	14.93514	15.015	15.47691	14.25242	15.76063	16.38808	16.46582	15.98887	15.77277	15.84239	17.41365	17.03444	15.26943	15.63185	15.29308	14.03335	15.1322	15.62549	16.10459	17.34195	16.39327	13.77695	15.04092	0	16.44445	12.75815	15.03463	14.87935	14.38707	15.0306	15.29444	16.05441	15.65506	14.28178	16.13442
O75022	LIRB3_HUMAN	"Leukocyte immunoglobulin-like receptor subfamily B member 3, LIR-3, Leukocyte immunoglobulin-like receptor 3 (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5, ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a)"	LILRB3 ILT5 LIR3	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; negative regulation of osteoclast differentiation [GO:0045671]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; inhibitory MHC class I receptor activity [GO:0032396]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; negative regulation of osteoclast differentiation [GO:0045671]	inhibitory MHC class I receptor activity [GO:0032396]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	GO:0002250; GO:0004888; GO:0005886; GO:0005887; GO:0006952; GO:0007166; GO:0019221; GO:0030667; GO:0032396; GO:0038023; GO:0045671	EMASPPSSLSGEFLDTKDR	2.779999971	0.204177871	0.204177871	0.026886521	2067.875034	0	0	15.07869	14.57667	15.58518	0	0	13.06811	0	0	16.21216	14.93014	14.81039	14.66652	0	0	0	0	15.19361	15.7326	13.22408	0	13.53228	0	14.37987	0	15.74856	11.40205	0	0	16.87556	13.45767	0	13.11962	13.58525	0	10.10363	14.44964	12.50205	0	0	0	0	0	0	13.46907	0	15.63128
O75027	ABCB7_HUMAN	"Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7, ABC transporter 7 protein)"	ABCB7 ABC7	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; protein homodimerization activity [GO:0042803]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085]	ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; protein homodimerization activity [GO:0042803]	GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0015232; GO:0016021; GO:0016226; GO:0034755; GO:0042626; GO:0042803; GO:0055072; GO:0055085; GO:0070455; GO:0140466; GO:0140481; GO:1903331; GO:1903427	GNSGQFLDAAK	10.31999969	1	1	0.468450106	1106.580201	0	0	0	0	0	18.06125	0	0	18.90147	0	18.26979	0	0	0	0	0	0	0	0	0	0	0	18.82068	0	0	19.24386	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.68478	0	0	0	0	0	0
O75030	MITF_HUMAN	"Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32, bHLHe32)"	MITF BHLHE32	Homo sapiens (Human)	"bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0010628; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0044336; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:2000144; GO:2001141	IKELGTLIPK	6.400000095	1	1	0.234645115	1111.915222	0	0	14.44857	0	0	0	13.8345	13.1812	0	0	0	0	0	12.66696	0	0	0	0	0	0	0	0	0	0	0	0	0	15.06929	16.18709	0	16.21889	0	0	0	0	0	0	15.43586	0	0	0	0	0	0	0	0	0	0
O75031	HSF2B_HUMAN	Heat shock factor 2-binding protein	HSF2BP MEILB2	Homo sapiens (Human)	double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]	chromosome [GO:0005694]; cytosol [GO:0005829]	chromosome [GO:0005694]; cytosol [GO:0005829]; double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]		GO:0005694; GO:0005829; GO:0006366; GO:0007141; GO:0007144; GO:0007283; GO:1990918	SASEFR	8.109999657	1	1	0.198981546	696.8561807	0	0	15.63481	15.57463	14.93282	15.82025	16.47044	0	15.62069	16.18568	15.68188	15.65072	0	0	0	16.16467	0	15.93187	16.22619	15.87156	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.07438	0	0	15.89213	0	0	16.10799	0	0	0	0	0	0	0
O75037	KI21B_HUMAN	Kinesin-like protein KIF21B	KIF21B KIAA0449	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030425; GO:0030426; GO:0031410	LLESEAMNESLRR	14.17000008	1	1	0.482684222	1549.089425	15.40997	0	15.30366	13.2381	0	0	11.75362	0	0	15.54522	15.88062	0	0	0	0	0	0	13.82892	0	0	0	16.58295	15.80043	0	0	0	0	0	0	0	16.21822	0	0	0	0	0	0	0	0	19.01976	0	0	0	20.5646	0	19.99013	0	0
O75038	PLCH2_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4, PLC-L4, Phospholipase C-like protein 4) (Phospholipase C-eta-2, PLC-eta2)"	PLCH2 KIAA0450 PLCL4	Homo sapiens (Human)	lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0016042; GO:0046488; GO:0048015	VKQMFR	1.600000024	1	1	0.132805704	823.6166636	0	14.12053	14.21042	13.59167	0	13.9795	15.92422	14.75883	14.19804	15.40029	16.13008	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.2118	0	0	0	0	0	0	0
O75051	PLXA2_HUMAN	Plexin-A2 (Semaphorin receptor OCT)	PLXNA2 KIAA0463 OCT PLXN2 UNQ209/PRO235	Homo sapiens (Human)	centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756]	identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]	GO:0001756; GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0043087; GO:0050772; GO:0051642; GO:0060037; GO:0060174; GO:0071526; GO:1902287	DPESSAMLDYELHSDFVSSLIK	7.340000153	1	1	0	2499.240373	13.55673	6.106655	12.80314	0	13.46231	12.34612	0	0	14.09054	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75052	CAPON_HUMAN	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein)	NOS1AP CAPON KIAA0464	Homo sapiens (Human)	positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]	caveola [GO:0005901]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]	caveola [GO:0005901]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]; nitric-oxide synthase binding [GO:0050998]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]	nitric-oxide synthase binding [GO:0050998]	GO:0003062; GO:0005634; GO:0005739; GO:0005829; GO:0005901; GO:0010628; GO:0010750; GO:0030018; GO:0030315; GO:0033017; GO:0042383; GO:0045428; GO:0045429; GO:0048471; GO:0050998; GO:0050999; GO:0051000; GO:0060307; GO:0098901; GO:0098974; GO:0098978; GO:1901381; GO:1901841; GO:1902261; GO:1902514; GO:1903762; GO:2000170	VSIMVSVDGVKVILK	8.859999657	0.101144798	0.101144798	0.489407461	1586.724875	0	0	0	0	0	0	0	17.29906	0	0	0	0	0	0	0	0	0	16.49227	0	0	0	18.12696	0	0	0	17.93469	0	0	18.63997	0	19.46382	22.06175	21.04115	0	20.24811	0	20.64942	20.82559	0	0	0	0	0	19.13733	0	18.85472	0	0
O75061	AUXI_HUMAN	"Putative tyrosine-protein phosphatase auxilin, EC 3.1.3.48 (DnaJ homolog subfamily C member 6)"	DNAJC6 KIAA0473	Homo sapiens (Human)	clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle uncoating [GO:0016191]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; vesicle [GO:0031982]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; vesicle [GO:0031982]; clathrin binding [GO:0030276]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle uncoating [GO:0016191]	clathrin binding [GO:0030276]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]	GO:0004725; GO:0005737; GO:0005829; GO:0014069; GO:0016191; GO:0017124; GO:0030276; GO:0031982; GO:0043231; GO:0072318; GO:0072583; GO:0098793; GO:2000369	EEMAKEMDPEK	5.590000153	1	1	0.407704478	1352.154638	15.23465	15.32422	0	14.71086	0	14.14453	0	0	0	0	15.63681	0	0	0	14.34121	0	0	0	0	17.33635	0	15.54386	13.28872	16.44112	0	0	15.3813	0	0	0	0	0	0	0	0	0	0	17.1441	16.61028	15.37483	15.94486	0	0	15.74149	0	17.10107	0	0
O75063	XYLK_HUMAN	"Glycosaminoglycan xylosylkinase, EC 2.7.1.- (Xylose kinase)"	FAM20B KIAA0475	Homo sapiens (Human)	proteoglycan biosynthetic process [GO:0030166]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; proteoglycan biosynthetic process [GO:0030166]"	"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016021; GO:0016301; GO:0016773; GO:0030166; GO:0046872	ADVGYK	5.800000191	0.856167316	0.856167316	0.066849103	652.7132268	19.40929	15.53854	17.43108	0	15.24298	0	0	17.02175	0	14.85486	12.54847	15.94636	0	17.34727	16.37269	18.6588	15.47414	0	0	15.29025	16.50895	18.18975	0	17.48896	0	16.80971	16.49783	18.51901	16.30078	15.81431	16.60548	15.2147	15.10472	16.12299	13.46004	14.85679	17.53252	17.27414	16.07667	15.58858	17.19739	16.68951	14.63066	13.21281	15.68757	0	16.82948	17.76792
O75064	DEN4B_HUMAN	DENN domain-containing protein 4B	DENND4B KIAA0476	Homo sapiens (Human)	regulation of Rab protein signal transduction [GO:0032483]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Rab protein signal transduction [GO:0032483]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005654; GO:0005794; GO:0005829; GO:0031410; GO:0032483	GRALGGR	14.39000034	0.056610402	0.056610402	0.237549494	686.6699319	16.83968	15.24532	17.86587	0	0	0	0	0	0	17.53036	0	0	17.05742	16.75134	0	0	0	0	0	17.04663	0	0	17.41701	0	0	0	0	15.06985	14.80557	14.23295	15.27149	15.27072	17.14434	0	14.68	0	0	0	0	0	0	0	17.4278	0	16.8929	0	0	0
O75069	TMCC2_HUMAN	Transmembrane and coiled-coil domains protein 2 (Cerebral protein 11)	TMCC2 KIAA0481 hucep-11	Homo sapiens (Human)	amyloid precursor protein metabolic process [GO:0042982]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; amyloid precursor protein metabolic process [GO:0042982]		GO:0005783; GO:0005789; GO:0012505; GO:0016021; GO:0042982	ERSPEMHR	6.329999924	1	1	0.264340872	1058.047663	0	0	0	0	0	16.66243	0	0	0	0	0	0	0	0	17.31417	0	0	0	0	0	0	17.94276	0	0	0	0	0	0	0	0	19.77888	17.80646	0	0	0	0	0	0	0	0	0	0	0	0	0	16.69334	0	0
O75078	ADA11_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 11, ADAM 11 (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein, MDC)"	ADAM11 MDC	Homo sapiens (Human)	integrin-mediated signaling pathway [GO:0007229]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; integrin-mediated signaling pathway [GO:0007229]	integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005178; GO:0005886; GO:0007229; GO:0008237; GO:0016021	GRSGGA	6.909999847	0.716748416	0.716748416	0.118454928	503.3132244	14.36887	16.31348	17.21415	16.29049	16.48137	17.374	16.58129	16.94117	16.27256	16.99569	17.10459	15.55225	17.52839	18.23333	18.23784	17.36022	17.78173	18.13273	17.88236	17.09319	18.79352	18.11571	17.35398	16.93536	15.83208	17.86202	18.47631	17.45174	17.28379	16.57258	18.24558	17.30359	17.76282	17.62323	16.79586	16.95381	19.05642	18.92632	17.56816	17.978	17.92596	17.64773	16.61033	17.88148	17.9143	19.26737	0	17.94126
O75081	MTG16_HUMAN	"Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein, hMTG16) (Zinc finger MYND domain-containing protein 4)"	CBFA2T3 MTG16 MTGR2 ZMYND4	Homo sapiens (Human)	"granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]"	Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]"	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000139; GO:0001666; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:0046872; GO:1903715	YSPSNGPPQPTPPPHYRLEDIAMAHHFR	4.639999866	1	1	0.15428583	3211.410425	11.66982	14.09813	13.68123	14.99758	13.23854	13.06419	14.5464	11.86324	0	12.82678	12.14728	12.03318	0	12.74628	13.27057	0	0	13.70524	9.220171	0	13.47402	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.61114	14.9185	0	0	0	11.59843	0	0	0
O75083	WDR1_HUMAN	"WD repeat-containing protein 1 (Actin-interacting protein 1, AIP1) (NORI-1)"	WDR1	Homo sapiens (Human)	actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]	cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; podosome [GO:0002102]	cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605]	actin filament binding [GO:0051015]	GO:0002102; GO:0002446; GO:0005576; GO:0005829; GO:0005886; GO:0005911; GO:0007605; GO:0008360; GO:0030042; GO:0030043; GO:0030054; GO:0030220; GO:0030834; GO:0030836; GO:0030864; GO:0030865; GO:0040011; GO:0042247; GO:0042995; GO:0043297; GO:0045199; GO:0045214; GO:0048713; GO:0051015; GO:0060307; GO:0070062; GO:1990266	KCFSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR	3.50999999	1	1	5.04E-12	3525.514089	14.36521	0	11.91837	11.81644	0	9.428669	14.01875	0	14.08981	15.36654	10.2548	0	0	0	0	14.46554	11.6172	11.93683	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.07378	0	0	0	0	0	0	0	0	0	0	0	0
O75093	SLIT1_HUMAN	"Slit homolog 1 protein, Slit-1 (Multiple epidermal growth factor-like domains protein 4, Multiple EGF-like domains protein 4)"	SLIT1 KIAA0813 MEGF4 SLIL1	Homo sapiens (Human)	axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]	calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	GO:0005509; GO:0005615; GO:0007097; GO:0007411; GO:0008045; GO:0008201; GO:0021510; GO:0022028; GO:0031290; GO:0033563; GO:0043395; GO:0048495; GO:0048843; GO:0048846; GO:0048853; GO:0050919; GO:0051964	QLRVLQLMENQIGAVER	5.5	0.098338269	0.098338269	0.055900676	1999.224324	0	16.02123	0	0	0	0	16.80529	17.79003	0	16.86737	0	0	0	12.68531	0	0	14.34189	0	15.81589	12.81631	8.954739	0	12.79447	10.28091	0	0	0	15.22144	0	16.50632	0	13.13713	18.0684	0	0	0	13.79185	15.57142	0	0	0	0	0	0	19.8985	16.6331	0	0
O75094	SLIT3_HUMAN	"Slit homolog 3 protein, Slit-3 (Multiple epidermal growth factor-like domains protein 5, Multiple EGF-like domains protein 5)"	SLIT3 KIAA0814 MEGF5 SLIL2 UNQ691/PRO1336	Homo sapiens (Human)	aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	extracellular space [GO:0005615]; mitochondrion [GO:0005739]	extracellular space [GO:0005615]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	GO:0003180; GO:0003181; GO:0005509; GO:0005615; GO:0005739; GO:0007411; GO:0008201; GO:0008285; GO:0010629; GO:0030308; GO:0032870; GO:0035385; GO:0048495; GO:0048846; GO:0050919; GO:0051414; GO:0060412; GO:0061364; GO:0070100	DSYVELASAK	9.829999924	1	1	0.248800473	1082.31692	16.27947	0	18.75583	19.16881	18.34421	0	0	16.49171	0	0	18.44579	19.20362	0	17.30766	0	0	0	17.76439	16.30583	0	17.27966	16.95063	18.98721	17.79003	17.10835	17.84658	16.93543	17.1626	0	0	0	20.28818	0	18.27736	16.42882	0	0	18.92617	0	17.85727	0	17.01554	15.89035	0	0	0	0	18.46743
O75096	LRP4_HUMAN	"Low-density lipoprotein receptor-related protein 4, LRP-4 (Multiple epidermal growth factor-like domains 7)"	LRP4 KIAA0816 LRP10 MEGF7	Homo sapiens (Human)	amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]	GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395	IEASSMDGSGR	10.84000015	1	1	0.148001519	1125.666017	0	18.23469	0	14.54139	16.75226	13.88151	16.78622	17.16895	0	0	18.08165	0	12.61971	0	11.305	0	0	0	0	0	0	0	0	0	0	14.86009	0	0	15.93717	0	0	0	0	0	0	0	0	0	0	0	15.19392	0	13.88125	0	15.91799	14.7598	0	0
O75110	ATP9A_HUMAN	"Probable phospholipid-transporting ATPase IIA, EC 7.6.2.1 (ATPase class II type 9A)"	ATP9A ATPIIA KIAA0611	Homo sapiens (Human)	"endocytosis [GO:0006897]; negative regulation of exosomal secretion [GO:1903542]; phospholipid translocation [GO:0045332]; regulation of endocytic recycling [GO:2001135]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	"early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; endocytosis [GO:0006897]; negative regulation of exosomal secretion [GO:1903542]; phospholipid translocation [GO:0045332]; regulation of endocytic recycling [GO:2001135]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]	GO:0000287; GO:0002020; GO:0005524; GO:0005768; GO:0005769; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0016887; GO:0031901; GO:0032588; GO:0045332; GO:0048471; GO:0055037; GO:0055038; GO:0140326; GO:1903542; GO:1905279; GO:2001135	NAHLVTR	9.420000076	1	1	0.248690194	810.7656594	16.36317	15.83936	15.06001	14.20308	15.84202	0	15.66094	0	15.58379	17.45351	16.24365	15.82726	15.9666	15.88445	15.62463	15.80304	14.52996	16.85122	0	16.35773	16.17247	15.81154	0	17.08763	16.11394	16.23485	16.87422	15.51101	0	0	16.72371	16.68021	17.08702	0	0	0	16.46431	0	16.18994	14.74712	0	16.40587	0	0	16.12098	15.9135	15.38578	15.69545
O75113	N4BP1_HUMAN	"NEDD4-binding protein 1, N4BP1, EC 3.1.-.-"	N4BP1 KIAA0615	Homo sapiens (Human)	cellular response to UV [GO:0034644]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of viral genome replication [GO:0045071]; regulation of innate immune response [GO:0045088]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ubiquitin binding [GO:0043130]; cellular response to UV [GO:0034644]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of viral genome replication [GO:0045071]; regulation of innate immune response [GO:0045088]	mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ubiquitin binding [GO:0043130]	GO:0001818; GO:0003729; GO:0004540; GO:0005634; GO:0005730; GO:0005829; GO:0016605; GO:0031397; GO:0032435; GO:0034644; GO:0043130; GO:0045071; GO:0045087; GO:0045088	IFPDSEQRLK	5.150000095	0.153016225	0.153016225	0.128338157	1233.370916	0	15.65272	0	0	16.85955	0	15.3709	12.66955	16.77768	12.33696	0	0	0	0	12.59281	0	17.43623	15.56841	15.35735	16.14155	15.29983	0	0	0	15.65897	0	0	0	14.83292	15.41933	15.12659	16.05618	14.50078	14.47837	0	0	14.91464	0	18.10532	0	0	10.25382	16.08115	11.06628	0	15.06228	0	15.18282
O75116	ROCK2_HUMAN	"Rho-associated protein kinase 2, EC 2.7.11.1 (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II, ROCK-II) (p164 ROCK-2)"	ROCK2 KIAA0619	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000281; GO:0001837; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0004712; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0018105; GO:0018107; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145	IYESIEEAKSEAMK	8.710000038	1	1	0.242598322	1641.423414	12.78121	0	0	13.76702	15.94857	0	15.10695	0	0	16.99837	0	0	0	0	0	15.49786	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.96564	0	0	0	0	0	0	0	0
O75121	MFA3L_HUMAN	Microfibrillar-associated protein 3-like (Testis development protein NYD-SP9)	MFAP3L KIAA0626 HSD-39 HSD39	Homo sapiens (Human)		cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0016021; GO:0030054	VSVHPQSK	5.130000114	1	1	8.04E-13	880.9131788	16.22906	14.29657	15.3573	0	0	0	0	0	0	0	0	0	0	0	0	16.4197	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.10957	0	0	0
O75122	CLAP2_HUMAN	"CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2, hOrbit2)"	CLASP2 KIAA0627	Homo sapiens (Human)	"cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]"	axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; trans-Golgi network [GO:0005802]	"axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]"	actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]	GO:0000226; GO:0000776; GO:0002162; GO:0005737; GO:0005794; GO:0005802; GO:0005815; GO:0005828; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051497; GO:0051895; GO:0072659; GO:0090091; GO:0090307; GO:1903690; GO:1903754; GO:1904261; GO:1990782	AMGDDK	7.739999771	1	1	2.29E-13	653.3120397	15.90991	0	0	0	0	0	14.52596	16.27653	15.05119	0	17.22665	15.24808	0	16.26687	0	0	15.2376	0	0	0	16.05568	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.54422	0
O75128	COBL_HUMAN	Protein cordon-bleu	COBL KIAA0633	Homo sapiens (Human)	actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; collateral sprouting in absence of injury [GO:0048669]; digestive tract development [GO:0048565]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; liver development [GO:0001889]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; positive regulation of dendrite development [GO:1900006]; positive regulation of ruffle assembly [GO:1900029]; somite specification [GO:0001757]	actin filament [GO:0005884]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; terminal web [GO:1990357]	actin filament [GO:0005884]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; terminal web [GO:1990357]; actin monomer binding [GO:0003785]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; collateral sprouting in absence of injury [GO:0048669]; digestive tract development [GO:0048565]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; liver development [GO:0001889]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; positive regulation of dendrite development [GO:1900006]; positive regulation of ruffle assembly [GO:1900029]; somite specification [GO:0001757]	actin monomer binding [GO:0003785]	GO:0000578; GO:0001726; GO:0001757; GO:0001843; GO:0001889; GO:0003785; GO:0005884; GO:0005886; GO:0005938; GO:0016020; GO:0030041; GO:0030424; GO:0030425; GO:0030903; GO:0033504; GO:0043025; GO:0044294; GO:0044295; GO:0048471; GO:0048565; GO:0048669; GO:0051639; GO:1900006; GO:1900029; GO:1990357	ELVNGSVR	9.119999886	0.282762855	0.282762855	0.527259681	870.1817469	16.22884	15.80824	16.38451	0	16.85126	0	0	12.62605	0	15.70712	14.82412	14.69665	0	0	0	16.90767	0	0	15.51422	0	17.30754	16.90552	0	0	0	0	0	16.93464	0	0	0	16.03289	0	0	0	0	0	17.10111	0	0	0	0	0	16.89686	16.42568	0	0	16.37392
O75129	ASTN2_HUMAN	Astrotactin-2	ASTN2 KIAA0634	Homo sapiens (Human)	establishment of body hair planar orientation [GO:0048105]; negative regulation of protein localization to cell surface [GO:2000009]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764]; protein transport [GO:0015031]	cell cortex [GO:0005938]; cell pole [GO:0060187]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perikaryon [GO:0043204]	"cell cortex [GO:0005938]; cell pole [GO:0060187]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perikaryon [GO:0043204]; calcium ion binding [GO:0005509]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; establishment of body hair planar orientation [GO:0048105]; negative regulation of protein localization to cell surface [GO:2000009]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764]; protein transport [GO:0015031]"	"calcium ion binding [GO:0005509]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]"	GO:0001764; GO:0005509; GO:0005768; GO:0005769; GO:0005770; GO:0005938; GO:0007158; GO:0015031; GO:0016021; GO:0030136; GO:0043204; GO:0043533; GO:0048105; GO:0060187; GO:2000009	EQQMAYNTLMEVSASMLFR	3.680000067	1	1	0.775606444	2280.217505	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75131	CPNE3_HUMAN	Copine-3 (Copine III)	CPNE3 CPN3 KIAA0636	Homo sapiens (Human)	cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335]	azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335]	calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]	GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363	LLPPKNPATK	11.55000019	1	1	0.210428257	1079.64239	0	0	0	0	0	0	0	0	0	0	0	0	0	17.66708	0	18.20291	0	0	0	0	17.81949	0	0	0	0	0	0	15.32462	0	0	0	19.87142	0	0	17.39623	0	0	0	0	18.0595	0	0	0	0	0	0	0	0
O75132	ZBED4_HUMAN	Zinc finger BED domain-containing protein 4	ZBED4 KIAA0637	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983	EAMVSR	21.20000076	1	1	0.274878514	707.7581776	0	0	0	0	0	0	0	0	22.16389	0	19.27697	0	0	0	19.37695	0	0	0	0	0	19.55424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.36942	20.27152	0	0	0	0	20.33256	0	0	0	0	0	0
O75140	DEPD5_HUMAN	GATOR complex protein DEPDC5 (DEP domain-containing protein 5)	DEPDC5 KIAA0645	Homo sapiens (Human)	cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]	cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]	GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]	GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0032007; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130	FGFVQDK	15.77999973	0.045147039	0.045147039	0.266703833	839.290761	16.8065	16.9962	16.31275	0	16.71148	13.71896	15.94005	15.57646	0	0	14.62791	15.77404	16.9558	0	16.31895	16.23014	15.97851	16.40159	0	0	0	0	17.3728	0	16.47909	0	0	17.42166	0	0	16.88708	17.29625	15.98515	0	0	16.69571	16.71943	15.52996	0	16.36109	0	0	0	16.77852	17.79755	15.30526	16.67554	0
O75145	LIPA3_HUMAN	"Liprin-alpha-3 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3, PTPRF-interacting protein alpha-3)"	PPFIA3 KIAA0654	Homo sapiens (Human)	neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synapse organization [GO:0050808]; synaptic vesicle docking [GO:0016081]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; epididymosome [GO:0098875]; glutamatergic synapse [GO:0098978]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; epididymosome [GO:0098875]; glutamatergic synapse [GO:0098978]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synapse organization [GO:0050808]; synaptic vesicle docking [GO:0016081]		GO:0001669; GO:0005829; GO:0007269; GO:0016081; GO:0048172; GO:0048786; GO:0050808; GO:0098831; GO:0098875; GO:0098978	DVMVWSNER	1.029999971	0.108114444	0.108114444	0.090443727	1149.741009	0	15.93266	13.28037	0	0	12.97031	15.62061	0	0	10.09088	0	14.14076	0	13.83364	0	0	15.67099	0	0	15.66017	13.78655	15.41275	16.0874	14.1961	0	0	0	0	14.48727	17.31376	13.58473	17.80634	14.88512	17.12564	14.01736	0	15.03227	16.24985	16.42056	15.55859	0	0	16.60821	0	0	0	17.50002	14.92217
O75146	HIP1R_HUMAN	"Huntingtin-interacting protein 1-related protein, HIP1-related protein (Huntingtin-interacting protein 12, HIP-12)"	HIP1R HIP12 KIAA0655	Homo sapiens (Human)	actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; clathrin coat assembly [GO:0048268]; digestive system development [GO:0055123]; endocytosis [GO:0006897]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein binding [GO:0032092]; protein stabilization [GO:0050821]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of gastric acid secretion [GO:0060453]	apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060]	"apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060]; actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; clathrin coat assembly [GO:0048268]; digestive system development [GO:0055123]; endocytosis [GO:0006897]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein binding [GO:0032092]; protein stabilization [GO:0050821]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of gastric acid secretion [GO:0060453]"	"actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124]"	GO:0005546; GO:0005547; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0005938; GO:0006897; GO:0006898; GO:0006915; GO:0006919; GO:0007015; GO:0014069; GO:0016324; GO:0017124; GO:0030100; GO:0030136; GO:0030276; GO:0030665; GO:0030837; GO:0032051; GO:0032092; GO:0032587; GO:0032839; GO:0032956; GO:0034316; GO:0035091; GO:0035615; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043066; GO:0043197; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048268; GO:0048471; GO:0050821; GO:0051015; GO:0055123; GO:0060453; GO:0080025; GO:0097060; GO:1901030; GO:1905445; GO:2000369; GO:2000588	GAATQQEFYAK	5.590000153	1	1	0.175421801	1212.781761	12.7187	13.53512	15.09398	0	0	13.17332	13.77588	11.74971	13.28546	15.18786	15.02642	15.87703	14.46354	11.82573	0	9.873562	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.6305	16.1813	0	0	0	0	0	0	0	0	0
O75147	OBSL1_HUMAN	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Z disc [GO:0030018]	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Z disc [GO:0030018]; cytoskeletal anchor activity [GO:0008093]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	cytoskeletal anchor activity [GO:0008093]	GO:0000226; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0007010; GO:0007030; GO:0007088; GO:0007156; GO:0007416; GO:0008093; GO:0010842; GO:0014704; GO:0030018; GO:0031430; GO:0034067; GO:0045202; GO:0048471; GO:0050775; GO:0055003; GO:1990393	DRDGGFVLK	4.440000057	1	1	0.277812441	1006.794255	16.2223	0	15.52117	0	0	0	0	0	0	0	14.12826	16.57036	0	0	0	14.50166	0	14.43084	0	0	0	0	0	0	0	0	16.11502	0	0	0	0	0	0	0	0	0	0	0	0	16.33387	0	0	14.11251	0	0	0	0	0
O75150	BRE1B_HUMAN	"E3 ubiquitin-protein ligase BRE1B, BRE1-B, EC 2.3.2.27 (95 kDa retinoblastoma-associated protein, RBP95) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B)"	RNF40 BRE1B KIAA0661	Homo sapiens (Human)	chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511]	axon terminus [GO:0043679]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; HULC complex [GO:0033503]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	axon terminus [GO:0043679]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; HULC complex [GO:0033503]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511]	metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]	GO:0000151; GO:0003730; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006511; GO:0010390; GO:0016020; GO:0017075; GO:0019898; GO:0031624; GO:0031625; GO:0033503; GO:0033523; GO:0042803; GO:0043005; GO:0043434; GO:0043679; GO:0044877; GO:0046872; GO:0061630; GO:0071894; GO:1900364; GO:1901800; GO:1902916; GO:2001168	MSGPGNK	4.150000095	1	1	0.141956838	689.2754138	15.15077	0	0	0	14.03949	15.59602	13.68901	0	15.01978	16.54569	0	0	0	0	14.92473	14.11301	12.83548	14.01618	0	0	16.16678	0	0	0	0	0	0	0	0	0	0	0	15.15169	0	15.09559	0	0	0	0	0	16.09482	16.95958	0	0	0	0	0	0
O75151	PHF2_HUMAN	"Lysine-specific demethylase PHF2, EC 1.14.11.- (GRC5) (PHD finger protein 2)"	PHF2 CENP-35 KIAA0662	Homo sapiens (Human)	epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone H4-K20 demethylation [GO:0035574]; liver development [GO:0001889]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]	kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone H4-K20 demethylation [GO:0035574]; liver development [GO:0001889]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]	histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000776; GO:0001889; GO:0003712; GO:0003713; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006482; GO:0008270; GO:0032454; GO:0035064; GO:0035574; GO:0035575; GO:0045815; GO:0061188	LDSAAYK	6.739999771	0.248014972	0.248014972	0.169065064	767.5294501	19.13977	20.04452	19.88574	18.70226	19.3258	17.56743	18.45731	17.3619	0	18.19748	18.53473	0	17.96694	18.55863	18.05087	20.53884	19.18867	19.39634	17.93583	18.82862	19.05081	0	19.1946	18.72593	18.52609	18.55873	19.63068	18.13873	18.51433	0	18.36461	18.99847	18.59419	18.71396	19.67306	16.14346	18.51711	18.98315	18.10904	20.04585	19.41124	18.40897	19.82828	18.85723	19.73632	19.26586	19.93555	19.69499
O75152	ZC11A_HUMAN	Zinc finger CCCH domain-containing protein 11A	ZC3H11A KIAA0663 ZC3HDC11A	Homo sapiens (Human)	poly(A)+ mRNA export from nucleus [GO:0016973]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; poly(A)+ mRNA export from nucleus [GO:0016973]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005654; GO:0016973; GO:0046872	SLAQRLGK	11.80000019	0.59279567	0.59279567	0.276752185	873.109229	16.63112	0	13.73112	0	14.97725	0	14.9312	0	13.87901	15.07329	15.52514	0	14.64631	15.02104	0	15.79352	15.04428	15.32596	0	13.55332	15.32334	16.00526	15.23826	15.43938	0	14.97573	0	0	0	16.27655	15.54402	16.26117	0	16.08318	0	0	0	0	15.04154	0	15.844	0	14.97327	16.72535	16.75541	15.06471	0	15.22837
O75153	CLU_HUMAN	Clustered mitochondria protein homolog	CLUH KIAA0664	Homo sapiens (Human)	intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005]	mRNA binding [GO:0003729]	GO:0003729; GO:0005737; GO:0007005; GO:0048312	QELVDAFVEHR	2.700000048	0.476546258	0.476546258	0.105335415	1342.513618	0	14.78308	0	0	14.83554	0	0	12.34791	0	0	0	0	0	0	0	14.997	0	0	0	18.41564	16.82857	0	16.45056	0	0	0	0	0	0	0	16.57618	16.52056	0	0	0	0	0	0	0	0	15.43798	16.86391	0	0	0	0	0	0
O75155	CAND2_HUMAN	"Cullin-associated NEDD8-dissociated protein 2 (Cullin-associated and neddylation-dissociated protein 2) (Epididymis tissue protein Li 169) (TBP-interacting protein of 120 kDa B, TBP-interacting protein 120B) (p120 CAND2)"	CAND2 KIAA0667 TIP120B	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]"	cytosol [GO:0005829]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleus [GO:0005634]; TBP-class protein binding [GO:0017025]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]"	TBP-class protein binding [GO:0017025]	GO:0005634; GO:0005829; GO:0010265; GO:0016567; GO:0017025; GO:0045893	DHYDIRMLTFIMVAR	8.479999542	1	1	0.26156773	1896.035345	15.62018	14.78203	14.56481	0	0	15.00069	0	15.29998	12.5645	0	0	0	0	0	0	0	0	0	0	0	16.25913	0	15.32786	0	15.81061	13.85032	0	13.06487	0	0	14.2836	0	15.52505	0	14.89091	15.039	0	16.15977	0	14.57837	0	0	16.0651	0	0	0	0	0
O75161	NPHP4_HUMAN	Nephrocystin-4 (Nephroretinin)	NPHP4 KIAA0673	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; flagellated sperm motility [GO:0030317]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization to ciliary transition zone [GO:1904491]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual behavior [GO:0007632]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor distal connecting cilium [GO:0120206]; ribbon synapse [GO:0097470]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor distal connecting cilium [GO:0120206]; ribbon synapse [GO:0097470]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; flagellated sperm motility [GO:0030317]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization to ciliary transition zone [GO:1904491]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual behavior [GO:0007632]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005654; GO:0005813; GO:0005829; GO:0005911; GO:0005923; GO:0007165; GO:0007632; GO:0016604; GO:0030036; GO:0030317; GO:0035845; GO:0035869; GO:0036064; GO:0043231; GO:0045494; GO:0060041; GO:0090090; GO:0097470; GO:0097546; GO:0097730; GO:0098609; GO:0120206; GO:1903348; GO:1904491	ESDATRR	6.360000134	1	1	0.048014502	834.519526	0	17.35629	0	0	15.46716	15.1524	14.99765	0	0	0	14.4009	0	0	0	0	0	0	0	0	0	13.30474	0	12.03702	0	0	0	13.37558	16.26228	0	15.89237	0	0	0	0	0	0	0	0	0	0	0	0	0	15.70243	0	0	0	0
O75164	KDM4A_HUMAN	"Lysine-specific demethylase 4A, EC 1.14.11.66, EC 1.14.11.69 (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) ([histone H3]-trimethyl-L-lysine(36) demethylase 4A) ([histone H3]-trimethyl-L-lysine(9) demethylase 4A)"	KDM4A JHDM3A JMJD2 JMJD2A KIAA0677	Homo sapiens (Human)	"cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; response to nutrient levels [GO:0031667]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-36 demethylase activity [GO:0140681]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; response to nutrient levels [GO:0031667]"	histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-36 demethylase activity [GO:0140681]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0001650; GO:0005634; GO:0005654; GO:0005721; GO:0005829; GO:0006338; GO:0008270; GO:0010507; GO:0010628; GO:0010629; GO:0014898; GO:0016577; GO:0031625; GO:0031667; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0045666; GO:0045892; GO:0048712; GO:0051864; GO:0060548; GO:0070544; GO:0140681; GO:0140684; GO:1900113	MTLISPLMLK	19.5	0.329739243	0.329739243	0.267599423	1163.767617	22.55484	23.43614	22.58543	18.50789	22.28448	21.48652	21.88889	21.958	22.50403	16.94842	17.7779	20.84171	21.58229	18.66158	16.20403	21.36371	22.46336	22.15061	21.67423	16.88223	18.34604	20.53154	21.74886	21.11478	0	0	22.41626	22.64814	0	18.77444	22.91304	20.59428	22.43478	23.19789	20.20256	23.3596	21.99648	21.27112	21.70564	21.09162	22.45425	22.17713	17.35196	21.47238	21.59006	22.41001	22.29437	21.95162
O75165	DJC13_HUMAN	"DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8, RME-8)"	DNAJC13 KIAA0678 RME8	Homo sapiens (Human)	endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]		GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641	DNVKIAMDQYGK	5.349999905	1	1	0.252458723	1397.390016	0	13.89209	0	0	0	0	0	0	0	15.23392	0	13.69128	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.96511	0	0	0	0	0	0	0	0	0	12.23028	0	0	16.91326	16.21006	15.10913	0	0	0	0	0	0
O75170	PP6R2_HUMAN	Serine/threonine-protein phosphatase 6 regulatory subunit 2 (SAPS domain family member 2)	PPP6R2 KIAA0685 PP6R2 SAPS2	Homo sapiens (Human)	regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]	GO:0005634; GO:0005829; GO:0019888; GO:0019903; GO:0043231; GO:0043666	EAPPLPTVARTEEAVGR	1.159999967	1	1	0.270731146	1792.001107	0	13.56706	0	15.99591	15.12358	0	13.1504	0	0	15.72495	0	0	14.62866	16.70498	0	0	0	15.33008	0	0	0	0	0	14.95142	0	16.67055	17.67824	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.52237	0	0	0	0	0
O75173	ATS4_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 4, ADAM-TS 4, ADAM-TS4, ADAMTS-4, EC 3.4.24.82 (ADMP-1) (Aggrecanase-1)"	ADAMTS4 KIAA0688 UNQ769/PRO1563	Homo sapiens (Human)	extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protease binding [GO:0002020]	GO:0001501; GO:0002020; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0016607; GO:0022617; GO:0030198; GO:0031012; GO:0046872; GO:0062023	CMVCGGDGSGCSKQSGSFR	4.760000229	1	1	0.109801292	2053.250254	13.78491	0	0	0	0	11.46987	0	0	14.00966	18.34324	14.52622	14.00817	0	0	0	13.72957	0	12.6633	11.92828	0	0	0	0	0	16.55867	16.71863	0	0	11.91625	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.582	0	0	0	0
O75177	CREST_HUMAN	Calcium-responsive transactivator (SS18-like protein 1) (SYT homolog 1)	SS18L1 CREST KIAA0693	Homo sapiens (Human)	"chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"	transcription coactivator activity [GO:0003713]	GO:0000776; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0016358; GO:0045893; GO:0045944; GO:0050775; GO:0071565	SVAFASARPR	5.940000057	0.853987515	0.853987515	0.184999267	1060.429733	0	0	15.08647	0	0	0	0	0	16.15563	0	0	0	0	15.21301	0	13.7447	0	15.87669	0	0	0	15.39677	16.02469	0	0	0	15.86252	16.82736	0	0	0	0	0	0	0	0	0	0	0	0	14.09079	14.24944	15.96335	0	0	0	0	0
O75182	SIN3B_HUMAN	Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)	SIN3B KIAA0700	Homo sapiens (Human)	histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]	autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]	autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]	chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0016580; GO:0030336; GO:0030849	KPAPGPHSSPPEEK	4.239999771	0.434092522	0.434092522	0.180279614	1457.160485	17.94113	0	16.36081	17.32984	0	0	17.71251	0	0	0	17.1036	0	0	0	0	0	0	14.63489	0	0	0	0	0	0	16.51177	0	0	16.30741	0	16.87473	0	0	16.06069	0	0	11.96868	0	0	14.94669	0	0	0	0	18.24959	15.4039	16.06795	0	0
O75185	AT2C2_HUMAN	"Calcium-transporting ATPase type 2C member 2, ATPase 2C2, EC 7.2.2.10 (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2, SPCA2)"	ATP2C2 KIAA0703 SPCA2	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; mammary gland epithelium development [GO:0061180]; manganese ion transport [GO:0006828]; positive regulation of calcium ion import [GO:0090280]; protein localization to plasma membrane [GO:0072659]	basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; mammary gland epithelium development [GO:0061180]; manganese ion transport [GO:0006828]; positive regulation of calcium ion import [GO:0090280]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613]	GO:0000139; GO:0005388; GO:0005524; GO:0005783; GO:0005886; GO:0006828; GO:0006874; GO:0009898; GO:0015662; GO:0016021; GO:0016323; GO:0016887; GO:0031410; GO:0032588; GO:0034220; GO:0046872; GO:0048471; GO:0061180; GO:0070588; GO:0072659; GO:0090280; GO:0140613	EVIKEFSNVSVGK	7.5	1	1	0.055331686	1435.765275	0	12.788	0	12.38397	0	11.08672	0	15.24415	0	0	0	0	14.27614	0	12.55923	13.44179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.35558	0	13.86634	0	0	0	0	15.46025	0	0	0	13.79793	0	0	0	0	0
O75190	DNJB6_HUMAN	"DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2, HSJ-2) (MRJ) (MSJ-1)"	DNAJB6 HSJ2 MRJ MSJ1	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; chaperone-mediated protein folding [GO:0061077]; chorio-allantoic fusion [GO:0060710]; chorion development [GO:0060717]; extracellular matrix organization [GO:0030198]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of cellular response to heat [GO:1900034]; regulation of protein localization [GO:0032880]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; actin cytoskeleton organization [GO:0030036]; chaperone-mediated protein folding [GO:0061077]; chorio-allantoic fusion [GO:0060710]; chorion development [GO:0060717]; extracellular matrix organization [GO:0030198]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of cellular response to heat [GO:1900034]; regulation of protein localization [GO:0032880]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]"	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0016020; GO:0030018; GO:0030036; GO:0030198; GO:0031072; GO:0032880; GO:0034504; GO:0042802; GO:0043154; GO:0044183; GO:0045109; GO:0045892; GO:0048471; GO:0051082; GO:0051087; GO:0060710; GO:0060715; GO:0060717; GO:0061077; GO:0090084; GO:1900034	SISTSTKMVNGR	4.480000019	1	1	0.147061564	1297.301201	0	0	0	14.52827	0	0	0	0	0	12.07569	0	0	0	12.75486	0	0	0	0	0	0	0	0	0	0	0	14.08744	0	0	0	0	14.85016	0	0	11.7345	14.97793	0	15.88617	0	0	12.94925	0	0	0	0	14.39482	0	0	0
O75191	XYLB_HUMAN	"Xylulose kinase, Xylulokinase, EC 2.7.1.17"	XYLB	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]	cytosol [GO:0005829]	"cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]"	"ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]"	GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0016310; GO:0016773; GO:0019640; GO:0042732	VAAFPGDVEVR	1.539999962	1	1	0.116363057	1156.109645	19.62378	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.71275	0	0	0	0	0	0	0
O75197	LRP5_HUMAN	"Low-density lipoprotein receptor-related protein 5, LRP-5 (Low-density lipoprotein receptor-related protein 7, LRP-7)"	LRP5 LR3 LRP7	Homo sapiens (Human)	"adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]"	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]"	coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001702; GO:0002053; GO:0002076; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0015026; GO:0016021; GO:0017147; GO:0033690; GO:0035019; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060764; GO:0061178; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262; GO:1904928; GO:1990851; GO:1990909	DVIIDQLPDLMGLK	3.349999905	1	1	0.030491528	1569.00252	14.71332	0	0	0	0	0	16.37691	0	0	0	0	0	15.17334	15.61888	0	13.65459	0	12.05898	0	0	0	0	0	0	0	0	15.26511	0	0	0	0	14.18887	19.92914	0	17.65977	16.51477	0	0	0	0	0	0	0	0	0	16.45337	0	0
O75223	GGCT_HUMAN	"Gamma-glutamylcyclotransferase, EC 4.3.2.9 (Cytochrome c-releasing factor 21)"	GGCT C7orf24 CRF21	Homo sapiens (Human)	release of cytochrome c from mitochondria [GO:0001836]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; release of cytochrome c from mitochondria [GO:0001836]	gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]	GO:0001836; GO:0003839; GO:0005829; GO:0042803; GO:0070062	KIICMGAK	4.809999943	1	1	0.107384374	919.9351067	0	0	15.46655	15.99645	16.16099	15.78581	15.10031	15.08668	13.7965	11.73639	11.07645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.10492	14.52787	13.02245	0	0	14.81436	0	0	16.89869	15.93604	0	0	0	0	0	0	0	0	0
O75290	Z780A_HUMAN	Zinc finger protein 780A	ZNF780A	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	NIHTGEKAS	5.360000134	1	1	0.24203175	955.9018118	14.93326	0	13.1502	14.7112	14.49074	0	18.44955	13.3364	0	0	16.07107	0	0	0	0	0	0	0	0	0	0	0	0	0	15.81195	16.27797	16.41351	0	0	0	0	0	0	0	0	0	0	17.36758	0	0	16.44089	15.65892	14.44966	15.26865	15.39075	0	15.20761	0
O75298	RTN2_HUMAN	"Reticulon-2 (Neuroendocrine-specific protein-like 1, NSP-like protein 1) (Neuroendocrine-specific protein-like I, NSP-like protein I, NSPLI)"	RTN2 NSPL1	Homo sapiens (Human)	gene expression [GO:0010467]; intracellular protein transmembrane transport [GO:0065002]; negative regulation of amyloid-beta formation [GO:1902430]; regulation of glucose import [GO:0046324]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; intermediate filament [GO:0005882]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; intermediate filament [GO:0005882]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; gene expression [GO:0010467]; intracellular protein transmembrane transport [GO:0065002]; negative regulation of amyloid-beta formation [GO:1902430]; regulation of glucose import [GO:0046324]		GO:0005783; GO:0005882; GO:0009986; GO:0010467; GO:0014802; GO:0030018; GO:0030176; GO:0030315; GO:0033017; GO:0046324; GO:0065002; GO:1902430	VLLKWAK	5.53000021	1	1	0.173638781	856.2931686	15.32004	14.88736	0	15.20216	0	0	0	15.48659	14.07154	14.70762	15.36339	16.98335	13.77072	11.54817	11.42315	0	0	14.84843	15.81547	15.33402	14.60989	16.29839	16.03044	0	13.07837	0	0	0	16.33372	0	0	0	0	0	0	0	0	0	0	0	15.44601	0	0	0	15.65094	0	0	0
O75312	ZPR1_HUMAN	Zinc finger protein ZPR1 (Zinc finger protein 259)	ZPR1 ZNF259	Homo sapiens (Human)	apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]	axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834]	receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]	GO:0000226; GO:0001833; GO:0001834; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0007165; GO:0008270; GO:0008283; GO:0008380; GO:0010628; GO:0015030; GO:0021510; GO:0030424; GO:0030426; GO:0030576; GO:0030971; GO:0031369; GO:0031641; GO:0033120; GO:0042023; GO:0042307; GO:0043025; GO:0043204; GO:0045787; GO:0045927; GO:0048471; GO:0061564; GO:0071364; GO:0071931; GO:0097504; GO:1902742; GO:1990261; GO:2000672	QQEEMLGLQEEAPAEKPEEEDLR	7.25	1	1	1.84E-12	2713.54641	13.17196	0	0	0	15.27507	14.23811	0	0	16.04095	0	0	0	0	0	15.86808	0	0	0	0	0	0	0	13.31608	0	0	0	16.26554	0	0	15.04984	0	12.59841	0	0	0	0	15.27638	0	0	0	0	0	0	0	0	0	0	0
O75324	SNN_HUMAN	Stannin (AG8_1)	SNN	Homo sapiens (Human)	response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; response to toxic substance [GO:0009636]	metal ion binding [GO:0046872]	GO:0005737; GO:0005741; GO:0009636; GO:0016021; GO:0046872	LMTPNGPEVHG	6.190000057	1	1	0.188030204	1153.918994	14.08683	15.92113	15.1525	15.71813	14.83957	0	11.87343	0	13.01755	0	0	0	15.35987	0	0	0	15.61484	0	0	0	0	0	0	0	0	16.68836	0	0	17.27419	0	15.09296	0	0	0	0	14.32109	0	0	0	14.59684	0	0	0	0	0	0	0	0
O75326	SEM7A_HUMAN	"Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1, Sema K1) (Semaphorin-L, Sema L) (CD antigen CD108)"	SEMA7A CD108 SEMAL	Homo sapiens (Human)	axon extension [GO:0048675]; axon guidance [GO:0007411]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory lobe development [GO:0021988]; osteoblast differentiation [GO:0001649]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of protein phosphorylation [GO:0001934]; regulation of inflammatory response [GO:0050727]; semaphorin-plexin signaling pathway [GO:0071526]	anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; integrin binding [GO:0005178]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; axon guidance [GO:0007411]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory lobe development [GO:0021988]; osteoblast differentiation [GO:0001649]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of protein phosphorylation [GO:0001934]; regulation of inflammatory response [GO:0050727]; semaphorin-plexin signaling pathway [GO:0071526]	chemorepellent activity [GO:0045499]; integrin binding [GO:0005178]; semaphorin receptor binding [GO:0030215]	GO:0001649; GO:0001755; GO:0001934; GO:0005178; GO:0005615; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007229; GO:0007411; GO:0009897; GO:0016020; GO:0021988; GO:0030215; GO:0030335; GO:0031225; GO:0045499; GO:0045773; GO:0048675; GO:0048843; GO:0050727; GO:0050919; GO:0060907; GO:0070374; GO:0071526	HPEVAQRVEPMGPLK	6.679999828	0.180612177	0.180612177	0.179716672	1687.113017	0	0	16.80714	15.64219	0	14.74487	9.436291	0	13.71357	0	18.63106	12.55059	0	0	0	0	17.66087	17.75113	15.41227	0	0	16.69915	15.73884	13.5548	0	19.01638	18.39611	13.68729	14.97643	0	12.701	0	0	15.09401	0	0	15.03873	0	15.46617	13.55773	13.27132	0	0	14.6145	18.35264	16.5739	17.94471	0
O75330	HMMR_HUMAN	Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168)	HMMR IHABP RHAMM	Homo sapiens (Human)		cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819]	cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819]; hyaluronic acid binding [GO:0005540]	hyaluronic acid binding [GO:0005540]	GO:0005540; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0009986; GO:0015630; GO:0016020	SSESK	4.460000038	0.486471981	0.486471981	0.288027791	535.2746156	17.26205	11.08824	0	0	0	0	0	0	0	0	17.32529	0	0	18.65825	0	0	17.08944	0	0	16.8373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.80834	0	0	15.87142	0	0	17.66399	0	0	0
O75333	TBX10_HUMAN	"T-box transcription factor TBX10, T-box protein 10"	TBX10 TBX7	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0005634; GO:0006357; GO:0009653	VHFHPDSPAK	5.190000057	1	1	0.108438799	1134.30651	12.99266	16.47058	13.70968	0	12.54606	14.00999	0	0	0	0	0	13.66916	0	0	0	0	14.03884	12.63078	0	12.60105	0	11.07858	0	0	16.35819	0	0	13.86062	13.28804	0	0	0	0	16.07951	0	0	0	0	0	0	0	0	16.14956	0	16.6826	0	0	0
O75343	GCYB2_HUMAN	"Guanylate cyclase soluble subunit beta-2, GCS-beta-2, EC 4.6.1.2"	GUCY1B2	Homo sapiens (Human)	cGMP-mediated signaling [GO:0019934]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; cGMP-mediated signaling [GO:0019934]	GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]	GO:0004383; GO:0005525; GO:0005737; GO:0019934; GO:0020037; GO:0046872	HLAIEK	2.160000086	9.97E-06	9.97E-06	0.038669427	709.7738753	15.54548	15.53547	16.68589	15.91828	6.682693	16.61292	14.1951	0	15.75063	14.64093	0	14.83593	14.76052	14.95783	0	0	15.61256	0	13.96192	0	16.2773	17.37085	17.93363	14.61214	0	16.70299	14.97299	15.32104	0	14.97991	17.1716	17.36819	16.79343	8.598118	13.55168	14.46637	14.76119	0	16.50701	0	15.14445	15.15113	0	15.3795	15.01265	0	17.2294	13.13783
O75351	VPS4B_HUMAN	"Vacuolar protein sorting-associated protein 4B, EC 3.6.4.6 (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1, Protein SKD1)"	VPS4B SKD1 VPS42 MIG1	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]	ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]	ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]	GO:0000922; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006813; GO:0006914; GO:0006997; GO:0007080; GO:0008022; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0030301; GO:0030496; GO:0031468; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0046761; GO:0051261; GO:0060548; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1903542; GO:1903543; GO:1903724; GO:1904903; GO:1904949	AIDLASK	17.09000015	1.19E-11	1.19E-11	0.293789422	716.6757971	17.75505	17.9043	18.39015	0	0	17.71265	0	18.61774	0	19.23131	18.20793	0	0	17.82423	0	0	0	19.01174	17.62486	19.05074	19.00177	0	18.83012	18.98188	0	0	0	18.82788	15.69094	0	0	0	0	0	19.12037	19.93402	18.37141	19.75829	0	0	0	19.72812	18.82511	18.8516	0	0	19.22292	17.38911
O75352	MPU1_HUMAN	"Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog, SL15)"	MPDU1	Homo sapiens (Human)	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide biosynthetic process [GO:0009312]; protein folding [GO:0006457]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide biosynthetic process [GO:0009312]; protein folding [GO:0006457]		GO:0005789; GO:0006457; GO:0006488; GO:0009312; GO:0016020; GO:0016021	AAEADGPLK	11.5	0.37905848	0.37905848	0.132944264	870.9713396	18.04637	17.84671	0	0	16.02115	0	17.39552	18.39446	14.11185	16.37863	16.58914	18.68475	0	14.87719	0	0	14.07203	17.16545	16.67751	16.55919	15.83423	0	14.84597	17.58722	0	15.79224	0	13.21843	16.81923	17.12063	0	16.66137	18.07632	0	0	18.03657	0	0	0	18.72223	0	12.40819	0	0	0	17.30503	0	0
O75354	ENTP6_HUMAN	"Ectonucleoside triphosphate diphosphohydrolase 6, NTPDase 6, EC 3.6.1.6 (CD39 antigen-like 2)"	ENTPD6 CD39L2 IL6ST2	Homo sapiens (Human)	nucleoside diphosphate catabolic process [GO:0009134]; response to calcium ion [GO:0051592]; response to magnesium ion [GO:0032026]	cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cytidine-diphosphatase activity [GO:0036384]; guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [GO:0008894]; guanosine-diphosphatase activity [GO:0004382]; inosine-diphosphatase activity [GO:1990003]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; nucleoside diphosphate catabolic process [GO:0009134]; response to calcium ion [GO:0051592]; response to magnesium ion [GO:0032026]"	"cytidine-diphosphatase activity [GO:0036384]; guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [GO:0008894]; guanosine-diphosphatase activity [GO:0004382]; inosine-diphosphatase activity [GO:1990003]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]"	GO:0000139; GO:0004382; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0008894; GO:0009134; GO:0009986; GO:0016020; GO:0016021; GO:0017110; GO:0017111; GO:0032026; GO:0036384; GO:0045134; GO:0051592; GO:1990003	QKSPAS	2.5	0.554157853	0.554157853	0.19126795	616.3945329	15.76735	14.42173	0	14.66047	0	15.00282	16.71923	0	14.33891	0	0	0	0	15.41153	15.06238	16.01419	0	16.1535	16.71639	14.91217	16.30441	15.5734	16.1521	16.04187	15.06212	15.63777	0	0	15.24968	0	0	0	13.63109	0	0	0	0	0	17.18743	0	17.10624	16.3541	15.96103	0	0	15.1242	16.4355	16.52638
O75363	BCAS1_HUMAN	Breast carcinoma-amplified sequence 1 (Amplified and overexpressed in breast cancer) (Novel amplified in breast cancer 1)	BCAS1 AIBC1 NABC1	Homo sapiens (Human)	myelination [GO:0042552]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myelination [GO:0042552]		GO:0005737; GO:0042552; GO:0070062	QQSLGGFFKGLGPK	8.380000114	1	1	2.32E-13	1463.325735	16.66679	18.23072	17.37612	0	0	14.44595	0	0	0	0	0	0	0	0	0	0	0	16.72911	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75365	TP4A3_HUMAN	"Protein tyrosine phosphatase type IVA 3, EC 3.1.3.48 (PRL-R) (Protein-tyrosine phosphatase 4a3) (Protein-tyrosine phosphatase of regenerating liver 3, PRL-3)"	PTP4A3 PRL3	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; endothelial cell migration [GO:0043542]; Notch signaling pathway [GO:0007219]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular permeability [GO:0043117]; regulation of transcription, DNA-templated [GO:0006355]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]"	cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to leukemia inhibitory factor [GO:1990830]; endothelial cell migration [GO:0043542]; Notch signaling pathway [GO:0007219]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular permeability [GO:0043117]; regulation of transcription, DNA-templated [GO:0006355]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]"	prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0004725; GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006355; GO:0007219; GO:0008138; GO:0043117; GO:0043542; GO:1900746; GO:1901224; GO:1904951; GO:1990830	MARMNRPAPVEVSYK	8.109999657	0.787114501	0.787114501	0.278422411	1764.652792	0	0	0	0	0	0	0	13.33355	0	15.05591	0	18.93148	14.33845	14.85778	0	0	14.95083	15.15478	0	0	12.83497	0	0	0	0	0	13.53748	0	0	0	0	0	0	12.31644	13.61844	14.84728	0	0	0	0	0	0	0	0	0	0	0	0
O75366	AVIL_HUMAN	Advillin (p92)	AVIL	Homo sapiens (Human)	actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]"	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480	GKGATK	8.300000191	1	1	0.306213735	562.6098595	17.85979	18.08295	0	0	17.37632	17.30751	0	0	18.97585	0	0	0	0	0	16.32713	0	20.31699	0	0	15.4846	0	17.58709	0	0	0	0	17.8677	0	18.53827	0	18.342	18.63624	0	0	19.73487	17.99871	0	17.12615	18.80969	0	18.49708	0	17.39246	0	0	0	0	18.30716
O75367	H2AY_HUMAN	"Core histone macro-H2A.1, Histone macroH2A1, mH2A1 (Histone H2A.y, H2A/y) (Medulloblastoma antigen MU-MB-50.205)"	MACROH2A1 H2AFY	Homo sapiens (Human)	"dosage compensation [GO:0007549]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"	"Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]"	"Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; dosage compensation [GO:0007549]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]"	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]	GO:0000122; GO:0000182; GO:0000228; GO:0000781; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0000979; GO:0001739; GO:0001740; GO:0003677; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0031490; GO:0031492; GO:0033128; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0051572; GO:0061086; GO:0070062; GO:0071169; GO:0071901; GO:1901837; GO:1902750; GO:1902882; GO:1902883; GO:1902884; GO:1903226; GO:1904815; GO:1990841	AGGKK	4.269999981	1	1	0.146828975	459.3023887	16.76309	18.60271	17.8002	18.36526	15.25355	12.50831	21.24178	0	19.95315	17.27336	21.48941	19.70541	0	0	18.66714	0	20.59755	21.38423	17.61379	17.47882	0	20.68002	0	0	0	0	0	18.93024	20.54028	18.7936	0	0	0	17.415	22.06598	0	0	0	0	0	17.45963	19.59584	20.63992	0	0	17.55938	17.86378	19.06192
O75369	FLNB_HUMAN	"Filamin-B, FLN-B (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1, Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein, Truncated ABP)"	FLNB FLN1L FLN3 TABP TAP	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0001725; GO:0003334; GO:0003382; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0005938; GO:0007165; GO:0007519; GO:0015629; GO:0016021; GO:0030018; GO:0030036; GO:0042802; GO:0045296; GO:0045335; GO:0051015; GO:0070062; GO:0071346	AQGDASKVTAK	5.260000229	0.514814258	0.514814258	0.192109773	1075.740548	14.39399	0	16.27685	13.35949	0	0	15.62932	0	0	15.59563	15.12547	0	0	0	0	0	0	0	0	16.00621	0	14.97168	0	0	0	15.90036	13.90837	13.87183	14.94034	15.70104	14.67722	15.5615	15.82587	0	15.29273	15.07998	0	14.64088	15.41862	0	14.5336	14.90431	12.81486	13.31843	11.83178	16.71805	14.71528	13.62763
O75376	NCOR1_HUMAN	"Nuclear receptor corepressor 1, N-CoR, N-CoR1"	NCOR1 KIAA1047	Homo sapiens (Human)	"chromatin organization [GO:0006325]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]"	chromatin [GO:0000785]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin [GO:0000785]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; thyroid hormone receptor binding [GO:0046966]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]"	histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; thyroid hormone receptor binding [GO:0046966]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000785; GO:0000976; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006357; GO:0016020; GO:0016922; GO:0017053; GO:0042826; GO:0045475; GO:0045820; GO:0045892; GO:0045922; GO:0046329; GO:0046966; GO:0051225; GO:0060766; GO:0061629; GO:0072686; GO:1903799	GPPPKSR	6.320000172	1	1	0.130003625	737.7046725	0	0	0	17.65147	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.70146	0	0	0	0	17.60299	0	0	0	0	16.19559	15.69722	0	0	0	0	0	0	0	13.90129	0
O75380	NDUS6_HUMAN	"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A, CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)"	NDUFS6	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]"	electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009055; GO:0009060; GO:0042776	VYINLDK	1.350000024	1	1	0.073954309	863.1876439	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.77299	0	0
O75385	ULK1_HUMAN	"Serine/threonine-protein kinase ULK1, EC 2.7.11.1 (Autophagy-related protein 1 homolog, ATG1, hATG1) (Unc-51-like kinase 1)"	ULK1 KIAA0722	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; regulation of protein lipidation [GO:1903059]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]	Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]	Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; regulation of protein lipidation [GO:1903059]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]	GO:0000045; GO:0000407; GO:0000422; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005741; GO:0005776; GO:0005789; GO:0005829; GO:0006468; GO:0006914; GO:0007165; GO:0008104; GO:0008285; GO:0010508; GO:0016236; GO:0016241; GO:0018105; GO:0018107; GO:0030424; GO:0031102; GO:0031175; GO:0031267; GO:0031333; GO:0031669; GO:0034045; GO:0034727; GO:0042594; GO:0042802; GO:0044805; GO:0044877; GO:0046777; GO:0048671; GO:0048675; GO:0051020; GO:0055037; GO:0061709; GO:0097629; GO:0097632; GO:0097635; GO:0106310; GO:1903059; GO:1990316; GO:2000786	DSGGSK	2.00999999	0.103492633	0.103492633	0.172003993	551.273793	14.87982	14.70627	14.56308	14.68824	13.5393	14.60755	15.03268	0	14.55537	0	16.30686	15.18065	16.16422	15.93013	15.3543	0	14.93084	16.00341	16.60226	15.67166	16.36449	0	0	0	0	0	15.79562	16.27692	15.34039	15.70212	15.39088	15.56206	0	17.44921	17.09468	17.40355	16.52688	16.18668	16.77096	17.08823	15.59487	0	17.33416	16.04713	15.91464	16.18153	0	16.86228
O75387	LAT3_HUMAN	Large neutral amino acids transporter small subunit 3 (L-type amino acid transporter 3) (Prostate cancer overexpressed gene 1 protein) (Solute carrier family 43 member 1)	SLC43A1 LAT3 PB39 POV1	Homo sapiens (Human)	amino acid transport [GO:0006865]; negative regulation of amino acid transport [GO:0051956]; negative regulation of leucine import [GO:0060358]; neutral amino acid transport [GO:0015804]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transport [GO:0006865]; negative regulation of amino acid transport [GO:0051956]; negative regulation of leucine import [GO:0060358]; neutral amino acid transport [GO:0015804]	amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0051956; GO:0060358	LQQEYAANGMGPLK	11.02999973	1	1	0	1520.170176	15.44963	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75388	GPR32_HUMAN	Probable G-protein coupled receptor 32	GPR32	Homo sapiens (Human)	complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]	GO:0002430; GO:0004875; GO:0004930; GO:0004982; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007200; GO:0007204	MNGVSEGTRGCSDR	4.75	0.030539576	0.030539576	0.184982563	1526.3837	0	0	0	15.29945	0	13.88488	0	0	0	0	15.50367	14.5711	16.05297	0	0	0	0	0	0	15.95291	0	0	0	0	0	0	0	15.52239	0	0	15.88752	16.33999	0	15.52029	17.97088	16.02166	14.58004	14.62049	14.70092	0	0	15.91363	0	0	15.44857	12.56137	0	0
O75390	CISY_HUMAN	"Citrate synthase, mitochondrial, EC 2.3.3.1 (Citrate (Si)-synthase)"	CS	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; citrate (Si)-synthase activity [GO:0004108]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099]	citrate (Si)-synthase activity [GO:0004108]; RNA binding [GO:0003723]	GO:0003723; GO:0004108; GO:0005634; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0006101; GO:0070062	VVPGYGHAVLR	7.46999979	0.480170876	0.480170876	0.245628694	1172.07978	0	16.72938	14.85317	0	0	0	0	15.181	0	0	0	0	18.09694	14.4713	0	0	0	11.84083	0	0	15.62986	16.09549	0	15.39686	0	0	15.31211	16.52457	16.22173	0	16.46555	0	17.34597	17.13145	0	17.39472	0	0	16.94538	15.31252	15.38142	15.63512	0	15.20208	0	0	0	0
O75400	PR40A_HUMAN	"Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10, HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6)"	PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225	Homo sapiens (Human)	"cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	"membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005685; GO:0007010; GO:0007049; GO:0008360; GO:0016020; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0051301; GO:0071004	RPGTGAER	7.860000134	1	1	0.14616816	843.4644199	0	0	14.53374	14.98284	15.62495	14.35511	0	0	0	0	15.48816	0	16.6482	15.43225	13.71118	16.88931	0	15.52394	0	17.01187	0	0	0	0	0	0	0	0	0	0	16.44178	0	0	16.58492	0	0	0	0	0	16.49831	15.09889	0	18.32422	0	0	0	0	0
O75410	TACC1_HUMAN	Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1)	TACC1 KIAA1103	Homo sapiens (Human)	cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]	estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]	GO:0000226; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0007052; GO:0008283; GO:0016020; GO:0016922; GO:0021987; GO:0030331; GO:0030374; GO:0030496; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301	SRLITSGCK	10.65999985	1	1	0.063268624	1021.282745	16.54311	13.40642	14.09438	0	16.73628	0	14.01739	12.34395	12.36545	12.29031	0	0	0	0	22.04712	0	17.14736	0	0	0	0	0	0	0	0	22.15586	0	0	0	0	22.18514	11.01523	0	0	0	0	0	21.03091	16.43581	0	0	0	0	0	19.98399	0	0	0
O75417	DPOLQ_HUMAN	"DNA polymerase theta, EC 2.7.7.7 (DNA polymerase eta)"	POLQ POLH	Homo sapiens (Human)	base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]	chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116]	GO:0003682; GO:0003684; GO:0003887; GO:0005524; GO:0005654; GO:0005694; GO:0005794; GO:0005829; GO:0006261; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0017116; GO:0042802; GO:0051260; GO:0051575; GO:0097681; GO:2000042	DGFVQTILGRR	7.800000191	1	1	0.101695865	1260.734579	14.0876	15.28877	14.86125	0	13.13464	0	15.26332	0	0	13.15066	0	0	0	0	15.45279	14.4925	0	14.05106	16.48204	0	0	15.2247	15.31029	0	15.10505	16.38265	0	14.19998	15.43092	15.33961	0	0	0	0	0	0	0	0	0	0	0	0	17.62832	0	0	0	0	0
O75419	CDC45_HUMAN	Cell division control protein 45 homolog (PORC-PI-1)	CDC45 CDC45L CDC45L2 UNQ374/PRO710	Homo sapiens (Human)	DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication preinitiation complex assembly [GO:1902977]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication preinitiation complex assembly [GO:1902977]	chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]	GO:0000076; GO:0000727; GO:0003682; GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006268; GO:0006270; GO:0031261; GO:0036064; GO:0071162; GO:1902977	LVLYQHWSLHDSLCNTSYTAARFK	5.329999924	0.676102519	0.676102519	3.66E-12	2911.103222	0	0	14.3303	15.09947	12.07381	14.06847	13.20282	15.20946	0	0	13.93256	17.3258	13.05474	14.73994	0	14.29707	15.77294	0	0	0	0	0	15.93973	9.693634	0	0	0	0	0	0	0	14.82364	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75420	GGYF1_HUMAN	GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1)	GIGYF1 CDS2 PERQ1 PP3360	Homo sapiens (Human)	insulin-like growth factor receptor signaling pathway [GO:0048009]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; insulin-like growth factor receptor signaling pathway [GO:0048009]		GO:0005829; GO:0032991; GO:0048009	QFLERR	7.150000095	0.698474646	0.698474646	0.005915449	849.2999003	0	0	0	0	0	16.5198	0	0	15.02597	0	0	0	15.02628	14.72279	0	0	0	12.57279	14.15462	0	13.21487	0	13.74939	0	14.23271	0	12.35973	0	15.00267	14.59023	12.35954	0	15.49384	11.92177	11.56457	15.0105	0	16.18699	0	13.06863	0	0	12.27978	0	13.71058	0	0	14.11435
O75426	FBX24_HUMAN	F-box only protein 24	FBXO24 FBX24	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	ubiquitin ligase complex [GO:0000151]	ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]	ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0004842; GO:0016567	ACRYVVLCR	13.43000031	1	1	1.83E-12	1195.779661	0	0	0	0	0	11.02479	15.14078	16.72454	16.43444	0	0	0	0	0	0	0	0	0	0	17.15001	0	0	0	0	14.41481	0	0	0	0	14.33273	15.48144	0	0	0	0	0	13.5399	17.08127	0	0	0	0	16.61886	0	0	0	15.81153	16.73865
O75437	ZN254_HUMAN	"Zinc finger protein 254 (Bone marrow zinc finger 5, BMZF-5) (Hematopoietic cell-derived zinc finger protein 1, HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)"	ZNF254 BMZF5 ZNF539 ZNF91L	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	HTEKK	1.070000052	1	1	0.212530223	642.6226171	0	0	15.93393	16.71593	0	0	14.57754	0	0	17.48495	15.42025	15.67649	0	0	0	0	0	0	0	0	0	16.61702	0	16.32371	0	13.51831	13.60596	0	16.73313	0	0	16.56711	15.93788	16.17994	15.85656	0	0	0	16.46491	0	0	0	0	0	16.17985	0	0	15.19
O75439	MPPB_HUMAN	"Mitochondrial-processing peptidase subunit beta, EC 3.4.24.64 (Beta-MPP) (P-52)"	PMPCB MPPB	Homo sapiens (Human)	mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005739; GO:0005743; GO:0006627; GO:0006851; GO:0017087; GO:0046872	TNMLLQLDGSTPICEDIGR	7.25	1	1	0.206147073	2148.417163	14.53383	12.61091	12.98562	0	0	0	0	0	0	0	0	12.77242	13.53239	0	0	0	0	0	7.786512	16.07463	0	0	0	0	0	0	0	0	0	14.94188	0	15.92297	0	14.90113	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75443	TECTA_HUMAN	Alpha-tectorin	TECTA	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]	anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005576; GO:0005886; GO:0007160; GO:0007605; GO:0031225; GO:0062023; GO:0070062	GCFSTK	11.22000027	0.36517325	0.36517325	0.225218671	700.0826168	16.34825	0	14.70474	9.149221	13.93659	14.76069	0	15.74989	15.80034	18.09201	16.43791	14.06832	17.88085	0	0	14.74352	14.45936	16.59694	18.65242	0	0	17.4683	0	14.98205	0	0	0	14.50394	14.93788	13.77059	0	0	15.0633	17.44849	0	0	0	17.15525	17.14553	0	16.98092	0	0	16.74196	14.81991	0	0	0
O75445	USH2A_HUMAN	Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein)	USH2A	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]	apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]	collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]	GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0016477; GO:0017022; GO:0032391; GO:0032421; GO:0034446; GO:0035315; GO:0036064; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0060113; GO:0060171; GO:1990075; GO:1990696	GLQCDTCR	6.820000172	1	1	0.246691803	1009.39901	0	15.53631	13.87747	0	13.31125	0	13.14737	0	14.82795	0	0	0	14.661	0	14.88821	0	0	0	16.60585	15.95521	0	0	0	0	0	0	0	0	0	0	0	17.08553	0	0	0	0	0	0	0	16.57508	0	14.95878	0	0	0	0	0	0
O75448	MED24_HUMAN	"Mediator of RNA polymerase II transcription subunit 24 (Activator-recruited cofactor 100 kDa component, ARC100) (Cofactor required for Sp1 transcriptional activation subunit 4, CRSP complex subunit 4) (Mediator complex subunit 24) (Thyroid hormone receptor-associated protein 4) (Thyroid hormone receptor-associated protein complex 100 kDa component, Trap100, hTRAP100) (Vitamin D3 receptor-interacting protein complex 100 kDa component, DRIP100)"	MED24 ARC100 CRSP4 DRIP100 KIAA0130 THRAP4 TRAP100	Homo sapiens (Human)	"positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; histone acetyltransferase activity [GO:0004402]; nuclear receptor coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]"	histone acetyltransferase activity [GO:0004402]; nuclear receptor coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]	GO:0000151; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0016592; GO:0030374; GO:0032968; GO:0042809; GO:0044877; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0061630; GO:0070847	QGLLSEASVNNLMAK	3.119999886	1	1	0.479857671	1590.315174	16.00226	16.10704	0	0	0	0	17.20899	0	0	0	0	0	16.65213	0	0	0	0	0	0	0	17.54943	0	0	0	0	0	17.0931	0	0	0	0	0	0	0	0	18.64107	0	0	18.6613	0	0	0	0	0	0	18.21128	0	0
O75449	KTNA1_HUMAN	"Katanin p60 ATPase-containing subunit A1, Katanin p60 subunit A1, EC 5.6.1.1 (p60 katanin)"	KATNA1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule severing [GO:0051013]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein heterodimerization activity [GO:0046982]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule severing [GO:0051013]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein heterodimerization activity [GO:0046982]	GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008568; GO:0015630; GO:0016853; GO:0016887; GO:0030496; GO:0046982; GO:0051013; GO:0051301; GO:0097431	TLESFKLDSTPLK	5.03000021	1	1	0.16671685	1478.307434	0	0	14.07313	0	0	10.07143	0	14.16807	0	0	0	0	0	14.88417	0	0	16.22315	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53459	0	0	0	0	0	0	0
O75452	RDH16_HUMAN	"Retinol dehydrogenase 16, EC 1.1.1.105, EC 1.1.1.209, EC 1.1.1.315, EC 1.1.1.53 (Human epidermal retinol dehydrogenase, hRDH-E) (Microsomal NAD(+)-dependent retinol dehydrogenase 4, RoDH-4) (Short chain dehydrogenase/reductase family 9C member 8) (Sterol/retinol dehydrogenase)"	RDH16 RODH4 SDR9C8	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; NAD-retinol dehydrogenase activity [GO:0004745]; lipid metabolic process [GO:0006629]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]"	"androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; NAD-retinol dehydrogenase activity [GO:0004745]"	GO:0004745; GO:0005789; GO:0006629; GO:0008202; GO:0009055; GO:0016021; GO:0042572; GO:0042802; GO:0043231; GO:0047023; GO:0047044	WLYLAVFVGLYYLLHWYR	13.57999992	1	1	0.362965279	2375.557278	0	0	0	0	0	16.91482	0	17.73854	0	0	0	0	0	0	0	0	0	0	17.60208	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.12083	0	0	0	0	0	0	0	17.46638	0	0	0
O75461	E2F6_HUMAN	"Transcription factor E2F6, E2F-6"	E2F6	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000083; GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0046983; GO:0071339; GO:0090575	KFMDLVR	12.09000015	0.745206118	0.745206118	0.276347708	909.796276	0	14.73585	15.44139	18.48604	13.49326	13.77041	14.45384	15.41718	11.49818	16.57388	16.19751	13.70359	14.17416	0	15.42208	14.24288	0	13.9608	16.36875	0	0	0	17.13084	14.84282	17.20004	17.121	0	0	0	0	0	0	0	14.93777	16.3223	15.88894	0	0	16.75885	0	0	17.10342	14.58368	0	0	0	15.33729	0
O75467	Z324A_HUMAN	Zinc finger protein 324A (Zinc finger protein ZF5128)	ZNF324 ZNF324A	Homo sapiens (Human)	cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000082; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008283; GO:0046872	QKPCAQEVPGR	8.079999924	0.928655326	0.928655326	0.375628816	1269.504239	16.97092	15.39416	14.3758	0	0	0	14.42447	0	0	0	0	15.71949	0	0	14.80738	16.89919	0	15.55407	0	0	0	0	0	0	15.64506	0	0	16.1046	0	0	16.42473	15.10797	16.53348	16.49096	15.95477	15.64386	16.78459	16.2033	14.83642	16.15775	14.25127	16.19389	16.05941	17.05794	0	14.76615	16.80913	15.7487
O75494	SRS10_HUMAN	"Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein, SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats, TASR, TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein, TLS-associated SR protein)"	SRSF10 FUSIP1 FUSIP2 SFRS13A TASR	Homo sapiens (Human)	"cytosolic transport [GO:0016482]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; cytosolic transport [GO:0016482]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006376; GO:0016482; GO:0016607; GO:0030425; GO:0043025; GO:0043679; GO:0048024; GO:0048025; GO:0050733; GO:0051082	TPNQMKAK	9.31000042	0.926737785	0.926737785	0.252169309	933.8481022	14.27501	15.18327	15.90442	15.29817	14.50339	14.75615	0	14.24477	14.9974	14.36849	15.35946	0	0	0	0	13.69583	14.94008	14.90089	0	0	14.53834	15.41364	14.3927	15.88016	0	15.989	0	14.23694	0	15.22467	15.67793	15.31714	15.22888	13.23606	0	0	0	0	14.95776	0	0	15.31797	11.00619	13.72161	0	17.79541	0	0
O75496	GEMI_HUMAN	Geminin	GMNN	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle [GO:0007346]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle [GO:0007346]"	chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]	GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006275; GO:0007346; GO:0008156; GO:0009887; GO:0017053; GO:0030174; GO:0035563; GO:0042826; GO:0045786; GO:0045892; GO:0071163; GO:0140297; GO:2000104	NPSMKQK	7.710000038	0.99320209	0.99320209	0.13917565	849.918045	0	15.44195	0	0	0	0	0	0	14.64108	0	0	0	0	0	0	0	0	0	0	15.78068	0	0	0	0	0	17.3329	15.09157	0	0	0	0	0	0	0	0	14.48273	15.21277	0	0	0	0	15.05776	0	16.19703	0	0	0	0
O75508	CLD11_HUMAN	Claudin-11 (Oligodendrocyte-specific protein)	CLDN11 OSP OTM	Homo sapiens (Human)	axon ensheathment [GO:0008366]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; spermatogenesis [GO:0007283]; tight junction assembly [GO:0120192]	axon [GO:0030424]; basal part of cell [GO:0045178]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; tight junction [GO:0070160]	axon [GO:0030424]; basal part of cell [GO:0045178]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; axon ensheathment [GO:0008366]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; spermatogenesis [GO:0007283]; tight junction assembly [GO:0120192]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005811; GO:0005883; GO:0005886; GO:0005923; GO:0007155; GO:0007283; GO:0008366; GO:0016021; GO:0016338; GO:0030054; GO:0030424; GO:0042802; GO:0045178; GO:0070160; GO:0070830; GO:0120192	MGQEPGVAKYR	7.329999924	1	1	0.366408861	1251.68837	0	14.78537	0	0	16.43753	0	0	0	0	0	0	0	0	0	0	0	14.29355	15.94072	0	0	10.56211	0	0	14.67482	0	0	0	0	0	0	0	0	0	16.56233	16.24792	0	0	0	0	0	0	0	0	0	15.24443	0	0	0
O75509	TNR21_HUMAN	Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358)	TNFRSF21 DR6 UNQ437/PRO868	Homo sapiens (Human)	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852]	axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852]		GO:0001783; GO:0002250; GO:0005737; GO:0005886; GO:0005887; GO:0006915; GO:0006959; GO:0007413; GO:0030424; GO:0030889; GO:0031226; GO:0031642; GO:0032693; GO:0032696; GO:0032714; GO:0042130; GO:0042552; GO:0048713; GO:0050852; GO:0051402; GO:0071356; GO:0097252	CDSTSSGSSALSR	5.03000021	1	1	0.316306984	1312.434913	0	13.47436	15.10336	0	0	13.51091	0	14.07359	16.27087	14.63152	0	0	0	15.14545	0	14.11201	15.36964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.90777	0	0	0	15.06637	14.15029	0	0	0	0	0	0
O75521	ECI2_HUMAN	"Enoyl-CoA delta isomerase 2, EC 5.3.3.8 (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase, D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1, DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase, pECI) (Renal carcinoma antigen NY-REN-1)"	ECI2 DRS1 HCA88 PECI	Homo sapiens (Human)	fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]	dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]	GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006631; GO:0006635; GO:0009062; GO:0016020; GO:0043231	ATEMLIFGK	7.699999809	0.681174219	0.681174219	0.20743462	1025.617326	15.90824	13.4706	0	0	14.80377	14.39326	0	0	17.02296	15.94495	0	0	0	0	0	13.21812	14.10523	14.90318	14.79267	13.23217	14.61437	16.618	13.99345	14.74667	0	16.45966	13.11436	14.58898	15.41686	0	17.42022	15.73366	15.52082	0	14.93167	0	0	0	0	0	15.75321	0	0	15.65748	0	0	0	0
O75525	KHDR3_HUMAN	"KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein T-Star) (Sam68-like mammalian protein 2, SLM-2) (Sam68-like phosphotyrosine protein)"	KHDRBS3 SALP SLM2	Homo sapiens (Human)	"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0017124; GO:0019904; GO:0032991; GO:0042802; GO:0048024	GKPTLR	12.34000015	1	1	0.315127206	671.6368852	0	0	0	0	0	0	0	18.58446	0	0	19.61599	17.97479	0	19.10561	0	0	17.25756	0	0	0	17.77906	19.38694	18.63206	19.02359	0	18.18839	0	17.13811	17.1088	18.75162	18.85109	0	20.70568	18.92662	0	20.59938	0	20.18014	17.90081	0	18.5508	17.68964	0	16.85017	18.23356	0	0	0
O75526	RMXL2_HUMAN	"RNA-binding motif protein, X-linked-like-2 (Testis-specific heterogeneous nuclear ribonucleoprotein G-T, hnRNP G-T)"	RBMXL2 HNRNPGT	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	U12-type spliceosomal complex [GO:0005689]	"U12-type spliceosomal complex [GO:0005689]; mRNA binding [GO:0003729]; snRNA binding [GO:0017069]; mRNA splicing, via spliceosome [GO:0000398]"	mRNA binding [GO:0003729]; snRNA binding [GO:0017069]	GO:0000398; GO:0003729; GO:0005689; GO:0017069	DRDYGDHLSR	5.920000076	1	1	0.284092952	1232.645619	15.61012	0	0	15.80026	17.04103	17.5755	0	15.76133	0	0	13.72139	0	0	0	13.48055	0	0	0	0	15.81442	15.90147	0	0	0	0	14.92466	16.40587	15.70056	16.85978	0	15.62126	16.53781	0	0	0	0	0	16.32813	0	0	16.63944	15.72679	0	13.71815	0	0	12.61062	0
O75528	TADA3_HUMAN	"Transcriptional adapter 3 (ADA3 homolog, hADA3) (STAF54) (Transcriptional adapter 3-like, ADA3-like protein)"	TADA3 ADA3 TADA3L	Homo sapiens (Human)	"histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; intracellular estrogen receptor signaling pathway [GO:0030520]; mitotic cell cycle [GO:0000278]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]"	ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]	"ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; intracellular estrogen receptor signaling pathway [GO:0030520]; mitotic cell cycle [GO:0000278]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]"	nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]	GO:0000124; GO:0000278; GO:0001932; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006355; GO:0006357; GO:0010628; GO:0016573; GO:0016922; GO:0019904; GO:0030374; GO:0030520; GO:0031063; GO:0031647; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0044154; GO:0045893; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0090043; GO:0140672	EKDQAWK	2.420000076	1	1	0.305666466	904.6900684	0	0	0	0	0	0	0	0	0	0	0	0	0	16.95349	17.28325	17.91667	0	0	0	0	0	0	18.64071	0	0	16.95067	0	0	17.18405	0	18.49435	19.10471	0	0	0	0	0	0	0	0	0	0	0	0	15.72825	0	0	0
O75530	EED_HUMAN	"Polycomb protein EED, hEED (Embryonic ectoderm development protein) (WD protein associating with integrin cytoplasmic tails 1, WAIT-1)"	EED	Homo sapiens (Human)	"chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; spinal cord development [GO:0021510]"	chromosome [GO:0005694]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; transcription corepressor binding [GO:0001222]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; spinal cord development [GO:0021510]"	chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; transcription corepressor binding [GO:0001222]	GO:0000122; GO:0001222; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0008047; GO:0021510; GO:0035098; GO:0042054; GO:0042802; GO:0045892	MSEREVSTAPAGTDMPAAK	5.590000153	1	1	0.550474017	1947.859749	0	0	0	0	0	0	0	0	0	0	0	0	0	18.83837	0	0	0	0	0	17.33391	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.45687	0	0	0	0	18.34487	18.05375	0	0	0	0	0
O75531	BAF_HUMAN	"Barrier-to-autointegration factor (Breakpoint cluster region protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed ]"	BANF1 BAF BCRG1	Homo sapiens (Human)	chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LEM domain binding [GO:0097726]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LEM domain binding [GO:0097726]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]	GO:0000793; GO:0003677; GO:0003690; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0007059; GO:0007084; GO:0008022; GO:0009615; GO:0015074; GO:0019899; GO:0030261; GO:0032480; GO:0042802; GO:0042803; GO:0045071; GO:0045824; GO:0047485; GO:0097726	KDEDLFR	6.809999943	1	1	0.11047095	923.1432667	15.73495	0	0	0	15.79132	12.17981	15.23194	15.78109	0	0	0	0	0	0	0	0	0	0	0	0	16.17626	0	0	0	0	0	0	0	15.21767	15.83277	0	0	0	0	0	0	0	18.11824	0	0	0	0	0	0	0	0	0	15.87669
O75533	SF3B1_HUMAN	"Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit, SF3b155) (Spliceosome-associated protein 155, SAP 155)"	SF3B1 SAP155	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	B-WICH complex [GO:0110016]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	"B-WICH complex [GO:0110016]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0005730; GO:0006338; GO:0008380; GO:0016607; GO:0034693; GO:0035066; GO:0045943; GO:0045944; GO:0045945; GO:0071004; GO:0071005; GO:0071013; GO:0110016; GO:1990935	GDTPGHATPGHGGATSSARK	6.059999943	0.821314454	0.821314454	0.334616197	1861.150616	16.31715	17.76494	14.12879	0	17.23547	15.94943	0	0	13.70013	0	0	0	0	12.87885	0	0	0	0	0	0	0	16.29265	0	0	0	12.11266	0	15.38319	0	14.60747	14.2158	0	0	0	15.07831	0	0	0	0	15.41591	0	0	0	15.18456	0	16.82667	15.38848	0
O75534	CSDE1_HUMAN	Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR)	CSDE1 D1S155E KIAA0885 NRU UNR	Homo sapiens (Human)	"CRD-mediated mRNA stabilization [GO:0070934]; IRES-dependent viral translational initiation [GO:0075522]; male gonad development [GO:0008584]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; stress granule assembly [GO:0034063]"	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mCRD-mediated mRNA stability complex [GO:0106002]; P-body [GO:0000932]; plasma membrane [GO:0005886]	"CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mCRD-mediated mRNA stability complex [GO:0106002]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; CRD-mediated mRNA stabilization [GO:0070934]; IRES-dependent viral translational initiation [GO:0075522]; male gonad development [GO:0008584]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; stress granule assembly [GO:0034063]"	RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]	GO:0000932; GO:0003723; GO:0005794; GO:0005829; GO:0005886; GO:0006446; GO:0008584; GO:0010494; GO:0034063; GO:0035613; GO:0070934; GO:0070937; GO:0070966; GO:0075522; GO:0106002; GO:1900152; GO:2000767	CVDRDVR	5.25	1	1	0.228546639	918.3918586	0	13.44939	15.75667	0	0	0	0	0	0	16.49751	0	0	0	0	15.2904	0	0	0	0	0	15.14441	0	15.32858	16.35924	14.93233	15.18622	15.81439	0	0	0	0	0	15.41529	16.44811	16.19788	0	0	0	0	15.90151	0	0	14.50343	16.01364	16.27225	0	0	0
O75541	ZN821_HUMAN	Zinc finger protein 821	ZNF821	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872; GO:1990837	LEKMDMMLR	10.73999977	1	1	0.237496005	1181.772101	15.98271	16.47376	0	15.35426	16.79697	0	0	0	15.84571	16.09854	0	15.50493	0	0	0	0	0	0	0	0	16.29895	0	16.48894	14.55411	0	0	0	0	16.90736	0	0	0	0	0	17.59261	0	16.84724	0	17.8201	0	0	18.26807	0	0	0	0	17.42422	0
O75554	WBP4_HUMAN	"WW domain-binding protein 4, WBP-4 (Formin-binding protein 21) (WW domain-containing-binding protein 4)"	WBP4 FBP21 FNBP21	Homo sapiens (Human)	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008270; GO:0008380; GO:0016607; GO:0045292; GO:0070064; GO:0071005; GO:0071011	NHKENVAK	8.210000038	0.72847873	0.72847873	0.291617695	938.9946948	15.45652	12.71911	13.85601	14.66137	12.69834	15.00513	0	0	14.578	13.58411	15.10269	7.114909	15.00062	13.6591	15.20099	0	0	16.04408	0	0	0	0	13.67481	16.26094	0	0	15.48708	15.00933	16.25728	15.5662	0	15.73607	0	14.77186	0	15.7637	15.48	0	0	0	15.93995	0	15.41727	0	14.98811	16.25135	0	14.88547
O75558	STX11_HUMAN	Syntaxin-11	STX11	Homo sapiens (Human)	exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000149; GO:0005484; GO:0005794; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0031201; GO:0031629; GO:0048278; GO:0048787; GO:0061025	FLTSMR	1.690000057	1	1	0.256316216	770.6762635	16.06959	17.62424	18.5064	0	0	0	17.03046	0	18.37582	16.79024	0	17.53717	0	0	0	19.22966	17.95499	16.79898	18.26621	0	15.31761	17.22375	0	19.30334	0	0	0	0	16.37977	0	0	18.2361	0	0	19.21598	0	18.39488	0	18.19987	16.64614	0	16.88547	17.65257	17.28824	0	0	16.19687	16.15459
O75564	JERKY_HUMAN	Jerky protein homolog	JRK JH8	Homo sapiens (Human)	positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904	CLPNPTPEGGAVPGPKQGK	5.139999866	1	1	2.36E-13	1905.067533	0	0	17.17699	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75569	PRKRA_HUMAN	"Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double-stranded RNA-dependent activator)"	PRKRA PACT RAX HSD-14 HSD14	Homo sapiens (Human)	cellular response to oxidative stress [GO:0034599]; immune response [GO:0006955]; middle ear morphogenesis [GO:0042474]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; negative regulation of cell population proliferation [GO:0008285]; outer ear morphogenesis [GO:0042473]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; RISC-loading complex [GO:0070578]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cellular response to oxidative stress [GO:0034599]; immune response [GO:0006955]; middle ear morphogenesis [GO:0042474]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; negative regulation of cell population proliferation [GO:0008285]; outer ear morphogenesis [GO:0042473]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]	double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0003723; GO:0003725; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0008047; GO:0008285; GO:0009615; GO:0016020; GO:0019899; GO:0030422; GO:0031054; GO:0034599; GO:0035196; GO:0035280; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0048471; GO:0048705; GO:0050821; GO:0070578; GO:0070883; GO:2001244	HRAAEAAINILK	12.81999969	4.34E-05	4.34E-05	0.111909196	1305.638633	21.57261	22.39692	20.50685	20.41325	19.96983	18.74008	20.62127	20.43565	21.24311	19.99679	20.4008	19.56234	20.43231	19.55067	19.69092	20.88196	20.49037	20.95728	20.78269	18.3802	17.3743	19.57936	21.79018	20.55344	21.11425	21.828	21.28923	20.66485	20.34644	19.87838	21.18554	21.2976	20.1753	19.78634	21.3209	0	21.92491	21.23256	21.5506	20.54881	20.4982	21.81103	20.02497	20.55005	21.10285	19.18888	19.74501	20.7354
O75581	LRP6_HUMAN	"Low-density lipoprotein receptor-related protein 6, LRP-6"	LRP6	Homo sapiens (Human)	"canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]	"cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"	coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909	AAMDGSER	4.110000134	1	1	0.233462545	837.3655639	16.5918	16.63914	0	16.6211	11.11186	14.05683	15.75117	15.07346	15.68786	15.56567	13.22404	14.88968	15.12693	16.23833	0	14.62295	14.30649	0	15.89334	0	14.90409	0	0	0	14.60838	0	16.23082	0	15.64293	15.51236	0	16.61641	0	0	0	17.11769	15.40703	16.09752	17.61878	0	0	0	15.53818	14.44822	0	0	0	0
O75592	MYCB2_HUMAN	"E3 ubiquitin-protein ligase MYCBP2, EC 2.3.2.33 (Myc-binding protein 2) (Protein associated with Myc)"	MYCBP2 KIAA0916 PAM	Homo sapiens (Human)	branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	axon [GO:0030424]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	axon [GO:0030424]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667	FTKTSQGR	11.14999962	1	1	0.082271221	925.3392538	14.95734	14.6864	15.17385	10.43821	10.74062	11.17559	11.6709	15.51217	15.54761	15.16265	14.06298	14.39936	13.55877	15.44134	11.40126	16.07269	15.11491	0	13.90458	15.0123	0	14.36053	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.43023	0	0	0	0
O75593	FOXH1_HUMAN	"Forkhead box protein H1 (Forkhead activin signal transducer 1, Fast-1, hFAST-1) (Forkhead activin signal transducer 2, Fast-2)"	FOXH1 FAST1 FAST2	Homo sapiens (Human)	"aorta morphogenesis [GO:0035909]; axial mesoderm development [GO:0048318]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to cytokine stimulus [GO:0071345]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; heart looping [GO:0001947]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; secondary heart field specification [GO:0003139]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein domain specific binding [GO:0019904]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; aorta morphogenesis [GO:0035909]; axial mesoderm development [GO:0048318]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to cytokine stimulus [GO:0071345]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; heart looping [GO:0001947]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; secondary heart field specification [GO:0003139]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	"androgen receptor binding [GO:0050681]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein domain specific binding [GO:0019904]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001228; GO:0001947; GO:0003139; GO:0003151; GO:0003215; GO:0003222; GO:0003700; GO:0005634; GO:0005667; GO:0007179; GO:0019904; GO:0032444; GO:0033147; GO:0035054; GO:0035909; GO:0043425; GO:0043433; GO:0043565; GO:0045893; GO:0045944; GO:0046332; GO:0048318; GO:0050681; GO:0060766; GO:0070410; GO:0070412; GO:0071345; GO:0140297; GO:1900164	GPCSGSR	6.550000191	0.923681259	0.923681259	0	718.4204413	14.4974	10.56202	0	12.38397	0	0	0	15.24415	0	0	0	0	0	0	0	13.44179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.64089	0	13.86634	0	0	0	0	15.46025	0	0	0	0	0	0	0	0	0
O75603	GCM2_HUMAN	"Chorion-specific transcription factor GCMb, hGCMb (GCM motif protein 2) (Glial cells missing homolog 2)"	GCM2 GCMB	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]; cellular phosphate ion homeostasis [GO:0030643]; gliogenesis [GO:0042063]; parathyroid gland development [GO:0060017]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular calcium ion homeostasis [GO:0006874]; cellular phosphate ion homeostasis [GO:0030643]; gliogenesis [GO:0042063]; parathyroid gland development [GO:0060017]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0006366; GO:0006874; GO:0030643; GO:0042063; GO:0043565; GO:0046872; GO:0060017; GO:1990837	AQRHLSGWAMR	2.710000038	1	1	0.60881388	1328.437553	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.86186	0	0	0	0	0	0	0	0	0	0	0	19.04489	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.93695	17.96767	0	0	0	0	0
O75604	UBP2_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 2, EC 3.4.19.12 (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)"	USP2 UBP41	Homo sapiens (Human)	cell cycle [GO:0007049]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; cell cycle [GO:0007049]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ubiquitin-dependent protein catabolic process [GO:0006511]	cyclin binding [GO:0030332]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005813; GO:0006511; GO:0007049; GO:0007517; GO:0016020; GO:0016579; GO:0030332; GO:0031625; GO:0032922; GO:0042802; GO:0043153; GO:0045475; GO:0045931; GO:0046872; GO:0048471; GO:0048512; GO:0050821; GO:1901796	SSSPGRDGMNSK	6.849999905	1	1	0.349597763	1240.128143	14.37969	15.36116	13.23326	15.50564	14.21457	14.16168	0	13.28185	12.69039	14.12646	14.77469	13.29886	14.39796	15.70423	0	0	16.45775	17.149	15.42367	15.44057	0	15.8803	16.66991	0	0	16.96487	0	0	0	15.53071	0	15.36969	0	0	0	0	0	0	0	0	16.97467	0	0	0	0	0	0	17.96788
O75608	LYPA1_HUMAN	"Acyl-protein thioesterase 1, APT-1, hAPT1, EC 3.1.2.- (Lysophospholipase 1) (Lysophospholipase I, LPL-I, LysoPLA I) (Palmitoyl-protein hydrolase, EC 3.1.2.22)"	LYPLA1 APT1 LPL1	Homo sapiens (Human)	fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084]	carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006631; GO:0008474; GO:0016298; GO:0031965; GO:0042997; GO:0052689; GO:0070062	SSHIK	2.019999981	0.394021332	0.394021332	0.180688486	571.8169612	0	14.6592	0	16.70234	15.66314	16.71317	0	16.0299	14.47002	15.03596	0	16.36699	0	18.15634	13.12317	14.27311	13.63028	0	15.53154	0	0	16.16183	15.3898	13.49242	17.53462	18.96453	15.42237	16.36109	15.99341	17.90047	14.33972	0	14.84972	18.14945	0	15.31616	15.48786	15.60309	0	16.32123	14.66331	16.9535	14.83042	0	0	16.29559	14.41772	17.66311
O75610	LFTY1_HUMAN	Left-right determination factor 1 (Left-right determination factor B) (Protein lefty-1) (Protein lefty-B)	LEFTY1 LEFTB LEFTYB UNQ278/PRO317	Homo sapiens (Human)	BMP signaling pathway [GO:0030509]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; BMP signaling pathway [GO:0030509]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]	GO:0000122; GO:0003007; GO:0005125; GO:0005160; GO:0005615; GO:0007179; GO:0007368; GO:0008083; GO:0010862; GO:0030509; GO:0060395	VRDDGSNR	15.77000046	1	1	0.42507944	917.3739664	0	16.71739	17.66615	0	0	16.62914	15.21251	0	0	0	17.15524	16.57744	0	17.0115	16.86458	16.69992	17.91907	16.90035	17.61591	0	0	17.16751	0	16.67349	17.27842	16.31673	17.23227	17.14225	0	16.42667	15.33607	17.64827	16.71638	17.51076	15.10627	0	14.67147	17.02987	17.56966	0	0	16.8924	0	0	16.08344	0	0	17.31539
O75618	DEDD_HUMAN	Death effector domain-containing protein (DEDPro1) (Death effector domain-containing testicular molecule) (FLDED-1)	DEDD DEDPRO1 DEFT KE05	Homo sapiens (Human)	decidualization [GO:0046697]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; decidualization [GO:0046697]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]	DNA binding [GO:0003677]	GO:0003677; GO:0005730; GO:0005737; GO:0007283; GO:0008625; GO:0042177; GO:0042981; GO:0046697; GO:1901837	NLMLQALP	5.619999886	1	1	0.26215615	914.8350222	16.9915	16.77886	0	17.95818	0	18.00696	19.5794	17.30096	18.29295	0	0	0	0	0	0	0	0	0	0	16.24189	0	0	0	16.37873	0	0	0	0	17.90136	0	0	0	18.37057	18.2306	0	18.77799	0	0	0	0	18.07142	0	18.18363	0	16.31626	0	17.84276	0
O75626	PRDM1_HUMAN	"PR domain zinc finger protein 1, EC 2.1.1.- (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1, PRDI-BF1, PRDI-binding factor 1)"	PRDM1 BLIMP1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0001227; GO:0001763; GO:0001822; GO:0001893; GO:0002250; GO:0003170; GO:0003281; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0009791; GO:0010468; GO:0010628; GO:0010629; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0045087; GO:0045165; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990837; GO:1990841	EETGLK	10.51000023	0.299693197	0.299693197	0.228264102	673.5616914	15.20462	0	0	15.69793	16.56689	0	15.36899	14.31648	0	0	16.80177	0	0	15.51814	14.88446	0	16.2406	16.45588	17.28892	16.28436	0	14.00153	16.02143	0	15.57722	14.88404	0	0	16.28769	16.06689	15.05896	16.57239	14.55741	17.14062	17.2195	0	17.44781	17.09808	0	15.96813	17.56398	16.80159	0	15.88639	17.069	17.0459	16.29829	0
O75638	CTAG2_HUMAN	"Cancer/testis antigen 2, CT2 (Autoimmunogenic cancer/testis antigen NY-ESO-2) (Cancer/testis antigen 6.2, CT6.2) (L antigen family member 1, LAGE-1)"	CTAG2 ESO2 LAGE1	Homo sapiens (Human)	tRNA threonylcarbamoyladenosine metabolic process [GO:0070525]	centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525]		GO:0005654; GO:0005813; GO:0016604; GO:0043231; GO:0070525	ASGPRGGAPR	5.489999771	0.932878911	0.932878911	4.60E-13	925.8129763	0	14.17548	14.75333	0	0	11.28788	13.69216	0	0	0	0	0	15.08019	0	0	15.51112	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.32135	0	0	0	0	0	0	15.32323	0	0	0	0	0	12.9489	0	0	0
O75643	U520_HUMAN	"U5 small nuclear ribonucleoprotein 200 kDa helicase, EC 3.6.4.13 (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein, U5-200KD)"	SNRNP200 ASCC3L1 HELIC2 KIAA0788	Homo sapiens (Human)	"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013	DMCLEK	4.800000191	1	1	0.222655514	795.8563301	11.64693	16.29322	0	15.96673	13.65875	15.41958	14.97294	0	14.1166	14.02966	13.91011	0	0	0	14.99591	0	0	0	0	0	0	0	16.80932	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75648	MTU1_HUMAN	"Mitochondrial tRNA-specific 2-thiouridylase 1, EC 2.8.1.14 (MTO2 homolog)"	TRMU MTU1 TRMT1	Homo sapiens (Human)	tRNA wobble position uridine thiolation [GO:0002143]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tRNA-5-taurinomethyluridine 2-sulfurtransferase [GO:0061708]; tRNA wobble position uridine thiolation [GO:0002143]	ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tRNA-5-taurinomethyluridine 2-sulfurtransferase [GO:0061708]	GO:0000049; GO:0002143; GO:0005524; GO:0005739; GO:0061708	NRFEVR	7.130000114	1	1	0.161778692	820.7500761	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75663	TIPRL_HUMAN	"TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein, TIP)"	TIPRL	Homo sapiens (Human)	DNA damage checkpoint signaling [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; TOR signaling [GO:0031929]	cytosol [GO:0005829]	cytosol [GO:0005829]; DNA damage checkpoint signaling [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; TOR signaling [GO:0031929]		GO:0000077; GO:0005829; GO:0031929; GO:0032515; GO:0043666	IDPNPADSQK	5.559999943	0.014428593	0.014428593	6.84E-13	1082.792149	14.79124	15.4694	15.2382	16.39597	0	15.67961	13.54678	16.01551	0	0	15.37207	0	0	14.49988	14.63125	13.68522	0	0	15.67372	14.41299	13.55656	0	14.3886	0	15.48582	11.37574	14.31597	0	10.70788	0	13.07356	15.97865	17.36901	15.41097	15.98068	12.20741	16.0484	0	0	0	13.73502	12.32564	15.26862	15.3951	14.1143	15.70047	15.63204	0
O75665	OFD1_HUMAN	Oral-facial-digital syndrome 1 protein (Protein 71-7A)	OFD1 CXorf5	Homo sapiens (Human)	cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]	alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]	GO:0005576; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0015630; GO:0016020; GO:0031514; GO:0034451; GO:0036064; GO:0042802; GO:0043014; GO:0043015; GO:0060271; GO:0060287	AEMCQK	18.11000061	1	1	0.268178144	766.3711683	0	0	17.19609	17.37725	0	0	19.07532	18.75241	0	0	0	0	0	0	0	0	0	0	0	18.25879	0	0	18.0634	19.21448	19.81069	0	0	0	0	0	0	18.08478	0	0	0	18.25706	0	0	0	17.76665	0	0	0	0	0	0	16.75823	0
O75676	KS6A4_HUMAN	"Ribosomal protein S6 kinase alpha-4, S6K-alpha-4, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B, RSKB)"	RPS6KA4 MSK2	Homo sapiens (Human)	"histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]"	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001818; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0006954; GO:0016572; GO:0018105; GO:0032793; GO:0033129; GO:0035066; GO:0035556; GO:0043987; GO:0043988; GO:0045944; GO:0051092; GO:0070498; GO:0106310	TPDVLESSGPAVR	13.61999989	1	1	0	1327.246995	9.915491	14.28151	0	0	0	14.51653	13.31391	0	0	15.35639	14.93465	16.11183	13.64208	14.78294	0	0	15.28191	0	15.08914	0	0	0	0	0	9.465178	12.30911	14.78574	0	0	0	0	0	0	0	0	0	17.51546	0	0	0	14.45935	14.82087	0	0	0	0	12.93427	0
O75677	RFPL1_HUMAN	Ret finger protein-like 1 (RING finger protein 78)	RFPL1 RFPL1L RNF78	Homo sapiens (Human)	"cell cycle [GO:0007049]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]"	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000785; GO:0004842; GO:0005654; GO:0005737; GO:0007049; GO:0008285; GO:0010972; GO:0032436; GO:0043065; GO:0045893; GO:0045930; GO:0046872; GO:0051782; GO:2001272	SVLSICPVINPGTTDAPVHPGEAK	6.110000134	1	1	0.042238379	2459.613249	13.38339	12.72434	15.81262	14.35891	0	14.93565	0	14.93101	13.23847	0	0	13.96941	0	0	14.93399	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75688	PPM1B_HUMAN	"Protein phosphatase 1B, EC 3.1.3.16 (Protein phosphatase 2C isoform beta, PP2C-beta)"	PPM1B PP2CB	Homo sapiens (Human)	N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005730; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223	ERIQNAGGSVMIQR	13.30000019	1	1	0.278024635	1574.134154	0	13.71874	0	0	15.20782	12.79656	8.157236	14.36643	0	0	0	0	0	0	0	0	15.95477	12.15299	0	0	16.10992	0	0	0	0	0	0	0	0	0	0	0	0	16.4041	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75689	ADAP1_HUMAN	"Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1, Cnt-a1) (Putative MAPK-activating protein PM25)"	ADAP1 CENTA1	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]"	"GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]"	GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0043087; GO:0043231; GO:0043533; GO:0043547; GO:0046872; GO:1902936	FLFACETESDQR	4.349999905	1	1	0.321719994	1504.84551	15.00442	15.13755	14.57655	0	14.89391	14.96586	13.06819	14.24041	15.02051	15.62043	15.76397	12.31412	11.15068	14.93457	12.15133	15.88316	14.59207	14.09151	14.95501	0	0	0	0	14.39315	0	0	17.82322	0	0	14.84886	0	16.79095	0	0	0	0	15.90537	0	0	14.68413	0	0	14.7813	15.33946	13.75121	0	0	0
O75691	UTP20_HUMAN	"Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73, NNP73) (Protein Key-1A6)"	UTP20 DRIM	Homo sapiens (Human)	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]"	"90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]"	"90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]"	RNA binding [GO:0003723]	GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040	LGNVNIDIIHRIDR	6.989999771	1	1	0.264918627	1647.613993	0	0	16.07757	0	0	16.49356	14.55868	13.15141	0	0	12.70361	16.22024	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.17848	0	0	0	17.00981	0	15.52189	14.28279	0	0	0	0	0	17.60734	0
O75694	NU155_HUMAN	Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)	NUP155 KIAA0791	Homo sapiens (Human)	atrial cardiac muscle cell action potential [GO:0086014]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	structural constituent of nuclear pore [GO:0017056]	GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0036228; GO:0044611; GO:0086014	PSSLLGAAMPASTSAAALQEALENAGR	2.25	1	1	0.142968133	2599.554814	13.8878	0	0	13.72871	12.33954	0	0	0	14.58562	13.69592	14.17287	0	0	11.20859	13.24332	12.21918	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75712	CXB3_HUMAN	"Gap junction beta-3 protein (Connexin-31, Cx31)"	GJB3 CX31	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	cell junction [GO:0030054]; connexin complex [GO:0005922]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	cell junction [GO:0030054]; connexin complex [GO:0005922]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	gap junction channel activity [GO:0005243]	GO:0001701; GO:0001890; GO:0005243; GO:0005737; GO:0005921; GO:0005922; GO:0007267; GO:0007283; GO:0016021; GO:0030054; GO:0043231; GO:0043588; GO:0071300	DFDCNTK	2.809999943	1	1	3.54E-13	899.3640186	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.83401	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75747	P3C2G_HUMAN	"Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma, PI3K-C2-gamma, PtdIns-3-kinase C2 subunit gamma, EC 2.7.1.137, EC 2.7.1.154 (Phosphoinositide 3-kinase-C2-gamma)"	PIK3C2G	Homo sapiens (Human)	cell migration [GO:0016477]; chemotaxis [GO:0006935]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphate kinase activity [GO:0016307]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; viral RNA genome replication [GO:0039694]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphate kinase activity [GO:0016307]	GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006935; GO:0014065; GO:0016020; GO:0016303; GO:0016307; GO:0016477; GO:0019898; GO:0035005; GO:0035091; GO:0036092; GO:0039694; GO:0046854; GO:0048015; GO:0052742	CTDPTYNEIVVYDEVTELQGHVLMLIVK	3.019999981	1	1	0.038894845	3279.550748	0	0	13.55567	0	17.48523	0	10.41497	0	0	15.50958	0	13.74823	13.00614	0	0	0	0	0	0	0	7.041451	0	12.87212	15.53413	16.09879	0	15.94167	0	11.86632	14.83445	0	12.07551	0	0	0	0	0	18.51288	0	15.43971	15.26141	0	0	0	13.34834	0	0	14.61874
O75762	TRPA1_HUMAN	"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120, p120) (Wasabi receptor)"	TRPA1 ANKTM1	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]	calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]	GO:0005262; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0071310; GO:0097604	HASLKR	5.349999905	0.490917861	0.490917861	0.256611823	710.1968754	0	14.27263	0	15.03725	15.57441	14.37571	0	16.05517	0	0	0	0	14.84139	15.08918	0	16.92018	15.78778	16.65298	14.2638	14.91115	15.902	15.04123	15.49129	14.93633	15.82054	16.28028	15.14711	15.91615	0	16.00365	0	14.94527	0	0	15.71278	0	16.92681	0	16.35312	16.47982	15.71257	0	16.98763	0	15.54767	0	15.66974	0
O75764	TCEA3_HUMAN	Transcription elongation factor A protein 3 (Transcription elongation factor S-II protein 3) (Transcription elongation factor TFIIS.h)	TCEA3 TFIISH	Homo sapiens (Human)	"transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]"	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0006351; GO:0006368; GO:0008270	LLDSPGPPK	18.68000031	0.43023631	0.43023631	0.161318832	920.9652506	0	0	0	0	17.53607	0	0	16.58365	16.11195	0	18.98579	16.25659	16.75567	18.04215	0	18.05974	0	0	17.38017	17.76485	0	18.23262	0	17.88365	18.01268	0	17.3293	0	15.28604	16.17694	0	0	16.78376	0	0	0	18.40907	0	17.13259	16.48937	17.92235	18.46298	16.87959	0	17.47127	0	16.61	15.42968
O75771	RA51D_HUMAN	DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD)	RAD51D RAD51L3	Homo sapiens (Human)	DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]"	"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]"	GO:0000722; GO:0000723; GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007131; GO:0008094; GO:0033063; GO:0036297; GO:0042148; GO:0043015; GO:0051726	VGLCPGLTEEMIQLLR	12.52999973	1	1	0.206137987	1828.694197	14.28581	11.77464	18.72571	14.32215	13.3327	17.16339	15.28765	14.3228	12.31922	13.86921	14.8454	10.54369	15.92108	12.78877	13.08317	18.26846	15.72139	0	0	0	17.55168	16.83323	14.02626	15.82888	0	16.1835	19.49247	19.47881	0	0	16.37254	17.78416	15.53836	18.35591	0	0	17.98567	16.63394	18.95754	15.78273	14.12396	17.36662	15.4198	0	14.64225	0	15.52018	15.9196
O75787	RENR_HUMAN	"Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9, ATP6M8-9, V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment ]"	ATP6AP2 ATP6IP2 CAPER ELDF10 HT028 MSTP009 PSEC0072	Homo sapiens (Human)	angiotensin maturation [GO:0002003]; central nervous system maturation [GO:0021626]; endosomal lumen acidification [GO:0048388]; eye pigmentation [GO:0048069]; Golgi lumen acidification [GO:0061795]; head morphogenesis [GO:0060323]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of MAPK cascade [GO:0043408]; rostrocaudal neural tube patterning [GO:0021903]; vacuolar acidification [GO:0007035]	"apical plasma membrane [GO:0016324]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cell body [GO:0044297]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proton-transporting V-type ATPase complex [GO:0033176]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"	"apical plasma membrane [GO:0016324]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cell body [GO:0044297]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proton-transporting V-type ATPase complex [GO:0033176]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; signaling receptor activity [GO:0038023]; angiotensin maturation [GO:0002003]; central nervous system maturation [GO:0021626]; endosomal lumen acidification [GO:0048388]; eye pigmentation [GO:0048069]; Golgi lumen acidification [GO:0061795]; head morphogenesis [GO:0060323]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of MAPK cascade [GO:0043408]; rostrocaudal neural tube patterning [GO:0021903]; vacuolar acidification [GO:0007035]"	signaling receptor activity [GO:0038023]	GO:0000139; GO:0000220; GO:0000421; GO:0002003; GO:0005764; GO:0005765; GO:0005789; GO:0005886; GO:0007035; GO:0007042; GO:0009897; GO:0010008; GO:0016020; GO:0016021; GO:0016324; GO:0016471; GO:0021626; GO:0021903; GO:0030177; GO:0030424; GO:0032591; GO:0032914; GO:0033176; GO:0038023; GO:0043408; GO:0044297; GO:0045211; GO:0048069; GO:0048388; GO:0051452; GO:0060323; GO:0061795; GO:0070062; GO:0070821; GO:0090263; GO:0101003; GO:1902600	VYMVGK	13.10000038	1	1	2.34E-13	713.3879413	0	0	0	12.73739	0	0	0	0	0	13.60587	0	0	0	15.54845	0	0	0	0	0	0	0	0	0	0	0	16.52226	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75791	GRAP2_HUMAN	"GRB2-related adapter protein 2 (Adapter protein GRID) (GRB-2-like protein, GRB2L) (GRBLG) (GRBX) (Grf40 adapter protein, Grf-40) (Growth factor receptor-binding protein) (Hematopoietic cell-associated adapter protein GrpL) (P38) (Protein GADS) (SH3-SH2-SH3 adapter Mona)"	GRAP2 GADS GRB2L GRID	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; Ras protein signal transduction [GO:0007265]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell-cell signaling [GO:0007267]; Ras protein signal transduction [GO:0007265]		GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007265; GO:0007267	TNSISRQK	7.53000021	0.114230849	0.114230849	0.185415443	933.9816988	11.77168	12.9361	15.54654	0	0	15.04394	0	16.31141	12.74117	0	16.45787	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.72574	0	0	0	0	14.95089	0	0	0	17.068	0	0	0	0	0	15.42912	13.76184	13.47117
O75792	RNH2A_HUMAN	"Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)"	RNASEH2A RNASEHI RNHIA	Homo sapiens (Human)	"DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]"	metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0003723; GO:0004523; GO:0004540; GO:0005654; GO:0005829; GO:0006260; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872	ADALYPVVSAASICAK	9.340000153	1	1	0.453309309	1635.851596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.76306	0	0	0	0	0	0	19.55413	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.87299	0
O75795	UDB17_HUMAN	"UDP-glucuronosyltransferase 2B17, UDPGT 2B17, UGT2B17, EC 2.4.1.17 (C19-steroid-specific UDP-glucuronosyltransferase, C19-steroid-specific UDPGT)"	UGT2B17	Homo sapiens (Human)	cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0008202; GO:0008210; GO:0015020; GO:0016020; GO:0016021; GO:0043231; GO:0052695	SVINDPIYK	4.900000095	0.100830138	0.100830138	0.225736788	1048.840363	14.77495	0	15.44856	0	0	14.57278	15.39956	12.71942	17.47982	12.61661	15.70452	0	0	0	13.5532	0	0	0	14.82744	0	0	0	0	0	0	0	0	0	0	0	0	0	15.37003	15.94418	15.99168	0	14.83025	0	16.77794	0	0	0	0	0	0	0	0	0
O75815	BCAR3_HUMAN	Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B)	BCAR3 NSP2 SH2D3B UNQ271/PRO308	Homo sapiens (Human)	endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007165; GO:0007264; GO:0008286; GO:0009410; GO:0016020; GO:0019900; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0045742; GO:0086100	LPSCAQGSHTELLTAK	1.129999995	0.427252978	0.427252978	0.286130176	1712.95557	16.88096	0	15.54234	0	14.10584	14.88077	0	15.7472	0	0	0	0	0	11.91987	16.31111	0	0	0	0	0	16.28751	0	16.07555	0	0	0	0	0	0	0	0	14.72242	0	16.33035	0	0	0	0	17.07592	12.9784	0	0	0	0	0	0	17.09168	0
O75818	RPP40_HUMAN	"Ribonuclease P protein subunit p40, RNaseP protein p40 (RNase P subunit 1)"	RPP40 RNASEP1	Homo sapiens (Human)	"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage involved in tRNA processing [GO:1905267]; tRNA 5'-leader removal [GO:0001682]"	multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]	"multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage involved in tRNA processing [GO:1905267]; tRNA 5'-leader removal [GO:0001682]"	ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]	GO:0000172; GO:0000447; GO:0001682; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0030681; GO:0033204; GO:1905267	SNFGNHK	2.150000095	0.368549824	0.368549824	0.236837703	804.9231258	0	15.19104	0	0	14.71457	0	0	0	0	0	14.77631	0	0	15.81383	16.72651	14.20292	0	0	0	16.61014	0	16.364	17.09041	0	0	0	0	0	16.59828	0	0	0	0	17.29977	15.87672	0	15.81639	0	16.15988	15.30688	15.82252	0	0	0	0	0	15.8783	0
O75828	CBR3_HUMAN	"Carbonyl reductase [NADPH] 3, EC 1.1.1.184 (NADPH-dependent carbonyl reductase 3) (Quinone reductase CBR3, EC 1.6.5.10) (Short chain dehydrogenase/reductase family 21C member 2)"	CBR3 SDR21C2	Homo sapiens (Human)	cognition [GO:0050890]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; oxidoreductase activity [GO:0016491]; cognition [GO:0050890]; xenobiotic metabolic process [GO:0006805]	carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; oxidoreductase activity [GO:0016491]	GO:0004090; GO:0005615; GO:0005654; GO:0005829; GO:0006805; GO:0016491; GO:0050890; GO:0070402	AEMTLK	6.78000021	1	1	0.235728491	692.1761385	16.59879	16.07717	0	14.73432	14.57283	12.94721	14.91511	14.79326	12.61529	10.07032	15.7234	15.2976	15.0212	16.71756	15.13348	16.04276	15.1084	16.19349	0	13.9296	15.84806	0	15.1539	15.18791	14.79737	14.54896	17.28356	0	0	14.2633	14.80789	0	0	16.02529	15.2198	0	15.38774	17.0234	0	0	15.20345	17.6463	15.65611	16.4815	0	15.62113	0	0
O75840	KLF7_HUMAN	Krueppel-like factor 7 (Ubiquitous krueppel-like factor)	KLF7 UKLF	Homo sapiens (Human)	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007409; GO:0007411; GO:0008270; GO:0042593; GO:0045604; GO:0045944; GO:0048813; GO:0061179; GO:1904178	TSQTLSAVDGTVTLKLVAK	4.5	1	1	0.310321487	1931.987245	14.35249	0	13.85964	15.63446	0	0	0	0	0	0	0	14.86658	0	0	15.79779	0	0	14.10638	0	0	19.01205	0	0	0	0	0	0	0	0	14.89862	0	0	0	10.01413	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75843	AP1G2_HUMAN	"AP-1 complex subunit gamma-like 2 (Gamma2-adaptin, G2ad)"	AP1G2	Homo sapiens (Human)	Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	AP-1 adaptor complex [GO:0030121]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; transport vesicle [GO:0030133]	AP-1 adaptor complex [GO:0030121]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; transport vesicle [GO:0030133]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]	GO:0000139; GO:0005794; GO:0005798; GO:0006886; GO:0006896; GO:0006898; GO:0010008; GO:0016020; GO:0016192; GO:0030121; GO:0030133; GO:0035615; GO:0140312	RVGYLGAMLLLDER	9.920000076	1	1	0.384071641	1622.960778	0	0	15.21208	0	16.58362	12.36921	0	0	0	0	0	0	15.6338	14.94714	0	0	0	0	15.32018	0	14.77159	0	0	17.05851	16.72242	16.41459	16.35185	16.0033	0	0	15.2671	15.17663	16.85682	17.06739	0	12.01829	16.83321	0	0	0	0	0	16.49511	0	0	0	16.34875	0
O75864	PPR37_HUMAN	Protein phosphatase 1 regulatory subunit 37 (Leucine-rich repeat-containing protein 68)	PPP1R37 KIAA1986 LRRC68	Homo sapiens (Human)			protein phosphatase inhibitor activity [GO:0004864]	protein phosphatase inhibitor activity [GO:0004864]	GO:0004864	ISVSSPGR	1.309999943	1	1	0.395362863	801.1592169	14.0875	12.9685	0	0	0	0	0	15.42173	14.52838	9.824983	0	14.46335	14.04722	12.83183	13.83191	0	0	15.79339	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.6596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75865	TPC6A_HUMAN	"Trafficking protein particle complex subunit 6A, TRAPP complex subunit 6A"	TRAPPC6A HSPC289	Homo sapiens (Human)	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; melanosome assembly [GO:1903232]; regulation of GTPase activity [GO:0043087]; vesicle tethering [GO:0099022]	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; melanosome assembly [GO:1903232]; regulation of GTPase activity [GO:0043087]; vesicle tethering [GO:0099022]		GO:0005737; GO:0005783; GO:0005801; GO:0005802; GO:0005829; GO:0006888; GO:0030008; GO:0043087; GO:0048208; GO:0099022; GO:1903232; GO:1990072	GALYTLGIESVVTASVAALPVCK	4.559999943	1	1	4.57E-13	2318.563211	10.88883	0	0	0	15.63482	14.93956	0	14.46624	0	0	0	0	15.34659	15.58645	16.02314	12.78059	15.2147	14.91164	0	16.50685	15.46057	15.65849	0	0	16.52607	0	12.48098	0	15.98666	0	14.48844	0	15.30326	14.06002	15.86586	14.36729	13.58731	15.47026	0	0	16.83999	16.16899	0	16.42824	0	0	0	0
O75874	IDHC_HUMAN	"Isocitrate dehydrogenase [NADP] cytoplasmic, IDH, IDH1, EC 1.1.1.42 (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)"	IDH1 PICD	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004450; GO:0005576; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006749; GO:0006979; GO:0008585; GO:0034774; GO:0042802; GO:0042803; GO:0045296; GO:0048545; GO:0050661; GO:0051287; GO:0060696; GO:0070062; GO:0071071; GO:1904724; GO:1904813	DAAEAIK	5.760000229	1	1	0	714.1211501	15.06736	0	12.89382	15.42605	13.91811	14.17459	0	0	0	15.36875	0	0	14.41536	0	0	0	14.27322	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75880	SCO1_HUMAN	"Protein SCO1 homolog, mitochondrial"	SCO1 SCOD1	Homo sapiens (Human)	cellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617]	copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]	GO:0005507; GO:0005739; GO:0006878; GO:0016531; GO:0030016; GO:0031305; GO:0033617	MAMLVLVPGR	7.800000191	1	1	1.37E-12	1112.258015	12.94839	0	12.67011	14.6989	15.08309	14.80187	14.41242	13.42665	14.93912	15.02543	12.94094	0	14.43227	0	15.02174	14.84373	0	0	15.94665	0	0	16.23546	16.28417	16.10474	15.08867	0	14.42963	14.1201	0	0	0	12.15058	0	0	14.57732	0	0	0	0	0	0	0	0	0	0	0	0	0
O75881	CP7B1_HUMAN	"Cytochrome P450 7B1 (24-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.26) (25/26-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.29) (3-hydroxysteroid 7-alpha hydroxylase) (Oxysterol 7-alpha-hydroxylase)"	CYP7B1	Homo sapiens (Human)	B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epithelial cell proliferation [GO:0050679]; prostate gland epithelium morphogenesis [GO:0060740]; sterol metabolic process [GO:0016125]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; 25-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033783]; 27-hydroxycholesterol 7-alpha-monooxygenase activity [GO:0047092]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid hydroxylase activity [GO:0008395]; B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epithelial cell proliferation [GO:0050679]; prostate gland epithelium morphogenesis [GO:0060740]; sterol metabolic process [GO:0016125]	24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; 25-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033783]; 27-hydroxycholesterol 7-alpha-monooxygenase activity [GO:0047092]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid hydroxylase activity [GO:0008395]	GO:0005506; GO:0005789; GO:0006699; GO:0008203; GO:0008395; GO:0008396; GO:0016021; GO:0016125; GO:0020037; GO:0033147; GO:0033782; GO:0033783; GO:0035754; GO:0042632; GO:0047092; GO:0050679; GO:0060740	IIKCFSSEK	2.710000038	0.344521582	0.344521582	0.085534414	1112.319106	0	0	0	15.69372	12.65832	13.23276	14.06231	0	0	11.04418	13.47582	0	0	15.25869	13.55441	15.91617	0	12.0438	0	15.34704	0	0	0	0	14.8541	16.41029	13.66725	15.56724	14.37553	15.27543	14.45067	17.48173	13.30412	12.68286	0	0	0	14.5273	16.36151	13.23577	0	16.52879	14.49869	14.36769	14.96735	0	17.25238	0
O75896	TUSC2_HUMAN	"Tumor suppressor candidate 2 (Fusion 1 protein, Fus-1 protein) (PDGFA-associated protein 2)"	TUSC2 C3orf11 FUS1 LGCC PDAP2	Homo sapiens (Human)	cell cycle [GO:0007049]; cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; cell cycle [GO:0007049]; cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]		GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0007049; GO:0032700; GO:0032733; GO:0048469; GO:0051881; GO:0070945; GO:2000377	MGASGSKAR	9.680000305	0.555243134	0.555243134	0.120386564	880.4361375	17.89635	0	0	0	17.03825	16.3643	0	14.86053	0	17.39235	17.33806	0	16.00421	0	16.23389	0	16.51255	0	0	0	14.95502	17.10447	0	0	0	0	15.54718	0	0	0	0	0	15.33869	0	0	0	0	16.36516	17.69682	16.50788	15.40708	15.89202	16.61973	0	0	0	0	13.84277
O75899	GABR2_HUMAN	"Gamma-aminobutyric acid type B receptor subunit 2, GABA-B receptor 2, GABA-B-R2, GABA-BR2, GABABR2, Gb2 (G-protein coupled receptor 51) (HG20)"	GABBR2 GPR51 GPRC3B	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]"	cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	"cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]"	G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712	GAPRPPPSSPPLSIMGLMPLTK	5.369999886	1	1	0.025387368	2277.316001	0	15.01895	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75901	RASF9_HUMAN	"Ras association domain-containing protein 9 (PAM COOH-terminal interactor protein 1, P-CIP1) (Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor)"	RASSF9 PAMCI PCIP1	Homo sapiens (Human)	endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; protein targeting [GO:0006605]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510]	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510]; endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; protein targeting [GO:0006605]; signal transduction [GO:0007165]		GO:0005768; GO:0005829; GO:0006605; GO:0007165; GO:0012510; GO:0016197; GO:0046907; GO:0055037; GO:0070062	MKELDLEIEK	6.28000021	1	1	0.350670128	1245.929413	0	0	0	0	0	0	0	0	0	0	0	0	17.9232	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75909	CCNK_HUMAN	Cyclin-K	CCNK CPR4	Homo sapiens (Human)	"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000079; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006974; GO:0007049; GO:0008024; GO:0008353; GO:0009966; GO:0016538; GO:0019901; GO:0032786; GO:0032968; GO:0044828; GO:0051301; GO:0061575; GO:0070816; GO:2001165	EENKAAEPPPPK	6.409999847	0.188485235	0.188485235	0.237347961	1303.91696	0	0	13.28045	14.08405	0	12.38861	0	0	0	0	0	0	15.89781	15.89363	15.04665	14.75478	0	0	15.82921	0	0	0	0	0	0	0	0	0	15.75781	0	15.96644	16.85353	0	0	0	0	15.70614	0	0	0	17.24806	0	0	14.9344	0	0	0	0
O75912	DGKI_HUMAN	"Diacylglycerol kinase iota, DAG kinase iota, DGK-iota, EC 2.7.1.107"	DGKI	Homo sapiens (Human)	"diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]"	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0014069; GO:0030168; GO:0030424; GO:0030672; GO:0032991; GO:0035556; GO:0043197; GO:0045202; GO:0046339; GO:0046834; GO:0046872; GO:0051966; GO:0097060	LQEDLQSVSSGSQR	19.94000053	0.909792006	0.909792006	0.190156403	1533.207992	9.351282	5.688414	0	0	15.91037	21.87612	22.20199	21.42892	12.36545	0	0	0	0	0	0	20.99565	0	0	0	0	0	0	0	13.10359	21.03778	0	0	0	21.33784	0	17.45081	14.95135	0	15.91234	12.36967	0	0	0	16.98199	0	0	0	0	0	0	0	21.76918	0
O75914	PAK3_HUMAN	"Serine/threonine-protein kinase PAK 3, EC 2.7.11.1 (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3, PAK-3)"	PAK3 OPHN3	Homo sapiens (Human)	axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; synapse organization [GO:0050808]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; synapse organization [GO:0050808]	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]	GO:0002223; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006468; GO:0007409; GO:0010763; GO:0014069; GO:0016358; GO:0017124; GO:0030833; GO:0031267; GO:0032956; GO:0035556; GO:0043408; GO:0043525; GO:0046872; GO:0048013; GO:0050770; GO:0050808; GO:0060997; GO:0061003; GO:0071407; GO:0098978; GO:0106310; GO:2000573	SIYTRSVVESIASPAVPNK	7.179999828	1	1	0.676699657	2019.345246	0	0	15.57922	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.62973	19.78549	0	0	0	0	0	18.20775	0	0	0	17.49567	0	0	0	0	0	0	0	0	0	0	0
O75916	RGS9_HUMAN	"Regulator of G-protein signaling 9, RGS9"	RGS9	Homo sapiens (Human)	dark adaptation [GO:1990603]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; light adaption [GO:0036367]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601]	glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]	glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dark adaptation [GO:1990603]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; light adaption [GO:0036367]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005886; GO:0007186; GO:0007601; GO:0008277; GO:0009968; GO:0035556; GO:0036367; GO:0098839; GO:0098978; GO:1990603	APPKAR	5.659999847	1	1	0.254452253	640.1158153	0	0	0	0	0	0	0	18.287	17.41173	0	17.46329	0	0	0	0	0	19.11569	0	0	0	17.37198	0	0	0	0	18.49308	0	0	0	0	16.18314	0	0	0	19.20506	0	19.0915	0	18.26895	0	0	0	0	16.98292	0	0	0	0
O75923	DYSF_HUMAN	Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1)	DYSF FER1L1	Homo sapiens (Human)	macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906]	centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]	centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipid binding [GO:0005543]; macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipid binding [GO:0005543]	GO:0001778; GO:0002280; GO:0002281; GO:0005509; GO:0005543; GO:0005544; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006906; GO:0007009; GO:0016021; GO:0030139; GO:0030315; GO:0030659; GO:0031410; GO:0033292; GO:0034451; GO:0042383; GO:0050765; GO:0061025; GO:0070062	ALAEEPQNSLPDIVIWMLQGDKR	5.96999979	1	1	3.66E-12	2624.41366	0	0	0	0	0	0	14.15266	0	0	0	0	0	0	0	0	7.86671	0	0	0	0	0	0	0	0	11.86382	0	12.8084	11.20702	0	13.5771	0	0	0	0	0	0	0	0	0	0	15.16247	0	11.40277	14.35669	0	0	0	0
O75925	PIAS1_HUMAN	"E3 SUMO-protein ligase PIAS1, EC 2.3.2.- (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein, GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein)"	PIAS1 DDXBP1	Homo sapiens (Human)	fat cell differentiation [GO:0045444]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; fat cell differentiation [GO:0045444]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0007259; GO:0008270; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0031625; GO:0032436; GO:0033235; GO:0042127; GO:0045444; GO:0061665; GO:0140297	EDGTWAPMR	4.099999905	1	1	0.289152667	1062.413629	0	0	0	0	0	0	0	0	0	16.87505	16.16557	0	16.16084	16.93838	0	17.51777	0	15.95071	17.69881	0	17.19302	0	0	0	0	16.16604	17.12036	17.79292	0	17.28374	0	0	0	0	0	0	0	17.75043	0	18.16643	17.44689	0	17.66125	16.39689	17.38099	17.10809	0	0
O75928	PIAS2_HUMAN	"E3 SUMO-protein ligase PIAS2, EC 2.3.2.- (Androgen receptor-interacting protein 3, ARIP3) (DAB2-interacting protein, DIP) (E3 SUMO-protein transferase PIAS2) (Msx-interacting zinc finger protein, Miz1) (PIAS-NY protein) (Protein inhibitor of activated STAT x) (Protein inhibitor of activated STAT2)"	PIAS2 PIASX	Homo sapiens (Human)	"negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0008270; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0031625; GO:0043433; GO:0060766; GO:0061629; GO:0061665	SGCSPAVQIK	1.600000024	0.09638375	0.09638375	0.247469201	1047.074557	0	0	0	16.28009	14.71596	0	15.44191	0	0	14.62264	16.48423	14.22905	13.29156	0	0	0	0	15.08027	0	0	0	0	0	0	0	0	0	0	0	0	15.50285	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O75934	SPF27_HUMAN	Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2) (DNA amplified in mammary carcinoma 1 protein) (Spliceosome-associated protein SPF 27)	BCAS2 DAM1	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"		GO:0000375; GO:0000398; GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005813; GO:0008380; GO:0016607; GO:0071007; GO:0071013	ENIRQDF	15	1	1	0.324121636	922.3013109	0	0	13.67299	17.16858	0	13.87743	0	15.15472	14.60473	0	0	0	0	0	14.32408	13.38473	0	0	0	0	0	13.94086	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.50058	0	0	0	0	0	0	0	0	0	0
O75936	BODG_HUMAN	"Gamma-butyrobetaine dioxygenase, EC 1.14.11.1 (Gamma-butyrobetaine hydroxylase, Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)"	BBOX1 BBH BBOX	Homo sapiens (Human)	carnitine biosynthetic process [GO:0045329]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329]	gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062	AEALDGAHLMQILWYDEEESLYPAVWLR	2.670000076	0.30265072	0.30265072	7.30E-12	3335.078461	0	0	13.99496	0	12.82514	15.29651	0	16.17106	15.96591	0	15.65413	14.29442	0	0	15.16603	14.10558	13.04548	14.75996	14.80111	0	0	16.26661	11.35871	0	0	0	0	14.44133	12.77921	0	19.21803	0	14.91094	16.6637	0	0	19.41488	0	0	15.87253	16.5983	0	0	12.50035	7.295877	0	0	0
O75943	RAD17_HUMAN	"Cell cycle checkpoint protein RAD17, hRad17 (RF-C/activator 1 homolog)"	RAD17 R24L	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]	GO:0000076; GO:0000077; GO:0003682; GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006974; GO:0008156; GO:0031389; GO:0031573; GO:0033314; GO:0042325	ATKYNK	7.199999809	0.040384822	0.040384822	0.30457703	725.0936164	16.21668	0	16.02153	20.46189	0	0	17.82329	19.90443	17.29342	0	0	17.05005	17.19504	17.90089	18.2881	0	17.53431	0	0	0	0	18.11954	17.78781	0	0	19.79291	0	0	15.86016	17.85599	0	19.47331	0	0	18.22905	0	19.42632	0	0	0	18.24346	18.18606	19.52679	17.91197	0	0	17.57133	0
O75955	FLOT1_HUMAN	Flotillin-1	FLOT1	Homo sapiens (Human)	"axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; plasma membrane raft organization [GO:0044857]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]"	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; sarcolemma [GO:0042383]; uropod [GO:0001931]	"adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; sarcolemma [GO:0042383]; uropod [GO:0001931]; ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020]; axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; plasma membrane raft organization [GO:0044857]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]"	ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020]	GO:0001819; GO:0001931; GO:0001934; GO:0002020; GO:0002090; GO:0005765; GO:0005768; GO:0005769; GO:0005815; GO:0005886; GO:0005901; GO:0005911; GO:0005912; GO:0005925; GO:0007409; GO:0009897; GO:0016020; GO:0016323; GO:0016600; GO:0022617; GO:0030027; GO:0031410; GO:0032092; GO:0032226; GO:0032728; GO:0033227; GO:0034116; GO:0034141; GO:0034451; GO:0034976; GO:0035023; GO:0035255; GO:0042383; GO:0042470; GO:0044291; GO:0044854; GO:0044857; GO:0045121; GO:0045807; GO:0048643; GO:0048786; GO:0050821; GO:0051092; GO:0051580; GO:0070062; GO:0070528; GO:0071360; GO:0072659; GO:0098691; GO:0098978; GO:0098982; GO:1901741; GO:1901890; GO:2000049	AQADLAYQLQVAKTK	5.170000076	1	1	0.345333315	1648.742684	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.93133	0	18.08452	0	0	0	0	0	0	0	0
O75962	TRIO_HUMAN	"Triple functional domain protein, EC 2.7.11.1 (PTPRF-interacting protein)"	TRIO	Homo sapiens (Human)	axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005085; GO:0005524; GO:0005737; GO:0005829; GO:0007185; GO:0007411; GO:0007417; GO:0019898; GO:0042995; GO:0045599; GO:0048812; GO:0051056; GO:0106310	EPIHIPK	2.559999943	0.061974954	0.061974954	0.12793992	834.0815485	0	14.62674	0	0	14.27568	14.55522	0	14.68286	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.89242	0	14.85954	14.25839	14.0977	0	0	0	0	0	0	0	0	16.31535	0	16.11971	0	0	0	0	0	0	0
O75964	ATP5L_HUMAN	"ATP synthase subunit g, mitochondrial, ATPase subunit g (ATP synthase membrane subunit g)"	ATP5MG ATP5L	Homo sapiens (Human)	ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	proton transmembrane transporter activity [GO:0015078]	GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0042776	GIIGYDV	20.01000023	0.950893998	0.950893998	0.168438597	734.2760439	0	16.58336	13.02538	0	0	12.45712	0	0	0	14.57136	16.46757	16.03595	0	14.22974	0	0	0	0	15.84722	0	0	17.12614	16.6214	0	14.5251	0	0	0	0	16.24283	0	0	0	0	14.83058	0	0	0	0	0	0	0	0	16.98632	0	16.0947	0	15.43139
O75969	AKAP3_HUMAN	"A-kinase anchor protein 3, AKAP-3 (A-kinase anchor protein 110 kDa, AKAP 110) (Cancer/testis antigen 82, CT82) (Fibrous sheath protein of 95 kDa, FSP95) (Fibrousheathin I) (Fibrousheathin-1) (Protein kinase A-anchoring protein 3, PRKA3) (Sperm oocyte-binding protein)"	AKAP3 AKAP110 SOB1	Homo sapiens (Human)	acrosome reaction [GO:0007340]; blastocyst hatching [GO:0001835]; protein localization [GO:0008104]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; protein kinase A binding [GO:0051018]; acrosome reaction [GO:0007340]; blastocyst hatching [GO:0001835]; protein localization [GO:0008104]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]	protein kinase A binding [GO:0051018]	GO:0001669; GO:0001835; GO:0005634; GO:0005737; GO:0007178; GO:0007338; GO:0007340; GO:0008104; GO:0035686; GO:0051018; GO:0097225; GO:0097228	AESYSLISMKGMGDPK	6.380000114	1	1	0.48369242	1728.259562	0	20.68707	0	0	0	0	0	0	0	0	19.40256	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.34178	0	0	0	0	0	0	0	21.4212	0	0	0	0	0	0	0	0	0	0	0	0	0
O75970	MPDZ_HUMAN	Multiple PDZ domain protein (Multi-PDZ domain protein 1)	MPDZ MUPP1	Homo sapiens (Human)	microtubule organizing center organization [GO:0031023]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein C-terminus binding [GO:0008022]; microtubule organizing center organization [GO:0031023]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192]	protein C-terminus binding [GO:0008022]	GO:0005737; GO:0005886; GO:0005923; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425; GO:0031023; GO:0045177; GO:0070507; GO:0120192	LSNGEVMR	6.139999866	1	1	0.173144214	922.1836027	15.31056	0	15.97978	14.96133	15.59164	0	14.01046	13.32874	14.87995	0	0	0	0	0	0	0	15.34886	15.09116	0	0	0	0	0	0	15.03271	15.07434	0	0	0	10.25205	14.66865	0	13.89792	15.07842	14.45057	0	0	0	0	0	14.60046	0	0	0	0	0	0	0
O76001	OR2J3_HUMAN	"Olfactory receptor 2J3 (Hs6M1-3) (Olfactory receptor OR6-16, OR6-6, Olfactory receptor 6-6)"	OR2J3	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	MNDDGK	11.21000004	0.057662439	0.057662439	0.253674627	678.3086988	0	16.81705	18.9553	17.74586	17.32284	17.10586	15.27844	17.82261	0	0	17.3532	17.07471	16.65782	16.20592	18.48305	14.25739	16.91628	16.3782	0	17.53382	16.27413	14.96956	0	17.52441	0	17.7019	17.83261	16.274	15.5223	0	0	16.63474	19.66105	0	0	15.47171	18.00701	0	0	0	17.68787	16.88907	17.58853	0	0	16.77269	17.11479	18.30393
O76003	GLRX3_HUMAN	"Glutaredoxin-3 (PKC-interacting cousin of thioredoxin, PICOT) (PKC-theta-interacting protein, PKCq-interacting protein) (Thioredoxin-like protein 2)"	GLRX3 PICOT TXNL2 HUSSY-22	Homo sapiens (Human)	[2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634]; Z disc [GO:0030018]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634]; Z disc [GO:0030018]; glutathione oxidoreductase activity [GO:0097573]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026]	glutathione oxidoreductase activity [GO:0097573]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]	GO:0002026; GO:0003723; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006879; GO:0010614; GO:0016226; GO:0030018; GO:0030425; GO:0042802; GO:0044571; GO:0045454; GO:0046872; GO:0051536; GO:0055072; GO:0097428; GO:0097573; GO:1990229	QMVEILHK	31.78000069	0.820335686	0.820335686	0.222393579	997.6606037	19.28768	18.79854	19.14678	0	20.43692	0	0	21.20729	0	20.59742	0	19.78274	16.37023	0	19.23566	19.87398	0	0	0	0	0	0	0	18.89617	17.34852	19.33272	0	0	20.21089	19.37366	0	19.8957	20.2069	0	0	20.68321	19.19604	20.21353	0	20.35655	0	19.80132	0	16.52645	19.91888	18.79209	0	20.0157
O76014	KRT37_HUMAN	"Keratin, type I cuticular Ha7 (Hair keratin, type I Ha7) (Keratin-37, K37)"	KRT37 HHA7 HKA7 KRTHA7	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109; GO:0070062	CGTQKLLDDATLAK	2.960000038	1	1	0.145121508	1537.300259	14.93949	0	0	0	15.08276	0	0	12.46851	14.529	0	0	0	0	0	0	0	0	0	0	16.94367	0	0	0	0	0	0	0	0	0	15.92539	14.01016	0	0	0	13.57902	0	0	16.3957	14.7857	0	15.49106	0	0	0	0	0	0	0
O76038	SEGN_HUMAN	Secretagogin	SCGN SECRET	Homo sapiens (Human)	regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0030425; GO:0030658; GO:0043005; GO:0043195; GO:0045202; GO:0051480; GO:0099509; GO:1900271	LGTDDTVMK	10	1	1	0.359338692	994.3794509	0	15.06336	15.15691	16.43098	15.21877	14.12743	14.64936	14.28166	12.02337	0	0	0	14.67339	13.79224	13.06857	0	0	0	0	0	0	0	0	0	15.85608	0	0	0	0	14.28342	0	0	0	0	15.69481	0	0	16.35336	15.83058	0	15.16907	0	0	0	0	0	0	0
O76039	CDKL5_HUMAN	"Cyclin-dependent kinase-like 5, EC 2.7.11.22 (Serine/threonine-protein kinase 9)"	CDKL5 STK9	Homo sapiens (Human)	neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]; neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]	GO:0001764; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0006468; GO:0016301; GO:0031267; GO:0032839; GO:0036064; GO:0043547; GO:0044294; GO:0045773; GO:0046777; GO:0050773; GO:0050775; GO:0097542; GO:0098978; GO:0099175; GO:0106310; GO:1902017	DIKPENLLISHNDVLK	7.860000134	0.067082226	0.067082226	0.597535294	1847.539125	0	16.20507	0	0	0	0	0	17.33088	0	0	0	0	0	0	0	0	0	0	0	0	18.27896	0	0	0	0	0	0	0	0	0	20.28888	0	0	0	19.8633	0	0	0	0	18.31999	0	0	0	0	0	0	0	0
O76050	NEUL1_HUMAN	"E3 ubiquitin-protein ligase NEURL1, EC 2.3.2.27 (Neuralized-like protein 1A, h-neu, h-neuralized 1) (RING finger protein 67) (RING-type E3 ubiquitin transferase NEURL1)"	NEURL1 NEURL NEURL1A RNF67	Homo sapiens (Human)	brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]	apical dendrite [GO:0097440]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	"apical dendrite [GO:0097440]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]"	"metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]"	GO:0004842; GO:0005886; GO:0006513; GO:0007219; GO:0007288; GO:0007399; GO:0007420; GO:0007519; GO:0007595; GO:0008285; GO:0014069; GO:0043065; GO:0043197; GO:0043204; GO:0045183; GO:0045741; GO:0045746; GO:0046872; GO:0048170; GO:0048471; GO:0051491; GO:0060999; GO:0061630; GO:0071230; GO:0090129; GO:0097440	FHALRAGAHVR	4.360000134	1	1	0.172301701	1235.194477	15.8249	13.32837	14.07584	13.40626	15.7231	0	0	14.3416	0	0	11.20993	0	14.91442	0	15.24328	0	14.61249	0	15.09622	0	15.90351	0	0	0	0	14.84385	0	0	0	0	15.83425	0	0	0	0	0	0	0	0	14.54449	0	0	16.42615	0	16.23179	0	0	14.42622
O76054	S14L2_HUMAN	"SEC14-like protein 2 (Alpha-tocopherol-associated protein, TAP, hTAP) (Squalene transfer protein) (Supernatant protein factor, SPF)"	SEC14L2 C22orf6 KIAA1186 KIAA1658	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; vitamin E binding [GO:0008431]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]"	phospholipid binding [GO:0005543]; vitamin E binding [GO:0008431]	GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008431; GO:0045540; GO:0045893; GO:0070062	ASEEKMK	4	0.27901423	0.27901423	0.077385353	837.3351865	13.85205	10.86302	0	15.88064	14.65521	15.42168	14.38907	14.00263	14.44259	0	15.92318	15.77688	17.03096	13.66637	11.93936	0	0	0	18.48078	0	17.30015	17.08488	0	16.15043	0	15.45406	13.90025	16.06955	0	15.94852	18.52045	0	0	0	15.10547	0	16.66175	0	16.42746	12.71804	0	16.29112	14.33617	15.67319	14.74873	14.31294	14.15339	16.59657
O76064	RNF8_HUMAN	"E3 ubiquitin-protein ligase RNF8, hRNF8, EC 2.3.2.27 (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8)"	RNF8 KIAA0646	Homo sapiens (Human)	"cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]"	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007049; GO:0007286; GO:0008270; GO:0010212; GO:0016567; GO:0030496; GO:0031625; GO:0033522; GO:0033523; GO:0034244; GO:0035093; GO:0035861; GO:0036297; GO:0042393; GO:0042802; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0051301; GO:0051865; GO:0061630; GO:0070534; GO:0070535; GO:0070936	ICPLMISR	10.18000031	1	1	0.353944064	1005.317913	16.41308	16.24079	0	16.39139	16.1106	15.57893	16.01295	15.58342	16.57942	0	16.81818	15.79953	0	16.36673	16.10411	0	0	16.65246	0	0	0	0	0	0	16.37163	0	16.85942	0	0	0	0	0	0	17.05824	0	0	0	0	0	0	0	16.95051	0	0	0	0	0	0
O76070	SYUG_HUMAN	"Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin, SR)"	SNCG BCSG1 PERSYN PRSN	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neuron death [GO:1901214]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	axon terminus [GO:0043679]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cuprous ion binding [GO:1903136]; adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neuron death [GO:1901214]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]	cuprous ion binding [GO:1903136]	GO:0005737; GO:0005815; GO:0005819; GO:0007268; GO:0008344; GO:0009306; GO:0014059; GO:0043025; GO:0043679; GO:0046928; GO:0048471; GO:0048488; GO:0050808; GO:0070062; GO:1901214; GO:1903136	TVEEAENIAVTSGVVR	8.890000343	1	1	0.132947581	1673.766249	0	0	0	13.70135	15.73741	0	0	15.8556	0	0	0	0	15.25972	0	15.18131	0	0	16.02146	15.49788	0	16.35649	0	0	15.78599	16.57621	0	0	0	15.85738	0	0	16.19962	16.8165	0	0	16.65326	0	0	0	0	0	15.82901	0	15.57308	0	16.97787	0	15.14044
O76074	PDE5A_HUMAN	"cGMP-specific 3',5'-cyclic phosphodiesterase, EC 3.1.4.35 (cGMP-binding cGMP-specific phosphodiesterase, CGB-PDE)"	PDE5A PDE5	Homo sapiens (Human)	cGMP catabolic process [GO:0046069]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; signal transduction [GO:0007165]	cytosol [GO:0005829]	"cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; signal transduction [GO:0007165]"	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]"	GO:0004114; GO:0005829; GO:0007165; GO:0010613; GO:0010749; GO:0030553; GO:0042130; GO:0043406; GO:0046069; GO:0046872; GO:0047555; GO:0055118; GO:0055119; GO:0060282	KEQMPLTPPR	9.93999958	0.79759866	0.79759866	1.60E-12	1212.690142	0	15.854	0	12.92944	0	0	0	0	0	0	0	15.10892	14.90182	0	13.88761	0	0	15.29905	0	14.98817	14.11143	0	0	0	16.21093	14.58473	0	10.0989	0	13.61909	14.55824	0	0	0	0	0	0	16.34968	0	9.985966	15.76644	0	0	15.5229	0	0	0	15.94313
O76075	DFFB_HUMAN	"DNA fragmentation factor subunit beta, EC 3.-.-.- (Caspase-activated deoxyribonuclease, CAD, Caspase-activated DNase) (Caspase-activated nuclease, CPAN) (DNA fragmentation factor 40 kDa subunit, DFF-40)"	DFFB CAD DFF2 DFF40	Homo sapiens (Human)	apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]	deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]	GO:0000785; GO:0003677; GO:0004520; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718	VLGSMCQR	7.010000229	0.266001016	0.266001016	0.184344708	949.5436246	0	16.55535	15.19963	0	0	13.99141	0	15.73968	0	0	0	0	15.19489	0	15.54575	15.40518	16.14353	16.02735	16.83704	15.53967	16.82581	16.03396	15.63052	17.48577	17.01892	15.46785	15.37659	15.69649	0	15.54107	17.00936	15.2866	0	15.89312	16.04541	13.3411	17.08436	16.48174	0	15.98875	16.46587	15.70755	15.49249	14.77924	17.8738	15.64097	16.26303	17.51567
O76090	BEST1_HUMAN	Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2)	BEST1 VMD2	Homo sapiens (Human)	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601]	bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]	GO:0005229; GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0009925; GO:0015106; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924; GO:1902476	QNVRGQEDNK	6.420000076	1	1	0.110002878	1189.152471	14.40098	11.72253	0	14.29212	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.95237	13.10874	0	0	0	15.14594	0	0	0	0	0	0	0	0	0
O77932	DXO_HUMAN	"Decapping and exoribonuclease protein, DXO, EC 3.6.1.- (5'-3' exoribonuclease DXO, EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO, DeNADding enzyme DXO, EC 3.6.1.-)"	DXO DOM3L DOM3Z NG6	Homo sapiens (Human)	mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779]	5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353]	GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090305; GO:0110152; GO:0110155	ELMYMGYK	8.100000381	0.99520427	0.99520427	0.256000865	1050.14881	14.47132	15.32616	12.9647	16.91505	15.63803	15.08627	0	14.52839	13.9071	0	15.39681	15.11653	15.41722	13.48928	14.34026	13.09951	16.58549	14.72191	15.68715	15.65912	14.13657	15.25587	15.51925	0	15.43762	0	0	16.39694	0	0	0	0	0	0	14.9168	0	0	16.34865	15.86983	0	0	0	16.20987	0	0	15.42587	0	0
O94759	TRPM2_HUMAN	"Transient receptor potential cation channel subfamily M member 2 (Estrogen-responsive element-associated gene 1 protein) (Long transient receptor potential channel 2, LTrpC-2, LTrpC2) (Transient receptor potential channel 7, TrpC7) (Transient receptor potential melastatin 2)"	TRPM2 EREG1 KNP3 LTRPC2 TRPC7	Homo sapiens (Human)	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; protein homotetramerization [GO:0051289]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577]	cytoplasmic vesicle membrane [GO:0030659]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	cytoplasmic vesicle membrane [GO:0030659]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; mono-ADP-D-ribose binding [GO:0072571]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; protein homotetramerization [GO:0051289]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; mono-ADP-D-ribose binding [GO:0072571]; sodium channel activity [GO:0005272]	GO:0001659; GO:0002407; GO:0005261; GO:0005262; GO:0005272; GO:0005384; GO:0005509; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0006816; GO:0009408; GO:0014074; GO:0015278; GO:0030659; GO:0032024; GO:0033194; GO:0035579; GO:0035584; GO:0043005; GO:0043204; GO:0044849; GO:0051209; GO:0051289; GO:0051489; GO:0070301; GO:0070588; GO:0070821; GO:0071277; GO:0071415; GO:0071502; GO:0071577; GO:0072571; GO:0097028; GO:0097553; GO:0098655; GO:0098703; GO:0099604; GO:0101003; GO:1903223; GO:2000249	SFHGPYTVQAGLPLNPMGR	2.529999971	0.240164325	0.240164325	0.266719231	2057.417447	13.02105	0	12.73519	14.24989	13.78313	0	17.33137	13.34092	13.60558	11.98988	0	0	9.740167	12.53611	0	0	0	0	0	0	0	0	0	15.50341	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94761	RECQ4_HUMAN	"ATP-dependent DNA helicase Q4, EC 3.6.4.12 (DNA helicase, RecQ-like type 4, RecQ4) (RTS) (RecQ protein-like 4)"	RECQL4 RECQ4	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]"	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]	GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0016887; GO:0032357; GO:0032508; GO:0043138; GO:0061820; GO:0061821; GO:1990814	TTAEAYHAGMCSRER	1.159999967	1	1	6.85E-13	1755.138919	0	15.07107	0	0	0	0	0	14.30772	0	16.31283	0	14.5285	0	0	0	13.34151	0	12.87607	0	15.08218	13.62716	0	0	14.48299	0	14.53563	0	10.73019	16.07488	0	0	0	0	11.38442	0	0	17.93745	15.86787	16.70332	0	0	16.24636	0	15.32428	14.79921	0	0	17.07205
O94762	RECQ5_HUMAN	"ATP-dependent DNA helicase Q5, EC 3.6.4.12 (DNA helicase, RecQ-like type 5, RecQ5) (RecQ protein-like 5)"	RECQL5 RECQ5	Homo sapiens (Human)	cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]"	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]"	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]	GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0016887; GO:0032508; GO:0034244; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0071466; GO:0072757; GO:1990414; GO:2000042	SSSGGSSLAKGR	10.5	1	1	0.038255716	1094.457941	14.69153	0	0	10.9562	13.25859	0	0	0	0	0	0	0	0	14.79146	14.47176	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.0489	0	0	0	0	0	0	0	0	0	0	0	0	0
O94768	ST17B_HUMAN	"Serine/threonine-protein kinase 17B, EC 2.7.11.1 (DAP kinase-related apoptosis-inducing protein kinase 2)"	STK17B DRAK2	Homo sapiens (Human)	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005793; GO:0005886; GO:0006468; GO:0006915; GO:0015629; GO:0035556; GO:0043065; GO:0046777; GO:0106310; GO:2000271	IVDFGMSR	1.549999952	0.721962631	0.721962631	0.110015265	940.6211024	16.44094	0	0	0	0	16.66604	12.28943	0	0	13.67313	14.89637	13.97239	15.57893	0	0	11.61836	0	0	0	0	0	0	0	0	14.74355	0	17.43274	11.76423	0	0	16.92956	14.37082	0	0	0	0	0	0	0	0	0	0	15.94893	17.00786	9.499145	0	12.21761	14.33234
O94769	ECM2_HUMAN	Extracellular matrix protein 2 (Matrix glycoprotein SC1/ECM2)	ECM2	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; collagen V binding [GO:0070052]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	collagen V binding [GO:0070052]; heparin binding [GO:0008201]; integrin binding [GO:0005178]	GO:0005178; GO:0005576; GO:0005614; GO:0007160; GO:0008201; GO:0010811; GO:0030198; GO:0031012; GO:0070052	LAHQQQR	6.880000114	0.746179521	0.746179521	0.227965822	877.0961532	0	15.2123	15.87756	0	0	16.49427	0	0	0	14.17302	0	13.70508	14.80147	0	15.43568	13.02764	16.30192	15.50942	15.82676	0	0	0	0	0	15.58094	15.318	16.51303	12.90135	15.54958	14.06613	12.93466	0	16.38723	15.40193	13.00126	14.84124	13.07093	15.3068	13.63548	13.34601	13.35566	0	13.90782	13.57554	13.55346	15.7364	13.04745	0
O94779	CNTN5_HUMAN	"Contactin-5 (Neural recognition molecule NB-2, hNB-2)"	CNTN5	Homo sapiens (Human)	axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605]	anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]	anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005576; GO:0005886; GO:0007411; GO:0007420; GO:0007605; GO:0030424; GO:0098609; GO:0098632; GO:0098982; GO:0099026; GO:0099054	MVTSSEASKFIYR	1.940000057	1	1	0.209183957	1518.044972	0	10.05914	14.41051	12.95243	0	0	0	15.79605	13.80958	0	12.83496	14.19597	0	0	11.70422	0	14.01854	0	15.24419	15.33656	0	0	13.9937	0	14.20106	13.48682	13.92929	0	15.52459	0	0	0	13.73681	0	14.18255	13.67126	0	0	0	15.67107	11.66277	0	0	0	0	0	0	13.48045
O94782	UBP1_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 1, EC 3.4.19.12 (Deubiquitinating enzyme 1, hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) [Cleaved into: Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment ]"	USP1	Homo sapiens (Human)	DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent deubiquitinase [GO:0004843]; DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent deubiquitinase [GO:0004843]	GO:0001501; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006282; GO:0006511; GO:0008233; GO:0009411; GO:0016579; GO:0035520	NVEAIGLLGGQK	1.74000001	0.151750356	0.151750356	0.053087366	1199.350648	14.09315	14.80043	11.48048	16.28661	7.37565	14.29186	0	0	0	0	0	14.99045	0	0	0	0	0	0	0	0	12.81301	0	0	0	0	11.43985	14.06965	0	0	0	0	16.73679	15.4019	13.86658	16.64585	15.08199	0	13.53775	10.17091	0	0	0	11.48711	12.63556	0	14.8999	0	12.99928
O94811	TPPP_HUMAN	"Tubulin polymerization-promoting protein, TPPP, EC 3.6.5.- (25 kDa brain-specific protein) (TPPP/p25) (p24) (p25-alpha)"	TPPP TPPP1	Homo sapiens (Human)	astral microtubule organization [GO:0030953]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule nucleation by microtubule organizing center [GO:0051418]; microtubule polymerization [GO:0046785]; myelin assembly [GO:0032288]; negative regulation of tubulin deacetylation [GO:1904428]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of protein polymerization [GO:0032273]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of microtubule cytoskeleton organization [GO:0070507]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic Golgi apparatus [GO:0150051]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic Golgi apparatus [GO:0150051]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule nucleation by microtubule organizing center [GO:0051418]; microtubule polymerization [GO:0046785]; myelin assembly [GO:0032288]; negative regulation of tubulin deacetylation [GO:1904428]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of protein polymerization [GO:0032273]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of microtubule cytoskeleton organization [GO:0070507]	GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]	GO:0000287; GO:0001578; GO:0003924; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0008017; GO:0014003; GO:0015631; GO:0030953; GO:0031334; GO:0031643; GO:0032273; GO:0032288; GO:0042803; GO:0046785; GO:0048471; GO:0048709; GO:0051301; GO:0051418; GO:0070507; GO:0072686; GO:0150051; GO:1904428	DCQVIDGR	12.25	0.636034369	0.636034369	0.257836813	963.070404	12.875	16.18546	14.81469	14.86514	14.63646	16.41829	0	14.14405	0	14.59765	0	0	15.43637	13.49718	0	14.26726	0	0	0	16.02656	0	16.01138	15.38058	0	0	18.19908	0	15.53984	0	0	15.57073	15.94643	0	0	14.90426	0	0	0	0	15.94114	14.56131	0	15.40718	15.42735	15.63405	0	15.66347	0
O94812	BAIP3_HUMAN	"BAI1-associated protein 3, BAP3 (Brain-specific angiogenesis inhibitor I-associated protein 3)"	BAIAP3 KIAA0734	Homo sapiens (Human)	"dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]	"cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]"	calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0055038; GO:0098793; GO:1905413; GO:1990502	EPRAQK	4.679999828	1	1	0.114764882	732.2710243	15.85381	15.64268	14.21953	0	15.85228	15.49592	0	0	0	0	0	0	0	0	0	15.43018	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94813	SLIT2_HUMAN	"Slit homolog 2 protein, Slit-2 [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product ]"	SLIT2 SLIL3	Homo sapiens (Human)	aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]	GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007411; GO:0008045; GO:0008201; GO:0009986; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288	DLEVLTLNNNNITR	11.72000027	1	1	2.32E-13	1625.614693	15.49028	0	0	15.76776	0	0	13.16634	0	0	0	0	14.34159	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94817	ATG12_HUMAN	"Ubiquitin-like protein ATG12 (Autophagy-related protein 12, APG12-like)"	ATG12 APG12 APG12L	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; protein lipidation [GO:0006497]; regulation of autophagosome maturation [GO:1901096]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; protein lipidation [GO:0006497]; regulation of autophagosome maturation [GO:1901096]		GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0006501; GO:0016236; GO:0030670; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0043231; GO:0044804; GO:0045824; GO:0050687; GO:1901096; GO:1904973	AVGDTPIMK	4.800000191	1	1	0.21128719	931.2921452	14.32651	12.70409	14.94165	0	11.93518	14.08235	13.73196	0	13.56857	0	15.06575	0	13.8488	0	13.81312	13.97878	0	12.34736	15.97417	0	16.9046	0	0	15.00207	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94819	KBTBB_HUMAN	Kelch repeat and BTB domain-containing protein 11 (Chronic myelogenous leukemia-associated protein) (Kelch domain-containing protein 7B)	KBTBD11 CMLAP KIAA0711 KLHDC7C	Homo sapiens (Human)						LPEGAPAR	32.15000153	1	1	0.29156532	810.5830471	17.16811	20.51155	16.0134	19.02399	14.33042	14.1032	20.15166	20.89687	20.77577	14.9787	19.61847	17.39757	0	0	17.42832	20.5262	20.6501	17.27418	20.67662	20.26859	11.91059	19.73469	20.25873	0	0	0	0	0	16.43583	0	17.26906	0	0	0	0	0	17.71212	0	19.43354	0	0	0	19.56662	0	0	0	0	0
O94822	LTN1_HUMAN	"E3 ubiquitin-protein ligase listerin, EC 2.3.2.27 (RING finger protein 160) (RING-type E3 ubiquitin transferase listerin) (Zinc finger protein 294)"	LTN1 C21orf10 C21orf98 KIAA0714 RNF160 ZNF294 HSPC087	Homo sapiens (Human)	protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	cytosol [GO:0005829]; RQC complex [GO:1990112]	cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0043023; GO:0051865; GO:0061630; GO:0072344; GO:1990112; GO:1990116	ISLDHDR	11.28999996	2.20E-08	2.20E-08	0.223523909	856.586583	17.4563	19.19633	17.88109	18.77887	16.29186	16.83613	17.55438	17.37544	14.34165	0	16.45	0	17.58231	0	19.07786	0	0	17.40084	15.8298	19.13513	17.11987	18.03585	18.94224	0	0	17.3307	17.7509	19.14998	0	17.38123	18.37844	0	0	0	18.3362	17.98312	0	16.83579	19.23558	19.28624	0	19.54129	0	0	18.71211	19.75687	19.42284	16.66581
O94823	AT10B_HUMAN	"Phospholipid-transporting ATPase VB, EC 7.6.2.1 (ATPase class V type 10B) (P4-ATPase flippase complex alpha subunit ATP10B)"	ATP10B ATPVB KIAA0715	Homo sapiens (Human)	lysosomal membrane organization [GO:0097212]; phospholipid translocation [GO:0045332]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of lysosomal membrane [GO:1905103]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of lysosomal membrane [GO:1905103]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; lysosomal membrane organization [GO:0097212]; phospholipid translocation [GO:0045332]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0016887; GO:0031902; GO:0045332; GO:0097212; GO:0140326; GO:0140345; GO:0140351; GO:1905103; GO:1990531	AMLNNSGPR	7.619999886	1	1	0.520245543	976.1421568	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.32709	0	0	0	0	0	0	0	19.38715	0	0	0	0	0	0	0	19.28533	0	17.91027	0	0
O94827	PKHG5_HUMAN	"Pleckstrin homology domain-containing family G member 5, PH domain-containing family G member 5 (Guanine nucleotide exchange factor 720, GEF720)"	PLEKHG5 KIAA0720	Homo sapiens (Human)	endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043123; GO:0043542; GO:0048471; GO:0051056	EVDKMEQLEGK	1.220000029	1	1	0.269132716	1321.553795	0	13.88539	0	0	0	0	16.36858	12.32623	13.62058	14.29331	0	0	12.20422	0	0	14.65106	0	0	14.83479	0	14.80303	0	15.19495	0	0	14.83309	13.88362	0	0	0	0	0	0	10.19002	15.69713	15.96065	13.57703	0	0	0	0	15.37412	13.21071	0	15.70669	16.61884	16.34036	0
O94832	MYO1D_HUMAN	Unconventional myosin-Id	MYO1D KIAA0727	Homo sapiens (Human)	actin filament organization [GO:0007015]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; actin filament organization [GO:0007015]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005790; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030050; GO:0030424; GO:0030673; GO:0031410; GO:0031982; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0070062; GO:0097440	CRHQVEYLGLLENVR	5.869999886	1	1	0.303796992	1884.840607	0	0	16.84479	0	0	0	0	0	18.11226	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.90909	0	0	0	15.4761	0	0	0	0	12.62827	0	0	0	0
O94842	TOX4_HUMAN	TOX high mobility group box family member 4 (Epidermal Langerhans cell protein LCP1)	TOX4 C14orf92 KIAA0737	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]	chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; chromatin DNA binding [GO:0031490]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin DNA binding [GO:0031490]	GO:0000785; GO:0005634; GO:0006357; GO:0031490; GO:0072357	NSNTVVFVK	5.559999943	0.641163409	0.641163409	0.293918332	1005.298535	15.9033	14.89698	0	0	0	15.54565	0	0	0	0	16.07155	11.60486	14.938	0	0	0	13.6146	15.24924	0	0	0	0	13.60452	0	0	14.46076	0	0	0	0	0	0	0	16.26969	0	0	0	16.85322	0	0	0	0	0	0	0	0	0	0
O94844	RHBT1_HUMAN	Rho-related BTB domain-containing protein 1	RHOBTB1 KIAA0740	Homo sapiens (Human)	actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]	GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0043652	VQKPLLQAPFLPPK	3.769999981	1	1	0.485008554	1575.62509	0	16.42137	13.25271	0	0	0	17.52416	0	0	0	0	0	0	16.34066	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.10855	0	0	0	0	0
O94850	DEND_HUMAN	Dendrin	DDN KIAA0749	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0005789; GO:0032591; GO:0042995; GO:0043204; GO:0045211; GO:0045944	GTQQGNRK	9.619999886	1	1	0.214171414	885.3709626	15.41184	13.80271	0	0	16.10785	15.48156	13.36791	13.30272	16.04109	15.36648	0	0	0	14.52213	0	0	0	0	15.18473	0	0	0	0	14.98326	9.465178	12.30911	15.74084	0	0	0	0	0	0	15.48228	0	0	17.82754	0	0	0	0	14.82087	14.16615	0	15.11763	0	0	0
O94851	MICA2_HUMAN	"[F-actin]-monooxygenase MICAL2, EC 1.14.13.225 (MICAL C-terminal-like protein, Mical-cL) (Molecule interacting with CasL protein 2, MICAL-2)"	MICAL2 KIAA0750 MICAL2PV1 MICAL2PV2 MICALCL	Homo sapiens (Human)	actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]	nucleus [GO:0005634]	"nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]"	"actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0001947; GO:0003779; GO:0005634; GO:0007010; GO:0007507; GO:0010735; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0071949	AAHLASMFGHGDFPQNKLLSK	13.46000004	0.250154287	0.250154287	0.578981088	2284.049443	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.95512	0	0	0	0	0	0	0	0	20.77465	18.73101	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94854	K0754_HUMAN	"Microtubule-actin cross-linking factor 1, isoforms 6/7 (Uncharacterized protein KIAA0754)"	MACF1 KIAA0754	Homo sapiens (Human)						GEEEDGYIEDCYVPQRSIYDTMR	8.729999542	0.078024939	0.078024939	0.109778816	2840.253008	0	15.46297	13.41513	0	0	0	0	16.77713	0	12.32702	0	0	0	0	14.06855	14.60461	0	16.00333	15.23116	0	0	11.84867	15.32954	0	0	0	14.33308	12.21272	17.34036	0	0	0	15.21411	0	15.17951	0	17.19806	18.02566	17.76939	0	15.81128	0	0	0	0	0	0	13.70163
O94855	SC24D_HUMAN	Protein transport protein Sec24D (SEC24-related protein D)	SEC24D KIAA0755	Homo sapiens (Human)	COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; intracellular membrane-bounded organelle [GO:0043231]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; intracellular membrane-bounded organelle [GO:0043231]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]	SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]	GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0043231; GO:0070971; GO:0090110	EEQEETSAIR	3.319999933	1	1	0.169418463	1192.271892	11.52194	13.18828	0	14.20424	13.87336	0	0	13.83483	0	0	0	0	0	0	0	15.32212	0	0	14.83501	0	0	0	0	0	0	0	0	14.79725	13.84289	14.83384	15.95213	8.028619	11.56851	0	0	16.19476	0	0	0	0	13.03362	0	14.41264	14.21537	0	14.94645	13.07249	11.91361
O94856	NFASC_HUMAN	Neurofascin	NFASC KIAA0756	Homo sapiens (Human)	axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226]	axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]	axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226]	cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005887; GO:0005925; GO:0007411; GO:0007420; GO:0007422; GO:0019226; GO:0019904; GO:0030424; GO:0030425; GO:0033010; GO:0033268; GO:0042552; GO:0043194; GO:0050808; GO:0072659; GO:0097454; GO:0098609; GO:0098632; GO:0101003	RSGTLVIDFR	6.070000172	1	1	0.019864039	1162.545745	0	15.60856	14.59651	10.01455	0	0	0	13.76195	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.71689	14.71565	14.85753	0	15.16963	0	0	0	0	0	11.5265	0	0	0	0	0	0	0	0	0	0	0	0
O94874	UFL1_HUMAN	"E3 UFM1-protein ligase 1, EC 2.3.2.- (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1)"	UFL1 KIAA0776 MAXER NLBP RCAD	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]	protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]	GO:0001649; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0008284; GO:0010508; GO:0016020; GO:0016570; GO:0019901; GO:0030218; GO:0031397; GO:0032088; GO:0032434; GO:0032880; GO:0032991; GO:0033146; GO:0034976; GO:0035861; GO:0043005; GO:0043066; GO:0043122; GO:0050727; GO:0060218; GO:0060252; GO:0061666; GO:0061709; GO:0071568; GO:0071569; GO:1902065; GO:1903895; GO:1990592	ATEGSGSMR	11.61999989	1	1	0.036219064	894.8331312	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.954424	0	0	0	0	0	0	8.754951	0	0	13.04446	0	0	16.24598	0	0	0	17.04049	0	0	16.30682	17.38985	0	17.38222	0	17.72816	17.82895	0	0	0	0	0	0
O94875	SRBS2_HUMAN	"Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2, ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin)"	SORBS2 ARGBP2 KIAA0777	Homo sapiens (Human)	actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Z disc [GO:0030018]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]	cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]	GO:0003723; GO:0005200; GO:0005634; GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0008093; GO:0008307; GO:0015629; GO:0016324; GO:0030018; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049	GGDDSK	7.309999943	0.409381747	0.409381747	0.110454563	579.0249295	13.15328	0	15.41287	9.96994	8.80643	0	0	0	16.30157	0	0	13.29156	16.23682	15.16246	13.47941	0	16.49081	0	15.40527	15.14019	0	17.04799	13.81332	15.63165	0	16.48153	15.95077	14.92179	11.66944	0	0	0	16.55881	0	16.17166	13.44625	0	0	16.83792	0	18.86159	0	12.237	0	13.5586	16.14857	15.99675	0
O94885	SASH1_HUMAN	SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein)	SASH1 KIAA0790 PEPE1	Homo sapiens (Human)	positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044]	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044]	G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]	GO:0000209; GO:0001965; GO:0005737; GO:0008022; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498	CGIPEALVQR	13.43999958	1	1	0	1141.4697	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94888	UBXN7_HUMAN	UBX domain-containing protein 7	UBXN7 KIAA0794 UBXD7	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629	QEQELRNGGAIDK	2.950000048	1	1	0.254081198	1456.277461	13.94125	14.05848	16.64098	0	0	11.9322	13.70323	0	12.54459	15.06419	0	16.19833	0	0	0	15.01003	0	0	15.44242	0	0	0	0	0	0	0	0	0	16.4981	0	0	0	0	16.33801	15.98004	16.04214	0	0	16.84195	0	0	0	16.96414	0	0	16.66711	0	16.20377
O94889	KLH18_HUMAN	Kelch-like protein 18	KLHL18 KIAA0795 OK/SW-cl.74	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]		cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567]		GO:0007049; GO:0016567; GO:0051301; GO:1901992	HGAASLGSK	2.809999943	1	1	8.02E-13	827.0347016	12.47534	15.42029	0	13.4883	16.58136	13.91849	13.93467	0	0	0	0	0	15.76116	0	0	0	13.47759	13.51557	0	14.81755	0	13.91963	0	0	0	0	0	0	13.03404	0	15.31401	0	14.66029	16.11088	14.85835	15.07367	0	0	0	0	0	0	0	0	0	14.28791	0	0
O94892	ZN432_HUMAN	Zinc finger protein 432	ZNF432 KIAA0798	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	GFTMKR	11.26000023	0.532623947	0.532623947	0.192609079	756.3570643	0	0	0	0	0	0	15.31599	15.6108	0	0	15.25044	0	17.28466	0	0	0	19.37458	17.74431	18.19042	0	0	14.31772	18.05141	17.52874	16.45192	16.24672	15.78105	16.76922	15.15594	14.96338	0	14.04178	16.15633	15.54176	17.19733	0	16.44915	18.14328	17.51658	16.18621	0	15.30481	0	17.61451	18.31937	19.95675	19.04605	18.06705
O94898	LRIG2_HUMAN	"Leucine-rich repeats and immunoglobulin-like domains protein 2, LIG-2"	LRIG2 KIAA0806 LIG2	Homo sapiens (Human)	innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0031012; GO:0043025; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222	LTVNEMPSFLK	10.90999985	1	1	0.019795204	1294.470937	0	0	0	0	15.30104	0	0	0	0	0	0	0	16.10262	14.02809	0	14.30783	12.72398	0	0	0	16.80062	0	0	14.52601	14.85437	0	0	14.28017	13.74846	0	15.07085	0	14.1182	15.7715	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94901	SUN1_HUMAN	SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1)	SUN1 KIAA0810 UNC84A	Homo sapiens (Human)	centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283]	cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495]	GO:0005521; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0021817; GO:0031965; GO:0034993; GO:0043231; GO:0043495; GO:0051642; GO:0070197; GO:0090292; GO:0140444	CLRNICK	1.899999976	1	1	0.190943448	963.8075214	14.24521	14.17493	0	0	0	0	0	0	13.67564	0	15.28627	0	0	11.96295	0	0	0	0	15.30191	0	0	0	0	0	0	0	16.60734	0	0	16.14038	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94903	PLPHP_HUMAN	"Pyridoxal phosphate homeostasis protein, PLP homeostasis protein (Proline synthase co-transcribed bacterial homolog protein) (Pyridoxal phosphate-binding protein)"	PLPBP PROSC	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; pyridoxal phosphate binding [GO:0030170]	pyridoxal phosphate binding [GO:0030170]	GO:0005737; GO:0005829; GO:0030170	WRAGSMSAELGVGCALR	2.24000001	1	1	0.386705399	1821.544147	15.01456	16.24496	15.23804	11.30474	0	0	0	0	0	0	15.58809	15.8039	0	0	0	0	0	0	13.18425	0	0	0	0	15.26352	0	0	17.10962	0	16.24953	0	0	0	0	17.07512	0	15.80392	0	0	0	0	0	16.14197	0	0	0	0	0	0
O94906	PRP6_HUMAN	"Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1, ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein, U5-102 kDa protein)"	PRPF6 C20orf14	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	androgen receptor binding [GO:0050681]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0000244; GO:0000245; GO:0000375; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0006403; GO:0008380; GO:0016020; GO:0016607; GO:0042802; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013	GTEMCPK	3.680000067	0.371773273	0.371773273	0.192362875	839.4072728	16.10647	14.8613	0	0	0	13.68824	0	16.07526	15.11531	15.75462	16.4452	0	14.68861	16.19457	0	15.31208	15.35307	0	15.4747	0	0	0	0	16.76521	14.29311	17.18737	14.71867	0	0	0	15.8703	0	16.75683	0	0	0	0	14.65133	0	16.19861	14.18033	14.81929	17.31655	0	0	15.69814	16.55549	0
O94907	DKK1_HUMAN	"Dickkopf-related protein 1, Dickkopf-1, Dkk-1, hDkk-1 (SK)"	DKK1 UNQ492/PRO1008	Homo sapiens (Human)	"cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; modulation of age-related behavioral decline [GO:0090647]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"	early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; modulation of age-related behavioral decline [GO:0090647]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"	co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]	GO:0000122; GO:0000904; GO:0001706; GO:0001707; GO:0001942; GO:0002090; GO:0005576; GO:0005615; GO:0005886; GO:0007611; GO:0008083; GO:0010628; GO:0010942; GO:0010977; GO:0030178; GO:0030279; GO:0030326; GO:0030514; GO:0030900; GO:0031901; GO:0032091; GO:0032526; GO:0033137; GO:0039706; GO:0042662; GO:0042663; GO:0043066; GO:0043507; GO:0045813; GO:0048019; GO:0050750; GO:0051966; GO:0060173; GO:0060325; GO:0060394; GO:0061743; GO:0090082; GO:0090090; GO:0090244; GO:0090647; GO:0098883; GO:1901216; GO:1901296; GO:1902949; GO:1904338; GO:1904723; GO:1904958; GO:1905607; GO:2000096; GO:2000726	CYCGEGLSCR	7.789999962	1	1	0.172485997	1261.778312	13.66806	0	0	14.78749	13.03788	13.57109	0	13.93002	0	0	0	0	0	16.25313	0	0	0	13.12324	12.89765	0	0	13.55999	0	13.88464	0	0	0	0	0	0	14.17988	0	0	0	0	14.39206	15.7535	0	0	0	0	0	0	0	0	0	0	0
O94910	AGRL1_HUMAN	"Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1, CIRL-1) (Latrophilin-1) (Lectomedin-2)"	ADGRL1 KIAA0821 LEC2 LPHN1	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse maturation [GO:0090129]	axon [GO:0030424]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]	axon [GO:0030424]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse maturation [GO:0090129]	carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]	GO:0004930; GO:0005886; GO:0005887; GO:0007157; GO:0007166; GO:0007186; GO:0007189; GO:0014069; GO:0016021; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0035584; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0090129	CPGSDVIMVENANYGRTDDK	1.399999976	1	1	1.37E-12	2257.635032	11.61921	12.63423	0	12.66544	15.55301	14.77354	12.74772	0	12.17352	11.37687	13.64783	14.25797	0	0	9.525908	13.47773	13.09453	12.91638	15.96643	13.12857	16.64007	0	0	0	15.56429	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.78691	13.99022	0	0	0	0	0	0	0
O94913	PCF11_HUMAN	Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11)	PCF11 KIAA0824	Homo sapiens (Human)	mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369]	mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0006378; GO:0006379	FDNPR	8.579999924	1	1	0.239556289	648.7561771	15.94829	15.64724	15.61706	15.75846	15.03605	0	16.63859	14.26298	0	15.8195	0	15.22568	0	0	16.69449	0	0	0	0	0	0	0	0	0	15.79508	0	15.6035	17.14151	16.86271	14.4122	17.4624	15.48456	16.84658	15.10756	15.97208	14.8913	17.68996	0	17.54471	17.77995	17.08158	17.00366	0	0	0	16.62584	19.02499	17.75712
O94915	FRYL_HUMAN	Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein)	FRYL AF4P12 KIAA0826	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175]	cell cortex [GO:0005938]; site of polarized growth [GO:0030427]	cell cortex [GO:0005938]; site of polarized growth [GO:0030427]; cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175]		GO:0000902; GO:0005938; GO:0030427; GO:0031175	EFNEPR	8.25	1.35E-05	1.35E-05	0.32090737	791.3414194	17.62293	16.06805	0	0	16.12658	0	16.64143	0	0	0	18.4387	16.96289	0	0	15.32431	0	0	0	16.47833	16.9466	16.66023	0	17.17979	0	17.80722	0	0	0	0	0	17.5433	0	0	0	0	0	19.0828	19.5291	0	18.73024	0	0	0	0	0	0	0	16.83068
O94916	NFAT5_HUMAN	"Nuclear factor of activated T-cells 5, NF-AT5 (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein, TonE-binding protein, TonEBP)"	NFAT5 KIAA0827 TONEBP	Homo sapiens (Human)	calcineurin-NFAT signaling cascade [GO:0033173]; cellular hyperosmotic response [GO:0071474]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular hyperosmotic response [GO:0071474]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0006366; GO:0007165; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:0071474; GO:1901224; GO:1904996; GO:1990837	AMQVESCSSAVGVSNR	6.659999847	1	1	0.212598263	1681.79441	0	0	14.54441	16.08964	13.29615	14.9894	14.22237	0	12.30065	0	0	0	0	0	0	0	0	0	13.48399	0	0	15.37673	0	15.56545	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94923	GLCE_HUMAN	"D-glucuronyl C5-epimerase, EC 5.1.3.17 (Heparan sulfate C5-epimerase, Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)"	GLCE KIAA0836	Homo sapiens (Human)	heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]"	"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]"	GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464	SRFTNVK	1.629999995	1	1	5.79E-13	850.8233737	0	0	0	16.64843	0	0	0	0	0	0	0	0	0	9.178016	16.27685	0	0	0	0	0	0	0	0	0	0	14.48147	0	0	0	0	0	0	0	0	0	0	0	0	14.8194	0	0	0	0	0	0	0	0	0
O94925	GLSK_HUMAN	"Glutaminase kidney isoform, mitochondrial, GLS, EC 3.5.1.2 (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain ]"	GLS GLS1 KIAA0838	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967]	glutaminase activity [GO:0004359]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0045202; GO:0051289; GO:0090461	AQPLVTLCR	5.119999886	1	1	0.296618804	1057.217192	14.92288	0	0	0	0	0	15.39883	0	0	0	0	0	15.21451	15.86595	0	0	15.60802	14.89929	15.9415	15.43349	0	0	0	15.5716	14.49157	16.62012	11.1675	14.35542	15.36456	14.76636	15.54861	0	13.75345	0	15.15529	15.19938	13.84241	14.87205	0	14.48309	0	0	15.30239	14.59062	0	12.6215	12.91934	0
O94927	HAUS5_HUMAN	HAUS augmin-like complex subunit 5	HAUS5 KIAA0841	Homo sapiens (Human)	cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]		GO:0005813; GO:0005829; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:1990498	ENLGQALK	5.159999847	0.2903561	0.2903561	0.183147017	872.7222189	17.66218	17.4924	0	14.56593	19.36279	0	0	0	17.51136	0	17.18186	19.27927	0	0	0	0	0	0	0	0	0	0	18.12932	0	0	0	0	0	0	0	0	0	0	0	18.69129	0	19.12464	0	19.34793	18.58121	0	0	17.08563	0	0	0	18.09902	17.26697
O94929	ABLM3_HUMAN	"Actin-binding LIM protein 3, abLIM-3 (Actin-binding LIM protein family member 3)"	ABLIM3 KIAA0843 HMFN1661	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]"	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]	GO:0001725; GO:0005737; GO:0006351; GO:0015629; GO:0030027; GO:0030032; GO:0030036; GO:0045944; GO:0046872; GO:0051015; GO:0060271; GO:0098978; GO:1903955	VLEAGGK	8.319999695	1	1	0.279509499	672.7130723	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94933	SLIK3_HUMAN	SLIT and NTRK-like protein 3	SLITRK3 KIAA0848	Homo sapiens (Human)	"axonogenesis [GO:0007409]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; synaptic transmission, GABAergic [GO:0051932]; terminal button organization [GO:0072553]"	cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]	"cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; synaptic transmission, GABAergic [GO:0051932]; terminal button organization [GO:0072553]"		GO:0005886; GO:0007409; GO:0009986; GO:0051932; GO:0051965; GO:0072553; GO:0072578; GO:0097116; GO:0098982; GO:0099060; GO:0099560; GO:1905606	ENAWPTKPSSMLSSVHFTASSVEYKSSNK	7.679999828	0.000412888	0.000412888	0.088050434	3199.404457	15.05892	13.92934	15.81327	9.492741	0	0	11.88937	13.39608	14.4539	0	0	0	16.01904	0	0	0	0	0	0	0	14.27786	0	0	0	11.35588	13.59157	11.95425	0	0	0	0	0	0	0	14.25189	0	0	0	0	0	13.81703	0	13.8883	0	0	0	11.69253	13.68025
O94952	FBX21_HUMAN	F-box only protein 21	FBXO21 FBX21 KIAA0875	Homo sapiens (Human)	ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]	cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511]	DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0003677; GO:0004842; GO:0005829; GO:0006511	AGLEARK	1.350000024	1	1	0.079878198	743.7300716	18.53696	16.80236	17.8516	0	16.54399	15.94106	17.33922	16.79087	0	16.96013	17.21138	0	11.45996	17.03477	0	0	16.74216	0	16.98263	17.49717	11.86151	16.10197	18.35961	0	17.31844	15.25396	14.47893	11.29307	0	17.02308	0	18.55983	16.01397	18.23566	17.55451	18.56088	16.52296	0	17.28567	17.23196	16.18422	17.46478	16.30309	11.81059	17.21696	0	17.2282	15.1759
O94953	KDM4B_HUMAN	"Lysine-specific demethylase 4B, EC 1.14.11.66 (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B) ([histone H3]-trimethyl-L-lysine(9) demethylase 4B)"	KDM4B JHDM3B JMJD2B KIAA0876	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]	histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]	GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0051864; GO:0070544; GO:0140684	MGSEDHGAQNPSCKIMTFRPTMEEFK	4.53000021	1	1	0.767545968	3029.10611	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.88975	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94955	RHBT3_HUMAN	"Rho-related BTB domain-containing protein 3, EC 3.6.1.-"	RHOBTB3 KIAA0878	Homo sapiens (Human)	"actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; male gonad development [GO:0008584]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; retrograde transport, endosome to Golgi [GO:0042147]; small GTPase mediated signal transduction [GO:0007264]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; male gonad development [GO:0008584]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; retrograde transport, endosome to Golgi [GO:0042147]; small GTPase mediated signal transduction [GO:0007264]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]	GO:0003924; GO:0005524; GO:0005525; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0008584; GO:0016477; GO:0016887; GO:0019901; GO:0030865; GO:0031267; GO:0031410; GO:0032588; GO:0032956; GO:0042147; GO:0042995; GO:0070062	ELASMNLDIVDLLKK	5.570000172	1	1	0.322655569	1719.882399	0	0	15.59048	0	0	15.21024	0	15.24521	0	0	0	14.07208	16.92071	0	16.64066	0	0	0	0	0	0	0	0	0	15.24959	0	0	16.07434	15.21474	0	14.66031	11.28608	13.43578	0	0	15.048	15.04158	0	0	16.98803	14.21192	0	0	0	0	0	0	16.85515
O94956	SO2B1_HUMAN	"Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B, OATP-B) (Organic anion transporter polypeptide-related protein 2, OATP-RP2, OATPRP2) (Solute carrier family 21 member 9)"	SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005886; GO:0005887; GO:0008514; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016324; GO:0042167; GO:0043252; GO:0055085; GO:0150104	WVGAWWLGFLIAAGAVALAAIPYFFFPKEMPK	4.610000134	1	1	2.74E-12	3583.611742	11.12053	0	0	0	11.17271	0	14.66879	0	0	0	11.63965	0	13.69654	0	0	12.44591	0	0	0	0	0	0	0	0	13.16506	0	0	0	0	16.78461	0	0	0	0	0	0	0	0	0	0	15.46405	12.68548	0	0	0	0	0	0
O94964	SOGA1_HUMAN	"Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form; C-terminal 80 kDa form, 80-kDa SOGA fragment ]"	SOGA1 C20orf117 KIAA0889 SOGA	Homo sapiens (Human)	insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506]		GO:0005615; GO:0008286; GO:0010506; GO:0045721; GO:0070062	ADAVLGCSVK	10.60999966	1	1	0.191265247	1023.433279	0	0	14.71086	0	0	15.94298	14.39545	14.87899	0	0	14.87401	0	15.96146	0	16.19555	0	0	15.07488	0	0	15.90263	0	16.34573	0	0	0	0	15.36543	0	0	0	16.13195	16.38376	15.95631	0	0	13.54418	12.50988	14.11225	15.05546	16.01529	15.16737	12.06849	15.91851	15.22547	0	0	0
O94966	UBP19_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 19, EC 3.4.19.12 (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9)"	USP19 KIAA0891 ZMYND9	Homo sapiens (Human)	negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0004843; GO:0005789; GO:0005829; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380	AVPPGNDPVSPAMVR	6.070000172	1	1	0.298919967	1508.101458	0	16.72966	0	16.40651	0	16.33445	0	0	0	0	15.05244	16.53962	0	16.36223	16.43638	0	16.91441	15.6039	0	0	0	0	0	0	0	16.45965	0	0	0	0	0	0	0	0	0	0	0	0	17.65721	16.67731	16.91099	16.70514	15.33278	0	0	0	16.99473	0
O94972	TRI37_HUMAN	"E3 ubiquitin-protein ligase TRIM37, EC 2.3.2.27 (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37)"	TRIM37 KIAA0898 MUL POB1	Homo sapiens (Human)	aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]	chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003682; GO:0003713; GO:0004842; GO:0005164; GO:0005737; GO:0005777; GO:0005829; GO:0008270; GO:0016235; GO:0031625; GO:0032088; GO:0035518; GO:0036353; GO:0042803; GO:0046600; GO:0048471; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070842	CMKTDVK	5.070000172	1	1	0.19152324	879.77097	0	15.73829	0	0	0	0	0	15.24903	15.01971	14.92702	15.85019	11.6877	0	13.99677	0	12.66343	0	0	15.66536	0	14.8186	0	0	0	0	0	0	0	0	0	16.782	0	0	0	16.87324	0	0	0	0	0	16.42038	0	0	0	0	0	0	0
O94973	AP2A2_HUMAN	"AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9, HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)"	AP2A2 ADTAB CLAPA2 HIP9 HYPJ KIAA0899	Homo sapiens (Human)	clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]	GO:0005829; GO:0005886; GO:0006886; GO:0006898; GO:0008289; GO:0009898; GO:0016192; GO:0019901; GO:0030122; GO:0030666; GO:0030667; GO:0030669; GO:0031410; GO:0035615; GO:0036020; GO:0045334; GO:0072583; GO:0097718; GO:0098884; GO:0101003; GO:0140312	LYRTSPDLVPMGDWTSR	2.359999895	0.093104161	0.093104161	0.330516494	1994.078953	13.46311	14.27246	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53668	13.99116	0	13.81557	0	0	0	0	0	13.49735	11.03064	13.14041	13.11609	13.26766	16.28258	14.65194	14.23454	0	0	13.34244	0	0	0	0	13.05181	0	0	0	0	17.17381	0	0	14.96924
O94983	CMTA2_HUMAN	Calmodulin-binding transcription activator 2	CAMTA2 KIAA0909	Homo sapiens (Human)	cardiac muscle hypertrophy in response to stress [GO:0014898]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cardiac muscle hypertrophy in response to stress [GO:0014898]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000785; GO:0003682; GO:0003690; GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0014898; GO:0042826; GO:0043565; GO:0045944	QIIEATPERIK	4.659999847	1	1	2.35E-13	1298.816855	0	0	0	0	0	0	0	0	0	0	16.59983	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O94985	CSTN1_HUMAN	"Calsyntenin-1 (Alcadein-alpha, Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha, SAlc-alpha; CTF1-alpha (C-terminal fragment 1-alpha) ]"	CLSTN1 CS1 KIAA0911	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003]	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003]	amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]	GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0014069; GO:0016021; GO:0019894; GO:0042988; GO:0043005; GO:0045211; GO:0050806; GO:0051965; GO:0090128; GO:0098845; GO:0098969; GO:0098978; GO:0099003	LIFLFR	15.18999958	0.014072784	0.014072784	0.25845811	808.6025659	19.21131	17.66228	0	18.83372	17.38361	0	20.59017	18.2932	20.27765	19.1927	19.6217	17.32143	16.64833	18.46679	17.5235	21.88412	19.05927	20.73772	19.93978	18.81689	20.42039	20.31653	0	20.06093	19.64735	0	20.04351	0	17.92034	19.438	0	0	19.62496	19.5573	20.67639	0	21.71114	0	20.72692	20.98789	19.85086	17.22446	0	0	21.45955	20.47965	18.8448	0
O94988	FA13A_HUMAN	Protein FAM13A	FAM13A FAM13A1 KIAA0914	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0051056	DMPKPPPKTK	5.769999981	0.264366329	0.264366329	0.198139566	1150.553975	13.96203	13.82053	12.34712	15.61758	0	0	15.3633	16.67415	14.33005	15.17071	15.85157	0	12.45894	12.32674	13.32957	13.53548	13.77809	0	14.41068	0	13.10549	0	16.02696	0	15.32196	15.67384	0	0	15.66672	15.62927	0	16.7396	11.58265	14.09526	15.43229	15.00942	16.36359	0	16.03077	15.05145	14.66564	0	0	0	0	0	0	15.45818
O94991	SLIK5_HUMAN	SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11)	SLITRK5 KIAA0918 LRRC11	Homo sapiens (Human)	axonogenesis [GO:0007409]; regulation of presynapse assembly [GO:1905606]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; axonogenesis [GO:0007409]; regulation of presynapse assembly [GO:1905606]		GO:0005886; GO:0007409; GO:0016021; GO:0043235; GO:1905606	GILEPDK	3.079999924	0.723750532	0.723750532	0.11957086	771.1953835	0	13.75394	15.39575	13.16529	0	14.12646	0	0	15.54332	15.11405	0	0	14.73004	0	0	0	15.13612	0	15.74449	0	14.76906	16.33997	16.08682	0	0	0	0	0	0	0	15.85127	0	0	0	0	0	0	0	0	0	15.16206	0	0	0	0	0	13.86282	0
O94993	SOX30_HUMAN	Transcription factor SOX-30	SOX30	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286]	chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286]"	"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007286; GO:0008013; GO:0010369; GO:0030178; GO:0031960; GO:0043231; GO:0045944; GO:0120211; GO:1990837	MQSLLEPSVK	18.94000053	1	1	0.358653986	1131.808457	0	19.66133	17.40363	18.61578	0	0	0	0	0	0	19.20435	19.21061	0	17.94836	17.79293	20.34134	0	0	19.17558	0	0	19.2517	19.28076	18.17122	0	0	0	0	0	0	0	0	20.42834	20.0076	0	0	20.10535	0	0	0	0	0	0	0	0	19.13557	0	0
O95067	CCNB2_HUMAN	G2/mitotic-specific cyclin-B2	CCNB2	Homo sapiens (Human)	cell division [GO:0051301]; G2/MI transition of meiotic cell cycle [GO:0008315]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; spindle assembly involved in female meiosis I [GO:0007057]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; G2/MI transition of meiotic cell cycle [GO:0008315]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; spindle assembly involved in female meiosis I [GO:0007057]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]	cadherin binding [GO:0045296]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0001701; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0007057; GO:0008315; GO:0015630; GO:0016020; GO:0016538; GO:0040008; GO:0043029; GO:0044772; GO:0045296; GO:0048538; GO:0051301	KLQLVGITALLLASK	15.19999981	1	1	0.551760286	1567.403097	0	19.58301	0	0	0	0	0	0	0	19.91162	0	0	0	0	0	0	0	17.70762	0	0	0	0	19.91612	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.20503	0	18.17787	0	0	18.8226	0	0	0	0	0
O95069	KCNK2_HUMAN	Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK-1) (Two pore potassium channel TPKC1)	KCNK2 TREK TREK1	Homo sapiens (Human)	cardiac ventricle development [GO:0003231]; cellular response to hypoxia [GO:0071456]; cochlea development [GO:0090102]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of cell death [GO:0010942]; positive regulation of cellular response to hypoxia [GO:1900039]; potassium ion transmembrane transport [GO:0071805]; response to axon injury [GO:0048678]; response to mechanical stimulus [GO:0009612]; stabilization of membrane potential [GO:0030322]	apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; outward rectifier potassium channel activity [GO:0015271]; potassium channel inhibitor activity [GO:0019870]; potassium ion leak channel activity [GO:0022841]; cardiac ventricle development [GO:0003231]; cellular response to hypoxia [GO:0071456]; cochlea development [GO:0090102]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of cell death [GO:0010942]; positive regulation of cellular response to hypoxia [GO:1900039]; potassium ion transmembrane transport [GO:0071805]; response to axon injury [GO:0048678]; response to mechanical stimulus [GO:0009612]; stabilization of membrane potential [GO:0030322]	outward rectifier potassium channel activity [GO:0015271]; potassium channel inhibitor activity [GO:0019870]; potassium ion leak channel activity [GO:0022841]	GO:0003231; GO:0005634; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007186; GO:0007613; GO:0008076; GO:0009612; GO:0009986; GO:0010942; GO:0015271; GO:0016324; GO:0019870; GO:0022841; GO:0030322; GO:0043025; GO:0044305; GO:0048678; GO:0060044; GO:0071456; GO:0071805; GO:0090102; GO:0097449; GO:1900039; GO:2000279	WNVSQTK	3.279999971	1	1	0.058004156	863.2910399	16.57471	17.55281	13.23041	0	0	0	0	13.3838	15.97404	14.85193	14.77557	0	0	0	0	0	0	0	0	0	0	0	15.65031	0	0	0	0	0	0	0	0	0	0	14.0722	15.48198	16.58194	13.32708	0	0	16.77021	15.88467	0	0	0	0	0	0	0
O95071	UBR5_HUMAN	"E3 ubiquitin-protein ligase UBR5, EC 2.3.2.26 (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog, hHYD) (Progestin-induced protein)"	UBR5 EDD EDD1 HYD KIAA0896	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016020; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000779; GO:2000780	AAVIIMAVEK	4.519999981	0.513791203	0.513791203	0.225211202	1061.059381	0	15.86914	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95081	AGFG2_HUMAN	"Arf-GAP domain and FG repeat-containing protein 2 (HIV-1 Rev-binding protein-like protein) (Rev/Rex activation domain-binding protein related, RAB-R)"	AGFG2 HRBL RABR	Homo sapiens (Human)		membrane [GO:0016020]	membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0016020; GO:0046872	GPGPGGGVSGGK	5.260000229	1	1	3.45E-13	925.5881985	0	0	17.22941	0	0	0	12.05638	0	0	0	17.52227	18.85374	0	0	0	0	0	0	0	0	0	0	15.8828	0	0	0	0	0	0	0	0	0	0	0	0	14.219	18.57976	0	0	0	15.12708	17.29328	0	0	13.78754	0	0	0
O95104	SCAF4_HUMAN	"SR-related and CTD-associated factor 4 (CTD-binding SR-like protein RA4) (Splicing factor, arginine/serine-rich 15)"	SCAF4 KIAA1172 SFRS15	Homo sapiens (Human)	"mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]"	protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008022; GO:1990269; GO:2000805	RSPDR	7.789999962	1	1	0.20859683	631.1629617	0	0	0	0	0	0	14.95545	0	13.22326	0	14.24735	0	0	0	0	0	0	12.92475	0	0	0	0	0	0	0	18.17812	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95140	MFN2_HUMAN	"Mitofusin-2, EC 3.6.5.- (Transmembrane GTPase MFN2)"	MFN2 CPRP1 KIAA0214	Homo sapiens (Human)	apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]	GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007006; GO:0008053; GO:0015630; GO:0016021; GO:0031306; GO:0031625; GO:0034497; GO:0046580; GO:0048593; GO:0048662; GO:0051646; GO:0061734; GO:0120162; GO:1904707; GO:1905461	LTWTTK	4.699999809	0.369828045	0.369828045	0.228564489	750.3749884	14.46221	15.21791	15.1535	0	15.74957	0	14.0288	0	15.29633	0	0	16.043	15.8892	16.56269	0	17.46918	15.92064	0	0	15.49467	0	0	0	18.44405	0	0	0	15.71855	15.55786	0	16.52274	0	16.33293	15.93428	16.71765	0	16.11595	16.85386	15.85909	0	16.74379	16.33973	0	16.06932	16.94959	15.89521	16.73771	0
O95153	RIMB1_HUMAN	"Peripheral-type benzodiazepine receptor-associated protein 1, PRAX-1 (Peripheral benzodiazepine receptor-interacting protein, PBR-IP) (RIMS-binding protein 1, RIM-BP1) (TSPO-associated protein 1)"	TSPOAP1 BZRAP1 KIAA0612 RBP1 RIMBP1	Homo sapiens (Human)		calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]	benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]	GO:0005737; GO:0005739; GO:0005829; GO:0030156; GO:0044305; GO:0098978; GO:0099626	EHEGAVQLLESTLDSMQARVR	2.700000048	1	1	0.031051392	2385.280298	13.48974	0	12.21145	0	11.67297	12.31898	13.23788	12.72703	13.81313	0	0	12.40353	12.46944	14.46071	0	13.01063	11.36925	17.85204	0	0	0	0	0	0	14.27527	10.39928	16.05426	0	0	0	0	0	0	0	15.31461	0	13.18053	0	0	12.41182	0	13.19598	0	0	0	0	0	0
O95155	UBE4B_HUMAN	"Ubiquitin conjugation factor E4 B, EC 2.3.2.27 (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2)"	UBE4B HDNB1 KIAA0684 UFD2	Homo sapiens (Human)	granzyme-mediated apoptotic signaling pathway [GO:0008626]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0008626; GO:0009411; GO:0019899; GO:0030433; GO:0034450; GO:0043161	LLVPSLMK	6.309999943	1	1	0.099159056	901.4984751	14.55632	15.1825	15.62775	16.00388	12.01884	0	0	0	14.95549	15.34287	17.47262	13.02136	0	0	0	13.58183	12.51111	0	15.19981	0	15.46894	0	14.45175	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.78442	0	0	0	0	0
O95171	SCEL_HUMAN	Sciellin	SCEL	Homo sapiens (Human)	embryo development ending in birth or egg hatching [GO:0009792]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; response to mechanical stimulus [GO:0009612]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; embryo development ending in birth or egg hatching [GO:0009792]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; response to mechanical stimulus [GO:0009612]	metal ion binding [GO:0046872]	GO:0001533; GO:0005737; GO:0008544; GO:0009612; GO:0009792; GO:0030216; GO:0046872; GO:0048471; GO:0070062; GO:0090263	MNKTSR	7.630000114	1.07E-05	1.07E-05	0.147499025	752.3744777	0	14.93537	14.3331	16.41783	18.06657	14.30923	11.56185	0	0	14.69351	17.40523	16.95333	17.78633	17.64554	15.10047	0	0	17.60315	0	13.96019	0	17.55538	15.22509	12.4424	13.79018	0	0	0	15.90129	14.17174	15.12617	0	19.73731	0	14.18579	0	17.75187	16.85629	17.28621	0	15.32721	0	13.72335	15.11189	17.68812	13.95462	18.55629	17.91195
O95180	CAC1H_HUMAN	Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2)	CACNA1H	Homo sapiens (Human)	aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008332; GO:0016021; GO:0019228; GO:0032342; GO:0032870; GO:0034651; GO:0034765; GO:0035865; GO:0042391; GO:0043005; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:2000344	TEGARAADEVR	8.050000191	1	1	0.062745499	1177.313865	0	0	0	0	15.40833	12.726	0	0	12.58994	14.60891	0	12.68196	0	11.13263	0	12.2099	0	11.87803	0	0	0	0	0	9.736792	14.45486	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.56714	0
O95197	RTN3_HUMAN	"Reticulon-3 (Homolog of ASY protein, HAP) (Neuroendocrine-specific protein-like 2, NSP-like protein 2) (Neuroendocrine-specific protein-like II, NSP-like protein II, NSPLII)"	RTN3 ASYIP NSPL2	Homo sapiens (Human)	apoptotic process [GO:0006915]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of amyloid-beta formation [GO:1902430]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; apoptotic process [GO:0006915]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of amyloid-beta formation [GO:1902430]; vesicle-mediated transport [GO:0016192]		GO:0000139; GO:0005615; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006915; GO:0016021; GO:0016192; GO:0045202; GO:0071786; GO:0071787; GO:1902430	EFKDSYK	3.960000038	0.344505519	0.344505519	0.118196915	916.9516922	17.78113	16.20635	16.18097	15.20245	13.51808	16.10883	0	0	16.10311	16.73683	16.72233	17.04469	15.2304	0	0	0	0	16.21337	0	17.07598	0	16.22158	17.0811	16.47489	19.08641	13.77998	15.43039	17.08866	12.48336	13.38523	17.34259	0	17.43588	18.02341	12.28403	14.76054	17.07106	14.2024	16.09004	16.91729	0	15.19614	15.08685	16.48494	16.50581	0	14.44461	0
O95206	PCDH8_HUMAN	Protocadherin-8 (Arcadlin)	PCDH8	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of embryonic epithelium [GO:0016331]; regulation of synaptic membrane adhesion [GO:0099179]; somitogenesis [GO:0001756]	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of embryonic epithelium [GO:0016331]; regulation of synaptic membrane adhesion [GO:0099179]; somitogenesis [GO:0001756]	calcium ion binding [GO:0005509]	GO:0001756; GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007268; GO:0016331; GO:0030425; GO:0042734; GO:0098978; GO:0099055; GO:0099179	EGDGQLTVGDAGLDR	4.809999943	1	1	0.298861363	1502.125357	0	0	0	0	14.83615	15.29737	14.87025	0	0	14.29632	14.28819	13.84926	13.86171	14.97077	13.39788	0	13.71975	0	14.45836	0	14.47664	15.34187	16.54905	0	0	0	0	0	0	0	0	0	0	0	0	0	16.25907	0	0	14.38706	0	14.946	0	0	12.85244	15.65828	0	0
O95218	ZRAB2_HUMAN	"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)"	ZRANB2 ZIS ZNF265	Homo sapiens (Human)	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0001530; GO:0003723; GO:0005654; GO:0006397; GO:0008380; GO:0046872	SSSSSQSR	12.27000046	1	1	0.426538921	825.4717574	0	0	0	0	0	17.0361	0	0	0	0	0	0	0	19.20469	0	0	0	18.2085	0	0	17.11318	0	19.29464	16.84844	18.79411	0	0	0	17.18979	18.52827	0	0	0	0	19.21564	0	18.79706	0	17.12213	19.74072	0	0	17.22799	19.88811	19.66656	20.00569	17.24561	0
O95219	SNX4_HUMAN	Sorting nexin-4	SNX4	Homo sapiens (Human)	endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459]; endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]	epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459]	GO:0005154; GO:0005158; GO:0005737; GO:0005769; GO:0005868; GO:0005886; GO:0015031; GO:0016020; GO:0031201; GO:0031901; GO:0032266; GO:0032456; GO:0032991; GO:0035091; GO:1903595; GO:1990459; GO:1990460; GO:2000786	VKNPDK	5.639999866	1	1	0.217259045	699.8482731	0	0	0	0	18.12345	0	18.99302	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42479	0	0	0	0	0	0	0	0	18.05341	0	0	0	0	0	0	0	0	0	0	0
O95221	OR5F1_HUMAN	"Olfactory receptor 5F1 (Olfactory receptor 11-10, OR11-10) (Olfactory receptor OR11-167)"	OR5F1	Homo sapiens (Human)	sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007608; GO:0016021	RTSSFL	8.75	1	1	0.183068011	711.4092084	15.3505	0	15.35603	0	0	0	0	0	14.98193	14.6615	0	0	16.56526	14.40646	12.45273	15.03292	15.25062	14.79173	13.5228	16.3156	16.0244	0	12.81763	0	0	14.46406	0	0	15.85322	15.6923	0	16.86955	0	0	14.28746	0	16.98678	15.13866	17.36036	16.01005	15.5636	15.29562	0	0	0	16.28754	15.94148	0
O95222	OR6A2_HUMAN	"Olfactory receptor 6A2 (Olfactory receptor 11-55, OR11-55) (Olfactory receptor 6A1) (Olfactory receptor OR11-83) (hP2 olfactory receptor)"	OR6A2 OR6A1 OR6A2P	Homo sapiens (Human)	sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0007608; GO:0016021	NQEVKR	18.82999992	1	1	0.223335387	772.2343804	0	14.39268	16.27769	0	15.53235	0	0	15.40941	0	0	0	0	15.36715	18.11714	17.06237	11.74928	17.0323	15.98536	0	0	0	0	15.66644	12.48825	0	0	0	15.35427	0	14.87418	0	0	0	16.29295	18.24002	0	0	0	16.04887	0	16.99086	0	16.48337	0	0	0	16.73166	0
O95229	ZWINT_HUMAN	"ZW10 interactor (ZW10-interacting protein 1, Zwint-1)"	ZWINT	Homo sapiens (Human)	cell division [GO:0051301]; establishment of localization in cell [GO:0051649]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein N-terminus binding [GO:0047485]; cell division [GO:0051301]; establishment of localization in cell [GO:0051649]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]	protein N-terminus binding [GO:0047485]	GO:0000070; GO:0000776; GO:0005654; GO:0005737; GO:0005829; GO:0007094; GO:0016604; GO:0030425; GO:0031617; GO:0047485; GO:0051301; GO:0051649	DPGVSFK	3.099999905	1	1	0.012319578	748.8880201	0	14.67204	14.92634	14.18153	0	0	14.13851	13.14845	11.90975	11.17278	0	15.92027	0	0	16.00469	0	0	0	0	0	15.37705	0	0	0	0	0	0	0	13.82149	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.96772	0	0	0	0
O95232	LC7L3_HUMAN	"Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1, CRE-associated protein 1, CREAP-1)"	LUC7L3 CREAP1 CROP O48	Homo sapiens (Human)	mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004	QHMGYAK	5.349999905	1	1	6.89E-13	834.0770096	14.55214	0	0	0	11.51802	12.33358	0	13.79305	0	0	0	14.02512	0	11.21696	14.34593	0	6.858786	12.83064	0	0	0	0	0	0	0	0	0	14.76944	0	0	11.70316	0	0	14.86858	0	0	0	0	15.26216	0	0	0	0	0	0	0	0	0
O95237	LRAT_HUMAN	"Lecithin retinol acyltransferase, EC 2.3.1.135 (Phosphatidylcholine--retinol O-acyltransferase)"	LRAT	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of lipid transport [GO:0032370]; response to bacterium [GO:0009617]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; acyltransferase activity [GO:0016746]; lecithin:11-cis retinol acyltransferase activity [GO:0102279]; O-palmitoyltransferase activity [GO:0016416]; phosphatidylcholine-retinol O-acyltransferase activity [GO:0047173]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of lipid transport [GO:0032370]; response to bacterium [GO:0009617]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776]	acyltransferase activity [GO:0016746]; lecithin:11-cis retinol acyltransferase activity [GO:0102279]; O-palmitoyltransferase activity [GO:0016416]; phosphatidylcholine-retinol O-acyltransferase activity [GO:0047173]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]	GO:0001523; GO:0001972; GO:0005771; GO:0005783; GO:0005789; GO:0005791; GO:0006776; GO:0007601; GO:0009617; GO:0016021; GO:0016416; GO:0016746; GO:0019841; GO:0032370; GO:0032526; GO:0033189; GO:0042572; GO:0047173; GO:0048471; GO:0102279; GO:1990830	NSFYETSSFHR	6.409999847	1	1	0.113206003	1375.401053	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.47882	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.70563	0	0	0	0	0	0	0	0	0
O95238	SPDEF_HUMAN	"SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor, Prostate-specific Ets) (Prostate-derived Ets factor)"	SPDEF PDEF PSE	Homo sapiens (Human)	cell differentiation [GO:0030154]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000981; GO:0005634; GO:0006357; GO:0010454; GO:0010455; GO:0030154; GO:0043065; GO:0043565; GO:0045944; GO:0060480; GO:0060576; GO:1990837	SAAWMK	9.840000153	1	1	0.235704842	708.8684024	17.1757	18.36908	13.83969	17.56962	0	15.81594	15.24125	18.74941	15.34993	0	0	0	15.45466	15.0319	0	15.50113	16.51878	15.11355	14.14798	0	0	0	16.45162	0	0	0	0	0	16.69664	17.76663	0	0	17.69477	0	0	0	0	18.46489	0	15.79307	0	17.83702	0	16.2931	0	0	0	16.75269
O95243	MBD4_HUMAN	"Methyl-CpG-binding domain protein 4, EC 3.2.2.- (Methyl-CpG-binding endonuclease 1) (Methyl-CpG-binding protein MBD4) (Mismatch-specific DNA N-glycosylase)"	MBD4 MED1	Homo sapiens (Human)	depyrimidination [GO:0045008]; DNA repair [GO:0006281]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]	DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]	GO:0003677; GO:0003696; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0008263; GO:0016607; GO:0019104; GO:0045008	EDVAMELERVGEDEEQMMIK	9.449999809	0.380656064	0.380656064	0.15805646	2412.550923	0	17.59369	16.82084	16.03253	17.10279	18.23702	0	18.80352	19.21604	18.31724	16.99654	17.45902	17.11166	16.3855	0	0	0	18.2578	0	0	17.67142	18.00657	17.47399	0	16.70946	17.18995	0	17.52957	0	18.11828	0	18.41122	16.76201	18.38701	18.59245	18.43717	17.49526	18.52682	17.03505	0	17.15352	17.38118	18.33039	17.81917	18.6608	15.29526	0	17.34332
O95248	MTMR5_HUMAN	"Myotubularin-related protein 5 (Inactive phosphatidylinositol 3-phosphatase 5) (SET-binding factor 1, Sbf1)"	SBF1 MTMR5	Homo sapiens (Human)	protein dephosphorylation [GO:0006470]; regulation of GTPase activity [GO:0043087]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]; regulation of GTPase activity [GO:0043087]; spermatid development [GO:0007286]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0005085; GO:0005737; GO:0005789; GO:0005829; GO:0006470; GO:0007286; GO:0008138; GO:0016021; GO:0016604; GO:0019208; GO:0043087; GO:0048471	MTMSSLVER	12.11999989	1	1	0.197667825	1069.72279	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95249	GOSR1_HUMAN	"Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28, GOS-28)"	GOSR1 GS28	Homo sapiens (Human)	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]"	SNAP receptor activity [GO:0005484]	GO:0000139; GO:0005484; GO:0005794; GO:0005797; GO:0005801; GO:0005829; GO:0006888; GO:0006891; GO:0006906; GO:0015031; GO:0016020; GO:0016021; GO:0030133; GO:0031201; GO:0042147	ENLMGSVR	20.01000023	1	1	0.293039521	910.0421879	0	0	17.68238	0	0	13.96199	0	0	0	0	0	15.707	0	0	14.74637	13.37754	16.29329	0	16.2716	0	0	0	0	0	16.68111	17.09714	0	15.9694	0	0	19.85723	0	0	15.66603	0	16.41302	0	0	0	15.33826	15.69237	0	0	16.64233	0	0	0	0
O95251	KAT7_HUMAN	"Histone acetyltransferase KAT7, EC 2.3.1.48 (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2, MYST-2)"	KAT7 HBO1 HBOa MYST2	Homo sapiens (Human)	"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]"	DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000123; GO:0000775; GO:0001558; GO:0001779; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006275; GO:0006281; GO:0006325; GO:0006355; GO:0008270; GO:0016570; GO:0018393; GO:0030174; GO:0031098; GO:0032786; GO:0036409; GO:0042393; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045648; GO:0045740; GO:0045892; GO:0045944; GO:0051726; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:0090734; GO:1900182; GO:1902035; GO:2000278; GO:2000819	DMSLKDSGSDLSHRPK	1.700000048	1	1	0.383182467	1788.810613	17.1493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.07319	0	0	16.29624	0	0	0
O95255	MRP6_HUMAN	"ATP-binding cassette sub-family C member 6, EC 7.6.2.-, EC 7.6.2.3 (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E, MOAT-E) (Multidrug resistance-associated protein 6)"	ABCC6 ARA MRP6	Homo sapiens (Human)	ATP metabolic process [GO:0046034]; ATP transport [GO:0015867]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; cellular phosphate ion homeostasis [GO:0030643]; gene expression [GO:0010467]; inorganic diphosphate transport [GO:0030505]; leukotriene transport [GO:0071716]; phosphate ion homeostasis [GO:0055062]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP metabolic process [GO:0046034]; ATP transport [GO:0015867]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; cellular phosphate ion homeostasis [GO:0030643]; gene expression [GO:0010467]; inorganic diphosphate transport [GO:0030505]; leukotriene transport [GO:0071716]; phosphate ion homeostasis [GO:0055062]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]	ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]	GO:0005524; GO:0005576; GO:0005654; GO:0005789; GO:0005886; GO:0007601; GO:0009410; GO:0010467; GO:0015431; GO:0015867; GO:0016020; GO:0016021; GO:0016323; GO:0030505; GO:0030643; GO:0032026; GO:0042626; GO:0043225; GO:0046034; GO:0055062; GO:0055074; GO:0055085; GO:0071716; GO:0110148; GO:1904383	GGSGMK	4.769999981	0.587293684	0.587293684	0.22225867	553.4783898	15.30953	14.99021	17.02662	14.21694	14.627	15.8136	0	0	13.57329	0	16.34831	16.35523	14.70198	15.69985	15.6251	15.94639	16.05392	0	14.87199	15.27765	15.6243	16.46009	15.75551	14.21219	0	0	16.40532	0	14.63259	13.7217	0	0	0	0	16.39523	0	16.75243	0	0	0	13.5108	15.96226	0	0	0	0	15.06683	0
O95258	UCP5_HUMAN	"Brain mitochondrial carrier protein 1, BMCP-1 (Mitochondrial uncoupling protein 5, UCP 5) (Solute carrier family 25 member 14)"	SLC25A14 BMCP1 UCP5 UNQ791/PRO1682	Homo sapiens (Human)	aerobic respiration [GO:0009060]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; aerobic respiration [GO:0009060]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]	GO:0005739; GO:0005743; GO:0005887; GO:0006839; GO:0008272; GO:0009060; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0035435; GO:0071422; GO:0071423	GIFPGIILIFLR	35.18000031	0.823441505	0.823441505	0.448124272	1357.984929	0	18.14391	0	18.83305	0	19.09233	18.61359	0	0	0	0	18.38532	19.20262	0	18.73328	18.92178	18.08693	18.68916	18.69314	17.75084	18.91332	18.81315	18.91315	19.09915	18.59063	0	0	0	0	19.02478	17.91822	0	17.9355	18.54943	0	0	0	19.08127	0	18.3962	0	0	0	0	18.91561	0	0	0
O95259	KCNH1_HUMAN	"Potassium voltage-gated channel subfamily H member 1 (Ether-a-go-go potassium channel 1, EAG channel 1, h-eag, hEAG1) (Voltage-gated potassium channel subunit Kv10.1)"	KCNH1 EAG EAG1	Homo sapiens (Human)	cellular response to calcium ion [GO:0071277]; myoblast fusion [GO:0007520]; phosphatidylinositol-mediated signaling [GO:0048015]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of cell population proliferation [GO:0042127]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	axon [GO:0030424]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]	axon [GO:0030424]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; phosphatidylinositol bisphosphate binding [GO:1902936]; voltage-gated potassium channel activity [GO:0005249]; cellular response to calcium ion [GO:0071277]; myoblast fusion [GO:0007520]; phosphatidylinositol-mediated signaling [GO:0048015]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of cell population proliferation [GO:0042127]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; phosphatidylinositol bisphosphate binding [GO:1902936]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005516; GO:0005637; GO:0005886; GO:0005887; GO:0006813; GO:0007520; GO:0008076; GO:0030424; GO:0030425; GO:0031901; GO:0034765; GO:0042127; GO:0042391; GO:0042734; GO:0043204; GO:0043231; GO:0048015; GO:0071277; GO:0071805; GO:0098839; GO:1902936	ESQGISSLFSSLKVVR	8.409999847	1	1	0.016867057	1735.852081	0	0	14.28423	0	11.83112	12.04894	0	14.5526	15.10628	0	0	13.19061	0	0	14.22025	14.35086	13.0247	15.50413	0	13.91516	14.36742	16.10558	16.03771	13.3992	14.87984	15.73699	16.27779	12.36313	12.41978	11.53031	15.51658	13.02151	14.91582	15.21298	0	15.20596	15.22333	0	0	14.20305	13.98263	0	0	0	0	0	17.00291	0
O95263	PDE8B_HUMAN	"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B, HsPDE8B, EC 3.1.4.53 (Cell proliferation-inducing gene 22 protein)"	PDE8B PIG22	Homo sapiens (Human)	cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165]	cytosol [GO:0005829]	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0046872	ASGPPSVAR	8.43999958	0.892270744	0.892270744	0.274750574	840.9836196	15.88018	14.8455	13.6723	0	0	15.02654	16.01928	15.64613	15.6014	0	16.79493	15.66018	0	0	14.84923	0	15.48935	14.94582	0	15.30025	16.21923	14.64706	16.21435	14.19252	0	0	13.91444	15.07901	0	0	15.39419	0	0	15.69883	15.63753	15.18196	0	14.89043	17.39093	14.72698	16.75428	15.7185	0	15.71218	15.73856	0	0	16.63415
O95271	TNKS1_HUMAN	"Poly [ADP-ribose] polymerase tankyrase-1, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 5, ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1, EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1, TANK1)"	TNKS PARP5A PARPL TIN1 TINF1 TNKS1	Homo sapiens (Human)	"cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"	histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404	GRTQLCALLLAHGADPTMK	5.630000114	1	1	0.22393652	2069.70416	14.64111	0	14.51488	0	11.53749	11.63343	0	0	0	0	0	0	15.55182	0	13.84185	0	0	14.52172	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95292	VAPB_HUMAN	"Vesicle-associated membrane protein-associated protein B/C, VAMP-B/VAMP-C, VAMP-associated protein B/C, VAP-B/VAP-C"	VAPB UNQ484/PRO983	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of viral genome replication [GO:0045070]; suppression of viral release by host [GO:0044790]; viral release from host cell [GO:0019076]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular calcium ion homeostasis [GO:0006874]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of viral genome replication [GO:0045070]; suppression of viral release by host [GO:0044790]; viral release from host cell [GO:0019076]	beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006874; GO:0006888; GO:0007029; GO:0008017; GO:0016021; GO:0019076; GO:0019899; GO:0030968; GO:0033149; GO:0036498; GO:0042803; GO:0044790; GO:0044828; GO:0044829; GO:0044830; GO:0045070; GO:0045296; GO:0046725; GO:0046982; GO:0048487; GO:0061817; GO:0090114; GO:0090158	FMVQSMFAPTDTSDMEAVWK	1.690000057	0.095172949	0.095172949	1.00E-11	2368.378854	0	0	15.80339	0	0	15.78047	13.36515	0	0	0	0	0	0	0	0	0	15.63542	0	0	0	13.78765	0	0	16.75773	13.06943	0	0	18.48545	0	0	15.87998	14.58382	0	12.37493	16.21254	16.02463	0	14.43169	0	0	0	0	0	0	0	13.38123	15.03588	15.55999
O95294	RASL1_HUMAN	RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein)	RASAL1 RASAL	Homo sapiens (Human)	cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0030154; GO:0035556; GO:0043087; GO:0046580; GO:0046872; GO:0071277; GO:1903861	LFDLRDQHADPQTSR	3.869999886	1	1	0.16104002	1798.681687	0	0	0	0	0	0	0	16.15533	0	0	0	0	0	0	0	0	14.96852	15.80866	0	0	0	0	0	0	0	14.01244	0	0	0	16.40719	0	14.43898	0	0	0	0	0	0	0	0	16.55867	0	0	0	0	0	0	0
O95299	NDUAA_HUMAN	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD, CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)"	NDUFA10	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005737; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776	VRGIHSSVQCK	2.099999905	1	1	0.266416682	1272.301144	0	0	0	0	0	0	0	0	0	0	0	0	0	15.55236	0	0	0	0	0	17.35388	0	0	0	0	0	15.13785	0	0	15.46331	0	15.87122	16.31893	15.40883	0	0	0	0	0	17.23899	0	0	0	0	0	0	0	0	0
O95342	ABCBB_HUMAN	"Bile salt export pump, EC 7.6.2.- (ATP-binding cassette sub-family B member 11)"	ABCB11 BSEP	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic export [GO:0046618]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; carbohydrate transmembrane transporter activity [GO:0015144]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic export [GO:0046618]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]	ABC-type bile acid transporter activity [GO:0015432]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; carbohydrate transmembrane transporter activity [GO:0015144]	GO:0000139; GO:0005524; GO:0005768; GO:0005886; GO:0006631; GO:0006699; GO:0006805; GO:0006855; GO:0006979; GO:0008206; GO:0008559; GO:0009986; GO:0010468; GO:0015125; GO:0015126; GO:0015144; GO:0015432; GO:0015721; GO:0015722; GO:0016021; GO:0016324; GO:0016567; GO:0031998; GO:0038183; GO:0042626; GO:0042632; GO:0043627; GO:0045471; GO:0046581; GO:0046618; GO:0046691; GO:0055037; GO:0055038; GO:0055085; GO:0055088; GO:0055091; GO:0070062; GO:0120189; GO:1904251; GO:1904486	GDGVR	2.180000067	1	1	0.267589259	505.8303267	0	0	14.09951	16.11217	15.286	14.58509	14.91297	12.4659	15.5467	17.09755	0	16.41474	15.41685	16.05125	0	0	0	0	15.10743	15.18618	0	16.01247	0	15.72379	15.65441	0	16.44972	0	0	0	0	0	0	0	0	16.61418	0	0	0	15.84124	0	0	14.42619	0	14.4446	0	0	0
O95347	SMC2_HUMAN	"Structural maintenance of chromosomes protein 2, SMC protein 2, SMC-2 (Chromosome-associated protein E, hCAP-E) (XCAP-E homolog)"	SMC2 CAPE SMC2L1 PRO0324	Homo sapiens (Human)	cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]	GO:0000228; GO:0000785; GO:0000793; GO:0000794; GO:0000796; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007076; GO:0010032; GO:0016887; GO:0045132; GO:0051301; GO:0051383; GO:0051984; GO:0070062; GO:1905820; GO:1905821	GLVASLISVK	4.199999809	1	1	0.181164704	987.7789492	0	15.03094	0	12.26422	15.39517	0	15.81594	0	14.30268	14.99128	13.71933	14.66066	14.96001	13.59574	15.40078	0	13.93358	0	0	13.19404	0	0	15.71507	0	12.01859	15.65154	0	12.70843	15.48826	15.05129	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95352	ATG7_HUMAN	"Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7, APG7-like, hAGP7) (Ubiquitin-activating enzyme E1-like protein)"	ATG7 APG7L	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521]	Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]	GO:0000045; GO:0000407; GO:0000422; GO:0005576; GO:0005737; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006995; GO:0009267; GO:0015031; GO:0016236; GO:0019778; GO:0019779; GO:0031401; GO:0032446; GO:0034727; GO:0034774; GO:0039521; GO:0042752; GO:0042803; GO:0043065; GO:0044805; GO:0045732; GO:0048511; GO:0051607; GO:0071455; GO:1904813	MVNLSECMDPKR	6.639999866	0.012799527	0.012799527	0.543471699	1510.285622	0	0	0	0	0	0	18.10585	0	0	0	0	0	0	18.59937	0	0	0	0	0	0	16.37887	0	0	0	0	0	0	19.22471	0	0	0	0	18.42877	0	0	0	19.01598	0	0	0	0	0	0	0	0	0	0	0
O95359	TACC2_HUMAN	"Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1, AZU-1)"	TACC2	Homo sapiens (Human)	cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nuclear receptor binding [GO:0016922]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]	nuclear receptor binding [GO:0016922]	GO:0000226; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0007052; GO:0008283; GO:0016922; GO:0021987	APSESARGPPGPTDGAK	9.789999962	0.44055602	0.44055602	0.280743917	1594.399127	0	15.37045	14.99122	15.57936	0	0	0	13.03325	0	14.82458	0	0	17.18326	16.31907	0	0	0	0	0	0	0	0	0	0	15.93744	13.80647	16.52894	0	16.52374	0	16.22183	14.71784	14.64087	13.75066	0	15.72273	15.23073	15.40582	15.03007	12.78309	11.99993	0	0	17.60183	16.14886	0	15.55037	0
O95361	TRI16_HUMAN	"Tripartite motif-containing protein 16, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRIM16) (Estrogen-responsive B box protein)"	TRIM16 EBBP	Homo sapiens (Human)	"histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; response to growth hormone [GO:0060416]; response to organophosphorus [GO:0046683]; response to retinoic acid [GO:0032526]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; PML body [GO:0016605]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; PML body [GO:0016605]; DNA binding [GO:0003677]; interleukin-1 binding [GO:0019966]; NACHT domain binding [GO:0032089]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; response to growth hormone [GO:0060416]; response to organophosphorus [GO:0046683]; response to retinoic acid [GO:0032526]"	DNA binding [GO:0003677]; interleukin-1 binding [GO:0019966]; NACHT domain binding [GO:0032089]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0016605; GO:0016740; GO:0019966; GO:0032089; GO:0032526; GO:0032731; GO:0043966; GO:0043967; GO:0045618; GO:0045893; GO:0046683; GO:0048386; GO:0060416	LKLNENAISR	15.81000042	0.173589319	0.173589319	0.381898827	1157.176766	17.29804	0	0	0	0	14.77581	0	0	0	0	0	0	0	0	0	0	16.41964	0	0	16.06468	0	0	0	12.70976	0	0	18.18475	0	0	0	15.37924	0	18.46403	0	16.85245	0	0	17.47955	0	0	0	0	0	16.69989	0	0	0	0
O95363	SYFM_HUMAN	"Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)"	FARS2 FARS1 HSPC320	Homo sapiens (Human)	phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006418; GO:0006432; GO:0008033	FVHPKTHK	11.34000015	1	1	0.190645043	995.6281769	15.59872	16.26418	13.93662	0	0	0	0	15.56878	15.62378	0	0	0	16.54042	0	17.38025	0	0	0	15.48328	0	0	12.07198	0	14.40398	0	0	15.14298	0	0	0	0	15.39402	0	0	0	16.48766	16.90174	0	0	0	0	16.63515	0	0	0	17.48439	0	15.86693
O95365	ZBT7A_HUMAN	"Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1, FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor, POK erythroid myeloid ontogenic factor, Pokemon, Pokemon 1) (TTF-I-interacting peptide 21, TIP21) (Zinc finger protein 857A)"	ZBTB7A FBI1 LRF ZBTB7 ZNF857A	Homo sapiens (Human)	"B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; erythrocyte maturation [GO:0043249]; fat cell differentiation [GO:0045444]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to nucleus [GO:0034504]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	"cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription corepressor binding [GO:0001222]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; erythrocyte maturation [GO:0043249]; fat cell differentiation [GO:0045444]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to nucleus [GO:0034504]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]; transcription, DNA-templated [GO:0006351]"	"androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription corepressor binding [GO:0001222]"	GO:0000122; GO:0000381; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006110; GO:0006325; GO:0006338; GO:0006351; GO:0006357; GO:0030183; GO:0030512; GO:0034504; GO:0035035; GO:0035861; GO:0042981; GO:0043249; GO:0045444; GO:0045746; GO:0045892; GO:0046332; GO:0046872; GO:0050681; GO:0051090; GO:0051092; GO:0060766; GO:0070418; GO:0097680; GO:0140297; GO:1990837; GO:2000677	LNVAGAGGGGDSGGGPGAATDGNFTAGLA	7.159999847	0.463647693	0.463647693	0.099040123	2380.750548	14.40098	0	0	0	0	12.35428	0	0	0	0	0	0	0	0	0	0	10.58476	12.50615	0	0	0	0	14.92535	13.7163	0	9.393777	0	0	0	0	0	12.62308	0	0	0	0	0	0	0	0	0	0	0	0	11.20987	0	0	0
O95371	OR2C1_HUMAN	Olfactory receptor 2C1 (OLFmf3) (Olfactory receptor 2C2) (Olfactory receptor OR16-1) (Olfactory receptor OR16-2)	OR2C1 OR2C2P	Homo sapiens (Human)		cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0005938; GO:0016021	SAEGRR	5.039999962	1	1	0.063402055	675.4782793	0	0	0	0	0	0	0	0	15.64418	0	0	0	14.7202	16.38551	0	13.12634	0	0	0	15.85927	0	15.30042	0	0	0	15.64071	16.02315	16.40504	0	15.77782	16.63928	15.07849	0	14.28067	0	0	0	0	0	16.33879	0	0	15.34669	14.96499	17.28834	0	0	0
O95372	LYPA2_HUMAN	"Acyl-protein thioesterase 2, APT-2, EC 3.1.2.- (Lysophospholipase II, LPL-II, LysoPLA II) (Palmitoyl-protein hydrolase, EC 3.1.2.22)"	LYPLA2 APT2	Homo sapiens (Human)	acylglycerol catabolic process [GO:0046464]; axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084]	cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0004622; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0007411; GO:0008474; GO:0045296; GO:0046464; GO:0052689; GO:0070062; GO:1905344	ALIEHEMK	7.400000095	0.277096421	0.277096421	0.243916458	986.8389784	15.67455	15.68423	15.22292	0	15.77719	14.96042	0	16.81825	0	16.02747	0	12.80117	15.54477	0	0	16.42845	0	14.73343	0	0	0	0	0	15.30983	16.25538	11.29567	0	15.8039	0	0	0	15.22482	11.93469	14.27454	15.47806	14.30359	14.98004	15.68684	14.61656	16.27322	16.04503	15.14205	14.25352	0	13.48396	16.49105	15.3512	16.01976
O95373	IPO7_HUMAN	"Importin-7, Imp7 (Ran-binding protein 7, RanBP7)"	IPO7 RANBP7	Homo sapiens (Human)	innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]	GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]	GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0016020; GO:0030695; GO:0031267; GO:0042393; GO:0045087; GO:0045736; GO:0046332	QYMAPR	5.46999979	0.156197295	0.156197295	0.310071114	781.8862102	0	0	0	16.99673	0	0	0	15.99798	16.43686	14.43704	0	0	15.46943	15.18167	16.47878	16.27853	16.4259	16.23578	16.72284	0	0	16.55775	17.32553	15.91335	16.22727	15.7858	0	0	0	15.82772	17.56844	16.68823	0	17.35748	0	0	18.12099	17.01044	16.42334	17.4705	18.59758	0	17.49992	0	17.1267	0	0	17.18834
O95379	TFIP8_HUMAN	"Tumor necrosis factor alpha-induced protein 8, TNF alpha-induced protein 8 (Head and neck tumor and metastasis-related protein) (MDC-3.13) (NF-kappa-B-inducible DED-containing protein, NDED) (SCC-S2) (TNF-induced protein GG2-1)"	TNFAIP8	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]	GO:0005654; GO:0005737; GO:0043027; GO:0043065; GO:0043066	EAEKIIK	11.57999992	1	1	0.308859573	827.4779717	16.07261	0	18.08409	0	0	0	0	0	0	0	0	19.46121	0	17.74552	0	0	17.06027	17.90232	0	0	0	0	19.43323	18.69017	0	17.89474	0	0	0	0	0	0	0	18.86738	0	19.19641	0	19.2787	0	0	0	0	18.03926	0	0	19.25989	0	0
O95382	M3K6_HUMAN	"Mitogen-activated protein kinase kinase kinase 6, EC 2.7.11.25 (Apoptosis signal-regulating kinase 2)"	MAP3K6 ASK2 MAPKKK6 MEKK6	Homo sapiens (Human)	protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004672; GO:0004709; GO:0004712; GO:0005524; GO:0006468; GO:0007165; GO:0106310	RCLSYGGTSQLR	2.210000038	1	1	2.30E-13	1398.063282	0	0	0	0	0	0	15.90727	16.03425	0	0	0	0	0	0	0	0	0	0	0	0	0	15.17545	0	0	0	0	0	15.40796	15.17683	15.52614	16.09295	0	16.00896	15.7911	0	15.11249	16.40843	0	0	0	0	0	0	0	0	0	0	0
O95389	CCN6_HUMAN	"Cellular communication network factor 6 (CCN family member 6) (WNT1-inducible-signaling pathway protein 3, WISP-3)"	CCN6 WISP3 UNQ462/PRO790/PRO956	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; signal transduction [GO:0007165]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; signal transduction [GO:0007165]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]	GO:0005178; GO:0005615; GO:0005739; GO:0007155; GO:0007165; GO:0007267; GO:0008083; GO:0008201; GO:0008285; GO:0016525; GO:0031012; GO:0051881; GO:0060548; GO:1903426	NLPLIWKK	5.579999924	1	1	0.168433384	1014.329749	0	0	0	0	13.52297	0	0	0	0	0	0	13.98488	0	0	12.31661	13.43069	13.9682	15.4753	10.99349	14.79585	0	0	0	0	0	16.85417	0	0	0	0	15.73891	0	16.00963	15.84133	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95390	GDF11_HUMAN	"Growth/differentiation factor 11, GDF-11 (Bone morphogenetic protein 11, BMP-11)"	GDF11 BMP11	Homo sapiens (Human)	camera-type eye morphogenesis [GO:0048593]; cell maturation [GO:0048469]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; pancreas development [GO:0031016]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; ureteric bud development [GO:0001657]	extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; camera-type eye morphogenesis [GO:0048593]; cell maturation [GO:0048469]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; pancreas development [GO:0031016]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; ureteric bud development [GO:0001657]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0005654; GO:0007399; GO:0007498; GO:0008083; GO:0008285; GO:0010862; GO:0021512; GO:0031016; GO:0032991; GO:0043231; GO:0045665; GO:0048469; GO:0048593; GO:0060021; GO:0060395	LKPLTGEGTAGGGGGGRR	7.619999886	1	1	0.385732169	1641.35125	15.39889	14.72343	0	0	0	0	15.87805	0	0	0	0	0	0	0	0	0	0	0	0	0	15.08068	0	17.39039	0	0	16.41201	16.02178	0	15.18548	15.33381	14.98971	15.78116	0	16.15483	15.77937	0	0	14.88181	0	0	0	15.10161	0	0	16.68449	0	16.55904	13.93235
O95391	SLU7_HUMAN	"Pre-mRNA-splicing factor SLU7, hSlu7"	SLU7	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270]	GO:0000375; GO:0000380; GO:0000386; GO:0000389; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0006886; GO:0008270; GO:0008380; GO:0016020; GO:0016607; GO:0030532; GO:0030628; GO:0034605; GO:0043231; GO:0071013	KALNAEEAR	11.18999958	0.168940201	0.168940201	0.167164496	1001.623078	17.43443	16.1445	17.74411	0	0	13.38406	13.85181	0	0	0	17.24664	16.25811	16.89744	15.92425	18.22053	14.0452	0	12.89259	16.11757	15.06643	19.12714	18.28426	17.52125	17.43493	17.06709	14.27427	16.80743	0	12.20396	18.36482	17.48854	0	16.47488	16.17971	17.21944	0	16.80078	18.05721	13.48858	18.32786	14.19225	16.5407	18.86903	18.1683	18.00995	12.11915	15.81836	15.90946
O95393	BMP10_HUMAN	"Bone morphogenetic protein 10, BMP-10"	BMP10	Homo sapiens (Human)	"activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433]; activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]"	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433]	GO:0001822; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0007512; GO:0008083; GO:0009986; GO:0010596; GO:0010613; GO:0010614; GO:0010628; GO:0010862; GO:0030018; GO:0030308; GO:0030336; GO:0030509; GO:0031433; GO:0032924; GO:0033612; GO:0045214; GO:0045893; GO:0055009; GO:0055010; GO:0055015; GO:0055117; GO:0060038; GO:0060045; GO:0060298; GO:0060347; GO:0060389; GO:0060395; GO:0061036; GO:1903242; GO:2000138	HAIIQALVHLKNSQK	20.21999931	1	1	0.278103044	1699.607577	0	0	0	0	19.51343	0	14.72253	0	0	0	0	19.02811	0	0	0	0	0	0	0	0	0	20.60263	20.59604	0	20.80595	0	0	0	0	0	0	0	0	0	21.05675	0	21.68832	0	0	0	20.69281	21.30724	0	0	0	0	20.84096	20.55113
O95394	AGM1_HUMAN	"Phosphoacetylglucosamine mutase, PAGM, EC 5.4.2.3 (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3, PGM 3)"	PGM3 AGM1	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytosol [GO:0005829]	cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004610; GO:0004614; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0019255; GO:0030097	MGLLAVLR	1.720000029	1	1	0.304942385	889.2671751	0	17.48978	0	0	0	0	17.31253	16.6014	18.37359	0	0	0	17.1141	0	0	0	0	0	0	0	17.29508	0	0	18.1291	18.71666	18.36693	18.23911	0	0	0	0	17.7037	0	0	0	18.11003	0	20.45976	0	0	0	0	16.96425	18.06878	0	16.09861	17.41773	0
O95405	ZFYV9_HUMAN	"Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein, Madh-interacting protein) (Novel serine protease, NSP) (Receptor activation anchor, hSARA) (Smad anchor for receptor activation)"	ZFYVE9 MADHIP SARA SMADIP	Homo sapiens (Human)	endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179]	1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]	GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872	SECYSNIYEQRGNEATEGSGLLLNSTGDLMK	5.079999924	0.935394406	0.935394406	0.125646046	3452.151455	0	14.6782	13.64977	16.3353	16.25899	0	14.64466	0	15.30784	14.89923	0	0	0	15.3582	16.47511	16.72436	17.74988	0	0	17.60577	0	0	0	17.05698	17.31916	0	15.09381	16.68068	13.91564	13.05246	13.77028	0	16.49941	0	0	16.21509	0	18.04397	0	18.09125	16.36289	18.71753	0	17.238	14.21155	16.95234	17.99185	15.83444
O95407	TNF6B_HUMAN	"Tumor necrosis factor receptor superfamily member 6B (Decoy receptor 3, DcR3) (Decoy receptor for Fas ligand) (M68)"	TNFRSF6B DCR3 TR6 UNQ186/PRO212	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; signaling receptor activity [GO:0038023]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]	signaling receptor activity [GO:0038023]	GO:0005576; GO:0005615; GO:0006915; GO:0038023; GO:0043066	GVAETPTYPWR	3.279999971	0.621582389	0.621582389	1.15E-12	1276.211321	0	16.31744	11.36148	0	0	14.27065	0	0	0	0	15.71222	14.75702	0	0	0	0	0	0	0	0	0	13.93498	15.32128	0	0	16.21059	15.58416	13.81888	0	0	0	0	0	0	0	0	0	0	0	0	16.76179	0	0	0	0	0	0	0
O95411	TIAF1_HUMAN	Putative TGFB1-induced anti-apoptotic factor 1 (12 kDa TGF-beta-1-induced antiapoptotic factor)	MYO18A TIAF1	Homo sapiens (Human)	apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066]	nucleus [GO:0005634]	nucleus [GO:0005634]; apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066]		GO:0005634; GO:0006915; GO:0007249; GO:0043066	VMCNDLFK	13.23999977	0.517688155	0.517688155	0.127424658	1024.945238	16.5438	15.81213	0	13.99188	16.49854	15.9626	16.29183	0	13.05303	15.93162	0	16.91367	15.5245	16.91833	0	15.1606	14.22359	11.09852	15.39521	0	13.1945	15.61764	14.57444	15.61451	16.85107	0	0	0	16.13678	15.1258	15.33495	0	12.8319	14.84103	15.46496	16.31341	13.23125	12.86423	16.90001	10.56634	14.06159	17.60753	13.46789	12.56162	16.48051	15.56859	10.45245	0
O95425	SVIL_HUMAN	Supervillin (Archvillin) (p205/p250)	SVIL	Homo sapiens (Human)	actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]	actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]	"actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]"	"actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007519; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016	AAGSTR	1.299999952	1	1	0.040373816	561.2376174	15.81519	0	0	0	0	0	16.81666	15.41575	16.4945	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88456	16.18834	15.99314	0	0	0	0	0	0	0	0	0	0	0	0	14.13384	0	0	0
O95428	PPN_HUMAN	Papilin	PAPLN UNQ2420/PRO4977	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]	metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004222; GO:0004867; GO:0005576; GO:0030198; GO:0031012	RSCNLHPCPETK	4.989999771	0.349322796	0.349322796	0.330922275	1498.658503	14.91155	0	0	0	0	0	0	15.72348	0	15.2182	0	12.18215	15.24217	15.72486	16.21842	0	14.80817	0	15.58788	0	14.08727	14.91542	0	0	16.25214	14.92642	16.48571	0	0	0	15.01488	13.32808	16.07946	15.00591	16.16783	12.70779	0	15.84876	0	15.25092	14.2227	0	0	0	14.1816	16.89077	12.5547	0
O95447	LCA5L_HUMAN	Lebercilin-like protein (Leber congenital amaurosis 5-like protein)	LCA5L C21orf13	Homo sapiens (Human)	intraciliary transport [GO:0042073]	axoneme [GO:0005930]	axoneme [GO:0005930]; intraciliary transport [GO:0042073]		GO:0005930; GO:0042073	GTAPYTK	6.429999828	1	1	5.74E-13	737.338493	16.04494	13.18288	16.16422	0	0	0	13.93345	0	0	17.14629	0	15.06937	15.09663	0	0	0	0	0	0	0	0	15.89559	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95450	ATS2_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 2, ADAM-TS 2, ADAM-TS2, ADAMTS-2, EC 3.4.24.14 (Procollagen I N-proteinase, PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase, pNPI)"	ADAMTS2 PCINP PCPNI	Homo sapiens (Human)	collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0007283; GO:0008237; GO:0008270; GO:0016485; GO:0030198; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588; GO:0062023	AAPVR	4.690000057	0.878085911	0.878085911	0.229997198	514.0596087	0	0	0	0	0	0	0	0	18.37419	0	0	0	0	17.76199	0	17.61468	0	17.16742	0	0	0	0	0	0	0	0	0	0	0	18.7895	17.99697	0	0	18.13646	0	0	0	0	0	17.23987	0	0	0	0	0	0	0	0
O95456	PSMG1_HUMAN	"Proteasome assembly chaperone 1, PAC-1 (Chromosome 21 leucine-rich protein, C21-LRP) (Down syndrome critical region protein 2)"	PSMG1 C21LRP DSCR2 PAC1	Homo sapiens (Human)	cerebellar granule cell precursor proliferation [GO:0021930]; chaperone-mediated protein complex assembly [GO:0051131]; proteasome core complex assembly [GO:0080129]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]; cerebellar granule cell precursor proliferation [GO:0021930]; chaperone-mediated protein complex assembly [GO:0051131]; proteasome core complex assembly [GO:0080129]	molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]	GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0021930; GO:0051131; GO:0060090; GO:0070628; GO:0080129; GO:0101031	KNMQITILTCR	9.729999542	0.352620006	0.352620006	0.332798558	1388.69695	9.542271	15.23393	15.67581	0	12.09003	0	0	0	13.52051	0	0	12.31268	0	0	16.48037	15.36427	0	0	0	0	0	15.56385	0	0	0	0	0	0	0	15.23106	0	16.79925	17.24714	17.74243	17.32445	17.90278	17.88444	16.69399	17.24251	17.57218	0	17.2598	15.79072	0	0	17.31855	17.33987	16.70997
O95460	MATN4_HUMAN	Matrilin-4	MATN4	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; extracellular matrix organization [GO:0030198]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0030198; GO:0062023	GLNVGPNATR	4.699999809	0.692750096	0.692750096	0.165288663	999.3529164	18.01334	17.1025	0	15.84905	0	16.94372	17.9213	0	0	0	16.60016	0	0	9.443223	0	0	0	0	0	0	0	15.06355	15.60652	0	15.12358	14.68396	0	18.99745	16.59338	0	17.00982	0	18.66315	16.96814	12.79837	17.78429	17.09179	0	11.81292	14.3644	0	0	0	14.86575	0	0	15.35525	17.282
O95466	FMNL1_HUMAN	Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin)	FMNL1 C17orf1 C17orf1B FMNL FRL1	Homo sapiens (Human)	actin filament severing [GO:0051014]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]	bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267]; actin filament severing [GO:0051014]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360]	actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267]	GO:0005829; GO:0005886; GO:0005938; GO:0008360; GO:0016020; GO:0016477; GO:0030866; GO:0031267; GO:0032059; GO:0032794; GO:0045335; GO:0051014; GO:0051015; GO:0070062	ANSPTMDKLLADSK	9.399999619	1	1	0.306619504	1493.983392	15.10659	0	14.20012	15.18938	14.07387	0	15.28351	13.36917	13.8044	0	0	14.1207	13.72063	11.00313	0	0	0	15.71168	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.25455	14.83537	0	0	0	0	0	0	0	0	14.46242	0	0	15.87566	0
O95473	SNG4_HUMAN	Synaptogyrin-4	SYNGR4	Homo sapiens (Human)		integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]	integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]		GO:0016021; GO:0030672; GO:0031594	MHIPKSLQELANSEAVQFLR	7.300000191	1	1	0.080092228	2326.239654	13.84566	15.35101	12.97986	15.03086	13.35979	13.8694	0	10.01045	0	0	13.56263	12.96986	13.15819	15.07785	0	12.92724	15.09085	0	14.1706	14.41056	14.82036	13.51581	0	15.25136	14.82267	14.8792	13.02274	14.38558	14.22083	13.28607	15.67512	0	0	0	0	15.85751	14.4305	11.34234	0	14.12274	15.19095	13.52038	0	0	0	0	0	15.51743
O95477	ABCA1_HUMAN	"Phospholipid-transporting ATPase ABCA1, EC 7.6.2.1 (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1, ABC-1, ATP-binding cassette 1) (Cholesterol efflux regulatory protein)"	ABCA1 ABC1 CERP	Homo sapiens (Human)	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"	endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	"endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]"	ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]	GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071404; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359	LKETMR	5.590000153	1	1	0.293293671	792.0245576	0	17.02147	16.4445	0	0	0	0	17.75689	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.09831	0	0	0	0	0	0	0	16.9477	0	0
O95478	NSA2_HUMAN	Ribosome biogenesis protein NSA2 homolog (Hairy cell leukemia protein 1) (TGF-beta-inducible nuclear protein 1)	NSA2 TINP1 HUSSY-29	Homo sapiens (Human)	maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	"nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]"	RNA binding [GO:0003723]	GO:0000460; GO:0000470; GO:0003723; GO:0005730; GO:0030687	GTVIEVNVSELGLVTQGGKVIWGK	3.450000048	1	1	1.37E-12	2482.819712	12.47796	0	0	0	0	0	0	11.70023	0	0	0	0	0	0	0	0	12.42429	0	12.54496	0	9.182977	0	0	0	6.282274	11.20108	0	0	12.62127	13.06398	0	0	13.16842	10.58043	10.32438	0	0	0	0	0	0	0	0	0	0	0	0	0
O95487	SC24B_HUMAN	Protein transport protein Sec24B (SEC24-related protein B)	SEC24B	Homo sapiens (Human)	aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178]	SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]	GO:0000149; GO:0001843; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0021747; GO:0030127; GO:0035909; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0070971; GO:0090110; GO:0090178; GO:1901301	SQPLVHLMKMIHPNLYR	5.110000134	1	1	0.181361069	2094.129244	0	0	11.52763	0	13.4353	12.25534	14.52335	15.23953	13.53474	15.18186	0	12.62707	0	13.89617	13.72756	12.98553	0	0	0	12.54502	0	0	0	0	13.66477	14.38904	14.98342	14.92486	13.62696	0	0	0	0	0	0	0	0	0	0	15.03574	15.67013	0	0	13.40979	14.71241	0	12.59659	0
O95490	AGRL2_HUMAN	"Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2, CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1)"	ADGRL2 KIAA0786 LEC1 LPHH1 LPHN2	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007420; GO:0016021; GO:0016524; GO:0030246; GO:0043005	TMMGYWSTQGCKLVDTNK	2.720000029	1	1	0.02897293	2148.416677	10.01925	0	13.83722	0	14.79539	0	11.86413	9.162121	7.907812	0	0	0	0	0	0	0	0	0	0	13.19218	15.40641	0	14.24433	0	0	14.05447	0	13.75077	13.4699	0	0	0	0	0	16.47492	0	0	0	0	0	0	0	0	0	0	0	0	0
O95567	CV031_HUMAN	Uncharacterized protein C22orf31	C22orf31	Homo sapiens (Human)						YSLELGKAIK	10.86999989	0.096896201	0.096896201	0.111472001	1120.72109	19.16601	17.89662	15.7725	0	0	0	0	0	16.38029	0	16.59715	0	0	0	0	0	0	16.02976	0	16.30497	16.98894	0	18.80052	17.49361	0	16.61846	17.49746	0	0	0	0	16.54852	17.48442	0	0	10.59192	17.82316	15.12942	16.67599	0	17.88964	19.43485	0	0	15.62275	0	17.24505	0
O95571	ETHE1_HUMAN	"Persulfide dioxygenase ETHE1, mitochondrial, EC 1.13.11.18 (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)"	ETHE1 HSCO	Homo sapiens (Human)	glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]"	"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]"	GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813	CGVQTPTA	12.42000008	1	1	0.128262507	832.6834305	0	11.89832	0	0	0	15.68256	0	17.17836	0	0	0	0	15.52806	13.42217	0	14.50482	0	15.80898	13.96271	16.95274	12.37844	0	15.49571	0	16.15833	12.10743	15.65655	16.73306	12.11657	14.61818	14.11067	18.53773	0	0	0	14.31965	17.22768	17.1501	0	14.72433	17.09004	12.97331	15.99472	13.16874	17.97709	15.30321	14.81146	0
O95613	PCNT_HUMAN	Pericentrin (Kendrin) (Pericentrin-B)	PCNT KIAA0402 PCNT2	Homo sapiens (Human)	cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165]	calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]	GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316	APRPGPRAR	2.420000076	0.494488329	0.494488329	0.111876138	976.9151635	15.42637	16.22843	12.42907	6.313928	15.78006	14.66656	13.87419	14.59741	0	13.40659	14.13661	15.79231	14.53742	15.4381	11.42952	12.30881	0	15.13142	12.75445	0	14.341	0	11.71261	0	0	0	0	0	0	0	0	0	0	0	12.24212	0	0	0	0	0	0	0	13.43312	0	15.56769	0	0	0
O95620	DUS4L_HUMAN	"tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like, EC 1.3.1.90 (pp35) (tRNA-dihydrouridine synthase 4-like)"	DUS4L	Homo sapiens (Human)			flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]	flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0017150; GO:0050660	VCAPMVR	10.77000046	1	1	0.263853867	848.3126901	0	0	18.6895	17.93208	0	0	0	0	0	18.41544	0	0	0	0	0	0	0	0	17.30455	0	0	0	17.92807	0	0	0	0	0	16.36	0	0	18.44376	18.51367	0	16.92036	19.42142	18.94142	0	0	16.90683	0	0	17.04626	16.86959	15.93141	0	0	0
O95622	ADCY5_HUMAN	"Adenylate cyclase type 5, EC 4.6.1.1 (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5, AC5)"	ADCY5	Homo sapiens (Human)	adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]	GO:0001973; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007191; GO:0007193; GO:0007195; GO:0007204; GO:0007626; GO:0008179; GO:0016021; GO:0035556; GO:0045111; GO:0046872; GO:0050885; GO:0061178; GO:0097110; GO:1904322	HVAMEMK	6.019999981	0.73628217	0.73628217	0.226930822	876.204212	0	13.49653	0	0	0	0	0	12.39251	0	15.29524	18.31275	15.10646	0	0	15.13428	0	0	0	0	0	0	0	15.98044	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.34566	0	0	0	0	0	17.57346
O95631	NET1_HUMAN	Netrin-1 (Epididymis tissue protein Li 131P)	NTN1 NTN1L	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]"	actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]	"actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]"		GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0008045; GO:0008284; GO:0009887; GO:0009888; GO:0015629; GO:0016358; GO:0030334; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060603; GO:0061643; GO:0098609; GO:2000147	FTVNIISVYK	3.789999962	1	1	0.233183194	1184.024779	0	0	0	0	16.58421	12.21367	0	0	10.59346	0	0	0	16.57572	0	12.52591	0	14.49284	0	0	0	0	0	0	0	15.10171	0	0	0	14.28969	0	11.70418	14.94154	11.24088	0	0	14.2034	0	15.27648	0	13.45613	10.92341	14.12658	0	0	13.31189	0	0	0
O95639	CPSF4_HUMAN	"Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit, CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1, Neb-1) (No arches homolog)"	CPSF4 CPSF30 NAR NEB1	Homo sapiens (Human)	pre-mRNA cleavage required for polyadenylation [GO:0098789]	intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005654; GO:0005847; GO:0008270; GO:0043231; GO:0098789; GO:1990837	GGMCPFR	10.72999954	0.00099606	0.00099606	0.045955741	839.4107729	15.80677	15.00348	0	0	15.00605	0	0	0	0	0	0	0	0	0	0	16.24643	0	0	0	0	0	0	16.86176	16.79346	0	0	0	16.48517	0	0	0	0	0	0	0	0	16.9879	16.94227	16.48717	16.31347	0	0	0	0	0	0	0	0
O95665	NTR2_HUMAN	"Neurotensin receptor type 2, NT-R-2, NTR2 (Levocabastine-sensitive neurotensin receptor)"	NTSR2	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of membrane potential [GO:0042391]; sensory perception [GO:0007600]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of membrane potential [GO:0042391]; sensory perception [GO:0007600]	G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007200; GO:0007218; GO:0007600; GO:0016492; GO:0042391	KLFLEAVSSLCGEHHPMK	11.13000011	1	1	0	2083.519817	17.35415	9.299329	13.24442	0	15.27205	13.90983	13.07182	0	15.22183	0	15.28281	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.56412	16.58095	0	0	0	0	11.0439	16.5789	14.75772	14.22301	17.43165	0	15.61163	14.4315	0	0	0	0	0	0	0	15.03136	0
O95670	VATG2_HUMAN	"V-type proton ATPase subunit G 2, V-ATPase subunit G 2 (V-ATPase 13 kDa subunit 2) (Vacuolar proton pump subunit G 2)"	ATP6V1G2 ATP6G ATP6G2 NG38	Homo sapiens (Human)	regulation of macroautophagy [GO:0016241]	"cytosol [GO:0005829]; melanosome [GO:0042470]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"cytosol [GO:0005829]; melanosome [GO:0042470]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0005829; GO:0016241; GO:0016471; GO:0042470; GO:0046961	ASQSQGIQQLLQAEK	17.29000092	0.240219593	0.240219593	0.437437952	1628.061106	0	17.06791	0	0	0	16.1378	0	0	17.08804	15.55986	0	17.03329	0	0	0	0	0	0	17.63605	0	0	0	17.52923	0	0	0	0	0	0	0	16.84383	0	0	0	17.27496	0	0	0	16.63802	17.54933	0	0	0	0	0	0	0	0
O95671	ASML_HUMAN	"Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase, dTTPase/UTPase, EC 3.6.1.9 (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase, Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein, ASMTL, EC 2.1.1.- ]"	ASMTL	Homo sapiens (Human)	methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	cytosol [GO:0005829]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; UTP diphosphatase activity [GO:0036221]; methylation [GO:0032259]; nucleotide metabolic process [GO:0009117]	dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; UTP diphosphatase activity [GO:0036221]	GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0035529; GO:0036218; GO:0036221; GO:0047429	VFDLLKDEAPQK	25.62999916	0.315691948	0.315691948	0.38709386	1401.976355	0	15.34292	0	16.6169	15.57572	15.83995	0	16.45619	0	0	15.78683	0	0	0	16.16046	16.53341	0	0	17.20298	16.99187	16.55043	15.20343	0	0	0	0	16.79875	16.84104	0	16.11959	0	16.7483	16.65237	0	16.15955	0	16.57689	16.41183	16.21773	16.94433	0	0	16.36458	0	0	0	15.67183	16.04681
O95696	BRD1_HUMAN	Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2)	BRD1 BRL BRPF2	Homo sapiens (Human)	chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902]	chromosome [GO:0005694]; dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]	chromosome [GO:0005694]; dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902]	histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0005634; GO:0005694; GO:0006325; GO:0006357; GO:0016607; GO:0030425; GO:0035902; GO:0036409; GO:0042393; GO:0043204; GO:0043249; GO:0043966; GO:0044154; GO:0045648; GO:0046872; GO:0050793; GO:0051602; GO:0070776; GO:1903706	IANQVAIQR	6.510000229	1	1	0.000411781	1012.198209	0	14.37657	0	10.43021	0	12.74056	15.68789	0	13.80889	0	0	13.85207	0	13.9339	0	15.03718	14.26006	0	15.62731	12.24854	0	0	0	10.62911	0	0	0	0	0	0	0	17.64127	0	0	0	0	0	0	0	0	0	0	13.41492	0	0	0	0	0
O95704	APBB3_HUMAN	"Amyloid-beta A4 precursor protein-binding family B member 3 (Protein Fe65-like 2, Fe65L2)"	APBB3 FE65L2	Homo sapiens (Human)	"positive regulation of protein secretion [GO:0050714]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle receptor binding [GO:0050750]; positive regulation of protein secretion [GO:0050714]; regulation of transcription, DNA-templated [GO:0006355]"	amyloid-beta binding [GO:0001540]; low-density lipoprotein particle receptor binding [GO:0050750]	GO:0001540; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0015629; GO:0016020; GO:0050714; GO:0050750	VWGVGSSK	10.65999985	1	1	6.89E-13	817.0215526	16.73115	15.07446	16.17686	0	0	15.44308	13.90408	0	15.09035	0	14.58272	15.31004	15.22599	0	0	0	0	0	0	0	0	0	15.68574	0	0	0	0	0	0	0	0	0	0	0	0	0	15.81285	0	0	0	0	0	0	0	0	0	0	0
O95714	HERC2_HUMAN	"E3 ubiquitin-protein ligase HERC2, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)"	HERC2	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630	FLRSVVTGDVHGTPATK	2.819999933	1	1	1.14E-12	1784.804651	13.81901	16.05768	11.88219	13.934	0	13.15912	14.24794	0	0	0	14.96706	13.57537	0	0	0	0	0	0	0	0	0	0	0	0	0	10.02056	15.40112	0	13.95241	0	0	0	0	0	0	0	0	0	0	0	15.28145	15.85492	0	0	12.27867	0	0	0
O95715	CXL14_HUMAN	C-X-C motif chemokine 14 (Chemokine BRAK) (MIP-2G) (Small-inducible cytokine B14)	CXCL14 MIP2G NJAC SCYB14 PSEC0212 UNQ240/PRO273	Homo sapiens (Human)	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; killing of cells of another organism [GO:0031640]; signal transduction [GO:0007165]	extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemokine activity [GO:0008009]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; killing of cells of another organism [GO:0031640]; signal transduction [GO:0007165]	chemokine activity [GO:0008009]	GO:0005615; GO:0005794; GO:0006935; GO:0007165; GO:0007267; GO:0008009; GO:0031640; GO:0061844	KLEMKPK	6.409999847	0.360791773	0.360791773	0.188794257	874.3513387	0	16.84071	0	0	13.38518	13.05828	10.49525	12.81575	17.06733	14.10739	0	0	0	0	0	0	0	17.45147	17.58713	16.6223	14.22745	0	17.47052	18.50286	17.27414	16.26979	0	13.30625	17.34599	17.07505	0	0	0	13.31924	14.70071	17.55906	17.62783	14.22472	13.7977	18.19546	14.1989	15.9687	0	0	17.20699	0	0	14.61614
O95721	SNP29_HUMAN	"Synaptosomal-associated protein 29, SNAP-29 (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29)"	SNAP29	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]	SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000421; GO:0005484; GO:0005654; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006887; GO:0006903; GO:0006906; GO:0015031; GO:0016082; GO:0016240; GO:0019905; GO:0020018; GO:0031201; GO:0031629; GO:0035577; GO:0060271; GO:0061025; GO:0097352; GO:0098793	LDDTDPVPRGAGSAMSTDAYPK	3.400000095	0.015778787	0.015778787	0.198803722	2278.876869	0	14.53815	0	0	0	11.06548	13.33021	12.03867	0	17.90138	13.71526	0	0	0	0	15.26858	0	0	0	0	14.02236	0	0	0	13.74931	12.30435	0	11.85822	0	0	0	17.54543	0	0	8.645548	0	0	0	0	14.83548	12.04424	0	11.3071	13.63766	0	0	0	0
O95727	CRTAM_HUMAN	Cytotoxic and regulatory T-cell molecule (Class-I MHC-restricted T-cell-associated molecule) (CD antigen CD355)	CRTAM	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; detection of tumor cell [GO:0002355]; establishment of T cell polarity [GO:0001768]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of activated T cell proliferation [GO:0046007]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; regulation of CD8-positive, alpha-beta T cell activation [GO:2001185]; regulation of T cell activation [GO:0050863]; regulation of T cell differentiation [GO:0045580]"	immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; detection of tumor cell [GO:0002355]; establishment of T cell polarity [GO:0001768]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of activated T cell proliferation [GO:0046007]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; regulation of CD8-positive, alpha-beta T cell activation [GO:2001185]; regulation of T cell activation [GO:0050863]; regulation of T cell differentiation [GO:0045580]"	identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	GO:0001768; GO:0001772; GO:0001819; GO:0002250; GO:0002355; GO:0002860; GO:0005102; GO:0005886; GO:0007157; GO:0008037; GO:0016021; GO:0032729; GO:0042802; GO:0045580; GO:0045954; GO:0046007; GO:0050863; GO:0051606; GO:0097021; GO:2001185	VIVLATPFKPILEASVIRK	1.039999962	0.549749196	0.549749196	1.38E-12	2093.876227	16.36327	0	0	0	14.21309	0	0	0	14.37355	0	15.57599	12.85833	0	0	0	0	0	0	0	0	0	0	0	0	15.8248	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.98559	0	14.71434	15.68647	0	0	14.237	14.96642
O95741	CPNE6_HUMAN	"Copine-6 (Copine VI) (Neuronal-copine, N-copine)"	CPNE6	Homo sapiens (Human)	cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]	axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005509; GO:0005544; GO:0005768; GO:0005886; GO:0016020; GO:0030154; GO:0030424; GO:0030425; GO:0043204; GO:0045334; GO:0070062; GO:0071277; GO:1903861	VTKPLLLKNGK	7.619999886	1	1	0.289306358	1210.779917	0	15.98826	0	0	0	0	0	0	0	0	16.03514	0	0	0	0	0	14.92832	0	0	0	0	17.0553	0	17.89413	0	0	0	0	0	0	0	17.97469	0	0	0	18.78285	0	0	0	0	0	0	17.48978	0	0	16.05541	0	0
O95747	OXSR1_HUMAN	"Serine/threonine-protein kinase OSR1, EC 2.7.11.1 (Oxidative stress-responsive 1 protein)"	OXSR1 KIAA1101 OSR1	Homo sapiens (Human)	cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0006468; GO:0006979; GO:0007165; GO:0007231; GO:0010820; GO:0018107; GO:0019901; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0046777; GO:0070062; GO:0071476; GO:0106310; GO:1901017; GO:1990869	RPTAAELLR	4.789999962	1	1	0.217205675	1027.230799	0	16.43021	15.39114	14.70062	15.22257	0	0	16.63186	0	0	16.5442	0	0	0	0	0	0	0	0	13.314	0	0	0	15.54025	15.72413	15.45333	16.00417	15.04982	0	0	0	13.90252	12.50297	16.11652	15.40116	14.13636	15.69518	15.09317	0	15.80867	13.58888	14.91125	15.80869	14.5629	13.89724	15.08833	16.0665	12.62763
O95749	GGPPS_HUMAN	"Geranylgeranyl pyrophosphate synthase, GGPP synthase, GGPPSase, EC 2.5.1.- ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase, EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase, EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase, EC 2.5.1.10)"	GGPS1	Homo sapiens (Human)	farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720]	dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]	GO:0004161; GO:0004311; GO:0004337; GO:0004659; GO:0005654; GO:0005829; GO:0006720; GO:0008299; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872	NTLKELEAK	3.269999981	1	1	0.073995963	1046.454729	15.69018	0	0	13.1109	0	13.73359	0	15.68977	15.50692	19.12731	15.54225	13.05129	15.49768	0	13.35748	0	15.23447	0	0	14.94406	0	0	0	0	0	0	14.5673	0	0	0	0	0	0	0	0	0	11.47111	0	0	0	0	0	0	0	13.74743	0	0	0
O95750	FGF19_HUMAN	"Fibroblast growth factor 19, FGF-19"	FGF19 UNQ334/PRO533	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; bile acid and bile salt transport [GO:0015721]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; bile acid and bile salt transport [GO:0015721]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	GO:0001755; GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007399; GO:0007507; GO:0008083; GO:0008284; GO:0008543; GO:0009617; GO:0009887; GO:0010628; GO:0010629; GO:0014070; GO:0015721; GO:0030154; GO:0030334; GO:0045471; GO:0046326; GO:0046330; GO:0070374; GO:0070858	YLCMGADGK	3.380000114	0.725594223	0.725594223	0.220844976	1015.483198	16.22164	17.04546	15.9027	0	0	15.34825	15.85092	15.49151	15.84276	0	15.38961	15.05004	0	15.9639	0	0	0	15.37517	14.77676	13.59084	0	14.32629	0	16.9576	16.88827	16.01884	12.22908	15.76609	0	0	16.49917	16.32277	0	0	14.62261	0	14.13687	12.4897	15.08439	16.09326	0	13.66245	0	13.51976	15.81059	15.28898	16.19921	14.59513
O95757	HS74L_HUMAN	"Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Heat-shock protein family A member 4-like protein, HSPA4-like protein) (Osmotic stress protein 94)"	HSPA4L APG1 OSP94	Homo sapiens (Human)	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986; GO:0016887	YMEHEERPK	6.360000134	0.049304262	0.049304262	1.37E-12	1218.213766	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.48746	0	0	0	0	0	0	0	0	0	16.81952	15.64075	0	0	17.86407	0	0	16.62305	0	0	0	17.50613	0	0	0	0	0	0	0	0	0	0	18.41842	0
O95777	LSM8_HUMAN	U6 snRNA-associated Sm-like protein LSm8	LSM8	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]"	Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	"Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]"	RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0016070; GO:0017070; GO:0046540; GO:0071005; GO:0071011; GO:0120115	TVAVITSDGR	3.660000086	0.638609707	0.638609707	0.131172367	1022.328823	0	0	0	15.80768	13.68336	0	14.52098	18.47568	14.44848	16.57547	0	15.30486	12.3696	16.91614	14.56401	0	14.38242	15.12349	0	0	13.60521	12.88109	13.24192	15.71061	14.1945	9.937032	14.41669	0	0	0	0	19.9114	0	0	0	14.75548	17.69913	0	16.69681	16.26404	15.75556	14.03551	18.53377	8.958298	14.36739	0	17.47774	16.83327
O95782	AP2A1_HUMAN	AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit)	AP2A1 ADTAA CLAPA1	Homo sapiens (Human)	clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]	AP-2 adaptor complex [GO:0030122]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]	GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0006897; GO:0006898; GO:0009898; GO:0016020; GO:0016192; GO:0019901; GO:0030122; GO:0030130; GO:0030666; GO:0030669; GO:0032433; GO:0035615; GO:0036020; GO:0045334; GO:0050750; GO:0072583; GO:0098884; GO:0140312; GO:1900126	THIDTVINALK	5.380000114	0.470431149	0.470431149	0.169591522	1225.461162	14.96789	0	15.84419	14.79577	0	12.9322	0	0	0	0	0	15.53623	14.88281	0	0	0	0	15.38493	0	0	0	0	0	0	15.03667	0	0	0	16.26551	0	0	0	14.44287	15.08168	14.9895	12.67266	15.79028	9.039378	11.16652	15.86702	0	14.01295	0	13.13907	0	10.61438	0	15.69182
O95785	WIZ_HUMAN	Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803)	WIZ ZNF803	Homo sapiens (Human)	positive regulation of nuclear cell cycle DNA replication [GO:0010571]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]	extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]"	GO:0000978; GO:0000981; GO:0001222; GO:0005634; GO:0005654; GO:0006357; GO:0010571; GO:0030496; GO:0044877; GO:0046872; GO:0050821; GO:0070062; GO:1990226	QKEHLLEHMSQHR	5.119999886	1	1	0.378510116	1687.634677	0	0	0	0	0	0	0	0	0	0	0	0	16.16486	0	0	0	0	0	0	0	16.37542	0	0	0	18.7399	0	0	0	11.34125	14.0061	15.98068	0	15.86599	0	18.60076	18.32221	15.66849	0	12.56223	13.97716	16.41158	15.2702	0	0	12.03339	15.34044	14.63814	0
O95786	DDX58_HUMAN	"Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58, EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1, RLR-1) (Retinoic acid-inducible gene 1 protein, RIG-1) (Retinoic acid-inducible gene I protein, RIG-I)"	DDX58	Homo sapiens (Human)	antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0002230; GO:0002735; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0039528; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904	GMMAGAEK	13.14000034	1	1	4.67E-13	826.7686652	18.40273	16.64095	17.39499	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.71496	0	0	0	0	0	0
O95800	GPR75_HUMAN	Probable G-protein coupled receptor 75	GPR75	Homo sapiens (Human)	chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron death [GO:1901214]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron death [GO:1901214]	C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0016493; GO:0070098; GO:1901214	GNLEVNR	5.909999847	1	1	0.238632401	801.8418719	14.58352	15.24719	16.63137	0	0	15.35899	15.51708	0	0	0	0	0	0	0	0	16.77991	16.04236	16.23359	0	0	17.68694	0	0	0	0	0	0	0	0	15.83466	14.82914	16.42558	16.78363	0	0	14.36992	0	0	16.59563	14.0716	0	0	0	0	15.61686	0	0	0
O95801	TTC4_HUMAN	"Tetratricopeptide repeat protein 4, TPR repeat protein 4"	TTC4 My044	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]	Hsp90 protein binding [GO:0051879]	GO:0005634; GO:0005654; GO:0005737; GO:0045087; GO:0051607; GO:0051879	AIIRGALCHLELK	2.170000076	1	1	0.523010479	1494.137601	0	17.62559	0	0	0	0	0	0	15.38539	0	0	18.26373	18.33935	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.09249	0	0	0	0	18.72355	0	0	0	0	0	16.32802	0	0	0	0	0	0	0
O95803	NDST3_HUMAN	"Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 (Glucosaminyl N-deacetylase/N-sulfotransferase 3, NDST-3, hNDST-3) (N-heparan sulfate sulfotransferase 3, N-HSST 3) [Includes: Heparan sulfate N-deacetylase NDST3, EC 3.-.-.-; [heparan sulfate]-glucosamine N-sulfotransferase NDST3, EC 2.8.2.8 ]"	NDST3 HSST3 UNQ2544/PRO4998	Homo sapiens (Human)	"heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]	GO:0000139; GO:0005794; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0102140	VTKSSK	6.380000114	0.798466742	0.798466742	0.201988298	649.5517474	15.41305	14.15813	15.90545	14.83423	15.94758	15.85931	16.50725	16.14596	15.53406	0	0	15.20306	16.3958	16.71249	0	15.97168	0	0	16.30261	17.44144	17.51073	16.06311	16.73189	16.44427	16.44543	16.00505	17.68645	0	15.78036	16.37335	15.72303	17.6253	16.98124	14.96713	16.81663	17.13678	17.19385	0	17.51149	16.68419	15.98086	16.85462	16.51034	15.64443	16.80472	17.00739	16.39188	17.26626
O95816	BAG2_HUMAN	"BAG family molecular chaperone regulator 2, BAG-2 (Bcl-2-associated athanogene 2)"	BAG2	Homo sapiens (Human)	negative regulation of protein binding [GO:0032091]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein folding [GO:0006457]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821]	axon [GO:0030424]; chaperone complex [GO:0101031]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic microtubule [GO:1901588]	axon [GO:0030424]; chaperone complex [GO:0101031]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic microtubule [GO:1901588]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein binding [GO:0032091]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein folding [GO:0006457]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821]	adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]	GO:0000774; GO:0005829; GO:0006457; GO:0010954; GO:0019538; GO:0030424; GO:0030425; GO:0031072; GO:0031397; GO:0031625; GO:0032091; GO:0042802; GO:0044325; GO:0048156; GO:0050821; GO:0051087; GO:0101031; GO:1901588; GO:1901800; GO:1904667	TLTVEVSVETIR	1.149999976	1	1	0.292855068	1347.547208	0	15.76207	13.88576	0	15.38707	17.37663	0	10.19413	14.38353	0	16.95013	15.75029	16.27047	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.34865	0	16.02649	0	16.72805	16.48198	0	16.51442	0	0	15.4654	0	0	0	15.89085	0	16.18224	0	0	0
O95817	BAG3_HUMAN	"BAG family molecular chaperone regulator 3, BAG-3 (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1)"	BAG3 BIS	Homo sapiens (Human)	aggresome assembly [GO:0070842]; autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein transport along microtubule [GO:0098840]; spinal cord development [GO:0021510]	aggresome [GO:0016235]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]	aggresome [GO:0016235]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; adenyl-nucleotide exchange factor activity [GO:0000774]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; aggresome assembly [GO:0070842]; autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein transport along microtubule [GO:0098840]; spinal cord development [GO:0021510]	adenyl-nucleotide exchange factor activity [GO:0000774]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]	GO:0000045; GO:0000774; GO:0001725; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0007420; GO:0008625; GO:0010664; GO:0016020; GO:0016235; GO:0021510; GO:0030018; GO:0034605; GO:0034620; GO:0042307; GO:0043005; GO:0043066; GO:0044877; GO:0045296; GO:0045505; GO:0046716; GO:0046827; GO:0050821; GO:0051087; GO:0061684; GO:0070842; GO:0071260; GO:0097192; GO:0097201; GO:0098840; GO:0101031; GO:0140597; GO:1903215; GO:1905337	DPLPPGWEIK	8.199999809	0.634471059	0.634471059	0.061505493	1152.654318	0	16.27839	0	0	15.68701	0	0	16.48167	0	0	12.17887	16.19303	17.94767	15.82443	15.97171	13.32932	18.46613	0	16.05329	0	16.0354	10.56811	16.85262	15.76556	16.69012	17.09752	15.58501	17.66281	0	16.33786	15.84075	17.51852	16.78209	16.30325	0	0	17.53453	16.5413	0	17.21478	0	19.94797	16.63927	15.5439	17.27301	17.85472	15.76625	0
O95819	M4K4_HUMAN	"Mitogen-activated protein kinase kinase kinase kinase 4, EC 2.7.11.1 (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4, MEK kinase kinase 4, MEKKK 4) (Nck-interacting kinase)"	MAP4K4 HGK KIAA0687 NIK	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0001953; GO:0004111; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005925; GO:0006468; GO:0008017; GO:0030335; GO:0032014; GO:0035556; GO:0043066; GO:0043408; GO:0043547; GO:0046328; GO:0048812; GO:0051549; GO:0051894; GO:0106310; GO:0120183	VRSSSK	5	0.739954174	0.739954174	0.200275987	662.2386826	0	0	15.61723	0	0	0	0	15.94348	15.94894	15.5141	15.00472	0	0	15.95086	0	13.03313	0	15.1507	0	15.93171	0	0	17.48491	0	15.35062	16.38103	17.0411	14.87797	15.74826	16.23086	15.92727	0	0	16.32467	16.5582	16.76114	16.31355	17.35603	16.30512	17.14196	16.08722	17.67373	16.88499	14.9499	16.23513	16.03935	0	16.93151
O95822	DCMC_HUMAN	"Malonyl-CoA decarboxylase, mitochondrial, MCD, EC 4.1.1.9"	MLYCD	Homo sapiens (Human)	acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]	identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]	GO:0002931; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006085; GO:0006633; GO:0006637; GO:0010906; GO:0019395; GO:0031998; GO:0042802; GO:0046321; GO:0050080; GO:2001294	LVRALQTPLMR	7.03000021	0.044998825	0.044998825	0.128066552	1293.080819	0	19.84267	0	14.06545	0	0	0	0	0	0	18.28795	0	0	0	0	0	0	0	14.19416	0	0	16.56736	15.83835	14.87559	0	16.3228	15.06631	0	0	18.09718	0	0	0	17.40295	0	0	16.56974	16.29292	0	0	0	0	0	17.95366	16.53379	0	0	11.5746
O95831	AIFM1_HUMAN	"Apoptosis-inducing factor 1, mitochondrial, EC 1.6.99.- (Programmed cell death protein 8)"	AIFM1 AIF PDCD8	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636]"	"DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]"	GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0009636; GO:0012501; GO:0016174; GO:0016651; GO:0030182; GO:0030261; GO:0032981; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0051402; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0090650; GO:1902065; GO:1902510; GO:1904045	CLIATGGTPR	4.409999847	1	1	0.181495261	1042.071602	0	0	0	0	0	0	16.01732	0	0	0	14.53945	0	15.08469	0	0	0	0	0	0	0	0	0	0	0	0	0	16.45365	0	0	0	0	0	15.70127	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95835	LATS1_HUMAN	"Serine/threonine-protein kinase LATS1, EC 2.7.11.1 (Large tumor suppressor homolog 1) (WARTS protein kinase, h-warts)"	LATS1 WARTS	Homo sapiens (Human)	cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0017015; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:0106310; GO:1900181; GO:2000058	QQSASYIPK	13.88000011	0.808553874	0.808553874	0.000317622	1022.109316	15.95036	14.57415	0	16.80984	15.94857	13.31959	12.14068	16.34452	16.09412	14.82049	17.49029	15.82757	15.63024	16.11421	15.45298	16.37535	13.38564	14.95784	15.63026	11.96448	17.16991	14.72493	13.90095	16.75173	17.57554	15.28106	15.2188	12.84289	15.71525	17.0658	15.07214	17.54424	17.50309	14.75975	16.8576	16.81763	17.27043	15.72154	14.71649	16.72013	16.24851	0	13.70364	0	16.3753	16.94182	12.85777	16.82541
O95837	GNA14_HUMAN	"Guanine nucleotide-binding protein subunit alpha-14, G alpha-14, G-protein subunit alpha-14"	GNA14	Homo sapiens (Human)	action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; signal transduction [GO:0007165]	extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; signal transduction [GO:0007165]	G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]	GO:0001508; GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0031683; GO:0046872; GO:0060158; GO:0070062	AMDTLRIQYVCEQNK	4.21999979	1	1	0.073852732	1878.196722	0	13.89927	0	0	0	0	14.15879	0	15.01165	0	0	14.53511	14.79129	0	0	0	0	0	0	0	0	0	14.27415	0	0	0	0	12.80354	0	0	0	0	0	0	0	0	13.55181	0	0	10.69519	13.05667	0	0	16.1745	0	0	0	14.7347
O95838	GLP2R_HUMAN	"Glucagon-like peptide 2 receptor, GLP-2 receptor, GLP-2-R, GLP-2R"	GLP2R	Homo sapiens (Human)	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell population proliferation [GO:0008284]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; glucagon receptor activity [GO:0004967]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell population proliferation [GO:0008284]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; glucagon receptor activity [GO:0004967]; peptide hormone binding [GO:0017046]	GO:0004930; GO:0004967; GO:0005886; GO:0007166; GO:0007188; GO:0008284; GO:0008528; GO:0016021; GO:0017046	LLISKLK	29.79000092	0.309883833	0.309883833	0.129702063	814.5860129	0	0	0	0	17.14733	16.74262	17.74254	17.00322	17.66695	17.80157	17.33864	0	16.72708	16.81095	0	17.09252	0	0	17.06565	0	0	0	0	0	0	0	17.89421	0	0	0	0	0	0	0	17.37006	0	16.33263	16.89855	0	0	0	0	0	16.94099	0	0	17.49522	0
O95841	ANGL1_HUMAN	"Angiopoietin-related protein 1 (Angiopoietin-3, ANG-3) (Angiopoietin-like protein 1)"	ANGPTL1 ANG3 ANGPT3 ARP1 PSEC0154 UNQ162/PRO188	Homo sapiens (Human)	transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005615; GO:0007169; GO:0062023; GO:0070062	GGQFKIK	7.980000019	1	1	0.311879665	775.4301705	0	0	0	0	17.55709	18.44908	0	0	17.77337	0	0	0	0	0	0	0	18.73898	0	0	0	0	18.3271	0	0	19.00055	0	0	18.31522	0	0	0	16.8742	0	18.25186	0	19.7296	0	0	0	0	0	0	0	0	0	0	18.55632	17.6586
O95847	UCP4_HUMAN	"Mitochondrial uncoupling protein 4, UCP 4 (Solute carrier family 25 member 27)"	SLC25A27 UCP4 UNQ772/PRO1566	Homo sapiens (Human)	response to cold [GO:0009409]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; response to cold [GO:0009409]		GO:0005739; GO:0005743; GO:0009409; GO:0016021; GO:0031966	MVTYEHLR	18	1	1	0.387096532	1044.281849	0	16.70175	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.62236	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95861	BPNT1_HUMAN	"3'(2'),5'-bisphosphate nucleotidase 1, EC 3.1.3.7 (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase, PIP)"	BPNT1	Homo sapiens (Human)	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]	cytosol [GO:0005829]	"cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]"	"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]"	GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046855; GO:0046872; GO:0050427	SHSNK	5.150000095	1	1	0.241083869	572.0174553	15.35039	0	0	13.23923	0	0	15.45768	0	0	0	0	14.91589	15.50322	14.04893	0	0	14.26983	0	0	0	16.21442	17.38887	6.087514	0	15.45362	17.28366	17.28305	14.73509	15.88408	16.36284	0	16.75247	15.18846	17.37044	17.11207	16.91549	15.91478	16.08609	13.7157	16.28346	14.95821	15.52802	0	14.75967	16.27157	15.84093	0	16.70075
O95865	DDAH2_HUMAN	"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2, DDAH-2, Dimethylarginine dimethylaminohydrolase 2, EC 3.5.3.18 (DDAHII) (Dimethylargininase-2) (Protein G6a) (S-phase protein)"	DDAH2 DDAH G6A NG30	Homo sapiens (Human)	arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of apoptotic process [GO:0043066]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of apoptotic process [GO:0043066]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]	amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]	GO:0000052; GO:0003824; GO:0005739; GO:0005829; GO:0006525; GO:0006527; GO:0006809; GO:0007263; GO:0016403; GO:0016597; GO:0043066; GO:0045429; GO:0050999; GO:0070062	AGAGLSSLCLVLSTRPHS	6.079999924	1	1	0.311986504	1826.146116	14.83771	13.48619	0	0	0	0	14.32591	14.77384	0	0	14.20981	17.14364	14.23321	12.63896	13.24988	0	13.85708	12.57608	0	0	0	16.43441	0	15.89381	0	0	0	0	0	0	15.55066	0	0	0	0	15.64236	15.78821	15.81244	16.6547	16.10367	14.27334	13.22347	14.79447	15.69551	0	0	0	0
O95876	FRITZ_HUMAN	"WD repeat-containing and planar cell polarity effector protein fritz homolog, hFRTZ (Bardet-Biedl syndrome 15 protein) (WD repeat-containing and planar cell polarity effector protein)"	WDPCP BBS15 C2orf86 FRITZ	Homo sapiens (Human)	auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; glomerular visceral epithelial cell migration [GO:0090521]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587]	axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886]	axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886]; auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; glomerular visceral epithelial cell migration [GO:0090521]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587]		GO:0001736; GO:0001822; GO:0002093; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007399; GO:0010762; GO:0016476; GO:0021915; GO:0032185; GO:0032880; GO:0042073; GO:0042733; GO:0043010; GO:0043587; GO:0044782; GO:0045184; GO:0051893; GO:0055123; GO:0060021; GO:0060271; GO:0060541; GO:0072359; GO:0090521; GO:0097541; GO:1900027; GO:1902017; GO:2000114	MESSDVNKR	18.67000008	1	1	0.195209141	1065.590916	16.48212	14.94889	0	15.11555	0	0	0	15.82733	0	15.04228	15.26185	0	9.789246	15.66847	0	0	0	0	14.61015	12.46377	0	13.15853	16.08866	0	14.7005	14.88608	0	0	9.533054	0	14.89128	15.6442	0	0	15.39183	13.63592	0	0	14.80558	13.93662	0	13.18041	0	0	0	0	0	15.7077
O95886	DLGP3_HUMAN	"Disks large-associated protein 3, DAP-3 (PSD-95/SAP90-binding protein 3) (SAP90/PSD-95-associated protein 3, SAPAP3)"	DLGAP3 DAP3	Homo sapiens (Human)	modification of synaptic structure [GO:0099563]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052]	cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]	cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090]; modification of synaptic structure [GO:0099563]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052]	amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090]	GO:0001540; GO:0005886; GO:0014069; GO:0023052; GO:0031594; GO:0060090; GO:0098962; GO:0098978; GO:0098981; GO:0099563; GO:0099572	ASPKPPTLIIKTIPGR	8	1	1	0.278350354	1690.135834	0	0	15.36632	0	15.49058	0	16.22827	0	0	13.49407	0	0	0	0	0	15.60993	0	0	0	0	0	0	15.63166	0	0	15.81726	0	0	0	0	0	0	0	0	0	0	15.29086	0	0	14.42096	16.42755	0	0	0	0	0	0	0
O95900	TRUB2_HUMAN	"Pseudouridylate synthase TRUB2, mitochondrial, EC 5.4.99.- (TruB pseudouridine synthase homolog 2) (tRNA pseudouridine 55 synthase TRUB2, Psi55 synthase TRUB2, EC 5.4.99.25)"	TRUB2	Homo sapiens (Human)	mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0003723; GO:0005739; GO:0005759; GO:0006397; GO:0009982; GO:0035770; GO:0070131; GO:1990481	GSAGLSRLHGLFAVYKPPGLK	2.130000114	1	1	0.020513209	2167.525338	10.33776	0	11.73155	13.06337	0	13.09083	0	0	12.54711	0	0	13.59439	0	0	0	0	0	0	0	0	0	12.27892	0	0	0	0	0	0	0	0	0	11.84501	16.51939	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95907	MOT3_HUMAN	"Monocarboxylate transporter 3, MCT 3 (Solute carrier family 16 member 8)"	SLC16A8 MCT3	Homo sapiens (Human)	lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]	lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0015727; GO:0016020; GO:0016021; GO:0016323; GO:0016324	MGAGGPR	6.409999847	0.029761037	0.029761037	0.236232035	660.8611872	0	15.41947	14.38598	0	14.77939	0	0	0	0	0	15.96387	13.10709	0	0	0	16.19494	13.65635	16.47326	0	0	0	0	0	0	0	14.82606	15.94089	0	0	16.44119	0	12.53014	16.78135	16.6356	0	16.81032	15.8835	17.50904	15.41939	16.43194	0	16.8699	16.84536	0	0	16.10707	16.56726	0
O95926	SYF2_HUMAN	Pre-mRNA-splicing factor SYF2 (CCNDBP1-interactor) (p29)	SYF2 CBPIN GCIPIP	Homo sapiens (Human)	"embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]"	RNA binding [GO:0003723]	GO:0000398; GO:0000974; GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0007095; GO:0007369; GO:0008284; GO:0016607; GO:0048568; GO:0071007; GO:0071013; GO:0071014	KLNHQEVVEEDK	10.60999966	0.977494299	0.977494299	0.586580537	1468.520466	0	19.14101	16.41913	0	18.55845	0	0	19.74071	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.43762	18.62581	0	20.35015	17.4681	18.99611	0	0	19.15004	0	0	0	0	0	19.38059	17.05991	20.19192	0	0	0	0	0	0	0
O95932	TGM3L_HUMAN	"Protein-glutamine gamma-glutamyltransferase 6, EC 2.3.2.13 (Transglutaminase Y, TGY, TGase Y) (Transglutaminase-3-like, TGase-3-like) (Transglutaminase-6, TG6, TGase-6)"	TGM6 TGM3L	Homo sapiens (Human)	peptide cross-linking [GO:0018149]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149]	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0005737; GO:0018149; GO:0046872	AVGSDSR	2.660000086	1	1	0.304429486	691.9130144	0	14.81809	16.11071	15.06834	15.55842	15.6195	0	16.3744	16.70091	14.74343	15.7593	0	0	15.01649	10.79514	16.00987	14.82017	14.82404	15.58749	0	16.34794	0	0	15.061	16.52767	0	16.0109	15.90356	0	15.47695	0	0	0	15.44565	0	0	8.162158	0	0	16.00911	16.24069	16.54907	15.92818	15.01733	15.82501	15.6356	14.98645	15.73149
O95936	EOMES_HUMAN	"Eomesodermin homolog (T-box brain protein 2, T-brain-2, TBR-2)"	EOMES TBR2	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; CD8-positive, alpha-beta T cell differentiation involved in immune response [GO:0002302]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell fate specification [GO:0001708]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; stem cell population maintenance [GO:0019827]; trophectodermal cell differentiation [GO:0001829]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; CD8-positive, alpha-beta T cell differentiation involved in immune response [GO:0002302]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell fate specification [GO:0001708]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; stem cell population maintenance [GO:0019827]; trophectodermal cell differentiation [GO:0001829]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001706; GO:0001707; GO:0001708; GO:0001714; GO:0001829; GO:0002250; GO:0002302; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007420; GO:0010002; GO:0019827; GO:0021772; GO:0021796; GO:0021895; GO:0035914; GO:0043433; GO:0043565; GO:0045893; GO:0045944; GO:0048382; GO:0060706; GO:0060809; GO:0061629; GO:1990837	VKEEIGSSWIETPPSIK	4.869999886	0.4177773	0.4177773	0.126772741	1894.711582	15.41275	15.3959	17.62996	0	16.77877	7.746377	0	15.46987	15.09443	0	16.69133	17.4604	14.93978	0	13.46154	0	15.30373	14.12297	15.06218	14.37843	15.29746	17.46715	16.78361	0	16.05636	15.72532	15.85507	12.04138	10.37851	15.37088	0	0	0	16.78003	16.68731	14.24017	16.77326	14.98544	0	15.38629	13.02406	0	15.81806	0	0	16.28443	11.07809	16.52376
O95944	NCTR2_HUMAN	"Natural cytotoxicity triggering receptor 2 (Lymphocyte antigen 95 homolog) (NK cell-activating receptor) (Natural killer cell p44-related protein, NK-p44, NKp44) (CD antigen CD336)"	NCR2 LY95	Homo sapiens (Human)	cellular defense response [GO:0006968]; signal transduction [GO:0007165]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; cellular defense response [GO:0006968]; signal transduction [GO:0007165]	signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0009986; GO:0038023	LVTSSKPR	7.820000172	1	1	0.281942802	887.1968621	14.46002	14.48709	15.74744	9.049343	13.88776	0	15.64137	14.69142	0	14.94571	15.46509	15.4033	0	0	0	0	15.08828	0	15.63811	0	0	0	16.46232	0	0	0	0	17.10362	14.6463	14.26861	0	0	15.37373	15.88087	14.92375	15.47958	0	14.60453	16.33748	0	0	0	0	0	15.39532	16.19009	15.74287	0
O95965	ITGBL_HUMAN	Integrin beta-like protein 1 (Osteoblast-specific cysteine-rich protein) (Ten integrin EGF-like repeat domain-containing protein)	ITGBL1 OSCP TIED	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]	extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]	integrin binding [GO:0005178]	GO:0005178; GO:0005576; GO:0005886; GO:0005925; GO:0007155; GO:0007160; GO:0007229; GO:0016477; GO:0033627	GSCHCGK	11.09000015	1	1	0.02722007	805.7588078	13.31949	12.95505	0	18.56709	16.42013	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.19669	0	14.63657	0	16.16065	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95972	BMP15_HUMAN	"Bone morphogenetic protein 15, BMP-15 (Growth/differentiation factor 9B, GDF-9B)"	BMP15 GDF9B	Homo sapiens (Human)	BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]; BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]	GO:0001541; GO:0005125; GO:0005615; GO:0005788; GO:0007292; GO:0008083; GO:0010862; GO:0030509; GO:0060016; GO:0060395; GO:0070698	VLLSILR	10.68000031	0.018590171	0.018590171	0.296527385	814.2671487	0	17.16137	0	0	0	0	17.95605	0	21.38138	0	0	19.01511	16.95337	0	0	17.78555	0	19.91516	0	16.1936	18.54481	16.45071	18.13908	0	16.58642	0	18.15518	16.77624	0	0	0	16.52141	0	0	0	0	0	0	0	0	0	0	0	0	17.14022	16.68848	0	0
O95985	TOP3B_HUMAN	"DNA topoisomerase 3-beta-1, EC 5.6.2.1 (DNA topoisomerase III beta-1)"	TOP3B TOP3B1	Homo sapiens (Human)	chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]	condensed chromosome [GO:0000793]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; nucleus [GO:0005634]	"condensed chromosome [GO:0000793]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]"	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]"	GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059; GO:0140225	KFHYFVDSIAGMDELMEVSFSPLAATGKPLSR	1.440000057	1	1	0.104287196	3559.55376	0	0	0	0	13.53921	15.00594	0	15.34278	14.21086	0	0	0	0	14.70533	0	12.82042	10.53826	13.48866	7.19164	0	11.52916	0	0	12.9256	12.0344	14.66412	0	0	0	0	13.6032	14.9867	11.18315	9.567358	13.05474	11.66383	12.03897	0	0	0	9.192397	0	0	14.87063	0	13.0924	0	14.63916
O95988	TCL1B_HUMAN	"T-cell leukemia/lymphoma protein 1B (Oncogene TCL-1B, Oncogene TCL1B) (SYN-1) (Syncytiotrophoblast-specific protein) (TCL1/MTCP1-like protein 1)"	TCL1B TCL1	Homo sapiens (Human)	positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]	protein-containing complex [GO:0032991]	protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]	protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]	GO:0019901; GO:0032991; GO:0033138; GO:0043539; GO:0071902	LGVPPGRLWIQRPGIYEDEEGR	4.630000114	1	1	0	2539.031029	0	0	14.9833	0	0	14.63862	0	10.09247	0	0	0	0	13.66513	0	0	0	0	12.45396	11.78562	0	0	0	0	0	11.28968	13.11453	11.85787	0	0	11.89314	0	0	0	11.50501	0	13.50751	0	14.29615	0	0	0	0	0	0	0	0	0	0
O95990	F107A_HUMAN	Actin-associated protein FAM107A (Down-regulated in renal cell carcinoma 1) (Protein TU3A)	FAM107A DRR1 TU3A	Homo sapiens (Human)	actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cell cycle [GO:0007049]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to nutrient levels [GO:0031669]; cognition [GO:0050890]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of long-term synaptic potentiation [GO:1900272]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein stability [GO:0031647]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725]; synapse [GO:0045202]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cell cycle [GO:0007049]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to nutrient levels [GO:0031669]; cognition [GO:0050890]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of long-term synaptic potentiation [GO:1900272]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein stability [GO:0031647]	actin binding [GO:0003779]	GO:0001558; GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005925; GO:0007049; GO:0015629; GO:0016607; GO:0030041; GO:0030335; GO:0031398; GO:0031647; GO:0031669; GO:0032587; GO:0032956; GO:0043005; GO:0045202; GO:0050890; GO:0051017; GO:0051895; GO:0070507; GO:0071385; GO:1900272; GO:2000134	ELLMNHRR	6.059999943	1	1	6.89E-13	1085.015087	14.06175	0	13.53836	0	13.15033	0	15.67974	12.65292	15.02206	0	0	16.96649	0	15.7948	0	0	0	0	0	0	0	0	15.58123	0	0	0	0	14.92959	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95996	APCL_HUMAN	"Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like, APC-like)"	APC2 APCL	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell differentiation [GO:0045595]; Wnt signaling pathway [GO:0016055]	actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]	actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell differentiation [GO:0045595]; Wnt signaling pathway [GO:0016055]	beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]	GO:0000226; GO:0001708; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005884; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0015630; GO:0016055; GO:0016342; GO:0016477; GO:0030496; GO:0030877; GO:0031258; GO:0043161; GO:0045171; GO:0045295; GO:0045595; GO:0045732; GO:0048471; GO:0090090; GO:0090630; GO:0098794	AAPAAPPPAR	6.199999809	1	1	0.445890719	918.8138577	15.79459	13.83802	0	14.89408	14.29891	0	0	0	0	0	16.3126	15.19935	14.75659	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.13204	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95997	PTTG1_HUMAN	"Securin (Esp1-associated protein) (Pituitary tumor-transforming gene 1 protein, Tumor-transforming protein 1, hPTTG)"	PTTG1 EAP1 PTTG TUTR1	Homo sapiens (Human)	cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; SH3 domain binding [GO:0017124]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816]; spermatogenesis [GO:0007283]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; SH3 domain binding [GO:0017124]	GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0007283; GO:0017124; GO:0045143; GO:0051276; GO:0051301; GO:2000816	ALDGRSQVSTPR	5.5	1	1	0.523816786	1287.389331	0	0	0	0	0	0	0	0	0	17.76223	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O95999	BCL10_HUMAN	"B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10, Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein, hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER) (Cellular homolog of vCARMEN, cCARMEN) (Cellular-E10, c-E10) (Mammalian CARD-containing adapter molecule E10, mE10)"	BCL10 CIPER CLAP	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; B cell apoptotic process [GO:0001783]; cell death [GO:0008219]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of mature B cell apoptotic process [GO:0002906]; neural tube closure [GO:0001843]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of kinase activity [GO:0033674]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; response to food [GO:0032094]; T cell apoptotic process [GO:0070231]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]"	CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]	"CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; B cell apoptotic process [GO:0001783]; cell death [GO:0008219]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of mature B cell apoptotic process [GO:0002906]; neural tube closure [GO:0001843]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of kinase activity [GO:0033674]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; response to food [GO:0032094]; T cell apoptotic process [GO:0070231]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]"	CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]	GO:0001772; GO:0001783; GO:0001843; GO:0002020; GO:0002096; GO:0002224; GO:0002250; GO:0002906; GO:0003713; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005881; GO:0006968; GO:0007249; GO:0008022; GO:0008219; GO:0016064; GO:0019899; GO:0019900; GO:0019901; GO:0031398; GO:0031625; GO:0031663; GO:0032094; GO:0032449; GO:0032755; GO:0032757; GO:0032761; GO:0032765; GO:0032991; GO:0033674; GO:0042327; GO:0042802; GO:0043065; GO:0043123; GO:0043280; GO:0043422; GO:0043621; GO:0044877; GO:0045087; GO:0045121; GO:0045893; GO:0048471; GO:0050700; GO:0050852; GO:0050862; GO:0050870; GO:0051059; GO:0051092; GO:0051260; GO:0061760; GO:0070231; GO:0071222; GO:0071260; GO:0140296; GO:2001238	SNSDESNFSEK	4.670000076	0.126180768	0.126180768	0.139108239	1244.049423	15.53675	0	13.91001	0	8.843431	0	0	11.99086	0	0	9.687071	0	0	0	0	15.56961	0	0	0	0	0	13.61032	14.7036	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
O96005	CLPT1_HUMAN	Cleft lip and palate transmembrane protein 1	CLPTM1	Homo sapiens (Human)	cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081]		GO:0005887; GO:0009897; GO:0016020; GO:0030154; GO:0033081	TKNLLTGETEADPEMIK	3.99000001	1	1	0.301242539	1888.357992	12.64775	14.43223	0	10.13172	0	0	0	0	13.75959	15.13181	0	14.50384	14.92611	13.19313	15.35512	0	0	0	0	0	15.919	0	0	0	0	14.45625	15.97369	0	0	12.75114	0	15.81905	0	0	0	0	0	0	0	0	0	0	0	14.20556	0	0	15.78245	0
O96006	ZBED1_HUMAN	"E3 SUMO-protein ligase ZBED1, EC 2.3.2.- (DNA replication-related element-binding factor) (Putative Ac-like transposable element) (Zinc finger BED domain-containing protein 1) (dREF homolog)"	ZBED1 ALTE DREF hDREF KIAA0785 TRAMP	Homo sapiens (Human)	"negative regulation by host of viral genome replication [GO:0044828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autosumoylation [GO:1990466]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autosumoylation [GO:1990466]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0016605; GO:0019789; GO:0031965; GO:0042802; GO:0043565; GO:0044828; GO:0045944; GO:0046872; GO:0046983; GO:0061665; GO:1990466; GO:1990837	QQNVAHCMLVSNR	7.130000114	1	1	0.236044818	1572.166839	14.26924	12.29658	11.2416	0	14.01386	14.2438	0	0	11.1823	0	0	14.70225	13.5763	11.81735	12.6792	14.45984	0	14.04109	13.37583	0	0	15.18738	14.59275	12.84836	0	14.2693	0	0	14.0074	0	0	0	15.26368	14.87399	15.28161	14.54386	0	0	0	15.1222	16.04351	12.51557	16.70074	0	0	0	0	0
O96015	DNAL4_HUMAN	Dynein axonemal light chain 4	DNAL4	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0030286; GO:0042802; GO:0045505; GO:0051959	HSDMPEEMR	1.600000024	0.49560377	0.49560377	0.214951681	1151.394076	12.3102	12.9148	16.03054	14.10201	13.78414	13.64403	12.21355	0	13.75393	0	0	15.79281	0	15.87411	0	15.34383	0	0	0	0	0	0	16.64534	15.72207	13.94171	16.1273	15.56056	0	0	14.41182	17.25233	0	0	0	0	0	0	0	0	0	14.96662	0	0	0	0	14.83315	0	0
O96017	CHK2_HUMAN	"Serine/threonine-protein kinase Chk2, EC 2.7.11.1 (CHK2 checkpoint homolog) (Cds1 homolog, Hucds1, hCds1) (Checkpoint kinase 2)"	CHEK2 CDS1 CHK2 RAD53	Homo sapiens (Human)	"cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]"	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]	GO:0000077; GO:0000086; GO:0001934; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0006978; GO:0008630; GO:0016605; GO:0018105; GO:0019901; GO:0031573; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044257; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0071466; GO:0071480; GO:0090307; GO:0090399; GO:0106310; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210	EATCK	8.739999771	0.707006812	0.707006812	0.277571203	608.2416099	13.3556	11.49946	16.06059	15.23335	14.51102	0	16.3083	0	0	0	16.89395	16.34989	15.61362	14.25199	17.47262	16.11345	15.71172	16.92599	0	0	16.38233	13.89969	0	15.09315	0	0	14.81942	16.11834	15.7837	0	17.12353	17.30782	16.77774	16.44945	16.53063	16.90333	0	17.74215	17.70793	17.11448	0	16.63233	16.49358	18.18866	17.29434	18.02908	18.79507	17.66537
O96020	CCNE2_HUMAN	G1/S-specific cyclin-E2	CCNE2	Homo sapiens (Human)	cell division [GO:0051301]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein localization [GO:0032880]; telomere maintenance [GO:0000723]	centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein localization [GO:0032880]; telomere maintenance [GO:0000723]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000082; GO:0000307; GO:0000723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006270; GO:0007129; GO:0016538; GO:0019901; GO:0032880; GO:0044772; GO:0051301; GO:0097134; GO:0097135	FMLTQK	16	0.885327697	0.885327697	0.222918117	769.6312672	0	16.91456	15.74623	14.90461	17.114	0	15.83934	14.8943	16.42812	16.43047	16.09135	15.49307	13.07109	0	13.71838	14.2086	13.82942	18.2167	16.17593	0	0	0	15.03119	0	16.81368	0	16.6372	15.85734	0	0	0	0	15.007	0	0	15.36593	16.98142	0	0	15.37969	15.80064	15.77628	0	15.51784	15.78952	0	18.01154	15.11179
O96028	NSD2_HUMAN	"Histone-lysine N-methyltransferase NSD2, EC 2.1.1.357 (Multiple myeloma SET domain-containing protein, MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein)"	NSD2 KIAA1090 MMSET TRX5 WHSC1	Homo sapiens (Human)	"atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]	GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006325; GO:0006355; GO:0018024; GO:0042799; GO:0043565; GO:0046872; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:2001032	GNYSR	1.600000024	1	1	0.084341105	593.6088819	15.50884	15.20111	11.90899	14.26039	0	13.88243	0	0	16.19829	14.97399	12.4285	0	13.89663	15.31296	12.84019	16.64923	14.61927	0	16.87613	16.44202	0	17.04613	16.12659	16.69713	16.54662	15.25236	0	0	16.47837	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.07191	0
P00325	ADH1B_HUMAN	"All-trans-retinol dehydrogenase [NAD(+)] ADH1B, EC 1.1.1.105 (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta)"	ADH1B ADH2	Homo sapiens (Human)	ethanol oxidation [GO:0006069]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	"alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]"	GO:0001523; GO:0004024; GO:0004745; GO:0005654; GO:0005829; GO:0005886; GO:0006069; GO:0008270; GO:0042572; GO:0042573	EGIPKLVADFMAK	8.760000229	1	1	0.231534261	1433.893112	15.87949	14.80612	0	14.98468	14.71394	13.57458	0	16.08062	13.63027	0	11.4483	15.01103	14.84946	0	12.96183	0	0	0	0	0	0	0	0	16.23063	16.32804	15.73832	0	15.42349	0	0	0	0	0	12.25008	0	0	16.99835	0	0	0	0	0	0	0	15.62411	0	15.52006	0
P00352	AL1A1_HUMAN	"Aldehyde dehydrogenase 1A1, EC 1.2.1.19, EC 1.2.1.28, EC 1.2.1.3, EC 1.2.1.36 (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1, RALDH 1, RalDH1)"	ALDH1A1 ALDC ALDH1 PUMB1	Homo sapiens (Human)	cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; negative regulation of cold-induced thermogenesis [GO:0120163]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; synapse [GO:0045202]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; 3-deoxyglucosone dehydrogenase activity [GO:0106373]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758]; cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; negative regulation of cold-induced thermogenesis [GO:0120163]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	3-deoxyglucosone dehydrogenase activity [GO:0106373]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0004029; GO:0005096; GO:0005497; GO:0005737; GO:0005829; GO:0006081; GO:0009449; GO:0018479; GO:0019145; GO:0030392; GO:0030424; GO:0036438; GO:0042572; GO:0043878; GO:0045202; GO:0051287; GO:0070062; GO:0106373; GO:0110095; GO:0120163	DRLLLATMESMNGGK	5.610000134	0.309017271	0.309017271	0.43549218	1656.628368	15.79446	14.35974	13.40374	0	15.6033	15.97759	0	15.62756	0	17.46737	13.95096	0	0	0	15.5235	0	15.22248	0	15.44327	0	0	0	0	0	0	0	0	0	0	0	0	15.42291	0	0	0	17.71263	13.08643	0	0	15.79241	16.11129	0	16.95329	0	0	15.33449	0	0
P00374	DYR_HUMAN	"Dihydrofolate reductase, EC 1.5.1.3"	DHFR	Homo sapiens (Human)	axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]"	"dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0003729; GO:0004146; GO:0005542; GO:0005739; GO:0005829; GO:0006545; GO:0006729; GO:0006730; GO:0017148; GO:0031103; GO:0031427; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0050661; GO:0051000; GO:0070402; GO:1990825; GO:2000121	VGSLNCIVAVSQNMGIGK	2.430000067	0.043809082	0.043809082	0.53574054	1864.399252	16.85336	0	0	0	15.29065	0	18.68001	0	0	17.61236	0	0	0	18.24322	0	0	0	0	16.42083	0	0	0	0	0	0	0	0	0	0	17.90273	0	0	0	0	0	0	0	0	0	0	0	17.08329	0	0	0	0	0	16.41437
P00450	CERU_HUMAN	"Ceruloplasmin, EC 1.16.3.1 (Ferroxidase)"	CP	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]	blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]	chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]	GO:0004322; GO:0005507; GO:0005576; GO:0005615; GO:0005765; GO:0005788; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0016491; GO:0051087; GO:0055072; GO:0070062; GO:0072562	DNEDFQESNR	9.340000153	0.996593177	0.996593177	0.338246075	1253.87013	0	15.47017	13.73197	15.37011	14.8294	15.84739	12.65066	14.19061	13.62177	15.75758	0	14.89973	15.81009	0	13.81502	15.03412	10.76392	15.00744	13.38825	0	0	0	0	0	14.74003	16.84193	14.63614	16.27914	15.30892	16.4542	0	0	16.11819	17.91216	0	0	0	17.31161	0	0	16.73774	0	15.21968	16.7869	0	0	0	15.94927
P00451	FA8_HUMAN	"Coagulation factor VIII (Antihemophilic factor, AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain ]"	F8 F8C	Homo sapiens (Human)	"acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]"	copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]	GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007596; GO:0007597; GO:0016020; GO:0016491; GO:0030134; GO:0031093; GO:0031638; GO:0032991; GO:0033116; GO:1905370	EGPIPPDAQNPDMSFFK	12.10000038	1	1	0.34770198	1904.693699	18.66834	0	0	0	0	0	17.22464	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P00488	F13A_HUMAN	"Coagulation factor XIII A chain, Coagulation factor XIIIa, EC 2.3.2.13 (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain)"	F13A1 F13A	Homo sapiens (Human)	"blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; transferase complex [GO:1990234]	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]"	metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]	GO:0003810; GO:0005576; GO:0005615; GO:0007596; GO:0018149; GO:0031093; GO:0046872; GO:0062023; GO:0072378; GO:0072562; GO:1990234	CGPASVQAIK	2.109999895	1	1	0.219729649	1030.324754	18.38947	0	16.96093	0	19.62103	0	17.26704	0	0	0	0	16.9847	0	0	0	0	0	0	0	0	0	17.31578	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.28524	0	0	0	0	16.64935	0	0	0	16.78802	17.29694
P00491	PNPH_HUMAN	"Purine nucleoside phosphorylase, PNP, EC 2.4.2.1 (Inosine phosphorylase) (Inosine-guanosine phosphorylase)"	PNP NP	Homo sapiens (Human)	allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418]	guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]	GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813	QMGEQR	5.840000153	1	1	0.022505402	748.371868	10.3404	13.0824	14.84119	15.60275	14.11516	15.57943	0	0	15.03675	16.61737	0	15.25465	13.47726	14.58729	16.48377	0	14.96199	14.74835	0	12.8536	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.34667	0
P00505	AATM_HUMAN	"Aspartate aminotransferase, mitochondrial, mAspAT, EC 2.6.1.1, EC 2.6.1.7 (Fatty acid-binding protein, FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein, FABPpm) (Transaminase A)"	GOT2 KYAT4	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471]	kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]	GO:0003723; GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0015908; GO:0016212; GO:0019470; GO:0019550; GO:0019551; GO:0030170; GO:0045471; GO:0070062	DAGMQLQGYR	10.34000015	0.219042182	0.219042182	0.112618125	1155.510016	0	14.35272	0	14.12096	0	12.78555	14.70073	0	0	14.96473	17.64238	0	12.9916	15.24338	11.12393	15.7804	13.98435	0	13.33961	0	12.24595	14.1215	0	0	15.05827	17.71877	16.21503	0	14.50677	14.08304	0	16.54463	0	0	0	14.82403	0	14.11356	15.07148	13.46128	0	12.49712	15.74435	14.84293	0	0	15.71392	0
P00519	ABL1_HUMAN	"Tyrosine-protein kinase ABL1, EC 2.7.10.2 (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)"	ABL1 ABL JTK7	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament polymerization [GO:0030041]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; associative learning [GO:0008306]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite development [GO:1900006]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to epinephrine [GO:0071871]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament polymerization [GO:0030041]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; associative learning [GO:0008306]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; collateral sprouting [GO:0048668]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization [GO:0045184]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite development [GO:1900006]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to epinephrine [GO:0071871]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]"	actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]	GO:0000278; GO:0000287; GO:0000400; GO:0000405; GO:0001726; GO:0001784; GO:0001843; GO:0001922; GO:0001934; GO:0002322; GO:0002333; GO:0003677; GO:0003713; GO:0003785; GO:0004515; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006298; GO:0006355; GO:0006464; GO:0006468; GO:0006897; GO:0006914; GO:0006974; GO:0006975; GO:0006979; GO:0007173; GO:0007204; GO:0007229; GO:0008022; GO:0008306; GO:0008630; GO:0009410; GO:0009791; GO:0010506; GO:0010595; GO:0015629; GO:0016301; GO:0016604; GO:0017124; GO:0018108; GO:0019905; GO:0021587; GO:0022408; GO:0030035; GO:0030036; GO:0030041; GO:0030100; GO:0030145; GO:0030155; GO:0030425; GO:0030426; GO:0030514; GO:0030516; GO:0031113; GO:0031965; GO:0032489; GO:0032729; GO:0032743; GO:0032956; GO:0032991; GO:0033690; GO:0034446; GO:0034599; GO:0034976; GO:0035791; GO:0038083; GO:0038096; GO:0038189; GO:0038191; GO:0042169; GO:0042770; GO:0042981; GO:0043025; GO:0043065; GO:0043123; GO:0043124; GO:0043525; GO:0043542; GO:0045184; GO:0045580; GO:0045907; GO:0045930; GO:0045931; GO:0045944; GO:0046632; GO:0046777; GO:0046875; GO:0048146; GO:0048471; GO:0048536; GO:0048538; GO:0048668; GO:0050731; GO:0050798; GO:0050852; GO:0050853; GO:0050885; GO:0051015; GO:0051019; GO:0051281; GO:0051353; GO:0051444; GO:0051496; GO:0051726; GO:0051882; GO:0051894; GO:0060020; GO:0060563; GO:0070064; GO:0070097; GO:0070301; GO:0070373; GO:0070374; GO:0071103; GO:0071222; GO:0071560; GO:0071871; GO:0071901; GO:0072359; GO:0090050; GO:0090135; GO:0098794; GO:1900006; GO:1900026; GO:1900272; GO:1900275; GO:1901300; GO:1902036; GO:1903055; GO:1903210; GO:1903351; GO:1904528; GO:1904531; GO:1905244; GO:1905555; GO:1990051; GO:1990837; GO:2000096; GO:2000145; GO:2000249; GO:2000251; GO:2000352; GO:2000773; GO:2001020	AGSGAPGGTSKGPAEESR	5.989999771	1	1	0.130345519	1616.864975	15.46117	0	0	13.03084	15.14676	13.32858	13.47115	0	14.91549	0	13.69406	13.84152	0	15.41421	13.04752	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.16493	0	0	0
P00533	EGFR_HUMAN	"Epidermal growth factor receptor, EC 2.7.10.1 (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)"	EGFR ERBB ERBB1 HER1	Homo sapiens (Human)	"activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; activation of phospholipase C activity [GO:0007202]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; digestive tract morphogenesis [GO:0048546]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein catabolic process [GO:0042177]; ossification [GO:0001503]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	"basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]"	"basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; activation of phospholipase C activity [GO:0007202]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; digestive tract morphogenesis [GO:0048546]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein catabolic process [GO:0042177]; ossification [GO:0001503]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]	GO:0000139; GO:0000902; GO:0001503; GO:0001618; GO:0001892; GO:0001934; GO:0001942; GO:0003682; GO:0003690; GO:0004709; GO:0004712; GO:0004713; GO:0004714; GO:0004888; GO:0005006; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0007165; GO:0007166; GO:0007169; GO:0007173; GO:0007202; GO:0007435; GO:0007611; GO:0008284; GO:0009925; GO:0009986; GO:0010008; GO:0010750; GO:0014066; GO:0016020; GO:0016323; GO:0018108; GO:0019899; GO:0019900; GO:0019903; GO:0021795; GO:0030054; GO:0030154; GO:0030307; GO:0030335; GO:0030669; GO:0031625; GO:0031901; GO:0031965; GO:0032587; GO:0032991; GO:0033138; GO:0033674; GO:0034614; GO:0038083; GO:0042059; GO:0042177; GO:0042327; GO:0042802; GO:0043006; GO:0043066; GO:0043235; GO:0043406; GO:0045121; GO:0045296; GO:0045737; GO:0045739; GO:0045740; GO:0045893; GO:0045944; GO:0046328; GO:0046777; GO:0048146; GO:0048408; GO:0048471; GO:0048546; GO:0050679; GO:0050730; GO:0050999; GO:0051015; GO:0051117; GO:0051205; GO:0051897; GO:0060571; GO:0061029; GO:0070141; GO:0070372; GO:0070374; GO:0070435; GO:0071230; GO:0071276; GO:0071364; GO:0071392; GO:0090263; GO:0097489; GO:0097708; GO:0098609; GO:1900020; GO:1900087; GO:1901224; GO:1903078; GO:1903800; GO:1905208	GMNYLEDR	3.99000001	0.354091287	0.354091287	0.284624116	1014.005472	16.65443	16.84907	15.44893	15.09824	0	15.92044	0	16.08417	17.66381	16.01744	0	0	14.50589	15.44144	0	0	14.29262	15.86395	0	0	0	0	15.01369	14.83849	16.47785	13.45772	0	0	0	0	0	0	0	17.37873	16.72512	0	0	0	17.59175	15.68133	0	0	17.18006	0	15.82936	0	16.53583	0
P00568	KAD1_HUMAN	"Adenylate kinase isoenzyme 1, AK 1, EC 2.7.4.3, EC 2.7.4.6 (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)"	AK1	Homo sapiens (Human)	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; outer dense fiber [GO:0001520]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; outer dense fiber [GO:0001520]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006165; GO:0006172; GO:0009142; GO:0015949; GO:0046033; GO:0046034; GO:0070062	RGETSGR	9.920000076	0.435549438	0.435549438	0.204385873	761.9273154	10.82939	16.06046	0	14.61098	17.87547	0	14.4097	0	13.52161	0	0	0	0	15.57925	0	0	14.37688	15.48763	0	0	15.41719	15.28546	17.37808	0	0	0	16.46365	0	0	0	18.22966	16.98073	16.35473	0	0	15.12523	0	0	15.70564	0	0	0	16.33411	0	16.95558	0	0	0
P00736	C1R_HUMAN	"Complement C1r subcomponent, EC 3.4.21.41 (Complement component 1 subcomponent r) [Cleaved into: Complement C1r subcomponent heavy chain; Complement C1r subcomponent light chain ]"	C1R	Homo sapiens (Human)	"complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]"	blood microparticle [GO:0072562]; complement component C1 complex [GO:0005602]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	"blood microparticle [GO:0072562]; complement component C1 complex [GO:0005602]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]"	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005509; GO:0005576; GO:0005602; GO:0005615; GO:0006955; GO:0006958; GO:0008236; GO:0031638; GO:0042802; GO:0045087; GO:0070062; GO:0072562	AGGSIPIPQK	1.850000024	1	1	0.129766775	965.3946456	0	12.32622	15.28381	14.96042	0	0	14.93054	0	13.58916	0	0	0	0	0	0	16.51129	14.56343	0	0	0	0	0	11.49149	0	0	0	0	0	0	0	0	0	0	0	13.67482	15.81229	0	0	0	0	0	0	0	0	0	0	0	0
P00748	FA12_HUMAN	"Coagulation factor XII, EC 3.4.21.38 (Hageman factor, HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Beta-factor XIIa part 1; Coagulation factor XIIa light chain (Beta-factor XIIa part 2) ]"	F12	Homo sapiens (Human)	"blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; plasma kallikrein-kinin cascade [GO:0002353]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibrinolysis [GO:0051919]; positive regulation of plasminogen activation [GO:0010756]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to misfolded protein [GO:0051788]; zymogen activation [GO:0031638]"	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; serine-type endopeptidase complex [GO:1905370]	"collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; plasma kallikrein-kinin cascade [GO:0002353]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibrinolysis [GO:0051919]; positive regulation of plasminogen activation [GO:0010756]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to misfolded protein [GO:0051788]; zymogen activation [GO:0031638]"	calcium ion binding [GO:0005509]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252]	GO:0002353; GO:0002542; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005791; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0010756; GO:0016485; GO:0016540; GO:0030194; GO:0031638; GO:0042730; GO:0045087; GO:0051787; GO:0051788; GO:0051919; GO:0062023; GO:0070062; GO:1905370	NKPGVYTDVAYYLAWIR	2.470000029	1	1	0.258008589	2027.671966	0	17.89402	14.01457	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P00813	ADA_HUMAN	"Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)"	ADA ADA1	Homo sapiens (Human)	adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; biomineralization [GO:0110148]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; GMP salvage [GO:0032263]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]	cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; biomineralization [GO:0110148]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; GMP salvage [GO:0032263]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]	2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]	GO:0000255; GO:0001666; GO:0001829; GO:0001889; GO:0001890; GO:0002314; GO:0002636; GO:0002686; GO:0002906; GO:0004000; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0006157; GO:0006196; GO:0007155; GO:0008270; GO:0009897; GO:0009986; GO:0010035; GO:0010460; GO:0014074; GO:0016020; GO:0030054; GO:0030890; GO:0032261; GO:0032263; GO:0033089; GO:0033632; GO:0042110; GO:0043101; GO:0043103; GO:0044209; GO:0045987; GO:0046059; GO:0046061; GO:0046085; GO:0046103; GO:0046111; GO:0046638; GO:0046936; GO:0048286; GO:0048541; GO:0048566; GO:0050728; GO:0050850; GO:0050862; GO:0060169; GO:0060205; GO:0060407; GO:0070244; GO:0070256; GO:0110148	SSFLPEDEKR	16.17000008	0.626702487	0.626702487	0.381135349	1207.72206	15.53759	14.87597	17.06404	0	0	0	17.91223	16.76676	17.69369	0	15.41112	0	17.72998	13.96482	16.95184	13.24366	15.55764	16.78905	0	16.45059	0	17.89851	0	0	0	0	0	16.34811	0	16.39692	0	0	0	16.47302	0	16.80366	0	0	0	17.14195	0	0	16.9593	0	0	0	16.17708	0
P00918	CAH2_HUMAN	"Carbonic anhydrase 2, EC 4.2.1.1 (Carbonate dehydratase II) (Carbonic anhydrase C, CAC) (Carbonic anhydrase II, CA-II) (Cyanamide hydratase CA2, EC 4.2.1.69)"	CA2	Homo sapiens (Human)	"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; secretion [GO:0046903]"	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]	"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; secretion [GO:0046903]"	arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]	GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070062; GO:2001150; GO:2001225	QSPVDIDTHTAK	3.049999952	1	1	0.455525026	1310.802776	14.24659	0	0	0	0	13.05506	11.96561	15.40796	0	0	14.52683	14.53285	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.26355	0	0	0	0	0	16.1596	0	0	16.35474	0	0	0	17.34951	0	0	0
P00966	ASSY_HUMAN	"Argininosuccinate synthase, EC 6.3.4.5 (Citrulline--aspartate ligase)"	ASS1 ASS	Homo sapiens (Human)	acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]	cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643]; acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643]	GO:0000050; GO:0000052; GO:0000053; GO:0001822; GO:0001889; GO:0003723; GO:0004055; GO:0005524; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005783; GO:0005829; GO:0006526; GO:0006531; GO:0006953; GO:0007494; GO:0007568; GO:0007584; GO:0007623; GO:0009410; GO:0010043; GO:0010046; GO:0015643; GO:0016597; GO:0032355; GO:0042802; GO:0043204; GO:0045429; GO:0060416; GO:0060539; GO:0070062; GO:0070852; GO:0071222; GO:0071230; GO:0071242; GO:0071320; GO:0071346; GO:0071356; GO:0071377; GO:0071400; GO:0071418; GO:0071499; GO:0071549; GO:1903038	LQSKVTAK	14.01000023	1	1	0.090140197	871.8613038	13.89795	13.49735	0	14.21644	0	14.54867	16.2554	0	0	0	0	0	0	0	0	0	0	0	0	0	14.01833	0	0	0	0	14.95953	0	0	0	0	0	0	16.62961	0	0	15.02201	0	0	13.91342	0	15.4318	0	0	0	0	0	0	0
P00973	OAS1_HUMAN	"2'-5'-oligoadenylate synthase 1, (2-5')oligo(A) synthase 1, 2-5A synthase 1, EC 2.7.7.84 (E18/E16) (p46/p42 OAS)"	OAS1 OIAS	Homo sapiens (Human)	antiviral innate immune response [GO:0140374]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; antiviral innate immune response [GO:0140374]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon signaling pathway [GO:0060337]	2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]	GO:0001730; GO:0003725; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0060700; GO:0070106; GO:0071639; GO:0071659; GO:0098586; GO:0140374; GO:1901857; GO:2000342	GGSSGK	3.779999971	0.485300809	0.485300809	0.259985971	489.8129661	14.97758	16.04685	15.93025	11.54774	15.12543	12.61279	16.37668	0	18.29361	18.49728	18.65075	14.78796	0	0	15.71471	16.09726	15.74295	16.7988	15.49883	14.70765	0	15.05342	0	0	16.40928	0	0	15.75937	0	15.12113	15.24311	14.89941	0	15.49983	16.67657	0	14.51475	0	0	15.9568	0	16.63626	15.33932	0	0	15.77323	15.95226	0
P01008	ANT3_HUMAN	"Antithrombin-III, ATIII (Serpin C1)"	SERPINC1 AT3 PRO0309	Homo sapiens (Human)	"blood coagulation [GO:0007596]; negative regulation of endopeptidase activity [GO:0010951]; regulation of blood coagulation, intrinsic pathway [GO:2000266]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; negative regulation of endopeptidase activity [GO:0010951]; regulation of blood coagulation, intrinsic pathway [GO:2000266]"	heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004867; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0007596; GO:0008201; GO:0010951; GO:0042802; GO:0062023; GO:0070062; GO:0072562; GO:2000266	IPEATNRR	3.950000048	1	1	0.255582547	956.6938472	0	0	0	17.77888	0	0	0	0	0	0	0	0	0	15.54789	0	0	0	0	14.73507	0	18.21554	0	0	17.39111	0	0	19.77674	0	0	0	0	0	0	17.71552	0	0	17.44225	0	0	0	0	0	0	0	0	0	16.94473	0
P01023	A2MG_HUMAN	"Alpha-2-macroglobulin, Alpha-2-M (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)"	A2M CPAMD5 FWP007	Homo sapiens (Human)	"acute inflammatory response to antigenic stimulus [GO:0002438]; acute-phase response [GO:0006953]; embryonic liver development [GO:1990402]; luteinization [GO:0001553]; negative regulation of complement activation, lectin pathway [GO:0001869]; response to carbon dioxide [GO:0010037]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to prostaglandin E [GO:0034695]; stem cell differentiation [GO:0048863]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; brain-derived neurotrophic factor binding [GO:0048403]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]; acute inflammatory response to antigenic stimulus [GO:0002438]; acute-phase response [GO:0006953]; embryonic liver development [GO:1990402]; luteinization [GO:0001553]; negative regulation of complement activation, lectin pathway [GO:0001869]; response to carbon dioxide [GO:0010037]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to prostaglandin E [GO:0034695]; stem cell differentiation [GO:0048863]"	brain-derived neurotrophic factor binding [GO:0048403]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]	GO:0001553; GO:0001869; GO:0002020; GO:0002438; GO:0004866; GO:0004867; GO:0005102; GO:0005576; GO:0005615; GO:0006953; GO:0007584; GO:0010037; GO:0019838; GO:0019899; GO:0019959; GO:0019966; GO:0031093; GO:0034695; GO:0042802; GO:0043120; GO:0048306; GO:0048403; GO:0048406; GO:0048863; GO:0051384; GO:0062023; GO:0070062; GO:0072562; GO:1990402	DMYSFLEDMGLK	15.31999969	0.682505786	0.682505786	0.119091888	1448.512004	15.1877	14.10036	16.28552	17.73866	17.29068	15.48487	0	0	0	13.10168	0	18.46198	15.41027	0	16.42905	0	15.54988	14.21406	12.45425	16.79742	14.38312	0	14.01925	0	7.02891	13.66681	11.29433	15.37437	13.84486	15.68912	13.88276	0	0	0	0	15.34938	11.45699	15.94485	17.04649	14.36128	0	13.50756	12.60561	13.00217	0	14.64429	15.41927	14.99733
P01024	CO3_HUMAN	"Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c, C3bc; Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein, ASP (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2 ]"	C3 CPAMD1	Homo sapiens (Human)	"amyloid-beta clearance [GO:0097242]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of apoptotic process in another organism [GO:0044533]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of immune response [GO:0050778]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]; vertebrate eye-specific patterning [GO:0150064]"	azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]	"azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; signaling receptor binding [GO:0005102]; amyloid-beta clearance [GO:0097242]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of apoptotic process in another organism [GO:0044533]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of immune response [GO:0050778]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]; vertebrate eye-specific patterning [GO:0150064]"	C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; signaling receptor binding [GO:0005102]	GO:0001798; GO:0001934; GO:0001970; GO:0004866; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006508; GO:0006631; GO:0006954; GO:0006955; GO:0006956; GO:0006957; GO:0006958; GO:0007165; GO:0007186; GO:0008228; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0030449; GO:0030451; GO:0031715; GO:0032991; GO:0034774; GO:0035578; GO:0035846; GO:0044533; GO:0045745; GO:0045766; GO:0048260; GO:0050766; GO:0050778; GO:0060100; GO:0070062; GO:0072562; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:1903028; GO:1905114; GO:1905370; GO:2000427	HQQTVTIPPK	10.63000011	1	1	0.024556099	1148.326514	0	14.15159	12.741	0	14.47459	14.33075	14.31162	15.54256	15.0996	0	0	15.59277	15.47377	14.36878	13.60842	15.61811	0	15.21023	0	0	14.99534	17.23835	0	0	0	0	0	14.64218	0	0	0	0	0	0	0	0	16.28781	0	0	0	0	0	0	0	0	0	14.74169	0
P01100	FOS_HUMAN	"Protein c-Fos (Cellular oncogene fos) (Fos proto-oncogene, AP-1 transcription factor subunit) (G0/G1 switch regulatory protein 7) (Proto-oncogene c-Fos) (Transcription factor AP-1 subunit c-Fos)"	FOS G0S7	Homo sapiens (Human)	"aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; conditioned taste aversion [GO:0001661]; DNA methylation [GO:0006306]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; nervous system development [GO:0007399]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to immobilization stress [GO:0035902]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle cell differentiation [GO:0035914]; sleep [GO:0030431]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]	"chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; conditioned taste aversion [GO:0001661]; DNA methylation [GO:0006306]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; nervous system development [GO:0007399]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to immobilization stress [GO:0035902]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle cell differentiation [GO:0035914]; sleep [GO:0030431]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]"	GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0000981; GO:0001221; GO:0001228; GO:0001661; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006306; GO:0006357; GO:0006366; GO:0006954; GO:0007179; GO:0007399; GO:0007565; GO:0007568; GO:0009409; GO:0009410; GO:0009416; GO:0009629; GO:0009636; GO:0016020; GO:0030431; GO:0031668; GO:0032496; GO:0032570; GO:0032870; GO:0032993; GO:0034097; GO:0034614; GO:0035902; GO:0035914; GO:0035976; GO:0035994; GO:0042802; GO:0043005; GO:0044877; GO:0045672; GO:0045893; GO:0045944; GO:0051412; GO:0051591; GO:0060395; GO:0061629; GO:0070412; GO:0071276; GO:0071277; GO:0090575; GO:0140467; GO:1901216; GO:1902895; GO:1990837	SISSMELK	5.239999771	1	1	0.140073328	909.6697061	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.74077	0	0	0	0	0	0	0	0	0	19.56149	18.76952	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P01112	RASH_HUMAN	"GTPase HRas, EC 3.6.5.2 (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed ]"	HRAS HRAS1	Homo sapiens (Human)	adipose tissue development [GO:0060612]; animal organ morphogenesis [GO:0009887]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; intrinsic apoptotic signaling pathway [GO:0097193]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAP kinase activity [GO:0043405]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase complex [GO:1905360]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase complex [GO:1905360]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein C-terminus binding [GO:0008022]; adipose tissue development [GO:0060612]; animal organ morphogenesis [GO:0009887]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; intrinsic apoptotic signaling pathway [GO:0097193]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAP kinase activity [GO:0043405]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]	G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein C-terminus binding [GO:0008022]	GO:0000139; GO:0000165; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006357; GO:0006897; GO:0006935; GO:0007165; GO:0007166; GO:0007265; GO:0008022; GO:0008284; GO:0008285; GO:0009887; GO:0010629; GO:0010863; GO:0019003; GO:0030335; GO:0032729; GO:0034260; GO:0042088; GO:0042127; GO:0042832; GO:0043405; GO:0043406; GO:0043410; GO:0043524; GO:0043547; GO:0045944; GO:0046330; GO:0048169; GO:0048471; GO:0050679; GO:0050852; GO:0051726; GO:0060612; GO:0070374; GO:0071480; GO:0090303; GO:0090314; GO:0090398; GO:0097193; GO:0098696; GO:0098978; GO:1900029; GO:1905360; GO:2000251; GO:2000630	LNPPDESGPGCMSCK	5.099999905	1	1	0.339279312	1663.581188	15.43748	17.48706	15.78436	0	16.62161	14.8555	16.61107	0	0	0	0	17.98607	0	0	0	0	0	0	0	15.53671	0	0	0	0	11.32737	0	0	0	0	0	0	15.54256	0	0	14.82613	0	17.85434	0	0	0	0	0	0	16.54252	0	0	15.01006	15.18429
P01116	RASK_HUMAN	"GTPase KRas, EC 3.6.5.2 (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed ]"	KRAS KRAS2 RASK2	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; endocrine signaling [GO:0038002]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; homeostasis of number of cells within a tissue [GO:0048873]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; striated muscle cell differentiation [GO:0051146]; visual learning [GO:0008542]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; endocrine signaling [GO:0038002]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; homeostasis of number of cells within a tissue [GO:0048873]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; striated muscle cell differentiation [GO:0051146]; visual learning [GO:0008542]"	G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]	GO:0000139; GO:0000165; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005741; GO:0005789; GO:0005829; GO:0005886; GO:0005925; GO:0007265; GO:0008284; GO:0008542; GO:0010628; GO:0016020; GO:0019003; GO:0021897; GO:0030036; GO:0031234; GO:0031647; GO:0032228; GO:0035022; GO:0038002; GO:0042802; GO:0043524; GO:0044877; GO:0045596; GO:0048169; GO:0048873; GO:0051146; GO:0060441	QRVEDAFYTLVR	12.72000027	1	1	0.078438139	1496.753345	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.01648	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P01133	EGF_HUMAN	"Pro-epidermal growth factor, EGF [Cleaved into: Epidermal growth factor (Urogastrone) ]"	EGF	Homo sapiens (Human)	"angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermal growth factor receptor signaling pathway via MAPK cascade [GO:0038029]; ERK1 and ERK2 cascade [GO:0070371]; mammary gland alveolus development [GO:0060749]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of secretion [GO:0051048]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of calcium ion import [GO:0090279]; regulation of protein localization to cell surface [GO:2000008]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]"	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]	"clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; guanyl-nucleotide exchange factor activity [GO:0005085]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermal growth factor receptor signaling pathway via MAPK cascade [GO:0038029]; ERK1 and ERK2 cascade [GO:0070371]; mammary gland alveolus development [GO:0060749]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of secretion [GO:0051048]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of calcium ion import [GO:0090279]; regulation of protein localization to cell surface [GO:2000008]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]"	calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; guanyl-nucleotide exchange factor activity [GO:0005085]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0001525; GO:0001938; GO:0002092; GO:0005085; GO:0005154; GO:0005509; GO:0005576; GO:0005615; GO:0005765; GO:0005886; GO:0007173; GO:0008083; GO:0008284; GO:0010595; GO:0010628; GO:0010800; GO:0014068; GO:0016021; GO:0018108; GO:0021940; GO:0030297; GO:0030335; GO:0030669; GO:0031093; GO:0038029; GO:0042327; GO:0043388; GO:0043406; GO:0043410; GO:0045740; GO:0045741; GO:0045840; GO:0045893; GO:0046425; GO:0048754; GO:0051048; GO:0051897; GO:0060749; GO:0070062; GO:0070371; GO:0090263; GO:0090279; GO:0090370; GO:1900127; GO:1902966; GO:1905278; GO:2000008; GO:2000060	ANMDGSQRER	8.970000267	0.572127402	0.572127402	0.177662557	1180.895591	17.54562	18.6224	16.99342	17.54133	0	16.6062	16.19902	17.35413	17.15378	15.80161	16.31798	13.3515	14.77612	19.277	17.75216	15.89763	14.77274	16.71447	15.84822	0	15.7693	0	17.85322	17.5626	17.22372	17.4136	16.38988	0	0	15.60407	15.70491	17.23005	16.77435	14.16946	15.25734	17.08024	15.81683	15.66085	16.98649	0	0	16.90982	16.31672	0	0	0	13.1579	17.87249
P01160	ANF_HUMAN	"Natriuretic peptides A (Atrial natriuretic factor prohormone, proANF) (Atrial natriuretic peptide prohormone, preproANP, proANP) (Atriopeptigen) (Cardiodilatin, CDD) (preproCDD-ANF) [Cleaved into: Long-acting natriuretic peptide, LANP (Long-acting natriuretic hormone, LANH) (Pro atrial natriuretic factor 1-30, proANF 1-30) (Pro atrial natriuretic peptide 1-30, proANP 1-30); Vessel dilator, VSDL (Pro atrial natriuretic factor 31-67, proANF 31-67) (Pro atrial natriuretic peptide 31-67, proANP 31-67); Kaliuretic peptide, KP (Pro atrial natriuretic factor 79-98, proANF 79-98) (Pro atrial natriuretic peptide 79-98, proANP 79-98); Urodilatin, URO (CDD 95-126) (CDD-ANP (95-126)) (Pro atrial natriuretic peptide 95-126, proANP 95-126); Auriculin-C (Atrial natriuretic factor 1-33, ANF 1-33); Auriculin-D (Atrial natriuretic factor 3-33, ANF 3-33); Atrial natriuretic peptide, ANP (Alpha-atrial natriuretic peptide) (Alpha-hANP) (Atrial natriuretic factor, ANF) (CDD-ANF) (CDD-ANP (99-126)) (Cardionatrin) (Pro atrial natriuretic factor 99-126, proANF 99-126); Auriculin-B (Atrial natriuretic factor 8-33, ANF 8-33); Auriculin-A; Atriopeptin-1 (Atriopeptin I); Atriopeptin-2 (Atriopeptin II); Atriopeptin-3 (Atriopeptin III) ]"	NPPA ANP PND	Homo sapiens (Human)	aortic valve morphogenesis [GO:0003180]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of high voltage-gated calcium channel activity [GO:1901841]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; vasodilation [GO:0042311]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; signaling receptor binding [GO:0005102]; aortic valve morphogenesis [GO:0003180]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of high voltage-gated calcium channel activity [GO:1901841]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; vasodilation [GO:0042311]	hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; signaling receptor binding [GO:0005102]	GO:0003085; GO:0003161; GO:0003180; GO:0005102; GO:0005179; GO:0005184; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006182; GO:0006457; GO:0007168; GO:0007218; GO:0007565; GO:0008217; GO:0010460; GO:0014898; GO:0019934; GO:0032991; GO:0035994; GO:0036376; GO:0042059; GO:0042311; GO:0042995; GO:0043204; GO:0043508; GO:0051427; GO:0060372; GO:0060452; GO:0062023; GO:0071855; GO:0090090; GO:1901841; GO:1902261; GO:1902514; GO:1903766	ANPMYNAVSNADLMDFK	5.079999924	1	1	0.165857753	1917.823658	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P01258	CALC_HUMAN	"Calcitonin [Cleaved into: Calcitonin; Katacalcin (Calcitonin carboxyl-terminal peptide, CCP) (PDN-21) ]"	CALCA CALC1	Homo sapiens (Human)	"activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase activity [GO:0032147]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001984]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; embryo implantation [GO:0007566]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; monocyte chemotaxis [GO:0002548]; negative regulation of bone resorption [GO:0045779]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to pain [GO:0048265]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; terminal bouton [GO:0043195]	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; calcitonin receptor binding [GO:0031716]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase activity [GO:0032147]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001984]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; embryo implantation [GO:0007566]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; monocyte chemotaxis [GO:0002548]; negative regulation of bone resorption [GO:0045779]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to pain [GO:0048265]"	calcitonin receptor binding [GO:0031716]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]	GO:0001984; GO:0002548; GO:0005179; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0007189; GO:0007190; GO:0007204; GO:0007218; GO:0007566; GO:0007568; GO:0007631; GO:0008016; GO:0009408; GO:0030279; GO:0031716; GO:0032147; GO:0042802; GO:0043025; GO:0043195; GO:0045779; GO:0045892; GO:0045986; GO:0048265; GO:0050965; GO:0051480; GO:0051482; GO:0071356; GO:1990090	CGNLSTCMLGTYTQDFNK	1.539999962	1	1	0.058076004	2126.444047	0	0	0	0	15.77133	14.23674	0	12.63113	0	0	0	0	13.56032	0	14.66382	0	0	14.41311	0	13.71988	0	0	0	0	0	0	13.35742	13.21536	14.98627	0	0	0	10.22237	14.68545	0	15.28305	0	0	0	0	0	0	0	13.35489	0	0	0	0
P01266	THYG_HUMAN	"Thyroglobulin, Tg"	TG	Homo sapiens (Human)	hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	GO:0005179; GO:0005576; GO:0005615; GO:0006590; GO:0007165; GO:0015705; GO:0030878; GO:0031641; GO:0042446; GO:0042802	ELPGSR	8.770000458	1	1	0.244632574	657.0366137	17.68551	17.32763	0	0	0	0	0	0	0	0	0	16.78307	0	0	0	0	16.00792	0	18.0054	0	0	0	0	17.48993	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.97107	0	0	0	0	16.7953
P01270	PTHY_HUMAN	"Parathyroid hormone, PTH (Parathormone) (Parathyrin)"	PTH	Homo sapiens (Human)	activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular macromolecule biosynthetic process [GO:0034645]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated apoptotic signaling pathway [GO:0008628]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; phosphate ion homeostasis [GO:0055062]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to lead ion [GO:0010288]; response to parathyroid hormone [GO:0071107]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; parathyroid hormone receptor binding [GO:0031856]; peptide hormone receptor binding [GO:0051428]; protein N-terminus binding [GO:0047485]; receptor ligand activity [GO:0048018]; type 1 parathyroid hormone receptor binding [GO:0031857]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular macromolecule biosynthetic process [GO:0034645]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated apoptotic signaling pathway [GO:0008628]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; phosphate ion homeostasis [GO:0055062]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to lead ion [GO:0010288]; response to parathyroid hormone [GO:0071107]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]	hormone activity [GO:0005179]; parathyroid hormone receptor binding [GO:0031856]; peptide hormone receptor binding [GO:0051428]; protein N-terminus binding [GO:0047485]; receptor ligand activity [GO:0048018]; type 1 parathyroid hormone receptor binding [GO:0031857]	GO:0001501; GO:0005179; GO:0005576; GO:0005615; GO:0006874; GO:0007186; GO:0007189; GO:0007202; GO:0007266; GO:0007267; GO:0008628; GO:0009410; GO:0009967; GO:0010288; GO:0010468; GO:0010629; GO:0010960; GO:0030282; GO:0030501; GO:0031856; GO:0031857; GO:0032331; GO:0033280; GO:0034645; GO:0045453; GO:0045471; GO:0045725; GO:0045944; GO:0046058; GO:0046326; GO:0046686; GO:0047485; GO:0048018; GO:0048873; GO:0051428; GO:0055062; GO:0060732; GO:0071107; GO:0071774; GO:0071864; GO:0071866; GO:0090290; GO:1900158	VMIVMLAICFLTKSDGK	6.5	0.001971818	0.001971818	0.420870412	1958.428137	24.26401	0	21.32964	0	0	0	20.43041	0	0	0	21.15667	0	23.35026	0	0	0	0	23.54872	0	0	0	0	0	23.5134	0	21.27507	23.4846	0	0	0	20.02189	0	0	0	0	0	0	0	0	0	0	0	0	0	23.56032	0	0	18.28256
P01344	IGF2_HUMAN	"Insulin-like growth factor II, IGF-II (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin ]"	IGF2 PP1446	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; embryonic placenta development [GO:0001892]; embryonic placenta morphogenesis [GO:0060669]; exocrine pancreas development [GO:0031017]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; insulin receptor signaling pathway [GO:0008286]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast cell proliferation [GO:0060720]; striated muscle cell differentiation [GO:0051146]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018]; animal organ morphogenesis [GO:0009887]; embryonic placenta development [GO:0001892]; embryonic placenta morphogenesis [GO:0060669]; exocrine pancreas development [GO:0031017]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; insulin receptor signaling pathway [GO:0008286]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast cell proliferation [GO:0060720]; striated muscle cell differentiation [GO:0051146]"	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018]	GO:0000122; GO:0001649; GO:0001701; GO:0001892; GO:0001934; GO:0005158; GO:0005159; GO:0005178; GO:0005179; GO:0005576; GO:0005615; GO:0006006; GO:0006349; GO:0006355; GO:0008083; GO:0008284; GO:0008286; GO:0009887; GO:0031017; GO:0031056; GO:0031093; GO:0038028; GO:0040018; GO:0042104; GO:0043085; GO:0043410; GO:0043539; GO:0045725; GO:0045840; GO:0045944; GO:0046622; GO:0046628; GO:0048018; GO:0048633; GO:0050731; GO:0051146; GO:0051147; GO:0051148; GO:0051781; GO:0051897; GO:0060669; GO:0060720; GO:1905564; GO:2000467	GLPALLRAR	16.88999939	0.093224764	0.093224764	0.133424556	966.5464546	13.68653	16.76486	11.61287	0	0	0	13.59775	14.4812	13.30288	0	16.7841	0	0	0	15.31725	0	13.33705	0	12.44792	12.6938	13.04847	0	0	0	0	0	14.99694	9.351836	0	13.01023	11.42883	12.30088	13.12185	0	17.53466	0	0	15.3659	0	11.33905	14.99804	18.82503	13.76405	0	12.72758	0	0	12.90847
P01374	TNFB_HUMAN	"Lymphotoxin-alpha, LT-alpha (TNF-beta) (Tumor necrosis factor ligand superfamily member 1)"	LTA TNFB TNFSF1	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; lymph node development [GO:0048535]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interferon-gamma production [GO:0032729]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; lymph node development [GO:0048535]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interferon-gamma production [GO:0032729]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	GO:0001666; GO:0002876; GO:0002925; GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006915; GO:0006959; GO:0007165; GO:0007267; GO:0007584; GO:0009410; GO:0032496; GO:0032729; GO:0043065; GO:0048147; GO:0048535; GO:0050830; GO:0060252	MTPPER	2.730000019	0.434452832	0.434452832	0.299805365	745.8146899	0	15.11056	0	12.65266	0	0	15.74877	14.09216	12.87943	0	0	0	0	14.81732	15.23325	0	15.90633	14.68279	0	15.78818	15.29517	15.90857	16.10332	15.63019	15.73778	15.47704	16.67574	15.86302	0	0	0	0	15.62809	0	0	16.19981	0	16.47894	16.97709	0	0	15.6373	15.92969	0	0	0	16.1311	0
P01568	IFN21_HUMAN	"Interferon alpha-21, IFN-alpha-21 (Interferon alpha-F, LeIF F)"	IFNA21	Homo sapiens (Human)	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005126; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586	RALILLAQMGR	10.22000027	1	1	0.153244774	1258.512479	16.97757	0	0	0	0	0	0	0	0	0	0	0	0	16.91156	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P01569	IFNA5_HUMAN	"Interferon alpha-5, IFN-alpha-5 (Interferon alpha-61) (Interferon alpha-G, LeIF G)"	IFNA5	Homo sapiens (Human)	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005126; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586	AEIMRSFSLSANLQER	8.140000343	1	1	0.209886755	1867.785093	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P01583	IL1A_HUMAN	"Interleukin-1 alpha, IL-1 alpha (Hematopoietin-1)"	IL1A IL1F1	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular sodium ion homeostasis [GO:0006883]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sensory perception of pain [GO:0051930]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283]	cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular sodium ion homeostasis [GO:0006883]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sensory perception of pain [GO:0051930]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283]	copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	GO:0001660; GO:0001666; GO:0001819; GO:0002248; GO:0005125; GO:0005149; GO:0005507; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006883; GO:0006915; GO:0006954; GO:0006955; GO:0007283; GO:0007507; GO:0008285; GO:0009986; GO:0010193; GO:0010243; GO:0010332; GO:0010575; GO:0010628; GO:0010893; GO:0019221; GO:0031424; GO:0032308; GO:0032743; GO:0032755; GO:0032760; GO:0032956; GO:0033092; GO:0033591; GO:0034605; GO:0035234; GO:0043123; GO:0045766; GO:0045840; GO:0045944; GO:0046330; GO:0046688; GO:0050714; GO:0050999; GO:0051781; GO:0051930; GO:0070374; GO:0071222; GO:0097192; GO:1902624; GO:1904445; GO:2001240	SSKDDAK	7.619999886	0.043223541	0.043223541	0.045128911	751.4426273	0	14.49789	15.3017	15.87265	17.63754	17.10123	18.76564	0	15.09307	17.00964	0	17.20083	0	0	14.46362	14.08454	14.68092	14.1789	14.73693	15.62247	0	0	17.27683	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P01584	IL1B_HUMAN	"Interleukin-1 beta, IL-1 beta (Catabolin)"	IL1B IL1F2	Homo sapiens (Human)	"apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; cellular response to xenobiotic stimulus [GO:0071466]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; hyaluronan biosynthetic process [GO:0030213]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; monocyte aggregation [GO:0070487]; negative regulation of adiponectin secretion [GO:0070164]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurogenesis [GO:0050768]; negative regulation of synaptic transmission [GO:0050805]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of complement activation [GO:0045917]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fever generation [GO:0031622]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phagocytosis [GO:0050766]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA biosynthetic process [GO:1902680]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein kinase B signaling [GO:0043491]; regulation of defense response to virus by host [GO:0050691]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of nitric-oxide synthase activity [GO:0050999]; response to ATP [GO:0033198]; response to carbohydrate [GO:0009743]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; sequestering of triglyceride [GO:0030730]; signal transduction [GO:0007165]; smooth muscle adaptation [GO:0014805]; vascular endothelial growth factor production [GO:0010573]"	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory granule [GO:0030141]	"cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory granule [GO:0030141]; cytokine activity [GO:0005125]; integrin binding [GO:0005178]; interleukin-1 receptor binding [GO:0005149]; protein domain specific binding [GO:0019904]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; cellular response to xenobiotic stimulus [GO:0071466]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; hyaluronan biosynthetic process [GO:0030213]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; monocyte aggregation [GO:0070487]; negative regulation of adiponectin secretion [GO:0070164]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurogenesis [GO:0050768]; negative regulation of synaptic transmission [GO:0050805]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of complement activation [GO:0045917]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fever generation [GO:0031622]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phagocytosis [GO:0050766]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA biosynthetic process [GO:1902680]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein kinase B signaling [GO:0043491]; regulation of defense response to virus by host [GO:0050691]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of nitric-oxide synthase activity [GO:0050999]; response to ATP [GO:0033198]; response to carbohydrate [GO:0009743]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; sequestering of triglyceride [GO:0030730]; signal transduction [GO:0007165]; smooth muscle adaptation [GO:0014805]; vascular endothelial growth factor production [GO:0010573]"	cytokine activity [GO:0005125]; integrin binding [GO:0005178]; interleukin-1 receptor binding [GO:0005149]; protein domain specific binding [GO:0019904]	GO:0000165; GO:0001660; GO:0001934; GO:0002711; GO:0005125; GO:0005149; GO:0005178; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0006915; GO:0006954; GO:0006955; GO:0007165; GO:0007267; GO:0007566; GO:0008284; GO:0008285; GO:0009743; GO:0010573; GO:0010575; GO:0010628; GO:0010718; GO:0010829; GO:0014805; GO:0019221; GO:0019904; GO:0030141; GO:0030213; GO:0030335; GO:0030593; GO:0030730; GO:0030949; GO:0031394; GO:0031622; GO:0031663; GO:0032308; GO:0032496; GO:0032725; GO:0032729; GO:0032743; GO:0032755; GO:0032757; GO:0033092; GO:0033129; GO:0033198; GO:0034116; GO:0035066; GO:0035234; GO:0035505; GO:0042102; GO:0043122; GO:0043123; GO:0043406; GO:0043407; GO:0043491; GO:0045429; GO:0045766; GO:0045833; GO:0045840; GO:0045893; GO:0045917; GO:0045944; GO:0046330; GO:0046627; GO:0046827; GO:0048143; GO:0050691; GO:0050729; GO:0050766; GO:0050767; GO:0050768; GO:0050796; GO:0050805; GO:0050830; GO:0050995; GO:0050996; GO:0050999; GO:0051044; GO:0051091; GO:0051092; GO:0051781; GO:0060252; GO:0060355; GO:0060559; GO:0070164; GO:0070372; GO:0070487; GO:0070498; GO:0070555; GO:0071222; GO:0071260; GO:0071310; GO:0071407; GO:0071466; GO:0071639; GO:0097192; GO:0150078; GO:1900745; GO:1901224; GO:1902680; GO:1903140; GO:1903597; GO:2000556; GO:2001240	ISDHHYSKGFR	5.590000153	1	1	0.210191203	1345.881432	11.73989	13.69793	13.49995	14.12848	13.58103	14.96543	14.15866	14.73503	14.40846	0	14.20604	14.39588	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.14395	0	0	16.44797	0	0	0	0	0	0	0	0	0
P01588	EPO_HUMAN	Erythropoietin (Epoetin)	EPO	Homo sapiens (Human)	"acute-phase response [GO:0006953]; aging [GO:0007568]; apoptotic process [GO:0006915]; blood circulation [GO:0008015]; cellular hyperosmotic response [GO:0071474]; embryo implantation [GO:0007566]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; hemoglobin biosynthetic process [GO:0042541]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cation channel activity [GO:2001258]; negative regulation of erythrocyte apoptotic process [GO:1902251]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to axon injury [GO:0048678]; response to dexamethasone [GO:0071548]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; response to testosterone [GO:0033574]; response to vitamin A [GO:0033189]; signal transduction [GO:0007165]"	cell body [GO:0044297]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	"cell body [GO:0044297]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; erythropoietin receptor binding [GO:0005128]; hormone activity [GO:0005179]; protein kinase activator activity [GO:0030295]; acute-phase response [GO:0006953]; aging [GO:0007568]; apoptotic process [GO:0006915]; blood circulation [GO:0008015]; cellular hyperosmotic response [GO:0071474]; embryo implantation [GO:0007566]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; hemoglobin biosynthetic process [GO:0042541]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cation channel activity [GO:2001258]; negative regulation of erythrocyte apoptotic process [GO:1902251]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to axon injury [GO:0048678]; response to dexamethasone [GO:0071548]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; response to testosterone [GO:0033574]; response to vitamin A [GO:0033189]; signal transduction [GO:0007165]"	cytokine activity [GO:0005125]; erythropoietin receptor binding [GO:0005128]; hormone activity [GO:0005179]; protein kinase activator activity [GO:0030295]	GO:0000122; GO:0001666; GO:0005125; GO:0005128; GO:0005179; GO:0005576; GO:0005615; GO:0006915; GO:0006953; GO:0007165; GO:0007566; GO:0007568; GO:0008015; GO:0008284; GO:0009651; GO:0009986; GO:0010523; GO:0010976; GO:0018105; GO:0030218; GO:0030295; GO:0032496; GO:0033189; GO:0033574; GO:0038162; GO:0042104; GO:0042531; GO:0042541; GO:0043249; GO:0043627; GO:0044297; GO:0045666; GO:0045893; GO:0046579; GO:0048678; GO:0051602; GO:0055093; GO:0070374; GO:0070555; GO:0071474; GO:0071548; GO:1901215; GO:1902219; GO:1902251; GO:2001258	LICDSRVLER	1.639999986	1	1	0.033562882	1260.245996	12.49458	0	0	0	0	9.52485	0	0	0	0	0	0	0	11.61305	0	0	0	0	0	0	0	0	0	0	0	0	0	9.264068	0	12.82987	0	0	0	0	0	0	0	0	0	0	13.34074	0	0	0	0	0	0	0
P01602	KV105_HUMAN	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	Homo sapiens (Human)	adaptive immune response [GO:0002250]; immune response [GO:0006955]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955]	antigen binding [GO:0003823]	GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062; GO:0072562	MDMRVPAQLLGLLLLWLPGAK	3.920000076	1	1	0.312575986	2351.114069	0	0	0	0	0	18.93863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.80006	0	0	13.59992	0	18.58883	0	0	18.24128	19.18176	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.8331	0	0	0
P01730	CD4_HUMAN	T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4)	CD4	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; defense response to Gram-negative bacterium [GO:0050829]; enzyme linked receptor protein signaling pathway [GO:0007167]; helper T cell enhancement of adaptive immune response [GO:0035397]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; macrophage differentiation [GO:0030225]; maintenance of protein location in cell [GO:0032507]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral entry into host cell [GO:0046598]; regulation of calcium ion transport [GO:0051924]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell selection [GO:0045058]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	"clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; interleukin-16 binding [GO:0042011]; interleukin-16 receptor activity [GO:0042012]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; defense response to Gram-negative bacterium [GO:0050829]; enzyme linked receptor protein signaling pathway [GO:0007167]; helper T cell enhancement of adaptive immune response [GO:0035397]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; macrophage differentiation [GO:0030225]; maintenance of protein location in cell [GO:0032507]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral entry into host cell [GO:0046598]; regulation of calcium ion transport [GO:0051924]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell selection [GO:0045058]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; interleukin-16 binding [GO:0042011]; interleukin-16 receptor activity [GO:0042012]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001618; GO:0001934; GO:0002250; GO:0004888; GO:0005201; GO:0005769; GO:0005788; GO:0005789; GO:0005886; GO:0005887; GO:0006955; GO:0007155; GO:0007165; GO:0007166; GO:0007167; GO:0007169; GO:0008270; GO:0009897; GO:0015026; GO:0019899; GO:0019901; GO:0023026; GO:0030217; GO:0030225; GO:0030669; GO:0032507; GO:0032743; GO:0033674; GO:0035397; GO:0035723; GO:0038023; GO:0042011; GO:0042012; GO:0042101; GO:0042110; GO:0042289; GO:0042802; GO:0042803; GO:0043123; GO:0043410; GO:0045058; GO:0045121; GO:0045657; GO:0045860; GO:0045893; GO:0046598; GO:0050731; GO:0050829; GO:0050850; GO:0050863; GO:0050870; GO:0051924; GO:0070374; GO:0097011; GO:1990782	NLTCEVWGPTSPK	3.920000076	0.200523198	0.200523198	0.297716769	1489.611266	11.81268	14.59295	0	10.9696	16.04862	13.44704	0	0	13.45947	0	0	0	0	0	0	14.22393	0	13.48406	0	15.73249	0	0	0	0	12.38288	10.5635	13.51237	0	13.0681	13.15199	0	0	0	14.87549	16.03532	0	0	15.90322	0	9.015884	15.61609	0	13.34074	0	0	0	0	15.52057
P01824	HV439_HUMAN	Immunoglobulin heavy variable 4-39 (Ig heavy chain V-II region WAH)	IGHV4-39	Homo sapiens (Human)	"B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]"	"external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]"	"external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]"	antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]	GO:0003823; GO:0005576; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871	DLMCKK	9.829999924	0.447312862	0.447312862	0.176821744	809.7071962	0	14.16801	15.16282	16.43054	15.09932	15.38345	14.54115	14.7927	14.0971	0	0	16.9361	15.86715	13.10282	0	14.84575	0	13.49331	15.16374	14.82631	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P01833	PIGR_HUMAN	"Polymeric immunoglobulin receptor, PIgR, Poly-Ig receptor (Hepatocellular carcinoma-associated protein TB6) [Cleaved into: Secretory component ]"	PIGR	Homo sapiens (Human)	detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc receptor signaling pathway [GO:0038093]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; receptor clustering [GO:0043113]; retina homeostasis [GO:0001895]	azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory IgA immunoglobulin complex [GO:0071751]	azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory IgA immunoglobulin complex [GO:0071751]; polymeric immunoglobulin receptor activity [GO:0001792]; transmembrane signaling receptor activity [GO:0004888]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc receptor signaling pathway [GO:0038093]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; receptor clustering [GO:0043113]; retina homeostasis [GO:0001895]	polymeric immunoglobulin receptor activity [GO:0001792]; transmembrane signaling receptor activity [GO:0004888]	GO:0001580; GO:0001792; GO:0001895; GO:0002415; GO:0004888; GO:0005615; GO:0005886; GO:0005887; GO:0007173; GO:0035577; GO:0038093; GO:0043113; GO:0043235; GO:0070062; GO:0071751	YWCLWEGAQNGRCPLLVDSEGWVK	3.950000048	1	1	1.83E-12	2924.272423	0	0	14.19936	12.79287	0	12.83694	0	14.76205	14.11211	0	14.6493	14.52203	0	0	0	11.57931	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.23685	0	0	0	12.99599	0	0	0	0	0	16.09884	0
P01854	IGHE_HUMAN	Immunoglobulin heavy constant epsilon (Ig epsilon chain C region) (Ig epsilon chain C region ND)	IGHE	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]"	"external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgE immunoglobulin complex [GO:0071742]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]"	"external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgE immunoglobulin complex [GO:0071742]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]"	antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]	GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0071742	AAPEVYAFATPEWPGSR	8.619999886	1	1	0.163332062	1854.344717	0	15.87814	0	0	0	0	0	0	12.26836	0	0	0	14.92326	0	0	0	14.60952	14.85705	14.8822	0	0	0	0	0	0	0	0	16.19243	14.60901	17.02578	15.95167	0	0	16.06789	13.51013	14.6957	0	15.11069	0	14.29338	16.24575	15.52711	0	0	12.75821	0	0	0
P01876	IGHA1_HUMAN	Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO)	IGHA1	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; glomerular filtration [GO:0003094]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]; positive regulation of respiratory burst [GO:0060267]; protein-chromophore linkage [GO:0018298]; retina homeostasis [GO:0001895]"	"blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgA immunoglobulin complex [GO:0071745]; IgG immunoglobulin complex [GO:0071735]; immunoglobulin complex, circulating [GO:0042571]; monomeric IgA immunoglobulin complex [GO:0071748]; plasma membrane [GO:0005886]; secretory dimeric IgA immunoglobulin complex [GO:0071752]; secretory IgA immunoglobulin complex [GO:0071751]"	"blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgA immunoglobulin complex [GO:0071745]; IgG immunoglobulin complex [GO:0071735]; immunoglobulin complex, circulating [GO:0042571]; monomeric IgA immunoglobulin complex [GO:0071748]; plasma membrane [GO:0005886]; secretory dimeric IgA immunoglobulin complex [GO:0071752]; secretory IgA immunoglobulin complex [GO:0071751]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; glomerular filtration [GO:0003094]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]; positive regulation of respiratory burst [GO:0060267]; protein-chromophore linkage [GO:0018298]; retina homeostasis [GO:0001895]"	antigen binding [GO:0003823]	GO:0001895; GO:0002250; GO:0003094; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0018298; GO:0019731; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0060267; GO:0070062; GO:0071735; GO:0071745; GO:0071748; GO:0071751; GO:0071752; GO:0072562	SAVQGPPER	6.449999809	0.87243104	0.87243104	0.265603166	939.6026092	13.14805	17.91848	11.76081	14.9597	15.15742	14.46299	16.14104	13.52716	0	17.31195	16.11487	17.03498	14.03138	14.90295	16.05694	0	15.34005	14.43679	0	15.8302	16.52561	0	16.08387	15.92525	17.533	0	0	0	0	15.79684	0	15.2137	17.04829	14.93504	0	18.3823	15.51868	0	0	16.03526	16.25193	14.35453	14.40036	15.94805	15.48232	0	0	15.68614
P01889	HLAB_HUMAN	"HLA class I histocompatibility antigen, B alpha chain (Human leukocyte antigen B, HLA-B)"	HLA-B HLAB	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; defense response [GO:0006952]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of T cell anergy [GO:0002667]"	cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]	"cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; chaperone binding [GO:0051087]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; TAP binding [GO:0046977]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; defense response [GO:0006952]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of T cell anergy [GO:0002667]"	chaperone binding [GO:0051087]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; TAP binding [GO:0046977]	GO:0000139; GO:0001916; GO:0002250; GO:0002486; GO:0002667; GO:0005102; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006952; GO:0006955; GO:0009986; GO:0012507; GO:0016020; GO:0016045; GO:0030667; GO:0030670; GO:0031901; GO:0032655; GO:0032675; GO:0042270; GO:0042605; GO:0042612; GO:0045087; GO:0046977; GO:0051087; GO:0055038; GO:0070062; GO:0071556; GO:2001198	SSGGK	1	1	1	0.244969077	435.7464338	15.90307	0	15.37351	11.77796	16.01497	0	13.90794	0	15.33055	15.64049	14.19017	13.297	0	15.82657	15.78291	15.74901	0	0	0	0	0	0	0	0	0	0	15.43723	0	15.45605	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P01903	DRA_HUMAN	"HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)"	HLA-DRA HLA-DRA1	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class II [GO:0002491]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002504]; cognition [GO:0050890]; immune response [GO:0006955]; myeloid dendritic cell antigen processing and presentation [GO:0002469]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of T-helper cell differentiation [GO:0045622]"	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]	"cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; polysaccharide binding [GO:0030247]; T cell receptor binding [GO:0042608]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class II [GO:0002491]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002504]; cognition [GO:0050890]; immune response [GO:0006955]; myeloid dendritic cell antigen processing and presentation [GO:0002469]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of T-helper cell differentiation [GO:0045622]"	MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; polysaccharide binding [GO:0030247]; T cell receptor binding [GO:0042608]	GO:0000139; GO:0001772; GO:0001916; GO:0002250; GO:0002469; GO:0002491; GO:0002503; GO:0002504; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0006955; GO:0009986; GO:0012507; GO:0019886; GO:0023026; GO:0030247; GO:0030658; GO:0030666; GO:0030669; GO:0031901; GO:0031902; GO:0032395; GO:0032588; GO:0032831; GO:0042605; GO:0042608; GO:0042613; GO:0043382; GO:0045622; GO:0050870; GO:0050890; GO:0070062; GO:0071556; GO:2000516	EPNVLICFIDK	5.380000114	0.4574669	0.4574669	5.02E-12	1348.855249	15.26988	15.98407	14.85613	0	14.18136	0	13.49291	15.45015	0	0	13.2535	14.81531	13.70702	14.14144	15.92773	14.3275	0	12.38978	15.01518	15.58563	16.85917	16.84103	14.93637	15.28663	14.44913	14.92072	16.165	0	0	0	16.14691	17.04276	12.73256	13.84005	14.96509	0	16.70895	16.78123	12.74274	0	14.11778	15.86333	14.94632	0	15.35043	16.4369	0	16.91908
P02042	HBD_HUMAN	Hemoglobin subunit delta (Delta-globin) (Hemoglobin delta chain)	HBD	Homo sapiens (Human)	cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]	blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]	blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]	heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005829; GO:0005833; GO:0019825; GO:0020037; GO:0031721; GO:0031838; GO:0042744; GO:0043177; GO:0046872; GO:0072562; GO:0098869	VLGAFSDGLAHLDNLK	7.510000229	1	1	1.83E-12	1669.629422	16.53255	15.89839	16.14794	0	0	0	18.11521	0	0	0	0	0	13.29064	0	14.165	0	0	0	15.10923	0	0	0	0	0	12.88192	0	14.7285	0	14.91338	14.71711	11.68494	16.33537	17.30822	0	0	0	14.23803	0	0	0	0	0	0	0	0	0	0	0
P02100	HBE_HUMAN	Hemoglobin subunit epsilon (Epsilon-globin) (Hemoglobin epsilon chain)	HBE1 HBE	Homo sapiens (Human)	cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; response to organic cyclic compound [GO:0014070]	blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]	blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; protein-containing complex binding [GO:0044877]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; response to organic cyclic compound [GO:0014070]	heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; protein-containing complex binding [GO:0044877]	GO:0005344; GO:0005829; GO:0005833; GO:0014070; GO:0019825; GO:0020037; GO:0031721; GO:0031838; GO:0042744; GO:0043177; GO:0044877; GO:0046872; GO:0072562; GO:0098869	LLVVYPWTQR	24.69000053	1	1	0.465472626	1274.672174	16.24594	0	16.7239	0	16.75123	0	0	0	0	18.42864	0	0	17.1216	0	0	19.06288	0	0	0	0	0	0	0	17.93425	0	0	0	0	0	0	0	0	0	0	0	19.0893	0	0	18.54058	0	0	0	0	0	0	0	0	0
P02144	MYG_HUMAN	Myoglobin	MB	Homo sapiens (Human)	brown fat cell differentiation [GO:0050873]; enucleate erythrocyte differentiation [GO:0043353]; heart development [GO:0007507]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; brown fat cell differentiation [GO:0050873]; enucleate erythrocyte differentiation [GO:0043353]; heart development [GO:0007507]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]	GO:0001666; GO:0005344; GO:0005829; GO:0007507; GO:0015671; GO:0019825; GO:0020037; GO:0043353; GO:0046872; GO:0050873; GO:0070062	DMASNYK	14.72000027	0.729673684	0.729673684	0.202732063	828.4322677	18.46674	17.83502	18.47093	15.72389	17.00193	18.2105	18.60992	14.80869	18.67311	17.92367	16.58893	16.9007	17.97416	17.83382	18.12886	16.65794	16.45656	17.23481	18.29957	16.76101	16.61716	16.98929	18.5387	15.13477	16.79307	19.15177	17.83072	17.86622	17.51786	17.15408	0	18.61896	19.01543	16.76619	0	17.51484	17.82991	18.55107	18.37719	18.77772	17.51471	18.62028	17.90641	16.18369	0	0	18.1981	17.9039
P02452	CO1A1_HUMAN	Collagen alpha-1(I) chain (Alpha-1 type I collagen)	COL1A1	Homo sapiens (Human)	"blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to fluoride [GO:1902618]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth eruption [GO:0044691]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]; wound healing [GO:0042060]"	collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141]	"collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to fluoride [GO:1902618]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth eruption [GO:0044691]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]; wound healing [GO:0042060]"	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]	GO:0001501; GO:0001503; GO:0001568; GO:0001649; GO:0001957; GO:0001958; GO:0002020; GO:0005201; GO:0005576; GO:0005584; GO:0005615; GO:0005737; GO:0005788; GO:0005794; GO:0007601; GO:0007605; GO:0009410; GO:0009612; GO:0010718; GO:0010812; GO:0015031; GO:0030020; GO:0030141; GO:0030198; GO:0030199; GO:0030335; GO:0031012; GO:0031960; GO:0032355; GO:0032964; GO:0034504; GO:0034505; GO:0038063; GO:0042060; GO:0042542; GO:0042802; GO:0043434; GO:0043588; GO:0043589; GO:0044344; GO:0044691; GO:0045893; GO:0046872; GO:0048407; GO:0048706; GO:0051591; GO:0055093; GO:0060325; GO:0060346; GO:0060351; GO:0062023; GO:0071230; GO:0071260; GO:0071300; GO:0071306; GO:0071356; GO:0071364; GO:0071560; GO:0090263; GO:1902618	GGPGSR	14.82999992	0.243084624	0.243084624	0.203523873	531.1677238	15.7587	15.47583	0	14.8173	15.63837	0	16.50504	15.713	0	14.2325	14.25109	15.12236	16.07442	15.44056	0	0	15.03394	16.39512	15.01389	15.96294	16.11217	17.14236	17.13312	17.01166	14.87952	0	16.02602	14.87328	16.11724	15.87396	0	15.38719	0	0	16.97433	0	17.06993	0	0	0	0	0	0	0	0	0	0	0
P02458	CO2A1_HUMAN	Collagen alpha-1(II) chain (Alpha-1 type II collagen) [Cleaved into: Collagen alpha-1(II) chain; Chondrocalcin ]	COL2A1	Homo sapiens (Human)	anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; MHC class II protein binding [GO:0042289]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]; anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; MHC class II protein binding [GO:0042289]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]	GO:0001501; GO:0001502; GO:0001894; GO:0001958; GO:0002062; GO:0003007; GO:0005201; GO:0005576; GO:0005581; GO:0005585; GO:0005592; GO:0005604; GO:0005615; GO:0005788; GO:0006029; GO:0007417; GO:0007601; GO:0007605; GO:0010468; GO:0030020; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0042289; GO:0042472; GO:0042802; GO:0043394; GO:0046872; GO:0048407; GO:0051216; GO:0060021; GO:0060174; GO:0060272; GO:0060351; GO:0062023; GO:0071599; GO:0071773; GO:0097065; GO:2001240	GDSGPPGR	2.839999914	1	1	0.221292506	743.3807948	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.96376	0	0	0	0	0	0	0	0	0
P02461	CO3A1_HUMAN	Collagen alpha-1(III) chain	COL3A1	Homo sapiens (Human)	aorta smooth muscle tissue morphogenesis [GO:0060414]; cell-matrix adhesion [GO:0007160]; cellular response to amino acid stimulus [GO:0071230]; cerebral cortex development [GO:0021987]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; digestive tract development [GO:0048565]; elastic fiber assembly [GO:0048251]; endochondral bone morphogenesis [GO:0060350]; extracellular matrix organization [GO:0030198]; fibroblast proliferation [GO:0048144]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; limb joint morphogenesis [GO:0036022]; lung development [GO:0030324]; multicellular organism growth [GO:0035264]; negative regulation of immune response [GO:0050777]; negative regulation of neuron migration [GO:2001223]; peptide cross-linking [GO:0018149]; platelet activation [GO:0030168]; positive regulation of Rho protein signal transduction [GO:0035025]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to radiation [GO:0009314]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tissue homeostasis [GO:0001894]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 production [GO:0032905]; wound healing [GO:0042060]	collagen type III trimer [GO:0005586]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type III trimer [GO:0005586]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; SMAD binding [GO:0046332]; aorta smooth muscle tissue morphogenesis [GO:0060414]; cell-matrix adhesion [GO:0007160]; cellular response to amino acid stimulus [GO:0071230]; cerebral cortex development [GO:0021987]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; digestive tract development [GO:0048565]; elastic fiber assembly [GO:0048251]; endochondral bone morphogenesis [GO:0060350]; extracellular matrix organization [GO:0030198]; fibroblast proliferation [GO:0048144]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; limb joint morphogenesis [GO:0036022]; lung development [GO:0030324]; multicellular organism growth [GO:0035264]; negative regulation of immune response [GO:0050777]; negative regulation of neuron migration [GO:2001223]; peptide cross-linking [GO:0018149]; platelet activation [GO:0030168]; positive regulation of Rho protein signal transduction [GO:0035025]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to radiation [GO:0009314]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tissue homeostasis [GO:0001894]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 production [GO:0032905]; wound healing [GO:0042060]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; SMAD binding [GO:0046332]	GO:0001701; GO:0001894; GO:0002020; GO:0002062; GO:0005178; GO:0005201; GO:0005576; GO:0005586; GO:0005615; GO:0005788; GO:0007160; GO:0007179; GO:0007229; GO:0007507; GO:0009314; GO:0018149; GO:0021987; GO:0030020; GO:0030168; GO:0030198; GO:0030199; GO:0030324; GO:0031012; GO:0032905; GO:0034097; GO:0035025; GO:0035264; GO:0036022; GO:0042060; GO:0043588; GO:0046332; GO:0046872; GO:0048144; GO:0048251; GO:0048407; GO:0048565; GO:0050777; GO:0060350; GO:0060414; GO:0062023; GO:0071230; GO:0097435; GO:1990776; GO:2001223	GFDGR	1.090000033	4.60E-07	4.60E-07	0.277093347	551.8470195	0	0	0	0	0	19.64944	0	0	17.53283	0	0	0	0	0	0	16.46671	18.02292	0	0	0	0	0	0	0	0	0	17.06596	18.50167	16.94663	0	0	0	18.04736	0	0	0	19.36202	0	18.27685	18.76469	0	0	0	16.20935	0	0	0	0
P02462	CO4A1_HUMAN	Collagen alpha-1(IV) chain [Cleaved into: Arresten ]	COL4A1	Homo sapiens (Human)	basement membrane organization [GO:0071711]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]; renal tubule morphogenesis [GO:0061333]; retinal blood vessel morphogenesis [GO:0061304]	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]; basement membrane organization [GO:0071711]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]; renal tubule morphogenesis [GO:0061333]; retinal blood vessel morphogenesis [GO:0061304]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]	GO:0001569; GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007420; GO:0007528; GO:0030020; GO:0030198; GO:0030855; GO:0031012; GO:0038063; GO:0048407; GO:0048514; GO:0061304; GO:0061333; GO:0062023; GO:0071230; GO:0071711	GDFATK	3.75	1	1	0.160185364	637.6856439	0	0	0	0	0	0	0	0	0	0	0	0	0	15.90152	0	0	0	0	0	0	0	17.32555	0	0	16.82162	0	0	0	0	0	16.18906	15.56302	0	0	0	0	17.29269	16.04559	0	0	14.73595	15.85035	0	17.16028	15.36047	0	0	0
P02489	CRYAA_HUMAN	"Alpha-crystallin A chain (Heat shock protein beta-4, HspB4) [Cleaved into: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162) ]"	CRYAA CRYA1 HSPB4	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; negative regulation of intracellular transport [GO:0032387]; protein stabilization [GO:0050821]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intracellular transport [GO:0032387]; protein stabilization [GO:0050821]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082]	GO:0005198; GO:0005212; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007601; GO:0032387; GO:0032991; GO:0042802; GO:0043066; GO:0046872; GO:0050821; GO:0050896; GO:0051082	DVTIQHPWFK	6.829999924	0.1188915	0.1188915	0.080693564	1270.858264	14.47769	14.29069	0	0	0	13.21922	16.95527	12.13456	16.10751	0	13.34966	14.78624	0	0	0	0	13.36136	8.30477	0	0	0	0	7.898808	0	0	0	13.37183	0	0	0	0	11.75168	10.39847	14.37825	15.96989	0	0	0	15.9644	14.57054	14.83868	16.90762	14.25083	0	0	14.07205	0	14.4836
P02533	K1C14_HUMAN	"Keratin, type I cytoskeletal 14 (Cytokeratin-14, CK-14) (Keratin-14, K14)"	KRT14	Homo sapiens (Human)	aging [GO:0007568]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; hair cycle [GO:0042633]; intermediate filament bundle assembly [GO:0045110]; intermediate filament organization [GO:0045109]	basal part of cell [GO:0045178]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; nucleus [GO:0005634]	basal part of cell [GO:0045178]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; nucleus [GO:0005634]; keratin filament binding [GO:1990254]; structural constituent of cytoskeleton [GO:0005200]; aging [GO:0007568]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; hair cycle [GO:0042633]; intermediate filament bundle assembly [GO:0045110]; intermediate filament organization [GO:0045109]	keratin filament binding [GO:1990254]; structural constituent of cytoskeleton [GO:0005200]	GO:0001533; GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005882; GO:0007568; GO:0008544; GO:0030855; GO:0042633; GO:0045095; GO:0045109; GO:0045110; GO:0045178; GO:0070062; GO:1990254	QFTSSSSMK	9.800000191	1	1	0.20115914	1018.610895	0	0	9.10591	14.6433	0	13.47232	0	15.91006	0	0	0	0	15.65694	15.53907	13.73792	15.89596	15.7357	14.01999	15.66355	0	0	14.49057	0	0	0	0	15.2005	0	0	0	12.39238	16.3443	0	13.25932	0	0	0	0	14.5847	0	15.4207	0	16.74818	0	16.65103	0	14.32853	0
P02545	LMNA_HUMAN	Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32) ]	LMNA LMN1	Homo sapiens (Human)	cellular protein localization [GO:0034613]; cellular response to hypoxia [GO:0071456]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; positive regulation of cell aging [GO:0090343]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of double-strand break [GO:0035861]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of double-strand break [GO:0035861]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; cellular protein localization [GO:0034613]; cellular response to hypoxia [GO:0071456]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; positive regulation of cell aging [GO:0090343]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005634; GO:0005635; GO:0005638; GO:0005652; GO:0005654; GO:0005829; GO:0005882; GO:0006606; GO:0006998; GO:0007517; GO:0008285; GO:0010628; GO:0016363; GO:0016607; GO:0030334; GO:0030951; GO:0031647; GO:0031965; GO:0032204; GO:0034504; GO:0034613; GO:0035861; GO:0042802; GO:0048471; GO:0055015; GO:0071456; GO:0072201; GO:0090201; GO:0090343; GO:1900114; GO:1900180; GO:1903243; GO:1990683; GO:2001237	QSAER	15.23999977	1	1	0.264963932	591.2354274	16.36295	15.27966	15.65103	0	0	15.91927	13.88515	13.71059	0	0	15.77993	15.84656	15.33071	14.55258	15.40483	15.64608	16.16669	16.84598	16.3432	16.02992	15.41401	16.36745	15.97035	16.70411	14.95916	15.34789	0	0	15.27924	15.91824	16.02132	0	0	0	16.66757	15.79149	0	16.75267	0	17.75453	0	0	16.30042	0	15.90258	16.11609	17.03595	16.53146
P02549	SPTA1_HUMAN	"Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)"	SPTA1 SPTA	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200]	GO:0002260; GO:0005200; GO:0005509; GO:0005829; GO:0005886; GO:0006779; GO:0007009; GO:0007015; GO:0008091; GO:0008360; GO:0014731; GO:0015629; GO:0030036; GO:0030054; GO:0030097; GO:0030424; GO:0030864; GO:0031235; GO:0032092; GO:0032437; GO:0042102; GO:0042995; GO:0051015; GO:0051693	EPLATR	5.960000038	0.621176422	0.621176422	0.252423193	685.8990993	14.77094	14.5735	0	0	0	14.67521	15.13517	0	14.35089	15.32201	14.15684	14.64672	16.11123	17.10189	17.29273	0	15.24535	0	15.96533	15.46443	0	16.81555	15.95763	0	0	15.25459	0	15.48782	0	0	16.69515	0	0	0	15.23545	0	0	0	0	0	16.28681	0	16.61916	0	16.8458	0	0	0
P02647	APOA1_HUMAN	"Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]"	APOA1	Homo sapiens (Human)	adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; glucocorticoid metabolic process [GO:0008211]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; negative chemotaxis [GO:0050919]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of triglyceride catabolic process [GO:0010898]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]; vitamin transport [GO:0051180]	blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]	blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; apolipoprotein receptor binding [GO:0034190]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; glucocorticoid metabolic process [GO:0008211]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; negative chemotaxis [GO:0050919]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of triglyceride catabolic process [GO:0010898]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]; vitamin transport [GO:0051180]	amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; apolipoprotein receptor binding [GO:0034190]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0001540; GO:0001932; GO:0001935; GO:0002719; GO:0005102; GO:0005543; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005829; GO:0005886; GO:0006656; GO:0006695; GO:0007186; GO:0007229; GO:0008035; GO:0008203; GO:0008211; GO:0010804; GO:0010873; GO:0010875; GO:0010898; GO:0010903; GO:0015485; GO:0018158; GO:0018206; GO:0019899; GO:0019915; GO:0030139; GO:0030300; GO:0030301; GO:0030325; GO:0031072; GO:0031210; GO:0031410; GO:0032489; GO:0032691; GO:0033344; GO:0033700; GO:0034115; GO:0034190; GO:0034191; GO:0034361; GO:0034364; GO:0034366; GO:0034372; GO:0034375; GO:0034380; GO:0034384; GO:0034774; GO:0035025; GO:0042157; GO:0042158; GO:0042627; GO:0042632; GO:0042802; GO:0042803; GO:0043534; GO:0043691; GO:0045499; GO:0045723; GO:0046470; GO:0046889; GO:0050728; GO:0050766; GO:0050821; GO:0050919; GO:0051006; GO:0051180; GO:0051345; GO:0051346; GO:0051496; GO:0055091; GO:0060228; GO:0060354; GO:0060761; GO:0062023; GO:0070062; GO:0070328; GO:0070508; GO:0070653; GO:0071682; GO:0072562; GO:0120020; GO:1900026; GO:1902995; GO:1903561	LSPLGEEMR	2.569999933	1	1	0.098734242	1028.341157	0	0	0	0	0	0	0	0	0	0	0	0	0	14.58436	0	0	0	14.51979	13.56748	15.88694	0	0	0	0	0	0	0	14.34413	12.17406	0	0	0	0	14.86998	0	0	0	0	0	0	15.84756	0	0	0	0	0	0	0
P02671	FIBA_HUMAN	Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain ]	FGA	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; blood coagulation, common pathway [GO:0072377]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of blood coagulation, common pathway [GO:2000261]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]"	blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]	"blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation, common pathway [GO:0072377]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of blood coagulation, common pathway [GO:2000261]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]"	extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]	GO:0002250; GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0005886; GO:0007160; GO:0009897; GO:0009986; GO:0031091; GO:0031093; GO:0031639; GO:0034116; GO:0042730; GO:0043152; GO:0045087; GO:0045907; GO:0045921; GO:0046872; GO:0050714; GO:0051258; GO:0051592; GO:0062023; GO:0065003; GO:0070062; GO:0070374; GO:0070527; GO:0072377; GO:0072378; GO:0072562; GO:0090277; GO:1900026; GO:1902042; GO:1903561; GO:2000261; GO:2000352	AQLVDMKR	5.559999943	0.707668364	0.707668364	0.2643215	976.8289604	0	0	0	13.34366	0	0	0	0	0	0	0	18.99424	0	0	0	0	16.53735	0	0	0	14.64174	0	0	0	15.30975	0	17.24426	0	13.6381	16.11487	0	0	15.79157	0	0	17.29362	0	0	0	0	13.66881	0	0	0	0	0	0	0
P02675	FIBB_HUMAN	Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain ]	FGB	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]"	blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; synapse [GO:0045202]	"blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; synapse [GO:0045202]; chaperone binding [GO:0051087]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]"	chaperone binding [GO:0051087]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]	GO:0002250; GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005886; GO:0005938; GO:0007155; GO:0007160; GO:0009897; GO:0009986; GO:0031091; GO:0031093; GO:0031639; GO:0034116; GO:0042730; GO:0043152; GO:0044320; GO:0045087; GO:0045202; GO:0045907; GO:0045921; GO:0050714; GO:0051087; GO:0051258; GO:0051592; GO:0062023; GO:0065003; GO:0070062; GO:0070374; GO:0070527; GO:0071347; GO:0072378; GO:0072562; GO:0090277; GO:1900026; GO:1902042; GO:1903561; GO:2000352	HGTDDGVVWMNWKGSWYSMR	7.920000076	0.718082547	0.718082547	0.077180025	2426.396381	0	0	17.32759	0	16.20427	0	18.0595	0	0	19.20722	17.97351	0	17.28178	0	16.81997	0	16.24279	17.23801	0	0	0	0	0	0	19.14809	15.52093	0	0	0	0	12.10856	16.58451	17.62871	0	0	16.4591	18.62223	17.61236	15.94431	0	0	0	18.24373	0	0	16.68504	17.02542	0
P02686	MBP_HUMAN	"Myelin basic protein, MBP (Myelin A1 protein) (Myelin membrane encephalitogenic protein)"	MBP	Homo sapiens (Human)	aging [GO:0007568]; axon ensheathment [GO:0008366]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; immune response [GO:0006955]; maintenance of blood-brain barrier [GO:0035633]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; myelination [GO:0042552]; negative regulation of axonogenesis [GO:0050771]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of metalloendopeptidase activity [GO:1904685]; response to fatty acid [GO:0070542]; response to mercury ion [GO:0046689]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; sensory perception of sound [GO:0007605]; substantia nigra development [GO:0021762]	cell periphery [GO:0071944]; cell surface [GO:0009986]; compact myelin [GO:0043218]; cytosol [GO:0005829]; internode region of axon [GO:0033269]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	cell periphery [GO:0071944]; cell surface [GO:0009986]; compact myelin [GO:0043218]; cytosol [GO:0005829]; internode region of axon [GO:0033269]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; protease binding [GO:0002020]; structural constituent of myelin sheath [GO:0019911]; aging [GO:0007568]; axon ensheathment [GO:0008366]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; immune response [GO:0006955]; maintenance of blood-brain barrier [GO:0035633]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; myelination [GO:0042552]; negative regulation of axonogenesis [GO:0050771]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of metalloendopeptidase activity [GO:1904685]; response to fatty acid [GO:0070542]; response to mercury ion [GO:0046689]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; sensory perception of sound [GO:0007605]; substantia nigra development [GO:0021762]	calmodulin binding [GO:0005516]; protease binding [GO:0002020]; structural constituent of myelin sheath [GO:0019911]	GO:0000165; GO:0002020; GO:0005516; GO:0005634; GO:0005829; GO:0005886; GO:0006955; GO:0007268; GO:0007417; GO:0007568; GO:0007605; GO:0008366; GO:0009636; GO:0009986; GO:0019911; GO:0021762; GO:0032570; GO:0032755; GO:0032991; GO:0033269; GO:0034115; GO:0034612; GO:0035633; GO:0042552; GO:0043025; GO:0043209; GO:0043218; GO:0045202; GO:0046689; GO:0050771; GO:0061024; GO:0070542; GO:0071944; GO:1904685; GO:2000343	MGNHAGK	6.079999924	0.201164246	0.201164246	0.172048625	712.4716851	15.17677	14.8061	14.65644	14.65606	14.98375	0	0	13.87737	0	15.50765	14.16415	0	0	14.44897	14.01568	0	13.65997	16.5868	0	15.56484	0	0	0	0	0	0	14.91233	0	17.02231	0	15.88213	16.03034	0	0	0	0	0	17.46883	16.02402	14.44584	15.70859	15.73926	16.42658	15.45039	0	16.06646	0	0
P02730	B3AT_HUMAN	"Band 3 anion transport protein (Anion exchange protein 1, AE 1, Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233)"	SLC4A1 AE1 DI EPB3	Homo sapiens (Human)	anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; ion homeostasis [GO:0050801]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; ion homeostasis [GO:0050801]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0005887; GO:0006820; GO:0006821; GO:0006873; GO:0007596; GO:0008509; GO:0009898; GO:0015106; GO:0015108; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0017121; GO:0022857; GO:0030018; GO:0030492; GO:0030506; GO:0030863; GO:0035811; GO:0042803; GO:0043495; GO:0045852; GO:0048821; GO:0050801; GO:0051354; GO:0051453; GO:0055085; GO:0070062; GO:0072562; GO:0072659; GO:1904539	RVLLPLIFR	24.93000031	1	1	0.151532449	1130.875782	16.80264	15.89133	16.83003	0	0	0	0	0	0	0	0	0	0	0	0	0	16.29959	0	0	0	0	0	0	0	0	0	0	0	15.93498	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.95009
P02741	CRP_HUMAN	C-reactive protein [Cleaved into: C-reactive protein(1-205) ]	CRP PTX1	Homo sapiens (Human)	"acute-phase response [GO:0006953]; complement activation, classical pathway [GO:0006958]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation by host of viral process [GO:0044793]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; opsonization [GO:0008228]; positive regulation of gene expression [GO:0010628]; positive regulation of superoxide anion generation [GO:0032930]; regulation of interleukin-8 production [GO:0032677]; vasoconstriction [GO:0042310]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; choline binding [GO:0033265]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; acute-phase response [GO:0006953]; complement activation, classical pathway [GO:0006958]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation by host of viral process [GO:0044793]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; opsonization [GO:0008228]; positive regulation of gene expression [GO:0010628]; positive regulation of superoxide anion generation [GO:0032930]; regulation of interleukin-8 production [GO:0032677]; vasoconstriction [GO:0042310]"	calcium ion binding [GO:0005509]; choline binding [GO:0033265]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]	GO:0001849; GO:0005509; GO:0005576; GO:0005615; GO:0006953; GO:0006954; GO:0006958; GO:0008228; GO:0010628; GO:0010745; GO:0010888; GO:0030169; GO:0032677; GO:0032930; GO:0032945; GO:0033265; GO:0042310; GO:0042802; GO:0044793; GO:0045087; GO:0050750; GO:0050830	ESDTSYVSLKAPLTKPLK	3.309999943	1	1	0.385376116	1977.268418	14.16947	0	0	0	0	0	0	14.87044	0	0	0	0	0	13.11329	14.01746	14.22868	0	0	0	15.29693	0	0	16.35142	0	0	15.39468	0	0	14.40939	0	0	0	0	13.24246	0	0	0	16.15302	0	0	0	0	0	0	15.94082	0	0	0
P02743	SAMP_HUMAN	"Serum amyloid P-component, SAP (9.5S alpha-1-glycoprotein) [Cleaved into: Serum amyloid P-component(1-203) ]"	APCS PTX2	Homo sapiens (Human)	"acute-phase response [GO:0006953]; chaperone-mediated protein complex assembly [GO:0051131]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation by host of viral exo-alpha-sialidase activity [GO:0044869]; negative regulation by host of viral glycoprotein metabolic process [GO:0044871]; negative regulation by host of viral process [GO:0044793]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of exo-alpha-sialidase activity [GO:1903016]; negative regulation of glycoprotein metabolic process [GO:1903019]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral process [GO:0048525]; negative regulation of wound healing [GO:0061045]; protein folding [GO:0006457]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]; acute-phase response [GO:0006953]; chaperone-mediated protein complex assembly [GO:0051131]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation by host of viral exo-alpha-sialidase activity [GO:0044869]; negative regulation by host of viral glycoprotein metabolic process [GO:0044871]; negative regulation by host of viral process [GO:0044793]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of exo-alpha-sialidase activity [GO:1903016]; negative regulation of glycoprotein metabolic process [GO:1903019]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral process [GO:0048525]; negative regulation of wound healing [GO:0061045]; protein folding [GO:0006457]"	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]	GO:0001849; GO:0002674; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0006457; GO:0006953; GO:0006958; GO:0030169; GO:0030246; GO:0042802; GO:0044793; GO:0044869; GO:0044871; GO:0045087; GO:0045656; GO:0046597; GO:0046790; GO:0048525; GO:0051082; GO:0051131; GO:0061045; GO:0062023; GO:0070062; GO:0072562; GO:1903016; GO:1903019	DNELLVYK	7.769999981	0.312284946	0.312284946	0.287864102	993.2719873	14.30875	0	0	0	0	0	18.27061	19.52189	0	17.16325	0	17.81207	0	0	0	0	0	0	0	0	16.86686	0	0	0	0	21.31824	0	16.34377	0	16.26847	0	0	18.58142	0	17.58187	17.5852	16.83205	0	20.995	0	0	0	0	16.39865	0	0	0	0
P02749	APOH_HUMAN	"Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H, Apo-H) (Beta-2-glycoprotein I, B2GPI, Beta(2)GPI)"	APOH B2G1	Homo sapiens (Human)	"blood coagulation, intrinsic pathway [GO:0007597]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; plasminogen activation [GO:0031639]; positive regulation of blood coagulation [GO:0030194]; positive regulation of lipoprotein lipase activity [GO:0051006]; regulation of fibrinolysis [GO:0051917]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]"	cell surface [GO:0009986]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; platelet dense granule lumen [GO:0031089]; very-low-density lipoprotein particle [GO:0034361]	"cell surface [GO:0009986]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; platelet dense granule lumen [GO:0031089]; very-low-density lipoprotein particle [GO:0034361]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipid binding [GO:0005543]; blood coagulation, intrinsic pathway [GO:0007597]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; plasminogen activation [GO:0031639]; positive regulation of blood coagulation [GO:0030194]; positive regulation of lipoprotein lipase activity [GO:0051006]; regulation of fibrinolysis [GO:0051917]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]"	heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipid binding [GO:0005543]	GO:0001937; GO:0005543; GO:0005576; GO:0005615; GO:0006641; GO:0007597; GO:0008201; GO:0008289; GO:0009986; GO:0010596; GO:0016525; GO:0030194; GO:0030195; GO:0031089; GO:0031639; GO:0033033; GO:0034197; GO:0034361; GO:0034364; GO:0034392; GO:0042627; GO:0042802; GO:0051006; GO:0051917; GO:0051918; GO:0060230; GO:0062023; GO:0070062	FKNGMLHGDK	19.02000046	1	1	0.509090771	1163.501589	0	0	21.64854	21.55151	18.468	0	18.91597	0	17.86226	0	22.78751	18.8724	17.56355	0	0	0	0	18.53506	21.4951	21.35763	17.88932	0	0	19.62814	0	0	0	0	0	21.80398	0	0	0	0	22.51414	0	18.77267	23.23482	0	0	0	0	22.47776	0	0	0	21.53797	0
P02751	FINC_HUMAN	"Fibronectin, FN (Cold-insoluble globulin, CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3 ]"	FN1 FN	Homo sapiens (Human)	"acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; biological process involved in interaction with symbiont [GO:0051702]; blood coagulation, fibrin clot formation [GO:0072378]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; heart development [GO:0007507]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of monocyte activation [GO:0150102]; negative regulation of transforming growth factor beta production [GO:0071635]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]"	apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]	"apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; biological process involved in interaction with symbiont [GO:0051702]; blood coagulation, fibrin clot formation [GO:0072378]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; heart development [GO:0007507]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of monocyte activation [GO:0150102]; negative regulation of transforming growth factor beta production [GO:0071635]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]"	chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0001932; GO:0002020; GO:0005102; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005577; GO:0005604; GO:0005615; GO:0005788; GO:0005793; GO:0005886; GO:0006953; GO:0007044; GO:0007155; GO:0007160; GO:0007161; GO:0007229; GO:0007399; GO:0007507; GO:0008022; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010628; GO:0014068; GO:0016324; GO:0016504; GO:0018149; GO:0019899; GO:0031012; GO:0031093; GO:0033622; GO:0034446; GO:0035987; GO:0042802; GO:0043394; GO:0045773; GO:0048146; GO:0051087; GO:0051702; GO:0062023; GO:0070062; GO:0070372; GO:0070527; GO:0071635; GO:0072378; GO:0072562; GO:0097718; GO:0150102; GO:1901166; GO:1904237	ARITGYIIK	7.909999847	1	1	0.238828338	1033.948761	15.64535	15.20401	16.05428	15.20325	15.59642	0	15.86494	0	0	15.75096	0	16.27077	0	15.15856	0	16.1463	0	15.00879	0	16.31404	0	16.17673	15.7739	0	0	0	0	0	0	0	0	0	15.97185	0	0	16.49563	0	0	0	0	0	0	0	0	0	0	0	0
P02753	RET4_HUMAN	"Retinol-binding protein 4 (Plasma retinol-binding protein, PRBP, RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176) ]"	RBP4 PRO2222	Homo sapiens (Human)	cardiac muscle tissue development [GO:0048738]; embryonic organ morphogenesis [GO:0048562]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; female genitalia morphogenesis [GO:0048807]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; lung development [GO:0030324]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion [GO:0032024]; response to retinoic acid [GO:0032526]; retinol metabolic process [GO:0042572]; retinol transport [GO:0034633]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; visual perception [GO:0007601]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; cardiac muscle tissue development [GO:0048738]; embryonic organ morphogenesis [GO:0048562]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; female genitalia morphogenesis [GO:0048807]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; lung development [GO:0030324]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion [GO:0032024]; response to retinoic acid [GO:0032526]; retinol metabolic process [GO:0042572]; retinol transport [GO:0034633]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; visual perception [GO:0007601]	retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]	GO:0001654; GO:0002639; GO:0005576; GO:0005615; GO:0006094; GO:0007507; GO:0007601; GO:0016918; GO:0019841; GO:0030277; GO:0030324; GO:0032024; GO:0032526; GO:0034632; GO:0034633; GO:0042572; GO:0042593; GO:0048562; GO:0048706; GO:0048738; GO:0048807; GO:0060044; GO:0060059; GO:0060065; GO:0060068; GO:0060157; GO:0060347; GO:0070062	MKWVWALLLLAALGSGR	4.289999962	1	1	0.26401932	1900.7846	0	14.86905	14.71201	0	15.39397	0	0	0	0	0	15.94584	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.43903	0	0	0	0
P02768	ALBU_HUMAN	Albumin	ALB GIG20 GIG42 PRO0903 PRO1708 PRO2044 PRO2619 PRO2675 UNQ696/PRO1341	Homo sapiens (Human)	cellular response to starvation [GO:0009267]; maintenance of mitochondrion location [GO:0051659]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; retina homeostasis [GO:0001895]	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; antioxidant activity [GO:0016209]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; exogenous protein binding [GO:0140272]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; maintenance of mitochondrion location [GO:0051659]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; retina homeostasis [GO:0001895]	antioxidant activity [GO:0016209]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; exogenous protein binding [GO:0140272]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]; zinc ion binding [GO:0008270]	GO:0001895; GO:0003677; GO:0005504; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0005794; GO:0008270; GO:0009267; GO:0015643; GO:0016209; GO:0030170; GO:0031093; GO:0032991; GO:0042802; GO:0043066; GO:0043069; GO:0051087; GO:0051659; GO:0070062; GO:0072562; GO:0140272; GO:1903981	DVFLGMFLYEYAR	11.34000015	1	1	0.38688134	1624.011723	0	0	0	0	0	0	0	0	0	0	17.47497	0	0	0	0	0	0	0	0	0	0	18.01288	0	17.31087	0	17.30442	17.00025	0	17.09709	0	0	0	0	0	16.17533	0	0	0	0	0	0	0	0	0	0	17.64644	15.82231	0
P02771	FETA_HUMAN	Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin)	AFP HPAFP	Homo sapiens (Human)	ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448]; SMAD protein signal transduction [GO:0060395]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fatty acid binding [GO:0005504]; zinc ion binding [GO:0008270]; ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448]; SMAD protein signal transduction [GO:0060395]	fatty acid binding [GO:0005504]; zinc ion binding [GO:0008270]	GO:0001542; GO:0005504; GO:0005615; GO:0005737; GO:0005788; GO:0008270; GO:0042448; GO:0060395	LSQKFTK	10.73999977	0.105451599	0.105451599	0.265009791	850.4107068	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.17652	0	18.01661	0	0	0	0	0	16.41977	0	14.92288	0	17.28553	16.68025	16.30595	0	0	0	0	0	0	15.7492	0	17.23081	15.32889	18.06121	0	17.76392	0	0	0	0	17.33779
P02786	TFR1_HUMAN	"Transferrin receptor protein 1, TR, TfR, TfR1, Trfr (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form, sTfR ]"	TFRC	Homo sapiens (Human)	acute-phase response [GO:0006953]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104]	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618]; acute-phase response [GO:0006953]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104]	chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001666; GO:0001934; GO:0003723; GO:0003725; GO:0004998; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005768; GO:0005769; GO:0005886; GO:0005887; GO:0005905; GO:0006826; GO:0006879; GO:0006953; GO:0007568; GO:0007584; GO:0009897; GO:0009986; GO:0010008; GO:0010039; GO:0010042; GO:0010628; GO:0010637; GO:0016020; GO:0016323; GO:0019901; GO:0030316; GO:0030544; GO:0030669; GO:0030890; GO:0031334; GO:0031410; GO:0031623; GO:0032526; GO:0033138; GO:0033572; GO:0035556; GO:0042102; GO:0042470; GO:0042802; GO:0042803; GO:0043066; GO:0043123; GO:0043231; GO:0044877; GO:0045780; GO:0045830; GO:0046688; GO:0048471; GO:0051087; GO:0051092; GO:0055037; GO:0055038; GO:0070062; GO:0071466; GO:0072562; GO:0150104; GO:1900182; GO:1903561; GO:1990712; GO:1990830	LVYLVENPGGYVAYSK	7.170000076	0.450583428	0.450583428	0.091458702	1771.040226	14.13295	0	0	0	0	0	0	0	0	15.11513	0	0	0	0	0	0	0	14.20027	0	0	0	0	16.50488	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P02787	TRFE_HUMAN	"Serotransferrin, Transferrin (Beta-1 metal-binding globulin) (Siderophilin)"	TF PRO1400	Homo sapiens (Human)	"actin filament organization [GO:0007015]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; regulation of protein stability [GO:0031647]; retina homeostasis [GO:0001895]; SMAD protein signal transduction [GO:0060395]"	apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	"apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459]; actin filament organization [GO:0007015]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; regulation of protein stability [GO:0031647]; retina homeostasis [GO:0001895]; SMAD protein signal transduction [GO:0060395]"	ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459]	GO:0001895; GO:0005576; GO:0005615; GO:0005769; GO:0005770; GO:0005788; GO:0005886; GO:0005905; GO:0006826; GO:0006879; GO:0007015; GO:0008198; GO:0008199; GO:0009925; GO:0009986; GO:0010008; GO:0016324; GO:0019731; GO:0030139; GO:0030316; GO:0030669; GO:0031232; GO:0031410; GO:0031647; GO:0031982; GO:0034756; GO:0034774; GO:0034986; GO:0042327; GO:0045178; GO:0045780; GO:0045893; GO:0048260; GO:0048471; GO:0055037; GO:0055072; GO:0060395; GO:0070062; GO:0070371; GO:0071281; GO:0072562; GO:1990459; GO:1990712; GO:2000147	CQSFRDHMK	8.430000305	1	1	0.297216825	1209.865511	0	15.58985	13.65306	0	0	0	0	14.6474	0	0	14.32667	0	0	16.79242	0	15.97163	0	0	16.60203	0	0	12.89966	0	16.23978	16.93279	0	16.90522	0	0	16.30219	0	0	16.49226	15.11431	15.68482	0	17.01353	18.60703	17.13335	16.08615	0	16.58801	15.58641	17.51308	16.96951	17.96209	0	17.21272
P02788	TRFL_HUMAN	"Lactotransferrin, Lactoferrin, EC 3.4.21.- (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H, Lfcin-H; Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C ]"	LTF GIG12 LF	Homo sapiens (Human)	antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of membrane potential [GO:0045837]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680]; retina homeostasis [GO:0001895]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of membrane potential [GO:0045837]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680]; retina homeostasis [GO:0001895]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252]	GO:0001503; GO:0001530; GO:0001817; GO:0001895; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045087; GO:0045669; GO:0045837; GO:0048525; GO:0050829; GO:0050830; GO:0051092; GO:0051673; GO:0055037; GO:0055072; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000117; GO:2000308; GO:2001205	CLAENAGDVAFVK	12.47999954	0.267643929	0.267643929	0.543798173	1393.643016	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.98142	17.33526	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P02794	FRIH_HUMAN	"Ferritin heavy chain, Ferritin H subunit, EC 1.16.3.1 (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed ]"	FTH1 FTH FTHL6 OK/SW-cl.84 PIG15	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]	autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular ferritin complex [GO:0008043]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]	autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular ferritin complex [GO:0008043]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; cellular iron ion homeostasis [GO:0006879]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]	ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]	GO:0004322; GO:0005506; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006826; GO:0006879; GO:0006880; GO:0006955; GO:0008043; GO:0008198; GO:0008199; GO:0008285; GO:0042802; GO:0044754; GO:0048147; GO:0070062; GO:1904724; GO:1904813	EHAEKLMK	3.910000086	0.69223237	0.69223237	0.198757822	1000.489216	0	14.36089	13.63578	0	14.66262	14.52642	0	16.83631	0	0	16.11303	0	0	0	0	0	13.80556	0	0	0	0	0	0	16.57761	16.08495	0	16.15829	15.63923	13.88686	15.47483	15.25402	12.94174	16.02598	15.71073	17.55422	15.88032	15.51087	15.83836	17.35156	15.13317	13.67509	13.90414	13.2715	10.21954	14.77607	0	17.18273	14.03963
P02814	SMR3B_HUMAN	Submaxillary gland androgen-regulated protein 3B (Proline-rich peptide P-B) (Proline-rich protein 3) [Cleaved into: Peptide P-A; Peptide D1A ]	SMR3B PBII PRL3 PROL3	Homo sapiens (Human)	regulation of sensory perception of pain [GO:0051930]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; regulation of sensory perception of pain [GO:0051930]	endopeptidase inhibitor activity [GO:0004866]	GO:0004866; GO:0005615; GO:0051930; GO:0070062	IPPPPPAPYGPGIFPPPPPQP	1.320000052	1	1	1.38E-12	2124.431845	14.51863	0	13.24382	0	0	0	12.3206	0	12.91801	13.35987	0	0	0	13.61551	14.74492	0	13.84456	12.73244	15.04159	16.58026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P03952	KLKB1_HUMAN	"Plasma kallikrein, EC 3.4.21.34 (Fletcher factor) (Kininogenin) (Plasma prekallikrein, PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain ]"	KLKB1 KLK3	Homo sapiens (Human)	"blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]"	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]	"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]"	serine-type endopeptidase activity [GO:0004252]	GO:0002542; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0070062; GO:1905370	DIYKGVDMR	1.649999976	1	1	0.290420228	1112.038552	0	0	18.19272	0	0	0	0	0	0	0	17.90966	0	15.82235	0	0	0	16.2301	17.03154	0	0	0	0	0	0	0	0	16.82345	0	19.66991	16.53101	18.53879	0	0	0	0	0	0	17.69953	0	0	0	0	0	16.92774	17.12096	0	0	0
P03973	SLPI_HUMAN	"Antileukoproteinase, ALP (BLPI) (HUSI-1) (Mucus proteinase inhibitor, MPI) (Protease inhibitor WAP4) (Secretory leukocyte protease inhibitor) (Seminal proteinase inhibitor) (WAP four-disulfide core domain protein 4)"	SLPI WAP4 WFDC4	Homo sapiens (Human)	antibacterial humoral response [GO:0019731]; immune response [GO:0006955]; innate immune response [GO:0045087]; modulation of process of another organism [GO:0035821]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; response to lipopolysaccharide [GO:0032496]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; specific granule lumen [GO:0035580]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; specific granule lumen [GO:0035580]; DNA binding [GO:0003677]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; immune response [GO:0006955]; innate immune response [GO:0045087]; modulation of process of another organism [GO:0035821]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; response to lipopolysaccharide [GO:0032496]	DNA binding [GO:0003677]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0003677; GO:0003729; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0005794; GO:0006955; GO:0019731; GO:0019899; GO:0032091; GO:0032496; GO:0035580; GO:0035821; GO:0045071; GO:0045087; GO:0062023; GO:0070062	AGVCPPK	8.460000038	0.300249696	0.300249696	0.21269339	730.631172	0	16.23092	0	14.85957	17.81767	0	0	0	18.57343	14.00258	16.54997	17.10642	0	0	0	0	0	0	0	0	0	0	16.96772	0	15.76333	17.72469	0	17.17053	0	15.67344	0	0	0	0	0	0	0	16.42731	0	0	0	16.09012	0	0	0	0	0	0
P04003	C4BPA_HUMAN	"C4b-binding protein alpha chain, C4bp (Proline-rich protein, PRP)"	C4BPA C4BP	Homo sapiens (Human)	"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of protein catabolic process [GO:0045732]; regulation of opsonization [GO:1903027]; response to symbiotic bacterium [GO:0009609]"	blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of protein catabolic process [GO:0045732]; regulation of opsonization [GO:1903027]; response to symbiotic bacterium [GO:0009609]"	RNA binding [GO:0003723]	GO:0003723; GO:0005576; GO:0005615; GO:0005886; GO:0006958; GO:0009609; GO:0045087; GO:0045732; GO:0045959; GO:0072562; GO:1903027	EDVYVVGTVLR	4.989999771	1	1	0.425975591	1249.73039	15.97274	16.36295	15.02375	14.91976	14.4015	0	15.15846	13.99526	13.9478	11.73898	10.30405	0	0	0	14.72149	0	0	0	0	0	14.63721	16.21278	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.59835	0	0	0	16.16773	0	0	16.23311	16.04446	0	0	0
P04035	HMDH_HUMAN	"3-hydroxy-3-methylglutaryl-coenzyme A reductase, HMG-CoA reductase, EC 1.1.1.34"	HMGCR	Homo sapiens (Human)	cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADPH binding [GO:0070402]; cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542]	coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADPH binding [GO:0070402]	GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0008299; GO:0008542; GO:0015936; GO:0016021; GO:0016126; GO:0042177; GO:0043407; GO:0050709; GO:0070402; GO:0120225; GO:1900222	MIMSLGLVLVHAHSR	3.630000114	0.589628339	0.589628339	0.139403677	1697.867707	14.96356	13.2652	0	14.9214	15.84287	0	12.97828	12.93932	17.44007	0	14.61535	13.89821	12.96465	15.48545	0	14.02151	14.71166	16.96993	16.89194	0	15.40104	13.64441	13.83936	15.05023	16.22686	0	0	10.15825	0	15.22197	0	0	17.93577	0	14.82745	0	17.42137	0	15.67035	0	17.66326	17.94104	0	16.00178	12.38111	0	0	13.79254
P04049	RAF1_HUMAN	"RAF proto-oncogene serine/threonine-protein kinase, EC 2.7.11.1 (Proto-oncogene c-RAF, cRaf) (Raf-1)"	RAF1 RAF	Homo sapiens (Human)	activation of adenylate cyclase activity [GO:0007190]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of Rho protein signal transduction [GO:0035023]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; wound healing [GO:0042060]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of adenylate cyclase activity [GO:0007190]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of Rho protein signal transduction [GO:0035023]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; wound healing [GO:0042060]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007165; GO:0007190; GO:0008285; GO:0019899; GO:0030154; GO:0030878; GO:0031143; GO:0031333; GO:0033138; GO:0035019; GO:0035023; GO:0035773; GO:0035994; GO:0042060; GO:0042802; GO:0042981; GO:0043066; GO:0043154; GO:0043410; GO:0045104; GO:0045595; GO:0045944; GO:0046872; GO:0048011; GO:0048538; GO:0060324; GO:0071550; GO:0106310; GO:1902042; GO:2000145	MPVSSQHR	1.049999952	1	1	4.58E-13	941.6328487	13.02791	0	14.93761	15.48782	13.73711	15.46948	14.03029	11.71781	15.25897	15.17048	9.576809	0	0	0	15.61405	0	12.52337	13.42341	12.94569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84702	0	0	0	14.8655	12.7025	0	14.35798	0	15.43478	0	0	0
P04062	GLCM_HUMAN	"Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)"	GBA GC GLUC	Homo sapiens (Human)	antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; glucosylceramide catabolic process [GO:0006680]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]; antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; glucosylceramide catabolic process [GO:0006680]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021]	glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005102; GO:0005124; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0008340; GO:0009267; GO:0009268; GO:0014004; GO:0016241; GO:0019882; GO:0019898; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032268; GO:0032436; GO:0032715; GO:0033077; GO:0033561; GO:0033574; GO:0035307; GO:0043161; GO:0043202; GO:0043243; GO:0043407; GO:0043524; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050905; GO:0051247; GO:0051402; GO:0061518; GO:0061744; GO:0070062; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037; GO:1905165	DVPLTIK	3.75999999	0.727228224	0.727228224	0.209113746	786.6154556	15.92838	15.8074	12.52286	13.6941	0	13.47001	15.968	0	0	0	15.47677	0	0	14.94749	0	14.38689	14.31611	14.04109	14.49999	14.09264	0	14.99933	0	0	0	0	0	0	0	15.14661	0	16.92397	0	0	15.75847	14.76055	15.07087	15.9107	17.37949	0	14.27721	0	0	16.5787	0	14.63552	16.44516	14.81667
P04114	APOB_HUMAN	"Apolipoprotein B-100, Apo B-100 [Cleaved into: Apolipoprotein B-48, Apo B-48 ]"	APOB	Homo sapiens (Human)	artery morphogenesis [GO:0048844]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]	chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983]	chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983]; cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; artery morphogenesis [GO:0048844]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]	cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]	GO:0001701; GO:0005543; GO:0005576; GO:0005615; GO:0005737; GO:0005769; GO:0005788; GO:0005789; GO:0005790; GO:0005811; GO:0005829; GO:0005886; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009743; GO:0009791; GO:0010008; GO:0010269; GO:0010628; GO:0010744; GO:0010884; GO:0010886; GO:0019433; GO:0030301; GO:0030317; GO:0030669; GO:0031904; GO:0031983; GO:0032355; GO:0032496; GO:0033344; GO:0034359; GO:0034360; GO:0034361; GO:0034362; GO:0034363; GO:0034364; GO:0034374; GO:0034379; GO:0034383; GO:0035473; GO:0042158; GO:0042159; GO:0042627; GO:0042632; GO:0042953; GO:0043025; GO:0043202; GO:0043231; GO:0045540; GO:0048844; GO:0050750; GO:0070062; GO:0070971; GO:0071356; GO:0071379; GO:0071682; GO:0120020	FVEGSHNSTVSLTTKNMEVSVATTTK	3.029999971	1	1	0	2767.959002	0	0	0	15.46925	15.26747	0	13.01864	15.69996	12.81859	17.59453	18.45324	0	16.79543	11.66231	14.1386	0	0	0	0	0	0	0	0	0	0	0	0	16.28976	0	0	0	17.43836	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.09735	0
P04150	GCR_HUMAN	"Glucocorticoid receptor, GR (Nuclear receptor subfamily 3 group C member 1)"	NR3C1 GRL	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor activity [GO:0004883]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]"	"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; glucocorticoid receptor activity [GO:0004883]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001046; GO:0001227; GO:0001228; GO:0003700; GO:0003723; GO:0004879; GO:0004883; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005815; GO:0005819; GO:0005829; GO:0006325; GO:0006355; GO:0006357; GO:0006915; GO:0007049; GO:0007059; GO:0007165; GO:0008270; GO:0016607; GO:0019901; GO:0030518; GO:0032991; GO:0045892; GO:0045944; GO:0051301; GO:0051879; GO:0071383; GO:0071385; GO:0071549; GO:0071560; GO:1902895; GO:1990239; GO:1990837	MDSKESLTPGR	10.63000011	1	1	0.140368792	1215.915566	0	0	15.46253	0	15.86932	0	0	0	0	0	0	0	0	0	0	0	0	13.95793	0	11.94495	0	13.43215	11.98067	0	13.14427	12.12846	0	0	0	0	0	0	0	0	0	0	0	0	16.36768	15.95968	16.63736	0	0	0	0	0	0	17.80731
P04181	OAT_HUMAN	"Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]"	OAT	Homo sapiens (Human)	arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; visual perception [GO:0007601]	identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]	GO:0004587; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0007601; GO:0010121; GO:0019544; GO:0030170; GO:0042802; GO:0050155; GO:0055129	ELCTR	9.579999924	0.750680685	0.750680685	0.297159806	678.0652734	0	18.03375	0	0	0	0	0	19.62502	0	0	0	0	20.01763	0	17.26767	0	18.20048	0	0	0	17.77547	0	18.16243	0	0	18.40976	0	18.54436	17.52336	0	19.07483	0	0	0	0	19.02043	17.99258	19.41105	0	0	0	0	17.78426	0	0	17.42926	0	0
P04234	CD3D_HUMAN	T-cell surface glycoprotein CD3 delta chain (T-cell receptor T3 delta chain) (CD antigen CD3d)	CD3D T3D	Homo sapiens (Human)	adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; positive thymic T cell selection [GO:0045059]; T cell receptor signaling pathway [GO:0050852]	alpha-beta T cell receptor complex [GO:0042105]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	alpha-beta T cell receptor complex [GO:0042105]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; positive thymic T cell selection [GO:0045059]; T cell receptor signaling pathway [GO:0050852]	identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]	GO:0002250; GO:0004888; GO:0005737; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0030669; GO:0042101; GO:0042105; GO:0042802; GO:0045059; GO:0046631; GO:0050852	DKESTVQVHYR	2.359999895	1	1	0.132245028	1361.117719	14.69304	12.29166	12.97384	14.32664	12.72793	0	0	12.32351	0	0	12.04435	0	0	0	0	0	0	10.704	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P04264	K2C1_HUMAN	"Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1, CK-1) (Hair alpha protein) (Keratin-1, K1) (Type-II keratin Kb1)"	KRT1 KRTA	Homo sapiens (Human)	"complement activation, lectin pathway [GO:0001867]; establishment of skin barrier [GO:0061436]; fibrinolysis [GO:0042730]; negative regulation of inflammatory response [GO:0050728]; peptide cross-linking [GO:0018149]; protein heterotetramerization [GO:0051290]; regulation of angiogenesis [GO:0045765]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; structural constituent of skin epidermis [GO:0030280]; complement activation, lectin pathway [GO:0001867]; establishment of skin barrier [GO:0061436]; fibrinolysis [GO:0042730]; negative regulation of inflammatory response [GO:0050728]; peptide cross-linking [GO:0018149]; protein heterotetramerization [GO:0051290]; regulation of angiogenesis [GO:0045765]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]"	carbohydrate binding [GO:0030246]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; structural constituent of skin epidermis [GO:0030280]	GO:0001533; GO:0001867; GO:0001895; GO:0005576; GO:0005615; GO:0005634; GO:0005829; GO:0005856; GO:0006979; GO:0016020; GO:0018149; GO:0030246; GO:0030280; GO:0038023; GO:0042730; GO:0045095; GO:0045765; GO:0046982; GO:0050728; GO:0051290; GO:0061436; GO:0062023; GO:0070062; GO:0072562; GO:1904813	FLEQQNQVLQTKWELLQQVDTSTR	24.29000092	1	1	0.535915731	2933.321284	0	0	0	0	0	0	0	0	0	0	20.30231	0	0	20.41424	0	0	0	0	0	0	0	0	18.97563	20.0874	0	0	19.11958	0	0	20.95913	0	0	0	0	0	0	0	0	0	20.52619	0	0	0	17.23863	0	0	0	0
P04275	VWF_HUMAN	"von Willebrand factor, vWF [Cleaved into: von Willebrand antigen 2 (von Willebrand antigen II) ]"	VWF F8VWF	Homo sapiens (Human)	blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to wounding [GO:0009611]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; Weibel-Palade body [GO:0033093]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; Weibel-Palade body [GO:0033093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to wounding [GO:0009611]	chaperone binding [GO:0051087]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]	GO:0002020; GO:0005178; GO:0005518; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0007596; GO:0007599; GO:0009611; GO:0019865; GO:0030168; GO:0031012; GO:0031091; GO:0031093; GO:0031589; GO:0033093; GO:0042802; GO:0047485; GO:0051087; GO:0062023; GO:0070062; GO:1902533	HIVTFDGQNFK	9.550000191	1	1	0.399664089	1306.234194	0	15.24716	16.33759	16.10467	0	12.52269	15.71198	0	17.08116	17.3627	0	14.8453	17.20226	16.00943	14.76658	14.10364	16.08062	0	16.10923	16.24019	15.51207	18.22773	15.78836	15.88322	0	15.40122	0	0	14.75896	14.66917	0	0	16.23445	17.41117	0	0	17.1325	0	0	17.22432	16.69505	0	0	15.98895	14.00044	0	0	0
P04279	SEMG1_HUMAN	"Semenogelin-1 (Cancer/testis antigen 103) (Semenogelin I, SGI) [Cleaved into: Alpha-inhibin-92; Alpha-inhibin-31; Seminal basic protein ]"	SEMG1 SEMG	Homo sapiens (Human)	antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; coagulation [GO:0050817]; insemination [GO:0007320]; killing of cells of another organism [GO:0031640]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; positive regulation of serine-type endopeptidase activity [GO:1900005]; sperm capacitation [GO:0048240]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; zinc ion binding [GO:0008270]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; coagulation [GO:0050817]; insemination [GO:0007320]; killing of cells of another organism [GO:0031640]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; positive regulation of serine-type endopeptidase activity [GO:1900005]; sperm capacitation [GO:0048240]	zinc ion binding [GO:0008270]	GO:0005576; GO:0005615; GO:0005634; GO:0007320; GO:0008270; GO:0019731; GO:0031640; GO:0032991; GO:0048240; GO:0050817; GO:0061844; GO:0070062; GO:0090281; GO:1900005; GO:1901318	AQGKSQK	3.720000029	0.110369481	0.110369481	0.265906203	742.8913891	14.28832	15.81728	15.08491	14.95615	0	12.7577	15.87137	0	0	10.8729	16.22962	15.45016	0	15.18696	12.78692	14.96944	14.55262	15.56004	16.26637	15.08363	15.03362	0	15.9748	0	0	0	16.52594	0	15.35714	0	15.23615	0	16.116	15.68558	14.96411	0	0	0	0	16.00301	14.7673	14.66027	0	0	15.8838	0	0	0
P04628	WNT1_HUMAN	Proto-oncogene Wnt-1 (Proto-oncogene Int-1 homolog)	WNT1 INT1	Homo sapiens (Human)	"animal organ regeneration [GO:0031100]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone development [GO:0060348]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system morphogenesis [GO:0021551]; cerebellum formation [GO:0021588]; diencephalon development [GO:0021536]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; forebrain anterior/posterior pattern specification [GO:0021797]; hematopoietic stem cell proliferation [GO:0071425]; hepatocyte differentiation [GO:0070365]; inner ear morphogenesis [GO:0042472]; midbrain development [GO:0030901]; midbrain-hindbrain boundary maturation during brain development [GO:0022004]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell aging [GO:0090344]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; neuron fate determination [GO:0048664]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to wounding [GO:0009611]; signal transduction in response to DNA damage [GO:0042770]; Spemann organizer formation [GO:0060061]; spinal cord association neuron differentiation [GO:0021527]; T cell differentiation in thymus [GO:0033077]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; morphogen activity [GO:0016015]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; animal organ regeneration [GO:0031100]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone development [GO:0060348]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system morphogenesis [GO:0021551]; cerebellum formation [GO:0021588]; diencephalon development [GO:0021536]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; forebrain anterior/posterior pattern specification [GO:0021797]; hematopoietic stem cell proliferation [GO:0071425]; hepatocyte differentiation [GO:0070365]; inner ear morphogenesis [GO:0042472]; midbrain development [GO:0030901]; midbrain-hindbrain boundary maturation during brain development [GO:0022004]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell aging [GO:0090344]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; neuron fate determination [GO:0048664]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to wounding [GO:0009611]; signal transduction in response to DNA damage [GO:0042770]; Spemann organizer formation [GO:0060061]; spinal cord association neuron differentiation [GO:0021527]; T cell differentiation in thymus [GO:0033077]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; morphogen activity [GO:0016015]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]	GO:0000578; GO:0001658; GO:0001934; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0007267; GO:0007520; GO:0008284; GO:0009611; GO:0009986; GO:0010592; GO:0010812; GO:0016015; GO:0019904; GO:0021527; GO:0021536; GO:0021551; GO:0021588; GO:0021797; GO:0022004; GO:0022408; GO:0030182; GO:0030512; GO:0030514; GO:0030579; GO:0030666; GO:0030901; GO:0031100; GO:0033077; GO:0033278; GO:0036520; GO:0042472; GO:0042770; GO:0043066; GO:0043568; GO:0045165; GO:0045599; GO:0045747; GO:0045893; GO:0045944; GO:0048018; GO:0048146; GO:0048664; GO:0051091; GO:0060061; GO:0060070; GO:0060348; GO:0061184; GO:0070062; GO:0070365; GO:0071375; GO:0071425; GO:0090344; GO:1903204; GO:1904953; GO:1904954; GO:1990403; GO:2000059	QNPGILHSVSGGLQSAVRECK	1.210000038	0.276206285	0.276206285	4.58E-13	2238.170872	14.64589	8.299011	0	0	13.24928	0	0	0	13.94382	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.85063	0	0	0	0	0	15.05377	0	15.83636	0	0
P04629	NTRK1_HUMAN	"High affinity nerve growth factor receptor, EC 2.7.10.1 (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A, Trk-A) (gp140trk) (p140-TrkA)"	NTRK1 MTC TRK TRKA	Homo sapiens (Human)	"aging [GO:0007568]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; sympathetic nervous system development [GO:0048485]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]	"axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotrophin binding [GO:0043121]; neurotrophin p75 receptor binding [GO:0005166]; neurotrophin receptor activity [GO:0005030]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; aging [GO:0007568]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; sympathetic nervous system development [GO:0048485]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotrophin binding [GO:0043121]; neurotrophin p75 receptor binding [GO:0005166]; neurotrophin receptor activity [GO:0005030]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005004; GO:0005030; GO:0005166; GO:0005524; GO:0005769; GO:0005770; GO:0005886; GO:0005887; GO:0006468; GO:0007169; GO:0007411; GO:0007568; GO:0007611; GO:0007623; GO:0008285; GO:0009314; GO:0009410; GO:0009986; GO:0010008; GO:0010465; GO:0010623; GO:0010976; GO:0014068; GO:0018108; GO:0019900; GO:0021553; GO:0030183; GO:0030424; GO:0030425; GO:0031175; GO:0031667; GO:0031901; GO:0031902; GO:0032991; GO:0033674; GO:0038083; GO:0038180; GO:0042490; GO:0042802; GO:0042803; GO:0043025; GO:0043066; GO:0043068; GO:0043121; GO:0043235; GO:0043524; GO:0043547; GO:0045766; GO:0046579; GO:0046777; GO:0048011; GO:0048406; GO:0048485; GO:0048666; GO:0048678; GO:0050965; GO:0050966; GO:0051092; GO:0051599; GO:0051602; GO:0051896; GO:0051965; GO:0051968; GO:0055038; GO:0060009; GO:0060385; GO:0061368; GO:0070374; GO:0071316; GO:1990090	NLTIVKSGLR	14.93999958	1	1	0.375932717	1098.76709	0	0	0	0	0	0	0	0	0	0	0	17.44343	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P04637	P53_HUMAN	Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)	TP53 P53	Homo sapiens (Human)	"autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac septum morphogenesis [GO:0060411]; cell aging [GO:0007569]; cellular protein localization [GO:0034613]; cellular response to actinomycin D [GO:0072717]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; chromatin assembly [GO:0031497]; circadian behavior [GO:0048512]; determination of adult lifespan [GO:0008340]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; gastrulation [GO:0007369]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial DNA repair [GO:0043504]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1 to G0 transition [GO:1903451]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of helicase activity [GO:0051097]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell aging [GO:0090343]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; Ras protein signal transduction [GO:0007265]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cellular senescence [GO:2000772]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; regulation of transcription, DNA-templated [GO:0006355]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to antibiotic [GO:0046677]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to salt stress [GO:0009651]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]"	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac septum morphogenesis [GO:0060411]; cell aging [GO:0007569]; cellular protein localization [GO:0034613]; cellular response to actinomycin D [GO:0072717]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; chromatin assembly [GO:0031497]; circadian behavior [GO:0048512]; determination of adult lifespan [GO:0008340]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; gastrulation [GO:0007369]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial DNA repair [GO:0043504]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1 to G0 transition [GO:1903451]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of helicase activity [GO:0051097]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell aging [GO:0090343]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; Ras protein signal transduction [GO:0007265]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cellular senescence [GO:2000772]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; regulation of transcription, DNA-templated [GO:0006355]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to antibiotic [GO:0046677]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to salt stress [GO:0009651]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]"	"ATP-dependent DNA/DNA annealing activity [GO:0036310]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001046; GO:0001094; GO:0001227; GO:0001228; GO:0001701; GO:0001756; GO:0001836; GO:0002020; GO:0002039; GO:0002244; GO:0002309; GO:0002326; GO:0002360; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0003730; GO:0005507; GO:0005634; GO:0005654; GO:0005657; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0006357; GO:0006606; GO:0006914; GO:0006974; GO:0006977; GO:0006978; GO:0006983; GO:0007179; GO:0007265; GO:0007369; GO:0007406; GO:0007569; GO:0008104; GO:0008156; GO:0008270; GO:0008285; GO:0008340; GO:0009299; GO:0009303; GO:0009651; GO:0010165; GO:0010332; GO:0010628; GO:0010666; GO:0016032; GO:0016363; GO:0016605; GO:0017053; GO:0019899; GO:0019901; GO:0019903; GO:0021549; GO:0030308; GO:0030330; GO:0030512; GO:0030971; GO:0031065; GO:0031497; GO:0031571; GO:0031625; GO:0032991; GO:0033077; GO:0033209; GO:0034103; GO:0034613; GO:0034644; GO:0035033; GO:0035035; GO:0035264; GO:0035794; GO:0035861; GO:0036003; GO:0036310; GO:0042149; GO:0042771; GO:0042802; GO:0042826; GO:0042981; GO:0043065; GO:0043066; GO:0043153; GO:0043504; GO:0043516; GO:0043525; GO:0043621; GO:0045861; GO:0045892; GO:0045893; GO:0045899; GO:0045944; GO:0046677; GO:0046982; GO:0047485; GO:0048147; GO:0048512; GO:0048539; GO:0048568; GO:0050731; GO:0050821; GO:0051087; GO:0051097; GO:0051262; GO:0051402; GO:0051721; GO:0051726; GO:0051974; GO:0060218; GO:0060333; GO:0060411; GO:0061419; GO:0061629; GO:0062100; GO:0065003; GO:0070059; GO:0070245; GO:0070266; GO:0071456; GO:0071466; GO:0071479; GO:0071480; GO:0071494; GO:0072331; GO:0072332; GO:0072717; GO:0090200; GO:0090343; GO:0090399; GO:0090403; GO:0097193; GO:0097252; GO:0097371; GO:0097718; GO:0140296; GO:1900119; GO:1901525; GO:1902108; GO:1902253; GO:1902749; GO:1902895; GO:1903451; GO:1903799; GO:1903800; GO:1904024; GO:1905856; GO:1990144; GO:1990248; GO:1990440; GO:1990841; GO:2000269; GO:2000378; GO:2000379; GO:2000772; GO:2001244	GQSTSR	2.019999981	1	1	3.48E-13	635.2196325	0	14.40222	0	0	0	0	14.82639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.60654	16.21217	0	15.60463	16.95922	0	0	0	0	0	0	0
P04792	HSPB1_HUMAN	"Heat shock protein beta-1, HspB1 (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein, HSP 27) (Stress-responsive protein 27, SRP27)"	HSPB1 HSP27 HSP28	Homo sapiens (Human)	anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]	axon cytoplasm [GO:1904115]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]	axon cytoplasm [GO:1904115]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]	identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]	GO:0000502; GO:0001533; GO:0001895; GO:0001932; GO:0003723; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005925; GO:0006446; GO:0006469; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0032731; GO:0032760; GO:0035556; GO:0035924; GO:0038033; GO:0042802; GO:0042803; GO:0043066; GO:0043122; GO:0043130; GO:0043536; GO:0044183; GO:0045766; GO:0061077; GO:0061629; GO:0070062; GO:0070527; GO:0099641; GO:1902176; GO:1904115; GO:2001028	AQLGGPEAAK	5.639999866	1	1	0.259843814	941.1462453	17.3541	19.57278	16.29141	0	17.13652	0	0	0	18.38872	0	0	16.57497	18.27049	0	0	0	18.03122	18.5081	0	0	0	0	0	18.58292	18.00386	17.75517	0	0	0	0	13.4335	0	0	0	0	0	18.46095	0	0	0	0	0	0	0	0	0	0	0
P04798	CP1A1_HUMAN	"Cytochrome P450 1A1, CYPIA1, EC 1.14.14.1 (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)"	CYP1A1	Homo sapiens (Human)	9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; DNA methylation [GO:0006306]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; ethylene metabolic process [GO:0009692]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in parturition [GO:0060137]; omega-hydroxylase P450 pathway [GO:0097267]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]	"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxygen binding [GO:0019825]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; DNA methylation [GO:0006306]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; ethylene metabolic process [GO:0009692]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in parturition [GO:0060137]; omega-hydroxylase P450 pathway [GO:0097267]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805]"	"arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxygen binding [GO:0019825]; vitamin D 24-hydroxylase activity [GO:0070576]"	GO:0001666; GO:0001676; GO:0002933; GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006306; GO:0006631; GO:0006694; GO:0006778; GO:0006805; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0009308; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009692; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0017143; GO:0019341; GO:0019373; GO:0019825; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042359; GO:0042572; GO:0042759; GO:0042904; GO:0043010; GO:0043231; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0097267; GO:0101020; GO:0101021; GO:0102033; GO:0106256; GO:0120319; GO:1900087	FLTPDGAIDKVLSEK	6.21999979	1	1	0.314156984	1632.763757	15.20638	14.53004	16.21153	18.41429	0	0	0	0	16.73917	15.83846	0	0	13.11231	14.46008	0	0	0	13.946	0	0	0	0	15.35065	0	0	0	16.721	0	0	13.96624	15.60534	0	0	0	0	0	0	0	0	0	17.83236	0	16.13444	0	0	0	0	0
P04843	RPN1_HUMAN	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I, RPN-I) (Ribophorin-1)"	RPN1	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	RNA binding [GO:0003723]	GO:0003723; GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006464; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0042470	GPFSR	6.190000057	0.048476871	0.048476871	0.221277414	563.3346403	0	14.04209	0	18.33301	14.68222	0	14.87383	0	0	17.59579	15.49071	0	0	16.06019	0	15.5659	0	0	17.09862	17.65249	15.83778	0	17.27607	0	17.75246	0	0	18.21204	16.72405	14.59263	0	15.95929	18.83696	17.95912	18.18505	19.23235	19.34442	18.1063	16.24612	16.24182	0	17.58478	18.59786	15.5911	12.97756	16.59452	17.18466	0
P04844	RPN2_HUMAN	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II, RPN-II) (Ribophorin-2)"	RPN2	Homo sapiens (Human)	aging [GO:0007568]; cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to xenobiotic stimulus [GO:0009410]	autophagosome membrane [GO:0000421]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]	autophagosome membrane [GO:0000421]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; ribosome binding [GO:0043022]; aging [GO:0007568]; cellular protein modification process [GO:0006464]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to xenobiotic stimulus [GO:0009410]	ribosome binding [GO:0043022]	GO:0000421; GO:0005783; GO:0005789; GO:0005791; GO:0006464; GO:0006487; GO:0007568; GO:0008250; GO:0009410; GO:0016020; GO:0016021; GO:0016604; GO:0018279; GO:0043022	YIANTVELRVK	7.630000114	1	1	0.25754244	1304.136333	0	15.58917	14.64744	15.28581	0	13.96988	0	14.54555	12.98134	0	0	15.52584	12.90968	0	14.98449	14.23265	0	0	13.82483	0	0	0	0	0	14.25504	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.74114	0	0	0	0	0	0
P04920	B3A2_HUMAN	"Anion exchange protein 2, AE 2, Anion exchanger 2 (Non-erythroid band 3-like protein, BND3L) (Solute carrier family 4 member 2)"	SLC4A2 AE2 EPB3L1 HKB3 MPB3L	Homo sapiens (Human)	amelogenesis [GO:0097186]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; ion homeostasis [GO:0050801]; positive regulation of enamel mineralization [GO:0070175]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]; amelogenesis [GO:0097186]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; ion homeostasis [GO:0050801]; positive regulation of enamel mineralization [GO:0070175]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085]	anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0005925; GO:0006820; GO:0007283; GO:0008509; GO:0015301; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019899; GO:0022857; GO:0048565; GO:0050801; GO:0051453; GO:0055085; GO:0070175; GO:0097186	NAKGSTQSGR	6.980000019	1	1	0.272882063	1006.054445	15.43805	0	0	15.22507	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.71544	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.92798	0	0	0	0	0	0
P05060	SCG1_HUMAN	"Secretogranin-1 (Chromogranin-B, CgB) (Secretogranin I, SgI) [Cleaved into: PE-11; GAWK peptide; CCB peptide ]"	CHGB SCG1	Homo sapiens (Human)		endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; hormone activity [GO:0005179]	hormone activity [GO:0005179]	GO:0005179; GO:0005615; GO:0005788; GO:0030141	VQENQMDK	1.899999976	1	1	3.45E-13	1008.370065	0	15.90867	0	0	14.68273	0	12.14779	0	9.782228	0	13.37439	0	0	0	13.42184	0	0	0	0	0	0	0	0	0	17.11844	16.11931	16.21931	0	0	0	0	0	0	0	0	0	0	0	0	12.99797	0	0	0	0	0	0	0	13.08536
P05067	A4_HUMAN	"Amyloid-beta precursor protein, APP (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide, CVAP) (PreA4) (Protease nexin-II, PN-II) [Cleaved into: N-APP; Soluble APP-alpha, S-APP-alpha; Soluble APP-beta, S-APP-beta; C99 (Beta-secretase C-terminal fragment, Beta-CTF); Amyloid-beta protein 42, Abeta42 (Beta-APP42); Amyloid-beta protein 40, Abeta40 (Beta-APP40); C83 (Alpha-secretase C-terminal fragment, Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59, AICD-59, AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57, AICD-57, AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50, AICD-50, AID(50)) (Gamma-CTF(50)); C31 ]"	APP A4 AD1	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; associative learning [GO:0008306]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cellular copper ion homeostasis [GO:0006878]; cellular response to amyloid-beta [GO:1904646]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; cognition [GO:0050890]; collateral sprouting in absence of injury [GO:0048669]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; lipoprotein metabolic process [GO:0042157]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of age-related behavioral decline [GO:0090647]; modulation of excitatory postsynaptic potential [GO:0098815]; mRNA polyadenylation [GO:0006378]; negative regulation of blood circulation [GO:1903523]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell activation [GO:0050867]; positive regulation of cellular response to thapsigargin [GO:1905893]; positive regulation of cellular response to tunicamycin [GO:1905896]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelin production [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of histone acetylation [GO:0035066]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import [GO:1904591]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor binding [GO:1900122]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of T cell migration [GO:2000406]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; protein trimerization [GO:0070206]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid-beta clearance [GO:1900221]; regulation of dendritic spine maintenance [GO:1902950]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of gene expression [GO:0010468]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of multicellular organism growth [GO:0040014]; regulation of NMDA receptor activity [GO:2000310]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of response to calcium ion [GO:1905945]; regulation of signaling receptor activity [GO:0010469]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse structure or activity [GO:0050803]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; regulation of Wnt signaling pathway [GO:0030111]; response to interleukin-1 [GO:0070555]; response to lead ion [GO:0010288]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; visual learning [GO:0008542]	amyloid-beta complex [GO:0106003]; apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; axon [GO:0030424]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome lumen [GO:0031904]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi-associated vesicle [GO:0005798]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; high-density lipoprotein particle [GO:0034364]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; main axon [GO:0044304]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]	amyloid-beta complex [GO:0106003]; apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; axon [GO:0030424]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome lumen [GO:0031904]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi-associated vesicle [GO:0005798]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; high-density lipoprotein particle [GO:0034364]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; main axon [GO:0044304]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; acetylcholine receptor activator activity [GO:0030549]; acetylcholine receptor binding [GO:0033130]; amylin binding [GO:0097645]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; heparan sulfate binding [GO:1904399]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; PTB domain binding [GO:0051425]; RAGE receptor binding [GO:0050786]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; associative learning [GO:0008306]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cellular copper ion homeostasis [GO:0006878]; cellular response to amyloid-beta [GO:1904646]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; cognition [GO:0050890]; collateral sprouting in absence of injury [GO:0048669]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; lipoprotein metabolic process [GO:0042157]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of age-related behavioral decline [GO:0090647]; modulation of excitatory postsynaptic potential [GO:0098815]; mRNA polyadenylation [GO:0006378]; negative regulation of blood circulation [GO:1903523]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell activation [GO:0050867]; positive regulation of cellular response to thapsigargin [GO:1905893]; positive regulation of cellular response to tunicamycin [GO:1905896]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelin production [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of histone acetylation [GO:0035066]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import [GO:1904591]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor binding [GO:1900122]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of T cell migration [GO:2000406]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; protein trimerization [GO:0070206]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid-beta clearance [GO:1900221]; regulation of dendritic spine maintenance [GO:1902950]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of gene expression [GO:0010468]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of multicellular organism growth [GO:0040014]; regulation of NMDA receptor activity [GO:2000310]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of response to calcium ion [GO:1905945]; regulation of signaling receptor activity [GO:0010469]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse structure or activity [GO:0050803]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; regulation of Wnt signaling pathway [GO:0030111]; response to interleukin-1 [GO:0070555]; response to lead ion [GO:0010288]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; visual learning [GO:0008542]	acetylcholine receptor activator activity [GO:0030549]; acetylcholine receptor binding [GO:0033130]; amylin binding [GO:0097645]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; heparan sulfate binding [GO:1904399]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; PTB domain binding [GO:0051425]; RAGE receptor binding [GO:0050786]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914]	GO:0000122; GO:0000978; GO:0001664; GO:0001774; GO:0001878; GO:0001934; GO:0001967; GO:0002265; GO:0003677; GO:0003682; GO:0004867; GO:0005102; GO:0005109; GO:0005158; GO:0005178; GO:0005576; GO:0005615; GO:0005634; GO:0005641; GO:0005737; GO:0005739; GO:0005768; GO:0005769; GO:0005783; GO:0005788; GO:0005790; GO:0005791; GO:0005794; GO:0005796; GO:0005798; GO:0005829; GO:0005886; GO:0005887; GO:0005905; GO:0005911; GO:0006357; GO:0006378; GO:0006417; GO:0006468; GO:0006878; GO:0006897; GO:0006979; GO:0007155; GO:0007176; GO:0007186; GO:0007189; GO:0007193; GO:0007204; GO:0007219; GO:0007409; GO:0007417; GO:0007611; GO:0007612; GO:0007613; GO:0007617; GO:0007626; GO:0008021; GO:0008088; GO:0008201; GO:0008203; GO:0008285; GO:0008306; GO:0008344; GO:0008542; GO:0009986; GO:0010288; GO:0010468; GO:0010469; GO:0010628; GO:0010629; GO:0010739; GO:0010800; GO:0010823; GO:0010971; GO:0014005; GO:0016020; GO:0016021; GO:0016199; GO:0016322; GO:0016358; GO:0016504; GO:0019722; GO:0019731; GO:0019732; GO:0019899; GO:0030111; GO:0030134; GO:0030178; GO:0030198; GO:0030424; GO:0030546; GO:0030549; GO:0030900; GO:0031093; GO:0031175; GO:0031594; GO:0031904; GO:0032092; GO:0032588; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032760; GO:0032930; GO:0032991; GO:0033130; GO:0033138; GO:0034121; GO:0034185; GO:0034363; GO:0034364; GO:0035066; GO:0035235; GO:0035253; GO:0040014; GO:0042056; GO:0042157; GO:0042327; GO:0042802; GO:0042803; GO:0043065; GO:0043197; GO:0043198; GO:0043204; GO:0043235; GO:0043280; GO:0043395; GO:0043406; GO:0043408; GO:0043410; GO:0043525; GO:0044304; GO:0045087; GO:0045121; GO:0045177; GO:0045202; GO:0045429; GO:0045665; GO:0045666; GO:0045745; GO:0045821; GO:0045931; GO:0045944; GO:0046330; GO:0046875; GO:0046914; GO:0046982; GO:0046983; GO:0048143; GO:0048169; GO:0048471; GO:0048669; GO:0048786; GO:0050729; GO:0050730; GO:0050750; GO:0050786; GO:0050803; GO:0050808; GO:0050829; GO:0050830; GO:0050867; GO:0050885; GO:0050890; GO:0051044; GO:0051087; GO:0051091; GO:0051092; GO:0051124; GO:0051233; GO:0051247; GO:0051260; GO:0051262; GO:0051402; GO:0051425; GO:0051563; GO:0051897; GO:0055037; GO:0061097; GO:0061098; GO:0061844; GO:0061903; GO:0070062; GO:0070206; GO:0070374; GO:0070381; GO:0070555; GO:0070851; GO:0071280; GO:0071287; GO:0071320; GO:0071874; GO:0090026; GO:0090090; GO:0090647; GO:0097449; GO:0097645; GO:0098815; GO:0106003; GO:0150003; GO:1900122; GO:1900181; GO:1900221; GO:1900272; GO:1900273; GO:1900454; GO:1901215; GO:1901216; GO:1901224; GO:1902894; GO:1902949; GO:1902950; GO:1902951; GO:1902961; GO:1903048; GO:1903223; GO:1903523; GO:1904022; GO:1904399; GO:1904472; GO:1904591; GO:1904646; GO:1905606; GO:1905893; GO:1905896; GO:1905898; GO:1905906; GO:1905908; GO:1905945; GO:1990000; GO:1990090; GO:1990535; GO:1990761; GO:1990777; GO:1990812; GO:2000310; GO:2000406; GO:2000463	MLPGLALLLLAAWTAR	2.650000095	0.518598914	0.518598914	0.009809446	1725.281258	0	0	0	0	0	0	0	0	0	0	0	0	13.35637	0	0	14.5614	0	0	0	0	0	16.11697	0	0	17.01441	0	17.19329	14.86834	12.74901	0	0	0	0	15.91179	0	15.63269	0	0	14.5182	0	0	0	0	13.60792	15.96508	0	0	16.33716
P05089	ARGI1_HUMAN	"Arginase-1, EC 3.5.3.1 (Liver-type arginase) (Type I arginase)"	ARG1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; arginine catabolic process to ornithine [GO:0019547]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen biosynthetic process [GO:0032964]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; liver development [GO:0001889]; lung development [GO:0030324]; mammary gland involution [GO:0060056]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; regulation of L-arginine import across plasma membrane [GO:1905541]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to herbicide [GO:0009635]; response to manganese ion [GO:0010042]; response to methylmercury [GO:0051597]; response to selenium ion [GO:0010269]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; arginase activity [GO:0004053]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; adaptive immune response [GO:0002250]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; arginine catabolic process to ornithine [GO:0019547]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen biosynthetic process [GO:0032964]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; liver development [GO:0001889]; lung development [GO:0030324]; mammary gland involution [GO:0060056]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; regulation of L-arginine import across plasma membrane [GO:1905541]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to herbicide [GO:0009635]; response to manganese ion [GO:0010042]; response to methylmercury [GO:0051597]; response to selenium ion [GO:0010269]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	arginase activity [GO:0004053]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]	GO:0000050; GO:0001889; GO:0001938; GO:0002250; GO:0004053; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005741; GO:0005829; GO:0006527; GO:0007568; GO:0009410; GO:0009635; GO:0010042; GO:0010043; GO:0010269; GO:0014075; GO:0019547; GO:0030145; GO:0030324; GO:0032964; GO:0033189; GO:0033197; GO:0035578; GO:0035580; GO:0042130; GO:0042802; GO:0042832; GO:0043005; GO:0043025; GO:0043200; GO:0045087; GO:0046007; GO:0046686; GO:0048678; GO:0051597; GO:0060056; GO:0060135; GO:0060336; GO:0070301; GO:0070965; GO:0071222; GO:0071353; GO:0071377; GO:0071549; GO:0071560; GO:1905541; GO:2000552	MSAKSR	8.029999733	1	1	0.285157353	696.3225209	0	14.21571	16.13375	16.20845	0	0	16.21206	15.78485	0	0	16.57296	0	15.47543	16.7758	17.62885	15.98289	17.50792	18.12889	16.95927	0	18.70604	0	16.55204	15.46752	18.06864	17.15661	17.85756	17.93166	18.56764	17.3667	17.86692	17.41857	14.83859	18.32436	18.32253	18.4649	19.84402	18.95323	19.41829	0	17.48713	18.7335	19.01868	19.27762	19.09428	0	19.20232	18.7176
P05091	ALDH2_HUMAN	"Aldehyde dehydrogenase, mitochondrial, EC 1.2.1.3 (ALDH class 2) (ALDH-E2) (ALDHI)"	ALDH2 ALDM	Homo sapiens (Human)	alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylic ester hydrolase activity [GO:0052689]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; nitroglycerin reductase activity [GO:0018547]; phenylacetaldehyde dehydrogenase activity [GO:0008957]; alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylic ester hydrolase activity [GO:0052689]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; nitroglycerin reductase activity [GO:0018547]; phenylacetaldehyde dehydrogenase activity [GO:0008957]	GO:0004029; GO:0004030; GO:0005739; GO:0005759; GO:0005975; GO:0006066; GO:0006068; GO:0008957; GO:0009055; GO:0018547; GO:0043878; GO:0046185; GO:0051287; GO:0052689; GO:0070062; GO:1903179; GO:1905627	MLRAAAR	12.10000038	1	1	0.246294628	805.0008298	14.88928	0	12.77021	0	13.69096	0	0	0	0	0	13.99126	14.13095	13.9422	0	0	0	16.15684	0	0	0	0	15.90091	16.15104	0	0	0	0	0	0	0	0	0	0	0	0	14.17943	0	0	0	14.28382	15.19905	0	0	0	0	13.33051	0	0
P05093	CP17A_HUMAN	"Steroid 17-alpha-hydroxylase/17,20 lyase, EC 1.14.14.19 (17-alpha-hydroxyprogesterone aldolase, EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17, Cytochrome P450c17) (Steroid 17-alpha-monooxygenase)"	CYP17A1 CYP17 S17AH	Homo sapiens (Human)	androgen biosynthetic process [GO:0006702]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]	axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]	axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; steroid 17-alpha-monooxygenase activity [GO:0004508]; androgen biosynthetic process [GO:0006702]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]	17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; steroid 17-alpha-monooxygenase activity [GO:0004508]	GO:0004508; GO:0005506; GO:0005783; GO:0005789; GO:0006694; GO:0006702; GO:0006704; GO:0007548; GO:0008202; GO:0019825; GO:0020037; GO:0030424; GO:0042446; GO:0042448; GO:0043025; GO:0047442	LKSHVK	2.309999943	1	1	0.155192505	711.5299848	15.75453	15.93694	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.7219	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.9983	0	0	0	0	0	0	0	0	0	0
P05107	ITB2_HUMAN	"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)"	ITGB2 CD18 MFI7	Homo sapiens (Human)	"amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; microglial cell activation [GO:0001774]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]"	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	"cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; microglial cell activation [GO:0001774]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]"	amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]	GO:0001540; GO:0001774; GO:0001851; GO:0005178; GO:0005886; GO:0005925; GO:0006898; GO:0006911; GO:0006915; GO:0006954; GO:0007155; GO:0007159; GO:0007160; GO:0007229; GO:0007267; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016020; GO:0016477; GO:0019901; GO:0030369; GO:0030593; GO:0031072; GO:0031623; GO:0032930; GO:0033627; GO:0034113; GO:0034687; GO:0034688; GO:0034689; GO:0035579; GO:0035987; GO:0043113; GO:0043235; GO:0043315; GO:0044853; GO:0045963; GO:0046872; GO:0050730; GO:0050839; GO:0070062; GO:0070821; GO:0071404; GO:0090314; GO:0097242; GO:0098609; GO:0098742; GO:0101003; GO:1901216; GO:1903561; GO:1904996; GO:1990266; GO:2000363	LGGDLLRALNEITESGR	15.60000038	1	1	6.86E-13	1813.903077	14.61625	11.24566	0	0	15.53208	0	0	13.3904	0	13.8054	11.45337	13.35747	0	14.5393	15.03092	13.16608	14.35559	15.01987	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.07204	16.34442	0	0	0	0	0	0
P05129	KPCG_HUMAN	"Protein kinase C gamma type, PKC-gamma, EC 2.7.11.13"	PRKCG PKCG	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]	calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060]	calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007268; GO:0007611; GO:0007635; GO:0008270; GO:0009636; GO:0014069; GO:0016310; GO:0018105; GO:0030425; GO:0031397; GO:0032095; GO:0032425; GO:0035556; GO:0042177; GO:0042752; GO:0043278; GO:0043524; GO:0044305; GO:0046777; GO:0048265; GO:0048471; GO:0048511; GO:0050764; GO:0060291; GO:0060384; GO:0097060; GO:0099171; GO:0099523; GO:0099524; GO:0106310; GO:1901799; GO:1990911; GO:2000300	MAGLGPGVGDSEGGPRPLFCR	4.389999866	1	1	0.167254045	2143.226611	8.450943	14.89953	13.38291	0	0	10.5889	8.367502	15.04598	12.82447	12.47677	14.02932	0	11.89357	9.904887	11.30427	0	0	13.21732	0	13.09219	0	14.3757	0	11.67899	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P05155	IC1_HUMAN	"Plasma protease C1 inhibitor, C1 Inh, C1Inh (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)"	SERPING1 C1IN C1NH	Homo sapiens (Human)	"aging [GO:0007568]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; complement activation, classical pathway [GO:0006958]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; negative regulation of complement activation, lectin pathway [GO:0001869]; negative regulation of endopeptidase activity [GO:0010951]"	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	"blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; serine-type endopeptidase inhibitor activity [GO:0004867]; aging [GO:0007568]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; complement activation, classical pathway [GO:0006958]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; negative regulation of complement activation, lectin pathway [GO:0001869]; negative regulation of endopeptidase activity [GO:0010951]"	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0001869; GO:0004867; GO:0005576; GO:0005615; GO:0005788; GO:0006958; GO:0007568; GO:0007596; GO:0008015; GO:0010951; GO:0031093; GO:0042730; GO:0045087; GO:0062023; GO:0070062; GO:0072562	LEDMEQALSPSVFKAIMEK	2.190000057	1	1	0.185613695	2181.444469	15.95649	12.18433	8.327921	0	0	0	0	13.37533	0	0	0	13.04023	0	0	12.36695	0	0	16.16309	10.54912	0	0	0	0	0	0	0	12.25033	0	0	0	9.700296	0	15.32236	0	0	13.92392	0	15.8573	0	12.58772	0	14.36892	15.73873	0	12.82387	0	0	0
P05164	PERM_HUMAN	"Myeloperoxidase, MPO, EC 1.11.2.2 [Cleaved into: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain ]"	MPO	Homo sapiens (Human)	aging [GO:0007568]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of apoptotic process [GO:0043066]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]	azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; secretory granule [GO:0030141]	azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; secretory granule [GO:0030141]; chromatin binding [GO:0003682]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; aging [GO:0007568]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of apoptotic process [GO:0043066]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]	chromatin binding [GO:0003682]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0001878; GO:0002149; GO:0002679; GO:0003682; GO:0004601; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0006952; GO:0006979; GO:0007568; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0035578; GO:0042582; GO:0042742; GO:0042744; GO:0043066; GO:0043231; GO:0046872; GO:0050832; GO:0070062; GO:0097013; GO:1990268	YLPTYRSYNDSVDPR	3.980000019	1	1	0.273378219	1845.864289	0	12.04664	14.5913	15.72934	14.10921	12.72083	0	12.08202	15.7888	0	0	0	0	15.73474	0	14.92364	14.41302	0	0	0	14.3326	0	0	0	0	0	0	0	13.50466	14.65789	14.95657	15.81841	11.93792	13.99662	12.84924	13.5797	14.25197	13.99091	0	10.9731	13.63999	16.10861	0	0	0	0	0	0
P05186	PPBT_HUMAN	"Alkaline phosphatase, tissue-nonspecific isozyme, AP-TNAP, TNS-ALP, TNSALP, EC 3.1.3.1 (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase, EC 3.9.1.1)"	ALPL	Homo sapiens (Human)	bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; multicellular organism aging [GO:0010259]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; adenosine-diphosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; multicellular organism aging [GO:0010259]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]	adenosine-diphosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462]	GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005576; GO:0005758; GO:0005886; GO:0010259; GO:0016020; GO:0016311; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031225; GO:0031966; GO:0032496; GO:0033280; GO:0033883; GO:0034516; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0070062; GO:0071407; GO:0071529; GO:0120162; GO:1904383	GNSIFGLAPMLSDTDK	6.130000114	0.761119485	0.761119485	3.65E-12	1665.97195	0	13.66486	0	15.23316	17.0866	0	0	0	0	11.04418	13.47582	12.65813	14.84858	14.01312	13.55441	15.15756	0	0	14.59792	16.43694	16.22413	13.46684	15.09488	16.99426	0	16.25692	0	14.30472	14.37553	14.86873	0	15.23321	13.30412	13.56043	15.43047	0	0	15.03484	16.36151	0	14.69392	0	14.49869	14.36769	12.87792	15.74997	0	16.39091
P05198	IF2A_HUMAN	"Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha, eIF-2-alpha, eIF-2A, eIF-2alpha)"	EIF2S1 EIF2A	Homo sapiens (Human)	aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005844; GO:0005850; GO:0005851; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034063; GO:0034198; GO:0034599; GO:0034605; GO:0034644; GO:0034976; GO:0036499; GO:0043022; GO:0043558; GO:0043614; GO:0044207; GO:0045202; GO:0046777; GO:0070062; GO:0097451; GO:1901216; GO:1905098; GO:1990737; GO:2000676	EALRAGLNCSTENMPIK	6.590000153	1	1	0.035624975	1920.006344	15.4584	14.06415	13.37564	0	0	11.98083	15.83902	0	0	0	0	14.48741	13.63791	0	0	0	0	0	0	0	0	13.64178	0	13.51523	0	0	0	0	0	13.70411	0	0	15.84177	0	0	15.08809	0	0	0	11.92897	0	0	0	0	0	13.34264	0	0
P05305	EDN1_HUMAN	"Endothelin-1 (Preproendothelin-1, PPET1) [Cleaved into: Endothelin-1, ET-1; Big endothelin-1 ]"	EDN1	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; body fluid secretion [GO:0007589]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to fatty acid [GO:0071398]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; epithelial fluid transport [GO:0042045]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion [GO:0001821]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; inositol phosphate-mediated signaling [GO:0048016]; leukocyte activation [GO:0045321]; maternal process involved in parturition [GO:0060137]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membrane depolarization [GO:0051899]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; multicellular organism aging [GO:0010259]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell fate commitment [GO:0014034]; nitric oxide transport [GO:0030185]; noradrenergic neuron differentiation [GO:0003357]; peptide hormone secretion [GO:0030072]; pharyngeal arch artery morphogenesis [GO:0061626]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase D-activating G protein-coupled receptor signaling pathway [GO:0031583]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of odontogenesis [GO:0042482]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin biosynthetic process [GO:0001516]; protein kinase A signaling [GO:0010737]; protein kinase C deactivation [GO:0042313]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to dexamethasone [GO:0071548]; response to leptin [GO:0044321]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to prostaglandin F [GO:0034696]; response to salt [GO:1902074]; response to testosterone [GO:0033574]; rhythmic excitation [GO:0043179]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory perception of pain [GO:0019233]; superoxide anion generation [GO:0042554]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum lumen [GO:0048237]; transport vesicle [GO:0030133]; Weibel-Palade body [GO:0033093]	basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum lumen [GO:0048237]; transport vesicle [GO:0030133]; Weibel-Palade body [GO:0033093]; cytokine activity [GO:0005125]; endothelin A receptor binding [GO:0031707]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; body fluid secretion [GO:0007589]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to fatty acid [GO:0071398]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; epithelial fluid transport [GO:0042045]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion [GO:0001821]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; inositol phosphate-mediated signaling [GO:0048016]; leukocyte activation [GO:0045321]; maternal process involved in parturition [GO:0060137]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membrane depolarization [GO:0051899]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; multicellular organism aging [GO:0010259]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell fate commitment [GO:0014034]; nitric oxide transport [GO:0030185]; noradrenergic neuron differentiation [GO:0003357]; peptide hormone secretion [GO:0030072]; pharyngeal arch artery morphogenesis [GO:0061626]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase D-activating G protein-coupled receptor signaling pathway [GO:0031583]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of odontogenesis [GO:0042482]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin biosynthetic process [GO:0001516]; protein kinase A signaling [GO:0010737]; protein kinase C deactivation [GO:0042313]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to dexamethasone [GO:0071548]; response to leptin [GO:0044321]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to prostaglandin F [GO:0034696]; response to salt [GO:1902074]; response to testosterone [GO:0033574]; rhythmic excitation [GO:0043179]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory perception of pain [GO:0019233]; superoxide anion generation [GO:0042554]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	cytokine activity [GO:0005125]; endothelin A receptor binding [GO:0031707]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]	GO:0000122; GO:0001516; GO:0001569; GO:0001701; GO:0001821; GO:0001975; GO:0003100; GO:0003253; GO:0003357; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0006366; GO:0006468; GO:0006874; GO:0006885; GO:0007005; GO:0007166; GO:0007186; GO:0007193; GO:0007204; GO:0007205; GO:0007249; GO:0007267; GO:0007585; GO:0007589; GO:0008284; GO:0009953; GO:0010193; GO:0010259; GO:0010460; GO:0010595; GO:0010613; GO:0010629; GO:0010737; GO:0010827; GO:0014034; GO:0014065; GO:0014823; GO:0014824; GO:0014826; GO:0019229; GO:0019233; GO:0019722; GO:0030072; GO:0030133; GO:0030185; GO:0030195; GO:0030335; GO:0030878; GO:0031583; GO:0031707; GO:0031708; GO:0032269; GO:0032308; GO:0032496; GO:0033093; GO:0033574; GO:0034392; GO:0034696; GO:0035050; GO:0035094; GO:0035810; GO:0035815; GO:0035994; GO:0042045; GO:0042310; GO:0042313; GO:0042474; GO:0042482; GO:0042554; GO:0043179; GO:0043200; GO:0043406; GO:0043507; GO:0044321; GO:0044751; GO:0045178; GO:0045321; GO:0045429; GO:0045793; GO:0045840; GO:0045944; GO:0045987; GO:0046887; GO:0046888; GO:0048016; GO:0048237; GO:0048661; GO:0048675; GO:0051091; GO:0051216; GO:0051482; GO:0051771; GO:0051899; GO:0051930; GO:0060070; GO:0060137; GO:0060298; GO:0060385; GO:0060585; GO:0061051; GO:0061626; GO:0070101; GO:0070294; GO:0070301; GO:0070371; GO:0070588; GO:0071277; GO:0071310; GO:0071346; GO:0071347; GO:0071356; GO:0071372; GO:0071373; GO:0071385; GO:0071389; GO:0071398; GO:0071456; GO:0071466; GO:0071548; GO:0071560; GO:0086100; GO:0086101; GO:0090023; GO:0097492; GO:1901224; GO:1902074; GO:1902287; GO:1903537; GO:1904707; GO:2000273; GO:2001259	GKPSRER	13	1	1	0.475300218	829.3586274	0	21.27126	21.4416	0	0	0	0	0	0	0	0	0	0	18.81847	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.52253	0	0	0	0	0	0	0	0	17.99474	0	0	0	0	0	0	0
P05362	ICAM1_HUMAN	"Intercellular adhesion molecule 1, ICAM-1 (Major group rhinovirus receptor) (CD antigen CD54)"	ICAM1	Homo sapiens (Human)	adhesion of symbiont to host [GO:0044406]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of endothelial barrier [GO:0061028]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of leukocyte mediated cytotoxicity [GO:0001910]; regulation of ruffle assembly [GO:1900027]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]; T cell antigen processing and presentation [GO:0002457]; T cell extravasation [GO:0072683]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adhesion of symbiont to host [GO:0044406]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of endothelial barrier [GO:0061028]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of leukocyte mediated cytotoxicity [GO:0001910]; regulation of ruffle assembly [GO:1900027]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]; T cell antigen processing and presentation [GO:0002457]; T cell extravasation [GO:0072683]	integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001772; GO:0001910; GO:0002291; GO:0002457; GO:0002693; GO:0004888; GO:0005178; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007157; GO:0007159; GO:0009897; GO:0009986; GO:0016020; GO:0022614; GO:0033627; GO:0038023; GO:0044406; GO:0045121; GO:0046813; GO:0050900; GO:0061028; GO:0062023; GO:0070062; GO:0070374; GO:0071333; GO:0072683; GO:1900027; GO:1902042; GO:1904646; GO:1990830; GO:2000352	ELLLPGNNRK	6.440000057	1	1	0.154319992	1155.533079	13.52659	10.56382	15.45796	0	10.9079	0	9.531847	14.98777	11.97197	15.48215	0	17.64503	12.3056	12.87432	0	13.59006	0	0	0	0	0	0	0	0	0	0	0	14.90837	0	0	0	0	0	0	15.38815	0	0	0	0	0	0	0	0	0	0	0	0	0
P05412	JUN_HUMAN	"Transcription factor Jun (Activator protein 1, AP1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39)"	JUN	Homo sapiens (Human)	"angiogenesis [GO:0001525]; axon regeneration [GO:0031103]; cellular response to anisomycin [GO:0072740]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to reactive oxygen species [GO:0034614]; eyelid development in camera-type eye [GO:0061029]; integrated stress response signaling [GO:0140467]; leading edge cell differentiation [GO:0035026]; liver development [GO:0001889]; microglial cell activation [GO:0001774]; monocyte differentiation [GO:0030224]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	"chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; angiogenesis [GO:0001525]; axon regeneration [GO:0031103]; cellular response to anisomycin [GO:0072740]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to reactive oxygen species [GO:0034614]; eyelid development in camera-type eye [GO:0061029]; integrated stress response signaling [GO:0140467]; leading edge cell differentiation [GO:0035026]; liver development [GO:0001889]; microglial cell activation [GO:0001774]; monocyte differentiation [GO:0030224]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]"	GO:0000122; GO:0000228; GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0001774; GO:0001889; GO:0001938; GO:0003151; GO:0003677; GO:0003682; GO:0003700; GO:0003723; GO:0005096; GO:0005634; GO:0005654; GO:0005667; GO:0005886; GO:0006357; GO:0007179; GO:0007265; GO:0008285; GO:0009410; GO:0010634; GO:0017053; GO:0019899; GO:0030224; GO:0031103; GO:0031625; GO:0031953; GO:0034614; GO:0035026; GO:0035497; GO:0035976; GO:0035994; GO:0042127; GO:0042802; GO:0043065; GO:0043392; GO:0043524; GO:0043922; GO:0043923; GO:0044389; GO:0045892; GO:0045893; GO:0045944; GO:0048146; GO:0051726; GO:0060395; GO:0061029; GO:0061629; GO:0070374; GO:0070412; GO:0071276; GO:0071277; GO:0072740; GO:0090575; GO:0140296; GO:0140467; GO:1901522; GO:1902895; GO:1904707; GO:1990441; GO:1990837; GO:2000144	VMNHVNSGCQLMLTQQLQTF	4.96999979	1	1	0.150491889	2365.668492	15.30593	0	0	16.21096	0	11.95969	15.13993	0	14.85243	14.89554	14.77001	13.96575	0	13.24929	0	10.5048	0	0	14.64711	0	0	0	0	15.17907	0	0	0	0	0	0	0	12.89867	0	0	0	0	0	0	0	15.7297	14.32555	0	0	0	0	0	11.4738	0
P05423	RPC4_HUMAN	"DNA-directed RNA polymerase III subunit RPC4, RNA polymerase III subunit C4 (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog)"	POLR3D BN51 BN51T	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607	MKAPPK	4.599999905	1	1	0.106925882	687.3321017	15.43717	0	13.41821	14.13871	0	15.79317	13.41966	0	0	0	15.37878	13.76284	15.13981	15.31639	15.92862	0	0	15.71729	15.76447	14.8785	0	0	15.76819	16.98924	14.72571	14.98416	13.82135	0	15.08294	0	16.50991	0	13.31605	0	0	0	0	0	0	0	0	0	16.51485	0	0	0	0	0
P05543	THBG_HUMAN	Thyroxine-binding globulin (Serpin A7) (T4-binding globulin)	SERPINA7 TBG	Homo sapiens (Human)	negative regulation of endopeptidase activity [GO:0010951]; thyroid hormone transport [GO:0070327]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; thyroid hormone transport [GO:0070327]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0070062; GO:0070327	NALALFVLPKEGQMESVEAAMSSK	2.319999933	0.715693831	0.715693831	5.48E-12	2582.148009	0	14.4283	0	0	0	0	14.08933	14.81254	13.00632	0	13.217	14.51068	0	0	0	0	15.4854	0	0	13.7493	0	16.33134	0	0	0	0	15.60499	14.45652	0	14.41392	0	16.97145	15.11792	0	0	15.05588	0	0	0	0	0	0	0	17.42417	0	0	0	16.29197
P05771	KPCB_HUMAN	"Protein kinase C beta type, PKC-B, PKC-beta, EC 2.7.11.13"	PRKCB PKCB PRKCB1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; chromatin organization [GO:0006325]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091]	calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; chromatin organization [GO:0006325]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear receptor coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]	GO:0002250; GO:0003682; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005080; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006357; GO:0006468; GO:0006816; GO:0006874; GO:0006915; GO:0007077; GO:0007165; GO:0008091; GO:0008270; GO:0010827; GO:0010829; GO:0018105; GO:0030374; GO:0030949; GO:0035403; GO:0035408; GO:0035556; GO:0042113; GO:0042393; GO:0042953; GO:0043123; GO:0044305; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0050861; GO:0051092; GO:0070062; GO:0071322; GO:0099171; GO:0099523; GO:0106310; GO:2000300	TTNTVSK	2.980000019	0.232961893	0.232961893	0.144241838	749.3400215	10.58972	13.36823	13.21026	0	13.78255	0	14.29954	14.72799	15.66821	15.00124	13.66183	0	0	0	0	0	0	0	15.96194	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P05783	K1C18_HUMAN	"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18, CK-18) (Keratin-18, K18)"	KRT18 CYK18 PIG46	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; hepatocyte apoptotic process [GO:0097284]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of apoptotic process [GO:0043066]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	adherens junction [GO:0005912]; cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]	adherens junction [GO:0005912]; cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding involved in cell-cell adhesion [GO:0098641]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]; anatomical structure morphogenesis [GO:0009653]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; hepatocyte apoptotic process [GO:0097284]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of apoptotic process [GO:0043066]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cadherin binding involved in cell-cell adhesion [GO:0098641]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]	GO:0003723; GO:0005198; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005856; GO:0005882; GO:0005912; GO:0007049; GO:0009653; GO:0033209; GO:0034451; GO:0043000; GO:0043066; GO:0045095; GO:0045104; GO:0048471; GO:0070062; GO:0071944; GO:0097110; GO:0097191; GO:0097284; GO:0098641	ETMQSLNDR	5.889999866	1	1	0.097369705	1092.888158	16.707	16.5993	16.95329	17.09519	0	16.92899	16.89478	15.21746	0	0	16.54449	0	16.06861	0	0	0	0	15.54434	0	16.41743	0	16.50558	0	0	16.33628	16.80792	17.51456	0	15.8865	0	0	0	13.92198	0	0	0	16.62647	15.79263	0	0	17.4412	0	0	0	17.45079	16.68587	17.59998	16.32858
P05787	K2C8_HUMAN	"Keratin, type II cytoskeletal 8 (Cytokeratin-8, CK-8) (Keratin-8, K8) (Type-II keratin Kb8)"	KRT8 CYK8	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; scaffold protein binding [GO:0097110]	scaffold protein binding [GO:0097110]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005882; GO:0016363; GO:0045095; GO:0045111; GO:0070062; GO:0097110	LALDIEIATYR	10.55000019	1	1	0.181504276	1277.572196	8.792447	0	0	0	0	15.53033	0	0	0	0	0	0	0	0	16.94536	0	0	0	0	0	0	0	16.45017	0	0	0	0	16.29118	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.99629	0	0	0
P05997	CO5A2_HUMAN	Collagen alpha-2(V) chain	COL5A2	Homo sapiens (Human)	cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; negative regulation of endodermal cell differentiation [GO:1903225]; ossification [GO:0001503]; skeletal system development [GO:0001501]; skin development [GO:0043588]	collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; negative regulation of endodermal cell differentiation [GO:1903225]; ossification [GO:0001503]; skeletal system development [GO:0001501]; skin development [GO:0043588]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]	GO:0001501; GO:0001503; GO:0005201; GO:0005576; GO:0005588; GO:0005592; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0043588; GO:0046332; GO:0046872; GO:0048592; GO:0062023; GO:0071230; GO:1903225	SPDGSKK	4.909999847	0.069618277	0.069618277	0.255445285	717.469816	19.16058	0	0	0	0	21.31725	22.53829	19.63417	18.14373	19.51937	22.28618	17.75579	17.44179	18.5394	0	0	16.70571	18.58261	19.71202	17.83315	0	18.07697	21.14262	0	18.74693	23.07689	21.90406	21.77824	0	19.8804	0	0	23.63797	20.14324	19.12059	22.57525	0	19.84151	18.08786	0	17.80903	0	20.83124	20.8683	20.86425	0	0	0
P06132	DCUP_HUMAN	"Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37"	UROD	Homo sapiens (Human)	heme biosynthetic process [GO:0006783]; porphyrin-containing compound catabolic process [GO:0006787]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound catabolic process [GO:0006787]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]	uroporphyrinogen decarboxylase activity [GO:0004853]	GO:0004853; GO:0005654; GO:0005829; GO:0006778; GO:0006782; GO:0006783; GO:0006787	MEANGLGPQGFPELKNDTFLR	1.450000048	1	1	0.15344947	2350.140373	0	13.30798	0	0	0	12.21253	18.13063	12.44521	10.50194	15.0987	13.30497	12.95444	0	11.55575	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32081	0	0	0	0	0	0	0	0
P06213	INSR_HUMAN	"Insulin receptor, IR, EC 2.7.10.1 (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta ]"	INSR	Homo sapiens (Human)	"activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of receptor internalization [GO:0002092]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718]"	axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of receptor internalization [GO:0002092]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718]"	amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001540; GO:0001934; GO:0002092; GO:0003007; GO:0004712; GO:0004713; GO:0004714; GO:0005009; GO:0005159; GO:0005198; GO:0005524; GO:0005525; GO:0005764; GO:0005770; GO:0005886; GO:0005887; GO:0005899; GO:0005901; GO:0005975; GO:0006355; GO:0006468; GO:0006898; GO:0007169; GO:0007186; GO:0007612; GO:0007613; GO:0008284; GO:0008286; GO:0008544; GO:0008584; GO:0009897; GO:0010008; GO:0014068; GO:0016020; GO:0018108; GO:0019904; GO:0030238; GO:0030325; GO:0030335; GO:0030424; GO:0031017; GO:0031994; GO:0031995; GO:0032147; GO:0032148; GO:0032590; GO:0032809; GO:0032869; GO:0033674; GO:0038024; GO:0038083; GO:0042593; GO:0042802; GO:0043235; GO:0043243; GO:0043406; GO:0043410; GO:0043548; GO:0043559; GO:0043560; GO:0044877; GO:0045429; GO:0045725; GO:0045821; GO:0045840; GO:0045893; GO:0045995; GO:0046326; GO:0046718; GO:0046777; GO:0048639; GO:0051425; GO:0051446; GO:0051897; GO:0060267; GO:0070062; GO:0071363; GO:0097062; GO:0097242; GO:0150104; GO:1990535; GO:2000194	LIMITDYLLLFR	15.17000008	1	1	0.049366752	1522.070448	0	0	0	0	13.98377	15.49574	15.5635	0	15.1183	15.30696	15.12236	0	15.52425	0	15.66901	13.15274	0	13.17568	0	0	12.16122	0	15.30535	0	15.40401	0	14.79316	0	0	0	0	0	0	0	0	0	0	0	0	14.52501	13.69082	0	0	0	14.81009	0	0	13.92908
P06239	LCK_HUMAN	"Tyrosine-protein kinase Lck, EC 2.7.10.2 (Leukocyte C-terminal Src kinase, LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK)"	LCK	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular zinc ion homeostasis [GO:0006882]; Fc-gamma receptor signaling pathway [GO:0038094]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein phosphorylation [GO:0006468]; regulation of lymphocyte activation [GO:0051249]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular zinc ion homeostasis [GO:0006882]; Fc-gamma receptor signaling pathway [GO:0038094]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein phosphorylation [GO:0006468]; regulation of lymphocyte activation [GO:0051249]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]	GO:0000242; GO:0001772; GO:0001784; GO:0004712; GO:0004713; GO:0004715; GO:0004722; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0006882; GO:0006919; GO:0007169; GO:0008022; GO:0009410; GO:0016004; GO:0018108; GO:0019901; GO:0019903; GO:0030097; GO:0030154; GO:0030168; GO:0030217; GO:0031234; GO:0031295; GO:0034116; GO:0035556; GO:0038083; GO:0038094; GO:0042169; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0043274; GO:0043548; GO:0045087; GO:0045121; GO:0050852; GO:0050853; GO:0050862; GO:0050870; GO:0050900; GO:0051117; GO:0051209; GO:0051249; GO:0070062; GO:1903039; GO:2001244	SLKQGSMSPDAFLAEANLMK	5.679999828	1	1	0.256814873	2155.061978	10.68677	14.43976	12.27713	0	0	15.64723	0	0	0	0	0	16.30666	14.74613	0	0	0	12.0188	0	13.19244	0	0	0	0	13.90884	0	0	0	0	0	11.84409	14.84551	0	0	13.88181	0	0	0	0	0	0	0	0	15.878	0	0	0	0	0
P06276	CHLE_HUMAN	"Cholinesterase, EC 3.1.1.8 (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase)"	BCHE CHE1	Homo sapiens (Human)	acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]	blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]	"blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; carboxylic ester hydrolase activity [GO:0052689]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]"	"acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; carboxylic ester hydrolase activity [GO:0052689]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]"	GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005615; GO:0005641; GO:0005788; GO:0005886; GO:0006581; GO:0007612; GO:0008285; GO:0009410; GO:0014016; GO:0016486; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050783; GO:0050805; GO:0051384; GO:0051593; GO:0052689; GO:0072562	LTGCSR	1.159999967	1	1	8.05E-13	694.3208762	0	0	14.63805	0	0	14.47685	13.85757	0	15.97894	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.0439	0	0	0	0	0	0	0	0	13.11809	0	0	0	0	0	0	0
P06312	KV401_HUMAN	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; immune response [GO:0006955]	blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955]	antigen binding [GO:0003823]	GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0072562	ATINCKSSQSVLYSSNNK	16.60000038	0.586031199	0.586031199	0.17544397	2001.202833	0	17.27553	0	18.4061	15.63492	0	0	0	15.85731	0	0	16.66673	0	16.01101	0	0	18.84464	0	17.86486	0	0	0	0	18.11025	0	0	0	16.41521	0	0	16.52576	17.88241	16.33334	0	18.08995	0	18.2518	0	0	0	17.04067	0	0	0	0	19.07651	0	17.24707
P06340	DOA_HUMAN	"HLA class II histocompatibility antigen, DO alpha chain (MHC DN-alpha) (MHC DZ alpha) (MHC class II antigen DOA)"	HLA-DOA HLA-DNA HLA-DZA	Homo sapiens (Human)	adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002587]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; regulation of T cell differentiation [GO:0045580]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002587]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; regulation of T cell differentiation [GO:0045580]	MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]	GO:0002250; GO:0002503; GO:0002587; GO:0005765; GO:0005886; GO:0010008; GO:0016021; GO:0019886; GO:0023026; GO:0032395; GO:0042613; GO:0045580; GO:0050870	FDPQGGLAGIAAIK	16.15999985	1	1	0.420909017	1356.279635	0	0	0	0	0	0	0	16.54195	0	0	0	0	16.48541	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.49491	0	0	0	0	0	0	0	0	0	0	0	0	0	17.73164	0	0	0
P06396	GELS_HUMAN	"Gelsolin (AGEL) (Actin-depolymerizing factor, ADF) (Brevin)"	GSN	Homo sapiens (Human)	"actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; amyloid fibril formation [GO:1990000]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]"	actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; blood microparticle [GO:0072562]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcoplasm [GO:0016528]; secretory granule lumen [GO:0034774]	"actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; blood microparticle [GO:0072562]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcoplasm [GO:0016528]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; amyloid fibril formation [GO:1990000]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]"	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0002102; GO:0003779; GO:0005509; GO:0005546; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006911; GO:0007417; GO:0008154; GO:0010628; GO:0014891; GO:0015629; GO:0016528; GO:0030027; GO:0030031; GO:0030041; GO:0030042; GO:0030478; GO:0030864; GO:0031648; GO:0034774; GO:0035994; GO:0036313; GO:0042989; GO:0045010; GO:0045159; GO:0045335; GO:0046597; GO:0051014; GO:0051015; GO:0051016; GO:0051127; GO:0051693; GO:0055119; GO:0060271; GO:0070062; GO:0071346; GO:0071801; GO:0072562; GO:0086003; GO:0090527; GO:0097017; GO:0097284; GO:1902174; GO:1903903; GO:1903906; GO:1903909; GO:1903923; GO:1904813; GO:1990000; GO:2001269	DSQEEEKTEALTSAK	5.659999847	1	1	0.168929459	1666.730535	14.4824	0	12.37397	0	15.11646	0	13.6266	13.85101	12.81543	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P06400	RB_HUMAN	"Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb, Rb) (pp110)"	RB1	Homo sapiens (Human)	"aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; glial cell apoptotic process [GO:0034349]; hepatocyte apoptotic process [GO:0097284]; heterochromatin assembly [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of cohesin loading [GO:0071922]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]"	chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; glial cell apoptotic process [GO:0034349]; hepatocyte apoptotic process [GO:0097284]; heterochromatin assembly [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of cohesin loading [GO:0071922]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]"	disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]	GO:0000122; GO:0000785; GO:0000977; GO:0001894; GO:0002062; GO:0003180; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005819; GO:0005829; GO:0006338; GO:0006355; GO:0006469; GO:0007265; GO:0007283; GO:0007346; GO:0010629; GO:0016514; GO:0016605; GO:0019900; GO:0030154; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043433; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045944; GO:0048565; GO:0048667; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051301; GO:0051402; GO:0051726; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0071901; GO:0071922; GO:0071930; GO:0090230; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1902948; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000134; GO:2000679; GO:2001234	VMESMLK	6.46999979	0.357148558	0.357148558	0.274401103	851.0675827	0	16.08199	0	14.74391	0	15.78734	0	14.73171	15.72152	15.79442	15.46322	15.90505	15.18691	15.0992	13.52425	15.43733	15.40787	0	14.36502	0	13.83746	14.2632	0	16.45504	0	15.84507	15.14257	0	0	0	0	15.26087	15.84692	16.07655	15.90959	15.93366	0	15.73545	0	16.04461	0	16.20161	0	15.9398	0	0	15.29459	0
P06401	PRGR_HUMAN	"Progesterone receptor, PR (Nuclear receptor subfamily 3 group C member 3)"	PGR NR3C3	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; epithelial cell maturation [GO:0002070]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lung alveolus development [GO:0048286]; negative regulation of gene expression [GO:0010629]; ovulation from ovarian follicle [GO:0001542]; paracrine signaling [GO:0038001]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]	chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; epithelial cell maturation [GO:0002070]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lung alveolus development [GO:0048286]; negative regulation of gene expression [GO:0010629]; ovulation from ovarian follicle [GO:0001542]; paracrine signaling [GO:0038001]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]"	"ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001542; GO:0002070; GO:0003677; GO:0003707; GO:0004879; GO:0005102; GO:0005496; GO:0005654; GO:0005741; GO:0005829; GO:0006357; GO:0007165; GO:0007267; GO:0008270; GO:0010628; GO:0010629; GO:0019899; GO:0030518; GO:0038001; GO:0042802; GO:0045944; GO:0048286; GO:0050678; GO:0050847; GO:0051117; GO:0060748	GVVSSSQR	9.25	1	1	3.45E-13	819.6462476	16.41669	0	0	15.56452	0	0	0	0	0	0	0	15.56346	0	0	0	0	15.85801	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.68437	0	0	16.47818	0	0	0	0	0	0	0	0	0	15.12513
P06493	CDK1_HUMAN	"Cyclin-dependent kinase 1, CDK1, EC 2.7.11.22, EC 2.7.11.23 (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)"	CDK1 CDC2 CDC28A CDKN1 P34CDC2	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; ERK1 and ERK2 cascade [GO:0070371]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein deubiquitination [GO:0016579]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015]	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; ERK1 and ERK2 cascade [GO:0070371]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein deubiquitination [GO:0016579]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015]"	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618]	GO:0000086; GO:0000226; GO:0000307; GO:0000781; GO:0001618; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005789; GO:0005813; GO:0005829; GO:0005876; GO:0006260; GO:0006281; GO:0006468; GO:0006915; GO:0007095; GO:0007098; GO:0007344; GO:0007569; GO:0008283; GO:0008353; GO:0009410; GO:0009636; GO:0010628; GO:0010629; GO:0010971; GO:0014038; GO:0014070; GO:0014075; GO:0014823; GO:0016020; GO:0016477; GO:0016579; GO:0018105; GO:0018107; GO:0030261; GO:0030332; GO:0030496; GO:0030544; GO:0030855; GO:0031100; GO:0034501; GO:0035173; GO:0042307; GO:0042752; GO:0043066; GO:0045471; GO:0045740; GO:0045995; GO:0046686; GO:0046688; GO:0048511; GO:0048678; GO:0051301; GO:0055015; GO:0060045; GO:0065003; GO:0070062; GO:0070301; GO:0070371; GO:0072686; GO:0090166; GO:0097125; GO:0097472; GO:0106310; GO:1900182; GO:1905448	MLIYDPAK	4.420000076	1	1	0.252398692	949.1766131	0	17.7497	0	0	15.69568	16.48587	0	0	0	0	0	17.73301	16.97733	0	0	0	0	0	17.48963	0	0	17.15826	0	0	16.9535	0	16.91212	0	18.3245	0	0	0	0	0	0	0	0	0	17.88104	0	0	0	0	0	0	0	0	0
P06576	ATPB_HUMAN	"ATP synthase subunit beta, mitochondrial, EC 7.1.2.2 (ATP synthase F1 subunit beta)"	ATP5F1B ATP5B ATPMB ATPSB	Homo sapiens (Human)	angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to interleukin-7 [GO:0098761]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]	"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to interleukin-7 [GO:0098761]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]"	"angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0001525; GO:0001649; GO:0005524; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006091; GO:0006629; GO:0006754; GO:0006933; GO:0009986; GO:0015986; GO:0016020; GO:0031966; GO:0042288; GO:0042645; GO:0042776; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0046961; GO:0051453; GO:0070062; GO:0098761; GO:1902600	LGFVGR	1.559999943	1	1	0.022347899	646.3365814	0	14.39395	0	0	15.62411	14.35553	0	14.93949	0	14.32199	16.11624	0	14.64007	15.5842	12.99866	15.80869	15.70415	14.47849	15.02098	12.09289	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.05874	0	0	0	0	16.425	0	0	15.21165	0	0	0	0	0
P06681	CO2_HUMAN	"Complement C2, EC 3.4.21.43 (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment ]"	C2	Homo sapiens (Human)	"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]; response to lipopolysaccharide [GO:0032496]; response to thyroid hormone [GO:0097066]"	classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]; response to lipopolysaccharide [GO:0032496]; response to thyroid hormone [GO:0097066]"	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005601; GO:0005615; GO:0005886; GO:0006956; GO:0006958; GO:0032496; GO:0045087; GO:0046872; GO:0050778; GO:0070062; GO:0097066; GO:1903028; GO:2000427	ESLGRK	4.119999886	0.790263355	0.790263355	0.023012705	689.2857189	0	14.24196	15.74219	0	0	0	0	12.33022	0	0	0	14.14018	15.59882	0	0	0	0	0	0	0	0	0	0	15.7013	0	0	0	0	14.07883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.14409	0
P06703	S10A6_HUMAN	"Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein, PRA) (S100 calcium-binding protein A6)"	S100A6 CACY	Homo sapiens (Human)	axonogenesis [GO:0007409]; positive regulation of fibroblast proliferation [GO:0048146]; signal transduction [GO:0007165]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ion transmembrane transporter activity [GO:0015075]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tropomyosin binding [GO:0005523]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; positive regulation of fibroblast proliferation [GO:0048146]; signal transduction [GO:0007165]	calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ion transmembrane transporter activity [GO:0015075]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tropomyosin binding [GO:0005523]; zinc ion binding [GO:0008270]	GO:0001726; GO:0005509; GO:0005523; GO:0005576; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007409; GO:0008270; GO:0015075; GO:0031234; GO:0042803; GO:0044548; GO:0048146; GO:0048306; GO:0048471; GO:0062023; GO:0070062	ELTIGSK	9.140000343	0.398185164	0.398185164	0.127977703	747.5053656	15.56002	0	14.07082	13.58872	14.35683	15.75728	0	15.14426	13.22398	0	0	0	14.67075	11.87936	0	15.09164	13.85621	14.32848	0	0	0	0	0	14.81523	0	0	0	0	0	0	0	0	0	0	14.63648	0	0	0	17.36613	0	15.16821	0	0	16.15556	0	0	0	0
P06732	KCRM_HUMAN	"Creatine kinase M-type, EC 2.7.3.2 (Creatine kinase M chain) (Creatine phosphokinase M-type, CPK-M) (M-CK)"	CKM CKMM	Homo sapiens (Human)	phosphocreatine biosynthetic process [GO:0046314]	cytosol [GO:0005829]; extracellular space [GO:0005615]	cytosol [GO:0005829]; extracellular space [GO:0005615]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; phosphocreatine biosynthetic process [GO:0046314]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]	GO:0004111; GO:0005524; GO:0005615; GO:0005829; GO:0016301; GO:0046314	GGVHVK	6.670000076	1	1	0.150984538	596.8671732	14.92782	0	14.85748	0	15.38874	0	0	0	0	0	0	16.27767	0	0	16.66425	0	17.02862	0	0	15.60102	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P06737	PYGL_HUMAN	"Glycogen phosphorylase, liver form, EC 2.4.1.1"	PYGL	Homo sapiens (Human)	5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; response to bacterium [GO:0009617]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; response to bacterium [GO:0009617]	AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842]	GO:0002060; GO:0005524; GO:0005536; GO:0005576; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0006015; GO:0008184; GO:0009617; GO:0016208; GO:0019842; GO:0030170; GO:0032052; GO:0034774; GO:0042593; GO:0042802; GO:0070062; GO:0070266; GO:0102250; GO:0102499; GO:1904813	HLDRIVALFPK	3.779999971	1	1	6.90E-13	1309.024202	16.07793	0	0	12.15612	0	12.37228	0	0	13.59614	0	0	13.63748	13.57064	0	0	14.89075	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.96656	0	0	0	0	0	0	0	0
P06744	G6PI_HUMAN	"Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)"	GPI	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]	ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]	cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]	GO:0001701; GO:0001707; GO:0002639; GO:0004347; GO:0005125; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0006959; GO:0007599; GO:0007611; GO:0008083; GO:0010595; GO:0016020; GO:0031625; GO:0032355; GO:0032570; GO:0033574; GO:0034101; GO:0034774; GO:0035902; GO:0035994; GO:0042593; GO:0043005; GO:0043154; GO:0043278; GO:0043524; GO:0046686; GO:0048029; GO:0051156; GO:0060170; GO:0070062; GO:1904813	HFVALSTNTTK	11.14999962	1	1	0.112787314	1219.670264	0	0	0	0	14.82951	0	0	0	0	0	0	0	12.53327	0	14.92222	0	0	0	0	0	0	0	0	14.47712	0	12.87201	0	0	0	0	0	13.25765	14.31022	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P06746	DPOLB_HUMAN	"DNA polymerase beta, EC 2.7.7.7, EC 4.2.99.-"	POLB	Homo sapiens (Human)	"aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, base-free sugar-phosphate removal [GO:0006286]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]"	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]	"cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, base-free sugar-phosphate removal [GO:0006286]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]"	damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0001701; GO:0003684; GO:0003887; GO:0003906; GO:0005634; GO:0005654; GO:0005737; GO:0005874; GO:0005876; GO:0006261; GO:0006281; GO:0006284; GO:0006286; GO:0006287; GO:0006290; GO:0006303; GO:0006954; GO:0006974; GO:0007435; GO:0007568; GO:0008017; GO:0008630; GO:0010332; GO:0016446; GO:0016829; GO:0019899; GO:0032991; GO:0045471; GO:0046872; GO:0048535; GO:0048536; GO:0048872; GO:0051402; GO:0055093; GO:0071707	KLPGVGTK	4.75	1	1	0.13081535	801.5370654	0	0	0	0	15.09174	0	0	0	0	0	0	0	17.12761	0	0	0	16.39268	16.1808	0	16.9232	0	0	0	0	16.38605	0	0	0	15.52686	16.87877	16.23252	0	16.63737	16.67505	0	15.74257	0	0	0	14.18707	0	0	0	0	14.98972	0	18.25527	0
P06748	NPM_HUMAN	"Nucleophosmin, NPM (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)"	NPM1 NPM	Homo sapiens (Human)	"cell aging [GO:0007569]; cellular response to UV [GO:0034644]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein localization [GO:0008104]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; ribosome assembly [GO:0042255]; rRNA export from nucleus [GO:0006407]; signal transduction [GO:0007165]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; spindle pole centrosome [GO:0031616]	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; spindle pole centrosome [GO:0031616]; chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; NF-kappaB binding [GO:0051059]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]; cell aging [GO:0007569]; cellular response to UV [GO:0034644]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein localization [GO:0008104]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; ribosome assembly [GO:0042255]; rRNA export from nucleus [GO:0006407]; signal transduction [GO:0007165]"	chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; NF-kappaB binding [GO:0051059]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]	GO:0000055; GO:0000056; GO:0001046; GO:0003682; GO:0003713; GO:0003723; GO:0004860; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005925; GO:0006281; GO:0006334; GO:0006338; GO:0006407; GO:0006886; GO:0006913; GO:0007098; GO:0007165; GO:0007569; GO:0008104; GO:0008284; GO:0008285; GO:0010824; GO:0010826; GO:0016020; GO:0019901; GO:0030957; GO:0031616; GO:0032071; GO:0032991; GO:0032993; GO:0034644; GO:0042255; GO:0042273; GO:0042274; GO:0042393; GO:0042803; GO:0043023; GO:0043024; GO:0043066; GO:0044387; GO:0045727; GO:0045893; GO:0045944; GO:0046599; GO:0051059; GO:0051082; GO:0051092; GO:0060699; GO:0060735; GO:0140297; GO:1902629; GO:1902751; GO:1990904	GPSSVEDIKAK	28.75	1	1	0.374557947	1131.72157	0	19.73075	0	18.74769	0	20.9517	0	0	0	0	19.27312	19.31093	0	0	0	20.35795	0	16.88567	0	0	17.43512	0	0	0	0	0	0	0	0	0	20.26901	20.22763	20.46977	20.03403	20.77296	0	19.28665	19.61457	0	17.46152	19.971	20.03755	19.38639	16.98491	20.10393	18.69711	0	18.47757
P06756	ITAV_HUMAN	Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain ]	ITGAV MSK8 VNRA VTNR	Homo sapiens (Human)	angiogenesis [GO:0001525]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; calcium ion transmembrane transport [GO:0070588]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; endodermal cell differentiation [GO:0035987]; entry into host cell by a symbiont-containing vacuole [GO:0085017]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of entry of bacterium into host cell [GO:2000536]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of phagocytosis [GO:0050764]; regulation of transforming growth factor beta activation [GO:1901388]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta production [GO:0071604]; vasculogenesis [GO:0001570]; viral entry into host cell [GO:0046718]	alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin alphav-beta3 complex [GO:0034683]; integrin alphav-beta5 complex [GO:0034684]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]	alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin alphav-beta3 complex [GO:0034683]; integrin alphav-beta5 complex [GO:0034684]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]; coreceptor activity [GO:0015026]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; opsonin binding [GO:0001846]; protease binding [GO:0002020]; protein kinase C binding [GO:0005080]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618]; voltage-gated calcium channel activity [GO:0005245]; angiogenesis [GO:0001525]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; calcium ion transmembrane transport [GO:0070588]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; endodermal cell differentiation [GO:0035987]; entry into host cell by a symbiont-containing vacuole [GO:0085017]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of entry of bacterium into host cell [GO:2000536]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of phagocytosis [GO:0050764]; regulation of transforming growth factor beta activation [GO:1901388]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta production [GO:0071604]; vasculogenesis [GO:0001570]; viral entry into host cell [GO:0046718]	coreceptor activity [GO:0015026]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; opsonin binding [GO:0001846]; protease binding [GO:0002020]; protein kinase C binding [GO:0005080]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618]; voltage-gated calcium channel activity [GO:0005245]	GO:0001525; GO:0001570; GO:0001618; GO:0001846; GO:0001968; GO:0002020; GO:0005080; GO:0005178; GO:0005245; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007160; GO:0007204; GO:0007229; GO:0008284; GO:0008305; GO:0009897; GO:0009986; GO:0010745; GO:0010888; GO:0015026; GO:0016020; GO:0016477; GO:0030335; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0032369; GO:0032587; GO:0033627; GO:0033690; GO:0034113; GO:0034446; GO:0034683; GO:0034684; GO:0034685; GO:0034686; GO:0035579; GO:0035866; GO:0035867; GO:0035868; GO:0035987; GO:0038027; GO:0043277; GO:0045335; GO:0045785; GO:0046718; GO:0046872; GO:0050431; GO:0050748; GO:0050764; GO:0050840; GO:0050919; GO:0051057; GO:0070062; GO:0070371; GO:0070588; GO:0071604; GO:0085017; GO:0097192; GO:0098609; GO:1901388; GO:1902533; GO:1905598; GO:1990430; GO:2000536; GO:2001237	MFLLVGAPK	3.50999999	0.202957124	0.202957124	0.112652064	991.1108875	18.64975	14.16818	0	17.01117	13.78686	0	13.85864	16.74511	16.33407	12.83758	15.76884	15.56679	15.68945	0	15.09009	13.69653	17.59537	13.2686	10.86873	0	17.58973	17.05543	0	14.08533	17.74392	14.34496	15.73651	0	15.52787	0	15.3194	15.79583	15.89812	14.99913	13.3903	10.26354	0	19.68204	0	15.68402	15.20205	0	0	13.40041	12.91889	16.54009	15.50574	0
P07195	LDHB_HUMAN	"L-lactate dehydrogenase B chain, LDH-B, EC 1.1.1.27 (LDH heart subunit, LDH-H) (Renal carcinoma antigen NY-REN-46)"	LDHB	Homo sapiens (Human)	lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; oxidoreductase complex [GO:1990204]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; oxidoreductase complex [GO:1990204]; identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459]; lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090]	identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459]	GO:0004459; GO:0005737; GO:0005743; GO:0005829; GO:0006089; GO:0006090; GO:0016020; GO:0042802; GO:0045121; GO:0070062; GO:1990204	GEMMDLQHGSLFLQTPKIVADK	2.49000001	1	1	0.216250564	2491.133203	0	11.71562	15.34961	0	0	0	14.65795	14.99577	16.25161	0	0	14.8413	0	13.82226	0	0	16.63783	0	13.40287	13.62945	0	0	15.43857	0	0	0	15.27493	0	0	15.19394	0	0	15.33968	0	0	13.92993	0	13.82082	0	0	0	14.73783	0	12.12823	0	0	0	13.11538
P07197	NFM_HUMAN	"Neurofilament medium polypeptide, NF-M (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein)"	NEFM NEF3 NFM	Homo sapiens (Human)	neurofilament bundle assembly [GO:0033693]	axon [GO:0030424]; intermediate filament cytoskeleton [GO:0045111]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883]	axon [GO:0030424]; intermediate filament cytoskeleton [GO:0045111]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883]; microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200]; neurofilament bundle assembly [GO:0033693]	microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005883; GO:0008017; GO:0030424; GO:0033693; GO:0045111; GO:0097418	TDISTALK	8.789999962	1	1	0.192434607	846.4724248	14.03161	0	15.60413	0	0	13.76194	15.50795	16.54458	0	0	15.09871	14.23819	15.96131	14.75997	0	15.24099	14.11562	0	16.0718	0	13.47601	0	0	0	0	0	0	0	0	15.60674	15.90196	0	0	0	0	0	0	0	0	0	0	0	14.23805	14.69797	0	0	0	0
P07202	PERT_HUMAN	"Thyroid peroxidase, TPO, EC 1.11.1.8"	TPO	Homo sapiens (Human)	embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]	GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0005886; GO:0005887; GO:0006590; GO:0006979; GO:0009986; GO:0020037; GO:0035162; GO:0042446; GO:0042744	LAAALK	8.859999657	0.940295756	0.940295756	0.219591859	587.2763323	11.96752	14.82441	15.24915	14.85878	15.64728	14.87434	16.1261	16.20025	14.81038	14.60004	0	15.49292	16.46983	16.83352	16.42438	0	16.89605	16.78084	16.84006	15.73528	17.34457	16.36913	15.98982	15.6353	17.10253	15.89887	16.76506	15.17157	0	16.13314	0	15.47287	16.71672	17.83755	0	15.32167	17.59268	18.17392	16.47336	16.38567	16.57688	17.81984	17.18258	17.47434	17.26746	17.46637	17.44181	16.84051
P07203	GPX1_HUMAN	"Glutathione peroxidase 1, GPx-1, GSHPx-1, EC 1.11.1.9 (Cellular glutathione peroxidase)"	GPX1	Homo sapiens (Human)	"aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]"	glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]	GO:0001659; GO:0001885; GO:0002862; GO:0004601; GO:0004602; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006641; GO:0006749; GO:0007568; GO:0007605; GO:0008631; GO:0009410; GO:0009609; GO:0009650; GO:0009725; GO:0010269; GO:0010332; GO:0017124; GO:0018158; GO:0019369; GO:0019372; GO:0032355; GO:0033194; GO:0033599; GO:0034599; GO:0035094; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043154; GO:0043403; GO:0043534; GO:0045444; GO:0045454; GO:0047066; GO:0048741; GO:0051402; GO:0051450; GO:0051593; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0071333; GO:0090201; GO:1902042; GO:1902176; GO:1902905	DYTQMNELQR	4.78000021	1	1	0.496251199	1297.624765	17.97674	0	0	0	16.58039	0	0	10.5233	18.64547	18.61095	18.15923	16.84427	0	0	0	0	0	0	0	0	0	0	17.69593	0	0	0	0	18.87796	0	0	18.3375	19.56051	0	0	0	0	19.58493	0	0	0	17.39911	0	0	0	0	0	0	0
P07204	TRBM_HUMAN	"Thrombomodulin, TM (Fetomodulin) (CD antigen CD141)"	THBD THRM	Homo sapiens (Human)	"blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; female pregnancy [GO:0007565]; negative regulation of blood coagulation [GO:0030195]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to lipopolysaccharide [GO:0032496]; response to X-ray [GO:0010165]; zymogen activation [GO:0031638]"	apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; vacuolar membrane [GO:0005774]	"apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; vacuolar membrane [GO:0005774]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; female pregnancy [GO:0007565]; negative regulation of blood coagulation [GO:0030195]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to lipopolysaccharide [GO:0032496]; response to X-ray [GO:0010165]; zymogen activation [GO:0031638]"	calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005509; GO:0005615; GO:0005774; GO:0005886; GO:0005887; GO:0006508; GO:0007565; GO:0007596; GO:0009897; GO:0009986; GO:0010165; GO:0010544; GO:0016020; GO:0016327; GO:0030195; GO:0031638; GO:0032496; GO:0038023; GO:0051591; GO:0051918; GO:0072377; GO:1905370	TERTPQR	5.369999886	0.80506587	0.80506587	0.312880545	887.9145216	17.02514	13.42106	14.61223	15.06908	16.46596	15.17549	16.30455	0	0	15.47964	16.65257	0	14.34946	16.11084	0	15.09692	15.1168	15.17132	0	13.98244	0	15.00526	15.62205	16.30721	0	0	15.0501	15.75077	0	0	0	0	16.07195	15.52655	15.21061	15.84927	0	16.04818	14.57051	15.84227	16.27141	0	0	11.20231	15.29945	0	14.72597	0
P07205	PGK2_HUMAN	"Phosphoglycerate kinase 2, EC 2.7.2.3 (Phosphoglycerate kinase, testis specific)"	PGK2 PGKB	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]	GO:0004618; GO:0005524; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0016310; GO:0030317; GO:0035686; GO:0043531; GO:0070062	NHAQVVAQAR	4.440000057	1	1	0.221628928	1096.744873	12.22482	15.39701	0	0	0	15.58386	0	0	0	0	16.46349	0	16.17658	12.39525	0	0	0	0	0	0	16.18882	0	14.85732	0	0	15.77758	13.04753	0	0	0	0	15.77013	0	0	0	0	14.91228	16.19529	16.57371	0	0	0	15.66116	13.26902	0	15.68419	0	14.54206
P07237	PDIA1_HUMAN	"Protein disulfide-isomerase, PDI, EC 5.3.4.1 (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)"	P4HB ERBA2L PDI PDIA1 PO4DB	Homo sapiens (Human)	cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; thiol oxidase activity [GO:0016972]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976]	actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; thiol oxidase activity [GO:0016972]	GO:0003723; GO:0003756; GO:0003779; GO:0004656; GO:0005178; GO:0005576; GO:0005783; GO:0005788; GO:0005793; GO:0005829; GO:0005856; GO:0005925; GO:0006457; GO:0009897; GO:0015035; GO:0016222; GO:0016972; GO:0018401; GO:0019899; GO:0030027; GO:0032991; GO:0034663; GO:0034975; GO:0034976; GO:0035722; GO:0038155; GO:0042470; GO:0045785; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:0098761; GO:1900026; GO:1902175	TVIDYNGER	3.75	0.404729575	0.404729575	0.060024513	1066.772226	16.03884	16.40288	0	16.57068	0	0	13.58152	11.53576	0	0	0	0	0	0	14.78303	13.89436	12.64241	0	10.56805	0	0	17.21019	16.69239	0	0	0	0	18.14019	17.90895	17.22645	17.42652	0	17.57821	17.52051	9.895951	0	11.8275	13.7478	15.02117	0	0	9.77811	0	0	12.63397	16.47629	16.9015	0
P07305	H10_HUMAN	"Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed ]"	H1-0 H1F0 H1FV	Homo sapiens (Human)	chromosome condensation [GO:0030261]; heterochromatin assembly [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription regulatory region DNA binding [GO:2000679]	actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; chromosome condensation [GO:0030261]; heterochromatin assembly [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription regulatory region DNA binding [GO:2000679]	chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]	GO:0000785; GO:0000786; GO:0000791; GO:0003680; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0006334; GO:0015629; GO:0016584; GO:0016604; GO:0017053; GO:0030261; GO:0031490; GO:0031492; GO:0031507; GO:0045910; GO:2000679	AGSSR	5.769999981	0.697394133	0.697394133	0.168505835	476.2894104	16.68996	15.37573	15.88911	16.03163	16.12284	15.62194	14.88586	15.83744	14.16697	16.75135	16.46789	15.90429	15.69551	17.18863	0	15.6821	16.87584	13.64268	16.46025	16.57283	16.75171	16.68747	16.28453	15.17809	17.07743	15.16023	15.9758	16.50639	16.22511	15.35153	16.1655	15.60525	16.58788	15.39733	16.28246	16.17745	16.98363	15.22267	10.81523	0	16.60594	0	16.95989	17.174	16.27874	15.21401	15.01258	15.95158
P07307	ASGR2_HUMAN	"Asialoglycoprotein receptor 2, ASGP-R 2, ASGPR 2 (C-type lectin domain family 4 member H2) (Hepatic lectin H2, HL-2)"	ASGR2 CLEC4H2	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]	endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; cell surface receptor signaling pathway [GO:0007166]	asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]	GO:0004873; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0030246; GO:0044322; GO:0048471	ADHDALLFHLKHFPVDLR	6.5	1	1	0.122862449	2143.278313	0	0	12.92989	0	0	13.31571	0	0	15.03867	0	0	0	12.86829	0	0	14.05215	14.07914	0	13.7785	0	0	0	14.82688	0	14.77449	6.473016	0	0	0	11.92966	15.00105	13.56698	15.13282	0	0	0	14.65513	0	0	0	15.09216	0	14.60569	0	0	13.79115	15.87809	11.93165
P07339	CATD_HUMAN	"Cathepsin D, EC 3.4.23.5 [Cleaved into: Cathepsin D light chain; Cathepsin D heavy chain ]"	CTSD CPSD	Homo sapiens (Human)	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201]	aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]	GO:0004190; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0006508; GO:0008233; GO:0010008; GO:0019886; GO:0035580; GO:0042159; GO:0042470; GO:0043065; GO:0043202; GO:0043280; GO:0045121; GO:0062023; GO:0070001; GO:0070062; GO:0070201; GO:1904724; GO:1904813	VGFAEAARL	7.269999981	1	1	0.143065453	933.7187713	12.21151	15.36171	0	14.26023	15.03513	15.08703	0	0	0	0	0	13.31307	0	0	0	0	0	0	0	15.20263	0	0	0	0	0	15.00183	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.26723	0	0	0	0	0
P07355	ANXA2_HUMAN	"Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV, PAP-IV) (Protein I) (p36)"	ANXA2 ANX2 ANX2L4 CAL1H LPC2D	Homo sapiens (Human)	angiogenesis [GO:0001525]; membrane raft assembly [GO:0001765]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of receptor internalization [GO:0002091]; osteoclast development [GO:0036035]; positive regulation of exocytosis [GO:0045921]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of low-density lipoprotein particle receptor binding [GO:1905597]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; vesicle budding from membrane [GO:0006900]	adherens junction [GO:0005912]; AnxA2-p11 complex [GO:1990665]; azurophil granule lumen [GO:0035578]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; vesicle [GO:0031982]	"adherens junction [GO:0005912]; AnxA2-p11 complex [GO:1990665]; azurophil granule lumen [GO:0035578]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; vesicle [GO:0031982]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; serine-type endopeptidase inhibitor activity [GO:0004867]; virion binding [GO:0046790]; angiogenesis [GO:0001525]; membrane raft assembly [GO:0001765]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of receptor internalization [GO:0002091]; osteoclast development [GO:0036035]; positive regulation of exocytosis [GO:0045921]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of low-density lipoprotein particle receptor binding [GO:1905597]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; vesicle budding from membrane [GO:0006900]"	"cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; serine-type endopeptidase inhibitor activity [GO:0004867]; virion binding [GO:0046790]"	GO:0001525; GO:0001765; GO:0001786; GO:0001921; GO:0002020; GO:0002091; GO:0003723; GO:0004867; GO:0005262; GO:0005509; GO:0005544; GO:0005546; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005811; GO:0005886; GO:0005912; GO:0006900; GO:0008092; GO:0009986; GO:0010756; GO:0016020; GO:0016323; GO:0016363; GO:0019834; GO:0030496; GO:0031340; GO:0031902; GO:0031982; GO:0032804; GO:0035578; GO:0036035; GO:0042470; GO:0042802; GO:0044090; GO:0044548; GO:0045921; GO:0046790; GO:0048306; GO:0062023; GO:0070062; GO:0090575; GO:0098641; GO:0098797; GO:1905581; GO:1905597; GO:1905599; GO:1905602; GO:1905686; GO:1990665; GO:1990667	DLYDAGVK	3.809999943	0.950794339	0.950794339	0.258452463	879.9051596	0	0	0	0	0	0	0	20.11278	19.49693	0	0	16.75366	0	0	0	0	18.72146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P07358	CO8B_HUMAN	Complement component C8 beta chain (Complement component 8 subunit beta)	C8B	Homo sapiens (Human)	"complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]"	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]	"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]"	protein-containing complex binding [GO:0044877]	GO:0005576; GO:0005579; GO:0005886; GO:0006955; GO:0006956; GO:0006957; GO:0006958; GO:0016020; GO:0019835; GO:0044877; GO:0050778; GO:0070062; GO:1903561	GILNEIKDR	15.17000008	1	1	0.149491737	1057.087028	0	0	0	14.09741	14.15948	0	14.83941	0	14.0939	15.44963	14.27433	15.62457	14.65031	0	13.54296	15.15015	13.82591	14.97695	0	14.92909	0	16.20293	0	0	0	16.67062	0	0	0	0	0	0	0	0	0	0	0	0	0	14.69896	0	0	0	0	0	0	0	0
P07360	CO8G_HUMAN	Complement component C8 gamma chain	C8G	Homo sapiens (Human)	"complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]"	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]	"blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; complement binding [GO:0001848]; retinol binding [GO:0019841]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]"	complement binding [GO:0001848]; retinol binding [GO:0019841]	GO:0001848; GO:0005576; GO:0005579; GO:0005886; GO:0006957; GO:0006958; GO:0019835; GO:0019841; GO:0050778; GO:0070062; GO:0072562	RPASPISTIQPK	1.870000005	1	1	0.490464154	1294.66278	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.77447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P07384	CAN1_HUMAN	"Calpain-1 catalytic subunit, EC 3.4.22.52 (Calcium-activated neutral proteinase 1, CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain, muCANP)"	CAPN1 CANPL1 PIG30	Homo sapiens (Human)	mammary gland involution [GO:0060056]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233]; mammary gland involution [GO:0060056]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264]	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233]	GO:0001533; GO:0004198; GO:0005509; GO:0005576; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0008233; GO:0008284; GO:0016020; GO:0016241; GO:0032801; GO:0050790; GO:0060056; GO:0070062; GO:0097264; GO:1904813; GO:2000310	ARELGLGR	7.190000057	1	1	0.187515845	870.9674938	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.76036	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P07476	INVO_HUMAN	Involucrin	IVL	Homo sapiens (Human)	isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; response to UV-B [GO:0010224]	centrosome [GO:0005813]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]	centrosome [GO:0005813]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; response to UV-B [GO:0010224]		GO:0001533; GO:0005737; GO:0005813; GO:0005829; GO:0010224; GO:0016604; GO:0018149; GO:0018153; GO:0030216; GO:0031424; GO:0070062	DEQLGMK	10.38000011	0.214226127	0.214226127	0.225640663	835.3181828	15.95152	13.78123	16.15219	15.1334	16.1818	15.206	0	15.40163	0	14.09661	14.83939	0	15.74715	12.29405	0	15.17411	0	15.78167	12.85079	15.74153	14.60188	15.46407	15.68387	16.50977	0	15.82168	15.93972	15.90314	13.36283	14.7764	16.71156	15.49811	11.42776	16.81952	0	13.5448	15.78607	16.27834	16.22145	14.24486	13.9562	16.43311	16.82743	13.77526	14.17579	14.301	16.13894	13.75557
P07478	TRY2_HUMAN	"Trypsin-2, EC 3.4.21.4 (Anionic trypsinogen) (Serine protease 2) (Trypsin II)"	PRSS2 TRY2 TRYP2	Homo sapiens (Human)	antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508]	azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508]	calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0008236; GO:0019730; GO:0022617; GO:0030307; GO:0030574; GO:0031012; GO:0035578; GO:0045785	LSSPAVINSR	3.910000086	1	1	0.244549345	1043.255575	0	0	15.18525	15.73153	15.26946	0	0	0	14.68054	0	16.04538	14.96488	0	0	0	0	0	0	15.3872	15.06291	0	14.7434	0	0	15.83935	0	0	0	0	0	0	15.91555	0	0	0	0	0	0	15.75564	0	0	0	0	0	0	16.64123	0	15.94663
P07585	PGS2_HUMAN	Decorin (Bone proteoglycan II) (PG-S2) (PG40)	DCN SLRR1B	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of transcription by RNA polymerase II [GO:0045944]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; RNA binding [GO:0003723]; animal organ morphogenesis [GO:0009887]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of transcription by RNA polymerase II [GO:0045944]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; RNA binding [GO:0003723]	GO:0003723; GO:0005518; GO:0005539; GO:0005576; GO:0005615; GO:0005796; GO:0009887; GO:0010508; GO:0010596; GO:0014068; GO:0016239; GO:0016525; GO:0019800; GO:0030021; GO:0043202; GO:0045944; GO:0050840; GO:0051901; GO:0062023; GO:0090141; GO:1900747	AHENEITK	15.10999966	0.913331211	0.913331211	1.71E-12	941.8494615	0	0	0	0	0	0	14.84293	14.29916	0	0	0	15.00641	0	0	0	13.97622	0	0	15.57692	0	0	16.38673	15.66796	0	14.75931	16.1581	17.34095	15.14664	15.06188	14.74144	12.19736	0	16.37565	15.98927	0	0	13.45749	0	15.79166	14.01064	13.58768	0	0	15.73172	0	16.07483	0	14.8686
P07602	SAP_HUMAN	"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator, CSAct) (Dispersin) (Sphingolipid activator protein 1, SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2, SAP-2); Saposin-D (Component C) (Protein C) ]"	PSAP GLBA SAP1	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; positive regulation of beta-galactosidase activity [GO:1903771]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]	azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; positive regulation of beta-galactosidase activity [GO:1903771]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]	enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]	GO:0002020; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006665; GO:0007041; GO:0007193; GO:0008047; GO:0010506; GO:0019216; GO:0035577; GO:0042802; GO:0042803; GO:0043202; GO:0043231; GO:0060736; GO:0060742; GO:0062023; GO:0070062; GO:0097110; GO:1903771; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577	NLEKNSTK	3.49000001	0.849907994	0.849907994	0.250612624	932.7510722	10.59517	14.52968	13.25555	13.53296	15.2245	15.22312	0	14.95233	12.56552	13.44969	14.74999	0	14.60305	0	0	14.43722	0	0	15.4256	0	0	14.26125	12.37707	0	14.71523	14.55074	0	15.63818	13.87761	13.23435	0	14.91416	16.52846	0	0	0	0	13.60324	0	12.37605	16.87933	16.79164	14.38709	16.34112	0	0	13.60608	0
P07766	CD3E_HUMAN	T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e)	CD3E T3E	Homo sapiens (Human)	adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell activation [GO:0046629]; negative regulation of gene expression [GO:0010629]; negative regulation of smoothened signaling pathway [GO:0045879]; negative thymic T cell selection [GO:0045060]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive thymic T cell selection [GO:0045059]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal complex assembly [GO:0007172]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	alpha-beta T cell receptor complex [GO:0042105]; cell body [GO:0044297]; cell-cell junction [GO:0005911]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	alpha-beta T cell receptor complex [GO:0042105]; cell body [GO:0044297]; cell-cell junction [GO:0005911]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor complex adaptor activity [GO:0030159]; T cell receptor binding [GO:0042608]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell activation [GO:0046629]; negative regulation of gene expression [GO:0010629]; negative regulation of smoothened signaling pathway [GO:0045879]; negative thymic T cell selection [GO:0045060]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive thymic T cell selection [GO:0045059]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal complex assembly [GO:0007172]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor complex adaptor activity [GO:0030159]; T cell receptor binding [GO:0042608]; transmembrane signaling receptor activity [GO:0004888]	GO:0001772; GO:0001954; GO:0002250; GO:0002669; GO:0004888; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005911; GO:0007166; GO:0007169; GO:0007172; GO:0007186; GO:0009897; GO:0010628; GO:0010629; GO:0016358; GO:0017124; GO:0019901; GO:0021549; GO:0030159; GO:0031295; GO:0032729; GO:0032743; GO:0032753; GO:0033634; GO:0042101; GO:0042102; GO:0042105; GO:0042106; GO:0042110; GO:0042608; GO:0042802; GO:0042981; GO:0043197; GO:0044297; GO:0045059; GO:0045060; GO:0045879; GO:0046629; GO:0046631; GO:0046641; GO:0050731; GO:0050850; GO:0050852; GO:0065003; GO:0097190	GAGAGGRQR	3.49000001	1	1	0.14204167	830.3428767	0	15.09166	0	15.44867	15.13451	14.46193	15.72938	14.78674	12.98646	15.1755	14.85965	16.39607	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.60798	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P07814	SYEP_HUMAN	"Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase, EC 6.1.1.17 (Glutamyl-tRNA synthetase, GluRS); Proline--tRNA ligase, EC 6.1.1.15 (Prolyl-tRNA synthetase) ]"	EPRS1 EPRS GLNS PARS QARS QPRS PIG32	Homo sapiens (Human)	cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; protein-containing complex assembly [GO:0065003]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; protein-containing complex assembly [GO:0065003]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418]	ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]	GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006418; GO:0006424; GO:0006433; GO:0008270; GO:0016020; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0065003; GO:0071346; GO:0097452; GO:0140212; GO:1990904	AEYKEK	4.820000172	7.06E-09	7.06E-09	0.288728142	767.4451445	0	17.51449	0	0	15.92839	0	0	0	0	0	0	0	0	0	0	0	18.17184	18.47656	17.98288	0	17.61297	0	0	17.34512	18.89197	0	0	0	0	17.16299	19.99267	19.15769	0	18.85761	0	0	0	0	0	0	0	0	0	0	0	19.29715	0	0
P07942	LAMB1_HUMAN	Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)	LAMB1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]	GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0009887; GO:0009888; GO:0016477; GO:0021812; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0050679; GO:0051149; GO:0062023; GO:0070062; GO:0070831; GO:0098637; GO:0110011; GO:2001046	SNEELRNLIK	6.849999905	1	1	0.445328889	1215.728133	0	0	0	0	0	0	0	0	18.38868	0	19.52842	0	0	0	0	0	0	0	0	0	0	18.64721	0	0	19.36945	0	0	0	16.19522	0	0	0	0	0	0	0	0	0	0	0	0	0	18.07239	0	0	0	0	0
P07947	YES_HUMAN	"Tyrosine-protein kinase Yes, EC 2.7.10.2 (Proto-oncogene c-Yes) (p61-Yes)"	YES1 YES	Homo sapiens (Human)	cell differentiation [GO:0030154]; cellular protein modification process [GO:0006464]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose transmembrane transport [GO:0010827]; regulation of vascular permeability [GO:0043114]; T cell costimulation [GO:0031295]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	actin filament [GO:0005884]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]	actin filament [GO:0005884]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cell differentiation [GO:0030154]; cellular protein modification process [GO:0006464]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose transmembrane transport [GO:0010827]; regulation of vascular permeability [GO:0043114]; T cell costimulation [GO:0031295]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]	GO:0001784; GO:0002862; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005794; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0006464; GO:0007169; GO:0010827; GO:0019899; GO:0030154; GO:0031234; GO:0031295; GO:0036120; GO:0038096; GO:0043114; GO:0044325; GO:0045087; GO:0045944; GO:0048013; GO:0050731; GO:0050900; GO:0070062; GO:0071300; GO:0071560	DWDEIRGDNVK	4.96999979	1	1	0.293518787	1347.243112	14.71701	0	0	8.16358	13.05047	9.322214	0	14.07913	0	13.42897	15.97753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.83633	0	0	0	0	0	0	14.89962	0	0	0	0	0	0	0	17.65906	16.99517	0	0
P07949	RET_HUMAN	"Proto-oncogene tyrosine-protein kinase receptor Ret, EC 2.7.10.1 (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment ]"	RET CDHF12 CDHR16 PTC RET51	Homo sapiens (Human)	"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]"	axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]	"axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]"	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004712; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0005887; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241	LLEGEGLPFR	14.53999996	1	1	0.486084253	1129.290184	16.72376	15.90966	0	0	0	16.8848	0	16.43923	0	0	0	0	0	0	0	0	16.0619	16.24109	0	0	17.61425	0	16.92515	0	16.85463	0	0	0	0	0	0	0	0	0	16.31538	0	0	0	0	0	0	0	0	0	17.13935	0	0	16.95918
P07954	FUMH_HUMAN	"Fumarate hydratase, mitochondrial, Fumarase, HsFH, EC 4.2.1.2"	FH	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050]	fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]	GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0070062; GO:0120162; GO:2001034	AFGILK	11.09000015	1	1	0.244191895	648.2855707	17.95023	18.8976	18.61673	16.11452	17.03864	17.8896	16.66287	15.6364	19.16463	18.91406	0	17.14021	16.59772	17.29584	0	0	0	17.9646	17.20618	0	16.2816	18.31192	0	0	0	0	0	16.54248	17.62046	16.00297	18.20477	19.4259	18.13675	18.57666	18.51138	0	18.39459	0	19.03565	0	17.42211	0	18.29368	0	18.20411	16.11363	0	18.27958
P07996	TSP1_HUMAN	Thrombospondin-1 (Glycoprotein G)	THBS1 TSP TSP1	Homo sapiens (Human)	behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040]	calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]	GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032695; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0040037; GO:0042327; GO:0042802; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043394; GO:0043406; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237	GDACDHDDDNDGIPDDK	2.910000086	1	1	3.66E-12	1873.958961	14.08979	0	0	11.69278	15.08741	0	14.9171	13.24294	15.79317	14.93049	0	15.60761	14.55093	0	0	0	0	0	15.04583	15.55768	14.8159	0	13.81528	0	0	0	0	14.84377	0	14.78799	0	15.11237	0	0	0	0	0	0	0	0	14.07155	0	0	0	0	0	0	0
P08034	CXB1_HUMAN	"Gap junction beta-1 protein (Connexin-32, Cx32) (GAP junction 28 kDa liver protein)"	GJB1 CX32	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; epididymis development [GO:1905867]; gap junction assembly [GO:0016264]; nervous system development [GO:0007399]; purine ribonucleotide transport [GO:0015868]	connexin complex [GO:0005922]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]	connexin complex [GO:0005922]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; cell-cell signaling [GO:0007267]; epididymis development [GO:1905867]; gap junction assembly [GO:0016264]; nervous system development [GO:0007399]; purine ribonucleotide transport [GO:0015868]	gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]	GO:0005243; GO:0005789; GO:0005922; GO:0007267; GO:0007399; GO:0015868; GO:0016021; GO:0016264; GO:0016328; GO:0042802; GO:1905867	LLSEQDGSLK	4.449999809	1	1	0.097672861	1087.214998	0	14.759	0	0	0	15.6085	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.24704	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P08047	SP1_HUMAN	Transcription factor Sp1	SP1 TSFP1	Homo sapiens (Human)	"cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]"	"bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]"	GO:0000785; GO:0000791; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008022; GO:0010628; GO:0017053; GO:0032869; GO:0032993; GO:0033194; GO:0035035; GO:0042802; GO:0042803; GO:0042826; GO:0043425; GO:0043536; GO:0043565; GO:0043923; GO:0045766; GO:0045893; GO:0045944; GO:0046872; GO:0048511; GO:0061629; GO:0071837; GO:0140297; GO:1902004; GO:1904828; GO:1905564; GO:1990837	MSDQDHSMDEMTAVVKIEK	1.299999952	1	1	0.176501601	2226.761515	10.9578	14.66578	13.37922	12.33289	0	0	10.136	9.77927	7.590746	13.59836	0	14.76721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P08069	IGF1R_HUMAN	"Insulin-like growth factor 1 receptor, EC 2.7.10.1 (Insulin-like growth factor I receptor, IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain ]"	IGF1R	Homo sapiens (Human)	amyloid-beta clearance [GO:0097242]; axonogenesis [GO:0007409]; cardiac atrium development [GO:0003230]; cellular response to aldosterone [GO:1904045]; cellular response to amyloid-beta [GO:1904646]; cellular response to angiotensin [GO:1904385]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to progesterone stimulus [GO:0071393]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; dendritic spine maintenance [GO:0097062]; establishment of cell polarity [GO:0030010]; estrous cycle [GO:0044849]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]; response to ethanol [GO:0045471]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to vitamin E [GO:0033197]; signal transduction [GO:0007165]; transcytosis [GO:0045056]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase complex [GO:1902911]; receptor complex [GO:0043235]; T-tubule [GO:0030315]	alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase complex [GO:1902911]; receptor complex [GO:0043235]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor-activated receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein transporter activity [GO:0140318]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; amyloid-beta clearance [GO:0097242]; axonogenesis [GO:0007409]; cardiac atrium development [GO:0003230]; cellular response to aldosterone [GO:1904045]; cellular response to amyloid-beta [GO:1904646]; cellular response to angiotensin [GO:1904385]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to progesterone stimulus [GO:0071393]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; dendritic spine maintenance [GO:0097062]; establishment of cell polarity [GO:0030010]; estrous cycle [GO:0044849]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]; response to ethanol [GO:0045471]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to vitamin E [GO:0033197]; signal transduction [GO:0007165]; transcytosis [GO:0045056]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-activated receptor activity [GO:0005009]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor-activated receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein transporter activity [GO:0140318]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001965; GO:0003230; GO:0004712; GO:0004713; GO:0004714; GO:0005009; GO:0005010; GO:0005158; GO:0005198; GO:0005520; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005899; GO:0005901; GO:0006955; GO:0007165; GO:0007169; GO:0007409; GO:0008284; GO:0008286; GO:0010656; GO:0014065; GO:0014068; GO:0016020; GO:0021549; GO:0021766; GO:0030010; GO:0030315; GO:0030335; GO:0030424; GO:0031994; GO:0032467; GO:0033197; GO:0033674; GO:0033690; GO:0035094; GO:0035867; GO:0038083; GO:0042593; GO:0042802; GO:0043025; GO:0043066; GO:0043231; GO:0043235; GO:0043243; GO:0043409; GO:0043410; GO:0043548; GO:0043559; GO:0043560; GO:0044849; GO:0045056; GO:0045471; GO:0046328; GO:0046777; GO:0048009; GO:0048015; GO:0048661; GO:0048680; GO:0051054; GO:0051897; GO:0071260; GO:0071333; GO:0071392; GO:0071393; GO:0071394; GO:0071549; GO:0071560; GO:0090031; GO:0090398; GO:0097062; GO:0097242; GO:0120162; GO:0140318; GO:1902065; GO:1902911; GO:1903944; GO:1904045; GO:1904193; GO:1904385; GO:1904646; GO:1990314	MCPSTCGK	2.680000067	1	1	0.229327511	955.850798	11.7745	0	16.39913	14.4079	0	0	16.22186	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.05925	14.32349	14.00356	0	0	0	0	0	0	0	0	0	0	0	16.8976	0	0	16.04057	0	16.01577	0
P08123	CO1A2_HUMAN	Collagen alpha-2(I) chain (Alpha-2 type I collagen)	COL1A2	Homo sapiens (Human)	blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; odontogenesis [GO:0042476]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]	collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; odontogenesis [GO:0042476]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]	GO:0001501; GO:0001568; GO:0002020; GO:0005201; GO:0005576; GO:0005584; GO:0005615; GO:0005783; GO:0005788; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042476; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070062; GO:0070208; GO:0071230; GO:0085029	GEPGAPGENGTPGQTGAR	8.06000042	0.863149345	0.863149345	0.147901477	1646.288499	14.07041	14.37413	13.72111	0	0	0	0	12.29126	0	0	0	15.21553	11.42148	14.17461	15.05706	0	12.52062	12.00641	16.83083	12.63717	12.31613	15.84726	0	0	14.78777	0	13.89544	14.69099	12.07604	14.55628	15.9892	16.18286	14.51538	11.33971	0	0	0	0	0	16.5959	15.36196	12.24034	16.35554	0	0	0	0	16.14232
P08138	TNR16_HUMAN	"Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor, NGF receptor) (p75 ICD) (CD antigen CD271)"	NGFR TNFRSF16	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266]	cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266]	amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]	GO:0001540; GO:0001678; GO:0004888; GO:0005035; GO:0005516; GO:0005576; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0006886; GO:0006919; GO:0007266; GO:0007411; GO:0007417; GO:0009986; GO:0014069; GO:0015026; GO:0016021; GO:0016048; GO:0021675; GO:0030336; GO:0030426; GO:0031069; GO:0031267; GO:0031625; GO:0032922; GO:0035907; GO:0038023; GO:0040037; GO:0042488; GO:0042593; GO:0043121; GO:0043197; GO:0043204; GO:0048146; GO:0048406; GO:0051402; GO:0051799; GO:1900182; GO:1902895; GO:1903588; GO:1904646; GO:2001235	ADLVESLCSESTATSPV	4.039999962	1	1	0	1765.14408	18.50038	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P08151	GLI1_HUMAN	Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI)	GLI1 GLI	Homo sapiens (Human)	"canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex morphogenesis [GO:0021696]; digestive tract morphogenesis [GO:0048546]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; liver regeneration [GO:0097421]; lung development [GO:0030324]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hh target transcription factor activity [GO:1990787]; notochord regression [GO:0060032]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of hepatocyte proliferation [GO:2000345]; regulation of osteoblast differentiation [GO:0045667]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; spermatogenesis [GO:0007283]; ventral midline development [GO:0007418]"	axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex morphogenesis [GO:0021696]; digestive tract morphogenesis [GO:0048546]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; liver regeneration [GO:0097421]; lung development [GO:0030324]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hh target transcription factor activity [GO:1990787]; notochord regression [GO:0060032]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of hepatocyte proliferation [GO:2000345]; regulation of osteoblast differentiation [GO:0045667]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; spermatogenesis [GO:0007283]; ventral midline development [GO:0007418]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005930; GO:0006357; GO:0007224; GO:0007283; GO:0007418; GO:0008017; GO:0008284; GO:0008589; GO:0009611; GO:0009913; GO:0009953; GO:0009954; GO:0021696; GO:0021938; GO:0021983; GO:0030324; GO:0030335; GO:0030850; GO:0043565; GO:0045667; GO:0045740; GO:0045880; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0060032; GO:0060045; GO:0060070; GO:0090090; GO:0097421; GO:0097542; GO:0097546; GO:1902808; GO:1990787; GO:1990788; GO:2000345	GDGPLPR	13.96000004	1	1	0.239891562	711.5485948	19.13028	15.23364	19.05984	0	16.70663	16.6147	16.84564	19.90467	20.00565	0	18.08817	0	19.00642	20.47789	17.86796	0	18.2939	0	17.86319	18.17665	0	16.25385	18.76543	17.57306	18.71954	0	17.25724	15.87718	0	0	0	19.8951	0	0	0	0	17.70488	18.52828	0	19.45015	0	0	17.6329	0	0	0	0	18.42772
P08172	ACM2_HUMAN	Muscarinic acetylcholine receptor M2	CHRM2	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; response to virus [GO:0009615]"	clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	"clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; response to virus [GO:0009615]"	arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]	GO:0004993; GO:0005886; GO:0005887; GO:0006940; GO:0007186; GO:0007187; GO:0007188; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007399; GO:0008016; GO:0009615; GO:0016021; GO:0016907; GO:0030425; GO:0030594; GO:0030669; GO:0045202; GO:0045211; GO:1990763	DENSKQTCIR	4.650000095	0.946824431	0.946824431	0.282231	1249.786241	0	0	0	0	0	0	0	0	16.321	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.52269	0	0	0	0	0	0	0	0	0	0	18.86886	18.32788	0	19.03027	0	0	0	0	0	0	0	0	0
P08183	MDR1_HUMAN	"ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1, EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1, EC 7.6.2.1) (CD antigen CD243)"	ABCB1 MDR1 PGY1	Homo sapiens (Human)	carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]; carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]	ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0000086; GO:0005524; GO:0005654; GO:0005886; GO:0008559; GO:0009410; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0031625; GO:0042626; GO:0042910; GO:0045332; GO:0046865; GO:0046943; GO:0047484; GO:0055085; GO:0070062; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0150104; GO:1901529; GO:1905039; GO:1990961; GO:1990962; GO:2001225	GLNLKVQSGQTVALVGNSGCGK	2.119999886	1	1	0.161500745	2186.245447	13.8615	0	15.49738	0	17.59687	14.51695	12.30041	11.35907	0	15.50958	14.88675	0	15.31345	14.43065	0	0	0	0	0	0	0	0	0	0	0	0	14.80825	12.2489	12.40758	0	12.31644	12.07551	0	0	8.711535	0	0	0	0	15.43971	15.26141	0	14.92064	0	0	0	15.18919	0
P08195	4F2_HUMAN	"4F2 cell-surface antigen heavy chain, 4F2hc (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98)"	SLC3A2 MDU1	Homo sapiens (Human)	amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; phenylalanine transport [GO:0015823]; response to exogenous dsRNA [GO:0043330]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; apical pole of neuron [GO:0044225]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]	amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; apical pole of neuron [GO:0044225]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; aromatic amino acid transmembrane transporter activity [GO:0015173]; cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; catalytic activity [GO:0003824]; double-stranded RNA binding [GO:0003725]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; RNA binding [GO:0003723]; amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; phenylalanine transport [GO:0015823]; response to exogenous dsRNA [GO:0043330]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]	aromatic amino acid transmembrane transporter activity [GO:0015173]; cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; catalytic activity [GO:0003824]; double-stranded RNA binding [GO:0003725]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; RNA binding [GO:0003723]	GO:0003723; GO:0003725; GO:0003824; GO:0005432; GO:0005654; GO:0005765; GO:0005886; GO:0005975; GO:0006816; GO:0006865; GO:0009925; GO:0009986; GO:0015173; GO:0015175; GO:0015180; GO:0015190; GO:0015820; GO:0015823; GO:0015827; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0042470; GO:0043330; GO:0044225; GO:0045202; GO:0045296; GO:0046718; GO:0070062; GO:0098713; GO:1903801; GO:1904273; GO:1990184	QPMNAASGAAMSLAGAEKNGLVK	1.970000029	1	1	0.409763268	2231.912287	0	0	19.41322	0	0	21.31328	19.69502	0	0	0	0	0	0	19.24814	0	20.19506	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.60127	0	20.39891	0	0	0
P08235	MCR_HUMAN	"Mineralocorticoid receptor, MR (Nuclear receptor subfamily 3 group C member 2)"	NR3C2 MCR MLR	Homo sapiens (Human)	intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]	"chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005654; GO:0005789; GO:0005829; GO:0006357; GO:0007165; GO:0008270; GO:0030518; GO:0043235; GO:1901224; GO:1990837	DVVPSPDTQEK	7.139999866	1	1	0.178063241	1211.768389	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.85627	11.73301	15.67332	0	0	0	0	0	0	0	0	14.25544	0	0	0	0	15.34917	16.26882	0	11.85512	0	0	0	0	0	0	0	0	0	0	12.993	0	0	0
P08237	PFKAM_HUMAN	"ATP-dependent 6-phosphofructokinase, muscle type, ATP-PFK, PFK-M, EC 2.7.1.11 (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A, PFK-A) (Phosphohexokinase)"	PFKM PFKX	Homo sapiens (Human)	"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycolysis from storage polysaccharide through glucose-1-phosphate [GO:0093001]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; sperm principal piece [GO:0097228]	"6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; sperm principal piece [GO:0097228]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein C-terminus binding [GO:0008022]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycolysis from storage polysaccharide through glucose-1-phosphate [GO:0093001]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein C-terminus binding [GO:0008022]	GO:0003872; GO:0005524; GO:0005634; GO:0005829; GO:0005945; GO:0005980; GO:0006002; GO:0006096; GO:0008022; GO:0016020; GO:0016208; GO:0016324; GO:0019900; GO:0030388; GO:0032024; GO:0042593; GO:0042802; GO:0045944; GO:0046716; GO:0046872; GO:0048029; GO:0061615; GO:0061621; GO:0070061; GO:0070095; GO:0093001; GO:0097228	SGSHTVAVMNVGAPAAGMNAAVRSTVR	5.230000019	1	1	0.034299727	2642.864576	0	14.37973	15.92543	0	12.79451	13.72076	15.29273	15.09299	15.0689	13.86488	15.07946	15.22649	15.3112	0	15.1916	14.77491	13.27802	0	0	0	0	0	14.80655	13.61081	0	13.13878	0	0	0	0	0	0	0	0	0	0	0	0	0	13.99139	14.47949	0	0	0	0	0	0	0
P08238	HS90B_HUMAN	"Heat shock protein HSP 90-beta, HSP 90 (Heat shock 84 kDa, HSP 84, HSP84)"	HSP90AB1 HSP90B HSPC2 HSPCB	Homo sapiens (Human)	axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]	apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913]	apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]; axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]	GO:0001890; GO:0002134; GO:0002135; GO:0003723; GO:0003725; GO:0005524; GO:0005525; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0005886; GO:0006457; GO:0006986; GO:0007004; GO:0009410; GO:0009651; GO:0009986; GO:0016020; GO:0016234; GO:0016323; GO:0016324; GO:0016887; GO:0017098; GO:0019062; GO:0019887; GO:0019900; GO:0019901; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030511; GO:0030911; GO:0031072; GO:0031396; GO:0031526; GO:0031625; GO:0032092; GO:0032435; GO:0032516; GO:0032564; GO:0032880; GO:0032991; GO:0033138; GO:0034605; GO:0034751; GO:0034774; GO:0042220; GO:0042277; GO:0042307; GO:0042470; GO:0042802; GO:0042803; GO:0042826; GO:0043008; GO:0043025; GO:0043524; GO:0044183; GO:0044294; GO:0044295; GO:0044325; GO:0045296; GO:0045429; GO:0045597; GO:0045793; GO:0046983; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0051082; GO:0051131; GO:0051248; GO:0051726; GO:0051897; GO:0051973; GO:0070062; GO:0070182; GO:0071353; GO:0071407; GO:0071902; GO:0097435; GO:0097718; GO:0120293; GO:1901389; GO:1901799; GO:1902949; GO:1903660; GO:1904031; GO:1904813; GO:1905323; GO:1990226; GO:1990565; GO:1990913; GO:1990917; GO:2000010	YHTSQSGDEMTSLSEYVSR	7.800000191	0.643881381	0.643881381	0.038854918	2177.457354	0	8.754793	14.15515	0	0	11.36596	0	0	0	15.45471	0	0	14.53166	0	12.91881	11.47857	14.58582	16.87105	15.83454	15.66111	18.58867	16.10534	16.45493	0	12.62232	13.08835	0	14.07529	17.21195	17.81452	0	0	16.32213	16.17003	0	0	16.39945	16.33333	0	16.20079	15.32237	16.70257	13.78458	15.91405	0	0	15.18538	18.95057
P08240	SRPRA_HUMAN	"Signal recognition particle receptor subunit alpha, SR-alpha (Docking protein alpha, DP-alpha)"	SRPRA SRPR	Homo sapiens (Human)	"cotranslational protein targeting to membrane [GO:0006613]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	"endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; cotranslational protein targeting to membrane [GO:0006613]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]	GO:0003723; GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006613; GO:0006617; GO:0016020; GO:0045047; GO:0070062	EAEESSK	2.410000086	1	1	0	780.4182167	0	0	0	0	0	0	0	16.76318	0	0	0	0	0	0	0	0	13.34067	14.2928	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.38577	0	0	0	0	0	0	0	0	0	16.18075	0	0
P08243	ASNS_HUMAN	"Asparagine synthetase [glutamine-hydrolyzing], EC 6.3.5.4 (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)"	ASNS TS11	Homo sapiens (Human)	asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931]	cytosol [GO:0005829]	cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931]	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]	GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0042149; GO:0043066; GO:0045931; GO:0070981	GLVTLK	7.730000019	0.710885048	0.710885048	0.251096414	631.6006643	0	18.53781	0	0	0	0	0	17.25218	0	0	19.23036	0	0	0	0	0	0	0	0	0	0	20.3633	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P08253	MMP2_HUMAN	"72 kDa type IV collagenase, EC 3.4.24.24 (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2, MMP-2) (TBE-1) [Cleaved into: PEX ]"	MMP2 CLG4A	Homo sapiens (Human)	aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771]	endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001541; GO:0001542; GO:0001553; GO:0001666; GO:0001955; GO:0001957; GO:0001968; GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0006508; GO:0007162; GO:0007507; GO:0007566; GO:0007567; GO:0007568; GO:0008237; GO:0008270; GO:0009410; GO:0009612; GO:0014012; GO:0014823; GO:0016477; GO:0022617; GO:0030017; GO:0030198; GO:0030335; GO:0030574; GO:0032526; GO:0034614; GO:0035094; GO:0035987; GO:0042542; GO:0043065; GO:0043627; GO:0044267; GO:0045906; GO:0048013; GO:0048771; GO:0051602; GO:0055093; GO:0060325; GO:0060346; GO:0060740; GO:0062023; GO:0071230; GO:0071347; GO:0071392; GO:0071492; GO:0071498; GO:1904645; GO:1904707	KMDPGFPK	7.119999886	1	1	0.271729272	934.6944502	0	0	15.83802	0	0	0	16.67753	0	17.38003	0	0	0	16.63826	0	0	0	16.79267	0	0	0	0	0	19.18429	0	0	0	17.44262	0	17.31639	15.9615	0	0	0	0	0	0	0	20.49655	0	16.81141	0	0	0	0	0	0	0	16.8325
P08254	MMP3_HUMAN	"Stromelysin-1, SL-1, EC 3.4.24.17 (Matrix metalloproteinase-3, MMP-3) (Transin-1)"	MMP3 STMY1	Homo sapiens (Human)	cellular response to nitric oxide [GO:0071732]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; positive regulation of oxidative stress-induced cell death [GO:1903209]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cellular response to nitric oxide [GO:0071732]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; positive regulation of oxidative stress-induced cell death [GO:1903209]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0010727; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0031334; GO:0071492; GO:0071732; GO:0150077; GO:1903209; GO:1904645	SLPILLLLCVAVCSAYPLDGAAR	11.89000034	1	1	4.63E-13	2471.979717	0	14.93326	13.95218	0	11.67545	0	12.75507	0	13.38441	13.19949	15.8975	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P08263	GSTA1_HUMAN	"Glutathione S-transferase A1, EC 2.5.1.18 (13-hydroperoxyoctadecadienoate peroxidase, EC 1.11.1.-) (Androst-5-ene-3,17-dione isomerase, EC 5.3.3.-) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Cleaved into: Glutathione S-transferase A1, N-terminally processed ]"	GSTA1	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; linoleic acid metabolic process [GO:0043651]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; steroid delta-isomerase activity [GO:0004769]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; linoleic acid metabolic process [GO:0043651]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805]	fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; steroid delta-isomerase activity [GO:0004769]	GO:0004364; GO:0004602; GO:0004769; GO:0005504; GO:0005829; GO:0006693; GO:0006749; GO:0006805; GO:0030855; GO:0043651; GO:0070062; GO:1901687	KPPMDEK	5.849999905	1	1	6.86E-13	864.4480888	0	0	0	13.69095	10.39571	13.28189	0	13.94107	0	15.19777	15.9223	15.35762	0	0	0	0	7.891293	14.7268	15.58861	0	14.05005	15.34159	15.1872	13.35188	0	14.3036	0	13.59572	13.6554	14.76146	0	0	0	0	0	0	0	0	0	0	0	0	14.72635	0	0	0	0	0
P08311	CATG_HUMAN	"Cathepsin G, CG, EC 3.4.21.20 [Cleaved into: Cathepsin G, C-terminal truncated form ]"	CTSG	Homo sapiens (Human)	angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; biofilm matrix disassembly [GO:0098786]; cellular protein metabolic process [GO:0044267]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; monocyte chemotaxis [GO:0002548]; negative regulation of T cell activation [GO:0050868]; neutrophil activation [GO:0042119]; neutrophil-mediated killing of gram-positive bacterium [GO:0070946]; platelet activation [GO:0030168]; positive regulation of immune response [GO:0050778]; positive regulation of platelet aggregation [GO:1901731]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; proteolysis [GO:0006508]; purinergic nucleotide receptor signaling pathway [GO:0035590]	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; caspase binding [GO:0089720]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; biofilm matrix disassembly [GO:0098786]; cellular protein metabolic process [GO:0044267]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; monocyte chemotaxis [GO:0002548]; negative regulation of T cell activation [GO:0050868]; neutrophil activation [GO:0042119]; neutrophil-mediated killing of gram-positive bacterium [GO:0070946]; platelet activation [GO:0030168]; positive regulation of immune response [GO:0050778]; positive regulation of platelet aggregation [GO:1901731]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; proteolysis [GO:0006508]; purinergic nucleotide receptor signaling pathway [GO:0035590]	caspase binding [GO:0089720]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0002003; GO:0002548; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005886; GO:0006468; GO:0006508; GO:0006955; GO:0008201; GO:0008233; GO:0008236; GO:0009986; GO:0010494; GO:0016020; GO:0016485; GO:0019221; GO:0019731; GO:0022617; GO:0030141; GO:0030168; GO:0035578; GO:0035590; GO:0042119; GO:0043231; GO:0044267; GO:0048018; GO:0050778; GO:0050829; GO:0050830; GO:0050832; GO:0050868; GO:0062023; GO:0070062; GO:0070946; GO:0071222; GO:0089720; GO:0098786; GO:1901731	SFKLLDQMETPL	10.30000019	1	1	0.074124896	1422.111174	13.36092	12.89067	14.6868	11.22182	9.660604	0	0	13.60679	7.773835	15.02376	15.79299	11.1737	0	12.35721	12.46983	0	7.519054	14.09237	15.0019	9.896761	0	0	0	0	15.46355	14.18868	15.82847	0	0	0	0	15.04254	0	0	15.18872	0	0	0	0	14.76933	0	0	0	0	0	0	13.192	0
P08476	INHBA_HUMAN	"Inhibin beta A chain (Activin beta-A chain) (Erythroid differentiation protein, EDF)"	INHBA	Homo sapiens (Human)	"activin receptor signaling pathway [GO:0032924]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; defense response [GO:0006952]; endodermal cell differentiation [GO:0035987]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; eyelid development in camera-type eye [GO:0061029]; GABAergic neuron differentiation [GO:0097154]; hair follicle development [GO:0001942]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; mesodermal cell differentiation [GO:0048333]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; nervous system development [GO:0007399]; odontogenesis [GO:0042476]; ovarian follicle development [GO:0001541]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of follicle-stimulating hormone secretion [GO:0046880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; striatal medium spiny neuron differentiation [GO:0021773]"	activin A complex [GO:0043509]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; perinuclear region of cytoplasm [GO:0048471]	"activin A complex [GO:0043509]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; perinuclear region of cytoplasm [GO:0048471]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; inhibin binding [GO:0034711]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; type II activin receptor binding [GO:0070699]; activin receptor signaling pathway [GO:0032924]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; defense response [GO:0006952]; endodermal cell differentiation [GO:0035987]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; eyelid development in camera-type eye [GO:0061029]; GABAergic neuron differentiation [GO:0097154]; hair follicle development [GO:0001942]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; mesodermal cell differentiation [GO:0048333]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; nervous system development [GO:0007399]; odontogenesis [GO:0042476]; ovarian follicle development [GO:0001541]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of follicle-stimulating hormone secretion [GO:0046880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; striatal medium spiny neuron differentiation [GO:0021773]"	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; inhibin binding [GO:0034711]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; type II activin receptor binding [GO:0070699]	GO:0001541; GO:0001942; GO:0002244; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0006357; GO:0006952; GO:0007166; GO:0007267; GO:0007399; GO:0008083; GO:0008285; GO:0008584; GO:0009410; GO:0010628; GO:0010862; GO:0017046; GO:0021773; GO:0030154; GO:0030218; GO:0030308; GO:0032270; GO:0032689; GO:0032924; GO:0034711; GO:0035987; GO:0042326; GO:0042476; GO:0042541; GO:0042701; GO:0042802; GO:0043509; GO:0043512; GO:0044877; GO:0045578; GO:0045648; GO:0045650; GO:0045893; GO:0045944; GO:0046880; GO:0046881; GO:0046882; GO:0048333; GO:0048471; GO:0060021; GO:0060279; GO:0060395; GO:0061029; GO:0070699; GO:0071372; GO:0071397; GO:0097154; GO:0097191; GO:2000134; GO:2001241	AALLNAIRK	10.05000019	0.482052654	0.482052654	0.255891473	969.0790284	14.24696	15.52963	14.40205	0	0	15.57164	0	0	15.19365	0	0	16.29624	14.51136	12.75626	16.50676	0	0	15.79526	14.5017	15.60507	0	15.28745	15.34572	0	15.06693	15.53763	0	14.26823	13.02122	15.46617	14.47351	15.06565	0	16.85769	14.04296	13.16828	14.50939	14.28758	0	12.67574	13.37279	13.39378	14.38985	13.03209	14.61495	13.88682	15.75937	15.47765
P08581	MET_HUMAN	"Hepatocyte growth factor receptor, HGF receptor, EC 2.7.10.1 (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor, SF receptor) (Tyrosine-protein kinase Met)"	MET	Homo sapiens (Human)	branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; negative regulation of autophagy [GO:0010507]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; negative regulation of autophagy [GO:0010507]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001886; GO:0001889; GO:0004712; GO:0004713; GO:0004714; GO:0005008; GO:0005524; GO:0005576; GO:0005886; GO:0005887; GO:0006909; GO:0007165; GO:0007166; GO:0007169; GO:0007399; GO:0009925; GO:0009986; GO:0010507; GO:0016021; GO:0016477; GO:0017154; GO:0019903; GO:0030182; GO:0031016; GO:0031116; GO:0033674; GO:0035024; GO:0042802; GO:0043235; GO:0045944; GO:0048754; GO:0050918; GO:0051497; GO:0051897; GO:0061436; GO:0070495; GO:0071526; GO:1901299; GO:1905098; GO:2001028	LPVKWMALESLQTQK	4.760000229	1	1	4.11E-12	1772.030508	14.79079	15.18917	0	0	0	0	0	0	0	0	14.16604	0	15.48089	0	0	13.14293	0	0	15.14744	14.80116	0	17.1438	0	15.95435	0	12.519	15.86739	14.8214	13.09511	0	16.01858	15.90343	0	16.46584	14.67146	16.47482	0	0	0	17.17441	0	15.77411	0	17.69142	0	17.63104	0	16.07411
P08588	ADRB1_HUMAN	"Beta-1 adrenergic receptor (Beta-1 adrenoreceptor, Beta-1 adrenoceptor)"	ADRB1 ADRB1R B1AR	Homo sapiens (Human)	"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; fear response [GO:0042596]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to cold [GO:0009409]"	early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	"early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-2A adrenergic receptor binding [GO:0031694]; beta-adrenergic receptor activity [GO:0004939]; beta1-adrenergic receptor activity [GO:0004940]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled receptor activity [GO:0004930]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; fear response [GO:0042596]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to cold [GO:0009409]"	alpha-2A adrenergic receptor binding [GO:0031694]; beta-adrenergic receptor activity [GO:0004939]; beta1-adrenergic receptor activity [GO:0004940]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled receptor activity [GO:0004930]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]	GO:0001996; GO:0001997; GO:0002024; GO:0002025; GO:0004930; GO:0004939; GO:0004940; GO:0005085; GO:0005769; GO:0005886; GO:0005887; GO:0007190; GO:0009409; GO:0030165; GO:0031649; GO:0031694; GO:0040015; GO:0042596; GO:0043547; GO:0045187; GO:0046982; GO:0050873; GO:0071880; GO:0098685; GO:0099579; GO:0120162	IDSCER	4.150000095	1	1	0.288237909	778.8460434	17.89565	19.42751	0	0	16.00192	0	0	0	0	0	17.77145	0	0	17.0842	0	0	0	0	16.91508	16.65513	0	0	0	0	17.16306	0	18.41577	0	0	0	18.56823	17.8448	17.83374	0	0	0	0	19.17356	19.34756	18.66875	17.56217	0	17.47506	18.40186	0	0	0	17.93308
P08621	RU17_HUMAN	"U1 small nuclear ribonucleoprotein 70 kDa, U1 snRNP 70 kDa, U1-70K, snRNP70"	SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of protein refolding [GO:0061084]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of ATP-dependent activity [GO:0043462]; regulation of RNA splicing [GO:0043484]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of protein refolding [GO:0061084]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of ATP-dependent activity [GO:0043462]; regulation of RNA splicing [GO:0043484]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005685; GO:0016607; GO:0017069; GO:0030619; GO:0043462; GO:0043484; GO:0048026; GO:0061084; GO:0071004; GO:1904715	RSGKPR	4.099999905	0.760947466	0.760947466	0.293449385	696.917349	16.20154	16.12355	16.51302	0	15.94015	15.26552	15.2029	0	14.7399	15.68521	15.18101	15.08169	14.07962	15.93175	16.16763	0	0	15.68903	0	15.57068	15.02079	14.48141	16.18978	0	13.48583	15.08539	16.32256	14.32093	15.365	15.59663	15.05503	16.04969	16.59081	15.49608	15.42481	14.92626	16.52294	17.33824	15.55255	14.26283	15.93868	16.73306	0	15.94473	16.09431	17.22744	0	16.44909
P08648	ITA5_HUMAN	Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain ]	ITGA5 FNRA	Homo sapiens (Human)	"angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]"	alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]	"alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]"	epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618]	GO:0001525; GO:0001618; GO:0001726; GO:0005154; GO:0005161; GO:0005178; GO:0005783; GO:0005794; GO:0005886; GO:0005925; GO:0007044; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007229; GO:0007565; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0010811; GO:0023035; GO:0030335; GO:0030949; GO:0031410; GO:0031589; GO:0033627; GO:0033631; GO:0034113; GO:0034674; GO:0035313; GO:0035987; GO:0043184; GO:0045202; GO:0046872; GO:0050731; GO:0071062; GO:0098609; GO:1903672; GO:2000811	SLPYGTAMEKAQLKPPATSDA	21.14999962	1	1	0.339881526	2191.686897	0	0	0	0	0	0	14.74936	0	17.44502	0	0	0	0	0	0	0	0	0	0	0	17.65874	0	0	0	0	24.15583	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P08697	A2AP_HUMAN	"Alpha-2-antiplasmin, Alpha-2-AP (Alpha-2-plasmin inhibitor, Alpha-2-PI) (Serpin F2)"	SERPINF2 AAP PLI	Homo sapiens (Human)	acute-phase response [GO:0006953]; blood vessel morphogenesis [GO:0048514]; collagen fibril organization [GO:0030199]; fibrinolysis [GO:0042730]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta production [GO:0071636]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; blood vessel morphogenesis [GO:0048514]; collagen fibril organization [GO:0030199]; fibrinolysis [GO:0042730]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta production [GO:0071636]	endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0002034; GO:0004866; GO:0004867; GO:0005576; GO:0005577; GO:0005615; GO:0006953; GO:0009986; GO:0010757; GO:0010951; GO:0030199; GO:0031093; GO:0032967; GO:0042730; GO:0042803; GO:0045597; GO:0045944; GO:0046330; GO:0048514; GO:0048661; GO:0051496; GO:0051918; GO:0062023; GO:0070062; GO:0070374; GO:0071636; GO:0072562; GO:2000049	EQQDSPGNKDFLQSLK	8.600000381	1	1	0.22295463	1834.221765	13.9317	15.49158	0	0	0	0	13.42426	0	0	0	0	0	0	0	0	0	0	0	14.75484	0	0	0	0	0	0	14.83365	15.46037	0	0	13.63859	0	0	0	0	0	0	0	0	16.60253	16.19102	0	0	0	0	0	14.90714	15.67178	15.74626
P08729	K2C7_HUMAN	"Keratin, type II cytoskeletal 7 (Cytokeratin-7, CK-7) (Keratin-7, K7) (Sarcolectin) (Type-II keratin Kb7)"	KRT7 SCL	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0045095; GO:0045111; GO:0070062	AQYEEMAK	9.710000038	0.006497107	0.006497107	1.14E-12	969.4062331	10.06834	0	0	16.69201	0	14.22462	0	0	0	10.86832	0	0	15.14209	14.1614	0	12.03451	0	0	0	15.14564	0	0	10.77332	17.98725	17.65318	13.74495	17.07917	15.11252	0	0	0	14.49526	15.14911	0	15.75406	14.00243	14.57252	0	15.71749	13.68158	0	0	14.36698	0	14.70997	0	12.90955	15.31436
P08758	ANXA5_HUMAN	"Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I, CPB-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4, PP4) (Placental anticoagulant protein I, PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha, VAC-alpha)"	ANXA5 ANX5 ENX2 PP4	Homo sapiens (Human)	blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]; signal transduction [GO:0007165]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543]; blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]; signal transduction [GO:0007165]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543]	GO:0004859; GO:0005509; GO:0005543; GO:0005544; GO:0005576; GO:0005737; GO:0005829; GO:0005925; GO:0007165; GO:0007596; GO:0009897; GO:0010033; GO:0016020; GO:0043066; GO:0050819; GO:0062023; GO:0070062; GO:0072563	GAGTDDHTLIRVMVSR	6.070000172	1	1	1.38E-12	1740.140345	0	0	0	0	0	0	16.30284	0	15.01128	0	0	0	0	12.91706	0	15.04259	0	12.75656	0	0	0	0	0	0	0	0	15.12923	0	0	0	0	0	12.44646	0	13.47176	0	0	0	0	0	0	15.85478	0	0	0	0	0	0
P08833	IBP1_HUMAN	"Insulin-like growth factor-binding protein 1, IBP-1, IGF-binding protein 1, IGFBP-1 (Placental protein 12, PP12)"	IGFBP1 IBP1	Homo sapiens (Human)	aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of cell growth [GO:0030307]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; tissue regeneration [GO:0042246]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of cell growth [GO:0030307]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; tissue regeneration [GO:0042246]	insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005520; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0007165; GO:0007568; GO:0008286; GO:0030307; GO:0031994; GO:0031995; GO:0042246; GO:0043567; GO:0090090	IELYRVVESLAK	8.539999962	1	1	0.373594059	1419.523226	0	0	15.42522	11.13068	0	14.16462	0	0	0	15.3147	0	0	0	15.57472	0	0	0	0	0	0	0	0	0	0	15.37067	0	15.10255	16.9851	14.13393	16.14609	15.00793	13.28813	0	15.4916	16.67186	17.98105	17.14487	18.16651	15.46189	0	16.32842	15.94252	0	16.54151	0	0	13.02146	16.71116
P08887	IL6RA_HUMAN	"Interleukin-6 receptor subunit alpha, IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA (IL-6R 1) (Membrane glycoprotein 80, gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha, sIL6R ]"	IL6R	Homo sapiens (Human)	acute-phase response [GO:0006953]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endocrine pancreas development [GO:0031018]; extrinsic apoptotic signaling pathway [GO:0097191]; hepatic immune response [GO:0002384]; interleukin-6-mediated signaling pathway [GO:0070102]; monocyte chemotaxis [GO:0002548]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of interleukin-8 production [GO:0032717]; neutrophil mediated immunity [GO:0002446]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573]	apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor binding [GO:0070119]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; protein homodimerization activity [GO:0042803]; acute-phase response [GO:0006953]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endocrine pancreas development [GO:0031018]; extrinsic apoptotic signaling pathway [GO:0097191]; hepatic immune response [GO:0002384]; interleukin-6-mediated signaling pathway [GO:0070102]; monocyte chemotaxis [GO:0002548]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of interleukin-8 production [GO:0032717]; neutrophil mediated immunity [GO:0002446]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573]	ciliary neurotrophic factor binding [GO:0070119]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; protein homodimerization activity [GO:0042803]	GO:0002384; GO:0002446; GO:0002548; GO:0002690; GO:0004896; GO:0004915; GO:0004921; GO:0005576; GO:0005615; GO:0005886; GO:0005896; GO:0006953; GO:0008284; GO:0009897; GO:0010536; GO:0010573; GO:0016324; GO:0019221; GO:0019899; GO:0019955; GO:0019970; GO:0019981; GO:0031018; GO:0032717; GO:0032722; GO:0032755; GO:0032966; GO:0034097; GO:0042531; GO:0042803; GO:0043235; GO:0043410; GO:0045669; GO:0048661; GO:0050731; GO:0050829; GO:0050830; GO:0070102; GO:0070110; GO:0070119; GO:0070120; GO:0072126; GO:0072540; GO:0097191; GO:1901731	KPAAGSHPSR	4.670000076	1	1	0.290126676	1006.57606	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.19439	0	0	0	0	0	0	0	0	0	17.53168	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.97167	0	0
P08913	ADA2A_HUMAN	"Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor, Alpha-2A adrenoceptor, Alpha-2AAR)"	ADRA2A ADRA2R ADRAR	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; intestinal absorption [GO:0050892]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; receptor transactivation [GO:0035624]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vasoconstriction [GO:0019229]; Rho protein signal transduction [GO:0007266]; thermoception [GO:0050955]; vasodilation [GO:0042311]	axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-1B adrenergic receptor binding [GO:0031692]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; heterotrimeric G-protein binding [GO:0032795]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; intestinal absorption [GO:0050892]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; receptor transactivation [GO:0035624]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vasoconstriction [GO:0019229]; Rho protein signal transduction [GO:0007266]; thermoception [GO:0050955]; vasodilation [GO:0042311]	alpha-1B adrenergic receptor binding [GO:0031692]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; heterotrimeric G-protein binding [GO:0032795]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]	GO:0001819; GO:0002526; GO:0004930; GO:0004938; GO:0005737; GO:0005886; GO:0005887; GO:0006260; GO:0007186; GO:0007189; GO:0007193; GO:0007265; GO:0007266; GO:0007565; GO:0008284; GO:0010700; GO:0016323; GO:0019229; GO:0019901; GO:0030036; GO:0030168; GO:0030335; GO:0031692; GO:0031696; GO:0031996; GO:0032147; GO:0032148; GO:0032795; GO:0032811; GO:0032870; GO:0035624; GO:0042311; GO:0042593; GO:0042596; GO:0042803; GO:0043025; GO:0043235; GO:0043268; GO:0043406; GO:0043410; GO:0043679; GO:0045741; GO:0045955; GO:0046676; GO:0046982; GO:0050892; GO:0050955; GO:0050995; GO:0051044; GO:0051379; GO:0051380; GO:0051926; GO:0061179; GO:0070473; GO:0071875; GO:0071880; GO:0071881; GO:0071882; GO:0090303; GO:0098691; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:1901020; GO:2000300	ASQVKPGDSLPR	14.15999985	0.358996183	0.358996183	0.433105807	1254.439389	0	15.04636	0	0	0	0	0	0	14.58635	0	0	15.83424	16.99987	0	0	16.4909	0	16.30253	0	0	17.37546	0	0	16.89672	14.98721	0	16.60517	15.06428	17.00221	13.68845	14.19795	17.28798	16.51792	15.0258	17.94845	17.07309	16.99037	19.12056	0	14.91888	17.4648	17.70894	16.84048	17.27536	15.97848	17.53421	14.03585	18.21865
P08F94	PKHD1_HUMAN	Fibrocystin (Polycystic kidney and hepatic disease 1 protein) (Polyductin) (Tigmin)	PKHD1 FCYT TIGM1	Homo sapiens (Human)	branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular calcium ion homeostasis [GO:0006874]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; homeostatic process [GO:0042592]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of cell adhesion [GO:0030155]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of centrosome duplication [GO:0010824]; regulation of cholangiocyte proliferation [GO:1904054]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of planar polarity [GO:0090175]; regulation of TOR signaling [GO:0032006]	"9+0 non-motile cilium [GO:0097731]; anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]"	"9+0 non-motile cilium [GO:0097731]; anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor activity [GO:0038023]; branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular calcium ion homeostasis [GO:0006874]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; homeostatic process [GO:0042592]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of cell adhesion [GO:0030155]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of centrosome duplication [GO:0010824]; regulation of cholangiocyte proliferation [GO:1904054]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of planar polarity [GO:0090175]; regulation of TOR signaling [GO:0032006]"	signaling receptor activity [GO:0038023]	GO:0000132; GO:0000775; GO:0001822; GO:0001952; GO:0003382; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005929; GO:0006874; GO:0008284; GO:0010824; GO:0016021; GO:0016324; GO:0022407; GO:0030155; GO:0031362; GO:0032006; GO:0032088; GO:0036064; GO:0038023; GO:0042592; GO:0043066; GO:0045216; GO:0048471; GO:0048754; GO:0050679; GO:0051271; GO:0051660; GO:0051898; GO:0060271; GO:0070062; GO:0070372; GO:0072686; GO:0090175; GO:0097731; GO:0098609; GO:1904036; GO:1904054	GAKPMEEIVTVETVQDTDLYLK	2.230000019	1	1	0.073855388	2495.520905	0	0	13.23922	0	0	0	9.227285	10.38401	11.56867	12.21529	0	12.6981	6.618318	11.68571	12.86072	8.967155	16.51223	0	0	0	0	0	13.89792	13.22414	12.26091	11.75852	0	0	0	0	0	9.569591	0	0	0	0	14.21044	0	0	13.76097	14.7224	0	0	0	14.31635	0	0	0
P09001	RM03_HUMAN	"39S ribosomal protein L3, mitochondrial, L3mt, MRP-L3 (Mitochondrial large ribosomal subunit protein uL3m)"	MRPL3 MRL3 RPML3	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543	MPGKMGNIYR	9.25	1	1	0.355024363	1166.286452	0	16.26962	0	0	0	14.04282	0	0	0	0	16.25641	0	14.56432	0	15.0126	14.71775	0	15.30742	15.78185	17.64939	15.39333	0	0	0	0	15.68699	16.2176	16.86859	15.6488	15.4319	0	16.6765	0	15.82081	0	15.92216	0	17.03138	16.34536	0	15.13944	15.30463	14.08436	16.10613	0	15.05941	17.19808	16.82775
P09012	SNRPA_HUMAN	"U1 small nuclear ribonucleoprotein A, U1 snRNP A, U1-A, U1A"	SNRPA	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA polyadenylation [GO:1900363]"	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	"nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA polyadenylation [GO:1900363]"	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]	GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0005685; GO:0030619; GO:0042802; GO:1900363; GO:1990446	SQETPATKK	2.25	1	1	0.047518219	990.5352494	9.3486	0	12.03723	0	0	0	14.30717	0	14.64036	0	0	12.50598	0	15.5012	0	0	0	13.70678	16.27362	0	16.1505	0	0	0	0	0	0	0	15.82717	14.23847	0	0	0	16.40812	0	14.42794	0	14.66243	0	0	0	15.29799	0	0	0	0	0	15.19557
P09016	HXD4_HUMAN	Homeobox protein Hox-D4 (Homeobox protein HHO.C13) (Homeobox protein Hox-4B) (Homeobox protein Hox-5.1)	HOXD4 HOX4B	Homo sapiens (Human)	anterior/posterior pattern specification [GO:0009952]; embryonic organ development [GO:0048568]; embryonic skeletal system morphogenesis [GO:0048704]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic organ development [GO:0048568]; embryonic skeletal system morphogenesis [GO:0048704]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0030054; GO:0045944; GO:0048568; GO:0048704; GO:1990837	AYSQSDPKQPPSGTALK	4.400000095	1	1	0.475496238	1774.544437	18.17311	0	0	0	0	0	0	0	0	0	0	18.34796	0	0	0	0	0	0	0	0	17.04285	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.62693	0	0	0	0
P09038	FGF2_HUMAN	"Fibroblast growth factor 2, FGF-2 (Basic fibroblast growth factor, bFGF) (Heparin-binding growth factor 2, HBGF-2)"	FGF2 FGFB	Homo sapiens (Human)	"aging [GO:0007568]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; growth factor dependent regulation of skeletal muscle satellite cell proliferation [GO:0014843]; hyaluronan catabolic process [GO:0030214]; inositol phosphate biosynthetic process [GO:0032958]; lung development [GO:0030324]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; nervous system development [GO:0007399]; organ induction [GO:0001759]; paracrine signaling [GO:0038001]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell fate specification [GO:0042660]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903587]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of retinal cell programmed cell death [GO:0046668]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chemoattractant activity [GO:0042056]; chemokine binding [GO:0019956]; cytokine activity [GO:0005125]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; receptor-receptor interaction [GO:0090722]; aging [GO:0007568]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; growth factor dependent regulation of skeletal muscle satellite cell proliferation [GO:0014843]; hyaluronan catabolic process [GO:0030214]; inositol phosphate biosynthetic process [GO:0032958]; lung development [GO:0030324]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; nervous system development [GO:0007399]; organ induction [GO:0001759]; paracrine signaling [GO:0038001]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell fate specification [GO:0042660]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903587]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of retinal cell programmed cell death [GO:0046668]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; wound healing [GO:0042060]"	chemoattractant activity [GO:0042056]; chemokine binding [GO:0019956]; cytokine activity [GO:0005125]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; receptor-receptor interaction [GO:0090722]	GO:0001658; GO:0001759; GO:0001934; GO:0001938; GO:0002042; GO:0005104; GO:0005125; GO:0005178; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006661; GO:0006935; GO:0007165; GO:0007265; GO:0007399; GO:0007568; GO:0008083; GO:0008201; GO:0008284; GO:0008285; GO:0008543; GO:0009792; GO:0009887; GO:0010001; GO:0010595; GO:0010628; GO:0010629; GO:0010764; GO:0010863; GO:0014068; GO:0014843; GO:0019956; GO:0021762; GO:0021940; GO:0030154; GO:0030214; GO:0030324; GO:0030334; GO:0030374; GO:0032958; GO:0038001; GO:0040037; GO:0042056; GO:0042060; GO:0042660; GO:0042802; GO:0043406; GO:0043410; GO:0043536; GO:0043537; GO:0043552; GO:0045669; GO:0045765; GO:0045766; GO:0045893; GO:0045944; GO:0046668; GO:0048598; GO:0048678; GO:0048864; GO:0050679; GO:0051209; GO:0051726; GO:0051781; GO:0051897; GO:0060045; GO:0060128; GO:0060129; GO:0060548; GO:0060591; GO:0060644; GO:0060978; GO:0061045; GO:0070374; GO:0072089; GO:0090049; GO:0090050; GO:0090263; GO:0090722; GO:1902748; GO:1902895; GO:1903587; GO:1903672; GO:1904707; GO:1905278; GO:1905564; GO:2000544; GO:2000546; GO:2000573; GO:2001028	LGSKTGPGQK	8.359999657	1	1	0.383434418	971.4718319	0	0	0	0	0	0	16.84231	0	17.86458	0	10.34019	18.19821	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.95911	0	0	15.43364	0	17.20817	0	0	0	0	17.82903	0	0	0	0	0	0
P09067	HXB5_HUMAN	Homeobox protein Hox-B5 (Homeobox protein HHO.C10) (Homeobox protein Hox-2A) (Homeobox protein Hu-1)	HOXB5 HOX2A	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell differentiation [GO:0045446]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell differentiation [GO:0045446]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0009653; GO:0009952; GO:0045446; GO:0048704; GO:1990837	LHISHDMTGPDGK	19.37000084	1	1	9.21E-13	1408.858656	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53433	0	0	0	15.20779	0	0	14.13648	0	0	15.11364	0	0	0	0	0	16.35922	0	0	0	0	0	0	14.10429
P09086	PO2F2_HUMAN	"POU domain, class 2, transcription factor 2 (Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2) (Octamer-binding protein 2, Oct-2) (Octamer-binding transcription factor 2, OTF-2)"	POU2F2 OCT2 OTF2	Homo sapiens (Human)	cellular response to virus [GO:0098586]; humoral immune response [GO:0006959]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to virus [GO:0098586]; humoral immune response [GO:0006959]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006959; GO:0032755; GO:0043231; GO:0043565; GO:0045944; GO:0098586; GO:1990837	MSKPLEAEK	9.079999924	1	1	0.306192578	1028.409381	14.92116	0	0	0	0	0	16.7963	0	14.94925	0	0	0	0	16.42326	0	0	16.28025	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.79109	0	0	0	0	0	0	0	0	0	0	0	0	19.16542	19.73247	0
P09210	GSTA2_HUMAN	"Glutathione S-transferase A2, EC 2.5.1.18 (GST HA subunit 2) (GST class-alpha member 2) (GST-gamma) (GSTA2-2) (GTH2)"	GSTA2 GST2	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805]	glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005829; GO:0006749; GO:0006805; GO:0030855; GO:0070062	GRMESIR	8.800000191	1	1	0.152586972	865.0028616	16.56969	0	17.88497	15.33759	13.34683	12.8489	14.64876	11.27299	0	14.93951	14.24035	15.86936	0	0	0	14.18151	0	15.84735	15.22431	0	0	0	15.77231	0	15.88633	0	0	0	16.57567	0	0	16.58247	0	0	0	0	0	0	0	0	0	0	15.32334	0	0	16.11586	0	0
P09237	MMP7_HUMAN	"Matrilysin, EC 3.4.24.23 (Matrin) (Matrix metalloproteinase-7, MMP-7) (Pump-1 protease) (Uterine metalloproteinase)"	MMP7 MPSL1 PUMP1	Homo sapiens (Human)	collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of cell migration [GO:0030335]; proteolysis [GO:0006508]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of cell migration [GO:0030335]; proteolysis [GO:0006508]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0006509; GO:0008237; GO:0008270; GO:0022617; GO:0030198; GO:0030335; GO:0030574; GO:0031012; GO:0031293; GO:0070062	EMQKFFGLPITGMLNSR	1.179999948	0.227779597	0.227779597	0.104526325	1984.382228	14.64569	0	15.59896	17.56249	14.71295	0	0	0	0	16.09197	17.21132	0	13.92826	0	17.91444	0	14.66385	16.32856	15.14311	13.20881	0	0	0	15.49303	0	12.73059	17.92797	0	16.08069	0	15.05972	19.40577	0	0	15.40546	15.42063	0	0	17.89423	0	15.72869	0	0	12.77399	15.87382	0	16.33751	13.44327
P09327	VILI_HUMAN	Villin-1	VIL1 VIL	Homo sapiens (Human)	actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex assembly [GO:0065003]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex assembly [GO:0065003]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]"	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]"	GO:0001726; GO:0001951; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0030836; GO:0030855; GO:0032233; GO:0032432; GO:0032433; GO:0032532; GO:0035727; GO:0035729; GO:0040018; GO:0042802; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0065003; GO:0070062; GO:0071364; GO:1902896; GO:1903078; GO:2000392; GO:2000394	LRGMTLAK	2.160000086	0.642530918	0.642530918	0.293685433	905.7840906	0	17.00671	18.13402	0	0	0	16.11362	17.21916	0	0	0	0	0	0	0	16.13462	17.98643	0	0	0	17.43452	16.20716	0	18.0896	17.65751	16.8783	0	0	0	16.4237	17.55909	0	18.52821	0	0	19.48418	0	18.98506	17.39795	16.47015	0	16.26524	0	0	0	17.98466	16.24331	17.01247
P09429	HMGB1_HUMAN	"High mobility group protein B1 (High mobility group protein 1, HMG-1)"	HMGB1 HMG1	Homo sapiens (Human)	"activation of innate immune response [GO:0002218]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell chemotaxis [GO:0002407]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; heterochromatin assembly [GO:0031507]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; neutrophil clearance [GO:0097350]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mismatch repair [GO:0032425]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of restriction endodeoxyribonuclease activity [GO:0032072]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of tolerance induction [GO:0002643]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 1 cell activation [GO:0035711]; T-helper 1 cell differentiation [GO:0045063]; V(D)J recombination [GO:0033151]"	alphav-beta3 integrin-HMGB1 complex [GO:0035868]; cell surface [GO:0009986]; condensed chromosome [GO:0000793]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; transcription repressor complex [GO:0017053]	"alphav-beta3 integrin-HMGB1 complex [GO:0035868]; cell surface [GO:0009986]; condensed chromosome [GO:0000793]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; transcription repressor complex [GO:0017053]; bubble DNA binding [GO:0000405]; C-X-C chemokine binding [GO:0019958]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; DNA polymerase binding [GO:0070182]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; integrin binding [GO:0005178]; lipopolysaccharide binding [GO:0001530]; lyase activity [GO:0016829]; phosphatidylserine binding [GO:0001786]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; activation of innate immune response [GO:0002218]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell chemotaxis [GO:0002407]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; heterochromatin assembly [GO:0031507]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; neutrophil clearance [GO:0097350]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mismatch repair [GO:0032425]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of restriction endodeoxyribonuclease activity [GO:0032072]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of tolerance induction [GO:0002643]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 1 cell activation [GO:0035711]; T-helper 1 cell differentiation [GO:0045063]; V(D)J recombination [GO:0033151]"	"bubble DNA binding [GO:0000405]; C-X-C chemokine binding [GO:0019958]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; DNA polymerase binding [GO:0070182]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; integrin binding [GO:0005178]; lipopolysaccharide binding [GO:0001530]; lyase activity [GO:0016829]; phosphatidylserine binding [GO:0001786]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]"	GO:0000122; GO:0000400; GO:0000405; GO:0000793; GO:0000976; GO:0001530; GO:0001773; GO:0001786; GO:0002218; GO:0002407; GO:0002437; GO:0002643; GO:0002840; GO:0003684; GO:0003690; GO:0003697; GO:0003713; GO:0003714; GO:0003723; GO:0005125; GO:0005178; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005768; GO:0005793; GO:0006265; GO:0006303; GO:0006310; GO:0006357; GO:0006914; GO:0006954; GO:0007204; GO:0008301; GO:0009986; GO:0010508; GO:0016829; GO:0017053; GO:0017055; GO:0019958; GO:0031175; GO:0031507; GO:0032072; GO:0032392; GO:0032425; GO:0032689; GO:0032732; GO:0032733; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0033151; GO:0034165; GO:0034774; GO:0035711; GO:0035868; GO:0042056; GO:0042104; GO:0043065; GO:0043277; GO:0043280; GO:0043371; GO:0043388; GO:0043410; GO:0043536; GO:0043537; GO:0045063; GO:0045087; GO:0045944; GO:0046330; GO:0050786; GO:0051106; GO:0061629; GO:0070182; GO:0070374; GO:0071222; GO:0090026; GO:0097100; GO:0097350; GO:0140297; GO:1904813; GO:1905564; GO:2000343; GO:2000426; GO:2001200	GKPDAAK	1.649999976	1	1	0.300456966	686.9730303	15.86749	14.85247	15.02617	15.42145	0	14.1894	0	14.6064	14.55013	0	0	0	0	15.7461	15.10078	13.43635	15.2683	0	16.52134	15.2159	16.94265	0	0	0	14.38449	0	0	14.64483	15.82803	16.81143	0	15.96709	0	15.67143	16.44983	0	0	15.70094	0	0	15.45874	16.0148	0	15.51797	0	0	16.26378	0
P09467	F16P1_HUMAN	"Fructose-1,6-bisphosphatase 1, FBPase 1, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)"	FBP1 FBP	Homo sapiens (Human)	"cellular response to insulin stimulus [GO:0032869]; cellular response to magnesium ion [GO:0071286]; cellular response to xenobiotic stimulus [GO:0071466]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; cellular response to insulin stimulus [GO:0032869]; cellular response to magnesium ion [GO:0071286]; cellular response to xenobiotic stimulus [GO:0071466]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]"	"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]"	GO:0000122; GO:0005634; GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0032869; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0061629; GO:0070062; GO:0071286; GO:0071466	LDVLSNDLVMNMLK	1.809999943	1	1	0.405242735	1613.531923	17.63447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P09471	GNAO_HUMAN	Guanine nucleotide-binding protein G(o) subunit alpha	GNAO1	Homo sapiens (Human)	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dopamine receptor signaling pathway [GO:0007212]; muscle contraction [GO:0006936]	heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]	heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dopamine receptor signaling pathway [GO:0007212]; muscle contraction [GO:0006936]	corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]	GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0006936; GO:0007188; GO:0007212; GO:0031683; GO:0031821; GO:0031852; GO:0046872; GO:0051430	KDLFGEK	10.52000046	1	1	1.15E-13	837.5391384	0	0	0	0	0	0	0	0	16.181	0	0	0	16.7347	0	0	15.84269	0	0	15.18881	0	0	0	0	0	16.37733	15.68937	0	0	15.2369	14.16814	15.66861	0	13.91184	0	0	0	15.98429	0	0	0	0	16.05459	0	0	0	0	0	15.43685
P09493	TPM1_HUMAN	Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1)	TPM1 C15orf13 TMSA	Homo sapiens (Human)	actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]	GO:0001725; GO:0003065; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005862; GO:0005884; GO:0006936; GO:0006937; GO:0007010; GO:0007015; GO:0008016; GO:0008092; GO:0008307; GO:0008360; GO:0015629; GO:0030017; GO:0030049; GO:0030336; GO:0031529; GO:0032059; GO:0032587; GO:0032781; GO:0034614; GO:0042060; GO:0042802; GO:0042803; GO:0045214; GO:0045785; GO:0046982; GO:0051015; GO:0051496; GO:0055010; GO:0060048; GO:1904706; GO:1904753	LKGTEDELDK	8.789999962	0.790153086	0.790153086	0.177959976	1148.082125	16.37974	0	0	12.8537	0	9.360046	0	0	0	0	0	16.11229	0	0	0	17.90522	0	0	0	0	0	0	15.27178	0	0	0	0	0	0	0	0	0	0	10.61657	15.77902	0	0	0	0	0	0	0	0	0	0	0	0	0
P09543	CN37_HUMAN	"2',3'-cyclic-nucleotide 3'-phosphodiesterase, CNP, CNPase, EC 3.1.4.37"	CNP	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202]	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202]; 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762]"	"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]"	GO:0000226; GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005874; GO:0005886; GO:0005902; GO:0007268; GO:0007409; GO:0007568; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0021762; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0045202; GO:0046902; GO:0048471; GO:0048709; GO:0070062	MVSADAYK	3.950000048	1	1	0.115748652	898.4887253	12.79378	13.97224	0	0	12.98413	0	0	15.17639	15.2388	15.17372	13.4296	15.98039	14.3842	14.43013	12.43311	14.23789	0	0	0	11.63042	0	0	14.64715	0	0	0	0	0	14.27363	0	0	0	0	14.73208	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P09544	WNT2_HUMAN	"Protein Wnt-2 (Int-1-like protein 1) (Int-1-related protein, IRP)"	WNT2 INT1L1 IRP	Homo sapiens (Human)	atrial cardiac muscle tissue morphogenesis [GO:0055009]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; iris morphogenesis [GO:0061072]; labyrinthine layer blood vessel development [GO:0060716]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; lung induction [GO:0060492]; mammary gland epithelium development [GO:0061180]; midbrain dopaminergic neuron differentiation [GO:1904948]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Wnt signalosome [GO:1990909]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Wnt signalosome [GO:1990909]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; iris morphogenesis [GO:0061072]; labyrinthine layer blood vessel development [GO:0060716]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; lung induction [GO:0060492]; mammary gland epithelium development [GO:0061180]; midbrain dopaminergic neuron differentiation [GO:1904948]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	GO:0001938; GO:0002053; GO:0002088; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0007267; GO:0008284; GO:0022008; GO:0030182; GO:0030324; GO:0031232; GO:0033278; GO:0045165; GO:0045944; GO:0048018; GO:0048146; GO:0050769; GO:0051091; GO:0055009; GO:0060045; GO:0060070; GO:0060317; GO:0060492; GO:0060501; GO:0060716; GO:0061072; GO:0061180; GO:0062023; GO:0071300; GO:0071560; GO:1904948; GO:1904954; GO:1990909	MGSAKDSK	8.819999695	1	1	0.246439562	840.8521643	18.11128	17.40507	15.79081	16.56078	16.17252	0	15.79916	0	16.43139	15.28049	16.62985	15.71	15.55726	15.16183	16.92221	15.67787	0	0	13.76663	16.40767	15.95085	19.14819	16.10292	17.15392	15.38897	15.49727	17.9777	16.76294	15.72387	14.03855	17.1468	17.31412	18.74373	16.27663	16.43547	13.34373	19.469	16.5672	15.95292	18.22733	15.13828	15.91086	0	14.71749	0	18.24494	16.37763	0
P09601	HMOX1_HUMAN	"Heme oxygenase 1, HO-1, EC 1.14.14.18 [Cleaved into: Heme oxygenase 1 soluble form ]"	HMOX1 HO HO1	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell death [GO:0008219]; cellular iron ion homeostasis [GO:0006879]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to cisplatin [GO:0072719]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient [GO:0031670]; endothelial cell proliferation [GO:0001935]; erythrocyte homeostasis [GO:0034101]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; iron ion homeostasis [GO:0055072]; liver regeneration [GO:0097421]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of chemokine production [GO:0032722]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; smooth muscle hyperplasia [GO:0014806]; wound healing involved in inflammatory response [GO:0002246]	caveola [GO:0005901]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	caveola [GO:0005901]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospholipase D activity [GO:0004630]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; cell death [GO:0008219]; cellular iron ion homeostasis [GO:0006879]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to cisplatin [GO:0072719]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient [GO:0031670]; endothelial cell proliferation [GO:0001935]; erythrocyte homeostasis [GO:0034101]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; iron ion homeostasis [GO:0055072]; liver regeneration [GO:0097421]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of chemokine production [GO:0032722]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; smooth muscle hyperplasia [GO:0014806]; wound healing involved in inflammatory response [GO:0002246]	enzyme binding [GO:0019899]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospholipase D activity [GO:0004630]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]	GO:0001525; GO:0001935; GO:0002246; GO:0002686; GO:0004392; GO:0004630; GO:0005198; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005741; GO:0005783; GO:0005789; GO:0005829; GO:0005901; GO:0006788; GO:0006879; GO:0006979; GO:0007264; GO:0008217; GO:0008219; GO:0008630; GO:0009410; GO:0010656; GO:0014806; GO:0016020; GO:0016239; GO:0016242; GO:0019899; GO:0020037; GO:0031670; GO:0032722; GO:0032764; GO:0034101; GO:0034383; GO:0034395; GO:0034605; GO:0035094; GO:0035556; GO:0042167; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0043123; GO:0043305; GO:0043392; GO:0043433; GO:0043524; GO:0043619; GO:0043627; GO:0045765; GO:0045766; GO:0046872; GO:0048471; GO:0048661; GO:0048662; GO:0051090; GO:0055072; GO:0071243; GO:0071276; GO:0071456; GO:0072719; GO:0090050; GO:0097421; GO:1902042; GO:1903589; GO:1904036; GO:1904706	VQDSAPVETPR	5.389999866	1	1	0.36254662	1197.395261	0	0	15.0158	0	0	0	16.78496	0	0	0	0	0	16.41691	15.18554	0	0	16.29488	15.59268	0	0	0	0	0	0	0	0	0	0	0	12.76198	0	14.77304	13.20412	16.28426	16.33416	15.81074	12.56987	15.15675	17.43379	17.24405	14.47716	0	0	15.57149	0	0	0	0
P09603	CSF1_HUMAN	"Macrophage colony-stimulating factor 1, CSF-1, M-CSF, MCSF (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1 ]"	CSF1	Homo sapiens (Human)	branching involved in mammary gland duct morphogenesis [GO:0060444]; developmental process involved in reproduction [GO:0003006]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary duct terminal end bud growth [GO:0060763]; mammary gland fat development [GO:0060611]; microglial cell proliferation [GO:0061518]; monocyte activation [GO:0042117]; negative regulation of neuron death [GO:1901215]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage colony-stimulating factor signaling pathway [GO:1902228]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage migration [GO:1905523]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of macrophage derived foam cell differentiation [GO:0010743]; regulation of ossification [GO:0030278]; response to ischemia [GO:0002931]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	CSF1-CSF1R complex [GO:1990682]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	CSF1-CSF1R complex [GO:1990682]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; protein homodimerization activity [GO:0042803]; branching involved in mammary gland duct morphogenesis [GO:0060444]; developmental process involved in reproduction [GO:0003006]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary duct terminal end bud growth [GO:0060763]; mammary gland fat development [GO:0060611]; microglial cell proliferation [GO:0061518]; monocyte activation [GO:0042117]; negative regulation of neuron death [GO:1901215]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage colony-stimulating factor signaling pathway [GO:1902228]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage migration [GO:1905523]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of macrophage derived foam cell differentiation [GO:0010743]; regulation of ossification [GO:0030278]; response to ischemia [GO:0002931]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; protein homodimerization activity [GO:0042803]	GO:0001503; GO:0001954; GO:0002158; GO:0002931; GO:0003006; GO:0005125; GO:0005157; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006954; GO:0007169; GO:0008083; GO:0008284; GO:0010628; GO:0010743; GO:0010744; GO:0010759; GO:0016020; GO:0016021; GO:0016604; GO:0030225; GO:0030278; GO:0030316; GO:0030335; GO:0032270; GO:0032946; GO:0038145; GO:0040018; GO:0042117; GO:0042476; GO:0042488; GO:0042802; GO:0042803; GO:0045087; GO:0045651; GO:0045657; GO:0045672; GO:0045860; GO:0046579; GO:0048471; GO:0048873; GO:0060444; GO:0060611; GO:0060763; GO:0061518; GO:1901215; GO:1902228; GO:1904141; GO:1905523; GO:1990682	DYEEHDK	12.10999966	0.014754312	0.014754312	0.257361704	935.7461167	0	0	0	0	17.15406	0	0	17.97257	0	0	0	0	0	17.49622	0	0	0	0	17.7403	0	16.5191	0	0	0	0	0	0	0	0	0	18.73095	20.73864	17.63024	0	0	0	17.98317	0	0	0	15.97788	16.99909	18.46187	0	17.49471	0	0	17.72022
P09619	PGFRB_HUMAN	"Platelet-derived growth factor receptor beta, PDGF-R-beta, PDGFR-beta, EC 2.7.10.1 (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1, PDGFR-1) (CD antigen CD140b)"	PDGFRB PDGFR PDGFR1	Homo sapiens (Human)	aging [GO:0007568]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in coronary angiogenesis [GO:0060981]; cell migration involved in vasculogenesis [GO:0035441]; glycosaminoglycan biosynthetic process [GO:0006024]; inner ear development [GO:0048839]; lung growth [GO:0060437]; male gonad development [GO:0008584]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerular capillary formation [GO:0072277]; metanephric glomerular mesangial cell proliferation involved in metanephros development [GO:0072262]; metanephric mesenchymal cell migration [GO:0035789]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; smooth muscle cell chemotaxis [GO:0071670]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; phosphatidylinositol 3-kinase binding [GO:0043548]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; platelet-derived growth factor-activated receptor activity [GO:0005017]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; aging [GO:0007568]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in coronary angiogenesis [GO:0060981]; cell migration involved in vasculogenesis [GO:0035441]; glycosaminoglycan biosynthetic process [GO:0006024]; inner ear development [GO:0048839]; lung growth [GO:0060437]; male gonad development [GO:0008584]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerular capillary formation [GO:0072277]; metanephric glomerular mesangial cell proliferation involved in metanephros development [GO:0072262]; metanephric mesenchymal cell migration [GO:0035789]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; smooth muscle cell chemotaxis [GO:0071670]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; phosphatidylinositol 3-kinase binding [GO:0043548]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; platelet-derived growth factor-activated receptor activity [GO:0005017]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]	GO:0001525; GO:0004712; GO:0004713; GO:0004714; GO:0004992; GO:0005017; GO:0005019; GO:0005102; GO:0005161; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005925; GO:0006024; GO:0007165; GO:0007169; GO:0007568; GO:0008284; GO:0008584; GO:0009636; GO:0009986; GO:0010863; GO:0014068; GO:0014911; GO:0016020; GO:0016324; GO:0016477; GO:0018108; GO:0019838; GO:0019899; GO:0019901; GO:0030335; GO:0031226; GO:0031410; GO:0032355; GO:0032516; GO:0032526; GO:0032956; GO:0032967; GO:0033674; GO:0034405; GO:0035025; GO:0035441; GO:0035789; GO:0035791; GO:0035793; GO:0035909; GO:0038085; GO:0038091; GO:0042060; GO:0042542; GO:0043065; GO:0043066; GO:0043202; GO:0043231; GO:0043235; GO:0043406; GO:0043548; GO:0043552; GO:0043627; GO:0045840; GO:0046488; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048661; GO:0048839; GO:0050921; GO:0055003; GO:0055093; GO:0060326; GO:0060437; GO:0060981; GO:0061298; GO:0070374; GO:0071670; GO:0072075; GO:0072262; GO:0072277; GO:0072278; GO:0072284; GO:0090280; GO:2000379; GO:2000491; GO:2000573	GRGMPQPNIIWSACR	5.21999979	1	1	0.429087889	1756.842634	13.44877	15.06414	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.64356	0	18.16613	17.47626	0	0	0	0	16.23944	0	0	0	0	0	0	0	18.56508	0	0	0	0	0	0	0	0	0	0
P09622	DLDH_HUMAN	"Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)"	DLD GCSL LAD PHE3	Homo sapiens (Human)	"acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]"	acrosomal matrix [GO:0043159]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]	"acrosomal matrix [GO:0043159]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]"	dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]	GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0005947; GO:0005967; GO:0006086; GO:0006120; GO:0006508; GO:0007369; GO:0009083; GO:0031514; GO:0042391; GO:0043159; GO:0045252; GO:0045254; GO:0045454; GO:0048240; GO:0050660; GO:0061732; GO:0106077	ADGGTQVIDTK	24.05999947	1	1	0.30346513	1104.637836	19.57624	17.33271	0	0	0	19.50475	18.07731	0	0	18.95667	19.44438	19.7795	19.56167	0	19.54257	18.75904	0	17.92903	19.08048	0	19.5669	0	0	0	0	18.78901	0	17.12132	19.41037	18.57482	20.94604	19.82836	0	19.09669	19.94548	20.59165	19.30623	0	0	0	0	0	19.89441	0	0	0	19.09348	19.48177
P09651	ROA1_HUMAN	"Heterogeneous nuclear ribonucleoprotein A1, hnRNP A1 (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed ]"	HNRNPA1 HNRPA1	Homo sapiens (Human)	"cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA export from nucleus [GO:0006405]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752]; cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA export from nucleus [GO:0006405]"	G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752]	GO:0000381; GO:0000398; GO:0003697; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006405; GO:0016020; GO:0019904; GO:0032211; GO:0032212; GO:0035198; GO:0036002; GO:0042149; GO:0042802; GO:0043484; GO:0051028; GO:0051168; GO:0051170; GO:0061752; GO:0070062; GO:0071013; GO:0098505; GO:1903936; GO:1990904	MSKSESPK	4.489999771	0.702185452	0.702185452	0.271289102	910.8152675	11.8565	15.43684	14.83953	14.18776	14.12428	15.70373	15.89583	13.33111	15.16426	15.73259	15.66809	15.88907	0	11.6786	15.32415	0	0	0	15.66319	0	0	0	0	0	16.95915	0	0	16.1562	0	0	0	17.23914	0	16.19578	0	15.87731	17.18396	0	15.34951	0	0	15.04034	17.19681	17.32941	14.99864	0	0	15.27647
P09874	PARP1_HUMAN	"Poly [ADP-ribose] polymerase 1, PARP-1, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 1, ARTD1) (DNA ADP-ribosyltransferase PARP1, EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1, ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1, EC 2.4.2.-)"	PARP1 ADPRT PPOL	Homo sapiens (Human)	apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]	"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]"	"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000723; GO:0000781; GO:0003677; GO:0003723; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006281; GO:0006302; GO:0006366; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016540; GO:0016604; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032880; GO:0032991; GO:0032993; GO:0033148; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0047485; GO:0050790; GO:0051287; GO:0051901; GO:0060391; GO:0061629; GO:0070212; GO:0070213; GO:0070412; GO:0071294; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170	FYTLIPHDFGMK	8.859999657	1	1	0.166903	1469.605669	0	0	10.21965	0	11.73451	0	0	0	15.23308	0	0	0	13.65963	0	0	0	0	14.52991	14.3972	0	0	0	0	10.41351	0	12.1184	0	0	15.02414	0	0	14.55725	13.82104	0	15.84951	0	14.6642	0	0	0	0	0	0	0	0	10.36276	0	0
P09913	IFIT2_HUMAN	"Interferon-induced protein with tetratricopeptide repeats 2, IFIT-2 (ISG-54 K) (Interferon-induced 54 kDa protein, IFI-54K, P54)"	IFIT2 CIG-42 G10P2 IFI54 ISG54	Homo sapiens (Human)	apoptotic mitochondrial changes [GO:0008637]; cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; RNA binding [GO:0003723]; apoptotic mitochondrial changes [GO:0008637]; cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; response to virus [GO:0009615]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005783; GO:0005829; GO:0008637; GO:0009615; GO:0032091; GO:0035457; GO:0043065; GO:0045087; GO:0051607	ENGMYGKR	7.420000076	1	1	0.187118279	955.0445931	13.16153	0	0	0	0	15.78932	0	0	0	0	0	15.90972	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95672	0	12.08902	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.18625	0
P09914	IFIT1_HUMAN	"Interferon-induced protein with tetratricopeptide repeats 1, IFIT-1 (Interferon-induced 56 kDa protein, IFI-56K, P56)"	IFIT1 G10P1 IFI56 IFNAI1 ISG56	Homo sapiens (Human)	antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to type I interferon [GO:0071357]; defense response to virus [GO:0051607]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of helicase activity [GO:0051097]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; regulation of defense response to virus [GO:0050688]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; RNA binding [GO:0003723]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to type I interferon [GO:0071357]; defense response to virus [GO:0051607]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of helicase activity [GO:0051097]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; regulation of defense response to virus [GO:0050688]; response to virus [GO:0009615]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005829; GO:0009615; GO:0019060; GO:0032091; GO:0043657; GO:0045070; GO:0045071; GO:0050688; GO:0051097; GO:0051607; GO:0071357; GO:0071360; GO:0140374	EATKGQPR	3.839999914	0.331111997	0.331111997	0.271190609	885.7507552	16.90167	14.98061	14.92968	15.42207	15.12253	14.74517	15.65673	15.45669	16.5365	13.15181	16.37129	16.65551	14.01431	15.77649	0	15.03703	0	16.84749	0	15.51873	0	15.63823	0	17.52551	16.25195	16.28203	0	0	0	0	0	0	18.17463	0	18.13413	0	0	0	0	14.9564	15.12824	16.51663	0	0	15.81945	0	0	15.10371
P09923	PPBI_HUMAN	"Intestinal-type alkaline phosphatase, IAP, Intestinal alkaline phosphatase, EC 3.1.3.1"	ALPI	Homo sapiens (Human)	dephosphorylation [GO:0016311]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]; dephosphorylation [GO:0016311]	alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]	GO:0000287; GO:0002020; GO:0004035; GO:0005576; GO:0005886; GO:0008270; GO:0016311; GO:0031225	SVGVVTTTRVQHASPAGTYAHTVNR	1.50999999	1	1	0.554779569	2610.066288	0	0	0	0	0	0	20.45974	19.78831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.04294	0	0	0	0	0	0	0	0	0	0	0	0
P09972	ALDOC_HUMAN	"Fructose-bisphosphate aldolase C, EC 4.1.2.13 (Brain-type aldolase)"	ALDOC ALDC	Homo sapiens (Human)	"epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]"	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]"	cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005576; GO:0005829; GO:0005856; GO:0006000; GO:0006096; GO:0008092; GO:0030388; GO:0030855; GO:0034774; GO:0070062; GO:1904724; GO:1904813	MPHSYPALSAEQKK	2.410000086	1	1	0.288430566	1601.131626	0	15.47696	0	0	0	14.70832	0	0	0	0	0	0	0	0	0	0	0	0	16.57753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0C024	NUDT7_HUMAN	"Peroxisomal coenzyme A diphosphatase NUDT7, EC 3.6.1.- (Nucleoside diphosphate-linked moiety X motif 7, Nudix motif 7)"	NUDT7	Homo sapiens (Human)	acetyl-CoA catabolic process [GO:0046356]; brown fat cell differentiation [GO:0050873]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; nucleoside diphosphate metabolic process [GO:0009132]; propionyl-CoA catabolic process [GO:1902859]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acetyl-CoA hydrolase activity [GO:0003986]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; snoRNA binding [GO:0030515]; acetyl-CoA catabolic process [GO:0046356]; brown fat cell differentiation [GO:0050873]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; nucleoside diphosphate metabolic process [GO:0009132]; propionyl-CoA catabolic process [GO:1902859]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289]	acetyl-CoA hydrolase activity [GO:0003986]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; snoRNA binding [GO:0030515]	GO:0000287; GO:0003986; GO:0005777; GO:0005782; GO:0005829; GO:0009132; GO:0010945; GO:0015938; GO:0030145; GO:0030515; GO:0036114; GO:0044580; GO:0046356; GO:0050873; GO:1901289; GO:1902858; GO:1902859; GO:2001294	APGEVCFPGGKR	1.600000024	1	1	0.191421919	1274.072456	12.6936	15.64714	0	10.97308	14.71528	0	0	0	13.98756	14.96912	0	15.78309	15.31404	14.0347	0	15.53025	0	15.48599	0	0	0	0	0	0	15.6153	0	0	14.21682	15.87095	14.76484	15.22317	14.7313	0	0	14.30376	0	0	0	0	0	0	0	0	0	0	0	0	0
P0C091	FREM3_HUMAN	FRAS1-related extracellular matrix protein 3	FREM3	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell communication [GO:0007154]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154]	metal ion binding [GO:0046872]	GO:0005604; GO:0005615; GO:0007154; GO:0007155; GO:0016021; GO:0046872	GAPALKR	11.15999985	1	1	0.186858435	713.3809636	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.37578	0	0	0	0	0	0	0	0
P0C0S8	H2A1_HUMAN	"Histone H2A type 1, H2A.1 (Histone H2A/ptl)"	H2AC11 H2AFP HIST1H2AG; H2AC13 H2AFC HIST1H2AI; H2AC15 H2AFD HIST1H2AK; H2AC16 H2AFI HIST1H2AL; H2AC17 H2AFN HIST1H2AM	Homo sapiens (Human)		extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein heterodimerization activity [GO:0046982]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0019899; GO:0046982; GO:0070062	AGLQFPVGR	36.04999924	1	1	0.463348219	945.381695	0	17.41966	0	0	18.491	0	18.74252	0	0	18.30534	0	18.86797	17.86744	0	18.29757	0	0	0	0	0	18.21299	19.60389	0	0	0	0	0	0	0	18.45388	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.93262	0	0	0
P0C1S8	WEE2_HUMAN	"Wee1-like protein kinase 2, EC 2.7.10.2 (Wee1-like protein kinase 1B) (Wee1B kinase)"	WEE2 WEE1B	Homo sapiens (Human)	female meiotic nuclear division [GO:0007143]; female pronucleus assembly [GO:0035038]; mitotic cell cycle [GO:0000278]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of phosphorylation [GO:0042327]; regulation of fertilization [GO:0080154]; regulation of meiosis I [GO:0060631]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; female meiotic nuclear division [GO:0007143]; female pronucleus assembly [GO:0035038]; mitotic cell cycle [GO:0000278]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of phosphorylation [GO:0042327]; regulation of fertilization [GO:0080154]; regulation of meiosis I [GO:0060631]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0000278; GO:0000287; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007143; GO:0035038; GO:0042327; GO:0045736; GO:0060631; GO:0080154; GO:1900194	NTVLRPSLGK	7.46999979	1	1	0.175990047	1085.19884	0	0	0	0	0	14.62492	0	0	14.02049	0	0	0	0	15.15766	16.33865	14.84593	11.52949	0	0	0	0	0	0	0	0	14.57786	0	13.21877	14.55247	0	14.24972	12.32601	0	0	13.88294	0	0	0	16.60951	0	0	0	15.5257	0	0	14.47195	13.80282	0
P0C221	CC175_HUMAN	Coiled-coil domain-containing protein 175	CCDC175 C14orf38	Homo sapiens (Human)						ATIDLLEIESMELNK	1.580000043	1	1	0.150506425	1719.029266	0	0	0	16.10718	0	0	0	0	0	0	15.18563	0	13.83174	0	0	0	15.78459	0	0	0	0	15.1729	17.26089	12.87902	18.43405	0	17.30049	0	0	0	14.78529	0	0	0	0	0	0	15.84003	0	0	0	0	0	0	0	16.12207	14.91012	0
P0C2W1	FBSP1_HUMAN	"F-box/SPRY domain-containing protein 1 (F-box only protein 45, hFbxo45)"	FBXO45 FBX45	Homo sapiens (Human)	anterior commissure morphogenesis [GO:0021960]; cellular response to DNA damage stimulus [GO:0006974]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511]	cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202]	cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202]; anterior commissure morphogenesis [GO:0021960]; cellular response to DNA damage stimulus [GO:0006974]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511]		GO:0001764; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0042995; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0098978; GO:0099523; GO:0099524	AFQHAFSTNDCSR	4.710000038	1	1	0.389999126	1541.415147	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97302	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0C2Y1	NBPF7_HUMAN	Putative neuroblastoma breakpoint family member 7	NBPF7P NBPF7	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	VLVHSQERELIQLR	4.670000076	1	1	4.61E-13	1720.24306	0	0	0	0	14.01702	0	14.8651	0	0	0	0	0	0	15.69037	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.00058	0	0	0	0	0	0	0	0	0	16.63533	0	0	0	0	17.93546	0	0
P0C604	OR4A8_HUMAN	Olfactory receptor 4A8 (Olfactory receptor OR11-110)	OR4A8 OR4A8P	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	TYSPEGR	2.529999971	1	1	0.100629659	807.6741176	14.74962	0	12.87721	0	0	0	0	15.79294	0	0	0	0	0	13.66026	0	15.4446	0	15.27471	0	15.91105	0	0	0	0	0	0	0	0	14.32919	16.07009	16.47345	0	16.44117	16.42467	0	16.80563	15.43634	16.90682	0	0	0	0	0	0	0	0	0	17.0955
P0C671	BNIP5_HUMAN	Protein BNIP5	BNIP5 C6orf222	Homo sapiens (Human)						ASEYK	6.980000019	1	1	0.265038332	598.1196782	0	0	0	16.87882	0	16.63546	0	0	16.94353	16.96441	16.80942	0	16.93425	0	15.65654	0	18.48314	0	0	0	0	0	0	0	0	0	0	0	0	17.76198	0	0	0	17.38001	0	0	0	0	0	0	0	0	0	17.4731	0	0	0	0
P0C672	TSN19_HUMAN	"Tetraspanin-19, Tspan-19"	TSPAN19	Homo sapiens (Human)		integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]		GO:0005887	NIIHAEM	5.119999886	1	1	0.252664347	842.3298782	15.84337	0	15.28667	0	0	0	0	0	0	0	15.91928	0	0	0	16.53807	0	15.73392	14.83351	15.91319	15.23492	15.9723	0	16.91844	0	0	15.30401	0	0	14.87653	0	0	14.80518	0	16.28175	0	0	0	0	16.24547	16.81831	15.85889	15.7119	14.14637	15.01105	14.31017	17.4626	18.55535	16.13374
P0C6C1	AN34C_HUMAN	Ankyrin repeat domain-containing protein 34C	ANKRD34C	Homo sapiens (Human)						ADPNIQDK	3.00999999	0.409243137	0.409243137	0.219770763	899.6345457	13.30512	16.55762	14.98302	0	15.72704	14.96614	16.05204	15.35806	0	0	15.65347	14.05164	0	0	0	16.61465	15.12189	15.89116	0	16.00093	16.63487	0	17.16692	17.19618	0	0	16.2854	16.0154	0	15.3643	14.85424	11.47691	13.90589	15.77986	15.70237	17.82258	17.09946	15.02623	16.92043	0	0	14.07082	14.03339	14.6916	0	16.79645	0	15.47895
P0C7A2	F153B_HUMAN	Protein FAM153B	FAM153B	Homo sapiens (Human)						MPGESTVCHRER	2.49000001	1	1	0.169253322	1458.800575	0	16.19148	14.98546	12.3693	15.71625	10.29575	0	0	15.58565	0	0	0	0	15.01707	0	0	0	0	0	0	0	17.17695	16.5822	17.4033	0	15.29119	0	16.43373	14.94688	0	15.82958	0	0	0	0	0	0	0	0	0	0	0	17.57932	0	0	0	0	14.45606
P0C7H9	U17L7_HUMAN	Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 7	USP17L7	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0042981	SKGNNK	1.879999995	1	1	0.029818834	644.5126648	0	0	0	0	0	0	0	0	0	0	0	0	0	16.18665	15.89965	15.37046	0	0	0	0	0	16.67674	0	12.00089	0	0	0	0	16.76549	0	0	0	0	16.72492	0	0	0	0	0	15.57147	16.57284	14.99177	0	0	0	0	0	0
P0C7I6	CC159_HUMAN	Coiled-coil domain-containing protein 159	CCDC159	Homo sapiens (Human)						QGEKEEHK	3.279999971	1	1	8.06E-13	984.8276605	14.57289	11.80863	0	14.11428	15.40299	13.41288	0	14.91389	0	17.11521	16.11016	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0C7P0	CISD3_HUMAN	"CDGSH iron-sulfur domain-containing protein 3, mitochondrial (MitoNEET-related protein 2, Miner2) (Mitochondrial inner NEET protein, MiNT)"	CISD3	Homo sapiens (Human)	protein maturation by [2Fe-2S] cluster transfer [GO:0106034]	mitochondrion [GO:0005739]	"mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]"	GO:0005739; GO:0046872; GO:0051537; GO:0106034	WCVCGR	13.11999989	0.181086332	0.181086332	6.87E-13	840.2883249	0	0	0	0	13.24672	15.01321	0	0	0	0	0	0	0	15.31252	0	16.577	0	0	0	0	0	0	18.32162	0	0	0	0	0	0	16.40018	16.52443	0	19.06909	0	0	18.84277	0	0	0	15.06858	0	0	0	14.74983	0	16.22139	0	17.26058
P0C7P4	UCRIL_HUMAN	Putative cytochrome b-c1 complex subunit Rieske-like protein 1 (Ubiquinol-cytochrome c reductase Rieske iron-sulfur subunit pseudogene 1)	UQCRFS1P1 UQCRFSL1	Homo sapiens (Human)	"mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	mitochondrial respiratory chain complex III [GO:0005750]	"mitochondrial respiratory chain complex III [GO:0005750]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005750; GO:0006122; GO:0008121; GO:0016491; GO:0046872; GO:0051537	SVAAR	1.210000038	1	1	0.19174174	500.7069737	15.58011	15.44761	0	0	15.7005	16.35495	0	0	0	0	0	0	0	0	15.9263	0	0	0	0	15.28144	0	0	0	0	15.297	15.68789	15.0735	0	16.05939	14.69986	13.75244	0	0	16.65298	15.14073	0	0	0	0	0	0	15.97147	17.55193	15.89661	0	14.52251	0	0
P0C7Q2	ARMS2_HUMAN	Age-related maculopathy susceptibility protein 2	ARMS2	Homo sapiens (Human)	retina homeostasis [GO:0001895]	mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]	mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; retina homeostasis [GO:0001895]		GO:0001895; GO:0001917; GO:0005739	ESVLDPGVGGEGASDKQR	5.230000019	1	1	0.363316999	1801.82936	14.13004	14.66356	0	0	0	14.90923	15.30394	0	0	0	0	16.29122	0	0	0	0	0	0	0	17.18525	0	16.64	16.15322	0	16.20161	0	16.42057	0	0	16.52277	14.602	0	15.20755	13.84694	0	0	0	15.75989	0	14.12185	13.93615	0	15.30651	0	0	17.02742	16.4701	0
P0C7T2	OR2T7_HUMAN	Olfactory receptor 2T7 (OST723) (olfactory receptor OR1-44)	OR2T7 OR2T7P	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	CVSSGKVTTF	4.670000076	1	1	0.648059549	1085.429688	0	0	0	0	0	0	0	18.76805	0	0	0	0	20.04783	0	17.57994	0	0	0	0	0	17.68117	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.40075	0	0	0	0	0	0	0	0	0	0
P0C7T5	ATX1L_HUMAN	"Ataxin-1-like (Brother of ataxin-1, Brother of ATXN1)"	ATXN1L BOAT BOAT1	Homo sapiens (Human)	"anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]"	dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000122; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0035176; GO:0048286; GO:0048856; GO:1902035	GVVVAGQSQAGAR	7.539999962	1	1	2.30E-13	1203.31591	14.58762	0	0	13.01017	0	0	0	13.33643	13.00237	0	0	13.87976	0	14.13747	13.7869	0	0	0	0	15.05966	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0C7T7	FMAS1_HUMAN	Putative uncharacterized protein FRMD6-AS1 (FRMD6 antisense RNA 1) (FRMD6 antisense gene protein 1)	FRMD6-AS1 C14orf82	Homo sapiens (Human)						EGGPRR	1.039999962	1	1	0.11506259	670.3329155	0	0	0	14.92046	0	0	0	0	15.00934	16.48685	15.83599	12.29555	0	0	0	0	0	0	0	0	0	0	0	0	0	15.21789	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.66981
P0C7U0	ELFN1_HUMAN	Protein ELFN1 (Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1) (Protein phosphatase 1 regulatory subunit 28)	ELFN1 PPP1R28	Homo sapiens (Human)	synapse organization [GO:0050808]	dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; protein phosphatase inhibitor activity [GO:0004864]; synapse organization [GO:0050808]	protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0005615; GO:0016021; GO:0030425; GO:0031012; GO:0050808; GO:0060076	AFRAEAVGVHK	4.460000038	1	1	0.451596656	1184.829745	0	0	14.67026	11.25935	14.47481	0	0	13.27323	9.825038	16.11889	0	16.27163	13.69925	0	0	0	0	0	0	0	0	15.00702	16.45977	0	0	0	16.3349	13.91689	16.32347	13.25117	15.91329	13.91877	15.43428	0	0	0	0	0	0	0	0	0	0	0	15.57004	0	15.21754	0
P0C7V0	CF217_HUMAN	Putative uncharacterized protein encoded by LINC00271 (AHI1 divergent transcript)	AHI1-DT C6orf217 LINC00271 NCRNA00271	Homo sapiens (Human)						NTRCATR	2.529999971	0.304524481	0.304524481	0.068765479	879.5994955	0	14.40941	13.24576	0	0	13.35676	15.29109	14.99614	16.87249	0	0	0	0	0	15.36673	0	0	13.5162	0	0	15.08335	0	0	0	0	0	0	0	17.31847	16.60616	13.831	0	0	0	18.82142	0	0	0	15.9163	0	0	16.59026	0	0	0	0	0	0
P0C7W0	PRR29_HUMAN	Proline-rich protein 29	PRR29 C17orf72	Homo sapiens (Human)						EDLLELMMLQNAQMHQLLLSR	6.980000019	1	1	1.024478656	2540.902907	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.25383	0	0	19.21467	0	0	0	0	0	0	0	0
P0C854	CECR9_HUMAN	Putative cat eye syndrome critical region protein 9	CECR9	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	QDGSEWVVPRSSASSNVLYH	5.420000076	1	1	1.38E-12	2218.951581	13.15693	0	0	0	18.58247	0	0	14.36571	14.10286	15.15639	15.28786	15.66038	15.4222	14.26388	15.7136	14.99945	13.73338	13.52908	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0C866	F91A2_HUMAN	Putative uncharacterized protein encoded by LINC00869	LINC00869 FAM91A2 KIAA0493	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]		GO:0005802; GO:0006886; GO:0031410; GO:0099041	SLSLSAGHTK	1.74000001	0.292765796	0.292765796	1.37E-12	1001.160374	12.17581	14.80799	12.98686	17.33811	14.53191	15.56809	17.72293	14.64595	0	14.85137	16.57996	0	17.10688	16.35699	16.19584	13.68627	14.25065	16.60774	15.99523	16.40125	12.73181	13.7223	14.30744	15.12393	16.08886	14.43729	16.69177	15.11118	12.46876	15.98747	9.40635	18.1364	12.08184	0	16.39845	15.26265	0	16.60801	15.57702	16.13849	15.62168	15.99886	0	15.11843	16.47754	15.60805	15.66124	14.70902
P0C8F1	PATE4_HUMAN	"Prostate and testis expressed protein 4 (PATE-like protein B, PATE-B)"	PATE4	Homo sapiens (Human)	regulation of neurotransmitter receptor activity [GO:0099601]	acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]	acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; acetylcholine receptor regulator activity [GO:0030548]; regulation of neurotransmitter receptor activity [GO:0099601]	acetylcholine receptor regulator activity [GO:0030548]	GO:0001669; GO:0005615; GO:0030548; GO:0099601	EEESSK	9.220000267	0.449613065	0.449613065	0.238216902	708.3865903	15.68156	18.12598	15.03025	0	17.50941	15.18924	16.58791	16.772	16.59481	16.43119	18.35698	16.48656	16.61497	0	16.92426	17.7779	15.47056	17.4994	15.26483	17.61681	17.06215	19.32522	19.05598	18.75181	16.43262	16.66438	16.76229	16.64561	16.70032	15.94043	16.15301	17.03365	16.12611	17.98556	16.78064	17.20016	16.49127	17.77929	0	18.32938	17.07297	0	17.04025	17.56471	17.25449	17.37453	16.91068	17.37588
P0CAP1	MYZAP_HUMAN	"Myocardial zonula adherens protein (GRINL1A upstream protein, Gup)"	MYZAP MYOZAP	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; I band [GO:0031674]; Z disc [GO:0030018]	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; I band [GO:0031674]; Z disc [GO:0030018]; intracellular signal transduction [GO:0035556]		GO:0005856; GO:0030018; GO:0030054; GO:0031234; GO:0031674; GO:0035556	EMVVYGWSTSQLK	10.10999966	1	1	0.461375777	1527.507355	17.3916	20.35408	13.82983	19.33693	20.32377	17.36205	17.80917	17.39614	0	0	0	17.82645	17.11362	19.80435	0	0	18.53081	0	16.4536	16.54769	0	19.91303	0	0	0	20.22778	0	0	0	0	0	0	0	0	0	0	0	0	0	17.81057	0	0	17.33836	0	0	0	0	0
P0CAP2	GRL1A_HUMAN	DNA-directed RNA polymerase II subunit GRINL1A (DNA-directed RNA polymerase II subunit M) (Glutamate receptor-like protein 1A)	POLR2M GRINL1A	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; maintenance of ER location [GO:0051685]	"neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase II, holoenzyme [GO:0016591]"	"neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase II, holoenzyme [GO:0016591]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; intracellular signal transduction [GO:0035556]; maintenance of ER location [GO:0051685]"	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003899; GO:0005635; GO:0005665; GO:0016591; GO:0035556; GO:0043025; GO:0051685	NLTGLSSGTEK	8.090000153	1	1	0.142763473	1106.151315	16.01606	10.91214	16.89978	12.98303	13.56794	0	8.679336	14.77537	0	0	15.19304	14.37626	17.3342	15.28632	0	0	15.43444	0	16.86435	0	0	0	0	16.7455	18.07649	16.40994	14.63616	0	16.14165	0	0	0	0	20.16621	16.59418	16.38713	0	0	0	0	16.11742	0	0	16.12712	0	0	0	0
P0CB47	UBFL1_HUMAN	Upstream-binding factor 1-like protein 1	UBTFL1 C11orf27	Homo sapiens (Human)	blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; regulation of gene expression [GO:0010468]	DNA binding [GO:0003677]	GO:0001832; GO:0003677; GO:0005634; GO:0005737; GO:0007566; GO:0010468	FGTLKELVLEAK	14.56999969	1	1	0.177247438	1347.748438	0	0	0	0	0	15.85202	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.7554	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0CF97	F200B_HUMAN	Protein FAM200B	FAM200B C4orf53	Homo sapiens (Human)						IANTAAEK	5.579999924	1	1	0.33788144	816.9788342	12.39545	14.37731	11.92198	15.374	14.04204	15.28668	13.94853	0	0	0	0	0	14.17584	12.98058	0	16.00564	12.84466	0	13.96225	15.07178	15.40984	13.54992	14.589	0	0	0	0	0	0	0	0	0	15.88091	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0CG01	GKN3_HUMAN	Gastrokine-3	GKN3P	Homo sapiens (Human)	regulation of cell population proliferation [GO:0042127]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; regulation of cell population proliferation [GO:0042127]		GO:0005615; GO:0042127	MACVLARMDK	1.159999967	1	1	0.075146755	1211.440083	8.862829	0	0	0	0	12.38475	13.04386	0	0	10.88238	0	11.81284	0	11.9989	13.05251	16.16766	0	0	4.028381	13.22343	13.05707	0	0	0	0	14.41197	13.62004	11.43821	11.51381	0	0	15.20184	0	0	7.84605	0	0	0	0	13.48017	0	0	13.8332	19.01495	0	9.30379	0	0
P0CG12	DERPC_HUMAN	Decreased expression in renal and prostate cancer protein	DERPC	Homo sapiens (Human)		extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]		GO:0005654; GO:0070062	MAGPQGLDLAPILR	7.019999981	0.111147925	0.111147925	0.186149951	1467.703525	0	15.06366	15.25686	13.86184	0	0	14.28973	15.75075	0	16.519	0	0	10.9473	14.89244	18.46526	13.93646	0	0	0	15.02297	14.989	16.90113	14.4455	16.48018	18.87838	0	16.02455	15.04595	0	13.3927	0	0	14.9652	14.95722	0	0	13.20827	12.48058	0	14.4834	14.47683	17.47926	16.36967	14.92805	0	16.60204	15.44232	0
P0CG20	PRR35_HUMAN	Proline-rich protein 35 (Uncharacterized protein RJD1)	PRR35 C16orf11	Homo sapiens (Human)						ALGDYAR	4.809999943	0.168047369	0.168047369	0.249232969	762.9305654	0	17.3441	0	0	16.69763	13.09886	0	15.77312	15.61797	16.89459	16.56204	17.53721	0	0	11.83538	0	0	16.81467	0	15.38246	16.95424	14.90647	0	12.10202	15.06213	0	0	15.0482	16.69239	12.84388	0	0	18.26003	17.69112	0	0	0	0	0	15.14646	0	15.6878	15.63257	16.63194	0	0	0	15.98809
P0CG32	ZCC18_HUMAN	Zinc finger CCHC domain-containing protein 18	ZCCHC18	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005634; GO:0046872	RSEPIMER	9.649999619	1	1	0.135605345	1017.879422	15.18922	0	0	0	0	0	15.16713	0	10.92546	0	0	14.56167	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.86433	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0CI00	Z705B_HUMAN	Putative zinc finger protein 705B	ZNF705B	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	NLLSPKPR	11.21000004	1	1	0.27340726	924.4970114	0	0	17.04075	0	18.06013	0	0	0	0	19.41579	0	0	16.08693	17.25107	18.59269	17.84191	0	0	0	16.62413	0	18.57974	0	0	19.62499	18.03377	0	18.32886	17.33243	0	18.8179	19.38634	0	0	19.8633	0	0	19.4786	0	16.11336	18.35978	17.28176	0	16.70928	18.68719	18.17848	18.5438	0
P0CW24	PNM6A_HUMAN	Paraneoplastic antigen-like protein 6A	PNMA6A PNMA6C	Homo sapiens (Human)						GTALQLVHALLAENPAR	5.809999943	1	1	0.266122454	1775.009088	0	15.93815	0	0	0	0	0	0	16.38481	0	0	0	0	15.34263	0	0	0	0	0	0	15.72206	0	0	0	0	17.53311	0	0	0	0	0	0	16.32537	0	0	12.9631	0	0	0	0	0	0	0	16.47404	0	0	0	0
P0CW27	CC166_HUMAN	Coiled-coil domain-containing protein 166	CCDC166	Homo sapiens (Human)						MPSLTASRAGSR	1.320000052	1	1	0.297475919	1247.836121	13.30508	14.35501	0	0	0	0	0	15.69837	0	0	0	0	0	0	0	0	0	0	0	13.86424	0	14.61314	0	15.10332	16.00074	14.88498	15.14073	15.40858	13.92686	14.0967	0	14.90579	14.60922	14.51293	14.46424	16.02172	0	15.8846	15.45098	14.57346	0	15.72536	16.92061	15.69238	15.65458	14.79051	0	15.13219
P0DI83	NARR_HUMAN	"Ras-related protein Rab-34, isoform NARR (Nine amino-acid residue-repeats)"	RAB34 NARR	Homo sapiens (Human)		nucleolus [GO:0005730]	nucleolus [GO:0005730]		GO:0005730	AEGSRPGGAAPVPEEGGR	16.31999969	1	1	0.006518278	1696.956292	20.05135	18.4212	18.78983	19.40816	19.05339	0	17.99776	18.07435	0	18.42195	0	18.11692	18.70895	0	0	0	0	0	0	19.79725	0	0	0	20.15746	18.6717	18.99868	18.14598	18.70505	0	18.28979	0	0	0	18.86081	0	0	19.92434	0	0	18.78527	0	0	19.58912	0	19.07687	18.98369	17.06309	19.06788
P0DJD1	RGPD2_HUMAN	"RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2, RanBP2-like 2, RanBP2L2)"	RGPD2 RANBP2L2 RGP2	Homo sapiens (Human)	NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790]		GO:0005643; GO:0005737; GO:0006607; GO:0050790	YLASVQGSAPSPGKK	13.93000031	1	1	6.99E-13	1488.746354	15.75937	16.6177	0	0	16.34013	0	0	14.57048	17.26053	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.01397	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.11291	0	0	0	0	0	0	0
P0DJI9	SAA2_HUMAN	"Serum amyloid A-2 protein, SAA2 [Cleaved into: Amyloid A2 protein, AA2 ]"	SAA2	Homo sapiens (Human)	acute-phase response [GO:0006953]	extracellular exosome [GO:0070062]; high-density lipoprotein particle [GO:0034364]	extracellular exosome [GO:0070062]; high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953]		GO:0006953; GO:0034364; GO:0070062	GAEDSLADQAANK	4.96999979	0.449551523	0.449551523	0.393784461	1290.754659	12.30267	15.55246	0	11.96686	14.30772	15.3018	8.546587	13.75929	14.90726	13.78848	0	0	0	15.00459	13.25564	0	0	0	16.04377	14.20615	0	15.83501	0	0	0	0	0	15.10311	0	0	0	0	0	0	0	0	15.95638	16.02792	0	0	0	0	16.81336	0	0	0	0	0
P0DKB6	MPC1L_HUMAN	Mitochondrial pyruvate carrier 1-like protein	MPC1L	Homo sapiens (Human)	mitochondrial pyruvate transmembrane transport [GO:0006850]	integral component of mitochondrial inner membrane [GO:0031305]	integral component of mitochondrial inner membrane [GO:0031305]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial pyruvate transmembrane transport [GO:0006850]	pyruvate transmembrane transporter activity [GO:0050833]	GO:0006850; GO:0031305; GO:0050833	ASPEIISGRMTTALILYSAIFMR	4.460000038	1	1	0.271478455	2543.593934	13.81344	0	0	16.75297	18.0325	0	13.4044	0	0	15.43055	16.30692	0	15.61945	0	0	0	0	0	0	0	0	0	0	16.57696	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.09015	0	0	0	0	0
P0DKV0	S31C1_HUMAN	Putative spermatogenesis-associated protein 31C1 (Protein FAM75C1)	SPATA31C1 FAM75C1	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		GO:0007283; GO:0016021; GO:0030154	VEVATLLGEPPMASLR	1.330000043	1	1	0.274556246	1697.831282	13.7702	0	0	0	14.01789	13.97302	0	10.05719	0	0	16.02737	0	0	15.63912	8.774094	0	12.76673	0	15.58955	15.30989	0	0	0	0	15.92492	16.30531	0	15.2185	0	0	0	0	14.05209	0	0	0	0	0	12.9706	0	14.50211	15.9594	0	0	0	15.72836	13.96136	0
P0DM35	M1BL1_HUMAN	Metallothionein 1H-like protein 1	MT1HL1	Homo sapiens (Human)	cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0006882; GO:0010273; GO:0046872; GO:0071276; GO:0071280; GO:0071294	MDPNCSCAAGGSYACAGSCKCK	1.200000048	1	1	0.215517244	2426.80748	0	0	0	0	0	0	15.07719	0	0	0	11.06562	0	0	0	0	0	0	0	0	0	10.49235	0	0	0	0	0	0	0	0	0	15.12648	0	0	0	15.4752	0	17.62856	0	16.77958	0	0	0	0	0	0	0	0	0
P0DMN0	ST1A4_HUMAN	"Sulfotransferase 1A4, ST1A4, EC 2.8.2.1 (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4)"	SULT1A4	Homo sapiens (Human)	catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]	aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005737; GO:0005829; GO:0006584; GO:0008146; GO:0008202; GO:0051923	DTPPPRLIK	9.75	1	1	0.001548151	1034.606884	0	0	0	0	0	18.64858	0	18.54248	17.97042	16.30255	16.73255	17.61779	18.42985	17.1245	18.34531	17.01452	0	0	17.87994	0	0	0	17.75534	0	17.55147	16.70548	0	17.18611	0	17.18661	0	0	18.88863	0	0	19.05886	17.23946	18.38305	0	16.90367	0	18.72902	17.5039	18.94737	16.62933	0	15.21565	0
P0DMU8	CT455_HUMAN	Cancer/testis antigen family 45 member A5 (Cancer/testis antigen 45-5) (Cancer/testis antigen 45A5)	CT45A5 CT45-5	Homo sapiens (Human)	snRNA 3'-end processing [GO:0034472]	integrator complex [GO:0032039]	integrator complex [GO:0032039]; snRNA 3'-end processing [GO:0034472]		GO:0032039; GO:0034472	IFEMLEGVQGPTAVRK	4.429999828	1	1	2.06E-12	1790.51964	0	0	0	0	14.10834	15.08877	15.37792	13.05053	14.09753	0	0	0	14.48819	14.25174	0	0	0	0	0	0	0	0	0	0	0	13.89904	0	0	0	0	0	14.13523	0	0	0	0	0	0	0	0	14.43455	0	12.15428	0	0	0	0	0
P0DMV9	HS71B_HUMAN	"Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2, HSP70-2, HSP70.2)"	HSPA1B HSP72	Homo sapiens (Human)	ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein ubiquitination [GO:0031396]; vesicle-mediated transport [GO:0016192]	aggresome [GO:0016235]; blood microparticle [GO:0072562]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]	aggresome [GO:0016235]; blood microparticle [GO:0072562]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inclusion body [GO:0016234]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; C3HC4-type RING finger domain binding [GO:0055131]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; protein disaggregase activity [GO:0140545]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; virus receptor activity [GO:0001618]; ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein ubiquitination [GO:0031396]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; C3HC4-type RING finger domain binding [GO:0055131]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; misfolded protein binding [GO:0051787]; protein disaggregase activity [GO:0140545]; protein folding chaperone [GO:0044183]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001664; GO:0003723; GO:0005102; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005925; GO:0006402; GO:0008285; GO:0010628; GO:0016192; GO:0016234; GO:0016235; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0031072; GO:0031396; GO:0031397; GO:0031625; GO:0031982; GO:0032436; GO:0032757; GO:0032991; GO:0034599; GO:0034605; GO:0034620; GO:0042026; GO:0042826; GO:0043066; GO:0044183; GO:0045648; GO:0046034; GO:0047485; GO:0048471; GO:0050821; GO:0051082; GO:0051085; GO:0051092; GO:0051787; GO:0055131; GO:0060548; GO:0070062; GO:0070370; GO:0070434; GO:0071383; GO:0072562; GO:0090063; GO:0090084; GO:0140545; GO:1901673; GO:1903265; GO:1904813; GO:1990904; GO:2001240	HWPFQVINDGDKPK	3.00999999	1	1	6.86E-13	1680.673417	0	0	13.20975	12.64302	0	14.35554	12.5472	14.07049	13.61911	11.88844	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53361	0	15.96821	0	0	0	0	0	0	0	0	0	0	0	0	0	14.11978	10.19223	13.27677	0	15.51552	0	0	0
P0DMW4	SIL2A_HUMAN	Small integral membrane protein 10-like protein 2A	SMIM10L2A LINC00086 NCRNA00086	Homo sapiens (Human)						AASAALSAAAAAAALSGLAVRLSR	4.550000191	0.162845567	0.162845567	0.135138793	2140.832217	14.59248	12.99179	0	0	17.56767	14.94202	0	14.12224	14.88673	0	0	0	0	16.85174	0	0	0	0	14.95859	8.7791	14.6345	18.03049	0	16.32117	14.4886	11.1525	0	0	13.80196	0	14.67816	14.08231	12.5505	8.24349	0	15.05046	13.10007	16.65703	12.5237	16.68271	12.0757	0	13.1545	12.23622	13.95005	14.50244	15.91612	12.19668
P0DN81	O13C7_HUMAN	Olfactory receptor 13C7	OR13C7 OR13C7P	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	DPLGADK	3.269999981	1	1	0.165656773	715.996698	0	0	0	13.3063	0	15.30295	0	15.40762	0	0	0	14.19391	0	0	0	0	14.46381	0	16.21472	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0DN87	CGB7_HUMAN	Choriogonadotropin subunit beta 7	CGB7	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	hormone activity [GO:0005179]	GO:0005179; GO:0005615; GO:0005737; GO:0006915; GO:0007165; GO:0007186; GO:0007267; GO:0007292	FQASSSSK	13.88000011	1	1	0.385234881	841.9108789	16.90856	0	16.85785	16.63388	0	0	15.97416	0	0	15.8504	15.2601	0	0	0	0	13.96266	0	15.50801	15.68669	15.75831	0	0	17.47725	0	15.22764	16.37896	0	13.71318	0	16.4173	17.18489	13.5607	16.09953	15.0322	14.82786	14.9816	12.135	14.95942	14.98404	0	16.42831	15.44362	0	13.87997	15.20588	14.84518	0	12.39447
P0DOX7	IGK_HUMAN	Immunoglobulin kappa light chain (Immunoglobulin kappa light chain EU)		Homo sapiens (Human)	adaptive immune response [GO:0002250]	extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]		GO:0002250; GO:0005576; GO:0005886; GO:0019814	MFGQGTK	3.410000086	1	1	0.173296932	785.7800179	0	13.18948	0	0	16.16109	0	0	0	0	0	0	0	15.172	0	0	13.04179	15.73637	15.51354	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42832	14.29941	14.61118	0	0	0	0	16.16158	16.23869	0	12.67364	0	0	0	0
P0DP25	CALM3_HUMAN	Calmodulin-3	CALM3 CALML2 CAM3 CAMC CAMIII	Homo sapiens (Human)	activation of adenylate cyclase activity [GO:0007190]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]	calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]	calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762]	adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; type 3 metabotropic glutamate receptor binding [GO:0031800]	GO:0000086; GO:0000922; GO:0001975; GO:0002027; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0005886; GO:0007186; GO:0007190; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019901; GO:0019904; GO:0021762; GO:0030017; GO:0030234; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0044325; GO:0048306; GO:0050848; GO:0050998; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0090151; GO:0097718; GO:0098901; GO:1900242; GO:1901842; GO:1901844; GO:1902494; GO:1905913; GO:2000300	EAFSLFDKDGDGTITTK	5.809999943	1	1	2.98E-12	1844.021229	15.26172	12.70381	14.02925	15.38403	0	12.28067	13.03384	14.44258	0	0	0	14.36351	13.78874	0	14.84069	14.7163	15.14158	14.13497	0	0	0	0	0	12.89548	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0DP73	D130B_HUMAN	Beta-defensin 130B	DEFB130B	Homo sapiens (Human)	cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]; cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	GO:0005615; GO:0031731; GO:0042056; GO:0042742; GO:0060326	LCSTLDDTIGICNEGK	8.270000458	0.926675737	0.926675737	0.566529154	1795.615719	0	19.10139	0	18.53881	0	0	0	0	17.04012	18.2212	19.59564	0	19.0924	18.01666	19.25077	18.84816	0	19.48734	18.36712	0	0	0	18.89954	0	0	0	0	0	0	17.8916	0	0	0	0	0	21.82573	18.7306	18.80972	0	0	19.09315	0	17.96866	0	19.41335	0	17.23538	0
P0DPA3	SNH28_HUMAN	"Putative uncharacterized protein SNHG28 (Small nucleolar RNA host gene 2) (VSIG8 overlapping transcript protein, VSIG8-OT1)"	SNHG28 C1orf204	Homo sapiens (Human)			RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723	ALPSPDCPGLRTTGEQMQK	5.579999924	0.923909247	0.923909247	1.38E-12	2102.22503	0	13.98836	0	0	0	0	0	0	0	0	0	13.3755	0	0	0	0	0	0	0	15.45814	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.10624	0	0	0	0	0	0	0	14.95383	16.86839	0	0	0
P0DPB3	SCHI1_HUMAN	"Schwannomin-interacting protein 1, SCHIP-1"	SCHIP1	Homo sapiens (Human)	positive regulation of hippo signaling [GO:0035332]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; positive regulation of hippo signaling [GO:0035332]	identical protein binding [GO:0042802]	GO:0005737; GO:0005886; GO:0030054; GO:0035332; GO:0042802	HMAEKMPAK	5.489999771	1	1	0.200667057	1057.609417	15.32109	0	14.74129	16.27336	0	0	0	16.81969	11.37834	0	0	17.32567	19.72366	0	0	0	15.11007	0	0	0	0	0	15.09744	13.27085	0	0	0	0	0	0	13.24032	15.71193	17.42463	16.7531	0	0	19.28724	0	16.81903	0	0	0	0	0	0	0	0	0
P0DPB5	RPC22_HUMAN	"Protein POLR1D, isoform 2"	POLR1D	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005829	GSASYSPPRK	4.21999979	1	1	0.01169742	1049.663896	0	14.72347	6.468819	0	0	16.26482	0	0	0	0	0	14.26921	15.03575	0	0	0	0	0	0	0	0	0	11.84095	14.70548	0	0	0	0	0	0	0	0	14.10971	0	14.38819	0	13.40956	16.12633	0	0	0	0	0	0	0	0	0	15.25804
P0DPD6	ECE2_HUMAN	"Endothelin-converting enzyme 2, ECE-2, EC 3.4.24.71"	ECE2 KIAA0604 UNQ403/PRO740	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]	cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]	cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168]	GO:0000139; GO:0004222; GO:0005886; GO:0007186; GO:0007267; GO:0008168; GO:0016021; GO:0016485; GO:0016486; GO:0030658; GO:0030659; GO:0032259; GO:0046872	MNVALQELGAGSNMVEYK	2.069999933	1	1	0.356082522	1985.858524	0	0	0	14.3694	16.26223	0	0	11.00286	0	0	16.82445	13.76501	13.46429	0	17.79497	12.57204	15.88766	0	15.72964	0	0	0	16.62136	0	0	0	0	0	0	15.6271	0	0	0	0	0	0	0	0	0	0	16.32912	17.97216	0	0	0	0	0	0
P0DPE3	TMDD1_HUMAN	Transmembrane and death domain protein 1	TMDD1 C12orf81	Homo sapiens (Human)	signal transduction [GO:0007165]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; signal transduction [GO:0007165]		GO:0007165; GO:0016021	FLPRPGAAAR	4.369999886	0.322689325	0.322689325	0.129061127	1055.893109	0	0	0	0	0	15.30256	0	0	0	0	0	0	0	0	0	0	11.59114	0	9.250324	0	0	0	0	15.42326	0	0	0	0	14.08242	0	0	11.61483	13.45534	14.24656	0	12.74693	5.027496	15.07117	14.66552	0	0	0	12.39386	0	0	0	0	8.606213
P0DPF3	NBPF9_HUMAN	Neuroblastoma breakpoint family member 9	NBPF9	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	SSAPREMQK	12.68999958	1	1	0.233267472	1032.879834	0	0	0	0	0	0	0	0	0	0	0	0	0	15.23701	0	0	15.54787	14.65973	0	16.83745	11.29825	0	15.74708	15.7253	15.70663	0	17.26308	0	0	0	16.13312	14.19642	0	0	0	0	15.55532	0	0	0	0	0	0	16.69278	0	0	0	0
P0DPQ3	PR20G_HUMAN	Proline-rich protein 20G	PRR20G	Homo sapiens (Human)						REPPAR	6.880000114	1	1	0.162812927	725.2559892	15.64949	0	13.75112	0	15.78115	15.22136	0	0	0	0	0	0	0	0	17.49568	16.18752	16.19193	0	18.28989	0	17.03731	17.2225	16.09268	0	15.97036	15.00042	0	13.92546	15.71882	0	16.91829	15.06011	0	0	15.74984	16.4297	0	0	17.04869	16.57046	14.98185	16.39451	15.96379	15.31203	16.95605	16.34366	16.78957	14.29527
P0DSN7	KVD37_HUMAN	Probable non-functional immunoglobulinn kappa variable 1D-37	IGKV1D-37	Homo sapiens (Human)	adaptive immune response [GO:0002250]	extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]		GO:0002250; GO:0005576; GO:0005886; GO:0019814	QKPGKVPK	3.75	1	1	0.164381923	881.232231	0	0	0	0	0	0	0	0	16.687	14.97608	0	0	0	0	0	0	0	0	0	0	0	0	18.00728	0	0	0	0	15.37356	0	0	0	0	0	0	0	15.9562	18.27211	15.41094	0	15.19586	0	0	0	0	0	0	0	0
P0DSO1	F246C_HUMAN	Protein FAM246C	FAM246C	Homo sapiens (Human)						GQLRAEAASR	6.659999847	0.499104589	0.499104589	0.248300915	1058.439607	15.55681	0	0	14.59793	0	13.71478	0	12.32264	14.48703	15.30716	11.80334	14.94984	0	12.78508	0	14.18088	15.43939	0	12.10209	14.0394	14.24356	0	0	0	0	15.5556	0	0	0	0	0	0	0	0	14.38628	16.04419	0	0	16.70204	0	15.4332	0	0	0	0	0	0	14.41658
P0DTE5	UD2A2_HUMAN	"UDP-glucuronosyltransferase 2A2, UDPGT 2A2, EC 2.4.1.17"	UGT2A2	Homo sapiens (Human)	bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695]	glucuronosyltransferase activity [GO:0015020]	GO:0005789; GO:0008206; GO:0015020; GO:0016021; GO:0052695	FSPASTVER	1.870000005	1	1	0.107372646	990.4151096	15.33216	0	14.60231	12.56605	0	0	11.29432	0	14.28954	16.60367	0	13.9688	0	0	15.51135	14.06189	15.02758	14.4002	0	0	0	0	0	0	16.14558	0	16.41849	0	15.88399	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P0DTE7	AMY1B_HUMAN	"Alpha-amylase 1B, EC 3.2.1.1"	AMY1B AMY1	Homo sapiens (Human)	oligosaccharide metabolic process [GO:0009311]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; oligosaccharide metabolic process [GO:0009311]	alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]	GO:0004556; GO:0005509; GO:0005615; GO:0009311; GO:0031404; GO:0070062	NWGEGWGFMPSDR	7.71999979	1	1	0.355635107	1538.041061	0	0	15.54281	0	0	0	14.3957	0	0	15.66404	14.8937	14.53563	14.25941	0	0	14.08304	0	0	0	0	0	0	0	15.92169	0	0	17.16858	0	0	0	0	0	0	0	18.18133	0	0	0	0	0	0	0	0	16.01749	0	0	17.98441	0
P0DUQ1	PRA15_HUMAN	PRAME family member 15	PRAMEF15	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"		"negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"		GO:0008284; GO:0043066; GO:0045596; GO:0045892	KPVQDCPRMR	6.940000057	0.418085814	0.418085814	0.074209017	1286.664355	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.35344	0	0	0	0	0	0	0	0	0	0	14.64726	0	0	0	0	0	0	0	14.64358	0	0	0	0
P10070	GLI2_HUMAN	Zinc finger protein GLI2 (GLI family zinc finger protein 2) (Tax helper protein)	GLI2 THP	Homo sapiens (Human)	"axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of DNA replication [GO:0045740]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517]"	ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of DNA replication [GO:0045740]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0001501; GO:0001649; GO:0001822; GO:0002076; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006357; GO:0007224; GO:0007389; GO:0007411; GO:0007418; GO:0007442; GO:0007507; GO:0008270; GO:0009913; GO:0009954; GO:0021508; GO:0021513; GO:0021517; GO:0021696; GO:0021775; GO:0021965; GO:0021983; GO:0030324; GO:0030879; GO:0030902; GO:0031069; GO:0033089; GO:0035295; GO:0042475; GO:0043565; GO:0045740; GO:0045893; GO:0045944; GO:0048566; GO:0048589; GO:0048666; GO:0048754; GO:0097542; GO:0097546; GO:0098586; GO:1990837; GO:1990841	LALLDAPER	10.56999969	0.75683713	0.75683713	0.258052125	998.1219187	15.33214	12.61762	0	14.62178	15.6243	0	15.61109	0	0	13.4858	0	13.65572	15.38554	15.83828	14.2228	0	0	11.20903	14.30168	14.46087	16.23199	16.79696	14.07248	16.91779	0	16.21651	0	0	0	15.22734	15.55312	0	15.60871	0	0	14.91889	0	0	16.61166	0	0	0	0	0	15.60252	0	0	0
P10071	GLI3_HUMAN	"Transcriptional activator GLI3 (GLI3 form of 190 kDa, GLI3-190) (GLI3 full-length protein, GLI3FL) [Cleaved into: Transcriptional repressor GLI3R (GLI3 C-terminally truncated form) (GLI3 form of 83 kDa, GLI3-83) ]"	GLI3	Homo sapiens (Human)	"anterior semicircular canal development [GO:0060873]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; axon guidance [GO:0007411]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye morphogenesis [GO:0048593]; cell differentiation involved in kidney development [GO:0061005]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain radial glial cell differentiation [GO:0021861]; frontal suture morphogenesis [GO:0060364]; heart development [GO:0007507]; hindgut morphogenesis [GO:0007442]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; lambdoid suture morphogenesis [GO:0060366]; larynx morphogenesis [GO:0120223]; lateral ganglionic eminence cell proliferation [GO:0022018]; lateral semicircular canal development [GO:0060875]; layer formation in cerebral cortex [GO:0021819]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; lung development [GO:0030324]; mammary gland specification [GO:0060594]; melanocyte differentiation [GO:0030318]; metanephros development [GO:0001656]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative thymic T cell selection [GO:0045060]; nose morphogenesis [GO:0043585]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; optic nerve morphogenesis [GO:0021631]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein processing [GO:0016485]; proximal/distal pattern formation [GO:0009954]; regulation of bone development [GO:1903010]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; sagittal suture morphogenesis [GO:0060367]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; T cell differentiation in thymus [GO:0033077]; thymocyte apoptotic process [GO:0070242]; tongue development [GO:0043586]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]"	axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior semicircular canal development [GO:0060873]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; axon guidance [GO:0007411]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye morphogenesis [GO:0048593]; cell differentiation involved in kidney development [GO:0061005]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain radial glial cell differentiation [GO:0021861]; frontal suture morphogenesis [GO:0060364]; heart development [GO:0007507]; hindgut morphogenesis [GO:0007442]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; lambdoid suture morphogenesis [GO:0060366]; larynx morphogenesis [GO:0120223]; lateral ganglionic eminence cell proliferation [GO:0022018]; lateral semicircular canal development [GO:0060875]; layer formation in cerebral cortex [GO:0021819]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; lung development [GO:0030324]; mammary gland specification [GO:0060594]; melanocyte differentiation [GO:0030318]; metanephros development [GO:0001656]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative thymic T cell selection [GO:0045060]; nose morphogenesis [GO:0043585]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; optic nerve morphogenesis [GO:0021631]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein processing [GO:0016485]; proximal/distal pattern formation [GO:0009954]; regulation of bone development [GO:1903010]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; roof of mouth development [GO:0060021]; sagittal suture morphogenesis [GO:0060367]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; T cell differentiation in thymus [GO:0033077]; thymocyte apoptotic process [GO:0070242]; tongue development [GO:0043586]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]"	"beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001656; GO:0001658; GO:0001701; GO:0002052; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005929; GO:0005930; GO:0006357; GO:0007224; GO:0007411; GO:0007442; GO:0007507; GO:0008013; GO:0008285; GO:0009952; GO:0009954; GO:0016485; GO:0016607; GO:0017053; GO:0021631; GO:0021766; GO:0021775; GO:0021776; GO:0021798; GO:0021819; GO:0021861; GO:0022018; GO:0030318; GO:0030324; GO:0030850; GO:0032332; GO:0033077; GO:0035035; GO:0035108; GO:0036033; GO:0042060; GO:0042307; GO:0042475; GO:0042733; GO:0042826; GO:0043066; GO:0043231; GO:0043585; GO:0043586; GO:0043627; GO:0045060; GO:0045665; GO:0045669; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0046638; GO:0046639; GO:0046872; GO:0048557; GO:0048566; GO:0048589; GO:0048593; GO:0048702; GO:0048709; GO:0060021; GO:0060364; GO:0060366; GO:0060367; GO:0060594; GO:0060831; GO:0060840; GO:0060873; GO:0060875; GO:0061005; GO:0070242; GO:0071625; GO:0090090; GO:0097421; GO:0097542; GO:0097546; GO:0120223; GO:1901620; GO:1903010; GO:1990787; GO:1990788; GO:1990837	GQQEQPEGTTLVK	1.909999967	1	1	2.06E-12	1414.109635	0	0	10.36153	0	0	10.08491	0	0	16.55214	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.33946	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P10072	ZN875_HUMAN	Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1)	ZNF875 HKR1	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	EDNTVVDIGSSPERR	7.050000191	1	1	0.470660131	1672.619769	0	0	13.2587	0	0	0	0	15.17804	0	0	0	0	0	15.47653	0	0	0	0	0	17.82851	0	15.35566	0	0	0	15.61033	0	0	15.83591	15.87619	0	0	0	0	16.23621	0	0	16.99944	0	0	15.53609	0	0	0	0	0	0	15.49683
P10073	ZSC22_HUMAN	Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50)	ZSCAN22 HKR2 ZNF50	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	KMFQSASALEAHQK	3.160000086	0.640619338	0.640619338	0.241632	1575.779598	14.72362	12.7207	0	15.34684	0	0	0	0	13.80054	0	12.08903	15.79119	0	7.55398	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.76074	0	0	0	0	14.82014	0	0	14.18215	0	0	0
P10109	ADX_HUMAN	"Adrenodoxin, mitochondrial (Adrenal ferredoxin) (Ferredoxin-1) (Hepatoredoxin)"	FDX1 ADX	Homo sapiens (Human)	cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cholesterol metabolic process [GO:0008203]; electron transport chain [GO:0022900]; hormone biosynthetic process [GO:0042446]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]; steroid biosynthetic process [GO:0006694]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cholesterol metabolic process [GO:0008203]; electron transport chain [GO:0022900]; hormone biosynthetic process [GO:0042446]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]; steroid biosynthetic process [GO:0006694]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]"	GO:0005506; GO:0005739; GO:0005759; GO:0006694; GO:0008203; GO:0009055; GO:0022900; GO:0042446; GO:0051353; GO:0051537; GO:0071320; GO:0140647; GO:1904322	AGSSGLLRNR	5.360000134	0.164695665	0.164695665	0.2298726	1029.056589	0	16.91575	10.93077	0	0	15.55365	13.98101	12.87724	0	14.76297	0	0	0	0	0	0	15.68779	0	0	0	0	0	0	0	0	18.51207	19.15108	14.33544	16.56397	0	16.332	0	0	0	0	0	0	0	0	0	0	0	0	0	13.85084	0	0	0
P10144	GRAB_HUMAN	"Granzyme B, EC 3.4.21.79 (C11) (CTLA-1) (Cathepsin G-like 1, CTSGL1) (Cytotoxic T-lymphocyte proteinase 2, Lymphocyte protease) (Fragmentin-2) (Granzyme-2) (Human lymphocyte protein, HLP) (SECT) (T-cell serine protease 1-3E)"	GZMB CGL1 CSPB CTLA1 GRB	Homo sapiens (Human)	apoptotic process [GO:0006915]; cytolysis [GO:0019835]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of translation [GO:0017148]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]	cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of translation [GO:0017148]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0001772; GO:0004252; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008236; GO:0016020; GO:0017148; GO:0019835; GO:0042267; GO:0043231; GO:0044194; GO:0051603; GO:0070269; GO:0140507; GO:1900740	ADAGEIIGGHEAKPHSRPYMAYLMIWDQK	8.050000191	0.517922878	0.517922878	4.57E-12	3300.633545	0	13.22796	14.8379	0	0	0	0	13.94656	13.60583	0	0	14.00149	0	14.64634	13.38384	11.65858	0	0	0	12.90576	0	0	16.07871	13.82033	12.32651	8.410801	0	0	0	12.70456	0	14.65195	12.30546	0	12.48487	13.43242	13.2115	0	0	12.52492	13.6485	0	0	10.69638	0	0	0	12.17492
P10153	RNAS2_HUMAN	"Non-secretory ribonuclease, EC 4.6.1.18 (Eosinophil-derived neurotoxin) (RNase UpI-2) (Ribonuclease 2, RNase 2) (Ribonuclease US)"	RNASE2 EDN RNS2	Homo sapiens (Human)	chemotaxis [GO:0006935]; defense response to virus [GO:0051607]; innate immune response in mucosa [GO:0002227]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540]; chemotaxis [GO:0006935]; defense response to virus [GO:0051607]; innate immune response in mucosa [GO:0002227]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501]	lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540]	GO:0002227; GO:0003676; GO:0004522; GO:0004540; GO:0005576; GO:0005615; GO:0006401; GO:0006935; GO:0016829; GO:0035578; GO:0051607; GO:0070062; GO:0090501	YAQTPANMFYIVACDNR	3.880000114	1	1	0.234605825	2049.288164	8.363194	13.86252	0	0	0	14.33193	0	0	0	0	15.94946	14.67395	13.52845	0	0	0	11.39134	0	8.254732	8.483124	12.59438	15.82075	0	0	0	0	13.70902	0	0	0	0	14.49093	0	14.64044	0	0	0	14.71889	0	0	0	0	15.41718	0	0	0	0	0
P10242	MYB_HUMAN	Transcriptional activator Myb (Proto-oncogene c-Myb)	MYB	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; myeloid cell development [GO:0061515]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; myeloid cell development [GO:0061515]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006355; GO:0016363; GO:0045624; GO:0045892; GO:0045893; GO:0045944; GO:0051571; GO:0051574; GO:0061515; GO:0090575; GO:1901533	TPTPFK	14.64999962	1	1	0.273683457	690.5549462	18.03048	0	17.46815	0	18.49309	0	17.37327	0	0	0	0	18.38286	17.80281	0	0	0	18.36928	0	0	0	0	0	0	0	18.20572	18.26897	18.53029	17.00326	0	0	18.99545	0	0	0	0	17.70491	0	18.61192	18.06584	0	17.92964	0	18.49882	15.96307	18.16666	0	0	0
P10243	MYBA_HUMAN	"Myb-related protein A, A-Myb (Myb-like protein 1)"	MYBL1 AMYB	Homo sapiens (Human)	"cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006355; GO:0007141; GO:0007283; GO:0010529; GO:0030154; GO:0045893; GO:0045944; GO:1990511	QENTASGK	15.92000008	1	1	0.081137446	835.2165395	15.97751	0	0	0	16.25133	0	14.42563	0	0	15.40606	13.63755	0	0	0	0	16.63073	15.64165	16.30318	0	0	0	0	0	0	0	0	15.5488	0	0	0	12.16442	15.29943	0	14.25451	15.79997	15.8215	0	17.20592	0	0	0	0	0	0	15.1924	16.22314	0	0
P10253	LYAG_HUMAN	"Lysosomal alpha-glucosidase, EC 3.2.1.20 (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase ]"	GAA	Homo sapiens (Human)	cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]	azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	"azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]"	"alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0000023; GO:0002026; GO:0002086; GO:0003007; GO:0004553; GO:0004558; GO:0005764; GO:0005765; GO:0005886; GO:0005980; GO:0005985; GO:0006006; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0035577; GO:0043181; GO:0043202; GO:0043231; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0070062; GO:0070821; GO:0090599; GO:0101003	QQPMALAVALTK	11.75	1	1	0.200092741	1264.267715	15.14737	0	14.70542	0	0	0	0	15.46019	0	0	0	0	0	0	0	0	0	0	0	0	0	15.65068	0	16.28288	15.73481	0	0	0	13.85904	14.28158	0	15.10553	0	15.63948	0	0	0	15.45325	0	0	0	0	0	0	0	16.59155	15.37377	0
P10321	HLAC_HUMAN	"HLA class I histocompatibility antigen, C alpha chain, HLA-C (HLA-Cw) (Human leukocyte antigen C)"	HLA-C HLAC	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; immune response [GO:0006955]; innate immune response [GO:0045087]"	cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]	"cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; peptide antigen binding [GO:0042605]; TAP binding [GO:0046977]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; immune response [GO:0006955]; innate immune response [GO:0045087]"	peptide antigen binding [GO:0042605]; TAP binding [GO:0046977]	GO:0000139; GO:0002250; GO:0002486; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006955; GO:0009986; GO:0012507; GO:0016020; GO:0030667; GO:0030670; GO:0031901; GO:0042605; GO:0042612; GO:0045087; GO:0046977; GO:0055038; GO:0070062; GO:0071556	MRVMAPR	3.160000086	1	1	0.082344679	875.6111205	0	0	14.62788	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.33767	0	15.50145	0	0	0	0	0	0	0	14.21523	0	0	0	0	0	0	12.63486	14.92926	0	0	0	13.45237	15.40314	15.93518	0	0	0	17.03228	0	0
P10412	H14_HUMAN	Histone H1.4 (Histone H1b) (Histone H1s-4)	H1-4 H1F4 HIST1H1E	Homo sapiens (Human)	chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]	heterochromatin [GO:0000792]; nucleosome [GO:0000786]; nucleus [GO:0005634]	heterochromatin [GO:0000792]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]	chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]	GO:0000122; GO:0000786; GO:0000792; GO:0003690; GO:0003723; GO:0005634; GO:0006334; GO:0016584; GO:0030261; GO:0031490; GO:0031492; GO:0045910; GO:0080182; GO:0098532	KSAGAAK	4.840000153	1	1	0.220315412	633.3263469	15.24625	16.54756	16.69556	15.79005	0	16.02705	0	0	16.38176	0	16.87251	16.74268	14.85834	16.12409	15.58115	16.94337	15.47821	17.22149	18.09488	16.0479	16.90795	16.7135	0	17.09542	0	0	0	15.9386	0	15.99744	0	0	0	17.3011	0	17.72389	0	0	0	0	17.48432	0	17.45057	17.9372	0	0	0	0
P10415	BCL2_HUMAN	Apoptosis regulator Bcl-2	BCL2	Homo sapiens (Human)	"actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; B cell homeostasis [GO:0001782]; B cell lineage commitment [GO:0002326]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; behavioral fear response [GO:0001662]; branching involved in ureteric bud morphogenesis [GO:0001658]; CD8-positive, alpha-beta T cell lineage commitment [GO:0043375]; cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to organic substance [GO:0071310]; cochlear nucleus development [GO:0021747]; defense response to virus [GO:0051607]; digestive tract morphogenesis [GO:0048546]; ear development [GO:0043583]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; gland morphogenesis [GO:0022612]; glomerulus development [GO:0032835]; hair follicle morphogenesis [GO:0031069]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; mesenchymal cell development [GO:0014031]; metanephros development [GO:0001656]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular pH reduction [GO:0032848]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of retinal cell programmed cell death [GO:0046671]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; organ growth [GO:0035265]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pigment granule organization [GO:0048753]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron maturation [GO:0014042]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of smooth muscle cell migration [GO:0014911]; post-embryonic development [GO:0009791]; protein dephosphorylation [GO:0006470]; protein polyubiquitination [GO:0000209]; reactive oxygen species metabolic process [GO:0072593]; regulation of calcium ion transport [GO:0051924]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; regulation of transmembrane transporter activity [GO:0022898]; regulation of viral genome replication [GO:0045069]; release of cytochrome c from mitochondria [GO:0001836]; renal system process [GO:0003014]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]; response to ischemia [GO:0002931]; response to nicotine [GO:0035094]; response to radiation [GO:0009314]; response to toxic substance [GO:0009636]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pore complex [GO:0046930]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pore complex [GO:0046930]; protein-containing complex [GO:0032991]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; channel inhibitor activity [GO:0016248]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; B cell homeostasis [GO:0001782]; B cell lineage commitment [GO:0002326]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; behavioral fear response [GO:0001662]; branching involved in ureteric bud morphogenesis [GO:0001658]; CD8-positive, alpha-beta T cell lineage commitment [GO:0043375]; cell aging [GO:0007569]; cell-cell adhesion [GO:0098609]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to organic substance [GO:0071310]; cochlear nucleus development [GO:0021747]; defense response to virus [GO:0051607]; digestive tract morphogenesis [GO:0048546]; ear development [GO:0043583]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; gland morphogenesis [GO:0022612]; glomerulus development [GO:0032835]; hair follicle morphogenesis [GO:0031069]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; mesenchymal cell development [GO:0014031]; metanephros development [GO:0001656]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular pH reduction [GO:0032848]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of retinal cell programmed cell death [GO:0046671]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; organ growth [GO:0035265]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pigment granule organization [GO:0048753]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron maturation [GO:0014042]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of smooth muscle cell migration [GO:0014911]; post-embryonic development [GO:0009791]; protein dephosphorylation [GO:0006470]; protein polyubiquitination [GO:0000209]; reactive oxygen species metabolic process [GO:0072593]; regulation of calcium ion transport [GO:0051924]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; regulation of transmembrane transporter activity [GO:0022898]; regulation of viral genome replication [GO:0045069]; release of cytochrome c from mitochondria [GO:0001836]; renal system process [GO:0003014]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]; response to ischemia [GO:0002931]; response to nicotine [GO:0035094]; response to radiation [GO:0009314]; response to toxic substance [GO:0009636]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]"	BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; channel inhibitor activity [GO:0016248]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0001503; GO:0001541; GO:0001656; GO:0001658; GO:0001662; GO:0001782; GO:0001836; GO:0001952; GO:0002020; GO:0002320; GO:0002326; GO:0002931; GO:0003014; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005829; GO:0006470; GO:0006582; GO:0006808; GO:0006915; GO:0006959; GO:0006974; GO:0007015; GO:0007409; GO:0007565; GO:0007569; GO:0008284; GO:0008584; GO:0008625; GO:0008630; GO:0008631; GO:0009314; GO:0009410; GO:0009636; GO:0009791; GO:0010039; GO:0010224; GO:0010332; GO:0010468; GO:0010507; GO:0010523; GO:0010559; GO:0014031; GO:0014042; GO:0014911; GO:0015267; GO:0016020; GO:0016248; GO:0018105; GO:0018107; GO:0021747; GO:0022612; GO:0022898; GO:0030279; GO:0030307; GO:0030308; GO:0030318; GO:0030336; GO:0030890; GO:0031069; GO:0031103; GO:0031625; GO:0031647; GO:0031965; GO:0032469; GO:0032835; GO:0032848; GO:0032880; GO:0032991; GO:0033033; GO:0033077; GO:0033138; GO:0033689; GO:0034097; GO:0035094; GO:0035265; GO:0040018; GO:0042100; GO:0042149; GO:0042542; GO:0042802; GO:0042803; GO:0043029; GO:0043066; GO:0043085; GO:0043209; GO:0043375; GO:0043524; GO:0043565; GO:0043583; GO:0045069; GO:0045636; GO:0046671; GO:0046902; GO:0046930; GO:0046982; GO:0048041; GO:0048536; GO:0048538; GO:0048546; GO:0048599; GO:0048743; GO:0048753; GO:0048873; GO:0050853; GO:0051384; GO:0051402; GO:0051434; GO:0051607; GO:0051721; GO:0051881; GO:0051902; GO:0051924; GO:0070059; GO:0071310; GO:0071456; GO:0072593; GO:0097192; GO:0098609; GO:0140297; GO:1902166; GO:2000134; GO:2000378; GO:2000811; GO:2001234; GO:2001240; GO:2001243	RDFAEMSSQLHLTPFTAR	5.869999886	1	1	0.229721573	2123.718471	17.89525	0	18.33822	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.56617	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P10523	ARRS_HUMAN	"S-arrestin (48 kDa protein) (Retinal S-antigen, S-AG) (Rod photoreceptor arrestin)"	SAG	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor internalization [GO:0002031]; rhodopsin mediated signaling pathway [GO:0016056]	cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor internalization [GO:0002031]; rhodopsin mediated signaling pathway [GO:0016056]	G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]	GO:0001664; GO:0001750; GO:0001917; GO:0002031; GO:0002046; GO:0004864; GO:0005829; GO:0007166; GO:0016020; GO:0016056; GO:0051219	KVQHAPLEMGPQPR	10.72000027	1	1	0.196844335	1588.813662	10.56273	16.18105	13.67753	14.86196	15.88075	14.24656	14.68322	15.12994	16.30014	14.79304	13.66053	13.86794	0	0	0	15.98649	0	0	0	0	0	0	15.94539	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P10586	PTPRF_HUMAN	"Receptor-type tyrosine-protein phosphatase F, EC 3.1.3.48 (Leukocyte common antigen related, LAR)"	PTPRF LAR	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121	SAVPFK	6.599999905	1	1	0.036697628	647.5738577	16.24107	13.86199	14.80957	0	0	0	0	0	0	0	0	0	16.55239	0	0	15.04779	0	0	17.32211	18.11	17.98354	15.9275	17.61903	15.87099	16.27713	0	0	0	0	16.12671	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P10588	NR2F6_HUMAN	"Nuclear receptor subfamily 2 group F member 6 (V-erbA-related protein 2, EAR-2)"	NR2F6 EAR2 ERBAL2	Homo sapiens (Human)	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0030154; GO:0043153; GO:0043565; GO:0048666; GO:0048856; GO:0050965; GO:1990837	AGGYPR	8.020000458	1	1	0.102043651	620.9830388	0	0	0	0	0	0	12.00258	0	13.74033	0	14.88325	0	0	0	0	0	0	0	0	0	0	0	13.91802	0	0	14.41531	0	0	0	0	0	14.87461	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88429	16.25425	0
P10636	TAU_HUMAN	"Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau, PHF-tau)"	MAPT MAPTL MTBT1 TAU	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; astrocyte activation [GO:0048143]; axon development [GO:0061564]; axonal transport [GO:0098930]; axonal transport of mitochondrion [GO:0019896]; cell-cell signaling [GO:0007267]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; central nervous system neuron development [GO:0021954]; cytoplasmic microtubule organization [GO:0031122]; generation of neurons [GO:0048699]; internal protein amino acid acetylation [GO:0006475]; intracellular distribution of mitochondria [GO:0048312]; learning or memory [GO:0007611]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of gene expression [GO:0010629]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of tubulin deacetylation [GO:1904428]; neurofibrillary tangle assembly [GO:1902988]; neuron projection development [GO:0031175]; plus-end-directed organelle transport along microtubule [GO:0072386]; positive regulation of axon extension [GO:0045773]; positive regulation of diacylglycerol kinase activity [GO:1905689]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of superoxide anion generation [GO:0032930]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular response to heat [GO:1900034]; regulation of chromosome organization [GO:0033044]; regulation of long-term synaptic depression [GO:1900452]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of mitochondrial fission [GO:0090140]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; rRNA metabolic process [GO:0016072]; stress granule assembly [GO:0034063]; supramolecular fiber organization [GO:0097435]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]	axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; main axon [GO:0044304]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; somatodendritic compartment [GO:0036477]; tubulin complex [GO:0045298]	axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; main axon [GO:0044304]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; somatodendritic compartment [GO:0036477]; tubulin complex [GO:0045298]; actin binding [GO:0003779]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; dynactin binding [GO:0034452]; enzyme binding [GO:0019899]; histone-dependent DNA binding [GO:0099077]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; single-stranded DNA binding [GO:0003697]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; astrocyte activation [GO:0048143]; axon development [GO:0061564]; axonal transport [GO:0098930]; axonal transport of mitochondrion [GO:0019896]; cell-cell signaling [GO:0007267]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; central nervous system neuron development [GO:0021954]; cytoplasmic microtubule organization [GO:0031122]; generation of neurons [GO:0048699]; internal protein amino acid acetylation [GO:0006475]; intracellular distribution of mitochondria [GO:0048312]; learning or memory [GO:0007611]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of gene expression [GO:0010629]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of tubulin deacetylation [GO:1904428]; neurofibrillary tangle assembly [GO:1902988]; neuron projection development [GO:0031175]; plus-end-directed organelle transport along microtubule [GO:0072386]; positive regulation of axon extension [GO:0045773]; positive regulation of diacylglycerol kinase activity [GO:1905689]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of superoxide anion generation [GO:0032930]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular response to heat [GO:1900034]; regulation of chromosome organization [GO:0033044]; regulation of long-term synaptic depression [GO:1900452]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of mitochondrial fission [GO:0090140]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; rRNA metabolic process [GO:0016072]; stress granule assembly [GO:0034063]; supramolecular fiber organization [GO:0097435]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]	actin binding [GO:0003779]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; dynactin binding [GO:0034452]; enzyme binding [GO:0019899]; histone-dependent DNA binding [GO:0099077]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; single-stranded DNA binding [GO:0003697]	GO:0000226; GO:0001774; GO:0003677; GO:0003680; GO:0003690; GO:0003697; GO:0003723; GO:0003779; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0005886; GO:0006475; GO:0006919; GO:0007267; GO:0007416; GO:0007611; GO:0007613; GO:0008017; GO:0010288; GO:0010506; GO:0010629; GO:0010917; GO:0015630; GO:0016072; GO:0016607; GO:0017124; GO:0019896; GO:0019899; GO:0019901; GO:0021954; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030674; GO:0031110; GO:0031113; GO:0031116; GO:0031122; GO:0031175; GO:0032930; GO:0033044; GO:0033673; GO:0034063; GO:0034185; GO:0034399; GO:0034452; GO:0034605; GO:0034614; GO:0035091; GO:0036464; GO:0036477; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043565; GO:0044297; GO:0044304; GO:0045121; GO:0045298; GO:0045773; GO:0046785; GO:0048143; GO:0048167; GO:0048312; GO:0048699; GO:0050808; GO:0050848; GO:0051087; GO:0051258; GO:0051260; GO:0051721; GO:0051879; GO:0061564; GO:0070507; GO:0071813; GO:0072386; GO:0090140; GO:0090258; GO:0097386; GO:0097418; GO:0097435; GO:0098930; GO:0099077; GO:0099609; GO:1900034; GO:1900452; GO:1901216; GO:1902474; GO:1902936; GO:1902988; GO:1903748; GO:1903829; GO:1904115; GO:1904428; GO:1905689; GO:1990000; GO:1990090; GO:1990416; GO:2001020	TGSSGAKEMK	6.880000114	0.443687707	0.443687707	0.237891639	1011.389786	14.69238	0	11.92965	14.83661	17.15506	11.95106	0	15.03528	15.12036	15.69489	16.8289	0	0	15.25263	15.58892	12.87375	15.04848	0	15.16959	17.12617	11.59855	13.53689	14.93554	15.2776	14.34963	14.83583	16.7895	15.281	14.91703	15.40587	0	0	0	14.91766	15.70875	15.24297	0	15.49766	0	0	0	0	15.55617	15.26922	15.36733	0	0	0
P10645	CMGA_HUMAN	"Chromogranin-A, CgA (Pituitary secretory protein I, SP-I) [Cleaved into: Vasostatin-1 (Vasostatin I); Vasostatin-2 (Vasostatin II); EA-92; ES-43; Pancreastatin; SS-18; WA-8; WE-14; LF-19; Catestatin (SL21); AL-11; GV-19; GR-44; ER-37; GE-25; Serpinin-RRG; Serpinin; p-Glu serpinin precursor ]"	CHGA	Homo sapiens (Human)	adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation [GO:0086030]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; mast cell activation [GO:0045576]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron death [GO:1901215]; organelle organization [GO:0006996]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of relaxation of cardiac muscle [GO:1901899]; protein localization to secretory granule [GO:0033366]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026]	chromaffin granule [GO:0042583]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]	chromaffin granule [GO:0042583]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation [GO:0086030]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; mast cell activation [GO:0045576]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron death [GO:1901215]; organelle organization [GO:0006996]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of relaxation of cardiac muscle [GO:1901899]; protein localization to secretory granule [GO:0033366]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026]		GO:0002026; GO:0002551; GO:0005576; GO:0005615; GO:0006996; GO:0008217; GO:0030133; GO:0030141; GO:0031640; GO:0033366; GO:0033604; GO:0042583; GO:0042742; GO:0043303; GO:0045087; GO:0045576; GO:0046676; GO:0048471; GO:0050829; GO:0050830; GO:0050832; GO:0060452; GO:0086030; GO:0098992; GO:1900738; GO:1901215; GO:1901899; GO:2000707	EDSLEAGLPLQVR	8.949999809	1	1	0.174482153	1425.786883	0	13.50196	0	0	0	13.59552	14.02569	14.55906	0	0	0	12.99809	0	0	15.42872	0	0	0	0	0	0	0	0	0	0	0	0	15.59832	0	15.37384	0	15.1531	14.9426	0	0	16.59131	0	0	0	15.37185	0	0	15.2476	14.17586	0	0	0	0
P10721	KIT_HUMAN	"Mast/stem cell growth factor receptor Kit, SCFR, EC 2.7.10.1 (Piebald trait protein, PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)"	KIT SCFR	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cellular response to thyroid hormone stimulus [GO:0097067]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of programmed cell death [GO:0043069]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; protein autophosphorylation [GO:0046777]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; signal transduction [GO:0007165]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual learning [GO:0008542]	acrosomal vesicle [GO:0001669]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	acrosomal vesicle [GO:0001669]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; stem cell factor receptor activity [GO:0005020]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; actin cytoskeleton reorganization [GO:0031532]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cellular response to thyroid hormone stimulus [GO:0097067]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of programmed cell death [GO:0043069]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; protein autophosphorylation [GO:0046777]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; signal transduction [GO:0007165]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual learning [GO:0008542]	ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; stem cell factor receptor activity [GO:0005020]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001541; GO:0001650; GO:0001669; GO:0002020; GO:0002244; GO:0002318; GO:0002320; GO:0002327; GO:0002551; GO:0002732; GO:0004712; GO:0004713; GO:0004714; GO:0005020; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0006687; GO:0006954; GO:0007165; GO:0007169; GO:0007283; GO:0007286; GO:0008284; GO:0008354; GO:0008360; GO:0008542; GO:0008584; GO:0009897; GO:0009898; GO:0010863; GO:0014068; GO:0019221; GO:0019827; GO:0019955; GO:0030032; GO:0030097; GO:0030183; GO:0030217; GO:0030218; GO:0030318; GO:0030335; GO:0031274; GO:0031532; GO:0032765; GO:0033674; GO:0035019; GO:0035162; GO:0035234; GO:0035556; GO:0035701; GO:0035855; GO:0038093; GO:0038109; GO:0038162; GO:0042127; GO:0042169; GO:0042531; GO:0042803; GO:0043069; GO:0043235; GO:0043303; GO:0043406; GO:0043410; GO:0043473; GO:0043552; GO:0043586; GO:0045747; GO:0046427; GO:0046686; GO:0046777; GO:0046872; GO:0048103; GO:0048170; GO:0048565; GO:0048863; GO:0050673; GO:0050910; GO:0051091; GO:0060326; GO:0060374; GO:0070662; GO:0097067; GO:0097324; GO:0097326; GO:0120072; GO:1904251; GO:1904343; GO:1904349; GO:1905065	SDAAMTVAVKMLKPSAHLTER	3.079999924	1	1	0.036374977	2272.20054	0	0	0	0	0	0	13.9047	10.68024	14.28503	0	0	0	0	0	14.16193	0	0	10.45831	0	13.50625	0	13.76937	0	0	0	0	0	0	0	0	0	0	0	14.08573	0	13.94875	14.67274	0	0	15.29637	0	0	0	0	0	0	0	0
P10745	RET3_HUMAN	"Retinol-binding protein 3 (Interphotoreceptor retinoid-binding protein, IRBP) (Interstitial retinol-binding protein)"	RBP3	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]	cone matrix sheath [GO:0090658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]	cone matrix sheath [GO:0090658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; serine-type peptidase activity [GO:0008236]; lipid metabolic process [GO:0006629]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]	retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; serine-type peptidase activity [GO:0008236]	GO:0001523; GO:0005501; GO:0005576; GO:0005615; GO:0006629; GO:0007601; GO:0008236; GO:0016918; GO:0019841; GO:0090658; GO:1903561	KIMHTDAMIIDMR	14.39999962	0.686471403	0.686471403	0.150600535	1590.82805	0	0	0	14.17484	0	14.33222	20.20503	0	14.19518	15.93587	0	15.70272	0	16.49006	13.38234	13.88956	14.40809	12.18203	12.96844	0	10.01305	15.99969	0	17.74608	0	18.06303	16.00557	11.50923	12.73655	0	14.51366	0	17.50455	0	0	15.05573	17.89666	0	17.08878	11.7828	15.2601	0	12.85929	0	0	18.20284	0	13.38031
P10809	CH60_HUMAN	"60 kDa heat shock protein, mitochondrial, EC 5.6.1.7 (60 kDa chaperonin) (Chaperonin 60, CPN60) (Heat shock protein 60, HSP-60, Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)"	HSPD1 HSP60	Homo sapiens (Human)	'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; chaperone-mediated protein complex assembly [GO:0051131]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; chaperone-mediated protein complex assembly [GO:0051131]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001530; GO:0002039; GO:0002755; GO:0002842; GO:0003688; GO:0003697; GO:0003723; GO:0003725; GO:0005524; GO:0005615; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005769; GO:0005829; GO:0005886; GO:0005905; GO:0006457; GO:0006458; GO:0006919; GO:0006986; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0016020; GO:0016853; GO:0016887; GO:0019899; GO:0030135; GO:0030141; GO:0031625; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0032991; GO:0034185; GO:0034186; GO:0034514; GO:0042026; GO:0042100; GO:0042110; GO:0042113; GO:0043032; GO:0043065; GO:0043066; GO:0045041; GO:0046696; GO:0048291; GO:0050821; GO:0050870; GO:0051082; GO:0051087; GO:0051131; GO:0051604; GO:0051702; GO:0070062; GO:0097225	DDAMLLKGK	6.090000153	0.009834972	0.009834972	0.341629543	1005.013348	0	0	0	0	0	0	0	17.35705	0	0	0	0	0	0	0	0	0	0	17.3134	0	0	0	0	0	0	17.67666	18.2158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P10826	RARB_HUMAN	"Retinoic acid receptor beta, RAR-beta (HBV-activated protein) (Nuclear receptor subfamily 1 group B member 2) (RAR-epsilon)"	RARB HAP NR1B2	Homo sapiens (Human)	cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; striatum development [GO:0021756]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; striatum development [GO:0021756]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001657; GO:0002068; GO:0003417; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0008270; GO:0008285; GO:0009755; GO:0021756; GO:0022008; GO:0030154; GO:0032331; GO:0035116; GO:0035264; GO:0043065; GO:0045944; GO:0048048; GO:0048384; GO:0048566; GO:0055012; GO:1990837	VRLDLGLWDK	3.170000076	0.627107143	0.627107143	0.182373517	1213.840421	15.27202	0	0	16.07287	0	16.22838	12.65822	10.60441	14.35428	12.5181	11.5861	0	0	0	0	15.78181	0	0	0	0	0	0	0	0	0	0	0	14.41659	0	0	14.84967	0	14.99545	14.04744	0	0	0	15.17018	0	0	0	0	0	0	0	0	14.76947	0
P10827	THA_HUMAN	"Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (V-erbA-related protein 7, EAR-7) (c-erbA-1) (c-erbA-alpha)"	THRA EAR7 ERBA1 NR1A1 THRA1 THRA2	Homo sapiens (Human)	"cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]"	"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001502; GO:0001503; GO:0002154; GO:0002155; GO:0002157; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007611; GO:0008016; GO:0008050; GO:0008270; GO:0009409; GO:0009755; GO:0017025; GO:0017055; GO:0019904; GO:0030154; GO:0030218; GO:0030878; GO:0031490; GO:0033032; GO:0042789; GO:0044877; GO:0045892; GO:0045925; GO:0045944; GO:0050994; GO:0060509; GO:0070324; GO:0090575; GO:0120162; GO:0140296; GO:2000143	NQCQLCR	12.56999969	0.711189926	0.711189926	0.214891363	977.3954822	17.07461	14.44471	0	0	16.40424	0	10.1133	0	15.64041	15.21933	0	15.51546	16.54435	14.31306	15.76258	0	16.26482	0	15.91899	0	0	16.42828	0	0	15.45592	17.67863	0	0	0	0	16.59686	19.89549	16.22246	17.00443	0	18.41832	0	18.48617	0	0	16.19064	16.43872	12.85008	0	0	14.40895	10.42019	17.00657
P10828	THB_HUMAN	Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta)	THRB ERBA2 NR1A2 THR1	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cellular response to thyroid hormone stimulus [GO:0097067]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of female receptivity [GO:0007621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; sensory perception of sound [GO:0007605]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription, DNA-templated [GO:0006351]; type I pneumocyte differentiation [GO:0060509]"	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid hormone binding [GO:0070324]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to thyroid hormone stimulus [GO:0097067]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of female receptivity [GO:0007621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; sensory perception of sound [GO:0007605]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription, DNA-templated [GO:0006351]; type I pneumocyte differentiation [GO:0060509]"	"chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid hormone binding [GO:0070324]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0002154; GO:0002157; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006351; GO:0007605; GO:0007621; GO:0008016; GO:0008050; GO:0008270; GO:0009755; GO:0016604; GO:0019899; GO:0030154; GO:0031490; GO:0042789; GO:0045944; GO:0046549; GO:0060509; GO:0070324; GO:0090575; GO:0097067; GO:0097474; GO:1990837	LLMKVTDLR	15.77000046	0.449489832	0.449489832	0.280770877	1103.848004	0	0	0	17.16027	0	16.9251	18.36456	17.23164	17.2055	0	19.13664	0	0	0	19.49002	0	0	0	0	0	0	0	21.0932	0	0	0	0	18.08519	0	19.97537	0	0	0	0	0	0	0	0	0	0	16.24501	16.7237	0	0	0	0	0	17.59137
P10911	MCF2_HUMAN	Proto-oncogene DBL (Proto-oncogene MCF-2) [Cleaved into: MCF2-transforming protein; DBL-transforming protein ]	MCF2 DBL	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005737; GO:0005829; GO:0005856; GO:0016020; GO:0016358; GO:0035556; GO:0050771; GO:0051056; GO:1990830	NDITAVTK	3.220000029	1	1	4.60E-13	858.8280096	0	13.07404	13.86194	14.62167	16.07124	0	0	0	0	0	0	0	18.26058	0	0	0	16.12852	0	0	0	0	0	0	0	0	0	0	0	13.64458	0	0	0	0	0	0	0	0	0	14.54294	0	0	0	0	0	0	15.52781	14.91012	0
P10915	HPLN1_HUMAN	"Hyaluronan and proteoglycan link protein 1 (Cartilage-linking protein 1, Cartilage-link protein) (Proteoglycan link protein)"	HAPLN1 CRTL1	Homo sapiens (Human)	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; synapse [GO:0045202]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; synapse [GO:0045202]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	hyaluronic acid binding [GO:0005540]	GO:0001501; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0031012; GO:0045202; GO:0062023	YPISRPRR	9.93999958	1	1	0.304791505	1044.937242	18.64334	0	16.63697	16.45243	0	0	0	0	0	0	18.31953	0	0	16.42987	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.21293	0	0	0
P11021	BIP_HUMAN	"Endoplasmic reticulum chaperone BiP, EC 3.6.4.10 (78 kDa glucose-regulated protein, GRP-78) (Binding-immunoglobulin protein, BiP) (Heat shock protein 70 family protein 5, HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)"	HSPA5 GRP78	Homo sapiens (Human)	"cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026]; regulation of ATF6-mediated unfolded protein response [GO:1903891]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of PERK-mediated unfolded protein response [GO:1903897]; regulation of protein folding in endoplasmic reticulum [GO:0060904]; response to cocaine [GO:0042220]; response to methamphetamine hydrochloride [GO:1904313]; stress response to metal ion [GO:0097501]; substantia nigra development [GO:0021762]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; posttranslational protein targeting to membrane, translocation [GO:0031204]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026]; regulation of ATF6-mediated unfolded protein response [GO:1903891]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of PERK-mediated unfolded protein response [GO:1903897]; regulation of protein folding in endoplasmic reticulum [GO:0060904]; response to cocaine [GO:0042220]; response to methamphetamine hydrochloride [GO:1904313]; stress response to metal ion [GO:0097501]; substantia nigra development [GO:0021762]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001554; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005793; GO:0005829; GO:0005886; GO:0005925; GO:0006983; GO:0009986; GO:0010976; GO:0016020; GO:0016887; GO:0019899; GO:0019904; GO:0021589; GO:0021680; GO:0021762; GO:0030176; GO:0030182; GO:0030335; GO:0030433; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0032991; GO:0034620; GO:0034663; GO:0034975; GO:0035437; GO:0042026; GO:0042149; GO:0042220; GO:0042470; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0045296; GO:0051082; GO:0051085; GO:0051087; GO:0051402; GO:0051787; GO:0060904; GO:0070062; GO:0071236; GO:0071277; GO:0071287; GO:0071320; GO:0071353; GO:0071466; GO:0071480; GO:0097501; GO:1901998; GO:1903891; GO:1903894; GO:1903895; GO:1903897; GO:1904313; GO:1990090; GO:1990440	KLSLVAAMLLLLSAAR	5.730000019	1	1	9.28E-13	1686.035743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.12239	0	0	0	0	0	0	0	0	16.81916	0	16.06645	16.3331	0	0	0	0	0	15.83988	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P11047	LAMC1_HUMAN	"Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma, S-LAM gamma)"	LAMC1 LAMB2	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of cell adhesion [GO:0045785]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; protein complex involved in cell-matrix adhesion [GO:0098637]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of cell adhesion [GO:0045785]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005615; GO:0005788; GO:0007155; GO:0007492; GO:0009887; GO:0009888; GO:0016477; GO:0022617; GO:0031581; GO:0034446; GO:0035633; GO:0043259; GO:0043260; GO:0045785; GO:0050679; GO:0051149; GO:0062023; GO:0065003; GO:0070062; GO:0098637; GO:0110011; GO:2001046	AHEAER	3.00999999	1	1	0.137858233	713.0329171	0	14.84001	0	13.77886	16.19128	16.27399	14.2716	15.18995	14.56038	0	0	0	0	0	0	0	0	14.99385	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P11055	MYH3_HUMAN	"Myosin-3 (Muscle embryonic myosin heavy chain) (Myosin heavy chain 3) (Myosin heavy chain, fast skeletal muscle, embryonic) (SMHCE)"	MYH3	Homo sapiens (Human)	actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; sarcomere [GO:0030017]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]	GO:0000146; GO:0003009; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0007517; GO:0016887; GO:0017018; GO:0030017; GO:0030048; GO:0030049; GO:0030326; GO:0032982; GO:0045214; GO:0046034; GO:0051015; GO:0060325; GO:0070062	ELTYQSEEDR	7.639999866	1	1	0.48749444	1264.258338	15.19526	16.44727	15.41131	15.84095	13.91794	11.97837	15.49345	16.0537	0	0	0	15.62947	13.66276	0	0	0	0	16.78023	16.31054	0	16.03799	0	0	0	16.5417	16.67924	15.99822	0	0	0	0	17.6075	17.03868	16.91685	15.63939	0	0	15.21969	0	15.6982	0	0	0	0	16.39025	0	0	0
P11137	MTAP2_HUMAN	"Microtubule-associated protein 2, MAP-2"	MAP2	Homo sapiens (Human)	central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513]; regulation of protein localization [GO:0032880]	apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]	apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513]; regulation of protein localization [GO:0032880]	calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]	GO:0000226; GO:0001578; GO:0002162; GO:0005198; GO:0005516; GO:0005737; GO:0005829; GO:0005874; GO:0005875; GO:0008017; GO:0016358; GO:0021954; GO:0030425; GO:0030517; GO:0031113; GO:0031115; GO:0031175; GO:0032839; GO:0032880; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0043203; GO:0044294; GO:0044307; GO:0048156; GO:0048813; GO:0097441; GO:0150001; GO:0150002; GO:0150014; GO:1901953; GO:1902513; GO:1902737; GO:1903744; GO:1904527; GO:1990635; GO:1990769	LDTVLEK	6.090000153	0.001556041	0.001556041	0.233387149	817.2305373	0	0	0	0	0	0	0	0	17.42921	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.46464	0	0	0	0	0
P11161	EGR2_HUMAN	"E3 SUMO-protein ligase EGR2, EC 2.3.2.- (AT591) (E3 SUMO-protein transferase ERG2) (Early growth response protein 2, EGR-2) (Zinc finger protein Krox-20)"	EGR2 KROX20	Homo sapiens (Human)	"aorta development [GO:0035904]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cellular response to organic substance [GO:0071310]; facial nerve structural organization [GO:0021612]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein export from nucleus [GO:0006611]; protein sumoylation [GO:0016925]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; rhombomere 3 formation [GO:0021660]; rhombomere 3 structural organization [GO:0021659]; rhombomere 5 formation [GO:0021666]; rhombomere 5 structural organization [GO:0021665]; rhythmic behavior [GO:0007622]; Schwann cell differentiation [GO:0014037]; skeletal muscle cell differentiation [GO:0035914]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; aorta development [GO:0035904]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cellular response to organic substance [GO:0071310]; facial nerve structural organization [GO:0021612]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein export from nucleus [GO:0006611]; protein sumoylation [GO:0016925]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; rhombomere 3 formation [GO:0021660]; rhombomere 3 structural organization [GO:0021659]; rhombomere 5 formation [GO:0021666]; rhombomere 5 structural organization [GO:0021665]; rhythmic behavior [GO:0007622]; Schwann cell differentiation [GO:0014037]; skeletal muscle cell differentiation [GO:0035914]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006611; GO:0007420; GO:0007422; GO:0007611; GO:0007622; GO:0008045; GO:0010467; GO:0014037; GO:0014040; GO:0016925; GO:0021612; GO:0021659; GO:0021660; GO:0021665; GO:0021666; GO:0030278; GO:0031625; GO:0031643; GO:0032868; GO:0035284; GO:0035904; GO:0035914; GO:0042552; GO:0043231; GO:0043565; GO:0045444; GO:0045893; GO:0045944; GO:0046872; GO:0048168; GO:0061629; GO:0061665; GO:0071310; GO:0071837; GO:1990837	DLHGTAGPDR	6.730000019	0.252737969	0.252737969	0.160026494	1033.936872	15.73011	0	14.92754	0	0	17.25937	0	0	0	0	15.71287	9.802708	14.81039	14.66652	15.00866	10.22993	14.87682	0	0	0	16.4267	11.9255	15.82467	16.25351	0	0	15.27756	14.31299	16.81703	16.19746	18.26402	14.91132	15.92558	16.58176	15.12089	16.53764	17.71276	0	0	12.02703	0	0	17.43141	18.41877	0	0	0	15.44092
P11169	GTR3_HUMAN	"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain, GLUT-3)"	SLC2A3 GLUT3	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; monosaccharide transmembrane transport [GO:0015749]; transport across blood-brain barrier [GO:0150104]	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; monosaccharide transmembrane transport [GO:0015749]; transport across blood-brain barrier [GO:0150104]	D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]	GO:0005355; GO:0005536; GO:0005886; GO:0005887; GO:0005975; GO:0015149; GO:0015749; GO:0016020; GO:0016021; GO:0019852; GO:0030667; GO:0033300; GO:0035579; GO:0042995; GO:0043204; GO:0046323; GO:0055056; GO:0070062; GO:0070821; GO:0070837; GO:0098708; GO:0101003; GO:0150104; GO:1904659	DGVMEMNSIEPAKETTTNV	3.700000048	1	1	0.246978007	2065.376088	13.01151	0	0	12.80667	0	13.07349	0	0	0	0	0	15.6089	16.87447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.55647	13.47108	0	0	0	0	0	0	12.18044	0	0	0	0	0	0
P11172	UMPS_HUMAN	"Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]"	UMPS OK/SW-cl.21	Homo sapiens (Human)	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UDP biosynthetic process [GO:0006225]; UMP biosynthetic process [GO:0006222]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UDP biosynthetic process [GO:0006225]; UMP biosynthetic process [GO:0006222]	identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]	GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006222; GO:0006225; GO:0007565; GO:0007595; GO:0019856; GO:0042802; GO:0044205; GO:0071466	GIVSRPR	1	0.054075073	0.054075073	0.246532049	782.1810778	0	16.92255	16.40084	0	15.46223	0	17.86414	0	0	0	0	0	0	0	0	16.34624	0	0	0	15.98597	0	0	17.62747	0	17.2874	0	0	14.79043	0	17.49779	0	16.73873	15.00926	0	0	17.53749	0	0	19.28787	17.57946	15.10535	0	0	0	0	16.92863	16.19176	0
P11182	ODB2_HUMAN	"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial, EC 2.3.1.168 (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2, BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2, BCKAD-E2, BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)"	DBT BCATE2	Homo sapiens (Human)	branched-chain amino acid catabolic process [GO:0009083]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]; branched-chain amino acid catabolic process [GO:0009083]	acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005947; GO:0009083; GO:0015630; GO:0016407; GO:0031405; GO:0031625; GO:0042645; GO:0043754	GEVYK	7.989999771	0.972556949	0.972556949	0.192322481	595.3835589	14.92085	15.63669	16.66295	0	13.32078	15.68603	16.59172	16.26192	15.83875	12.45166	15.61134	16.60718	0	0	16.54383	15.91622	16.20202	16.13547	16.1033	0	15.82971	17.28779	16.43002	17.09546	0	15.74511	16.33559	15.09118	0	15.72139	17.14894	15.33471	15.35115	15.90974	15.87295	16.84446	16.92706	16.74526	17.21644	15.81244	16.33796	0	16.69158	17.33321	0	15.45387	15.47312	16.2258
P11216	PYGB_HUMAN	"Glycogen phosphorylase, brain form, EC 2.4.1.1"	PYGB	Homo sapiens (Human)	glycogen catabolic process [GO:0005980]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0005576; GO:0005737; GO:0005980; GO:0008184; GO:0016020; GO:0030170; GO:0035578; GO:0070062; GO:0102250; GO:0102499	EPDCFK	16.15999985	1	1	0.291129328	796.1421952	0	0	19.8111	0	18.43054	0	0	0	0	0	0	0	0	0	0	0	0	19.18197	0	17.97684	0	0	0	18.74459	0	0	0	0	0	0	0	0	0	0	0	19.87795	0	0	0	0	0	0	0	18.02262	0	0	0	17.18376
P11217	PYGM_HUMAN	"Glycogen phosphorylase, muscle form, EC 2.4.1.1 (Myophosphorylase)"	PYGM	Homo sapiens (Human)	glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]	glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]	GO:0000166; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0008184; GO:0030170; GO:0070062; GO:0102250; GO:0102499	TIAQYAR	7.409999847	0.149041995	0.149041995	0.214648064	823.3853938	13.10915	14.31428	14.91808	14.98698	15.18936	12.51512	0	16.49076	15.69441	18.8748	0	15.51941	0	0	15.64923	0	14.72228	15.38546	15.61407	15.46454	15.55407	16.03312	0	14.81998	17.56336	0	0	0	0	0	0	16.53571	0	0	16.15652	0	16.0864	16.16931	17.02902	17.11577	16.63845	14.19613	0	16.18115	15.5062	0	15.74753	0
P11230	ACHB_HUMAN	Acetylcholine receptor subunit beta	CHRNB1 ACHRB CHRNB	Homo sapiens (Human)	"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202]	"acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0001941; GO:0003009; GO:0004888; GO:0005887; GO:0005892; GO:0006812; GO:0006936; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015267; GO:0015276; GO:0022848; GO:0030594; GO:0031594; GO:0034220; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0055001; GO:0095500; GO:0099060; GO:1904315	AVALLPELR	8.210000038	1	1	2.97E-12	981.6806557	15.09911	0	13.66867	13.87029	14.91388	14.41778	14.11044	14.93327	11.97094	14.89916	12.92299	13.42947	10.91324	13.89743	0	15.30778	14.75651	12.79654	14.51818	15.78069	15.31182	14.97993	0	13.1432	14.95071	0	13.39102	15.68668	15.83855	0	11.53772	0	0	0	0	0	0	13.10785	0	0	11.92752	0	0	0	0	0	0	0
P11233	RALA_HUMAN	"Ras-related protein Ral-A, EC 3.6.5.2"	RALA RAL	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165]	ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]	GO:0001843; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005886; GO:0005925; GO:0006887; GO:0006935; GO:0007049; GO:0007165; GO:0007265; GO:0009986; GO:0017022; GO:0017157; GO:0019003; GO:0030659; GO:0031532; GO:0031625; GO:0031755; GO:0032154; GO:0051117; GO:0051301; GO:0051491; GO:0051665; GO:0070062; GO:0072655; GO:0090141; GO:0090543	ADSYRK	6.920000076	0.647675276	0.647675276	0.279909221	737.9563522	15.96748	15.77202	14.33087	14.1918	16.12496	15.83809	15.95647	15.43218	16.24834	15.85337	15.87706	15.8425	0	14.57468	14.1566	15.36538	15.69923	0	16.31016	16.37434	14.37741	16.04037	15.68632	15.64475	17.26779	0	16.29793	15.85869	0	15.99228	16.79121	0	0	0	0	0	16.6025	16.72609	16.70997	15.6453	16.19624	16.41711	0	0	0	0	16.96443	0
P11245	ARY2_HUMAN	"Arylamine N-acetyltransferase 2, EC 2.3.1.5 (Arylamide acetylase 2) (N-acetyltransferase type 2, NAT-2) (Polymorphic arylamine N-acetyltransferase, PNAT)"	NAT2 AAC2	Homo sapiens (Human)	xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]	cytosol [GO:0005829]; arylamine N-acetyltransferase activity [GO:0004060]; xenobiotic metabolic process [GO:0006805]	arylamine N-acetyltransferase activity [GO:0004060]	GO:0004060; GO:0005829; GO:0006805	NKLDLETLTDILEHQIR	2.069999933	1	1	0.277975627	2051.101224	16.46861	0	12.1619	11.57856	0	15.30961	12.84338	13.99135	15.38735	9.998976	13.39438	15.06442	0	0	11.38823	14.41337	13.94793	0	14.38687	0	14.73603	0	14.62006	0	0	9.839924	0	0	14.29453	0	0	15.81691	0	0	15.61765	0	16.43528	0	0	11.18439	0	12.27753	0	0	0	0	0	0
P11274	BCR_HUMAN	"Breakpoint cluster region protein, EC 2.7.11.1 (Renal carcinoma antigen NY-REN-26)"	BCR BCR1 D22S11	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; positive regulation of phagocytosis [GO:0050766]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]	axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]	axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; positive regulation of phagocytosis [GO:0050766]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]	ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0002692; GO:0003014; GO:0004674; GO:0004712; GO:0004713; GO:0005085; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007264; GO:0007420; GO:0014069; GO:0016020; GO:0030036; GO:0030216; GO:0030424; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043314; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051056; GO:0051171; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0070062; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0106310; GO:2000378	DVSVMMSEMDVNAIAGTLKLYFR	3.269999981	1	1	0.309395399	2606.203847	0	0	14.35771	0	0	0	15.01021	14.65801	12.03475	0	15.85489	0	0	0	0	0	0	0	0	0	0	0	0	14.06444	13.82347	0	15.56658	0	0	0	0	0	0	0	0	0	0	0	0	0	14.32343	14.73877	0	0	0	0	0	0
P11277	SPTB1_HUMAN	"Spectrin beta chain, erythrocytic (Beta-I spectrin)"	SPTB SPTB1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200]	GO:0003779; GO:0005200; GO:0005829; GO:0005886; GO:0008091; GO:0009986; GO:0014731; GO:0015629; GO:0030036; GO:0030054; GO:0030506; GO:0030864; GO:0031235; GO:0032991; GO:0042995; GO:0051015; GO:0051693	AITAATLKFTEGK	1.269999981	1	1	0.284219286	1351.203123	0	0	0	0	11.72699	13.25926	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P11308	ERG_HUMAN	Transcriptional regulator ERG (Transforming protein ERG)	ERG	Homo sapiens (Human)	cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0007165; GO:0030154; GO:0045944; GO:1990837; GO:1990904	HMPPPNMTTNER	10.93999958	3.37E-07	3.37E-07	0.337970874	1440.040951	0	0	17.60086	0	0	0	0	19.1796	21.38416	0	0	0	17.4972	0	0	0	0	19.70896	0	0	0	0	0	0	22.02108	21.49721	21.9451	17.35588	0	0	22.90838	22.95225	21.6214	0	0	0	22.96769	21.46051	22.39134	0	0	18.2606	0	20.88869	19.78422	0	19.49252	0
P11362	FGFR1_HUMAN	"Fibroblast growth factor receptor 1, FGFR-1, EC 2.7.10.1 (Basic fibroblast growth factor receptor 1, BFGFR, bFGF-R-1) (Fms-like tyrosine kinase 2, FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)"	FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR	Homo sapiens (Human)	cell migration [GO:0016477]; chordate embryonic development [GO:0043009]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; chordate embryonic development [GO:0043009]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000165; GO:0001501; GO:0001764; GO:0001837; GO:0004712; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0010518; GO:0010863; GO:0014068; GO:0016021; GO:0016477; GO:0017134; GO:0018108; GO:0031410; GO:0033674; GO:0042802; GO:0042803; GO:0043009; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0045595; GO:0045597; GO:0045666; GO:0046777; GO:0048015; GO:0048705; GO:0051897; GO:0090722; GO:1905564; GO:2000546; GO:2001239	DKPNR	9.199999809	0.621665418	0.621665418	0.218972654	631.3270017	13.98625	15.61786	0	14.48509	0	16.62454	0	0	15.32977	0	0	0	15.81591	0	15.80679	15.72741	16.73527	16.22479	0	0	0	16.29915	0	0	16.10204	0	16.58012	14.81885	15.40769	15.83031	16.83684	15.68534	14.18248	16.40389	16.93172	16.31598	16.66043	18.02356	16.66933	15.4988	18.07601	15.32713	17.2925	16.30086	17.2327	13.81609	0	17.8527
P11388	TOP2A_HUMAN	"DNA topoisomerase 2-alpha, EC 5.6.2.2 (DNA topoisomerase II, alpha isozyme)"	TOP2A TOP2	Homo sapiens (Human)	apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]"	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]"	"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]"	GO:0000287; GO:0000712; GO:0000775; GO:0000793; GO:0000819; GO:0002244; GO:0003677; GO:0003682; GO:0003723; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008301; GO:0009330; GO:0019899; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904	AAIGCGIVESILNWVKFK	8.449999809	1	1	0.248406864	2005.204212	0	14.15415	13.35091	13.57519	16.47119	0	0	0	0	0	0	0	13.55696	15.51669	16.0561	0	0	10.86837	0	0	14.26175	0	0	0	0	0	0	0	0	14.10726	14.37146	0	14.44249	0	0	14.78976	0	16.29907	0	14.92888	0	0	12.42718	0	0	0	0	0
P11413	G6PD_HUMAN	"Glucose-6-phosphate 1-dehydrogenase, G6PD, EC 1.1.1.49"	G6PD	Homo sapiens (Human)	"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]	"centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]"	glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]	GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006629; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0016020; GO:0019322; GO:0021762; GO:0032094; GO:0034451; GO:0034599; GO:0042802; GO:0042803; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378	LTVADIRK	11.85999966	0.535161793	0.535161793	0.118729823	915.5158789	0	14.0944	16.50196	15.71415	0	11.9778	14.54687	15.92382	18.59821	13.54247	16.76991	17.17195	17.17749	16.66122	17.19865	17.90286	0	0	0	19.18016	0	16.21053	17.17734	17.15451	15.86817	16.06625	15.14259	0	14.74226	15.74314	0	0	15.33102	15.70263	14.54554	0	0	14.76875	18.10202	14.79103	15.70347	0	16.14378	14.75576	18.26336	13.98821	13.51903	17.9071
P11473	VDR_HUMAN	"Vitamin D3 receptor, VDR (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)"	VDR NR1I1	Homo sapiens (Human)	"bile acid signaling pathway [GO:0038183]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular calcium ion homeostasis [GO:0006874]; decidualization [GO:0046697]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; mammary gland branching involved in pregnancy [GO:0060745]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of calcidiol 1-monooxygenase activity [GO:0060558]; skeletal system development [GO:0001501]; vitamin D receptor signaling pathway [GO:0070561]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; lithocholic acid receptor activity [GO:0038186]; nuclear receptor activity [GO:0004879]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; bile acid signaling pathway [GO:0038183]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular calcium ion homeostasis [GO:0006874]; decidualization [GO:0046697]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; mammary gland branching involved in pregnancy [GO:0060745]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of calcidiol 1-monooxygenase activity [GO:0060558]; skeletal system development [GO:0001501]; vitamin D receptor signaling pathway [GO:0070561]"	"calcitriol binding [GO:1902098]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; lithocholic acid receptor activity [GO:0038186]; nuclear receptor activity [GO:0004879]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0001501; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006816; GO:0006874; GO:0007595; GO:0008270; GO:0008285; GO:0010628; GO:0010839; GO:0010980; GO:0030154; GO:0030501; GO:0038183; GO:0038186; GO:0042789; GO:0043235; GO:0045618; GO:0045892; GO:0045944; GO:0046697; GO:0046965; GO:0050892; GO:0060058; GO:0060558; GO:0060745; GO:0070561; GO:0070564; GO:0090575; GO:1902098; GO:1902121	CLSFQPECSMK	3.430000067	1	1	0.183770812	1387.187735	15.02774	16.35719	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.52317	0	0	0	0	0	0	0	0	0	0	0
P11474	ERR1_HUMAN	"Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha, ERR-alpha) (Nuclear receptor subfamily 3 group B member 1)"	ESRRA ERR1 ESRL1 NR3B1	Homo sapiens (Human)	"cartilage development [GO:0051216]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of ossification [GO:0030278]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; cartilage development [GO:0051216]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of ossification [GO:0030278]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0001650; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008270; GO:0015630; GO:0019904; GO:0030278; GO:0032355; GO:0042127; GO:0043565; GO:0045171; GO:0045667; GO:0045670; GO:0045944; GO:0051216; GO:1900078; GO:1990837	AGPGGGAERR	9.25	0.128983974	0.128983974	0.29234978	927.3456145	16.5508	15.86547	15.90308	10.47604	17.27906	0	0	14.50269	15.64522	14.89608	16.26871	16.13998	0	15.06501	0	16.15571	15.69042	0	0	0	15.4243	0	0	0	17.18322	16.10345	15.98953	15.41811	16.14272	0	15.40796	16.84768	16.4742	16.48138	0	0	15.55883	17.27056	0	17.20229	0	15.9351	0	15.12521	17.00891	0	0	16.46237
P11488	GNAT1_HUMAN	Guanine nucleotide-binding protein G(t) subunit alpha-1 (Transducin alpha-1 chain)	GNAT1 GNATR	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell population proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; phototransduction, visible light [GO:0007603]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; response to light intensity [GO:0009642]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of umami taste [GO:0050917]; signal transduction [GO:0007165]; visual perception [GO:0007601]"	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; acyl binding [GO:0000035]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell population proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; phototransduction, visible light [GO:0007603]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; response to light intensity [GO:0009642]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of umami taste [GO:0050917]; signal transduction [GO:0007165]; visual perception [GO:0007601]"	acyl binding [GO:0000035]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]	GO:0000035; GO:0001580; GO:0001664; GO:0001750; GO:0001917; GO:0001973; GO:0003924; GO:0005525; GO:0005829; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0007193; GO:0007601; GO:0007603; GO:0008283; GO:0009416; GO:0009642; GO:0016020; GO:0016056; GO:0016324; GO:0019003; GO:0019901; GO:0022400; GO:0031683; GO:0032391; GO:0042462; GO:0042622; GO:0043025; GO:0046872; GO:0050908; GO:0050917; GO:0051343; GO:0051344; GO:0060041; GO:0071257; GO:0097381	EMSDIIQR	6.090000153	0.68122828	0.68122828	0.25226666	1008.327007	0	17.41539	15.79281	0	19.05868	0	16.90337	0	17.42524	0	0	0	0	0	0	17.09541	0	16.97859	16.03306	0	15.85802	17.02267	0	0	17.66945	0	0	0	15.87818	0	0	19.39615	0	18.68954	0	18.48934	17.22458	0	19.13522	17.42023	17.43861	16.7124	0	16.69802	17.42027	0	17.60952	0
P11498	PYC_HUMAN	"Pyruvate carboxylase, mitochondrial, EC 6.4.1.1 (Pyruvic carboxylase, PCB)"	PC	Homo sapiens (Human)	gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074]	ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]	GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0006629; GO:0009374; GO:0010629; GO:0019074; GO:0019076; GO:0042802; GO:0044794; GO:0046872	DVKGQIGAPMPGK	5.659999847	0.607494593	0.607494593	0.388723938	1313.351818	0	15.38992	0	0	17.07096	0	0	0	0	0	0	0	16.07808	0	0	0	0	0	0	0	13.31919	12.4682	0	0	0	0	0	16.16822	16.20188	0	16.63296	13.93827	15.45929	15.99146	15.29943	0	0	0	0	12.94287	0	0	0	16.09016	0	15.54235	16.17903	15.94205
P11532	DMD_HUMAN	Dystrophin	DMD	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cellular protein localization [GO:0034613]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519]	cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; cortical actin cytoskeleton [GO:0030864]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018]	cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; cortical actin cytoskeleton [GO:0030864]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cellular protein localization [GO:0034613]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]	GO:0002027; GO:0002162; GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007517; GO:0007519; GO:0008270; GO:0008307; GO:0009986; GO:0010880; GO:0010881; GO:0010976; GO:0014809; GO:0014819; GO:0016010; GO:0016013; GO:0017022; GO:0017166; GO:0030018; GO:0030036; GO:0030054; GO:0030055; GO:0030175; GO:0030864; GO:0031527; GO:0032991; GO:0033137; GO:0034613; GO:0035633; GO:0035994; GO:0042383; GO:0042995; GO:0043034; GO:0043043; GO:0044306; GO:0044458; GO:0045121; GO:0045202; GO:0045211; GO:0045666; GO:0046716; GO:0048666; GO:0050998; GO:0051015; GO:0055001; GO:0060048; GO:0060314; GO:0065003; GO:0086001; GO:0090257; GO:0090287; GO:1901385; GO:1902083; GO:2000651	DLGQLEKK	18.52000046	0.34236449	0.34236449	0.21277197	930.0991831	15.66252	15.62077	16.15004	14.69693	0	0	0	14.95083	0	15.24268	14.96418	12.36775	0	0	0	13.61288	0	0	13.64457	14.92949	14.6282	0	0	0	0	0	0	13.42789	16.43912	0	15.89834	13.78347	14.98565	15.46161	11.65919	0	0	0	15.38275	0	16.06431	0	15.72133	16.0756	15.56225	0	0	0
P11678	PERE_HUMAN	"Eosinophil peroxidase, EPO, EC 1.11.1.7 [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain ]"	EPX EPER EPO EPP	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979]	heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0002215; GO:0004601; GO:0005576; GO:0005615; GO:0006979; GO:0020037; GO:0032693; GO:0032714; GO:0032753; GO:0034774; GO:0042742; GO:0042744; GO:0046872; GO:0070062; GO:0072677	STETPKLAAMHTLFMR	4.360000134	1	1	6.88E-13	1868.36353	15.09608	15.14441	0	13.01913	14.45682	14.44812	11.48464	14.87265	12.36657	14.00833	14.53173	13.58976	12.42413	14.04791	15.47977	16.50711	11.94572	12.59085	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P11712	CP2C9_HUMAN	"Cytochrome P450 2C9, EC 1.14.14.1 ((R)-limonene 6-monooxygenase, EC 1.14.14.53) ((S)-limonene 6-monooxygenase, EC 1.14.14.51) ((S)-limonene 7-monooxygenase, EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)"	CYP2C9 CYP2C10	Homo sapiens (Human)	cellular amide metabolic process [GO:0043603]; cholesterol metabolic process [GO:0008203]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; (R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; cellular amide metabolic process [GO:0043603]; cholesterol metabolic process [GO:0008203]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]"	"(R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0005886; GO:0006082; GO:0006805; GO:0008202; GO:0008203; GO:0008210; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016098; GO:0016491; GO:0016712; GO:0018675; GO:0018676; GO:0019373; GO:0019627; GO:0020037; GO:0032787; GO:0034875; GO:0042178; GO:0042759; GO:0043231; GO:0043603; GO:0046456; GO:0052741; GO:0070330; GO:0070989; GO:0097267	MDSLVVLVLCLSCLLLLSLWR	1.110000014	0.53293705	0.53293705	0.037970604	2519.368481	0	15.44789	0	0	0	0	13.09437	0	0	15.03075	0	13.18742	14.10739	0	0	0	0	0	0	0	14.86085	0	0	19.43904	0	16.82595	12.48961	0	0	0	0	15.81737	0	0	0	0	0	15.67935	0	0	14.72496	0	0	0	0	0	0	13.66233
P11717	MPRI_HUMAN	"Cation-independent mannose-6-phosphate receptor, CI Man-6-P receptor, CI-MPR, M6PR (300 kDa mannose 6-phosphate receptor, MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor, IGF-II receptor) (M6P/IGF2 receptor, M6P/IGF2R) (CD antigen CD222)"	IGF2R MPRI	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]	cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]	cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]	enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023]	GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394	DGSPCPSKSGLSYK	5.070000172	1	1	0.218336875	1481.78694	13.74435	15.04842	13.47388	12.79126	15.1138	14.56801	12.45124	0	9.39849	13.0906	0	8.925361	9.343613	15.81824	11.71504	13.15128	13.39485	12.9319	0	12.08413	0	0	0	14.95683	0	0	13.01144	0	16.08092	0	0	14.0421	0	0	0	0	0	0	0	14.82225	14.16451	12.94686	15.51344	0	12.32497	0	0	0
P11766	ADHX_HUMAN	"Alcohol dehydrogenase class-3, EC 1.1.1.1 (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase, FALDH, FDH, GSH-FDH, EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase, EC 1.1.1.284)"	ADH5 ADHX FDH	Homo sapiens (Human)	ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; S-(hydroxymethyl)glutathione dehydrogenase NAD activity [GO:0106322]; S-(hydroxymethyl)glutathione dehydrogenase NADP activity [GO:0106321]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]"	"alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; S-(hydroxymethyl)glutathione dehydrogenase NAD activity [GO:0106322]; S-(hydroxymethyl)glutathione dehydrogenase NADP activity [GO:0106321]; zinc ion binding [GO:0008270]"	GO:0001523; GO:0003016; GO:0004024; GO:0005504; GO:0005739; GO:0005829; GO:0006069; GO:0008270; GO:0009055; GO:0010430; GO:0018119; GO:0018467; GO:0032496; GO:0042802; GO:0045777; GO:0046294; GO:0051409; GO:0051775; GO:0051903; GO:0070062; GO:0106321; GO:0106322	LVSEYMSK	5.380000114	0.068696558	0.068696558	0.219587219	957.3340624	16.99941	0	0	14.55053	15.4779	14.7049	11.00628	15.26164	12.54361	12.7429	14.14048	16.47237	14.49456	16.22796	15.41026	14.84751	14.72957	0	14.32154	15.11722	15.39787	16.23055	16.37663	0	0	16.08457	16.51303	15.78363	15.25457	15.66954	14.99245	15.57558	16.38467	15.22983	15.13029	0	0	0	15.16834	15.3573	16.03762	14.76948	15.04226	0	0	0	0	16.08821
P11801	KPSH1_HUMAN	"Serine/threonine-protein kinase H1, EC 2.7.11.1 (Protein serine kinase H1, PSK-H1)"	PSKH1	Homo sapiens (Human)	determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005789; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0016607; GO:0106310	KGDDCLMK	7.329999924	1	1	0.185276296	981.2206366	0	0	15.04023	0	0	0	0	17.59045	0	18.23224	0	17.03	17.3103	16.73852	14.6962	17.10807	13.07128	18.59606	0	14.92812	18.00048	0	0	0	0	17.33825	0	17.29865	0	14.56272	0	0	0	0	17.89472	17.22166	0	0	17.79897	18.0703	0	0	0	0	0	15.56473	15.74637	0
P11802	CDK4_HUMAN	"Cyclin-dependent kinase 4, EC 2.7.11.22 (Cell division protein kinase 4) (PSK-J3)"	CDK4	Homo sapiens (Human)	adipose tissue development [GO:0060612]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid catabolic process [GO:0050994]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]	bicellular tight junction [GO:0005923]; chromatin [GO:0000785]; cyclin D1-CDK4 complex [GO:0097128]; cyclin D2-CDK4 complex [GO:0097129]; cyclin D3-CDK4 complex [GO:0097130]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	bicellular tight junction [GO:0005923]; chromatin [GO:0000785]; cyclin D1-CDK4 complex [GO:0097128]; cyclin D2-CDK4 complex [GO:0097129]; cyclin D3-CDK4 complex [GO:0097130]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; adipose tissue development [GO:0060612]; cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid catabolic process [GO:0050994]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000082; GO:0000307; GO:0000785; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005923; GO:0006468; GO:0007165; GO:0008284; GO:0008353; GO:0009410; GO:0010468; GO:0010971; GO:0016538; GO:0016592; GO:0030332; GO:0031965; GO:0032869; GO:0040014; GO:0046626; GO:0046890; GO:0048146; GO:0050994; GO:0051301; GO:0051726; GO:0060260; GO:0060612; GO:0071222; GO:0071353; GO:0097128; GO:0097129; GO:0097130; GO:0106310; GO:1904628; GO:1904637	DEGNPE	9.659999847	1	1	0.09490792	659.9825374	0	0	0	0	0	0	14.5859	0	0	0	0	15.43691	0	13.77343	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.86036	12.79487	0	0	15.3787	0	0	0	0	0	16.04515	0	0	0	0	0	0	0	0	0
P11844	CRGA_HUMAN	Gamma-crystallin A (Gamma-A-crystallin) (Gamma-crystallin 5)	CRYGA CRYG1	Homo sapiens (Human)	lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601]		structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601]	structural constituent of eye lens [GO:0005212]	GO:0002088; GO:0005212; GO:0007601	QYLLRPGDYRR	4.570000172	1	1	0.247752854	1437.465689	14.24394	15.57005	14.23799	9.558227	12.4826	0	0	0	13.82623	0	0	0	0	0	15.12588	14.98035	14.40102	13.99809	0	0	0	0	0	0	0	0	0	0	0	0	15.08532	0	0	0	0	0	16.22616	0	0	0	0	9.173209	0	0	0	0	14.32968	0
P11926	DCOR_HUMAN	"Ornithine decarboxylase, ODC, EC 4.1.1.17"	ODC1	Homo sapiens (Human)	kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008284; GO:0009615; GO:0033387; GO:0042176; GO:0042803	AACASASINV	7.460000038	0.847302437	0.847302437	0.190150745	963.3257757	0	14.36603	15.00088	0	13.91186	14.82565	10.72909	0	12.75441	15.51327	0	14.86939	14.01689	12.39008	10.58255	15.69713	0	17.28908	14.95331	13.89766	14.57061	15.94821	14.30132	0	0	0	0	15.43143	0	18.36178	0	0	0	0	16.01266	0	0	0	15.62464	0	0	15.93648	0	0	0	14.99398	0	0
P11940	PABP1_HUMAN	"Polyadenylate-binding protein 1, PABP-1, Poly(A)-binding protein 1"	PABPC1 PAB1 PABP PABP1 PABPC2	Homo sapiens (Human)	"CRD-mediated mRNA stabilization [GO:0070934]; gene silencing by RNA [GO:0031047]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]"	catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; CRD-mediated mRNA stabilization [GO:0070934]; gene silencing by RNA [GO:0031047]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]"	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]	GO:0000184; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006378; GO:0008022; GO:0008143; GO:0008266; GO:0008494; GO:0010494; GO:0016020; GO:0030027; GO:0031047; GO:0031252; GO:0036464; GO:0045070; GO:0048255; GO:0060213; GO:0070062; GO:0070934; GO:0071013; GO:0106002; GO:1900152; GO:1900153; GO:1990904; GO:2000623; GO:2000767	VDEAVAVLQAHQAKEAAQK	7.03000021	1	1	1.14E-12	2006.779296	14.10932	13.70679	13.72327	13.7894	14.63626	0	13.46913	14.00577	16.18822	13.63419	15.23568	0	11.43806	0	15.4818	11.05566	13.55655	15.27287	0	13.64225	0	15.47126	0	0	0	0	0	15.50255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P12018	VPREB_HUMAN	"Immunoglobulin iota chain (CD179 antigen-like family member A) (Protein VPreB1) (V(pre)B protein, VpreB protein) (CD antigen CD179a)"	VPREB1 VPREB	Homo sapiens (Human)	immune response [GO:0006955]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immune response [GO:0006955]		GO:0005576; GO:0005615; GO:0005783; GO:0006955	GYLSISELQPEDEAMYYCAMGAR	6.610000134	0.543482304	0.543482304	2.28E-12	2682.332075	12.44742	12.14765	0	0	11.46653	14.34404	0	9.281473	0	0	0	10.00218	0	0	0	0	10.91568	11.17129	0	0	13.91329	0	14.69347	13.34161	0	0	7.664812	13.34603	11.96281	0	13.69713	14.56464	0	12.86013	0	2.980586	13.13042	15.15746	0	12.68984	0	10.07072	0	0	0	12.87905	0	0
P12034	FGF5_HUMAN	"Fibroblast growth factor 5, FGF-5 (Heparin-binding growth factor 5, HBGF-5) (Smag-82)"	FGF5	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction involved in regulation of gene expression [GO:0023019]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction involved in regulation of gene expression [GO:0023019]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010001; GO:0010628; GO:0023019; GO:0030154; GO:0030334; GO:0051781	MSLSFLLLLFFSHLILSAWAHGEK	4.480000019	0.393643558	0.393643558	0.021605776	2761.561974	13.52792	14.92126	16.65445	0	0	14.35586	17.20115	16.17143	0	18.90758	15.21375	0	0	0	10.08058	16.83525	0	17.05455	0	15.93938	0	17.5266	11.71293	17.12687	0	15.99834	15.74326	0	17.65506	17.54624	15.57105	19.19246	15.06336	0	0	16.18678	0	17.55955	16.30201	19.02417	18.55173	0	0	0	16.26248	0	17.0195	0
P12104	FABPI_HUMAN	"Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein, I-FABP)"	FABP2 FABPI	Homo sapiens (Human)	fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal lipid absorption [GO:0098856]	apical cortex [GO:0045179]; cytosol [GO:0005829]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apical cortex [GO:0045179]; cytosol [GO:0005829]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal lipid absorption [GO:0098856]	fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]	GO:0005324; GO:0005504; GO:0005634; GO:0005829; GO:0005886; GO:0005902; GO:0006631; GO:0015908; GO:0036041; GO:0045179; GO:0098856	SENYDK	8.609999657	1	1	0.221604526	753.0211116	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P12107	COBA1_HUMAN	Collagen alpha-1(XI) chain	COL11A1 COLL6	Homo sapiens (Human)	cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601]	collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601]	extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]	GO:0001502; GO:0001503; GO:0002063; GO:0005201; GO:0005576; GO:0005592; GO:0005615; GO:0005788; GO:0006029; GO:0007601; GO:0007605; GO:0008201; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0050840; GO:0050910; GO:0055010; GO:0062023; GO:1904399	GADGVRGLK	11.97000027	1	1	0.258179411	871.8233016	16.12247	15.80718	14.41988	16.82464	0	12.42722	15.23977	16.43072	17.471	17.26116	14.29676	15.28405	0	13.85234	14.97179	0	0	0	0	14.49144	15.32486	0	13.72974	0	0	0	0	14.64866	0	15.10575	0	0	0	0	16.65035	0	0	0	15.63057	0	0	0	0	0	15.97738	0	0	0
P12109	CO6A1_HUMAN	Collagen alpha-1(VI) chain	COL6A1	Homo sapiens (Human)	cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; endodermal cell differentiation [GO:0035987]; osteoblast differentiation [GO:0001649]	collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]	collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]; cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; endodermal cell differentiation [GO:0035987]; osteoblast differentiation [GO:0001649]	collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]	GO:0001649; GO:0005518; GO:0005576; GO:0005589; GO:0005615; GO:0005765; GO:0005788; GO:0007155; GO:0016020; GO:0030020; GO:0032991; GO:0035987; GO:0042383; GO:0048407; GO:0062023; GO:0070062; GO:0071230	GGPGER	5.210000038	1	1	0.303255797	572.7135734	0	0	0	19.86048	19.55608	0	19.96841	17.80306	0	0	18.38557	19.43684	0	0	17.10431	19.47353	17.1289	0	0	15.80766	19.29796	0	20.95307	0	0	18.606	0	16.20905	0	0	0	0	0	0	20.90983	0	0	18.94617	0	18.85472	0	0	0	0	21.56074	0	0	17.82928
P12110	CO6A2_HUMAN	Collagen alpha-2(VI) chain	COL6A2	Homo sapiens (Human)	cell adhesion [GO:0007155]; response to glucose [GO:0009749]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; response to glucose [GO:0009749]	collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005518; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0007155; GO:0009749; GO:0030020; GO:0032991; GO:0042383; GO:0062023; GO:0070062; GO:1903561	GDPGRPGFSYPGPR	13.18999958	1	1	0.554079411	1460.404513	0	16.97917	0	0	0	21.54411	21.77511	0	0	0	0	0	0	0	0	0	0	0	0	0	20.09708	0	0	23.43532	0	18.58976	0	0	0	0	0	0	0	0	0	18.27336	0	0	0	17.63156	18.44954	24.0209	0	0	0	22.77329	0	24.56344
P12111	CO6A3_HUMAN	Collagen alpha-3(VI) chain	COL6A3	Homo sapiens (Human)	cell adhesion [GO:0007155]; muscle organ development [GO:0007517]	collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]	collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; muscle organ development [GO:0007517]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0030020; GO:0031012; GO:0042383; GO:0062023; GO:0070062; GO:1903561	LPIGTQQIR	8.5	1	1	0.497951378	1026.891744	0	16.94935	0	0	17.72252	0	18.24296	17.69477	0	0	0	0	0	0	0	0	19.45873	0	0	0	0	16.52254	0	0	0	0	16.82478	0	0	0	0	17.41918	0	16.58897	0	0	19.55956	20.04629	0	0	0	18.43022	17.61893	0	0	17.90213	16.59196	0
P12236	ADT3_HUMAN	"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2, ANT 2) (Adenine nucleotide translocator 3, ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed ]"	SLC25A6 AAC3 ANT3 CDABP0051	Homo sapiens (Human)	apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP:ADP antiporter activity [GO:0005471]; apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005634; GO:0005739; GO:0005743; GO:0005744; GO:0006915; GO:0016020; GO:0016021; GO:0140021; GO:1990544	LAADVGK	1.080000043	1	1	0.089922747	672.559439	16.04693	13.72648	0	0	13.05029	0	0	15.93329	0	11.1222	0	0	16.29942	15.32324	16.39879	16.06777	0	0	0	0	0	0	0	0	0	0	15.97942	0	0	0	0	0	0	0	0	0	15.78355	0	0	0	0	16.45334	0	0	0	0	0	0
P12259	FA5_HUMAN	"Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain ]"	F5	Homo sapiens (Human)	"blood circulation [GO:0008015]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; blood coagulation, extrinsic pathway [GO:0007598]; proteolysis [GO:0006508]; response to vitamin K [GO:0032571]; zymogen activation [GO:0031638]"	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]	"COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; copper ion binding [GO:0005507]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; blood coagulation, extrinsic pathway [GO:0007598]; proteolysis [GO:0006508]; response to vitamin K [GO:0032571]; zymogen activation [GO:0031638]"	copper ion binding [GO:0005507]	GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0005886; GO:0006508; GO:0007596; GO:0007598; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0031638; GO:0032571; GO:0032991; GO:0033116; GO:0072377; GO:1903561; GO:1905370	ASEFLGYWEPRLAR	8.909999847	1	1	0.390711134	1695.825084	13.8146	16.18283	15.15662	0	0	15.93441	0	0	0	0	0	0	0	0	14.30672	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.22805	15.4145	0	0	15.30951	16.84572	17.0234	0	0	0	0	16.18055	0	0	0	0
P12268	IMDH2_HUMAN	"Inosine-5'-monophosphate dehydrogenase 2, IMP dehydrogenase 2, IMPD 2, IMPDH 2, EC 1.1.1.205 (Inosine-5'-monophosphate dehydrogenase type II, IMP dehydrogenase II, IMPDH-II)"	IMPDH2 IMPD2	Homo sapiens (Human)	'de novo' XMP biosynthetic process [GO:0097294]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; retina development in camera-type eye [GO:0060041]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; 'de novo' XMP biosynthetic process [GO:0097294]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; retina development in camera-type eye [GO:0060041]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]	GO:0000166; GO:0003677; GO:0003723; GO:0003938; GO:0005576; GO:0005634; GO:0005737; GO:0005778; GO:0005829; GO:0006177; GO:0006183; GO:0007623; GO:0016020; GO:0034774; GO:0042802; GO:0046651; GO:0046872; GO:0060041; GO:0070062; GO:0071353; GO:0097294; GO:1904813	YFSEADKIK	5.340000153	1	1	0.210802772	1101.581661	12.08868	15.27815	9.223608	0	0	15.60463	14.4935	14.3112	15.23648	0	15.07033	13.38659	14.34854	0	10.58509	14.14458	13.5545	6.905028	12.23513	0	0	0	0	0	0	16.51536	0	0	0	15.56126	15.97308	14.84572	15.97237	13.84889	0	0	0	13.86677	14.67369	14.90449	0	0	0	14.99048	16.20594	0	0	15.81953
P12270	TPR_HUMAN	Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)	TPR	Homo sapiens (Human)	cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]	GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673	APILK	3.279999971	1	1	0.090733195	539.4767764	0	0	15.59367	0	15.75238	15.69107	15.28434	0	0	15.36762	15.7317	14.68656	0	0	0	0	0	0	0	0	0	0	16.69693	0	0	0	0	0	0	0	0	0	16.65944	0	0	0	0	0	0	0	0	0	14.76268	0	0	0	0	0
P12318	FCG2A_HUMAN	"Low affinity immunoglobulin gamma Fc region receptor II-a, IgG Fc receptor II-a (CDw32) (Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a) (CD antigen CD32)"	FCGR2A CD32 FCG2 FCGR2A1 IGFR2	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; immune system process [GO:0002376]; regulation of immune response [GO:0050776]	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; immune system process [GO:0002376]; regulation of immune response [GO:0050776]	IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888]	GO:0002376; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0007166; GO:0019864; GO:0030667; GO:0050776	TMETQMSQNVCPR	10.42000008	1	1	0.54619833	1613.334753	17.998	0	0	0	17.8972	0	0	0	0	18.20217	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.84559	0	0	0	0	19.33747	19.11647	0	0	0	18.48601	0	0	0	0	0	19.02268	0	0	0	0	0
P12319	FCERA_HUMAN	"High affinity immunoglobulin epsilon receptor subunit alpha (Fc-epsilon RI-alpha, FcERI) (IgE Fc receptor subunit alpha)"	FCER1A FCE1A	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; regulation of immune response [GO:0050776]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; IgE binding [GO:0019863]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; regulation of immune response [GO:0050776]	IgE binding [GO:0019863]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007166; GO:0009986; GO:0019863; GO:0050776	FEDSGEYK	8.020000458	1	1	0.305694988	974.0070236	0	15.96557	0	0	0	0	0	0	0	0	0	0	0	17.58836	0	0	0	0	0	0	0	17.88498	18.81637	0	0	0	0	0	0	0	0	0	19.46383	0	0	0	0	0	17.31904	0	0	0	0	0	0	0	17.19338	0
P12525	MYCP1_HUMAN	Putative myc-like protein MYCLP1 (Protein L-Myc-2) (V-myc myelocytomatosis viral oncogene homolog pseudogene 1)	MYCLP1 MYCL1P1 MYCL2	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0046983	ADLLDPR	9.100000381	0.219426602	0.219426602	0.255259927	800.5260413	0	18.80354	0	18.18	18.39592	0	0	17.57752	18.32884	0	19.1359	0	0	0	17.69492	19.8975	0	0	0	17.84981	0	19.031	19.11187	0	18.07247	18.56649	19.38436	17.32712	17.42199	0	18.77567	0	19.77852	0	19.63329	0	0	0	20.20933	18.67198	19.28217	0	16.28415	17.36861	0	16.92669	18.30139	15.7561
P12532	KCRU_HUMAN	"Creatine kinase U-type, mitochondrial, EC 2.7.3.2 (Acidic-type mitochondrial creatine kinase, Mia-CK) (Ubiquitous mitochondrial creatine kinase, U-MtCK)"	CKMT1A CKMT; CKMT1B CKMT	Homo sapiens (Human)	phosphocreatine biosynthetic process [GO:0046314]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; phosphocreatine biosynthetic process [GO:0046314]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]	GO:0004111; GO:0005524; GO:0005739; GO:0005743; GO:0016301; GO:0046314	DSRFPK	7.559999943	1	1	0.038849061	750.5507887	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.39905	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P12544	GRAA_HUMAN	"Granzyme A, EC 3.4.21.78 (CTL tryptase) (Cytotoxic T-lymphocyte proteinase 1) (Fragmentin-1) (Granzyme-1) (Hanukkah factor, H factor, HF)"	GZMA CTLA3 HFSP	Homo sapiens (Human)	apoptotic process [GO:0006915]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; response to bacterium [GO:0009617]	extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]	extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; response to bacterium [GO:0009617]	protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]	GO:0001772; GO:0004252; GO:0005576; GO:0005634; GO:0006915; GO:0006955; GO:0009617; GO:0019835; GO:0032078; GO:0042803; GO:0043065; GO:0043392; GO:0051354; GO:0051603; GO:0070269; GO:0140507; GO:1902483	EGDLKLLQLMEK	3.539999962	1	1	0.320177026	1432.223969	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.14536	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P12645	BMP3_HUMAN	"Bone morphogenetic protein 3, BMP-3 (Bone morphogenetic protein 3A, BMP-3A) (Osteogenin)"	BMP3 BMP3A	Homo sapiens (Human)	cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	GO:0001501; GO:0001649; GO:0005102; GO:0005125; GO:0005615; GO:0007267; GO:0008083; GO:0010862; GO:0051216; GO:0060395; GO:0070062; GO:0070700	AVPGDR	10.30000019	0.593963146	0.593963146	0.18808658	613.4189867	15.72646	15.33637	0	15.13165	0	16.02054	14.32344	14.77129	0	13.58833	13.44475	15.73506	15.75081	16.69251	16.43644	17.08534	16.90431	17.5403	16.16583	15.08051	18.10607	15.88016	16.58061	16.34937	14.91453	17.65781	15.27298	16.51513	17.50728	17.41326	16.6972	16.79553	16.83437	17.7261	16.56712	18.61186	15.47031	19.67529	19.9964	19.01913	19.28899	16.56595	16.2547	18.92456	17.89481	19.46667	15.97552	16.54901
P12694	ODBA_HUMAN	"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, EC 1.2.4.4 (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain, BCKDE1A, BCKDH E1-alpha)"	BCKDHA	Homo sapiens (Human)	branched-chain amino acid catabolic process [GO:0009083]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; carboxy-lyase activity [GO:0016831]; metal ion binding [GO:0046872]; branched-chain amino acid catabolic process [GO:0009083]	3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; carboxy-lyase activity [GO:0016831]; metal ion binding [GO:0046872]	GO:0003863; GO:0005739; GO:0005759; GO:0005947; GO:0009083; GO:0016831; GO:0046872	SMTLLNTMDR	6.300000191	1	1	0.467436425	1198.051295	0	0	0	0	17.41925	0	0	17.35311	0	0	0	0	0	0	17.66965	19.14234	0	20.24794	0	0	0	0	0	18.81553	0	19.33739	19.44802	0	0	0	0	0	19.41223	0	0	22.23103	0	0	20.25592	0	0	0	0	0	17.65496	18.37139	0	0
P12755	SKI_HUMAN	Ski oncogene (Proto-oncogene c-Ski)	SKI	Homo sapiens (Human)	"anterior/posterior axis specification [GO:0009948]; bone morphogenesis [GO:0060349]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell motility [GO:0048870]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; lens morphogenesis in camera-type eye [GO:0002089]; myelination in peripheral nervous system [GO:0022011]; myotube differentiation [GO:0014902]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neural tube closure [GO:0001843]; nose morphogenesis [GO:0043585]; olfactory bulb development [GO:0021772]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; retina development in camera-type eye [GO:0060041]; roof of mouth development [GO:0060021]; skeletal muscle fiber development [GO:0048741]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase inhibitor activity [GO:0046811]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; bone morphogenesis [GO:0060349]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell motility [GO:0048870]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; lens morphogenesis in camera-type eye [GO:0002089]; myelination in peripheral nervous system [GO:0022011]; myotube differentiation [GO:0014902]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neural tube closure [GO:0001843]; nose morphogenesis [GO:0043585]; olfactory bulb development [GO:0021772]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; retina development in camera-type eye [GO:0060041]; roof of mouth development [GO:0060021]; skeletal muscle fiber development [GO:0048741]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase inhibitor activity [GO:0046811]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001843; GO:0002089; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0006351; GO:0007179; GO:0008270; GO:0008285; GO:0009948; GO:0010626; GO:0014902; GO:0016604; GO:0016605; GO:0017053; GO:0019901; GO:0019904; GO:0021772; GO:0022011; GO:0030177; GO:0030326; GO:0030512; GO:0030514; GO:0031625; GO:0032926; GO:0032991; GO:0035019; GO:0042802; GO:0043010; GO:0043388; GO:0043585; GO:0045668; GO:0045944; GO:0046332; GO:0046811; GO:0048147; GO:0048593; GO:0048741; GO:0048870; GO:0060021; GO:0060041; GO:0060325; GO:0060349; GO:0060395; GO:0140297	QALEGGLDTK	3.549999952	0.706174672	0.706174672	0.223706791	1030.564281	0	0	14.73085	0	15.70652	0	16.47468	0	0	0	0	0	0	0	0	0	0	0	0	16.98699	0	0	16.17232	0	0	0	0	0	0	0	0	0	0	16.79816	13.69286	13.92581	0	0	0	16.27964	0	0	18.83529	0	0	0	16.37616	0
P12757	SKIL_HUMAN	Ski-like protein (Ski-related oncogene) (Ski-related protein)	SKIL SNO	Homo sapiens (Human)	blastocyst formation [GO:0001825]; lens fiber cell differentiation [GO:0070306]; lymphocyte homeostasis [GO:0002260]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of axonogenesis [GO:0050772]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of cell cycle [GO:0051726]; response to antibiotic [GO:0046677]; response to cytokine [GO:0034097]; response to growth factor [GO:0070848]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; blastocyst formation [GO:0001825]; lens fiber cell differentiation [GO:0070306]; lymphocyte homeostasis [GO:0002260]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of axonogenesis [GO:0050772]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of cell cycle [GO:0051726]; response to antibiotic [GO:0046677]; response to cytokine [GO:0034097]; response to growth factor [GO:0070848]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001669; GO:0001825; GO:0002260; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0007179; GO:0007283; GO:0007519; GO:0016605; GO:0019904; GO:0030512; GO:0030514; GO:0032991; GO:0034097; GO:0042802; GO:0044877; GO:0045596; GO:0046332; GO:0046677; GO:0050772; GO:0051726; GO:0070306; GO:0070848; GO:1902043; GO:1902231	IMEEVMR	10.23999977	0.493102938	0.493102938	0.234321003	922.4991627	16.98567	18.08422	16.41587	16.71873	9.843862	16.10004	11.58678	16.49992	17.39977	16.26508	17.25677	15.5834	14.82313	15.68764	15.19724	14.64241	17.08391	17.34405	16.01376	15.00571	17.34143	16.76284	16.43702	15.876	19.28653	13.01025	14.13981	16.57871	15.09875	16.26776	17.14149	0	16.01153	15.69097	0	16.33445	16.71676	16.58694	16.96399	16.73291	16.61124	15.9752	17.86456	15.91393	15.85428	16.43323	15.76725	17.03214
P12814	ACTN1_HUMAN	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	ACTN1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; muscle cell development [GO:0055001]; negative regulation of cellular component movement [GO:0051271]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981]	brush border [GO:0005903]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]	brush border [GO:0005903]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal regulatory protein binding [GO:0005519]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; transmembrane transporter binding [GO:0044325]; vinculin binding [GO:0017166]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; muscle cell development [GO:0055001]; negative regulation of cellular component movement [GO:0051271]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal regulatory protein binding [GO:0005519]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; transmembrane transporter binding [GO:0044325]; vinculin binding [GO:0017166]	GO:0001725; GO:0001726; GO:0003725; GO:0005178; GO:0005509; GO:0005519; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005916; GO:0005925; GO:0007015; GO:0017166; GO:0019904; GO:0030018; GO:0030036; GO:0030054; GO:0030220; GO:0030374; GO:0030864; GO:0031093; GO:0031143; GO:0036344; GO:0042803; GO:0042981; GO:0042995; GO:0043197; GO:0044325; GO:0048041; GO:0051015; GO:0051017; GO:0051271; GO:0051639; GO:0055001; GO:0070062; GO:0098978; GO:0099186	NYITMDELRR	1.820000052	1	1	0.124944939	1325.81446	16.83821	0	0	14.0211	17.26755	16.56994	0	0	16.2905	0	12.42773	0	12.4722	15.73106	16.82236	17.65627	15.45835	16.71461	14.0773	0	0	14.06392	0	13.87743	0	0	17.30189	15.06793	0	13.4652	14.12283	15.3242	13.94784	0	14.46739	14.68676	16.91953	16.92978	15.81496	12.76583	0	16.11411	0	0	17.97329	13.01642	0	0
P12821	ACE_HUMAN	"Angiotensin-converting enzyme, ACE, EC 3.2.1.-, EC 3.4.15.1 (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form ]"	ACE DCP DCP1	Homo sapiens (Human)	aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]	basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]	basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]	actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]	GO:0001666; GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0007420; GO:0007565; GO:0007568; GO:0008217; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009410; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010815; GO:0014910; GO:0016021; GO:0019229; GO:0019233; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0032091; GO:0032092; GO:0032496; GO:0032943; GO:0034616; GO:0035814; GO:0042310; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045907; GO:0046325; GO:0048286; GO:0050435; GO:0050482; GO:0050729; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0060978; GO:0061098; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0090281; GO:0097066; GO:0097225; GO:0097746; GO:1900086; GO:1901363; GO:1902033; GO:1903597; GO:1904045; GO:2000170	GAASGR	1.889999986	1	1	0.266102299	515.8328911	15.15178	15.65399	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.5935	16.06918	0	0	17.45228	15.69483	0	0	0	0	16.20398	0	15.50019	0	16.77117	0	0	0	0	0	16.94756	16.17552	0	0	15.39838	0	0	0	0	0
P12882	MYH1_HUMAN	"Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x, MyHC-2x) (Myosin heavy chain IIx/d, MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1)"	MYH1	Homo sapiens (Human)	muscle contraction [GO:0006936]	A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; intercalated disc [GO:0014704]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]	A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; intercalated disc [GO:0014704]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; muscle contraction [GO:0006936]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]	GO:0003774; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0014704; GO:0031672; GO:0032982; GO:0036464; GO:0051015	GFLARVEYQK	6.900000095	1	1	0.243796362	1210.731596	0	16.04944	0	0	0	0	0	16.02617	0	0	0	0	0	16.04054	0	0	0	0	0	0	0	16.71002	0	0	0	0	0	16.73686	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.07304	0	0
P12883	MYH7_HUMAN	"Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform, MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform, MyHC-beta)"	MYH7 MYHCB	Homo sapiens (Human)	adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart rate [GO:0002027]; regulation of slow-twitch skeletal muscle fiber contraction [GO:0031449]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of skeletal muscle contraction [GO:0014728]; skeletal muscle contraction [GO:0003009]; striated muscle contraction [GO:0006941]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]	muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart rate [GO:0002027]; regulation of slow-twitch skeletal muscle fiber contraction [GO:0031449]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of skeletal muscle contraction [GO:0014728]; skeletal muscle contraction [GO:0003009]; striated muscle contraction [GO:0006941]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0001725; GO:0002026; GO:0002027; GO:0003009; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0006941; GO:0007512; GO:0014728; GO:0014883; GO:0014898; GO:0016459; GO:0030016; GO:0030017; GO:0030018; GO:0030049; GO:0031449; GO:0032982; GO:0046034; GO:0051015; GO:0055010; GO:0060048	AKLQTENGELSR	11.67000008	0.15638575	0.15638575	0.221812886	1344.818198	14.13157	0	13.60188	0	0	0	0	13.54751	13.3247	0	14.81881	15.27514	13.25741	14.49537	13.43165	11.52277	13.97498	16.86364	0	15.36817	14.72896	11.58539	0	13.14459	14.68264	0	0	0	0	15.9667	0	16.99047	0	0	0	0	0	0	0	0	0	0	0	13.44971	0	0	0	18.33246
P12931	SRC_HUMAN	"Proto-oncogene tyrosine-protein kinase Src, EC 2.7.10.2 (Proto-oncogene c-Src) (pp60c-src, p60-Src)"	SRC SRC1	Homo sapiens (Human)	"activation of protein kinase B activity [GO:0032148]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; entry of bacterium into host cell [GO:0035635]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein transport [GO:0051222]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of protein binding [GO:0043393]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	"actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]"	"actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; estrogen receptor binding [GO:0030331]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; activation of protein kinase B activity [GO:0032148]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; entry of bacterium into host cell [GO:0035635]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein transport [GO:0051222]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of protein binding [GO:0043393]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"	ATP binding [GO:0005524]; ATPase binding [GO:0051117]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; estrogen receptor binding [GO:0030331]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]	GO:0001545; GO:0001819; GO:0002102; GO:0002223; GO:0002862; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005080; GO:0005102; GO:0005158; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005886; GO:0005901; GO:0005925; GO:0007049; GO:0007155; GO:0007165; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0008022; GO:0008283; GO:0009410; GO:0009612; GO:0009615; GO:0010447; GO:0010632; GO:0010634; GO:0010907; GO:0010954; GO:0014068; GO:0014069; GO:0014911; GO:0016004; GO:0016236; GO:0018105; GO:0018108; GO:0019899; GO:0019900; GO:0020037; GO:0022407; GO:0030054; GO:0030154; GO:0030168; GO:0030331; GO:0030900; GO:0031234; GO:0031295; GO:0031333; GO:0031648; GO:0031667; GO:0031954; GO:0032148; GO:0032211; GO:0032587; GO:0032869; GO:0033146; GO:0033625; GO:0034332; GO:0034446; GO:0035306; GO:0035556; GO:0035635; GO:0036035; GO:0036120; GO:0038083; GO:0038096; GO:0038128; GO:0042169; GO:0042476; GO:0043005; GO:0043065; GO:0043066; GO:0043114; GO:0043149; GO:0043154; GO:0043274; GO:0043393; GO:0043406; GO:0043552; GO:0044325; GO:0045056; GO:0045087; GO:0045121; GO:0045124; GO:0045296; GO:0045453; GO:0045737; GO:0045747; GO:0045892; GO:0045893; GO:0046628; GO:0046777; GO:0046875; GO:0048010; GO:0048011; GO:0048013; GO:0048041; GO:0048471; GO:0048477; GO:0050731; GO:0050847; GO:0050900; GO:0051057; GO:0051117; GO:0051219; GO:0051222; GO:0051385; GO:0051602; GO:0051895; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060444; GO:0060491; GO:0060576; GO:0070062; GO:0070102; GO:0070301; GO:0070374; GO:0070555; GO:0070700; GO:0070851; GO:0071222; GO:0071253; GO:0071375; GO:0071393; GO:0071398; GO:0071456; GO:0071498; GO:0071803; GO:0071902; GO:0086098; GO:0090263; GO:0097110; GO:0098609; GO:0098962; GO:0098978; GO:0099091; GO:1900182; GO:1903997; GO:2000386; GO:2000394; GO:2000573; GO:2000588; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286	MGSNKSKPK	8.739999771	1	1	0.236192409	995.3329072	16.07785	14.40203	15.39156	15.5903	16.47844	15.45918	14.09555	14.23173	15.74714	14.22993	0	15.34756	14.60731	15.40716	18.06437	0	0	15.34259	13.55314	13.99834	15.21616	17.01111	15.73309	18.2365	15.52867	16.70873	0	15.77836	0	14.56113	15.92759	15.10764	17.15818	16.73523	0	0	17.06649	16.38539	0	13.96254	15.71605	0	12.84016	0	14.52525	0	16.73637	14.61593
P12980	LYL1_HUMAN	"Protein lyl-1 (Class A basic helix-loop-helix protein 18, bHLHa18) (Lymphoblastic leukemia-derived sequence 1)"	LYL1 BHLHA18	Homo sapiens (Human)	"B cell differentiation [GO:0030183]; blood vessel maturation [GO:0001955]; definitive hemopoiesis [GO:0060216]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; B cell differentiation [GO:0030183]; blood vessel maturation [GO:0001955]; definitive hemopoiesis [GO:0060216]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001955; GO:0003677; GO:0005654; GO:0006355; GO:0006357; GO:0030183; GO:0045893; GO:0046983; GO:0060216	YIGFLVR	8.819999695	1	1	0.1433622	868.6109248	0	17.24712	15.6019	16.18514	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.09293	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P13010	XRCC5_HUMAN	"X-ray repair cross-complementing protein 5, EC 3.6.4.- (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit, CTC85, CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen, TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))"	XRCC5 G22P2	Homo sapiens (Human)	"activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to chromosome, telomeric region [GO:0070198]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to xenobiotic stimulus [GO:0009410]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]"	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]"	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to chromosome, telomeric region [GO:0070198]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to xenobiotic stimulus [GO:0009410]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]"	"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000723; GO:0000725; GO:0000781; GO:0000783; GO:0000976; GO:0002218; GO:0003677; GO:0003678; GO:0003684; GO:0003690; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007420; GO:0008022; GO:0008047; GO:0008094; GO:0008283; GO:0009410; GO:0016020; GO:0016787; GO:0031625; GO:0032040; GO:0032204; GO:0032212; GO:0032991; GO:0032993; GO:0034462; GO:0034511; GO:0034774; GO:0042162; GO:0043085; GO:0043564; GO:0044877; GO:0045027; GO:0045087; GO:0045860; GO:0045892; GO:0048660; GO:0050769; GO:0051973; GO:0060218; GO:0070198; GO:0070418; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0090734; GO:1904430; GO:1990830; GO:1990904	HLMLPDFDLLEDIESK	2.789999962	0.154980078	0.154980078	4.56E-12	1930.571097	13.72396	0	13.93259	0	15.8547	16.38943	12.55151	15.71761	0	0	0	0	17.03446	16.04251	14.84245	0	15.00294	14.56955	0	16.16145	0	13.37473	14.56647	0	0	19.4073	0	14.30769	0	0	13.34701	0	0	16.61086	0	13.22577	16.27819	17.41803	15.67263	17.90747	0	14.20344	0	18.0962	14.59834	17.50367	0	0
P13196	HEM1_HUMAN	"5-aminolevulinate synthase, non-specific, mitochondrial, ALAS-H, EC 2.3.1.37 (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)"	ALAS1 ALAS3 ALASH OK/SW-cl.121	Homo sapiens (Human)	erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]	5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]	GO:0003870; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0042802; GO:0048821	QHGAGAGGTR	3.680000067	1	1	0.183683856	910.4722299	0	11.42923	16.16462	16.19666	0	0	0	16.10566	0	0	0	0	14.4703	15.05865	15.61904	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.18494	0	0	0	0	0	15.57065	15.66138	0	15.78604	15.44567	0	15.62891	15.84408	16.65701	15.05026	13.7355	15.79294	12.62284
P13224	GP1BB_HUMAN	"Platelet glycoprotein Ib beta chain, GP-Ib beta, GPIb-beta, GPIbB (Antigen CD42b-beta) (CD antigen CD42c)"	GP1BB	Homo sapiens (Human)	"blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]"	glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]"	identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007155; GO:0007166; GO:0007597; GO:0010572; GO:0030168; GO:0035855; GO:0042802; GO:0051209; GO:1990779	MGSGPR	1.340000033	0.540464878	0.540464878	0.24308619	603.8620968	0	0	0	14.92061	16.07214	0	0	11.72222	17.16085	0	16.47633	0	0	0	14.82346	13.88964	15.71694	0	0	0	0	0	0	0	0	0	17.47978	15.76155	15.78158	0	0	0	15.98521	17.31313	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P13232	IL7_HUMAN	"Interleukin-7, IL-7"	IL7	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; bone resorption [GO:0045453]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell differentiation [GO:0045582]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; T cell lineage commitment [GO:0002360]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-7 receptor binding [GO:0005139]; animal organ morphogenesis [GO:0009887]; bone resorption [GO:0045453]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell differentiation [GO:0045582]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; T cell lineage commitment [GO:0002360]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-7 receptor binding [GO:0005139]	GO:0001961; GO:0002360; GO:0005125; GO:0005139; GO:0005576; GO:0005615; GO:0006959; GO:0007267; GO:0008083; GO:0008284; GO:0009887; GO:0019221; GO:0030890; GO:0032722; GO:0043066; GO:0043086; GO:0045453; GO:0045579; GO:0045582; GO:0046622; GO:0048873; GO:0050730; GO:0062023; GO:2001240	ILMGTK	6.170000076	1	1	0.078727718	660.8359229	12.87719	0	16.9943	16.21235	13.10558	0	0	9.597343	0	0	15.23492	0	11.22187	15.85217	0	15.13725	16.68532	0	0	0	0	14.08414	17.12876	14.9541	0	0	0	0	0	0	12.73713	0	14.70638	0	13.96406	0	0	18.30804	0	0	0	0	16.73489	15.92674	0	20.23965	13.58051	0
P13349	MYF5_HUMAN	"Myogenic factor 5, Myf-5 (Class C basic helix-loop-helix protein 2, bHLHc2)"	MYF5 BHLHC2	Homo sapiens (Human)	camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; embryonic skeletal system morphogenesis [GO:0048704]; extracellular matrix organization [GO:0030198]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle tissue morphogenesis [GO:0060415]; ossification [GO:0001503]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of skeletal muscle fiber development [GO:0048743]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; embryonic skeletal system morphogenesis [GO:0048704]; extracellular matrix organization [GO:0030198]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle tissue morphogenesis [GO:0060415]; ossification [GO:0001503]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of skeletal muscle fiber development [GO:0048743]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001502; GO:0001503; GO:0001756; GO:0001952; GO:0005654; GO:0006357; GO:0007517; GO:0007519; GO:0030198; GO:0035914; GO:0042693; GO:0043010; GO:0045663; GO:0046983; GO:0048704; GO:0048743; GO:0060415; GO:0090575	KSTTMDR	9.479999542	1	1	0.168110064	854.6122666	0	17.94858	0	19.72093	17.31596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.31636	0
P13473	LAMP2_HUMAN	"Lysosome-associated membrane glycoprotein 2, LAMP-2, Lysosome-associated membrane protein 2 (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b)"	LAMP2	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; establishment of protein localization to organelle [GO:0072594]; lysosomal protein catabolic process [GO:1905146]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of protein stability [GO:0031647]	autolysosome [GO:0044754]; azurophil granule membrane [GO:0035577]; chaperone-mediated autophagy translocation complex [GO:0061742]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of autophagosome membrane [GO:0097637]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; trans-Golgi network [GO:0005802]	autolysosome [GO:0044754]; azurophil granule membrane [GO:0035577]; chaperone-mediated autophagy translocation complex [GO:0061742]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of autophagosome membrane [GO:0097637]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; trans-Golgi network [GO:0005802]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; establishment of protein localization to organelle [GO:0072594]; lysosomal protein catabolic process [GO:1905146]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of protein stability [GO:0031647]	enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]	GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005802; GO:0005886; GO:0006605; GO:0009267; GO:0016020; GO:0017038; GO:0019899; GO:0019904; GO:0030670; GO:0031088; GO:0031333; GO:0031647; GO:0031902; GO:0035577; GO:0043202; GO:0043231; GO:0044754; GO:0046716; GO:0048471; GO:0050821; GO:0061684; GO:0061740; GO:0061742; GO:0070062; GO:0072594; GO:0097352; GO:0097637; GO:0101003; GO:1905146	SYALELNLTDSENATCLYAK	11.69999981	1	1	0.232196263	2276.820501	13.09011	8.917396	0	0	11.42121	11.15979	0	14.9392	11.47054	0	0	14.42623	15.07405	0	15.93397	12.54122	0	0	12.55189	0	0	0	0	12.36822	0	0	0	14.03872	0	0	0	11.99525	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P13489	RINI_HUMAN	"Ribonuclease inhibitor (Placental ribonuclease inhibitor, Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1, RAI)"	RNH1 PRI RNH	Homo sapiens (Human)	mRNA catabolic process [GO:0006402]; regulation of angiogenesis [GO:0045765]	angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ribonuclease inhibitor activity [GO:0008428]; mRNA catabolic process [GO:0006402]; regulation of angiogenesis [GO:0045765]	ribonuclease inhibitor activity [GO:0008428]	GO:0005654; GO:0005829; GO:0006402; GO:0008428; GO:0032311; GO:0045765; GO:0070062	DLCGIVASK	10.69999981	0.706026733	0.706026733	0.231586717	961.4824856	15.03849	16.75363	19.53063	15.14621	0	0	0	0	13.88659	16.22454	0	16.05908	14.93073	14.1469	0	15.02625	0	15.64116	16.42626	15.54258	15.65991	16.68508	15.67155	0	15.08933	16.23522	0	0	15.95787	15.51892	16.61229	15.4533	0	18.27277	16.52648	0	17.01935	17.25845	17.90033	16.14087	0	17.79839	0	16.46607	16.39691	17.37494	0	0
P13497	BMP1_HUMAN	"Bone morphogenetic protein 1, BMP-1, EC 3.4.24.19 (Mammalian tolloid protein, mTld) (Procollagen C-proteinase, PCP)"	BMP1 PCOLC	Homo sapiens (Human)	cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0001501; GO:0001502; GO:0001503; GO:0004222; GO:0004252; GO:0005125; GO:0005509; GO:0005576; GO:0005615; GO:0005794; GO:0006508; GO:0007275; GO:0008083; GO:0008233; GO:0008237; GO:0008270; GO:0030154; GO:0030199; GO:0031982; GO:0042802; GO:0061036	KPEPVLATGSR	9.390000343	0.692942858	0.692942858	0.042082232	1155.170291	0	0	19.1804	0	18.22153	0	0	0	0	0	0	18.74011	0	19.43854	0	15.73498	18.4304	0	0	16.79726	18.90874	19.11491	19.55251	0	0	19.80053	18.45627	0	0	0	0	19.41882	0	19.32016	0	18.28719	0	0	18.96215	20.24587	0	0	16.35524	18.05314	18.75849	18.69455	0	0
P13500	CCL2_HUMAN	"C-C motif chemokine 2 (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor, MCAF) (Monocyte chemotactic protein 1, MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2)"	CCL2 MCP1 SCYA2	Homo sapiens (Human)	"angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; astrocyte cell migration [GO:0043615]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular homeostasis [GO:0019725]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; helper T cell extravasation [GO:0035684]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of natural killer cell chemotaxis [GO:2000502]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; neutrophil chemotaxis [GO:0030593]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of calcium ion import [GO:0090280]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; viral genome replication [GO:0019079]"	extracellular region [GO:0005576]; extracellular space [GO:0005615]	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR2 chemokine receptor binding [GO:0031727]; chemokine activity [GO:0008009]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; astrocyte cell migration [GO:0043615]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular homeostasis [GO:0019725]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; helper T cell extravasation [GO:0035684]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of natural killer cell chemotaxis [GO:2000502]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; neutrophil chemotaxis [GO:0030593]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of calcium ion import [GO:0090280]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; viral genome replication [GO:0019079]"	CCR chemokine receptor binding [GO:0048020]; CCR2 chemokine receptor binding [GO:0031727]; chemokine activity [GO:0008009]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]	GO:0000165; GO:0001525; GO:0002548; GO:0004672; GO:0005102; GO:0005576; GO:0005615; GO:0006468; GO:0006935; GO:0006954; GO:0006959; GO:0007010; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007187; GO:0007259; GO:0008009; GO:0008360; GO:0009617; GO:0009887; GO:0019079; GO:0019221; GO:0019233; GO:0019725; GO:0030593; GO:0031663; GO:0031727; GO:0034351; GO:0035684; GO:0043491; GO:0043524; GO:0043547; GO:0043615; GO:0044344; GO:0048020; GO:0048245; GO:0048246; GO:0048247; GO:0050870; GO:0051770; GO:0051968; GO:0070098; GO:0070374; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0071407; GO:0090280; GO:1904783; GO:1905563; GO:2000134; GO:2000353; GO:2000427; GO:2000502	RITSSK	7.809999943	0.332642704	0.332642704	0.101247861	691.4514456	0	14.92451	0	15.31593	0	14.84153	14.21645	15.69636	0	13.77932	15.14227	14.78309	15.0632	14.10603	0	15.31918	13.80944	0	15.94069	14.30065	15.10004	15.97261	15.67235	14.94841	0	0	0	0	0	0	0	0	0	16.21984	15.99691	0	0	0	0	0	0	0	0	16.55201	0	0	0	0
P13521	SCG2_HUMAN	"Secretogranin-2 (Chromogranin-C) (Secretogranin II, SgII) [Cleaved into: Secretoneurin, SN; Manserin ]"	SCG2 CHGC	Homo sapiens (Human)	angiogenesis [GO:0001525]; endothelial cell migration [GO:0043542]; eosinophil chemotaxis [GO:0048245]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell proliferation [GO:0001938]; protein secretion [GO:0009306]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; secretory granule [GO:0030141]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; secretory granule [GO:0030141]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; angiogenesis [GO:0001525]; endothelial cell migration [GO:0043542]; eosinophil chemotaxis [GO:0048245]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell proliferation [GO:0001938]; protein secretion [GO:0009306]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]	GO:0000165; GO:0001525; GO:0001937; GO:0001938; GO:0005125; GO:0005615; GO:0005788; GO:0006954; GO:0009306; GO:0030141; GO:0035556; GO:0042056; GO:0043542; GO:0048245; GO:0050918; GO:0050930; GO:0098992; GO:2000352; GO:2001237	LQNGQNGERATR	4.099999905	1	1	0.305254148	1344.36568	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88712	0	0	0	16.67243	0	0	0	0	0	0	0	0	0	17.20638	0	0	15.98709	16.00818	16.08985	0	16.17752	0	16.01612	0	0	16.51862	0	15.80396
P13533	MYH6_HUMAN	"Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform, MyHC-alpha)"	MYH6 MYHCA	Homo sapiens (Human)	adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; regulation of ATP-dependent activity [GO:0043462]; regulation of blood pressure [GO:0008217]; regulation of heart contraction [GO:0008016]; regulation of heart growth [GO:0060420]; regulation of heart rate [GO:0002027]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral muscle development [GO:0007522]	cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]	cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; protein kinase binding [GO:0019901]; adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; regulation of ATP-dependent activity [GO:0043462]; regulation of blood pressure [GO:0008217]; regulation of heart contraction [GO:0008016]; regulation of heart growth [GO:0060420]; regulation of heart rate [GO:0002027]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral muscle development [GO:0007522]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; protein kinase binding [GO:0019901]	GO:0000146; GO:0001701; GO:0001725; GO:0002026; GO:0002027; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0006936; GO:0006941; GO:0007512; GO:0007522; GO:0008016; GO:0008217; GO:0014898; GO:0016459; GO:0017018; GO:0019901; GO:0030016; GO:0030017; GO:0030018; GO:0030049; GO:0030239; GO:0032982; GO:0043462; GO:0045214; GO:0046034; GO:0051015; GO:0055009; GO:0055010; GO:0055013; GO:0060048; GO:0060420	MTDAQMADFGAAAQYLRK	12.78999996	1	1	1.38E-12	2019.417455	0	0	0	0	0	0	0	13.17701	14.39116	0	0	16.14706	0	15.53875	0	14.96913	0	0	0	0	16.57436	0	0	0	14.14308	0	14.94739	14.57356	0	0	0	0	16.38806	0	0	0	16.02355	0	0	0	0	0	0	0	0	16.29051	0	0
P13535	MYH8_HUMAN	"Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal, MyHC-perinatal)"	MYH8	Homo sapiens (Human)	ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle contraction [GO:0003009]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; sarcomere [GO:0030017]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; myosin phosphatase activity [GO:0017018]; structural constituent of muscle [GO:0008307]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle contraction [GO:0003009]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; myosin phosphatase activity [GO:0017018]; structural constituent of muscle [GO:0008307]	GO:0000146; GO:0003009; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005859; GO:0006936; GO:0008307; GO:0016887; GO:0017018; GO:0030017; GO:0030049; GO:0032027; GO:0032982; GO:0046034; GO:0051015	LEEAGGATSAQVELNK	3.230000019	1	1	1.84E-12	1616.758004	0	15.36901	0	16.18384	0	12.77654	15.26556	0	0	16.47993	0	16.27042	15.46328	15.41236	0	0	0	0	14.29167	0	0	0	15.45868	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P13569	CFTR_HUMAN	"Cystic fibrosis transmembrane conductance regulator, CFTR (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase, EC 5.6.1.6) (cAMP-dependent chloride channel)"	CFTR ABCC7	Homo sapiens (Human)	amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chaperone binding [GO:0051087]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; Sec61 translocon complex binding [GO:0106138]; amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chaperone binding [GO:0051087]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; Sec61 translocon complex binding [GO:0106138]	GO:0005254; GO:0005260; GO:0005524; GO:0005634; GO:0005737; GO:0005765; GO:0005769; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006695; GO:0006904; GO:0009986; GO:0010008; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016021; GO:0016324; GO:0016853; GO:0016887; GO:0017081; GO:0019869; GO:0019899; GO:0030165; GO:0030301; GO:0030660; GO:0030669; GO:0031901; GO:0032991; GO:0034707; GO:0034976; GO:0035377; GO:0035774; GO:0042626; GO:0043225; GO:0045921; GO:0048240; GO:0050891; GO:0051087; GO:0051454; GO:0055037; GO:0055038; GO:0055085; GO:0060081; GO:0070175; GO:0071320; GO:0097186; GO:0106138; GO:0140359; GO:1902161; GO:1902476; GO:1902943; GO:1904322	SPLEKASVVSK	2.960000038	1	1	0.185680174	1144.713707	15.64422	0	0	0	0	0	13.26488	13.06898	0	0	0	0	14.95004	0	0	14.74815	0	0	0	0	10.94251	0	15.32317	0	15.36473	16.06022	0	0	15.34028	0	15.53602	0	0	14.12394	0	0	0	16.41869	0	0	0	0	15.99277	0	15.17934	0	0	0
P13584	CP4B1_HUMAN	"Cytochrome P450 4B1, EC 1.14.14.1 (CYPIVB1) (Cytochrome P450-HP)"	CYP4B1	Homo sapiens (Human)	biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631]	endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]	GO:0004497; GO:0005506; GO:0005789; GO:0006631; GO:0018879; GO:0019825; GO:0020037; GO:0070330	QTLAKAMDK	6.380000114	1	1	0.232616927	1006.2858	0	15.92311	11.66368	12.62055	15.04934	15.20641	16.06245	15.63195	15.32934	15.86819	15.12019	15.36528	13.62892	0	15.24357	14.58609	15.98414	0	0	0	15.6137	14.29118	0	15.80366	0	0	0	0	0	0	0	0	0	15.83334	15.48589	0	0	15.94646	15.35508	0	13.60205	15.36746	0	0	0	14.30481	0	0
P13611	CSPG2_HUMAN	"Versican core protein (Chondroitin sulfate proteoglycan core protein 2, Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein, GHAP) (Large fibroblast proteoglycan) (PG-M)"	VCAN CSPG2	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell recognition [GO:0008037]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]; skeletal system development [GO:0001501]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell recognition [GO:0008037]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]; skeletal system development [GO:0001501]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540]	GO:0001501; GO:0001649; GO:0001750; GO:0005509; GO:0005539; GO:0005540; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0007155; GO:0007275; GO:0007417; GO:0008037; GO:0008347; GO:0016020; GO:0030021; GO:0030246; GO:0031012; GO:0033165; GO:0043202; GO:0062023	HLPTIR	2.859999895	1	1	0.228656085	737.5133324	15.19944	16.24537	16.22699	16.48432	16.50246	0	15.36825	14.41114	14.91826	16.15966	15.01829	16.58554	0	15.48331	0	15.40908	0	0	15.15751	16.0318	0	15.03371	15.79993	13.79269	0	0	0	16.56169	0	0	17.07165	0	0	0	17.34191	0	16.14728	0	15.36972	0	15.90025	0	16.31113	0	17.20772	16.53118	15.1678	15.56095
P13645	K1C10_HUMAN	"Keratin, type I cytoskeletal 10 (Cytokeratin-10, CK-10) (Keratin-10, K10)"	KRT10 KPP	Homo sapiens (Human)	epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; keratinocyte differentiation [GO:0030216]; morphogenesis of an epithelium [GO:0002009]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684]; protein heterotetramerization [GO:0051290]	cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]	cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; structural constituent of skin epidermis [GO:0030280]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; keratinocyte differentiation [GO:0030216]; morphogenesis of an epithelium [GO:0002009]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684]; protein heterotetramerization [GO:0051290]	protein heterodimerization activity [GO:0046982]; structural constituent of skin epidermis [GO:0030280]	GO:0001533; GO:0002009; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0009986; GO:0016020; GO:0018149; GO:0030216; GO:0030280; GO:0030855; GO:0045095; GO:0045684; GO:0046982; GO:0051290; GO:0070062	ALEESNYELEGK	79.70999908	1	1	0.386415343	1381.944233	18.2483	17.79395	0	0	18.05818	0	18.40403	0	18.68943	0	17.96967	0	0	18.67007	0	0	0	0	18.36544	0	19.00358	18.3416	0	19.11823	18.30611	0	19.25679	0	0	0	0	0	0	0	17.32948	0	18.97156	0	0	0	0	0	0	18.27715	16.69971	0	17.66531	0
P13671	CO6_HUMAN	Complement component C6	C6	Homo sapiens (Human)	"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]"	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]	"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]"		GO:0001701; GO:0005576; GO:0005579; GO:0005886; GO:0006956; GO:0006958; GO:0019835; GO:0045087; GO:0050778; GO:0070062	QSPDYK	6.900000095	0.21404089	0.21404089	0.208819209	740.2983247	0	16.46821	16.26677	14.3478	15.60141	15.45888	14.66714	16.64581	0	16.01172	0	14.41985	13.78162	0	16.86863	14.76711	15.11617	14.95195	15.91753	0	16.7351	0	16.6706	0	10.00825	12.11982	15.15521	15.57037	14.89835	15.55468	14.50346	14.04836	15.77488	15.49304	0	14.42701	16.04434	16.28296	16.02512	0	0	14.49238	15.45839	14.80521	15.72978	14.3935	14.7191	14.9838
P13688	CEAM1_HUMAN	"Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1, BGP-1) (CD antigen CD66a)"	CEACAM1 BGP BGP1	Homo sapiens (Human)	"angiogenesis [GO:0001525]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; wound healing, spreading of cells [GO:0044319]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle membrane [GO:0030658]	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle membrane [GO:0030658]; actin binding [GO:0003779]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; angiogenesis [GO:0001525]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; wound healing, spreading of cells [GO:0044319]"	actin binding [GO:0003779]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]	GO:0001525; GO:0001558; GO:0001568; GO:0001915; GO:0002859; GO:0003779; GO:0005516; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006469; GO:0007155; GO:0007156; GO:0007229; GO:0009925; GO:0009986; GO:0010594; GO:0014066; GO:0015125; GO:0015721; GO:0016020; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0019900; GO:0019903; GO:0030054; GO:0030334; GO:0030658; GO:0030853; GO:0031005; GO:0031528; GO:0032692; GO:0032869; GO:0035579; GO:0035726; GO:0038016; GO:0038158; GO:0042058; GO:0042802; GO:0042803; GO:0043116; GO:0043318; GO:0044319; GO:0045601; GO:0045717; GO:0046983; GO:0050860; GO:0051055; GO:0060312; GO:0070062; GO:0070372; GO:0070821; GO:0090331; GO:0098742; GO:1901143; GO:1903385; GO:1903670; GO:1990782; GO:2000346; GO:2001214	LSQGNTTLSINPVK	4.269999981	1	1	0.402716124	1471.737905	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.92846	0	0	0	0	0	0	0	0	0	17.21578	0	0	0	0	0	0
P13725	ONCM_HUMAN	"Oncostatin-M, OSM"	OSM	Homo sapiens (Human)	immune response [GO:0006955]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hormone secretion [GO:0046888]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; oncostatin-M receptor binding [GO:0005147]; immune response [GO:0006955]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hormone secretion [GO:0046888]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; oncostatin-M receptor binding [GO:0005147]	GO:0002675; GO:0005125; GO:0005147; GO:0005576; GO:0005615; GO:0006955; GO:0007275; GO:0008083; GO:0008284; GO:0008285; GO:0014068; GO:0032740; GO:0033138; GO:0038165; GO:0040008; GO:0042531; GO:0043410; GO:0045944; GO:0046888; GO:0050729; GO:0050731; GO:0051781; GO:0051897; GO:1902036	HSPHQALR	14.02999973	0.088571332	0.088571332	0.14367339	946.111105	15.51987	16.76709	13.00736	11.72395	14.97313	13.0942	12.63919	20.01467	0	12.44699	13.78089	0	15.04949	0	0	12.54491	15.56666	0	12.65309	16.75556	15.29693	0	14.25064	14.6816	15.82134	0	0	12.63525	0	0	0	0	18.01155	17.47856	14.22159	16.55825	0	14.55976	11.76692	12.30744	19.48876	10.49745	14.65869	0	0	0	0	18.7139
P13796	PLSL_HUMAN	"Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1, LCP-1)"	LCP1 PLS2	Homo sapiens (Human)	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; extracellular matrix disassembly [GO:0022617]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; integrin binding [GO:0005178]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; extracellular matrix disassembly [GO:0022617]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; integrin binding [GO:0005178]	GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0003779; GO:0005178; GO:0005509; GO:0005615; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030054; GO:0030175; GO:0030866; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0048471; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0051764; GO:0070062; GO:0071803	EGESLEDLMKLSPEELLLR	9.760000229	1	1	0.153769634	2201.232456	14.24864	0	0	0	0	0	0	0	0	0	0	0	15.58869	0	11.16986	11.65858	0	0	0	15.91805	0	0	0	13.82033	0	0	0	12.47356	0	12.70456	0	0	12.30546	0	0	14.36417	13.26776	0	0	0	0	11.80029	0	10.69638	0	0	0	0
P13797	PLST_HUMAN	Plastin-3 (T-plastin)	PLS3	Homo sapiens (Human)	actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone development [GO:0060348]	actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone development [GO:0060348]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0032432; GO:0051015; GO:0051017; GO:0051639; GO:0060348	LGANMK	11.25	0.240291372	0.240291372	0.224842272	647.6659487	20.43426	17.0231	15.09075	18.74028	18.36981	16.66094	14.32419	12.56326	14.89456	16.72866	17.04955	16.37416	14.5609	16.13199	15.42259	15.41468	17.70995	15.60046	14.87348	14.46536	16.21093	14.78751	15.97602	15.81601	18.77179	0	15.91446	17.34241	16.2936	18.09877	21.26013	15.28309	21.45991	19.19207	19.5903	0	18.88292	16.64204	16.25439	15.35687	20.9149	16.96213	16.10705	17.85911	0	13.58799	15.52394	16.67627
P13798	ACPH_HUMAN	"Acylamino-acid-releasing enzyme, AARE, EC 3.4.19.1 (Acyl-peptide hydrolase, APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase, OPH)"	APEH D3F15S2 D3S48E DNF15S2	Homo sapiens (Human)	amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508]; translational termination [GO:0006415]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508]; translational termination [GO:0006415]	identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]	GO:0003723; GO:0004252; GO:0005576; GO:0005829; GO:0006415; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0050435; GO:0070062; GO:1904813	THLGS	4.559999943	0.296668291	0.296668291	0.154048603	514.7764256	17.36359	10.69761	19.10852	0	19.56621	16.76781	17.0001	0	12.5466	0	0	0	17.10431	15.48477	0	0	0	0	15.50119	0	17.06211	16.42638	14.29138	14.61645	0	0	0	0	17.1543	16.97251	19.075	17.07822	0	16.66922	16.17018	16.76193	18.89164	16.77201	18.28745	0	0	16.93834	17.36738	17.0936	0	14.48323	0	15.54485
P13804	ETFA_HUMAN	"Electron transfer flavoprotein subunit alpha, mitochondrial, Alpha-ETF"	ETFA	Homo sapiens (Human)	cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0016491; GO:0022904; GO:0033539; GO:0045251; GO:0050660	VVVSGGRGLK	15.15999985	1	1	0.158359419	971.6494386	13.43192	15.65594	15.62842	11.46884	13.40022	12.46851	13.85287	15.37894	0	0	0	7.634297	12.53251	12.79175	14.53629	0	11.36857	13.87194	0	15.4397	0	0	15.7053	15.96327	0	0	0	0	0	0	0	0	16.49117	0	0	0	0	0	17.23252	0	15.3801	0	0	15.8544	0	0	0	0
P13928	ANXA8_HUMAN	"Annexin A8 (Annexin VIII) (Annexin-8) (Vascular anticoagulant-beta, VAC-beta)"	ANXA8 ANX8	Homo sapiens (Human)	blood coagulation [GO:0007596]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of serine-type endopeptidase activity [GO:1900004]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]	"collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; blood coagulation [GO:0007596]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of serine-type endopeptidase activity [GO:1900004]"	"actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0005509; GO:0005544; GO:0005546; GO:0005547; GO:0005737; GO:0005829; GO:0005886; GO:0007032; GO:0007596; GO:0016197; GO:0031902; GO:0043325; GO:0051015; GO:0062023; GO:1900004; GO:1900138	LYYAMKGAGTR	3.269999981	1	1	0.368157635	1231.239581	0	0	14.77883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P13942	COBA2_HUMAN	Collagen alpha-2(XI) chain	COL11A2	Homo sapiens (Human)	cartilage development [GO:0051216]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]	collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; cartilage development [GO:0051216]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]	GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005592; GO:0005615; GO:0005788; GO:0007605; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0046872; GO:0051216; GO:0060021; GO:0060023; GO:0062023	GAKGATGPGGPK	7.340000153	1	1	5.76E-13	998.6441417	10.53213	14.04172	11.76908	14.64697	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.02131	0	0	0	0	16.3434	0	0	0	0	0	0	0	0	0	0	0
P13985	HRES1_HUMAN	Putative HTLV-1-related endogenous sequence (p25)	HRES1	Homo sapiens (Human)						HPQDPR	3.769999981	1	1	0.122954277	748.2769655	0	16.89686	12.87914	12.13341	0	11.52189	14.28992	0	0	11.82578	14.64802	14.52009	0	0	14.39544	0	0	0	0	0	0	0	0	0	0	0	15.857	15.79343	0	14.51364	16.29172	0	0	0	0	0	13.60374	16.7567	0	14.88828	0	15.48285	0	0	17.90107	0	15.12693	0
P13994	YJU2B_HUMAN	Probable splicing factor YJU2B (Coiled-coil domain-containing protein 130)	YJU2B CCDC130 SB115	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA splicing [GO:0008380]"	post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]	"post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA splicing [GO:0008380]"		GO:0000398; GO:0005684; GO:0008380; GO:0009615; GO:0071014	YNAEKK	8.539999962	1	1	0.257117347	752.9402039	0	0	0	17.49644	0	0	15.86288	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.16306	0	0	0	0
P14061	DHB1_HUMAN	"17-beta-hydroxysteroid dehydrogenase type 1, 17-beta-HSD 1, EC 1.1.1.51 (20 alpha-hydroxysteroid dehydrogenase, 20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 1, EC 1.1.1.62) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1)"	HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1	Homo sapiens (Human)	bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; estrogen metabolic process [GO:0008210]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; catalytic activity [GO:0003824]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estradiol binding [GO:1903924]; NADP binding [GO:0050661]; NADP+ binding [GO:0070401]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; estrogen metabolic process [GO:0008210]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370]	17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; catalytic activity [GO:0003824]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estradiol binding [GO:1903924]; NADP binding [GO:0050661]; NADP+ binding [GO:0070401]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]	GO:0003824; GO:0004303; GO:0005496; GO:0005737; GO:0005829; GO:0006694; GO:0006703; GO:0008210; GO:0030283; GO:0035410; GO:0042803; GO:0044594; GO:0047035; GO:0047045; GO:0050661; GO:0060348; GO:0061370; GO:0070401; GO:0071248; GO:0072582; GO:1903924	VLGSPEEVLDRTDIHTFHR	8.600000381	1	1	0.001037454	2221.203089	13.84844	0	14.03402	0	0	15.55687	0	10.22846	9.427062	0	0	13.72553	12.99735	0	16.0967	12.94275	14.49607	0	0	14.03841	14.79952	0	14.48433	15.74802	0	11.57596	0	14.11499	13.40407	14.04391	14.83829	15.70294	14.18924	15.28463	15.19609	0	12.78864	12.66271	0	0	0	0	0	0	16.04534	0	0	0
P14136	GFAP_HUMAN	"Glial fibrillary acidic protein, GFAP"	GFAP	Homo sapiens (Human)	astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; D-aspartate import across plasma membrane [GO:0070779]; extracellular matrix organization [GO:0030198]; gene expression [GO:0010467]; intermediate filament organization [GO:0045109]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron projection development [GO:0010977]; neuron projection regeneration [GO:0031102]; positive regulation of Schwann cell proliferation [GO:0010625]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of neurotransmitter uptake [GO:0051580]; regulation of protein-containing complex assembly [GO:0043254]; response to wounding [GO:0009611]	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]	astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; structural constituent of cytoskeleton [GO:0005200]; astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; D-aspartate import across plasma membrane [GO:0070779]; extracellular matrix organization [GO:0030198]; gene expression [GO:0010467]; intermediate filament organization [GO:0045109]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron projection development [GO:0010977]; neuron projection regeneration [GO:0031102]; positive regulation of Schwann cell proliferation [GO:0010625]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of neurotransmitter uptake [GO:0051580]; regulation of protein-containing complex assembly [GO:0043254]; response to wounding [GO:0009611]	identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; structural constituent of cytoskeleton [GO:0005200]	GO:0005178; GO:0005200; GO:0005737; GO:0005829; GO:0005882; GO:0006886; GO:0009611; GO:0010467; GO:0010625; GO:0010977; GO:0014002; GO:0019900; GO:0030198; GO:0031102; GO:0042802; GO:0043254; GO:0044297; GO:0045109; GO:0045111; GO:0051580; GO:0060020; GO:0060291; GO:0070779; GO:0097450; GO:0098574; GO:1904714	SYVSSGEMMVGGLAPGR	6.989999771	1	1	0.215947325	1713.603977	0	11.80717	12.33689	0	0	0	0	0	14.29349	0	0	12.66154	15.37587	0	0	0	0	0	0	14.2764	16.5623	0	0	0	0	14.50641	16.7911	13.42965	16.24598	15.58367	14.19082	0	16.06304	0	15.26392	0	13.29187	16.02327	0	0	15.77191	0	0	0	0	15.73749	0	0
P14210	HGF_HUMAN	"Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor, SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain ]"	HGF HPTA	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; regulation of tau-protein kinase activity [GO:1902947]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; regulation of tau-protein kinase activity [GO:1902947]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	GO:0000278; GO:0000902; GO:0001837; GO:0001889; GO:0001934; GO:0005102; GO:0005576; GO:0005615; GO:0008083; GO:0010507; GO:0014068; GO:0016020; GO:0030335; GO:0031093; GO:0031100; GO:0031643; GO:0032715; GO:0032733; GO:0033137; GO:0035729; GO:0042056; GO:0042802; GO:0043066; GO:0043154; GO:0043410; GO:0044877; GO:0045669; GO:0045766; GO:0045944; GO:0048012; GO:0050673; GO:0050728; GO:0050731; GO:0051450; GO:0060326; GO:0060665; GO:0070572; GO:0090201; GO:1900744; GO:1901299; GO:1902042; GO:1902947; GO:2000573	VVNGIPTR	4.460000038	1	1	0.366565653	854.69662	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.58967	0	0	0	0	0	0	0	0	0	0	18.20362	18.76095	0	0	0	0	0	0	0	0	0	0
P14222	PERF_HUMAN	"Perforin-1, P1 (Cytolysin) (Lymphocyte pore-forming protein, PFP)"	PRF1 PFP	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; cytolysis [GO:0019835]; defense response to tumor cell [GO:0002357]; defense response to virus [GO:0051607]; immune response to tumor cell [GO:0002418]; immunological synapse formation [GO:0001771]; positive regulation of killing of cells of another organism [GO:0051712]; protein homooligomerization [GO:0051260]; T cell mediated cytotoxicity [GO:0001913]	cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; wide pore channel activity [GO:0022829]; apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; cytolysis [GO:0019835]; defense response to tumor cell [GO:0002357]; defense response to virus [GO:0051607]; immune response to tumor cell [GO:0002418]; immunological synapse formation [GO:0001771]; positive regulation of killing of cells of another organism [GO:0051712]; protein homooligomerization [GO:0051260]; T cell mediated cytotoxicity [GO:0001913]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; wide pore channel activity [GO:0022829]	GO:0001771; GO:0001913; GO:0002357; GO:0002418; GO:0005509; GO:0005576; GO:0005829; GO:0005886; GO:0006915; GO:0006968; GO:0016020; GO:0016021; GO:0019835; GO:0022829; GO:0031904; GO:0042802; GO:0044194; GO:0051260; GO:0051607; GO:0051712	AVELGGR	6.03000021	1	1	0.22001105	698.8409099	16.26211	0	13.3872	0	0	16.14204	0	0	15.97658	0	0	0	0	0	16.231	16.35708	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.01023	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P14317	HCLS1_HUMAN	Hematopoietic lineage cell-specific protein (Hematopoietic cell-specific LYN substrate 1) (LckBP1) (p75)	HCLS1 HS1	Homo sapiens (Human)	"actin filament polymerization [GO:0030041]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; intracellular signal transduction [GO:0035556]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]"	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; transcription regulator complex [GO:0005667]	"cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; transcription regulator complex [GO:0005667]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SH3 domain binding [GO:0017124]; actin filament polymerization [GO:0030041]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; intracellular signal transduction [GO:0035556]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]"	actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SH3 domain binding [GO:0017124]	GO:0000122; GO:0005634; GO:0005667; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0008284; GO:0009725; GO:0014068; GO:0017124; GO:0019901; GO:0030041; GO:0030218; GO:0030427; GO:0030833; GO:0030854; GO:0030864; GO:0033138; GO:0035556; GO:0042307; GO:0042531; GO:0045651; GO:0045944; GO:0050731; GO:0051015; GO:0051091; GO:0051897; GO:0061629; GO:0071345; GO:2000107; GO:2000251	FESMAEEKR	10.80000019	1	1	0.137933043	1142.128413	0	14.98887	16.17016	0	0	0	0	0	17.8843	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P14410	SUIS_HUMAN	"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase, EC 3.2.1.48; Isomaltase, EC 3.2.1.10 ]"	SI	Homo sapiens (Human)	polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987]"	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]"	GO:0004553; GO:0004558; GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005987; GO:0016021; GO:0016324; GO:0030246; GO:0044245; GO:0070062	VTTNPSDSGKCPNVLNDPVNVR	5.860000134	1	1	0.041505772	2383.634914	14.97486	11.87518	14.61186	0	16.89283	16.47707	11.90528	14.27086	17.58855	13.27273	0	0	16.47783	0	14.25865	15.89185	13.59905	15.75185	0	0	14.36018	0	15.85033	0	0	17.31248	13.46823	14.92047	9.277158	0	17.16951	0	14.95997	19.04672	18.09991	16.66699	0	17.88985	0	15.68891	17.73621	14.64213	0	0	15.18457	0	9.939624	13.47311
P14415	AT1B2_HUMAN	"Sodium/potassium-transporting ATPase subunit beta-2 (Adhesion molecule in glia, AMOG) (Sodium/potassium-dependent ATPase subunit beta-2)"	ATP1B2	Homo sapiens (Human)	cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-substrate adhesion [GO:0031589]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; lateral ventricle development [GO:0021670]; membrane repolarization [GO:0086009]; motor behavior [GO:0061744]; negative regulation of glial cell migration [GO:1903976]; neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration [GO:0021944]; photoreceptor cell maintenance [GO:0045494]; plasma membrane bounded cell projection organization [GO:0120036]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein stabilization [GO:0050821]; retina homeostasis [GO:0001895]; sodium ion export across plasma membrane [GO:0036376]; third ventricle development [GO:0021678]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; astrocyte projection [GO:0097449]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]	apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; astrocyte projection [GO:0097449]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-substrate adhesion [GO:0031589]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; lateral ventricle development [GO:0021670]; membrane repolarization [GO:0086009]; motor behavior [GO:0061744]; negative regulation of glial cell migration [GO:1903976]; neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration [GO:0021944]; photoreceptor cell maintenance [GO:0045494]; plasma membrane bounded cell projection organization [GO:0120036]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein stabilization [GO:0050821]; retina homeostasis [GO:0001895]; sodium ion export across plasma membrane [GO:0036376]; third ventricle development [GO:0021678]; transport across blood-brain barrier [GO:0150104]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]	GO:0001671; GO:0001895; GO:0001917; GO:0005737; GO:0005886; GO:0005890; GO:0006883; GO:0009897; GO:0010976; GO:0016020; GO:0016324; GO:0016328; GO:0021670; GO:0021678; GO:0021944; GO:0030007; GO:0030674; GO:0031253; GO:0031589; GO:0032781; GO:0036376; GO:0044298; GO:0045494; GO:0046982; GO:0050821; GO:0051117; GO:0061744; GO:0071944; GO:0086009; GO:0086064; GO:0097449; GO:0097450; GO:0098984; GO:0120036; GO:0150104; GO:1901018; GO:1903278; GO:1903288; GO:1903976; GO:1990573	YQDRLATPGLMIRPK	3.619999886	1	1	0.185362736	1775.353663	0	13.72505	14.93531	14.2764	0	14.80338	15.23331	13.66804	13.5528	0	16.65257	14.12114	12.83046	0	0	12.10906	0	0	0	0	0	0	0	11.12125	0	0	0	0	16.70266	0	0	0	0	0	0	0	0	0	0	15.14679	0	0	0	0	0	0	0	0
P14543	NID1_HUMAN	"Nidogen-1, NID-1 (Entactin)"	NID1 NID	Homo sapiens (Human)	basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394]	GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0005886; GO:0007160; GO:0010811; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0051149; GO:0062023; GO:0070062; GO:0071711; GO:0098637; GO:0110011; GO:2001046	ESVENLAK	16.23999977	1	1	0.281199505	889.1500647	13.65478	14.38574	0	17.72152	14.66879	0	15.62574	0	0	16.26463	0	0	0	15.30274	0	15.04883	15.38338	13.77057	15.13753	0	0	0	0	16.08991	16.91676	0	16.27917	15.99199	0	16.02674	0	14.88419	0	0	0	0	0	0	16.79114	0	15.92893	16.28679	14.65332	0	0	14.80277	14.40036	16.25066
P14618	KPYM_HUMAN	"Pyruvate kinase PKM, EC 2.7.1.40 (Cytosolic thyroid hormone-binding protein, CTHBP) (Opa-interacting protein 3, OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2, EC 2.7.11.1) (Thyroid hormone-binding protein 1, THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2, EC 2.7.10.2) (p58)"	PKM OIP3 PK2 PK3 PKM2	Homo sapiens (Human)	cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0003729; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006096; GO:0012501; GO:0016301; GO:0023026; GO:0030955; GO:0031982; GO:0032869; GO:0034774; GO:0045296; GO:0062023; GO:0070062; GO:1903561; GO:1903672; GO:1904813; GO:2000767	APIIAVTR	4.519999981	1	1	0.202805806	840.6978062	15.0654	14.60759	0	15.78854	14.7333	13.6597	16.39034	15.64857	14.22154	0	16.35725	15.71125	0	15.99761	15.55681	0	0	0	14.42604	0	14.71295	16.61	0	15.20025	15.61885	0	0	16.18617	0	15.0153	14.99417	17.62095	16.22594	0	16.45184	0	0	0	0	0	0	0	0	0	0	0	15.10575	0
P14635	CCNB1_HUMAN	G2/mitotic-specific cyclin-B1	CCNB1 CCNB	Homo sapiens (Human)	cell division [GO:0051301]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]	centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; cell division [GO:0051301]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]	cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000079; GO:0000307; GO:0000922; GO:0000940; GO:0001701; GO:0005113; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0006468; GO:0007052; GO:0007080; GO:0010971; GO:0016020; GO:0016538; GO:0019901; GO:0044389; GO:0044772; GO:0045931; GO:0048146; GO:0051301; GO:0051987; GO:0061575; GO:0090266; GO:0097125; GO:1905448	AKINMAGAK	7.650000095	1	1	0.279199091	919.2056103	0	0	0	0	0	17.32446	0	0	0	0	0	0	0	17.8857	0	0	0	0	0	0	0	0	0	0	0	0	0	19.37235	0	0	0	0	18.1042	0	18.63435	18.61949	0	0	0	0	0	0	0	0	0	0	0	0
P14651	HXB3_HUMAN	Homeobox protein Hox-B3 (Homeobox protein Hox-2.7) (Homeobox protein Hox-2G)	HOXB3 HOX2G	Homo sapiens (Human)	angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; face development [GO:0060324]; glossopharyngeal nerve morphogenesis [GO:0021615]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere development [GO:0021546]; thyroid gland development [GO:0030878]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; face development [GO:0060324]; glossopharyngeal nerve morphogenesis [GO:0021615]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere development [GO:0021546]; thyroid gland development [GO:0030878]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0002244; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0021546; GO:0021615; GO:0030878; GO:0045944; GO:0048704; GO:0050767; GO:0051216; GO:0060216; GO:0060324	CGPGTNSTLTKQIFPWMK	4.269999981	1	1	0.034922872	2065.296944	13.38255	14.31179	0	0	0	13.04203	15.38691	16.3615	14.59265	14.1923	0	14.03551	0	13.24294	14.03263	11.94281	0	0	0	10.50894	0	0	14.56491	0	11.79201	0	0	14.95719	13.62541	13.23843	14.46992	12.42562	0	0	0	0	15.57328	0	0	0	15.99149	0	14.67095	14.41966	12.95281	0	15.19591	11.3373
P14735	IDE_HUMAN	"Insulin-degrading enzyme, EC 3.4.24.56 (Abeta-degrading protease) (Insulin protease, Insulinase) (Insulysin)"	IDE	Homo sapiens (Human)	amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]	ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0030163; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045732; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715	RIGNHITK	6.090000153	1	1	0.169500691	937.9102229	14.35722	12.7797	13.96532	0	0	0	15.69023	0	0	0	0	0	14.36528	0	0	14.12441	15.43042	0	0	0	13.88785	0	0	0	0	0	14.2817	0	15.33372	13.52285	14.56229	0	14.64812	0	0	0	0	0	15.25383	0	13.94805	13.93979	0	0	0	0	0	0
P14867	GBRA1_HUMAN	Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1)	GABRA1	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	"chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0004890; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0030659; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862	GDPGLATIAK	3.309999943	0.34675324	0.34675324	0.15807683	942.0489029	14.30571	0	0	12.10917	0	15.10325	12.88597	16.94847	15.82259	0	0	0	0	0	15.04553	0	0	0	0	0	0	0	0	0	0	0	13.98898	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.13081	0	0	0	0
P14920	OXDA_HUMAN	"D-amino-acid oxidase, DAAO, DAMOX, DAO, EC 1.4.3.3"	DAO DAMOX	Homo sapiens (Human)	D-alanine catabolic process [GO:0055130]; D-amino acid catabolic process [GO:0019478]; D-serine catabolic process [GO:0036088]; D-serine metabolic process [GO:0070178]; dopamine biosynthetic process [GO:0042416]; proline catabolic process [GO:0006562]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; identical protein binding [GO:0042802]; D-alanine catabolic process [GO:0055130]; D-amino acid catabolic process [GO:0019478]; D-serine catabolic process [GO:0036088]; D-serine metabolic process [GO:0070178]; dopamine biosynthetic process [GO:0042416]; proline catabolic process [GO:0006562]	D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; identical protein binding [GO:0042802]	GO:0003884; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006562; GO:0019478; GO:0036088; GO:0042416; GO:0042802; GO:0055130; GO:0070178; GO:0071949	DTVLGFRK	10.59000015	0.620060742	0.620060742	0.172721482	936.7408266	16.67354	17.66318	14.42397	18.46426	16.64543	17.36	14.43834	12.60015	0	15.95899	17.31373	17.49605	0	16.89367	12.948	18.36046	15.75777	13.92767	0	17.59023	14.9593	17.90152	0	15.91971	0	16.55886	16.65059	16.5885	14.84335	13.67811	17.70963	17.74196	0	0	13.63496	15.01592	15.85181	18.13865	0	16.94383	0	16.84945	13.91112	0	0	15.57425	17.22351	15.9628
P15036	ETS2_HUMAN	Protein C-ets-2	ETS2	Homo sapiens (Human)	cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0001712; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0007498; GO:0019904; GO:0030154; GO:0045944; GO:0061629; GO:0090009; GO:1990837	AVMSQALKATFSGFK	5.090000153	0.053106867	0.053106867	0.006795641	1600.713047	10.03347	12.67134	14.28063	14.49269	0	13.80353	16.7709	16.79241	0	16.85243	14.27862	13.89714	0	14.72064	0	0	12.98399	14.71296	12.47271	14.42185	15.22915	16.11029	17.83875	0	12.98541	16.48336	0	14.73842	0	14.99571	12.27282	0	0	13.66989	15.79585	12.76352	16.74256	0	13.7038	0	16.117	18.57766	15.8313	0	0	12.97941	0	12.23023
P15056	BRAF_HUMAN	"Serine/threonine-protein kinase B-raf, EC 2.7.11.1 (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1)"	BRAF BRAF1 RAFB1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cellular response to calcium ion [GO:0071277]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to membrane [GO:0090150]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; trehalose metabolism in response to stress [GO:0070413]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; animal organ morphogenesis [GO:0009887]; cellular response to calcium ion [GO:0071277]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to membrane [GO:0090150]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; trehalose metabolism in response to stress [GO:0070413]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]	GO:0000165; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007173; GO:0009887; GO:0010628; GO:0010828; GO:0033138; GO:0042802; GO:0043066; GO:0043231; GO:0070374; GO:0070413; GO:0071277; GO:0090150; GO:0097110; GO:0106310	TPIQAGGYGAFPVH	3.480000019	1	1	0.141734634	1414.138888	17.85282	0	0	0	0	0	14.68836	0	0	0	14.33412	0	13.07781	0	0	17.40973	0	0	0	0	0	0	0	0	17.24239	0	0	0	0	0	13.7317	0	17.14228	16.85957	0	15.2106	0	17.34189	0	0	0	0	0	0	0	0	0	0
P15088	CBPA3_HUMAN	"Mast cell carboxypeptidase A, MC-CPA, EC 3.4.17.1 (Carboxypeptidase A3)"	CPA3	Homo sapiens (Human)	angiotensin maturation [GO:0002003]; proteolysis [GO:0006508]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; proteolysis [GO:0006508]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0002003; GO:0004181; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0030133; GO:0030141; GO:0062023	VKPQDEK	3.400000095	1	1	0.036797721	842.9938735	16.13415	17.29984	16.90011	0	14.32509	0	0	18.02487	14.22771	0	15.08682	16.47415	15.75587	0	13.95344	0	0	17.43102	0	0	16.32555	17.16372	0	16.5588	14.64336	15.75019	13.9957	0	17.42112	16.2403	16.46915	16.39722	16.42178	18.40287	18.5207	17.35439	13.71807	16.39	16.08326	16.06295	17.93156	15.13568	17.98114	13.20187	15.97539	15.34498	18.42413	0
P15090	FABP4_HUMAN	"Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein, ALBP) (Adipocyte-type fatty acid-binding protein, A-FABP, AFABP) (Fatty acid-binding protein 4)"	FABP4	Homo sapiens (Human)	"brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; fatty acid transport [GO:0015908]; long-chain fatty acid transport [GO:0015909]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of inflammatory response [GO:0050729]; response to bacterium [GO:0009617]; white fat cell differentiation [GO:0050872]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; hormone receptor binding [GO:0051427]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; fatty acid transport [GO:0015908]; long-chain fatty acid transport [GO:0015909]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of inflammatory response [GO:0050729]; response to bacterium [GO:0009617]; white fat cell differentiation [GO:0050872]"	fatty acid binding [GO:0005504]; hormone receptor binding [GO:0051427]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]	GO:0005324; GO:0005504; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0006469; GO:0009617; GO:0015908; GO:0015909; GO:0036041; GO:0042632; GO:0045892; GO:0050729; GO:0050872; GO:0050873; GO:0051427; GO:0070062; GO:0071285; GO:0071356; GO:0120162	SESTFK	18.39999962	0.823070586	0.823070586	0.252676275	697.7681996	15.52331	14.53323	15.15488	15.06919	0	0	14.94043	0	0	15.55395	15.14984	15.19723	0	0	0	15.56635	0	0	17.31388	0	0	0	0	0	0	16.5919	0	15.88	0	16.6172	0	0	0	0	0	0	16.86364	0	0	0	15.91817	15.84303	13.58443	14.50961	0	16.11561	0	16.42264
P15144	AMPN_HUMAN	"Aminopeptidase N, AP-N, hAPN, EC 3.4.11.2 (Alanyl aminopeptidase) (Aminopeptidase M, AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)"	ANPEP APN CD13 PEPN	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0070006; GO:0070062	AALACSKELWILNR	5.170000076	1	1	0.081589482	1643.968962	18.32044	0	0	0	0	0	17.53761	0	0	0	0	0	0	0	0	0	0	0	0	0	16.65061	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.32048	0	0
P15169	CBPN_HUMAN	"Carboxypeptidase N catalytic chain, CPN, EC 3.4.17.3 (Anaphylatoxin inactivator) (Arginine carboxypeptidase) (Carboxypeptidase N polypeptide 1) (Carboxypeptidase N small subunit) (Kininase-1) (Lysine carboxypeptidase) (Plasma carboxypeptidase B) (Serum carboxypeptidase N, SCPN)"	CPN1 ACBP	Homo sapiens (Human)	bradykinin catabolic process [GO:0010815]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; response to glucocorticoid [GO:0051384]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; bradykinin catabolic process [GO:0010815]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; response to glucocorticoid [GO:0051384]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005576; GO:0005615; GO:0006518; GO:0008270; GO:0010815; GO:0016485; GO:0051384	RSIPQVSPVR	15.17000008	1	1	0.572321657	1138.029985	0	0	0	0	0	18.94167	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.41846	0	0	0	19.10924	0	0	0	0	0	0	0	17.57111	0	0	0	0	0	0	0	0
P15311	EZRI_HUMAN	Ezrin (Cytovillin) (Villin-2) (p81)	EZR VIL2	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell periphery [GO:0071944]; cell projection [GO:0042995]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell periphery [GO:0071944]; cell projection [GO:0042995]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]	GO:0000122; GO:0001650; GO:0001726; GO:0001772; GO:0001931; GO:0001951; GO:0003376; GO:0003723; GO:0003779; GO:0005615; GO:0005737; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0005925; GO:0007159; GO:0008017; GO:0008022; GO:0008360; GO:0010628; GO:0010737; GO:0015629; GO:0016020; GO:0016323; GO:0016324; GO:0019898; GO:0019904; GO:0022614; GO:0030033; GO:0030175; GO:0030863; GO:0030953; GO:0031503; GO:0031528; GO:0031532; GO:0031623; GO:0031982; GO:0032532; GO:0032587; GO:0032703; GO:0032991; GO:0034236; GO:0034237; GO:0035088; GO:0036064; GO:0040018; GO:0042802; GO:0042995; GO:0043622; GO:0044548; GO:0044853; GO:0045177; GO:0045296; GO:0046847; GO:0048015; GO:0048471; GO:0050714; GO:0050839; GO:0050860; GO:0051015; GO:0051017; GO:0051018; GO:0051117; GO:0051660; GO:0061028; GO:0070062; GO:0070373; GO:0071320; GO:0071944; GO:0072659; GO:0072697; GO:0097718; GO:0098592; GO:1902115; GO:1902896; GO:1902966; GO:1903078; GO:1903364; GO:1903753; GO:2000643	EAQDDLVKTK	5.960000038	1	1	0.208784738	1146.992206	0	0	14.6764	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.55589	0	16.90415	0	0	0	0	0	0	16.42097	0	0	0	16.06508	15.71529	12.67869	16.00848	0	14.70187	0	0	0	0	0	0	0	0	16.90035	0	0	0
P15336	ATF2_HUMAN	"Cyclic AMP-dependent transcription factor ATF-2, cAMP-dependent transcription factor ATF-2 (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2, CREB-2, cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1)"	ATF2 CREB2 CREBP1	Homo sapiens (Human)	"abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; cellular lipid metabolic process [GO:0044255]; cellular response to anisomycin [GO:0072740]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; facial nucleus development [GO:0021754]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; liver development [GO:0001889]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to organic cyclic compound [GO:0014070]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872]"	CCAAT-binding factor complex [GO:0016602]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; H4 histone acetyltransferase complex [GO:1902562]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861]	"CCAAT-binding factor complex [GO:0016602]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; H4 histone acetyltransferase complex [GO:1902562]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861]; cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; H2B histone acetyltransferase activity [GO:0044013]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; cellular lipid metabolic process [GO:0044255]; cellular response to anisomycin [GO:0072740]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; facial nucleus development [GO:0021754]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; histone H2B acetylation [GO:0043969]; histone H4 acetylation [GO:0043967]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; liver development [GO:0001889]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to organic cyclic compound [GO:0014070]; response to osmotic stress [GO:0006970]; response to water deprivation [GO:0009414]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872]"	"cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; H2B histone acetyltransferase activity [GO:0044013]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001701; GO:0001865; GO:0001889; GO:0001934; GO:0002244; GO:0003151; GO:0003360; GO:0003418; GO:0003419; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006606; GO:0006970; GO:0006974; GO:0007033; GO:0007254; GO:0008140; GO:0009414; GO:0010485; GO:0010628; GO:0014070; GO:0016525; GO:0016602; GO:0018107; GO:0019901; GO:0021742; GO:0021743; GO:0021754; GO:0030509; GO:0031573; GO:0032915; GO:0034599; GO:0035497; GO:0035861; GO:0038066; GO:0042789; GO:0042802; GO:0042803; GO:0043522; GO:0043525; GO:0043967; GO:0043969; GO:0044013; GO:0044255; GO:0044877; GO:0045944; GO:0046872; GO:0046982; GO:0050680; GO:0050872; GO:0051091; GO:0060052; GO:0060245; GO:0060612; GO:0061629; GO:0072740; GO:0090575; GO:0097049; GO:0097186; GO:0097284; GO:0098586; GO:0110024; GO:1901522; GO:1902110; GO:1902562; GO:1902742; GO:1990144; GO:1990253; GO:1990837; GO:1990841	NEVAQLKQLLLAHK	3.49000001	1	1	0.135332497	1605.097354	0	16.4703	0	0	0	0	0	15.45006	11.29482	0	0	0	0	0	0	0	15.00405	0	0	0	0	15.80735	0	0	0	0	0	0	0	0	0	0	0	16.35389	0	0	0	0	15.41449	0	0	0	0	0	0	16.86945	15.85703	0
P15391	CD19_HUMAN	B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19)	CD19	Homo sapiens (Human)	antigen receptor-mediated signaling pathway [GO:0050851]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell differentiation [GO:0001923]; immunoglobulin mediated immune response [GO:0016064]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of B cell activation [GO:0050864]; regulation of B cell receptor signaling pathway [GO:0050855]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell differentiation [GO:0001923]; immunoglobulin mediated immune response [GO:0016064]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of B cell activation [GO:0050864]; regulation of B cell receptor signaling pathway [GO:0050855]		GO:0001923; GO:0002322; GO:0005886; GO:0005887; GO:0009897; GO:0016064; GO:0032991; GO:0043552; GO:0045121; GO:0050851; GO:0050853; GO:0050855; GO:0050864; GO:0051281; GO:0070062	MTDPTR	1.350000024	0.381401271	0.381401271	0.163404875	720.6130063	15.99596	15.53069	15.05434	16.09015	16.58195	0	15.21255	0	16.42769	0	15.63002	0	15.66224	14.86107	0	0	0	0	0	13.82705	15.90071	0	0	0	0	0	15.67315	13.15592	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.59819	0	0	15.31454	0	14.56588
P15421	GLPE_HUMAN	Glycophorin-E	GYPE GPE	Homo sapiens (Human)		integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]		GO:0005886; GO:0005887	VIFEVMLVVVGMIILISYCIR	3.289999962	1	1	0.219370574	2484.429333	0	0	13.94209	13.73173	14.40789	0	0	0	0	0	0	0	0	0	8.843905	14.16782	0	0	0	0	0	0	16.65621	0	13.82078	0	0	0	0	13.74746	0	14.34863	17.55197	0	14.88743	0	0	0	0	15.62299	15.88585	0	16.65109	0	0	0	0	0
P15498	VAV_HUMAN	Proto-oncogene vav	VAV1 VAV	Homo sapiens (Human)	Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; reactive oxygen species metabolic process [GO:0072593]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; reactive oxygen species metabolic process [GO:0072593]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0005085; GO:0005829; GO:0005886; GO:0005911; GO:0006955; GO:0007186; GO:0007229; GO:0007264; GO:0008361; GO:0030168; GO:0030217; GO:0030593; GO:0031295; GO:0038095; GO:0038096; GO:0043087; GO:0043547; GO:0045954; GO:0046872; GO:0048010; GO:0051056; GO:0072593; GO:0140031	MTEYDK	13.05000019	0.395824045	0.395824045	0.248829248	784.6633894	0	21.84504	19.32614	0	19.06609	0	0	21.85353	0	19.7939	18.9259	16.7252	18.02124	0	21.81762	18.16906	18.0875	0	0	0	0	20.34839	0	19.54928	21.34356	0	0	21.49378	21.59355	0	18.30663	21.21682	19.37924	0	0	22.74775	0	22.58463	18.40299	17.84862	19.35474	0	19.32137	21.19185	0	21.02371	18.70575	0
P15531	NDKA_HUMAN	"Nucleoside diphosphate kinase A, NDK A, NDP kinase A, EC 2.7.4.6 (Granzyme A-activated DNase, GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)"	NME1 NDPKA NM23	Homo sapiens (Human)	cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228]	ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007399; GO:0007595; GO:0008285; GO:0016020; GO:0030154; GO:0032587; GO:0042802; GO:0042981; GO:0043024; GO:0043388; GO:0050679; GO:0070062	YMHSGPVVAMVWEGLNVVKTGR	5.920000076	1	1	0	2446.088003	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P15586	GNS_HUMAN	"N-acetylglucosamine-6-sulfatase, EC 3.1.6.14 (Glucosamine-6-sulfatase, G6S)"	GNS	Homo sapiens (Human)	glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340]	glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]	GO:0005539; GO:0005576; GO:0006027; GO:0008449; GO:0008484; GO:0035578; GO:0042340; GO:0043199; GO:0043202; GO:0046872; GO:0070062; GO:1904813	GASNLTWR	5.309999943	1	1	0.168516331	905.8549776	14.41324	0	0	0	0	0	0	0	20.98875	15.59586	0	0	0	13.79557	0	0	0	0	0	0	11.24756	0	0	0	0	0	0	14.8139	17.01835	0	0	15.39174	0	0	0	14.51689	0	0	0	0	0	0	0	0	0	0	0	0
P15622	ZN250_HUMAN	Zinc finger protein 250 (Zinc finger protein 647)	ZNF250 ZNF647	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872; GO:1990837	MAAARLLPVPAGPQPLSFQAK	8.640000343	1	1	5.03E-12	2162.242692	11.44547	10.69405	0	13.77168	11.59686	13.4074	13.5928	0	0	11.88991	0	12.02445	0	0	0	12.24455	0	13.26184	13.20756	12.07723	0	15.11365	12.9112	0	0	14.35334	13.30765	9.870798	13.57672	0	0	0	0	0	0	0	0	12.93715	0	15.54993	0	0	13.77635	0	15.80492	0	0	0
P15692	VEGFA_HUMAN	"Vascular endothelial growth factor A, VEGF-A (Vascular permeability factor, VPF)"	VEGFA VEGF	Homo sapiens (Human)	activation of protein kinase activity [GO:0032147]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; epithelial cell differentiation [GO:0030855]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; induction of positive chemotaxis [GO:0050930]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lymph vessel morphogenesis [GO:0036303]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cellular component movement [GO:0051272]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein kinase D signaling [GO:1903572]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172]; activation of protein kinase activity [GO:0032147]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; epithelial cell differentiation [GO:0030855]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; induction of positive chemotaxis [GO:0050930]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lymph vessel morphogenesis [GO:0036303]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cellular component movement [GO:0051272]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein kinase D signaling [GO:1903572]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172]	GO:0000122; GO:0001525; GO:0001541; GO:0001569; GO:0001570; GO:0001666; GO:0001701; GO:0001822; GO:0001934; GO:0001938; GO:0001968; GO:0002040; GO:0002042; GO:0002052; GO:0002092; GO:0002575; GO:0002687; GO:0003007; GO:0003151; GO:0003169; GO:0005125; GO:0005161; GO:0005172; GO:0005576; GO:0005615; GO:0005737; GO:0005912; GO:0006357; GO:0007399; GO:0007498; GO:0007595; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009986; GO:0010595; GO:0010628; GO:0010629; GO:0010749; GO:0014068; GO:0016020; GO:0030141; GO:0030224; GO:0030225; GO:0030324; GO:0030335; GO:0030855; GO:0031012; GO:0031077; GO:0031093; GO:0031334; GO:0031954; GO:0032147; GO:0032793; GO:0033138; GO:0035148; GO:0035767; GO:0035924; GO:0036303; GO:0036324; GO:0038033; GO:0038084; GO:0038089; GO:0038091; GO:0038190; GO:0038191; GO:0042056; GO:0042327; GO:0042462; GO:0042802; GO:0042803; GO:0043066; GO:0043117; GO:0043129; GO:0043154; GO:0043183; GO:0043184; GO:0043406; GO:0043410; GO:0043536; GO:0045766; GO:0045785; GO:0045944; GO:0048010; GO:0048018; GO:0048469; GO:0048593; GO:0048842; GO:0048844; GO:0050679; GO:0050731; GO:0050840; GO:0050918; GO:0050927; GO:0050930; GO:0051272; GO:0051781; GO:0051894; GO:0051897; GO:0055013; GO:0060319; GO:0060749; GO:0060754; GO:0060948; GO:0060982; GO:0061042; GO:0061419; GO:0070374; GO:0071456; GO:0071542; GO:0071679; GO:0090037; GO:0090050; GO:0090190; GO:0090259; GO:0097475; GO:0097533; GO:0120162; GO:1900086; GO:1900745; GO:1901165; GO:1901727; GO:1902336; GO:1902966; GO:1903141; GO:1903392; GO:1903572; GO:1903589; GO:1903672; GO:1905278; GO:1905604; GO:2000048; GO:2000573	CECRPKK	8.920000076	1	1	6.88E-13	977.4326054	13.984	14.02255	14.79265	12.73269	11.48849	8.977355	0	15.7995	7.88237	15.47023	14.18085	15.7798	0	0	0	0	0	0	15.50954	0	0	14.71471	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P15822	ZEP1_HUMAN	"Zinc finger protein 40 (Cirhin interaction protein, CIRIP) (Gate keeper of apoptosis-activating protein, GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1, HIV-EP1) (Major histocompatibility complex-binding protein 1, MBP-1) (Positive regulatory domain II-binding factor 1, PRDII-BF1)"	HIVEP1 ZNF40	Homo sapiens (Human)	BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0016604; GO:0030509; GO:0045944; GO:0046872; GO:1990837	GPLVR	9.090000153	1	1	0.086287968	543.4449006	15.35148	0	0	0	0	14.06765	13.90918	0	0	12.20738	13.59472	0	15.72367	0	0	16.18967	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P15848	ARSB_HUMAN	"Arylsulfatase B, ASB, EC 3.1.6.12 (N-acetylgalactosamine-4-sulfatase, G4S)"	ARSB	Homo sapiens (Human)	autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]	GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813	ATGVWGPWM	8.880000114	1	1	0.09976728	1003.520433	0	0	0	0	13.86872	15.32968	0	0	0	17.9988	0	0	17.21329	15.33686	14.14537	14.59101	0	0	0	0	0	0	0	15.65541	15.48353	12.76367	0	0	0	0	0	0	0	0	0	12.41613	0	0	15.61114	0	0	16.4245	0	0	16.09735	0	0	0
P15863	PAX1_HUMAN	Paired box protein Pax-1 (HuP48)	PAX1 HUP48	Homo sapiens (Human)	anatomical structure development [GO:0048856]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001501; GO:0005634; GO:0006357; GO:0006366; GO:0048856; GO:1990837	VSWEGAAAAAAGPGAGGSALR	4.659999847	1	1	1.37E-12	1831.251143	11.14623	14.7937	13.91632	0	0	0	15.63934	15.70772	0	0	0	0	0	0	0	14.30272	0	15.5	0	0	0	0	0	10.57163	0	0	14.80181	0	17.62069	15.48992	15.61528	15.42216	0	13.41363	13.84973	16.31514	0	15.80939	0	0	15.94409	0	0	0	0	0	0	0
P15882	CHIN_HUMAN	"N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin, NC) (Rho GTPase-activating protein 2)"	CHN1 ARHGAP2 CHN	Homo sapiens (Human)	ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; positive regulation of GTPase activity [GO:0043547]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]	cytosol [GO:0005829]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; positive regulation of GTPase activity [GO:0043547]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005829; GO:0008045; GO:0043087; GO:0043547; GO:0046872; GO:0046875; GO:0048013; GO:0050770; GO:0051056	LTSLVRR	2.079999924	0.453846276	0.453846276	0.156074019	844.1879879	14.71621	15.19019	14.94928	0	0	0	0	0	15.5293	0	0	0	16.71324	15.71127	0	0	0	0	0	0	17.10112	0	0	0	16.51146	0	15.81645	0	0	0	0	0	0	15.56847	12.9827	0	0	14.70285	0	14.965	15.59299	0	0	14.93611	15.32523	14.1168	13.70387	15.47932
P15918	RAG1_HUMAN	"V(D)J recombination-activating protein 1, RAG-1 (RING finger protein 74) [Includes: Endonuclease RAG1, EC 3.1.-.-; E3 ubiquitin-protein ligase RAG1, EC 2.3.2.27 (RING-type E3 ubiquitin transferase RAG1) ]"	RAG1 RNF74	Homo sapiens (Human)	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; histone monoubiquitination [GO:0010390]; immune response [GO:0006955]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542]	DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; histone monoubiquitination [GO:0010390]; immune response [GO:0006955]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542]	DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0002250; GO:0002331; GO:0003677; GO:0004519; GO:0004842; GO:0005634; GO:0005654; GO:0006310; GO:0006325; GO:0006955; GO:0008270; GO:0008542; GO:0010390; GO:0030183; GO:0033077; GO:0033151; GO:0042393; GO:0042803; GO:0043029; GO:0043154; GO:0043565; GO:0045582; GO:0046872; GO:0048538; GO:0051865; GO:0061630; GO:0070244; GO:0097519; GO:1905347; GO:2000822	AFADKEEGGDVK	8.670000076	0.297007918	0.297007918	2.74E-12	1265.279272	12.63001	0	0	0	0	0	0	13.59039	15.23119	13.34428	0	0	0	0	0	15.53465	0	0	13.1353	14.20733	0	0	11.76884	0	0	14.48346	0	0	12.47758	15.10697	0	0	14.17507	14.84296	0	0	0	0	14.02388	8.49655	0	12.75364	13.14605	0	0	0	0	0
P15924	DESP_HUMAN	"Desmoplakin, DP (250/210 kDa paraneoplastic pemphigus antigen)"	DSP	Homo sapiens (Human)	adherens junction organization [GO:0034332]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein localization to cell-cell junction [GO:0150105]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]; ventricular compact myocardium morphogenesis [GO:0003223]; wound healing [GO:0042060]	basolateral plasma membrane [GO:0016323]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; ficolin-1-rich granule membrane [GO:0101003]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; ficolin-1-rich granule membrane [GO:0101003]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; adherens junction organization [GO:0034332]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein localization to cell-cell junction [GO:0150105]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]; ventricular compact myocardium morphogenesis [GO:0003223]; wound healing [GO:0042060]	cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0001533; GO:0002934; GO:0003223; GO:0003723; GO:0005080; GO:0005198; GO:0005200; GO:0005634; GO:0005737; GO:0005882; GO:0005886; GO:0005916; GO:0008544; GO:0014704; GO:0016020; GO:0016323; GO:0018149; GO:0030057; GO:0030216; GO:0034332; GO:0042060; GO:0043588; GO:0045104; GO:0045109; GO:0070062; GO:0086073; GO:0086083; GO:0086091; GO:0090136; GO:0097110; GO:0098609; GO:0098911; GO:0101003; GO:0150105	EDDSKNLR	5.079999924	0.284780771	0.284780771	0.247028315	976.3109716	14.92463	14.55288	0	18.85769	11.14079	15.58499	15.15109	0	17.04773	16.60365	9.780122	14.62633	16.19275	0	0	15.51148	0	16.05028	0	0	15.21854	0	16.22834	16.64079	16.09124	0	16.86503	0	0	18.33374	0	12.52546	0	16.40579	0	0	0	0	0	0	19.05638	13.87966	0	0	13.76253	0	15.80614	17.04364
P15976	GATA1_HUMAN	"Erythroid transcription factor (Eryf1) (GATA-binding factor 1, GATA-1, GF-1) (NF-E1 DNA-binding protein)"	GATA1 ERYF1 GF1	Homo sapiens (Human)	"animal organ regeneration [GO:0031100]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; dendritic cell differentiation [GO:0097028]; embryonic hemopoiesis [GO:0035162]; eosinophil differentiation [GO:0030222]; eosinophil fate commitment [GO:0035854]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of primitive erythrocyte differentiation [GO:0010725]; Sertoli cell development [GO:0060009]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; C2H2 zinc finger domain binding [GO:0070742]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; animal organ regeneration [GO:0031100]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; dendritic cell differentiation [GO:0097028]; embryonic hemopoiesis [GO:0035162]; eosinophil differentiation [GO:0030222]; eosinophil fate commitment [GO:0035854]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of primitive erythrocyte differentiation [GO:0010725]; Sertoli cell development [GO:0060009]"	"C2H2 zinc finger domain binding [GO:0070742]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001223; GO:0001228; GO:0001701; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0007204; GO:0007267; GO:0008270; GO:0008285; GO:0008584; GO:0010559; GO:0010724; GO:0010725; GO:0017053; GO:0030218; GO:0030219; GO:0030220; GO:0030221; GO:0030222; GO:0030502; GO:0031100; GO:0031490; GO:0032993; GO:0033690; GO:0035162; GO:0035854; GO:0043066; GO:0043306; GO:0043565; GO:0045165; GO:0045648; GO:0045893; GO:0045944; GO:0048821; GO:0048873; GO:0050731; GO:0060009; GO:0061629; GO:0070527; GO:0070742; GO:0071222; GO:0071320; GO:0071372; GO:0097028; GO:0097067; GO:1990837; GO:2000678; GO:2001240	LHQVNRPLTMRK	13.94999981	1	1	0.509681502	1508.762528	0	20.39921	0	18.21398	19.07066	16.85939	0	0	0	16.67211	18.43862	0	0	0	0	20.27287	0	0	17.36158	0	17.07206	18.50924	19.16523	0	19.06165	19.08005	18.16147	0	0	0	19.98598	0	19.36139	20.60911	0	0	19.04477	21.15723	19.79757	0	0	0	19.78264	20.19123	0	0	19.64235	0
P16070	CD44_HUMAN	"CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III, ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1, PGP-1) (Phagocytic glycoprotein I, PGP-I) (CD antigen CD44)"	CD44 LHR MDU2 MDU3 MIC4	Homo sapiens (Human)	"cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of lamellipodium morphogenesis [GO:2000392]; T cell activation [GO:0042110]; wound healing, spreading of cells [GO:0044319]"	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; macrophage migration inhibitory factor receptor complex [GO:0035692]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; macrophage migration inhibitory factor receptor complex [GO:0035692]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; collagen binding [GO:0005518]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of lamellipodium morphogenesis [GO:2000392]; T cell activation [GO:0042110]; wound healing, spreading of cells [GO:0044319]"	collagen binding [GO:0005518]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005518; GO:0005540; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0005902; GO:0005925; GO:0006954; GO:0007155; GO:0007160; GO:0009986; GO:0016323; GO:0016324; GO:0016477; GO:0019221; GO:0030214; GO:0030667; GO:0031258; GO:0033138; GO:0034116; GO:0035692; GO:0042110; GO:0042995; GO:0043066; GO:0043154; GO:0043518; GO:0044319; GO:0044344; GO:0050731; GO:0051216; GO:0070062; GO:0070374; GO:0070487; GO:0098609; GO:1900625; GO:1902166; GO:2000392	GHQAGRR	3.930000067	1	1	0.104433189	781.0861453	17.07309	0	0	0	0	0	0	0	15.71623	13.64817	0	14.68261	0	0	0	0	0	0	0	0	0	0	0	0	15.07003	0	15.98192	16.36374	0	0	0	0	0	0	17.39378	0	15.86637	0	0	0	0	0	0	0	0	0	0	15.32774
P16104	H2AX_HUMAN	"Histone H2AX, H2a/x (Histone H2A.X)"	H2AX H2AFX	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; cerebral cortex development [GO:0021987]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleosome assembly [GO:0006334]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; XY body [GO:0001741]	centrosome [GO:0005813]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; XY body [GO:0001741]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; cerebral cortex development [GO:0021987]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleosome assembly [GO:0006334]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283]	damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]	GO:0000077; GO:0000724; GO:0000786; GO:0000794; GO:0001673; GO:0001741; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005813; GO:0006302; GO:0006334; GO:0006974; GO:0007283; GO:0010212; GO:0016607; GO:0019899; GO:0021987; GO:0035861; GO:0042393; GO:0045739; GO:0046982; GO:0051321; GO:0070062; GO:0071480; GO:0090398; GO:0090734	TGGKAR	5.239999771	1	1	2.34E-13	588.3318245	15.30542	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.65662	0	0	0	0	0	0	0	15.3111	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P16112	PGCA_HUMAN	"Aggrecan core protein (Cartilage-specific proteoglycan core protein, CSPCP) (Chondroitin sulfate proteoglycan core protein 1, Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2 ]"	ACAN AGC1 CSPG1 MSK16	Homo sapiens (Human)	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]	GO:0001501; GO:0005201; GO:0005540; GO:0005576; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0043202; GO:0046872; GO:0062023	HMPTIR	5.039999962	0.86012578	0.86012578	0.077635943	753.6436928	0	0	14.31046	15.56879	0	0	0	0	0	15.92118	0	0	0	0	12.67881	0	0	0	0	0	0	0	16.64122	0	0	0	13.64476	0	0	0	0	0	0	0	0	0	0	0	0	14.72611	0	0	0	0	0	0	11.17219	0
P16144	ITB4_HUMAN	Integrin beta-4 (GP150) (CD antigen CD104)	ITGB4	Homo sapiens (Human)	autophagy [GO:0006914]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; nail development [GO:0035878]; peripheral nervous system myelin formation [GO:0032290]; response to wounding [GO:0009611]; skin morphogenesis [GO:0043589]; trophoblast cell migration [GO:0061450]	basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin complex [GO:0008305]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin complex [GO:0008305]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; nail development [GO:0035878]; peripheral nervous system myelin formation [GO:0032290]; response to wounding [GO:0009611]; skin morphogenesis [GO:0043589]; trophoblast cell migration [GO:0061450]	G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]	GO:0001664; GO:0005178; GO:0005604; GO:0005730; GO:0005886; GO:0005925; GO:0006914; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009611; GO:0009925; GO:0009986; GO:0016477; GO:0030054; GO:0030056; GO:0031252; GO:0031581; GO:0031965; GO:0032290; GO:0033627; GO:0035878; GO:0043235; GO:0043589; GO:0046847; GO:0048333; GO:0048870; GO:0061450; GO:0070062	GRTCEECNFK	11.43000031	1	1	0.061291665	1299.515541	0	0	14.04369	12.93812	13.08401	14.86662	10.92796	13.183	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.11685	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P16219	ACADS_HUMAN	"Short-chain specific acyl-CoA dehydrogenase, mitochondrial, SCAD, EC 1.3.8.1 (Butyryl-CoA dehydrogenase)"	ACADS	Homo sapiens (Human)	butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0004085; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005813; GO:0006635; GO:0033539; GO:0046359; GO:0050660	DSILGEPGMGFKIAMQTLDMGR	6.730000019	1	1	0.289871679	2397.765969	10.03615	17.01389	15.94276	0	0	13.63868	0	0	0	0	0	0	0	0	0	0	0	0	0	17.19669	0	17.11286	0	0	0	0	14.6814	0	0	0	0	0	0	16.19895	0	16.35322	17.58188	17.40964	0	0	0	16.76763	0	19.69076	0	18.59716	0	0
P16233	LIPP_HUMAN	"Pancreatic triacylglycerol lipase, PL, PTL, Pancreatic lipase, EC 3.1.1.3"	PNLIP	Homo sapiens (Human)	intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	"extracellular region [GO:0005576]; extracellular space [GO:0005615]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]"	"all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]"	GO:0004806; GO:0005576; GO:0005615; GO:0006629; GO:0016042; GO:0016298; GO:0030299; GO:0046872; GO:0047376; GO:0061365	FIWYNNVINPTLPRVGASK	3.940000057	1	1	0.002796517	2189.263808	0	0	0	0	10.32672	14.49562	0	14.26673	13.1307	0	14.82579	16.25221	14.42795	14.3122	16.00526	15.10184	0	0	16.16781	0	0	0	16.19172	0	15.78032	16.2986	0	0	16.36696	0	0	0	0	0	0	0	15.93694	0	0	0	0	0	0	0	0	0	15.21045	0
P16234	PGFRA_HUMAN	"Platelet-derived growth factor receptor alpha, PDGF-R-alpha, PDGFR-alpha, EC 2.7.10.1 (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2, PDGFR-2) (CD antigen CD140a)"	PDGFRA PDGFR2 RHEPDGFRA	Homo sapiens (Human)	adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]	cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001553; GO:0001701; GO:0001775; GO:0002244; GO:0004672; GO:0004712; GO:0004714; GO:0005018; GO:0005021; GO:0005161; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0007169; GO:0007204; GO:0008210; GO:0008284; GO:0009897; GO:0010544; GO:0010863; GO:0014068; GO:0016020; GO:0018108; GO:0019838; GO:0023019; GO:0030054; GO:0030198; GO:0030324; GO:0030325; GO:0030335; GO:0030539; GO:0031226; GO:0032991; GO:0033327; GO:0033674; GO:0034614; GO:0035790; GO:0038085; GO:0038091; GO:0042060; GO:0042475; GO:0042803; GO:0043235; GO:0043552; GO:0044877; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048557; GO:0048701; GO:0048704; GO:0050872; GO:0050920; GO:0055003; GO:0060021; GO:0060325; GO:0060326; GO:0061298; GO:0070374; GO:0070527; GO:0071230; GO:0072277; GO:2000249; GO:2000739	SQPVMKVAVK	4.690000057	1	1	0.392138321	1102.101043	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P16298	PP2BB_HUMAN	"Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, EC 3.1.3.16 (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform, CNA beta)"	PPP3CB CALNA2 CALNB CNA2	Homo sapiens (Human)	"axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of signaling [GO:0023057]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]"	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; T-tubule [GO:0030315]; Z disc [GO:0030018]	"calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of signaling [GO:0023057]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]"	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007507; GO:0007612; GO:0007613; GO:0008287; GO:0016311; GO:0017156; GO:0019899; GO:0023057; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035774; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0048741; GO:0050796; GO:0070886; GO:0097720; GO:0098978; GO:1900242; GO:1901386; GO:1901387; GO:1905665; GO:1905949	EKTMIEVEAPITVCGDIHGQFFDLMK	9.390000343	1	1	3.21E-12	3023.928362	0	11.95848	8.395365	0	0	0	0	13.4402	14.70389	13.064	14.4515	0	13.67146	0	13.36747	0	0	10.55255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P16333	NCK1_HUMAN	"Cytoplasmic protein NCK1 (NCK adaptor protein 1, Nck-1) (SH2/SH3 adaptor protein NCK-alpha)"	NCK1 NCK	Homo sapiens (Human)	"actin filament organization [GO:0007015]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]"	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]	"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]"	cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007165; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0016477; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0033137; GO:0035591; GO:0036493; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048013; GO:0051707; GO:0060548; GO:0070262; GO:0071074; GO:1902237; GO:1903676; GO:1903679; GO:1903898; GO:1903912; GO:1990441	INGMVGLVPK	5.489999771	0.295540839	0.295540839	0.218748338	1040.336322	15.89307	0	14.36255	14.50646	14.44487	14.79122	15.99092	0	12.5208	14.72217	13.79245	0	15.29052	15.28048	15.58806	0	0	9.915851	15.21427	0	15.0302	0	0	0	14.49058	0	15.15793	14.61765	11.00121	15.47578	13.46935	13.4323	0	15.29383	14.02797	14.52394	14.5812	14.03617	14.73775	0	0	16.28871	13.96566	12.35346	0	0	14.59017	6.682618
P16383	GCFC2_HUMAN	"Intron Large complex component GCFC2 (GC-rich sequence DNA-binding factor) (GC-rich sequence DNA-binding factor 2) (Transcription factor 9, TCF-9)"	GCFC2 C2orf3 GCF TCF9	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal complex assembly [GO:0000245]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type post-mRNA release spliceosomal complex [GO:0071008]	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; DNA binding [GO:0003677]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal complex assembly [GO:0000245]"	DNA binding [GO:0003677]	GO:0000245; GO:0000398; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0045892; GO:0071008	ALNQAESFIGEHHLDHLKSLIK	3.589999914	1	1	0.033925888	2499.856349	0	0	0	0	0	0	12.57595	0	0	0	0	0	0	18.2803	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P16435	NCPR_HUMAN	"NADPH--cytochrome P450 reductase, CPR, P450R, EC 1.6.2.4"	POR CYPOR	Homo sapiens (Human)	carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; electron transport chain [GO:0022900]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to dexamethasone [GO:0071548]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; electron transport chain [GO:0022900]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to dexamethasone [GO:0071548]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]"	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]"	GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0006805; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0022900; GO:0032332; GO:0032770; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0071548; GO:0090031; GO:0090346	LMTKGR	5.630000114	1	1	0	720.824981	0	8.526248	15.74719	0	0	0	0	0	0	0	0	0	0	0	0	0	16.11996	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P16442	BGAT_HUMAN	"Histo-blood group ABO system transferase (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase, EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase, EC 2.4.1.37) (Histo-blood group A transferase, A transferase) (Histo-blood group B transferase, B transferase) (NAGAT) [Cleaved into: Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form ]"	ABO	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; antigen binding [GO:0003823]; fucosylgalactoside 3-alpha-galactosyltransferase activity [GO:0004381]; glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [GO:0004380]; glycosyltransferase activity [GO:0016757]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486]	antigen binding [GO:0003823]; fucosylgalactoside 3-alpha-galactosyltransferase activity [GO:0004381]; glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [GO:0004380]; glycosyltransferase activity [GO:0016757]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]	GO:0000139; GO:0000166; GO:0003823; GO:0004380; GO:0004381; GO:0005576; GO:0005794; GO:0005975; GO:0006486; GO:0016021; GO:0016757; GO:0030145; GO:0030259; GO:0031982; GO:0032580	FLSEVDYLVCVDVDMEFR	1.070000052	1	1	0.218919687	2251.510755	13.49286	14.90195	0	17.3778	11.4203	0	0	0	11.10445	13.35407	15.83303	0	0	8.022273	14.91194	13.77026	0	0	16.87082	0	14.2783	0	0	0	0	11.56125	12.67125	13.98487	0	0	0	0	0	0	0	0	0	16.12988	0	0	0	0	0	0	0	0	0	0
P16444	DPEP1_HUMAN	"Dipeptidase 1, EC 3.4.13.19 (Beta-lactamase, EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase, hRDP)"	DPEP1 MDP RDP	Homo sapiens (Human)	antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]	beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]	GO:0005615; GO:0005654; GO:0005886; GO:0006629; GO:0006749; GO:0006751; GO:0008235; GO:0008270; GO:0008800; GO:0016324; GO:0016999; GO:0030054; GO:0030336; GO:0031225; GO:0031528; GO:0034235; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071466; GO:0071732; GO:0072340; GO:0072341	AGFVGGQFWSVYTPCDTQNK	5.980000019	1	1	0.490761336	2262.39535	18.59659	0	0	16.89558	18.92202	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P16452	EPB42_HUMAN	"Protein 4.2, P4.2 (Erythrocyte membrane protein band 4.2, Erythrocyte protein 4.2)"	EPB42 E42P	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; erythrocyte maturation [GO:0043249]; hemoglobin metabolic process [GO:0020027]; iron ion homeostasis [GO:0055072]; peptide cross-linking [GO:0018149]; regulation of cell shape [GO:0008360]; spleen development [GO:0048536]	cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]	cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; erythrocyte maturation [GO:0043249]; hemoglobin metabolic process [GO:0020027]; iron ion homeostasis [GO:0055072]; peptide cross-linking [GO:0018149]; regulation of cell shape [GO:0008360]; spleen development [GO:0048536]	ATP binding [GO:0005524]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural constituent of cytoskeleton [GO:0005200]	GO:0000902; GO:0003810; GO:0005200; GO:0005524; GO:0005856; GO:0005886; GO:0008360; GO:0018149; GO:0020027; GO:0030863; GO:0043249; GO:0048536; GO:0055072	SVWPENTMCAKFQFTPTHVGLQR	6.409999847	1	1	0	2749.668013	0	0	14.24603	15.56353	11.86075	13.75518	12.95404	0	12.14522	0	12.57907	0	0	11.68136	0	0	0	0	0	0	0	0	0	0	15.42903	0	15.56014	15.26492	0	14.54626	0	0	0	0	0	0	0	0	0	0	16.67836	0	14.28776	14.79651	13.37609	0	15.62694	15.73612
P16455	MGMT_HUMAN	"Methylated-DNA--protein-cysteine methyltransferase, EC 2.1.1.63 (6-O-methylguanine-DNA methyltransferase, MGMT) (O-6-methylguanine-DNA-alkyltransferase)"	MGMT	Homo sapiens (Human)	cellular response to ionizing radiation [GO:0071479]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; positive regulation of double-strand break repair [GO:2000781]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]	membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168]; cellular response to ionizing radiation [GO:0071479]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; positive regulation of double-strand break repair [GO:2000781]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]	calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168]	GO:0003677; GO:0003908; GO:0005509; GO:0005634; GO:0005654; GO:0006266; GO:0006281; GO:0006307; GO:0008168; GO:0009008; GO:0009410; GO:0009636; GO:0016020; GO:0034599; GO:0043066; GO:0043281; GO:0045471; GO:0051593; GO:0060644; GO:0071407; GO:0071479; GO:2000781	DCEMKR	3.210000038	1	1	0.117620499	853.7241468	0	16.01556	0	0	15.31728	0	14.90828	15.8949	0	0	0	0	0	0	0	12.52921	0	0	0	0	15.28626	16.12838	0	0	0	0	0	0	0	15.14819	17.75624	0	0	0	0	0	0	0	0	0	0	0	0	0	14.62194	0	12.74606	15.38335
P16471	PRLR_HUMAN	"Prolactin receptor, PRL-R"	PRLR	Homo sapiens (Human)	activation of Janus kinase activity [GO:0042976]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; prostate gland growth [GO:0060736]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; response to bacterium [GO:0009617]; steroid biosynthetic process [GO:0006694]	cell surface [GO:0009986]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cell surface [GO:0009986]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; prolactin receptor activity [GO:0004925]; protein kinase binding [GO:0019901]; activation of Janus kinase activity [GO:0042976]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; prostate gland growth [GO:0060736]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; response to bacterium [GO:0009617]; steroid biosynthetic process [GO:0006694]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; prolactin receptor activity [GO:0004925]; protein kinase binding [GO:0019901]	GO:0004896; GO:0004923; GO:0004925; GO:0005127; GO:0005576; GO:0005886; GO:0006694; GO:0007171; GO:0007259; GO:0007566; GO:0007595; GO:0008284; GO:0009617; GO:0009897; GO:0009986; GO:0016021; GO:0017046; GO:0019221; GO:0019901; GO:0019955; GO:0030155; GO:0030856; GO:0031904; GO:0038165; GO:0042976; GO:0043066; GO:0043235; GO:0046872; GO:0060644; GO:0060736; GO:0060749; GO:0120162	ENSGKPK	11.68000031	1	1	0.160686016	759.7712906	16.1313	16.12919	15.86091	13.49117	14.39664	15.82394	0	0	0	15.15292	0	15.2654	13.30645	15.95197	16.38154	0	14.59861	0	0	14.12878	0	15.8324	15.45836	15.86463	0	0	0	0	0	0	0	0	0	13.7498	0	15.39332	15.66349	15.52633	0	15.30067	15.48497	16.35947	0	15.06955	16.75321	11.57808	13.79711	0
P16499	PDE6A_HUMAN	"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha, GMP-PDE alpha, EC 3.1.4.35 (PDE V-B1)"	PDE6A PDEA	Homo sapiens (Human)	retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601]	photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]	"photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601]"	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0042622; GO:0046872; GO:0047555; GO:0060041; GO:0097381	IVDQSK	1.950000048	1	1	0.172673068	690.6323914	15.97551	14.67525	9.554473	14.04964	12.41552	11.63343	0	0	0	0	15.14693	0	14.65774	16.01002	0	0	16.27758	0	0	0	0	0	0	14.12187	0	0	0	0	0	0	16.93493	0	16.59837	0	15.98311	0	0	15.13435	0	0	0	0	0	0	0	0	0	0
P16519	NEC2_HUMAN	"Neuroendocrine convertase 2, NEC 2, EC 3.4.21.94 (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2, PC2)"	PCSK2 NEC2	Homo sapiens (Human)	enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]	dendrite [GO:0030425]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]	dendrite [GO:0030425]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0005654; GO:0006508; GO:0007399; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0030425; GO:0034230; GO:0034231; GO:0043005; GO:0043204; GO:0043231	DMQHLTVLTSKR	6.710000038	1	1	0.050826717	1428.778184	0	15.3764	0	0	0	0	0	10.2512	14.44438	0	14.81231	0	15.99723	0	0	0	13.99435	13.38774	0	0	15.50515	0	12.89402	0	15.11857	13.75286	13.72448	0	0	0	0	10.98601	0	0	11.32733	14.07527	0	0	0	14.13756	16.55455	0	0	0	0	0	0	0
P16591	FER_HUMAN	"Tyrosine-protein kinase Fer, EC 2.7.10.2 (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer)"	FER TYK3	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]	cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; gamma-catenin binding [GO:0045295]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260]	actin binding [GO:0003779]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; gamma-catenin binding [GO:0045295]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]	GO:0000226; GO:0001932; GO:0003779; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005938; GO:0006468; GO:0006935; GO:0007155; GO:0007169; GO:0007260; GO:0008157; GO:0008283; GO:0008284; GO:0008289; GO:0010591; GO:0010762; GO:0018108; GO:0019221; GO:0019901; GO:0030054; GO:0030154; GO:0030335; GO:0030838; GO:0031234; GO:0031267; GO:0031532; GO:0032496; GO:0032869; GO:0033007; GO:0034446; GO:0034614; GO:0035426; GO:0035556; GO:0036006; GO:0036119; GO:0038028; GO:0038095; GO:0038109; GO:0042058; GO:0042995; GO:0043304; GO:0044331; GO:0045087; GO:0045295; GO:0045296; GO:0046777; GO:0048008; GO:0050904; GO:0051092; GO:0070102	EMNSAK	9.880000114	0.886090398	0.886090398	0.305010942	697.9529863	16.99186	0	0	15.81484	16.55579	0	15.42214	15.61544	16.31988	0	0	15.89607	0	15.84924	15.71736	0	16.05674	0	0	17.96214	18.46926	0	0	16.61459	0	14.99975	0	16.92145	0	0	17.33621	16.54197	16.6176	17.48084	17.72688	0	16.58422	16.96882	17.37411	11.59164	16.16574	16.46317	17.55727	15.46691	16.2639	17.14954	16.282	17.19121
P16885	PLCG2_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV, PLC-IV) (Phospholipase C-gamma-2, PLC-gamma-2)"	PLCG2	Homo sapiens (Human)	"activation of store-operated calcium channel activity [GO:0032237]; antifungal innate immune response [GO:0061760]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cellular response to calcium ion [GO:0071277]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; Fc-epsilon receptor signaling pathway [GO:0038095]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of receptor internalization [GO:0002092]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of lipid metabolic process [GO:0019216]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110]; activation of store-operated calcium channel activity [GO:0032237]; antifungal innate immune response [GO:0061760]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cellular response to calcium ion [GO:0071277]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; Fc-epsilon receptor signaling pathway [GO:0038095]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of receptor internalization [GO:0002092]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of lipid metabolic process [GO:0019216]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]; Wnt signaling pathway [GO:0016055]"	phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110]	GO:0001775; GO:0001784; GO:0001878; GO:0002092; GO:0002223; GO:0002224; GO:0002281; GO:0002316; GO:0002732; GO:0004435; GO:0004629; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0009395; GO:0010628; GO:0010634; GO:0016055; GO:0019216; GO:0019722; GO:0019901; GO:0030168; GO:0030183; GO:0031663; GO:0032237; GO:0032481; GO:0032587; GO:0032733; GO:0032735; GO:0032743; GO:0032747; GO:0032755; GO:0032760; GO:0032959; GO:0035556; GO:0038095; GO:0043069; GO:0043122; GO:0043410; GO:0048471; GO:0048678; GO:0050731; GO:0050850; GO:0050852; GO:0050853; GO:0051091; GO:0051092; GO:0051209; GO:0060100; GO:0060907; GO:0061760; GO:0070062; GO:0070884; GO:0071277; GO:0071396; GO:0097110; GO:0097708; GO:0140031; GO:0150078; GO:1900227; GO:1902808; GO:1903428; GO:1903721; GO:1990782; GO:1990858	NSISLR	12.44999981	0.550050318	0.550050318	0.289535971	686.8929439	0	16.36123	15.41597	14.30648	0	0	0	15.10595	14.90656	16.32937	0	0	0	0	16.33939	16.85816	15.423	15.09912	0	0	17.0617	16.30956	16.75328	0	0	16.39758	16.16902	14.97669	15.72989	0	16.23092	15.81328	15.48423	14.47014	0	0	0	15.54501	16.43177	0	16.12568	17.2493	16.64133	17.21371	15.98292	0	15.98445	16.30148
P17010	ZFX_HUMAN	Zinc finger X-chromosomal protein	ZFX	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0001228; GO:0005654; GO:0005694; GO:0005730; GO:0006357; GO:0043035; GO:0045944; GO:0046872	KHVAAHK	10.93999958	0.281579852	0.281579852	0.197371567	789.1456545	11.75965	0	14.80729	15.20329	0	0	13.43464	0	17.34838	16.52339	0	0	0	0	0	0	0	0	0	16.00495	0	15.65908	0	0	0	18.17398	15.80415	17.20177	0	17.08218	0	16.01614	16.63461	0	18.35543	14.80413	15.3717	15.88052	0	17.37988	0	0	15.97629	0	0	19.6466	15.41172	16.28973
P17014	ZNF12_HUMAN	"Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3, GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)"	ZNF12 GIOT3 KOX3 ZNF325	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837	SLGPVSFK	8.890000343	1	1	0.216841983	834.7139708	0	0	0	10.53661	5.787189	11.97547	15.23836	15.68353	12.79804	0	17.10456	12.87322	12.86849	10.94903	15.71306	15.17446	0	14.82649	15.18653	14.6916	16.52529	0	0	15.36748	0	16.45232	17.10422	13.82963	0	0	18.37379	15.76148	0	13.77911	14.82398	14.68529	17.46611	16.89878	16.22079	15.33835	16.89477	18.72282	0	15.84179	15.23289	16.69541	0	15.47566
P17019	ZN708_HUMAN	Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)	ZNF708 KOX8 ZNF15 ZNF15L1	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	GLNRCVTTTQSK	8.600000381	1	1	0.318037506	1365.549024	13.63799	14.04388	13.39613	11.75388	14.50489	0	13.24183	0	0	0	13.04806	14.41149	16.83947	12.29711	14.47179	14.61383	0	0	0	16.35815	16.09834	0	0	16.6098	17.14958	0	0	0	0	0	16.31581	0	0	0	15.94435	0	15.42138	0	17.16676	0	0	15.90924	16.05555	0	0	18.52967	0	0
P17022	ZNF18_HUMAN	Zinc finger protein 18 (Heart development-specific gene 1 protein) (Zinc finger protein 535) (Zinc finger protein KOX11) (Zinc finger protein with KRAB and SCAN domains 6)	ZNF18 HDSG1 KOX11 ZKSCAN6 ZNF535	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	QENDKENLNLENHR	6.769999981	1	1	2.29E-13	1752.832689	0	13.81193	0	10.8859	0	14.34414	0	14.40156	0	0	0	0	0	0	0	12.86572	0	15.65805	0	13.34554	14.50111	0	0	0	0	15.36995	11.07686	0	14.90263	0	13.82882	14.76725	14.01752	15.34269	0	0	0	0	0	14.00986	0	0	0	0	0	0	0	0
P17035	ZNF28_HUMAN	Zinc finger protein 28 (Zinc finger protein KOX24)	ZNF28 KOX24	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	CKSHLER	11.38000011	1	1	0.218365094	929.8775413	13.93261	13.7005	14.3946	14.48263	0	14.04167	0	0	14.46186	0	0	13.74226	14.98467	13.6064	16.45869	0	0	0	0	16.80256	0	0	15.7962	0	0	0	0	13.26697	13.92145	0	0	0	13.54205	0	0	0	0	0	0	0	0	0	0	0	0	16.28132	15.69085	0
P17040	ZSC20_HUMAN	Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29)	ZSCAN20 KOX29 ZNF31 ZNF360	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AMGTVR	6.099999905	0.542093396	0.542093396	0.150557629	631.6728619	18.53654	0	0	0	0	0	14.9959	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.40122	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.1801	0	0	0	0	0	0	16.80658	0	0	0	0
P17096	HMGA1_HUMAN	"High mobility group protein HMG-I/HMG-Y, HMG-I(Y) (High mobility group AT-hook protein 1, High mobility group protein A1) (High mobility group protein R)"	HMGA1 HMGIY	Homo sapiens (Human)	"base-excision repair [GO:0006284]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; oncogene-induced cell senescence [GO:0090402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; transcription regulator complex [GO:0005667]	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; transcription regulator complex [GO:0005667]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; enzyme binding [GO:0019899]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; structural constituent of chromatin [GO:0030527]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221]; base-excision repair [GO:0006284]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; oncogene-induced cell senescence [GO:0090402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; enzyme binding [GO:0019899]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; structural constituent of chromatin [GO:0030527]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221]	GO:0000978; GO:0000987; GO:0001221; GO:0003677; GO:0003680; GO:0003682; GO:0003712; GO:0003713; GO:0003906; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0005925; GO:0006268; GO:0006284; GO:0006337; GO:0006355; GO:0008285; GO:0019899; GO:0030374; GO:0030527; GO:0035985; GO:0042974; GO:0042975; GO:0045892; GO:0045893; GO:0045944; GO:0046965; GO:0051575; GO:0090402; GO:0090575	KTTTTPGR	10.03999996	1	1	0.207928222	862.761103	16.27711	14.43744	13.12259	13.82967	15.04512	0	15.01604	15.56352	15.54893	0	0	0	13.85407	13.91832	14.47498	16.29611	15.57355	12.75936	16.03039	9.09822	16.52024	15.44415	17.70754	13.56571	0	15.27547	0	0	0	0	15.354	16.54185	0	0	0	16.28087	9.65832	0	0	0	0	0	0	0	0	15.07353	15.70598	0
P17098	ZNF8_HUMAN	Zinc finger protein 8 (Zinc finger protein HF.18)	ZNF8	Homo sapiens (Human)	BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0030509	EQNNLKQLEFGLK	24.5	0.001511431	0.001511431	0.310687539	1560.914602	18.01134	20.21765	21.21584	18.62426	18.25113	20.019	19.21766	0	15.74523	14.53786	16.06715	20.2804	19.10798	18.93338	0	0	19.08444	21.08417	19.8824	19.25642	18.19532	0	0	18.09592	20.41854	21.10638	19.76959	18.38497	20.12361	0	0	0	21.18427	19.94908	20.77322	19.62466	20.51931	21.00008	19.79175	18.23304	0	0	19.56126	19.10603	18.681	0	19.46616	0
P17174	AATC_HUMAN	"Aspartate aminotransferase, cytoplasmic, cAspAT, EC 2.6.1.1, EC 2.6.1.3 (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic, cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)"	GOT1	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine transaminase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384]	L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine transaminase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]	GO:0004069; GO:0004609; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0019550; GO:0019551; GO:0030170; GO:0032869; GO:0047801; GO:0051384; GO:0055089; GO:0070062	QIASVMK	3.49000001	0.737790704	0.737790704	0.044711095	779.3555125	16.55764	14.71046	0	14.49602	12.75173	0	0	0	0	12.69591	0	15.24192	15.5544	0	14.29106	15.08557	14.94354	0	0	0	0	0	0	16.42782	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.11529	0	0	0	0
P17181	INAR1_HUMAN	"Interferon alpha/beta receptor 1, IFN-R-1, IFN-alpha/beta receptor 1 (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1, CRF2-1) (Type I interferon receptor 1)"	IFNAR1 IFNAR	Homo sapiens (Human)	cellular response to interferon-alpha [GO:0035457]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of cellular respiration [GO:1901857]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to lipopolysaccharide [GO:0032496]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]; cellular response to interferon-alpha [GO:0035457]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of cellular respiration [GO:1901857]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to lipopolysaccharide [GO:0032496]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	cytokine receptor activity [GO:0004896]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]	GO:0004896; GO:0004905; GO:0005764; GO:0005770; GO:0005886; GO:0005887; GO:0007259; GO:0009615; GO:0019221; GO:0019962; GO:0032496; GO:0035457; GO:0060337; GO:0098586; GO:1901857	TSEELQQDFV	5.050000191	1	1	0.130466389	1195.771366	0	0	0	0	0	0	0	15.20551	12.6974	0	10.81315	0	0	0	0	0	0	0	14.8976	15.49362	0	15.61222	0	0	0	14.33555	14.64224	13.61491	15.93832	14.43832	11.52684	13.85432	0	13.33028	15.78292	14.76981	15.12769	13.81656	0	15.60928	13.75106	13.56518	12.76044	14.8057	14.1552	0	9.064601	0
P17252	KPCA_HUMAN	"Protein kinase C alpha type, PKC-A, PKC-alpha, EC 2.7.11.13"	PRKCA PKCA PRKACA	Homo sapiens (Human)	angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; desmosome assembly [GO:0002159]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to interleukin-1 [GO:0070555]	alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; histone kinase activity (H3-T6 specific) [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; desmosome assembly [GO:0002159]; histone H3-T6 phosphorylation [GO:0035408]; intracellular signal transduction [GO:0035556]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to interleukin-1 [GO:0070555]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; histone kinase activity (H3-T6 specific) [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]	GO:0001525; GO:0001938; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007077; GO:0007155; GO:0008270; GO:0010595; GO:0010613; GO:0018105; GO:0018107; GO:0019899; GO:0030335; GO:0031666; GO:0031966; GO:0034351; GO:0035403; GO:0035408; GO:0035556; GO:0035866; GO:0043488; GO:0043536; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045931; GO:0048471; GO:0070062; GO:0070374; GO:0070555; GO:0090330; GO:0097190; GO:0106071; GO:0106310; GO:2000707	MPASGWYK	3.400000095	1	1	0.188561105	938.9541231	16.18718	14.93344	14.25759	14.18493	0	0	0	14.63696	0	0	0	0	14.14347	14.68968	0	15.64435	0	0	15.50553	0	15.82538	0	0	0	0	0	0	0	0	0	0	0	0	16.57071	0	15.49161	0	0	0	0	11.35415	0	0	0	0	0	0	0
P17301	ITA2_HUMAN	"Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia, GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)"	ITGA2 CD49B	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; collagen-activated signaling pathway [GO:0038065]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; hepatocyte differentiation [GO:0070365]; hypotonic response [GO:0006971]; integrin-mediated signaling pathway [GO:0007229]; mammary gland development [GO:0030879]; mesodermal cell differentiation [GO:0048333]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell projection organization [GO:0031346]; positive regulation of collagen binding [GO:0033343]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of translation [GO:0045727]; positive regulation of transmission of nerve impulse [GO:0051971]; response to amine [GO:0014075]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to muscle activity [GO:0014850]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; skin morphogenesis [GO:0043589]; substrate-dependent cell migration [GO:0006929]"	axon terminus [GO:0043679]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha2-beta1 complex [GO:0034666]; integrin complex [GO:0008305]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"axon terminus [GO:0043679]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha2-beta1 complex [GO:0034666]; integrin complex [GO:0008305]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; heparan sulfate proteoglycan binding [GO:0043395]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; animal organ morphogenesis [GO:0009887]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; collagen-activated signaling pathway [GO:0038065]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; hepatocyte differentiation [GO:0070365]; hypotonic response [GO:0006971]; integrin-mediated signaling pathway [GO:0007229]; mammary gland development [GO:0030879]; mesodermal cell differentiation [GO:0048333]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell projection organization [GO:0031346]; positive regulation of collagen binding [GO:0033343]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of translation [GO:0045727]; positive regulation of transmission of nerve impulse [GO:0051971]; response to amine [GO:0014075]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to muscle activity [GO:0014850]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; skin morphogenesis [GO:0043589]; substrate-dependent cell migration [GO:0006929]"	amyloid-beta binding [GO:0001540]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; heparan sulfate proteoglycan binding [GO:0043395]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]	GO:0001540; GO:0001618; GO:0001666; GO:0002687; GO:0005178; GO:0005518; GO:0005634; GO:0005886; GO:0005925; GO:0006929; GO:0006971; GO:0007155; GO:0007160; GO:0007229; GO:0007565; GO:0007596; GO:0008283; GO:0008305; GO:0009410; GO:0009887; GO:0009897; GO:0009986; GO:0010634; GO:0010694; GO:0014075; GO:0014850; GO:0014911; GO:0030879; GO:0031346; GO:0031589; GO:0032967; GO:0033343; GO:0033591; GO:0033627; GO:0034666; GO:0038064; GO:0038065; GO:0043236; GO:0043388; GO:0043395; GO:0043589; GO:0043679; GO:0044877; GO:0045178; GO:0045184; GO:0045727; GO:0045785; GO:0045987; GO:0046872; GO:0048041; GO:0048333; GO:0048471; GO:0048661; GO:0050729; GO:0050927; GO:0050966; GO:0051971; GO:0060100; GO:0070365; GO:0071107; GO:0071260; GO:0071392; GO:0098609; GO:0098639	EKNPLMYLTGVQTDK	11.27000046	0.603987098	0.603987098	0.22556912	1752.499714	17.51977	13.99761	0	15.25365	0	0	12.95903	0	16.26269	0	0	0	13.94975	0	0	0	0	0	0	0	15.30023	0	0	0	0	13.9142	0	0	0	0	0	0	0	0	0	0	0	0	15.18343	0	0	0	0	0	13.80553	0	0	15.87246
P17342	ANPRC_HUMAN	"Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C, ANP-C, ANPR-C, NPR-C)"	NPR3 ANPRC C5orf23 NPRC	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]; vasodilation [GO:0042311]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]; chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; skeletal system development [GO:0001501]; vasodilation [GO:0042311]	chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]	GO:0001501; GO:0002158; GO:0005887; GO:0007193; GO:0007194; GO:0007200; GO:0008217; GO:0008528; GO:0016941; GO:0017046; GO:0030157; GO:0031404; GO:0032991; GO:0033688; GO:0035810; GO:0042277; GO:0042311; GO:0042562; GO:0042803; GO:0048015; GO:0048662; GO:0051000; GO:0070062; GO:0120163	EALPPQKIEVLVLLPQDDSYLFSLTR	1.220000029	1	1	0.212539976	2985.735712	0	15.47985	14.97105	12.32946	13.26202	12.42759	12.71231	15.78624	0	0	14.68806	0	14.06409	0	0	0	14.21477	0	0	11.40648	13.05065	0	0	12.59272	0	0	0	0	13.93952	11.66061	0	0	0	12.60163	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P17480	UBF1_HUMAN	"Nucleolar transcription factor 1 (Autoantigen NOR-90) (Upstream-binding factor 1, UBF-1)"	UBTF UBF UBF1	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription initiation from RNA polymerase I promoter [GO:0006361]	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase I cis-regulatory region sequence-specific DNA binding [GO:0001165]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; scaffold protein binding [GO:0097110]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription initiation from RNA polymerase I promoter [GO:0006361]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase I cis-regulatory region sequence-specific DNA binding [GO:0001165]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; scaffold protein binding [GO:0097110]	GO:0001164; GO:0001165; GO:0001181; GO:0001650; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006360; GO:0006361; GO:0045943; GO:0097110	VLGEEK	10.86999989	1	1	0.261389241	675.3454318	19.43969	18.0969	18.74606	18.71921	17.41735	18.9893	0	19.00856	19.66338	19.93478	19.8021	19.44304	17.08724	17.75579	17.79099	0	18.86854	0	0	17.64302	17.61959	19.24495	18.09249	17.43596	0	18.66104	0	0	0	17.96167	19.04492	17.67555	0	18.29017	18.04154	0	0	0	20.58195	0	0	0	0	18.58683	17.17787	0	0	18.78921
P17483	HXB4_HUMAN	Homeobox protein Hox-B4 (Homeobox protein Hox-2.6) (Homeobox protein Hox-2F)	HOXB4 HOX2F	Homo sapiens (Human)	anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; cell population proliferation [GO:0008283]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; hematopoietic stem cell differentiation [GO:0060218]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]; spleen development [GO:0048536]	centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; cell population proliferation [GO:0008283]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; hematopoietic stem cell differentiation [GO:0060218]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]; spleen development [GO:0048536]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0002011; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0008283; GO:0009952; GO:0045944; GO:0048103; GO:0048536; GO:0048539; GO:0048704; GO:0060216; GO:0060218; GO:1990837; GO:2000738	AACTVQR	5.400000095	1	1	0.108602097	806.1205148	15.48638	0	14.7137	0	0	0	0	0	0	0	0	0	0	0	15.50264	15.12468	0	0	0	0	0	0	0	0	14.13683	14.71427	0	0	0	16.17878	0	0	0	0	0	0	0	0	15.26108	0	0	0	0	17.47823	0	0	0	0
P17540	KCRS_HUMAN	"Creatine kinase S-type, mitochondrial, EC 2.7.3.2 (Basic-type mitochondrial creatine kinase, Mib-CK) (Sarcomeric mitochondrial creatine kinase, S-MtCK)"	CKMT2	Homo sapiens (Human)	muscle contraction [GO:0006936]; phosphocreatine biosynthetic process [GO:0046314]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; muscle contraction [GO:0006936]; phosphocreatine biosynthetic process [GO:0046314]	ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]	GO:0004111; GO:0005524; GO:0005739; GO:0005743; GO:0006936; GO:0016301; GO:0046314	VPPPLPQFGKK	5.130000114	1	1	0.401995225	1207.855607	0	0	15.14572	0	14.08985	15.75657	12.73028	15.07807	14.4141	13.93484	0	0	12.2734	13.99391	0	0	0	14.95781	0	0	16.65985	0	0	0	0	0	0	0	0	14.04779	16.20793	15.25144	0	0	16.28152	15.39493	0	16.86853	0	0	0	0	0	0	0	16.0597	16.5599	0
P17542	TAL1_HUMAN	"T-cell acute lymphocytic leukemia protein 1, TAL-1 (Class A basic helix-loop-helix protein 17, bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5)"	TAL1 BHLHA17 SCL TCL5	Homo sapiens (Human)	"angiogenesis [GO:0001525]; astrocyte fate commitment [GO:0060018]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet formation [GO:0030220]; positive regulation of cell division [GO:0051781]; positive regulation of chromatin assembly or disassembly [GO:0045799]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell population proliferation [GO:0042127]; regulation of mast cell differentiation [GO:0060375]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; transcription by RNA polymerase II [GO:0006366]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; astrocyte fate commitment [GO:0060018]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; hemangioblast cell differentiation [GO:0060217]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet formation [GO:0030220]; positive regulation of cell division [GO:0051781]; positive regulation of chromatin assembly or disassembly [GO:0045799]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell population proliferation [GO:0042127]; regulation of mast cell differentiation [GO:0060375]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; transcription by RNA polymerase II [GO:0006366]"	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001525; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006366; GO:0007626; GO:0019899; GO:0021527; GO:0030097; GO:0030218; GO:0030219; GO:0030220; GO:0030221; GO:0030297; GO:0031334; GO:0035162; GO:0035855; GO:0042127; GO:0042826; GO:0043249; GO:0045165; GO:0045648; GO:0045799; GO:0045893; GO:0045931; GO:0045944; GO:0046983; GO:0051781; GO:0060018; GO:0060216; GO:0060217; GO:0060218; GO:0060375; GO:0061629; GO:0070888; GO:2000036	DAATAEAR	6.03000021	0.00024742	0.00024742	0.036968054	803.0364055	16.42911	16.29334	14.67971	13.92632	13.16481	0	0	16.96928	15.1169	0	12.87863	15.64514	16.78681	14.40982	0	13.74498	16.07041	12.5738	15.67983	0	15.81012	15.55798	15.39897	16.47451	17.38898	0	15.05716	15.46072	13.99496	16.28564	16.87426	18.0509	17.69488	17.46946	17.37236	0	17.88204	15.78074	0	11.75427	0	0	17.62223	0	15.15531	14.18795	11.54499	0
P17568	NDUB7_HUMAN	"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 (Cell adhesion protein SQM1) (Complex I-B18, CI-B18) (NADH-ubiquinone oxidoreductase B18 subunit)"	NDUFB7	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]"	NADH dehydrogenase (ubiquinone) activity [GO:0008137]	GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776	DYVMRMK	13.18999958	0.480276525	0.480276525	0.057836655	974.1290505	0	0	12.16862	0	0	0	15.44974	15.67395	0	0	0	0	17.4714	0	0	0	0	0	0	0	0	0	16.11602	0	0	0	0	0	15.69514	0	0	10.37208	17.61639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P17612	KAPCA_HUMAN	"cAMP-dependent protein kinase catalytic subunit alpha, PKA C-alpha, EC 2.7.11.11"	PRKACA PKACA	Homo sapiens (Human)	calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein kinase A signaling [GO:0010737]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]	acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]	acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein kinase A signaling [GO:0010737]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]	AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005952; GO:0006397; GO:0006468; GO:0010737; GO:0010881; GO:0016020; GO:0016241; GO:0016607; GO:0018105; GO:0018107; GO:0019221; GO:0019901; GO:0019904; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035584; GO:0036126; GO:0043197; GO:0043393; GO:0044853; GO:0045667; GO:0046777; GO:0046827; GO:0048240; GO:0048471; GO:0050804; GO:0051480; GO:0051726; GO:0055117; GO:0060314; GO:0061136; GO:0070062; GO:0070417; GO:0070613; GO:0071333; GO:0071374; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0106310; GO:1901621; GO:1903779; GO:1990044; GO:2000810	NLLQVDLTK	2.930000067	0.05256249	0.05256249	0.24655334	1043.28227	0	15.56563	15.99614	0	16.56846	15.35573	0	14.55049	14.65085	16.22622	16.56962	15.85353	0	14.84804	0	14.10832	14.76854	14.5082	0	16.45241	16.63257	0	0	0	0	16.34251	0	0	15.35786	14.97519	0	0	16.35696	0	14.5877	15.92645	0	0	16.53304	16.05075	0	16.1464	14.8856	15.03253	0	16.15798	16.46272	0
P17643	TYRP1_HUMAN	"5,6-dihydroxyindole-2-carboxylic acid oxidase, DHICA oxidase, EC 1.14.18.- (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1, TRP, TRP-1, TRP1)"	TYRP1 CAS2 TYRP TYRRP	Homo sapiens (Human)	acetoacetic acid metabolic process [GO:0043438]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome organization [GO:0032438]; positive regulation of melanin biosynthetic process [GO:0048023]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tyrosinase activity [GO:0004503]; acetoacetic acid metabolic process [GO:0043438]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome organization [GO:0032438]; positive regulation of melanin biosynthetic process [GO:0048023]	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tyrosinase activity [GO:0004503]	GO:0004503; GO:0005737; GO:0010008; GO:0016021; GO:0016491; GO:0030318; GO:0030669; GO:0032438; GO:0033162; GO:0042438; GO:0042470; GO:0042803; GO:0043438; GO:0046872; GO:0048023; GO:0097708	ALDMAK	4.710000038	1	1	0.055267728	663.4078687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.9334	19.02843	19.36766	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P17655	CAN2_HUMAN	"Calpain-2 catalytic subunit, EC 3.4.22.53 (Calcium-activated neutral proteinase 2, CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain, M-calpain)"	CAPN2 CANPL2	Homo sapiens (Human)	behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]	calpain complex [GO:0110158]; chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	calpain complex [GO:0110158]; chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]	GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008234; GO:0009897; GO:0010666; GO:0016540; GO:0019899; GO:0030425; GO:0030864; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0043025; GO:0044877; GO:0045121; GO:0048266; GO:0051493; GO:0051603; GO:0070062; GO:0071222; GO:0071230; GO:0097038; GO:0110158; GO:1901216; GO:1901741; GO:2001247	DGDFCIR	5.679999828	1	1	0.195987963	882.9340588	14.32673	16.04664	13.90605	14.3169	13.16158	0	15.10471	14.38643	17.08187	14.36914	15.20909	0	0	0	0	15.0937	0	0	0	15.91447	0	0	0	0	0	0	0	0	0	0	0	15.75679	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P17677	NEUM_HUMAN	Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46)	GAP43	Homo sapiens (Human)	axon choice point recognition [GO:0016198]; axon regeneration [GO:0031103]; cell fate commitment [GO:0045165]; glial cell differentiation [GO:0010001]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of filopodium assembly [GO:0051489]; regulation of growth [GO:0040008]; regulation of postsynaptic specialization assembly [GO:0099150]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; growth cone membrane [GO:0032584]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; growth cone membrane [GO:0032584]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calmodulin binding [GO:0005516]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786]; axon choice point recognition [GO:0016198]; axon regeneration [GO:0031103]; cell fate commitment [GO:0045165]; glial cell differentiation [GO:0010001]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of filopodium assembly [GO:0051489]; regulation of growth [GO:0040008]; regulation of postsynaptic specialization assembly [GO:0099150]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246]	calmodulin binding [GO:0005516]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786]	GO:0001786; GO:0005516; GO:0005737; GO:0005886; GO:0007205; GO:0009611; GO:0010001; GO:0014069; GO:0016198; GO:0030425; GO:0031103; GO:0031527; GO:0032584; GO:0035727; GO:0040008; GO:0042246; GO:0043204; GO:0045165; GO:0051489; GO:0098982; GO:0099150; GO:1901981	AHKAATK	5.78000021	1	1	0.272204368	726.7918677	13.80101	15.27591	14.67129	12.31573	14.53529	15.64085	15.98985	0	14.31162	0	16.02539	16.42218	0	13.03659	0	14.24924	14.11714	14.05339	0	15.16312	14.92684	16.0413	14.57983	14.30599	16.66079	0	0	16.21708	14.7773	0	0	15.83436	16.26564	16.93443	16.00216	0	16.18719	16.59009	0	15.95072	15.28799	0	15.75127	0	15.80821	0	0	0
P17706	PTN2_HUMAN	"Tyrosine-protein phosphatase non-receptor type 2, EC 3.1.3.48 (T-cell protein-tyrosine phosphatase, TCPTP)"	PTPN2 PTPT	Homo sapiens (Human)	B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]	integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]	GO:0000122; GO:0004725; GO:0005178; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587	CTGLSSK	5.789999962	0.879477262	0.879477262	0.181634252	752.5326218	17.19992	17.32751	16.85304	14.46123	14.66403	15.82677	0	0	0	0	0	0	0	16.56737	0	17.79099	16.51669	0	16.34865	16.23039	16.71276	14.85134	0	0	16.43151	16.06465	0	15.41367	16.43709	16.72465	15.47917	16.18735	15.74673	18.15624	15.3447	0	17.67831	17.20407	0	17.79204	15.7736	16.62674	16.12449	0	0	0	17.00513	16.71426
P17735	ATTY_HUMAN	"Tyrosine aminotransferase, TAT, EC 2.6.1.5 (L-tyrosine:2-oxoglutarate aminotransferase)"	TAT	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572]	amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]	GO:0004838; GO:0005739; GO:0005829; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0071548	AIVDNMKVKPNPNK	4.449999809	1	1	0.306140167	1567.119918	0	15.93185	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.7272	0	0	0	0	0	0	0	0	0	0	18.69392	0	19.76253	0	0	0	0	0	0	0	0	17.8536	0	0	0	0	0	0	0	18.37204
P17813	EGLN_HUMAN	Endoglin (CD antigen CD105)	ENG END	Homo sapiens (Human)	"artery morphogenesis [GO:0048844]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; atrioventricular canal morphogenesis [GO:1905222]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell motility [GO:0048870]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; detection of hypoxia [GO:0070483]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; extracellular matrix constituent secretion [GO:0070278]; extracellular matrix disassembly [GO:0022617]; heart looping [GO:0001947]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of phosphorylation [GO:0042325]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to corticosteroid [GO:0031960]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]"	cell surface [GO:0009986]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"cell surface [GO:0009986]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; coreceptor activity [GO:0015026]; galactose binding [GO:0005534]; glycosaminoglycan binding [GO:0005539]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane signaling receptor activity [GO:0004888]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; artery morphogenesis [GO:0048844]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; atrioventricular canal morphogenesis [GO:1905222]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell motility [GO:0048870]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; detection of hypoxia [GO:0070483]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; extracellular matrix constituent secretion [GO:0070278]; extracellular matrix disassembly [GO:0022617]; heart looping [GO:0001947]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of phosphorylation [GO:0042325]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to corticosteroid [GO:0031960]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]"	activin binding [GO:0048185]; coreceptor activity [GO:0015026]; galactose binding [GO:0005534]; glycosaminoglycan binding [GO:0005539]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane signaling receptor activity [GO:0004888]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]	GO:0000122; GO:0001569; GO:0001570; GO:0001666; GO:0001837; GO:0001934; GO:0001937; GO:0001947; GO:0003084; GO:0003148; GO:0003198; GO:0003203; GO:0003208; GO:0003209; GO:0003222; GO:0003273; GO:0004888; GO:0005024; GO:0005114; GO:0005534; GO:0005539; GO:0005615; GO:0005886; GO:0005925; GO:0006355; GO:0007155; GO:0007179; GO:0009410; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010862; GO:0015026; GO:0016021; GO:0016477; GO:0016604; GO:0017015; GO:0022009; GO:0022617; GO:0030155; GO:0030336; GO:0030509; GO:0030512; GO:0030513; GO:0031953; GO:0031960; GO:0032967; GO:0034713; GO:0035912; GO:0042060; GO:0042127; GO:0042325; GO:0042802; GO:0042803; GO:0043235; GO:0045766; GO:0045944; GO:0048185; GO:0048745; GO:0048844; GO:0048845; GO:0048870; GO:0050431; GO:0051001; GO:0051897; GO:0055009; GO:0060326; GO:0060348; GO:0060394; GO:0070278; GO:0070483; GO:0071260; GO:0072563; GO:0097084; GO:1905007; GO:1905065; GO:1905222	GDKFVLR	1.149999976	1	1	0.164788907	833.8639717	15.65438	17.70286	0	15.22384	0	0	14.59099	0	0	16.16886	14.23801	15.45336	0	0	0	16.08128	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41149	0	0	0	0	0	0	0	15.3958	16.76418	0	0	0	0	0	0	0
P17844	DDX5_HUMAN	"Probable ATP-dependent RNA helicase DDX5, EC 3.6.4.13 (DEAD box protein 5) (RNA helicase p68)"	DDX5 G17P1 HELR HLR1	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]"	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]	GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016887; GO:0030509; GO:0030520; GO:0030521; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045445; GO:0045667; GO:0046332; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1903800; GO:1990841; GO:1990904; GO:2001014	DRYSAGK	9.039999962	1	1	0.261822194	794.4155506	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.50089	0	0	0	0	0	0	0	17.62091	0	0	0	0	0	0	0	17.51837	0	0	0	0	0	0	0	0	0	0
P17927	CR1_HUMAN	Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35)	CR1 C3BR	Homo sapiens (Human)	"ATP export [GO:1904669]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; immune complex clearance by erythrocytes [GO:0002435]; negative regulation of activation of membrane attack complex [GO:0001971]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of cytolysis [GO:0045918]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of T cell proliferation [GO:0042130]; plasma membrane organization [GO:0007009]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of serine-type endopeptidase activity [GO:1900005]"	cell surface [GO:0009986]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667]	"cell surface [GO:0009986]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667]; complement component C3b binding [GO:0001851]; complement component C3b receptor activity [GO:0004877]; complement component C4b binding [GO:0001855]; complement component C4b receptor activity [GO:0001861]; virus receptor activity [GO:0001618]; ATP export [GO:1904669]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; immune complex clearance by erythrocytes [GO:0002435]; negative regulation of activation of membrane attack complex [GO:0001971]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of cytolysis [GO:0045918]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of T cell proliferation [GO:0042130]; plasma membrane organization [GO:0007009]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of serine-type endopeptidase activity [GO:1900005]"	complement component C3b binding [GO:0001851]; complement component C3b receptor activity [GO:0004877]; complement component C4b binding [GO:0001855]; complement component C4b receptor activity [GO:0001861]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001851; GO:0001855; GO:0001861; GO:0001970; GO:0001971; GO:0002430; GO:0002435; GO:0002638; GO:0004877; GO:0005615; GO:0005856; GO:0005886; GO:0005887; GO:0006957; GO:0006958; GO:0007009; GO:0008284; GO:0009986; GO:0030667; GO:0032689; GO:0032703; GO:0042130; GO:0044853; GO:0045591; GO:0045916; GO:0045918; GO:0045957; GO:0045959; GO:0070062; GO:0101003; GO:1900004; GO:1900005; GO:1900099; GO:1904669	MGASSPR	3.400000095	1	1	0.322662154	721.0300826	0	0	0	0	0	0	20.03923	0	0	0	0	0	0	0	0	16.10988	0	0	0	17.80667	0	0	0	0	17.69972	17.90272	17.58392	16.95329	0	0	0	18.60903	18.07431	0	0	0	18.14639	0	17.69502	0	17.08135	0	0	0	0	18.40079	0	0
P17931	LEG3_HUMAN	"Galectin-3, Gal-3 (35 kDa lectin) (Carbohydrate-binding protein 35, CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein, GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)"	LGALS3 MAC2	Homo sapiens (Human)	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spliceosomal complex [GO:0005681]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spliceosomal complex [GO:0005681]; carbohydrate binding [GO:0030246]; chemoattractant activity [GO:0042056]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380]	carbohydrate binding [GO:0030246]; chemoattractant activity [GO:0042056]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]	GO:0001772; GO:0002548; GO:0003723; GO:0004864; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005743; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0009986; GO:0016020; GO:0019863; GO:0019903; GO:0030246; GO:0030593; GO:0030667; GO:0030855; GO:0031334; GO:0031640; GO:0042056; GO:0042129; GO:0043236; GO:0045087; GO:0045806; GO:0048245; GO:0048246; GO:0050860; GO:0050918; GO:0061844; GO:0062023; GO:0070062; GO:0070232; GO:0070492; GO:0071674; GO:0071677; GO:0090280; GO:0101003; GO:1902041; GO:1903078; GO:1903614; GO:2000521; GO:2001189; GO:2001237	MLITILGTVKPNANR	2.150000095	1	1	0.373553203	1656.133766	15.29071	0	15.93291	13.73173	15.75317	0	16.20056	15.30312	16.12355	17.41451	0	0	0	0	0	0	0	0	15.60944	0	0	15.37064	16.65621	16.61077	14.51611	0	0	0	16.10424	0	0	0	0	0	0	17.61547	0	0	16.40228	16.93834	0	0	13.83648	0	0	16.52145	16.02477	0
P17947	SPI1_HUMAN	Transcription factor PU.1 (31 kDa-transforming protein)	SPI1	Homo sapiens (Human)	"anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; endothelial to hematopoietic transition [GO:0098508]; erythrocyte differentiation [GO:0030218]; follicular B cell differentiation [GO:0002316]; germinal center B cell differentiation [GO:0002314]; granulocyte differentiation [GO:0030851]; histone H3 acetylation [GO:0043966]; hypermethylation of CpG island [GO:0044027]; immature B cell differentiation [GO:0002327]; interleukin-6-mediated signaling pathway [GO:0070102]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage differentiation [GO:0030225]; myeloid dendritic cell differentiation [GO:0043011]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; pericyte cell differentiation [GO:1904238]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pro-T cell differentiation [GO:0002572]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of erythrocyte differentiation [GO:0045646]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of myeloid progenitor cell differentiation [GO:1905453]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; NFAT protein binding [GO:0051525]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; endothelial to hematopoietic transition [GO:0098508]; erythrocyte differentiation [GO:0030218]; follicular B cell differentiation [GO:0002316]; germinal center B cell differentiation [GO:0002314]; granulocyte differentiation [GO:0030851]; histone H3 acetylation [GO:0043966]; hypermethylation of CpG island [GO:0044027]; immature B cell differentiation [GO:0002327]; interleukin-6-mediated signaling pathway [GO:0070102]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage differentiation [GO:0030225]; myeloid dendritic cell differentiation [GO:0043011]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; pericyte cell differentiation [GO:1904238]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pro-T cell differentiation [GO:0002572]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of erythrocyte differentiation [GO:0045646]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of myeloid progenitor cell differentiation [GO:1905453]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; NFAT protein binding [GO:0051525]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001217; GO:0001227; GO:0001228; GO:0002314; GO:0002316; GO:0002327; GO:0002357; GO:0002572; GO:0002573; GO:0003682; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007179; GO:0010628; GO:0010629; GO:0030154; GO:0030218; GO:0030225; GO:0030851; GO:0031663; GO:0032088; GO:0035019; GO:0036462; GO:0042826; GO:0043011; GO:0043314; GO:0043966; GO:0044027; GO:0045347; GO:0045646; GO:0045814; GO:0045892; GO:0045944; GO:0051090; GO:0051525; GO:0060033; GO:0061629; GO:0070102; GO:0090241; GO:0090402; GO:0097677; GO:0098508; GO:0120186; GO:0140297; GO:0140311; GO:1900745; GO:1901223; GO:1901674; GO:1902262; GO:1902895; GO:1904151; GO:1904178; GO:1904238; GO:1905036; GO:1905453; GO:2000529	EALAHR	1.769999981	1	1	0.199040256	695.8661151	0	17.02664	0	0	0	0	18.84513	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.42672	19.18019	0	0	0	0	0	0	18.20611	0	0	16.3476	0
P17948	VGFR1_HUMAN	"Vascular endothelial growth factor receptor 1, VEGFR-1, EC 2.7.10.1 (Fms-like tyrosine kinase 1, FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT, FLT) (Vascular permeability factor receptor)"	FLT1 FLT FRT VEGFR1	Homo sapiens (Human)	angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor-activated receptor activity [GO:0036332]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0002244; GO:0002548; GO:0004712; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005768; GO:0005886; GO:0005887; GO:0005925; GO:0007169; GO:0008284; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036332; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048598; GO:1905563; GO:1990384	KFPLDTLIPDGK	10.25	1	1	0.455592878	1342.576522	20.26542	18.89669	17.76403	0	0	20.13531	0	0	0	17.73741	0	0	0	0	0	19.74322	19.07281	0	0	0	0	0	0	0	0	0	17.84377	0	0	0	0	20.38396	0	0	19.12823	20.43404	0	0	0	0	19.28409	0	0	0	0	0	0	0
P17980	PRS6A_HUMAN	"26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1, TBP-1)"	PSMC3 TBP1	Homo sapiens (Human)	modulation by host of viral transcription [GO:0043921]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]"	"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]; modulation by host of viral transcription [GO:0043921]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]	GO:0000502; GO:0000932; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016887; GO:0022624; GO:0034774; GO:0036402; GO:0042802; GO:0043161; GO:0043921; GO:0045944; GO:1901800; GO:1904813	LAGPQLVQMFIGDGAKLVR	10.52000046	1	1	9.16E-13	2028.733968	17.01319	0	15.17487	0	0	12.23477	13.80981	0	0	18.93749	0	0	0	0	0	0	15.99478	15.33757	0	0	14.52024	0	0	0	17.48461	0	0	15.74237	0	0	0	16.18105	19.13415	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P18031	PTN1_HUMAN	"Tyrosine-protein phosphatase non-receptor type 1, EC 3.1.3.48 (Protein-tyrosine phosphatase 1B, PTP-1B)"	PTPN1 PTP1B	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338]	cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0004725; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0006470; GO:0008270; GO:0008286; GO:0009966; GO:0009968; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031532; GO:0032991; GO:0033157; GO:0034620; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0043507; GO:0045296; GO:0046627; GO:0046875; GO:0051721; GO:0060338; GO:0060397; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903896; GO:1903898; GO:1990264; GO:2000646	KVLLEMR	7.989999771	0.688866377	0.688866377	0.047895653	904.8538511	0	13.96825	0	16.18529	0	14.87467	0	14.30892	14.28769	14.59406	14.96504	15.01484	0	0	14.61918	14.06142	16.48102	15.13357	0	0	0	16.7355	0	15.25099	16.49356	0	15.09341	15.76241	17.02984	16.09929	15.05471	16.07047	0	0	15.73501	13.76033	0	15.21987	15.89613	0	16.01252	15.34303	16.10727	0	16.06095	0	15.82905	12.88094
P18054	LOX12_HUMAN	"Polyunsaturated fatty acid lipoxygenase ALOX12, EC 1.13.11.- (Arachidonate (12S)-lipoxygenase, 12S-LOX, 12S-lipoxygenase, EC 1.13.11.31) (Arachidonate (15S)-lipoxygenase, EC 1.13.11.33) (Linoleate (13S)-lipoxygenase) (Lipoxin synthase 12-LO, EC 3.3.2.-) (Platelet-type lipoxygenase 12)"	ALOX12 12LO LOG12	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxygenase pathway [GO:0019372]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]; unsaturated fatty acid metabolic process [GO:0033559]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxygenase pathway [GO:0019372]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]; unsaturated fatty acid metabolic process [GO:0033559]"	"arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]"	GO:0004052; GO:0005506; GO:0005737; GO:0005829; GO:0005886; GO:0006629; GO:0010656; GO:0016020; GO:0016165; GO:0016702; GO:0019369; GO:0019372; GO:0019395; GO:0033559; GO:0034440; GO:0042383; GO:0042554; GO:0043651; GO:0047977; GO:0050473; GO:0051122; GO:0061436; GO:0070062; GO:0090331; GO:1901751; GO:2001303; GO:2001306	QACLQMAISWHLSR	3.609999895	1	1	0.331056202	1715.385291	0	0	0	0	15.76972	14.82734	0	0	10.95961	0	16.33741	15.26104	0	0	0	0	0	0	0	0	13.10698	0	0	0	15.65931	0	0	12.03689	14.05145	12.87792	0	0	0	0	0	15.79605	0	12.95863	0	0	0	0	15.89233	0	0	0	0	14.9568
P18084	ITB5_HUMAN	Integrin beta-5	ITGB5	Homo sapiens (Human)	cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta5 complex [GO:0034684]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta5 complex [GO:0034684]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179]	integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]	GO:0001618; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0016477; GO:0033627; GO:0034684; GO:0035987; GO:0038023; GO:0043149; GO:0043235; GO:0045335; GO:0070062; GO:0090136	NFTALIPGTTVEILDGDSK	4.789999962	1	1	0.312880657	1990.195558	0	12.64851	0	0	11.85224	16.8809	19.00971	20.13375	0	14.61839	0	0	14.8727	0	0	13.13587	16.74041	0	0	0	10.48192	15.20498	18.96865	19.50511	0	0	0	17.39201	0	16.09461	0	0	0	0	0	0	16.81275	0	0	0	16.65027	0	16.5717	0	16.19354	0	18.28295	15.75559
P18089	ADA2B_HUMAN	"Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor, Alpha-2B adrenoceptor, Alpha-2BAR)"	ADRA2B ADRA2L1 ADRA2RL1	Homo sapiens (Human)	activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of norepinephrine secretion [GO:0010700]; platelet activation [GO:0030168]; positive regulation of blood pressure [GO:0045777]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of uterine smooth muscle contraction [GO:0070474]; receptor transactivation [GO:0035624]; regulation of vascular associated smooth muscle contraction [GO:0003056]	cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of norepinephrine secretion [GO:0010700]; platelet activation [GO:0030168]; positive regulation of blood pressure [GO:0045777]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of uterine smooth muscle contraction [GO:0070474]; receptor transactivation [GO:0035624]; regulation of vascular associated smooth muscle contraction [GO:0003056]	alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]	GO:0003056; GO:0004930; GO:0004938; GO:0005829; GO:0005886; GO:0005887; GO:0007186; GO:0007267; GO:0007565; GO:0009986; GO:0010700; GO:0030168; GO:0032148; GO:0032811; GO:0035624; GO:0043231; GO:0043410; GO:0045666; GO:0045777; GO:0051379; GO:0070474; GO:0071875; GO:0071880	GGPGQGESK	7.369999886	0.189658865	0.189658865	0.266368229	816.5173233	0	0	0	16.22865	19.72475	0	18.53385	0	0	0	0	0	19.77582	17.19311	0	0	0	18.09334	0	0	0	0	0	0	0	0	0	17.69867	18.28414	17.64807	0	0	17.77636	0	0	0	0	20.20408	0	0	0	0	18.27993	0	0	0	0	16.41425
P18206	VINC_HUMAN	"Vinculin (Metavinculin, MV)"	VCL	Homo sapiens (Human)	adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702]	adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]	adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702]	actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]	GO:0002009; GO:0002102; GO:0002162; GO:0003779; GO:0005198; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005912; GO:0005915; GO:0005916; GO:0005925; GO:0007155; GO:0007160; GO:0008013; GO:0030032; GO:0030055; GO:0030336; GO:0031625; GO:0032991; GO:0034333; GO:0034394; GO:0034774; GO:0035580; GO:0035633; GO:0042383; GO:0043034; GO:0043297; GO:0044291; GO:0045121; GO:0045294; GO:0045296; GO:0048675; GO:0051893; GO:0070062; GO:0070527; GO:0090136; GO:0090636; GO:0090637; GO:1903140; GO:1903561; GO:1904702; GO:1904813; GO:1990357	DIAKASDEVTR	10.02000046	1	1	0.185180519	1204.442872	12.73292	0	10.27198	12.43763	15.48624	0	0	0	0	0	0	0	17.63752	0	0	0	14.34043	13.48746	15.02959	0	0	0	0	0	0	0	14.61677	14.18311	10.99495	0	0	0	0	16.17894	0	12.68552	0	0	0	0	0	0	14.94625	0	0	0	15.04173	0
P18433	PTPRA_HUMAN	"Receptor-type tyrosine-protein phosphatase alpha, Protein-tyrosine phosphatase alpha, R-PTP-alpha, EC 3.1.3.48"	PTPRA PTPA PTPRL2	Homo sapiens (Human)	insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893]	protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006468; GO:0006470; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0050804; GO:0051893; GO:0070062; GO:0098685; GO:0099699	MRTGNLPANMK	2.039999962	1	1	0.323533879	1248.333689	13.93914	0	14.95008	0	13.01505	0	15.58004	15.27671	16.69305	14.84022	14.65424	15.89943	15.35918	0	14.84183	15.98885	0	15.3024	16.49563	0	16.57014	0	15.78939	0	0	0	0	0	0	0	0	15.83094	0	0	0	0	17.31392	0	17.91507	0	14.54476	15.39657	0	0	15.30017	0	0	0
P18505	GBRB1_HUMAN	Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1)	GABRB1	Homo sapiens (Human)	cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]	GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0004890; GO:0005635; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007214; GO:0007268; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030425; GO:0030594; GO:0032570; GO:0034220; GO:0034707; GO:0042391; GO:0042698; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0071420; GO:0098982; GO:1902476; GO:1902711; GO:1904315	KSFVHGVTVK	8.329999924	1	1	0.120807613	1100.753639	0	0	0	0	0	13.48349	0	13.24395	0	15.98661	12.53002	0	0	0	0	0	0	0	0	0	0	0	0	16.66974	0	0	13.3921	9.259307	0	0	0	17.25187	0	0	0	0	0	0	0	0	0	0	0	15.75085	14.46091	0	7.898982	14.22099
P18545	CNRG_HUMAN	"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma, GMP-PDE gamma, EC 3.1.4.35"	PDE6G PDEG	Homo sapiens (Human)	positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]	"photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]; spectrin binding [GO:0030507]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]; spectrin binding [GO:0030507]"	GO:0004857; GO:0005886; GO:0007601; GO:0030507; GO:0030553; GO:0042622; GO:0043410; GO:0045742; GO:0045745; GO:0047555; GO:0050896; GO:0097381	NLEPPK	15.14000034	0.195002824	0.195002824	0.215409174	696.4242314	19.0093	19.81599	19.15555	19.5963	19.17426	17.8184	18.27	18.92907	19.74088	16.97219	20.1167	18.96585	17.7744	18.91723	19.47013	19.68696	18.85304	20.24701	18.92631	18.78565	18.67536	19.84653	19.22281	19.14584	18.60497	19.22168	19.6899	19.50886	18.02242	19.08613	17.73852	18.13035	0	17.60214	18.11977	17.97568	19.18503	19.40742	18.62186	18.91339	19.84154	19.22202	18.29216	18.26902	18.56573	18.38948	18.16603	19.54143
P18583	SON_HUMAN	"Protein SON (Bax antagonist selected in saccharomyces 1, BASS1) (Negative regulatory element-binding protein, NRE-binding protein) (Protein DBP-5) (SON3)"	SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312	Homo sapiens (Human)	"microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]	"nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0051726	ATNIEQIFR	10.39000034	1	1	0.159814993	1092.439103	0	0	0	0	18.42929	0	17.93022	0	0	17.19412	0	0	0	0	0	0	0	0	17.70513	0	0	0	17.98958	17.53556	0	16.89931	0	0	17.34932	0	19.77042	0	0	0	18.30624	0	18.78329	17.92078	0	0	17.91094	0	0	0	18.07927	0	17.06066	0
P18615	NELFE_HUMAN	"Negative elongation factor E, NELF-E (RNA-binding protein RD)"	NELFE RD RDBP	Homo sapiens (Human)	negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]	NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000122; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005886; GO:0016604; GO:0032021; GO:0034244; GO:0045944; GO:0051571; GO:0070374; GO:1900364	SGAHSSASPPR	8.909999847	0.755031943	0.755031943	0.230133057	1053.307785	0	0	17.38997	16.50688	0	0	0	0	0	0	0	0	15.62607	0	13.81904	15.02223	0	0	0	0	0	0	0	12.85591	0	15.70534	0	14.46936	0	14.75164	14.30405	0	13.03133	0	0	0	16.46803	0	15.92934	0	0	0	0	0	0	0	13.78399	0
P18627	LAG3_HUMAN	"Lymphocyte activation gene 3 protein, LAG-3 (CD antigen CD223) [Cleaved into: Secreted lymphocyte activation gene 3 protein, sLAG-3 ]"	LAG3 FDC	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of regulatory T cell differentiation [GO:0045590]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; MHC class II protein binding [GO:0042289]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of regulatory T cell differentiation [GO:0045590]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776]	antigen binding [GO:0003823]; MHC class II protein binding [GO:0042289]; transmembrane signaling receptor activity [GO:0004888]	GO:0002250; GO:0002270; GO:0003823; GO:0004888; GO:0005576; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0032703; GO:0042289; GO:0045590; GO:0045954; GO:0050776	SFLTAK	6.980000019	0.123425685	0.123425685	0.236336525	665.0628298	0	14.34673	14.28277	15.93763	14.71546	14.96283	0	14.18266	14.84573	0	15.27114	0	0	16.737	16.36747	0	15.93801	0	0	0	0	17.22786	0	0	15.62581	0	16.12706	16.29746	0	0	16.54661	0	15.06698	0	16.24133	0	15.91344	15.42654	0	0	0	0	16.89087	16.12218	0	16.54362	0	0
P18754	RCC1_HUMAN	Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1)	RCC1 CHC1	Homo sapiens (Human)	cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032]	chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032]	chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199]	GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301	AEYGRLGLGEGAEEK	1.019999981	1	1	0.320827106	1578.594219	15.6359	0	14.63991	14.7887	0	0	0	0	0	0	0	13.37418	0	0	0	0	0	0	0	0	0	0	0	14.52309	0	0	0	15.6305	0	0	0	0	0	0	0	0	15.14093	13.53983	0	0	13.12563	0	14.30949	14.37349	14.03771	15.40826	0	11.25104
P19012	K1C15_HUMAN	"Keratin, type I cytoskeletal 15 (Cytokeratin-15, CK-15) (Keratin-15, K15)"	KRT15 KRTB	Homo sapiens (Human)	epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; nucleus [GO:0005634]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0030855; GO:0045109; GO:0070062; GO:0097110	GGSLLAGGGGFGGGSLSGGGGSR	3.779999971	1	1	0.54899222	1821.548333	0	18.71927	0	0	0	0	0	0	0	0	0	0	17.90564	0	0	0	0	0	0	0	16.72738	0	0	0	19.03678	0	0	0	0	0	0	0	18.97574	0	0	18.13956	0	0	0	0	0	0	0	0	0	0	0	0
P19013	K2C4_HUMAN	"Keratin, type II cytoskeletal 4 (Cytokeratin-4, CK-4) (Keratin-4, K4) (Type-II keratin Kb4)"	KRT4 CYK4	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell proliferation [GO:0050680]	cell surface [GO:0009986]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634]	cell surface [GO:0009986]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell proliferation [GO:0050680]		GO:0005634; GO:0005829; GO:0005882; GO:0007010; GO:0009986; GO:0030855; GO:0045095; GO:0045111; GO:0050680	TAAENDFVVLK	10.69999981	0.67299664	0.67299664	0.133381483	1207.372311	15.58205	0	9.393642	0	17.44429	0	11.42688	12.15237	0	0	0	11.83621	15.27377	0	14.13208	0	0	0	0	0	0	0	15.06025	16.54045	0	0	0	0	0	14.79813	0	0	0	0	0	0	13.69876	0	0	13.76587	0	0	0	0	0	0	0	0
P19021	AMD_HUMAN	"Peptidyl-glycine alpha-amidating monooxygenase, PAM [Includes: Peptidylglycine alpha-hydroxylating monooxygenase, PHM, EC 1.14.17.3; Peptidyl-alpha-hydroxyglycine alpha-amidating lyase, EC 4.3.2.5 (Peptidylamidoglycolate lyase, PAL) ]"	PAM	Homo sapiens (Human)	central nervous system development [GO:0007417]; fatty acid primary amide biosynthetic process [GO:0062112]; heart development [GO:0007507]; lactation [GO:0007595]; limb development [GO:0060173]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in female pregnancy [GO:0060135]; odontogenesis [GO:0042476]; ovulation cycle process [GO:0022602]; peptide amidation [GO:0001519]; protein amidation [GO:0018032]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein secretion [GO:0050708]; regulation of transcription by RNA polymerase II [GO:0006357]; response to copper ion [GO:0046688]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; toxin metabolic process [GO:0009404]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; fatty acid primary amide biosynthetic process [GO:0062112]; heart development [GO:0007507]; lactation [GO:0007595]; limb development [GO:0060173]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in female pregnancy [GO:0060135]; odontogenesis [GO:0042476]; ovulation cycle process [GO:0022602]; peptide amidation [GO:0001519]; protein amidation [GO:0018032]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein secretion [GO:0050708]; regulation of transcription by RNA polymerase II [GO:0006357]; response to copper ion [GO:0046688]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; toxin metabolic process [GO:0009404]	calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]	GO:0001519; GO:0001666; GO:0001676; GO:0004504; GO:0004598; GO:0005507; GO:0005509; GO:0005576; GO:0005802; GO:0005886; GO:0006357; GO:0007417; GO:0007507; GO:0007595; GO:0008270; GO:0009268; GO:0009404; GO:0009410; GO:0009986; GO:0010043; GO:0016020; GO:0016021; GO:0018032; GO:0019901; GO:0022602; GO:0030658; GO:0030667; GO:0031418; GO:0032355; GO:0032956; GO:0042476; GO:0042802; GO:0043005; GO:0043204; GO:0046688; GO:0048471; GO:0050708; GO:0051384; GO:0060135; GO:0060173; GO:0062112; GO:0070062	GNAILVR	48.40000153	0.840457499	0.840457499	0.252099713	741.533853	0	16.11907	17.6814	0	0	0	0	0	0	0	20.04002	0	0	18.86345	0	17.22007	0	0	17.77993	17.40459	16.41014	0	18.63938	0	0	0	0	0	0	0	0	0	18.44562	0	0	0	0	0	17.48522	0	0	19.97041	0	15.08378	15.69326	17.18712	0	0
P19174	PLCG1_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, EC 3.1.4.11 (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II, PLC-II) (Phospholipase C-gamma-1, PLC-gamma-1)"	PLCG1 PLC1	Homo sapiens (Human)	calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; T cell receptor signaling pathway [GO:0050852]	cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; T cell receptor signaling pathway [GO:0050852]	calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]	GO:0001726; GO:0002862; GO:0004435; GO:0004629; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0008180; GO:0009395; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0032587; GO:0038095; GO:0042995; GO:0043536; GO:0045766; GO:0046488; GO:0050429; GO:0050852; GO:0051281; GO:0071364; GO:1905564; GO:2000353	DGAFLVR	10.35999966	1	1	0.11857279	776.6054612	0	13.76748	0	15.85316	14.28632	12.92138	12.18619	13.45609	0	0	15.21312	14.93041	0	0	0	0	14.50079	0	0	16.05966	16.18834	0	0	15.66249	0	0	14.7073	0	0	0	15.07473	14.4763	0	14.66355	15.57225	10.90733	0	0	0	0	0	16.28568	0	0	0	13.71269	12.42202	0
P19237	TNNI1_HUMAN	"Troponin I, slow skeletal muscle (Troponin I, slow-twitch isoform)"	TNNI1	Homo sapiens (Human)	cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; regulation of striated muscle contraction [GO:0006942]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	cytosol [GO:0005829]; troponin complex [GO:0005861]	cytosol [GO:0005829]; troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; regulation of striated muscle contraction [GO:0006942]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	actin binding [GO:0003779]; metal ion binding [GO:0046872]	GO:0003009; GO:0003779; GO:0005829; GO:0005861; GO:0006936; GO:0006942; GO:0014883; GO:0046872; GO:0055010; GO:0060048	HKVSMDLR	6.480000019	1	1	0.176221533	1004.487334	15.71816	0	16.416	14.27142	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.28136	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P19256	LFA3_HUMAN	"Lymphocyte function-associated antigen 3, Ag3 (Surface glycoprotein LFA-3) (CD antigen CD58)"	CD58 LFA3	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cellular response to interferon-gamma [GO:0071346]; cellular response to tumor necrosis factor [GO:0071356]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of interleukin-8 production [GO:0032757]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; signaling receptor binding [GO:0005102]; cell-cell adhesion [GO:0098609]; cellular response to interferon-gamma [GO:0071346]; cellular response to tumor necrosis factor [GO:0071356]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of interleukin-8 production [GO:0032757]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005886; GO:0005887; GO:0009986; GO:0016020; GO:0030667; GO:0032757; GO:0034113; GO:0070062; GO:0071346; GO:0071356; GO:0098609; GO:0101003	VAGSDAGR	5.010000229	0.325730324	0.325730324	0.178966778	732.9556284	17.67907	17.13288	0	13.68799	0	15.28841	11.64523	17.37512	0	0	0	16.61182	0	17.72696	18.78799	16.48368	0	16.47597	15.84407	15.87476	0	18.45922	0	0	18.05788	0	0	0	17.03503	15.73991	0	18.55732	18.2828	0	0	17.47127	17.49578	0	18.05485	0	0	17.1888	17.5934	14.92805	16.72529	0	16.01645	14.67485
P19338	NUCL_HUMAN	Nucleolin (Protein C23)	NCL	Homo sapiens (Human)	"angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]"	cell cortex [GO:0005938]; chromosome [GO:0005694]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	"cell cortex [GO:0005938]; chromosome [GO:0005694]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; DNA topoisomerase binding [GO:0044547]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]"	DNA topoisomerase binding [GO:0044547]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0001525; GO:0001533; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005694; GO:0005730; GO:0005938; GO:0008022; GO:0016020; GO:0017148; GO:0036464; GO:0042162; GO:0042802; GO:0044547; GO:0045944; GO:0048026; GO:0048027; GO:0070062; GO:0071364; GO:0140297; GO:1901838; GO:1990830; GO:1990904	ALVATPGK	5.590000153	0.162219644	0.162219644	0.230733247	756.9183008	15.07325	11.55915	13.66618	0	13.97775	0	15.86053	0	16.19008	0	15.87103	15.15275	0	0	19.86967	15.77242	16.94238	0	16.74069	0	0	0	0	0	17.06273	14.60756	17.54287	16.02609	0	0	16.53919	15.38993	16.69903	16.07593	16.14676	16.21418	15.54108	15.30295	15.66059	0	0	0	0	14.41892	16.57313	14.42949	0	16.21458
P19367	HXK1_HUMAN	"Hexokinase-1, EC 2.7.1.1 (Brain form hexokinase) (Hexokinase type I, HK I) (Hexokinase-A)"	HK1	Homo sapiens (Human)	canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]	GO:0001678; GO:0002720; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0006002; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0019158; GO:0032731; GO:0042834; GO:0045087; GO:0045121; GO:0046835; GO:0047931; GO:0051156; GO:0061621; GO:0072655; GO:0072656	RAAQLCGAGMAAVVDK	10.15999985	1	1	0.297893421	1634.418397	0	0	14.27099	13.96809	16.08879	14.2886	0	0	14.25957	0	16.48931	0	17.88401	0	0	0	0	0	0	0	0	0	20.32018	20.08195	0	0	0	0	0	0	0	0	0	0	0	21.1986	18.51111	0	0	0	0	0	0	0	0	0	0	0
P19388	RPAB1_HUMAN	"DNA-directed RNA polymerases I, II, and III subunit RPABC1, RNA polymerases I, II, and III subunit ABC1 (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4)"	POLR2E	Homo sapiens (Human)	protein stabilization [GO:0050821]; transcription by RNA polymerase II [GO:0006366]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein stabilization [GO:0050821]; transcription by RNA polymerase II [GO:0006366]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006366; GO:0050821; GO:1990062	YITYR	2.529999971	0.752361655	0.752361655	0.262087893	716.1016856	17.33239	15.09672	15.54881	0	18.22036	19.38368	18.14697	18.15386	0	0	14.79933	18.74157	0	0	0	0	0	0	16.60214	19.19499	0	17.82057	0	0	18.68425	0	0	20.47954	0	0	20.1498	18.6846	0	0	19.15776	0	0	0	0	19.05124	0	0	0	17.01764	0	17.09001	18.26428	16.99068
P19447	ERCC3_HUMAN	"General transcription and DNA repair factor IIH helicase subunit XPB, TFIIH subunit XPB, EC 3.6.4.12 (Basic transcription factor 2 89 kDa subunit, BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit, TFIIH 89 kDa subunit, TFIIH p89) (Xeroderma pigmentosum group B-complementing protein)"	ERCC3 XPB XPBC	Homo sapiens (Human)	"apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"	nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	"nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]	GO:0000112; GO:0000439; GO:0000717; GO:0001666; GO:0003677; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006362; GO:0006366; GO:0006367; GO:0006368; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841	TGVPDGIMQFIK	11.02000046	1	1	0.235133199	1321.928839	0	0	0	13.38879	0	15.95632	0	0	17.86989	14.70008	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.18959	0	0	17.83054	0	0	0	0	17.49006	16.66855	0	0	0	0	15.83314	0	16.32983	0	0	0	0	0	16.25074	0
P19532	TFE3_HUMAN	"Transcription factor E3 (Class E basic helix-loop-helix protein 33, bHLHe33)"	TFE3 BHLHE33	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002250; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006959; GO:0045670; GO:0045785; GO:0045893; GO:0045944; GO:0046983; GO:0090336; GO:0120163; GO:1990837	SSDPEMR	9.029999733	0.69196552	0.69196552	0.21376252	837.2591199	0	0	15.23003	13.80481	14.55621	15.07173	13.92081	15.71402	13.99658	13.15874	16.51997	0	16.9064	0	15.43064	0	0	16.37909	0	17.87028	0	16.26233	15.96932	17.5	14.89894	16.50995	16.0567	16.0383	16.33019	16.55736	18.27333	14.88995	14.78877	15.32077	16.66525	15.91625	15.53933	16.53934	17.1414	14.84538	15.46	16.23601	14.24118	15.3377	15.82418	14.39648	16.73426	15.93799
P19544	WT1_HUMAN	Wilms tumor protein (WT33)	WT1	Homo sapiens (Human)	"adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal to epithelial transition [GO:0060231]; metanephric epithelium development [GO:0072207]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of female gonad development [GO:2000195]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA methylation [GO:1905643]; positive regulation of gene expression [GO:0010628]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal to epithelial transition [GO:0060231]; metanephric epithelium development [GO:0072207]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of female gonad development [GO:2000195]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA methylation [GO:1905643]; positive regulation of gene expression [GO:0010628]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]"	"C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001657; GO:0001658; GO:0001822; GO:0003156; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007281; GO:0007356; GO:0007507; GO:0007530; GO:0008270; GO:0008285; GO:0008380; GO:0008406; GO:0008584; GO:0009888; GO:0010385; GO:0010628; GO:0016607; GO:0017148; GO:0030308; GO:0030325; GO:0030539; GO:0030855; GO:0032835; GO:0032836; GO:0035802; GO:0043010; GO:0043065; GO:0043066; GO:0043565; GO:0044729; GO:0045892; GO:0045893; GO:0045944; GO:0060231; GO:0060421; GO:0060539; GO:0060923; GO:0061032; GO:0070742; GO:0071320; GO:0071371; GO:0072075; GO:0072112; GO:0072166; GO:0072207; GO:0072284; GO:0072302; GO:1902895; GO:1905643; GO:2000020; GO:2000195; GO:2001076	RHTGVKPFQCK	6.619999886	0.637913525	0.637913525	0.072545382	1357.856681	0	15.88269	0	0	16.42744	15.30017	0	15.94251	0	10.94867	15.47469	0	14.01874	18.83452	0	0	11.19986	15.94576	0	17.2264	0	16.82831	13.29068	0	17.35502	13.29333	16.14614	0	0	18.08219	12.67613	0	13.4585	0	15.4236	17.17763	0	0	15.57708	17.96565	13.25891	0	16.82322	17.64703	15.27399	14.78876	16.23866	0
P19634	SL9A1_HUMAN	"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1, NHE-1) (Solute carrier family 9 member 1)"	SLC9A1 APNH1 NHE1	Homo sapiens (Human)	cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ion transport [GO:0006811]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]	"apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; protein-macromolecule adaptor activity [GO:0030674]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]; solute:proton antiporter activity [GO:0015299]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ion transport [GO:0006811]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]"	"calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; protein-macromolecule adaptor activity [GO:0030674]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]; solute:proton antiporter activity [GO:0015299]"	GO:0005516; GO:0005546; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0006811; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014704; GO:0015299; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0016477; GO:0030011; GO:0030027; GO:0030307; GO:0030315; GO:0030346; GO:0030674; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0051259; GO:0051453; GO:0051492; GO:0051893; GO:0051930; GO:0055007; GO:0060090; GO:0070062; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071260; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086036; GO:0086040; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902600; GO:1903281	DQFIIAYGGLRGAIAFSLGYLLDK	1.919999957	1	1	0.187372722	2600.503507	0	15.50042	0	0	9.632399	13.52694	0	0	0	0	15.77954	16.62801	10.64753	0	13.28561	10.66238	0	0	0	14.38879	0	0	0	0	0	16.54587	15.25139	0	0	0	0	0	0	16.84352	13.71049	0	0	0	0	0	0	0	0	0	0	0	13.77217	14.05326
P19784	CSK22_HUMAN	"Casein kinase II subunit alpha', CK II alpha', EC 2.7.11.1"	CSNK2A2 CK2A2	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]	acrosomal vesicle [GO:0001669]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956]	acrosomal vesicle [GO:0001669]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000785; GO:0001669; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005956; GO:0006915; GO:0007049; GO:0007283; GO:0016055; GO:0018105; GO:0018107; GO:0021987; GO:0047485; GO:0051726; GO:0097421; GO:0106310; GO:1903146; GO:1903955; GO:1905818; GO:2000059; GO:2001234	MPGPAAGSR	15.89000034	0.379846632	0.379846632	0.111728109	843.8230624	18.41801	15.24424	0	15.58995	14.14646	13.66886	0	15.31209	17.08315	14.19365	15.19999	17.87786	0	16.9065	0	0	16.51449	15.44641	15.06873	16.23815	0	18.10188	13.23625	17.637	17.15686	15.61509	16.1683	0	13.27357	16.37403	0	18.92581	19.84074	17.84228	14.05624	16.10052	0	0	15.94815	0	15.43664	18.35454	0	0	0	16.34264	10.90204	16.62288
P19801	AOC1_HUMAN	"Amiloride-sensitive amine oxidase [copper-containing], DAO, Diamine oxidase, EC 1.4.3.22 (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase, KAO)"	AOC1 ABP1 DAO1	Homo sapiens (Human)	amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to heparin [GO:0071504]; cellular response to histamine [GO:0071420]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677]	bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]	"bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]; amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to heparin [GO:0071504]; cellular response to histamine [GO:0071420]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677]"	"calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]"	GO:0005507; GO:0005509; GO:0005576; GO:0005615; GO:0005777; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0008270; GO:0009308; GO:0009445; GO:0035580; GO:0035874; GO:0042803; GO:0044877; GO:0046677; GO:0048038; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0070062; GO:0071280; GO:0071420; GO:0071504; GO:0097185	LQPSSTTTMAK	5.300000191	0.086851701	0.086851701	0.09029823	1180.772631	0	10.0166	0	0	17.76792	13.00206	0	11.34817	14.37557	0	15.18632	13.7991	0	14.55076	12.98331	0	9.965039	0	0	0	0	0	0	15.73503	0	14.03565	17.04394	17.34967	15.26692	0	0	16.69905	16.27756	14.19303	0	0	13.78341	11.74944	14.21061	0	0	12.43735	0	14.12069	0	9.861722	0	11.30642
P19823	ITIH2_HUMAN	"Inter-alpha-trypsin inhibitor heavy chain H2, ITI heavy chain H2, ITI-HC2, Inter-alpha-inhibitor heavy chain 2 (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein, SHAP)"	ITIH2 IGHEP2	Homo sapiens (Human)	hyaluronan metabolic process [GO:0030212]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]	endopeptidase inhibitor activity [GO:0004866]; hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004866; GO:0004867; GO:0005540; GO:0005576; GO:0005788; GO:0030212; GO:0062023; GO:0070062; GO:0072562	FYNQVSTPLLR	6.869999886	1	1	0.493680241	1337.775522	19.58867	0	17.78749	17.1098	0	0	0	0	0	0	17.03796	0	0	18.17385	0	18.00154	18.99382	0	0	17.26642	0	0	0	19.27934	0	0	0	16.60856	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P19878	NCF2_HUMAN	"Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)"	NCF2 NOXA2 P67PHOX	Homo sapiens (Human)	cellular defense response [GO:0006968]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; cellular defense response [GO:0006968]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	electron transfer activity [GO:0009055]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activator activity [GO:0016176]	GO:0001669; GO:0005829; GO:0005886; GO:0006801; GO:0006909; GO:0006968; GO:0008022; GO:0009055; GO:0016020; GO:0016175; GO:0016176; GO:0031267; GO:0032010; GO:0042554; GO:0043020; GO:0045087; GO:0045730	EALIQLR	7.059999943	1	1	0.181652454	841.4040434	0	0	0	0	17.31179	0	16.22773	17.07026	0	0	0	0	0	16.76971	0	0	0	0	17.18826	0	0	14.52878	0	14.90618	16.61599	16.72708	17.95356	16.05252	17.32154	15.93485	14.17078	10.99515	0	16.28636	0	0	0	0	18.19106	12.93027	15.19297	0	15.94837	15.75059	14.34811	15.62431	0	0
P19971	TYPH_HUMAN	"Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)"	TYMP ECGF1	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]	cytosol [GO:0005829]	"cytosol [GO:0005829]; 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]"	"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]"	GO:0000002; GO:0001525; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0008083; GO:0009032; GO:0016154; GO:0030154; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333	QLLPRAR	9.119999886	1	1	0.075111498	853.5548294	0	13.69798	0	16.84548	15.31046	13.5175	17.87845	0	16.65742	11.26132	16.13465	0	0	16.80706	0	0	13.13297	15.19003	14.58588	17.69232	16.8728	0	0	0	15.01231	16.81405	15.33162	17.13233	0	16.12764	0	17.29686	0	15.17528	18.41451	0	0	14.40839	14.82832	0	0	0	16.29623	12.0892	0	17.58778	0	0
P20020	AT2B1_HUMAN	"Plasma membrane calcium-transporting ATPase 1, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 1, PMCA1) (Plasma membrane calcium pump isoform 1)"	ATP2B1 PMCA1	Homo sapiens (Human)	aging [GO:0007568]; brain development [GO:0007420]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; aging [GO:0007568]; brain development [GO:0007420]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]	GO:0001772; GO:0001818; GO:0003056; GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005654; GO:0005886; GO:0005887; GO:0006874; GO:0007420; GO:0007568; GO:0008217; GO:0009409; GO:0009898; GO:0015085; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030165; GO:0030285; GO:0030501; GO:0032591; GO:0032809; GO:0034220; GO:0043231; GO:0045121; GO:0046872; GO:0051480; GO:0051481; GO:0051928; GO:0070062; GO:0071305; GO:0071386; GO:0098978; GO:0098982; GO:0099056; GO:0099059; GO:1900076; GO:1903779; GO:1905056; GO:1990034	REAVFGK	5.039999962	1	1	0.239354229	806.037023	14.89126	0	15.36113	0	15.34784	0	0	12.86797	15.14327	0	0	0	0	0	14.85047	0	0	0	0	0	0	15.81855	0	15.27741	16.22681	16.7296	0	0	15.96769	0	0	0	18.05857	16.58276	0	0	0	0	0	14.53053	15.66755	15.31952	0	0	0	0	16.25771	0
P20042	IF2B_HUMAN	"Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta, eIF-2-beta)"	EIF2S2 EIF2B	Homo sapiens (Human)	formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]"	"metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"	GO:0001701; GO:0001731; GO:0001732; GO:0002176; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0008135; GO:0008584; GO:0031369; GO:0046872	EVEPEPTEDK	3.980000019	1	1	0.337248534	1172.947411	13.43756	14.00174	13.55915	14.39444	14.77924	12.13958	12.70963	0	13.30718	14.8329	0	0	0	16.13877	0	14.47721	0	0	14.93967	16.05825	0	15.57473	0	13.92494	0	0	0	15.46926	14.80928	0	15.66533	0	0	0	0	0	16.38729	0	0	0	0	0	0	16.11276	0	0	0	0
P20073	ANXA7_HUMAN	Annexin A7 (Annexin VII) (Annexin-7) (Synexin)	ANXA7 ANX7 SNX OK/SW-cl.95	Homo sapiens (Human)	autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; negative regulation of gene expression [GO:0010629]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; negative regulation of gene expression [GO:0010629]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; RNA binding [GO:0003723]	GO:0003723; GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005789; GO:0006914; GO:0010629; GO:0016020; GO:0030855; GO:0048306; GO:0062023; GO:0070062	LYYAMKGAGTDDSTLVR	1.159999967	1	1	0.092064969	1877.557255	12.01294	14.14432	0	14.71698	0	0	0	0	14.46738	14.78371	14.91358	13.41244	0	0	14.13749	0	0	18.09468	0	0	16.20363	16.20222	15.79288	12.16533	0	0	0	0	0	0	0	0	13.45436	0	0	0	0	0	16.86461	0	0	16.75021	17.1112	15.30437	0	12.84514	0	0
P20155	ISK2_HUMAN	Serine protease inhibitor Kazal-type 2 (Acrosin-trypsin inhibitor) (Epididymis tissue protein Li 172) (HUSI-II)	SPINK2	Homo sapiens (Human)	acrosome assembly [GO:0001675]; negative regulation of serine-type endopeptidase activity [GO:1900004]; spermatid development [GO:0007286]	acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]	acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acrosome assembly [GO:0001675]; negative regulation of serine-type endopeptidase activity [GO:1900004]; spermatid development [GO:0007286]	endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0001669; GO:0001675; GO:0004866; GO:0004867; GO:0005576; GO:0007286; GO:1900004	TPNCSQYRLPGCPR	9.279999733	1	1	0.06904904	1706.178977	14.42016	10.58933	13.45439	15.65639	0	15.58438	10.51178	0	15.51779	13.83249	14.54965	0	0	14.83107	14.45821	0	14.03756	0	15.11944	0	0	0	11.67198	0	13.88351	13.01475	14.86455	0	0	0	0	15.77919	0	0	14.06583	0	8.401255	17.94201	0	15.16063	0	13.47994	12.9414	10.89446	19.26811	0	0	0
P20226	TBP_HUMAN	TATA-box-binding protein (TATA sequence-binding protein) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit)	TBP GTF2D1 TF2D TFIID	Homo sapiens (Human)	"DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; aryl hydrocarbon receptor binding [GO:0017162]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; TFIIB-class transcription factor binding [GO:0001093]; transcription cis-regulatory region binding [GO:0000976]; DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	aryl hydrocarbon receptor binding [GO:0017162]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; TFIIB-class transcription factor binding [GO:0001093]; transcription cis-regulatory region binding [GO:0000976]	GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000979; GO:0000995; GO:0001046; GO:0001091; GO:0001093; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0005737; GO:0006352; GO:0006366; GO:0006367; GO:0006383; GO:0006468; GO:0016251; GO:0017162; GO:0019899; GO:0032991; GO:0042789; GO:0051123; GO:0060261; GO:0097550; GO:0140223; GO:0140297	VVLTGAKVR	1.179999948	1	1	0.103690162	942.4073732	15.18074	16.54842	14.78716	0	0	0	0	0	0	0	0	0	0	0	14.8383	0	0	0	14.00183	0	15.96571	15.74635	15.96265	0	0	0	15.56009	0	15.48395	0	0	0	0	15.61134	14.25265	0	16.91157	15.1351	0	14.14362	0	14.57998	0	15.34399	0	15.75876	0	15.53835
P20265	PO3F2_HUMAN	"POU domain, class 3, transcription factor 2 (Brain-specific homeobox/POU domain protein 2, Brain-2, Brn-2) (Nervous system-specific octamer-binding transcription factor N-Oct-3) (Octamer-binding protein 7, Oct-7) (Octamer-binding transcription factor 7, OTF-7)"	POU3F2 BRN2 OCT7 OTF7	Homo sapiens (Human)	astrocyte development [GO:0014002]; cellular response to organic substance [GO:0071310]; cerebral cortex radially oriented cell migration [GO:0021799]; epidermis development [GO:0008544]; forebrain ventricular zone progenitor cell division [GO:0021869]; hypothalamus cell differentiation [GO:0021979]; myelination in peripheral nervous system [GO:0022011]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neurohypophysis development [GO:0021985]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axonogenesis [GO:0050770]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; astrocyte development [GO:0014002]; cellular response to organic substance [GO:0071310]; cerebral cortex radially oriented cell migration [GO:0021799]; epidermis development [GO:0008544]; forebrain ventricular zone progenitor cell division [GO:0021869]; hypothalamus cell differentiation [GO:0021979]; myelination in peripheral nervous system [GO:0022011]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neurohypophysis development [GO:0021985]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axonogenesis [GO:0050770]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005654; GO:0005667; GO:0006357; GO:0007399; GO:0008284; GO:0008544; GO:0010629; GO:0014002; GO:0021799; GO:0021869; GO:0021979; GO:0021985; GO:0022011; GO:0030182; GO:0040018; GO:0042802; GO:0045595; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050770; GO:0071310; GO:1990837	RMTPPGGTLPGAEDVYGGSR	2.910000086	1	1	0.403204997	2020.299284	0	14.94762	0	0	0	0	0	0	0	0	0	0	14.96661	0	0	0	0	0	16.67341	0	0	0	0	0	0	0	0	0	0	0	15.89614	0	0	15.16459	0	0	0	0	0	14.67882	15.66662	0	0	0	0	14.51653	0	0
P20336	RAB3A_HUMAN	Ras-related protein Rab-3A	RAB3A	Homo sapiens (Human)	acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; constitutive secretory pathway [GO:0045054]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; lung development [GO:0030324]; lysosome localization [GO:0032418]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; post-embryonic development [GO:0009791]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of plasma membrane repair [GO:1905684]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]	acrosomal vesicle [GO:0001669]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	acrosomal vesicle [GO:0001669]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; GDP-dissociation inhibitor binding [GO:0051021]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022]; acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; constitutive secretory pathway [GO:0045054]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; lung development [GO:0030324]; lysosome localization [GO:0032418]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; post-embryonic development [GO:0009791]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of plasma membrane repair [GO:1905684]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; GDP-dissociation inhibitor binding [GO:0051021]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022]	GO:0001669; GO:0001671; GO:0001778; GO:0003016; GO:0003924; GO:0005525; GO:0005764; GO:0005768; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0007005; GO:0007274; GO:0007409; GO:0008021; GO:0008022; GO:0009306; GO:0009791; GO:0010807; GO:0014059; GO:0016079; GO:0016188; GO:0017157; GO:0030324; GO:0030424; GO:0030667; GO:0030742; GO:0031489; GO:0031630; GO:0032418; GO:0032991; GO:0036465; GO:0043195; GO:0045054; GO:0045055; GO:0045921; GO:0048172; GO:0048471; GO:0048489; GO:0048786; GO:0048790; GO:0050975; GO:0051021; GO:0051117; GO:0051602; GO:0060201; GO:0060203; GO:0060478; GO:0061202; GO:0061670; GO:0070083; GO:0072659; GO:0097091; GO:0098793; GO:0098794; GO:0098993; GO:1903307; GO:1903561; GO:1905684; GO:2000300	CDMEDER	9.699999809	1	1	1.15E-12	956.5966766	16.57403	14.92637	14.1534	13.24425	15.36987	13.78873	0	15.15368	13.15958	0	0	0	0	0	14.14614	0	0	0	0	0	14.38384	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.32019	0	0	0	0	0	0	15.88763	0	0	0
P20338	RAB4A_HUMAN	"Ras-related protein Rab-4A, EC 3.6.5.2"	RAB4A RAB4	Homo sapiens (Human)	antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982]	cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]	G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0015031; GO:0019003; GO:0019882; GO:0030100; GO:0030659; GO:0031901; GO:0031982; GO:0032482; GO:0032593; GO:0048471; GO:0055038; GO:0070062; GO:0098837	DLDADR	1.879999995	1	1	0.16967475	703.786964	0	0	0	0	0	0	0	13.70734	0	0	0	0	0	0	0	16.35836	14.89254	16.99622	0	0	0	0	17.36741	0	15.06596	0	17.80988	0	0	0	13.74976	0	0	0	0	0	0	0	0	0	0	0	16.42395	0	0	0	0	0
P20472	PRVA_HUMAN	Parvalbumin alpha	PVALB	Homo sapiens (Human)	cochlea development [GO:0090102]; excitatory chemical synaptic transmission [GO:0098976]; gene expression [GO:0010467]; inhibitory chemical synaptic transmission [GO:0098977]	axon [GO:0030424]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; stereocilium [GO:0032420]; synapse [GO:0045202]	axon [GO:0030424]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; stereocilium [GO:0032420]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; cochlea development [GO:0090102]; excitatory chemical synaptic transmission [GO:0098976]; gene expression [GO:0010467]; inhibitory chemical synaptic transmission [GO:0098977]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]	GO:0005509; GO:0005634; GO:0005737; GO:0010467; GO:0030424; GO:0032420; GO:0032437; GO:0032991; GO:0042802; GO:0043025; GO:0044877; GO:0045202; GO:0090102; GO:0098976; GO:0098977	MLMAAGDK	4.010000229	1	1	0.16493014	851.7876138	0	14.5331	0	7.702677	0	0	14.39725	14.21717	14.4255	16.73908	15.01545	14.44329	0	14.33291	0	0	0	0	0	0	16.37099	0	0	0	0	17.33439	16.04989	13.95668	15.05683	16.29185	0	12.84489	0	0	0	0	16.85018	0	15.39637	0	0	0	0	0	0	0	13.03782	16.37424
P20591	MX1_HUMAN	"Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78, IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed ]"	MX1	Homo sapiens (Human)	antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; signal transduction [GO:0007165]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]	GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005874; GO:0006915; GO:0006952; GO:0007165; GO:0008017; GO:0009615; GO:0016020; GO:0031965; GO:0034340; GO:0042802; GO:0045071; GO:0045087; GO:0048471; GO:0051607; GO:0070106; GO:0140374	LARLTQAR	12.63000011	1	1	0.243307949	925.2933359	0	15.44652	0	0	0	15.27916	15.62639	15.99342	15.37786	16.76268	18.42949	0	0	0	0	0	0	14.62576	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.69662	0	0	0	15.80562	0	0	0
P20594	ANPRB_HUMAN	"Atrial natriuretic peptide receptor 2, EC 4.6.1.2 (Atrial natriuretic peptide receptor type B, ANP-B, ANPR-B, NPR-B) (Guanylate cyclase B, GC-B)"	NPR2 ANPRB	Homo sapiens (Human)	bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; reproductive process [GO:0022414]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; reproductive process [GO:0022414]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]	GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0022414; GO:0042562; GO:0042802; GO:0051447; GO:0060348; GO:0097011; GO:1900194	QVLFELKHMR	1.440000057	0.304574162	0.304574162	0.240409329	1315.89542	0	0	16.84423	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.76646	0	0	0	18.59183	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20618	PSB1_HUMAN	Proteasome subunit beta type-1 (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1 PSC5	Homo sapiens (Human)	proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004298; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0008233; GO:0010498; GO:0019774; GO:0034774; GO:0043161; GO:0070062; GO:1904813	FSPYVFNGGTILAIAGEDFAIVASDTR	4.21999979	1	1	3.66E-12	2832.53322	0	0	0	9.051687	0	10.64586	0	0	0	11.6054	0	0	0	0	0	11.36448	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20645	MPRD_HUMAN	"Cation-dependent mannose-6-phosphate receptor, CD Man-6-P receptor, CD-MPR (46 kDa mannose 6-phosphate receptor, MPR 46)"	M6PR MPR46 MPRD	Homo sapiens (Human)	endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299]	clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]	clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888]; endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299]	protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0005886; GO:0005887; GO:0006622; GO:0006898; GO:0007041; GO:0008333; GO:0016020; GO:0019904; GO:0030133; GO:0030669; GO:0032588; GO:0033299; GO:0048471; GO:1905394	SNGKETVVGR	8.720000267	0.001186251	0.001186251	0.014111354	1049.740715	0	0	15.96525	0	0	10.60041	10.74378	14.42082	15.09474	0	0	0	16.59129	0	0	14.42104	0	7.904917	15.86917	0	16.46863	16.75834	0	0	13.46828	16.38155	17.94919	0	16.529	0	0	0	17.20721	16.47146	16.76557	14.46837	15.68174	0	0	0	0	17.69315	0	0	0	0	15.76944	14.10571
P20648	ATP4A_HUMAN	"Potassium-transporting ATPase alpha chain 1, EC 7.2.2.19 (Gastric H(+)/K(+) ATPase subunit alpha) (Proton pump)"	ATP4A	Homo sapiens (Human)	cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376]	apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; potassium ion binding [GO:0030955]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; potassium ion binding [GO:0030955]	GO:0000287; GO:0005391; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006883; GO:0008900; GO:0016324; GO:0016887; GO:0030007; GO:0030955; GO:0034220; GO:0036376; GO:1902600; GO:1990573	DGDKFQINADQLVVGDLVEMK	3.329999924	1	1	0.016395364	2351.026035	0	0	13.94223	14.51054	12.88537	12.46459	13.69044	0	0	0	12.58127	0	14.92725	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20674	COX5A_HUMAN	"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)"	COX5A	Homo sapiens (Human)	"cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]	"mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]"	cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]	GO:0004129; GO:0005743; GO:0005751; GO:0006123; GO:0009055; GO:0031966; GO:0045333; GO:0046872	GLLHSAR	5.949999809	1	1	0.122266616	753.9209316	16.74435	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.88445	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20700	LMNB1_HUMAN	Lamin-B1	LMNB1 LMN2 LMNB	Homo sapiens (Human)	nuclear envelope organization [GO:0006998]	lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural molecule activity [GO:0005198]; nuclear envelope organization [GO:0006998]	phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0016020; GO:0016363; GO:0031965; GO:0043274; GO:1990837	DAALATALGDK	11.06000042	1	1	0.276783538	1045.739398	17.76805	18.08528	17.83708	16.53775	0	16.61573	18.76977	17.89675	0	16.42836	18.58145	17.77639	0	17.47311	0	17.50057	0	17.73012	0	16.53949	18.77319	0	0	0	18.04741	0	16.34539	18.52701	18.52351	0	18.55525	0	18.32525	0	18.96818	19.81698	0	0	19.31243	18.0538	16.37909	0	16.8483	0	19.01899	0	16.87247	0
P20701	ITAL_HUMAN	"Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)"	ITGAL CD11A	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory T cell extravasation [GO:0035683]; phagocytosis [GO:0006909]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integrin alphaL-beta2 complex [GO:0034687]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integrin alphaL-beta2 complex [GO:0034687]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; cell adhesion molecule binding [GO:0050839]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory T cell extravasation [GO:0035683]; phagocytosis [GO:0006909]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]	cell adhesion molecule binding [GO:0050839]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]	GO:0002291; GO:0005178; GO:0005886; GO:0006909; GO:0006954; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007165; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0016020; GO:0030369; GO:0033627; GO:0034687; GO:0035579; GO:0035683; GO:0043113; GO:0046872; GO:0050839; GO:0070062; GO:0098609	GLFPGGR	5.25	1	1	0.254710951	704.2679452	0	0	0	0	0	0	0	16.92762	17.38826	0	0	0	0	0	0	0	16.46919	0	15.88572	0	15.92817	0	0	0	0	0	17.08044	0	0	0	0	0	0	0	0	0	18.17974	0	17.03588	18.5015	0	0	0	0	0	18.4348	0	0
P20702	ITAX_HUMAN	"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)"	ITGAX CD11C	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; defense response to virus [GO:0051607]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial tube morphogenesis [GO:1905956]; positive regulation of gene expression [GO:0010628]; positive regulation of myelination [GO:0031643]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; defense response to virus [GO:0051607]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial tube morphogenesis [GO:1905956]; positive regulation of gene expression [GO:0010628]; positive regulation of myelination [GO:0031643]	integrin binding [GO:0005178]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]	GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008284; GO:0008305; GO:0009887; GO:0009897; GO:0009986; GO:0010628; GO:0016020; GO:0030335; GO:0030667; GO:0030971; GO:0031643; GO:0033627; GO:0034113; GO:0034689; GO:0038023; GO:0045766; GO:0046872; GO:0051607; GO:0070821; GO:0098609; GO:0101003; GO:1905956	EGDSLDYKDVIPMADAAGIIR	8.899999619	1	1	0.154691347	2248.5378	12.41898	0	0	0	11.33893	13.54773	13.35346	15.91055	14.10706	0	15.39179	0	0	0	13.78252	12.77852	16.13467	13.1676	14.46257	0	15.07727	0	0	16.99991	14.52549	0	15.04227	15.61055	0	14.4733	0	14.89677	15.01075	13.51024	14.52125	0	14.91703	14.85494	0	13.78562	0	15.8768	0	0	0	0	0	17.21778
P20711	DDC_HUMAN	"Aromatic-L-amino-acid decarboxylase, AADC, EC 4.1.1.28 (DOPA decarboxylase, DDC)"	DDC AADC	Homo sapiens (Human)	aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine metabolic process [GO:0006584]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to growth factor stimulus [GO:0071363]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; 5-hydroxy-L-tryptophan decarboxylase activity [GO:0036467]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine metabolic process [GO:0006584]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to growth factor stimulus [GO:0071363]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427]	5-hydroxy-L-tryptophan decarboxylase activity [GO:0036467]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]	GO:0004058; GO:0005737; GO:0005829; GO:0006520; GO:0006584; GO:0007623; GO:0008021; GO:0010259; GO:0015842; GO:0016597; GO:0016831; GO:0019899; GO:0019904; GO:0030170; GO:0030424; GO:0033076; GO:0036467; GO:0036468; GO:0042416; GO:0042427; GO:0043025; GO:0046684; GO:0052314; GO:0070062; GO:0071312; GO:0071363; GO:0071466	AGEGGGVIQGSASEATLVALLAAR	1.129999995	1	1	0.210167717	2199.785024	0	0	14.79779	0	15.87597	0	0	13.34679	0	13.83272	12.53002	11.03738	0	13.63764	12.18844	0	0	0	0	0	0	0	0	0	0	11.2948	11.58356	0	0	0	0	16.65193	0	0	0	0	0	12.8237	0	15.05676	0	0	11.56428	0	0	0	7.898982	0
P20742	PZP_HUMAN	Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6)	PZP CPAMD6	Homo sapiens (Human)	female pregnancy [GO:0007565]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565]	endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0007565; GO:0070062; GO:0072562	DLFHCVSFTLPR	12.64999962	0.608530462	0.608530462	0.471014165	1491.847798	0	0	17.36709	0	0	0	0	0	0	0	0	0	0	0	0	17.13412	18.52248	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.82902	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20749	BCL3_HUMAN	"B-cell lymphoma 3 protein, BCL-3 (Proto-oncogene BCL3)"	BCL3 BCL4 D19S37	Homo sapiens (Human)	"antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]"	Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	"Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]"	DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0140297; GO:1901222	MPRCPAGAMDEGPVDLR	5.28000021	1	1	0.259184436	1903.646153	0	0	13.79969	0	0	0	0	0	0	0	0	0	16.08702	0	0	0	0	14.43728	0	0	0	0	0	0	0	0	0	15.84673	0	0	0	12.25921	15.94302	0	0	0	0	13.35117	0	0	14.64842	0	0	15.2823	9.739427	0	0	0
P20800	EDN2_HUMAN	"Endothelin-2, ET-2 (Preproendothelin-2, PPET2)"	EDN2	Homo sapiens (Human)	angiogenesis [GO:0001525]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; cell tip growth [GO:0009932]; cellular calcium ion homeostasis [GO:0006874]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; hormonal regulation of the force of heart contraction [GO:0003058]; inositol phosphate-mediated signaling [GO:0048016]; lung alveolus development [GO:0048286]; macrophage activation [GO:0042116]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by chemical signal [GO:0003099]; prostaglandin biosynthetic process [GO:0001516]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; temperature homeostasis [GO:0001659]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; angiogenesis [GO:0001525]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; cell tip growth [GO:0009932]; cellular calcium ion homeostasis [GO:0006874]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; hormonal regulation of the force of heart contraction [GO:0003058]; inositol phosphate-mediated signaling [GO:0048016]; lung alveolus development [GO:0048286]; macrophage activation [GO:0042116]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by chemical signal [GO:0003099]; prostaglandin biosynthetic process [GO:0001516]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; temperature homeostasis [GO:0001659]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]	GO:0001516; GO:0001525; GO:0001659; GO:0002690; GO:0003058; GO:0003099; GO:0003100; GO:0005179; GO:0005576; GO:0005615; GO:0006874; GO:0007166; GO:0007204; GO:0008284; GO:0009932; GO:0010460; GO:0014824; GO:0014826; GO:0019221; GO:0019229; GO:0019722; GO:0030593; GO:0031708; GO:0042116; GO:0042310; GO:0043542; GO:0045987; GO:0048016; GO:0048246; GO:0048286; GO:0048675; GO:0060585; GO:0097009	QQEAMR	11.53999996	0.021119764	0.021119764	0.270683988	762.4397637	17.00355	0	17.52452	0	17.58167	17.15586	18.66693	19.22166	17.87127	19.69727	0	0	17.65874	0	16.81477	17.15963	0	0	0	0	17.9225	17.40971	0	17.97002	0	17.97276	17.33281	0	0	16.95476	17.51209	18.80835	18.36873	0	0	17.87886	0	18.00099	19.3381	18.99549	18.18873	17.27612	0	18.72223	0	0	18.05714	0
P20807	CAN3_HUMAN	"Calpain-3, EC 3.4.22.54 (Calcium-activated neutral proteinase 3, CANP 3) (Calpain L3) (Calpain p94) (Muscle-specific calcium-activated neutral protease 3) (New calpain 1, nCL-1)"	CAPN3 CANP3 CANPL3 NCL1	Homo sapiens (Human)	"apoptotic process [GO:0006915]; calcium-dependent self proteolysis [GO:1990092]; cellular response to calcium ion [GO:0071277]; cellular response to salt stress [GO:0071472]; G1 to G0 transition involved in cell differentiation [GO:0070315]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of myoblast differentiation [GO:0045661]; response to calcium ion [GO:0051592]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; self proteolysis [GO:0097264]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular anatomical structure [GO:0005622]; myofibril [GO:0030016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; Z disc [GO:0030018]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular anatomical structure [GO:0005622]; myofibril [GO:0030016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; catalytic activity [GO:0003824]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; ligase regulator activity [GO:0055103]; molecular adaptor activity [GO:0060090]; peptidase activity [GO:0008233]; sodium ion binding [GO:0031402]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; apoptotic process [GO:0006915]; calcium-dependent self proteolysis [GO:1990092]; cellular response to calcium ion [GO:0071277]; cellular response to salt stress [GO:0071472]; G1 to G0 transition involved in cell differentiation [GO:0070315]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of myoblast differentiation [GO:0045661]; response to calcium ion [GO:0051592]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; self proteolysis [GO:0097264]"	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; catalytic activity [GO:0003824]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; ligase regulator activity [GO:0055103]; molecular adaptor activity [GO:0060090]; peptidase activity [GO:0008233]; sodium ion binding [GO:0031402]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]	GO:0003824; GO:0004198; GO:0005509; GO:0005622; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0007517; GO:0008233; GO:0008234; GO:0008307; GO:0014718; GO:0014850; GO:0030016; GO:0030018; GO:0030163; GO:0030239; GO:0030315; GO:0031402; GO:0031432; GO:0031648; GO:0032991; GO:0033234; GO:0042802; GO:0043066; GO:0043122; GO:0045214; GO:0045661; GO:0045862; GO:0045892; GO:0045893; GO:0046716; GO:0050790; GO:0051092; GO:0051281; GO:0051592; GO:0055103; GO:0060090; GO:0061061; GO:0065003; GO:0070315; GO:0071277; GO:0071472; GO:0072657; GO:0097264; GO:1990092	VLNTVVNK	3.140000105	0.490183949	0.490183949	0.215273343	886.2664366	0	17.104	16.44641	15.43114	14.28086	0	15.90599	16.53034	16.42797	0	14.75648	14.9634	13.0499	16.89989	0	15.39591	16.85909	16.18734	0	0	15.40466	0	0	17.5473	15.58779	18.09456	17.77475	0	14.32837	0	15.70711	0	18.23237	0	0	0	0	16.61066	0	0	0	0	15.22823	15.21704	0	0	0	10.83677
P20810	ICAL_HUMAN	Calpastatin (Calpain inhibitor) (Sperm BS-17 component)	CAST	Homo sapiens (Human)	inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; presynaptic active zone organization [GO:1990709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; cadherin binding [GO:0045296]; calcium-dependent cysteine-type endopeptidase inhibitor activity [GO:0010859]; endopeptidase inhibitor activity [GO:0004866]; RNA binding [GO:0003723]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; presynaptic active zone organization [GO:1990709]	cadherin binding [GO:0045296]; calcium-dependent cysteine-type endopeptidase inhibitor activity [GO:0010859]; endopeptidase inhibitor activity [GO:0004866]; RNA binding [GO:0003723]	GO:0003723; GO:0004866; GO:0005737; GO:0005783; GO:0005829; GO:0010859; GO:0016020; GO:0045296; GO:0097340; GO:1990709; GO:2000675	MNPTETKAIPVSQQMEGPHLPNK	5.760000229	1	1	3.22E-12	2579.246637	14.20511	14.14852	0	0	13.10913	11.34715	16.88927	0	0	13.18581	14.49176	13.7275	13.11853	0	13.8137	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20813	CP2B6_HUMAN	"Cytochrome P450 2B6, EC 1.14.13.- (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1)"	CYP2B6	Homo sapiens (Human)	cellular ketone metabolic process [GO:0042180]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid epoxygenase activity [GO:0008392]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; testosterone 16-alpha-hydroxylase activity [GO:0008390]; testosterone 16-beta-hydroxylase activity [GO:0062184]; cellular ketone metabolic process [GO:0042180]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]"	"anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid epoxygenase activity [GO:0008392]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; testosterone 16-alpha-hydroxylase activity [GO:0008390]; testosterone 16-beta-hydroxylase activity [GO:0062184]"	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008390; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042178; GO:0042180; GO:0043231; GO:0062184; GO:0062187; GO:0062188; GO:0062189; GO:0101021	AEAFSGRGK	4.260000229	1	1	0.2650428	921.3003514	0	0	0	0	0	0	0	0	0	16.2186	0	0	0	0	0	0	15.42429	0	9.428202	0	0	14.80208	0	0	14.89658	14.24995	16.53676	14.64425	13.76507	0	10.30799	0	0	15.36228	0	12.36156	0	13.67643	0	0	0	14.60037	14.06211	0	0	0	0	0
P20815	CP3A5_HUMAN	"Cytochrome P450 3A5, EC 1.14.14.1 (CYPIIIA5) (Cytochrome P450-PCN3)"	CYP3A5	Homo sapiens (Human)	aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]	aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016491; GO:0019825; GO:0020037; GO:0042178; GO:0042572; GO:0042573; GO:0043231; GO:0046222; GO:0050649; GO:0070330; GO:0070989; GO:0101020	DVEINGVFIPK	4.059999943	1	1	0.233692649	1231.415024	21.49418	0	0	15.50616	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20823	HNF1A_HUMAN	"Hepatocyte nuclear factor 1-alpha, HNF-1-alpha, HNF-1A (Liver-specific transcription factor LF-B1, LFB1) (Transcription factor 1, TCF-1)"	HNF1A TCF1	Homo sapiens (Human)	"glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; insulin secretion [GO:0030073]; liver development [GO:0001889]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; renal glucose absorption [GO:0035623]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; insulin secretion [GO:0030073]; liver development [GO:0001889]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; renal glucose absorption [GO:0035623]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0030073; GO:0031016; GO:0032991; GO:0035623; GO:0042593; GO:0042803; GO:0045893; GO:0045944; GO:0046323; GO:0046982; GO:0046983; GO:0060261	EVVDTTGLNQSHLSQHLNKGTPMK	5.880000114	1	1	0.521382184	2635.666782	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20849	CO9A1_HUMAN	Collagen alpha-1(IX) chain	COL9A1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]	GO:0005201; GO:0005576; GO:0005594; GO:0005604; GO:0005615; GO:0005788; GO:0009887; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023	NGRDGER	3.200000048	0.602728009	0.602728009	0.221338776	806.6548099	15.75312	15.16039	14.77615	14.01834	14.22089	15.9746	16.44612	10.78537	14.78186	12.40239	15.13487	0	13.74201	15.07018	0	0	0	14.47178	0	14.78764	0	0	15.64266	15.93037	16.4628	0	15.55547	15.77715	0	0	0	15.62319	16.63743	0	0	15.37911	15.94148	16.13093	0	16.90574	0	15.74516	14.98753	0	0	0	16.04192	0
P20908	CO5A1_HUMAN	Collagen alpha-1(V) chain	COL5A1	Homo sapiens (Human)	"blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]"	basement membrane [GO:0005604]; collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	"basement membrane [GO:0005604]; collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]"	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]	GO:0001568; GO:0003007; GO:0005178; GO:0005201; GO:0005576; GO:0005588; GO:0005592; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0008201; GO:0016477; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0032964; GO:0035313; GO:0035989; GO:0043394; GO:0043588; GO:0045112; GO:0046872; GO:0048407; GO:0048592; GO:0051128; GO:0062023; GO:0097435; GO:1903225	GGPNGDPGPLGPPGEKGK	10.47999954	1	1	4.67E-13	1631.743391	16.8159	0	15.60294	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20916	MAG_HUMAN	Myelin-associated glycoprotein (Siglec-4a)	MAG GMA	Homo sapiens (Human)	axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelin formation [GO:0032289]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; substantia nigra development [GO:0021762]; transmission of nerve impulse [GO:0019226]	compact myelin [GO:0043218]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]	compact myelin [GO:0043218]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelin formation [GO:0032289]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; substantia nigra development [GO:0021762]; transmission of nerve impulse [GO:0019226]	carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0010977; GO:0019226; GO:0019901; GO:0021762; GO:0030246; GO:0030517; GO:0031103; GO:0031643; GO:0032289; GO:0033270; GO:0033691; GO:0035749; GO:0042803; GO:0043209; GO:0043218; GO:0043220; GO:0043524; GO:0045121; GO:0045665; GO:0048711; GO:0071260; GO:0097453; GO:0098742; GO:1905576	EFVYSER	5.349999905	1	1	0.015897643	927.3355427	15.41153	0	13.80671	0	14.74597	15.45388	0	0	0	0	0	16.54457	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.87576	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P20929	NEBU_HUMAN	Nebulin	NEB	Homo sapiens (Human)	cardiac muscle thin filament assembly [GO:0071691]; muscle organ development [GO:0007517]; regulation of actin filament length [GO:0030832]; somatic muscle development [GO:0007525]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; structural constituent of muscle [GO:0008307]; cardiac muscle thin filament assembly [GO:0071691]; muscle organ development [GO:0007517]; regulation of actin filament length [GO:0030832]; somatic muscle development [GO:0007525]	actin filament binding [GO:0051015]; structural constituent of muscle [GO:0008307]	GO:0005829; GO:0007517; GO:0007525; GO:0008307; GO:0015629; GO:0030018; GO:0030832; GO:0051015; GO:0070062; GO:0071691	AKINIPADMVSVLAAK	4.329999924	1	1	0.220192682	1655.545124	19.27618	14.23835	16.89001	0	17.56437	16.61035	0	15.64071	16.50084	17.14221	17.03007	16.71788	16.08236	20.06069	15.58409	19.22919	15.56875	17.72777	0	19.18937	16.91064	19.07798	15.6425	10.98852	16.05023	19.15177	0	17.21119	0	18.27612	0	18.61896	16.75426	14.32969	17.29437	15.16664	16.38346	16.47176	17.84908	0	16.87471	0	0	15.7994	18.40273	18.0283	0	15.16146
P20930	FILA_HUMAN	Filaggrin	FLG	Homo sapiens (Human)	establishment of skin barrier [GO:0061436]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]	collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]	collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; structural constituent of skin epidermis [GO:0030280]; transition metal ion binding [GO:0046914]; establishment of skin barrier [GO:0061436]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]	calcium ion binding [GO:0005509]; structural constituent of skin epidermis [GO:0030280]; transition metal ion binding [GO:0046914]	GO:0001533; GO:0005509; GO:0005634; GO:0005829; GO:0018149; GO:0030216; GO:0030280; GO:0036457; GO:0036464; GO:0046914; GO:0061436; GO:0062023	GQSGSRSASR	1.629999995	1	1	0	991.9163931	15.19886	0	13.61388	16.24642	0	10.86445	0	14.18708	16.42828	0	15.68753	15.49423	0	14.91963	0	0	0	0	16.6473	0	15.06729	0	0	0	0	0	0	13.47161	0	13.22396	0	0	0	0	0	0	0	0	0	0	0	0	16.79984	0	0	0	0	0
P20936	RASA1_HUMAN	"Ras GTPase-activating protein 1, GAP, GTPase-activating protein, RasGAP (Ras p21 protein activator) (p120GAP)"	RASA1 GAP RASA	Homo sapiens (Human)	blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of GTPase activity [GO:0043547]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of GTPase activity [GO:0043547]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]	GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001953; GO:0003924; GO:0005096; GO:0005102; GO:0005737; GO:0005829; GO:0005886; GO:0007162; GO:0007165; GO:0008360; GO:0019870; GO:0030833; GO:0035556; GO:0043066; GO:0043524; GO:0043547; GO:0046580; GO:0048013; GO:0048514; GO:0051020; GO:0051252	GIEPGSLRVR	3.769999981	1	1	0.166828086	1083.581855	14.01005	16.61711	0	0	0	0	14.63175	0	0	0	0	0	15.94896	0	0	15.55508	15.19454	14.55068	0	0	0	0	15.22579	0	15.34011	12.94292	0	14.75333	15.59928	14.64811	16.43075	15.2396	13.40475	13.92855	15.01582	14.32605	15.45291	15.36015	15.91187	15.93425	14.28174	15.87904	16.02432	14.86368	14.59907	13.63768	12.66373	12.15343
P21281	VATB2_HUMAN	"V-type proton ATPase subunit B, brain isoform, V-ATPase subunit B 2 (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)"	ATP6V1B2 ATP6B2 VPP3	Homo sapiens (Human)	ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]"	"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000221; GO:0001726; GO:0005524; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0015078; GO:0016021; GO:0016241; GO:0016324; GO:0016787; GO:0042470; GO:0043231; GO:0046034; GO:0046961; GO:0070062; GO:1902600	ALRAMR	6.349999905	0.343120068	0.343120068	0.209240685	717.4055477	14.64421	15.21464	13.19555	13.90432	15.12561	16.10978	13.94603	15.64277	16.23625	15.78545	0	13.4009	11.33164	15.69878	15.22618	14.95169	0	0	15.72477	15.3598	15.36763	15.65941	16.17318	16.0848	15.60746	15.81153	16.15024	0	16.20207	0	16.53697	15.87133	16.68528	0	15.79733	0	16.34268	0	17.34505	16.28358	15.79212	15.06848	0	14.86407	0	14.85355	15.92524	0
P21291	CSRP1_HUMAN	"Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1, CRP, CRP1) (Epididymis luminal protein 141, HEL-141)"	CSRP1 CSRP CYRP	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214]	actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005634; GO:0005737; GO:0005925; GO:0008270; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0060537; GO:0070062; GO:0070527	GYGYGQGAGTLSTDKGESLGIK	5.349999905	1	1	0.141020464	2158.11063	7.989704	12.67412	13.70794	12.31624	16.09186	13.61321	0	0	13.71909	0	15.79189	0	16.68814	13.67958	0	14.56754	13.00461	12.47733	12.15709	0	0	0	0	0	14.84571	0	0	0	0	0	0	0	0	0	0	0	0	0	15.26074	0	16.94284	14.27806	0	0	0	0	0	0
P21333	FLNA_HUMAN	"Filamin-A, FLN-A (Actin-binding protein 280, ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)"	FLNA FLN FLN1	Homo sapiens (Human)	"actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]	"actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]"	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]	GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0003007; GO:0003723; GO:0005080; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005925; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0030018; GO:0030334; GO:0031267; GO:0031523; GO:0031532; GO:0032231; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0045022; GO:0045184; GO:0045216; GO:0045296; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0140297; GO:1900026; GO:1901381; GO:1905000; GO:1905031; GO:1990779; GO:2001046	LKPGAPLRPK	4.170000076	0.246697024	0.246697024	0.250623676	1077.036821	0	0	0	0	0	0	0	0	0	0	0	0	16.0986	0	0	0	0	18.30701	0	0	0	18.01509	0	0	0	0	0	0	0	0	0	0	0	0	18.51163	0	18.01767	0	0	0	0	16.66791	0	0	0	0	0	0
P21359	NF1_HUMAN	Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated ]	NF1	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060]"	GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]	GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0034605; GO:0035021; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0061534; GO:0061535; GO:0098597; GO:0098793; GO:1900271; GO:2001241	ALAGHGGSRQLTESAAIACVK	7.920000076	1	1	3.20E-12	2096.289008	12.74083	0	0	0	0	0	0	0	0	0	0	14.01481	0	14.29233	14.60311	13.71478	15.81366	14.91983	14.89565	15.11129	13.11893	15.56295	0	0	0	12.86875	16.5365	13.43087	12.3726	13.09009	14.06349	15.5699	14.65875	0	0	13.49084	13.24291	14.174	0	15.96017	15.26153	15.52385	17.18878	0	16.92609	0	0	0
P21397	AOFA_HUMAN	"Amine oxidase [flavin-containing] A, EC 1.4.3.21, EC 1.4.3.4 (Monoamine oxidase type A, MAO-A)"	MAOA	Homo sapiens (Human)	cellular biogenic amine metabolic process [GO:0006576]; dopamine catabolic process [GO:0042420]; neurotransmitter catabolic process [GO:0042135]; positive regulation of signal transduction [GO:0009967]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131]; cellular biogenic amine metabolic process [GO:0006576]; dopamine catabolic process [GO:0042420]; neurotransmitter catabolic process [GO:0042135]; positive regulation of signal transduction [GO:0009967]	flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131]	GO:0005739; GO:0005741; GO:0005829; GO:0006576; GO:0008131; GO:0009967; GO:0016021; GO:0042135; GO:0042420; GO:0050660; GO:0097621	WSGYMEGAVEAGER	4.340000153	1	1	0.168931969	1557.425222	0	15.97319	14.3669	0	0	0	15.61405	0	14.55737	0	0	15.61312	0	0	0	0	0	0	0	15.76137	17.73647	0	0	14.45846	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.52925	0	0
P21399	ACOHC_HUMAN	"Cytoplasmic aconitate hydratase, Aconitase, EC 4.2.1.3 (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1, IRP1) (Iron-responsive element-binding protein 1, IRE-BP 1)"	ACO1 IREB1	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]"	"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]"	GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006879; GO:0009791; GO:0010040; GO:0030350; GO:0046872; GO:0047780; GO:0050892; GO:0051538; GO:0051539; GO:0070062	RADSLQK	1.799999952	1	1	0.303017271	817.3688078	16.56954	0	17.87276	0	0	0	0	0	0	0	17.56892	0	19.78051	0	0	18.30581	0	0	0	0	0	0	0	0	0	0	0	0	0	16.27742	19.16347	0	0	0	19.16229	0	0	0	0	0	0	0	0	0	15.6455	16.41863	0	0
P21439	MDR3_HUMAN	"Phosphatidylcholine translocator ABCB4, EC 7.6.2.1 (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)"	ABCB4 MDR3 PGY3	Homo sapiens (Human)	bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0042910; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0090555; GO:0140359; GO:1901557; GO:1903413; GO:2001140	MDLEAAK	4.840000153	0.394905657	0.394905657	0.198716716	776.7115681	13.84798	0	15.68724	15.65657	0	13.95926	0	0	0	15.05968	0	0	0	0	0	16.6206	0	0	0	14.6346	0	0	16.06075	0	17.6358	0	0	0	15.79586	0	0	0	0	0	0	0	0	16.03543	15.94249	0	0	0	0	0	0	14.59725	0	0
P21453	S1PR1_HUMAN	"Sphingosine 1-phosphate receptor 1, S1P receptor 1, S1P1 (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1, S1P receptor Edg-1) (CD antigen CD363)"	S1PR1 CHEDG1 EDG1	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226]	cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226]	G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036]	GO:0001525; GO:0001664; GO:0001955; GO:0003245; GO:0003376; GO:0004930; GO:0005654; GO:0005737; GO:0005768; GO:0005886; GO:0006935; GO:0007155; GO:0007186; GO:0007189; GO:0007193; GO:0007420; GO:0009897; GO:0016021; GO:0016477; GO:0019222; GO:0019226; GO:0030032; GO:0030155; GO:0030182; GO:0030335; GO:0030500; GO:0030595; GO:0031226; GO:0031532; GO:0038036; GO:0043231; GO:0043547; GO:0045121; GO:0045124; GO:0045446; GO:0045944; GO:0046625; GO:0048661; GO:0050927; GO:0051482; GO:0051497; GO:0061384; GO:0072678	CPSGDSAGK	5.579999924	1	1	0.069280653	880.72389	14.02929	15.83934	14.72091	14.13157	0	0	15.29407	16.57811	0	15.74536	0	15.97042	0	0	0	0	13.76284	0	17.95123	0	14.44716	0	16.25718	0	15.25208	0	0	15.39229	0	0	0	0	0	0	0	0	0	0	0	13.81403	0	0	0	0	0	0	0	0
P21462	FPR1_HUMAN	"fMet-Leu-Phe receptor, fMLP receptor (N-formyl peptide receptor, FPR) (N-formylpeptide chemoattractant receptor)"	FPR1	Homo sapiens (Human)	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; nitric oxide mediated signal transduction [GO:0007263]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165]	azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; N-formyl peptide receptor activity [GO:0004982]; RAGE receptor binding [GO:0050786]; scavenger receptor binding [GO:0005124]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; nitric oxide mediated signal transduction [GO:0007263]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165]	complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; N-formyl peptide receptor activity [GO:0004982]; RAGE receptor binding [GO:0050786]; scavenger receptor binding [GO:0005124]	GO:0001664; GO:0002430; GO:0004875; GO:0004930; GO:0004982; GO:0005124; GO:0005737; GO:0005886; GO:0006935; GO:0006954; GO:0007165; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007263; GO:0016021; GO:0030667; GO:0035577; GO:0050786; GO:0101003	VIIGPWVMALLLTLPVIIR	18.54999924	0.228623599	0.228623599	0.10614877	2132.38204	12.5373	16.24571	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P21583	SCF_HUMAN	"Kit ligand (Mast cell growth factor, MGF) (Stem cell factor, SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand, sKITLG ]"	KITLG MGF SCF	Homo sapiens (Human)	cell adhesion [GO:0007155]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; male gonad development [GO:0008584]; negative regulation of mast cell apoptotic process [GO:0033026]; neural crest cell migration [GO:0001755]; ovarian follicle development [GO:0001541]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myeloid leukocyte differentiation [GO:0002763]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173]; cell adhesion [GO:0007155]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; male gonad development [GO:0008584]; negative regulation of mast cell apoptotic process [GO:0033026]; neural crest cell migration [GO:0001755]; ovarian follicle development [GO:0001541]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myeloid leukocyte differentiation [GO:0002763]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173]	GO:0001541; GO:0001755; GO:0002687; GO:0002763; GO:0005125; GO:0005173; GO:0005576; GO:0005615; GO:0005737; GO:0005856; GO:0005886; GO:0007155; GO:0008083; GO:0008284; GO:0008584; GO:0016021; GO:0030027; GO:0030175; GO:0033026; GO:0035162; GO:0035234; GO:0043406; GO:0045636; GO:0046579; GO:0050731; GO:0070668; GO:0097192; GO:1901534; GO:1902035	LFTPEEFFRIFNR	1.870000005	1	1	0.371978438	1716.245321	15.84751	0	0	16.04485	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.40878	14.48721	0	15.96514	0	0	0	14.64121	0
P21589	5NTD_HUMAN	"5'-nucleotidase, 5'-NT, EC 3.1.3.5 (Ecto-5'-nucleotidase) (CD antigen CD73)"	NT5E NT5 NTE	Homo sapiens (Human)	adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; DNA metabolic process [GO:0006259]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; DNA metabolic process [GO:0006259]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0006259; GO:0007159; GO:0008253; GO:0009897; GO:0009986; GO:0010035; GO:0016020; GO:0031225; GO:0033198; GO:0046032; GO:0046034; GO:0046086; GO:0046872; GO:0050728; GO:0055074; GO:0070062; GO:0110148	CMGGVARLFTK	8.430000305	1	1	0.226365135	1256.182392	0	16.82064	0	14.64118	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.51402	0	0	15.60885	0	0	0	0	14.54386	0	17.21233
P21695	GPDA_HUMAN	"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, GPD-C, GPDH-C, EC 1.1.1.8"	GPD1	Homo sapiens (Human)	cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821]	glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]	GO:0004367; GO:0004368; GO:0005829; GO:0006072; GO:0006094; GO:0006116; GO:0006127; GO:0009331; GO:0042803; GO:0045821; GO:0046168; GO:0046486; GO:0051287; GO:0070062; GO:0071320; GO:0071356	LQGPETAR	2.480000019	0.296699375	0.296699375	0.231578346	868.3507804	15.77687	15.46756	15.30588	14.58353	15.76811	14.74796	14.04675	14.96183	14.5053	15.05052	15.43125	16.15064	0	15.41542	14.50499	16.67941	14.4059	15.02215	0	0	0	16.26267	15.17206	16.33455	15.44832	0	0	0	0	16.1379	16.46526	0	15.69894	16.76537	0	0	16.8681	0	16.13222	0	0	15.96569	0	0	15.52738	16.91916	16.16327	0
P21709	EPHA1_HUMAN	"Ephrin type-A receptor 1, hEpha1, EC 2.7.10.1 (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH)"	EPHA1 EPH EPHT EPHT1	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of cell migration [GO:0030336]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of kinase activity [GO:0033674]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of cell migration [GO:0030336]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of kinase activity [GO:0033674]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0001525; GO:0001954; GO:0001968; GO:0004672; GO:0004712; GO:0004714; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006469; GO:0007166; GO:0007169; GO:0007411; GO:0008284; GO:0018108; GO:0019901; GO:0030335; GO:0030336; GO:0033674; GO:0034446; GO:0043005; GO:0043087; GO:0043235; GO:0045766; GO:0046777; GO:0051496; GO:0090630	LPSLSGSDGIPYR	8.220000267	1	1	1.84E-12	1362.215261	15.98131	16.53781	15.50908	0	0	10.94199	15.92075	11.64145	14.6341	11.26138	16.1883	13.65897	16.01444	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.61463	0	0	0	0	0	0	0	0	0	0	0	0
P21757	MSRE_HUMAN	Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204)	MSR1 SCARA1	Homo sapiens (Human)	"amyloid-beta clearance [GO:0097242]; cellular response to organic cyclic compound [GO:0071407]; cholesterol transport [GO:0030301]; lipoprotein transport [GO:0042953]; negative regulation of gene expression [GO:0010629]; phagocytosis, engulfment [GO:0006911]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; receptor-mediated endocytosis [GO:0006898]"	collagen trimer [GO:0005581]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]	"collagen trimer [GO:0005581]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; amyloid-beta clearance [GO:0097242]; cellular response to organic cyclic compound [GO:0071407]; cholesterol transport [GO:0030301]; lipoprotein transport [GO:0042953]; negative regulation of gene expression [GO:0010629]; phagocytosis, engulfment [GO:0006911]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; receptor-mediated endocytosis [GO:0006898]"	amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]	GO:0001540; GO:0005044; GO:0005581; GO:0005829; GO:0005886; GO:0005887; GO:0006898; GO:0006911; GO:0009897; GO:0010629; GO:0010744; GO:0010886; GO:0016021; GO:0030169; GO:0030301; GO:0030666; GO:0034362; GO:0034381; GO:0038024; GO:0042953; GO:0071407; GO:0097242	GPTGESGPR	6.78000021	1	1	0.061070159	856.6323765	0	0	0	0	0	0	16.67239	0	16.40163	0	0	0	18.08916	0	0	15.96555	0	0	0	0	0	0	17.15767	0	0	0	0	15.33529	0	0	0	0	0	0	0	15.09231	18.02559	0	14.97813	0	0	0	0	0	0	0	0	0
P21781	FGF7_HUMAN	"Fibroblast growth factor 7, FGF-7 (Heparin-binding growth factor 7, HBGF-7) (Keratinocyte growth factor)"	FGF7 KGF	Homo sapiens (Human)	"actin cytoskeleton reorganization [GO:0031532]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle morphogenesis [GO:0031069]; lung development [GO:0030324]; mesenchymal cell proliferation [GO:0010463]; positive chemotaxis [GO:0050918]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cell surface [GO:0034394]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; response to wounding [GO:0009611]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]; actin cytoskeleton reorganization [GO:0031532]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle morphogenesis [GO:0031069]; lung development [GO:0030324]; mesenchymal cell proliferation [GO:0010463]; positive chemotaxis [GO:0050918]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cell surface [GO:0034394]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; response to wounding [GO:0009611]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; signal transduction [GO:0007165]"	chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]	GO:0001934; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0005794; GO:0007165; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008544; GO:0009611; GO:0009887; GO:0010463; GO:0010628; GO:0010838; GO:0030154; GO:0030324; GO:0030334; GO:0031069; GO:0031532; GO:0034394; GO:0042056; GO:0045893; GO:0050679; GO:0050731; GO:0050918; GO:0051549; GO:0051781; GO:0060445; GO:0060501; GO:0060665; GO:0061033	GTQEMKNNYNIMEIR	2.589999914	1	1	0.357259954	1871.693016	21.36663	15.83912	16.73738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.43367	0	0	0	0	0	0	0	0	0	0	0	0	0	19.77324	0	0	0	0	0	0	0	0	17.24464	17.46605
P21802	FGFR2_HUMAN	"Fibroblast growth factor receptor 2, FGFR-2, EC 2.7.10.1 (K-sam, KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)"	FGFR2 BEK KGFR KSAM	Homo sapiens (Human)	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060]	cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060]	ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001837; GO:0002053; GO:0003148; GO:0003149; GO:0003416; GO:0004712; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005938; GO:0006915; GO:0007169; GO:0007267; GO:0007409; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009791; GO:0009880; GO:0009887; GO:0009986; GO:0010518; GO:0010839; GO:0016020; GO:0016021; GO:0016331; GO:0017134; GO:0018108; GO:0021769; GO:0021847; GO:0021860; GO:0022612; GO:0030177; GO:0030282; GO:0030324; GO:0030855; GO:0030901; GO:0030916; GO:0031069; GO:0031410; GO:0032496; GO:0032808; GO:0033674; GO:0033688; GO:0035265; GO:0035602; GO:0035603; GO:0035604; GO:0035607; GO:0042060; GO:0042472; GO:0042476; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0045165; GO:0045471; GO:0045667; GO:0045787; GO:0045944; GO:0046777; GO:0048286; GO:0048333; GO:0048557; GO:0048562; GO:0048565; GO:0048568; GO:0048608; GO:0048661; GO:0048701; GO:0048705; GO:0048730; GO:0048755; GO:0048762; GO:0050679; GO:0051150; GO:0051781; GO:0055010; GO:0060045; GO:0060076; GO:0060174; GO:0060348; GO:0060349; GO:0060442; GO:0060445; GO:0060449; GO:0060463; GO:0060484; GO:0060501; GO:0060512; GO:0060523; GO:0060527; GO:0060529; GO:0060595; GO:0060601; GO:0060615; GO:0060664; GO:0060667; GO:0060670; GO:0060688; GO:0060915; GO:0060916; GO:0070372; GO:0070374; GO:0071300; GO:0071560; GO:0090263	CPAGGNPMPTMR	12.86999989	1	1	0.497870881	1319.053946	17.60336	18.8536	17.72404	18.51737	0	18.62373	0	18.68591	17.94075	19.59601	20.244	17.91227	0	0	19.56845	17.39623	19.46235	20.36172	18.34653	19.33938	18.90147	20.83992	19.52987	17.16319	19.84763	20.74978	19.53228	18.85882	20.27319	0	19.06491	18.36217	20.38514	20.12182	0	0	0	21.72973	18.71072	18.56759	0	19.91101	0	0	20.06905	19.52038	18.35622	0
P21810	PGS1_HUMAN	Biglycan (Bone/cartilage proteoglycan I) (PG-S1)	BGN SLRR1A	Homo sapiens (Human)	articular cartilage development [GO:0061975]; bone development [GO:0060348]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]	extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]	GO:0005201; GO:0005539; GO:0005576; GO:0005615; GO:0005796; GO:0009986; GO:0019800; GO:0030021; GO:0030133; GO:0031012; GO:0042383; GO:0043202; GO:0050840; GO:0060348; GO:0061975; GO:0062023; GO:0070062	VPKGVFSGLR	7.03000021	0.553973496	0.553973496	0.20084532	1059.501424	15.4751	11.18383	15.87221	14.11606	16.17919	12.42862	12.90718	0	0	15.50494	13.48442	14.41278	14.14682	15.18825	0	15.26832	14.0071	12.20618	0	0	0	0	0	0	0	0	0	15.86887	0	14.24633	0	0	0	0	15.48344	0	0	0	15.95504	14.74949	0	0	14.49421	0	0	0	0	0
P21817	RYR1_HUMAN	"Ryanodine receptor 1, RYR-1, RyR1 (Skeletal muscle calcium release channel) (Skeletal muscle ryanodine receptor) (Skeletal muscle-type ryanodine receptor) (Type 1 ryanodine receptor)"	RYR1 RYDR	Homo sapiens (Human)	calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; muscle contraction [GO:0006936]; ossification involved in bone maturation [GO:0043931]; outflow tract morphogenesis [GO:0003151]; protein homotetramerization [GO:0051289]; regulation of cytosolic calcium ion concentration [GO:0051480]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; skeletal muscle fiber development [GO:0048741]; skin development [GO:0043588]	calcium channel complex [GO:0034704]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; I band [GO:0031674]; integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; ryanodine receptor complex [GO:1990425]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]	calcium channel complex [GO:0034704]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; I band [GO:0031674]; integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; ryanodine receptor complex [GO:1990425]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; muscle contraction [GO:0006936]; ossification involved in bone maturation [GO:0043931]; outflow tract morphogenesis [GO:0003151]; protein homotetramerization [GO:0051289]; regulation of cytosolic calcium ion concentration [GO:0051480]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; skeletal muscle fiber development [GO:0048741]; skin development [GO:0043588]	ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; voltage-gated calcium channel activity [GO:0005245]	GO:0001666; GO:0003151; GO:0005219; GO:0005245; GO:0005262; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005790; GO:0005886; GO:0005887; GO:0005938; GO:0006816; GO:0006936; GO:0014701; GO:0014802; GO:0014808; GO:0015278; GO:0016529; GO:0030018; GO:0030659; GO:0031000; GO:0031301; GO:0031674; GO:0033017; GO:0034704; GO:0042383; GO:0043588; GO:0043931; GO:0048741; GO:0048763; GO:0051209; GO:0051289; GO:0051480; GO:0070062; GO:0071277; GO:0071313; GO:1990425	DFQKAMDSQK	2.589999914	1	1	0.148748164	1212.615533	11.74376	14.89558	0	14.98933	0	13.62143	12.32771	0	0	0	0	0	0	0	0	12.76658	9.511829	15.60132	10.5316	6.903043	0	0	0	0	0	0	0	0	15.07142	0	15.32608	0	0	0	0	0	0	0	15.09534	15.0027	15.85138	0	0	0	0	0	0	0
P21860	ERBB3_HUMAN	"Receptor tyrosine-protein kinase erbB-3, EC 2.7.10.1 (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)"	ERBB3 HER3	Homo sapiens (Human)	cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell population proliferation [GO:0042127]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell population proliferation [GO:0042127]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]	GO:0003197; GO:0004712; GO:0004714; GO:0004888; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0007162; GO:0007165; GO:0007169; GO:0007399; GO:0007422; GO:0007507; GO:0008284; GO:0009925; GO:0009968; GO:0010628; GO:0014037; GO:0014065; GO:0014068; GO:0016323; GO:0016324; GO:0016328; GO:0019838; GO:0021545; GO:0030296; GO:0031625; GO:0033674; GO:0038131; GO:0038132; GO:0038143; GO:0042060; GO:0042127; GO:0042802; GO:0043125; GO:0043235; GO:0043524; GO:0046982; GO:0051048; GO:0051402; GO:0055025; GO:0061098; GO:0070886; GO:0097192	ANAQRT	10.06999969	1	1	0.235048407	659.5574629	0	15.61524	11.04852	0	0	0	18.45768	0	0	0	0	0	0	17.92562	16.54392	0	0	15.51027	0	0	0	0	0	0	0	0	0	0	18.97047	17.00379	0	19.60155	0	0	0	0	18.38178	17.62019	0	0	0	17.36031	0	0	0	0	0	0
P21917	DRD4_HUMAN	D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor)	DRD4	Homo sapiens (Human)	"adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adult locomotory behavior [GO:0008344]; arachidonic acid secretion [GO:0050482]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inhibitory postsynaptic potential [GO:0060080]; negative regulation of protein secretion [GO:0050709]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of sodium:proton antiporter activity [GO:0032417]; regulation of circadian rhythm [GO:0042752]; regulation of dopamine metabolic process [GO:0042053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to amphetamine [GO:0001975]; response to histamine [GO:0034776]; rhythmic process [GO:0048511]; social behavior [GO:0035176]"	centrosome [GO:0005813]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	"centrosome [GO:0005813]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; epinephrine binding [GO:0051379]; G protein-coupled serotonin receptor activity [GO:0004993]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adult locomotory behavior [GO:0008344]; arachidonic acid secretion [GO:0050482]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inhibitory postsynaptic potential [GO:0060080]; negative regulation of protein secretion [GO:0050709]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of sodium:proton antiporter activity [GO:0032417]; regulation of circadian rhythm [GO:0042752]; regulation of dopamine metabolic process [GO:0042053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to amphetamine [GO:0001975]; response to histamine [GO:0034776]; rhythmic process [GO:0048511]; social behavior [GO:0035176]"	"dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; epinephrine binding [GO:0051379]; G protein-coupled serotonin receptor activity [GO:0004993]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; SH3 domain binding [GO:0017124]"	GO:0001591; GO:0001662; GO:0001975; GO:0004952; GO:0004993; GO:0005813; GO:0005886; GO:0005887; GO:0006874; GO:0007187; GO:0007195; GO:0007212; GO:0007268; GO:0008344; GO:0015459; GO:0016020; GO:0017124; GO:0030425; GO:0030594; GO:0032417; GO:0033674; GO:0034776; GO:0035176; GO:0035240; GO:0042053; GO:0042417; GO:0042596; GO:0042752; GO:0042802; GO:0043406; GO:0046872; GO:0048148; GO:0048149; GO:0048511; GO:0050482; GO:0050709; GO:0051379; GO:0051380; GO:0051586; GO:0060080; GO:0098794; GO:0098978; GO:0099149; GO:1901386	RQLLLIGATWLLSAAVAAPVLCGLNDVR	2.289999962	1	1	1.39E-12	2990.218605	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.51674	0	0	0	0	0	0	0	0	0	0	0	0	18.77897	0	0	18.03691	0	0	17.32414	0	0	16.81527	18.07957
P21953	ODBB_HUMAN	"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial, EC 1.2.4.4 (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain, BCKDE1B, BCKDH E1-beta)"	BCKDHB	Homo sapiens (Human)	branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; protein-containing complex binding [GO:0044877]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]	3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; protein-containing complex binding [GO:0044877]	GO:0003863; GO:0005654; GO:0005730; GO:0005739; GO:0005759; GO:0005947; GO:0006629; GO:0007584; GO:0009083; GO:0044877; GO:0051384; GO:0051591	CTVGLRDK	1.49000001	0.6225245	0.6225245	0.236850734	949.3407232	13.38241	16.17466	17.93187	16.88467	0	0	0	0	0	17.51427	0	0	17.22121	0	0	0	0	17.52175	0	0	0	16.17836	0	0	0	0	0	0	0	0	0	17.96777	0	0	18.25661	0	0	0	0	0	0	16.89883	0	0	0	17.65676	17.10468	0
P22059	OSBP1_HUMAN	Oxysterol-binding protein 1	OSBP OSBP1	Homo sapiens (Human)	bile acid biosynthetic process [GO:0006699]; ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918]	oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]	GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006686; GO:0006699; GO:0008142; GO:0015248; GO:0015914; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0035627; GO:0035774; GO:0042531; GO:0043231; GO:0048471; GO:0070273; GO:0097038; GO:0120015; GO:1904411	DFLMLAQTHSK	4.03000021	1	1	0.270871553	1305.981237	0	15.3527	15.56773	14.93061	0	14.34189	14.7952	15.1723	0	0	12.42046	15.77948	0	0	13.15555	0	0	15.28603	0	0	0	0	0	0	15.5092	16.11071	0	0	0	15.26812	0	0	15.636	0	13.90889	15.07804	0	17.32205	0	16.01208	0	15.95188	0	0	0	0	0	0
P22102	PUR2_HUMAN	"Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase, EC 6.3.4.13 (Glycinamide ribonucleotide synthetase, GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase, EC 6.3.3.1 (AIR synthase, AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase, EC 2.1.2.2 (5'-phosphoribosylglycinamide transformylase) (GAR transformylase, GART) ]"	GART PGFT PRGS	Homo sapiens (Human)	'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]	GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0044208; GO:0046084; GO:0046654; GO:0046872; GO:0070062; GO:0097294	VKLAEHK	11.46000004	1	1	0.176735076	824.7419513	0	14.78746	16.33445	14.104	14.8996	0	0	0	14.82568	0	17.079	0	14.98449	0	13.93467	15.36289	0	0	14.91895	15.5857	0	0	17.20217	0	0	16.24382	0	0	0	0	0	0	0	0	0	0	0	17.46332	0	0	0	14.86673	15.77273	0	15.99246	0	0	0
P22105	TENX_HUMAN	"Tenascin-X, TN-X (Hexabrachion-like protein)"	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; positive regulation of cell fate determination [GO:1905935]; positive regulation of collagen fibril organization [GO:1904028]; regulation of cell differentiation [GO:0045595]; regulation of JUN kinase activity [GO:0043506]; triglyceride metabolic process [GO:0006641]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; positive regulation of cell fate determination [GO:1905935]; positive regulation of collagen fibril organization [GO:1904028]; regulation of cell differentiation [GO:0045595]; regulation of JUN kinase activity [GO:0043506]; triglyceride metabolic process [GO:0006641]	collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]	GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0043506; GO:0045595; GO:0048251; GO:0062023; GO:0070062; GO:0098609; GO:0098633; GO:1904028; GO:1905935	LGELTVTDR	6.239999771	1	1	0.18435986	1000.85489	17.34765	18.1734	16.60277	10.56632	14.89623	14.61992	0	0	0	0	0	0	17.16063	0	0	0	0	0	0	13.99087	15.9129	0	15.75618	17.66405	0	0	0	0	16.28082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P22223	CADH3_HUMAN	"Cadherin-3 (Placental cadherin, P-cadherin)"	CDH3 CDHP	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; hair cycle process [GO:0022405]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinization [GO:0031424]; negative regulation of timing of catagen [GO:0051796]; negative regulation of transforming growth factor beta2 production [GO:0032912]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanosome transport [GO:1902910]; positive regulation of tyrosinase activity [GO:0032773]; regulation of hair cycle by canonical Wnt signaling pathway [GO:0060901]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]; wound healing [GO:0042060]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; hair cycle process [GO:0022405]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinization [GO:0031424]; negative regulation of timing of catagen [GO:0051796]; negative regulation of transforming growth factor beta2 production [GO:0032912]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanosome transport [GO:1902910]; positive regulation of tyrosinase activity [GO:0032773]; regulation of hair cycle by canonical Wnt signaling pathway [GO:0060901]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]; wound healing [GO:0042060]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001895; GO:0005509; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007156; GO:0007601; GO:0009410; GO:0010628; GO:0010838; GO:0016021; GO:0016342; GO:0022405; GO:0030054; GO:0031424; GO:0032773; GO:0032912; GO:0042060; GO:0043568; GO:0045296; GO:0048023; GO:0051796; GO:0060901; GO:0090263; GO:0098742; GO:1902910	KLADMYGGGEDD	3.130000114	1	1	0.141396586	1275.017534	13.95029	12.71764	13.32014	10.86541	13.15969	0	0	0	0	0	12.58967	13.06203	12.73599	13.14	12.18758	0	14.40235	0	14.5595	0	0	0	0	16.42974	16.07369	12.09744	15.49824	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.66141	0	0	0	0	0
P22303	ACES_HUMAN	"Acetylcholinesterase, AChE, EC 3.1.1.7"	ACHE	Homo sapiens (Human)	"acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416]"	anchored component of membrane [GO:0031225]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	"anchored component of membrane [GO:0031225]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine hydrolase activity [GO:0017171]; acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416]"	acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine hydrolase activity [GO:0017171]	GO:0001507; GO:0001540; GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007399; GO:0007416; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0031225; GO:0031594; GO:0031623; GO:0032223; GO:0042166; GO:0042803; GO:0042982; GO:0043083; GO:0043236; GO:0043621; GO:0045202; GO:0048471; GO:0050714; GO:0060041; GO:0095500; GO:0120162	TGDPNEPR	9.930000305	1	1	0.314016466	884.7318212	19.10099	17.92848	18.11502	15.16556	0	0	17.54884	0	0	17.92892	0	19.08578	0	18.49313	0	20.13799	0	17.80993	0	18.94686	17.87004	0	18.07856	18.34855	0	18.86513	0	0	0	0	0	19.309	0	17.57435	0	20.63708	0	19.17581	0	19.10545	18.60156	19.12061	20.65704	0	17.91248	0	18.42643	17.25718
P22307	SCP2_HUMAN	"Sterol carrier protein 2, SCP-2 (Acetyl-CoA C-myristoyltransferase, EC 2.3.1.155) (Non-specific lipid-transfer protein, NSL-TP) (Propanoyl-CoA C-acyltransferase, EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase, EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X, SCP-X)"	SCP2	Homo sapiens (Human)	alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular cholesterol transport [GO:0032367]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; regulation of phospholipid biosynthetic process [GO:0071071]; steroid biosynthetic process [GO:0006694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular cholesterol transport [GO:0032367]; lipid hydroperoxide transport [GO:1901373]; peroxisome organization [GO:0007031]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; regulation of phospholipid biosynthetic process [GO:0071071]; steroid biosynthetic process [GO:0006694]	acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]	GO:0000062; GO:0003988; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006694; GO:0006699; GO:0006701; GO:0007031; GO:0008206; GO:0008526; GO:0015485; GO:0015914; GO:0016020; GO:0032367; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033540; GO:0033814; GO:0036042; GO:0036109; GO:0043231; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0071071; GO:0072659; GO:0120019; GO:0120020; GO:1901373	ADCTITMADSDFLALMTGKMNPQSAFFQGK	5.449999809	1	1	3.20E-12	3329.624729	13.39465	0	0	0	0	0	14.15721	10.18603	0	0	12.40461	0	11.82641	0	0	0	0	5.915354	14.46407	0	0	0	14.32099	0	11.63772	0	10.2769	0	16.04687	0	17.45611	0	0	0	0	0	0	0	0	0	13.08972	0	0	0	0	0	11.82181	0
P22413	ENPP1_HUMAN	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, E-NPP 1 (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form ] [Includes: Alkaline phosphodiesterase I, EC 3.1.4.1; Nucleotide pyrophosphatase, NPPase, EC 3.6.1.9 (Nucleotide diphosphatase) ]"	ENPP1 M6S1 NPPS PC1 PDNP1	Homo sapiens (Human)	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; bone mineralization [GO:0030282]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; gene expression [GO:0010467]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035]; sequestering of triglyceride [GO:0030730]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphatase activity [GO:0016791]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; bone mineralization [GO:0030282]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; gene expression [GO:0010467]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035]; sequestering of triglyceride [GO:0030730]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphatase activity [GO:0016791]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]	GO:0003676; GO:0004527; GO:0004528; GO:0004551; GO:0005044; GO:0005158; GO:0005509; GO:0005524; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0006091; GO:0006796; GO:0006955; GO:0008270; GO:0009143; GO:0009986; GO:0010035; GO:0010467; GO:0016021; GO:0016323; GO:0016791; GO:0030247; GO:0030282; GO:0030308; GO:0030318; GO:0030500; GO:0030502; GO:0030505; GO:0030643; GO:0030730; GO:0031953; GO:0032869; GO:0033198; GO:0035529; GO:0036218; GO:0042803; GO:0045599; GO:0045719; GO:0046034; GO:0046325; GO:0046627; GO:0047429; GO:0050427; GO:0050656; GO:0055062; GO:0090305; GO:0106177; GO:0110148; GO:1990787	DPNTYK	6.460000038	1	1	0.114075834	735.87712	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.32324	0	0	0	0	0	0	0	0	0	0	14.98748	16.73225	0	13.37832	15.10251	0	0	15.87352	0	16.0255	0	0	0	0	15.73313	15.34017	16.62606
P22455	FGFR4_HUMAN	"Fibroblast growth factor receptor 4, FGFR-4, EC 2.7.10.1 (CD antigen CD334)"	FGFR4 JTK2 TKF	Homo sapiens (Human)	cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004712; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010715; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0033674; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0055062; GO:0070374; GO:0070857; GO:2000573	CPAAGNPTPTIR	5.269999981	1	1	0	1254.716563	13.34154	11.79951	0	14.29328	13.7275	14.87176	0	13.07428	0	16.26983	14.72343	14.58542	0	12.88577	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P22459	KCNA4_HUMAN	Potassium voltage-gated channel subfamily A member 4 (HPCN2) (Voltage-gated K(+) channel HuKII) (Voltage-gated potassium channel HBK4) (Voltage-gated potassium channel HK1) (Voltage-gated potassium channel subunit Kv1.4)	KCNA4 KCNA4L	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	axon [GO:0030424]; axon initial segment [GO:0043194]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	axon [GO:0030424]; axon initial segment [GO:0043194]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium ion binding [GO:0030955]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	delayed rectifier potassium channel activity [GO:0005251]; potassium ion binding [GO:0030955]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0030424; GO:0030955; GO:0034765; GO:0043194; GO:0043197; GO:0051260; GO:0071805	HSKGLQILGHTLR	9.18999958	1	1	0.208650119	1459.267803	0	0	0	0	12.85087	0	15.26921	11.40897	13.76201	0	0	0	15.70852	0	14.5301	0	0	14.09381	0	0	0	0	0	0	15.56863	0	0	0	0	0	0	16.05105	0	0	0	0	0	0	0	0	0	0	0	16.01213	0	0	0	0
P22460	KCNA5_HUMAN	Potassium voltage-gated channel subfamily A member 5 (HPCN1) (Voltage-gated potassium channel HK2) (Voltage-gated potassium channel subunit Kv1.5)	KCNA5	Homo sapiens (Human)	atrial cardiac muscle cell action potential [GO:0086014]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during bundle of His cell action potential [GO:0086050]; membrane repolarization during SA node cell action potential [GO:0086052]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of myoblast proliferation [GO:2000288]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of insulin secretion [GO:0050796]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular canaliculus [GO:0046691]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; Z disc [GO:0030018]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular canaliculus [GO:0046691]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090]; atrial cardiac muscle cell action potential [GO:0086014]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during bundle of His cell action potential [GO:0086050]; membrane repolarization during SA node cell action potential [GO:0086052]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of myoblast proliferation [GO:2000288]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of insulin secretion [GO:0050796]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033]	alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090]	GO:0001666; GO:0005102; GO:0005249; GO:0005251; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006813; GO:0007219; GO:0008076; GO:0009612; GO:0009986; GO:0010033; GO:0014704; GO:0015271; GO:0016021; GO:0019229; GO:0019901; GO:0030018; GO:0034705; GO:0042391; GO:0042542; GO:0043266; GO:0045121; GO:0046691; GO:0048471; GO:0050796; GO:0051260; GO:0051393; GO:0051481; GO:0055075; GO:0055093; GO:0060081; GO:0060372; GO:0071805; GO:0086014; GO:0086050; GO:0086052; GO:0086087; GO:0086089; GO:0086090; GO:0086091; GO:0097110; GO:0097623; GO:0098914; GO:1900087; GO:2000288	GSCPLEK	7.360000134	1	1	0.247521966	790.3215087	14.79014	0	15.6861	0	13.86973	0	16.32837	0	0	19.16473	0	0	16.14626	17.7269	13.04922	0	0	0	0	16.77368	14.62012	0	0	15.18757	15.10989	0	16.59157	0	16.01961	14.40626	0	0	0	16.23323	0	0	0	0	17.86654	17.57152	0	0	0	0	18.88865	17.80909	0	15.30728
P22492	H1T_HUMAN	Histone H1t (Testicular H1 histone)	H1-6 H1FT H1T HIST1H1T	Homo sapiens (Human)	cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; spermatogenesis [GO:0007283]	nucleosome [GO:0000786]; nucleus [GO:0005634]	nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; spermatogenesis [GO:0007283]	double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]	GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0007283; GO:0016584; GO:0030154; GO:0030261; GO:0031492; GO:0045910	SETVPAASASAGVAAMEK	11.55000019	0.852197468	0.852197468	2.75E-12	1677.587212	9.36487	13.8968	11.9323	0	0	17.21857	0	0	0	0	0	0	0	0	0	0	15.54862	16.52372	0	0	0	0	0	0	0	0	0	0	0	0	15.85248	13.15514	0	0	0	0	0	17.33873	0	0	0	0	0	0	0	0	0	0
P22557	HEM0_HUMAN	"5-aminolevulinate synthase, erythroid-specific, mitochondrial, ALAS-E, EC 2.3.1.37 (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)"	ALAS2 ALASE ASB	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; oxygen homeostasis [GO:0032364]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; oxygen homeostasis [GO:0032364]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666]	5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]	GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0006879; GO:0030170; GO:0030218; GO:0032364; GO:0042541; GO:0048821	DLVDMVR	3.150000095	0.184408203	0.184408203	0.07987018	860.0106993	17.07775	0	16.49077	0	0	12.82977	12.78672	13.39537	10.88059	13.0535	15.4035	0	13.51159	0	14.92704	16.5275	12.83979	0	15.7866	0	12.8139	15.63091	0	14.13727	0	0	15.12878	14.14778	0	0	17.11557	0	15.98885	0	13.80268	0	14.84029	14.67871	0	0	14.10903	0	0	14.03587	0	17.08914	15.77263	16.79306
P22570	ADRO_HUMAN	"NADPH:adrenodoxin oxidoreductase, mitochondrial, AR, Adrenodoxin reductase, EC 1.18.1.6 (Ferredoxin--NADP(+) reductase, Ferredoxin reductase)"	FDXR ADXR	Homo sapiens (Human)	cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744]	ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]	GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491	RGPLQVAFTIK	5.71999979	0.027935086	0.027935086	0.147262665	1229.935901	0	17.57015	13.02847	0	12.78219	0	0	0	0	0	0	0	0	0	9.240887	0	0	0	0	0	0	12.03507	0	0	0	0	0	0	15.75224	0	0	16.44725	11.76002	15.5171	13.56798	0	0	0	16.16295	0	0	15.99995	0	0	13.77552	0	0	14.12283
P22607	FGFR3_HUMAN	"Fibroblast growth factor receptor 3, FGFR-3, EC 2.7.10.1 (CD antigen CD333)"	FGFR3 JTK4	Homo sapiens (Human)	bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000165; GO:0001501; GO:0001958; GO:0002062; GO:0003416; GO:0004712; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007267; GO:0008284; GO:0008543; GO:0009986; GO:0010518; GO:0017134; GO:0018108; GO:0030133; GO:0030282; GO:0033674; GO:0035988; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0048640; GO:0060349; GO:0070374; GO:0070977; GO:1902178	AAKPVTVAVK	10.39999962	1	1	0.27916355	983.0644586	0	0	15.64145	11.69553	0	15.01006	0	0	0	16.78367	15.44725	15.23159	14.27207	0	0	12.60975	14.80223	15.3844	0	14.81584	0	0	0	0	0	14.2827	0	0	14.37827	0	0	0	0	0	15.11368	14.67089	15.34665	0	0	0	0	15.94903	15.97041	14.55032	16.51246	0	0	15.52326
P22676	CALB2_HUMAN	"Calretinin, CR (29 kDa calbindin)"	CALB2 CAB29	Homo sapiens (Human)	regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]	cytosol [GO:0005829]; dendrite [GO:0030425]; gap junction [GO:0005921]; neuron projection [GO:0043005]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; synapse [GO:0045202]; terminal bouton [GO:0043195]	cytosol [GO:0005829]; dendrite [GO:0030425]; gap junction [GO:0005921]; neuron projection [GO:0043005]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]	calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534]	GO:0005509; GO:0005634; GO:0005829; GO:0005921; GO:0030425; GO:0043005; GO:0043195; GO:0045202; GO:0051480; GO:0098688; GO:0099509; GO:0099534; GO:1900271	KSVMSLAEAGK	7.949999809	0.540627837	0.540627837	0.132805887	1117.908567	0	0	10.30764	14.15701	17.20401	13.03393	0	13.39338	0	16.51323	13.71878	10.28533	0	0	11.90985	0	0	0	12.77882	16.00767	13.74332	14.82589	0	14.7613	15.44643	15.42562	0	15.72569	0	15.99154	0	17.46791	15.41847	0	17.91962	13.41365	0	13.19991	17.83333	0	15.45835	15.42705	16.80384	0	0	17.29576	0	0
P22680	CP7A1_HUMAN	"Cytochrome P450 7A1 (24-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.26) (CYPVII) (Cholesterol 7-alpha-hydroxylase) (Cholesterol 7-alpha-monooxygenase, EC 1.14.14.23)"	CYP7A1 CYP7	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of gene expression [GO:0010468]; response to ethanol [GO:0045471]; sterol metabolic process [GO:0016125]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of gene expression [GO:0010468]; response to ethanol [GO:0045471]; sterol metabolic process [GO:0016125]	24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]	GO:0005506; GO:0005789; GO:0006699; GO:0006707; GO:0008123; GO:0008395; GO:0010468; GO:0015721; GO:0016021; GO:0016125; GO:0020037; GO:0032966; GO:0033782; GO:0038183; GO:0042632; GO:0043231; GO:0045471; GO:0045542; GO:0045717; GO:0070857; GO:0071333; GO:0071397	AHILNNLDNFKQFDK	15.53999996	1	1	0.06708826	1816.76543	15.15662	16.0791	0	17.12336	12.64295	12.35656	0	0	0	15.46719	0	0	0	13.69403	15.25167	0	14.54981	0	15.48013	0	14.84911	0	0	17.40956	0	0	17.99832	11.28342	0	12.80259	15.15659	0	0	15.321	16.09739	0	0	0	15.9497	12.40473	0	15.57511	14.858	9.472074	0	0	0	0
P22681	CBL_HUMAN	"E3 ubiquitin-protein ligase CBL, EC 2.3.2.27 (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL)"	CBL CBL2 RNF55	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron death [GO:1901215]; neuron death [GO:0070997]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]	cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell surface receptor signaling pathway [GO:0007166]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron death [GO:1901215]; neuron death [GO:0070997]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0001784; GO:0004842; GO:0005509; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0006511; GO:0006513; GO:0006974; GO:0007165; GO:0007166; GO:0007173; GO:0007175; GO:0008584; GO:0010332; GO:0014068; GO:0014823; GO:0016567; GO:0016600; GO:0017124; GO:0019221; GO:0030426; GO:0030971; GO:0032487; GO:0033574; GO:0035635; GO:0036120; GO:0036312; GO:0042059; GO:0042594; GO:0043066; GO:0043303; GO:0045121; GO:0045296; GO:0045471; GO:0045742; GO:0046677; GO:0046875; GO:0048260; GO:0048471; GO:0051865; GO:0061630; GO:0070997; GO:0090650; GO:1901215; GO:1990090; GO:2000583	LDLLPQR	10.52000046	0.10676226	0.10676226	0.289530602	853.8941944	0	0	0	19.51251	17.23712	20.22594	0	19.13848	20.89313	18.9184	20.03676	19.71874	0	0	21.22459	21.31147	18.06025	0	19.86093	0	0	20.70121	0	0	19.22543	18.6995	0	17.70804	0	0	20.616	17.47513	20.26875	19.41845	19.68025	0	0	19.24709	18.31259	19.24911	0	18.12317	18.175	19.47002	19.68809	19.89124	0	17.2859
P22692	IBP4_HUMAN	"Insulin-like growth factor-binding protein 4, IBP-4, IGF-binding protein 4, IGFBP-4"	IGFBP4 IBP4	Homo sapiens (Human)	inflammatory response [GO:0006954]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; inflammatory response [GO:0006954]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342]	insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]	GO:0001558; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0006954; GO:0007165; GO:0010906; GO:0031994; GO:0031995; GO:0043410; GO:0043567; GO:0043568; GO:0044342; GO:0090090	STSGGK	6.309999943	1	1	0.015166158	535.1600932	0	0	0	14.6067	0	0	0	0	15.3499	13.8781	0	15.87488	14.5006	13.70256	15.90755	0	0	0	0	15.57608	0	0	0	14.65139	16.27884	12.32999	0	0	0	0	0	13.77449	0	0	0	0	0	0	0	0	0	15.55108	0	0	0	0	16.90343	0
P22695	QCR2_HUMAN	"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)"	UQCRC2	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]"	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005654; GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006119; GO:0006122; GO:0009060; GO:0045333; GO:0046872	GASSFK	2.650000095	1	1	0.15617329	596.5458037	15.34938	15.09072	14.00718	0	0	0	0	15.78025	0	15.28447	0	16.3624	0	0	0	0	16.89915	0	0	15.65134	16.59731	0	15.61295	0	0	0	16.76285	0	0	0	15.64901	14.64855	15.43194	0	14.011	14.64614	0	0	0	0	0	0	0	11.79447	17.17838	0	0	0
P22732	GTR5_HUMAN	"Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine, GLUT-5)"	SLC2A5 GLUT5	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; intestinal hexose absorption [GO:0106001]; monosaccharide transmembrane transport [GO:0015749]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; specific granule membrane [GO:0035579]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; specific granule membrane [GO:0035579]; fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; carbohydrate metabolic process [GO:0005975]; cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; intestinal hexose absorption [GO:0106001]; monosaccharide transmembrane transport [GO:0015749]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750]	fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]	GO:0003044; GO:0005353; GO:0005355; GO:0005886; GO:0005887; GO:0005975; GO:0009750; GO:0015149; GO:0015749; GO:0015755; GO:0016020; GO:0016324; GO:0035579; GO:0042383; GO:0070061; GO:0070062; GO:0071332; GO:0106001; GO:1904659; GO:1990539	AAGFISVLKLFR	8.420000076	0.337520987	0.337520987	0.144884051	1321.142806	0	0	16.3542	17.07712	16.36892	0	14.56138	0	0	0	0	16.82051	13.08115	16.86899	0	0	18.47407	0	12.66951	0	13.03782	0	0	14.01576	14.18198	12.57298	0	13.81263	8.114845	0	14.13309	18.10905	12.6479	16.15509	0	15.40345	17.12237	19.18883	0	15.67434	12.41842	10.31821	0	0	0	16.68977	0	14.86819
P22830	HEMH_HUMAN	"Ferrochelatase, mitochondrial, EC 4.99.1.1 (Heme synthase) (Protoheme ferro-lyase)"	FECH	Homo sapiens (Human)	generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to light stimulus [GO:0009416]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]; protein homodimerization activity [GO:0042803]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to light stimulus [GO:0009416]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]; protein homodimerization activity [GO:0042803]"	GO:0004325; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006783; GO:0008198; GO:0009416; GO:0042803; GO:0046501; GO:0051537	VGPMPWLGPQTDESIK	3.799999952	1	1	0.42421838	1769.287569	17.36274	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.42399	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.54985	0	18.81294	0	0	0	0	0
P22888	LSHR_HUMAN	"Lutropin-choriogonadotropic hormone receptor, LH/CG-R (Luteinizing hormone receptor, LHR, LSH-R)"	LHCGR LCGR LGR2 LHRHR	Homo sapiens (Human)	"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]"	endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]"	choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964]	GO:0001541; GO:0004964; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007189; GO:0007190; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0030539; GO:0032962; GO:0035472; GO:0038106; GO:0042700; GO:0050890; GO:0071371; GO:0071373	DFSAYTSNCK	10.34000015	1	1	0.307130208	1192.380518	15.49672	0	15.20468	0	0	0	0	0	0	0	13.35415	13.77792	15.17336	0	15.8719	0	0	15.60117	0	0	17.05113	0	0	0	16.82729	14.77473	0	15.41247	14.69229	12.72501	16.62192	14.14447	0	0	0	0	17.21802	0	0	15.99048	0	0	0	15.88815	0	17.36709	0	0
P22897	MRC1_HUMAN	"Macrophage mannose receptor 1, MMR (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor, hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)"	MRC1 CLEC13D CLEC13DL MRC1L1	Homo sapiens (Human)	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]	cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353	QEDCVVMK	8.449999809	0.217628121	0.217628121	0.141904505	1024.466098	0	13.60475	0	0	0	0	16.57195	13.96157	17.18432	14.6535	14.69789	15.7064	0	0	16.13211	0	16.86837	13.55454	0	14.0016	14.88513	0	16.96127	18.05071	13.95205	14.03089	17.69237	0	8.26675	0	14.88016	15.11446	15.56564	15.6655	10.22704	0	0	17.11833	14.45911	0	17.05577	8.319553	15.74961	0	14.83457	15.8143	0	15.00449
P22914	CRYGS_HUMAN	Gamma-crystallin S (Beta-crystallin S) (Gamma-S-crystallin)	CRYGS CRYG8	Homo sapiens (Human)	lens development in camera-type eye [GO:0002088]; morphogenesis of an epithelium [GO:0002009]; visual perception [GO:0007601]		structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; morphogenesis of an epithelium [GO:0002009]; visual perception [GO:0007601]	structural constituent of eye lens [GO:0005212]	GO:0002009; GO:0002088; GO:0005212; GO:0007601	KPIDWGAASPAVQSFR	13.48999977	1	1	0.335279408	1730.404626	13.67649	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.22173	0	15.84699	0	0	16.82695	0	15.09535	14.74296	15.4832	12.40267	15.9093	15.76267	13.55718	0	0	13.49742	0	0	0	0	0	16.99024	0	0	16.0435	0	18.97322	0	14.99752	0
P23025	XPA_HUMAN	DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein)	XPA XPAC	Homo sapiens (Human)	"base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; protein localization to nucleus [GO:0034504]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]"	intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]	"intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; sequence-specific double-stranded DNA binding [GO:1990837]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; protein localization to nucleus [GO:0034504]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]"	damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000110; GO:0000715; GO:0003684; GO:0005634; GO:0005654; GO:0006281; GO:0006284; GO:0009650; GO:0019904; GO:0033683; GO:0034504; GO:0042803; GO:0045171; GO:0046872; GO:0070914; GO:1901255; GO:1990837	EFMDSYLMNHFDLPTCDNCR	14.13000011	1	1	3.66E-12	2577.687467	14.61718	12.85822	0	16.34755	13.98989	0	15.20115	14.41457	0	12.11796	14.73802	0	14.31261	0	11.39605	0	0	0	0	0	0	0	13.11537	0	0	14.86674	0	0	0	0	0	0	0	0	0	0	13.90683	15.64592	0	0	0	0	0	0	10.57384	0	0	0
P23109	AMPD1_HUMAN	"AMP deaminase 1, EC 3.5.4.6 (AMP deaminase isoform M) (Myoadenylate deaminase)"	AMPD1	Homo sapiens (Human)	AMP metabolic process [GO:0046033]; GMP salvage [GO:0032263]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]	cytosol [GO:0005829]	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; GMP salvage [GO:0032263]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0032263; GO:0032264; GO:0042802; GO:0046033; GO:0046872	GEDPFR	16.54999924	0.331667334	0.331667334	0.099656187	721.0396829	0	15.71584	15.10807	0	15.18659	0	11.11392	17.00752	0	0	15.55074	0	14.75447	0	0	14.22032	15.58071	0	0	0	0	15.73277	14.744	13.17816	13.90653	0	16.06175	11.94802	0	15.80831	15.62396	0	0	13.66957	13.9845	0	17.68987	16.21824	0	0	14.90599	0	15.95679	0	17.29523	15.15029	0	16.50531
P23141	EST1_HUMAN	"Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase, ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1, CE-1, hCE-1, EC 3.1.1.1) (Cholesteryl ester hydrolase, CEH, EC 3.1.1.13) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1, EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase, REH) (Serine esterase 1) (Triacylglycerol hydrolase, TGH)"	CES1 CES2 SES1	Homo sapiens (Human)	cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771]; cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691]	carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771]	GO:0004771; GO:0005737; GO:0005783; GO:0005788; GO:0005811; GO:0005829; GO:0006695; GO:0008203; GO:0009636; GO:0010875; GO:0010887; GO:0016042; GO:0030855; GO:0042632; GO:0043691; GO:0047374; GO:0051791; GO:0052689; GO:0070857; GO:0071397; GO:0071404; GO:0080030; GO:0090122; GO:0090205; GO:0120188	ENIPLK	7.510000229	0.138861328	0.138861328	0.248788219	713.9410226	0	0	17.83964	19.0055	0	0	19.95247	18.55139	19.23826	18.93607	17.08226	17.04864	0	0	0	19.33765	18.15969	0	0	18.60374	19.00473	17.89532	17.93649	20.09544	0	19.61254	20.20666	18.62848	17.63951	19.44176	19.04761	0	19.38504	19.7271	20.02498	0	20.08945	18.52194	0	0	17.99708	0	18.31898	0	0	18.07349	17.03588	0
P23142	FBLN1_HUMAN	"Fibulin-1, FIBL-1"	FBLN1 PP213	Homo sapiens (Human)	"blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]"	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]"	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]	GO:0001933; GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0008022; GO:0010628; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0062023; GO:0070051; GO:0070062; GO:0070373; GO:0071635; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647	AITPPHPASQANIIFDITEGNLR	14.59000015	0.909185171	0.909185171	1.37E-12	2475.606403	15.65854	13.15672	0	14.24032	0	14.08503	14.4167	0	0	14.2008	0	0	0	0	0	8.118492	14.90916	0	0	0	0	0	0	0	0	16.55872	14.64535	13.56964	0	0	14.73638	0	0	14.19579	0	9.741462	0	0	10.22167	0	0	0	0	0	13.06068	0	0	0
P23229	ITA6_HUMAN	"Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6, Alpha6p ]"	ITGA6	Homo sapiens (Human)	cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; ectodermal cell differentiation [GO:0010668]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; ectodermal cell differentiation [GO:0010668]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589]	cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]	GO:0005178; GO:0005886; GO:0005925; GO:0007044; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0010668; GO:0010976; GO:0030335; GO:0031589; GO:0031994; GO:0033627; GO:0035878; GO:0038132; GO:0042327; GO:0043065; GO:0043547; GO:0043589; GO:0045296; GO:0045944; GO:0046872; GO:0050900; GO:0098609; GO:2001237	QLSCVANQNGSQADCELGNPFKR	4.349999905	1	1	0.00437217	2593.553669	15.71838	15.72124	0	0	0	0	0	0	13.17699	0	0	0	13.88278	15.15072	0	0	14.74224	15.5033	15.30999	0	0	0	0	0	0	13.61478	13.98333	14.29516	0	0	0	15.95572	0	15.28764	11.58883	0	13.81124	12.4991	12.92671	0	14.69974	13.77287	13.64413	0	19.03225	0	0	0
P23246	SFPQ_HUMAN	"Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein, hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor, PSF, PTB-associated-splicing factor)"	SFPQ PSF	Homo sapiens (Human)	"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; chromosome organization [GO:0051276]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]"	chromatin [GO:0000785]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; chromosome organization [GO:0051276]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]	GO:0000122; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0002218; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006397; GO:0008380; GO:0016363; GO:0016607; GO:0032839; GO:0042382; GO:0042752; GO:0042754; GO:0042803; GO:0042826; GO:0045087; GO:0045876; GO:0045892; GO:0045944; GO:0048511; GO:0051276; GO:0070932; GO:0090575; GO:0098963; GO:1902177	LAQKNPMYQK	3.75999999	0.055765118	0.055765118	0.358564269	1237.723923	12.5538	13.90906	15.63389	14.58185	14.37209	14.68059	0	0	0	14.72035	0	0	0	13.43125	0	12.6237	0	0	0	14.89382	16.11757	0	17.09496	16.41756	13.12781	0	15.29752	0	15.47961	16.27984	0	0	0	0	14.00124	0	0	0	0	15.20083	15.69856	0	0	15.56156	16.30597	12.55553	16.82995	0
P23276	KELL_HUMAN	"Kell blood group glycoprotein, EC 3.4.24.- (CD antigen CD238)"	KEL	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; negative regulation of potassium ion transmembrane transport [GO:1901380]; protein processing [GO:0016485]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741]; vasoconstriction [GO:0042310]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; negative regulation of potassium ion transmembrane transport [GO:1901380]; protein processing [GO:0016485]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741]; vasoconstriction [GO:0042310]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0006874; GO:0008361; GO:0010961; GO:0016021; GO:0016485; GO:0031133; GO:0042310; GO:0042552; GO:0046872; GO:0048741; GO:1901380	NLPWMNEETQNMAQDK	1.370000005	0.272544891	0.272544891	0.342420838	1965.433578	15.76724	0	0	0	0	0	0	0	0	0	14.71875	0	15.60157	0	0	0	19.10077	0	0	0	0	0	14.28857	0	0	0	0	0	10.36008	13.83504	12.373	0	0	0	0	0	0	0	0	0	13.69657	0	0	0	0	0	0	0
P23352	KALM_HUMAN	Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein)	ANOS1 ADMLX KAL KAL1 KALIG1	Homo sapiens (Human)	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182]	extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0007155; GO:0007411; GO:0008201; GO:0009986; GO:0030182; GO:0031012	SHKPVGCLGEAGHVLSK	12.11999989	1	1	2.75E-12	1775.226074	14.36282	13.71455	14.15878	15.22364	15.74035	14.03354	0	0	0	0	0	14.72963	0	0	0	0	14.80346	15.17849	14.12691	0	15.5942	17.64818	0	0	13.72758	13.90478	14.11415	15.22836	0	0	0	14.5604	14.1451	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P23368	MAOM_HUMAN	"NAD-dependent malic enzyme, mitochondrial, NAD-ME, EC 1.1.1.38 (Malic enzyme 2)"	ME2	Homo sapiens (Human)	malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]	electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0009055; GO:0043231; GO:0046872; GO:0051287; GO:1902031	KMTSPLEK	6.03000021	1	1	0.198582625	948.3058138	0	0	0	13.14983	14.40615	0	0	0	16.07496	0	0	17.77391	16.40004	14.41163	0	0	15.23135	0	0	0	0	0	16.71562	13.24053	0	0	13.12749	0	0	0	0	14.30201	17.1806	0	0	18.41744	0	16.83071	18.0974	16.0852	0	0	0	0	0	0	15.37363	17.24596
P23378	GCSP_HUMAN	"Glycine dehydrogenase (decarboxylating), mitochondrial, EC 1.4.4.2 (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))"	GLDC GCSP	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]	glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]	electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]	GO:0004375; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0005960; GO:0006546; GO:0009055; GO:0016594; GO:0016829; GO:0019464; GO:0030170; GO:0036255; GO:0042803; GO:0070280; GO:1903442; GO:1990830	AMVDKHK	12.52000046	0.066276804	0.066276804	0.167275493	842.9388854	17.73817	12.97843	14.23695	0	0	0	18.27209	0	0	0	0	0	19.17917	0	0	0	0	0	0	0	0	0	0	15.2377	0	0	0	0	0	18.39304	0	0	0	0	0	16.8543	0	0	0	14.43372	0	0	0	0	0	0	0	0
P23396	RS3_HUMAN	"40S ribosomal protein S3, EC 4.2.99.18 (Small ribosomal subunit protein uS3)"	RPS3 OK/SW-cl.26	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron-sulfur cluster binding [GO:0051536]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]; translational initiation [GO:0006413]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron-sulfur cluster binding [GO:0051536]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	GO:0002181; GO:0003677; GO:0003684; GO:0003723; GO:0003729; GO:0003735; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0005783; GO:0005829; GO:0005840; GO:0005844; GO:0005886; GO:0005925; GO:0006281; GO:0006412; GO:0006413; GO:0006915; GO:0006974; GO:0007059; GO:0008017; GO:0010628; GO:0014069; GO:0015631; GO:0016020; GO:0017148; GO:0019899; GO:0019900; GO:0019901; GO:0022626; GO:0022627; GO:0030544; GO:0031116; GO:0031334; GO:0031397; GO:0032079; GO:0032357; GO:0032358; GO:0032587; GO:0032743; GO:0034614; GO:0042104; GO:0042981; GO:0043507; GO:0044390; GO:0044877; GO:0045738; GO:0045739; GO:0050862; GO:0051018; GO:0051092; GO:0051225; GO:0051301; GO:0051536; GO:0051879; GO:0061481; GO:0070062; GO:0070181; GO:0070301; GO:0071159; GO:0071356; GO:0072686; GO:0097100; GO:0140078; GO:0140297; GO:1901224; GO:1902231; GO:1902546; GO:1905053; GO:1990904; GO:2001235; GO:2001272	ELTAVVQKR	1.24000001	0.363488078	0.363488078	0.326482484	1042.64352	0	0	0	0	0	15.34904	16.58707	0	0	0	15.90626	0	0	15.69638	0	0	0	0	0	15.82664	16.74933	0	0	0	0	0	0	16.07406	15.97796	15.66641	0	0	0	15.1854	14.87442	0	16.75751	16.5497	0	0	0	14.77604	16.40664	0	0	16.99568	0	0
P23443	KS6B1_HUMAN	"Ribosomal protein S6 kinase beta-1, S6K-beta-1, S6K1, EC 2.7.11.1 (70 kDa ribosomal protein S6 kinase 1, P70S6K1, p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha, p70 S6 kinase alpha, p70 S6K-alpha, p70 S6KA)"	RPS6KB1 STK14A	Homo sapiens (Human)	aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0007568; GO:0007584; GO:0007616; GO:0009408; GO:0009410; GO:0009611; GO:0009612; GO:0009636; GO:0009749; GO:0009986; GO:0014732; GO:0014878; GO:0014911; GO:0016477; GO:0018105; GO:0030165; GO:0031667; GO:0031929; GO:0032496; GO:0032869; GO:0033574; GO:0033762; GO:0034612; GO:0042277; GO:0042802; GO:0043005; GO:0043066; GO:0043201; GO:0043491; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048015; GO:0048471; GO:0048633; GO:0048661; GO:0051721; GO:0071346; GO:0071363; GO:0071549; GO:0106310; GO:2001237	LGAGPGDAGEVQAHPFFR	3.970000029	0.568511486	0.568511486	0.108196836	1823.663533	0	7.651083	15.33721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59962	0	0	0	15.73388	0	16.9607	0	0	0	0	0
P23458	JAK1_HUMAN	"Tyrosine-protein kinase JAK1, EC 2.7.10.2 (Janus kinase 1, JAK-1)"	JAK1 JAK1A JAK1B	Homo sapiens (Human)	cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to antibiotic [GO:0046677]; type I interferon signaling pathway [GO:0060337]; type III interferon signaling pathway [GO:0038196]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to antibiotic [GO:0046677]; type I interferon signaling pathway [GO:0060337]; type III interferon signaling pathway [GO:0038196]	ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]	GO:0004712; GO:0004713; GO:0004715; GO:0005131; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007259; GO:0016020; GO:0019221; GO:0019903; GO:0031625; GO:0031730; GO:0034112; GO:0035556; GO:0038110; GO:0038196; GO:0046677; GO:0046872; GO:0060333; GO:0060337; GO:0070102; GO:0098586; GO:0150105; GO:1903672	EGIDSECGPFIK	6.789999962	1	1	0.093474325	1352.179818	11.95301	13.27981	0	0	13.878	0	0	0	0	11.71222	0	0	12.34913	0	0	0	0	0	0	0	0	0	0	0	0	16.08157	0	0	0	0	0	0	14.37955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P23467	PTPRB_HUMAN	"Receptor-type tyrosine-protein phosphatase beta, Protein-tyrosine phosphatase beta, R-PTP-beta, EC 3.1.3.48 (Vascular endothelial protein tyrosine phosphatase, VE-PTP)"	PTPRB PTPB	Homo sapiens (Human)	angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; cadherin binding [GO:0045296]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470]	cadherin binding [GO:0045296]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001525; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0016311; GO:0035579; GO:0043235; GO:0045296; GO:0070821; GO:1990264	IISLDEER	8.649999619	0.32276085	0.32276085	0.268110761	974.9829124	16.23165	16.53067	14.94278	0	14.68517	0	16.72988	15.70052	15.22348	15.02132	15.30717	15.71048	14.91276	15.01786	14.46218	14.74868	14.52043	13.66844	0	14.09874	16.12419	0	0	15.00917	0	15.35863	15.30883	0	0	16.17914	16.24616	16.18125	0	0	0	0	0	16.37226	16.07464	0	0	14.16985	14.56908	15.26407	16.73582	0	0	0
P23468	PTPRD_HUMAN	"Receptor-type tyrosine-protein phosphatase delta, Protein-tyrosine phosphatase delta, R-PTP-delta, EC 3.1.3.48"	PTPRD	Homo sapiens (Human)	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0099151; GO:0099545; GO:0099560; GO:1905606	AHTSKGPGPYSPSVQFR	3.619999886	1	1	0.106405885	1816.21901	13.46863	12.55281	15.42111	0	0	0	14.48983	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.68163	0	0	0	0	15.56172	14.80815	0	14.78084	0	16.00017	14.5345	13.93914	0	0	0	0	0	0	15.09011
P23470	PTPRG_HUMAN	"Receptor-type tyrosine-protein phosphatase gamma, Protein-tyrosine phosphatase gamma, R-PTP-gamma, EC 3.1.3.48"	PTPRG PTPG	Homo sapiens (Human)	brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005887; GO:0006470; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062	IHACYTVR	9.789999962	3.76E-05	3.76E-05	0.226554502	1022.103913	14.2123	0	14.22254	14.3224	18.41556	15.27343	14.44337	14.75747	14.92136	16.18574	16.54306	14.58776	14.43928	15.19522	0	0	11.74405	0	0	14.39181	13.57466	15.95509	14.41178	15.20698	12.54449	0	13.61062	14.70786	0	0	15.32825	16.60078	0	0	14.17798	0	15.85849	0	16.00587	0	0	14.36641	0	15.89256	0	0	14.59108	0
P23471	PTPRZ_HUMAN	"Receptor-type tyrosine-protein phosphatase zeta, R-PTP-zeta, EC 3.1.3.48 (Protein-tyrosine phosphatase receptor type Z polypeptide 1) (Protein-tyrosine phosphatase receptor type Z polypeptide 2) (R-PTP-zeta-2)"	PTPRZ1 HTPZP2 PTPRZ PTPRZ2 PTPZ	Homo sapiens (Human)	axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; integrin binding [GO:0005178]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	integrin binding [GO:0005178]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0002244; GO:0004725; GO:0005001; GO:0005178; GO:0005576; GO:0005886; GO:0005887; GO:0006470; GO:0007409; GO:0007417; GO:0007611; GO:0031226; GO:0031641; GO:0035335; GO:0043524; GO:0045202; GO:0048709; GO:0048714; GO:0070445; GO:0072534	LIHSDEILTSTK	21.38999939	1	1	0.11676666	1356.367065	0	0	0	17.00661	0	15.3738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.82352	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P23497	SP100_HUMAN	Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa)	SP100	Homo sapiens (Human)	"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; interferon-gamma-mediated signaling pathway [GO:0060333]; maintenance of protein location [GO:0045185]; negative regulation of cellular component movement [GO:0051271]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral transcription [GO:0032897]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Fas signaling pathway [GO:1902044]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to retinoic acid [GO:0032526]; response to type I interferon [GO:0034340]; retinoic acid receptor signaling pathway [GO:0048384]; telomere maintenance [GO:0000723]; type I interferon signaling pathway [GO:0060337]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; interferon-gamma-mediated signaling pathway [GO:0060333]; maintenance of protein location [GO:0045185]; negative regulation of cellular component movement [GO:0051271]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral transcription [GO:0032897]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Fas signaling pathway [GO:1902044]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to retinoic acid [GO:0032526]; response to type I interferon [GO:0034340]; retinoic acid receptor signaling pathway [GO:0048384]; telomere maintenance [GO:0000723]; type I interferon signaling pathway [GO:0060337]"	"chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]"	GO:0000122; GO:0000723; GO:0000781; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0006978; GO:0010596; GO:0016604; GO:0016605; GO:0019900; GO:0019904; GO:0032526; GO:0032897; GO:0034097; GO:0034340; GO:0034341; GO:0034399; GO:0042802; GO:0042803; GO:0043392; GO:0043433; GO:0045185; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0046826; GO:0046983; GO:0048384; GO:0051091; GO:0051271; GO:0060333; GO:0060337; GO:0061629; GO:0070087; GO:1902041; GO:1902044	ANTRPLKR	8.739999771	0.305004865	0.305004865	0.210638367	956.3522284	12.82498	15.27257	13.75816	15.2307	0	15.79442	0	14.73187	0	14.57121	16.1225	15.19086	0	0	13.85593	13.48988	0	0	0	14.42207	0	0	0	0	14.76235	15.1918	16.73656	0	15.07867	13.48609	15.59391	15.71767	12.18844	14.93491	15.08852	14.94049	0	0	13.89602	16.9204	15.88952	15.62371	15.60115	15.66526	12.36294	13.93859	14.80655	0
P23508	CRCM_HUMAN	"Colorectal mutant cancer protein, Protein MCC"	MCC	Homo sapiens (Human)	establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	signaling receptor activity [GO:0038023]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0036464; GO:0038023; GO:0045184; GO:0050680; GO:0090090	LTKSSEIR	5.539999962	1	1	0.106577258	931.9178255	17.16266	0	17.60025	14.96083	15.97357	0	17.34157	0	15.83279	15.1278	0	15.74874	17.46269	16.79502	0	0	17.17076	17.21491	18.1134	16.52947	17.6331	17.04181	0	15.16684	0	16.34619	0	0	16.36938	0	0	18.37738	17.51806	17.41448	13.91165	14.63127	16.31747	18.17679	0	0	16.14291	0	0	15.44479	0	15.5559	17.56473	0
P23526	SAHH_HUMAN	"Adenosylhomocysteinase, AdoHcyase, EC 3.3.1.1 (S-adenosyl-L-homocysteine hydrolase)"	AHCY SAHH	Homo sapiens (Human)	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]	adenosylhomocysteinase activity [GO:0004013]	GO:0004013; GO:0005829; GO:0006730; GO:0033353; GO:0042470; GO:0070062	MSDKLPYK	1.629999995	1	1	1.71E-12	981.6471029	14.49056	0	0	0	0	14.28296	11.18347	0	15.03173	0	0	0	0	15.13911	0	12.43467	14.84475	13.98157	0	11.60211	14.95607	0	0	0	13.17421	14.26696	15.35657	11.47818	15.2332	0	0	0	0	12.61375	15.51111	14.64497	14.26544	13.81069	0	14.18502	14.22811	11.8849	0	0	0	0	0	0
P23588	IF4B_HUMAN	"Eukaryotic translation initiation factor 4B, eIF-4B"	EIF4B	Homo sapiens (Human)	eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]	cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]	cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]	ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]	GO:0001731; GO:0003723; GO:0003743; GO:0005829; GO:0006446; GO:0016281; GO:0033592; GO:0034057; GO:0043024; GO:0097010	LPREPSNPER	7.849999905	1	1	0.034724364	1194.343974	0	0	0	16.07337	15.81982	0	0	15.0382	14.68224	0	14.37991	14.42007	7.956654	16.76566	0	0	0	15.08293	11.63948	0	15.75207	0	18.6197	13.91731	0	0	0	0	0	0	16.09999	18.1137	0	6.804862	0	0	0	0	16.14268	0	0	0	14.56332	0	0	0	0	12.59336
P23634	AT2B4_HUMAN	"Plasma membrane calcium-transporting ATPase 4, PMCA4, EC 7.2.2.10 (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)"	ATP2B4 ATP2B2 MXRA1	Homo sapiens (Human)	calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]	GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0010751; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019829; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0033138; GO:0034220; GO:0036126; GO:0036487; GO:0043005; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0099059; GO:0140199; GO:0150104; GO:1900082; GO:1901660; GO:1902083; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145; GO:2000481	LVPSSSYIK	5.190000057	1	1	0.136233144	995.3394229	14.70808	14.27663	15.01978	0	14.27462	15.46423	0	0	0	0	14.99794	17.00587	14.43917	14.54002	0	0	0	0	0	0	0	0	15.80361	0	15.43362	0	0	0	0	0	17.38815	0	0	15.37954	0	0	14.70964	0	0	0	0	0	0	0	0	0	0	0
P23677	IP3KA_HUMAN	"Inositol-trisphosphate 3-kinase A, EC 2.7.1.127 (Inositol 1,4,5-trisphosphate 3-kinase A, IP3 3-kinase A, IP3K A, InsP 3-kinase A)"	ITPKA	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"	"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; small GTPase binding [GO:0031267]"	GO:0000828; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006020; GO:0007165; GO:0008440; GO:0016301; GO:0030036; GO:0031267; GO:0032958; GO:0043197; GO:0046854; GO:0048167; GO:0061003; GO:0097062	TTPLPDGQILDHR	5.710000038	1	1	0.456750582	1463.7373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.08232	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.12136	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P23743	DGKA_HUMAN	"Diacylglycerol kinase alpha, DAG kinase alpha, EC 2.7.1.107 (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha, DGK-alpha)"	DGKA DAGK DAGK1	Homo sapiens (Human)	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]	GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005543; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834	RPHGDIYGINQALGATAK	2.569999933	1	1	0.186899429	1882.622519	0	16.30376	13.87861	0	0	0	0	11.01243	14.73309	0	0	0	0	0	0	13.27943	0	0	0	0	16.04263	0	0	0	0	0	15.65764	0	0	0	0	15.78603	0	15.44555	0	15.10259	15.756	15.27699	16.04897	12.42833	12.54896	14.87289	0	0	0	0	0	0
P23759	PAX7_HUMAN	Paired box protein Pax-7 (HuP1)	PAX7 HUP1	Homo sapiens (Human)	anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007517; GO:0009653; GO:0043066; GO:0048856; GO:1990837	MAALPGTVPRMMRPAPGQNYPR	4.639999866	1	1	0.061591366	2426.830222	0	0	15.38444	13.08328	16.20675	0	0	12.23479	17.61581	13.36105	14.72508	0	0	0	0	0	14.02237	14.37528	0	0	0	0	15.50645	10.59933	0	0	0	18.59425	0	0	0	0	0	0	15.32126	0	0	18.48992	15.3938	0	0	0	0	0	0	0	0	0
P23769	GATA2_HUMAN	Endothelial transcription factor GATA-2 (GATA-binding protein 2)	GATA2	Homo sapiens (Human)	"cell differentiation in hindbrain [GO:0021533]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; urogenital system development [GO:0001655]; vascular wound healing [GO:0061042]; ventral spinal cord interneuron differentiation [GO:0021514]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; cell differentiation in hindbrain [GO:0021533]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; urogenital system development [GO:0001655]; vascular wound healing [GO:0061042]; ventral spinal cord interneuron differentiation [GO:0021514]"	"C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0000981; GO:0001221; GO:0001223; GO:0001228; GO:0001655; GO:0001709; GO:0001764; GO:0001892; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006909; GO:0007204; GO:0008270; GO:0010628; GO:0010629; GO:0010725; GO:0021514; GO:0021533; GO:0021902; GO:0021954; GO:0021983; GO:0033993; GO:0035019; GO:0035065; GO:0035854; GO:0042472; GO:0043306; GO:0043536; GO:0045165; GO:0045599; GO:0045648; GO:0045650; GO:0045654; GO:0045666; GO:0045746; GO:0045766; GO:0045944; GO:0048469; GO:0048873; GO:0050766; GO:0060100; GO:0060216; GO:0060872; GO:0061042; GO:0061629; GO:0070345; GO:0070742; GO:0090050; GO:0090102; GO:0097154; GO:1902895; GO:1903589; GO:1990837; GO:2000178; GO:2000352; GO:2000977	MNGQNRPLIKPKR	8.149999619	0.378360212	0.378360212	0.449583388	1569.484469	19.5158	0	0	0	17.18353	0	21.03955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.38592	0	0	0	0	0	0	0	18.4264	0	0	0	0	0	0	18.40417	0	0	0	0	18.68584	21.94406	0	0	0
P23771	GATA3_HUMAN	Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3)	GATA3	Homo sapiens (Human)	"anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; cellular response to interferon-alpha [GO:0035457]; cellular response to interleukin-4 [GO:0071353]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; defense response [GO:0006952]; developmental growth [GO:0048589]; ear development [GO:0043583]; embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; erythrocyte differentiation [GO:0030218]; gene expression [GO:0010467]; humoral immune response [GO:0006959]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lymphocyte migration [GO:0072676]; male gonad development [GO:0008584]; mast cell differentiation [GO:0060374]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in mesonephros development [GO:2000607]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [GO:2000703]; negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [GO:2000734]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; nephric duct morphogenesis [GO:0072178]; neuron migration [GO:0001764]; norepinephrine biosynthetic process [GO:0042421]; otic vesicle development [GO:0071599]; parathyroid gland development [GO:0060017]; parathyroid hormone secretion [GO:0035898]; pharyngeal system development [GO:0060037]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; post-embryonic development [GO:0009791]; pro-T cell differentiation [GO:0002572]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of cellular response to X-ray [GO:2000683]; regulation of cytokine production [GO:0001817]; regulation of epithelial cell differentiation [GO:0030856]; regulation of establishment of cell polarity [GO:2000114]; regulation of histone H3-K27 methylation [GO:0061085]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell differentiation [GO:0045064]; thymic T cell selection [GO:0045061]; thymus development [GO:0048538]; TOR signaling [GO:0031929]; type IV hypersensitivity [GO:0001806]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud formation [GO:0060676]; uterus development [GO:0060065]; ventricular septum development [GO:0003281]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; interleukin-2 receptor binding [GO:0005134]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; cellular response to interferon-alpha [GO:0035457]; cellular response to interleukin-4 [GO:0071353]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; defense response [GO:0006952]; developmental growth [GO:0048589]; ear development [GO:0043583]; embryonic hemopoiesis [GO:0035162]; embryonic organ development [GO:0048568]; erythrocyte differentiation [GO:0030218]; gene expression [GO:0010467]; humoral immune response [GO:0006959]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lymphocyte migration [GO:0072676]; male gonad development [GO:0008584]; mast cell differentiation [GO:0060374]; mesenchymal to epithelial transition [GO:0060231]; mesonephros development [GO:0001823]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell motility [GO:2000146]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in mesonephros development [GO:2000607]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [GO:2000703]; negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [GO:2000734]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; nephric duct morphogenesis [GO:0072178]; neuron migration [GO:0001764]; norepinephrine biosynthetic process [GO:0042421]; otic vesicle development [GO:0071599]; parathyroid gland development [GO:0060017]; parathyroid hormone secretion [GO:0035898]; pharyngeal system development [GO:0060037]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; post-embryonic development [GO:0009791]; pro-T cell differentiation [GO:0002572]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of cellular response to X-ray [GO:2000683]; regulation of cytokine production [GO:0001817]; regulation of epithelial cell differentiation [GO:0030856]; regulation of establishment of cell polarity [GO:2000114]; regulation of histone H3-K27 methylation [GO:0061085]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell differentiation [GO:0045064]; thymic T cell selection [GO:0045061]; thymus development [GO:0048538]; TOR signaling [GO:0031929]; type IV hypersensitivity [GO:0001806]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud formation [GO:0060676]; uterus development [GO:0060065]; ventricular septum development [GO:0003281]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; interleukin-2 receptor binding [GO:0005134]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001223; GO:0001227; GO:0001228; GO:0001701; GO:0001709; GO:0001764; GO:0001806; GO:0001817; GO:0001822; GO:0001823; GO:0002088; GO:0002520; GO:0002572; GO:0003180; GO:0003215; GO:0003281; GO:0003677; GO:0003700; GO:0005134; GO:0005634; GO:0005654; GO:0006338; GO:0006952; GO:0006959; GO:0007165; GO:0007411; GO:0008270; GO:0008285; GO:0008584; GO:0009410; GO:0009615; GO:0009653; GO:0009791; GO:0009967; GO:0010332; GO:0010467; GO:0010595; GO:0010719; GO:0010975; GO:0014065; GO:0030217; GO:0030218; GO:0030856; GO:0031929; GO:0032689; GO:0032703; GO:0032736; GO:0032753; GO:0032754; GO:0033600; GO:0035162; GO:0035457; GO:0035799; GO:0035898; GO:0042421; GO:0042472; GO:0042802; GO:0043370; GO:0043523; GO:0043583; GO:0043627; GO:0045061; GO:0045064; GO:0045087; GO:0045165; GO:0045471; GO:0045582; GO:0045599; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0048485; GO:0048538; GO:0048568; GO:0048589; GO:0048646; GO:0050728; GO:0050852; GO:0051569; GO:0051897; GO:0060017; GO:0060037; GO:0060065; GO:0060231; GO:0060374; GO:0060676; GO:0061085; GO:0061290; GO:0061629; GO:0070888; GO:0071353; GO:0071356; GO:0071442; GO:0071599; GO:0071773; GO:0071837; GO:0072107; GO:0072178; GO:0072179; GO:0072182; GO:0072197; GO:0072676; GO:0090102; GO:1901536; GO:1902895; GO:1990837; GO:2000114; GO:2000146; GO:2000352; GO:2000553; GO:2000607; GO:2000611; GO:2000617; GO:2000679; GO:2000683; GO:2000703; GO:2000734	YQVPLPDSMK	7.619999886	0.096987322	0.096987322	0.115419578	1172.245861	0	0	0	0	0	17.48848	0	0	0	0	10.40838	0	0	15.62873	18.79077	0	16.14392	0	0	16.96139	16.69368	15.12187	0	0	14.08293	0	0	18.31003	0	16.58049	9.943246	19.32541	0	17.64933	0	17.61073	16.92243	0	0	0	16.15476	17.00745	0	15.34888	19.69693	14.26749	0	16.27946
P23919	KTHY_HUMAN	"Thymidylate kinase, EC 2.7.4.9 (dTMP kinase)"	DTYMK CDC8 TMPK TYMK	Homo sapiens (Human)	cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; thymidine biosynthetic process [GO:0046105]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; thymidine biosynthetic process [GO:0046105]	ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]	GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0046105; GO:0071363	LLSSYLQKK	1.230000019	1	1	0.073025028	1080.103446	0	0	0	15.09966	12.60845	0	0	14.70854	13.05814	0	0	15.28101	0	14.28202	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P23945	FSHR_HUMAN	"Follicle-stimulating hormone receptor, FSH-R (Follitropin receptor)"	FSHR LGR1	Homo sapiens (Human)	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; gonad development [GO:0008406]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; gonad development [GO:0008406]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]; spermatogenesis [GO:0007283]	follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]	GO:0004963; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007190; GO:0007283; GO:0007292; GO:0008406; GO:0008528; GO:0008584; GO:0008585; GO:0009755; GO:0010738; GO:0014068; GO:0016021; GO:0042699; GO:0043235; GO:0070374; GO:0071372	MALLLVSLLAFLSLGSGCHHR	1.590000033	0.652694941	0.652694941	0.197698472	2311.78743	0	0	0	14.66623	14.85221	0	11.14068	0	0	17.12362	0	13.7824	0	15.05056	14.59302	12.57963	0	0	0	0	0	0	15.01375	13.69862	12.75815	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.25521	0	0	0	0	0	15.37714	0
P23975	SC6A2_HUMAN	"Sodium-dependent noradrenaline transporter (Norepinephrine transporter, NET) (Solute carrier family 6 member 2)"	SLC6A2 NAT1 NET1 SLC6A5	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]; chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]	GO:0003779; GO:0005326; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0007268; GO:0008504; GO:0009410; GO:0009986; GO:0015844; GO:0015874; GO:0016020; GO:0032809; GO:0035725; GO:0042734; GO:0043005; GO:0043014; GO:0045121; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0051620; GO:0070050	NGVQCLLAPR	6.460000038	1	1	0	1128.107423	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P24043	LAMA2_HUMAN	Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain)	LAMA2 LAMM	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]"	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]	"basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]"	extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]	GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0030334; GO:0031594; GO:0032224; GO:0035633; GO:0042383; GO:0043083; GO:0045785; GO:0045995; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046	ADAVR	6.590000153	1	1	0.213908494	531.148643	21.00065	17.71219	16.93293	15.47288	18.94195	19.27722	19.08435	18.79632	19.8485	19.89354	17.5563	18.08605	18.4883	17.53272	17.98589	20.73543	17.59656	18.3007	18.46921	16.71507	18.85563	19.24538	17.19011	19.9161	0	20.29735	20.64292	16.66467	19.51908	19.65993	21.34558	19.52242	17.78222	16.73917	20.0084	0	19.87393	18.59037	18.16333	19.76605	19.4621	18.00175	19.69067	19.78545	19.55984	18.11697	17.67431	20.00587
P24046	GBRR1_HUMAN	Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor)	GABRR1	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; identical protein binding [GO:0042802]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]	chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; identical protein binding [GO:0042802]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0098978; GO:0098982; GO:0099507; GO:1902476; GO:1902711; GO:1904315	SQRSSYVSMR	5.5	1	1	0.323824405	1218.965539	0	0	0	10.62519	0	10.05176	0	8.968627	0	0	13.00693	0	0	0	0	0	13.42151	0	17.53091	14.71059	0	14.30363	0	0	0	0	16.14436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P24278	ZBT25_HUMAN	Zinc finger and BTB domain-containing protein 25 (Zinc finger protein 46) (Zinc finger protein KUP)	ZBTB25 C14orf51 KUP ZNF46	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]	"nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0006357; GO:0046872	GPKQIVDHSR	9.649999619	1	1	0.08485826	1136.515627	0	13.5591	15.21127	0	0	15.65896	7.148998	0	0	0	14.84109	0	0	0	0	0	0	0	0	11.81745	0	0	14.29637	0	14.79819	0	0	13.58843	0	0	0	14.37685	0	0	0	0	0	0	0	0	0	0	13.56428	0	0	0	13.14589	0
P24298	ALAT1_HUMAN	"Alanine aminotransferase 1, ALT1, EC 2.6.1.2 (Glutamate pyruvate transaminase 1, GPT 1) (Glutamic--alanine transaminase 1) (Glutamic--pyruvic transaminase 1)"	GPT AAT1 GPT1	Homo sapiens (Human)	biosynthetic process [GO:0009058]; cellular response to insulin stimulus [GO:0032869]; L-alanine catabolic process [GO:0042853]; positive regulation of gluconeogenesis [GO:0045722]; response to starvation [GO:0042594]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular response to insulin stimulus [GO:0032869]; L-alanine catabolic process [GO:0042853]; positive regulation of gluconeogenesis [GO:0045722]; response to starvation [GO:0042594]	L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]	GO:0004021; GO:0005829; GO:0009058; GO:0030170; GO:0032869; GO:0042594; GO:0042853; GO:0045722; GO:0070062	AWALDVAELHRALGQAR	10.03999996	0.2560395	0.2560395	0.139038581	1876.364665	0	0	0	16.22481	0	16.86836	0	0	12.88028	0	0	0	0	9.981988	15.20149	12.36101	0	0	0	0	14.52642	0	0	11.97532	13.83281	0	12.14592	17.03841	0	0	16.28425	13.54497	15.68865	0	15.4491	14.8893	15.00223	16.81449	18.02919	13.39363	0	11.21561	17.44265	14.46825	0	16.24993	15.22804	18.27799
P24386	RAE1_HUMAN	"Rab proteins geranylgeranyltransferase component A 1 (Choroideremia protein) (Rab escort protein 1, REP-1) (TCD protein)"	CHM REP1 TCD	Homo sapiens (Human)	protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]	GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]	GO:0004663; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005968; GO:0006612; GO:0007264; GO:0007601; GO:0016192; GO:0018344; GO:0031267	FNIDLVSKLLYSR	3.829999924	1	1	0.342063078	1568.104755	14.26739	13.98199	13.94223	15.19837	12.88537	12.40896	14.47559	0	14.14327	14.8826	0	16.45267	0	0	0	14.98107	13.44868	13.92104	0	0	0	0	17.26178	0	0	0	15.46092	0	0	0	0	0	0	0	0	0	16.73038	0	0	0	0	0	0	0	0	0	0	15.25643
P24387	CRHBP_HUMAN	"Corticotropin-releasing factor-binding protein, CRF-BP, CRF-binding protein (Corticotropin-releasing hormone-binding protein, CRH-BP)"	CRHBP CRFBP	Homo sapiens (Human)	"behavioral response to ethanol [GO:0048149]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cocaine [GO:0071314]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to potassium ion [GO:0035865]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; hormone-mediated signaling pathway [GO:0009755]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; negative regulation of corticotropin secretion [GO:0051460]; negative regulation of corticotropin-releasing hormone receptor activity [GO:1900011]; regulated exocytosis [GO:0045055]; regulation of cellular response to stress [GO:0080135]; regulation of corticotropin secretion [GO:0051459]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]"	axon terminus [GO:0043679]; dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microtubule [GO:0005874]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secondary lysosome [GO:0005767]; secretory granule [GO:0030141]; varicosity [GO:0043196]	"axon terminus [GO:0043679]; dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microtubule [GO:0005874]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secondary lysosome [GO:0005767]; secretory granule [GO:0030141]; varicosity [GO:0043196]; corticotropin-releasing hormone binding [GO:0051424]; peptide binding [GO:0042277]; behavioral response to ethanol [GO:0048149]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cocaine [GO:0071314]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to potassium ion [GO:0035865]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; hormone-mediated signaling pathway [GO:0009755]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; negative regulation of corticotropin secretion [GO:0051460]; negative regulation of corticotropin-releasing hormone receptor activity [GO:1900011]; regulated exocytosis [GO:0045055]; regulation of cellular response to stress [GO:0080135]; regulation of corticotropin secretion [GO:0051459]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]"	corticotropin-releasing hormone binding [GO:0051424]; peptide binding [GO:0042277]	GO:0001963; GO:0005576; GO:0005615; GO:0005634; GO:0005767; GO:0005771; GO:0005874; GO:0006954; GO:0007165; GO:0007565; GO:0007611; GO:0009755; GO:0030141; GO:0030425; GO:0031045; GO:0035865; GO:0042277; GO:0043196; GO:0043204; GO:0043679; GO:0045055; GO:0048149; GO:0051424; GO:0051459; GO:0051460; GO:0071277; GO:0071314; GO:0071320; GO:0071356; GO:0071391; GO:0071392; GO:0071466; GO:0080135; GO:0097211; GO:1900011; GO:2000310	NCSFSIIYPVVIK	6.25	1	1	0.154956444	1539.794606	18.20912	13.72815	12.68737	15.49268	14.37537	14.60065	0	0	11.45084	13.3509	14.50595	13.09973	0	0	0	0	0	0	0	0	0	0	0	0	12.33595	16.68666	0	12.68274	13.9905	15.14622	15.64858	0	0	0	0	0	0	0	0	14.41788	0	0	0	0	0	0	0	0
P24394	IL4RA_HUMAN	"Interleukin-4 receptor subunit alpha, IL-4 receptor subunit alpha, IL-4R subunit alpha, IL-4R-alpha, IL-4RA (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha, Soluble IL-4 receptor subunit alpha, Soluble IL-4R-alpha, sIL4Ralpha/prot (IL-4-binding protein, IL4-BP) ]"	IL4R IL4RA 582J2.1	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; ovulation [GO:0030728]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to odorant [GO:1990834]; signal transduction [GO:0007165]	centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine receptor activity [GO:0004896]; interleukin-4 receptor activity [GO:0004913]; cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; ovulation [GO:0030728]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to odorant [GO:1990834]; signal transduction [GO:0007165]	cytokine receptor activity [GO:0004896]; interleukin-4 receptor activity [GO:0004913]	GO:0002532; GO:0002639; GO:0004896; GO:0004913; GO:0005615; GO:0005654; GO:0005886; GO:0005887; GO:0006955; GO:0007165; GO:0009897; GO:0016064; GO:0019221; GO:0030728; GO:0032722; GO:0034451; GO:0042127; GO:0042832; GO:0043032; GO:0043235; GO:0043306; GO:0043627; GO:0045626; GO:0045630; GO:0120162; GO:1901741; GO:1990834	IVNFVSVGPTYMRVS	3.519999981	0.089389458	0.089389458	0.146962806	1683.748091	0	16.10092	0	0	0	16.40424	14.98174	18.41749	0	17.73779	0	12.32163	15.99345	0	16.0361	14.27956	14.57645	16.12494	14.82433	12.69557	13.73627	16.28421	0	0	14.35908	0	14.89272	16.71565	15.03328	16.55348	16.69215	15.93955	16.70524	18.28516	15.04309	17.92485	0	0	0	14.92135	16.49061	16.23142	17.13597	0	0	0	16.60525	14.39097
P24462	CP3A7_HUMAN	"Cytochrome P450 3A7, EC 1.14.14.1 (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)"	CYP3A7	Homo sapiens (Human)	estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]	GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006694; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0019825; GO:0020037; GO:0042572; GO:0042573; GO:0050649; GO:0062183; GO:0070330; GO:0070989; GO:0101020; GO:0101021	KVISFLTK	17.52000046	8.97E-06	8.97E-06	0.138998462	935.9057344	17.35969	17.49731	12.13428	14.53071	0	13.55794	15.06165	17.96222	13.06138	16.8205	14.28108	16.26318	15.1478	16.07281	13.44543	13.70844	15.44858	15.7158	15.18454	15.69851	15.48213	15.13129	14.77697	16.23307	16.47157	14.04727	0	15.62881	14.54223	0	18.15408	16.53964	13.44556	15.17184	0	14.7473	0	17.32549	16.14154	15.34062	13.68286	0	15.09768	14.87055	16.53161	13.92199	15.80005	14.22558
P24539	AT5F1_HUMAN	"ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase peripheral stalk-membrane subunit b) (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b, ATPase subunit b)"	ATP5PB ATP5F1	Homo sapiens (Human)	ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762]	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; nucleus [GO:0005634]"	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762]"	proton transmembrane transporter activity [GO:0015078]	GO:0000276; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0015078; GO:0015986; GO:0016020; GO:0021762; GO:0042776	HVVQSISTQQEKETIAK	2.190000057	1	1	0.147893201	1918.87977	0	0	14.45401	0	0	0	0	0	13.62095	0	0	13.87715	14.56329	0	0	0	0	0	0	14.10552	0	0	0	0	0	16.33907	15.42424	15.66956	0	14.11131	16.37401	0	13.80242	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P24588	AKAP5_HUMAN	"A-kinase anchor protein 5, AKAP-5 (A-kinase anchor protein 79 kDa, AKAP 79) (H21) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)"	AKAP5 AKAP79	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; protein serine/threonine phosphatase complex [GO:0008287]	cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; protein serine/threonine phosphatase complex [GO:0008287]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; calmodulin binding [GO:0005516]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165]	adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; calmodulin binding [GO:0005516]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]	GO:0005516; GO:0005829; GO:0005886; GO:0007165; GO:0007193; GO:0007194; GO:0007268; GO:0008179; GO:0008287; GO:0009898; GO:0010738; GO:0014069; GO:0017124; GO:0030346; GO:0031698; GO:0032590; GO:0034237; GO:0035254; GO:0043197; GO:0045121; GO:0045762; GO:0050811; GO:0051018; GO:0060076; GO:0060090; GO:0070886; GO:0097110; GO:0098837; GO:1900273; GO:1901387; GO:1903078; GO:1905665; GO:1905751	MEPIAIIITDTEISEFDVTK	6.460000038	0.31640628	0.31640628	0.212750464	2264.089411	0	0	16.23513	14.25978	15.88858	0	14.59815	0	14.08066	0	0	15.12351	14.31279	0	0	13.98384	0	0	0	0	0	16.63712	17.77605	0	0	14.33823	0	0	0	0	0	16.63431	16.80534	0	0	14.14942	17.85082	0	13.8312	16.89962	17.74926	15.662	0	0	14.88601	13.74969	0	0
P24723	KPCL_HUMAN	"Protein kinase C eta type, EC 2.7.11.13 (PKC-L) (nPKC-eta)"	PRKCH PKCL PRKCL	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0010744; GO:0018105; GO:0019899; GO:0034351; GO:0035556; GO:0045618; GO:0046872; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:0106310; GO:1903078; GO:2000810	MNVHIRCQANVAPNCGVNAVELAK	6.739999771	0.511851668	0.511851668	0.135471713	2680.881628	0	0	14.93232	15.41795	0	15.43245	18.18173	0	0	13.76056	15.29098	12.911	11.48331	0	0	12.98015	0	0	0	0	0	0	13.88831	0	11.80125	12.57778	0	13.87338	0	0	0	16.55133	0	0	14.46109	0	0	0	0	0	0	0	0	13.72501	0	0	0	0
P24752	THIL_HUMAN	"Acetyl-CoA acetyltransferase, mitochondrial, EC 2.3.1.9 (Acetoacetyl-CoA thiolase) (T2)"	ACAT1 ACAT MAT	Homo sapiens (Human)	acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cholesterol esterification [GO:0034435]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]	GO:0001889; GO:0003985; GO:0005739; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0034435; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0070062; GO:0072229; GO:0120225; GO:1902224; GO:1902860	VDFSKVPK	2.930000067	0.847869933	0.847869933	0.224483953	920.2939333	16.44088	14.5605	16.44748	15.72379	0	0	0	0	15.06718	16.21119	17.35951	12.95365	15.53929	0	14.60402	14.29624	15.7768	15.78113	15.35523	16.43688	14.32235	0	15.68981	0	16.39249	0	15.30172	15.34774	14.27615	0	16.47588	0	0	14.31914	0	0	0	0	0	0	15.50799	15.38367	0	0	0	15.12138	0	0
P24821	TENA_HUMAN	"Tenascin, TN (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C, TN-C)"	TNC HXB	Homo sapiens (Human)	cell adhesion [GO:0007155]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; neuromuscular junction development [GO:0007528]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to wounding [GO:0009611]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]; extracellular matrix structural constituent [GO:0005201]; syndecan binding [GO:0045545]; cell adhesion [GO:0007155]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; neuromuscular junction development [GO:0007528]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to wounding [GO:0009611]	extracellular matrix structural constituent [GO:0005201]; syndecan binding [GO:0045545]	GO:0001558; GO:0001649; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007528; GO:0008284; GO:0009611; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0045545; GO:0050727; GO:0060739; GO:0060740; GO:0062023; GO:0090733; GO:0098966	FSVGDAK	3.75999999	1	1	0.181178796	724.2606762	0	0	0	0	0	0	0	0	17.52191	0	0	0	15.17671	17.32697	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.42386	0	0	0	0	0	18.25367	0	0	0	0	0	0	17.79541	0	0	16.43069	0
P24903	CP2F1_HUMAN	"Cytochrome P450 2F1, EC 1.14.14.1 (CYPIIF1)"	CYP2F1	Homo sapiens (Human)	epoxygenase P450 pathway [GO:0019373]; naphthalene catabolic process [GO:1901170]; organic acid metabolic process [GO:0006082]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; naphthalene catabolic process [GO:1901170]; organic acid metabolic process [GO:0006082]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]"	"arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]"	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0009636; GO:0016712; GO:0019373; GO:0019825; GO:0020037; GO:0043231; GO:0070330; GO:1901170	ARLPALK	5.71999979	1	1	0.117013234	770.3126832	13.14719	16.38742	15.32268	13.98708	14.03561	12.89	14.34024	13.33416	15.31308	15.19768	12.6889	12.86717	0	0	0	0	15.53812	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.69408	0	0	0	0	0	0	15.31977	0	15.89312	0	0	0
P24928	RPB1_HUMAN	"DNA-directed RNA polymerase II subunit RPB1, RNA polymerase II subunit B1, EC 2.7.7.6 (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1, EC 2.7.7.48)"	POLR2A POLR2	Homo sapiens (Human)	"DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]	GO:0003677; GO:0003723; GO:0003899; GO:0003968; GO:0005634; GO:0005654; GO:0005665; GO:0005694; GO:0005737; GO:0006353; GO:0006355; GO:0006366; GO:0008022; GO:0019900; GO:0031625; GO:0033120; GO:0046872; GO:1990841	AMQKSGRPLK	8.479999542	0.050566699	0.050566699	0.119785985	1114.570668	0	0	16.63104	0	16.72217	0	15.6945	0	0	13.21293	0	14.66397	0	0	0	13.82763	15.31206	0	0	11.88425	13.80678	0	18.23308	12.98427	0	0	8.095345	0	16.21315	0	10.18171	15.60167	16.59043	0	17.37893	0	15.70206	17.3187	15.87233	16.91937	16.2552	0	0	0	15.1605	16.5433	15.42066	14.67483
P25025	CXCR2_HUMAN	"C-X-C chemokine receptor type 2, CXC-R2, CXCR-2 (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B, IL-8R B) (IL-8 receptor type 2) (CD antigen CD182)"	CXCR2 IL8RB	Homo sapiens (Human)	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-8-mediated signaling pathway [GO:0038112]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; mast cell granule [GO:0042629]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; mast cell granule [GO:0042629]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-8-mediated signaling pathway [GO:0038112]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918]	GO:0002407; GO:0004918; GO:0004930; GO:0005654; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0006968; GO:0007165; GO:0007166; GO:0007200; GO:0007204; GO:0008284; GO:0009897; GO:0009986; GO:0015630; GO:0016020; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0019959; GO:0030593; GO:0030667; GO:0031623; GO:0038112; GO:0042119; GO:0042629; GO:0060326; GO:0072686	YLAIVHATRTLTQK	7.53000021	1	1	0.355975647	1610.606665	12.93303	12.8338	13.68809	0	15.61626	0	14.38368	0	15.12922	13.49531	13.89157	16.04709	15.95889	12.92905	13.65231	13.41152	16.06739	0	0	0	0	0	0	0	14.75792	0	0	15.46638	0	0	0	15.82219	0	0	0	0	0	0	0	16.20992	0	0	0	0	16.16865	0	0	0
P25054	APC_HUMAN	"Adenomatous polyposis coli protein, Protein APC (Deleted in polyposis 2.5)"	APC DP2.5	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell differentiation [GO:0045595]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]	adherens junction [GO:0005912]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; Wnt signalosome [GO:1990909]	adherens junction [GO:0005912]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; Wnt signalosome [GO:1990909]; beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell differentiation [GO:0045595]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055]	beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625]	GO:0000281; GO:0000776; GO:0001708; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0006974; GO:0007026; GO:0007094; GO:0007155; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0008286; GO:0010942; GO:0016055; GO:0016328; GO:0016342; GO:0016477; GO:0019887; GO:0019901; GO:0030027; GO:0030335; GO:0030877; GO:0031274; GO:0031625; GO:0032587; GO:0032886; GO:0043065; GO:0043161; GO:0045295; GO:0045595; GO:0045732; GO:0045736; GO:0048471; GO:0051010; GO:0051988; GO:0065003; GO:0070830; GO:0070840; GO:0090090; GO:0120162; GO:1902807; GO:1904781; GO:1990909; GO:2000134	GQPKPILQK	11.02999973	1	1	2.30E-13	1005.271905	15.93077	0	16.80179	16.56148	0	0	16.59215	15.68456	15.83667	17.4116	16.2515	15.69505	0	16.47388	0	16.59162	0	16.05189	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P25067	CO8A2_HUMAN	Collagen alpha-2(VIII) chain (Endothelial collagen)	COL8A2	Homo sapiens (Human)	angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674]	GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609	GPPGPKGEAGPGGPPGVPGIR	7.46999979	0.839480221	0.839480221	0.266194977	1850.942787	15.57658	14.60454	15.56563	0	0	11.28788	14.28115	14.88224	0	0	0	0	15.03796	0	0	15.51112	0	15.06111	0	0	0	0	16.28075	0	0	0	0	0	0	0	0	13.32135	0	0	0	0	0	0	15.32323	0	0	0	0	0	0	0	0	0
P25090	FPR2_HUMAN	"N-formyl peptide receptor 2 (FMLP-related receptor I, FMLP-R-I) (Formyl peptide receptor-like 1) (HM63) (Lipoxin A4 receptor, LXA4 receptor) (RFP)"	FPR2 FPRH1 FPRL1 LXA4R	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of inflammatory response [GO:0050728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive chemotaxis [GO:0050918]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898]	cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; scavenger receptor binding [GO:0005124]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of inflammatory response [GO:0050728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive chemotaxis [GO:0050918]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898]	amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; scavenger receptor binding [GO:0005124]; signaling receptor activity [GO:0038023]	GO:0001540; GO:0001774; GO:0001934; GO:0002430; GO:0002768; GO:0004875; GO:0004930; GO:0004982; GO:0005124; GO:0005737; GO:0005886; GO:0006898; GO:0006935; GO:0006954; GO:0007155; GO:0007166; GO:0007186; GO:0007193; GO:0007200; GO:0007204; GO:0016021; GO:0019722; GO:0032930; GO:0035579; GO:0038023; GO:0038024; GO:0042742; GO:0045089; GO:0048143; GO:0050728; GO:0050766; GO:0050918; GO:0061903; GO:0070374; GO:0070821; GO:0090026; GO:0101003; GO:1904646	VAITMLTAR	5.690000057	0.776135504	0.776135504	0.206104095	991.0980565	14.31647	16.6524	14.19714	0	0	0	0	18.19661	0	0	0	0	15.7061	15.82093	0	0	14.1686	0	0	0	0	14.45224	0	0	0	0	0	0	15.24349	14.11575	10.93091	0	0	17.30657	0	0	0	0	14.86826	14.31821	15.43982	0	16.83371	0	0	0	0	0
P25092	GUC2C_HUMAN	"Guanylyl cyclase C, GC-C, EC 4.6.1.2 (Heat-stable enterotoxin receptor, STA receptor, hSTAR) (Intestinal guanylate cyclase)"	GUCY2C GUC2C STAR	Homo sapiens (Human)	cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of cell population proliferation [GO:0042127]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; toxic substance binding [GO:0015643]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of cell population proliferation [GO:0042127]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; toxic substance binding [GO:0015643]	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005789; GO:0005886; GO:0006182; GO:0007165; GO:0007168; GO:0009636; GO:0015643; GO:0016021; GO:0016941; GO:0017046; GO:0035556; GO:0042127	NESYMDTLIR	4.75	1	1	1.60E-12	1256.513798	13.00239	0	0	14.3196	12.82854	11.08301	15.43394	0	6.684303	0	14.3062	0	12.71263	0	11.2935	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P25098	ARBK1_HUMAN	"Beta-adrenergic receptor kinase 1, Beta-ARK-1, EC 2.7.11.15 (G-protein coupled receptor kinase 2)"	GRK2 ADRBK1 BARK BARK1	Homo sapiens (Human)	cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; regulation of the force of heart contraction [GO:0002026]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; regulation of the force of heart contraction [GO:0002026]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]	alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	GO:0001664; GO:0002026; GO:0002029; GO:0003108; GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007186; GO:0007213; GO:0007217; GO:0007507; GO:0009966; GO:0016020; GO:0018105; GO:0018107; GO:0019079; GO:0031623; GO:0031694; GO:0031755; GO:0033605; GO:0045202; GO:0045988; GO:0046718; GO:0047696; GO:0060048; GO:1901081	ILLPEPSIR	8.350000381	1	1	0.250521057	1037.986707	15.47177	15.08728	14.87193	16.20667	0	14.87483	14.24553	0	14.5595	0	0	0	15.2912	0	0	0	14.73462	0	16.05243	14.09823	14.08874	0	0	0	16.15906	0	14.60375	0	0	0	15.04421	0	13.77996	0	0	0	0	0	0	0	15.68138	0	0	15.6406	0	15.20836	0	0
P25101	EDNRA_HUMAN	"Endothelin-1 receptor (Endothelin receptor type A, ET-A, ETA-R, hET-AR)"	EDNRA ETA ETRA	Homo sapiens (Human)	activation of adenylate cyclase activity [GO:0007190]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cranial skeletal system development [GO:1904888]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; glomerular visceral epithelial cell differentiation [GO:0072112]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organism aging [GO:0010259]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; endothelin receptor activity [GO:0004962]; phosphatidylinositol phospholipase C activity [GO:0004435]; activation of adenylate cyclase activity [GO:0007190]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cranial skeletal system development [GO:1904888]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell apoptotic process [GO:1903210]; glomerular visceral epithelial cell differentiation [GO:0072112]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organism aging [GO:0010259]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310]	endothelin receptor activity [GO:0004962]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0000278; GO:0001569; GO:0001666; GO:0001701; GO:0001974; GO:0001975; GO:0002027; GO:0003094; GO:0003207; GO:0003220; GO:0003228; GO:0003253; GO:0003357; GO:0004435; GO:0004962; GO:0005886; GO:0005887; GO:0006468; GO:0006874; GO:0006939; GO:0007005; GO:0007165; GO:0007186; GO:0007190; GO:0007193; GO:0007202; GO:0007204; GO:0007249; GO:0007585; GO:0008217; GO:0008283; GO:0009611; GO:0010259; GO:0010467; GO:0010737; GO:0010827; GO:0014034; GO:0014824; GO:0016322; GO:0030202; GO:0030878; GO:0034599; GO:0035050; GO:0035904; GO:0042310; GO:0042415; GO:0042474; GO:0044751; GO:0048484; GO:0048485; GO:0048675; GO:0048706; GO:0050905; GO:0055078; GO:0060070; GO:0060324; GO:0060385; GO:0061028; GO:0061626; GO:0070294; GO:0070588; GO:0071372; GO:0071373; GO:0071806; GO:0072011; GO:0072112; GO:0086101; GO:0097018; GO:0097084; GO:0097152; GO:0097492; GO:1902287; GO:1903210; GO:1903537; GO:1904888; GO:1905144; GO:1905871; GO:2001259	TVYNEMDK	3.970000029	0.911170602	0.911170602	0.244387869	1014.428829	14.17432	16.48572	15.21749	15.92752	14.81888	17.42311	12.39711	16.49562	15.19305	13.7494	15.71513	12.61059	15.307	14.11329	0	16.06696	0	14.73455	0	14.79452	17.1687	0	0	0	0	0	14.903	0	15.4045	0	16.59841	15.57582	16.76636	12.6507	16.69094	15.93012	0	17.01552	0	16.8533	0	0	0	0	0	0	16.5	15.9854
P25205	MCM3_HUMAN	"DNA replication licensing factor MCM3, EC 3.6.4.12 (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102)"	MCM3	Homo sapiens (Human)	DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	"alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]"	"alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000781; GO:0003677; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005658; GO:0005813; GO:0006268; GO:0006270; GO:0006271; GO:0016020; GO:0016887; GO:0030174; GO:0042555; GO:0048471; GO:0071162; GO:1902975	AGIHAR	3.440000057	1	1	0.280803267	621.6574238	17.15264	0	17.70041	0	17.06231	17.68281	0	0	17.42926	0	16.00813	0	0	15.88033	15.30063	0	16.55379	16.55021	0	0	0	0	17.13739	16.40808	17.24649	0	0	0	0	0	0	0	0	0	0	18.12807	17.55942	18.6033	0	0	16.90567	0	18.03805	0	0	0	0	0
P25391	LAMA1_HUMAN	"Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha, S-LAM alpha)"	LAMA1 LAMA	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637]	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]	extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]	GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0043010; GO:0043208; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046	QAASIKVAVSADR	12.48999977	1	1	0.062554892	1315.296272	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.19983	0	0	0	0
P25440	BRD2_HUMAN	Bromodomain-containing protein 2 (O27.1.1) (Really interesting new gene 3 protein)	BRD2 KIAA9001 RING3	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; chromatin remodeling [GO:0006338]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"	chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]	GO:0000785; GO:0001843; GO:0003682; GO:0004674; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0006468; GO:0007283; GO:0016607; GO:0070577	KPVGKTK	5.78000021	1	1	0.237081701	758.5634154	14.58637	14.95896	15.21087	0	13.33683	0	14.23426	0	15.95137	15.9214	0	15.78777	14.50894	15.39258	14.98831	0	0	0	0	0	15.14731	15.6265	0	15.68712	0	14.71786	16.12012	15.53408	0	0	15.27464	0	0	0	0	0	16.22773	0	0	0	0	0	0	0	0	0	0	0
P25686	DNJB2_HUMAN	"DnaJ homolog subfamily B member 2 (Heat shock 40 kDa protein 3) (Heat shock protein J1, HSJ-1)"	DNAJB2 HSJ1 HSPF3	Homo sapiens (Human)	chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; neuron cellular homeostasis [GO:0070050]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; neuron cellular homeostasis [GO:0070050]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0008285; GO:0016234; GO:0030308; GO:0030433; GO:0030544; GO:0031227; GO:0031396; GO:0031398; GO:0031593; GO:0031625; GO:0031965; GO:0032091; GO:0032436; GO:0032781; GO:0032880; GO:0042026; GO:0042406; GO:0043130; GO:0043161; GO:0048471; GO:0051082; GO:0051087; GO:0061077; GO:0070050; GO:0070628; GO:0090084; GO:0090086; GO:0098554; GO:0140036; GO:1903644	GEATKR	9.539999962	1	1	0.20574442	660.2248822	14.1396	16.14088	16.40766	13.89842	0	0	11.18259	14.89626	15.46293	0	0	16.23572	0	15.212	15.7101	16.30515	14.65204	15.46004	16.02372	0	16.21169	16.40406	16.94272	12.58326	16.55313	14.39877	0	0	0	0	0	0	0	0	16.22803	0	0	15.59845	17.1533	16.70283	0	14.27833	0	0	0	0	15.88114	0
P25705	ATPA_HUMAN	"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)"	ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM	Homo sapiens (Human)	aging [GO:0007568]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nitric oxide [GO:0071732]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; response to ethanol [GO:0045471]; response to muscle activity [GO:0014850]	"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; aging [GO:0007568]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nitric oxide [GO:0071732]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; response to ethanol [GO:0045471]; response to muscle activity [GO:0014850]"	"ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]"	GO:0001937; GO:0002020; GO:0003723; GO:0005524; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006629; GO:0006754; GO:0006915; GO:0007568; GO:0009986; GO:0014850; GO:0015986; GO:0016020; GO:0016887; GO:0042288; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045121; GO:0045259; GO:0045261; GO:0045471; GO:0046933; GO:0070062; GO:0071549; GO:0071732	AMKQVAGTMK	1.799999952	1	1	0.267167879	1080.423914	0	17.9082	0	16.58348	0	0	0	0	0	0	0	0	18.13688	16.47456	0	0	0	0	18.4271	0	16.81205	0	0	0	17.9445	19.48786	0	16.02556	16.16637	16.74331	0	17.52546	0	0	0	17.30521	18.26491	0	0	0	16.72419	0	17.05013	19.01437	17.31923	0	0	0
P25787	PSA2_HUMAN	Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3)	PSMA2 HC3 PSC3	Homo sapiens (Human)	proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]"		GO:0000502; GO:0000932; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0009615; GO:0010498; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813	AANGVVLATEK	9.25	1	1	0.291948743	1073.962417	0	0	0	0	0	0	0	0	15.82734	0	0	0	18.18179	0	0	18.56139	18.89972	0	0	0	16.04744	0	18.51863	0	0	0	17.71517	18.96008	17.1462	0	0	0	0	18.65877	17.49972	0	0	0	18.14755	17.44604	0	0	0	0	0	0	0	0
P25791	RBTN2_HUMAN	"Rhombotin-2 (Cysteine-rich protein TTG-2) (LIM domain only protein 2, LMO-2) (T-cell translocation protein 2)"	LMO2 RBTN2 RBTNL1 RHOM2 TTG2	Homo sapiens (Human)	cellular response to thyroid hormone stimulus [GO:0097067]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; cellular response to thyroid hormone stimulus [GO:0097067]; multicellular organism development [GO:0007275]; positive regulation of transcription by RNA polymerase II [GO:0045944]	bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]	GO:0001221; GO:0003713; GO:0005654; GO:0005667; GO:0007275; GO:0042802; GO:0043425; GO:0045944; GO:0046872; GO:0061629; GO:0097067	CAACQK	4.929999828	0.783069909	0.783069909	2.31E-13	738.5143583	0	0	0	0	0	0	0	0	15.73198	0	0	0	0	16.54991	0	0	0	0	0	0	0	0	0	0	17.81234	0	15.96789	15.75051	0	0	0	15.20358	0	0	12.91619	12.95939	0	0	0	0	0	0	0	0	17.52291	0	0	0
P25800	RBTN1_HUMAN	"Rhombotin-1 (Cysteine-rich protein TTG-1) (LIM domain only protein 1, LMO-1) (T-cell translocation protein 1)"	LMO1 RBTN1 RHOM1 TTG1	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell homeostatic proliferation [GO:0046013]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell homeostatic proliferation [GO:0046013]	metal ion binding [GO:0046872]	GO:0000122; GO:0005634; GO:0005654; GO:0045944; GO:0046013; GO:0046872	MMVLDKEDGVPMLSVQPK	1.409999967	0.781573236	0.781573236	0.165004097	2064.598669	5.999097	16.35059	0	15.06802	16.82699	15.75039	0	0	15.10415	14.87001	15.49325	15.44906	14.94365	14.26896	0	13.65029	0	16.45696	13.27548	0	14.51553	14.84341	14.02049	16.16496	0	14.92006	0	0	15.23965	0	0	16.8516	16.78782	0	13.37162	14.96864	0	16.70263	0	0	13.91523	13.34618	0	16.23046	14.6859	14.8978	16.37631	0
P25874	UCP1_HUMAN	"Mitochondrial brown fat uncoupling protein 1, UCP 1 (Solute carrier family 25 member 7) (Thermogenin)"	UCP1 SLC25A7 UCP	Homo sapiens (Human)	adaptive thermogenesis [GO:1990845]; brown fat cell differentiation [GO:0050873]; cellular response to cold [GO:0070417]; cellular response to dehydroepiandrosterone [GO:1903495]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; diet induced thermogenesis [GO:0002024]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; response to nutrient levels [GO:0031667]; response to temperature stimulus [GO:0009266]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cardiolipin binding [GO:1901612]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; long-chain fatty acid binding [GO:0036041]; oxidative phosphorylation uncoupler activity [GO:0017077]; purine ribonucleotide binding [GO:0032555]; transmembrane transporter activity [GO:0022857]; adaptive thermogenesis [GO:1990845]; brown fat cell differentiation [GO:0050873]; cellular response to cold [GO:0070417]; cellular response to dehydroepiandrosterone [GO:1903495]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; diet induced thermogenesis [GO:0002024]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; response to nutrient levels [GO:0031667]; response to temperature stimulus [GO:0009266]	cardiolipin binding [GO:1901612]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; long-chain fatty acid binding [GO:0036041]; oxidative phosphorylation uncoupler activity [GO:0017077]; purine ribonucleotide binding [GO:0032555]; transmembrane transporter activity [GO:0022857]	GO:0002024; GO:0005525; GO:0005739; GO:0005743; GO:0006357; GO:0006839; GO:0009266; GO:0009409; GO:0016021; GO:0017077; GO:0019003; GO:0022857; GO:0031667; GO:0032555; GO:0032870; GO:0034614; GO:0036041; GO:0050873; GO:0070417; GO:0071398; GO:0120162; GO:1901612; GO:1902600; GO:1903426; GO:1903495; GO:1990542; GO:1990845	SVPNCAMK	9.239999771	1	1	0.1003114	920.3933881	17.71431	18.17121	15.72677	14.89067	15.79426	3.899829	15.09572	0	0	0	0	0	17.24568	0	13.78305	11.32341	0	0	0	0	0	0	15.5312	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.49726	0	0	0	17.35569	14.91946	0	0	0
P25940	CO5A3_HUMAN	Collagen alpha-3(V) chain	COL5A3	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; skin development [GO:0043588]	collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; skin development [GO:0043588]	collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]	GO:0005201; GO:0005518; GO:0005576; GO:0005588; GO:0005615; GO:0005788; GO:0007160; GO:0008201; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0043394; GO:0043588; GO:0062023	GEVGDVGSMGPHGAPGPR	13.75	1	1	7.12E-13	1688.003335	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.69364	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P25942	TNR5_HUMAN	Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)	CD40 TNFRSF5	Homo sapiens (Human)	B cell activation [GO:0042113]; B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to tumor necrosis factor [GO:0071356]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase B signaling [GO:0043491]; protein-containing complex assembly [GO:0065003]; response to interferon-gamma [GO:0034341]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]	CD40 receptor complex [GO:0035631]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	CD40 receptor complex [GO:0035631]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; B cell activation [GO:0042113]; B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to tumor necrosis factor [GO:0071356]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase B signaling [GO:0043491]; protein-containing complex assembly [GO:0065003]; response to interferon-gamma [GO:0034341]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]	antigen binding [GO:0003823]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]	GO:0001934; GO:0002768; GO:0003823; GO:0005886; GO:0005887; GO:0006874; GO:0006954; GO:0009897; GO:0009986; GO:0019724; GO:0019899; GO:0023035; GO:0030168; GO:0030890; GO:0031625; GO:0032735; GO:0034341; GO:0035631; GO:0035666; GO:0038023; GO:0042100; GO:0042113; GO:0042531; GO:0042832; GO:0043123; GO:0043231; GO:0043406; GO:0043491; GO:0043536; GO:0043547; GO:0045766; GO:0045944; GO:0048304; GO:0051092; GO:0051607; GO:0065003; GO:0070062; GO:0071260; GO:0071347; GO:0071356; GO:0090037; GO:2000353	SCSPGFGVK	10.22999954	1	1	0.170155312	936.3140586	0	0	0	0	0	0	18.32744	0	0	0	0	0	0	17.2309	0	0	0	0	0	0	0	0	0	0	0	18.13036	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P26012	ITB8_HUMAN	Integrin beta-8	ITGB8	Homo sapiens (Human)	cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ganglioside metabolic process [GO:0001573]; hard palate development [GO:0060022]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; Langerhans cell differentiation [GO:0061520]; negative regulation of gene expression [GO:0010629]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; response to virus [GO:0009615]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; extracellular matrix protein binding [GO:1990430]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ganglioside metabolic process [GO:0001573]; hard palate development [GO:0060022]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; Langerhans cell differentiation [GO:0061520]; negative regulation of gene expression [GO:0010629]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; response to virus [GO:0009615]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]	extracellular matrix protein binding [GO:1990430]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]	GO:0001570; GO:0001573; GO:0005178; GO:0005886; GO:0005925; GO:0006955; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008305; GO:0009615; GO:0009986; GO:0010628; GO:0010629; GO:0016477; GO:0033627; GO:0034686; GO:0038023; GO:0045766; GO:0051216; GO:0060022; GO:0060674; GO:0061520; GO:0070062; GO:1901388; GO:1990430	KPGMEGCR	7.710000038	0.950713754	0.950713754	0.165784747	934.8801635	0	0	13.29152	0	0	0	16.02624	13.98157	9.885447	15.90144	0	0	15.59852	0	0	15.7137	12.43515	0	0	0	0	15.81898	0	0	0	16.76547	0	0	0	0	0	0	0	11.60004	0	16.65443	0	0	0	16.53605	14.25716	0	16.18943	0	14.98936	15.31361	0	0
P26196	DDX6_HUMAN	"Probable ATP-dependent RNA helicase DDX6, EC 3.6.4.13 (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK)"	DDX6 HLR2 RCK	Homo sapiens (Human)	negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0016442; GO:0016887; GO:0017148; GO:0019074; GO:0019827; GO:0019904; GO:0033962; GO:0034063; GO:0036464; GO:0045296; GO:0045665; GO:1905618	VFHDFR	10.60999966	1	1	0.289170896	821.2030613	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.84158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P26232	CTNA2_HUMAN	Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein)	CTNNA2 CAPR	Homo sapiens (Human)	axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823]	actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0016477; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222	EFGKEMVK	7.769999981	1	1	1.26E-12	964.2457325	14.55154	12.90639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.42362	0	0	0	0	0	16.03957	0	16.15708	0	15.44638	0	0	0	0	0	0	0	0	16.97631	17.38558	0	0	0	0	0	0	0	0	0	0	0
P26358	DNMT1_HUMAN	"DNA (cytosine-5)-methyltransferase 1, Dnmt1, EC 2.1.1.37 (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI, DNA MTase HsaI, M.HsaI) (MCMT)"	DNMT1 AIM CXXC9 DNMT	Homo sapiens (Human)	cellular response to amino acid stimulus [GO:0071230]; cellular response to bisphenol A [GO:1903926]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to bisphenol A [GO:1903926]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]	DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003677; GO:0003723; GO:0003886; GO:0005634; GO:0005654; GO:0005657; GO:0005721; GO:0006306; GO:0006346; GO:0007265; GO:0008270; GO:0008327; GO:0009008; GO:0010216; GO:0010628; GO:0010629; GO:0043045; GO:0051571; GO:0051573; GO:0071230; GO:0090309; GO:1903926; GO:1904707; GO:1905460; GO:1905931; GO:1990841	CPNMAMK	3.210000038	0.724348485	0.724348485	0.075384308	883.6809082	14.93659	0	0	11.8141	15.94248	0	0	0	13.11451	13.29259	15.94192	0	16.11118	0	16.46042	0	15.7421	16.32042	0	0	0	0	0	16.03502	0	15.05648	0	0	13.29192	13.8671	16.20539	0	0	0	0	0	13.61609	15.24839	15.23567	13.41393	10.75841	0	0	0	15.774	18.54401	0	0
P26368	U2AF2_HUMAN	"Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit, hU2AF(65), hU2AF65) (U2 snRNP auxiliary factor large subunit)"	U2AF2 U2AF65	Homo sapiens (Human)	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]"	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]	"commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]"	C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000243; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701	FANRVVVTK	4.510000229	0.556852937	0.556852937	0.066323814	1030.598819	0	15.11156	0	15.59356	0	0	14.52276	0	14.6238	0	0	0	0	0	0	15.44248	0	0	15.67824	16.27144	0	15.24577	0	0	14.19724	14.5981	13.52699	0	0	0	0	0	18.88409	0	14.69314	0	0	0	0	16.23028	18.01113	0	15.18145	0	15.48456	13.7117	16.89465	13.08909
P26374	RAE2_HUMAN	"Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2, REP-2)"	CHML REP2	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]	GO:0005092; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005968; GO:0006886; GO:0007264; GO:0016192; GO:0018344; GO:0031267	TCMHTVSDKDGDK	8.81000042	1	1	0.525721389	1509.200344	16.80687	0	0	0	0	0	0	0	16.66564	18.17705	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.83112	17.02731	0	17.92121	0	0	19.03835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.81635	0
P26440	IVD_HUMAN	"Isovaleryl-CoA dehydrogenase, mitochondrial, IVD, EC 1.3.8.4 (Butyryl-CoA dehydrogenase, EC 1.3.8.1)"	IVD	Homo sapiens (Human)	branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552]	acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]	GO:0003995; GO:0004085; GO:0005654; GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0033539; GO:0042802; GO:0050660	MAEMATATRLLGWR	4.929999828	1	1	0.446905945	1639.37617	0	0	0	0	0	15.76558	0	0	0	0	14.95375	15.41982	0	0	16.28207	0	0	0	0	16.27795	0	16.55187	16.21532	0	0	0	15.26144	15.64791	14.66693	15.5967	17.07843	14.22016	16.27891	17.0009	0	0	15.91383	0	0	0	16.52758	15.32802	0	0	0	0	0	0
P26572	MGAT1_HUMAN	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, EC 2.4.1.101 (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I, GNT-I, GlcNAc-T I)"	MGAT1 GGNT1 GLCT1 GLYT1 MGAT	Homo sapiens (Human)	in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]; viral protein processing [GO:0019082]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	"endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]; viral protein processing [GO:0019082]"	"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]"	GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030145; GO:0033116; GO:0048471; GO:0070062; GO:1903561	GLLQQIGDALSSQRGR	3.25999999	1	1	0.240771739	1698.287992	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P26599	PTBP1_HUMAN	"Polypyrimidine tract-binding protein 1, PTB (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I, hnRNP I)"	PTBP1 PTB	Homo sapiens (Human)	"IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0008187; GO:0008380; GO:0016020; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522	MALIQMGSVEEAVQALIDLHNHDLGENHHLR	2.200000048	1	1	0.037269464	3507.873561	15.25154	13.4392	0	0	15.59891	0	0	10.94594	12.79427	12.50827	11.876	0	15.13831	0	0	13.23097	13.23972	14.19986	0	0	0	0	0	8.43784	15.22909	11.80609	11.08836	0	0	0	0	0	0	0	0	13.00277	0	14.82665	0	0	0	0	0	0	14.9735	13.91543	0	0
P26639	SYTC_HUMAN	"Threonine--tRNA ligase 1, cytoplasmic, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase 1)"	TARS1 TARS	Homo sapiens (Human)	threonyl-tRNA aminoacylation [GO:0006435]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0004829; GO:0005524; GO:0005829; GO:0006435; GO:0008270; GO:0042802; GO:0070062	EGSGDGGR	7.010000229	1	1	0.1972419	733.9091717	15.12753	15.62482	15.61514	13.69611	15.23756	15.10414	0	0	0	0	15.41131	0	14.70187	15.12579	15.41674	15.21754	13.3867	0	0	0	13.15394	14.27654	16.05527	16.53914	0	15.0434	0	15.98338	0	0	0	0	16.0689	0	0	0	0	0	16.85451	0	16.75871	14.99843	0	0	0	0	0	0
P26640	SYVC_HUMAN	"Valine--tRNA ligase, EC 6.1.1.9 (Protein G7a) (Valyl-tRNA synthetase, ValRS)"	VARS1 G7A VARS VARS2	Homo sapiens (Human)	tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]	cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438	KAVLVALK	8.520000458	1	1	0.076866057	841.5179687	0	0	0	0	0	0	15.67064	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.46705	14.85218	0	15.64439	0	16.69695	17.12953	0	15.93672	17.18145	16.35869	17.29018	15.68998	15.22821	17.00523	0	0	0	0	0	0
P26641	EF1G_HUMAN	"Elongation factor 1-gamma, EF-1-gamma (eEF-1B gamma)"	EEF1G EF1G PRO1608	Homo sapiens (Human)	glutathione metabolic process [GO:0006749]; response to virus [GO:0009615]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746]; glutathione metabolic process [GO:0006749]; response to virus [GO:0009615]; translational elongation [GO:0006414]	cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0005634; GO:0005737; GO:0005829; GO:0006414; GO:0006749; GO:0009615; GO:0016020; GO:0045296; GO:0070062	TFLVGER	17.84000015	0.586025774	0.586025774	0.266013197	820.4220955	0	18.65949	21.36036	16.32264	18.72488	0	0	16.1839	18.62717	0	0	21.92337	0	0	17.55638	19.62793	16.13141	18.66372	0	0	17.37714	18.72333	19.41184	18.8873	0	0	19.4218	18.65923	0	0	0	18.62302	0	20.09179	20.33241	17.45144	0	0	17.14748	18.14391	0	18.34088	18.27878	17.7247	0	16.37328	16.80261	0
P26718	NKG2D_HUMAN	NKG2-D type II integral membrane protein (Killer cell lectin-like receptor subfamily K member 1) (NK cell receptor D) (NKG2-D-activating NK receptor) (CD antigen CD314)	KLRK1 D12S2489E NKG2D	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of GTPase activity [GO:0034260]; negative regulation of natural killer cell chemotaxis [GO:2000502]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; MHC class Ib receptor activity [GO:0032394]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of GTPase activity [GO:0034260]; negative regulation of natural killer cell chemotaxis [GO:2000502]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; MHC class Ib receptor activity [GO:0032394]; signaling receptor activity [GO:0038023]	GO:0002223; GO:0002250; GO:0005886; GO:0005887; GO:0007165; GO:0009897; GO:0009986; GO:0016021; GO:0030101; GO:0030154; GO:0030246; GO:0031295; GO:0032394; GO:0032729; GO:0034260; GO:0038023; GO:0042267; GO:0042288; GO:0042802; GO:0045429; GO:0045954; GO:0050830; GO:0071222; GO:2000502	EDQDLLK	11.71000004	1	1	0.093968123	859.5864317	0	0	15.29605	12.83542	16.82565	12.7548	15.4077	15.22274	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.02799	0	0	0	0	0	0	0	0	0	15.509	0	0	0	0	0	0	0	16.39343	0
P26885	FKBP2_HUMAN	"Peptidyl-prolyl cis-trans isomerase FKBP2, PPIase FKBP2, EC 5.2.1.8 (13 kDa FK506-binding protein, 13 kDa FKBP, FKBP-13) (FK506-binding protein 2, FKBP-2) (Immunophilin FKBP13) (Rotamase)"	FKBP2 FKBP13	Homo sapiens (Human)	chaperone-mediated protein folding [GO:0061077]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]	FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005528; GO:0005783; GO:0005789; GO:0061077	GAPPK	4.71999979	0.700169265	0.700169265	0.110434824	468.1510252	0	0	15.29174	14.73181	15.20051	0	16.09403	15.55384	15.32625	0	15.82854	0	0	14.26143	0	0	15.98402	17.48414	0	0	0	0	0	0	12.10435	13.92168	0	15.68009	15.62823	14.42848	14.42843	14.79558	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P26992	CNTFR_HUMAN	"Ciliary neurotrophic factor receptor subunit alpha, CNTF receptor subunit alpha, CNTFR-alpha"	CNTFR	Homo sapiens (Human)	brainstem development [GO:0003360]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; sex differentiation [GO:0007548]; signal transduction [GO:0007165]; skeletal muscle organ development [GO:0060538]; suckling behavior [GO:0001967]	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; CNTFR-CLCF1 complex [GO:0097059]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; CNTFR-CLCF1 complex [GO:0097059]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor activity [GO:0004897]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor binding [GO:0005102]; brainstem development [GO:0003360]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; sex differentiation [GO:0007548]; signal transduction [GO:0007165]; skeletal muscle organ development [GO:0060538]; suckling behavior [GO:0001967]	ciliary neurotrophic factor receptor activity [GO:0004897]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor binding [GO:0005102]	GO:0001967; GO:0003360; GO:0004896; GO:0004897; GO:0005102; GO:0005886; GO:0007165; GO:0007399; GO:0007548; GO:0008284; GO:0009897; GO:0016324; GO:0019221; GO:0019898; GO:0019955; GO:0031225; GO:0043235; GO:0043524; GO:0060538; GO:0070110; GO:0070120; GO:0097059	DSWHLR	7.380000114	1	1	0.275909197	813.4147716	0	18.00033	17.10719	0	0	0	0	0	0	0	0	0	16.86432	15.40506	0	16.55748	0	0	0	0	0	0	0	18.62142	17.78634	0	16.37967	0	0	0	0	18.81357	16.98948	18.4426	0	17.38421	18.05144	0	17.06357	0	0	0	0	0	17.18663	0	16.49035	0
P27169	PON1_HUMAN	"Serum paraoxonase/arylesterase 1, PON 1, EC 3.1.1.2, EC 3.1.1.81, EC 3.1.8.1 (Aromatic esterase 1, A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)"	PON1 PON	Homo sapiens (Human)	aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]	acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]	GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617	IHVYEKHANWTLTPLK	10.26000023	1	1	2.29E-13	1942.47383	0	0	13.54965	13.1814	12.31812	14.4217	13.89681	0	0	0	0	0	15.00385	0	0	13.65549	0	12.33195	16.11245	0	15.70885	0	0	0	16.6858	15.95978	14.97802	15.55479	15.28497	0	0	0	0	0	0	0	17.24075	15.31448	0	15.65348	0	16.60089	0	0	11.09826	0	0	0
P27348	1433T_HUMAN	14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1)	YWHAQ	Homo sapiens (Human)	"cellular protein localization [GO:0034613]; negative regulation of transcription, DNA-templated [GO:0045892]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; substantia nigra development [GO:0021762]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; cellular protein localization [GO:0034613]; negative regulation of transcription, DNA-templated [GO:0045892]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; substantia nigra development [GO:0021762]"	identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]	GO:0005737; GO:0005829; GO:0005925; GO:0006605; GO:0007165; GO:0007264; GO:0016020; GO:0019904; GO:0021762; GO:0032991; GO:0034613; GO:0042802; GO:0045892; GO:0047485; GO:0070062	NVVGGRR	6.679999828	1	1	0.257636319	757.8663552	15.06349	15.73614	13.98706	14.84737	15.44148	15.71161	14.60532	15.4135	0	17.24402	15.53723	14.98785	14.78952	16.17943	12.68564	13.19862	16.23418	15.6052	16.26756	0	15.65515	14.78869	0	0	16.78505	13.868	15.8789	13.31903	0	0	0	16.03615	15.55217	18.27711	0	0	16.59614	0	0	16.92884	15.69354	0	0	14.65211	0	0	16.14051	0
P27352	IF_HUMAN	"Cobalamin binding intrinsic factor (Gastric intrinsic factor) (Intrinsic factor, IF, INF)"	CBLIF GIF IFMH	Homo sapiens (Human)	cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824]	apical plasma membrane [GO:0016324]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; microvillus [GO:0005902]	apical plasma membrane [GO:0016324]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; microvillus [GO:0005902]; cobalamin binding [GO:0031419]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824]	cobalamin binding [GO:0031419]	GO:0005576; GO:0005615; GO:0005768; GO:0005902; GO:0006824; GO:0009235; GO:0015889; GO:0016324; GO:0031419; GO:0043202	TTDMILNEIK	6.400000095	1	1	0.120559364	1193.092901	10.77246	9.309872	0	13.35634	13.35196	0	8.454234	13.99011	13.361	11.7655	13.85165	0	14.39315	0	0	14.0431	0	16.07258	0	0	0	0	0	16.32641	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P27540	ARNT_HUMAN	"Aryl hydrocarbon receptor nuclear translocator, ARNT protein (Class E basic helix-loop-helix protein 2, bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta, HIF-1-beta, HIF1-beta)"	ARNT BHLHE2	Homo sapiens (Human)	cell differentiation [GO:0030154]; embryonic placenta development [GO:0001892]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]	aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; embryonic placenta development [GO:0001892]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]"	"aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001666; GO:0001892; GO:0001938; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010575; GO:0016604; GO:0017162; GO:0030154; GO:0030949; GO:0033235; GO:0034751; GO:0042803; GO:0043565; GO:0043619; GO:0045648; GO:0045821; GO:0045944; GO:0046886; GO:0046982; GO:0061629; GO:0090575; GO:1990837	SDGLFAQDR	5.139999866	0.307365298	0.307365298	0.18648679	1009.560783	16.33922	0	10.72975	0	14.9255	0	10.60396	0	16.31755	16.77174	13.19368	0	0	13.42458	0	0	17.00205	0	0	0	0	0	17.35905	15.38072	0	0	13.44795	14.57106	0	14.84617	0	13.97698	0	15.85276	0	0	0	0	16.42569	0	0	0	0	16.28206	0	0	0	0
P27544	CERS1_HUMAN	"Ceramide synthase 1, CerS1 (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1, EC 2.3.1.299)"	CERS1 LAG1 LASS1 UOG1	Homo sapiens (Human)	cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of telomerase activity [GO:0051974]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of telomerase activity [GO:0051974]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148]	N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]	GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0016410; GO:0030148; GO:0036146; GO:0043231; GO:0046513; GO:0050291; GO:0051974; GO:0071466; GO:0071492; GO:0072721; GO:1901526	LNIYFKSR	12.64999962	1	1	0.33898831	1038.839073	0	13.20653	12.40517	0	16.42804	15.57354	0	0	0	16.30595	0	0	14.64607	0	0	17.0308	0	0	0	0	17.59013	0	0	0	0	0	16.12391	0	15.16016	0	0	14.7063	15.36346	17.68171	0	0	0	16.46783	0	15.63688	16.95505	15.98623	0	0	0	0	0	0
P27658	CO8A1_HUMAN	Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin ]	COL8A1 C3orf7	Homo sapiens (Human)	angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	collagen type VIII trimer [GO:0005591]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type VIII trimer [GO:0005591]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	extracellular matrix structural constituent [GO:0005201]	GO:0001525; GO:0005201; GO:0005576; GO:0005591; GO:0005615; GO:0005788; GO:0007155; GO:0010811; GO:0030198; GO:0031012; GO:0035987; GO:0048593; GO:0050673; GO:0062023	GDRGPK	1.600000024	1	1	0.011966224	630.4907211	15.30122	0	0	0	15.39143	0	14.74539	0	0	0	0	0	0	14.92717	0	16.43293	0	0	0	0	0	0	0	0	0	0	0	0	17.18805	0	0	0	0	18.33655	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P27694	RFA1_HUMAN	"Replication protein A 70 kDa DNA-binding subunit, RP-A p70 (Replication factor A protein 1, RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed ]"	RPA1 REPA1 RPA70	Homo sapiens (Human)	base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	"chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]"	"chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]"	damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000723; GO:0000724; GO:0000781; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0006310; GO:0006974; GO:0007004; GO:0016605; GO:0034502; GO:0043047; GO:0046872; GO:0051321; GO:0090734; GO:0098505	VGQLSEGAIAAIMQK	2.25	1	1	0.092137001	1530.433944	0	0	0	0	0	0	0	0	0	0	0	0	15.66704	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.15603	0	0	0	0	0	18.9554	0	0	0	0	0	0	17.37106	0	0	0	0
P27695	APEX1_HUMAN	"DNA-(apurinic or apyrimidinic site) endonuclease, EC 3.1.11.2 (APEX nuclease, APEN) (Apurinic-apyrimidinic endonuclease 1, AP endonuclease 1, APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial ]"	APEX1 APE APE1 APEX APX HAP1 REF1	Homo sapiens (Human)	"aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell redox homeostasis [GO:0045454]; cellular response to cAMP [GO:0071320]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to peptide hormone stimulus [GO:0071375]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA demethylation [GO:0080111]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of smooth muscle cell migration [GO:0014912]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; telomere maintenance via base-excision repair [GO:0097698]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]; transcription regulator complex [GO:0005667]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]; transcription regulator complex [GO:0005667]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; chromatin DNA binding [GO:0031490]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(abasic site) binding [GO:0140431]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; double-stranded telomeric DNA binding [GO:0003691]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; oxidoreductase activity [GO:0016491]; phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands [GO:0090580]; phosphodiesterase I activity [GO:0004528]; phosphoric diester hydrolase activity [GO:0008081]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; uracil DNA N-glycosylase activity [GO:0004844]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell redox homeostasis [GO:0045454]; cellular response to cAMP [GO:0071320]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to peptide hormone stimulus [GO:0071375]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA demethylation [GO:0080111]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of smooth muscle cell migration [GO:0014912]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; telomere maintenance via base-excision repair [GO:0097698]"	"3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; chromatin DNA binding [GO:0031490]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(abasic site) binding [GO:0140431]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; double-stranded telomeric DNA binding [GO:0003691]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; oxidoreductase activity [GO:0016491]; phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands [GO:0090580]; phosphodiesterase I activity [GO:0004528]; phosphoric diester hydrolase activity [GO:0008081]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; uracil DNA N-glycosylase activity [GO:0004844]"	GO:0000723; GO:0000737; GO:0000781; GO:0003677; GO:0003684; GO:0003691; GO:0003713; GO:0003714; GO:0003723; GO:0003906; GO:0004519; GO:0004520; GO:0004523; GO:0004528; GO:0004844; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005813; GO:0005840; GO:0006281; GO:0006284; GO:0006287; GO:0006310; GO:0007568; GO:0008081; GO:0008296; GO:0008309; GO:0008311; GO:0008408; GO:0009410; GO:0014912; GO:0016491; GO:0016607; GO:0016890; GO:0031490; GO:0042981; GO:0043488; GO:0044877; GO:0045454; GO:0045944; GO:0046872; GO:0048471; GO:0051059; GO:0052720; GO:0070301; GO:0071320; GO:0071375; GO:0080111; GO:0090580; GO:0097698; GO:0140431; GO:1900087	KGLDWVK	12.89999962	1	1	0.29074355	846.0862819	16.06376	15.14544	14.76797	16.35011	16.32797	14.68396	17.5992	17.14577	14.8854	16.43544	15.52599	16.1496	16.23083	14.49797	14.82873	16.89796	14.24389	13.52541	0	12.94643	14.89577	14.97853	0	16.24379	0	0	15.93863	16.19175	0	0	16.36836	16.18168	14.92329	0	0	15.24534	15.51715	0	14.84189	15.12725	0	15.6985	0	14.82988	0	15.75841	15.43767	0
P27708	PYR1_HUMAN	"CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase, EC 6.3.5.5; Aspartate carbamoyltransferase, EC 2.1.3.2; Dihydroorotase, EC 3.5.2.3 ]"	CAD	Homo sapiens (Human)	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; UDP biosynthetic process [GO:0006225]; UTP biosynthetic process [GO:0006228]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; terminal bouton [GO:0043195]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; UDP biosynthetic process [GO:0006225]; UTP biosynthetic process [GO:0006228]	aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]	GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006225; GO:0006228; GO:0006541; GO:0006807; GO:0008270; GO:0016020; GO:0016363; GO:0018107; GO:0019240; GO:0019899; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046777; GO:0070062; GO:0070335	AHWTPFEGQK	5.670000076	1	1	0.176675116	1201.582125	12.39625	12.92208	15.12611	14.08532	8.049208	0	0	0	0	14.93783	0	0	14.10243	13.82524	0	0	10.072	0	0	0	0	13.33002	0	14.25117	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.37792	0	13.45495	15.41441
P27815	PDE4A_HUMAN	"cAMP-specific 3',5'-cyclic phosphodiesterase 4A, EC 3.1.4.53 (DPDE2) (PDE46)"	PDE4A DPDE2	Homo sapiens (Human)	cAMP catabolic process [GO:0006198]; cellular response to xenobiotic stimulus [GO:0071466]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to xenobiotic stimulus [GO:0071466]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006198; GO:0007165; GO:0007186; GO:0007608; GO:0010738; GO:0016020; GO:0030552; GO:0032587; GO:0046872; GO:0048471; GO:0071466; GO:0106070	SPLDSQASPGLVLHAGAATSQR	1.820000052	1	1	0.097244007	2162.215963	0	14.62019	10.64564	0	11.82762	14.25802	16.51659	10.9062	13.87089	13.65648	15.80849	10.38719	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P27816	MAP4_HUMAN	"Microtubule-associated protein 4, MAP-4"	MAP4	Homo sapiens (Human)	cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175]	axon [GO:0030424]; axoneme [GO:0005930]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]	axon [GO:0030424]; axoneme [GO:0005930]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175]	microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]	GO:0000226; GO:0003723; GO:0005198; GO:0005815; GO:0005874; GO:0005875; GO:0005930; GO:0007052; GO:0008017; GO:0030424; GO:0031175; GO:0043005; GO:0051012; GO:0051294; GO:0051301; GO:0072686; GO:1902856	DMAQLPETEIAPAKDVAPSTVK	2.829999924	1	1	2.75E-12	2327.20846	13.83916	8.475406	0	12.46649	13.82551	13.58507	8.263049	12.54245	13.91964	0	12.32251	13.92016	8.364546	13.6342	10.96595	10.82794	10.44425	11.64148	0	13.65139	0	5.260672	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P27918	PROP_HUMAN	Properdin (Complement factor P)	CFP PFC	Homo sapiens (Human)	"complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]"	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	"endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]"		GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006955; GO:0006956; GO:0006957; GO:0035580; GO:0042742; GO:0050778; GO:1903028; GO:1904724	SGGLCQPCR	1.399999976	0.651835442	0.651835442	0.191989506	1029.477389	15.36747	13.48513	16.0551	14.62899	12.8172	15.86975	0	14.39423	16.11633	0	0	14.88721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.25881	15.49223	0	0	17.04139	16.48244	15.41388	13.46978	15.39528	15.63948	16.59017	15.81262	15.21579	16.18513	13.79215	14.46491	15.85076	14.32007	0	16.03017	13.58264	15.19299
P27986	P85A_HUMAN	"Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha)"	PIK3R1 GRB1	Homo sapiens (Human)	B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]	"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]"	"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]"	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001678; GO:0001784; GO:0001953; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006468; GO:0006606; GO:0006955; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0014065; GO:0016020; GO:0019903; GO:0030183; GO:0030217; GO:0030335; GO:0032760; GO:0032869; GO:0033120; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0042307; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0050821; GO:0051491; GO:0051497; GO:0060396; GO:0120183; GO:1900103; GO:1903078; GO:1990578	TQSSSNLAELR	7.289999962	1	1	0.382272856	1205.591707	14.10085	15.50641	0	15.20858	0	14.92506	0	13.18291	0	11.87535	0	10.85885	0	14.01781	0	0	0	0	14.90738	0	0	14.72345	15.85561	0	0	0	0	0	0	0	0	0	0	0	0	16.52508	0	0	0	0	0	0	0	0	0	0	0	0
P27987	IP3KB_HUMAN	"Inositol-trisphosphate 3-kinase B, EC 2.7.1.127 (Inositol 1,4,5-trisphosphate 3-kinase B, IP3 3-kinase B, IP3K B, InsP 3-kinase B)"	ITPKB	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165]"	"ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]"	GO:0000165; GO:0000828; GO:0001932; GO:0002262; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007166; GO:0008440; GO:0016020; GO:0016301; GO:0032957; GO:0032958; GO:0033030; GO:0035726; GO:0045059; GO:0045638; GO:0046579; GO:0046638; GO:0046854; GO:0071277	CGSPTAMEIDKR	13.56000042	1	1	0.298489001	1379.962961	12.96596	0	14.5569	0	0	0	0	0	0	0	0	0	16.64013	0	16.76771	15.62354	0	0	0	16.57861	0	0	0	0	14.25224	0	0	0	0	16.17308	0	0	14.58323	15.31138	12.858	17.41176	0	0	18.09654	14.77015	0	0	0	0	14.69495	0	0	0
P28065	PSB9_HUMAN	"Proteasome subunit beta type-9, EC 3.4.25.1 (Low molecular mass protein 2) (Macropain chain 7) (Multicatalytic endopeptidase complex chain 7) (Proteasome chain 7) (Proteasome subunit beta-1i) (Really interesting new gene 12 protein)"	PSMB9 LMP2 PSMB6i RING12	Homo sapiens (Human)	immune system process [GO:0002376]; proteasomal protein catabolic process [GO:0010498]; regulation of cysteine-type endopeptidase activity [GO:2000116]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; proteasomal protein catabolic process [GO:0010498]; regulation of cysteine-type endopeptidase activity [GO:2000116]"	threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0002376; GO:0004298; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0070062; GO:1990111; GO:2000116	MLRAGAPTGDLPR	4.880000114	0.119190536	0.119190536	0.09240048	1370.724709	16.32598	0	0	0	0	16.04112	14.59734	17.14468	0	14.59121	0	0	14.8278	0	0	17.16182	0	0	0	0	0	14.74811	12.62743	11.80515	0	0	0	14.78677	0	11.54985	0	0	15.46523	0	0	0	15.23178	0	0	0	0	0	0	0	0	0	0	0
P28070	PSB4_HUMAN	"Proteasome subunit beta type-4 (26 kDa prosomal protein, HsBPROS26, PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3, HsN3)"	PSMB4 PROS26	Homo sapiens (Human)	negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	"ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	lipopolysaccharide binding [GO:0001530]; threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0001530; GO:0002862; GO:0004298; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0036064; GO:0043161; GO:0070062	NISRIMR	22.81999969	0.301447928	0.301447928	0.178971302	906.0230426	16.19034	0	0	14.06707	0	0	0	0	22.69271	16.86632	0	0	17.32859	0	17.78484	17.04353	0	16.41579	0	0	0	16.70211	18.23228	15.86996	22.41624	0	13.19685	0	16.3142	19.79557	18.38465	16.98749	0	0	23.42444	0	13.17715	18.41098	17.24602	0	16.91515	23.35167	0	0	0	15.07843	0	20.86913
P28221	5HT1D_HUMAN	"5-hydroxytryptamine receptor 1D, 5-HT-1D, 5-HT1D (Serotonin 1D alpha receptor, 5-HT-1D-alpha) (Serotonin receptor 1D)"	HTR1D HTR1DA HTRL	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intestine smooth muscle contraction [GO:0014827]; regulation of behavior [GO:0050795]; regulation of locomotion [GO:0040012]; vasoconstriction [GO:0042310]"	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intestine smooth muscle contraction [GO:0014827]; regulation of behavior [GO:0050795]; regulation of locomotion [GO:0040012]; vasoconstriction [GO:0042310]"	G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]	GO:0004993; GO:0005886; GO:0005887; GO:0007187; GO:0007193; GO:0007198; GO:0007268; GO:0014827; GO:0030425; GO:0030594; GO:0040012; GO:0042310; GO:0045202; GO:0050795; GO:0051378	LADSALERK	6.579999924	1	1	0.051875566	1002.405235	14.19981	16.81581	13.66957	13.45467	14.10984	0	0	0	11.71778	0	0	0	12.67915	15.56106	0	0	14.09804	0	0	0	0	15.45092	15.44235	16.37992	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P28222	5HT1B_HUMAN	"5-hydroxytryptamine receptor 1B, 5-HT-1B, 5-HT1B (S12) (Serotonin 1D beta receptor, 5-HT-1D-beta) (Serotonin receptor 1B)"	HTR1B HTR1DB	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to temperature stimulus [GO:0071502]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; drinking behavior [GO:0042756]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to mineralocorticoid [GO:0051385]; vasoconstriction [GO:0042310]"	calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; G protein-coupled serotonin receptor complex [GO:0098666]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154]	"calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; G protein-coupled serotonin receptor complex [GO:0098666]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to temperature stimulus [GO:0071502]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; drinking behavior [GO:0042756]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to mineralocorticoid [GO:0051385]; vasoconstriction [GO:0042310]"	G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]	GO:0002031; GO:0004993; GO:0005783; GO:0005886; GO:0005887; GO:0007187; GO:0007193; GO:0007198; GO:0007205; GO:0007268; GO:0014053; GO:0014059; GO:0014063; GO:0030425; GO:0030594; GO:0032229; GO:0042220; GO:0042310; GO:0042756; GO:0044305; GO:0045471; GO:0046849; GO:0050795; GO:0051378; GO:0051385; GO:0051967; GO:0071312; GO:0071466; GO:0071502; GO:0098666; GO:0099056; GO:0099154; GO:0099171; GO:0099626; GO:1904707; GO:2000300	VSDALLEK	13.46000004	0.833871782	0.833871782	0.207318591	874.4395414	15.70607	14.49049	14.95833	15.58562	14.08694	14.59037	11.83052	17.865	15.04538	14.33791	17.35931	14.62771	14.87598	14.75158	14.59334	14.46219	14.73609	15.60167	16.32095	15.65186	15.53565	0	16.22731	15.48023	13.94681	15.28786	15.94547	14.80891	16.63351	14.72372	16.54963	15.42748	16.24929	0	0	0	0	0	0	15.6463	15.14219	0	0	14.67568	0	15.0706	15.58328	15.62014
P28288	ABCD3_HUMAN	"ATP-binding cassette sub-family D member 3, EC 3.1.2.-, EC 7.6.2.- (70 kDa peroxisomal membrane protein, PMP70)"	ABCD3 PMP70 PXMP1	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]	ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0014070; GO:0015721; GO:0015910; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0043621; GO:0047617; GO:0140359; GO:1903512	MLLRMSQALGR	4.630000114	1	1	2.51E-12	1292.884592	11.84071	0	0	7.713251	10.86927	11.99267	9.233284	13.77593	11.55657	12.19429	0	13.85774	11.5564	12.00963	0	13.45387	11.32127	9.602461	11.17879	0	0	12.85065	0	14.86507	0	0	14.12858	13.8035	10.12636	13.9469	0	0	0	0	0	0	11.20452	0	0	13.11506	0	0	12.58754	0	13.44719	0	0	0
P28290	ITPI2_HUMAN	"Protein ITPRID2 (Cleavage signal-1 protein, CS-1) (ITPR-interacting domain-containing protein 2) (Ki-ras-induced actin-interacting protein) (Sperm-specific antigen 2)"	ITPRID2 CS1 KIAA1927 KRAP SSFA2	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102]	actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005654; GO:0005829; GO:0005886; GO:0051015	ASNSK	5.019999981	1	1	0.191968952	507.0050106	0	15.58846	14.37591	0	13.84359	13.91929	13.92626	0	15.82285	15.15761	14.23512	0	0	0	0	15.93529	14.46521	0	14.52995	13.19257	16.97593	0	0	0	0	16.2775	0	0	0	0	16.35779	0	16.1727	0	16.43782	15.44683	16.32349	0	0	0	0	0	0	0	16.46959	0	15.67861	0
P28300	LYOX_HUMAN	"Protein-lysine 6-oxidase, EC 1.4.3.13 (Lysyl oxidase) [Cleaved into: Protein-lysine 6-oxidase, long form; Protein-lysine 6-oxidase, short form ]"	LOX	Homo sapiens (Human)	ascending aorta development [GO:0035905]; blood vessel morphogenesis [GO:0048514]; bone mineralization [GO:0030282]; cell chemotaxis [GO:0060326]; cellular protein modification process [GO:0006464]; cellular response to chemokine [GO:1990869]; collagen fibril organization [GO:0030199]; connective tissue development [GO:0061448]; descending aorta development [GO:0035906]; DNA biosynthetic process [GO:0071897]; elastic fiber assembly [GO:0048251]; heart development [GO:0007507]; lung development [GO:0030324]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; osteoblast differentiation [GO:0001649]; peptidyl-lysine oxidation [GO:0018057]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; protein kinase B signaling [GO:0043491]; regulation of apoptotic process [GO:0042981]; regulation of bone development [GO:1903010]; regulation of gene expression [GO:0010468]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000586]; regulation of protein phosphorylation [GO:0001932]; regulation of receptor binding [GO:1900120]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060]	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; collagen binding [GO:0005518]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; ascending aorta development [GO:0035905]; blood vessel morphogenesis [GO:0048514]; bone mineralization [GO:0030282]; cell chemotaxis [GO:0060326]; cellular protein modification process [GO:0006464]; cellular response to chemokine [GO:1990869]; collagen fibril organization [GO:0030199]; connective tissue development [GO:0061448]; descending aorta development [GO:0035906]; DNA biosynthetic process [GO:0071897]; elastic fiber assembly [GO:0048251]; heart development [GO:0007507]; lung development [GO:0030324]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; osteoblast differentiation [GO:0001649]; peptidyl-lysine oxidation [GO:0018057]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; protein kinase B signaling [GO:0043491]; regulation of apoptotic process [GO:0042981]; regulation of bone development [GO:1903010]; regulation of gene expression [GO:0010468]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000586]; regulation of protein phosphorylation [GO:0001932]; regulation of receptor binding [GO:1900120]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060]	collagen binding [GO:0005518]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]	GO:0001649; GO:0001932; GO:0004720; GO:0005507; GO:0005518; GO:0005576; GO:0005581; GO:0005615; GO:0005634; GO:0006464; GO:0007507; GO:0009410; GO:0010468; GO:0016202; GO:0017015; GO:0018057; GO:0030199; GO:0030282; GO:0030324; GO:0031012; GO:0035791; GO:0035905; GO:0035906; GO:0042060; GO:0042981; GO:0043491; GO:0045652; GO:0046716; GO:0048251; GO:0048514; GO:0048545; GO:0055001; GO:0060326; GO:0061448; GO:0071897; GO:1900120; GO:1903010; GO:1990869; GO:2000586	EAGASR	3.289999962	1	1	0.080478213	590.4139562	0	17.0072	0	16.60516	16.28313	0	17.05271	0	11.96872	14.82801	16.02978	15.08661	0	15.68913	15.80143	0	0	15.11113	12.18004	0	16.14933	15.48045	11.91047	0	17.33714	0	15.87086	16.70239	17.03622	13.09344	15.87803	12.97743	0	18.05795	15.53317	15.97321	0	0	16.23114	16.35222	16.80686	16.21632	15.32642	10.33003	19.50406	0	0	0
P28329	CLAT_HUMAN	"Choline O-acetyltransferase, CHOACTase, ChAT, Choline acetylase, EC 2.3.1.6"	CHAT	Homo sapiens (Human)	acetylcholine biosynthetic process [GO:0008292]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; phosphatidylcholine biosynthetic process [GO:0006656]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; choline O-acetyltransferase activity [GO:0004102]; acetylcholine biosynthetic process [GO:0008292]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; phosphatidylcholine biosynthetic process [GO:0006656]	choline O-acetyltransferase activity [GO:0004102]	GO:0004102; GO:0005634; GO:0005737; GO:0005829; GO:0006656; GO:0006836; GO:0007274; GO:0008292; GO:0043005; GO:0045202	FDNYGKTFIK	6.059999943	1	1	0.205125474	1232.035105	0	0	0	0	0	0	0	0	0	0	0	0	0	15.7841	0	0	0	0	16.33687	0	0	0	0	0	0	15.85347	17.30688	0	0	0	16.44955	0	13.81069	0	15.52443	0	0	0	0	0	0	0	0	16.30561	0	0	0	0
P28330	ACADL_HUMAN	"Long-chain specific acyl-CoA dehydrogenase, mitochondrial, LCAD, EC 1.3.8.8"	ACADL	Homo sapiens (Human)	"carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; temperature homeostasis [GO:0001659]"	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	"mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; temperature homeostasis [GO:0001659]"	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]	GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0090181; GO:0120162	GFYYIMKELPQER	2.579999924	1	1	2.98E-12	1690.443287	0	0	14.7226	12.90394	14.27616	13.81243	13.30454	8.660499	0	13.65764	0	15.5578	15.85082	0	0	0	0	0	0	16.83742	15.64522	15.11355	0	0	0	13.10486	0	0	15.09943	14.0731	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P28331	NDUS1_HUMAN	"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial, EC 7.1.1.2 (Complex I-75kD, CI-75kD)"	NDUFS1	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]"	GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0005759; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593	MTSGVTGDWKVMNILHR	7.929999828	1	1	0.156497985	1961.728157	0	0	12.71442	14.80806	13.08534	13.88486	13.59078	15.62965	14.13199	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P28332	ADH6_HUMAN	"Alcohol dehydrogenase 6, EC 1.1.1.1"	ADH6	Homo sapiens (Human)	ethanol oxidation [GO:0006069]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]"	"alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]"	GO:0004022; GO:0004024; GO:0004745; GO:0005829; GO:0006069; GO:0008270; GO:0042572; GO:0042573; GO:0045471; GO:0070062	INEAVELMKTGK	5.340000153	1	1	0.26874459	1344.888367	0	15.95257	8.445833	13.5844	13.10025	11.89704	14.99225	10.76684	0	0	14.41817	13.39167	0	0	12.96743	0	0	0	13.84569	13.60117	15.80889	13.91758	15.62814	16.59986	12.91372	0	15.33997	14.62553	13.51969	16.12107	16.06528	0	11.30228	0	0	0	17.52748	16.49333	17.08951	0	0	0	0	0	13.38925	0	0	10.47578
P28356	HXD9_HUMAN	Homeobox protein Hox-D9 (Homeobox protein Hox-4C) (Homeobox protein Hox-5.2)	HOXD9 HOX4C	Homo sapiens (Human)	"adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal system morphogenesis [GO:0048704]; hindlimb morphogenesis [GO:0035137]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]"	chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal system morphogenesis [GO:0048704]; hindlimb morphogenesis [GO:0035137]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0006357; GO:0007338; GO:0007519; GO:0008344; GO:0009952; GO:0009954; GO:0030879; GO:0035115; GO:0035137; GO:0045944; GO:0048704; GO:0048935; GO:1990837	MLGGSAGRLK	10.43999958	1	1	0.177474768	989.4338633	0	14.19049	0	0	12.92681	14.60622	0	0	15.08661	0	12.98525	0	15.00722	13.00047	15.3226	15.20406	14.57211	11.47103	0	14.84498	0	0	0	0	0	0	0	0	0	0	0	0	14.86499	0	16.51902	0	0	0	0	0	16.38436	16.45462	0	0	0	0	0	0
P28476	GBRR2_HUMAN	Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor)	GABRR2	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]	chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]	chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0004890; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902476; GO:1902711; GO:1904315	SMTFDGR	1.50999999	1	1	0.302920092	812.9572701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.9611	17.45947	0	0	0	0	0	0	18.28117	0	0	0	18.48707	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.68502	0
P28676	GRAN_HUMAN	Grancalcin	GCA GCL	Homo sapiens (Human)	membrane fusion [GO:0061025]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; membrane fusion [GO:0061025]	calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005509; GO:0005576; GO:0005737; GO:0005829; GO:0005886; GO:0035578; GO:0042803; GO:0046982; GO:0061025; GO:0070062	IMIAMLDRDHTGK	7.230000019	1	1	0.257749496	1516.029597	0	0	0	16.29127	13.28905	13.7061	15.61622	14.2441	0	14.56678	11.27157	0	0	0	13.55363	0	0	14.14002	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.33268	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P28698	MZF1_HUMAN	"Myeloid zinc finger 1, MZF-1 (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42)"	MZF1 MZF ZNF42 ZSCAN6	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	"nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0006355; GO:0042803; GO:0045944; GO:0046872	SRGRPSTGGGVVR	7.019999981	0.489197224	0.489197224	0.375856741	1285.425592	0	13.4	0	0	15.30165	15.11392	0	0	15.00019	0	0	0	14.03226	16.47829	16.51415	0	15.76457	15.70331	0	0	16.07557	0	0	0	0	0	13.93624	0	0	0	14.40155	15.21784	0	15.90441	15.64994	15.68271	15.45603	0	0	16.40501	0	16.13216	0	0	0	15.30774	0	0
P28715	ERCC5_HUMAN	"DNA excision repair protein ERCC-5, EC 3.1.-.- (DNA repair protein complementing XP-G cells) (Xeroderma pigmentosum group G-complementing protein)"	ERCC5 ERCM2 XPG XPGC	Homo sapiens (Human)	"base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of catalytic activity [GO:0050790]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697]; base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of catalytic activity [GO:0050790]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]"	bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697]	GO:0000109; GO:0000405; GO:0000724; GO:0000993; GO:0003684; GO:0003690; GO:0003697; GO:0004519; GO:0004520; GO:0005634; GO:0005654; GO:0005694; GO:0006283; GO:0006285; GO:0006289; GO:0006295; GO:0006296; GO:0008047; GO:0009411; GO:0009650; GO:0010225; GO:0032991; GO:0042803; GO:0043066; GO:0044877; GO:0046872; GO:0047485; GO:0050790	NGGATTSSSSDSDDDGGK	6.289999962	1	1	0.218769081	1656.476237	0	14.23522	0	0	0	0	13.99952	0	16.37421	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.54576	0	0	0	0	0	0	0	0	0	0	0	13.78648	0	15.51593	0	0	0	0	0	0	0
P28799	GRN_HUMAN	"Progranulin, PGRN (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda, GP88, Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor, PCDGF) (Proepithelin, PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E) ]"	GRN	Homo sapiens (Human)	astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]	chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]	GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060266; GO:0070062; GO:0106016; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905247; GO:1905673	AVALSSSVMCPDARSR	6.019999981	1	1	0.19847547	1706.361514	15.22789	15.32817	15.00172	13.63272	0	16.96018	0	0	0	10.82467	0	0	14.64511	0	13.70082	15.60331	0	14.88746	0	0	8.472771	0	0	0	0	17.5009	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P28827	PTPRM_HUMAN	"Receptor-type tyrosine-protein phosphatase mu, Protein-tyrosine phosphatase mu, R-PTP-mu, EC 3.1.3.48"	PTPRM PTPRL1	Homo sapiens (Human)	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010842; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042802; GO:0045296; GO:0048471	MVWHENTASIIMVTNLVEVGRVK	5.190000057	1	1	0.085551319	2641.277025	12.83995	0	0	0	0	13.93718	0	0	0	0	14.72546	15.80562	0	16.84452	0	14.41083	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.74171	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P28838	AMPL_HUMAN	"Cytosol aminopeptidase, EC 3.4.11.1 (Cysteinylglycine-S-conjugate dipeptidase, EC 3.4.13.23) (Leucine aminopeptidase 3, LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase, EC 3.4.11.5) (Prolyl aminopeptidase)"	LAP3 LAPEP PEPS	Homo sapiens (Human)	proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]	GO:0004177; GO:0004180; GO:0005634; GO:0005654; GO:0005737; GO:0005802; GO:0005829; GO:0005925; GO:0006508; GO:0008233; GO:0008235; GO:0030145; GO:0030496; GO:0070006; GO:0070062	SASSK	11.23999977	0.15848574	0.15848574	0.215455766	478.6941709	19.32543	16.54704	20.97867	18.80485	16.45023	20.55668	21.88043	0	17.59224	21.9084	21.18071	16.55543	15.48882	0	20.92155	17.24655	20.34218	0	0	19.52603	19.52759	19.69846	17.43947	18.14172	0	19.22227	18.85203	20.12335	0	20.9118	0	22.28261	22.64803	20.99924	17.26164	21.4671	0	21.85884	17.64931	17.59485	19.75279	21.0281	20.83362	19.29103	19.66465	0	18.23324	20.5869
P28845	DHI1_HUMAN	"11-beta-hydroxysteroid dehydrogenase 1, 11-DH, 11-beta-HSD1, EC 1.1.1.146 (7-oxosteroid reductase, EC 1.1.1.201) (Corticosteroid 11-beta-dehydrogenase isozyme 1) (Short chain dehydrogenase/reductase family 26C member 1)"	HSD11B1 HSD11 HSD11L SDR26C1	Homo sapiens (Human)	lung development [GO:0030324]; steroid catabolic process [GO:0006706]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; 11-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0070524]; cortisol dehydrogenase activity [GO:0102196]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; lung development [GO:0030324]; steroid catabolic process [GO:0006706]	11-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0070524]; cortisol dehydrogenase activity [GO:0102196]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]	GO:0005496; GO:0005789; GO:0006706; GO:0016020; GO:0030176; GO:0030324; GO:0042803; GO:0050661; GO:0070524; GO:0102196	MGAHVVVTAR	21.46999931	1	1	9.17E-13	1056.624308	0	0	0	0	0	0	0	0	0	11.04838	0	0	0	14.07048	11.06831	0	0	0	0	0	0	0	0	13.60815	15.4295	0	0	0	0	0	0	0	0	18.77139	0	0	0	0	13.21575	0	0	12.04268	0	0	0	0	0	0
P28908	TNR8_HUMAN	Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30)	TNFRSF8 CD30 D1S166E	Homo sapiens (Human)	cellular response to mechanical stimulus [GO:0071260]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]	transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005737; GO:0005886; GO:0007165; GO:0008285; GO:0016021; GO:0032759; GO:0032760; GO:0043065; GO:0070062; GO:0071260	VCECRPGMFCSTSAVNSCAR	4.53000021	0.465791315	0.465791315	2.75E-12	2349.006306	0	10.88446	13.41485	15.25731	0	0	0	0	0	0	0	0	0	14.56744	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.98242	0	0	0	0	0	0	0	12.49941	0	0	0	0	0	0	0	0
P29074	PTN4_HUMAN	"Tyrosine-protein phosphatase non-receptor type 4, EC 3.1.3.48 (Protein-tyrosine phosphatase MEG1, MEG, PTPase-MEG1)"	PTPN4	Homo sapiens (Human)	peptidyl-tyrosine phosphorylation [GO:0018108]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein dephosphorylation [GO:0006470]	cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0018108; GO:0035254	TMRDQR	16.11000061	0.142945573	0.142945573	0.158445642	822.61897	16.29128	16.12163	14.44005	14.28837	15.30284	0	14.92646	14.71287	0	15.01451	17.2818	0	0	0	17.35494	15.53198	16.61663	0	0	0	0	0	0	0	0	0	0	0	0	15.92206	17.14001	16.03367	0	16.29123	0	16.63378	0	17.20424	0	16.22723	16.21904	15.93437	15.73754	15.63408	16.50584	15.981	14.5702	15.05702
P29120	NEC1_HUMAN	"Neuroendocrine convertase 1, NEC 1, EC 3.4.21.93 (Prohormone convertase 1) (Proprotein convertase 1, PC1)"	PCSK1 NEC1	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; cell-cell signaling [GO:0007267]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]	identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0005791; GO:0005802; GO:0006508; GO:0007267; GO:0009410; GO:0009749; GO:0010157; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0021983; GO:0022008; GO:0030133; GO:0030425; GO:0031016; GO:0031667; GO:0032496; GO:0034774; GO:0042802; GO:0043005; GO:0043043; GO:0043204; GO:0043278; GO:0043434; GO:0043679; GO:0048471; GO:0048678; GO:0050714; GO:0051384; GO:0051592; GO:0070542; GO:0070555	CAGEIAMQANNHK	3.5	0.889502227	0.889502227	0.17168235	1460.146502	15.86648	0	0	0	15.46842	0	14.43493	14.43565	14.45138	0	0	0	0	0	0	16.24619	0	15.4211	0	0	0	0	16.38914	0	0	0	0	0	0	0	0	0	0	0	0	0	16.14561	0	0	0	0	0	0	16.21254	0	0	0	0
P29144	TPP2_HUMAN	"Tripeptidyl-peptidase 2, TPP-2, EC 3.4.14.10 (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II, TPP-II)"	TPP2	Homo sapiens (Human)	amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]	GO:0000209; GO:0004175; GO:0004177; GO:0004252; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042802; GO:0080144	IPKGAGPGCYLAGSLTLSK	9.770000458	1	1	0.264786413	1890.438747	0	0	0	5.92349	0	15.64774	12.71516	13.53287	0	0	14.45075	14.63416	10.19043	16.75287	0	0	0	0	0	0	0	0	0	0	15.89241	15.40048	0	0	0	0	0	0	0	0	14.36319	0	16.76491	0	0	16.27343	0	16.42918	16.07544	0	16.98611	0	0	0
P29218	IMPA1_HUMAN	"Inositol monophosphatase 1, IMP 1, IMPase 1, EC 3.1.3.25 (D-galactose 1-phosphate phosphatase, EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1)"	IMPA1 IMPA	Homo sapiens (Human)	inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006661; GO:0006796; GO:0007165; GO:0008934; GO:0030145; GO:0031403; GO:0042802; GO:0042803; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834	NEMNVMLKSSPVDLVTATDQK	7.449999809	1	1	0.23783294	2336.764125	0	14.41512	14.09782	13.715	0	14.67085	11.42558	16.59395	0	0	0	0	0	0	0	14.42763	12.52976	0	0	0	0	0	13.68148	0	10.68738	0	0	0	0	0	0	0	17.54366	0	0	0	0	0	14.33133	0	0	0	0	0	0	13.66174	19.05039	0
P29279	CCN2_HUMAN	"CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8, IBP-8, IGF-binding protein 8, IGFBP-8)"	CCN2 CTGF HCS24 IGFBP8	Homo sapiens (Human)	aging [GO:0007568]; angiogenesis [GO:0001525]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; cytosolic calcium ion transport [GO:0060401]; DNA biosynthetic process [GO:0071897]; epidermis development [GO:0008544]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]	cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]; aging [GO:0007568]; angiogenesis [GO:0001525]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chondrocyte proliferation [GO:0035988]; cytosolic calcium ion transport [GO:0060401]; DNA biosynthetic process [GO:0071897]; epidermis development [GO:0008544]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]	fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]	GO:0001502; GO:0001503; GO:0001525; GO:0001894; GO:0001934; GO:0001968; GO:0005178; GO:0005520; GO:0005576; GO:0005615; GO:0005801; GO:0005829; GO:0005886; GO:0005938; GO:0007155; GO:0007160; GO:0007165; GO:0007229; GO:0007568; GO:0008022; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008544; GO:0009611; GO:0009749; GO:0010628; GO:0010629; GO:0010942; GO:0016477; GO:0030154; GO:0030324; GO:0031012; GO:0032330; GO:0032355; GO:0032967; GO:0034059; GO:0035556; GO:0035988; GO:0043200; GO:0043280; GO:0043434; GO:0045597; GO:0046330; GO:0048471; GO:0050867; GO:0051385; GO:0051496; GO:0060401; GO:0060452; GO:0060548; GO:0070278; GO:0070318; GO:0070374; GO:0070542; GO:0071897; GO:0072593	LCMVRPCEADLEENIKK	3.160000086	1	1	0.273284181	2120.342188	14.81859	0	17.96753	0	11.65921	0	11.54693	16.47728	0	0	14.14193	0	0	11.08185	0	0	0	0	0	0	0	0	15.57849	0	0	0	15.80862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P29317	EPHA2_HUMAN	"Ephrin type-A receptor 2, EC 2.7.10.1 (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK)"	EPHA2 ECK	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; axial mesoderm formation [GO:0048320]; axon guidance [GO:0007411]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cAMP metabolic process [GO:0046058]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; defense response to Gram-positive bacterium [GO:0050830]; ephrin receptor signaling pathway [GO:0048013]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinocyte differentiation [GO:0030216]; lens fiber cell morphogenesis [GO:0070309]; mammary gland epithelial cell proliferation [GO:0033598]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of chemokine production [GO:0032682]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of protein kinase B signaling [GO:0051898]; neural tube development [GO:0021915]; notochord cell development [GO:0060035]; notochord formation [GO:0014028]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericyte cell differentiation [GO:1904238]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-anal tail morphogenesis [GO:0036342]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of lamellipodium assembly [GO:0010591]; response to growth factor [GO:0070848]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; tight junction [GO:0070160]	cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; tight junction [GO:0070160]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; virus receptor activity [GO:0001618]; activation of GTPase activity [GO:0090630]; axial mesoderm formation [GO:0048320]; axon guidance [GO:0007411]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cAMP metabolic process [GO:0046058]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; defense response to Gram-positive bacterium [GO:0050830]; ephrin receptor signaling pathway [GO:0048013]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinocyte differentiation [GO:0030216]; lens fiber cell morphogenesis [GO:0070309]; mammary gland epithelial cell proliferation [GO:0033598]; multicellular organism development [GO:0007275]; negative regulation of angiogenesis [GO:0016525]; negative regulation of chemokine production [GO:0032682]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of protein kinase B signaling [GO:0051898]; neural tube development [GO:0021915]; notochord cell development [GO:0060035]; notochord formation [GO:0014028]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericyte cell differentiation [GO:1904238]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-anal tail morphogenesis [GO:0036342]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of lamellipodium assembly [GO:0010591]; response to growth factor [GO:0070848]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; virus receptor activity [GO:0001618]	GO:0001501; GO:0001570; GO:0001618; GO:0001649; GO:0002043; GO:0004712; GO:0004714; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0006954; GO:0007155; GO:0007169; GO:0007275; GO:0007411; GO:0008630; GO:0009986; GO:0010591; GO:0014028; GO:0016477; GO:0016525; GO:0019838; GO:0021915; GO:0030027; GO:0030216; GO:0030316; GO:0030335; GO:0031256; GO:0031258; GO:0032587; GO:0032682; GO:0033598; GO:0033628; GO:0033674; GO:0036342; GO:0043005; GO:0043235; GO:0043491; GO:0043535; GO:0045296; GO:0045765; GO:0046058; GO:0046849; GO:0048013; GO:0048320; GO:0048870; GO:0050830; GO:0051898; GO:0060035; GO:0060326; GO:0060444; GO:0070160; GO:0070309; GO:0070372; GO:0070848; GO:0072659; GO:0090630; GO:1901491; GO:1903078; GO:1903348; GO:1904238	KEVPVAIK	9.399999619	1	1	0.230072407	884.6577865	15.48135	12.24577	0	12.60956	15.44337	13.8555	13.46699	12.9896	0	0	0	0	0	0	15.30523	0	0	0	0	0	0	0	0	0	14.45471	0	14.87477	16.16585	14.78866	0	0	0	0	0	0	0	16.17344	0	0	0	0	0	0	0	0	18.60089	0	14.96746
P29322	EPHA8_HUMAN	"Ephrin type-A receptor 8, EC 2.7.10.1 (EPH- and ELK-related kinase) (EPH-like kinase 3, EK3, hEK3) (Tyrosine-protein kinase receptor EEK)"	EPHA8 EEK HEK3 KIAA1459	Homo sapiens (Human)	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; ephrin receptor signaling pathway [GO:0048013]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; substrate-dependent cell migration [GO:0006929]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; ephrin receptor signaling pathway [GO:0048013]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; substrate-dependent cell migration [GO:0006929]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0004712; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006929; GO:0007155; GO:0007169; GO:0007411; GO:0016322; GO:0019838; GO:0030155; GO:0031175; GO:0031901; GO:0033628; GO:0033674; GO:0043005; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0048013; GO:0071372	SVGPLSKR	5.840000153	0.663136244	0.663136244	0.159402766	844.5545414	15.33854	13.8591	0	14.79338	0	13.97962	14.22127	0	15.82923	14.53004	0	0	19.00107	18.21875	18.5932	18.15682	17.64046	18.3114	18.41448	19.94408	18.12976	17.97445	18.09832	18.00736	18.78153	18.47018	18.16777	18.31243	18.85409	18.79133	18.37408	17.78674	16.83314	18.96291	18.60371	18.32221	19.07451	18.80542	19.2129	18.26066	18.17183	19.31953	19.5208	19.45799	18.6526	19.04239	18.32647	18.69653
P29323	EPHB2_HUMAN	"Ephrin type-B receptor 2, EC 2.7.10.1 (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5, EK5, hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2 ]"	EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5	Homo sapiens (Human)	"angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; hindbrain tangential cell migration [GO:0021934]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; learning or memory [GO:0007611]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; nervous system development [GO:0007399]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; postsynaptic membrane assembly [GO:0097104]; regulation of behavioral fear response [GO:2000822]; regulation of blood coagulation [GO:0030193]; regulation of body fluid levels [GO:0050878]; regulation of filopodium assembly [GO:0051489]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T-helper 17 type immune response [GO:2000316]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]; vesicle-mediated intercellular transport [GO:0110077]"	axon [GO:0030424]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]	"axon [GO:0030424]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; hindbrain tangential cell migration [GO:0021934]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; learning or memory [GO:0007611]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; nervous system development [GO:0007399]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; postsynaptic membrane assembly [GO:0097104]; regulation of behavioral fear response [GO:2000822]; regulation of blood coagulation [GO:0030193]; regulation of body fluid levels [GO:0050878]; regulation of filopodium assembly [GO:0051489]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T-helper 17 type immune response [GO:2000316]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]; vesicle-mediated intercellular transport [GO:0110077]"	amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0001525; GO:0001540; GO:0001655; GO:0001933; GO:0002639; GO:0004712; GO:0004713; GO:0004714; GO:0005005; GO:0005102; GO:0005524; GO:0005576; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006469; GO:0007162; GO:0007169; GO:0007399; GO:0007411; GO:0007413; GO:0007611; GO:0007612; GO:0008046; GO:0009986; GO:0010628; GO:0016310; GO:0018108; GO:0021631; GO:0021934; GO:0021952; GO:0022038; GO:0030193; GO:0030335; GO:0030424; GO:0030425; GO:0030890; GO:0031290; GO:0031915; GO:0032760; GO:0033674; GO:0042113; GO:0042472; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043235; GO:0044877; GO:0046425; GO:0046580; GO:0048013; GO:0048168; GO:0048170; GO:0048593; GO:0050771; GO:0050878; GO:0051489; GO:0051965; GO:0060021; GO:0060996; GO:0060997; GO:0061003; GO:0070373; GO:0071222; GO:0071679; GO:0097104; GO:0098794; GO:0098978; GO:0099055; GO:0099056; GO:0099557; GO:0106028; GO:0110077; GO:0120192; GO:1900016; GO:1900273; GO:1903078; GO:1904646; GO:1904782; GO:1904783; GO:2000316; GO:2000822	AQMNQIQSVEGQPLARRPR	5.659999847	1	1	0.395093863	2193.997162	18.20913	0	17.15383	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.23779	0	0	0	0	0	0	0	0
P29353	SHC1_HUMAN	"SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1, SH2 domain protein C1)"	SHC1 SHC SHCA	Homo sapiens (Human)	"actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of growth [GO:0040008]; regulation of superoxide metabolic process [GO:0090322]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of growth [GO:0040008]; regulation of superoxide metabolic process [GO:0090322]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001525; GO:0001784; GO:0005068; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005543; GO:0005759; GO:0005829; GO:0005886; GO:0007169; GO:0007173; GO:0007176; GO:0007507; GO:0008284; GO:0008286; GO:0016525; GO:0019901; GO:0030971; GO:0031532; GO:0035556; GO:0040008; GO:0042742; GO:0043066; GO:0043410; GO:0045892; GO:0045893; GO:0046875; GO:0048408; GO:0070374; GO:0070435; GO:0071363; GO:0071864; GO:0090322; GO:0098609	FAGMPITLTVSTSSLNLMAADCK	3.529999971	0.386979997	0.386979997	0.381955451	2460.812188	13.41752	0	0	0	0	12.93534	0	0	0	0	0	0	0	0	0	0	0	0	16.03381	16.55325	0	0	16.9336	0	15.90546	15.16366	15.85367	0	13.87052	0	0	0	0	0	0	0	14.44511	15.92043	15.53941	0	0	0	15.62928	0	0	13.2733	0	0
P29373	RABP2_HUMAN	"Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II, CRABP-II)"	CRABP2	Homo sapiens (Human)	"embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; positive regulation of collateral sprouting [GO:0048672]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid biosynthetic process [GO:0002138]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; positive regulation of collateral sprouting [GO:0048672]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid biosynthetic process [GO:0002138]; signal transduction [GO:0007165]"	cyclin binding [GO:0030332]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]	GO:0001972; GO:0002138; GO:0005501; GO:0005504; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006355; GO:0007165; GO:0008544; GO:0015908; GO:0016918; GO:0019841; GO:0030332; GO:0035115; GO:0048672; GO:0070062	KIAVAAASKPAVEIK	2.50999999	1	1	0.157174214	1497.234241	11.80029	0	0	10.51219	0	12.09374	0	12.54962	15.64636	12.87449	14.03172	13.61165	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.71753	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P29374	ARI4A_HUMAN	"AT-rich interactive domain-containing protein 4A, ARID domain-containing protein 4A (Retinoblastoma-binding protein 1, RBBP-1)"	ARID4A RBBP1 RBP1	Homo sapiens (Human)	"erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]	GO:0000122; GO:0000976; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006349; GO:0006357; GO:0007283; GO:0016580; GO:0017053; GO:0030336; GO:0030512; GO:0034773; GO:0036124; GO:0045892; GO:0045944; GO:0048821; GO:0080182; GO:0097368; GO:1902455; GO:1902459	AADEPAYLTVGTDVSAKYR	2.569999933	1	1	1.14E-12	2027.235076	12.42344	12.4446	11.19239	13.84302	13.25548	9.838446	0	14.10398	0	0	12.88528	9.008441	13.00393	0	12.35955	0	0	14.95231	11.57304	0	0	16.28299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P29375	KDM5A_HUMAN	"Lysine-specific demethylase 5A, EC 1.14.11.67 (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2, RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)"	KDM5A JARID1A RBBP2 RBP2	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; methylated histone binding [GO:0035064]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]"	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; methylated histone binding [GO:0035064]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0008270; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034720; GO:0035064; GO:0042393; GO:0045893; GO:0051090; GO:1901726	MAADPECLDVGLAAMVCK	3.859999895	1	1	0.038011094	1967.425252	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P29400	CO4A5_HUMAN	Collagen alpha-5(IV) chain	COL4A5	Homo sapiens (Human)	collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007528; GO:0030020; GO:0030198; GO:0031012; GO:0031594; GO:0038063; GO:0062023	GEPGFALPGPPGPPGLPGFK	4.71999979	1	1	0.546192119	1888.280265	17.21894	0	16.81458	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.3068	0	18.45619	18.94003	0	16.87726	0	0	0	0	18.16415	18.3251	0	0	0	0	0	0	0	0	0	0	0	0	0
P29475	NOS1_HUMAN	"Nitric oxide synthase, brain, EC 1.14.13.39 (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS, N-NOS, nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) (bNOS)"	NOS1	Homo sapiens (Human)	"arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; multicellular organismal response to stress [GO:0033555]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter biosynthetic process [GO:0042136]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178]"	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; synapse [GO:0045202]; vesicle membrane [GO:0012506]	"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325]; arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; multicellular organismal response to stress [GO:0033555]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter biosynthetic process [GO:0042136]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178]"	arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325]	GO:0001666; GO:0001917; GO:0002028; GO:0004517; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006527; GO:0006809; GO:0006936; GO:0006941; GO:0007263; GO:0007520; GO:0009408; GO:0009725; GO:0010181; GO:0010523; GO:0012506; GO:0014069; GO:0016491; GO:0016529; GO:0017080; GO:0018119; GO:0020037; GO:0031284; GO:0032496; GO:0032991; GO:0033138; GO:0033555; GO:0034617; GO:0034618; GO:0035066; GO:0042136; GO:0042178; GO:0042311; GO:0042383; GO:0043197; GO:0043267; GO:0044325; GO:0045121; GO:0045202; GO:0045454; GO:0045776; GO:0045893; GO:0045944; GO:0046870; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0051346; GO:0051612; GO:0051926; GO:0055117; GO:0060314; GO:0071363; GO:0071944; GO:0097110; GO:0098735; GO:0098924; GO:1902307; GO:1902514	LMGQAMAK	14	0.816728294	0.816728294	0.257698001	864.314874	16.6601	16.71007	15.52457	0	17.3624	16.02845	0	15.93385	0	17.07416	0	13.91011	15.67165	13.10608	14.54404	0	0	0	0	15.99899	15.55522	0	0	16.29662	0	15.97343	14.39257	14.35247	13.17515	17.14951	16.92767	16.12725	0	17.61003	0	16.94113	0	17.72084	16.31351	0	17.11151	17.88407	15.9432	16.28778	17.33995	0	15.65985	13.18706
P29558	RBMS1_HUMAN	"RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1) (Suppressor of CDC2 with RNA-binding motif 2)"	RBMS1 C2orf12 MSSP MSSP1 SCR2	Homo sapiens (Human)	DNA replication [GO:0006260]; RNA processing [GO:0006396]	cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; RNA processing [GO:0006396]	double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0003690; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006260; GO:0006396; GO:0008143; GO:0008266; GO:1990904	DSSGTSR	1.299999952	1	1	0.213272139	709.9454986	0	15.45079	14.12371	0	0	0	15.44926	16.04482	0	15.43372	0	0	15.38064	17.37124	0	0	0	0	0	0	16.69347	0	0	0	14.44414	15.71621	16.73209	15.48423	11.95086	14.61512	13.44974	14.60754	0	16.13693	0	0	0	17.02992	0	0	0	0	15.94026	0	0	0	0	0
P29728	OAS2_HUMAN	"2'-5'-oligoadenylate synthase 2, (2-5')oligo(A) synthase 2, 2-5A synthase 2, EC 2.7.7.84 (p69 OAS / p71 OAS, p69OAS / p71OAS)"	OAS2	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337]	2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]	GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006139; GO:0006401; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0042742; GO:0043231; GO:0045071; GO:0046872; GO:0048471; GO:0051607; GO:0060337; GO:0060700; GO:0070106; GO:1903487	LKPKGSLPPK	9.489999771	0.057732765	0.057732765	0.114277921	1065.285226	11.76857	0	15.7309	16.19142	15.80338	16.52613	0	15.38667	0	0	0	16.18928	18.04036	16.59123	14.58454	16.39788	12.80385	0	14.18351	0	0	17.30947	14.0068	0	10.39349	15.14512	16.5913	0	0	0	0	13.0935	12.30093	0	17.55385	17.03705	15.92641	0	0	0	13.56388	14.31431	17.32119	0	0	16.34217	10.1588	16.25957
P29803	ODPAT_HUMAN	"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial, EC 1.2.4.1 (PDHE1-A type II)"	PDHA2 PDHAL	Homo sapiens (Human)	acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099]	pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]	GO:0004739; GO:0005634; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0006086; GO:0006090; GO:0006099; GO:0034604	GKGGSMHMYTK	9.93999958	1	1	1.37E-12	1212.683181	15.13916	0	10.24819	14.71929	0	13.93652	15.68971	14.98845	13.86016	0	12.96019	14.17751	9.88433	14.57252	0	16.28308	14.28873	15.94241	14.86491	14.8412	0	15.54634	14.73327	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P29966	MARCS_HUMAN	"Myristoylated alanine-rich C-kinase substrate, MARCKS (Protein kinase C substrate, 80 kDa protein, light chain, 80K-L protein, PKCSL)"	MARCKS MACS PRKCSL	Homo sapiens (Human)	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; central nervous system development [GO:0007417]	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; germinal vesicle [GO:0042585]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; germinal vesicle [GO:0042585]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; central nervous system development [GO:0007417]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]	GO:0005080; GO:0005516; GO:0005737; GO:0005813; GO:0005886; GO:0005925; GO:0005938; GO:0007015; GO:0007417; GO:0015629; GO:0032432; GO:0042585; GO:0042802; GO:0051015; GO:0051017; GO:0051764; GO:0070062	VNGDASPAAAESGAK	8.350000381	1	1	0.37815471	1345.642808	14.83716	10.99411	0	0	0	17.02748	0	16.40367	14.9741	0	0	16.24998	0	0	0	0	17.1236	0	17.35284	15.77001	16.81402	14.85445	0	16.61786	0	17.70753	0	0	0	0	0	0	0	17.98917	0	17.42343	15.82666	15.59763	0	16.68084	0	16.75707	14.46545	0	0	0	0	0
P30038	AL4A1_HUMAN	"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial, P5C dehydrogenase, EC 1.2.1.88 (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)"	ALDH4A1 ALDH4 P5CDH	Homo sapiens (Human)	4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; 4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]	1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]	GO:0003842; GO:0004029; GO:0005739; GO:0005759; GO:0005829; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802	SSPSLTILAGGK	3.549999952	1	1	6.87E-13	1133.426151	13.19058	14.40011	12.98008	9.692815	13.15419	0	13.21116	15.94937	14.55811	13.52823	14.18401	13.66916	0	0	0	0	0	0	0	0	0	14.45958	14.77194	14.46939	0	0	0	0	12.72147	11.08299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P30041	PRDX6_HUMAN	"Peroxiredoxin-6, EC 1.11.1.27 (1-Cys peroxiredoxin, 1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2, aiPLA2, EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Liver 2D page spot 40) (Lysophosphatidylcholine acyltransferase 5, LPC acyltransferase 5, LPCAT-5, Lyso-PC acyltransferase 5, EC 2.3.1.23) (Non-selenium glutathione peroxidase, NSGPx) (Red blood cells page spot 12)"	PRDX6 AOP2 KIAA0106	Homo sapiens (Human)	"cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]"	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipase A2 activity [GO:0004623]; thioredoxin peroxidase activity [GO:0008379]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]"	1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipase A2 activity [GO:0004623]; thioredoxin peroxidase activity [GO:0008379]; ubiquitin protein ligase binding [GO:0031625]	GO:0004602; GO:0004623; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006979; GO:0008379; GO:0016020; GO:0031625; GO:0035578; GO:0042802; GO:0045296; GO:0045454; GO:0046475; GO:0047184; GO:0047499; GO:0048026; GO:0048471; GO:0070062; GO:0098869	ELAILLGMLDPAEKDEK	3.019999981	1	1	0.147157179	1900.47493	14.6231	0	0	0	15.3303	0	0	0	0	0	0	15.80211	0	0	0	13.6906	0	0	0	15.51219	0	15.62758	0	0	15.97094	15.49044	15.53165	0	0	0	15.38682	0	0	0	0	0	16.15272	16.20018	0	15.0826	0	15.30927	0	15.59789	0	0	0	0
P30048	PRDX3_HUMAN	"Thioredoxin-dependent peroxide reductase, mitochondrial, EC 1.11.1.24 (Antioxidant protein 1, AOP-1) (HBC189) (Peroxiredoxin III, Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog) (Thioredoxin-dependent peroxiredoxin 3)"	PRDX3 AOP1	Homo sapiens (Human)	cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; alkyl hydroperoxide reductase activity [GO:0008785]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; maternal placenta development [GO:0001893]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of kinase activity [GO:0033673]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of mitochondrial membrane potential [GO:0051881]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]	alkyl hydroperoxide reductase activity [GO:0008785]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; thioredoxin peroxidase activity [GO:0008379]	GO:0001893; GO:0005737; GO:0005739; GO:0005759; GO:0005769; GO:0005829; GO:0006979; GO:0007005; GO:0008022; GO:0008284; GO:0008379; GO:0008785; GO:0018171; GO:0019900; GO:0019901; GO:0030099; GO:0032496; GO:0032991; GO:0033673; GO:0034599; GO:0034614; GO:0042542; GO:0042744; GO:0042802; GO:0043027; GO:0043066; GO:0045454; GO:0051092; GO:0051881	NGGLGHMNIALLSDLTK	9.930000305	1	1	0.395739602	1771.130834	16.78173	20.32995	16.87026	0	0	0	0	17.77429	0	17.55753	0	0	0	0	0	19.25627	0	0	0	0	0	17.7093	0	18.19289	0	0	18.27629	0	0	17.55788	0	20.26873	0	0	0	0	17.84883	20.98736	0	18.83974	0	0	0	17.2232	0	0	0	0
P30049	ATPD_HUMAN	"ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)"	ATP5F1D ATP5D	Homo sapiens (Human)	aerobic respiration [GO:0009060]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to copper ion [GO:0046688]	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; aerobic respiration [GO:0009060]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; response to copper ion [GO:0046688]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000275; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0009060; GO:0015986; GO:0033615; GO:0042776; GO:0046688; GO:0046933	IEANEALVK	5.590000153	1	1	0.277909003	985.6245987	16.68213	0	0	0	15.88043	0	0	0	0	0	0	17.48955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.21951	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P30050	RL12_HUMAN	60S ribosomal protein L12 (Large ribosomal subunit protein uL11)	RPL12	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0015934; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:0070180	VVYLRCTGGEVGATSALAPK	3.400000095	0.335014582	0.335014582	5.47E-12	2048.402494	13.83052	12.56427	0	0	14.47517	13.65792	0	0	0	14.82149	16.92685	15.38384	13.55464	15.5534	14.6271	13.68649	13.98832	14.34183	16.26883	0	14.87808	0	0	0	0	16.63886	14.98092	15.09471	0	0	14.12989	17.04211	18.76088	0	13.09365	12.44351	14.1129	16.52919	12.17653	14.85995	18.11	0	15.65091	0	14.93333	0	15.25965	0
P30153	2AAA_HUMAN	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)	PPP2R1A	Homo sapiens (Human)	"apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]"	"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]"	protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000159; GO:0000775; GO:0004722; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007143; GO:0008380; GO:0010033; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0043005; GO:0043025; GO:0043409; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0098978; GO:1903538; GO:1990405; GO:2001241	VLELDNVK	21.34000015	1	1	0.180464951	928.1998739	0	0	15.64647	0	0	14.82633	15.23606	0	15.98507	15.16745	0	0	0	16.3628	16.02858	0	14.64156	0	0	17.09291	0	0	0	0	0	0	0	0	0	15.76723	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P30154	2AAB_HUMAN	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta)	PPP2R1B	Homo sapiens (Human)	apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005737; GO:0006470; GO:0019888; GO:0045121; GO:0060561; GO:0070062; GO:2001241	LGQDEDMDVK	5.099999905	1	1	0.267597354	1149.251095	11.36827	0	14.21832	15.50526	14.1133	15.0682	0	0	0	15.36344	0	0	0	14.25456	15.00017	0	0	0	0	0	14.36775	15.70773	0	0	0	0	0	0	0	17.06312	0	15.05297	0	0	0	0	0	0	0	0	0	0	0	0	14.68635	0	0	0
P30260	CDC27_HUMAN	"Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3, APC3) (CDC27 homolog, CDC27Hs) (H-NUC)"	CDC27 ANAPC3 D0S1430E D17S978E	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979; GO:0072686	NPLCKFHR	1.960000038	1	1	0.01071306	1071.875106	0	0	0	15.98036	0	0	0	0	0	0	0	0	16.79535	0	0	0	0	0	19.00721	0	0	15.98052	0	0	16.46148	0	0	0	0	0	15.88451	16.90351	14.86456	0	14.95664	0	0	16.31942	15.13979	13.68259	15.5135	0	0	0	13.87366	0	0	0
P30305	MPIP2_HUMAN	"M-phase inducer phosphatase 2, EC 3.1.3.48 (Dual specificity phosphatase Cdc25B)"	CDC25B CDC25HU2	Homo sapiens (Human)	cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]	phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000086; GO:0000278; GO:0000922; GO:0001556; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007144; GO:0008284; GO:0010971; GO:0019901; GO:0032467; GO:0045860; GO:0045931; GO:0051301; GO:0110032	DTPVQNKR	8.970000267	1	1	4.59E-13	958.4109027	0	16.18066	13.32864	13.91826	14.30569	0	0	0	12.92268	0	14.13712	0	13.64433	0	0	0	0	0	0	14.91659	0	0	16.0086	0	0	0	16.26251	0	0	0	0	0	0	0	0	0	0	0	0	15.52468	0	0	0	0	16.0915	0	16.0505	0
P30307	MPIP3_HUMAN	"M-phase inducer phosphatase 3, EC 3.1.3.48 (Dual specificity phosphatase Cdc25C)"	CDC25C	Homo sapiens (Human)	cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; WW domain binding [GO:0050699]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]; spermatogenesis [GO:0007283]	phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; WW domain binding [GO:0050699]	GO:0000079; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005758; GO:0005829; GO:0007088; GO:0007283; GO:0008283; GO:0010971; GO:0016607; GO:0019901; GO:0048471; GO:0050699; GO:0051301; GO:0110032	YFSGQGKLR	5.320000172	1	1	0.221980879	1056.644978	14.01408	0	11.51556	13.0265	14.00309	15.38954	0	0	0	0	0	15.58341	16.53215	15.64413	0	14.78902	16.57482	14.67402	14.35203	0	14.7437	15.31498	0	15.58728	0	14.63821	0	14.84477	16.97337	0	16.36143	0	0	0	0	0	15.28915	0	0	0	0	16.08809	0	0	0	0	0	0
P30414	NKTR_HUMAN	"NK-tumor recognition protein, NK-TR protein (Natural-killer cells cyclophilin-related protein) (Peptidyl-prolyl cis-trans isomerase NKTR, PPIase, EC 5.2.1.8) (Rotamase)"	NKTR	Homo sapiens (Human)	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0005886; GO:0006457; GO:0016018; GO:0043231	IQEMKAK	2.839999914	0.020012626	0.020012626	0.277843673	864.8304015	15.60784	13.27637	13.01524	15.71124	14.61881	14.8628	15.40902	15.13602	15.81267	15.54619	15.08642	15.14586	14.08658	14.98205	0	15.98351	14.50245	15.20419	16.46195	14.94707	16.68302	16.40234	0	15.99929	14.8458	15.50343	12.71169	0	15.38059	15.35399	15.71881	0	0	16.06091	15.50483	0	14.49807	15.84625	15.67432	8.684264	15.77396	15.52078	0	15.7955	13.74703	0	0	16.78426
P30519	HMOX2_HUMAN	"Heme oxygenase 2, HO-2, EC 1.14.14.18 [Cleaved into: Heme oxygenase 2 soluble form ]"	HMOX2 HO2	Homo sapiens (Human)	heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; iron ion homeostasis [GO:0055072]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; iron ion homeostasis [GO:0055072]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]	heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872]	GO:0001666; GO:0004392; GO:0005789; GO:0005886; GO:0006788; GO:0006979; GO:0016020; GO:0020037; GO:0035579; GO:0042167; GO:0046872; GO:0055072	DMEYFFGENWEEQVQCPKAAQK	3.450000048	1	1	9.19E-13	2749.178898	0	14.30429	13.80828	14.02761	14.08815	13.16892	0	12.82271	0	0	0	15.28629	11.39692	0	0	0	0	0	0	0	0	0	16.04392	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P30530	UFO_HUMAN	"Tyrosine-protein kinase receptor UFO, EC 2.7.10.1 (AXL oncogene)"	AXL UFO	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of viral life cycle [GO:1903902]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral entry into host cell [GO:0046718]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]; animal organ regeneration [GO:0031100]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of viral life cycle [GO:1903902]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral entry into host cell [GO:0046718]	ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001764; GO:0001779; GO:0001786; GO:0001961; GO:0001974; GO:0004712; GO:0004713; GO:0004714; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006909; GO:0006954; GO:0007165; GO:0007169; GO:0007283; GO:0007399; GO:0009986; GO:0015629; GO:0016477; GO:0021885; GO:0030168; GO:0031100; GO:0031668; GO:0032036; GO:0032689; GO:0032720; GO:0032825; GO:0032940; GO:0033674; GO:0034101; GO:0034446; GO:0035457; GO:0042698; GO:0043066; GO:0043231; GO:0043235; GO:0043491; GO:0043524; GO:0043548; GO:0044228; GO:0045087; GO:0046718; GO:0048010; GO:0048469; GO:0048549; GO:0051250; GO:0051897; GO:0060068; GO:0070062; GO:0070301; GO:0071222; GO:0097028; GO:0097350; GO:1903902; GO:2000669	MAWRCPR	7.320000172	1	1	3.49E-13	977.4422231	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.90676	0	0	0	0	0	0	0	0	0	0	16.00702	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.65414	0	0	0	0	0	0
P30533	AMRP_HUMAN	"Alpha-2-macroglobulin receptor-associated protein, Alpha-2-MRAP (Low density lipoprotein receptor-related protein-associated protein 1, RAP)"	LRPAP1 A2MRAP	Homo sapiens (Human)	amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]	cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]	amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0001540; GO:0002091; GO:0005102; GO:0005576; GO:0005768; GO:0005783; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0007165; GO:0008201; GO:0009986; GO:0010916; GO:0012505; GO:0031904; GO:0032091; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0060548; GO:0070326; GO:0150093; GO:1900116; GO:1900222; GO:1900223	ELGYTVK	15.80000019	0.421353638	0.421353638	0.186871164	809.7839771	15.77502	15.54391	15.30959	0	17.04225	0	15.76031	15.81629	15.68475	17.05042	17.03868	15.23482	0	15.51443	13.23229	14.96219	14.82333	16.18302	15.1357	14.87432	15.17606	15.88692	15.69119	0	17.26547	15.17601	0	14.55359	0	0	0	0	0	0	0	0	0	0	0	16.07945	0	0	15.9561	16.62621	0	15.55917	0	0
P30559	OXYR_HUMAN	"Oxytocin receptor, OT-R"	OXTR	Homo sapiens (Human)	"cell surface receptor signaling pathway [GO:0007166]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; muscle contraction [GO:0006936]; negative regulation of gastric acid secretion [GO:0060455]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of penile erection [GO:0060406]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to anoxia [GO:0034059]; response to cocaine [GO:0042220]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; suckling behavior [GO:0001967]; telencephalon development [GO:0021537]"	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; oxytocin receptor activity [GO:0004990]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; vasopressin receptor activity [GO:0005000]; cell surface receptor signaling pathway [GO:0007166]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; muscle contraction [GO:0006936]; negative regulation of gastric acid secretion [GO:0060455]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of penile erection [GO:0060406]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to anoxia [GO:0034059]; response to cocaine [GO:0042220]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; suckling behavior [GO:0001967]; telencephalon development [GO:0021537]"	G protein-coupled receptor activity [GO:0004930]; oxytocin receptor activity [GO:0004990]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; vasopressin receptor activity [GO:0005000]	GO:0001967; GO:0001975; GO:0001992; GO:0004930; GO:0004990; GO:0005000; GO:0005886; GO:0005887; GO:0005902; GO:0005912; GO:0006936; GO:0007166; GO:0007186; GO:0007204; GO:0007507; GO:0007565; GO:0007595; GO:0007613; GO:0009410; GO:0010701; GO:0016324; GO:0017046; GO:0021537; GO:0030431; GO:0032230; GO:0032355; GO:0032570; GO:0034059; GO:0034097; GO:0035176; GO:0042220; GO:0042277; GO:0042711; GO:0042713; GO:0042755; GO:0043434; GO:0044849; GO:0045777; GO:0045907; GO:0048565; GO:0051965; GO:0051968; GO:0060137; GO:0060406; GO:0060455; GO:0070371; GO:0070474; GO:0120162	SNSSSFVLSHRSSSQR	10.78999996	0.330198169	0.330198169	0.139816932	1765.83388	19.3426	15.43837	13.90024	11.04575	0	18.50197	0	0	16.57429	0	0	0	0	20.93537	19.1565	19.13198	21.29325	0	19.37889	15.51088	0	19.37313	0	13.18803	19.88796	0	0	18.02341	0	0	18.48937	17.79355	0	0	0	0	0	0	18.66286	20.67951	0	20.23602	0	0	0	0	0	0
P30622	CLIP1_HUMAN	"CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2, CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin)"	CLIP1 CYLN1 RSN	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; ruffle [GO:0001726]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010	LLDLDALR	9.279999733	1	1	0.164722932	928.5593221	0	0	15.07514	15.22426	15.13047	13.71602	0	0	14.51502	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P30740	ILEU_HUMAN	"Leukocyte elastase inhibitor, LEI (Monocyte/neutrophil elastase inhibitor, EI, M/NEI) (Peptidase inhibitor 2, PI-2) (Serpin B1)"	SERPINB1 ELANH2 MNEI PI2	Homo sapiens (Human)	negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; type B pancreatic cell proliferation [GO:0044342]	collagen-containing extracellular matrix [GO:0062023]; cytolytic granule [GO:0044194]; cytoplasmic ribonucleoprotein granule [GO:0036464]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]	collagen-containing extracellular matrix [GO:0062023]; cytolytic granule [GO:0044194]; cytoplasmic ribonucleoprotein granule [GO:0036464]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; type B pancreatic cell proliferation [GO:0044342]	peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0005615; GO:0005769; GO:0010951; GO:0016020; GO:0030414; GO:0032691; GO:0034774; GO:0036464; GO:0044194; GO:0044342; GO:0062023; GO:0070062	GASYILK	1.649999976	1	1	0.280122644	751.8358392	0	0	0	0	0	0	0	0	0	0	18.23445	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.04745	0	0	0	0	0
P30793	GCH1_HUMAN	"GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)"	GCH1 DYT5 GCH	Homo sapiens (Human)	"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]"	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]"	calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]	GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0006809; GO:0008217; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032496; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042559; GO:0042802; GO:0042803; GO:0044306; GO:0044877; GO:0045776; GO:0046654; GO:0048265; GO:0050884; GO:0051000; GO:0051019; GO:0065003; GO:2000121	EDPKTR	3.299999952	0.672652006	0.672652006	0.212062056	745.6985358	0	14.72472	15.60779	15.94825	0	10.80241	0	0	14.97889	0	14.73238	15.46902	0	13.46917	0	0	0	0	17.10832	16.62129	0	0	0	0	16.43327	0	0	14.57507	14.42513	15.32682	0	14.83057	0	0	17.05207	14.90061	16.4715	0	0	0	16.80774	0	0	0	15.05958	14.49693	0	0
P30837	AL1B1_HUMAN	"Aldehyde dehydrogenase X, mitochondrial, EC 1.2.1.3 (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)"	ALDH1B1 ALDH5 ALDHX	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]	GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005975; GO:0006068; GO:0043878; GO:0051287	AYTEVK	5.25	1	1	0.051197977	711.5450659	0	0	13.09058	0	0	0	10.66578	0	0	0	0	0	0	0	0	0	15.04172	0	0	0	0	0	0	0	16.91482	0	0	0	0	0	0	16.07069	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P30876	RPB2_HUMAN	"DNA-directed RNA polymerase II subunit RPB2, EC 2.7.7.6 (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)"	POLR2B	Homo sapiens (Human)	transcription by RNA polymerase II [GO:0006366]	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"	"membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; transcription by RNA polymerase II [GO:0006366]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]	GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0016020; GO:0032549; GO:0046872	DLCELNECPLDPGGYFIINGSEKVLIAQEK	1.720000029	1	1	0.141442571	3420.908527	0	15.55668	0	12.99324	12.46539	0	7.823	14.36472	14.2036	14.50432	13.71526	13.4627	0	0	0	0	0	0	0	0	0	0	11.90963	0	14.74931	0	0	15.1828	0	0	0	0	0	0	0	0	0	13.14517	0	0	0	0	0	13.49096	14.38285	16.92401	0	12.56644
P30926	ACHB4_HUMAN	Neuronal acetylcholine receptor subunit beta-4	CHRNB4	Homo sapiens (Human)	"action potential [GO:0001508]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of smooth muscle contraction [GO:0006940]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]	"acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; action potential [GO:0001508]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of smooth muscle contraction [GO:0006940]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]	GO:0001508; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006939; GO:0006940; GO:0007165; GO:0007268; GO:0007271; GO:0007626; GO:0015276; GO:0015464; GO:0016021; GO:0022848; GO:0030594; GO:0034220; GO:0035095; GO:0035579; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046928; GO:0050877; GO:0051899; GO:0051971; GO:0060084; GO:0070821; GO:0098981	RPGPDSSPAR	5.099999905	1	1	4.59E-13	1039.858465	15.83608	15.34951	16.03504	0	15.67782	12.7199	0	13.87322	0	0	11.83678	0	0	0	15.72085	0	12.85893	15.22042	0	14.47083	0	0	8.242668	14.91918	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.86037	0	0	0
P30954	O10J1_HUMAN	Olfactory receptor 10J1 (Olfactory receptor OR1-26) (Olfactory receptor-like protein HGMP07J)	OR10J1	Homo sapiens (Human)	detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; single fertilization [GO:0007338]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; single fertilization [GO:0007338]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005887; GO:0007186; GO:0007338; GO:0007606; GO:0016021; GO:0050911	AVGGK	2.609999895	1	1	0.097229063	429.6957479	15.34717	0	14.97433	0	14.50231	0	15.62829	15.17158	0	0	14.16526	14.1623	0	14.5028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P30988	CALCR_HUMAN	"Calcitonin receptor, CT-R"	CALCR	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384]	amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amylin receptor activity [GO:0097643]; amyloid-beta binding [GO:0001540]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384]	amylin receptor activity [GO:0097643]; amyloid-beta binding [GO:0001540]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]	GO:0001540; GO:0001635; GO:0004948; GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0007204; GO:0008528; GO:0010628; GO:0010739; GO:0010942; GO:0030424; GO:0032841; GO:0033138; GO:0038041; GO:0045762; GO:0051384; GO:0051897; GO:0070374; GO:0097643; GO:0097647; GO:0150056; GO:0150057; GO:0150058; GO:1904645; GO:1905665	VLVTKMR	3.130000114	1	1	0.223262962	862.7530645	15.58947	17.45474	14.25517	14.6814	0	15.10597	0	15.82965	15.65336	15.83706	14.73144	14.65559	16.98739	13.75128	16.36475	16.40856	16.2096	16.65781	0	15.04355	0	14.97463	0	17.01176	0	0	15.75372	0	15.537	16.8241	16.04555	14.73323	16.47016	15.84901	16.38949	14.63574	15.73784	17.02841	13.25286	14.77896	15.78112	13.7571	17.23806	15.26613	14.32324	15.79709	17.36787	15.46102
P31040	SDHA_HUMAN	"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial, EC 1.3.5.1 (Flavoprotein subunit of complex II, Fp)"	SDHA SDH2 SDHF	Homo sapiens (Human)	"mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; nervous system development [GO:0007399]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]"	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]	GO:0005730; GO:0005739; GO:0005743; GO:0005749; GO:0006099; GO:0006105; GO:0006121; GO:0007399; GO:0008177; GO:0009055; GO:0022904; GO:0042776; GO:0050660	SHTVAAQGGINAALGNMEEDNWR	7.679999828	1	1	0.261211265	2442.496476	0	0	0	0	0	0	0	0	17.74515	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P31153	METK2_HUMAN	"S-adenosylmethionine synthase isoform type-2, AdoMet synthase 2, EC 2.5.1.6 (Methionine adenosyltransferase 2, MAT 2) (Methionine adenosyltransferase II, MAT-II)"	MAT2A AMS2 MATA2	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]	cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]	GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830	HIGYDDSSK	2.440000057	1	1	0.113694621	1020.904238	13.92816	14.82083	0	0	0	11.24018	0	14.29481	11.77401	10.56096	14.19364	16.01483	0	13.90713	11.77844	13.61105	15.36032	15.83026	14.72864	14.21737	0	14.68022	13.34382	15.65504	0	0	14.78547	0	0	0	0	0	0	14.38939	14.52973	0	0	0	0	0	0	0	13.81062	15.14881	0	0	0	0
P31249	HXD3_HUMAN	Homeobox protein Hox-D3 (Homeobox protein Hox-4A)	HOXD3 HOX1D HOX4A	Homo sapiens (Human)	"anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; cell-matrix adhesion [GO:0007160]; embryonic skeletal system morphogenesis [GO:0048704]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]"	aggresome [GO:0016235]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"aggresome [GO:0016235]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; cell-matrix adhesion [GO:0007160]; embryonic skeletal system morphogenesis [GO:0048704]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0007160; GO:0007219; GO:0009952; GO:0010628; GO:0016235; GO:0016604; GO:0030878; GO:0045666; GO:0045944; GO:0048704; GO:0051216; GO:1990837	AKGILHSPASQSPER	6.329999924	1	1	0.41455801	1577.22084	0	0	11.53832	13.7158	13.78868	0	10.94746	0	13.85464	13.51162	14.98858	0	0	16.59167	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.9971	0	0	0	15.35377	15.19868	0	0	0
P31274	HXC9_HUMAN	Homeobox protein Hox-C9 (Homeobox protein Hox-3B)	HOXC9 HOX3B	Homo sapiens (Human)	"anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell cycle [GO:0045786]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	aggresome [GO:0016235]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"aggresome [GO:0016235]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell cycle [GO:0045786]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0009952; GO:0009954; GO:0016235; GO:0017053; GO:0045786; GO:0048704; GO:1990837	SYPDYMYGSPGELRDR	2.289999962	1	1	1.61E-12	1906.359225	0	0	13.51076	0	0	0	0	0	0	0	0	0	16.04954	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.23166	0	0	0
P31327	CPSM_HUMAN	"Carbamoyl-phosphate synthase [ammonia], mitochondrial, EC 6.3.4.16 (Carbamoyl-phosphate synthetase I, CPSase I)"	CPS1	Homo sapiens (Human)	'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; nitrogen compound metabolic process [GO:0006807]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; nitrogen compound metabolic process [GO:0006807]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]	GO:0000050; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0006207; GO:0006541; GO:0006807; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019240; GO:0019433; GO:0032094; GO:0032496; GO:0032991; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0050667; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341	AMLSTGFKIPQK	2.920000076	1	1	0.175264631	1335.823512	12.39229	15.01958	0	14.87634	0	0	14.99766	0	0	0	0	0	0	0	0	13.64872	15.17593	0	0	15.48812	0	14.81087	0	0	0	0	0	0	17.03037	0	0	0	0	15.86916	0	14.40719	16.82516	16.99399	0	0	15.72528	14.93529	0	16.21317	0	0	0	16.21812
P31350	RIR2_HUMAN	"Ribonucleoside-diphosphate reductase subunit M2, EC 1.17.4.1 (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)"	RRM2 RR2	Homo sapiens (Human)	2'-deoxyribonucleotide biosynthetic process [GO:0009265]; blastocyst development [GO:0001824]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185]	cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoside-diphosphate reductase complex [GO:0005971]	"cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; blastocyst development [GO:0001824]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185]"	"ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]"	GO:0001824; GO:0004748; GO:0005634; GO:0005829; GO:0005971; GO:0006260; GO:0008199; GO:0009185; GO:0009263; GO:0009265; GO:0042803; GO:0051290; GO:1900087	VENPFDFMENISLEGK	9.93999958	0.720016539	0.720016539	0.046185063	1878.746438	13.61057	0	12.66521	15.45555	0	0	15.79458	14.31809	15.80845	12.0586	0	0	14.90357	0	0	15.70224	13.61239	15.05067	0	0	0	0	14.63148	14.51313	0	9.424219	15.66629	0	0	0	0	0	0	0	0	0	0	14.31121	0	15.70924	0	0	0	0	14.11065	13.53141	0	0
P31415	CASQ1_HUMAN	"Calsequestrin-1 (Calmitine) (Calsequestrin, skeletal muscle isoform)"	CASQ1 CASQ	Homo sapiens (Human)	endoplasmic reticulum organization [GO:0007029]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of store-operated calcium channel activity [GO:1901341]; protein polymerization [GO:0051258]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of store-operated calcium entry [GO:2001256]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to heat [GO:0009408]; response to organic substance [GO:0010033]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; terminal cisterna lumen [GO:0014804]; Z disc [GO:0030018]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; terminal cisterna lumen [GO:0014804]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of store-operated calcium channel activity [GO:1901341]; protein polymerization [GO:0051258]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of store-operated calcium entry [GO:2001256]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to heat [GO:0009408]; response to organic substance [GO:0010033]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]	GO:0005509; GO:0005739; GO:0005759; GO:0005783; GO:0005790; GO:0005794; GO:0007029; GO:0007519; GO:0009408; GO:0010033; GO:0014804; GO:0014809; GO:0014894; GO:0016529; GO:0030018; GO:0030315; GO:0033017; GO:0033018; GO:0042802; GO:0045214; GO:0051258; GO:0051279; GO:0051281; GO:1901341; GO:2001256	SATDRMGPR	3.319999933	0.804740489	0.804740489	0.221906277	988.3514891	0	15.14279	0	15.11762	14.15429	14.38621	0	0	15.93306	14.71022	0	0	15.35815	0	16.39069	15.02111	15.40149	0	0	0	0	16.50266	0	16.24351	13.28745	15.73392	14.75768	14.88311	14.14704	15.21841	15.08179	14.85777	15.07483	13.2612	14.91956	13.95983	13.75719	15.83616	14.55589	12.6543	14.74549	17.32078	14.9065	13.03689	15.24766	14.9984	14.24029	13.30549
P31483	TIA1_HUMAN	"Cytotoxic granule associated RNA binding protein TIA1 (Nucleolysin TIA-1 isoform p40) (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1, TIA-1) (p40-TIA-1)"	TIA1	Homo sapiens (Human)	"apoptotic process [GO:0006915]; negative regulation of cytokine production [GO:0001818]; negative regulation of translation [GO:0017148]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; stress granule assembly [GO:0034063]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of cytokine production [GO:0001818]; negative regulation of translation [GO:0017148]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; stress granule assembly [GO:0034063]"	mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0000381; GO:0001818; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0008143; GO:0010494; GO:0017148; GO:0034063; GO:0035925; GO:0048024; GO:0097165; GO:1903608	AAFAPFGR	3.670000076	1	1	0.252095229	835.3538154	0	0	19.13787	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.39626	0	0	0	16.49909	18.4812	0	0	0	0	0	0	0	0	16.7101	17.35946	0	0	0	0	0	0	0	0	0	0	16.35385	0	0
P31629	ZEP2_HUMAN	"Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2, HIV-EP2) (MHC-binding protein 2, MBP-2)"	HIVEP2	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0046872	ACAKPSVLK	3.390000105	1	1	0.140894058	971.6666188	12.66181	15.01737	12.42766	0	0	0	0	0	9.571422	13.95131	0	0	0	0	0	15.34875	0	0	0	0	0	15.28054	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P31644	GBRA5_HUMAN	Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5)	GABRA5	Homo sapiens (Human)	"associative learning [GO:0008306]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	chloride channel complex [GO:0034707]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]	"chloride channel complex [GO:0034707]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; transporter activity [GO:0005215]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; transporter activity [GO:0005215]	GO:0001662; GO:0004890; GO:0005215; GO:0005237; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007420; GO:0007605; GO:0008306; GO:0022851; GO:0030594; GO:0032590; GO:0032809; GO:0034220; GO:0034707; GO:0038023; GO:0042391; GO:0043005; GO:0043524; GO:0045202; GO:0050811; GO:0050877; GO:0051932; GO:0060078; GO:0060119; GO:0060384; GO:0090102; GO:0098794; GO:0098982; GO:0099056; GO:0099060; GO:1902476; GO:1902711; GO:1904315	EVILNKSTNAFTTGK	6.670000076	1	1	0.427569239	1622.578469	14.3821	14.69711	0	17.43026	0	15.93455	0	12.21436	16.74065	0	0	12.71421	0	13.95535	0	0	15.10054	0	0	14.49163	0	0	0	0	0	0	0	0	0	0	0	0	17.08015	15.64668	0	0	0	17.68139	0	0	0	0	15.73341	0	15.67614	0	14.41282	15.10634
P31689	DNJA1_HUMAN	"DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2, HSJ-2) (Human DnaJ protein 2, hDj-2)"	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]	ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001664; GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0009408; GO:0015630; GO:0016020; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1903748; GO:1905259	GTGMQIR	8.670000076	0.005675995	0.005675995	0.227256546	779.2533295	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.67577	16.65579	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.01578	0	0	0	0	0	0	0	0	0	17.74759	0	18.17566	0	0	0	0
P31751	AKT2_HUMAN	"RAC-beta serine/threonine-protein kinase, EC 2.7.11.1 (Protein kinase Akt-2) (Protein kinase B beta, PKB beta) (RAC-PK-beta)"	AKT2	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001934; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0006417; GO:0006464; GO:0007165; GO:0008284; GO:0008286; GO:0008643; GO:0010748; GO:0010907; GO:0010918; GO:0018105; GO:0030334; GO:0030335; GO:0031340; GO:0032000; GO:0032287; GO:0032587; GO:0032869; GO:0032991; GO:0035556; GO:0043066; GO:0043231; GO:0045444; GO:0045725; GO:0046326; GO:0046872; GO:0051726; GO:0060644; GO:0065002; GO:0071486; GO:0072659; GO:0090314; GO:0090630; GO:0097473; GO:0106310; GO:2000147	CGSPSDSSTTEEMEVAVSKAR	2.470000029	0.09853588	0.09853588	0.116673975	2244.797846	19.86241	12.08189	17.09597	14.65707	0	0	15.26229	0	11.46877	17.09906	0	16.71559	12.94517	0	10.95577	0	0	17.42413	9.368748	17.28105	0	16.05973	0	17.02787	16.72805	0	13.23329	14.20586	0	0	0	0	16.54447	0	18.79686	0	0	14.47794	15.5737	14.20735	15.84711	0	14.87994	0	13.96235	0	0	16.98802
P31937	3HIDH_HUMAN	"3-hydroxyisobutyrate dehydrogenase, mitochondrial, HIBADH, EC 1.1.1.31"	HIBADH	Homo sapiens (Human)	valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574]"	"3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0016616; GO:0050661; GO:0051287	SVASKTPVGFIGLGNMGNPMAK	13.27000046	0.299686491	0.299686491	0.312750476	2192.39952	17.34487	15.59229	14.05554	14.66611	13.63975	14.17657	12.10709	0	11.26939	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.42737	0	0	0	0	0	19.18259	19.02341	17.42842	16.47952	11.43176	0	0	19.40459	0	0	0	0	0	14.04044	0	0	0	0
P31939	PUR9_HUMAN	"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase, ATIC) [Cleaved into: Bifunctional purine biosynthesis protein ATIC, N-terminally processed ] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase, EC 2.1.2.3 (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase, AICAR formyltransferase) (AICAR transformylase); Inosine 5'-monophosphate cyclohydrolase, IMP cyclohydrolase, EC 3.5.4.10 (IMP synthase) (Inosinicase) ]"	ATIC PURH OK/SW-cl.86	Homo sapiens (Human)	'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654]	cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]	GO:0003360; GO:0003937; GO:0004643; GO:0005829; GO:0005886; GO:0006139; GO:0006177; GO:0006189; GO:0009116; GO:0010035; GO:0016020; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0044208; GO:0045296; GO:0046452; GO:0046654; GO:0070062; GO:0097294; GO:0098761	GVSQMPLR	11.35000038	1	1	6.88E-13	883.7379278	0	16.53341	15.65392	0	0	17.41723	14.87954	15.23831	0	0	0	0	0	0	10.6898	0	0	0	0	0	0	0	0	0	0	12.71094	0	0	0	0	0	0	0	0	12.88514	0	0	0	0	0	14.42802	0	0	12.48739	0	0	0	9.944818
P31948	STIP1_HUMAN	"Stress-induced-phosphoprotein 1, STI1 (Hsc70/Hsp90-organizing protein, Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)"	STIP1	Homo sapiens (Human)	cellular response to interleukin-7 [GO:0098761]; protein folding [GO:0006457]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; protein folding [GO:0006457]	Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005794; GO:0005829; GO:0006457; GO:0030544; GO:0032991; GO:0051879; GO:0098761; GO:0101031; GO:0120293	KAAALEAMK	2.640000105	0.923701942	0.923701942	0.236643717	935.078134	13.46296	15.69988	0	14.72041	0	15.00213	0	0	0	0	14.86391	0	0	0	13.89784	0	14.56939	14.84703	13.74596	0	13.7408	0	0	16.59318	0	0	0	0	0	0	0	16.37254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.94316	0
P31997	CEAM8_HUMAN	Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b)	CEACAM8 CGM6	Homo sapiens (Human)	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]	anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; protein heterodimerization activity [GO:0046982]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]	protein heterodimerization activity [GO:0046982]	GO:0005615; GO:0005886; GO:0006955; GO:0007157; GO:0009986; GO:0031225; GO:0035577; GO:0035579; GO:0046982; GO:0070062; GO:0070821	ATVSIMIGVLAR	10.22000027	1	1	0.334986026	1247.712976	0	12.82627	12.89954	0	0	0	0	0	0	0	0	0	16.59638	14.5035	0	0	15.86734	0	0	17.16322	0	0	17.87452	0	0	0	0	0	15.36352	0	0	13.97843	0	14.55794	0	17.24986	0	0	0	15.26431	14.10969	16.45466	0	17.73489	0	13.20672	18.74496	0
P32004	L1CAM_HUMAN	"Neural cell adhesion molecule L1, N-CAM-L1, NCAM-L1 (CD antigen CD171)"	L1CAM CAML1 MIC5	Homo sapiens (Human)	axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; protein domain specific binding [GO:0019904]; axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808]	axon guidance receptor activity [GO:0008046]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005925; GO:0006935; GO:0007155; GO:0007156; GO:0007160; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0016021; GO:0016477; GO:0019904; GO:0030424; GO:0030425; GO:0031175; GO:0043025; GO:0044295; GO:0045773; GO:0050808; GO:0061564; GO:0062023	TNGTGRVR	5.150000095	0.780909717	0.780909717	0.260257653	859.1024224	16.63042	15.04756	17.12413	16.32662	0	14.90902	0	16.60287	16.22883	15.59382	16.16397	15.67048	0	0	16.37923	0	14.81382	17.0398	16.24617	0	15.3599	0	0	0	16.46115	0	0	13.7739	16.16849	0	0	16.39326	18.23135	0	15.42044	15.29692	0	0	15.16319	14.31939	18.96354	12.85613	0	0	15.47779	0	15.51207	17.97952
P32019	I5P2_HUMAN	"Type II inositol 1,4,5-trisphosphate 5-phosphatase, EC 3.1.3.36 (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase, 5PTase)"	INPP5B OCRL2	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]"	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]"	GO:0001701; GO:0004439; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007283; GO:0016020; GO:0016021; GO:0030317; GO:0030670; GO:0031901; GO:0043647; GO:0046855; GO:0046856; GO:0046872; GO:0052658; GO:0052659; GO:0070613	AVSEGLHPDAK	8.619999886	1	1	0.043671542	1119.888521	0	0	18.05671	0	0	0	0	0	14.91265	0	0	14.89682	0	0	0	0	0	0	0	0	0	0	0	0	15.42754	16.45808	0	0	0	0	0	0	14.61431	14.05477	0	0	0	0	0	0	0	0	0	14.85148	0	0	0	0
P32238	CCKAR_HUMAN	"Cholecystokinin receptor type A, CCK-A receptor, CCK-AR (Cholecystokinin-1 receptor, CCK1-R)"	CCKAR CCKRA	Homo sapiens (Human)	axonogenesis [GO:0007409]; cholecystokinin signaling pathway [GO:0038188]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of hormone secretion [GO:0046883]	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; axonogenesis [GO:0007409]; cholecystokinin signaling pathway [GO:0038188]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of hormone secretion [GO:0046883]	cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]	GO:0001764; GO:0004930; GO:0004951; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007409; GO:0016020; GO:0017046; GO:0030900; GO:0038188; GO:0046883	LELRQLSTGSSSR	7.809999943	0.783611357	0.783611357	0.179292918	1433.649803	14.13095	16.07453	0	0	0	11.35327	15.38188	14.76256	0	0	0	0	0	15.37733	0	0	0	13.95386	0	0	0	0	0	0	0	0	0	13.24746	15.07181	8.982446	0	14.11217	0	0	16.13777	15.13739	14.79983	0	0	14.65809	0	0	0	13.85206	0	0	0	0
P32241	VIPR1_HUMAN	"Vasoactive intestinal polypeptide receptor 1, VIP-R-1 (Pituitary adenylate cyclase-activating polypeptide type II receptor, PACAP type II receptor, PACAP-R-2, PACAP-R2) (VPAC1)"	VIPR1	Homo sapiens (Human)	"adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of cell population proliferation [GO:0008284]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of cell population proliferation [GO:0008284]"	G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]	GO:0004999; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007187; GO:0007188; GO:0008284; GO:0008528; GO:0017046; GO:0043235	SSSFQAEVSLV	8.510000229	1	1	0.17427039	1152.628833	0	14.73993	14.94607	14.4579	14.2638	12.89766	15.08214	13.73525	9.172163	15.24465	15.0856	16.08663	14.15061	15.31639	0	0	0	15.0158	0	0	0	0	0	0	0	0	0	15.89319	0	0	0	15.75776	16.37257	0	13.72566	0	14.38809	0	0	0	14.89301	0	0	0	0	0	13.73144	0
P32242	OTX1_HUMAN	Homeobox protein OTX1 (Orthodenticle homolog 1)	OTX1	Homo sapiens (Human)	anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030901; GO:0042472; GO:0045944; GO:0048852; GO:1990837	CRQQQQSGSGTK	3.529999971	1	1	0.669120429	1364.393126	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P32248	CCR7_HUMAN	"C-C chemokine receptor type 7, C-C CKR-7, CC-CKR-7, CCR-7 (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1, EBI1, EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197)"	CCR7 CMKBR7 EBI1 EVI1	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte migration into lymph node [GO:0097022]; mature conventional dendritic cell differentiation [GO:0097029]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interleukin-12 production [GO:0032695]; negative thymic T cell selection [GO:0045060]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation [GO:2000526]; positive regulation of humoral immune response [GO:0002922]; positive regulation of hypersensitivity [GO:0002885]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of T cell costimulation [GO:2000525]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of dendritic cell dendrite assembly [GO:2000547]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-1 beta production [GO:0032651]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-C motif chemokine 19 receptor activity [GO:0038117]; C-C motif chemokine 21 receptor activity [GO:0038121]; chemokine (C-C motif) ligand 19 binding [GO:0035757]; chemokine (C-C motif) ligand 21 binding [GO:0035758]; G protein-coupled receptor activity [GO:0004930]; activation of GTPase activity [GO:0090630]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte migration into lymph node [GO:0097022]; mature conventional dendritic cell differentiation [GO:0097029]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interleukin-12 production [GO:0032695]; negative thymic T cell selection [GO:0045060]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation [GO:2000526]; positive regulation of humoral immune response [GO:0002922]; positive regulation of hypersensitivity [GO:0002885]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of T cell costimulation [GO:2000525]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of dendritic cell dendrite assembly [GO:2000547]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-1 beta production [GO:0032651]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-C motif chemokine 19 receptor activity [GO:0038117]; C-C motif chemokine 21 receptor activity [GO:0038121]; chemokine (C-C motif) ligand 19 binding [GO:0035757]; chemokine (C-C motif) ligand 21 binding [GO:0035758]; G protein-coupled receptor activity [GO:0004930]	GO:0001768; GO:0001954; GO:0002407; GO:0002408; GO:0002606; GO:0002885; GO:0002922; GO:0004930; GO:0005739; GO:0005886; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0009986; GO:0016021; GO:0016493; GO:0019722; GO:0019957; GO:0030838; GO:0031274; GO:0031529; GO:0032496; GO:0032649; GO:0032651; GO:0032695; GO:0032735; GO:0034695; GO:0035757; GO:0035758; GO:0038117; GO:0038121; GO:0043123; GO:0043552; GO:0045060; GO:0045785; GO:0045860; GO:0046330; GO:0048872; GO:0050862; GO:0051209; GO:0051491; GO:0051897; GO:0060326; GO:0070374; GO:0071345; GO:0071731; GO:0090023; GO:0090630; GO:0097022; GO:0097029; GO:2000147; GO:2000510; GO:2000522; GO:2000525; GO:2000526; GO:2000547; GO:2000669	MDLGKPMK	6.769999981	0.91098237	0.91098237	0.103342197	934.7156174	0	0	12.24507	13.48662	0	0	0	0	14.95552	0	0	0	15.33173	0	0	7.780131	15.42387	0	15.29773	0	14.13477	0	0	14.88941	0	0	0	0	0	14.93777	0	0	0	11.75554	13.49058	0	0	0	15.10545	0	0	0	14.01921	0	0	0	0	0
P32249	GP183_HUMAN	"G-protein coupled receptor 183 (Epstein-Barr virus-induced G-protein coupled receptor 2, EBI2, EBV-induced G-protein coupled receptor 2, hEBI2)"	GPR183 EBI2	Homo sapiens (Human)	adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; dendritic cell chemotaxis [GO:0002407]; dendritic cell homeostasis [GO:0036145]; G protein-coupled receptor signaling pathway [GO:0007186]; humoral immune response [GO:0006959]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; mature B cell differentiation involved in immune response [GO:0002313]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of astrocyte chemotaxis [GO:2000458]; T cell chemotaxis [GO:0010818]; T follicular helper cell differentiation [GO:0061470]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; dendritic cell chemotaxis [GO:0002407]; dendritic cell homeostasis [GO:0036145]; G protein-coupled receptor signaling pathway [GO:0007186]; humoral immune response [GO:0006959]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; mature B cell differentiation involved in immune response [GO:0002313]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of astrocyte chemotaxis [GO:2000458]; T cell chemotaxis [GO:0010818]; T follicular helper cell differentiation [GO:0061470]	G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]	GO:0002250; GO:0002312; GO:0002313; GO:0002407; GO:0004930; GO:0005886; GO:0005887; GO:0006955; GO:0006959; GO:0007186; GO:0008142; GO:0010818; GO:0030316; GO:0030595; GO:0030890; GO:0036145; GO:0061470; GO:0070374; GO:2000458	LFRTAK	8.109999657	1	1	0.121059623	734.5615451	15.71476	12.03742	14.74505	14.8034	16.01896	14.44973	14.81648	16.43636	15.34868	12.22449	14.76235	14.14128	0	0	15.94793	15.36905	0	0	15.57477	0	0	0	0	15.65544	0	0	0	0	0	0	0	0	0	0	0	0	16.5273	0	0	0	0	0	0	0	0	0	15.94241	0
P32298	GRK4_HUMAN	"G protein-coupled receptor kinase 4, EC 2.7.11.16 (G protein-coupled receptor kinase GRK4) (ITI1)"	GRK4 GPRK2L GPRK4	Homo sapiens (Human)	protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]	GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0007165; GO:0008277; GO:0009966; GO:0022400; GO:0031623; GO:0050254; GO:0097381	MYACKK	2.279999971	1	1	0.282060679	800.5884482	19.467	0	0	16.12736	0	16.41208	0	18.51824	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.43785	18.19177	17.77588	0	0	19.06111	0	0	0	0	0	0	18.85913	16.66084	0	0	17.39035	0	0
P32314	FOXN2_HUMAN	Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor)	FOXN2 HTLF	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]"	chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0035914; GO:0043231; GO:1990837	MGPVIGMTPDKR	8.050000191	0.665376902	0.665376902	0.336182411	1317.320571	12.33784	15.95181	0	0	15.21252	0	0	13.01972	13.22465	15.08594	15.2447	13.86196	0	15.70421	0	13.06323	0	0	16.42169	0	16.02439	0	14.74131	13.60663	16.76346	0	0	0	14.69383	0	0	0	0	0	0	0	0	16.16324	0	0	15.04179	14.26992	0	0	0	0	0	0
P32321	DCTD_HUMAN	"Deoxycytidylate deaminase, EC 3.5.4.12 (dCMP deaminase)"	DCTD	Homo sapiens (Human)	dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; pyrimidine nucleotide metabolic process [GO:0006220]	cytosol [GO:0005829]	cytosol [GO:0005829]; dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; pyrimidine nucleotide metabolic process [GO:0006220]	dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0004132; GO:0005829; GO:0006220; GO:0006226; GO:0006231; GO:0008270; GO:0042802	SEVSCKK	3.00999999	1	1	0.209609564	840.7418286	15.13895	15.46295	0	16.81213	0	0	15.17746	16.55529	18.05901	0	15.60595	15.75923	0	14.68914	16.16538	0	0	0	0	0	0	0	0	0	0	0	0	15.8329	14.76708	0	0	16.51697	17.0958	0	0	0	17.5372	15.47713	15.90972	16.71054	0	0	14.80726	15.87741	0	15.20196	0	0
P32418	NAC1_HUMAN	Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)	SLC8A1 CNC NCX1	Homo sapiens (Human)	calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; cytosolic calcium ion transport [GO:0060401]; ion transport [GO:0006811]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; metal ion transport [GO:0030001]; muscle contraction [GO:0006936]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of bone mineralization [GO:0030501]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]; vascular associated smooth muscle contraction [GO:0014829]	axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]	axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; transmembrane transporter binding [GO:0044325]; calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; cytosolic calcium ion transport [GO:0060401]; ion transport [GO:0006811]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; metal ion transport [GO:0030001]; muscle contraction [GO:0006936]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of bone mineralization [GO:0030501]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]; vascular associated smooth muscle contraction [GO:0014829]	ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; transmembrane transporter binding [GO:0044325]	GO:0002026; GO:0002027; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0006883; GO:0006936; GO:0007584; GO:0008092; GO:0009410; GO:0009749; GO:0010468; GO:0010649; GO:0010763; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0014829; GO:0015491; GO:0016020; GO:0021537; GO:0030001; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030501; GO:0030506; GO:0033198; GO:0034614; GO:0035725; GO:0035902; GO:0035994; GO:0036376; GO:0042383; GO:0042542; GO:0043025; GO:0043197; GO:0043198; GO:0043679; GO:0044325; GO:0044557; GO:0045202; GO:0051481; GO:0055013; GO:0055074; GO:0055119; GO:0060048; GO:0060401; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0071456; GO:0071901; GO:0071944; GO:0086012; GO:0086064; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:0099055; GO:0099580; GO:1901660; GO:1903779; GO:1905060	EITIK	10.77000046	1	1	0.36319251	602.081034	0	15.51277	0	16.41039	0	0	15.53092	0	16.40648	0	0	16.28139	0	0	16.45623	0	0	16.71488	16.71406	0	17.12329	17.13085	0	0	15.75047	0	16.69158	0	0	14.70383	0	0	0	15.56396	0	0	16.41121	0	0	0	0	0	17.16035	15.7427	0	15.31151	0	0
P32455	GBP1_HUMAN	"Guanylate-binding protein 1, EC 3.6.5.- (GTP-binding protein 1, GBP-1, HuGBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1)"	GBP1	Homo sapiens (Human)	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein localization to vacuole [GO:0072665]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein localization to plasma membrane [GO:1903076]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein localization to vacuole [GO:0072665]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein localization to plasma membrane [GO:1903076]	actin binding [GO:0003779]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507]	GO:0000139; GO:0003779; GO:0003924; GO:0005525; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0012506; GO:0015629; GO:0019003; GO:0019899; GO:0019955; GO:0030507; GO:0031410; GO:0032703; GO:0042802; GO:0042803; GO:0050848; GO:0050860; GO:0051607; GO:0051879; GO:0070373; GO:0071346; GO:0071347; GO:0071356; GO:0072665; GO:1900025; GO:1903076; GO:1903077	KCFVFDRPVHR	14.52999973	0.613608778	0.613608778	0.346804008	1460.914193	24.15809	23.70652	19.17202	24.00822	0	20.81191	18.78517	23.69541	23.57257	21.65736	20.19261	19.8013	24.1816	17.27866	23.28447	19.27511	22.14352	18.73712	23.16518	17.81815	22.38601	15.60749	23.5218	18.76335	19.42748	0	23.67548	18.30952	0	18.40166	17.96951	18.8555	21.25859	24.65096	24.03484	24.38722	21.63239	22.85222	23.75747	19.53605	17.99763	19.58674	23.5098	23.23439	18.48552	18.82818	0	21.56064
P32456	GBP2_HUMAN	"Guanylate-binding protein 2, EC 3.6.5.- (GTP-binding protein 2, GBP-2, HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)"	GBP2	Homo sapiens (Human)	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; protein localization to nucleus [GO:0034504]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0031410; GO:0034504; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0071346; GO:0071347; GO:0071356	ILSAITQPVVVVAIVGLYRTGK	9.319999695	1	1	0.224726483	2299.026903	15.88145	0	14.07225	0	20.93835	0	14.57548	0	0	14.44313	0	0	0	0	0	0	15.79462	20.99292	0	0	0	0	15.45264	14.05856	0	0	0	0	0	0	0	19.36364	0	0	0	0	0	0	0	0	20.85575	0	0	0	0	0	0	0
P32519	ELF1_HUMAN	ETS-related transcription factor Elf-1 (E74-like factor 1)	ELF1	Homo sapiens (Human)	"cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001817; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0045893; GO:0045944; GO:0050860; GO:1990837	AAKPK	3.039999962	0.706035733	0.706035733	0.222791083	514.4274588	13.88716	15.04667	14.08838	15.77502	14.82356	0	15.54942	0	12.81894	0	15.6892	14.95569	0	0	14.05746	16.05588	14.90574	0	14.91447	15.48847	14.33319	0	15.6615	0	0	14.90603	0	0	0	0	0	0	15.2233	0	0	0	0	0	0	16.61971	0	0	15.7914	0	15.71672	16.74388	15.17606	15.68407
P32926	DSG3_HUMAN	"Desmoglein-3 (130 kDa pemphigus vulgaris antigen, PVA) (Cadherin family member 6)"	DSG3 CDHF6	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0001533; GO:0005509; GO:0005829; GO:0005886; GO:0005911; GO:0007156; GO:0016021; GO:0030057; GO:0070062; GO:0098609	TNEGILKVVK	2.029999971	1	1	0.285213053	1100.775735	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.7381	0	0	0	0	16.90659	0	0	0	0	0	0	17.34679	0	0	17.82435	0	0	18.86126	0	0	0	0	0	0	0	0	0	0	0	0	0
P32971	TNFL8_HUMAN	"Tumor necrosis factor ligand superfamily member 8 (CD30 ligand, CD30-L) (CD antigen CD153)"	TNFSF8 CD30L CD30LG	Homo sapiens (Human)	"CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell proliferation [GO:0042129]"	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell proliferation [GO:0042129]"	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0007267; GO:0042129; GO:0043374; GO:0045944; GO:0050830	DGILHGVR	3.700000048	0.891243219	0.891243219	0.242023627	868.2859691	13.29235	15.83342	12.76633	13.62849	0	0	17.59521	0	0	16.00855	16.72816	0	12.27819	0	0	14.88258	0	0	16.73722	0	0	0	0	14.84671	0	17.24056	0	15.92898	14.97303	15.76521	0	15.44644	17.60415	0	0	15.74294	16.58868	15.67549	0	17.1014	0	15.61287	0	0	0	0	0	15.36747
P33121	ACSL1_HUMAN	"Long-chain-fatty-acid--CoA ligase 1, EC 6.2.1.3 (Acyl-CoA synthetase 1, ACS1) (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1, LACS 1) (Long-chain acyl-CoA synthetase 2, LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase, EC 6.2.1.24)"	ACSL1 FACL1 FACL2 LACS LACS1 LACS2	Homo sapiens (Human)	adiponectin-activated signaling pathway [GO:0033211]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oleoyl-CoA ligase activity [GO:0090434]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]	arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oleoyl-CoA ligase activity [GO:0090434]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]	GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0007584; GO:0008610; GO:0010747; GO:0014070; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0044539; GO:0047676; GO:0050197; GO:0070251; GO:0071902; GO:0090434; GO:0120162	GAMVTHR	3.059999943	0.444636703	0.444636703	0.120170281	788.4624632	17.03327	11.14578	16.12272	15.52839	12.374	0	12.29546	14.30175	14.94466	0	13.76528	0	13.38128	14.50863	0	14.6786	16.08467	15.35315	17.25468	0	0	17.53561	14.11111	15.19232	13.6782	0	16.3126	16.67356	15.71517	10.60936	0	0	17.62555	0	11.45811	0	17.11877	0	15.57034	16.36448	0	0	15.6065	0	15.5245	15.88509	14.44829	0
P33151	CADH5_HUMAN	"Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin, VE-cadherin) (CD antigen CD144)"	CDH5	Homo sapiens (Human)	adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; blood vessel endothelial cell migration [GO:0043534]; blood vessel maturation [GO:0001955]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to bicellular tight junction [GO:1902396]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein phosphorylation [GO:0001932]; regulation of vascular permeability [GO:0043114]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculature development [GO:0001944]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; fibrinogen binding [GO:0070051]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; blood vessel endothelial cell migration [GO:0043534]; blood vessel maturation [GO:0001955]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to bicellular tight junction [GO:1902396]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein phosphorylation [GO:0001932]; regulation of vascular permeability [GO:0043114]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculature development [GO:0001944]	beta-catenin binding [GO:0008013]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; fibrinogen binding [GO:0070051]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	GO:0000902; GO:0001932; GO:0001944; GO:0001955; GO:0005102; GO:0005509; GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0006874; GO:0007043; GO:0007156; GO:0007179; GO:0008013; GO:0008285; GO:0009897; GO:0009986; GO:0010628; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0019903; GO:0030054; GO:0030335; GO:0030513; GO:0031115; GO:0031334; GO:0031965; GO:0034332; GO:0035307; GO:0035633; GO:0043114; GO:0043184; GO:0043534; GO:0044325; GO:0044331; GO:0045296; GO:0045766; GO:0050728; GO:0070051; GO:0070700; GO:0070830; GO:0098609; GO:0098742; GO:1902396; GO:1903142; GO:1990782; GO:2000114; GO:2000352	GKEYFAIDNSGR	18.21999931	1	1	0.36458655	1357.768931	16.43885	16.57498	15.53297	16.11377	0	16.92084	16.72491	17.12971	0	16.04331	16.9198	16.38179	0	16.17942	0	0	0	0	16.81629	0	16.92482	0	16.78313	18.52339	0	0	17.51875	16.68847	15.61153	0	0	13.8111	17.07385	15.94279	16.1976	17.06212	16.57844	15.82713	0	0	0	0	16.45255	15.94814	17.09357	0	0	17.04384
P33176	KINH_HUMAN	"Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain, UKHC)"	KIF5B KNS KNS1	Homo sapiens (Human)	"anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; natural killer cell mediated cytotoxicity [GO:0042267]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]"	axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]	"axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; natural killer cell mediated cytotoxicity [GO:0042267]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0003777; GO:0005524; GO:0005765; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007028; GO:0007411; GO:0008017; GO:0008574; GO:0016020; GO:0016887; GO:0030705; GO:0031982; GO:0032230; GO:0032418; GO:0032839; GO:0034451; GO:0035253; GO:0035617; GO:0042267; GO:0042391; GO:0042802; GO:0043268; GO:0045296; GO:0045335; GO:0047496; GO:0048471; GO:0048489; GO:0051642; GO:0071346; GO:0072383; GO:0098971; GO:0099641; GO:1903078; GO:1904115; GO:1990048; GO:1990049	AAEMMASLLK	8.470000267	1	1	0.111774686	1095.559293	0	16.2752	15.73716	13.12809	17.10811	0	12.06922	15.47204	0	0	17.10444	16.53126	15.68961	0	0	14.01845	12.74744	16.45202	14.06819	0	15.85982	0	14.38994	14.27898	17.56816	16.63058	0	15.07557	11.15821	0	15.97363	20.53679	16.81482	16.77153	14.32081	16.9137	0	13.23389	15.92925	15.88728	0	16.87916	0	0	0	0	13.71939	0
P33241	LSP1_HUMAN	"Lymphocyte-specific protein 1 (47 kDa actin-binding protein) (52 kDa phosphoprotein, pp52) (Lymphocyte-specific antigen WP34)"	LSP1 WP34	Homo sapiens (Human)	cellular defense response [GO:0006968]; cellular response to interleukin-7 [GO:0098761]; chemotaxis [GO:0006935]; signal transduction [GO:0007165]	actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cellular defense response [GO:0006968]; cellular response to interleukin-7 [GO:0098761]; chemotaxis [GO:0006935]; signal transduction [GO:0007165]	actin binding [GO:0003779]	GO:0003779; GO:0005886; GO:0006935; GO:0006968; GO:0007165; GO:0015629; GO:0016020; GO:0070062; GO:0098761	VLVEGGPAP	5.510000229	1	1	0.281024816	837.9689396	15.42486	0	16.51301	15.395	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.3053	18.50182	19.42141	0	18.61782	0	18.36986	0	0	0	0	17.71802	0	0	0	0
P33527	MRP1_HUMAN	"Multidrug resistance-associated protein 1, EC 7.6.2.2 (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1, EC 7.6.2.3) (Leukotriene C(4) transporter, LTC4 transporter)"	ABCC1 MRP MRP1	Homo sapiens (Human)	carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; heme catabolic process [GO:0042167]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; hydrolase activity [GO:0016787]; xenobiotic transmembrane transporter activity [GO:0042910]; carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; heme catabolic process [GO:0042167]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962]	ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; hydrolase activity [GO:0016787]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0008559; GO:0009235; GO:0009410; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016787; GO:0034040; GO:0034599; GO:0034634; GO:0034775; GO:0042167; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0045332; GO:0046943; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646; GO:1905039; GO:1990962	VEGHVAIK	1.899999976	1	1	0.211494453	853.6975816	12.58715	0	15.07251	0	0	14.5964	14.95041	13.89047	14.3118	15.32274	0	14.46493	0	0	0	15.45725	0	14.91783	15.10598	16.44697	16.82674	0	0	0	16.34739	0	0	0	14.85047	16.0962	0	14.73666	0	0	0	16.04525	0	0	0	15.65238	0	15.99552	13.4084	15.61384	14.83624	0	15.66546	0
P33763	S10A5_HUMAN	Protein S100-A5 (Protein S-100D) (S100 calcium-binding protein A5)	S100A5 S100D	Homo sapiens (Human)		neuronal cell body [GO:0043025]; nucleus [GO:0005634]	neuronal cell body [GO:0043025]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; copper ion binding [GO:0005507]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; copper ion binding [GO:0005507]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005507; GO:0005509; GO:0005634; GO:0008270; GO:0042803; GO:0043025; GO:0048306	ELCLGEMKESSIDDLMK	2.410000086	1	1	0.321271045	2000.78728	15.90704	0	0	12.06299	0	15.05211	0	0	0	0	17.90049	0	15.02811	0	0	0	0	13.46564	0	0	0	14.27721	0	0	0	0	17.52284	0	15.37464	16.27715	0	0	0	0	0	0	0	16.79458	0	13.86704	15.6957	0	0	14.08494	14.93854	0	0	0
P33981	TTK_HUMAN	"Dual specificity protein kinase TTK, EC 2.7.12.1 (Phosphotyrosine picked threonine-protein kinase, PYT)"	TTK MPS1 MPS1L1	Homo sapiens (Human)	chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]; spindle organization [GO:0007051]	cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]	cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]; spindle organization [GO:0007051]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0000776; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0007052; GO:0007059; GO:0007094; GO:0008284; GO:0010862; GO:0016020; GO:0016321; GO:0018105; GO:0018107; GO:0033316; GO:0034501; GO:0042802; GO:0043515; GO:0046777; GO:0051304; GO:0106310; GO:1903096	DYFQMARANCK	9.199999809	1	1	0.473257943	1417.965998	0	0	0	18.8041	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.87129
P33991	MCM4_HUMAN	"DNA replication licensing factor MCM4, EC 3.6.4.12 (CDC21 homolog) (P1-CDC21)"	MCM4 CDC21	Homo sapiens (Human)	DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006268; GO:0006271; GO:0016020; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975	DFSHTGRGK	20.75	0.64206928	0.64206928	0.237699888	1007.723073	0	0	14.9242	0	0	16.61162	0	15.37801	0	0	0	0	15.85975	0	15.32319	0	0	15.00051	0	16.56265	0	0	16.72969	0	0	14.43517	17.61842	14.44992	0	15.75815	17.08453	0	13.9243	0	14.42967	0	0	16.7124	0	0	0	0	14.79831	0	0	0	0	15.79594
P33993	MCM7_HUMAN	"DNA replication licensing factor MCM7, EC 3.6.4.12 (CDC47 homolog) (P1.1-MCM3)"	MCM7 CDC47 MCM2	Homo sapiens (Human)	cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of phosphorylation [GO:0042325]	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of phosphorylation [GO:0042325]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000781; GO:0000785; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006268; GO:0006270; GO:0006271; GO:0006974; GO:0007049; GO:0008283; GO:0016020; GO:0016887; GO:0030174; GO:0042325; GO:0042555; GO:0071162; GO:0071364; GO:0071466	SQYTTGR	9.090000153	0.341144562	0.341144562	0.049458748	810.4987717	16.03207	16.35446	17.10339	16.36881	12.34711	0	17.16894	16.25809	14.51498	18.31243	16.82355	14.2849	16.79791	0	0	14.75329	15.12676	16.87949	15.51395	13.35999	13.83496	0	17.88244	18.80441	17.77974	17.21157	16.98516	0	18.70345	17.40975	16.01677	0	17.42756	0	15.74547	0	17.01605	17.11146	0	15.38811	17.93505	17.61136	16.58391	12.77652	17.15562	16.60155	15.22583	15.66098
P34059	GALNS_HUMAN	"N-acetylgalactosamine-6-sulfatase, EC 3.1.6.4 (Chondroitinsulfatase, Chondroitinase) (Galactose-6-sulfate sulfatase, GalN6S) (N-acetylgalactosamine-6-sulfate sulfatase, GalNAc6S sulfatase)"	GALNS	Homo sapiens (Human)		azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]	GO:0003943; GO:0004065; GO:0005576; GO:0008484; GO:0035578; GO:0043202; GO:0043890; GO:0046872; GO:0070062	GRYGDAVR	2.269999981	0.336799055	0.336799055	0.179127332	894.5432797	0	15.18186	13.39258	0	0	16.62181	16.54004	13.92691	0	0	0	0	0	0	0	0	13.35721	16.05369	0	15.83873	14.75222	0	0	0	0	0	0	13.99815	15.44643	15.37718	15.21338	0	12.10742	10.48007	14.00742	0	0	15.79265	15.48028	13.27641	11.08557	14.97831	0	0	14.49102	15.3222	10.28125	0
P34897	GLYM_HUMAN	"Serine hydroxymethyltransferase, mitochondrial, SHMT, EC 2.1.2.1 (Glycine hydroxymethyltransferase) (Serine methylase)"	SHMT2	Homo sapiens (Human)	folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]"	"chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]"	GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006565; GO:0006730; GO:0008270; GO:0009113; GO:0015630; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715	TGREIPYTFEDR	13.82999992	0.731046259	0.731046259	0.038278594	1483.662269	16.15674	15.5222	13.271	0	13.73878	14.62504	15.92109	15.8372	15.75044	0	0	0	16.48399	14.90581	0	0	0	12.65737	13.84151	0	0	0	0	17.47245	0	12.94777	14.59578	10.70582	15.16499	14.39544	14.83459	14.4403	0	15.53508	0	14.14405	0	12.59274	0	0	13.14016	16.48508	0	13.03209	0	0	0	0
P34903	GBRA3_HUMAN	Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3)	GABRA3	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]	"chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	benzodiazepine receptor activity [GO:0008503]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0004890; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315	FDGPMK	15.84000015	0.427481592	0.427481592	0.247526265	710.0315251	14.39392	17.72525	17.48738	0	0	0	0	15.09816	17.09598	0	0	0	17.19892	18.01062	0	0	0	17.82644	14.41169	16.24464	0	0	16.35679	0	16.28691	0	0	0	14.47976	16.24357	18.15187	16.55865	0	0	0	0	18.06473	16.92054	0	0	18.49981	0	14.72763	0	0	0	0	0
P34913	HYES_HUMAN	"Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2, CEH, EC 3.3.2.10 (Epoxide hydratase) (Soluble epoxide hydrolase, SEH); Lipid-phosphate phosphatase, EC 3.1.3.76 ]"	EPHX2	Homo sapiens (Human)	cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272]	10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]	GO:0000287; GO:0004301; GO:0005777; GO:0005782; GO:0005829; GO:0009636; GO:0010628; GO:0015643; GO:0016311; GO:0016787; GO:0016791; GO:0033885; GO:0042577; GO:0042632; GO:0042803; GO:0046272; GO:0046839; GO:0052642; GO:0070062; GO:0090181; GO:0097176	GLLNDAFQKGGPEGATTR	1.309999943	0.940174758	0.940174758	0.165208354	1832.30081	0	0	0	0	0	0	0	0	14.73522	0	14.59937	0	0	0	0	0	13.31646	0	0	0	0	17.4262	0	15.54394	14.94055	0	0	0	0	0	0	15.18941	0	0	0	0	0	12.70881	0	0	0	0	0	0	0	16.53939	0	0
P34925	RYK_HUMAN	"Tyrosine-protein kinase RYK, EC 2.7.10.1"	RYK JTK5A	Homo sapiens (Human)	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]"	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; kinase activity [GO:0016301]; transmembrane signaling receptor activity [GO:0004888]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016301; GO:0017147; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953	EKQAFVK	14.92000008	0.005167995	0.005167995	0.25686196	848.9361867	0	18.30803	0	15.43806	0	0	0	0	16.74264	0	0	0	0	0	0	0	15.26115	0	0	15.32293	0	17.06051	0	0	0	0	18.47084	16.46911	13.95286	0	16.72163	18.71352	0	14.29584	16.59493	16.8305	17.07869	0	17.56519	0	0	0	0	0	0	15.33955	15.65238	17.31669
P34931	HS71L_HUMAN	"Heat shock 70 kDa protein 1-like, Heat shock 70 kDa protein 1L (Heat shock 70 kDa protein 1-Hom, HSP70-Hom)"	HSPA1L	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	blood microparticle [GO:0072562]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]	blood microparticle [GO:0072562]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006986; GO:0007339; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0044297; GO:0051082; GO:0051085; GO:0051787; GO:0072562; GO:1903955	DAKMDK	6.659999847	0.738773048	0.738773048	3.19E-12	724.7631955	15.89464	14.63874	11.90653	12.3748	14.36802	11.2843	14.00188	14.07067	14.66866	14.51804	16.32074	0	16.39539	0	14.61523	16.98964	16.69501	14.35211	14.20608	13.50053	15.00756	16.7883	14.9072	15.74051	12.7714	16.12	16.99414	10.00959	13.68416	14.14942	15.10106	14.55143	14.64201	16.26328	14.21713	15.8807	0	17.09874	11.4407	0	11.9383	13.46287	15.93777	13.88465	17.6327	14.72116	15.38508	14.52849
P34932	HSP74_HUMAN	Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2)	HSPA4 APG2	Homo sapiens (Human)	chaperone-mediated protein complex assembly [GO:0051131]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone-mediated protein complex assembly [GO:0051131]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006986; GO:0016887; GO:0045040; GO:0051131; GO:0070062	VEPPLR	18.67000008	0.000350627	0.000350627	0.263276766	710.3050134	0	0	0	17.77026	18.0766	17.48187	18.30046	0	16.86969	0	16.73072	0	17.5856	0	15.94323	0	16.93385	18.28366	0	0	0	18.1386	0	15.87365	0	20.20675	19.38611	17.58371	16.64479	16.10994	0	18.55553	18.70013	18.57315	0	0	0	0	0	17.3091	16.00175	18.0657	0	0	0	15.88797	0	0
P34972	CNR2_HUMAN	"Cannabinoid receptor 2, CB-2, CB2, hCB2 (CX5)"	CNR2 CB2A CB2B	Homo sapiens (Human)	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; leukocyte chemotaxis [GO:0030595]; negative regulation of action potential [GO:0045759]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation [GO:0033004]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; regulation of metabolic process [GO:0019222]; response to amphetamine [GO:0001975]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; leukocyte chemotaxis [GO:0030595]; negative regulation of action potential [GO:0045759]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation [GO:0033004]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; regulation of metabolic process [GO:0019222]; response to amphetamine [GO:0001975]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]"	cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930]	GO:0001975; GO:0004930; GO:0004949; GO:0005737; GO:0005783; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007187; GO:0007189; GO:0019222; GO:0019233; GO:0030425; GO:0030595; GO:0031234; GO:0032229; GO:0032496; GO:0033004; GO:0038171; GO:0043204; GO:0045759; GO:0050728; GO:0051001	SSVTETEADGK	11.97999954	1	1	0.063488867	1127.358841	13.75952	0	0	0	0	0	0	0	0	0	0	0	0	0	15.82614	15.75529	0	0	0	15.65036	0	11.27263	0	13.83111	0	0	0	0	0	0	0	14.39788	15.14739	14.34293	14.43659	0	0	0	0	7.502865	14.26281	0	0	0	10.20111	0	0	0
P35222	CTNB1_HUMAN	Catenin beta-1 (Beta-catenin)	CTNNB1 CTNNB OK/SW-cl.35 PRO2286	Homo sapiens (Human)	"adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal stem cell differentiation [GO:0072497]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell differentiation [GO:0045597]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]"	"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]"	"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear receptor binding [GO:0016922]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transmembrane transporter binding [GO:0044325]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal stem cell differentiation [GO:0072497]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell differentiation [GO:0045597]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]"	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear receptor binding [GO:0016922]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transmembrane transporter binding [GO:0044325]	GO:0000122; GO:0000209; GO:0000578; GO:0000791; GO:0000904; GO:0000922; GO:0001221; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001837; GO:0001840; GO:0002052; GO:0002053; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007268; GO:0007398; GO:0007403; GO:0008013; GO:0008022; GO:0008285; GO:0009410; GO:0009948; GO:0009950; GO:0009954; GO:0010628; GO:0010629; GO:0010718; GO:0010909; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0016922; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035315; GO:0035995; GO:0036023; GO:0036520; GO:0042129; GO:0042475; GO:0042733; GO:0042734; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044336; GO:0044338; GO:0044339; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045597; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048145; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050767; GO:0050808; GO:0051091; GO:0051145; GO:0051571; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060492; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0061047; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0061629; GO:0070062; GO:0070369; GO:0070411; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072182; GO:0072497; GO:0090090; GO:0090279; GO:0097091; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:0099092; GO:0140297; GO:1903204; GO:1904798; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990226; GO:1990403; GO:1990711; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2001234	LIILASGGPQALVNIMRTYTYEK	6.159999847	0.515365362	0.515365362	6.84E-12	2552.482186	16.3438	15.19177	0	10.74024	16.8584	15.63275	17.27225	0	15.35626	15.66203	14.94756	0	0	0	0	16.30747	14.87893	0	0	17.50135	0	15.11075	0	16.63379	0	0	15.43413	16.74952	18.21961	0	15.58811	0	16.20784	15.6501	16.75715	0	16.16348	0	14.20119	16.27756	0	0	0	14.52677	14.86472	10.08344	14.29024	12.6998
P35226	BMI1_HUMAN	Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) (RING finger protein 51)	BMI1 PCGF4 RNF51	Homo sapiens (Human)	"hemopoiesis [GO:0030097]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of gene expression [GO:0010468]; segment specification [GO:0007379]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RING-like zinc finger domain binding [GO:0071535]; zinc ion binding [GO:0008270]; hemopoiesis [GO:0030097]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of gene expression [GO:0010468]; segment specification [GO:0007379]"	promoter-specific chromatin binding [GO:1990841]; RING-like zinc finger domain binding [GO:0071535]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000151; GO:0005634; GO:0005654; GO:0005829; GO:0007379; GO:0008270; GO:0010468; GO:0016604; GO:0030097; GO:0031519; GO:0035102; GO:0036353; GO:0045814; GO:0048146; GO:0051443; GO:0071535; GO:1990841	DFYAAHPSADAANGSNEDRGEVADEDK	4.440000057	1	1	3.68E-12	2851.367154	15.02647	15.91141	16.03915	0	15.75916	15.44999	13.74836	0	13.8533	0	0	0	0	0	9.092084	0	0	0	14.79172	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P35228	NOS2_HUMAN	"Nitric oxide synthase, inducible, EC 1.14.13.39 (Hepatocyte NOS, HEP-NOS) (Inducible NO synthase, Inducible NOS, iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2)"	NOS2 NOS2A	Homo sapiens (Human)	arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response in mucosa [GO:0002227]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of leukocyte mediated cytotoxicity [GO:0001912]; prostaglandin secretion [GO:0032310]; regulation of cell population proliferation [GO:0042127]; regulation of cellular respiration [GO:0043457]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of insulin secretion [GO:0050796]; response to bacterium [GO:0009617]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; superoxide metabolic process [GO:0006801]	cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; arginine binding [GO:0034618]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tetrahydrobiopterin binding [GO:0034617]; arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response in mucosa [GO:0002227]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of leukocyte mediated cytotoxicity [GO:0001912]; prostaglandin secretion [GO:0032310]; regulation of cell population proliferation [GO:0042127]; regulation of cellular respiration [GO:0043457]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of insulin secretion [GO:0050796]; response to bacterium [GO:0009617]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; superoxide metabolic process [GO:0006801]	arginine binding [GO:0034618]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tetrahydrobiopterin binding [GO:0034617]	GO:0001666; GO:0001912; GO:0002227; GO:0004517; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0005886; GO:0006527; GO:0006801; GO:0006809; GO:0006954; GO:0007263; GO:0007623; GO:0009617; GO:0009725; GO:0010181; GO:0010629; GO:0012506; GO:0016491; GO:0018119; GO:0020037; GO:0030863; GO:0031284; GO:0032310; GO:0032496; GO:0032755; GO:0032757; GO:0034617; GO:0034618; GO:0042127; GO:0042177; GO:0042742; GO:0042803; GO:0043457; GO:0045454; GO:0045776; GO:0046872; GO:0048471; GO:0050660; GO:0050661; GO:0050796; GO:0050829; GO:0051712; GO:0071222; GO:0071346; GO:0071466; GO:1900015	LEALCQPSEYSK	3.410000086	1	1	0.242444351	1424.53698	16.41394	0	15.04465	15.48273	0	0	0	0	0	0	14.80628	0	16.24165	15.25707	14.709	0	0	0	0	0	0	0	0	0	0	0	0	15.40053	17.30301	15.98537	0	15.99656	16.66998	0	0	16.72292	0	17.3656	0	0	0	0	0	0	0	0	0	0
P35236	PTN7_HUMAN	"Tyrosine-protein phosphatase non-receptor type 7, EC 3.1.3.48 (Hematopoietic protein-tyrosine phosphatase, HEPTP) (Protein-tyrosine phosphatase LC-PTP)"	PTPN7	Homo sapiens (Human)	MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]	non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000165; GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0009898; GO:0015630; GO:0072686	QPPSPK	3.279999971	1	1	3.44E-13	650.3255487	10.26213	14.43083	13.67713	12.24557	15.28331	13.48884	0	0	0	14.75034	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.64831	16.1045	0	0	0	0	0	0	0	0	0	0	0	0	0	15.24874	0	0	0
P35240	MERL_HUMAN	Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin)	NF2 SCH	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]	actin binding [GO:0003779]; integrin binding [GO:0005178]	GO:0001707; GO:0001953; GO:0003779; GO:0005178; GO:0005634; GO:0005730; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006469; GO:0007398; GO:0008285; GO:0014010; GO:0014013; GO:0016020; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030336; GO:0030864; GO:0031527; GO:0031647; GO:0032154; GO:0032587; GO:0035330; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0046426; GO:0048471; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177	KLTLQSAK	9.279999733	0.300119907	0.300119907	0.291431751	887.3634892	13.87481	15.834	0	15.71632	14.05053	13.8906	14.49555	12.61591	0	0	0	16.37297	0	0	0	0	16.25882	14.76449	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.8608	0	15.09145	0	14.88245	0
P35241	RADI_HUMAN	Radixin	RDX	Homo sapiens (Human)	apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein kinase A signaling [GO:0010737]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of Rap protein signal transduction [GO:0032487]; regulation of ruffle assembly [GO:1900027]	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein kinase A signaling [GO:0010737]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of Rap protein signal transduction [GO:0032487]; regulation of ruffle assembly [GO:1900027]	actin binding [GO:0003779]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]	GO:0003723; GO:0003779; GO:0005615; GO:0005886; GO:0005902; GO:0005912; GO:0005925; GO:0008360; GO:0008361; GO:0010628; GO:0010737; GO:0016324; GO:0030027; GO:0030175; GO:0030315; GO:0030335; GO:0030496; GO:0030864; GO:0032154; GO:0032231; GO:0032487; GO:0034111; GO:0034260; GO:0036120; GO:0043087; GO:0045176; GO:0045177; GO:0045184; GO:0045296; GO:0045792; GO:0050839; GO:0051016; GO:0051018; GO:0051117; GO:0051286; GO:0061028; GO:0070062; GO:0071944; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903364; GO:1903392; GO:2000643	EELMER	5.309999943	1	1	0.050327597	822.7428624	15.40314	15.06281	15.34901	15.5346	15.03284	0	0	16.32776	15.93786	16.28447	14.77271	15.62341	14.8371	16.03724	15.3237	0	0	0	0	0	0	0	0	14.76208	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.81318	0	0	0	16.90845	0	0	0
P35247	SFTPD_HUMAN	"Pulmonary surfactant-associated protein D, PSP-D, SP-D (Collectin-7) (Lung surfactant protein D)"	SFTPD COLEC7 PSPD SFTP4	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; lung alveolus development [GO:0048286]; macrophage chemotaxis [GO:0048246]; negative regulation by host of symbiont catalytic activity [GO:0052403]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of phagocytosis [GO:0050766]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; regulation of adhesion of symbiont to host epithelial cell [GO:1905226]; regulation of cytokine production [GO:0001817]; respiratory gaseous exchange by respiratory system [GO:0007585]; surfactant homeostasis [GO:0043129]	clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791]	clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; defense response to bacterium [GO:0042742]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; lung alveolus development [GO:0048286]; macrophage chemotaxis [GO:0048246]; negative regulation by host of symbiont catalytic activity [GO:0052403]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of phagocytosis [GO:0050766]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; regulation of adhesion of symbiont to host epithelial cell [GO:1905226]; regulation of cytokine production [GO:0001817]; respiratory gaseous exchange by respiratory system [GO:0007585]; surfactant homeostasis [GO:0043129]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]	GO:0001817; GO:0005576; GO:0005581; GO:0005615; GO:0005764; GO:0005771; GO:0005789; GO:0005791; GO:0006898; GO:0007585; GO:0030139; GO:0030246; GO:0032703; GO:0042130; GO:0042742; GO:0042802; GO:0043129; GO:0043152; GO:0045087; GO:0045334; GO:0048246; GO:0048286; GO:0050766; GO:0052403; GO:0072593; GO:1905226	DGREGPR	3.329999924	1	1	0.221079825	786.7175933	0	16.67574	15.68139	15.49705	14.25085	16.02061	14.88115	0	15.23814	16.02844	0	15.50952	0	0	14.31173	15.74899	0	0	15.87613	15.81249	14.94281	0	15.31244	0	14.99597	15.22644	13.36575	0	0	0	0	17.41122	0	0	0	0	0	17.96299	15.02856	15.70133	14.82509	15.66693	0	0	0	15.71974	18.0254	0
P35250	RFC2_HUMAN	"Replication factor C subunit 2 (Activator 1 40 kDa subunit, A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit, RF-C 40 kDa subunit, RFC40)"	RFC2	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0019899; GO:0031390; GO:0032508; GO:1900264	TMAPVAS	6.039999962	1	1	0.200694196	691.3366521	14.54518	0	14.86483	13.89635	15.44738	12.95339	0	14.89028	11.98316	0	0	15.41621	15.82562	0	15.04033	15.34002	13.79812	0	0	15.25651	16.46923	16.3706	14.81038	0	0	0	0	0	0	0	0	0	15.63159	0	0	16.26735	0	15.8513	0	0	0	0	0	0	15.22221	0	15.29778	0
P35251	RFC1_HUMAN	"Replication factor C subunit 1 (Activator 1 140 kDa subunit, A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit, RF-C 140 kDa subunit, RFC140) (Replication factor C large subunit)"	RFC1 RFC140	Homo sapiens (Human)	"DNA clamp unloading [GO:0090618]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomerase [GO:0007004]"	cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomerase [GO:0007004]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]	GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0005730; GO:0005737; GO:0006261; GO:0006281; GO:0007004; GO:0008047; GO:0016887; GO:0019904; GO:0031391; GO:0043565; GO:0045893; GO:0061860; GO:0070062; GO:0090618	DTEAGETFSSVQANLSKAEK	1.24000001	1	1	0.114967866	2111.657553	11.69499	0	0	0	14.75684	0	0	0	0	0	0	12.13356	0	14.06494	0	0	0	0	0	0	0	14.87456	0	0	0	0	0	0	0	0	0	14.93809	0	9.623371	0	0	0	13.46167	14.3778	14.17301	14.07994	13.7418	11.45103	0	12.52317	0	0	8.606213
P35318	ADML_HUMAN	"Pro-adrenomedullin [Cleaved into: Adrenomedullin, AM; Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide, PAMP, ProAM-N20) ]"	ADM AM	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; aging [GO:0007568]; amylin receptor signaling pathway [GO:0097647]; androgen metabolic process [GO:0008209]; animal organ regeneration [GO:0031100]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cAMP-mediated signaling [GO:0019933]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; developmental growth [GO:0048589]; female pregnancy [GO:0007565]; G protein-coupled receptor internalization [GO:0002031]; heart development [GO:0007507]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular permeability [GO:0043116]; negative regulation of vasoconstriction [GO:0045906]; neural tube closure [GO:0001843]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of vasculogenesis [GO:2001214]; receptor internalization [GO:0031623]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of the force of heart contraction [GO:0002026]; regulation of urine volume [GO:0035809]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; spongiotrophoblast layer development [GO:0060712]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; adrenomedullin receptor binding [GO:0031700]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; aging [GO:0007568]; amylin receptor signaling pathway [GO:0097647]; androgen metabolic process [GO:0008209]; animal organ regeneration [GO:0031100]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cAMP-mediated signaling [GO:0019933]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; developmental growth [GO:0048589]; female pregnancy [GO:0007565]; G protein-coupled receptor internalization [GO:0002031]; heart development [GO:0007507]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular permeability [GO:0043116]; negative regulation of vasoconstriction [GO:0045906]; neural tube closure [GO:0001843]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of vasculogenesis [GO:2001214]; receptor internalization [GO:0031623]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of the force of heart contraction [GO:0002026]; regulation of urine volume [GO:0035809]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; spongiotrophoblast layer development [GO:0060712]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]	adrenomedullin receptor binding [GO:0031700]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	GO:0001570; GO:0001666; GO:0001843; GO:0002026; GO:0002031; GO:0003073; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0007165; GO:0007189; GO:0007204; GO:0007507; GO:0007565; GO:0007568; GO:0008209; GO:0008284; GO:0008285; GO:0009409; GO:0009611; GO:0010460; GO:0019731; GO:0019933; GO:0031100; GO:0031102; GO:0031623; GO:0031700; GO:0032496; GO:0032868; GO:0035809; GO:0042475; GO:0042594; GO:0043065; GO:0043116; GO:0045766; GO:0045906; GO:0046879; GO:0048589; GO:0050829; GO:0050830; GO:0051384; GO:0060670; GO:0060712; GO:0061844; GO:0097084; GO:0097647; GO:1990410; GO:2000184; GO:2001214	RSLPEAGPGR	15.81000042	0.722483158	0.722483158	0.227860111	1039.605079	16.53131	0	16.59941	13.82741	0	14.51525	15.82398	0	0	0	15.84043	0	0	14.50985	0	15.63825	13.14852	0	15.66771	0	0	0	0	16.26041	0	0	14.57064	0	16.17367	0	16.53425	0	0	15.5781	0	16.72439	15.74988	0	0	0	0	0	16.08494	0	16.25973	17.95992	16.58158	0
P35348	ADA1A_HUMAN	"Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor, Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c)"	ADRA1A ADRA1C	Homo sapiens (Human)	"activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; aging [GO:0007568]; apoptotic process [GO:0006915]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; micturition [GO:0060073]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]	"caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; aging [GO:0007568]; apoptotic process [GO:0006915]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; micturition [GO:0060073]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]"	alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]	GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004930; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0006915; GO:0006939; GO:0007165; GO:0007186; GO:0007200; GO:0007202; GO:0007204; GO:0007267; GO:0007512; GO:0007568; GO:0008285; GO:0009410; GO:0009725; GO:0010259; GO:0010507; GO:0010613; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0035556; GO:0043231; GO:0043410; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060073; GO:0060402; GO:0060452; GO:0061049; GO:0070374; GO:0071880; GO:0090037; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1903997; GO:2000300	SGLKTDK	5.960000038	1	1	0.278743268	749.1090209	19.21196	18.13272	17.39554	17.59787	18.42957	15.29064	0	19.07443	0	0	0	0	0	0	0	17.9202	0	17.1347	15.4304	0	17.56937	18.1734	0	0	0	0	17.4063	0	0	0	19.38658	19.06661	0	0	17.57396	0	0	0	18.67458	17.78477	18.73151	18.94588	17.89246	0	0	17.09541	0	16.88465
P35354	PGH2_HUMAN	"Prostaglandin G/H synthase 2, EC 1.14.99.1 (Cyclooxygenase-2, COX-2) (PHS II) (Prostaglandin H2 synthase 2, PGH synthase 2, PGHS-2) (Prostaglandin-endoperoxide synthase 2)"	PTGS2 COX2	Homo sapiens (Human)	"aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]"	caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]	"caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]"	"enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]"	GO:0001516; GO:0001525; GO:0004601; GO:0004666; GO:0005637; GO:0005640; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005901; GO:0006954; GO:0006979; GO:0007566; GO:0007568; GO:0007612; GO:0007613; GO:0008217; GO:0008285; GO:0009410; GO:0009750; GO:0010042; GO:0010226; GO:0010575; GO:0016702; GO:0019233; GO:0019371; GO:0019899; GO:0020037; GO:0030282; GO:0030728; GO:0031394; GO:0031622; GO:0031915; GO:0032227; GO:0032355; GO:0032496; GO:0032991; GO:0033138; GO:0033280; GO:0034605; GO:0034612; GO:0034644; GO:0035633; GO:0042307; GO:0042633; GO:0042803; GO:0043005; GO:0043065; GO:0043154; GO:0043231; GO:0045429; GO:0045786; GO:0045907; GO:0045986; GO:0045987; GO:0046697; GO:0046872; GO:0048661; GO:0050727; GO:0050873; GO:0051384; GO:0051926; GO:0051968; GO:0070542; GO:0071260; GO:0071284; GO:0071318; GO:0071456; GO:0071471; GO:0071498; GO:0071636; GO:0090050; GO:0090271; GO:0090336; GO:0090362; GO:0150077; GO:1902219; GO:1990776	NVPPAVQKVSQASIDQSR	4.599999905	1	1	1.14E-12	1923.052324	14.68652	14.97547	13.58909	0	0	0	0	12.1826	0	0	0	12.71858	0	0	14.4311	0	0	14.26089	14.05222	13.45106	0	0	0	11.3683	12.69618	0	15.33926	14.04582	0	15.14729	15.75311	0	0	16.56538	0	17.03003	16.52745	15.53492	0	0	0	13.8838	0	15.94152	0	15.22771	0	13.53049
P35367	HRH1_HUMAN	"Histamine H1 receptor, H1R, HH1R"	HRH1	Homo sapiens (Human)	"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; inositol phosphate-mediated signaling [GO:0048016]; memory [GO:0007613]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; regulation of vascular permeability [GO:0043114]; visual learning [GO:0008542]"	cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; inositol phosphate-mediated signaling [GO:0048016]; memory [GO:0007613]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; regulation of vascular permeability [GO:0043114]; visual learning [GO:0008542]"	G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]	GO:0004930; GO:0004969; GO:0004993; GO:0005829; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007187; GO:0007200; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0032962; GO:0043114; GO:0045202; GO:0045907; GO:0048016; GO:0048167; GO:0048245; GO:0071420	DYVAVNR	9.920000076	1	1	0.221070652	836.7746932	18.01187	0	13.8635	17.80339	0	0	0	0	0	16.74045	0	18.53539	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.34039
P35368	ADA1B_HUMAN	"Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor, Alpha-1B adrenoceptor)"	ADRA1B	Homo sapiens (Human)	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117]	caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117]	alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]	GO:0001996; GO:0004930; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007267; GO:0031965; GO:0035556; GO:0043410; GO:0045907; GO:0046982; GO:0055117; GO:0071880; GO:0150099	VYIVAKR	8.609999657	1	1	0.13060354	847.6413013	15.63522	15.27558	0	14.54325	14.81838	10.85104	16.58894	0	0	0	12.64604	0	13.66291	16.05901	0	13.89428	0	14.89095	13.1163	0	0	0	0	14.91558	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.73242	0	0	0
P35372	OPRM_HUMAN	"Mu-type opioid receptor, M-OR-1, MOR-1 (Mu opiate receptor) (Mu opioid receptor, MOP, hMOP)"	OPRM1 MOR1	Homo sapiens (Human)	"acute inflammatory response to antigenic stimulus [GO:0002438]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to ethanol [GO:0048149]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of appetite [GO:0032100]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of cellular response to stress [GO:0080135]; regulation of NMDA receptor activity [GO:2000310]; regulation of sensory perception of pain [GO:0051930]; response to cocaine [GO:0042220]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; wound healing [GO:0042060]"	axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; spine apparatus [GO:0097444]	"axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; spine apparatus [GO:0097444]; beta-endorphin receptor activity [GO:0004979]; filamin binding [GO:0031005]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; morphine receptor activity [GO:0038047]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; voltage-gated calcium channel activity [GO:0005245]; acute inflammatory response to antigenic stimulus [GO:0002438]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to ethanol [GO:0048149]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of appetite [GO:0032100]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of cellular response to stress [GO:0080135]; regulation of NMDA receptor activity [GO:2000310]; regulation of sensory perception of pain [GO:0051930]; response to cocaine [GO:0042220]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; wound healing [GO:0042060]"	beta-endorphin receptor activity [GO:0004979]; filamin binding [GO:0031005]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; morphine receptor activity [GO:0038047]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; voltage-gated calcium channel activity [GO:0005245]	GO:0001965; GO:0002438; GO:0004930; GO:0004979; GO:0005245; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005925; GO:0007187; GO:0007197; GO:0007200; GO:0007204; GO:0007218; GO:0007600; GO:0008022; GO:0008285; GO:0009314; GO:0019233; GO:0019904; GO:0030424; GO:0030425; GO:0031005; GO:0031635; GO:0031681; GO:0032094; GO:0032100; GO:0032496; GO:0032590; GO:0032839; GO:0038003; GO:0038047; GO:0042060; GO:0042220; GO:0042277; GO:0042383; GO:0042755; GO:0042923; GO:0043005; GO:0043204; GO:0043950; GO:0043951; GO:0044849; GO:0045019; GO:0045121; GO:0045429; GO:0048149; GO:0050769; GO:0051481; GO:0051930; GO:0060079; GO:0061358; GO:0070374; GO:0070848; GO:0080135; GO:0097444; GO:0099055; GO:0099056; GO:0106072; GO:2000310	SVRMLSGSK	14.80000019	1	1	0.198583391	966.4845713	13.03815	0	14.24991	15.15316	0	0	14.27855	15.79455	13.68108	13.27993	12.94085	0	0	0	0	16.40199	0	0	0	0	0	0	0	0	15.65507	0	0	0	0	0	0	16.63694	0	0	0	0	0	0	0	0	14.72659	0	0	0	0	0	0	0
P35442	TSP2_HUMAN	Thrombospondin-2	THBS2 TSP2	Homo sapiens (Human)	cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	GO:0005509; GO:0005576; GO:0005604; GO:0007155; GO:0008201; GO:0016525; GO:0031091; GO:0051965; GO:0062023	KTIGAK	6.869999886	1	1	1.16E-13	614.5101731	0	15.47089	15.27632	12.46426	15.11952	0	0	0	13.897	0	15.39655	13.26902	14.79292	0	0	0	14.71845	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P35443	TSP4_HUMAN	Thrombospondin-4	THBS4 TSP4	Homo sapiens (Human)	behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771]	calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]	GO:0001938; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0050731; GO:0051451; GO:0051781; GO:0062023; GO:0070062; GO:0071603; GO:0090023	YLKNDGK	15.57999992	0.855605543	0.855605543	0.099949329	837.5944834	14.78243	0	16.76542	10.51993	14.95755	0	0	13.43949	14.52833	16.94598	14.59381	13.9454	12.57811	14.22984	14.27553	15.03067	13.82661	0	0	14.13567	14.47674	0	14.09863	0	16.12794	0	0	0	13.31045	0	0	0	0	0	0	0	16.70823	16.26994	0	16.51392	0	0	0	0	0	0	0	0
P35498	SCN1A_HUMAN	Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)	SCN1A NAC1 SCN1	Homo sapiens (Human)	adult walking behavior [GO:0007628]; cardiac muscle cell action potential involved in contraction [GO:0086002]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane depolarization during action potential [GO:0086010]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; axon initial segment [GO:0043194]; intercalated disc [GO:0014704]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]	axon [GO:0030424]; axon initial segment [GO:0043194]; intercalated disc [GO:0014704]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; adult walking behavior [GO:0007628]; cardiac muscle cell action potential involved in contraction [GO:0086002]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane depolarization during action potential [GO:0086010]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0005654; GO:0005886; GO:0006814; GO:0007628; GO:0014704; GO:0016604; GO:0019227; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0033268; GO:0034765; GO:0035725; GO:0043025; GO:0043194; GO:0050884; GO:0050966; GO:0086002; GO:0086010	VTKPIVEK	6.789999962	0.117582701	0.117582701	0.266719857	913.7009541	0	0	18.14782	0	0	16.99015	0	0	16.10964	0	17.28975	0	18.40174	17.12722	17.67137	17.58267	18.20687	15.1849	18.56015	18.47091	19.06392	17.15223	18.95362	17.12436	18.54336	0	17.15629	17.64262	17.00224	17.70195	19.20103	0	0	0	17.76374	18.12784	17.40505	19.40658	18.58965	0	17.8781	18.34489	18.56704	18.54014	17.20016	18.42267	18.74565	18.39238
P35499	SCN4A_HUMAN	Sodium channel protein type 4 subunit alpha (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4)	SCN4A	Homo sapiens (Human)	membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0006814; GO:0006936; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0086010; GO:0100001	FYYCINTTTSER	1.710000038	0.216668978	0.216668978	2.28E-13	1552.557941	0	17.51038	0	0	0	14.31123	15.82438	15.48728	16.63931	0	15.52062	15.46105	17.33604	15.89983	0	15.23647	15.52907	13.9763	17.15736	17.29074	14.49931	14.91165	14.74026	0	0	15.90378	15.9675	13.76708	0	15.58895	17.98817	18.77323	15.07565	16.86115	10.86665	0	17.04133	0	0	18.31655	0	15.48498	0	0	16.56555	0	0	13.43668
P35520	CBS_HUMAN	"Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)"	CBS	Homo sapiens (Human)	cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]	carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]	GO:0004122; GO:0005634; GO:0005737; GO:0005829; GO:0006535; GO:0006563; GO:0006565; GO:0019343; GO:0019344; GO:0019448; GO:0019825; GO:0019899; GO:0020037; GO:0030170; GO:0031625; GO:0042262; GO:0042802; GO:0042803; GO:0043418; GO:0046872; GO:0050421; GO:0050667; GO:0070025; GO:0070026; GO:0070814; GO:0072341; GO:1904047	TPTNAR	6.699999809	1	1	4.60E-13	659.3121598	13.91256	15.70398	15.38078	15.59226	0	0	0	0	0	0	0	0	13.86102	0	0	14.81571	0	0	0	0	0	0	15.61875	13.83719	14.14925	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P35523	CLCN1_HUMAN	"Chloride channel protein 1, ClC-1 (Chloride channel protein, skeletal muscle)"	CLCN1 CLC1	Homo sapiens (Human)	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; muscle contraction [GO:0006936]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; muscle contraction [GO:0006936]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]	protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0006936; GO:0019227; GO:0034707; GO:0034765; GO:0042383; GO:0042803; GO:1902476	TLPLVDSK	7.420000076	1	1	0.071505378	871.4358522	15.60866	0	13.62144	12.20435	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.93947	0	0	0	14.83108	0	0	0	0	0	0	0	0	0	0	13.61087	0	0	0	0	0	0	0	0
P35527	K1C9_HUMAN	"Keratin, type I cytoskeletal 9 (Cytokeratin-9, CK-9) (Keratin-9, K9)"	KRT9	Homo sapiens (Human)	epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005615; GO:0005634; GO:0005829; GO:0005856; GO:0007283; GO:0008544; GO:0016020; GO:0030855; GO:0043588; GO:0045095; GO:0045109; GO:0070062	GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK	41.41999817	1	1	0.009109023	3223.183777	0	0	10.3562	0	16.22086	15.68518	0	0	0	0	14.56312	0	14.52857	0	0	0	0	15.10601	0	0	0	0	18.27425	0	13.90871	15.38919	12.59739	0	0	0	0	17.09306	0	16.82262	16.27458	15.12011	0	0	15.73158	0	0	0	0	0	0	0	15.8467	0
P35556	FBN2_HUMAN	Fibrillin-2 [Cleaved into: Placensin ]	FBN2	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179]; anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179]	GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009653; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023; GO:1901163	GMMCKNLIGTFMCICPPGMAR	2.230000019	1	1	2.28E-12	2510.248376	0	14.61461	16.04387	0	0	0	0	15.45472	15.03354	0	0	13.65997	16.5269	0	14.3797	0	12.89238	12.15075	14.78297	0	0	0	13.81557	16.16713	0	0	14.32272	0	0	0	14.14346	15.12096	0	12.94963	0	13.87869	13.09764	14.20217	0	15.94673	15.22218	15.47871	0	15.47438	0	15.26772	0	0
P35557	HXK4_HUMAN	"Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)"	GCK	Homo sapiens (Human)	calcium ion import [GO:0070509]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; detection of glucose [GO:0051594]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; NADP metabolic process [GO:0006739]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; regulation of glycolytic process [GO:0006110]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transport [GO:0043266]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]; calcium ion import [GO:0070509]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; detection of glucose [GO:0051594]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; NADP metabolic process [GO:0006739]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; regulation of glycolytic process [GO:0006110]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transport [GO:0043266]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005654; GO:0005739; GO:0005829; GO:0006096; GO:0006110; GO:0006739; GO:0008865; GO:0019158; GO:0032024; GO:0032869; GO:0042593; GO:0043266; GO:0044320; GO:0045721; GO:0045725; GO:0050796; GO:0051156; GO:0051594; GO:0061621; GO:0070509	GAALVSAVACK	2.099999905	1	1	0.01324984	1045.548862	0	0	16.20282	0	0	0	0	0	15.45372	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.49577	0	0	0	0	0	0	0	0	14.36288	0	0	0	0	0	0	0	0	0	0
P35558	PCKGC_HUMAN	"Phosphoenolpyruvate carboxykinase, cytosolic [GTP], PEPCK-C, EC 4.1.1.32 (Serine-protein kinase PCK1, EC 2.7.11.-)"	PCK1 PEPCK1	Homo sapiens (Human)	aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to potassium ion starvation [GO:0051365]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; propionate catabolic process [GO:0019543]; regulation of lipid biosynthetic process [GO:0046890]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]; aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to potassium ion starvation [GO:0051365]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; propionate catabolic process [GO:0019543]; regulation of lipid biosynthetic process [GO:0046890]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]	carboxylic acid binding [GO:0031406]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]	GO:0000287; GO:0004613; GO:0005525; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006006; GO:0006094; GO:0006107; GO:0007568; GO:0014823; GO:0018105; GO:0019003; GO:0019543; GO:0030145; GO:0031406; GO:0032496; GO:0032868; GO:0032869; GO:0033993; GO:0042593; GO:0042594; GO:0043382; GO:0046327; GO:0046890; GO:0051365; GO:0061402; GO:0070062; GO:0070365; GO:0070741; GO:0071300; GO:0071320; GO:0071332; GO:0071333; GO:0071347; GO:0071356; GO:0071377; GO:0071456; GO:0071549; GO:0106264; GO:1904640	AINPENGFFGVAPGTSVKTNPNAIK	5.480000019	1	1	0.493030531	2543.996343	0	14.19248	0	0	0	0	0	0	0	0	0	19.55729	0	0	0	0	0	0	0	0	0	0	0	20.50883	0	17.99925	0	0	0	18.95021	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P35568	IRS1_HUMAN	"Insulin receptor substrate 1, IRS-1"	IRS1	Homo sapiens (Human)	cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]	insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001784; GO:0005068; GO:0005080; GO:0005158; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005899; GO:0005901; GO:0007165; GO:0008284; GO:0008286; GO:0010907; GO:0014065; GO:0030159; GO:0032000; GO:0032868; GO:0032869; GO:0042169; GO:0042593; GO:0043231; GO:0043434; GO:0043548; GO:0043552; GO:0045725; GO:0046326; GO:0046627; GO:0046628; GO:0046676; GO:0048009; GO:0071398	HRGSAR	2.170000076	1	1	0.13760952	684.9289999	0	0	14.84035	0	0	14.17019	15.07663	14.87504	0	15.48892	14.42459	0	0	0	0	0	9.609847	13.34886	0	0	0	0	15.78033	0	0	0	0	13.94186	0	13.95137	0	0	0	0	0	0	0	0	0	15.64661	0	0	0	0	0	0	15.77192	0
P35573	GDE_HUMAN	"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase, EC 2.4.1.25 (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase, Amylo-1,6-glucosidase, EC 3.2.1.33 (Dextrin 6-alpha-D-glucosidase) ]"	AGL GDE	Homo sapiens (Human)	glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]"	"4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]"	GO:0004133; GO:0004134; GO:0004135; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0007584; GO:0016234; GO:0016529; GO:0030247; GO:0031593; GO:0034774; GO:0043033; GO:0051384; GO:0102500; GO:1904813	GYDELVPHQISVVSEER	6.239999771	0.322890729	0.322890729	0.137201338	1954.182349	0	17.52385	0	17.99683	0	14.77843	0	15.25991	0	0	0	0	0	15.8058	15.43541	0	14.93113	0	0	14.40935	0	0	17.70776	18.44991	0	14.81535	0	17.62333	15.68744	0	16.2599	0	0	16.89527	0	0	16.02686	18.25759	0	0	15.47169	0	0	0	0	15.46793	0	0
P35579	MYH9_HUMAN	"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A, NMMHC-A) (Non-muscle myosin heavy chain IIa, NMMHC II-a, NMMHC-IIA)"	MYH9	Homo sapiens (Human)	"actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]"	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931]	"actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; RNA binding [GO:0003723]; actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]"	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; RNA binding [GO:0003723]	GO:0000146; GO:0000212; GO:0001525; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0003723; GO:0003774; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005826; GO:0005829; GO:0005886; GO:0005903; GO:0005912; GO:0005925; GO:0006509; GO:0006911; GO:0007229; GO:0007520; GO:0008360; GO:0009898; GO:0015031; GO:0015629; GO:0016020; GO:0016460; GO:0016604; GO:0019904; GO:0030048; GO:0030220; GO:0030224; GO:0031032; GO:0031252; GO:0031532; GO:0031594; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032991; GO:0042641; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045296; GO:0050900; GO:0051015; GO:0051295; GO:0060471; GO:0060473; GO:0070062; GO:0070527; GO:0097513; GO:1903919; GO:1903923; GO:1905684	ELESQISELQEDLESERASR	2.339999914	1	1	3.20E-12	2348.179039	12.37281	0	13.31705	10.55386	0	14.44732	13.79065	12.1472	0	0	10.95015	13.64246	14.39987	13.32983	0	0	13.21078	12.08474	0	13.13126	13.1569	0	14.71194	0	0	7.627217	0	0	12.81499	0	0	0	0	0	0	0	0	0	0	12.92756	0	15.9087	14.77121	0	0	0	0	0
P35580	MYH10_HUMAN	"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B, NMMHC-B) (Non-muscle myosin heavy chain IIb, NMMHC II-b, NMMHC-IIB)"	MYH10	Homo sapiens (Human)	actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; cell adhesion [GO:0007155]; mitotic cytokinesis [GO:0000281]; positive regulation of protein secretion [GO:0050714]; regulation of cell shape [GO:0008360]	actomyosin [GO:0042641]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; nucleus [GO:0005634]; polysome [GO:0005844]; stress fiber [GO:0001725]	actomyosin [GO:0042641]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; nucleus [GO:0005634]; polysome [GO:0005844]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; cell adhesion [GO:0007155]; mitotic cytokinesis [GO:0000281]; positive regulation of protein secretion [GO:0050714]; regulation of cell shape [GO:0008360]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]	GO:0000146; GO:0000281; GO:0001725; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005938; GO:0007155; GO:0008360; GO:0016459; GO:0016460; GO:0030027; GO:0030048; GO:0030496; GO:0031032; GO:0032154; GO:0035613; GO:0042641; GO:0043531; GO:0048027; GO:0050714; GO:0051015; GO:0070062; GO:0097513	IVGLDQVTGMTETAFGSAYK	3.730000019	1	1	0.109849268	2104.182482	13.65015	15.7247	0	12.64548	0	0	18.5432	0	0	18.49135	14.03226	13.85629	0	0	0	0	0	0	18.24342	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P35606	COPB2_HUMAN	"Coatomer subunit beta' (Beta'-coat protein, Beta'-COP) (p102)"	COPB2	Homo sapiens (Human)	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030133; GO:1901998	IAYQLAVEAESEQK	13.22000027	1	1	0.211115445	1577.733558	0	13.95164	14.96273	0	0	0	0	14.13148	12.60073	0	0	0	15.92664	13.25384	0	14.49508	12.64377	13.49682	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P35612	ADDB_HUMAN	Beta-adducin (Erythrocyte adducin subunit beta)	ADD2 ADDB	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; synapse assembly [GO:0007416]	cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]	cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; synapse assembly [GO:0007416]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0003779; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0007416; GO:0008290; GO:0014069; GO:0019901; GO:0030036; GO:0030097; GO:0030507; GO:0031410; GO:0032092; GO:0042803; GO:0044853; GO:0046982; GO:0050900; GO:0050901; GO:0051015; GO:0051016; GO:0051017; GO:0065003	QDFNLMEQK	3.200000048	1	1	0.122597421	1168.201707	16.52963	0	0	11.54233	17.09461	0	0	0	0	14.56173	0	0	0	0	0	0	0	0	0	13.18243	0	16.41284	13.54319	0	15.89591	0	0	17.32561	15.66144	15.55693	12.00814	0	0	16.12186	0	0	0	6.963031	0	0	0	16.0489	0	7.950767	0	0	0	0
P35626	ARBK2_HUMAN	"Beta-adrenergic receptor kinase 2, Beta-ARK-2, EC 2.7.11.15 (G-protein-coupled receptor kinase 3)"	GRK3 ADRBK2 BARK2	Homo sapiens (Human)	desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]	GO:0001664; GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007186; GO:0009966; GO:0031623; GO:0047696	ADTGKMYAMK	4.199999809	1	1	0.551322884	1147.618024	14.69812	0	18.93713	0	0	0	0	0	0	18.35854	17.77075	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.62963	0	0	0	0	0	0	0	0	16.70548	0	0	0
P35637	FUS_HUMAN	RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein)	FUS TLS	Homo sapiens (Human)	"mRNA stabilization [GO:0048255]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein homooligomerization [GO:0051260]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; mRNA stabilization [GO:0048255]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein homooligomerization [GO:0051260]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008380; GO:0042802; GO:0043484; GO:0046872; GO:0048255; GO:0051260; GO:1905168	GGRGGYDR	5.590000153	0.356355637	0.356355637	0.130048005	836.7658053	0	16.52675	15.78129	15.52506	14.60997	16.75208	15.11924	15.41845	15.83231	16.53531	0	15.16951	16.65887	17.1844	15.04568	16.28597	15.03847	12.17722	14.01445	16.71151	15.5692	14.66172	15.91607	15.6974	15.39816	0	0	0	0	10.84249	17.78993	15.14787	0	15.28697	15.09252	13.23997	15.5762	12.74183	0	10.94158	16.2427	12.83538	14.89109	15.35142	12.79287	15.27358	13.95792	13.76769
P35658	NU214_HUMAN	Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)	NUP214 CAIN CAN KIAA0023	Homo sapiens (Human)	mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]	cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]	nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]	GO:0000278; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876	DDEAVVQAPR	2.609999895	0.313917398	0.313917398	0.095458091	1099.526279	0	14.74462	14.41018	0	0	0	0	17.099	0	0	0	0	0	0	0	0	0	17.20179	0	0	12.24713	16.6714	13.13533	15.25669	11.74401	15.93403	0	14.78455	17.19767	0	17.20214	18.18288	14.12521	13.76446	17.70095	0	0	0	0	18.8189	17.47071	0	0	0	0	15.34097	15.51243	16.39635
P35659	DEK_HUMAN	Protein DEK	DEK	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079]	B-WICH complex [GO:0110016]; contractile fiber [GO:0043292]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	B-WICH complex [GO:0110016]; contractile fiber [GO:0043292]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079]	DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006357; GO:0006366; GO:0007165; GO:0019079; GO:0035066; GO:0042393; GO:0043292; GO:0045943; GO:0045944; GO:0045945; GO:0110016; GO:2000779; GO:2001032	LLASANLEEVTMKQICK	5.050000191	0.363604248	0.363604248	0.248997385	1963.28866	0	17.60265	0	16.59077	0	19.07198	14.55104	11.8888	9.777299	17.28427	17.40735	16.55449	17.70271	13.616	18.32004	0	13.89908	15.40302	17.0872	0	0	18.51689	15.50641	17.58015	12.86681	12.34451	0	17.76614	16.54314	17.07996	11.42146	19.24255	16.94058	15.42757	17.72093	0	15.06174	16.43529	19.7932	14.79144	17.67649	18.31813	0	0	16.6214	13.70424	0	0
P35663	CYLC1_HUMAN	Cylicin-1 (Cylicin I) (Multiple-band polypeptide I)	CYLC1 CYL CYL1	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	acrosomal matrix [GO:0043159]; cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]	acrosomal matrix [GO:0043159]; cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005200; GO:0005634; GO:0007283; GO:0030154; GO:0033150; GO:0043159	QIVEEKTK	10.39999962	1	1	0.31488229	974.471829	16.74672	0	16.32881	0	0	0	0	0	14.66013	0	0	0	0	0	0	0	0	0	0	0	14.24491	0	0	0	0	0	0	19.02744	0	16.28145	0	0	0	0	0	0	0	0	0	18.41569	0	0	0	0	0	0	16.60918	0
P35670	ATP7B_HUMAN	"Copper-transporting ATPase 2, EC 7.2.2.8 (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa ]"	ATP7B PWD WC1 WND	Homo sapiens (Human)	cellular copper ion homeostasis [GO:0006878]; cellular zinc ion homeostasis [GO:0006882]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; ion transmembrane transport [GO:0034220]; lactation [GO:0007595]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; cellular copper ion homeostasis [GO:0006878]; cellular zinc ion homeostasis [GO:0006882]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; ion transmembrane transport [GO:0034220]; lactation [GO:0007595]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]	GO:0000139; GO:0005375; GO:0005507; GO:0005524; GO:0005739; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0015677; GO:0015680; GO:0016020; GO:0016887; GO:0032588; GO:0034220; GO:0043682; GO:0046688; GO:0051208; GO:0055070; GO:0060003; GO:0140581; GO:1990961	RNGLTISSDVSDAMTDHEMK	9.079999924	0.411015481	0.411015481	0.193717344	2240.116434	0	11.6877	13.40451	14.68102	0	0	15.3526	0	10.07511	18.17312	14.05539	11.64565	14.73289	12.48767	0	0	0	0	14.73685	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.24718	0	0	0	0	0
P35711	SOX5_HUMAN	Transcription factor SOX-5	SOX5	Homo sapiens (Human)	asymmetric neuroblast division [GO:0055059]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; asymmetric neuroblast division [GO:0055059]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001502; GO:0002062; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0032332; GO:0045165; GO:0051216; GO:0055059; GO:0061036; GO:0071560; GO:2000741	AMTNLEK	2.069999933	1	1	0.04673244	822.5807234	15.97049	14.99168	16.72566	12.85255	13.25927	14.61568	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.34824	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P35716	SOX11_HUMAN	Transcription factor SOX-11	SOX11	Homo sapiens (Human)	"anatomical structure morphogenesis [GO:0009653]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001822; GO:0001841; GO:0002089; GO:0003151; GO:0003211; GO:0003357; GO:0003700; GO:0005634; GO:0005654; GO:0005886; GO:0006355; GO:0008284; GO:0009653; GO:0010628; GO:0010629; GO:0014003; GO:0014009; GO:0014032; GO:0017015; GO:0021510; GO:0021782; GO:0030154; GO:0030182; GO:0030513; GO:0035332; GO:0035914; GO:0045666; GO:0045669; GO:0045778; GO:0045893; GO:0045944; GO:0046887; GO:0048485; GO:0048557; GO:0048704; GO:0050672; GO:0050769; GO:0060022; GO:0060023; GO:0060174; GO:0060253; GO:0060412; GO:0060425; GO:0060548; GO:0060563; GO:0061029; GO:0061053; GO:0061303; GO:0061386; GO:2000648; GO:2000678; GO:2001111	VSGSGGGGAGK	6.420000076	1	1	0.120401874	833.5545314	0	0	0	15.53069	13.57279	0	12.82897	13.47216	11.42146	9.33055	0	10.13552	13.02325	0	0	14.03497	0	14.97219	0	13.25754	0	15.4307	13.32916	15.56554	0	0	16.70308	0	0	15.6461	0	0	0	0	0	0	0	0	0	0	15.81743	0	0	0	0	0	0	0
P35749	MYH11_HUMAN	"Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC)"	MYH11 KIAA0866	Homo sapiens (Human)	cardiac muscle cell development [GO:0055013]; elastic fiber assembly [GO:0048251]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; cardiac muscle cell development [GO:0055013]; elastic fiber assembly [GO:0048251]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]	GO:0003774; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0006939; GO:0008307; GO:0030241; GO:0032982; GO:0042470; GO:0048251; GO:0051015; GO:0055013; GO:0070062	CSDGER	1.870000005	1	1	0.291126475	724.1340443	18.68684	18.20679	17.42946	0	20.14646	17.41597	0	17.34364	0	0	17.51882	0	0	17.0444	0	0	0	0	0	16.36488	0	18.5625	0	0	0	18.23685	17.952	0	0	0	0	19.39701	0	0	0	0	19.59877	18.79705	0	18.37985	18.27936	0	17.32168	16.36719	0	17.64478	0	0
P35789	ZNF93_HUMAN	Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34)	ZNF93 ZNF505	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895	HNIRHTEK	10.47999954	0.338966399	0.338966399	0.240229789	1035.42797	13.19379	13.41331	16.54251	16.06595	17.5324	0	0	0	0	17.88032	16.75413	15.58186	0	15.45765	16.40314	16.11367	0	0	16.15656	0	0	16.63332	0	0	0	0	17.6771	15.54582	15.51233	0	18.01778	0	0	0	16.8469	17.33695	0	0	16.50175	0	17.55859	15.96276	0	0	0	0	15.87896	0
P35790	CHKA_HUMAN	"Choline kinase alpha, CK, EC 2.7.1.32 (CHETK-alpha) (Ethanolamine kinase, EK, EC 2.7.1.82)"	CHKA CHK CKI	Homo sapiens (Human)	CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]	GO:0004103; GO:0004104; GO:0004305; GO:0004713; GO:0005524; GO:0005737; GO:0005811; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0006657; GO:0006869; GO:0042149; GO:0042803; GO:1905691	EEMLLEVNR	2.710000038	1	1	6.86E-13	1148.181099	0	0	14.95492	15.07401	0	0	16.65073	0	15.14296	16.72386	17.62967	15.97184	14.93264	14.3842	15.3572	0	0	0	0	15.8278	0	0	16.38827	5.796014	11.72756	14.98626	0	0	0	0	0	13.15893	0	16.92152	0	0	0	0	15.14578	0	15.0801	13.34895	0	0	0	0	15.74916	0
P35908	K22E_HUMAN	"Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e, CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e, K2e) (Type-II keratin Kb2)"	KRT2 KRT2A KRT2E	Homo sapiens (Human)	epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte activation [GO:0032980]; keratinocyte development [GO:0003334]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684]	cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]	cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280]; epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte activation [GO:0032980]; keratinocyte development [GO:0003334]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684]	cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280]	GO:0001533; GO:0003334; GO:0005200; GO:0005615; GO:0005634; GO:0005829; GO:0005882; GO:0008092; GO:0008544; GO:0016020; GO:0018149; GO:0030280; GO:0031424; GO:0032980; GO:0043616; GO:0045095; GO:0045109; GO:0045684; GO:0051546; GO:0070062	GSSSGGGYSSGSSSYGSGGR	7.760000229	1	1	0.594639402	1741.252331	0	18.92305	0	18.71874	0	0	0	0	18.0418	18.78392	0	0	0	0	0	0	0	20.12783	18.7444	0	0	0	0	0	0	18.81131	0	0	0	0	0	0	18.03543	19.65771	0	0	0	0	0	0	0	18.82718	0	0	0	0	0	0
P35913	PDE6B_HUMAN	"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta, GMP-PDE beta, EC 3.1.4.35"	PDE6B PDEB	Homo sapiens (Human)	"entrainment of circadian clock by photoperiod [GO:0043153]; phototransduction, visible light [GO:0007603]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; signal transduction [GO:0007165]; visual perception [GO:0007601]"	photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]	"photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; entrainment of circadian clock by photoperiod [GO:0043153]; phototransduction, visible light [GO:0007603]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; signal transduction [GO:0007165]; visual perception [GO:0007601]"	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0007603; GO:0042622; GO:0043153; GO:0046872; GO:0047555; GO:0060041; GO:0097381; GO:1990009	AAELPKLQVGFIDFVCTFVYK	11.35000038	0.815097868	0.815097868	0.021658277	2444.755688	18.27792	0	0	0	16.55283	0	0	0	0	17.08498	0	16.74653	0	0	17.61228	0	0	17.44882	0	16.92683	18.60364	0	15.77505	17.74022	0	17.75813	0	0	17.44952	0	15.94351	16.15823	0	16.53611	17.74355	17.06074	17.73457	17.7857	16.1484	0	17.44243	16.8527	0	15.51477	0	0	0	16.58205
P35916	VGFR3_HUMAN	"Vascular endothelial growth factor receptor 3, VEGFR-3, EC 2.7.10.1 (Fms-like tyrosine kinase 4, FLT-4) (Tyrosine-protein kinase receptor FLT4)"	FLT4 VEGFR3	Homo sapiens (Human)	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004712; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037	RPERGAR	4.840000153	1	1	3.46E-13	840.9107306	14.86007	15.39441	14.25969	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.6902	0	0	0	0	0	12.48961	0	0	13.43262	0	15.81737	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P35968	VGFR2_HUMAN	"Vascular endothelial growth factor receptor 2, VEGFR-2, EC 2.7.10.1 (Fetal liver kinase 1, FLK-1) (Kinase insert domain receptor, KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)"	KDR FLK1 VEGFR2	Homo sapiens (Human)	angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001525; GO:0001541; GO:0001569; GO:0001570; GO:0001934; GO:0001938; GO:0001945; GO:0002042; GO:0002053; GO:0002244; GO:0003157; GO:0003158; GO:0004712; GO:0004713; GO:0004714; GO:0005021; GO:0005178; GO:0005524; GO:0005576; GO:0005634; GO:0005768; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0008360; GO:0009897; GO:0010595; GO:0010629; GO:0014068; GO:0016239; GO:0016477; GO:0018108; GO:0019838; GO:0030054; GO:0030335; GO:0030513; GO:0033674; GO:0035162; GO:0035584; GO:0035924; GO:0036324; GO:0038033; GO:0038083; GO:0038084; GO:0038085; GO:0042802; GO:0043066; GO:0043129; GO:0043235; GO:0043410; GO:0043491; GO:0043536; GO:0045121; GO:0045165; GO:0045296; GO:0045446; GO:0045766; GO:0046777; GO:0048010; GO:0048286; GO:0048469; GO:0048597; GO:0050927; GO:0051770; GO:0051879; GO:0051894; GO:0051901; GO:0055074; GO:0061042; GO:0070371; GO:0070374; GO:0090050; GO:0090141; GO:0097443; GO:1901532; GO:1903010; GO:1904881; GO:2000352; GO:2001214	NILLSEK	6.480000019	1	1	0.204638426	816.9916661	0	0	0	0	0	0	0	0	14.36907	0	0	0	0	17.42074	17.62955	0	0	0	18.29225	0	0	0	17.95178	0	0	0	0	0	0	15.70833	16.28625	16.97934	15.51045	0	0	0	0	17.41984	18.20158	0	15.515	0	18.11214	17.7147	0	0	0	0
P35998	PRS7_HUMAN	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)	PSMC2 MSS1	Homo sapiens (Human)	osteoblast differentiation [GO:0001649]; positive regulation of proteasomal protein catabolic process [GO:1901800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]"	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; osteoblast differentiation [GO:0001649]; positive regulation of proteasomal protein catabolic process [GO:1901800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]	GO:0000502; GO:0000932; GO:0001649; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008540; GO:0016020; GO:0016887; GO:0022624; GO:0034774; GO:0036402; GO:0036464; GO:0043161; GO:1901800; GO:1904813	VGVDRNK	15	0.040627543	0.040627543	0.202242651	786.4657939	15.22894	14.58361	14.37485	17.68303	15.16912	0	0	15.18325	15.59327	15.34606	15.09897	0	15.30019	14.8641	0	14.61494	0	14.23166	15.2215	15.84181	15.25971	15.73116	0	16.75829	16.59138	0	0	14.01707	15.75897	15.92813	15.77229	16.2211	0	14.48373	0	0	0	16.46575	15.20908	0	15.25404	0	0	16.08866	16.87476	15.74021	0	0
P36222	CH3L1_HUMAN	"Chitinase-3-like protein 1 (39 kDa synovial protein) (Cartilage glycoprotein 39, CGP-39, GP-39, hCGP-39) (YKL-40)"	CHI3L1	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to tumor necrosis factor [GO:0071356]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; extracellular matrix structural constituent [GO:0005201]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to tumor necrosis factor [GO:0071356]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]	carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005975; GO:0006032; GO:0006915; GO:0006954; GO:0007250; GO:0008061; GO:0009612; GO:0010800; GO:0030246; GO:0030324; GO:0031012; GO:0032757; GO:0034612; GO:0035580; GO:0045766; GO:0048471; GO:0051216; GO:0051897; GO:0070062; GO:0070374; GO:0070555; GO:0070741; GO:0071356	DALAAT	2.460000038	0.264769107	0.264769107	0.080091345	560.1786355	14.33133	14.5589	14.66758	10.70436	14.3165	18.49831	0	14.02089	16.63073	15.43739	0	16.93703	0	14.46911	0	17.33711	16.77274	0	0	17.0718	19.10678	15.78781	0	0	0	0	17.60447	0	0	0	0	16.93845	16.93789	16.17582	0	15.8115	18.24033	17.59234	0	15.4007	0	17.38668	0	0	18.98388	0	0	16.19535
P36269	GGT5_HUMAN	"Glutathione hydrolase 5 proenzyme, EC 3.4.19.13 (Gamma-glutamyl transpeptidase-related enzyme, GGT-rel) (Gamma-glutamyltransferase 5, GGT 5, EC 2.3.2.2) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Leukotriene-C4 hydrolase, EC 3.4.19.14) [Cleaved into: Glutathione hydrolase 5 heavy chain; Glutathione hydrolase 5 light chain ]"	GGT5 GGTLA1	Homo sapiens (Human)	cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; inflammatory response [GO:0006954]; leukotriene D4 biosynthetic process [GO:1901750]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; inflammatory response [GO:0006954]; leukotriene D4 biosynthetic process [GO:1901750]; proteolysis [GO:0006508]	glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]	GO:0000048; GO:0002951; GO:0005886; GO:0006508; GO:0006520; GO:0006631; GO:0006750; GO:0006751; GO:0006954; GO:0016021; GO:0031226; GO:0036374; GO:0102953; GO:0103068; GO:1901750	SGEAAGY	6.46999979	1	1	0.077938304	651.5057411	0	14.95729	15.73083	0	13.65157	14.22388	12.99672	15.77847	0	14.14779	16.28491	12.78521	0	15.86411	15.68631	15.5509	15.95558	0	16.53662	0	0	16.23162	14.04989	14.31161	0	15.86357	16.40891	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.68727	0
P36507	MP2K2_HUMAN	"Dual specificity mitogen-activated protein kinase kinase 2, MAP kinase kinase 2, MAPKK 2, EC 2.7.12.2 (ERK activator kinase 2) (MAPK/ERK kinase 2, MEK 2)"	MAP2K2 MEK2 MKK2 PRKMK2	Homo sapiens (Human)	"ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]"	cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]	"cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]"	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]	GO:0000165; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005078; GO:0005524; GO:0005576; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005778; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005911; GO:0005925; GO:0009898; GO:0030165; GO:0032872; GO:0036289; GO:0043539; GO:0045893; GO:0046872; GO:0048471; GO:0070371; GO:0071902; GO:0090170; GO:0097110; GO:0106310; GO:1903800; GO:2000641	DDDFER	6.46999979	0.399946094	0.399946094	0.183136493	795.8242021	0	0	12.76384	0	0	0	0	0	14.85029	0	0	0	12.66704	15.12869	12.34944	16.51562	0	0	0	0	0	0	14.95047	14.5184	0	0	0	0	0	0	15.54987	0	0	18.91138	16.40867	0	0	0	0	16.77132	0	0	0	0	0	0	0	0
P36542	ATPG_HUMAN	"ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)"	ATP5F1C ATP5C ATP5C1 ATP5CL1	Homo sapiens (Human)	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; oxidative phosphorylation [GO:0006119]	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"	"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; oxidative phosphorylation [GO:0006119]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]"	GO:0000275; GO:0003723; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0006119; GO:0006754; GO:0015986; GO:0016020; GO:0042776; GO:0046933	ADIKGPEDK	10.69999981	1	1	0.357472707	973.257861	0	15.43463	11.72013	16.05252	15.78837	14.4684	0	0	0	13.51978	0	16.65989	11.40234	0	0	14.12836	16.16286	13.67832	14.96245	12.89788	15.23245	0	15.3226	0	0	15.54142	16.69433	15.07918	13.48731	14.72093	15.09788	15.74016	0	0	0	15.33949	0	16.62842	15.59728	17.07027	16.7591	16.93945	15.50222	0	0	0	0	16.81291
P36551	HEM6_HUMAN	"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3"	CPOX CPO CPX	Homo sapiens (Human)	heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597]	coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]	GO:0004109; GO:0005212; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006782; GO:0006783; GO:0010039; GO:0010288; GO:0017085; GO:0042803; GO:0046685; GO:0051597	AEMLPK	1.149999976	1	1	0.246950918	703.9203973	16.02111	0	17.5499	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.4573	0	0	18.09192	0	0	0	0	0	0
P36578	RL4_HUMAN	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	RPL4 RPL1	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:1990904	KPVVGKK	14.14000034	0.044555541	0.044555541	0.275330527	755.8345837	16.7345	18.16791	18.32743	0	0	18.74442	18.41505	0	0	0	0	0	18.02641	0	0	0	17.67462	0	0	0	0	0	0	18.99605	0	18.77824	0	0	0	0	0	19.89637	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.81915	17.08154
P36888	FLT3_HUMAN	"Receptor-type tyrosine-protein kinase FLT3, EC 2.7.10.1 (FL cytokine receptor) (Fetal liver kinase-2, FLK-2) (Fms-like tyrosine kinase 3, FLT-3) (Stem cell tyrosine kinase 1, STK-1) (CD antigen CD135)"	FLT3 CD135 FLK2 STK1	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; cellular response to glucocorticoid stimulus [GO:0071385]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; lymphocyte proliferation [GO:0046651]; myeloid progenitor cell differentiation [GO:0002318]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; pro-B cell differentiation [GO:0002328]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; response to organonitrogen compound [GO:0010243]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine receptor activity [GO:0004896]; glucocorticoid receptor binding [GO:0035259]; growth factor binding [GO:0019838]; protein self-association [GO:0043621]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; animal organ regeneration [GO:0031100]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; cellular response to glucocorticoid stimulus [GO:0071385]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; lymphocyte proliferation [GO:0046651]; myeloid progenitor cell differentiation [GO:0002318]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; pro-B cell differentiation [GO:0002328]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; response to organonitrogen compound [GO:0010243]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; cytokine receptor activity [GO:0004896]; glucocorticoid receptor binding [GO:0035259]; growth factor binding [GO:0019838]; protein self-association [GO:0043621]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	GO:0001776; GO:0002318; GO:0002328; GO:0004712; GO:0004713; GO:0004714; GO:0004896; GO:0005021; GO:0005524; GO:0005634; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0010008; GO:0010243; GO:0014068; GO:0018108; GO:0019221; GO:0019838; GO:0030097; GO:0030183; GO:0031100; GO:0033674; GO:0035259; GO:0035726; GO:0042531; GO:0042981; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0043621; GO:0044877; GO:0046651; GO:0046777; GO:0071345; GO:0071385; GO:0097028	CTWTFSRK	10.38000011	0.096745528	0.096745528	0.324690332	1086.184203	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.85144	0	0	0	0	0	0	0	0	0	0	0	0	0	15.73078	0	0
P36896	ACV1B_HUMAN	"Activin receptor type-1B, EC 2.7.11.30 (Activin receptor type IB, ACTR-IB) (Activin receptor-like kinase 4, ALK-4) (Serine/threonine-protein kinase receptor R2, SKR2)"	ACVR1B ACVRLK4 ALK4	Homo sapiens (Human)	"activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"	activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]"	"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000082; GO:0001701; GO:0001942; GO:0004674; GO:0004675; GO:0005524; GO:0005829; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007399; GO:0009986; GO:0010628; GO:0010629; GO:0016361; GO:0018107; GO:0030308; GO:0031625; GO:0032924; GO:0032927; GO:0034711; GO:0038092; GO:0043235; GO:0045648; GO:0046332; GO:0046777; GO:0046872; GO:0048179; GO:0048185; GO:0071363; GO:0097191; GO:1901165	VMGKMMR	8.300000191	0.047738899	0.047738899	0.27255755	852.821864	17.33111	18.33264	0	17.76715	0	17.10046	17.57794	15.71457	17.01588	16.75112	19.25191	0	0	0	17.4801	16.9591	16.24457	0	0	0	0	18.43521	0	0	0	18.85494	18.92229	18.38146	0	0	0	18.90137	17.81704	18.83559	19.59391	0	0	18.43496	0	0	17.44735	15.78999	18.19785	0	17.35597	0	18.48721	0
P36897	TGFR1_HUMAN	"TGF-beta receptor type-1, TGFR-1, EC 2.7.11.30 (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5, ALK-5, ALK5) (Serine/threonine-protein kinase receptor R4, SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I, TGF-beta receptor type I, TbetaR-I)"	TGFBR1 ALK5 SKR4	Homo sapiens (Human)	"activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]"	activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]	"activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]"	"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]"	GO:0001501; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0005024; GO:0005025; GO:0005114; GO:0005524; GO:0005634; GO:0005768; GO:0005886; GO:0005923; GO:0006355; GO:0006468; GO:0006915; GO:0007165; GO:0007179; GO:0007399; GO:0007507; GO:0008284; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0010862; GO:0016020; GO:0016361; GO:0018105; GO:0018107; GO:0030199; GO:0030307; GO:0030335; GO:0031396; GO:0032331; GO:0032924; GO:0035556; GO:0042060; GO:0042118; GO:0043062; GO:0043235; GO:0043393; GO:0043410; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051272; GO:0051491; GO:0051496; GO:0051726; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060389; GO:0060391; GO:0060412; GO:0060978; GO:0060982; GO:0070021; GO:0070411; GO:0070723; GO:0071363; GO:0071560; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237	KNGTCCIADLGLAVR	3.299999952	1	1	0.475553074	1646.863294	16.52308	0	0	0	0	0	0	16.15806	0	0	0	0	10.7086	14.14576	0	0	0	0	0	14.92444	0	0	0	0	0	0	0	0	15.27114	0	0	0	0	0	0	0	0	0	0	0	16.17458	0	0	0	0	0	0	0
P36915	GNL1_HUMAN	Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1)	GNL1 HSR1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]	extracellular space [GO:0005615]; nucleus [GO:0005634]	extracellular space [GO:0005615]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural molecule activity [GO:0005198]; cellular response to DNA damage stimulus [GO:0006974]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural molecule activity [GO:0005198]	GO:0002456; GO:0003924; GO:0005198; GO:0005525; GO:0005615; GO:0005634; GO:0006974; GO:0007165	EQLMSQEER	3.349999905	1	1	0.202371794	1150.638259	15.86839	0	13.99193	14.73501	0	15.42481	15.67595	0	14.56527	15.34938	0	12.13713	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.18327	0	0	0	0	0	0	15.86567	16.50969	15.59837	15.38017	0	0	0	0	0
P36956	SRBP1_HUMAN	"Sterol regulatory element-binding protein 1, SREBP-1 (Class D basic helix-loop-helix protein 1, bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1) ]"	SREBF1 BHLHD1 SREBP1	Homo sapiens (Human)	aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid localization [GO:0010876]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of lipid storage [GO:0010883]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription coregulator binding [GO:0001221]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid localization [GO:0010876]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of lipid storage [GO:0010883]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription coregulator binding [GO:0001221]"	GO:0000122; GO:0000139; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0007568; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009410; GO:0009749; GO:0010867; GO:0010876; GO:0010883; GO:0012507; GO:0016021; GO:0019217; GO:0019901; GO:0030324; GO:0031065; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032933; GO:0032991; GO:0033762; GO:0042789; GO:0044877; GO:0045444; GO:0045471; GO:0045542; GO:0045944; GO:0046676; GO:0046983; GO:0051591; GO:0071398; GO:1902895; GO:1903146; GO:1903214; GO:1990837	LMAGASPTR	1.879999995	1	1	0.020978883	920.4140648	15.92473	15.5241	0	14.50373	0	0	16.59416	16.17143	0	0	0	16.42401	14.89617	0	0	13.11162	14.82416	0	16.9809	0	17.73829	17.58609	13.32172	0	0	16.61539	15.74326	0	17.62579	17.37772	15.57105	0	17.85096	0	0	0	0	17.55955	0	0	0	16.26884	0	0	0	0	0	0
P36959	GMPR1_HUMAN	"GMP reductase 1, GMPR 1, EC 1.7.1.7 (Guanosine 5'-monophosphate oxidoreductase 1, Guanosine monophosphate reductase 1)"	GMPR GMPR1	Homo sapiens (Human)	purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; response to cold [GO:0009409]	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; response to cold [GO:0009409]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0005829; GO:0006144; GO:0006163; GO:0009409; GO:0046872; GO:1902560	IDADLK	6.119999886	0.843445659	0.843445659	0.20962238	674.5520796	0	0	15.98045	17.53611	0	0	15.01291	0	15.4249	16.00544	14.41817	0	0	0	0	0	15.78041	0	15.84861	15.1452	16.37951	15.97557	16.22646	0	14.9697	0	0	15.22461	0	18.50981	0	16.97903	0	0	15.53228	16.73606	0	0	17.26329	0	0	0	17.55081	14.59743	14.5527	15.71413	17.06991	0
P37023	ACVL1_HUMAN	"Serine/threonine-protein kinase receptor R3, SKR3, EC 2.7.11.30 (Activin receptor-like kinase 1, ALK-1) (TGF-B superfamily receptor type I, TSR-I)"	ACVRL1 ACVRLK1 ALK1	Homo sapiens (Human)	"angiogenesis [GO:0001525]; artery development [GO:0060840]; blood circulation [GO:0008015]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; blood vessel maturation [GO:0001955]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral pattern formation [GO:0009953]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of DNA replication [GO:0006275]; regulation of endothelial cell proliferation [GO:0001936]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]"	BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; angiogenesis [GO:0001525]; artery development [GO:0060840]; blood circulation [GO:0008015]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; blood vessel maturation [GO:0001955]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral pattern formation [GO:0009953]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of DNA replication [GO:0006275]; regulation of endothelial cell proliferation [GO:0001936]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]"	"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transforming growth factor beta-activated receptor activity [GO:0005024]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]"	GO:0001525; GO:0001666; GO:0001701; GO:0001936; GO:0001937; GO:0001938; GO:0001946; GO:0001955; GO:0001974; GO:0002043; GO:0003203; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006275; GO:0006355; GO:0006468; GO:0007162; GO:0007165; GO:0007179; GO:0007507; GO:0008015; GO:0008217; GO:0008285; GO:0009953; GO:0009986; GO:0010596; GO:0010629; GO:0010862; GO:0016361; GO:0019901; GO:0030308; GO:0030336; GO:0030425; GO:0030509; GO:0030513; GO:0032332; GO:0035313; GO:0035912; GO:0043025; GO:0043235; GO:0043535; GO:0043537; GO:0045602; GO:0045603; GO:0045766; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048185; GO:0050431; GO:0051895; GO:0060836; GO:0060840; GO:0060841; GO:0061154; GO:0061298; GO:0070724; GO:0071363; GO:0071560; GO:0071773; GO:0098821; GO:2000279	QTLEPHLALR	10.76000023	1	1	0.481330667	1176.799366	0	19.33875	0	0	0	17.9129	0	0	0	0	0	18.46904	0	0	0	0	0	0	17.00016	0	0	0	0	0	0	18.65847	18.7079	0	0	0	0	17.58172	0	0	0	20.60143	0	0	0	17.45099	17.50074	0	0	17.31551	0	0	0	0
P37059	DHB2_HUMAN	"17-beta-hydroxysteroid dehydrogenase type 2, 17-beta-HSD 2 (20 alpha-hydroxysteroid dehydrogenase, 20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 2, EC 1.1.1.62) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase, EC 1.1.1.239)"	HSD17B2 EDH17B2 SDR9C2	Homo sapiens (Human)	estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]"	"17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]"	GO:0001701; GO:0001890; GO:0004303; GO:0005789; GO:0006703; GO:0016021; GO:0032526; GO:0044594; GO:0047006; GO:0047035; GO:0072582	DFSPVLRDIQHAILAK	6.800000191	0.828461826	0.828461826	0.103895923	1822.166321	13.15779	15.61246	0	11.09169	14.97486	0	14.68234	15.72168	15.46178	12.86231	15.00582	0	0	0	0	14.13933	0	0	14.44466	0	0	0	0	0	0	14.64539	16.72348	0	0	0	0	0	0	0	0	0	16.53788	0	0	0	0	16.63401	0	0	0	0	0	0
P37088	SCNNA_HUMAN	"Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha, Alpha-ENaC, ENaCA) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)"	SCNN1A SCNN1	Homo sapiens (Human)	cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; multicellular organismal water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228]	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; multicellular organismal water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]	GO:0001669; GO:0005737; GO:0005886; GO:0005887; GO:0006883; GO:0008217; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725; GO:0036254; GO:0050699; GO:0050891; GO:0050914; GO:0050915; GO:0055078; GO:0060170; GO:0070062; GO:0071468; GO:0097228; GO:0098719; GO:1904045; GO:1904117	ARSVASSLR	3.230000019	0.410047352	0.410047352	0.121425133	947.432514	0	15.00219	14.50709	15.5827	0	14.1943	14.62527	13.69479	12.90307	0	0	14.98407	15.00463	0	15.46619	0	0	15.03478	13.91762	14.93615	0	14.82121	14.06519	0	0	15.38701	0	14.8274	13.71532	13.00102	0	0	0	0	0	0	16.04093	0	0	0	0	0	0	0	0	0	0	0
P37268	FDFT_HUMAN	"Squalene synthase, SQS, SS, EC 2.5.1.21 (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase 1)"	FDFT1	Homo sapiens (Human)	cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; steroid biosynthetic process [GO:0006694]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; steroid biosynthetic process [GO:0006694]	farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996]	GO:0004310; GO:0005783; GO:0005789; GO:0006694; GO:0006695; GO:0016021; GO:0045338; GO:0046872; GO:0051996	ANSMGLFLQKTNIIR	5.679999828	1	1	0.244100249	1705.35618	12.11716	0	0	0	0	13.79795	0	0	0	14.64789	0	0	0	0	0	16.39488	0	14.31019	0	0	0	0	0	0	0	16.09748	0	10.69402	0	0	0	0	13.32182	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P37275	ZEB1_HUMAN	"Zinc finger E-box-binding homeobox 1 (NIL-2-A zinc finger protein) (Negative regulator of IL2) (Transcription factor 8, TCF-8)"	ZEB1 AREB6 TCF8	Homo sapiens (Human)	"anatomical structure development [GO:0048856]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cochlea morphogenesis [GO:0090103]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system morphogenesis [GO:0048704]; forebrain development [GO:0030900]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mesenchymal cell proliferation [GO:0010464]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to activity [GO:0014823]; response to nutrient levels [GO:0031667]; semicircular canal morphogenesis [GO:0048752]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cochlea morphogenesis [GO:0090103]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system morphogenesis [GO:0048704]; forebrain development [GO:0030900]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mesenchymal cell proliferation [GO:0010464]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to activity [GO:0014823]; response to nutrient levels [GO:0031667]; semicircular canal morphogenesis [GO:0048752]"	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007389; GO:0008270; GO:0008285; GO:0010464; GO:0014823; GO:0017015; GO:0030154; GO:0030900; GO:0031667; GO:0033081; GO:0045602; GO:0045666; GO:0045892; GO:0045944; GO:0048596; GO:0048704; GO:0048752; GO:0048856; GO:0051150; GO:0051216; GO:0070888; GO:0071230; GO:0071560; GO:0090103	HMTSHK	6.400000095	1	1	0.272302794	740.7648516	15.23026	14.15948	13.61182	0	0	0	0	0	15.92188	16.09127	14.49946	0	18.36744	14.13969	18.10731	0	0	17.23489	16.62639	18.29617	0	17.09033	0	0	18.24108	0	16.77978	17.94265	15.47607	16.32275	18.08372	17.30389	0	18.44721	17.89692	16.09371	19.84968	20.02179	19.07007	0	16.8231	16.72702	19.0487	19.77574	0	19.19586	0	16.72601
P37802	TAGL2_HUMAN	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2 KIAA0120 CDABP0035	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epithelial cell differentiation [GO:0030855]	cadherin binding [GO:0045296]	GO:0005576; GO:0005829; GO:0005856; GO:0030855; GO:0031982; GO:0045296; GO:0070062	GASQAGMTGYGMPRQIL	9.649999619	1	1	0.385897341	1737.817072	16.96805	15.21325	0	0	0	0	0	0	15.08887	16.9011	17.00313	15.2353	0	13.58414	0	15.9429	0	0	15.9654	0	0	15.77701	0	17.32243	0	0	16.86936	12.56532	16.48759	0	0	0	17.34847	0	17.3467	16.0918	17.29122	16.34722	0	0	0	0	0	16.182	14.8374	0	14.91648	0
P37837	TALDO_HUMAN	"Transaldolase, EC 2.2.1.2"	TALDO1 TAL TALDO TALDOR	Homo sapiens (Human)	"carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; transaldolase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]"	monosaccharide binding [GO:0048029]; transaldolase activity [GO:0004801]	GO:0004801; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0006002; GO:0009052; GO:0019682; GO:0048029; GO:0070062	FSYKTIVMGASFR	9.289999962	1	1	0.211446281	1517.140448	15.45681	15.54471	15.56721	14.80621	0	14.57045	16.59299	0	15.65833	14.03302	13.02451	11.06841	0	0	0	15.06785	15.51012	0	16.90372	0	0	0	0	0	0	0	0	0	0	0	0	16.52715	0	0	0	0	18.57074	0	0	16.16396	0	0	17.87834	0	18.35807	0	0	0
P38117	ETFB_HUMAN	"Electron transfer flavoprotein subunit beta, Beta-ETF"	ETFB FP585	Homo sapiens (Human)	cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]	electron transfer activity [GO:0009055]	GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251	IEVIKPGDLGVDLTSKLSVISVEDPPQR	1.360000014	1	1	0.004176649	2996.392171	15.26037	0	6.668431	0	0	0	0	15.10983	0	0	0	0	0	0	15.33024	0	10.72084	15.33264	13.52017	0	0	0	0	0	14.58076	0	13.39313	14.37315	13.68655	14.63197	15.28788	0	15.02518	9.619596	11.45368	15.88058	0	16.8381	0	0	14.40001	0	0	0	0	0	0	0
P38159	RBMX_HUMAN	"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G, hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed ]"	RBMX HNRPG RBMXP1	Homo sapiens (Human)	"cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]"	catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]	"catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]"	chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000381; GO:0000398; GO:0000791; GO:0000978; GO:0001649; GO:0003682; GO:0003723; GO:0003729; GO:0005615; GO:0005634; GO:0005654; GO:0005681; GO:0006366; GO:0006509; GO:0016020; GO:0019904; GO:0032991; GO:0042802; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347; GO:1990904	DAARDMNGK	3.410000086	1	1	0.159834533	992.3908264	15.91829	0	14.78223	11.69514	0	14.65729	11.72316	0	0	0	0	0	13.81247	12.03884	0	0	0	14.32106	15.80779	0	0	0	12.49281	0	13.84616	0	0	0	15.44738	0	17.43404	0	13.64638	16.34404	0	0	15.72237	15.05726	0	0	0	0	16.61167	0	15.48528	0	14.09567	0
P38398	BRCA1_HUMAN	"Breast cancer type 1 susceptibility protein, EC 2.3.2.27 (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)"	BRCA1 RNF53	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cell cycle [GO:0045786]; negative regulation of centriole replication [GO:0046600]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA methylation [GO:0044030]; regulation of DNA repair [GO:0006282]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]"	BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; gamma-tubulin large complex [GO:0000931]; lateral element [GO:0000800]; nuclear body [GO:0016604]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]	"BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; gamma-tubulin large complex [GO:0000931]; lateral element [GO:0000800]; nuclear body [GO:0016604]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cell cycle [GO:0045786]; negative regulation of centriole replication [GO:0046600]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA methylation [GO:0044030]; regulation of DNA repair [GO:0006282]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]"	damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000152; GO:0000209; GO:0000724; GO:0000800; GO:0000931; GO:0000976; GO:0003677; GO:0003684; GO:0003713; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005886; GO:0006281; GO:0006282; GO:0006301; GO:0006302; GO:0006349; GO:0006357; GO:0006633; GO:0006974; GO:0007059; GO:0007095; GO:0007098; GO:0008270; GO:0008630; GO:0009048; GO:0010212; GO:0010575; GO:0010628; GO:0015631; GO:0016567; GO:0016604; GO:0019899; GO:0031398; GO:0031436; GO:0031625; GO:0032991; GO:0033147; GO:0035066; GO:0035067; GO:0035518; GO:0035825; GO:0043009; GO:0043627; GO:0044030; GO:0044818; GO:0045717; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0046600; GO:0051571; GO:0051572; GO:0051573; GO:0051574; GO:0051726; GO:0051865; GO:0070063; GO:0070512; GO:0070531; GO:0070532; GO:0070533; GO:0070537; GO:0071356; GO:0071479; GO:0071681; GO:0085020; GO:0110025; GO:1902042; GO:1990391; GO:1990904; GO:2000001; GO:2000378; GO:2000617; GO:2000620	IICAFQLDTGLEYANSYNFAK	7.53000021	1	1	0.204978487	2437.218576	0	15.322	0	0	0	14.85372	0	0	0	0	0	0	0	0	0	16.40094	15.57976	16.00301	0	0	14.67525	0	0	16.74988	0	0	15.97646	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P38570	ITAE_HUMAN	Integrin alpha-E (HML-1 antigen) (Integrin alpha-IEL) (Mucosal lymphocyte 1 antigen) (CD antigen CD103) [Cleaved into: Integrin alpha-E light chain; Integrin alpha-E heavy chain ]	ITGAE	Homo sapiens (Human)	cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]	external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]	integrin binding [GO:0005178]; metal ion binding [GO:0046872]	GO:0005178; GO:0005886; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0033627; GO:0046872; GO:0098609	GVTVVR	5.829999924	0.716462433	0.716462433	0.270925981	631.9464749	0	0	0	0	0	14.60493	0	0	0	0	15.50442	0	0	16.84053	0	0	0	0	0	17.45231	0	0	0	17.44035	16.79085	16.81969	0	0	0	16.87676	17.65065	0	0	0	17.96096	16.60195	18.69402	0	17.87761	0	0	17.49984	17.46148	0	0	0	0	0
P38606	VATA_HUMAN	"V-type proton ATPase catalytic subunit A, V-ATPase subunit A, EC 7.1.2.2 (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha)"	ATP6V1A ATP6A1 ATP6V1A1 VPP2	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]"	"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000139; GO:0000221; GO:0005524; GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0006879; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0016324; GO:0016469; GO:0030133; GO:0030141; GO:0033176; GO:0036295; GO:0043231; GO:0046933; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:1902600	IKSDYAQLLEDMQNAFR	1.080000043	1	1	0.414673825	2041.946824	17.41804	0	15.98902	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6385	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.09694	0	0	0	0
P38646	GRP75_HUMAN	"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein, GRP-75) (Heat shock 70 kDa protein 9) (Mortalin, MOT) (Peptide-binding protein 74, PBP74)"	HSPA9 GRP75 HSPA9B mt-HSP70	Homo sapiens (Human)	cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; inner mitochondrial membrane organization [GO:0007007]; intracellular protein transport [GO:0006886]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; MIB complex [GO:0140275]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; MIB complex [GO:0140275]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; inner mitochondrial membrane organization [GO:0007007]; intracellular protein transport [GO:0006886]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0001401; GO:0003723; GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0005925; GO:0006611; GO:0006886; GO:0007007; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0042645; GO:0043066; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:0070062; GO:0140275; GO:1902037; GO:1903707	ETGVDLTKDNMALQR	5.480000019	1	1	0.540323242	1706.833199	0	0	17.8355	0	0	0	19.73081	0	0	0	0	0	0	0	0	0	18.47109	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.69291	0	19.26715	0	19.5931	0	0	0	0	0	0
P38919	IF4A3_HUMAN	"Eukaryotic initiation factor 4A-III, eIF-4A-III, eIF4A-III, EC 3.6.4.13 (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic initiation factor 4A-like NUK-34) (Eukaryotic translation initiation factor 4A isoform 3) (Nuclear matrix protein 265, NMP 265, hNMP 265) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed ]"	EIF4A3 DDX48 KIAA0111	Homo sapiens (Human)	"associative learning [GO:0008306]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to selenite ion [GO:0072715]; embryonic cranial skeleton morphogenesis [GO:0048701]; exploration behavior [GO:0035640]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of selenocysteine incorporation [GO:1904570]; negative regulation of selenocysteine insertion sequence binding [GO:1904574]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to organic cyclic compound [GO:0014070]; rRNA processing [GO:0006364]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; U2-type catalytic step 1 spliceosome [GO:0071006]	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; U2-type catalytic step 1 spliceosome [GO:0071006]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; selenocysteine insertion sequence binding [GO:0035368]; translation regulator activity [GO:0045182]; associative learning [GO:0008306]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to selenite ion [GO:0072715]; embryonic cranial skeleton morphogenesis [GO:0048701]; exploration behavior [GO:0035640]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of selenocysteine incorporation [GO:1904570]; negative regulation of selenocysteine insertion sequence binding [GO:1904574]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to organic cyclic compound [GO:0014070]; rRNA processing [GO:0006364]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; selenocysteine insertion sequence binding [GO:0035368]; translation regulator activity [GO:0045182]	GO:0000184; GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006406; GO:0008143; GO:0008306; GO:0014070; GO:0016020; GO:0016607; GO:0016887; GO:0017148; GO:0030425; GO:0035145; GO:0035368; GO:0035613; GO:0035640; GO:0043021; GO:0043025; GO:0045182; GO:0045727; GO:0048701; GO:0071006; GO:0071013; GO:0072715; GO:0090394; GO:0098978; GO:0099524; GO:0099578; GO:1904570; GO:1904574; GO:1990416; GO:2000622	ATTATMATSGSAR	9.920000076	1	1	0.184642349	1225.49093	15.61026	17.54864	16.00884	15.2785	15.82135	13.52523	14.44588	14.86542	15.03225	15.63908	0	15.36565	9.500751	14.20311	0	15.71432	14.20621	12.87953	13.5978	15.96098	14.91934	0	0	15.99526	14.33321	14.63587	15.6159	15.36835	14.34769	0	16.45911	16.20283	15.73555	15.71409	0	0	15.63166	15.47506	0	0	15.43366	0	0	14.43727	0	14.98655	0	16.01023
P38936	CDN1A_HUMAN	"Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6, MDA-6) (p21)"	CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1	Homo sapiens (Human)	"cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV-B [GO:0071493]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into nucleus [GO:0006606]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; stress-induced premature senescence [GO:0090400]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]"	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA-p21 complex [GO:0070557]; protein-containing complex [GO:0032991]	"cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA-p21 complex [GO:0070557]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activating kinase activity [GO:0019912]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV-B [GO:0071493]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into nucleus [GO:0006606]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; stress-induced premature senescence [GO:0090400]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]"	cyclin binding [GO:0030332]; cyclin-dependent protein kinase activating kinase activity [GO:0019912]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]	GO:0000079; GO:0000082; GO:0000307; GO:0004860; GO:0004861; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006606; GO:0006974; GO:0006977; GO:0006978; GO:0007095; GO:0007265; GO:0007507; GO:0008285; GO:0010389; GO:0010629; GO:0016604; GO:0019901; GO:0019912; GO:0030308; GO:0030332; GO:0030890; GO:0031625; GO:0031668; GO:0032091; GO:0032991; GO:0034198; GO:0042060; GO:0042246; GO:0042326; GO:0042771; GO:0043068; GO:0044877; GO:0045860; GO:0046872; GO:0048146; GO:0051726; GO:0070557; GO:0071479; GO:0071480; GO:0071493; GO:0090398; GO:0090399; GO:0090400; GO:0097193; GO:0140311; GO:1902806; GO:1904030; GO:1904706; GO:1905179; GO:2000045; GO:2000134; GO:2000279; GO:2000379	VRGLGLPK	8.970000267	0.737521827	0.737521827	0.277227116	840.824544	16.16827	19.94989	16.95428	0	0	20.39725	18.60201	0	0	0	18.0931	19.86804	0	0	0	0	0	0	16.43746	0	0	17.37691	0	0	0	19.36571	0	0	0	18.35717	0	0	0	0	0	0	0	17.58217	0	0	0	0	0	0	0	0	0	0
P39059	COFA1_HUMAN	Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV) ]	COL15A1	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165]	collagen type XV trimer [GO:0005582]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	collagen type XV trimer [GO:0005582]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005582; GO:0005615; GO:0005788; GO:0007155; GO:0007165; GO:0016021; GO:0030020; GO:0030198; GO:0031012; GO:0062023; GO:0070062	EHVGMK	5.900000095	0.575181901	0.575181901	0.271589496	716.2550664	16.6883	0	0	15.19177	0	13.97071	0	0	0	0	0	0	15.2609	0	15.23937	16.99994	0	0	0	0	16.11071	0	17.8227	17.53383	17.38065	17.57635	0	14.85168	0	16.53258	15.35092	15.79238	0	0	16.50559	0	17.3711	15.83704	17.48728	16.68282	0	16.43194	15.87372	0	0	15.6096	16.85218	16.18157
P39060	COIA1_HUMAN	"Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin; Non-collagenous domain 1, NC1 ]"	COL18A1	Homo sapiens (Human)	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; visual perception [GO:0007601]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; visual perception [GO:0007601]	extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0007601; GO:0008285; GO:0009887; GO:0030198; GO:0031012; GO:0042802; GO:0046872; GO:0062023; GO:0070062	GDPGVGERGPPGPQGPPGPPGPSFR	1.960000038	1	1	1.37E-12	2366.462833	13.76386	13.96818	14.35296	13.02308	12.43392	9.51579	13.46207	12.13718	13.95757	0	12.91554	0	13.05844	10.5538	0	12.85297	14.85028	13.26105	12.84457	13.45651	0	0	0	0	0	0	12.90338	0	0	14.00902	0	0	0	0	16.29263	0	0	0	0	0	0	0	0	0	0	0	0	0
P39687	AN32A_HUMAN	"Acidic leucine-rich nuclear phosphoprotein 32 family member A (Acidic nuclear phosphoprotein pp32, pp32) (Leucine-rich acidic nuclear protein, LANP) (Mapmodulin) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A) (Putative HLA-DR-associated protein I, PHAPI)"	ANP32A C15orf1 LANP MAPM PHAP1	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; nucleocytoplasmic transport [GO:0006913]; regulation of apoptotic process [GO:0042981]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; histone binding [GO:0042393]; RNA binding [GO:0003723]; intracellular signal transduction [GO:0035556]; nucleocytoplasmic transport [GO:0006913]; regulation of apoptotic process [GO:0042981]	histone binding [GO:0042393]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006913; GO:0035556; GO:0042393; GO:0042981; GO:0048471	LELSDNR	9.239999771	0.432190657	0.432190657	0.286825354	845.136747	12.7822	16.68593	0	17.58176	0	0	19.73032	0	0	0	0	0	0	0	0	0	0	17.56051	0	0	0	0	0	17.15638	0	17.81487	17.85088	0	0	0	0	0	19.63802	17.61335	16.67837	0	0	0	0	0	0	0	17.58648	0	0	0	18.81672	0
P39748	FEN1_HUMAN	"Flap endonuclease 1, FEN-1, EC 3.1.-.- (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1, MF1, hFEN-1)"	FEN1 RAD2	Homo sapiens (Human)	"base-excision repair, gap-filling [GO:0006287]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; memory [GO:0007613]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of sister chromatid cohesion [GO:0045876]; telomere maintenance via semi-conservative replication [GO:0032201]; UV protection [GO:0009650]"	"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]"	"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; base-excision repair, gap-filling [GO:0006287]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; memory [GO:0007613]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of sister chromatid cohesion [GO:0045876]; telomere maintenance via semi-conservative replication [GO:0032201]; UV protection [GO:0009650]"	5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	GO:0000287; GO:0000724; GO:0000781; GO:0003677; GO:0003684; GO:0003690; GO:0004519; GO:0004523; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006281; GO:0006287; GO:0006302; GO:0007613; GO:0008309; GO:0008409; GO:0009650; GO:0016020; GO:0017108; GO:0030145; GO:0032201; GO:0032991; GO:0043137; GO:0045876; GO:0048256; GO:0090305	QLQQAQAAGAEQEVEKFTK	2.00999999	1	1	9.20E-13	2103.919564	14.61167	0	15.31278	0	13.93341	13.69027	14.00632	0	0	0	17.93694	0	0	0	0	0	13.14449	8.138556	16.13827	0	0	0	0	0	0	0	0	0	14.82455	0	0	16.7904	0	0	0	0	0	0	0	16.04643	0	0	9.158997	0	12.91676	0	0	0
P39900	MMP12_HUMAN	"Macrophage metalloelastase, MME, EC 3.4.24.65 (Macrophage elastase, ME, hME) (Matrix metalloproteinase-12, MMP-12)"	MMP12 HME	Homo sapiens (Human)	"bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; response to amyloid-beta [GO:1904645]; wound healing, spreading of epidermal cells [GO:0035313]"	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; response to amyloid-beta [GO:1904645]; wound healing, spreading of epidermal cells [GO:0035313]"	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0000122; GO:0001046; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0032727; GO:0035313; GO:0043565; GO:0045944; GO:0048286; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0060435; GO:0098586; GO:1904645; GO:1904905	NFQGIGPK	22.18000031	1	1	0.417937646	861.4382305	0	0	0	18.87777	0	16.90228	0	17.69146	0	0	0	0	0	0	18.04396	0	0	0	18.96446	0	0	0	0	17.45011	0	0	0	19.25212	0	0	0	17.70692	0	0	0	0	0	0	0	0	17.89345	0	0	0	0	0	16.6807	0
P39905	GDNF_HUMAN	"Glial cell line-derived neurotrophic factor, hGDNF (Astrocyte-derived trophic factor, ATF)"	GDNF	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; branching involved in ureteric bud morphogenesis [GO:0001658]; commissural neuron axon guidance [GO:0071679]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; enteric nervous system development [GO:0048484]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; metanephros development [GO:0001656]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; peripheral nervous system development [GO:0007422]; peristalsis [GO:0030432]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; postganglionic parasympathetic fiber development [GO:0021784]; postsynaptic membrane organization [GO:0001941]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of gene expression [GO:0010468]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of stem cell differentiation [GO:2000736]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; ureteric bud formation [GO:0060676]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemoattractant activity involved in axon guidance [GO:1902379]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; adult locomotory behavior [GO:0008344]; branching involved in ureteric bud morphogenesis [GO:0001658]; commissural neuron axon guidance [GO:0071679]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; enteric nervous system development [GO:0048484]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; metanephros development [GO:0001656]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; peripheral nervous system development [GO:0007422]; peristalsis [GO:0030432]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; postganglionic parasympathetic fiber development [GO:0021784]; postsynaptic membrane organization [GO:0001941]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of gene expression [GO:0010468]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of stem cell differentiation [GO:2000736]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; ureteric bud formation [GO:0060676]	chemoattractant activity involved in axon guidance [GO:1902379]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0001656; GO:0001658; GO:0001755; GO:0001759; GO:0001941; GO:0003337; GO:0005102; GO:0005576; GO:0005615; GO:0005794; GO:0007165; GO:0007399; GO:0007422; GO:0008083; GO:0008284; GO:0008344; GO:0010468; GO:0021516; GO:0021784; GO:0030116; GO:0030432; GO:0030971; GO:0031175; GO:0032770; GO:0033603; GO:0042803; GO:0043066; GO:0043524; GO:0045597; GO:0045944; GO:0048255; GO:0048484; GO:0048485; GO:0048568; GO:0051584; GO:0060676; GO:0060688; GO:0071679; GO:0072107; GO:0072108; GO:0090190; GO:1902379; GO:2000736; GO:2001240; GO:2001260	EELIFR	5.980000019	1	1	0.248153966	806.4396594	0	18.68217	0	0	0	17.60364	0	0	0	0	0	0	0	0	17.27774	0	0	0	0	0	16.89309	0	18.99319	0	0	0	0	0	0	0	0	0	0	0	18.74016	0	0	0	0	0	0	0	16.90273	0	0	0	0	0
P40126	TYRP2_HUMAN	"L-dopachrome tautomerase, DCT, DT, EC 5.3.3.12 (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2, TRP-2, TRP2)"	DCT TYRP2	Homo sapiens (Human)	cell development [GO:0048468]; developmental pigmentation [GO:0048066]; epidermis development [GO:0008544]; melanin biosynthetic process from tyrosine [GO:0006583]; positive regulation of neuroblast proliferation [GO:0002052]; response to blue light [GO:0009637]; ventricular zone neuroblast division [GO:0021847]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; dopachrome isomerase activity [GO:0004167]; oxidoreductase activity [GO:0016491]; cell development [GO:0048468]; developmental pigmentation [GO:0048066]; epidermis development [GO:0008544]; melanin biosynthetic process from tyrosine [GO:0006583]; positive regulation of neuroblast proliferation [GO:0002052]; response to blue light [GO:0009637]; ventricular zone neuroblast division [GO:0021847]	copper ion binding [GO:0005507]; dopachrome isomerase activity [GO:0004167]; oxidoreductase activity [GO:0016491]	GO:0002052; GO:0004167; GO:0005507; GO:0005829; GO:0005886; GO:0006583; GO:0008544; GO:0009637; GO:0016021; GO:0016491; GO:0021847; GO:0033162; GO:0042470; GO:0043231; GO:0048066; GO:0048468	ILPGAQGQFPR	3.029999971	0.740159988	0.740159988	0.126475898	1183.725997	14.46044	0	15.1141	14.5778	0	14.38694	14.73714	0	0	0	0	0	0	0	0	5.616707	0	0	0	16.65364	15.46918	0	15.49655	15.65984	13.2257	0	12.58537	0	14.65853	0	0	14.60401	13.75525	14.76948	14.51696	9.927031	14.41144	13.45428	16.16864	0	12.80942	14.82702	10.39183	14.84074	14.35864	0	13.67297	14.30447
P40197	GPV_HUMAN	"Platelet glycoprotein V, GPV (Glycoprotein 5) (CD antigen CD42d)"	GP5	Homo sapiens (Human)	"blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; megakaryocyte development [GO:0035855]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]"	extracellular exosome [GO:0070062]; glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"extracellular exosome [GO:0070062]; glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; megakaryocyte development [GO:0035855]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]"		GO:0005886; GO:0005887; GO:0007155; GO:0007597; GO:0010572; GO:0035855; GO:0051209; GO:0070062; GO:1990779	MLRGTLLCAVLGLLR	2.470000029	0.444742441	0.444742441	0.10739221	1685.712434	15.85537	0	17.13475	0	0	16.27272	18.15873	0	12.51626	14.26365	0	0	12.73829	17.35601	17.592	0	15.77435	11.63822	0	14.14511	0	14.95839	0	13.02538	14.03956	14.15441	14.35675	16.24057	11.66264	15.78679	11.20309	17.29965	15.90587	17.45548	14.63842	14.15391	17.11105	17.86357	16.37788	12.66536	14.04734	14.42894	15.45504	10.47565	13.48634	14.8777	17.61877	17.38227
P40200	TACT_HUMAN	T-cell surface protein tactile (Cell surface antigen CD96) (T cell-activated increased late expression protein) (CD antigen CD96)	CD96	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell cytokine production [GO:0002728]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell cytokine production [GO:0002728]; response to lipopolysaccharide [GO:0032496]		GO:0002728; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007155; GO:0007160; GO:0032496; GO:0032689	YCAVYYIIQIHFVK	6.679999828	1	1	0.223103882	1816.236428	0	0	0	0	0	0	0	13.89287	8.259936	0	0	0	16.01646	13.95853	14.39601	11.85565	0	14.28571	0	16.03164	16.52544	0	16.28316	0	15.52503	14.2141	16.25867	0	0	0	10.09592	0	13.45282	11.85512	0	0	0	0	14.53695	0	11.85411	15.73244	0	0	12.97298	0	0	13.98984
P40222	TXLNA_HUMAN	Alpha-taxilin	TXLNA TXLN	Homo sapiens (Human)	B cell activation [GO:0042113]; exocytosis [GO:0006887]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; syntaxin binding [GO:0019905]; B cell activation [GO:0042113]; exocytosis [GO:0006887]	syntaxin binding [GO:0019905]	GO:0005576; GO:0005737; GO:0005829; GO:0006887; GO:0016020; GO:0019905; GO:0042113	QQETHLK	6.989999771	0.733694255	0.733694255	0.261425256	885.8929624	13.57946	16.12739	14.63681	0	0	0	0	0	0	15.64335	16.50197	14.10398	0	15.48263	15.57187	0	15.94884	15.94938	0	16.34735	15.92275	0	16.70601	0	15.87711	0	16.77793	12.71028	0	14.87082	16.3128	14.71762	12.03648	17.21234	15.97744	17.14599	15.10353	16.07378	17.26694	12.21836	0	14.25868	14.87602	15.43174	15.13168	13.53093	16.95658	14.32618
P40227	TCPZ_HUMAN	"T-complex protein 1 subunit zeta, TCP-1-zeta (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)"	CCT6A CCT6 CCTZ	Homo sapiens (Human)	chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]	GO:0003723; GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0016887; GO:0032212; GO:0044183; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:0071987; GO:1904851; GO:1904871; GO:1904874	TNLGPKGTMK	3.559999943	0.435032576	0.435032576	0.225303682	1061.746643	15.60852	16.53756	16.71461	15.35146	16.48883	15.62342	16.43287	14.46768	0	16.31906	15.89611	15.65906	15.86289	0	14.41218	13.37494	8.657065	16.59475	12.35954	0	0	0	17.26516	0	16.23988	16.14338	17.31905	16.01291	16.23796	16.71605	17.76549	16.96649	0	0	0	16.11316	15.7905	15.77421	15.07191	15.8969	0	16.18885	0	0	16.34903	15.20667	0	0
P40261	NNMT_HUMAN	"Nicotinamide N-methyltransferase, EC 2.1.1.1"	NNMT	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; methylation [GO:0032259]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinamide metabolic process [GO:0006769]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein deacetylation [GO:0090312]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone methylation [GO:0031060]; regulation of polyamine biosynthetic process [GO:0010967]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410]	cytosol [GO:0005829]	cytosol [GO:0005829]; N-methyltransferase activity [GO:0008170]; nicotinamide N-methyltransferase activity [GO:0008112]; pyridine N-methyltransferase activity [GO:0030760]; animal organ regeneration [GO:0031100]; methylation [GO:0032259]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinamide metabolic process [GO:0006769]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein deacetylation [GO:0090312]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone methylation [GO:0031060]; regulation of polyamine biosynthetic process [GO:0010967]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410]	N-methyltransferase activity [GO:0008170]; nicotinamide N-methyltransferase activity [GO:0008112]; pyridine N-methyltransferase activity [GO:0030760]	GO:0005829; GO:0006769; GO:0008112; GO:0008170; GO:0009410; GO:0010243; GO:0010967; GO:0030760; GO:0031060; GO:0031100; GO:0032259; GO:0034356; GO:0045722; GO:0051569; GO:0090312	GPEKEEK	2.329999924	0.012895986	0.012895986	0.293129403	815.1402217	0	0	0	0	0	0	17.49388	0	0	16.24482	0	0	0	0	16.58021	18.92771	0	0	0	0	15.58942	0	0	0	0	0	0	0	0	0	0	0	16.85048	19.29276	0	0	0	19.11261	0	0	0	19.14519	0	0	0	0	18.30837	18.23711
P40305	IFI27_HUMAN	"Interferon alpha-inducible protein 27, mitochondrial, p27 (Interferon alpha-induced 11.5 kDa protein) (Interferon-stimulated gene 12a protein, ISG12(a), ISG12A)"	IFI27	Homo sapiens (Human)	apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; innate immune response [GO:0045087]; modulation by host of viral genome replication [GO:0044827]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein export from nucleus [GO:0046825]; type I interferon signaling pathway [GO:0060337]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; innate immune response [GO:0045087]; modulation by host of viral genome replication [GO:0044827]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein export from nucleus [GO:0046825]; type I interferon signaling pathway [GO:0060337]	identical protein binding [GO:0042802]; lamin binding [GO:0005521]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]	GO:0000122; GO:0005521; GO:0005635; GO:0005637; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0042802; GO:0043161; GO:0044827; GO:0045087; GO:0046825; GO:0051607; GO:0060337; GO:0061629; GO:0070936; GO:0097190; GO:0097191	MEASALTSSAVTSVAK	12.60999966	1	1	2.98E-12	1567.804607	16.04218	16.16045	15.19956	0	13.17155	15.26841	14.93603	14.86384	0	15.0766	14.15178	12.22171	13.57547	15.17122	15.41633	0	13.34886	0	14.75638	0	0	14.74458	0	0	0	13.53048	0	15.45611	14.4596	15.40026	15.93318	0	0	0	15.12477	0	0	0	0	0	0	0	0	0	0	0	0	0
P40306	PSB10_HUMAN	"Proteasome subunit beta type-10, EC 3.4.25.1 (Low molecular mass protein 10) (Macropain subunit MECl-1) (Multicatalytic endopeptidase complex subunit MECl-1) (Proteasome MECl-1) (Proteasome subunit beta-2i)"	PSMB10 LMP10 MECL1	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; humoral immune response [GO:0006959]; proteasomal protein catabolic process [GO:0010498]; T cell proliferation [GO:0042098]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]; threonine-type endopeptidase activity [GO:0004298]; cell morphogenesis [GO:0000902]; humoral immune response [GO:0006959]; proteasomal protein catabolic process [GO:0010498]; T cell proliferation [GO:0042098]"	threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0000902; GO:0004298; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0006959; GO:0010498; GO:0019774; GO:0042098; GO:1990111	LKPALEPR	11.14000034	1	1	0.194278344	922.1040733	0	15.65114	15.4038	0	0	0	0	14.48697	15.32291	0	16.12284	0	15.51746	15.24474	15.52336	14.46018	15.6565	0	0	0	15.71862	0	12.00359	0	16.13958	14.85802	17.0539	13.6617	12.17192	14.85061	15.2436	0	0	14.15825	0	14.75943	0	13.39568	12.28691	0	14.81475	14.28318	13.84099	11.79069	15.04021	14.81857	14.81286	0
P40394	ADH7_HUMAN	"All-trans-retinol dehydrogenase [NAD(+)] ADH7, EC 1.1.1.105 (Alcohol dehydrogenase class 4 mu/sigma chain, EC 1.1.1.1) (Alcohol dehydrogenase class IV mu/sigma chain) (Gastric alcohol dehydrogenase) (Omega-hydroxydecanoate dehydrogenase ADH7, EC 1.1.1.66) (Retinol dehydrogenase)"	ADH7	Homo sapiens (Human)	ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	"cytosol [GO:0005829]; plasma membrane [GO:0005886]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; aldehyde oxidase activity [GO:0004031]; ethanol binding [GO:0035276]; NAD-retinol dehydrogenase activity [GO:0004745]; omega-hydroxydecanoate dehydrogenase activity [GO:0050153]; receptor antagonist activity [GO:0048019]; retinol binding [GO:0019841]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	"alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; aldehyde oxidase activity [GO:0004031]; ethanol binding [GO:0035276]; NAD-retinol dehydrogenase activity [GO:0004745]; omega-hydroxydecanoate dehydrogenase activity [GO:0050153]; receptor antagonist activity [GO:0048019]; retinol binding [GO:0019841]; zinc ion binding [GO:0008270]"	GO:0001523; GO:0004022; GO:0004024; GO:0004031; GO:0004745; GO:0005829; GO:0005886; GO:0006069; GO:0008270; GO:0009617; GO:0010430; GO:0019841; GO:0035276; GO:0042572; GO:0042573; GO:0045471; GO:0048019; GO:0050153	MFAEIQIQDKDR	11.01000023	1	1	0.137327969	1510.569927	14.06023	15.44807	11.76532	0	13.69052	15.64009	13.75569	15.3309	14.19408	0	0	13.0461	0	0	0	15.21229	13.96113	15.06618	0	18.78513	0	19.28446	0	0	0	14.06273	14.38199	16.22409	15.95404	14.05328	15.59924	0	0	0	0	0	14.59056	0	0	14.15717	0	0	0	0	16.34608	0	0	14.28237
P40429	RL13A_HUMAN	60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13)	RPL13A	Homo sapiens (Human)	cellular response to interferon-gamma [GO:0071346]; cytoplasmic translation [GO:0002181]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; cytoplasmic translation [GO:0002181]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0015934; GO:0016020; GO:0017148; GO:0022625; GO:0022626; GO:0071346; GO:0097452; GO:1901194; GO:1990904	CEGINISGNFYR	4.659999847	0.17408675	0.17408675	0.342314204	1426.282743	0	17.23615	18.28396	15.47017	15.60462	12.71182	16.71512	0	13.6853	0	0	0	0	13.2584	0	0	0	0	15.02666	16.48881	0	0	0	0	12.16763	0	16.64468	0	13.37304	14.53586	14.85965	17.77323	14.02909	0	0	15.63278	0	0	16.3076	0	0	0	0	14.27473	0	0	0	0
P40879	S26A3_HUMAN	"Chloride anion exchanger (Down-regulated in adenoma, Protein DRA) (Solute carrier family 26 member 3)"	SLC26A3 DRA	Homo sapiens (Human)	anion transport [GO:0006820]; cellular response to cAMP [GO:0071320]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; membrane hyperpolarization [GO:0060081]; sperm capacitation [GO:0048240]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; anion transport [GO:0006820]; cellular response to cAMP [GO:0071320]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; membrane hyperpolarization [GO:0060081]; sperm capacitation [GO:0048240]	anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005452; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0016020; GO:0016324; GO:0019531; GO:0031526; GO:0048240; GO:0051454; GO:0060081; GO:0071320; GO:0097225	QGLLQVTPK	3.680000067	1	1	0.095238267	984.7320353	0	16.20818	13.88983	0	0	15.15885	0	0	0	0	0	0	0	0	15.22353	12.56332	14.7561	0	0	0	0	0	0	0	0	15.97289	0	15.10958	0	0	14.29527	0	0	0	0	16.59436	0	0	15.72476	14.07712	0	15.57355	0	13.29775	0	12.78586	0	0
P40937	RFC5_HUMAN	"Replication factor C subunit 5 (Activator 1 36 kDa subunit, A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit, RF-C 36 kDa subunit, RFC36)"	RFC5	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0016887; GO:0019899; GO:0031390; GO:0032508; GO:1900264	FGPLTPELMVPR	10.89999962	0.744022906	0.744022906	0.096641538	1373.013038	0	0	17.62174	15.13889	16.77954	0	0	0	16.54709	16.58079	0	15.9495	0	0	15.50728	0	0	0	0	0	0	0	16.41169	0	0	0	0	0	0	0	0	16.21291	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P40939	ECHA_HUMAN	"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase, EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase, EC 4.2.1.17; Long chain 3-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.211 ]"	HADHA HADH	Homo sapiens (Human)	cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD+ binding [GO:0070403]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD+ binding [GO:0070403]; protein-containing complex binding [GO:0044877]	GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0070403	HLAILGAGLMGAGIAQVSVDK	13.53999996	1	1	0.153661373	2034.331227	0	0	0	0	15.02372	0	0	0	0	0	0	0	0	0	0	0	0	15.64507	0	13.63337	0	0	16.58872	0	15.09789	0	14.53207	0	0	0	0	0	16.19713	15.67756	0	16.04073	0	16.51701	0	14.60769	17.27371	0	0	0	0	0	0	0
P40967	PMEL_HUMAN	"Melanocyte protein PMEL (ME20-M, ME20M) (Melanocyte protein Pmel 17) (Melanocytes lineage-specific antigen GP100) (Melanoma-associated ME20 antigen) (P1) (P100) (Premelanosome protein) (Silver locus protein homolog) [Cleaved into: M-alpha (95 kDa melanocyte-specific secreted glycoprotein) (P26) (Secreted melanoma-associated ME20 antigen, ME20-S, ME20S); M-beta ]"	PMEL D12S53E PMEL17 SILV	Homo sapiens (Human)	melanin biosynthetic process [GO:0042438]; melanosome organization [GO:0032438]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; melanin biosynthetic process [GO:0042438]; melanosome organization [GO:0032438]	identical protein binding [GO:0042802]	GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0032438; GO:0032585; GO:0042438; GO:0042470; GO:0042802	QVPLDCVLYR	16.52000046	1	1	1.83E-12	1262.726229	15.01539	0	14.33815	0	0	0	0	16.30451	16.88182	0	14.30562	0	0	0	0	15.20149	0	0	0	0	0	0	0	0	16.23344	0	13.21649	0	0	0	0	0	0	0	11.59389	13.24671	0	15.21907	16.88374	0	0	0	0	0	13.97772	16.21779	14.46609	0
P41002	CCNF_HUMAN	Cyclin-F (F-box only protein 1)	CCNF FBX1 FBXO1	Homo sapiens (Human)	cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of centrosome duplication [GO:0010826]; placenta development [GO:0001890]; protein ubiquitination [GO:0016567]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]	cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; anaphase-promoting complex binding [GO:0010997]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of centrosome duplication [GO:0010826]; placenta development [GO:0001890]; protein ubiquitination [GO:0016567]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	anaphase-promoting complex binding [GO:0010997]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0000320; GO:0001890; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010826; GO:0010997; GO:0016538; GO:0016567; GO:0019005; GO:0030054; GO:0031146; GO:0044772; GO:0048471; GO:0051301; GO:0051726	INLCIHSEEEDMNLGLVRL	2.799999952	1	1	0.131034311	2274.555916	12.28208	8.917396	13.17071	9.153482	14.87333	13.63015	0	0	0	0	0	0	14.09449	0	0	0	15.14626	16.47614	12.65143	0	0	0	0	0	0	12.0212	0	0	11.3891	14.10146	0	0	0	14.81688	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P41182	BCL6_HUMAN	"B-cell lymphoma 6 protein, BCL-6 (B-cell lymphoma 5 protein, BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51)"	BCL6 BCL5 LAZ3 ZBTB27 ZNF51	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]"	Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	"Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular component movement [GO:0051272]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092]"	"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]"	GO:0000122; GO:0000902; GO:0000978; GO:0001161; GO:0001222; GO:0001227; GO:0001817; GO:0001953; GO:0002467; GO:0002634; GO:0002682; GO:0002903; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006357; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0031065; GO:0031490; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0042382; GO:0042802; GO:0043065; GO:0043087; GO:0043380; GO:0043565; GO:0045591; GO:0045595; GO:0045629; GO:0045666; GO:0045746; GO:0045892; GO:0046872; GO:0048294; GO:0048821; GO:0050727; GO:0050776; GO:0051272; GO:0140297; GO:1903464; GO:1990837; GO:2000773	AYTAPPACQPPMEPENLDLQSPTK	3.599999905	1	1	0.325879595	2655.10188	0	0	0	0	0	0	0	0	16.35949	0	16.46231	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.65412	0	18.56643	18.6596	0	17.71205	0	0	0	19.33681	0	17.75858	0	17.53621	0	0	0	0	0	0	0	0	0
P41220	RGS2_HUMAN	"Regulator of G-protein signaling 2, RGS2 (Cell growth-inhibiting gene 31 protein) (G0/G1 switch regulatory protein 8)"	RGS2 G0S8 GIG31	Homo sapiens (Human)	brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenylate cyclase inhibitor activity [GO:0010855]; beta-tubulin binding [GO:0048487]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283]	adenylate cyclase inhibitor activity [GO:0010855]; beta-tubulin binding [GO:0048487]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0001965; GO:0001975; GO:0003924; GO:0005096; GO:0005516; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0007049; GO:0007186; GO:0007283; GO:0007420; GO:0008277; GO:0009898; GO:0010519; GO:0010614; GO:0010855; GO:0010976; GO:0017148; GO:0030728; GO:0043005; GO:0043407; GO:0045471; GO:0045744; GO:0048487; GO:0050873; GO:0055119; GO:0060087; GO:0060135; GO:0060452; GO:0061052; GO:0140194; GO:1900924	SAGSGHK	1.649999976	1	1	0.051792043	642.4623318	15.80597	0	0	0	0	0	0	0	16.20962	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.47868	0	0	16.07696	0	0	15.44717	15.77576	0	15.95546	17.11504	0	18.33155	16.74666	16.68013	17.92086	16.05849	17.36955	16.72406	0	0	15.33134	0	0
P41221	WNT5A_HUMAN	Protein Wnt-5a	WNT5A	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein phosphorylation [GO:0006468]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	"cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]; activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein phosphorylation [GO:0006468]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"	chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]	GO:0001736; GO:0001756; GO:0001822; GO:0001837; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002720; GO:0003138; GO:0003139; GO:0003283; GO:0003323; GO:0003402; GO:0003408; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006468; GO:0007223; GO:0007254; GO:0007411; GO:0007442; GO:0007494; GO:0008584; GO:0008595; GO:0009986; GO:0010033; GO:0010595; GO:0010628; GO:0010800; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030514; GO:0030666; GO:0030669; GO:0031012; GO:0032092; GO:0032148; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0033138; GO:0034613; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0038031; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0043507; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048850; GO:0050680; GO:0050727; GO:0050729; GO:0050807; GO:0051092; GO:0051216; GO:0051885; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060775; GO:0060809; GO:0060907; GO:0061036; GO:0061347; GO:0061348; GO:0061349; GO:0061350; GO:0061354; GO:0062009; GO:0070062; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090037; GO:0090082; GO:0090090; GO:0090103; GO:0090179; GO:0090630; GO:0097325; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:0099566; GO:0150012; GO:1900020; GO:1901216; GO:1902379; GO:1902474; GO:1904861; GO:1904862; GO:1904934; GO:1904938; GO:1904953; GO:1904955; GO:2000049; GO:2000052	ETAFTYAVSAAGVVNAMSR	3.269999981	1	1	0.322299525	1944.365012	0	0	14.36478	0	16.16375	12.42273	0	16.00208	13.03943	15.04213	0	0	0	0	0	0	0	0	16.34543	0	0	0	12.75397	0	15.00962	0	0	13.98309	0	0	0	16.46864	0	0	0	0	0	0	0	12.90329	10.82842	0	0	13.31606	10.98093	0	0	0
P41225	SOX3_HUMAN	Transcription factor SOX-3	SOX3	Homo sapiens (Human)	"anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; face development [GO:0060324]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sex determination [GO:0007530]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; face development [GO:0060324]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sex determination [GO:0007530]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0005654; GO:0006355; GO:0007417; GO:0007423; GO:0007530; GO:0009653; GO:0021854; GO:0021983; GO:0030154; GO:0045665; GO:0045944; GO:0060324; GO:1990837	KMALENPK	2.839999914	0.801410735	0.801410735	0.272108632	945.0907006	0	17.752	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32054	0	0	0	0	0	0	18.73675	0	0	0	0	0	0	0	0	0	0	0	17.91622	0	0	0	0	0	0	0	0	0	0	0	0	0
P41226	UBA7_HUMAN	"Ubiquitin-like modifier-activating enzyme 7, Ubiquitin-activating enzyme 7 (D8) (Ubiquitin-activating enzyme E1 homolog)"	UBA7 UBE1L UBE2	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; protein modification by small protein conjugation [GO:0032446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; protein modification by small protein conjugation [GO:0032446]	ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006974; GO:0019782; GO:0019941; GO:0032020; GO:0032446	AEVAAAAAR	12.59000015	1	1	0.585272981	830.3154954	0	17.78492	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.36632	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.11123	0	0	0	0	0	0	0
P41229	KDM5C_HUMAN	"Lysine-specific demethylase 5C, EC 1.14.11.67 (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) (Protein Xe169) ([histone H3]-trimethyl-L-lysine(4) demethylase 5C)"	KDM5C DXS1272E JARID1C SMCX XE169	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]"	DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0008270; GO:0009636; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0045892; GO:0048511	EELGGDVK	1.149999976	0.925545633	0.925545633	0.227000847	845.7917112	16.45136	14.11662	0	0	15.46727	13.07177	0	0	14.46719	16.29424	12.73263	0	0	11.71419	14.14129	0	0	0	0	0	0	0	16.0414	15.83236	0	0	0	0	15.4647	0	15.35303	0	0	15.92439	0	0	15.06633	0	0	0	0	0	0	0	0	0	0	0
P41235	HNF4A_HUMAN	"Hepatocyte nuclear factor 4-alpha, HNF-4-alpha (Nuclear receptor subfamily 2 group A member 1) (Transcription factor 14, TCF-14) (Transcription factor HNF-4)"	HNF4A HNF4 NR2A1 TCF14	Homo sapiens (Human)	"anatomical structure development [GO:0048856]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; ornithine metabolic process [GO:0006591]; phospholipid homeostasis [GO:0055091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of gastrulation [GO:0010470]; regulation of growth hormone receptor signaling pathway [GO:0060398]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; sex differentiation [GO:0007548]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; triglyceride homeostasis [GO:0070328]; type B pancreatic cell development [GO:0003323]; xenobiotic metabolic process [GO:0006805]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; fatty acid binding [GO:0005504]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; ornithine metabolic process [GO:0006591]; phospholipid homeostasis [GO:0055091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of gastrulation [GO:0010470]; regulation of growth hormone receptor signaling pathway [GO:0060398]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; sex differentiation [GO:0007548]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; triglyceride homeostasis [GO:0070328]; type B pancreatic cell development [GO:0003323]; xenobiotic metabolic process [GO:0006805]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; fatty acid binding [GO:0005504]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003323; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005102; GO:0005504; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006591; GO:0006629; GO:0006805; GO:0007548; GO:0007596; GO:0008270; GO:0008285; GO:0009749; GO:0010470; GO:0019216; GO:0023019; GO:0030154; GO:0030308; GO:0042593; GO:0042632; GO:0042752; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0048856; GO:0050796; GO:0055088; GO:0055091; GO:0060395; GO:0060398; GO:0061629; GO:0070328; GO:0070365; GO:1990837	GLSDPGK	4.579999924	1	1	0.189289101	673.8683866	0	0	0	18.76492	0	0	0	0	0	0	20.72919	0	0	0	17.56078	0	0	0	0	0	0	0	0	0	0	0	19.76257	20.75463	0	18.14199	0	0	0	0	0	0	0	21.79123	0	0	0	0	0	0	0	0	0	0
P41240	CSK_HUMAN	"Tyrosine-protein kinase CSK, EC 2.7.10.2 (C-Src kinase) (Protein-tyrosine kinase CYL)"	CSK	Homo sapiens (Human)	adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0002250; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007420; GO:0008022; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0033673; GO:0034236; GO:0034332; GO:0042802; GO:0042997; GO:0043406; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375	DVVPR	5.929999828	1	1	0.245244261	586.2417895	19.3192	20.05147	17.40082	18.38002	15.80417	16.50706	0	18.44284	18.43357	17.57188	18.84932	0	17.81716	0	0	0	17.94732	17.24786	17.28772	16.33865	0	17.01897	16.62882	0	17.35443	17.70781	0	0	0	0	0	0	0	17.61031	0	0	0	19.50239	18.12068	0	17.1686	0	17.77876	17.61815	0	0	17.97673	17.83817
P41250	GARS_HUMAN	"Glycine--tRNA ligase, EC 6.1.1.14 (Diadenosine tetraphosphate synthetase, Ap4A synthetase, EC 2.7.7.-) (Glycyl-tRNA synthetase, GlyRS) (Glycyl-tRNA synthetase 1)"	GARS1 GARS	Homo sapiens (Human)	diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150	SSMDGAGAEEVLAPLR	8.899999619	1	1	0.433454516	1618.453369	18.13333	16.31779	18.42829	18.6523	18.07343	18.25989	0	0	18.23044	19.98959	18.52441	0	0	0	0	18.76666	18.38591	0	0	0	0	0	0	0	17.8123	17.16165	0	0	0	0	19.69491	18.36099	19.77109	0	0	17.25898	18.82991	0	20.46226	18.58054	18.98746	0	0	0	0	0	0	18.37161
P41252	SYIC_HUMAN	"Isoleucine--tRNA ligase, cytoplasmic, EC 6.1.1.5 (Isoleucyl-tRNA synthetase, IRS, IleRS)"	IARS1 IARS	Homo sapiens (Human)	isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062	GDNRLDLLK	9.300000191	1	1	0.283579155	1042.413695	0	17.17486	0	17.64126	17.68721	0	0	0	0	0	0	0	0	17.44943	0	0	0	0	0	0	16.77466	0	0	15.24101	0	0	0	0	0	16.85706	0	19.19724	0	17.95005	0	0	17.15683	0	0	16.72031	0	15.03757	0	0	0	0	0	0
P41271	NBL1_HUMAN	Neuroblastoma suppressor of tumorigenicity 1 (DAN domain family member 1) (Protein N03) (Zinc finger protein DAN)	NBL1 DAN DAND1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; determination of dorsal identity [GO:0048263]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of monocyte chemotaxis [GO:0090027]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron differentiation [GO:0045666]; sequestering of BMP from receptor via BMP binding [GO:0038098]; sequestering of BMP in extracellular matrix [GO:0035582]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; BMP binding [GO:0036122]; identical protein binding [GO:0042802]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018]; animal organ morphogenesis [GO:0009887]; determination of dorsal identity [GO:0048263]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of monocyte chemotaxis [GO:0090027]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron differentiation [GO:0045666]; sequestering of BMP from receptor via BMP binding [GO:0038098]; sequestering of BMP in extracellular matrix [GO:0035582]	BMP binding [GO:0036122]; identical protein binding [GO:0042802]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018]	GO:0005615; GO:0007399; GO:0009887; GO:0016015; GO:0030514; GO:0035582; GO:0036122; GO:0038098; GO:0042802; GO:0045666; GO:0048018; GO:0048263; GO:0048812; GO:0090027	SAWCEAKNITQIVGHSGCEAK	2.960000038	0.634345174	0.634345174	1.83E-12	2344.906038	0	14.29169	0	14.71239	0	0	0	0	0	11.08725	12.19804	0	14.41526	0	12.96529	0	0	0	0	0	14.10785	0	0	0	0	0	0	0	14.3721	14.62681	0	12.48739	0	0	9.968405	0	0	15.85833	0	0	0	0	0	0	0	0	0	13.36421
P41439	FOLR3_HUMAN	"Folate receptor gamma, FR-gamma (Folate receptor 3)"	FOLR3	Homo sapiens (Human)	cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036]	anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; folic acid binding [GO:0005542]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036]	folic acid binding [GO:0005542]; signaling receptor activity [GO:0038023]	GO:0005542; GO:0005576; GO:0007155; GO:0007342; GO:0015884; GO:0016020; GO:0019898; GO:0031362; GO:0035036; GO:0035580; GO:0038023; GO:1904724	CIQMWFDSAQGNPNEEVAKFYAAAMNAGAPSR	1.840000033	1	1	5.95E-12	3548.497503	14.45915	12.18768	0	13.31811	11.65049	0	7.999961	0	6.540313	14.0611	15.50743	0	14.58053	10.35672	0	0	0	0	0	0	0	12.39611	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P41586	PACR_HUMAN	"Pituitary adenylate cyclase-activating polypeptide type I receptor, PACAP type I receptor, PACAP-R-1, PACAP-R1"	ADCYAP1R1	Homo sapiens (Human)	activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]	bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]	bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]	adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999]	GO:0004999; GO:0005768; GO:0005791; GO:0005886; GO:0005887; GO:0005901; GO:0005923; GO:0007166; GO:0007188; GO:0007202; GO:0007283; GO:0008179; GO:0008528; GO:0009410; GO:0009986; GO:0010524; GO:0017046; GO:0019933; GO:0030154; GO:0031267; GO:0032355; GO:0033555; GO:0038023; GO:0042923; GO:0043005; GO:0043231; GO:0043235; GO:0043950; GO:0045471; GO:0046545; GO:0051057; GO:0060548; GO:0060732	EQAMCLEK	2.430000067	1	1	0.226614187	1024.601429	0	0	0	0	0	17.29879	17.04424	0	0	0	16.63216	0	0	14.75195	0	0	0	0	0	0	0	0	0	0	0	16.49015	16.13088	0	0	0	0	17.8206	0	0	0	0	17.37362	17.2694	17.91673	0	0	0	0	0	0	0	0	0
P41587	VIPR2_HUMAN	"Vasoactive intestinal polypeptide receptor 2, VIP-R-2 (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor, PACAP type III receptor, PACAP-R-3, PACAP-R3) (VPAC2)"	VIPR2 VIP2R	Homo sapiens (Human)	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; signal transduction [GO:0007165]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]	GO:0004930; GO:0004999; GO:0005886; GO:0005887; GO:0007165; GO:0007166; GO:0007188; GO:0007190; GO:0007267; GO:0008528; GO:0017046; GO:0048662	SRCPTPSASR	9.800000191	0.023275699	0.023275699	0.112840038	1119.515108	0	18.34216	14.76836	15.59381	0	13.05548	14.36716	0	0	16.52712	13.55085	15.53094	14.62993	14.08931	0	0	0	16.30324	0	0	0	0	0	0	13.23492	0	14.48257	0	10.12903	12.84514	16.22	18.376	0	17.27035	11.49804	15.73283	16.61841	17.71398	16.35037	0	16.67422	0	17.45767	12.74791	15.09314	12.93749	16.26212	14.86314
P41594	GRM5_HUMAN	"Metabotropic glutamate receptor 5, mGluR5"	GRM5 GPRC1E MGLUR5	Homo sapiens (Human)	"calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of locomotion [GO:0040013]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]"	astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]	"astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of locomotion [GO:0040013]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]"	A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782]	GO:0001640; GO:0001932; GO:0002029; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006417; GO:0006448; GO:0006468; GO:0007205; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0030296; GO:0031687; GO:0035584; GO:0040013; GO:0042802; GO:0043197; GO:0043198; GO:0043410; GO:0048170; GO:0050808; GO:0050890; GO:0051966; GO:0061098; GO:0090647; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099055; GO:0099170; GO:0099530; GO:0099553; GO:0099583; GO:1902938; GO:1904646; GO:1990782	VVPSDAQQARAMVDIVK	9.75	0.279409349	0.279409349	0.312598123	1825.898807	11.80555	16.75723	0	0	0	0	0	15.38362	0	0	0	0	17.68538	0	0	0	0	0	0	0	15.79302	0	15.57138	0	0	0	0	0	14.18191	0	0	14.22601	17.67824	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P41732	TSN7_HUMAN	"Tetraspanin-7, Tspan-7 (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1, TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231)"	TSPAN7 A15 DXS1692E MXS1 TM4SF2	Homo sapiens (Human)		integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]		GO:0005887	SRAVDHVQR	4.150000095	1	1	0.181367489	1068.306513	12.81413	15.60257	0	10.36313	13.67472	0	12.79941	0	0	0	15.90653	15.64233	0	0	0	11.47787	0	0	0	0	14.95618	0	0	0	0	0	0	0	0	14.43261	0	15.99889	15.46644	13.6353	16.0836	16.23931	16.32257	16.20676	0	0	0	0	0	0	0	14.71469	13.93228	0
P42025	ACTY_HUMAN	"Beta-centractin (Actin-related protein 1B, ARP1B)"	ACTR1B CTRN2	Homo sapiens (Human)		centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524; GO:0005576; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0015630; GO:0016020; GO:0034774; GO:0070062; GO:1904813	VDIAGRDVSR	2.380000114	1	1	0.021744985	1086.023643	12.03901	15.79753	16.61615	13.50919	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P42126	ECI1_HUMAN	"Enoyl-CoA delta isomerase 1, mitochondrial, EC 5.3.3.8 (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase, D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase)"	ECI1 DCI	Homo sapiens (Human)	fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; fatty acid beta-oxidation [GO:0006635]"	"dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]"	GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0016863	VLVEPDAGAGVAVMKFK	2.470000029	1	1	0.25539344	1747.049805	0	10.50574	0	0	0	0	14.71523	15.78446	0	0	0	0	14.72687	0	0	0	0	14.36802	0	0	0	0	0	0	0	0	0	0	0	0	0	12.78662	0	0	0	0	0	0	0	0	15.58528	0	0	0	0	0	0	0
P42261	GRIA1_HUMAN	"Glutamate receptor 1, GluR-1 (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1, GluA1)"	GRIA1 GLUH1 GLUR1	Homo sapiens (Human)	cellular response to ammonium ion [GO:0071242]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	AMPA glutamate receptor complex [GO:0032281]; axonal spine [GO:0044308]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]	AMPA glutamate receptor complex [GO:0032281]; axonal spine [GO:0044308]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to ammonium ion [GO:0071242]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]	AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0001540; GO:0004971; GO:0005789; GO:0005886; GO:0007165; GO:0007268; GO:0007616; GO:0008066; GO:0009986; GO:0012507; GO:0014069; GO:0015276; GO:0030165; GO:0030425; GO:0030666; GO:0030672; GO:0031623; GO:0031901; GO:0032281; GO:0032591; GO:0033116; GO:0038023; GO:0043025; GO:0043197; GO:0044308; GO:0044309; GO:0055037; GO:0055038; GO:0060076; GO:0060292; GO:0071242; GO:0097060; GO:0098793; GO:0098978; GO:0099061; GO:0099544; GO:0099583; GO:1904315	MVSPIESAEDLAKQTEIAYGTLEAGSTK	6.519999981	1	1	0.16682988	2940.544673	0	0	0	0	0	19.42353	0	0	0	0	0	0	13.82615	14.98576	17.06543	0	0	0	0	0	0	0	10.0504	0	0	0	0	0	0	14.56272	0	0	18.3001	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P42262	GRIA2_HUMAN	"Glutamate receptor 2, GluR-2 (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2, GluA2)"	GRIA2 GLUR2	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]"	AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843]	"AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]"	AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]	GO:0001540; GO:0004970; GO:0004971; GO:0005789; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0009897; GO:0014069; GO:0015276; GO:0030425; GO:0030666; GO:0032279; GO:0032281; GO:0035235; GO:0035249; GO:0038023; GO:0043025; GO:0043197; GO:0060076; GO:0098794; GO:0098839; GO:0098843	IGYWSEVDK	2.700000048	1	1	0.142578112	1096.196592	14.23509	0	15.53155	0	14.36941	13.34315	0	0	0	15.00793	0	0	0	16.56765	14.57847	0	0	0	15.278	12.87627	15.67152	0	0	0	0	0	0	14.53686	0	0	0	0	0	0	0	0	0	0	0	0	14.11361	0	0	0	12.33657	0	0	0
P42285	MTREX_HUMAN	"Exosome RNA helicase MTR4, EC 3.6.4.13 (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)"	MTREX DOB1 KIAA0052 MTR4 SKIV2L2	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to DNA damage stimulus [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0006974; GO:0016076; GO:0016607; GO:0016887; GO:0031499; GO:0071013	DIVFAASLYL	5.699999809	1	1	0.38667306	1108.460264	15.53765	12.15261	13.12836	0	0	0	14.56984	14.61853	14.78982	14.35162	0	13.87651	0	0	0	0	0	0	0	15.3597	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.97824	0	0	16.00549	0	0	0	0	0	0	0	0	0
P42336	PK3CA_HUMAN	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, PI3-kinase subunit alpha, PI3K-alpha, PI3Kalpha, PtdIns-3-kinase subunit alpha, EC 2.7.1.137, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha, PtdIns-3-kinase subunit p110-alpha, p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA, EC 2.7.11.1)"	PIK3CA	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; epidermal growth factor receptor signaling pathway [GO:0007173]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; epidermal growth factor receptor signaling pathway [GO:0007173]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]"	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]"	GO:0001525; GO:0001889; GO:0001944; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006006; GO:0006909; GO:0007173; GO:0010592; GO:0010629; GO:0014065; GO:0014704; GO:0014823; GO:0014870; GO:0016020; GO:0016242; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030027; GO:0030036; GO:0030168; GO:0030295; GO:0030835; GO:0031295; GO:0032008; GO:0033138; GO:0035004; GO:0035005; GO:0035994; GO:0036092; GO:0038028; GO:0038084; GO:0040014; GO:0043201; GO:0043276; GO:0043457; GO:0043491; GO:0043524; GO:0043542; GO:0043560; GO:0044029; GO:0046854; GO:0046934; GO:0048015; GO:0048471; GO:0048661; GO:0050852; GO:0051897; GO:0052742; GO:0052812; GO:0055119; GO:0060048; GO:0060612; GO:0071333; GO:0071464; GO:0071548; GO:0086003; GO:0097009; GO:0106310; GO:0110053; GO:1903544; GO:2000270; GO:2000653; GO:2000811	DPEVQDFR	4.949999809	1	1	5.80E-13	1005.723772	0	12.66482	14.6225	0	0	0	0	0	0	0	0	0	0	0	0	0	13.9196	16.18713	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.76347	0
P42338	PK3CB_HUMAN	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform, PI3-kinase subunit beta, PI3K-beta, PI3Kbeta, PtdIns-3-kinase subunit beta, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta, PtdIns-3-kinase subunit p110-beta, p110beta) (Serine/threonine protein kinase PIK3CB, EC 2.7.11.1)"	PIK3CB PIK3C1	Homo sapiens (Human)	angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; cellular calcium ion homeostasis [GO:0006874]; chemotaxis [GO:0006935]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of autophagy [GO:0010508]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; regulation of clathrin-dependent endocytosis [GO:2000369]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; cellular calcium ion homeostasis [GO:0006874]; chemotaxis [GO:0006935]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of autophagy [GO:0010508]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; regulation of clathrin-dependent endocytosis [GO:2000369]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]"	GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0006935; GO:0007156; GO:0007165; GO:0007169; GO:0007186; GO:0010508; GO:0010595; GO:0010628; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030168; GO:0030496; GO:0033031; GO:0035004; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0043231; GO:0043407; GO:0043560; GO:0046854; GO:0046934; GO:0048015; GO:0051000; GO:0051897; GO:0051898; GO:0052742; GO:0052812; GO:0060055; GO:0070527; GO:1900747; GO:1903298; GO:1903671; GO:2000369	TGNTEKFGR	8.550000191	2.35E-06	2.35E-06	0.087466249	1010.613871	11.03196	14.32707	16.24487	16.08631	15.66042	12.6563	15.61143	18.7085	14.31269	13.62231	12.6855	15.59262	14.90373	15.61681	0	11.89482	0	0	16.4268	0	15.8796	16.29169	15.78632	14.04781	0	15.55656	15.69624	15.94969	0	16.13458	14.87419	18.00076	17.1911	16.54398	15.79334	14.64404	0	17.0675	0	15.89594	16.11657	18.97243	13.26267	0	16.20131	15.20512	11.95197	11.77896
P42345	MTOR_HUMAN	"Serine/threonine-protein kinase mTOR, EC 2.7.11.1 (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin, mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)"	MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1	Homo sapiens (Human)	"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; lysosome organization [GO:0007040]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; neuronal action potential [GO:0019228]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; voluntary musculoskeletal movement [GO:0050882]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; lysosome organization [GO:0007040]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; neuronal action potential [GO:0019228]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; voluntary musculoskeletal movement [GO:0050882]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0000139; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005789; GO:0005829; GO:0006112; GO:0006207; GO:0006468; GO:0006954; GO:0006974; GO:0007010; GO:0007040; GO:0007281; GO:0007584; GO:0008361; GO:0009267; GO:0009408; GO:0009791; GO:0010507; GO:0010592; GO:0010628; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016241; GO:0016242; GO:0016301; GO:0016310; GO:0016605; GO:0018105; GO:0018107; GO:0019228; GO:0030163; GO:0030307; GO:0030425; GO:0030838; GO:0031529; GO:0031641; GO:0031667; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0032148; GO:0032516; GO:0032868; GO:0032956; GO:0034198; GO:0035264; GO:0038202; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043087; GO:0043200; GO:0043276; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0046777; GO:0046889; GO:0048266; GO:0048511; GO:0048714; GO:0050731; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051647; GO:0051896; GO:0055013; GO:0060048; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0106310; GO:1900034; GO:1901796; GO:1901838; GO:1903691; GO:1904059; GO:1904690; GO:1905857; GO:1990253	AALETVDR	2.549999952	1	1	0.213473571	874.6899108	0	0	16.71886	0	0	0	16.76404	22.96552	0	0	0	0	0	0	0	0	0	0	0	0	17.13008	0	0	0	0	0	0	0	0	17.00745	0	0	0	0	0	0	0	0	0	0	19.80456	0	0	19.15491	0	0	0	18.96212
P42574	CASP3_HUMAN	"Caspase-3, CASP-3, EC 3.4.22.56 (Apopain) (Cysteine protease CPP32, CPP-32) (Protein Yama) (SREBP cleavage activity 1, SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12 ]"	CASP3 CPP32	Homo sapiens (Human)	anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet formation [GO:0030220]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet formation [GO:0030220]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]	aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]	GO:0001554; GO:0001666; GO:0001782; GO:0002020; GO:0004190; GO:0004197; GO:0004861; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007413; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008303; GO:0008627; GO:0009410; GO:0009411; GO:0009749; GO:0010165; GO:0016005; GO:0016241; GO:0016485; GO:0021766; GO:0030182; GO:0030216; GO:0030218; GO:0030220; GO:0030889; GO:0031264; GO:0031647; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0034612; GO:0035094; GO:0042060; GO:0042542; GO:0043025; GO:0043029; GO:0043065; GO:0043066; GO:0043200; GO:0043525; GO:0044877; GO:0045121; GO:0045165; GO:0046007; GO:0046677; GO:0048011; GO:0051146; GO:0051384; GO:0051402; GO:0061713; GO:0071887; GO:0072734; GO:0097153; GO:0097190; GO:0097193; GO:0097194; GO:0097199; GO:0097200; GO:1902004; GO:1902512	EEIVELMR	2.75	1	1	0.223756591	1017.992461	15.18693	0	0	0	0	0	0	0	0	15.48726	13.07239	0	14.35724	0	14.18756	0	15.27236	13.76595	0	0	14.84534	0	0	0	0	0	0	13.71663	0	0	0	13.84822	0	14.52683	15.01989	0	0	0	0	13.50624	14.99056	0	13.95841	14.5123	0	14.01035	15.23032	0
P42658	DPP6_HUMAN	"Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI, DPP VI)"	DPP6	Homo sapiens (Human)	protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]	potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]	GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016021; GO:0072659; GO:1901379	KIESLR	4.329999924	1	1	0.153528389	747.6852912	0	17.25364	0	15.68516	6.498616	0	0	15.46903	14.51994	0	0	0	0	0	0	14.07198	0	0	0	0	15.60895	15.77499	15.99511	0	15.60227	15.52976	0	0	13.7732	0	16.8515	15.90177	0	15.5188	0	13.31997	0	16.48685	0	15.08231	16.34909	15.84084	0	14.29096	0	0	0	0
P42680	TEC_HUMAN	"Tyrosine-protein kinase Tec, EC 2.7.10.2"	TEC PSCTK4	Homo sapiens (Human)	adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0002250; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005543; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0007229; GO:0010543; GO:0018108; GO:0035556; GO:0038083; GO:0042246; GO:0046872; GO:0050731; GO:0050852; GO:0050853	VSDFGMAR	15.26000023	1	1	0.15399454	882.4385126	15.39425	0	15.78432	0	0	13.93718	10.15197	0	0	14.55714	14.00034	0	14.51983	14.21214	0	0	0	0	14.70878	0	0	0	14.58654	0	0	0	14.8378	15.76447	16.64649	16.46298	0	0	0	0	16.15672	0	0	0	0	0	0	0	0	0	0	0	0	0
P42684	ABL2_HUMAN	"Tyrosine-protein kinase ABL2, EC 2.7.10.2 (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG)"	ABL2 ABLL ARG	Homo sapiens (Human)	cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; negative regulation of Rho protein signal transduction [GO:0035024]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phospholipase C activity [GO:0010863]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; negative regulation of Rho protein signal transduction [GO:0035024]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phospholipase C activity [GO:0010863]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]	actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0000287; GO:0001784; GO:0003785; GO:0004672; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005829; GO:0006464; GO:0007155; GO:0007165; GO:0007204; GO:0010506; GO:0010863; GO:0010976; GO:0015629; GO:0018108; GO:0030100; GO:0030145; GO:0030155; GO:0035024; GO:0035640; GO:0051015; GO:0051353; GO:0071300; GO:2000145; GO:2000249	GATALPLRTPSGDLAITEK	11.07999992	1	1	0.313586236	1910.835077	21.2481	0	21.08735	21.03334	19.46405	19.58027	20.77288	21.66411	19.96332	0	20.62064	20.42925	20.84188	21.47982	21.60142	21.63276	21.17495	0	21.51244	19.75976	19.79983	21.33901	21.46425	20.61762	20.77693	21.27645	21.33505	20.7954	18.78081	21.51509	21.12703	21.17278	20.08316	20.48926	21.87405	0	21.84428	21.58953	21.72039	21.84752	20.35537	20.39256	21.51244	0	21.44255	0	0	0
P42685	FRK_HUMAN	"Tyrosine-protein kinase FRK, EC 2.7.10.2 (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5)"	FRK PTK5 RAK	Homo sapiens (Human)	cell differentiation [GO:0030154]; innate immune response [GO:0045087]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular anatomical structure [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular anatomical structure [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0000122; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005576; GO:0005622; GO:0005634; GO:0005654; GO:0005829; GO:0006468; GO:0007169; GO:0008285; GO:0030154; GO:0031234; GO:0035578; GO:0035580; GO:0045087; GO:0070062	WTAPEAIR	1.24000001	1	1	0.195659104	943.492953	0	0	0	0	0	0	0	0	0	0	17.34411	0	0	0	0	16.97763	0	0	17.49559	0	0	0	0	0	0	0	0	0	0	0	17.51922	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P42694	HELZ_HUMAN	"Probable helicase with zinc finger domain, EC 3.6.4.- (Down-regulated in human cancers protein)"	HELZ DRHC KIAA0054	Homo sapiens (Human)	post-transcriptional gene silencing by RNA [GO:0035194]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0016787; GO:0035194; GO:0043186; GO:0046872	LMASGKQPAHK	3.680000067	1	1	0.248738018	1161.836228	0	0	0	0	0	0	15.41907	0	16.04386	0	0	0	0	14.757	0	13.83097	0	14.97912	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.11249	15.11219	0	14.40145	0	0	0	0	0	0	0	0	0	0	0	13.3741
P42695	CNDD3_HUMAN	"Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3, hCAP-D3)"	NCAPD3 CAPD3 KIAA0056	Homo sapiens (Human)	cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]	"condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]"	"condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]"	histone binding [GO:0042393]; methylated histone binding [GO:0035064]	GO:0000779; GO:0000796; GO:0005654; GO:0005721; GO:0007076; GO:0010032; GO:0016020; GO:0035064; GO:0042393; GO:0051301	APLAVTSQVINCR	5.559999943	1	1	0.007865006	1427.930807	15.57907	0	15.45807	0	0	0	13.92581	12.72201	0	0	0	0	15.75887	14.20867	0	0	0	0	0	15.27479	13.93398	0	0	0	0	13.29193	0	13.37381	15.42176	0	0	0	0	0	0	0	0	0	0	14.76715	16.22727	14.74144	14.17704	14.27195	14.14371	0	0	0
P42701	I12R1_HUMAN	"Interleukin-12 receptor subunit beta-1, IL-12 receptor subunit beta-1, IL-12R subunit beta-1, IL-12R-beta-1, IL-12RB1 (IL-12 receptor beta component) (CD antigen CD212)"	IL12RB1 IL12R IL12RB	Homo sapiens (Human)	cellular response to interferon-gamma [GO:0071346]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; signal transduction [GO:0007165]	external side of plasma membrane [GO:0009897]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	external side of plasma membrane [GO:0009897]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; cellular response to interferon-gamma [GO:0071346]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; signal transduction [GO:0007165]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]	GO:0001916; GO:0002230; GO:0002827; GO:0004896; GO:0005886; GO:0006955; GO:0007165; GO:0009897; GO:0019221; GO:0019955; GO:0032729; GO:0032740; GO:0032819; GO:0035722; GO:0038155; GO:0042022; GO:0042102; GO:0042104; GO:0043235; GO:0043382; GO:0046427; GO:0051142; GO:0071346; GO:0072536; GO:2000318; GO:2000330	QLGSQGSSWSK	6.380000114	1	1	0.015037682	1164.748105	16.04421	13.92605	15.84513	15.34903	11.61848	0	14.37181	0	15.58358	16.69414	15.79637	0	14.84508	0	16.4563	0	13.52399	0	0	15.15461	16.37616	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.3064	0	0	0	0	0	0	0	0
P42702	LIFR_HUMAN	"Leukemia inhibitory factor receptor, LIF receptor, LIF-R (CD antigen CD118)"	LIFR	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; leukemia inhibitory factor signaling pathway [GO:0048861]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923]; cell surface receptor signaling pathway [GO:0007166]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; leukemia inhibitory factor signaling pathway [GO:0048861]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923]	GO:0004896; GO:0004923; GO:0005127; GO:0005886; GO:0005887; GO:0007166; GO:0008284; GO:0009897; GO:0019221; GO:0019838; GO:0019955; GO:0034097; GO:0038165; GO:0043235; GO:0048861; GO:0070062; GO:0070120	NISWIPDSQTKVFPQDK	6.380000114	1	1	0.210343413	2003.911008	0	0	16.00695	12.65003	0	15.21079	12.79291	14.45121	0	0	0	0	0	0	0	14.14195	16.04923	14.40215	0	15.77649	0	0	15.18218	16.58302	15.49815	0	12.25381	11.89864	0	0	0	0	16.21822	15.74828	15.20606	0	14.20408	0	0	15.4018	0	0	0	0	0	0	15.63667	0
P42704	LPPRC_HUMAN	"Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein, LRP 130) (GP130)"	LRPPRC LRP130	Homo sapiens (Human)	mitochondrion transport along microtubule [GO:0047497]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]	condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]	condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; mitochondrion transport along microtubule [GO:0047497]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]	beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]	GO:0000794; GO:0000961; GO:0003697; GO:0003723; GO:0005634; GO:0005637; GO:0005640; GO:0005654; GO:0005739; GO:0005856; GO:0005874; GO:0008017; GO:0016020; GO:0031625; GO:0042645; GO:0047497; GO:0048471; GO:0048487; GO:0051028; GO:0070129; GO:1990904	GAYDIFLNAK	6.940000057	0.645694554	0.645694554	0.201062382	1111.480467	14.15459	15.9709	15.41459	14.69745	13.36039	0	12.90543	14.34997	14.90378	0	12.76637	0	16.53008	0	0	0	0	5.915354	14.49453	16.51583	0	15.43243	15.34634	15.4301	0	15.34787	15.54173	0	14.355	0	15.86436	0	0	0	0	0	15.93457	0	0	0	0	0	0	17.04803	0	15.33491	0	0
P42765	THIM_HUMAN	"3-ketoacyl-CoA thiolase, mitochondrial, EC 2.3.1.16 (Acetyl-CoA acetyltransferase, EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial, EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)"	ACAA2	Homo sapiens (Human)	cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]; cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]	GO:0003723; GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005759; GO:0006635; GO:0006695; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109	VGIPK	6.079999924	0.506393015	0.506393015	0.056552476	513.4267575	9.250315	16.2043	17.1988	16.80984	13.19148	15.64567	0	0	17.28569	18.18407	11.4019	0	16.93309	17.42027	7.67266	15.18308	0	14.32797	17.35661	18.45402	0	9.794936	0	11.48801	17.56468	18.10063	13.57873	15.05467	16.26103	0	16.35156	0	0	15.66048	0	0	17.20048	17.09265	17.10382	0	16.67795	15.70805	14.06987	0	15.99963	17.0708	16.27043	15.34841
P42766	RL35_HUMAN	60S ribosomal protein L35 (Large ribosomal subunit protein uL29)	RPL35	Homo sapiens (Human)	"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleolus [GO:0005730]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000463; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626	VTGGAASKLSK	8.930000305	1	1	0.2349972	1018.768586	12.41575	16.34691	13.9696	0	0	15.38698	16.31401	15.33895	14.08974	13.7976	0	14.22919	15.30224	0	14.61579	0	14.42354	15.22203	14.73921	14.95257	15.07079	0	0	17.71084	15.12121	0	0	14.87961	14.91681	0	15.20346	15.41011	14.74408	0	0	15.39605	0	14.10894	15.01	0	0	0	13.58955	13.16948	0	15.3164	15.31426	0
P42771	CDN2A_HUMAN	"Cyclin-dependent kinase inhibitor 2A (Cyclin-dependent kinase 4 inhibitor A, CDK4I) (Multiple tumor suppressor 1, MTS-1) (p16-INK4a, p16-INK4, p16INK4A)"	CDKN2A CDKN2 MTS1	Homo sapiens (Human)	"cell cycle [GO:0007049]; cellular senescence [GO:0090398]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; replicative senescence [GO:0090399]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cellular senescence [GO:0090398]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; replicative senescence [GO:0090399]"	cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0001953; GO:0003723; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007265; GO:0008285; GO:0019901; GO:0030308; GO:0032088; GO:0034393; GO:0035985; GO:0042326; GO:0045736; GO:0045892; GO:0051059; GO:0051726; GO:0090398; GO:0090399; GO:2000045; GO:2000111	EPAAGSSMEPSADWLATAAAR	2.299999952	1	1	0.27196914	2089.791519	14.97787	13.4907	13.77808	0	0	14.19136	0	0	15.71372	0	0	0	14.65361	0	0	0	0	14.44559	13.35706	0	0	16.54818	0	0	14.92363	0	15.17225	0	12.77132	0	0	14.5192	15.80641	16.25387	15.97338	0	0	0	0	0	0	0	0	0	0	0	0	0
P42785	PCP_HUMAN	"Lysosomal Pro-X carboxypeptidase, EC 3.4.16.2 (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase, PRCP)"	PRCP PCP	Homo sapiens (Human)	angiogenesis involved in wound healing [GO:0060055]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]	azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185]; angiogenesis involved in wound healing [GO:0060055]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]	dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185]	GO:0002155; GO:0002353; GO:0003085; GO:0004185; GO:0005886; GO:0006508; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377	DITDTLVAVTISEGAHHLDLRTK	2.49000001	1	1	0.109078861	2504.15803	15.41086	0	0	14.66198	15.97925	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P42858	HD_HUMAN	"Huntingtin (Huntington disease protein, HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment ]"	HTT HD IT15	Homo sapiens (Human)	"apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]"	autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]	"autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transmembrane transporter binding [GO:0044325]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]"	beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transmembrane transporter binding [GO:0044325]	GO:0000132; GO:0002039; GO:0005522; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006890; GO:0006915; GO:0007030; GO:0016234; GO:0019900; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0042297; GO:0042802; GO:0043065; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048471; GO:0048487; GO:0099111; GO:0099523; GO:0099524; GO:1903599; GO:1904504; GO:1905289; GO:1905337; GO:2000479; GO:2001237	FGGFLR	8.970000267	0.860495508	0.860495508	0.111871852	693.6380089	12.13352	0	11.11048	0	16.70671	17.17319	17.84189	9.900942	17.49606	0	8.761048	12.03685	17.13111	16.59098	12.27157	12.78298	13.53298	16.88111	17.50073	12.85898	14.61978	16.34764	9.733035	17.0568	15.83153	16.43325	16.77448	14.00683	0	12.79663	15.44713	16.1063	16.0007	10.16494	12.79205	6.848244	15.28776	12.9702	16.43867	16.18041	0	16.06297	0	14.59603	16.17606	16.10435	16.60619	0
P42892	ECE1_HUMAN	"Endothelin-converting enzyme 1, ECE-1, EC 3.4.24.71"	ECE1	Homo sapiens (Human)	axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]	early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]	early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0001921; GO:0003100; GO:0004175; GO:0004222; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007186; GO:0007507; GO:0008270; GO:0009897; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0017046; GO:0019229; GO:0031302; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0042447; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0070062; GO:0097492; GO:1902287	EFSEHFR	11.21000004	1	1	0.32217205	951.3274584	14.84884	0	15.31983	0	15.0738	14.88497	16.60731	0	14.59257	16.96348	15.97856	16.13615	16.02689	0	16.5056	14.77812	16.68155	0	0	17.33	0	0	15.28955	16.16098	14.19509	14.49764	15.01824	0	16.07723	15.84612	14.86214	15.9276	15.64704	13.87096	0	0	14.24286	14.35835	0	0	14.8702	15.25605	0	0	16.46827	17.07418	0	15.07157
P42898	MTHR_HUMAN	"Methylenetetrahydrofolate reductase, EC 1.5.1.20"	MTHFR	Homo sapiens (Human)	heterochromatin organization [GO:0070828]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; regulation of histone methylation [GO:0031060]; response to amino acid [GO:0043200]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; response to xenobiotic stimulus [GO:0009410]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; synapse [GO:0045202]	cytosol [GO:0005829]; synapse [GO:0045202]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase NADH activity [GO:0106312]; methylenetetrahydrofolate reductase NADPH activity [GO:0106313]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]; heterochromatin organization [GO:0070828]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; regulation of histone methylation [GO:0031060]; response to amino acid [GO:0043200]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; response to xenobiotic stimulus [GO:0009410]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999]	FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase NADH activity [GO:0106312]; methylenetetrahydrofolate reductase NADPH activity [GO:0106313]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]	GO:0001666; GO:0001843; GO:0004489; GO:0005829; GO:0006555; GO:0009086; GO:0009410; GO:0031060; GO:0033274; GO:0035999; GO:0043200; GO:0044877; GO:0045202; GO:0046500; GO:0050660; GO:0050661; GO:0050667; GO:0051593; GO:0070555; GO:0070828; GO:0071949; GO:0072341; GO:0106312; GO:0106313	DNDAAIR	4.590000153	1	1	0.249297648	775.1043578	16.71505	15.8461	16.92026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.89358	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.21022	0	0	0	17.16921	0	0	0	0
P43003	EAA1_HUMAN	"Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1, GLAST-1) (Solute carrier family 1 member 3)"	SLC1A3 EAAT1 GLAST GLAST1	Homo sapiens (Human)	auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to cocaine [GO:0071314]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]	basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]	basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to cocaine [GO:0071314]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]	glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0006836; GO:0006883; GO:0007268; GO:0007605; GO:0009410; GO:0009416; GO:0009449; GO:0009611; GO:0009925; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0016595; GO:0021545; GO:0031223; GO:0031410; GO:0043005; GO:0043025; GO:0045202; GO:0046677; GO:0046872; GO:0048471; GO:0048667; GO:0050806; GO:0050885; GO:0051938; GO:0070633; GO:0070779; GO:0071314; GO:0071805; GO:0098712; GO:0098796; GO:0140009; GO:0150104; GO:1902476	SNGEEPKMGGR	11.72999954	1	1	9.17E-13	1177.829157	0	16.17439	15.62415	15.70278	0	0	0	0	15.3663	0	0	0	0	0	0	0	0	0	0	0	0	15.28017	0	14.63041	14.56678	0	0	0	14.82101	0	15.63257	0	0	0	0	16.19858	16.15032	17.27498	0	0	0	0	0	0	0	0	0	0
P43004	EAA2_HUMAN	Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)	SLC1A2 EAAT2 GLT1	Homo sapiens (Human)	adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632]	astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; ion transport [GO:0006811]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632]	cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006750; GO:0006811; GO:0006836; GO:0007268; GO:0007632; GO:0009410; GO:0009611; GO:0009986; GO:0010259; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0031982; GO:0033229; GO:0035264; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0046326; GO:0046872; GO:0070207; GO:0070633; GO:0070778; GO:0070779; GO:0071314; GO:0097449; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0099056; GO:0150104	MGDQAKLMVDFFNILNEIVMK	1.820000052	1	1	1.84E-12	2489.32684	14.44176	14.4302	0	0	12.75466	11.92717	12.6281	0	11.80233	0	15.19482	0	0	14.71536	11.97549	14.23663	0	11.68163	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P43026	GDF5_HUMAN	"Growth/differentiation factor 5, GDF-5 (Bone morphogenetic protein 14, BMP-14) (Cartilage-derived morphogenetic protein 1, CDMP-1) (Lipopolysaccharide-associated protein 4, LAP-4, LPS-associated protein 4) (Radotermin)"	GDF5 BMP14 CDMP1	Homo sapiens (Human)	BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; embryonic limb morphogenesis [GO:0030326]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron apoptotic process [GO:0043524]; ossification involved in bone remodeling [GO:0043932]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of multicellular organism growth [GO:0040014]; regulation of SMAD protein signal transduction [GO:0060390]; response to mechanical stimulus [GO:0009612]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; embryonic limb morphogenesis [GO:0030326]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron apoptotic process [GO:0043524]; ossification involved in bone remodeling [GO:0043932]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of multicellular organism growth [GO:0040014]; regulation of SMAD protein signal transduction [GO:0060390]; response to mechanical stimulus [GO:0009612]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	BMP binding [GO:0036122]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0007179; GO:0007267; GO:0008083; GO:0009612; GO:0010862; GO:0030326; GO:0030509; GO:0030513; GO:0032331; GO:0032332; GO:0035136; GO:0035137; GO:0036122; GO:0040014; GO:0042802; GO:0043524; GO:0043932; GO:0045666; GO:0050680; GO:0060390; GO:0060395; GO:0060591; GO:2001054	GGNSSVK	4.659999847	1	1	0.059377273	649.1282207	14.15584	14.47085	0	14.95041	0	13.33282	12.2949	14.20238	0	13.67412	13.91996	0	14.04573	0	14.63205	12.0116	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P43119	PI2R_HUMAN	"Prostacyclin receptor (Prostaglandin I2 receptor, PGI receptor, PGI2 receptor) (Prostanoid IP receptor)"	PTGIR PRIPR	Homo sapiens (Human)	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to lipopolysaccharide [GO:0032496]"	cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; prostacyclin receptor activity [GO:0016501]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to lipopolysaccharide [GO:0032496]"	guanyl-nucleotide exchange factor activity [GO:0005085]; prostacyclin receptor activity [GO:0016501]	GO:0005085; GO:0005829; GO:0005886; GO:0005887; GO:0006954; GO:0007187; GO:0007189; GO:0007204; GO:0007267; GO:0010642; GO:0016501; GO:0032496; GO:0048662	CFTQAVAPDSSSEMGDLLAFR	6.309999943	1	1	0.025825652	2302.941129	0	15.20354	15.10757	12.68858	14.57154	13.82614	0	16.37959	0	14.06128	12.74327	11.84113	14.3373	0	13.98577	0	0	0	0	0	0	0	11.56439	0	13.16258	14.96509	0	0	0	0	0	0	0	0	0	0	0	0	0	14.50733	15.18816	0	0	0	0	0	13.88249	0
P43155	CACP_HUMAN	"Carnitine O-acetyltransferase, Carnitine acetylase, EC 2.3.1.137, EC 2.3.1.7 (Carnitine acetyltransferase, CAT, CrAT)"	CRAT CAT1	Homo sapiens (Human)	"carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]"	acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]	GO:0003997; GO:0004092; GO:0005739; GO:0005743; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791	ALLDMR	5.789999962	0.094629638	0.094629638	0.218552519	717.5801258	18.11277	17.45964	13.22443	17.2424	16.76908	0	0	0	0	18.0103	17.17104	16.80779	17.67931	16.36674	0	16.95752	16.57253	18.65675	0	16.67589	0	0	17.99105	18.6487	18.87341	0	19.00439	17.44637	16.97273	0	20.81571	0	18.62573	0	17.97886	18.72087	19.37731	0	0	0	17.62196	0	0	17.91609	18.04705	0	0	17.0549
P43220	GLP1R_HUMAN	"Glucagon-like peptide 1 receptor, GLP-1 receptor, GLP-1-R, GLP-1R"	GLP1R	Homo sapiens (Human)	"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; hormone secretion [GO:0046879]; learning or memory [GO:0007611]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; posttranslational protein targeting to membrane, translocation [GO:0031204]; regulation of heart contraction [GO:0008016]; response to psychosocial stress [GO:1990911]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; glucagon receptor activity [GO:0004967]; glucagon-like peptide 1 receptor activity [GO:0044508]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; hormone secretion [GO:0046879]; learning or memory [GO:0007611]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; posttranslational protein targeting to membrane, translocation [GO:0031204]; regulation of heart contraction [GO:0008016]; response to psychosocial stress [GO:1990911]"	G protein-coupled peptide receptor activity [GO:0008528]; glucagon receptor activity [GO:0004967]; glucagon-like peptide 1 receptor activity [GO:0044508]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004967; GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007204; GO:0007611; GO:0008016; GO:0008528; GO:0016021; GO:0017046; GO:0019933; GO:0031204; GO:0044508; GO:0045776; GO:0045777; GO:0046879; GO:1990911	ANLMCK	10.40999985	1.49E-05	1.49E-05	0.193266511	752.6078909	16.84062	16.95706	15.72576	17.51375	16.49722	17.0484	15.9108	15.61173	0	17.49513	17.13935	17.60048	16.89987	0	0	17.49294	16.18431	16.47371	0	16.80087	0	18.33896	0	17.94669	17.58169	16.6514	16.31087	0	16.36407	15.2168	14.92363	0	16.59964	17.48306	17.61682	17.43409	18.1123	16.53312	17.40656	17.06391	18.24304	17.83123	18.31876	17.36966	18.40771	0	16.77929	17.47139
P43243	MATR3_HUMAN	Matrin-3	MATR3 KIAA0723	Homo sapiens (Human)	activation of innate immune response [GO:0002218]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281]	membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]	membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281]	identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]	GO:0002218; GO:0003170; GO:0003281; GO:0003723; GO:0005198; GO:0005634; GO:0005637; GO:0008270; GO:0010608; GO:0016020; GO:0016363; GO:0035198; GO:0042802; GO:0045087	EPSDKAVK	9.300000191	1	1	0.306507614	873.236155	14.60456	0	12.62735	13.58368	13.78315	0	0	11.69448	13.27293	13.26771	14.41807	12.87269	0	13.78205	0	13.99273	14.99231	14.60968	10.63733	14.80291	0	11.86807	0	0	0	0	15.22023	0	0	0	0	0	0	14.64502	0	0	0	0	0	0	14.72853	0	0	0	14.30378	0	0	0
P43246	MSH2_HUMAN	"DNA mismatch repair protein Msh2, hMSH2 (MutS protein homolog 2)"	MSH2	Homo sapiens (Human)	B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]	"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]"	GO:0000781; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0019899; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168	ENDWYLAYK	7.670000076	1	1	0.037878417	1203.625135	12.03838	0	13.00921	0	11.75572	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P43353	AL3B1_HUMAN	"Aldehyde dehydrogenase family 3 member B1, EC 1.2.1.28, EC 1.2.1.5, EC 1.2.1.7 (Aldehyde dehydrogenase 7)"	ALDH3B1 ALDH7	Homo sapiens (Human)	alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid biosynthetic process [GO:0030148]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid biosynthetic process [GO:0030148]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]	GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0005886; GO:0006066; GO:0006068; GO:0006081; GO:0006629; GO:0006979; GO:0018477; GO:0018479; GO:0030148; GO:0030667; GO:0031982; GO:0034599; GO:0035579; GO:0046185; GO:0070062	DPLGDTLRR	12.27999973	1	1	0.247219213	1041.459205	15.24298	0	0	16.30618	14.61502	0	15.67768	0	0	15.0442	0	0	0	0	0	0	0	0	0	0	0	15.72612	0	0	0	0	0	0	0	0	15.52375	0	0	0	15.40161	0	0	0	0	0	0	0	0	0	0	0	16.50429	0
P43358	MAGA4_HUMAN	"Melanoma-associated antigen 4 (Cancer/testis antigen 1.4, CT1.4) (MAGE-4 antigen) (MAGE-41 antigen) (MAGE-X2 antigen)"	MAGEA4 MAGE4	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]	nucleus [GO:0005634]	nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]	histone deacetylase binding [GO:0042826]	GO:0000122; GO:0005634; GO:0042826; GO:0043066; GO:0045787	MSSEQK	8.010000229	0.986952126	0.986952126	0.204819638	724.2688921	16.28748	15.16154	15.82789	15.96393	15.84071	15.75998	0	15.85822	14.53249	15.81069	15.82587	15.49243	14.76402	0	0	15.33932	15.59901	0	0	14.50595	0	14.92002	16.39432	14.8969	0	0	0	0	0	0	16.95711	0	0	0	0	0	16.2268	16.91939	16.35586	16.63448	0	0	0	0	0	0	0	0
P43366	MAGB1_HUMAN	"Melanoma-associated antigen B1 (Cancer/testis antigen 3.1, CT3.1) (DSS-AHC critical interval MAGE superfamily 10, DAM10) (MAGE-B1 antigen) (MAGE-XP antigen)"	MAGEB1 MAGEL1 MAGEXP	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005634	VLEFLAK	15.53999996	0.838282228	0.838282228	0.120115376	817.3396088	15.20638	0	0	9.348648	0	0	0	14.48373	13.3269	0	15.43457	14.74626	13.60547	0	0	13.56089	0	0	0	0	0	0	0	0	0	0	15.22958	0	0	14.20323	14.58006	0	0	0	0	0	18.25755	0	0	0	0	0	0	0	0	0	0	0
P43403	ZAP70_HUMAN	"Tyrosine-protein kinase ZAP-70, EC 2.7.10.2 (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase)"	ZAP70 SRK	Homo sapiens (Human)	adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; cell differentiation [GO:0030154]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; cell differentiation [GO:0030154]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001772; GO:0001784; GO:0002250; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006955; GO:0007169; GO:0018108; GO:0030154; GO:0030217; GO:0031234; GO:0035556; GO:0042101; GO:0042110; GO:0042113; GO:0043366; GO:0045059; GO:0045060; GO:0045087; GO:0045582; GO:0046638; GO:0046641; GO:0046777; GO:0050850; GO:0050852; GO:0070489; GO:0072678	FLVGKR	5.989999771	0.644873023	0.644873023	0.128599062	719.7442932	14.10708	15.2056	15.96478	14.32199	15.11479	15.19502	0	0	15.73524	0	16.05041	0	15.97363	0	0	15.20044	14.7649	15.66089	12.59508	15.51311	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.25998	0	0	16.94927	0	0	15.8243
P43405	KSYK_HUMAN	"Tyrosine-protein kinase SYK, EC 2.7.10.2 (Spleen tyrosine kinase) (p72-Syk)"	SYK	Homo sapiens (Human)	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; cell activation [GO:0001775]; cell differentiation [GO:0030154]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101]	B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; cell activation [GO:0001775]; cell differentiation [GO:0030154]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325]	GO:0001525; GO:0001775; GO:0001784; GO:0001945; GO:0002092; GO:0002223; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0002862; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006606; GO:0007159; GO:0007169; GO:0007229; GO:0009887; GO:0010543; GO:0010803; GO:0016170; GO:0018105; GO:0018108; GO:0019370; GO:0019815; GO:0019901; GO:0019902; GO:0030154; GO:0030168; GO:0030593; GO:0031234; GO:0031334; GO:0031623; GO:0032009; GO:0032481; GO:0032725; GO:0032733; GO:0032735; GO:0032752; GO:0032753; GO:0032755; GO:0032757; GO:0032760; GO:0032928; GO:0032930; GO:0032991; GO:0033630; GO:0035325; GO:0035556; GO:0038063; GO:0038095; GO:0038096; GO:0038156; GO:0042101; GO:0042169; GO:0042742; GO:0043274; GO:0043280; GO:0043306; GO:0043313; GO:0043366; GO:0043507; GO:0045087; GO:0045579; GO:0045588; GO:0045780; GO:0046638; GO:0046641; GO:0046777; GO:0048514; GO:0050731; GO:0050764; GO:0050850; GO:0050853; GO:0051090; GO:0051712; GO:0070372; GO:0071226; GO:0071396; GO:0071404; GO:0071639; GO:0090237; GO:0090330; GO:0097110; GO:0120162; GO:1990858	KSSPAQGNR	4.269999981	0.674909711	0.674909711	0.19589281	945.6453856	13.43104	17.58049	0	0	0	0	17.38078	0	0	14.79217	0	0	0	16.44154	0	0	0	0	17.14996	0	0	0	18.80598	14.00738	0	0	0	16.36284	14.70465	0	0	15.69141	17.11384	0	17.97877	0	0	0	19.26487	15.43024	0	0	0	0	13.3684	0	0	0
P43490	NAMPT_HUMAN	"Nicotinamide phosphoribosyltransferase, NAmPRTase, Nampt, EC 2.4.2.12 (Pre-B-cell colony-enhancing factor 1, Pre-B cell-enhancing factor) (Visfatin)"	NAMPT PBEF PBEF1	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; circadian regulation of gene expression [GO:0032922]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD biosynthetic process [GO:0009435]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; cell-cell signaling [GO:0007267]; circadian regulation of gene expression [GO:0032922]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD biosynthetic process [GO:0009435]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]	GO:0004514; GO:0005125; GO:0005829; GO:0007165; GO:0007267; GO:0008284; GO:0009435; GO:0016607; GO:0030054; GO:0032922; GO:0034356; GO:0042802; GO:0045944; GO:0047280; GO:0051770; GO:0070062	KYYGTK	4.039999962	1	1	0.122928329	759.7811689	13.35166	0	13.83417	14.07136	0	0	0	0	16.34822	0	0	0	0	0	13.77587	0	15.36289	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.96605	16.57194	0	0	0	0	0	15.23915	16.21535	0	0
P43626	KI2L1_HUMAN	"Killer cell immunoglobulin-like receptor 2DL1 (CD158 antigen-like family member A) (Natural killer-associated transcript 1, NKAT-1) (p58 natural killer cell receptor clones CL-42/47.11, p58 NK receptor CL-42/47.11) (p58.1 MHC class-I-specific NK receptor) (CD antigen CD158a)"	KIR2DL1 CD158A NKAT1	Homo sapiens (Human)	immune response [GO:0006955]; natural killer cell inhibitory signaling pathway [GO:0002769]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]; natural killer cell inhibitory signaling pathway [GO:0002769]	signaling receptor activity [GO:0038023]	GO:0002769; GO:0005886; GO:0005887; GO:0006955; GO:0038023	LIGEHHDGVSK	7.510000229	1	1	0.367809614	1191.903543	13.88898	0	0	14.79992	0	0	0	0	0	0	0	0	16.9668	0	0	15.91781	0	0	0	0	17.10237	15.96081	15.10129	16.41348	15.73838	15.11785	0	0	16.40463	14.39277	15.64901	14.58492	15.43194	13.84319	13.38138	14.64614	0	0	15.95756	0	0	0	0	16.45709	0	15.52849	14.22567	15.65541
P43681	ACHA4_HUMAN	Neuronal acetylcholine receptor subunit alpha-4	CHRNA4 NACRA4	Homo sapiens (Human)	"action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	"acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]	GO:0001508; GO:0001666; GO:0005886; GO:0005887; GO:0005892; GO:0006281; GO:0006811; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0009897; GO:0014059; GO:0015276; GO:0015464; GO:0016020; GO:0016021; GO:0019233; GO:0022848; GO:0030425; GO:0030594; GO:0034220; GO:0035094; GO:0035095; GO:0042113; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0050877; GO:0050890; GO:0051899; GO:0060080	SPSDQLPPQQPLEAEK	4.690000057	0.025167055	0.025167055	0.447323265	1763.816286	0	17.85128	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.86998	0	0	0	18.02485	19.17244	0	0	0	0	0	0	17.867	0	0	0	0	0	19.91168	19.50319	20.03139	0	0	18.35971	0	0	0	0	0	0	0	0
P43686	PRS6B_HUMAN	"26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (MB67-interacting protein) (MIP224) (Proteasome 26S subunit ATPase 4) (Tat-binding protein 7, TBP-7)"	PSMC4 MIP224 TBP7	Homo sapiens (Human)	blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]	GO:0000502; GO:0001824; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0008540; GO:0016020; GO:0016887; GO:0022624; GO:0036402; GO:0043161	QIGIDPPR	7.949999809	0.425813168	0.425813168	0.154477131	896.4156598	14.44021	19.43012	18.10065	15.37661	17.76851	17.0247	0	16.35093	14.11302	17.19248	0	11.80007	0	0	15.88597	0	16.61468	15.87518	15.76602	15.72269	0	17.05151	15.2967	17.50467	0	16.09409	16.61507	0	0	0	16.53019	0	19.58064	15.95002	0	14.67187	16.66393	17.3743	16.98545	18.35236	0	19.82535	0	17.33698	17.77513	0	19.18749	15.25158
P43694	GATA4_HUMAN	Transcription factor GATA-4 (GATA-binding factor 4)	GATA4	Homo sapiens (Human)	"aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; atrioventricular canal development [GO:0036302]; atrioventricular node development [GO:0003162]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue regeneration [GO:0061026]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle morphogenesis [GO:0003208]; cell fate commitment [GO:0045165]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; cellular response to glucose stimulus [GO:0071333]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion development [GO:0003197]; endoderm development [GO:0007492]; heart looping [GO:0001947]; intestinal epithelial cell differentiation [GO:0060575]; male gonad development [GO:0008584]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein kinase B signaling [GO:0051896]; regulation of transcription, DNA-templated [GO:0006355]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; transdifferentiation [GO:0060290]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]"	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; atrioventricular canal development [GO:0036302]; atrioventricular node development [GO:0003162]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue regeneration [GO:0061026]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle morphogenesis [GO:0003208]; cell fate commitment [GO:0045165]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; cellular response to glucose stimulus [GO:0071333]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion development [GO:0003197]; endoderm development [GO:0007492]; heart looping [GO:0001947]; intestinal epithelial cell differentiation [GO:0060575]; male gonad development [GO:0008584]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein kinase B signaling [GO:0051896]; regulation of transcription, DNA-templated [GO:0006355]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; transdifferentiation [GO:0060290]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]"	"co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0001947; GO:0003162; GO:0003180; GO:0003190; GO:0003197; GO:0003208; GO:0003215; GO:0003281; GO:0003289; GO:0003290; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007267; GO:0007492; GO:0008270; GO:0008584; GO:0009410; GO:0009612; GO:0010507; GO:0010575; GO:0010667; GO:0016604; GO:0019901; GO:0030513; GO:0033189; GO:0035054; GO:0036302; GO:0042060; GO:0043565; GO:0045165; GO:0045766; GO:0045893; GO:0045944; GO:0048617; GO:0051525; GO:0051891; GO:0051896; GO:0060290; GO:0060413; GO:0060575; GO:0061026; GO:0061049; GO:0061629; GO:0070374; GO:0070410; GO:0071333; GO:0086004; GO:0090575; GO:1903202; GO:1990837; GO:2001234	EAAAYSSGGGAAGAGLAGREQYGR	6.409999847	1	1	0.163806004	2228.100347	0	12.7316	0	0	0	0	0	0	0	0	0	0	11.83405	15.16312	0	0	14.72147	14.02646	14.58515	0	0	13.4203	0	0	12.52244	11.96911	11.47133	0	13.6617	0	13.34538	0	13.15752	13.68454	0	12.56862	14.02001	0	0	0	0	0	0	0	0	0	15.62715	0
P43699	NKX21_HUMAN	"Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1, TTF-1) (Thyroid-specific enhancer-binding protein, T/EBP)"	NKX2-1 NKX2A TITF1 TTF1	Homo sapiens (Human)	"brain development [GO:0007420]; cell differentiation [GO:0030154]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; globus pallidus development [GO:0021759]; lung development [GO:0030324]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; cell differentiation [GO:0030154]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; globus pallidus development [GO:0021759]; lung development [GO:0030324]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001161; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007420; GO:0009725; GO:0010628; GO:0010719; GO:0019899; GO:0021759; GO:0030154; GO:0030324; GO:0030336; GO:0030512; GO:0030878; GO:0030900; GO:0042753; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0060441; GO:0061629	MSMSPK	2.470000029	1	1	6.90E-13	696.5419585	0	14.77521	13.94257	0	0	0	0	0	0	0	0	0	15.9965	0	0	0	0	0	0	16.02525	0	0	0	0	15.8276	0	0	0	0	0	0	0	0	17.28879	0	0	0	16.84366	0	16.41508	0	0	0	0	0	0	17.1504	0
P45452	MMP13_HUMAN	"Collagenase 3, EC 3.4.24.- (Matrix metalloproteinase-13, MMP-13)"	MMP13	Homo sapiens (Human)	bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cellular protein metabolic process [GO:0044267]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cellular protein metabolic process [GO:0044267]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0001958; GO:0003417; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0044267; GO:0060349; GO:1904645	CDPSLSLDAITSLR	11.89999962	1	1	4.59E-13	1547.925931	0	12.86708	0	16.56105	13.97457	9.144051	15.73909	13.08253	14.11699	0	0	14.92264	13.37391	14.94259	0	0	0	0	0	12.94505	0	0	0	0	0	0	0	0	0	0	0	0	16.6308	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P45984	MK09_HUMAN	"Mitogen-activated protein kinase 9, MAP kinase 9, MAPK 9, EC 2.7.11.24 (JNK-55) (Stress-activated protein kinase 1a, SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2)"	MAPK9 JNK2 PRKM9 SAPK1A	Homo sapiens (Human)	cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; rhythmic process [GO:0048511]	ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004705; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0010628; GO:0010744; GO:0016607; GO:0018105; GO:0031398; GO:0034614; GO:0035556; GO:0038095; GO:0042752; GO:0048511; GO:0051090; GO:0061833; GO:0071276; GO:0071803; GO:0090398; GO:0106310; GO:1901485; GO:2001235	TACTNFMMTPYVVTR	3.319999933	0.132062569	0.132062569	0.341977052	1824.376327	0	16.97224	0	0	0	14.03186	16.8051	0	0	0	15.3581	15.62918	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.8224	0	0	14.94915	13.07927	16.50842	0	14.0696	0	0	0	0	0	15.63745	0	0	0	0	17.28271	0	0
P46013	KI67_HUMAN	"Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67, Antigen KI-67, Antigen Ki67)"	MKI67	Homo sapiens (Human)	cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]	chromosome [GO:0005694]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0007049; GO:0007088; GO:0008022; GO:0008283; GO:0016020; GO:0016604; GO:0051983; GO:1902275	AMLTPKPAGGDEK	13.21000004	1	1	0.020078667	1313.892902	15.66159	0	14.32349	14.01922	0	13.17359	15.372	0	0	14.6076	0	14.98457	13.66067	0	15.19885	15.07769	15.02871	14.78948	0	0	0	0	0	11.88152	0	14.05967	0	0	0	0	0	0	0	0	0	0	0	0	0	14.8955	18.816	14.43595	18.68974	0	0	0	0	0
P46020	KPB1_HUMAN	"Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform, Phosphorylase kinase alpha M subunit"	PHKA1 PHKA	Homo sapiens (Human)	generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]	calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689]	GO:0004689; GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005977; GO:0006091	GGLDRFQAAVQTTCDLMSLVTK	4.630000114	0.387754709	0.387754709	0.07149616	2418.050614	15.59078	0	13.39712	16.97249	0	0	0	16.65956	0	0	18.79285	0	16.65426	0	0	0	17.07747	0	0	0	0	0	0	0	0	0	0	14.77022	0	0	0	17.98959	0	15.61004	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P46063	RECQ1_HUMAN	"ATP-dependent DNA helicase Q1, EC 3.6.4.12 (DNA helicase, RecQ-like type 1, RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)"	RECQL RECQ1 RECQL1	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]	GO:0000724; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0016887; GO:0032508; GO:0036310; GO:0043138; GO:1990814	QLGISATMLNASSSK	1.429999948	1	1	0.173211626	1528.599455	0	0	14.94087	0	0	0	0	0	0	15.05481	0	0	0	0	0	14.81331	0	0	0	0	0	0	16.10332	0	0	0	0	0	0	0	16.57649	0	15.31983	0	0	16.0125	16.70395	14.49635	15.85902	15.63843	15.22046	16.24968	0	0	0	0	0	0
P46087	NOP2_HUMAN	"Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase, EC 2.1.1.- (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)"	NOP2 NOL1 NSUN1	Homo sapiens (Human)	maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]	GO:0000027; GO:0000470; GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796	SSRPPPAK	4.269999981	1	1	0.076931445	838.7748979	0	14.44281	0	15.25217	13.86294	0	15.10482	13.18047	15.09305	16.22668	15.60707	14.86119	0	11.93364	0	0	15.74933	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.47137	0	0	0	0	0	0	0	0	0	0	0
P46098	5HT3A_HUMAN	"5-hydroxytryptamine receptor 3A, 5-HT3-A, 5-HT3A (5-hydroxytryptamine receptor 3, 5-HT-3, 5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)"	HTR3A 5HT3R HTR3	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165]	cleavage furrow [GO:0032154]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]	cleavage furrow [GO:0032154]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165]	neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0032154; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051378; GO:0098662; GO:1904602	EFSMESSNYYAEMKFYVVIR	4.809999943	1	1	0.140430634	2493.902968	0	11.89847	13.08952	0	0	0	0	0	0	0	15.04648	0	0	0	0	0	0	13.2006	14.46092	9.444768	13.06319	0	0	12.81861	0	11.32034	0	0	7.550521	12.17518	14.16963	0	0	0	0	0	13.74574	11.06748	0	0	0	0	0	0	11.33204	0	0	0
P46100	ATRX_HUMAN	"Transcriptional regulator ATRX, EC 3.6.4.12 (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein, XNP) (Znf-HX)"	ATRX RAD54L XH2	Homo sapiens (Human)	"cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; DNA replication-independent chromatin assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]"	"chromosome, subtelomeric region [GO:0099115]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]"	"chromosome, subtelomeric region [GO:0099115]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; DNA replication-independent chromatin assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000212; GO:0000228; GO:0000779; GO:0000781; GO:0000792; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005721; GO:0006281; GO:0006306; GO:0006334; GO:0006336; GO:0006338; GO:0006355; GO:0007283; GO:0010571; GO:0015616; GO:0016604; GO:0016605; GO:0016887; GO:0030330; GO:0030900; GO:0031297; GO:0032206; GO:0035064; GO:0035128; GO:0035264; GO:0042393; GO:0045944; GO:0046872; GO:0060009; GO:0070087; GO:0070192; GO:0070198; GO:0072520; GO:0072711; GO:0099115; GO:0140658; GO:1900112; GO:1901581; GO:1901582; GO:1904908	CKLLGK	11.39999962	1	1	0.273037936	718.3147153	18.97087	17.1433	18.5822	0	0	0	16.77532	18.27941	0	0	18.38175	0	18.85032	17.13089	0	0	17.4561	0	0	0	0	0	0	17.72496	0	0	19.62623	18.83665	0	0	0	23.14476	0	18.73639	0	0	0	0	0	0	0	0	18.05347	0	0	18.31393	17.67128	0
P46199	IF2M_HUMAN	"Translation initiation factor IF-2, mitochondrial, IF-2(Mt), IF-2Mt, IF2(mt)"	MTIF2	Homo sapiens (Human)	mitochondrial translational initiation [GO:0070124]; regulation of translational initiation [GO:0006446]; ribosome disassembly [GO:0032790]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; regulation of translational initiation [GO:0006446]; ribosome disassembly [GO:0032790]"	"GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0006446; GO:0008135; GO:0032790; GO:0043024; GO:0070124	FHTIYR	5.730000019	0.78430891	0.78430891	0.188869079	833.5283901	15.06717	15.21601	16.60435	0	15.02878	15.34508	16.65987	0	14.26518	0	0	0	12.03021	0	0	15.781	0	0	14.88944	0	0	0	0	0	0	15.90798	0	13.08799	13.96295	14.53336	16.21827	15.66739	15.76288	15.33658	14.08286	14.8072	6.987453	16.68	15.7485	12.67907	16.52566	13.28811	14.23141	14.74921	14.18566	16.04101	15.40525	14.59092
P46379	BAG6_HUMAN	"Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6, BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe)"	BAG6 BAT3 G3	Homo sapiens (Human)	apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]	GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030433; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071712; GO:0071816; GO:0071818; GO:1904294; GO:1904378; GO:1904379; GO:1990381	EHIAASVSIPSEKQR	6.440000057	1	1	1.15E-12	1651.427962	14.364	16.02101	16.14286	0	0	0	16.58093	0	0	14.59568	0	0	14.26989	0	0	15.01955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P46459	NSF_HUMAN	"Vesicle-fusing ATPase, EC 3.6.4.6 (N-ethylmaleimide-sensitive fusion protein, NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)"	NSF	Homo sapiens (Human)	exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; dendritic shaft [GO:0043198]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cytosol [GO:0005829]; dendritic shaft [GO:0043198]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein disaggregase activity [GO:0140545]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein disaggregase activity [GO:0140545]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]	GO:0000149; GO:0001921; GO:0005524; GO:0005765; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0006887; GO:0006891; GO:0014069; GO:0016192; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030165; GO:0035255; GO:0035494; GO:0043001; GO:0043198; GO:0044877; GO:0045026; GO:0045732; GO:0046872; GO:0140545	CQAMKK	1.809999943	1	1	0.107352218	781.5784666	0	15.02011	13.22082	0	14.94819	12.81883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.13406	0	0	15.53366	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.96912	0	0	0
P46531	NOTC1_HUMAN	"Neurogenic locus notch homolog protein 1, Notch 1, hN1 (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation, NEXT; Notch 1 intracellular domain, NICD ]"	NOTCH1 TAN1	Homo sapiens (Human)	"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]	GO:0000122; GO:0000139; GO:0001669; GO:0001701; GO:0001708; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009986; GO:0010467; GO:0010614; GO:0010628; GO:0010629; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050679; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027	SDAAK	4.119999886	1	1	0.081585544	490.7267016	16.04057	16.18785	0	14.79546	15.70204	0	0	0	15.55982	13.75556	15.07441	15.01537	13.94836	10.19237	15.26442	14.88513	15.22757	16.1562	16.20173	12.45448	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P46597	ASMT_HUMAN	"Acetylserotonin O-methyltransferase, EC 2.1.1.4 (Hydroxyindole O-methyltransferase, HIOMT)"	ASMT	Homo sapiens (Human)	aromatic compound biosynthetic process [GO:0019438]; indolalkylamine biosynthetic process [GO:0046219]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]; translation [GO:0006412]	cytosol [GO:0005829]	cytosol [GO:0005829]; acetylserotonin O-methyltransferase activity [GO:0017096]; identical protein binding [GO:0042802]; O-methyltransferase activity [GO:0008171]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; S-methyltransferase activity [GO:0008172]; aromatic compound biosynthetic process [GO:0019438]; indolalkylamine biosynthetic process [GO:0046219]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]; translation [GO:0006412]	acetylserotonin O-methyltransferase activity [GO:0017096]; identical protein binding [GO:0042802]; O-methyltransferase activity [GO:0008171]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; S-methyltransferase activity [GO:0008172]	GO:0005829; GO:0006412; GO:0006629; GO:0008171; GO:0008172; GO:0008757; GO:0017096; GO:0019438; GO:0030187; GO:0032259; GO:0042802; GO:0042803; GO:0046219	MGSSEDQAYR	17.56999969	0.015698219	0.015698219	0.279199293	1158.74289	19.36813	20.1644	20.2628	18.59654	19.03615	18.45171	19.84192	19.51251	19.60135	19.30134	18.93127	19.97608	0	19.69799	0	0	0	17.60062	18.32779	19.08625	0	18.94561	19.74531	18.44012	18.62597	19.19934	19.32041	19.03078	19.05424	19.99658	0	19.58893	0	19.33965	19.88071	21.39491	0	18.15112	19.17857	18.49601	16.60184	17.37129	17.14394	17.80854	16.93619	16.4786	20.07789	19.99842
P46695	IEX1_HUMAN	"Radiation-inducible immediate-early gene IEX-1 (Differentiation-dependent gene 2 protein, Protein DIF-2) (Immediate early protein GLY96) (Immediate early response 3 protein) (PACAP-responsive gene 1 protein, Protein PRG1)"	IER3 DIF2 IEX1 PRG1	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of response to DNA damage stimulus [GO:2001020]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of response to DNA damage stimulus [GO:2001020]		GO:0005634; GO:0005829; GO:0006915; GO:0009653; GO:0016021; GO:0043066; GO:2001020	QLPVEEPNPAK	12.97999954	1	1	1.14E-12	1220.585857	0	11.90281	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.40163	0	0	0	0	0	10.93806	0	0	0	0	0	0	0	0	0	13.64285	0	0	13.7874	0	0	0	0	0	0	0	0	12.79988	0	0
P46734	MP2K3_HUMAN	"Dual specificity mitogen-activated protein kinase kinase 3, MAP kinase kinase 3, MAPKK 3, EC 2.7.12.2 (MAPK/ERK kinase 3, MEK 3) (Stress-activated protein kinase kinase 2, SAPK kinase 2, SAPKK-2, SAPKK2)"	MAP2K3 MEK3 MKK3 PRKMK3 SKK2	Homo sapiens (Human)	"cardiac muscle contraction [GO:0060048]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to sorbitol [GO:0072709]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular senescence [GO:0090398]; heart development [GO:0007507]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cardiac muscle contraction [GO:0060048]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to sorbitol [GO:0072709]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular senescence [GO:0090398]; heart development [GO:0007507]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]"	ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000165; GO:0001817; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0006954; GO:0007165; GO:0007507; GO:0016020; GO:0019901; GO:0035331; GO:0035924; GO:0038066; GO:0043410; GO:0043536; GO:0045860; GO:0045893; GO:0051770; GO:0060048; GO:0071222; GO:0072709; GO:0090398; GO:0106310	VRHAQSGTIMAVK	14.82999992	0.323838025	0.323838025	0.564233797	1412.475723	17.60055	0	0	0	0	18.92564	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.19235	0	0	19.07385	0	0	0	0	0	0	0	0	0	0	19.02998	0	0	18.77492	0	19.24562	0	0	0	19.47598	0	0	17.70677
P46736	BRCC3_HUMAN	"Lys-63-specific deubiquitinase BRCC36, EC 3.4.19.- (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36)"	BRCC3 BRCC36 C6.1A CXorf53	Homo sapiens (Human)	cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; enzyme regulator activity [GO:0030234]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent deubiquitinase [GO:0004843]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165]	enzyme regulator activity [GO:0030234]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent deubiquitinase [GO:0004843]	GO:0000151; GO:0000152; GO:0000922; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006302; GO:0006325; GO:0007095; GO:0008237; GO:0010165; GO:0010212; GO:0016579; GO:0030234; GO:0031593; GO:0035518; GO:0044818; GO:0045739; GO:0046872; GO:0051301; GO:0051865; GO:0061578; GO:0070122; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0071479; GO:0140492; GO:2000001	RIHSLTHLDSVTK	7.300000191	1	1	0.596232902	1509.502751	0	0	0	0	0	0	0	11.52388	0	0	14.4374	0	0	0	0	0	0	0	0	16.08073	0	0	0	15.12407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.82572	0	0	0	0	0	0	0	0	0
P46779	RL28_HUMAN	60S ribosomal protein L28 (Large ribosomal subunit protein eL28)	RPL28	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0030425; GO:0036464; GO:0044297; GO:0070062	YNGLIHR	2.109999895	0.511811316	0.511811316	0.102318151	872.8313573	15.67436	14.79537	14.24209	0	0	0	0	0	0	0	0	12.75476	0	0	0	0	0	0	0	0	0	0	14.87885	0	0	0	0	0	0	0	0	15.80378	0	15.11666	0	15.49811	0	0	0	0	0	0	0	0	16.63479	0	0	0
P46781	RS9_HUMAN	40S ribosomal protein S9 (Small ribosomal subunit protein uS4)	RPS9	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	5.8S rRNA binding [GO:1990932]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0008284; GO:0015935; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0045182; GO:0045202; GO:0045903; GO:0070062; GO:1990904; GO:1990932	IGVLDEGK	9.680000305	0.088859603	0.088859603	0.226228562	831.7166875	19.55972	17.21027	16.44655	15.5997	18.19014	15.26655	17.4421	17.75603	16.73529	18.99947	18.10642	18.65896	16.04616	15.06124	18.51532	17.14312	18.02336	0	18.85095	17.24142	0	18.52761	0	18.05575	18.60266	16.9665	17.86912	19.39437	15.50099	16.75206	18.52536	18.80622	16.71927	0	18.69927	0	16.39407	15.048	18.11779	15.22582	0	0	17.95188	0	0	17.19944	16.62004	0
P46783	RS10_HUMAN	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0016020; GO:0022626; GO:0022627	NVPNLHVMK	2.410000086	0.077198572	0.077198572	0.093842966	1069.040769	13.77055	0	14.27823	12.16347	0	0	0	0	17.06022	0	0	0	13.62253	14.72391	0	0	12.91061	0	10.00215	0	0	17.38972	11.72904	0	12.51245	0	0	17.6494	0	0	0	14.23081	16.51678	0	0	0	0	18.76275	0	18.72251	16.11373	13.77853	14.94083	0	0	0	0	14.82937
P46821	MAP1B_HUMAN	"Microtubule-associated protein 1B, MAP-1B [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1 ]"	MAP1B	Homo sapiens (Human)	axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; odontoblast differentiation [GO:0071895]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron differentiation [GO:0045666]; regulation of microtubule depolymerization [GO:0031114]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]	apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196]	apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; odontoblast differentiation [GO:0071895]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron differentiation [GO:0045666]; regulation of microtubule depolymerization [GO:0031114]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]	actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]	GO:0000226; GO:0001578; GO:0001750; GO:0001764; GO:0003779; GO:0005198; GO:0005543; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0007026; GO:0007409; GO:0007416; GO:0008017; GO:0009410; GO:0009612; GO:0009743; GO:0010035; GO:0014012; GO:0014069; GO:0016358; GO:0017085; GO:0021700; GO:0030424; GO:0030425; GO:0030426; GO:0031114; GO:0031116; GO:0032355; GO:0032387; GO:0033189; GO:0036477; GO:0043025; GO:0043196; GO:0043197; GO:0043204; GO:0044877; GO:0045202; GO:0045666; GO:0045773; GO:0047497; GO:0048471; GO:0048675; GO:0051915; GO:0061162; GO:0071363; GO:0071375; GO:0071895; GO:0097440; GO:0097441; GO:0097457	DSGGK	2.200000048	0.700094461	0.700094461	0.177632711	464.3534486	15.87958	15.37977	16.48793	16.54111	15.43235	16.51538	15.53744	15.79317	16.07691	15.3945	16.36295	16.25985	14.62274	15.75281	13.97948	16.84348	16.14178	15.46022	15.5598	15.37875	14.96149	15.91129	16.98864	16.03603	16.83288	15.29456	16.87367	15.86738	15.65512	16.58752	16.65997	16.03356	16.12002	16.41906	16.5558	15.67847	16.36919	16.72781	17.04158	16.57519	16.35781	15.75116	15.04259	16.27902	16.53823	16.02871	16.77803	15.93579
P46934	NEDD4_HUMAN	"E3 ubiquitin-protein ligase NEDD4, EC 2.3.2.26 (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4, NEDD-4)"	NEDD4 KIAA0093 NEDD4-1 PIG53	Homo sapiens (Human)	cellular response to UV [GO:0034644]; formation of structure involved in a symbiotic process [GO:0044111]; glucocorticoid receptor signaling pathway [GO:0042921]; lysosomal transport [GO:0007041]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of synapse organization [GO:0050807]; response to calcium ion [GO:0051592]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]	apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; cellular response to UV [GO:0034644]; formation of structure involved in a symbiotic process [GO:0044111]; glucocorticoid receptor signaling pathway [GO:0042921]; lysosomal transport [GO:0007041]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of synapse organization [GO:0050807]; response to calcium ion [GO:0051592]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]	beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0000785; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006622; GO:0007041; GO:0007528; GO:0010766; GO:0010768; GO:0014068; GO:0016241; GO:0016327; GO:0016567; GO:0019871; GO:0019899; GO:0019904; GO:0030948; GO:0031175; GO:0031623; GO:0031698; GO:0032801; GO:0032991; GO:0034644; GO:0034765; GO:0042391; GO:0042921; GO:0043130; GO:0043161; GO:0043162; GO:0043197; GO:0044111; GO:0045732; GO:0046755; GO:0046824; GO:0048471; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0050847; GO:0051592; GO:0061630; GO:0070062; GO:0070063; GO:0070064; GO:0070534; GO:1901016; GO:2000650	ISTSNVVQMK	5.019999981	0.113614954	0.113614954	0.085064914	1124.212827	16.1272	0	16.17823	16.33171	0	15.20006	13.96278	14.04464	17.64342	16.11738	8.4025	0	0	0	0	16.01629	0	12.99125	15.03871	0	0	0	17.25817	0	0	14.39756	0	18.2671	0	0	13.74556	17.74217	11.02235	15.11243	15.88597	0	12.81141	17.31739	0	13.72709	0	13.92524	0	0	13.68405	16.34536	17.42206	14.61931
P46939	UTRN_HUMAN	"Utrophin (Dystrophin-related protein 1, DRP-1)"	UTRN DMDL DRP1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649]	cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]	cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]	GO:0001954; GO:0003779; GO:0005178; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0006936; GO:0007517; GO:0008270; GO:0016010; GO:0016020; GO:0017166; GO:0019901; GO:0030036; GO:0030054; GO:0030175; GO:0030864; GO:0031527; GO:0031594; GO:0032991; GO:0042383; GO:0042995; GO:0045211; GO:0051015; GO:0070062; GO:2000649	DQALILMNAR	8.329999924	0.290454626	0.290454626	0.179072843	1160.718337	9.183744	0	13.28478	0	0	0	0	13.06425	0	14.649	0	0	15.88314	0	13.42389	0	0	0	0	0	0	0	0	0	0	16.33217	0	15.44949	0	0	15.64632	0	16.48233	0	0	0	0	16.26576	0	0	0	0	0	0	0	16.87564	0	0
P46940	IQGA1_HUMAN	Ras GTPase-activating-like protein IQGAP1 (p195)	IQGAP1 KIAA0051	Homo sapiens (Human)	cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of GTPase activity [GO:0043087]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165]	actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]	"actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of GTPase activity [GO:0043087]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165]"	"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]"	GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031234; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043087; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0045860; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1990138; GO:1990904	GLQQQNSDWYLK	2.49000001	1	1	1.61E-12	1480.226842	0	14.85942	13.77508	14.94214	0	0	0	0	12.0717	13.57647	15.61352	15.17698	15.49464	14.26388	15.64273	0	14.22596	0	0	0	0	17.57166	13.93566	15.8485	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P47224	MSS4_HUMAN	Guanine nucleotide exchange factor MSS4 (Rab-interacting factor)	RABIF MSS4 RASGRF3	Homo sapiens (Human)	membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; membrane [GO:0016020]	cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]	GO:0005085; GO:0005829; GO:0006892; GO:0007264; GO:0008270; GO:0015031; GO:0016020; GO:0061025	DVGNIK	3.799999952	1	1	0.019276791	646.3382066	14.0167	16.42446	13.65647	15.67682	16.55693	15.06556	15.11382	15.1466	0	14.23949	0	16.81957	14.02667	0	0	0	14.88196	0	14.76001	0	0	15.57388	0	15.35646	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.10191	0	0	0
P47712	PA24A_HUMAN	"Cytosolic phospholipase A2, cPLA2 (Phospholipase A2 group IVA) [Includes: Phospholipase A2, EC 3.1.1.4 (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase, EC 3.1.1.5 ]"	PLA2G4A CPLA2 PLA2G4	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid metabolic process [GO:0006690]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid metabolic process [GO:0006690]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127]	calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623]	GO:0000139; GO:0001516; GO:0002827; GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006071; GO:0006640; GO:0006663; GO:0006690; GO:0008374; GO:0010314; GO:0010572; GO:0019369; GO:0019370; GO:0032266; GO:0032308; GO:0034478; GO:0034638; GO:0036151; GO:0042127; GO:0043032; GO:0043231; GO:0046475; GO:0047498; GO:0047499; GO:0050482; GO:0070273; GO:0071236; GO:0102545; GO:1902387	MNTTLSSLK	5.260000229	1	1	0.068084844	1011.564384	0	0	13.47056	0	0	0	15.48967	0	0	0	0	13.59486	0	0	0	15.04278	0	14.61491	0	0	0	0	13.47287	0	0	14.88122	15.39657	13.68285	0	0	0	0	0	0	0	0	15.58262	0	16.47259	0	13.58112	0	0	0	0	0	0	0
P47884	OR1D4_HUMAN	"Olfactory receptor 1D4 (Olfactory receptor 17-30, OR17-30)"	OR1D4	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005887; GO:0007186; GO:0007606	DMHGAPGR	7.440000057	1	1	0.157607873	857.3858015	14.45884	15.3076	0	15.56114	14.16504	13.58155	15.42357	15.55486	14.02886	14.60529	14.50197	0	14.40895	14.40568	13.11961	0	0	0	15.64844	0	0	0	0	0	0	0	15.07962	0	0	15.10168	0	0	0	0	0	0	0	0	0	0	0	13.68638	0	0	0	0	0	0
P47895	AL1A3_HUMAN	"Aldehyde dehydrogenase family 1 member A3, EC 1.2.1.36 (Aldehyde dehydrogenase 6) (Retinaldehyde dehydrogenase 3, RALDH-3, RalDH3)"	ALDH1A3 ALDH6	Homo sapiens (Human)	embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324]	GO:0001758; GO:0002072; GO:0002138; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0007626; GO:0021768; GO:0031076; GO:0042472; GO:0042572; GO:0042573; GO:0042574; GO:0042803; GO:0043065; GO:0048048; GO:0050885; GO:0051289; GO:0060013; GO:0060166; GO:0060324; GO:0070062; GO:0070324; GO:0070384; GO:0070403	EGAKLECGGSAMEDK	4.75	1	1	0.293096119	1596.09426	12.66212	15.30991	16.75741	13.76105	0	14.45451	0	13.71386	0	0	0	13.8975	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.68026	13.85703	16.74826	15.78207	0	0	16.7117	0	0	0	0	0	15.14434	0	16.2479	14.11172	14.62236	0	0	17.53215
P47929	LEG7_HUMAN	"Galectin-7, Gal-7 (HKL-14) (PI7) (p53-induced gene 1 protein)"	LGALS7 PIG1; LGALS7B	Homo sapiens (Human)	"apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]"	carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936]	GO:0005615; GO:0005634; GO:0005829; GO:0006915; GO:0007157; GO:0010628; GO:0016936; GO:0030246; GO:0032689; GO:0070062; GO:2000562	GLVPPNASR	4.300000191	0.421272457	0.421272457	0.28573853	911.7736732	15.37967	15.48147	15.03742	14.25024	14.77378	15.53916	0	0	15.81007	15.59874	0	0	13.70215	16.35296	0	14.46727	12.93514	15.18737	15.48804	16.12289	12.31346	14.63988	0	15.62981	0	15.80772	16.28275	13.78551	0	0	0	0	0	14.71484	0	14.97438	0	0	0	0	16.39911	15.94009	0	0	0	0	0	0
P47972	NPTX2_HUMAN	"Neuronal pentraxin-2, NP2 (Neuronal pentraxin II, NP-II)"	NPTX2	Homo sapiens (Human)	associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]	extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0007268; GO:0008306; GO:0030246; GO:0046872; GO:0098962; GO:0098978	GNSAFK	7.760000229	1	1	0.232767054	623.0131646	0	16.80519	0	17.83956	15.82772	13.412	17.83496	13.17524	17.60936	16.08442	14.00947	16.24849	16.43789	0	14.54239	16.25287	16.78004	16.15674	0	14.95631	15.43568	17.92053	16.93907	0	15.42144	15.91412	0	0	16.2918	15.85598	0	0	16.17169	0	16.95391	0	0	17.29984	16.39935	0	0	16.49236	0	16.98066	18.29713	17.38311	0	18.03391
P47985	UCRI_HUMAN	"Cytochrome b-c1 complex subunit Rieske, mitochondrial, EC 7.1.1.8 (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein, RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9, Su9, Subunit 9 (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence, UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein) ]"	UQCRFS1	Homo sapiens (Human)	"cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; respiratory electron transport chain [GO:0022904]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; respiratory electron transport chain [GO:0022904]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]"	GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006122; GO:0008121; GO:0016491; GO:0022904; GO:0034551; GO:0045333; GO:0046872; GO:0051537	SSRESSEAR	4.019999981	0.854323149	0.854323149	0.131279232	1006.574231	0	0	0	0	0	0	0	0	0	0	0	0	16.02015	0	0	0	0	0	0	0	0	0	0	0	15.04233	13.59762	0	0	16.05858	0	0	16.43816	14.55357	0	0	0	0	0	0	0	0	0	0	0	0	12.85391	0	0
P47989	XDH_HUMAN	"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase, XD, EC 1.17.1.4; Xanthine oxidase, XO, EC 1.17.3.2 (Xanthine oxidoreductase, XOR) ]"	XDH XDHA	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xanthine catabolic process [GO:0009115]	cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]	"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; hypoxanthine oxidase activity [GO:0070675]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xanthine catabolic process [GO:0009115]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; hypoxanthine oxidase activity [GO:0070675]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]"	GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007595; GO:0009114; GO:0009115; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071949; GO:1900745; GO:1900747; GO:2000379; GO:2001213	ETRSTVVSTAVALAAYK	2.849999905	1	1	4.61E-13	1765.051613	0	0	13.58624	0	0	0	0	0	0	0	0	0	0	0	0	14.90733	16.16775	0	0	16.01688	0	0	0	0	0	0	0	0	0	0	0	0	0	14.49677	14.43185	0	0	0	0	0	0	16.11247	0	15.73861	0	0	0	15.0419
P48039	MTR1A_HUMAN	"Melatonin receptor type 1A, Mel-1A-R, Mel1a receptor"	MTNR1A	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]"	G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159]	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0097159	KPKLKPQDFR	13.86999989	1	1	4.61E-13	1253.669414	0	0	14.7534	0	12.92755	0	0	0	0	15.30917	0	0	0	0	0	15.44547	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.75387	0	0	0	0	17.80119	0	0	0	0	0	0	0	0	0	0	0
P48047	ATPO_HUMAN	"ATP synthase subunit O, mitochondrial (ATP synthase peripheral stalk subunit OSCP) (Oligomycin sensitivity conferral protein, OSCP)"	ATP5PO ATP5O ATPO	Homo sapiens (Human)	ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"	"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]"	GO:0000274; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005886; GO:0006754; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:1902600	YVDMSVKTK	7.210000038	1	1	0.346699351	1086.677046	0	12.77991	0	0	0	0	0	0	14.27127	0	0	0	0	13.63812	0	0	0	0	0	0	16.46431	0	0	0	15.05363	0	14.60393	0	0	16.9042	0	0	0	0	16.53957	0	0	0	0	0	15.55944	0	0	15.60493	0	0	0	0
P48048	KCNJ1_HUMAN	"ATP-sensitive inward rectifier potassium channel 1 (ATP-regulated potassium channel ROM-K) (Inward rectifier K(+) channel Kir1.1) (Potassium channel, inwardly rectifying subfamily J member 1)"	KCNJ1 ROMK1	Homo sapiens (Human)	potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]"	"ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0005242; GO:0005524; GO:0005546; GO:0005886; GO:0015272; GO:0016021; GO:0034765; GO:1990573	ARLVSK	12.39999962	1	1	0.28955954	672.6219465	0	18.90489	18.19082	18.44025	18.29711	20.37617	0	0	18.54023	0	17.63449	16.93083	17.64443	0	17.84325	0	0	19.26311	18.00825	18.20887	0	18.84817	0	18.25687	18.22281	19.28543	19.63525	0	0	0	0	19.04263	0	0	18.01874	17.61303	0	0	0	19.73661	0	0	18.8409	0	0	0	0	18.92422
P48052	CBPA2_HUMAN	"Carboxypeptidase A2, EC 3.4.17.15"	CPA2	Homo sapiens (Human)	protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508]	carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270	EWVTQATALWTANK	4.730000019	0.547881484	0.547881484	0.558239482	1618.855884	0	0	0	18.91158	20.50661	0	0	0	0	0	19.75159	0	0	0	0	0	18.15853	0	0	0	0	0	18.35352	0	19.9122	19.11403	0	18.18909	0	0	0	19.49971	20.56816	19.41208	0	0	0	0	0	0	18.7999	0	0	0	18.04373	0	0	0
P48058	GRIA4_HUMAN	"Glutamate receptor 4, GluR-4, GluR4 (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4, GluA4)"	GRIA4 GLUR4	Homo sapiens (Human)	glutamate receptor signaling pathway [GO:0007215]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]	AMPA glutamate receptor complex [GO:0032281]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	AMPA glutamate receptor complex [GO:0032281]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]	AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]	GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0007215; GO:0015276; GO:0030666; GO:0032281; GO:0034392; GO:0038023; GO:0043025; GO:0043197; GO:0045211; GO:1903561	VGYWNDMDK	6.369999886	1	1	0.012889517	1126.772396	16.26621	13.85065	14.54538	13.40653	0	11.84449	0	0	12.67483	0	0	0	14.18644	0	0	13.77026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P48067	SC6A9_HUMAN	"Sodium- and chloride-dependent glycine transporter 1, GlyT-1, GlyT1 (Solute carrier family 6 member 9)"	SLC6A9	Homo sapiens (Human)	glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter transport [GO:0006836]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter transport [GO:0006836]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]	glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]	GO:0005768; GO:0005886; GO:0005887; GO:0006836; GO:0009925; GO:0014069; GO:0015187; GO:0015375; GO:0015816; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030285; GO:0031045; GO:0035725; GO:0046985; GO:0070455; GO:0098686; GO:0098688; GO:0099055; GO:0099056; GO:0150104; GO:1903804; GO:1904782	ISPMFK	10.59000015	0.185325891	0.185325891	0.305606041	738.0439392	17.07602	15.65111	15.97191	14.443	0	0	16.14784	16.7446	15.82617	16.0893	15.47974	16.11539	16.90261	0	17.519	15.58809	16.36807	15.43977	17.71171	16.21593	16.99227	16.08273	16.25679	15.91695	17.4895	16.80161	17.05926	16.2956	16.08718	17.00795	16.81698	17.13568	17.63303	16.20824	16.92964	18.1362	18.13017	17.74477	16.51681	0	17.58516	17.51113	17.26836	17.8285	18.21548	18.65331	18.91962	17.40075
P48163	MAOX_HUMAN	"NADP-dependent malic enzyme, NADP-ME, EC 1.1.1.40 (Malic enzyme 1)"	ME1	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; nucleotide biosynthetic process [GO:0009165]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; nucleotide biosynthetic process [GO:0009165]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725]	ADP binding [GO:0043531]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005829; GO:0005975; GO:0006090; GO:0006108; GO:0008948; GO:0009055; GO:0009165; GO:0009725; GO:0009743; GO:0030145; GO:0042802; GO:0043531; GO:0050661; GO:0051287; GO:1902031	DLAFTLEER	5.639999866	1	1	0.047695594	1094.307457	0	0	0	0	0	0	0	0	14.80902	14.93051	0	0	0	0	0	16.21908	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P48200	IREB2_HUMAN	"Iron-responsive element-binding protein 2, IRE-BP 2 (Iron regulatory protein 2, IRP2)"	IREB2	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; erythrocyte homeostasis [GO:0034101]; intestinal absorption [GO:0050892]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; post-embryonic development [GO:0009791]; protoporphyrinogen IX biosynthetic process [GO:0006782]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; erythrocyte homeostasis [GO:0034101]; intestinal absorption [GO:0050892]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; post-embryonic development [GO:0009791]; protoporphyrinogen IX biosynthetic process [GO:0006782]; tricarboxylic acid cycle [GO:0006099]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]"	GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005829; GO:0006099; GO:0006101; GO:0006782; GO:0006826; GO:0006879; GO:0009791; GO:0030316; GO:0030350; GO:0030371; GO:0034101; GO:0046872; GO:0050892; GO:0051539; GO:0055072	RPQDRVAVTDMK	4.579999924	1	1	0.395868095	1414.636515	0	0	13.70889	3.840729	14.12833	0	0	13.1947	12.86454	14.47363	13.39035	0	0	0	0	15.78551	13.22179	0	16.1899	15.26084	0	0	0	16.21718	0	0	17.12324	0	0	0	0	0	0	16.84198	0	0	0	0	0	0	0	0	0	16.73917	0	0	0	0
P48230	T4S4_HUMAN	"Transmembrane 4 L6 family member 4 (Intestine and liver tetraspan membrane protein, IL-TMP)"	TM4SF4 ILTMP	Homo sapiens (Human)	tissue regeneration [GO:0042246]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; tissue regeneration [GO:0042246]		GO:0016021; GO:0042246	CTGGCAR	8.729999542	1	1	0.223008862	781.3776207	15.71748	12.18167	13.31264	12.00015	15.07596	15.10154	15.15155	13.17654	12.57708	14.52222	11.55755	0	16.25455	0	14.69159	0	14.14744	15.41564	14.5701	14.79007	14.4479	13.29896	15.50445	15.7261	0	0	0	0	16.16153	0	15.25048	15.24569	16.40239	16.66804	0	0	15.95675	0	0	0	0	16.23147	14.95442	15.82973	0	0	14.26439	0
P48382	RFX5_HUMAN	DNA-binding protein RFX5 (Regulatory factor X 5)	RFX5	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0006357; GO:0043231; GO:0043565; GO:0045944; GO:0090575; GO:1990837	DPKATPP	7.429999828	0.005704093	0.005704093	0.301889813	724.9982842	0	0	0	0	0	17.02672	17.32599	0	16.55493	19.77218	0	0	17.81569	0	0	0	0	0	0	0	0	17.27406	0	0	0	0	0	0	0	16.26705	0	0	17.83897	0	0	21.08801	18.13789	0	0	16.64049	0	0	0	17.00104	0	18.09323	0	0
P48444	COPD_HUMAN	"Coatomer subunit delta (Archain) (Delta-coat protein, Delta-COP)"	ARCN1 COPD	Homo sapiens (Human)	"adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intracellular protein transport [GO:0006886]; pigmentation [GO:0043473]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intracellular protein transport [GO:0006886]; pigmentation [GO:0043473]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	RNA binding [GO:0003723]	GO:0000139; GO:0003723; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0008344; GO:0016020; GO:0021691; GO:0030126; GO:0030133; GO:0043473; GO:0051645	EAKAEMR	10.43000031	1	1	0.106532927	853.3841964	16.09563	0	14.94134	0	15.48423	0	17.32993	12.72704	0	0	16.39867	0	0	0	0	13.92221	0	0	0	0	0	0	0	0	14.30043	0	17.71048	0	0	0	0	0	0	14.85322	0	0	0	0	0	15.44814	0	0	15.67027	0	14.62445	0	0	0
P48448	AL3B2_HUMAN	"Aldehyde dehydrogenase family 3 member B2, EC 1.2.1.3 (Aldehyde dehydrogenase 8)"	ALDH3B2 ALDH8	Homo sapiens (Human)	alcohol metabolic process [GO:0006066]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; sphingolipid biosynthetic process [GO:0030148]	cytoplasm [GO:0005737]; lipid droplet [GO:0005811]	cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; alcohol metabolic process [GO:0006066]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; sphingolipid biosynthetic process [GO:0030148]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005811; GO:0006066; GO:0006068; GO:0006081; GO:0006629; GO:0030148; GO:0043878	LDSVFIWK	17.06999969	1	1	0.14466097	1007.383992	16.34175	17.54528	0	0	0	16.41759	0	15.77456	0	16.1782	0	0	14.938	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.00561	16.75914	0	0	0	0	0	0	17.68198	0	0	0	0	0	0	0	0
P48449	LSS_HUMAN	"Lanosterol synthase, EC 5.4.99.7 (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase, OSC, hOSC)"	LSS OSC	Homo sapiens (Human)	cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104]	endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]; lanosterol synthase activity [GO:0000250]; cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104]	lanosterol synthase activity [GO:0000250]	GO:0000250; GO:0005789; GO:0005811; GO:0006694; GO:0006695; GO:0016020; GO:0016104; GO:0031647	HPDIEAQERGVR	2.549999952	1	1	0.238817851	1410.777089	12.24374	14.4745	0	0	0	14.59571	0	0	0	0	0	0	0	0	0	0	0	0	16.68012	0	0	0	0	0	12.9021	15.84683	0	0	0	14.19923	0	0	15.7579	0	15.12946	0	15.64864	0	0	0	14.39411	14.31103	16.33491	0	13.62574	16.20144	14.91211	0
P48454	PP2BC_HUMAN	"Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform, EC 3.1.3.16 (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)"	PPP3CC CALNA3 CNA3	Homo sapiens (Human)	brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; protein serine/threonine phosphatase complex [GO:0008287]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; protein serine/threonine phosphatase complex [GO:0008287]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470]	calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]	GO:0004723; GO:0005516; GO:0005737; GO:0005829; GO:0005955; GO:0006470; GO:0007420; GO:0008287; GO:0033173; GO:0033192; GO:0046872; GO:0070886; GO:0097720; GO:0098793; GO:0098978; GO:1900244; GO:1901386; GO:1901387; GO:1905665; GO:1905949	EGRLEEEVALK	16.92000008	1	1	0	1272.145119	0	0	12.50264	0	0	14.69264	0	10.68264	0	0	0	0	0	14.45607	0	0	13.23838	0	0	12.61398	11.57588	15.60628	0	0	0	0	14.4016	0	0	0	0	15.2146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P48546	GIPR_HUMAN	"Gastric inhibitory polypeptide receptor, GIP-R (Glucose-dependent insulinotropic polypeptide receptor)"	GIPR	Homo sapiens (Human)	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; gastric inhibitory peptide signaling pathway [GO:0038192]; generation of precursor metabolites and energy [GO:0006091]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; regulation of insulin secretion [GO:0050796]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; gastric inhibitory peptide receptor activity [GO:0016519]; glucagon family peptide binding [GO:0120022]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; gastric inhibitory peptide signaling pathway [GO:0038192]; generation of precursor metabolites and energy [GO:0006091]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; regulation of insulin secretion [GO:0050796]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]	G protein-coupled peptide receptor activity [GO:0008528]; gastric inhibitory peptide receptor activity [GO:0016519]; glucagon family peptide binding [GO:0120022]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]	GO:0002029; GO:0004888; GO:0005886; GO:0006091; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007204; GO:0007584; GO:0008528; GO:0009749; GO:0016021; GO:0016519; GO:0017046; GO:0031018; GO:0032024; GO:0038192; GO:0043950; GO:0048678; GO:0050796; GO:0051592; GO:0070542; GO:0120022	QLPERAFR	21.62999916	1	1	0.250296485	1018.430424	15.53631	15.31723	0	16.33716	0	0	0	0	16.14358	0	0	0	0	0	0	16.08253	16.45207	0	0	0	0	17.16245	0	0	0	0	0	16.31901	0	0	15.20692	15.51065	15.23037	0	0	15.65948	0	0	16.06474	0	0	0	14.43228	16.92644	16.42279	0	0	0
P48551	INAR2_HUMAN	"Interferon alpha/beta receptor 2, IFN-R-2, IFN-alpha binding protein, IFN-alpha/beta receptor 2 (Interferon alpha binding protein) (Type I interferon receptor 2)"	IFNAR2 IFNABR IFNARB	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]; cell surface receptor signaling pathway [GO:0007166]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]	GO:0004896; GO:0004905; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0007166; GO:0007259; GO:0009615; GO:0019221; GO:0019901; GO:0019962; GO:0035455; GO:0035456; GO:0051607; GO:0060337; GO:0098586	MLLSQNAFIFR	17.03000069	1	1	0.363898661	1355.58003	17.10367	0	0	0	0	0	0	16.91567	16.00985	0	16.90299	0	0	0	0	0	0	0	0	0	16.62296	0	0	0	16.19458	0	0	0	15.77386	0	16.55559	16.07123	16.697	15.85044	0	16.49685	16.72244	16.04882	0	16.24434	16.34139	15.56427	0	15.02828	0	0	15.28232	16.39562
P48552	NRIP1_HUMAN	Nuclear receptor-interacting protein 1 (Nuclear factor RIP140) (Receptor-interacting protein 140)	NRIP1	Homo sapiens (Human)	cellular response to estradiol stimulus [GO:0071392]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; lipid storage [GO:0019915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle rupture [GO:0001543]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cellular response to estradiol stimulus [GO:0071392]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; lipid storage [GO:0019915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle rupture [GO:0001543]; positive regulation of transcription by RNA polymerase II [GO:0045944]	estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0000122; GO:0000785; GO:0000978; GO:0001543; GO:0001650; GO:0003713; GO:0003714; GO:0005102; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007623; GO:0016607; GO:0016922; GO:0019915; GO:0030331; GO:0032922; GO:0035259; GO:0042826; GO:0045944; GO:0046965; GO:0071392	GGNSVTSR	8.619999886	1	1	0.268089935	776.5582048	0	21.42441	0	0	0	0	22.56304	0	0	0	0	0	0	0	17.53389	17.38414	0	0	0	16.96992	0	0	0	0	18.90318	0	0	0	0	0	0	0	22.52046	21.32101	18.48248	0	19.46584	17.94281	0	17.47121	0	23.112	0	0	0	0	20.25338	0
P48553	TPC10_HUMAN	"Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein, EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1, TRAPP subunit TMEM1)"	TRAPPC10 EHOC1 TMEM1	Homo sapiens (Human)	early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022]		GO:0005737; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0034498; GO:0099022; GO:1990071	EELLPK	8.909999847	1	1	0.148417546	728.122666	15.17627	0	0	0	12.78524	0	0	13.53232	0	0	0	14.95018	0	14.59807	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.31337	0	0	0	0	0	0	0	0	0	0	0
P48556	PSMD8_HUMAN	26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31)	PSMD8	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"		GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0022624; GO:0043161	KSPNLSK	6.599999905	0.027521163	0.027521163	0.162705118	773.0910569	0	0	12.2981	0	0	0	0	0	0	0	16.50685	16.23527	14.52794	0	15.74074	15.18063	0	0	15.00676	14.35494	0	14.42394	0	0	0	0	16.57494	13.87238	15.53764	15.37279	0	0	0	16.0526	0	0	0	16.25862	0	0	14.44812	15.01362	0	0	0	0	16.6292	0
P48594	SPB4_HUMAN	"Serpin B4 (Leupin) (Peptidase inhibitor 11, PI-11) (Squamous cell carcinoma antigen 2, SCCA-2)"	SERPINB4 PI11 SCCA2	Homo sapiens (Human)	negative regulation of endopeptidase activity [GO:0010951]; negative regulation of peptidase activity [GO:0010466]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of proteolysis [GO:0030162]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; enzyme binding [GO:0019899]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of peptidase activity [GO:0010466]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of proteolysis [GO:0030162]	enzyme binding [GO:0019899]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004867; GO:0005615; GO:0005737; GO:0010466; GO:0010951; GO:0019899; GO:0030162; GO:0042270	SVQMMR	3.190000057	1	1	0.242876771	768.1807788	0	0	18.34989	17.58006	0	0	0	19.71088	0	0	0	0	17.70296	0	0	0	0	0	15.78265	0	0	0	0	0	0	0	0	0	0	0	0	18.23704	0	0	0	0	0	0	17.74448	0	0	0	0	13.63093	0	0	0	0
P48595	SPB10_HUMAN	"Serpin B10 (Bomapin) (Peptidase inhibitor 10, PI-10)"	SERPINB10 PI10	Homo sapiens (Human)	negative regulation of endopeptidase activity [GO:0010951]	cytosol [GO:0005829]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	cytosol [GO:0005829]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0010951; GO:0030667; GO:0101003	LEDSYDLKSTLSSMGMSDAFSQSK	7.25	1	1	0	2659.543919	0	14.63851	14.75476	0	0	14.44635	15.02855	0	16.12797	0	0	14.32844	0	0	13.39322	0	0	0	0	14.13094	0	0	0	0	0	14.04377	0	0	0	0	0	0	0	0	15.23307	0	0	0	0	0	0	13.85551	0	0	0	0	0	0
P48634	PRC2A_HUMAN	Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2)	PRRC2A BAT2 G2	Homo sapiens (Human)	cell differentiation [GO:0030154]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016020; GO:0030154; GO:0070062	FTARGGR	2.920000076	0.739350438	0.739350438	0.078566936	763.9573695	0	0	0	14.93698	0	0	0	0	0	15.30964	16.14678	17.62052	16.43544	0	15.55914	0	0	0	0	16.17087	0	0	19.21737	17.45926	14.37875	0	0	0	0	15.20399	17.50447	18.4279	16.98011	17.81095	0	16.36009	18.02652	0	0	0	12.07497	15.5816	0	17.08528	0	0	17.54742	0
P48643	TCPE_HUMAN	"T-complex protein 1 subunit epsilon, TCP-1-epsilon (CCT-epsilon)"	CCT5 CCTE KIAA0098	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:1901998; GO:1904851; GO:1904871; GO:1904874	LGFAGLVQEISFGTTKDK	5.570000172	1	1	0.167807133	1908.944355	0	0	21.1893	0	0	0	0	0	0	0	20.63477	20.3568	0	0	0	0	0	0	0	0	0	0	0	0	0	18.72664	0	0	0	0	18.25617	0	0	0	20.78612	0	0	0	21.24161	0	0	0	0	18.48227	0	0	0	0
P48664	EAA4_HUMAN	Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6)	SLC1A6 EAAT4	Homo sapiens (Human)	aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]	integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; plasma membrane [GO:0005886]; synapse [GO:0045202]	integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]	glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0006836; GO:0007268; GO:0015175; GO:0015183; GO:0015501; GO:0015810; GO:0015813; GO:0016020; GO:0045111; GO:0045202; GO:0046872; GO:0098712; GO:0098796	GGNESAM	4.260000229	0.117794767	0.117794767	0.306313731	665.9023223	16.66728	15.60071	16.48793	0	0	0	0	0	16.70096	0	0	0	0	0	0	15.61083	17.96878	0	0	0	0	17.86779	0	0	0	0	16.38257	16.47487	0	0	16.05163	15.20357	16.49084	16.80887	15.78863	17.35974	17.00318	16.40104	16.78766	16.28974	16.35229	16.12761	16.0804	16.66091	16.00066	14.96917	16.34354	16.20218
P48668	K2C6C_HUMAN	"Keratin, type II cytoskeletal 6C (Cytokeratin-6C, CK-6C) (Cytokeratin-6E, CK-6E) (Keratin K6h) (Keratin-6C, K6C) (Type-II keratin Kb12)"	KRT6C KRT6E	Homo sapiens (Human)	intermediate filament cytoskeleton organization [GO:0045104]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; intermediate filament cytoskeleton organization [GO:0045104]		GO:0005829; GO:0005882; GO:0045095; GO:0045104; GO:0070062	NLDLDSIIAEVK	35.97000122	1	1	0.49886175	1330.933123	18.68451	18.39654	15.04518	0	18.31794	17.98781	18.75218	18.75999	0	0	0	0	0	18.24176	0	0	0	18.61377	0	0	0	0	17.88731	0	0	0	0	0	0	0	19.05411	0	0	19.94614	18.91449	0	0	0	0	0	0	16.57355	0	0	18.1065	0	0	18.90485
P48681	NEST_HUMAN	Nestin	NES Nbla00170	Homo sapiens (Human)	brain development [GO:0007420]; cell projection morphogenesis [GO:0048858]; central nervous system development [GO:0007417]; embryonic camera-type eye development [GO:0031076]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; positive regulation of intermediate filament depolymerization [GO:0030844]; positive regulation of neural precursor cell proliferation [GO:2000179]; stem cell proliferation [GO:0072089]	cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]	cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; CCR5 chemokine receptor binding [GO:0031730]; intermediate filament binding [GO:0019215]; brain development [GO:0007420]; cell projection morphogenesis [GO:0048858]; central nervous system development [GO:0007417]; embryonic camera-type eye development [GO:0031076]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; positive regulation of intermediate filament depolymerization [GO:0030844]; positive regulation of neural precursor cell proliferation [GO:2000179]; stem cell proliferation [GO:0072089]	CCR5 chemokine receptor binding [GO:0031730]; intermediate filament binding [GO:0019215]	GO:0000086; GO:0005737; GO:0005882; GO:0007417; GO:0007420; GO:0019215; GO:0030844; GO:0031076; GO:0031730; GO:0032091; GO:0043086; GO:0043524; GO:0045111; GO:0048858; GO:0072089; GO:2000179	SPTSPR	15.72999954	1	1	0.305645174	643.1767544	16.8695	0	18.29173	17.76147	0	0	18.19915	0	19.47171	0	0	0	18.35073	0	17.98532	0	0	0	0	17.35596	17.74807	0	0	18.20135	0	0	0	0	0	0	19.59162	0	19.88712	16.6517	0	18.31475	0	0	0	19.24353	0	0	16.72333	18.98116	0	0	0	0
P48729	KC1A_HUMAN	"Casein kinase I isoform alpha, CKI-alpha, EC 2.7.11.1 (CK1)"	CSNK1A1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819]	beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000776; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005929; GO:0006468; GO:0007030; GO:0007049; GO:0007165; GO:0007166; GO:0016020; GO:0016055; GO:0016607; GO:0018105; GO:0019082; GO:0030877; GO:0032436; GO:0036064; GO:0043161; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1904424	MASSSGSK	18.98999977	1	1	0.097096613	769.8043147	15.50831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P48730	KC1D_HUMAN	"Casein kinase I isoform delta, CKI-delta, CKId, EC 2.7.11.1 (Tau-protein kinase CSNK1D, EC 2.7.11.26)"	CSNK1D HCKID	Homo sapiens (Human)	cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; signal transduction [GO:0007165]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; signal transduction [GO:0007165]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau-protein kinase activity [GO:0050321]	GO:0001934; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0006468; GO:0007020; GO:0007030; GO:0007165; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0033116; GO:0034067; GO:0036064; GO:0042752; GO:0043005; GO:0045296; GO:0048208; GO:0048471; GO:0050321; GO:0051225; GO:0061512; GO:0071539; GO:0090263; GO:0106310; GO:1905426; GO:1905515; GO:1990090; GO:2000052	FSLKTVLLLADQMISR	4.78000021	0.315631777	0.315631777	0.181695848	1835.682067	0	17.55433	17.12333	0	0	12.75087	0	0	0	0	14.95185	17.20745	13.45244	14.92007	0	15.72003	0	0	0	16.91225	17.1551	18.42368	16.87651	15.30793	0	0	16.97784	16.53596	0	0	17.28538	0	17.48582	16.13692	13.08964	18.40095	17.44351	17.31167	0	0	0	14.46023	0	13.84232	15.04971	12.55426	0	0
P48735	IDHP_HUMAN	"Isocitrate dehydrogenase [NADP], mitochondrial, IDH, EC 1.1.1.42 (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)"	IDH2	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; carbohydrate metabolic process [GO:0005975]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; carbohydrate metabolic process [GO:0005975]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099]	isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004450; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0005975; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0051287; GO:0070062	AGTFKMVFTPK	6.579999924	1	1	0.37180717	1242.464731	0	15.76427	0	0	0	15.55934	16.26741	14.86082	14.99482	0	13.9864	0	17.17992	14.18368	0	0	0	16.54278	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.21207	0	0	0	16.20453	0	0	16.69979	0	0	0	0	0	0	0	0
P48736	PK3CG_HUMAN	"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, PI3-kinase subunit gamma, PI3K-gamma, PI3Kgamma, PtdIns-3-kinase subunit gamma, EC 2.7.1.137, EC 2.7.1.153, EC 2.7.1.154 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma, PtdIns-3-kinase subunit p110-gamma, p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG, EC 2.7.11.1) (p120-PI3K)"	PIK3CG	Homo sapiens (Human)	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to cAMP [GO:0071320]; dendritic cell chemotaxis [GO:0002407]; endocytosis [GO:0006897]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte apoptotic process [GO:0097284]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell degranulation [GO:0043303]; natural killer cell chemotaxis [GO:0035747]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of triglyceride catabolic process [GO:0010897]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet aggregation [GO:0070527]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cell adhesion mediated by integrin [GO:0033628]; respiratory burst involved in defense response [GO:0002679]; secretory granule localization [GO:0032252]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell proliferation [GO:0042098]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; ephrin receptor binding [GO:0046875]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to cAMP [GO:0071320]; dendritic cell chemotaxis [GO:0002407]; endocytosis [GO:0006897]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte apoptotic process [GO:0097284]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell degranulation [GO:0043303]; natural killer cell chemotaxis [GO:0035747]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of triglyceride catabolic process [GO:0010897]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet aggregation [GO:0070527]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cell adhesion mediated by integrin [GO:0033628]; respiratory burst involved in defense response [GO:0002679]; secretory granule localization [GO:0032252]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell proliferation [GO:0042098]"	"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; ephrin receptor binding [GO:0046875]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]"	GO:0001525; GO:0001819; GO:0002250; GO:0002407; GO:0002675; GO:0002679; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006897; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0010595; GO:0010818; GO:0010897; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030593; GO:0032252; GO:0033628; GO:0035004; GO:0035005; GO:0035022; GO:0035747; GO:0036092; GO:0042098; GO:0042110; GO:0042802; GO:0043303; GO:0043406; GO:0045087; GO:0046854; GO:0046875; GO:0046934; GO:0048015; GO:0051897; GO:0052742; GO:0052812; GO:0055118; GO:0070527; GO:0071320; GO:0072672; GO:0097284; GO:0106310; GO:1903169; GO:2000270	LFSSVK	1.950000048	0.10599222	0.10599222	0.194656049	680.1827186	0	0	0	0	0	0	10.85496	0	16.00883	0	0	0	0	0	0	0	0	0	0	0	15.48249	0	0	0	0	0	0	0	0	0	0	16.87348	15.30719	0	0	0	0	0	17.50135	16.67311	0	0	0	0	0	0	0	0
P48751	B3A3_HUMAN	"Anion exchange protein 3, AE 3, Anion exchanger 3 (CAE3/BAE3) (Cardiac/brain band 3-like protein) (Neuronal band 3-like protein) (Solute carrier family 4 member 3)"	SLC4A3 AE3	Homo sapiens (Human)	bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential [GO:0086001]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential [GO:0086001]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0005887; GO:0009897; GO:0015106; GO:0015301; GO:0015701; GO:0016020; GO:0022857; GO:0050801; GO:0051453; GO:0055085; GO:0061337; GO:0086001; GO:0150104	LTVPTGLSVTSPDK	1.429999948	1	1	0.57515725	1414.693356	0	0	0	0	0	0	0	0	0	0	20.68279	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.39496	0	0	0	0	0	0	0	0	0	18.00862	0	0	0	0	0	0	17.81251	0
P48960	AGRE5_HUMAN	Adhesion G protein-coupled receptor E5 (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: Adhesion G protein-coupled receptor E5 subunit alpha; Adhesion G protein-coupled receptor E5 subunit beta ]	ADGRE5 CD97	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0006954; GO:0006955; GO:0007155; GO:0007166; GO:0007186; GO:0007189; GO:0007267; GO:0016020; GO:0030667; GO:0070062	DPPAKDVMPGPR	5.880000114	1	1	0.133441067	1294.69027	0	0	0	14.88079	0	13.25806	15.37204	0	0	14.05959	0	0	0	0	15.9713	0	0	17.64869	11.8604	0	15.3672	0	0	15.35658	0	0	19.57505	0	0	0	0	21.90153	0	0	0	0	18.43285	0	0	0	0	18.92819	0	0	0	0	0	17.45496
P49005	DPOD2_HUMAN	DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50)	POLD2	Homo sapiens (Human)	DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; DNA binding [GO:0003677]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0042575; GO:0043625; GO:0071897	MFSEQAAQR	9.430000305	1	1	0.312660505	1084.345583	0	0	11.41837	15.97196	0	13.83837	13.65967	12.678	0	0	15.51015	0	0	14.64499	0	15.65526	14.92677	0	15.69314	14.94137	0	0	0	14.8734	0	0	0	0	0	0	16.78497	0	0	0	0	16.1767	0	16.20354	0	0	0	0	15.65116	0	16.20381	0	0	0
P49006	MRP_HUMAN	"MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate, Mac-MARCKS, MacMARCKS)"	MARCKSL1 MLP MRP	Homo sapiens (Human)	actin filament organization [GO:0007015]; central nervous system development [GO:0007417]; positive regulation of cell population proliferation [GO:0008284]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; actin filament organization [GO:0007015]; central nervous system development [GO:0007417]; positive regulation of cell population proliferation [GO:0008284]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]	GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0007015; GO:0007417; GO:0008284; GO:0051015; GO:0070062	ANGQENGHVKSNGDLSPK	1.610000014	1	1	4.70E-13	1850.440624	0	0	0	0	0	15.21611	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.20903	0	0	0	0	0	0	0	0
P49069	CAMLG_HUMAN	Guided entry of tail-anchored proteins factor CAMLG (Calcium signal-modulating cyclophilin ligand)	CAMLG CAML GET2	Homo sapiens (Human)	B cell homeostasis [GO:0001782]; defense response [GO:0006952]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; receptor recycling [GO:0001881]; signal transduction [GO:0007165]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ubiquitin protein ligase binding [GO:0031625]; B cell homeostasis [GO:0001782]; defense response [GO:0006952]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; receptor recycling [GO:0001881]; signal transduction [GO:0007165]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; vesicle-mediated transport [GO:0016192]	ubiquitin protein ligase binding [GO:0031625]	GO:0001782; GO:0001881; GO:0005737; GO:0005783; GO:0005789; GO:0006952; GO:0007165; GO:0007173; GO:0016020; GO:0016192; GO:0030176; GO:0031397; GO:0031625; GO:0032435; GO:0043529; GO:0045048; GO:0050821; GO:0071816	MESMAVATDGGERPGVPAGSGLSASQRR	11.56000042	1	1	7.31E-12	2791.509355	0	8.971267	0	0	9.735036	13.41425	0	13.93827	13.24718	15.30583	0	11.45457	14.7081	13.01662	0	13.29079	13.11484	0	0	0	13.33733	14.47991	0	15.40569	0	13.37091	14.70889	0	13.08028	14.71436	12.90199	0	0	0	0	0	0	0	0	9.918921	0	15.53038	15.95489	0	11.24393	0	0	0
P49116	NR2C2_HUMAN	Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4)	NR2C2 TAK1 TR4	Homo sapiens (Human)	"anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0007399; GO:0008270; GO:0030154; GO:0040019; GO:0043565; GO:0045944; GO:0048856; GO:1990837	TSPSPR	2.140000105	1	1	0.137679902	644.464459	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.55232	0	0	0	0	16.39491	0	19.00511	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P49137	MAPK2_HUMAN	"MAP kinase-activated protein kinase 2, MAPK-activated protein kinase 2, MAPKAP kinase 2, MAPKAP-K2, MAPKAPK-2, MK-2, MK2, EC 2.7.11.1"	MAPKAPK2	Homo sapiens (Human)	3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; leukotriene metabolic process [GO:0006691]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of interleukin-6 production [GO:0032675]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; leukotriene metabolic process [GO:0006691]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of interleukin-6 production [GO:0032675]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0002224; GO:0004672; GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006691; GO:0006954; GO:0006974; GO:0009931; GO:0018105; GO:0032496; GO:0032675; GO:0032680; GO:0032760; GO:0034097; GO:0035556; GO:0035924; GO:0038066; GO:0043488; GO:0044351; GO:0046777; GO:0048010; GO:0048839; GO:0051019; GO:0070062; GO:0070935; GO:0106310; GO:1900034	MGQYEFPNPEWSEVSEEVK	2.910000086	0.561289847	0.561289847	0.315508467	2301.876975	17.80699	17.00659	14.64977	16.35867	15.74386	17.28759	17.94175	16.24029	15.30784	14.89923	0	0	17.98816	15.3582	15.5598	0	17.74988	17.77516	16.67278	17.60577	0	0	0	20.31006	17.31916	0	17.40271	18.03987	0	18.95056	16.02647	18.91776	16.87334	17.63815	17.74329	0	18.14932	18.04397	18.11877	18.22666	18.76389	18.71753	18.52293	16.1012	14.21155	17.07256	0	18.06788
P49146	NPY2R_HUMAN	"Neuropeptide Y receptor type 2, NPY2-R (NPY-Y2 receptor, Y2 receptor)"	NPY2R	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cardiac left ventricle morphogenesis [GO:0003214]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cardiac left ventricle morphogenesis [GO:0003214]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151]	calcium channel regulator activity [GO:0005246]; neuropeptide Y receptor activity [GO:0004983]; peptide YY receptor activity [GO:0001601]; signaling receptor activity [GO:0038023]	GO:0001601; GO:0003151; GO:0003214; GO:0004983; GO:0005246; GO:0005886; GO:0005887; GO:0005929; GO:0007193; GO:0007626; GO:0038023; GO:0097730	GELVPDPEPELIDSTK	11.06000042	1	1	0.640865859	1740.84419	0	20.43828	19.47298	0	0	0	0	0	18.13845	0	0	0	0	18.6473	0	18.95478	0	20.16969	0	0	0	0	0	0	0	18.87914	18.76103	0	0	0	0	0	0	19.76769	0	0	0	19.61745	19.66566	18.57795	0	0	0	0	0	0	17.06151	0
P49189	AL9A1_HUMAN	"4-trimethylaminobutyraldehyde dehydrogenase, TMABA-DH, TMABALDH, EC 1.2.1.47 (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1, EC 1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase, EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed ]"	ALDH9A1 ALDH4 ALDH7 ALDH9	Homo sapiens (Human)	carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; protein homotetramerization [GO:0051289]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; protein homotetramerization [GO:0051289]	1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004029; GO:0005737; GO:0005829; GO:0006081; GO:0019145; GO:0033737; GO:0042136; GO:0042445; GO:0043878; GO:0045329; GO:0047105; GO:0051289; GO:0070062	GIKPVTLELGGK	14.98999977	0.874573648	0.874573648	0.346343713	1214.157999	15.56209	13.50115	12.93104	0	0	0	0	15.54071	0	0	15.83389	0	0	0	0	0	0	0	0	13.41228	0	0	0	0	0	0	0	13.61108	0	0	0	16.59571	0	0	0	0	0	0	15.67694	0	0	0	0	0	17.26531	0	0	0
P49257	LMAN1_HUMAN	Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1)	LMAN1 ERGIC53 F5F8D	Homo sapiens (Human)	blood coagulation [GO:0007596]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein transport [GO:0015031]	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]	collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; blood coagulation [GO:0007596]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein transport [GO:0015031]	mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]	GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0007596; GO:0010638; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0030017; GO:0030134; GO:0033116; GO:0046872; GO:0051082; GO:0062023; GO:0070062; GO:1903215	EISEKEK	19.73999977	1	1	0.177546523	862.6371299	14.79028	15.37094	0	15.27363	15.26465	0	15.6993	15.95851	0	16.66925	0	14.65342	15.67819	13.51701	15.53833	0	0	15.35277	15.45726	14.59304	0	16.65267	0	16.36337	16.53109	0	15.74879	15.70495	0	16.35635	16.60982	16.61372	15.50792	15.55325	15.31626	15.73845	16.01346	13.99127	16.82591	15.78012	15.6086	13.8024	15.04371	13.85962	16.02188	14.26653	15.47727	15.80328
P49321	NASP_HUMAN	"Nuclear autoantigenic sperm protein, NASP"	NASP	Homo sapiens (Human)	blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574]	histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]	GO:0000082; GO:0000785; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0006336; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0043486; GO:0044877	EKGGQEK	5.130000114	1	1	0.317991728	777.0715506	15.97133	0	15.5588	15.33776	15.42007	0	14.82141	13.94581	12.13544	15.60292	0	15.10436	16.06084	15.50777	0	0	15.37615	15.64523	15.49268	15.21113	16.5339	15.74199	15.77138	15.98841	15.05309	16.60199	15.9655	0	15.75262	15.86399	0	0	15.77011	0	16.53864	14.38912	16.62472	16.77567	0	16.15831	15.1704	14.59735	16.92345	0	0	16.51793	18.86146	0
P49327	FAS_HUMAN	"Fatty acid synthase, EC 2.3.1.85 (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase, EC 2.3.1.38; [Acyl-carrier-protein] S-malonyltransferase, EC 2.3.1.39; 3-oxoacyl-[acyl-carrier-protein] synthase, EC 2.3.1.41; 3-oxoacyl-[acyl-carrier-protein] reductase, EC 1.1.1.100; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase, EC 4.2.1.59; Enoyl-[acyl-carrier-protein] reductase, EC 1.3.1.39; Acyl-[acyl-carrier-protein] hydrolase, EC 3.1.2.14 ]"	FASN FAS	Homo sapiens (Human)	cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell development [GO:0002068]; inflammatory response [GO:0006954]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; osteoblast differentiation [GO:0001649]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723]; cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell development [GO:0002068]; inflammatory response [GO:0006954]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; osteoblast differentiation [GO:0001649]"	"(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723]"	GO:0001649; GO:0002068; GO:0003723; GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006631; GO:0006633; GO:0006954; GO:0008611; GO:0008659; GO:0008693; GO:0016020; GO:0016295; GO:0016296; GO:0030223; GO:0030224; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0045296; GO:0047117; GO:0047451; GO:0070062; GO:0071353; GO:0090557	AAAYR	7.940000057	0.017480614	0.017480614	0.193211443	551.3269721	15.13384	0	15.8526	15.58512	15.99129	14.95807	15.59851	15.53635	13.23227	15.6849	16.2148	0	0	15.64056	15.96317	14.32886	0	15.44984	0	15.69338	14.66404	0	17.58921	0	0	0	0	14.1608	15.24138	13.7013	15.35153	15.2316	0	14.41868	0	16.00933	16.31959	16.79436	16.88716	15.33675	15.44453	15.42178	15.50231	12.04421	15.59919	0	14.39638	16.14554
P49335	PO3F4_HUMAN	"POU domain, class 3, transcription factor 4 (Brain-specific homeobox/POU domain protein 4, Brain-4, Brn-4) (Octamer-binding protein 9, Oct-9) (Octamer-binding transcription factor 9, OTF-9)"	POU3F4 BRN4 OTF9	Homo sapiens (Human)	brain development [GO:0007420]; cochlea morphogenesis [GO:0090103]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; cochlea morphogenesis [GO:0090103]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0007605; GO:0090103; GO:1990837; GO:2001054	TSIEVSVKGVLETHFLK	10.97000027	1	1	6.84E-13	1887.808832	14.80157	0	13.77662	0	18.34983	0	0	16.48417	15.83886	0	16.53779	0	10.44891	0	17.63298	14.63444	0	15.36305	0	0	13.8903	16.07635	0	15.1858	0	0	15.8035	17.32786	12.97958	0	0	0	0	14.03209	0	0	17.48459	0	15.42522	11.88137	14.18818	14.15638	0	0	0	10.85888	15.49885	0
P49406	RM19_HUMAN	"39S ribosomal protein L19, mitochondrial, L19mt, MRP-L19 (39S ribosomal protein L15, mitochondrial, L15mt, MRP-L15) (Mitochondrial large ribosomal subunit protein bL19m)"	MRPL19 KIAA0104 MRPL15	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005634; GO:0005739; GO:0005743; GO:0005762; GO:0032543	LDDSLLYLR	6.019999981	1	1	0.002468858	1106.411189	14.69288	14.23449	14.31216	13.02117	0	12.48492	15.11727	9.055379	12.46113	10.79951	0	14.88296	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P49407	ARRB1_HUMAN	Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2)	ARRB1 ARR1	Homo sapiens (Human)	G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]	chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511]	angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0000785; GO:0001664; GO:0001934; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007165; GO:0008134; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0035066; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0070374; GO:0090240; GO:1990763	KDLFVANVQSFPPAPEDK	2.400000095	1	1	0.149603802	2002.657456	0	18.90118	0	0	21.26469	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P49411	EFTU_HUMAN	"Elongation factor Tu, mitochondrial, EF-Tu (P43)"	TUFM	Homo sapiens (Human)	mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; synapse [GO:0045202]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0042645; GO:0045202; GO:0045471; GO:0070062; GO:0070125	TVVTGIEMFHK	6.460000038	0.003787601	0.003787601	0.024024455	1278.266107	16.59906	0	0	0	0	0	0	0	15.83541	0	0	0	0	0	0	0	0	0	12.46566	0	0	0	0	0	0	0	13.97077	0	16.02111	0	13.76128	12.69933	11.25941	15.1661	0	0	0	15.71043	0	0	0	0	0	0	0	0	0	0
P49419	AL7A1_HUMAN	"Alpha-aminoadipic semialdehyde dehydrogenase, Alpha-AASA dehydrogenase, EC 1.2.1.31 (Aldehyde dehydrogenase family 7 member A1, EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase, EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase, P6c dehydrogenase)"	ALDH7A1 ATQ1	Homo sapiens (Human)	cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605]	aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]	GO:0004029; GO:0004043; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006081; GO:0007605; GO:0008802; GO:0019285; GO:0042426; GO:0042802; GO:0043878; GO:0070062	HTGGGR	6.489999771	0.258735925	0.258735925	0.253385215	583.6021481	15.53282	15.63867	16.27815	15.2467	16.08066	15.85806	15.64437	15.88746	16.82583	15.99194	15.21709	16.87638	16.6315	0	16.30861	15.7175	14.95747	16.39594	16.52035	16.96335	16.69306	15.72468	17.19534	16.37742	15.86381	16.98718	0	0	0	0	0	15.5696	15.86668	15.72119	15.6987	17.22565	17.25128	17.58161	0	15.95624	16.63616	16.132	16.72974	0	0	0	16.39374	0
P49427	UB2R1_HUMAN	"Ubiquitin-conjugating enzyme E2 R1, EC 2.3.2.23 ((E3-independent) E2 ubiquitin-conjugating enzyme R1, EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme R1) (Ubiquitin-conjugating enzyme E2-32 kDa complementing) (Ubiquitin-conjugating enzyme E2-CDC34) (Ubiquitin-protein ligase R1)"	CDC34 UBCH3 UBE2R1	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]; ubiquitin-dependent protein catabolic process [GO:0006511]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006270; GO:0006464; GO:0006511; GO:0016567; GO:0016607; GO:0035458; GO:0043161; GO:0043525; GO:0043951; GO:0061631; GO:0070848; GO:0070936; GO:0090261	ALLLELK	3.599999905	1	1	0.290911781	800.8290204	0	0	0	0	0	0	0	0	18.39124	0	0	0	0	0	17.18021	0	0	0	0	0	0	0	0	0	19.7053	0	0	18.61979	0	0	0	0	0	18.69208	19.47912	0	0	0	0	0	0	0	0	18.23837	0	17.14798	0	19.58303
P49454	CENPF_HUMAN	"Centromere protein F, CENP-F (AH antigen) (Kinetochore protein CENPF) (Mitosin)"	CENPF	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to xenobiotic stimulus [GO:0009410]; ventricular system development [GO:0021591]"	"axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]"	"axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to xenobiotic stimulus [GO:0009410]; ventricular system development [GO:0021591]"	chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]	GO:0000278; GO:0000775; GO:0000776; GO:0000922; GO:0000940; GO:0001822; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005930; GO:0007059; GO:0007094; GO:0007517; GO:0008017; GO:0008022; GO:0009410; GO:0010389; GO:0015031; GO:0016202; GO:0016363; GO:0021591; GO:0030154; GO:0030496; GO:0036064; GO:0042803; GO:0045120; GO:0045892; GO:0048471; GO:0051301; GO:0051310; GO:0051382; GO:0070840; GO:0071897; GO:0097539; GO:0140297	ALLSALELKK	5.619999886	0.208951995	0.208951995	0.227432605	1086.0721	12.80112	11.18408	12.18836	0	14.97518	13.58138	13.70158	14.63905	13.51821	0	15.03546	10.7962	0	14.12877	14.15478	0	15.32685	0	0	0	15.37425	0	13.77324	0	16.30609	14.68406	0	0	0	15.46023	0	0	15.86924	0	15.3473	0	0	0	0	0	18.27329	0	0	0	16.41875	0	0	0
P49585	PCY1A_HUMAN	"Choline-phosphate cytidylyltransferase A, EC 2.7.7.15 (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A, CCT A, CT A) (Phosphorylcholine transferase A)"	PCYT1A CTPCT PCYT1	Homo sapiens (Human)	CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]; CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656]	calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]	GO:0004105; GO:0005516; GO:0005634; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006656; GO:0006657; GO:0031210; GO:0042587; GO:0042802; GO:0042803	MLQAISPK	1.399999976	0.258276552	0.258276552	0.249745281	888.8217374	19.00346	20.71278	11.10868	15.2703	17.24454	17.10128	0	0	18.11054	0	0	0	0	0	0	0	0	0	0	0	16.43887	0	0	0	0	20.05757	0	0	0	0	20.33097	0	0	17.7533	0	0	18.1584	0	18.10364	0	0	18.2475	16.70736	17.55687	17.57073	0	18.00325	18.04474
P49588	SYAC_HUMAN	"Alanine--tRNA ligase, cytoplasmic, EC 6.1.1.7 (Alanyl-tRNA synthetase, AlaRS) (Renal carcinoma antigen NY-REN-42)"	AARS1 AARS	Homo sapiens (Human)	alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0070062; GO:0140018	AIQGLR	1.179999948	1	1	0.200917717	658.4194563	0	15.92869	13.7701	0	0	0	0	0	0	0	0	15.49266	0	0	0	0	0	0	0	0	0	0	0	0	15.76573	0	0	15.79005	16.38461	0	0	15.50072	0	0	16.25049	0	16.79208	0	0	0	0	0	0	0	0	16.64283	0	0
P49589	SYCC_HUMAN	"Cysteine--tRNA ligase, cytoplasmic, EC 6.1.1.16 (Cysteinyl-tRNA synthetase, CysRS)"	CARS1 CARS	Homo sapiens (Human)	cysteinyl-tRNA aminoacylation [GO:0006423]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423]	ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0005829; GO:0006423; GO:0042802; GO:0042803; GO:0046872	MKIPPSEMFLSETDK	2.559999943	1	1	0.276065849	1783.618212	0	0	0	0	0	0	0	15.84206	0	0	16.09333	16.4387	14.15528	0	0	0	14.63836	13.95754	0	0	0	0	0	11.14207	14.51188	15.38843	14.12671	0	0	0	0	16.63707	19.51906	0	0	0	15.8657	0	0	0	0	0	0	0	0	0	13.52686	0
P49593	PPM1F_HUMAN	"Protein phosphatase 1F, EC 3.1.3.16 (Ca(2+)/calmodulin-dependent protein kinase phosphatase, CaM-kinase phosphatase, CaMKPase) (Partner of PIX 2) (Protein fem-2 homolog, hFem-2)"	PPM1F KIAA0015 POPX2	Homo sapiens (Human)	"cellular response to xenobiotic stimulus [GO:0071466]; histone dephosphorylation [GO:0016576]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470]; regulation of protein localization [GO:0032880]"	cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	"cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to xenobiotic stimulus [GO:0071466]; histone dephosphorylation [GO:0016576]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470]; regulation of protein localization [GO:0032880]"	calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0004722; GO:0005634; GO:0005829; GO:0006469; GO:0006470; GO:0008138; GO:0010628; GO:0010634; GO:0010811; GO:0016576; GO:0030335; GO:0032880; GO:0032991; GO:0033137; GO:0033192; GO:0035970; GO:0043280; GO:0044387; GO:0045892; GO:0045927; GO:0046872; GO:0048471; GO:0050921; GO:0051224; GO:0051496; GO:0051894; GO:0070262; GO:0071466; GO:0097193; GO:2000048	SSGAPQK	2.859999895	1	1	0.300119991	673.8589272	16.87342	0	15.16414	15.55099	15.13484	15.17577	15.2916	15.90517	0	13.9482	17.15177	15.69609	16.05723	0	0	15.73325	15.70257	15.91088	15.9084	0	0	0	16.84737	15.52886	15.97603	14.33851	0	15.48272	0	16.41403	17.3767	0	15.54337	0	15.58268	16.77655	16.39222	17.53204	17.75512	16.72128	0	0	15.39211	0	0	0	16.77747	0
P49619	DGKG_HUMAN	"Diacylglycerol kinase gamma, DAG kinase gamma, EC 2.7.1.107 (Diglyceride kinase gamma, DGK-gamma)"	DGKG DAGK3	Homo sapiens (Human)	diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005829; GO:0005856; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0048666; GO:0050773; GO:0090038	YTVHERCVSR	8.359999657	1	1	0.025729924	1306.733199	0	16.58093	0	0	0	15.29678	0	0	0	0	0	0	0	0	0	15.85519	0	0	0	0	0	0	0	0	0	15.50083	0	0	0	11.92756	13.74595	0	0	0	0	15.75751	14.16075	0	0	0	0	0	0	13.73778	0	0	0	0
P49639	HXA1_HUMAN	Homeobox protein Hox-A1 (Homeobox protein Hox-1F)	HOXA1 HOX1F	Homo sapiens (Human)	abducens nerve formation [GO:0021599]; anatomical structure morphogenesis [GO:0009653]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; cognition [GO:0050890]; embryonic neurocranium morphogenesis [GO:0048702]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; neuromuscular process [GO:0050905]; optokinetic behavior [GO:0007634]; outer ear morphogenesis [GO:0042473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal formation [GO:0060876]; sensory perception of sound [GO:0007605]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; abducens nerve formation [GO:0021599]; anatomical structure morphogenesis [GO:0009653]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; cognition [GO:0050890]; embryonic neurocranium morphogenesis [GO:0048702]; inner ear development [GO:0048839]; multicellular organism development [GO:0007275]; neuromuscular process [GO:0050905]; optokinetic behavior [GO:0007634]; outer ear morphogenesis [GO:0042473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal formation [GO:0060876]; sensory perception of sound [GO:0007605]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007275; GO:0007605; GO:0007634; GO:0009653; GO:0021599; GO:0042473; GO:0042802; GO:0043565; GO:0045944; GO:0048702; GO:0048839; GO:0048844; GO:0050795; GO:0050890; GO:0050905; GO:0060840; GO:0060876; GO:0090102; GO:0090103; GO:1990837	NPPKTGK	1.980000019	0.320195377	0.320195377	0.07351725	741.5393552	15.72514	13.78709	13.17941	0	12.56483	16.50126	15.19361	0	15.63092	0	16.88511	0	15.77375	0	13.39984	0	14.43193	0	0	0	13.54057	0	0	0	0	16.77115	15.2435	0	14.13156	16.60693	15.0325	15.91337	0	15.74247	16.08468	15.5783	0	15.24596	13.61169	0	0	17.1658	12.58691	0	0	15.31378	11.48659	13.89045
P49641	MA2A2_HUMAN	"Alpha-mannosidase 2x, EC 3.2.1.114 (Alpha-mannosidase IIx, Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	MAN2A2 MANA2X	Homo sapiens (Human)	mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]"	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]"	GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872	RTLGLFQHHDAITGTAK	4.690000057	1	1	0.012192353	1865.245383	10.11702	14.49385	12.41719	0	14.35213	0	14.11261	0	16.74252	13.97243	13.47662	0	0	14.31585	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P49703	ARL4D_HUMAN	ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L)	ARL4D ARF4L	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005730; GO:0005737; GO:0005886; GO:0006886; GO:0009306; GO:0016192	GNHLTEMAPTASSFLPHFQALHVVVIGLDSAGK	4.480000019	1	1	6.86E-12	3459.96953	14.13951	0	10.85804	12.30672	0	13.30061	0	13.09757	13.02542	14.83254	14.439	15.00665	0	0	13.27358	0	13.53423	0	0	0	0	0	12.64082	14.45201	14.18945	12.3463	0	9.890716	0	9.567399	15.21068	10.95296	15.27484	15.06084	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P49711	CTCF_HUMAN	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)	CTCF	Homo sapiens (Human)	"chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; genomic imprinting [GO:0071514]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; genomic imprinting [GO:0071514]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000775; GO:0000793; GO:0000976; GO:0000978; GO:0001221; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0006357; GO:0007059; GO:0008270; GO:0008285; GO:0010216; GO:0010628; GO:0016584; GO:0031060; GO:0035065; GO:0040029; GO:0043035; GO:0043565; GO:0045892; GO:0045893; GO:0070602; GO:0071459; GO:0071514	SNLDRHMK	4.309999943	1	1	0.172773189	1000.110154	0	0	15.01872	14.9187	0	0	12.18374	15.60571	15.85475	10.47291	15.21879	15.50402	13.74346	0	13.84593	13.87095	14.54781	14.27895	15.09199	13.75711	14.61846	15.1613	16.33723	15.10012	0	0	15.50542	0	0	0	0	0	15.28624	0	16.96215	0	0	0	0	14.08871	15.21702	0	0	15.98352	0	0	0	0
P49720	PSB3_HUMAN	Proteasome subunit beta type-3 (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	Homo sapiens (Human)	proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	threonine-type endopeptidase activity [GO:0004298]	GO:0000502; GO:0004298; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0043161; GO:0070062	MSIMSYNGGAVMAMK	1.720000029	1	1	0.194070092	1639.650919	16.21867	14.99582	15.79513	15.62715	0	14.84591	0	16.00542	0	17.59726	0	0	0	0	14.86923	0	0	0	0	15.35331	0	0	0	0	15.76061	16.53528	0	16.35778	0	15.36496	0	0	0	0	0	0	0	0	0	0	15.95345	0	16.14312	15.02344	14.57646	0	15.19714	0
P49736	MCM2_HUMAN	DNA replication licensing factor MCM2 (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)	MCM2 BM28 CCNL1 CDCL1 KIAA0030	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000781; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0016887; GO:0019899; GO:0030174; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775	ERVHPK	7.840000153	0.449966073	0.449966073	0.268832924	766.7921178	0	14.90869	0	0	0	0	17.3625	0	0	0	0	0	0	0	0	0	0	15.82293	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.83155	0	12.04887	0	16.83023	0	16.56202	0	14.39007	0	0	0	21.43478	0	0	0
P49746	TSP3_HUMAN	Thrombospondin-3	THBS3 TSP3	Homo sapiens (Human)	bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023	MQGFVESMKIILGGSMAR	8.18999958	0.354046583	0.354046583	0.084161075	1996.926125	16.91268	0	0	0	14.5581	15.82415	14.15064	12.7455	0	0	0	0	17.03911	12.81567	11.90973	11.06204	15.98703	14.70199	0	0	0	15.28256	14.84817	12.06439	15.50489	14.83148	0	11.35472	12.81272	0	15.00622	0	17.65635	0	0	0	0	14.06144	13.90746	0	0	16.17015	0	0	16.00303	13.98432	0	16.66541
P49750	YLPM1_HUMAN	YLP motif-containing protein 1 (Nuclear protein ZAP3) (ZAP113)	YLPM1 C14orf170 ZAP3	Homo sapiens (Human)	regulation of telomere maintenance [GO:0032204]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; regulation of telomere maintenance [GO:0032204]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0032204	DEPPR	7.929999828	1	1	0.115285495	613.1569638	14.86987	15.31001	14.52318	0	10.21889	14.52729	0	0	15.21746	12.68696	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.76019	0	0	17.70991	0	14.61502	0	0	0	0	0	0
P49754	VPS41_HUMAN	Vacuolar protein sorting-associated protein 41 homolog (S53)	VPS41	Homo sapiens (Human)	cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192]	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016192; GO:0016236; GO:0030136; GO:0030897; GO:0031902; GO:0034058; GO:0035542; GO:0042802; GO:0046872; GO:0048193; GO:1902501; GO:1902774	ILVADSLSLLK	1.610000014	1	1	0.069857143	1172.706464	12.03502	0	9.342105	12.25472	14.47064	12.69842	0	0	12.09741	0	9.591857	12.9937	9.61278	14.32983	12.80678	16.38993	16.4514	8.264584	12.80208	0	13.22074	0	0	0	8.841568	0	0	0	12.51167	12.53026	0	0	0	0	0	0	16.20332	0	0	12.78072	0	0	0	0	0	0	0	15.07511
P49756	RBM25_HUMAN	"RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa, RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7)"	RBM25 RNPC7	Homo sapiens (Human)	"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981	EKEMEADER	8.18999958	1	1	1.83E-12	1137.687028	13.90153	14.12804	14.79593	14.49864	11.3648	15.74406	15.95359	13.12839	10.02912	12.26546	12.45781	0	0	14.48457	11.14463	14.55713	15.34928	13.65084	15.98162	11.0778	14.8966	15.9849	15.38704	11.98545	14.64452	14.98872	13.76956	0	13.81708	0	14.99346	0	0	15.68402	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P49757	NUMB_HUMAN	"Protein numb homolog, h-Numb (Protein S171)"	NUMB C14orf41	Homo sapiens (Human)	adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of cell migration [GO:0030335]; positive regulation of neurogenesis [GO:0050769]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extrinsic component of plasma membrane [GO:0019897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extrinsic component of plasma membrane [GO:0019897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of cell migration [GO:0030335]; positive regulation of neurogenesis [GO:0050769]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]	GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0005905; GO:0005925; GO:0007409; GO:0008013; GO:0010008; GO:0016323; GO:0019897; GO:0021670; GO:0021849; GO:0030136; GO:0030335; GO:0034332; GO:0045177; GO:0045294; GO:0045296; GO:0050769; GO:0098978; GO:0099149; GO:1903077	KAETDK	10.38000011	0.587427676	0.587427676	0.288445675	691.1229872	15.31472	0	0	0	16.97963	0	14.19249	15.75066	0	11.31071	15.32302	0	0	14.52041	14.5102	15.98765	15.45749	0	15.73809	15.91132	16.09926	0	15.41191	0	0	14.11756	15.6502	0	0	15.31555	0	15.48907	15.93505	15.889	16.38635	15.79091	0	17.36925	0	15.42107	0	15.2563	16.70431	0	15.97244	0	15.83717	16.39032
P49758	RGS6_HUMAN	"Regulator of G-protein signaling 6, RGS6 (S914)"	RGS6	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0019898; GO:0035556; GO:0043547	IPSVVTGTDIVQWLMK	1.190000057	1	1	2.06E-12	1785.943431	14.06131	13.90353	13.17122	13.39881	13.34979	14.27052	0	0	0	14.39351	11.97206	15.09172	14.06838	0	14.80559	0	0	0	13.85876	14.68753	0	0	0	0	0	0	0	0	0	0	0	13.53567	0	0	0	0	13.14802	0	0	0	0	0	0	0	0	0	14.59219	0
P49760	CLK2_HUMAN	"Dual specificity protein kinase CLK2, EC 2.7.12.1 (CDC-like kinase 2)"	CLK2	Homo sapiens (Human)	negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]	nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0042802; GO:0043484; GO:0045721; GO:0046777; GO:0106310	GGARVALK	8.699999809	1	1	0.150818099	770.2921212	0	16.33956	14.66878	0	0	0	0	0	0	13.35995	15.16465	15.89577	0	0	14.12904	0	0	14.04517	0	0	0	0	0	0	16.69393	0	0	0	0	0	16.10583	0	15.9292	0	16.28645	15.98299	15.99619	14.86339	15.22134	13.32179	0	15.1395	15.43283	0	0	0	0	0
P49761	CLK3_HUMAN	"Dual specificity protein kinase CLK3, EC 2.7.12.1 (CDC-like kinase 3)"	CLK3	Homo sapiens (Human)	protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]	acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]	GO:0001669; GO:0003723; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0016020; GO:0016607; GO:0042802; GO:0043484; GO:0045111; GO:0046777; GO:0106310	SQQSSKR	3.890000105	1	1	0.210072627	821.3392595	13.93647	12.74909	15.1281	0	0	15.75975	0	0	0	16.32252	0	0	16.09477	16.5803	0	0	0	15.48723	0	0	0	0	16.01865	0	14.27559	15.02391	14.96354	0	0	0	14.50802	6.408769	14.17546	12.72284	0	12.5924	0	0	0	0	0	0	0	0	16.5249	16.61723	0	0
P49763	PLGF_HUMAN	"Placenta growth factor, PlGF"	PGF PGFL PLGF	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor receptor binding [GO:0005172]; animal organ regeneration [GO:0031100]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor receptor binding [GO:0005172]	GO:0001666; GO:0001934; GO:0001938; GO:0002040; GO:0005172; GO:0005576; GO:0005615; GO:0007165; GO:0007267; GO:0007565; GO:0008083; GO:0008201; GO:0008284; GO:0009410; GO:0016020; GO:0030154; GO:0031100; GO:0032870; GO:0038084; GO:0042056; GO:0042802; GO:0044877; GO:0045766; GO:0048010; GO:0050930; GO:0051781; GO:0060754	EKMKPER	4.050000191	1	1	0.228221887	929.9838556	15.69901	0	15.51233	0	0	14.83089	0	16.09713	0	0	0	16.65006	15.5451	14.36391	0	0	14.9645	0	0	0	0	0	16.45231	0	0	0	0	0	15.34104	14.18133	15.78702	13.60353	0	15.57665	0	16.94254	15.99777	14.85002	16.32109	0	0	17.469	0	15.10344	14.10405	0	11.41137	15.2484
P49792	RBP2_HUMAN	"E3 SUMO-protein ligase RanBP2, EC 2.3.2.- (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2, RanBP2) (p270)"	RANBP2 NUP358	Homo sapiens (Human)	centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; positive regulation of glucokinase activity [GO:0033133]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; positive regulation of glucokinase activity [GO:0033133]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]	GO:0000413; GO:0003723; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0016020; GO:0016925; GO:0019789; GO:0031267; GO:0031965; GO:0033133; GO:0042405; GO:0043231; GO:0044614; GO:0044615; GO:0046872; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068	EVADCFKK	4.170000076	1	1	0.018046783	994.5457831	16.3742	0	13.72737	0	13.48145	15.35255	0	0	12.72991	0	0	0	0	13.3225	0	12.73883	0	0	0	0	0	0	15.63033	14.79804	0	9.759493	0	11.83953	0	0	0	14.34418	0	0	0	0	0	0	0	14.18436	0	0	0	0	0	0	0	0
P49796	RGS3_HUMAN	"Regulator of G-protein signaling 3, RGP3, RGS3"	RGS3	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0008277; GO:0009968	ADKMMK	2.99000001	0.16628854	0.16628854	0.174234514	722.4044718	0	14.38203	15.68244	15.68812	0	14.9036	0	0	15.93996	0	14.51113	14.87556	0	15.14149	13.70829	16.32286	15.73236	17.29005	0	0	13.82045	0	0	0	16.40893	0	15.5786	14.84572	0	14.38625	15.71908	0	0	15.5603	16.15534	16.45721	17.08534	0	0	0	15.49658	17.70088	15.47124	0	0	0	15.32848	15.68095
P49810	PSN2_HUMAN	"Presenilin-2, PS-2, EC 3.4.23.- (AD3LP) (AD5) (E5-1) (STM-2) [Cleaved into: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit ]"	PSEN2 AD4 PS2 PSNL2 STM2	Homo sapiens (Human)	amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; calcium ion transport [GO:0006816]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of apoptotic process [GO:0043066]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of calcium import into the mitochondrion [GO:0110097]	apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]	"apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; endopeptidase activity [GO:0004175]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; calcium ion transport [GO:0006816]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of apoptotic process [GO:0043066]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of calcium import into the mitochondrion [GO:0110097]"	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; endopeptidase activity [GO:0004175]"	GO:0000139; GO:0000776; GO:0004175; GO:0005634; GO:0005637; GO:0005743; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005813; GO:0005886; GO:0005887; GO:0005938; GO:0006509; GO:0006816; GO:0007219; GO:0007220; GO:0009986; GO:0016020; GO:0016324; GO:0016485; GO:0030018; GO:0030426; GO:0031594; GO:0032991; GO:0034205; GO:0035253; GO:0035556; GO:0042500; GO:0042987; GO:0043025; GO:0043066; GO:0043085; GO:0043198; GO:0045121; GO:0048471; GO:0050435; GO:0070765; GO:0110097; GO:1990456	YGAKHVIMLFVPVTLCMIVVVATIK	2.720000029	1	1	7.30E-12	2818.310089	0	13.02574	0	0	0	17.08818	14.39664	0	0	0	18.58334	0	0	15.7252	0	0	0	0	0	16.00972	0	0	0	0	0	0	0	15.99239	0	16.41442	12.51901	16.94658	0	0	0	15.04692	0	0	14.65256	19.84721	14.87494	0	0	0	14.81495	16.2048	0	0
P49815	TSC2_HUMAN	Tuberin (Tuberous sclerosis 2 protein)	TSC2 TSC4	Homo sapiens (Human)	anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of GTPase activity [GO:0043547]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of GTPase activity [GO:0043547]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192]	GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0006469; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0014067; GO:0014069; GO:0016020; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0043491; GO:0043547; GO:0046626; GO:0046627; GO:0048009; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525	SLRIARPPK	1.279999971	1	1	0.141864355	1038.011554	0	0	0	0	0	0	0	0	16.5804	0	0	13.87286	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.77794	0	0	0	0	0	0	14.18137	0	0	14.39824	0	0	0	0	0	0	0	0
P49862	KLK7_HUMAN	"Kallikrein-7, hK7, EC 3.4.21.117 (Serine protease 6) (Stratum corneum chymotryptic enzyme, hSCCE)"	KLK7 PRSS6 SCCE	Homo sapiens (Human)	epidermis development [GO:0008544]; extracellular matrix disassembly [GO:0022617]; positive regulation of antibacterial peptide production [GO:0002803]	cornified envelope [GO:0001533]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	cornified envelope [GO:0001533]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; epidermis development [GO:0008544]; extracellular matrix disassembly [GO:0022617]; positive regulation of antibacterial peptide production [GO:0002803]	metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0001533; GO:0002803; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0008233; GO:0008236; GO:0008544; GO:0022617; GO:0030141; GO:0097209	VRLPSR	9.300000191	0.372418612	0.372418612	0.308417661	727.7689079	0	14.26962	14.44479	12.99841	15.316	15.46687	0	16.67917	14.34206	0	14.11879	17.02679	0	14.14653	16.48805	13.08964	15.94854	14.28463	16.14869	16.74277	14.47977	14.17496	15.43899	0	16.2018	15.92021	15.68111	14.99951	0	0	0	16.24307	17.14794	0	15.84408	0	0	17.82189	17.87836	17.10889	17.90138	17.12174	15.56343	0	16.03075	15.80684	17.54222	0
P49863	GRAK_HUMAN	"Granzyme K, EC 3.4.21.- (Fragmentin-3) (Granzyme-3) (NK-tryptase-2, NK-Tryp-2)"	GZMK TRYP2	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0008236	EVTVTVLSRK	4	1	1	0.197837245	1132.33293	0	0	14.06361	0	10.45888	0	12.73097	0	0	13.46704	11.01736	0	0	13.40449	15.68214	13.90896	0	0	15.83282	13.81439	17.40274	0	0	13.41476	0	14.54527	16.36634	0	0	0	0	16.21899	0	14.86167	16.18371	16.20985	16.78479	18.60282	0	0	15.79421	12.05435	0	16.14905	0	14.89046	0	0
P49888	ST1E1_HUMAN	"Sulfotransferase 1E1, ST1E1, EC 2.8.2.4 (EST-1) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring)"	SULT1E1 STE	Homo sapiens (Human)	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]	aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0006068; GO:0006711; GO:0008146; GO:0008202; GO:0008210; GO:0031965; GO:0045600; GO:0047894; GO:0050294; GO:0050427; GO:0051923	ENLMNGVK	28.29999924	0.357325405	0.357325405	0.185685033	905.7131676	0	18.91262	19.03189	19.26961	18.87896	0	0	18.58674	19.05465	18.74212	18.51397	18.44296	18.48772	19.29705	18.72138	18.41189	18.28701	0	19.01744	18.82463	0	18.4078	18.60606	18.70943	19.26276	0	0	18.62621	18.40404	18.44134	0	18.91056	0	18.34676	18.76949	0	18.55119	18.33238	18.30431	0	0	18.57019	0	18.84868	0	18.49724	0	18.83772
P49902	5NTC_HUMAN	"Cytosolic purine 5'-nucleotidase, EC 3.1.3.5, EC 3.1.3.99 (Cytosolic 5'-nucleotidase II, cN-II) (Cytosolic IMP/GMP-specific 5'-nucleotidase) (Cytosolic nucleoside phosphotransferase 5'N, EC 2.7.1.77) (High Km 5'-nucleotidase)"	NT5C2 NT5B NT5CP PNT5	Homo sapiens (Human)	adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP catabolic process [GO:0006204]; IMP metabolic process [GO:0046040]; nucleotide phosphorylation [GO:0046939]	cytosol [GO:0005829]	cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP catabolic process [GO:0006204]; IMP metabolic process [GO:0046040]; nucleotide phosphorylation [GO:0046939]	5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]	GO:0000255; GO:0005524; GO:0005829; GO:0006204; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046085; GO:0046872; GO:0046939; GO:0050146; GO:0050483; GO:0050484	VTHDMDMCYGMMGSLFR	7.489999771	1	1	0.172425289	2066.434252	0	0	0	12.11923	0	13.2796	14.65725	9.425071	0	0	0	14.98968	14.14619	0	0	0	0	14.098	0	16.26787	0	11.16328	0	0	0	0	0	0	0	0	0	0	0	0	15.35805	0	0	15.71159	10.61832	12.67447	14.91566	11.12981	14.32933	0	0	0	0	0
P49913	CAMP_HUMAN	"Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein, CAP-18, hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37 ]"	CAMP CAP18 FALL39 HSD26	Homo sapiens (Human)	antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing by host of symbiont cells [GO:0051873]; modulation of process of another organism [GO:0035821]; neutrophil activation [GO:0042119]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein phosphorylation [GO:0001934]; response to yeast [GO:0001878]	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	cell projection [GO:0042995]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; lipopolysaccharide binding [GO:0001530]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing by host of symbiont cells [GO:0051873]; modulation of process of another organism [GO:0035821]; neutrophil activation [GO:0042119]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein phosphorylation [GO:0001934]; response to yeast [GO:0001878]	lipopolysaccharide binding [GO:0001530]	GO:0001530; GO:0001878; GO:0001934; GO:0002227; GO:0002544; GO:0005576; GO:0005615; GO:0008284; GO:0019731; GO:0019732; GO:0032757; GO:0035580; GO:0035821; GO:0042119; GO:0042581; GO:0042742; GO:0042995; GO:0045087; GO:0045766; GO:0050829; GO:0050830; GO:0051838; GO:0051873; GO:0061844; GO:0070062; GO:0071222; GO:0071224; GO:0071347; GO:0071354; GO:0071356; GO:1904724	RCMGTVTLNQAR	4.619999886	0.561758339	0.561758339	4.56E-13	1422.540626	11.08924	0	12.5074	16.09953	0	0	0	15.0557	17.36563	0	15.91681	0	0	0	0	0	0	0	0	15.63645	16.0131	13.00794	13.89354	15.9327	16.13909	0	0	0	0	17.08631	0	14.82988	0	0	14.7804	0	15.27119	14.85968	14.7165	17.38776	0	14.5869	15.20232	14.9439	15.35492	0	10.4353	11.68732
P49916	DNLI3_HUMAN	"DNA ligase 3, EC 6.5.1.1 (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3)"	LIG3	Homo sapiens (Human)	"base-excision repair, DNA ligation [GO:0006288]; base-excision repair, gap-filling [GO:0006287]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]"	cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair, DNA ligation [GO:0006288]; base-excision repair, gap-filling [GO:0006287]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]	GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006287; GO:0006288; GO:0006302; GO:0007005; GO:0007049; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681	APSKPSASTKK	1.460000038	1	1	0.117211419	1102.153772	15.40975	0	14.31371	15.67608	15.7061	0	14.07586	0	0	0	0	15.05458	0	0	0	0	0	0	14.33727	13.30349	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P49917	DNLI4_HUMAN	"DNA ligase 4, EC 6.5.1.1 (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)"	LIG4	Homo sapiens (Human)	"cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151]"	"chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]	GO:0000012; GO:0000781; GO:0000793; GO:0001701; GO:0002328; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005958; GO:0006260; GO:0006266; GO:0006297; GO:0006302; GO:0006303; GO:0007049; GO:0007417; GO:0008022; GO:0008283; GO:0010165; GO:0010332; GO:0016874; GO:0032807; GO:0033077; GO:0033151; GO:0033152; GO:0033153; GO:0035019; GO:0036464; GO:0043524; GO:0045190; GO:0046872; GO:0048146; GO:0050769; GO:0051102; GO:0051103; GO:0051276; GO:0051301; GO:0051402; GO:0070419; GO:0071285; GO:0071479; GO:0071897; GO:0075713; GO:0097680; GO:2001252	ALELRFHGAK	6.670000076	1	1	0.199976824	1142.390851	13.99116	15.04971	14.06206	0	15.66777	0	0	0	13.40223	0	14.36415	16.40774	14.96251	15.6804	13.75147	9.234618	0	0	0	0	0	0	15.68928	13.62129	14.89425	0	0	0	0	14.33512	0	0	14.09139	0	0	0	15.54742	16.24401	0	0	0	0	15.30604	0	0	0	0	0
P49918	CDN1C_HUMAN	Cyclin-dependent kinase inhibitor 1C (Cyclin-dependent kinase inhibitor p57) (p57Kip2)	CDKN1C KIP2	Homo sapiens (Human)	"adrenal gland development [GO:0030325]; aging [GO:0007568]; camera-type eye development [GO:0043010]; cell cycle [GO:0007049]; digestive system development [GO:0055123]; embryonic placenta morphogenesis [GO:0060669]; genomic imprinting [GO:0071514]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; myeloid cell differentiation [GO:0030099]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of exit from mitosis [GO:0007096]; regulation of lens fiber cell differentiation [GO:1902746]; skeletal system development [GO:0001501]; uterus development [GO:0060065]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877]; adrenal gland development [GO:0030325]; aging [GO:0007568]; camera-type eye development [GO:0043010]; cell cycle [GO:0007049]; digestive system development [GO:0055123]; embryonic placenta morphogenesis [GO:0060669]; genomic imprinting [GO:0071514]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; myeloid cell differentiation [GO:0030099]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of exit from mitosis [GO:0007096]; regulation of lens fiber cell differentiation [GO:1902746]; skeletal system development [GO:0001501]; uterus development [GO:0060065]"	cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877]	GO:0000122; GO:0001501; GO:0001822; GO:0004860; GO:0004861; GO:0005634; GO:0005737; GO:0007049; GO:0007096; GO:0007568; GO:0030099; GO:0030325; GO:0030511; GO:0033673; GO:0035264; GO:0042326; GO:0042551; GO:0043010; GO:0044877; GO:0045736; GO:0045892; GO:0045893; GO:0045930; GO:0050680; GO:0055123; GO:0060065; GO:0060669; GO:0071514; GO:1902746; GO:1904030	MSDASLRSTSTMER	8.779999733	1	1	6.87E-13	1586.864401	0	0	0	0	0	14.10325	0	0	13.21515	0	0	0	0	0	14.93295	13.76045	13.38437	11.47819	0	16.83724	14.07803	13.89841	13.8596	15.40365	0	13.50625	0	14.33753	0	0	14.12986	15.50194	0	12.36368	13.43015	0	0	0	0	0	0	0	0	0	0	0	15.5983	0
P49959	MRE11_HUMAN	"Double-strand break repair protein MRE11, EC 3.1.-.- (Double-strand break repair protein MRE11A) (Meiotic recombination 11 homolog 1, MRE11 homolog 1) (Meiotic recombination 11 homolog A, MRE11 homolog A)"	MRE11 HNGS1 MRE11A	Homo sapiens (Human)	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]	"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 5'-3' exonuclease activity [GO:0008409]; cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]"	3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 5'-3' exonuclease activity [GO:0008409]; cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008022; GO:0008283; GO:0008296; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0070533; GO:0097552; GO:0098687; GO:0110025	LITKPSEGTTLR	2.809999943	1	1	0.003525978	1314.97207	0	12.2051	14.06486	11.19699	0	0	0	13.04136	0	0	0	11.33074	13.23268	12.19771	0	0	0	11.68692	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P50213	IDH3A_HUMAN	"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial, EC 1.1.1.41 (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)"	IDH3A	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0005962; GO:0005975; GO:0006099; GO:0006102; GO:0051287	ANIMR	13.39000034	1	1	0.034192112	619.4105314	16.78457	0	0	16.53938	0	0	0	0	0	0	0	15.05193	0	0	0	0	0	0	0	0	0	18.33909	19.16124	17.87462	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P50219	MNX1_HUMAN	Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9)	MNX1 HLXB9	Homo sapiens (Human)	central nervous system development [GO:0007417]; endocrine pancreas development [GO:0031018]; neuron projection morphogenesis [GO:0048812]; spinal cord motor neuron cell fate specification [GO:0021520]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; central nervous system development [GO:0007417]; endocrine pancreas development [GO:0031018]; neuron projection morphogenesis [GO:0048812]; spinal cord motor neuron cell fate specification [GO:0021520]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007417; GO:0021520; GO:0031018; GO:0048812; GO:1990837	AESPSPPR	13.13000011	1	1	0	841.1844265	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.76654	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P50221	MEOX1_HUMAN	Homeobox protein MOX-1 (Mesenchyme homeobox 1)	MEOX1 MOX1	Homo sapiens (Human)	hematopoietic stem cell differentiation [GO:0060218]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; somite development [GO:0061053]; somite specification [GO:0001757]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; hematopoietic stem cell differentiation [GO:0060218]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; somite development [GO:0061053]; somite specification [GO:0001757]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001757; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007275; GO:0043565; GO:0060218; GO:0061053; GO:0061056; GO:0071837; GO:1990837	QVKVWFQNR	8.149999619	1	1	0.107441495	1203.828753	14.21359	13.95458	13.75008	13.43128	10.79489	9.514137	13.25601	0	0	15.42934	12.61792	14.33612	15.70118	0	0	0	0	14.28542	16.03528	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P50225	ST1A1_HUMAN	"Sulfotransferase 1A1, ST1A1, EC 2.8.2.1 (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1, P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase, Ts-PST)"	SULT1A1 STP STP1 OK/SW-cl.88	Homo sapiens (Human)	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]	GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006584; GO:0006805; GO:0008146; GO:0008210; GO:0009308; GO:0009812; GO:0047894; GO:0050294; GO:0050427; GO:0050656; GO:0051923	NAKDVAVSYYHFYHMAK	2.410000086	1	1	9.24E-13	2062.89343	0	15.26729	14.62653	0	0	0	0	0	17.34301	0	15.87944	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.13405	0
P50281	MMP14_HUMAN	"Matrix metalloproteinase-14, MMP-14, EC 3.4.24.80 (MMP-X1) (Membrane-type matrix metalloproteinase 1, MT-MMP 1, MTMMP1) (Membrane-type-1 matrix metalloproteinase, MT1-MMP, MT1MMP)"	MMP14	Homo sapiens (Human)	angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; branching morphogenesis of an epithelial tube [GO:0048754]; cell motility [GO:0048870]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Notch signaling pathway [GO:0045746]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; branching morphogenesis of an epithelial tube [GO:0048754]; cell motility [GO:0048870]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Notch signaling pathway [GO:0045746]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638]	endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	GO:0001501; GO:0001525; GO:0001541; GO:0001666; GO:0001935; GO:0001958; GO:0004175; GO:0004222; GO:0004252; GO:0005178; GO:0005615; GO:0005634; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006508; GO:0006979; GO:0008270; GO:0008584; GO:0009612; GO:0010831; GO:0010954; GO:0014070; GO:0016485; GO:0022617; GO:0030198; GO:0030307; GO:0030324; GO:0030335; GO:0030574; GO:0031012; GO:0031410; GO:0031638; GO:0035987; GO:0035988; GO:0042470; GO:0043615; GO:0043627; GO:0044354; GO:0045111; GO:0045579; GO:0045746; GO:0048701; GO:0048754; GO:0048771; GO:0048870; GO:0051895; GO:0060322; GO:0070006; GO:0097094; GO:1903076; GO:1905523; GO:1990834	GDKHWVFDEASLEPGYPK	4.230000019	1	1	0.143205159	2073.337068	15.49423	15.42844	0	13.17239	14.83584	0	0	0	0	0	14.97516	0	0	15.39837	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.72124	0	19.29975	19.04338	0	0	0	0	16.44308	0	0	0	0	15.3233	15.95576	0	0	0	0
P50336	PPOX_HUMAN	"Protoporphyrinogen oxidase, PPO, EC 1.3.3.4"	PPOX	Homo sapiens (Human)	heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]	intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]	intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]	flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]	GO:0004729; GO:0005758; GO:0006779; GO:0006782; GO:0006783; GO:0016491; GO:0031304; GO:0031966; GO:0050660	GVSVLR	12.76000023	0.933712244	0.933712244	0.297827683	631.6467942	0	18.95697	17.63337	0	0	15.07876	0	0	17.55127	16.89049	18.38707	0	17.51476	0	16.98365	0	0	0	0	0	0	17.64557	18.03773	0	17.48554	17.82291	0	19.12818	0	0	0	0	18.53161	0	0	16.89677	0	0	16.93684	0	0	16.47858	0	0	16.60281	0	0	17.67745
P50395	GDIB_HUMAN	"Rab GDP dissociation inhibitor beta, Rab GDI beta (Guanosine diphosphate dissociation inhibitor 2, GDI-2)"	GDI2 RABGDIB	Homo sapiens (Human)	negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0031267; GO:0031982; GO:0034774; GO:0035578; GO:0045202; GO:0070062; GO:1902018; GO:1903565	IPGSPPESMGR	1.899999976	1	1	0.235725338	1129.096779	0	17.15849	0	0	0	0	19.56825	0	0	0	0	14.48993	14.07804	0	0	0	0	0	0	0	0	0	0	0	0	15.76651	0	17.45898	0	0	17.14393	0	0	0	18.63406	0	0	0	0	0	0	0	0	15.19831	0	19.6181	16.23252	0
P50416	CPT1A_HUMAN	"Carnitine O-palmitoyltransferase 1, liver isoform, CPT1-L, EC 2.3.1.21 (Carnitine O-palmitoyltransferase I, liver isoform, CPT I, CPTI-L) (Carnitine palmitoyltransferase 1A)"	CPT1A CPT1	Homo sapiens (Human)	carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]	carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]	GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0009410; GO:0009437; GO:0010883; GO:0014070; GO:0016020; GO:0030855; GO:0031307; GO:0031667; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045471; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698	ATKIWMGMVK	5.570000172	1	1	4.59E-13	1179.566486	0	0	12.06045	0	0	14.8017	14.45419	0	16.25104	0	14.99222	16.3895	15.47857	0	0	0	0	13.23608	15.99421	0	0	15.78521	0	14.91487	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P50452	SPB8_HUMAN	"Serpin B8 (Cytoplasmic antiproteinase 2, CAP-2, CAP2) (Peptidase inhibitor 8, PI-8)"	SERPINB8 PI8	Homo sapiens (Human)	epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615; GO:0005737; GO:0005829; GO:0010951; GO:0062023; GO:0070062; GO:0090136	HINDWVAEK	2.5	1	1	0.242815842	1112.574286	0	0	0	0	16.86478	0	0	0	0	0	16.62864	0	0	16.09462	0	0	0	0	15.99331	0	0	0	0	0	0	0	0	0	0	0	19.15395	0	0	0	0	0	0	17.86113	20.13629	0	0	0	0	17.00942	0	0	0	0
P50453	SPB9_HUMAN	"Serpin B9 (Cytoplasmic antiproteinase 3, CAP-3, CAP3) (Peptidase inhibitor 9, PI-9)"	SERPINB9 PI9	Homo sapiens (Human)	cellular response to estrogen stimulus [GO:0071391]; immune response [GO:0006955]; mast cell mediated immunity [GO:0002448]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endopeptidase activity [GO:0010951]; protection from natural killer cell mediated cytotoxicity [GO:0042270]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cellular response to estrogen stimulus [GO:0071391]; immune response [GO:0006955]; mast cell mediated immunity [GO:0002448]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endopeptidase activity [GO:0010951]; protection from natural killer cell mediated cytotoxicity [GO:0042270]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0002448; GO:0004867; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0010951; GO:0016020; GO:0042270; GO:0043027; GO:0043066; GO:0062023; GO:0070062; GO:0071391	ETLSNASGTFAIRLLK	4.53000021	0.841047227	0.841047227	0.328490657	1719.81653	12.28564	0	0	14.70546	13.42427	0	14.68714	0	13.83763	0	16.5067	0	0	12.96437	0	0	16.54223	0	0	0	0	0	13.7498	0	16.30392	0	0	0	0	14.91144	0	17.88653	0	0	11.76486	0	0	0	0	15.39646	18.57681	0	0	14.77841	0	0	0	0
P50454	SERPH_HUMAN	"Serpin H1 (47 kDa heat shock protein) (Arsenic-transactivated protein 3, AsTP3) (Cell proliferation-inducing gene 14 protein) (Collagen-binding protein, Colligin) (Rheumatoid arthritis-related antigen RA-A47)"	SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14	Homo sapiens (Human)	chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; negative regulation of endopeptidase activity [GO:0010951]; protein maturation [GO:0051604]; response to unfolded protein [GO:0006986]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; membrane raft [GO:0045121]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; collagen binding [GO:0005518]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867]; unfolded protein binding [GO:0051082]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; negative regulation of endopeptidase activity [GO:0010951]; protein maturation [GO:0051604]; response to unfolded protein [GO:0006986]	collagen binding [GO:0005518]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867]; unfolded protein binding [GO:0051082]	GO:0003433; GO:0003723; GO:0004867; GO:0005518; GO:0005615; GO:0005783; GO:0005788; GO:0005793; GO:0006986; GO:0010951; GO:0030199; GO:0032964; GO:0045121; GO:0051082; GO:0051604; GO:0062023	DTQSGSLLFIGRLVRPK	1.580000043	0.319030166	0.319030166	0.269252233	1891.022034	15.69541	16.24449	0	0	0	0	0	0	0	0	0	0	0	12.00496	0	15.01006	0	0	0	0	0	14.5382	0	0	15.82383	0	15.90211	0	0	0	15.97693	16.0294	0	0	0	0	0	0	0	0	16.44457	0	15.39881	15.64635	0	0	0	0
P50479	PDLI4_HUMAN	PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein)	PDLIM4 RIL	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; muscle structure development [GO:0061061]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; recycling endosome lumen [GO:0034777]; recycling endosome membrane [GO:0055038]; stress fiber [GO:0001725]; Z disc [GO:0030018]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; recycling endosome lumen [GO:0034777]; recycling endosome membrane [GO:0055038]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; muscle structure development [GO:0061061]	actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]	GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0005912; GO:0007507; GO:0019903; GO:0030018; GO:0030027; GO:0030036; GO:0031532; GO:0031901; GO:0031905; GO:0031941; GO:0034777; GO:0042803; GO:0043197; GO:0045211; GO:0046872; GO:0048471; GO:0051371; GO:0051393; GO:0055038; GO:0061061; GO:0098976	VHAGSK	7.510000229	0.248028293	0.248028293	0.152059584	599.430596	15.78697	14.9634	0	15.98805	16.94057	15.1129	15.19925	0	15.68341	0	15.88765	0	0	14.41079	0	0	16.34422	15.05716	0	17.42271	0	0	18.08822	15.32367	16.61408	17.23365	17.64629	0	16.1188	15.25039	16.7848	0	15.64526	0	17.3351	0	16.46149	16.59836	17.64042	0	15.76016	16.28461	0	0	0	16.84616	14.83077	15.14052
P50552	VASP_HUMAN	"Vasodilator-stimulated phosphoprotein, VASP"	VASP	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289]	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]	GO:0001843; GO:0003779; GO:0005522; GO:0005829; GO:0005886; GO:0005923; GO:0005925; GO:0007411; GO:0008154; GO:0015629; GO:0017124; GO:0030036; GO:0030838; GO:0031258; GO:0031527; GO:0045296; GO:0051289; GO:0070062	AESGRSGGGGLMEEMNAMLAR	2.940000057	1	1	9.16E-13	2156.442726	11.61452	13.62268	0	0	15.25169	0	13.92119	0	17.90582	11.72905	0	0	15.38126	0	0	0	13.95329	12.64283	0	0	0	0	0	13.10217	12.22444	0	17.96341	15.36764	0	0	0	13.96608	0	0	0	0	0	0	12.53826	0	0	0	0	0	15.82718	0	15.46356	0
P50553	ASCL1_HUMAN	"Achaete-scute homolog 1, ASH-1, hASH1 (Class A basic helix-loop-helix protein 46, bHLHa46)"	ASCL1 ASH1 BHLHA46 HASH1	Homo sapiens (Human)	"adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to lithium ion [GO:0010226]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]"	chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to lithium ion [GO:0010226]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]"	"bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001764; GO:0003358; GO:0003359; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0007346; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0010226; GO:0010468; GO:0014003; GO:0021527; GO:0021530; GO:0021750; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030182; GO:0030856; GO:0032526; GO:0042802; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0046983; GO:0048469; GO:0048485; GO:0048663; GO:0048665; GO:0048666; GO:0050767; GO:0050769; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060487; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:1990837; GO:2000179	SSSPELMR	4.760000229	1	1	1.03E-12	923.4634346	15.6521	13.79667	0	0	0	0	0	12.72604	0	0	0	0	0	15.7519	0	13.8349	13.90293	0	15.9298	0	15.38665	0	0	15.64643	16.20393	0	0	13.92085	0	14.60234	0	0	16.43864	16.18342	14.43308	0	0	0	0	0	0	0	0	0	14.60249	0	0	0
P50613	CDK7_HUMAN	"Cyclin-dependent kinase 7, EC 2.7.11.22, EC 2.7.11.23 (39 kDa protein kinase, p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit)"	CDK7 CAK CAK1 CDKN7 MO15 STK1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]	"CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]"	GO:0000079; GO:0000439; GO:0001650; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005829; GO:0005886; GO:0006281; GO:0006366; GO:0006367; GO:0006468; GO:0007049; GO:0008022; GO:0008094; GO:0008353; GO:0019907; GO:0042795; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0051726; GO:0070516; GO:0070816; GO:0070985; GO:0106310; GO:2000045	SFGSPNR	4.610000134	1	1	0.13526671	765.6590285	0	0	0	0	0	0	12.52421	14.62407	0	0	14.64759	15.77186	0	13.28356	14.36119	0	15.48896	15.36321	0	0	0	0	16.89039	0	0	0	0	0	15.44271	0	0	0	0	0	0	0	0	16.63559	0	0	0	0	0	0	0	0	0	15.11259
P50748	KNTC1_HUMAN	"Kinetochore-associated protein 1 (Rough deal homolog, HsROD, Rod, hRod)"	KNTC1 KIAA0166	Homo sapiens (Human)	cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; small GTPase binding [GO:0031267]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]	small GTPase binding [GO:0031267]	GO:0000070; GO:0000922; GO:0005634; GO:0005737; GO:0005828; GO:0005829; GO:0005886; GO:0007094; GO:0007096; GO:0015629; GO:0031267; GO:0051301; GO:0065003; GO:1903394; GO:1990423	ALEMVPLLTSTK	8.779999733	0.252650887	0.252650887	0.150775031	1317.629466	10.39036	6.674703	15.85952	14.44918	13.96317	12.89821	0	0	15.1306	17.07332	0	15.36271	14.72575	13.52532	0	0	15.73426	0	13.52664	13.93828	15.4653	14.41304	13.34347	10.2185	0	0	12.72052	12.28593	0	15.00924	0	0	15.14542	15.00924	10.4899	11.26959	16.50954	13.63702	15.45738	11.17748	16.07117	18.21642	5.75191	13.40706	0	0	0	0
P50851	LRBA_HUMAN	Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein)	LRBA BGL CDC4L LBA	Homo sapiens (Human)	mitophagy [GO:0000423]; protein localization [GO:0008104]; protein localization to phagophore assembly site [GO:0034497]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; mitophagy [GO:0000423]; protein localization [GO:0008104]; protein localization to phagophore assembly site [GO:0034497]	protein kinase binding [GO:0019901]	GO:0000423; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0016021; GO:0019901; GO:0034497	LLSQTMK	12.93999958	0.006300548	0.006300548	0.251954175	820.4813427	16.20104	0	0	0	0	0	0	18.40668	0	19.6026	0	16.43886	17.60266	0	18.05159	17.40858	0	0	0	0	0	16.75424	0	0	0	23.88933	20.85461	18.07425	22.27825	19.96266	0	18.30501	0	18.49442	19.22211	0	21.31993	0	0	17.29693	15.51707	0	0	0	0	0	0	0
P50876	R144A_HUMAN	"E3 ubiquitin-protein ligase RNF144A, EC 2.3.2.31 (RING finger protein 144A) (UbcM4-interacting protein 4) (Ubiquitin-conjugating enzyme 7-interacting protein 4)"	RNF144A KIAA0161 RNF144 UBCE7IP4	Homo sapiens (Human)	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0005794; GO:0005886; GO:0006511; GO:0010008; GO:0016021; GO:0016567; GO:0031624; GO:0032436; GO:0043231; GO:0046872; GO:0061630	MTTTRYRPTWDLALDPLVSCK	2.809999943	1	1	0.149999572	2541.028296	15.4166	15.18951	13.76629	0	15.85953	14.34941	15.32471	12.42374	13.65065	0	13.46882	11.73211	0	14.14259	0	13.36771	0	16.30619	0	14.97714	13.3322	13.7587	0	0	0	0	15.52333	0	0	0	14.81524	16.59545	0	0	0	13.41589	0	14.04831	0	16.05247	14.88755	0	0	15.1566	0	0	0	0
P50914	RL14_HUMAN	60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)	RPL14	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006364; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0042273; GO:0045296; GO:0070062	AAPAPK	3.230000019	1	1	0	553.1466552	0	17.44293	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P50991	TCPD_HUMAN	"T-complex protein 1 subunit delta, TCP-1-delta (CCT-delta) (Stimulator of TAR RNA-binding)"	CCT4 CCTD SRB	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]	cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0003723; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0042470; GO:0042995; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	LTEYSR	17.29999924	1	1	0.29442441	768.2712167	18.44672	17.36542	14.93194	20.85106	17.67994	0	17.91764	18.10455	0	18.52517	0	17.47104	17.70574	0	0	0	20.0958	19.79278	17.52941	16.69356	0	19.97549	0	0	19.72364	19.80593	0	0	0	17.19109	22.73005	20.57466	21.38872	20.55574	19.52614	0	16.93161	20.861	20.70351	18.5569	16.25222	18.4935	18.39226	17.70436	0	19.38926	0	16.44991
P50993	AT1A2_HUMAN	"Sodium/potassium-transporting ATPase subunit alpha-2, Na(+)/K(+) ATPase alpha-2 subunit, EC 7.2.2.13 (Sodium pump subunit alpha-2)"	ATP1A2 KIAA0778	Homo sapiens (Human)	"adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cardiac muscle contraction [GO:0060048]; cation transmembrane transport [GO:0098655]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization [GO:0086009]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium:sodium antiporter activity [GO:1903280]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; positive regulation of heart contraction [GO:0045823]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of muscle contraction [GO:0006937]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of striated muscle contraction [GO:0006942]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; relaxation of cardiac muscle [GO:0055119]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; response to nicotine [GO:0035094]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; visual learning [GO:0008542]"	caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]	"caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; chaperone binding [GO:0051087]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; sodium ion binding [GO:0031402]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cardiac muscle contraction [GO:0060048]; cation transmembrane transport [GO:0098655]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization [GO:0086009]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium:sodium antiporter activity [GO:1903280]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; positive regulation of heart contraction [GO:0045823]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of muscle contraction [GO:0006937]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of striated muscle contraction [GO:0006942]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; relaxation of cardiac muscle [GO:0055119]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; response to nicotine [GO:0035094]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; visual learning [GO:0008542]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; chaperone binding [GO:0051087]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; sodium ion binding [GO:0031402]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]	GO:0001504; GO:0001662; GO:0002026; GO:0002087; GO:0005391; GO:0005496; GO:0005524; GO:0005737; GO:0005768; GO:0005886; GO:0005890; GO:0005901; GO:0006813; GO:0006814; GO:0006883; GO:0006937; GO:0006940; GO:0006942; GO:0008217; GO:0008344; GO:0008542; GO:0010881; GO:0010996; GO:0014704; GO:0016020; GO:0016791; GO:0016887; GO:0019229; GO:0019829; GO:0021764; GO:0021989; GO:0030007; GO:0030315; GO:0030955; GO:0031090; GO:0031402; GO:0035094; GO:0035641; GO:0035725; GO:0036376; GO:0040011; GO:0042995; GO:0043025; GO:0043197; GO:0045822; GO:0045823; GO:0045988; GO:0046034; GO:0046982; GO:0051087; GO:0051481; GO:0051946; GO:0051966; GO:0055119; GO:0060048; GO:0071260; GO:0071383; GO:0071805; GO:0086004; GO:0086009; GO:0086012; GO:0086064; GO:0098655; GO:0150104; GO:1902600; GO:1903170; GO:1903280; GO:1903416; GO:1903561; GO:1990239; GO:1990573	VLGFCQLNLPSGKFPR	1.659999967	1	1	2.30E-12	1833.708119	0	15.36718	15.2473	12.15525	0	0	0	0	0	14.01571	14.11612	0	13.12512	0	0	14.51651	0	0	14.12426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.03293	15.89164	14.67792	0	0	0	0	0
P50995	ANX11_HUMAN	"Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50, CAP-50)"	ANXA11 ANX11	Homo sapiens (Human)	cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592]	azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819]	azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]	GO:0003723; GO:0005509; GO:0005544; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006909; GO:0008429; GO:0016020; GO:0023026; GO:0030496; GO:0032506; GO:0042470; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592; GO:0062023; GO:0070062	GAGTK	10.19999981	1	1	0.25666332	432.6567568	17.20149	0	14.79039	0	17.00592	0	16.17131	0	0	0	0	0	0	17.81468	17.12517	17.65844	0	18.83824	0	0	0	0	0	15.30379	0	18.72993	0	17.69724	17.13247	0	0	16.59223	17.16056	19.14574	0	0	0	0	0	0	16.82042	17.33916	16.44647	17.09904	0	16.50242	0	0
P51114	FXR1_HUMAN	"Fragile X mental retardation syndrome-related protein 1, hFXR1p"	FXR1	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; skeletal muscle organ development [GO:0060538]"	axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]	"axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; skeletal muscle organ development [GO:0060538]"	mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]	GO:0000381; GO:0001934; GO:0003723; GO:0003730; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005844; GO:0006915; GO:0007517; GO:0014069; GO:0016020; GO:0017148; GO:0030154; GO:0030424; GO:0030426; GO:0033592; GO:0036464; GO:0042803; GO:0043025; GO:0043034; GO:0043197; GO:0043488; GO:0044326; GO:0045182; GO:0045727; GO:0046982; GO:0048471; GO:0051489; GO:0060538; GO:0098793; GO:0098978; GO:1902737; GO:2000637; GO:2001022	NLPRETLAK	6.690000057	0.307483464	0.307483464	0.154852669	1041.904304	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.15133	0	14.67961	0	0	0	0	0	0	0	15.33348	14.85995	0	14.97973	0	0	0	0	0	0	0	13.58685	15.15005	15.83325	12.10019	14.33558	12.4722	0	0	10.22003	0	0	0
P51116	FXR2_HUMAN	Fragile X mental retardation syndrome-related protein 2	FXR2 FMR1L2	Homo sapiens (Human)	"negative regulation of translation [GO:0017148]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; negative regulation of translation [GO:0017148]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]"	identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]	GO:0000381; GO:0001934; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0014069; GO:0016020; GO:0017148; GO:0022625; GO:0030424; GO:0030426; GO:0036464; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043488; GO:0044326; GO:0045182; GO:0045727; GO:0046982; GO:0051489; GO:0098793; GO:1902737; GO:2001022	GGLASGGDVEPGLPVEVR	13.86999989	0.816957593	0.816957593	0.12048856	1708.838379	0	18.13283	17.00154	0	0	15.05648	0	0	0	0	17.15071	17.92665	0	0	0	13.75468	0	0	14.96068	0	11.90033	14.49122	0	12.70045	17.60485	15.06195	16.12743	16.84046	15.03533	16.0535	14.16972	19.40909	13.63762	0	19.02135	0	16.92859	17.4278	15.29452	0	16.77789	17.0323	0	0	17.75229	0	15.73233	0
P51124	GRAM_HUMAN	"Granzyme M, EC 3.4.21.- (Met-1 serine protease, Hu-Met-1) (Met-ase) (Natural killer cell granular protease)"	GZMM MET1	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell death [GO:0008219]; cytolysis [GO:0019835]; innate immune response [GO:0045087]; T cell mediated cytotoxicity [GO:0001913]	extracellular region [GO:0005576]; membrane [GO:0016020]	extracellular region [GO:0005576]; membrane [GO:0016020]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytolysis [GO:0019835]; innate immune response [GO:0045087]; T cell mediated cytotoxicity [GO:0001913]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0001913; GO:0004252; GO:0005576; GO:0006915; GO:0008219; GO:0008236; GO:0016020; GO:0019835; GO:0045087	DQAPCK	1.5	0.951138318	0.951138318	0.268559928	717.9179956	14.53081	0	16.0204	0	0	0	14.20838	0	0	0	0	0	0	0	0	15.78782	0	14.3085	0	17.08013	0	0	0	0	16.48297	15.05345	0	0	0	14.58895	15.93242	0	0	0	16.83384	0	17.35191	0	17.2535	16.46088	16.26974	17.30963	16.06609	15.98998	15.20172	0	16.82938	16.06611
P51148	RAB5C_HUMAN	"Ras-related protein Rab-5C, EC 3.6.5.2 (L1880) (RAB5L)"	RAB5C RABL	Homo sapiens (Human)	endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886]	azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]	G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0003925; GO:0005525; GO:0005765; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0012505; GO:0019003; GO:0030100; GO:0030139; GO:0031901; GO:0035577; GO:0042470; GO:0048227; GO:0070062	TAMNVNEIFMAIAK	1.809999943	1	1	2.29E-12	1552.682535	0	13.7695	0	0	0	0	0	0	0	0	0	0	14.67579	0	0	10.71174	0	0	0	15.03695	0	0	0	0	0	0	14.23904	0	0	0	0	0	0	0	0	0	0	0	0	16.22417	0	0	0	13.33814	0	0	0	0
P51151	RAB9A_HUMAN	Ras-related protein Rab-9A	RAB9A RAB9	Homo sapiens (Human)	"negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]"	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005789; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030133; GO:0030670; GO:0032482; GO:0032588; GO:0032880; GO:0042147; GO:0042470; GO:0045335; GO:0045921; GO:0052403; GO:0070062	SSLFKVILLGDGGVGK	6.630000114	1	1	0.29643146	1588.607689	14.33861	15.42584	0	13.77435	0	0	12.78794	15.21473	15.82836	0	14.99996	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41529	0	0	0	0	0	0	0	0	14.34631	0	0	0	0	0	0	0	0
P51157	RAB28_HUMAN	Ras-related protein Rab-28	RAB28	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; toxin transport [GO:1901998]	ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]	ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; toxin transport [GO:1901998]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0006886; GO:0012505; GO:0019003; GO:0035253; GO:0036064; GO:1901998	IVVLGDGASGK	9.649999619	0.635935605	0.635935605	0.240997111	1012.963947	15.73107	14.02949	15.93784	0	14.28135	15.46495	13.85641	13.24332	13.3612	16.37777	14.4495	15.83539	14.41762	15.81461	14.06229	14.84455	15.22204	0	13.54113	0	0	0	14.98674	0	15.10544	0	16.00615	16.25254	15.13707	15.58342	18.43809	12.44182	13.32821	15.07892	15.50535	14.44137	14.21554	14.36074	14.35842	10.97687	15.18624	14.24543	17.75132	14.00426	13.24517	15.01983	0	11.83592
P51160	PDE6C_HUMAN	"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha', EC 3.1.4.35 (cGMP phosphodiesterase 6C)"	PDE6C PDEA2	Homo sapiens (Human)	"phototransduction, visible light [GO:0007603]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601]"	plasma membrane [GO:0005886]	"plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; phototransduction, visible light [GO:0007603]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601]"	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]"	GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0007603; GO:0030553; GO:0046549; GO:0046872; GO:0047555	LAHLLQADR	13.44999981	0.141659871	0.141659871	0.254445064	1036.529587	10.39713	13.807	17.09233	16.0385	0	15.29185	15.51982	0	0	0	16.28635	16.06165	0	0	0	14.70519	0	0	0	15.9901	0	0	0	0	0	15.77979	15.85444	0	0	0	0	17.46945	0	0	0	0	0	15.8101	0	17.52347	16.16014	16.95326	14.88842	0	16.8644	17.32861	0	16.84696
P51172	SCNND_HUMAN	"Amiloride-sensitive sodium channel subunit delta (Delta-NaCH) (Epithelial Na(+) channel subunit delta, Delta-ENaC, ENaCD) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED)"	SCNN1D DNACH	Homo sapiens (Human)	cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]	actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	ligand-gated sodium channel activity [GO:0015280]	GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0008217; GO:0015280; GO:0015629; GO:0016020; GO:0034706; GO:0035725; GO:0036254; GO:0050914; GO:0050915; GO:0071468; GO:0098719; GO:1904045; GO:1904117	QPHGGALTSR	3.569999933	1	1	0.263754237	1024.253769	15.53767	18.97772	0	0	17.85341	0	0	0	15.17647	0	0	0	0	0	0	0	17.9461	0	0	0	0	0	16.91392	0	0	0	18.27511	0	0	0	0	0	0	19.18668	0	19.44936	0	0	0	15.94406	0	0	0	16.36976	0	0	16.22227	0
P51178	PLCD1_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1, EC 3.1.4.11 (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III, PLC-III) (Phospholipase C-delta-1, PLC-delta-1)"	PLCD1	Homo sapiens (Human)	lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid metabolic process [GO:0006644]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid metabolic process [GO:0006644]"	"calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0004435; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0006644; GO:0016042; GO:0032794; GO:0046488; GO:0048015; GO:0070062	AIRDYAFK	2.269999981	1	1	0.212602244	983.6095384	0	15.56728	10.50305	0	11.03771	17.2906	14.14476	0	0	15.4726	0	0	0	14.15658	15.45822	14.58223	12.32654	0	0	0	0	0	12.44885	14.15931	14.60736	0	0	0	14.30312	0	0	14.34557	0	0	0	16.88631	0	16.22666	19.28532	0	0	0	17.41136	0	0	0	16.86273	0
P51397	DAP1_HUMAN	"Death-associated protein 1, DAP-1"	DAP DAP1	Homo sapiens (Human)	"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]"		"death domain binding [GO:0070513]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]"	death domain binding [GO:0070513]	GO:0006914; GO:0006915; GO:0006919; GO:0010507; GO:0032088; GO:0034198; GO:0045892; GO:0070513; GO:0097190	AGGMR	4.369999886	1	1	0.215696635	509.9400763	0	17.75465	0	17.89462	17.84249	16.22616	18.15151	17.34515	17.47786	17.34118	17.87255	17.98147	0	0	0	17.74621	16.91619	0	0	16.70882	17.83584	17.68483	0	0	0	0	0	17.43826	16.92558	18.11416	0	0	0	16.83822	0	0	18.4679	17.89719	17.97241	0	0	17.29214	0	0	0	0	17.2	0
P51398	RT29_HUMAN	"28S ribosomal protein S29, mitochondrial, MRP-S29, S29mt (Death-associated protein 3, DAP-3) (Ionizing radiation resistance conferring protein) (Mitochondrial small ribosomal subunit protein mS29)"	DAP3 MRPS29	Homo sapiens (Human)	apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543]	GTP binding [GO:0005525]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005525; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0097190	LISRIHK	6.829999924	1	1	0.32339582	868.1483735	0	0	0	0	0	15.52351	0	10.95126	14.79239	0	0	0	0	12.32896	0	0	0	0	0	16.64231	15.51692	0	14.97068	14.74002	14.74749	0	0	0	15.41961	17.123	12.67958	15.0422	0	12.59952	16.59426	10.9994	0	0	0	0	0	12.41258	0	0	16.99288	0	0	16.56973
P51449	RORG_HUMAN	Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma)	RORC NR1F3 RORG RZRG	Homo sapiens (Human)	"adipose tissue development [GO:0060612]; cellular response to sterol [GO:0036315]; circadian regulation of gene expression [GO:0032922]; lymph node development [GO:0048535]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Peyer's patch development [GO:0048541]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fat cell differentiation [GO:0045598]; regulation of glucose metabolic process [GO:0010906]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper cell differentiation [GO:0042093]; xenobiotic metabolic process [GO:0006805]"	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; adipose tissue development [GO:0060612]; cellular response to sterol [GO:0036315]; circadian regulation of gene expression [GO:0032922]; lymph node development [GO:0048535]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Peyer's patch development [GO:0048541]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fat cell differentiation [GO:0045598]; regulation of glucose metabolic process [GO:0010906]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper cell differentiation [GO:0042093]; xenobiotic metabolic process [GO:0006805]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006357; GO:0006805; GO:0008142; GO:0008270; GO:0010906; GO:0016604; GO:0019218; GO:0032922; GO:0036315; GO:0042093; GO:0042753; GO:0045598; GO:0045893; GO:0048535; GO:0048541; GO:0060612; GO:0070244; GO:0072539; GO:0098531; GO:1990837	AGLNGASCHLEYSPERGK	11.77000046	1	1	0.252795977	1943.189792	17.1584	0	8.906747	0	0	16.34233	0	17.44945	0	16.64001	0	0	0	0	0	17.73009	16.21185	0	0	0	0	0	16.30826	0	0	0	0	0	0	0	0	0	0	0	0	13.86774	0	16.62348	0	0	0	17.30123	0	0	12.24291	0	0	0
P51530	DNA2_HUMAN	"DNA replication ATP-dependent helicase/nuclease DNA2, hDNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2, EC 3.1.-.-; DNA replication ATP-dependent helicase DNA2, EC 3.6.4.12 ]"	DNA2 DNA2L KIAA0083	Homo sapiens (Human)	"base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]"	GO:0000076; GO:0000723; GO:0000729; GO:0000781; GO:0003677; GO:0003678; GO:0003723; GO:0004386; GO:0004518; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006260; GO:0006264; GO:0006284; GO:0016887; GO:0016890; GO:0017108; GO:0017116; GO:0032201; GO:0033567; GO:0042645; GO:0043137; GO:0043139; GO:0043504; GO:0044806; GO:0045740; GO:0046872; GO:0051539; GO:0071932; GO:0090305; GO:0090656; GO:1902990	GGVSNVTEAK	7.170000076	1	1	0.25239961	961.1867513	0	14.77777	0	14.34117	14.08974	14.8673	14.23142	14.51866	15.27738	0	0	16.71699	15.33513	13.49785	0	13.33375	0	14.22019	0	0	15.26955	16.00002	15.17353	0	0	0	0	0	0	0	15.95443	0	0	0	0	0	16.45445	17.01882	0	0	0	0	0	15.19925	0	0	0	0
P51531	SMCA2_HUMAN	"Probable global transcription activator SNF2L2, EC 3.6.4.- (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B, BAF190B) (Protein brahma homolog, hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2)"	SMARCA2 BAF190B BRM SNF2A SNF2L2	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]"	bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	"bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]"	GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007286; GO:0007399; GO:0008094; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0035060; GO:0042393; GO:0043231; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819	MDMDRR	4.199999809	0.73310256	0.73310256	0.146954683	841.5325768	17.39839	15.81542	0	14.11461	15.38822	16.33232	0	0	0	14.01066	13.14259	17.01404	14.34087	0	11.72276	0	14.22919	0	0	0	14.98827	15.42013	18.3068	14.85664	15.94003	17.84872	16.28481	17.70932	16.96612	16.54007	17.42872	16.26913	17.85618	0	14.984	14.09862	14.85758	14.35817	17.41281	13.98297	15.82318	15.99485	15.19665	11.79941	16.41321	0	0	0
P51532	SMCA4_HUMAN	"Transcription activator BRG1, EC 3.6.4.- (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A, BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)"	SMARCA4 BAF190A BRG1 SNF2B SNF2L4	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]"	bBAF complex [GO:0140092]; chromatin [GO:0000785]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	"bBAF complex [GO:0140092]; chromatin [GO:0000785]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; helicase activity [GO:0004386]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]"	"androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; helicase activity [GO:0004386]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]"	GO:0000122; GO:0000776; GO:0000785; GO:0001188; GO:0001221; GO:0001650; GO:0002039; GO:0003407; GO:0003677; GO:0003713; GO:0003714; GO:0003723; GO:0004386; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008094; GO:0008284; GO:0016020; GO:0016363; GO:0016514; GO:0016586; GO:0016887; GO:0030071; GO:0030177; GO:0030308; GO:0030957; GO:0032991; GO:0043923; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050681; GO:0051091; GO:0060766; GO:0070182; GO:0070316; GO:0070577; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140658; GO:1901838; GO:1902459; GO:1902661; GO:1902895; GO:2000045; GO:2000781; GO:2000819	GKGGTK	10.57999992	0.654559851	0.654559851	0.13578109	547.3961835	15.34884	17.1312	16.63241	16.35367	16.38975	16.13679	16.36152	15.32678	16.54749	16.08618	16.67941	15.34028	17.11764	16.93012	16.16588	17.20557	16.16774	17.10238	16.20425	16.41616	16.82438	16.99118	18.50525	17.0458	17.67469	15.31288	17.39012	16.36291	16.78302	15.78451	17.84731	17.03113	17.12554	16.7859	15.78964	17.12421	17.70461	18.49506	17.3078	17.08506	16.83388	15.95566	17.57384	16.68002	17.40664	17.31799	17.4406	16.91256
P51553	IDH3G_HUMAN	"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)"	IDH3G	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]	ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0005962; GO:0005975; GO:0006099; GO:0006102; GO:0051287	HTVTMIPGDGIGPELMLHVK	10.89000034	1	1	0.704715535	2160.429636	0	0	0	0	0	0	0	0	0	0	20.38357	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P51580	TPMT_HUMAN	"Thiopurine S-methyltransferase, EC 2.1.1.67 (Thiopurine methyltransferase)"	TPMT	Homo sapiens (Human)	methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]	cytosol [GO:0005829]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic metabolic process [GO:0006805]	S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]	GO:0005829; GO:0006139; GO:0006805; GO:0008119; GO:0032259; GO:1904047	NQVLTLEEWQDK	10.53999996	1	1	0.491119446	1502.646687	0	0	0	0	0	0	16.27913	0	0	0	0	0	17.21939	0	0	0	0	0	0	0	19.45773	19.70907	0	0	0	0	0	0	0	20.25694	0	0	0	0	0	0	0	0	19.48217	0	0	0	0	0	0	0	0	0
P51589	CP2J2_HUMAN	"Cytochrome P450 2J2, EC 1.14.14.- (Albendazole monooxygenase (hydroxylating), EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming), EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase, EC 5.4.4.7)"	CYP2J2	Homo sapiens (Human)	epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid 5,6-epoxygenase activity [GO:0106301]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]"	"arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid 5,6-epoxygenase activity [GO:0106301]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]"	GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006631; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043231; GO:0043651; GO:0070062; GO:0071614; GO:0106255; GO:0106301	FTFRPPNNEK	26.38999939	1	1	0.44135767	1250.046821	0	18.72214	0	0	0	0	19.00081	17.05429	0	0	17.47438	0	0	0	0	0	16.86825	0	18.58604	0	0	21.00346	0	0	0	15.03525	17.81551	20.92517	0	0	17.0192	0	0	0	0	0	0	0	0	0	0	0	0	0	17.32294	17.88029	19.62883	0
P51608	MECP2_HUMAN	"Methyl-CpG-binding protein 2, MeCp-2 protein, MeCp2"	MECP2	Homo sapiens (Human)	"adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; cardiolipin metabolic process [GO:0032048]; cellular biogenic amine metabolic process [GO:0006576]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin assembly [GO:0031507]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]"	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]	"centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; cardiolipin metabolic process [GO:0032048]; cellular biogenic amine metabolic process [GO:0006576]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin assembly [GO:0031507]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; ventricular system development [GO:0021591]; visual learning [GO:0008542]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000792; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003714; GO:0003723; GO:0003729; GO:0005615; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006020; GO:0006349; GO:0006541; GO:0006576; GO:0007052; GO:0007416; GO:0007585; GO:0007616; GO:0008104; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009791; GO:0010385; GO:0010629; GO:0010971; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019904; GO:0021549; GO:0021591; GO:0031507; GO:0032048; GO:0035176; GO:0035197; GO:0042551; GO:0043524; GO:0043537; GO:0045892; GO:0045944; GO:0046470; GO:0047485; GO:0051151; GO:0051707; GO:0060079; GO:0060291; GO:0090063; GO:0098794; GO:1900114; GO:1905643; GO:1990841; GO:2000820	MVAGMLGLR	12.60000038	1	1	0.201721008	946.9951122	11.53055	15.99174	16.16466	0	19.71838	0	17.52515	17.17419	15.92273	13.41762	16.2688	15.25315	16.45209	0	0	0	0	16.82417	0	14.88164	17.14709	0	15.85256	0	17.47803	0	0	15.02317	14.60626	15.33303	0	18.21982	17.91936	17.48818	16.25765	0	0	17.11568	0	0	0	0	16.37403	0	16.99258	16.81023	15.77034	0
P51610	HCFC1_HUMAN	"Host cell factor 1, HCF, HCF-1 (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6 ]"	HCFC1 HCF1 HFC1	Homo sapiens (Human)	"cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"	cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]	"cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]"	cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000123; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0007049; GO:0010628; GO:0016020; GO:0019046; GO:0030674; GO:0032991; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0044665; GO:0045296; GO:0045787; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0051568; GO:0051571; GO:0071339; GO:0140297	SSVGAGEPR	13	0.719359756	0.719359756	0.354038439	860.9471597	15.53941	0	0	16.40024	0	0	0	0	16.0166	0	15.18602	15.58764	17.23277	0	15.76532	16.42381	15.9422	13.57107	0	15.00798	0	0	17.14623	0	0	16.44686	0	16.97189	0	0	0	15.681	16.24669	0	15.88242	0	13.95607	18.30487	0	13.78615	0	0	0	16.92459	0	0	0	0
P51649	SSDH_HUMAN	"Succinate-semialdehyde dehydrogenase, mitochondrial, EC 1.2.1.24 (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)"	ALDH5A1 SSADH	Homo sapiens (Human)	central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]	identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]	GO:0004777; GO:0005739; GO:0005759; GO:0006105; GO:0006536; GO:0007417; GO:0009450; GO:0009791; GO:0042135; GO:0042802	QPIGVAAVITPWNFPSAMITRK	3.849999905	1	1	0.605902685	2412.455193	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P51654	GPC3_HUMAN	Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Glypican-3 alpha subunit; Glypican-3 beta subunit ]	GPC3 OCI5	Homo sapiens (Human)	"anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in kidney development [GO:0072111]; cell proliferation involved in metanephros development [GO:0072203]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of peptidase activity [GO:0010466]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]"	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]	"anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; peptidyl-dipeptidase inhibitor activity [GO:0060422]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in kidney development [GO:0072111]; cell proliferation involved in metanephros development [GO:0072203]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of peptidase activity [GO:0010466]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]"	peptidyl-dipeptidase inhibitor activity [GO:0060422]	GO:0001658; GO:0005788; GO:0005796; GO:0005886; GO:0009617; GO:0009653; GO:0009948; GO:0009986; GO:0010171; GO:0010466; GO:0016477; GO:0030282; GO:0030316; GO:0030324; GO:0030513; GO:0031226; GO:0035116; GO:0042074; GO:0043202; GO:0045732; GO:0045807; GO:0045879; GO:0045880; GO:0045926; GO:0046326; GO:0046658; GO:0050680; GO:0060422; GO:0060828; GO:0060976; GO:0062023; GO:0072111; GO:0072138; GO:0072180; GO:0072203; GO:0090090; GO:0090263; GO:1905475; GO:2000050; GO:2000096	DLKVFGNFPK	1.940000057	1	1	0.323679495	1163.439486	16.28312	0	0	0	15.83864	16.1032	0	0	0	0	0	16.17126	0	16.07324	0	0	0	0	15.77987	0	0	0	0	0	0	0	15.72918	14.26748	0	16.1202	16.09178	15.64504	0	16.49375	0	0	0	16.21052	14.83372	0	15.02696	16.44524	11.05288	15.51773	0	0	0	16.86902
P51659	DHB4_HUMAN	"Peroxisomal multifunctional enzyme type 2, MFE-2 (17-beta-hydroxysteroid dehydrogenase 4, 17-beta-HSD 4) (D-bifunctional protein, DBP) (Multifunctional protein 2, MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.n12; Enoyl-CoA hydratase 2, EC 4.2.1.107, EC 4.2.1.119 (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase) ]"	HSD17B4 EDH17B4 SDR8C1	Homo sapiens (Human)	androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	"cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]"	"(3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]"	GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386	VVLVTGAGAGLGR	4.190000057	1	1	0.202803767	1170.09391	0	0	15.84156	0	0	0	0	0	0	0	16.91687	0	0	16.23018	0	0	15.95583	0	0	0	0	0	0	0	0	0	15.74541	0	16.19139	0	17.11707	0	17.13552	17.66329	17.9207	17.9403	17.15279	0	0	0	15.39485	16.5505	0	16.35875	0	0	0	0
P51665	PSMD7_HUMAN	26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40)	PSMD7 MOV34L	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; protein homodimerization activity [GO:0042803]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	protein homodimerization activity [GO:0042803]	GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813	GLNSKLLDIR	3.269999981	0.648185432	0.648185432	0.139980898	1129.587392	0	0	0	0	0	0	0	13.29287	14.59235	0	0	0	0	0	15.03641	0	0	0	0	0	0	0	0	0	14.63183	16.79865	0	0	0	0	0	0	0	0	0	0	16.4852	0	0	0	0	0	0	0	15.39137	0	0	0
P51671	CCL11_HUMAN	Eotaxin (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11)	CCL11 SCYA11	Homo sapiens (Human)	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; learning or memory [GO:0007611]; lymphocyte chemotaxis [GO:0048247]; mammary duct terminal end bud growth [GO:0060763]; modulation of age-related behavioral decline [GO:0090647]; monocyte chemotaxis [GO:0002548]; negative regulation of neurogenesis [GO:0050768]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; response to radiation [GO:0009314]; response to virus [GO:0009615]; signal transduction [GO:0007165]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; protein dimerization activity [GO:0046983]; receptor ligand activity [GO:0048018]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; learning or memory [GO:0007611]; lymphocyte chemotaxis [GO:0048247]; mammary duct terminal end bud growth [GO:0060763]; modulation of age-related behavioral decline [GO:0090647]; monocyte chemotaxis [GO:0002548]; negative regulation of neurogenesis [GO:0050768]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; response to radiation [GO:0009314]; response to virus [GO:0009615]; signal transduction [GO:0007165]	CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; protein dimerization activity [GO:0046983]; receptor ligand activity [GO:0048018]	GO:0001938; GO:0002548; GO:0005576; GO:0005615; GO:0006468; GO:0006874; GO:0006935; GO:0006954; GO:0007010; GO:0007155; GO:0007165; GO:0007186; GO:0007611; GO:0008009; GO:0008360; GO:0009314; GO:0009615; GO:0030335; GO:0030593; GO:0030838; GO:0031640; GO:0031728; GO:0043547; GO:0045766; GO:0046983; GO:0048018; GO:0048020; GO:0048245; GO:0048247; GO:0050768; GO:0060444; GO:0060763; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0090647	SPTPKP	4.480000019	1	1	0.077141393	625.9878798	15.39811	14.22756	0	14.31053	0	14.50822	13.72292	0	12.79469	0	14.70897	0	0	0	13.1495	15.67753	0	0	0	0	0	0	15.89337	0	0	16.7399	16.01143	0	15.17855	16.32798	0	0	0	0	0	0	0	0	0	0	0	0	16.93856	0	0	0	15.35571	0
P51689	ARSD_HUMAN	"Arylsulfatase D, ASD, EC 3.1.6.-"	ARSD	Homo sapiens (Human)		endoplasmic reticulum lumen [GO:0005788]; lysosome [GO:0005764]	endoplasmic reticulum lumen [GO:0005788]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005764; GO:0005788; GO:0046872	TASLMLK	6.480000019	1	1	0.262429787	763.3043258	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.9381	0	0	0	0	17.74885	0	19.29838	17.07037	0	0	0	0	0	0	0	0	16.41504	0	0	0	0	0	0	0	18.19669	0	0	0	17.47948
P51692	STA5B_HUMAN	Signal transducer and activator of transcription 5B	STAT5B	Homo sapiens (Human)	cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001553; GO:0001779; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033077; GO:0035259; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042448; GO:0042802; GO:0042803; GO:0043029; GO:0043066; GO:0043434; GO:0045579; GO:0045588; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0090575; GO:0097531	EANNGSSPAGSLADAMSQK	2.460000038	1	1	0.261753344	1835.544569	0	15.84951	13.98707	15.72912	14.81636	13.65036	15.65557	0	9.172726	14.52737	14.07296	13.24494	0	0	13.25796	8.520136	0	0	0	0	0	18.61188	0	0	0	0	0	0	15.04123	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.69163	15.72688
P51693	APLP1_HUMAN	"Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1, APLP, APLP-1) [Cleaved into: C30 ]"	APLP1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399]	basement membrane [GO:0005604]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	basement membrane [GO:0005604]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; alpha-2A adrenergic receptor binding [GO:0031694]; alpha-2B adrenergic receptor binding [GO:0031695]; alpha-2C adrenergic receptor binding [GO:0031696]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399]	alpha-2A adrenergic receptor binding [GO:0031694]; alpha-2B adrenergic receptor binding [GO:0031695]; alpha-2C adrenergic receptor binding [GO:0031696]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]	GO:0005604; GO:0005654; GO:0005794; GO:0005886; GO:0006897; GO:0006915; GO:0007155; GO:0007399; GO:0007409; GO:0007417; GO:0008201; GO:0009887; GO:0016021; GO:0030198; GO:0030900; GO:0031694; GO:0031695; GO:0031696; GO:0042802; GO:0046914; GO:0048471; GO:0071874; GO:0106072	GPASPAARGLSR	5.360000134	1	1	0.192831803	1142.134435	16.16857	16.13287	14.20412	0	0	0	0	14.29669	15.2795	0	10.92595	13.57339	0	0	0	14.16182	0	13.68908	0	14.38106	16.24194	0	0	0	14.6983	0	16.82504	13.42965	0	0	0	0	16.31662	0	15.58188	0	13.37336	0	0	16.48057	15.77191	0	0	0	0	0	0	0
P51786	ZN157_HUMAN	Zinc finger protein 157 (Zinc finger protein HZF22)	ZNF157	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	KAFHEK	16.85000038	1	1	0.195236796	759.8634089	0	0	10.57609	0	0	0	0	0	0	0	14.02553	0	13.98423	14.99434	0	16.0269	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P51788	CLCN2_HUMAN	"Chloride channel protein 2, ClC-2"	CLCN2	Homo sapiens (Human)	cell differentiation involved in salivary gland development [GO:0060689]; chloride transport [GO:0006821]; lung development [GO:0030324]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of ion transmembrane transport [GO:0034765]; retina development in camera-type eye [GO:0060041]	chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated chloride channel activity [GO:0005247]; cell differentiation involved in salivary gland development [GO:0060689]; chloride transport [GO:0006821]; lung development [GO:0030324]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of ion transmembrane transport [GO:0034765]; retina development in camera-type eye [GO:0060041]	voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0030324; GO:0030425; GO:0032347; GO:0034707; GO:0034765; GO:0043204; GO:0060041; GO:0060689	HQQYRVR	14.73999977	0.235560209	0.235560209	0.142167342	987.3499289	13.05419	7.274232	16.17768	16.14162	15.47805	15.95321	12.32564	16.62247	0	13.9401	0	15.69015	10.91738	14.79442	16.06095	15.06328	16.1687	15.82453	12.18155	16.27616	15.72149	16.94924	18.16889	16.37837	11.55924	15.94258	17.1862	16.00388	0	13.9403	16.80502	17.24745	16.95637	0	7.800774	16.5622	16.69738	16.16128	18.17344	12.40465	0	0	10.01772	13.1844	0	15.6989	0	13.68165
P51797	CLCN6_HUMAN	"H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6, ClC-6) (Chloride transport protein 6)"	CLCN6 KIAA0046	Homo sapiens (Human)	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005524; GO:0005765; GO:0006821; GO:0006884; GO:0007165; GO:0009612; GO:0010008; GO:0015108; GO:0015297; GO:0016021; GO:0034220; GO:0043231	ASDIMEPNLTYVYPHTR	1.570000052	1	1	0.292671818	2011.517471	14.0786	0	0	0	14.71715	0	11.01034	0	0	0	15.12019	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.21428	0	0	0	0	0	16.74743	0	0	0	0	15.93445	0	0
P51798	CLCN7_HUMAN	"H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7, ClC-7)"	CLCN7	Homo sapiens (Human)	response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321]	chloride channel complex [GO:0034707]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	chloride channel complex [GO:0034707]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247]; response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321]	antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0030321; GO:0031410; GO:0034707; GO:0043231	GNIDKFTEK	4.949999809	0.673665226	0.673665226	0.240549057	1052.134366	15.68237	0	15.12658	0	15.76489	0	15.50539	11.81684	0	0	15.3281	12.24069	0	13.97427	0	16.10498	15.21087	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P51800	CLCKA_HUMAN	"Chloride channel protein ClC-Ka, Chloride channel Ka (ClC-K1)"	CLCNKA	Homo sapiens (Human)	chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]; transepithelial chloride transport [GO:0030321]	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]; transepithelial chloride transport [GO:0030321]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; voltage-gated chloride channel activity [GO:0005247]	GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0030321; GO:0034707; GO:0034765; GO:0042802; GO:0046872; GO:0070293	AVGCVSWVEMK	1.460000038	0.932888985	0.932888985	0.259690733	1286.278683	14.80743	0	12.97865	0	0	0	0	0	0	0	15.23802	13.14658	0	0	0	16.02841	0	0	0	0	0	0	13.08358	0	14.60558	0	18.09586	0	15.84383	0	15.59939	0	15.45679	0	0	15.45617	0	17.07649	0	15.57303	16.29667	0	0	0	0	0	0	0
P51805	PLXA3_HUMAN	Plexin-A3 (Plexin-4) (Semaphorin receptor SEX)	PLXNA3 PLXN4 SEX	Homo sapiens (Human)	axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; trigeminal nerve structural organization [GO:0021637]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; trigeminal nerve structural organization [GO:0021637]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008360; GO:0017154; GO:0021612; GO:0021637; GO:0021766; GO:0021785; GO:0021860; GO:0030334; GO:0043087; GO:0048843; GO:0050772; GO:0050919; GO:0051495; GO:0071526; GO:0097485; GO:1902287; GO:1990138	AHVTGPVEDNARCYPPPSMR	5.46999979	1	1	0.122198286	2254.282428	0	13.06569	13.18266	0	0	0	0	0	14.59235	0	12.70889	0	0	0	0	0	0	14.07639	0	0	0	0	0	16.88931	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.67366	0	0	0
P51810	GP143_HUMAN	G-protein coupled receptor 143 (Ocular albinism type 1 protein)	GPR143 OA1	Homo sapiens (Human)	calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601]	dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545]	GO:0004930; GO:0005737; GO:0005765; GO:0005794; GO:0005886; GO:0006726; GO:0007165; GO:0007186; GO:0007601; GO:0016020; GO:0016021; GO:0016324; GO:0032400; GO:0032402; GO:0032438; GO:0033162; GO:0035240; GO:0035584; GO:0035643; GO:0042470; GO:0048015; GO:0050848; GO:0072544; GO:0072545; GO:1902908; GO:1903056	ILRAAAACDLLGCLGMVIR	14.93999958	0.272873402	0.272873402	0.094211761	2083.67419	12.72162	0	9.970794	12.46461	0	14.46504	0	0	14.32318	11.86138	0	17.20021	17.52757	15.10854	18.60382	13.22065	0	13.65306	19.43191	16.93025	0	16.38791	15.36761	12.53341	0	16.23414	18.36036	16.40014	18.02353	0	18.24474	0	0	14.91053	0	16.15006	17.33826	17.51439	18.89943	0	0	0	0	0	19.08181	17.42925	18.28277	14.96238
P51811	XK_HUMAN	Endoplasmic reticulum membrane adapter protein XK (Kell complex 37 kDa component) (Kx antigen) (Membrane transport protein XK) (XK-related protein 1)	XK XKR1 XRG1	Homo sapiens (Human)	amino acid transport [GO:0006865]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transporter activity [GO:0005215]; amino acid transport [GO:0006865]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741]	transporter activity [GO:0005215]	GO:0005215; GO:0005886; GO:0006865; GO:0006874; GO:0008361; GO:0010961; GO:0016021; GO:0031133; GO:0042552; GO:0048741	CNILAIK	4.269999981	1	1	0.022393491	831.9310466	15.49856	0	0	14.95778	0	14.54167	13.12672	15.56313	12.71519	0	0	0	0	14.59012	13.68027	0	0	14.89643	0	0	0	15.4541	14.44106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.25957	0	0	0	0	0
P51812	KS6A3_HUMAN	"Ribosomal protein S6 kinase alpha-3, S6K-alpha-3, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 3, p90-RSK 3, p90RSK3) (Insulin-stimulated protein kinase 1, ISPK-1) (MAP kinase-activated protein kinase 1b, MAPK-activated protein kinase 1b, MAPKAP kinase 1b, MAPKAPK-1b) (Ribosomal S6 kinase 2, RSK-2) (pp90RSK2)"	RPS6KA3 ISPK1 MAPKAPK1B RSK2	Homo sapiens (Human)	cell cycle [GO:0007049]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007268; GO:0007417; GO:0018105; GO:0019901; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045202; GO:0045597; GO:0045944; GO:0106310	KISGSDAR	5.25	0.768581629	0.768581629	0.28222634	832.5347261	0	17.45096	0	17.39494	0	0	17.73546	17.47952	0	17.97895	18.24826	0	17.09489	0	0	0	16.50513	0	0	0	0	18.87429	17.12783	0	0	18.06152	18.62469	0	0	17.92089	18.97857	19.38813	18.03345	18.82253	17.7061	17.6666	18.70613	17.67262	0	16.05669	0	0	16.01063	0	0	18.60055	17.68831	0
P51814	ZNF41_HUMAN	Zinc finger protein 41	ZNF41	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	MHSGEKR	7.119999886	1	1	0.26873056	861.4625618	14.28188	0	16.92835	14.95737	0	0	16.40825	0	0	0	0	0	0	0	0	15.49546	16.42877	15.9703	15.93954	0	0	0	15.32768	0	0	0	0	0	15.2132	0	0	13.63201	15.94251	15.75701	0	0	17.11658	0	0	16.64554	0	0	0	16.41159	0	0	0	0
P51815	ZN75D_HUMAN	Zinc finger protein 75D (Zinc finger protein 75) (Zinc finger protein 82)	ZNF75D ZNF75 ZNF82	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270	NDTGNDHPISVSTSEIQTSGCEVSKK	6.980000019	0.86424005	0.86424005	3.20E-12	2790.850085	14.1048	15.14267	15.4668	0	0	0	13.62834	16.26116	0	0	0	0	0	11.59891	14.82592	13.55849	14.75681	14.49427	15.36009	0	15.10364	0	13.55938	0	15.48918	12.49333	14.31454	0	14.87335	13.20253	0	16.09238	0	13.376	15.96914	0	0	0	0	15.69958	15.64644	15.25962	0	0	0	0	0	15.61192
P51816	AFF2_HUMAN	"AF4/FMR2 family member 2 (Fragile X E mental retardation syndrome protein) (Fragile X mental retardation 2 protein, FMR2P, Protein FMR-2) (Protein Ox19)"	AFF2 FMR2 OX19	Homo sapiens (Human)	brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]	nuclear speck [GO:0016607]; G-quadruplex RNA binding [GO:0002151]; brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	G-quadruplex RNA binding [GO:0002151]	GO:0002151; GO:0006397; GO:0007420; GO:0007611; GO:0008380; GO:0010468; GO:0010629; GO:0016607; GO:0035063; GO:0043484	LAVLCYR	14.22000027	0.553734303	0.553734303	0.52148722	894.5620604	17.96896	0	0	0	0	0	0	0	18.83366	0	16.28478	18.82429	16.16402	0	0	0	0	0	0	0	17.26131	17.79355	0	0	0	17.19319	18.37988	0	0	0	0	0	17.71918	0	0	0	0	0	0	0	0	17.93195	0	0	0	0	0	0
P51817	PRKX_HUMAN	"cAMP-dependent protein kinase catalytic subunit PRKX, PrKX, Protein kinase X, Protein kinase X-linked, Serine/threonine-protein kinase PRKX, EC 2.7.11.1 (Protein kinase PKX1)"	PRKX PKX1	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001525; GO:0001935; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005952; GO:0007155; GO:0007165; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:0106310; GO:2000696	EAPGLAQAAAAESDSRK	1.210000038	1	1	0.616200538	1672.37503	0	0	0	0	17.36213	0	18.69303	0	0	0	0	0	0	17.40325	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.22271	17.87449	0	17.86676	0	0	0	0	0	0
P51825	AFF1_HUMAN	"AF4/FMR2 family member 1 (ALL1-fused gene from chromosome 4 protein, Protein AF-4) (Protein FEL) (Proto-oncogene AF4)"	AFF1 AF4 FEL MLLT2 PBM1	Homo sapiens (Human)	regulation of gene expression [GO:0010468]	super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]	super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; regulation of gene expression [GO:0010468]		GO:0008023; GO:0010468; GO:0032783	AAQSSLYNDDR	3.680000067	1	1	0.107675353	1240.692224	12.62517	14.30736	0	14.82135	0	14.32749	10.29907	13.82851	0	13.53726	0	0	13.67732	12.93354	0	0	0	11.74841	15.30677	0	0	0	0	0	10.99791	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P51841	GUC2F_HUMAN	"Retinal guanylyl cyclase 2, RETGC-2, EC 4.6.1.2 (Guanylate cyclase 2F, retinal) (Guanylate cyclase F, GC-F) (Rod outer segment membrane guanylate cyclase 2, ROS-GC2)"	GUCY2F GUC2F RETGC2	Homo sapiens (Human)	cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601]	integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]	integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]	GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005640; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0019934; GO:0022400; GO:0038023; GO:0042802; GO:0044877; GO:0050908; GO:0097381; GO:0120200	IRIGLHSGPVVAGVVGLTMPR	5.789999962	0.290212572	0.290212572	0.270964175	2128.501934	14.19888	0	15.01422	13.69963	13.17293	0	0	8.987993	0	0	0	0	13.12589	0	14.04263	0	12.24976	0	14.05837	0	16.10458	0	16.23515	0	0	11.08754	0	0	12.3924	0	0	0	13.99189	0	0	14.37583	15.13718	0	0	13.86322	0	0	16.5775	0	0	0	0	0
P51946	CCNH_HUMAN	Cyclin-H (MO15-associated protein) (p34) (p37)	CCNH	Homo sapiens (Human)	cell cycle [GO:0007049]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]	CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle [GO:0007049]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000439; GO:0005634; GO:0005654; GO:0005675; GO:0006357; GO:0006366; GO:0006367; GO:0007049; GO:0016538; GO:0019907; GO:0050821; GO:0070516; GO:0070816; GO:0070985; GO:2000045	AVANGKVLPNDPVFLEPHEEMTLCK	2.339999914	1	1	9.14E-13	2824.723791	0	16.11746	13.0628	0	0	15.36046	0	16.36017	0	0	0	15.86947	15.00002	12.5492	0	0	12.97615	0	14.00183	13.6078	15.70252	0	13.97268	12.94753	0	0	15.28712	0	0	14.72992	0	0	14.97455	14.93518	0	0	16.91157	14.81731	0	13.56881	0	14.69109	0	15.10849	0	0	0	15.51965
P51959	CCNG1_HUMAN	"Cyclin-G1, Cyclin-G"	CCNG1 CCNG CYCG1	Homo sapiens (Human)	brain development [GO:0007420]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to organonitrogen compound [GO:0010243]; syncytium formation [GO:0006949]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; brain development [GO:0007420]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to organonitrogen compound [GO:0010243]; syncytium formation [GO:0006949]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0005634; GO:0005654; GO:0005737; GO:0006949; GO:0007095; GO:0007420; GO:0010243; GO:0016538; GO:0030425; GO:0043025; GO:0043066; GO:0044772; GO:0048471; GO:0051301	CSKPNVQK	6.690000057	1	1	0.132784097	959.5842616	0	14.96427	14.40705	14.16507	14.08977	0	12.60882	15.51074	15.50885	16.64237	0	11.26091	12.19411	11.19648	13.00898	0	0	0	0	13.05966	0	14.69472	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P52179	MYOM1_HUMAN	Myomesin-1 (190 kDa connectin-associated protein) (190 kDa titin-associated protein) (Myomesin family member 1)	MYOM1	Homo sapiens (Human)	muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]	M band [GO:0031430]; striated muscle myosin thick filament [GO:0005863]	M band [GO:0031430]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]	actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]	GO:0005863; GO:0006936; GO:0008307; GO:0010628; GO:0010737; GO:0019900; GO:0031430; GO:0042802; GO:0042803; GO:0050714; GO:0051015	DVRSTVSHYQR	9.199999809	1	1	0.356052034	1348.138063	15.78597	13.87451	15.72514	13.38334	14.85265	13.95163	0	14.26541	15.57468	0	12.55668	13.62263	0	15.01333	15.79966	16.04798	0	15.26812	15.79942	17.75702	15.20491	16.2808	0	0	0	0	0	16.31342	0	0	0	0	15.82594	16.5656	16.55328	0	17.14677	18.20529	0	15.37916	18.4738	16.15379	0	0	16.61391	17.23297	0	16.04733
P52198	RND2_HUMAN	Rho-related GTP-binding protein RhoN (Rho family GTPase 2) (Rho-related GTP-binding protein Rho7) (Rnd2)	RND2 ARHN RHO7	Homo sapiens (Human)	actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of collateral sprouting [GO:0048672]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]	acrosomal membrane [GO:0002080]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; plasma membrane [GO:0005886]	acrosomal membrane [GO:0002080]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of collateral sprouting [GO:0048672]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]	GO:0002080; GO:0003924; GO:0005525; GO:0005769; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0047485; GO:0048672	GNEGEIHK	8.920000076	1	1	0.482476905	885.0992674	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.1191	0	0	0	0
P52272	HNRPM_HUMAN	"Heterogeneous nuclear ribonucleoprotein M, hnRNP M"	HNRNPM HNRPM NAGR1	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"	catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	"catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]"	mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]	GO:0000380; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0016020; GO:0016363; GO:0019904; GO:0042382; GO:0062023; GO:0070062; GO:0071013; GO:0071014; GO:1990904; GO:2000815	ACRMMNGMK	5.489999771	1	1	0.156864243	1114.26277	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.98625	0	0	0	0	0
P52292	IMA1_HUMAN	Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha)	KPNA2 RCH1 SRP1	Homo sapiens (Human)	DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018]	histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]	GO:0000018; GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0042564; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902	GKDSTEMR	15.53999996	1	1	0.068144716	939.1262855	0	0	0	14.58157	0	0	0	0	0	15.70836	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.39484	0	0	0	0	0	14.75866	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.78169	15.29937	0
P52294	IMA5_HUMAN	"Importin subunit alpha-5 (Karyopherin subunit alpha-1) (Nucleoprotein interactor 1, NPI-1) (RAG cohort protein 2) (SRP1-beta) [Cleaved into: Importin subunit alpha-5, N-terminally processed ]"	KPNA1 RCH2	Homo sapiens (Human)	NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of apoptotic process [GO:0042981]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA recombination [GO:0000018]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell proliferation [GO:0014841]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of apoptotic process [GO:0042981]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA recombination [GO:0000018]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell proliferation [GO:0014841]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]	GO:0000018; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006607; GO:0008139; GO:0014069; GO:0014841; GO:0014901; GO:0030425; GO:0042564; GO:0042981; GO:0060828; GO:0061608; GO:0098978; GO:0099527	SPPPEFAK	1.230000019	0.788121283	0.788121283	0.218725335	873.082874	13.9273	14.22867	15.11069	0	0	15.26185	0	0	16.69286	15.47793	0	0	0	0	0	13.58099	16.52186	16.38421	0	0	0	0	14.76222	16.99361	16.45681	0	0	17.02582	0	0	16.06884	0	15.48003	0	0	17.12616	15.17739	0	16.66483	0	14.05129	13.95738	12.36941	15.33631	16.50147	17.16408	0	15.6179
P52298	NCBP2_HUMAN	"Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (Cell proliferation-inducing gene 55 protein) (NCBP 20 kDa subunit, CBP20) (NCBP-interacting protein 1, NIP1)"	NCBP2 CBP20 PIG55	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; gene silencing by miRNA [GO:0035195]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901409]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of translational initiation [GO:0006446]; RNA interference [GO:0016246]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; snRNA binding [GO:0017069]; alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; gene silencing by miRNA [GO:0035195]; histone mRNA metabolic process [GO:0008334]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901409]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of translational initiation [GO:0006446]; RNA interference [GO:0016246]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]"	mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; snRNA binding [GO:0017069]	GO:0000184; GO:0000339; GO:0000340; GO:0000380; GO:0000398; GO:0002191; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005845; GO:0005846; GO:0006406; GO:0006408; GO:0006446; GO:0008334; GO:0008380; GO:0016246; GO:0017069; GO:0031053; GO:0031124; GO:0031442; GO:0032968; GO:0034518; GO:0035195; GO:0042789; GO:0045292; GO:0046833; GO:0098789; GO:1901409	GRSGGQVR	1.649999976	1	1	0.021030766	817.6218616	15.43343	14.65613	0	0	13.35225	14.03688	13.40714	14.50024	0	0	15.41436	0	12.09653	13.57433	0	0	0	9.652579	0	0	0	16.08026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P52306	GDS1_HUMAN	Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein)	RAP1GDS1 SMGGDS	Homo sapiens (Human)	myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; vascular associated smooth muscle contraction [GO:0014829]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; vascular associated smooth muscle contraction [GO:0014829]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005739; GO:0005783; GO:0005829; GO:0014829; GO:0031034; GO:0032471; GO:0043547; GO:0051561; GO:0070062	SKDVIK	2.839999914	0.778034627	0.778034627	0.226666743	688.2609777	14.95733	14.43102	14.99213	14.71123	0	0	0	15.88626	0	0	0	0	0	13.71472	0	0	15.89365	14.45849	16.14317	16.1932	0	0	0	0	0	0	0	0	0	0	15.14738	16.11605	0	13.96091	16.73218	16.71215	0	0	0	17.27376	0	0	17.42437	15.81201	14.9479	17.66052	15.10441	16.47554
P52333	JAK3_HUMAN	"Tyrosine-protein kinase JAK3, EC 2.7.10.2 (Janus kinase 3, JAK-3) (Leukocyte janus kinase, L-JAK)"	JAK3	Homo sapiens (Human)	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; innate immune response [GO:0045087]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; intracellular signal transduction [GO:0035556]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL production [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; innate immune response [GO:0045087]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; intracellular signal transduction [GO:0035556]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL production [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0002250; GO:0002731; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0007167; GO:0007204; GO:0007260; GO:0018108; GO:0019221; GO:0019903; GO:0030183; GO:0030218; GO:0032693; GO:0032695; GO:0035556; GO:0035771; GO:0038110; GO:0042102; GO:0042104; GO:0042981; GO:0043029; GO:0045087; GO:0045221; GO:0045626; GO:0046425; GO:0050868; GO:0051770; GO:0051928; GO:0060397; GO:0070232; GO:0070244; GO:0070669; GO:0070670; GO:0070672; GO:0071104	LPAPPACPAEVHELMK	3.369999886	1	1	9.21E-13	1776.027886	13.97643	0	0	0	13.77048	0	0	0	0	0	15.85203	11.44245	15.60352	16.14586	0	0	0	0	15.62985	14.77367	0	0	0	0	0	0	0	0	0	16.0756	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P52429	DGKE_HUMAN	"Diacylglycerol kinase epsilon, DAG kinase epsilon, EC 2.7.1.107 (Diglyceride kinase epsilon, DGK-epsilon)"	DGKE DAGK5	Homo sapiens (Human)	diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0006661; GO:0007205; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046834; GO:0046872; GO:0050804; GO:0098978	CDFGEFK	3.200000048	0.249682739	0.249682739	0.173378855	903.4571138	14.77048	0	15.14981	0	0	13.62088	11.35868	15.7333	0	0	0	15.46684	15.00949	14.5409	14.66316	0	0	0	0	15.25749	0	0	16.11943	16.43972	0	0	15.88744	15.35054	0	15.06352	0	15.22815	16.54196	15.09452	0	0	16.45242	16.78922	15.63536	0	15.89655	16.00552	0	0	0	0	0	0
P52564	MP2K6_HUMAN	"Dual specificity mitogen-activated protein kinase kinase 6, MAP kinase kinase 6, MAPKK 6, EC 2.7.12.2 (MAPK/ERK kinase 6, MEK 6) (Stress-activated protein kinase kinase 3, SAPK kinase 3, SAPKK-3, SAPKK3)"	MAP2K6 MEK6 MKK6 PRKMK6 SKK3	Homo sapiens (Human)	apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; DNA damage induced protein phosphorylation [GO:0006975]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; osteoblast differentiation [GO:0001649]; ovulation cycle process [GO:0022602]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; phosphatase activator activity [GO:0019211]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; DNA damage induced protein phosphorylation [GO:0006975]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; osteoblast differentiation [GO:0001649]; ovulation cycle process [GO:0022602]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; phosphatase activator activity [GO:0019211]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]	GO:0000165; GO:0001649; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006915; GO:0006975; GO:0007165; GO:0009410; GO:0019211; GO:0019901; GO:0022602; GO:0032308; GO:0038066; GO:0042802; GO:0043065; GO:0043406; GO:0043539; GO:0051403; GO:0051726; GO:0051770; GO:0060048; GO:0060348; GO:0070423; GO:0072709; GO:0090398; GO:0106310; GO:0120163; GO:1901796	ERPTYPELMQHPFFTLHESK	21.46999931	1	1	0.298045234	2486.609263	13.89782	13.93018	10.79714	0	17.51942	16.31498	0	0	0	0	15.38534	11.63026	0	0	0	14.3598	14.58913	0	13.30096	0	0	0	15.36402	13.83733	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.4004	15.96819	13.5807	0	0	0	0	14.63304	0
P52565	GDIR1_HUMAN	"Rho GDP-dissociation inhibitor 1, Rho GDI 1 (Rho-GDI alpha)"	ARHGDIA GDIA1	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526]	GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094]	GO:0001772; GO:0005094; GO:0005096; GO:0005634; GO:0005829; GO:0005856; GO:0007162; GO:0007266; GO:0016020; GO:0032880; GO:0035023; GO:0043066; GO:0070062; GO:0071526; GO:2000249	EIVSGMK	15.07999992	0.428972721	0.428972721	0.196252878	762.5349322	18.49399	17.85013	0	17.61083	18.01243	16.7911	0	17.66859	15.64754	20.07211	16.50297	16.75486	17.48661	19.6442	0	16.23365	16.89806	17.07257	16.89891	0	15.00252	18.48297	16.53064	16.97302	15.66851	18.00795	17.26521	13.43054	15.96809	18.07042	15.54196	20.21898	15.50424	18.80619	17.56952	17.26583	18.20539	17.44119	19.3614	18.89957	18.01885	15.72673	16.30449	18.11963	15.71569	13.29104	15.3601	17.37235
P52569	CTR2_HUMAN	"Cationic amino acid transporter 2, CAT-2, CAT2 (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)"	SLC7A2 ATRC2 CAT2	Homo sapiens (Human)	amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104]	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104]	amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]	GO:0000064; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352	HSLEGHLR	4.059999943	1	1	0.461931487	948.0164578	14.38623	0	0	0	0	17.80651	0	0	0	18.38986	0	18.34975	16.92827	17.28458	0	0	0	17.35807	0	15.29275	16.90046	0	17.5	0	0	0	0	0	16.0916	0	0	0	0	17.59559	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P52594	AGFG1_HUMAN	Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein)	AGFG1 HRB RAB RIP	Homo sapiens (Human)	cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; spermatogenesis [GO:0007283]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; spermatogenesis [GO:0007283]	DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005829; GO:0006406; GO:0007283; GO:0030154; GO:0031410; GO:0043231; GO:0046872	MAASAKR	3.869999886	0.303053617	0.303053617	7.98E-13	750.6206581	17.77005	15.46308	16.34896	10.99802	11.49881	0	0	0	15.10274	15.71587	16.10741	17.72859	12.50299	15.49329	0	11.43106	14.7213	0	14.50432	11.86784	15.56594	0	16.43765	14.51074	16.01392	17.49656	14.09845	16.23909	14.71389	13.94108	17.09905	18.56405	0	15.39019	0	14.87563	15.08943	0	16.87599	0	11.74167	0	13.14369	17.53622	13.35224	14.86901	17.38871	17.47723
P52597	HNRPF_HUMAN	"Heterogeneous nuclear ribonucleoprotein F, hnRNP F (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed ]"	HNRNPF HNRPF	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]"	RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0016020; GO:0043484; GO:0071013; GO:1990904	QSGEAFVELGSEDDVKMALK	1.559999943	0.664443314	0.664443314	0.138908157	2154.001959	14.19402	13.90304	14.6619	16.82177	13.66231	0	14.61661	0	0	0	0	0	0	0	0	12.91773	0	0	0	0	12.61336	14.8844	12.663	0	15.22867	11.98218	15.87737	0	0	15.77783	0	15.80453	0	0	0	0	0	0	0	0	14.98201	0	0	15.53488	13.77875	13.7986	0	14.04469
P52630	STAT2_HUMAN	Signal transducer and activator of transcription 2 (p113)	STAT2	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337]	chromatin [GO:0000785]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]"	GO:0000785; GO:0000978; GO:0000981; GO:0001932; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006952; GO:0007259; GO:0019221; GO:0042127; GO:0042802; GO:0043434; GO:0044389; GO:0045944; GO:0051607; GO:0060337; GO:0060339; GO:0070721; GO:0090140; GO:0090575	ILQETLNELDKR	4.840000153	0.642845392	0.642845392	0.258925187	1471.313501	15.83002	14.27888	14.13824	0	0	14.82796	14.91392	0	14.92548	0	12.58487	15.82961	17.82512	13.40067	13.24834	0	0	0	0	0	0	17.53033	0	0	15.79398	15.50721	16.82517	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.82635	0	0	0	0	0	12.8281
P52655	TF2AA_HUMAN	"Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit, TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit) ]"	GTF2A1 TF2A1	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025]	GO:0000979; GO:0001091; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0016251; GO:0017025; GO:0045944; GO:0046982; GO:0051123; GO:0060261; GO:0061629; GO:0097550	ANSANTNTVPK	4.059999943	1	1	0.110558258	1114.460588	10.9578	15.03908	12.71124	17.6647	12.69849	13.65479	0	0	0	0	0	0	0	0	0	0	14.49938	0	0	0	0	0	14.254	0	0	0	0	0	0	0	0	0	13.52237	0	0	0	0	0	0	0	0	0	0	14.88158	0	0	0	0
P52701	MSH6_HUMAN	"DNA mismatch repair protein Msh6, hMSH6 (G/T mismatch-binding protein, GTBP, GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit, p160)"	MSH6 GTBP	Homo sapiens (Human)	determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MutSalpha complex [GO:0032301]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MutSalpha complex [GO:0032301]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; spermatogenesis [GO:0007283]"	"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]"	GO:0000710; GO:0000785; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006298; GO:0007283; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032301; GO:0035064; GO:0043231; GO:0045190; GO:0045910; GO:0051096; GO:0097193	EVCLASER	9.470000267	0.361504257	0.361504257	0.118666266	961.1074392	0	0	0	14.31725	17.58903	0	15.4482	0	12.92381	0	0	0	0	0	0	0	0	0	0	0	0	17.9391	0	0	0	0	0	0	0	16.53594	16.67842	15.17126	0	0	0	0	0	0	0	0	0	0	0	0	16.0802	0	15.18141	0
P52732	KIF11_HUMAN	"Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5, TR-interacting protein 5, TRIP-5)"	KIF11 EG5 KNSL1 TRIP5	Homo sapiens (Human)	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle organization [GO:0007051]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle organization [GO:0007051]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007051; GO:0007052; GO:0007100; GO:0008017; GO:0008574; GO:0016020; GO:0019901; GO:0032991; GO:0046602; GO:0051301; GO:0072686; GO:0090307	DGSSK	2.279999971	1	1	0.098390231	490.6684157	14.23647	14.84312	0	15.47143	0	15.5922	14.41978	0	0	14.52877	14.74673	0	0	0	0	0	0	13.94396	0	0	0	0	0	14.41159	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P52735	VAV2_HUMAN	"Guanine nucleotide exchange factor VAV2, VAV-2"	VAV2	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell migration [GO:0016477]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]	GO:0001525; GO:0001784; GO:0005085; GO:0005154; GO:0005829; GO:0005886; GO:0007165; GO:0007264; GO:0008361; GO:0016477; GO:0030032; GO:0030168; GO:0038095; GO:0038096; GO:0043087; GO:0043552; GO:0046872; GO:0048010; GO:0051056	MGMTEDDK	4.519999981	0.05974362	0.05974362	0.307075014	942.9298451	0	14.82452	13.30697	15.66693	16.19909	14.03135	0	0	13.84328	15.37375	0	0	14.70495	15.44869	0	0	0	0	0	14.36981	0	16.51382	15.69895	14.99248	0	0	0	0	15.1342	0	0	16.64103	0	15.20233	0	0	0	0	0	0	14.52054	0	0	0	0	0	15.22149	0
P52737	ZN136_HUMAN	Zinc finger protein 136	ZNF136	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	DQNIKDHYK	6.440000057	0.259810984	0.259810984	0.011349261	1160.130395	10.34847	15.13797	13.01401	0	0	0	13.47999	0	16.3953	0	14.06628	14.87446	0	19.25463	13.5155	13.75334	0	0	17.76147	17.6111	16.62435	16.49043	17.9059	0	8.937066	15.64651	17.06167	16.64012	13.92924	15.64944	11.01807	14.45768	13.74753	0	14.97595	15.61487	15.17143	15.17648	13.52091	13.38287	15.9272	0	15.76674	16.32095	15.55609	0	0	13.04188
P52739	ZN131_HUMAN	Zinc finger protein 131	ZNF131	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]	"intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0045111; GO:0046872	HLIEFTYTAKLMIQGEEEANDVWK	2.289999962	1	1	0.185054741	2881.337943	15.50954	12.28498	9.98414	10.64358	16.69535	12.48581	12.80824	0	0	0	15.91176	15.97418	12.31653	0	0	0	0	0	0	13.66466	14.05122	0	0	0	16.53975	0	14.73716	0	16.20208	0	0	0	0	0	16.23214	0	0	17.14613	0	0	0	0	0	12.63534	0	0	14.35782	15.17167
P52740	ZN132_HUMAN	Zinc finger protein 132	ZNF132	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	DALMKSSK	1.019999981	1	1	0.114371493	896.2648574	14.93915	14.27732	0	0	0	12.92535	13.41118	14.76966	13.82904	0	0	14.53759	0	13.52667	0	0	16.9822	0	15.02234	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P52741	ZN134_HUMAN	Zinc finger protein 134	ZNF134	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872	VHNGARPYKCSDCGK	2.819999933	1	1	0.135462644	1749.264733	16.04366	15.60069	0	14.46252	0	14.59925	15.80989	15.06615	14.69287	15.66671	12.5645	0	13.19135	0	15.74579	0	0	0	0	16.25356	0	0	15.91522	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P52746	ZN142_HUMAN	Zinc finger protein 142	ZNF142 KIAA0236	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AVDKGQGAQR	13.65999985	1	1	0.066660752	1025.751058	0	0	16.04016	15.91392	0	13.849	0	14.95638	0	0	0	0	0	0	14.6566	0	0	0	0	0	0	0	0	0	0	0	0	0	16.2638	0	0	0	0	0	0	0	0	0	0	14.87243	14.60584	0	0	0	0	0	0	0
P52747	ZN143_HUMAN	"Zinc finger protein 143 (SPH-binding factor) (Selenocysteine tRNA gene transcription-activating factor, hStaf)"	ZNF143 SBF STAF	Homo sapiens (Human)	"positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	"nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription, DNA-templated [GO:0006355]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005654; GO:0006355; GO:0006357; GO:0006359; GO:0045944; GO:0045945; GO:0046872; GO:0048661; GO:1905382	CPFEGCGR	9.329999924	1	1	0.017249203	981.4124547	16.1347	12.9218	11.97564	13.75437	13.14642	15.53393	15.12953	0	12.58852	0	15.59012	14.29078	0	0	0	12.41615	0	0	0	0	0	0	16.50709	0	0	14.35182	13.81894	0	0	11.0975	13.95403	16.69555	0	15.46143	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P52756	RBM5_HUMAN	RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9)	RBM5 H37 LUCA15	Homo sapiens (Human)	"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0006915; GO:0008285; GO:0043065; GO:0046872	ESAAADAGFALFEKK	15.22999954	0.755996644	0.755996644	0.239734795	1554.306889	14.93296	13.10366	16.01489	0	0	14.50068	17.09393	14.99381	0	0	0	13.23839	0	0	0	16.15666	15.11243	13.59758	12.01405	13.45957	12.25113	0	0	0	0	14.56917	0	14.02973	0	12.98817	16.52203	14.92798	16.16815	15.50407	0	15.57628	0	13.64173	0	15.81502	15.44716	13.55569	15.26959	0	0	0	0	15.46508
P52758	RIDA_HUMAN	"2-iminobutanoate/2-iminopropanoate deaminase, EC 3.5.99.10 (14.5 kDa translational inhibitor protein, hp14.5, p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog)"	RIDA HRSP12	Homo sapiens (Human)	brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; 2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; identical protein binding [GO:0042802]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]"	"2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; identical protein binding [GO:0042802]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]"	GO:0001822; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0006629; GO:0007420; GO:0016892; GO:0017148; GO:0019239; GO:0019518; GO:0030324; GO:0033993; GO:0036041; GO:0042802; GO:0046914; GO:0050680; GO:0061157; GO:0070062; GO:0070314; GO:0120242; GO:0120243; GO:1901565; GO:1902074	GSRIEIEAVAIQGPLTTASL	2.75999999	1	1	0.348226315	2027.866147	0	12.23272	12.67667	0	0	13.36324	15.66007	0	0	0	14.45254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.19754	0	0	0	0	0	0	0	0	0	0	0	0	0	14.62462	0	0	0
P52788	SPSY_HUMAN	"Spermine synthase, SPMSY, EC 2.5.1.22 (Spermidine aminopropyltransferase)"	SMS	Homo sapiens (Human)	methionine metabolic process [GO:0006555]; polyamine metabolic process [GO:0006595]; spermine biosynthetic process [GO:0006597]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; spermine synthase activity [GO:0016768]; methionine metabolic process [GO:0006555]; polyamine metabolic process [GO:0006595]; spermine biosynthetic process [GO:0006597]	spermine synthase activity [GO:0016768]	GO:0005829; GO:0006555; GO:0006595; GO:0006597; GO:0016768; GO:0070062	EDYTGK	5.659999847	1	1	0.247423439	714.3391575	0	16.531	16.03113	0	15.56508	0	0	16.34585	14.7935	0	16.24944	15.03032	0	0	0	0	0	0	0	0	15.61298	0	0	0	0	16.31805	16.17697	0	0	15.80484	0	17.31052	16.79478	16.13973	16.18275	17.14406	17.33923	16.81058	14.75386	15.45758	16.05102	16.34821	15.76624	16.28962	0	15.82617	17.11245	15.1252
P52789	HXK2_HUMAN	"Hexokinase-2, EC 2.7.1.1 (Hexokinase type II, HK II) (Hexokinase-B) (Muscle form hexokinase)"	HK2	Homo sapiens (Human)	apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]	centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]	centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]	GO:0001666; GO:0001678; GO:0002931; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0005886; GO:0006002; GO:0006096; GO:0007595; GO:0008637; GO:0008865; GO:0016020; GO:0016529; GO:0019158; GO:0035795; GO:0043231; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1904925; GO:1990830; GO:2000378	GLLFR	18.35000038	1	1	0.159398463	604.376079	12.7083	14.64927	14.83323	12.05239	14.47258	0	0	0	0	15.44219	12.64119	14.4995	0	0	0	0	16.28733	16.92588	17.9537	0	15.76992	0	16.11949	15.80458	0	0	0	0	0	0	0	15.36971	0	0	0	0	0	0	0	0	0	0	15.60831	14.84762	0	0	0	17.07228
P52790	HXK3_HUMAN	"Hexokinase-3, EC 2.7.1.1 (Hexokinase type III, HK III) (Hexokinase-C)"	HK3	Homo sapiens (Human)	canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; secretory granule lumen [GO:0034774]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005576; GO:0005739; GO:0005829; GO:0006002; GO:0006096; GO:0008865; GO:0019158; GO:0034774; GO:0051156; GO:0061621; GO:1904813	AMAKGLR	4.929999828	0.308782578	0.308782578	0.200325723	746.8652318	0	13.95535	14.55132	0	0	0	0	0	14.35654	0	0	0	13.93751	0	0	15.69703	0	0	0	0	0	0	16.43528	16.21803	15.06181	0	15.35814	14.92268	11.9528	15.14724	13.97187	0	14.01779	14.74814	0	15.59361	15.75185	15.08171	14.03595	15.04073	17.02055	16.67271	15.51622	16.24954	16.11554	16.8365	16.61349	15.19337
P52823	STC1_HUMAN	"Stanniocalcin-1, STC-1"	STC1 STC	Homo sapiens (Human)	bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; chondrocyte proliferation [GO:0035988]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial cell morphogenesis [GO:0001886]; growth plate cartilage axis specification [GO:0003421]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of renal phosphate excretion [GO:1903403]; ossification [GO:0001503]; positive regulation of calcium ion import [GO:0090280]; regulation of anion transport [GO:0044070]; regulation of cardiac muscle cell contraction [GO:0086004]; response to vitamin D [GO:0033280]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; chondrocyte proliferation [GO:0035988]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial cell morphogenesis [GO:0001886]; growth plate cartilage axis specification [GO:0003421]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of renal phosphate excretion [GO:1903403]; ossification [GO:0001503]; positive regulation of calcium ion import [GO:0090280]; regulation of anion transport [GO:0044070]; regulation of cardiac muscle cell contraction [GO:0086004]; response to vitamin D [GO:0033280]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	GO:0001503; GO:0001886; GO:0003421; GO:0005179; GO:0005615; GO:0005634; GO:0005737; GO:0006874; GO:0007566; GO:0010596; GO:0016324; GO:0030336; GO:0033280; GO:0035988; GO:0042802; GO:0044070; GO:0046697; GO:0051926; GO:0060348; GO:0071320; GO:0071385; GO:0071456; GO:0086004; GO:0090280; GO:1903403	CIANGVTSK	7.21999979	0.425121099	0.425121099	0.253049123	950.0578485	14.5987	14.97112	14.87731	11.66671	0	15.01311	0	0	15.58999	0	0	16.05718	0	14.21614	15.57611	16.3234	15.93885	15.97115	15.38267	13.65901	15.77345	16.86238	0	17.8288	15.15722	16.35373	16.94182	0	16.19803	0	15.88197	17.90594	15.20776	16.69883	0	0	15.477	17.02743	0	0	15.42171	14.69783	0	0	0	15.28241	0	0
P52824	DGKQ_HUMAN	"Diacylglycerol kinase theta, DAG kinase theta, DGKtheta, EC 2.7.1.107 (Diglyceride kinase theta, DGK-theta)"	DGKQ DAGK4	Homo sapiens (Human)	cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030168; GO:0030297; GO:0033198; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903432; GO:2000064; GO:2000182	AGTTR	5.420000076	1	1	0.189114777	506.0826306	13.34838	14.98253	0	15.95096	16.38899	13.84928	0	0	13.37636	15.05368	14.8086	15.51769	15.22741	14.93021	16.17925	15.02758	15.36872	16.71662	15.42755	0	15.86426	0	0	0	0	0	16.83899	0	0	0	0	0	0	0	16.83966	0	18.83031	19.25756	19.00043	17.66119	0	0	17.21681	0	0	0	0	0
P52848	NDST1_HUMAN	"Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (Glucosaminyl N-deacetylase/N-sulfotransferase 1, NDST-1) (N-heparan sulfate sulfotransferase 1, N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1, HSNST 1) [Includes: Heparan sulfate N-deacetylase 1, EC 3.5.1.-; Heparan sulfate N-sulfotransferase 1, EC 2.8.2.8 ]"	NDST1 HSST HSST1	Homo sapiens (Human)	"aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; protein sulfation [GO:0006477]; respiratory gaseous exchange by respiratory system [GO:0007585]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; protein sulfation [GO:0006477]; respiratory gaseous exchange by respiratory system [GO:0007585]"	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119]	GO:0000139; GO:0003279; GO:0005794; GO:0006024; GO:0006477; GO:0006954; GO:0007585; GO:0008283; GO:0008543; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0030900; GO:0030901; GO:0032588; GO:0035904; GO:0043410; GO:0045880; GO:0048702; GO:0048703; GO:0050119; GO:0060976; GO:0102140	TEPAKVMDMVQK	1.909999967	0.475386828	0.475386828	0.252892965	1392.055987	0	0	0	0	16.02253	0	14.34526	0	0	0	0	0	0	0	0	16.33544	14.20801	15.13394	0	0	0	0	16.11542	0	15.45797	0	16.2627	10.95218	0	0	16.55902	17.1276	0	16.12984	0	0	0	0	0	0	0	0	0	0	14.00705	0	0	0
P52849	NDST2_HUMAN	"Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2, EC 2.8.2.8 (Glucosaminyl N-deacetylase/N-sulfotransferase 2, NDST-2) (N-heparan sulfate sulfotransferase 2, N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2, EC 3.-.-.-; Heparan sulfate N-sulfotransferase 2, EC 2.8.2.- ]"	NDST2 HSST2	Homo sapiens (Human)	"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; N-acetylglucosamine deacetylase activity [GO:0050119]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]"	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; N-acetylglucosamine deacetylase activity [GO:0050119]	GO:0000139; GO:0005794; GO:0006024; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0050119	FRYSTELAPGR	11.21000004	0.870581269	0.870581269	0.076326431	1292.319954	0	0	8.62858	0	11.7216	10.87558	0	0	8.906544	0	13.14157	0	10.10185	0	10.60703	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.09132	0	0	10.6702	0	9.162917	0	0	0	11.56895	0	0	0	0	0	0	0
P52888	THOP1_HUMAN	"Thimet oligopeptidase, EC 3.4.24.15 (Endopeptidase 24.15) (MP78)"	THOP1	Homo sapiens (Human)	peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0000209; GO:0004222; GO:0005758; GO:0005829; GO:0006508; GO:0006518; GO:0046872	TASTEADK	13.82999992	0.901486635	0.901486635	0.218639438	822.3800345	0	0	14.1183	14.66191	0	15.33806	14.20059	14.86952	16.86765	17.94751	0	14.41872	15.38676	0	14.52716	0	12.21898	14.61516	14.75478	14.47104	14.87992	14.99544	16.93293	17.65154	0	0	0	0	0	15.89187	15.4415	0	0	0	16.24892	0	0	0	0	15.08699	13.82292	0	0	0	0	15.78344	0	0
P52907	CAZA1_HUMAN	F-actin-capping protein subunit alpha-1 (CapZ alpha-1)	CAPZA1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]; protein-containing complex assembly [GO:0065003]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]	actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]; protein-containing complex assembly [GO:0065003]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]	GO:0003779; GO:0005576; GO:0005829; GO:0005856; GO:0008290; GO:0015629; GO:0030036; GO:0034329; GO:0045296; GO:0051015; GO:0051016; GO:0065003; GO:0070062; GO:0071203	ADFDDR	3.559999943	0.899589777	0.899589777	0.219924802	736.574395	17.48151	0	0	0	0	17.50599	0	0	0	17.38028	17.32001	0	0	0	17.23668	19.05236	17.42686	0	18.82906	17.69935	0	0	0	0	17.69235	0	0	0	17.36482	17.39739	0	19.64647	0	0	0	0	17.74879	19.06187	0	19.21357	0	17.16768	16.94565	17.34678	18.01935	0	16.28738	18.23133
P52945	PDX1_HUMAN	"Pancreas/duodenum homeobox protein 1, PDX-1 (Glucose-sensitive factor, GSF) (Insulin promoter factor 1, IPF-1) (Insulin upstream factor 1, IUF-1) (Islet/duodenum homeobox-1, IDX-1) (Somatostatin-transactivating factor 1, STF-1)"	PDX1 IPF1 STF1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; animal organ senescence [GO:0010260]; central nervous system development [GO:0007417]; detection of glucose [GO:0051594]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin secretion [GO:0030073]; liver development [GO:0001889]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; response to chlorate [GO:0010157]; response to cytokine [GO:0034097]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to iron(II) ion [GO:0010040]; response to leucine [GO:0043201]; response to nicotine [GO:0035094]; response to vitamin [GO:0033273]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]	chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; animal organ senescence [GO:0010260]; central nervous system development [GO:0007417]; detection of glucose [GO:0051594]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin secretion [GO:0030073]; liver development [GO:0001889]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; response to chlorate [GO:0010157]; response to cytokine [GO:0034097]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to iron(II) ion [GO:0010040]; response to leucine [GO:0043201]; response to nicotine [GO:0035094]; response to vitamin [GO:0033273]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001889; GO:0003309; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006006; GO:0006091; GO:0006357; GO:0006366; GO:0007224; GO:0007263; GO:0007417; GO:0008284; GO:0008285; GO:0009410; GO:0009611; GO:0009887; GO:0010040; GO:0010157; GO:0010260; GO:0010942; GO:0016331; GO:0016607; GO:0030073; GO:0031017; GO:0031100; GO:0033273; GO:0034097; GO:0035094; GO:0035774; GO:0042593; GO:0043201; GO:0043279; GO:0043388; GO:0044877; GO:0045944; GO:0048565; GO:0048863; GO:0051384; GO:0051594; GO:0060290; GO:0070542; GO:1902236; GO:1990837; GO:1990841; GO:2000675	GPAPEFSASPPACLYMGR	2.549999952	0.649890125	0.649890125	0.254929595	1907.721441	15.30845	16.53416	0	0	13.783	13.39925	13.50167	0	0	0	0	0	0	0	0	14.54778	13.64336	12.39935	0	0	0	0	0	0	15.05191	0	0	0	0	0	17.10053	11.66533	0	0	8.664305	0	0	0	0	0	0	0	0	0	0	15.71363	13.16569	0
P52948	NUP98_HUMAN	"Nuclear pore complex protein Nup98-Nup96, EC 3.4.21.- [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98, Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96, Nup96) ]"	NUP98 ADAR2	Homo sapiens (Human)	"mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]"	cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	"cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; transporter activity [GO:0005215]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]"	mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; transporter activity [GO:0005215]	GO:0003713; GO:0003729; GO:0005215; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0042405; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:1990841; GO:1990904	DRLAQSDMAK	2.430000067	1	1	0.011463868	1135.624846	0	14.87632	0	0	0	0	14.69914	0	15.2568	0	0	0	0	0	0	0	13.73198	0	0	0	0	0	0	0	0	15.26973	0	14.96959	0	0	0	11.5025	0	0	0	0	0	0	0	0	0	13.32714	0	0	0	13.1082	0	0
P53007	TXTP_HUMAN	"Tricarboxylate transport protein, mitochondrial (Citrate transport protein, CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)"	SLC25A1 SLC20A3	Homo sapiens (Human)	fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transmembrane transport [GO:0006843]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; citrate secondary active transmembrane transporter activity [GO:0071913]; citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142]; fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transmembrane transport [GO:0006843]	citrate secondary active transmembrane transporter activity [GO:0071913]; citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142]	GO:0005634; GO:0005743; GO:0006094; GO:0006843; GO:0015137; GO:0015142; GO:0016021; GO:0046949; GO:0070062; GO:0071913	AKLTHPGK	11	1	1	0.289359927	851.7543008	19.52477	19.58433	0	0	0	0	0	0	19.32091	20.55405	19.00406	0	17.35113	18.77417	0	19.01203	18.75641	17.1012	17.36151	16.48796	0	0	0	0	0	18.97931	17.48457	18.21644	18.80075	18.27091	0	0	0	0	0	17.88445	19.74971	0	20.07658	20.26011	19.17373	17.43637	0	18.49212	19.27831	19.38117	0	15.91384
P53041	PPP5_HUMAN	"Serine/threonine-protein phosphatase 5, PP5, EC 3.1.3.16 (Protein phosphatase T, PP-T, PPT)"	PPP5C PPP5	Homo sapiens (Human)	"double-strand break repair [GO:0006302]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"	chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	"chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; double-strand break repair [GO:0006302]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]"	ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]	GO:0000165; GO:0000278; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006302; GO:0006351; GO:0006470; GO:0008289; GO:0010288; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0048156; GO:0051879; GO:0070262; GO:0101031; GO:1904550	AMAEGER	2.569999933	0.771713257	0.771713257	0.178525011	764.2032945	0	16.01867	14.02845	0	11.91042	18.41219	0	17.22493	0	0	16.12921	0	0	15.26192	0	0	0	0	0	0	0	0	0	0	16.23394	0	0	0	0	0	0	16.65281	0	0	0	0	0	15.48391	0	0	0	0	0	0	11.77328	0	13.97234	14.93403
P53350	PLK1_HUMAN	"Serine/threonine-protein kinase PLK1, EC 2.7.11.21 (Polo-like kinase 1, PLK-1) (Serine/threonine-protein kinase 13, STPK13)"	PLK1 PLK	Homo sapiens (Human)	centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194]	anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000776; GO:0000785; GO:0000795; GO:0000922; GO:0000940; GO:0001578; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006468; GO:0007052; GO:0007062; GO:0007076; GO:0007077; GO:0007094; GO:0007095; GO:0007098; GO:0007346; GO:0008017; GO:0010800; GO:0010997; GO:0015630; GO:0016321; GO:0016567; GO:0018105; GO:0019901; GO:0030071; GO:0030496; GO:0031648; GO:0032436; GO:0032465; GO:0034451; GO:0042802; GO:0043066; GO:0043393; GO:0045143; GO:0045184; GO:0045736; GO:0045862; GO:0051081; GO:0051233; GO:0051443; GO:0051726; GO:0070194; GO:0071168; GO:0090435; GO:0097431; GO:0106310; GO:1900182; GO:1901673; GO:1901990; GO:1904668; GO:1904776; GO:1905784	MSAAVTAGK	10.90999985	0.56186527	0.56186527	0.270853986	836.8881432	0	11.26095	16.60099	14.9719	15.09929	14.99207	14.81709	15.85903	0	0	13.63593	14.74845	12.83243	0	0	0	16.30737	13.82716	17.59414	17.89328	12.06291	14.9509	14.9244	15.98272	17.50543	0	0	0	0	16.50755	18.29716	14.6846	0	16.13302	16.68048	0	16.33278	0	0	0	0	16.2908	0	15.43932	0	0	0	0
P53370	NUDT6_HUMAN	"Nucleoside diphosphate-linked moiety X motif 6, Nudix motif 6, EC 3.6.1.- (Antisense basic fibroblast growth factor) (Protein GFG)"	NUDT6 FGF2AS	Homo sapiens (Human)	negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]	ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]	GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0051287	TYGPGPSAGYRWASGAQGYVR	5.690000057	1	1	0.204999225	2200.904605	0	0	13.82582	0	0	15.10216	0	0	15.37414	0	0	0	0	16.03733	0	14.6947	0	14.62935	16.90746	17.01728	0	0	0	16.32153	13.29386	0	14.95215	15.90748	14.14694	14.69055	13.88566	0	0	15.447	0	0	0	16.57068	16.87136	0	0	0	0	0	0	0	0	0
P53396	ACLY_HUMAN	"ATP-citrate synthase, EC 2.3.3.8 (ATP-citrate (pro-S-)-lyase, ACL) (Citrate cleavage enzyme)"	ACLY	Homo sapiens (Human)	acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]	ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]	GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0035578; GO:0046872; GO:0070062; GO:1904813	EAYPEEAYIADLDAKSGASLK	7.039999962	1	1	0.041659024	2241.263805	12.05335	15.6203	0	0	0	0	0	0	15.01081	0	0	0	0	12.78199	0	11.49876	0	0	13.93253	0	13.34086	10.69497	0	14.08614	0	0	0	0	0	0	0	0	0	0	0	0	13.82299	0	0	14.97389	0	0	0	0	0	0	0	0
P53420	CO4A4_HUMAN	Collagen alpha-4(IV) chain	COL4A4	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0031012; GO:0032836; GO:0062023	GDKGPTGVPGFPGLDGIPGHPGPPGPR	1.440000057	1	1	0.098978827	2533.545282	0	17.29064	15.37178	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P53609	PGTB1_HUMAN	"Geranylgeranyl transferase type-1 subunit beta, EC 2.5.1.59 (Geranylgeranyl transferase type I subunit beta, GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta)"	PGGT1B	Homo sapiens (Human)	protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]	CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342]	CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]	GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018342; GO:0018344	LLDLHQSWK	9.569999695	1	1	0.287189469	1140.807441	0	0	0	0	0	0	0	0	0	0	0	0	0	16.04587	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.98476	0	0	0	18.57434	0	0	16.03125	15.73391
P53618	COPB_HUMAN	"Coatomer subunit beta (Beta-coat protein, Beta-COP)"	COPB1 COPB MSTP026	Homo sapiens (Human)	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133]	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005789; GO:0005793; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030667; GO:0043231; GO:0070821; GO:0101003	RNAFMMLIHADQDR	26.04000092	1	1	0.955044384	1749.0372	0	21.65672	0	0	0	0	0	21.73325	0	0	21.81184	0	19.7856	0	0	0	0	0	0	0	0	22.37612	0	0	0	0	19.19144	0	0	0	0	0	0	22.45666	0	0	0	0	0	0	0	0	0	21.77445	0	0	18.38358	0
P53621	COPA_HUMAN	"Coatomer subunit alpha (Alpha-coat protein, Alpha-COP) (HEP-COP, HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin ]"	COPA	Homo sapiens (Human)	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]	"COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	hormone activity [GO:0005179]; structural molecule activity [GO:0005198]	GO:0000139; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062	GKPVEK	3.950000048	1	1	0.058652846	656.6870288	0	0	7.409853	0	0	0	0	0	14.20928	0	0	0	0	0	0	0	0	0	0	0	0	0	14.14495	14.28219	0	0	13.77525	0	0	0	0	14.65098	0	0	0	0	0	0	17.47379	0	0	0	0	0	0	0	15.93704	0
P53634	CATC_HUMAN	"Dipeptidyl peptidase 1, EC 3.4.14.1 (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I, DPP-I, DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain) ]"	CTSC CPPI	Homo sapiens (Human)	aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]	chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]	GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005794; GO:0005813; GO:0006508; GO:0006955; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235	MGAGPSLLLAALLLLLSGDGAVR	21.23999977	1	1	3.67E-12	2204.55394	0	18.1152	17.40345	15.90526	16.6966	15.95255	0	15.48279	13.94681	0	0	14.15796	15.38098	0	13.24834	0	0	0	0	0	0	0	0	0	12.05372	0	0	14.79591	14.43909	0	0	12.91	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.55661	12.53917
P53671	LIMK2_HUMAN	"LIM domain kinase 2, LIMK-2, EC 2.7.11.1"	LIMK2	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; phosphorylation [GO:0016310]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton organization [GO:0030036]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; phosphorylation [GO:0016310]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001934; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005801; GO:0005813; GO:0006468; GO:0007283; GO:0016310; GO:0030036; GO:0030953; GO:0046872; GO:0048471; GO:0051650; GO:0060322; GO:0061303; GO:0072686; GO:0106310; GO:1900182; GO:1902018	ATGKVMVMK	2.289999962	0.55510956	0.55510956	0.141259933	997.5947437	14.98042	0	14.88594	0	15.60944	0	0	0	0	0	0	0	0	0	0	0	14.32908	0	0	0	0	0	0	0	15.83231	15.24907	0	14.9904	0	0	0	0	13.34356	15.56837	11.25379	15.58689	0	15.10372	14.29918	15.60172	0	0	0	0	0	11.38943	0	0
P53778	MK12_HUMAN	"Mitogen-activated protein kinase 12, MAP kinase 12, MAPK 12, EC 2.7.11.24 (Extracellular signal-regulated kinase 6, ERK-6) (Mitogen-activated protein kinase p38 gamma, MAP kinase p38 gamma) (Stress-activated protein kinase 3)"	MAPK12 ERK6 SAPK3	Homo sapiens (Human)	cell cycle [GO:0007049]; DNA damage induced protein phosphorylation [GO:0006975]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; negative regulation of cell cycle [GO:0045786]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; DNA damage induced protein phosphorylation [GO:0006975]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; negative regulation of cell cycle [GO:0045786]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0000287; GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006975; GO:0007049; GO:0007165; GO:0007517; GO:0010952; GO:0018105; GO:0035556; GO:0045445; GO:0045786; GO:0051149; GO:0051726; GO:0106310	APEVILNWMR	2.799999952	1	1	6.89E-13	1244.294068	14.28873	14.25143	12.88834	0	0	0	0	0	0	0	0	0	0	0	0	13.54966	0	0	0	13.46825	0	0	0	0	15.16774	16.12763	15.02918	0	0	14.28548	0	11.83884	0	14.97602	0	0	16.60443	15.45067	0	15.0108	0	0	0	0	0	0	0	15.74259
P53794	SC5A3_HUMAN	"Sodium/myo-inositol cotransporter, Na(+)/myo-inositol cotransporter (Sodium/myo-inositol transporter 1, SMIT1) (Solute carrier family 5 member 3)"	SLC5A3	Homo sapiens (Human)	fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol import across plasma membrane [GO:1904679]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transporter activity [GO:0032409]; transport across blood-brain barrier [GO:0150104]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol import across plasma membrane [GO:1904679]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transporter activity [GO:0032409]; transport across blood-brain barrier [GO:0150104]	fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]	GO:0005365; GO:0005367; GO:0005412; GO:0005886; GO:0005887; GO:0006020; GO:0007422; GO:0008076; GO:0015146; GO:0015150; GO:0015166; GO:0015459; GO:0015750; GO:0015756; GO:0015791; GO:0015798; GO:0016021; GO:0032409; GO:0043085; GO:0043576; GO:0044325; GO:0048471; GO:0150104; GO:1903428; GO:1904659; GO:1904679; GO:1905477	RFGGHR	5.820000172	0.295105785	0.295105785	0.094565938	730.584906	14.63884	15.77834	0	15.82921	16.18327	16.46231	17.82162	16.7139	0	0	16.21793	15.24997	0	18.01093	17.26914	16.50319	17.72064	0	15.17942	15.66731	16.05093	15.61203	16.04495	15.59828	18.49169	11.53572	17.27862	17.91628	16.67442	14.31705	0	18.08545	17.28716	16.68572	15.95615	16.47588	16.84545	16.31344	17.1109	14.39249	17.43769	16.58061	16.4306	13.65071	0	14.65277	14.37173	16.57251
P53801	PTTG_HUMAN	"Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor, PBF, PTTG-binding factor)"	PTTG1IP C21orf1 C21orf3	Homo sapiens (Human)	"negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; p53 binding [GO:0002039]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]"	p53 binding [GO:0002039]	GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0006606; GO:0016020; GO:0016021; GO:0031398; GO:0043518; GO:0070062; GO:1902254; GO:1903364	APGVAR	4.03000021	0.460382998	0.460382998	0.289944967	571.0065141	16.47922	13.86261	14.23852	14.7788	0	15.48673	0	0	14.66503	14.10684	15.91665	14.47303	0	0	15.63468	17.27781	16.13485	0	0	15.04484	0	0	0	0	15.08776	0	0	0	16.09393	0	0	0	15.86552	17.27567	16.03852	15.938	17.37074	17.3181	0	16.3933	15.68455	15.5423	16.3255	16.51039	0	13.47933	16.32387	13.5002
P53804	TTC3_HUMAN	"E3 ubiquitin-protein ligase TTC3, EC 2.3.2.27 (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3, TPR repeat protein 3)"	TTC3 DCRR1 RNF105 TPRD	Homo sapiens (Human)	protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0046872; GO:0070936	IIIFSSGGEVK	12.34000015	1	1	0.29903557	1150.050726	0	0	17.68311	0	17.63647	17.0871	0	0	0	0	17.7366	0	0	0	16.92127	0	0	0	0	0	0	18.70176	15.46897	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.40197	0	0	0	0
P53990	IST1_HUMAN	"IST1 homolog, hIST1 (Charged multivesicular body protein 8, CHMP8) (Putative MAPK-activating protein PM28)"	IST1 KIAA0174	Homo sapiens (Human)	abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]	azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]	GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903	YSKEYGK	9.119999886	0.332827777	0.332827777	0.096589147	873.4580826	16.45924	8.796071	0	18.27293	15.27552	16.28647	15.16974	17.2029	16.82609	17.51544	0	0	17.6782	14.75493	17.90264	12.19697	16.08204	17.65473	0	15.57288	19.35294	17.21754	16.63088	16.28062	18.17068	0	14.98148	15.67552	0	0	17.14949	18.33216	18.78448	0	18.3691	0	11.2674	15.44613	16.64439	0	16.02492	0	0	0	0	0	14.99586	16.7925
P53992	SC24C_HUMAN	Protein transport protein Sec24C (SEC24-related protein C)	SEC24C KIAA0079	Homo sapiens (Human)	COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]	SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]	GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110	GQVPPLVTTNFLVK	6.880000114	1	1	0.375517571	1511.181674	0	14.58646	16.98463	0	0	0	17.49971	13.21502	0	0	0	0	11.72018	0	0	10.19415	13.70277	0	0	15.86346	15.79436	0	0	12.73723	14.60964	16.13252	0	12.70873	0	0	0	0	14.8944	16.07661	0	13.55416	17.2445	0	0	0	16.32208	0	16.16764	16.38613	15.25675	17.26357	0	0
P54098	DPOG1_HUMAN	"DNA polymerase subunit gamma-1, EC 2.7.7.7 (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)"	POLG MDP1 POLG1 POLGA	Homo sapiens (Human)	"base-excision repair, gap-filling [GO:0006287]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]"	gamma DNA polymerase complex [GO:0005760]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	"gamma DNA polymerase complex [GO:0005760]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]; base-excision repair, gap-filling [GO:0006287]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]"	3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]	GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0005739; GO:0005759; GO:0005760; GO:0006259; GO:0006261; GO:0006264; GO:0006287; GO:0008408; GO:0032991; GO:0042645	GTDLHSK	13.43000031	0.675810397	0.675810397	0.189422877	756.7041425	14.96531	13.88724	12.18771	14.54009	15.13711	0	15.47222	0	0	0	0	0	0	0	0	0	0	16.3504	0	14.1608	15.25144	0	0	17.08738	0	0	0	0	0	15.0839	15.89557	0	0	0	14.37908	0	0	0	0	0	0	0	0	0	12.01522	0	0	0
P54108	CRIS3_HUMAN	"Cysteine-rich secretory protein 3, CRISP-3 (Specific granule protein of 28 kDa, SGP28)"	CRISP3	Homo sapiens (Human)	defense response [GO:0006952]; innate immune response [GO:0045087]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; defense response [GO:0006952]; innate immune response [GO:0045087]		GO:0005576; GO:0005615; GO:0006952; GO:0031012; GO:0035580; GO:0042581; GO:0045087; GO:1904724	HSNPK	4.800000191	0.386320442	0.386320442	0.158483007	581.3461242	0	0	0	0	15.4677	0	0	0	0	14.38486	0	19.2412	16.06265	0	17.20645	0	17.45548	15.20959	16.22051	0	15.52192	0	0	16.72186	0	0	15.02669	0	11.6364	0	0	0	15.21907	0	0	17.7195	0	13.86189	16.9815	17.08177	0	17.65226	0	11.90451	0	17.09859	16.04068	0
P54132	BLM_HUMAN	"Bloom syndrome protein, EC 3.6.4.12 (DNA helicase, RecQ-like type 2, RecQ2) (RecQ protein-like 3)"	BLM RECQ2 RECQL3	Homo sapiens (Human)	"cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RecQ family helicase-topoisomerase III complex [GO:0031422]; replication fork [GO:0005657]	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RecQ family helicase-topoisomerase III complex [GO:0031422]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]"	"3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]"	GO:0000079; GO:0000228; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000729; GO:0000800; GO:0002039; GO:0003677; GO:0003678; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0007095; GO:0008094; GO:0008270; GO:0009378; GO:0010165; GO:0016363; GO:0016605; GO:0016887; GO:0031297; GO:0031422; GO:0032201; GO:0032508; GO:0032991; GO:0042802; GO:0042803; GO:0043138; GO:0044806; GO:0045893; GO:0045910; GO:0048478; GO:0051259; GO:0051260; GO:0051782; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0071139; GO:0071479; GO:0072711; GO:0072757; GO:0090329; GO:0090656; GO:1905773; GO:1990814	DLDTSDR	14.73999977	1	1	0.128561517	821.9390193	16.12385	14.66493	0	15.97674	15.29592	15.33943	14.55729	14.36912	14.12722	18.8262	15.12159	13.43481	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.4373	0	0	0	0	0	0
P54136	SYRC_HUMAN	"Arginine--tRNA ligase, cytoplasmic, EC 6.1.1.19 (Arginyl-tRNA synthetase, ArgRS)"	RARS1 RARS	Homo sapiens (Human)	arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]	GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006420; GO:0016020; GO:0017101; GO:0034618; GO:0045296; GO:0070062	FGDYQCNSAMGISQMLK	2.99000001	1	1	0.075640575	1966.548903	0	13.49561	10.5037	0	14.84472	14.17921	15.9319	13.37011	0	15.79628	16.20092	11.6342	13.41129	0	0	0	0	0	0	0	0	0	0	0	0	0	14.4508	0	0	0	0	0	0	0	0	0	12.60945	0	0	13.34855	14.36866	0	0	0	14.33833	0	0	0
P54252	ATX3_HUMAN	"Ataxin-3, EC 3.4.19.12 (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein)"	ATXN3 ATX3 MJD MJD1 SCA3	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; chemical synaptic transmission [GO:0007268]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; nervous system development [GO:0007399]; nucleotide-excision repair [GO:0006289]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; chemical synaptic transmission [GO:0007268]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; nervous system development [GO:0007399]; nucleotide-excision repair [GO:0006289]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511]	ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0000226; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006289; GO:0006511; GO:0006515; GO:0007268; GO:0007399; GO:0010810; GO:0016363; GO:0016579; GO:0030036; GO:0031625; GO:0031966; GO:0034605; GO:0035520; GO:0042405; GO:0042802; GO:0043161; GO:0045104; GO:0045202; GO:0051117; GO:0061578; GO:0070536; GO:0071108; GO:0071218; GO:1904294; GO:1904379; GO:1990380	TEGKK	8.399999619	1	1	0.31847561	560.9606498	0	0	0	0	0	0	17.32536	18.04934	0	0	0	0	18.56812	18.08836	0	0	0	0	0	0	16.10293	0	18.44578	21.44697	0	0	0	17.10448	19.38151	0	17.3299	0	18.05518	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P54253	ATX1_HUMAN	Ataxin-1 (Spinocerebellar ataxia type 1 protein)	ATXN1 ATX1 SCA1	Homo sapiens (Human)	"anatomical structure development [GO:0048856]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; social behavior [GO:0035176]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; social behavior [GO:0035176]"	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]	GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006396; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0008022; GO:0008266; GO:0016363; GO:0034046; GO:0035176; GO:0042405; GO:0042802; GO:0043621; GO:0045892; GO:0048856; GO:0051168	GHGGGR	6.5	0.404272199	0.404272199	0.240365081	539.1278174	14.48092	15.13802	15.38849	0	15.01661	14.29126	14.94354	14.38943	14.99591	0	0	0	0	0	0	15.32029	0	0	0	0	0	16.58831	16.02111	12.16725	0	0	0	0	15.68837	15.95085	0	0	0	15.74157	0	0	17.00317	0	0	0	0	16.15221	0	0	16.70531	0	16.52975	0
P54257	HAP1_HUMAN	"Huntingtin-associated protein 1, HAP-1 (Neuroan 1)"	HAP1 HAP2 HLP1	Homo sapiens (Human)	"anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; autophagy [GO:0006914]; brain development [GO:0007420]; cell projection organization [GO:0030030]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; hypothalamus cell differentiation [GO:0021979]; mitochondrion distribution [GO:0048311]; negative regulation of amyloid-beta formation [GO:1902430]; neurogenesis [GO:0022008]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotrophin production [GO:0032901]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of exocytosis [GO:0017157]; regulation of organelle transport along microtubule [GO:1902513]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]"	actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021]	"actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021]; brain-derived neurotrophic factor binding [GO:0048403]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; autophagy [GO:0006914]; brain development [GO:0007420]; cell projection organization [GO:0030030]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; hypothalamus cell differentiation [GO:0021979]; mitochondrion distribution [GO:0048311]; negative regulation of amyloid-beta formation [GO:1902430]; neurogenesis [GO:0022008]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotrophin production [GO:0032901]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of exocytosis [GO:0017157]; regulation of organelle transport along microtubule [GO:1902513]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]"	brain-derived neurotrophic factor binding [GO:0048403]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]	GO:0005102; GO:0005730; GO:0005739; GO:0005764; GO:0005769; GO:0005776; GO:0005783; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0006605; GO:0006887; GO:0006914; GO:0007268; GO:0007420; GO:0008021; GO:0008089; GO:0008090; GO:0008104; GO:0015629; GO:0016234; GO:0017022; GO:0017157; GO:0021549; GO:0021979; GO:0022008; GO:0030030; GO:0030425; GO:0030426; GO:0031410; GO:0031587; GO:0032230; GO:0032901; GO:0043197; GO:0044325; GO:0045742; GO:0047496; GO:0048011; GO:0048311; GO:0048403; GO:0050769; GO:0098957; GO:1902430; GO:1902513; GO:1902857; GO:1904115	MYGAETEK	2.769999981	0.048424594	0.048424594	0.187331709	925.4939994	0	0	0	0	0	0	18.58569	0	0	0	18.92264	0	0	0	0	0	0	0	0	0	17.76298	0	0	0	0	0	0	18.39082	15.9748	0	19.02217	0	0	0	19.57635	0	0	0	0	0	0	0	0	16.72417	0	0	0	0
P54274	TERF1_HUMAN	Telomeric repeat-binding factor 1 (NIMA-interacting protein 2) (TTAGGG repeat-binding factor 1) (Telomeric protein Pin2/TRF1)	TERF1 PIN2 TRBF1 TRF TRF1	Homo sapiens (Human)	cell division [GO:0051301]; meiotic telomere clustering [GO:0045141]; negative regulation of DNA replication [GO:0008156]; negative regulation of establishment of protein localization to telomere [GO:1904850]; negative regulation of establishment of protein-containing complex localization to telomere [GO:1904914]; negative regulation of establishment of RNA localization to telomere [GO:1904911]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of shelterin complex assembly [GO:1904792]; positive regulation of telomere maintenance [GO:0032206]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820]	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; spindle [GO:0005819]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; spindle [GO:0005819]; ankyrin repeat binding [GO:0071532]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded telomeric DNA binding [GO:0003691]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; telomeric DNA binding [GO:0042162]; cell division [GO:0051301]; meiotic telomere clustering [GO:0045141]; negative regulation of DNA replication [GO:0008156]; negative regulation of establishment of protein localization to telomere [GO:1904850]; negative regulation of establishment of protein-containing complex localization to telomere [GO:1904914]; negative regulation of establishment of RNA localization to telomere [GO:1904911]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of shelterin complex assembly [GO:1904792]; positive regulation of telomere maintenance [GO:0032206]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820]"	"ankyrin repeat binding [GO:0071532]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded telomeric DNA binding [GO:0003691]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; telomeric DNA binding [GO:0042162]"	GO:0000723; GO:0000781; GO:0000783; GO:0001650; GO:0003677; GO:0003691; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0007004; GO:0008017; GO:0008022; GO:0008156; GO:0008301; GO:0009410; GO:0016233; GO:0016604; GO:0032206; GO:0032211; GO:0032214; GO:0042162; GO:0042802; GO:0042803; GO:0045141; GO:0051301; GO:0051974; GO:0061820; GO:0070187; GO:0071532; GO:0090656; GO:0098505; GO:1904357; GO:1904792; GO:1904850; GO:1904911; GO:1904914; GO:1905778; GO:1905839	NSAEAIIHGLSSLTACQLR	2.670000076	1	1	0.185673067	2040.480981	14.50085	10.60307	14.65209	0	13.35267	0	13.41251	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.14042	17.48378	0	0	0	0	0	17.73061	0	0	18.20323	15.51187	0	0	16.99635	0	0	0	0	17.21278	0	0	0	0
P54284	CACB3_HUMAN	"Voltage-dependent L-type calcium channel subunit beta-3, CAB3 (Calcium channel voltage-dependent subunit beta 3)"	CACNB3 CACNLB3	Homo sapiens (Human)	calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; protein localization to plasma membrane [GO:0072659]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of voltage-gated calcium channel activity [GO:1901385]; T cell receptor signaling pathway [GO:0050852]	cytosol [GO:0005829]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]	cytosol [GO:0005829]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; protein localization to plasma membrane [GO:0072659]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of voltage-gated calcium channel activity [GO:1901385]; T cell receptor signaling pathway [GO:0050852]	calcium channel regulator activity [GO:0005246]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005246; GO:0005829; GO:0005891; GO:0006816; GO:0007268; GO:0007528; GO:0008331; GO:0016020; GO:0045202; GO:0050852; GO:0060402; GO:0061577; GO:0072659; GO:0098903; GO:1901385; GO:1901843; GO:1990454	QAWTGSSQRSSR	8.529999733	1	1	0.279967281	1352.08537	0	0	13.2055	0	0	0	0	0	0	0	0	0	0	0	15.69911	15.79263	0	16.66486	0	16.0514	18.05	0	16.61865	0	13.37222	0	0	16.93376	0	15.38062	15.99963	16.65442	0	0	16.02718	17.84929	17.65692	15.81856	18.18678	17.06367	0	15.13351	15.31785	11.80767	15.31428	17.11534	18.53025	0
P54289	CA2D1_HUMAN	Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1 ]	CACNA2D1 CACNL2A CCHL2A MHS3	Homo sapiens (Human)	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to amyloid-beta [GO:1904646]; membrane depolarization during bundle of His cell action potential [GO:0086048]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]	extracellular exosome [GO:0070062]; L-type voltage-gated calcium channel complex [GO:1990454]; sarcoplasmic reticulum [GO:0016529]; voltage-gated calcium channel complex [GO:0005891]	extracellular exosome [GO:0070062]; L-type voltage-gated calcium channel complex [GO:1990454]; sarcoplasmic reticulum [GO:0016529]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to amyloid-beta [GO:1904646]; membrane depolarization during bundle of His cell action potential [GO:0086048]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]	metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005891; GO:0006816; GO:0016529; GO:0045933; GO:0046872; GO:0051924; GO:0060307; GO:0060402; GO:0061577; GO:0070062; GO:0070588; GO:0086002; GO:0086048; GO:0086091; GO:0098703; GO:0098903; GO:1901843; GO:1902514; GO:1904646; GO:1990454	AKLEETITQAR	5.289999962	0.373666167	0.373666167	0.291996873	1259.023672	11.83228	14.85262	13.34895	0	0	0	0	0	11.81213	0	0	0	0	0	0	0	15.87425	0	0	15.75829	15.09938	0	0	0	14.91195	0	16.94788	15.84097	0	14.81696	16.29814	15.06867	15.91659	14.74335	0	0	15.73495	14.79377	17.3821	0	0	16.53523	0	0	0	16.0846	14.58885	0
P54296	MYOM2_HUMAN	Myomesin-2 (165 kDa connectin-associated protein) (165 kDa titin-associated protein) (M-protein) (Myomesin family member 2)	MYOM2	Homo sapiens (Human)	muscle contraction [GO:0006936]; sarcomere organization [GO:0045214]	M band [GO:0031430]; mitochondrion [GO:0005739]; myosin filament [GO:0032982]	M band [GO:0031430]; mitochondrion [GO:0005739]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; kinase binding [GO:0019900]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; sarcomere organization [GO:0045214]	actin filament binding [GO:0051015]; kinase binding [GO:0019900]; structural constituent of muscle [GO:0008307]	GO:0005739; GO:0006936; GO:0008307; GO:0019900; GO:0031430; GO:0032982; GO:0045214; GO:0051015	GDEEPFR	4.96999979	0.21573177	0.21573177	0.151665893	849.5481993	16.64848	0	15.96664	18.61421	0	0	15.54827	15.38976	14.16677	0	0	0	0	0	0	15.15441	0	0	15.41613	0	0	0	0	0	16.72697	18.05971	0	16.51407	0	0	0	0	0	0	0	0	0	0	16.10825	0	0	15.15796	0	0	0	0	0	0
P54577	SYYC_HUMAN	"Tyrosine--tRNA ligase, cytoplasmic, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed ]"	YARS1 YARS	Homo sapiens (Human)	apoptotic process [GO:0006915]; tyrosyl-tRNA aminoacylation [GO:0006437]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; apoptotic process [GO:0006915]; tyrosyl-tRNA aminoacylation [GO:0006437]	ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0000049; GO:0003723; GO:0004831; GO:0005153; GO:0005524; GO:0005615; GO:0005737; GO:0005829; GO:0006437; GO:0006915; GO:0016604	AMLESIGVPLEKLK	11.01000023	1	1	0.249604164	1545.364149	0	0	0	0	15.9757	0	14.57178	12.91221	0	0	0	0	0	0	0	0	7.573669	14.45838	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.61115	0	0	0	0	0	0	0	0	0	0	17.75363	0
P54578	UBP14_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 14, EC 3.4.19.12 (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14)"	USP14 TGT	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; innate immune response [GO:0045087]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of chemotaxis [GO:0050920]; regulation of proteasomal protein catabolic process [GO:0061136]	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; synapse [GO:0045202]	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; synapse [GO:0045202]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent deubiquitinase [GO:0004843]; chemical synaptic transmission [GO:0007268]; innate immune response [GO:0045087]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of chemotaxis [GO:0050920]; regulation of proteasomal protein catabolic process [GO:0061136]	cysteine-type endopeptidase activity [GO:0004197]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent deubiquitinase [GO:0004843]	GO:0000502; GO:0004197; GO:0004843; GO:0004866; GO:0005829; GO:0005886; GO:0007268; GO:0009986; GO:0016579; GO:0031410; GO:0043161; GO:0045087; GO:0045202; GO:0050920; GO:0061136; GO:0070062; GO:0070628; GO:1903070	DLFDSMDK	8.079999924	1	1	0.140684073	969.4149499	15.1697	15.31639	0	13.04071	0	0	0	0	0	0	0	0	12.9389	0	12.44505	0	0	0	0	0	0	15.03049	0	12.98614	0	0	0	14.35587	0	0	0	15.71802	0	15.50468	0	0	14.99868	14.72174	0	0	15.44853	15.54203	0	0	0	16.03559	0	0
P54646	AAPK2_HUMAN	"5'-AMP-activated protein kinase catalytic subunit alpha-2, AMPK subunit alpha-2, EC 2.7.11.1 (Acetyl-CoA carboxylase kinase, ACACA kinase, EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase, HMGCR kinase, EC 2.7.11.31)"	PRKAA2 AMPK AMPK2	Homo sapiens (Human)	autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	[acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006325; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008610; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016239; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0035174; GO:0035556; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:1903829; GO:1904428; GO:1905691; GO:1990044; GO:2000758	AMKQLDFEWK	4.349999905	1	1	0.18800355	1311.186128	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.86167	0	0	0	0	0	9.316563	0	0	12.36376	0	15.94809	0	0	0	0	0	0	0	14.45812	0	0	0	0	0	0	0	0
P54707	AT12A_HUMAN	"Potassium-transporting ATPase alpha chain 2 (HK alpha 2) (Non-gastric H(+)/K(+) ATPase subunit alpha, EC 7.2.2.19) (Non-gastric Na(+)/K(+) ATPase subunit alpha, EC 7.2.2.13) (Proton pump) (Sodium pump)"	ATP12A ATP1AL1	Homo sapiens (Human)	cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sodium ion export across plasma membrane [GO:0036376]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; potassium:proton exchanging ATPase complex [GO:0005889]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; potassium:proton exchanging ATPase complex [GO:0005889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sodium ion export across plasma membrane [GO:0036376]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]	GO:0005391; GO:0005524; GO:0005829; GO:0005886; GO:0005889; GO:0006883; GO:0006885; GO:0008900; GO:0015629; GO:0016323; GO:0016324; GO:0016887; GO:0030007; GO:0036376; GO:0046872; GO:1902600; GO:1990573	FLMVMK	4.96999979	0.674874008	0.674874008	0.232071137	768.6370009	15.46529	14.92165	14.6064	15.23947	0	14.93363	15.52016	14.61427	14.5674	0	0	14.10118	16.23237	15.93921	13.20481	14.12811	15.64201	13.8518	15.6858	15.55106	14.93587	0	15.34167	0	15.25204	0	16.93638	0	15.75493	0	15.09766	14.7861	0	15.68566	16.52703	17.00957	15.73868	0	16.69869	0	16.67993	0	0	0	0	0	15.81849	0
P54710	ATNG_HUMAN	"Sodium/potassium-transporting ATPase subunit gamma, Na(+)/K(+) ATPase subunit gamma (FXYD domain-containing ion transport regulator 2) (Sodium pump gamma chain)"	FXYD2 ATP1C ATP1G1	Homo sapiens (Human)	establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; sodium ion export across plasma membrane [GO:0036376]; transmembrane transport [GO:0055085]	extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]	extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; sodium ion export across plasma membrane [GO:0036376]; transmembrane transport [GO:0055085]	ATPase activator activity [GO:0001671]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]	GO:0001671; GO:0005886; GO:0005890; GO:0010248; GO:0017080; GO:0030674; GO:0036376; GO:0055085; GO:0070062; GO:1902600; GO:1903408; GO:1990573; GO:2000649	MTGLSMDGGGSPK	16.10000038	1	1	0.303719691	1269.828147	15.59428	15.61083	17.09304	0	0	0	15.8868	16.63935	0	14.73851	13.34414	15.34701	16.15344	0	0	0	0	0	18.57034	18.68082	0	0	0	0	0	0	0	0	0	17.94738	0	0	15.98623	0	0	16.95206	19.69548	18.66263	16.26176	18.67788	19.41348	16.803	17.91267	0	18.32261	17.33155	18.01297	19.28293
P54753	EPHB3_HUMAN	"Ephrin type-B receptor 3, EC 2.7.10.1 (EPH-like tyrosine kinase 2, EPH-like kinase 2) (Embryonic kinase 2, EK2, hEK2) (Tyrosine-protein kinase TYRO6)"	EPHB3 ETK2 HEK2 TYRO6	Homo sapiens (Human)	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]	cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]	ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0001525; GO:0001655; GO:0004712; GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0007413; GO:0008046; GO:0016477; GO:0021952; GO:0022038; GO:0022407; GO:0030425; GO:0031290; GO:0033674; GO:0034446; GO:0043005; GO:0043087; GO:0043235; GO:0046777; GO:0048013; GO:0048538; GO:0048546; GO:0050770; GO:0051965; GO:0060021; GO:0060996; GO:0060997	EIDVSCVKIEEVIGAGEFGEVCR	2.319999933	1	1	0.107080509	2595.24761	0	13.47064	13.95716	13.44659	12.76276	14.25336	0	13.183	12.24994	0	0	11.02627	10.57085	0	12.55096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P54756	EPHA5_HUMAN	"Ephrin type-A receptor 5, EC 2.7.10.1 (Brain-specific kinase) (EPH homology kinase 1, EHK-1) (EPH-like kinase 7, EK7, hEK7)"	EPHA5 BSK EHK1 HEK7 TYRO4	Homo sapiens (Human)	axon guidance [GO:0007411]; cAMP-mediated signaling [GO:0019933]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of kinase activity [GO:0033674]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]	axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cAMP-mediated signaling [GO:0019933]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of kinase activity [GO:0033674]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0004712; GO:0004714; GO:0005003; GO:0005004; GO:0005005; GO:0005524; GO:0005791; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0009897; GO:0019933; GO:0021766; GO:0030424; GO:0030425; GO:0032793; GO:0032956; GO:0033674; GO:0043005; GO:0043025; GO:0043087; GO:0043235; GO:0048013; GO:0048471; GO:0048666; GO:0061178	IMNSLQEMKVQLVNGMVPL	10.27999973	1	1	0	2185.765361	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P54760	EPHB4_HUMAN	"Ephrin type-B receptor 4, EC 2.7.10.1 (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)"	EPHB4 HTK MYK1 TYRO11	Homo sapiens (Human)	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; heart morphogenesis [GO:0003007]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; heart morphogenesis [GO:0003007]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0001525; GO:0002042; GO:0003007; GO:0004712; GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0007169; GO:0007411; GO:0033674; GO:0043005; GO:0043235; GO:0046777; GO:0048013; GO:0070062	QSNGREAEYSDK	7.570000172	0.958838522	0.958838522	0.124211826	1384.21405	15.13563	12.99933	15.31977	0	0	0	17.04079	0	11.44565	15.55541	12.59228	16.59294	14.81829	17.58204	0	14.63451	0	13.76537	14.56542	14.8092	16.20068	11.28774	14.90921	0	11.503	0	18.9576	16.81245	13.56688	8.711724	14.79399	17.1034	17.4598	18.6998	0	11.97885	0	16.05159	0	0	14.01445	16.65879	14.29152	16.20749	13.63958	0	13.5453	0
P54762	EPHB1_HUMAN	"Ephrin type-B receptor 1, EC 2.7.10.1 (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6, EK6, hEK6) (Neuronally-expressed EPH-related tyrosine kinase, NET) (Tyrosine-protein kinase receptor EPH-2)"	EPHB1 ELK EPHT2 HEK6 NET	Homo sapiens (Human)	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0001525; GO:0001771; GO:0004712; GO:0004714; GO:0005005; GO:0005524; GO:0005576; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0008046; GO:0014719; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0033674; GO:0043005; GO:0043235; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070062; GO:0070372; GO:0098978; GO:1901214; GO:1902723; GO:1902725	NGFYLAFQDYGACMSLLSVR	4.940000057	0.212792337	0.212792337	0.147619986	2326.904804	14.80291	0	12.33123	0	13.10309	12.20814	0	10.83592	15.07269	0	0	14.34779	15.04206	12.57555	13.41095	0	0	0	0	0	0	0	0	0	15.64347	0	0	0	0	0	0	0	0	0	0	0	0	15.1496	0	0	15.343	0	0	0	0	0	0	0
P54764	EPHA4_HUMAN	"Ephrin type-A receptor 4, EC 2.7.10.1 (EPH-like kinase 8, EK8, hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK)"	EPHA4 HEK8 SEK TYRO1	Homo sapiens (Human)	adherens junction organization [GO:0034332]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron projection development [GO:0010977]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; neuron projection fasciculation [GO:0106030]; neuron projection guidance [GO:0097485]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	adherens junction [GO:0005912]; axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	adherens junction [GO:0005912]; axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; DH domain binding [GO:0097161]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase binding [GO:1990782]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; adherens junction organization [GO:0034332]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron projection development [GO:0010977]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; neuron projection fasciculation [GO:0106030]; neuron projection guidance [GO:0097485]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; DH domain binding [GO:0097161]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase binding [GO:1990782]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0001540; GO:0004672; GO:0004712; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005741; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005912; GO:0007155; GO:0007162; GO:0007169; GO:0007411; GO:0007628; GO:0008045; GO:0008284; GO:0008347; GO:0009986; GO:0010719; GO:0010977; GO:0016301; GO:0018108; GO:0021957; GO:0030175; GO:0030335; GO:0030336; GO:0030424; GO:0030425; GO:0031594; GO:0031901; GO:0033674; GO:0034332; GO:0042731; GO:0042802; GO:0043005; GO:0043087; GO:0043197; GO:0043198; GO:0043204; GO:0043235; GO:0043507; GO:0043679; GO:0044295; GO:0045785; GO:0046777; GO:0046875; GO:0048013; GO:0048681; GO:0048710; GO:0050770; GO:0050775; GO:0050821; GO:0061001; GO:0061098; GO:0070373; GO:0072178; GO:0090102; GO:0097155; GO:0097156; GO:0097161; GO:0097485; GO:0098685; GO:0098839; GO:0098883; GO:0098978; GO:0099055; GO:0099056; GO:0106030; GO:1900038; GO:1900272; GO:1902004; GO:1902961; GO:1903051; GO:1904646; GO:1905244; GO:1990782; GO:2001108	IDTIAADESFTQVDIGDRIMK	5.329999924	0.262988836	0.262988836	0.106981058	2353.853234	0	0	10.39093	13.0351	0	11.7025	14.60383	0	0	0	0	0	14.35911	0	12.88106	14.05974	0	14.96567	0	0	0	0	13.15359	0	16.1611	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.29137	0	0	0	0	0	11.00607	0
P54793	ARSF_HUMAN	"Arylsulfatase F, ASF, EC 3.1.6.1"	ARSF	Homo sapiens (Human)		endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005788; GO:0046872; GO:0070062	VANALK	4.71999979	1	1	0.226956934	615.2803785	15.16555	15.32144	0	16.0262	14.99555	14.4753	15.87533	15.18495	0	16.03597	16.35844	14.17748	15.93639	0	0	15.43662	15.50315	15.27691	0	0	0	17.04633	16.99103	0	0	16.56468	0	0	13.91029	15.3774	16.55933	16.66987	17.00648	16.47845	16.35463	15.2391	0	16.81966	0	17.14249	16.13552	15.34572	0	0	0	0	16.57661	0
P54826	GAS1_HUMAN	"Growth arrest-specific protein 1, GAS-1"	GAS1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell fate commitment [GO:0045165]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; developmental growth [GO:0048589]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; regulation of apoptotic process [GO:0042981]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589]	anchored component of plasma membrane [GO:0046658]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	anchored component of plasma membrane [GO:0046658]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; cell fate commitment [GO:0045165]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; developmental growth [GO:0048589]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; regulation of apoptotic process [GO:0042981]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589]		GO:0005886; GO:0007049; GO:0008589; GO:0010955; GO:0016021; GO:0035924; GO:0042981; GO:0045165; GO:0045930; GO:0046658; GO:0048589; GO:0060628	RSSGGGGR	3.029999971	1	1	0	734.4438965	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P54886	P5CS_HUMAN	"Delta-1-pyrroline-5-carboxylate synthase, P5CS (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase, GK, EC 2.7.2.11 (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase, GPR, EC 1.2.1.41 (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase) ]"	ALDH18A1 GSAS P5CS PYCS	Homo sapiens (Human)	citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]	ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0006536; GO:0006561; GO:0006592; GO:0019240; GO:0042802; GO:0055129	EMMLVTSGAVAFGK	6.170000076	0.547357678	0.547357678	0.046058723	1457.773031	0	0	14.13883	0	14.98448	0	13.81918	0	0	0	0	11.86026	0	0	0	0	0	0	0	0	0	17.42975	0	0	0	0	0	0	0	0	0	0	15.15802	0	0	16.92385	0	15.34289	16.70142	0	0	0	16.04791	0	16.7163	0	0	0
P54922	ADPRH_HUMAN	"ADP-ribosylhydrolase ARH1, EC 3.2.2.19 (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase, ADP-ribosylarginine hydrolase, hARH1)"	ADPRH ARH1	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; protein de-ADP-ribosylation [GO:0051725]; regulation of autophagosome assembly [GO:2000785]	autophagosome [GO:0005776]; cytosol [GO:0005829]; extracellular space [GO:0005615]; recycling endosome [GO:0055037]	autophagosome [GO:0005776]; cytosol [GO:0005829]; extracellular space [GO:0005615]; recycling endosome [GO:0055037]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; protein de-ADP-ribosylation [GO:0051725]; regulation of autophagosome assembly [GO:2000785]	ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]	GO:0000287; GO:0003875; GO:0005096; GO:0005615; GO:0005776; GO:0005829; GO:0006464; GO:0030955; GO:0051725; GO:0055037; GO:0090630; GO:2000785	ALYSLGSK	3.25	1	1	0.051951075	839.0311143	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P55008	AIF1_HUMAN	"Allograft inflammatory factor 1, AIF-1 (Ionized calcium-binding adapter molecule 1) (Protein G1)"	AIF1 G1 IBA1	Homo sapiens (Human)	"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cellular response to oxidative stress [GO:0034599]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178]"	actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	"actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cellular response to oxidative stress [GO:0034599]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178]"	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]	GO:0001726; GO:0001774; GO:0001891; GO:0001934; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0010629; GO:0014739; GO:0016601; GO:0021549; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0031668; GO:0032587; GO:0032722; GO:0032755; GO:0032870; GO:0034599; GO:0042102; GO:0043066; GO:0043204; GO:0045429; GO:0048471; GO:0048661; GO:0048662; GO:0048678; GO:0050921; GO:0051015; GO:0051017; GO:0051384; GO:0051602; GO:0051764; GO:0071315; GO:0071346; GO:0071447; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:1900087; GO:2000406	MILMYEEKAR	2.670000076	1	1	0.290167027	1302.347182	17.08277	0	15.2185	15.84943	0	15.5902	15.50213	0	0	15.30858	14.65358	11.87961	0	14.92024	0	17.44869	0	16.20908	0	0	0	0	0	0	16.17364	0	14.77163	0	0	14.03044	15.91271	0	15.7578	0	0	0	16.86386	16.44034	0	0	16.78064	16.39557	0	0	14.70204	0	15.92564	0
P55011	S12A2_HUMAN	Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2)	SLC12A2 NKCC1	Homo sapiens (Human)	aging [GO:0007568]; ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; ion transport [GO:0006811]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium:potassium:chloride symporter activity [GO:0008511]; aging [GO:0007568]; ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; ion transport [GO:0006811]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104]	ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium:potassium:chloride symporter activity [GO:0008511]	GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0007568; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015377; GO:0015379; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0031253; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0044298; GO:0045795; GO:0046873; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0061044; GO:0070062; GO:0070634; GO:0071944; GO:0072488; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:0150104; GO:1902476; GO:1903561; GO:1904450; GO:1904464; GO:1990573; GO:1990869	KDWLQADMR	3.789999962	0.4536919	0.4536919	0.111860126	1179.694872	12.27754	14.88014	0	0	13.02374	13.88027	11.89399	14.94889	12.24087	10.84768	14.83923	0	12.90355	0	0	0	0	0	0	0	0	14.95719	0	0	15.67414	0	0	0	0	0	0	15.20936	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P55017	S12A3_HUMAN	"Solute carrier family 12 member 3 (Na-Cl cotransporter, NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter)"	SLC12A3 NCC TSC	Homo sapiens (Human)	cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]	GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006814; GO:0006884; GO:0008511; GO:0015081; GO:0015378; GO:0015379; GO:0016020; GO:0016324; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070062; GO:1902476; GO:1990573	QRMPELQLIANGHTK	3.150000095	0.547539294	0.547539294	0.068097072	1736.965735	0	15.34426	15.65643	16.87302	0	15.67527	0	0	14.71838	15.27422	0	11.87218	16.71309	16.68339	0	16.25728	15.3407	0	0	16.5075	15.83677	0	16.42797	15.96143	0	16.50299	0	0	17.85055	15.60859	13.72674	13.50149	16.31343	0	15.67175	16.22217	17.61217	0	15.02523	16.34109	17.06461	15.9081	0	16.13536	14.99073	0	16.47539	17.14432
P55036	PSMD4_HUMAN	"26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1, AF, ASF) (Multiubiquitin chain-binding protein)"	PSMD4 MCB1	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]	GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161	QGKNHK	3.680000067	1	1	0.062018189	710.7949773	0	0	16.84025	0	14.2152	0	13.1807	12.09969	15.74613	12.52888	0	0	0	16.33853	15.42934	13.61292	16.70315	16.33587	0	15.9672	15.92366	12.67189	16.67394	0	14.72213	18.28248	0	0	0	14.68004	0	17.18171	17.09234	12.98392	0	12.4	0	16.78999	16.92489	0	0	0	16.73902	15.99812	14.3903	15.08406	0	0
P55039	DRG2_HUMAN	"Developmentally-regulated GTP-binding protein 2, DRG-2 (Translation factor GTPase DRG2, TRAFAC GTPase DRG2, EC 3.6.5.-)"	DRG2	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872	EIARTQK	7.539999962	1	1	0.201333099	844.6300668	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.89075	0	0	0	0	17.81585	18.24983	0	0	0	0	0	0	0	20.16177	0	0	0	0	0	0	0	0	0	18.86451	0	0	0	0	0	0	0
P55040	GEM_HUMAN	GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR)	GEM KIR	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]	cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]	cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165]	calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]	GO:0000278; GO:0000287; GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005634; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686; GO:1901842	EPHQYSHRNR	5.75	1	1	0.273717765	1323.370799	12.35344	0	0	0	0	0	0	0	0	0	0	0	11.65255	0	0	13.42477	0	15.04785	15.85738	13.72389	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.38115	0	0	0	0	14.51569	14.89581	0	0	0	0	0	0	0
P55042	RAD_HUMAN	GTP-binding protein RAD (RAD1) (Ras associated with diabetes)	RRAD RAD	Homo sapiens (Human)	negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264]	calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005829; GO:0005886; GO:0007264; GO:1901842	WLPGHCMAMGDAYVIVYSVTDK	8.5	1	1	0.953887156	2530.128909	13.08135	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.99654	0	20.7683	0	0	0	0	0	19.07871	0	0	0	0	0	0	0	0	0	0	0
P55060	XPO2_HUMAN	"Exportin-2, Exp2 (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter)"	CSE1L CAS XPO2	Homo sapiens (Human)	protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]	nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]	GO:0005049; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006611; GO:0016020; GO:0031267; GO:0070062	YGALALQEIFDGIQPK	1.149999976	1	1	0.360104535	1761.593864	14.36925	0	15.92543	14.10694	0	15.00332	12.82528	15.24331	0	14.64727	15.24057	15.41733	15.43098	15.06944	14.93116	14.46526	0	14.09508	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.14876	15.24359	0	17.36704	11.29607	0	0	0	0	0	0	16.26564	0
P55061	BI1_HUMAN	"Bax inhibitor 1, BI-1 (Testis-enhanced gene transcript protein) (Transmembrane BAX inhibitor motif-containing protein 6)"	TMBIM6 BI1 TEGT	Homo sapiens (Human)	autophagy [GO:0006914]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoribonuclease activity [GO:0060702]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of protein binding [GO:0032091]; negative regulation of RNA splicing [GO:0033119]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; response to L-glutamate [GO:1902065]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; endoribonuclease inhibitor activity [GO:0060698]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoribonuclease activity [GO:0060702]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of protein binding [GO:0032091]; negative regulation of RNA splicing [GO:0033119]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; response to L-glutamate [GO:1902065]	endoribonuclease inhibitor activity [GO:0060698]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]	GO:0002638; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005887; GO:0006914; GO:0010523; GO:0016020; GO:0016021; GO:0019899; GO:0031625; GO:0031966; GO:0032091; GO:0032469; GO:0033119; GO:0034620; GO:0043066; GO:0060698; GO:0060702; GO:0070059; GO:1902065; GO:1902236; GO:1903298; GO:1990441; GO:2001234	MNIFDRK	19.12000084	1	1	9.19E-13	923.8351542	13.87424	14.5412	14.1581	15.89871	0	14.44396	15.96484	0	0	15.83563	0	0	0	0	0	15.11804	0	13.87082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P55157	MTP_HUMAN	Microsomal triglyceride transfer protein large subunit	MTTP MTP	Homo sapiens (Human)	cholesterol homeostasis [GO:0042632]; chylomicron assembly [GO:0034378]; circadian rhythm [GO:0007623]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle remodeling [GO:0034374]; phospholipid transport [GO:0015914]; plasma lipoprotein particle assembly [GO:0034377]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; response to calcium ion [GO:0051592]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]; very-low-density lipoprotein particle assembly [GO:0034379]	basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; microvillus membrane [GO:0031528]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; vesicle [GO:0031982]	basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; microvillus membrane [GO:0031528]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; vesicle [GO:0031982]; apolipoprotein binding [GO:0034185]; ceramide 1-phosphate transfer activity [GO:1902388]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transfer activity [GO:0120014]; phospholipid transporter activity [GO:0005548]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; triglyceride transfer activity [GO:0140344]; cholesterol homeostasis [GO:0042632]; chylomicron assembly [GO:0034378]; circadian rhythm [GO:0007623]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle remodeling [GO:0034374]; phospholipid transport [GO:0015914]; plasma lipoprotein particle assembly [GO:0034377]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; response to calcium ion [GO:0051592]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]; very-low-density lipoprotein particle assembly [GO:0034379]	apolipoprotein binding [GO:0034185]; ceramide 1-phosphate transfer activity [GO:1902388]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transfer activity [GO:0120014]; phospholipid transporter activity [GO:0005548]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; triglyceride transfer activity [GO:0140344]	GO:0005319; GO:0005548; GO:0005783; GO:0005788; GO:0005791; GO:0005794; GO:0005829; GO:0006497; GO:0006629; GO:0006641; GO:0007623; GO:0008289; GO:0009306; GO:0015914; GO:0016323; GO:0031526; GO:0031528; GO:0031982; GO:0034185; GO:0034197; GO:0034374; GO:0034377; GO:0034378; GO:0034379; GO:0042157; GO:0042632; GO:0042953; GO:0043235; GO:0044877; GO:0046982; GO:0051592; GO:0120014; GO:0120019; GO:0120020; GO:0140344; GO:1902388; GO:1904121	LILGGLEKAEK	5.070000172	1	1	0.432460978	1169.024955	14.24029	13.11784	0	0	0	0	0	0	0	0	0	0	0	13.53526	14.73322	0	0	15.40255	0	0	0	0	0	0	0	0	0	0	16.14112	0	0	16.71243	16.63819	0	0	0	0	0	0	0	16.46307	0	0	0	0	0	0	0
P55196	AFAD_HUMAN	"Afadin (ALL1-fused gene from chromosome 6 protein, Protein AF-6) (Afadin adherens junction formation factor)"	AFDN AF6 MLLT4	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tight junction [GO:0070160]	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]	GO:0005654; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007155; GO:0007165; GO:0007267; GO:0008022; GO:0010628; GO:0016607; GO:0022409; GO:0030054; GO:0030336; GO:0031267; GO:0032880; GO:0043547; GO:0044291; GO:0044331; GO:0045296; GO:0046930; GO:0046931; GO:0050839; GO:0051015; GO:0061951; GO:0070160; GO:0070830; GO:0090557; GO:2000049	LEKQQQMHIVDMLSK	5.929999828	1	1	0.263573182	1842.873353	0	15.69566	15.28402	13.79205	14.28177	0	16.05872	0	14.89027	0	0	0	0	0	16.64326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P55197	AF10_HUMAN	Protein AF-10 (ALL1-fused gene from chromosome 10 protein)	MLLT10 AF10	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]	GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0031491; GO:0032991; GO:0042393; GO:0045944; GO:0046872	GSLSPR	8.380000114	0.736656785	0.736656785	0.187224268	617.4371217	11.49012	17.40365	15.15821	15.46749	16.94231	17.90914	16.92758	14.49627	14.79374	16.94396	12.85021	15.8128	16.43525	0	14.17697	16.1218	16.63297	14.60446	17.03393	14.44267	16.2469	16.63011	0	16.67248	14.80337	15.31225	16.59394	0	15.50287	0	0	15.79224	0	0	0	0	0	15.9786	0	15.16394	0	0	0	0	15.79748	15.41502	17.29524	16.138
P55201	BRPF1_HUMAN	Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140)	BRPF1 BR140	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006355; GO:0006357; GO:0010698; GO:0043966; GO:0043972; GO:0044154; GO:0045893; GO:0046872; GO:0050793; GO:0070776; GO:1903706	GWSSEKVK	7.440000057	1	1	0.107883744	922.0681364	0	0	16.01969	0	12.00015	16.18491	0	0	0	16.50458	0	0	0	0	0	0	0	0	0	0	0	0	17.21257	0	0	14.91734	0	0	0	0	0	0	0	14.93705	0	0	0	0	18.17082	0	0	0	0	0	0	0	0	0
P55211	CASP9_HUMAN	"Caspase-9, CASP-9, EC 3.4.22.62 (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3, APAF-3) (ICE-like apoptotic protease 6, ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10 ]"	CASP9 MCH6	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770]	apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]	GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0007568; GO:0008047; GO:0008233; GO:0008303; GO:0008630; GO:0008635; GO:0017124; GO:0019901; GO:0030220; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0046677; GO:0071549; GO:0071887; GO:0097153; GO:0097193; GO:0097199; GO:0097200; GO:0097202; GO:2001020	FSSLHFMVEVK	13.11999989	0.130947992	0.130947992	0.171013223	1323.781735	15.50791	10.64948	14.02824	13.30874	17.26755	15.78446	15.11166	0	0	19.40303	0	15.01896	0	9.777634	16.82236	13.78352	15.99185	0	0	10.2878	0	0	14.43179	0	0	0	17.44132	0	0	0	0	0	0	0	15.83981	14.48325	0	0	0	0	13.8764	11.27624	13.91194	0	0	14.87883	15.88564	0
P55268	LAMB2_HUMAN	"Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta, S-LAM beta)"	LAMB2 LAMS	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]	GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005788; GO:0007411; GO:0007528; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0014044; GO:0016477; GO:0031594; GO:0034446; GO:0043083; GO:0043256; GO:0043260; GO:0045785; GO:0048677; GO:0051149; GO:0060041; GO:0062023; GO:0070062; GO:0070831; GO:0072249; GO:0072274; GO:0098637; GO:0110011; GO:2001046	AGFGGR	6.150000095	1	1	0.296107849	565.1939611	18.34848	0	0	0	0	0	0	0	0	0	0	0	15.84965	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6777	0	0
P55283	CADH4_HUMAN	"Cadherin-4 (Retinal cadherin, R-CAD, R-cadherin)"	CDH4	Homo sapiens (Human)	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of axon extension [GO:0045773]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of axon extension [GO:0045773]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007157; GO:0007411; GO:0016342; GO:0045296; GO:0045773; GO:0098742	APGVR	3.140000105	1	1	0.110324714	497.242226	15.31079	0	0	0	16.2468	15.56313	14.82787	15.62335	0	16.74092	14.19755	0	0	0	0	0	13.10404	15.08436	0	0	0	0	0	0	0	0	0	0	0	0	0	15.57069	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P55285	CADH6_HUMAN	"Cadherin-6 (Kidney cadherin, K-cadherin)"	CDH6	Homo sapiens (Human)	adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0000902; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0007219; GO:0016021; GO:0016339; GO:0016342; GO:0030054; GO:0034332; GO:0045296; GO:0098742	EPLIISK	8.279999733	1	1	0.253396638	799.9774703	0	0	14.46641	16.60804	0	0	0	0	0	0	0	0	0	0	0	0	0	10.57193	0	15.15888	15.20592	0	0	12.70999	0	0	0	12.94975	15.03498	0	0	13.66415	14.62481	0	9.445889	0	0	0	13.69946	0	0	0	0	0	0	15.55521	0	0
P55286	CADH8_HUMAN	Cadherin-8	CDH8	Homo sapiens (Human)	"adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]; response to cold [GO:0009409]; synaptic transmission, glutamatergic [GO:0035249]"	adherens junction [GO:0005912]; axon terminus [GO:0043679]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]	"adherens junction [GO:0005912]; axon terminus [GO:0043679]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]; response to cold [GO:0009409]; synaptic transmission, glutamatergic [GO:0035249]"	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]	GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0009409; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0035249; GO:0042802; GO:0043083; GO:0043679; GO:0045296; GO:0050807; GO:0097060; GO:0098742; GO:0098978	LGELYSVGESDKET	6.809999943	1	1	0.570730549	1526.976465	17.57046	14.99858	17.30116	18.33448	0	0	0	0	20.21659	0	0	0	0	0	0	0	0	0	0	0	19.38949	0	19.17293	0	18.9988	0	0	18.83149	18.50285	0	0	0	0	0	0	0	0	0	19.35379	17.67505	0	0	18.58521	0	0	0	17.54944	19.16897
P55287	CAD11_HUMAN	"Cadherin-11 (OSF-4) (Osteoblast cadherin, OB-cadherin)"	CDH11	Homo sapiens (Human)	adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; ossification [GO:0001503]; skeletal system development [GO:0001501]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; ossification [GO:0001503]; skeletal system development [GO:0001501]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0000902; GO:0001501; GO:0001503; GO:0005509; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0021957; GO:0034332; GO:0045296; GO:0050804; GO:0070062; GO:0098685; GO:0098742; GO:0098978	FISNGPFK	2.75999999	1	1	0.125717434	908.9321082	0	0	14.91607	0	0	14.91142	0	15.21268	0	0	0	0	0	0	0	0	14.22147	0	0	0	15.56013	0	0	0	0	15.10839	0	0	0	15.72262	14.76106	14.64612	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P55289	CAD12_HUMAN	"Cadherin-12 (Brain cadherin, BR-cadherin) (Neural type cadherin 2, N-cadherin 2)"	CDH12	Homo sapiens (Human)	adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742	QQELYFLPVVIEDSSYPVQSSTNTMTIR	2.779999971	0.443344593	0.443344593	0.104611869	3246.17986	0	13.57175	11.25035	0	16.22326	12.31431	14.38055	0	0	14.30008	14.45798	14.78254	13.65509	0	0	0	11.77996	0	0	0	0	0	0	13.10347	0	12.94452	0	0	0	0	0	15.91326	0	0	12.46939	0	16.18086	0	0	0	0	0	0	0	0	0	0	0
P55290	CAD13_HUMAN	"Cadherin-13 (Heart cadherin, H-cadherin) (P105) (Truncated cadherin, T-cad, T-cadherin)"	CDH13 CDHH	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; endothelial cell migration [GO:0043542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte proliferation [GO:0043616]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rac protein signal transduction [GO:0016601]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; Rho protein signal transduction [GO:0007266]; sprouting angiogenesis [GO:0002040]	anchored component of membrane [GO:0031225]; catenin complex [GO:0016342]; caveola [GO:0005901]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; catenin complex [GO:0016342]; caveola [GO:0005901]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; adiponectin binding [GO:0055100]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; protein homodimerization activity [GO:0042803]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; endothelial cell migration [GO:0043542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte proliferation [GO:0043616]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rac protein signal transduction [GO:0016601]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; Rho protein signal transduction [GO:0007266]; sprouting angiogenesis [GO:0002040]	adiponectin binding [GO:0055100]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; protein homodimerization activity [GO:0042803]	GO:0001938; GO:0001954; GO:0002040; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005901; GO:0005925; GO:0007156; GO:0007162; GO:0007266; GO:0008285; GO:0009897; GO:0016339; GO:0016342; GO:0016601; GO:0030032; GO:0030100; GO:0030169; GO:0030335; GO:0031225; GO:0042058; GO:0042803; GO:0043005; GO:0043542; GO:0043616; GO:0045296; GO:0045944; GO:0048661; GO:0050850; GO:0050927; GO:0051668; GO:0055096; GO:0055100; GO:0062023; GO:0070062; GO:0071813; GO:0098742	FRLTGK	2.349999905	1	1	0.012766722	720.4907271	0	14.43275	12.93909	15.22894	14.15733	14.6527	10.05674	0	0	13.46335	16.32388	13.2812	0	0	0	14.48438	0	0	0	0	0	0	12.73179	13.85256	0	16.45147	16.72025	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P55291	CAD15_HUMAN	"Cadherin-15 (Cadherin-14) (Muscle cadherin, M-cadherin)"	CDH15 CDH14 CDH3	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	catenin complex [GO:0016342]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]	catenin complex [GO:0016342]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005794; GO:0005886; GO:0005901; GO:0007155; GO:0007156; GO:0016021; GO:0016342; GO:0031594; GO:0045296; GO:0070062; GO:0098742	APALSRVR	1.960000038	1	1	0.175016166	868.4766631	0	13.74587	11.69242	13.14795	15.71865	0	17.52649	0	0	0	15.77578	0	0	0	11.45944	0	0	0	15.07874	0	15.26703	0	0	0	0	14.05777	0	0	0	0	0	13.02279	0	0	0	0	0	0	0	0	0	0	0	15.83433	13.6209	0	0	0
P55316	FOXG1_HUMAN	"Forkhead box protein G1 (Brain factor 1, BF-1, BF1) (Brain factor 2, BF-2, BF2, hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1, HFK1) (Forkhead-related protein FKHL2, HFK2) (Forkhead-related protein FKHL3, HFK3)"	FOXG1 FKH2 FKHL1 FKHL2 FKHL3 FKHL4 FOXG1A FOXG1B FOXG1C	Homo sapiens (Human)	"aging [GO:0007568]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000981; GO:0002052; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007346; GO:0007420; GO:0007568; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0045892; GO:0048664; GO:1990837	HYDDPGK	6.650000095	0.083838508	0.083838508	0.258988986	831.6952958	0	14.12935	14.7957	14.65871	14.50438	13.97103	15.2517	14.64971	16.509	15.2721	15.64463	15.41601	16.59264	15.81905	14.72586	16.74903	12.98943	15.7154	15.8639	15.79666	15.12489	16.50934	0	16.76589	14.14215	15.49098	14.47513	14.0515	15.79399	16.40002	15.78696	15.91269	16.27365	0	14.74409	16.5706	0	0	16.71909	16.0089	0	16.34496	0	0	0	0	16.67793	16.62246
P55317	FOXA1_HUMAN	"Hepatocyte nuclear factor 3-alpha, HNF-3-alpha, HNF-3A (Forkhead box protein A1) (Transcription factor 3A, TCF-3A)"	FOXA1 HNF3A TCF3A	Homo sapiens (Human)	alveolar secondary septum development [GO:0061144]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell maturation involved in prostate gland development [GO:0060743]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; glucose homeostasis [GO:0042593]; hormone metabolic process [GO:0042445]; lung epithelial cell differentiation [GO:0060487]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland stromal morphogenesis [GO:0060741]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory basal cell differentiation [GO:1902691]; response to estradiol [GO:0032355]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]	chromatin [GO:0000785]; fibrillar center [GO:0001650]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; fibrillar center [GO:0001650]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; alveolar secondary septum development [GO:0061144]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell maturation involved in prostate gland development [GO:0060743]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; glucose homeostasis [GO:0042593]; hormone metabolic process [GO:0042445]; lung epithelial cell differentiation [GO:0060487]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland stromal morphogenesis [GO:0060741]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory basal cell differentiation [GO:1902691]; response to estradiol [GO:0032355]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005902; GO:0006338; GO:0006357; GO:0007219; GO:0009653; GO:0010719; GO:0019904; GO:0021904; GO:0030154; GO:0032355; GO:0033148; GO:0042445; GO:0042593; GO:0043065; GO:0045666; GO:0045880; GO:0045931; GO:0045944; GO:0048646; GO:0048665; GO:0051091; GO:0060441; GO:0060487; GO:0060528; GO:0060738; GO:0060740; GO:0060741; GO:0060743; GO:0061144; GO:0071542; GO:1902691; GO:1990837; GO:2000049	KDPSGASNPSADSPLHR	6.150000095	0.575532258	0.575532258	0.437254938	1734.859409	17.43912	14.75449	0	17.69515	16.20185	18.12926	0	18.4011	19.88032	17.6419	0	0	0	0	18.44109	0	0	0	0	18.20014	17.23256	19.05057	0	0	0	0	0	0	0	0	21.11275	20.05754	0	0	0	0	0	0	0	0	17.90803	18.59443	0	0	0	0	0	0
P55318	FOXA3_HUMAN	"Hepatocyte nuclear factor 3-gamma, HNF-3-gamma, HNF-3G (Fork head-related protein FKH H3) (Forkhead box protein A3) (Transcription factor 3G, TCF-3G)"	FOXA3 HNF3G TCF3G	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chromatin organization [GO:0006325]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chromatin organization [GO:0006325]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0007283; GO:0009267; GO:0009653; GO:0015629; GO:0019904; GO:0030154; GO:0045944; GO:0061484; GO:1990837	GGSGAATTTR	11.94999981	0.179220498	0.179220498	0.258685278	879.2297295	16.39581	19.04329	19.35646	18.54907	16.64985	18.46301	19.09434	19.74566	18.12743	16.55727	17.9194	0	0	0	18.53381	0	0	17.92162	15.91511	17.06656	0	0	0	18.71995	19.54972	0	17.54637	16.83347	18.34478	17.31459	18.57338	18.2757	18.59491	0	18.61165	19.55503	0	20.68924	18.44432	19.33301	17.63851	17.43625	18.86804	16.9281	0	18.17582	17.449	19.11287
P55771	PAX9_HUMAN	Paired box protein Pax-9	PAX9	Homo sapiens (Human)	"anatomical structure development [GO:0048856]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; face morphogenesis [GO:0060325]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; face morphogenesis [GO:0060325]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0005730; GO:0006357; GO:0007492; GO:0042476; GO:0042481; GO:0045892; GO:0048856; GO:0060325; GO:0071363; GO:1990837	GALEQEAK	11.76000023	1	1	0.169674657	846.1891269	16.404	16.40831	0	12.65336	0	16.39572	16.21364	0	16.8029	17.454	16.78902	16.93912	15.10299	11.29748	14.20023	16.77333	0	15.32126	0	11.10855	18.61987	16.37934	0	15.54832	0	0	0	14.4311	0	16.81696	0	0	0	0	16.28646	0	0	0	0	13.52035	0	0	0	0	0	0	0	0
P55773	CCL23_HUMAN	"C-C motif chemokine 23 (CK-beta-8, CKB-8) (Macrophage inflammatory protein 3, MIP-3) (Myeloid progenitor inhibitory factor 1, MPIF-1) (Small-inducible cytokine A23) [Cleaved into: CCL23(19-99); CCL23(22-99); CCL23(27-99); CCL23(30-99) ]"	CCL23 MIP3 MPIF1 SCYA23	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of C-C chemokine binding [GO:2001264]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR1 chemokine receptor binding [GO:0031726]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of C-C chemokine binding [GO:2001264]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	CCR chemokine receptor binding [GO:0048020]; CCR1 chemokine receptor binding [GO:0031726]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]	GO:0002548; GO:0005576; GO:0005615; GO:0006874; GO:0006935; GO:0006954; GO:0006955; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0008201; GO:0008285; GO:0030593; GO:0031726; GO:0043547; GO:0048020; GO:0048247; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:2001264	VSVAALSCLMLVTALGSQAR	4.949999809	1	1	0.343623808	2063.235085	0	12.01971	0	0	15.1702	12.88122	0	14.90448	14.83877	13.82801	0	0	11.62377	12.68561	0	0	0	0	0	0	0	0	16.60466	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P55786	PSA_HUMAN	"Puromycin-sensitive aminopeptidase, PSA, EC 3.4.11.14 (Cytosol alanyl aminopeptidase, AAP-S)"	NPEPPS PSA	Homo sapiens (Human)	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	DGVCVR	1.789999962	0.99680531	0.99680531	0.113652861	706.6479425	17.37532	14.23928	15.8168	17.82019	15.38473	12.84841	14.56008	10.77607	17.13355	17.07593	15.6393	15.60369	0	14.4791	6.445952	14.62421	17.60699	0	14.11929	10.19686	0	17.11225	17.34791	17.23329	17.12101	15.26021	17.41661	14.59222	16.20083	14.38986	16.31813	19.16525	12.71138	18.79445	15.22729	16.0492	15.29969	10.56645	12.18166	12.66564	17.46143	14.80652	15.55661	13.44103	15.39679	16.49874	13.50813	14.42048
P55789	ALR_HUMAN	"FAD-linked sulfhydryl oxidase ALR, EC 1.8.3.2 (Augmenter of liver regeneration, hERV1) (Hepatopoietin)"	GFER ALR HERV1 HPO	Homo sapiens (Human)	cellular response to actinomycin D [GO:0072717]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573]	cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein-disulfide reductase activity [GO:0015035]; cellular response to actinomycin D [GO:0072717]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573]	flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein-disulfide reductase activity [GO:0015035]	GO:0001889; GO:0005615; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0043066; GO:0045953; GO:0050660; GO:0071222; GO:0071356; GO:0072717; GO:0097237; GO:0097421; GO:1903204; GO:2000573	MAAPGERGR	1.070000052	0.964522481	0.964522481	0.217969659	943.9784943	0	12.68378	11.73563	14.03912	0	0	15.72034	0	0	0	0	15.87185	0	0	15.58062	0	15.69162	0	0	0	0	0	0	15.16048	15.79928	0	0	0	15.16517	0	0	17.06751	15.83824	16.11339	0	0	16.02366	16.19541	15.73539	0	15.65232	15.44347	15.42479	0	0	14.69052	15.97877	0
P55809	SCOT1_HUMAN	"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)"	OXCT1 OXCT SCOT	Homo sapiens (Human)	adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]	GO:0005739; GO:0005759; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612	GNAHKIMEK	5.800000191	0.301409006	0.301409006	0.217822097	1044.398263	0	16.18262	15.94956	0	0	13.87238	0	13.85288	13.16085	0	12.11344	0	16.31375	15.54548	15.71288	0	12.10609	16.06211	15.72489	15.61403	0	0	0	15.5365	0	14.94119	15.65316	0	0	14.89507	16.75641	16.17147	16.40398	16.14038	15.77055	14.8178	14.94528	14.53831	15.00908	11.57842	13.95423	15.39535	14.1223	14.52651	0	0	15.7685	15.09864
P55851	UCP2_HUMAN	"Mitochondrial uncoupling protein 2, UCP 2 (Solute carrier family 25 member 8) (UCPH)"	UCP2 SLC25A8	Homo sapiens (Human)	adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; female pregnancy [GO:0007565]; liver regeneration [GO:0097421]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; positive regulation of cell death [GO:0010942]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidative phosphorylation uncoupler activity [GO:0017077]; adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; female pregnancy [GO:0007565]; liver regeneration [GO:0097421]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; positive regulation of cell death [GO:0010942]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303]	oxidative phosphorylation uncoupler activity [GO:0017077]	GO:0000303; GO:0001666; GO:0005739; GO:0005743; GO:0006839; GO:0007565; GO:0007568; GO:0009409; GO:0010942; GO:0016021; GO:0017077; GO:0032869; GO:0034198; GO:0043066; GO:0051881; GO:0061179; GO:0070542; GO:0071333; GO:0097421; GO:0120162; GO:1902600; GO:1990542; GO:1990845	RALMAACTSR	7.96999979	0.010960368	0.010960368	0.293394902	1152.335296	9.198606	14.55956	14.71666	14.22561	0	13.37722	11.14678	14.20837	0	15.08236	0	0	12.01298	0	12.51858	15.57523	15.58869	0	0	0	0	0	0	0	0	0	16.09105	0	0	0	0	0	0	0	0	0	16.3688	0	18.14846	14.7841	0	0	15.74987	16.13536	0	0	14.44882	17.66197
P55884	EIF3B_HUMAN	"Eukaryotic translation initiation factor 3 subunit B, eIF3b (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog, hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)"	EIF3B EIF3S9	Homo sapiens (Human)	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525	AAEAEPR	10.92000008	0.429452658	0.429452658	0.119309704	743.7918088	15.8298	0	17.26027	16.17418	12.08706	0	15.49287	12.48323	0	0	16.24035	16.47086	15.52771	16.24423	14.5949	15.45294	15.47891	11.34542	13.92022	17.57628	15.23912	12.53727	17.21091	15.01338	16.99706	15.9962	0	14.74323	13.84183	16.08002	0	16.96877	0	15.76732	16.69553	17.23319	16.48137	15.35948	17.39163	13.97517	17.17979	15.44915	11.77604	15.92755	0	0	0	18.59544
P55916	UCP3_HUMAN	"Mitochondrial uncoupling protein 3, UCP 3 (Solute carrier family 25 member 9)"	UCP3 SLC25A9	Homo sapiens (Human)	adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; proton transmembrane transport [GO:1902600]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to superoxide [GO:0000303]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidative phosphorylation uncoupler activity [GO:0017077]; transporter activity [GO:0005215]; adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; proton transmembrane transport [GO:1902600]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to superoxide [GO:0000303]	oxidative phosphorylation uncoupler activity [GO:0017077]; transporter activity [GO:0005215]	GO:0000303; GO:0001666; GO:0005215; GO:0005739; GO:0005743; GO:0006629; GO:0006631; GO:0006839; GO:0007568; GO:0007584; GO:0007585; GO:0009409; GO:0014823; GO:0016021; GO:0017077; GO:0032868; GO:0032870; GO:0051384; GO:1902600; GO:1990542; GO:1990845	TIAREEGVR	10.06999969	1	1	0.264690876	1031.963968	16.77022	15.10652	17.91646	15.85232	15.02886	14.09576	0	0	15.82178	15.91022	17.05101	0	0	0	0	16.15759	18.34431	0	15.09053	16.14431	0	17.22886	0	0	0	0	17.16573	0	0	15.74177	16.08552	0	0	17.24147	14.30036	0	0	17.32054	15.48367	0	0	0	0	0	17.22719	0	0	16.11213
P56134	ATPK_HUMAN	"ATP synthase subunit f, mitochondrial (ATP synthase membrane subunit f)"	ATP5MF ATP5J2 ATP5JL	Homo sapiens (Human)	ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]"	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600]"		GO:0005739; GO:0005743; GO:0005753; GO:0015986; GO:0016021; GO:0031965; GO:0042776; GO:0045263; GO:1902600	DFSPSGIFGAFQR	8.600000381	1	1	0.451380851	1428.265674	0	17.47961	17.54454	0	0	0	17.29262	17.36186	0	0	0	0	0	0	0	0	0	0	0	0	0	18.92537	0	0	0	17.19041	0	0	0	0	0	0	20.50217	0	0	0	19.83587	20.41628	0	0	16.23897	0	0	0	0	0	0	0
P56199	ITA1_HUMAN	Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a)	ITGA1	Homo sapiens (Human)	cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; vasodilation [GO:0042311]	acrosomal vesicle [GO:0001669]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha1-beta1 complex [GO:0034665]; integrin complex [GO:0008305]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	acrosomal vesicle [GO:0001669]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha1-beta1 complex [GO:0034665]; integrin complex [GO:0008305]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein phosphatase binding [GO:0019903]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; vasodilation [GO:0042311]	collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein phosphatase binding [GO:0019903]	GO:0001669; GO:0005178; GO:0005518; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008285; GO:0008305; GO:0009897; GO:0009986; GO:0016020; GO:0019903; GO:0030593; GO:0032516; GO:0033627; GO:0034665; GO:0042059; GO:0042311; GO:0043005; GO:0043204; GO:0043410; GO:0043525; GO:0045121; GO:0045123; GO:0045178; GO:0046872; GO:0048812; GO:0070062; GO:0098609; GO:0098639	DSNTDILLVGAPMYMGTEK	10.18000031	0.338006318	0.338006318	2.29E-12	2066.117029	14.54581	13.7532	0	13.93405	0	15.85123	16.34797	0	15.67454	0	14.49024	0	0	0	0	0	0	16.22969	0	0	0	0	0	0	17.76843	16.58701	13.75278	0	0	0	0	12.52395	17.34018	16.31149	0	16.24146	0	18.92094	0	0	0	0	0	0	0	0	0	0
P56202	CATW_HUMAN	"Cathepsin W, EC 3.4.22.- (Lymphopain)"	CTSW	Homo sapiens (Human)	immune response [GO:0006955]; proteolysis involved in cellular protein catabolic process [GO:0051603]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; immune response [GO:0006955]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0006955; GO:0008234; GO:0016020; GO:0031089; GO:0051603	VASAISPIK	3.450000048	0.701552391	0.701552391	0.231289137	885.3997119	17.94172	13.04194	0	11.82659	12.18867	14.35753	4.152008	0	0	0	0	0	0	0	15.61449	16.84937	16.35393	0	15.46624	15.96756	0	15.45903	15.47027	15.47141	15.50735	14.69398	15.33675	15.5277	0	12.9889	11.78272	0	0	0	0	16.98638	0	0	0	0	0	0	16.63947	0	18.51423	0	0	0
P56277	CMC4_HUMAN	"Cx9C motif-containing protein 4 (Mature T-cell proliferation 1 neighbor protein) (Mature T-cell proliferation-1 type A, MTCP-1 type A) (Protein p8 MTCP-1, p8MTCP1)"	CMC4 C6.1B MTCP1 MTCP1NB	Homo sapiens (Human)		mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]		GO:0005739; GO:0005758	MPQKDPCQK	8.180000305	0.165379256	0.165379256	0.0594234	1130.465237	0	12.59302	0	0	0	0	18.37629	0	10.43123	0	17.94592	0	0	0	0	0	0	9.825944	14.45968	16.69141	0	0	0	0	9.220648	0	10.37258	0	0	0	0	0	0	0	11.67631	0	11.81413	14.70876	0	12.69269	12.77254	0	13.5366	0	13.44457	16.23573	15.67117	0
P56282	DPOE2_HUMAN	DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)	POLE2 DPE2	Homo sapiens (Human)	DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	GO:0003677; GO:0003887; GO:0005654; GO:0006260; GO:0006261; GO:0006281; GO:0008622; GO:0016604; GO:0042276; GO:0043231	ALSAFK	5.070000172	0.129544988	0.129544988	0.290287288	633.8426117	15.28478	0	16.63618	15.9084	15.51164	15.86739	0	0	0	0	15.26906	15.59892	15.90531	16.24816	0	15.65576	16.27023	16.16641	0	16.5844	17.24311	13.89484	0	0	15.97389	16.8155	16.85073	16.25026	16.83151	17.10768	0	0	0	0	16.41287	17.81067	0	0	17.35535	16.31543	0	16.80584	0	17.05745	0	0	16.49074	16.54315
P56378	ATP68_HUMAN	"ATP synthase subunit ATP5MJ, mitochondrial (6.8 kDa mitochondrial proteolipid protein, MLQ) (ATP synthase membrane subunit 6.8PL)"	ATP5MJ ATP5MPL C14orf2 MP68 PRO1574	Homo sapiens (Human)	ATP synthesis coupled proton transport [GO:0015986]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; ATP synthesis coupled proton transport [GO:0015986]		GO:0005743; GO:0005753; GO:0015986; GO:0016021	VYQEIWIGMGLMGFIVYKIR	4.389999866	1	1	2.29E-12	2432.400766	12.3794	0	13.19529	0	11.18998	13.39434	11.65093	12.30033	0	0	0	0	12.8984	13.32367	0	13.2589	0	10.94026	13.06878	0	0	0	0	11.88696	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P56385	ATP5I_HUMAN	"ATP synthase subunit e, mitochondrial, ATPase subunit e (ATP synthase membrane subunit e) [Cleaved into: ATP synthase subunit e, mitochondrial, N-terminally processed ]"	ATP5ME ATP5I ATP5K	Homo sapiens (Human)	ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]"	"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]"	proton transmembrane transporter activity [GO:0015078]	GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0042776	YNYLKPR	9.380000114	1	1	0.002902314	955.6373569	0	0	0	0	0	14.34387	0	11.47258	14.16219	0	0	0	14.30756	0	15.0048	13.91057	0	13.83307	15.10206	0	14.9802	14.83728	0	0	0	13.51645	0	0	0	13.58745	14.37962	14.13609	0	11.88477	15.7122	12.59972	0	0	0	0	0	0	0	0	0	0	0	0
P56524	HDAC4_HUMAN	"Histone deacetylase 4, HD4, EC 3.5.1.98"	HDAC4 KIAA0288	Homo sapiens (Human)	"B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]"	DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0000978; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006476; GO:0006954; GO:0007399; GO:0008270; GO:0008284; GO:0010832; GO:0014894; GO:0014898; GO:0016575; GO:0016607; GO:0017053; GO:0019789; GO:0030183; GO:0030955; GO:0033235; GO:0033558; GO:0034983; GO:0040029; GO:0042113; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0045820; GO:0045892; GO:0045893; GO:0045944; GO:0051091; GO:0061629; GO:0070555; GO:0070932; GO:0070933; GO:0140297	MSSQSHPDGLSGR	6.940000057	1	1	0.254951557	1375.425594	0	10.62505	10.80485	0	15.005	0	0	13.50025	0	0	0	14.08425	0	0	0	0	0	0	16.14317	14.19529	0	0	0	0	0	0	0	0	0	0	0	0	0	15.09995	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P56537	IF6_HUMAN	"Eukaryotic translation initiation factor 6, eIF-6 (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP))"	EIF6 EIF3A ITGB4BP OK/SW-cl.27	Homo sapiens (Human)	assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; mature ribosome assembly [GO:0042256]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; mature ribosome assembly [GO:0042256]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054]"	ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0000054; GO:0000460; GO:0000470; GO:0003743; GO:0005634; GO:0005638; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006110; GO:0030687; GO:0032868; GO:0035195; GO:0035278; GO:0042256; GO:0042304; GO:0043022; GO:0043023; GO:0045652; GO:0045727; GO:0070062; GO:1902626; GO:2000377	LNEAQPSTIATSMRDSLIDSLT	12.82999992	0.622301698	0.622301698	0.575378217	2375.321174	0	0	0	0	0	0	0	0	0	20.8195	19.8529	0	0	0	0	0	0	0	0	24.78999	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	24.37992	0	0	0	0	0	0
P56696	KCNQ4_HUMAN	Potassium voltage-gated channel subfamily KQT member 4 (KQT-like 4) (Potassium channel subunit alpha KvLQT4) (Voltage-gated potassium channel subunit Kv7.4)	KCNQ4	Homo sapiens (Human)	inner ear morphogenesis [GO:0042472]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of sound [GO:0007605]	basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; inner ear morphogenesis [GO:0042472]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of sound [GO:0007605]	calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005267; GO:0005516; GO:0005886; GO:0006813; GO:0007605; GO:0008076; GO:0009925; GO:0016021; GO:0034765; GO:0042472; GO:0071805	GPGDRK	2.809999943	0.331344664	0.331344664	0.134011762	628.9158962	15.5656	0	16.85749	0	17.62005	0	0	0	0	0	15.7413	0	15.95654	15.6696	17.15026	17.68485	16.9477	15.43756	15.75326	0	16.66018	17.89735	13.56337	16.22893	0	17.5347	16.74179	16.9861	17.42725	0	16.68174	16.47388	16.90406	0	17.44344	16.36941	17.08764	18.21051	15.91805	0	15.21922	15.84338	17.44664	15.79295	16.25537	17.91506	17.3866	0
P56703	WNT3_HUMAN	Proto-oncogene Wnt-3 (Proto-oncogene Int-4 homolog)	WNT3 INT4	Homo sapiens (Human)	anterior/posterior axis specification [GO:0009948]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in stem cell proliferation [GO:1905474]; cell fate commitment [GO:0045165]; cell morphogenesis [GO:0000902]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral axis specification [GO:0009950]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; gamete generation [GO:0007276]; head morphogenesis [GO:0060323]; limb bud formation [GO:0060174]; mammary gland epithelium development [GO:0061180]; mesoderm formation [GO:0001707]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of gene expression [GO:0010628]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; Spemann organizer formation at the anterior end of the primitive streak [GO:0060064]; stem cell proliferation [GO:0072089]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; anterior/posterior axis specification [GO:0009948]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in stem cell proliferation [GO:1905474]; cell fate commitment [GO:0045165]; cell morphogenesis [GO:0000902]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral axis specification [GO:0009950]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; gamete generation [GO:0007276]; head morphogenesis [GO:0060323]; limb bud formation [GO:0060174]; mammary gland epithelium development [GO:0061180]; mesoderm formation [GO:0001707]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of gene expression [GO:0010628]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; Spemann organizer formation at the anterior end of the primitive streak [GO:0060064]; stem cell proliferation [GO:0072089]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]	GO:0000902; GO:0001707; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007276; GO:0007411; GO:0009948; GO:0009950; GO:0010628; GO:0019904; GO:0030177; GO:0030182; GO:0030666; GO:0031012; GO:0035115; GO:0035116; GO:0044338; GO:0044339; GO:0045165; GO:0048018; GO:0048697; GO:0048843; GO:0050767; GO:0060064; GO:0060070; GO:0060174; GO:0060323; GO:0061180; GO:0070062; GO:0071300; GO:0072089; GO:1904954; GO:1905474; GO:1990909	AIGDFLK	3.519999981	0.407504529	0.407504529	0.19628621	763.7254052	13.62969	0	0	0	16.79716	14.87515	15.17842	0	0	15.3776	0	15.36778	18.33489	15.34576	0	0	0	15.26038	16.13117	0	0	0	0	0	0	0	0	16.19663	0	0	15.73851	0	0	0	0	0	15.24144	0	0	0	0	0	0	0	0	0	0	0
P56715	RP1_HUMAN	Oxygen-regulated protein 1 (Retinitis pigmentosa 1 protein) (Retinitis pigmentosa RP1 protein)	RP1 ORP1	Homo sapiens (Human)	"axoneme assembly [GO:0035082]; cellular response to light stimulus [GO:0071482]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction, visible light [GO:0007603]; positive regulation of non-motile cilium assembly [GO:1902857]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]"	axoneme [GO:0005930]; ciliary tip [GO:0097542]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	"axoneme [GO:0005930]; ciliary tip [GO:0097542]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; microtubule binding [GO:0008017]; axoneme assembly [GO:0035082]; cellular response to light stimulus [GO:0071482]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction, visible light [GO:0007603]; positive regulation of non-motile cilium assembly [GO:1902857]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]"	microtubule binding [GO:0008017]	GO:0001750; GO:0001917; GO:0005874; GO:0005875; GO:0005930; GO:0007601; GO:0007603; GO:0008017; GO:0032391; GO:0035082; GO:0035556; GO:0035845; GO:0042461; GO:0045494; GO:0046548; GO:0046549; GO:0060041; GO:0071482; GO:0097542; GO:1902857	KISTHMSSSSR	4.980000019	0.20971863	0.20971863	1.38E-12	1235.845993	0	0	14.52301	0	0	14.78333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.03455	15.76236	16.64734	0	16.17535	16.33392	0	16.39792	17.42454	16.99552	0	0	0	0	0	0	0	0	0	0
P56730	NETR_HUMAN	"Neurotrypsin, EC 3.4.21.- (Leydin) (Motopsin) (Serine protease 12)"	PRSS12	Homo sapiens (Human)	exocytosis [GO:0006887]; zymogen activation [GO:0031638]	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; exocytosis [GO:0006887]; zymogen activation [GO:0031638]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0008236; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195	ASGNSNKESLSSVCGLR	1.019999981	0.906421304	0.906421304	0.400126566	1766.02975	0	14.91692	13.91103	15.25717	0	0	0	0	0	0	11.94776	0	0	0	0	15.70854	13.41256	0	0	0	0	0	0	0	0	14.91762	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P56851	EP3B_HUMAN	"Epididymal secretory protein E3-beta (Human epididymis-specific protein 3-beta, HE3-beta)"	EDDM3B FAM12B HE3B UNQ6412/PRO21187	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	MASSLK	4.519999981	1	1	0.159457618	653.4798627	15.56847	0	0	0	0	0	0	16.41266	0	16.19464	0	0	0	16.26746	0	0	0	0	0	0	0	0	0	16.42374	0	0	0	0	16.3009	0	16.4286	16.99897	17.21223	0	0	0	16.6002	16.6887	17.08946	0	0	0	15.89454	16.58282	17.53999	16.54056	15.79486	16.27464
P56880	CLD20_HUMAN	Claudin-20	CLDN20	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]	bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tight junction [GO:0070160]	bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0016338; GO:0042802; GO:0070160; GO:0070830	LGGDRETK	6.570000172	0.99400574	0.99400574	0.23287717	875.7633556	0	14.64289	0	0	16.51517	0	0	0	14.92908	16.7081	0	0	0	15.98559	13.77761	12.30768	16.41574	15.23208	14.02505	15.85914	0	16.65578	0	16.75303	15.31792	14.85174	15.48346	14.42925	0	0	0	0	15.23985	15.76328	14.26009	16.22972	4.030753	15.66042	15.76826	13.35856	15.82256	16.1617	15.8338	16.14714	15.92531	15.07857	14.40506	15.82164
P56945	BCAR1_HUMAN	Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas)	BCAR1 CAS CASS1 CRKAS	Homo sapiens (Human)	actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; ruffle [GO:0001726]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; ruffle [GO:0001726]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]	GO:0001558; GO:0001726; GO:0005737; GO:0005829; GO:0005925; GO:0007015; GO:0007155; GO:0007169; GO:0007173; GO:0007186; GO:0007229; GO:0008286; GO:0010595; GO:0015629; GO:0016020; GO:0016477; GO:0017124; GO:0019901; GO:0030027; GO:0030335; GO:0030424; GO:0035729; GO:0042981; GO:0048008; GO:0048010; GO:0048011; GO:0048012; GO:0050851; GO:0050852; GO:0050853; GO:0051301; GO:0060326; GO:0086100; GO:0090527	SQLELQQLK	5.769999981	1	1	0.284365871	1086.713221	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P57052	RBM11_HUMAN	Splicing regulator RBM11 (RNA-binding motif protein 11)	RBM11	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727]	GO:0000381; GO:0003727; GO:0005634; GO:0005654; GO:0006397; GO:0008266; GO:0008380; GO:0016607; GO:0030154; GO:0034599; GO:0042803	DREGKPK	9.710000038	0.191917539	0.191917539	0.299030193	826.9631462	16.98273	0	16.04583	0	16.35973	16.36345	18.37725	0	0	0	17.14368	16.25801	15.72128	0	0	14.03602	0	0	0	16.21416	0	0	16.42737	0	15.78426	0	0	15.45735	16.51309	0	19.68047	16.68545	16.25341	15.79729	16.63834	0	13.28011	16.80238	0	17.46852	0	0	0	16.69255	0	0	0	0
P57053	H2BFS_HUMAN	"Histone H2B type F-S (H2B-clustered histone 12 like) (H2B.S histone 1) (Histone H2B.s, H2B/s)"	H2BC12L H2BFS H2BS1	Homo sapiens (Human)	antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; nucleosome assembly [GO:0006334]; substantia nigra development [GO:0021762]	cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; nucleosome assembly [GO:0006334]; substantia nigra development [GO:0021762]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0002227; GO:0003677; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0019731; GO:0021762; GO:0046982; GO:0050830; GO:0061844	LLLPGELAK	17.97999954	1	1	0.517211844	953.2943562	0	0	0	0	0	0	0	0	0	0	0	17.23379	0	0	0	0	17.61959	0	0	0	0	0	0	18.17498	0	0	18.9077	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.49369	0	0	0	0
P57055	DSCR6_HUMAN	Protein ripply3 (Down syndrome critical region protein 6)	RIPPLY3 DSCR6	Homo sapiens (Human)	embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pharyngeal system development [GO:0060037]	nucleus [GO:0005634]	nucleus [GO:0005634]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pharyngeal system development [GO:0060037]		GO:0000122; GO:0005634; GO:0007507; GO:0008285; GO:0009880; GO:0060037	VYLPMSK	9.039999962	1	1	2.05E-12	853.1693219	0	15.88369	0	0	15.31046	0	13.06612	12.99312	0	11.26132	16.90601	0	0	16.74982	0	14.97231	15.116	15.86246	14.58588	16.32789	0	16.49778	16.18783	16.52724	0	14.72127	15.34299	15.88877	14.31433	12.28583	0	17.02561	0	15.29319	15.93069	16.14919	16.18536	13.30701	0	15.32829	14.99367	0	17.29874	12.07023	17.16563	16.70309	15.70657	16.23383
P57071	PRD15_HUMAN	"PR domain zinc finger protein 15, EC 2.1.1.- (PR domain-containing protein 15) (Zinc finger protein 298)"	PRDM15 C21orf83 ZNF298	Homo sapiens (Human)	methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0008168; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035	DSFVLSRAR	5.630000114	1	1	0.136760383	1054.582815	0	0	0	15.70682	0	0	0	11.76309	0	0	0	16.76501	0	0	12.23181	0	0	13.93993	0	0	11.96262	17.62689	15.49049	14.56562	0	0	0	0	16.34338	0	18.18344	0	14.87435	19.97561	16.45597	11.46747	18.83409	14.9741	0	17.01299	0	17.14487	16.48587	0	0	16.71136	0	0
P57073	SOX8_HUMAN	Transcription factor SOX-8	SOX8	Homo sapiens (Human)	"adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hormone levels [GO:0010817]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hormone levels [GO:0010817]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001649; GO:0001701; GO:0001755; GO:0002009; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007165; GO:0007283; GO:0007422; GO:0008584; GO:0010628; GO:0010817; GO:0014015; GO:0014032; GO:0033690; GO:0035914; GO:0043066; GO:0045165; GO:0045444; GO:0045662; GO:0045892; GO:0045893; GO:0045944; GO:0046533; GO:0048469; GO:0048484; GO:0048709; GO:0060009; GO:0060018; GO:0060041; GO:0060221; GO:0060612; GO:0061138; GO:0072034; GO:0072197; GO:0072289; GO:0090184; GO:0090190; GO:0140297; GO:1990837	MLDMSEAR	18.29000092	1	1	0.212964077	968.4374597	12.95834	11.52923	13.69113	0	14.2838	14.82287	13.78403	12.79996	14.39221	14.08435	13.1518	14.10827	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P57075	UBS3A_HUMAN	"Ubiquitin-associated and SH3 domain-containing protein A (Cbl-interacting protein 4, CLIP4) (Suppressor of T-cell receptor signaling 2, STS-2) (T-cell ubiquitin ligand 1, TULA-1)"	UBASH3A STS2	Homo sapiens (Human)	negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of cytokine production [GO:0001817]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of cytokine production [GO:0001817]		GO:0001817; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0050860; GO:0070062	KSVLVVR	8.699999809	0.005558686	0.005558686	0.045114155	799.5288825	13.01436	0	0	17.73679	12.53417	0	10.93469	0	0	15.16166	15.22125	12.33157	15.79178	0	0	9.892531	16.11937	0	17.39603	0	14.19042	16.85188	0	17.52205	16.71671	0	14.49343	0	13.70149	0	12.49233	0	16.13495	0	0	0	17.91654	15.27731	0	0	15.55729	10.68781	0	10.57974	11.17272	15.95507	14.42599	16.07144
P57087	JAM2_HUMAN	"Junctional adhesion molecule B, JAM-B (Junctional adhesion molecule 2, JAM-2) (Vascular endothelial junction-associated molecule, VE-JAM) (CD antigen CD322)"	JAM2 C21orf43 VEJAM UNQ219/PRO245	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cellular extravasation [GO:0045123]; hematopoietic stem cell migration to bone marrow [GO:0097241]; leukocyte tethering or rolling [GO:0050901]; lymphocyte aggregation [GO:0071593]; maintenance of blood-brain barrier [GO:0035633]; myoblast fusion [GO:0007520]; negative regulation of myelination [GO:0031642]; positive regulation of lymphocyte migration [GO:2000403]; spermatid development [GO:0007286]	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]; integrin binding [GO:0005178]; cell-cell adhesion [GO:0098609]; cellular extravasation [GO:0045123]; hematopoietic stem cell migration to bone marrow [GO:0097241]; leukocyte tethering or rolling [GO:0050901]; lymphocyte aggregation [GO:0071593]; maintenance of blood-brain barrier [GO:0035633]; myoblast fusion [GO:0007520]; negative regulation of myelination [GO:0031642]; positive regulation of lymphocyte migration [GO:2000403]; spermatid development [GO:0007286]	integrin binding [GO:0005178]	GO:0005178; GO:0005886; GO:0005887; GO:0005923; GO:0007286; GO:0007520; GO:0009986; GO:0031642; GO:0035633; GO:0036477; GO:0044291; GO:0045123; GO:0050901; GO:0070160; GO:0071593; GO:0097241; GO:0098609; GO:0098636; GO:2000403	LLLLLLR	23.97999954	0.801279604	0.801279604	0.282482847	853.6877555	0	0	18.78638	18.91116	0	19.36277	0	0	19.33487	0	0	0	18.89988	0	19.05045	19.09879	14.24944	18.79829	16.11754	18.80874	19.33857	16.88318	0	19.26757	18.64894	18.70389	19.17568	16.95239	18.29045	17.36835	17.71364	18.42615	0	18.25829	0	18.41339	17.67666	18.2523	0	17.61972	17.4924	17.25936	17.98454	18.08103	0	0	18.75033	18.4626
P57103	NAC3_HUMAN	Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)	SLC8A3 NCX3	Homo sapiens (Human)	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]	axon [GO:0030424]; axon terminus [GO:0043679]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202]	axon [GO:0030424]; axon terminus [GO:0043679]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]	calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]	GO:0002244; GO:0005432; GO:0005516; GO:0005741; GO:0005789; GO:0005886; GO:0005887; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015491; GO:0016020; GO:0016528; GO:0030001; GO:0030424; GO:0030425; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0070588; GO:0071456; GO:0071901; GO:0098703; GO:0098794; GO:0098815; GO:0099580; GO:1903779	TTVDKLIK	10.64000034	0.490459889	0.490459889	0.215021506	917.4315376	13.9832	0	12.51505	0	14.792	0	17.59099	16.91892	14.73522	0	0	0	7.922195	14.53376	0	14.33124	14.60812	15.92651	0	16.65171	12.25491	16.1112	13.3612	15.51188	0	0	15.80826	0	0	0	0	15.48938	0	12.11912	0	0	0	0	0	0	0	0	0	0	13.15459	0	0	0
P57679	EVC_HUMAN	Ellis-van Creveld syndrome protein (DWF-1)	EVC	Homo sapiens (Human)	cartilage development [GO:0051216]; endochondral bone growth [GO:0003416]; muscle organ development [GO:0007517]; positive regulation of smoothened signaling pathway [GO:0045880]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]	ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane protein complex [GO:0098797]	ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane protein complex [GO:0098797]; cartilage development [GO:0051216]; endochondral bone growth [GO:0003416]; muscle organ development [GO:0007517]; positive regulation of smoothened signaling pathway [GO:0045880]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]		GO:0001501; GO:0003416; GO:0005737; GO:0005929; GO:0007224; GO:0007517; GO:0016021; GO:0036064; GO:0045880; GO:0051216; GO:0060170; GO:0098797	QLMMTLTER	3.650000095	1	1	0.133402469	1139.511742	0	0	0	0	0	0	0	16.36353	0	0	13.0796	0	0	0	0	0	0	14.92559	14.61684	0	0	0	0	13.74975	12.96963	0	15.09466	14.10524	0	13.61777	16.86769	0	0	0	0	0	15.93265	0	16.25296	0	0	0	0	0	0	0	0	0
P57682	KLF3_HUMAN	Krueppel-like factor 3 (Basic krueppel-like factor) (CACCC-box-binding protein BKLF) (TEF-2)	KLF3 BKLF	Homo sapiens (Human)	cellular response to peptide [GO:1901653]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide [GO:1901653]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0006357; GO:0007275; GO:0046872; GO:1901653; GO:1990837	FPSSHR	4.199999809	1	1	0.108814519	730.8136934	16.11328	0	15.75186	0	0	15.67599	0	16.05383	0	16.1523	16.69672	0	0	15.2287	0	0	0	0	16.9604	0	0	0	0	0	0	16.69107	0	0	0	0	0	0	0	16.02719	0	0	16.63305	0	0	0	0	0	0	0	0	0	0	0
P57721	PCBP3_HUMAN	Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1)	PCBP3 PCBP3-OT1 PCBP3OT	Homo sapiens (Human)	mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0016071; GO:0051252; GO:0070062	QMSGAQIKIANATEGSSER	4.510000229	1	1	0.37728699	1995.075599	14.08809	14.88601	0	15.91809	13.79409	14.92373	0	0	17.32213	0	12.34279	14.49894	14.40408	0	15.89345	0	0	0	13.94832	0	0	0	0	0	0	0	0	12.03872	15.4664	13.92774	15.16733	0	0	0	0	0	0	0	16.76197	0	0	0	0	0	0	0	0	0
P57737	CORO7_HUMAN	"Coronin-7, Crn7 (70 kDa WD repeat tumor rejection antigen homolog)"	CORO7	Homo sapiens (Human)	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0000139; GO:0003779; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0007015; GO:0015031; GO:0016020; GO:0016021; GO:0030041; GO:0031410; GO:0051015	DSHITNLK	18.07999992	0.177959993	0.177959993	0.272662234	927.689079	17.63099	16.30408	16.29117	16.19375	15.03226	16.20398	16.63862	0	16.74804	14.88078	15.53721	14.7468	14.87567	16.2584	15.20593	14.9475	0	17.27485	0	15.77511	16.48821	16.25997	16.38827	16.86366	15.38802	15.9697	14.85899	15.34066	16.36769	0	15.95745	15.88877	16.45807	17.52523	0	0	15.30801	0	17.2942	15.41264	0	0	0	0	17.30253	0	15.44895	16.54975
P57740	NU107_HUMAN	Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107)	NUP107	Homo sapiens (Human)	"female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]	"cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]"	structural constituent of nuclear pore [GO:0017056]	GO:0000776; GO:0000973; GO:0005635; GO:0005643; GO:0005829; GO:0006355; GO:0006406; GO:0006606; GO:0006913; GO:0008585; GO:0016020; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006	EKMYNVLLFVDGGWMVDVR	1.409999967	1	1	0.10358199	2287.40132	12.23007	0	13.57641	0	11.20906	9.663874	10.85551	0	8.664252	10.3828	11.24213	0	10.0949	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.87985	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P57775	FBXW4_HUMAN	F-box/WD repeat-containing protein 4 (Dactylin) (F-box and WD-40 domain-containing protein 4)	FBXW4 FBW4 SHFM3	Homo sapiens (Human)	embryonic limb morphogenesis [GO:0030326]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]	cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; embryonic limb morphogenesis [GO:0030326]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]		GO:0000151; GO:0005829; GO:0006511; GO:0016055; GO:0019005; GO:0030326; GO:0031146	ACLHAFPLTSTPLSSPVYCLR	13.01000023	1	1	0.045258059	2390.339636	15.63191	0	13.96037	0	0	14.49608	0	0	0	0	13.65736	13.77625	0	15.4896	15.2501	0	0	14.91903	16.63978	9.923644	16.63362	15.60018	0	0	0	0	0	15.00623	17.24457	0	0	0	0	15.83227	15.79324	16.08586	17.55953	0	0	0	0	0	0	17.62199	0	17.40344	0	0
P57789	KCNKA_HUMAN	Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit)	KCNK10 TREK2	Homo sapiens (Human)	memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322]	potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005267; GO:0005886; GO:0005887; GO:0007165; GO:0007613; GO:0022841; GO:0030322; GO:0034765; GO:0071805	EEVGEIKAHAAEWK	5.170000076	1	1	0.10422167	1596.241221	13.97386	14.31819	0	13.9903	0	13.60792	14.21776	0	0	14.35107	0	0	0	0	0	0	0	0	0	0	18.4888	0	0	0	16.09799	0	14.8893	16.08376	0	0	14.7121	13.52065	15.30742	12.95339	13.64068	0	0	0	0	0	0	0	0	0	0	0	0	0
P57796	CABP4_HUMAN	"Calcium-binding protein 4, CaBP4"	CABP4	Homo sapiens (Human)	photoreceptor cell morphogenesis [GO:0008594]; phototransduction [GO:0007602]; retinal bipolar neuron differentiation [GO:0060040]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601]	cytosol [GO:0005829]; extracellular region [GO:0005576]; synapse [GO:0045202]; terminal bouton [GO:0043195]	cytosol [GO:0005829]; extracellular region [GO:0005576]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; transmembrane transporter binding [GO:0044325]; photoreceptor cell morphogenesis [GO:0008594]; phototransduction [GO:0007602]; retinal bipolar neuron differentiation [GO:0060040]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601]	calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; transmembrane transporter binding [GO:0044325]	GO:0005246; GO:0005509; GO:0005576; GO:0005829; GO:0007165; GO:0007601; GO:0007602; GO:0008594; GO:0043195; GO:0044325; GO:0045202; GO:0046549; GO:0060040	DRDGR	6.940000057	1	1	0.230548186	618.1282392	0	14.761	0	0	0	13.54278	14.21078	16.05253	0	14.46857	15.55893	0	0	0	15.72181	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.67949	0	0	0	0	14.26628	0	0	0	0	0	0	0	0	0	17.10336	0	0
P58004	SESN2_HUMAN	"Sestrin-2, EC 1.11.1.- (Hypoxia-induced gene)"	SESN2 Hi95 SEST2	Homo sapiens (Human)	"cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]"	Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]	"Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]; GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; protein-containing complex binding [GO:0044877]; sulfiredoxin activity [GO:0032542]; cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]"	"GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; protein-containing complex binding [GO:0044877]; sulfiredoxin activity [GO:0032542]"	GO:0001932; GO:0005092; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006111; GO:0006635; GO:0009749; GO:0016239; GO:0016684; GO:0030308; GO:0030330; GO:0031588; GO:0031932; GO:0032042; GO:0032542; GO:0032868; GO:0034198; GO:0034599; GO:0036091; GO:0042149; GO:0042593; GO:0043491; GO:0044877; GO:0046323; GO:0070328; GO:0070728; GO:0071230; GO:0071233; GO:0072593; GO:0098869; GO:1900182; GO:1901031; GO:1902010; GO:1904262; GO:1904504; GO:1990253; GO:1990316; GO:2000479	GPRGPSAFIPVEEVLR	1.970000029	0.316693574	0.316693574	0.22295378	1723.247166	14.6848	15.23841	14.18506	0	0	15.07743	0	0	0	0	0	14.7285	0	0	0	0	0	0	0	0	0	0	0	16.69405	0	0	0	0	0	15.93668	13.84257	14.27298	15.17491	16.74869	13.56474	15.11251	0	0	0	0	0	0	0	0	13.9231	0	0	0
P58107	EPIPL_HUMAN	Epiplakin (450 kDa epidermal antigen)	EPPK1 EPIPL	Homo sapiens (Human)	intermediate filament bundle assembly [GO:0045110]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; regulation of epithelium regeneration [GO:1905041]; wound healing [GO:0042060]	apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; membrane [GO:0016020]; perinucleolar compartment [GO:0097356]	apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; membrane [GO:0016020]; perinucleolar compartment [GO:0097356]; intermediate filament binding [GO:0019215]; keratin filament binding [GO:1990254]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; intermediate filament bundle assembly [GO:0045110]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; regulation of epithelium regeneration [GO:1905041]; wound healing [GO:0042060]	intermediate filament binding [GO:0019215]; keratin filament binding [GO:1990254]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]	GO:0003723; GO:0005198; GO:0005737; GO:0005856; GO:0005923; GO:0010839; GO:0016020; GO:0016323; GO:0016327; GO:0019215; GO:0030054; GO:0030056; GO:0030336; GO:0042060; GO:0042995; GO:0045095; GO:0045104; GO:0045109; GO:0045110; GO:0045111; GO:0050680; GO:0051548; GO:0061045; GO:0071944; GO:0097356; GO:1905041; GO:1990254	RQDLLSR	6.829999924	1	1	0.246099368	888.3138276	16.81128	14.76501	16.81208	14.56113	14.87941	0	0	14.98646	14.8395	16.04999	15.88452	0	0	0	16.26328	16.63746	16.16982	0	17.1037	14.80627	15.97687	15.47019	17.52239	15.72504	15.59432	15.77829	14.97349	15.38115	16.63034	16.20086	0	15.59338	15.9603	18.38796	0	0	18.27661	16.33402	18.60733	16.42429	14.07155	14.53053	16.02249	17.66843	16.29743	15.77175	15.99045	18.15185
P58215	LOXL3_HUMAN	"Lysyl oxidase homolog 3, EC 1.4.3.-, EC 1.4.3.13 (Lysyl oxidase-like protein 3)"	LOXL3 LOXL	Homo sapiens (Human)	"collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]"	copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]	GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046	ADFRPK	5.300000191	1	1	0.279887681	733.0212174	15.5636	0	15.09336	15.15908	16.87458	15.17608	14.72313	15.41562	13.47223	13.41014	14.99769	14.63275	16.04936	14.44998	0	15.716	16.10982	14.25176	0	0	16.35586	16.11621	15.37279	0	0	15.6568	0	0	15.99994	0	16.49592	17.40212	0	16.43396	18.22173	0	0	0	0	14.88973	0	0	0	16.27201	0	0	17.07779	15.20653
P58397	ATS12_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 12, ADAM-TS 12, ADAM-TS12, ADAMTS-12, EC 3.4.24.-"	ADAMTS12 UNQ1918/PRO4389	Homo sapiens (Human)	cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0002062; GO:0004222; GO:0005576; GO:0007160; GO:0016477; GO:0030167; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113	IVHHAEKTLSSFCK	7.739999771	1	1	9.17E-13	1656.044194	12.65104	14.78942	14.76217	15.29819	13.10811	16.00645	0	0	0	0	0	0	15.27394	0	0	0	0	0	0	0	0	0	15.27646	15.59968	0	0	0	0	0	0	16.78666	16.90275	15.17884	14.16339	0	0	13.69326	0	0	0	0	0	0	0	0	0	0	14.79203
P58505	CU058_HUMAN	Uncharacterized protein C21orf58	C21orf58	Homo sapiens (Human)						AQAWSGPSR	5.090000153	1	1	0.160683669	959.7506068	0	14.29266	13.59452	0	0	10.85574	14.78653	16.76937	15.04573	16.93526	13.43216	0	13.3824	13.78172	14.72858	14.6136	13.73464	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.92945	0	0	15.0865	0	15.94963	0	0	0	0	0	16.12279	0	0	0	0
P58743	S26A5_HUMAN	Prestin (Solute carrier family 26 member 5)	SLC26A5 PRES	Homo sapiens (Human)	cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; lateral wall of outer hair cell [GO:0120249]	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; lateral wall of outer hair cell [GO:0120249]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]	anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]	GO:0002931; GO:0005737; GO:0005887; GO:0007605; GO:0008271; GO:0008360; GO:0009410; GO:0009751; GO:0010996; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015755; GO:0016323; GO:0016328; GO:0019531; GO:0030507; GO:0034766; GO:0035864; GO:0042391; GO:0042802; GO:0045793; GO:0090102; GO:0097066; GO:0120249; GO:1902074; GO:2000147	QAFTCTPK	8.220000267	0.060231302	0.060231302	0.25137875	951.7581167	0	15.44255	11.44378	15.28674	15.2375	15.72392	17.54147	0	13.65586	17.46763	16.60873	16.17435	15.32775	15.64014	16.71629	0	14.27191	16.16147	15.62401	14.25293	15.60461	16.18993	14.24617	16.7632	14.47416	0	16.09105	0	14.67642	0	0	16.51911	15.44026	0	14.85971	16.19408	0	16.71994	15.63325	17.03275	16.50259	16.65426	16.36899	15.15083	14.43621	15.58041	15.48494	0
P58872	RHBL3_HUMAN	"Rhomboid-related protein 3, EC 3.4.21.105 (Ventrhoid transmembrane protein)"	RHBDL3 RHBDL4 VRHO	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005509; GO:0016021	LDPHKR	5.230000019	1	1	0.220336569	766.6185994	0	0	0	0	0	14.92527	0	13.58515	16.32779	14.53166	0	0	7.232177	0	20.24051	11.41759	0	16.70512	0	12.28356	0	16.86795	0	0	17.9077	0	17.09841	0	0	0	17.25651	0	0	17.53925	0	13.69946	16.0683	0	0	0	16.38403	18.84472	16.62074	17.30902	11.91322	18.02431	0	0
P59046	NAL12_HUMAN	"NACHT, LRR and PYD domains-containing protein 12 (Monarch-1) (PYRIN-containing APAF1-like protein 7) (Regulated by nitric oxide)"	NLRP12 NALP12 PYPAF7 RNO	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell migration [GO:0036336]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of signal transduction [GO:0009968]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interleukin-18 production [GO:0032661]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell migration [GO:0036336]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of signal transduction [GO:0009968]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interleukin-18 production [GO:0032661]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]	GO:0001818; GO:0005524; GO:0005737; GO:0006919; GO:0007165; GO:0008656; GO:0009968; GO:0031953; GO:0032088; GO:0032661; GO:0032692; GO:0032715; GO:0032731; GO:0036336; GO:0043122; GO:0043124; GO:0043281; GO:0045345; GO:0045751; GO:0050728; GO:0050729; GO:0070373; GO:0071345; GO:1901223; GO:1901224	DINCER	3.75999999	1	1	0.349728103	807.1615883	0	0	16.22425	0	17.93489	0	0	0	0	0	0	0	0	0	17.01428	0	0	0	17.80268	18.19259	0	0	0	0	0	18.71168	0	0	0	19.61469	0	0	0	0	0	0	0	0	0	0	17.23555	0	0	0	0	17.66985	17.72485	17.65951
P59051	BRAS2_HUMAN	Putative uncharacterized protein encoded by BRWD1-AS2 (ATP1A1 antisense RNA 1) (ATP1A1 antisense gene protein 1) (BRWD1 intronic transcript 2)	BRWD1-AS2 BRWD1-IT2 C21orf87 NCRNA00257	Homo sapiens (Human)						GSGRR	6.239999771	1	1	0.138930108	532.479149	13.20234	0	16.85147	14.13984	14.87646	15.79861	15.23487	0	14.09628	14.04807	12.39964	0	0	15.12892	16.04347	0	0	16.52485	0	0	0	0	0	0	0	13.6005	0	15.12615	0	0	0	0	0	15.24637	0	0	0	0	0	0	0	0	16.6079	0	0	0	0	0
P59095	STAR6_HUMAN	"StAR-related lipid transfer protein 6 (START domain-containing protein 6, StARD6)"	STARD6	Homo sapiens (Human)	lipid transport [GO:0006869]		lipid binding [GO:0008289]; lipid transport [GO:0006869]	lipid binding [GO:0008289]	GO:0006869; GO:0008289	LVMFVQTEMR	6.940000057	1	1	0.136289062	1257.455887	14.42829	8.948898	14.43997	0	0	14.34449	0	0	0	0	14.78068	15.98027	0	0	0	0	14.23899	0	0	0	0	14.9952	0	0	0	14.66369	0	0	0	0	14.57216	0	0	0	14.05055	0	16.44083	0	0	0	0	0	0	0	0	0	0	0
P59510	ATS20_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 20, ADAM-TS 20, ADAM-TS20, ADAMTS-20, EC 3.4.24.-"	ADAMTS20	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005615; GO:0008270; GO:0009967; GO:0030198; GO:0031012; GO:0043066; GO:0045636	GVGQVVEEMCDQSTRPCSQR	1.029999971	1	1	0.173819314	2323.288542	14.08014	14.58257	15.53995	12.30026	0	14.12091	0	0	0	0	0	14.52602	0	14.04021	15.04697	0	13.29087	0	0	0	0	0	0	0	0	12.88303	0	0	0	0	13.33648	0	0	0	0	0	0	0	0	0	0	0	15.14072	0	0	0	0	0
P59551	T2R60_HUMAN	"Taste receptor type 2 member 60, T2R60 (Taste receptor type 2 member 56, T2R56)"	TAS2R60	Homo sapiens (Human)	sensory perception of bitter taste [GO:0050913]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of bitter taste [GO:0050913]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021; GO:0050913	MNGDHMVLGSSVTDKK	12.27000046	1	1	0.459482921	1749.472714	0	18.06564	0	0	0	0	16.76404	0	16.44665	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.09212	0	0	0	0	0	0	0	0	0	0	0	0	0
P59780	AP3S2_HUMAN	"AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adaptor-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin, Sigma3B-adaptin) (Sigma-adaptin 3b)"	AP3S2	Homo sapiens (Human)	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]"		GO:0005769; GO:0005794; GO:0006886; GO:0006896; GO:0008089; GO:0016183; GO:0016192; GO:0030123; GO:0030659; GO:0035654; GO:0036465; GO:0043231; GO:0046907; GO:0048490; GO:0060155; GO:1903232; GO:1904115	CFENVCELDLIFHMDK	5.78000021	1	1	0.043695496	2069.939747	0	14.74383	0	13.55479	0	12.81476	0	0	0	0	12.92373	14.08015	0	12.31224	0	12.99461	0	0	0	0	0	11.16328	0	16.04329	0	0	0	15.27544	0	0	0	0	0	0	0	0	0	0	0	11.93024	0	0	16.61123	0	0	0	0	16.10751
P59797	SELV_HUMAN	"Selenoprotein V, SelV"	SELENOV SELV	Homo sapiens (Human)	response to selenium ion [GO:0010269]	cytosol [GO:0005829]	cytosol [GO:0005829]; response to selenium ion [GO:0010269]		GO:0005829; GO:0010269	ASTPTR	6.079999924	1	1	0.250676999	634.0851604	14.73672	15.7621	0	16.35037	15.14544	0	0	0	0	0	0	0	14.37137	15.32785	0	15.50398	0	16.34993	15.60748	16.36834	14.99355	17.00559	0	16.9164	15.34221	0	16.91083	0	15.27802	0	15.23206	0	15.75919	17.11692	15.61494	16.2797	0	16.41207	17.298	16.10225	16.22392	17.18133	16.40199	0	16.38459	0	15.95997	0
P59817	Z280A_HUMAN	Zinc finger protein 280A (3'OY11.1) (Suppressor of hairy wing homolog 1) (Zinc finger protein 636)	ZNF280A SUHW1 ZNF280 ZNF636	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	SSSEPGYK	6.519999981	1	1	0.35472443	855.7838083	16.48303	13.99488	16.56106	0	0	0	0	0	17.16352	16.486	13.68912	14.98106	0	0	0	15.50212	0	0	0	15.34312	0	0	15.52913	15.59033	14.47083	15.29219	0	14.76619	16.187	14.38539	0	0	0	16.05093	0	0	14.86346	15.85874	0	0	16.44787	0	0	0	0	16.37001	0	0
P59827	BPIB4_HUMAN	"BPI fold-containing family B member 4 (Ligand-binding protein RY2G5) (Long palate, lung and nasal epithelium carcinoma-associated protein 4)"	BPIFB4 C20orf186 LPLUNC4	Homo sapiens (Human)		actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular region [GO:0005576]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lipid binding [GO:0008289]	lipid binding [GO:0008289]	GO:0005576; GO:0005829; GO:0008289; GO:0015629	VLATAEVMVSQPK	21.87999916	1	1	0.067802492	1372.281147	14.76698	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42465	0	0	0	15.50451	14.89119	17.14632	13.93513	16.23616	0	16.4271	0	17.14453	15.69101	13.76408	17.00968	0	16.09132	16.5438	16.43949	17.35222
P59910	DJB13_HUMAN	DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein)	DNAJB13 TSARG3 TSARG6	Homo sapiens (Human)	axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085]	axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]	axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085]	chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0005829; GO:0005930; GO:0031514; GO:0036126; GO:0051082; GO:0051085; GO:0051087; GO:0097224; GO:1904158	NSEDAQIK	13.68000031	1	1	0.241775461	904.9098549	0	17.58284	0	0	17.33347	16.81015	16.70788	0	0	0	0	0	0	0	0	17.48018	0	0	0	0	18.36482	0	17.2123	0	0	18.79778	0	0	0	0	0	18.02011	0	0	0	17.22486	0	0	18.37816	0	19.02791	0	0	0	17.36183	0	0	19.2715
P59923	ZN445_HUMAN	"Zinc finger protein 445, ZFP445 (Zinc finger protein 168) (Zinc finger protein with KRAB and SCAN domains 15)"	ZNF445 ZFP445 ZKSCAN15 ZNF168	Homo sapiens (Human)	maintenance of DNA methylation [GO:0010216]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; maintenance of DNA methylation [GO:0010216]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003682; GO:0005634; GO:0006357; GO:0010216; GO:0010385; GO:0046872; GO:2000653	CSQCGKAFR	8.569999695	0.988021195	0.988021195	0.175620956	1109.331655	14.97059	15.95605	12.16842	15.18788	0	0	15.28554	0	0	15.04325	9.679208	14.44937	0	0	0	0	15.07945	0	0	14.46936	15.34974	0	0	16.3862	0	13.62699	0	0	0	14.4312	13.80541	0	12.9714	11.34559	14.73064	15.99441	15.24898	13.70386	14.7834	13.28854	12.85824	11.20097	13.14917	0	12.29054	14.351	0	0
P60153	RNAS9_HUMAN	Inactive ribonuclease-like protein 9	RNASE9	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; nucleic acid binding [GO:0003676]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005576	SFLSEDGVFVISP	5.699999809	0.871983647	0.871983647	0.193512499	1396.3675	0	0	12.44988	0	0	15.71934	0	0	0	15.46258	16.5659	0	0	0	0	0	14.38185	0	0	0	0	0	0	0	15.33585	0	0	0	0	0	0	0	0	15.61282	0	0	0	16.93179	15.04564	16.85195	0	16.35898	0	0	16.86189	0	0	0
P60174	TPIS_HUMAN	"Triosephosphate isomerase, TIM, EC 5.3.1.1 (Methylglyoxal synthase, EC 4.2.3.3) (Triose-phosphate isomerase)"	TPI1 TPI	Homo sapiens (Human)	gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]	methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]	GO:0004807; GO:0005615; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0031625; GO:0042803; GO:0046166; GO:0070062	EAGITEK	6.840000153	1	1	0.145934315	749.2227081	0	16.23354	14.63606	0	16.06709	0	0	14.37643	0	0	15.5582	0	0	15.59307	0	15.40645	0	0	0	0	15.62973	0	15.62707	0	0	0	0	15.23512	0	0	0	0	0	0	0	0	0	15.88609	0	0	0	0	0	14.80546	0	0	15.65436	0
P60228	EIF3E_HUMAN	"Eukaryotic translation initiation factor 3 subunit E, eIF3e (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48)"	EIF3E EIF3S6 INT6	Homo sapiens (Human)	"formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0000184; GO:0001732; GO:0003723; GO:0003743; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0016605; GO:0033290; GO:0045296; GO:0045727; GO:0045947; GO:0047485; GO:0070062; GO:0071540; GO:1902416	DLVKVIQQESYTYK	3.49000001	0.158679485	0.158679485	0.249920075	1710.466604	0	0	0	0	0	15.80331	0	0	0	18.35552	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.67761	0	0	0	15.20293	0	0	15.61236	15.84167	0	14.58457	0	0	0	0	0	0	0	0	0	0	0	0
P60321	NANO2_HUMAN	"Nanos homolog 2, NOS-2"	NANOS2 NOS2	Homo sapiens (Human)	"germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]"	mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]	GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:1900153	NSAGRR	3.650000095	1	1	0.188528358	661.40767	15.72935	16.11358	0	10.88289	16.37495	15.49915	14.7982	16.09454	11.82937	15.82135	13.34527	14.88797	14.67838	14.80839	13.5131	14.59376	0	16.23253	16.46205	16.51723	15.61665	16.69331	0	0	0	15.17158	16.46351	12.40077	14.46814	13.76259	0	16.47246	0	15.3331	0	0	14.01544	0	15.73392	0	0	0	0	0	16.65776	16.98873	0	0
P60323	NANO3_HUMAN	"Nanos homolog 3, NOS-3"	NANOS3 NOS3	Homo sapiens (Human)	"germ cell development [GO:0007281]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of cell cycle [GO:0051726]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of cell cycle [GO:0051726]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006417; GO:0007281; GO:0007283; GO:0008270; GO:0010494; GO:0017148; GO:0048471; GO:0048477; GO:0051726; GO:1900153; GO:2001234	GGGGGAGFR	9.670000076	1	1	0.224707137	735.6230087	0	0	0	18.45483	0	0	0	0	17.20829	0	0	0	0	16.40394	0	0	0	17.4628	0	0	15.70821	0	0	0	0	0	18.87372	18.76573	0	0	0	17.92738	0	0	0	0	0	0	19.98285	0	0	0	0	0	0	0	0	0
P60411	KR109_HUMAN	Keratin-associated protein 10-9 (High sulfur keratin-associated protein 10.9) (Keratin-associated protein 10.9) (Keratin-associated protein 18-9) (Keratin-associated protein 18.9)	KRTAP10-9 KAP10.9 KAP18-9 KRTAP10.9 KRTAP18-9 KRTAP18.9	Homo sapiens (Human)		cytosol [GO:0005829]; keratin filament [GO:0045095]	cytosol [GO:0005829]; keratin filament [GO:0045095]		GO:0005829; GO:0045095	MAASTMSIR	1.220000029	1	1	0.201566633	999.3417225	0	0	0	0	0	0	17.08192	0	0	18.60071	0	15.99324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.15405	0	0	0
P60468	SC61B_HUMAN	Protein transport protein Sec61 subunit beta	SEC61B	Homo sapiens (Human)	"posttranslational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum Sec complex [GO:0031205]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum Sec complex [GO:0031205]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]; epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; posttranslational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]"	epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]	GO:0003723; GO:0005783; GO:0005784; GO:0005789; GO:0005829; GO:0006616; GO:0016020; GO:0016021; GO:0030433; GO:0030970; GO:0031204; GO:0031205; GO:0043022; GO:0044322; GO:0048408	NASCGTR	6.389999866	0.307348788	0.307348788	0.155016142	765.3650672	0	14.6148	0	0	15.36402	0	0	16.72976	14.95626	0	14.01576	8.689112	14.23932	15.408	14.95078	15.29855	16.98965	14.63243	17.01766	0	0	0	16.17454	0	0	0	0	0	0	0	16.2632	0	0	17.10807	16.35765	14.72398	15.13419	0	0	16.60293	17.16567	0	0	16.28372	16.16184	13.1562	16.26225	0
P60602	ROMO1_HUMAN	"Reactive oxygen species modulator 1, ROS modulator 1 (Epididymis tissue protein Li 175) (Glyrichin) (Mitochondrial targeting GxxxG motif protein, MTGM) (Protein MGR2 homolog)"	ROMO1 C20orf52	Homo sapiens (Human)	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; intracellular protein transport [GO:0006886]; killing of cells of another organism [GO:0031640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative senescence [GO:0090399]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; intracellular protein transport [GO:0006886]; killing of cells of another organism [GO:0031640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative senescence [GO:0090399]		GO:0005739; GO:0005743; GO:0005744; GO:0006886; GO:0008284; GO:0016021; GO:0030150; GO:0031640; GO:0034614; GO:0042742; GO:0045039; GO:0050829; GO:0050830; GO:0051838; GO:0061844; GO:0090399; GO:2000379	TMMQSGGTFGTFMAIGMGIR	4.320000172	1	1	0.267093329	2127.444466	15.64132	13.65976	0	11.87088	16.10947	0	14.13573	12.70972	12.89519	13.48314	16.31375	17.1439	14.05511	13.70553	0	14.65636	12.94262	0	0	0	0	0	0	0	15.01202	15.56823	0	0	13.15186	0	12.19995	15.29937	0	0	0	0	16.35451	0	15.9143	0	0	0	14.97148	13.16213	0	13.78704	0	16.2217
P60604	UB2G2_HUMAN	"Ubiquitin-conjugating enzyme E2 G2, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)"	UBE2G2 UBC7	Homo sapiens (Human)	"cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0030433; GO:0035458; GO:0042802; GO:0044257; GO:0061631; GO:0070936; GO:1904153	QIVQKSLGL	4.630000114	1	1	0.130569735	985.7687661	15.36235	0	12.07876	12.45421	13.31406	15.25403	15.83964	0	0	12.70531	15.01071	15.84327	0	14.30934	13.22456	0	14.32938	0	0	14.40031	14.47786	0	15.98707	15.85112	15.24649	11.83195	15.84704	13.90892	11.81464	14.6725	0	0	0	0	0	0	0	0	0	14.78837	12.94897	0	16.14803	0	16.85699	0	0	0
P60608	EFC2_HUMAN	"Endogenous retrovirus group FC1 member 1 Env polyprotein (Envelope polyprotein) (Fc2deltaenv) (HERV-F(c)2_7q36.2 provirus ancestral Env polyprotein) [Includes: Surface protein, SU; Truncated transmembrane protein, TM ]"	ERVFC1-1	Homo sapiens (Human)						LVATAASPPAGCQAPIAFLGLK	2.349999905	1	1	0.165546865	2149.62789	12.52686	10.09709	15.01879	14.17412	14.4099	13.06649	0	0	0	0	0	0	0	0	0	0	13.61651	0	0	15.27565	0	13.46881	0	16.18459	16.41414	0	13.99005	0	0	12.75101	0	10.92377	11.93299	0	11.28748	0	0	13.94887	0	0	13.11804	15.45005	0	13.8308	0	0	0	0
P60842	IF4A1_HUMAN	"Eukaryotic initiation factor 4A-I, eIF-4A-I, eIF4A-I, EC 3.6.4.13 (ATP-dependent RNA helicase eIF4A-1)"	EIF4A1 DDX2A EIF4A	Homo sapiens (Human)	cytoplasmic translational initiation [GO:0002183]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; RNA helicase activity [GO:0003724]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; translational initiation [GO:0006413]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; RNA helicase activity [GO:0003724]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0000339; GO:0002183; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0003743; GO:0004386; GO:0005524; GO:0005737; GO:0005829; GO:0006413; GO:0008135; GO:0016020; GO:0016281; GO:0016887; GO:0070062	FMRDPIR	10.07999992	5.95E-07	5.95E-07	0.232541839	951.5572207	17.62556	18.30836	0	18.07152	19.04095	19.01148	21.26771	0	19.6833	19.52434	0	17.59049	17.62293	0	19.83475	18.42392	0	0	0	0	17.25064	18.23339	0	18.20374	20.5755	0	20.52001	0	20.84458	0	20.54253	0	0	19.25929	18.80609	0	19.84046	0	0	20.83854	20.07613	20.09698	17.57824	17.28568	0	18.72363	18.47586	18.82913
P60866	RS20_HUMAN	40S ribosomal protein S20 (Small ribosomal subunit protein uS10)	RPS20	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cytoplasmic translation [GO:0002181]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412]	MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]	GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0016020; GO:0022626; GO:0022627; GO:0045202; GO:0070062; GO:0097371; GO:1901798; GO:1990948	MAFKDTGK	2.279999971	0.673708677	0.673708677	0.247163166	898.0967286	15.04818	0	0	15.70253	0	0	0	0	15.96738	0	15.87911	0	0	0	0	15.67446	15.1389	16.14201	0	15.03488	0	0	0	0	16.38503	14.42518	15.40349	13.95359	14.92088	14.68616	15.26438	16.6976	9.090755	0	11.44591	15.60174	15.81741	15.86424	0	16.06319	0	15.50067	15.01748	16.79125	13.94671	16.72614	11.39379	16.13925
P60903	S10AA_HUMAN	Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11)	S100A10 ANX2LG CAL1L CLP11	Homo sapiens (Human)	membrane raft assembly [GO:0001765]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of binding [GO:0051099]; positive regulation of exocytosis [GO:0045921]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of neurogenesis [GO:0050767]; vesicle budding from membrane [GO:0006900]	AnxA2-p11 complex [GO:1990665]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]	AnxA2-p11 complex [GO:1990665]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; transmembrane transporter binding [GO:0044325]; membrane raft assembly [GO:0001765]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of binding [GO:0051099]; positive regulation of exocytosis [GO:0045921]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of neurogenesis [GO:0050767]; vesicle budding from membrane [GO:0006900]	calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; transmembrane transporter binding [GO:0044325]	GO:0001765; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006900; GO:0010756; GO:0016020; GO:0016363; GO:0019897; GO:0042789; GO:0042803; GO:0043547; GO:0044325; GO:0045921; GO:0045944; GO:0048306; GO:0050767; GO:0051099; GO:0051496; GO:0051894; GO:0062023; GO:0070062; GO:0072659; GO:0090575; GO:0098797; GO:1900026; GO:1905686; GO:1990665	IMKDLDQCR	8.390000343	1	1	4.58E-13	1191.941794	0	14.99567	11.70028	0	16.06337	11.04299	0	0	0	12.01748	0	13.1215	0	0	0	0	0	0	16.18728	0	0	0	0	12.11981	0	0	11.15294	15.37431	15.83853	0	0	0	0	0	0	0	0	14.55039	0	0	0	0	16.46102	0	0	0	0	0
P61006	RAB8A_HUMAN	"Ras-related protein Rab-8A, EC 3.6.5.2 (Oncogene c-mel)"	RAB8A MEL RAB8	Homo sapiens (Human)	"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]"	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]	"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]"	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]	GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017157; GO:0019003; GO:0019901; GO:0030140; GO:0030496; GO:0030670; GO:0031267; GO:0031489; GO:0032588; GO:0032869; GO:0036064; GO:0043025; GO:0043197; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055038; GO:0060271; GO:0061512; GO:0070062; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:0099003	TIELDGKR	11.02999973	0.214359015	0.214359015	0.170268218	930.3956238	17.56657	0	0	15.51798	15.52997	16.96204	15.58718	17.83978	13.36388	14.26366	17.44487	17.71535	16.98886	15.99648	16.24178	17.89329	0	16.31066	17.09887	17.28285	17.2001	17.47412	17.32964	15.87819	18.75731	16.70966	17.31416	15.45071	16.61726	0	16.11975	17.92513	16.69981	16.37983	17.07856	18.38408	18.99642	17.16627	19.36782	17.32984	15.30434	17.1562	16.64463	18.5079	16.27174	16.69304	14.02451	17.20805
P61011	SRP54_HUMAN	"Signal recognition particle 54 kDa protein, SRP54, EC 3.6.5.-"	SRP54	Homo sapiens (Human)	"exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]	GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0006616; GO:0006617; GO:0008312; GO:0016607; GO:0019003; GO:0030593; GO:0030851; GO:0030942; GO:0031017; GO:0043021; GO:0045047	MGPFSQILGMIPGFGTDFMSK	6.039999962	1	1	0.084512808	2298.517724	0	12.96954	12.34712	12.70595	0	0	13.47108	0	12.53076	12.89814	12.35966	14.84879	0	13.08789	16.06526	13.28444	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.76925	12.57289	0	0	0	0	0	0
P61020	RAB5B_HUMAN	"Ras-related protein Rab-5B, EC 3.6.5.2"	RAB5B	Homo sapiens (Human)	antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]	anchored component of synaptic vesicle membrane [GO:0098993]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	anchored component of synaptic vesicle membrane [GO:0098993]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100]	G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]	GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0012505; GO:0016020; GO:0019003; GO:0019882; GO:0030100; GO:0030139; GO:0030667; GO:0030742; GO:0031901; GO:0042470; GO:0043231; GO:0048227; GO:0070062; GO:0098993	QASPSIVIALAGNK	7.320000172	0.275028706	0.275028706	0.318933052	1366.147741	13.08796	14.95685	13.61064	0	0	0	0	0	14.20718	0	0	0	0	15.39777	16.11914	0	0	0	0	15.43414	15.59734	17.23539	0	16.64385	17.02167	0	0	16.20992	0	0	0	15.39396	16.43133	12.8786	0	0	17.1196	17.2394	18.94601	16.95949	15.3819	15.67048	0	0	0	0	16.14845	18.09925
P61073	CXCR4_HUMAN	"C-X-C chemokine receptor type 4, CXC-R4, CXCR-4 (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor, LESTR) (Lipopolysaccharide-associated protein 3, LAP-3, LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor, SDF-1 receptor) (CD antigen CD184)"	CXCR4	Homo sapiens (Human)	apoptotic process [GO:0006915]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cardiac muscle contraction [GO:0060048]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to xenobiotic stimulus [GO:0071466]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; dendritic cell chemotaxis [GO:0002407]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; endothelial cell differentiation [GO:0045446]; endothelial tube morphogenesis [GO:0061154]; epithelial cell development [GO:0002064]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; myelin maintenance [GO:0043217]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; neuron recognition [GO:0008038]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite extension [GO:1903861]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of vascular wound healing [GO:0035470]; regulation of calcium ion transport [GO:0051924]; regulation of cell adhesion [GO:0030155]; regulation of chemotaxis [GO:0050920]; regulation of programmed cell death [GO:0043067]; regulation of viral process [GO:0050792]; response to activity [GO:0014823]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; telencephalon cell migration [GO:0022029]	cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; C-X-C motif chemokine 12 receptor activity [GO:0038147]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; myosin light chain binding [GO:0032027]; small molecule binding [GO:0036094]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; apoptotic process [GO:0006915]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cardiac muscle contraction [GO:0060048]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to xenobiotic stimulus [GO:0071466]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; dendritic cell chemotaxis [GO:0002407]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; endothelial cell differentiation [GO:0045446]; endothelial tube morphogenesis [GO:0061154]; epithelial cell development [GO:0002064]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; myelin maintenance [GO:0043217]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; neuron recognition [GO:0008038]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite extension [GO:1903861]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of vascular wound healing [GO:0035470]; regulation of calcium ion transport [GO:0051924]; regulation of cell adhesion [GO:0030155]; regulation of chemotaxis [GO:0050920]; regulation of programmed cell death [GO:0043067]; regulation of viral process [GO:0050792]; response to activity [GO:0014823]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; telencephalon cell migration [GO:0022029]	actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; C-X-C motif chemokine 12 receptor activity [GO:0038147]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; myosin light chain binding [GO:0032027]; small molecule binding [GO:0036094]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001666; GO:0001764; GO:0002064; GO:0002407; GO:0003779; GO:0004930; GO:0005634; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005886; GO:0006915; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0007420; GO:0008038; GO:0009615; GO:0009897; GO:0009986; GO:0014823; GO:0015026; GO:0016021; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0022008; GO:0022029; GO:0030054; GO:0030155; GO:0031252; GO:0031410; GO:0031625; GO:0032027; GO:0032991; GO:0035470; GO:0036094; GO:0038147; GO:0038160; GO:0043067; GO:0043130; GO:0043217; GO:0043278; GO:0045446; GO:0048714; GO:0050792; GO:0050920; GO:0050921; GO:0050965; GO:0050966; GO:0051924; GO:0060048; GO:0060326; GO:0061154; GO:0070062; GO:0071345; GO:0071466; GO:0120162; GO:1903861; GO:1905322; GO:1990478; GO:2000448	YLAIVHATNSQRPRK	5.349999905	1	1	1.83E-12	1753.774071	15.23585	14.44227	14.61424	13.43171	0	13.1806	14.71682	0	0	0	16.67068	16.13914	14.74955	14.67656	14.28119	15.16971	14.08494	0	15.48434	0	0	14.40836	13.7056	14.87766	14.55848	15.01237	14.50536	0	0	13.39529	0	0	0	0	0	0	14.31815	0	0	0	0	15.1909	0	0	14.21883	0	0	0
P61129	ZC3H6_HUMAN	Zinc finger CCCH domain-containing protein 6	ZC3H6 KIAA2035 ZC3HDC6	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; negative regulation of transcription, DNA-templated [GO:0045892]"	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000785; GO:0003723; GO:0005634; GO:0045892; GO:0046872	EGYLEQFGDSHGSGAKLGDPR	10.19999981	1	1	0.431766711	2219.802367	20.17195	22.10819	18.29768	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P61163	ACTZ_HUMAN	"Alpha-centractin, Centractin (ARP1) (Actin-RPV) (Centrosome-associated actin homolog)"	ACTR1A CTRN1	Homo sapiens (Human)	vesicle-mediated transport [GO:0016192]	cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]	cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0005875; GO:0015630; GO:0016192; GO:0070062; GO:0099738	TLFSNIVLSGGSTLFKGFGDR	2.700000048	0.437011212	0.437011212	0.135762499	2217.26398	0	0	13.62663	0	0	12.78847	0	13.40104	0	0	0	0	0	0	0	0	0	0	13.65106	13.65037	9.292399	0	0	0	0	0	0	0	0	14.56339	15.32007	0	12.77944	0	0	0	15.30232	16.13754	15.08464	0	12.15085	0	12.81324	0	14.18086	14.31452	15.17937	0
P61201	CSN2_HUMAN	"COP9 signalosome complex subunit 2, SGN2, Signalosome subunit 2 (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15, TR-interacting protein 15, TRIP-15)"	COPS2 CSN2 TRIP15	Homo sapiens (Human)	inner cell mass cell proliferation [GO:0001833]; negative regulation of nucleic acid-templated transcription [GO:1903507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; protein phosphorylation [GO:0006468]; regulation of protein neddylation [GO:2000434]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; inner cell mass cell proliferation [GO:0001833]; negative regulation of nucleic acid-templated transcription [GO:1903507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; protein phosphorylation [GO:0006468]; regulation of protein neddylation [GO:2000434]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]	transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000338; GO:0001833; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0006468; GO:0007165; GO:0008180; GO:0030182; GO:0035914; GO:0045116; GO:1903507; GO:2000434	LIKPYTR	4.010000229	1	1	0.059153718	890.7752899	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.28129	0	0	0	0	0	0	0	0	13.92666	0	14.10992	0	0	0	16.24621	14.3773	15.31028	0	15.24331	0	0	0	0	0	0	0	0	0	0	0	0	0
P61244	MAX_HUMAN	"Protein max (Class D basic helix-loop-helix protein 4, bHLHd4) (Myc-associated factor X)"	MAX BHLHD4	Homo sapiens (Human)	"cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Mad-Max complex [GO:0070443]; MLL1 complex [GO:0071339]; Myc-Max complex [GO:0071943]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Mad-Max complex [GO:0070443]; MLL1 complex [GO:0071339]; Myc-Max complex [GO:0071943]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0009267; GO:0010629; GO:0016605; GO:0030425; GO:0032868; GO:0032993; GO:0042802; GO:0044877; GO:0045893; GO:0045944; GO:0046982; GO:0048678; GO:0051402; GO:0060041; GO:0065003; GO:0070443; GO:0070888; GO:0071339; GO:0071375; GO:0071943; GO:0090575; GO:0140297; GO:1990837	DSFHSLRDSVPSLQGEK	12.68000031	1	1	0.270902077	1900.63509	17.72794	16.50704	17.01423	0	17.29532	16.5927	0	0	0	0	17.70909	0	17.24209	16.80796	15.45485	16.49004	13.24023	0	15.26901	8.203424	0	17.62894	15.78084	0	0	14.27602	17.39834	17.33095	15.61121	0	19.41022	16.86159	18.41092	0	0	15.15089	16.17355	0	18.95889	0	10.66511	16.50875	13.82006	12.42288	9.749958	0	15.44725	0
P61247	RS3A_HUMAN	"40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein, Fte-1)"	RPS3A FTE1 MFTL	Homo sapiens (Human)	cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of apoptotic process [GO:0043066]; translation [GO:0006412]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of apoptotic process [GO:0043066]; translation [GO:0006412]; translational initiation [GO:0006413]	mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0022626; GO:0022627; GO:0030154; GO:0043066; GO:0045202; GO:0048027; GO:0070062; GO:1990904	ADGYEPPVQESV	8.409999847	1	1	0.069406716	1290.938918	0	14.74291	0	0	0	12.04976	13.0242	16.36042	0	0	0	0	0	0	0	11.06535	0	0	0	0	0	0	13.03507	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.38091	0	0	0	0	0	0	10.78271	0
P61353	RL27_HUMAN	60S ribosomal protein L27 (Large ribosomal subunit protein eL27)	RPL27	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:0098556; GO:1904044; GO:1990904	KVTAAMGK	7.050000191	0.558614373	0.558614373	0.108410792	806.6292541	17.26147	14.24074	0	16.78574	14.95897	0	0	17.06932	15.89031	13.17008	16.72236	0	17.68881	14.63709	12.6584	15.53977	16.0803	14.09647	15.54113	15.16949	17.25462	17.0257	14.977	14.49234	9.503288	14.48913	0	14.69454	0	15.52198	14.75359	0	17.07886	15.20875	15.16533	15.51533	15.98466	14.0979	16.59282	15.31467	14.8095	13.47116	13.90247	13.3598	15.69307	15.89164	15.7113	17.97311
P61371	ISL1_HUMAN	"Insulin gene enhancer protein ISL-1, Islet-1"	ISL1	Homo sapiens (Human)	atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; mesenchymal cell differentiation [GO:0048762]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage colony-stimulating factor production [GO:1901258]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; sinoatrial node cell development [GO:0060931]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; mesenchymal cell differentiation [GO:0048762]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage colony-stimulating factor production [GO:1901258]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; sinoatrial node cell development [GO:0060931]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]"	"bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001755; GO:0003139; GO:0003148; GO:0003151; GO:0003203; GO:0003215; GO:0003266; GO:0005634; GO:0005737; GO:0006357; GO:0007409; GO:0007507; GO:0008284; GO:0010575; GO:0010718; GO:0016922; GO:0021520; GO:0021522; GO:0021524; GO:0021559; GO:0021983; GO:0030331; GO:0031016; GO:0031103; GO:0031290; GO:0031333; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033147; GO:0035066; GO:0042531; GO:0043388; GO:0043425; GO:0043524; GO:0045597; GO:0045665; GO:0045766; GO:0045944; GO:0046872; GO:0048665; GO:0048762; GO:0048880; GO:0048936; GO:0050680; GO:0050728; GO:0055010; GO:0060037; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0060931; GO:0061629; GO:0071385; GO:0071657; GO:0086091; GO:0090090; GO:1901258; GO:1990837; GO:1990841	GDMGDPPK	9.270000458	0.348409742	0.348409742	0.275328333	833.3865978	0	19.02407	17.65172	14.3324	16.79147	16.7478	0	0	18.44608	17.07923	15.44255	17.79753	16.42121	0	0	18.21831	17.64329	18.58777	15.82037	0	17.35375	0	0	0	18.54749	0	19.34115	17.06456	0	18.31031	0	0	0	19.48832	19.71513	0	20.12254	19.46807	21.85934	0	16.3935	16.85104	0	18.35456	19.19306	16.90444	18.16792	17.95912
P61513	RL37A_HUMAN	60S ribosomal protein L37a (Large ribosomal subunit protein eL43)	RPL37A	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0046872; GO:0070062	RAVGIWHCGSCMK	2.920000076	0.350984991	0.350984991	0.185271292	1577.774634	15.29668	16.1535	15.48002	0	15.58383	15.75628	19.02723	16.94605	0	15.12767	16.50735	15.78433	0	15.88444	16.70549	0	14.39799	18.05973	16.94299	15.60337	13.38042	0	0	0	15.3623	15.45128	18.25026	14.46656	0	17.15973	13.83227	0	15.7535	17.1947	0	16.32485	18.00377	0	17.53221	0	17.26975	15.85468	17.632	0	17.43632	16.20571	18.58842	0
P61579	ERK25_HUMAN	Endogenous retrovirus group K member 25 Rec protein (Endogenous retrovirus group K member 25) (HERV-K_11q22.1 provirus Rec protein)	ERVK-25	Homo sapiens (Human)	mRNA transport [GO:0051028]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0005737; GO:0051028	MNPSEMQR	9.359999657	1	1	0.2501761	991.3764034	0	0	0	15.35571	15.86321	0	14.7604	14.59022	15.1144	13.47237	15.371	16.50225	13.31997	14.93731	14.13466	12.55839	0	15.23374	0	0	15.68135	0	15.98541	14.38985	16.72923	15.49701	0	14.44375	0	13.92139	16.58742	16.38402	16.1684	14.63043	0	0	0	0	0	0	16.72778	0	15.63585	14.49798	14.193	0	0	0
P61647	SIA8F_HUMAN	"Alpha-2,8-sialyltransferase 8F, EC 2.4.99.- (Sialyltransferase 8F, SIAT8-F) (Sialyltransferase St8Sia VI, ST8SiaVI)"	ST8SIA6 SIAT8F	Homo sapiens (Human)	blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]; blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]"	"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]"	GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006486; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016021; GO:0016051	ARILVEESR	27.68000031	0.999402642	0.999402642	0.305707961	1072.919176	18.27632	18.81347	0	0	0	16.24295	0	0	0	0	0	0	16.30232	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.92376	0	0	18.77012	0	17.73869	0	0	0	0	0	0	0	16.85709	0	0	0	0	0	0	0
P61758	PFD3_HUMAN	"Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1, VBP-1, VHL-binding protein 1)"	VBP1 PFDN3	Homo sapiens (Human)	microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; tubulin complex assembly [GO:0007021]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]; amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082]; microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; tubulin complex assembly [GO:0007021]	amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082]	GO:0001540; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231; GO:0050821; GO:0051082; GO:1905907	GQIPEIK	6.75	1	1	0.237207895	783.7253118	16.80408	13.81115	17.56085	17.18659	16.21061	0	0	0	18.73739	0	16.93437	0	19.06334	0	0	0	0	17.3189	16.07871	18.49658	0	0	0	0	0	0	0	0	0	0	0	0	18.93488	0	0	20.21969	17.08991	0	16.8779	17.73617	0	0	17.80548	16.73694	0	18.99746	0	17.91818
P61764	STXB1_HUMAN	"Syntaxin-binding protein 1 (MUNC18-1) (N-Sec1) (Protein unc-18 homolog 1, Unc18-1) (Protein unc-18 homolog A, Unc-18A) (p67)"	STXBP1 UNC18A	Homo sapiens (Human)	"axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]"	identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]	GO:0000149; GO:0002576; GO:0003006; GO:0003723; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0007274; GO:0007412; GO:0010807; GO:0016082; GO:0016188; GO:0016192; GO:0017075; GO:0019901; GO:0019904; GO:0019905; GO:0030141; GO:0030424; GO:0031091; GO:0031333; GO:0031630; GO:0032229; GO:0032355; GO:0032991; GO:0035493; GO:0035542; GO:0042802; GO:0043274; GO:0043306; GO:0043524; GO:0045335; GO:0045956; GO:0047485; GO:0048471; GO:0048787; GO:0050821; GO:0060292; GO:0070062; GO:0070527; GO:0071346; GO:0072659; GO:0098794; GO:0098978; GO:0099525; GO:0106022; GO:1903296; GO:2000367	VLVVDQLSMR	9.109999657	0.805649102	0.805649102	0.246289698	1177.698571	19.3426	16.41288	0	0	0	18.50197	0	16.60851	16.94419	0	0	17.80223	19.44275	0	20.87889	20.27939	19.47934	20.17008	20.64961	21.23249	0	19.37313	20.61532	20.00376	0	19.69909	20.06455	0	20.29529	20.4872	19.00351	20.74852	19.37513	21.11993	20.79391	20.50785	21.39771	20.5324	0	19.47315	19.84653	21.17811	20.66276	20.77619	20.75217	20.96748	0	20.10077
P61812	TGFB2_HUMAN	"Transforming growth factor beta-2 proprotein (Cetermin) (Glioblastoma-derived T-cell suppressor factor, G-TSF) [Cleaved into: Latency-associated peptide, LAP; Transforming growth factor beta-2, TGF-beta-2 ]"	TGFB2	Homo sapiens (Human)	activation of protein kinase activity [GO:0032147]; ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cell death [GO:0008219]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell junction organization [GO:0045216]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; generation of neurons [GO:0048699]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neutrophil chemotaxis [GO:0030593]; odontogenesis [GO:0042476]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ossification [GO:0045778]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; protein phosphorylation [GO:0006468]; pulmonary valve morphogenesis [GO:0003184]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714]; activation of protein kinase activity [GO:0032147]; ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cell death [GO:0008219]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell junction organization [GO:0045216]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; generation of neurons [GO:0048699]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neutrophil chemotaxis [GO:0030593]; odontogenesis [GO:0042476]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ossification [GO:0045778]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; protein phosphorylation [GO:0006468]; pulmonary valve morphogenesis [GO:0003184]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]	amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714]	GO:0000902; GO:0001501; GO:0001540; GO:0001654; GO:0001666; GO:0001822; GO:0001837; GO:0001843; GO:0001942; GO:0003007; GO:0003148; GO:0003149; GO:0003179; GO:0003181; GO:0003184; GO:0003203; GO:0003215; GO:0003222; GO:0003274; GO:0003289; GO:0003407; GO:0005102; GO:0005114; GO:0005125; GO:0005160; GO:0005576; GO:0005615; GO:0005886; GO:0006468; GO:0007179; GO:0007435; GO:0007507; GO:0008083; GO:0008219; GO:0008284; GO:0008285; GO:0008347; GO:0008584; GO:0009410; GO:0009611; GO:0009792; GO:0010002; GO:0010629; GO:0010634; GO:0010693; GO:0010718; GO:0010862; GO:0010936; GO:0014068; GO:0016477; GO:0016525; GO:0030097; GO:0030199; GO:0030307; GO:0030308; GO:0030326; GO:0030424; GO:0030509; GO:0030593; GO:0031069; GO:0031093; GO:0032147; GO:0032570; GO:0032874; GO:0032909; GO:0033630; GO:0034714; GO:0035910; GO:0042060; GO:0042127; GO:0042416; GO:0042476; GO:0042704; GO:0042803; GO:0043025; GO:0043525; GO:0045216; GO:0045726; GO:0045747; GO:0045778; GO:0045787; GO:0045823; GO:0046580; GO:0048103; GO:0048566; GO:0048666; GO:0048699; GO:0048839; GO:0050680; GO:0050714; GO:0050778; GO:0051781; GO:0051794; GO:0051795; GO:0051891; GO:0060038; GO:0060065; GO:0060317; GO:0060389; GO:0060395; GO:0060412; GO:0060413; GO:0061626; GO:0062009; GO:0062023; GO:0097191; GO:0099126; GO:1902256; GO:1902895; GO:1903701; GO:1904888; GO:1905006; GO:1905007	GQILSKLK	10.57999992	0.357692569	0.357692569	0.190400743	885.0542485	16.87346	0	0	0	15.6776	16.67971	0	0	10.47238	0	18.17506	15.10554	14.33381	15.92828	0	15.95972	14.77444	0	0	0	0	13.78636	17.80945	0	17.1497	0	16.2962	0	0	18.4584	17.8111	15.88247	14.3842	17.27933	18.61825	0	18.60328	14.84589	0	0	0	17.26026	0	0	0	0	0	17.36394
P61916	NPC2_HUMAN	"NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1, He1) (Niemann-Pick disease type C2 protein)"	NPC2 HE1	Homo sapiens (Human)	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615]; sterol transport [GO:0015918]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615]; sterol transport [GO:0015918]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; sterol binding [GO:0032934]	GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0009615; GO:0015485; GO:0015914; GO:0015918; GO:0019747; GO:0019899; GO:0030301; GO:0032366; GO:0032367; GO:0032934; GO:0033344; GO:0035578; GO:0042632; GO:0043202; GO:0046836; GO:0070062; GO:0120020	TYSYLNK	6.760000229	0.399758875	0.399758875	0.028845245	889.0592815	15.00363	16.19634	17.3354	15.80115	14.67489	0	10.10945	0	17.62313	0	0	14.26074	12.44512	17.29483	0	0	14.31972	0	14.60329	15.6572	14.16262	15.089	17.09136	17.96355	17.93556	14.55697	16.88331	0	0	13.84806	0	15.25964	16.47277	0	10.12378	14.72219	16.95601	16.80511	16.78062	16.82352	12.38201	16.90943	16.93844	0	13.93016	15.38718	0	0
P61923	COPZ1_HUMAN	"Coatomer subunit zeta-1 (Zeta-1-coat protein, Zeta-1 COP)"	COPZ1 COPZ CGI-120 HSPC181	Homo sapiens (Human)	"intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]"		GO:0000139; GO:0005789; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0030126; GO:0030133; GO:1901998	AILILDNDGDR	1.549999952	1	1	9.24E-13	1211.882594	11.0971	13.90069	0	0	0	12.06463	13.29102	11.74971	10.69058	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.00952	0	19.05616	0	0	0	0
P61962	DCAF7_HUMAN	DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog)	DCAF7 HAN11 WDR68	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-macromolecule adaptor activity [GO:0030674]; protein ubiquitination [GO:0016567]	protein-macromolecule adaptor activity [GO:0030674]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016363; GO:0016567; GO:0016604; GO:0030674; GO:0032991; GO:0080008	QDPNYLATMAMDGMEVVILDVR	11	1	1	3.66E-12	2496.019923	0	13.3188	0	15.73139	8.734538	14.50779	9.74501	0	0	16.03922	0	0	11.88614	0	0	12.24318	11.52548	0	0	0	0	0	16.10292	0	14.43992	14.78461	13.2298	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.61645	0
P62072	TIM10_HUMAN	Mitochondrial import inner membrane translocase subunit Tim10	TIMM10 TIM10	Homo sapiens (Human)	protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605]	chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0051087	MTSACHRK	3.24000001	1	1	0.106096322	991.360414	0	0	0	17.69032	15.53749	0	13.12465	15.68918	0	15.57117	13.58727	13.99654	15.23953	0	10.57698	0	0	15.91818	13.93851	0	0	0	0	14.81614	16.73969	0	0	15.06065	14.0537	12.12824	15.9375	15.61142	14.17149	0	15.33056	11.44668	0	16.35036	16.17524	14.51002	16.20951	0	0	15.4084	0	16.1622	0	0
P62081	RS7_HUMAN	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	Homo sapiens (Human)	cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]	GO:0001843; GO:0002181; GO:0003723; GO:0003730; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0010628; GO:0016020; GO:0019901; GO:0022626; GO:0022627; GO:0030154; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1904667; GO:1990904; GO:1990948; GO:2000059	LIKVHLDK	3.24000001	1	1	1.15E-13	963.707274	0	0	14.70838	12.71924	0	0	0	0	0	16.08955	0	0	14.89406	0	0	9.898818	0	0	0	0	0	0	0	0	0	17.22884	0	0	0	0	0	17.01875	0	13.40938	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P62140	PP1B_HUMAN	"Serine/threonine-protein phosphatase PP1-beta catalytic subunit, PP-1B, PPP1CD, EC 3.1.3.16, EC 3.1.3.53"	PPP1CB	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]	metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000164; GO:0000165; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005977; GO:0005979; GO:0005981; GO:0006470; GO:0007049; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042587; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0070062; GO:0072357	FNIKLWK	12.52999973	1	1	0.230373783	948.5178591	0	16.93631	18.18767	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.65945	0	0	0	0	17.47104	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P62191	PRS4_HUMAN	"26S proteasome regulatory subunit 4, P26s4 (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)"	PSMC1	Homo sapiens (Human)	negative regulation of neuron death [GO:1901215]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]; negative regulation of neuron death [GO:1901215]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]	GO:0000502; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0043161; GO:1901215	MGQSQSGGHGPGGGKK	3.140000105	1	1	0.260925691	1468.161036	0	0	0	0	0	0	12.61802	0	0	0	0	0	0	0	0	0	16.26883	0	0	0	0	0	0	0	0	0	16.59932	0	14.2889	12.6635	15.42267	15.72352	0	0	16.31667	0	0	17.28601	0	17.91127	16.17661	15.31197	14.65599	14.52235	15.96178	0	0	17.07542
P62249	RS16_HUMAN	40S ribosomal protein S16 (Small ribosomal subunit protein uS9)	RPS16	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]"	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000462; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0015935; GO:0016020; GO:0022626; GO:0022627; GO:0042274; GO:0070062; GO:1990830	GGGHVAQIYAIR	7.860000134	0.261804909	0.261804909	0.051579894	1242.120463	0	11.46271	0	0	12.84164	0	14.36516	0	12.35209	11.41752	0	9.725883	0	13.08104	0	0	0	0	0	10.2862	12.96654	0	0	0	12.15728	0	10.7781	0	12.64234	0	0	0	0	0	0	0	0	0	0	0	0	14.76481	0	14.44518	0	13.80111	11.26174	0
P62253	UB2G1_HUMAN	"Ubiquitin-conjugating enzyme E2 G1, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed ]"	UBE2G1 UBE2G	Homo sapiens (Human)	cellular protein catabolic process [GO:0044257]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein catabolic process [GO:0044257]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0031625; GO:0043161; GO:0044257; GO:0061631; GO:0070062; GO:0070534; GO:0070936	MTELQSALLLRR	3.700000048	1	1	4.63E-13	1444.463123	0	0	0	0	16.61692	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.68757	0	0	0	0	0	0	0	0	0	0	0	0
P62263	RS14_HUMAN	40S ribosomal protein S14 (Small ribosomal subunit protein uS11)	RPS14 PRO2640	Homo sapiens (Human)	"cytoplasmic translation [GO:0002181]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; cytoplasmic translation [GO:0002181]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]"	mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	GO:0000028; GO:0000122; GO:0000462; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022626; GO:0022627; GO:0030218; GO:0030490; GO:0045182; GO:0048027; GO:0070062; GO:0070181	TKTPGPGAQSALR	4.230000019	1	1	0.332956221	1284.641868	15.72281	0	15.19549	15.03942	14.98009	14.14027	0	0	13.7882	14.96733	0	0	0	0	0	0	0	0	16.11832	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P62266	RS23_HUMAN	40S ribosomal protein S23 (Small ribosomal subunit protein uS12)	RPS23	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; maintenance of translational fidelity [GO:1990145]; stress granule assembly [GO:0034063]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maintenance of translational fidelity [GO:1990145]; stress granule assembly [GO:0034063]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005783; GO:0005791; GO:0005829; GO:0005840; GO:0006412; GO:0016020; GO:0022626; GO:0022627; GO:0034063; GO:0042788; GO:0045202; GO:1990145	ANPFGGASHAK	2.839999914	1	1	0.240183357	1055.873331	0	14.99058	14.2101	0	0	0	14.76186	16.97686	15.98914	16.84521	0	14.54981	0	0	0	0	0	0	0	0	0	0	15.80278	0	0	15.47655	13.93261	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P62304	RUXE_HUMAN	"Small nuclear ribonucleoprotein E, snRNP-E (Sm protein E, Sm-E, SmE)"	SNRPE	Homo sapiens (Human)	"7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]"	RNA binding [GO:0003723]	GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005829; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013	VQKVMVQPINLIFR	17.59000015	1	1	0.172466673	1696.933827	0	0	0	15.65855	0	0	17.26033	0	15.77932	0	0	16.03246	0	17.43492	16.99095	0	0	0	0	0	0	0	16.49808	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.14919	0	0	0	0	0	0	0
P62312	LSM6_HUMAN	U6 snRNA-associated Sm-like protein LSm6	LSM6	Homo sapiens (Human)	"maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]"	protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]	GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005730; GO:0005732; GO:0005737; GO:0005829; GO:0006402; GO:0008033; GO:0008380; GO:0030490; GO:0030532; GO:0046540; GO:0046982; GO:0071005; GO:0120115	LNSGVDYR	13.43999958	0.65057075	0.65057075	0.249136048	922.4132202	15.89528	14.62244	16.94974	16.78567	15.50045	0	15.48272	11.51796	0	17.76616	0	0	16.48379	15.613	16.54691	16.0669	0	15.39255	13.37689	0	0	16.93709	0	15.38431	17.11794	16.42903	17.28361	0	0	16.57635	15.57691	18.66901	14.39855	15.45613	17.3025	16.35244	0	0	17.47309	0	16.6826	14.55964	0	0	15.65208	0	16.96508	0
P62314	SMD1_HUMAN	"Small nuclear ribonucleoprotein Sm D1, Sm-D1 (Sm-D autoantigen) (snRNP core protein D1)"	SNRPD1	Homo sapiens (Human)	"7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	"catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]"	RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]	GO:0000243; GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0008380; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526; GO:1990446	MTLKNR	8.960000038	1	1	0.137678744	761.4255694	0	15.713	15.20479	14.50589	0	0	15.82324	15.16524	0	15.09699	0	13.77977	0	0	13.45716	15.37381	0	0	0	0	15.02419	0	0	16.01647	16.1534	15.94038	16.34572	0	0	0	0	0	0	16.48492	15.86452	0	0	0	0	0	15.78171	15.24895	0	0	0	0	16.26159	0
P62316	SMD2_HUMAN	"Small nuclear ribonucleoprotein Sm D2, Sm-D2 (snRNP core protein D2)"	SNRPD2 SNRPD1	Homo sapiens (Human)	"7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]"	RNA binding [GO:0003723]	GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0008380; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0070062; GO:0071005; GO:0071007; GO:0071011; GO:0071013	KSKPVNK	5.070000172	1	1	0.164062315	799.899837	14.94933	14.52427	15.5707	18.14825	0	0	0	14.96361	11.44918	14.64293	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.03816	0	15.04996	0	0	0	0	0	0	0	15.71993	0	0	0	0	0
P62495	ERF1_HUMAN	"Eukaryotic peptide chain release factor subunit 1, Eukaryotic release factor 1, eRF1 (Protein Cl1) (TB3-1)"	ETF1 ERF1 RF1 SUP45L1	Homo sapiens (Human)	"cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translational termination [GO:0006415]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translational termination [GO:0006415]"	"ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]"	GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0005737; GO:0005829; GO:0006415; GO:0006449; GO:0006479; GO:0008079; GO:0016149; GO:0018444; GO:0043022; GO:1990825	SLEAARGNGTSMISLIIPPK	1.610000014	1	1	0.063206538	2054.305733	13.43222	0	14.88673	11.43059	15.95656	0	0	15.12256	0	0	0	0	0	0	0	12.80817	13.14727	0	10.75036	0	0	0	12.1068	0	0	0	0	0	0	0	11.66459	14.90301	0	15.10764	11.93452	0	0	0	0	0	0	0	0	0	0	0	0	0
P62508	ERR3_HUMAN	Estrogen-related receptor gamma (ERR gamma-2) (Estrogen receptor-related protein 3) (Nuclear receptor subfamily 3 group B member 3)	ESRRG ERR3 ERRG2 KIAA0832 NR3B3	Homo sapiens (Human)	"positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]"	"AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003707; GO:0004879; GO:0005496; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0034056; GO:0042802; GO:0045944; GO:0048384; GO:0050682; GO:0120162; GO:1990837	MSNKDR	7.559999943	0.132377043	0.132377043	0.226315628	766.2520159	0	15.02199	12.85774	0	0	14.78592	0	14.80348	0	15.7654	15.67385	0	15.11805	0	0	15.66319	14.45765	15.77142	11.30777	15.31869	0	15.82958	16.68583	16.59477	16.41713	15.57313	16.89854	15.3963	14.03243	15.43801	15.5909	14.75794	15.06096	14.20164	15.13606	0	15.96156	16.56681	17.03652	15.78589	15.11249	0	16.16484	15.6466	0	17.5347	16.45448	13.29746
P62699	YPEL5_HUMAN	Protein yippee-like 5	YPEL5 CGI-127	Homo sapiens (Human)	cell population proliferation [GO:0008283]	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; cell population proliferation [GO:0008283]	metal ion binding [GO:0046872]	GO:0000151; GO:0005576; GO:0005634; GO:0005815; GO:0008283; GO:0030496; GO:0046872; GO:0097431; GO:1904724; GO:1904813	IFLDHIGGTRLFSCANCDTILTNR	3.420000076	1	1	0.257846168	2793.387312	0	0	0	0	13.0979	0	15.77623	12.72061	14.25091	0	15.48024	15.3136	15.01217	0	16.27109	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.50731	0	0	15.85072	0	0	13.27119	0	12.32614	0	0	0
P62701	RS4X_HUMAN	"40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)"	RPS4X CCG2 RPS4 SCAR	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; translation [GO:0006412]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; translation [GO:0006412]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005829; GO:0005840; GO:0005844; GO:0005925; GO:0006412; GO:0008284; GO:0015935; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0036464; GO:0045202; GO:0045727; GO:0070062; GO:1990904	IFVGTK	3.5	1	1	0.184863866	660.2809816	0	0	0	0	0	0	0	0	0	15.42138	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.32588	14.67406	16.19633	0	17.59393	15.11211	0	0	15.66757	16.25126	15.30504	0	17.29513	15.89993	15.30664	16.14176	16.28561	0	14.45216	16.68844	0	16.80134	0	0
P62750	RL23A_HUMAN	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0019843; GO:0022625; GO:0022626; GO:0045296; GO:0070062; GO:1904841	AEAKAK	4.5	1	1	0.272296924	618.5479879	18.02871	0	0	17.98967	16.3672	17.69796	0	16.74787	0	19.64554	0	0	0	0	17.30378	16.50912	0	0	0	0	0	16.4812	0	0	0	0	0	0	0	0	0	19.85608	18.11066	0	17.40999	16.9273	0	0	0	0	0	0	0	0	0	15.83907	17.05518	16.97594
P62760	VISL1_HUMAN	"Visinin-like protein 1, VILIP, VLP-1 (Hippocalcin-like protein 3, HLP3)"	VSNL1 VISL1	Homo sapiens (Human)	negative regulation of insulin secretion [GO:0046676]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	cytosol [GO:0005829]; membrane [GO:0016020]	cytosol [GO:0005829]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; negative regulation of insulin secretion [GO:0046676]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005829; GO:0016020; GO:0035774; GO:0045921; GO:0046676	ITRVEMLEIIEAIYK	5.920000076	1	1	2.29E-12	1838.026933	14.24954	13.7137	12.63508	16.08727	11.32512	11.58822	13.71248	13.57839	16.10073	15.31514	0	14.49613	14.8768	12.10101	0	9.161159	0	0	0	0	0	0	17.44812	0	0	0	0	11.8529	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P62805	H4_HUMAN	Histone H4	H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4-16 HIST4H4	Homo sapiens (Human)	"chromatin assembly or disassembly [GO:0006333]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]; protein localization to CENP-A containing chromatin [GO:0061644]; telomere organization [GO:0032200]"	"CENP-A containing nucleosome [GO:0043505]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]"	"CENP-A containing nucleosome [GO:0043505]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; chromatin assembly or disassembly [GO:0006333]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]; protein localization to CENP-A containing chromatin [GO:0061644]; telomere organization [GO:0032200]"	DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]	GO:0000228; GO:0000781; GO:0000786; GO:0003677; GO:0003723; GO:0005576; GO:0005634; GO:0005654; GO:0006333; GO:0006334; GO:0006335; GO:0006336; GO:0006352; GO:0016020; GO:0019904; GO:0032200; GO:0032991; GO:0043505; GO:0045653; GO:0046982; GO:0061644; GO:0070062	DNIQGITKPAIR	8.270000458	1	1	0.600376309	1325.258649	17.6842	18.69282	18.65944	18.15025	18.03087	0	0	0	18.82685	18.13805	18.04042	0	0	0	0	0	0	0	0	0	0	0	0	0	18.89689	18.53666	18.9112	0	20.62943	0	0	0	0	19.49536	0	0	0	0	0	0	0	0	0	0	19.04379	0	16.71337	18.63189
P62841	RS15_HUMAN	40S ribosomal protein S15 (RIG protein) (Small ribosomal subunit protein uS19)	RPS15 RIG	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; liver regeneration [GO:0097421]; osteoblast differentiation [GO:0001649]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; DNA binding [GO:0003677]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cytoplasmic translation [GO:0002181]; liver regeneration [GO:0097421]; osteoblast differentiation [GO:0001649]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA processing [GO:0006364]; translation [GO:0006412]	DNA binding [GO:0003677]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]	GO:0000028; GO:0000056; GO:0001649; GO:0002181; GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0016020; GO:0022626; GO:0022627; GO:0042274; GO:0045202; GO:0097371; GO:0097421; GO:1901798; GO:1990948	KEAPPMEKPEVVK	10.46000004	1	1	0.178727415	1497.720369	17.16512	15.96383	13.56403	0	0	0	0	0	14.63402	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.60145	0	0	13.78459	12.94157	0	0	0	12.02116	16.13244	14.03191	0	0	0	0	0	0	0
P62851	RS25_HUMAN	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006364; GO:0006412; GO:0014069; GO:0015935; GO:0022626; GO:0022627; GO:0042274; GO:0070062	GSLAR	27.59000015	0.13446945	0.13446945	0.227925871	503.2931449	0	0	16.67961	16.84442	17.50853	16.01312	0	0	0	16.98872	14.35327	0	14.938	16.0988	15.24763	0	15.27256	16.4083	0	0	0	0	0	0	0	0	0	0	0	0	0	15.25155	0	17.25253	0	0	0	17.11947	0	0	0	0	0	0	0	0	0	0
P62879	GBB2_HUMAN	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2)	GNB2	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; G protein-coupled receptor signaling pathway [GO:0007186]	GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]	GO:0003924; GO:0005615; GO:0005737; GO:0005765; GO:0005829; GO:0005834; GO:0005925; GO:0007186; GO:0016020; GO:0030159; GO:0031982; GO:0044877; GO:0048471; GO:0051020; GO:0070062	AGVLAGHDNR	7.039999962	1	1	0.157611261	1010.521439	0	0	15.78585	11.63188	0	12.95902	0	14.52889	13.33796	0	17.2089	15.07308	14.60708	14.5171	11.74643	12.39805	12.2894	15.26774	0	0	0	0	16.0326	12.2078	14.37364	0	0	0	0	0	0	0	0	0	16.18712	0	17.28576	0	0	15.86362	0	0	0	0	0	14.28014	14.82069	0
P62906	RL10A_HUMAN	"60S ribosomal protein L10a (CSA-19) (Large ribosomal subunit protein uL1) (Neural precursor cell expressed developmentally down-regulated protein 6, NEDD-6)"	RPL10A NEDD6	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788; GO:0070062	AGKFPSLLTHNENMVAK	4.420000076	1	1	0.41821146	1856.957441	15.45908	0	0	15.30325	0	13.86132	0	0	0	15.70649	0	16.43372	0	15.69605	13.92162	15.01803	0	0	0	0	0	0	15.64089	0	14.55178	0	0	14.70335	16.99566	0	0	0	0	0	0	0	0	0	17.45941	15.89241	0	0	0	0	0	0	0	0
P62913	RL11_HUMAN	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; protein-containing complex [GO:0032991]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006412; GO:0006605; GO:0008097; GO:0010628; GO:0016020; GO:0022625; GO:0022626; GO:0031625; GO:0032092; GO:0032435; GO:0032991; GO:0034504; GO:0042273; GO:0042788; GO:0050821; GO:0070062; GO:1901796; GO:1904667; GO:1990948; GO:2000059; GO:2000435	RTGCIGAK	5.480000019	0.97114116	0.97114116	0.193695788	861.8029938	0	0	0	0	0	14.92458	0	0	0	0	0	0	16.63341	0	15.96835	0	0	16.76106	16.90626	0	0	17.04296	16.70572	0	15.99127	15.97047	16.53276	15.5749	17.16523	14.66697	15.89528	14.59376	15.3806	14.76406	0	15.7519	0	18.60434	0	14.81109	15.6129	17.90733	0	0	0	17.77989	16.30108	15.70098
P62917	RL8_HUMAN	60S ribosomal protein L8 (Large ribosomal subunit protein uL2)	RPL8	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0019843; GO:0022625; GO:0022626; GO:0042788; GO:0098794	DAPAGR	2.789999962	0.125394166	0.125394166	0.17924101	587.4815874	0	0	0	15.28645	0	0	0	0	0	0	0	14.15033	15.74908	15.73772	15.25952	0	16.51171	16.70033	0	17.66064	0	14.60681	0	16.32406	16.58177	0	15.80728	16.34484	15.70434	16.58496	16.70559	15.7806	16.11666	16.88462	16.59237	16.1292	17.36728	17.44714	0	15.38239	17.84591	17.14762	16.59292	17.54695	16.91042	16.48071	17.63082	17.53618
P62942	FKB1A_HUMAN	"Peptidyl-prolyl cis-trans isomerase FKBP1A, PPIase FKBP1A, EC 5.2.1.8 (12 kDa FK506-binding protein, 12 kDa FKBP, FKBP-12) (Calstabin-1) (FK506-binding protein 1A, FKBP-1A) (Immunophilin FKBP12) (Rotamase)"	FKBP1A FKBP1 FKBP12	Homo sapiens (Human)	'de novo' protein folding [GO:0006458]; amyloid fibril formation [GO:1990000]; calcium ion transmembrane transport [GO:0070588]; chaperone-mediated protein folding [GO:0061077]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein folding [GO:0006457]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell activation [GO:0042110]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum [GO:0016529]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]	cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum [GO:0016529]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; activin binding [GO:0048185]; FK506 binding [GO:0005528]; macrolide binding [GO:0005527]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; transmembrane transporter binding [GO:0044325]; type I transforming growth factor beta receptor binding [GO:0034713]; 'de novo' protein folding [GO:0006458]; amyloid fibril formation [GO:1990000]; calcium ion transmembrane transport [GO:0070588]; chaperone-mediated protein folding [GO:0061077]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein folding [GO:0006457]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell activation [GO:0042110]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	activin binding [GO:0048185]; FK506 binding [GO:0005528]; macrolide binding [GO:0005527]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; transmembrane transporter binding [GO:0044325]; type I transforming growth factor beta receptor binding [GO:0034713]	GO:0000413; GO:0003007; GO:0003755; GO:0005160; GO:0005527; GO:0005528; GO:0005737; GO:0005829; GO:0006457; GO:0006458; GO:0007183; GO:0014802; GO:0016020; GO:0016529; GO:0022417; GO:0030018; GO:0030512; GO:0031312; GO:0031398; GO:0032092; GO:0032515; GO:0032880; GO:0032925; GO:0034713; GO:0042026; GO:0042110; GO:0043123; GO:0044325; GO:0046332; GO:0048185; GO:0050776; GO:0055010; GO:0060314; GO:0060347; GO:0061077; GO:0070588; GO:0097435; GO:0098562; GO:1902991; GO:1990000; GO:1990425	GVQVETISPGDGRTFPK	2.019999981	1	1	0.355696879	1788.660791	14.9806	0	13.52266	0	15.88729	15.57154	0	14.31106	0	0	15.12129	15.56596	0	15.94261	0	0	0	15.34679	0	0	14.5195	0	0	0	0	0	0	0	0	0	0	0	16.5132	0	0	0	15.73967	0	0	0	0	15.28306	14.31856	15.86095	0	0	16.14652	0
P62979	RS27A_HUMAN	Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a (Small ribosomal subunit protein eS31) ]	RPS27A UBA80 UBCEP1	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; vesicle [GO:0031982]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]	metal ion binding [GO:0046872]; protein tag [GO:0031386]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]	GO:0002181; GO:0003723; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005741; GO:0005789; GO:0005829; GO:0005886; GO:0006412; GO:0010008; GO:0015935; GO:0016020; GO:0016567; GO:0019941; GO:0022626; GO:0022627; GO:0030666; GO:0031386; GO:0031625; GO:0031982; GO:0046872; GO:0070062	ECPSDECGAGVFMASHFDR	5.090000153	0.737137556	0.737137556	9.17E-13	2187.665899	0	13.68255	0	0	0	0	0	0	0	0	14.37717	0	0	0	0	0	0	0	0	0	0	0	0	0	12.84867	0	0	0	0	0	0	0	13.05967	0	15.16888	0	0	0	0	12.50515	15.41513	0	16.42677	0	0	0	14.12745	0
P62995	TRA2B_HUMAN	"Transformer-2 protein homolog beta, TRA-2 beta, TRA2-beta, hTRA2-beta (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)"	TRA2B SFRS10	Homo sapiens (Human)	"cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]"	nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]	"nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]"	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]	GO:0000375; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0032991; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0071333; GO:1990403	RHVGNR	16.65999985	0.188871741	0.188871741	0.252866801	738.0982895	21.35303	21.75138	21.0042	20.67184	21.5294	18.45864	20.90093	17.50442	17.81156	23.66089	22.39239	20.41472	21.64298	21.67666	22.2518	19.09248	21.69338	22.2335	18.52192	22.34629	22.03534	21.39548	21.96998	20.93264	22.2586	21.69568	22.1257	19.02243	22.39345	22.46122	19.27356	22.20298	23.23166	20.07294	18.55356	21.05899	21.07968	20.26331	19.22321	22.68487	0	21.22766	22.47094	17.90149	21.75358	22.14205	22.30303	22.22487
P63010	AP2B1_HUMAN	AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit)	AP2B1 ADTB2 CLAPB1	Homo sapiens (Human)	aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; negative regulation of neuron death [GO:1901215]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; ventricular septum development [GO:0003281]; vesicle-mediated transport [GO:0016192]	AP-2 adaptor complex [GO:0030122]; clathrin adaptor complex [GO:0030131]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	AP-2 adaptor complex [GO:0030122]; clathrin adaptor complex [GO:0030131]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; signal sequence binding [GO:0005048]; aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; negative regulation of neuron death [GO:1901215]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; ventricular septum development [GO:0003281]; vesicle-mediated transport [GO:0016192]	clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; signal sequence binding [GO:0005048]	GO:0001822; GO:0003281; GO:0005048; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0016020; GO:0016192; GO:0030122; GO:0030131; GO:0030276; GO:0030666; GO:0030669; GO:0035904; GO:0036020; GO:0044877; GO:0045334; GO:0045807; GO:0048268; GO:0048488; GO:0060976; GO:0072583; GO:0098793; GO:0098794; GO:0098884; GO:0098978; GO:1901215; GO:1905477	AKGLEISGTFTHR	13.89000034	0.72466588	0.72466588	0.562874709	1416.5803	18.38314	15.5886	18.92485	0	16.7352	0	0	0	0	0	0	0	17.31833	0	18.0609	0	17.53606	0	0	0	0	0	0	0	0	0	0	0	16.94509	0	0	0	0	0	0	0	17.53762	21.44996	19.00719	0	0	0	0	0	0	0	0	0
P63208	SKP1_HUMAN	"S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19, p19A) (Organ of Corti protein 2, OCP-2) (Organ of Corti protein II, OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1)"	SKP1 EMC19 OCP2 SKP1A TCEB1L	Homo sapiens (Human)	histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; protein domain specific binding [GO:0019904]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; protein domain specific binding [GO:0019904]; ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0008013; GO:0016567; GO:0019005; GO:0019904; GO:0031146; GO:0031467; GO:0035518; GO:0051457; GO:0070936; GO:0097602; GO:1904668; GO:1990444; GO:1990756	KVIQWCTHHK	2.819999933	1	1	0.182024698	1336.27379	0	0	15.58512	14.19685	0	0	15.27904	0	0	13.56422	0	0	15.0919	16.00498	14.92476	0	0	15.55719	0	0	0	0	0	0	0	0	0	16.33232	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P63211	GBG1_HUMAN	Guanine nucleotide-binding protein G(T) subunit gamma-T1 (Transducin gamma chain)	GNGT1	Homo sapiens (Human)	cardiac muscle cell apoptotic process [GO:0010659]; cellular response to hypoxia [GO:0071456]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein localization [GO:0008104]; signal transduction [GO:0007165]	heterotrimeric G-protein complex [GO:0005834]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]	heterotrimeric G-protein complex [GO:0005834]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to hypoxia [GO:0071456]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; protein localization [GO:0008104]; signal transduction [GO:0007165]	G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]	GO:0001917; GO:0003924; GO:0005834; GO:0007165; GO:0007186; GO:0007602; GO:0008104; GO:0010659; GO:0031681; GO:0042462; GO:0071456; GO:0097381	KEVTLER	6.010000229	0.720902443	0.720902443	0.183641934	874.7345254	0	18.14283	13.22206	14.99033	0	16.32693	0	0	15.21856	0	0	15.93334	10.54984	0	0	13.48968	0	0	15.26335	0	0	0	16.50496	0	13.986	14.34479	13.98558	0	14.40165	14.78197	16.37385	16.11816	14.55875	11.15514	14.8934	14.61258	13.47948	14.2201	13.05504	13.1854	15.68504	15.25999	12.86671	14.93482	15.48123	16.09286	14.88171	0
P63218	GBG5_HUMAN	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GNG5 GNGT5	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]	GO:0003924; GO:0005834; GO:0005886; GO:0007165; GO:0007186; GO:0016020; GO:0030165; GO:0031681; GO:0070062	SGSSSVAAMKK	5.590000153	1	1	0.052555223	1068.253645	15.01276	0	15.26174	14.71696	13.75192	15.65383	16.98365	14.87683	0	9.820301	0	0	0	15.79417	0	0	0	13.1963	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P63261	ACTG_HUMAN	"Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed ]"	ACTG1 ACTG	Homo sapiens (Human)	angiogenesis [GO:0001525]; cellular response to interferon-gamma [GO:0071346]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of a polarized epithelium [GO:0001738]; platelet aggregation [GO:0070527]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of wound healing [GO:0090303]; protein localization to bicellular tight junction [GO:1902396]; regulation of focal adhesion assembly [GO:0051893]; regulation of stress fiber assembly [GO:0051492]; regulation of transepithelial transport [GO:0150111]; response to calcium ion [GO:0051592]; response to mechanical stimulus [GO:0009612]; retina homeostasis [GO:0001895]; sarcomere organization [GO:0045214]; synaptic vesicle endocytosis [GO:0048488]; tight junction assembly [GO:0120192]	actin filament [GO:0005884]; apical junction complex [GO:0043296]; basal body patch [GO:0120220]; blood microparticle [GO:0072562]; calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane [GO:0016020]; myofibril [GO:0030016]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic actin cytoskeleton [GO:0099143]; Schaffer collateral - CA1 synapse [GO:0098685]	actin filament [GO:0005884]; apical junction complex [GO:0043296]; basal body patch [GO:0120220]; blood microparticle [GO:0072562]; calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane [GO:0016020]; myofibril [GO:0030016]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynaptic actin cytoskeleton [GO:0099143]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; profilin binding [GO:0005522]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; ubiquitin protein ligase binding [GO:0031625]; angiogenesis [GO:0001525]; cellular response to interferon-gamma [GO:0071346]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of a polarized epithelium [GO:0001738]; platelet aggregation [GO:0070527]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of wound healing [GO:0090303]; protein localization to bicellular tight junction [GO:1902396]; regulation of focal adhesion assembly [GO:0051893]; regulation of stress fiber assembly [GO:0051492]; regulation of transepithelial transport [GO:0150111]; response to calcium ion [GO:0051592]; response to mechanical stimulus [GO:0009612]; retina homeostasis [GO:0001895]; sarcomere organization [GO:0045214]; synaptic vesicle endocytosis [GO:0048488]; tight junction assembly [GO:0120192]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; profilin binding [GO:0005522]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; ubiquitin protein ligase binding [GO:0031625]	GO:0001525; GO:0001738; GO:0001895; GO:0005200; GO:0005522; GO:0005524; GO:0005615; GO:0005634; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0009612; GO:0010628; GO:0016020; GO:0030016; GO:0030335; GO:0031625; GO:0031941; GO:0035633; GO:0042802; GO:0043296; GO:0044305; GO:0045214; GO:0045335; GO:0048488; GO:0051492; GO:0051592; GO:0051893; GO:0070062; GO:0070527; GO:0071346; GO:0072562; GO:0090303; GO:0097433; GO:0098685; GO:0098871; GO:0098973; GO:0099143; GO:0120192; GO:0120220; GO:0150111; GO:1902396	EEEIAALVIDNGSGMCK	6.630000114	1	1	0.474297403	1852.5328	18.42013	16.32761	0	18.8229	0	0	0	18.79424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.32844	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P63302	SELW_HUMAN	"Selenoprotein W, SelW"	SELENOW SELW SEPW1	Homo sapiens (Human)	response to selenium ion [GO:0010269]	cytosol [GO:0005829]	cytosol [GO:0005829]; antioxidant activity [GO:0016209]; response to selenium ion [GO:0010269]	antioxidant activity [GO:0016209]	GO:0005829; GO:0010269; GO:0016209	AALAQG	9.31000042	0.041423291	0.041423291	2.31E-13	529.3177399	0	0	0	0	0	0	0	0	14.94238	0	0	0	14.39846	0	0	0	0	0	14.79496	0	0	0	0	0	0	0	0	14.04488	0	0	0	0	0	15.04064	0	0	0	15.76586	0	0	15.64652	0	0	0	0	0	0	0
P63313	TYB10_HUMAN	Thymosin beta-10	TMSB10 PTMB10 THYB10	Homo sapiens (Human)	actin filament organization [GO:0007015]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989]	actin monomer binding [GO:0003785]	GO:0003785; GO:0005737; GO:0005856; GO:0007015; GO:0030334; GO:0042989	ETIEQEKR	11.75	1	1	0.02755552	1032.316491	13.7033	12.84306	0	15.56684	14.16307	0	0	0	13.00924	15.17639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P63316	TNNC1_HUMAN	"Troponin C, slow skeletal and cardiac muscles, TN-C"	TNNC1 TNNC	Homo sapiens (Human)	cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; regulation of ATP-dependent activity [GO:0043462]; regulation of muscle contraction [GO:0006937]; regulation of muscle filament sliding speed [GO:0032972]; response to metal ion [GO:0010038]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	cardiac Troponin complex [GO:1990584]; cytosol [GO:0005829]; troponin complex [GO:0005861]	cardiac Troponin complex [GO:1990584]; cytosol [GO:0005829]; troponin complex [GO:0005861]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; troponin I binding [GO:0031013]; troponin T binding [GO:0031014]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; regulation of ATP-dependent activity [GO:0043462]; regulation of muscle contraction [GO:0006937]; regulation of muscle filament sliding speed [GO:0032972]; response to metal ion [GO:0010038]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; troponin I binding [GO:0031013]; troponin T binding [GO:0031014]	GO:0002086; GO:0003009; GO:0005509; GO:0005829; GO:0005861; GO:0006937; GO:0010038; GO:0014883; GO:0031013; GO:0031014; GO:0032972; GO:0042803; GO:0043462; GO:0048306; GO:0051015; GO:0055010; GO:0060048; GO:1990584	MDDIYK	4.889999866	0.146289662	0.146289662	0.064132952	783.2452695	16.61732	8.454315	16.3296	15.87954	12.56158	16.41373	0	16.84114	15.44235	14.88545	0	0	11.74791	18.23301	11.47377	0	15.41045	14.62039	0	17.41368	14.20629	0	0	0	0	0	15.63671	0	16.47988	0	0	16.8874	16.49655	15.28295	17.49956	14.58214	15.76772	17.36232	16.30096	19.29443	16.65944	16.50573	0	16.41134	0	16.37299	14.51971	13.61186
P67870	CSK2B_HUMAN	"Casein kinase II subunit beta, CK II beta (Phosvitin) (Protein G5a)"	CSNK2B CK2N G5A	Homo sapiens (Human)	adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of DNA binding [GO:0051101]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; secretory granule lumen [GO:0034774]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; secretory granule lumen [GO:0034774]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of DNA binding [GO:0051101]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]	GO:0003682; GO:0004674; GO:0005102; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005956; GO:0006468; GO:0007165; GO:0008285; GO:0010862; GO:0016055; GO:0018107; GO:0019887; GO:0019904; GO:0032927; GO:0033211; GO:0034774; GO:0042802; GO:0043537; GO:0046872; GO:0051101; GO:0061154; GO:0061629; GO:0065003; GO:0070062; GO:0080163; GO:1904813	FNLTGLNEQVPHYR	7.960000038	1	1	0.473899515	1686.918266	0	15.5569	19.28711	17.8104	0	0	0	0	0	0	0	19.89815	0	0	0	0	0	17.88873	0	0	17.63392	0	0	0	0	19.40433	20.39991	0	0	0	0	20.69477	0	0	19.03891	0	0	18.43144	18.3585	0	18.40112	0	17.64387	19.52315	0	0	0	0
P68104	EF1A1_HUMAN	"Elongation factor 1-alpha 1, EF-1-alpha-1 (Elongation factor Tu, EF-Tu) (Eukaryotic elongation factor 1 A-1, eEF1A-1) (Leukocyte receptor cluster member 7)"	EEF1A1 EEF1A EF1A LENG7	Homo sapiens (Human)	cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414]	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414]	calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003746; GO:0003924; GO:0005516; GO:0005525; GO:0005576; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005853; GO:0005886; GO:0006412; GO:0006414; GO:0016020; GO:0019900; GO:0019901; GO:0030864; GO:0032587; GO:0034774; GO:0070062; GO:0071364; GO:0098574; GO:1900022; GO:1904714; GO:1904813	YYVTIIDAPGHRDFIK	7.989999771	1	1	2.29E-13	1906.815646	15.14618	15.23615	0	14.92212	13.89657	0	0	0	0	0	0	0	14.53949	14.79672	0	15.61892	14.65371	0	15.36608	0	15.6158	0	17.59999	0	0	14.30936	0	16.16725	14.43173	0	15.61866	0	15.27784	16.39979	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P68133	ACTS_HUMAN	"Actin, alpha skeletal muscle (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form ]"	ACTA1 ACTA	Homo sapiens (Human)	cellular response to organonitrogen compound [GO:0071417]; mesenchyme migration [GO:0090131]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; response to extracellular stimulus [GO:0009991]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to steroid hormone [GO:0048545]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; blood microparticle [GO:0072562]; cell body [GO:0044297]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; striated muscle thin filament [GO:0005865]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; blood microparticle [GO:0072562]; cell body [GO:0044297]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; striated muscle thin filament [GO:0005865]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; cellular response to organonitrogen compound [GO:0071417]; mesenchyme migration [GO:0090131]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; response to extracellular stimulus [GO:0009991]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to steroid hormone [GO:0048545]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]	GO:0001725; GO:0005200; GO:0005524; GO:0005615; GO:0005829; GO:0005865; GO:0005869; GO:0005884; GO:0006936; GO:0009612; GO:0009991; GO:0010226; GO:0010628; GO:0015629; GO:0017022; GO:0030017; GO:0030027; GO:0030175; GO:0030240; GO:0043503; GO:0043531; GO:0044297; GO:0048545; GO:0048741; GO:0070062; GO:0071417; GO:0072562; GO:0090131	IIAPPERK	13.65999985	0.807957172	0.807957172	0.159065372	922.7909802	0	0	16.68257	17.50018	0	0	15.87307	16.45311	15.4604	16.27998	15.1031	18.22038	0	17.00347	0	0	0	14.69863	15.81218	14.56946	16.37766	0	0	0	0	0	0	0	14.41142	18.06801	0	0	0	0	0	0	0	0	0	16.23185	0	0	17.68408	0	15.44619	17.11801	16.91676	16.15209
P69905	HBA_HUMAN	Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain)	HBA1; HBA2	Homo sapiens (Human)	carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; nitric oxide transport [GO:0030185]; oxygen transport [GO:0015671]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542]	blood microparticle [GO:0072562]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; membrane [GO:0016020]	blood microparticle [GO:0072562]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; nitric oxide transport [GO:0030185]; oxygen transport [GO:0015671]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542]	heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]	GO:0005344; GO:0005506; GO:0005576; GO:0005615; GO:0005829; GO:0005833; GO:0010942; GO:0015670; GO:0015671; GO:0016020; GO:0019825; GO:0020037; GO:0022627; GO:0030185; GO:0031838; GO:0042542; GO:0042744; GO:0043177; GO:0070062; GO:0071682; GO:0072562; GO:0098869	MFLSFPTTK	36.68000031	0.392430454	0.392430454	0.500494597	1072.227802	17.1698	0	18.10488	17.95998	15.86436	0	0	16.78073	19.09537	0	0	0	0	0	0	0	18.42781	15.80583	0	0	17.48314	0	0	0	0	0	0	17.23116	0	0	0	0	0	0	19.44726	17.29887	0	0	0	0	0	0	16.56437	0	0	17.71197	0	16.76264
P78310	CXAR_HUMAN	"Coxsackievirus and adenovirus receptor, CAR, hCAR (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR)"	CXADR CAR	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633]	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633]	beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001669; GO:0005102; GO:0005178; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0005923; GO:0007005; GO:0007157; GO:0007507; GO:0008013; GO:0008354; GO:0010669; GO:0014704; GO:0016323; GO:0016327; GO:0030054; GO:0030165; GO:0030175; GO:0030426; GO:0030593; GO:0031532; GO:0031594; GO:0032991; GO:0034109; GO:0042802; GO:0043005; GO:0044297; GO:0045121; GO:0045216; GO:0046629; GO:0050839; GO:0051607; GO:0055013; GO:0070633; GO:0071253; GO:0086067; GO:0086072; GO:0086082; GO:0098904	TPQSPTLPPAKVAAPNLSR	6.96999979	1	1	0.09737292	1945.037302	12.34644	0	15.08348	13.83093	8.175155	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P78314	3BP2_HUMAN	"SH3 domain-binding protein 2, 3BP-2"	SH3BP2 3BP2 RES4-23	Homo sapiens (Human)	signal transduction [GO:0007165]		phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]; signal transduction [GO:0007165]	phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]	GO:0001784; GO:0007165; GO:0017124	TWFFSASSEEER	2.769999981	1	1	0.125303657	1476.110823	0	0	13.1246	0	13.14446	0	0	0	0	0	0	0	0	15.41711	0	0	0	0	0	0	0	16.63717	0	13.97138	0	15.98883	0	16.2956	0	0	0	0	0	0	0	0	0	16.97758	16.6596	0	17.25239	16.17513	17.47327	0	0	0	0	0
P78316	NOP14_HUMAN	Nucleolar protein 14 (Nucleolar complex protein 14)	NOP14 C4orf9 NOL14 RES4-25	Homo sapiens (Human)	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]"	90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	"90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]"	enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0000447; GO:0000462; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0019899; GO:0030490; GO:0030515; GO:0030686; GO:0030692; GO:0032040; GO:0042274	EIQTLLSHKTPK	9.069999695	1	1	0.556953479	1393.820031	0	0	0	0	0	0	18.47214	0	0	0	0	18.6774	18.87749	0	0	19.27534	0	0	0	0	0	0	0	0	0	0	0	0	0	19.50138	0	0	0	0	0	19.11095	0	0	0	0	0	17.85351	0	0	18.96084	0	0	0
P78318	IGBP1_HUMAN	"Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4, Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16)"	IGBP1 IBP1	Homo sapiens (Human)	B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]	protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]	GO:0000122; GO:0005737; GO:0005829; GO:0007165; GO:0019888; GO:0032873; GO:0034612; GO:0035303; GO:0042113; GO:0043154; GO:0051721; GO:0060632; GO:0070555	KYGALPDQGIAK	5.769999981	1	1	9.18E-13	1261.052149	11.73881	13.27674	10.66244	14.75607	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.35206	0	0	0	0	0	0	0	0	0	0	4.238778	0	0	0	0	0	0	13.91702	0	0	10.94239	0	0	0	0
P78329	CP4F2_HUMAN	"Cytochrome P450 4F2, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase, EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1, EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2, EC 1.14.14.78)"	CYP4F2	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805]"	"20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]"	GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008391; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0052872; GO:0055078; GO:0070330; GO:0097258; GO:0097259; GO:0097267; GO:0102033; GO:0102207	VLPDHTEPR	7.5	0.002162628	0.002162628	0.127417813	1063.476198	0	18.37406	14.30178	0	16.54371	14.42214	15.26597	15.03939	14.20514	14.86491	15.34476	16.52557	15.0212	17.97562	15.04192	14.46198	13.88138	16.82517	14.55191	14.89562	16.08877	17.53926	15.65714	0	17.29461	0	15.88325	15.32207	13.60636	0	0	15.97421	0	14.75091	16.88958	16.72918	17.24712	13.18476	17.94216	0	0	0	15.33256	0	16.66759	17.10876	15.8623	19.07397
P78332	RBM6_HUMAN	RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3)	RBM6 DEF3	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0006396	EHSGMNVNR	3.180000067	1	1	4.63E-13	1056.903242	0	14.15255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.08289	0	10.68692	0	0	0	0	14.51242	13.97567	0	0	0	0	0	0	0	14.14843	13.0251	11.24978	0	0	0	0	0	0
P78333	GPC5_HUMAN	Glypican-5 [Cleaved into: Secreted glypican-5 ]	GPC5	Homo sapiens (Human)	cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475]		GO:0005576; GO:0005615; GO:0005796; GO:0005886; GO:0009986; GO:0016021; GO:0016477; GO:0043202; GO:0046658; GO:0062023; GO:0090263; GO:1905475	HGMKTTTR	4.550000191	1	1	0.157082431	946.4182141	0	16.40325	17.36738	0	0	11.80322	0	0	0	16.62717	0	0	0	16.60781	0	0	0	0	0	0	16.05877	17.40988	0	15.19201	0	0	13.91649	10.17163	0	0	16.71804	14.77275	0	0	0	0	17.19734	18.5482	18.97791	15.20605	0	16.44619	0	0	14.58302	17.16394	0	0
P78344	IF4G2_HUMAN	"Eukaryotic translation initiation factor 4 gamma 2, eIF-4-gamma 2, eIF-4G 2, eIF4G 2 (Death-associated protein 5, DAP-5) (p97)"	EIF4G2 DAP5 OK/SW-cl.75	Homo sapiens (Human)	cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of cell cycle [GO:0051726]; regulation of translational initiation [GO:0006446]	adherens junction [GO:0005912]; axon [GO:0030424]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]	"adherens junction [GO:0005912]; axon [GO:0030424]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of cell cycle [GO:0051726]; regulation of translational initiation [GO:0006446]"	"cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0005912; GO:0006446; GO:0007507; GO:0008135; GO:0008219; GO:0010507; GO:0016020; GO:0016281; GO:0030307; GO:0030424; GO:0034645; GO:0045296; GO:0045727; GO:0045773; GO:0051726; GO:0060999	ESAIAEGGASR	5.050000191	0.571685076	0.571685076	0.211662125	1046.708313	16.43524	15.71106	16.41683	17.69015	15.09348	17.65618	13.17778	15.75444	14.94991	15.52017	16.55206	12.46594	15.11713	15.35684	10.31196	13.88869	14.56098	15.72097	15.37095	15.8855	15.49817	17.74374	16.59781	12.93507	15.87759	15.22439	17.69312	0	12.97649	16.33354	0	17.68203	0	17.17947	0	0	0	18.0924	0	15.0753	16.69592	0	15.08899	16.49226	16.90182	15.64072	0	0
P78346	RPP30_HUMAN	"Ribonuclease P protein subunit p30, RNaseP protein p30 (RNase P subunit 2)"	RPP30 RNASEP2	Homo sapiens (Human)	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]"	multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]	"multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]"	ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]	GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0006364; GO:0008033; GO:0030681; GO:0033204; GO:0090502	GLAFELVYSPAIKDSTMR	9.670000076	1	1	0.354837494	2014.622935	0	0	0	0	0	0	17.03017	0	0	0	18.47764	0	0	0	0	0	0	0	0	0	17.57453	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P78348	ASIC1_HUMAN	"Acid-sensing ion channel 1, ASIC1 (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2, BNaC2)"	ASIC1 ACCN2 BNAC2	Homo sapiens (Human)	associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acid-sensing ion channel activity [GO:0044736]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	acid-sensing ion channel activity [GO:0044736]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]	GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0005887; GO:0006814; GO:0007165; GO:0007613; GO:0008306; GO:0009268; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0035725; GO:0042391; GO:0044736; GO:0045202; GO:0046929; GO:0050915; GO:0070207; GO:0070588; GO:0071467	VVFTRYGK	10.86999989	0.219259754	0.219259754	0.147879153	969.3744886	14.04808	14.41084	16.7074	14.94415	15.89815	13.60204	0	13.25651	0	16.50965	19.87745	13.91145	0	0	0	0	11.45915	14.6341	0	17.21376	15.22869	15.17692	15.27864	10.86104	17.59632	14.92687	0	17.08243	0	16.57258	14.96291	17.87439	15.11796	17.84067	13.20927	0	13.94713	14.94113	16.04766	11.98983	14.77741	17.16876	17.57795	13.25592	13.4826	17.97478	0	16.45289
P78357	CNTP1_HUMAN	"Contactin-associated protein 1, Caspr, Caspr1 (Neurexin IV) (Neurexin-4) (p190)"	CNTNAP1 CASPR NRXN4	Homo sapiens (Human)	"axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; signal transduction [GO:0007165]"	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; presynaptic active zone membrane [GO:0048787]	"integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; presynaptic active zone membrane [GO:0048787]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; signal transduction [GO:0007165]"	SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]	GO:0002175; GO:0005887; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016021; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048787; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0097106; GO:0098529; GO:1990227	YMLLYGDR	1.929999948	1.04E-08	1.04E-08	0.079711579	1044.513085	0	14.96635	12.98489	17.23559	14.32092	14.13439	15.46838	13.22422	0	0	14.98618	0	0	16.1762	12.23644	15.61702	16.22203	10.19302	0	0	0	16.43049	18.46323	14.38394	17.11619	0	0	15.2476	16.04309	15.67189	13.28151	0	16.46865	15.79073	17.48018	13.56975	17.79729	0	17.56615	15.94826	16.942	0	17.20846	14.64761	0	0	16.4712	0
P78362	SRPK2_HUMAN	"SRSF protein kinase 2, EC 2.7.11.1 (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2, SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal ]"	SRPK2	Homo sapiens (Human)	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]"	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]	GO:0000245; GO:0000287; GO:0000785; GO:0001525; GO:0003723; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010628; GO:0016607; GO:0018105; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045087; GO:0045787; GO:0048024; GO:0050684; GO:0062176; GO:0071889; GO:0106310	CVKSIIR	9.81000042	0.460923374	0.460923374	0.11513376	874.4541612	16.36854	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.01179	0	0	0	18.04086	16.32869	0	0	0	0	17.83213	0	0	0	0	0	0	0	0	0	0	16.48444	0	0	0	17.3165	0	0	0	0	0	16.69123	18.13186
P78363	ABCA4_HUMAN	"Retinal-specific phospholipid-transporting ATPase ABCA4, EC 7.6.2.1 (ATP-binding cassette sub-family A member 4) (RIM ABC transporter, RIM proteinv, RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein)"	ABCA4 ABCR	Homo sapiens (Human)	"lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]"	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; rod photoreceptor disc membrane [GO:0120202]	"cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; rod photoreceptor disc membrane [GO:0120202]; 11-cis retinal binding [GO:0005502]; ABC-type transporter activity [GO:0140359]; all-trans retinal binding [GO:0005503]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; GTPase activity [GO:0003924]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; retinoid binding [GO:0005501]; retinol transmembrane transporter activity [GO:0034632]; transporter activity [GO:0005215]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]"	11-cis retinal binding [GO:0005502]; ABC-type transporter activity [GO:0140359]; all-trans retinal binding [GO:0005503]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; GTPase activity [GO:0003924]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; retinoid binding [GO:0005501]; retinol transmembrane transporter activity [GO:0034632]; transporter activity [GO:0005215]	GO:0001523; GO:0001750; GO:0003924; GO:0005215; GO:0005319; GO:0005501; GO:0005502; GO:0005503; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0007603; GO:0016020; GO:0016887; GO:0031410; GO:0034632; GO:0042574; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0055085; GO:0090555; GO:0097381; GO:0120202; GO:0140326; GO:0140327; GO:0140347; GO:0140359	AAKPLLMGK	5.650000095	1	1	0.22909836	928.5766783	0	0	0	0	0	0	16.10185	0	0	0	0	0	0	0	0	0	18.99758	0	0	0	0	17.51108	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.0942	0
P78367	NKX32_HUMAN	Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B)	NKX3-2 BAPX1 NKX3B	Homo sapiens (Human)	animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0005634; GO:0006357; GO:0006366; GO:0007368; GO:0030154; GO:0031016; GO:0032331; GO:0042474; GO:0043066; GO:0048536; GO:0048645; GO:0048705; GO:0048706; GO:0060576; GO:1990837	GANTLTSFSIQAILNKK	4.789999962	0.906781793	0.906781793	0.092932496	1807.017562	14.64096	14.59316	16.744	13.83294	10.70653	13.18586	11.95541	14.30892	13.28769	17.93561	11.42506	14.98538	17.17951	0	0	13.1808	16.77586	15.39828	0	16.58246	14.67975	16.22064	14.92513	15.05364	16.1316	18.2595	0	12.58681	0	14.63658	15.05471	0	14.78091	0	0	14.64849	12.7917	18.19166	14.58946	15.99081	16.05066	15.60381	0	0	14.52768	0	14.82905	0
P78368	KC1G2_HUMAN	"Casein kinase I isoform gamma-2, CKI-gamma 2, EC 2.7.11.1"	CSNK1G2 CK1G2	Homo sapiens (Human)	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; Wnt signaling pathway [GO:0016055]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0006897; GO:0007165; GO:0016020; GO:0016055; GO:0018105; GO:0030148; GO:0090263; GO:0106310	TVLMIAIQLITRMEYVHTK	6.190000057	1	1	0.318726873	2276.230842	15.39621	12.66564	17.80079	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.17578	0	0
P78369	CLD10_HUMAN	"Claudin-10 (Oligodendrocyte-specific protein-like, OSP-like)"	CLDN10	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269]	identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005737; GO:0005886; GO:0005923; GO:0006811; GO:0007155; GO:0016021; GO:0016338; GO:0042802; GO:0043269; GO:0070830	VGGSDKAK	2.920000076	1	1	0.181802524	760.9137519	0	16.68108	17.41803	10.00897	15.21432	16.22514	0	0	13.89572	16.43321	17.29163	16.79487	0	16.69709	0	12.86219	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.00031	0	16.56354	0	0	0	0	0	0	17.23585	0	14.64831	0	16.00671	0
P78371	TCPB_HUMAN	"T-complex protein 1 subunit beta, TCP-1-beta (CCT-beta)"	CCT2 99D8.1 CCTB	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0035578; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874	STLGPK	5.71999979	1	1	0.092197314	601.3320199	0	0	0	0	14.85576	15.5416	13.79932	0	14.18192	15.69027	16.07737	15.69861	0	0	0	14.75944	15.3309	0	0	14.89722	0	0	15.79983	14.86455	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.5806	0
P78381	S35A2_HUMAN	"UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter, UDP-Gal-Tr, UGT)"	SLC35A2 UGALT UGT UGTL	Homo sapiens (Human)	carbohydrate transport [GO:0008643]; galactose metabolic process [GO:0006012]; UDP-galactose transmembrane transport [GO:0072334]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; galactose metabolic process [GO:0006012]; UDP-galactose transmembrane transport [GO:0072334]	UDP-galactose transmembrane transporter activity [GO:0005459]	GO:0000139; GO:0005459; GO:0005654; GO:0005783; GO:0005794; GO:0006012; GO:0008643; GO:0030173; GO:0072334	MAAVGAGGSTAAPGPGAVSAGALEPGTASAAHRR	5.809999943	1	1	0.035686031	2974.320691	0	15.80112	13.77737	14.31109	0	12.50001	12.97438	0	0	12.93987	0	14.90673	12.1585	12.7884	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P78382	S35A1_HUMAN	"CMP-sialic acid transporter, CMP-SA-Tr, CMP-Sia-Tr (Solute carrier family 35 member A1)"	SLC35A1	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate metabolic process [GO:0005975]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]	antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456]; UDP-galactose transmembrane transporter activity [GO:0005459]	GO:0000139; GO:0005456; GO:0005459; GO:0005794; GO:0005887; GO:0005975; GO:0006464; GO:0008643; GO:0015297; GO:0015782; GO:0016021; GO:0030173	LYCLAVMTLMAAVYTIALRYTR	3.710000038	1	1	1.38E-12	2608.299756	15.72068	14.08662	3.630296	14.54883	15.22621	0	16.06914	0	0	14.41233	14.77473	0	11.83354	0	12.65956	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P78406	RAE1L_HUMAN	mRNA export factor RAE1 (Rae1 protein homolog) (mRNA-associated protein mrnp 41)	RAE1 MRNP41	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	microtubule binding [GO:0008017]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]	GO:0000972; GO:0001650; GO:0003723; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0006913; GO:0007049; GO:0008017; GO:0043130; GO:0051301; GO:0060236; GO:0071407; GO:0097431	AQQMHTGPVLDVCWSDDGSK	7.010000229	1	1	0.182682267	2246.307656	13.69067	13.78366	15.41933	0	0	0	0	0	0	0	0	13.19137	13.85695	0	0	0	13.68648	0	0	12.10064	0	0	14.08503	0	0	0	0	0	0	0	14.9397	0	0	11.54164	0	0	15.65352	0	15.95173	0	0	13.21413	0	0	0	13.68533	0	0
P78411	IRX5_HUMAN	Iroquois-class homeodomain protein IRX-5 (Homeodomain protein IRX-2A) (Homeodomain protein IRXB2) (Iroquois homeobox protein 5)	IRX5 IRX2A IRXB2	Homo sapiens (Human)	cell development [GO:0048468]; embryonic cranial skeleton morphogenesis [GO:0048701]; gonad development [GO:0008406]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; vitamin D binding [GO:0005499]; cell development [GO:0048468]; embryonic cranial skeleton morphogenesis [GO:0048701]; gonad development [GO:0008406]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; vitamin D binding [GO:0005499]"	GO:0000785; GO:0000978; GO:0000981; GO:0005499; GO:0005634; GO:0006357; GO:0007601; GO:0008406; GO:0030182; GO:0048468; GO:0048701; GO:0050896; GO:1990837	NDEDEPQKPEDKGDPEGPEAGGAEQK	11.35999966	0.136541501	0.136541501	0.200932998	2765.072697	0	0	0	0	19.1602	0	0	0	0	0	0	18.42662	0	19.56995	0	0	0	0	0	0	0	0	0	0	18.37676	16.26259	0	0	17.29655	0	19.522	19.58566	18.9548	19.27189	0	0	0	19.75602	0	0	0	0	0	18.79523	18.49041	18.17261	18.47347	0
P78413	IRX4_HUMAN	Iroquois-class homeodomain protein IRX-4 (Homeodomain protein IRXA3) (Iroquois homeobox protein 4)	IRX4 IRXA3	Homo sapiens (Human)	cell development [GO:0048468]; establishment of animal organ orientation [GO:0048561]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell development [GO:0048468]; establishment of animal organ orientation [GO:0048561]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007507; GO:0030182; GO:0048468; GO:0048561	MSLAAGGGAALDEDLERAR	8.06000042	1	1	1.83E-12	1902.599915	14.04364	0	0	14.74642	16.49265	12.57235	14.77365	17.18326	14.7172	16.35272	14.77726	15.62133	0	0	15.4779	15.73171	15.32114	16.43541	0	15.74552	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P78414	IRX1_HUMAN	Iroquois-class homeodomain protein IRX-1 (Homeodomain protein IRXA1) (Iroquois homeobox protein 1)	IRX1 IRXA1	Homo sapiens (Human)	cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; proximal/distal pattern formation involved in metanephric nephron development [GO:0072272]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; proximal/distal pattern formation involved in metanephric nephron development [GO:0072272]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0030182; GO:0043565; GO:0048468; GO:0072086; GO:0072272; GO:1990837	EAPEPGSTR	10.27999973	1	1	0.124053753	944.2949512	16.29367	0	15.92038	0	0	0	0	0	0	0	0	0	0	0	0	0	16.10254	0	0	0	0	0	0	0	0	0	0	0	0	0	18.87146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P78417	GSTO1_HUMAN	"Glutathione S-transferase omega-1, GSTO-1, EC 2.5.1.18 (Glutathione S-transferase omega 1-1, GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase, EC 1.8.5.1) (Monomethylarsonic acid reductase, MMA(V) reductase, EC 1.20.4.2) (S-(Phenacyl)glutathione reductase, SPG-R)"	GSTO1 GSTTLP28	Homo sapiens (Human)	cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178]	glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]	GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0060315; GO:0060316; GO:0070062; GO:0071243	GSAPPGPVPEGSIRIYSMR	5.480000019	1	1	0.113727359	1986.444051	14.9358	14.44153	0	0	15.68414	0	0	0	14.5961	0	0	0	0	0	12.86938	0	0	0	0	0	0	0	0	0	0	0	0	14.86391	14.67447	0	0	0	0	0	0	0	0	0	16.96375	14.74532	12.73142	0	0	0	0	0	0	0
P78423	X3CL1_HUMAN	Fractalkine (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Cleaved into: Processed fractalkine ]	CX3CL1 FKN NTT SCYD1 A-152E5.2	Homo sapiens (Human)	aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; autocrine signaling [GO:0035425]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin activation [GO:0033622]; leukocyte adhesive activation [GO:0050902]; leukocyte chemotaxis [GO:0030595]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glutamate receptor signaling pathway [GO:1900450]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron migration [GO:2001223]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of calcium-independent cell-cell adhesion [GO:0051041]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of neurogenesis [GO:0050767]; regulation of synaptic plasticity [GO:0048167]; response to ischemia [GO:0002931]; synapse pruning [GO:0098883]	cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; CXCR1 chemokine receptor binding [GO:0045237]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; autocrine signaling [GO:0035425]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin activation [GO:0033622]; leukocyte adhesive activation [GO:0050902]; leukocyte chemotaxis [GO:0030595]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glutamate receptor signaling pathway [GO:1900450]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron migration [GO:2001223]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of calcium-independent cell-cell adhesion [GO:0051041]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of neurogenesis [GO:0050767]; regulation of synaptic plasticity [GO:0048167]; response to ischemia [GO:0002931]; synapse pruning [GO:0098883]	CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; CXCR1 chemokine receptor binding [GO:0045237]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]	GO:0001774; GO:0001954; GO:0002052; GO:0002523; GO:0002548; GO:0002931; GO:0005102; GO:0005178; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0006952; GO:0006954; GO:0006955; GO:0007155; GO:0007186; GO:0007267; GO:0007568; GO:0008009; GO:0008284; GO:0009986; GO:0010812; GO:0010976; GO:0016020; GO:0016021; GO:0016322; GO:0019221; GO:0030336; GO:0030593; GO:0030595; GO:0031664; GO:0031737; GO:0032233; GO:0032690; GO:0032691; GO:0032715; GO:0032720; GO:0032914; GO:0033622; GO:0035425; GO:0042056; GO:0042995; GO:0043005; GO:0043025; GO:0043066; GO:0043123; GO:0043410; GO:0043547; GO:0045237; GO:0045944; GO:0048020; GO:0048167; GO:0048245; GO:0048247; GO:0048471; GO:0048661; GO:0050729; GO:0050767; GO:0050902; GO:0050918; GO:0051041; GO:0051092; GO:0051281; GO:0051897; GO:0060055; GO:0060326; GO:0061518; GO:0070050; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0098609; GO:0098883; GO:0110091; GO:1900450; GO:1903721; GO:1903979; GO:1904141; GO:2001223; GO:2001234; GO:2001240	LGVLITPVPDAQAATRR	3.50999999	1	1	0.359032873	1777.208214	13.65478	14.84992	0	0	0	0	0	0	0	0	15.56385	13.30653	11.52079	0	0	0	0	13.74743	0	14.75012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.69872	0	16.75398	0	0	0	0	0	0	0	0	0
P78424	PO6F2_HUMAN	"POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1, RPF-1)"	POU6F2 RPF1	Homo sapiens (Human)	"central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601	AGMQNLTEFIGSEPSK	7.389999866	0.025273658	0.025273658	0.198127147	1710.795818	0	18.94085	14.45746	0	0	0	0	0	0	0	17.15071	14.85876	0	17.6386	0	13.75468	0	0	14.96068	13.24239	0	0	16.67819	15.06551	12.50912	10.23629	16.12743	18.72256	15.03533	0	14.68049	15.27129	17.9815	18.91825	0	14.07115	17.21705	11.21363	17.1319	0	20.45263	13.61591	0	0	17.97806	13.74399	0	0
P78508	KCJ10_HUMAN	"ATP-sensitive inward rectifier potassium channel 10 (ATP-dependent inwardly rectifying potassium channel Kir4.1) (Inward rectifier K(+) channel Kir1.2) (Potassium channel, inwardly rectifying subfamily J member 10)"	KCNJ10	Homo sapiens (Human)	adult walking behavior [GO:0007628]; central nervous system myelination [GO:0022010]; glutamate reuptake [GO:0051935]; non-motile cilium assembly [GO:1905515]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of resting membrane potential [GO:0060075]; visual perception [GO:0007601]	astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; ciliary base [GO:0097546]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; ciliary base [GO:0097546]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; adult walking behavior [GO:0007628]; central nervous system myelination [GO:0022010]; glutamate reuptake [GO:0051935]; non-motile cilium assembly [GO:1905515]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of resting membrane potential [GO:0060075]; visual perception [GO:0007601]	ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]	GO:0005242; GO:0005524; GO:0005886; GO:0005887; GO:0006813; GO:0007601; GO:0007628; GO:0015272; GO:0016323; GO:0022010; GO:0034765; GO:0044297; GO:0048169; GO:0051935; GO:0055075; GO:0060075; GO:0097449; GO:0097546; GO:0098793; GO:1905515; GO:1990573	VANMRK	1.809999943	0.566258252	0.566258252	0.239276562	716.024978	0	13.60061	0	0	14.95015	0	0	15.32828	0	0	0	0	0	15.9438	15.5415	0	16.19769	0	0	0	0	0	0	0	0	0	16.78321	0	0	0	0	0	0	0	0	0	0	17.14205	0	0	0	0	15.5256	0	0	0	0	0
P78509	RELN_HUMAN	"Reelin, EC 3.4.21.-"	RELN	Homo sapiens (Human)	"associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of neuron differentiation [GO:0045664]; regulation of neuron migration [GO:2001222]; regulation of NMDA receptor activity [GO:2000310]; regulation of synaptic activity [GO:0060025]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157]	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of neuron differentiation [GO:0045664]; regulation of neuron migration [GO:2001222]; regulation of NMDA receptor activity [GO:2000310]; regulation of synaptic activity [GO:0060025]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]"	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0000904; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010976; GO:0014068; GO:0016358; GO:0018108; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0045664; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060025; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:0110157; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969; GO:2001222	ALVFNKDGR	10.43000031	0.317293137	0.317293137	0.019427665	1015.779817	13.15355	16.63336	0	0	0	0	11.45171	13.63727	15.31154	16.01729	0	0	0	12.37396	13.32453	15.94768	0	0	14.3082	0	0	15.32452	0	16.92204	0	0	0	0	14.55884	0	0	14.47804	0	14.52446	0	17.15068	16.67493	12.5958	0	14.61925	17.45077	0	0	0	15.15967	0	0	0
P78524	DEN2B_HUMAN	DENN domain-containing protein 2B (HeLa tumor suppression 1) (Suppression of tumorigenicity 5 protein)	DENND2B HTS1 ST5	Homo sapiens (Human)	positive regulation of ERK1 and ERK2 cascade [GO:0070374]	cell cortex [GO:0005938]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	cell cortex [GO:0005938]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005886; GO:0005938; GO:0055037; GO:0070374	EGSGSTKPGTPGNSPSSQR	2.220000029	1	1	0.082509998	1829.757976	13.56242	0	15.81812	0	0	0	0	0	0	0	14.26961	0	15.06392	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.71978	0	0	0	0	0	0	0	0	0	0	0
P78527	PRKDC_HUMAN	"DNA-dependent protein kinase catalytic subunit, DNA-PK catalytic subunit, DNA-PKcs, EC 2.7.11.1 (DNPK1) (p460)"	PRKDC HYRC HYRC1	Homo sapiens (Human)	activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maturation of 5.8S rRNA [GO:0000460]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of platelet formation [GO:1905221]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of smooth muscle cell proliferation [GO:0048660]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; small-subunit processome assembly [GO:0034462]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; small-subunit processome [GO:0032040]; transcription regulator complex [GO:0005667]"	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; small-subunit processome [GO:0032040]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; U3 snoRNA binding [GO:0034511]; activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maturation of 5.8S rRNA [GO:0000460]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of platelet formation [GO:1905221]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of smooth muscle cell proliferation [GO:0048660]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; small-subunit processome assembly [GO:0034462]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]"	ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; U3 snoRNA binding [GO:0034511]	GO:0000460; GO:0000723; GO:0000781; GO:0001756; GO:0001933; GO:0002218; GO:0002326; GO:0002328; GO:0002360; GO:0003690; GO:0003723; GO:0004672; GO:0004674; GO:0004677; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005958; GO:0006302; GO:0006303; GO:0006464; GO:0006468; GO:0006974; GO:0007420; GO:0007507; GO:0008630; GO:0010332; GO:0016020; GO:0016233; GO:0018105; GO:0018107; GO:0019899; GO:0019904; GO:0031571; GO:0031648; GO:0032040; GO:0032869; GO:0032991; GO:0032993; GO:0033077; GO:0033152; GO:0033153; GO:0034462; GO:0034511; GO:0035234; GO:0042752; GO:0043065; GO:0043066; GO:0045087; GO:0045621; GO:0045648; GO:0045727; GO:0045944; GO:0048511; GO:0048660; GO:0050678; GO:0061629; GO:0070418; GO:0070419; GO:0097681; GO:0106310; GO:1902036; GO:1905221; GO:2001034	ALKMSPYK	10.68000031	0.591060877	0.591060877	0.211284229	952.7742565	0	18.54961	0	15.25253	14.60767	14.86355	14.76576	14.17582	0	0	15.80803	13.80286	15.64865	0	15.3886	15.71905	0	14.71714	0	16.47168	16.71548	0	15.31949	16.07169	15.69221	14.96621	15.37257	13.46071	16.53569	13.39303	14.40136	15.79914	16.28712	15.88103	0	0	14.98672	14.50515	13.97474	13.5938	0	15.22104	14.32154	15.58288	13.23676	0	12.16277	14.21984
P78536	ADA17_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 17, ADAM 17, EC 3.4.24.86 (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b)"	ADAM17 CSVP TACE	Homo sapiens (Human)	"amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of chemokine production [GO:0032722]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein processing [GO:0016485]; proteolysis [GO:0006508]; receptor transactivation [GO:0035624]; regulation of mast cell apoptotic process [GO:0033025]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]"	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; peptidase activity [GO:0008233]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of chemokine production [GO:0032722]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein processing [GO:0016485]; proteolysis [GO:0006508]; receptor transactivation [GO:0035624]; regulation of mast cell apoptotic process [GO:0033025]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]"	endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; peptidase activity [GO:0008233]; SH3 domain binding [GO:0017124]	GO:0000139; GO:0001666; GO:0001934; GO:0002446; GO:0002467; GO:0002690; GO:0004175; GO:0004222; GO:0005112; GO:0005138; GO:0005178; GO:0005737; GO:0005788; GO:0005829; GO:0005886; GO:0005887; GO:0006508; GO:0006509; GO:0007155; GO:0007173; GO:0007219; GO:0007220; GO:0008233; GO:0008237; GO:0008284; GO:0009410; GO:0009986; GO:0010820; GO:0015629; GO:0016020; GO:0016324; GO:0016485; GO:0017124; GO:0030165; GO:0030183; GO:0030307; GO:0030335; GO:0030511; GO:0030512; GO:0032496; GO:0032722; GO:0033025; GO:0033077; GO:0033627; GO:0035313; GO:0035624; GO:0042987; GO:0043536; GO:0045121; GO:0045737; GO:0045741; GO:0046872; GO:0048536; GO:0048870; GO:0050830; GO:0051272; GO:0071403; GO:0120163; GO:1900087; GO:1902945; GO:1903265; GO:1905564	MDTIQEDPSTDSHMDEDGFEK	2.680000067	0.502673388	0.502673388	0.030040214	2463.99221	0	8.8047	0	10.49651	0	0	0	17.56976	12.21216	0	11.39443	0	11.76199	7.977896	14.35592	12.52374	10.81268	0	12.85856	0	0	0	12.23238	12.50696	15.06873	13.23395	15.1772	0	0	0	0	16.58966	0	0	12.80665	0	0	0	0	12.1406	13.47701	0	0	0	0	0	11.90637	15.17134
P78540	ARGI2_HUMAN	"Arginase-2, mitochondrial, EC 3.5.3.1 (Arginase II) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase)"	ARG2	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; arginine catabolic process to ornithine [GO:0019547]; innate immune response [GO:0045087]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine (C-C motif) ligand 4 production [GO:0071644]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cellular senescence [GO:2000774]; regulation of interleukin-1 beta production [GO:0032651]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; striated muscle contraction [GO:0006941]; urea cycle [GO:0000050]; ureteric bud development [GO:0001657]"	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginase activity [GO:0004053]; manganese ion binding [GO:0030145]; adaptive immune response [GO:0002250]; arginine catabolic process to ornithine [GO:0019547]; innate immune response [GO:0045087]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine (C-C motif) ligand 4 production [GO:0071644]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cellular senescence [GO:2000774]; regulation of interleukin-1 beta production [GO:0032651]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; striated muscle contraction [GO:0006941]; urea cycle [GO:0000050]; ureteric bud development [GO:0001657]"	arginase activity [GO:0004053]; manganese ion binding [GO:0030145]	GO:0000050; GO:0001657; GO:0002250; GO:0002829; GO:0004053; GO:0005737; GO:0005739; GO:0005759; GO:0006809; GO:0006941; GO:0019547; GO:0030145; GO:0032651; GO:0032696; GO:0032700; GO:0032720; GO:0045087; GO:0071641; GO:0071644; GO:0071650; GO:1900425; GO:1903426; GO:1905403; GO:2000562; GO:2000774	EAGLMK	4.039999962	0.043280583	0.043280583	0.211863059	663.5177496	14.94866	15.22009	15.48619	15.94601	14.98519	15.59106	15.67781	14.8102	14.88103	14.90841	15.62219	15.61874	12.68381	15.17829	14.55255	0	0	15.20737	0	16.01755	14.98729	17.53962	16.75471	17.09578	0	16.21498	15.55299	0	15.59048	15.62746	15.35968	15.62283	0	0	16.19136	16.91476	16.33604	16.57495	16.09908	15.76114	13.31561	0	0	15.99099	16.74173	0	0	15.38883
P78543	BTG2_HUMAN	Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3)	BTG2 PC3	Homo sapiens (Human)	anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914]	transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006479; GO:0006974; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0014070; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0045930; GO:0051602; GO:0060213; GO:0070062; GO:2000178	NYVMAVSS	9.56000042	0.886669934	0.886669934	1.14E-12	869.3957995	15.56309	0	0	18.07521	16.16008	18.11085	15.88246	15.79299	15.43768	15.2391	10.93391	19.1288	14.83038	0	15.38756	13.90372	15.55409	14.49767	11.88076	13.51546	15.73214	16.24994	0	18.18322	16.75214	16.6843	0	14.05073	16.37453	13.81083	15.508	0	15.20022	18.08972	17.74096	14.91252	16.3709	18.48576	15.2461	16.89276	16.60817	14.7598	16.07004	17.29218	14.89199	0	16.06581	17.38839
P78559	MAP1A_HUMAN	"Microtubule-associated protein 1A, MAP-1A (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2 ]"	MAP1A MAP1L	Homo sapiens (Human)	anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein localization to microtubule [GO:1902817]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642]; voluntary musculoskeletal movement [GO:0050882]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic branch [GO:0044307]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; synapse [GO:0045202]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic branch [GO:0044307]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; synapse [GO:0045202]; actin binding [GO:0003779]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein localization to microtubule [GO:1902817]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642]; voluntary musculoskeletal movement [GO:0050882]	actin binding [GO:0003779]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]	GO:0000226; GO:0003779; GO:0005198; GO:0005737; GO:0005829; GO:0005874; GO:0005875; GO:0007409; GO:0007613; GO:0008017; GO:0008093; GO:0008306; GO:0015631; GO:0016358; GO:0030424; GO:0030425; GO:0031114; GO:0032435; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0044307; GO:0045202; GO:0048156; GO:0048167; GO:0050882; GO:0070050; GO:0099641; GO:0099642; GO:0150001; GO:1901588; GO:1902817; GO:1903829; GO:1904115; GO:1990535; GO:2000010	DGHSPMSK	1.019999981	1	1	0.080410034	877.7594301	14.90687	0	0	0	0	0	0	0	0	0	14.64216	0	0	0	0	0	0	15.03714	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.40927	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.62839
P78562	PHEX_HUMAN	"Phosphate-regulating neutral endopeptidase PHEX, EC 3.4.24.- (Metalloendopeptidase homolog PEX) (Vitamin D-resistant hypophosphatemic rickets protein) (X-linked hypophosphatemia protein, HYP)"	PHEX PEX	Homo sapiens (Human)	bone development [GO:0060348]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular protein modification process [GO:0006464]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; lung development [GO:0030324]; odontogenesis [GO:0042476]; organophosphate metabolic process [GO:0019637]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular protein modification process [GO:0006464]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; lung development [GO:0030324]; odontogenesis [GO:0042476]; organophosphate metabolic process [GO:0019637]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0001501; GO:0004222; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006464; GO:0006508; GO:0007267; GO:0008270; GO:0016485; GO:0019637; GO:0030282; GO:0030324; GO:0042476; GO:0048471; GO:0060348; GO:0060416; GO:0071305; GO:0071374; GO:1904383; GO:1990418	AFNCPPNSTMNR	2.470000029	1	1	0.240058838	1425.303341	14.22343	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.81688	16.12339	0	0	0	0	14.09513	0	0	14.72145	14.19822	14.10993	0	0	0	0	0	0	17.65359	16.03639	0	0	16.25412	0	15.35983	0	0	0	12.09464	0
P78563	RED1_HUMAN	"Double-stranded RNA-specific editase 1, EC 3.5.4.37 (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)"	ADARB1 ADAR2 DRADA2 RED1	Homo sapiens (Human)	adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]	double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0003723; GO:0003725; GO:0003726; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045087; GO:0045202; GO:0046872; GO:0050884; GO:0051607; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049	ARLFTAFIK	9.069999695	0.193426535	0.193426535	0.061661535	1065.549767	0	18.28167	0	12.16347	0	0	0	0	0	0	0	0	15.53261	17.18306	0	14.82353	0	14.15927	10.89888	14.58064	14.14963	0	10.97858	0	13.42807	0	14.47029	0	14.73676	0	13.80669	18.52674	16.66856	0	0	9.984141	0	0	0	16.40659	0	0	15.40839	17.6274	0	13.11564	15.71935	0
P80162	CXCL6_HUMAN	"C-X-C motif chemokine 6 (Chemokine alpha 3, CKA-3) (Granulocyte chemotactic protein 2, GCP-2) (Small-inducible cytokine B6) [Cleaved into: Small-inducible cytokine B6, N-processed variant 1; Small-inducible cytokine B6, N-processed variant 2; Small-inducible cytokine B6, N-processed variant 3 ]"	CXCL6 GCP2 SCYB6	Homo sapiens (Human)	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; leukocyte homeostasis [GO:0001776]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; regulation of chemokine production [GO:0032642]; regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070951]; signal transduction [GO:0007165]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; leukocyte homeostasis [GO:0001776]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; regulation of chemokine production [GO:0032642]; regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070951]; signal transduction [GO:0007165]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	GO:0001776; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007267; GO:0008009; GO:0008201; GO:0030593; GO:0032642; GO:0042119; GO:0042742; GO:0045236; GO:0061844; GO:0070098; GO:0070951; GO:0071222	LQVFPAGPQCSK	7.949999809	0.011608184	0.011608184	0.106828162	1331.478075	18.56622	0	15.55088	13.92114	0	0	13.01587	15.10229	0	0	16.78293	0	12.46746	0	0	15.87503	0	14.10078	0	14.63636	15.96848	0	0	0	15.57145	15.87092	13.75312	0	0	14.01912	8.619217	14.73118	0	15.56256	0	0	0	15.6282	14.6359	16.2039	0	16.77355	17.60533	0	0	16.08963	14.81533	13.83168
P80365	DHI2_HUMAN	"11-beta-hydroxysteroid dehydrogenase type 2, 11-DH2, 11-beta-HSD2, EC 1.1.1.- (11-beta-hydroxysteroid dehydrogenase type II, 11-HSD type II, 11-beta-HSD type II) (Corticosteroid 11-beta-dehydrogenase isozyme 2) (NAD-dependent 11-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 3)"	HSD11B2 HSD11K SDR9C3	Homo sapiens (Human)	cortisol metabolic process [GO:0034650]; female pregnancy [GO:0007565]; regulation of blood volume by renal aldosterone [GO:0002017]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]	endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]	endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; 11-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0070523]; NAD binding [GO:0051287]; steroid binding [GO:0005496]; cortisol metabolic process [GO:0034650]; female pregnancy [GO:0007565]; regulation of blood volume by renal aldosterone [GO:0002017]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]	11-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0070523]; NAD binding [GO:0051287]; steroid binding [GO:0005496]	GO:0001666; GO:0002017; GO:0005496; GO:0005654; GO:0005789; GO:0005811; GO:0007565; GO:0009410; GO:0032094; GO:0032868; GO:0034650; GO:0051287; GO:0051384; GO:0070523	SCMEVNFFGALELTKGLLPLLR	1.120000005	1	1	2.29E-12	2509.052327	15.89465	0	0	0	0	0	14.21882	13.32347	11.72552	0	15.24319	0	11.56476	0	0	0	0	0	15.24436	12.60862	0	0	14.73248	0	14.06652	0	0	0	0	14.04171	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.294927	13.98645
P80370	DLK1_HUMAN	"Protein delta homolog 1, DLK-1 (pG2) [Cleaved into: Fetal antigen 1, FA1 ]"	DLK1 DLK	Homo sapiens (Human)	cell differentiation [GO:0030154]; negative regulation of Notch signaling pathway [GO:0045746]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; negative regulation of Notch signaling pathway [GO:0045746]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005615; GO:0005737; GO:0016020; GO:0016021; GO:0030154; GO:0045746	VSMKELNK	2.109999895	0.678392291	0.678392291	0.232406676	962.900881	15.35591	12.70529	13.39125	15.0646	15.11522	14.3008	0	0	14.4974	14.48275	15.88327	0	0	14.56567	16.05377	15.28491	11.57096	14.88394	0	15.92529	14.93773	0	15.2942	13.94139	14.44973	0	0	14.78506	14.39696	13.77328	14.16954	12.81785	14.86414	13.98883	14.54941	15.90839	14.02605	12.85408	0	0	0	0	15.57075	0	14.66469	0	16.88873	14.89964
P80404	GABT_HUMAN	"4-aminobutyrate aminotransferase, mitochondrial, EC 2.6.1.19 ((S)-3-amino-2-methylpropionate transaminase, EC 2.6.1.22) (GABA aminotransferase, GABA-AT) (Gamma-amino-N-butyrate transaminase, GABA transaminase, GABA-T) (L-AIBAT)"	ABAT GABAT	Homo sapiens (Human)	aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]	4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]	(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]	GO:0001666; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009410; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042135; GO:0042802; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450	ASMLLAQR	7.480000019	0.675725639	0.675725639	0.172214553	889.3074644	17.84327	16.68305	17.60863	13.86132	15.30974	0	16.57631	16.93931	17.01244	16.19764	15.47534	16.70654	14.99795	0	0	0	13.1364	0	0	0	14.7496	17.65633	0	0	16.96816	0	0	14.42926	0	12.40203	12.73866	13.23725	17.37613	0	0	14.92369	0	0	16.48597	0	15.80482	15.35406	0	0	14.56424	0	12.36744	17.44588
P80723	BASP1_HUMAN	Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22)	BASP1 NAP22	Homo sapiens (Human)	"diaphragm development [GO:0060539]; glomerular visceral epithelial cell differentiation [GO:0072112]; gonad development [GO:0008406]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of heart growth [GO:0060421]; positive regulation of metanephric ureteric bud development [GO:2001076]; substantia nigra development [GO:0021762]; thorax and anterior abdomen determination [GO:0007356]"	cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; vesicle [GO:0031982]	"cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; vesicle [GO:0031982]; protein domain specific binding [GO:0019904]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; diaphragm development [GO:0060539]; glomerular visceral epithelial cell differentiation [GO:0072112]; gonad development [GO:0008406]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of heart growth [GO:0060421]; positive regulation of metanephric ureteric bud development [GO:2001076]; substantia nigra development [GO:0021762]; thorax and anterior abdomen determination [GO:0007356]"	protein domain specific binding [GO:0019904]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]	GO:0000785; GO:0000976; GO:0003714; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0007356; GO:0008406; GO:0016363; GO:0016605; GO:0016607; GO:0019904; GO:0021762; GO:0030054; GO:0030426; GO:0031982; GO:0045892; GO:0060231; GO:0060421; GO:0060539; GO:0070062; GO:0072075; GO:0072112; GO:2001076	TEAPAAPAAQETK	11.60000038	0.462975144	0.462975144	0.485540099	1284.719318	0	0	0	18.2246	18.32791	0	0	17.9437	0	0	16.88243	0	0	17.67093	0	0	18.4243	0	0	0	0	0	0	0	0	0	0	0	0	17.66978	0	0	0	0	18.75898	0	19.04482	0	0	0	18.92914	15.70966	0	0	0	0	16.28868	0
P80748	LV321_HUMAN	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	Homo sapiens (Human)	adaptive immune response [GO:0002250]; immune response [GO:0006955]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955]	antigen binding [GO:0003823]	GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062; GO:0072562	VEAGDEADYYCQVWDSSSDHPT	6.21999979	1	1	0.18511913	2531.197429	12.56069	0	15.86059	0	0	0	0	0	15.07697	0	15.06046	16.35926	0	0	14.87643	15.50814	0	0	15.18761	0	0	17.24943	15.67692	0	17.37318	0	14.45414	0	0	0	0	16.43806	16.19993	14.40827	0	15.42905	0	0	18.5731	0	0	15.48072	0	0	0	0	0	0
P81274	GPSM2_HUMAN	G-protein-signaling modulator 2 (Mosaic protein LGN)	GPSM2 LGN	Homo sapiens (Human)	cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236]	dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]	GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832	HLEISR	14.68000031	0.211586028	0.211586028	0.191369826	755.2904788	17.22524	19.86753	0	15.60316	16.54783	0	14.70875	11.68604	13.55177	14.87407	16.54449	15.98744	15.24701	13.25655	10.67486	16.3233	0	0	0	16.53258	15.36499	17.65563	15.48843	15.7043	17.39316	16.95105	0	17.29291	18.58455	13.99456	20.50205	17.17324	18.1366	17.79955	12.39781	15.67212	16.87826	17.3993	17.04942	19.22843	15.46178	0	0	0	18.24131	18.20104	18.24957	0
P81408	F189B_HUMAN	Protein FAM189B (Protein COTE1)	FAM189B C1orf2 COTE1	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; WW domain binding [GO:0050699]	WW domain binding [GO:0050699]	GO:0016021; GO:0050699	MMPSPSDSSR	6.670000076	0.55117923	0.55117923	0.157803296	1111.179581	0	14.94595	0	12.52859	0	0	0	0	12.28289	14.1458	10.94046	13.59897	16.32021	14.78142	15.90945	12.84807	14.90134	17.08641	16.39256	15.48881	18.25901	17.24979	0	15.45449	15.26099	14.28849	13.5806	14.6873	14.77191	18.89858	17.61954	17.30015	17.48822	0	0	13.83709	17.53588	16.98896	17.36791	16.45591	14.87548	13.27628	16.26727	0	9.934694	16.77416	15.71026	15.10934
P82279	CRUM1_HUMAN	Protein crumbs homolog 1	CRB1	Homo sapiens (Human)	blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular protein localization [GO:0034613]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular protein localization [GO:0034613]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]	calcium ion binding [GO:0005509]	GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0010001; GO:0010467; GO:0010842; GO:0016021; GO:0016324; GO:0032991; GO:0034613; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386	FQTVQPMALLLFR	22.62999916	1	1	0.254672005	1580.030357	10.39801	9.62536	13.05708	15.48158	0	0	14.29234	14.71725	0	0	0	17.3594	16.91651	13.35657	0	0	15.81485	13.90786	0	0	13.93722	0	0	0	0	0	0	0	0	0	0	16.75031	0	0	0	0	0	0	0	17.19278	0	14.08166	0	0	0	0	0	0
P82663	RT25_HUMAN	"28S ribosomal protein S25, mitochondrial, MRP-S25, S25mt (Mitochondrial small ribosomal subunit protein mS25)"	MRPS25 RPMS25	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543	YCLRECICEVEGQVPCPSLVPLPK	7.190000057	1	1	0.124699017	2904.02062	0	12.36089	0	15.18849	13.3006	0	0	12.77717	0	13.13826	0	12.62132	0	0	13.83512	14.33814	0	15.60267	18.9058	0	13.19956	0	0	0	14.16287	15.21346	16.05082	14.24674	0	0	0	0	0	0	0	0	0	0	0	0	15.1113	0	0	0	0	0	0	11.46725
P82673	RT35_HUMAN	"28S ribosomal protein S35, mitochondrial, MRP-S35, S35mt (28S ribosomal protein S28, mitochondrial, MRP-S28, S28mt) (Mitochondrial small ribosomal subunit protein mS35)"	MRPS35 MRPS28 HDCMD11P MDS023 PSEC0213	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0032543	LIKLVGER	8.239999771	0.64988023	0.64988023	0.193477981	926.3876975	0	0	16.04644	12.90564	0	0	15.33187	16.74243	15.93885	0	14.15709	0	0	0	0	0	0	0	0	15.30613	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P82675	RT05_HUMAN	"28S ribosomal protein S5, mitochondrial, MRP-S5, S5mt (Mitochondrial small ribosomal subunit protein uS5m)"	MRPS5	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0032543	VLVAVGNGKGAAGFSIGK	3.200000048	1	1	0.305423461	1645.460822	13.88942	15.1475	13.99621	16.43687	0	14.37676	12.45492	0	15.39958	16.11153	16.96868	0	15.71996	0	15.0879	0	0	0	0	0	0	0	0	16.79263	0	0	0	0	0	0	0	16.11257	0	0	15.05606	16.50319	0	0	17.02902	0	0	0	15.9824	17.13283	0	0	0	0
P82921	RT21_HUMAN	"28S ribosomal protein S21, mitochondrial, MRP-S21, S21mt (Mitochondrial small ribosomal subunit protein bS21m)"	MRPS21 RPMS21 MDS016	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543	INFLMR	18.76000023	0.671834707	0.671834707	0.09880202	808.4338117	17.21058	18.77052	15.37557	19.09672	17.28871	0	18.70747	17.01197	16.82806	18.15485	18.23485	17.64516	17.75361	15.97517	16.46646	17.0587	16.66052	16.56445	17.20124	17.56855	17.69651	16.98775	18.05601	18.14016	0	19.81186	0	16.45366	18.88077	16.5539	16.50977	16.48412	15.44322	16.52947	16.91611	18.15552	15.82689	18.10538	18.66339	0	0	17.94158	17.62634	18.01371	16.54878	0	16.25175	16.27261
P82930	RT34_HUMAN	"28S ribosomal protein S34, mitochondrial, MRP-S34, S34mt (Mitochondrial small ribosomal subunit protein mS34)"	MRPS34	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543	AKGTPV	2.460000038	1	1	0.259282056	569.4091211	0	0	0	0	0	0	0	0	0	0	17.59894	0	0	0	0	18.92919	19.15811	0	0	0	18.89458	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.48076	0	0	0	0	0	0	0
P82987	ATL3_HUMAN	"ADAMTS-like protein 3, ADAMTSL-3 (Punctin-2)"	ADAMTSL3 KIAA1233	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; extracellular matrix organization [GO:0030198]		GO:0005576; GO:0030198; GO:0031012; GO:0043231	ANGTVQVVSPR	13.57999992	1	1	0.371870962	1128.660295	0	0	0	0	0	0	21.08774	0	0	0	0	0	0	0	0	0	0	17.67794	0	0	0	0	0	0	0	21.29974	0	0	0	0	0	0	0	0	20.96049	0	0	0	0	0	0	0	0	0	0	0	0	0
P83105	HTRA4_HUMAN	"Serine protease HTRA4, EC 3.4.21.- (High-temperature requirement factor A4)"	HTRA4	Homo sapiens (Human)	negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]	endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0012501; GO:0030512; GO:0042802; GO:0043065	AENRAAR	2.460000038	0.132308453	0.132308453	0.234706851	787.0012372	0	17.79713	17.99995	0	0	16.29683	0	0	0	0	0	17.97571	0	16.81205	17.61915	17.22593	0	0	0	0	0	17.32586	0	0	0	0	0	0	0	0	19.64041	17.85976	17.75603	0	18.82034	0	0	17.37691	17.75334	17.70219	18.30595	0	0	0	0	0	0	0
P83111	LACTB_HUMAN	"Serine beta-lactamase-like protein LACTB, mitochondrial, EC 3.4.-.-"	LACTB MRPL56 UNQ843/PRO1781	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]	identical protein binding [GO:0042802]; peptidase activity [GO:0008233]	GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802	IALEFDK	2.180000067	1	1	0.11739997	834.3770594	0	0	13.38432	0	0	14.95873	15.61521	0	9.737894	12.776	0	13.08567	0	0	0	14.11219	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.56971	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P83369	LSM11_HUMAN	U7 snRNA-associated Sm-like protein LSm11	LSM11	Homo sapiens (Human)	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin organization [GO:1902275]	histone pre-mRNA 3'end processing complex [GO:0071204]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; U7 snRNP [GO:0005683]	histone pre-mRNA 3'end processing complex [GO:0071204]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; U7 snRNP [GO:0005683]; U7 snRNA binding [GO:0071209]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin organization [GO:1902275]	U7 snRNA binding [GO:0071209]	GO:0005634; GO:0005654; GO:0005683; GO:0005697; GO:0006398; GO:0016604; GO:0071204; GO:0071209; GO:1900087; GO:1902275	GPGRSR	8.930000305	0.839136004	0.839136004	0.158910917	632.2884866	0	0	0	0	0	15.96299	0	0	0	0	14.29793	0	15.88354	0	0	0	0	0	0	0	0	0	0	17.3734	15.85223	16.75826	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.43631	14.43061	0	0	0
P84074	HPCA_HUMAN	Neuron-specific calcium-binding protein hippocalcin (Calcium-binding protein BDR-2)	HPCA BDR2	Homo sapiens (Human)	activation of phospholipase D activity [GO:0031584]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cellular response to monosodium glutamate [GO:1904009]; inner ear development [GO:0048839]; negative regulation of guanylate cyclase activity [GO:0031283]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to Aroclor 1254 [GO:1904010]; response to ketamine [GO:1901986]; response to L-glutamate [GO:1902065]; retina development in camera-type eye [GO:0060041]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic spine head [GO:0044327]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; dendritic spine head [GO:0044327]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; activation of phospholipase D activity [GO:0031584]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cellular response to monosodium glutamate [GO:1904009]; inner ear development [GO:0048839]; negative regulation of guanylate cyclase activity [GO:0031283]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to Aroclor 1254 [GO:1904010]; response to ketamine [GO:1901986]; response to L-glutamate [GO:1902065]; retina development in camera-type eye [GO:0060041]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]	GO:0003779; GO:0005509; GO:0005737; GO:0005829; GO:0007420; GO:0019722; GO:0019898; GO:0019900; GO:0030424; GO:0031283; GO:0031584; GO:0032590; GO:0032809; GO:0032839; GO:0042802; GO:0043204; GO:0044327; GO:0045762; GO:0048839; GO:0060041; GO:0071257; GO:0071277; GO:0090314; GO:0098978; GO:0099149; GO:1901385; GO:1901986; GO:1902065; GO:1904009; GO:1904010	EEMLEIVQAIYK	14.73999977	0.226357818	0.226357818	0.032474607	1482.116467	14.96981	0	0	16.3493	0	0	15.22648	0	16.88739	0	0	0	17.2414	18.61985	0	16.69648	0	0	0	0	0	0	14.72913	13.7092	0	0	16.86998	0	0	0	15.22835	0	0	18.1539	17.97884	0	15.84721	14.27239	14.98548	18.62449	0	0	0	0	16.73775	15.1098	0	0
P84098	RL19_HUMAN	60S ribosomal protein L19 (Large ribosomal subunit protein eL19)	RPL19	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788; GO:0045202	MPEKVTWMR	8.460000038	1	1	0.33497506	1209.557045	0	15.50477	0	15.24216	0	0	0	0	15.10218	0	0	0	0	15.81357	0	0	0	0	0	16.57952	0	0	15.45178	16.51987	16.72537	0	0	0	15.83766	16.77743	0	0	0	0	0	13.09929	0	0	14.53695	16.50309	0	0	12.74419	11.26368	0	16.8891	0	16.55654
P84550	SKOR1_HUMAN	"SKI family transcriptional corepressor 1 (Functional Smad-suppressing element on chromosome 15, Fussel-15) (LBX1 corepressor 1) (Ladybird homeobox corepressor 1)"	SKOR1 CORL1 FUSSEL15 LBXCOR1	Homo sapiens (Human)	"negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0005667; GO:0006355; GO:0030425; GO:0030514; GO:0043025; GO:0046332; GO:1990837	AMFNGGTR	5.269999981	1	1	0.156482857	866.3676804	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.64384	0	0	0	0	16.5725	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P85299	PRR5_HUMAN	"Proline-rich protein 5 (Protein observed with Rictor-1, Protor-1)"	PRR5 PROTOR1 PP610	Homo sapiens (Human)	cell cycle [GO:0007049]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; TORC2 signaling [GO:0038203]	cytosol [GO:0005829]; TORC2 complex [GO:0031932]	cytosol [GO:0005829]; TORC2 complex [GO:0031932]; cell cycle [GO:0007049]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; TORC2 signaling [GO:0038203]		GO:0001934; GO:0005829; GO:0007010; GO:0007049; GO:0014068; GO:0016310; GO:0030307; GO:0031669; GO:0031932; GO:0038203; GO:0043066	FYEGQK	9.670000076	0.659758091	0.659758091	0.167167164	770.4203166	17.51473	17.04577	16.85724	15.9807	17.36126	14.90365	0	16.09416	0	16.71706	0	14.91996	15.34036	18.18549	16.11027	16.69602	16.66927	0	16.04521	16.80098	14.17209	19.29599	12.09572	0	16.45218	0	17.34789	0	13.92058	0	15.80308	15.3781	16.91273	14.86623	14.53215	16.2398	17.78908	15.90199	0	16.49687	14.56817	14.99214	0	15.52115	17.60751	17.23801	0	15.00214
P86397	HTD2_HUMAN	"Hydroxyacyl-thioester dehydratase type 2, mitochondrial, HsHTD2, EC 4.2.1.59 (3-hydroxyacyl-[acyl-carrier-protein] dehydratase)"	HTD2	Homo sapiens (Human)	fatty acid metabolic process [GO:0006631]; fatty-acyl-CoA biosynthetic process [GO:0046949]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; fatty acid metabolic process [GO:0006631]; fatty-acyl-CoA biosynthetic process [GO:0046949]	(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]	GO:0004317; GO:0005730; GO:0005739; GO:0005759; GO:0006631; GO:0008659; GO:0008693; GO:0018812; GO:0046949; GO:0047451	VMVPEASKS	6.309999943	0.384634376	0.384634376	0.216948544	946.4453382	15.97576	15.40101	17.42211	12.78814	15.9156	15.93588	0	16.03278	12.85738	0	13.96859	14.80977	16.04153	15.13226	12.73998	0	0	0	0	0	15.30882	17.59004	16.8425	0	16.69873	15.98171	14.93561	15.0918	12.20297	0	16.08189	16.0294	18.68885	0	14.00489	0	0	16.9942	15.42476	0	0	16.54472	15.95455	15.77495	14.88805	16.29915	15.38711	12.84447
P86452	ZBED6_HUMAN	Zinc finger BED domain-containing protein 6	ZBED6	Homo sapiens (Human)	"blastocyst hatching [GO:0001835]; negative regulation of cell death [GO:0060548]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle [GO:0045787]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]"	centriolar satellite [GO:0034451]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"centriolar satellite [GO:0034451]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]; blastocyst hatching [GO:0001835]; negative regulation of cell death [GO:0060548]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle [GO:0045787]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000981; GO:0001227; GO:0001835; GO:0003309; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0034451; GO:0045787; GO:0045892; GO:0046872; GO:0046983; GO:0051148; GO:0060548; GO:0061178	GRPGSHLGTSTLQR	5.179999828	1	1	0.169038926	1467.835894	0	0	16.0001	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42358	0	0	17.7669	0	0	0	16.0095	0	0	0	0	0	0	0
P87889	GAK10_HUMAN	"Endogenous retrovirus group K member 10 Gag polyprotein (HERV-K10 Gag protein) (HERV-K107 Gag protein) (HERV-K_5q33.3 provirus ancestral Gag polyprotein, Gag polyprotein)"	ERVK-10	Homo sapiens (Human)	viral process [GO:0016032]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032]	nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032	TWWIDGVQEQVRR	6.170000076	1	1	0.087236235	1671.808506	0	14.61484	16.15098	0	0	0	0	0	14.48161	0	0	0	0	0	9.540847	0	0	0	0	0	0	14.67813	0	0	0	0	15.90708	14.63697	0	14.82141	0	0	0	0	0	0	0	0	0	15.35617	0	0	15.30964	0	0	0	0	0
P98088	MUC5A_HUMAN	"Mucin-5AC, MUC-5AC (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin, TBM)"	MUC5AC MUC5	Homo sapiens (Human)	phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; phosphatidylinositol-mediated signaling [GO:0048015]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005615; GO:0005737; GO:0005796; GO:0005886; GO:0031012; GO:0048015; GO:0070062; GO:0070701	SVECRAEDAPGVPLR	9.270000458	1	1	0.315101962	1655.828407	0	0	17.10004	0	0	0	0	0	16.14919	0	15.19091	0	17.22892	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.79945	0	0	18.07553	0	0	0	0	0	18.81486	0	17.58505	0	0	0	0	17.50516	0	0	16.17813	0
P98155	VLDLR_HUMAN	"Very low-density lipoprotein receptor, VLDL receptor, VLDL-R"	VLDLR	Homo sapiens (Human)	cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]	GO:0005041; GO:0005509; GO:0005765; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007165; GO:0007399; GO:0007613; GO:0008203; GO:0016020; GO:0016021; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045860; GO:0048306; GO:0048813; GO:1900006	CPASEIQCGSGECIHKK	3.160000086	1	1	0.354436877	1960.577753	0	15.1643	10.11792	13.6676	8.990589	13.92411	0	0	0	15.92483	12.49665	0	0	0	0	14.81955	11.26006	0	13.32023	15.37913	0	0	0	15.50637	0	0	0	0	0	0	14.82979	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P98160	PGBM_HUMAN	"Basement membrane-specific heparan sulfate proteoglycan core protein, HSPG (Perlecan, PLC) [Cleaved into: Endorepellin; LG3 peptide ]"	HSPG2	Homo sapiens (Human)	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]	amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]	GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907	SIGASVEFHCAVPSDR	4.409999847	1	1	0.157181043	1731.169557	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P98161	PKD1_HUMAN	"Polycystin-1, PC1 (Autosomal dominant polycystic kidney disease 1 protein)"	PKD1	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-independent cell-matrix adhesion [GO:0007161]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell-cell signaling by wnt [GO:0198738]; cell-matrix adhesion [GO:0007160]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; digestive tract development [GO:0048565]; embryonic placenta development [GO:0001892]; establishment of cell polarity [GO:0030010]; genitalia development [GO:0048806]; heart development [GO:0007507]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; liver development [GO:0001889]; lung epithelium development [GO:0060428]; lymph vessel morphogenesis [GO:0036303]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric collecting duct development [GO:0072205]; metanephric distal tubule morphogenesis [GO:0072287]; metanephric proximal tubule development [GO:0072237]; neural tube development [GO:0021915]; peptidyl-serine phosphorylation [GO:0018105]; placenta blood vessel development [GO:0060674]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein export from nucleus [GO:0006611]; protein heterotetramerization [GO:0051290]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic spindle organization [GO:0060236]; regulation of proteasomal protein catabolic process [GO:0061136]; response to fluid shear stress [GO:0034405]; skin development [GO:0043588]; spinal cord development [GO:0021510]	basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133]	basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133]; calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; Wnt-activated receptor activity [GO:0042813]; anatomical structure morphogenesis [GO:0009653]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-independent cell-matrix adhesion [GO:0007161]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell-cell signaling by wnt [GO:0198738]; cell-matrix adhesion [GO:0007160]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; digestive tract development [GO:0048565]; embryonic placenta development [GO:0001892]; establishment of cell polarity [GO:0030010]; genitalia development [GO:0048806]; heart development [GO:0007507]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; liver development [GO:0001889]; lung epithelium development [GO:0060428]; lymph vessel morphogenesis [GO:0036303]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric collecting duct development [GO:0072205]; metanephric distal tubule morphogenesis [GO:0072287]; metanephric proximal tubule development [GO:0072237]; neural tube development [GO:0021915]; peptidyl-serine phosphorylation [GO:0018105]; placenta blood vessel development [GO:0060674]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein export from nucleus [GO:0006611]; protein heterotetramerization [GO:0051290]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic spindle organization [GO:0060236]; regulation of proteasomal protein catabolic process [GO:0061136]; response to fluid shear stress [GO:0034405]; skin development [GO:0043588]; spinal cord development [GO:0021510]	calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; Wnt-activated receptor activity [GO:0042813]	GO:0000139; GO:0001502; GO:0001701; GO:0001822; GO:0001889; GO:0001892; GO:0002133; GO:0005262; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006611; GO:0006816; GO:0007156; GO:0007160; GO:0007161; GO:0007204; GO:0007259; GO:0007507; GO:0009653; GO:0009986; GO:0016020; GO:0016021; GO:0016323; GO:0016328; GO:0018105; GO:0019901; GO:0019904; GO:0021510; GO:0021915; GO:0030010; GO:0030155; GO:0030246; GO:0030660; GO:0031514; GO:0032092; GO:0034405; GO:0034703; GO:0034704; GO:0036303; GO:0042813; GO:0042994; GO:0043588; GO:0044325; GO:0045737; GO:0045944; GO:0048565; GO:0048754; GO:0048806; GO:0050982; GO:0051216; GO:0051290; GO:0051726; GO:0060170; GO:0060236; GO:0060428; GO:0060674; GO:0061136; GO:0070062; GO:0070588; GO:0072164; GO:0072177; GO:0072205; GO:0072218; GO:0072237; GO:0072287; GO:0198738; GO:2000045	AVFLELTR	1.580000043	1	1	0.10556598	949.4080118	0	15.69222	15.19138	15.04783	13.76627	0	0	15.59998	13.05251	17.80483	0	0	0	0	0	0	0	0	0	0	0	0	14.06749	0	0	0	0	12.01901	16.40454	13.11815	0	0	0	0	0	0	0	16.43413	0	15.00932	0	0	0	0	0	0	0	0
P98169	ZXDB_HUMAN	Zinc finger X-linked protein ZXDB	ZXDB	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0006357; GO:0046872	EIPKLLPAR	12.26000023	1	1	0.250885626	1038.571777	0	0	0	15.38701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.49706	15.99748	0	0	0	0	0	16.73801	0	0	14.97474	0	0	15.20275	0	0	0	0	0	0	0	0	0	0	0	0
P98170	XIAP_HUMAN	"E3 ubiquitin-protein ligase XIAP, EC 2.3.2.27 (Baculoviral IAP repeat-containing protein 4) (IAP-like protein, ILP, hILP) (Inhibitor of apoptosis protein 3, IAP-3, hIAP-3, hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein, X-linked IAP)"	XIAP API3 BIRC4 IAP3	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of apoptotic process [GO:0042981]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of apoptotic process [GO:0042981]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005876; GO:0006974; GO:0010804; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046330; GO:0046872; GO:0050727; GO:0051402; GO:0051726; GO:0055070; GO:0060785; GO:0061630; GO:0070424; GO:0090263; GO:0097340; GO:0120283; GO:1902530; GO:1990001	DSMQDESSQTSLQK	11.81000042	1	1	0.446593394	1584.187682	17.50076	18.31447	11.25885	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.87019	0	0	0	0	0	17.79813	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
P98171	RHG04_HUMAN	Rho GTPase-activating protein 4 (Rho-GAP hematopoietic protein C1) (Rho-type GTPase-activating protein 4) (p115)	ARHGAP4 KIAA0131 RGC1 RHOGAP4	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast migration [GO:0010764]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; cytoskeleton organization [GO:0007010]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast migration [GO:0010764]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]	GO:0005096; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0007010; GO:0007266; GO:0010764; GO:0030336; GO:0030426; GO:0030517; GO:0042802; GO:0051056	QAKFMEHK	5.949999809	0.929957747	0.929957747	0.220279022	1037.698402	16.74676	0	0	0	17.39382	14.55409	0	14.87217	11.71614	16.72951	0	0	0	0	0	0	0	0	0	0	0	0	16.52583	0	0	16.51042	0	15.73494	13.79132	0	17.62178	0	16.8988	0	17.64956	17.58513	16.58261	16.32693	0	16.86502	17.1627	13.63934	0	15.55241	0	0	16.72286	0
P98172	EFNB1_HUMAN	"Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]"	EFNB1 EFL3 EPLG2 LERK2	Homo sapiens (Human)	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ephrin receptor binding [GO:0046875]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]	ephrin receptor binding [GO:0046875]	GO:0001755; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007267; GO:0007411; GO:0009880; GO:0031295; GO:0042102; GO:0045121; GO:0045202; GO:0046875; GO:0048013; GO:0070062	LATPLAK	8.579999924	1	1	0.178667499	714.786318	0	0	15.54706	0	0	0	13.24029	0	14.78237	0	17.2558	0	16.51756	0	0	0	15.80433	0	0	0	17.07204	14.5336	16.35943	0	0	16.9194	0	16.04116	15.35678	0	0	14.04577	0	0	15.72551	15.76535	0	0	0	0	17.54587	0	0	16.15567	15.82911	0	0	0
P98173	FAM3A_HUMAN	Protein FAM3A (Cytokine-like protein 2-19)	FAM3A 2-19 2.19	Homo sapiens (Human)	antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of gluconeogenesis [GO:0045721]; regulation of lipid biosynthetic process [GO:0046890]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of gluconeogenesis [GO:0045721]; regulation of lipid biosynthetic process [GO:0046890]		GO:0005615; GO:0019732; GO:0045721; GO:0046890; GO:0061844; GO:1905035	YEGWPEALEMEGCIPRR	7.849999905	1	1	0.030680802	2109.801257	10.72247	14.21578	0	0	13.73555	0	14.49188	0	12.79288	0	14.9883	13.72831	14.07262	0	0	14.68967	0	0	0	0	0	0	0	0	14.47607	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.79645	0	0	0
P98175	RBM10_HUMAN	"RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1, S1-1)"	RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122	Homo sapiens (Human)	"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	GO:0000122; GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0008285; GO:0016607; GO:0032991; GO:0034393; GO:0035198; GO:0042802; GO:0046872; GO:0048025; GO:0070935	DRAAER	7.78000021	0.578762591	0.578762591	0.076524888	716.6247491	13.97782	14.24446	14.02073	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.9417	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.75406	0	0	0	0	0	0	0	0	0
P98177	FOXO4_HUMAN	Forkhead box protein O4 (Fork head domain transcription factor AFX1)	FOXO4 AFX AFX1 MLLT7	Homo sapiens (Human)	"aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]"	"beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007095; GO:0007517; GO:0007568; GO:0008013; GO:0008285; GO:0008286; GO:0014911; GO:0016525; GO:0016607; GO:0019899; GO:0031667; GO:0042802; GO:0043565; GO:0045944; GO:0048863; GO:0051151; GO:0070317; GO:0140297; GO:1990785; GO:1990837; GO:1990841	AASMDSSSK	3.349999905	0.002145959	0.002145959	0.279817859	899.8266368	0	0	16.52324	0	0	0	16.68164	0	0	17.85969	0	17.2781	18.67351	16.65868	0	0	0	18.09267	0	0	0	0	0	0	0	19.01526	17.25444	0	0	0	17.19337	16.21908	0	0	0	0	0	0	0	17.27215	0	17.8462	0	16.88539	16.6639	15.60011	16.51469	0
P98182	ZN200_HUMAN	Zinc finger protein 200	ZNF200 ZNFMF	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005634; GO:0046872	HEKTHSACK	5.900000095	0.533334434	0.533334434	0.197517049	1096.629413	15.96887	0	13.78021	15.58273	14.98974	0	0	0	11.71654	14.19235	13.75412	0	14.25999	12.47069	0	14.69186	13.93399	15.81897	15.27291	13.01125	16.13785	0	11.88348	0	15.78503	15.2711	0	0	0	0	0	0	0	0	0	0	0	15.02334	0	0	17.19864	0	0	0	0	0	0	0
P98194	AT2C1_HUMAN	"Calcium-transporting ATPase type 2C member 1, ATPase 2C1, EC 7.2.2.10 (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1, SPCA1)"	ATP2C1 KIAA1347 PMR1L HUSSY-28	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; trans-Golgi network membrane organization [GO:0098629]	cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; trans-Golgi network membrane organization [GO:0098629]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613]	GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0015662; GO:0016020; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030145; GO:0030173; GO:0031532; GO:0032468; GO:0032472; GO:0032580; GO:0033106; GO:0034220; GO:0042998; GO:0043123; GO:0046872; GO:0070588; GO:0098629; GO:0140613	TPLQKSMDLLGK	3.549999952	1	1	0.365376921	1345.364192	12.07363	13.83246	12.60731	13.13042	0	15.73045	0	0	14.80994	10.9901	12.93333	15.29039	14.62847	0	14.72756	0	0	0	0	0	16.31178	0	0	0	13.21715	0	0	0	0	15.75527	0	0	0	0	0	0	0	0	0	0	0	15.28636	0	0	0	0	0	0
P98196	AT11A_HUMAN	"Phospholipid-transporting ATPase IH, EC 7.6.2.1 (ATPase IS) (ATPase class VI type 11A) (P4-ATPase flippase complex alpha subunit ATP11A)"	ATP11A ATPIH ATPIS KIAA1021	Homo sapiens (Human)	in utero embryonic development [GO:0001701]; phospholipid translocation [GO:0045332]; positive regulation of myotube differentiation [GO:0010831]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; in utero embryonic development [GO:0001701]; phospholipid translocation [GO:0045332]; positive regulation of myotube differentiation [GO:0010831]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]	GO:0000287; GO:0001701; GO:0005524; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0010831; GO:0016020; GO:0016887; GO:0035579; GO:0043231; GO:0045332; GO:0055037; GO:0070821; GO:0090555; GO:0090556; GO:0140326; GO:0140346; GO:1990531	DLTLLGATAVEDRLQEK	1.730000019	1	1	0.218965156	1874.695526	11.91422	9.165891	8.837191	13.25782	13.0803	0	0	14.55231	14.37602	16.20026	0	15.96008	0	0	15.02548	13.71261	0	0	15.59419	0	12.55615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.05384	0	0	0	0	0	0	0	0	0	0	0	0
Q00056	HXA4_HUMAN	Homeobox protein Hox-A4 (Homeobox protein Hox-1.4) (Homeobox protein Hox-1D)	HOXA4 HOX1D	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0009952; GO:0016604; GO:0048704; GO:1990837	LPNTKMR	6.769999981	0.471686721	0.471686721	0.199794923	861.6569696	14.7803	14.27041	12.66263	15.87738	13.86568	13.64574	14.81398	0	14.73748	15.40493	15.48575	15.19946	0	15.43627	14.17911	12.6844	16.10146	14.77214	16.02324	15.45551	0	15.01628	0	0	0	0	14.60507	0	0	15.90084	0	14.53729	0	0	0	16.1878	0	0	15.60201	0	0	0	0	0	0	0	0	0
Q00169	PIPNA_HUMAN	"Phosphatidylinositol transfer protein alpha isoform, PI-TP-alpha, PtdIns transfer protein alpha, PtdInsTP alpha"	PITPNA PITPN	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; stearic acid binding [GO:0070540]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601]	fatty-acyl-CoA binding [GO:0000062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; stearic acid binding [GO:0070540]	GO:0000062; GO:0005634; GO:0005737; GO:0005829; GO:0006629; GO:0007601; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0070062; GO:0070540; GO:0120019; GO:1901611	QLDEMR	11.64000034	0.132624596	0.132624596	0.051249596	807.8901541	17.79198	0	15.60151	15.81491	17.2596	16.42995	0	16.40644	0	17.98764	17.93525	15.54255	0	0	14.33344	16.21651	0	15.67024	0	16.40719	17.01695	0	0	17.8171	0	0	16.79858	15.60067	15.15097	0	15.19418	17.78852	0	17.49001	15.90207	0	0	17.51234	18.16638	17.19495	0	16.21001	16.80344	0	0	0	16.18028	0
Q00325	MPCP_HUMAN	"Phosphate carrier protein, mitochondrial (Phosphate transport protein, PTP) (Solute carrier family 25 member 3)"	SLC25A3 PHC OK/SW-cl.48	Homo sapiens (Human)	mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]	extracellular exosome [GO:0070062]; integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	extracellular exosome [GO:0070062]; integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate:proton symporter activity [GO:0015317]; protein-containing complex binding [GO:0044877]; mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]	inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate:proton symporter activity [GO:0015317]; protein-containing complex binding [GO:0044877]	GO:0005315; GO:0005739; GO:0005743; GO:0005887; GO:0015317; GO:0016020; GO:0031305; GO:0035435; GO:0044877; GO:0070062; GO:1990547	DAAPK	1.659999967	1	1	0.277829794	502.0102	15.89019	15.10861	0	0	16.89513	16.16642	0	0	16.34767	16.10365	17.44177	15.77255	0	0	0	17.09608	0	17.53235	17.64632	18.25799	0	0	0	0	0	17.13822	0	0	17.25206	16.61279	17.6004	0	17.33162	16.75538	0	0	0	16.67965	19.06133	17.75435	17.73147	0	16.54237	16.62024	16.4493	17.13236	16.3946	16.57594
Q00341	VIGLN_HUMAN	"Vigilin (High density lipoprotein-binding protein, HDL-binding protein)"	HDLBP HBP VGL	Homo sapiens (Human)	cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]	cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0045296	DLIIEQRFHR	5.789999962	0.481925786	0.481925786	0.102447473	1326.617267	13.66619	14.39933	13.48622	15.40085	13.26199	12.81131	13.61818	14.72647	14.80443	0	11.91178	0	0	0	0	0	0	0	12.47476	0	0	14.86839	0	0	0	15.36728	13.9296	0	14.3924	14.8557	0	0	14.42692	12.23674	11.4572	0	0	14.13075	0	12.58899	0	0	12.66482	15.02994	11.65205	0	0	0
Q00403	TF2B_HUMAN	"Transcription initiation factor IIB, EC 2.3.1.48 (General transcription factor TFIIB) (S300-II)"	GTF2B TF2B TFIIB	Homo sapiens (Human)	"DNA-templated transcription, initiation [GO:0006352]; positive regulation of core promoter binding [GO:1904798]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083]"	chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]	"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; acetyltransferase activity [GO:0016407]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of core promoter binding [GO:1904798]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083]"	acetyltransferase activity [GO:0016407]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; zinc ion binding [GO:0008270]	GO:0000979; GO:0000993; GO:0001174; GO:0004402; GO:0005634; GO:0005654; GO:0005669; GO:0005694; GO:0006352; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0016251; GO:0016407; GO:0016604; GO:0017025; GO:0019083; GO:0032993; GO:0046966; GO:0051123; GO:0090575; GO:0097550; GO:0140297; GO:1904798; GO:1990114; GO:1990841	AMMNAFK	3.470000029	1	1	0.233715714	811.8488049	0	0	15.92427	16.40691	17.59659	0	0	0	17.47003	14.61123	0	0	0	0	0	0	0	0	0	0	0	15.98106	14.68018	0	15.68017	0	0	0	0	0	15.51838	17.57682	0	15.07424	14.22978	0	16.43336	0	0	0	0	0	0	0	0	0	0	15.60449
Q00535	CDK5_HUMAN	"Cyclin-dependent kinase 5, EC 2.7.11.1 (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit, TPKII catalytic subunit)"	CDK5 CDKN5 PSSALRE	Homo sapiens (Human)	"axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"	axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]	"axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]"	acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]	GO:0000083; GO:0000226; GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0004712; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006468; GO:0006886; GO:0006913; GO:0007005; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0009611; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016310; GO:0016533; GO:0016572; GO:0018105; GO:0018107; GO:0019233; GO:0019901; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0030866; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0034352; GO:0035249; GO:0035418; GO:0042501; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046777; GO:0046826; GO:0046875; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051726; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:0098685; GO:0098793; GO:0098883; GO:0098978; GO:0099635; GO:0106310; GO:1901215; GO:1901387; GO:1903076; GO:1903421; GO:1904646; GO:2000251	HKNIVR	17.94000053	0.731312335	0.731312335	0.297407743	766.9975491	18.77433	17.7145	18.65128	17.34744	18.29691	0	0	21.24397	0	0	18.43351	18.01321	0	0	0	0	18.3692	17.95963	0	17.55663	16.65524	0	17.87792	0	0	0	0	19.26956	18.12523	0	0	19.93414	0	18.85303	0	20.72654	17.35696	21.25883	0	18.43114	0	0	17.47214	0	17.19384	0	0	17.4746
Q00536	CDK16_HUMAN	"Cyclin-dependent kinase 16, EC 2.7.11.22 (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1)"	CDK16 PCTAIRE1 PCTK1	Homo sapiens (Human)	exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000083; GO:0004674; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006887; GO:0007283; GO:0008021; GO:0015630; GO:0030252; GO:0031175; GO:0031234; GO:0043005; GO:0061178; GO:0106310	RQLSMTLR	8.380000114	1	1	0.466385873	1017.728869	0	0	18.4896	0	19.27969	0	0	18.4048	0	0	0	0	19.12867	0	0	20.3159	0	19.12062	0	0	18.92368	0	0	0	0	19.68562	0	18.30233	17.26978	17.74712	20.07993	19.4383	0	0	0	0	0	0	0	0	0	0	0	18.99442	18.61102	0	0	0
Q00537	CDK17_HUMAN	"Cyclin-dependent kinase 17, EC 2.7.11.22 (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)"	CDK17 PCTAIRE2 PCTK2	Homo sapiens (Human)	protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000083; GO:0004672; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310	ASLSEIGFGK	10.89999962	1	1	0.27021881	1011.120716	15.98227	15.43145	13.33971	15.15368	13.50965	13.2844	12.59024	13.66202	15.84428	14.12504	0	14.69423	15.28929	15.69835	15.39284	14.41544	0	0	0	15.6111	0	0	0	0	0	17.12839	15.5078	0	0	15.04947	0	0	16.64517	0	15.2702	17.56924	0	0	16.13196	0	0	0	15.85284	0	15.32161	0	0	15.63193
Q00653	NFKB2_HUMAN	"Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10, Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit ]"	NFKB2 LYT10	Homo sapiens (Human)	"extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; spleen development [GO:0048536]"	Bcl3/NF-kappaB2 complex [GO:0033257]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"Bcl3/NF-kappaB2 complex [GO:0033257]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; spleen development [GO:0048536]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002268; GO:0002467; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0030198; GO:0033257; GO:0038061; GO:0045944; GO:0048511; GO:0048536; GO:0071159; GO:1990837	GPETRDK	7.429999828	1	1	0.291872952	803.4488278	0	14.54671	15.10011	0	0	0	0	13.67546	14.58456	16.16841	0	14.51289	0	16.17552	0	0	0	16.51819	0	17.42493	0	0	0	0	0	15.03493	0	15.90117	0	14.18114	14.95027	0	14.60955	0	0	14.6431	13.98394	0	11.33484	0	15.51276	14.27316	10.83948	10.64604	14.57266	14.53273	15.45786	13.9979
Q00722	PLCB2_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-2) (Phospholipase C-beta-2, PLC-beta-2)"	PLCB2	Homo sapiens (Human)	activation of phospholipase C activity [GO:0007202]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipid metabolic process [GO:0006644]	cytosol [GO:0005829]; G-protein beta/gamma-subunit complex [GO:0031680]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; G-protein beta/gamma-subunit complex [GO:0031680]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phospholipid binding [GO:0005543]; activation of phospholipase C activity [GO:0007202]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipid metabolic process [GO:0006644]	calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phospholipid binding [GO:0005543]	GO:0001580; GO:0004435; GO:0004629; GO:0005509; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0006644; GO:0007186; GO:0007200; GO:0007202; GO:0016042; GO:0031680; GO:0031683; GO:0046488; GO:0048015	LKEAMGGLPEKPFPLASPVASQVNGALAPTSNGSPAAR	6.21999979	1	1	0.162541002	3745.894828	0	0	16.50043	0	0	0	13.74763	0	0	0	15.307	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.16592	0	0	0	0	0	0	0	0	0	0	14.76219	0	16.50941	0	0	0	0	12.83768	0	0	0	0
Q00872	MYPC1_HUMAN	"Myosin-binding protein C, slow-type, Slow MyBP-C (C-protein, skeletal muscle slow isoform)"	MYBPC1 MYBPCS	Homo sapiens (Human)	cell adhesion [GO:0007155]; muscle contraction [GO:0006936]	cytosol [GO:0005829]; myofibril [GO:0030016]; myosin filament [GO:0032982]	cytosol [GO:0005829]; myofibril [GO:0030016]; myosin filament [GO:0032982]; actin binding [GO:0003779]; myosin binding [GO:0017022]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cell adhesion [GO:0007155]; muscle contraction [GO:0006936]	actin binding [GO:0003779]; myosin binding [GO:0017022]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]	GO:0003779; GO:0005829; GO:0006936; GO:0007155; GO:0008307; GO:0017022; GO:0030016; GO:0031432; GO:0032982	GRIHK	2.880000114	1	1	0.190380887	610.4342973	0	0	15.81486	12.7017	15.04998	14.17451	0	0	14.76845	14.20787	15.55138	16.78807	15.0888	0	15.67774	0	14.06072	0	0	16.51681	0	0	0	14.76184	15.25553	15.02248	0	0	0	0	0	0	0	0	15.22152	0	0	0	0	0	14.37708	0	0	16.73073	0	15.64091	16.29792	16.01763
Q00975	CAC1B_HUMAN	"Voltage-dependent N-type calcium channel subunit alpha-1B (Brain calcium channel III, BIII) (Calcium channel, L type, alpha-1 polypeptide isoform 5) (Voltage-gated calcium channel subunit alpha Cav2.2)"	CACNA1B CACH5 CACNL1A5	Homo sapiens (Human)	calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645]	plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]	plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; protein C-terminus binding [GO:0008022]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645]	amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; protein C-terminus binding [GO:0008022]; voltage-gated calcium channel activity [GO:0005245]	GO:0001540; GO:0005245; GO:0005509; GO:0005524; GO:0005886; GO:0005891; GO:0006816; GO:0007268; GO:0008022; GO:0008331; GO:0034765; GO:0045202; GO:0050804; GO:0070509; GO:1904645	ARTMALYNPIPVK	11.02999973	1	1	0.487983813	1472.812219	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.64796	0	0	0	17.78571	0	0	0	0	0	0	0	0	0	17.13847	0	0	18.61656	0	18.35679	0	0	0	0	18.5929	0	0	0	0	17.97306	0	0	0
Q00994	BEX3_HUMAN	Protein BEX3 (Brain-expressed X-linked protein 3) (Nerve growth factor receptor-associated protein 1) (Ovarian granulosa cell 13.0 kDa protein HGR74) (p75NTR-associated cell death executor)	BEX3 DXS6984E NADE NGFRAP1	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005163; GO:0005634; GO:0005737; GO:0005829; GO:0006919; GO:0007165; GO:0007275; GO:0008625; GO:0008656; GO:0042802; GO:0046872	QINDGMGGDGDDMEIFMEEMR	1.980000019	1	1	1.37E-12	2420.798015	0	12.88762	11.6261	15.89766	0	15.21568	13.14151	0	0	0	13.98128	0	0	11.9989	5.916334	14.39033	0	12.79227	0	13.22343	13.05707	0	0	0	0	14.41197	13.62004	0	11.51381	11.93375	0	0	0	0	0	0	0	0	0	13.48017	0	0	0	13.41166	11.17179	0	12.35913	0
Q01064	PDE1B_HUMAN	"Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B, Cam-PDE 1B, EC 3.1.4.17 (63 kDa Cam-PDE)"	PDE1B PDES1B	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; locomotory behavior [GO:0007626]; monocyte differentiation [GO:0030224]; regulation of dopamine metabolic process [GO:0042053]; regulation of neurotransmitter levels [GO:0001505]; response to amphetamine [GO:0001975]; serotonin metabolic process [GO:0042428]; signal transduction [GO:0007165]; visual learning [GO:0008542]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]	"cytosol [GO:0005829]; neuronal cell body [GO:0043025]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; locomotory behavior [GO:0007626]; monocyte differentiation [GO:0030224]; regulation of dopamine metabolic process [GO:0042053]; regulation of neurotransmitter levels [GO:0001505]; response to amphetamine [GO:0001975]; serotonin metabolic process [GO:0042428]; signal transduction [GO:0007165]; visual learning [GO:0008542]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]"	GO:0001505; GO:0001975; GO:0004114; GO:0004115; GO:0004117; GO:0005516; GO:0005829; GO:0006915; GO:0007165; GO:0007626; GO:0008542; GO:0030224; GO:0036006; GO:0042053; GO:0042428; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0097011	SDAVPSEVR	21.28000069	0.566990137	0.566990137	0.462287655	960.4104939	17.69439	19.76056	0	0	18.02165	0	0	0	0	0	19.00774	0	0	0	0	0	19.52567	0	16.92981	0	17.70926	0	0	20.05742	0	21.32247	21.50541	0	16.25776	0	0	0	0	0	18.83125	0	0	22.47102	18.22619	0	0	18.76124	0	20.26186	0	0	19.68869	0
Q01081	U2AF1_HUMAN	Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit)	U2AF1 U2AF35 U2AFBP FP793	Homo sapiens (Human)	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0015030; GO:0016607; GO:0030628; GO:0046872; GO:0071013; GO:0089701	GRGGGGGGGGGGGGR	3.450000048	0.00930344	0.00930344	0.183554805	1072.019539	0	0	15.19162	14.05837	0	16.87345	0	0	12.27913	0	0	14.48487	14.36909	17.72645	0	17.90604	12.92845	0	16.14039	0	0	0	0	16.25888	16.9455	14.89293	14.48363	0	15.52309	0	0	0	0	0	14.66434	0	16.6002	15.73614	0	12.59925	0	15.93087	0	17.822	16.67206	16.31662	0	0
Q01082	SPTB2_HUMAN	"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)"	SPTBN1 SPTB2	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]	axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]	GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007182; GO:0008091; GO:0014069; GO:0014731; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0042995; GO:0043001; GO:0045296; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:0098978; GO:1903076; GO:1903078	ETASELLMRLK	2.180000067	1	1	0.69738817	1305.514237	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q01118	SCN7A_HUMAN	Sodium channel protein type 7 subunit alpha (Putative voltage-gated sodium channel subunit alpha Nax) (Sodium channel protein cardiac and skeletal muscle subunit alpha) (Sodium channel protein type VII subunit alpha)	SCN7A SCN6A	Homo sapiens (Human)	membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; response to bacterium [GO:0009617]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; glial cell projection [GO:0097386]; voltage-gated sodium channel complex [GO:0001518]	axon [GO:0030424]; glial cell projection [GO:0097386]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; response to bacterium [GO:0009617]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0006814; GO:0006936; GO:0009617; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0055078; GO:0086010; GO:0097386	LKEFVHR	11.36999989	1	1	0.218788889	928.0382078	14.16079	15.96532	14.48494	0	0	14.42639	0	0	0	14.5672	12.66322	0	0	0	0	0	0	0	0	15.45416	17.32269	0	0	0	0	0	0	0	0	18.07576	0	0	0	0	17.27019	0	0	0	0	0	0	0	0	0	0	0	0	0
Q01151	CD83_HUMAN	"CD83 antigen, hCD83 (B-cell activation protein) (Cell surface protein HB15) (CD antigen CD83)"	CD83	Homo sapiens (Human)	"defense response [GO:0006952]; humoral immune response [GO:0006959]; negative regulation of interleukin-4 production [GO:0032713]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]"	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; defense response [GO:0006952]; humoral immune response [GO:0006959]; negative regulation of interleukin-4 production [GO:0032713]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]"		GO:0005886; GO:0005887; GO:0006952; GO:0006959; GO:0007165; GO:0009897; GO:0014070; GO:0032713; GO:0032733; GO:0032743; GO:0043372	LLEGGEER	5.599999905	0.2271595	0.2271595	0.268949032	901.6429572	18.3219	0	0	0	18.40643	19.27757	18.11848	0	0	16.54429	17.28163	0	16.60759	0	0	0	0	0	17.46265	16.11578	16.3342	18.43714	0	0	0	0	0	17.91958	0	0	19.96668	19.24266	0	0	0	19.7213	17.93129	0	20.11892	0	0	0	0	0	0	17.30191	17.78817	19.18712
Q01201	RELB_HUMAN	Transcription factor RelB (I-Rel)	RELB	Homo sapiens (Human)	"antigen processing and presentation [GO:0019882]; cellular response to osmotic stress [GO:0071470]; circadian regulation of gene expression [GO:0032922]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lymphocyte differentiation [GO:0030098]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; T-helper 1 cell differentiation [GO:0045063]"	chromatin [GO:0000785]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	"chromatin [GO:0000785]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; antigen processing and presentation [GO:0019882]; cellular response to osmotic stress [GO:0071470]; circadian regulation of gene expression [GO:0032922]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lymphocyte differentiation [GO:0030098]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; T-helper 1 cell differentiation [GO:0045063]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006357; GO:0006954; GO:0007249; GO:0010628; GO:0017053; GO:0019882; GO:0019901; GO:0030098; GO:0032688; GO:0032922; GO:0032991; GO:0034097; GO:0038061; GO:0042802; GO:0043011; GO:0045063; GO:0045087; GO:0045892; GO:0045944; GO:0071159; GO:0071470	DHDSYGVDK	2.789999962	1	1	0.08000125	1034.980229	0	0	0	0	0	0	0	0	0	0	0	14.25865	0	0	0	0	15.36042	0	0	0	0	0	0	0	15.85579	0	0	15.45184	15.84562	0	0	0	12.43298	0	0	0	0	0	0	0	0	0	0	0	0	0	14.40555	0
Q01344	IL5RA_HUMAN	"Interleukin-5 receptor subunit alpha, IL-5 receptor subunit alpha, IL-5R subunit alpha, IL-5R-alpha, IL-5RA (CDw125) (CD antigen CD125)"	IL5RA IL5R	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of interleukin-5 production [GO:0032674]; signal transduction [GO:0007165]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-5 receptor activity [GO:0004914]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of interleukin-5 production [GO:0032674]; signal transduction [GO:0007165]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-5 receptor activity [GO:0004914]	GO:0002437; GO:0004896; GO:0004914; GO:0005615; GO:0005886; GO:0007165; GO:0009897; GO:0016021; GO:0019221; GO:0019955; GO:0032674; GO:0043235; GO:0070665	NVNLEYQVK	5.460000038	0.282229811	0.282229811	0.177997614	1103.537735	12.4168	7.650814	13.72603	13.09255	13.61117	11.29896	0	15.13016	0	12.06332	0	13.2325	14.28022	0	14.01814	14.01548	14.86636	0	0	0	14.72674	0	0	15.59448	0	14.02582	0	0	0	14.98043	15.05348	0	14.79861	14.40155	13.94574	13.72811	0	13.58448	13.52833	15.10902	0	14.43157	0	0	16.44794	0	0	0
Q01415	GALK2_HUMAN	"N-acetylgalactosamine kinase, EC 2.7.1.157 (GalNAc kinase) (Galactokinase 2)"	GALK2 GK2	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]; carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]	ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]	GO:0004335; GO:0005524; GO:0005829; GO:0005975; GO:0006012; GO:0033858	AATSHFNIR	4.309999943	0.922966659	0.922966659	0.139054207	1017.508227	0	0	0	0	15.64374	0	15.59529	16.34508	0	0	0	0	16.52721	16.42826	0	16.46836	0	0	0	16.63783	13.49794	0	0	0	0	0	0	10.46961	0	0	15.64847	14.4292	0	14.51542	0	14.02342	0	15.53834	0	0	0	0	0	14.45809	17.61605	0	0	0
Q01432	AMPD3_HUMAN	"AMP deaminase 3, EC 3.5.4.6 (AMP deaminase isoform E) (Erythrocyte AMP deaminase)"	AMPD3	Homo sapiens (Human)	AMP catabolic process [GO:0006196]; AMP metabolic process [GO:0046033]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; AMP catabolic process [GO:0006196]; AMP metabolic process [GO:0046033]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]	AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]	GO:0003876; GO:0005576; GO:0005829; GO:0006188; GO:0006196; GO:0032264; GO:0034774; GO:0046033; GO:0046872; GO:1904813	EFLHK	10.21000004	0.373507261	0.373507261	0.139975763	673.4877573	16.66371	16.28241	17.22622	0	16.73049	15.83932	15.74117	16.64943	16.56141	16.29214	17.73045	16.78338	18.04227	16.07555	16.99462	17.40107	16.9773	16.68502	17.35559	17.72049	17.31581	15.20599	17.45751	16.51198	16.61151	17.90181	17.36148	17.26273	17.87074	17.58972	18.23969	17.23742	0	16.70417	17.02297	15.46986	17.57975	17.12981	17.13473	18.07293	17.62351	16.64482	16.89054	16.58127	16.14596	17.78556	17.63416	17.60039
Q01433	AMPD2_HUMAN	"AMP deaminase 2, EC 3.5.4.6 (AMP deaminase isoform L)"	AMPD2	Homo sapiens (Human)	AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]	cytosol [GO:0005829]	cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]	AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0042802; GO:0046033; GO:0046872; GO:0052652; GO:0097009	HFPLDLRTSMDGK	5.440000057	1	1	0.158936404	1531.910652	14.92481	0	13.4915	14.77137	15.70589	13.16584	15.43666	15.32289	0	15.14765	0	0	15.122	11.05253	13.64009	0	12.29934	13.11847	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q01484	ANK2_HUMAN	"Ankyrin-2, ANK-2 (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)"	ANK2 ANKB	Homo sapiens (Human)	atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]	A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]	ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]	GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259	AGQVEVVR	8.960000038	1	1	0.128015356	858.334164	0	13.31343	13.60927	0	16.57537	0	0	16.71115	0	12.64419	16.12045	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88814	0	0	0	0	0	0	0	0	0	15.22568	0	0	0	0	0	0	0	0	0	0	0	0	0
Q01538	MYT1_HUMAN	"Myelin transcription factor 1, MyT1 (Myelin transcription factor I, MyTI) (PLPB1) (Proteolipid protein-binding protein)"	MYT1 KIAA0835 KIAA1050 MTF1 MYTI PLPB1	Homo sapiens (Human)	"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007399; GO:0008270; GO:0030154	LSGDEVLSPKFK	13.5	0.47557795	0.47557795	0.156538642	1320.199688	14.08448	14.85333	0	15.50437	0	0	0	0	0	0	18.04161	0	0	0	0	16.43546	0	0	17.39702	0	0	0	0	12.75416	17.32027	17.66609	19.26654	0	0	0	0	0	0	0	0	0	0	15.91732	0	0	0	0	0	0	0	0	0	0
Q01581	HMCS1_HUMAN	"Hydroxymethylglutaryl-CoA synthase, cytoplasmic, HMG-CoA synthase, EC 2.3.3.10 (3-hydroxy-3-methylglutaryl coenzyme A synthase)"	HMGCS1 HMGCS	Homo sapiens (Human)	"acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]"	hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803]	GO:0004421; GO:0005737; GO:0005829; GO:0006084; GO:0006629; GO:0006695; GO:0010142; GO:0042803	TGVAPDVFAENMKLR	4.829999924	1	1	0.377713927	1647.506371	0	0	0	0	0	0	0	0	0	0	0	15.7531	16.13859	0	0	0	0	0	0	0	0	0	0	0	0	0	17.67798	0	0	0	0	0	0	0	18.32953	0	17.69785	0	20.18344	0	0	0	0	16.91972	17.83151	0	18.03039	0
Q01629	IFM2_HUMAN	"Interferon-induced transmembrane protein 2 (Dispanin subfamily A member 2c, DSPA2c) (Interferon-inducible protein 1-8D)"	IFITM2	Homo sapiens (Human)	cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; immune response [GO:0006955]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; immune response [GO:0006955]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]		GO:0005654; GO:0005765; GO:0005886; GO:0006955; GO:0009615; GO:0016021; GO:0030054; GO:0031902; GO:0032991; GO:0034341; GO:0035455; GO:0035456; GO:0035458; GO:0045071; GO:0046597; GO:0051607; GO:0060337	KMVGDVTGAQAYASTAK	6.949999809	1	1	9.22E-13	1713.084408	16.55168	0	11.83033	12.71823	14.80793	0	0	0	15.0625	0	14.91902	0	0	14.10484	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.8778	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q01668	CAC1D_HUMAN	"Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)"	CACNA1D CACH3 CACN4 CACNL1A2 CCHL1A2	Homo sapiens (Human)	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cardiac muscle cell action potential involved in contraction [GO:0086002]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; sensory perception of sound [GO:0007605]	L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]	L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; ankyrin binding [GO:0030506]; calcium channel activity [GO:0005262]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cardiac muscle cell action potential involved in contraction [GO:0086002]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; sensory perception of sound [GO:0007605]	alpha-actinin binding [GO:0051393]; ankyrin binding [GO:0030506]; calcium channel activity [GO:0005262]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]	GO:0005245; GO:0005262; GO:0005886; GO:0005891; GO:0006816; GO:0007188; GO:0007605; GO:0030018; GO:0030506; GO:0045762; GO:0046872; GO:0051393; GO:0051928; GO:0060372; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086046; GO:0086059; GO:0086091; GO:1901016; GO:1901379; GO:1990454	TEGNLEQANEELRAVIK	1.320000052	1	1	0.277715197	1913.104316	0	0	0	0	0	0	0	0	0	13.62453	15.18919	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.33375	0	0	0	0	0	0	0	0	0	0	0	0	0
Q01726	MSHR_HUMAN	"Melanocyte-stimulating hormone receptor, MSH-R (Melanocortin receptor 1, MC1-R)"	MC1R MSHR	Homo sapiens (Human)	"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]; negative regulation of tumor necrosis factor production [GO:0032720]; pigmentation [GO:0043473]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of metabolic process [GO:0019222]; sensory perception of pain [GO:0019233]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]"	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; multicellular organism development [GO:0007275]; negative regulation of tumor necrosis factor production [GO:0032720]; pigmentation [GO:0043473]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of metabolic process [GO:0019222]; sensory perception of pain [GO:0019233]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]"	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625]	GO:0004930; GO:0004977; GO:0004980; GO:0005737; GO:0005886; GO:0005887; GO:0007187; GO:0007189; GO:0007275; GO:0008528; GO:0009650; GO:0010739; GO:0019222; GO:0019233; GO:0031625; GO:0032720; GO:0035556; GO:0042438; GO:0042562; GO:0043473; GO:0045944; GO:0051897; GO:0070914; GO:0090037; GO:2000253	AVQGSQR	10.47000027	0.91760689	0.91760689	0.020054239	744.4392453	0	15.75051	0	12.44218	0	0	0	11.79094	14.19207	18.22303	14.55044	0	16.00311	16.16341	15.66612	15.27517	14.21096	14.91183	16.64772	13.75768	15.60462	17.44912	0	0	15.92893	15.42645	12.34268	0	0	0	16.16321	14.69396	0	13.26603	10.45659	0	15.74151	16.28917	0	10.46861	14.15868	0	14.90577	0	12.92795	0	16.32965	16.02453
Q01740	FMO1_HUMAN	"Dimethylaniline monooxygenase [N-oxide-forming] 1, EC 1.14.13.8 (Dimethylaniline oxidase 1) (Fetal hepatic flavin-containing monooxygenase 1, FMO 1)"	FMO1	Homo sapiens (Human)	NADPH oxidation [GO:0070995]; organic acid metabolic process [GO:0006082]; response to lipopolysaccharide [GO:0032496]; response to osmotic stress [GO:0006970]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidation [GO:0070995]; organic acid metabolic process [GO:0006082]; response to lipopolysaccharide [GO:0032496]; response to osmotic stress [GO:0006970]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]"	"flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004497; GO:0004499; GO:0005788; GO:0005789; GO:0006082; GO:0006805; GO:0006970; GO:0009404; GO:0016021; GO:0032496; GO:0050660; GO:0050661; GO:0070995	SVVSNSCK	6.78000021	1	1	0.128171111	881.0044543	15.27709	11.97105	13.50879	14.33144	13.99451	13.66379	12.93301	0	15.19402	15.17321	15.84264	15.50437	14.60953	13.11331	14.20643	13.31577	0	14.39965	14.35954	14.92156	0	15.94443	0	14.09691	0	0	0	0	0	0	0	0	0	0	0	0	15.48232	0	0	0	0	14.80126	0	0	0	0	0	0
Q01814	AT2B2_HUMAN	"Plasma membrane calcium-transporting ATPase 2, PMCA2, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2)"	ATP2B2 PMCA2	Homo sapiens (Human)	brain development [GO:0007420]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of sound [GO:0007605]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of sound [GO:0007605]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]	GO:0003407; GO:0005388; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006874; GO:0007420; GO:0007605; GO:0008022; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030165; GO:0030182; GO:0032591; GO:0032809; GO:0034220; GO:0035254; GO:0043231; GO:0045121; GO:0046872; GO:0051480; GO:0070062; GO:0098688; GO:0098839; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:1903779; GO:1905056; GO:1905059	ASMHKK	5.610000134	0.736428201	0.736428201	0.122133907	716.9873161	14.07804	14.11581	16.88393	16.18818	16.22305	0	11.68613	13.59464	14.64875	15.66982	16.80809	0	16.9861	14.86038	17.63614	13.14303	14.46477	0	16.58975	0	15.23666	13.58331	14.64401	12.60855	16.61619	15.61888	15.03209	16.42819	16.50643	15.17924	12.57143	15.39153	16.38359	16.75123	16.65017	0	11.02547	0	11.62211	13.7916	16.60498	17.24986	14.92782	17.20121	13.9534	14.42056	12.91221	13.5433
Q01826	SATB1_HUMAN	DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1)	SATB1	Homo sapiens (Human)	chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003690; GO:0005634; GO:0005654; GO:0006325; GO:0006338; GO:0006357; GO:0016363; GO:0016604; GO:0016605; GO:0043565	DHLNEATQGK	6.829999924	0.675147891	0.675147891	0.164921555	1112.554794	12.44407	15.31885	14.77392	0	0	0	0	0	0	0	15.12162	0	0	12.86448	14.378	0	0	0	15.3165	0	0	16.93588	0	0	13.53021	12.49653	13.08466	12.18712	12.8357	13.67812	12.51285	12.8581	15.47565	15.16728	13.17911	14.86884	0	15.87218	0	13.74392	14.90968	14.4898	13.7034	14.73369	12.06131	11.70338	13.8979	14.32764
Q01844	EWS_HUMAN	RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein)	EWSR1 EWS	Homo sapiens (Human)		Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0003723; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0015030; GO:0042802; GO:0046872	GGMSR	2.930000067	0.329243243	0.329243243	0.05883209	523.7653575	17.21283	12.58255	0	17.99013	13.23871	16.02632	11.26424	0	15.6102	17.93219	0	17.87056	0	16.38022	14.39544	14.94437	0	0	17.37306	15.23583	16.13104	0	0	17.04775	16.88484	17.80438	14.99803	15.85901	17.1538	16.1132	13.44206	0	17.69533	10.42266	17.92287	16.49228	16.11389	17.41164	13.18292	16.36484	16.55035	17.15984	0	13.67953	19.2529	14.50065	16.37803	16.64704
Q01850	CDR2_HUMAN	Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen)	CDR2 PCD17	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	LVPDSLYVPFK	6.769999981	1	1	0.417674246	1276.774813	0	0	0	0	0	0	0	0	0	15.29723	15.93183	0	0	0	0	0	0	16.55097	17.18279	0	15.43486	0	0	0	0	0	0	0	0	0	15.73482	15.0613	0	15.85374	16.92117	16.42519	16.36173	0	14.80509	0	16.80409	0	0	17.22949	0	15.30215	14.62918	14.62144
Q01851	PO4F1_HUMAN	"POU domain, class 4, transcription factor 1 (Brain-specific homeobox/POU domain protein 3A, Brain-3A, Brn-3A) (Homeobox/POU domain protein RDC-1) (Oct-T1)"	POU4F1 BRN3A RDC1	Homo sapiens (Human)	axonogenesis [GO:0007409]; cell migration in hindbrain [GO:0021535]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; central nervous system neuron differentiation [GO:0021953]; habenula development [GO:0021986]; heart development [GO:0007507]; innervation [GO:0060384]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; neuron projection development [GO:0031175]; peripheral nervous system neuron development [GO:0048935]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; proprioception involved in equilibrioception [GO:0051355]; regulation of cell cycle [GO:0051726]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory system development [GO:0048880]; suckling behavior [GO:0001967]; synapse assembly [GO:0007416]; trigeminal nerve development [GO:0021559]; ventricular compact myocardium morphogenesis [GO:0003223]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; axonogenesis [GO:0007409]; cell migration in hindbrain [GO:0021535]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; central nervous system neuron differentiation [GO:0021953]; habenula development [GO:0021986]; heart development [GO:0007507]; innervation [GO:0060384]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; neuron projection development [GO:0031175]; peripheral nervous system neuron development [GO:0048935]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; proprioception involved in equilibrioception [GO:0051355]; regulation of cell cycle [GO:0051726]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory system development [GO:0048880]; suckling behavior [GO:0001967]; synapse assembly [GO:0007416]; trigeminal nerve development [GO:0021559]; ventricular compact myocardium morphogenesis [GO:0003223]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001967; GO:0003223; GO:0003682; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007409; GO:0007416; GO:0007498; GO:0007507; GO:0010628; GO:0010629; GO:0021535; GO:0021559; GO:0021953; GO:0021986; GO:0031175; GO:0043005; GO:0043065; GO:0043066; GO:0043069; GO:0043524; GO:0043565; GO:0045672; GO:0045944; GO:0048665; GO:0048880; GO:0048935; GO:0050767; GO:0051020; GO:0051090; GO:0051355; GO:0051726; GO:0060384; GO:0061629; GO:0071345; GO:0071392; GO:0072332; GO:0090575; GO:1990837; GO:2000679	MSMNSK	6.5	0.76463449	0.76463449	0.110197547	728.7061253	0	21.02493	15.96624	0	0	0	15.18544	9.510246	17.07266	0	0	0	0	13.88147	13.4149	11.81508	14.34995	15.28625	14.02505	15.8835	14.90215	16.75235	16.12657	0	0	16.89064	0	0	16.57777	16.38141	15.37508	15.79154	18.09389	18.97135	16.83949	16.48672	16.31725	15.80083	16.98992	17.78589	0	16.02777	15.54456	15.52016	15.71131	0	12.76003	16.84366
Q01955	CO4A3_HUMAN	Collagen alpha-3(IV) chain (Goodpasture antigen) [Cleaved into: Tumstatin ]	COL4A3	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endothelial cell apoptotic process [GO:0072577]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; response to glucose [GO:0009749]; sensory perception of sound [GO:0007605]	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metalloendopeptidase inhibitor activity [GO:0008191]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endothelial cell apoptotic process [GO:0072577]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; response to glucose [GO:0009749]; sensory perception of sound [GO:0007605]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metalloendopeptidase inhibitor activity [GO:0008191]; structural molecule activity [GO:0005198]	GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005783; GO:0005788; GO:0006919; GO:0007155; GO:0007166; GO:0007605; GO:0008015; GO:0008191; GO:0008285; GO:0009749; GO:0016525; GO:0030020; GO:0030198; GO:0031012; GO:0032836; GO:0038063; GO:0043231; GO:0062023; GO:0072577; GO:1905563	GAMGDAGPR	7.110000134	1	1	0.570046992	832.3788057	0	0	0	0	0	0	0	0	13.50736	0	0	0	0	0	9.483438	0	0	14.97743	0	0	0	0	0	0	0	0	0	15.01068	0	0	12.79081	15.14298	0	15.65686	0	0	0	15.52387	16.63281	0	9.808957	0	0	0	0	0	14.90282	0
Q01959	SC6A3_HUMAN	"Sodium-dependent dopamine transporter, DA transporter, DAT (Solute carrier family 6 member 3)"	SLC6A3 DAT1	Homo sapiens (Human)	adenohypophysis development [GO:0021984]; aging [GO:0007568]; dopamine biosynthetic process [GO:0042416]; dopamine catabolic process [GO:0042420]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; dopamine uptake involved in synaptic transmission [GO:0051583]; hyaloid vascular plexus regression [GO:1990384]; lactation [GO:0007595]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; positive regulation of multicellular organism growth [GO:0040018]; prepulse inhibition [GO:0060134]; regulation of dopamine metabolic process [GO:0042053]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]	axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; flotillin complex [GO:0016600]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; flotillin complex [GO:0016600]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; amine binding [GO:0043176]; dopamine binding [GO:0035240]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; adenohypophysis development [GO:0021984]; aging [GO:0007568]; dopamine biosynthetic process [GO:0042416]; dopamine catabolic process [GO:0042420]; dopamine transport [GO:0015872]; dopamine uptake [GO:0090494]; dopamine uptake involved in synaptic transmission [GO:0051583]; hyaloid vascular plexus regression [GO:1990384]; lactation [GO:0007595]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; positive regulation of multicellular organism growth [GO:0040018]; prepulse inhibition [GO:0060134]; regulation of dopamine metabolic process [GO:0042053]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]	amine binding [GO:0043176]; dopamine binding [GO:0035240]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	GO:0002020; GO:0005102; GO:0005326; GO:0005330; GO:0005334; GO:0005737; GO:0005886; GO:0005887; GO:0006836; GO:0007568; GO:0007595; GO:0007608; GO:0007626; GO:0008504; GO:0009410; GO:0009986; GO:0010039; GO:0015844; GO:0015872; GO:0015874; GO:0016021; GO:0016600; GO:0021984; GO:0030424; GO:0032809; GO:0035094; GO:0035240; GO:0035725; GO:0040018; GO:0042053; GO:0042220; GO:0042416; GO:0042420; GO:0042734; GO:0043005; GO:0043025; GO:0043176; GO:0043679; GO:0044877; GO:0045121; GO:0045471; GO:0046872; GO:0047485; GO:0051583; GO:0051591; GO:0051721; GO:0060134; GO:0090494; GO:0098691; GO:0099055; GO:0099056; GO:1990384	GVTLPGAIDGIR	4.269999981	1	1	2.51E-12	1168.986825	15.69033	0	13.91199	15.90881	14.10991	16.81905	0	15.46351	11.41565	14.27536	11.67899	0	10.869	13.53073	16.91662	16.24415	0	0	0	0	16.69368	11.1972	15.45012	0	14.85473	15.19809	13.68202	11.41297	11.42483	0	0	16.57031	0	12.87243	14.23831	0	0	15.64558	13.24649	0	9.759056	8.672221	0	15.44414	0	13.4304	12.27199	0
Q01970	PLCB3_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3, PLC-beta-3)"	PLCB3	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of systemic arterial blood pressure [GO:0003073]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of systemic arterial blood pressure [GO:0003073]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]	GO:0003073; GO:0004435; GO:0004629; GO:0005509; GO:0005516; GO:0005634; GO:0005829; GO:0007186; GO:0016020; GO:0016042; GO:0032991; GO:0045296; GO:0046488; GO:0048015; GO:0099524	IAAFEEGGKFVGHR	5.75	1	1	0.386515402	1518.500483	0	0	0	0	20.38991	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.37686	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q01973	ROR1_HUMAN	"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)"	ROR1 NTRKR1	Homo sapiens (Human)	astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]	"axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	"ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]"	GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0033674; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092; GO:1904929	NILIGEQLHVK	29.70000076	1	1	0.538705089	1262.897501	0	0	17.63337	18.1973	17.44654	0	0	0	0	17.18734	0	17.7811	17.30287	0	0	18.22428	18.84914	0	0	0	0	17.80731	0	0	0	0	0	0	16.62077	17.31097	0	0	0	0	18.43169	0	0	0	0	0	0	0	0	0	0	0	0	0
Q01995	TAGL_HUMAN	"Transgelin (22 kDa actin-binding protein) (Protein WS3-10) (Smooth muscle protein 22-alpha, SM22-alpha)"	TAGLN SM22 WS3-10	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; muscle organ development [GO:0007517]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; epithelial cell differentiation [GO:0030855]; muscle organ development [GO:0007517]	actin filament binding [GO:0051015]	GO:0005737; GO:0005856; GO:0007517; GO:0030855; GO:0051015	GPSYGMSR	6.199999809	0.505950868	0.505950868	0.266319785	853.0779765	15.3759	15.33414	16.06796	0	15.05524	15.53721	15.39057	16.86964	12.48685	0	18.11842	16.06922	13.42802	15.69505	15.23949	0	15.69272	0	16.92725	15.58964	0	17.07683	16.12648	16.83998	16.45086	16.80154	17.08943	15.5902	15.49135	17.70698	16.90217	16.32187	14.58702	0	15.46577	17.09739	10.66669	15.82506	15.94721	0	0	16.23837	15.75329	10.58758	16.29006	15.094	0	0
Q02040	AK17A_HUMAN	"A-kinase anchor protein 17A, AKAP-17A (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A, PRKA17A) (Splicing factor, arginine/serine-rich 17A)"	AKAP17A CXYorf3 DXYS155E SFRS17A XE7	Homo sapiens (Human)	"B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]"	protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018	STMDFIR	5.380000114	1	1	0.077253118	884.469946	0	17.33116	14.43489	15.01326	15.0369	16.9823	17.51952	0	14.2004	0	8.968304	0	0	15.20127	15.60202	0	16.48784	15.48221	15.32548	0	16.52278	0	0	17.46202	14.17277	16.33568	14.38986	14.50038	0	0	15.99092	17.44527	0	14.43471	16.68979	16.00687	0	0	11.43836	0	14.59482	15.07796	16.23148	0	15.96329	16.97192	14.06919	15.70183
Q02080	MEF2B_HUMAN	Myocyte-specific enhancer factor 2B (RSRFR2) (Serum response factor-like protein 2)	MEF2B XMEF2	Homo sapiens (Human)	cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cell junction [GO:0030054]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"cell junction [GO:0030054]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0007517; GO:0030054; GO:0030154; GO:0042826; GO:0045944; GO:0046983; GO:1990837	VLLKYTEYSEPHESR	8.720000267	1	1	0.265473491	1850.181932	13.86262	0	13.06017	0	0	0	0	13.73577	0	0	0	0	0	0	0	16.43179	14.9578	0	0	0	14.86765	0	15.30399	16.12513	0	0	16.33557	0	15.30233	15.12373	14.37077	11.59262	0	15.37711	0	15.28354	0	0	0	0	0	0	0	0	0	0	0	0
Q02156	KPCE_HUMAN	"Protein kinase C epsilon type, EC 2.7.11.13 (nPKC-epsilon)"	PRKCE PKCE	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]"	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor activator activity [GO:0030546]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]"	14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor activator activity [GO:0030546]	GO:0002281; GO:0003785; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0008047; GO:0010634; GO:0010763; GO:0010811; GO:0018105; GO:0019899; GO:0030546; GO:0030838; GO:0031397; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0043123; GO:0043231; GO:0043278; GO:0043410; GO:0045111; GO:0046872; GO:0048471; GO:0050730; GO:0050996; GO:0051279; GO:0051301; GO:0061178; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:0106310; GO:1903078; GO:2000650; GO:2001031	VMLAELK	8.829999924	1	1	0.168557886	818.954529	15.26135	0	15.98314	0	0	14.55814	14.49127	0	12.22108	19.04009	16.03854	17.14177	0	0	0	0	0	0	0	0	0	0	0	0	16.94481	0	0	17.44981	0	0	0	16.33108	0	0	0	0	0	17.97741	0	0	0	0	0	0	0	0	0	0
Q02218	ODO1_HUMAN	"2-oxoglutarate dehydrogenase complex component E1, E1o, OGDC-E1, OGDH-E1, EC 1.2.4.2 (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase, Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase)"	OGDH	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099]	chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0034602; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0106077	DPAAAPATGNK	13.31999969	1	1	0.478420745	1011.207699	0	18.71668	0	19.40862	17.38501	0	18.13123	0	0	17.50635	0	0	0	0	0	0	18.10114	0	0	17.88435	0	0	0	0	0	18.66995	0	0	18.91631	0	0	0	0	19.34698	21.03711	18.49658	0	0	0	17.58996	17.9177	0	19.53313	18.82158	18.88612	18.69606	0	0
Q02224	CENPE_HUMAN	"Centromere-associated protein E (Centromere protein E, CENP-E) (Kinesin-7) (Kinesin-related protein CENPE)"	CENPE	Homo sapiens (Human)	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]"	ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0000278; GO:0000775; GO:0000776; GO:0000779; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0008017; GO:0008574; GO:0015630; GO:0016020; GO:0030071; GO:0030496; GO:0043231; GO:0043515; GO:0045171; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0072686; GO:0099606; GO:0099607; GO:1990023	EEQHESINK	2.519999981	1	1	2.30E-13	1113.223342	12.59208	0	0	0	0	0	0	0	0	0	0	0	13.12895	0	0	14.37844	0	14.02646	14.47231	0	13.17218	0	0	0	0	0	0	0	0	0	12.83051	0	0	12.9176	14.80378	13.98394	0	0	17.19579	0	0	0	0	0	0	0	0	0
Q02241	KIF23_HUMAN	Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1)	KIF23 KNSL5 MKLP1	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]	centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149	MIVCVNPK	6.659999847	0.371962547	0.371962547	0.228591432	961.0024696	16.99418	14.40764	14.0249	12.59059	0	0	0	0	0	0	0	0	12.7325	0	0	0	0	15.23986	0	0	0	0	0	0	0	16.75187	0	0	15.5641	0	0	0	0	17.25563	0	0	0	0	0	15.81582	0	0	16.34627	0	16.66606	11.86912	13.88372	0
Q02252	MMSA_HUMAN	"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, MMSDH, Malonate-semialdehyde dehydrogenase [acylating], EC 1.2.1.18, EC 1.2.1.27 (Aldehyde dehydrogenase family 6 member A1)"	ALDH6A1 MMSDH	Homo sapiens (Human)	branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity [GO:0102662]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]; branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]"	"fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity [GO:0102662]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]"	GO:0000062; GO:0003723; GO:0004491; GO:0005654; GO:0005739; GO:0005759; GO:0006210; GO:0006573; GO:0006574; GO:0009083; GO:0018478; GO:0019859; GO:0050873; GO:0102662	ILQVSSKVK	1.950000048	1	1	0.032218615	1001.588604	17.44798	0	0	0	15.91619	0	0	0	0	17.26728	0	0	0	14.14085	13.84467	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q02297	NRG1_HUMAN	"Pro-neuregulin-1, membrane-bound isoform, Pro-NRG1 [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity, ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin, HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor) ]"	NRG1 GGF HGL HRGA NDF SMDF	Homo sapiens (Human)	"activation of protein kinase B activity [GO:0032148]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ development [GO:0048513]; cardiac conduction system development [GO:0003161]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell communication [GO:0007154]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; endocardial cell differentiation [GO:0060956]; ERBB signaling pathway [GO:0038127]; ERBB3 signaling pathway [GO:0038129]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; glial cell fate commitment [GO:0021781]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of secretion [GO:0051048]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neuron fate commitment [GO:0048663]; neurotransmitter receptor metabolic process [GO:0045213]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of striated muscle cell differentiation [GO:0051155]; postsynapse to nucleus signaling pathway [GO:0099527]; protein-containing complex disassembly [GO:0032984]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]"	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; cytokine activity [GO:0005125]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; activation of protein kinase B activity [GO:0032148]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ development [GO:0048513]; cardiac conduction system development [GO:0003161]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell communication [GO:0007154]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; endocardial cell differentiation [GO:0060956]; ERBB signaling pathway [GO:0038127]; ERBB3 signaling pathway [GO:0038129]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; glial cell fate commitment [GO:0021781]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of secretion [GO:0051048]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neuron fate commitment [GO:0048663]; neurotransmitter receptor metabolic process [GO:0045213]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of striated muscle cell differentiation [GO:0051155]; postsynapse to nucleus signaling pathway [GO:0099527]; protein-containing complex disassembly [GO:0032984]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]"	chemorepellent activity [GO:0045499]; cytokine activity [GO:0005125]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0000165; GO:0000902; GO:0003161; GO:0003222; GO:0003712; GO:0005102; GO:0005125; GO:0005176; GO:0005178; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0007154; GO:0007169; GO:0007171; GO:0007399; GO:0007416; GO:0007626; GO:0008083; GO:0008283; GO:0008284; GO:0010628; GO:0010667; GO:0014032; GO:0016020; GO:0016324; GO:0021781; GO:0021842; GO:0022011; GO:0030154; GO:0030296; GO:0030297; GO:0030307; GO:0030424; GO:0030879; GO:0030971; GO:0031334; GO:0031594; GO:0032148; GO:0032984; GO:0035556; GO:0038127; GO:0038129; GO:0038130; GO:0038138; GO:0042060; GO:0042177; GO:0043125; GO:0045213; GO:0045499; GO:0045785; GO:0045892; GO:0046579; GO:0048018; GO:0048513; GO:0048663; GO:0048709; GO:0051048; GO:0051155; GO:0051897; GO:0055007; GO:0055012; GO:0060045; GO:0060379; GO:0060956; GO:0070374; GO:0070886; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:0099149; GO:0099527; GO:0099560; GO:1900086; GO:2001223; GO:2001240	ASLADSGEYMCK	10.81999969	1	1	0.451621113	1347.203548	19.08724	20.37949	0	0	20.84619	0	0	19.42525	20.66261	0	0	0	0	21.43326	0	0	0	0	20.22317	18.71846	0	0	0	20.78869	19.57745	19.06438	0	0	0	19.56374	0	20.39973	0	0	22.09475	0	21.20185	0	0	20.8735	21.18248	0	0	21.14359	18.89387	0	0	0
Q02318	CP27A_HUMAN	"Sterol 26-hydroxylase, mitochondrial, EC 1.14.15.15 (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)"	CYP27A1 CYP27	Homo sapiens (Human)	bile acid biosynthetic process [GO:0006699]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; sterol metabolic process [GO:0016125]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity [GO:0047103]; cholestanetetraol 26-dehydrogenase activity [GO:0047748]; cholestanetriol 26-monooxygenase activity [GO:0047749]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]; bile acid biosynthetic process [GO:0006699]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; sterol metabolic process [GO:0016125]"	"3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity [GO:0047103]; cholestanetetraol 26-dehydrogenase activity [GO:0047748]; cholestanetriol 26-monooxygenase activity [GO:0047749]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]"	GO:0005506; GO:0005739; GO:0005743; GO:0005759; GO:0006699; GO:0006707; GO:0008203; GO:0008395; GO:0016125; GO:0020037; GO:0030343; GO:0031073; GO:0036378; GO:0047103; GO:0047748; GO:0047749	SIGLMFQNSLYATFLPK	3.930000067	0.992457092	0.992457092	6.94E-13	1945.84238	15.5162	15.71988	0	0	14.63202	0	0	0	0	0	0	0	16.90265	0	0	0	0	0	0	0	0	0	0	0	0	12.58506	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.02878	0
Q02338	BDH_HUMAN	"D-beta-hydroxybutyrate dehydrogenase, mitochondrial, EC 1.1.1.30 (3-hydroxybutyrate dehydrogenase, BDH) (Short chain dehydrogenase/reductase family 9C member 1)"	BDH1 BDH SDR9C1	Homo sapiens (Human)	lipid metabolic process [GO:0006629]	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; lipid metabolic process [GO:0006629]	3-hydroxybutyrate dehydrogenase activity [GO:0003858]	GO:0003858; GO:0005739; GO:0005759; GO:0006629; GO:0099617	AVLVTGCDSGFGFSLAKHLHSK	2.059999943	1	1	0.237175233	2332.385692	12.07836	0	11.5046	0	0	0	0	13.60747	14.08392	0	0	0	0	0	0	0	0	0	14.4266	0	10.89394	15.95693	13.63155	15.72935	0	0	14.04857	13.62581	0	0	0	0	13.50227	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q02388	CO7A1_HUMAN	"Collagen alpha-1(VII) chain (Long-chain collagen, LC collagen)"	COL7A1	Homo sapiens (Human)	cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]	basement membrane [GO:0005604]; collagen type VII trimer [GO:0005590]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen type VII trimer [GO:0005590]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0005590; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0008544; GO:0030020; GO:0030134; GO:0033116; GO:0035987; GO:0062023	EGRDGPK	1.450000048	1	1	0.092638966	757.156273	0	13.69992	12.11433	14.73382	0	0	0	0	0	0	13.76145	10.94707	12.79029	0	0	15.68599	0	13.92082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q02505	MUC3A_HUMAN	"Mucin-3A, MUC-3A (Intestinal mucin-3A)"	MUC3A MUC3	Homo sapiens (Human)		extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent, lubricant activity [GO:0030197]; extracellular matrix structural constituent [GO:0005201]"	"extracellular matrix constituent, lubricant activity [GO:0030197]; extracellular matrix structural constituent [GO:0005201]"	GO:0005201; GO:0005576; GO:0005796; GO:0005886; GO:0016021; GO:0030197	SGWWGGQR	8.380000114	1	1	1.03E-12	932.6075072	15.52916	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.27187	0	0	0	0	0	0	13.81044	14.84775	0	0	12.99434	0	13.09721	0	16.44987	15.37012	0	0	15.69034	16.33071	15.46732	0	0	0	0	0	0	0
Q02509	OC90_HUMAN	"Otoconin-90, Oc90 (Phospholipase A2 homolog)"	OC90 PLA2L	Homo sapiens (Human)	arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; otolith mineralization [GO:0045299]; phospholipid metabolic process [GO:0006644]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; otolith mineralization [GO:0045299]; phospholipid metabolic process [GO:0006644]	calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]	GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0031012; GO:0045299; GO:0050482	ATSPPGSAEIVATR	9.529999733	1	1	0.209705387	1351.793875	16.2254	0	0	16.07718	16.20886	0	16.93773	0	0	17.09147	0	0	0	0	15.12964	15.82512	15.57004	15.21098	0	15.67622	0	0	17.66508	14.8244	0	17.40531	0	0	0	0	0	0	17.90215	14.80728	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q02539	H11_HUMAN	Histone H1.1 (Histone H1a)	H1-1 H1F1 HIST1H1A	Homo sapiens (Human)	chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of receptor-mediated endocytosis [GO:0048260]; spermatogenesis [GO:0007283]	cell surface [GO:0009986]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; vesicle [GO:0031982]	cell surface [GO:0009986]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; vesicle [GO:0031982]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; heparin binding [GO:0008201]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of receptor-mediated endocytosis [GO:0048260]; spermatogenesis [GO:0007283]	chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; heparin binding [GO:0008201]; nucleosomal DNA binding [GO:0031492]	GO:0000785; GO:0000786; GO:0000791; GO:0003690; GO:0005634; GO:0005654; GO:0006334; GO:0007283; GO:0008201; GO:0009986; GO:0016584; GO:0030261; GO:0031490; GO:0031492; GO:0031982; GO:0045910; GO:0048260	MSETVPPAPAASAAPEKPLAGK	4.340000153	1	1	0.267643787	2121.223976	0	13.52593	9.799041	14.97141	14.75389	14.73765	13.99924	14.94625	14.10909	15.79965	14.76437	13.37191	15.47874	0	14.61778	15.01199	15.50689	0	0	0	0	0	0	16.49731	0	0	0	0	0	0	0	0	0	0	14.02841	0	15.77483	0	0	0	0	13.30948	0	0	0	0	0	0
Q02641	CACB1_HUMAN	"Voltage-dependent L-type calcium channel subunit beta-1, CAB1 (Calcium channel voltage-dependent subunit beta 1)"	CACNB1 CACNLB1	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of voltage-gated calcium channel activity [GO:1901385]	plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]	plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport [GO:0070588]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of voltage-gated calcium channel activity [GO:1901385]	high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005886; GO:0005891; GO:0007268; GO:0007528; GO:0008331; GO:0042383; GO:0045202; GO:0045933; GO:0070588; GO:1901385; GO:1902514; GO:1904646	MVQKTSMSR	1.600000024	0.456063747	0.456063747	0.176291174	1082.601669	0	15.17512	14.42062	14.64943	0	0	0	13.44269	12.96387	0	0	0	0	0	0	0	15.7395	10.82605	0	15.07981	16.3789	13.44846	0	0	0	15.98456	14.55375	16.02421	12.89883	15.35279	15.813	0	14.84079	13.53282	0	0	0	13.46185	0	0	0	0	15.13824	0	15.1787	15.39588	0	0
Q02643	GHRHR_HUMAN	"Growth hormone-releasing hormone receptor, GHRH receptor (Growth hormone-releasing factor receptor, GRF receptor, GRFR)"	GHRHR	Homo sapiens (Human)	"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; determination of adult lifespan [GO:0008340]; hormone metabolic process [GO:0042445]; lactation [GO:0007595]; multicellular organismal reproductive process [GO:0048609]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of intracellular steroid hormone receptor signaling pathway [GO:0033143]; regulation of protein metabolic process [GO:0051246]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; somatotropin secreting cell development [GO:0060133]; water homeostasis [GO:0030104]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; growth factor binding [GO:0019838]; growth hormone-releasing hormone receptor activity [GO:0016520]; peptide hormone binding [GO:0017046]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; determination of adult lifespan [GO:0008340]; hormone metabolic process [GO:0042445]; lactation [GO:0007595]; multicellular organismal reproductive process [GO:0048609]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of intracellular steroid hormone receptor signaling pathway [GO:0033143]; regulation of protein metabolic process [GO:0051246]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; somatotropin secreting cell development [GO:0060133]; water homeostasis [GO:0030104]"	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; growth factor binding [GO:0019838]; growth hormone-releasing hormone receptor activity [GO:0016520]; peptide hormone binding [GO:0017046]	GO:0004930; GO:0005637; GO:0005640; GO:0005737; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007595; GO:0008284; GO:0008340; GO:0008528; GO:0009986; GO:0016021; GO:0016363; GO:0016520; GO:0017046; GO:0019838; GO:0019933; GO:0030104; GO:0030141; GO:0032868; GO:0032869; GO:0033143; GO:0040018; GO:0042383; GO:0042445; GO:0043568; GO:0043627; GO:0046010; GO:0048469; GO:0048609; GO:0051246; GO:0051384; GO:0060124; GO:0060133; GO:0071333	AKWTTPSR	14.46000004	1	1	0.025962565	945.8971001	0	0	0	0	0	0	17.77651	0	16.744	16.30673	0	16.314	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.13237	0	0	16.73776	0	0	0	0	0	0	0	21.78753	0	0	0	0	17.09928	0	0	0	0
Q02763	TIE2_HUMAN	"Angiopoietin-1 receptor, EC 2.7.10.1 (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2, hTIE2) (p140 TEK) (CD antigen CD202b)"	TEK TIE2 VMCM VMCM1	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001525; GO:0001934; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004712; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352	GDNVNISFK	5.519999981	1	1	0.195056427	993.385382	15.46298	15.1199	0	0	14.0556	14.50068	15.4095	11.20136	0	0	0	0	0	0	0	12.57204	0	0	0	0	0	16.91346	0	13.23238	0	0	0	0	0	0	0	0	0	15.65114	0	0	16.73522	0	0	15.8056	0	17.97216	0	0	14.81596	0	0	0
Q02779	M3K10_HUMAN	"Mitogen-activated protein kinase kinase kinase 10, EC 2.7.11.25 (Mixed lineage kinase 2) (Protein kinase MST)"	MAP3K10 MLK2 MST	Homo sapiens (Human)	"apoptotic process [GO:0006915]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein autophosphorylation [GO:0046777]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]"	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein autophosphorylation [GO:0046777]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]"	ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0004672; GO:0004674; GO:0004706; GO:0004712; GO:0005524; GO:0005737; GO:0006915; GO:0007165; GO:0007224; GO:0007254; GO:0018105; GO:0018107; GO:0042803; GO:0043065; GO:0043425; GO:0043433; GO:0043507; GO:0045892; GO:0046330; GO:0046777; GO:0106310	EEEEGAVAK	4.480000019	0.236107633	0.236107633	0.151623871	960.5888904	15.02588	0	12.79301	13.21378	0	13.48706	5.317218	0	14.66066	14.07791	0	16.89116	14.87061	0	0	0	14.50218	16.30989	0	11.75179	16.51366	11.22556	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.59433	0	0	0	0	0	0	0	0	0	0
Q02809	PLOD1_HUMAN	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1, EC 1.14.11.4 (Lysyl hydroxylase 1, LH1)"	PLOD1 LLH PLOD	Homo sapiens (Human)	epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]	catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]	catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]	GO:0001666; GO:0005506; GO:0005783; GO:0005789; GO:0008475; GO:0008544; GO:0017185; GO:0030867; GO:0031418; GO:0070062; GO:1902494	HTLGHLLSLDSYR	13.57999992	1	1	0.008693053	1510.954377	16.10531	0	0	0	0	15.0699	0	0	15.51841	0	0	0	0	15.02326	0	0	0	0	0	15.89824	0	0	0	0	13.73593	15.07259	0	0	17.34586	14.45857	15.30407	0	0	0	0	0	16.49508	0	0	0	0	0	12.13656	0	13.37682	0	0	15.10696
Q02817	MUC2_HUMAN	"Mucin-2, MUC-2 (Intestinal mucin-2)"	MUC2 SMUC	Homo sapiens (Human)	maintenance of gastrointestinal epithelium [GO:0030277]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; inner mucus layer [GO:0070702]; outer mucus layer [GO:0070703]; plasma membrane [GO:0005886]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; inner mucus layer [GO:0070702]; outer mucus layer [GO:0070703]; plasma membrane [GO:0005886]; maintenance of gastrointestinal epithelium [GO:0030277]		GO:0005615; GO:0005796; GO:0005886; GO:0030277; GO:0031012; GO:0062023; GO:0070702; GO:0070703	CVTADKCGCYVEDTHYPPGASVPTEETCK	5.400000095	1	1	3.20E-12	3332.309904	0	0	12.6226	0	0	0	0	15.09884	0	0	0	11.91927	0	0	12.74082	12.08036	0	0	12.88645	0	0	11.50371	0	0	0	0	0	13.46379	12.72317	0	13.59272	14.91611	10.73436	12.45822	0	0	0	0	0	0	12.3398	0	14.59352	0	13.30388	0	0	0
Q02833	RASF7_HUMAN	Ras association domain-containing protein 7 (HRAS1-related cluster protein 1)	RASSF7 C11orf13 HRC1	Homo sapiens (Human)	apoptotic process [GO:0006915]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction [GO:0007165]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction [GO:0007165]		GO:0005737; GO:0006915; GO:0007165; GO:0034451; GO:0070507	ALEAELQLAAEAPGPPSPMASATER	2.25	1	1	0.095288559	2503.000863	9.035954	12.56209	13.63477	13.25506	15.71458	12.41905	0	0	0	0	0	0	0	0	15.37697	14.00798	0	12.07009	0	0	15.40545	11.19294	0	0	0	0	10.74678	0	9.870693	0	0	14.44361	0	0	0	0	0	0	10.55028	11.79578	13.12403	15.11042	10.21133	0	0	0	0	9.87142
Q02846	GUC2D_HUMAN	"Retinal guanylyl cyclase 1, RETGC-1, EC 4.6.1.2 (CG-E) (Guanylate cyclase 2D, retinal) (Rod outer segment membrane guanylate cyclase, ROS-GC)"	GUCY2D CORD6 GUC1A4 GUC2D RETGC RETGC1	Homo sapiens (Human)	cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]	GO:0001653; GO:0001750; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005640; GO:0005789; GO:0005886; GO:0005887; GO:0006182; GO:0007165; GO:0007168; GO:0007601; GO:0019934; GO:0022400; GO:0038023; GO:0042622; GO:0042803; GO:0044877; GO:0097381	AAAGGR	3.819999933	0.050310113	0.050310113	0.295463473	501.6237666	17.41238	0	16.48067	16.59225	0	17.70796	16.41121	0	15.70979	17.5235	16.61772	17.02296	0	0	0	16.96598	17.92414	17.22528	17.83739	16.64606	17.16808	16.8947	0	17.20248	17.45155	0	0	16.6852	16.61677	15.63671	16.49014	17.64243	0	0	0	16.18333	0	16.86451	17.49775	17.54016	0	0	18.22954	17.25812	16.78583	0	17.70512	17.01839
Q02880	TOP2B_HUMAN	"DNA topoisomerase 2-beta, EC 5.6.2.2 (DNA topoisomerase II, beta isozyme)"	TOP2B	Homo sapiens (Human)	axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]"	"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]"	GO:0000712; GO:0000819; GO:0001764; GO:0003677; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006265; GO:0007409; GO:0008022; GO:0019899; GO:0030900; GO:0042826; GO:0045870; GO:0046872; GO:0046982; GO:1990904	ADASK	14.05000019	0.603010535	0.603010535	0.172068965	490.3151642	15.07102	15.61122	16.92739	15.70871	14.43002	15.00698	15.85794	15.45997	15.35375	14.82453	15.20726	15.97559	15.68522	14.2808	14.6117	15.63117	0	11.62394	14.04065	15.34279	15.26662	15.76886	13.00937	16.43596	14.95945	15.66235	15.00469	14.14818	15.92284	13.2037	0	15.06159	0	0	16.20871	0	0	0	16.21514	15.11727	0	0	14.78537	0	14.91495	0	0	0
Q02928	CP4AB_HUMAN	"Cytochrome P450 4A11, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (CYP4AII) (CYPIVA11) (Cytochrome P-450HK-omega) (Cytochrome P450HL-omega) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase, EC 1.14.14.80)"	CYP4A11 CYP4A2	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; leukotriene metabolic process [GO:0006691]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid metabolic process [GO:0001676]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; leukotriene metabolic process [GO:0006691]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid metabolic process [GO:0001676]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]	alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]	GO:0001676; GO:0001822; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006631; GO:0006691; GO:0008391; GO:0008392; GO:0016324; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0031408; GO:0032305; GO:0043231; GO:0043651; GO:0046456; GO:0048252; GO:0050051; GO:0055078; GO:0070330; GO:0097267; GO:0102033	SVSVLSPSR	1.799999952	1	1	0.292884289	931.1237649	0	0	16.97428	16.33536	0	0	0	0	0	0	0	0	0	0	0	0	16.79733	0	15.729	0	0	0	0	0	0	0	18.44647	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q02952	AKA12_HUMAN	"A-kinase anchor protein 12, AKAP-12 (A-kinase anchor protein 250 kDa, AKAP 250) (Gravin) (Myasthenia gravis autoantigen)"	AKAP12 AKAP250	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatic stellate cell activation [GO:0035733]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of vascular permeability [GO:0043116]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hepatic stellate cell migration [GO:0061870]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase binding [GO:0008179]; calmodulin binding [GO:0005516]; protein kinase A binding [GO:0051018]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatic stellate cell activation [GO:0035733]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of vascular permeability [GO:0043116]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hepatic stellate cell migration [GO:0061870]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]	adenylate cyclase binding [GO:0008179]; calmodulin binding [GO:0005516]; protein kinase A binding [GO:0051018]	GO:0005516; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007186; GO:0007193; GO:0008179; GO:0010738; GO:0010739; GO:0032496; GO:0032760; GO:0035733; GO:0043025; GO:0043116; GO:0050804; GO:0051018; GO:0051602; GO:0051770; GO:0061870; GO:0070374; GO:0071347; GO:0071356; GO:0090036; GO:0098685; GO:1900143	EDEVEASEK	6.070000172	0.739284098	0.739284098	0.297530743	1036.033093	11.65697	15.69108	12.51298	0	0	0	16.05739	0	0	0	0	0	14.97767	0	0	0	0	0	0	16.18017	14.88761	16.46214	15.13198	0	0	16.99485	16.24523	15.6249	16.39533	15.63126	0	0	16.17373	0	0	0	0	0	0	15.23385	14.65246	0	0	0	0	0	0	0
Q02978	M2OM_HUMAN	"Mitochondrial 2-oxoglutarate/malate carrier protein, OGCP (Solute carrier family 25 member 11)"	SLC25A11 SLC20A4	Homo sapiens (Human)	malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]	antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]	GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005887; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015367; GO:0015709; GO:0015729; GO:0035435; GO:0071422; GO:0071423	NVFNALIR	4.389999866	1	1	0.199236931	947.4865212	15.11559	16.57971	15.99181	15.43891	0	0	13.72816	0	16.96684	15.52105	15.73968	17.22737	0	0	0	15.26393	11.01451	15.95513	0	0	0	0	16.49788	0	15.6378	0	15.74972	0	15.63659	17.00058	16.38024	14.85256	15.47014	16.06363	16.63984	16.80834	0	0	0	16.7695	0	0	14.26828	15.24007	16.07599	14.14412	14.87028	14.92663
Q03001	DYST_HUMAN	"Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1, BPA, Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein)"	DST BP230 BP240 BPAG1 DMH DT KIAA0728	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]	actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]	GO:0000226; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008022; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031122; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115	AADPSSLQSHIPVLDKGR	4.139999866	0.213439569	0.213439569	0.067568491	1887.900686	0	0	15.6522	9.518503	0	12.91568	15.31872	13.91213	0	0	0	0	15.96839	0	0	0	16.54289	15.91535	15.17609	0	14.64643	0	0	0	16.89762	0	0	0	0	0	0	18.7168	18.07944	15.20086	16.99634	15.82535	15.76001	0	0	18.0365	16.09747	16.09881	15.69718	0	17.43006	0	15.99503	0
Q03052	PO3F1_HUMAN	"POU domain, class 3, transcription factor 1 (Octamer-binding protein 6, Oct-6) (Octamer-binding transcription factor 6, OTF-6) (POU domain transcription factor SCIP)"	POU3F1 OCT6 OTF6	Homo sapiens (Human)	"axon ensheathment [GO:0008366]; forebrain development [GO:0030900]; keratinocyte differentiation [GO:0030216]; myelination in peripheral nervous system [GO:0022011]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; axon ensheathment [GO:0008366]; forebrain development [GO:0030900]; keratinocyte differentiation [GO:0030216]; myelination in peripheral nervous system [GO:0022011]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0008366; GO:0010628; GO:0022011; GO:0030216; GO:0030900; GO:0043565; GO:0045893; GO:1990837	LHAGAAYR	4.710000038	0.287619531	0.287619531	0.143164212	858.8211124	0	13.52237	13.26275	15.16223	13.71855	17.22716	17.23692	14.51704	13.59941	16.00539	0	15.44017	16.10475	18.86727	16.17663	13.74963	15.20662	16.65518	11.85338	17.58854	0	0	15.03145	15.11529	16.69199	16.95533	15.58445	17.22012	17.89715	17.06253	0	16.49351	0	17.65418	15.78151	17.44985	18.02171	0	15.61486	16.01965	18.8508	10.65337	12.4187	11.28888	15.02917	17.56216	0	0
Q03111	ENL_HUMAN	Protein ENL (YEATS domain-containing protein 1)	MLLT1 ENL LTG19 YEATS1	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of protein kinase activity [GO:0006469]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; histone binding [GO:0042393]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of protein kinase activity [GO:0006469]; regulation of transcription by RNA polymerase II [GO:0006357]	histone binding [GO:0042393]	GO:0001650; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006469; GO:0008023; GO:0016573; GO:0032783; GO:0035267; GO:0042393	APPPK	4.570000172	0.301207364	0.301207364	0.285395781	509.7444274	18.94998	20.71637	20.53437	21.461	0	18.95425	0	0	18.12445	18.91116	0	19.20178	0	0	19.69235	20.5808	0	19.44791	0	18.25209	0	19.42549	18.52135	0	19.47433	0	0	0	17.93137	19.21775	20.20349	19.3515	18.02323	0	21.1527	20.58962	0	0	18.77363	16.70825	19.26954	20.85345	19.21426	19.36435	18.65321	17.508	0	19.83067
Q03164	KMT2A_HUMAN	"Histone-lysine N-methyltransferase 2A, Lysine N-methyltransferase 2A, EC 2.1.1.364 (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A, EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa, p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa, p180) ]"	KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1	Homo sapiens (Human)	"apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]"	histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	GO:0003680; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006915; GO:0008270; GO:0032411; GO:0032922; GO:0035097; GO:0035162; GO:0042800; GO:0042802; GO:0042803; GO:0043984; GO:0044648; GO:0045322; GO:0045893; GO:0045944; GO:0051568; GO:0051571; GO:0065003; GO:0070577; GO:0071339; GO:0071440; GO:0080182; GO:0097692; GO:0106363; GO:1905642; GO:2000615	EALSFPHLHLRGQR	3.470000029	1	1	7.00E-13	1662.085603	15.77327	0	0	0	13.19774	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84667	0	0	0	0	0	0	0	0	0	0	0
Q03167	TGBR3_HUMAN	"Transforming growth factor beta receptor type 3, TGF-beta receptor type 3, TGFR-3 (Betaglycan) (Transforming growth factor beta receptor III, TGF-beta receptor type III)"	TGFBR3	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]"	"activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta-activated receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]"	GO:0001666; GO:0001837; GO:0001889; GO:0003007; GO:0003150; GO:0003151; GO:0003223; GO:0005024; GO:0005114; GO:0005160; GO:0005539; GO:0005615; GO:0005737; GO:0005887; GO:0006955; GO:0007179; GO:0007181; GO:0008201; GO:0009897; GO:0009986; GO:0015026; GO:0016477; GO:0017015; GO:0017134; GO:0030165; GO:0030509; GO:0030511; GO:0030512; GO:0031012; GO:0031100; GO:0032354; GO:0034673; GO:0034695; GO:0034699; GO:0035556; GO:0043235; GO:0043393; GO:0046332; GO:0048185; GO:0050431; GO:0050680; GO:0051271; GO:0055010; GO:0060038; GO:0060045; GO:0060216; GO:0060317; GO:0060318; GO:0060347; GO:0060389; GO:0060412; GO:0060939; GO:0060979; GO:0061384; GO:0062009; GO:0070062; GO:0070123	ESERSMTMTK	9.979999542	1	1	6.87E-13	1232.141026	16.16304	16.32115	0	0	15.24817	14.43098	16.46722	15.96864	16.64334	0	0	15.61638	0	14.21896	0	0	0	0	0	0	15.14028	14.25049	0	15.35883	0	15.33176	0	15.1008	0	15.60707	0	0	12.99462	11.71279	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q03181	PPARD_HUMAN	"Peroxisome proliferator-activated receptor delta, PPAR-delta (NUCI) (Nuclear hormone receptor 1, NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta, PPAR-beta)"	PPARD NR1C2 PPARB	Homo sapiens (Human)	"adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol metabolic process [GO:0008203]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; glucose transmembrane transport [GO:1904659]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid biosynthetic process [GO:0008654]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteoglycan metabolic process [GO:0006029]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; vitamin A metabolic process [GO:0006776]; wound healing [GO:0042060]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol metabolic process [GO:0008203]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; glucose transmembrane transport [GO:1904659]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid biosynthetic process [GO:0008654]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteoglycan metabolic process [GO:0006029]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; vitamin A metabolic process [GO:0006776]; wound healing [GO:0042060]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid hormone receptor activity [GO:0003707]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006006; GO:0006029; GO:0006091; GO:0006357; GO:0006629; GO:0006631; GO:0006635; GO:0006776; GO:0006915; GO:0007507; GO:0007566; GO:0008203; GO:0008270; GO:0008283; GO:0008289; GO:0008366; GO:0008654; GO:0009062; GO:0009749; GO:0009755; GO:0010628; GO:0010887; GO:0014068; GO:0014823; GO:0014842; GO:0014912; GO:0015908; GO:0019216; GO:0030154; GO:0030308; GO:0031589; GO:0032966; GO:0033189; GO:0033993; GO:0035774; GO:0042060; GO:0042311; GO:0043066; GO:0043415; GO:0043616; GO:0045600; GO:0045662; GO:0045684; GO:0045892; GO:0045893; GO:0045923; GO:0045944; GO:0046321; GO:0046697; GO:0048662; GO:0050680; GO:0050728; GO:0051059; GO:0051546; GO:0060612; GO:0070539; GO:0071222; GO:0071456; GO:0097190; GO:0140297; GO:1902894; GO:1904659; GO:1990837; GO:2000288	ELTEFAK	9.569999695	0.642555594	0.642555594	0.280741699	837.4409063	0	0	0	16.60181	0	17.31115	16.69414	16.14992	18.51727	0	11.53109	0	17.50825	16.83841	15.83932	0	0	0	0	18.27529	0	0	17.12701	17.32499	14.70317	0	0	16.02235	0	16.57214	0	15.7043	0	18.7074	16.62862	0	0	15.23276	0	0	0	0	0	0	13.28962	0	0	0
Q03188	CENPC_HUMAN	"Centromere protein C, CENP-C (Centromere autoantigen C) (Centromere protein C 1, CENP-C 1) (Interphase centromere complex protein 7)"	CENPC CENPC1 ICEN7	Homo sapiens (Human)	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]; monopolar spindle attachment to meiosis I kinetochore [GO:0051455]	"condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]"	"condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]; monopolar spindle attachment to meiosis I kinetochore [GO:0051455]"	centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]	GO:0000278; GO:0000776; GO:0000779; GO:0003677; GO:0005654; GO:0005721; GO:0005829; GO:0007059; GO:0016604; GO:0019237; GO:0030496; GO:0042802; GO:0051301; GO:0051315; GO:0051382; GO:0051455	EKHHNILPK	2.480000019	1	1	0.177273142	1116.643419	15.71391	13.73194	0	0	0	0	0	0	13.37164	15.28098	15.06937	0	0	15.71002	15.74432	15.33711	0	0	0	14.78503	15.75663	0	0	14.8532	15.70476	13.35153	12.11466	0	14.74866	13.10181	14.70911	12.82214	0	14.89324	13.50513	14.87862	12.08346	16.23174	0	0	12.67158	13.96251	0	14.05659	0	15.39575	14.60737	10.78293
Q03252	LMNB2_HUMAN	Lamin-B2	LMNB2 LMN2	Homo sapiens (Human)		intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]	intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]	identical protein binding [GO:0042802]	GO:0005637; GO:0005882; GO:0031965; GO:0042802	AELDEVNK	5.130000114	1	1	0.225850023	920.1713747	0	11.33113	16.31811	15.32366	16.25981	14.41583	0	14.37747	0	0	14.79489	0	0	0	0	0	16.02984	14.96145	0	15.34562	16.63616	17.73723	0	0	15.26321	0	15.83087	15.45456	12.31862	12.99929	15.19135	15.27415	15.71504	15.24298	14.51527	13.84851	15.01247	16.14175	16.3136	14.68625	14.86526	14.86224	12.0053	15.76861	14.58531	15.14921	12.67507	16.89511
Q03468	ERCC6_HUMAN	"DNA excision repair protein ERCC-6, EC 3.6.4.- (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)"	ERCC6 CSB	Homo sapiens (Human)	"base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]"	B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]	"B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]"	GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006366; GO:0006979; GO:0007254; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032784; GO:0032786; GO:0034243; GO:0035066; GO:0035264; GO:0042262; GO:0044877; GO:0045494; GO:0045739; GO:0045943; GO:0045944; GO:0045945; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:0110016; GO:0140658; GO:1905168; GO:2001033	KSVGVHSVMK	6.159999847	0.717871368	0.717871368	0.222847738	1084.137889	0	0	0	0	14.69214	0	0	15.57886	12.78462	0	0	16.6162	0	0	0	0	0	0	0	16.33735	18.13993	0	0	0	0	17.28439	0	0	10.6477	13.55616	0	0	0	0	12.63353	0	0	0	0	0	15.90806	0	16.75187	12.90785	15.72201	14.02859	15.10584	11.68128
Q03519	TAP2_HUMAN	"Antigen peptide transporter 2, APT2, EC 7.4.2.- (ATP-binding cassette sub-family B member 3) (Peptide supply factor 2) (Peptide transporter PSF2, PSF-2) (Peptide transporter TAP2) (Peptide transporter involved in antigen processing 2) (Really interesting new gene 11 protein, RING11)"	TAP2 ABCB3 PSF2 RING11 Y1	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]; ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; metal ion binding [GO:0046872]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; tapasin binding [GO:0046980]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]"	ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; metal ion binding [GO:0046872]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; tapasin binding [GO:0046980]	GO:0002250; GO:0002489; GO:0005524; GO:0005783; GO:0005789; GO:0015031; GO:0015433; GO:0015440; GO:0015833; GO:0016020; GO:0016021; GO:0016607; GO:0019885; GO:0023029; GO:0030176; GO:0030670; GO:0033116; GO:0042605; GO:0042626; GO:0042824; GO:0042825; GO:0046872; GO:0046967; GO:0046968; GO:0046978; GO:0046980; GO:0055085	ALYLLVR	15.59000015	0.97877419	0.97877419	0.278104805	846.926361	15.69115	17.48926	0	0	14.66181	15.90647	14.68227	15.07469	0	0	14.69918	16.66827	0	0	15.86095	0	15.99782	15.09334	0	17.67828	18.44324	0	16.88659	0	0	0	16.22435	15.9039	0	15.36288	15.04418	0	14.55418	17.18059	16.70155	0	15.89409	0	15.72017	0	14.99425	16.08382	0	0	0	15.8676	0	0
Q03692	COAA1_HUMAN	Collagen alpha-1(X) chain	COL10A1	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]	collagen trimer [GO:0005581]; collagen type X trimer [GO:0005599]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; collagen type X trimer [GO:0005599]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]	GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005599; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023	GFPGEMGPIGPPGPQGPPGER	8.5	0.805894017	0.805894017	0.212085449	2047.147769	0	0	0	0	0	14.76029	15.30039	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.00874	0	0	0	0	0	0	0	0	0	0	0	0	13.81195	0	0	0
Q03701	CEBPZ_HUMAN	"CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor, CBF, CCAAT-binding factor)"	CEBPZ CBF2	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]	CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]	CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]	RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0003723; GO:0005634; GO:0016602; GO:0045944	DDMDFAGNVK	1.799999952	0.159218714	0.159218714	0.104248203	1128.021746	0	16.85178	0	12.2894	0	0	0	17.56799	0	16.21181	0	0	15.12279	0	0	17.07751	15.92299	0	0	14.81927	17.67675	0	14.94013	12.287	0	14.06229	15.04911	0	0	16.61705	0	0	0	15.60795	0	0	14.82243	0	15.47012	0	0	12.46187	0	0	0	0	0	0
Q03924	ZN117_HUMAN	"Zinc finger protein 117 (Provirus-linked krueppel, h-PLK) (Zinc finger protein HPF9)"	ZNF117	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270	SSTLIGHK	16.30999947	1	1	0.485692413	842.332358	0	17.84724	15.64727	0	0	17.29417	0	0	16.90929	0	0	17.85095	0	16.48472	17.90616	18.55222	0	0	0	0	0	0	0	18.13561	0	0	18.42548	0	0	0	0	0	0	0	18.454	17.78728	0	0	18.32381	17.10925	0	0	18.84333	0	0	18.35389	0	0
Q03933	HSF2_HUMAN	"Heat shock factor protein 2, HSF 2 (Heat shock transcription factor 2, HSTF 2)"	HSF2 HSTF2	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001162; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007283; GO:0042802; GO:0045944; GO:1990837	KQSSNVPAFLSK	7.179999828	1	1	0.19127027	1306.016163	14.81279	0	0	0	0	0	0	0	15.36817	0	0	16.36585	0	0	0	0	15.33769	14.03465	13.98673	0	0	14.00018	0	0	0	14.1764	0	0	0	0	0	0	16.24499	0	11.65396	0	0	0	0	16.67949	0	0	0	0	0	0	0	0
Q03938	ZNF90_HUMAN	Zinc finger protein 90 (Zinc finger protein HTF9)	ZNF90	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270	IIHSGEKPYK	13.64000034	0.541611254	0.541611254	0.247352036	1172.054749	0	14.4332	0	15.37173	0	0	0	13.95898	13.08919	0	11.54657	0	0	15.10349	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.92717	15.61091	0	16.19632	14.699	0	0	0	0	0	16.07275	0	0	0	0	0	0	0	15.18665
Q03989	ARI5A_HUMAN	"AT-rich interactive domain-containing protein 5A, ARID domain-containing protein 5A (Modulator recognition factor 1, MRF-1)"	ARID5A MRF1	Homo sapiens (Human)	"cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondrocyte differentiation [GO:0002062]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; retinoid X receptor binding [GO:0046965]; RNA stem-loop binding [GO:0035613]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondrocyte differentiation [GO:0002062]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]"	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; retinoid X receptor binding [GO:0046965]; RNA stem-loop binding [GO:0035613]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000976; GO:0002062; GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0008134; GO:0030331; GO:0032729; GO:0032740; GO:0032755; GO:0032760; GO:0035066; GO:0035613; GO:0042802; GO:0043565; GO:0045087; GO:0045892; GO:0045944; GO:0046965; GO:0046966; GO:0050681; GO:0071222; GO:0071391; GO:2000318; GO:2000556	AVSPFLK	12.81999969	1	1	0.2292807	760.5619576	0	0	18.34053	0	0	0	18.17455	0	17.81138	0	0	0	0	0	0	17.71487	0	0	0	0	0	17.26205	0	0	0	16.50491	0	0	0	0	0	0	0	17.92179	0	0	0	0	18.99911	0	18.6143	0	18.11431	0	0	0	0	0
Q04609	FOLH1_HUMAN	"Glutamate carboxypeptidase 2, EC 3.4.17.21 (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase, FGCP) (Glutamate carboxypeptidase II, GCPII) (Membrane glutamate carboxypeptidase, mGCP) (N-acetylated-alpha-linked acidic dipeptidase I, NAALADase I) (Prostate-specific membrane antigen, PSM, PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)"	FOLH1 FOLH NAALAD1 PSM PSMA GIG27	Homo sapiens (Human)	C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493]; C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508]	Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493]	GO:0004180; GO:0004181; GO:0005737; GO:0005886; GO:0005887; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0035609; GO:0046872; GO:0070062; GO:1904492; GO:1904493	YADKIYSISMK	12.23999977	1	1	0.574806528	1318.317955	19.18199	18.04092	0	19.6985	0	19.10013	0	0	0	0	19.71306	0	19.97913	0	20.04136	17.1316	0	0	19.29363	0	16.3879	0	0	0	18.94794	0	0	18.18468	0	0	19.90743	18.58104	0	0	0	20.0119	0	0	0	0	0	19.35147	0	0	17.1586	0	20.05415	0
Q04637	IF4G1_HUMAN	"Eukaryotic translation initiation factor 4 gamma 1, eIF-4-gamma 1, eIF-4G 1, eIF-4G1 (p220)"	EIF4G1 EIF4F EIF4G EIF4GI	Homo sapiens (Human)	behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; developmental process [GO:0032502]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of gene silencing by miRNA [GO:0060964]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; developmental process [GO:0032502]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of gene silencing by miRNA [GO:0060964]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413]"	"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]"	GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0010801; GO:0010942; GO:0016020; GO:0016281; GO:0030307; GO:0031369; GO:0031669; GO:0032270; GO:0032502; GO:0033138; GO:0034645; GO:0036493; GO:0042802; GO:0045666; GO:0060090; GO:0060964; GO:0080135; GO:0097009; GO:1900087; GO:1901215; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696	AASLLLEILGLLCKSMGPK	6.800000191	1	1	1.83E-12	2027.412048	0	0	0	0	0	14.94584	0	0	0	0	0	0	0	0	0	15.5596	0	0	0	0	0	0	0	0	0	0	0	14.25115	0	0	0	0	14.89507	10.49996	12.03615	0	0	12.66068	0	13.34718	14.29486	16.2498	0	14.49105	0	0	0	0
Q04656	ATP7A_HUMAN	"Copper-transporting ATPase 1, EC 7.2.2.8 (Copper pump 1) (Menkes disease-associated protein)"	ATP7A MC1 MNK	Homo sapiens (Human)	blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of response to wounding [GO:1903036]; positive regulation of tyrosinase activity [GO:0032773]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; small GTPase binding [GO:0031267]; superoxide dismutase copper chaperone activity [GO:0016532]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of response to wounding [GO:1903036]; positive regulation of tyrosinase activity [GO:0032773]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; small GTPase binding [GO:0031267]; superoxide dismutase copper chaperone activity [GO:0016532]	GO:0001568; GO:0001701; GO:0001889; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007565; GO:0007595; GO:0007626; GO:0010041; GO:0010042; GO:0010043; GO:0010273; GO:0010468; GO:0010592; GO:0014069; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0016887; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0030424; GO:0030425; GO:0030670; GO:0031069; GO:0031252; GO:0031267; GO:0031526; GO:0031901; GO:0032588; GO:0032767; GO:0032773; GO:0033162; GO:0034760; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043204; GO:0043473; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0048023; GO:0048251; GO:0048286; GO:0048471; GO:0048812; GO:0050679; GO:0051087; GO:0051216; GO:0051542; GO:0055070; GO:0060003; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:0140581; GO:1903036; GO:1903136; GO:1904754; GO:1904959	SPSYTNDSTATFIIDGMHCK	1.779999971	1	1	1.38E-12	2245.683366	12.90988	12.61414	12.53804	14.1025	13.41551	13.40416	13.3196	8.795127	10.87823	12.40369	8.625686	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q04671	P_HUMAN	P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog)	OCA2 D15S12 P	Homo sapiens (Human)	cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; L-tyrosine transmembrane transporter activity [GO:0005302]; transporter activity [GO:0005215]; cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286]	L-tyrosine transmembrane transporter activity [GO:0005302]; transporter activity [GO:0005215]	GO:0005215; GO:0005302; GO:0005737; GO:0005765; GO:0005789; GO:0006726; GO:0007286; GO:0008283; GO:0010008; GO:0016021; GO:0030318; GO:0033162; GO:0042438	QISQEDK	19.85000038	1	1	0.167775219	847.5543616	0	14.50044	17.18675	16.44411	19.70057	14.52628	17.61931	17.03557	17.90154	18.5263	18.74257	19.09187	18.15864	18.69015	18.58202	16.62221	17.63364	16.29442	15.44681	18.42594	0	17.6217	18.54571	17.94998	18.70675	0	17.76982	0	18.19909	18.6568	19.30513	19.46638	19.6212	18.36942	14.41682	0	17.77418	15.58443	19.02732	16.32124	15.63223	17.12438	17.38589	17.94196	14.91984	17.03899	19.44298	17.63086
Q04695	K1C17_HUMAN	"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17, CK-17) (Keratin-17, K17)"	KRT17	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; positive regulation of cell growth [GO:0030307]; positive regulation of hair follicle development [GO:0051798]; positive regulation of translation [GO:0045727]	cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]	cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; positive regulation of cell growth [GO:0030307]; positive regulation of hair follicle development [GO:0051798]; positive regulation of translation [GO:0045727]	structural molecule activity [GO:0005198]	GO:0001533; GO:0005198; GO:0005829; GO:0005856; GO:0030307; GO:0030855; GO:0031069; GO:0031424; GO:0045095; GO:0045109; GO:0045111; GO:0045727; GO:0051798	DYSQYYR	10.81000042	0.378516406	0.378516406	0.246704747	994.4718428	18.36171	18.66052	20.02773	18.11696	16.41002	18.80966	20.31351	14.66908	18.51357	0	0	17.44554	0	16.47324	0	0	17.27269	17.06725	17.46999	17.49064	17.36218	0	17.63867	0	19.23986	18.68604	17.85008	15.61945	0	0	19.68283	19.53874	19.34937	17.96828	0	17.7989	0	0	0	17.88036	18.44006	16.5191	17.72623	18.28738	17.83114	17.3103	17.9376	0
Q04721	NOTC2_HUMAN	"Neurogenic locus notch homolog protein 2, Notch 2, hN2 [Cleaved into: Notch 2 extracellular truncation, N2ECD; Notch 2 intracellular domain, N2ICD ]"	NOTCH2	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060]	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060]	calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204	GEQCVHTASGPR	11.56000042	1	1	0.001751911	1299.626878	10.26213	14.17862	13.58464	12.24557	14.81694	13.19458	12.77438	12.26464	14.22429	13.46894	0	15.4056	0	0	0	13.60545	15.40598	0	15.16947	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.61195	0	15.73328	0	0	0	0	0	15.67469
Q04726	TLE3_HUMAN	"Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3, ESG3)"	TLE3 KIAA1547	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cold-induced thermogenesis [GO:0120163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cold-induced thermogenesis [GO:0120163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0007165; GO:0009887; GO:0016055; GO:0090090; GO:0120163; GO:1990907	GSADYSMEAK	6.710000038	1	1	0.191303502	1074.47062	12.36206	10.6897	0	16.74081	0	13.72808	0	0	0	0	0	0	0	0	0	13.99009	14.75665	12.63162	15.07974	0	0	0	13.85422	0	16.0222	0	0	16.5569	0	13.3248	0	14.80788	13.30308	13.10872	13.32222	0	0	0	14.21763	0	0	16.18384	0	0	16.00648	0	15.99723	0
Q04727	TLE4_HUMAN	Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4)	TLE4 GRG4 KIAA1261	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055]	beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055]	chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907	EIAARYDSDGEK	3.470000029	1	1	0.18143993	1353.683413	0	0	15.0549	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.72426	0	0	0	0	0	0	0	0	0	0
Q04759	KPCT_HUMAN	"Protein kinase C theta type, EC 2.7.11.13 (nPKC-theta)"	PRKCQ PRKCT	Homo sapiens (Human)	"axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]"	aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	"aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; axon guidance [GO:0007411]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]"	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001558; GO:0001772; GO:0002376; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006468; GO:0006509; GO:0006954; GO:0007411; GO:0016235; GO:0018105; GO:0032212; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0038095; GO:0042102; GO:0046627; GO:0046872; GO:0050870; GO:0051092; GO:0051973; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:1904355; GO:2000318; GO:2000570	GSFGK	2.380000114	1	1	0.083311329	493.2466279	13.70205	0	0	0	15.42267	14.14237	14.5273	0	0	15.56489	16.3303	13.44683	0	15.27721	15.86901	0	0	15.3509	17.11911	0	0	16.57802	0	0	14.14196	0	15.70071	16.06959	14.25002	0	0	0	0	0	14.71884	0	0	0	0	14.29964	14.8435	16.4818	0	0	16.41409	0	0	0
Q04760	LGUL_HUMAN	"Lactoylglutathione lyase, EC 4.4.1.5 (Aldoketomutase) (Glyoxalase I, Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)"	GLO1	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357]	lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]	GO:0004462; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066; GO:0070062	CDFPIMK	13.81999969	1	1	0.147620467	927.18281	15.80873	16.47677	14.77676	15.48279	0	15.79216	16.64714	15.73019	0	14.52877	0	16.68336	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q04912	RON_HUMAN	"Macrophage-stimulating protein receptor, MSP receptor, EC 2.7.10.1 (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain ]"	MST1R PTK8 RON	Homo sapiens (Human)	cell migration [GO:0016477]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773]	basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001725; GO:0004712; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0005887; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009925; GO:0009986; GO:0016477; GO:0019899; GO:0033674; GO:0043235; GO:0043406; GO:0045087; GO:0051897	DVLIPHER	3.819999933	1	1	0.280529304	979.7549869	0	0	16.44749	0	0	0	17.52408	0	0	18.72255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.90343	0	0	0	0	0	0	0	0	17.78404	0	0	0	0	17.9067	0	0	0
Q04917	1433F_HUMAN	14-3-3 protein eta (Protein AS1)	YWHAH YWHA1	Homo sapiens (Human)	"cellular protein localization [GO:0034613]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; cellular protein localization [GO:0034613]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]"	actin binding [GO:0003779]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]	GO:0002028; GO:0003779; GO:0005159; GO:0005737; GO:0005829; GO:0005886; GO:0006713; GO:0006886; GO:0007165; GO:0014704; GO:0017080; GO:0019899; GO:0019904; GO:0021762; GO:0034613; GO:0035259; GO:0042802; GO:0042921; GO:0044325; GO:0045664; GO:0045893; GO:0046982; GO:0048167; GO:0050774; GO:0070062; GO:0086010; GO:2000649	KNSVVEASEAAYK	1.049999952	1	1	2.43E-13	1395.272111	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q05048	CSTF1_HUMAN	"Cleavage stimulation factor subunit 1 (CF-1 50 kDa subunit) (Cleavage stimulation factor 50 kDa subunit, CSTF 50 kDa subunit, CstF-50)"	CSTF1	Homo sapiens (Human)	mRNA 3'-end processing [GO:0031124]	mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654]	mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005848; GO:0031124	MLAKSAMPIEVMMNETAQQNMENHPVIR	4.840000153	0.379318088	0.379318088	0.084113315	3230.105446	12.41745	15.31683	13.17435	0	0	11.80941	10.95914	14.82864	0	0	13.15046	13.91754	0	0	10.46096	12.91773	0	0	0	0	12.61336	0	0	0	15.47025	0	0	0	15.38226	0	0	0	0	0	11.92119	0	0	0	0	14.89558	14.98201	0	10.5888	0	0	0	0	12.69776
Q05086	UBE3A_HUMAN	"Ubiquitin-protein ligase E3A, EC 2.3.2.26 (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)"	UBE3A E6AP EPVE6AP HPVE6A	Homo sapiens (Human)	androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]	metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0014068; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:1905528; GO:1990416; GO:2000058	VYEILELCR	6.179999828	1	1	0.240927548	1193.96428	15.88875	15.11411	0	14.39827	0	13.61565	0	0	15.15912	0	0	0	0	15.79759	0	0	14.38619	15.74612	0	14.64091	0	0	0	15.78422	0	13.96823	0	15.55773	0	0	13.05478	0	0	16.32067	12.43784	12.99252	0	0	0	0	0	0	0	0	0	0	15.31188	0
Q05193	DYN1_HUMAN	"Dynamin-1, EC 3.6.5.5"	DNM1 DNM	Homo sapiens (Human)	endocytosis [GO:0006897]; endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; toxin transport [GO:1901998]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; toxin transport [GO:1901998]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0001917; GO:0003723; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0006898; GO:0007032; GO:0008017; GO:0016020; GO:0016185; GO:0019901; GO:0030117; GO:0031623; GO:0042802; GO:0045202; GO:0048488; GO:0050804; GO:0070062; GO:0098684; GO:0098835; GO:0098978; GO:1901998	GWLTINNIGIMKGGSK	4.710000038	1	1	0.056980688	1687.994215	0	0	15.71024	0	0	0	0	0	0	0	0	0	16.48044	0	0	0	0	0	0	0	0	0	0	0	0	16.65958	0	0	0	17.80714	0	0	0	17.85376	18.32991	0	19.86804	0	0	0	0	0	0	17.49983	0	0	0	0
Q05195	MAD1_HUMAN	"Max dimerization protein 1, Max dimerizer 1 (Protein MAD)"	MXD1 MAD	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytosol [GO:0005829]; Mad-Max complex [GO:0070443]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; cytosol [GO:0005829]; Mad-Max complex [GO:0070443]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0046983; GO:0070443	GLVPLGPESSRHTTLSLLTK	1.799999952	1	1	2.29E-12	2105.600832	0	12.40606	15.62844	14.66982	0	0	18.4418	10.75061	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.43398	0	12.75047	14.44192	0	15.09149	0	0	0	0	0	0	0	0	0	16.23856	0	0	15.73469	0	0	14.80528	0	0	0	0
Q05209	PTN12_HUMAN	"Tyrosine-protein phosphatase non-receptor type 12, EC 3.1.3.48 (PTP-PEST) (Protein-tyrosine phosphatase G1, PTPG1)"	PTPN12	Homo sapiens (Human)	cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246]	non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]	GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006470; GO:0017124; GO:0035335; GO:0042058; GO:0042246; GO:0042995; GO:0071364; GO:1901185; GO:2000587	HNIAGTTHSGAEKDVDVSEDSPPPLPER	7.690000057	1	1	9.16E-13	2956.574036	0	10.81372	10.90728	12.66895	0	0	10.33197	13.40667	11.06053	14.92112	14.17314	15.59308	0	0	16.22349	0	0	0	12.476	14.03628	0	12.61724	13.0999	13.50834	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q05329	DCE2_HUMAN	"Glutamate decarboxylase 2, EC 4.1.1.15 (65 kDa glutamic acid decarboxylase, GAD-65) (Glutamate decarboxylase 65 kDa isoform)"	GAD2 GAD65	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to xenobiotic stimulus [GO:0009410]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein-containing complex binding [GO:0044877]; pyridoxal phosphate binding [GO:0030170]; chemical synaptic transmission [GO:0007268]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to xenobiotic stimulus [GO:0009410]	glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein-containing complex binding [GO:0044877]; pyridoxal phosphate binding [GO:0030170]	GO:0000139; GO:0004351; GO:0005829; GO:0005886; GO:0006540; GO:0007268; GO:0009410; GO:0016595; GO:0030170; GO:0030424; GO:0030672; GO:0031225; GO:0042136; GO:0042734; GO:0044877; GO:0048471; GO:0060077; GO:0061202	IWMHVDAAWGGGLLMSR	3.539999962	1	1	0.410348679	1931.589258	0	0	0	0	16.31427	15.6076	0	15.35702	0	0	15.42169	16.45482	0	0	0	0	0	0	16.00669	0	0	0	0	15.59199	0	0	0	0	0	0	13.9682	0	15.80608	14.81755	0	0	11.75232	0	0	0	0	16.18499	0	12.65622	0	16.04381	0	0
Q05397	FAK1_HUMAN	"Focal adhesion kinase 1, FADK 1, EC 2.7.10.2 (Focal adhesion kinase-related nonkinase, FRNK) (Protein phosphatase 1 regulatory subunit 71, PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)"	PTK2 FAK FAK1	Homo sapiens (Human)	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0001725; GO:0001890; GO:0001932; GO:0001934; GO:0003007; GO:0003779; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0006468; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007411; GO:0008284; GO:0008360; GO:0008432; GO:0010594; GO:0010632; GO:0010759; GO:0010763; GO:0014068; GO:0016477; GO:0018108; GO:0019901; GO:0019903; GO:0022408; GO:0030010; GO:0030154; GO:0030155; GO:0030335; GO:0031234; GO:0033628; GO:0035995; GO:0036064; GO:0038007; GO:0038096; GO:0042127; GO:0042169; GO:0043066; GO:0043087; GO:0043197; GO:0043231; GO:0043552; GO:0045087; GO:0045667; GO:0045860; GO:0046777; GO:0048010; GO:0048013; GO:0048870; GO:0051493; GO:0051893; GO:0051897; GO:0060396; GO:0090303; GO:0120041; GO:1900024; GO:2000060; GO:2000811	SFLQVR	7.380000114	1	1	0.124288571	748.9612073	0	15.12623	15.53593	0	0	0	13.92612	0	0	0	14.97912	13.33182	0	0	0	0	0	15.77051	0	0	15.52804	0	0	0	0	0	0	13.4084	0	0	0	0	0	0	13.20791	0	0	0	17.6487	0	0	14.87325	14.47553	15.25949	15.57907	15.33097	12.89076	16.27158
Q05586	NMDZ1_HUMAN	"Glutamate receptor ionotropic, NMDA 1, GluN1 (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1, NMD-R1)"	GRIN1 NMDAR1	Homo sapiens (Human)	"brain development [GO:0007420]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; propylene metabolic process [GO:0018964]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of membrane potential [GO:0042391]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; response to glycine [GO:1905429]; visual learning [GO:0008542]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; brain development [GO:0007420]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; propylene metabolic process [GO:0018964]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of membrane potential [GO:0042391]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; response to glycine [GO:1905429]; visual learning [GO:0008542]"	amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]	GO:0001540; GO:0004972; GO:0005509; GO:0005516; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0006812; GO:0007268; GO:0007420; GO:0008021; GO:0008542; GO:0009986; GO:0010524; GO:0014069; GO:0015276; GO:0016594; GO:0016595; GO:0017146; GO:0018964; GO:0022849; GO:0030425; GO:0035235; GO:0038023; GO:0042165; GO:0042391; GO:0043005; GO:0043083; GO:0043195; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0045471; GO:0045944; GO:0048167; GO:0048168; GO:0051290; GO:0051968; GO:0055074; GO:0060076; GO:0060079; GO:0097060; GO:0097553; GO:0098655; GO:0098976; GO:1903428; GO:1904062; GO:1905429; GO:2000463; GO:2001056	GCVGNTNIWKTGPLFK	4.889999866	0.360014647	0.360014647	0.032567008	1790.917731	12.68994	0	15.42365	18.1229	13.16008	12.18642	15.98278	14.85089	14.37593	0	0	0	11.5729	12.71783	0	13.42283	16.00377	10.69816	15.29398	12.51569	13.17895	13.77329	0	16.4556	13.29077	13.8899	17.44064	14.27738	14.41034	0	18.50213	16.89721	17.78297	0	0	14.22166	0	17.42329	9.700487	0	13.06431	12.70297	14.42798	14.23382	0	16.71707	0	17.06571
Q05639	EF1A2_HUMAN	"Elongation factor 1-alpha 2, EF-1-alpha-2 (Eukaryotic elongation factor 1 A-2, eEF1A-2) (Statin-S1)"	EEF1A2 EEF1AL STN	Homo sapiens (Human)	positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid kinase activity [GO:0090218]; regulation of chaperone-mediated autophagy [GO:1904714]; translation [GO:0006412]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; eukaryotic translation elongation factor 1 complex [GO:0005853]; synapse [GO:0045202]	"cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; eukaryotic translation elongation factor 1 complex [GO:0005853]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid kinase activity [GO:0090218]; regulation of chaperone-mediated autophagy [GO:1904714]; translation [GO:0006412]; translational elongation [GO:0006414]"	"GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]"	GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005853; GO:0006412; GO:0006414; GO:0008135; GO:0019901; GO:0043065; GO:0045202; GO:0090218; GO:0098574; GO:1904714	EVSAYIKK	4.260000229	1	1	0.126525855	939.4396731	0	14.71753	11.99394	16.06714	12.15245	8.527781	13.00568	0	14.71493	14.86741	12.89129	0	13.27683	10.3602	13.58274	14.48363	8.172278	15.21112	15.56989	13.49417	15.10034	9.938073	13.03195	16.32427	14.99941	14.60996	14.99382	0	15.00979	15.09342	16.58087	14.1556	0	0	0	0	16.08526	0	0	16.08585	0	14.22372	0	15.07827	15.66183	0	0	0
Q05655	KPCD_HUMAN	"Protein kinase C delta type, EC 2.7.11.13 (Tyrosine-protein kinase PRKCD, EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1, SDK1) ]"	PRKCD PKCD	Homo sapiens (Human)	activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004712; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0007049; GO:0007165; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0016572; GO:0018105; GO:0018107; GO:0019899; GO:0019900; GO:0019901; GO:0023021; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035307; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235	AAEEPVSEVTVGVSVLAER	7.690000057	1	1	0.31560312	1941.243241	0	13.9431	0	0	0	0	0	0	0	0	14.36534	0	0	0	16.49481	0	14.3087	15.14507	0	0	0	0	0	15.59041	0	12.21632	0	13.86204	13.60661	15.42747	0	0	15.12915	0	12.23401	16.0379	14.87517	14.02566	16.89806	13.68667	0	14.39203	15.57871	0	0	15.61556	13.28993	0
Q05682	CALD1_HUMAN	"Caldesmon, CDM"	CALD1 CAD CDM	Homo sapiens (Human)	actin filament bundle assembly [GO:0051017]; angiogenesis [GO:0001525]; muscle contraction [GO:0006936]	actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myofibril [GO:0030016]; plasma membrane [GO:0005886]	actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; tropomyosin binding [GO:0005523]; actin filament bundle assembly [GO:0051017]; angiogenesis [GO:0001525]; muscle contraction [GO:0006936]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; tropomyosin binding [GO:0005523]	GO:0001525; GO:0003779; GO:0005516; GO:0005523; GO:0005829; GO:0005856; GO:0005886; GO:0006936; GO:0015629; GO:0017022; GO:0030016; GO:0030478; GO:0045296; GO:0051017	AAAQERER	14.31000042	1	1	0.283490466	930.1439988	13.96179	15.20933	0	14.43218	15.88237	0	11.6737	14.31488	15.47853	15.48544	15.30484	15.81401	15.17783	14.08177	0	16.18767	0	16.74404	0	15.03479	14.39134	17.55719	16.46488	17.06207	0	16.20416	14.99809	14.88482	15.33723	0	15.3194	15.93272	0	0	0	0	0	0	17.02889	0	0	14.98801	0	0	15.49885	17.43368	0	0
Q05707	COEA1_HUMAN	Collagen alpha-1(XIV) chain (Undulin)	COL14A1 UND	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]	collagen trimer [GO:0005581]; collagen type XIV trimer [GO:0005596]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]	collagen trimer [GO:0005581]; collagen type XIV trimer [GO:0005596]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; cell-cell adhesion [GO:0098609]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]	collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]	GO:0003723; GO:0005201; GO:0005518; GO:0005576; GO:0005581; GO:0005596; GO:0005614; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0062023; GO:0098609	GPDGPR	4.309999943	0.29339841	0.29339841	0.237980357	600.7298512	15.94463	15.83819	0	16.34246	11.86503	12.05777	0	15.54747	12.9052	0	0	0	13.70601	0	14.36544	15.88239	0	16.41451	15.81122	0	15.25591	15.36771	15.68689	0	15.15218	15.21821	15.54946	15.4461	0	14.48205	16.25109	0	15.7139	15.51542	17.13556	17.12004	15.71454	16.23268	15.53177	14.09153	15.31112	10.03243	0	15.25906	15.03747	17.28331	16.01311	0
Q05823	RN5A_HUMAN	"2-5A-dependent ribonuclease, 2-5A-dependent RNase, EC 3.1.26.- (Ribonuclease 4) (Ribonuclease L, RNase L)"	RNASEL RNS4	Homo sapiens (Human)	defense response to virus [GO:0051607]; fat cell differentiation [GO:0045444]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; defense response to virus [GO:0051607]; fat cell differentiation [GO:0045444]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0003723; GO:0004521; GO:0004540; GO:0004672; GO:0005524; GO:0005759; GO:0005829; GO:0006364; GO:0006396; GO:0006397; GO:0006468; GO:0016363; GO:0019843; GO:0042802; GO:0043021; GO:0043488; GO:0045071; GO:0045444; GO:0045944; GO:0046326; GO:0046872; GO:0051607	NVGNESDIK	7.829999924	1	1	0.230643363	974.8553932	16.20166	0	0	12.73196	15.04183	14.16914	15.56241	12.51922	15.35509	0	14.51973	0	13.24507	0	13.92821	0	0	0	0	0	0	15.80445	0	0	15.52234	0	0	14.43001	14.47445	10.17717	15.8446	16.29808	15.05945	0	14.12833	0	0	0	0	15.51836	0	0	0	0	0	0	0	0
Q05923	DUS2_HUMAN	"Dual specificity protein phosphatase 2, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PAC-1)"	DUSP2 PAC1	Homo sapiens (Human)	endoderm formation [GO:0001706]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; endoderm formation [GO:0001706]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]	GO:0001706; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0008330; GO:0017017; GO:0031965; GO:0043409; GO:0051019	LVRGELAR	9.289999962	0.644912004	0.644912004	0.238690783	913.6354201	0	0	13.81806	18.97731	0	0	0	15.80897	9.578279	0	0	0	15.79577	0	15.24232	14.29027	16.40927	16.80405	18.24875	15.60238	16.18219	0	0	0	0	16.17127	0	0	17.22955	15.08933	18.07078	15.83362	0	0	15.9365	0	0	16.42116	0	15.88519	0	15.44554	0	16.60233	15.12597	0	16.7401	0
Q05925	HME1_HUMAN	"Homeobox protein engrailed-1, Homeobox protein en-1, Hu-En-1"	EN1	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cerebellum development [GO:0021549]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; drinking behavior [GO:0042756]; embryonic brain development [GO:1990403]; embryonic forelimb morphogenesis [GO:0035115]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; motor learning [GO:0061743]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; skeletal system development [GO:0001501]; social behavior [GO:0035176]	chromatin [GO:0000785]; membrane [GO:0016020]; nucleus [GO:0005634]	"chromatin [GO:0000785]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cerebellum development [GO:0021549]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; drinking behavior [GO:0042756]; embryonic brain development [GO:1990403]; embryonic forelimb morphogenesis [GO:0035115]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; motor learning [GO:0061743]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; skeletal system development [GO:0001501]; social behavior [GO:0035176]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0005634; GO:0006357; GO:0008344; GO:0009653; GO:0009953; GO:0009954; GO:0016020; GO:0021549; GO:0030182; GO:0030901; GO:0030917; GO:0035115; GO:0035176; GO:0035264; GO:0042220; GO:0042756; GO:0043473; GO:0043524; GO:0045944; GO:0048666; GO:0061743; GO:0071542; GO:1990403; GO:1990837	YSDRPSSGPR	5.599999905	1	1	0.122069001	1120.862178	11.90442	13.93509	12.78764	12.90038	14.80566	13.77365	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.8019	0	0	0	0	0	0	0	0	0	15.49901	0	0	0	0	0	0	0	0	0	0	0	0
Q05996	ZP2_HUMAN	"Zona pellucida sperm-binding protein 2 (Zona pellucida glycoprotein 2, Zp-2) (Zona pellucida protein A) [Cleaved into: Processed zona pellucida sperm-binding protein 2 ]"	ZP2 ZPA	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468]	collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]	collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; acrosin binding [GO:0032190]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804]; binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468]	acrosin binding [GO:0032190]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804]	GO:0005576; GO:0005771; GO:0005783; GO:0005886; GO:0007339; GO:0015026; GO:0016021; GO:0032190; GO:0035804; GO:0035805; GO:0042802; GO:0060468; GO:0062023	NDMLLNINVESLTPPVASVK	9.760000229	0.018162979	0.018162979	1.83E-12	2170.780238	0	0	0	0	14.43462	13.75095	0	0	14.70043	14.31574	0	0	0	0	0	0	0	0	0	14.58068	0	14.13292	0	16.52555	15.82073	0	0	0	0	0	0	15.17473	0	0	0	0	0	0	9.188151	0	0	0	0	0	0	0	0	0
Q05BQ5	MBTD1_HUMAN	MBT domain-containing protein 1	MBTD1	Homo sapiens (Human)	"chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; embryonic skeletal system development [GO:0048706]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]"	NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; nucleus [GO:0005634]	"NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; embryonic skeletal system development [GO:0048706]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0000724; GO:0000786; GO:0003682; GO:0005634; GO:0006325; GO:0008270; GO:0016573; GO:0035064; GO:0035267; GO:0042393; GO:0042981; GO:0043967; GO:0043968; GO:0045892; GO:0045893; GO:0048706; GO:0051726; GO:1905168; GO:2000779	ENQSASSK	6.230000019	0.369322836	0.369322836	0.286036761	850.5941957	19.22931	0	16.92939	17.71533	17.62151	16.54242	18.97611	0	20.95825	16.75961	0	0	17.25208	16.39305	0	17.81326	0	0	0	0	17.06415	19.42414	18.14358	18.61026	19.17275	0	0	0	0	17.16629	19.09188	0	0	0	20.22747	19.80909	19.22563	0	0	17.42264	0	0	18.82803	17.50054	0	0	16.78174	16.8998
Q05BV3	EMAL5_HUMAN	"Echinoderm microtubule-associated protein-like 5, EMAP-5"	EML5	Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; catalytic activity [GO:0003824]; microtubule binding [GO:0008017]	catalytic activity [GO:0003824]; microtubule binding [GO:0008017]	GO:0003824; GO:0005737; GO:0005874; GO:0008017; GO:0070062	AALAPGSK	12.28999996	0.261318833	0.261318833	0.244849032	714.7238189	16.11194	14.61307	14.76993	0	13.95876	13.99272	15.86632	16.41089	14.80011	14.90261	14.13465	14.15122	0	16.53336	0	0	0	0	0	15.2306	14.33986	18.08057	16.72796	0	0	0	0	0	15.58962	16.43053	0	0	14.96808	0	0	0	16.41408	16.41344	0	0	0	0	16.03723	16.08676	15.08054	0	16.00411	16.62197
Q06124	PTN11_HUMAN	"Tyrosine-protein phosphatase non-receptor type 11, EC 3.1.3.48 (Protein-tyrosine phosphatase 1D, PTP-1D) (Protein-tyrosine phosphatase 2C, PTP-2C) (SH-PTP2, SHP-2, Shp2) (SH-PTP3)"	PTPN11 PTP2C SHPTP2	Homo sapiens (Human)	abortive mitotic cell cycle [GO:0033277]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159]; abortive mitotic cell cycle [GO:0033277]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]	cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000077; GO:0001784; GO:0004721; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0007420; GO:0007507; GO:0008543; GO:0009755; GO:0019221; GO:0019901; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0031295; GO:0032331; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033277; GO:0033628; GO:0033629; GO:0035264; GO:0035265; GO:0035335; GO:0035855; GO:0036302; GO:0038127; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0050839; GO:0051428; GO:0051463; GO:0060020; GO:0060125; GO:0060325; GO:0060338; GO:0061582; GO:0070374; GO:0071364; GO:1990782	GVDGSFLARPSK	15.13000011	1	1	0.629719003	1233.401422	20.90428	0	19.1169	0	0	0	0	19.20665	0	0	0	0	0	0	0	0	0	0	0	0	0	19.47094	0	0	0	0	0	0	0	17.75074	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.75733	0	0	0
Q06187	BTK_HUMAN	"Tyrosine-protein kinase BTK, EC 2.7.10.2 (Agammaglobulinemia tyrosine kinase, ATK) (B-cell progenitor kinase, BPK) (Bruton tyrosine kinase)"	BTK AGMX1 ATK BPK	Homo sapiens (Human)	adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cytokine production [GO:0001818]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cytokine production [GO:0001818]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]"	"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]"	GO:0001805; GO:0001812; GO:0001818; GO:0002250; GO:0002344; GO:0002553; GO:0002721; GO:0002755; GO:0002902; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007249; GO:0007498; GO:0016004; GO:0018108; GO:0019722; GO:0030889; GO:0031410; GO:0034614; GO:0035556; GO:0038095; GO:0042113; GO:0042802; GO:0043274; GO:0045087; GO:0045121; GO:0045579; GO:0046777; GO:0046872; GO:0048469; GO:0048471; GO:0050853; GO:0051092; GO:0071226; GO:0097190; GO:0098761	SDIWAFGVLMWEIYSLGKMPYER	2.069999933	1	1	0.199641155	2822.987356	14.64362	11.36619	10.37134	10.06087	14.67931	14.21328	14.73351	12.65244	14.09753	14.9183	0	0	12.63074	13.4808	0	16.00905	13.20467	13.66714	0	0	0	0	0	0	0	11.44597	13.11598	0	0	0	0	15.37391	0	0	0	0	0	0	0	0	0	0	14.93457	0	10.30806	0	12.30469	0
Q06190	P2R3A_HUMAN	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B)	PPP2R3A PPP2R3	Homo sapiens (Human)	eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	protein phosphatase type 2A complex [GO:0000159]	protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]	GO:0000159; GO:0001754; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0061053; GO:0090090; GO:0090244; GO:0090249; GO:0090263	APMFRAAGGEK	5.789999962	1	1	0.040621424	1134.247166	15.7456	0	14.86096	15.01386	0	16.08904	14.33878	15.01639	16.25669	0	0	0	0	0	0	0	0	12.96424	17.39803	0	0	14.40889	0	0	0	0	0	0	0	0	0	0	0	0	0	16.3331	13.59134	15.79075	0	16.39831	13.91558	0	0	0	0	0	0	15.09076
Q06203	PUR1_HUMAN	"Amidophosphoribosyltransferase, ATase, EC 2.4.2.14 (Glutamine phosphoribosylpyrophosphate amidotransferase, GPAT)"	PPAT GPAT	Homo sapiens (Human)	'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]	cytosol [GO:0005829]	"cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]"	GO:0004044; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006541; GO:0009113; GO:0044208; GO:0046872; GO:0051539; GO:0097294	SGHCTACLTGKYPVELEW	9.430000305	0.339682072	0.339682072	0.149677101	2109.079697	0	10.08757	15.82058	0	16.01148	0	18.21721	0	11.01711	16.40681	0	0	0	0	13.99451	11.99734	0	0	12.4945	14.58057	0	0	0	10.91506	0	0	0	0	15.75792	15.66419	18.10484	18.93666	0	19.97561	0	0	10.24807	15.81774	16.20535	0	17.06885	14.51371	0	0	12.10961	15.38605	0	16.3299
Q06210	GFPT1_HUMAN	"Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1, EC 2.6.1.16 (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1, GFAT 1, GFAT1) (Hexosephosphate aminotransferase 1)"	GFPT1 GFAT GFPT	Homo sapiens (Human)	circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]	GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0070062; GO:0097367	EDTETIKNTK	7.710000038	1	1	0.200765567	1178.599981	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q06278	AOXA_HUMAN	"Aldehyde oxidase, EC 1.2.3.1 (Aldehyde oxidase 1) (Azaheterocycle hydroxylase, EC 1.17.3.-)"	AOX1 AO	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]"	GO:0004031; GO:0005506; GO:0005829; GO:0006629; GO:0006805; GO:0016491; GO:0042802; GO:0042803; GO:0043546; GO:0050660; GO:0051287; GO:0051537; GO:0070062; GO:0071949; GO:0102797; GO:0102798	GPDQYK	3.480000019	1	1	0.279467773	707.8858269	14.075	0	14.53282	14.59967	14.85899	0	0	15.6916	15.83165	15.0383	0	14.73888	0	15.79754	0	15.01199	0	0	0	0	0	0	16.85762	17.04742	15.7346	0	16.58383	0	0	0	15.99599	0	16.89446	15.43583	15.8295	0	0	16.7827	16.06545	15.76413	15.77598	14.30006	0	13.45556	0	16.06073	15.48911	0
Q06413	MEF2C_HUMAN	Myocyte-specific enhancer factor 2C (Myocyte enhancer factor 2C)	MEF2C	Homo sapiens (Human)	"apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; excitatory postsynaptic potential [GO:0060079]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; myotube differentiation [GO:0014902]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary heart field specification [GO:0003138]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine development [GO:0060998]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of neuron apoptotic process [GO:0043523]; regulation of neurotransmitter secretion [GO:0046928]; regulation of NMDA receptor activity [GO:2000310]; regulation of synapse assembly [GO:0051963]; regulation of synaptic activity [GO:0060025]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal tubule morphogenesis [GO:0061333]; response to ischemia [GO:0002931]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; excitatory postsynaptic potential [GO:0060079]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; myotube differentiation [GO:0014902]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary heart field specification [GO:0003138]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine development [GO:0060998]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of neuron apoptotic process [GO:0043523]; regulation of neurotransmitter secretion [GO:0046928]; regulation of NMDA receptor activity [GO:2000310]; regulation of synapse assembly [GO:0051963]; regulation of synaptic activity [GO:0060025]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal tubule morphogenesis [GO:0061333]; response to ischemia [GO:0002931]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000165; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001649; GO:0001764; GO:0001782; GO:0001947; GO:0001958; GO:0001974; GO:0002062; GO:0002467; GO:0002634; GO:0002931; GO:0003138; GO:0003139; GO:0003151; GO:0003185; GO:0003211; GO:0003677; GO:0003680; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006915; GO:0006959; GO:0007399; GO:0007507; GO:0007517; GO:0007519; GO:0007521; GO:0007611; GO:0010628; GO:0010629; GO:0010694; GO:0014033; GO:0014902; GO:0016528; GO:0016607; GO:0030154; GO:0030182; GO:0030220; GO:0030279; GO:0030318; GO:0030501; GO:0030890; GO:0032991; GO:0035984; GO:0042100; GO:0042826; GO:0043231; GO:0043406; GO:0043523; GO:0043524; GO:0043537; GO:0045652; GO:0045663; GO:0045666; GO:0045669; GO:0045893; GO:0045944; GO:0046928; GO:0046982; GO:0048167; GO:0048643; GO:0048666; GO:0048667; GO:0050853; GO:0051145; GO:0051963; GO:0051966; GO:0055012; GO:0060025; GO:0060045; GO:0060079; GO:0060998; GO:0061333; GO:0061629; GO:0071222; GO:0071277; GO:0071374; GO:0071466; GO:0071498; GO:0071560; GO:0072102; GO:0072160; GO:0098794; GO:0140297; GO:1904706; GO:1904753; GO:1905563; GO:1990837; GO:2000111; GO:2000310; GO:2000311; GO:2000727; GO:2000987; GO:2001013; GO:2001016	SEPVSPPR	12.72999954	1	1	0.426661359	869.7505506	0	0	0	0	0	0	0	0	0	0	0	0	0	18.65778	18.10912	0	0	0	20.88303	0	19.08023	0	0	0	0	0	0	0	0	0	0	0	0	0	19.7926	0	0	0	19.01407	0	17.04328	17.92471	0	0	0	20.59266	0	0
Q06418	TYRO3_HUMAN	"Tyrosine-protein kinase receptor TYRO3, EC 2.7.10.1 (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF)"	TYRO3 BYK DTK RSE SKY TIF	Homo sapiens (Human)	apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; forebrain cell migration [GO:0021885]; natural killer cell differentiation [GO:0001779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; nervous system development [GO:0007399]; neuron cellular homeostasis [GO:0070050]; neuropeptide signaling pathway [GO:0007218]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of kinase activity [GO:0033674]; positive regulation of viral life cycle [GO:1903902]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; receptor complex [GO:0043235]	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; forebrain cell migration [GO:0021885]; natural killer cell differentiation [GO:0001779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; nervous system development [GO:0007399]; neuron cellular homeostasis [GO:0070050]; neuropeptide signaling pathway [GO:0007218]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of kinase activity [GO:0033674]; positive regulation of viral life cycle [GO:1903902]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]	ATP binding [GO:0005524]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001779; GO:0004712; GO:0004713; GO:0004714; GO:0005524; GO:0005634; GO:0005635; GO:0005789; GO:0005887; GO:0006909; GO:0007155; GO:0007165; GO:0007169; GO:0007218; GO:0007283; GO:0007399; GO:0009986; GO:0014065; GO:0016477; GO:0021885; GO:0030168; GO:0032940; GO:0033674; GO:0034122; GO:0034446; GO:0042698; GO:0043235; GO:0043277; GO:0043491; GO:0043524; GO:0043548; GO:0045824; GO:0046777; GO:0050728; GO:0051250; GO:0060068; GO:0070050; GO:0070527; GO:1903902	IEATLDSLGISDELK	5.039999962	1	1	0.12443595	1603.548919	0	0	15.95957	0	0	0	0	0	0	0	0	0	15.94401	0	15.71989	0	0	0	17.02437	0	0	0	0	0	13.38638	0	0	12.87024	0	0	14.32648	0	12.75022	13.81674	14.71572	11.17059	0	0	0	0	0	0	0	0	0	0	0	0
Q06455	MTG8_HUMAN	Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2)	RUNX1T1 AML1T1 CBFA2T1 CDR ETO MTG8 ZMYND2	Homo sapiens (Human)	"negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]"	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]"	DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0016363; GO:0045599; GO:0045892; GO:0046872; GO:0140297	DSYRHPSHR	8.06000042	0.237457782	0.237457782	0.182560214	1152.004201	0	0	0	0	0	17.36695	15.91403	18.24039	0	0	0	0	15.43487	16.15928	16.41341	16.70898	18.62111	16.59307	0	0	0	18.77117	0	19.41402	18.7545	15.43762	17.58514	0	19.0183	0	15.12752	17.02433	0	17.35583	0	17.38808	19.11465	18.4499	0	20.4236	17.19277	0	17.35706	0	0	17.50061	19.69793	15.808
Q06546	GABPA_HUMAN	"GA-binding protein alpha chain, GABP subunit alpha (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60)"	GABPA E4TF1A	Homo sapiens (Human)	blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001825; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030154; GO:0045653; GO:0045944; GO:1903351; GO:1990837	SSPGNR	5.510000229	1	1	0.054981876	617.5543936	0	0	0	15.80587	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.69617	0	0	0	0	0	0	0	0	0	17.62772	0	0	0	0	16.79855	0	0	0	0	0	0	0	0
Q06710	PAX8_HUMAN	Paired box protein Pax-8	PAX8	Homo sapiens (Human)	"anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular response to gonadotropin stimulus [GO:0071371]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesonephros development [GO:0001823]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric nephron tubule formation [GO:0072289]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; otic vesicle development [GO:0071599]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of thyroid-stimulating hormone secretion [GO:2000612]; regulation of transcription by RNA polymerase II [GO:0006357]; sulfur compound metabolic process [GO:0006790]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventricular septum development [GO:0003281]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid-stimulating hormone receptor activity [GO:0004996]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular response to gonadotropin stimulus [GO:0071371]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesonephros development [GO:0001823]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric nephron tubule formation [GO:0072289]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; otic vesicle development [GO:0071599]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of thyroid-stimulating hormone secretion [GO:2000612]; regulation of transcription by RNA polymerase II [GO:0006357]; sulfur compound metabolic process [GO:0006790]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventricular septum development [GO:0003281]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid-stimulating hormone receptor activity [GO:0004996]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001655; GO:0001658; GO:0001822; GO:0001823; GO:0003281; GO:0003337; GO:0003677; GO:0003700; GO:0004996; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0006790; GO:0007417; GO:0009653; GO:0010667; GO:0030878; GO:0039003; GO:0042472; GO:0042981; GO:0045893; GO:0045944; GO:0048793; GO:0048856; GO:0071371; GO:0071599; GO:0072108; GO:0072207; GO:0072221; GO:0072278; GO:0072284; GO:0072289; GO:0072305; GO:0072307; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000594; GO:2000611; GO:2000612	LSIDSQSSSSGPRK	7.659999847	1	1	0.354895824	1448.895087	15.39889	0	0	0	0	0	0	0	0	0	15.87059	13.63036	0	0	0	0	0	16.35096	0	0	0	0	18.11608	0	0	0	0	15.7963	0	16.12202	0	12.38251	16.62693	0	15.60873	0	15.8888	16.92482	15.87828	0	16.50583	15.62893	0	16.33812	0	16.76709	0	0
Q06730	ZN33A_HUMAN	"Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain, ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)"	ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33	Homo sapiens (Human)	"regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872	HIGENLMNEMDIR	4.269999981	0.878921747	0.878921747	0.386345368	1592.828506	13.56955	13.88332	14.27194	13.89064	12.68208	14.55847	12.70593	14.6465	0	12.85378	0	13.46911	0	0	0	0	0	0	0	0	0	0	0	0	15.8521	0	0	15.29085	0	15.33788	15.10187	14.60718	15.63811	15.65703	0	17.56842	0	16.01898	0	16.13177	15.91577	18.17441	0	0	15.48224	0	0	0
Q06732	ZN33B_HUMAN	Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2)	ZNF33B KOX2 ZNF11B	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	TFSQKSNLIVHQR	2.660000086	0.661153734	0.661153734	2.30E-13	1557.092704	0	0	0	0	0	0	0	0	15.01041	16.09769	18.72049	0	0	14.61912	12.92759	0	0	0	0	0	0	0	0	0	0	9.849862	11.70353	0	0	0	0	0	0	0	0	0	0	15.70506	0	14.04141	15.37443	0	0	0	0	0	0	14.11145
Q06787	FMR1_HUMAN	"Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1, FMRP, Protein FMR-1)"	FMR1	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]"	"axon [GO:0030424]; axon terminus [GO:0043679]; Cajal body [GO:0015030]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; extrinsic component of plasma membrane [GO:0019897]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]"	"axon [GO:0030424]; axon terminus [GO:0043679]; Cajal body [GO:0015030]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; extrinsic component of plasma membrane [GO:0019897]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; transmembrane transporter binding [GO:0044325]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]"	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; transmembrane transporter binding [GO:0044325]	GO:0000381; GO:0000775; GO:0001934; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006397; GO:0006974; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0014069; GO:0015030; GO:0016020; GO:0017148; GO:0019897; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0031047; GO:0031369; GO:0032433; GO:0033129; GO:0033592; GO:0034046; GO:0034644; GO:0035064; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042802; GO:0042803; GO:0042995; GO:0043005; GO:0043022; GO:0043025; GO:0043197; GO:0043204; GO:0043488; GO:0043679; GO:0044325; GO:0044326; GO:0044830; GO:0045182; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060964; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0072711; GO:0097386; GO:0098586; GO:0098793; GO:0098794; GO:0098908; GO:1900453; GO:1901254; GO:1901386; GO:1901800; GO:1902373; GO:1902416; GO:1902737; GO:1990124; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766; GO:2001022	EPCCWWLAKVR	4.230000019	0.001364865	0.001364865	0.19666118	1503.889123	14.02087	16.31732	0	14.3808	14.55019	14.29956	15.47389	11.94858	0	0	16.23836	15.59811	0	0	0	12.59129	0	0	0	0	0	0	13.37168	0	0	0	0	0	0	15.57305	0	0	0	14.62873	16.05621	0	14.67616	0	0	16.25451	15.30202	0	0	0	0	0	15.73082	0
Q07002	CDK18_HUMAN	"Cyclin-dependent kinase 18, EC 2.7.11.22 (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3)"	CDK18 PCTAIRE3 PCTK3	Homo sapiens (Human)	protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000083; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310	AKSVPTK	5.429999828	0.953535616	0.953535616	0.108129521	727.4712088	0	0	0	14.6231	0	0	0	15.59417	0	0	0	0	15.60176	15.56388	15.70532	0	0	0	0	0	0	0	17.09086	17.7645	0	0	16.82322	0	0	15.00628	16.86602	0	0	16.71176	14.18055	14.08587	0	0	15.86154	0	15.54644	16.90222	16.55664	16.43581	16.40583	0	0	0
Q07065	CKAP4_HUMAN	"Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein, Climp-63, p63)"	CKAP4	Homo sapiens (Human)		azurophil granule membrane [GO:0035577]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579]	azurophil granule membrane [GO:0035577]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005811; GO:0005856; GO:0005886; GO:0016020; GO:0016021; GO:0035577; GO:0035579; GO:0042599; GO:0048471; GO:0070062	PSAKQR	7.96999979	1	1	0.133785289	686.2449799	0	15.60033	14.19046	15.63619	15.89383	0	12.94474	12.35776	16.05638	0	15.25712	0	0	0	15.17007	15.62067	14.74295	0	14.56608	0	0	0	0	0	15.35621	0	16.06349	0	0	0	0	15.86185	0	0	16.22306	0	0	0	0	0	15.0999	0	0	16.33825	0	0	0	0
Q07075	AMPE_HUMAN	"Glutamyl aminopeptidase, EAP, EC 3.4.11.7 (Aminopeptidase A, AP-A) (Differentiation antigen gp160) (CD antigen CD249)"	ENPEP	Homo sapiens (Human)	angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0001525; GO:0002003; GO:0003081; GO:0004177; GO:0005737; GO:0005765; GO:0005886; GO:0005887; GO:0005903; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0008283; GO:0009897; GO:0016324; GO:0016477; GO:0031410; GO:0032835; GO:0042277; GO:0043171; GO:0045177; GO:0070006; GO:0070062	MNFAEREGSK	5.389999866	1	1	0.001803573	1185.639987	14.13332	15.95842	14.6366	0	0	13.25477	0	2.465566	0	0	0	0	0	0	13.74306	0	0	0	0	14.42044	14.97025	0	0	0	14.90049	14.80136	16.71693	14.61079	0	0	0	0	0	0	15.66326	0	0	0	0	0	0	0	14.79507	16.99528	15.67168	0	0	0
Q07092	COGA1_HUMAN	Collagen alpha-1(XVI) chain	COL16A1 FP1572	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amino acid stimulus [GO:0071230]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of focal adhesion assembly [GO:0051894]	collagen type V trimer [GO:0005588]; collagen type XVI trimer [GO:0005597]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type V trimer [GO:0005588]; collagen type XVI trimer [GO:0005597]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amino acid stimulus [GO:0071230]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of focal adhesion assembly [GO:0051894]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]	GO:0005178; GO:0005201; GO:0005576; GO:0005588; GO:0005597; GO:0005615; GO:0005788; GO:0007155; GO:0007229; GO:0007565; GO:0030020; GO:0030198; GO:0031012; GO:0033622; GO:0033627; GO:0051894; GO:0062023; GO:0071230	GLPGTKGEK	4.110000134	1	1	0.115398976	885.3640075	0	15.43397	0	0	0	14.82133	0	13.33051	0	10.44698	12.99156	14.63	15.88162	14.51057	0	11.68508	9.783952	0	0	0	0	0	0	16.17066	18.08863	16.02625	0	16.45706	0	16.35367	0	0	0	0	14.00212	0	0	0	0	0	15.20732	0	16.17126	16.20182	13.14861	0	0	0
Q07283	TRHY_HUMAN	Trichohyalin	TCHH THH THL TRHY	Homo sapiens (Human)	intermediate filament organization [GO:0045109]; keratinization [GO:0031424]	cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]	calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	GO:0001533; GO:0005509; GO:0005829; GO:0005856; GO:0031424; GO:0045109; GO:0046914	DLKNLLER	3.809999943	1	1	0.249308158	1001.676403	20.13673	20.3735	19.41194	21.30654	0	14.75595	0	0	0	0	17.84848	18.03326	0	17.36487	0	0	0	0	0	0	0	0	0	0	17.97116	19.86382	0	0	17.78163	18.91421	17.92446	18.79403	0	18.42372	0	0	0	0	0	20.44508	0	0	16.76164	0	19.24153	17.18725	17.47372	0
Q07325	CXCL9_HUMAN	"C-X-C motif chemokine 9 (Gamma-interferon-induced monokine) (Monokine induced by interferon-gamma, HuMIG, MIG) (Small-inducible cytokine B9)"	CXCL9 CMK MIG SCYB9	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; cytokine activity [GO:0005125]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; cytokine activity [GO:0005125]	GO:0005125; GO:0005576; GO:0005615; GO:0006935; GO:0006952; GO:0006954; GO:0006968; GO:0007165; GO:0007186; GO:0007189; GO:0007267; GO:0008009; GO:0009897; GO:0030593; GO:0031640; GO:0042127; GO:0045236; GO:0045663; GO:0048248; GO:0051281; GO:0051607; GO:0061844; GO:0070098; GO:0071222; GO:1901741	DLKQFAPSPSCEK	5.190000057	1	1	6.96E-13	1507.435008	0	16.43694	16.31169	15.83302	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q07617	SPAG1_HUMAN	Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1)	SPAG1	Homo sapiens (Human)	axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821]; single fertilization [GO:0007338]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821]; single fertilization [GO:0007338]	GTP binding [GO:0005525]; hydrolase activity [GO:0016787]	GO:0005525; GO:0005737; GO:0005829; GO:0007338; GO:0016787; GO:0050821; GO:0070286; GO:0101031; GO:0120293	EEPGRPAGEVSMGCLASEK	6.960000038	1	1	0.39488264	2019.961048	19.13461	21.15317	0	0	18.81078	0	0	0	18.59434	0	0	0	18.81161	0	0	20.59874	18.27675	0	0	0	0	19.61356	19.74146	0	0	0	0	0	0	0	0	0	0	0	0	20.70223	0	0	20.9039	0	0	20.12495	0	0	0	0	0	18.01963
Q07666	KHDR1_HUMAN	"KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein, Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)"	KHDRBS1 SAM68	Homo sapiens (Human)	"G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of translational initiation [GO:0045948]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA export from nucleus [GO:0046831]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Grb2-Sos complex [GO:0070618]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Grb2-Sos complex [GO:0070618]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of translational initiation [GO:0045948]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA export from nucleus [GO:0046831]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]"	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]	GO:0000082; GO:0000086; GO:0000122; GO:0000381; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007283; GO:0008143; GO:0008266; GO:0016020; GO:0017124; GO:0019904; GO:0032991; GO:0035591; GO:0042169; GO:0042802; GO:0044877; GO:0045892; GO:0045948; GO:0046831; GO:0046833; GO:0048024; GO:0050852; GO:0070618; GO:1990782	GAPAPR	7.050000191	0.530669034	0.530669034	0.297844922	567.8804296	0	17.83321	0	16.68437	17.60258	17.44579	18.43859	18.81584	0	18.24079	18.10195	0	17.97733	16.10803	0	0	18.95144	0	0	16.74049	0	0	17.30913	0	0	0	0	0	0	17.68151	0	19.57834	0	0	0	0	0	0	0	17.54572	0	0	0	0	0	0	0	0
Q07699	SCN1B_HUMAN	Sodium channel subunit beta-1	SCN1B	Homo sapiens (Human)	axon guidance [GO:0007411]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; corticospinal neuron axon guidance [GO:0021966]; locomotion [GO:0040011]; membrane depolarization [GO:0051899]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transmembrane transport [GO:0035725]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; node of Ranvier [GO:0033268]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; node of Ranvier [GO:0033268]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; axon guidance [GO:0007411]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; corticospinal neuron axon guidance [GO:0021966]; locomotion [GO:0040011]; membrane depolarization [GO:0051899]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transmembrane transport [GO:0035725]	sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]	GO:0001518; GO:0005244; GO:0005248; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010765; GO:0010976; GO:0014704; GO:0017080; GO:0019227; GO:0019871; GO:0021966; GO:0030315; GO:0033268; GO:0035725; GO:0040011; GO:0043204; GO:0044325; GO:0051899; GO:0060048; GO:0060307; GO:0060371; GO:0061337; GO:0086002; GO:0086006; GO:0086012; GO:0086047; GO:0086062; GO:0086091; GO:2000649	ENCTGVQVAE	4.809999943	0.409832209	0.409832209	0.160353878	1107.79559	0	0	15.26786	0	0	15.08571	14.889	15.73318	14.39164	15.88331	15.18116	0	0	14.5316	14.88933	0	0	14.89637	14.80883	0	0	0	15.35001	16.41356	16.17846	0	0	0	0	12.79772	15.52772	16.34771	0	0	12.23302	0	14.09842	14.2327	15.61156	0	15.54704	13.78723	10.82489	0	6.330514	0	15.34696	0
Q07820	MCL1_HUMAN	"Induced myeloid leukemia cell differentiation protein Mcl-1 (Bcl-2-like protein 3, Bcl2-L-3) (Bcl-2-related protein EAT/mcl1) (mcl1/EAT)"	MCL1 BCL2L3	Homo sapiens (Human)	cell fate determination [GO:0001709]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; regulation of apoptotic process [GO:0042981]; regulation of response to DNA damage stimulus [GO:2001020]; response to cytokine [GO:0034097]	Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; BH3 domain binding [GO:0051434]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein transmembrane transporter activity [GO:0008320]; cell fate determination [GO:0001709]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; regulation of apoptotic process [GO:0042981]; regulation of response to DNA damage stimulus [GO:2001020]; response to cytokine [GO:0034097]	BH3 domain binding [GO:0051434]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein transmembrane transporter activity [GO:0008320]	GO:0001709; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0008320; GO:0008630; GO:0010507; GO:0016020; GO:0016021; GO:0019725; GO:0034097; GO:0042803; GO:0042981; GO:0043065; GO:0043066; GO:0046982; GO:0051434; GO:0097136; GO:0097192; GO:1903378; GO:2000811; GO:2001020; GO:2001240; GO:2001243	AAPLEEMEAPAADAIMSPEEELDGYEPEPLGK	1.850000024	0.387719363	0.387719363	1.83E-12	3416.157502	12.24713	13.66541	12.8028	12.77194	12.60345	0	0	0	0	0	0	0	0	0	12.86383	10.43099	0	14.02042	0	0	0	0	15.2957	0	10.28484	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.29063	0	13.23347	0	0	0	0	16.0051	0
Q07864	DPOE1_HUMAN	"DNA polymerase epsilon catalytic subunit A, EC 2.7.7.7 (3'-5' exodeoxyribonuclease, EC 3.1.11.-) (DNA polymerase II subunit A)"	POLE POLE1	Homo sapiens (Human)	"base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]"	GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006261; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539	CILNSFYGYVMR	11.73999977	1	1	0.342778933	1538.639513	14.5413	15.69537	13.43747	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.35357	0	0
Q07889	SOS1_HUMAN	"Son of sevenless homolog 1, SOS-1"	SOS1	Homo sapiens (Human)	axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296]	DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]	GO:0001782; GO:0001942; GO:0003209; GO:0003344; GO:0003677; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0014069; GO:0017124; GO:0019221; GO:0033081; GO:0035264; GO:0038095; GO:0042127; GO:0042129; GO:0043025; GO:0043405; GO:0043547; GO:0045742; GO:0046982; GO:0048011; GO:0048514; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:1905360; GO:2000973	LVGNYVR	11.21000004	1	1	0.015150679	820.5883269	0	15.83381	15.62358	15.69769	0	0	15.72872	0	0	16.56608	12.77931	0	0	15.08366	0	0	0	0	12.94714	0	0	0	15.01971	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q07890	SOS2_HUMAN	"Son of sevenless homolog 2, SOS-2"	SOS2	Homo sapiens (Human)	B cell homeostasis [GO:0001782]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; B cell homeostasis [GO:0001782]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]	DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]	GO:0001782; GO:0003677; GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0033081; GO:0042129; GO:0043547; GO:0046982; GO:0051057; GO:2000973	ELNMIIK	8.31000042	1	1	0.144269139	877.2728454	14.38034	15.39753	12.1972	15.45626	14.85261	0	15.63921	0	16.35817	16.24006	16.69049	15.2589	0	14.67656	0	15.16971	0	15.33625	0	15.89169	15.04588	0	16.52981	15.35954	14.55848	0	15.28628	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.56326	0	0	0	0
Q07912	ACK1_HUMAN	"Activated CDC42 kinase 1, ACK-1, EC 2.7.10.2, EC 2.7.11.1 (Tyrosine kinase non-receptor protein 2)"	TNK2 ACK1	Homo sapiens (Human)	cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of clathrin-dependent endocytosis [GO:2000369]; small GTPase mediated signal transduction [GO:0007264]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	adherens junction [GO:0005912]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; GTPase inhibitor activity [GO:0005095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of clathrin-dependent endocytosis [GO:2000369]; small GTPase mediated signal transduction [GO:0007264]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; GTPase inhibitor activity [GO:0005095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]	GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005095; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007166; GO:0007169; GO:0007264; GO:0016020; GO:0016310; GO:0030136; GO:0030154; GO:0030659; GO:0031234; GO:0031625; GO:0042802; GO:0043231; GO:0045087; GO:0046872; GO:0048471; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:0106310; GO:2000369	GECHK	3.289999962	0.722785592	0.722785592	0.19060886	628.2154458	0	0	0	0	0	0	0	0	17.56225	0	0	0	0	0	18.48959	17.03937	0	16.21655	0	13.84643	16.44963	0	13.37559	14.99094	0	0	0	16.13674	0	0	0	0	0	0	16.97131	0	0	0	0	0	0	0	16.64919	0	0	0	0	14.07737
Q07954	LRP1_HUMAN	"Prolow-density lipoprotein receptor-related protein 1, LRP-1 (Alpha-2-macroglobulin receptor, A2MR) (Apolipoprotein E receptor, APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit, LRP-85; Low-density lipoprotein receptor-related protein 1 515 kDa subunit, LRP-515; Low-density lipoprotein receptor-related protein 1 intracellular domain, LRPICD ]"	LRP1 A2MR APR	Homo sapiens (Human)	amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]	basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein receptor complex [GO:0062136]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]	basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein receptor complex [GO:0062136]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]	alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]	GO:0001523; GO:0001540; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0010629; GO:0010715; GO:0010875; GO:0010942; GO:0014912; GO:0016020; GO:0016323; GO:0016964; GO:0030178; GO:0030226; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032956; GO:0034185; GO:0035909; GO:0038023; GO:0038024; GO:0042953; GO:0043235; GO:0043277; GO:0043395; GO:0044877; GO:0045056; GO:0045807; GO:0060392; GO:0060394; GO:0062136; GO:0070325; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:0150104; GO:1900223; GO:1903078; GO:1904300; GO:1904646; GO:1905049; GO:1905167; GO:2000587	DVIEVAQMK	3.950000048	1	1	0.242987118	1048.320114	17.60935	0	0	12.54894	0	17.31341	0	15.29589	16.32651	16.37692	15.67747	16.3228	0	15.31187	0	14.83546	15.71267	14.96318	0	0	0	0	16.54662	16.17927	0	19.02221	17.25742	17.28434	13.01869	14.91192	0	0	0	18.00999	0	0	17.61442	0	0	18.09862	15.29819	16.04014	18.61311	17.08971	15.45436	0	15.49115	12.71177
Q07955	SRSF1_HUMAN	"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1, ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)"	SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; regulation of RNA splicing [GO:0043484]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA topoisomerase binding [GO:0044547]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; regulation of RNA splicing [GO:0043484]"	DNA topoisomerase binding [GO:0044547]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000380; GO:0000395; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006397; GO:0016607; GO:0043484; GO:0044547; GO:0051028; GO:0071013	GGGGGGGGGAPR	5.690000057	0.946176291	0.946176291	0.289249487	857.0016062	16.9908	14.69415	16.20741	0	15.18376	0	16.86765	16.67274	14.24934	14.56927	15.10323	14.55243	16.95765	14.58014	0	15.30735	16.57797	0	0	0	0	16.17003	15.08241	16.23394	0	0	15.61744	0	13.68061	14.61543	16.93882	0	16.64256	0	0	0	15.7441	15.52779	0	14.56707	15.6508	14.2457	15.05247	0	0	15.57916	0	0
Q08116	RGS1_HUMAN	"Regulator of G-protein signaling 1, RGS1 (B-cell activation protein BL34) (Early response protein 1R20)"	RGS1 1R20 BL34 IER1	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]	calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]	GO:0001965; GO:0003924; GO:0005096; GO:0005516; GO:0005829; GO:0005886; GO:0006955; GO:0007165; GO:0007186; GO:0007193; GO:0008277; GO:0009617; GO:0009968; GO:0031234; GO:0043547; GO:0061737	DVLSAAEVMQWSQSLEK	8.649999619	1	1	2.07E-12	1937.708705	0	0	0	14.25818	0	0	0	0	0	0	0	14.01285	0	0	13.72715	0	0	0	18.98971	0	13.21655	0	0	0	0	0	0	14.9189	0	0	14.22689	17.0262	0	0	0	0	9.11864	15.49455	0	0	0	0	0	0	0	0	0	0
Q08170	SRSF4_HUMAN	"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)"	SRSF4 SFRS4 SRP75	Homo sapiens (Human)	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]	GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825	DSKAGSSK	10.68999958	1	1	0	780.6323389	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.38461	0	0	0	0	0	0	0	0	0	16.64358	0	0	16.6092	0	0	0	0	0	0	0
Q08188	TGM3_HUMAN	"Protein-glutamine gamma-glutamyltransferase E, EC 2.3.2.13 (Transglutaminase E, TG(E), TGE, TGase E) (Transglutaminase-3, TGase-3) [Cleaved into: Protein-glutamine gamma-glutamyltransferase E 50 kDa catalytic chain; Protein-glutamine gamma-glutamyltransferase E 27 kDa non-catalytic chain ]"	TGM3	Homo sapiens (Human)	cell envelope organization [GO:0043163]; cellular protein modification process [GO:0006464]; hair follicle morphogenesis [GO:0031069]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; protein-containing complex [GO:0032991]; acyltransferase activity [GO:0016746]; calcium ion binding [GO:0005509]; catalytic activity [GO:0003824]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural molecule activity [GO:0005198]; cell envelope organization [GO:0043163]; cellular protein modification process [GO:0006464]; hair follicle morphogenesis [GO:0031069]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]	acyltransferase activity [GO:0016746]; calcium ion binding [GO:0005509]; catalytic activity [GO:0003824]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural molecule activity [GO:0005198]	GO:0003810; GO:0003824; GO:0005198; GO:0005509; GO:0005737; GO:0006464; GO:0016746; GO:0018149; GO:0030216; GO:0031069; GO:0031234; GO:0031424; GO:0032991; GO:0043163; GO:0070062	FSSQELILR	11.47000027	0.00211179	0.00211179	0.024548257	1095.867589	0	0	17.95312	0	0	0	19.83443	0	16.41924	0	13.89338	0	0	0	19.05622	15.96725	8.562559	18.0036	0	17.0553	0	17.78304	0	0	16.61486	17.92994	17.53047	18.86376	15.87843	0	0	16.49876	0	0	0	0	0	0	0	10.33169	16.45913	17.39974	0	10.57589	17.46922	14.45787	0	0
Q08211	DHX9_HUMAN	"ATP-dependent RNA helicase A, EC 3.6.4.13 (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin, LKP) (Nuclear DNA helicase II, NDH II) (RNA helicase A)"	DHX9 DDX9 LKP NDH2	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; protein-containing complex assembly [GO:0065003]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; protein-containing complex assembly [GO:0065003]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]"	3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]	GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0001649; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006357; GO:0006954; GO:0010501; GO:0015629; GO:0016020; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032741; GO:0032755; GO:0032760; GO:0032991; GO:0033679; GO:0034458; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045089; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0050691; GO:0050729; GO:0051028; GO:0051092; GO:0060760; GO:0061629; GO:0061676; GO:0065003; GO:0070063; GO:0070269; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1900152; GO:1903608; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767	GMTLVTPLQLLLFASK	4.309999943	1	1	0.550680712	1748.175293	0	18.74759	0	0	0	16.91486	0	0	19.31925	0	0	0	0	0	0	0	0	0	0	16.90215	15.64011	0	0	0	0	0	0	0	0	18.05545	0	0	0	0	0	0	0	0	0	17.88951	0	0	17.16233	0	0	17.45259	17.86936	0
Q08345	DDR1_HUMAN	"Epithelial discoidin domain-containing receptor 1, Epithelial discoidin domain receptor 1, EC 2.7.10.1 (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10, MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)"	DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE	Homo sapiens (Human)	"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]"	ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001558; GO:0001952; GO:0004712; GO:0004714; GO:0005518; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0007155; GO:0007169; GO:0007566; GO:0007595; GO:0008285; GO:0010715; GO:0014909; GO:0033674; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046777; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:0070062; GO:1990138	GPAMAWEGEPMR	2.630000114	1	1	2.29E-12	1333.507901	13.67168	12.95035	0	14.34208	14.44962	13.61053	0	0	15.01098	13.82953	14.34096	0	13.92982	0	15.27298	0	0	0	0	0	0	0	15.80435	0	0	14.05952	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.9941	0	0	0
Q08378	GOGA3_HUMAN	"Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa, GCP170) (Golgin-160)"	GOLGA3	Homo sapiens (Human)	spermatogenesis [GO:0007283]	cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; spermatogenesis [GO:0007283]	cadherin binding [GO:0045296]	GO:0000139; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0007283; GO:0016020; GO:0032580; GO:0045296; GO:0090498	DKFMLQAK	3.910000086	1	1	0.286093925	996.009814	16.96085	15.48891	15.40892	0	0	0	0	0	0	17.98174	0	0	14.46315	0	0	0	0	0	14.4491	0	0	0	15.56646	0	15.43692	16.47824	0	0	0	0	0	0	0	0	15.74448	0	0	16.6032	0	0	0	0	0	0	0	0	0	15.53189
Q08379	GOGA2_HUMAN	"Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein, GM130) (GM130 autoantigen) (Golgin-95)"	GOLGA2	Homo sapiens (Human)	asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]	cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]	cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]	GO:0000137; GO:0000139; GO:0000922; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0015031; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0033116; GO:0042802; GO:0045296; GO:0051225; GO:0051289; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307	LAHLLASAQK	10.09000015	1	1	0.302032924	1052.221227	13.88035	16.37358	15.4451	14.92213	0	15.03625	0	14.5296	15.13132	11.54752	9.931681	14.79926	14.38002	15.61143	14.26645	0	0	0	0	0	0	0	0	14.51048	0	0	16.24307	0	16.18036	0	16.38888	0	0	0	0	0	0	16.21827	0	14.33592	15.9498	13.91041	13.87454	0	0	16.17485	0	0
Q08462	ADCY2_HUMAN	"Adenylate cyclase type 2, EC 4.6.1.1 (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2)"	ADCY2 KIAA1060	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322]	adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]	GO:0000287; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0019933; GO:0030145; GO:0030425; GO:0045121; GO:1904322	ENECMR	2.849999905	1	1	0.194209424	854.615858	14.93736	15.88795	13.51871	15.4756	0	0	15.92294	15.72676	14.42832	0	16.28641	14.91533	0	0	0	17.26357	0	0	0	0	0	0	0	0	14.37907	0	0	15.18333	0	0	0	14.39167	0	0	0	0	0	17.1132	0	0	0	0	0	0	0	0	0	0
Q08477	CP4F3_HUMAN	"Cytochrome P450 4F3, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (CYPIVF3) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase CYP4F3, EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2, EC 1.14.14.94)"	CYP4F3 LTB4H	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; lipoxin B4 metabolic process [GO:2001304]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; very long-chain fatty acid omega-hydroxylase activity [GO:0140692]; arachidonic acid metabolic process [GO:0019369]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; lipoxin B4 metabolic process [GO:2001304]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]	20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; very long-chain fatty acid omega-hydroxylase activity [GO:0140692]	GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0006691; GO:0008391; GO:0010430; GO:0016021; GO:0019369; GO:0020037; GO:0036101; GO:0042361; GO:0042376; GO:0043231; GO:0050051; GO:0070330; GO:0097258; GO:0097259; GO:0097267; GO:0102033; GO:0102207; GO:0120319; GO:0140692; GO:2001302; GO:2001304	VVLGLTLLR	10.44999981	1	1	0.29630232	984.0033637	14.92194	13.79364	14.35564	14.29685	13.56049	14.80451	13.62292	11.22916	0	0	14.81535	0	15.18731	0	15.69435	0	14.4071	0	0	14.97637	0	15.2597	15.5532	15.22455	14.16341	16.47042	0	0	0	0	0	0	0	14.05827	15.84751	0	0	0	0	11.38986	15.74551	0	0	0	0	0	12.75975	0
Q08493	PDE4C_HUMAN	"cAMP-specific 3',5'-cyclic phosphodiesterase 4C, EC 3.1.4.53 (DPDE1) (PDE21)"	PDE4C DPDE1	Homo sapiens (Human)	cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165]	cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0005615; GO:0005634; GO:0005829; GO:0005929; GO:0006198; GO:0007165; GO:0046872; GO:0048471	ALDPQSSPGLGR	5.360000134	0.341059238	0.341059238	0.47916037	1196.85828	16.79156	0	0	17.44776	18.58297	0	16.55416	0	0	0	0	0	0	0	17.27161	0	0	0	0	0	0	0	18.90803	0	0	0	0	0	0	16.96235	0	0	0	0	0	0	0	0	0	0	0	0	17.12205	0	0	0	0	0
Q08554	DSC1_HUMAN	"Desmocollin-1 (Cadherin family member 1) (Desmosomal glycoprotein 2/3, DG2/DG3)"	DSC1 CDHF1	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0001533; GO:0005509; GO:0005886; GO:0005911; GO:0005921; GO:0007156; GO:0016020; GO:0016021; GO:0030057; GO:0070062; GO:0098609; GO:0101003	EKCDTYQLIMEVR	3.5	1	1	0.271024163	1685.56087	0	12.97843	0	0	0	0	13.73223	0	0	0	0	0	0	0	0	0	17.7664	0	0	0	0	0	18.3524	0	17.8952	0	19.08347	0	0	0	0	0	19.61881	0	0	0	0	0	0	0	0	0	15.02823	0	15.94386	0	0	0
Q08722	CD47_HUMAN	"Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein, IAP) (Protein MER6) (CD antigen CD47)"	CD47 MER6	Homo sapiens (Human)	ATP export [GO:1904669]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-12 [GO:0071349]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phagocytosis [GO:0050766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of tumor necrosis factor production [GO:0032680]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; thrombospondin receptor activity [GO:0070053]; ATP export [GO:1904669]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-12 [GO:0071349]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phagocytosis [GO:0050766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of tumor necrosis factor production [GO:0032680]	cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; thrombospondin receptor activity [GO:0070053]	GO:0005886; GO:0005887; GO:0007229; GO:0008284; GO:0009986; GO:0016477; GO:0022409; GO:0032649; GO:0032653; GO:0032655; GO:0032675; GO:0032680; GO:0035579; GO:0045428; GO:0050729; GO:0050766; GO:0050870; GO:0051496; GO:0070053; GO:0070062; GO:0070821; GO:0071346; GO:0071347; GO:0071349; GO:0086080; GO:0098632; GO:1904669; GO:1905450; GO:2000439	TIQPPRK	1.409999967	1	1	0.131762506	839.7027248	0	12.78294	0	13.81484	13.44374	0	15.84086	14.67418	0	0	15.46096	0	0	0	0	13.29997	0	14.67615	0	0	15.22764	0	15.84296	16.1169	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q08752	PPID_HUMAN	"Peptidyl-prolyl cis-trans isomerase D, PPIase D, EC 5.2.1.8 (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40, CYP-40) (Cyclophilin-related protein) (Rotamase D)"	PPID CYP40 CYPD	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076]	cyclosporin A binding [GO:0016018]; estrogen receptor binding [GO:0030331]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]	GO:0000122; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006457; GO:0006915; GO:0008134; GO:0015031; GO:0016018; GO:0019076; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0043065; GO:0045070; GO:0050714; GO:0051879; GO:0061077; GO:0065003; GO:0071492	AVIETADR	1.409999967	1	1	0.182555542	873.8612044	15.39485	0	12.63855	13.46813	16.025	0	13.81234	0	0	0	0	0	0	0	0	0	14.79785	0	0	0	0	0	15.46932	15.26822	0	15.81707	14.75428	0	0	0	16.02573	15.96278	0	14.97258	15.72548	0	0	0	15.2767	17.50307	0	0	16.53387	0	0	0	0	0
Q08828	ADCY1_HUMAN	"Adenylate cyclase type 1, EC 4.6.1.1 (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase)"	ADCY1	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226]; response to xenobiotic stimulus [GO:0009410]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226]; response to xenobiotic stimulus [GO:0009410]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]	GO:0004016; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007189; GO:0007409; GO:0007420; GO:0007616; GO:0007623; GO:0008294; GO:0009410; GO:0010226; GO:0019933; GO:0032793; GO:0042752; GO:0045121; GO:0046872; GO:0070062; GO:0071277; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0150076; GO:1900273; GO:1904322; GO:2000300	RPPVCPMPGVSVR	7.320000172	0.054527655	0.054527655	0.520498899	1467.183083	0	0	0	0	0	0	18.35394	18.72077	19.3072	0	0	19.51984	18.75311	0	0	0	18.52083	0	0	0	18.96033	0	0	0	0	0	0	19.66223	17.49246	20.36747	21.47166	0	0	0	0	20.60203	0	0	20.64136	20.56218	0	0	0	20.09792	20.27473	0	18.9292	0
Q08830	FGL1_HUMAN	"Fibrinogen-like protein 1 (HP-041) (Hepassocin, HPS) (Hepatocyte-derived fibrinogen-related protein 1, HFREP-1) (Liver fibrinogen-related protein 1, LFIRE-1)"	FGL1 HFREP1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776]	signaling receptor binding [GO:0005102]	GO:0002250; GO:0005102; GO:0005576; GO:0005577; GO:0005615; GO:0050776; GO:0050868; GO:0062023; GO:0072574	MAKVFSFILVTTALTMGR	2.569999933	0.816740334	0.816740334	2.97E-12	2013.823516	14.75925	7.565807	13.71171	15.02456	11.30651	13.10707	0	15.51062	0	0	10.81509	14.84019	14.75382	15.07917	12.36629	15.61834	11.96649	14.13415	0	0	0	0	15.06463	0	0	13.67834	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.85255	0	0	0	0	0	0	0
Q08945	SSRP1_HUMAN	"FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit, FACT 80 kDa subunit, FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1, hSSRP1) (T160)"	SSRP1 FACT80	Homo sapiens (Human)	DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of chromatin organization [GO:1902275]	FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of chromatin organization [GO:1902275]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0006334; GO:0006337; GO:0031491; GO:0035101; GO:0042393; GO:1902275	GSSSK	4.769999981	0.645693898	0.645693898	0.263144246	465.5479916	0	15.10642	0	15.40516	17.21402	14.33077	16.52642	0	16.30795	0	0	0	14.78736	0	0	0	16.07155	14.15752	15.70912	18.04123	0	16.29806	14.77638	12.51149	17.58245	0	16.08735	17.4564	16.11981	15.76862	17.87848	16.98027	0	18.02039	15.85493	18.14184	17.51718	17.68918	15.57949	16.82581	0	17.53641	0	16.05049	17.24951	0	0	14.82384
Q08999	RBL2_HUMAN	"Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein, p130) (Retinoblastoma-related protein 2, RBR-2) (pRb2)"	RBL2 RB2	Homo sapiens (Human)	cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357]	promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0005694; GO:0005730; GO:0005829; GO:0006325; GO:0006357; GO:0007049; GO:0010629; GO:0030154; GO:0043550; GO:0051302; GO:0070062; GO:1990841; GO:2000134	SFQNIMRCYR	11.68000031	1	1	3.19E-12	1390.97828	16.81364	0	0	0	0	16.56151	16.11902	0	15.96412	14.76617	0	0	0	19.26333	17.22321	17.14058	16.74269	0	0	0	0	0	0	0	0	16.76226	14.49373	15.36448	15.75213	15.92728	14.54075	16.93757	0	0	14.58946	15.91649	16.31989	18.83637	18.45492	0	0	12.90459	0	12.84724	14.61233	17.02112	0	17.09423
Q08AD1	CAMP2_HUMAN	Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1)	CAMSAP2 CAMSAP1L1 KIAA1078	Homo sapiens (Human)	axon development [GO:0061564]; cytoplasmic microtubule organization [GO:0031122]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of dendrite development [GO:0050773]; regulation of Golgi organization [GO:1903358]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043]	ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule end [GO:1990752]	ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule end [GO:1990752]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; axon development [GO:0061564]; cytoplasmic microtubule organization [GO:0031122]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of dendrite development [GO:0050773]; regulation of Golgi organization [GO:1903358]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043]	calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]	GO:0000226; GO:0005516; GO:0005794; GO:0005829; GO:0007026; GO:0030507; GO:0031113; GO:0031122; GO:0033043; GO:0036064; GO:0050773; GO:0051011; GO:0061564; GO:1903358; GO:1990752	EDSVQRSTPNR	5.639999866	1	1	0.407359327	1288.140641	0	0	0	0	0	0	0	0	17.91174	0	0	17.71022	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.73018	0	0
Q08AE8	SPIR1_HUMAN	"Protein spire homolog 1, Spir-1"	SPIRE1 KIAA1135 SPIR1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	actin binding [GO:0003779]	GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030041; GO:0030659; GO:0031307; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:0090141; GO:2000781	KLRPVSPEEIR	3.789999962	0.448135108	0.448135108	0.024206553	1323.633215	0	0	11.87399	12.89944	10.39276	0	8.186041	12.23048	12.66369	14.82517	12.56251	0	11.12253	0	11.1461	0	0	0	13.59371	0	0	0	0	0	13.15395	11.74325	14.85239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.14165	0	0	0	0	0	0
Q08AG5	ZN844_HUMAN	Zinc finger protein 844	ZNF844	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	HTLERNPIR	3.650000095	0.211252108	0.211252108	0.074773386	1136.821718	0	0	17.43709	0	0	0	13.85775	17.43207	0	15.29575	0	14.12559	0	14.48236	18.07705	15.15787	0	0	0	0	14.44539	17.28385	15.21542	13.76344	17.23504	0	0	0	0	0	12.09704	0	0	0	16.4736	18.22081	17.71075	0	0	0	0	0	0	18.15796	0	0	0	0
Q08AG7	MZT1_HUMAN	Mitotic-spindle organizing protein 1 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1)	MZT1 C13orf37 MOZART1	Homo sapiens (Human)	gamma-tubulin complex localization [GO:0033566]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic spindle assembly [GO:0090307]	centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; interphase microtubule organizing center [GO:0031021]; spindle [GO:0005819]	centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; interphase microtubule organizing center [GO:0031021]; spindle [GO:0005819]; gamma-tubulin complex localization [GO:0033566]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic spindle assembly [GO:0090307]		GO:0000931; GO:0005813; GO:0005819; GO:0005829; GO:0031021; GO:0033566; GO:0051415; GO:0090307	LCEQGINPEALSSVIKELR	8.590000153	1	1	0.20263494	2157.076485	17.66288	14.82189	15.82738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.93338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q08AH1	ACSM1_HUMAN	"Acyl-coenzyme A synthetase ACSM1, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 1) (Benzoate--CoA ligase, EC 6.2.1.25) (Butyrate--CoA ligase 1) (Butyryl-coenzyme A synthetase 1) (Lipoate-activating enzyme) (Middle-chain acyl-CoA synthetase 1) (Xenobiotic/medium-chain fatty acid-CoA ligase HXM-B)"	ACSM1 BUCS1 LAE MACS1	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; benzoate metabolic process [GO:0018874]; butyrate metabolic process [GO:0019605]; cholesterol homeostasis [GO:0042632]; energy derivation by oxidation of organic compounds [GO:0015980]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; xenobiotic metabolic process [GO:0006805]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; long-chain fatty acid-CoA ligase activity [GO:0004467]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; benzoate metabolic process [GO:0018874]; butyrate metabolic process [GO:0019605]; cholesterol homeostasis [GO:0042632]; energy derivation by oxidation of organic compounds [GO:0015980]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; xenobiotic metabolic process [GO:0006805]	ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; long-chain fatty acid-CoA ligase activity [GO:0004467]; metal ion binding [GO:0046872]	GO:0004321; GO:0004467; GO:0005524; GO:0005525; GO:0005759; GO:0006633; GO:0006637; GO:0006805; GO:0015645; GO:0015980; GO:0016405; GO:0018858; GO:0018874; GO:0019395; GO:0019605; GO:0042632; GO:0046872; GO:0047760; GO:0070062; GO:0072562; GO:0102391	EMGDLTR	1.289999962	0.495234698	0.495234698	0.301485224	836.3596217	0	18.17088	18.36909	18.48446	0	0	0	0	17.87434	18.84871	19.01484	0	0	17.21739	0	17.60057	17.30527	0	0	18.07014	0	19.02702	0	0	0	0	18.89266	0	16.42078	0	0	0	0	19.14788	16.5101	0	20.2176	0	17.11975	17.78299	17.36781	0	18.48467	0	18.5442	0	18.1033	16.71293
Q08AI8	MB214_HUMAN	Protein mab-21-like 4	MAB21L4 C2orf54	Homo sapiens (Human)						MVLLWASVLFLAPEDWAELQGAVYR	3.130000114	1	1	3.20E-12	2894.052532	12.83144	13.47825	14.12189	0	10.25163	0	0	12.77242	13.34821	13.6616	0	12.78012	11.28062	10.76633	15.08963	15.58893	0	14.98456	17.41649	0	0	0	15.20425	0	0	0	0	0	0	0	0	0	0	11.72558	12.4417	0	0	0	0	0	0	0	0	0	0	0	0	0
Q08AM6	VAC14_HUMAN	Protein VAC14 homolog (Tax1-binding protein 2)	VAC14 TAX1BP2 TRX	Homo sapiens (Human)	phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]; signal transduction [GO:0007165]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; PAS complex [GO:0070772]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; PAS complex [GO:0070772]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]	GO:0000139; GO:0000306; GO:0005783; GO:0005829; GO:0006661; GO:0007165; GO:0010008; GO:0031901; GO:0031902; GO:0033674; GO:0038023; GO:0042802; GO:0043231; GO:0070772	GPFIIR	5.840000153	0.228924736	0.228924736	0.159251342	702.403294	16.49645	15.17189	0	0	0	0	15.54138	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.04104	0	0	0	0	0	0	0	0	14.51769	15.95328	17.33658	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q08AN1	ZN616_HUMAN	Zinc finger protein 616	ZNF616	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	DGETNDK	7.579999924	1	1	0.223854262	776.3322031	0	0	0	15.82471	0	0	0	0	0	0	0	0	0	0	0	19.11148	0	0	0	0	0	0	0	0	16.527	0	0	0	0	0	0	0	0	0	0	0	0	15.94888	0	0	0	0	0	0	0	15.66516	0	0
Q09013	DMPK_HUMAN	"Myotonin-protein kinase, MT-PK, EC 2.7.11.1 (DM-kinase, DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase)"	DMPK DM1PK MDPK	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; muscle cell apoptotic process [GO:0010657]; nuclear envelope organization [GO:0006998]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction [GO:0014853]; regulation of heart contraction [GO:0008016]; regulation of myotube differentiation [GO:0010830]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of mitochondrial outer membrane [GO:0031307]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of mitochondrial outer membrane [GO:0031307]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin phosphatase regulator activity [GO:0017020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; muscle cell apoptotic process [GO:0010657]; nuclear envelope organization [GO:0006998]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction [GO:0014853]; regulation of heart contraction [GO:0008016]; regulation of myotube differentiation [GO:0010830]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin phosphatase regulator activity [GO:0017020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0002028; GO:0004674; GO:0004712; GO:0005524; GO:0005640; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006874; GO:0006998; GO:0008016; GO:0010657; GO:0010830; GO:0014722; GO:0014853; GO:0017020; GO:0018105; GO:0031307; GO:0031965; GO:0033017; GO:0035556; GO:0046872; GO:0051823; GO:0106310	EMEAIR	12.39000034	1	1	0.22593847	764.3264606	20.15292	19.89665	21.16914	0	20.41545	18.38149	18.46548	20.16853	0	0	0	0	19.89178	0	20.71208	19.15499	21.3942	18.8348	0	18.69531	0	18.28081	19.38713	0	0	0	0	0	0	0	18.51072	0	21.79505	21.09788	21.24051	19.23859	19.08638	18.30076	19.13932	19.05552	0	0	19.32317	20.05893	17.61672	0	0	18.51151
Q09019	DMWD_HUMAN	Dystrophia myotonica WD repeat-containing protein (Dystrophia myotonica-containing WD repeat motif protein) (Protein 59) (Protein DMR-N9)	DMWD DM9	Homo sapiens (Human)		dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]	dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]		GO:0005634; GO:0030425; GO:0043204	LGEPDSAGAGEPPATPAGLGSGGDR	4.309999943	1	1	0.044382092	2236.80089	14.90535	12.96668	0	12.91819	12.94009	14.38238	13.75846	14.45323	14.55941	14.38656	14.17813	12.65295	0	13.63492	0	14.18626	13.26762	0	14.7566	13.77927	14.15339	0	16.66195	13.3507	10.01906	0	14.64504	0	0	13.76784	15.70474	0	0	0	0	0	16.80775	16.05049	0	12.64632	15.7445	0	8.992576	0	0	0	0	0
Q09328	MGT5A_HUMAN	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A, EC 2.4.1.155 (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V, GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V, Secreted GNT-V) ]"	MGAT5 GGNT5	Homo sapiens (Human)	negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]"	"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]"	GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1903614; GO:1904894	LAEPGQSCKQVCQESQLICEPSFFQHLNK	8.199999809	0.798162222	0.798162222	0.19854598	3462.130721	18.00458	18.85111	0	0	19.19776	16.95204	16.82319	18.31708	15.02483	16.09056	17.8475	0	0	15.06411	15.31825	18.66194	13.6775	15.30888	18.27583	0	16.46572	18.45874	0	0	17.5555	15.43762	18.0851	18.53527	14.4543	0	17.09126	15.93829	18.54511	14.85716	0	16.54253	19.33762	0	18.5736	19.18833	17.73779	0	18.06683	16.70701	19.22399	16.76125	16.65576	16.29501
Q09428	ABCC8_HUMAN	ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1)	ABCC8 HRINS SUR SUR1	Homo sapiens (Human)	cellular glucose homeostasis [GO:0001678]; cellular response to organic substance [GO:0071310]; female pregnancy [GO:0007565]; inorganic cation transmembrane transport [GO:0098662]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of wound healing [GO:0061045]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542]	inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672]	inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325]; cellular glucose homeostasis [GO:0001678]; cellular response to organic substance [GO:0071310]; female pregnancy [GO:0007565]; inorganic cation transmembrane transport [GO:0098662]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of wound healing [GO:0061045]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325]	GO:0001678; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016020; GO:0016525; GO:0019829; GO:0030672; GO:0031004; GO:0032496; GO:0032760; GO:0032868; GO:0042383; GO:0042626; GO:0044325; GO:0046676; GO:0055085; GO:0060253; GO:0061045; GO:0061855; GO:0071310; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1903818; GO:1905075; GO:1905604; GO:1990573	QRISVAR	7.949999809	1	1	0.324425325	829.4571644	0	0	17.01907	0	17.50898	16.12441	0	16.00328	16.21529	16.25404	16.02907	16.75738	0	15.74642	0	0	0	0	16.19292	16.70444	0	0	0	0	0	0	0	0	16.41286	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q09666	AHNK_HUMAN	Neuroblast differentiation-associated protein AHNAK (Desmoyokin)	AHNAK PM227	Homo sapiens (Human)	positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484]; regulation of voltage-gated calcium channel activity [GO:1901385]	actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493]; positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484]; regulation of voltage-gated calcium channel activity [GO:1901385]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493]	GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1901385; GO:1905686	FSMPGFKGEGPDVDVTLPK	10.59000015	0.481221795	0.481221795	0.227018606	2017.87126	14.72537	12.67943	14.58192	0	0	14.58997	0	0	13.95598	0	0	0	0	0	0	13.56372	16.40714	0	0	0	0	0	0	0	14.65732	0	0	12.70895	15.01428	14.29242	13.02416	14.8015	14.87169	0	15.17349	12.71212	0	0	15.57314	15.14811	0	14.18007	12.11174	0	0	0	0	0
Q09FC8	ZN415_HUMAN	Zinc finger protein 415	ZNF415	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001650; GO:0005634; GO:0005737; GO:0006357; GO:0015630; GO:0046872	HWRIHTGEKPYK	3.00999999	1	1	0.246564268	1551.254629	16.30229	0	0	0	15.17172	0	14.53643	0	16.76971	16.3158	14.86644	0	0	0	0	0	0	14.44491	0	0	15.25622	0	16.05951	0	15.98217	0	15.30274	16.60394	0	0	0	17.00531	0	0	15.52008	0	0	0	0	0	0	0	0	0	0	0	17.16851	0
Q09MP3	R51A2_HUMAN	RAD51-associated protein 2	RAD51AP2	Homo sapiens (Human)	double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]	protein-containing complex [GO:0032991]	protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]	double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0003690; GO:0003697; GO:0032991; GO:0036297	QIGIIGIQNLITR	2.690000057	0.022008244	0.022008244	0.512684098	1438.260524	0	0	0	0	0	0	0	0	0	0	0	0	16.97953	0	17.07885	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.67772	0	0	18.21212	0	18.28623	0	0	0	0	0	0	0	0	0	0
Q0D2J5	ZN763_HUMAN	Zinc finger protein 763	ZNF763	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872	SLIEGNVNEIK	6.739999771	0.264810741	0.264810741	0.04764788	1213.251889	11.92958	0	0	13.47055	9.79976	14.86224	12.09572	0	13.64587	0	0	0	10.85009	13.93284	0	15.83275	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.75956	12.44435	0	0	0	0	0
Q0IIM8	TBC8B_HUMAN	TBC1 domain family member 8B	TBC1D8B	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; glomerular filtration [GO:0003094]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]	cytosol [GO:0005829]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; glomerular filtration [GO:0003094]; vesicle-mediated transport [GO:0016192]	calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]	GO:0003094; GO:0005096; GO:0005509; GO:0005829; GO:0016192; GO:0090630	DDAEAVTALNR	9.06000042	1	1	0.091231362	1173.896388	11.26269	0	12.98564	0	13.76949	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.99251	0	0	13.49542	0	17.33408	0	0	0	0	0	0	0	0	14.72753	0	0	0	0	0	0	0
Q0IIN9	ZNFS1_HUMAN	Putative uncharacterized protein ZNF252P-AS1 (ZNF252P antisense RNA 1) (ZNF252P antisense gene protein 1)	ZNF252P-AS1 C8orf77	Homo sapiens (Human)						GALSPSLGR	3.210000038	1	1	0.19764193	857.4092145	0	14.20658	14.92356	14.51554	13.49022	11.01616	14.30709	15.2449	0	0	15.63489	0	14.30302	14.4171	15.12986	14.55	0	12.55949	0	0	0	0	0	0	0	12.64778	0	0	0	0	0	0	0	14.80449	0	0	13.14029	0	0	0	0	0	15.19425	15.89268	0	0	15.66839	0
Q0JRZ9	FCHO2_HUMAN	F-BAR domain only protein 2	FCHO2	Homo sapiens (Human)	clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]	"clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]"	"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]"	GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098835	FAESKGTGK	4.730000019	1	1	0.250852397	923.3208385	0	0	0	18.53074	0	17.11599	0	0	0	18.38458	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.08578	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97838	0	0	0	0	0	0	0
Q0P6D6	CCD15_HUMAN	Coiled-coil domain-containing protein 15	CCDC15	Homo sapiens (Human)		centrosome [GO:0005813]	centrosome [GO:0005813]		GO:0005813	LFMDIER	1.279999971	1	1	0.120981815	922.8556337	14.32397	16.54199	14.71139	0	15.97254	0	0	0	0	12.31927	15.41602	15.65022	0	0	0	14.92806	14.44058	14.99482	13.88457	16.41321	0	14.27039	0	0	0	0	0	0	0	0	0	0	16.44026	0	0	0	0	0	0	0	0	14.8887	0	0	0	0	0	0
Q0VAA2	LR74A_HUMAN	Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)	LRRC74A C14orf166B LRRC74	Homo sapiens (Human)						SLNPTGTMK	3.359999895	1	1	0.146498186	964.2129078	15.05932	11.13174	13.76277	13.33813	12.91695	16.23054	0	13.53774	15.1823	0	14.92285	15.69585	16.53053	14.37688	0	0	11.27748	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.30929	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.61058	0
Q0VAK6	LMOD3_HUMAN	"Leiomodin-3 (Leiomodin, fetal form)"	LMOD3	Homo sapiens (Human)	actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of skeletal muscle fiber development [GO:0048743]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of skeletal muscle fiber development [GO:0048743]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523]	GO:0003785; GO:0005523; GO:0005737; GO:0005856; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0030016; GO:0030239; GO:0030240; GO:0031430; GO:0045010; GO:0048741; GO:0048743; GO:0051694	EMLLDFVNAMK	1.679999948	1	1	0.193366567	1325.687737	0	0	13.59807	14.92426	13.87748	13.37363	0	12.40461	15.25234	0	0	0	0	0	13.29631	0	0	0	0	0	0	0	0	0	14.36254	15.84392	11.25754	13.73744	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.45026	0	0	0
Q0VD83	APOBR_HUMAN	"Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor, Apolipoprotein B48 receptor, apoB-48R)"	APOBR APOB48R	Homo sapiens (Human)	cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; triglyceride metabolic process [GO:0006641]	chylomicron [GO:0042627]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]	chylomicron [GO:0042627]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; triglyceride metabolic process [GO:0006641]	very-low-density lipoprotein particle receptor activity [GO:0030229]	GO:0005886; GO:0006641; GO:0006869; GO:0008203; GO:0016020; GO:0030229; GO:0034361; GO:0034362; GO:0042627	QDSGAGETAKAAR	15.68000031	1	1	0.064740118	1260.464829	0	0	0	0	14.48358	0	0	0	13.82293	0	0	0	0	0	0	0	13.06497	15.51265	0	0	0	0	16.70125	0	0	0	0	0	0	0	16.46061	16.59182	0	14.43229	0	15.08186	14.80561	15.92239	0	0	0	0	17.78062	17.48424	15.73037	17.0843	0	0
Q0VDF9	HSP7E_HUMAN	Heat shock 70 kDa protein 14 (HSP70-like protein 1) (Heat shock protein HSP60)	HSPA14 HSP60 HSP70L1	Homo sapiens (Human)	'de novo' cotranslational protein folding [GO:0051083]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' cotranslational protein folding [GO:0051083]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016020; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051083; GO:0051085; GO:0051787	YEIDTGEETKFVNPEDVAR	5.21999979	1	1	9.25E-13	2213.171065	0	14.77097	16.0274	14.41843	14.28701	15.03845	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q0VF96	CGNL1_HUMAN	Cingulin-like protein 1 (Junction-associated coiled-coil protein) (Paracingulin)	CGNL1 JACOP KIAA1749	Homo sapiens (Human)	actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]	bicellular tight junction [GO:0005923]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]	bicellular tight junction [GO:0005923]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]; actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]		GO:0005923; GO:0007015; GO:0016459; GO:0032991; GO:0051058; GO:0051497; GO:0150105	AGSYGVSIR	7.699999809	0.719096363	0.719096363	0.219089202	909.784052	0	0	16.22267	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.8754	0	0	0	0	0	0	0	17.94899	0	15.47108	16.00912	0	17.46378	0	17.34924	15.34381	0	0	0	0	0	0	0	0
Q0VFZ6	CF210_HUMAN	Protein CFAP210 (Cilia- and flagella- associated protein 210) (Coiled-coil domain-containing protein 173)	CFAP210 C2orf77 CCDC173	Homo sapiens (Human)						NFHSGLLLSRVMK	16.23999977	1	1	0.399707775	1501.892049	14.96165	17.18717	14.97572	14.95504	16.53875	0	14.08843	12.97025	0	0	18.49967	0	13.43135	15.02299	0	16.18246	15.92726	18.86009	15.22981	14.28232	18.52483	14.38459	18.17645	15.45072	15.65923	0	0	0	0	0	17.93374	0	0	0	0	0	0	0	0	16.08578	0	0	0	15.83378	0	0	19.02308	0
Q0VG06	FP100_HUMAN	Fanconi anemia core complex-associated protein 100 (Fanconi anemia-associated protein of 100 kDa)	FAAP100 C17orf70	Homo sapiens (Human)	interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]	chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]	chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]	DNA binding [GO:0003677]	GO:0000785; GO:0003677; GO:0005654; GO:0005829; GO:0006513; GO:0036297; GO:0043240	APSPLGPTR	11.81000042	1	1	0.281431334	892.4570603	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.98244	0	0	0	0	17.58659	0	0	0
Q0VGE8	ZN816_HUMAN	Zinc finger protein 816	ZNF816 ZNF816A	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AVMLENYRNLEFVDSSLK	4.349999905	0.282074928	0.282074928	0.059832161	2142.963691	15.82286	7.584185	14.27823	10.84104	13.48766	0	0	13.36495	0	0	0	14.97279	14.66516	11.10452	12.24583	13.66384	13.46228	13.86915	15.0499	13.94005	14.73888	0	13.71207	12.10808	15.49489	13.75098	0	0	0	0	0	0	11.88336	0	0	0	13.93249	16.37534	13.61216	0	0	0	0	12.69598	14.29276	0	13.65682	0
Q0Z7S8	FABP9_HUMAN	"Fatty acid-binding protein 9 (Testis lipid-binding protein, TLBP) (Testis-type fatty acid-binding protein, T-FABP)"	FABP9	Homo sapiens (Human)	acrosome assembly [GO:0001675]; fatty acid transport [GO:0015908]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; nucleus [GO:0005634]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; acrosome assembly [GO:0001675]; fatty acid transport [GO:0015908]	fatty acid binding [GO:0005504]	GO:0001669; GO:0001675; GO:0005504; GO:0005634; GO:0005829; GO:0015908	MMTIRTESSFQDTK	8.869999886	1	1	0.230786822	1707.960619	0	0	13.02615	0	0	0	0	0	0	0	15.38947	16.10301	0	0	0	0	15.26853	0	0	0	0	0	0	0	0	0	0	0	0	0	15.24885	0	14.68446	15.76179	0	0	0	0	0	0	15.36797	15.68967	15.2469	16.09081	0	0	0	0
Q0ZGT2	NEXN_HUMAN	Nexilin (F-actin-binding protein) (Nelin)	NEXN	Homo sapiens (Human)	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cell-cell adhesion mediator activity [GO:0098632]; structural constituent of muscle [GO:0008307]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493]	actin filament binding [GO:0051015]; cell-cell adhesion mediator activity [GO:0098632]; structural constituent of muscle [GO:0008307]	GO:0005886; GO:0005912; GO:0005925; GO:0007156; GO:0007411; GO:0008307; GO:0015629; GO:0030018; GO:0030334; GO:0030424; GO:0051015; GO:0051493; GO:0070593; GO:0098632	FEAMQR	10.14999962	0.239273623	0.239273623	0.255915858	796.4102194	17.66896	16.46177	14.69303	0	17.75861	16.63856	15.25037	15.78611	15.62248	17.53489	15.87241	14.75103	16.85486	15.63127	16.64138	16.15269	16.65452	16.91459	16.8121	15.9521	0	18.22032	18.00914	18.70011	16.94915	17.50556	16.76902	15.59807	15.53218	15.95609	17.36738	17.33474	15.66642	16.0561	15.99015	16.63568	17.36968	16.57049	17.15233	16.88256	16.38254	16.79282	16.29837	17.62074	17.15473	17.84788	17.52175	17.28156
Q10567	AP1B1_HUMAN	AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit)	AP1B1 ADTB1 BAM22 CLAPB2	Homo sapiens (Human)	basolateral protein secretion [GO:0110010]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192]	AP-1 adaptor complex [GO:0030121]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]	AP-1 adaptor complex [GO:0030121]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; basolateral protein secretion [GO:0110010]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192]	clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]	GO:0000139; GO:0001822; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019901; GO:0030121; GO:0030276; GO:0030659; GO:0032588; GO:0043231; GO:0060155; GO:0110010; GO:1903232	QVGSISMDLQLTNK	4.559999943	1	1	0.481339393	1551.144538	11.9591	0	0	0	0	13.16705	0	0	13.77797	0	13.57405	10.8834	16.66139	0	14.99625	0	0	0	0	0	0	16.2876	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.02279	0	0	19.29578	0	0	0	0	0	0	0
Q10570	CPSF1_HUMAN	"Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit, CPSF 160 kDa subunit)"	CPSF1 CPSF160	Homo sapiens (Human)	mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0019899; GO:0035925; GO:0098789	DRNLMVYMYLPEAK	1.870000005	1	1	0.400220109	1775.303048	17.29749	16.68771	0	0	12.23725	0	0	0	12.31323	0	0	15.10504	0	0	0	0	0	14.84279	0	0	0	0	0	0	0	18.08858	0	0	14.33889	0	0	0	0	0	0	0	0	18.5416	0	15.81126	0	0	0	9.824821	0	0	0	0
Q10571	MN1_HUMAN	Transcriptional activator MN1 (Probable tumor suppressor protein MN1)	MN1	Homo sapiens (Human)	"intramembranous ossification [GO:0001957]; negative regulation of osteoblast proliferation [GO:0033689]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; intramembranous ossification [GO:0001957]; negative regulation of osteoblast proliferation [GO:0033689]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of transcription, DNA-templated [GO:0006355]"		GO:0001957; GO:0005634; GO:0006355; GO:0033689; GO:0070564; GO:1902806	QVPGGAFPGASAMPRAAGMVGLSK	3.970000029	0.04826124	0.04826124	0.174145878	2274.223994	0	13.26732	13.65168	12.5833	0	0	0	0	0	0	0	16.69919	0	0	14.00174	13.05566	0	0	0	0	0	5.593435	0	0	0	0	14.84518	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.08859	0	0	0	0
Q10586	DBP_HUMAN	"D site-binding protein (Albumin D box-binding protein) (Albumin D-element-binding protein) (Tax-responsive enhancer element-binding protein 302, TaxREB302)"	DBP	Homo sapiens (Human)	circadian rhythm [GO:0007623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; circadian rhythm [GO:0007623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007623; GO:0045944; GO:0090575; GO:1990837	AALPAATTPGPGLETAGPADAPAGAVVGGGSPR	3.589999914	1	1	0.235455972	2853.566518	0	15.77548	10.32825	14.81871	14.78175	0	17.83749	12.85416	15.56822	0	0	0	0	0	0	14.13048	0	0	11.56709	0	0	0	0	16.12284	0	14.44765	0	0	0	0	0	0	0	0	0	0	15.00954	0	0	0	15.43535	15.12385	7.086082	0	13.23	0	0	0
Q10588	BST1_HUMAN	"ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2, EC 3.2.2.6 (ADP-ribosyl cyclase 2) (Bone marrow stromal antigen 1, BST-1) (Cyclic ADP-ribose hydrolase 2, cADPr hydrolase 2) (CD antigen CD157)"	BST1	Homo sapiens (Human)	humoral immune response [GO:0006959]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cellular extravasation [GO:0002691]; regulation of inflammatory response [GO:0050727]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of neutrophil chemotaxis [GO:0090022]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of superoxide metabolic process [GO:0090322]; signal transduction [GO:0007165]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; uropod [GO:0001931]	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; uropod [GO:0001931]; ADP-ribosyl cyclase activity [GO:0061811]; cyclic ADP-ribose hydrolase [GO:0061812]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]; humoral immune response [GO:0006959]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cellular extravasation [GO:0002691]; regulation of inflammatory response [GO:0050727]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of neutrophil chemotaxis [GO:0090022]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of superoxide metabolic process [GO:0090322]; signal transduction [GO:0007165]"	"ADP-ribosyl cyclase activity [GO:0061811]; cyclic ADP-ribose hydrolase [GO:0061812]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]"	GO:0001931; GO:0001952; GO:0002691; GO:0003953; GO:0005576; GO:0005886; GO:0006959; GO:0007165; GO:0008284; GO:0016740; GO:0016849; GO:0019898; GO:0030890; GO:0031225; GO:0032956; GO:0035579; GO:0050135; GO:0050727; GO:0050730; GO:0050848; GO:0061809; GO:0061811; GO:0061812; GO:0070062; GO:0090022; GO:0090322; GO:2001044	AAQGCAASR	2.220000029	1	1	0.30064953	891.7027498	17.76853	18.00359	12.35729	0	18.14924	16.33835	0	0	17.44713	16.8725	0	0	0	0	15.74201	0	0	17.34059	17.51038	0	0	18.43262	18.18508	0	17.38628	18.39063	0	0	0	17.47091	0	19.99886	18.40836	17.70806	18.10131	0	17.91997	17.09074	17.4537	17.57371	0	0	16.02273	0	18.47423	16.87398	17.71062	18.58931
Q10713	MPPA_HUMAN	Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) (P-55)	PMPCA INPP5E KIAA0123 MPPA	Homo sapiens (Human)	protein processing involved in protein targeting to mitochondrion [GO:0006627]	extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]	extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005615; GO:0005739; GO:0005743; GO:0006627; GO:0017087; GO:0046872	EFILMGGTVDTVELER	8.760000229	1	1	0.066200147	1808.080403	0	0	0	0	0	0	0	0	0	0	0	0	0	16.63014	16.59763	0	0	0	16.44748	16.91184	0	16.62152	15.57758	15.94406	15.15444	14.87762	0	0	14.83986	15.72534	16.48899	13.10997	14.7356	0	16.42533	14.84851	0	0	0	0	0	0	0	0	0	0	0	0
Q11206	SIA4C_HUMAN	"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4, Alpha 2,3-ST 4, Beta-galactoside alpha-2,3-sialyltransferase 4, EC 2.4.99.2, EC 2.4.99.4 (Alpha 2,3-sialyltransferase IV) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Gal-beta-1,4-GlcNAc-alpha-2,3-sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase, EC 2.4.99.6) (SAT-3) (ST-4) (ST3Gal IV, ST3GalIV) (ST3GalA.2) (STZ) (Sialyltransferase 4C, SIAT4-C)"	ST3GAL4 CGS23 NANTA3 SIAT4C STZ	Homo sapiens (Human)	cognition [GO:0050890]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082]	extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; neolactotetraosylceramide alpha-2,3-sialyltransferase activity [GO:0004513]; sialyltransferase activity [GO:0008373]; cognition [GO:0050890]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082]"	"beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; neolactotetraosylceramide alpha-2,3-sialyltransferase activity [GO:0004513]; sialyltransferase activity [GO:0008373]"	GO:0000139; GO:0003836; GO:0004513; GO:0005576; GO:0006486; GO:0008118; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0016020; GO:0016021; GO:0016266; GO:0018146; GO:0019082; GO:0030194; GO:0030259; GO:0032580; GO:0047288; GO:0050890; GO:0097503; GO:1903238; GO:1990743	NSSLGDAINK	14.27000046	0.922327399	0.922327399	0.258445891	1018.708698	20.11616	17.20646	16.23134	0	20.02279	19.58641	0	0	19.46795	19.45614	0	0	17.9198	0	16.51909	0	18.69532	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.67696	19.79011	0	0	0	20.6636	0	0	0	19.81395	0	0	16.6186	17.54998	18.2052
Q12756	KIF1A_HUMAN	"Kinesin-like protein KIF1A (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein, hUnc-104)"	KIF1A ATSV C2orf20	Homo sapiens (Human)	anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; dense core granule cytoskeletal transport [GO:0099519]; microtubule-based movement [GO:0007018]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; dense core granule cytoskeletal transport [GO:0099519]; microtubule-based movement [GO:0007018]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0003774; GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0030705; GO:0042802; GO:0045202; GO:0048471; GO:0060998; GO:0061001; GO:0098674; GO:0098992; GO:0099519; GO:1904115; GO:1990048; GO:1990049	GILLQAASDK	8.550000191	0.428292245	0.428292245	0.222774245	1015.531074	16.0846	14.13052	16.04079	12.31861	13.77478	0	0	15.94486	15.85265	15.43063	16.66422	16.71443	16.20513	13.6951	16.38459	14.09835	13.74673	0	0	0	16.57109	14.63651	0	15.33973	14.37607	13.9165	0	0	0	14.31466	17.15919	0	16.28315	0	0	16.51446	0	16.20609	17.12751	15.47712	0	0	18.06801	14.75446	13.54078	15.21431	14.80231	0
Q12767	TMM94_HUMAN	Transmembrane protein 94	TMEM94 KIAA0195	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	EKHLGEPPSALGLSTR	5.429999828	1	1	0.209419892	1692.543027	0	0	15.61562	13.9932	16.68289	0	0	14.87036	16.09964	16.41921	16.82897	0	15.64166	14.95551	15.53602	17.52652	15.78273	0	0	14.09	0	15.3203	0	0	16.20265	14.66225	0	14.56043	14.33513	17.12557	14.85449	17.52917	16.44279	17.60928	14.18097	16.90428	0	14.89768	0	17.71465	14.4426	12.88108	14.49733	14.40312	0	0	15.08108	16.54243
Q12769	NU160_HUMAN	Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160)	NUP160 KIAA0197 NUP120	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]	structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0005829; GO:0006406; GO:0006913; GO:0015031; GO:0017056; GO:0031080; GO:0072006	LFSVTRNR	7.130000114	1	1	0.152205077	993.2459018	13.80795	15.9172	15.03899	13.65549	14.71704	15.65038	0	0	12.22117	0	14.42799	0	15.49563	0	0	13.34586	0	0	0	0	0	0	0	0	0	15.55066	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12770	SCAP_HUMAN	"Sterol regulatory element-binding protein cleavage-activating protein, SCAP, SREBP cleavage-activating protein"	SCAP KIAA0199 PSEC0227	Homo sapiens (Human)	aging [GO:0007568]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; negative regulation of cholesterol biosynthetic process [GO:0045541]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of fatty acid biosynthetic process [GO:0042304]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; SREBP signaling pathway [GO:0032933]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934]; unfolded protein binding [GO:0051082]; aging [GO:0007568]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; negative regulation of cholesterol biosynthetic process [GO:0045541]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of fatty acid biosynthetic process [GO:0042304]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; SREBP signaling pathway [GO:0032933]	protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934]; unfolded protein binding [GO:0051082]	GO:0000139; GO:0001666; GO:0005783; GO:0005789; GO:0005794; GO:0006955; GO:0007568; GO:0008203; GO:0012507; GO:0016021; GO:0032868; GO:0032933; GO:0032934; GO:0032991; GO:0042304; GO:0044255; GO:0044877; GO:0045541; GO:0045542; GO:0051082; GO:0090110	VAALGLATGIVLVLLLLCLYR	16.15999985	1	1	0.17117943	2241.976319	0	0	13.42465	0	14.07387	12.51488	14.78797	12.65928	14.14258	13.40534	14.26261	11.19977	0	11.00313	14.71295	0	0	13.41991	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12772	SRBP2_HUMAN	"Sterol regulatory element-binding protein 2, SREBP-2 (Class D basic helix-loop-helix protein 2, bHLHd2) (Sterol regulatory element-binding transcription factor 2) [Cleaved into: Processed sterol regulatory element-binding protein 2 (Transcription factor SREBF2) ]"	SREBF2 BHLHD2 SREBP2	Homo sapiens (Human)	cellular response to laminar fluid shear stress [GO:0071499]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription by RNA polymerase II [GO:0006357]; SREBP signaling pathway [GO:0032933]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription by RNA polymerase II [GO:0006357]; SREBP signaling pathway [GO:0032933]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000139; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0008022; GO:0008203; GO:0008593; GO:0009267; GO:0010886; GO:0012507; GO:0032933; GO:0032937; GO:0042632; GO:0043231; GO:0045542; GO:0045944; GO:0046983; GO:0070888; GO:0071404; GO:0071499; GO:0090370; GO:1902895; GO:1903146; GO:1903955; GO:1990837	LLHSFVDSVGVMSPPLSRSSVLK	7.730000019	1	1	0.197076687	2471.368046	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.8938	0	0	0	0	0	0	17.0785	0	0	15.9569	0	0	0	0	0	16.08197	0	16.7879	0	0	0	0	0	0	0	0	15.61668	0	0	0	0	0	0
Q12774	ARHG5_HUMAN	Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM)	ARHGEF5 TIM	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; hematopoietic stem cell homeostasis [GO:0061484]; intracellular signal transduction [GO:0035556]; myeloid dendritic cell chemotaxis [GO:0002408]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein import [GO:1904591]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]	cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; hematopoietic stem cell homeostasis [GO:0061484]; intracellular signal transduction [GO:0035556]; myeloid dendritic cell chemotaxis [GO:0002408]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein import [GO:1904591]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]	GO:0002102; GO:0002408; GO:0005085; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008289; GO:0030036; GO:0030054; GO:0032956; GO:0035556; GO:0042995; GO:0043087; GO:0043507; GO:0051056; GO:0051091; GO:0051493; GO:0051496; GO:0061484; GO:0071803; GO:0071944; GO:0090630; GO:1904591	DEAGVSEHPEAPAR	5.21999979	0.137883857	0.137883857	0.442895508	1465.15018	0	14.54199	14.60955	0	0	0	0	0	0	0	16.84524	0	0	0	0	15.98726	13.35607	15.67317	16.02935	0	16.03693	15.21339	16.16037	16.9565	15.12253	0	14.14316	15.66244	0	15.78823	0	15.08042	15.72281	0	14.20337	0	0	0	0	0	0	0	0	0	0	0	16.99643	0
Q12789	TF3C1_HUMAN	"General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit, TFIIIC 220 kDa subunit, TFIIIC220) (Transcription factor IIIC subunit alpha)"	GTF3C1	Homo sapiens (Human)	5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797]	DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]	GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904	CTMVEAFDRWGK	11.31999969	0.124028206	0.124028206	0.123770158	1515.191513	16.49962	0	14.1715	0	0	0	0	0	0	0	0	0	15.36061	18.53643	0	18.83105	0	0	0	14.01466	0	0	17.50195	0	0	0	0	0	0	17.79841	0	0	0	0	0	0	15.22503	0	0	0	14.4777	0	0	0	18.76607	0	0	0
Q12791	KCMA1_HUMAN	"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel, MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog, Slo homolog, hSlo)"	KCNMA1 KCNMA SLO	Homo sapiens (Human)	cellular potassium ion homeostasis [GO:0030007]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; positive regulation of apoptotic process [GO:0043065]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; relaxation of vascular associated smooth muscle [GO:0060087]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; smooth muscle contraction involved in micturition [GO:0060083]	apical plasma membrane [GO:0016324]; caveola [GO:0005901]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]	apical plasma membrane [GO:0016324]; caveola [GO:0005901]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]; cellular potassium ion homeostasis [GO:0030007]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; positive regulation of apoptotic process [GO:0043065]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; relaxation of vascular associated smooth muscle [GO:0060087]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; smooth muscle contraction involved in micturition [GO:0060083]	actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]	GO:0001666; GO:0003779; GO:0005249; GO:0005886; GO:0005901; GO:0006813; GO:0006970; GO:0008076; GO:0015269; GO:0016021; GO:0016324; GO:0030007; GO:0034465; GO:0034765; GO:0042391; GO:0042802; GO:0043065; GO:0045211; GO:0045794; GO:0046872; GO:0051592; GO:0060072; GO:0060073; GO:0060083; GO:0060087	EEAVAAEVGWMTSVK	16.31999969	1	1	0.328626706	1623.849079	0	13.7647	0	14.9952	13.69944	13.81045	13.31987	0	11.03575	14.02112	14.14839	14.94264	0	14.06841	14.80835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12796	PNRC1_HUMAN	Proline-rich nuclear receptor coactivator 1 (Proline-rich protein 2) (Protein B4-2)	PNRC1 PROL2	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634	TVVSVPQR	3.079999924	1	1	0.24460022	885.1979084	18.73903	0	0	0	0	0	0	0	0	0	0	0	0	0	15.96973	0	0	17.28553	0	0	0	0	0	0	20.15	0	0	0	0	0	0	0	17.43353	20.12304	0	0	0	19.34356	0	0	0	0	0	0	0	0	0	0
Q12802	AKP13_HUMAN	"A-kinase anchor protein 13, AKAP-13 (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene, LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13, PRKA13) (p47)"	AKAP13 BRX HT31 LBC	Homo sapiens (Human)	adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056]	cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056]	cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]	GO:0004691; GO:0005078; GO:0005085; GO:0005634; GO:0005829; GO:0005938; GO:0007186; GO:0007507; GO:0016020; GO:0031267; GO:0035023; GO:0035025; GO:0043123; GO:0043406; GO:0046872; GO:0048471; GO:0051018; GO:0051056; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:0086023	APPSGRER	8.020000458	0.871123195	0.871123195	6.87E-13	869.3881974	0	15.56786	0	0	12.91119	13.58581	0	13.63017	0	0	0	0	0	0	0	13.95084	15.53891	0	0	11.73236	0	0	0	0	0	14.9872	12.64389	0	11.99812	0	0	0	10.91298	0	0	0	16.67789	0	0	0	15.78705	0	0	0	0	0	0	0
Q12809	KCNH2_HUMAN	"Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1, ERG-1, Eag-related protein 1, Ether-a-go-go-related protein 1, H-ERG, hERG-1, hERG1) (Voltage-gated potassium channel subunit Kv11.1)"	KCNH2 ERG ERG1 HERG	Homo sapiens (Human)	"cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]"	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel complex [GO:1902937]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	"cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel complex [GO:1902937]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; C3HC4-type RING finger domain binding [GO:0055131]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]"	C3HC4-type RING finger domain binding [GO:0055131]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]	GO:0000976; GO:0003064; GO:0005242; GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0008076; GO:0009986; GO:0031625; GO:0042391; GO:0042802; GO:0042803; GO:0045893; GO:0048471; GO:0055075; GO:0055131; GO:0060048; GO:0060306; GO:0060307; GO:0071466; GO:0071805; GO:0086005; GO:0086008; GO:0086009; GO:0086010; GO:0086011; GO:0086013; GO:0086091; GO:0097110; GO:0097623; GO:0098915; GO:1901379; GO:1901380; GO:1901381; GO:1902282; GO:1902937; GO:1903765; GO:1990573	GDPFLASPTSDREIIAPK	1.840000033	1	1	0	1914.900578	0	0	0	0	0	0	0	0	15.03913	0	14.35095	13.05647	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12815	TROAP_HUMAN	Tastin (Trophinin-assisting protein) (Trophinin-associated protein)	TROAP	Homo sapiens (Human)	cell adhesion [GO:0007155]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; cell adhesion [GO:0007155]		GO:0005737; GO:0007155	ENREMSHTR	12.03999996	1	1	6.89E-13	1177.607804	0	0	14.65128	0	0	13.74646	0	0	0	0	0	13.14043	0	0	12.42151	0	0	0	15.70052	0	0	0	15.10243	0	0	14.65291	0	0	0	0	0	16.73081	15.34147	0	0	0	0	0	0	16.08454	0	0	0	0	0	0	0	0
Q12829	RB40B_HUMAN	"Ras-related protein Rab-40B (SOCS box-containing protein RAR, Protein Rar)"	RAB40B SEC4L	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; toxin transport [GO:1901998]	endosome [GO:0005768]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	endosome [GO:0005768]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; toxin transport [GO:1901998]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005635; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0048471; GO:0072659; GO:1901998	MSALGSPVR	2.769999981	1	1	0.458582536	917.4750658	0	0	0	0	0	0	17.48656	0	17.6206	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12830	BPTF_HUMAN	Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen)	BPTF FAC1 FALZ	Homo sapiens (Human)	"anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	ATPase complex [GO:1904949]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]	"ATPase complex [GO:1904949]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome mobilization [GO:0042766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000122; GO:0000785; GO:0000978; GO:0001892; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007420; GO:0007492; GO:0009952; GO:0016589; GO:0035064; GO:0042766; GO:0043565; GO:0045944; GO:0046872; GO:0070062; GO:1904949	DVGPYGIR	8.569999695	1	1	0.186740135	875.8995553	16.45269	14.96656	14.0559	0	0	0	0	0	14.85799	15.99482	16.17006	0	15.94698	15.41322	15.6986	0	16.27895	0	14.13048	0	0	16.58043	16.45698	0	0	0	0	0	14.98566	0	12.55419	14.20443	14.14347	0	0	16.0509	15.95925	17.30628	15.86229	16.11461	13.26018	0	0	16.16517	0	0	0	12.80671
Q12837	PO4F2_HUMAN	"POU domain, class 4, transcription factor 2 (Brain-specific homeobox/POU domain protein 3B, Brain-3B, Brn-3B)"	POU4F2 BRN3B	Homo sapiens (Human)	axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000165; GO:0000785; GO:0000791; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002039; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0007283; GO:0007411; GO:0007507; GO:0007605; GO:0010666; GO:0016607; GO:0030182; GO:0030520; GO:0031290; GO:0032869; GO:0043068; GO:0043433; GO:0045596; GO:0045597; GO:0045672; GO:0045773; GO:0045944; GO:0046326; GO:0048675; GO:0050885; GO:0051090; GO:0060041; GO:0071345; GO:0071392; GO:0071453; GO:0072332; GO:0090259; GO:1902870; GO:1904178; GO:1990791; GO:1990841; GO:2000679	ACLPTPPSNIFGGLDESLLAR	7.889999866	0.078829594	0.078829594	4.56E-13	2227.775053	14.34465	0	17.81418	0	0	0	16.57355	12.92313	0	0	0	15.52442	17.24232	0	0	0	0	0	15.79932	0	12.81538	15.48432	0	0	0	12.75602	0	0	0	0	0	9.58836	0	0	0	0	0	0	18.09142	0	14.42439	0	0	0	0	0	0	0
Q12840	KIF5A_HUMAN	"Kinesin heavy chain isoform 5A (Kinesin heavy chain neuron-specific 1) (Neuronal kinesin heavy chain, NKHC)"	KIF5A NKHC1	Homo sapiens (Human)	anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]	axon cytoplasm [GO:1904115]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]	axon cytoplasm [GO:1904115]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0003774; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007268; GO:0007411; GO:0008017; GO:0008574; GO:0016020; GO:0016192; GO:0016887; GO:0019894; GO:0030705; GO:0032839; GO:0035253; GO:0043204; GO:0045202; GO:0048471; GO:0048489; GO:0098971; GO:0099641; GO:1904115; GO:1990049	DVLAGYNGTIFAYGQTSSGK	5.980000019	1	1	0.108644121	2050.187963	12.49773	13.84643	13.61713	15.7399	0	0	0	17.67514	13.24779	0	0	0	0	0	13.44772	0	0	13.49941	13.7603	15.09789	11.28378	0	0	0	16.55867	15.16886	14.14704	14.68631	13.92987	13.3122	0	0	0	0	0	0	0	0	0	0	0	0	12.66254	0	0	0	9.654997	0
Q12841	FSTL1_HUMAN	Follistatin-related protein 1 (Follistatin-like protein 1)	FSTL1 FRP	Homo sapiens (Human)	cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0008201; GO:0030154; GO:0030510; GO:0043066; GO:0043542; GO:0045446; GO:0061484; GO:0070062	ECAVTEK	8.399999619	0.451223701	0.451223701	0.085752749	835.9061392	0	14.61855	18.215	13.96661	0	12.5789	0	17.64826	15.64898	16.66714	0	14.68183	0	13.89486	0	10.89161	15.87014	15.14527	15.89914	16.89708	0	16.26395	12.08498	15.27921	0	14.85397	0	14.57141	15.9642	0	18.78975	15.76327	0	18.64425	0	0	15.31287	13.02777	16.31695	15.78286	17.04752	9.632765	14.99448	0	0	16.00459	0	12.53948
Q12851	M4K2_HUMAN	"Mitogen-activated protein kinase kinase kinase kinase 2, EC 2.7.11.1 (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase, GC kinase) (MAPK/ERK kinase kinase kinase 2, MEK kinase kinase 2, MEKKK 2) (Rab8-interacting protein)"	MAP4K2 GCK RAB8IP	Homo sapiens (Human)	immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903]	basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]	basolateral plasma membrane [GO:0016323]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000139; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0006903; GO:0006955; GO:0007254; GO:0008349; GO:0016323; GO:0031435; GO:0035556; GO:0043507; GO:0045087; GO:0046330; GO:0106310	FELLQRVGAGTYGDVYK	6.260000229	0.35990718	0.35990718	0.3053461	1916.123388	14.72402	14.74105	14.6798	0	0	0	0	16.59292	13.85857	0	0	0	0	0	13.8883	0	14.10248	16.18908	16.556	0	15.89309	16.01873	0	14.7294	0	16.04346	0	13.55958	15.15827	14.04254	15.59661	15.88139	16.27725	15.85025	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12852	M3K12_HUMAN	"Mitogen-activated protein kinase kinase kinase 12, EC 2.7.11.25 (Dual leucine zipper bearing kinase, DLK) (Leucine-zipper protein kinase, ZPK) (MAPK-upstream kinase, MUK) (Mixed lineage kinase)"	MAP3K12 ZPK	Homo sapiens (Human)	"histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]"	ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004706; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0016020; GO:0016572; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0043507; GO:0043539; GO:0045860; GO:0045893; GO:0046777; GO:0070374; GO:0106310; GO:2000672	AGSQHLTPAALLYR	1.860000014	1	1	0.488431297	1496.37413	18.4423	0	0	0	0	0	0	17.93949	0	0	18.48824	0	0	0	0	0	16.84538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.51839	0	0	0	0	0	0	0	0	17.29233	0	0	0	0	0	0	0
Q12857	NFIA_HUMAN	"Nuclear factor 1 A-type, NF1-A, Nuclear factor 1/A (CCAAT-box-binding transcription factor, CTF) (Nuclear factor I/A, NF-I/A, NFI-A) (TGGCA-binding protein)"	NFIA KIAA1439	Homo sapiens (Human)	"DNA replication [GO:0006260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; synapse maturation [GO:0060074]; ureter development [GO:0072189]; viral genome replication [GO:0019079]"	cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; DNA replication [GO:0006260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; synapse maturation [GO:0060074]; ureter development [GO:0072189]; viral genome replication [GO:0019079]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006355; GO:0006357; GO:0019079; GO:0030054; GO:0045944; GO:0060074; GO:0072189; GO:0140297	YHPQETLK	23.36000061	1	1	0.370191529	1012.739747	0	17.9824	0	0	0	0	0	0	0	0	0	0	0	0	17.59649	0	0	0	0	0	0	0	0	0	0	0	18.50883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12860	CNTN1_HUMAN	Contactin-1 (Glycoprotein gp135) (Neural cell surface protein F3)	CNTN1	Homo sapiens (Human)	axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system myelin formation [GO:0032289]; cerebellum development [GO:0021549]; locomotory behavior [GO:0007626]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sodium ion transport [GO:0010765]	anchored component of postsynaptic membrane [GO:0099025]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	anchored component of postsynaptic membrane [GO:0099025]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system myelin formation [GO:0032289]; cerebellum development [GO:0021549]; locomotory behavior [GO:0007626]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sodium ion transport [GO:0010765]	carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0007155; GO:0007219; GO:0007411; GO:0007420; GO:0007626; GO:0010628; GO:0010765; GO:0010976; GO:0016020; GO:0021549; GO:0030246; GO:0030424; GO:0032289; GO:0045121; GO:0050731; GO:0070062; GO:0098609; GO:0098632; GO:0099025; GO:0099026	AVDLIPWMEYEFR	2.099999905	1	1	0.591003626	1682.977504	0	0	0	18.67152	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.96015	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12864	CAD17_HUMAN	"Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin, LI-cadherin)"	CDH17	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; germinal center B cell differentiation [GO:0002314]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; integrin-mediated signaling pathway [GO:0007229]; marginal zone B cell differentiation [GO:0002315]; oligopeptide transmembrane transport [GO:0035672]; oligopeptide transport [GO:0006857]; positive regulation of integrin activation by cell surface receptor linked signal transduction [GO:0033626]; spleen development [GO:0048536]	basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; transporter activity [GO:0005215]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; germinal center B cell differentiation [GO:0002314]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; integrin-mediated signaling pathway [GO:0007229]; marginal zone B cell differentiation [GO:0002315]; oligopeptide transmembrane transport [GO:0035672]; oligopeptide transport [GO:0006857]; positive regulation of integrin activation by cell surface receptor linked signal transduction [GO:0033626]; spleen development [GO:0048536]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; transporter activity [GO:0005215]	GO:0002314; GO:0002315; GO:0005178; GO:0005215; GO:0005427; GO:0005509; GO:0005654; GO:0005886; GO:0006857; GO:0007155; GO:0007156; GO:0007229; GO:0009986; GO:0016021; GO:0016323; GO:0016339; GO:0016342; GO:0030054; GO:0033626; GO:0035672; GO:0045296; GO:0048536; GO:0098742	LPMDGLFLIQTYAGMLQLAK	2.970000029	1	1	0.16863069	2239.551784	0	0	16.80939	0	12.94546	12.60555	0	14.77962	16.55042	0	16.27346	0	0	0	0	14.43437	13.91141	12.46291	16.66807	0	0	0	15.80502	13.10296	0	14.88435	0	15.66883	0	0	0	15.66088	15.42414	0	0	14.45234	0	0	0	0	0	0	0	0	0	0	14.81933	0
Q12872	SFSWA_HUMAN	"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)"	SFSWAP SFRS8 SWAP	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]"	RNA binding [GO:0003723]	GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025	AMLAASK	8.609999657	1	1	0.239670549	708.9700843	15.88118	15.86119	15.5402	0	0	15.79183	16.15991	0	14.10398	15.69776	15.58383	16.00212	0	0	0	0	16.38148	16.0202	15.11972	0	0	0	0	16.3887	0	15.72205	15.74791	0	0	0	0	0	15.24144	16.00688	0	0	0	0	0	0	0	15.87692	0	16.18956	0	0	0	0
Q12873	CHD3_HUMAN	"Chromodomain-helicase-DNA-binding protein 3, CHD-3, EC 3.6.4.12 (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase, hZFH)"	CHD3	Homo sapiens (Human)	"centrosome cycle [GO:0007098]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; spindle organization [GO:0007051]"	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605]	"centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; centrosome cycle [GO:0007098]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; spindle organization [GO:0007051]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000976; GO:0003677; GO:0003678; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006333; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736	ERPEGETGDLGK	2.210000038	0.406411409	0.406411409	0.157028079	1289.581201	16.1146	0	0	17.50521	0	0	0	13.38792	15.18661	15.08489	16.23643	0	0	0	0	0	13.07471	10.93977	0	0	0	0	0	0	0	11.12556	0	0	15.42079	15.69531	0	16.97641	0	11.79415	0	0	0	12.70042	13.84406	14.39091	16.03127	11.62759	0	0	0	0	13.32044	13.63993
Q12879	NMDE1_HUMAN	"Glutamate receptor ionotropic, NMDA 2A, GluN2A (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A, NMDAR2A, NR2A, hNR2A)"	GRIN2A NMDAR2A	Homo sapiens (Human)	"activation of cysteine-type endopeptidase activity [GO:0097202]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; directional locomotion [GO:0033058]; dopamine metabolic process [GO:0042417]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; serotonin metabolic process [GO:0042428]; sleep [GO:0030431]; startle response [GO:0001964]; visual learning [GO:0008542]"	cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]	"cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; amyloid-beta binding [GO:0001540]; glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity [GO:0097202]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; directional locomotion [GO:0033058]; dopamine metabolic process [GO:0042417]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; serotonin metabolic process [GO:0042428]; sleep [GO:0030431]; startle response [GO:0001964]; visual learning [GO:0008542]"	amyloid-beta binding [GO:0001540]; glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]	GO:0001540; GO:0001964; GO:0001975; GO:0004972; GO:0005789; GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007420; GO:0007611; GO:0007613; GO:0008021; GO:0008270; GO:0008542; GO:0009410; GO:0009611; GO:0009986; GO:0014069; GO:0015276; GO:0017146; GO:0019233; GO:0022008; GO:0022849; GO:0030431; GO:0030659; GO:0033058; GO:0035235; GO:0038023; GO:0042177; GO:0042417; GO:0042428; GO:0042734; GO:0043065; GO:0043197; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0051968; GO:0060079; GO:0060291; GO:0097060; GO:0097202; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:0099061; GO:1903539; GO:1904062; GO:2000463	GPPALNIAVMLGHSHDVTER	5.760000229	1	1	1.37E-12	2134.494216	14.42828	7.326535	13.99076	14.27406	11.96112	15.3848	0	14.6047	0	13.3508	0	0	0	8.119555	12.05867	11.46318	16.02106	11.46035	15.82599	0	0	0	0	0	0	0	13.18747	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.79565	0	0	0	0	11.28574	0
Q12882	DPYD_HUMAN	"Dihydropyrimidine dehydrogenase [NADP(+)], DHPDHase, DPD, EC 1.3.1.2 (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)"	DPYD	Homo sapiens (Human)	beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]"	GO:0002058; GO:0005737; GO:0005829; GO:0006145; GO:0006208; GO:0006210; GO:0006212; GO:0006214; GO:0006248; GO:0006249; GO:0017113; GO:0019483; GO:0042803; GO:0046050; GO:0046079; GO:0046872; GO:0050660; GO:0050661; GO:0051536; GO:0051539	GKPVPR	1.620000005	1	1	0.11355461	652.5524168	0	0	15.20951	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12888	TP53B_HUMAN	"TP53-binding protein 1, 53BP1, p53-binding protein 1, p53BP1"	TP53BP1	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin modification-dependent histone binding [GO:0061649]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]"	damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0000077; GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006303; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0042393; GO:0045830; GO:0045893; GO:0045944; GO:0051091; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:1990391; GO:2000042	ASSLHRTSSGTSLSAMHSSGSSGK	4.920000076	0.850175381	0.850175381	1.37E-12	2336.543694	0	15.33086	16.10574	14.59661	0	0	0	14.29517	0	16.09769	18.71879	14.06332	0	0	0	0	0	0	0	0	0	0	14.70451	0	15.26442	0	15.46779	15.17511	0	14.51055	0	15.51192	0	0	0	0	0	16.32097	0	10.59597	15.51089	0	12.9678	14.31655	14.26811	0	15.36581	0
Q12893	TM115_HUMAN	Transmembrane protein 115 (Placental protein 6) (Protein PL6)	TMEM115 PL6 LUCA11.2	Homo sapiens (Human)	"negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	identical protein binding [GO:0042802]	GO:0000139; GO:0005634; GO:0005794; GO:0006890; GO:0008285; GO:0015031; GO:0016021; GO:0032580; GO:0042802	QTMGDCVVLRVPQVR	3.900000095	1	1	0.162799092	1773.011804	0	16.32031	13.27799	0	13.70596	0	15.10678	14.88127	0	0	16.19765	15.62352	0	15.08323	0	0	0	0	0	0	0	0	0	0	0	0	0	15.03417	0	0	0	0	0	0	0	0	0	0	0	0	0	13.95801	15.5387	0	0	0	0	0
Q12905	ILF2_HUMAN	Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa)	ILF2 NF45 PRO3063	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]"	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	"extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; positive regulation of transcription, DNA-templated [GO:0045893]"	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003725; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0035580; GO:0045893; GO:1904724; GO:1904813; GO:1990904	VLQSALAAIR	3.390000105	0.314452767	0.314452767	0.227907335	1040.058496	0	13.61474	15.46787	15.66327	15.90161	15.35032	14.56017	14.46681	15.7729	15.39332	13.3082	15.91697	14.50972	13.87506	0	0	15.91604	14.99701	15.60592	0	17.08264	16.52776	0	15.19507	0	0	0	15.21027	15.83132	14.75506	0	15.85379	12.10786	12.92048	15.03381	15.16635	16.00278	10.87296	0	0	13.6216	13.49122	14.73304	15.5892	13.82394	14.23723	15.54699	15.23299
Q12912	IRAG2_HUMAN	"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2 ]"	IRAG2 JAW1 LRMP	Homo sapiens (Human)	immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]	azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]	azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]	microtubule binding [GO:0008017]	GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005815; GO:0005886; GO:0005887; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0016021; GO:0035577	DGALDVKR	10.22000027	1	1	0.083463352	869.8598286	15.7308	0	13.66829	0	0	16.20588	0	0	9.571892	0	0	0	0	0	0	14.03319	13.94511	0	0	0	0	0	0	0	14.10357	15.34358	0	15.23638	0	14.27054	16.65591	0	0	15.12166	15.71852	0	0	0	12.2178	12.58172	0	14.8949	0	0	0	0	0	15.88083
Q12913	PTPRJ_HUMAN	"Receptor-type tyrosine-protein phosphatase eta, Protein-tyrosine phosphatase eta, R-PTP-eta, EC 3.1.3.48 (Density-enhanced phosphatase 1, DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J, R-PTP-J) (CD antigen CD148)"	PTPRJ DEP1	Homo sapiens (Human)	B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; contact inhibition [GO:0060242]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; T cell receptor signaling pathway [GO:0050852]	cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]	cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; contact inhibition [GO:0060242]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; T cell receptor signaling pathway [GO:0050852]	beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001772; GO:0004725; GO:0005161; GO:0005886; GO:0005887; GO:0005911; GO:0006470; GO:0008013; GO:0008285; GO:0009986; GO:0010642; GO:0016791; GO:0019221; GO:0019901; GO:0030155; GO:0030183; GO:0030308; GO:0030336; GO:0032587; GO:0032760; GO:0035335; GO:0035579; GO:0035584; GO:0042059; GO:0043116; GO:0043407; GO:0043410; GO:0045295; GO:0045296; GO:0045785; GO:0048008; GO:0050731; GO:0050852; GO:0050860; GO:0050918; GO:0051019; GO:0051894; GO:0051897; GO:0051898; GO:0060242; GO:0070062; GO:0070097; GO:1905451	EPALVLK	4.409999847	1	1	0.001131754	768.500755	0	0	0	0	0	14.3745	0	0	0	0	0	14.54485	0	0	0	0	0	14.22997	16.28385	16.81037	0	16.64308	17.14101	0	17.15492	14.30311	15.14649	0	14.24894	16.66751	0	0	0	0	0	0	0	0	0	0	15.49106	0	0	0	0	0	0	0
Q12923	PTN13_HUMAN	"Tyrosine-protein phosphatase non-receptor type 13, EC 3.1.3.48 (Fas-associated protein-tyrosine phosphatase 1, FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E, PTP-E1, hPTPE1) (Protein-tyrosine phosphatase PTPL1)"	PTPN13 PNP1 PTP1E PTPL1	Homo sapiens (Human)	negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0014066; GO:0030027; GO:0035335; GO:0036312; GO:0043005; GO:0044297; GO:0070062	AVIPQGAAESDGRIHK	2.450000048	0.419624627	0.419624627	0.450850705	1648.965244	0	13.2281	0	15.90979	17.44425	12.05944	10.85054	14.30634	13.81254	0	17.31091	14.19205	0	0	0	14.06721	0	16.78156	0	15.26011	0	0	0	17.35461	15.67675	0	0	14.84624	15.0473	16.91083	0	0	0	16.99336	0	17.12914	14.86036	0	16.44046	15.45469	17.18573	0	15.26217	17.11347	0	0	0	16.22774
Q12926	ELAV2_HUMAN	"ELAV-like protein 2 (ELAV-like neuronal protein 1) (Hu-antigen B, HuB) (Nervous system-specific RNA-binding protein Hel-N1)"	ELAVL2 HUB	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	"nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]"	mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005654; GO:0006355; GO:1990904	TNKTHK	3.75	1	1	0.024251436	728.5671761	0	0	14.93712	15.22537	0	16.33776	0	14.31667	0	0	0	0	0	0	0	17.63597	0	16.13761	13.89036	16.12739	0	14.88532	14.79842	0	0	15.81497	13.60644	0	0	0	0	16.25673	16.97544	0	0	0	16.39898	13.86212	0	14.44741	14.36755	0	15.13998	0	15.65239	13.66615	0	0
Q12929	EPS8_HUMAN	Epidermal growth factor receptor kinase substrate 8	EPS8	Homo sapiens (Human)	actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]	brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; actin binding [GO:0003779]; signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	actin binding [GO:0003779]; signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267]	GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030426; GO:0030832; GO:0031267; GO:0031532; GO:0031982; GO:0032420; GO:0032426; GO:0032587; GO:0035023; GO:0035591; GO:0036336; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070062; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830	SAAQKK	6.78000021	0.135072246	0.135072246	0.207785965	630.447196	0	15.691	15.06163	14.0605	11.43516	0	0	16.73308	0	0	0	0	0	14.91777	0	15.41656	15.60407	16.21146	16.19624	0	0	0	0	0	0	16.31221	0	15.2772	0	15.25981	0	0	17.56014	0	0	0	16.02608	17.92973	16.61094	16.69123	0	0	0	0	15.92328	16.63337	15.77977	0
Q12931	TRAP1_HUMAN	"Heat shock protein 75 kDa, mitochondrial, HSP 75 (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein, TRAP-1)"	TRAP1 HSP75	Homo sapiens (Human)	chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	cell periphery [GO:0071944]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cell periphery [GO:0071944]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]	GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0061077; GO:0071944; GO:1901856; GO:1903427; GO:1903751	RTTAQLGPR	5.050000191	1	1	0.017156312	1000.337187	0	14.86962	14.37811	12.89305	0	13.92087	0	14.49923	12.78212	14.07522	0	15.90005	13.08752	15.00162	14.11429	14.65954	14.76049	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.98257	15.64638	0	0	0	0	0	0	0
Q12933	TRAF2_HUMAN	"TNF receptor-associated factor 2, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)"	TRAF2 TRAP3	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; TRAF2-GSTP1 complex [GO:0097057]; tumor necrosis factor receptor superfamily complex [GO:0002947]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]	CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; TRAF2-GSTP1 complex [GO:0097057]; tumor necrosis factor receptor superfamily complex [GO:0002947]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238	SIGLKDLAMADLEQK	6.769999981	1	1	0.447604634	1631.790402	0	0	0	17.97144	0	0	0	0	19.76501	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.89159	0	0	0	0	0
Q12934	BFSP1_HUMAN	"Filensin (Beaded filament structural protein 1) (Lens fiber cell beaded-filament structural protein CP 115, CP115) (Lens intermediate filament-like heavy, LIFL-H) [Cleaved into: Filensin C-terminal fragment; Filensin N-terminal fragment ]"	BFSP1	Homo sapiens (Human)	cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]; cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]	structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]	GO:0005200; GO:0005212; GO:0005737; GO:0005882; GO:0005886; GO:0005938; GO:0045109; GO:0048469; GO:0070307	SGEKSS	9.239999771	1	1	5.74E-13	593.2152132	15.39891	0	12.57422	13.76869	14.09944	16.11982	15.52868	0	11.4259	15.30394	13.80202	0	0	0	0	0	0	16.24695	0	0	0	0	0	0	0	15.67545	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q12946	FOXF1_HUMAN	"Forkhead box protein F1 (Forkhead-related activator 1, FREAC-1) (Forkhead-related protein FKHL5) (Forkhead-related transcription factor 1)"	FOXF1 FKHL5 FREAC1	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]"	chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001570; GO:0001701; GO:0001756; GO:0001763; GO:0002053; GO:0003197; GO:0003214; GO:0003677; GO:0005634; GO:0005667; GO:0006357; GO:0007224; GO:0007368; GO:0007494; GO:0007507; GO:0009887; GO:0010811; GO:0014822; GO:0030198; GO:0030323; GO:0030324; GO:0030335; GO:0031016; GO:0043305; GO:0043565; GO:0045198; GO:0045893; GO:0045944; GO:0048286; GO:0048371; GO:0048557; GO:0048565; GO:0048613; GO:0048617; GO:0050728; GO:0051145; GO:0060426; GO:0060438; GO:0060441; GO:0060461; GO:0060463; GO:0060841; GO:0061030; GO:0071345; GO:0071407; GO:0072189; GO:0090131; GO:0097070; GO:0098609	MSSAPEKQQPPHGGGGGGGGGGGAAMDPASSGPSK	3.019999981	1	1	5.95E-12	3080.427215	0	0	13.61713	0	14.39799	0	15.16927	15.03736	12.82676	0	0	0	0	13.97735	0	12.72957	0	12.6633	11.92828	0	11.78791	0	13.47781	0	9.774635	0	13.629	0	12.72537	11.65072	16.24666	16.96522	0	0	0	0	0	0	0	0	0	0	0	14.582	0	0	0	0
Q12952	FOXL1_HUMAN	"Forkhead box protein L1 (Forkhead-related protein FKHL11) (Forkhead-related transcription factor 7, FREAC-7)"	FOXL1 FKHL11 FREAC7	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495]"	"DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007495; GO:0007507; GO:0008301; GO:0009653; GO:0030111; GO:0030154; GO:0030166; GO:0043565; GO:0061146	SSPKSSDK	6.070000172	0.874079525	0.874079525	0.226275887	833.9997713	14.18839	12.60442	0	0	13.92925	13.84546	5.413892	15.8614	14.77359	0	13.56493	15.47089	0	0	14.51666	15.97023	0	0	15.75815	0	15.30431	0	8.076458	15.33852	0	13.05766	0	15.62446	14.77549	0	0	15.12465	0	0	0	16.11899	15.62826	0	0	15.21461	16.1277	13.8159	11.72699	0	0	0	12.32375	0
Q12955	ANK3_HUMAN	"Ankyrin-3, ANK-3 (Ankyrin-G)"	ANK3	Homo sapiens (Human)	axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]	axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]	cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]	GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259	GLPQTAVCNLNITLPAHK	2.319999933	1	1	0.232810484	1948.087159	11.54089	14.40475	12.74105	13.31739	0	11.34104	0	12.78342	7.084725	0	14.77632	0	15.53297	15.1192	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.68926	0	0
Q12959	DLG1_HUMAN	"Disks large homolog 1 (Synapse-associated protein 97, SAP-97, SAP97) (hDlg)"	DLG1	Homo sapiens (Human)	actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]	cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325]	GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0004385; GO:0004721; GO:0005604; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007015; GO:0007163; GO:0007268; GO:0008022; GO:0008092; GO:0008284; GO:0008360; GO:0009898; GO:0014704; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0019902; GO:0030054; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031434; GO:0031503; GO:0031579; GO:0031594; GO:0031641; GO:0032147; GO:0033268; GO:0035748; GO:0042110; GO:0042130; GO:0042383; GO:0042391; GO:0042982; GO:0043005; GO:0043113; GO:0043219; GO:0043268; GO:0043622; GO:0044325; GO:0045121; GO:0045197; GO:0045296; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070062; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0097120; GO:0098609; GO:0098839; GO:0098911; GO:0098919; GO:0098978; GO:0099645; GO:1902305; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903760; GO:1903764; GO:2000134	ALFDYDK	3.730000019	1	1	0.09834576	871.6236845	0	0	0	0	14.45034	0	0	15.74833	16.12078	0	0	0	0	0	0	0	0	15.51421	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.15024	0	0	0	0	0	0	0	0	0	0
Q12965	MYO1E_HUMAN	Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E)	MYO1E MYO1C	Homo sapiens (Human)	actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]	GO:0000146; GO:0001570; GO:0001701; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030136; GO:0031982; GO:0032437; GO:0032836; GO:0035091; GO:0035166; GO:0048008; GO:0051015; GO:0070062; GO:0072015	KYVQMR	8.699999809	1	1	0.176482103	840.4624491	16.06732	0	0	0	0	0	0	0	0	0	0	0	17.21359	18.37119	16.19969	15.97516	17.80864	16.02232	17.99387	17.33689	17.16966	17.01461	16.782	0	16.58504	16.50281	17.20759	15.91177	17.3282	15.90763	17.39679	0	15.89222	18.32557	15.2513	17.01423	15.6722	18.86964	14.51267	17.83845	16.05099	16.68857	18.11159	14.24758	13.84821	18.03197	15.52051	15.59141
Q12967	GNDS_HUMAN	"Ral guanine nucleotide dissociation stimulator, RalGDS (Ral guanine nucleotide exchange factor, RalGEF)"	RALGDS KIAA1308 RGF	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]	brush border [GO:0005903]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	brush border [GO:0005903]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]	GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005634; GO:0005829; GO:0005886; GO:0005903; GO:0007265; GO:0030695; GO:0043547	LLQSACNNYSIAPDEQFGAWFRAVER	11.25	1	1	0.03042763	3042.358785	16.84169	0	0	15.09498	0	0	0	0	0	17.65338	18.49036	16.49063	0	0	18.62997	0	0	15.45718	0	0	17.10669	0	14.1236	0	17.24425	0	0	0	0	0	0	0	0	0	0	0	0	14.0797	0	0	0	0	16.29917	0	16.68157	0	13.7687	0
Q12979	ABR_HUMAN	Active breakpoint cluster region-related protein	ABR	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; modulation of chemical synaptic transmission [GO:0050804]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]	axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; modulation of chemical synaptic transmission [GO:0050804]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005829; GO:0007264; GO:0016020; GO:0030424; GO:0043197; GO:0050804; GO:0051056; GO:0090630; GO:0098685; GO:0098978	DTAEPK	3.089999914	0.1470256	0.1470256	0.280060776	659.9881815	0	0	0	0	0	0	20.4064	0	0	0	16.71669	0	0	17.29714	0	20.80958	0	0	0	0	0	0	0	16.74461	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.63716	0	0	0	0	0	0
Q12986	NFX1_HUMAN	"Transcriptional repressor NF-X1, EC 2.3.2.- (Nuclear transcription factor, X box-binding protein 1)"	NFX1 NFX2	Homo sapiens (Human)	"inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006366; GO:0006954; GO:0008270; GO:0016567; GO:0045347; GO:0051865; GO:0061630	DVLCGTDVGK	5.380000114	0.475031644	0.475031644	0.122984328	1062.427246	0	0	0	0	0	0	0	0	11.57943	0	0	0	16.70806	16.90191	17.14172	17.37187	16.14575	17.38941	0	0	17.06414	16.9825	0	0	0	12.51874	17.17925	0	14.96602	0	0	16.68583	0	14.42453	16.56704	17.33138	18.6865	18.51862	17.15854	17.49936	18.35364	14.74589	18.04931	15.83245	18.61129	18.37117	16.86945	14.40179
Q12996	CSTF3_HUMAN	"Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit, CSTF 77 kDa subunit, CstF-77)"	CSTF3	Homo sapiens (Human)	mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006378; GO:0006379; GO:0031123	GDMNNAK	8.239999771	0.607895255	0.607895255	0.162702333	764.9473777	17.04314	12.7455	17.92461	14.74275	0	9.178978	0	18.84385	17.87928	0	16.80542	15.18329	14.64896	0	18.66253	14.88964	13.39847	16.08015	15.97601	17.73642	0	0	0	14.67451	14.48593	0	0	14.33878	0	14.33651	17.37297	12.58354	14.89264	13.49733	14.18015	10.96449	16.44395	16.30553	16.50511	18.82934	11.06096	11.45376	16.89286	0	17.05394	0	11.39209	0
Q13003	GRIK3_HUMAN	"Glutamate receptor ionotropic, kainate 3, GluK3 (Excitatory amino acid receptor 5, EAA5) (Glutamate receptor 7, GluR-7, GluR7)"	GRIK3 GLUR7	Homo sapiens (Human)	"G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]"	axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]	"axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]"	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015276; GO:0015277; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0098978; GO:0099507; GO:1904315	FSLTCQR	8.039999962	1	1	0.205687205	911.3467547	0	15.70067	14.9914	14.97783	13.77112	14.31681	10.62286	14.41055	14.94538	15.4937	16.48319	0	15.68631	0	0	15.31953	0	15.33607	15.06889	0	14.76127	14.60433	13.80072	15.621	0	14.54468	14.42609	0	14.58819	0	14.83745	15.20478	16.29929	14.95601	11.34799	14.74473	16.08563	14.5625	15.19371	16.37585	0	12.72898	10.96572	15.52038	15.51695	10.59041	14.73062	0
Q13009	TIAM1_HUMAN	"Rho guanine nucleotide exchange factor TIAM1 (T-lymphoma invasion and metastasis-inducing protein 1, TIAM-1)"	TIAM1	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; lipid binding [GO:0008289]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; lipid binding [GO:0008289]	GO:0005085; GO:0005829; GO:0005886; GO:0005911; GO:0007160; GO:0007264; GO:0008284; GO:0008289; GO:0010717; GO:0010718; GO:0016020; GO:0016477; GO:0016601; GO:0019900; GO:0030335; GO:0031234; GO:0032092; GO:0044291; GO:0045202; GO:0048013; GO:0050772; GO:0051056; GO:0060071; GO:0065003; GO:0090630; GO:1904338; GO:2000050	IDMDEKMK	11.88000011	0.495987862	0.495987862	0.186745148	1026.337151	15.92348	14.67551	15.69276	13.67466	13.8664	0	13.58297	14.49829	14.4593	15.28362	16.65777	15.09274	15.14743	13.87395	14.13832	12.97363	0	0	0	0	0	0	0	0	14.79529	0	15.8759	13.73751	15.38043	13.75146	17.1673	14.8379	14.61664	0	15.62991	0	0	14.26136	0	14.47263	0	14.88188	0	12.91164	16.32886	12.30834	16.55586	15.28728
Q13011	ECH1_HUMAN	"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial, EC 5.3.3.-"	ECH1	Homo sapiens (Human)	fatty acid beta-oxidation [GO:0006635]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]; fatty acid beta-oxidation [GO:0006635]"	"delta3,5-delta2,4-dienoyl-CoA isomerase activity [GO:0051750]"	GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0016020; GO:0051750; GO:0070062	MFTAGIDLMDMASDILQPK	6.239999771	1	1	0.188880138	2129.473775	11.37372	0	0	13.16221	0	0	0	9.349054	0	0	0	16.14412	15.03815	0	0	0	0	0	0	0	13.51716	0	0	0	9.511147	12.66303	0	2.24726	15.14071	0	0	0	12.3904	0	14.42399	13.12236	14.94898	0	0	11.81147	11.72004	0	0	0	16.30856	13.67096	12.2577	15.45257
Q13015	AF1Q_HUMAN	Protein AF1q	MLLT11 AF1Q	Homo sapiens (Human)	"extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of transcription, DNA-templated [GO:0045893]"		GO:0005654; GO:0005815; GO:0005829; GO:0043065; GO:0045893; GO:0051901; GO:0090200; GO:0097191; GO:0097193	VKDSSVGK	19.55999947	0.325341105	0.325341105	0.226368301	820.5180696	16.6768	16.63196	16.37879	17.93892	15.35142	0	16.53892	16.41944	16.85904	17.5364	14.77114	16.10388	16.5062	13.59346	14.92315	16.54464	17.44162	0	15.88566	16.46839	0	17.41588	16.9427	17.28053	15.3082	16.76571	17.05941	16.71135	14.8113	16.16508	15.91912	0	16.92381	17.53911	13.79936	17.31977	17.49357	18.85577	14.16508	17.12906	16.64491	16.43789	15.98334	17.10733	17.37817	17.22593	17.37053	16.19044
Q13017	RHG05_HUMAN	Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B)	ARHGAP5 RHOGAP5	Homo sapiens (Human)	cell adhesion [GO:0007155]; mammary gland development [GO:0030879]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169]; cell adhesion [GO:0007155]; mammary gland development [GO:0030879]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169]	GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007266; GO:0030879; GO:0042169; GO:0051056	ASMGMLR	6.090000153	0.133473203	0.133473203	0.258794189	796.1140493	15.68383	18.34369	0	0	0	13.4427	0	0	18.53219	0	0	0	0	16.91481	0	0	0	18.35344	16.26236	16.61809	0	18.18924	0	0	0	0	0	14.95208	14.67764	0	0	16.00043	16.51853	17.05081	0	0	19.41842	0	0	0	16.53745	17.37422	0	0	0	17.49491	15.3273	0
Q13018	PLA2R_HUMAN	"Secretory phospholipase A2 receptor, PLA2-R, PLA2R (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor, Soluble PLA2-R, Soluble PLA2R ]"	PLA2R1 CLEC13C	Homo sapiens (Human)	"negative regulation of arachidonic acid secretion [GO:1900139]; negative regulation of phospholipase A2 activity [GO:1900138]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of glomerular visceral epithelial cell apoptotic process [GO:1904635]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; replicative senescence [GO:0090399]"	cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; carbohydrate binding [GO:0030246]; phospholipase binding [GO:0043274]; signaling receptor activity [GO:0038023]; negative regulation of arachidonic acid secretion [GO:1900139]; negative regulation of phospholipase A2 activity [GO:1900138]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of glomerular visceral epithelial cell apoptotic process [GO:1904635]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; replicative senescence [GO:0090399]"	carbohydrate binding [GO:0030246]; phospholipase binding [GO:0043274]; signaling receptor activity [GO:0038023]	GO:0001819; GO:0005576; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0016021; GO:0030246; GO:0038023; GO:0043235; GO:0043274; GO:0043517; GO:0072593; GO:0090238; GO:0090399; GO:0090403; GO:1900138; GO:1900139; GO:1904635	REWICK	6.230000019	0.924707532	0.924707532	0.209131053	891.6235282	0	15.63593	14.30779	15.15904	15.13327	14.41282	0	15.93034	15.34209	15.68061	13.19374	14.82202	14.40812	14.61065	16.08166	13.29434	14.30417	0	13.91845	11.56617	12.33276	14.97846	14.07011	15.64098	15.75898	15.55611	0	15.87772	14.9534	14.15062	15.58816	13.65916	0	0	0	0	16.41651	0	0	15.6649	15.96636	0	0	15.39032	0	15.74942	15.00793	16.05915
Q13023	AKAP6_HUMAN	"A-kinase anchor protein 6, AKAP-6 (A-kinase anchor protein 100 kDa, AKAP 100) (Protein kinase A-anchoring protein 6, PRKA6) (mAKAP)"	AKAP6 AKAP100 KIAA0311	Homo sapiens (Human)	action potential [GO:0001508]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell growth [GO:0030307]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; protein targeting [GO:0006605]; regulation of membrane repolarization [GO:0060306]; regulation of protein kinase A signaling [GO:0010738]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]	calcium channel complex [GO:0034704]; caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]	calcium channel complex [GO:0034704]; caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; adenylate cyclase binding [GO:0008179]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter binding [GO:0044325]; action potential [GO:0001508]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell growth [GO:0030307]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; protein targeting [GO:0006605]; regulation of membrane repolarization [GO:0060306]; regulation of protein kinase A signaling [GO:0010738]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]	adenylate cyclase binding [GO:0008179]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter binding [GO:0044325]	GO:0001508; GO:0005635; GO:0005737; GO:0005901; GO:0006605; GO:0008179; GO:0010738; GO:0010880; GO:0014701; GO:0014704; GO:0016529; GO:0019933; GO:0030307; GO:0030315; GO:0031965; GO:0034237; GO:0034704; GO:0043495; GO:0044325; GO:0048471; GO:0051018; GO:0051281; GO:0060090; GO:0060306; GO:0060316; GO:0061051; GO:0070886; GO:0071320; GO:0071345; GO:1901381; GO:1902261	GKPNVTSK	6.619999886	0.51880151	0.51880151	0.329186402	829.3449427	0	0	0	0	0	16.5139	17.02641	0	0	16.55645	0	0	16.63625	15.78345	16.36953	0	13.65758	0	0	14.49722	15.38462	16.52258	0	0	14.84607	15.42109	0	0	16.02955	11.8214	0	0	16.20557	15.64414	16.15473	0	16.85815	14.46829	14.88661	0	17.046	15.41548	0	15.87537	0	16.77437	0	17.01987
Q13029	PRDM2_HUMAN	"PR domain zinc finger protein 2, EC 2.1.1.355 (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ)"	PRDM2 KMT8 RIZ	Homo sapiens (Human)	"determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity [GO:0042054]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity [GO:0042054]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0010468; GO:0042054; GO:0043565; GO:0045944	EEEELNDSSEELYTTIK	5.239999771	1	1	0.267175737	2029.31022	13.80418	16.95425	13.82822	0	0	15.15425	0	0	0	0	0	0	0	0	0	0	16.58719	0	13.96868	13.59084	0	0	15.69388	0	15.94112	0	0	15.3568	0	14.77194	15.23771	0	14.21562	14.23285	0	15.15813	0	9.979179	13.72716	0	14.50635	12.59759	15.88036	0	0	0	0	0
Q13033	STRN3_HUMAN	Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen)	STRN3 GS2NA SG2NA	Homo sapiens (Human)	"negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]"	armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]	GO:0000122; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443	DELAGGGGGGPGMAAPPR	10.68000031	0.714185655	0.714185655	0.476107361	1581.650111	17.27465	0	16.065	16.62467	0	0	0	0	0	20.23133	0	0	17.00816	0	0	0	0	0	17.31592	18.08846	0	0	0	0	0	0	0	0	0	0	0	19.73712	18.2461	0	0	0	0	0	20.35993	0	0	0	0	0	0	0	0	0
Q13042	CDC16_HUMAN	"Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6, APC6) (CDC16 homolog, CDC16Hs) (Cyclosome subunit 6)"	CDC16 ANAPC6	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]	anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]		GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979; GO:0072686	ATTLEK	6.869999886	1	1	0.088008916	662.1454868	0	13.38567	14.45525	0	15.6639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.17753	0	0	0	0	0	0	0	0	0	0	15.27346	0	0	0	0	0	0	0	0	0	15.51316	0	0	0	0	0	0	0
Q13045	FLII_HUMAN	Protein flightless-1 homolog	FLII FLIL	Homo sapiens (Human)	actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; myofibril assembly [GO:0030239]	actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; myofibril assembly [GO:0030239]"	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0003779; GO:0005546; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005903; GO:0005925; GO:0008154; GO:0015629; GO:0030239; GO:0034451; GO:0051014; GO:0051015; GO:0051016	KFESLFPGK	3.680000067	1	1	0.229043207	1053.463103	20.34112	0	0	0	15.94056	0	0	0	17.40648	0	0	0	0	0	17.47855	0	16.99623	0	0	0	0	0	0	0	16.0413	0	0	0	0	0	18.77062	0	17.17245	0	0	16.77868	17.78263	0	18.05377	0	0	0	0	0	0	0	0	18.22953
Q13057	COASY_HUMAN	"Bifunctional coenzyme A synthase, CoA synthase (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase, EC 2.7.7.3 (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase, PPAT); Dephospho-CoA kinase, DPCK, EC 2.7.1.24 (Dephosphocoenzyme A kinase, DPCOAK) ]"	COASY PSEC0106	Homo sapiens (Human)	coenzyme A biosynthetic process [GO:0015937]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937]	ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]	GO:0004140; GO:0004595; GO:0005524; GO:0005741; GO:0005759; GO:0015937; GO:0070062	LLPELLQPYTER	20.62999916	0.503819883	0.503819883	0.458633473	1471.466962	0	18.26169	17.68041	18.81136	17.65485	18.24049	18.00356	0	17.38213	0	18.10536	17.6914	14.33903	0	14.06909	0	0	0	0	17.20611	0	17.86806	18.03647	15.09956	16.12727	15.40206	0	15.75622	0	0	0	15.47655	0	0	15.06431	0	16.97961	17.24958	17.83033	0	17.71824	17.64075	17.1915	17.5034	0	15.75801	16.47704	17.04627
Q13061	TRDN_HUMAN	Triadin	TRDN	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum membrane organization [GO:0090158]; heart contraction [GO:0060047]; muscle contraction [GO:0006936]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901846]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to bacterium [GO:0009617]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cellular calcium ion homeostasis [GO:0006874]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum membrane organization [GO:0090158]; heart contraction [GO:0060047]; muscle contraction [GO:0006936]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901846]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to bacterium [GO:0009617]	protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]	GO:0005102; GO:0005783; GO:0005829; GO:0005886; GO:0006874; GO:0006936; GO:0009617; GO:0010649; GO:0010880; GO:0014701; GO:0014808; GO:0016021; GO:0016529; GO:0030314; GO:0030674; GO:0031122; GO:0033017; GO:0033018; GO:0044325; GO:0051279; GO:0060047; GO:0060315; GO:0060316; GO:0086036; GO:0090158; GO:1901846	MSKAGK	3.819999933	0.057074577	0.057074577	0.015184783	637.4811227	15.80251	0	12.47569	0	0	13.71183	14.72037	0	0	0	0	14.74726	16.2972	16.01453	0	0	0	0	0	18.1482	0	0	18.09573	0	0	0	0	13.3738	0	14.11514	0	0	0	15.64111	0	0	0	0	0	0	15.91213	15.4506	0	0	0	0	0	0
Q13064	MKRN3_HUMAN	"Probable E3 ubiquitin-protein ligase makorin-3, EC 2.3.2.27 (RING finger protein 63) (RING-type E3 ubiquitin transferase makorin-3) (Zinc finger protein 127)"	MKRN3 D15S9 RNF63 ZNF127	Homo sapiens (Human)	protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	ribonucleoprotein complex [GO:1990904]	ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0003723; GO:0016567; GO:0042802; GO:0046872; GO:0061630; GO:1990904	RGGLRPAPASGGGAWPSPLPSR	2.25999999	1	1	0.049071313	2143.744148	15.85248	14.02587	0	14.37761	0	13.40752	15.00658	11.10775	0	14.93587	14.58424	13.78792	13.42209	14.44746	12.24405	0	0	0	13.55828	0	0	0	13.57975	14.27685	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13075	BIRC1_HUMAN	Baculoviral IAP repeat-containing protein 1 (Neuronal apoptosis inhibitory protein)	NAIP BIRC1	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nervous system development [GO:0007399]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; inflammasome complex [GO:0061702]; IPAF inflammasome complex [GO:0072557]	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; inflammasome complex [GO:0061702]; IPAF inflammasome complex [GO:0072557]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nervous system development [GO:0007399]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]	GO:0002221; GO:0005524; GO:0005737; GO:0006954; GO:0007399; GO:0010804; GO:0016045; GO:0016323; GO:0032731; GO:0042742; GO:0042981; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0045087; GO:0046330; GO:0046456; GO:0046872; GO:0050729; GO:0061702; GO:0070269; GO:0072557; GO:0120283	GGKMR	5.679999828	0.314957023	0.314957023	0.26832961	549.7158541	17.03679	15.69483	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.61815	0	16.83867	16.67051	0	16.85143	0	0	0	0	17.0892	0	0	18.54959	0	0	0	0	18.49747	0	0	0	0	0
Q13084	RM28_HUMAN	"39S ribosomal protein L28, mitochondrial, L28mt, MRP-L28 (Melanoma antigen p15) (Melanoma-associated antigen recognized by T-lymphocytes) (Mitochondrial large ribosomal subunit protein bL28m)"	MRPL28 MAAT1	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0005829; GO:0006412; GO:0032543	QDPQLHPEDPER	1.470000029	1	1	0.569633499	1461.248029	0	0	0	0	0	17.22938	0	0	0	0	0	0	0	0	0	0	0	16.59928	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.61998	0	0	0	0	0
Q13103	SPP24_HUMAN	"Secreted phosphoprotein 24, Spp-24 (Secreted phosphoprotein 2)"	SPP2 SPP24	Homo sapiens (Human)	bone remodeling [GO:0046849]; skeletal system development [GO:0001501]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; bone remodeling [GO:0046849]; skeletal system development [GO:0001501]	endopeptidase inhibitor activity [GO:0004866]	GO:0001501; GO:0004866; GO:0005576; GO:0005788; GO:0031089; GO:0046849; GO:0062023	ARINTDFE	8.329999924	0.776203752	0.776203752	0.233251685	965.3238187	15.16501	14.93951	15.66988	16.05988	16.33975	0	14.30384	14.70829	14.33983	16.75118	14.27708	14.12189	0	15.88024	0	14.62921	0	0	17.41649	14.78644	0	16.1739	15.45934	0	14.71294	14.8066	0	0	0	14.33141	0	16.54907	0	16.48296	14.72213	0	15.09228	16.88873	11.94472	0	15.62958	0	2.903741	13.75324	0	0	0	0
Q13107	UBP4_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 4, EC 3.4.19.12 (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) (Ubiquitous nuclear protein homolog)"	USP4 UNP UNPH	Homo sapiens (Human)	negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511]	adenosine receptor binding [GO:0031685]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]	GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005886; GO:0006511; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872	QTLQSKSSTAPSR	8.890000343	0.581496775	0.581496775	0.149680524	1390.373587	15.30869	14.31405	14.32617	16.40925	15.93638	14.95113	14.21384	16.16177	14.64287	16.13558	17.49709	16.69839	14.57903	16.35772	14.79146	9.617546	14.77124	12.37328	0	0	13.96662	14.5542	17.4161	15.63361	18.90072	14.4476	0	0	0	16.64124	16.37548	16.64103	12.51938	16.21452	15.75282	12.47711	14.16093	0	16.47818	18.3747	16.63225	14.50519	11.3484	15.85337	16.81477	14.09268	0	12.85766
Q13112	CAF1B_HUMAN	"Chromatin assembly factor 1 subunit B, CAF-1 subunit B (Chromatin assembly factor I p60 subunit, CAF-I 60 kDa subunit, CAF-I p60) (M-phase phosphoprotein 7)"	CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7	Homo sapiens (Human)	cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334]	CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082]	GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042393; GO:0051082	EKPVLNMR	4.380000114	1	1	0.230417321	1002.703664	21.82562	0	14.33476	15.24339	0	0	0	0	17.71386	21.0205	17.91858	17.36512	0	0	0	19.11642	0	0	18.65561	0	0	17.45237	0	0	20.50208	0	21.33656	17.66314	0	0	0	18.71756	0	0	18.16735	0	0	18.81091	0	0	18.9257	20.94732	19.73673	0	0	0	0	0
Q13115	DUS4_HUMAN	"Dual specificity protein phosphatase 4, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2, MAP kinase phosphatase 2, MKP-2)"	DUSP4 MKP2 VH2	Homo sapiens (Human)	dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]	MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]	GO:0001706; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0043409; GO:0070373; GO:1990439	SPRAESLR	8.479999542	1	1	0.097297288	915.775741	0	16.73298	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.07825	0	0	0	0	0
Q13126	MTAP_HUMAN	"S-methyl-5'-thioadenosine phosphorylase, EC 2.4.2.28 (5'-methylthioadenosine phosphorylase, MTA phosphorylase, MTAP, MTAPase)"	MTAP MSAP	Homo sapiens (Human)	L-methionine salvage from methylthioadenosine [GO:0019509]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574]"	"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]"	GO:0004645; GO:0005654; GO:0005829; GO:0006139; GO:0006166; GO:0017061; GO:0019509; GO:0033574; GO:0070062	ENANKAK	13.5	1	1	0.17764681	771.6505124	16.15644	16.44898	0	17.73705	18.03669	0	15.18519	0	0	17.12613	0	16.73499	0	16.66385	16.01718	13.13035	0	16.9891	0	0	0	16.53226	15.62356	15.0881	16.69694	0	18.94043	0	15.1726	15.26464	0	16.89033	0	0	17.42915	0	16.26247	0	0	16.19752	0	15.01049	0	0	17.70816	17.29819	15.6313	15.44689
Q13127	REST_HUMAN	RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor)	REST NRSF XBR	Homo sapiens (Human)	"auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]"	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000381; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0042802; GO:0043065; GO:0043280; GO:0043922; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0061629; GO:0070933; GO:0071257; GO:0071385; GO:0071466; GO:0097150; GO:0099563; GO:1902459; GO:1902894; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798	TADRSNFK	6.96999979	0.62349999	0.62349999	0.274555361	937.9479974	14.22041	16.35242	14.53684	15.76273	16.22339	13.93082	0	11.07697	14.34724	0	0	0	15.20203	14.81572	14.08278	15.39349	16.84816	16.2792	16.07479	0	0	15.90223	15.91844	0	16.77444	15.9814	0	15.33655	0	0	18.08123	16.36577	16.50005	14.35481	0	16.12312	15.30539	0	16.10565	14.96111	0	0	0	14.60441	15.47329	0	0	16.25977
Q13136	LIPA1_HUMAN	"Liprin-alpha-1 (LAR-interacting protein 1, LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1, PTPRF-interacting protein alpha-1)"	PPFIA1 LIP1	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808]		GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0030424; GO:0030425; GO:0032991; GO:0048786; GO:0050808; GO:0051497; GO:1903077	LDSATVRTYSC	10.21000004	0.481265038	0.481265038	0.382964889	1274.425784	13.04985	13.02996	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.9072	16.10275	16.96688	0	0	0	16.50702	15.87869	16.03035	0	15.61153	0	0	0	16.67081	0	13.86985	0	0	0	0	0	0	0	17.36803	16.65897	16.16593	0	0	17.22701	11.7976	15.60289
Q13144	EI2BE_HUMAN	Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon)	EIF2B5 EIF2BE	Homo sapiens (Human)	aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]	guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045948; GO:0048708; GO:0050852	AAPVVAPPGVVVSRANK	6.869999886	0.611792803	0.611792803	1.37E-12	1630.920209	14.62749	11.70309	0	0	0	0	0	11.19352	14.18141	0	0	0	0	0	11.71471	14.46655	0	16.40976	0	14.60577	16.60637	14.05799	13.91241	0	0	0	15.07973	15.02246	16.8616	0	0	12.94214	16.0799	0	15.82911	16.21309	0	0	0	12.3452	0	15.40591	0	0	0	0	0	14.87162
Q13153	PAK1_HUMAN	"Serine/threonine-protein kinase PAK 1, EC 2.7.11.1 (Alpha-PAK) (p21-activated kinase 1, PAK-1) (p65-PAK)"	PAK1	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; wound healing [GO:0042060]	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018]	actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; wound healing [GO:0042060]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001726; GO:0001934; GO:0002223; GO:0004672; GO:0004674; GO:0004712; GO:0005518; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006468; GO:0006887; GO:0006915; GO:0006974; GO:0008284; GO:0014704; GO:0016310; GO:0016477; GO:0030018; GO:0030027; GO:0030335; GO:0030424; GO:0030425; GO:0031116; GO:0031532; GO:0031965; GO:0032587; GO:0032956; GO:0032991; GO:0033138; GO:0033148; GO:0035556; GO:0038096; GO:0042060; GO:0042802; GO:0043015; GO:0043408; GO:0043507; GO:0046777; GO:0048012; GO:0048013; GO:0048754; GO:0048812; GO:0050770; GO:0051496; GO:0060244; GO:0090063; GO:0106310	SILPGDK	5.510000229	0.322979689	0.322979689	0.094831779	731.1872563	15.95207	0	14.0563	0	14.63823	15.3545	15.02444	15.03926	12.91653	0	0	0	0	0	15.81239	15.10042	0	0	0	0	0	17.10555	0	0	0	0	0	15.89799	0	0	0	0	0	0	0	0	0	16.99532	0	0	0	0	0	0	0	0	0	0
Q13155	AIMP2_HUMAN	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1)	AIMP2 JTV1 PRO0992	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of neuron death [GO:1901216]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of neuron death [GO:1901216]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510]	molecular adaptor activity [GO:0060090]	GO:0005634; GO:0005829; GO:0006412; GO:0006915; GO:0008285; GO:0016020; GO:0017101; GO:0031398; GO:0060090; GO:0060510; GO:0065003; GO:1901216; GO:1903632	HNAVNATLIDSWVDIAIFQLK	11.59000015	1	1	0.034597498	2369.227947	13.93561	12.7477	0	0	12.87667	12.47154	14.67269	10.94339	0	10.16141	11.53501	11.70876	11.80807	0	0	0	0	6.616193	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.89874	0	0	0	0	0	0	0	0
Q13162	PRDX4_HUMAN	"Peroxiredoxin-4, EC 1.11.1.24 (Antioxidant enzyme AOE372, AOE37-2) (Peroxiredoxin IV, Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)"	PRDX4	Homo sapiens (Human)	cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]	identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]	GO:0005576; GO:0005634; GO:0005783; GO:0005829; GO:0006979; GO:0007252; GO:0007283; GO:0008379; GO:0008584; GO:0018401; GO:0022417; GO:0030198; GO:0034774; GO:0042802; GO:0045454; GO:0070062; GO:0072593; GO:1904813; GO:2000255	LTDYRGK	6.159999847	1	1	0.048769084	851.8222148	0	0	0	0	0	0	16.3075	0	0	0	0	0	0	0	0	0	0	0	0	0	15.71587	0	0	0	0	0	0	0	0	14.60449	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13185	CBX3_HUMAN	"Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma, HP1 gamma) (Modifier 2 protein)"	CBX3	Homo sapiens (Human)	"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	"chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]"	"chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription coregulator binding [GO:0001221]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription coregulator binding [GO:0001221]	GO:0000122; GO:0000775; GO:0000779; GO:0000781; GO:0000785; GO:0000791; GO:0000792; GO:0001221; GO:0003682; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005721; GO:0005819; GO:0006325; GO:0006338; GO:0006974; GO:0019899; GO:0019904; GO:0031507; GO:0035064; GO:0035985; GO:0042802; GO:0045892; GO:0048511; GO:0061793; GO:0071549; GO:0090575; GO:0090734; GO:1990226	SLSDSESDDSK	6.889999866	1	1	6.88E-13	1170.447992	0	15.12655	13.45548	14.31964	0	0	10.78019	0	15.0753	0	0	14.06102	0	12.70289	0	0	0	0	0	0	16.98307	0	0	0	15.76181	17.66529	16.53652	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.70843	0	0	18.08392	0
Q13188	STK3_HUMAN	"Serine/threonine-protein kinase 3, EC 2.7.11.1 (Mammalian STE20-like protein kinase 2, MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit, MST2/N; Serine/threonine-protein kinase 3 20kDa subunit, MST2/C ]"	STK3 KRS1 MST2	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006606; GO:0006915; GO:0007165; GO:0007417; GO:0008285; GO:0032092; GO:0032991; GO:0035329; GO:0035556; GO:0042802; GO:0043065; GO:0043408; GO:0043539; GO:0045600; GO:0046330; GO:0046621; GO:0050821; GO:0051091; GO:0051262; GO:0051897; GO:0060215; GO:0060706; GO:0060800; GO:0090090; GO:0097284; GO:0106310; GO:1902043	ATATQLLQHPFIKNAKPVSILR	3.359999895	1	1	0.20492037	2447.353664	0	0	0	0	8.235969	13.41767	13.31157	15.21031	14.56466	0	10.06672	15.18314	0	0	0	0	0	0	0	0	9.397076	0	14.87944	0	0	0	9.867883	8.382201	0	12.43562	14.67552	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13200	PSMD2_HUMAN	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2 TRAP2	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]"	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]"	enzyme regulator activity [GO:0030234]	GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008540; GO:0016020; GO:0022624; GO:0030234; GO:0034515; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813	LALMLNDMELVEDIFTSCK	1.409999967	1	1	3.20E-12	2257.076995	0	14.06569	12.75837	0	0	0	0	11.60029	14.59235	15.24148	12.42074	0	0	0	0	0	0	0	0	0	10.76776	0	14.5493	0	14.63183	16.79865	13.4705	0	0	0	0	0	12.49877	0	0	0	0	0	0	0	0	0	0	0	13.81504	15.74325	11.37086	0
Q13201	MMRN1_HUMAN	"Multimerin-1 (EMILIN-4) (Elastin microfibril interface located protein 4, Elastin microfibril interfacer 4) (Endothelial cell multimerin) [Cleaved into: Platelet glycoprotein Ia*; 155 kDa platelet multimerin, p-155, p155 ]"	MMRN1 ECM EMILIN4 GPIA* MMRN	Homo sapiens (Human)	blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of wound healing [GO:0061045]; positive regulation of platelet aggregation [GO:1901731]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; multimerin complex [GO:1990972]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; multimerin complex [GO:1990972]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of wound healing [GO:0061045]; positive regulation of platelet aggregation [GO:1901731]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0007155; GO:0007596; GO:0031091; GO:0031093; GO:0033627; GO:0061045; GO:0062023; GO:1901731; GO:1990972	KSNEQATSLNTVGGTGGIGGVGGTGGVGNR	3.569999933	1	1	0.187241751	2697.966029	14.77423	12.98009	14.6586	0	0	0	0	0	0	0	0	0	15.16127	15.88491	15.18221	0	0	15.80866	0	16.03016	0	0	0	0	14.73465	14.01244	0	14.58684	13.9325	15.07434	0	14.34447	0	13.16986	9.667798	14.84434	14.74489	14.12761	0	0	0	13.15853	0	0	13.34613	14.86641	0	0
Q13203	MYBPH_HUMAN	"Myosin-binding protein H, MyBP-H (H-protein)"	MYBPH	Homo sapiens (Human)	cell adhesion [GO:0007155]; regulation of striated muscle contraction [GO:0006942]	myosin filament [GO:0032982]	myosin filament [GO:0032982]; structural constituent of muscle [GO:0008307]; cell adhesion [GO:0007155]; regulation of striated muscle contraction [GO:0006942]	structural constituent of muscle [GO:0008307]	GO:0006942; GO:0007155; GO:0008307; GO:0032982	MEIQGNPK	10.48999977	1	1	0	930.7574832	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.57051	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13206	DDX10_HUMAN	"Probable ATP-dependent RNA helicase DDX10, EC 3.6.4.13 (DEAD box protein 10)"	DDX10	Homo sapiens (Human)	anterior head development [GO:0097065]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; anterior head development [GO:0097065]; rRNA processing [GO:0006364]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364; GO:0016887; GO:0097065	EVQYLYR	4.690000057	0.045438614	0.045438614	0.258172476	971.4781422	0	0	0	0	15.09848	0	17.96738	0	0	15.70224	0	0	17.06799	0	0	0	0	17.75637	0	0	0	18.68012	0	18.59507	0	19.51368	0	0	0	0	0	19.18813	16.45507	18.8132	0	0	0	18.77517	0	0	0	0	17.8262	17.99596	16.21428	17.5167	16.71108	0
Q13214	SEM3B_HUMAN	"Semaphorin-3B (Sema A(V)) (Semaphorin-V, Sema V)"	SEMA3B SEMA5 SEMAA	Homo sapiens (Human)	axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; chemorepulsion of axon [GO:0061643]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; chemorepulsion of axon [GO:0061643]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0005615; GO:0005783; GO:0005887; GO:0007267; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050919; GO:0061643; GO:0062023; GO:0071526	MGRAGAAAVIPGLALLWAVGLGSAAPSPPR	2.930000067	1	1	0	2843.534471	0	0	14.84618	0	13.52396	13.45007	0	15.67929	15.44305	0	0	11.60632	0	0	0	0	15.65304	0	0	0	0	16.01747	0	16.70438	0	14.26123	0	0	13.44715	10.64695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13216	ERCC8_HUMAN	DNA excision repair protein ERCC-8 (Cockayne syndrome WD repeat protein CSA)	ERCC8 CKN1 CSA	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of transcription-coupled nucleotide-excision repair [GO:0090262]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of transcription-coupled nucleotide-excision repair [GO:0090262]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283]	protein-containing complex binding [GO:0044877]	GO:0000012; GO:0000109; GO:0000209; GO:0005634; GO:0005654; GO:0006283; GO:0006974; GO:0006979; GO:0009411; GO:0010165; GO:0016363; GO:0031464; GO:0032991; GO:0043161; GO:0044877; GO:0045739; GO:0051865; GO:0080008; GO:0090262; GO:0097680	MLGFLSAR	4.480000019	1	1	0.17866682	911.0541638	0	0	14.62172	0	0	13.49547	0	15.70937	15.60035	13.46155	0	0	0	0	0	0	0	15.177	0	0	15.49507	14.8559	15.80331	0	0	0	0	0	14.40406	0	0	18.31352	16.14165	0	0	0	0	16.77755	16.62366	0	16.20522	0	0	0	0	14.66143	0	14.73545
Q13217	DNJC3_HUMAN	"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6, ER-resident protein ERdj6, ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa, Protein kinase inhibitor p58)"	DNAJC3 P58IPK PRKRI	Homo sapiens (Human)	cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986]	chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]	GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0006986; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0043066; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1903561; GO:1903912	MVAPGSVTSR	10.63000011	0.284210265	0.284210265	0.0611732	1019.987993	12.81179	10.64522	0	0	0	14.59386	0	0	0	0	13.02993	0	17.02991	0	0	0	16.67312	0	17.00235	0	16.33278	14.01152	14.93373	0	16.57369	15.43281	14.22816	0	0	16.13106	17.73295	17.00611	17.20731	0	14.716	14.39356	13.81853	0	0	0	11.52287	16.9057	9.712174	0	16.24509	16.80112	16.62897	11.63463
Q13219	PAPP1_HUMAN	"Pappalysin-1, EC 3.4.24.79 (Insulin-like growth factor-dependent IGF-binding protein 4 protease, IGF-dependent IGFBP-4 protease, IGFBP-4ase) (Pregnancy-associated plasma protein A, PAPP-A)"	PAPPA	Homo sapiens (Human)	cellular protein metabolic process [GO:0044267]; female pregnancy [GO:0007565]; response to follicle-stimulating hormone [GO:0032354]; response to glucocorticoid [GO:0051384]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cellular protein metabolic process [GO:0044267]; female pregnancy [GO:0007565]; response to follicle-stimulating hormone [GO:0032354]; response to glucocorticoid [GO:0051384]	metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0005615; GO:0007565; GO:0008237; GO:0008270; GO:0032354; GO:0044267; GO:0051384	HPAFVK	17.31999969	1	1	0.271565441	697.8921831	14.51624	0	0	0	0	0	0	17.50212	0	0	0	0	0	0	0	0	0	18.02444	0	0	0	0	0	0	16.66761	0	0	17.84939	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.1809	0	16.97564	0	0
Q13224	NMDE2_HUMAN	"Glutamate receptor ionotropic, NMDA 2B, GluN2B (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B, NMDAR2B, NR2B) (N-methyl-D-aspartate receptor subunit 3, NR3, hNR3)"	GRIN2B NMDAR2B	Homo sapiens (Human)	"brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]"	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]; amyloid-beta binding [GO:0001540]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]"	amyloid-beta binding [GO:0001540]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]	GO:0001540; GO:0004972; GO:0005737; GO:0005764; GO:0005770; GO:0005789; GO:0005856; GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007420; GO:0007611; GO:0008270; GO:0009986; GO:0014069; GO:0015276; GO:0016594; GO:0016595; GO:0017146; GO:0022849; GO:0035235; GO:0038023; GO:0043005; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0051290; GO:0051968; GO:0060079; GO:0060291; GO:0097060; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:1901216; GO:1902951; GO:1904062; GO:2000463; GO:2001056	DKSLQMK	10.52000046	0.589194238	0.589194238	0.17182744	849.8785697	0	14.20862	0	0	0	14.05238	16.90441	0	0	14.81323	14.83061	0	0	0	0	0	15.53889	12.47066	0	0	0	0	0	15.05863	15.49609	0	16.08714	0	0	0	14.08315	0	15.88067	15.21618	0	0	0	0	12.74195	0	0	0	0	0	0	11.63446	13.77808	0
Q13227	GPS2_HUMAN	"G protein pathway suppressor 2, GPS-2"	GPS2	Homo sapiens (Human)	B cell differentiation [GO:0030183]; JNK cascade [GO:0007254]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; cyclin binding [GO:0030332]; GTPase inhibitor activity [GO:0005095]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; B cell differentiation [GO:0030183]; JNK cascade [GO:0007254]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780]	cyclin binding [GO:0030332]; GTPase inhibitor activity [GO:0005095]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003712; GO:0003713; GO:0003714; GO:0005095; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0005829; GO:0006357; GO:0007254; GO:0010804; GO:0010875; GO:0017053; GO:0019216; GO:0030183; GO:0030332; GO:0034122; GO:0035360; GO:0045598; GO:0045599; GO:0045944; GO:0046329; GO:0050728; GO:0050859; GO:0098780; GO:1900045	KEMEER	9.579999924	0.41687566	0.41687566	0.136920215	835.2402877	17.83847	0	15.844	0	0	0	18.22606	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.18017	17.66723	0	0	0	0	0	0	0	0	0	0	0	0	0	13.85061	0	0	0	0	0	0	15.77055	0	0	0
Q13233	M3K1_HUMAN	"Mitogen-activated protein kinase kinase kinase 1, EC 2.7.11.25 (MAPK/ERK kinase kinase 1, MEK kinase 1, MEKK 1)"	MAP3K1 MAPKKK1 MEKK MEKK1	Homo sapiens (Human)	cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]	GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0038095; GO:0071260; GO:0106310	ATSPEAGGGGGALK	12.01000023	1	1	0.135498226	1168.840746	15.61387	15.35287	0	14.16854	0	0	15.40211	15.71975	14.47568	0	15.06117	14.50967	0	0	0	15.73023	0	0	0	0	0	0	0	13.10568	0	0	0	0	0	0	0	0	0	0	0	0	16.8971	0	0	0	0	0	0	0	0	0	0	0
Q13242	SRSF9_HUMAN	"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)"	SRSF9 SFRS9 SRP30C	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]"	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]	GO:0000380; GO:0000398; GO:0003723; GO:0005654; GO:0005730; GO:0006376; GO:0006397; GO:0009636; GO:0016607; GO:0019904; GO:0043279; GO:0048025	DLEDLFYK	21.62000084	0.233182058	0.233182058	0.135332529	1041.999523	17.08821	18.3033	17.47962	15.98031	11.52056	17.12803	0	15.87423	14.51183	17.69873	17.76747	18.63335	17.33707	17.99522	0	16.3152	14.83004	16.0813	0	17.10376	17.48799	0	0	14.75745	16.25202	17.34376	0	16.51439	15.87544	0	16.94279	14.78458	0	18.14724	17.17088	18.38545	0	16.95618	18.13318	17.65938	14.43042	15.32992	15.37117	13.45872	15.98143	14.82746	17.18856	15.88048
Q13243	SRSF5_HUMAN	"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)"	SRSF5 HRS SFRS5 SRP40	Homo sapiens (Human)	"cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of cell cycle [GO:0051726]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of cell cycle [GO:0051726]"	mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0005730; GO:0005829; GO:0006376; GO:0006397; GO:0016607; GO:0032869; GO:0033120; GO:0043422; GO:0051726; GO:0097421	SKSPASVDR	2.380000114	0.796537697	0.796537697	0.130739988	947.5076324	15.6571	0	11.1612	0	0	0	0	0	0	0	19.41302	17.8646	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.67061	0	0	14.77195	0	0	0	0	0	0	0	0	0	0	15.74157	0	15.87294	0	17.06094	0	0
Q13263	TIF1B_HUMAN	"Transcription intermediary factor 1-beta, TIF1-beta (E3 SUMO-protein ligase TRIM28, EC 2.3.2.27) (KRAB-associated protein 1, KAP-1) (KRAB-interacting protein 1, KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28)"	TRIM28 KAP1 RNF96 TIF1B	Homo sapiens (Human)	"chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]; suppression of viral release by host [GO:0044790]"	chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]; suppression of viral release by host [GO:0044790]"	chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0001837; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0007265; GO:0007566; GO:0008270; GO:0016925; GO:0019789; GO:0031625; GO:0032991; GO:0035851; GO:0042307; GO:0043045; GO:0043388; GO:0044790; GO:0045087; GO:0045739; GO:0045869; GO:0045892; GO:0045893; GO:0046777; GO:0060028; GO:0060669; GO:0070087; GO:0090309; GO:0090575; GO:1901536; GO:1990841; GO:2000653	FASWALESDNNTALLLSKK	20.37999916	1	1	2.74E-12	2107.533963	0	16.33562	11.85658	0	13.30876	14.67436	15.2698	16.01868	10.9686	0	0	12.0474	15.39888	0	0	14.26274	0	0	0	0	0	15.18865	0	0	14.83784	15.80471	0	13.13294	13.86106	0	14.05128	0	15.99161	14.89851	0	12.34235	0	15.35581	0	16.58202	0	0	0	16.00388	0	0	0	11.42546
Q13268	DHRS2_HUMAN	"Dehydrogenase/reductase SDR family member 2, mitochondrial, EC 1.1.1.- (Dicarbonyl reductase HEP27) (Protein D) (Short chain dehydrogenase/reductase family 25C member 1, Protein SDR25C1)"	DHRS2 SDR25C1	Homo sapiens (Human)	C21-steroid hormone metabolic process [GO:0008207]; cellular response to oxidative stress [GO:0034599]; electron transport chain [GO:0022900]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; C21-steroid hormone metabolic process [GO:0008207]; cellular response to oxidative stress [GO:0034599]; electron transport chain [GO:0022900]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; response to toxic substance [GO:0009636]"	"carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0004090; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0008207; GO:0008285; GO:0009636; GO:0016616; GO:0022900; GO:0034599; GO:0043011; GO:0043066	LSAVAR	11.13000011	0.188181326	0.188181326	0.087362007	616.9950272	17.17731	0	17.45066	13.66393	14.08061	17.85992	0	0	0	0	0	16.98137	0	14.54136	0	0	15.78507	17.51338	16.75052	16.69664	0	0	14.42708	14.89149	17.1531	17.26866	0	14.73616	15.38764	17.16789	13.44256	15.75304	0	0	13.69214	15.90891	0	17.26801	15.64404	16.47879	0	0	13.18044	15.85801	0	0	13.56032	16.00573
Q13275	SEM3F_HUMAN	"Semaphorin-3F (Sema III/F) (Semaphorin IV, Sema IV)"	SEMA3F	Homo sapiens (Human)	axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; positive regulation of cell migration [GO:0030335]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]	extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]	extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; positive regulation of cell migration [GO:0030335]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0021612; GO:0021637; GO:0021675; GO:0021785; GO:0030215; GO:0030335; GO:0036486; GO:0045499; GO:0048843; GO:0048846; GO:0050919; GO:0061549; GO:0071526; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1902285; GO:1902287	LESGKGK	7.28000021	1	1	0.2052585	718.4813591	15.30935	14.55562	12.67255	13.85905	15.65881	15.1834	0	16.20462	16.1477	0	0	15.26587	15.71039	0	15.13528	0	14.72519	15.4748	15.97847	12.91862	15.29301	0	16.53809	15.96046	15.64046	15.60519	0	0	0	0	16.8964	0	0	16.12918	16.01746	0	0	16.20565	17.33807	0	14.94597	0	0	0	0	16.03053	15.9846	0
Q13286	CLN3_HUMAN	Battenin (Batten disease protein) (Protein CLN3)	CLN3 BTS	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amyloid precursor protein catabolic process [GO:0042987]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; cell migration [GO:0016477]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; ionotropic glutamate receptor signaling pathway [GO:0035235]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of intracellular pH [GO:0051453]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]"	autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]	"autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]; actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amyloid precursor protein catabolic process [GO:0042987]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; cell migration [GO:0016477]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; ionotropic glutamate receptor signaling pathway [GO:0035235]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of intracellular pH [GO:0051453]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]"	calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]	GO:0000139; GO:0001508; GO:0001934; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005776; GO:0005783; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0008306; GO:0009992; GO:0010762; GO:0016021; GO:0016243; GO:0016477; GO:0016485; GO:0030036; GO:0030176; GO:0031901; GO:0031902; GO:0032228; GO:0035235; GO:0035752; GO:0036359; GO:0042133; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0043086; GO:0043524; GO:0044754; GO:0044857; GO:0045121; GO:0045861; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048306; GO:0048549; GO:0050885; GO:0051453; GO:0051480; GO:0051489; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061024; GO:0061909; GO:0070613; GO:0072659; GO:0090160; GO:0090384; GO:0090385; GO:0097352; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288	MGGCAGSR	5.159999847	0.407441616	0.407441616	0.049413457	794.8993251	19.71768	16.30089	18.13819	18.72212	17.90107	17.93939	0	17.46789	17.11365	16.58081	16.40582	17.47927	18.88604	18.25698	17.22054	18.99136	17.13692	17.73851	17.7667	18.66299	17.27368	17.87725	18.28862	18.88276	17.45714	18.24358	17.30708	17.89945	0	17.36264	18.07425	18.207	17.98961	16.33185	17.88247	15.93168	19.12081	18.11785	18.13729	16.97336	18.05065	17.05792	18.37919	17.27839	16.95466	16.49822	13.61875	15.65299
Q13287	NMI_HUMAN	"N-myc-interactor, Nmi (N-myc and STAT interactor)"	NMI	Homo sapiens (Human)	interferon-gamma-mediated signaling pathway [GO:0060333]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to virus [GO:0009615]; toll-like receptor 4 signaling pathway [GO:0034142]; transcription by RNA polymerase II [GO:0006366]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; interferon-gamma-mediated signaling pathway [GO:0060333]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to virus [GO:0009615]; toll-like receptor 4 signaling pathway [GO:0034142]; transcription by RNA polymerase II [GO:0006366]	identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]	GO:0002281; GO:0003712; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007259; GO:0008285; GO:0009615; GO:0016020; GO:0032687; GO:0032688; GO:0034142; GO:0042802; GO:0045089; GO:0045824; GO:0050729; GO:0060333; GO:1901223; GO:1901224; GO:1902524	SRNGGGEVDR	2.99000001	1	1	0.134073913	1047.809871	15.14564	15.07474	0	0	15.656	15.26853	15.17024	14.21692	15.38491	14.80276	15.52076	15.16652	0	15.20274	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.54852	0	0	0	0	0	0	0	15.75416	0
Q13303	KCAB2_HUMAN	"Voltage-gated potassium channel subunit beta-2, EC 1.1.1.- (K(+) channel subunit beta-2) (Kv-beta-2, hKvbeta2)"	KCNAB2 KCNA2B KCNK2	Homo sapiens (Human)	NADPH oxidation [GO:0070995]; regulation of action potential [GO:0098900]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; pinceau fiber [GO:1990031]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; voltage-gated potassium channel complex [GO:0008076]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; pinceau fiber [GO:1990031]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; NADPH oxidation [GO:0070995]; regulation of action potential [GO:0098900]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008]	aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]	GO:0004033; GO:0005249; GO:0005829; GO:0005856; GO:0005886; GO:0008076; GO:0015459; GO:0016020; GO:0031234; GO:0035579; GO:0044224; GO:0044325; GO:0045202; GO:0070821; GO:0070995; GO:0098900; GO:1901379; GO:1990031; GO:2000008	MYPESTTGSPARLSLR	9.800000191	1	1	4.58E-13	1781.286695	0	0	15.35496	14.59316	13.15567	0	0	0	11.79222	0	0	16.47555	12.27195	16.22128	15.00204	0	0	0	0	0	0	0	14.83632	0	16.7573	0	0	13.33247	0	0	0	14.62409	0	0	13.6969	13.277	16.27325	13.66171	0	0	16.18656	0	0	0	0	0	0	0
Q13304	GPR17_HUMAN	"Uracil nucleotide/cysteinyl leukotriene receptor, UDP/CysLT receptor (G-protein coupled receptor 17) (P2Y-like receptor) (R12)"	GPR17	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemokine receptor activity [GO:0004950]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]	chemokine receptor activity [GO:0004950]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0004950; GO:0005886; GO:0005887; GO:0007186; GO:0035025; GO:0051482	SLRQGLR	11.02000046	1	1	0.215297549	828.4439189	15.89683	15.6648	14.75949	16.59678	14.90187	17.30162	0	0	14.31325	14.66904	15.41041	14.21627	15.31018	15.93905	15.30685	16.26308	14.90309	14.46357	14.90272	16.24366	0	0	0	0	16.51943	16.79176	15.9462	0	15.7094	0	0	0	16.57682	15.51931	0	0	16.16722	0	0	15.32384	15.53873	0	0	13.72764	0	16.27321	15.20704	0
Q13315	ATM_HUMAN	"Serine-protein kinase ATM, EC 2.7.11.1 (Ataxia telangiectasia mutated, A-T mutated)"	ATM	Homo sapiens (Human)	"brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; spindle [GO:0005819]	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; spindle [GO:0005819]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]	GO:0000077; GO:0000723; GO:0000724; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0003677; GO:0004674; GO:0004677; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0005829; GO:0006302; GO:0006303; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0007094; GO:0007095; GO:0007131; GO:0007140; GO:0007143; GO:0007165; GO:0007420; GO:0007507; GO:0008340; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0016572; GO:0018105; GO:0030335; GO:0030889; GO:0031410; GO:0032210; GO:0032212; GO:0033129; GO:0033151; GO:0035264; GO:0036289; GO:0042159; GO:0042802; GO:0042981; GO:0043065; GO:0043231; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0047485; GO:0048538; GO:0048599; GO:0051402; GO:0051726; GO:0071044; GO:0071300; GO:0071480; GO:0071481; GO:0071500; GO:0090398; GO:0090399; GO:0097694; GO:0097695; GO:0106310; GO:1900034; GO:1901796; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1905843; GO:1990391	HLVELSILAR	6.809999943	1	1	0.242408597	1150.842461	18.13395	0	15.67817	0	0	0	0	0	0	0	15.1918	15.29667	0	0	0	0	0	0	0	0	0	0	0	18.67816	0	0	15.36967	0	0	15.88534	0	14.62244	0	0	0	15.42491	0	0	0	15.88929	0	0	0	0	16.08604	0	0	0
Q13316	DMP1_HUMAN	"Dentin matrix acidic phosphoprotein 1, DMP-1, Dentin matrix protein 1"	DMP1	Homo sapiens (Human)	biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of enamel mineralization [GO:0070173]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of enamel mineralization [GO:0070173]	calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]	GO:0001503; GO:0005178; GO:0005509; GO:0005576; GO:0005634; GO:0005788; GO:0010811; GO:0030198; GO:0031012; GO:0031214; GO:0050840; GO:0070173	SERGNSR	16.70000076	1	1	0.128236832	805.7161405	14.65088	14.44049	15.415	0	2.393256	0	15.50295	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.74808	0	0	0	0	0	0
Q13322	GRB10_HUMAN	Growth factor receptor-bound protein 10 (GRB10 adapter protein) (Insulin receptor-binding protein Grb-IR)	GRB10 GRBIR KIAA0207	Homo sapiens (Human)	ERK1 and ERK2 cascade [GO:0070371]; gene expression [GO:0010467]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of phosphorylation [GO:0042326]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of phosphorylation [GO:0042327]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; response to insulin [GO:0032868]; vascular associated smooth muscle cell migration [GO:1904738]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159]; ERK1 and ERK2 cascade [GO:0070371]; gene expression [GO:0010467]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of phosphorylation [GO:0042326]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of phosphorylation [GO:0042327]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; response to insulin [GO:0032868]; vascular associated smooth muscle cell migration [GO:1904738]	identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159]	GO:0005158; GO:0005737; GO:0005829; GO:0005886; GO:0008286; GO:0010467; GO:0030159; GO:0030178; GO:0030949; GO:0032868; GO:0032991; GO:0042326; GO:0042327; GO:0042802; GO:0045719; GO:0046325; GO:0046627; GO:0048009; GO:0070371; GO:0120162; GO:1904738	ASGPPR	9.890000343	0.556246936	0.556246936	0.072782352	583.4287448	15.31685	16.65962	15.23695	15.96243	17.1761	15.98388	19.66538	16.29917	15.65474	16.89411	18.26668	17.09406	0	14.75751	0	13.39969	14.24886	15.87956	15.35749	17.72037	15.47536	15.47836	0	15.5435	16.45129	16.75628	15.96927	16.22705	14.9187	14.3229	15.23433	15.50527	16.49156	16.23956	14.88531	14.71254	16.92555	0	15.71094	15.71304	16.59076	16.96616	16.51769	15.15445	15.45484	16.48567	14.20889	16.46212
Q13324	CRFR2_HUMAN	"Corticotropin-releasing factor receptor 2, CRF-R-2, CRF-R2, CRFR-2 (Corticotropin-releasing hormone receptor 2, CRH-R-2, CRH-R2)"	CRHR2 CRF2R CRH2R	Homo sapiens (Human)	adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; long-term synaptic potentiation [GO:0060291]	axon terminus [GO:0043679]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	axon terminus [GO:0043679]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; long-term synaptic potentiation [GO:0060291]	corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]	GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0008528; GO:0015056; GO:0017046; GO:0030425; GO:0043404; GO:0043679; GO:0060291	KYDLHYR	7.78000021	1	1	0.055911383	994.1692588	0	0	0	16.21501	15.60133	0	13.48631	0	15.97959	13.34266	0	0	13.35494	0	16.67941	16.60687	14.77197	16.29385	0	0	0	15.95063	0	0	0	0	16.79467	12.97197	14.05849	15.60721	17.51605	16.94183	15.06947	18.32037	14.74524	16.08563	18.37961	17.83671	14.77843	0	14.94123	0	15.52059	0	16.06308	16.14126	12.71976	0
Q13330	MTA1_HUMAN	Metastasis-associated protein MTA1	MTA1	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of gene expression, epigenetic [GO:0040029]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of gene expression, epigenetic [GO:0040029]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]"	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006302; GO:0006338; GO:0007165; GO:0010212; GO:0016575; GO:0016581; GO:0032922; GO:0040029; GO:0042659; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:0045892; GO:0045893; GO:0046872; GO:0061629; GO:1902499; GO:2000736	LDGERPGPNR	10	0.432997495	0.432997495	0.393044974	1109.544322	14.40494	0	14.10038	0	0	13.03595	0	0	0	0	16.26706	0	0	0	0	16.60536	0	0	14.46511	14.86039	0	0	0	0	14.72248	17.3392	16.04663	0	0	0	0	0	0	0	0	0	16.85211	15.14777	0	16.47415	14.32422	0	14.1011	0	12.82397	15.73798	16.0871	16.467
Q13332	PTPRS_HUMAN	"Receptor-type tyrosine-protein phosphatase S, R-PTP-S, EC 3.1.3.48 (Receptor-type tyrosine-protein phosphatase sigma, R-PTP-sigma)"	PTPRS	Homo sapiens (Human)	negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]	axon [GO:0030424]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]	axon [GO:0030424]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560]	chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004721; GO:0004725; GO:0005829; GO:0005886; GO:0005887; GO:0006470; GO:0008201; GO:0010977; GO:0030285; GO:0030424; GO:0030426; GO:0030517; GO:0032687; GO:0032688; GO:0034164; GO:0035335; GO:0035374; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0070062; GO:0099061; GO:0099560	SRGGLGEEAAEVLSIPEDTPR	3.210000038	1	1	0.25037937	2182.824094	15.10059	14.85809	0	0	11.59916	0	0	0	0	0	17.27674	16.07188	0	0	0	14.74189	0	0	12.80529	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.84446	0	0	0	0	0	0	0	0
Q13342	SP140_HUMAN	"Nuclear body protein SP140 (Lymphoid-restricted homolog of Sp100, LYSp100) (Nuclear autoantigen Sp-140) (Speckled 140 kDa)"	SP140 LYSP100	Homo sapiens (Human)	defense response [GO:0006952]; regulation of transcription by RNA polymerase II [GO:0006357]	fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; PML body [GO:0016605]	"fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; defense response [GO:0006952]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000981; GO:0001650; GO:0003677; GO:0005634; GO:0005739; GO:0006357; GO:0006952; GO:0016605; GO:0046872	AQQGQQGQMASGDSNLNFR	24.68000031	0.369252175	0.369252175	0.049959099	2036.051512	18.79892	19.41188	18.97955	0	19.2985	0	20.78355	19.47733	0	18.68255	0	0	0	0	0	0	19.15012	0	19.04241	18.97195	0	19.01727	19.34811	18.58535	19.89494	19.97638	0	0	19.76078	0	19.95518	0	0	0	0	0	18.79685	19.36968	0	0	0	19.90288	0	0	18.41759	0	0	0
Q13347	EIF3I_HUMAN	"Eukaryotic translation initiation factor 3 subunit I, eIF3i (Eukaryotic translation initiation factor 3 subunit 2) (TGF-beta receptor-interacting protein 1, TRIP-1) (eIF-3-beta) (eIF3 p36)"	EIF3I EIF3S2 TRIP1	Homo sapiens (Human)	cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]"	"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]"	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002183; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0070062; GO:0071541	DPSQIDNNEPYMK	5.960000038	1	1	0.310547557	1565.355338	12.42718	13.47615	15.37443	0	12.95442	0	0	0	0	0	0	0	12.16236	0	0	0	0	10.42078	12.97454	15.49488	0	0	0	15.20718	0	0	0	0	0	0	0	0	0	13.93269	0	0	0	0	14.71114	0	14.95997	15.44859	12.77677	12.16074	16.95708	12.68331	8.728999	15.14585
Q13356	PPIL2_HUMAN	"RING-type E3 ubiquitin-protein ligase PPIL2, EC 2.3.2.27 (CYC4) (Cyclophilin-60, Cyclophilin-like protein Cyp-60, Cyp60, hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2, PPIase) (Rotamase PPIL2)"	PPIL2	Homo sapiens (Human)	protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0000413; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0061630; GO:0072659	GDEILAATMKAPEK	5.489999771	0.164503217	0.164503217	5.24E-12	1474.359346	0	0	0	0	0	0	14.11795	17.53951	0	0	0	0	15.6464	0	0	0	15.99786	0	17.87886	14.57381	0	13.74413	0	14.50471	16.35862	15.88428	0	0	14.0219	15.89723	13.89114	7.264241	15.1565	0	17.97649	0	0	16.1714	17.95827	14.83803	13.45994	15.32634	17.39467	13.58769	15.51439	17.30992	0	16.7783
Q13360	ZN177_HUMAN	Zinc finger protein 177	ZNF177	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	blood microparticle [GO:0072562]; nucleus [GO:0005634]	"blood microparticle [GO:0072562]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872; GO:0072562; GO:1990837	TPTGQK	5.260000229	1	1	0.272615966	626.6452053	16.08966	15.68754	15.87127	16.43806	15.22931	0	0	14.49889	14.61513	16.02521	0	15.60406	16.6658	0	15.53771	0	15.92554	0	0	15.47868	0	0	15.96977	0	15.77045	0	0	16.73534	0	15.41332	0	16.7311	0	0	0	16.2588	15.60935	16.49716	16.46106	0	0	17.05581	15.09352	16.53313	0	16.25341	0	0
Q13361	MFAP5_HUMAN	"Microfibrillar-associated protein 5, MFAP-5 (MP25) (Microfibril-associated glycoprotein 2, MAGP-2)"	MFAP5 MAGP2	Homo sapiens (Human)	definitive hemopoiesis [GO:0060216]; embryonic eye morphogenesis [GO:0048048]; supramolecular fiber organization [GO:0097435]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527]; extracellular matrix structural constituent [GO:0005201]; definitive hemopoiesis [GO:0060216]; embryonic eye morphogenesis [GO:0048048]; supramolecular fiber organization [GO:0097435]	extracellular matrix structural constituent [GO:0005201]	GO:0001527; GO:0005201; GO:0005576; GO:0048048; GO:0060216; GO:0062023; GO:0097435	MSLLGPK	2.50999999	1	1	0.228899205	745.7187885	16.28671	11.68475	13.45196	0	14.78315	14.89997	0	0	0	13.45812	14.89872	0	0	15.67877	15.61119	0	0	0	15.41766	0	0	16.62194	13.23322	0	16.60134	15.43699	0	0	0	0	0	15.3422	0	15.85323	14.07557	0	0	0	0	0	0	16.16013	15.55309	0	0	0	15.5691	0
Q13362	2A5G_HUMAN	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29)	PPP2R5C KIAA0044	Homo sapiens (Human)	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]"	protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000775; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006470; GO:0006977; GO:0007165; GO:0008285; GO:0019888; GO:0042771; GO:0043161; GO:0072542	IMEPLFR	34.27999878	1	1	0.081390861	905.7305221	21.20466	20.51707	21.47322	20.86341	19.60842	21.11116	0	20.133	20.05882	0	20.48373	0	22.97377	0	18.15106	20.41107	19.57396	20.67099	20.10201	21.35054	0	20.05244	0	20.33079	18.87472	16.55421	17.64074	19.20984	0	0	18.74614	0	0	19.05875	19.7184	0	0	20.63961	20.09307	18.42338	0	18.97137	0	17.27919	19.18209	18.00718	19.68001	17.89678
Q13368	MPP3_HUMAN	MAGUK p55 subfamily member 3 (Discs large homolog 3) (Protein MPP3)	MPP3 DLG3	Homo sapiens (Human)		cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]	PDZ domain binding [GO:0030165]	GO:0005886; GO:0005911; GO:0030165	LVVLIGSLGAR	4.25	1	1	0.013564472	1098.316768	13.52878	0	0	13.31188	0	14.77236	14.54463	0	0	0	12.31431	0	0	0	0	13.05733	0	12.98493	0	0	0	0	0	14.6873	0	0	0	0	0	0	0	0	0	0	14.05922	0	0	0	11.87845	0	13.66907	13.02823	14.86825	0	0	0	0	0
Q13370	PDE3B_HUMAN	"cGMP-inhibited 3',5'-cyclic phosphodiesterase B, EC 3.1.4.17 (CGIPDE1, CGIP1) (Cyclic GMP-inhibited phosphodiesterase B, CGI-PDE B)"	PDE3B	Homo sapiens (Human)	angiogenesis [GO:0001525]; cellular response to insulin stimulus [GO:0032869]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of lipid catabolic process [GO:0050995]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; protein kinase B binding [GO:0043422]; angiogenesis [GO:0001525]; cellular response to insulin stimulus [GO:0032869]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of lipid catabolic process [GO:0050995]; signal transduction [GO:0007165]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; protein kinase B binding [GO:0043422]"	GO:0001525; GO:0004114; GO:0004115; GO:0004119; GO:0005783; GO:0005794; GO:0005829; GO:0007162; GO:0007165; GO:0007186; GO:0016020; GO:0016021; GO:0016525; GO:0032045; GO:0032869; GO:0033629; GO:0043422; GO:0043951; GO:0046872; GO:0050995	IPTQQFMNYFR	2.710000038	0.324099749	0.324099749	0.275396281	1461.030028	0	0	0	0	16.48924	15.51578	15.8634	10.44893	15.46105	0	19.28346	17.60951	14.02384	14.73628	0	12.28498	18.87627	0	14.5107	14.30723	18.36881	15.94779	0	17.27417	0	17.60511	15.28654	18.49638	14.00656	17.09151	0	0	17.01219	0	15.66316	16.34265	0	16.79431	16.13664	11.77569	17.2654	16.25603	16.60889	0	0	15.7624	15.766	15.20094
Q13371	PHLP_HUMAN	"Phosducin-like protein, PHLP"	PDCL PHLOP1 PhLP1	Homo sapiens (Human)	cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601]		GO:0005737; GO:0005829; GO:0005929; GO:0007165; GO:0007601; GO:0008277; GO:0030030; GO:0045880; GO:1902605	GGELIGNFVR	8.18999958	1	1	6.89E-13	1060.814491	0	15.15722	0	0	0	13.58886	0	15.43372	15.32312	0	0	14.55845	0	14.32529	14.52052	16.19261	15.61855	0	15.68447	0	0	0	0	0	0	13.9534	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13395	TARB1_HUMAN	"Probable methyltransferase TARBP1, EC 2.1.1.- (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa, TRP-185)"	TARBP1 TRM3 TRP185	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]	nucleus [GO:0005634]	nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488]	RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]	GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488	LQKFLVTYISLLPEEIK	7.440000057	1	1	0.278963858	2034.47713	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.00445	0	0	0	21.57458	0	0	0	0	20.14936	21.90141	0	20.80829	0	21.8055	0	19.36227	0	19.69311	0	0	0	0	0	0	0	0	0
Q13398	ZN211_HUMAN	Zinc finger protein 211 (Zinc finger protein C2H2-25)	ZNF211	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	SNLMQHR	15.27999973	1	1	0.267261695	902.2985464	0	0	15.8861	0	0	0	0	0	16.65466	0	0	0	17.71201	0	0	0	0	0	0	0	0	0	0	0	0	0	18.39424	0	0	18.23806	17.62161	0	17.35281	20.39416	19.74082	0	0	0	0	0	0	0	0	0	0	0	16.77494	0
Q13402	MYO7A_HUMAN	Unconventional myosin-VIIa	MYO7A USH1B	Homo sapiens (Human)	actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; cellular protein localization [GO:0034613]; equilibrioception [GO:0050957]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagolysosome assembly [GO:0001845]; pigment granule transport [GO:0051904]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory organ development [GO:0007423]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; myosin complex [GO:0016459]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; stereocilium base [GO:0120044]; synapse [GO:0045202]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; myosin complex [GO:0016459]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; stereocilium base [GO:0120044]; synapse [GO:0045202]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; cellular protein localization [GO:0034613]; equilibrioception [GO:0050957]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagolysosome assembly [GO:0001845]; pigment granule transport [GO:0051904]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory organ development [GO:0007423]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]	GO:0000146; GO:0001750; GO:0001845; GO:0001917; GO:0005516; GO:0005524; GO:0005737; GO:0005765; GO:0005829; GO:0005902; GO:0005938; GO:0006886; GO:0007015; GO:0007040; GO:0007423; GO:0007601; GO:0007605; GO:0015629; GO:0016324; GO:0016459; GO:0019904; GO:0030048; GO:0030050; GO:0030507; GO:0031982; GO:0032391; GO:0032420; GO:0034613; GO:0042462; GO:0042470; GO:0042490; GO:0045202; GO:0048563; GO:0050953; GO:0050957; GO:0051015; GO:0051904; GO:0060088; GO:0120044	HAGKSK	10.77000046	0.687597692	0.687597692	0.225732875	627.2649815	16.02338	14.85619	14.96168	15.28711	15.06856	15.50384	13.14875	14.8416	14.85876	0	0	0	0	16.03441	15.95419	14.95377	0	16.66578	15.38264	14.86372	0	15.66021	16.67435	15.85877	0	17.55538	0	16.93077	0	16.07809	15.3139	0	15.91079	0	0	15.88661	15.85657	16.00181	0	0	17.41345	0	16.25441	16.49505	16.54441	16.74187	14.98089	0
Q13404	UB2V1_HUMAN	"Ubiquitin-conjugating enzyme E2 variant 1, UEV-1 (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)"	UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19	Homo sapiens (Human)	"cell differentiation [GO:0030154]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of transcription, DNA-templated [GO:0045893]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of DNA repair [GO:0006282]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; UBC13-UEV1A complex [GO:0035370]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; UBC13-UEV1A complex [GO:0035370]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; cell differentiation [GO:0030154]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of transcription, DNA-templated [GO:0045893]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of DNA repair [GO:0006282]; regulation of transcription, DNA-templated [GO:0006355]"		GO:0000151; GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006301; GO:0006355; GO:0030154; GO:0031371; GO:0032991; GO:0035370; GO:0043123; GO:0045893; GO:0051092; GO:0070062; GO:0070534; GO:1902523; GO:1902533	MAATTGSGVKVPR	9.649999619	0.988025427	0.988025427	0.441591603	1293.39262	0	0	0	0	0	0	15.99222	14.81397	0	0	15.9124	15.03169	0	0	0	0	0	0	15.12513	0	16.14285	0	17.49349	17.03353	0	0	0	0	0	0	0	17.58448	0	16.34081	19.51215	15.74292	0	0	16.9397	17.42923	15.31466	0	0	0	0	0	0	0
Q13405	RM49_HUMAN	"39S ribosomal protein L49, mitochondrial, L49mt, MRP-L49 (Mitochondrial large ribosomal subunit protein mL49) (Neighbor of FAU, NOF) (Protein NOF1)"	MRPL49 C11orf4 NOF1 OK/SW-cl.67	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543	IPDPPK	4.929999828	1	1	0.252546165	666.9270239	18.50889	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.06295	0	0	18.46416	19.93124	0	18.94938	0	0	0	0	17.4642	0	0	0	18.95713	0	0	0	0
Q13418	ILK_HUMAN	"Integrin-linked protein kinase, EC 2.7.11.1 (59 kDa serine/threonine-protein kinase) (Beta-integrin-linked kinase) (ILK-1) (ILK-2) (p59ILK)"	ILK ILK1 ILK2	Homo sapiens (Human)	"branching involved in ureteric bud morphogenesis [GO:0001658]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000902; GO:0001658; GO:0001934; GO:0003151; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0007160; GO:0007229; GO:0008284; GO:0009967; GO:0010761; GO:0016020; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0042327; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0070527; GO:0090263; GO:0106310; GO:1900026; GO:1901224; GO:2000178	MGQNLNR	9.569999695	0.651828289	0.651828289	0.220969058	831.7417544	16.79988	15.8042	17.02829	15.30654	13.58999	16.43261	17.15177	17.91121	16.26835	16.3227	17.62478	15.58205	16.39198	17.47722	14.40113	12.95871	17.01062	15.242	15.43606	17.1542	16.41619	16.82137	16.052	16.85977	13.93533	15.23781	16.72213	16.06367	17.18482	15.64296	16.0734	16.88453	0	17.41619	15.91723	16.84176	15.90947	16.39732	16.69699	0	17.63364	16.89053	0	16.59455	0	14.86412	0	15.59154
Q13421	MSLN_HUMAN	"Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor, MPF; Mesothelin, cleaved form ]"	MSLN MPF	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; pancreas development [GO:0031016]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; pancreas development [GO:0031016]		GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0005886; GO:0007155; GO:0007160; GO:0009986; GO:0016020; GO:0031016; GO:0031225	QLDVLYPK	4.409999847	0.399064809	0.399064809	0.244416989	976.4918283	15.91268	15.12912	16.39867	14.70494	14.6638	14.78362	14.04679	15.80544	0	0	14.94291	14.54218	14.79138	14.83686	0	13.82292	13.32763	15.68502	15.26485	16.87001	0	0	14.95647	14.3637	15.7913	15.01697	0	0	0	14.74511	16.79724	13.46384	0	0	16.1475	15.18918	0	15.05472	0	15.88754	0	0	0	15.99308	14.75959	0	0	0
Q13423	NNTM_HUMAN	"NAD(P) transhydrogenase, mitochondrial, EC 7.1.1.1 (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)"	NNT	Homo sapiens (Human)	NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; tricarboxylic acid cycle [GO:0006099]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; tricarboxylic acid cycle [GO:0006099]	NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]	GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0016020; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600	APVKPGIPYK	10.67000008	1	1	0.162557231	1068.951154	15.74537	0	14.80093	15.32823	14.30645	0	15.52586	12.33258	0	15.11674	0	15.2899	0	0	0	0	0	0	0	0	0	0	17.41932	0	0	0	0	0	0	0	0	0	0	0	0	16.00389	0	0	0	0	14.65538	0	0	0	0	0	0	0
Q13427	PPIG_HUMAN	"Peptidyl-prolyl cis-trans isomerase G, PPIase G, Peptidyl-prolyl isomerase G, EC 5.2.1.8 (CASP10) (Clk-associating RS-cyclophilin, CARS-Cyp, CARS-cyclophilin, SR-cyclophilin, SR-cyp, SRcyp) (Cyclophilin G) (Rotamase G)"	PPIG	Homo sapiens (Human)	protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0008380; GO:0016018; GO:0016363; GO:0016607; GO:0043231	DFMVQGGDFSEGNGRGGESIYGGFFEDESFAVK	6.320000172	0.415827721	0.415827721	0.185390758	3552.524178	15.50797	15.30515	0	12.92224	11.03824	0	0	0	12.42556	0	0	0	0	10.50377	14.50657	0	0	0	0	0	0	0	12.77335	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.524495	13.58534	0	0	0	14.36029	0	0	0
Q13428	TCOF_HUMAN	Treacle protein (Treacher Collins syndrome protein)	TCOF1	Homo sapiens (Human)	neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of translation [GO:0006417]; skeletal system development [GO:0001501]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; transporter activity [GO:0005215]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of translation [GO:0006417]; skeletal system development [GO:0001501]	protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; transporter activity [GO:0005215]	GO:0001501; GO:0001650; GO:0003723; GO:0005215; GO:0005654; GO:0005730; GO:0005829; GO:0006417; GO:0014029; GO:0014032; GO:0030674; GO:0042790; GO:0046982; GO:0097110	AALAPAK	3.670000076	1	1	0.126202725	639.9800271	15.46075	0	0	0	0	0	0	0	0	0	0	0	0	16.12891	0	16.4115	0	0	0	0	16.26392	0	0	0	0	0	0	0	16.01631	0	16.79413	15.29323	0	14.56514	0	0	15.55482	0	0	0	17.5331	0	15.60882	0	0	0	0	13.70813
Q13434	MKRN4_HUMAN	"Putative E3 ubiquitin-protein ligase makorin-4, EC 2.3.2.27 (Makorin RING finger protein pseudogene 4) (Makorin RING finger protein pseudogene 5) (RING finger protein 64) (RING-type E3 ubiquitin transferase makorin-4) (Zinc finger protein 127-Xp, ZNF127-Xp) (Zinc finger protein 127-like 1)"	MKRN4P MKRN4 MKRNP5 RNF64 ZNF127L1	Homo sapiens (Human)	protein ubiquitination [GO:0016567]		metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0016567; GO:0046872; GO:0061630	QEEATATELTTK	3.460000038	0.632642329	0.632642329	0.30890583	1317.311295	15.03795	15.87587	18.03634	14.78952	12.45787	0	9.146317	15.48571	13.6896	14.97751	15.10898	15.35503	0	15.81164	0	0	0	0	16.22423	14.43691	0	15.77401	0	0	16.69021	0	15.56099	0	15.20388	0	0	0	0	0	0	0	0	0	0	15.19366	0	0	0	0	0	0	0	16.42974
Q13435	SF3B2_HUMAN	"Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit, SF3b145) (Spliceosome-associated protein 145, SAP 145)"	SF3B2 SAP145	Homo sapiens (Human)	"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0016607; GO:0071005; GO:0071011; GO:0071013	LHDAFFKWQTKPK	4.579999924	1	1	2.75E-12	1645.879542	15.08273	0	13.3993	14.84015	15.36193	15.10337	14.35212	0	0	0	15.90575	12.34958	13.18845	0	11.81471	0	15.274	0	0	0	0	0	12.91834	0	0	12.13831	15.02924	15.81055	0	14.80493	15.55304	0	0	0	0	0	0	0	0	15.12716	0	15.25109	0	0	0	0	0	0
Q13439	GOGA4_HUMAN	Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230)	GOLGA4	Homo sapiens (Human)	Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; small GTPase binding [GO:0031267]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192]	GTPase binding [GO:0051020]; small GTPase binding [GO:0031267]	GO:0000139; GO:0005654; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0016192; GO:0031267; GO:0043001; GO:0045773; GO:0048193; GO:0051020; GO:0070062	EAAISSLR	7.920000076	1	1	0.18684387	845.4576349	15.35568	0	0	0	0	0	14.0379	13.32646	12.68558	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13442	HAP28_HUMAN	"28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein, PAP) (PDGFA-associated protein 1, PAP1)"	PDAP1 HASPP28	Homo sapiens (Human)	signal transduction [GO:0007165]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; signal transduction [GO:0007165]	RNA binding [GO:0003723]	GO:0003723; GO:0005576; GO:0005829; GO:0005886; GO:0007165; GO:1904813	MHLAGK	1.120000005	1	1	0.159006488	656.406021	15.32219	0	14.13606	0	0	0	15.25456	0	0	16.06381	13.22566	0	15.20128	0	16.53965	0	0	14.57975	0	0	16.22171	0	0	0	0	0	0	0	0	0	15.15454	0	0	0	0	16.93512	0	16.25101	0	0	0	0	0	0	0	0	0	15.68324
Q13443	ADAM9_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 9, ADAM 9, EC 3.4.24.- (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase)"	ADAM9 KIAA0021 MCMP MDC9 MLTNG	Homo sapiens (Human)	amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intrinsic component of external side of plasma membrane [GO:0031233]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intrinsic component of external side of plasma membrane [GO:0031233]; collagen binding [GO:0005518]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein kinase C binding [GO:0005080]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179]	collagen binding [GO:0005518]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein kinase C binding [GO:0005080]; SH3 domain binding [GO:0017124]	GO:0004222; GO:0005080; GO:0005178; GO:0005518; GO:0005615; GO:0005925; GO:0006509; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008237; GO:0009986; GO:0010042; GO:0016021; GO:0016477; GO:0016485; GO:0017124; GO:0030216; GO:0030335; GO:0031233; GO:0031293; GO:0033627; GO:0033630; GO:0033631; GO:0034241; GO:0034612; GO:0042117; GO:0042542; GO:0042987; GO:0043236; GO:0043406; GO:0046872; GO:0050714; GO:0051044; GO:0051384; GO:0051549; GO:0051592; GO:0070062; GO:0071222; GO:1902945	DLLPEDFVVYTYNK	2.549999952	0.079339616	0.079339616	4.56E-13	1717.051675	14.62201	14.06615	15.19156	0	16.06593	0	0	15.16442	0	0	0	14.57497	0	0	0	0	16.2874	13.89353	17.45216	0	12.8139	0	17.59074	14.13727	0	0	0	0	0	13.38639	15.05122	0	15.0475	13.02775	0	0	17.93669	0	16.68221	15.7803	0	0	0	0	15.3807	0	15.15077	16.25117
Q13445	TMED1_HUMAN	"Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1, Tp24, p24gamma1)"	TMED1 IL1RL1L IL1RL1LG	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; cell-cell signaling [GO:0007267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0007165; GO:0007267; GO:0016021; GO:0030134; GO:0033116	NLQEGNLER	6.260000229	1	1	0.081946747	1073.308099	0	10.43294	15.88032	13.99102	16.97544	13.70796	14.11932	14.98376	14.58384	15.50319	0	14.10182	15.39149	0	11.7176	15.01488	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.40272	0	0	0	0	0	0	0	0
Q13449	LSAMP_HUMAN	"Limbic system-associated membrane protein, LSAMP (IgLON family member 3)"	LSAMP IGLON3 LAMP	Homo sapiens (Human)	cell adhesion [GO:0007155]; nervous system development [GO:0007399]	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; nervous system development [GO:0007399]		GO:0005576; GO:0005829; GO:0005886; GO:0007155; GO:0007399; GO:0031225	HLTPTGR	9.699999809	1	1	0.305647824	781.7064589	15.74301	17.62641	0	0	0	18.1695	0	0	17.78034	18.03849	0	17.6468	0	16.58251	0	0	0	0	0	0	16.72799	18.8301	0	17.63251	17.8122	0	0	0	0	0	0	0	18.97072	17.67477	19.88098	0	16.61873	18.08628	19.03423	0	0	0	0	0	17.02594	17.88468	0	18.16502
Q13451	FKBP5_HUMAN	"Peptidyl-prolyl cis-trans isomerase FKBP5, PPIase FKBP5, EC 5.2.1.8 (51 kDa FK506-binding protein, 51 kDa FKBP, FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding protein 5, FKBP-5) (FKBP54, p54) (HSP90-binding immunophilin) (Rotamase)"	FKBP5 AIG6 FKBP51	Homo sapiens (Human)	chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; response to bacterium [GO:0009617]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; response to bacterium [GO:0009617]	FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000413; GO:0003755; GO:0005528; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0009617; GO:0016020; GO:0031072; GO:0061077; GO:0070062	LQISMCQK	6.110000134	1	1	0.149957573	1008.45766	13.75526	0	0	0	0	0	0	15.30532	0	0	15.26772	0	0	0	0	0	0	0	0	0	14.95868	0	0	13.4524	0	0	0	0	13.8592	0	0	14.01253	0	0	14.87186	0	0	0	15.07612	0	0	0	0	0	15.06157	0	0	0
Q13454	TUSC3_HUMAN	"Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3, Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)"	TUSC3 N33	Homo sapiens (Human)	cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085]	magnesium ion transmembrane transporter activity [GO:0015095]	GO:0005739; GO:0005789; GO:0005886; GO:0005887; GO:0006487; GO:0008250; GO:0015095; GO:0015693; GO:0018279; GO:0050890; GO:0055085	ENLLAEK	21.07999992	1.23E-05	1.23E-05	0.255372311	815.6149896	0	18.17075	19.16272	0	0	18.82667	20.51067	20.25373	0	19.63844	0	18.40676	0	0	19.37134	17.73226	0	19.70794	17.49251	0	18.20327	20.60297	0	19.0176	20.50087	20.38181	19.90574	18.91854	0	0	21.81751	17.79106	21.76125	0	0	19.91964	17.21062	20.82137	21.18775	20.01738	19.38895	18.43753	19.61944	19.97467	16.91296	0	0	19.22841
Q13459	MYO9B_HUMAN	Unconventional myosin-IXb (Unconventional myosin-9b)	MYO9B MYR5	Homo sapiens (Human)	actin filament-based movement [GO:0030048]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Roundabout binding [GO:0048495]; small GTPase binding [GO:0031267]; actin filament-based movement [GO:0030048]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]	actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Roundabout binding [GO:0048495]; small GTPase binding [GO:0031267]	GO:0000146; GO:0003779; GO:0005096; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005884; GO:0005938; GO:0007266; GO:0015629; GO:0016020; GO:0016459; GO:0030048; GO:0031267; GO:0035023; GO:0035385; GO:0043531; GO:0046872; GO:0048471; GO:0048495; GO:0051056	EAGSSGRR	11.22000027	0.288480133	0.288480133	0.299099876	817.8333462	14.32056	0	15.96744	0	0	0	16.84498	16.30559	14.90198	0	0	0	17.17137	16.89029	17.97577	17.58023	16.95209	18.10577	0	17.90709	17.70606	17.80501	0	15.09372	17.54492	16.93866	18.29054	15.76661	15.34529	17.57436	17.0928	15.24131	18.76279	17.56909	16.77721	17.72707	19.00094	16.68064	19.33938	18.3024	16.55601	15.3113	17.28981	15.39224	17.02668	18.3138	16.43632	18.42076
Q13464	ROCK1_HUMAN	"Rho-associated protein kinase 1, EC 2.7.11.1 (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I, ROCK-I) (p160 ROCK-1, p160ROCK)"	ROCK1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; blood vessel diameter maintenance [GO:0097746]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; glomerular visceral epithelial cell migration [GO:0090521]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatase activity [GO:0010922]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]	bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]	bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; blood vessel diameter maintenance [GO:0097746]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; glomerular visceral epithelial cell migration [GO:0090521]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatase activity [GO:0010922]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]	aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000139; GO:0000281; GO:0001726; GO:0001837; GO:0003180; GO:0003383; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005576; GO:0005737; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006915; GO:0006939; GO:0007159; GO:0007165; GO:0007249; GO:0007266; GO:0010494; GO:0010506; GO:0010508; GO:0010613; GO:0010628; GO:0010922; GO:0016525; GO:0018105; GO:0018107; GO:0019828; GO:0022614; GO:0030027; GO:0030036; GO:0030155; GO:0030334; GO:0030866; GO:0031032; GO:0031175; GO:0031267; GO:0032059; GO:0032060; GO:0032091; GO:0032956; GO:0034774; GO:0035306; GO:0035509; GO:0042326; GO:0043410; GO:0043524; GO:0045616; GO:0045664; GO:0046872; GO:0048156; GO:0048598; GO:0050321; GO:0050900; GO:0050901; GO:0051045; GO:0051451; GO:0051492; GO:0051893; GO:0051894; GO:0061157; GO:0070168; GO:0070507; GO:0071559; GO:0072518; GO:0072659; GO:0090521; GO:0097746; GO:0106310; GO:0110061; GO:0140058; GO:1900223; GO:1900242; GO:1901888; GO:1902003; GO:1902430; GO:1902992; GO:1903140; GO:1903347; GO:1905205; GO:1990776; GO:2000114; GO:2000145	EEEISNLKAAFEK	5.010000229	0.87825948	0.87825948	0.117268153	1505.27137	0	0	0	0	0	16.42419	14.5066	0	12.84794	0	0	0	0	0	0	0	0	0	0	0	0	0	14.76907	13.90609	15.79418	15.72939	17.2917	0	0	0	0	0	11.88319	0	0	0	0	16.20992	16.09618	0	0	0	0	0	0	0	0	0
Q13472	TOP3A_HUMAN	"DNA topoisomerase 3-alpha, EC 5.6.2.1 (DNA topoisomerase III alpha)"	TOP3A TOP3	Homo sapiens (Human)	chromosome separation [GO:0051304]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; resolution of recombination intermediates [GO:0071139]	mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RecQ family helicase-topoisomerase III complex [GO:0031422]	"mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RecQ family helicase-topoisomerase III complex [GO:0031422]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; resolution of recombination intermediates [GO:0071139]"	"DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]"	GO:0000724; GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005759; GO:0006265; GO:0008270; GO:0016605; GO:0031422; GO:0032042; GO:0051304; GO:0051321; GO:0071139	NDAAKGIADLLSNGR	3.609999895	0.014115586	0.014115586	0.219434346	1518.416986	14.167	13.96496	0	0	0	0	0	15.38051	0	0	15.08881	0	0	0	16.62887	14.07973	14.50793	14.19483	15.74353	0	0	11.7244	16.03231	14.1255	0	0	14.51445	15.52665	0	0	13.27667	15.15149	0	0	0	0	0	0	0	0	15.36341	15.8691	16.66967	14.87942	0	0	0	0
Q13474	DRP2_HUMAN	"Dystrophin-related protein 2, DRP-2"	DRP2	Homo sapiens (Human)	central nervous system development [GO:0007417]; synapse organization [GO:0050808]; synaptic signaling [GO:0099536]	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; synapse organization [GO:0050808]; synaptic signaling [GO:0099536]	zinc ion binding [GO:0008270]	GO:0005886; GO:0007417; GO:0008270; GO:0014069; GO:0030425; GO:0043204; GO:0050808; GO:0098978; GO:0099536	VTIAEQVKHQTK	14.31000042	1	1	0.152700347	1381.13485	13.42433	13.31276	13.04418	0	0	0	0	15.79542	0	0	0	0	0	0	15.96963	0	0	0	0	0	0	0	0	0	0	0	0	15.30979	12.80637	0	0	15.77235	0	15.60019	16.04396	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13480	GAB1_HUMAN	GRB2-associated-binding protein 1 (GRB2-associated binder 1) (Growth factor receptor bound protein 2-associated protein 1)	GAB1	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; endothelial cell chemotaxis to vascular endothelial growth factor [GO:0090668]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; response to hepatocyte growth factor [GO:0035728]; vascular endothelial growth factor signaling pathway [GO:0038084]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; endothelial cell chemotaxis to vascular endothelial growth factor [GO:0090668]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; response to hepatocyte growth factor [GO:0035728]; vascular endothelial growth factor signaling pathway [GO:0038084]		GO:0001525; GO:0005829; GO:0005911; GO:0007173; GO:0008286; GO:0031532; GO:0035728; GO:0038084; GO:0038089; GO:0045766; GO:0090668	SSGSGSSVADER	19.48999977	1	1	0.29650184	1137.68038	0	0	0	0	0	0	11.23531	15.36234	15.54401	14.63503	14.84566	14.996	0	15.62744	15.12984	14.68334	15.69528	15.19391	0	17.89826	18.89818	0	0	15.76329	17.6679	18.69469	17.14514	15.34535	15.38476	16.78918	0	17.98591	0	18.57576	18.25454	0	20.0561	19.57298	0	19.51539	19.39701	19.32121	19.34402	18.59147	18.89766	19.55849	16.15896	19.41177
Q13488	VPP3_HUMAN	"V-type proton ATPase 116 kDa subunit a 3, V-ATPase 116 kDa subunit a 3 (Osteoclastic proton pump 116 kDa subunit, OC-116 kDa, OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein, TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)"	TCIRG1 ATP6N1C ATP6V0A3	Homo sapiens (Human)	apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; establishment of cell polarity [GO:0030010]; establishment of vesicle localization [GO:0051650]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; lysosomal lumen acidification [GO:0007042]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; protein localization to organelle [GO:0033365]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; ruffle organization [GO:0031529]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; vacuolar acidification [GO:0007035]	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"	"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; establishment of cell polarity [GO:0030010]; establishment of vesicle localization [GO:0051650]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; lysosomal lumen acidification [GO:0007042]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; protein localization to organelle [GO:0033365]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; ruffle organization [GO:0031529]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; vacuolar acidification [GO:0007035]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; transporter activity [GO:0005215]"	GO:0000045; GO:0000220; GO:0001503; GO:0002158; GO:0005215; GO:0005634; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0006954; GO:0006968; GO:0007035; GO:0007039; GO:0007042; GO:0008284; GO:0010008; GO:0010155; GO:0010272; GO:0010467; GO:0010468; GO:0016064; GO:0016236; GO:0016324; GO:0016471; GO:0021554; GO:0030010; GO:0030183; GO:0030217; GO:0030316; GO:0030670; GO:0031529; GO:0033176; GO:0033365; GO:0035709; GO:0035711; GO:0043029; GO:0044691; GO:0045453; GO:0045667; GO:0046961; GO:0050796; GO:0051117; GO:0051650; GO:0060041; GO:0061484; GO:0070166; GO:0071345; GO:0090383; GO:0097188; GO:0101003; GO:1902600	GSMFRSEEVALVQLFLPTAAAYTCVSR	7.860000134	1	1	4.57E-12	3018.721016	0	16.66955	0	0	16.01412	0	10.36513	0	13.88381	11.93619	0	13.20584	13.00862	11.97204	0	0	0	0	0	0	14.15518	0	0	0	0	15.17078	15.48734	13.50327	0	0	0	0	0	0	0	0	0	0	0	0	15.0957	0	13.48651	15.40538	12.68707	0	15.2149	0
Q13489	BIRC3_HUMAN	"Baculoviral IAP repeat-containing protein 3, EC 2.3.2.27 (Apoptosis inhibitor 2, API2) (Cellular inhibitor of apoptosis 2, C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1, hIAP-1, hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)"	BIRC3 API2 MIHC RNF49	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0007283; GO:0016740; GO:0031398; GO:0032991; GO:0033209; GO:0034121; GO:0038061; GO:0039535; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0044877; GO:0045088; GO:0045121; GO:0046872; GO:0050727; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070424; GO:2000116	ANQDFSALMR	7.340000153	1	1	0.207916358	1167.866022	0	0	0	0	0	0	0	15.07373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.53485	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.6534	0	0
Q13490	BIRC2_HUMAN	"Baculoviral IAP repeat-containing protein 2, EC 2.3.2.27 (Cellular inhibitor of apoptosis 1, C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2, hIAP-2, hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)"	BIRC2 API1 MIHB RNF48	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741]	CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045121; GO:0045471; GO:0045595; GO:0047485; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377	NLFVDKNMK	11.88000011	1	1	0.068550489	1108.325537	14.96108	16.30565	16.57979	0	0	13.48264	13.9659	0	0	15.1194	0	15.83463	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13495	MAMD1_HUMAN	Mastermind-like domain-containing protein 1 (F18) (Protein CG1)	MAMLD1 CG1 CXorf6	Homo sapiens (Human)	male gonad development [GO:0008584]; regulation of transcription by RNA polymerase II [GO:0006357]	centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; male gonad development [GO:0008584]; regulation of transcription by RNA polymerase II [GO:0006357]		GO:0005654; GO:0005794; GO:0005813; GO:0006357; GO:0008584; GO:0016604	AWRQVPAPLLPSCDATAR	3.440000057	1	1	0	2008.884224	0	0	0	0	0	0	0	0	15.05202	0	0	0	13.06292	14.06188	0	0	0	0	12.73914	13.45778	0	0	14.34778	15.77381	0	0	0	0	0	0	12.96075	14.99624	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13496	MTM1_HUMAN	"Myotubularin (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)"	MTM1 CG2	Homo sapiens (Human)	endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]"	"intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]"	GO:0001726; GO:0004438; GO:0004721; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008333; GO:0015031; GO:0019215; GO:0030175; GO:0031674; GO:0032007; GO:0032435; GO:0035091; GO:0044088; GO:0045109; GO:0046716; GO:0046856; GO:0048311; GO:0048633; GO:0051898; GO:0052629; GO:0070584; GO:1902902	GRVYITNYR	2.25	0.744905531	0.744905531	0.242329106	1141.928217	13.64638	14.91016	14.09028	15.51452	0	16.18847	0	0	14.8247	12.43201	0	13.28877	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.70347	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.05333	0	0	0	0	0	0
Q13505	MTX1_HUMAN	Metaxin-1 (Mitochondrial outer membrane import complex protein 1)	MTX1 MTX MTXN	Homo sapiens (Human)	inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; SAM complex [GO:0001401]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; SAM complex [GO:0001401]; inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040]		GO:0001401; GO:0005737; GO:0005741; GO:0007005; GO:0007007; GO:0007595; GO:0016021; GO:0045040; GO:0140275	LLGGPPR	4.480000019	1	1	0.114281102	710.5212061	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.15245	0	0	0	0	0	0	0	0	0	17.54947	0	17.78204	0	16.47715	0	0	17.15034	17.47034	0	0	0	0	0	0	0	0	0
Q13507	TRPC3_HUMAN	"Short transient receptor potential channel 3, TrpC3 (Transient receptor protein 3, TRP-3, hTrp-3, hTrp3)"	TRPC3 TRP3	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]	cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]"	"calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"	GO:0005262; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007338; GO:0007602; GO:0010524; GO:0015279; GO:0033198; GO:0034703; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903244	LANIEK	3.420000076	1	1	0.075292813	686.6019617	15.73714	12.16498	0	18.40331	0	0	14.59734	14.56112	15.99589	0	0	13.99871	0	11.54006	0	16.20466	16.72024	0	14.01168	0	0	0	16.40966	11.80515	0	0	0	0	0	13.49981	17.31675	0	15.46523	16.77119	15.40231	0	0	15.05074	17.05123	0	0	17.3466	0	0	0	0	14.01269	0
Q13508	NAR3_HUMAN	"Ecto-ADP-ribosyltransferase 3, EC 2.4.2.31 (ADP-ribosyltransferase C2 and C3 toxin-like 3, ARTC3) (Mono(ADP-ribosyl)transferase 3) (NAD(P)(+)--arginine ADP-ribosyltransferase 3)"	ART3 TMART	Homo sapiens (Human)	peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NADP+-protein-arginine ADP-ribosyltransferase activity [GO:0106275]; peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NADP+-protein-arginine ADP-ribosyltransferase activity [GO:0106275]	GO:0003950; GO:0005576; GO:0005886; GO:0006471; GO:0018120; GO:0031225; GO:0031226; GO:0070062; GO:0106274; GO:0106275	TQIFLPMNFK	5.739999771	1	1	0.179413372	1238.857543	0	11.77949	14.49056	0	0	0	16.49282	0	14.13241	0	15.33663	14.79022	0	0	0	0	0	0	14.38497	0	0	0	0	0	0	16.31597	16.25655	0	0	16.63161	0	0	0	0	0	0	0	0	0	14.48113	0	15.7336	0	0	0	0	0	17.03293
Q13515	BFSP2_HUMAN	"Phakinin (49 kDa cytoskeletal protein) (Beaded filament structural protein 2) (Lens fiber cell beaded filament protein CP 47, CP47) (Lens fiber cell beaded filament protein CP 49, CP49) (Lens intermediate filament-like light, LIFL-L)"	BFSP2	Homo sapiens (Human)	cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]; cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]	GO:0005200; GO:0005212; GO:0005856; GO:0005882; GO:0005886; GO:0005938; GO:0007601; GO:0045109; GO:0048469; GO:0050896; GO:0070307	AHLLAR	22.77000046	0.214761347	0.214761347	0.018164733	679.4629593	0	20.24072	20.04775	20.19418	21.21476	20.42071	20.6992	0	19.07105	21.18272	20.03892	19.14118	0	20.34567	20.57897	0	19.61736	19.46073	0	0	0	0	0	19.60399	19.30084	19.86255	0	19.68776	0	19.55117	19.95271	18.43375	19.78937	19.41177	20.13346	18.61513	0	0	19.63367	18.94691	20.07505	0	20.18968	20.47891	19.42604	19.36489	20.23854	19.06649
Q13520	AQP6_HUMAN	"Aquaporin-6, AQP-6 (Aquaporin-2-like) (Kidney-specific aquaporin, hKID)"	AQP6 AQP2L	Homo sapiens (Human)	carbon dioxide transport [GO:0015670]; odontogenesis [GO:0042476]; renal water transport [GO:0003097]; water transport [GO:0006833]	apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nitrate transmembrane transporter activity [GO:0015112]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; odontogenesis [GO:0042476]; renal water transport [GO:0003097]; water transport [GO:0006833]	nitrate transmembrane transporter activity [GO:0015112]; water channel activity [GO:0015250]	GO:0003097; GO:0005886; GO:0006833; GO:0015112; GO:0015250; GO:0015670; GO:0016021; GO:0016324; GO:0030659; GO:0042476	ETLGINVVR	5.269999981	1	1	0.176793919	1000.743123	0	17.15566	0	0	17.77326	14.51403	0	14.00494	0	0	15.24685	13.00192	14.44729	0	0	0	0	0	0	0	0	17.02505	0	0	0	0	0	0	0	0	0	0	0	0	15.66153	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13522	PPR1A_HUMAN	"Protein phosphatase 1 regulatory subunit 1A (Protein phosphatase inhibitor 1, I-1, IPP-1)"	PPP1R1A IPP1	Homo sapiens (Human)	glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]	protein serine/threonine phosphatase inhibitor activity [GO:0004865]	GO:0004865; GO:0005737; GO:0005977; GO:0035556	ITPTMK	2.75999999	0.417607158	0.417607158	0.145623344	691.3265959	17.06451	17.08771	0	0	0	0	0	0	0	0	0	0	0	0	17.81719	0	0	0	0	0	18.23993	0	0	16.74379	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13523	PRP4B_HUMAN	"Serine/threonine-protein kinase PRP4 homolog, EC 2.7.11.1 (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog)"	PRPF4B KIAA0536 PRP4 PRP4H PRP4K	Homo sapiens (Human)	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]"	catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	"catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]"	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005694; GO:0006468; GO:0008380; GO:0016607; GO:0045292; GO:0071013; GO:0106310	SSSTK	6.449999809	0.36381796	0.36381796	0.276412559	510.4376635	0	0	15.2088	17.58433	0	0	0	0	0	15.98001	16.72167	13.98451	16.43645	21.70251	0	0	0	13.07654	0	0	0	0	16.6034	0	0	16.23717	19.79429	0	0	0	17.20133	0	0	0	0	0	21.87134	0	0	0	16.03841	0	15.03679	0	0	16.05751	0	0
Q13535	ATR_HUMAN	"Serine/threonine-protein kinase ATR, EC 2.7.11.1 (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1)"	ATR FRP1	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; nucleobase-containing compound metabolic process [GO:0006139]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of double-strand break repair [GO:2000779]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to arsenic-containing substance [GO:0046685]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]"	ATR-ATRIP complex [GO:0070310]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"ATR-ATRIP complex [GO:0070310]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; multicellular organism development [GO:0007275]; negative regulation of DNA replication [GO:0008156]; nucleobase-containing compound metabolic process [GO:0006139]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of double-strand break repair [GO:2000779]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to arsenic-containing substance [GO:0046685]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000077; GO:0000723; GO:0003677; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006139; GO:0006260; GO:0006281; GO:0006468; GO:0006974; GO:0007275; GO:0008156; GO:0009410; GO:0016605; GO:0018105; GO:0031297; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0036297; GO:0043517; GO:0046685; GO:0046777; GO:0070198; GO:0070310; GO:0071480; GO:0090399; GO:0097694; GO:0097695; GO:0106310; GO:1900034; GO:1904884; GO:2000779	CPHSK	7.840000153	1	1	0.094290264	624.6143262	16.61443	16.24302	13.16223	18.76237	0	12.71729	0	16.56268	13.86326	14.20853	0	0	0	15.42407	0	0	13.55852	15.84167	14.50037	0	16.23112	0	16.017	15.31722	14.56807	13.56427	0	12.34089	0	15.37717	13.43414	0	15.22389	15.86719	15.19793	0	0	0	15.54161	16.11088	13.87458	0	17.11715	13.52066	15.70253	0	15.79569	0
Q13541	4EBP1_HUMAN	"Eukaryotic translation initiation factor 4E-binding protein 1, 4E-BP1, eIF4E-binding protein 1 (Phosphorylated heat- and acid-stable protein regulated by insulin 1, PHAS-I)"	EIF4EBP1	Homo sapiens (Human)	G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929]	eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371]	GO:0000082; GO:0005737; GO:0005829; GO:0008190; GO:0030371; GO:0031929; GO:0045931; GO:0045947	SGGSSCSQTPSR	2.019999981	0.848240256	0.848240256	0.437912891	1207.043441	20.07094	0	0	18.06987	0	0	0	0	19.6149	18.15903	17.48381	0	0	0	0	0	18.5879	18.48686	0	0	0	0	18.22668	0	0	0	18.57112	0	0	0	0	0	19.33314	20.34833	21.10911	0	0	18.56512	0	0	0	0	0	0	0	18.6464	0	0
Q13547	HDAC1_HUMAN	"Histone deacetylase 1, HD1, EC 3.5.1.98 (Protein deacetylase HDAC1, EC 3.5.1.-) (Protein decrotonylase HDAC1, EC 3.5.1.-)"	HDAC1 RPD3L1	Homo sapiens (Human)	"cellular response to platelet-derived growth factor stimulus [GO:0036120]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic digit morphogenesis [GO:0042733]; endoderm development [GO:0007492]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of amyloid-beta clearance [GO:1900221]; regulation of cell fate specification [GO:0042659]; regulation of endopeptidase activity [GO:0052548]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; core promoter sequence-specific DNA binding [GO:0001046]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; Krueppel-associated box domain binding [GO:0035851]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic digit morphogenesis [GO:0042733]; endoderm development [GO:0007492]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of amyloid-beta clearance [GO:1900221]; regulation of cell fate specification [GO:0042659]; regulation of endopeptidase activity [GO:0052548]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]"	core promoter sequence-specific DNA binding [GO:0001046]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; Krueppel-associated box domain binding [GO:0035851]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]	GO:0000118; GO:0000122; GO:0000785; GO:0000792; GO:0000978; GO:0000979; GO:0001046; GO:0001222; GO:0002039; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006338; GO:0006346; GO:0006357; GO:0006476; GO:0007492; GO:0008284; GO:0009913; GO:0010628; GO:0010629; GO:0016575; GO:0016580; GO:0016581; GO:0017053; GO:0019213; GO:0019899; GO:0021766; GO:0030182; GO:0030336; GO:0030512; GO:0032922; GO:0032991; GO:0033558; GO:0035851; GO:0036120; GO:0042475; GO:0042659; GO:0042733; GO:0042826; GO:0043025; GO:0043066; GO:0043124; GO:0043922; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0048661; GO:0048714; GO:0051059; GO:0052548; GO:0060766; GO:0060789; GO:0061029; GO:0061198; GO:0061629; GO:0070888; GO:0070932; GO:0070933; GO:0090090; GO:0140297; GO:0160009; GO:1900221; GO:1902455; GO:1902459; GO:1990841; GO:2000273; GO:2000736; GO:2001243	VMTVSFHK	12.80000019	0.428011984	0.428011984	0.181418298	966.5673798	0	15.08894	15.09189	0	0	0	16.60533	0	15.42413	0	15.42169	16.88264	16.70699	16.34007	16.05016	16.94802	15.99783	16.30895	0	15.99587	0	0	15.99439	15.80645	16.20832	16.22571	15.86058	16.14408	15.16315	15.55912	16.23397	14.8605	15.59745	0	15.24761	0	0	0	14.0775	15.42786	13.39212	0	12.61704	13.52277	14.74911	13.47138	0	14.73736
Q13555	KCC2G_HUMAN	"Calcium/calmodulin-dependent protein kinase type II subunit gamma, CaM kinase II subunit gamma, CaMK-II subunit gamma, EC 2.7.11.17"	CAMK2G CAMK CAMK-II CAMKG	Homo sapiens (Human)	cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; nervous system development [GO:0007399]; regulation of calcium ion transport [GO:0051924]; regulation of neuron projection development [GO:0010975]; regulation of skeletal muscle adaptation [GO:0014733]	calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017]	calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; nervous system development [GO:0007399]; regulation of calcium ion transport [GO:0051924]; regulation of neuron projection development [GO:0010975]; regulation of skeletal muscle adaptation [GO:0014733]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004683; GO:0004712; GO:0004723; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005954; GO:0007399; GO:0010975; GO:0014733; GO:0016020; GO:0030073; GO:0030154; GO:0030666; GO:0033017; GO:0042802; GO:0042803; GO:0043005; GO:0051924; GO:0106310	GAILTTMLVSRNFSAAK	1.320000052	1	1	1.83E-12	1795.334712	0	14.25372	14.42708	0	0	14.44954	0	14.42131	12.51289	0	0	14.60108	0	15.13216	0	15.5242	0	0	0	0	0	15.76779	15.81033	0	0	14.36377	17.54168	0	0	11.58739	16.45395	15.09212	14.195	0	16.29123	0	14.47747	15.15675	0	12.57881	14.47716	0	0	15.27204	0	16.82598	0	0
Q13557	KCC2D_HUMAN	"Calcium/calmodulin-dependent protein kinase type II subunit delta, CaM kinase II subunit delta, CaMK-II subunit delta, EC 2.7.11.17"	CAMK2D CAMKD	Homo sapiens (Human)	cardiac muscle cell contraction [GO:0086003]; cellular response to calcium ion [GO:0071277]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cell growth [GO:0001558]; regulation of cellular localization [GO:0060341]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of histone deacetylase activity [GO:1901725]; regulation of membrane depolarization [GO:0003254]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of transcription by RNA polymerase II [GO:0006357]; relaxation of cardiac muscle [GO:0055119]	calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]	calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel inhibitor activity [GO:0019871]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; cardiac muscle cell contraction [GO:0086003]; cellular response to calcium ion [GO:0071277]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cell growth [GO:0001558]; regulation of cellular localization [GO:0060341]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of histone deacetylase activity [GO:1901725]; regulation of membrane depolarization [GO:0003254]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of transcription by RNA polymerase II [GO:0006357]; relaxation of cardiac muscle [GO:0055119]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel inhibitor activity [GO:0019871]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]	GO:0001558; GO:0002026; GO:0003254; GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005954; GO:0006357; GO:0006468; GO:0008016; GO:0010613; GO:0010649; GO:0010666; GO:0010880; GO:0010881; GO:0016020; GO:0018105; GO:0018107; GO:0019871; GO:0030666; GO:0031432; GO:0032469; GO:0033017; GO:0042383; GO:0042802; GO:0042803; GO:0043005; GO:0044325; GO:0046777; GO:0055119; GO:0060314; GO:0060341; GO:0071277; GO:0086003; GO:0086091; GO:0098901; GO:0098909; GO:0106310; GO:1901725; GO:1901844; GO:1901897; GO:1902306; GO:1902514; GO:2000650	SKGAAVK	2.859999895	1	1	0.130088269	661.3425027	0	12.56515	0	0	17.56273	0	0	0	17.86989	16.1123	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.24597	18.50072	13.68016	0	0	0	0	17.50776	0	0	0	0	0	0	0	0	0	0	0	17.63321	0	0
Q13564	ULA1_HUMAN	"NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa, APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)"	NAE1 APPBP1 HPP1	Homo sapiens (Human)	mitotic DNA replication checkpoint signaling [GO:0033314]; neuron apoptotic process [GO:0051402]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]; mitotic DNA replication checkpoint signaling [GO:0033314]; neuron apoptotic process [GO:0051402]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165]	NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0019781; GO:0031625; GO:0032446; GO:0032991; GO:0033314; GO:0042981; GO:0043523; GO:0045116; GO:0046982; GO:0051402	GTIPDMIADSGKYIK	1.889999986	1	1	0.03692039	1624.356208	16.26831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13568	IRF5_HUMAN	"Interferon regulatory factor 5, IRF-5"	IRF5	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0006954; GO:0019221; GO:0019901; GO:0032481; GO:0032494; GO:0032495; GO:0032727; GO:0032728; GO:0032735; GO:0042802; GO:0043065; GO:0043565; GO:0045087; GO:0045944; GO:0051607; GO:1990837	MNQSIPVAPTPPRR	3.380000114	1	1	0.314071414	1562.969939	0	0	0	13.93313	0	0	0	0	0	0	0	0	0	0	0	16.32326	0	0	0	0	0	0	0	14.20311	0	0	16.21283	0	0	0	0	0	0	0	0	0	0	17.07915	0	0	0	0	16.95827	0	0	0	0	15.38191
Q13572	ITPK1_HUMAN	"Inositol-tetrakisphosphate 1-kinase, EC 2.7.1.134 (Inositol 1,3,4-trisphosphate 5/6-kinase, Inositol-triphosphate 5/6-kinase, Ins(1,3,4)P(3) 5/6-kinase, EC 2.7.1.159)"	ITPK1	Homo sapiens (Human)	blood coagulation [GO:0007596]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915]; signal transduction [GO:0007165]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; ATP binding [GO:0005524]; catalytic activity [GO:0003824]; hydrolase activity [GO:0016787]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; blood coagulation [GO:0007596]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915]; signal transduction [GO:0007165]"	"ATP binding [GO:0005524]; catalytic activity [GO:0003824]; hydrolase activity [GO:0016787]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0000825; GO:0003824; GO:0005524; GO:0005829; GO:0007165; GO:0007596; GO:0016324; GO:0016787; GO:0016853; GO:0021915; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266	AEADAGGTAK	9.140000343	1	1	0.034235768	887.805867	13.8242	0	0	0	0	14.5919	15.68766	14.62221	0	15.58983	0	0	0	14.16656	16.71863	0	0	0	0	0	0	0	0	0	0	15.53531	0	0	0	0	0	0	0	0	0	0	15.05397	0	0	0	0	14.61837	0	0	0	0	0	0
Q13586	STIM1_HUMAN	Stromal interaction molecule 1	STIM1 GOK	Homo sapiens (Human)	activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; sarcoplasmic reticulum membrane [GO:0033017]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115]	calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]	GO:0002020; GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006874; GO:0030176; GO:0032237; GO:0032541; GO:0033017; GO:0042802; GO:0044853; GO:0045762; GO:0045766; GO:0051010; GO:0051924; GO:0070166; GO:2001256	QLLVAK	8.350000381	1	1	0.197184177	671.5308981	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.84441	0	0	0	0	0	0	0	0	17.93755	0	0	0	0	0	0	0	0	0	18.2394	0	0	16.97256	0	0	0	0
Q13608	PEX6_HUMAN	"Peroxisome assembly factor 2, PAF-2 (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1)"	PEX6 PXAAA1	Homo sapiens (Human)	"peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]	GO:0001750; GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016561; GO:0016887; GO:0044877; GO:0050821; GO:0097733	KFAAC	10.93999958	0.258877218	0.258877218	0.190621438	595.4405088	16.10456	15.87054	15.93712	15.61607	16.88646	16.32662	12.95236	14.80205	15.33444	15.48571	0	16.62087	14.60153	16.87198	16.5745	0	16.65698	16.55874	16.96553	17.02992	0	16.63682	16.03366	16.51835	16.52353	15.41645	17.36114	16.236	17.17925	15.85186	0	13.86055	17.09046	17.51874	0	16.94259	17.46328	16.94649	18.45307	16.08368	17.61034	17.54497	17.10563	17.17866	16.19382	0	18.06591	17.30193
Q13614	MTMR2_HUMAN	"Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)"	MTMR2 KIAA1073	Homo sapiens (Human)	dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]; identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	"identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]"	GO:0002091; GO:0004438; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0006470; GO:0006661; GO:0008021; GO:0008138; GO:0014069; GO:0030424; GO:0030425; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0043197; GO:0043231; GO:0045806; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304; GO:0070062; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645	EDEKYLQAIMDSNAQSHK	5.210000038	1	1	1.38E-12	2101.385075	13.53891	16.15454	0	12.44137	15.34103	14.80651	0	11.95175	0	0	14.09461	0	0	0	0	0	0	13.83392	0	0	0	0	0	14.56885	12.89427	0	0	0	14.35323	14.41303	0	15.8706	13.10167	0	0	0	12.09112	0	0	0	0	14.93666	0	0	0	0	0	0
Q13615	MTMR3_HUMAN	"Myotubularin-related protein 3, EC 3.1.3.48 (FYVE domain-containing dual specificity protein phosphatase 1, FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)"	MTMR3 KIAA0371 ZFYVE10	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]"	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]"	GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0010506; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785	QLSAMSCSSAHLHSRNLHHK	2.75999999	1	1	0.154412286	2317.969899	15.00064	16.23569	0	15.55075	0	0	0	11.75658	14.8155	0	0	0	0	0	0	0	0	15.53981	0	0	13.70193	0	0	14.89318	0	14.14004	12.32425	0	14.67546	13.47885	0	11.22691	15.49663	0	8.450513	0	0	0	0	0	14.08763	14.574	0	11.62077	0	0	0	0
Q13616	CUL1_HUMAN	"Cullin-1, CUL-1"	CUL1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0005654; GO:0005829; GO:0005886; GO:0006513; GO:0008283; GO:0009887; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031625; GO:0070936; GO:0097193; GO:1990452	FINNNAVTK	11.96000004	1	1	0.002985093	1019.486822	15.8834	14.11337	16.21312	0	14.74838	17.00471	17.40596	0	0	16.49301	15.40993	0	15.85143	16.72259	0	0	15.49475	0	17.01579	0	0	0	16.58256	16.6773	0	0	0	16.75639	16.25017	0	0	0	0	0	17.92405	17.67572	0	19.24855	16.16919	17.22624	0	17.19017	0	0	17.89642	0	0	17.24234
Q13617	CUL2_HUMAN	"Cullin-2, CUL-2"	CUL2	Homo sapiens (Human)	G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0005654; GO:0005730; GO:0005829; GO:0016567; GO:0019005; GO:0030674; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0044877; GO:0097193	DTPQEMEQTR	5.289999962	1	1	0.192341925	1231.057748	12.97794	0	0	13.40751	0	13.98427	0	0	0	0	0	0	15.08422	13.91965	14.73383	0	0	12.97332	0	14.11008	12.00635	14.37696	0	0	13.54414	0	0	14.11365	0	0	0	0	0	0	13.80409	14.23993	14.60265	0	0	0	11.8106	15.02818	14.45829	0	0	14.5373	0	15.30713
Q13618	CUL3_HUMAN	"Cullin-3, CUL-3"	CUL3 KIAA0617	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0000122; GO:0000209; GO:0000922; GO:0001831; GO:0005112; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006888; GO:0007080; GO:0007229; GO:0007369; GO:0008284; GO:0016020; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031461; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0042802; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0070062; GO:0070936; GO:0071630; GO:0072576; GO:0072686; GO:0097193; GO:1901992	EPKSK	3.579999924	1	1	0.276118853	589.119212	18.88385	0	0	0	0	0	0	17.36991	17.6392	0	0	0	0	0	0	0	0	0	0	16.97556	0	19.1228	0	0	18.16207	0	0	0	17.19641	15.22179	0	0	0	18.23628	0	18.82095	0	0	0	0	0	0	0	16.06642	0	0	18.07296	0
Q13619	CUL4A_HUMAN	"Cullin-4A, CUL-4A"	CUL4A	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]	protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0001701; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0008284; GO:0016567; GO:0030097; GO:0030674; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0034644; GO:0035019; GO:0042254; GO:0043161; GO:0048511; GO:0051246; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819	LHEAVR	3.049999952	0.536819994	0.536819994	0.183201988	723.4654552	0	15.37702	0	0	0	16.4944	16.08072	16.35523	0	0	16.46283	15.09857	0	16.5714	15.45201	15.9397	15.49308	0	0	0	0	17.77132	0	0	15.84188	15.68588	16.60097	15.06933	14.32067	15.49506	0	14.34214	16.5125	0	16.84467	16.88695	17.45765	15.07876	15.98282	13.85321	15.34151	16.62641	15.18821	15.67551	15.75362	15.66283	16.495	16.11287
Q13620	CUL4B_HUMAN	"Cullin-4B, CUL-4B"	CUL4B KIAA0695	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; UV-damage excision repair [GO:0070914]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; UV-damage excision repair [GO:0070914]	protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0010498; GO:0016567; GO:0030674; GO:0031146; GO:0031175; GO:0031461; GO:0031464; GO:0031465; GO:0031625; GO:0034644; GO:0035518; GO:0042254; GO:0045732; GO:0070062; GO:0070914; GO:0080008; GO:1900087	IMIIFR	23.37999916	0.421558499	0.421558499	0.205259554	796.4536751	15.46363	14.69687	0	12.92286	17.25577	14.24679	14.9472	15.6445	0	17.97898	16.5021	15.34917	16.36615	15.73323	15.88986	12.16017	10.25821	13.77442	0	0	13.01953	16.55907	0	17.01686	15.23988	0	15.77304	13.94578	14.97371	14.51731	16.61606	14.89835	16.13925	15.94073	0	15.67271	15.76206	15.62406	0	0	15.18564	0	0	15.29348	0	15.59887	0	0
Q13621	S12A1_HUMAN	Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (Kidney-specific Na-K-Cl symporter)	SLC12A1 NKCC2	Homo sapiens (Human)	cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]	potassium:chloride symporter activity [GO:0015379]; sodium:potassium:chloride symporter activity [GO:0008511]	GO:0005886; GO:0006811; GO:0006884; GO:0008511; GO:0015379; GO:0016020; GO:0016021; GO:0016324; GO:0034220; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070062; GO:1902476; GO:1990573	EMNSGMAK	7.03000021	0.250868082	0.250868082	0.220051693	901.3938637	14.75072	14.53314	15.45836	15.14328	13.91822	15.12589	15.30394	15.947	0	16.4664	14.70689	16.76246	15.80538	16.20508	0	15.64128	16.03371	0	16.97742	17.21031	15.85664	15.62785	16.12606	16.17492	15.81153	15.30777	16.3699	15.59828	18.16295	17.43851	15.95191	15.99819	17.22643	17.51192	16.7663	15.36926	16.65283	17.31149	18.06074	15.72572	16.21359	15.69753	15.65933	16.96992	16.49226	16.09511	0	0
Q13625	ASPP2_HUMAN	"Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein, Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2, 53BP2, p53-binding protein 2, p53BP2)"	TP53BP2 ASPP2 BBP	Homo sapiens (Human)	cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; signal transduction [GO:0007165]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3 domain binding [GO:0017124]; cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3 domain binding [GO:0017124]	GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0017124; GO:0030054; GO:0042802; GO:0045786; GO:0048471; GO:0051059; GO:0072332; GO:1900119	ALKGHVEQK	4.010000229	1	1	0.133706707	1010.128109	0	0	0	0	17.07337	0	0	0	0	0	0	0	14.90318	0	0	16.8467	0	13.00675	0	0	0	0	0	14.37996	19.03211	15.6329	0	0	13.47655	14.81945	16.00167	0	14.29065	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13627	DYR1A_HUMAN	"Dual specificity tyrosine-phosphorylation-regulated kinase 1A, EC 2.7.12.1 (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog, MNBH, hMNB)"	DYRK1A DYRK MNB MNBH	Homo sapiens (Human)	"amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]"	actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]	GO:0003713; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006468; GO:0007399; GO:0007623; GO:0008092; GO:0015631; GO:0016607; GO:0018105; GO:0018107; GO:0018108; GO:0030424; GO:0030425; GO:0031115; GO:0033120; GO:0034205; GO:0036289; GO:0038083; GO:0042802; GO:0043518; GO:0043621; GO:0045893; GO:0046777; GO:0048025; GO:0048156; GO:0050321; GO:0090312; GO:0106310; GO:1990904	RAGESGHTVADYLK	12.77000046	1	1	0.484954135	1502.43575	0	0	17.76602	0	17.0707	0	0	0	0	19.12153	0	0	0	18.61447	0	0	0	17.87079	0	0	0	20.32942	0	0	0	0	20.15262	0	0	0	15.16457	0	18.57014	17.51313	16.71167	0	0	0	0	0	0	0	19.64495	17.64711	16.74697	0	0	0
Q13630	FCL_HUMAN	"GDP-L-fucose synthase, EC 1.1.1.271 (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)"	GFUS SDR4E1 TSTA3	Homo sapiens (Human)	'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]"	"electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]"	GO:0005829; GO:0007159; GO:0009055; GO:0010595; GO:0019673; GO:0042351; GO:0042356; GO:0042802; GO:0047918; GO:0050577; GO:0070062; GO:1904906	GEPQGSMRILVTGGSGLVGK	4.360000134	0.760000169	0.760000169	1.38E-12	1942.631175	0	0	0	0	0	0	0	14.83766	14.75327	0	15.52472	0	0	0	0	0	0	0	0	16.26198	0	0	16.69666	16.16946	0	0	0	0	0	0	0	0	15.78133	0	15.88315	0	0	0	16.14045	0	15.91131	0	0	0	0	0	0	0
Q13635	PTC1_HUMAN	"Protein patched homolog 1, PTC, PTC1"	PTCH1 PTCH	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; somite development [GO:0061053]; spinal cord motor neuron differentiation [GO:0021522]"	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	"apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; somite development [GO:0061053]; spinal cord motor neuron differentiation [GO:0021522]"	cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]	GO:0000122; GO:0001658; GO:0001701; GO:0001709; GO:0001843; GO:0003007; GO:0005113; GO:0005119; GO:0005634; GO:0005886; GO:0005901; GO:0007224; GO:0007346; GO:0007420; GO:0008158; GO:0008201; GO:0008589; GO:0009410; GO:0009612; GO:0009887; GO:0009953; GO:0009957; GO:0010157; GO:0010875; GO:0014069; GO:0015485; GO:0016021; GO:0016485; GO:0021522; GO:0021532; GO:0021997; GO:0030326; GO:0030332; GO:0030496; GO:0030666; GO:0030850; GO:0032355; GO:0032526; GO:0032880; GO:0035108; GO:0035137; GO:0040015; GO:0042593; GO:0043231; GO:0043433; GO:0043616; GO:0044294; GO:0044295; GO:0044877; GO:0045177; GO:0045606; GO:0045668; GO:0045879; GO:0045893; GO:0048471; GO:0048568; GO:0048745; GO:0050680; GO:0051782; GO:0060037; GO:0060170; GO:0060603; GO:0060644; GO:0060831; GO:0061005; GO:0061053; GO:0071397; GO:0071679; GO:0072203; GO:0072205; GO:0072659; GO:0097108; GO:0097421	DPPREGLWPPPYRPR	10.09000015	0.794503808	0.794503808	2.06E-12	1833.684513	0	0	0	15.47912	13.24971	14.95853	14.97137	12.59966	15.39623	16.09181	15.49544	0	0	0	0	0	14.18572	0	0	0	0	0	0	12.71582	15.21739	16.25391	0	0	15.59868	0	16.5255	0	0	0	0	15.75529	0	14.68556	0	0	0	0	0	0	0	16.43595	15.93287	0
Q13639	5HT4R_HUMAN	"5-hydroxytryptamine receptor 4, 5-HT-4, 5-HT4 (Serotonin receptor 4)"	HTR4	Homo sapiens (Human)	"adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]"	G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]	GO:0004993; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007198; GO:0007268; GO:0016020; GO:0030425; GO:0030594; GO:0032098; GO:0045202; GO:0051378	TETKAAK	4.28000021	0.882031322	0.882031322	0.068309042	749.2825367	16.52372	0	12.74472	0	13.24052	16.00822	18.64826	0	0	16.71365	15.74932	0	13.50299	12.56915	12.92077	0	0	0	15.71308	12.86784	16.35791	0	17.39136	0	16.08789	16.81697	0	0	0	16.30552	16.13359	14.91628	18.38307	0	16.41169	14.28866	17.19589	13.20755	16.32201	16.22641	14.51702	13.38025	0	0	0	0	17.25469	0
Q13642	FHL1_HUMAN	"Four and a half LIM domains protein 1, FHL-1 (Skeletal muscle LIM-protein 1, SLIM, SLIM-1)"	FHL1 SLIM1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; positive regulation of potassium ion transport [GO:0043268]; regulation of membrane depolarization [GO:0003254]; regulation of potassium ion transmembrane transporter activity [GO:1901016]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; positive regulation of potassium ion transport [GO:0043268]; regulation of membrane depolarization [GO:0003254]; regulation of potassium ion transmembrane transporter activity [GO:1901016]	metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]	GO:0003254; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007517; GO:0009887; GO:0010972; GO:0030154; GO:0030308; GO:0043268; GO:0044325; GO:0046872; GO:1901016; GO:2000134	DNPGTTTASTAK	4.269999981	1	1	0.082509642	1163.387778	14.62755	13.9647	14.81569	14.41934	0	15.3388	0	0	14.77268	15.94054	14.44629	14.21447	0	0	13.41358	13.18247	4.663669	13.2653	0	0	14.11288	0	15.00033	0	0	12.97014	0	0	0	0	0	0	0	0	0	0	14.1722	0	0	0	0	0	13.97719	0	0	0	0	0
Q13683	ITA7_HUMAN	Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form ]	ITGA7 UNQ406/PRO768	Homo sapiens (Human)	cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519]	integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]	GO:0005178; GO:0005886; GO:0007160; GO:0007229; GO:0007517; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0033627; GO:0034113; GO:0035987; GO:0043236; GO:0046872; GO:0050900; GO:0098609	DSASR	2.690000057	0.296095759	0.296095759	0.272840692	534.8121309	15.35541	0	0	15.80443	15.69515	0	0	15.01173	0	0	16.45167	15.91162	15.71364	0	0	14.45453	0	0	0	0	0	0	0	0	16.41342	15.51644	0	14.93376	0	15.54364	0	0	15.81547	15.37776	0	0	0	0	0	0	15.87506	0	0	16.59875	14.94694	13.55474	16.0843	13.58232
Q13698	CAC1S_HUMAN	"Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1)"	CACNA1S CACH1 CACN1 CACNL1A3	Homo sapiens (Human)	calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; muscle contraction [GO:0006936]; positive regulation of muscle contraction [GO:0045933]; regulation of ion transmembrane transport [GO:0034765]	cytoplasm [GO:0005737]; I band [GO:0031674]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]	cytoplasm [GO:0005737]; I band [GO:0031674]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; muscle contraction [GO:0006936]; positive regulation of muscle contraction [GO:0045933]; regulation of ion transmembrane transport [GO:0034765]	calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0006936; GO:0008331; GO:0030315; GO:0031674; GO:0034765; GO:0045933; GO:0046872; GO:0070509; GO:0070588; GO:0071313; GO:1990454	SEEEKSTMAK	1.039999962	1	1	0.19930192	1155.490088	0	0	11.01523	15.03104	15.5301	0	11.63381	15.36309	14.71132	14.39921	14.90076	15.75655	0	0	0	0	0	14.92792	15.18491	0	13.56104	0	0	0	0	0	0	14.87035	15.22428	0	0	0	0	16.0602	0	16.12173	14.19715	0	15.51075	15.17078	15.67982	14.21654	15.53694	0	0	0	0	0
Q13702	RAPSN_HUMAN	"43 kDa receptor-associated protein of the synapse, RAPsyn (43 kDa postsynaptic protein) (Acetylcholine receptor-associated 43 kDa protein) (RING finger protein 205)"	RAPSN RNF205	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; establishment of protein localization to postsynaptic membrane [GO:1903540]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of postsynaptic membrane organization [GO:1901626]; synaptic transmission, cholinergic [GO:0007271]"	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]	"centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; acetylcholine receptor binding [GO:0033130]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; protein-membrane adaptor activity [GO:0043495]; chemical synaptic transmission [GO:0007268]; establishment of protein localization to postsynaptic membrane [GO:1903540]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of postsynaptic membrane organization [GO:1901626]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine receptor binding [GO:0033130]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; protein-membrane adaptor activity [GO:0043495]	GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0007268; GO:0007271; GO:0031594; GO:0033130; GO:0035255; GO:0043495; GO:0043525; GO:0046872; GO:0099634; GO:1900075; GO:1901626; GO:1903540	YRAMSQYHMAVAYR	3.339999914	1	1	0.143429501	1779.233974	0	0	14.32194	0	0	0	18.1994	0	0	17.59055	17.42337	17.8257	0	14.57544	16.8987	0	0	15.52719	0	0	15.14075	0	12.22743	0	18.28721	18.79317	16.80786	0	0	0	0	16.62975	0	0	0	18.58624	0	0	18.8986	0	0	15.48732	14.74065	16.46976	0	0	17.61923	0
Q13705	AVR2B_HUMAN	"Activin receptor type-2B, EC 2.7.11.30 (Activin receptor type IIB, ACTR-IIB)"	ACVR2B	Homo sapiens (Human)	"activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]"	activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	"activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]"	activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000122; GO:0001702; GO:0001822; GO:0001946; GO:0001974; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007368; GO:0007498; GO:0007507; GO:0009749; GO:0009791; GO:0009952; GO:0017002; GO:0019838; GO:0030073; GO:0030324; GO:0030501; GO:0030509; GO:0031016; GO:0032147; GO:0032924; GO:0032927; GO:0032991; GO:0035265; GO:0042475; GO:0043235; GO:0045669; GO:0046872; GO:0048179; GO:0048185; GO:0048617; GO:0048705; GO:0060021; GO:0060836; GO:0060840; GO:0060841; GO:0061298; GO:0071363; GO:0120163	KMRPTIK	4.210000038	0.860309482	0.860309482	0.225109118	874.5676169	13.89775	15.0575	15.90558	16.95085	15.15548	15.24271	14.37945	0	15.86978	15.52515	15.45993	15.84019	0	15.3813	14.67999	16.18038	0	16.24221	15.43438	16.10522	15.80673	16.11621	16.48366	0	16.50074	15.89699	16.29624	15.22665	15.50671	14.4785	17.37	16.31992	18.60707	0	0	0	0	17.91698	14.42327	15.5064	15.60757	15.931	14.98009	0	15.62322	14.68848	16.87003	15.02467
Q13724	MOGS_HUMAN	"Mannosyl-oligosaccharide glucosidase, EC 3.2.1.106 (Processing A-glucosidase I)"	MOGS GCS1	Homo sapiens (Human)	oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Glc3Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0004573]; glucosidase activity [GO:0015926]; oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082]	Glc3Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0004573]; glucosidase activity [GO:0015926]	GO:0004573; GO:0005783; GO:0005789; GO:0006457; GO:0006487; GO:0009311; GO:0015926; GO:0016020; GO:0016021; GO:0019082; GO:0070062	AVPAEGVR	9.539999962	1	1	0.250334191	798.6822171	16.90468	17.62568	14.06477	17.6203	16.04206	0	13.11838	15.3683	15.83274	17.09605	10.93102	0	16.30934	0	16.12339	15.74072	13.84135	0	15.53513	17.24434	0	16.95735	0	17.08469	15.13071	0	0	0	0	14.49958	17.67803	18.2953	17.3712	0	0	0	0	0	16.51724	15.92666	15.30863	17.10814	15.5162	17.07458	15.7196	16.88636	16.35297	16.52985
Q13733	AT1A4_HUMAN	"Sodium/potassium-transporting ATPase subunit alpha-4, Na(+)/K(+) ATPase alpha-4 subunit, EC 7.2.2.13 (Sodium pump subunit alpha-4)"	ATP1A4 ATP1AL2	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; ion transport [GO:0006811]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]	integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; photoreceptor cell cilium [GO:0097733]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm midpiece [GO:0097225]	integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; photoreceptor cell cilium [GO:0097733]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; cell surface receptor signaling pathway [GO:0007166]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; ion transport [GO:0006811]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]	GO:0005391; GO:0005524; GO:0005886; GO:0005887; GO:0005890; GO:0006811; GO:0006813; GO:0006814; GO:0006883; GO:0007166; GO:0007283; GO:0009566; GO:0016887; GO:0019829; GO:0019900; GO:0030007; GO:0030317; GO:0030641; GO:0035725; GO:0036376; GO:0042391; GO:0045121; GO:0046872; GO:0071805; GO:0097225; GO:0097733; GO:0120200; GO:0150104; GO:1902600; GO:1990573	GHSHQRAK	6.889999866	0.961003542	0.961003542	0.161912208	920.5278641	12.90365	15.22667	14.55072	0	0	14.31739	15.97878	10.56187	15.28818	15.11338	16.73655	16.04274	15.52581	0	0	0	0	0	0	0	0	0	0	0	16.3487	0	0	0	0	0	0	0	15.78766	16.02346	0	0	0	0	0	0	0	15.97807	0	0	0	0	0	0
Q13751	LAMB3_HUMAN	Laminin subunit beta-3 (Epiligrin subunit bata) (Kalinin B1 chain) (Kalinin subunit beta) (Laminin B1k chain) (Laminin-5 subunit beta) (Nicein subunit beta)	LAMB3 LAMNB1	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; brown fat cell differentiation [GO:0050873]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-5 complex [GO:0005610]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-5 complex [GO:0005610]; extracellular matrix structural constituent [GO:0005201]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; brown fat cell differentiation [GO:0050873]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	extracellular matrix structural constituent [GO:0005201]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005201; GO:0005576; GO:0005610; GO:0008544; GO:0009887; GO:0009888; GO:0016477; GO:0034446; GO:0035987; GO:0043256; GO:0044877; GO:0050873; GO:0062023; GO:0070831	QAGGGGGTGSPK	16.22999954	1	1	0.181906319	973.2186609	13.00683	15.89714	13.92559	14.99827	13.6633	14.50709	14.65473	15.1409	0	0	13.86125	15.5201	16.28688	0	0	13.1207	0	15.30633	14.2498	0	0	0	15.87312	13.44145	0	12.10127	15.39602	0	15.35786	0	0	0	15.58448	15.18642	0	16.18566	16.23404	0	17.71768	0	15.52633	16.59017	0	0	0	17.33871	0	0
Q13753	LAMC2_HUMAN	"Laminin subunit gamma-2 (Cell-scattering factor 140 kDa subunit, CSF 140 kDa subunit) (Epiligrin subunit gamma) (Kalinin subunit gamma) (Kalinin/nicein/epiligrin 100 kDa subunit) (Ladsin 140 kDa subunit) (Laminin B2t chain) (Laminin-5 subunit gamma) (Large adhesive scatter factor 140 kDa subunit) (Nicein subunit gamma)"	LAMC2 LAMB2T LAMNB2	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; epidermis development [GO:0008544]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; tissue development [GO:0009888]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-2 complex [GO:0005607]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-2 complex [GO:0005607]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; epidermis development [GO:0008544]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; tissue development [GO:0009888]	heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0005604; GO:0005607; GO:0005615; GO:0005938; GO:0007155; GO:0008045; GO:0008201; GO:0008284; GO:0008544; GO:0009887; GO:0009888; GO:0016020; GO:0016358; GO:0030335; GO:0048471; GO:0062023	SGYYNLDGGNPEGCTQCFCYGHSASCR	1.980000019	1	1	4.59E-13	3109.872563	15.06752	0	15.65657	14.3511	14.31032	0	14.98165	15.41915	13.95627	0	0	0	0	0	0	12.31933	0	12.06794	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13772	NCOA4_HUMAN	"Nuclear receptor coactivator 4, NCoA-4 (Androgen receptor coactivator 70 kDa protein, 70 kDa AR-activator, 70 kDa androgen receptor coactivator) (Androgen receptor-associated protein of 70 kDa) (Ret-activating protein ELE1)"	NCOA4 ARA70 ELE1 RFG	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; cellular response to estrogen stimulus [GO:0071391]; cellular response to testosterone stimulus [GO:0071394]; intracellular estrogen receptor signaling pathway [GO:0030520]; male gonad development [GO:0008584]; protein targeting to lysosome [GO:0006622]; response to hormone [GO:0009725]	autolysosome [GO:0044754]; nucleus [GO:0005634]	autolysosome [GO:0044754]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; cellular iron ion homeostasis [GO:0006879]; cellular response to estrogen stimulus [GO:0071391]; cellular response to testosterone stimulus [GO:0071394]; intracellular estrogen receptor signaling pathway [GO:0030520]; male gonad development [GO:0008584]; protein targeting to lysosome [GO:0006622]; response to hormone [GO:0009725]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0006622; GO:0006879; GO:0008584; GO:0009725; GO:0030520; GO:0044754; GO:0071391; GO:0071394	LLFQSYNVNDWLVK	6.650000095	1	1	0.49195743	1737.267769	0	16.02724	13.94833	11.76233	13.97969	0	0	0	0	0	13.25214	0	10.15104	0	15.21659	14.16463	14.77317	0	0	0	0	15.73808	0	0	0	0	16.35991	0	0	0	0	0	0	0	0	16.64392	0	0	0	0	15.73391	0	0	0	0	0	0	0
Q13796	SHRM2_HUMAN	Protein Shroom2 (Apical-like protein) (Protein APXL)	SHROOM2 APXL	Homo sapiens (Human)	actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]	GO:0002089; GO:0003779; GO:0005737; GO:0005856; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0007015; GO:0007420; GO:0008013; GO:0008057; GO:0015280; GO:0016324; GO:0016477; GO:0032401; GO:0032438; GO:0043010; GO:0043296; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015; GO:0070062	ATSFK	3.109999895	0.363764018	0.363764018	0.238942938	554.5850016	12.68279	14.65059	15.5092	14.98448	14.68459	14.80549	16.79715	13.31533	0	15.98589	15.6763	16.07589	15.15596	14.98403	0	0	16.13578	15.2439	0	15.37998	13.84884	15.4429	15.07675	0	17.11302	14.6072	15.19823	0	0	15.13091	0	0	16.19266	0	16.78278	15.87705	0	16.37723	17.19042	0	0	17.85424	0	16.16169	16.77729	0	15.89054	16.06768
Q13797	ITA9_HUMAN	Integrin alpha-9 (Integrin alpha-RLC)	ITGA9	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; neutrophil chemotaxis [GO:0030593]	basal plasma membrane [GO:0009925]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]	basal plasma membrane [GO:0009925]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; neutrophil chemotaxis [GO:0030593]	integrin binding [GO:0005178]; metal ion binding [GO:0046872]	GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0030593; GO:0033627; GO:0046872; GO:0050900; GO:0098609	DEGQVTVYINR	4.78000021	1	1	0.223989764	1293.445243	0	0	0	0	0	0	13.55961	0	0	0	0	0	0	0	17.06066	0	16.42634	0	0	0	0	0	0	0	0	0	0	13.86726	16.64614	0	0	0	17.10722	0	0	0	0	17.20244	0	15.41744	0	0	0	0	0	17.55787	0	0
Q13813	SPTN1_HUMAN	"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)"	SPTAN1 NEAS SPTA2	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]	cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]	cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0005886; GO:0008091; GO:0015630; GO:0016020; GO:0030036; GO:0030054; GO:0030864; GO:0035580; GO:0042995; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0070062; GO:1903561; GO:1904724	EWIEEK	4.829999924	1	1	0.110876522	834.6140219	0	14.05871	13.20141	8.565074	15.37274	13.36698	14.78204	15.2712	14.09562	0	15.33832	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13823	NOG2_HUMAN	Nucleolar GTP-binding protein 2 (Autoantigen NGP-1)	GNL2 NGP1	Homo sapiens (Human)	ribosome biogenesis [GO:0042254]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]	GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0016020; GO:0042254	DPMGTR	11.22999954	0.428022295	0.428022295	0.235762796	693.1060209	0	14.52673	0	13.44914	17.39633	0	13.66561	14.64796	0	17.2725	0	17.82918	0	0	0	14.03377	14.61906	13.89257	14.93759	0	0	13.56989	0	15.8797	0	0	0	14.75665	16.27209	14.22953	0	0	0	16.75652	18.25116	0	0	0	16.58999	0	16.05839	14.55786	17.30498	0	18.69766	0	0	0
Q13829	BACD2_HUMAN	"BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2, hBACURD2 (BTB/POZ domain-containing protein TNFAIP1) (Protein B12) (Tumor necrosis factor, alpha-induced protein 1, endothelial)"	TNFAIP1 BACURD2 EDP1	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell migration [GO:0016477]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149]	cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]	GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006915; GO:0006955; GO:0016477; GO:0016567; GO:0030332; GO:0031267; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0051260	YYLIQGLVNMCQSALQDK	7.159999847	0.314446211	0.314446211	0.025418918	2159.402724	0	0	0	0	0	0	0	0	0	0	0	15.28514	0	0	0	0	0	0	0	16.30261	0	0	0	0	0	16.67985	17.24164	0	0	0	0	16.59507	0	0	0	8.363275	13.37045	18.46362	15.47076	0	0	15.31399	0	0	0	0	17.94915	0
Q13835	PKP1_HUMAN	"Plakophilin-1 (Band 6 protein, B6P)"	PKP1	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; intermediate filament bundle assembly [GO:0045110]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165]	adherens junction [GO:0005912]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; ficolin-1-rich granule membrane [GO:0101003]; intermediate filament [GO:0005882]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; ficolin-1-rich granule membrane [GO:0101003]; intermediate filament [GO:0005882]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; lamin binding [GO:0005521]; structural constituent of skin epidermis [GO:0030280]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; intermediate filament bundle assembly [GO:0045110]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165]	cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; lamin binding [GO:0005521]; structural constituent of skin epidermis [GO:0030280]	GO:0001533; GO:0005521; GO:0005634; GO:0005654; GO:0005737; GO:0005882; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007165; GO:0010628; GO:0019215; GO:0030057; GO:0030280; GO:0045110; GO:0045296; GO:0098609; GO:0101003; GO:1902373; GO:1990124	QRVQEQVMMTVK	6.21999979	1	1	0.221494267	1477.564046	0	7.565827	13.01238	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.52864	16.63935	0	0	0	0	17.04283	0	0	0	0	16.0057	0	0	0	0	0	0	0	0	19.10314	0	0	0	0
Q13838	DX39B_HUMAN	"Spliceosome RNA helicase DDX39B, EC 3.6.4.13 (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)"	DDX39B BAT1 UAP56	Homo sapiens (Human)	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]"	GO:0000245; GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006405; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0032786; GO:0042802; GO:0043008; GO:0046784; GO:2000002	KDEEVLK	6.289999962	1	1	1.15E-13	860.7328211	0	0	11.00436	0	0	0	0	12.74464	14.60297	0	0	0	0	0	0	15.59669	15.73544	0	0	0	0	0	0	0	0	0	17.30049	0	0	0	12.48485	16.01389	0	0	17.15484	0	0	15.86021	0	0	0	0	0	0	0	0	0	0
Q13867	BLMH_HUMAN	"Bleomycin hydrolase, BH, BLM hydrolase, BMH, EC 3.4.22.40"	BLMH	Homo sapiens (Human)	homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]	aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]	GO:0000209; GO:0004177; GO:0004180; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008234; GO:0009410; GO:0009636; GO:0042802; GO:0043418; GO:0070062	MVAASIK	2.099999905	1	1	1.03E-12	735.4221463	14.56129	13.77299	15.15157	0	0	0	13.00759	0	15.21283	16.12769	0	14.70767	15.37965	0	0	0	0	0	15.32645	0	0	15.69729	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13882	PTK6_HUMAN	"Protein-tyrosine kinase 6, EC 2.7.10.2 (Breast tumor kinase) (Tyrosine-protein kinase BRK)"	PTK6 BRK	Homo sapiens (Human)	cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ERBB2 signaling pathway [GO:0038128]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of growth [GO:0045926]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of cell cycle [GO:0045787]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ERBB2 signaling pathway [GO:0038128]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of growth [GO:0045926]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of cell cycle [GO:0045787]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001726; GO:0004712; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007260; GO:0010976; GO:0016477; GO:0016604; GO:0030154; GO:0031234; GO:0038128; GO:0042531; GO:0042802; GO:0045087; GO:0045742; GO:0045787; GO:0045926; GO:0046777; GO:0060575; GO:0061099; GO:0071300	VGDFGLARLIK	7.440000057	0.281557411	0.281557411	0	1191.47392	14.40207	0	10.7486	13.71365	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.83549	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13884	SNTB1_HUMAN	"Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1, DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43, TIP-43)"	SNTB1 SNT2B1	Homo sapiens (Human)	muscle contraction [GO:0006936]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; muscle contraction [GO:0006936]	actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202	HTVILR	6.010000229	1	1	0.156278676	738.2632307	16.18101	0	16.30087	15.76474	0	13.90923	0	0	17.30006	0	16.42507	15.57385	0	16.04811	0	14.27306	0	0	0	0	15.18342	0	0	0	15.38967	0	0	15.83084	0	0	16.02518	16.42647	0	16.54608	0	0	0	0	0	0	0	0	15.65207	0	0	17.17602	0	0
Q13885	TBB2A_HUMAN	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A TUBB2	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0001764; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0045171; GO:0070062; GO:0072686; GO:1903561	NSSYFVEWIPNNVK	2.319999933	1	1	2.29E-12	1697.676581	15.06997	0	0	0	0	0	0	0	14.06294	0	15.63172	14.05447	16.40087	15.85932	0	0	0	0	0	16.37363	0	0	0	14.59959	12.75734	15.13509	16.40279	16.33732	17.27395	16.5056	0	0	16.24492	15.84729	0	0	17.52958	15.62655	0	0	0	15.60401	0	0	0	0	0	0
Q13888	TF2H2_HUMAN	"General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit, BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit)"	GTF2H2 BTF2P44	Homo sapiens (Human)	G protein-coupled receptor internalization [GO:0002031]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270]; G protein-coupled receptor internalization [GO:0002031]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270]	GO:0000438; GO:0000439; GO:0002031; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0006367; GO:0008270; GO:0009411; GO:0016251; GO:0016607; GO:0047485; GO:1905776	HITSLKK	15	0.183471575	0.183471575	0.263338389	826.2781782	17.17612	17.74716	16.98068	13.5942	17.97333	0	0	0	18.7409	17.04806	18.11011	17.45672	18.65292	0	16.51786	0	0	0	0	0	0	0	0	0	17.92777	0	0	0	0	0	0	20.11021	0	17.99953	18.20777	0	19.33906	19.42924	17.94839	0	19.95623	17.66187	0	19.50883	0	18.22466	18.16327	0
Q13889	TF2H3_HUMAN	"General transcription factor IIH subunit 3 (Basic transcription factor 2 34 kDa subunit, BTF2 p34) (General transcription factor IIH polypeptide 3) (TFIIH basal transcription factor complex p34 subunit)"	GTF2H3	Homo sapiens (Human)	DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]	metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0000438; GO:0000439; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006289; GO:0006366; GO:0016251; GO:0046872; GO:0047485; GO:0070816; GO:0097550	DNQEMKSR	2.650000095	1	1	0.269342673	1007.509494	0	0	15.98948	0	0	0	0	0	17.44923	0	0	16.41339	0	0	0	0	0	0	0	0	0	0	17.6138	0	16.83984	0	0	16.28499	0	0	0	0	0	0	0	0	0	0	18.25373	17.39894	0	0	0	0	0	0	0	16.08467
Q13901	C1D_HUMAN	"Nuclear nucleic acid-binding protein C1D, hC1D"	C1D	Homo sapiens (Human)	apoptotic process [GO:0006915]; maturation of 5.8S rRNA [GO:0000460]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; maturation of 5.8S rRNA [GO:0000460]; regulation of gene expression [GO:0010468]	DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]	GO:0000176; GO:0000178; GO:0000460; GO:0003677; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006915; GO:0010468; GO:0016922; GO:0017053	SKNASK	1.370000005	0.124442875	0.124442875	0.195481597	632.4978087	0	0	12.46994	14.6354	17.41806	16.45585	16.93781	16.60639	0	0	0	0	0	15.38665	17.15495	18.42168	16.52203	0	0	20.11696	0	0	16.12903	18.13268	18.45476	0	0	16.88656	17.66959	17.90837	18.82585	17.89819	19.03239	0	17.65808	19.0596	0	16.53267	18.37667	17.75557	17.26406	0	0	20.02952	0	17.0829	0	15.60742
Q13905	RPGF1_HUMAN	Rap guanine nucleotide exchange factor 1 (CRK SH3-binding GNRP) (Guanine nucleotide-releasing factor 2) (Protein C3G)	RAPGEF1 GRF2	Homo sapiens (Human)	cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]	GO:0005085; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0007165; GO:0007169; GO:0007265; GO:0007399; GO:0010976; GO:0017124; GO:0032486; GO:0038180; GO:0043231; GO:0043547; GO:0061028; GO:0071320; GO:1901888; GO:1990090	LLMELVFR	12.52000046	1	1	0.028071738	1036.522839	0	15.82878	16.92041	14.97963	0	16.48288	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13936	CAC1C_HUMAN	"Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2)"	CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1	Homo sapiens (Human)	calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; embryonic forelimb morphogenesis [GO:0035115]; heart development [GO:0007507]; immune system development [GO:0002520]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; embryonic forelimb morphogenesis [GO:0035115]; heart development [GO:0007507]; immune system development [GO:0002520]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]	alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]	GO:0002520; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005887; GO:0005891; GO:0006816; GO:0007204; GO:0007507; GO:0008331; GO:0010881; GO:0014069; GO:0016021; GO:0030018; GO:0030425; GO:0035115; GO:0035585; GO:0043010; GO:0043204; GO:0045762; GO:0046872; GO:0051393; GO:0060402; GO:0061337; GO:0061577; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086064; GO:0086091; GO:0098839; GO:0098911; GO:0098912; GO:1990454	IFKITR	4.570000172	1	1	0.224393121	777.0301137	0	18.12568	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.17488	0	0	0	0	0	0	0	18.15404	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32291
Q13939	CALI_HUMAN	Calicin	CCIN	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	actin cytoskeleton [GO:0015629]; cytoskeletal calyx [GO:0033150]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]	actin cytoskeleton [GO:0015629]; cytoskeletal calyx [GO:0033150]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	actin filament binding [GO:0051015]	GO:0005634; GO:0007283; GO:0007420; GO:0015629; GO:0030036; GO:0030154; GO:0032839; GO:0033150; GO:0051015	LVGMENTSSHTTLIESVLMDRK	7.739999771	1	1	0.140633836	2471.618903	0	15.25152	0	0	0	0	15.29774	0	0	14.03253	0	0	0	0	0	0	0	0	0	15.35574	0	0	0	0	14.73691	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.28279	0	0	0	0	0	0	0
Q13956	CNCG_HUMAN	"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma, GMP-PDE gamma, EC 3.1.4.35"	PDE6H	Homo sapiens (Human)	positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	photoreceptor outer segment membrane [GO:0042622]	"photoreceptor outer segment membrane [GO:0042622]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"	"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]"	GO:0004857; GO:0007601; GO:0030553; GO:0042622; GO:0043410; GO:0045742; GO:0045745; GO:0047555; GO:0050896	SDNTTLPAPASNQGPTTPRK	8.640000343	1	1	0.447719864	2052.623085	19.41935	16.86166	14.02878	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q13972	RGRF1_HUMAN	"Ras-specific guanine nucleotide-releasing factor 1, Ras-GRF1 (Guanine nucleotide-releasing protein, GNRP) (Ras-specific nucleotide exchange factor CDC25)"	RASGRF1 CDC25 GNRP GRF1	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; long-term memory [GO:0007616]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]	cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; long-term memory [GO:0007616]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]	glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0008283; GO:0030426; GO:0031175; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043005; GO:0043547; GO:0046578; GO:0046579; GO:0048167; GO:0048168; GO:0090630; GO:2000310	QHYFTVNFSHENQKALELR	1.309999943	1	1	0.393565702	2362.002338	14.30462	0	14.71504	14.03158	0	12.08324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.57618	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.107	0	0	0	0	0	0	0	0	0
Q13976	KGP1_HUMAN	"cGMP-dependent protein kinase 1, cGK 1, cGK1, EC 2.7.11.12 (cGMP-dependent protein kinase I, cGKI)"	PRKG1 PRKG1B PRKGR1A PRKGR1B	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]	GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0016358; GO:0019934; GO:0030036; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0060087; GO:0090331; GO:1904706; GO:1904753	SEESKTFAMK	14.93000031	0.204659775	0.204659775	0.387009538	1158.130176	13.23366	15.06272	0	15.14693	15.68862	0	0	0	14.07844	0	0	0	0	0	0	0	0	17.66396	0	15.39038	0	0	0	16.07051	0	0	13.37961	0	14.76878	0	0	14.4727	0	16.49974	0	0	0	0	0	0	0	0	0	15.81403	0	0	0	0
Q14004	CDK13_HUMAN	"Cyclin-dependent kinase 13, EC 2.7.11.22, EC 2.7.11.23 (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13, hCDK13) (Cholinesterase-related cell division controller)"	CDK13 CDC2L CDC2L5 CHED KIAA1791	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; multicellular organism development [GO:0007275]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction [GO:0009966]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cyclin K-CDK13 complex [GO:0002945]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cyclin K-CDK13 complex [GO:0002945]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; multicellular organism development [GO:0007275]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction [GO:0009966]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000307; GO:0000380; GO:0002945; GO:0003723; GO:0004672; GO:0004693; GO:0004712; GO:0005524; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006368; GO:0006468; GO:0007088; GO:0007275; GO:0008024; GO:0008284; GO:0008353; GO:0009966; GO:0016607; GO:0019901; GO:0019908; GO:0030097; GO:0030332; GO:0032968; GO:0070816; GO:0106310; GO:1904813; GO:2000737	HSSYER	6.059999943	0.887243807	0.887243807	0.248064427	777.5985693	0	15.57122	15.75117	12.69713	0	0	15.14033	15.71228	0	15.86772	0	9.05366	0	15.80374	0	0	0	0	13.83368	15.07247	17.25644	14.66773	14.22524	15.12389	0	0	0	16.6441	15.63713	15.92633	15.59502	16.22315	0	16.68502	0	14.8543	16.60511	15.92024	0	0	0	15.10308	15.54331	0	16.27613	0	15.48439	0
Q14005	IL16_HUMAN	"Pro-interleukin-16 [Cleaved into: Interleukin-16, IL-16 (Lymphocyte chemoattractant factor, LCF) ]"	IL16	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924]	CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]	GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0005925; GO:0006955; GO:0016607; GO:0019221; GO:0030595; GO:0032730; GO:0032735; GO:0032755; GO:0042609; GO:0050729; GO:0050930; GO:0051924; GO:0090543; GO:1902565	SFEILVR	22.63999939	0.190015107	0.190015107	0.264676181	863.2207797	18.87725	18.19181	19.79305	17.71592	15.48967	17.41168	0	0	19.99866	16.12195	18.81618	18.12746	0	18.16527	0	18.65494	0	18.78356	0	0	17.65482	18.31823	17.9527	18.21785	19.07364	0	19.51331	0	18.88609	17.36217	19.23494	19.41505	0	0	0	17.66636	19.73017	19.76105	17.42532	17.14896	0	0	18.82502	0	0	16.49243	0	17.93335
Q14008	CKAP5_HUMAN	"Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein, Ch-TOG)"	CKAP5 KIAA0097	Homo sapiens (Human)	cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; microtubule plus-end binding [GO:0051010]; ribonucleoprotein complex binding [GO:0043021]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051]	cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; microtubule plus-end binding [GO:0051010]; ribonucleoprotein complex binding [GO:0043021]	GO:0000776; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007052; GO:0007098; GO:0008017; GO:0016020; GO:0030951; GO:0032991; GO:0043021; GO:0045296; GO:0046785; GO:0050658; GO:0051010; GO:0051298; GO:0051301; GO:0061863; GO:0090063	AKAPGLSSK	2.890000105	0.617307782	0.617307782	0.184462552	855.4041361	0	11.77219	14.85558	14.80963	0	0	15.65509	0	0	15.45817	0	15.4993	15.55512	0	0	15.89551	0	0	0	0	0	0	16.37071	0	15.31528	16.00591	15.20811	16.15747	13.24618	15.54519	16.24028	13.17675	16.46433	16.92048	16.7156	14.68079	15.44385	0	0	15.02763	0	0	17.58118	17.25546	0	0	16.11034	16.14931
Q14011	CIRBP_HUMAN	Cold-inducible RNA-binding protein (A18 hnRNP) (Glycine-rich RNA-binding protein CIRP)	CIRBP A18HNRNP CIRP	Homo sapiens (Human)	"mRNA stabilization [GO:0048255]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to UV [GO:0009411]; stress granule assembly [GO:0034063]"	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; translation repressor activity [GO:0030371]; mRNA stabilization [GO:0048255]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to UV [GO:0009411]; stress granule assembly [GO:0034063]"	mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; translation repressor activity [GO:0030371]	GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0009409; GO:0009411; GO:0010494; GO:0030371; GO:0034063; GO:0045727; GO:0048026; GO:0048255; GO:0070181	SGGYGGSR	8.31000042	1	1	0.243738742	741.292271	0	0	13.29667	17.23098	0	0	0	0	0	0	0	16.8262	0	17.85611	0	0	0	14.60109	0	0	0	16.27144	16.57419	0	0	18.78359	18.88158	14.6641	0	17.56953	0	0	0	16.43423	0	15.82736	15.9234	0	0	0	0	15.6416	0	0	0	14.09211	15.00496	0
Q14019	COTL1_HUMAN	Coactosin-like protein	COTL1 CLP	Homo sapiens (Human)	defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]	GO:0003779; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0034774; GO:0050832; GO:0051015; GO:0070062; GO:1904813	EVVQNFAK	8.369999886	1	1	0.210113353	932.1719032	15.51264	0	12.1931	0	0	0	0	0	15.07973	0	0	13.49639	0	0	0	15.59933	0	12.96053	0	0	0	0	0	0	12.83292	16.34539	0	0	17.61577	0	0	0	0	0	0	14.91283	15.00943	16.90195	16.08474	15.21567	12.14664	13.50604	0	0	0	16.50835	0	16.32055
Q14028	CNGB1_HUMAN	"Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4, CNG channel 4, CNG-4, CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1, CNG channel beta-1) (Glutamic acid-rich protein, GARP)"	CNGB1 CNCG2 CNCG3L CNCG4 RCNC2	Homo sapiens (Human)	"cation transport [GO:0006812]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; detection of light stimulus involved in visual perception [GO:0050908]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; membrane depolarization [GO:0051899]; olfactory nerve maturation [GO:0021630]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; protein localization to organelle [GO:0033365]; response to odorant [GO:1990834]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]"	ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]	"ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; cation transport [GO:0006812]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; detection of light stimulus involved in visual perception [GO:0050908]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; membrane depolarization [GO:0051899]; olfactory nerve maturation [GO:0021630]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; protein localization to organelle [GO:0033365]; response to odorant [GO:1990834]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]"	cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]	GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0007601; GO:0007602; GO:0010628; GO:0015276; GO:0021630; GO:0030552; GO:0030553; GO:0030660; GO:0033365; GO:0035845; GO:0045494; GO:0050908; GO:0050911; GO:0051899; GO:0060170; GO:0099105; GO:1902495; GO:1990834	LEMALPQPVLHGK	4.28000021	1	1	0.36037494	1449.443038	15.01204	0	13.50278	14.49823	14.2781	0	14.38614	0	0	0	0	0	14.16424	0	0	0	0	0	15.63921	14.69799	0	0	0	0	13.75482	0	0	14.8876	0	0	0	13.83317	0	0	14.68256	0	0	0	0	15.1154	0	0	0	0	0	0	12.7702	0
Q14031	CO4A6_HUMAN	Collagen alpha-6(IV) chain	COL4A6	Homo sapiens (Human)	cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]	collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005201; GO:0005576; GO:0005587; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030198; GO:0031012; GO:0038063; GO:0062023; GO:0071230	GDPVLAPGSFK	6.730000019	1	1	0.133015721	1084.718385	13.53808	0	14.8779	10.93821	12.31697	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.36328	0	0	0	0	0	0	0	0
Q14050	CO9A3_HUMAN	Collagen alpha-3(IX) chain	COL9A3	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; female gonad development [GO:0008585]; male gonad development [GO:0008584]	basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; female gonad development [GO:0008585]; male gonad development [GO:0008584]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005201; GO:0005576; GO:0005594; GO:0005604; GO:0005615; GO:0005788; GO:0008584; GO:0008585; GO:0030020; GO:0030198; GO:0031012; GO:0062023	AGELGEAGPSGEPGVPGDAGMPGERGEAGHR	1.25	1	1	0.522342244	2918.72239	0	0	0	0	0	0	17.40085	0	0	0	0	0	0	0	0	0	0	0	0	0	14.72	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14055	CO9A2_HUMAN	Collagen alpha-2(IX) chain	COL9A2	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]	collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0001501; GO:0005201; GO:0005576; GO:0005594; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0062023	GDKGSPGK	14.82999992	1	1	0.269776749	744.0382156	0	0	16.32907	0	12.78645	14.69846	15.55216	15.43529	0	17.0048	11.84193	13.63431	16.00185	11.45642	14.55436	14.87509	15.67125	16.66039	15.7416	16.26813	16.09642	14.36783	14.09468	16.00406	0	0	15.66427	16.04897	0	15.14801	0	0	0	16.86366	13.64923	15.04176	14.30488	16.54622	17.73417	15.68196	16.32104	14.82061	15.94337	11.81059	14.88106	13.26817	17.41613	15.34487
Q14088	RB33A_HUMAN	Ras-related protein Rab-33A (Small GTP-binding protein S10)	RAB33A RABS10	Homo sapiens (Human)	antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005886; GO:0019882; GO:0032482	VQVWDTAGQERFR	1.960000038	1	1	0.309160151	1592.953854	12.98955	15.98344	16.29917	13.58933	0	0	10.45909	0	15.57789	0	0	0	0	0	0	15.79505	0	0	0	0	0	0	0	0	14.5344	0	15.43779	0	0	0	16.64125	16.67402	17.80552	0	0	0	13.25563	0	0	0	0	0	0	0	0	0	13.32282	0
Q14093	CYLC2_HUMAN	Cylicin-2 (Cylicin II) (Multiple-band polypeptide II)	CYLC2 CYL2	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]	cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005634; GO:0007283; GO:0030154; GO:0033150	GGTEKDSK	9.210000038	1	1	0.125295013	819.4622331	0	0	16.323	0	0	0	0	0	0	0	0	16.66992	16.18198	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14094	CCNI_HUMAN	Cyclin-I	CCNI	Homo sapiens (Human)	mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0007283; GO:0016538; GO:0031965; GO:0044772	GSMLALAMVSLEMEK	7.840000153	1	1	0.107425367	1657.660104	15.17854	13.92767	14.54521	0	0	13.666	0	0	0	0	0	0	0	0	0	8.425894	12.97833	13.02234	15.82528	0	16.38285	15.60647	0	0	14.61703	15.0011	0	13.26058	10.0677	13.90465	0	0	13.24428	0	12.90269	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14117	DPYS_HUMAN	"Dihydropyrimidinase, DHP, DHPase, EC 3.5.2.2 (Dihydropyrimidine amidohydrolase) (Hydantoinase)"	DPYS	Homo sapiens (Human)	CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]	dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270]	GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0042802; GO:0046050; GO:0046079; GO:0051219; GO:0070062	EIGAIAQVHAENGDLIAEGAK	7.739999771	1	1	2.30E-12	2105.092933	0	0	0	0	0	15.29914	0	0	14.71057	15.18776	16.81522	15.28042	0	0	0	0	0	0	0	0	0	0	0	16.21271	0	15.11324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.38287	0	0	0	0	0	0	0
Q14118	DAG1_HUMAN	"Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan, Alpha-DG; Beta-dystroglycan, Beta-DG ]"	DAG1	Homo sapiens (Human)	aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403]	actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618]	GO:0001618; GO:0001954; GO:0002009; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005654; GO:0005737; GO:0005788; GO:0005796; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006509; GO:0007411; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016021; GO:0016203; GO:0016323; GO:0016340; GO:0016476; GO:0017166; GO:0021675; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043231; GO:0043236; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0062023; GO:0070062; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261	IVPTPTSPAIAPPTETMAPPVR	5.889999866	1	1	4.57E-12	2254.547068	15.87526	16.01691	0	0	15.2681	0	12.60921	0	0	0	0	0	0	0	16.72986	16.15247	0	16.6657	16.42668	16.11402	16.71867	0	18.40558	0	16.78609	0	14.42877	0	0	0	16.22527	0	16.08547	15.43646	15.01229	17.04501	0	16.45594	0	16.80067	16.56391	14.3665	0	17.3916	0	0	0	17.49655
Q14134	TRI29_HUMAN	Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein)	TRIM29 ATDC	Homo sapiens (Human)	innate immune response [GO:0045087]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]	adherens junction [GO:0005912]; lysosome [GO:0005764]	adherens junction [GO:0005912]; lysosome [GO:0005764]; cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]	cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]	GO:0000122; GO:0002039; GO:0005764; GO:0005912; GO:0008270; GO:0042802; GO:0045087; GO:0098641; GO:1900181	AALEQREQDAVDQVK	2.99000001	1	1	0.364561609	1699.305466	15.52317	13.8737	13.42585	14.62661	0	0	12.85686	0	13.61922	15.7438	0	0	16.15535	15.36917	15.21548	12.39686	0	0	0	0	0	0	0	0	16.34756	0	0	0	0	15.5799	0	0	0	0	0	0	0	0	0	0	17.23327	0	0	0	0	0	0	0
Q14135	VGLL4_HUMAN	"Transcription cofactor vestigial-like protein 4, Vgl-4"	VGLL4 KIAA0121	Homo sapiens (Human)	"negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell growth [GO:0030308]; negative regulation of hippo signaling [GO:0035331]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cellular protein catabolic process [GO:1903364]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; transcription coactivator binding [GO:0001223]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell growth [GO:0030308]; negative regulation of hippo signaling [GO:0035331]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cellular protein catabolic process [GO:1903364]"	transcription coactivator binding [GO:0001223]	GO:0001223; GO:0005634; GO:0030178; GO:0030308; GO:0035331; GO:0045892; GO:0060044; GO:1903364	MQTLPVASALSSHRTGPPPISPSK	6.159999847	1	1	1.83E-12	2476.057697	0	0	0	0	0	0	0	0	0	0	12.87878	7.441803	0	0	0	0	0	0	17.5254	7.114703	0	0	0	0	12.82599	0	13.15864	13.90664	13.8503	15.05704	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14139	UBE4A_HUMAN	"Ubiquitin conjugation factor E4 A, EC 2.3.2.27 (RING-type E3 ubiquitin transferase E4 A)"	UBE4A KIAA0126	Homo sapiens (Human)	protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0030433; GO:0034450	INKPGNMIMAFSNLAER	1.149999976	1	1	0.346681634	1921.75135	0	0	0	14.89102	0	0	0	11.92011	13.77752	0	15.91176	0	0	0	12.10882	0	14.8795	0	0	13.66466	0	0	0	0	0	0	0	0	0	0	16.73834	15.4533	0	0	16.52648	0	0	17.0101	17.35378	0	0	0	0	12.63534	0	0	13.67651	15.39609
Q14140	SRTD2_HUMAN	"SERTA domain-containing protein 2 (Transcriptional regulator interacting with the PHD-bromodomain 2, TRIP-Br2)"	SERTAD2 KIAA0127 TRIPBR2	Homo sapiens (Human)	negative regulation of cell growth [GO:0030308]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; negative regulation of cell growth [GO:0030308]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030308	MLGKGGK	5.170000076	0.572767198	0.572767198	0.252809471	707.0160264	0	0	15.47905	0	0	14.5726	18.10239	19.36983	16.99442	16.4024	0	14.13556	0	0	15.45559	0	15.41121	14.79252	0	0	0	0	16.75646	14.63397	0	0	0	0	0	0	0	17.95116	0	15.46909	0	0	15.90744	0	0	13.52675	0	0	0	0	0	0	16.10159	16.47246
Q14146	URB2_HUMAN	Unhealthy ribosome biogenesis protein 2 homolog	URB2 KIAA0133	Homo sapiens (Human)	regulation of signal transduction by p53 class mediator [GO:1901796]; ribosome biogenesis [GO:0042254]	aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]	aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosome biogenesis [GO:0042254]		GO:0005730; GO:0016235; GO:0030496; GO:0042254; GO:1901796	AFGDVTAHLLQPCLVLR	8.420000076	1	1	2.98E-12	1907.041392	0	13.59046	9.967553	0	14.08024	0	0	0	0	0	0	0	15.85818	16.27518	0	14.77938	16.32666	0	0	0	0	0	0	17.31816	14.25036	0	0	0	0	0	0	15.6612	14.59332	0	0	0	16.41449	14.98479	0	0	15.10573	0	0	0	0	15.61889	0	0
Q14151	SAFB2_HUMAN	"Scaffold attachment factor B2, SAF-B2"	SAFB2 KIAA0138	Homo sapiens (Human)	regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062	LSEGRGLPPPPR	6.210000038	1	1	0.498413547	1276.359907	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.55023	18.50323	0	0	18.73234	0	0	0	0	0	0	0	0	0	18.37864	0	0	0	0	0	18.73777	0	0	0	0	0	0	0	0	0	0	0
Q14152	EIF3A_HUMAN	"Eukaryotic translation initiation factor 3 subunit A, eIF3a (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185)"	EIF3A EIF3S10 KIAA0139	Homo sapiens (Human)	formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]"	mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0002188; GO:0003723; GO:0003729; GO:0003743; GO:0005198; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005852; GO:0005874; GO:0006413; GO:0014069; GO:0016020; GO:0016282; GO:0030971; GO:0033290; GO:0043614; GO:0070373; GO:0071540; GO:0071541; GO:0075522; GO:0075525	KSHLAK	17.63999939	1	1	0.270543364	682.3012132	18.88682	18.90172	17.59488	0	17.51228	0	0	0	17.69938	17.78926	18.97473	0	0	0	0	17.58676	0	0	0	17.12884	0	19.34553	18.78037	0	0	18.49972	17.45486	19.96106	0	0	18.99191	19.70149	19.82335	0	0	0	20.15564	19.7535	19.39944	0	20.63219	0	0	0	0	0	0	18.04863
Q14153	FA53B_HUMAN	Protein FAM53B (Protein simplet)	FAM53B KIAA0140 SMP	Homo sapiens (Human)	positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein import into nucleus [GO:0006606]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	nucleus [GO:0005634]	nucleus [GO:0005634]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein import into nucleus [GO:0006606]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]		GO:0005634; GO:0006606; GO:0016055; GO:0060828; GO:0090263	AEPAAAWR	1.399999976	1	1	1.15E-12	874.8196721	14.60172	0	0	0	0	14.6813	0	0	14.70622	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.06793	0	0	0	14.23233	0	0	0	0	13.94338	0	0	0	0	0	14.78908	0	15.11956	15.10947	0	15.98935	0	0	0	13.36932
Q14154	DELE1_HUMAN	"DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form, DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form, DELE1(S), S-DELE1 ]"	DELE1 DELE KIAA0141	Homo sapiens (Human)	extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]	protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]	GO:0005739; GO:0005743; GO:0005829; GO:0008625; GO:0019901; GO:0043281; GO:0043539; GO:0140467; GO:0140468	GLGVQR	15.28999996	0.010608478	0.010608478	0.152589048	630.2327545	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.0115	0	0	0	0	0	0	0	0	18.44495	20.02964	0	0	0	0	0	0	18.41561	0	0	0	0	0	0	0	0	0
Q14156	EFR3A_HUMAN	Protein EFR3 homolog A (Protein EFR3-like)	EFR3A KIAA0143	Homo sapiens (Human)	phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]		GO:0005829; GO:0005886; GO:0046854; GO:0072659	SEIMMFIMGK	5.929999828	1	1	0.208573044	1218.004761	13.75887	0	14.71919	16.23834	14.0467	0	14.45749	12.85918	0	0	15.25953	16.06246	16.29061	14.92492	15.22394	16.66349	13.95793	0	0	0	16.37432	15.54122	12.97295	0	16.28954	15.1342	15.8379	0	0	0	0	15.41117	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14160	SCRIB_HUMAN	"Protein scribble homolog, Scribble, hScrib (Protein LAP4)"	SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; establishment of apical/basal cell polarity [GO:0035089]; establishment of T cell polarity [GO:0001768]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; polarized epithelial cell differentiation [GO:0030859]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of receptor recycling [GO:0001921]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]"	adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750]	"adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750]; cadherin binding [GO:0045296]; activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; establishment of apical/basal cell polarity [GO:0035089]; establishment of T cell polarity [GO:0001768]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; polarized epithelial cell differentiation [GO:0030859]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of receptor recycling [GO:0001921]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]"	cadherin binding [GO:0045296]	GO:0001768; GO:0001772; GO:0001843; GO:0001921; GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016080; GO:0016323; GO:0016477; GO:0021747; GO:0030027; GO:0030054; GO:0030859; GO:0032729; GO:0034750; GO:0035089; GO:0035748; GO:0036342; GO:0042060; GO:0043065; GO:0043113; GO:0043615; GO:0044291; GO:0045197; GO:0045296; GO:0045930; GO:0046007; GO:0048488; GO:0050918; GO:0060088; GO:0060561; GO:0060603; GO:0070062; GO:0071896; GO:0090630; GO:0097120; GO:0098609; GO:0098793; GO:0098887; GO:0098968; GO:0098978; GO:0099147; GO:0099149	GAGTAVQMR	6.889999866	0.068647385	0.068647385	0.246334829	905.0145949	16.38569	14.86357	0	0	0	0	16.261	15.92695	16.93204	15.57021	0	0	0	0	0	14.3968	14.88916	16.24482	15.21027	0	17.19611	0	14.36557	0	15.13075	0	0	14.28842	0	0	0	15.11809	0	0	0	0	15.76615	16.22177	0	0	0	17.95459	0	0	0	0	0	0
Q14161	GIT2_HUMAN	"ARF GTPase-activating protein GIT2, ARF GAP GIT2 (Cool-interacting tyrosine-phosphorylated protein 2, CAT-2, CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)"	GIT2 KIAA0148	Homo sapiens (Human)	regulation of G protein-coupled receptor signaling pathway [GO:0008277]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005654; GO:0005925; GO:0008277; GO:0046872	QLVTITTK	4.550000191	0.289805532	0.289805532	0.242870815	900.4302803	18.93577	16.70528	16.83197	14.69831	13.80194	0	19.77857	20.20448	17.93856	0	0	0	0	0	0	0	18.04359	0	0	0	17.96369	0	0	0	18.67984	20.72304	0	0	0	19.01348	17.84898	18.92167	0	0	0	17.11687	0	19.16211	20.13716	16.29761	0	17.91085	0	18.62989	0	17.7662	18.02572	0
Q14164	IKKE_HUMAN	"Inhibitor of nuclear factor kappa-B kinase subunit epsilon, I-kappa-B kinase epsilon, IKK-E, IKK-epsilon, IkBKE, EC 2.7.11.10 (Inducible I kappa-B kinase, IKK-i)"	IKBKE IKKE IKKI KIAA0151	Homo sapiens (Human)	cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; gene expression [GO:0010467]; immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mRNA stabilization [GO:0048255]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; regulation of protein-containing complex assembly [GO:0043254]; response to interferon-beta [GO:0035456]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; gene expression [GO:0010467]; immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mRNA stabilization [GO:0048255]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; regulation of protein-containing complex assembly [GO:0043254]; response to interferon-beta [GO:0035456]; type I interferon signaling pathway [GO:0060337]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]	GO:0004674; GO:0004704; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0008384; GO:0008630; GO:0010467; GO:0010884; GO:0016605; GO:0018105; GO:0019903; GO:0031625; GO:0031966; GO:0035456; GO:0036435; GO:0042802; GO:0043123; GO:0043254; GO:0048255; GO:0051091; GO:0051607; GO:0060337; GO:0060340; GO:0097400; GO:0098586; GO:1902554	ELDDDEKFVSVYGTEEYLHPDMYER	5.889999866	1	1	4.59E-12	3094.865681	0	12.01971	0	16.05289	15.1702	12.88122	0	11.63419	15.05912	13.82801	11.67898	0	11.62377	13.63672	12.83828	0	0	12.32018	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14181	DPOA2_HUMAN	DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit)	POLA2	Homo sapiens (Human)	"DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]"	alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]"	DNA binding [GO:0003677]	GO:0003677; GO:0005654; GO:0005658; GO:0005829; GO:0006260; GO:0006269; GO:0006270	GGAGNISLKVLGCPEALTGSYK	11.94999981	0.176109672	0.176109672	1.83E-12	2192.210961	13.06949	14.44666	0	10.55271	12.47216	12.22601	0	0	12.8479	15.02973	0	12.93659	0	0	0	0	0	17.05605	0	0	0	0	13.12917	0	0	0	0	0	14.61468	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14188	TFDP2_HUMAN	Transcription factor Dp-2 (E2F dimerization partner 2)	TFDP2 DP2	Homo sapiens (Human)	"cell cycle [GO:0007049]; heart development [GO:0007507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; heart development [GO:0007507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]"	GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007049; GO:0007507; GO:0008134; GO:0019904; GO:0045892; GO:0045944; GO:0051726; GO:0072686; GO:0090575	RVYDALNVLMAMNIISK	2.970000029	1	1	0.220379231	1966.154322	0	0	12.65547	15.15583	14.10352	15.23707	0	0	11.96466	0	0	0	0	0	0	0	0	0	0	15.33775	14.61298	0	12.94656	0	15.75437	0	13.63404	14.16436	0	14.76379	0	0	0	0	0	0	13.47642	13.08781	0	0	0	0	15.73531	0	0	0	10.67045	0
Q14191	WRN_HUMAN	"Werner syndrome ATP-dependent helicase, EC 3.6.4.12 (DNA helicase, RecQ-like type 3, RecQ3) (Exonuclease WRN, EC 3.1.-.-) (RecQ protein-like 2)"	WRN RECQ3 RECQL2	Homo sapiens (Human)	aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]	"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]"	"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cell aging [GO:0007569]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]"	3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]	GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0003682; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007568; GO:0007569; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773	FGIGLPILFLR	11.75	1	1	0.261754495	1244.783631	15.40785	15.3888	0	14.91603	14.0053	14.01871	0	15.16135	15.01454	0	15.86353	0	16.60305	15.53666	14.92322	15.07193	0	16.32862	18.05246	14.93469	0	0	0	0	0	0	15.84132	0	0	13.60559	0	13.77767	0	0	14.68367	0	0	16.83671	0	0	16.41277	0	0	0	0	0	0	0
Q14192	FHL2_HUMAN	"Four and a half LIM domains protein 2, FHL-2 (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3, SLIM-3)"	FHL2 DRAL SLIM3	Homo sapiens (Human)	atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]	focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015]	bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885	KTIMPGTR	4.630000114	1	1	0.204694017	919.2513804	13.68589	14.00071	17.11532	0	15.82671	13.64731	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.4948	0	17.53279	15.5063	0	0	13.96585	0	0	0	0	16.76266	17.46506	0	0	0	0	0	15.77433	0	0	0	0	0	0	0	0
Q14194	DPYL1_HUMAN	"Dihydropyrimidinase-related protein 1, DRP-1 (Collapsin response mediator protein 1, CRMP-1) (Inactive dihydropyrimidinase) (Unc-33-like phosphoprotein 3, ULIP-3)"	CRMP1 DPYSL1 ULIP3	Homo sapiens (Human)	axon guidance [GO:0007411]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of actin filament binding [GO:1904530]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]	centrosome [GO:0005813]; cytosol [GO:0005829]; growth cone [GO:0030426]; midbody [GO:0030496]; perikaryon [GO:0043204]; spindle [GO:0005819]	"centrosome [GO:0005813]; cytosol [GO:0005829]; growth cone [GO:0030426]; midbody [GO:0030496]; perikaryon [GO:0043204]; spindle [GO:0005819]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of actin filament binding [GO:1904530]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]"	"filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; identical protein binding [GO:0042802]"	GO:0000226; GO:0005813; GO:0005819; GO:0005829; GO:0006139; GO:0007399; GO:0007411; GO:0010977; GO:0016810; GO:0030426; GO:0030496; GO:0031005; GO:0042802; GO:0043204; GO:1904530	GLGAVILVHAENGDLIAQEQKR	4.820000172	1	1	1.38E-12	2331.998535	11.7804	15.15724	0	0	0	15.28586	0	13.39937	12.6598	0	17.36799	0	0	0	0	0	0	11.30289	0	0	17.49751	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14203	DCTN1_HUMAN	"Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150, DP-150) (p135) (p150-glued)"	DCTN1	Homo sapiens (Human)	"cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517]"	axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	"axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517]"	microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]	GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0007399; GO:0007528; GO:0008017; GO:0010457; GO:0015630; GO:0015631; GO:0016020; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0031116; GO:0031122; GO:0034454; GO:0035371; GO:0042147; GO:0043005; GO:0043025; GO:0045171; GO:0048156; GO:0050905; GO:0051010; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0099558; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535	TPSGSRMSAEASARPLR	1.350000024	1	1	0.326087601	1774.149504	12.97543	14.73333	14.50786	13.99965	14.6823	12.6291	15.68766	0	0	0	9.227219	0	0	13.51317	16.68533	0	0	0	0	0	0	0	0	15.74306	13.07972	15.53531	0	0	0	0	0	0	0	16.98906	0	0	15.05397	17.3276	0	0	0	14.58281	0	0	0	16.06257	0	0
Q14204	DYHC1_HUMAN	"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)"	DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325	Homo sapiens (Human)	cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]	axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; RNA binding [GO:0003723]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; RNA binding [GO:0003723]	GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0016020; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832	GRTGNVLK	7.920000076	0.236538708	0.236538708	0.260986287	844.9001826	16.05958	13.85565	15.81302	14.90746	15.26362	14.8493	14.3619	15.10633	16.00796	17.02416	15.60159	14.98668	14.09028	16.61562	15.03472	14.25636	0	14.2563	11.80197	15.04227	16.63736	15.34458	15.2696	0	16.24271	16.28927	15.93394	13.58638	15.60935	15.49419	15.71383	16.99281	16.74752	16.52835	15.51601	15.48726	15.89229	15.77103	0	0	14.66348	16.12847	14.66952	14.89315	15.76752	16.04251	14.041	14.52161
Q14207	NPAT_HUMAN	"Protein NPAT (Nuclear protein of the ataxia telangiectasia mutated locus, Nuclear protein of the ATM locus) (p220)"	NPAT CAND3 E14	Homo sapiens (Human)	"in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0000083; GO:0001701; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008022; GO:0010468; GO:0015030; GO:0045893; GO:0045944; GO:0097504	EKPPLPK	14.44999981	1	1	0.208419772	808.5022703	0	15.25162	12.71355	0	0	0	0	14.33892	0	0	0	0	0	0	14.90845	12.48336	0	15.05644	0	12.36786	14.86453	0	15.94248	0	0	14.62352	15.55375	0	0	0	14.41391	16.27978	14.92799	0	15.14102	15.75602	14.72424	15.35173	13.88498	0	0	0	15.60762	0	0	0	0	0
Q14209	E2F2_HUMAN	"Transcription factor E2F2, E2F-2"	E2F2	Homo sapiens (Human)	cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; lens fiber cell apoptotic process [GO:1990086]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; lens fiber cell apoptotic process [GO:1990086]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005654; GO:0006357; GO:0006367; GO:0007049; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0072332; GO:0090575; GO:1903671; GO:1990086; GO:1990837	TPKSPGEK	7.659999847	1	1	0.078167655	844.1605576	0	0	0	11.50559	0	13.82305	0	0	16.11813	0	15.28138	0	17.49123	0	17.52903	15.2317	0	18.45329	16.53335	18.31802	15.91561	16.44514	0	17.67846	17.7051	15.20026	0	14.18977	15.57217	0	16.80368	0	16.68047	16.98325	15.64044	18.6224	0	17.7674	16.40088	0	0	0	11.65875	16.09367	17.19031	18.15527	0	0
Q14241	ELOA1_HUMAN	"Elongin-A, EloA (Elongin 110 kDa subunit) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110) (Transcription elongation factor B polypeptide 3)"	ELOA TCEB3 MSTP059	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	elongin complex [GO:0070449]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]	elongin complex [GO:0070449]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]		GO:0005615; GO:0005654; GO:0006357; GO:0006367; GO:0006368; GO:0070449; GO:0090734	CAYLPK	9.909999847	0.378670841	0.378670841	0.257253356	752.1132545	15.12348	16.2653	14.75908	15.17499	15.16768	14.22081	16.08307	15.42749	14.75979	0	14.98361	16.68174	0	14.35612	15.35821	0	15.5201	16.09454	0	0	15.92031	16.23917	16.60699	0	15.72688	0	0	14.999	14.54247	15.19684	15.18451	16.35837	17.69639	12.92228	15.99908	15.49307	17.32203	17.93671	16.3926	15.29892	0	0	0	0	0	16.45137	0	16.57582
Q14244	MAP7_HUMAN	"Ensconsin (Epithelial microtubule-associated protein of 115 kDa, E-MAP-115) (Microtubule-associated protein 7, MAP-7)"	MAP7	Homo sapiens (Human)	establishment or maintenance of cell polarity [GO:0007163]; microtubule cytoskeleton organization [GO:0000226]; protein localization to plasma membrane [GO:0072659]; response to osmotic stress [GO:0006970]	axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]	axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; establishment or maintenance of cell polarity [GO:0007163]; microtubule cytoskeleton organization [GO:0000226]; protein localization to plasma membrane [GO:0072659]; response to osmotic stress [GO:0006970]	signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]	GO:0000226; GO:0005102; GO:0005198; GO:0005829; GO:0005874; GO:0005875; GO:0006970; GO:0007163; GO:0015630; GO:0016323; GO:0030424; GO:0048471; GO:0072659	AAHSR	5.769999981	1	1	0.273530536	541.6937951	0	0	0	0	0	0	0	0	0	0	17.71295	15.90775	0	0	0	0	0	0	15.47871	0	18.11982	0	0	0	16.75178	0	0	0	0	17.61329	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14247	SRC8_HUMAN	Src substrate cortactin (Amplaxin) (Oncogene EMS1)	CTTN EMS1	Homo sapiens (Human)	"actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]"	cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076]	"cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]"	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]	GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0030027; GO:0030041; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0043231; GO:0045296; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0097062; GO:0097581; GO:1903146; GO:1990023; GO:2001237	DYSSGFGGK	7.699999809	0.293169886	0.293169886	0.194395471	916.2684985	17.73756	0	17.60985	12.56441	0	16.36855	13.01008	0	18.35344	15.92298	16.54364	12.60753	0	0	16.11964	12.7782	0	16.69439	13.13697	15.53316	15.6832	17.27831	13.76381	14.99029	16.59737	0	16.27292	16.56167	16.05664	0	0	0	0	18.37301	0	17.42249	18.16249	18.64216	18.34396	0	15.16433	16.27589	15.39792	16.2887	19.24332	0	16.66667	12.71431
Q14315	FLNC_HUMAN	"Filamin-C, FLN-C, FLNc (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)"	FLNC ABPL FLN2	Homo sapiens (Human)	sarcomere organization [GO:0045214]	costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]	costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; sarcomere organization [GO:0045214]	actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]	GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045214; GO:0051015	FTVETRGAGTGGLGLAIEGPSEAK	11.64000034	1	1	0.117509842	2317.859056	14.0328	14.32901	0	13.1172	0	12.93444	13.54897	10.25075	15.26437	0	0	12.5087	13.98958	12.2031	0	15.49085	0	0	14.68667	0	0	0	16.98387	0	0	0	12.95257	0	0	0	0	0	0	0	0	0	14.48753	0	0	0	14.13694	0	0	0	13.28252	0	0	0
Q14324	MYPC2_HUMAN	"Myosin-binding protein C, fast-type, Fast MyBP-C (C-protein, skeletal muscle fast isoform)"	MYBPC2 MYBPCF	Homo sapiens (Human)	cell adhesion [GO:0007155]; muscle contraction [GO:0006936]	cytosol [GO:0005829]; myosin filament [GO:0032982]	cytosol [GO:0005829]; myosin filament [GO:0032982]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell adhesion [GO:0007155]; muscle contraction [GO:0006936]	actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]	GO:0003779; GO:0005829; GO:0006936; GO:0007155; GO:0008307; GO:0032982	HILIFSDVVQEDR	1.690000057	1	1	0.213595096	1570.977733	13.13054	15.24186	16.48421	0	0	0	15.24054	0	6.6469	0	0	15.10516	0	0	14.98088	15.70638	0	0	0	0	0	0	14.49043	0	0	0	11.95211	13.62223	12.13093	13.93065	14.57608	17.53514	0	0	0	0	0	0	0	0	16.26569	0	0	0	15.94302	0	0	0
Q14344	GNA13_HUMAN	"Guanine nucleotide-binding protein subunit alpha-13, G alpha-13, G-protein subunit alpha-13"	GNA13	Homo sapiens (Human)	activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; multicellular organism aging [GO:0010259]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; multicellular organism aging [GO:0010259]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]	D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]	GO:0001569; GO:0001664; GO:0001701; GO:0003924; GO:0005085; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007188; GO:0007189; GO:0007204; GO:0007266; GO:0008217; GO:0008360; GO:0010259; GO:0016020; GO:0030154; GO:0030168; GO:0031526; GO:0031584; GO:0031683; GO:0031752; GO:0042470; GO:0046872; GO:0051056; GO:0070062; GO:1904706; GO:1904753	APMAAQGMVETR	1.179999948	1	1	0.007800176	1294.252361	12.40259	0	0	11.60619	0	0	12.42084	0	10.98017	0	12.98413	12.48869	10.93002	16.41673	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.7345	10.08664	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14393	GAS6_HUMAN	"Growth arrest-specific protein 6, GAS-6 (AXL receptor tyrosine kinase ligand)"	GAS6 AXLLG	Homo sapiens (Human)	"activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; cell-substrate adhesion [GO:0031589]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]"	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093]	"cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activator activity [GO:0030296]; protein-macromolecule adaptor activity [GO:0030674]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; cell-substrate adhesion [GO:0031589]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]"	calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activator activity [GO:0030296]; protein-macromolecule adaptor activity [GO:0030674]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0001764; GO:0001786; GO:0001934; GO:0001961; GO:0003104; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0006468; GO:0006909; GO:0007165; GO:0007167; GO:0007596; GO:0009267; GO:0010628; GO:0010804; GO:0018105; GO:0019064; GO:0019079; GO:0030296; GO:0030674; GO:0030971; GO:0031093; GO:0031100; GO:0031589; GO:0032008; GO:0032148; GO:0032689; GO:0032692; GO:0032715; GO:0032720; GO:0032825; GO:0033138; GO:0035457; GO:0035754; GO:0040008; GO:0043027; GO:0043066; GO:0043154; GO:0043277; GO:0043433; GO:0043491; GO:0045860; GO:0045892; GO:0046718; GO:0046813; GO:0046827; GO:0048018; GO:0048146; GO:0050766; GO:0051897; GO:0061098; GO:0070062; GO:0070168; GO:0070374; GO:0070588; GO:0071307; GO:0071333; GO:0071363; GO:0071466; GO:0072659; GO:0085029; GO:0097028; GO:0097241; GO:1900142; GO:2000270; GO:2000352; GO:2000510; GO:2000533; GO:2000669	ACRDVDECLQGR	5	1	1	0.083941077	1479.321002	0	0	11.70633	15.6496	0	0	0	0	0	0	0	0	0	0	0	0	0	12.42879	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14409	GLPK3_HUMAN	"Glycerol kinase 3, GK 3, Glycerokinase 3, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 3) (Glycerol kinase 3 pseudogene) (Glycerol kinase, testis specific 1)"	GK3P GKP3 GKTB	Homo sapiens (Human)	glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	EILDAMNR	3.130000114	1	1	0.217687997	961.1153414	14.22277	14.02054	14.00433	0	0	0	0	15.34445	0	14.31795	0	14.6415	0	0	0	0	0	0	13.69432	13.07352	0	0	0	0	0	0	15.49353	0	14.1902	0	0	13.29051	0	15.10136	13.17167	0	0	15.18017	0	0	0	0	0	0	0	0	0	0
Q14410	GLPK2_HUMAN	"Glycerol kinase 2, GK 2, Glycerokinase 2, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 2) (Glycerol kinase, testis specific 2)"	GK2 GKP2 GKTA	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]; triglyceride metabolic process [GO:0006641]	extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226]	"extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; flagellated sperm motility [GO:0030317]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]; triglyceride metabolic process [GO:0006641]"	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0007283; GO:0016310; GO:0016773; GO:0019563; GO:0030317; GO:0046167; GO:0070062; GO:0097225; GO:0097226; GO:0120317	IPGNSNFVK	9.539999962	1	1	0.175397268	974.3304617	0	0	14.99362	0	13.96462	0	0	13.88255	0	0	14.88	0	14.05276	0	15.05442	14.58149	0	14.8805	0	0	0	0	17.19332	0	0	0	0	0	0	13.89993	16.61523	0	0	0	0	0	0	0	0	14.19357	0	0	0	0	0	13.07812	0	0
Q14416	GRM2_HUMAN	"Metabotropic glutamate receptor 2, mGluR2"	GRM2 GPRC1B MGLUR2	Homo sapiens (Human)	"behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]"	astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]"	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]	GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0035095; GO:0042220; GO:0042734; GO:0051896; GO:0051966; GO:0090461; GO:0097110; GO:0097449; GO:0099055; GO:2001023	LGAHILDSCSK	1.74000001	1	1	0.07441536	1199.632807	13.06722	12.09644	15.53261	0	10.38965	0	8.942883	14.09189	11.46114	15.19337	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14435	GALT3_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 3, EC 2.4.1.41 (Polypeptide GalNAc transferase 3, GalNAc-T3, pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3)"	GALNT3	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; spermatogenesis [GO:0007283]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; spermatogenesis [GO:0007283]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005509; GO:0005794; GO:0005975; GO:0006493; GO:0007283; GO:0008543; GO:0016020; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0070062	MQIGAPVR	4.550000191	1	1	0.270074404	885.6443932	0	0	0	0	0	0	0	20.65878	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.69386	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14442	PIGH_HUMAN	"Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (Phosphatidylinositol-glycan biosynthesis class H protein, PIG-H)"	PIGH	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; catalytic activity [GO:0003824]; cellular protein modification process [GO:0006464]; GPI anchor biosynthetic process [GO:0006506]	catalytic activity [GO:0003824]	GO:0000506; GO:0003824; GO:0005783; GO:0005789; GO:0006464; GO:0006506	EFCLSCPR	7.170000076	1	1	0.122568599	1069.474404	14.07602	0	0	0	13.4523	15.29583	0	15.81873	0	15.91772	14.78455	0	0	0	16.42186	0	15.04168	13.51194	0	0	0	13.49658	0	0	13.81323	0	14.8046	0	15.02656	14.55278	14.60909	0	14.13515	0	0	15.23477	0	13.05563	0	16.14434	0	15.45402	15.71515	0	0	0	0	0
Q14444	CAPR1_HUMAN	"Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137, GPI-p137, p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105)"	CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105	Homo sapiens (Human)	negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; postsynapse [GO:0098794]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; postsynapse [GO:0098794]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]	RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0050775; GO:0061003; GO:0098794; GO:0098978	LNQDQLDAVSK	6.96999979	1	1	0.011241763	1227.578281	0	0	12.43257	15.24688	12.82157	0	15.55088	0	11.57671	0	10.56363	0	11.61447	12.52975	0	0	0	14.64067	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14451	GRB7_HUMAN	Growth factor receptor-bound protein 7 (B47) (Epidermal growth factor receptor GRB-7) (GRB7 adapter protein)	GRB7	Homo sapiens (Human)	epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of translation [GO:0017148]; positive regulation of cell migration [GO:0030335]; stress granule assembly [GO:0034063]	cell projection [GO:0042995]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	cell projection [GO:0042995]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of translation [GO:0017148]; positive regulation of cell migration [GO:0030335]; stress granule assembly [GO:0034063]	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	GO:0003723; GO:0005829; GO:0005886; GO:0005925; GO:0007173; GO:0010494; GO:0017148; GO:0019901; GO:0030335; GO:0034063; GO:0035091; GO:0042802; GO:0042995	GTSKDPR	3.980000019	1	1	4.59E-13	759.611798	0	16.20935	0	14.22999	14.25241	14.7549	0	0	15.07007	0	0	0	15.88938	16.17941	0	0	0	0	0	0	0	15.1761	0	16.23245	15.55055	0	0	0	0	0	0	0	0	16.83021	0	0	16.37487	0	0	0	16.40535	0	0	0	0	0	0	0
Q14469	HES1_HUMAN	"Transcription factor HES-1 (Class B basic helix-loop-helix protein 39, bHLHb39) (Hairy and enhancer of split 1) (Hairy homolog) (Hairy-like protein, hHL)"	HES1 BHLHB39 HL HRY	Homo sapiens (Human)	"adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; artery morphogenesis [GO:0048844]; ascending aorta morphogenesis [GO:0035910]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-1 [GO:0071347]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hair cell differentiation [GO:0035315]; hindbrain morphogenesis [GO:0021575]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of calcium ion import [GO:0090281]; negative regulation of cell fate determination [GO:1905934]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; outflow tract morphogenesis [GO:0003151]; pancreas development [GO:0031016]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of protein-containing complex assembly [GO:0043254]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; renal interstitial fibroblast development [GO:0072141]; response to alkaloid [GO:0043279]; response to organic cyclic compound [GO:0014070]; response to thyroid hormone [GO:0097066]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular associated smooth muscle cell development [GO:0097084]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; HLH domain binding [GO:0043398]; JUN kinase binding [GO:0008432]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; adenohypophysis development [GO:0021984]; anterior/posterior pattern specification [GO:0009952]; artery morphogenesis [GO:0048844]; ascending aorta morphogenesis [GO:0035910]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-1 [GO:0071347]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hair cell differentiation [GO:0035315]; hindbrain morphogenesis [GO:0021575]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of calcium ion import [GO:0090281]; negative regulation of cell fate determination [GO:1905934]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; outflow tract morphogenesis [GO:0003151]; pancreas development [GO:0031016]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of protein-containing complex assembly [GO:0043254]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; renal interstitial fibroblast development [GO:0072141]; response to alkaloid [GO:0043279]; response to organic cyclic compound [GO:0014070]; response to thyroid hormone [GO:0097066]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular associated smooth muscle cell development [GO:0097084]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]"	"chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; HLH domain binding [GO:0043398]; JUN kinase binding [GO:0008432]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0001889; GO:0003143; GO:0003151; GO:0003266; GO:0003281; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007155; GO:0007219; GO:0007224; GO:0007399; GO:0008284; GO:0008432; GO:0009952; GO:0010628; GO:0010629; GO:0010977; GO:0014070; GO:0016363; GO:0016477; GO:0021537; GO:0021555; GO:0021557; GO:0021558; GO:0021575; GO:0021861; GO:0021984; GO:0030324; GO:0030513; GO:0030901; GO:0031016; GO:0032991; GO:0035019; GO:0035315; GO:0035910; GO:0042102; GO:0042531; GO:0042803; GO:0042826; GO:0043254; GO:0043279; GO:0043388; GO:0043398; GO:0043433; GO:0043565; GO:0044877; GO:0045598; GO:0045608; GO:0045665; GO:0045747; GO:0045892; GO:0045944; GO:0045977; GO:0046331; GO:0046425; GO:0046427; GO:0048469; GO:0048538; GO:0048667; GO:0048711; GO:0048715; GO:0048844; GO:0050678; GO:0050767; GO:0051087; GO:0060122; GO:0060164; GO:0060253; GO:0060412; GO:0060675; GO:0060716; GO:0061009; GO:0061106; GO:0061309; GO:0061626; GO:0061629; GO:0065003; GO:0070888; GO:0071347; GO:0071356; GO:0071398; GO:0071820; GO:0072012; GO:0072049; GO:0072050; GO:0072141; GO:0072282; GO:0090102; GO:0090162; GO:0090281; GO:0097066; GO:0097084; GO:0097150; GO:1905934; GO:1990090; GO:1990837; GO:2000227; GO:2000737; GO:2000974; GO:2000978	PADIMEK	9.289999962	0.016748223	0.016748223	0.21678398	820.5731111	15.86814	16.16836	0	15.13655	14.65365	0	15.48666	15.40894	16.05914	15.26419	16.05098	12.97008	15.92142	15.65891	17.02457	15.98226	15.12668	16.17407	15.15131	16.17866	15.51544	16.33462	0	17.38224	15.47692	0	15.9965	15.71154	15.28354	15.5967	16.58706	17.1116	14.89147	15.8264	16.93794	16.39091	16.39635	16.51291	14.97739	0	15.21892	15.81918	15.00213	15.93391	16.1677	15.56292	11.47156	15.56296
Q14493	SLBP_HUMAN	Histone RNA hairpin-binding protein (Histone stem-loop-binding protein)	SLBP HBP	Homo sapiens (Human)	cap-dependent translational initiation [GO:0002191]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone mRNA stem-loop binding complex [GO:0062073]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone mRNA stem-loop binding complex [GO:0062073]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; histone pre-mRNA DCP binding [GO:0071208]; histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cap-dependent translational initiation [GO:0002191]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028]	histone pre-mRNA DCP binding [GO:0071208]; histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0002191; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006398; GO:0042802; GO:0051028; GO:0062073; GO:0071204; GO:0071207; GO:0071208; GO:1990904	SSSGSSDSK	3.420000076	1	1	0.210587641	842.5407122	11.4291	15.14412	0	15.9184	14.52511	16.29981	15.86408	15.454	18.02724	15.14696	16.77028	0	16.14992	13.15016	15.90781	14.82677	15.24558	14.96206	14.55979	0	15.29423	15.39633	14.79452	15.03002	17.15475	16.649	0	0	0	16.08185	0	0	0	0	16.46075	0	16.8016	0	15.80833	16.81127	16.58827	0	0	0	0	15.72481	14.82912	0
Q14498	RBM39_HUMAN	"RNA-binding protein 39 (CAPER alpha, CAPERalpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1)"	RBM39 HCC1 RNPC2	Homo sapiens (Human)	"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	"centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]"	RNA binding [GO:0003723]; RS domain binding [GO:0050733]	GO:0003723; GO:0005654; GO:0006396; GO:0006397; GO:0008380; GO:0015630; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733	IESIQLMMDSETGRSK	7.329999924	1	1	4.59E-13	1843.981152	0	14.38815	14.06614	0	14.72458	0	0	0	0	16.59244	0	0	0	0	11.39074	14.8792	12.16879	0	0	14.29148	14.60202	14.30462	0	15.66099	0	15.22021	11.91876	0	0	0	0	0	0	0	0	0	14.95129	0	0	12.3245	0	0	13.23098	0	0	0	0	0
Q14500	KCJ12_HUMAN	"ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2, IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12)"	KCNJ12 IRK2 KCNJN1	Homo sapiens (Human)	muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]	inward rectifier potassium channel activity [GO:0005242]	GO:0005242; GO:0005886; GO:0006813; GO:0006936; GO:0008016; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573	MTAASR	3.730000019	0.792112648	0.792112648	0.332586063	635.1881665	18.60668	17.46655	18.30959	18.37243	19.41263	18.42294	17.81077	0	0	18.48105	0	0	17.81505	0	0	18.11481	20.81812	21.19035	0	17.3001	0	17.24416	0	16.72306	17.74032	17.5808	20.98018	17.2858	0	19.29598	0	18.66544	19.66141	0	0	21.4461	0	0	19.4662	0	22.4437	0	17.74489	19.79755	21.45941	22.92868	0	0
Q14507	EP3A_HUMAN	"Epididymal secretory protein E3-alpha (Human epididymis-specific protein 3-alpha, HE3-alpha)"	EDDM3A FAM12A HE3A	Homo sapiens (Human)	sperm displacement [GO:0007321]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; sperm displacement [GO:0007321]		GO:0005615; GO:0007321	CDVLMR	4.960000038	1	1	0.247295154	807.6103143	14.51701	15.19951	16.68051	12.75078	0	14.98456	0	15.83996	0	0	12.91904	14.62297	15.99005	0	15.02074	14.72842	14.90859	15.46007	14.48993	0	0	15.77759	16.16576	14.95156	16.43936	15.92354	0	15.12802	15.67164	15.3978	0	15.74126	0	0	16.725	15.10906	16.57982	0	16.77931	17.34466	16.17554	16.38809	0	15.91342	0	15.81735	16.08812	15.2774
Q14508	WFDC2_HUMAN	WAP four-disulfide core domain protein 2 (Epididymal secretory protein E4) (Major epididymis-specific protein E4) (Putative protease inhibitor WAP5)	WFDC2 HE4 WAP5	Homo sapiens (Human)	antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283]	aspartic-type endopeptidase inhibitor activity [GO:0019828]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004866; GO:0004867; GO:0004869; GO:0005615; GO:0006508; GO:0007283; GO:0019731; GO:0019828; GO:0045087; GO:0070062	VSCVTPNF	6.71999979	1	1	0.274340992	923.9778482	0	15.19928	18.78664	18.47726	17.92214	0	0	17.59903	17.87962	16.96087	0	0	17.78681	0	18.29492	17.60436	0	0	0	17.39166	0	17.19248	17.46227	0	0	0	0	17.8063	17.38645	0	0	0	0	0	17.33751	18.46034	0	17.97293	18.26919	0	0	17.96592	0	18.0386	16.65292	0	16.63222	0
Q14512	FGFP1_HUMAN	"Fibroblast growth factor-binding protein 1, FGF-BP, FGF-BP1, FGF-binding protein 1, FGFBP-1 (17 kDa heparin-binding growth factor-binding protein, 17 kDa HBGF-binding protein, HBp17)"	FGFBP1 FGFBP HBP17	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; signal transduction [GO:0007165]	cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; signal transduction [GO:0007165]	fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]	GO:0005576; GO:0005615; GO:0005886; GO:0007165; GO:0007267; GO:0008201; GO:0008285; GO:0009986; GO:0017134; GO:0019838; GO:0045743; GO:0090050; GO:1903589	NGLHSK	1.220000029	0.245217741	0.245217741	0.208326748	656.1019251	15.119	0	0	0	0	15.19527	13.50223	12.19512	0	14.38531	13.36351	11.47045	0	0	0	0	0	0	18.91353	0	14.41244	0	0	0	16.08388	17.20824	14.61867	13.07188	17.38202	15.50098	0	0	0	0	18.12264	16.67903	17.07148	16.2417	0	15.54471	16.0349	16.88076	0	0	0	0	0	0
Q14524	SCN5A_HUMAN	Sodium channel protein type 5 subunit alpha (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5) (hH1)	SCN5A	Homo sapiens (Human)	atrial cardiac muscle cell action potential [GO:0086014]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell communication [GO:0086067]; brainstem development [GO:0003360]; bundle of His cell action potential [GO:0086043]; cardiac conduction system development [GO:0003161]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cardiac ventricle development [GO:0003231]; cellular response to calcium ion [GO:0071277]; cerebellum development [GO:0021549]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of action potential [GO:0045760]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; SA node cell action potential [GO:0086015]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]; ventricular cardiac muscle cell action potential [GO:0086005]	caveola [GO:0005901]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]	caveola [GO:0005901]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; nitric-oxide synthase binding [GO:0050998]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in AV node cell action potential [GO:0086060]; voltage-gated sodium channel activity involved in bundle of His cell action potential [GO:0086061]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; voltage-gated sodium channel activity involved in SA node cell action potential [GO:0086063]; atrial cardiac muscle cell action potential [GO:0086014]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell communication [GO:0086067]; brainstem development [GO:0003360]; bundle of His cell action potential [GO:0086043]; cardiac conduction system development [GO:0003161]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cardiac ventricle development [GO:0003231]; cellular response to calcium ion [GO:0071277]; cerebellum development [GO:0021549]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of action potential [GO:0045760]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; SA node cell action potential [GO:0086015]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]; ventricular cardiac muscle cell action potential [GO:0086005]	ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; nitric-oxide synthase binding [GO:0050998]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in AV node cell action potential [GO:0086060]; voltage-gated sodium channel activity involved in bundle of His cell action potential [GO:0086061]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; voltage-gated sodium channel activity involved in SA node cell action potential [GO:0086063]	GO:0001518; GO:0002027; GO:0003161; GO:0003231; GO:0003360; GO:0005244; GO:0005248; GO:0005516; GO:0005654; GO:0005730; GO:0005783; GO:0005886; GO:0005901; GO:0006814; GO:0009986; GO:0010765; GO:0014704; GO:0014894; GO:0016021; GO:0016328; GO:0017134; GO:0019228; GO:0019899; GO:0019901; GO:0019904; GO:0021537; GO:0021549; GO:0030018; GO:0030315; GO:0030506; GO:0031625; GO:0035725; GO:0042383; GO:0042475; GO:0044325; GO:0045760; GO:0048471; GO:0050679; GO:0050998; GO:0051899; GO:0060048; GO:0060307; GO:0060371; GO:0060372; GO:0060373; GO:0071277; GO:0086002; GO:0086004; GO:0086005; GO:0086006; GO:0086010; GO:0086012; GO:0086014; GO:0086015; GO:0086016; GO:0086043; GO:0086045; GO:0086046; GO:0086047; GO:0086048; GO:0086060; GO:0086061; GO:0086062; GO:0086063; GO:0086067; GO:0086091; GO:0097110; GO:0098912; GO:1902305	WHMMDFFHAFLIIFR	14.01000023	1	1	2.07E-12	2042.403556	15.13398	0	13.44872	12.61119	12.31849	15.81487	14.38165	15.22758	14.51905	13.87037	11.37984	0	13.0099	10.00606	0	7.309761	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.5967	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14526	HIC1_HUMAN	"Hypermethylated in cancer 1 protein, Hic-1 (Zinc finger and BTB domain-containing protein 29)"	HIC1 ZBTB29	Homo sapiens (Human)	"intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008630; GO:0016055; GO:0030178; GO:0042826; GO:0043517; GO:0043565; GO:0046872; GO:1990837	AEAAEVAAGAAGLGPPFGGGGDK	6.760000229	1	1	0.122798734	1970.62493	13.82087	14.01179	16.75245	15.92213	0	0	0	0	0	0	0	0	0	16.24866	0	0	0	0	0	0	0	0	0	14.63308	0	0	0	0	0	0	0	15.29375	0	16.29698	0	15.20652	0	15.29392	0	0	0	0	0	0	0	0	0	0
Q14527	HLTF_HUMAN	"Helicase-like transcription factor, EC 2.3.2.27, EC 3.6.4.- (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3)"	HLTF HIP116A RNF80 SMARCA3 SNF2L3 ZBU1	Homo sapiens (Human)	mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]"	"ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]"	GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008270; GO:0016020; GO:0016363; GO:0016567; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0061630; GO:0090575; GO:0140658	DPNNPYDK	7.849999905	1	1	0.057797574	962.7191797	14.18352	0	15.55168	0	0	12.47881	0	0	0	0	0	0	16.13229	15.06148	14.49182	14.67953	13.88946	8.890539	0	0	0	0	0	0	0	0	16.76374	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14534	ERG1_HUMAN	"Squalene monooxygenase, EC 1.14.14.17 (Squalene epoxidase, SE)"	SQLE ERG1	Homo sapiens (Human)	cellular aromatic compound metabolic process [GO:0006725]; cholesterol metabolic process [GO:0008203]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to organic substance [GO:0010033]; sterol biosynthetic process [GO:0016126]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506]; cellular aromatic compound metabolic process [GO:0006725]; cholesterol metabolic process [GO:0008203]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to organic substance [GO:0010033]; sterol biosynthetic process [GO:0016126]	FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506]	GO:0004506; GO:0005783; GO:0005789; GO:0006725; GO:0008203; GO:0010033; GO:0016021; GO:0016126; GO:0042127; GO:0043231; GO:0071949; GO:0140042	AAMAEPNAK	5.440000057	1	1	0.287746163	918.1201261	0	0	0	0	0	0	0	0	0	0	0	0	15.82719	0	0	0	0	0	0	0	0	0	0	0	0	17.53009	19.39878	19.01036	0	0	0	0	0	0	0	0	0	0	17.66325	0	0	0	16.11742	0	0	0	0	0
Q14554	PDIA5_HUMAN	"Protein disulfide-isomerase A5, EC 5.3.4.1 (Protein disulfide isomerase-related protein)"	PDIA5 PDIR	Homo sapiens (Human)	electron transport chain [GO:0022900]; protein folding [GO:0006457]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; electron transport chain [GO:0022900]; protein folding [GO:0006457]	oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]	GO:0003756; GO:0005788; GO:0005789; GO:0006457; GO:0015035; GO:0016491; GO:0022900	KHTLVMFYAPWCPHCK	4.420000076	1	1	0	2074.413074	0	0	0	0	0	0	0	0	0	13.00104	14.77899	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14562	DHX8_HUMAN	"ATP-dependent RNA helicase DHX8, EC 3.6.4.13 (DEAH box protein 8) (RNA helicase HRH1)"	DHX8 DDX8	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008380; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013	ASYGK	3.380000114	0.077928357	0.077928357	0.285769394	523.0277658	17.41155	16.67956	16.52612	16.42686	15.09486	15.80632	0	14.88562	15.50788	16.15497	16.62302	14.91344	16.23697	0	15.95876	0	16.30928	15.0206	15.61179	16.01773	0	15.95244	13.69806	16.967	0	0	16.66956	15.43692	16.08111	15.97588	14.62286	15.49686	16.74373	16.782	15.31698	15.52349	16.50177	16.48859	16.34093	17.24113	16.80455	16.44255	17.64167	16.75111	16.21338	15.8752	16.77311	17.10862
Q14563	SEM3A_HUMAN	"Semaphorin-3A (Semaphorin III, Sema III)"	SEMA3A SEMAD	Homo sapiens (Human)	apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; branchiomotor neuron axon guidance [GO:0021785]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neural crest cell migration involved in sympathetic nervous system development [GO:1903045]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of male gonad development [GO:2000020]; positive regulation of neuron migration [GO:2001224]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of heart rate [GO:0002027]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory system development [GO:0048880]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; branchiomotor neuron axon guidance [GO:0021785]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neural crest cell migration involved in sympathetic nervous system development [GO:1903045]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of male gonad development [GO:2000020]; positive regulation of neuron migration [GO:2001224]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of heart rate [GO:0002027]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory system development [GO:0048880]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]	chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0001764; GO:0002027; GO:0005576; GO:0005615; GO:0005887; GO:0006915; GO:0007411; GO:0007413; GO:0008045; GO:0010633; GO:0010977; GO:0021612; GO:0021637; GO:0021675; GO:0021772; GO:0021785; GO:0021828; GO:0030215; GO:0030335; GO:0030424; GO:0030425; GO:0036486; GO:0038191; GO:0045499; GO:0046330; GO:0048485; GO:0048841; GO:0048843; GO:0048846; GO:0048880; GO:0050919; GO:0060385; GO:0060666; GO:0061549; GO:0061551; GO:0071526; GO:0097490; GO:0097491; GO:0150020; GO:1901166; GO:1902285; GO:1902287; GO:1903045; GO:1903375; GO:2000020; GO:2001224	IGQICK	8.300000191	1	1	2.30E-13	717.5293463	0	15.85547	12.45294	0	0	0	15.30186	0	0	0	0	15.03263	0	0	0	13.93331	0	15.05398	0	17.99394	0	0	0	14.01348	0	15.37611	16.31822	0	0	0	0	17.38409	0	16.73954	0	0	16.67953	0	0	0	0	0	0	0	0	0	0	0
Q14566	MCM6_HUMAN	"DNA replication licensing factor MCM6, EC 3.6.4.12 (p105MCM)"	MCM6	Homo sapiens (Human)	DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]	GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006268; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0042802; GO:0071162; GO:1902969	GVLLMLFGGVPK	4.300000191	0.470317006	0.470317006	0.161452288	1247.269426	16.56788	16.70498	15.54803	16.35799	0	0	14.54154	0	15.1162	0	16.89052	17.16138	12.84142	11.62464	13.48851	0	13.88631	0	15.8352	18.23485	0	16.8859	0	16.72091	15.83157	0	12.0852	18.14924	15.08449	15.81894	0	15.85222	0	0	11.69823	15.39145	15.7261	13.77068	16.53346	15.84062	16.34071	12.08976	0	0	15.18912	15.33966	0	0
Q14571	ITPR2_HUMAN	"Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2, IP3R 2, InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor, Type 2 InsP3 receptor)"	ITPR2	Homo sapiens (Human)	cellular response to cAMP [GO:0071320]; cellular response to ethanol [GO:0071361]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; secretory granule membrane [GO:0030667]	"cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; cellular response to cAMP [GO:0071320]; cellular response to ethanol [GO:0071361]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]"	"calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]"	GO:0001666; GO:0005220; GO:0005509; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0005938; GO:0007165; GO:0015085; GO:0016020; GO:0016021; GO:0016529; GO:0030659; GO:0030667; GO:0031095; GO:0033017; GO:0035091; GO:0043235; GO:0044325; GO:0051209; GO:0070679; GO:0071320; GO:0071361; GO:0097110	EETLLNVIK	3.930000067	0.300433338	0.300433338	0.005471434	1057.659447	13.69745	13.3804	13.70785	16.33372	15.25134	13.84476	0	0	13.09047	0	16.53871	12.76077	15.28195	13.78326	0	0	0	14.67893	0	15.10031	0	0	0	13.9142	0	15.84286	0	14.84255	0	16.06305	14.7456	16.85117	0	16.75142	15.79831	0	0	13.49913	6.506029	0	16.13885	0	0	16.33281	13.56859	14.63283	15.34598	15.56279
Q14573	ITPR3_HUMAN	"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3, IP3R 3, InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor, Type 3 InsP3 receptor)"	ITPR3	Homo sapiens (Human)	calcium ion transport into cytosol [GO:0060402]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917]	apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]	"apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; phosphatidylinositol binding [GO:0035091]; calcium ion transport into cytosol [GO:0060402]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917]"	"calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; phosphatidylinositol binding [GO:0035091]"	GO:0000822; GO:0005220; GO:0005509; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005903; GO:0007186; GO:0007204; GO:0007613; GO:0015278; GO:0016020; GO:0016529; GO:0030659; GO:0030667; GO:0031095; GO:0035091; GO:0043025; GO:0043209; GO:0043235; GO:0043533; GO:0045177; GO:0050909; GO:0050913; GO:0050916; GO:0050917; GO:0051209; GO:0051592; GO:0060291; GO:0060402; GO:0070679	ASLAHLLDMMK	13.18999958	0.648336768	0.648336768	0.456033625	1230.354813	0	0	0	18.75472	18.25688	0	18.69787	0	0	0	0	0	0	0	0	0	0	0	18.91123	0	0	18.54911	18.98195	0	0	0	0	18.554	0	0	0	18.60123	0	0	0	0	0	20.79716	0	0	0	0	0	19.81719	0	16.48991	0	0
Q14574	DSC3_HUMAN	Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP)	DSC3 CDHF3 DSC4	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; protein stabilization [GO:0050821]	cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; protein stabilization [GO:0050821]	calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]	GO:0001533; GO:0001701; GO:0005509; GO:0005576; GO:0005737; GO:0005886; GO:0005911; GO:0007155; GO:0007156; GO:0016020; GO:0016021; GO:0030054; GO:0030057; GO:0045295; GO:0050821; GO:0098609	GWITIDEISGSIITSK	3.380000114	1	1	1.16E-12	1719.481362	14.65066	16.56436	0	15.15972	17.29875	18.25127	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.11723	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14584	ZN266_HUMAN	Zinc finger protein 266 (Zinc finger protein HZF1)	ZNF266 KIAA2007	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	QCGDVSSEHSCLK	8.31000042	1	1	0.224958643	1506.783174	0	15.18967	13.42732	14.81388	0	0	0	15.41037	0	15.9381	0	0	14.81316	13.68804	14.80385	14.61415	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.0118	0	0	0	0	0	0	0
Q14585	ZN345_HUMAN	Zinc finger protein 345 (Zinc finger protein HZF10)	ZNF345	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0046872; GO:1990837	AFYSGSSLTQHQRIHTGEK	3.619999886	1	1	2.75E-12	2146.83531	13.46548	0	12.67646	0	0	12.25556	15.63313	12.34348	13.67373	0	0	0	0	14.09548	0	15.20346	0	0	0	0	0	0	0	0	0	0	0	16.129	0	0	0	0	0	0	0	0	0	0	0	0	15.38586	16.41847	0	15.7644	0	0	0	14.17254
Q14586	ZN267_HUMAN	Zinc finger protein 267 (Zinc finger protein HZF2)	ZNF267	Homo sapiens (Human)	multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0007275; GO:0046872	SSCLTQHRK	3.519999981	1	1	0.126271477	1116.54833	14.63114	14.243	0	17.89639	14.42277	13.58833	0	0	13.39071	0	0	0	12.09191	0	0	0	0	0	0	0	12.42701	0	14.82397	16.95187	15.8052	0	14.92558	14.64589	15.55313	14.90284	0	15.50993	14.4295	17.67476	0	0	0	16.04235	0	0	0	0	0	0	0	0	0	0
Q14587	ZN268_HUMAN	Zinc finger protein 268 (Zinc finger protein HZF3)	ZNF268	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0051726; GO:0071356; GO:0090073; GO:1901224	CGTHGK	5.619999886	1	1	0.171998299	660.3503205	12.2249	15.74134	0	12.56269	12.45127	16.36169	15.28593	15.82724	15.24796	16.39104	13.34527	14.92857	14.27325	0	15.93511	15.06015	12.74255	13.92522	17.30673	0	0	17.45622	0	0	15.56714	0	15.34936	14.84182	15.87089	0	0	0	16.39303	13.24543	0	14.39543	0	0	15.46633	16.76406	15.88427	0	0	16.93316	0	15.88715	0	16.29135
Q14590	ZN235_HUMAN	"Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog, Zfp-93) (Zinc finger protein HZF6)"	ZNF235 ZFP93 ZNF270	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	ELQTQR	9.470000267	1	1	0.214151633	773.6170306	0	14.98541	15.42966	15.27703	0	0	0	0	0	15.43555	15.53815	12.91165	17.68386	17.77975	17.67395	17.77793	16.65632	16.96401	17.97029	0	17.0526	17.59474	16.86678	16.97901	16.8843	0	15.82565	16.25884	0	0	0	17.78242	17.61589	16.88113	13.5118	15.48993	18.57563	18.48061	18.84384	16.54617	0	19.14142	15.81861	16.7997	17.79949	17.23421	15.95334	0
Q14593	ZN273_HUMAN	Zinc finger protein 273 (Zinc finger protein HZF9)	ZNF273	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	TPGLPGSLEMGPLTFR	8.800000191	0.054029968	0.054029968	0.102227101	1688.374931	0	0	0	0	16.16559	16.8138	15.71831	14.06708	16.10258	0	0	0	16.88658	0	0	15.15721	15.8289	16.82834	0	0	0	0	0	0	16.50853	17.91489	17.15066	0	0	0	16.18712	0	0	16.69885	16.79728	19.32046	0	17.18661	16.71348	0	0	0	0	17.79675	0	0	0	0
Q14596	NBR1_HUMAN	Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B)	NBR1 1A13B KIAA0049 M17S2 MIG19	Homo sapiens (Human)	macroautophagy [GO:0016236]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of bone mineralization [GO:0030500]; regulation of stress-activated MAPK cascade [GO:0032872]	autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; phagophore assembly site [GO:0000407]; receptor complex [GO:0043235]	autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; phagophore assembly site [GO:0000407]; receptor complex [GO:0043235]; mitogen-activated protein kinase binding [GO:0051019]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; macroautophagy [GO:0016236]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of bone mineralization [GO:0030500]; regulation of stress-activated MAPK cascade [GO:0032872]	mitogen-activated protein kinase binding [GO:0051019]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0000407; GO:0005654; GO:0005758; GO:0005764; GO:0005770; GO:0005776; GO:0005778; GO:0005829; GO:0008270; GO:0016020; GO:0016236; GO:0016604; GO:0030500; GO:0031430; GO:0032872; GO:0043130; GO:0043231; GO:0043235; GO:0045668; GO:0051019	QLNLRLLK	18.23999977	1	1	0.626359786	996.8547216	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.74061	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14624	ITIH4_HUMAN	"Inter-alpha-trypsin inhibitor heavy chain H4, ITI heavy chain H4, ITI-HC4, Inter-alpha-inhibitor heavy chain 4 (Inter-alpha-trypsin inhibitor family heavy chain-related protein, IHRP) (Plasma kallikrein sensitive glycoprotein 120, Gp120, PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4 ]"	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097]	endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562	ETLFSVMPGLKMTMDK	3.99000001	1	1	0.234451609	1842.828243	0	0	0	0	0	13.95664	16.31387	0	0	0	14.52346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.43064	0	0	0	0	0	0	0	0	0	0
Q14626	I11RA_HUMAN	"Interleukin-11 receptor subunit alpha, IL-11 receptor subunit alpha, IL-11R subunit alpha, IL-11R-alpha, IL-11RA [Cleaved into: Soluble interleukin-11 receptor subunit alpha, sIL-11R, sIL-11RA, sIL11RA ]"	IL11RA	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; developmental process [GO:0032502]; head development [GO:0060322]; positive regulation of cell population proliferation [GO:0008284]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; transmembrane signaling receptor activity [GO:0004888]; cytokine-mediated signaling pathway [GO:0019221]; developmental process [GO:0032502]; head development [GO:0060322]; positive regulation of cell population proliferation [GO:0008284]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004896; GO:0004921; GO:0005576; GO:0005886; GO:0005887; GO:0008284; GO:0009897; GO:0019221; GO:0019955; GO:0019970; GO:0032502; GO:0043235; GO:0060322	SSSCSGLSR	7.900000095	0.93107605	0.93107605	0.210443695	938.4119922	0	12.17434	0	0	15.56973	14.59619	16.17627	0	0	0	0	0	0	0	0	0	15.55619	0	0	15.10852	0	0	16.33924	0	0	0	0	15.55699	14.64776	15.86177	15.2058	12.38243	15.05352	0	15.47459	0	17.13052	0	0	0	17.77974	0	0	0	13.64587	0	0	0
Q14642	I5P1_HUMAN	"Inositol polyphosphate-5-phosphatase A, EC 3.1.3.56 (43 kDa inositol polyphosphate 5-phosphatase) (Type I inositol 1,4,5-trisphosphate 5-phosphatase, 5PTase)"	INPP5A 5PTASE	Homo sapiens (Human)	inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]	dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]"	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]"	GO:0004445; GO:0005886; GO:0016020; GO:0030425; GO:0042731; GO:0043647; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:1901215	DNNGTALLEFDK	3.720000029	1	1	0.060766357	1335.972327	13.17236	13.68898	0	12.29586	14.01287	11.41784	8.044075	12.28236	0	0	0	0	12.8934	0	13.96397	0	0	15.64528	0	0	0	0	15.96096	16.29745	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14643	ITPR1_HUMAN	"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1, IP3R 1, InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor, Type 1 InsP3 receptor)"	ITPR1 INSP3R1	Homo sapiens (Human)	calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]	calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]	"calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]"	"calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]"	GO:0000902; GO:0001666; GO:0005220; GO:0005509; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007165; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016021; GO:0016529; GO:0019855; GO:0019904; GO:0030658; GO:0030659; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032469; GO:0035091; GO:0042045; GO:0048471; GO:0050849; GO:0050882; GO:0051209; GO:0070059; GO:0070679; GO:0098685; GO:0098695	CQDMVMAELVNSGEDVLVFYNDR	2.160000086	0.626472712	0.626472712	0.023878495	2736.677381	14.21702	11.94331	0	12.37398	15.54248	13.83522	14.81971	14.49635	14.86753	0	14.36395	15.00676	0	0	0	0	0	0	0	0	0	0	0	15.01684	14.50229	0	15.25691	0	0	0	0	0	0	0	0	0	15.92193	0	0	16.15354	15.24725	0	0	0	0	0	0	0
Q14653	IRF3_HUMAN	"Interferon regulatory factor 3, IRF-3"	IRF3	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage apoptotic process [GO:0071888]; MDA-5 signaling pathway [GO:0039530]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; programmed necrotic cell death [GO:0097300]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon signaling pathway [GO:0060337]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage apoptotic process [GO:0071888]; MDA-5 signaling pathway [GO:0039530]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; programmed necrotic cell death [GO:0097300]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon signaling pathway [GO:0060337]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0006915; GO:0006974; GO:0019904; GO:0031663; GO:0032481; GO:0032727; GO:0032728; GO:0035666; GO:0039530; GO:0042802; GO:0042803; GO:0042981; GO:0043123; GO:0043565; GO:0045944; GO:0050727; GO:0051607; GO:0060337; GO:0060340; GO:0071360; GO:0071888; GO:0097300; GO:0098586; GO:1990837; GO:1990841	GVMSYVR	3.75999999	1	1	0.078802919	828.0325638	0	15.50332	13.96809	0	14.36428	15.98556	14.39189	0	13.68231	0	0	16.0717	0	14.81466	12.48519	0	16.67451	13.22877	15.09213	0	0	0	14.86424	0	0	15.92301	0	0	0	0	0	0	0	15.77082	0	0	0	0	17.18383	0	0	0	0	0	0	0	14.96928	0
Q14656	TM187_HUMAN	Transmembrane protein 187 (Protein ITBA1)	TMEM187 CXorf12 DXS9878E ITBA1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]	integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]		GO:0016021; GO:0030133	FHPSGGK	6.170000076	1	1	0.187756422	730.5505344	0	0	0	0	0	0	16.90054	0	0	0	0	17.46858	18.1406	0	0	0	0	0	0	0	16.4993	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	24.10687	0
Q14667	K0100_HUMAN	Protein KIAA0100 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein)	KIAA0100 BCOX1	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	LLIGLSVGDKNPGK	3.549999952	1	1	2.06E-12	1410.816665	14.8494	13.71649	14.62231	13.10838	0	4.732379	14.70699	0	14.4238	0	14.75671	0	15.37773	0	0	0	0	0	0	14.65371	0	0	0	0	14.39025	0	14.76834	14.8677	14.71251	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.76753	0	0	0	0
Q14671	PUM1_HUMAN	"Pumilio homolog 1, HsPUM, Pumilio-1"	PUM1 KIAA0099 PUMH1	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0003729; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0060964; GO:0061157; GO:1900246; GO:2000637	QHGEQLGGGGSGGGGYNNSKHR	1.139999986	1	1	0.250561064	2155.482042	0	0	0	0	0	0	14.32625	0	0	0	13.49704	13.52569	13.67827	0	0	12.79681	0	0	0	0	0	0	0	0	0	0	14.37947	0	0	0	0	0	0	0	0	0	14.43986	0	0	0	0	0	11.80218	0	0	0	0	0
Q14676	MDC1_HUMAN	Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1)	MDC1 KIAA0170 NFBD1	Homo sapiens (Human)	DNA repair [GO:0006281]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]	chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; FHA domain binding [GO:0070975]; protein C-terminus binding [GO:0008022]; DNA repair [GO:0006281]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]	FHA domain binding [GO:0070975]; protein C-terminus binding [GO:0008022]	GO:0005634; GO:0005654; GO:0005694; GO:0005925; GO:0006281; GO:0008022; GO:0016604; GO:0031573; GO:0070975	AIPGDQHPESPVHTEPMGIQGRGR	4.079999924	1	1	0.045133401	2581.271189	0	16.56976	15.11526	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14677	EPN4_HUMAN	"Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region, Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein, EpsinR)"	CLINT1 ENTH EPN4 EPNR KIAA0171	Homo sapiens (Human)	endocytosis [GO:0006897]	clathrin vesicle coat [GO:0030125]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	clathrin vesicle coat [GO:0030125]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897]	cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005654; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0030125; GO:0030276; GO:0043231; GO:0045296; GO:0048471	IGSTIDDTISK	1.25999999	1	1	0.012853074	1154.295203	15.58967	0	0	0	15.40071	0	0	14.29341	0	0	0	14.8024	0	0	0	0	0	0	0	0	15.16097	0	0	0	0	0	11.25254	0	10.53004	0	0	0	12.65352	0	13.92638	12.53186	0	0	0	0	0	0	0	0	0	0	0	0
Q14678	KANK1_HUMAN	KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein)	KANK1 ANKRD15 KANK KIAA0172	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023]	beta-catenin binding [GO:0008013]	GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393	DGNKDSNGAK	7.03000021	1	1	0.379030359	1005.521018	16.34314	16.69003	16.16658	15.55179	15.70838	16.33676	0	15.52183	0	15.18803	0	16.93355	16.3078	16.09009	16.05907	16.30911	16.78809	16.94409	16.50683	16.06664	0	16.47021	17.23429	0	16.12614	0	16.15134	0	16.36608	0	0	15.14716	0	16.90358	0	16.4546	17.66838	0	0	0	0	16.11156	0	0	0	0	0	0
Q14679	TTLL4_HUMAN	"Tubulin monoglutamylase TTLL4, EC 6.3.2.- (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4)"	TTLL4 KIAA0173	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]	9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]	9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222	SLASAISGK	21.21999931	1	1	0.381995733	833.5478292	19.54319	19.19823	0	19.90115	0	18.96174	0	0	0	0	0	0	0	0	0	20.73211	0	0	19.13504	17.03803	0	20.57516	0	0	19.84086	18.13102	19.06878	0	0	19.37195	0	19.81964	0	0	0	0	0	21.40161	0	0	0	0	0	0	0	17.41888	0	0
Q14681	KCTD2_HUMAN	BTB/POZ domain-containing protein KCTD2 (Potassium channel tetramerization domain-containing protein 2)	KCTD2 KIAA0176	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cullin family protein binding [GO:0097602]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]	cullin family protein binding [GO:0097602]; protein-containing complex binding [GO:0044877]	GO:0005737; GO:0031463; GO:0043161; GO:0044877; GO:0051260; GO:0097602	HGKLIITK	21.44000053	1	1	0.006140819	905.6993119	0	15.83546	0	14.4465	0	13.6875	0	0	15.92189	0	0	0	15.86033	0	0	15.09826	0	0	0	0	0	0	0	0	0	0	0	0	16.54143	15.98811	0	0	0	0	0	0	0	0	0	16.70489	0	0	0	15.82489	0	0	0	0
Q14683	SMC1A_HUMAN	"Structural maintenance of chromosomes protein 1A, SMC protein 1A, SMC-1-alpha, SMC-1A (Sb1.8)"	SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1	Homo sapiens (Human)	cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]	GO:0000070; GO:0000775; GO:0000776; GO:0000794; GO:0003677; GO:0003682; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0007062; GO:0007064; GO:0008278; GO:0009314; GO:0016363; GO:0016887; GO:0019827; GO:0030893; GO:0034089; GO:0034991; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0090307; GO:0097431	EKDSELNQK	5.300000191	1	1	1.83E-12	1091.013109	10.78944	17.59565	17.44936	0	15.40883	13.49815	0	0	0	0	16.11787	15.14736	16.87362	0	16.99994	16.23674	16.16745	0	0	0	17.68802	0	15.21282	0	0	18.49867	17.75787	18.0569	0	16.28587	0	0	17.96656	0	19.28693	17.02243	0	18.56423	19.65148	19.27687	0	14.9402	0	16.99109	0	0	0	0
Q14686	NCOA6_HUMAN	"Nuclear receptor coactivator 6 (Activating signal cointegrator 2, ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250, NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein, PPAR-interacting protein, PRIP) (Thyroid hormone receptor-binding protein)"	NCOA6 AIB3 KIAA0181 RAP250 TRBP	Homo sapiens (Human)	"brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; histone H3-K4 methylation [GO:0051568]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]"	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; histone H3-K4 methylation [GO:0051568]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]"	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006352; GO:0006974; GO:0007420; GO:0007507; GO:0009725; GO:0019899; GO:0030099; GO:0030331; GO:0030374; GO:0035097; GO:0043231; GO:0044666; GO:0045893; GO:0045944; GO:0046965; GO:0046966; GO:0051568	SLQGGPSR	4.079999924	1	1	0.240504236	800.8006689	0	15.58095	0	0	0	0	0	0	0	0	0	0	0	16.31977	0	0	0	0	17.19394	16.5922	0	16.21416	0	15.95972	0	0	0	0	0	16.80031	0	16.65619	0	17.10934	16.53201	16.03137	0	17.84435	16.67365	16.49319	16.91131	16.52702	16.2239	17.84695	15.78647	16.19618	17.71675	16.78353
Q14689	DIP2A_HUMAN	"Disco-interacting protein 2 homolog A, DIP2 homolog A, EC 6.2.1.1"	DIP2A C21orf106 DIP2 KIAA0184	Homo sapiens (Human)	acetyl-CoA biosynthetic process [GO:0006085]; dendritic spine morphogenesis [GO:0060997]; negative regulation of gene expression [GO:0010629]; positive regulation of peptidyl-lysine acetylation [GO:2000758]	cell surface [GO:0009986]; dendritic spine [GO:0043197]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; dendritic spine [GO:0043197]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; acetate-CoA ligase activity [GO:0003987]; acetyl-CoA biosynthetic process [GO:0006085]; dendritic spine morphogenesis [GO:0060997]; negative regulation of gene expression [GO:0010629]; positive regulation of peptidyl-lysine acetylation [GO:2000758]	acetate-CoA ligase activity [GO:0003987]	GO:0003987; GO:0005739; GO:0005886; GO:0006085; GO:0009986; GO:0010629; GO:0016020; GO:0043197; GO:0060997; GO:2000758	GLGAQTGVLR	3.099999905	0.199586928	0.199586928	0.247499555	971.1252802	15.07492	15.52985	0	13.94112	0	12.6138	15.20455	14.24518	17.4797	14.20141	14.92636	0	15.65653	14.54263	0	14.70333	0	16.19559	0	0	0	15.99215	0	16.09664	14.51336	15.20173	15.48117	14.44463	14.74749	15.99101	12.95698	16.17669	10.93209	15.53273	14.89496	14.6231	10.30316	14.87597	0	0	13.72043	16.1251	13.77098	14.33809	14.94925	0	0	14.51259
Q14690	RRP5_HUMAN	"Protein RRP5 homolog (NF-kappa-B-binding protein, NFBP) (Programmed cell death protein 11)"	PDCD11 KIAA0185	Homo sapiens (Human)	rRNA processing [GO:0006364]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0032040; GO:0051059	CVVSSLGITDR	3.880000114	1	1	0.108762012	1205.292693	9.562236	0	14.12538	0	0	13.46728	0	0	0	0	0	0	0	11.19983	0	14.09542	0	0	0	0	11.60018	0	0	0	0	11.18551	0	13.27218	10.03938	12.06357	13.26994	12.0353	6.009861	14.31749	12.71252	12.72404	13.55498	0	0	0	0	0	15.68581	14.78825	0	0	0	0
Q14692	BMS1_HUMAN	Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog)	BMS1 BMS1L KIAA0187	Homo sapiens (Human)	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0030686; GO:0034511	ILALLDALSTVHSQKMK	3.380000114	1	1	0.044973841	1880.677831	0	14.67542	13.03147	11.44325	14.33333	0	15.82811	0	0	13.045	14.79612	0	0	14.43194	0	0	0	0	11.94268	0	0	15.66009	0	0	0	12.31283	14.60632	0	0	0	0	0	0	0	15.54788	0	0	0	0	0	0	13.1657	14.17759	0	10.30806	0	0	0
Q14693	LPIN1_HUMAN	"Phosphatidate phosphatase LPIN1, EC 3.1.3.4 (Lipin-1)"	LPIN1 KIAA0188	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of myelination [GO:0031642]; negative regulation of phosphatidate phosphatase activity [GO:1903741]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; animal organ regeneration [GO:0031100]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of myelination [GO:0031642]; negative regulation of phosphatidate phosphatase activity [GO:1903741]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005783; GO:0005789; GO:0005829; GO:0006642; GO:0006654; GO:0007077; GO:0008195; GO:0009062; GO:0019432; GO:0031100; GO:0031642; GO:0031965; GO:0032869; GO:0044255; GO:0045740; GO:0045944; GO:0046473; GO:0120162; GO:1903741	SSSPHK	4.460000038	1	1	0.183020087	641.1400293	0	0	17.54236	0	0	16.13879	0	0	0	0	0	15.31502	0	14.89911	0	0	0	0	0	0	0	16.34127	17.43598	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.84034	16.72959	16.81834	16.68771	16.19316	15.44022	16.90973	16.46952	0	0	0
Q14696	MESD_HUMAN	LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development LRP chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61)	MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369	Homo sapiens (Human)	mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055]	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055]	identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]	GO:0001503; GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0007498; GO:0016055; GO:0034394; GO:0042802; GO:0050750; GO:1904395	RPSAPVDFSK	1.429999948	1	1	0.199867983	1103.23203	0	0	0	0	0	0	0	0	0	0	0	16.34738	0	13.51	0	16.4212	0	0	0	0	0	0	0	0	0	0	14.96122	0	0	0	0	0	0	0	0	15.11081	0	0	0	0	14.0267	15.42813	16.89404	0	0	0	0	0
Q14703	MBTP1_HUMAN	"Membrane-bound transcription factor site-1 protease, EC 3.4.21.112 (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1, SKI-1)"	MBTPS1 KIAA0091 S1P SKI1	Homo sapiens (Human)	ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]	serine-type endopeptidase activity [GO:0004252]	GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0060627	LPIKVK	9.659999847	0.162881121	0.162881121	0.154576993	693.3923742	14.32559	14.97188	13.73491	12.14208	14.36776	14.02524	15.55909	0	0	0	0	0	14.02123	16.84674	8.724483	0	0	0	0	0	0	16.47601	14.94918	0	15.59355	15.47978	0	15.06568	14.72941	0	0	0	0	0	16.84092	0	0	15.09318	0	0	0	0	0	0	16.69666	0	0	14.9362
Q14721	KCNB1_HUMAN	"Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1, DRK1, h-DRK1) (Voltage-gated potassium channel subunit Kv2.1)"	KCNB1	Homo sapiens (Human)	action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]	axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]	axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]	delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]	GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016021; GO:0016328; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0097623; GO:0098900; GO:1900454; GO:2000671	EQGSPEKAR	3.089999914	1	1	0.317056648	1001.276101	17.85933	0	18.19378	0	0	0	0	0	0	18.27516	0	0	0	16.68087	0	0	0	0	0	17.72647	0	0	0	0	0	17.8708	16.96231	16.30172	0	0	0	0	0	18.8406	0	0	0	0	0	0	0	0	0	15.48708	0	0	0	16.34439
Q14722	KCAB1_HUMAN	"Voltage-gated potassium channel subunit beta-1, EC 1.1.1.- (K(+) channel subunit beta-1) (Kv-beta-1)"	KCNAB1 KCNA1B	Homo sapiens (Human)	negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion transport [GO:0006813]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion transport [GO:0006813]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379]	aldo-keto reductase (NADP) activity [GO:0004033]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]	GO:0004033; GO:0005249; GO:0005829; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0019904; GO:0031234; GO:0034705; GO:0044224; GO:0044325; GO:0070402; GO:1901379; GO:1902259; GO:1902260; GO:1903817	KASENAK	11.97000027	0.246909708	0.246909708	0.130161602	747.0304686	0	15.67267	14.06575	14.77951	10.90378	15.14306	10.80798	14.00279	0	13.33924	15.1065	16.6652	14.68567	14.43438	15.92083	0	17.21465	17.22884	9.588581	14.69865	11.16532	0	14.26784	14.24939	11.53059	0	10.8138	15.28335	14.2214	15.7445	17.66318	15.61177	16.24218	14.71301	15.01966	14.48473	17.22845	16.67844	0	14.687	0	15.49229	16.81559	0	13.72697	16.2247	18.28115	12.15821
Q14738	2A5D_HUMAN	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta)	PPP2R5D	Homo sapiens (Human)	nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]	phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0019888; GO:0035307; GO:0072542	VMEPLFR	13.25	1	1	0.090750935	907.0790228	15.61603	14.48673	16.38467	14.45759	13.63327	0	14.92595	0	12.54401	16.17097	15.7327	13.16419	14.48879	14.31422	0	0	0	0	0	0	0	0	15.21566	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.30014	0	0	0	0	0	0	0
Q14739	LBR_HUMAN	"Delta(14)-sterol reductase LBR, Delta-14-SR, EC 1.3.1.70 (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase, C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase)"	LBR	Homo sapiens (Human)	cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; RNA binding [GO:0003723]; cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]"	"chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; RNA binding [GO:0003723]"	GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005639; GO:0005737; GO:0005789; GO:0006695; GO:0016020; GO:0016021; GO:0016126; GO:0016627; GO:0030223; GO:0031965; GO:0050613; GO:0070087; GO:0070402	NDAPHK	2.160000086	0.474781573	0.474781573	0.202350679	682.0323739	0	0	0	14.18	0	0	15.03043	0	0	0	0	0	0	16.87114	0	0	15.72453	0	0	0	15.08358	15.78822	17.77477	16.83683	0	0	16.98688	0	18.34167	0	17.38756	13.59391	0	15.4345	17.17472	16.74919	19.22736	0	16.28894	0	16.25808	0	16.16675	0	15.81649	0	0	0
Q14766	LTBP1_HUMAN	"Latent-transforming growth factor beta-binding protein 1, LTBP-1 (Transforming growth factor beta-1-binding protein 1, TGF-beta1-BP-1)"	LTBP1	Homo sapiens (Human)	regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; protein-containing complex [GO:0032991]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583]	calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]	GO:0001527; GO:0005024; GO:0005509; GO:0005576; GO:0005788; GO:0031012; GO:0032991; GO:0035583; GO:0050431; GO:0050436; GO:0062023; GO:1901388	NTEGSFR	13.28999996	0.710636854	0.710636854	0.278242431	810.3548051	15.98645	15.74847	12.98032	15.64601	0	16.08164	15.27962	15.34482	15.86174	17.15494	0	15.78204	15.31556	15.10095	16.67105	15.97429	15.55247	15.70163	16.78178	16.85804	16.67465	16.4668	0	16.39569	17.20451	16.45391	16.38932	15.67127	15.07403	16.34493	16.2816	16.48708	16.6843	16.27066	16.5535	15.97494	17.21745	17.41966	16.64419	16.68086	0	17.64963	17.75237	16.27197	16.54073	15.91797	16.59138	16.85714
Q14781	CBX2_HUMAN	Chromobox protein homolog 2	CBX2	Homo sapiens (Human)	cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; development of primary sexual characteristics [GO:0045137]; negative regulation of transcription by RNA polymerase II [GO:0000122]	euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]	euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; development of primary sexual characteristics [GO:0045137]; negative regulation of transcription by RNA polymerase II [GO:0000122]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]	GO:0000122; GO:0000791; GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0030154; GO:0031519; GO:0035064; GO:0035102; GO:0045137	APSGGAVEQK	2.940000057	1	1	0.271978318	944.1137932	0	14.81321	13.6257	14.02611	0	16.58149	0	14.70752	0	14.57137	15.55124	14.24197	10.59936	0	0	0	15.32414	15.19857	0	0	0	0	0	0	0	0	16.15649	0	13.99698	0	14.90602	0	15.22204	0	14.56214	15.872	0	14.96649	0	0	16.01667	0	0	16.56583	0	0	13.72191	0
Q14789	GOGB1_HUMAN	"Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein, GCP372) (Giantin) (Macrogolgin)"	GOLGB1	Homo sapiens (Human)	"chondrocyte proliferation [GO:0035988]; Golgi organization [GO:0007030]; protein localization to pericentriolar material [GO:1905793]; regulation of transcription, DNA-templated [GO:0006355]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; chondrocyte proliferation [GO:0035988]; Golgi organization [GO:0007030]; protein localization to pericentriolar material [GO:1905793]; regulation of transcription, DNA-templated [GO:0006355]"	RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0000139; GO:0003723; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005829; GO:0006355; GO:0007030; GO:0016020; GO:0016021; GO:0035988; GO:0043565; GO:1905793	DQLIQEAAAENNKLK	3.200000048	1	1	2.46E-13	1684.013964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q147U1	ZN846_HUMAN	Zinc finger protein 846	ZNF846	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	AFSNSSHLIGHGR	11.43999958	1	1	0.165184587	1382.094682	15.03008	14.91786	10.01925	0	0	14.08214	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.06144	0	0	0	0	15.23977	0	0	0	0	0	0
Q14807	KIF22_HUMAN	Kinesin-like protein KIF22 (Kinesin-like DNA-binding protein) (Kinesin-like protein 4)	KIF22 KID KNSL4	Homo sapiens (Human)	DNA repair [GO:0006281]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; DNA repair [GO:0006281]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; sister chromatid cohesion [GO:0007062]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0006281; GO:0007018; GO:0007062; GO:0007080; GO:0008017; GO:0016607; GO:0016887; GO:0051310; GO:0072686	EGKLYLIDLAGSEDNR	11.36999989	1	1	0.05422227	1792.791131	15.63101	0	0	0	15.91068	0	12.53988	0	15.5941	11.36332	15.738	0	14.03949	0	0	0	15.27058	15.91978	0	0	0	0	0	15.73705	14.67525	0	15.55457	14.11833	0	0	0	0	13.9789	0	0	0	0	14.61353	14.91596	0	0	0	0	0	0	0	0	0
Q14831	GRM7_HUMAN	"Metabotropic glutamate receptor 7, mGluR7"	GRM7 GPRC1G MGLUR7	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; axon development [GO:0061564]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glycosylation [GO:0070085]; negative regulation of glutamate secretion [GO:0014050]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]"	asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]	"asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; axon development [GO:0061564]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glycosylation [GO:0070085]; negative regulation of glutamate secretion [GO:0014050]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]"	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]	GO:0001640; GO:0001642; GO:0005509; GO:0005886; GO:0005887; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0008066; GO:0010855; GO:0014050; GO:0016021; GO:0016595; GO:0030165; GO:0030424; GO:0030425; GO:0032279; GO:0043198; GO:0043235; GO:0045211; GO:0046983; GO:0048786; GO:0051966; GO:0061564; GO:0070085; GO:0070905	AVVTAATMSSR	8.949999809	1	1	0	1093.62543	0	15.29657	15.00567	0	0	0	16.28946	0	0	0	0	0	0	0	0	0	15.61222	0	16.48389	16.16774	0	0	0	0	0	16.79426	0	0	16.50274	16.04353	0	17.41704	0	0	0	0	0	0	18.76499	0	0	0	0	0	0	0	0	0
Q14832	GRM3_HUMAN	"Metabotropic glutamate receptor 3, mGluR3"	GRM3 GPRC1C MGLUR3	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]"	astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	"astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]"	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]	GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0043197; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099055; GO:0099056	INFTAPFNPNK	11.67000008	1	1	0.309225177	1263.841493	14.30679	15.10916	0	0	0	16.06344	0	0	0	0	0	0	0	0	16.08396	0	0	0	0	16.65299	16.51218	0	16.79483	16.44299	17.03827	14.42134	0	14.48936	13.31554	14.62164	12.51629	16.245	16.1695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14839	CHD4_HUMAN	"Chromodomain-helicase-DNA-binding protein 4, CHD-4, EC 3.6.4.12 (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)"	CHD4	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]"	"centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]"	"centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone deacetylase binding [GO:0042826]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone deacetylase binding [GO:0042826]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]	GO:0000781; GO:0000785; GO:0001221; GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0006338; GO:0008270; GO:0010629; GO:0016020; GO:0016575; GO:0016581; GO:0016887; GO:0032991; GO:0042659; GO:0042826; GO:0045892; GO:0045893; GO:0061629; GO:0090575; GO:0140658; GO:2000736	NDMDEPPSGDFGGDEEKSR	5.96999979	0.683359802	0.683359802	0.255277977	2082.679306	0	15.12619	0	16.03242	16.52992	14.5585	15.49879	0	0	15.08426	0	0	12.69519	0	0	13.49154	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.09709	0	0	0	14.96378	0	0	16.44263	12.70438	0	0	0	15.15559	0	0	0
Q14865	ARI5B_HUMAN	"AT-rich interactive domain-containing protein 5B, ARID domain-containing protein 5B (MRF1-like protein) (Modulator recognition factor 2, MRF-2)"	ARID5B DESRT MRF2	Homo sapiens (Human)	"adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]"	DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000976; GO:0001822; GO:0001889; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006807; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0045892; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0051091; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830	TINDIFK	4.019999981	1	1	0.171904015	850.2241368	15.34776	0	0	0	0	17.65718	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14894	CRYM_HUMAN	"Ketimine reductase mu-crystallin, EC 1.5.1.25 (NADP-regulated thyroid-hormone-binding protein)"	CRYM THBP	Homo sapiens (Human)	lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]	hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0006554; GO:0007605; GO:0042403; GO:0042562; GO:0042803; GO:0047127; GO:0050661; GO:0070062; GO:0070324; GO:0070327	LVTFYEDR	7.769999981	1	1	0.091233095	1043.34461	14.15949	0	13.70214	13.26294	14.47467	0	14.85323	15.07278	14.99733	15.6212	16.62412	16.0492	0	0	0	15.39721	0	11.15787	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14896	MYPC3_HUMAN	"Myosin-binding protein C, cardiac-type, Cardiac MyBP-C (C-protein, cardiac muscle isoform)"	MYBPC3	Homo sapiens (Human)	cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; heart morphogenesis [GO:0003007]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of muscle filament sliding [GO:0032971]; regulation of striated muscle contraction [GO:0006942]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	A band [GO:0031672]; C zone [GO:0014705]; cardiac myofibril [GO:0097512]; cytosol [GO:0005829]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]	A band [GO:0031672]; C zone [GO:0014705]; cardiac myofibril [GO:0097512]; cytosol [GO:0005829]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin binding [GO:0003779]; ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; heart morphogenesis [GO:0003007]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of muscle filament sliding [GO:0032971]; regulation of striated muscle contraction [GO:0006942]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	actin binding [GO:0003779]; ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]	GO:0001671; GO:0003007; GO:0003779; GO:0005829; GO:0005863; GO:0006942; GO:0007155; GO:0008307; GO:0014705; GO:0017022; GO:0030017; GO:0031432; GO:0031672; GO:0032036; GO:0032781; GO:0032971; GO:0042802; GO:0046872; GO:0055010; GO:0060048; GO:0097512	IPDTIVVVAGNK	5.639999866	1	1	0.157888221	1230.426786	0	8.841285	0	13.50558	10.4974	12.77671	14.92197	0	0	0	0	13.44125	12.9099	0	0	0	0	0	0	0	0	15.2543	0	0	0	14.8203	0	0	0	0	0	0	0	0	0	0	14.41148	0	14.30132	0	0	0	14.11991	0	0	14.58366	0	0
Q14914	PTGR1_HUMAN	"Prostaglandin reductase 1, PRG-1 (15-oxoprostaglandin 13-reductase, EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein, D3T-inducible gene 1 protein, DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase, EC 1.3.1.74)"	PTGR1 LTB4DH	Homo sapiens (Human)	leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]; response to antineoplastic agent [GO:0097327]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]; response to antineoplastic agent [GO:0097327]	13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]	GO:0005737; GO:0006691; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0070062; GO:0097257; GO:0097327; GO:2001302	GTIVLASPGWTTHSISDGKDLEK	3.75999999	1	1	1.83E-12	2412.881703	14.52804	0	11.55705	0	14.42752	0	0	0	0	0	0	13.16718	0	0	0	0	0	0	15.15034	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.75833	0	0	0	0	0	12.48128	0
Q14929	ZN169_HUMAN	Zinc finger protein 169	ZNF169	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	ASLSIHQRK	8.850000381	0.62375474	0.62375474	0.143593222	1040.095515	16.31304	16.58177	13.24345	0	15.62728	15.26221	17.15672	16.24673	17.31656	0	14.31059	0	15.0335	16.3716	17.25168	15.93053	0	17.15638	16.93301	0	0	17.54851	0	14.17452	16.89677	18.05593	13.63559	0	16.75731	14.72638	16.95266	18.47309	17.47558	10.71028	12.54143	0	15.27602	17.61441	17.67713	18.65491	12.95338	17.18226	18.37235	17.76034	17.13359	15.61584	0	18.7588
Q14934	NFAC4_HUMAN	"Nuclear factor of activated T-cells, cytoplasmic 4, NF-ATc4, NFATc4 (T-cell transcription factor NFAT3, NF-AT3)"	NFATC4 NFAT3	Homo sapiens (Human)	brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular respiration [GO:0045333]; cellular response to lithium ion [GO:0071285]; cellular response to UV [GO:0034644]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; muscle cell development [GO:0055001]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synapse maturation [GO:2000297]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]; smooth muscle cell differentiation [GO:0051145]	chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular respiration [GO:0045333]; cellular response to lithium ion [GO:0071285]; cellular response to UV [GO:0034644]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; muscle cell development [GO:0055001]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synapse maturation [GO:2000297]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]; smooth muscle cell differentiation [GO:0051145]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001569; GO:0005634; GO:0005667; GO:0005829; GO:0006357; GO:0006954; GO:0007507; GO:0007616; GO:0008630; GO:0016607; GO:0030178; GO:0031547; GO:0032091; GO:0032760; GO:0033173; GO:0034644; GO:0035562; GO:0042975; GO:0043524; GO:0045333; GO:0045944; GO:0050774; GO:0051145; GO:0055001; GO:0060291; GO:0071285; GO:1902894; GO:1990837; GO:2000297; GO:2001235	FGLGSPLPSPR	5.210000038	1	1	0.218929949	1125.930514	0	0	0	14.63515	0	0	0	0	0	13.29846	0	0	0	0	13.86624	0	0	0	0	0	0	17.55266	0	0	15.37726	11.6803	15.84748	0	17.09707	17.40811	0	0	16.47137	0	0	0	0	0	0	15.75158	0	0	0	0	0	15.55237	11.86788	14.20479
Q14940	SL9A5_HUMAN	"Sodium/hydrogen exchanger 5 (Na(+)/H(+) exchanger 5, NHE-5) (Solute carrier family 9 member 5)"	SLC9A5 NHE5	Homo sapiens (Human)	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719	SSFAFPPSLAK	4.260000229	1	1	0.305830705	1151.677096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.10015	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38988	0	0	0	0	0
Q14943	KI3S1_HUMAN	"Killer cell immunoglobulin-like receptor 3DS1 (Natural killer-associated transcript 10, NKAT-10)"	KIR3DS1 NKAT10	Homo sapiens (Human)	immune response [GO:0006955]; natural killer cell activation [GO:0030101]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; MHC class I receptor activity [GO:0032393]; immune response [GO:0006955]; natural killer cell activation [GO:0030101]	MHC class I receptor activity [GO:0032393]	GO:0005886; GO:0005887; GO:0006955; GO:0030101; GO:0032393	GSHPHSPTGWSAPSNPMVIMVTGNHR	5.079999924	1	1	0.151532198	2768.704206	14.06868	0	0	14.79145	14.2131	13.72653	15.45084	0	15.45194	0	14.25276	0	14.14826	0	0	14.71264	14.20044	14.35327	0	0	0	14.17044	16.43667	14.39825	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14952	KI2S3_HUMAN	"Killer cell immunoglobulin-like receptor 2DS3 (Natural killer-associated transcript 7, NKAT-7)"	KIR2DS3 NKAT7	Homo sapiens (Human)	cellular defense response [GO:0006968]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cellular defense response [GO:0006968]		GO:0005886; GO:0005887; GO:0006968	KNASVMDQGPAGNR	5.420000076	1	1	4.59E-13	1462.635086	0	16.19872	0	0	15.49495	0	14.73201	0	0	0	0	14.54173	0	12.474	15.27813	0	0	14.33522	0	0	0	0	0	0	0	0	0	12.93589	0	0	0	15.97949	15.83217	16.20397	15.22233	0	16.01123	14.9173	0	16.58694	16.2093	0	0	0	0	0	0	0
Q14953	KI2S5_HUMAN	"Killer cell immunoglobulin-like receptor 2DS5 (CD158 antigen-like family member G) (Natural killer-associated transcript 9, NKAT-9) (CD antigen CD158g)"	KIR2DS5 CD158G NKAT9	Homo sapiens (Human)	immune response [GO:0006955]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; HLA-C specific inhibitory MHC class I receptor activity [GO:0030110]; immune response [GO:0006955]	HLA-C specific inhibitory MHC class I receptor activity [GO:0030110]	GO:0005886; GO:0005887; GO:0006955; GO:0016021; GO:0030110	LPAGPK	4.119999886	0.000918195	0.000918195	0.18123889	583.4665652	15.73763	16.62717	16.00279	16.6332	0	0	16.27306	0	16.21581	0	16.28035	0	0	17.39965	17.09943	0	17.5454	16.67412	15.92554	16.90707	0	17.96096	17.98787	17.95573	16.76998	15.98632	18.7638	16.27577	16.79415	17.40907	18.17356	18.01448	17.23783	17.24426	16.28034	17.37097	17.76127	17.13675	17.3829	15.72265	17.26126	17.15247	17.18768	17.44345	16.89866	16.44842	15.88713	16.42808
Q14966	ZN638_HUMAN	"Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1, CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein)"	ZNF638 NP220 ZFML	Homo sapiens (Human)	RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; RNA splicing [GO:0008380]	double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0043231	AVSLQRK	1.570000052	0.227253616	0.227253616	0.148217983	801.7501186	0	0	0	0	0	16.90235	11.72666	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42338	0	0	0	0	0	0	0	0	0	0	0	16.46721	0	0	0	0	0	0	0	0	0	17.14123	0	0	14.06573
Q14974	IMB1_HUMAN	"Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit, PTAC97)"	KPNB1 NTF97	Homo sapiens (Human)	astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404]	enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0010494; GO:0016020; GO:0019899; GO:0019904; GO:0030953; GO:0031267; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0042564; GO:0045184; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0090307; GO:1904813	YMEAFKPFLGIGLK	4.039999962	1	1	0.777174187	1630.770148	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.11484	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q14980	NUMA1_HUMAN	"Nuclear mitotic apparatus protein 1 (Nuclear matrix protein-22, NMP-22) (Nuclear mitotic apparatus protein, NuMA protein) (SP-H antigen)"	NUMA1 NMP22 NUMA	Homo sapiens (Human)	anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]	disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]	GO:0000132; GO:0000139; GO:0000922; GO:0001578; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005938; GO:0006997; GO:0007059; GO:0008017; GO:0008022; GO:0015631; GO:0016328; GO:0016363; GO:0019897; GO:0019904; GO:0030425; GO:0030513; GO:0030953; GO:0031116; GO:0031616; GO:0032388; GO:0032991; GO:0035091; GO:0035371; GO:0036449; GO:0043025; GO:0044877; GO:0045618; GO:0051010; GO:0051011; GO:0051301; GO:0051321; GO:0051798; GO:0051984; GO:0055028; GO:0055048; GO:0060236; GO:0061673; GO:0070062; GO:0070840; GO:0072686; GO:0090235; GO:0097427; GO:0097431; GO:0097575; GO:0097718; GO:0099738; GO:1902365; GO:1902846; GO:1904778; GO:1905720; GO:1905820; GO:1905832; GO:1990023	ELEVMTAKYEGAK	4.800000191	1	1	0.105936785	1484.677272	14.16709	15.41251	14.32762	0	0	0	0	14.73972	0	0	0	0	9.907016	0	0	13.65701	12.22664	0	0	0	0	0	0	0	0	10.65304	0	14.84862	10.57791	0	0	0	0	14.05326	15.03605	0	0	0	0	14.06424	0	0	14.87515	11.31882	0	0	0	15.96167
Q14995	NR1D2_HUMAN	"Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor, RVR) (Rev-erb-beta) (V-erbA-related protein 1-related, EAR-1R)"	NR1D2	Homo sapiens (Human)	"cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014	IDCSMK	3.140000105	0.264877439	0.264877439	0.203928263	752.1712864	0	16.31732	16.04565	0	14.85114	14.29956	0	0	13.95462	16.6526	0	0	0	0	0	13.35209	0	0	0	0	0	0	0	15.50436	0	0	0	0	0	0	0	0	0	0	0	0	0	15.38282	0	0	0	14.92011	0	0	0	0	0	15.23984
Q14997	PSME4_HUMAN	Proteasome activator complex subunit 4 (Proteasome activator PA200)	PSME4 KIAA0077	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]	"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]	GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035093; GO:0070577; GO:0070628; GO:1990111	MVADMCR	1.24000001	1	1	0.290897516	882.8642407	18.24619	0	0	0	17.26315	16.9277	0	0	17.00837	17.06133	0	0	0	0	17.18524	0	0	0	18.02528	17.36147	15.71492	0	0	0	0	0	0	0	0	0	17.03063	0	0	0	17.9076	0	17.78332	0	18.23427	0	0	0	16.41482	0	0	0	0	0
Q14999	CUL7_HUMAN	"Cullin-7, CUL-7"	CUL7 KIAA0076	Homo sapiens (Human)	epithelial to mesenchymal transition [GO:0001837]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; placenta development [GO:0001890]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]; vasculogenesis [GO:0001570]	3M complex [GO:1990393]; anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	3M complex [GO:1990393]; anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ubiquitin protein ligase binding [GO:0031625]; epithelial to mesenchymal transition [GO:0001837]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; placenta development [GO:0001890]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]; vasculogenesis [GO:0001570]	ubiquitin protein ligase binding [GO:0031625]	GO:0000226; GO:0000281; GO:0001570; GO:0001837; GO:0001890; GO:0005680; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0006508; GO:0006511; GO:0007030; GO:0007088; GO:0016567; GO:0031461; GO:0031467; GO:0031625; GO:0048471; GO:0050775; GO:1990393	DTLQPGMR	19.27000046	0.199781731	0.199781731	0.043469474	929.6097653	0	16.59456	17.13485	18.0704	13.68655	15.77858	10.56915	0	15.80867	0	18.32312	0	0	0	16.90776	15.80204	17.51309	17.56793	17.45918	16.10512	17.68625	17.41698	17.09656	15.27414	18.97645	17.01061	0	13.36777	17.12066	15.48401	16.50931	17.55974	16.39444	13.5839	16.40368	0	18.0196	0	17.96211	17.81829	16.89639	16.64029	17.5249	14.45867	16.5283	16.70791	16.09422	0
Q149M9	NWD1_HUMAN	NACHT domain- and WD repeat-containing protein 1	NWD1	Homo sapiens (Human)	negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]	cytosol [GO:0005829]; nucleolus [GO:0005730]	cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]	ATP binding [GO:0005524]	GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088	GKPCR	11.97000027	0.639899373	0.639899373	0.208675277	617.4503313	14.21529	15.15513	16.56778	0	15.1257	14.98447	16.30409	14.81361	14.77623	16.30144	16.48738	0	0	15.98647	14.74179	0	15.24684	0	0	0	0	16.26935	0	0	16.70627	15.56354	15.90187	0	15.8887	0	16.4399	15.99278	16.18049	16.48021	15.67514	0	16.12759	0	0	14.66421	0	13.83982	16.08134	15.9539	0	16.43968	15.55452	16.39466
Q149N8	SHPRH_HUMAN	"E3 ubiquitin-protein ligase SHPRH, EC 2.3.2.27, EC 3.6.4.- (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)"	SHPRH KIAA2023	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0016787; GO:0031625; GO:0046872; GO:0061630; GO:0140658	EEVAHR	1.840000033	1	1	0.264131739	739.2913875	0	16.22335	15.16066	0	15.79072	0	0	0	16.14713	0	0	0	16.58406	0	0	0	14.99778	0	0	0	0	0	16.77242	16.36031	0	0	0	15.41723	16.25861	15.30261	0	15.38029	16.8608	0	0	16.03849	17.10749	0	0	0	0	0	0	0	0	0	14.3928	0
Q14BN4	SLMAP_HUMAN	"Sarcolemmal membrane-associated protein, Sarcolemmal-associated protein"	SLMAP KIAA1601 SLAP UNQ1847/PRO3577	Homo sapiens (Human)	muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]	integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]		GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150	FEMTEQEK	6.920000076	1	1	0.079243465	1059.509619	15.08693	15.64094	14.03749	0	15.69886	0	0	0	15.19299	0	17.00781	0	0	15.03551	0	0	0	13.37817	0	0	14.60002	0	0	0	0	15.56875	0	14.21139	0	0	15.00233	11.45916	0	15.11606	12.63467	0	0	0	0	0	13.90612	0	0	0	16.71194	0	0	0
Q14C86	GAPD1_HUMAN	GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6)	GAPVD1 GAPEX5 KIAA1521 RAP6	Homo sapiens (Human)	endocytosis [GO:0006897]; regulation of GTPase activity [GO:0043087]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; regulation of GTPase activity [GO:0043087]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165]	cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0030139; GO:0031267; GO:0032794; GO:0043087; GO:0045296; GO:0051223	LPNFGSHVLTPAEMEAFKQR	4.059999943	1	1	0.042527475	2287.922811	12.42719	0	14.37346	0	0	0	0	14.65376	0	0	15.60012	12.54023	15.80833	15.15048	14.42267	15.25431	0	14.31174	16.11785	15.95291	0	0	0	14.75398	0	14.66609	15.2686	0	0	13.42205	0	0	15.65667	0	15.82927	14.41862	15.49316	16.28946	17.01224	0	0	0	0	0	0	12.56137	0	0
Q14C87	T132D_HUMAN	"Transmembrane protein 132D (Mature oligodendrocytes transmembrane protein, Mature OL transmembrane protein)"	TMEM132D HBE120 KIAA1944 MOLT	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	ERTDYTGK	9.649999619	0.672527969	0.672527969	1.14E-13	969.6254875	13.99892	0	14.16686	0	0	15.29936	0	14.33205	15.25326	0	14.50692	15.64787	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.55443	0	13.41757	11.95781	13.47846	13.61131	15.27238	12.40115	13.77552	16.54903	13.98656	0	16.09073	16.6116	14.85579	0	0	0	0	0	14.58823
Q14CM0	FRPD4_HUMAN	"FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis, Preso)"	FRMPD4 KIAA0316 PDZD10 PDZK10	Homo sapiens (Human)	positive regulation of synapse structural plasticity [GO:0051835]	cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; protein-containing complex [GO:0032991]	"cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; protein-containing complex [GO:0032991]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of synapse structural plasticity [GO:0051835]"	"phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0005546; GO:0005856; GO:0032991; GO:0043197; GO:0051835	LHMGSVAYSCTSK	4.369999886	1	1	0.448674285	1457.5739	17.18623	0	18.32444	0	0	18.73462	0	0	17.99747	0	0	0	0	0	18.7218	0	0	0	0	17.66811	0	0	0	0	0	19.13451	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.73732	0	0	0	0	0
Q14CN2	CLCA4_HUMAN	"Calcium-activated chloride channel regulator 4, EC 3.4.-.- (Calcium-activated chloride channel family member 4, hCLCA4) (Calcium-activated chloride channel protein 2, CaCC-2, hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form ]"	CLCA4 CaCC2 UNQ562/PRO1124	Homo sapiens (Human)	chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0006821; GO:0016324; GO:0034220; GO:0046872	AHGGANTAR	1.299999952	1	1	0.078388387	855.3939511	0	0	0	0	0	0	0	15.04791	0	0	0	0	12.7692	0	0	0	0	15.69919	0	0	0	0	0	0	0	0	0	0	16.41487	13.43689	0	0	16.31292	0	16.69368	0	0	0	0	0	0	0	0	0	0	15.90067	0	0
Q14CN4	K2C72_HUMAN	"Keratin, type II cytoskeletal 72 (Cytokeratin-72, CK-72) (Keratin-72, K72) (Type II inner root sheath-specific keratin-K6irs2) (Type-II keratin Kb35)"	KRT72 K6IRS2 KB35 KRT6 KRT6IRS2	Homo sapiens (Human)		cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]		GO:0005829; GO:0045095; GO:0070062	SLALSAAARR	10.68000031	0.518424809	0.518424809	0.231269084	1013.257829	16.19272	0	10.95972	16.84034	15.88822	0	16.21534	11.5992	13.32967	16.76761	10.70963	14.81176	14.79982	15.52644	14.82603	9.825819	11.76138	13.87014	16.25753	15.15756	0	14.03605	15.34707	11.10279	0	16.82955	16.05318	0	15.36674	14.76112	0	15.43579	0	0	16.62903	0	0	17.18499	0	0	0	16.65884	0	17.4028	0	15.78715	0	16.09995
Q14CW9	AT7L3_HUMAN	Ataxin-7-like protein 3 (SAGA-associated factor 11 homolog)	ATXN7L3	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone monoubiquitination [GO:0010390]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]"	DUBm complex [GO:0071819]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]	"DUBm complex [GO:0071819]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone monoubiquitination [GO:0010390]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0000124; GO:0003713; GO:0005634; GO:0006282; GO:0006325; GO:0006357; GO:0008270; GO:0010390; GO:0016578; GO:0030374; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0071819	KMEEMSLSGLDNSK	4.409999847	1	1	0.197975466	1600.868444	0	0	14.48141	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.34356	0	14.44003	14.61363	16.39353	15.96798	0	0	13.97003	0	14.48546	0	14.0716	16.07579	0	12.7389	0	15.0596	0	0	0
Q14CX7	NAA25_HUMAN	"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20, NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)"	NAA25 C12orf30 MDM20 NAP1	Homo sapiens (Human)	N-terminal peptidyl-methionine acetylation [GO:0017196]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196]		GO:0005737; GO:0005794; GO:0005829; GO:0017196; GO:0031416	DLNVFFSWDPK	5.150000095	1	1	0.56624277	1367.285828	0	0	0	0	0	0	16.52748	17.19823	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.33559	18.21937	0	0	18.80378	0	0	0	0	0	0	0	0	0	0	0	17.53889	0
Q14CZ7	FAKD3_HUMAN	"FAST kinase domain-containing protein 3, mitochondrial"	FASTKD3	Homo sapiens (Human)	mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial RNA processing [GO:0000963]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial RNA processing [GO:0000963]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]	RNA binding [GO:0003723]	GO:0000963; GO:0003723; GO:0005654; GO:0005739; GO:0005759; GO:0033617; GO:0035770; GO:0044528; GO:0070131	LFSQNTVHWLQE	3.160000086	0.339035213	0.339035213	0.012569748	1500.941934	15.24825	16.16336	14.83029	17.07038	9.775543	15.55696	0	11.13361	0	16.40034	13.9156	13.59685	0	14.79917	0	13.96418	17.53338	0	0	12.47594	0	11.98009	17.88556	13.56854	12.30716	15.61201	0	0	0	13.6501	18.07808	12.51605	12.7801	15.50339	15.90601	14.89381	0	16.08477	0	16.84957	0	13.50059	0	0	17.20936	16.65116	14.63973	0
Q14D04	MELT_HUMAN	Ventricular zone-expressed PH domain-containing protein homolog 1 (Protein melted)	VEPH1 KIAA1692 VEPH	Homo sapiens (Human)	negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966]	phosphatidylinositol-5-phosphate binding [GO:0010314]	GO:0005886; GO:0009966; GO:0010314; GO:0030512; GO:0060392	LIVTENEDHEK	3.559999943	0.000522895	0.000522895	0.207013039	1326.920013	15.96313	14.9905	13.97855	0	0	15.91511	14.97347	0	0	0	0	0	12.2073	0	0	0	0	15.66327	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1709	0	0	0	0
Q14D33	RTP5_HUMAN	Receptor-transporting protein 5 (3CxxC-type zinc finger protein 5) (CXXC-type zinc finger protein 11)	RTP5 C2orf85 CXXC11 Z3CXXC5	Homo sapiens (Human)	detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; olfactory receptor binding [GO:0031849]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612]	olfactory receptor binding [GO:0031849]	GO:0001580; GO:0006612; GO:0016021; GO:0031849; GO:0051205	DRAGADMWASTFTLAMAER	6.840000153	1	1	0.142758497	2128.097133	0	0	0	14.24444	13.75256	0	15.21071	0	0	0	13.89247	0	15.88749	12.79752	17.8211	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.21114	0	0	0	0	0	0
Q15003	CND2_HUMAN	"Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H, hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog)"	NCAPH BRRN BRRN1 CAPH KIAA0074	Homo sapiens (Human)	cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]	condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]	chromatin binding [GO:0003682]	GO:0000794; GO:0000796; GO:0003682; GO:0005654; GO:0005829; GO:0007076; GO:0010032; GO:0016020; GO:0051301; GO:0051309; GO:0051984; GO:1905820; GO:1905821	EADAEANHR	6.900000095	0.528186917	0.528186917	0.240447061	1012.673624	15.64407	0	15.41156	14.06575	14.73396	16.2521	0	15.19783	0	17.60909	14.36763	16.08989	0	14.44956	12.78306	0	15.38866	0	0	17.07266	14.48603	0	14.41205	12.88927	15.2202	15.51546	0	0	14.97782	15.15344	18.45687	14.9143	0	15.31117	0	16.33416	0	0	15.74572	0	0	16.29422	14.87895	13.70137	0	15.42944	0	13.9504
Q15005	SPCS2_HUMAN	"Signal peptidase complex subunit 2 (Microsomal signal peptidase 25 kDa subunit, SPase 25 kDa subunit)"	SPCS2 KIAA0102 SPC25	Homo sapiens (Human)	protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]	peptidase activity [GO:0008233]	GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021; GO:0045047	MAAAAVQGGRSGGSGGCSGAGGASNCGTGSGR	7.559999943	1	1	6.39E-12	2769.644804	0	9.687933	8.689016	0	12.98337	0	7.517529	0	9.438098	11.23512	0	0	0	12.31192	0	14.32968	0	0	15.17907	0	0	17.74889	13.64961	0	0	13.28516	0	11.77499	12.56602	10.5086	0	0	0	0	0	0	0	0	0	0	0	11.62114	0	0	15.36715	0	0	0
Q15006	EMC2_HUMAN	"ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35, TPR repeat protein 35)"	EMC2 KIAA0103 TTC35	Homo sapiens (Human)	protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]	cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		GO:0005737; GO:0005783; GO:0005789; GO:0042406; GO:0045050; GO:0071816; GO:0072546	ALFGLYMSASHIASNPK	3.089999914	1	1	0.213287202	1823.247189	9.348573	16.10849	17.3224	12.95411	0	0	13.10961	17.32612	0	0	0	0	0	0	0	16.11685	0	0	0	0	0	0	0	0	0	16.44086	16.07962	0	0	0	0	0	16.35774	0	0	17.22787	0	0	13.74165	0	0	0	0	0	0	0	19.10897	0
Q15008	PSMD6_HUMAN	26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A)	PSMD6 KIAA0107 PFAAP4	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]	cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	enzyme regulator activity [GO:0030234]	GO:0000502; GO:0005576; GO:0005654; GO:0005829; GO:0005838; GO:0022624; GO:0030234; GO:0034774; GO:0043161; GO:1904813	TVALGHR	7.199999809	0.541916907	0.541916907	0.161094496	754.3163953	17.10027	17.46671	16.65597	14.00241	0	13.92556	0	0	14.08066	17.25011	15.62619	0	17.53037	17.12237	0	15.80391	11.1515	0	12.91559	15.86101	0	0	17.46015	0	14.79304	0	0	13.44001	0	0	0	19.21856	0	16.90081	18.33246	14.14942	16.81937	0	18.60494	17.36207	16.50473	15.64289	16.15029	0	17.05342	16.16748	0	0
Q15018	ABRX2_HUMAN	BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (Protein FAM175B)	ABRAXAS2 ABRO1 FAM175B KIAA0157	Homo sapiens (Human)	attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931]	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931]	microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0000278; GO:0000922; GO:0002931; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0007059; GO:0008017; GO:0008608; GO:0031593; GO:0051301; GO:0070536; GO:0070552; GO:0090307	MPSSGFAAEGR	1.429999948	0.02792218	0.02792218	0.103465828	1105.632404	0	0	0	14.25501	17.0579	0	0	0	13.72461	16.96911	16.48461	12.75106	16.01402	17.10429	16.13329	16.25605	13.835	15.09943	11.56866	12.40127	0	16.6881	0	15.57108	0	0	0	13.344	17.10239	17.59456	15.81578	18.64572	14.76646	0	15.92416	17.06072	0	0	0	14.44011	14.91796	17.24174	12.18916	14.29215	14.17323	16.06254	0	16.14958
Q15019	SEPT2_HUMAN	"Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5, NEDD-5)"	SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2	Homo sapiens (Human)	cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]	cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0000776; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005940; GO:0007224; GO:0007283; GO:0008021; GO:0015629; GO:0015630; GO:0017157; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0032391; GO:0034613; GO:0042802; GO:0045171; GO:0045296; GO:0060090; GO:0060170; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730	MQAQMQMQMQGGDGDGGALGHHV	2.710000038	1	1	9.21E-13	2447.64231	13.75428	0	0	0	12.4171	0	13.04018	15.28894	10.03378	12.24708	0	14.17276	0	0	0	0	0	12.52338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15021	CND1_HUMAN	"Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2, hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog)"	NCAPD2 CAPD2 CNAP1 KIAA0159	Homo sapiens (Human)	cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]	"condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]"	histone binding [GO:0042393]	GO:0000779; GO:0000793; GO:0000796; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007076; GO:0010032; GO:0016020; GO:0042393; GO:0051301; GO:1905821	CSSVMLLGMMAR	11.88000011	1	1	2.52E-12	1371.486218	14.74979	0	14.96603	0	14.01522	14.00772	0	0	13.32706	0	0	14.90411	13.69379	12.49557	0	11.29086	12.79229	0	14.8922	14.74352	12.44853	9.37339	14.07189	13.43763	0	13.18789	0	15.829	13.71776	12.5717	0	9.936569	13.31138	13.38437	14.37128	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15024	EXOS7_HUMAN	Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8)	EXOSC7 KIAA0116 RRP42	Homo sapiens (Human)	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042; GO:0101019	GVVTCMRK	2.789999962	0.903079748	0.903079748	0.212887989	951.7401347	15.29195	16.75135	0	16.80164	15.69022	15.71524	15.22157	14.80955	13.90129	16.24888	0	0	14.17829	16.75752	15.3051	15.63872	0	13.98417	0	0	15.13773	16.42763	0	16.23928	17.09472	16.31815	15.17266	14.00273	15.19341	15.2235	15.71634	16.11686	15.52852	0	14.8616	13.19108	0	0	0	15.02456	14.01688	14.93532	16.07992	15.83832	0	0	12.9398	12.28696
Q15025	TNIP1_HUMAN	"TNFAIP3-interacting protein 1 (A20-binding inhibitor of NF-kappa-B activation 1, ABIN-1) (HIV-1 Nef-interacting protein) (Nef-associated factor 1, Naf1) (Nip40-1) (Virion-associated nuclear shuttling protein, VAN, hVAN)"	TNIP1 KIAA0113 NAF1	Homo sapiens (Human)	cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; glycoprotein biosynthetic process [GO:0009101]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral genome replication [GO:0045071]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; translation [GO:0006412]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; glycoprotein biosynthetic process [GO:0009101]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral genome replication [GO:0045071]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; translation [GO:0006412]	identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]	GO:0002755; GO:0005654; GO:0005829; GO:0006357; GO:0006412; GO:0006952; GO:0006954; GO:0007159; GO:0009101; GO:0042802; GO:0043124; GO:0045071; GO:0045944; GO:0050729; GO:0051019; GO:0070373; GO:0071222; GO:1903003	MLGELLEESQMEATR	3.099999905	1	1	0.475125579	1769.692515	15.79644	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.74551	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.62761	0	0	0	0
Q15027	ACAP1_HUMAN	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (Centaurin-beta-1, Cnt-b1)"	ACAP1 CENTB1 KIAA0050	Homo sapiens (Human)	protein transport [GO:0015031]	membrane [GO:0016020]; recycling endosome membrane [GO:0055038]	membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein transport [GO:0015031]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0015031; GO:0016020; GO:0046872; GO:0055038	GADLGARDSEGR	3.24000001	1	1	0.213582476	1201.212091	0	0	0	0	14.56894	0	0	14.83743	0	10.16094	0	0	0	14.20166	14.63176	0	0	15.82582	0	0	0	0	14.77549	15.5989	15.03786	0	15.67876	0	16.96322	15.55353	0	0	0	14.9142	0	15.22678	0	0	0	15.95223	16.40151	0	14.09281	0	0	0	15.56573	15.24123
Q15029	U5S1_HUMAN	"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (SNU114 homolog, hSNU114) (U5 snRNP-specific protein, 116 kDa, U5-116 kDa)"	EFTUD2 KIAA0031 SNRP116	Homo sapiens (Human)	"cellular response to xenobiotic stimulus [GO:0071466]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to xenobiotic stimulus [GO:0071466]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]"	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]	GO:0000398; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016020; GO:0016607; GO:0030623; GO:0042220; GO:0043231; GO:0046540; GO:0071005; GO:0071007; GO:0071013; GO:0071466; GO:1990904	CFAETPNKK	5.03000021	1	1	0.215069016	1093.821169	19.62734	0	19.25459	0	0	0	0	19.9768	19.63722	16.3584	0	19.50293	19.32859	17.84555	0	0	17.71014	16.83368	0	0	0	0	0	18.28475	0	0	0	17.6101	18.08394	0	19.72553	20.97241	18.78731	0	0	0	0	19.55324	18.43356	0	0	19.71866	18.04385	0	0	17.53823	0	17.94871
Q15031	SYLM_HUMAN	"Leucine--tRNA ligase, mitochondrial, EC 6.1.1.4 (Leucyl-tRNA synthetase, LeuRS)"	LARS2 KIAA0028	Homo sapiens (Human)	leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004823; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006429; GO:0032543	ASGKSPQPQLLSNK	9.789999962	1	1	0.162432952	1453.896171	13.13112	0	14.03106	13.78306	14.25531	0	12.47236	0	13.24802	0	15.12865	0	0	0	0	15.36932	0	15.70803	0	0	0	0	0	0	0	13.48704	0	0	11.9638	12.43469	0	14.37617	15.37133	12.47803	14.89556	0	0	0	0	0	0	0	0	0	0	0	16.35888	0
Q15032	R3HD1_HUMAN	R3H domain-containing protein 1	R3HDM1 KIAA0029 R3HDM	Homo sapiens (Human)			RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723	GDSSGSSKSIGR	9.569999695	1	1	0.048672814	1138.074272	0	0	0	0	0	0	0	0	0	0	14.26045	0	15.36128	0	0	15.62809	13.23317	0	12.16823	15.44577	0	0	0	0	14.99806	0	0	0	0	0	15.00461	0	0	0	14.84656	0	13.26064	0	16.38442	0	8.817944	0	0	0	0	0	0	0
Q15034	HERC3_HUMAN	"Probable E3 ubiquitin-protein ligase HERC3, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 3) (HECT-type E3 ubiquitin transferase HERC3)"	HERC3 KIAA0032	Homo sapiens (Human)		cytoplasmic vesicle [GO:0031410]	cytoplasmic vesicle [GO:0031410]; ubiquitin-protein transferase activity [GO:0004842]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0031410	YYITLTIPLAMAILR	5.570000172	0.391465366	0.391465366	0.289815474	1768.135658	0	0	14.63898	0	0	0	0	0	0	0	0	0	16.68126	15.90018	0	15.1136	0	0	17.29496	16.847	0	0	15.34605	0	0	0	0	0	16.25477	0	0	15.69907	0	13.596	0	16.77809	0	0	0	0	17.26129	11.88963	0	0	0	18.54401	0	0
Q15042	RB3GP_HUMAN	"Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130, Rab3-GAP)"	RAB3GAP1 KIAA0066 RAB3GAP	Homo sapiens (Human)	brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005096; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0007420; GO:0021854; GO:0031267; GO:0032991; GO:0034389; GO:0043010; GO:0043087; GO:0043547; GO:0048172; GO:0060079; GO:0060325; GO:0061646; GO:0070062; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786	GHAGR	6.519999981	0.610762775	0.610762775	0.248668479	499.6484668	0	0	15.1936	0	0	16.08014	0	14.52093	15.11264	0	0	14.83547	15.66989	15.12701	16.42997	16.20772	0	15.90323	16.23846	15.76032	17.94275	0	0	0	17.60006	0	16.89395	15.4021	17.6285	15.25415	0	16.42677	0	15.62261	0	0	17.31109	13.27021	15.05511	16.7345	16.63208	0	15.54355	0	13.78148	17.8729	17.1201	15.52004
Q15047	SETB1_HUMAN	"Histone-lysine N-methyltransferase SETDB1, EC 2.1.1.366 (ERG-associated protein with SET domain, ESET) (Histone H3-K9 methyltransferase 4, H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1)"	SETDB1 ESET KIAA0067 KMT1E	Homo sapiens (Human)	heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; negative regulation of gene expression [GO:0010629]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; negative regulation of gene expression [GO:0010629]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007265; GO:0008270; GO:0010629; GO:0018024; GO:0043231; GO:0045869; GO:0046974; GO:0051567; GO:0070828; GO:0090309; GO:1990841	AGGSRMEAEK	2.74000001	1	1	0.163564392	1039.326455	14.28052	12.96847	15.17864	14.70311	0	0	0	15.39472	13.45301	0	0	0	0	0	0	0	0	0	0	0	15.10817	0	0	0	15.36689	15.10785	0	13.63847	13.88652	12.64149	13.64139	14.70148	12.22001	0	13.19448	0	12.02265	16.02484	15.5469	14.64443	15.1689	14.28106	11.17708	0	0	0	0	0
Q15048	LRC14_HUMAN	Leucine-rich repeat-containing protein 14	LRRC14 KIAA0014	Homo sapiens (Human)	negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; kinase binding [GO:0019900]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]	kinase binding [GO:0019900]	GO:0005737; GO:0019900; GO:0032088; GO:0034122	ELSMGSSLLSGR	3.839999914	1	1	0.194215488	1252.437917	0	15.17369	15.0013	0	0	0	15.64097	0	16.14854	0	0	0	0	0	0	0	0	0	0	16.73707	0	0	0	0	0	17.57361	16.21264	0	0	0	14.90147	0	15.61146	15.96374	0	0	16.2234	0	16.13006	15.7045	14.84967	15.50664	16.00868	0	14.92181	0	0	16.56827
Q15050	RRS1_HUMAN	Ribosome biogenesis regulatory protein homolog	RRS1 KIAA0112 RRR	Homo sapiens (Human)	"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]"	"condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	"condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]"	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]	GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0002244; GO:0003723; GO:0005654; GO:0005730; GO:0005783; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570	KGGLGGK	10.94999981	0.811682403	0.811682403	0.203333967	616.5188588	13.78838	13.95049	0	0	16.92517	15.67105	0	0	14.37867	16.31097	0	0	16.8357	0	16.001	0	0	16.10555	16.58013	0	16.45928	0	0	15.93948	15.13522	0	0	0	17.2436	0	16.40809	0	0	0	14.63663	0	15.79546	16.02068	0	0	0	0	15.15541	0	0	15.66096	18.32788	15.71101
Q15051	IQCB1_HUMAN	"IQ calmodulin-binding motif-containing protein 1 (Nephrocystin-5) (p53 and DNA damage-regulated IQ motif protein, PIQ)"	IQCB1 KIAA0036 NPHP5 OK/SW-cl.85	Homo sapiens (Human)	cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]	centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]	centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]	calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]	GO:0001750; GO:0005516; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0015630; GO:0019899; GO:0032391; GO:0045171; GO:0045494; GO:0048496; GO:0060271; GO:0070062; GO:0072686	KPTGTDPR	8.619999886	1	1	0.121161583	870.9259021	13.84754	15.73291	0	13.14374	14.74755	15.79809	0	17.38656	13.09818	0	16.50336	12.98059	13.42513	0	15.81789	15.45084	0	0	0	0	0	16.75388	16.27582	16.28404	16.43297	0	0	0	0	0	0	13.66706	17.77542	0	0	18.53261	15.17406	0	16.45298	18.14827	12.24668	15.40091	14.91031	16.90306	0	16.43839	17.21592	0
Q15053	K0040_HUMAN	Uncharacterized protein KIAA0040	KIAA0040	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	RPSLPV	6.440000057	0.246709287	0.246709287	0.169718542	668.1841522	0	0	16.1626	16.86334	16.67532	0	17.4377	16.76834	14.31022	15.95947	16.11219	15.08029	0	0	14.53178	14.5422	16.08984	15.32699	13.97101	9.055669	11.82093	14.85326	16.48693	15.96592	8.877218	0	15.8915	11.21004	16.57357	0	15.84788	16.15376	0	17.12729	17.14552	15.03741	15.81393	17.11415	0	16.20609	0	0	0	0	0	16.29819	15.80082	13.98219
Q15057	ACAP2_HUMAN	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2, Cnt-b2)"	ACAP2 CENTB2 KIAA0041	Homo sapiens (Human)	actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]	endosome membrane [GO:0010008]; membrane [GO:0016020]; ruffle [GO:0001726]	endosome membrane [GO:0010008]; membrane [GO:0016020]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0001726; GO:0005096; GO:0010008; GO:0016020; GO:0030029; GO:0032456; GO:0046872; GO:1990090	AFCVANKQFMNGIR	1.49000001	1	1	0.191565328	1670.059012	0	0	13.38176	0	0	0	0	0	14.94796	0	0	0	0	0	0	0	15.37393	0	0	0	0	0	0	0	0	16.05639	15.44923	15.05451	0	13.93405	0	0	15.14397	12.96281	0	15.75206	15.26227	16.5353	15.29553	0	15.20445	15.94577	15.18509	0	12.94331	0	0	0
Q15058	KIF14_HUMAN	Kinesin-like protein KIF14	KIF14 KIAA0042	Homo sapiens (Human)	activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446]	cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]	GO:0001558; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0008284; GO:0008574; GO:0010389; GO:0015631; GO:0016020; GO:0016887; GO:0019901; GO:0021685; GO:0021693; GO:0021695; GO:0021766; GO:0021772; GO:0021846; GO:0021987; GO:0030155; GO:0030165; GO:0030334; GO:0030496; GO:0031146; GO:0031641; GO:0032147; GO:0032467; GO:0032487; GO:0033624; GO:0034446; GO:0043066; GO:0043161; GO:0043523; GO:0043524; GO:0045184; GO:0051233; GO:0051301; GO:0090543; GO:1903429; GO:2000045	ANENVALK	12.27999973	1	1	0.022909502	860.8352713	0	0	0	0	0	0	14.67136	0	14.91227	0	0	13.80249	15.3901	0	0	0	0	0	0	0	0	0	14.16326	0	0	0	0	0	16.55484	13.96054	0	16.12746	0	0	0	0	0	0	0	0	15.71407	0	0	0	0	0	0	0
Q15061	WDR43_HUMAN	WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog)	WDR43 KIAA0007 UTP5	Homo sapiens (Human)	positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; rRNA processing [GO:0006364]	chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation regulator activity [GO:0003711]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation regulator activity [GO:0003711]	GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0034243; GO:0045943; GO:2000036; GO:2000234	EKSAVMSFTVTDEPVYIDLTLSENK	11.61999989	0.337015063	0.337015063	0.179545733	2832.846118	0	15.22995	12.64414	0	0	0	0	14.32964	0	0	15.21695	14.7816	0	15.44353	0	0	0	0	0	0	14.47001	0	0	14.02229	0	0	0	12.18295	11.87299	15.22784	0	0	0	0	0	15.29211	0	15.6264	0	17.17562	0	14.18539	0	15.74137	0	0	0	13.9533
Q15063	POSTN_HUMAN	"Periostin, PN (Osteoblast-specific factor 2, OSF-2)"	POSTN OSF2	Homo sapiens (Human)	cell adhesion [GO:0007155]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; regulation of Notch signaling pathway [GO:0008593]; tissue development [GO:0009888]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; regulation of Notch signaling pathway [GO:0008593]; tissue development [GO:0009888]	cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]	GO:0005615; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009888; GO:0030198; GO:0031012; GO:0046872; GO:0050839; GO:0062023; GO:0071307	VASEALMK	12.71000004	1	1	0.282446863	846.3791803	19.08572	16.66887	18.19933	0	0	0	0	0	0	0	0	18.37125	0	0	16.66895	0	17.48654	18.40566	0	0	0	0	17.14905	0	0	0	0	0	0	0	0	0	19.00997	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15070	OXA1L_HUMAN	"Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein, OXA1-like protein)"	OXA1L	Homo sapiens (Human)	aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]	integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262]	membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]	GO:0005739; GO:0005759; GO:0009060; GO:0031305; GO:0031966; GO:0032592; GO:0032780; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0033617; GO:0042803; GO:0051205; GO:0051262; GO:0051354; GO:0097177	VVHDLDK	10.52999973	1	1	0.170957311	825.9587716	0	15.12569	0	0	15.61051	17.89898	0	17.65057	16.98528	16.57242	0	0	16.27917	0	0	0	0	15.11528	12.9984	0	0	0	15.56914	16.71145	0	14.78781	14.84032	16.32089	17.67804	0	15.32711	18.44329	0	18.06345	16.47929	17.31914	16.72355	0	18.5634	0	16.31526	16.24981	16.70769	0	17.39575	18.37684	0	16.50746
Q15072	OZF_HUMAN	Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146)	ZNF146 OZF	Homo sapiens (Human)	"regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270	SNLTEHEK	11.71000004	1	1	0.398413838	956.2380933	0	20.38863	16.53399	0	0	0	19.84156	20.69789	0	0	0	0	0	20.87478	0	20.18973	20.04416	0	0	0	0	19.61917	0	0	0	22.07177	0	0	0	0	21.58579	0	0	0	22.11994	21.41937	0	21.58211	0	0	18.90218	21.00041	20.81047	0	19.61791	20.10996	0	0
Q15075	EEA1_HUMAN	Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2)	EEA1 ZFYVE2	Homo sapiens (Human)	early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]	axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; serine-pyruvate aminotransferase complex [GO:0005969]	axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694]	1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005516; GO:0005545; GO:0005737; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0008270; GO:0016020; GO:0016189; GO:0019897; GO:0030742; GO:0031901; GO:0039694; GO:0042803; GO:0044308; GO:0045022; GO:0070062	GEATQK	4.730000019	1	1	0.057249039	632.7511555	0	12.07302	0	0	0	0	0	0	0	18.22157	15.65896	0	15.23914	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15078	CD5R1_HUMAN	"Cyclin-dependent kinase 5 activator 1, CDK5 activator 1 (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35, p35; Cyclin-dependent kinase 5 activator 1, p25, p25 (Tau protein kinase II 23 kDa subunit, p23) ]"	CDK5R1 CDK5R NCK5A	Homo sapiens (Human)	"activation of protein kinase activity [GO:0032147]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signaling receptor activity [GO:2000273]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic vesicle cycle [GO:0098693]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]"	axon [GO:0030424]; contractile fiber [GO:0043292]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]	"axon [GO:0030424]; contractile fiber [GO:0043292]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ephrin receptor binding [GO:0046875]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; activation of protein kinase activity [GO:0032147]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signaling receptor activity [GO:2000273]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic vesicle cycle [GO:0098693]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]"	actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ephrin receptor binding [GO:0046875]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]	GO:0000079; GO:0000226; GO:0000307; GO:0001764; GO:0002020; GO:0004672; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007158; GO:0007213; GO:0007411; GO:0007413; GO:0007420; GO:0009792; GO:0014069; GO:0016020; GO:0016241; GO:0016301; GO:0016533; GO:0018105; GO:0018107; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030182; GO:0030295; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0031116; GO:0031175; GO:0031594; GO:0032147; GO:0032956; GO:0035235; GO:0035255; GO:0042501; GO:0043005; GO:0043014; GO:0043025; GO:0043197; GO:0043204; GO:0043231; GO:0043292; GO:0043525; GO:0043539; GO:0045296; GO:0045348; GO:0045664; GO:0045737; GO:0045892; GO:0046875; GO:0048013; GO:0048471; GO:0048487; GO:0048511; GO:0051015; GO:0061001; GO:0061575; GO:0070315; GO:0090314; GO:0098693; GO:0098793; GO:2000273	GTVLSLSPSYR	4.380000114	1	1	0.231053062	1179.102545	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.43636	0	0	0	15.90262	15.85745	0	15.09177	14.46664	16.83244	16.1548	15.10585	13.67685	14.31494	15.27293	0	16.83205	0	0	16.10535	0	0	15.23594	16.24961	0	0	0
Q15080	NCF4_HUMAN	"Neutrophil cytosol factor 4, NCF-4 (Neutrophil NADPH oxidase factor 4) (SH3 and PX domain-containing protein 4) (p40-phox, p40phox)"	NCF4 SH3PXD4	Homo sapiens (Human)	phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; phosphatidylinositol-3-phosphate binding [GO:0032266]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]	phosphatidylinositol-3-phosphate binding [GO:0032266]; superoxide-generating NADPH oxidase activator activity [GO:0016176]	GO:0005737; GO:0005829; GO:0005886; GO:0006909; GO:0010008; GO:0016020; GO:0016176; GO:0032010; GO:0032266; GO:0042554; GO:0043020; GO:0045730	VYVGVKQEIAEMR	4.559999943	0.600545824	0.600545824	0.423751484	1519.581791	0	0	11.99633	15.95126	0	0	0	0	0	14.42404	0	0	0	13.56548	16.45324	0	0	0	0	16.62231	16.25186	0	0	0	0	0	0	0	15.83415	14.83029	15.94189	16.13166	11.1607	0	15.19372	14.16992	0	0	0	16.19355	0	16.97358	15.9588	16.75834	0	17.28474	0	17.33318
Q15111	PLCL1_HUMAN	"Inactive phospholipase C-like protein 1, PLC-L1 (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein, PRIP)"	PLCL1	Homo sapiens (Human)	"gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission, GABAergic [GO:0032228]"	"GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]"	GO:0004435; GO:0004629; GO:0005737; GO:0005886; GO:0006629; GO:0007214; GO:0032228; GO:0033135; GO:0035556; GO:0048015; GO:0050811; GO:0070679; GO:0120163; GO:1900122	FMWLKTVFEAADVDGNGIMLEDTSVELIK	1.409999967	1	1	1.83E-12	3270.63911	0	10.70178	0	0	12.01745	0	0	0	0	15.02259	0	15.64151	0	0	0	0	0	0	0	0	0	0	13.35752	11.69586	0	0	0	0	0	0	0	0	0	0	0	0	15.22897	0	0	0	0	0	13.56143	0	12.22797	0	0	0
Q15113	PCOC1_HUMAN	"Procollagen C-endopeptidase enhancer 1 (Procollagen COOH-terminal proteinase enhancer 1, PCPE-1, Procollagen C-proteinase enhancer 1) (Type 1 procollagen C-proteinase enhancer protein) (Type I procollagen COOH-terminal proteinase enhancer)"	PCOLCE PCPE1	Homo sapiens (Human)	multicellular organism development [GO:0007275]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; multicellular organism development [GO:0007275]	collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]	GO:0005518; GO:0005576; GO:0005615; GO:0007275; GO:0008201; GO:0016504; GO:0070062	EPGEGLAVTVSLIGAYK	1.190000057	1	1	1.38E-12	1704.482453	0	14.8936	13.94352	0	0	0	0	14.02216	0	0	0	0	0	0	15.7792	0	0	0	0	0	0	15.87668	0	13.22918	15.16558	0	0	0	0	0	14.22636	0	0	0	0	0	0	0	13.20309	0	0	15.2674	0	0	0	0	0	0
Q15118	PDK1_HUMAN	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 1, PDH kinase 1)"	PDK1 PDHK1	Homo sapiens (Human)	cell population proliferation [GO:0008283]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cell population proliferation [GO:0008283]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006468; GO:0008283; GO:0008631; GO:0010510; GO:0010906; GO:0097411	DGYENAR	8.119999886	1	1	0.497556734	824.6335976	15.34266	0	0	15.63029	0	0	0	0	0	0	0	14.50544	0	0	16.02068	0	0	0	0	0	0	0	0	0	0	0	0	14.94286	14.46893	0	0	14.91637	15.93943	12.65649	0	0	0	0	0	0	17.23896	0	0	0	0	17.43552	14.16123	12.73552
Q15120	PDK3_HUMAN	"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 3)"	PDK3 PDHK3	Homo sapiens (Human)	cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]	GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0006468; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377	KELPVR	4.179999828	1	1	0.223084687	741.1323937	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.92903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41251	0	0	0
Q15126	PMVK_HUMAN	"Phosphomevalonate kinase, PMKase, hPMK, EC 2.7.4.2"	PMVK PMKI	Homo sapiens (Human)	"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]"	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]"	ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]	GO:0004631; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0016020; GO:0016126; GO:0019287; GO:0070062; GO:0070723	APLGGAPR	14.27999973	0.944415748	0.944415748	0.273750813	737.501087	18.1768	17.67585	17.27153	17.93211	0	15.17672	17.65707	18.2051	15.7415	17.80464	19.13704	17.28502	0	17.76023	16.83166	16.94139	18.37725	18.41084	16.41491	17.59237	17.89561	17.91923	0	16.73454	18.06813	17.07707	0	16.89448	18.28389	18.06409	0	19.05206	18.35007	0	17.83778	0	0	17.9571	0	0	16.83202	0	17.87994	18.83274	0	16.81435	16.86419	17.71337
Q15147	PLCB4_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4, PLC-beta-4)"	PLCB4	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]	cytosol [GO:0005829]	cytosol [GO:0005829]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]	calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]	GO:0004435; GO:0004629; GO:0005509; GO:0005829; GO:0007186; GO:0016042; GO:0048015	AMQIIEMYEPDEDLKK	5.300000191	1	1	0.198473948	1969.386903	13.51618	14.9402	16.52758	15.97964	11.80037	11.75177	17.79169	0	0	14.02279	0	12.68097	0	0	0	0	0	0	0	0	0	0	0	0	13.6179	0	0	17.12644	13.30472	0	0	14.33904	0	0	0	0	0	0	0	0	0	0	0	16.09736	0	0	0	0
Q15149	PLEC_HUMAN	"Plectin, PCN, PLTN (Hemidesmosomal protein 1, HD1) (Plectin-1)"	PLEC PLEC1	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; actomyosin contractile ring assembly actin filament organization [GO:2000689]; adherens junction organization [GO:0034332]; cardiac muscle cell development [GO:0055013]; cell morphogenesis [GO:0000902]; cellular protein localization [GO:0034613]; cellular response to extracellular stimulus [GO:0031668]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to mechanical stimulus [GO:0071260]; establishment of skin barrier [GO:0061436]; fibroblast migration [GO:0010761]; gene expression [GO:0010467]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte development [GO:0003334]; leukocyte migration involved in immune response [GO:0002522]; mitochondrion morphogenesis [GO:0070584]; multicellular organism growth [GO:0035264]; myoblast differentiation [GO:0045445]; negative regulation of protein kinase activity [GO:0006469]; nucleus organization [GO:0006997]; peripheral nervous system myelin maintenance [GO:0032287]; protein-containing complex organization [GO:0043933]; regulation of ATP citrate synthase activity [GO:2000983]; regulation of vascular permeability [GO:0043114]; respiratory electron transport chain [GO:0022904]; response to food [GO:0032094]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]; skeletal myofibril assembly [GO:0014866]; T cell chemotaxis [GO:0010818]; tight junction organization [GO:0120193]; transmission of nerve impulse [GO:0019226]; wound healing [GO:0042060]	axon [GO:0030424]; brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]	axon [GO:0030424]; brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; actin cytoskeleton reorganization [GO:0031532]; actomyosin contractile ring assembly actin filament organization [GO:2000689]; adherens junction organization [GO:0034332]; cardiac muscle cell development [GO:0055013]; cell morphogenesis [GO:0000902]; cellular protein localization [GO:0034613]; cellular response to extracellular stimulus [GO:0031668]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to mechanical stimulus [GO:0071260]; establishment of skin barrier [GO:0061436]; fibroblast migration [GO:0010761]; gene expression [GO:0010467]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte development [GO:0003334]; leukocyte migration involved in immune response [GO:0002522]; mitochondrion morphogenesis [GO:0070584]; multicellular organism growth [GO:0035264]; myoblast differentiation [GO:0045445]; negative regulation of protein kinase activity [GO:0006469]; nucleus organization [GO:0006997]; peripheral nervous system myelin maintenance [GO:0032287]; protein-containing complex organization [GO:0043933]; regulation of ATP citrate synthase activity [GO:2000983]; regulation of vascular permeability [GO:0043114]; respiratory electron transport chain [GO:0022904]; response to food [GO:0032094]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]; skeletal myofibril assembly [GO:0014866]; T cell chemotaxis [GO:0010818]; tight junction organization [GO:0120193]; transmission of nerve impulse [GO:0019226]; wound healing [GO:0042060]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]	GO:0000902; GO:0002162; GO:0002522; GO:0003334; GO:0003723; GO:0003779; GO:0005198; GO:0005200; GO:0005737; GO:0005741; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0006469; GO:0006997; GO:0008307; GO:0010467; GO:0010761; GO:0010818; GO:0014866; GO:0016020; GO:0016528; GO:0019226; GO:0022904; GO:0030018; GO:0030056; GO:0030424; GO:0030425; GO:0030506; GO:0031532; GO:0031581; GO:0031668; GO:0032094; GO:0032287; GO:0034332; GO:0034613; GO:0035264; GO:0042060; GO:0042383; GO:0043034; GO:0043114; GO:0043209; GO:0043621; GO:0043933; GO:0045104; GO:0045109; GO:0045111; GO:0045214; GO:0045296; GO:0045445; GO:0048471; GO:0048741; GO:0055013; GO:0061436; GO:0070062; GO:0070584; GO:0071260; GO:0071464; GO:0071498; GO:0120193; GO:2000689; GO:2000983	ASFEKAAAGK	5.860000134	1	1	0.204560983	979.1845326	13.58891	0	14.19689	0	0	0	0	15.71023	14.08725	0	0	13.41874	0	13.25399	14.20541	12.87551	0	14.51314	14.51818	15.59242	0	0	13.67312	0	15.27232	0	0	15.52708	0	0	13.7821	0	0	14.19977	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15154	PCM1_HUMAN	"Pericentriolar material 1 protein, PCM-1, hPCM-1"	PCM1	Homo sapiens (Human)	centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring [GO:0034453]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176]	apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991]	apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring [GO:0034453]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176]	identical protein binding [GO:0042802]	GO:0000242; GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007098; GO:0016020; GO:0022027; GO:0031122; GO:0031965; GO:0032991; GO:0034451; GO:0034453; GO:0034454; GO:0035176; GO:0035735; GO:0035869; GO:0036064; GO:0042802; GO:0045177; GO:0050768; GO:0060271; GO:0071539; GO:0090316; GO:0097150; GO:1905515	EDLVEK	6.849999905	1	1	0.230788202	733.2875363	15.08037	0	14.27741	15.00185	14.06846	14.94094	0	15.10579	15.4438	13.65642	0	14.82045	15.1335	16.85286	15.41267	15.49281	15.68419	15.541	0	16.6167	16.53952	0	0	0	0	0	0	16.06118	13.45517	15.32065	16.63059	0	0	15.47626	16.43411	15.94165	16.53879	16.55184	16.5707	0	15.02207	0	0	15.90995	0	0	0	16.96449
Q15166	PON3_HUMAN	"Serum paraoxonase/lactonase 3, EC 3.1.1.2, EC 3.1.1.81, EC 3.1.8.1"	PON3	Homo sapiens (Human)	aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; coumarin catabolic process [GO:0046226]; establishment of localization in cell [GO:0051649]; negative regulation of superoxide anion generation [GO:0032929]; phenylacetate catabolic process [GO:0010124]; renal sodium ion transport [GO:0003096]; response to toxic substance [GO:0009636]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; 3,4-dihydrocoumarin hydrolase activity [GO:0018733]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; coumarin catabolic process [GO:0046226]; establishment of localization in cell [GO:0051649]; negative regulation of superoxide anion generation [GO:0032929]; phenylacetate catabolic process [GO:0010124]; renal sodium ion transport [GO:0003096]; response to toxic substance [GO:0009636]"	"3,4-dihydrocoumarin hydrolase activity [GO:0018733]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"	GO:0003096; GO:0004063; GO:0004064; GO:0005576; GO:0005615; GO:0009636; GO:0010124; GO:0018733; GO:0019439; GO:0032929; GO:0042803; GO:0043231; GO:0046226; GO:0046395; GO:0046872; GO:0051649; GO:0070062; GO:0102007	NIHIMEK	3.980000019	0.455293715	0.455293715	0.228858706	885.2742443	0	0	14.09456	13.44299	15.17428	0	0	0	14.98918	15.15374	16.2396	14.76425	14.84053	14.91998	16.88838	0	14.07449	15.22726	14.76153	14.04574	15.8019	0	15.41015	16.45528	0	15.1634	0	15.46973	0	15.98665	16.13333	0	0	16.09884	16.85341	14.91912	15.7683	0	14.5688	15.9889	0	14.90782	0	0	0	16.08891	16.23285	0
Q15198	PGFRL_HUMAN	"Platelet-derived growth factor receptor-like protein, PDGFR-like protein (PDGF receptor beta-like tumor suppressor)"	PDGFRL PRLTS	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019]	platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019]	GO:0004992; GO:0005019; GO:0005576	DSANSAPKTQSIMMQVLDK	5.159999847	1	1	0.291679343	2094.918629	0	10.47303	14.29091	9.679258	0	7.951466	14.13028	13.87362	13.06485	14.18979	0	13.68585	12.24655	13.72694	12.411	14.41087	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.30805	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15208	STK38_HUMAN	"Serine/threonine-protein kinase 38, EC 2.7.11.1 (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1)"	STK38 NDR1	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular protein modification process [GO:0006464]; intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006468; GO:0018105; GO:0031435; GO:0035556; GO:0043407; GO:0045296; GO:0106310	MAMTGSTPCSSMSNHTK	12.98999977	0.274705678	0.274705678	0.092503373	1860.031316	16.53708	17.00293	18.7874	0	15.38392	16.79084	17.24761	0	0	14.87335	0	18.59724	17.48072	16.23102	17.44928	0	17.46268	0	0	13.07119	0	0	16.86494	16.40805	0	0	17.98129	13.36777	0	17.69287	16.84216	17.65801	14.30843	15.93226	16.50993	0	15.33037	18.48431	17.01866	0	17.38269	16.69076	0	0	15.53533	16.40331	14.50709	0
Q15223	NECT1_HUMAN	"Nectin-1 (Herpes virus entry mediator C, Herpesvirus entry mediator C, HveC) (Herpesvirus Ig-like receptor, HIgR) (Nectin cell adhesion molecule 1) (Poliovirus receptor-related protein 1) (CD antigen CD111)"	NECTIN1 HVEC PRR1 PVRL1	Homo sapiens (Human)	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; enamel mineralization [GO:0070166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune response [GO:0006955]; iron ion transport [GO:0006826]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; regulation of synapse assembly [GO:0051963]; retina development in camera-type eye [GO:0060041]; viral entry into host cell [GO:0046718]; virion attachment to host cell [GO:0019062]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone membrane [GO:0032584]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone membrane [GO:0032584]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; enamel mineralization [GO:0070166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune response [GO:0006955]; iron ion transport [GO:0006826]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; regulation of synapse assembly [GO:0051963]; retina development in camera-type eye [GO:0060041]; viral entry into host cell [GO:0046718]; virion attachment to host cell [GO:0019062]	carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]	GO:0001618; GO:0002089; GO:0002934; GO:0005576; GO:0005886; GO:0005912; GO:0006826; GO:0006955; GO:0007155; GO:0007156; GO:0007157; GO:0007411; GO:0015026; GO:0016020; GO:0016021; GO:0019062; GO:0030246; GO:0030425; GO:0032584; GO:0042802; GO:0042803; GO:0043231; GO:0043296; GO:0044291; GO:0044877; GO:0046718; GO:0046790; GO:0050839; GO:0051963; GO:0060041; GO:0070166; GO:0098609; GO:0098686; GO:0099059; GO:1902414	MGLAGAAGR	11.60999966	0.815202773	0.815202773	0.203021547	803.2933688	14.914	14.8461	12.81294	16.00487	0	0	15.51246	15.79858	14.74193	0	15.93568	14.98503	13.34342	12.63546	15.10496	0	0	0	14.03799	0	0	0	0	0	17.02268	0	14.59338	14.5665	0	15.25037	15.7459	14.6547	0	0	15.41852	0	16.59299	0	0	0	15.14609	16.12714	0	0	0	0	0	0
Q15233	NONO_HUMAN	"Non-POU domain-containing octamer-binding protein, NonO protein (54 kDa nuclear RNA- and DNA-binding protein, p54(nrb), p54nrb) (55 kDa nuclear protein, NMT55) (DNA-binding p52/p100 complex, 52 kDa subunit)"	NONO NRB54	Homo sapiens (Human)	"activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"	chromosome [GO:0005694]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromosome [GO:0005694]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0001650; GO:0002218; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006355; GO:0006397; GO:0007623; GO:0008380; GO:0016020; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0042802; GO:0045087; GO:0045892; GO:0090575; GO:1903377	ALIEMEK	4.610000134	1	1	0.118505026	849.186881	0	0	0	0	0	15.8496	14.34221	0	15.92658	0	0	12.38398	14.48825	15.83135	0	14.38764	12.76673	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.31422	0	15.08098	12.9706	13.07935	0	16.36748	15.72642	13.49522	15.80679	10.31128	0	15.88606
Q15262	PTPRK_HUMAN	"Receptor-type tyrosine-protein phosphatase kappa, Protein-tyrosine phosphatase kappa, R-PTP-kappa, EC 3.1.3.48"	PTPRK PTPK	Homo sapiens (Human)	"cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]	"adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041	AAYFDMIR	6.730000019	1	1	0.235481216	1001.768713	13.66362	18.21702	18.63136	14.48057	14.55681	16.78174	16.95326	16.09964	0	0	0	0	16.83062	0	17.22213	17.49499	19.77803	16.94691	0	0	0	17.58028	0	0	0	0	0	0	0	0	0	0	0	18.46989	0	0	0	0	18.58279	16.28424	17.94678	0	0	0	0	0	0	0
Q15269	PWP2_HUMAN	Periodic tryptophan protein 2 homolog	PWP2 PWP2H	Homo sapiens (Human)	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]"	nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	"nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]"	RNA binding [GO:0003723]	GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388	DSEEEMLA	7.849999905	0.916638613	0.916638613	0.244725594	939.9739122	14.36241	0	14.52683	0	13.29151	14.72806	15.47594	15.48285	14.42118	14.81902	14.68904	0	0	0	0	16.73837	0	0	16.48999	10.26016	16.12273	12.56223	15.21312	16.2789	0	0	15.67661	11.9866	0	14.56232	16.14857	13.8545	0	14.20315	0	15.915	12.24414	14.74408	0	0	16.35135	0	12.03969	0	15.13713	0	16.13277	0
Q15276	RABE1_HUMAN	Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17)	RABEP1 RAB5EP RABPT5 RABPT5A	Homo sapiens (Human)	apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]	GO:0005096; GO:0005768; GO:0005769; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0031901; GO:0032991; GO:0042803; GO:0043231; GO:0055037; GO:0061025; GO:1903441	QSSEDSSHQISALVLR	2.769999981	1	1	0.284461529	1756.025464	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.66748	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15283	RASA2_HUMAN	"Ras GTPase-activating protein 2 (GTPase-activating protein 1m, GAP1m)"	RASA2 GAP1M RASGAP	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0035556; GO:0043087; GO:0046580; GO:0046872; GO:0048471	EGDNVENNKENLR	25.28000069	1	1	6.92E-13	1528.215283	0	0	0	0	0	16.93213	0	0	16.97638	16.76692	16.97521	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15287	RNPS1_HUMAN	RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2)	RNPS1 LDC2	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"	ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]"	mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]	GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0008380; GO:0016607; GO:0043065; GO:0048025; GO:0061574	SRSSSNSSR	4.949999809	1	1	0	969.813425	10.19687	14.56372	0	0	0	14.82053	14.85589	0	0	0	0	0	15.34236	0	0	0	0	0	18.92211	11.8978	16.70539	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.6754	0	0	0	0	0
Q15293	RCN1_HUMAN	Reticulocalbin-1	RCN1 RCN	Homo sapiens (Human)	camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701]	calcium ion binding [GO:0005509]	GO:0001701; GO:0005509; GO:0005783; GO:0005788; GO:0043010	AKPTVR	1.620000005	1	1	0.266574569	672.0671496	0	0	0	0	0	0	14.00646	0	0	16.09495	0	16.70816	0	0	0	15.6304	0	16.28226	0	0	17.35038	0	16.96728	0	17.0921	0	0	15.45959	15.53751	0	0	0	17.64724	0	0	0	0	0	15.75093	15.83566	0	17.05415	0	0	0	16.95779	0	0
Q15303	ERBB4_HUMAN	"Receptor tyrosine-protein kinase erbB-4, EC 2.7.10.1 (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain, 4ICD, E4ICD (s80HER4) ]"	ERBB4 HER4	Homo sapiens (Human)	"cardiac muscle tissue regeneration [GO:0061026]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; central nervous system morphogenesis [GO:0021551]; embryonic pattern specification [GO:0009880]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; heart development [GO:0007507]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; olfactory bulb interneuron differentiation [GO:0021889]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]	"basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; neuregulin receptor activity [GO:0038131]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cardiac muscle tissue regeneration [GO:0061026]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; central nervous system morphogenesis [GO:0021551]; embryonic pattern specification [GO:0009880]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; heart development [GO:0007507]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; olfactory bulb interneuron differentiation [GO:0021889]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"	ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; neuregulin receptor activity [GO:0038131]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0000976; GO:0001755; GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005154; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007399; GO:0007416; GO:0007507; GO:0007595; GO:0008284; GO:0008285; GO:0009880; GO:0009925; GO:0014068; GO:0016323; GO:0016477; GO:0018108; GO:0021551; GO:0021889; GO:0030334; GO:0033674; GO:0038130; GO:0038131; GO:0038138; GO:0042531; GO:0042803; GO:0043066; GO:0043235; GO:0043552; GO:0043653; GO:0045165; GO:0045211; GO:0045893; GO:0046427; GO:0046777; GO:0060045; GO:0060644; GO:0060749; GO:0061026; GO:0070374; GO:0071364; GO:0072046; GO:0098978; GO:0098982; GO:0099056; GO:0099061; GO:2000010	GMMYLEER	15.43999958	1	1	1.37E-12	1043.595507	0	0	0	14.65892	14.44456	14.3726	15.17961	14.95099	0	15.05746	14.50415	0	14.92214	14.399	16.32561	15.81444	14.12933	0	0	0	16.05139	0	0	0	0	0	0	16.29933	15.43109	16.12523	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15306	IRF4_HUMAN	"Interferon regulatory factor 4, IRF-4 (Lymphocyte-specific interferon regulatory factor, LSIRF) (Multiple myeloma oncogene 1) (NF-EM5)"	IRF4 MUM1	Homo sapiens (Human)	"defense response to protozoan [GO:0042832]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; immune system process [GO:0002376]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA binding [GO:0043388]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of T-helper cell differentiation [GO:0045622]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]"	chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; defense response to protozoan [GO:0042832]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; immune system process [GO:0002376]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA binding [GO:0043388]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of T-helper cell differentiation [GO:0045622]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]"	GO:0000785; GO:0000786; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016020; GO:0032733; GO:0032736; GO:0032743; GO:0032753; GO:0034122; GO:0042110; GO:0042832; GO:0043011; GO:0043388; GO:0043565; GO:0043966; GO:0043967; GO:0045622; GO:0045893; GO:0045944; GO:0072540; GO:0120162; GO:1990837	GGEFGMSAVSCGNGK	11.64000034	0.456298918	0.456298918	0.133753423	1473.070251	15.75898	15.71624	15.62852	16.33324	12.07032	13.9612	0	16.48713	13.04539	17.39146	16.83359	14.77948	15.93258	14.53548	14.12735	15.31957	17.36169	0	0	15.06649	12.30285	19.33252	15.89526	14.77062	17.1951	15.96418	16.05472	13.83342	0	14.93645	13.73734	14.42044	18.51309	0	15.821	14.19536	17.05344	17.32336	16.92801	18.01892	0	0	0	18.12601	16.33798	0	0	0
Q15311	RBP1_HUMAN	"RalA-binding protein 1, RalBP1 (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase, DNP-SG ATPase, EC 7.6.2.2, EC 7.6.2.3) (Ral-interacting protein 1)"	RALBP1 RLIP RLIP1 RLIP76	Homo sapiens (Human)	chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein phosphorylation [GO:0001934]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein phosphorylation [GO:0001934]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]	ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0000922; GO:0001934; GO:0005096; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006897; GO:0006935; GO:0007264; GO:0008559; GO:0015431; GO:0016020; GO:0022857; GO:0031267; GO:0032489; GO:0042626; GO:0042910; GO:0043087; GO:0043547; GO:0051056; GO:0055085; GO:0090141; GO:1900753; GO:1990961	IAQEIASLSK	12.31999969	1	1	0.061819078	1056.558611	0	0	0	0	0	0	0	0	18.81334	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15319	PO4F3_HUMAN	"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C, Brain-3C, Brn-3C)"	POU4F3 BRN3C	Homo sapiens (Human)	axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837	MMAMNSK	2.339999914	1	1	0.267629375	844.944032	0	0	14.77218	0	16.60466	0	0	0	0	0	0	0	0	15.94172	15.75058	15.69478	0	15.74978	0	15.97125	0	0	0	15.18852	0	16.79358	16.41258	0	16.78633	0	17.1376	17.88753	16.66472	16.52909	0	0	16.74334	0	0	16.96925	16.09217	16.7377	17.00978	17.28983	17.11951	17.1598	15.55384	17.67187
Q15326	ZMY11_HUMAN	Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69)	ZMYND11 BRAM1 BS69	Homo sapiens (Human)	"cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]"	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]"	double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0007049; GO:0008270; GO:0034243; GO:0035064; GO:0043124; GO:0045892; GO:0046329; GO:0051607; GO:2001237	LATQHK	4.03000021	0.921088517	0.921088517	0	697.6231659	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.33296	13.89059	0	0	0	0	0	16.26836	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15334	L2GL1_HUMAN	"Lethal(2) giant larvae protein homolog 1, LLGL (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein)"	LLGL1 DLG4 HUGL HUGL1	Homo sapiens (Human)	axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708]	adherens junction [GO:0005912]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	adherens junction [GO:0005912]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708]	GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]	GO:0000137; GO:0000139; GO:0005096; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0007409; GO:0008593; GO:0019901; GO:0030424; GO:0030864; GO:0030866; GO:0031901; GO:0032588; GO:0032878; GO:0045159; GO:0045197; GO:0050708; GO:0051294; GO:0065003	DPTKILIGYSR	2.910000086	1	1	0.025677312	1262.933562	13.15287	14.8706	0	13.92642	12.66815	13.10128	0	15.6784	0	14.41983	10.60272	12.97035	0	13.51084	0	0	15.43204	0	16.18076	0	0	0	0	14.89769	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.30737	0	0	0	0	0	0	0	0
Q15349	KS6A2_HUMAN	"Ribosomal protein S6 kinase alpha-2, S6K-alpha-2, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 2, p90-RSK 2, p90RSK2) (MAP kinase-activated protein kinase 1c, MAPK-activated protein kinase 1c, MAPKAP kinase 1c, MAPKAPK-1c) (Ribosomal S6 kinase 3, RSK-3) (pp90RSK3)"	RPS6KA2 MAPKAPK1C RSK3	Homo sapiens (Human)	brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001556; GO:0002035; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007268; GO:0007507; GO:0008285; GO:0010628; GO:0010659; GO:0018105; GO:0035556; GO:0043065; GO:0045202; GO:0045786; GO:0045835; GO:0060047; GO:0070613; GO:0071322; GO:0072687; GO:0106310	MDLSMKK	13.03999996	0.52723223	0.52723223	0.194348685	852.4909061	0	0	10.51201	0	0	15.84095	16.60219	0	0	0	15.13173	0	0	0	0	0	0	0	0	0	14.60386	0	9.923775	0	16.01339	0	0	0	15.50733	16.84521	0	0	0	0	16.27458	0	0	0	0	0	0	0	0	0	13.87326	0	0	15.9082
Q15365	PCBP1_HUMAN	"Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1, hnRNP E1) (Nucleic acid-binding protein SUB2.3)"	PCBP1	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]"	"cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]"	GO:0000981; GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010468; GO:0016020; GO:0016607; GO:0036464; GO:0039694; GO:0045296; GO:0045944; GO:0051252; GO:0070062; GO:0098847	GMGCS	2.75	0.142886505	0.142886505	0.241650339	510.035216	23.60294	0	0	0	21.63396	22.42804	17.68967	0	20.92361	23.57718	21.33696	17.01475	23.33804	15.96519	23.99295	22.80141	22.07223	23.04521	17.63911	22.88627	23.42544	23.0835	0	23.43832	0	23.484	22.94203	15.77489	23.35035	23.75535	20.16621	22.98475	0	23.44913	22.87537	22.73927	0	23.11452	23.00313	0	23.38743	23.28196	22.73921	23.41472	0	23.42832	22.73858	24.0261
Q15366	PCBP2_HUMAN	"Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2, hnRNP E2)"	PCBP2	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; mRNA metabolic process [GO:0016071]; negative regulation of defense response to virus [GO:0050687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; C-rich single-stranded DNA binding [GO:1990829]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; mRNA metabolic process [GO:0016071]; negative regulation of defense response to virus [GO:0050687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]	C-rich single-stranded DNA binding [GO:1990829]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]	GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0010468; GO:0014069; GO:0016020; GO:0016071; GO:0019899; GO:0031625; GO:0039694; GO:0043161; GO:0045087; GO:0045944; GO:0050687; GO:0051252; GO:0051607; GO:0070062; GO:0075522; GO:1990829	AITIAGIPQSIIECVK	4.929999828	0.866804361	0.866804361	0.139822709	1713.499919	15.01248	13.65551	17.05215	14.54939	13.64053	9.847911	14.52252	14.12039	14.3894	14.50056	12.3312	0	15.53591	0	0	12.40324	0	18.53643	12.76427	0	13.09525	0	15.3377	16.87931	13.12719	0	17.3785	15.06971	12.01329	15.40487	14.99747	14.77547	15.96783	0	0	12.70211	0	17.05424	16.0496	0	16.72087	12.0777	14.59219	16.62446	13.69392	0	0	0
Q15370	ELOB_HUMAN	"Elongin-B, EloB (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)"	ELOB TCEB2	Homo sapiens (Human)	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891]	Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]	GO:0001222; GO:0005654; GO:0005829; GO:0006367; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0032436; GO:0065003; GO:0070449	MDVFLMIR	6.75	1	1	6.93E-13	1041.399748	16.91127	0	0	0	16.21964	15.96989	0	0	0	0	0	0	0	0	0	0	0	0	17.10188	0	15.1969	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.68043	0	0	0
Q15375	EPHA7_HUMAN	"Ephrin type-A receptor 7, EC 2.7.10.1 (EPH homology kinase 3, EHK-3) (EPH-like kinase 11, EK11, hEK11)"	EPHA7 EHK3 HEK11	Homo sapiens (Human)	apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; phosphorylation [GO:0016310]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]	dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; phosphorylation [GO:0016310]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006915; GO:0007169; GO:0007411; GO:0007420; GO:0008046; GO:0016310; GO:0019838; GO:0022407; GO:0030425; GO:0031290; GO:0031594; GO:0031952; GO:0033674; GO:0043005; GO:0043025; GO:0043235; GO:0043281; GO:0043525; GO:0045499; GO:0046875; GO:0048013; GO:0048671; GO:0048755; GO:0050730; GO:0050919; GO:0051964; GO:0070372; GO:0072178; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0099175	GIAAGMRYLADMGYVHR	9.75	1	1	0.191338446	1895.883445	0	0	0	0	14.39492	0	13.71306	13.94212	0	0	0	14.63934	16.3448	0	15.79043	15.21084	14.68311	0	16.35615	16.28281	0	0	16.59892	0	0	0	0	16.56197	0	16.38242	0	0	0	17.31074	15.75247	0	0	16.92091	0	13.90661	0	0	0	0	0	0	0	0
Q15386	UBE3C_HUMAN	"Ubiquitin-protein ligase E3C, EC 2.3.2.26 (HECT-type ubiquitin transferase E3C) (Homologous to E6AP carboxyl terminus homologous protein 2, HectH2) (RTA-associated ubiquitin ligase, RAUL)"	UBE3C KIAA0010 KIAA10	Homo sapiens (Human)	protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; proteasome complex [GO:0000502]	nucleus [GO:0005634]; proteasome complex [GO:0000502]; ubiquitin protein ligase activity [GO:0061630]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0000502; GO:0005634; GO:0006511; GO:0035519; GO:0061630; GO:0070936	IGPLQSTLDVGLESPPLSVSEER	2.039999962	1	1	9.20E-13	2422.433004	15.57288	0	0	0	0	14.99924	0	0	16.27801	15.85001	0	15.58666	0	15.06755	0	15.29492	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.79684	0	0	0	0	12.9656	0	0	0	0	0	0
Q15388	TOM20_HUMAN	Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20)	TOMM20 KIAA0016	Homo sapiens (Human)	"protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; response to 3,3',5-triiodo-L-thyronine [GO:1905242]; response to muscle activity [GO:0014850]; tRNA import into mitochondrion [GO:0016031]"	integral component of mitochondrial outer membrane [GO:0031307]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]	"integral component of mitochondrial outer membrane [GO:0031307]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; response to 3,3',5-triiodo-L-thyronine [GO:1905242]; response to muscle activity [GO:0014850]; tRNA import into mitochondrion [GO:0016031]"	mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082]	GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0014850; GO:0015450; GO:0016031; GO:0030150; GO:0030943; GO:0031307; GO:0044233; GO:0045040; GO:0051082; GO:0097225; GO:1905242	RSDPNFK	6.199999809	1	1	0.111754318	864.0510605	15.3184	13.99699	14.02648	15.21816	15.34097	13.57495	15.02234	13.04338	0	16.2436	14.95108	0	14.6809	11.7154	13.40811	15.98567	0	14.38741	13.8474	12.85316	14.28077	0	15.4475	16.58121	13.65137	0	15.57589	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.40606	0	0	0
Q15389	ANGP1_HUMAN	"Angiopoietin-1, ANG-1"	ANGPT1 KIAA0003	Homo sapiens (Human)	activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014]	identical protein binding [GO:0042802]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0001701; GO:0001933; GO:0001934; GO:0002040; GO:0002092; GO:0002719; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0005902; GO:0007162; GO:0007171; GO:0010595; GO:0010628; GO:0014068; GO:0014842; GO:0030097; GO:0030154; GO:0030210; GO:0030971; GO:0031398; GO:0031589; GO:0032680; GO:0033138; GO:0034394; GO:0042308; GO:0042802; GO:0043066; GO:0043116; GO:0043122; GO:0043393; GO:0043524; GO:0043536; GO:0045121; GO:0045785; GO:0048014; GO:0050731; GO:0050918; GO:0051897; GO:0062023; GO:0070062; GO:0070374; GO:0072012; GO:1905605; GO:2000352; GO:2000446	GHTGTAGK	6.960000038	1	1	0.164257753	729.2719082	0	0	0	0	0	0	16.01136	0	0	16.46862	16.26711	0	0	0	0	15.92014	16.58115	0	0	0	0	0	16.82917	0	0	0	17.02034	17.09714	0	0	16.29216	15.93441	0	0	15.64795	0	0	17.38886	0	16.20958	0	0	16.14528	0	0	16.68846	14.21415	0
Q15390	MTFR1_HUMAN	Mitochondrial fission regulator 1 (Chondrocyte protein with a poly-proline region)	MTFR1 CHPPR FAM54A2 KIAA0009	Homo sapiens (Human)	aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]		GO:0000266; GO:0005739; GO:0005829; GO:0005886; GO:0007005; GO:0009060	VLFGPHMLKPTGK	10.31000042	0.458219171	0.458219171	0.067699449	1440.247764	14.25767	14.77194	0	0	15.17551	0	0	0	0	0	15.65069	12.74558	13.2456	13.88673	13.88605	0	0	14.01676	12.54649	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.37911	0
Q15391	P2Y14_HUMAN	"P2Y purinoceptor 14, P2Y14 (G-protein coupled receptor 105) (UDP-glucose receptor)"	P2RY14 GPR105 KIAA0001	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UDP receptor activity [GO:0045029]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UDP receptor activity [GO:0045029]	GO:0005886; GO:0007186; GO:0016021; GO:0045028; GO:0045029	SFIIYLK	4.880000114	0.788902283	0.788902283	0.238789586	883.4708494	0	18.25076	16.59179	0	15.38746	0	0	0	0	16.76071	19.29826	13.61893	0	0	0	0	0	0	0	0	0	15.09783	16.93331	0	14.57848	15.12804	16.03352	15.09992	0	0	16.91413	15.43333	14.46022	0	15.15438	0	0	0	15.95247	15.13503	0	0	0	14.85781	0	0	0	0
Q15393	SF3B3_HUMAN	"Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit, SF3b130) (STAF130) (Spliceosome-associated protein 130, SAP 130)"	SF3B3 KIAA0017 SAP130	Homo sapiens (Human)	"histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]	"catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; protein-containing complex binding [GO:0044877]; U2 snRNA binding [GO:0030620]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	protein-containing complex binding [GO:0044877]; U2 snRNA binding [GO:0030620]	GO:0000124; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0005689; GO:0005730; GO:0006282; GO:0008380; GO:0030620; GO:0035521; GO:0035522; GO:0042177; GO:0043484; GO:0043966; GO:0044877; GO:0045893; GO:0071005; GO:0071013	SEHPPLCGRDHLSFR	4.980000019	1	1	0.342929193	1804.238782	11.73533	15.3589	0	9.831487	0	13.02746	14.79028	0	0	15.51257	0	13.30655	15.14274	0	0	0	0	16.07712	0	15.01231	0	16.71077	15.91864	0	0	0	0	0	0	0	0	0	0	0	0	16.36086	0	0	0	0	0	0	0	0	0	0	0	0
Q15397	PUM3_HUMAN	"Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8, HLA-HA8)"	PUM3 cPERP-C KIAA0020 PUF-A XTP5	Homo sapiens (Human)	regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0006417; GO:0010835	EGGPK	2.450000048	1	1	0.200973859	487.4227964	0	0	16.38727	15.72904	14.96386	15.24891	15.34184	16.03811	0	16.19232	0	0	14.81978	15.16652	0	15.82825	15.53854	0	0	0	0	16.70503	0	0	0	0	0	0	15.89977	0	16.02078	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15398	DLGP5_HUMAN	"Disks large-associated protein 5, DAP-5 (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein, HURP)"	DLGAP5 DLG7 KIAA0008	Homo sapiens (Human)	centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; microtubule binding [GO:0008017]; centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052]	microtubule binding [GO:0008017]	GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007052; GO:0007059; GO:0007079; GO:0007346; GO:0008017; GO:0023052; GO:0031616; GO:0034451; GO:0045842; GO:0051382; GO:0051642	NVETKPDK	8.479999542	0.219535992	0.219535992	0.16162088	931.486156	0	16.14426	17.3172	18.1318	17.74934	15.93419	18.06581	18.27695	16.96516	16.40203	18.47642	17.58895	16.70465	16.59378	17.43167	14.95142	16.92039	17.65883	18.18448	16.10512	17.69122	17.34088	18.61052	15.51696	16.50794	15.424	14.57117	16.07439	17.29985	0	17.41223	17.75926	0	14.36514	0	15.59572	14.1303	19.55841	17.0465	16.43272	0	16.91544	16.68157	0	16.47082	0	16.45361	16.48455
Q15399	TLR1_HUMAN	"Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein, TIL) (CD antigen CD281)"	TLR1 KIAA0012	Homo sapiens (Human)	cell activation [GO:0001775]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]	"Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; cell activation [GO:0001775]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]"	"identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]"	GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0032755; GO:0032757; GO:0032760; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0042116; GO:0042495; GO:0042802; GO:0043235; GO:0045087; GO:0045121; GO:0050135; GO:0061809; GO:0071221; GO:0071723; GO:0071727	ILIISHNR	11.84000015	1	1	0.243118019	966.6717345	17.5034	17.03132	13.58961	17.67095	17.89412	14.1697	14.86125	12.41632	17.68938	10.23153	18.17527	14.92597	17.1696	11.83974	16.91036	13.61101	12.66115	14.91261	18.38997	11.9342	14.86467	17.48967	8.000308	16.70778	14.53007	15.41445	18.3373	0	0	17.77201	14.62482	0	0	18.64263	17.78003	17.25582	0	0	16.47564	0	0	18.00447	16.56945	0	17.33299	13.8096	0	0
Q15404	RSU1_HUMAN	"Ras suppressor protein 1, RSP-1, Rsu-1"	RSU1 RSP1	Homo sapiens (Human)	positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]		GO:0005829; GO:0005925; GO:0007165; GO:0010811; GO:0043547; GO:0070062	LTVLPPELGNLDLTGQK	11.48999977	1	1	0.140168838	1807.014684	13.22316	0	0	0	0	0	14.65671	0	0	0	0	0	0	0	15.51493	0	0	0	0	0	15.42573	0	0	0	16.2854	15.24775	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.01506	0	14.24346	0	16.70412	15.67776
Q15406	NR6A1_HUMAN	"Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor, GCNF, hGCNF) (Retinoid receptor-related testis-specific receptor, RTR, hRTR)"	NR6A1 GCNF	Homo sapiens (Human)	gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0004879; GO:0005654; GO:0005667; GO:0006357; GO:0007276; GO:0008270; GO:0042803; GO:0043565; GO:1990837	YWYICQDFTEYK	7.579999924	1	1	0.073677699	1711.452145	0	0	0	0	0	0	0	0	0	0	15.08469	14.43588	15.56897	0	0	0	15.99373	0	0	0	0	0	0	15.97539	0	0	0	0	15.09792	12.83946	15.99255	0	0	12.08094	13.84237	16.54884	0	15.72939	0	13.97204	15.03342	0	16.28045	17.32292	0	0	0	0
Q15413	RYR3_HUMAN	"Ryanodine receptor 3, RYR-3, RyR3 (Brain ryanodine receptor-calcium release channel) (Brain-type ryanodine receptor) (Type 3 ryanodine receptor)"	RYR3 HBRR	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to ATP [GO:0071318]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; cellular response to magnesium ion [GO:0071286]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209]	calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]	calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to ATP [GO:0071318]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; cellular response to magnesium ion [GO:0071286]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209]	calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]	GO:0005219; GO:0005509; GO:0005516; GO:0005790; GO:0005886; GO:0006816; GO:0015278; GO:0016021; GO:0016529; GO:0030018; GO:0030659; GO:0033017; GO:0034704; GO:0042383; GO:0048763; GO:0051209; GO:0051289; GO:0070588; GO:0071277; GO:0071286; GO:0071313; GO:0071318	AQDAK	5.71999979	0.285290956	0.285290956	0.237458569	534.0189823	13.01365	14.29813	13.24821	9.855077	14.84747	0	0	0	0	15.6265	15.29162	15.51746	14.56917	0	15.73638	0	14.86852	13.11205	15.45018	15.64422	0	0	14.68797	0	14.79642	15.73075	0	15.0862	15.2582	15.14324	14.79061	0	0	15.32981	13.88795	14.91078	0	11.92817	0	15.31524	15.10121	15.97231	16.58428	14.79288	15.21128	0	0	16.13178
Q15418	KS6A1_HUMAN	"Ribosomal protein S6 kinase alpha-1, S6K-alpha-1, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 1, p90-RSK 1, p90RSK1, p90S6K) (MAP kinase-activated protein kinase 1a, MAPK-activated protein kinase 1a, MAPKAP kinase 1a, MAPKAPK-1a) (Ribosomal S6 kinase 1, RSK-1)"	RPS6KA1 MAPKAPK1A RSK1	Homo sapiens (Human)	"cell cycle [GO:0007049]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]"	ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007268; GO:0018105; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045202; GO:0045597; GO:0045893; GO:0045944; GO:0072574; GO:0106310; GO:2000491	AKLGMPQFLSTEAQSLLR	4.420000076	0.336288393	0.336288393	0.103843316	2005.465821	13.79205	16.03595	15.89767	0	12.40114	14.86224	15.75383	14.82602	15.89243	0	12.21299	0	0	15.47564	15.27943	0	14.01443	15.62598	15.84016	0	0	0	0	14.13032	15.37047	15.14159	0	0	16.72257	13.70803	15.45011	15.04206	15.52212	16.5078	14.6793	15.09613	16.86231	15.66769	0	15.10644	14.97207	15.23445	0	0	0	16.36841	0	15.51357
Q15424	SAFB1_HUMAN	"Scaffold attachment factor B1, SAF-B, SAF-B1 (HSP27 estrogen response element-TATA box-binding protein, HSP27 ERE-TATA-binding protein)"	SAFB HAP HET SAFB1	Homo sapiens (Human)	chromatin organization [GO:0006325]; intracellular estrogen receptor signaling pathway [GO:0030520]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; intracellular estrogen receptor signaling pathway [GO:0030520]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	GO:0000978; GO:0003682; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0030496; GO:0030520; GO:0043565; GO:0050684	DSESHSR	6.360000134	0.882324994	0.882324994	0.228156106	817.0793664	0	15.15632	12.38712	0	10.25619	13.5558	0	15.3165	13.36601	13.9424	14.99641	0	12.83916	16.45246	15.33264	14.63492	0	15.24411	0	0	13.09551	0	0	0	13.78304	14.51284	15.3134	15.22184	11.95566	14.43856	13.97138	12.35853	16.30741	0	14.94468	0	0	0	0	0	0	0	0	0	0	0	17.45284	14.65572
Q15431	SYCP1_HUMAN	"Synaptonemal complex protein 1, SCP-1 (Cancer/testis antigen 8, CT8)"	SYCP1 SCP1	Homo sapiens (Human)	cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]	"central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; male germ cell nucleus [GO:0001673]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]"	"central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; male germ cell nucleus [GO:0001673]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]"	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]	GO:0000711; GO:0000775; GO:0000795; GO:0000801; GO:0000802; GO:0001673; GO:0003677; GO:0003690; GO:0005694; GO:0007129; GO:0007130; GO:0007131; GO:0007283; GO:0032880; GO:0035092; GO:0051026; GO:0051289; GO:0051301; GO:0051878	DEVKCK	5.880000114	1	1	0.025585239	778.1535973	0	0	0	0	15.37327	16.19477	0	0	15.75509	17.38737	0	0	0	13.07902	15.53268	0	17.36049	15.32981	0	0	0	0	0	14.28784	0	15.09181	17.91743	15.10567	13.06324	0	15.64496	16.84466	0	14.84604	0	16.94535	0	0	15.84213	15.95042	0	15.94191	12.65357	0	0	0	0	11.89262
Q15434	RBMS2_HUMAN	"RNA-binding motif, single-stranded-interacting protein 2 (Suppressor of CDC2 with RNA-binding motif 3)"	RBMS2 SCR3	Homo sapiens (Human)	RNA processing [GO:0006396]	cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA processing [GO:0006396]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006396; GO:0008143; GO:0008266; GO:1990904	CEAIITHFNGK	11.81000042	1	1	0.242827635	1290.230025	0	15.82556	12.23182	0	0	16.24511	16.3685	0	0	0	0	12.1513	15.94956	13.74137	13.74543	14.73415	0	16.66174	0	0	15.04445	14.286	15.65369	0	0	14.54243	0	0	0	0	15.61317	0	0	0	16.57698	0	0	14.5551	0	0	0	0	0	0	0	15.67937	0	0
Q15436	SC23A_HUMAN	"Protein transport protein Sec23A, hSec23A (SEC23-related protein A)"	SEC23A	Homo sapiens (Human)	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012507; GO:0019898; GO:0030127; GO:0048471; GO:0070971; GO:0072659; GO:0090110	LAVSSAA	4.019999981	1	1	0.255367905	618.7730428	16.17269	0	12.52288	0	0	14.95933	16.28214	0	0	0	0	0	0	16.49193	0	15.25921	13.55518	0	0	0	0	0	16.45263	0	0	15.57029	15.74798	0	0	0	0	0	0	0	0	0	0	0	0	16.96142	17.12939	0	0	0	0	0	15.91854	0
Q15437	SC23B_HUMAN	"Protein transport protein Sec23B, hSec23B (SEC23-related protein B)"	SEC23B	Homo sapiens (Human)	COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]	COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]	GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]	GO:0005096; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012505; GO:0030127; GO:0048471; GO:0070971; GO:0090110	LSDSFSLYPQFMFHLRR	2.480000019	1	1	0.112506024	2141.016275	0	0	15.23759	0	0	0	0	15.35833	0	0	0	16.37587	0	12.35411	0	0	0	14.04948	0	14.06345	0	15.03996	0	0	11.45883	0	0	0	14.01721	0	14.61105	15.15933	0	0	12.17935	14.61596	0	0	0	0	15.02608	13.24089	0	0	0	0	0	0
Q15459	SF3A1_HUMAN	"Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114, SAP 114)"	SF3A1 SAP114	Homo sapiens (Human)	"mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]"	RNA binding [GO:0003723]	GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241	MQEHMR	8.600000381	1	1	0.292286666	831.0404863	0	18.57569	0	0	18.38471	0	0	0	18.49764	16.49102	0	0	15.75132	16.47712	17.92108	0	0	0	0	0	17.45505	0	0	18.3556	0	0	0	0	17.65736	17.34649	0	17.8139	20.22981	19.28976	0	18.2002	0	17.33354	0	0	0	0	0	17.5158	0	17.55871	0	0
Q15465	SHH_HUMAN	"Sonic hedgehog protein, SHH (HHG-1) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains, ShhNC) [Cleaved into: Sonic hedgehog protein N-product, ShhN (Shh N-terminal processed signaling domains, ShhNp) ]"	SHH	Homo sapiens (Human)	"androgen metabolic process [GO:0008209]; animal organ formation [GO:0048645]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of cell polarity [GO:0030010]; forebrain development [GO:0030900]; formation of anatomical boundary [GO:0048859]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; myotube differentiation [GO:0014902]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron fate commitment [GO:0048663]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein localization to nucleus [GO:0034504]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900175]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; vasculogenesis [GO:0001570]; ventral midline development [GO:0007418]"	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; zinc ion binding [GO:0008270]; androgen metabolic process [GO:0008209]; animal organ formation [GO:0048645]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of cell polarity [GO:0030010]; forebrain development [GO:0030900]; formation of anatomical boundary [GO:0048859]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; myotube differentiation [GO:0014902]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron fate commitment [GO:0048663]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein localization to nucleus [GO:0034504]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900175]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; vasculogenesis [GO:0001570]; ventral midline development [GO:0007418]"	calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000139; GO:0001569; GO:0001570; GO:0001656; GO:0001658; GO:0001708; GO:0001755; GO:0001947; GO:0002052; GO:0002076; GO:0002320; GO:0003140; GO:0004175; GO:0005113; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006897; GO:0007224; GO:0007228; GO:0007267; GO:0007389; GO:0007398; GO:0007405; GO:0007411; GO:0007417; GO:0007418; GO:0007442; GO:0007507; GO:0007596; GO:0008209; GO:0008270; GO:0008284; GO:0009880; GO:0009949; GO:0009953; GO:0009986; GO:0010468; GO:0010628; GO:0010629; GO:0014003; GO:0014706; GO:0014858; GO:0014902; GO:0016015; GO:0016539; GO:0016540; GO:0021513; GO:0021522; GO:0021794; GO:0021904; GO:0021930; GO:0021938; GO:0021978; GO:0030010; GO:0030162; GO:0030177; GO:0030324; GO:0030326; GO:0030336; GO:0030539; GO:0030850; GO:0030878; GO:0030900; GO:0030901; GO:0030902; GO:0031016; GO:0031069; GO:0032435; GO:0033077; GO:0033089; GO:0033092; GO:0034244; GO:0034504; GO:0035115; GO:0035116; GO:0042127; GO:0042130; GO:0042307; GO:0042475; GO:0042481; GO:0042733; GO:0043010; GO:0043066; GO:0043237; GO:0043369; GO:0045059; GO:0045060; GO:0045109; GO:0045121; GO:0045445; GO:0045596; GO:0045880; GO:0045893; GO:0045944; GO:0046638; GO:0046639; GO:0048468; GO:0048538; GO:0048557; GO:0048617; GO:0048643; GO:0048645; GO:0048663; GO:0048706; GO:0048709; GO:0048714; GO:0048745; GO:0048754; GO:0048839; GO:0048859; GO:0048864; GO:0051155; GO:0051781; GO:0060020; GO:0060021; GO:0060070; GO:0060174; GO:0060428; GO:0060439; GO:0060445; GO:0060447; GO:0060458; GO:0060459; GO:0060463; GO:0060484; GO:0060516; GO:0060523; GO:0060662; GO:0060664; GO:0060685; GO:0060738; GO:0060769; GO:0060782; GO:0060783; GO:0060840; GO:0060916; GO:0061053; GO:0061189; GO:0062023; GO:0071285; GO:0071542; GO:0072136; GO:0072205; GO:0090090; GO:0090370; GO:0097190; GO:1900175; GO:1900180; GO:1904339; GO:1905327; GO:2000062; GO:2000063; GO:2000357; GO:2000358; GO:2000729; GO:2001054	MLLLARCLLLVLVSSLLVCSGLACGPGR	7.039999962	1	1	4.58E-13	3058.379744	15.58539	15.25342	13.86627	0	0	11.8682	0	0	13.21633	0	0	0	0	0	0	0	0	0	13.96716	0	0	0	0	0	12.53105	9.006156	0	0	0	0	0	0	0	0	0	0	14.46122	0	0	14.95511	7.610174	0	0	0	0	0	12.39724	0
Q15468	STIL_HUMAN	SCL-interrupting locus protein (TAL-1-interrupting locus protein)	STIL SIL	Homo sapiens (Human)	centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099]; identical protein binding [GO:0042802]; centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224]	identical protein binding [GO:0042802]	GO:0000578; GO:0001701; GO:0001843; GO:0001947; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007052; GO:0007224; GO:0007368; GO:0021915; GO:0030900; GO:0030903; GO:0033504; GO:0035264; GO:0042802; GO:0043066; GO:0046599; GO:0046601; GO:0051298; GO:0060236; GO:0071539; GO:0120099; GO:1900087; GO:1905832	TESDNGMMGLSPDAYR	4.489999771	1	1	0.283693785	1759.580182	0	0	0	0	0	0	15.27533	0	15.45915	0	0	0	0	0	0	0	0	0	0	0	0	16.49172	0	0	0	0	0	16.04771	0	12.55689	14.37576	15.46505	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15477	SKIV2_HUMAN	"Helicase SKI2W, Ski2, EC 3.6.4.- (Helicase-like protein, HLP)"	SKIV2L DDX13 SKI2W SKIV2 W	Homo sapiens (Human)	"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"	cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]	"cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]"	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0016787; GO:0055087; GO:0070478	VLFATETFAMGVNMPARTVVFDSMR	1.440000057	1	1	3.66E-12	2799.999211	14.15381	0	0	0	0	15.26275	13.91289	0	15.92543	0	0	13.32348	0	14.89677	9.989975	0	0	0	14.94706	0	0	13.57139	12.59199	0	0	15.49647	0	15.13553	14.61804	0	15.72706	0	13.36263	14.87902	15.2318	0	0	14.0729	0	0	0	0	0	0	0	0	0	0
Q15485	FCN2_HUMAN	Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35)	FCN2 FCNL	Homo sapiens (Human)	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]"	blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]	"blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]"	antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065	GEAGTNGK	1.840000033	1	1	0.157672114	733.4866622	0	18.11256	16.85279	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.52026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15493	RGN_HUMAN	"Regucalcin, RC (Gluconolactonase, GNL, EC 3.1.1.17) (Senescence marker protein 30, SMP-30)"	RGN SMP30	Homo sapiens (Human)	aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283]	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]	GO:0001822; GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0006874; GO:0007283; GO:0007568; GO:0008270; GO:0010867; GO:0010907; GO:0010922; GO:0019853; GO:0030234; GO:0032515; GO:0032781; GO:0034260; GO:0043066; GO:0043547; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0051344; GO:0097421; GO:1901318; GO:1901671; GO:1901896; GO:1902679; GO:1903011; GO:1903052; GO:1903611; GO:1903625; GO:1903629; GO:1903634; GO:2000279	FNDGKVDPAGR	5.860000134	0.228776529	0.228776529	0.036822641	1174.543939	15.83296	16.87434	14.95435	0	15.68606	14.33862	0	15.35677	14.37867	0	0	0	18.4456	0	0	17.48243	0	11.9351	0	14.94943	16.38657	0	12.29327	0	14.32506	0	16.63074	13.05512	12.05658	11.24432	0	16.5329	15.57212	0	12.58123	0	14.39541	17.36042	16.6898	0	10.95629	0	15.59973	12.69345	12.59004	11.17614	14.46066	15.87091
Q15506	SP17_HUMAN	"Sperm surface protein Sp17 (Cancer/testis antigen 22, CT22) (Sp17-1) (Sperm autoantigenic protein 17, Sperm protein 17)"	SPA17 SP17	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]	cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]	cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]	calmodulin binding [GO:0005516]	GO:0003351; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0007283; GO:0007338; GO:0007339; GO:0009897; GO:0031514; GO:0035686; GO:0097228	IQAAFR	4.260000229	1	1	0.21783419	704.2314769	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.85241	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15527	SURF2_HUMAN	"Surfeit locus protein 2, Surf-2"	SURF2	Homo sapiens (Human)		nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0005654; GO:0005730; GO:0005886; GO:0016607	CPEHVLR	5.480000019	1	1	0.235258609	910.8126736	15.24185	0	13.68841	0	0	15.57738	0	14.64599	15.96961	14.5876	15.16571	15.67898	15.80579	0	15.49254	0	11.89893	0	0	0	0	0	0	0	0	0	0	0	14.54206	15.01886	0	15.56028	0	0	0	0	0	0	0	16.75351	0	0	0	0	0	0	14.45136	0
Q15532	SSXT_HUMAN	Protein SSXT (Protein SYT) (Synovial sarcoma translocated to X chromosome protein)	SS18 SSXT SYT	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell differentiation [GO:0045596]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]	chromatin [GO:0000785]; GBAF complex [GO:0140288]; microtubule cytoskeleton [GO:0015630]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	chromatin [GO:0000785]; GBAF complex [GO:0140288]; microtubule cytoskeleton [GO:0015630]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; nuclear receptor coactivator activity [GO:0030374]; cell morphogenesis [GO:0000902]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell differentiation [GO:0045596]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]	nuclear receptor coactivator activity [GO:0030374]	GO:0000226; GO:0000785; GO:0000902; GO:0005634; GO:0006338; GO:0006357; GO:0008284; GO:0009410; GO:0015630; GO:0016514; GO:0030374; GO:0035556; GO:0045596; GO:0045944; GO:0048013; GO:0071564; GO:0097150; GO:0140288; GO:1902459	GKGEITPAAIQK	10.48999977	1	1	0.122086713	1212.38833	0	0	14.88029	0	0	16.1406	0	13.10238	14.60069	16.19485	0	0	14.7437	16.56722	0	16.41497	17.33258	16.71069	16.65495	0	14.69573	17.66679	0	0	0	0	16.42715	14.48867	11.89367	16.14767	0	18.08319	17.61259	13.64428	17.50997	16.34795	14.23384	16.63669	0	14.74249	0	14.82118	17.52243	17.17918	16.72976	15.90909	0	15.15228
Q15544	TAF11_HUMAN	"Transcription initiation factor TFIID subunit 11 (TFIID subunit p30-beta) (Transcription initiation factor TFIID 28 kDa subunit, TAF(II)28, TAFII-28, TAFII28)"	TAF11 TAF2I PRO2134	Homo sapiens (Human)	mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; vitamin D receptor binding [GO:0042809]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; vitamin D receptor binding [GO:0042809]	GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0005794; GO:0006366; GO:0006367; GO:0006468; GO:0016251; GO:0017025; GO:0042789; GO:0042809; GO:0043923; GO:0046966; GO:0046982; GO:0047485; GO:0051123; GO:0060261	SKGQIPNSK	10.15999985	0.746895432	0.746895432	0.216593987	957.4799568	0	0	0	17.61056	18.24173	0	0	0	0	0	0	0	16.96121	17.19569	18.53914	17.09748	17.69081	16.06326	0	16.3943	17.13762	17.25402	18.76011	0	0	17.55049	17.63378	17.51046	0	17.00828	0	18.19991	18.05994	17.81246	16.84833	18.31557	18.51499	18.44258	17.64178	17.67785	16.97963	15.31872	0	17.18137	17.24149	17.38371	18.78109	16.87954
Q15560	TCEA2_HUMAN	Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l)	TCEA2	Homo sapiens (Human)	"DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]"	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]	"centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]"	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005654; GO:0005813; GO:0006351; GO:0006354; GO:0006368; GO:0008023; GO:0008270; GO:0032784; GO:0045944	LSAQIEECIFR	8.119999886	0.903567612	0.903567612	0.235145196	1364.840502	0	0	0	15.77065	0	12.576	0	0	12.09172	0	12.85743	14.21077	15.93161	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.71482	0	14.78713	17.0634	0	15.68638	0	0	0	0	14.99518	17.13651	14.25882	0	0	0	0	14.44355	0
Q15562	TEAD2_HUMAN	"Transcriptional enhancer factor TEF-4 (TEA domain family member 2, TEAD-2)"	TEAD2 TEF4	Homo sapiens (Human)	"cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; negative regulation of cell death [GO:0060548]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; vasculogenesis [GO:0001570]"	chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; negative regulation of cell death [GO:0060548]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; vasculogenesis [GO:0001570]"	"disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]"	GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001570; GO:0001843; GO:0003143; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006355; GO:0006357; GO:0030903; GO:0035329; GO:0043231; GO:0045893; GO:0045944; GO:0048339; GO:0048368; GO:0048568; GO:0060548; GO:0065003; GO:0071300; GO:0097718; GO:0140552; GO:1990837; GO:2000736	MGEPR	9.279999733	1.28E-10	1.28E-10	0.263218946	587.2424438	0	18.37471	0	0	18.17223	0	0	0	18.85059	0	0	0	17.57753	17.72501	0	0	16.37462	15.79789	0	0	17.55178	0	0	0	0	17.98033	17.35436	0	0	0	0	19.07206	19.08138	18.01139	18.56179	18.55322	0	0	17.70273	18.47965	0	18.72436	0	0	0	0	16.74571	18.55484
Q15572	TAF1C_HUMAN	"TATA box-binding protein-associated factor RNA polymerase I subunit C (RNA polymerase I-specific TBP-associated factor 110 kDa, TAFI110) (TATA box-binding protein-associated factor 1C, TBP-associated factor 1C) (Transcription initiation factor SL1/TIF-IB subunit C)"	TAF1C	Homo sapiens (Human)	transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361]	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361]	RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]	GO:0001164; GO:0001181; GO:0001650; GO:0005654; GO:0005730; GO:0006360; GO:0006361; GO:0006366	SQQHTPVLSSSQPLR	5.179999828	1	1	0.434431172	1665.884343	15.08286	0	0	14.64399	15.20015	11.67422	14.60617	14.65035	0	0	13.91047	0	0	14.72824	15.30187	11.748	0	0	15.7082	0	0	0	0	0	0	0	0	0	0	0	0	14.52672	0	0	0	0	0	0	16.22186	0	0	0	0	15.67548	0	0	0	0
Q15573	TAF1A_HUMAN	"TATA box-binding protein-associated factor RNA polymerase I subunit A (RNA polymerase I-specific TBP-associated factor 48 kDa, TAFI48) (TATA box-binding protein-associated factor 1A, TBP-associated factor 1A) (Transcription factor SL1) (Transcription initiation factor SL1/TIF-IB subunit A)"	TAF1A	Homo sapiens (Human)	transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]	microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; RNA polymerase I transcription regulator complex [GO:0000120]	microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; RNA polymerase I transcription regulator complex [GO:0000120]; DNA binding [GO:0003677]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]	DNA binding [GO:0003677]	GO:0000120; GO:0003677; GO:0005654; GO:0006360; GO:0006366; GO:0015630	HGENTSSR	7.5	1	1	0.239757178	888.1878557	15.09367	15.45719	15.71017	0	0	15.50012	14.89987	15.18898	14.10615	15.89482	0	0	12.8724	16.10593	14.94985	15.08799	13.09577	14.67577	17.45289	15.39629	16.60858	14.75614	14.90548	15.88738	15.0092	13.80519	14.44332	0	0	0	16.30435	0	15.64207	0	15.94359	0	16.48253	0	0	0	15.32771	0	0	16.22482	0	16.99783	15.47909	0
Q15582	BGH3_HUMAN	"Transforming growth factor-beta-induced protein ig-h3, Beta ig-h3 (Kerato-epithelin) (RGD-containing collagen-associated protein, RGD-CAP)"	TGFBI BIGH3	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0050896; GO:0062023; GO:0070062	LLERMK	4.889999866	0.665235758	0.665235758	0.223947523	788.5073719	13.42495	14.46821	14.26898	18.00662	15.15724	14.45871	15.71493	15.14963	0	18.08778	15.26486	15.87094	15.54113	15.61296	13.7628	13.30332	0	16.24996	12.79791	15.96461	14.9743	14.79338	14.50464	15.88058	0	0	0	0	0	0	14.15109	15.99829	15.6125	13.84534	15.59082	0	14.67642	15.32307	0	16.46927	0	0	0	15.45883	15.33573	0	0	0
Q15596	NCOA2_HUMAN	"Nuclear receptor coactivator 2, NCoA-2 (Class E basic helix-loop-helix protein 75, bHLHe75) (Transcriptional intermediary factor 2, hTIF2)"	NCOA2 BHLHE75 SRC2 TIF2	Homo sapiens (Human)	"cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to progesterone [GO:0032570]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription coactivator activity [GO:0003713]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription, DNA-templated [GO:0006355]; response to progesterone [GO:0032570]"	aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000785; GO:0000978; GO:0001162; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0010906; GO:0016604; GO:0016922; GO:0017162; GO:0019904; GO:0030374; GO:0032570; GO:0032870; GO:0032922; GO:0032991; GO:0035357; GO:0042789; GO:0045475; GO:0045944; GO:0046983; GO:0090575; GO:1900076; GO:1904017; GO:1904179	EQMGMPMGR	3.299999952	0.592853248	0.592853248	0.245796802	1067.871744	13.1418	14.51709	15.29163	0	0	14.07853	0	15.40683	14.31999	0	0	14.67333	0	0	0	14.40332	0	0	15.15834	14.94544	0	0	15.3037	0	0	0	0	15.20536	0	0	0	11.63531	0	10.43104	0	0	0	0	0	0	0	0	0	0	13.06349	0	0	0
Q155Q3	DIXC1_HUMAN	"Dixin (Coiled-coil protein DIX1, Coiled-coil-DIX1) (DIX domain-containing protein 1)"	DIXDC1 CCD1 KIAA1735	Homo sapiens (Human)	canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex development [GO:0021695]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507]	axon terminus [GO:0043679]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]	axon terminus [GO:0043679]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex development [GO:0021695]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507]	actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]	GO:0003779; GO:0005829; GO:0005856; GO:0005925; GO:0019904; GO:0021695; GO:0021799; GO:0021869; GO:0030177; GO:0031435; GO:0032956; GO:0032991; GO:0043015; GO:0043025; GO:0043679; GO:0045665; GO:0046330; GO:0050772; GO:0060070; GO:0070507	ELLKCK	7.909999847	1	1	0.276929242	791.8338414	16.78382	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.19758	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15612	OR1Q1_HUMAN	"Olfactory receptor 1Q1 (OST226) (Olfactory receptor 1Q2) (Olfactory receptor 1Q3) (Olfactory receptor 9-A, OR9-A) (Olfactory receptor OR9-25) (Olfactory receptor TPCR106)"	OR1Q1 OR1Q2 OR1Q3	Homo sapiens (Human)	sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021	LHIPMYIFLSNLALTDICFTSTTVPK	5.840000153	0.506001294	0.506001294	3.66E-12	2994.932279	17.10466	15.8811	0	15.25506	0	15.67224	0	14.59507	0	0	15.73791	0	0	0	13.8537	0	0	0	0	14.75362	0	0	0	0	14.16344	13.29904	14.45927	0	0	16.90171	0	15.93738	0	0	0	0	0	14.17435	0	12.9512	13.11424	0	0	0	0	0	15.64742	0
Q15628	TRADD_HUMAN	"Tumor necrosis factor receptor type 1-associated DEATH domain protein, TNFR1-associated DEATH domain protein (TNFRSF1A-associated via death domain)"	TRADD	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of hair follicle development [GO:0051798]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947]; death domain binding [GO:0070513]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; tumor necrosis factor receptor binding [GO:0005164]; apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of hair follicle development [GO:0051798]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	death domain binding [GO:0070513]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; tumor necrosis factor receptor binding [GO:0005164]	GO:0002947; GO:0005068; GO:0005164; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006915; GO:0007165; GO:0008625; GO:0019900; GO:0030335; GO:0031264; GO:0033209; GO:0042802; GO:0043065; GO:0043123; GO:0043235; GO:0044877; GO:0045121; GO:0050729; GO:0051092; GO:0051798; GO:0070513; GO:0071356; GO:0097191; GO:1901224	CGSGAR	4.489999771	0.421011508	0.421011508	0.258958963	608.1843441	13.22333	12.07675	16.10137	15.56927	0	0	16.37204	14.10239	0	0	16.46012	15.09338	15.83031	12.11607	0	16.13618	17.14113	16.01152	0	0	0	0	0	16.85768	0	0	16.56651	14.71138	15.14948	0	0	0	0	16.21127	0	0	16.13366	16.40676	15.5576	17.19606	17.04736	0	0	16.70987	15.98973	0	16.48502	0
Q15633	TRBP2_HUMAN	RISC-loading complex subunit TARBP2 (TAR RNA-binding protein 2) (Trans-activation-responsive RNA-binding protein)	TARBP2 TRBP	Homo sapiens (Human)	miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; multicellular organism growth [GO:0035264]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of protein kinase activity [GO:0006469]; neural precursor cell proliferation [GO:0061351]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of viral transcription [GO:0046782]; single fertilization [GO:0007338]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; skeletal muscle tissue regeneration [GO:0043403]; spermatid development [GO:0007286]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; pre-mRNA binding [GO:0036002]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; multicellular organism growth [GO:0035264]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of protein kinase activity [GO:0006469]; neural precursor cell proliferation [GO:0061351]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903798]; regulation of production of siRNA involved in RNA interference [GO:0090065]; regulation of viral transcription [GO:0046782]; single fertilization [GO:0007338]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; skeletal muscle tissue regeneration [GO:0043403]; spermatid development [GO:0007286]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]	double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; pre-mRNA binding [GO:0036002]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]	GO:0003725; GO:0005654; GO:0005737; GO:0005829; GO:0006469; GO:0007286; GO:0007338; GO:0016442; GO:0016604; GO:0019899; GO:0030422; GO:0030423; GO:0031054; GO:0035087; GO:0035196; GO:0035197; GO:0035198; GO:0035264; GO:0035280; GO:0036002; GO:0042802; GO:0042803; GO:0043403; GO:0045070; GO:0045727; GO:0046782; GO:0047485; GO:0048471; GO:0050689; GO:0051149; GO:0061351; GO:0070578; GO:0070883; GO:0090065; GO:1903798	GEAAR	8.079999924	0.734649003	0.734649003	0.154588343	503.2721079	16.56074	15.60116	17.0051	16.87451	16.45673	16.41856	15.01053	15.81059	15.8009	16.12704	16.50074	16.7139	16.52388	15.93579	15.98515	16.23593	17.34527	0	16.3147	16.64983	16.01237	17.2204	16.69827	17.05768	16.49115	15.61352	16.91632	17.01999	16.4783	15.62086	16.40824	17.05393	16.11264	17.35442	15.48519	16.30386	16.93973	15.85658	17.25187	17.37033	16.03997	17.23897	16.61199	0	17.00865	16.66883	16.97591	16.95739
Q15643	TRIPB_HUMAN	"Thyroid receptor-interacting protein 11, TR-interacting protein 11, TRIP-11 (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210, GMAP-210) (Trip230)"	TRIP11 CEV14	Homo sapiens (Human)	cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041]	cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]	cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713]; cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041]	small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713]	GO:0000139; GO:0002079; GO:0002081; GO:0003281; GO:0003413; GO:0003713; GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0006366; GO:0006486; GO:0006888; GO:0007030; GO:0016607; GO:0030133; GO:0031267; GO:0033116; GO:0051216; GO:0060122; GO:0090161; GO:0099041	ETEYQALQETNMKFSMMLR	2.470000029	0.11333739	0.11333739	0.065045377	2350.71792	14.03413	0	10.80961	0	0	14.8962	0	0	14.37867	14.24636	0	0	0	0	0	0	12.999	0	0	0	0	0	15.63108	0	0	13.0726	16.42777	11.6972	13.90621	0	0	0	15.57212	0	0	18.82295	15.53866	10.26982	0	0	0	0	0	13.92524	0	13.76214	18.15443	0
Q15645	PCH2_HUMAN	"Pachytene checkpoint protein 2 homolog (Human papillomavirus type 16 E1 protein-binding protein, 16E1-BP, HPV16 E1 protein-binding protein) (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13, TR-interacting protein 13, TRIP-13)"	TRIP13 PCH2	Homo sapiens (Human)	double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint signaling [GO:0051598]; mitotic spindle assembly checkpoint signaling [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; transcription by RNA polymerase II [GO:0006366]	chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]	chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint signaling [GO:0051598]; mitotic spindle assembly checkpoint signaling [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; transcription by RNA polymerase II [GO:0006366]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]	GO:0001556; GO:0001673; GO:0003712; GO:0005524; GO:0005634; GO:0005694; GO:0006302; GO:0006366; GO:0007094; GO:0007130; GO:0007131; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0016887; GO:0042802; GO:0048477; GO:0051598	DEAVGDLK	11.28999996	0.936810076	0.936810076	0.080269413	846.5150142	15.70148	0	0	0	0	12.84541	0	0	12.01666	13.3489	16.1188	15.42009	14.91503	0	0	15.61623	0	17.2303	0	14.66107	13.45885	16.31979	13.97526	15.34697	0	14.72437	15.09689	0	18.73891	9.210407	16.30129	0	0	15.7886	0	14.89735	0	0	14.90274	16.38068	15.19651	11.92416	15.04351	0	14.39818	15.31418	0	0
Q15648	MED1_HUMAN	"Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component, ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein, PBP, PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component, Trap220) (Thyroid receptor-interacting protein 2, TR-interacting protein 2, TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A)"	MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2	Homo sapiens (Human)	"androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; RNA polymerase II preinitiation complex assembly [GO:0051123]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; RNA polymerase II preinitiation complex assembly [GO:0051123]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]	GO:0000122; GO:0000902; GO:0001223; GO:0001525; GO:0001889; GO:0001892; GO:0002088; GO:0002154; GO:0003222; GO:0003406; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006590; GO:0006606; GO:0006702; GO:0007420; GO:0007595; GO:0010628; GO:0010839; GO:0016020; GO:0016592; GO:0016922; GO:0030216; GO:0030224; GO:0030331; GO:0030374; GO:0030518; GO:0031100; GO:0032968; GO:0033148; GO:0035050; GO:0035116; GO:0035162; GO:0035357; GO:0035729; GO:0035855; GO:0042789; GO:0042809; GO:0042974; GO:0042975; GO:0043066; GO:0044877; GO:0045444; GO:0045618; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0046966; GO:0048821; GO:0048822; GO:0050693; GO:0051123; GO:0060261; GO:0060335; GO:0060744; GO:0060745; GO:0060750; GO:0070318; GO:0070562; GO:0070847; GO:0071364; GO:0071383; GO:0097067; GO:0140297; GO:1990841; GO:2000347; GO:2001141	CMSIPVTMR	8.529999733	1	1	2.28E-13	1110.210711	0	0	15.02393	16.58949	14.01421	0	0	0	0	16.20396	0	0	0	0	0	0	0	0	15.43222	0	14.6053	0	0	13.18932	0	15.50156	0	17.07423	0	11.52625	15.14089	0	17.73404	0	0	0	0	0	15.18763	0	0	0	0	0	0	0	0	15.25703
Q15651	HMGN3_HUMAN	"High mobility group nucleosome-binding domain-containing protein 3 (Thyroid receptor-interacting protein 7, TR-interacting protein 7, TRIP-7)"	HMGN3 TRIP7 PNAS-24	Homo sapiens (Human)	chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; thyroid hormone receptor binding [GO:0046966]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]	chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; thyroid hormone receptor binding [GO:0046966]	GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0031492; GO:0045944; GO:0046966; GO:0061178	EEKQEAGK	3.150000095	1	1	0.14159789	920.4373953	0	0	0	0	0	0	15.86463	0	0	0	0	0	0	0	0	0	0	0	0	16.47046	14.12928	15.00883	0	0	0	12.15737	13.872	0	14.38658	14.95102	15.60632	13.58265	0	0	0	0	0	0	0	0	14.5054	15.06349	0	0	13.83202	0	0	0
Q15652	JHD2C_HUMAN	"Probable JmjC domain-containing histone demethylation protein 2C, EC 1.14.11.- (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8, TR-interacting protein 8, TRIP-8)"	JMJD1C JHDM2C KIAA1380 TRIP8	Homo sapiens (Human)	"blood coagulation [GO:0007596]; chromatin organization [GO:0006325]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; blood coagulation [GO:0007596]; chromatin organization [GO:0006325]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006325; GO:0006355; GO:0006357; GO:0007596; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0046966; GO:0051213	AGVIR	9.760000229	1	1	0.246725191	516.2931202	15.56895	0	0	0	0	0	17.4929	0	0	0	0	0	0	0	0	0	0	0	17.89065	0	0	17.04761	0	0	0	0	17.7639	17.39774	0	0	0	0	18.88003	0	0	0	0	18.17096	17.54722	0	18.09039	17.39745	0	0	0	0	0	0
Q15653	IKBB_HUMAN	"NF-kappa-B inhibitor beta, NF-kappa-BIB (I-kappa-B-beta, IkB-B, IkB-beta, IkappaBbeta) (Thyroid receptor-interacting protein 9, TR-interacting protein 9, TRIP-9)"	NFKBIB IKBB TRIP9	Homo sapiens (Human)	"cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; inflammatory response [GO:0006954]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; inflammatory response [GO:0006954]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]"	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005829; GO:0006351; GO:0006954; GO:0007165; GO:0007253; GO:0043122; GO:0071222	EEEESEEDWK	13.06999969	1	1	0.259431281	1310.230162	16.25556	0	0	16.30327	16.82091	0	16.66367	16.94207	0	0	0	0	17.34436	15.95826	0	0	0	0	0	0	17.6453	16.2583	16.17722	15.39081	0	15.82086	17.15811	0	16.17795	0	15.86931	0	16.17256	16.03386	0	17.01325	13.40227	15.09345	15.78269	15.99225	0	0	0	14.39001	13.18624	15.399	16.34871	16.56434
Q15661	TRYB1_HUMAN	"Tryptase alpha/beta-1, Tryptase-1, EC 3.4.21.59 (Tryptase I) (Tryptase alpha-1)"	TPSAB1 TPS1 TPS2 TPSB1	Homo sapiens (Human)	defense response [GO:0006952]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase complex [GO:1905368]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase complex [GO:1905368]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; defense response [GO:0006952]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508]	identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0006952; GO:0008236; GO:0022617; GO:0042802; GO:1905368	VGIVGGQEAPR	8.699999809	0.03084968	0.03084968	0.145529986	1082.206552	15.63002	12.89042	13.86902	14.13666	12.52373	13.16044	18.92781	13.05416	0	12.87638	12.13625	0	16.11071	0	0	0	0	13.92147	0	0	0	0	0	0	0	0	0	15.18351	0	0	15.3964	17.33005	0	0	13.00595	0	0	0	15.0488	0	0	0	15.9264	0	16.63558	0	0	16.05742
Q15669	RHOH_HUMAN	Rho-related GTP-binding protein RhoH (GTP-binding protein TTF) (Translocation three four protein)	RHOH ARHH TTF	Homo sapiens (Human)	"actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; mast cell activation [GO:0045576]; motor neuron axon guidance [GO:0008045]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of T cell differentiation [GO:0045582]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]"	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; mast cell activation [GO:0045576]; motor neuron axon guidance [GO:0008045]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of T cell differentiation [GO:0045582]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]"	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]	GO:0001772; GO:0003924; GO:0005095; GO:0005525; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0006355; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016601; GO:0019210; GO:0019901; GO:0030031; GO:0030217; GO:0030865; GO:0031267; GO:0031410; GO:0032956; GO:0042995; GO:0043124; GO:0043652; GO:0045576; GO:0045582; GO:1902622	CVLVGDSAVGKTSLLVR	2.700000048	1	1	0.492301727	1774.205679	18.93929	0	10.10868	0	0	0	0	0	0	0	16.57287	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.38631	0	0	0	17.98114	0	18.37195	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15672	TWST1_HUMAN	"Twist-related protein 1 (Class A basic helix-loop-helix protein 38, bHLHa38) (H-twist)"	TWIST1 BHLHA38 TWIST	Homo sapiens (Human)	"aortic valve morphogenesis [GO:0003180]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in heart valve development [GO:2000793]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cranial suture morphogenesis [GO:0060363]; developmental process [GO:0032502]; embryonic camera-type eye formation [GO:0060900]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion morphogenesis [GO:0003203]; eyelid development in camera-type eye [GO:0061029]; in utero embryonic development [GO:0001701]; mitral valve morphogenesis [GO:0003183]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; outer ear morphogenesis [GO:0042473]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell motility [GO:2000147]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [GO:2000802]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of bone mineralization [GO:0030500]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; roof of mouth development [GO:0060021]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator binding [GO:0001221]; aortic valve morphogenesis [GO:0003180]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in heart valve development [GO:2000793]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cranial suture morphogenesis [GO:0060363]; developmental process [GO:0032502]; embryonic camera-type eye formation [GO:0060900]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion morphogenesis [GO:0003203]; eyelid development in camera-type eye [GO:0061029]; in utero embryonic development [GO:0001701]; mitral valve morphogenesis [GO:0003183]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; outer ear morphogenesis [GO:0042473]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell motility [GO:2000147]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [GO:2000802]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of bone mineralization [GO:0030500]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; roof of mouth development [GO:0060021]"	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator binding [GO:0001221]"	GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001221; GO:0001503; GO:0001649; GO:0001701; GO:0001764; GO:0001843; GO:0003180; GO:0003183; GO:0003203; GO:0003253; GO:0005634; GO:0005654; GO:0006357; GO:0007517; GO:0010628; GO:0010718; GO:0014067; GO:0019904; GO:0030500; GO:0032000; GO:0032502; GO:0032720; GO:0032755; GO:0032760; GO:0033128; GO:0035067; GO:0035115; GO:0035116; GO:0035359; GO:0042473; GO:0042476; GO:0042733; GO:0042803; GO:0043066; GO:0043425; GO:0043433; GO:0043518; GO:0045668; GO:0045766; GO:0045892; GO:0045944; GO:0048511; GO:0048642; GO:0048701; GO:0050679; GO:0060021; GO:0060363; GO:0060900; GO:0061029; GO:0070888; GO:0071363; GO:0071456; GO:0071639; GO:0140297; GO:2000144; GO:2000147; GO:2000276; GO:2000679; GO:2000773; GO:2000780; GO:2000793; GO:2000802	QRTQSLNEAFAALR	4.619999886	0.875827491	0.875827491	0.351943789	1604.553374	0	0	14.33479	14.06758	13.93141	15.64974	0	0	1.877092	0	0	14.31055	15.20802	14.56477	14.67724	0	13.59713	0	11.19132	0	0	0	0	0	14.78485	0	0	14.34553	0	13.03488	0	0	0	0	0	0	15.13098	0	0	0	0	13.88582	0	15.38705	0	0	14.84717	0
Q15678	PTN14_HUMAN	"Tyrosine-protein phosphatase non-receptor type 14, EC 3.1.3.48 (Protein-tyrosine phosphatase pez)"	PTPN14 PEZ PTPD2	Homo sapiens (Human)	lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; protein dephosphorylation [GO:0006470]; regulation of protein export from nucleus [GO:0046825]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712]; lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; protein dephosphorylation [GO:0006470]; regulation of protein export from nucleus [GO:0046825]	protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712]	GO:0001946; GO:0003712; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006470; GO:0008285; GO:0030971; GO:0046825	HTNSMLEGTK	8.920000076	0.084949799	0.084949799	2.31E-13	1116.3478	0	0	0	0	20.31581	0	0	0	0	0	18.01124	0	0	0	0	17.26016	0	0	0	0	0	0	0	0	16.83232	0	0	0	0	0	16.93892	0	17.78795	0	0	16.44914	0	0	0	0	0	0	0	0	16.91946	0	14.55821	0
Q15697	ZN174_HUMAN	Zinc finger protein 174 (AW-1) (Zinc finger and SCAN domain-containing protein 8)	ZNF174 ZSCAN8	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634]	"chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001650; GO:0003700; GO:0005634; GO:0006357; GO:0016604; GO:0042803; GO:0043565; GO:0045892; GO:0046872; GO:1990837	ASKKPK	2.819999933	1	1	0.190562824	657.597496	0	0	0	0	15.41869	0	14.20749	0	0	0	0	14.77193	15.49419	16.35151	0	0	0	15.49531	0	15.36312	0	15.96134	16.14086	16.15821	17.79625	0	0	16.59874	17.0866	0	17.31934	0	0	0	15.92544	16.2649	16.39696	0	0	0	15.09434	16.61613	0	16.93932	0	12.60586	15.39991	16.64894
Q15700	DLG2_HUMAN	"Disks large homolog 2 (Channel-associated protein of synapse-110, Chapsyn-110) (Postsynaptic density protein PSD-93)"	DLG2	Homo sapiens (Human)	anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; retrograde axonal protein transport [GO:0099642]	adherens junction [GO:0005912]; axon cytoplasm [GO:1904115]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]	adherens junction [GO:0005912]; axon cytoplasm [GO:1904115]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; guanylate kinase activity [GO:0004385]; kinase binding [GO:0019900]; anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; retrograde axonal protein transport [GO:0099642]	guanylate kinase activity [GO:0004385]; kinase binding [GO:0019900]	GO:0004385; GO:0005829; GO:0005886; GO:0005912; GO:0007268; GO:0014069; GO:0016020; GO:0016323; GO:0019900; GO:0030054; GO:0031594; GO:0035865; GO:0043005; GO:0043113; GO:0043204; GO:0044224; GO:0045197; GO:0097120; GO:0098609; GO:0098839; GO:0099641; GO:0099642; GO:1904115	GSFNDKR	8.789999962	0.402984709	0.402984709	0.21324755	822.7427099	18.98382	17.0069	0	16.12507	0	0	15.50237	0	15.85905	18.41437	16.56685	16.78356	16.14328	14.87783	15.65244	13.63881	0	13.12908	17.56001	17.42377	0	18.3349	17.8755	16.95394	0	16.25788	0	0	13.05747	15.31082	0	0	14.35501	10.58369	16.19334	17.24493	18.26913	17.52229	17.86724	17.68488	18.43309	14.08731	16.60681	0	16.83447	16.57811	14.79031	11.10948
Q15714	T22D1_HUMAN	TSC22 domain family protein 1 (Cerebral protein 2) (Regulatory protein TSC-22) (TGFB-stimulated clone 22 homolog) (Transforming growth factor beta-1-induced transcript 4 protein)	TSC22D1 KIAA1994 TGFB1I4 TSC22 hucep-2	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]		GO:0005634; GO:0005737; GO:0006357; GO:0006366	NSQLEQENNLLK	2.339999914	1	1	0.0049172	1429.015287	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15722	LT4R1_HUMAN	"Leukotriene B4 receptor 1, LTB4-R 1, LTB4-R1 (Chemoattractant receptor-like 1) (G-protein coupled receptor 16) (P2Y purinoceptor 7, P2Y7)"	LTB4R BLT BLT1 BLTR CMKRL1 GPR16 P2RY7	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; muscle contraction [GO:0006936]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; nucleotide binding [GO:0000166]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; muscle contraction [GO:0006936]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]	G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; nucleotide binding [GO:0000166]	GO:0000166; GO:0001632; GO:0004974; GO:0005886; GO:0005887; GO:0006936; GO:0006954; GO:0006955; GO:0007186; GO:0007200; GO:0007218; GO:0008528	RGGSLGQTAR	7.710000038	1	1	0.100572615	1001.85959	16.49066	0	15.9835	14.31165	14.68011	13.94868	12.07982	13.46928	15.9581	15.98793	0	15.89954	15.59225	0	15.00981	0	13.86953	14.99897	0	0	15.55473	15.99972	15.36616	15.82388	0	0	0	0	0	0	0	15.01306	16.48491	0	0	0	0	15.8524	0	0	0	0	0	0	0	0	0	0
Q15735	PI5PA_HUMAN	"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A, EC 3.1.3.56 (Inositol polyphosphate 5-phosphatase J)"	INPP5J PIB5PA PIPP	Homo sapiens (Human)	inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extrinsic component of membrane [GO:0019898]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extrinsic component of membrane [GO:0019898]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]"	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]"	GO:0001726; GO:0004439; GO:0004445; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0010977; GO:0017124; GO:0019898; GO:0030426; GO:0031115; GO:0033137; GO:0034485; GO:0043198; GO:0043647; GO:0046855; GO:0046856; GO:0052658; GO:0052659	TGLGGYWGNKGGVSVR	4.28000021	1	1	0.222830093	1607.840548	0	14.59197	0	0	15.1419	14.76449	0	13.93694	0	0	16.16281	14.32693	0	0	15.10286	14.99983	0	0	0	0	0	15.83925	0	13.28713	0	0	0	0	0	0	14.35189	14.15953	0	16.78211	13.54085	0	0	14.48439	0	0	0	0	16.18604	14.47392	0	15.2311	0	0
Q15738	NSDHL_HUMAN	"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating, EC 1.1.1.170 (Protein H105e3)"	NSDHL H105E3	Homo sapiens (Human)	cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; hair follicle development [GO:0001942]; labyrinthine layer blood vessel development [GO:0060716]; smoothened signaling pathway [GO:0007224]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity [GO:0102175]; 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; hair follicle development [GO:0001942]; labyrinthine layer blood vessel development [GO:0060716]; smoothened signaling pathway [GO:0007224]"	"3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity [GO:0102175]; 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]"	GO:0000252; GO:0001942; GO:0003854; GO:0005783; GO:0005789; GO:0005811; GO:0006695; GO:0007224; GO:0008203; GO:0016021; GO:0016616; GO:0047012; GO:0060716; GO:0102175; GO:0103066; GO:0103067	NVIETCK	9.529999733	1	1	0.504473385	863.3182256	0	0	17.28937	0	0	0	0	0	0	0	0	17.31137	0	0	0	0	0	0	0	19.38737	0	0	0	0	0	0	0	0	0	0	0	0	18.24644	18.95622	0	0	0	0	0	0	0	0	19.48513	0	0	19.25363	0	0
Q15746	MYLK_HUMAN	"Myosin light chain kinase, smooth muscle, MLCK, smMLCK, EC 2.7.11.18 (Kinase-related protein, KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form ]"	MYLK MLCK MLCK1 MYLK1	Homo sapiens (Human)	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]	GO:0001725; GO:0003779; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006939; GO:0014820; GO:0015629; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0046872; GO:0051928; GO:0060414; GO:0071476; GO:0090303	ITGRPQPQVTWLK	3.380000114	1	1	0.37685244	1524.089669	13.41602	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15751	HERC1_HUMAN	"Probable E3 ubiquitin-protein ligase HERC1, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)"	HERC1	Homo sapiens (Human)	cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]	guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885	FVSGR	12.65999985	8.05E-05	8.05E-05	0.262366452	565.2504685	0	0	20.48667	16.12131	0	0	21.11973	0	21.47198	0	0	0	0	17.69674	0	20.19321	0	20.2476	19.08296	0	0	0	0	0	21.01398	0	16.59161	0	16.67963	0	22.15944	22.28066	21.77039	0	0	21.42838	0	0	21.01723	20.22534	20.1518	0	20.40635	21.18751	15.97133	19.9517	20.3757	19.91485
Q15762	CD226_HUMAN	"CD226 antigen (DNAX accessory molecule 1, DNAM-1) (CD antigen CD226)"	CD226 DNAM1	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell recognition [GO:0008037]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of immunoglobulin mediated immune response [GO:0002891]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of mast cell activation [GO:0033005]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of T cell receptor signaling pathway [GO:0050862]; signal transduction [GO:0007165]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; cell adhesion [GO:0007155]; cell recognition [GO:0008037]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of immunoglobulin mediated immune response [GO:0002891]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of mast cell activation [GO:0033005]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of T cell receptor signaling pathway [GO:0050862]; signal transduction [GO:0007165]	cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]	GO:0002729; GO:0002860; GO:0002891; GO:0005178; GO:0005886; GO:0005887; GO:0007155; GO:0007165; GO:0008037; GO:0009897; GO:0009986; GO:0019901; GO:0032729; GO:0033005; GO:0045121; GO:0045954; GO:0050839; GO:0050862; GO:0060369	APNNYR	5.590000153	1	1	0.289178751	737.0042033	17.86736	16.30591	0	0	0	0	0	0	16.02493	15.8144	0	0	0	0	0	0	15.65383	0	17.04094	0	0	0	17.09704	14.98742	0	16.56728	0	0	0	16.13311	0	0	0	0	0	16.9677	18.40337	18.33602	0	0	0	0	17.39567	0	17.47598	0	0	17.00777
Q15771	RAB30_HUMAN	Ras-related protein Rab-30	RAB30	Homo sapiens (Human)	Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]	cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]	cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000139; GO:0003924; GO:0005525; GO:0005795; GO:0005801; GO:0005802; GO:0007030; GO:0031985; GO:0032482; GO:0043231	SANALILTYDITCEESFR	12.52000046	1	1	0.229612408	2101.624591	16.37746	0	15.72171	0	0	14.88457	15.99946	15.68599	16.56826	0	0	0	15.48718	14.21031	15.64785	15.30503	0	15.34564	0	15.27936	14.90404	14.77569	15.98106	0	0	0	16.57678	0	16.8178	14.94491	16.07225	0	16.25597	15.85154	0	0	17.18096	15.68778	0	16.29446	16.75507	16.60642	17.76059	0	0	16.42313	15.60684	0
Q15772	SPEG_HUMAN	"Striated muscle preferentially expressed protein kinase, EC 2.7.11.1 (Aortic preferentially expressed protein 1, APEG-1)"	SPEG APEG1 KIAA1297	Homo sapiens (Human)	muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0007517; GO:0008285; GO:0042692; GO:0106310	AGPEAEKR	8.210000038	0.357725948	0.357725948	0.251722583	856.7934404	17.66035	20.30079	19.65582	0	0	0	0	0	0	0	20.52256	0	0	0	0	0	0	0	0	0	0	0	0	18.03841	18.66824	0	0	0	0	17.5126	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15773	MLF2_HUMAN	Myeloid leukemia factor 2 (Myelodysplasia-myeloid leukemia factor 2)	MLF2	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]"		GO:0005634; GO:0005737; GO:0006355; GO:0016020	AHILQR	12.72000027	1	1	0.119077651	734.3982965	15.17492	16.78677	12.81823	0	0	0	0	0	16.53409	15.14371	0	0	0	16.37633	0	0	0	0	0	0	0	18.05361	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15776	ZKSC8_HUMAN	Zinc finger protein with KRAB and SCAN domains 8 (LD5-1) (Zinc finger protein 192)	ZKSCAN8 ZNF192	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	GSSGDQEMTATLLTAGFQTLEKIEDMAVSLIR	1.330000043	0.314845979	0.314845979	1.37E-12	3427.794829	10.21671	12.02386	0	13.31227	13.36745	13.77152	16.84101	11.96838	13.34491	16.16869	13.98341	15.04524	14.50845	14.84237	0	15.31073	0	0	0	0	0	0	0	0	0	0	13.12637	0	0	0	0	0	0	0	13.22154	0	14.29649	0	0	15.41149	15.63204	0	0	0	0	0	0	0
Q15782	CH3L2_HUMAN	Chitinase-3-like protein 2 (Chondrocyte protein 39) (YKL-39)	CHI3L2	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; hydrolase activity [GO:0016787]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]	carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; hydrolase activity [GO:0016787]	GO:0005576; GO:0005615; GO:0005975; GO:0006032; GO:0008061; GO:0016787; GO:0030246	GMPSEK	6.489999771	1	1	0.013245722	663.4708367	16.13328	15.38234	0	0	0	16.11223	15.53814	12.27281	0	0	12.0352	14.89822	0	0	15.7152	0	0	0	0	0	0	18.13074	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15785	TOM34_HUMAN	"Mitochondrial import receptor subunit TOM34, hTom34 (Translocase of outer membrane 34 kDa subunit)"	TOMM34 URCC3	Homo sapiens (Human)	protein targeting to mitochondrion [GO:0006626]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; heat shock protein binding [GO:0031072]; protein targeting to mitochondrion [GO:0006626]	heat shock protein binding [GO:0031072]	GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0016020; GO:0016021; GO:0031072; GO:0043231	DCTEALK	5.429999828	0.839038491	0.839038491	0.183388984	837.7844973	16.62606	15.1625	16.65414	15.59608	0	0	0	0	14.34998	0	0	0	0	16.53	14.3797	15.55213	0	14.78602	0	16.10021	0	0	0	16.34499	0	0	0	0	0	0	15.26766	0	0	0	16.22725	0	16.78141	0	0	16.7934	0	0	13.62784	0	0	15.27996	13.80132	16.56391
Q15788	NCOA1_HUMAN	"Nuclear receptor coactivator 1, NCoA-1, EC 2.3.1.48 (Class E basic helix-loop-helix protein 74, bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1, SRC-1)"	NCOA1 BHLHE74 SRC1	Homo sapiens (Human)	"cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; histone H4 acetylation [GO:0043967]; labyrinthine layer morphogenesis [GO:0060713]; mRNA transcription by RNA polymerase II [GO:0042789]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; histone H4 acetylation [GO:0043967]; labyrinthine layer morphogenesis [GO:0060713]; mRNA transcription by RNA polymerase II [GO:0042789]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]"	aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]	GO:0000435; GO:0000785; GO:0002155; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0005886; GO:0016922; GO:0017162; GO:0019899; GO:0030331; GO:0030374; GO:0032870; GO:0032991; GO:0035357; GO:0042789; GO:0043065; GO:0043967; GO:0045666; GO:0045893; GO:0045944; GO:0046983; GO:0047485; GO:0060713; GO:0090575; GO:1900076; GO:1904017; GO:1904179	LNIQPAKAESK	14.76000023	1	1	1.60E-12	1198.915752	0	12.12543	0	0	13.96241	0	0	12.80631	14.65477	0	0	0	0	0	13.84081	12.93228	0	11.99777	0	0	15.20592	0	17.75822	0	14.30606	0	0	12.77078	0	14.50744	14.20949	13.66415	14.62481	9.530681	9.445889	14.82991	0	0	0	13.95648	15.18418	0	0	0	0	0	0	14.20774
Q15796	SMAD2_HUMAN	"Mothers against decapentaplegic homolog 2, MAD homolog 2, Mothers against DPP homolog 2 (JV18-1) (Mad-related protein 2, hMAD-2) (SMAD family member 2, SMAD 2, Smad2, hSMAD2)"	SMAD2 MADH2 MADR2	Homo sapiens (Human)	"activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]"	activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]	"activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]"	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003682; GO:0003690; GO:0003700; GO:0005160; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0007179; GO:0007182; GO:0007183; GO:0007352; GO:0007369; GO:0008285; GO:0009653; GO:0009749; GO:0009791; GO:0009952; GO:0010628; GO:0010718; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030154; GO:0030324; GO:0030325; GO:0030509; GO:0030513; GO:0031016; GO:0031053; GO:0031625; GO:0032444; GO:0032924; GO:0032991; GO:0034713; GO:0035265; GO:0035556; GO:0038092; GO:0042060; GO:0042802; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048156; GO:0048340; GO:0048617; GO:0048701; GO:0051098; GO:0060039; GO:0060395; GO:0061629; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0071141; GO:0071142; GO:0071144; GO:0097718; GO:0140297; GO:1900224	MSSILPFTPPVVKR	17.37999916	0.29062286	0.29062286	0.454881068	1587.062279	21.97269	0	18.09935	0	0	0	19.90443	0	0	0	0	22.12028	21.90495	0	0	0	0	22.57702	0	0	0	23.05238	16.94968	17.31201	0	21.8102	0	0	20.85517	23.91348	0	0	0	0	17.32711	0	0	0	17.68007	0	0	0	0	0	18.75842	22.25669	22.67124	21.88808
Q15811	ITSN1_HUMAN	Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17)	ITSN1 ITSN SH3D1A	Homo sapiens (Human)	cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; cellular protein localization [GO:0034613]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]	GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0016197; GO:0030027; GO:0034613; GO:0035556; GO:0043005; GO:0051056; GO:0055037; GO:0060090; GO:0070064; GO:0098793; GO:0150007	CKGMPLSSFILKPMQR	3.210000038	1	1	0.397719736	1908.865996	16.23431	0	0	18.26516	0	14.96792	0	0	0	0	15.74321	13.64671	16.17654	0	0	0	0	0	0	0	0	0	15.81607	0	17.56934	16.80709	16.45406	0	0	0	0	0	0	15.60843	0	0	0	0	0	0	0	0	15.92723	0	0	0	17.27094	0
Q15818	NPTX1_HUMAN	"Neuronal pentraxin-1, NP1 (Neuronal pentraxin I, NP-I)"	NPTX1	Homo sapiens (Human)	axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133]	glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	metal ion binding [GO:0046872]	GO:0005739; GO:0005886; GO:0006839; GO:0007268; GO:0007417; GO:0030133; GO:0035865; GO:0043005; GO:0043083; GO:0043653; GO:0046872; GO:0060385; GO:0071333; GO:0098962; GO:0098978; GO:0099151; GO:0099645	FQLTFPLR	9.010000229	0.482115418	0.482115418	0.31377978	1019.429874	0	14.28462	0	0	0	13.69138	0	21.11012	0	0	12.96778	0	13.68103	0	0	0	0	0	0	0	0	0	16.07668	14.04495	0	0	0	0	0	0	0	11.01523	0	19.42931	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q15842	KCNJ8_HUMAN	"ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1)"	KCNJ8	Homo sapiens (Human)	defense response to virus [GO:0051607]; heart development [GO:0007507]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; transport across blood-brain barrier [GO:0150104]	inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]	inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; defense response to virus [GO:0051607]; heart development [GO:0007507]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; transport across blood-brain barrier [GO:0150104]	ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]	GO:0001822; GO:0005242; GO:0005524; GO:0005739; GO:0005886; GO:0006813; GO:0007507; GO:0008076; GO:0008282; GO:0015272; GO:0017098; GO:0019829; GO:0030016; GO:0031004; GO:0032496; GO:0034765; GO:0042383; GO:0043330; GO:0051607; GO:0071805; GO:0098662; GO:0098915; GO:0150104; GO:1902282; GO:1990573	NNSMRR	6.869999886	0.371970206	0.371970206	0.211667584	778.5603027	16.24683	15.7079	16.37302	0	15.17861	0	13.91029	12.33312	13.64147	17.44301	16.53609	16.36879	15.09478	16.35241	9.365269	15.11709	0	13.437	16.07435	14.566	15.39076	0	15.20204	16.2313	15.19987	0	0	15.67516	15.3127	16.00734	17.0878	16.68679	17.30091	15.26568	16.08445	0	17.18301	15.70506	15.43621	15.04109	0	0	11.7244	15.79808	15.03885	0	16.18913	16.3716
Q15853	USF2_HUMAN	"Upstream stimulatory factor 2 (Class B basic helix-loop-helix protein 12, bHLHb12) (FOS-interacting protein, FIP) (Major late transcription factor 2) (Upstream transcription factor 2)"	USF2 BHLHB12	Homo sapiens (Human)	lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]	chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]"	"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000430; GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007595; GO:0019086; GO:0042803; GO:0043231; GO:0043425; GO:0043565; GO:0045944; GO:0046982; GO:0055088; GO:1990837	GGILSK	8.449999809	1	1	0.255144573	574.0410442	14.31706	17.11441	13.66205	16.02585	14.92738	15.29468	0	0	15.57072	0	0	0	0	0	0	0	14.51848	14.0448	0	16.66225	14.95265	17.62757	17.03378	0	14.57528	0	0	0	0	16.27707	15.15411	0	0	15.98123	0	0	0	0	0	0	0	16.36717	16.09302	0	0	16.4548	0	16.17302
Q15858	SCN9A_HUMAN	"Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel, hNE-Na) (Peripheral sodium channel 1, PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7)"	SCN9A NENA	Homo sapiens (Human)	behavioral response to formalin induced pain [GO:0061368]; inflammatory response [GO:0006954]; membrane depolarization during action potential [GO:0086010]; negative regulation of action potential [GO:0045759]; neuronal action potential [GO:0019228]; post-embryonic development [GO:0009791]; regulation of ion transmembrane transport [GO:0034765]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; behavioral response to formalin induced pain [GO:0061368]; inflammatory response [GO:0006954]; membrane depolarization during action potential [GO:0086010]; negative regulation of action potential [GO:0045759]; neuronal action potential [GO:0019228]; post-embryonic development [GO:0009791]; regulation of ion transmembrane transport [GO:0034765]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0006814; GO:0006954; GO:0009408; GO:0009409; GO:0009636; GO:0009791; GO:0019228; GO:0019233; GO:0030424; GO:0031402; GO:0034765; GO:0035725; GO:0045759; GO:0061368; GO:0086010	GDAEKLSK	27.87999916	1	1	0.13058594	847.5235429	16.77713	0	0	15.57878	0	16.96724	14.55553	13.83834	0	15.40423	15.87236	0	14.47263	0	0	16.53234	0	0	0	0	0	0	15.61827	16.52385	0	13.15851	14.90339	0	0	0	14.62273	16.65061	16.43329	0	0	0	16.69193	0	0	0	0	0	19.21361	0	11.89198	0	0	0
Q15878	CAC1E_HUMAN	"Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II, BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3)"	CACNA1E CACH6 CACNL1A6	Homo sapiens (Human)	calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; regulation of ion transmembrane transport [GO:0034765]	plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]	plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; regulation of ion transmembrane transport [GO:0034765]	calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]	GO:0005245; GO:0005509; GO:0005886; GO:0005891; GO:0006816; GO:0007268; GO:0022843; GO:0034765; GO:0045202; GO:0070509	ASSMPR	5.550000191	1	1	0.136457626	647.2857063	14.81303	0	0	0	14.34418	14.19986	15.43844	14.70038	13.86987	13.03669	0	0	0	14.76835	12.77355	13.79709	0	0	0	0	0	0	0	0	0	0	0	15.96458	0	0	16.49848	0	0	0	15.51833	0	0	0	16.97268	0	16.30202	0	0	0	0	0	0	0
Q15904	VAS1_HUMAN	"V-type proton ATPase subunit S1, V-ATPase subunit S1 (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)"	ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; endosome to plasma membrane protein transport [GO:0099638]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; osteoclast development [GO:0036035]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; vacuolar acidification [GO:0007035]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; ATP binding [GO:0005524]; small GTPase binding [GO:0031267]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; endosome to plasma membrane protein transport [GO:0099638]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; osteoclast development [GO:0036035]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; vacuolar acidification [GO:0007035]	ATP binding [GO:0005524]; small GTPase binding [GO:0031267]	GO:0000139; GO:0005524; GO:0005765; GO:0005789; GO:0005886; GO:0006879; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016021; GO:0016469; GO:0030641; GO:0031267; GO:0033116; GO:0033176; GO:0036035; GO:0036295; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:0099638; GO:1902600	MAAMATAR	12.89000034	0.367831081	0.367831081	0.045755377	839.4808326	17.48634	15.47803	0	0	13.24672	0	17.39882	0	14.44259	0	15.69432	17.0686	0	16.78671	16.0923	17.38292	14.77305	17.45578	0	17.24847	0	15.54834	15.20434	18.17637	17.08168	18.1904	17.94703	15.48396	0	15.70865	16.50506	0	18.44621	0	17.35534	0	20.59898	0	19.56947	17.0141	18.30882	0	18.23241	17.28259	0	18.63082	17.41669	18.10386
Q15906	VPS72_HUMAN	Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1) (Transcription factor-like 1)	VPS72 TCFL1 YL1	Homo sapiens (Human)	"histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]"	NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]"	DNA binding [GO:0003677]; histone binding [GO:0042393]	GO:0000122; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0016573; GO:0016607; GO:0032991; GO:0035019; GO:0035267; GO:0042393; GO:0042981; GO:0043486; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779	VQERQGQSR	6.920000076	0.621879756	0.621879756	0.046134777	1086.824409	15.69193	11.59879	0	0	0	0	15.79606	7.807497	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.12616	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.84398	0
Q15910	EZH2_HUMAN	"Histone-lysine N-methyltransferase EZH2, EC 2.1.1.356 (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)"	EZH2 KMT6	Homo sapiens (Human)	"B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell development [GO:0048468]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; subtelomeric heterochromatin assembly [GO:0031509]; synaptic transmission, GABAergic [GO:0051932]"	"chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; pronucleus [GO:0045120]; synapse [GO:0045202]"	"chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; pronucleus [GO:0045120]; synapse [GO:0045202]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell development [GO:0048468]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; liver regeneration [GO:0097421]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; subtelomeric heterochromatin assembly [GO:0031509]; synaptic transmission, GABAergic [GO:0051932]"	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]	GO:0000122; GO:0000781; GO:0000785; GO:0000978; GO:0000979; GO:0001222; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005737; GO:0006306; GO:0006325; GO:0006338; GO:0006355; GO:0008284; GO:0010718; GO:0014013; GO:0014834; GO:0014898; GO:0016279; GO:0016571; GO:0018024; GO:0021695; GO:0021766; GO:0030183; GO:0031490; GO:0031509; GO:0032355; GO:0034244; GO:0035098; GO:0035984; GO:0036333; GO:0042054; GO:0042752; GO:0043021; GO:0043406; GO:0043433; GO:0043547; GO:0045120; GO:0045202; GO:0045605; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048468; GO:0048511; GO:0051154; GO:0051932; GO:0070301; GO:0070314; GO:0070734; GO:0070878; GO:0071168; GO:0071902; GO:0097421; GO:0098532; GO:1900006; GO:1900016; GO:1902808; GO:1904772; GO:1990841; GO:2000134	VHGDR	17.75	3.39E-09	3.39E-09	0.227105462	583.5157355	22.04046	0	0	0	0	21.38398	18.67087	0	16.41492	0	0	20.39174	0	0	21.82368	0	21.03763	0	18.80379	0	20.21462	0	0	22.02426	0	0	19.12612	0	0	0	17.89397	0	21.56611	0	19.27551	0	21.60058	0	0	0	0	0	0	21.80548	20.76873	0	0	0
Q15911	ZFHX3_HUMAN	"Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3, ZFH-3)"	ZFHX3 ATBF1 C16orf47	Homo sapiens (Human)	"brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to transforming growth factor beta [GO:0071559]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to transforming growth factor beta [GO:0071559]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007420; GO:0007517; GO:0008270; GO:0016604; GO:0019899; GO:0032922; GO:0045662; GO:0045663; GO:0045664; GO:0045785; GO:0045893; GO:0045944; GO:0051726; GO:0071559; GO:1904059	SMKHQR	6.949999809	0.371435642	0.371435642	0.095380956	800.2708041	16.56835	0	0	15.67749	0	0	0	0	0	0	17.04414	0	17.48096	0	0	0	0	0	18.74016	0	0	0	14.96191	14.13509	15.71155	0	0	0	0	16.9883	11.41659	0	16.17458	14.98886	18.622	0	0	0	0	0	16.7725	0	16.57807	14.94003	15.58563	0	0	0
Q15928	ZN141_HUMAN	Zinc finger protein 141	ZNF141 D4S90	Homo sapiens (Human)	"anatomical structure morphogenesis [GO:0009653]; limb morphogenesis [GO:0035108]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; limb morphogenesis [GO:0035108]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006366; GO:0009653; GO:0035108; GO:0046872	SRVLNEHK	10.59000015	0.572269917	0.572269917	0.197712766	980.3110032	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.34843	17.70488	0	0	0	0	0	0	0	0	0	0	18.41291	0	17.09862	0	0
Q15935	ZNF77_HUMAN	Zinc finger protein 77 (ZNFpT1)	ZNF77	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	SLYRDVMLETCR	9.289999962	1	1	0.09241205	1558.546529	0	15.84784	0	0	0	14.05251	0	0	0	16.30595	15.27727	12.76751	0	16.40199	15.96789	0	0	0	0	14.30343	14.15536	0	14.20263	0	13.84502	15.51498	0	0	0	0	0	0	0	0	0	0	0	16.50738	0	13.6193	16.61053	0	14.79832	0	13.2169	0	0	0
Q15973	ZN124_HUMAN	Zinc finger protein 124 (Zinc finger protein HZF-16)	ZNF124	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0006357; GO:0046872	QCQKTSLSVTR	7.760000229	1	1	4.69E-13	1308.105567	0	0	0	0	0	0	19.2274	0	0	0	18.32745	0	0	0	0	0	0	0	0	0	16.32679	0	0	0	0	0	0	0	0	0	0	0	0	0	19.82019	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16082	HSPB2_HUMAN	"Heat shock protein beta-2, HspB2 (DMPK-binding protein, MKBP)"	HSPB2	Homo sapiens (Human)	response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; structural constituent of eye lens [GO:0005212]; response to unfolded protein [GO:0006986]	enzyme activator activity [GO:0008047]; structural constituent of eye lens [GO:0005212]	GO:0005212; GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0008047	AAPAGEGSR	9.25	1	1	0.2408018	815.0720416	18.84178	0	0	13.9532	0	0	17.42564	13.59956	0	16.36225	0	17.18761	0	0	15.78354	14.12283	12.91196	16.00154	0	0	15.99701	15.52964	0	15.41317	0	0	15.09955	14.59299	15.75644	16.22239	15.37238	14.28413	15.20078	16.53469	0	0	16.35148	17.51447	0	0	14.41259	0	0	0	0	15.20015	0	18.95074
Q16099	GRIK4_HUMAN	"Glutamate receptor ionotropic, kainate 4, GluK4 (Excitatory amino acid receptor 1, EAA1) (Glutamate receptor KA-1, KA1)"	GRIK4 GRIK	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]"	hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]	"hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]"	glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0008066; GO:0015276; GO:0015277; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0045211; GO:0050804; GO:0098686; GO:0099055; GO:0099056; GO:1904315	ARPSPAR	9.729999542	1	1	0.254925406	754.9680265	15.29823	15.82068	0	15.52592	14.89297	0	15.00927	14.33211	13.02943	17.27096	16.50358	16.6048	16.19696	0	14.80111	15.91567	13.62065	0	16.74035	0	0	0	16.2581	0	16.95017	16.4038	16.83772	0	16.10049	15.24002	0	16.91537	15.47786	17.2113	15.80733	16.53552	16.78501	16.39566	17.42065	0	0	0	15.55231	0	15.89379	0	0	16.37158
Q16181	SEPT7_HUMAN	Septin-7 (CDC10 protein homolog)	SEPTIN7 CDC10 SEPT7	Homo sapiens (Human)	cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]	axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cellular protein localization [GO:0034613]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]	cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]	GO:0000776; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0034613; GO:0042802; GO:0045296; GO:0060090; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857	MEMEMEQVFEMK	8.920000076	1	1	0.536877314	1572.92481	0	0	0	0	0	0	0	0	0	0	18.74123	17.31984	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.60672	0	17.72434	0	0	0	0	0	0	0	0	0	0	0
Q16204	CCDC6_HUMAN	Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4)	CCDC6 D10S170 TST1	Homo sapiens (Human)		cytoskeleton [GO:0005856]; cytosol [GO:0005829]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]	identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802	LENDTISK	2.809999943	0.511065423	0.511065423	0.173449585	920.5638414	14.34049	0	14.70265	0	0	15.02175	0	0	0	0	0	0	0	0	0	0	0	0	0	15.12562	0	0	0	0	0	14.63517	0	0	16.98907	0	12.20286	15.33358	13.64549	15.335	0	0	0	13.45341	0	0	0	16.3509	17.56539	15.01323	14.92916	0	0	14.41933
Q16236	NF2L2_HUMAN	"Nuclear factor erythroid 2-related factor 2, NF-E2-related factor 2, NFE2-related factor 2, Nrf-2 (HEBP1) (Nuclear factor, erythroid derived 2, like 2)"	NFE2L2 NRF2	Homo sapiens (Human)	aflatoxin catabolic process [GO:0046223]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to copper ion [GO:0071280]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of embryonic development [GO:0045995]; regulation of innate immune response [GO:0045088]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lithium ion [GO:0010226]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]	"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; aflatoxin catabolic process [GO:0046223]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to copper ion [GO:0071280]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of embryonic development [GO:0045995]; regulation of innate immune response [GO:0045088]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lithium ion [GO:0010226]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006357; GO:0006954; GO:0007568; GO:0010226; GO:0010499; GO:0010628; GO:0010667; GO:0010976; GO:0016567; GO:0019904; GO:0030194; GO:0030968; GO:0032993; GO:0034599; GO:0036003; GO:0036091; GO:0036499; GO:0042149; GO:0043161; GO:0043536; GO:0043565; GO:0045088; GO:0045454; GO:0045766; GO:0045944; GO:0045995; GO:0046223; GO:0046326; GO:0061419; GO:0061629; GO:0070301; GO:0071280; GO:0071356; GO:0071466; GO:0071498; GO:0071499; GO:0090575; GO:0140467; GO:1902037; GO:1902176; GO:1903071; GO:1903206; GO:1903788; GO:1904385; GO:1904753; GO:2000121; GO:2000352; GO:2000379	DGNVFLVPK	7.420000076	0.796585619	0.796585619	0.222487355	989.3970414	0	16.027	14.44061	15.35151	0	15.33501	15.49761	0	0	0	14.93906	14.57843	16.43436	14.39593	15.35729	15.3458	12.95861	15.60048	16.34663	14.26754	15.43866	17.30674	0	0	14.37253	15.82798	16.42137	13.61938	14.05564	14.55156	16.59516	0	0	15.19892	15.96112	15.99417	13.31334	15.45093	0	16.26645	15.4238	15.62217	14.36267	13.30139	14.97433	14.05736	14.23514	15.86852
Q16254	E2F4_HUMAN	"Transcription factor E2F4, E2F-4"	E2F4	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000083; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0002064; GO:0003677; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0006884; GO:0008015; GO:0009887; GO:0019904; GO:0042127; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251; GO:1990837; GO:1990841	SLGLLTTKFVSLLQEAK	9.430000305	1	1	0.365474502	1848.515612	14.99606	15.86347	0	0	14.81144	0	0	0	0	13.83276	14.3221	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.3392	0	0	15.67576	0	0	0	0	0	0	0	0	0	0	0	0	0	14.65198	0	0	0	0
Q16288	NTRK3_HUMAN	"NT-3 growth factor receptor, EC 2.7.10.1 (GP145-TrkC, Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase)"	NTRK3 TRKC	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; heart development [GO:0007507]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell death [GO:0060548]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	axon [GO:0030424]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	axon [GO:0030424]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; p53 binding [GO:0002039]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; heart development [GO:0007507]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell death [GO:0060548]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; p53 binding [GO:0002039]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001764; GO:0001933; GO:0001934; GO:0002039; GO:0004712; GO:0004714; GO:0005004; GO:0005030; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007507; GO:0008284; GO:0010628; GO:0010976; GO:0014068; GO:0030335; GO:0030424; GO:0032148; GO:0033138; GO:0033674; GO:0043121; GO:0043235; GO:0043406; GO:0045471; GO:0048665; GO:0048678; GO:0048712; GO:0050927; GO:0051412; GO:0051896; GO:0060548; GO:0071300; GO:0090102; GO:0090630; GO:0098978; GO:0099055; GO:0099151; GO:1905606; GO:1990090; GO:2000251	FYGVCGDGDPLIMVFEYMK	2.029999971	1	1	0.15538984	2242.064822	0	0	0	0	11.78362	11.62876	15.67127	8.853601	0	0	13.69494	0	13.36345	12.49492	0	12.84948	0	11.17543	0	15.69893	0	0	0	0	14.79089	0	13.56954	0	0	0	14.95719	14.4382	14.99108	12.85563	0	9.479057	0	13.30175	0	0	0	0	0	0	0	13.85351	0	11.86041
Q16322	KCA10_HUMAN	Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8)	KCNA10	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	delayed rectifier potassium channel activity [GO:0005251]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; voltage-gated potassium channel activity [GO:0005249]	GO:0005221; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805	MGSTDSLNK	1.909999967	1	1	0.140564116	953.6238519	16.49466	14.65982	15.43026	0	0	0	14.8448	0	10.87349	0	15.05309	0	0	0	0	0	0	0	0	0	0	0	0	0	15.99522	0	15.90871	0	0	0	0	0	0	0	15.9439	0	0	0	0	16.15416	0	0	0	0	0	0	0	15.33675
Q16363	LAMA4_HUMAN	Laminin subunit alpha-4 (Laminin-14 subunit alpha) (Laminin-8 subunit alpha) (Laminin-9 subunit alpha)	LAMA4	Homo sapiens (Human)	cell adhesion [GO:0007155]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]	extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0030155; GO:0030334; GO:0045995; GO:0062023; GO:0070062; GO:0120163	ATAARQR	10.75	0.406806678	0.406806678	0.271866606	769.9735878	0	0	15.54428	0	14.64915	15.49772	0	15.15715	15.76112	14.81736	0	0	0	0	16.92643	0	0	0	15.98947	17.87962	14.46035	0	0	0	16.74141	0	16.55707	15.39254	0	0	13.4577	15.12338	16.62729	0	15.93379	15.38451	0	16.37096	16.03506	16.88704	15.77798	0	14.93562	0	16.79597	0	0	16.58888
Q16401	PSMD5_HUMAN	26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B)	PSMD5 KIAA0072	Homo sapiens (Human)	proteasome regulatory particle assembly [GO:0070682]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle assembly [GO:0070682]		GO:0000502; GO:0005654; GO:0005829; GO:0022624; GO:0070682	MAAQALALLR	5.019999981	1	1	0.278285784	1058.555966	0	17.17194	0	0	0	0	0	0	0	0	0	17.16189	0	0	17.11327	0	0	0	0	15.78681	17.41923	0	17.62107	16.87802	18.02492	18.05993	17.72221	0	0	16.89889	0	0	19.01787	17.8983	0	18.04174	0	18.02856	0	17.95769	0	0	0	0	0	16.79338	0	17.57324
Q16478	GRIK5_HUMAN	"Glutamate receptor ionotropic, kainate 5, GluK5 (Excitatory amino acid receptor 2, EAA2) (Glutamate receptor KA-2, KA2)"	GRIK5 GRIK2	Homo sapiens (Human)	"cellular response to glucose stimulus [GO:0071333]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]"	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; terminal bouton [GO:0043195]	"dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; terminal bouton [GO:0043195]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to glucose stimulus [GO:0071333]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]"	glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0005654; GO:0005783; GO:0005886; GO:0006621; GO:0008066; GO:0015276; GO:0015277; GO:0017124; GO:0030165; GO:0030425; GO:0031630; GO:0032983; GO:0035249; GO:0038023; GO:0042802; GO:0043113; GO:0043195; GO:0043204; GO:0043525; GO:0045211; GO:0050804; GO:0051649; GO:0060079; GO:0071333; GO:0098686; GO:0098978; GO:0099056; GO:0099061; GO:1904315	ADLAVAAFTITAER	5.389999866	1	1	0.501800548	1449.592108	15.38431	16.28395	18.31925	20.15237	0	19.41608	0	19.21532	0	17.49766	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.66259	0	20.8153	19.05762	0	0	0	0	17.81394	18.30869	0	0	0
Q16513	PKN2_HUMAN	"Serine/threonine-protein kinase N2, EC 2.7.11.13 (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)"	PKN2 PRK2 PRKCL2	Homo sapiens (Human)	apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium-dependent protein kinase C activity [GO:0004698]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium-dependent protein kinase C activity [GO:0004698]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]	GO:0003723; GO:0004672; GO:0004674; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0018105; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0106310; GO:2000145	TKIEVIR	5.670000076	1	1	0.120693972	858.3066305	0	0	0	0	12.85185	14.76763	17.65874	0	0	14.34456	15.58283	12.33599	14.92688	0	0	14.2847	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16520	BATF_HUMAN	"Basic leucine zipper transcriptional factor ATF-like (B-cell-activating transcription factor, B-ATF) (SF-HT-activated gene 2 protein, SFA-2)"	BATF	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hematopoietic stem cell differentiation [GO:0060218]; integrated stress response signaling [GO:0140467]; isotype switching [GO:0045190]; lymphoid progenitor cell differentiation [GO:0002320]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of cytokine production [GO:0001819]; regulation of T-helper 17 cell differentiation [GO:2000319]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 2 cell differentiation [GO:0045064]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to DNA damage stimulus [GO:0006974]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hematopoietic stem cell differentiation [GO:0060218]; integrated stress response signaling [GO:0140467]; isotype switching [GO:0045190]; lymphoid progenitor cell differentiation [GO:0002320]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of cytokine production [GO:0001819]; regulation of T-helper 17 cell differentiation [GO:2000319]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 2 cell differentiation [GO:0045064]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001819; GO:0002320; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006974; GO:0030330; GO:0042832; GO:0043011; GO:0043565; GO:0045064; GO:0045190; GO:0060218; GO:0072539; GO:0072540; GO:0090575; GO:0140467; GO:1990837; GO:2000319	SPPPGK	6.75	1	1	0.155378503	583.4960785	0	0	0	15.69959	0	0	0	0	0	0	0	0	0	0	0	0	0	16.18258	0	16.94363	0	0	17.92029	17.46245	18.54019	0	17.23595	0	16.66672	16.93298	16.6586	0	16.25501	17.10684	16.4761	17.22683	17.67957	17.73052	17.22453	16.23227	0	0	18.00803	16.76499	17.23225	0	17.76141	16.49666
Q16531	DDB1_HUMAN	"DNA damage-binding protein 1 (DDB p127 subunit) (DNA damage-binding protein a, DDBa) (Damage-specific DNA-binding protein 1) (HBV X-associated protein 1, XAP-1) (UV-damaged DNA-binding factor) (UV-damaged DNA-binding protein 1, UV-DDB 1) (XPE-binding factor, XPE-BF) (Xeroderma pigmentosum group E-complementing protein, XPCe)"	DDB1 XAP1	Homo sapiens (Human)	biological process involved in interaction with symbiont [GO:0051702]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055]	"chromosome, telomeric region [GO:0000781]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]"	"chromosome, telomeric region [GO:0000781]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055]"	cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]	GO:0000781; GO:0003677; GO:0003684; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006511; GO:0006974; GO:0010498; GO:0016055; GO:0016567; GO:0019076; GO:0030674; GO:0031464; GO:0031465; GO:0032991; GO:0034644; GO:0035518; GO:0035861; GO:0042752; GO:0043066; GO:0043161; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051702; GO:0070062; GO:0070914; GO:0071987; GO:0080008; GO:0097602; GO:1901990	YLLGDMEGR	5.360000134	1	1	0.224481535	1068.607648	0	0	0	0	0	0	15.74892	0	0	17.43333	0	0	0	0	16.63542	0	0	0	0	0	15.50372	0	0	0	18.67903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.15507	17.24654	0	0	0	0	16.61326	17.07219
Q16533	SNPC1_HUMAN	"snRNA-activating protein complex subunit 1, SNAPc subunit 1 (Proximal sequence element-binding transcription factor subunit gamma, PSE-binding factor subunit gamma, PTF subunit gamma) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit, SNAPc 43 kDa subunit)"	SNAPC1 SNAP43	Homo sapiens (Human)	snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; sequence-specific DNA binding [GO:0043565]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; sequence-specific DNA binding [GO:0043565]	GO:0000995; GO:0005654; GO:0005730; GO:0016251; GO:0019185; GO:0042795; GO:0042796; GO:0043565	AEVTEEFK	10.42000008	0.629959762	0.629959762	0.223377831	951.7891056	16.19521	14.34926	16.15513	16.52568	0	0	0	15.62637	15.73858	14.98082	13.8769	16.082	15.39964	0	16.49789	16.0302	14.60384	0	0	0	0	0	17.21801	0	0	15.47964	0	16.07463	15.93353	16.37435	13.89337	14.83619	14.59846	15.84908	0	16.16039	0	15.33746	0	16.14583	15.99152	14.67408	14.87129	15.31383	15.26581	16.66902	15.67064	12.66666
Q16538	GP162_HUMAN	Probable G-protein coupled receptor 162 (Gene-rich cluster gene A protein)	GPR162 GRCA	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021	MARGGAGAEEASLR	12.98999977	1	1	0.222169164	1376.181037	18.88653	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16552	IL17_HUMAN	"Interleukin-17A, IL-17, IL-17A (Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8)"	IL17A CTLA8 IL17	Homo sapiens (Human)	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cell-cell signaling [GO:0007267]; cellular response to interleukin-1 [GO:0071347]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; fibroblast activation [GO:0072537]; granulocyte migration [GO:0097530]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; intestinal epithelial structure maintenance [GO:0060729]; Notch signaling pathway [GO:0007219]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-16 production [GO:0032739]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cell-cell signaling [GO:0007267]; cellular response to interleukin-1 [GO:0071347]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; fibroblast activation [GO:0072537]; granulocyte migration [GO:0097530]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; intestinal epithelial structure maintenance [GO:0060729]; Notch signaling pathway [GO:0007219]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-16 production [GO:0032739]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]	cytokine activity [GO:0005125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0002225; GO:0002250; GO:0005125; GO:0005576; GO:0005615; GO:0006915; GO:0006954; GO:0006955; GO:0007219; GO:0007267; GO:0008219; GO:0009897; GO:0032731; GO:0032735; GO:0032739; GO:0032747; GO:0032755; GO:0032760; GO:0042803; GO:0045087; GO:0045672; GO:0045944; GO:0046982; GO:0050829; GO:0050830; GO:0050832; GO:0060729; GO:0071347; GO:0072537; GO:0097400; GO:0097530; GO:1900017; GO:1903348; GO:2000340	AGITIPR	5.150000095	1	1	0.111386135	724.4980549	14.83744	16.11393	14.7634	0	0	0	0	0	14.06768	15.98149	0	0	0	0	0	0	0	0	0	12.42449	15.33219	0	0	0	0	0	0	0	12.06139	0	0	14.69341	0	0	0	0	0	0	0	0	0	15.468	0	0	14.8335	0	14.85479	0
Q16553	LY6E_HUMAN	"Lymphocyte antigen 6E, Ly-6E (Retinoic acid-induced gene E protein, RIG-E) (Stem cell antigen 2, SCA-2) (Thymic shared antigen 1, TSA-1)"	LY6E 9804 RIGE SCA2 TSA1	Homo sapiens (Human)	acetylcholine receptor signaling pathway [GO:0095500]; adrenal gland development [GO:0030325]; cell surface receptor signaling pathway [GO:0007166]; epinephrine secretion [GO:0048242]; in utero embryonic development [GO:0001701]; negative regulation of viral entry into host cell [GO:0046597]; norepinephrine metabolic process [GO:0042415]; organ growth [GO:0035265]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550]; acetylcholine receptor signaling pathway [GO:0095500]; adrenal gland development [GO:0030325]; cell surface receptor signaling pathway [GO:0007166]; epinephrine secretion [GO:0048242]; in utero embryonic development [GO:0001701]; negative regulation of viral entry into host cell [GO:0046597]; norepinephrine metabolic process [GO:0042415]; organ growth [GO:0035265]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550]	GO:0001701; GO:0005576; GO:0005886; GO:0007166; GO:0030325; GO:0030550; GO:0031225; GO:0033130; GO:0035265; GO:0042415; GO:0045202; GO:0046597; GO:0048242; GO:0055010; GO:0095500	IFLPVLLAALLGVER	10.47000027	1	1	0.204683059	1623.899754	17.22647	0	0	0	0	0	16.67496	16.55489	16.23175	0	0	0	0	0	0	0	0	0	0	17.38378	0	17.16437	0	0	0	16.42346	15.43517	0	16.19953	16.84237	16.27275	0	16.30061	0	0	0	16.26774	0	0	0	0	0	16.8768	0	0	0	0	0
Q16560	U1SBP_HUMAN	"U11/U12 small nuclear ribonucleoprotein 35 kDa protein, U11/U12 snRNP 35 kDa protein, U11/U12-35K (Protein HM-1) (U1 snRNP-binding protein homolog)"	SNRNP35 HM1 U1SNRNPBP	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; mRNA binding [GO:0003729]; snRNA binding [GO:0017069]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]"	mRNA binding [GO:0003729]; snRNA binding [GO:0017069]	GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0008380; GO:0017069	GYAFIEYK	4.559999943	0.870999634	0.870999634	0.102208675	989.190763	13.36375	15.33719	15.00416	0	0	0	13.97904	18.15439	0	0	0	0	0	0	14.78927	0	0	0	0	17.33059	0	0	0	0	0	15.43436	0	0	0	0	0	14.87752	12.42935	15.33844	0	0	12.21276	0	0	0	0	0	0	0	0	15.11442	0	16.11896
Q16566	KCC4_HUMAN	"Calcium/calmodulin-dependent protein kinase type IV, CaMK IV, EC 2.7.11.17 (CaM kinase-GR)"	CAMK4 CAMK CAMK-GR CAMKIV	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]"	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001650; GO:0002250; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0018105; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0046777; GO:0070062; GO:0098794; GO:0098978; GO:0106310	QKGTQKPYALK	6.210000038	0.230148628	0.230148628	0.190004935	1261.101053	16.63851	0	0	17.39779	12.90196	14.27615	13.06552	0	13.01127	0	0	13.91463	14.68418	18.34177	15.61457	16.55108	17.1292	16.1153	17.98921	15.686	15.08761	15.37091	17.74021	12.71344	13.73863	14.42143	0	15.24772	17.09973	15.36795	16.43699	17.41827	18.36209	14.79215	16.55066	16.66949	16.46286	15.73205	18.88415	0	0	16.12263	15.22466	18.19783	0	16.67559	0	17.1527
Q16572	VACHT_HUMAN	"Vesicular acetylcholine transporter, VAChT (Solute carrier family 18 member 3)"	SLC18A3 VACHT	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]	AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]	AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; acetylcholine transmembrane transporter activity [GO:0005277]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]	acetylcholine transmembrane transporter activity [GO:0005277]; transmembrane transporter activity [GO:0022857]	GO:0005277; GO:0005886; GO:0006836; GO:0007268; GO:0016021; GO:0022857; GO:0030121; GO:0030122; GO:0030669; GO:0043195; GO:0060201	ESAEPAGQAR	4.230000019	1	1	0.023121147	1014.612894	0	0	0	0	0	0	0	0	15.79792	0	15.25974	12.97785	0	0	0	0	0	0	0	0	0	0	0	0	14.80635	0	0	0	0	15.57206	0	14.19699	0	0	13.51161	0	0	0	0	0	0	0	0	13.54242	0	0	0	0
Q16584	M3K11_HUMAN	"Mitogen-activated protein kinase kinase kinase 11, EC 2.7.11.25 (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase)"	MAP3K11 MLK3 PTK1 SPRK	Homo sapiens (Human)	cell cycle G1/S phase transition [GO:0044843]; cell death [GO:0008219]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule-based process [GO:0007017]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron apoptotic process [GO:0043525]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]	centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]; cell cycle G1/S phase transition [GO:0044843]; cell death [GO:0008219]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule-based process [GO:0007017]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron apoptotic process [GO:0043525]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]	GO:0000165; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005813; GO:0005829; GO:0005874; GO:0006468; GO:0007017; GO:0007254; GO:0008219; GO:0016020; GO:0031267; GO:0031434; GO:0031435; GO:0042802; GO:0042803; GO:0043065; GO:0043507; GO:0043525; GO:0044843; GO:0046330; GO:0046777; GO:0106310	ELTLLLQQVDRERPHVR	10.39000034	0.608926535	0.608926535	4.57E-12	2102.261825	0	18.10396	0	19.11632	18.50659	0	0	0	0	0	19.02521	18.48958	0	0	17.83665	19.41207	18.23659	0	0	0	18.30459	18.80685	18.71118	18.79136	0	18.00873	17.53246	18.30155	0	18.38939	0	0	17.33533	17.18379	17.88639	0	17.65235	0	0	17.69348	0	0	0	15.9345	18.47948	18.25919	0	18.17438
Q16587	ZNF74_HUMAN	Zinc finger protein 74 (Zinc finger protein 520) (hZNF7)	ZNF74 ZNF520	Homo sapiens (Human)	"multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; multicellular organism development [GO:0007275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007275; GO:0015629; GO:0046872	ENLEDISGWGLPEARSK	15.32999992	0.359327197	0.359327197	0.482658036	1900.871596	0	19.05022	0	0	0	0	0	17.75686	0	0	18.29385	0	18.18436	0	0	0	17.54137	16.56619	0	0	0	0	16.79842	0	0	18.83504	17.32899	0	0	0	18.89931	19.18965	0	0	0	0	0	0	0	0	18.21554	0	16.44893	0	0	0	0	0
Q16610	ECM1_HUMAN	Extracellular matrix protein 1 (Secretory component p85)	ECM1	Homo sapiens (Human)	angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; chondrocyte development [GO:0002063]; endochondral bone growth [GO:0003416]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidase activity [GO:0010466]; ossification [GO:0001503]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of bone mineralization [GO:0030500]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type 2 immune response [GO:0002828]; signal transduction [GO:0007165]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]; enzyme binding [GO:0019899]; interleukin-2 receptor binding [GO:0005134]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; chondrocyte development [GO:0002063]; endochondral bone growth [GO:0003416]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidase activity [GO:0010466]; ossification [GO:0001503]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of bone mineralization [GO:0030500]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type 2 immune response [GO:0002828]; signal transduction [GO:0007165]	enzyme binding [GO:0019899]; interleukin-2 receptor binding [GO:0005134]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]	GO:0001503; GO:0001525; GO:0001938; GO:0001960; GO:0002020; GO:0002063; GO:0002828; GO:0003416; GO:0005134; GO:0005576; GO:0005615; GO:0006357; GO:0006954; GO:0007165; GO:0008022; GO:0010466; GO:0019899; GO:0030500; GO:0030502; GO:0031012; GO:0031089; GO:0031214; GO:0043123; GO:0043236; GO:0045766; GO:0062023; GO:0070062; GO:2000404	VTPNLMGHLCGNQR	4.210000038	1	1	0.356001372	1612.238823	18.48355	0	14.76396	0	0	0	18.33242	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.71638	0	0	17.40222	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16620	NTRK2_HUMAN	"BDNF/NT-3 growth factors receptor, EC 2.7.10.1 (GP145-TrkB, Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B)"	NTRK2 TRKB	Homo sapiens (Human)	"brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron apoptotic process [GO:0043524]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; regulation of protein kinase B signaling [GO:0051896]; retinal rod cell development [GO:0046548]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO:0099551]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]"	axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; terminal bouton [GO:0043195]	"axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; brain-derived neurotrophic factor binding [GO:0048403]; brain-derived neurotrophic factor-activated receptor activity [GO:0060175]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron apoptotic process [GO:0043524]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; regulation of protein kinase B signaling [GO:0051896]; retinal rod cell development [GO:0046548]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO:0099551]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]"	ATP binding [GO:0005524]; brain-derived neurotrophic factor binding [GO:0048403]; brain-derived neurotrophic factor-activated receptor activity [GO:0060175]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0001570; GO:0001764; GO:0001934; GO:0002020; GO:0004712; GO:0004714; GO:0005030; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007612; GO:0007623; GO:0007631; GO:0008284; GO:0010628; GO:0010976; GO:0014047; GO:0014068; GO:0014069; GO:0019227; GO:0021954; GO:0021987; GO:0022011; GO:0030182; GO:0030424; GO:0030425; GO:0031547; GO:0031901; GO:0033138; GO:0033674; GO:0042490; GO:0042803; GO:0043087; GO:0043121; GO:0043195; GO:0043197; GO:0043235; GO:0043410; GO:0043524; GO:0043679; GO:0046548; GO:0046777; GO:0048403; GO:0048471; GO:0048709; GO:0048935; GO:0050772; GO:0051896; GO:0051965; GO:0060175; GO:0060291; GO:0071230; GO:0099183; GO:0099551; GO:1902430; GO:1990090; GO:1990416; GO:2000811	VGGHTMLPIR	6.420000076	0.137475818	0.137475818	0.079498087	1080.814648	0	15.82905	11.01223	0	15.79255	0	0	14.03617	0	16.44177	14.74258	0	0	0	13.59553	15.60626	14.82874	0	14.4095	0	0	14.60711	0	13.47409	0	13.09707	0	16.94068	0	16.16981	18.06446	0	13.19381	0	0	14.97054	14.83085	0	0	16.37994	0	14.40274	0	16.26504	0	0	15.32565	14.4413
Q16625	OCLN_HUMAN	Occludin	OCLN	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of wound healing [GO:0090303]; protein localization to cell leading edge [GO:1902463]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of wound healing [GO:0090303]; protein localization to cell leading edge [GO:1902463]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827]	protein domain specific binding [GO:0019904]	GO:0001933; GO:0005765; GO:0005886; GO:0005911; GO:0005923; GO:0010592; GO:0010628; GO:0010629; GO:0010827; GO:0016021; GO:0016324; GO:0016327; GO:0019904; GO:0030054; GO:0030139; GO:0031116; GO:0031252; GO:0031410; GO:0032991; GO:0035633; GO:0045216; GO:0046326; GO:0065003; GO:0070160; GO:0070830; GO:0090303; GO:1902463; GO:1905605	KMVGDYDR	6.980000019	0.243256882	0.243256882	0.19332057	998.2764531	16.89428	13.35712	17.07773	16.968	0	11.70386	12.56128	0	0	17.28896	16.16532	18.02548	16.69717	0	16.37584	15.70928	16.86321	17.5494	15.96417	0	15.78402	0	0	17.5771	14.35563	14.83806	14.7525	0	0	0	14.95499	0	13.53078	17.48223	11.63845	16.79193	16.16746	16.78848	17.49896	14.59331	0	0	11.32954	11.47572	14.80133	17.22216	0	16.35173
Q16626	MEA1_HUMAN	"Male-enhanced antigen 1, MEA-1"	MEA1 MEA	Homo sapiens (Human)	cell differentiation [GO:0030154]; male gonad development [GO:0008584]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; cell differentiation [GO:0030154]; male gonad development [GO:0008584]; spermatogenesis [GO:0007283]		GO:0005737; GO:0007283; GO:0008584; GO:0030154	EISDAQWEDVVQKALQAR	2.069999933	1	1	0.639786578	2086.152654	0	18.83576	0	0	0	18.13846	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.57356	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16630	CPSF6_HUMAN	"Cleavage and polyadenylation specificity factor subunit 6 (Cleavage and polyadenylation specificity factor 68 kDa subunit, CPSF 68 kDa subunit) (Cleavage factor Im complex 68 kDa subunit, CFIm68) (Pre-mRNA cleavage factor Im 68 kDa subunit) (Protein HPBRII-4/7)"	CPSF6 CFIM68	Homo sapiens (Human)	messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005847; GO:0005849; GO:0006397; GO:0016020; GO:0016607; GO:0031124; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051262; GO:0051290; GO:0098789; GO:0110104; GO:1990120; GO:1990448; GO:1990904	ELHGQNPVVTPCNK	16.76000023	1	1	0.565920338	1592.993342	0	0	0	0	18.94914	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41697	0	0	0	18.80201	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.56405	0	0	0	0	0
Q16643	DREB_HUMAN	Drebrin (Developmentally-regulated brain protein)	DBN1 D0S117E	Homo sapiens (Human)	actin filament organization [GO:0007015]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling [GO:0010644]; cytoplasmic sequestering of protein [GO:0051220]; in utero embryonic development [GO:0001701]; maintenance of protein location in cell [GO:0032507]; neural precursor cell proliferation [GO:0061351]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic plasticity [GO:0031915]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendrite development [GO:0050773]; regulation of neuronal synaptic plasticity [GO:0048168]	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; gap junction [GO:0005921]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; gap junction [GO:0005921]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin filament organization [GO:0007015]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling [GO:0010644]; cytoplasmic sequestering of protein [GO:0051220]; in utero embryonic development [GO:0001701]; maintenance of protein location in cell [GO:0032507]; neural precursor cell proliferation [GO:0061351]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic plasticity [GO:0031915]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendrite development [GO:0050773]; regulation of neuronal synaptic plasticity [GO:0048168]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]	GO:0001701; GO:0003779; GO:0005522; GO:0005737; GO:0005856; GO:0005886; GO:0005921; GO:0007015; GO:0010643; GO:0010644; GO:0014069; GO:0015629; GO:0030027; GO:0030425; GO:0030426; GO:0030427; GO:0030833; GO:0030863; GO:0030864; GO:0031915; GO:0032507; GO:0042641; GO:0045211; GO:0045296; GO:0045773; GO:0048168; GO:0048812; GO:0050773; GO:0051015; GO:0051220; GO:0061003; GO:0061351; GO:0098974; GO:0098978; GO:0099524; GO:1902685	MAGVSFSGHR	4.150000095	0.768232107	0.768232107	2.29E-13	1048.50767	0	0	0	0	0	0	0	0	0	0	17.48973	0	0	0	0	14.65569	0	14.50208	16.89557	11.14928	0	8.124182	16.83158	0	13.52314	15.27349	17.11379	0	0	0	0	0	17.42272	0	16.9304	0	0	17.27125	0	0	17.15615	0	0	0	16.82745	0	16.87911	14.46465
Q16647	PTGIS_HUMAN	"Prostacyclin synthase, EC 5.3.99.4 (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152) (Prostaglandin I2 synthase)"	PTGIS CYP8 CYP8A1	Homo sapiens (Human)	apoptotic signaling pathway [GO:0097190]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of angiogenesis [GO:0045766]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostaglandin biosynthetic process [GO:0001516]	caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	"caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; prostaglandin-I synthase activity [GO:0008116]; apoptotic signaling pathway [GO:0097190]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of angiogenesis [GO:0045766]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostaglandin biosynthetic process [GO:0001516]"	"heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; prostaglandin-I synthase activity [GO:0008116]"	GO:0001516; GO:0004497; GO:0005506; GO:0005615; GO:0005634; GO:0005783; GO:0005789; GO:0005901; GO:0006690; GO:0008116; GO:0016021; GO:0016705; GO:0019371; GO:0020037; GO:0032088; GO:0034356; GO:0035360; GO:0045019; GO:0045766; GO:0050728; GO:0071347; GO:0071354; GO:0071456; GO:0097190; GO:0106256; GO:1900119	LLPKLAR	10.52000046	1	1	0.068197855	809.5905038	15.57879	15.13744	0	0	0	0	0	16.07917	16.13757	0	0	14.89504	0	0	0	12.36964	0	0	0	16.97196	0	0	0	0	17.08441	0	0	0	15.87746	0	0	16.31205	16.98186	15.91775	0	16.33801	15.69334	0	0	17.33364	14.92087	14.49164	16.2635	0	0	0	15.9881	0
Q16658	FSCN1_HUMAN	Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55)	FSCN1 FAN1 HSN SNL	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]	GO:0001725; GO:0001726; GO:0002102; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0005902; GO:0005911; GO:0005938; GO:0007043; GO:0007163; GO:0010592; GO:0015629; GO:0016477; GO:0030027; GO:0030035; GO:0030036; GO:0030046; GO:0030175; GO:0030426; GO:0030674; GO:0031253; GO:0032534; GO:0032956; GO:0035089; GO:0044393; GO:0045296; GO:0048870; GO:0051015; GO:0051017; GO:0051491; GO:0070062; GO:0071803; GO:0090091	NGQLAASVETAGDSELFLMK	4.78000021	1	1	0.200817806	2081.138893	0	13.668	15.27485	15.3319	0	0	0	14.90065	14.83145	0	13.72008	14.52765	14.49215	12.67734	0	0	0	11.88499	0	15.46831	0	0	15.60088	0	15.88547	0	0	0	14.3416	0	0	0	0	13.47338	15.0597	0	13.81754	14.85608	0	0	0	14.18421	0	15.06127	0	0	0	0
Q16659	MK06_HUMAN	"Mitogen-activated protein kinase 6, MAP kinase 6, MAPK 6, EC 2.7.11.24 (Extracellular signal-regulated kinase 3, ERK-3) (MAP kinase isoform p97, p97-MAPK)"	MAPK6 ERK3 PRKM6	Homo sapiens (Human)	cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0007165; GO:0019901; GO:0032156; GO:0032991; GO:0035556; GO:0046982; GO:0060999; GO:0106310	KYLDGDR	10.43999958	1	1	0.195178333	866.023802	16.76678	15.47918	17.03121	15.27602	14.36059	12.8489	16.10837	0	0	15.78614	0	0	14.08396	15.91845	0	15.87497	0	0	0	0	0	15.23514	0	15.1751	0	0	0	0	0	0	0	0	16.46407	0	16.245	0	9.050385	15.43869	0	0	0	0	0	18.00078	15.24477	0	0	0
Q16666	IF16_HUMAN	"Gamma-interferon-inducible protein 16, Ifi-16 (Interferon-inducible myeloid differentiation transcriptional activator)"	IFI16 IFNGIP1	Homo sapiens (Human)	"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to interferon-beta [GO:0035458]; cellular response to ionizing radiation [GO:0071479]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of DNA binding [GO:0043392]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]; regulation of gene expression, epigenetic [GO:0040029]"	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to interferon-beta [GO:0035458]; cellular response to ionizing radiation [GO:0071479]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of DNA binding [GO:0043392]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]; regulation of gene expression, epigenetic [GO:0040029]"	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]	GO:0000122; GO:0001819; GO:0002218; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006914; GO:0006954; GO:0008134; GO:0010506; GO:0016020; GO:0016607; GO:0030099; GO:0030224; GO:0032731; GO:0035458; GO:0040029; GO:0042149; GO:0042771; GO:0042802; GO:0043392; GO:0045071; GO:0045087; GO:0045824; GO:0045892; GO:0045944; GO:0051607; GO:0071479; GO:0072332; GO:0097202; GO:2000117	NNDPKSMK	3.269999981	0.176921293	0.176921293	0.254531672	950.6532609	0	0	0	0	17.56471	0	0	19.07226	0	0	0	0	0	0	0	0	0	0	20.67959	0	0	0	0	0	0	0	0	0	14.6207	0	18.68262	0	17.2047	0	0	17.96656	0	0	0	0	0	19.24942	0	0	0	18.05774	0	0
Q16671	AMHR2_HUMAN	"Anti-Muellerian hormone type-2 receptor, EC 2.7.11.30 (Anti-Muellerian hormone type II receptor, AMH type II receptor) (MIS type II receptor, MISRII, MRII)"	AMHR2 AMHR MISR2	Homo sapiens (Human)	activin receptor signaling pathway [GO:0032924]; anti-Mullerian hormone signaling pathway [GO:1990262]; cellular response to growth factor stimulus [GO:0071363]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; Mullerian duct regression [GO:0001880]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; transforming growth factor beta receptor signaling pathway [GO:0007179]	activin receptor complex [GO:0048179]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"activin receptor complex [GO:0048179]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; anti-Mullerian hormone receptor activity [GO:1990272]; ATP binding [GO:0005524]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transforming growth factor beta receptor activity, type II [GO:0005026]; activin receptor signaling pathway [GO:0032924]; anti-Mullerian hormone signaling pathway [GO:1990262]; cellular response to growth factor stimulus [GO:0071363]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; Mullerian duct regression [GO:0001880]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"activin binding [GO:0048185]; activin-activated receptor activity [GO:0017002]; anti-Mullerian hormone receptor activity [GO:1990272]; ATP binding [GO:0005524]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transforming growth factor beta receptor activity, type II [GO:0005026]"	GO:0001880; GO:0004674; GO:0005026; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007548; GO:0008584; GO:0008585; GO:0017002; GO:0032924; GO:0042562; GO:0042803; GO:0043235; GO:0046872; GO:0048179; GO:0048185; GO:0060389; GO:0071363; GO:1990262; GO:1990272	AQVEMQGCR	9.75	1	1	0.043628859	1094.70768	0	16.49128	10.01361	14.45804	15.19992	0	0	13.81838	12.99149	13.34494	16.54108	12.74854	14.64893	14.97659	0	0	0	0	14.91071	12.26229	0	0	14.68437	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16706	MA2A1_HUMAN	"Alpha-mannosidase 2, EC 3.2.1.114 (Golgi alpha-mannosidase II, AMan II, Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)"	MAN2A1 MANA2	Homo sapiens (Human)	in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]; viral protein processing [GO:0019082]	cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]; viral protein processing [GO:0019082]"	"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0019082; GO:0030246; GO:0042803; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062	MTLSKLPLQANVYPMTTMAYIQDAK	1.340000033	0.731106997	0.731106997	6.39E-12	2845.625512	0	0	0	12.61428	10.90699	13.79985	0	0	12.06264	0	10.61234	12.08115	0	15.73705	0	0	0	7.704344	0	12.84223	13.02759	14.05988	0	0	0	0	10.02037	0	0	0	0	0	16.22806	12.81177	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16719	KYNU_HUMAN	"Kynureninase, EC 3.7.1.3 (L-kynurenine hydrolase)"	KYNU	Homo sapiens (Human)	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to interferon-gamma [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to interferon-gamma [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441]	3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006569; GO:0009435; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034341; GO:0034354; GO:0034516; GO:0042803; GO:0043420; GO:0061981; GO:0097053	DENAIYFLGNSLGLQPKMVK	4.400000095	1	1	0.086870098	2236.222768	12.05582	11.74794	0	14.26189	11.8631	11.52681	4.767719	0	0	0	13.59152	0	0	14.06681	0	10.81407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.48225	0	0	0	0	0	0	0
Q16720	AT2B3_HUMAN	"Plasma membrane calcium-transporting ATPase 3, PMCA3, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3)"	ATP2B3	Homo sapiens (Human)	calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]	extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; parallel fiber [GO:1990032]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]	extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; parallel fiber [GO:1990032]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]	GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0006874; GO:0015085; GO:0016887; GO:0019829; GO:0030165; GO:0034220; GO:0043231; GO:0046872; GO:0051480; GO:0098688; GO:0098978; GO:0098982; GO:0099056; GO:1903561; GO:1903779; GO:1905056; GO:1990032; GO:1990034	QQDGAMESSQTK	4.110000134	1	1	0.226230374	1324.818969	0	15.83323	0	0	0	14.38608	0	0	0	0	0	0	0	0	0	0	12.94316	0	0	16.32777	0	0	0	0	0	0	0	0	16.24497	0	14.78289	0	0	0	0	0	0	16.19678	0	0	16.06601	17.52887	0	0	0	0	0	0
Q16740	CLPP_HUMAN	"ATP-dependent Clp protease proteolytic subunit, mitochondrial, EC 3.4.21.92 (Endopeptidase Clp)"	CLPP	Homo sapiens (Human)	membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006508; GO:0006515; GO:0008233; GO:0009368; GO:0033619; GO:0042802; GO:0051117; GO:0051603	DRYMSPMEAQEFGILDK	9.350000381	1	1	0.084311378	2046.520544	12.07431	14.03635	0	13.81391	12.86457	0	13.37353	14.20284	13.51016	15.4104	0	10.9957	13.87511	11.41331	14.50596	16.03711	0	0	0	10.62711	0	0	13.63932	15.30982	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16760	DGKD_HUMAN	"Diacylglycerol kinase delta, DAG kinase delta, EC 2.7.1.107 (130 kDa diacylglycerol kinase) (Diglyceride kinase delta, DGK-delta)"	DGKD KIAA0145	Homo sapiens (Human)	diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; signal transduction [GO:0007165]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007165; GO:0007173; GO:0007205; GO:0010033; GO:0015031; GO:0019900; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370	DMEQELAHAVNASSKSMDR	4.869999886	1	1	0.303274999	2134.125183	0	14.73298	11.11938	0	0	0	0	0	0	0	0	0	0	0	11.52611	0	10.23092	0	15.25371	0	0	0	14.63669	0	16.48872	13.59157	0	14.08916	0	0	0	0	15.67899	0	0	0	14.52873	0	0	0	15.67885	10.48464	0	0	0	0	0	0
Q16787	LAMA3_HUMAN	"Laminin subunit alpha-3 (Epiligrin 170 kDa subunit, E170) (Epiligrin subunit alpha) (Kalinin subunit alpha) (Laminin-5 subunit alpha) (Laminin-6 subunit alpha) (Laminin-7 subunit alpha) (Nicein subunit alpha)"	LAMA3 LAMNA	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; integrin-mediated signaling pathway [GO:0007229]; morphogenesis of a polarized epithelium [GO:0001738]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-5 complex [GO:0005610]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-5 complex [GO:0005610]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; integrin-mediated signaling pathway [GO:0007229]; morphogenesis of a polarized epithelium [GO:0001738]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]	GO:0001738; GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005610; GO:0005783; GO:0007229; GO:0007411; GO:0008544; GO:0009887; GO:0009888; GO:0016477; GO:0030155; GO:0030334; GO:0035987; GO:0045995; GO:0062023; GO:0070062; GO:0098609	DGLHGIQRGDIDAMISSAK	9.300000191	1	1	0.254084192	2001.452856	0	0	13.47408	0	0	15.42733	15.9054	0	15.80032	0	0	0	12.42146	0	0	0	14.41792	0	13.00185	12.11757	10.14926	16.4971	16.24797	0	13.80514	12.49925	13.36873	0	0	0	16.38156	0	15.51862	0	0	0	0	0	0	15.953	0	13.52788	16.51167	0	15.10901	0	0	0
Q16795	NDUA9_HUMAN	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD, CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)"	NDUFA9 NDUFS2L	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; circadian rhythm [GO:0007623]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; sodium ion transport [GO:0006814]; ubiquinone-6 biosynthetic process [GO:1901006]"	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; circadian rhythm [GO:0007623]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; sodium ion transport [GO:0006814]; ubiquinone-6 biosynthetic process [GO:1901006]"	NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]	GO:0003954; GO:0005634; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006814; GO:0007623; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776; GO:0044877; GO:1901006	AAAAQSRVVR	2.700000048	1	1	0.001217163	1027.411089	14.79495	16.32314	0	0	0	0	15.10308	0	0	16.72315	15.15935	12.31235	12.88786	13.97735	13.81626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.46963	0	0	0	0	0	0	0	0	0	0	0	0	0	15.11543	0	0	0	0
Q16798	MAON_HUMAN	"NADP-dependent malic enzyme, mitochondrial, NADP-ME, EC 1.1.1.40 (Malic enzyme 3)"	ME3	Homo sapiens (Human)	aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; oxygen metabolic process [GO:0072592]; pyruvate metabolic process [GO:0006090]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADP+ binding [GO:0070401]; oxaloacetate decarboxylase activity [GO:0008948]; aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; oxygen metabolic process [GO:0072592]; pyruvate metabolic process [GO:0006090]	malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADP+ binding [GO:0070401]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0009060; GO:0046872; GO:0051287; GO:0070401; GO:0072592	QQSDLDK	6.380000114	0.46258989	0.46258989	0.204250085	833.4683651	0	15.49641	0	13.94308	0	15.85358	15.11455	14.58029	0	0	0	0	0	14.51607	0	16.60169	16.60876	16.57793	14.51393	0	15.32594	0	14.73195	16.06558	0	0	16.17864	0	13.57482	14.53667	14.38092	0	15.74303	16.30737	15.52498	15.84094	15.85596	13.10916	15.45842	14.4433	15.62661	15.52925	0	0	13.04417	14.74524	16.96966	0
Q16799	RTN1_HUMAN	Reticulon-1 (Neuroendocrine-specific protein)	RTN1 NSP	Homo sapiens (Human)	negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182]		GO:0000139; GO:0005783; GO:0005789; GO:0030176; GO:0030182; GO:1902430	LFLVQDLVDSLK	11.48999977	1	1	0.597336188	1388.915533	0	0	0	0	0	0	0	0	18.59349	19.15301	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q16821	PPR3A_HUMAN	"Protein phosphatase 1 regulatory subunit 3A (Protein phosphatase 1 glycogen-associated regulatory subunit) (Protein phosphatase type-1 glycogen targeting subunit, RG1)"	PPP1R3A PP1G	Homo sapiens (Human)	glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]	integral component of membrane [GO:0016021]; protein phosphatase type 1 complex [GO:0000164]	integral component of membrane [GO:0016021]; protein phosphatase type 1 complex [GO:0000164]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]	glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]	GO:0000164; GO:0005977; GO:0005979; GO:0008157; GO:0016021; GO:2001069	EKAIIAK	7.579999924	0.358134747	0.358134747	0.299190862	775.1665435	16.8323	14.73876	15.38812	14.84936	0	15.02439	15.05723	0	14.82745	0	14.21102	0	15.86235	15.92748	16.23796	0	0	15.72003	16.09288	15.4681	0	15.32777	0	15.86376	16.46933	16.72852	17.04307	15.78607	13.48665	15.18837	16.07579	16.13426	16.0317	15.5118	17.52524	15.97774	17.01047	17.19047	15.14643	0	15.44172	17.44716	17.28169	17.31155	16.03238	16.88498	15.7731	15.07328
Q16831	UPP1_HUMAN	"Uridine phosphorylase 1, UPase 1, UrdPase 1, EC 2.4.2.3"	UPP1 UP	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; nucleobase-containing compound metabolic process [GO:0006139]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; nucleobase-containing compound metabolic process [GO:0006139]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]	deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850]	GO:0004850; GO:0005654; GO:0005829; GO:0006139; GO:0006218; GO:0006248; GO:0006249; GO:0009032; GO:0042149; GO:0042802; GO:0044206; GO:0046050; GO:0046074; GO:0046079; GO:0047847	YAMYKVGPVLSVSHGMGIPSISIMLHELIK	6.539999962	1	1	0.06471632	3302.1728	17.20425	16.03261	10.56058	0	0	0	0	0	12.04455	12.5883	0	0	0	11.67675	11.12258	0	0	0	0	0	9.005888	0	14.62668	0	13.44431	15.79906	11.58356	0	0	0	0	20.90502	19.17465	0	0	0	0	13.42518	0	0	16.9751	0	14.32896	14.1044	13.46091	0	0	0
Q16836	HCDH_HUMAN	"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial, HCDH, EC 1.1.1.35 (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)"	HADH HAD HAD1 HADHSC SCHAD	Homo sapiens (Human)	fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]	GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0009410; GO:0014823; GO:0016740; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162	EDIDTAMK	5.449999809	1	1	0.11856701	921.2258594	16.69769	0	14.77683	0	0	15.8092	15.07538	13.75488	0	0	14.2775	0	0	0	13.15882	14.02962	0	0	0	0	0	0	14.77611	0	10.38027	0	11.80033	0	0	0	0	0	0	0	0	0	0	0	17.09337	0	0	0	0	0	0	0	0	15.11242
Q16849	PTPRN_HUMAN	"Receptor-type tyrosine-protein phosphatase-like N, R-PTP-N (Islet cell antigen 512, ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment, ICA512-NTF; ICA512-transmembrane fragment, ICA512-TMF; ICA512-cleaved cytosolic fragment, ICA512-CCF ]"	PTPRN ICA3 ICA512	Homo sapiens (Human)	dense core granule maturation [GO:1990502]; insulin secretion [GO:0030073]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; luteinization [GO:0001553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; response to reactive oxygen species [GO:0000302]	axon terminus [GO:0043679]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]	axon terminus [GO:0043679]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; spectrin binding [GO:0030507]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389]; dense core granule maturation [GO:1990502]; insulin secretion [GO:0030073]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; luteinization [GO:0001553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; response to reactive oxygen species [GO:0000302]	spectrin binding [GO:0030507]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000302; GO:0001553; GO:0005634; GO:0005768; GO:0005886; GO:0008134; GO:0016021; GO:0030073; GO:0030141; GO:0030507; GO:0030658; GO:0035773; GO:0043025; GO:0043204; GO:0043679; GO:0044389; GO:0045202; GO:0045944; GO:1904692; GO:1990502	TMEGPVEGR	6.019999981	0.696742058	0.696742058	0.110212588	976.7487836	16.79384	16.31394	0	10.55883	17.32532	16.73327	13.70232	0	0	0	0	14.8712	0	0	0	10.02496	0	16.48529	0	14.33446	0	16.57878	0	13.90489	15.00388	17.61795	0	0	16.41706	16.00748	14.61778	0	16.52437	0	18.67855	17.67747	0	17.86091	0	0	12.63549	0	0	16.5136	0	0	15.90945	0
Q16851	UGPA_HUMAN	"UTP--glucose-1-phosphate uridylyltransferase, EC 2.7.7.9 (UDP-glucose pyrophosphorylase, UDPGP, UGPase)"	UGP2 UGP1	Homo sapiens (Human)	brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; glucose binding [GO:0005536]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyrimidine ribonucleotide binding [GO:0032557]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]	glucose binding [GO:0005536]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyrimidine ribonucleotide binding [GO:0032557]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]	GO:0003983; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0005977; GO:0005978; GO:0006011; GO:0007420; GO:0019255; GO:0032557; GO:0042802; GO:0046872; GO:0070062	KDLDGFR	11.26000023	0.000102049	0.000102049	0.262829418	851.2429237	0	17.5757	0	0	0	0	17.8235	18.24239	19.37015	18.04853	0	0	0	0	0	0	19.62498	0	0	0	16.9323	19.32086	0	0	19.28637	0	0	0	0	0	0	0	17.85904	18.53233	20.54473	19.40279	0	0	0	0	0	0	18.9464	0	17.46683	18.42023	0	17.09157
Q16853	AOC3_HUMAN	"Membrane primary amine oxidase, EC 1.4.3.21 (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase, SSAO) (Vascular adhesion protein 1, VAP-1)"	AOC3 VAP1	Homo sapiens (Human)	amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of primary amine oxidase activity [GO:1902283]; response to antibiotic [GO:0046677]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of primary amine oxidase activity [GO:1902283]; response to antibiotic [GO:0046677]	aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]	GO:0005507; GO:0005509; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005902; GO:0006954; GO:0007155; GO:0008131; GO:0009308; GO:0009986; GO:0016021; GO:0042802; GO:0046677; GO:0046982; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596; GO:1902283	GSPPPAREALAIVFFGR	5.75	1	1	4.60E-13	1783.986529	15.86601	13.35403	0	13.72651	12.85892	0	0	0	0	11.44223	15.06343	0	10.93826	14.87441	0	15.47982	0	14.11185	14.68254	13.85666	0	0	13.08176	0	0	0	0	0	0	0	0	0	0	0	0	0	15.28687	0	0	0	0	0	16.07772	0	0	0	0	0
Q16877	F264_HUMAN	"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4, 6PF-2-K/Fru-2,6-P2ase 4, PFK/FBPase 4 (6PF-2-K/Fru-2,6-P2ase testis-type isozyme) [Includes: 6-phosphofructo-2-kinase, EC 2.7.1.105; Fructose-2,6-bisphosphatase, EC 3.1.3.46 ]"	PFKFB4	Homo sapiens (Human)	"fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]"	cytosol [GO:0005829]	"cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]"	"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]"	GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003	DVVKTYK	10.68000031	1	1	0.309247904	851.8314498	0	0	15.60239	0	0	0	0	0	0	0	0	0	0	0	0	17.12689	0	0	0	0	16.85798	16.50909	16.29932	0	0	0	0	0	17.21137	16.2799	16.16072	16.79766	16.97024	15.44878	0	0	16.62796	0	15.35333	0	17.11843	16.8172	16.26506	0	0	16.50294	0	16.46167
Q16880	CGT_HUMAN	"2-hydroxyacylsphingosine 1-beta-galactosyltransferase, EC 2.4.1.47 (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase)"	UGT8 CGT UGT4	Homo sapiens (Human)	central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid metabolic process [GO:0006687]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid metabolic process [GO:0006687]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]"	"2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]"	GO:0002175; GO:0003851; GO:0005783; GO:0005886; GO:0006682; GO:0006687; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0016021; GO:0030913; GO:0043231; GO:0047263; GO:0048812	NIFSGR	8.350000381	0.461994886	0.461994886	0.011207411	691.3882539	16.03187	17.98369	16.40552	15.94407	16.66408	0	17.01791	0	15.22945	16.77162	18.38042	0	0	15.89404	0	15.19185	0	0	0	0	16.38002	16.34671	17.80727	16.23056	16.58099	12.65892	0	0	16.25004	16.23159	0	18.14198	0	16.63535	17.77677	0	16.56333	0	0	0	0	0	15.91804	0	16.2518	0	16.60192	0
Q16891	MIC60_HUMAN	MICOS complex subunit MIC60 (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89)	IMMT HMP MIC60 MINOS2 PIG4 PIG52	Homo sapiens (Human)	cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]	membrane [GO:0016020]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]	membrane [GO:0016020]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; RNA binding [GO:0003723]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]	RNA binding [GO:0003723]	GO:0001401; GO:0003723; GO:0005739; GO:0005743; GO:0005758; GO:0007007; GO:0016020; GO:0042407; GO:0044284; GO:0051560; GO:0061617; GO:0140275	AVDEAADALLKAK	8.979999542	1	1	0.245868212	1315.036833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.78764	0	0	14.2981	0	16.13581	0	14.78849	0	0	0	0	15.71921	0	0	0	0	0	15.27881	14.72549	0	0	0	0	0	0
Q17R60	IMPG1_HUMAN	"Interphotoreceptor matrix proteoglycan 1 (Interphotoreceptor matrix proteoglycan of 150 kDa, IPM-150) (Sialoprotein associated with cones and rods)"	IMPG1 IPM150 SPACR	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; visual perception [GO:0007601]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; chondroitin sulfate binding [GO:0035374]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540]; extracellular matrix organization [GO:0030198]; visual perception [GO:0007601]	chondroitin sulfate binding [GO:0035374]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540]	GO:0001750; GO:0001917; GO:0005201; GO:0005540; GO:0005576; GO:0007601; GO:0008201; GO:0030198; GO:0031012; GO:0033165; GO:0035374	MYKMSTMR	6.03000021	1	1	0.189867985	1080.524949	0	0	0	0	0	16.91241	0	0	13.72465	18.02118	15.66481	0	0	0	0	15.44427	0	16.69289	0	16.48481	16.52075	0	0	0	0	15.352	0	14.31498	0	0	0	16.23905	0	16.33627	14.13243	0	17.63468	15.56134	0	0	16.59389	0	0	0	0	0	0	15.97815
Q17R98	ZN827_HUMAN	Zinc finger protein 827	ZNF827	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; establishment of protein localization to telomere [GO:0070200]; negative regulation of shelterin complex assembly [GO:1904791]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; telomere maintenance [GO:0000723]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; NuRD complex binding [GO:0120325]; chromatin remodeling [GO:0006338]; establishment of protein localization to telomere [GO:0070200]; negative regulation of shelterin complex assembly [GO:1904791]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; telomere maintenance [GO:0000723]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; NuRD complex binding [GO:0120325]	GO:0000723; GO:0000781; GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0010468; GO:0045892; GO:0045944; GO:0046872; GO:0070200; GO:0120325; GO:1904791; GO:1990904	EHNHTK	4	1	1	0.115765585	765.0204174	14.63909	11.98665	15.89892	0	0	13.95298	15.30227	14.92141	0	0	13.40278	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q17RC7	EX3L4_HUMAN	Exocyst complex component 3-like protein 4	EXOC3L4 C14orf73	Homo sapiens (Human)	exocyst localization [GO:0051601]; exocytosis [GO:0006887]	exocyst [GO:0000145]	exocyst [GO:0000145]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]	SNARE binding [GO:0000149]	GO:0000145; GO:0000149; GO:0006887; GO:0051601	ELQPLFR	22.79999924	0.856251538	0.856251538	0.290233038	902.0622626	18.94564	17.86097	18.45502	17.79362	17.26597	17.47273	17.3941	17.8224	17.08589	18.07226	0	16.91172	0	0	15.4721	0	17.18437	17.87216	0	17.88681	16.93937	17.83328	15.49702	17.47027	0	19.80522	0	16.44245	15.12069	15.26879	16.73747	0	0	17.30924	17.18251	0	19.29025	0	16.78617	17.0898	17.50137	20.1692	18.50292	17.86819	15.85588	18.46845	18.04478	17.34851
Q17RD7	SYT16_HUMAN	Synaptotagmin-16 (Chr14Syt) (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein)	SYT16 STREP14 SYT14L SYT14R	Homo sapiens (Human)	exocytosis [GO:0006887]		exocytosis [GO:0006887]		GO:0006887	EKVTFAK	3.869999886	1	1	2.30E-13	821.6640256	0	17.64342	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.79657	0	0	0	0	14.5539	14.75438	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q17RG1	KCD19_HUMAN	BTB/POZ domain-containing protein KCTD19	KCTD19	Homo sapiens (Human)	protein homooligomerization [GO:0051260]		protein homooligomerization [GO:0051260]		GO:0051260	AHSTASEK	6.289999962	1	1	0.204890632	828.7586741	16.01001	0	0	0	0	0	0	15.01593	0	0	0	0	0	17.43916	0	0	16.3622	16.50125	16.23674	16.6625	18.88618	0	16.52355	16.54357	0	0	15.21085	0	0	14.74176	17.12201	17.77121	16.18946	15.47144	16.04539	15.43929	17.62935	16.26409	15.9463	17.96783	15.72303	18.1182	14.16886	17.32975	13.41066	18.11857	16.76251	18.27301
Q17RH7	TPRXL_HUMAN	Putative protein TPRXL	TPRXL	Homo sapiens (Human)						CSISGSTK	4.940000057	0.706355393	0.706355393	0.325449269	839.9548557	17.25587	0	0	0	0	0	17.22729	0	0	0	17.55606	18.79078	0	0	0	0	19.05627	18.38008	16.83315	16.78305	0	0	0	0	18.66368	0	0	17.82261	16.53597	0	0	0	0	17.51295	17.62659	18.09793	0	0	18.33619	0	18.27298	17.42918	18.31495	16.95872	17.15549	18.39284	18.68923	0
Q17RM4	CC142_HUMAN	Coiled-coil domain-containing protein 142	CCDC142 PSEC0243	Homo sapiens (Human)						QDFGVVR	3.650000095	1	1	0.115077293	821.2163424	17.58655	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.22727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q17RN3	FA98C_HUMAN	Protein FAM98C	FAM98C	Homo sapiens (Human)		tRNA-splicing ligase complex [GO:0072669]	tRNA-splicing ligase complex [GO:0072669]		GO:0072669	EAGAEVLSAGDGPGAEEDFLRQLGSLLR	3.00999999	1	1	0	2858.109538	0	11.56595	13.49408	14.55323	13.96143	0	12.11378	0	14.74054	15.63464	0	14.83119	12.87711	13.49497	14.72979	12.02732	9.837444	14.00304	9.661214	12.60977	0	0	12.00128	14.26336	0	0	0	0	15.32803	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q17RS7	GEN_HUMAN	"Flap endonuclease GEN homolog 1, EC 3.1.-.-"	GEN1	Homo sapiens (Human)	double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139]	centrosome [GO:0005813]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; nucleoplasm [GO:0005654]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139]	5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0000400; GO:0000724; GO:0005654; GO:0005813; GO:0008821; GO:0010824; GO:0017108; GO:0031297; GO:0042803; GO:0071139; GO:0071140; GO:0090267	GVPGVGK	3.410000086	0.4798792	0.4798792	0.173876523	612.5410746	0	0	14.3668	16.08088	0	14.64164	0	15.82622	16.20221	0	0	0	0	0	15.10052	0	0	0	0	0	15.85395	14.82376	16.17677	15.9868	15.939	16.37893	0	0	15.26726	14.93208	16.5461	0	0	16.67523	0	16.84194	14.95197	0	16.62046	15.68731	0	0	16.42084	13.33525	0	15.15047	15.78059	0
Q17RW2	COOA1_HUMAN	Collagen alpha-1(XXIV) chain	COL24A1	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030198; GO:0031012; GO:0062023	DNPAR	7.190000057	0.286106884	0.286106884	0.211513189	572.4446545	14.27303	14.70958	15.31397	15.6995	10.25208	15.90626	16.39384	15.80403	15.31387	17.61112	16.05613	14.93611	16.3743	14.49401	15.14875	13.93989	15.59993	14.67246	16.2331	14.41687	14.68152	0	17.51958	14.4651	15.9532	15.49462	15.91135	15.78853	15.49703	0	15.76323	0	0	0	16.30655	16.43271	0	15.48635	17.2584	16.2612	15.46217	15.6231	13.89621	0	17.08154	15.80306	0	0
Q19T08	ECSCR_HUMAN	"Endothelial cell-specific chemotaxis regulator (Apoptosis regulator through modulating IAP expression, ARIA) (Endothelial cell-specific molecule 2)"	ECSCR ECSM2	Homo sapiens (Human)	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; negative regulation of angiogenesis [GO:0016525]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of proteasomal protein catabolic process [GO:1901800]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; negative regulation of angiogenesis [GO:0016525]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of proteasomal protein catabolic process [GO:1901800]		GO:0001525; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0006935; GO:0016021; GO:0016525; GO:0030154; GO:0043231; GO:1901800; GO:2000353	DSITLISMK	1.879999995	0.459200412	0.459200412	0.246955582	1008.654895	16.44528	13.00307	15.39995	12.1938	15.17394	13.14288	14.7194	13.81655	14.31822	16.08894	10.65466	13.22564	15.96917	0	13.53142	15.7349	10.87702	3.771567	14.17908	14.36807	0	0	16.56161	16.3071	0	17.22287	16.44417	12.88167	0	15.21188	15.79168	17.66602	0	16.34265	0	0	16.79982	0	0	16.19267	0	0	0	17.48277	15.09865	15.32427	16.92741	0
Q1A5X7	WHAL1_HUMAN	"Putative WASP homolog-associated protein with actin, membranes and microtubules-like protein 1 (WAS protein homolog associated with actin, Golgi membranes and microtubules pseudogene 3) (WAS protein homology region 2 domain-containing protein 1-like protein 1, WH2 domain-containing protein 1-like protein 1, WHDC1-like protein 1)"	WHAMMP3 WHAMML1 WHDC1L1	Homo sapiens (Human)	Arp2/3 complex-mediated actin nucleation [GO:0034314]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]	cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Arp2/3 complex binding [GO:0071933]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]	Arp2/3 complex binding [GO:0071933]	GO:0005737; GO:0006888; GO:0033116; GO:0034314; GO:0071933	NNMEASVPK	11.06000042	1	1	0.220042392	1005.660032	16.29761	14.93012	0	0	16.07436	12.38301	14.81992	16.25937	0	0	16.05451	15.60357	16.30688	15.14544	11.65202	9.802341	17.35929	13.61757	14.4682	13.04196	0	0	0	15.78191	13.39062	12.90443	0	0	15.41709	0	0	17.08197	19.02502	0	0	0	14.93273	17.76393	0	15.65119	16.91966	15.58377	0	15.84459	15.40145	0	17.0337	0
Q1ED39	KNOP1_HUMAN	Lysine-rich nucleolar protein 1 (Protein FAM191A) (Testis-specific gene 118 protein)	KNOP1 C16orf88 FAM191A TSG118	Homo sapiens (Human)		nucleolus [GO:0005730]	nucleolus [GO:0005730]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005730	DVGDTCSVGK	5.360000134	1	1	1.15E-12	1037.294874	14.25828	13.67297	0	13.87235	15.26193	12.90639	13.67469	15.45539	0	14.91534	0	15.67175	0	0	12.82747	0	0	12.06794	0	0	0	0	15.36375	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q1KMD3	HNRL2_HUMAN	"Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2, SAF-A2)"	HNRNPUL2 HNRPUL2	Homo sapiens (Human)		membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0016020	EEAQPIVTKYK	10.02999973	1	1	0.306894008	1305.074823	0	0	15.59501	15.99225	15.5445	14.59909	13.85422	15.66967	0	14.65114	0	14.03338	0	0	0	15.30764	15.03327	16.12669	0	0	15.18405	14.21819	15.49537	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q1L5Z9	LONF2_HUMAN	LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192)	LONRF2 RNF192	Homo sapiens (Human)			metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0046872; GO:0061630	AELYLTMK	9.199999809	0.349849164	0.349849164	0.198692885	984.1953805	17.01998	16.97067	17.6057	0	19.24825	18.62191	0	17.36063	16.11661	18.55898	18.72416	17.88876	14.99754	17.13482	17.77394	17.482	13.48334	18.62329	0	0	15.82049	0	0	0	18.52532	16.7023	0	0	18.71548	0	16.38639	19.39824	18.57199	13.37274	15.87436	0	15.29882	0	13.41248	17.18602	0	0	0	0	0	0	0	18.0669
Q1L6U9	MSMP_HUMAN	Prostate-associated microseminoprotein (PC3-secreted microprotein)	MSMP PSMP	Homo sapiens (Human)	inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; CCR2 chemokine receptor binding [GO:0031727]; cytokine activity [GO:0005125]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]	CCR2 chemokine receptor binding [GO:0031727]; cytokine activity [GO:0005125]	GO:0002548; GO:0005125; GO:0005615; GO:0005737; GO:0006954; GO:0031727; GO:0048247	SDPRLPCK	1.480000019	1	1	0.283414525	970.9990964	0	16.07494	17.68854	0	17.09088	0	0	0	0	16.33801	0	0	16.87949	0	16.32619	0	0	17.57845	0	0	0	15.40536	0	0	19.05475	0	0	0	0	17.16861	0	0	0	18.4234	0	0	17.00279	0	0	0	0	0	0	0	16.09806	17.53776	0	0
Q1MSJ5	CSPP1_HUMAN	Centrosome and spindle pole-associated protein 1	CSPP1 CSPP	Homo sapiens (Human)	positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467]		GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0032467; GO:0034451; GO:0051781	SGLSSALGEMVSPR	8.510000229	1	1	0.310517375	1391.749352	15.79974	15.11527	15.00801	0	0	0	0	0	0	0	0	0	13.14912	13.56623	0	13.41003	14.56113	15.37099	0	0	15.81381	0	0	13.41926	15.24167	13.97591	0	0	13.56411	0	0	0	0	0	0	0	0	16.52692	0	0	0	0	0	0	14.5422	0	0	0
Q1RMZ1	SAMTR_HUMAN	"S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog, EC 2.1.1.-)"	BMT2 C7orf60 SAMTOR	Homo sapiens (Human)	cellular response to amino acid starvation [GO:0034198]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262]	cytosol [GO:0005829]	cytosol [GO:0005829]; methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047]; cellular response to amino acid starvation [GO:0034198]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262]	methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005829; GO:0008168; GO:0032259; GO:0034198; GO:1904047; GO:1904262	EVGDFDK	9.930000305	0.41472134	0.41472134	0.227155367	809.5970784	15.48754	0	15.61296	17.7461	17.62253	0	17.74177	0	0	0	0	17.37523	0	0	0	0	0	0	15.41492	0	15.99674	0	17.86547	0	15.30945	18.60609	17.80119	0	17.91842	0	0	0	16.8577	16.66684	0	0	0	0	0	0	0	15.29048	0	17.4187	18.1844	18.0778	15.27588	0
Q1W6H9	F110C_HUMAN	Protein FAM110C	FAM110C	Homo sapiens (Human)	positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cell projection assembly [GO:0060491]	cell cortex [GO:0005938]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]	cell cortex [GO:0005938]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cell projection assembly [GO:0060491]	alpha-tubulin binding [GO:0043014]	GO:0000922; GO:0005634; GO:0005815; GO:0005874; GO:0005938; GO:0030335; GO:0043014; GO:0051897; GO:0060491	SAAPSSVPAAPPGPEPRVVR	4.230000019	1	1	0.362791292	1941.692273	0	0	0	0	0	0	15.03986	0	0	0	0	12.15746	0	0	0	0	0	0	0	12.7105	16.04836	0	0	0	0	15.26943	16.6293	0	0	0	14.00231	15.24953	15.08891	15.59287	14.12718	0	0	16.99328	16.0927	16.62819	15.00077	0	17.0179	15.4883	0	0	15.69036	0
Q1X8D7	LRC36_HUMAN	Leucine-rich repeat-containing protein 36 (ROR gamma-binding protein 70)	LRRC36 RORBP70	Homo sapiens (Human)						KIFTK	19.01000023	0.472334832	0.472334832	0.230217441	635.5168624	19.81129	19.42146	20.91532	17.14399	19.90903	20.33257	17.43144	20.70727	18.26969	16.22284	18.29488	20.04231	0	17.33634	14.94012	16.63806	0	22.00642	19.8653	18.09991	0	20.4215	21.56559	20.73293	20.60112	21.10676	0	0	19.81962	21.71539	18.02561	18.38056	0	21.78534	19.54803	22.86525	0	18.7451	17.73532	17.58855	20.66852	18.8536	21.28522	17.62947	22.02892	0	0	0
Q1XH10	SKDA1_HUMAN	SKI/DACH domain-containing protein 1 (Protein DLN-1)	SKIDA1 C10orf140 DLN1	Homo sapiens (Human)						ALATKAPPPER	6.510000229	1	1	0.249613955	1150.320725	0	15.451	14.32063	15.69533	14.10934	16.12402	14.14779	13.71583	0	14.65491	13.89092	0	0	0	15.08021	14.04786	0	13.834	15.34543	0	0	14.26741	0	15.38006	14.88588	0	0	0	0	0	0	14.75825	15.59794	0	0	0	13.82365	16.6405	14.17124	15.05156	15.02354	14.32152	0	0	14.64744	0	0	0
Q24JP5	T132A_HUMAN	Transmembrane protein 132A (HSPA5-binding protein 1)	TMEM132A HSPA5BP1 KIAA1583	Homo sapiens (Human)		endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016021; GO:0070062	QVAGSVGGNTGVRGK	5.880000114	0.681205332	0.681205332	0.206059451	1386.148584	0	14.7385	13.73491	0	0	0	0	0	14.38657	12.43982	0	14.10425	13.34287	14.7718	8.724483	0	0	0	0	0	14.51483	0	0	0	0	14.95072	0	0	16.7714	10.1694	0	15.36438	0	0	0	0	16.38452	0	0	15.60419	0	0	0	0	13.3277	0	13.08712	14.9362
Q29RF7	PDS5A_HUMAN	"Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112, SCC-112)"	PDS5A KIAA0648 PDS5 PIG54	Homo sapiens (Human)	cell division [GO:0051301]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156]	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell division [GO:0051301]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156]"		GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0005886; GO:0006281; GO:0007064; GO:0008156; GO:0051301	IISVTPVK	1.529999971	1	1	0.28429771	856.3767053	0	16.13089	0	0	0	0	0	0	0	0	0	0	0	0	15.36711	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.33104	0	0	0	0	17.86022	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2I0M5	RSPO4_HUMAN	"R-spondin-4 (Roof plate-specific spondin-4, hRspo4)"	RSPO4 C20orf182	Homo sapiens (Human)	nail development [GO:0035878]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; heparin binding [GO:0008201]; nail development [GO:0035878]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055]	heparin binding [GO:0008201]	GO:0005576; GO:0008201; GO:0016055; GO:0030177; GO:0035878	GQEVNRCK	1.210000038	0.564201415	0.564201415	0.098939094	987.8111237	16.23026	15.90506	15.79316	14.36486	0	0	13.0527	16.17974	15.70725	0	15.35152	0	0	11.60349	0	17.31031	14.17398	13.85723	17.33146	0	15.148	0	16.39373	0	0	0	12.31194	14.80062	0	0	16.79916	9.923174	16.19168	16.57978	13.11035	0	15.84211	15.45624	13.36414	14.35183	0	0	16.34131	14.7595	0	11.55815	14.2556	0
Q2KHM9	MOONR_HUMAN	"Protein moonraker, MNR (OFD1- and FOPNL-interacting protein)"	KIAA0753 MNR OFIP	Homo sapiens (Human)	centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539]		GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0034451; GO:0071539	ALQMFVTQFTDRGEHPLPAR	6.539999962	1	1	3.20E-12	2330.610939	12.6858	0	10.32333	14.86825	10.61792	12.98698	14.77524	0	13.79948	11.46316	11.94896	0	15.56939	0	11.91054	13.98755	13.57002	0	13.52531	0	0	0	14.3994	13.39048	0	0	11.00871	14.30049	0	12.44017	12.1174	10.96353	13.8121	9.461546	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2KHR2	RFX7_HUMAN	DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2)	RFX7 RFXDC2	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:1990837	DHPTVEMLG	6.320000172	0.797766805	0.797766805	0.186934312	1015.500115	14.92479	0	13.62438	14.54346	15.49069	0	15.16281	12.71425	14.36724	15.01098	0	16.74221	0	0	15.2225	0	0	11.86421	0	0	14.99758	15.71031	14.43741	15.8299	10.99684	15.06261	0	15.26033	0	0	11.82545	0	16.6205	14.09814	15.74556	12.99104	17.11259	0	0	16.01161	12.89273	0	12.97863	15.24723	13.43276	0	0	0
Q2KHR3	QSER1_HUMAN	Glutamine and serine-rich protein 1	QSER1	Homo sapiens (Human)		chromosome [GO:0005694]	chromosome [GO:0005694]		GO:0005694	SVSTPLTTLDATSDK	2.309999943	0.322107404	0.322107404	0.14967021	1534.633955	11.89132	12.03062	10.62206	0	0	16.74912	0	13.96284	11.79325	15.23555	15.79885	18.19191	15.08754	0	15.50292	15.91231	0	14.97862	0	11.57827	15.3581	0	15.56376	13.58873	15.07977	16.33134	0	13.17804	0	0	0	14.75543	0	14.76121	17.76142	0	15.15556	17.93642	16.07945	0	17.28475	0	13.38108	0	16.6044	12.97266	14.59082	15.03255
Q2KJY2	KI26B_HUMAN	Kinesin-like protein KIF26B	KIF26B	Homo sapiens (Human)	establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0022409; GO:0030010; GO:0072092	DGTMPRAGR	4.96999979	1	1	0.072691578	977.8723029	0	0	0	0	0	14.77843	13.59148	15.25991	14.97983	15.80384	15.63926	0	0	0	12.33719	12.0521	0	14.72416	14.40486	17.40948	14.70987	17.29881	17.70776	17.2358	14.0537	16.52563	0	16.73328	0	0	15.79552	18.37466	0	0	13.1903	15.456	18.46191	0	14.50242	15.56741	12.44813	0	15.77906	0	13.871	0	15.29212	19.26455
Q2LD37	K1109_HUMAN	Transmembrane protein KIAA1109 (Fragile site-associated protein)	KIAA1109 FSA KIAA1371	Homo sapiens (Human)	endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]		GO:0001558; GO:0005634; GO:0006909; GO:0016020; GO:0016021; GO:0016197; GO:0030856; GO:0032456; GO:0048488; GO:0098793	EISMSVGLGR	2.269999981	1	1	0.256304	1048.896753	0	0	0	0	0	0	0	0	0	17.52262	0	0	0	0	0	0	0	0	0	0	0	16.8202	16.66186	17.63072	0	16.7147	18.93933	16.10462	0	0	0	0	0	0	18.12364	0	0	16.3953	0	0	0	15.92357	0	17.17469	0	0	0	19.62048
Q2M1K9	ZN423_HUMAN	"Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein, hOAZ) (Smad- and Olf-interacting zinc finger protein)"	ZNF423 KIAA0760 NPHP14 OAZ	Homo sapiens (Human)	"cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0061512; GO:0120163	GFSSTSSLQSHMQAHK	4.929999828	1	1	0.448204861	1747.051942	0	15.64514	15.29875	15.0196	0	0	0	14.77363	0	14.98261	13.39006	14.56386	15.56505	0	0	0	0	15.07871	0	0	0	0	0	0	0	16.85054	0	0	0	0	0	0	0	0	0	0	15.80134	0	0	0	0	0	0	0	0	0	0	0
Q2M1P5	KIF7_HUMAN	Kinesin-like protein KIF7	KIF7 UNQ340/PRO539	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]	ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0036064; GO:0045879; GO:0045880; GO:0097542	DIQLREDER	1.870000005	0.434641689	0.434641689	0.219684561	1175.428781	0	16.97725	11.61951	14.04613	0	13.11896	14.11666	13.22559	0	0	0	12.76818	15.9179	0	14.02589	16.37742	14.13782	14.69241	0	0	16.93526	0	0	0	0	0	0	0	14.86154	16.64391	16.31427	0	0	0	0	0	16.56368	0	0	0	0	0	17.84224	16.81884	15.48733	15.68926	0	0
Q2M1Z3	RHG31_HUMAN	Rho GTPase-activating protein 31 (Cdc42 GTPase-activating protein)	ARHGAP31 CDGAP KIAA1204	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]	GO:0005096; GO:0005829; GO:0005925; GO:0007264; GO:0017124; GO:0030027; GO:0051056	NGSVFVRGQR	11.71000004	0.965562999	0.965562999	0.196792439	1120.107021	16.22702	13.22495	17.10399	0	0	0	0	0	0	0	0	0	15.98903	14.55375	15.35691	14.97586	0	10.75313	12.47974	13.88518	13.78553	11.64368	15.18292	0	14.61728	0	0	15.93245	14.7808	14.44265	15.89022	0	0	0	15.69149	14.67992	13.82299	0	14.57632	0	0	0	0	14.40825	0	15.19533	12.45222	0
Q2M2E5	CE064_HUMAN	Uncharacterized protein C5orf64	C5orf64	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	KVLPTTMMFSMLADCVLK	5.559999943	1	1	0.038399796	2116.416888	14.80276	0	0	12.96197	0	14.64928	0	0	15.21317	0	0	0	0	0	0	14.32946	16.16258	14.26849	12.10209	11.68296	0	13.40736	15.22735	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2M2H8	MGAL_HUMAN	"Probable maltase-glucoamylase 2 (Maltase-glucoamylase (alpha-glucosidase) pseudogene) [Includes: Glucoamylase, EC 3.2.1.3 (Glucan 1,4-alpha-glucosidase) ]"	MGAM2	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]	integral component of membrane [GO:0016021]	"integral component of membrane [GO:0016021]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]"	"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004339; GO:0004553; GO:0004558; GO:0005975; GO:0016021; GO:0030246	EVVSRNR	13.68000031	1	1	0.289777705	858.1021931	0	0	0	13.01102	14.056	0	15.39972	0	0	0	0	0	0	0	0	0	12.33218	0	0	0	0	16.62745	0	0	0	0	0	0	0	0	0	0	0	15.95901	12.03767	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2M2I3	FA83E_HUMAN	Protein FAM83E	FAM83E	Homo sapiens (Human)	signal transduction [GO:0007165]		protein kinase binding [GO:0019901]; signal transduction [GO:0007165]	protein kinase binding [GO:0019901]	GO:0007165; GO:0019901	DTPAKALMR	8.170000076	0.236290216	0.236290216	0.22771587	1018.889794	15.91787	15.45349	11.57094	13.2303	14.88126	14.94407	14.16969	0	15.64716	15.35361	14.87087	15.09902	0	0	0	0	15.97342	0	0	14.61431	0	0	15.23971	0	14.7759	13.50788	15.11605	14.78086	14.57479	10.82628	15.21908	12.3672	15.44587	12.56944	0	11.50202	10.84997	0	15.26346	15.3735	13.85254	0	13.28078	0	0	15.2433	11.43682	12.2186
Q2M2I5	K1C24_HUMAN	"Keratin, type I cytoskeletal 24 (Cytokeratin-24, CK-24) (Keratin-24, K24) (Type I keratin-24)"	KRT24 KA24	Homo sapiens (Human)		cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0070062	ASSSRAGGSSSAR	6.78000021	0.073738776	0.073738776	0.589602849	1181.033526	0	0	0	0	18.54186	0	0	0	0	0	0	0	0	0	0	0	19.6611	17.74348	0	0	17.89585	0	0	0	0	18.33609	0	0	0	0	0	0	0	18.16721	17.95122	0	0	0	0	18.64393	0	0	18.25635	0	0	0	17.2307	0
Q2M2I8	AAK1_HUMAN	"AP2-associated protein kinase 1, EC 2.7.11.1 (Adaptor-associated kinase 1)"	AAK1 KIAA1048	Homo sapiens (Human)	endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880]	cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; terminal bouton [GO:0043195]	cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880]	AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005112; GO:0005524; GO:0005737; GO:0005829; GO:0005905; GO:0006468; GO:0006897; GO:0019897; GO:0030136; GO:0031252; GO:0032880; GO:0035612; GO:0043195; GO:0045747; GO:0046777; GO:0050821; GO:0061024; GO:0106310; GO:2000369	EQGGSGLGSGSSGGGGSTSGLGSGYIGR	7.159999847	1	1	0.291853409	2387.343288	18.23099	14.87105	17.99296	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2M2W7	CQ058_HUMAN	UPF0450 protein C17orf58	C17orf58	Homo sapiens (Human)		collagen-containing extracellular matrix [GO:0062023]	collagen-containing extracellular matrix [GO:0062023]		GO:0062023	KPDSRGCPSAEETPGPR	6.78000021	1	1	0.139268484	1840.096982	0	15.63195	0	0	10.212	14.34146	14.30894	14.1509	13.59212	0	0	0	13.69449	0	14.60402	0	0	0	0	13.94432	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.33865	0	0	0	0	0	0	0	0	0	0	0
Q2M329	CCD96_HUMAN	Coiled-coil domain-containing protein 96	CCDC96	Homo sapiens (Human)	cilium assembly [GO:0060271]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium assembly [GO:0060271]		GO:0005930; GO:0036064; GO:0060271	EMSAVR	9.619999886	0.971573591	0.971573591	0.223032496	707.4980003	14.62358	14.1107	15.73408	14.88451	15.93728	14.90507	15.83439	15.93658	15.12735	16.13257	14.93776	16.27989	15.77625	13.90679	15.21897	15.55209	15.77904	16.55556	13.23559	15.19164	14.71588	16.57164	17.18231	17.84945	15.1616	14.93027	0	15.9026	14.73596	0	0	16.17873	16.61489	0	16.27706	15.90654	15.36228	16.74031	15.9707	15.19302	15.8895	16.09713	0	0	0	15.67529	15.41915	15.29164
Q2M3C7	SPKAP_HUMAN	A-kinase anchor protein SPHKAP (SPHK1-interactor and AKAP domain-containing protein) (Sphingosine kinase type 1-interacting protein)	SPHKAP KIAA1678 SKIP	Homo sapiens (Human)		cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein kinase A binding [GO:0051018]	protein kinase A binding [GO:0051018]	GO:0005737; GO:0005739; GO:0051018	ASSVSK	1.389999986	0.013491042	0.013491042	0.210796453	579.4627958	0	0	14.46888	13.84435	14.80285	0	16.20314	0	14.88124	0	15.19183	0	14.73685	0	15.39188	16.92624	0	0	0	0	0	16.33793	0	15.73809	0	16.22464	0	16.54814	0	0	15.70736	16.60353	0	0	16.86201	16.67301	16.3493	16.74751	0	15.7086	16.55207	15.09581	14.94616	16.31454	0	0	0	0
Q2M3D2	EX3L2_HUMAN	Exocyst complex component 3-like protein 2 (HBV X-transactivated gene 7 protein) (HBV XAg-transactivated protein 7)	EXOC3L2 XTP7	Homo sapiens (Human)	exocyst localization [GO:0051601]; exocytosis [GO:0006887]	exocyst [GO:0000145]	exocyst [GO:0000145]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]	SNARE binding [GO:0000149]	GO:0000145; GO:0000149; GO:0006887; GO:0051601	FHENPAVR	7.639999866	0.744922817	0.744922817	0.196551921	968.5624575	0	0	11.53818	0	15.26429	0	15.63526	0	0	0	16.88065	0	15.90928	5.791163	15.46661	0	16.36845	0	16.11533	0	17.24858	0	0	0	0	16.47114	16.94147	16.22508	16.92317	15.82216	16.47107	15.41192	0	15.19633	14.86897	0	0	13.46289	13.35856	14.29233	16.97922	13.03965	14.73304	0	12.98877	14.88555	13.90767	15.02646
Q2M3G0	ABCB5_HUMAN	"ATP-binding cassette sub-family B member 5 (ABCB5 P-gp) (P-glycoprotein ABCB5, EC 7.6.2.2)"	ABCB5	Homo sapiens (Human)	cell differentiation [GO:0030154]; eye development [GO:0001654]; regulation of membrane potential [GO:0042391]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; cell differentiation [GO:0030154]; eye development [GO:0001654]; regulation of membrane potential [GO:0042391]; transmembrane transport [GO:0055085]	ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]	GO:0001654; GO:0005524; GO:0005886; GO:0005887; GO:0008559; GO:0015562; GO:0016021; GO:0030154; GO:0042391; GO:0042626; GO:0055085	ENSERAEEMQENYQR	1.940000057	1	1	0.198326653	1927.853784	11.96763	0	0	15.57893	0	12.78096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.23216	0	0	0	0	0	0	15.54734	0	0	0	0	0	0	0	0	0	0	0	0
Q2M3G4	SHRM1_HUMAN	Protein Shroom1 (Apical protein 2)	SHROOM1 APXL2 KIAA1960	Homo sapiens (Human)	actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; microtubule [GO:0005874]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902]	actin filament binding [GO:0051015]; myosin II binding [GO:0045159]	GO:0000902; GO:0005874; GO:0005912; GO:0007015; GO:0016324; GO:0030864; GO:0043296; GO:0045159; GO:0051015; GO:0051017	EHVARR	3.099999905	1	1	0.120101955	766.7103788	0	0	0	0	0	0	0	0	14.50091	0	0	0	0	15.991	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.8966	13.63998	0	0	0	16.16415	0	0	13.23367	0	0	0	0	15.00105
Q2M3R5	S35G1_HUMAN	Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20)	SLC35G1 C10orf60 POST TMEM20	Homo sapiens (Human)	calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480]		GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034	TGFIGPK	3.25999999	1.09E-05	1.09E-05	0.162926365	719.6587147	10.74152	14.38119	17.36234	17.15968	0	14.72169	15.90175	0	14.63634	16.49935	17.13316	15.40357	16.16011	0	14.06866	0	0	17.80318	14.80855	16.1848	15.86282	15.9316	0	0	17.31832	14.62235	16.03923	15.08898	0	17.35721	11.66502	17.16345	17.56271	0	13.80046	15.81267	11.73267	17.09094	16.07023	16.10881	16.80749	14.14476	14.38889	16.41779	18.00826	15.22765	11.32781	13.43714
Q2M3T9	HYAL4_HUMAN	"Hyaluronidase-4, Hyal-4, EC 3.2.1.35 (Chondroitin sulfate endo-beta-N-acetylgalactosaminidase) (Chondroitin sulfate hydrolase, CSHY) (Hyaluronoglucosaminidase-4)"	HYAL4	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]; hyaluronan catabolic process [GO:0030214]	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]	cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]; hyaluronan catabolic process [GO:0030214]	hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005975; GO:0006027; GO:0009986; GO:0016021; GO:0030207; GO:0030214; GO:0031410	SLGDSENILR	1.860000014	1	1	4.60E-13	1102.805759	0	13.78374	0	14.10133	0	0	12.94353	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84772	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.33529	0	0	17.13818	0	0	0	0	0	13.20972	0
Q2M3V2	SWAHA_HUMAN	Ankyrin repeat domain-containing protein SOWAHA (Ankyrin repeat domain-containing protein 43) (Protein sosondowah homolog A)	SOWAHA ANKRD43	Homo sapiens (Human)						AYQYLRPGSSYALRR	3.109999895	1	1	0	1800.191733	15.09385	15.56345	13.96146	0	12.11274	12.30546	14.83942	0	0	15.25723	13.0026	0	0	0	0	0	13.74161	0	0	0	0	0	15.9803	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2M5E4	RGS21_HUMAN	"Regulator of G-protein signaling 21, RGS21"	RGS21	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]	GTPase activity [GO:0003924]	GO:0003924; GO:0005886; GO:0007186; GO:0009968	IASKAK	16.79000092	0.002793448	0.002793448	0.242956242	615.4764648	19.58893	0	21.03395	0	17.29678	0	17.26077	0	19.11306	0	18.58927	17.42345	17.72538	0	18.95248	17.56408	18.30314	0	17.59927	0	18.69974	16.84921	18.44641	19.02174	18.82758	18.4038	19.38334	19.19244	19.50479	0	0	0	18.14819	0	0	0	0	0	18.06384	0	0	18.20603	0	17.98291	18.79171	0	18.42961	17.29967
Q2NKJ3	CTC1_HUMAN	CST complex subunit CTC1 (Conserved telomere maintenance component 1) (HBV DNAPTP1-transactivated protein B)	CTC1 C17orf68	Homo sapiens (Human)	bone marrow development [GO:0048539]; cellular response to DNA damage stimulus [GO:0006974]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; spleen development [GO:0048536]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; thymus development [GO:0048538]	"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162]; bone marrow development [GO:0048539]; cellular response to DNA damage stimulus [GO:0006974]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; spleen development [GO:0048536]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; thymus development [GO:0048538]"	G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162]	GO:0000723; GO:0000781; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0010389; GO:0010833; GO:0016233; GO:0032211; GO:0035264; GO:0042162; GO:0045740; GO:0048146; GO:0048536; GO:0048538; GO:0048539; GO:0071425; GO:0090399; GO:0098505; GO:1990879	DQSGSLPCLLLAK	13.15999985	1	1	0.467553755	1403.598199	0	16.40237	0	15.27192	0	0	0	0	0	0	0	0	0	0	14.14371	0	0	0	0	0	0	15.81496	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.27193	0	0	15.99922	0	0
Q2NKQ1	SGSM1_HUMAN	Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2)	SGSM1 KIAA1941 RUTBC2	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]	GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]	GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0030659; GO:0031267; GO:0090630	ASAPAEAETR	7.670000076	0.738238573	0.738238573	0.227103466	1003.111262	16.38788	14.90362	16.23513	16.71689	0	16.9278	16.95515	0	0	16.9957	15.20161	16.63964	0	16.01758	16.57858	17.47914	0	0	0	0	0	0	0	0	15.5172	16.83807	0	0	0	0	0	16.80969	0	0	16.41808	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2NKX8	ERC6L_HUMAN	"DNA excision repair protein ERCC-6-like, EC 3.6.4.12 (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15)"	ERCC6L PICH	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]	cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]	cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; cell cycle [GO:0007049]; cell division [GO:0051301]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]	GO:0000776; GO:0003677; GO:0003678; GO:0005524; GO:0005829; GO:0007049; GO:0015616; GO:0016020; GO:0016887; GO:0051301; GO:0140658	MEASR	5.130000114	1	1	3.44E-13	609.7282492	0	0	12.71186	14.2145	11.64799	0	15.84362	12.48256	0	15.14324	0	14.90614	13.81885	14.17406	0	0	0	0	0	0	0	0	0	0	0	0	16.40248	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2NL67	PARP6_HUMAN	"Protein mono-ADP-ribosyltransferase PARP6, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 17, ARTD17) (Poly [ADP-ribose] polymerase 6, PARP-6)"	PARP6	Homo sapiens (Human)	positive regulation of dendrite morphogenesis [GO:0050775]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]		NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0003950; GO:0006471; GO:0050775; GO:0070213; GO:0140289; GO:1990404	NIPTLEYGFLVQIMKYAEQR	3.049999952	1	1	0	2428.917767	0	14.95863	14.23169	0	0	13.89932	14.86341	15.91034	12.93614	13.82542	0	15.228	0	15.65005	11.67342	14.96776	14.76174	15.00819	0	0	0	0	0	0	0	0	0	0	0	0	0	16.36432	0	0	0	0	16.55147	0	0	0	15.21821	0	0	0	0	0	0	0
Q2NL82	TSR1_HUMAN	Pre-rRNA-processing protein TSR1 homolog	TSR1 KIAA1401	Homo sapiens (Human)	"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]"	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511	LLLLDTQQEAGMLLR	4.489999771	1	1	0.629572587	1714.023538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.65369	0	0	0	0	0	0	0	0	0	0	0	0
Q2NL98	VMAC_HUMAN	Vimentin-type intermediate filament-associated coiled-coil protein	VMAC	Homo sapiens (Human)		cytoplasm [GO:0005737]; type III intermediate filament [GO:0045098]	cytoplasm [GO:0005737]; type III intermediate filament [GO:0045098]		GO:0005737; GO:0045098	AAELEAR	3.119999886	1	1	0.014198956	761.5806523	0	0	0	0	0	0	0	16.11917	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.14983	16.39718	0	0	0	0	0	0	0	0	0	0	0
Q2PPJ7	RGPA2_HUMAN	"Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt, AS250) (p220)"	RALGAPA2 C20orf74 KIAA1272	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]	GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0046982; GO:0051056; GO:0090630	AVLIIFR	14.02999973	0.364871532	0.364871532	0.50758288	829.97444	16.78314	17.95302	17.05273	0	17.01872	14.11664	16.13995	16.55533	17.81536	0	17.17777	17.65516	0	18.2717	0	0	0	0	16.78515	17.78627	0	0	0	0	17.18563	0	16.37278	16.72598	0	16.11987	0	0	0	0	0	16.89541	15.15103	17.22665	0	17.02768	0	0	0	17.76837	0	16.30348	16.82656	0
Q2Q1W2	LIN41_HUMAN	"E3 ubiquitin-protein ligase TRIM71, EC 2.3.2.27 (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)"	TRIM71 LIN41	Homo sapiens (Human)	3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]	P-body [GO:0000932]	P-body [GO:0000932]; miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]	miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637	IQIFTFEGQFLLK	4.150000095	1	1	0.469866862	1583.930251	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.11009	0	0	0	0	18.99085	0	0	0	19.69424	0	17.95122	0	0	0	17.66137	0	0	0	18.11758	0	0	0	0	0	0	17.67814
Q2QGD7	ZXDC_HUMAN	Zinc finger protein ZXDC (ZXD-like zinc finger protein)	ZXDC ZXDL	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; LRR domain binding [GO:0030275]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	C2H2 zinc finger domain binding [GO:0070742]; LRR domain binding [GO:0030275]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0030275; GO:0045893; GO:0046872; GO:0070742	APAPLGASPAR	3.099999905	0.698470891	0.698470891	0.173882587	1005.641961	13.44392	0	15.08579	0	13.73455	15.26729	16.09104	13.6625	14.2674	0	0	0	13.67578	15.58786	16.01504	0	14.65737	14.37174	12.60636	15.26129	0	15.16711	14.86794	16.04327	0	13.67159	14.50752	14.07248	15.22677	13.4193	0	12.46694	15.01177	16.10907	15.78024	14.22768	15.66511	14.63697	15.51138	14.73957	14.24155	14.84398	11.4905	12.64963	15.56081	0	0	0
Q2T9K0	TMM44_HUMAN	Transmembrane protein 44	TMEM44	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	MRQALGFAK	4.610000134	0.836968958	0.836968958	0.2162461	1034.623364	0	0	0	0	0	0	14.28744	0	0	0	0	0	0	0	14.1408	0	0	0	0	0	0	0	0	0	0	0	0	0	12.94905	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.77895	18.03801	0	0
Q2TAC2	CCD57_HUMAN	Coiled-coil domain-containing protein 57	CCDC57	Homo sapiens (Human)	centriole replication [GO:0007099]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; positive regulation of mitotic cell cycle [GO:0045931]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; positive regulation of mitotic cell cycle [GO:0045931]		GO:0000086; GO:0005737; GO:0005813; GO:0005814; GO:0005876; GO:0007020; GO:0007099; GO:0034451; GO:0045931; GO:0060271	RPVKMQAGIATPGMK	1.409999967	1	1	0.402369531	1579.138749	0	15.46902	19.00968	17.73295	0	0	0	17.58122	0	0	0	18.56751	0	0	18.05564	0	19.26118	0	0	0	17.07766	0	0	0	19.53474	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.02998	0	0	0	17.89549	0	0
Q2TAC6	KIF19_HUMAN	Kinesin-like protein KIF19	KIF19	Homo sapiens (Human)	axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462]	axoneme [GO:0005930]; cilium [GO:0005929]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	axoneme [GO:0005930]; cilium [GO:0005929]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0060404; GO:0070462	LFMIDLAGSER	7.670000076	0.026113836	0.026113836	0.201610044	1268.57109	0	10.41102	0	0	0	0	0	16.48975	0	0	0	0	14.08788	0	0	0	0	15.00787	0	0	0	0	20.22841	0	0	0	0	0	0	0	0	13.29776	0	15.54286	16.88137	16.44385	0	0	0	0	0	0	0	0	0	0	0	0
Q2TAK8	PWP3A_HUMAN	"PWWP domain-containing DNA repair factor 3A, PWWP3A (Mutated melanoma-associated antigen 1, MUM-1) (PWWP domain-containing protein MUM1) (Protein expandere)"	PWWP3A EXPAND1 MUM1	Homo sapiens (Human)	chromatin organization [GO:0006325]; DNA repair [GO:0006281]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]	nucleosome binding [GO:0031491]	GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0031491	DMGSK	3.190000057	1	1	0.178766781	536.4868127	15.48468	15.16192	15.02521	0	0	0	0	14.56436	0	13.55905	15.78577	13.46554	13.44783	14.73836	15.84388	13.7895	14.27323	0	0	15.30575	12.98687	14.41842	0	0	0	15.24599	0	12.6068	15.13663	14.97574	15.5653	15.81432	15.50821	16.76271	15.64112	13.94941	14.99681	16.32024	13.91088	14.51161	13.98727	15.69002	15.60401	13.28951	14.82621	13.8893	16.98368	15.38069
Q2TAL5	SMTL2_HUMAN	Smoothelin-like protein 2	SMTNL2	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; positive regulation of vasoconstriction [GO:0045907]	filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]	filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; positive regulation of vasoconstriction [GO:0045907]	protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]	GO:0005523; GO:0005815; GO:0008157; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0045907	QVEALGLASGMSPVPGTPGTPSPPPAPGVPDR	6.210000038	1	1	4.59E-13	3052.465055	0	13.22851	14.52525	15.24083	13.46552	0	15.31391	14.142	15.45708	15.02226	11.72368	15.83611	0	0	14.3986	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2TB10	ZN800_HUMAN	Zinc finger protein 800	ZNF800 PP902	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872	KPKLSAGFDFK	7.309999943	1	1	1.14E-12	1237.886512	0	10.0308	0	14.44501	12.02355	10.66885	13.39988	15.28362	0	15.20096	12.12706	13.29785	0	0	12.9693	14.58706	0	14.3716	14.26513	10.62493	0	13.03711	12.86339	13.80534	0	0	0	0	0	0	0	0	0	0	14.5601	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2TB18	ASTE1_HUMAN	Protein asteroid homolog 1	ASTE1 HT001	Homo sapiens (Human)			nuclease activity [GO:0004518]	nuclease activity [GO:0004518]	GO:0004518	EELQEDGAKMLYAEFQR	4.269999981	1	1	0.229747957	2071.591436	0	0	0	0	13.97929	0	0	0	0	0	0	12.90032	0	16.63387	0	11.59673	15.72771	0	0	0	0	16.38293	16.30538	0	15.15508	13.7555	15.33123	14.41705	16.03646	0	0	0	12.34374	0	12.95796	15.16225	14.643	14.63527	0	12.63555	12.68051	14.23816	15.47204	0	0	0	0	14.27205
Q2TB90	HKDC1_HUMAN	"Hexokinase HKDC1, EC 2.7.1.1 (Hexokinase domain-containing protein 1)"	HKDC1	Homo sapiens (Human)	cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]	cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]	ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]	GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005739; GO:0005829; GO:0006096; GO:0008865; GO:0019158; GO:0019318; GO:0031966; GO:0051156	GTLIGWTKGFK	6.860000134	0.43261686	0.43261686	0.231748985	1208.206205	15.06789	15.67995	13.88159	14.96802	11.53934	0	0	0	10.92832	0	13.84299	14.22909	0	14.37509	14.63799	9.941988	14.53765	0	13.78604	0	0	0	15.28132	0	15.27729	0	0	0	0	0	15.11575	0	0	0	0	13.49257	0	0	0	0	0	0	0	0	0	0	0	0
Q2TBA0	KLH40_HUMAN	Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5) (Sarcosynapsin)	KLHL40 KBTBD5 SRYP	Homo sapiens (Human)	negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]	A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674]	A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]		GO:0005737; GO:0031397; GO:0031398; GO:0031463; GO:0031672; GO:0031674; GO:0032435; GO:0032436; GO:0048741; GO:0098528	EIAYAAGATFLPVR	11.38000011	0.551831722	0.551831722	0.342369966	1477.950465	0	0	0	0	0	15.11669	0	0	14.5453	0	14.28747	14.67071	0	0	0	0	0	0	0	16.19816	0	16.80001	0	0	16.74937	0	0	0	0	17.80236	0	0	17.43095	0	0	0	18.4732	0	0	0	0	14.89873	0	19.68954	0	11.98323	0	15.53727
Q2TBE0	C19L2_HUMAN	CWF19-like protein 2	CWF19L2	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	post-mRNA release spliceosomal complex [GO:0071014]	"post-mRNA release spliceosomal complex [GO:0071014]; mRNA splicing, via spliceosome [GO:0000398]"		GO:0000398; GO:0071014	FMGKTDGDYYTLDDMFVSK	3.25	1	1	0.267504216	2232.765157	11.81268	14.63426	11.63867	0	0	0	0	0	0	0	0	0	8.706917	14.58871	0	0	12.46585	13.48406	0	11.94048	12.50277	15.77685	16.3334	14.65015	10.75142	0	0	14.10098	8.817921	0	15.39343	16.01869	0	14.09277	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2TBF2	WSCD2_HUMAN	WSC domain-containing protein 2	WSCD2 KIAA0789	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	GKDGNER	6.880000114	1	1	0.1964885	775.4569058	14.22053	0	15.02637	16.09361	14.22283	15.35259	0	16.00532	15.68118	16.36659	16.08869	0	0	15.15206	15.69928	15.99695	14.57023	14.75745	0	15.27618	14.48419	0	0	15.10705	0	0	15.14461	14.0273	15.14626	0	0	0	14.00088	0	15.08047	0	0	0	0	0	15.62172	15.76127	15.72878	0	16.23775	0	0	0
Q2TV78	MST1L_HUMAN	"Putative macrophage stimulating 1-like protein (Brain rescue factor 1, BRF-1) (Hepatocyte growth factor-like protein homolog)"	MST1L D1F15S1A MST1P9 MSTP9	Homo sapiens (Human)	regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; peptidase activity [GO:0008233]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	peptidase activity [GO:0008233]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005615; GO:0008233; GO:0030971; GO:0046425	LQALTLGRHALMSGTR	4.46999979	1	1	0.20473495	1742.094551	0	14.6517	0	14.56305	0	14.36171	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.45252	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2UY09	COSA1_HUMAN	Collagen alpha-1(XXVIII) chain	COL28A1 COL28	Homo sapiens (Human)	cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0030198; GO:0031012; GO:0062023	GLPGEGFPGPK	7.929999828	1	1	0.172972298	1056.996625	16.13904	17.57003	14.66734	15.60801	0	14.52465	0	0	13.15034	0	0	0	0	0	0	0	0	0	14.66826	0	0	0	15.40934	0	15.60791	0	14.6229	0	0	0	0	15.79217	0	0	0	0	0	16.13353	0	0	0	0	0	0	0	0	0	15.00682
Q2V2M9	FHOD3_HUMAN	"FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2, hFHOS2)"	FHOD3 FHOS2 KIAA1695	Homo sapiens (Human)	actin filament network formation [GO:0051639]; cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actin filament network formation [GO:0051639]; cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214]	actin filament binding [GO:0051015]	GO:0005737; GO:0005856; GO:0030018; GO:0030837; GO:0030866; GO:0045214; GO:0051015; GO:0051639; GO:0055003	DNCSASSVSSSSSTLER	4.53000021	0.842168808	0.842168808	0.386746002	1773.163316	0	15.13674	11.08363	0	14.86198	0	0	0	0	0	0	0	0	0	0	0	0	15.19366	0	0	0	0	0	14.73117	0	0	0	0	0	0	0	0	17.20583	0	0	15.13822	13.93084	0	0	0	0	13.58899	14.31302	15.65434	16.92892	0	0	0
Q2VIQ3	KIF4B_HUMAN	Chromosome-associated kinesin KIF4B (Chromokinesin-B)	KIF4B	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]	cytosol [GO:0005829]; microtubule [GO:0005874]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; microtubule [GO:0005874]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005829; GO:0005874; GO:0007018; GO:0007052; GO:0008017; GO:0016363; GO:0046872; GO:0051256; GO:0051536	LNQEIWMMK	13.56999969	1	1	0.922608759	1208.637856	0	0	0	0	0	0	0	0	0	0	0	0	19.22649	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2VIR3	IF2GL_HUMAN	"Eukaryotic translation initiation factor 2 subunit 3B, EC 3.6.5.3 (Eukaryotic translation initiation factor 2 subunit gamma A, eIF-2-gamma A, eIF-2gA)"	EIF2S3B	Homo sapiens (Human)	formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]	eukaryotic translation initiation factor 2 complex [GO:0005850]	eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]	GO:0000049; GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005850; GO:0045903	DFTSEPR	5.989999771	0.041176915	0.041176915	0.25073281	852.6618812	0	0	0	16.30301	0	0	17.4776	0	16.67175	0	0	15.90461	15.24277	15.36731	0	16.37853	16.1509	0	15.2057	0	0	17.04141	0	0	0	0	0	14.02572	15.57063	16.9144	0	0	0	0	15.16876	14.6469	0	0	0	0	0	0	0	13.76102	0	0	0	0
Q2VPA4	CR1L_HUMAN	Complement component receptor 1-like protein (Complement C4b-binding protein CR-1-like protein)	CR1L	Homo sapiens (Human)	"negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]"	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235]	"cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]"		GO:0005615; GO:0005737; GO:0016020; GO:0030449; GO:0043235; GO:0045959; GO:1903659	NPPDPVNGMAHVIK	9.979999542	1	1	6.87E-13	1504.115181	14.86081	14.1042	0	9.340553	15.49782	14.44421	0	11.37234	0	15.4395	9.68795	11.20657	0	16.51122	0	0	0	0	0	0	17.8366	15.51428	0	0	14.45097	0	0	14.60076	0	13.27924	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q2VPJ9	LR75B_HUMAN	Leucine-rich repeat-containing protein 75B (Leucine-rich repeat-containing protein FAM211B)	LRRC75B C22orf36 FAM211B	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	TLLPDILYR	10	1	1	0.130412129	1103.13813	15.20289	16.07313	0	0	11.37272	17.36724	0	0	0	11.85612	0	15.8706	0	0	0	0	0	0	0	0	0	0	0	0	16.43449	16.13928	0	0	0	0	0	0	16.22495	0	0	0	0	0	0	0	0	16.58909	0	0	0	0	0	0
Q2VWP7	PRTG_HUMAN	Protogenin (Protein Shen-Dan)	PRTG	Homo sapiens (Human)	negative regulation of neurogenesis [GO:0050768]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; negative regulation of neurogenesis [GO:0050768]	identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]	GO:0005615; GO:0005886; GO:0016021; GO:0038023; GO:0042802; GO:0050768	EPQDVTVTR	5.610000134	0.713170469	0.713170469	0.279236093	1044.464619	0	0	0	0	0	0	0	0	16.63606	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.27389	0	0	0	0	0	0	0	0	0	0	0	0	0	16.10915
Q2WGJ6	KLH38_HUMAN	Kelch-like protein 38	KLHL38 C8orfK36	Homo sapiens (Human)						HDLQARK	2.319999933	1	1	0.118534004	867.0311836	0	0	12.37228	14.90204	11.48233	14.30971	0	15.04687	15.82462	0	14.256	0	13.08867	15.52788	14.90292	0	0	0	0	15.24266	0	0	0	0	0	0	0	0	0	16.32931	15.44701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.05326
Q2WGJ9	FR1L6_HUMAN	Fer-1-like protein 6	FER1L6 C8orfK23	Homo sapiens (Human)	plasma membrane organization [GO:0007009]; response to bacterium [GO:0009617]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; plasma membrane organization [GO:0007009]; response to bacterium [GO:0009617]	metal ion binding [GO:0046872]	GO:0007009; GO:0009617; GO:0016021; GO:0046872	GLILANKAAK	20.95999908	0.485645801	0.485645801	0.276241043	1001.689088	17.50029	16.09807	0	15.8271	0	17.16815	14.35257	14.97788	16.05735	0	16.81294	0	20.74464	21.69994	21.53172	21.15547	18.15991	21.46077	18.48641	21.67611	19.54666	20.14189	21.48141	18.98586	21.0983	20.33719	16.50367	20.42988	20.65233	20.93066	21.27589	20.11492	20.39294	21.29329	0	20.57174	21.50533	0	19.41543	21.66788	21.67514	21.8503	22.30656	21.63424	22.19328	21.37303	21.90396	22.3266
Q2WGN9	GAB4_HUMAN	"GRB2-associated-binding protein 4 (GRB2-associated binder 2-like, GAB2-like) (GRB2-associated binder 4) (GRB2-associated-binding protein 2-like) (Growth factor receptor bound protein 2-associated protein 4)"	GAB4	Homo sapiens (Human)						EIQKGYMFDIK	3.75999999	1	1	0.341677924	1368.345897	15.9113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.04741	0	0	0	0	0	0	0	0	15.545	0	15.32779	0	0	0	15.23524	13.44602	16.24025	15.36877	15.59254	17.98357	16.48395	17.56178	16.48985	0	16.41073	0	0	16.75469	0	0	0
Q32M45	ANO4_HUMAN	Anoctamin-4 (Transmembrane protein 16D)	ANO4 TMEM16D	Homo sapiens (Human)	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0034220; GO:0046983; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476	EASSSGITNGK	4	0.774528205	0.774528205	0.158534273	1046.652062	15.73923	15.73146	14.16482	0	15.43548	0	0	14.65882	0	14.94315	0	0	13.99454	0	15.30418	0	15.24762	15.64306	14.74668	0	0	0	14.90976	0	15.00477	13.86621	15.5528	13.46402	13.66861	0	15.33337	0	13.82856	0	14.41488	0	10.69265	0	17.28866	0	0	16.45007	14.88729	11.08231	15.13212	0	16.67978	0
Q32M78	ZN699_HUMAN	Zinc finger protein 699 (Hangover homolog)	ZNF699	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	IQYECK	8.81000042	0.105309017	0.105309017	0.245825243	840.5831598	17.1449	18.78148	16.98095	0	0	0	18.23489	0	19.85111	18.75364	17.57843	0	0	0	0	0	0	0	17.17063	0	0	0	0	17.07756	18.7792	0	0	0	16.93458	16.68273	18.89201	0	0	18.26497	0	0	0	0	0	18.81127	18.28724	0	0	0	0	0	0	0
Q32M84	BTBDG_HUMAN	BTB/POZ domain-containing protein 16	BTBD16 C10orf87	Homo sapiens (Human)						MIMSNTHK	10.02000046	1	1	0.390719701	960.9585351	14.67615	13.69873	13.61114	0	15.18175	14.91207	0	15.49761	15.50487	0	15.41488	16.46602	0	15.77282	16.03315	13.7717	15.76621	0	16.76442	15.16354	15.66111	0	0	0	16.24649	0	0	0	0	0	0	16.19687	0	0	16.37025	15.95521	16.70079	0	0	17.82149	0	16.083	0	0	0	0	16.40651	17.00485
Q32MZ4	LRRF1_HUMAN	"Leucine-rich repeat flightless-interacting protein 1, LRR FLII-interacting protein 1 (GC-binding factor 2) (TAR RNA-interacting protein)"	LRRFIP1 GCF2 TRIP	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003725; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006357; GO:0042803; GO:0045296	GGNEKGK	12.27999973	1	1	0.2625736	689.8680516	17.20561	14.3407	17.94404	0	0	0	0	0	0	0	0	0	0	0	0	0	17.44623	0	0	0	0	0	0	0	0	0	18.79923	0	0	16.88103	0	17.57721	0	0	0	0	0	15.35762	0	0	0	17.28617	0	0	0	0	0	0
Q32P41	TRM5_HUMAN	"tRNA (guanine(37)-N1)-methyltransferase, EC 2.1.1.228 (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog)"	TRMT5 KIAA1393 TRM5	Homo sapiens (Human)	mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]; mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939]	tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]	GO:0002939; GO:0005634; GO:0005737; GO:0005759; GO:0008175; GO:0009019; GO:0030488; GO:0052906; GO:0070901	DANPAEDVR	10.63000011	1	1	0.286711882	986.3295965	18.23691	0	0	0	20.38431	0	17.02359	0	0	0	17.03246	0	17.48906	18.30701	0	0	0	17.83896	0	0	17.01929	16.25486	16.72905	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.45463	0	17.35113	17.07308	17.21792	0	0	0	17.23061
Q32P51	RA1L2_HUMAN	"Heterogeneous nuclear ribonucleoprotein A1-like 2, hnRNP A1-like 2 (hnRNP core protein A1-like 2)"	HNRNPA1L2 HNRNPA1L	Homo sapiens (Human)	mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]	cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]	GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0051028	RGSGNFGGGR	8.43999958	1	1	0.242415948	964.5401115	17.16873	19.62201	17.75149	16.99489	20.35543	20.18715	0	20.75126	0	0	0	0	0	18.81639	0	20.4869	0	21.28007	0	0	0	21.09945	18.10986	19.95376	0	21.25922	0	16.06244	19.48408	21.31036	0	0	0	0	18.44604	21.0434	20.24323	18.07627	18.64651	0	17.8418	17.76777	0	0	19.81869	0	16.99952	0
Q330K2	NDUF6_HUMAN	"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)"	NDUFAF6 C8orf38	Homo sapiens (Human)	biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981]		GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0009058; GO:0032981	KVFLPMDICMLHGVSQEDFLR	5.400000095	1	1	9.37E-13	2551.138668	0	0	0	0	19.25561	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.57729	0	0	0	0	17.55373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q38SD2	LRRK1_HUMAN	"Leucine-rich repeat serine/threonine-protein kinase 1, EC 2.7.11.1"	LRRK1 KIAA1790	Homo sapiens (Human)	bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0004722; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0036035; GO:0042802; GO:0043231; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:0106310; GO:1902533	APNAVVLVVGTHLDLIEAK	3.599999905	1	1	0.110564625	1958.566644	16.46589	15.65264	0	16.10467	14.38452	0	0	0	15.3112	15.75193	0	14.43666	14.89791	0	0	14.10364	0	15.48082	0	0	15.19671	0	0	0	14.71613	15.89192	16.40424	0	0	14.66917	0	16.13377	0	0	0	0	15.72504	16.77619	0	16.11635	16.4763	0	16.28734	14.32405	0	0	15.21918	0
Q3B726	RPA43_HUMAN	DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein)	POLR1F TWISTNB	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; DNA-templated transcription, initiation [GO:0006352]"	nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]	"nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA-templated transcription, initiation [GO:0006352]"	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003899; GO:0005654; GO:0005736; GO:0006352; GO:1990830	RSEVSEEVTENGTEEAAK	2.269999981	1	1	4.60E-13	1963.807598	0	14.11486	14.02004	14.01958	13.72243	0	13.83038	0	0	0	0	14.54455	14.23034	0	9.432412	13.28748	14.87829	14.00004	0	14.03528	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3B7J2	GFOD2_HUMAN	"Glucose-fructose oxidoreductase domain-containing protein 2, EC 1.-.-.-"	GFOD2 UNQ9430/PRO34691	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491]; extracellular matrix organization [GO:0030198]	nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491]	GO:0000166; GO:0005576; GO:0016491; GO:0030198; GO:0031012	MKMLPGVGVFGTGSSAR	3.230000019	1	1	0.212658248	1726.441517	0	0	15.05136	0	14.31094	14.18799	0	0	0	0	0	0	14.67227	15.7425	0	0	0	0	0	0	0	0	15.85494	0	0	0	14.39257	0	0	0	0	17.32554	17.58673	0	0	0	0	0	0	0	0	0	15.30138	0	0	0	0	0
Q3B7T1	EDRF1_HUMAN	Erythroid differentiation-related factor 1	EDRF1 C10orf137	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; positive regulation of transcription, DNA-templated [GO:0045893]"		GO:0005634; GO:0045893	GNYSSQSGMIPGSWQHKMK	1.74000001	1	1	0.037852266	2138.591281	13.01859	12.83922	0	10.91222	0	14.39631	0	13.30147	14.1297	14.5254	11.47123	14.06547	0	0	0	0	14.56966	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.9874	0	0	0	0	0	0	0	0	0	0
Q3B8N5	PROX2_HUMAN	"Prospero homeobox protein 2 (Homeobox prospero-like protein PROX2, PROX-2)"	PROX2	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357	ARVETIVR	5.639999866	1	1	0.075408145	941.2588205	14.74186	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.81658	12.84304	0	0	0	0	0	14.95726	11.73623	0	12.57696	14.01405	13.83744	0	0	12.32827	0	0	15.49668	0	0	0	0	13.38114	12.0337	0	0
Q3C1V9	YK041_HUMAN	Putative uncharacterized protein ENSP00000334305		Homo sapiens (Human)	ubiquitin-dependent protein catabolic process [GO:0006511]	ubiquitin ligase complex [GO:0000151]	ubiquitin ligase complex [GO:0000151]; ubiquitin-dependent protein catabolic process [GO:0006511]		GO:0000151; GO:0006511	EEMNVPSLR	7.889999866	1	1	0.105989163	1072.385403	15.47944	0	15.50564	15.70798	0	0	0	0	12.80108	0	0	0	15.33603	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.18568	14.11548	0	0	0	15.01462	16.33111	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3KP31	ZN791_HUMAN	Zinc finger protein 791	ZNF791	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	SFSARPAFR	5.829999924	0.078589521	0.078589521	0.218614733	1039.63037	20.97795	16.82834	13.6286	0	17.55882	15.99831	0	17.53258	0	0	16.38235	0	0	0	0	18.10223	0	15.7486	0	0	0	0	0	0	0	0	0	17.42431	0	0	16.0334	0	0	0	0	0	17.45281	0	17.03703	0	0	0	0	15.60098	0	16.14491	0	0
Q3KQU3	MA7D1_HUMAN	MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1)	MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; microtubule cytoskeleton organization [GO:0000226]		GO:0000226; GO:0005737; GO:0005819; GO:0015630	LMTPTLSFLAR	1.360000014	0.365308911	0.365308911	0.49916243	1264.679452	17.76697	0	0	0	17.11723	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.49249	0	0	0	0	17.42362	0	0	0	0	0	0	0
Q3KQV9	UAP1L_HUMAN	"UDP-N-acetylhexosamine pyrophosphorylase-like protein 1, EC 2.7.7.-"	UAP1L1	Homo sapiens (Human)	UDP-N-acetylglucosamine biosynthetic process [GO:0006048]		UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]	GO:0003977; GO:0006048	LGVTYPKGMYR	4.699999809	1	1	9.24E-13	1285.821737	0	0	15.72142	14.97367	12.20868	0	0	0	0	0	0	16.35515	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3KQZ1	S2535_HUMAN	Solute carrier family 25 member 35	SLC25A35	Homo sapiens (Human)		integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]		GO:0005743; GO:0016021	MDFLMSGLAACGACVFTNPLEVVK	6.869999886	1	1	4.59E-13	2645.057204	11.92427	0	0	13.04748	0	0	0	0	13.58928	0	0	0	0	0	0	0	15.25237	0	0	0	0	0	15.12519	0	16.36265	0	0	0	0	0	0	15.70918	0	0	0	15.00098	0	0	0	0	0	0	0	0	0	0	0	0
Q3L8U1	CHD9_HUMAN	"Chromodomain-helicase-DNA-binding protein 9, CHD-9, EC 3.6.4.12 (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator, CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein)"	CHD9 KIAA0308 KISH2 PRIC320 AD-013 x0008	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005829; GO:0016887; GO:0140658	NYSQSK	11.40999985	0.639806747	0.639806747	0.21207021	727.1105629	0	0	0	14.39548	0	14.90247	14.72249	18.71477	16.4719	16.0997	15.53718	11.40871	13.36845	0	0	15.25727	0	9.983633	0	0	0	0	0	0	17.59264	0	0	0	0	0	16.82071	15.14437	16.9667	0	16.95621	14.5498	0	0	0	0	0	0	0	0	15.07435	0	0	0
Q3LI58	KR211_HUMAN	Keratin-associated protein 21-1	KRTAP21-1 KAP21.1	Homo sapiens (Human)	hair follicle development [GO:0001942]	cytosol [GO:0005829]; intermediate filament [GO:0005882]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; hair follicle development [GO:0001942]		GO:0001942; GO:0005829; GO:0005882	RCYSSC	1.580000043	1	1	0	831.4574115	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3LIE5	ADPRM_HUMAN	"Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase, EC 3.6.1.13, EC 3.6.1.16, EC 3.6.1.53 (ADPRibase-Mn) (CDP-choline phosphohydrolase)"	ADPRM C17orf48 MDS006 Nbla03831	Homo sapiens (Human)		cytosol [GO:0005829]	"cytosol [GO:0005829]; 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]"	"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]"	GO:0005829; GO:0008663; GO:0030145; GO:0047631; GO:0047734	SLELVMDMFK	4.71999979	0.219502255	0.219502255	3.42E-12	1243.652249	0	14.37723	14.42006	13.29768	0	0	15.28705	14.51654	0	15.21808	0	13.85073	15.75051	0	11.39879	13.14696	12.7353	12.56952	0	13.4307	14.97319	0	16.14919	0	0	10.90556	0	12.78031	15.94863	0	0	13.80281	0	14.10895	17.25891	16.43878	16.17024	17.29934	15.29036	13.60882	15.2492	15.43411	15.90576	7.979604	15.21734	0	15.15199	0
Q3MHD2	LSM12_HUMAN	Protein LSM12 homolog	LSM12	Homo sapiens (Human)						EAALSS	7.519999981	1	1	0.144560171	579.8569185	14.07384	0	15.08547	0	14.8363	15.30712	0	13.96529	15.08888	13.51581	13.90647	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.28565	0	0	0	0	0	14.97485	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3MII6	TBC25_HUMAN	TBC1 domain family member 25	TBC1D25 OATL1	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005776; GO:0006914; GO:0031410; GO:0090630; GO:1901096	RSSLTTAALPFTQSILTQVGR	12.57999992	1	1	0.396457246	2247.999593	0	20.13299	0	18.46679	0	0	20.30453	0	19.16336	18.07323	19.29082	0	0	0	0	20.77072	0	0	0	18.86195	19.52192	19.4252	0	20.32179	20.14009	0	0	0	19.6474	18.45226	0	0	0	0	0	19.29239	19.64609	18.77757	19.65376	20.44386	18.62484	16.99196	0	0	0	19.28904	20.83733	0
Q3MIN7	RGL3_HUMAN	"Ral guanine nucleotide dissociation stimulator-like 3, RalGDS-like 3"	RGL3	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0043547	LSAKLAR	15.48999977	1	1	0.280576875	758.4403636	0	0	0	0	0	0	0	0	0	0	0	0	0	17.03749	18.3596	0	0	0	17.79318	17.03183	0	0	0	0	19.42356	0	0	0	0	0	0	0	0	0	0	0	20.07654	0	18.23819	18.82582	0	0	0	17.53557	0	0	18.4177	0
Q3MIS6	ZN528_HUMAN	Zinc finger protein 528	ZNF528 KIAA1827	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	IFTQKSSLTNHHR	2.410000086	1	1	0.187039871	1569.549087	15.21975	0	0	15.39396	10.56331	15.0116	0	16.24252	7.558211	14.87743	15.58153	15.83117	14.60596	13.60492	0	0	0	0	0	0	14.10657	0	0	0	0	0	9.917341	0	0	15.42447	0	17.65086	0	0	0	0	14.95295	0	0	0	0	0	0	14.5426	16.23039	0	14.18941	0
Q3MIW9	MUCL3_HUMAN	Mucin-like protein 3 (Diffuse panbronchiolitis critical region protein 1)	MUCL3 C6orf37 DPCR1 PBLT	Homo sapiens (Human)		cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005737; GO:0005886; GO:0016021	STEIHEQKR	3.940000057	0.585564017	0.585564017	0.185853584	1127.450389	0	0	12.56349	0	0	0	15.74027	16.26407	0	0	15.65315	0	0	0	15.02163	0	0	0	15.33755	0	0	14.43822	0	15.44468	0	15.59499	0	16.62797	12.29734	13.84871	16.42799	13.98363	15.46017	16.61301	12.28038	16.00825	16.70129	14.87615	16.08626	15.16314	13.48567	10.0428	14.9651	10.94656	13.25062	14.28164	13.49887	12.17833
Q3MIX3	ADCK5_HUMAN	"Uncharacterized aarF domain-containing protein kinase 5, EC 2.7.11.-"	ADCK5	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; protein serine/threonine kinase activity [GO:0004674]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0016021	FEVALR	5.53000021	1	1	0.061796137	734.7449906	0	0	0	0	0	0	12.61802	0	15.56046	0	0	0	0	0	0	0	0	0	0	17.81808	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3MJ13	WDR72_HUMAN	WD repeat-containing protein 72	WDR72	Homo sapiens (Human)	enamel mineralization [GO:0070166]; extracellular matrix disassembly [GO:0022617]; protein localization to plasma membrane [GO:0072659]	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; enamel mineralization [GO:0070166]; extracellular matrix disassembly [GO:0022617]; protein localization to plasma membrane [GO:0072659]		GO:0005634; GO:0005737; GO:0005768; GO:0022617; GO:0070166; GO:0072659	ARLLEGGSLVK	5.340000153	1	1	0.41255398	1142.238436	0	15.76945	0	13.53953	14.42702	0	16.06897	0	14.07349	16.97816	14.43979	11.37578	14.77683	15.90188	0	13.84231	0	15.777	0	14.857	0	0	0	15.22728	15.07688	0	15.50912	0	0	0	0	0	15.85918	0	0	0	16.25173	0	0	0	15.99968	0	0	0	0	16.21726	0	0
Q3SXM0	DC4L1_HUMAN	DDB1- and CUL4-associated factor 4-like protein 1 (WD repeat-containing protein 21B)	DCAF4L1 WDR21B	Homo sapiens (Human)						LGGIRGAAPGLLMAVR	8.539999962	1	1	6.90E-13	1566.642544	0	0	14.87211	0	0	15.14936	0	0	14.98775	0	0	0	0	0	0	0	0	10.76529	0	0	0	14.34438	0	0	0	0	12.73882	0	13.61991	14.95781	14.97631	0	14.06204	0	15.22149	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3SXY8	AR13B_HUMAN	"ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1, ARL2-like protein 1)"	ARL13B ARL2L1	Homo sapiens (Human)	cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224]	axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]	axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0001947; GO:0003924; GO:0005525; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0009953; GO:0010226; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0060170; GO:0060271; GO:0070986; GO:0097500; GO:0097730; GO:1905515	EAMSEMLR	5.28000021	1	1	0.267225784	999.0283541	15.87446	0	15.73696	16.7397	17.34529	17.56332	0	0	0	17.7586	18.32747	0	15.85734	0	0	0	0	0	0	0	0	0	17.82945	0	18.54296	19.78375	17.25649	18.25666	0	17.90011	18.46299	16.52808	0	18.92276	0	17.11622	0	19.11206	0	0	15.72398	17.67357	0	0	16.70178	17.37401	0	0
Q3SXZ3	ZN718_HUMAN	Zinc finger protein 718	ZNF718	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	THTGGKF	6.619999886	1	1	0.286789537	747.5453527	17.87526	17.97264	16.13096	0	16.898	18.94591	0	17.81637	17.9444	17.60048	16.12351	17.65083	0	17.35596	0	0	0	0	0	0	0	0	0	17.45392	0	0	0	0	0	0	0	18.65151	0	0	0	18.58748	0	0	0	0	17.34396	0	16.97529	19.25829	0	0	0	16.91212
Q3SY00	T10IP_HUMAN	Testis-specific protein 10-interacting protein (Tsga10-interacting protein)	TSGA10IP	Homo sapiens (Human)	cilium organization [GO:0044782]	photoreceptor connecting cilium [GO:0032391]	photoreceptor connecting cilium [GO:0032391]; cilium organization [GO:0044782]		GO:0032391; GO:0044782	QGCLGSGDGVPNQDLQQR	5.78000021	0.347872049	0.347872049	0.312970573	1929.381787	15.97833	0	0	0	0	0	0	15.58355	0	0	0	0	14.37266	0	0	0	0	0	0	0	0	0	15.11366	0	0	0	0	0	0	16.09979	12.94977	15.95851	12.92241	15.19394	8.993846	14.71662	0	15.69572	0	0	14.29261	14.08871	0	0	0	15.96073	8.776133	15.24816
Q3SY52	ZIK1_HUMAN	Zinc finger protein interacting with ribonucleoprotein K (Zinc finger protein 762)	ZIK1 ZNF762	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	LLRSLVFPGGK	4.849999905	0.260606229	0.260606229	0.362574122	1186.603106	13.04937	13.33304	14.92732	15.93273	0	13.38984	0	15.39162	0	13.79	0	0	12.57816	15.28929	0	0	15.82611	14.05445	0	0	0	16.10482	0	0	0	0	0	15.82839	0	0	0	0	0	0	0	16.79734	15.80619	17.03905	17.02698	0	0	15.85051	0	0	16.21667	0	0	0
Q3SY69	AL1L2_HUMAN	"Mitochondrial 10-formyltetrahydrofolate dehydrogenase, Mitochondrial 10-FTHFDH, mtFDH, EC 1.5.1.6 (Aldehyde dehydrogenase family 1 member L2)"	ALDH1L2	Homo sapiens (Human)	10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730]"	"aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]"	GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0006635; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155; GO:0016742; GO:0046655; GO:0070062	KEPLGVCAIIIPWNYPLMMLAWK	6.230000019	0.278535426	0.278535426	0.164494377	2758.851434	7.583083	12.33205	14.03116	12.04897	0	0	0	13.68343	10.04701	12.18202	14.62161	15.43892	0	12.27534	13.66149	0	0	0	9.105042	0	0	0	0	15.12902	16.61635	0	16.74842	0	0	0	0	16.98722	0	0	0	0	17.5055	0	0	0	0	12.54568	0	0	13.54794	0	16.00218	0
Q3SY84	K2C71_HUMAN	"Keratin, type II cytoskeletal 71 (Cytokeratin-71, CK-71) (Keratin-71, K71) (Type II inner root sheath-specific keratin-K6irs1, Keratin 6 irs, hK6irs, hK6irs1) (Type-II keratin Kb34)"	KRT71 K6IRS1 KB34 KRT6IRS1	Homo sapiens (Human)	hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]		GO:0005829; GO:0031069; GO:0045095; GO:0045109; GO:0070062	AGSKGLSGGFGSR	6.090000153	1	1	0.302403116	1181.449428	0	0	14.91754	14.2392	0	0	15.06637	14.08578	14.82875	14.76234	14.61037	0	0	0	0	15.4772	0	0	0	0	0	0	0	0	15.3155	14.38236	15.9437	0	12.35623	0	0	0	0	0	0	0	0	0	0	0	16.03481	0	0	16.44892	0	0	0	0
Q3SYA9	P12L1_HUMAN	Putative POM121-like protein 1	POM121L1P POM121L1	Homo sapiens (Human)						KFPLLPR	5.820000172	1	1	0.006567016	872.5570842	0	12.90955	14.93733	0	16.17445	0	15.56505	17.78699	13.59593	14.27378	7.170825	0	0	14.72081	14.22366	0	0	0	14.83766	12.33335	0	0	15.27559	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3SYG4	PTHB1_HUMAN	Protein PTHB1 (Bardet-Biedl syndrome 9 protein) (Parathyroid hormone-responsive B1 gene protein)	BBS9 PTHB1	Homo sapiens (Human)	cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; pericentriolar material [GO:0000242]	BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; pericentriolar material [GO:0000242]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		GO:0000242; GO:0005829; GO:0005929; GO:0007601; GO:0015031; GO:0016020; GO:0034451; GO:0034464; GO:0035869; GO:0045444; GO:0050896; GO:0060170; GO:0060271; GO:0061512	DPVLQVEVGK	4.139999866	0.000638054	0.000638054	0.50208872	1083.450185	0	0	0	0	0	0	18.58972	0	18.33862	0	18.17563	0	17.51847	0	0	17.64949	0	0	0	0	0	0	18.47736	0	0	18.9143	0	0	0	16.51774	18.43361	0	0	0	18.33348	0	0	0	17.91938	0	17.67204	0	0	0	0	0	0	0
Q3T906	GNPTA_HUMAN	"N-acetylglucosamine-1-phosphotransferase subunits alpha/beta, EC 2.7.8.17 (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta ]"	GNPTAB GNPTA KIAA1208	Homo sapiens (Human)	carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299]	calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]	GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835	FEIMGEEEIAFK	6.860000134	1	1	0.174378728	1457.866952	0	14.85192	15.65383	13.78246	13.36962	14.58135	0	15.94472	0	15.02856	16.47536	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3V5L5	MGT5B_HUMAN	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B, EC 2.4.1.-, EC 2.4.1.155 (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase B) (GlcNAc-T Vb, GNT-Vb, hGnTVb) (Mannoside acetylglucosaminyltransferase 5B) (N-acetylglucosaminyl-transferase Vb) (N-acetylglucosaminyltransferase IX, GNT-IX)"	MGAT5B KIAA2008	Homo sapiens (Human)	protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation via serine [GO:0018242]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation via serine [GO:0018242]"	"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]"	GO:0000139; GO:0005794; GO:0006487; GO:0016021; GO:0018242; GO:0030144; GO:0030145	DQCEAPSDPKFPDCSGK	3.319999933	1	1	9.18E-13	1933.054451	14.18703	0	0	0	0	0	15.67946	15.1674	0	0	0	13.17881	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.78346	0	0	0	0	0	0	0	0	0	0	15.03009	0	0	0	10.96597	11.8345	0	0	0
Q3YBR2	TBRG1_HUMAN	Transforming growth factor beta regulator 1 (Nuclear interactor of ARF and Mdm2)	TBRG1 NIAM	Homo sapiens (Human)	cell cycle [GO:0007049]; DNA replication [GO:0006260]; negative regulation of cell population proliferation [GO:0008285]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; DNA replication [GO:0006260]; negative regulation of cell population proliferation [GO:0008285]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]		GO:0005634; GO:0005654; GO:0006260; GO:0007049; GO:0008285; GO:0050821; GO:0051726; GO:1990173	IYASMK	2.680000067	1	1	0.162524278	711.4849031	0	0	0	0	0	0	0	0	0	16.57274	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6027	0	0	0	16.32095	0	0	17.60856	18.88531	16.18594	0	0	0	0	0	0	19.66002	0	0	0	0	0	0	0
Q3ZCN5	OTOGL_HUMAN	Otogelin-like protein	OTOGL C12orf64	Homo sapiens (Human)	L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; alpha-L-arabinofuranosidase activity [GO:0046556]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605]	alpha-L-arabinofuranosidase activity [GO:0046556]	GO:0005615; GO:0007605; GO:0031012; GO:0046373; GO:0046556	LSEDHK	7.130000114	0.768933356	0.768933356	0.231419771	728.6080629	0	17.98009	16.00084	14.62003	15.98696	12.43279	17.10454	16.31771	14.81055	16.37017	14.21792	16.83422	13.95912	15.14422	14.75369	16.21424	12.74096	0	0	16.27342	12.87705	0	15.39661	17.61633	16.28072	16.34062	0	0	14.848	16.23018	16.85102	0	16.10512	0	0	0	0	16.59318	0	15.63696	0	0	13.68493	15.79826	0	0	0	15.82277
Q3ZCQ8	TIM50_HUMAN	Mitochondrial import inner membrane translocase subunit TIM50	TIMM50 TIM50 PRO1512	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]; release of cytochrome c from mitochondria [GO:0001836]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; interleukin-2 receptor binding [GO:0005134]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; intracellular protein transport [GO:0006886]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]; release of cytochrome c from mitochondria [GO:0001836]	interleukin-2 receptor binding [GO:0005134]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]	GO:0001836; GO:0003723; GO:0004721; GO:0004722; GO:0004725; GO:0005134; GO:0005654; GO:0005739; GO:0005743; GO:0005744; GO:0006470; GO:0006886; GO:0007006; GO:0016021; GO:0016607; GO:0030150; GO:0043021	MAASAAVFSR	4.269999981	1	1	0.094211618	1008.021659	0	14.22808	12.54743	0	14.73318	14.36993	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q3ZCT8	KBTBC_HUMAN	Kelch repeat and BTB domain-containing protein 12 (Kelch domain-containing protein 6)	KBTBD12 KLHDC6	Homo sapiens (Human)						LYVCGGFHGADR	4.659999847	0.4114317	0.4114317	1.60E-12	1352.499483	0	0	0	14.60316	0	0	0	0	0	0	14.98849	0	0	0	0	0	0	0	0	0	0	0	0	9.901195	14.99331	0	0	0	0	0	0	11.00747	0	0	0	12.04353	0	0	13.83923	0	0	0	0	0	15.0707	14.63082	0	0
Q3ZCU0	GVQW3_HUMAN	Protein GVQW3 (GVQW motif-containing protein 3)	GVQW3	Homo sapiens (Human)						ENLNMR	21.29999924	1	1	0.160944787	795.0564972	17.21391	0	16.01467	0	16.36685	0	0	14.69401	0	15.31155	0	14.31234	15.12861	0	0	16.72562	0	15.30762	14.05477	13.05255	16.29377	0	15.74757	0	0	14.93359	0	0	0	0	0	0	17.51403	0	0	0	0	16.03628	0	0	0	0	0	0	0	0	0	0
Q3ZCV2	LEXM_HUMAN	Lymphocyte expansion molecule	LEXM LEM C1orf177	Homo sapiens (Human)						GSGAK	7.519999981	0.740128815	0.740128815	0.08387783	419.335806	19.04789	18.41166	17.39922	15.46519	17.35724	0	15.9949	15.02035	17.22567	15.7582	16.67544	14.98287	15.72505	15.17038	16.06389	0	0	0	0	0	0	17.70457	0	16.97564	14.84912	0	0	17.11861	16.02618	14.67552	16.19111	15.77808	16.06291	15.99773	15.72232	15.87192	18.37133	17.54448	16.74808	17.75277	18.54263	17.33909	15.39252	15.77008	15.98912	17.75188	17.74787	17.4222
Q460N3	PAR15_HUMAN	"Protein mono-ADP-ribosyltransferase PARP15, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 7, ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15, PARP-15)"	PARP15 BAL3	Homo sapiens (Human)	negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0070212; GO:0070403; GO:0140289; GO:1990404	EAGSVLPAGNR	18.69000053	1	1	0.240237083	1070.383355	15.30767	15.58599	0	15.88282	15.40508	0	15.60014	0	15.88054	0	15.22738	15.22379	0	0	15.09579	0	0	15.0518	0	0	16.03603	0	0	0	0	16.39642	0	14.99275	0	0	0	0	0	15.84727	0	0	11.74858	14.37387	14.55232	15.77991	15.13553	0	14.51535	16.12277	11.65257	16.15026	12.80476	13.90439
Q460N5	PAR14_HUMAN	"Protein mono-ADP-ribosyltransferase PARP14, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 8, ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14, PARP-14)"	PARP14 BAL2 KIAA1268	Homo sapiens (Human)	innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]	enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404	EKPLIK	6.039999962	1	1	0.131328204	727.4498522	0	0	15.58591	0	0	11.97842	0	13.08811	0	0	0	13.3271	0	11.97107	0	13.42356	0	0	14.70814	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.63255	0
Q494R0	FBAS1_HUMAN	Putative uncharacterized protein FBXL19-AS1 (FBXL19 antisense RNA 1) (FBXL19 antisense gene protein 1)	FBXL19-AS1 NCRNA00095	Homo sapiens (Human)						DGRLPSLSR	3.980000019	1	1	0.097848023	1000.740239	0	14.49226	14.65759	13.39886	0	0	0	14.91229	0	0	0	0	11.94054	0	0	0	13.04247	0	0	0	0	0	0	0	0	0	0	0	0	15.47483	14.05485	0	14.95193	14.70868	0	15.57004	14.61265	11.83967	13.23502	14.80096	14.5404	15.77797	0	15.59007	15.41343	0	0	0
Q495W5	FUT11_HUMAN	"Alpha-(1,3)-fucosyltransferase 11, EC 2.4.1.- (Fucosyltransferase XI, Fuc-TXI, FucT-XI) (Galactoside 3-L-fucosyltransferase 11, Fucosyltransferase 11)"	FUT11	Homo sapiens (Human)	fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]	GO:0000139; GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0036071; GO:0046920	NDEEYMK	16.81999969	1	1	3.58E-13	929.0518705	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q495X7	TRI60_HUMAN	Tripartite motif-containing protein 60 (RING finger protein 129) (RING finger protein 33)	TRIM60 RNF129 RNF33	Homo sapiens (Human)	innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630	FSSGR	3.630000114	1	1	0.071450963	554.4702083	0	0	0	0	0	10.47351	0	0	0	0	0	0	0	0	0	0	0	13.45254	0	15.3812	14.42691	0	16.27742	0	0	0	14.44259	0	12.40332	13.38966	0	14.843	0	0	0	13.96445	0	0	0	0	0	0	0	15.81678	16.58174	0	0	0
Q496A3	SPAS1_HUMAN	Spermatogenesis-associated serine-rich protein 1	SPATS1	Homo sapiens (Human)						NGIPKLTPGDNPYMYPEQSK	10.65999985	1	1	0.185011533	2248.966919	0	17.3084	16.56826	15.28122	0	0	12.30889	17.00321	13.35833	0	18.13277	0	0	0	12.305	0	0	13.02839	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q496F6	CLM2_HUMAN	"CMRF35-like molecule 2, CLM-2 (CD300 antigen-like family member E) (CMRF35-A5) (Immune receptor expressed on myeloid cells 2, IREM-2) (Polymeric immunoglobulin receptor 2, PIgR-2, PIgR2, Poly-Ig receptor 2) (CD antigen CD300e)"	CD300E CD300LE CLM2 CMRF35A5 IREM2	Homo sapiens (Human)	immune system process [GO:0002376]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; immune system process [GO:0002376]	transmembrane signaling receptor activity [GO:0004888]	GO:0002376; GO:0004888; GO:0005886; GO:0016021	NLSTGEVLTQNSGFR	7.869999886	0.004950723	0.004950723	0.167680106	1622.265821	0	13.87356	0	15.93678	0	0	14.70522	15.34216	13.67702	16.23624	0	0	14.66288	15.906	13.88521	0	0	0	15.27015	0	0	14.99777	15.72665	0	14.78229	0	17.23426	15.78386	0	13.58901	0	15.07759	0	0	0	0	14.90367	0	0	0	0	0	14.67163	0	0	0	0	0
Q496Y0	LONF3_HUMAN	LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127)	LONRF3 RNF127	Homo sapiens (Human)			metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0046872; GO:0061630	AGQQPPPPLR	6.829999924	0.304046512	0.304046512	0.200554824	1061.80874	15.03674	15.99251	0	0	16.18866	15.27532	0	15.36687	0	0	0	14.72929	13.53895	15.11235	0	6.157752	0	14.21785	13.83821	12.50026	14.78732	13.3515	15.26152	15.93435	14.40122	15.24081	0	11.93415	14.42024	0	13.82035	13.58244	10.58542	13.94597	14.51274	13.38166	13.6023	12.03081	14.49589	0	12.27135	12.80661	14.52838	10.82718	14.80243	15.09126	15.783	13.10576
Q499Z4	ZN672_HUMAN	Zinc finger protein 672	ZNF672	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0046872	IHVSRSPTRPR	9.130000114	1	1	0.273152835	1304.066936	14.65701	16.92789	0	0	0	0	0	16.11579	0	15.74624	16.11242	0	0	0	0	0	0	14.38169	14.05162	0	16.4515	0	0	0	0	0	0	16.99529	0	0	0	0	17.03315	0	15.47435	18.22275	0	0	0	0	17.54154	0	15.53506	15.98148	16.07477	0	18.23385	17.88475
Q49AA0	ZFP69_HUMAN	Zinc finger protein 69 homolog (Zinc finger protein 642)	ZFP69 ZNF642	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0006629; GO:0019216; GO:0046872	NTYKLDLINHPTSYIR	1.220000029	1	1	0.125254473	1947.416446	0	0	12.16862	0	0	0	14.33695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.12465	0	0	11.25121	0	0	0	0	0	17.61639	14.07437	0	0	0	0	0	14.55172	0	0	0	0	0	0	0	0
Q49AH0	CDNF_HUMAN	Cerebral dopamine neurotrophic factor (ARMET-like protein 1) (Conserved dopamine neurotrophic factor)	CDNF ARMETL1	Homo sapiens (Human)	dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]	growth factor activity [GO:0008083]	GO:0005615; GO:0005783; GO:0008083; GO:0031175; GO:0071542	ILSEVTRPMSVHMPAMK	6.980000019	1	1	0.394471735	1959.546986	0	0	0	0	0	0	18.61805	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q49MI3	CERKL_HUMAN	Ceramide kinase-like protein	CERKL	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; sphingolipid binding [GO:0046625]; negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]	lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; sphingolipid binding [GO:0046625]	GO:0001727; GO:0001750; GO:0001917; GO:0003951; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006665; GO:0016310; GO:0030148; GO:0043066; GO:0046625; GO:0048471	AQGSPK	3	1	1	0.318977042	587.8548044	0	16.99572	16.51845	0	15.96777	15.22603	16.10344	13.81926	16.18088	0	14.4924	0	0	0	0	15.95304	0	0	0	17.02178	0	0	0	16.68238	0	0	0	14.61922	16.00397	0	0	0	0	15.80677	0	17.08263	0	0	15.05926	0	0	0	16.53097	17.1902	16.31848	16.71527	14.15255	16.84081
Q4AC94	C2CD3_HUMAN	C2 domain-containing protein 3	C2CD3	Homo sapiens (Human)	brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]		GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0060271; GO:0061511; GO:0071539; GO:1905515	GPPIDSSDIR	5.840000153	1	1	0.030935004	1057.45471	15.25251	0	14.28376	15.75763	11.76072	14.31997	0	10.63078	0	0	0	0	14.88124	0	0	0	0	0	0	0	0	0	0	0	0	13.07045	0	0	0	0	0	0	0	0	0	0	16.02261	0	0	0	0	0	0	11.23236	0	0	0	0
Q4ADV7	RIC1_HUMAN	Guanine nucleotide exchange factor subunit RIC1 (Connexin-43-interacting protein of 150 kDa) (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1)	RIC1 CIP150 KIAA1432	Homo sapiens (Human)	"cranial skeletal system development [GO:1904888]; intracellular protein transport [GO:0006886]; negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; regulation of extracellular matrix constituent secretion [GO:0003330]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588]	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; cranial skeletal system development [GO:1904888]; intracellular protein transport [GO:0006886]; negative regulation of cellular protein catabolic process [GO:1903363]; positive regulation of GTPase activity [GO:0043547]; regulation of extracellular matrix constituent secretion [GO:0003330]; retrograde transport, endosome to Golgi [GO:0042147]"	guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0000139; GO:0003330; GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0043547; GO:1903363; GO:1904888	FSLQKTLSMPSGPSGK	3.029999971	1	1	0.112623017	1657.810967	13.45809	0	14.13773	14.56935	14.72977	15.34361	15.08678	12.56752	0	15.5279	0	15.02346	14.31895	0	0	13.97078	15.66862	11.63019	13.4187	16.26259	15.57306	0	13.52078	0	0	0	0	14.80718	0	14.95279	0	0	0	0	0	0	16.76748	0	0	15.53674	13.58473	15.87337	0	0	0	17.5049	15.37026	0
Q4FZB7	KMT5B_HUMAN	"Histone-lysine N-methyltransferase KMT5B (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1, Su(var)4-20 homolog 1, Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B, EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B, EC 2.1.1.361)"	KMT5B SUV420H1 CGI-85	Homo sapiens (Human)	chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]	"condensed chromosome, centromeric region [GO:0000779]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"condensed chromosome, centromeric region [GO:0000779]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]"	chromatin binding [GO:0003682]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0000779; GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0007517; GO:0018024; GO:0034772; GO:0034773; GO:0042799; GO:0045830; GO:0046872; GO:1904047; GO:2001034	HDSSSK	7.110000134	1	1	0.285955447	658.9039539	16.12882	15.36903	15.74457	15.25099	15.9592	14.44479	14.7676	9.875813	14.9854	15.76103	15.02184	15.1791	15.37022	15.28811	14.95589	14.33329	14.56423	15.38137	16.95325	15.5288	0	15.13423	0	16.0969	17.25936	0	16.41341	16.22176	16.35795	14.23446	16.18583	16.25592	14.68569	17.32384	16.38441	15.48636	18.35592	0	17.13176	15.6868	16.50484	0	16.54344	15.73114	15.94569	16.02668	18.08735	16.27064
Q4G0A6	MINY4_HUMAN	"Probable ubiquitin carboxyl-terminal hydrolase MINDY-4, EC 3.4.19.12 (Probable deubiquitinating enzyme MINDY-4)"	MINDY4 C7orf67 FAM188B	Homo sapiens (Human)			Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]	Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004843; GO:1990380	GIAARSDIGFLSLFEHYNMCQVGCFLK	1.960000038	1	1	0.597222796	3134.001264	0	0	0	0	0	0	0	0	0	0	0	0	16.50105	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.52351	0	0	0	0	0	0	19.79537	0	0	0	0	0	0	0	0	0	0	0	0
Q4G0J3	LARP7_HUMAN	"La-related protein 7 (La ribonucleoprotein domain family member 7, hLARP7) (P-TEFb-interaction protein for 7SK stability, PIP7S)"	LARP7 HDCMA18P	Homo sapiens (Human)	"box C/D RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]"	7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]	"7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; box C/D RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]"	7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]	GO:0000122; GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0030532; GO:0032897; GO:0034244; GO:0048024; GO:0097322; GO:0120259; GO:1904871; GO:1905382; GO:1990438; GO:1990904	QVLADIAK	8.369999886	0.919344604	0.919344604	0.209832728	856.4726731	15.49419	15.15226	15.44823	15.01132	0	15.39376	0	16.32167	12.94062	14.74011	15.72286	12.43674	0	14.81564	15.79267	0	0	15.55206	0	15.77598	0	15.61192	0	16.18839	15.44931	16.27073	0	0	0	15.56852	16.05638	16.54106	0	0	0	17.24783	15.40689	16.6243	16.34916	15.02325	13.58504	15.84659	0	15.31129	15.38536	15.74617	15.43532	15.4421
Q4G0M1	ERFE_HUMAN	Erythroferrone (Complement C1q tumor necrosis factor-related protein 15) (Myonectin)	ERFE C1QTNF15 CTRP15 FAM132B	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of fatty acid transport [GO:2000193]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; regulation of fatty acid metabolic process [GO:0019217]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; cellular iron ion homeostasis [GO:0006879]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of fatty acid transport [GO:2000193]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; regulation of fatty acid metabolic process [GO:0019217]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	GO:0005179; GO:0005576; GO:0005615; GO:0006879; GO:0019217; GO:0042802; GO:0045721; GO:0046326; GO:0046628; GO:2000193	GPGESR	3.109999895	0.262454182	0.262454182	0.038753383	602.7225384	0	14.28796	15.24599	0	15.43916	15.40345	0	0	0	0	12.18956	16.96067	13.3576	17.60746	14.52623	14.15386	0	13.27887	13.6359	14.2893	13.9334	16.92682	12.0694	15.15824	14.24132	0	9.632298	8.608623	15.30166	0	12.78006	14.44324	0	0	14.7638	15.17528	17.49068	14.65121	16.49767	14.60094	17.11442	14.66267	16.6364	0	0	15.98673	13.09033	16.9889
Q4G0N4	NAKD2_HUMAN	"NAD kinase 2, mitochondrial, EC 2.7.1.23 (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial)"	NADK2 C5orf33 MNADK NADKD1	Homo sapiens (Human)	NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]	ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]	GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0019674; GO:0042803	VVVVAK	5.150000095	0.549252987	0.549252987	0.139427023	615.5192003	0	14.88171	15.82277	0	0	0	0	0	0	0	0	0	15.38355	0	0	14.21046	13.85159	15.53164	0	16.06469	15.40713	14.39308	15.40466	15.50593	14.7172	0	16.16551	15.51813	16.15504	16.08257	0	15.87435	17.47988	16.33327	0	15.18141	13.94197	15.24201	16.54006	14.78138	16.07182	15.08521	16.49158	16.17218	16.50041	0	0	16.56916
Q4G0N8	SL9C1_HUMAN	"Sodium/hydrogen exchanger 10 (Na(+)/H(+) exchanger 10, NHE-10) (Solute carrier family 9 member 10) (Solute carrier family 9 member C1) (Sperm-specific Na(+)/H(+) exchanger, sNHE)"	SLC9C1 SLC9A10	Homo sapiens (Human)	cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; spermatogenesis [GO:0007283]	ion channel activity [GO:0005216]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0005216; GO:0005886; GO:0007283; GO:0015385; GO:0015386; GO:0016021; GO:0030154; GO:0030317; GO:0031514; GO:0051453; GO:0071805; GO:0098719	EIDEIFNTEAMELANR	6.650000095	1	1	0.533590346	1911.320305	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.40416	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.48132
Q4G0P3	HYDIN_HUMAN	Hydrocephalus-inducing protein homolog	HYDIN HYDIN1 KIAA1864	Homo sapiens (Human)	axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]	axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]	axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]		GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718	EGTYAAK	11.21000004	1	1	0.115867402	738.9957815	14.77694	15.44373	0	0	15.29517	0	13.54652	13.79765	15.37243	0	14.82989	0	16.64779	0	16.49182	0	0	0	16.04556	0	0	14.85972	0	0	16.35093	15.23522	0	16.03254	0	14.02837	0	0	0	0	0	0	0	0	0	0	0	0	17.54074	0	0	0	0	0
Q4G0T1	SRCRM_HUMAN	Scavenger receptor cysteine-rich domain-containing protein SCART1 (Scavenger receptor family member expressed on T cells 1)	SCART1	Homo sapiens (Human)	T cell mediated immunity [GO:0002456]	brush border [GO:0005903]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]	brush border [GO:0005903]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; T cell mediated immunity [GO:0002456]	scavenger receptor activity [GO:0005044]	GO:0002456; GO:0005044; GO:0005737; GO:0005903; GO:0009897; GO:0016021	FGRGSGPVWTEAFR	12.27000046	1	1	0.286103678	1566.689668	0	13.43385	14.89857	0	13.05915	16.25147	0	0	14.66945	0	15.05268	0	13.98677	16.01561	0	15.11851	0	14.78468	0	0	15.42445	0	14.95067	15.41576	0	0	0	0	0	0	0	0	16.00042	0	0	16.46246	0	15.94041	0	0	0	0	0	0	0	0	0	0
Q4G0W2	DUS28_HUMAN	"Dual specificity phosphatase 28, EC 3.1.3.16, EC 3.1.3.48"	DUSP28	Homo sapiens (Human)	dephosphorylation [GO:0016311]		phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]	phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0004722; GO:0004725; GO:0008138; GO:0016311; GO:0016791	AFQMVK	6.010000229	0.367746502	0.367746502	0.301936329	723.928709	0	12.86751	0	15.3483	13.7631	0	15.54366	14.99997	14.94971	16.03214	15.01795	17.46494	17.41594	16.25029	0	0	16.33204	13.36327	0	0	0	17.93303	0	16.47505	0	0	17.48994	0	0	0	0	15.81596	16.08874	0	0	15.58439	16.45122	16.08863	0	16.77575	16.25672	0	16.13915	16.22236	15.46754	14.37444	15.54166	15.20342
Q4G0X9	CCD40_HUMAN	Coiled-coil domain-containing protein 40	CCDC40 KIAA1640	Homo sapiens (Human)	axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356]	axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]	axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356]		GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0060287; GO:0070286; GO:0071907; GO:0071910	AEPGGAAGRSHPEDGSASEGEK	8.710000038	0.405265391	0.405265391	0.06375795	2096.331427	13.00413	0	12.82485	0	0	15.8474	0	16.03425	14.3754	0	15.31048	15.50411	0	0	0	15.19683	12.1753	0	14.75202	0	16.02172	15.17545	14.23743	10.29927	12.50831	8.606413	0	14.4203	15.51725	15.0469	15.87571	0	15.7459	15.30141	14.49069	14.83883	0	14.03851	0	0	0	11.08547	0	0	0	0	0	15.55242
Q4G112	HSF5_HUMAN	"Heat shock factor protein 5, HSF 5 (Heat shock transcription factor 5, HSTF 5)"	HSF5 HSTF5	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:1990837	TTSFTSFIR	5.800000191	1	1	0.596974679	1059.882043	0	0	0	0	18.12115	0	0	0	0	0	0	0	19.17793	0	0	0	18.72334	17.14723	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.85629	20.51385	0	0	0	0	0	0	0	0	0	0	0	0
Q4G163	FBX43_HUMAN	F-box only protein 43 (Endogenous meiotic inhibitor 2)	FBXO43 EMI2	Homo sapiens (Human)	meiotic cell cycle [GO:0051321]; negative regulation of meiotic nuclear division [GO:0045835]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]	nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; meiotic cell cycle [GO:0051321]; negative regulation of meiotic nuclear division [GO:0045835]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]	metal ion binding [GO:0046872]	GO:0005634; GO:0007088; GO:0016567; GO:0045835; GO:0046872; GO:0051321	HKGTPK	1.100000024	1	1	0.211741382	670.9341624	15.73519	13.32337	0	0	0	0	0	0	0	0	0	0	0	0	16.74393	14.03271	0	15.18455	0	0	16.6504	0	0	0	0	0	0	0	0	0	0	0	0	0	15.64437	0	0	0	0	0	0	0	0	0	0	0	0	0
Q4JDL3	PTN20_HUMAN	"Tyrosine-protein phosphatase non-receptor type 20, hPTPN20, EC 3.1.3.48"	PTPN20 PTPN20A PTPN20B	Homo sapiens (Human)		centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005654; GO:0005737; GO:0005874; GO:0034451	SKVFENK	6.940000057	1	1	0.29862597	850.6713999	15.05975	15.50989	12.91108	12.12103	14.41578	0	0	15.48591	0	0	0	14.65964	0	13.47618	0	0	0	11.41707	0	0	0	0	0	0	0	0	14.70875	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q4KMG0	CDON_HUMAN	Cell adhesion molecule-related/down-regulated by oncogenes	CDON CDO	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; embryonic morphogenesis [GO:0048598]; nervous system development [GO:0007399]; positive regulation of myoblast differentiation [GO:0045663]; regulation of neuron differentiation [GO:0045664]; smoothened signaling pathway [GO:0007224]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; embryonic morphogenesis [GO:0048598]; nervous system development [GO:0007399]; positive regulation of myoblast differentiation [GO:0045663]; regulation of neuron differentiation [GO:0045664]; smoothened signaling pathway [GO:0007224]		GO:0005886; GO:0005887; GO:0007155; GO:0007224; GO:0007399; GO:0045663; GO:0045664; GO:0048598; GO:0098609	YVTYMVNVLEHASISK	3.380000114	1	1	1.60E-12	1870.451106	13.13941	13.70549	13.95827	0	0	0	0	0	14.44812	0	0	0	0	11.99439	0	0	15.40983	16.12276	0	15.45735	0	14.83209	0	0	0	14.51144	0	0	14.60588	14.36129	14.21334	0	12.57787	14.55794	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q4KMG9	TM52B_HUMAN	Transmembrane protein 52B	TMEM52B C12orf59 UNQ5927/PRO19821	Homo sapiens (Human)		extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0016021; GO:0070062	QLPPTEKESTR	5.579999924	1	1	2.41E-13	1285.245628	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q4KMQ1	TPRN_HUMAN	Taperin	TPRN C9orf75	Homo sapiens (Human)	auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045]	stereocilium [GO:0032420]; stereocilium base [GO:0120044]	stereocilium [GO:0032420]; stereocilium base [GO:0120044]; phosphatase binding [GO:0019902]; auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045]	phosphatase binding [GO:0019902]	GO:0007605; GO:0019902; GO:0032420; GO:0060088; GO:0120044; GO:0120045	AAVPAWK	8.619999886	1	1	0.288039062	741.8950377	0	0	0	0	0	0	0	0	0	18.47228	0	0	0	0	17.99277	17.1454	0	0	17.07886	17.91051	0	17.12551	19.74755	0	0	17.77534	0	0	17.31387	0	18.71943	0	0	18.33507	18.85662	18.24809	17.71143	0	0	19.10921	18.17065	0	18.79385	18.42849	17.34346	0	17.91455	0
Q4KMQ2	ANO6_HUMAN	"Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel, SCAN channel) (Transmembrane protein 16F)"	ANO6 TMEM16F	Homo sapiens (Human)	"activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]"	cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	"cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]"	calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]	GO:0002407; GO:0002543; GO:0005227; GO:0005229; GO:0005244; GO:0005247; GO:0005254; GO:0005829; GO:0005886; GO:0006812; GO:0006821; GO:0007596; GO:0009986; GO:0016020; GO:0017121; GO:0017128; GO:0030501; GO:0032060; GO:0034220; GO:0034707; GO:0034767; GO:0035579; GO:0035590; GO:0035725; GO:0043065; GO:0045794; GO:0046872; GO:0046931; GO:0046983; GO:0055085; GO:0060100; GO:0061589; GO:0061590; GO:0070062; GO:0070588; GO:0070821; GO:0090026; GO:0097045; GO:1902476; GO:1903766; GO:2000353	EVCHPDIGGK	10.05000019	0.853705585	0.853705585	0.174234049	1111.868115	15.09885	14.69134	16.07165	15.54909	12.2683	0	13.60621	11.90293	12.63101	0	13.31668	12.27838	0	0	14.25898	0	0	0	0	0	13.82879	14.20196	0	0	0	0	0	12.15515	0	0	0	0	0	15.19924	0	0	0	16.17663	0	0	0	0	0	0	12.81149	0	15.45572	15.46311
Q4KMZ1	IQCC_HUMAN	IQ domain-containing protein C	IQCC	Homo sapiens (Human)						MEPELLVRK	4.210000038	0.31564033	0.31564033	2.28E-12	1115.235413	18.16112	14.7542	0	0	0	13.76068	0	0	13.65881	0	0	0	0	0	0	15.56405	0	0	11.36776	11.666	0	0	14.75482	0	14.63758	0	15.63336	0	0	0	0	0	0	0	16.95479	0	15.34549	13.46222	0	13.71096	16.15211	0	16.6921	0	16.13206	15.85651	9.774176	15.18851
Q4KWH8	PLCH1_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1, EC 3.1.4.11 (Phosphoinositide phospholipase C-eta-1) (Phospholipase C-eta-1, PLC-eta-1) (Phospholipase C-like protein 3, PLC-L3)"	PLCH1 KIAA1069 PLCL3	Homo sapiens (Human)	lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]	calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0016042; GO:0043231; GO:0048015; GO:0050429	DTSQGDTIVSTAHMSVTGEQLGMSSPRGGR	2.49000001	1	1	0	3095.283818	7.631774	13.00137	13.21103	0	0	0	15.45562	0	0	0	0	0	0	0	0	11.69245	14.96865	0	0	0	0	11.58305	0	12.77905	11.29089	15.93051	10.65914	12.49556	12.88542	0	13.86767	13.11996	0	0	13.79969	0	14.29192	12.38735	0	0	9.782114	0	0	0	0	14.01744	0	0
Q4L180	FIL1L_HUMAN	"Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1, DOC-1)"	FILIP1L COL4A3BPIP DOC1 GIP90	Homo sapiens (Human)		cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]		GO:0005634; GO:0005737; GO:0016020	HTKGHSFQGPK	7.769999981	0.635849774	0.635849774	0.195372073	1223.326244	15.26774	10.21004	0	0	0	0	0	0	15.09213	0	16.69365	0	0	14.01875	15.35212	0	17.09672	11.22013	0	0	17.03223	14.34622	0	13.30051	15.84721	15.82485	14.89451	0	0	13.28129	0	0	0	14.5233	15.84932	15.17646	15.26746	14.30488	0	15.88765	11.04093	10.93818	14.10785	15.68659	15.90666	16.13984	8.392829	14.6208
Q4L235	ACSF4_HUMAN	"Beta-alanine-activating enzyme, EC 6.2.1.- (Acyl-CoA synthetase family member 4) (Protein NRPS998)"	AASDH ACSF4 U26 HSPC318	Homo sapiens (Human)	amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631]		acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631]	acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]	GO:0005524; GO:0006631; GO:0016878; GO:0019482; GO:0043041	DPSCVAK	4.650000095	0.500534177	0.500534177	0.222194382	776.0459255	0	15.39315	0	0	15.0281	15.9409	0	13.93797	0	15.0339	0	0	0	0	0	15.40256	16.0567	15.40568	16.62613	17.74339	16.20487	0	16.41656	15.79961	0	16.36415	16.29542	14.87127	9.528615	16.07438	0	0	15.22233	14.18437	17.3138	15.7394	0	0	0	16.13038	0	0	15.13362	0	0	0	0	16.74292
Q4LDE5	SVEP1_HUMAN	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein, SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)"	SVEP1 C9orf13 CCP22 SELOB	Homo sapiens (Human)	cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]	calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]	GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193	KSNPK	4.579999924	0.949057698	0.949057698	0.19551809	575.0972078	14.24029	15.40452	0	14.81989	14.9194	15.75952	16.69224	15.65263	0	15.67783	16.40998	0	14.5461	15.64356	15.74663	16.01673	15.39818	16.0995	0	0	0	17.6342	17.47711	15.68224	0	0	16.95851	16.37613	0	0	0	0	0	17.14634	0	0	0	0	0	0	0	15.7985	0	0	0	0	0	0
Q4LE39	ARI4B_HUMAN	"AT-rich interactive domain-containing protein 4B, ARID domain-containing protein 4B (180 kDa Sin3-associated polypeptide, Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)"	ARID4B BRCAA1 RBBP1L1 RBP1L1 SAP180	Homo sapiens (Human)	establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription cis-regulatory region binding [GO:0000976]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	transcription cis-regulatory region binding [GO:0000976]	GO:0000122; GO:0000976; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006349; GO:0006357; GO:0007283; GO:0016580; GO:0030336; GO:0030512; GO:0034773; GO:0036124; GO:0045944; GO:0097368; GO:1902455; GO:1902459	NDLISK	5.829999924	1	1	0.249061981	689.0979339	0	0	0	16.50157	0	0	0	15.63316	0	0	0	15.38926	0	0	0	0	0	0	0	0	0	0	17.17324	0	0	0	16.92776	14.77374	0	0	16.64962	16.45045	15.94792	16.14637	0	16.41637	17.49483	17.07234	0	17.41428	16.67122	0	16.61765	14.36011	15.10782	15.33722	16.25964	16.64478
Q4LEZ3	AARD_HUMAN	Alanine and arginine-rich domain-containing protein	AARD C8orf85	Homo sapiens (Human)						GPGDFR	5.400000095	1	1	0.184633789	649.5392062	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.57407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q4U2R8	S22A6_HUMAN	"Solute carrier family 22 member 6 (Organic anion transporter 1, hOAT1) (PAH transporter, hPAHT) (Renal organic anion transporter 1, hROAT1)"	SLC22A6 OAT1 PAHT	Homo sapiens (Human)	alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to organic cyclic compound [GO:0014070]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to organic cyclic compound [GO:0014070]; sodium-independent organic anion transport [GO:0043252]	anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0008514; GO:0014070; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0031404; GO:0032991; GO:0042802; GO:0043252; GO:0070062; GO:0097254	ELTMGK	11.47000027	0.008612338	0.008612338	0.229887315	676.2400681	0	0	0	0	0	0	0	0	0	0	16.15976	0	18.29813	17.73716	16.3221	16.07869	0	0	0	0	16.53234	0	0	16.52292	0	0	15.20415	16.37424	13.51308	0	0	19.04248	19.55064	0	0	0	0	0	0	0	0	13.95406	15.46169	16.14372	14.74132	0	0	16.33314
Q4V328	GRAP1_HUMAN	"GRIP1-associated protein 1, GRASP-1 [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form) ]"	GRIPAP1 KIAA1167	Homo sapiens (Human)	"neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"	axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]	"axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]"	identical protein binding [GO:0042802]	GO:0005654; GO:0005829; GO:0030424; GO:0030425; GO:0042802; GO:0043231; GO:0055038; GO:0072562; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244	DLVKPGDENLR	15.26000023	0.373620182	0.373620182	0.126776946	1255.225217	0	0	14.08105	14.16706	14.66309	0	14.7011	13.09858	15.88188	14.07344	14.99387	0	13.879	0	0	13.94705	0	0	0	14.54565	15.58616	0	15.46865	0	0	13.85387	13.07199	14.73842	0	0	0	0	0	0	0	0	0	0	0	0	13.87666	0	0	0	0	13.16537	9.783981	14.56482
Q4VC44	FWCH1_HUMAN	FLYWCH-type zinc finger-containing protein 1	FLYWCH1 KIAA1552	Homo sapiens (Human)		cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005654; GO:0005829; GO:0016604; GO:0046872	RVMVMR	14.27999973	1	1	0.232054196	808.587519	0	0	0	18.95191	0	0	20.64497	0	20.34454	0	19.70568	0	0	19.54976	0	21.88819	20.55899	20.75596	0	18.77923	20.41905	0	0	20.01118	0	18.45103	0	0	0	19.47208	18.41136	20.47887	19.71589	19.02255	20.78525	18.88666	21.73646	0	19.80522	21.02046	0	19.36948	0	0	21.44621	20.47278	19.26918	0
Q4VCS5	AMOT_HUMAN	Angiomotin	AMOT KIAA1071	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell migration involved in gastrulation [GO:0042074]; cell-cell junction assembly [GO:0007043]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]	actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell migration involved in gastrulation [GO:0042074]; cell-cell junction assembly [GO:0007043]; cellular protein localization [GO:0034613]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570]	angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0007043; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0034613; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0045793; GO:0051056; GO:0051496	DQALSNAQAK	15.64999962	1	1	0.412153987	1045.366907	0	0	0	15.66754	14.66872	15.72712	0	15.86702	14.80609	16.57583	16.4155	15.39978	0	0	14.93478	0	0	15.67964	0	13.28287	16.94613	0	16.20439	0	0	0	0	15.76985	0	16.17893	0	0	15.59922	0	15.72192	0	0	0	0	0	16.13763	16.05363	0	16.17468	16.03315	0	16.41455	0
Q4VNC1	AT134_HUMAN	"Probable cation-transporting ATPase 13A4, EC 7.2.2.- (P5-ATPase isoform 4)"	ATP13A4 UNQ3052/PRO9871	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]	early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]	GO:0005524; GO:0005886; GO:0006874; GO:0016021; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0034220; GO:0046872; GO:0055038	EVLNPFYIFQLFSVCLWFSEDYK	4.150000095	1	1	0.829133813	2943.936417	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.31958	0	0	0	0	0	0	0	0	0
Q4VXF1	F74A3_HUMAN	Putative protein FAM74A3	FAM74A3	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	ESSEAVPEK	8.069999695	1	1	0.33809863	972.6928854	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.20001	0	0	0	0	0	0	0	0	0	0	18.03031	0	0	0	0	0	0	0	0
Q4VXU2	PAP1L_HUMAN	Polyadenylate-binding protein 1-like	PABPC1L C20orf119	Homo sapiens (Human)		cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:0070062; GO:1990904	AVVHMNGKEVSGR	5.789999962	0.464063495	0.464063495	1.14E-12	1383.082116	0	0	16.40552	0	16.82906	15.43636	17.37855	17.85486	15.22945	16.95729	0	0	16.29366	14.01408	15.9025	14.88448	15.04201	0	0	0	0	0	17.66449	17.23056	16.58099	0	0	17.43942	16.03212	0	18.53484	0	16.24322	15.93016	0	18.08547	16.49449	0	14.35675	0	12.41509	16.9043	16.70157	0	16.40159	0	14.09873	14.46969
Q4ZG55	GREB1_HUMAN	Protein GREB1 (Gene regulated in breast cancer 1 protein)	GREB1 KIAA0575	Homo sapiens (Human)		extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]		GO:0005654; GO:0016021; GO:0070062	LDTEAQTK	6.050000191	1	1	0.279189089	904.7660977	18.02736	0	17.18328	17.74827	0	16.88391	0	0	0	0	0	0	16.30728	0	17.7847	16.49229	0	0	0	15.8265	17.18775	0	18.62151	0	0	17.17622	17.29915	0	18.05584	0	0	18.80805	0	0	17.84517	0	17.56841	0	18.57868	17.30238	16.82758	16.85069	0	0	16.91207	16.47626	0	17.62833
Q4ZHG4	FNDC1_HUMAN	Fibronectin type III domain-containing protein 1 (Activation-associated cDNA protein) (Expressed in synovial lining protein)	FNDC1 FNDC2 KIAA1866 MEL4B3	Homo sapiens (Human)		extracellular region [GO:0005576]; nuclear speck [GO:0016607]	extracellular region [GO:0005576]; nuclear speck [GO:0016607]		GO:0005576; GO:0016607	EDGGRQAEATAQTLR	7.670000076	0.350863636	0.350863636	0.051886787	1603.48884	15.80164	0	14.5592	0	15.89152	14.55904	13.78844	14.05852	14.44758	0	11.8382	13.77321	0	14.49699	14.6559	13.00861	0	0	14.65406	0	0	15.93212	14.84184	0	14.14253	0	14.65906	0	0	0	0	0	0	0	0	0	14.89823	0	0	0	12.08872	15.37262	0	0	0	0	13.86856	0
Q4ZIN3	MBRL_HUMAN	Membralin (Transmembrane protein 259)	TMEM259 C19orf6	Homo sapiens (Human)	negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976]		GO:0005783; GO:0005789; GO:0016021; GO:0034976; GO:1901215; GO:1904294	VEVRHNSSR	5.940000057	1	1	9.26E-13	1083.251247	14.54157	0	0	0	14.67008	0	0	0	14.0266	0	0	14.62465	11.25846	0	14.02518	12.05218	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q502W6	VWA3B_HUMAN	"von Willebrand factor A domain-containing protein 3B, VWA domain-containing protein 3B"	VWA3B	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005829	QRMDWLTSK	7.440000057	0.36180976	0.36180976	0.014089483	1164.780671	0	13.01354	13.53959	14.71059	15.79016	14.72709	0	0	15.17601	14.60938	0	15.05775	0	0	14.36849	15.853	15.39013	13.77389	0	0	14.76541	0	13.62215	16.15875	0	12.85543	15.05804	12.33718	15.16824	14.89342	14.69129	10.75325	14.48418	0	10.58947	14.7648	16.23128	13.07323	0	0	17.32874	14.81153	15.03004	14.52966	15.3553	14.42365	15.28637	10.04952
Q504Q3	PAN2_HUMAN	"PAN2-PAN3 deadenylation complex catalytic subunit PAN2, EC 3.1.13.4 (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2, PAN deadenylation complex subunit 2)"	PAN2 KIAA0710 USP52	Homo sapiens (Human)	mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0005829; GO:0006397; GO:0010606; GO:0031251; GO:0046872	SDGTKSTIKPSQMSVAR	1.950000048	1	1	1.16E-12	1809.999531	15.60519	14.72796	0	0	0	15.33712	0	0	15.38164	0	0	0	0	14.55014	0	0	0	13.79879	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.17788	0	0	0	0	0	0	0	0	0	0	0	0	16.73956
Q504Y2	PKDCC_HUMAN	"Extracellular tyrosine-protein kinase PKDCC, EC 2.7.10.2 (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)"	PKDCC SGK493 VLK	Homo sapiens (Human)	bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001501; GO:0004672; GO:0004712; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021	YSRGGPGPGAGRPER	5.889999866	1	1	0.258544337	1514.169606	13.82361	0	15.64774	0	0	0	0	14.85145	0	0	0	14.53762	0	0	16.65201	0	15.00279	15.80807	17.20155	18.17146	16.84458	16.84588	0	16.25851	0	0	15.18331	0	17.31956	16.34083	0	0	0	0	16.70902	16.7283	16.32434	0	0	16.3503	17.82169	16.49248	14.92093	15.21144	0	0	16.89114	16.3567
Q52LC2	VAS1L_HUMAN	V-type proton ATPase subunit S1-like protein (Vacuolar proton pump subunit S1-like protein)	ATP6AP1L	Homo sapiens (Human)	regulation of cellular pH [GO:0030641]	integral component of membrane [GO:0016021]; proton-transporting V-type ATPase complex [GO:0033176]	integral component of membrane [GO:0016021]; proton-transporting V-type ATPase complex [GO:0033176]; regulation of cellular pH [GO:0030641]		GO:0016021; GO:0030641; GO:0033176	DTAEEKELLR	5.179999828	1	1	0.074780244	1204.608541	8.524769	15.22043	0	12.91009	16.25641	0	12.93333	0	11.18617	12.44265	14.67613	12.78045	11.49681	0	0	0	12.61454	10.58794	0	0	0	14.15528	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q52LW3	RHG29_HUMAN	Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29)	ARHGAP29 PARG1	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]	GO:0005096; GO:0005737; GO:0005829; GO:0007266; GO:0030165; GO:0032991; GO:0046872; GO:0051056; GO:0090630	AALTHK	2.230000019	0.306777984	0.306777984	0.054966577	638.7916312	12.25791	15.60235	16.68237	0	0	7.035766	17.12166	17.04599	14.09766	16.45622	16.21684	16.71295	12.11687	18.15324	16.4001	12.86325	11.73402	11.34139	15.67946	13.74709	14.46408	15.19468	16.61587	17.70522	16.52143	10.72294	0	18.17546	14.9932	16.02987	0	17.49023	17.384	0	17.5806	0	14.29444	16.4229	15.74766	0	14.37743	16.00971	0	14.93697	15.35731	9.82727	0	10.76698
Q52M93	Z585B_HUMAN	Zinc finger protein 585B (zinc finger protein 41-like protein)	ZNF585B	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	CGICGKGFVQK	1.970000029	1	1	0	1251.329952	0	0	0	0	0	0	0	0	15.8004	0	0	0	0	0	0	10.9718	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.05291	0	0	0	11.62352	0	11.82094	11.37715
Q537H7	SPT45_HUMAN	Spermatogenesis-associated protein 45	SPATA45 C1orf227 HSD-44 HSD44	Homo sapiens (Human)						ASINRTIEIMK	19.20999908	1	1	0.245405837	1291.686434	0	0	13.83427	18.99651	18.56701	0	0	0	0	0	16.77624	0	17.76111	0	0	17.96523	0	17.84145	0	0	0	18.72878	18.67652	17.9608	17.45143	17.90771	19.27098	19.46814	18.57366	17.40102	18.99684	14.81614	17.42563	17.33003	0	0	0	16.06606	18.60445	18.6085	0	18.98632	19.34844	0	0	18.37558	0	18.97267
Q53EL6	PDCD4_HUMAN	Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a)	PDCD4 H731	Homo sapiens (Human)	"apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]"	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007569; GO:0030509; GO:0043066; GO:0043508; GO:0045786; GO:0045892; GO:0050729; GO:0060940; GO:0071222; GO:1900016; GO:1901224; GO:1904706; GO:1904761; GO:1905064; GO:1905461; GO:2000353	ATVLLSMSK	2.890000105	1	1	0.092219867	949.2787329	0	0	0	0	0	0	0	12.2217	0	15.06404	0	0	0	0	0	0	0	14.55195	12.74178	0	16.01656	0	16.88025	16.30862	0	15.53925	15.27493	0	15.14947	12.78095	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q53EL9	SEZ6_HUMAN	"Seizure protein 6 homolog, SEZ-6, hSEZ-6"	SEZ6	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer development [GO:0021680]; excitatory postsynaptic potential [GO:0060079]; regulation of dendrite development [GO:0050773]; regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074]	apical dendrite [GO:0097440]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apical dendrite [GO:0097440]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer development [GO:0021680]; excitatory postsynaptic potential [GO:0060079]; regulation of dendrite development [GO:0050773]; regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074]		GO:0005783; GO:0005886; GO:0008344; GO:0016021; GO:0021680; GO:0043025; GO:0043197; GO:0043198; GO:0048471; GO:0050773; GO:0060074; GO:0060079; GO:0090036; GO:0097440	NATTGR	1.75	1	1	0.09174922	619.9556811	11.8906	16.15388	0	12.35622	0	12.58227	13.60609	0	10.34391	16.17205	0	11.19998	0	15.94333	0	16.39394	0	0	0	17.40357	14.70171	0	16.82738	18.30707	14.21544	17.41172	0	14.0982	0	0	0	16.5164	16.34422	16.17257	17.2465	15.7343	0	13.02779	15.20693	16.44014	16.16366	18.10696	15.25858	7.899835	15.21746	0	16.42743	0
Q53EP0	FND3B_HUMAN	Fibronectin type III domain-containing protein 3B (Factor for adipocyte differentiation 104) (HCV NS5A-binding protein 37)	FNDC3B FAD104 NS5ABP37 UNQ2421/PRO4979/PRO34274	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0016021	FRLTASNTEGK	4.570000172	0.325886577	0.325886577	0.147619273	1224.520207	14.59779	0	17.51005	16.59199	0	16.64071	0	0	17.39126	0	16.79231	16.14053	0	13.62271	0	0	0	9.391575	0	17.04992	0	16.52808	16.71378	17.39119	0	0	0	11.72853	16.45499	13.53896	16.55914	16.7045	0	14.66681	14.28605	15.66443	14.57398	17.78369	17.18421	0	17.30328	12.17209	0	0	0	0	5.833508	0
Q53ET0	CRTC2_HUMAN	"CREB-regulated transcription coactivator 2 (Transducer of regulated cAMP response element-binding protein 2, TORC-2, Transducer of CREB protein 2)"	CRTC2 TORC2	Homo sapiens (Human)	gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; histone H3-K9 acetylation [GO:0043970]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; toxin transport [GO:1901998]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; histone H3-K9 acetylation [GO:0043970]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; toxin transport [GO:1901998]	cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006094; GO:0008140; GO:0032793; GO:0042593; GO:0043970; GO:0045944; GO:0051289; GO:0070062; GO:1901998	ATSGANGPGSATASASNPR	5.079999924	1	1	0.517740186	1671.49103	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q53EU6	GPAT3_HUMAN	"Glycerol-3-phosphate acyltransferase 3, GPAT-3, EC 2.3.1.15 (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10, AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9, 1-AGP acyltransferase 9, 1-AGPAT 9, EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3, hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta, LPAAT-theta) (MAG-1)"	GPAT3 AGPAT9 MAG1 HMFN0839 UNQ2753/PRO6492	Homo sapiens (Human)	CDP-diacylglycerol biosynthetic process [GO:0016024]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0006072; GO:0006654; GO:0016021; GO:0016024; GO:0019432; GO:0032006; GO:0102420	EGAELAGK	9.090000153	1	1	0.151973071	775.2944859	0	15.10998	15.75467	14.29952	14.6423	15.2324	0	0	0	0	0	0	0	0	15.77633	15.8163	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.17072	0	16.04992	0	13.57084	15.12852	0	0	0	16.64171	15.71747	0	15.17314	0	18.98562	18.73328	16.84407	0
Q53EZ4	CEP55_HUMAN	"Centrosomal protein of 55 kDa, Cep55 (Up-regulated in colon cancer 6)"	CEP55 C10orf3 URCC6	Homo sapiens (Human)	cranial skeletal system development [GO:1904888]; establishment of protein localization [GO:0045184]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; midbody [GO:0030496]	centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; midbody [GO:0030496]; identical protein binding [GO:0042802]; cranial skeletal system development [GO:1904888]; establishment of protein localization [GO:0045184]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	identical protein binding [GO:0042802]	GO:0000281; GO:0005737; GO:0005813; GO:0005814; GO:0014066; GO:0016020; GO:0030496; GO:0032154; GO:0042802; GO:0045171; GO:0045184; GO:0061952; GO:0090543; GO:1904888	SSRSTK	2.730000019	1	1	0.160181374	666.5521868	16.41329	14.71603	16.79593	13.96836	14.76068	14.14919	15.40066	0	14.60727	0	14.89884	0	0	0	15.66157	16.8977	0	0	0	0	16.64989	0	0	0	0	0	0	15.56396	14.17172	0	16.85644	0	16.1709	0	0	0	0	0	0	0	18.4861	0	0	0	0	15.79199	15.47572	0
Q53F19	NCBP3_HUMAN	Nuclear cap-binding protein subunit 3 (Protein ELG)	NCBP3 C17orf85	Homo sapiens (Human)	7-methylguanosine mRNA capping [GO:0006370]; defense response to virus [GO:0051607]; mRNA export from nucleus [GO:0006406]; mRNA transcription by RNA polymerase II [GO:0042789]; RNA interference [GO:0016246]; snRNA export from nucleus [GO:0006408]	cytoplasm [GO:0005737]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]	cytoplasm [GO:0005737]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; defense response to virus [GO:0051607]; mRNA export from nucleus [GO:0006406]; mRNA transcription by RNA polymerase II [GO:0042789]; RNA interference [GO:0016246]; snRNA export from nucleus [GO:0006408]	mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]	GO:0000339; GO:0000340; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005845; GO:0005846; GO:0006370; GO:0006406; GO:0006408; GO:0016246; GO:0016607; GO:0034518; GO:0042789; GO:0051607	AWGALIK	16.40999985	1	1	0.232301873	757.7787229	14.17637	0	0	0	0	0	0	0	15.36799	0	0	0	15.12596	0	0	16.05735	0	0	0	14.72273	0	0	0	0	17.46101	0	0	0	0	0	16.41952	0	0	0	17.77574	0	0	0	0	0	0	15.73766	0	0	0	14.82956	0	0
Q53F39	MPPE1_HUMAN	"Metallophosphoesterase 1, EC 3.1.-.- (Post-GPI attachment to proteins factor 5)"	MPPE1 PGAP5 PP579	Homo sapiens (Human)	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]	GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]	GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0006506; GO:0006888; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971	QNFHPLK	2.079999924	1	1	0.24422907	884.2820161	0	0	0	0	0	0	0	0	0	19.58678	0	0	18.43098	0	0	18.42813	0	18.33668	0	0	0	0	17.60918	0	0	0	0	0	0	0	0	19.02617	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q53FP2	NACHO_HUMAN	Novel acetylcholine receptor chaperone	TMEM35A NACHO TMEM35	Homo sapiens (Human)	chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of protein localization to cell surface [GO:2000010]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; acetylcholine receptor regulator activity [GO:0030548]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of protein localization to cell surface [GO:2000010]	acetylcholine receptor regulator activity [GO:0030548]	GO:0005778; GO:0005783; GO:0005789; GO:0016021; GO:0030548; GO:0031410; GO:0051131; GO:2000010	LLIARKPEDR	6.739999771	1	1	0.538560928	1209.306726	16.95356	0	15.03162	0	0	15.2408	17.08094	0	0	0	0	0	17.64885	15.74844	0	0	0	0	0	0	0	16.97571	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.28992	0	0	0	0	0	0	0	0
Q53FZ2	ACSM3_HUMAN	"Acyl-coenzyme A synthetase ACSM3, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase, EC 6.2.1.17) (Protein SA homolog)"	ACSM3 SAH	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; regulation of blood pressure [GO:0008217]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; methylbutanoate-CoA ligase activity [GO:0043759]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; regulation of blood pressure [GO:0008217]	ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; methylbutanoate-CoA ligase activity [GO:0043759]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]	GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0008217; GO:0015645; GO:0018729; GO:0042632; GO:0043759; GO:0046872; GO:0047760; GO:0050218	CENLHSKLIVSENSR	6.320000172	1	1	0.38988474	1786.268921	0	15.90094	17.63949	0	0	0	0	0	17.6764	0	0	0	0	0	0	0	0	0	0	16.22937	0	0	0	0	0	0	0	17.2871	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q53GA4	PHLA2_HUMAN	"Pleckstrin homology-like domain family A member 2 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein) (Imprinted in placenta and liver protein) (Tumor-suppressing STF cDNA 3 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein) (p17-Beckwith-Wiedemann region 1 C, p17-BWR1C)"	PHLDA2 BWR1C HLDA2 IPL TSSC3	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of gene expression [GO:0010468]; regulation of glycogen metabolic process [GO:0070873]; regulation of growth hormone activity [GO:1903547]; regulation of spongiotrophoblast cell proliferation [GO:0060721]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; phosphatidylinositol phosphate binding [GO:1901981]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of gene expression [GO:0010468]; regulation of glycogen metabolic process [GO:0070873]; regulation of growth hormone activity [GO:1903547]; regulation of spongiotrophoblast cell proliferation [GO:0060721]	phosphatidylinositol phosphate binding [GO:1901981]	GO:0001890; GO:0005737; GO:0006915; GO:0009887; GO:0010468; GO:0016020; GO:0030334; GO:0043065; GO:0045995; GO:0060721; GO:0070873; GO:1901981; GO:1903547	RALQDFR	25.07999992	1	1	0.485335839	905.4810948	0	0	0	0	18.70611	17.3898	0	0	0	0	19.17684	0	0	0	0	17.65449	0	0	0	0	18.11114	16.93352	0	0	17.77356	18.40312	18.07248	17.43372	16.95983	0	0	0	16.77806	17.86356	17.93036	0	0	0	0	0	17.9587	17.83593	17.57523	17.41378	17.24334	0	0	17.27522
Q53GD3	CTL4_HUMAN	"Choline transporter-like protein 4 (Solute carrier family 44 member 4) (Thiamine pyrophosphate transporter 1, hTPPT1)"	SLC44A4 C6orf29 CTL4 NG22 TPPT1 UNQ441/PRO874	Homo sapiens (Human)	acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085]	choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006656; GO:0008292; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0055085; GO:0061526; GO:0070062; GO:0090422	MGGKQR	4.590000153	1	1	0.159721969	693.4646405	11.97463	0	15.05611	0	14.7634	12.61665	15.97779	0	14.93299	15.11989	14.30861	12.84477	0	13.56392	0	14.9859	16.9569	0	0	0	0	15.20649	0	0	0	14.41698	0	16.02838	0	16.05658	0	15.89851	0	0	14.92291	0	16.00062	15.53981	0	0	0	16.12811	16.02069	14.24241	16.77456	16.23916	0	0
Q53GG5	PDLI3_HUMAN	PDZ and LIM domain protein 3 (Actinin-associated LIM protein) (Alpha-actinin-2-associated LIM protein)	PDLIM3 ALP	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]	adherens junction [GO:0005912]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; stress fiber [GO:0001725]; Z disc [GO:0030018]	adherens junction [GO:0005912]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]	actin binding [GO:0003779]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]	GO:0001725; GO:0003779; GO:0005829; GO:0005912; GO:0007507; GO:0030018; GO:0030036; GO:0031941; GO:0046872; GO:0051371; GO:0061061	LAPNIPLEMELPGVK	3.299999952	0.677848816	0.677848816	0.001330342	1637.200502	14.99714	17.06996	0	0	14.90272	15.60445	12.03434	16.06731	0	0	16.00812	14.24343	12.94456	0	12.64428	15.91413	15.87686	17.46092	14.88741	11.83	14.47612	0	16.28066	0	15.74071	15.56972	17.33983	0	0	0	0	16.07032	17.41224	16.91414	0	14.51248	18.33452	14.51826	0	0	17.36016	16.42434	16.49805	17.43013	0	16.78977	0	13.93703
Q53GL0	PKHO1_HUMAN	"Pleckstrin homology domain-containing family O member 1, PH domain-containing family O member 1 (C-Jun-binding protein, JBP) (Casein kinase 2-interacting protein 1, CK2-interacting protein 1, CKIP-1) (Osteoclast maturation-associated gene 120 protein)"	PLEKHO1 CKIP1 OC120 HQ0024c	Homo sapiens (Human)	lamellipodium morphogenesis [GO:0072673]; myoblast fusion [GO:0007520]; myoblast migration [GO:0051451]; regulation of cell shape [GO:0008360]; regulation of myoblast fusion [GO:1901739]	cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; lamellipodium morphogenesis [GO:0072673]; myoblast fusion [GO:0007520]; myoblast migration [GO:0051451]; regulation of cell shape [GO:0008360]; regulation of myoblast fusion [GO:1901739]		GO:0005634; GO:0005737; GO:0007520; GO:0008360; GO:0032587; GO:0036195; GO:0051451; GO:0072673; GO:1901739	TLQLRAEEPPTPALPNPGQLSR	7.309999943	1	1	4.60E-13	2384.138587	16.01641	0	15.18543	14.46214	0	0	0	0	0	0	14.25627	0	0	0	0	0	0	0	0	15.97287	0	15.94009	0	0	0	0	0	15.23367	0	11.73462	0	0	0	0	15.17303	0	15.36891	0	0	0	0	0	0	0	0	0	0	0
Q53GL7	PAR10_HUMAN	"Protein mono-ADP-ribosyltransferase PARP10, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 10, ARTD10) (Poly [ADP-ribose] polymerase 10, PARP-10)"	PARP10	Homo sapiens (Human)	NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]; translesion synthesis [GO:0019985]; viral protein processing [GO:0019082]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]; translesion synthesis [GO:0019985]; viral protein processing [GO:0019082]	DNA-binding transcription factor binding [GO:0140297]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0003950; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0010629; GO:0010847; GO:0019082; GO:0019985; GO:0032088; GO:0034356; GO:0045071; GO:0048147; GO:0070212; GO:0070213; GO:0070530; GO:0140289; GO:0140297; GO:1900045; GO:1990404	MVAMAEAEAGVAVEVR	5.940000057	1	1	4.57E-13	1664.225372	14.53369	0	15.11882	12.58852	11.76208	0	14.44932	0	14.87658	0	14.30633	12.49867	0	8.809167	0	0	14.36593	13.14425	15.07227	13.12976	14.19769	11.86252	12.58456	13.51562	14.5136	14.77514	0	15.53806	15.19354	0	14.89197	0	0	0	0	0	0	0	0	0	14.21531	0	0	0	0	0	0	0
Q53GS7	GLE1_HUMAN	"mRNA export factor GLE1, hGLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1)"	GLE1 GLE1L	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; regulation of translational initiation [GO:0006446]; regulation of translational termination [GO:0006449]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; regulation of translational initiation [GO:0006446]; regulation of translational termination [GO:0006449]	identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369]	GO:0000822; GO:0005543; GO:0005615; GO:0005635; GO:0005643; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006406; GO:0006446; GO:0006449; GO:0006913; GO:0015031; GO:0016020; GO:0016973; GO:0031369; GO:0031965; GO:0036064; GO:0042802; GO:0044614	EIFDK	2.960000038	0.064786434	0.064786434	0.17212967	651.1645971	16.99216	15.2192	0	14.28131	18.27162	15.89082	0	0	0	15.67791	0	0	16.96594	0	15.54953	0	0	0	0	14.90927	0	13.55427	0	0	0	0	0	17.17902	14.84368	0	0	17.72011	0	16.83482	19.13878	15.69353	0	0	18.39608	0	0	0	14.02135	0	0	0	18.04695	0
Q53GT1	KLH22_HUMAN	Kelch-like protein 22	KLHL22	Homo sapiens (Human)	cell division [GO:0051301]; cellular response to leucine [GO:0071233]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827]	centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; 14-3-3 protein binding [GO:0071889]; cell division [GO:0051301]; cellular response to leucine [GO:0071233]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]	14-3-3 protein binding [GO:0071889]	GO:0000070; GO:0005634; GO:0005737; GO:0005764; GO:0005813; GO:0005827; GO:0005829; GO:0006513; GO:0007094; GO:0010507; GO:0015630; GO:0030307; GO:0031463; GO:0043161; GO:0043231; GO:0045171; GO:0051301; GO:0071233; GO:0071889; GO:0072686; GO:1904263	DTVASALMYHR	7.840000153	1	1	0.324722489	1261.695028	14.10998	0	15.72653	0	12.98476	14.95508	14.26221	14.64253	15.71667	14.55124	14.49895	0	14.49282	12.19596	0	14.65129	0	15.86385	14.1985	15.44016	0	15.05156	15.84385	0	14.12992	0	0	0	0	0	0	15.7651	0	0	16.02982	0	15.98287	16.76353	0	0	0	0	16.82726	0	0	0	0	0
Q53H54	TYW2_HUMAN	"tRNA wybutosine-synthesizing protein 2 homolog, tRNA-yW-synthesizing protein 2, EC 2.5.1.114 (tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase)"	TRMT12 TRM12 TYW2	Homo sapiens (Human)	tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]	tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175]	GO:0005737; GO:0008175; GO:0030488; GO:0102522	NNLEINGVADR	29.61000061	1	1	0.285979972	1215.671202	0	17.73816	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q53H96	P5CR3_HUMAN	"Pyrroline-5-carboxylate reductase 3, P5C reductase 3, P5CR 3, EC 1.5.1.2 (Pyrroline-5-carboxylate reductase-like protein)"	PYCR3 PYCRL	Homo sapiens (Human)	L-proline biosynthetic process [GO:0055129]	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005829; GO:0045171; GO:0055129; GO:0072686	AAAEPSPR	5.670000076	0.319127321	0.319127321	0.245768954	797.5868087	13.01567	16.56262	12.97847	0	14.25755	15.69756	15.36352	14.52402	14.98516	15.21127	14.41731	15.61509	0	15.42323	15.0699	16.62812	15.22523	17.12376	15.3096	11.3429	14.87396	15.93046	14.71875	15.80875	15.12447	15.42083	0	17.0577	0	15.81867	0	0	16.15552	15.55322	0	0	15.23344	0	0	0	0	0	0	0	0	0	0	0
Q53HC0	CCD92_HUMAN	Coiled-coil domain-containing protein 92 (Limkain beta-2)	CCDC92	Homo sapiens (Human)	innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688]	identical protein binding [GO:0042802]	GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0042802; GO:0043231; GO:0045087; GO:0050688	AHVGVAHRIHHATPPQAQPEVK	1.519999981	1	1	0.117425958	2379.596682	14.37338	0	0	0	0	14.25244	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.69957	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.92453	0	0	0	0	0	0	17.25166	0
Q53LP3	SWAHC_HUMAN	Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C)	SOWAHC ANKRD57 C2orf26	Homo sapiens (Human)						HGRQELLAMLVNFANK	4.550000191	1	1	0.462048203	1841.231801	0	0	0	0	15.52927	14.62146	0	13.10373	17.51165	17.20241	17.79734	0	0	0	0	0	0	0	0	0	15.76785	0	0	0	0	0	0	0	0	0	0	17.91884	19.40881	0	0	0	0	0	17.46978	0	0	0	17.70562	0	16.57667	16.5719	16.98293	0
Q53QZ3	RHG15_HUMAN	Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15)	ARHGAP15 BM-024 BM-030 BM-046	Homo sapiens (Human)	regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0008360; GO:0016020; GO:0043087; GO:0051056	QQALSNMK	10.13000011	1	1	0.22824682	915.4300404	16.89303	16.11707	0	15.13889	16.77954	0	0	17.91438	16.6701	17.11761	16.61072	0	0	0	0	0	0	0	0	0	17.56504	0	16.41169	0	0	17.25463	17.16686	0	0	14.88053	16.71688	17.0431	0	0	0	0	0	17.21363	0	16.0264	0	0	0	0	0	0	0	0
Q53R41	FAKD1_HUMAN	"FAST kinase domain-containing protein 1, mitochondrial"	FASTKD1 KIAA1800	Homo sapiens (Human)	mitochondrial RNA metabolic process [GO:0000959]; mitochondrial RNA processing [GO:0000963]; regulation of mitochondrial mRNA stability [GO:0044528]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial RNA metabolic process [GO:0000959]; mitochondrial RNA processing [GO:0000963]; regulation of mitochondrial mRNA stability [GO:0044528]	RNA binding [GO:0003723]	GO:0000959; GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0035770; GO:0044528	LDHYGR	10.14000034	0.078689076	0.078689076	0.265555889	759.4330779	18.27008	0	19.54748	0	19.44683	0	0	0	19.48565	17.59099	0	0	17.85188	0	0	16.67555	19.15512	17.45172	18.66841	0	0	0	18.04545	17.67684	18.4622	0	18.45388	16.5892	0	0	0	0	19.85699	0	0	19.73992	0	0	0	0	0	20.148	0	18.5492	0	0	19.03087	0
Q53RT3	APRV1_HUMAN	"Retroviral-like aspartic protease 1, EC 3.4.23.- (Skin-specific retroviral-like aspartic protease, SASPase, Skin aspartic protease) (TPA-inducible aspartic proteinase-like protein, TAPS)"	ASPRV1 SASP	Homo sapiens (Human)	protein processing [GO:0016485]; skin development [GO:0043588]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; aspartic-type endopeptidase activity [GO:0004190]; protein processing [GO:0016485]; skin development [GO:0043588]	aspartic-type endopeptidase activity [GO:0004190]	GO:0004190; GO:0016021; GO:0016485; GO:0043588	VANGAEMK	4.400000095	1	1	3.47E-13	818.6133202	0	15.95342	0	0	15.22495	0	0	0	15.42522	0	0	0	15.10987	0	0	0	0	0	0	0	0	0	0	0	0	0	16.34805	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.58605	0
Q53RY4	KCP3_HUMAN	"Keratinocyte-associated protein 3, KCP-3"	KRTCAP3 KCP3 UNQ3066/PRO9898	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	CSLCAFDAAR	12.60999966	1	1	0.530275368	1171.298749	0	0	0	0	17.55136	0	0	0	0	0	17.68542	17.30595	17.94835	0	0	0	0	0	0	17.31614	0	18.62303	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.09052	0	18.8147	0	0	0	17.532
Q53T59	H1BP3_HUMAN	"HCLS1-binding protein 3 (HS1-binding protein 3, HSP1BP-3)"	HS1BP3	Homo sapiens (Human)	regulation of apoptotic process [GO:0042981]	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; phosphatidylinositol binding [GO:0035091]; regulation of apoptotic process [GO:0042981]	phosphatidylinositol binding [GO:0035091]	GO:0005739; GO:0005783; GO:0035091; GO:0042981	LAAFKSAK	2.519999981	1	1	0.187751918	837.0926075	14.46244	13.66583	14.32538	0	0	0	0	0	0	17.09264	0	15.27047	0	13.79785	0	15.70935	0	0	0	0	0	0	0	14.10594	0	0	16.27205	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.08814	0	0	13.51506	0	0	0
Q53T94	TAF1B_HUMAN	"TATA box-binding protein-associated factor RNA polymerase I subunit B (RNA polymerase I-specific TBP-associated factor 63 kDa, TAFI63) (TATA box-binding protein-associated factor 1B, TBP-associated factor 1B) (Transcription initiation factor SL1/TIF-IB subunit B)"	TAF1B	Homo sapiens (Human)	"nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668]; metal ion binding [GO:0046872]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; TBP-class protein binding [GO:0017025]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]"	metal ion binding [GO:0046872]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; TBP-class protein binding [GO:0017025]	GO:0001164; GO:0001188; GO:0005634; GO:0005654; GO:0005668; GO:0005730; GO:0006351; GO:0017025; GO:0042790; GO:0046872; GO:0070860	SKQAYCK	4.630000114	1	1	0.269844196	882.0218436	14.16021	0	14.02268	13.37889	0	14.16588	0	14.18447	14.7023	0	15.07736	0	0	15.51746	17.1633	0	0	16.09325	0	17.64765	14.53745	15.84711	15.84795	14.86694	16.36676	0	14.92032	15.71971	15.47255	15.96198	0	0	0	13.9498	14.89002	14.34055	15.5348	0	16.18653	15.27143	15.8196	14.34309	14.10596	10.53706	15.52613	13.41302	15.37064	14.34242
Q53TN4	CYBR1_HUMAN	"Plasma membrane ascorbate-dependent reductase CYBRD1, EC 7.2.1.3 (Cytochrome b reductase 1) (Duodenal cytochrome b) (Ferric-chelate reductase 3)"	CYBRD1 DCYTB FRRS3	Homo sapiens (Human)	ascorbate homeostasis [GO:0140576]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; reductive iron assimilation [GO:0033215]; response to iron ion [GO:0010039]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	"apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions [GO:0016722]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575]; ascorbate homeostasis [GO:0140576]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; reductive iron assimilation [GO:0033215]; response to iron ion [GO:0010039]"	"identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions [GO:0016722]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575]"	GO:0005765; GO:0005886; GO:0006879; GO:0010039; GO:0016021; GO:0016324; GO:0016491; GO:0016722; GO:0031526; GO:0033215; GO:0042802; GO:0046872; GO:0055072; GO:0070062; GO:0140571; GO:0140575; GO:0140576	MAMEGYWR	7.03000021	0.983703196	0.983703196	0.221827592	1060.267964	15.82997	15.67634	13.51604	17.56808	11.15038	13.41493	13.31964	15.41788	14.47157	11.82191	16.00339	16.43105	14.86495	0	15.31355	0	0	14.65754	15.84486	16.37171	0	15.15583	0	0	15.47465	16.25171	16.45308	0	0	0	14.84604	0	0	15.61594	0	15.33125	17.5735	16.75502	16.72923	0	0	0	0	19.00414	16.74346	0	0	0
Q53TQ3	IN80D_HUMAN	INO80 complex subunit D	INO80D	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]"	Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]"		GO:0000723; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0042766; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507	KTKPPALTK	7.039999962	1	1	0.166706673	984.8418704	0	14.99211	14.54901	12.81766	15.44685	14.00351	0	15.72839	14.91441	17.30343	0	14.62583	14.94262	14.27308	0	16.0361	0	16.30293	0	0	0	15.79116	17.33354	16.04684	13.94328	15.02987	0	0	0	14.42277	18.02822	0	15.19368	0	13.70771	0	0	0	0	0	15.321	0	0	0	0	0	0	14.97836
Q562E7	WDR81_HUMAN	WD repeat-containing protein 81	WDR81	Homo sapiens (Human)	aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]	autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511]	K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]	GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022; GO:0050821; GO:0070530	LQSFPGHSGAVK	5.090000153	1	1	0.248691943	1227.920736	15.62104	0	0	14.88274	13.86524	14.53604	15.63489	13.68765	14.61195	0	14.43583	14.67854	14.47811	0	0	0	15.97454	0	17.42852	0	0	15.30215	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.47252	0	0	0	0	0	0	0	0	0	0
Q562F6	SGO2_HUMAN	Shugoshin 2 (Shugoshin-2) (Shugoshin-like 2) (Tripin)	SGO2 SGOL2	Homo sapiens (Human)	"cell division [GO:0051301]; homologous chromosome segregation [GO:0045143]; meiotic sister chromatid cohesion [GO:0051177]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic sister chromatid segregation [GO:0000070]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic cohesin complex [GO:0030892]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic cohesin complex [GO:0030892]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; homologous chromosome segregation [GO:0045143]; meiotic sister chromatid cohesion [GO:0051177]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic sister chromatid segregation [GO:0000070]"		GO:0000070; GO:0000775; GO:0000776; GO:0005654; GO:0005829; GO:0016604; GO:0030892; GO:0045143; GO:0051177; GO:0051301; GO:0051754	VKDSSSEK	5.190000057	1	1	0.020419432	882.6006489	0	0	0	0	0	0	0	14.23453	0	0	0	0	0	0	0	0	0	0	13.99781	0	0	0	15.79959	0	0	0	14.93469	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q562R1	ACTBL_HUMAN	Beta-actin-like protein 2 (Kappa-actin)	ACTBL2	Homo sapiens (Human)	axonogenesis [GO:0007409]; cell motility [GO:0048870]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; synapse [GO:0045202]	actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; NuA4 histone acetyltransferase complex [GO:0035267]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; axonogenesis [GO:0007409]; cell motility [GO:0048870]	ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]	GO:0005524; GO:0005615; GO:0005737; GO:0005884; GO:0007409; GO:0016020; GO:0019901; GO:0030424; GO:0035267; GO:0045202; GO:0048870; GO:0070062; GO:0098973; GO:0098978	GVLTLK	6.659999847	0.432683378	0.432683378	0.163270326	625.4737216	16.37523	15.02814	15.99743	14.67057	15.4246	14.90427	15.68927	16.43833	15.20905	15.51692	16.83109	15.99274	16.13966	10.23686	16.31933	15.32164	0	15.89053	16.88626	17.5354	17.03948	16.78637	0	15.6648	17.21122	0	15.94739	16.65244	16.86038	15.43205	16.39474	17.23295	15.66784	16.69077	17.34336	15.79912	16.12054	16.44432	16.00146	16.47624	17.20641	14.67309	16.98176	16.15369	17.52862	16.74231	15.9291	16.73882
Q567U6	CCD93_HUMAN	Coiled-coil domain-containing protein 93	CCDC93	Homo sapiens (Human)	endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]	early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		GO:0005769; GO:0006893; GO:0015031; GO:0032456; GO:0043231	YNMEK	7.71999979	0.882183671	0.882183671	0.274885985	684.5532695	18.60838	0	0	17.26803	17.79871	17.56583	0	0	0	17.45375	0	0	16.50123	0	18.6922	18.74742	0	0	0	0	0	0	17.42261	0	0	19.53305	0	16.68194	0	18.14714	0	17.96872	20.11773	0	0	0	18.62194	0	0	0	17.38793	18.41969	17.34575	19.30921	0	0	18.20018	0
Q56UN5	M3K19_HUMAN	"Mitogen-activated protein kinase kinase kinase 19, EC 2.7.11.1 (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)"	MAP3K19 RCK YSK4	Homo sapiens (Human)			ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0106310	LSVSVR	7.130000114	1	1	0.159906408	662.2684924	14.0166	13.37078	0	0	14.86788	0	13.94885	0	16.14029	14.14359	15.44032	0	15.09338	0	0	0	16.29045	15.10828	0	16.33313	16.30806	0	16.72114	0	0	0	0	15.52076	14.75827	0	15.18242	0	0	17.20703	15.78201	15.7908	17.63142	16.59672	0	16.15667	0	16.59037	16.73726	0	14.15337	0	0	0
Q587J7	TDR12_HUMAN	"Putative ATP-dependent RNA helicase TDRD12, EC 3.6.4.13 (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12)"	TDRD12 ECAT8	Homo sapiens (Human)	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	PET complex [GO:1990923]	PET complex [GO:1990923]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:1990923	AGRPLCPYLK	6.21999979	0.487641513	0.487641513	0.209667557	1173.66137	0	0	0	14.05339	12.38167	0	0	0	0	0	0	15.46147	14.44714	0	14.89829	14.0547	0	0	0	0	0	15.23126	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.93471	0	0	0	0	0	0	0	0	0	15.27293	0
Q587J8	KHDC3_HUMAN	KH domain-containing protein 3 (ES cell-associated transcript 1 protein) (KHDC3-like protein)	KHDC3L C6orf221 ECAT1	Homo sapiens (Human)	actin filament organization [GO:0007015]; establishment of organelle localization [GO:0051656]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite development [GO:1900006]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of embryonic development [GO:0040019]; positive regulation of neurogenesis [GO:0050769]; regulation of protein localization [GO:0032880]; replication fork processing [GO:0031297]	apical cortex [GO:0045179]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333]	apical cortex [GO:0045179]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; establishment of organelle localization [GO:0051656]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite development [GO:1900006]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of embryonic development [GO:0040019]; positive regulation of neurogenesis [GO:0050769]; regulation of protein localization [GO:0032880]; replication fork processing [GO:0031297]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005813; GO:0005938; GO:0007015; GO:0031297; GO:0032880; GO:0032991; GO:0040019; GO:0043066; GO:0045179; GO:0050769; GO:0051656; GO:0106333; GO:1900006; GO:1905168; GO:2000781	IFGRGGER	3.359999895	1	1	0.09011112	889.3519187	0	14.82539	0	0	0	0	0	0	14.89055	10.81243	14.99062	0	0	13.44192	0	15.74407	0	9.320238	0	0	0	0	0	0	0	0	0	0	0	15.27118	0	0	0	0	0	0	0	0	0	0	0	15.23016	0	0	0	0	0	0
Q58A45	PAN3_HUMAN	"PAN2-PAN3 deadenylation complex subunit PAN3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3, PAN deadenylation complex subunit 3)"	PAN3	Homo sapiens (Human)	"mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	cytosol [GO:0005829]; P-body [GO:0000932]; PAN complex [GO:0031251]	"cytosol [GO:0005829]; P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; protein kinase activity [GO:0004672]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; protein kinase activity [GO:0004672]	GO:0000289; GO:0000932; GO:0004672; GO:0005524; GO:0005829; GO:0006397; GO:0008143; GO:0010606; GO:0031251; GO:0046872; GO:0090503	LVPMGSK	1.919999957	0.178090781	0.178090781	0.255752451	731.2106161	16.49765	17.26956	16.2119	14.82765	16.86705	15.42177	16.52517	15.13451	0	16.45256	14.7723	16.50571	16.04263	16.67369	15.89633	16.27005	15.43461	16.67671	15.47995	16.17102	16.59571	15.99066	0	15.9501	16.99785	0	0	16.3152	16.51401	15.72139	16.81201	16.3843	16.44411	16.81438	0	16.19742	0	17.71611	16.0765	16.15881	16.51347	16.0199	16.53417	17.25726	16.86899	16.67444	15.38987	15.90552
Q58DX5	NADL2_HUMAN	"Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2, NAALADase L2"	NAALADL2	Homo sapiens (Human)	response to bacterium [GO:0009617]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; response to bacterium [GO:0009617]		GO:0005654; GO:0009617; GO:0016021	ERAPIR	6.659999847	1	1	0.08970939	740.228726	0	0	0	12.30481	0	0	0	0	0	13.43781	0	13.43207	0	15.57782	0	11.9694	12.18932	0	0	0	0	0	0	15.94109	0	0	14.94422	0	15.41673	0	0	0	0	0	15.84265	0	17.38074	15.2737	0	0	16.34132	16.13481	0	0	0	0	0	14.37032
Q58EX2	SDK2_HUMAN	Protein sidekick-2	SDK2 KIAA1514	Homo sapiens (Human)	camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]		GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0045202; GO:0060219	GINNPGATWAELTSMYSMR	3.430000067	0.091261499	0.091261499	0.111918481	2129.879757	16.93812	0	0	0	0	15.265	0	0	17.73623	0	0	17.04274	0	0	14.53164	0	0	0	17.86506	0	0	0	0	0	0	14.7646	0	0	15.30316	15.05566	0	13.92996	14.62185	16.58883	14.83683	13.59056	0	15.39721	13.56078	15.00877	15.80389	14.9516	0	11.8148	0	12.02561	9.437829	13.16604
Q58EX7	PKHG4_HUMAN	"Puratrophin-1 (Pleckstrin homology domain-containing family G member 4, PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1)"	PLEKHG4 PRTPHN1	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0051056	FEIWFRR	13.77000046	1	1	0.177539152	1054.916936	0	10.54012	15.21878	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.97773	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q58F21	BRDT_HUMAN	"Bromodomain testis-specific protein (Cancer/testis antigen 9, CT9) (RING3-like protein)"	BRDT	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; histone binding [GO:0042393]; histone reader [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	histone binding [GO:0042393]; histone reader [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; transcription coactivator activity [GO:0003713]	GO:0000785; GO:0003713; GO:0005634; GO:0006338; GO:0006355; GO:0006397; GO:0007140; GO:0007141; GO:0008380; GO:0035093; GO:0042393; GO:0043484; GO:0051039; GO:0070577; GO:0140566	EELHSQK	7.519999981	1	1	0.167710891	869.8510886	0	0	0	0	0	0	0	0	15.09918	15.90859	12.89753	13.48593	0	0	0	0	0	0	0	0	0	15.84048	15.39658	0	0	0	16.97647	0	0	0	0	0	0	0	0	0	17.1708	0	0	15.85435	14.33975	0	15.35894	0	0	16.42822	0	0
Q58FF8	H90B2_HUMAN	"Putative heat shock protein HSP 90-beta 2 (Heat shock protein 90-beta b, Heat shock protein 90Bb)"	HSP90AB2P HSP90BB	Homo sapiens (Human)	cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; unfolded protein binding [GO:0051082]	GO:0005524; GO:0005829; GO:0005886; GO:0006457; GO:0016887; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082; GO:0070062; GO:0097718	DHLAVR	7.360000134	0.183698982	0.183698982	0.294975638	708.0588545	13.26879	0	15.45084	14.55377	14.73064	14.96316	14.54178	0	12.79612	16.28164	15.88645	0	0	15.91487	16.00643	15.77386	14.95226	16.06475	0	14.10405	14.8362	16.85637	17.48473	0	0	0	0	0	0	0	0	16.36439	16.9973	0	0	0	15.61934	17.25998	17.51837	15.6479	15.16777	0	0	15.69983	0	0	15.07555	0
Q58HT5	AWAT1_HUMAN	"Acyl-CoA wax alcohol acyltransferase 1, EC 2.3.1.75 (Diacylglycerol O-acyltransferase 2-like protein 3) (Diacylglycerol acyltransferase 2) (Long-chain-alcohol O-fatty-acyltransferase 1)"	AWAT1 DGA2 DGAT2L3	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; lipid metabolic process [GO:0006629]; wax biosynthetic process [GO:0010025]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; arachidonic acid metabolic process [GO:0019369]; lipid metabolic process [GO:0006629]; wax biosynthetic process [GO:0010025]	arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]	GO:0005789; GO:0006629; GO:0010025; GO:0016021; GO:0019369; GO:0047196; GO:0102966	FQSCFRR	6.75	0.203663155	0.203663155	0.263437503	1001.278992	16.38249	15.73145	15.78001	12.06299	0	0	15.83996	16.45357	15.85059	16.90784	0	15.97403	0	15.88511	0	0	0	13.46564	0	8.448284	15.85259	16.40429	15.68979	17.63011	0	15.51157	17.53705	15.4258	17.18779	16.36887	16.67762	16.494	17.69004	0	18.21748	14.81845	17.20467	18.18169	0	16.15154	16.12319	0	16.37573	0	14.96052	15.70965	17.10339	15.95277
Q58WW2	DCAF6_HUMAN	"DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein, ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein, NRIP)"	DCAF6 IQWD1 MSTP055	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]	nuclear receptor coactivator activity [GO:0030374]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0016567; GO:0030374; GO:0045944; GO:0080008	ANIFSAK	6.179999828	0.088140532	0.088140532	0.27073109	749.7542043	15.23364	15.83392	15.22813	14.83929	0	0	14.8107	0	0	15.26571	0	0	14.53662	15.08031	15.98247	0	15.84039	0	0	16.09236	16.68539	16.56093	17.53495	17.4923	0	16.01765	0	0	16.06136	14.90666	0	15.76219	16.82621	16.29515	15.85118	16.15979	16.51026	16.45523	16.90611	16.02115	15.18951	17.41165	16.72282	17.2533	14.54232	14.6952	0	16.17418
Q59EK9	RUN3A_HUMAN	"RUN domain-containing protein 3A (Rap2-interacting protein 8, RPIP-8)"	RUNDC3A RAP2IP RPIP8	Homo sapiens (Human)	positive regulation of cGMP-mediated signaling [GO:0010753]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; positive regulation of cGMP-mediated signaling [GO:0010753]; small GTPase mediated signal transduction [GO:0007264]	GTPase regulator activity [GO:0030695]	GO:0005829; GO:0005886; GO:0007264; GO:0010753; GO:0030695; GO:0043231	MEASFVQTTMALGLSSKK	3.730000019	1	1	0.083722226	1960.782934	15.38051	13.41327	14.97578	0	0	0	0	16.64757	0	0	0	15.29851	0	0	0	0	0	0	0	16.67122	0	0	0	0	0	0	0	0	0	16.3055	0	0	0	17.14512	13.74189	0	0	16.13421	0	14.8338	15.04053	15.26065	0	0	0	15.46036	0	0
Q5BIV9	SPRN_HUMAN	"Shadow of prion protein, Protein shadoo"	SPRN SHO	Homo sapiens (Human)	protein import into nucleus [GO:0006606]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; protein import into nucleus [GO:0006606]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005576; GO:0005634; GO:0005886; GO:0006606; GO:0031225	VRVRPAQR	4.139999866	1	1	0.19272437	982.3551031	0	0	0	0	0	0	13.50248	18.40837	0	0	0	14.81526	0	16.13437	16.5678	0	0	14.70662	0	0	0	15.41108	0	0	16.50535	16.69059	0	14.22566	0	0	15.68069	15.18396	0	12.13766	0	15.23167	0	0	15.70132	0	0	0	0	0	0	0	0	0
Q5BJE1	CC178_HUMAN	Coiled-coil domain-containing protein 178	CCDC178 C18orf34	Homo sapiens (Human)		ciliary basal body [GO:0036064]	ciliary basal body [GO:0036064]		GO:0036064	NKFITMR	6.079999924	1	1	2.34E-13	925.8577531	0	0	0	0	0	0	0	0	0	0	15.01918	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.42313	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5BJF2	SGMR2_HUMAN	"Sigma intracellular receptor 2, Sigma-2 receptor, Sigma2 receptor (Meningioma-associated protein 30) (Transmembrane protein 97)"	TMEM97 MAC30 S2R	Homo sapiens (Human)	cholesterol homeostasis [GO:0042632]; regulation of cell growth [GO:0001558]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; cholesterol homeostasis [GO:0042632]; regulation of cell growth [GO:0001558]		GO:0001558; GO:0005764; GO:0005783; GO:0005791; GO:0005886; GO:0016021; GO:0030867; GO:0031965; GO:0042632	MGAPATR	1.649999976	1	1	0.177161967	718.3837916	15.0897	0	15.92513	0	0	0	0	0	0	0	0	0	0	15.91028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5BJF6	ODFP2_HUMAN	Outer dense fiber protein 2 (Cenexin) (Outer dense fiber of sperm tails protein 2)	ODF2	Homo sapiens (Human)	centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286]	small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]	GO:0000922; GO:0001520; GO:0005198; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005929; GO:0007286; GO:0008104; GO:0010457; GO:0031267; GO:0036064; GO:0036126; GO:0043231; GO:0044782; GO:0097539; GO:0120103; GO:1902017	EHALSKER	4.03000021	1	1	0.061115096	968.3714489	0	0	0	0	0	15.33387	0	14.16339	13.76497	0	0	0	0	0	0	14.70234	0	13.88909	13.87964	0	11.94344	0	0	0	0	0	0	0	0	15.06421	0	15.71501	0	13.58229	0	0	0	13.01713	16.01826	0	0	13.40068	0	0	0	0	0	0
Q5BKX6	S45A4_HUMAN	Solute carrier family 45 member 4	SLC45A4 KIAA1126	Homo sapiens (Human)	sucrose transport [GO:0015770]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; sucrose:proton symporter activity [GO:0008506]; sucrose transport [GO:0015770]	sucrose:proton symporter activity [GO:0008506]	GO:0008506; GO:0015770; GO:0016020; GO:0016021	DALGGYTR	7.349999905	4.89E-05	4.89E-05	0.289131643	854.0021072	0	0	0	0	0	16.14075	0	0	0	0	16.87683	0	0	0	18.09648	0	18.31822	0	0	0	15.74842	0	0	16.45003	18.67759	0	0	0	0	0	0	0	0	0	0	0	17.79519	0	18.10459	0	0	0	0	0	0	0	17.221	0
Q5BKX8	CAVN4_HUMAN	Caveolae-associated protein 4 (Muscle-related coiled-coil protein) (Muscle-restricted coiled-coil protein)	CAVIN4 MURC	Homo sapiens (Human)	cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of Rho protein signal transduction [GO:0035023]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of Rho protein signal transduction [GO:0035023]		GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007517; GO:0010468; GO:0030018; GO:0030154; GO:0035023; GO:0042383; GO:0045944	EMGVDIIAR	13.76000023	1	1	0	1020.097723	14.39001	0	0	13.65904	0	0	0	13.28726	15.15517	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.22036	0	0	13.07232	0	0	0	0	0	0	0	0	0	0	0	0	0	14.32129	0	0	0	0	0
Q5BKZ1	ZN326_HUMAN	DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs and DBC1)	ZNF326 ZIRD	Homo sapiens (Human)	"mRNA processing [GO:0006397]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016363; GO:0032784; GO:0043231; GO:0043484; GO:0044609; GO:0046872	NTYQGFNGMDRDYGPGSYGGMDR	1.110000014	0.582038045	0.582038045	3.20E-12	2568.464503	0	13.77094	0	0	0	11.54956	0	12.83848	14.67767	0	14.70199	15.12772	14.24199	0	0	12.79277	0	13.24462	15.76309	0	0	0	0	0	0	0	0	14.47704	0	14.14325	0	0	0	0	0	0	0	16.04743	0	12.89678	14.78781	0	0	16.18125	14.03909	0	12.99841	0
Q5BLP8	CD048_HUMAN	Neuropeptide-like protein C4orf48	C4orf48 Chr4_55	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	MAPPPACR	13.43000031	0.672300935	0.672300935	0.200839677	899.5819068	20.36531	20.55723	20.16782	19.06108	0	17.78386	0	0	18.66693	17.81743	19.71454	0	18.66341	0	17.83458	0	0	19.63638	0	18.06693	17.0456	19.73042	0	0	19.32879	18.14824	19.97346	17.53094	0	17.97997	19.96993	0	0	18.76821	18.43786	18.11343	19.31574	19.84785	17.97044	0	17.92713	0	19.3833	0	0	0	16.71627	19.4241
Q5BVD1	TTMP_HUMAN	TPA-induced transmembrane protein	TTMP C3orf52	Homo sapiens (Human)		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021	IPEECVAEEELPHLLTER	1.00999999	0.634119451	0.634119451	0.011564621	2163.524177	13.67807	14.61916	0	13.87137	15.88165	13.74348	12.98522	0	0	0	0	0	0	0	0	0	14.50333	8.792977	0	0	0	0	15.65833	13.79735	15.7093	0	0	14.10819	16.23847	0	0	0	0	0	0	17.82338	0	13.33335	0	0	0	0	0	0	0	8.429543	18.74326	0
Q5C9Z4	NOM1_HUMAN	Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog)	NOM1 C7orf3	Homo sapiens (Human)	hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]	nucleolus [GO:0005730]	nucleolus [GO:0005730]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0042274; GO:0048820	TAGPEQGPGLGGRSGAEEASGHR	4.980000019	1	1	0.07412388	2177.231658	14.98417	15.60165	14.06468	13.34743	0	0	0	15.6879	14.21516	0	0	0	0	15.01202	13.31015	0	0	0	12.28822	0	15.04848	17.07908	0	15.81166	14.88219	14.45189	0	12.67673	0	0	15.90553	0	14.38886	0	13.72634	14.08658	15.9086	0	16.08345	0	12.63482	0	0	0	0	0	0	0
Q5CZ79	AN20B_HUMAN	Ankyrin repeat domain-containing protein 20B (Ankyrin repeat domain-containing protein 20A pseudogene)	ANKRD20A8P ANKRD20B	Homo sapiens (Human)						LAAAIGK	4.519999981	1	1	0.104026781	642.0587585	0	0	0	15.62532	0	0	0	0	0	0	0	15.68435	0	0	0	0	15.87405	0	0	0	0	0	0	16.35059	15.49028	0	0	0	0	14.91308	16.37296	13.65417	0	0	0	16.90203	0	0	0	0	0	0	17.48388	0	0	0	0	0
Q5CZC0	FSIP2_HUMAN	Fibrous sheath-interacting protein 2	FSIP2	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; sperm axoneme assembly [GO:0007288]	sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; sperm axoneme assembly [GO:0007288]		GO:0007288; GO:0030317; GO:0061512; GO:0097224; GO:0097225; GO:0097228; GO:0097229	ALPSDQIIAAGK	9.159999847	1	1	6.87E-13	1183.411553	14.45915	0	0	13.85729	0	13.99466	7.999961	0	6.540313	12.86794	0	9.919008	14.58053	12.58708	12.517	0	14.54222	0	0	0	0	0	14.42099	0	0	0	0	0	0	0	0	0	0	0	0	14.30728	0	0	0	0	0	0	0	0	0	0	0	0
Q5D862	FILA2_HUMAN	"Filaggrin-2, FLG-2 (Intermediate filament-associated and psoriasis-susceptibility protein, Ifapsoriasin)"	FLG2 IFPS	Homo sapiens (Human)	cell adhesion [GO:0007155]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]; transition metal ion binding [GO:0046914]; cell adhesion [GO:0007155]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436]	calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]; transition metal ion binding [GO:0046914]	GO:0001533; GO:0005198; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0007155; GO:0036457; GO:0046914; GO:0048730; GO:0061436; GO:1904724	GYGAR	6.619999886	0.240608588	0.240608588	0.246705903	520.1261909	0	15.60981	17.06063	15.70316	14.07833	0	16.12455	0	15.57807	16.55569	15.62686	15.60835	16.49614	0	0	15.6983	0	15.70879	0	16.43895	16.3841	0	16.86634	0	16.43048	15.49712	16.11497	0	0	0	16.88115	14.74657	16.27569	15.16082	15.15904	15.24287	16.22203	0	0	15.7738	0	15.67122	14.81692	0	17.13051	15.98713	15.25859	15.96564
Q5DID0	UROL1_HUMAN	Uromodulin-like 1 (Olfactorin)	UMODL1	Homo sapiens (Human)	adipose tissue development [GO:0060612]; cellular response to gonadotropin-releasing hormone [GO:0097211]; multicellular organismal reproductive process [GO:0048609]; neutrophil migration [GO:1990266]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]; regulation of ovarian follicle development [GO:2000354]; single fertilization [GO:0007338]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; peptidase inhibitor activity [GO:0030414]; adipose tissue development [GO:0060612]; cellular response to gonadotropin-releasing hormone [GO:0097211]; multicellular organismal reproductive process [GO:0048609]; neutrophil migration [GO:1990266]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]; regulation of ovarian follicle development [GO:2000354]; single fertilization [GO:0007338]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; peptidase inhibitor activity [GO:0030414]	GO:0005201; GO:0005509; GO:0005615; GO:0005737; GO:0007338; GO:0009897; GO:0009986; GO:0010468; GO:0016021; GO:0016324; GO:0030414; GO:0042981; GO:0048609; GO:0060612; GO:0097211; GO:1990266; GO:2000354	MQIVSLQAGSVVVR	4.170000076	1	1	0.062436947	1502.255907	16.16916	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.26299	0	0	0	0	0	0	12.45935	0	0	0	12.88369	0	0	0	0	0	0	0	0	0	0	12.27613	0	0	0
Q5EBM4	ZN542_HUMAN	Putative zinc finger protein 542 (Zinc finger protein 542 pseudogene)	ZNF542P ZNF542	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	LENYQNLVWLGLSISK	4.130000114	1	1	0.236362714	1878.077391	0	0	14.56721	0	16.7993	0	16.13612	0	0	0	16.18761	16.59288	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.33414	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5EG05	CAR16_HUMAN	"Caspase recruitment domain-containing protein 16 (Caspase recruitment domain-only protein 1, CARD-only protein 1) (Caspase-1 inhibitor COP) (Pseudo interleukin-1 beta converting enzyme, Pseudo-ICE, Pseudo-IL1B-converting enzyme)"	CARD16 COP COP1	Homo sapiens (Human)	cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-C [GO:0071494]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of protein binding [GO:0032091]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]	protease inhibitor complex [GO:0097179]; protein-containing complex [GO:0032991]	protease inhibitor complex [GO:0097179]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-C [GO:0071494]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of protein binding [GO:0032091]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]	CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]	GO:0004869; GO:0010804; GO:0019900; GO:0031665; GO:0032091; GO:0032691; GO:0032991; GO:0042802; GO:0043123; GO:0043154; GO:0050700; GO:0051092; GO:0071222; GO:0071456; GO:0071494; GO:0089720; GO:0097179; GO:0097340	IPGLGKELQTGTHK	1.539999962	0.186682388	0.186682388	0.402313438	1477.903342	16.83624	0	0	0	0	0	0	0	0	14.76783	0	14.78118	0	0	0	14.67363	15.5779	0	0	0	0	0	0	0	0	0	16.93029	14.93438	15.30907	17.32483	0	14.8567	0	0	0	0	0	0	0	0	0	0	0	0	0	16.2058	0	0
Q5F1R6	DJC21_HUMAN	DnaJ homolog subfamily C member 21 (DnaJ homolog subfamily A member 5) (Protein GS3)	DNAJC21 DNAJA5	Homo sapiens (Human)	protein folding [GO:0006457]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ribosome [GO:0005840]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ribosome [GO:0005840]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006457; GO:0008270	ATGHAR	4.070000172	1	1	0.157892574	612.4267646	15.41359	0	0	0	0	0	0	15.18828	15.72115	0	0	0	0	0	0	0	0	0	0	13.7084	0	16.0793	16.81116	0	0	15.7353	0	15.9839	0	14.9977	11.85012	14.74256	0	16.73598	15.78223	13.64949	0	0	0	0	0	15.74698	15.56057	16.24737	0	14.5547	0	0
Q5FVE4	ACBG2_HUMAN	"Long-chain-fatty-acid--CoA ligase ACSBG2, EC 6.2.1.3 (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2, EC 6.2.1.15) (Bubblegum-related protein) (PRTD-NY3)"	ACSBG2 BGR UNQ2443/PRO5005	Homo sapiens (Human)	cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA hydrolase activity [GO:0047617]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; spermatogenesis [GO:0007283]	acyl-CoA hydrolase activity [GO:0047617]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006631; GO:0007283; GO:0016020; GO:0016405; GO:0030154; GO:0031957; GO:0035338; GO:0042759; GO:0047617; GO:0047676	CEMNQMSGEPLDK	5.929999828	1	1	0.048222256	1554.508189	0	0	18.66799	0	0	0	18.90646	0	19.35556	0	17.93411	0	0	0	0	0	0	0	0	0	16.53033	0	0	0	0	18.0267	0	0	0	0	17.61778	0	0	0	20.45546	0	18.73951	0	0	0	0	0	0	0	0	0	0	0
Q5FWF5	ESCO1_HUMAN	"N-acetyltransferase ESCO1, EC 2.3.1.- (CTF7 homolog 1) (Establishment factor-like protein 1, EFO1, EFO1p, hEFO1) (Establishment of cohesion 1 homolog 1, ECO1 homolog 1, ESO1 homolog 1)"	ESCO1 EFO1 KIAA1911	Homo sapiens (Human)	peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]	acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270]	GO:0000785; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733	ENSSKVTK	7.070000172	1	1	0.215624919	893.2110555	18.67892	0	0	0	17.02623	18.44758	0	0	0	0	16.97913	15.25054	0	0	0	0	17.41726	0	0	0	0	17.16696	0	17.90099	0	0	0	0	0	0	0	0	0	18.13341	0	0	18.46172	0	0	0	0	18.72308	0	16.76636	16.53427	0	0	0
Q5FYB0	ARSJ_HUMAN	"Arylsulfatase J, ASJ, EC 3.1.6.-"	ARSJ UNQ372/PRO708	Homo sapiens (Human)		actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005576; GO:0005788; GO:0015629; GO:0046872	YFEHYRSIININR	12.10999966	0.426299185	0.426299185	0.574266083	1724.509716	0	19.83705	19.86154	19.07064	16.47234	15.11091	15.29776	15.78878	17.71118	17.84931	18.26426	17.48815	17.6837	0	17.05262	0	0	0	17.09303	0	0	17.09572	0	18.11472	21.07832	0	0	0	17.13223	18.59083	0	18.53559	20.28968	19.7989	19.08036	20.36186	0	19.14477	18.69102	18.44128	17.47604	0	18.73136	18.65502	0	0	18.85653	17.71377
Q5GFL6	VWA2_HUMAN	"von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen, AMACO) (Colon cancer secreted protein 2, CCSP-2)"	VWA2 AMACO	Homo sapiens (Human)	calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]	GO:0005509; GO:0005604; GO:0005615; GO:0007161; GO:0042802; GO:0046626; GO:0062023; GO:0070062	MMWCSAAVDIMFLLDGSNSVGK	2.25	1	1	4.59E-13	2444.467349	14.62252	14.82084	13.0154	13.81125	12.22638	0	0	0	0	11.94827	0	0	12.34681	0	0	0	0	15.69561	13.39486	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5GH72	XKR7_HUMAN	XK-related protein 7	XKR7 C20orf159 XRG7	Homo sapiens (Human)	apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]		GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742	MAAKSDGAAASASPDPEGAAGGAR	5.949999809	1	1	0.028562292	2132.158028	0	0	14.45837	11.94938	13.98402	0	14.45719	0	14.617	0	0	0	16.00621	15.87287	14.9516	0	0	0	16.58302	0	0	15.23341	15.87885	0	14.27837	0	15.67242	0	14.98703	13.67591	0	0	15.24182	16.10793	16.39083	0	0	0	0	15.76075	0	0	0	17.15464	0	0	0	0
Q5GH76	XKR4_HUMAN	"XK-related protein 4, hXKR4 [Cleaved into: XK-related protein 4, processed form ]"	XKR4 KIAA1889 XRG4	Homo sapiens (Human)	apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]	phospholipid scramblase activity [GO:0017128]	GO:0005886; GO:0016020; GO:0016021; GO:0017128; GO:0043652; GO:0070782; GO:1902742	AILAFECSPSPPR	4.130000114	1	1	0.078160804	1442.041686	13.78681	14.45919	14.0036	13.80359	10.46199	12.98751	12.14483	14.37488	15.24051	12.94538	12.88148	15.3184	0	14.43963	13.8313	16.1609	0	14.24672	0	0	15.40411	0	0	0	15.45439	14.70038	14.72389	0	0	13.35992	0	0	0	0	0	0	13.49597	0	0	0	0	0	15.47484	0	16.31867	0	0	0
Q5GH77	XKR3_HUMAN	XK-related protein 3 (X Kell blood group-related 3) (XTES)	XKR3 XRG3	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021	CLHTIR	3.849999905	0.318578005	0.318578005	0.244317091	799.7308971	15.82868	13.70272	17.06756	13.12738	12.31261	15.03218	16.68855	15.61843	0	0	0	0	0	16.44674	0	0	16.12097	0	0	0	15.35597	16.78105	16.19538	16.46367	0	16.79539	0	14.51337	15.81081	15.79351	16.51785	15.75009	16.1642	0	0	0	0	16.23729	16.79924	15.55673	14.97576	0	0	15.04914	0	0	14.53203	15.48105
Q5GLZ8	HERC4_HUMAN	"Probable E3 ubiquitin-protein ligase HERC4, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)"	HERC4 KIAA1593	Homo sapiens (Human)	cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; fibrillar center [GO:0001650]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; spermatogenesis [GO:0007283]	ubiquitin-protein transferase activity [GO:0004842]	GO:0001650; GO:0004842; GO:0005829; GO:0007283; GO:0030154; GO:0045879	FSGVDMNAAR	4.889999866	1	1	0.403330697	1083.635225	0	0	0	0	0	0	18.43487	0	0	0	0	0	0	0	0	0	0	17.53276	0	0	0	19.58829	20.01917	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.2195	0	0	0	0	0	0	0	0
Q5H8A4	PIGG_HUMAN	"GPI ethanolamine phosphate transferase 2, EC 2.-.-.- (GPI7 homolog, hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein, PIG-G)"	PIGG GPI7 UNQ1930/PRO4405	Homo sapiens (Human)	GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]"	"CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]"	GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267	LSEMDSVLMK	2.930000067	0.599211693	0.599211693	0.175610139	1168.608187	0	0	0	0	0	16.14366	0	0	0	17.26557	19.53212	0	17.95175	0	0	0	18.63218	0	0	0	0	19.68982	18.51458	0	0	0	18.68697	0	0	0	0	0	0	18.63768	0	18.91027	0	0	0	19.62809	17.40143	19.41843	0	17.92011	0	17.67774	17.63548	0
Q5H8C1	FREM1_HUMAN	FRAS1-related extracellular matrix protein 1 (Protein QBRICK)	FREM1 C9orf143 C9orf145 C9orf154	Homo sapiens (Human)	cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094]	basement membrane [GO:0005604]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	basement membrane [GO:0005604]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0005576; GO:0005604; GO:0007154; GO:0007160; GO:0016021; GO:0030246; GO:0046872; GO:0097094	KAEIAMNMGETR	1.360000014	1	1	0.134867263	1381.993748	14.9984	0	0	0	13.67866	0	0	15.86865	15.20628	0	11.5623	13.37843	13.73273	0	15.75122	14.41621	14.84078	13.54133	0	0	0	0	0	0	0	0	0	0	0	0	0	17.10504	0	0	0	0	0	0	0	0	0	15.14093	15.45012	0	15.81279	0	0	0
Q5H943	KKLC1_HUMAN	"Kita-kyushu lung cancer antigen 1, KK-LC-1 (Cancer/testis antigen 83)"	CT83 CXorf61 KKLC1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		GO:0005634; GO:0005886; GO:0016021	GASPHR	11.05000019	0.001077825	0.001077825	0.09227497	623.1087937	15.22527	14.93754	18.1487	0	0	0	0	16.36985	0	18.70637	16.88105	0	0	16.26862	13.20811	12.2374	11.24131	14.17188	10.36503	0	15.31679	16.23728	0	17.68833	17.24129	0	0	16.30281	0	0	11.45771	0	0	16.60056	13.17431	14.95998	16.77167	0	15.34229	15.98066	10.78024	0	0	13.95955	17.72805	13.7985	14.08865	15.61211
Q5H9B9	BM2KL_HUMAN	Putative BMP-2-inducible kinase-like protein	BMP2KL	Homo sapiens (Human)						IAPSPK	9.409999847	0.709456563	0.709456563	0.173267496	612.3232738	15.32155	16.14061	0	15.6009	13.90086	14.83421	14.77301	16.11077	15.38983	0	14.49765	15.12198	0	0	14.79354	0	0	15.47574	15.38132	12.78127	14.78894	12.98826	15.4592	0	13.69892	14.03598	14.08661	0	0	0	15.41797	0	0	16.51287	15.16621	15.048	15.55882	0	17.3202	0	0	15.14888	0	14.68887	0	0	0	0
Q5H9F3	BCORL_HUMAN	"BCL-6 corepressor-like protein 1, BCoR-L1, BCoR-like protein 1"	BCORL1	Homo sapiens (Human)	chromatin organization [GO:0006325]	nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chromatin organization [GO:0006325]		GO:0005654; GO:0005886; GO:0006325	NLLLPNK	29.35000038	0.023055254	0.023055254	0.224636748	810.5526643	18.10441	18.75359	19.10748	20.02481	0	19.81225	19.19981	19.49874	19.00409	18.27023	19.1528	19.53933	18.91846	19.78637	19.49664	0	19.45956	18.70322	19.4724	18.93974	18.34528	18.78769	19.0905	19.94272	20.29041	20.23861	19.92443	18.9543	0	19.99239	19.60381	20.09396	0	19.30783	19.35342	19.93378	19.70457	19.33519	18.5613	0	18.72852	18.90471	20.64096	19.62639	18.57016	18.84735	19.28559	19.71125
Q5H9J9	T11X2_HUMAN	T-complex protein 11 X-linked protein 2	TCP11X2	Homo sapiens (Human)	protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165]	acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]	acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165]		GO:0001669; GO:0007165; GO:0010737; GO:0036126; GO:1902490	SFSGEVLFR	14.06999969	1	1	0.13436412	1038.414654	0	0	13.29979	0	0	0	7.941629	0	0	15.79668	0	0	12.41518	0	0	0	0	14.8055	0	0	16.71538	0	0	0	14.38695	0	0	0	0	0	0	14.67745	0	0	0	0	14.95051	10.44867	0	0	0	15.83547	15.89391	0	0	0	0	0
Q5H9K5	ZMAT1_HUMAN	Zinc finger matrin-type protein 1	ZMAT1 KIAA1789	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0008270	HLSSENNTADHQAGHK	8.050000191	0.00027706	0.00027706	0.146374797	1744.631878	17.60372	0	0	17.73693	9.00833	0	18.52559	17.64594	15.29016	18.77392	0	14.65449	12.15117	0	14.95243	14.5987	12.75835	15.70451	15.70338	15.53458	17.48203	13.84777	10.12452	18.49166	0	0	0	0	15.97199	15.14275	14.87383	0	0	0	0	0	15.91962	17.46892	16.90053	18.30771	14.28699	0	0	0	0	15.09267	0	17.13797
Q5H9R4	ARMX4_HUMAN	Armadillo repeat-containing X-linked protein 4	ARMCX4	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	ASAQPQIFAK	8.470000267	1	1	0.391632906	1060.947292	0	15.29973	15.59908	0	14.94954	14.64052	0	16.23714	13.61677	14.63037	14.67706	0	15.36621	13.64847	13.90771	16.02565	0	15.33625	15.39328	0	0	0	16.30853	16.25028	0	0	0	13.44946	16.01764	15.67444	0	0	0	0	0	0	16.51287	0	0	0	15.49718	0	0	0	0	15.74044	13.12641	0
Q5H9R7	PP6R3_HUMAN	Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL)	PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3	Homo sapiens (Human)	regulation of phosphoprotein phosphatase activity [GO:0043666]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666]	protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]	GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0019888; GO:0019903; GO:0043666	DLPDEVR	6	1	1	1.15E-13	842.8086679	0	0	15.09536	0	0	0	0	0	0	0	15.07309	0	15.8523	0	15.11516	15.31449	0	0	0	0	0	0	16.53008	0	0	0	15.45027	0	16.54992	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5H9U9	DDX6L_HUMAN	"Probable ATP-dependent RNA helicase DDX60-like, EC 3.6.4.13 (DEAD box protein 60-like)"	DDX60L	Homo sapiens (Human)			ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0016887	FYAYTMESTDR	8.710000038	1	1	0.228740313	1399.167893	12.8569	15.04681	11.53437	0	0	15.68321	0	0	0	12.65242	16.11484	0	0	0	0	0	0	16.46153	0	0	16.6756	17.25012	0	0	16.44517	16.3316	16.01381	0	0	0	0	0	0	15.49589	0	0	18.13633	0	0	0	0	0	0	0	0	0	0	0
Q5HY64	FA47C_HUMAN	Putative protein FAM47C	FAM47C	Homo sapiens (Human)						VSSLCPEPTK	9.220000267	1	1	0.132986383	1117.242859	15.2172	13.22495	17.13699	0	0	0	0	0	0	14.96537	0	12.82931	14.22418	0	14.35313	0	0	0	0	13.8793	13.71036	0	0	0	0	0	13.69384	13.70307	0	0	15.88393	14.22009	15.22791	14.07099	14.28129	14.63159	0	0	0	0	12.70082	0	0	14.52777	15.19899	0	0	13.22581
Q5HY92	FIGN_HUMAN	Fidgetin	FIGN	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule-severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]	GO:0005524; GO:0005737; GO:0005815; GO:0005874; GO:0007049; GO:0008022; GO:0008568; GO:0016363; GO:0016887; GO:0051301	STQSPMYR	12.84000015	1	1	0.401836906	983.933917	17.74358	19.35141	20.53923	0	0	20.35266	0	0	20.22394	17.3538	14.85208	19.38096	18.67052	19.9178	20.42469	18.48548	19.43522	0	19.02336	0	19.93002	20.50945	21.63449	18.72688	0	0	19.46163	0	20.49606	0	20.09005	19.56918	21.23017	20.60247	20.88663	0	0	0	0	18.1239	18.49664	20.28206	19.85893	18.79897	0	0	0	18.70054
Q5HYA8	MKS3_HUMAN	Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67)	TMEM67 MKS3	Homo sapiens (Human)	cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433]	centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]	centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; filamin binding [GO:0031005]; unfolded protein binding [GO:0051082]; cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433]	filamin binding [GO:0031005]; unfolded protein binding [GO:0051082]	GO:0005789; GO:0005813; GO:0010826; GO:0016021; GO:0030433; GO:0030659; GO:0031005; GO:0035869; GO:0036038; GO:0051082; GO:0060170; GO:0060271	EAENLCSQR	3.779999971	1	1	0.028301438	1106.472813	14.11608	12.5767	15.32618	16.0855	12.65787	14.26474	13.27003	12.80828	12.53854	0	12.79612	14.67866	0	0	14.43989	14.28144	0	0	13.7901	0	0	0	16.10016	0	0	0	0	0	13.44554	14.49345	14.80621	0	0	0	0	0	0	0	0	0	0	14.47628	9.364709	0	0	14.31073	12.91912	0
Q5HYC2	K2026_HUMAN	Uncharacterized protein KIAA2026	KIAA2026	Homo sapiens (Human)						VPVPPPVPTVSLTSVIK	3.279999971	1	1	9.19E-13	1724.999255	0	0	15.27835	0	0	0	0	0	0	0	0	0	0	0	14.57838	15.72668	0	14.64089	15.84825	14.27361	0	0	0	0	13.65137	14.56451	0	0	0	0	0	0	0	0	0	0	13.21404	0	0	0	0	0	0	0	0	0	0	0
Q5HYJ1	TECRL_HUMAN	"Trans-2,3-enoyl-CoA reductase-like, EC 1.3.1.- (Steroid 5-alpha-reductase 2-like 2 protein)"	TECRL SRD5A2L2	Homo sapiens (Human)	very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	"endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; very long-chain fatty acid biosynthetic process [GO:0042761]"	"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]"	GO:0005783; GO:0016021; GO:0016491; GO:0016627; GO:0042761	KSAMIPFIL	11.21000004	1	1	0.146750325	1022.040439	0	14.23131	13.14004	14.76008	16.09352	0	0	15.16602	0	0	15.73107	14.20231	0	0	16.80189	0	0	15.47742	0	0	15.40841	16.29355	0	0	0	0	11.12846	0	17.48596	13.15864	15.98535	0	0	0	0	0	0	0	0	14.97218	14.00941	0	0	0	0	0	0	0
Q5HYK3	COQ5_HUMAN	"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, EC 2.1.1.201 (Ubiquinone biosynthesis methyltransferase COQ5)"	COQ5	Homo sapiens (Human)	methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142]	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142]; 2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0043430]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]"	"2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0043430]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]"	GO:0005743; GO:0005759; GO:0006744; GO:0008168; GO:0031314; GO:0032259; GO:0032991; GO:0043333; GO:0043430; GO:0110142	FLCLEFSQVNNPLISR	4.659999847	1	1	0.430471231	1936.036795	0	0	0	0	0	0	0	0	0	18.84968	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.85803	0	0	0	18.48034	0	0	0	0	0	0	0
Q5HYK9	ZN667_HUMAN	Zinc finger protein 667	ZNF667	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872	SGQSICQK	5.5	0.721264124	0.721264124	0.096668399	908.4534757	0	13.6997	0	0	0	0	14.58054	0	16.32063	0	12.1456	0	0	0	0	0	0	0	0	0	0	0	0	0	16.27418	0	0	16.53074	0	0	18.37306	16.16929	16.97864	0	0	16.01019	0	0	0	0	0	0	0	0	0	15.10985	0	0
Q5HYW2	NHSL2_HUMAN	NHS-like protein 2	NHSL2	Homo sapiens (Human)	cell differentiation [GO:0030154]		cell differentiation [GO:0030154]		GO:0030154	KKPSPPTR	8.56000042	1	1	0.081083408	911.1391043	14.52411	0	12.35066	13.62611	14.84301	0	0	0	0	17.02361	12.88738	15.6486	13.12817	13.52985	0	0	12.72241	13.31882	0	0	0	0	0	0	16.41521	0	0	0	0	0	0	0	0	0	0	15.7687	0	0	0	16.28061	0	0	0	0	0	0	0	0
Q5HYW3	RTL5_HUMAN	Retrotransposon Gag-like protein 5 (Retrotransposon gag domain-containing protein 4)	RTL5 KIAA2001 RGAG4	Homo sapiens (Human)						ALAEVNSLR	6.380000114	0.194737539	0.194737539	0.233565884	972.0587671	0	0	16.50352	15.89627	0	0	14.39063	0	9.765297	0	0	0	12.12887	0	16.94625	0	14.88115	0	0	0	0	0	0	0	15.27793	0	16.56174	11.39043	13.0154	14.94187	15.54529	15.29104	16.79148	11.59643	12.68868	0	0	15.40592	0	10.07718	11.79824	16.41264	0	16.31071	0	0	0	14.48027
Q5IJ48	CRUM2_HUMAN	Protein crumbs homolog 2 (Crumbs-like protein 2)	CRB2	Homo sapiens (Human)	circulatory system development [GO:0072359]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; photoreceptor cell maintenance [GO:0045494]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; retinal cone cell development [GO:0046549]; somitogenesis [GO:0001756]; visual perception [GO:0007601]	apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]	apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; circulatory system development [GO:0072359]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; photoreceptor cell maintenance [GO:0045494]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; retinal cone cell development [GO:0046549]; somitogenesis [GO:0001756]; visual perception [GO:0007601]	aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]	GO:0001707; GO:0001756; GO:0001895; GO:0005509; GO:0005737; GO:0005886; GO:0007157; GO:0007601; GO:0010470; GO:0010718; GO:0010951; GO:0014028; GO:0016021; GO:0016324; GO:0016327; GO:0019828; GO:0030010; GO:0030513; GO:0032991; GO:0035003; GO:0043296; GO:0044877; GO:0045197; GO:0045199; GO:0045494; GO:0046549; GO:0050896; GO:0055111; GO:0070062; GO:0072359	NGSLAGGVR	5.739999771	1	1	0.146580394	829.8879019	15.95049	0	0	0	0	0	15.84029	0	0	0	14.39018	16.33348	0	0	0	14.29345	0	0	0	0	0	0	16.0551	0	0	0	16.12363	0	0	0	0	0	18.59614	0	0	0	0	16.37083	0	0	0	0	0	0	0	0	0	0
Q5JNZ3	ZN311_HUMAN	Zinc finger protein 311 (Zinc finger protein zfp-31)	ZNF311 ZFP31	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	NLNPNSKHSQCNK	3.579999924	1	1	0.271784021	1541.075775	0	0	13.01491	14.14127	0	0	15.98184	0	14.99268	0	14.4672	0	0	0	0	0	0	0	16.48527	0	0	0	0	0	0	0	0	0	0	14.06235	14.65448	0	0	0	0	0	16.23661	0	0	0	0	0	0	0	0	16.81033	13.20066	0
Q5JPB2	ZN831_HUMAN	Zinc finger protein 831	ZNF831 C20orf174	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	ATPLHPAAPAPAEHPSLATPPQAPR	10.96000004	0.883595943	0.883595943	3.66E-12	2495.605407	0	0	0	0	18.22453	0	16.6676	0	0	17.68869	0	0	0	0	0	16.04449	14.04867	0	0	0	0	17.19053	16.42322	0	15.13904	0	14.35416	0	0	0	0	17.56693	0	0	0	0	16.83333	11.54503	13.92317	16.154	0	15.87226	0	15.17528	0	0	16.11911	0
Q5JPF3	AN36C_HUMAN	Ankyrin repeat domain-containing protein 36C (Protein immuno-reactive with anti-PTH polyclonal antibodies)	ANKRD36C	Homo sapiens (Human)			ion channel inhibitor activity [GO:0008200]	ion channel inhibitor activity [GO:0008200]	GO:0008200	DGEISRTVTSEKPAGLK	9.989999771	1	1	2.35E-13	1787.271801	16.7393	9.859726	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5JQC9	AKAP4_HUMAN	"A-kinase anchor protein 4, AKAP-4 (A-kinase anchor protein 82 kDa, AKAP 82, hAKAP82) (Major sperm fibrous sheath protein, HI) (Protein kinase A-anchoring protein 4, PRKA4)"	AKAP4 AKAP82	Homo sapiens (Human)	establishment of protein localization [GO:0045184]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; protein localization [GO:0008104]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; Z disc [GO:0030018]	cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; Z disc [GO:0030018]; protein kinase A binding [GO:0051018]; establishment of protein localization [GO:0045184]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; protein localization [GO:0008104]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]	protein kinase A binding [GO:0051018]	GO:0005634; GO:0005737; GO:0005856; GO:0005952; GO:0007165; GO:0007178; GO:0007338; GO:0008104; GO:0030018; GO:0030317; GO:0031514; GO:0035686; GO:0044458; GO:0045184; GO:0048471; GO:0051018; GO:0097224; GO:0097225; GO:0097228; GO:0097229	AAEKGYSVGGLLQEVMK	5.519999981	0.2339544	0.2339544	0.009133103	1795.917671	16.0814	0	0	0	0	14.88938	12.90465	0	0	11.73989	11.54409	0	0	0	13.40232	14.26217	0	0	16.08677	0	13.79668	12.25853	15.45293	0	16.04718	0	0	0	13.72862	0	0	15.12577	0	0	15.30967	0	0	17.31108	0	0	15.86413	0	13.90762	15.46636	15.33032	0	0	15.82092
Q5JQF8	PAP1M_HUMAN	Polyadenylate-binding protein 1-like 2 (RNA-binding motif protein 32) (RNA-binding protein 32)	PABPC1L2A PABPC1L2 RBM32A; PABPC1L2B PABPC1L2 RBM32B	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0070062	ALETLNFDVIKGRPVR	9.850000381	1	1	0.272392204	1828.271845	13.46462	0	13.45287	0	15.84674	12.89053	14.6074	16.44789	0	13.74915	0	0	14.03759	0	15.37562	0	0	0	0	0	0	0	0	0	0	0	0	16.46011	0	0	0	0	0	0	15.61688	0	0	0	0	0	0	0	15.74682	0	15.29326	15.86406	0	0
Q5JR59	MTUS2_HUMAN	"Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150, Tracking protein of 150 kDa)"	MTUS2 CAZIP KIAA0774 TIP150	Homo sapiens (Human)		cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]	microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0005874; GO:0008017; GO:0015630; GO:0042803; GO:0045171	AAGGDLKPSANLYEK	3.099999905	1	1	0.327135601	1534.209753	0	0	18.08704	0	17.43103	0	18.83707	0	19.45184	0	0	17.99357	14.2007	0	0	0	18.57003	0	0	0	17.05698	0	0	0	0	18.71223	0	0	0	0	19.69838	0	0	0	18.99626	0	18.71555	0	18.12633	0	0	0	0	0	0	0	16.78728	0
Q5JR98	DYLT4_HUMAN	Dynein light chain Tctex-type 4 (Protein N22.1) (Tctex-2-beta) (Tctex1 domain-containing protein 4)	DYNLT4 TCTEX1D4	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]	acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; dynein intermediate chain binding [GO:0045505]; protein phosphatase 1 binding [GO:0008157]; microtubule-based movement [GO:0007018]	dynein intermediate chain binding [GO:0045505]; protein phosphatase 1 binding [GO:0008157]	GO:0001669; GO:0005634; GO:0005737; GO:0005815; GO:0005868; GO:0005930; GO:0007018; GO:0008157; GO:0036126; GO:0045505	GSMLGLAASFSRR	3.150000095	0.058475059	0.058475059	0.037793825	1367.814898	13.83119	0	0	0	0	0	0	14.95438	0	0	0	0	0	0	0	0	15.43815	0	0	15.73779	0	16.56923	0	16.10446	0	13.48398	0	16.43828	15.64807	15.77713	16.09383	15.93791	0	0	0	0	0	0	0	0	0	17.05822	0	0	0	0	0	0
Q5JRA6	TGO1_HUMAN	"Transport and Golgi organization protein 1 homolog, TANGO1 (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3)"	MIA3 KIAA0268 TANGO UNQ6077/PRO20088	Homo sapiens (Human)	cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cargo receptor activity [GO:0038024]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060]	cargo receptor activity [GO:0038024]	GO:0002042; GO:0002687; GO:0005788; GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0007162; GO:0009306; GO:0015031; GO:0016020; GO:0016021; GO:0030336; GO:0035459; GO:0038024; GO:0042060; GO:0042953; GO:0043231; GO:0070971; GO:0070973; GO:0090110; GO:0140052; GO:1903038; GO:2000402	EAANLR	7.300000191	1	1	0.083025968	673.3921675	14.90854	14.07247	15.65767	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.19843	0	0	15.87822	0	0	0	16.25194	0	0	0	16.27033	15.57949	0	15.5647	14.00127	16.29886	0	0	0	0	0	0	0	0	0	0	0	0
Q5JRK9	GGEE3_HUMAN	"Putative G antigen family E member 3 (Prostate-associated gene 2B protein, PAGE-2B)"	PAGE2B GAGEE3	Homo sapiens (Human)						VLEAGDAQP	4.889999866	1	1	0.237274733	899.2687976	15.26287	14.72305	0	12.82096	15.30634	0	0	13.88821	12.90956	9.370031	17.09719	0	14.95541	0	17.2241	15.1131	15.20032	16.3702	14.63898	16.00386	15.83633	16.98502	16.06371	16.15765	0	0	14.93418	15.03576	13.84539	15.38003	15.85464	17.88218	14.4914	16.25049	14.38923	12.84253	0	0	16.45547	0	0	0	0	0	15.09667	8.824966	15.03834	16.29464
Q5JRX3	PREP_HUMAN	"Presequence protease, mitochondrial, hPreP, EC 3.4.24.- (Pitrilysin metalloproteinase 1, Metalloprotease 1, hMP1)"	PITRM1 KIAA1104 MP1 PREP	Homo sapiens (Human)	protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]	enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006626; GO:0008047; GO:0008237; GO:0008270; GO:0016485	LTLSMRPDDK	5.489999771	1	1	0.266947723	1191.09798	13.13021	13.36145	12.6768	13.15642	12.27826	0	16.77687	13.23769	0	16.43623	13.62821	12.68709	0	0	14.73625	15.40164	13.21237	0	15.31246	0	15.81283	0	0	0	0	17.24827	0	14.16103	0	0	0	0	0	0	0	0	16.38564	0	0	0	17.56554	15.5003	14.03406	0	15.99932	17.00673	0	15.09194
Q5JS13	RGPS1_HUMAN	"Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2, RalGEF 2) (RalA exchange factor RalGPS1)"	RALGPS1 KIAA0351 RALGEF2	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005737; GO:0005886; GO:0007265; GO:0032485; GO:0035556; GO:0043547	ARHLLDDSVLESR	10.43000031	1	1	0.265072455	1509.612649	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.65658	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5JS37	NHLC3_HUMAN	NHL repeat-containing protein 3	NHLRC3	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]	azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]	azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005576; GO:0035578; GO:0043161; GO:0061630	GDNIPK	13.65999985	0.760124981	0.760124981	0.038870859	643.5678801	0	0	16.95095	0	16.04494	17.35154	0	11.59948	0	0	0	0	14.83866	13.63763	14.79263	0	12.07471	0	16.43811	0	14.61477	15.77437	17.38993	16.78189	0	18.84275	0	10.38368	0	0	13.16987	0	0	14.65961	0	12.72053	0	0	15.70543	13.39091	0	11.62759	0	0	9.684146	17.18761	0	0
Q5JSH3	WDR44_HUMAN	WD repeat-containing protein 44 (Rabphilin-11)	WDR44 RPH11	Homo sapiens (Human)		cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]		GO:0005794; GO:0005829; GO:0010008; GO:0048471	VVQDLSGEHMGAVWTMK	6.989999771	1	1	0.168550743	1903.950496	0	0	0	15.12696	13.63929	14.40739	16.49903	13.93364	14.79706	13.47206	0	14.55924	14.54314	0	15.98264	0	0	15.65576	0	0	0	15.49663	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.21952	0	0
Q5JSJ4	INT6L_HUMAN	Integrator complex subunit 6-like (Protein DDX26B)	INTS6L DDX26B	Homo sapiens (Human)	snRNA 3'-end processing [GO:0034472]	integrator complex [GO:0032039]	integrator complex [GO:0032039]; snRNA 3'-end processing [GO:0034472]		GO:0032039; GO:0034472	GMMIDEADEFVAGPQNKVK	1.460000038	1	1	0.142820706	2093.858596	17.72932	16.14836	14.88478	14.73275	13.76948	14.89549	7.801178	0	0	11.67604	15.42298	0	13.70368	0	14.58404	0	0	0	14.65421	0	15.8614	14.97313	17.57178	16.38205	0	0	0	0	15.81269	0	16.01788	18.25353	13.41493	0	0	0	13.59708	13.64991	15.60271	15.66578	0	0	0	12.90452	0	14.95458	16.97238	17.14676
Q5JSL3	DOC11_HUMAN	"Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor, ACG) (Zizimin-2)"	DOCK11 ZIZ2	Homo sapiens (Human)	B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0001782; GO:0002315; GO:0005085; GO:0005829; GO:0007264; GO:0031267; GO:0043547; GO:0051491	ETEQLNK	7.550000191	1	1	0.251580111	858.4977619	0	0	15.85042	15.79887	14.37805	14.81095	0	0	0	0	0	12.4852	15.6799	0	0	0	0	0	0	0	0	0	15.76284	0	0	14.72694	12.87923	0	14.1156	14.09928	14.75983	16.30688	15.05499	0	0	0	0	0	0	0	0	0	0	16.5211	12.59	15.58356	10.64845	0
Q5JSP0	FGD3_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 3 (Zinc finger FYVE domain-containing protein 5)"	FGD3 ZFYVE5	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]	GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872; GO:0051056	MESGRGSSTPPGPIAALGMPDTGPGSSSLGK	4.599999905	1	1	4.13E-12	2915.054198	14.91265	0	0	0	0	16.05155	13.8091	0	0	15.12654	0	0	0	0	0	12.93156	0	0	13.39938	0	13.80661	0	11.94697	0	11.71288	0	0	0	0	11.82957	0	0	0	0	0	0	0	14.62166	0	13.14084	0	0	13.80557	0	10.98093	0	0	0
Q5JST6	EFHC2_HUMAN	EF-hand domain-containing family member C2	EFHC2	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of neuron projection development [GO:0010975]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of neuron projection development [GO:0010975]	alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]	GO:0000281; GO:0005509; GO:0005930; GO:0007052; GO:0010975; GO:0036064; GO:0043014; GO:0060285; GO:0072686; GO:1990830	DSYGSK	10.15999985	0.042415351	0.042415351	0.184516341	657.5166423	16.59557	13.87803	16.66072	15.48309	17.13968	16.64716	0	15.96045	14.75222	16.24277	16.0831	14.94784	16.3309	16.01786	16.9723	14.96253	15.77631	16.10765	15.94639	16.37101	16.44232	17.05227	18.30602	16.79675	0	16.31403	16.175	15.41929	16.30572	14.46396	15.87948	15.52836	15.80294	17.02349	16.06833	16.58036	16.49967	17.80131	17.3081	16.44705	15.42977	16.81278	16.40481	0	16.36525	16.50543	16.20626	0
Q5JTD0	TJAP1_HUMAN	Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4)	TJAP1 PILT TJP4	Homo sapiens (Human)	Golgi organization [GO:0007030]	bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Golgi organization [GO:0007030]		GO:0005794; GO:0005802; GO:0005886; GO:0005923; GO:0007030	MTSAAPAKKPYR	2.74000001	1	1	0.159301638	1320.166308	15.27496	0	15.53246	0	0	0	0	0	0	0	0	0	0	0	0	14.96165	0	0	0	13.04839	16.01285	12.41398	14.82005	0	0	0	0	0	0	0	0	15.09306	0	0	0	0	17.18901	0	0	15.54294	15.74755	16.06514	0	0	0	16.10361	0	0
Q5JTD7	LRC73_HUMAN	Leucine-rich repeat-containing protein 73	LRRC73 C6orf154	Homo sapiens (Human)						LPSSIQISGEPLSGAEVR	5.659999847	0.154029697	0.154029697	0.390056006	1843.725012	0	15.58188	0	15.65628	16.00562	16.33675	0	15.10943	0	0	0	0	0	16.38933	15.46533	0	0	0	0	13.81834	0	0	0	0	0	17.57976	0	0	0	0	0	0	0	0	0	0	0	17.03438	0	0	18.1115	15.28316	16.42872	0	0	0	0	0
Q5JTH9	RRP12_HUMAN	RRP12-like protein	RRP12 KIAA0690	Homo sapiens (Human)	rRNA processing [GO:0006364]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]	GO:0003723; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0016021; GO:0031965; GO:0043231	LYSTIRPYLESKAHGVQK	14.84000015	0.267957985	0.267957985	0.285644533	2089.173212	15.07878	0	0	0	18.42634	17.78488	17.01044	20.10204	18.82707	15.58206	17.33255	18.70227	12.82854	18.1291	16.67527	18.11105	0	17.42185	16.15425	0	17.1237	0	13.38828	0	15.93793	0	19.02056	0	17.97784	14.50062	18.64826	18.07579	18.30223	0	0	0	19.19225	19.88107	17.62098	16.50014	12.85666	18.04952	0	15.49698	17.99335	17.12041	17.65335	17.99656
Q5JTN6	WDR38_HUMAN	WD repeat-containing protein 38	WDR38	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]		hematopoietic progenitor cell differentiation [GO:0002244]		GO:0002244	MNSGVPATLAVR	2.470000029	1	1	0.312844056	1231.256747	16.51703	0	0	13.95548	13.95115	14.69197	0	15.65268	15.21564	0	0	13.03182	15.03723	0	0	0	16.0066	0	0	15.66542	0	15.30269	0	0	14.56386	0	0	0	0	0	0	0	15.3377	0	15.56705	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5JTV8	TOIP1_HUMAN	"Torsin-1A-interacting protein 1 (Lamin-associated protein 1B, LAP1B)"	TOR1AIP1 LAP1	Homo sapiens (Human)	membrane organization [GO:0061024]; nuclear membrane organization [GO:0071763]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; lamin binding [GO:0005521]; membrane organization [GO:0061024]; nuclear membrane organization [GO:0071763]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; lamin binding [GO:0005521]	GO:0001671; GO:0005521; GO:0005634; GO:0005637; GO:0008092; GO:0016020; GO:0016021; GO:0031965; GO:0032781; GO:0034504; GO:0051117; GO:0061024; GO:0071763; GO:0090435	SDSAKEEVR	3.450000048	1	1	0.095990246	1019.48378	18.1228	0	0	0	0	0	0	0	0	16.77981	14.22392	0	14.98852	15.53907	0	0	0	0	0	14.33081	0	15.43541	0	0	0	0	0	0	0	0	0	0	12.85072	0	0	14.48702	0	14.80395	0	0	0	0	13.69594	0	0	0	0	0
Q5JTW2	CEP78_HUMAN	"Centrosomal protein of 78 kDa, Cep78"	CEP78 C9orf81	Homo sapiens (Human)	cilium organization [GO:0044782]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; cilium organization [GO:0044782]		GO:0005813; GO:0005814; GO:0005829; GO:0036064; GO:0044782	MCSPSPDATSGTGSQRK	1.600000024	1	1	0.4419634	1781.971938	16.81617	12.74844	15.01932	0	0	0	0	0	0	0	0	18.44368	0	17.11468	0	0	0	17.18068	0	0	0	0	0	0	18.80358	0	19.66808	0	0	0	20.48009	19.99535	19.92168	0	19.49179	0	20.07228	0	0	0	0	0	0	0	0	17.42229	0	0
Q5JU85	IQEC2_HUMAN	IQ motif and SEC7 domain-containing protein 2	IQSEC2 KIAA0522	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ARF protein signal transduction [GO:0032012]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]	cytoplasm [GO:0005737]; Schaffer collateral - CA1 synapse [GO:0098685]	cytoplasm [GO:0005737]; Schaffer collateral - CA1 synapse [GO:0098685]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ARF protein signal transduction [GO:0032012]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005737; GO:0030036; GO:0032012; GO:0050804; GO:0098685; GO:0098696	GPPGR	3.599999905	0.143695548	0.143695548	0.290775369	481.0312145	16.26682	15.67366	16.23034	15.56405	12.97992	0	14.68883	16.49963	15.62048	16.01374	15.7709	15.96461	0	0	15.25087	15.8424	14.58704	16.05201	15.86643	0	0	15.36827	16.62061	0	16.13569	15.41248	15.64055	15.92658	15.30504	0	15.28004	0	0	0	16.94337	0	0	16.45115	15.12825	15.1646	0	15.03504	16.09367	16.67092	15.23544	17.46214	0	0
Q5JUK3	KCNT1_HUMAN	Potassium channel subfamily T member 1 (KCa4.1)	KCNT1 KIAA1422	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271]	intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271]	GO:0005228; GO:0005886; GO:0015271; GO:0016021	APKQAGR	6.210000038	1	1	0.163457298	728.7697219	0	15.93621	14.32655	0	0	0	0	0	0	0	0	0	0	15.6336	0	0	0	15.11034	0	0	0	0	0	17.21834	0	0	14.2141	15.74234	0	14.01671	0	0	0	0	0	0	16.94291	17.06272	0	0	17.18324	0	15.75308	0	0	0	0	0
Q5JUR7	TEX30_HUMAN	Testis-expressed protein 30	TEX30 C13orf27	Homo sapiens (Human)			hydrolase activity [GO:0016787]	hydrolase activity [GO:0016787]	GO:0016787	MQAPHKIHWIEK	27.03000069	0.000689835	0.000689835	0.220488773	1532.82913	21.15711	16.32931	0	19.86873	15.14042	0	17.6597	21.31096	18.94238	0	21.35679	20.81112	22.34649	20.67843	21.43239	0	0	17.17115	22.05924	20.36659	20.42982	17.78941	22.18701	21.14532	20.63305	21.38129	20.53271	19.7366	20.39002	20.97482	19.91807	21.3768	0	22.00254	20.30237	21.17376	0	20.69159	18.29226	18.54381	0	17.52155	22.00191	21.17759	21.37775	21.34727	21.53622	19.94348
Q5JUX0	SPIN3_HUMAN	"Spindlin-3 (Spindlin-like protein 3, SPIN-3)"	SPIN3	Homo sapiens (Human)	"gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; methylated histone binding [GO:0035064]; gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]"	methylated histone binding [GO:0035064]	GO:0005654; GO:0005829; GO:0006355; GO:0007276; GO:0035064	AAAGQRSR	12.60000038	1	1	5.73E-13	815.6547854	0	0	12.16453	14.25578	14.59232	12.8092	0	0	14.77422	0	15.69636	15.51733	0	13.80601	15.51985	12.94936	12.38947	13.96835	0	13.47023	0	0	0	0	0	0	15.9421	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.67763
Q5JV73	FRPD3_HUMAN	FERM and PDZ domain-containing protein 3	FRMPD3 KIAA1817	Homo sapiens (Human)		cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]	cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]		GO:0005856; GO:0005886; GO:0030667; GO:0070821	KGGKPGSSR	3.519999981	0.628057182	0.628057182	0.022093267	873.4662439	14.00918	16.96991	16.42058	17.59546	0	13.20748	15.26779	13.8799	0	16.01178	16.54412	14.14875	16.13033	12.76755	13.90695	16.0334	16.40936	15.98274	0	15.22981	14.66979	15.73906	15.17785	14.81755	16.36044	17.05656	14.67694	15.99148	10.39747	17.25882	15.39419	17.00827	18.07518	15.3243	19.00167	15.34758	13.11499	15.6973	17.2366	17.74522	14.25727	14.80877	0	13.89585	15.72726	17.20918	16.62107	15.06674
Q5JVF3	PCID2_HUMAN	PCI domain-containing protein 2 (CSN12-like protein)	PCID2 HT004	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear mRNA surveillance [GO:0071028]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	"cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear mRNA surveillance [GO:0071028]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]	GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045579; GO:0045893; GO:0048536; GO:0070390; GO:0071028; GO:0090267; GO:2000117	SKVGDMLEK	7.039999962	1	1	0.155607971	1022.360965	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.37238	0	0	0	0	0	18.8854	0	0	0	0	0	0	0	0	0	0
Q5JVS0	HABP4_HUMAN	"Intracellular hyaluronan-binding protein 4, IHABP-4, IHABP4 (Hyaluronan-binding protein 4) (Ki-1/57 intracellular antigen)"	HABP4	Homo sapiens (Human)	cellular response to mechanical stimulus [GO:0071260]; mRNA processing [GO:0006397]; negative regulation of DNA binding [GO:0043392]; PML body organization [GO:0030578]; positive regulation of RNA splicing [GO:0033120]; positive regulation of translational initiation [GO:0045948]; RNA splicing [GO:0008380]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Gemini of coiled bodies [GO:0097504]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sarcomere [GO:0030017]; sarcoplasm [GO:0016528]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Gemini of coiled bodies [GO:0097504]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sarcomere [GO:0030017]; sarcoplasm [GO:0016528]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; cellular response to mechanical stimulus [GO:0071260]; mRNA processing [GO:0006397]; negative regulation of DNA binding [GO:0043392]; PML body organization [GO:0030578]; positive regulation of RNA splicing [GO:0033120]; positive regulation of translational initiation [GO:0045948]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]; SUMO binding [GO:0032183]	GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0010494; GO:0015030; GO:0016528; GO:0016607; GO:0030017; GO:0030578; GO:0031965; GO:0032183; GO:0033120; GO:0043392; GO:0045948; GO:0071260; GO:0097504	DEAAAAAGAGPR	8.43999958	0.857553422	0.857553422	0.198626345	1055.407203	13.22871	15.33075	15.04682	10.78734	0	0	0	16.12965	0	15.99402	15.40036	0	0	14.82665	15.8135	0	0	0	16.72029	14.81404	13.7531	14.81787	13.92086	14.30289	0	0	0	0	14.49212	14.90519	15.0988	15.58187	14.89091	15.18655	14.3464	14.48168	0	0	16.43357	0	0	0	0	13.01621	0	8.09767	0	16.05609
Q5JVX7	CA141_HUMAN	Uncharacterized protein C1orf141	C1orf141	Homo sapiens (Human)						INRLQSEGR	3.809999943	0.547834814	0.547834814	0.197893727	1073.326464	14.58744	16.77176	0	15.57455	16.00134	13.94284	17.24385	16.04793	15.43066	16.14678	15.65166	14.35203	0	15.10444	14.99219	0	15.52205	15.12001	0	15.68742	0	0	16.35614	16.62466	15.49541	0	15.90148	14.63308	14.77076	16.26121	11.00222	15.67961	13.73573	15.15181	14.89908	14.97325	16.25457	15.48249	13.20736	16.13825	15.36226	0	13.70842	14.94083	15.95711	16.11824	13.61907	14.10261
Q5JW98	CAHM4_HUMAN	Calcium homeostasis modulator protein 4 (Protein FAM26D)	CALHM4 C6orf78 FAM26D UNQ6481/PRO21277	Homo sapiens (Human)		integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]	cation channel activity [GO:0005261]	GO:0005261; GO:0005887	ISPLECK	6.849999905	1	1	0.09124467	848.370582	14.26321	13.08471	15.30814	0	0	14.285	0	0	0	0	0	0	0	0	0	0	0	16.19909	0	0	0	0	0	0	0	0	15.30788	0	0	0	15.08334	14.64012	0	0	0	0	0	13.14505	0	16.25584	0	14.13945	0	0	0	0	0	0
Q5JX71	F209A_HUMAN	Protein FAM209A	FAM209A C20orf106	Homo sapiens (Human)		extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]		GO:0005634; GO:0005637; GO:0016021; GO:0070062	AMATGSGSNLR	2.859999895	1	1	0.073472623	1064.177985	17.536	10.97559	15.97162	14.00453	14.0611	0	0	12.99382	0	0	14.79351	15.92326	0	14.05483	0	0	0	14.68542	13.79189	0	0	0	16.23944	14.51474	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5JY77	GASP1_HUMAN	"G-protein coupled receptor-associated sorting protein 1, GASP-1"	GPRASP1 GASP KIAA0443	Homo sapiens (Human)	endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172]	cytosol [GO:0005829]	cytosol [GO:0005829]; endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172]		GO:0005829; GO:0008333; GO:1990172	KETVFSDDDFNIEPLISAFHK	3.430000067	1	1	2.75E-12	2451.725444	0	13.90431	14.1353	0	14.89981	13.41869	13.97959	0	13.51973	0	0	14.30256	0	0	13.82413	0	0	14.72552	14.21439	0	12.33853	0	15.24927	0	13.46085	12.9481	13.79598	13.86563	14.77485	14.06536	14.39384	16.23897	0	0	0	0	0	17.29439	0	0	0	0	0	0	0	0	16.15011	0
Q5JYT7	K1755_HUMAN	Uncharacterized protein KIAA1755	KIAA1755	Homo sapiens (Human)						IACLPGGRDR	8.090000153	1	1	0.176813568	1115.294567	13.97589	14.65144	0	0	15.5159	12.89768	0	0	15.60365	0	14.97367	0	13.78111	12.95242	14.69951	0	12.40799	14.70737	0	0	0	0	0	0	0	0	14.45743	13.72849	14.03037	8.158913	14.54458	13.47296	14.17314	0	0	15.05363	0	0	0	14.79824	0	0	0	0	0	14.6117	0	14.05174
Q5JZY3	EPHAA_HUMAN	"Ephrin type-A receptor 10, EC 2.7.10.1"	EPHA10	Homo sapiens (Human)	axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]	GO:0004712; GO:0004714; GO:0005005; GO:0005524; GO:0005576; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0016021; GO:0033674; GO:0043005; GO:0043235	ELDAKSVTLER	6.400000095	1	1	0.339492789	1260.118195	0	0	0	0	15.35654	0	0	12.85071	0	0	0	16.19664	16.92958	0	16.80286	16.51765	16.07785	14.76742	16.18638	0	0	0	0	0	0	14.60685	0	16.16382	0	16.21507	0	17.14627	0	0	0	0	0	0	0	0	15.44292	0	16.34431	0	0	16.60099	0	0
Q5K651	SAMD9_HUMAN	"Sterile alpha motif domain-containing protein 9, SAM domain-containing protein 9"	SAMD9 C7orf5 DRIF1 KIAA2004 OEF1	Homo sapiens (Human)	endosomal vesicle fusion [GO:0034058]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058]		GO:0005737; GO:0005829; GO:0034058; GO:0043231	IDQCFK	16.45999908	0.359456271	0.359456271	0.202918681	811.3735955	15.8943	0	15.54891	0	0	0	0	15.59404	0	15.95296	0	0	15.94344	0	0	15.51027	15.4746	15.55442	17.4341	0	0	15.97408	0	16.70689	14.2909	0	16.56477	17.22922	0	0	16.77841	16.51776	16.08317	13.83801	16.46594	14.37276	0	16.19586	15.52169	14.87957	0	16.15411	16.14734	15.75277	0	13.11352	15.66585	0
Q5KSL6	DGKK_HUMAN	"Diacylglycerol kinase kappa, DAG kinase kappa, DGK-kappa, EC 2.7.1.107 (142 kDa diacylglycerol kinase) (Diglyceride kinase kappa)"	DGKK	Homo sapiens (Human)	diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to oxidative stress [GO:0006979]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to oxidative stress [GO:0006979]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0004143; GO:0005524; GO:0005886; GO:0006979; GO:0007205; GO:0030168; GO:0035556; GO:0046339; GO:0046834; GO:0046872	TIQQGEIYK	5.460000038	1	1	0.193664905	1079.46718	0	14.45577	15.91026	0	14.86444	0	0	15.70238	0	0	14.71681	13.42874	0	14.09417	0	12.71361	0	18.04309	15.56867	16.27341	0	14.02521	0	0	0	16.90171	16.8518	0	15.17594	0	0	17.43838	0	16.29968	15.92294	0	0	16.01969	0	15.02261	0	0	0	17.58333	0	15.37558	0	0
Q5KU26	COL12_HUMAN	"Collectin-12 (Collectin placenta protein 1, CL-P1, hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin)"	COLEC12 CLP1 NSR2 SCARA4 SRCL	Homo sapiens (Human)	"carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; plasma membrane raft organization [GO:0044857]; toll-like receptor 3 signaling pathway [GO:0034138]"	collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; plasma membrane raft organization [GO:0044857]; toll-like receptor 3 signaling pathway [GO:0034138]"	galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005534; GO:0005581; GO:0005615; GO:0005886; GO:0006910; GO:0006952; GO:0009756; GO:0016021; GO:0030169; GO:0030666; GO:0031012; GO:0034138; GO:0038187; GO:0042742; GO:0044857; GO:0045087; GO:0046872; GO:0071360	CYYFSVEK	5	1	1	0.125914575	1096.73582	13.71965	14.80389	13.84868	0	14.38979	13.58186	15.26561	12.62927	0	0	0	0	13.93638	14.93042	14.19279	12.71715	0	13.62405	0	0	12.8241	0	0	0	0	15.6495	0	0	0	13.91382	0	0	16.25541	0	15.07037	0	0	0	0	0	0	14.4756	12.13232	0	0	0	15.99346	0
Q5M775	CYTSB_HUMAN	"Cytospin-B (Nuclear structure protein 5, NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1)"	SPECC1 CYTSB NSP5	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824]	apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]	apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824]		GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177	SVSSPTSSNTPTPTKHLR	5.539999962	1	1	0	1892.926883	0	0	0	0	0	13.71824	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.01484	0	16.22008	16.67496	0	0	0	0	0	16.28008	0	0	0	0	0	0
Q5M7Z0	RNFT1_HUMAN	"E3 ubiquitin-protein ligase RNFT1, EC 2.3.2.27 (Protein PTD016) (RING finger and transmembrane domain-containing protein 1)"	RNFT1 PTD016	Homo sapiens (Human)	positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865]	metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]	GO:0005783; GO:0005789; GO:0016021; GO:0043130; GO:0046872; GO:0051865; GO:0061630; GO:1904294	ECAENASSRNIR	8.239999771	1	1	0.411461532	1406.580752	15.80665	0	18.74233	0	0	0	17.76847	0	0	0	0	0	0	0	0	18.17401	18.56263	0	0	0	0	0	17.9918	0	0	18.18176	0	0	0	0	0	0	18.08692	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5M8T2	S35D3_HUMAN	Solute carrier family 35 member D3 (Fringe connection-like protein 1)	SLC35D3 FRCL1	Homo sapiens (Human)	carbohydrate transport [GO:0008643]; energy homeostasis [GO:0097009]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]; energy homeostasis [GO:0097009]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]	antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]	GO:0005461; GO:0005462; GO:0005463; GO:0005769; GO:0005783; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0070863; GO:0097009	FMETR	2.269999981	0.414923251	0.414923251	0.272795197	682.9949045	16.20916	15.2856	14.11642	0	0	0	15.79806	16.27	0	0	0	0	14.53904	16.46131	0	0	0	16.34085	0	0	16.24577	16.68771	16.76935	0	0	15.82524	14.6467	0	16.18871	14.91052	15.98881	0	0	15.62642	15.73048	16.77291	0	15.97564	15.70395	16.13424	11.47008	0	14.65948	15.97827	14.32436	16.97096	17.73511	17.0235
Q5M9N0	CD158_HUMAN	Coiled-coil domain-containing protein 158	CCDC158	Homo sapiens (Human)						LLADLHKR	3.569999933	0.382597446	0.382597446	0.218916477	963.4177846	13.32961	16.4465	11.72318	15.55872	0	0	16.12162	0	0	16.41592	15.90096	0	0	0	15.24126	14.36509	0	0	0	0	0	16.85681	15.53224	15.42968	14.56957	15.9977	16.06035	0	15.38083	15.40472	14.96487	15.89813	9.501472	13.72328	16.51	14.61316	16.15234	14.81495	15.70381	14.64103	16.35061	14.14693	16.08471	14.87851	13.39173	16.66648	16.05074	15.5074
Q5M9Q1	NKAPL_HUMAN	NKAP-like protein	NKAPL C6orf194	Homo sapiens (Human)	cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0007283; GO:0010468; GO:0030154	EMVHKK	10.10000038	0.697117031	0.697117031	0.214870044	772.3351574	16.12512	15.80205	15.28684	14.60085	0	15.63899	14.94232	12.93301	0	17.37723	14.21627	0	14.80249	14.93821	15.97381	15.86635	14.80103	16.09136	15.51291	14.3419	15.5094	16.34917	9.752864	15.97805	0	0	16.27816	16.62634	0	15.45564	15.7341	16.41364	15.46219	0	15.91567	0	16.5069	16.48036	12.7637	14.3539	0	14.96782	14.0752	15.54635	13.92747	16.38019	0	16.24171
Q5MIZ7	P4R3B_HUMAN	Serine/threonine-protein phosphatase 4 regulatory subunit 3B (SMEK homolog 2)	PPP4R3B KIAA1387 PP4R3B SMEK2	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; histone dephosphorylation [GO:0016576]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; histone dephosphorylation [GO:0016576]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779]	protein phosphatase activator activity [GO:0072542]	GO:0000785; GO:0005654; GO:0005737; GO:0005813; GO:0006470; GO:0006974; GO:0016576; GO:0016607; GO:0030289; GO:0033128; GO:0045722; GO:0072542; GO:2000779	LGILPALEIVMGMDDLQVR	2.789999962	1	1	0.151025724	2099.371375	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5MJ07	SPXN5_HUMAN	"Sperm protein associated with the nucleus on the X chromosome N5 (Nuclear-associated protein SPAN-Xn5, SPANX-N5) (SPANX family member N5)"	SPANXN5	Homo sapiens (Human)						MKTSEYSTVLVLCYR	5.96999979	1	1	4.60E-13	1866.230505	0	15.79427	16.02037	15.90814	15.08603	0	0	0	15.72694	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.76324	0	0	0	0	0	0	0	0	0	0	0	15.4003	16.22012	13.89062	0	0	0	0	0	16.40766	0	0
Q5MJ08	SPXN4_HUMAN	"Sperm protein associated with the nucleus on the X chromosome N4 (Nuclear-associated protein SPAN-Xn4, SPANX-N4) (SPANX family member N4)"	SPANXN4	Homo sapiens (Human)						EKGDLDISAGSPQDGGQN	6.730000019	1	1	0.246974653	1786.707564	13.86928	14.63995	0	14.75774	0	0	0	14.12415	14.56909	16.42405	0	0	13.30154	0	0	11.83052	0	0	0	0	0	0	16.0027	0	0	16.5536	0	0	0	0	0	0	0	14.70782	0	15.77831	0	0	17.0146	11.37553	0	0	0	0	16.12075	0	0	0
Q5MJ70	SPDYA_HUMAN	"Speedy protein A (Rapid inducer of G2/M progression in oocytes A, RINGO A, hSpy/Ringo A) (Speedy-1, Spy1)"	SPDYA SPDY1 SPY1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein kinase activity [GO:0045860]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein kinase activity [GO:0045860]	protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]	GO:0000082; GO:0005634; GO:0005654; GO:0006974; GO:0007140; GO:0008284; GO:0019901; GO:0030295; GO:0045737; GO:0045860	AKFTISEHTR	6.599999905	1	1	0.163863263	1189.729415	12.19053	14.59038	12.78638	0	13.4207	0	14.21924	0	0	14.39351	12.38496	15.84478	0	0	0	0	0	0	0	0	16.10814	0	13.93069	0	13.83822	0	0	0	0	0	0	0	15.70728	0	0	0	14.97002	0	17.33261	11.30105	0	0	0	0	0	0	0	0
Q5MNV8	FBX47_HUMAN	F-box only protein 47	FBXO47	Homo sapiens (Human)						LLLQDFHNLELPDR	9.359999657	1	1	0.583892031	1721.045089	0	0	19.28968	17.87244	0	18.80801	0	0	18.67376	0	0	0	0	0	0	0	0	0	0	16.54537	0	0	0	0	0	0	0	0	0	0	0	19.08533	0	0	0	18.86304	0	0	0	0	0	0	0	0	0	17.20289	0	0
Q5PRF9	SMAG2_HUMAN	"Protein Smaug homolog 2, Smaug 2, hSmaug2 (Sterile alpha motif domain-containing protein 4B, SAM domain-containing protein 4B)"	SAMD4B SMAUG2	Homo sapiens (Human)	nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]	GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0030371	MGLLSPSGIGGVSPR	6.480000019	1	1	0.346503062	1444.529231	13.89989	14.04933	0	0	12.67159	10.52411	15.29937	14.22316	14.63248	14.35865	0	0	15.70266	0	0	0	0	0	0	0	0	0	0	15.32765	16.12493	0	0	0	0	0	0	0	0	0	0	0	12.56075	0	0	16.67206	15.70735	14.88632	15.30098	14.96249	0	0	0	15.68095
Q5PSV4	BRM1L_HUMAN	Breast cancer metastasis-suppressor 1-like protein (BRMS1-homolog protein p40) (BRMS1-like protein p40)	BRMS1L	Homo sapiens (Human)	histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of growth [GO:0040008]	nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]	nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of growth [GO:0040008]	histone deacetylase binding [GO:0042826]	GO:0000122; GO:0005634; GO:0016575; GO:0016580; GO:0030336; GO:0030512; GO:0040008; GO:0042826; GO:0070822; GO:1902455; GO:1902459	AMATLGPHR	12.90999985	1	1	8.01E-13	970.4464935	13.72007	12.47567	14.29302	13.8503	0	13.99768	14.531	11.41263	15.23027	15.56349	13.17486	14.12597	0	13.60404	13.43163	12.97575	14.58315	13.65342	13.46068	12.59666	0	0	11.23203	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5QFB9	PAPAS_HUMAN	Protein PAPPAS (DIPLA1 antisense RNA 1) (DIPLA1 antisense gene protein 1) (DIPLA1-antisense expressed) (PAPPAS antisense RNA 1) (PAPPAS antisense gene protein 1) (PAPPAS-antisense expressed)	PAPPA-AS1 DIPAS PAPPAS	Homo sapiens (Human)		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021	HLDMFLSVIGQR	1.75999999	0.251813799	0.251813799	0.283985802	1431.903935	16.19319	14.26467	15.48836	0	0	0	15.2836	0	13.71115	0	12.19388	14.91433	15.83714	15.98198	0	14.62034	15.99753	0	14.80047	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.76188	0	0	0	0	0	0	0	0	0	0	0
Q5QJ38	TCHL1_HUMAN	Trichohyalin-like protein 1 (Basalin) (Protein S100-A17) (S100 calcium-binding protein A17)	TCHHL1 S100A17 THHL1	Homo sapiens (Human)			transition metal ion binding [GO:0046914]	transition metal ion binding [GO:0046914]	GO:0046914	EASTTKQ	4.369999886	0.068895482	0.068895482	0.306103192	761.7766248	15.95669	14.75872	15.49534	14.57157	13.00586	0	16.45039	15.43962	0	15.96605	14.93956	16.51252	15.55214	15.07174	14.83829	15.90721	14.80316	0	15.19465	14.95582	0	0	0	16.48745	16.81665	17.12625	16.28875	0	14.69261	14.01029	16.41799	15.15193	16.63751	15.90984	15.36358	14.921	0	15.21972	0	16.06487	16.21957	15.23165	14.90491	0	0	15.59418	13.85234	15.71558
Q5QP82	DCA10_HUMAN	DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32)	DCAF10 WDR32	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567]		GO:0005654; GO:0016567; GO:0080008	FSPTHCQIASGCLSGRVSLYQPK	1.950000048	1	1	0.356452395	2593.795096	0	0	15.36186	14.34111	13.74646	13.1342	0	0	0	0	13.91307	0	0	0	14.49618	12.05164	0	0	0	0	0	16.00297	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5R372	RBG1L_HUMAN	Rab GTPase-activating protein 1-like	RABGAP1L HHL KIAA0471	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]	GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]	GO:0005096; GO:0005634; GO:0005769; GO:0005794; GO:0006897; GO:0015031; GO:0031267; GO:0032880; GO:0090630	LTYLGCMKVSSPR	6.920000076	0.82420969	0.82420969	0.057742507	1528.3886	0	13.34919	13.48506	14.39667	0	15.60614	0	0	18.09369	14.61512	0	16.15467	14.72618	15.84092	15.55914	10.41048	14.77443	15.24614	0	0	11.48907	0	15.47462	0	0	10.58321	16.1809	12.8044	0	14.48509	0	17.67317	15.99217	0	15.68282	0	16.13739	15.59893	0	11.49303	14.93851	14.13874	0	0	0	18.61603	0	0
Q5R3I4	TTC38_HUMAN	"Tetratricopeptide repeat protein 38, TPR repeat protein 38"	TTC38	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]		GO:0070062	MAAASPLR	9.31000042	1	1	0.210644375	832.4251742	15.97214	14.25687	0	16.4272	0	0	0	18.00962	0	0	0	0	0	0	0	14.58208	16.00385	16.40984	0	0	0	14.50261	0	17.13724	0	14.77416	15.90073	15.74567	0	0	14.89134	15.32984	0	15.25393	0	0	16.25578	0	14.39926	0	0	14.25291	0	0	0	16.27606	0	15.21477
Q5RHP9	ERIC3_HUMAN	Glutamate-rich protein 3	ERICH3 C1orf173	Homo sapiens (Human)						ANALK	1.75	1	1	0.121459745	515.4553112	0	0	15.39123	0	15.34857	0	13.88907	10.70766	15.3053	16.05535	15.85892	16.2929	14.71957	0	0	0	0	14.67778	16.80176	0	0	0	0	15.13863	0	0	15.65134	0	0	0	16.12024	0	0	0	15.83387	0	0	0	0	0	0	0	0	0	16.80205	0	0	0
Q5RKV6	EXOS6_HUMAN	"Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog, hMtr3) (p11)"	EXOSC6 MTR3	Homo sapiens (Human)	"DNA deamination [GO:0045006]; isotype switching [GO:0045190]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; DNA deamination [GO:0045006]; isotype switching [GO:0045190]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	RNA binding [GO:0003723]	GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034475; GO:0045006; GO:0045190; GO:0045830; GO:0071028; GO:0071051; GO:0101019	AGLLSQAKGSAYLEAGGTK	2.589999914	1	1	6.89E-13	1816.812418	0	13.24606	14.61131	0	14.47632	0	11.73264	15.9058	0	15.06921	14.57921	0	11.94916	0	15.21366	0	0	0	0	0	13.2665	0	0	0	0	0	13.33678	0	0	0	0	0	15.83598	0	0	0	0	0	0	0	0	0	0	0	13.54531	0	0	0
Q5RL73	RBM48_HUMAN	RNA-binding protein 48	RBM48 C7orf64 HSPC304	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005654	TTQLQERK	9.109999657	0.139721498	0.139721498	0.072273152	1002.089767	0	9.033824	0	9.656753	0	0	14.51379	0	11.12693	13.09885	0	17.08019	16.8821	16.95479	13.65669	18.01945	16.37227	16.16326	14.28907	9.617247	0	0	0	16.73854	12.84509	0	14.98242	0	15.38216	14.64153	16.95262	14.64854	0	15.1912	15.60324	16.86453	15.49775	19.0459	14.93613	0	13.46407	0	17.02703	0	17.24593	0	0	16.0455
Q5S007	LRRK2_HUMAN	"Leucine-rich repeat serine/threonine-protein kinase 2, EC 2.7.11.1, EC 3.6.5.- (Dardarin)"	LRRK2 PARK8	Homo sapiens (Human)	"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]"	"amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]"	"amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]; actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]; autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]"	actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]	GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0004722; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007165; GO:0007254; GO:0007283; GO:0007528; GO:0008017; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016234; GO:0016242; GO:0016301; GO:0016310; GO:0017075; GO:0018105; GO:0018107; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031398; GO:0031410; GO:0031647; GO:0031966; GO:0032091; GO:0032092; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034613; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043406; GO:0044325; GO:0044753; GO:0044754; GO:0045121; GO:0045860; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051770; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0070997; GO:0071287; GO:0071407; GO:0072593; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:1900244; GO:1901214; GO:1901215; GO:1901727; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903125; GO:1903206; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300	CYNIVVEAMKAFPMSER	13.64999962	0.676503956	0.676503956	0.102471047	2076.336558	0	14.80967	0	16.76141	0	0	0	0	0	0	0.4614795	0	0	15.9767	0	0	13.51547	15.18386	0	10.59204	0	17.65881	0	16.71193	13.29368	16.89545	0	16.47162	16.01621	17.86945	0	0	17.87271	14.00565	18.92503	13.2274	13.81772	16.71931	0	0	0	0	17.99761	0	0	15.01582	13.24917	0
Q5SQN1	SNP47_HUMAN	"Synaptosomal-associated protein 47, SNAP-47 (Epididymis luminal protein 170) (Synaptosomal-associated 47 kDa protein)"	SNAP47 C1orf142 HEL170 SVAP1	Homo sapiens (Human)	exocytosis [GO:0006887]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]	endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]	endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]	SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]	GO:0005484; GO:0005886; GO:0006887; GO:0006906; GO:0012505; GO:0016082; GO:0019905; GO:0031201; GO:0031629; GO:0048471; GO:0098793	EASHFIFSSITILEK	1.269999981	1	1	0.282553789	1721.033201	0	14.75741	0	0	0	0	0	12.74464	14.60297	0	0	0	0	0	0	0	0	16.12202	0	0	0	0	15.59704	9.713362	0	0	0	0	0	0	0	0	17.09171	0	0	0	0	0	14.20286	0	0	0	0	0	18.19863	0	17.34412	0
Q5SQQ9	VAX1_HUMAN	Ventral anterior homeobox 1	VAX1	Homo sapiens (Human)	axon guidance [GO:0007411]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; central nervous system development [GO:0007417]; negative regulation of neuroblast proliferation [GO:0007406]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle cell differentiation [GO:0035914]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]; axon guidance [GO:0007411]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; central nervous system development [GO:0007417]; negative regulation of neuroblast proliferation [GO:0007406]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle cell differentiation [GO:0035914]"	"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001162; GO:0001227; GO:0001764; GO:0005634; GO:0006357; GO:0007406; GO:0007411; GO:0007417; GO:0007420; GO:0030182; GO:0031490; GO:0035914; GO:0043010; GO:0060021; GO:1990837	MFGKPDK	13.56000042	0.043752044	0.043752044	0.269691136	838.2234526	17.80264	18.25256	0	18.34863	17.57449	17.52482	20.44973	0	20.68309	0	17.64452	16.99977	17.49881	16.9471	0	0	18.50524	0	0	16.25193	17.19448	0	0	0	17.95906	0	0	17.58007	0	0	19.46682	0	19.92704	0	17.75665	18.91003	0	0	19.46223	0	17.25173	0	0	17.98635	18.43382	17.91677	0	17.54539
Q5SQS7	SH24B_HUMAN	SH2 domain-containing protein 4B	SH2D4B	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	AAKVLEER	2.079999924	0.04704446	0.04704446	0.282650622	915.1307538	0	16.33909	18.21795	0	0	0	16.0856	0	18.15732	0	17.49552	0	0	0	17.35398	0	0	17.27241	16.8589	0	17.50876	0	0	16.29257	0	18.76083	0	0	0	0	0	0	17.11897	17.75579	16.97755	17.4527	17.65069	17.85256	0	0	0	0	17.87913	0	0	16.86444	0	0
Q5SRN2	TSBP1_HUMAN	Testis-expressed basic protein 1 (Uncharacterized protein C6orf10)	TSBP1 C6orf10	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nucleus [GO:0005634]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]		GO:0005634; GO:0016021	GQEAQVEKSEMGVPR	5.769999981	1	1	0.446627309	1644.98471	0	16.0264	0	0	0	0	0	15.1626	0	0	0	0	0	0	0	0	0	0	17.14161	0	0	0	0	16.81656	0	16.46559	0	0	0	0	14.77435	0	0	0	0	0	0	0	16.91675	0	0	0	0	0	0	0	0	0
Q5ST30	SYVM_HUMAN	"Valine--tRNA ligase, mitochondrial, EC 6.1.1.9 (Valyl-tRNA synthetase, ValRS) (Valyl-tRNA synthetase-like)"	VARS2 KIAA1885 VARS2L VARSL	Homo sapiens (Human)	valyl-tRNA aminoacylation [GO:0006438]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]	GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006438	SLGNVLDPRDIISGVEMQVLQEK	4.389999866	1	1	0.06909733	2555.156888	0	0	0	0	0	11.0937	0	15.17165	0	0	0	14.33358	14.41682	0	11.37109	10.78229	14.26199	0	13.41684	0	0	14.68811	14.33146	15.53092	0	0	0	0	13.13187	0	11.11676	13.48745	13.32182	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5SVQ8	ZBT41_HUMAN	Zinc finger and BTB domain-containing protein 41	ZBTB41 FRBZ1	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	SLLLGKK	11.30000019	1	1	0.296540974	759.0638749	0	0	0	0	0	0	17.51717	0	0	0	0	18.20117	0	0	0	0	15.7607	0	18.02556	0	0	18.36482	0	0	19.61025	20.19626	0	0	0	0	0	0	0	20.17815	0	0	0	0	17.3193	18.82803	0	18.2445	17.95701	0	0	0	0	0
Q5SVZ6	ZMYM1_HUMAN	Zinc finger MYM-type protein 1	ZMYM1	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]	protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]	GO:0005634; GO:0008270; GO:0046983	SMKISDELCHPK	7.650000095	0.61274749	0.61274749	0.246224925	1461.099451	16.84852	14.473	13.84777	14.94119	16.42609	0	0	0	14.35523	0	15.72733	0	15.25107	0	0	0	0	0	0	0	16.25815	0	0	0	15.36814	0	0	15.10613	0	0	0	0	17.60366	0	0	16.6231	0	0	0	0	0	0	0	0	16.44618	16.5731	0	0
Q5SW79	CE170_HUMAN	"Centrosomal protein of 170 kDa, Cep170 (KARP-1-binding protein, KARP1-binding protein)"	CEP170 FAM68A KAB KIAA0470	Homo sapiens (Human)		centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; spindle [GO:0005819]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; spindle [GO:0005819]		GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0120103	AKVVTQR	4.75	1	1	0.080145523	800.8176973	0	14.87565	15.94807	15.24582	0	13.2117	0	0	15.12067	0	13.99118	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.41882	17.24743	0	0	17.80203	0	0	0	0	0	18.66304	0	18.50809
Q5SW96	ARH_HUMAN	Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein)	LDLRAP1 ARH	Homo sapiens (Human)	amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]	axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	"axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]"	"amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]"	GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030669; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602	SLVATGNLLDLEETAK	6.869999886	1	1	6.92E-13	1672.807463	0	0	0	0	0	0	0	16.90906	19.70546	0	15.44203	0	16.29497	0	0	0	19.47347	0	0	0	0	0	0	0	16.85545	0	16.36447	0	0	0	15.71922	0	17.47132	0	0	0	0	17.49962	0	0	0	0	0	0	0	16.35342	0	0
Q5SWA1	PR15B_HUMAN	Protein phosphatase 1 regulatory subunit 15B	PPP1R15B	Homo sapiens (Human)	ER overload response [GO:0006983]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]	endoplasmic reticulum [GO:0005783]; protein phosphatase type 1 complex [GO:0000164]	endoplasmic reticulum [GO:0005783]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase regulator activity [GO:0019888]; ER overload response [GO:0006983]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]	protein phosphatase regulator activity [GO:0019888]	GO:0000164; GO:0001933; GO:0005783; GO:0006983; GO:0019888; GO:0032516; GO:0034976; GO:0042542; GO:0070262; GO:1903898; GO:1903912	SQAGSSK	2.690000057	0.258664578	0.258664578	0.263899395	664.8712305	17.6349	16.2798	16.35283	16.90662	13.59832	17.41674	15.18336	15.1495	15.28456	15.13124	17.52933	15.72795	15.68364	14.39266	15.0053	15.33535	15.21595	15.84674	15.63575	16.63772	14.55478	15.6034	16.53388	14.82914	17.41255	14.79355	16.47598	16.00577	0	16.61431	16.87585	16.41055	18.6879	15.74809	0	17.55115	16.8705	15.52504	16.91668	17.17752	16.26249	0	15.65147	15.29037	16.09547	15.76222	16.8644	16.2219
Q5SWX8	ODR4_HUMAN	"Protein odr-4 homolog, hODR-4 (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1)"	ODR4 C1orf27 TTG1 TTG1A	Homo sapiens (Human)	protein localization [GO:0008104]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; protein localization [GO:0008104]		GO:0008104; GO:0016021	TYDIHDPK	3.25	3.71E-11	3.71E-11	0.322470568	988.1776286	0	0	0	17.51299	17.15676	0	0	0	18.78791	0	0	17.94942	0	0	0	17.87783	19.13151	0	16.41205	0	0	0	0	0	18.09278	0	17.98986	18.6352	15.77958	17.28427	0	18.50684	0	18.67137	18.26895	18.53656	18.87573	0	0	0	0	0	17.03232	0	0	0	16.77795	17.0625
Q5SXM1	ZN678_HUMAN	Zinc finger protein 678	ZNF678	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	FSSLTQHRR	14.39000034	0.496763587	0.496763587	0.748939288	1131.298338	0	16.80654	0	0	0	0	0	0	0	0	0	17.51641	0	0	17.40442	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.65224	0	0	0
Q5SXM2	SNPC4_HUMAN	"snRNA-activating protein complex subunit 4, SNAPc subunit 4 (Proximal sequence element-binding transcription factor subunit alpha, PSE-binding factor subunit alpha, PTF subunit alpha) (snRNA-activating protein complex 190 kDa subunit, SNAPc 190 kDa subunit)"	SNAPC4 SNAP190	Homo sapiens (Human)	snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]	GO:0000995; GO:0003677; GO:0005634; GO:0005654; GO:0016251; GO:0019185; GO:0042795; GO:0042796	MLTQLVQEMR	8.68999958	1	1	0.335957604	1265.615634	0	0	14.99025	0	0	0	14.64788	0	16.29879	0	0	15.9623	0	14.90361	17.04295	0	0	17.31682	0	18.71487	0	0	17.03596	16.32889	16.1389	0	0	0	0	16.25541	17.44362	16.25423	16.49419	17.12831	17.10605	16.15698	18.39485	16.43546	0	15.5284	0	16.20486	0	0	0	16.87444	18.12262	17.60695
Q5SXM8	DNLZ_HUMAN	"DNL-type zinc finger protein (Hsp70-escort protein 1, HEP1) (mtHsp70-escort protein)"	DNLZ C9orf151	Homo sapiens (Human)	protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; zinc ion binding [GO:0008270]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein stabilization [GO:0050821]	chaperone binding [GO:0051087]; zinc ion binding [GO:0008270]	GO:0005654; GO:0005739; GO:0006457; GO:0008270; GO:0030150; GO:0050821; GO:0051087	VCGTR	1.340000033	1	1	0.285012971	591.1453576	16.13166	16.5755	16.08646	0	16.38357	15.13163	15.73242	15.40983	15.88243	0	15.80199	16.671	0	13.80523	16.18365	0	0	16.24784	0	0	0	0	0	0	16.05007	0	0	0	0	15.74841	0	0	0	16.45111	0	0	16.04152	0	0	16.40555	0	15.85648	16.10118	0	17.03365	16.46122	0	16.96956
Q5SY16	NOL9_HUMAN	"Polynucleotide 5'-hydroxyl-kinase NOL9, EC 2.7.1.- (Nucleolar protein 9)"	NOL9	Homo sapiens (Human)	"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]"	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0016020; GO:0045111; GO:0051731	ARPQLILSR	20.38999939	0.639324069	0.639324069	0.371163845	1056.904724	17.07399	15.88627	14.56575	14.30525	0	15.6678	0	15.9082	0	16.77361	16.13762	0	16.5137	16.85714	0	0	0	16.25013	18.61948	0	0	0	18.7337	18.17042	15.91335	0	0	15.31119	0	0	0	0	0	15.31566	16.69821	15.85502	0	0	0	13.79948	0	0	15.43077	0	0	0	17.03434	0
Q5SYB0	FRPD1_HUMAN	FERM and PDZ domain-containing protein 1 (FERM domain-containing protein 2)	FRMPD1 FRMD2 KIAA0967	Homo sapiens (Human)	establishment of protein localization to membrane [GO:0090150]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; establishment of protein localization to membrane [GO:0090150]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		GO:0005829; GO:0005856; GO:0005886; GO:0008277; GO:0032991; GO:0090150	EVTNKNGTNVFQEESR	3.710000038	1	1	0.500339391	1852.235242	18.55407	0	0	0	18.36507	0	0	0	0	0	0	18.53937	0	0	0	0	0	0	0	0	0	0	0	0	19.18564	0	0	0	0	19.96996	19.14893	0	18.98555	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5SZD1	CF141_HUMAN	Uncharacterized protein C6orf141	C6orf141	Homo sapiens (Human)						METRGPQGAANPMDSSR	2.180000067	1	1	0.008750818	1819.608941	14.61635	12.74549	0	0	0	10.68822	0	11.97333	14.8081	0	0	11.6424	16.2033	0	14.11921	15.64447	0	11.25893	15.95684	0	0	14.13538	15.96558	0	0	13.2452	14.17367	14.52711	16.61966	14.50648	0	0	16.31389	15.63078	15.65803	15.60606	14.7592	0	14.54095	14.04896	0	16.59587	0	0	0	0	0	14.90389
Q5SZD4	GLYL3_HUMAN	"Glycine N-acyltransferase-like protein 3, EC 2.3.1.13 (Acyl-CoA:glycine-N-acyltransferase-like protein 3)"	GLYATL3 C6orf140	Homo sapiens (Human)	lipid metabolic process [GO:0006629]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]; lipid metabolic process [GO:0006629]	glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]	GO:0005739; GO:0006629; GO:0016410; GO:0047961	FHRLILTPATFSGLPHL	10.06999969	1	1	0.3129262	1920.282448	15.15281	0	13.91058	13.40547	13.54988	11.86441	0	13.47924	0	0	14.66629	16.9875	14.87061	0.5218458	0	13.33375	14.85349	14.22019	12.38537	0	0	11.95782	15.53797	14.25178	0	0	15.67913	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5SZJ8	BEND6_HUMAN	BEN domain-containing protein 6	BEND6 C6orf65	Homo sapiens (Human)	negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]	nucleus [GO:0005634]	nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]	GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0007399; GO:0045666; GO:0045746	EKLTNTR	4.039999962	1	1	0.239252821	860.7682564	0	0	0	0	0	14.9615	14.79229	0	0	0	0	0	0	17.39598	16.88319	0	0	0	0	0	0	0	0	18.703	0	0	0	19.65926	0	16.42812	0	0	0	0	0	0	0	0	0	0	0	17.09382	0	0	0	0	17.15524	0
Q5SZK8	FREM2_HUMAN	FRAS1-related extracellular matrix protein 2 (ECM3 homolog)	FREM2	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]	metal ion binding [GO:0046872]	GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0016021; GO:0042733; GO:0046872; GO:0048839; GO:0070062	HSAGTPGLSSRR	17.80999947	1	1	0.253026984	1225.859586	0	14.82245	0	14.92339	0	0	0	0	0	13.17819	0	0	0	0	0	0	0	15.94647	18.12456	0	18.33595	0	0	0	0	17.34011	18.08047	0	17.16843	0	16.15978	0	0	0	18.02987	0	19.88357	19.49401	20.14282	0	0	18.49088	19.20117	0	18.00641	19.72207	19.45969	19.4306
Q5SZL2	CE85L_HUMAN	Centrosomal protein of 85 kDa-like (Serologically defined breast cancer antigen NY-BR-15)	CEP85L C6orf204	Homo sapiens (Human)	neuron migration [GO:0001764]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; pericentriolar material [GO:0000242]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; pericentriolar material [GO:0000242]; neuron migration [GO:0001764]		GO:0000242; GO:0001764; GO:0005737; GO:0005813	EGLLRQK	4.659999847	1	1	0.247693219	842.3081739	15.01539	0	14.33815	0	0	0	12.08051	16.30451	16.88182	0	14.30562	0	16.10252	14.71416	0	15.20149	0	0	0	0	0	0	0	0	16.23344	0	13.21649	15.39576	0	0	16.2408	15.32655	16.56433	0	14.4244	0	0	16.17442	0	0	0	0	0	0	0	16.45091	14.46609	0
Q5T011	SZT2_HUMAN	KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog)	SZT2 C1orf84 KIAA0467	Homo sapiens (Human)	cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]	KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]		GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262	HKTESVR	5.559999943	1	1	0.229999224	856.6070913	0	0	16.79222	16.79501	0	0	0	14.52473	0	0	0	0	13.74521	14.42399	15.41288	16.14442	15.06125	0	0	16.50649	0	0	16.44184	16.85472	12.09103	0	16.84468	0	0	0	16.84767	14.87777	8.886654	0	15.72289	0	0	0	0	17.08261	0	0	12.76938	14.84685	15.79246	0	0	14.81755
Q5T013	HYI_HUMAN	"Putative hydroxypyruvate isomerase, EC 5.3.1.22 (Endothelial cell apoptosis protein E-CE1)"	HYI HT036 SB156	Homo sapiens (Human)	glyoxylate metabolic process [GO:0046487]		hydroxypyruvate isomerase activity [GO:0008903]; glyoxylate metabolic process [GO:0046487]	hydroxypyruvate isomerase activity [GO:0008903]	GO:0008903; GO:0046487	IHLMAGR	6.539999962	0.572448492	0.572448492	0.170014941	812.8333432	16.4268	17.85976	0	0	0	15.44808	15.40709	13.70628	0	0	0	0	0	0	13.95497	0	0	16.32311	0	0	0	0	0	15.6411	0	17.29861	15.1584	0	16.04825	0	18.29497	0	15.28883	0	0	0	0	0	0	0	0	0	0	0	0	13.72777	0	0
Q5T0F9	C2D1B_HUMAN	"Coiled-coil and C2 domain-containing protein 1B (Five prime repressor element under dual repression-binding protein 2, FRE under dual repression-binding protein 2, Freud-2)"	CC2D1B KIAA1836	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005635; GO:0005654; GO:0006357; GO:0043231	CLLFSK	2.940000057	1	1	0.203405903	768.8467559	15.79365	13.98571	13.9161	14.92351	15.63714	11.83741	0	15.38404	0	16.01633	16.25667	14.95995	16.19411	0	15.94602	0	0	14.72526	0	0	0	0	0	0	16.78416	17.01894	16.63403	0	0	15.64505	17.01757	0	16.84601	0	16.70354	16.07796	16.14867	15.82879	15.5289	0	0	0	15.42324	0	16.46631	0	0	15.72488
Q5T0N1	CFA70_HUMAN	"Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18, TPR repeat protein 18)"	CFAP70 TTC18	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium movement [GO:0003341]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular exosome [GO:0070062]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular exosome [GO:0070062]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]		GO:0003341; GO:0005930; GO:0036064; GO:0036126; GO:0036157; GO:0060271; GO:0070062	DIDGRPRPGDVQAPSIK	5.679999828	1	1	0.151197841	1820.790106	0	14.56952	13.67483	13.72303	16.69341	14.55498	0	0	14.36523	0	0	0	0	13.50907	15.06137	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5T0N5	FBP1L_HUMAN	"Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1, Toca-1)"	FNBP1L C1orf39 TOCA1	Homo sapiens (Human)	autophagy [GO:0006914]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; lipid binding [GO:0008289]; autophagy [GO:0006914]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050]	cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; lipid binding [GO:0008289]	GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0031410; GO:0045296; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320	AIYPFDGHNEGTLAMK	5.730000019	0.118506551	0.118506551	0.129988401	1763.601744	14.43754	0	0	0	0	0	14.06565	0	16.88859	16.48625	18.01918	0	0	20.5622	0	19.43328	0	0	16.68428	0	0	19.10695	14.71351	14.83101	0	15.76672	0	19.39327	0	0	0	0	18.19773	0	9.539261	15.12977	17.10325	19.42727	0	0	0	15.98222	17.67205	0	0	14.99087	17.0984	0
Q5T0W9	FA83B_HUMAN	Protein FAM83B	FAM83B C6orf143	Homo sapiens (Human)	cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; epidermal growth factor receptor binding [GO:0005154]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; signal transduction [GO:0007165]	epidermal growth factor receptor binding [GO:0005154]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]	GO:0005154; GO:0005737; GO:0007165; GO:0007173; GO:0008283; GO:0016020; GO:0019901; GO:0036312; GO:0036313	EDLLKSSK	31.18000031	1	1	0.238790646	918.5913938	14.51629	18.30243	10.96141	0	17.5059	0	16.04609	0	0	0	18.08132	0	17.03398	17.09602	0	0	16.11004	16.83984	0	0	0	0	17.36944	0	15.56159	0	16.36733	16.9227	13.969	17.22962	0	17.60469	16.42382	0	15.60137	0	0	0	0	0	0	0	0	18.00171	17.16644	17.20861	17.36793	0
Q5T0Z8	CF132_HUMAN	Uncharacterized protein C6orf132	C6orf132	Homo sapiens (Human)						DPSQMEK	4.900000095	0.29154712	0.29154712	0.172568147	850.2883051	15.90319	0	13.60298	0	0	17.02363	0	0	0	0	0	0	0	0	0	0	0	0	15.31916	15.88842	14.54083	0	13.6753	0	17.50112	19.88775	17.4087	18.31479	0	17.16628	0	17.72351	0	0	0	17.12188	16.95047	12.17805	0	14.67773	15.8795	16.72061	16.67098	0	12.58992	14.0772	16.6015	0
Q5T160	SYRM_HUMAN	"Probable arginine--tRNA ligase, mitochondrial, EC 6.1.1.19 (Arginyl-tRNA synthetase, ArgRS)"	RARS2 RARSL	Homo sapiens (Human)	arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	GO:0003723; GO:0004814; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006420; GO:0032543	YNFDTMIYVTDK	2.170000076	1	1	0.297375762	1509.687864	0	0	0	0	0	15.54073	0	0	0	0	0	0	0	0	19.19517	0	0	0	0	0	0	0	0	0	0	0	0	16.84441	14.87152	0	0	0	0	0	0	16.32807	0	0	0	0	0	15.82958	0	0	0	11.00142	0	0
Q5T1A1	DCST2_HUMAN	DC-STAMP domain-containing protein 2	DCST2	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	AADQGHR	5.380000114	1	1	0.234602978	752.284745	16.23936	13.92825	15.80662	14.40224	13.66683	0	15.1844	15.18021	14.94009	15.85242	16.09596	0	13.70636	14.67332	14.47066	16.26424	14.03226	14.60959	12.44708	14.10819	15.52336	16.13112	15.96157	17.06617	16.06167	15.25906	13.64103	16.14162	14.93085	15.67653	0	16.53856	0	0	15.94104	0	14.97033	15.96023	0	0	0	13.69059	0	15.55716	16.49504	15.52644	0	15.86579
Q5T1B0	AXDN1_HUMAN	Axonemal dynein light chain domain-containing protein 1	AXDND1 C1orf125	Homo sapiens (Human)						AHDVK	6.699999809	0	0	0.259494396	570.2263783	18.42959	19.5038	0	19.53509	0	0	17.3367	18.89088	18.92394	0	17.1291	0	18.66177	18.3345	18.73882	18.92497	18.37416	0	18.58797	18.28765	0	17.27109	18.32559	0	18.47983	0	19.85026	19.98099	18.15776	17.14886	19.73051	0	18.8144	0	18.88358	0	0	0	0	0	18.08615	0	19.27537	0	0	19.15365	18.79398	19.6092
Q5T1C6	THEM4_HUMAN	"Acyl-coenzyme A thioesterase THEM4, Acyl-CoA thioesterase THEM4, EC 3.1.2.2 (Carboxyl-terminal modulator protein) (Thioesterase superfamily member 4)"	THEM4 CTMP	Homo sapiens (Human)	fatty acid metabolic process [GO:0006631]; protein kinase B signaling [GO:0043491]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; fatty acid metabolic process [GO:0006631]; protein kinase B signaling [GO:0043491]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]	myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0005886; GO:0006631; GO:0016290; GO:0032587; GO:0043491; GO:0102991; GO:1902108	LLFDQFMK	9.270000458	1	1	0.262082424	1057.769773	0	0	0	0	15.33384	0	13.01126	0	0	0	0	0	0	0	0	0	16.31013	0	16.1232	0	0	0	0	0	16.44959	15.67187	0	0	0	0	17.46181	0	0	0	18.44325	0	0	0	0	0	17.06645	0	0	0	0	0	17.19292	0
Q5T1H1	EYS_HUMAN	"Protein eyes shut homolog (Epidermal growth factor-like protein 10, EGF-like protein 10) (Epidermal growth factor-like protein 11, EGF-like protein 11) (Protein spacemaker homolog)"	EYS C6orf178 C6orf179 C6orf180 EGFL10 EGFL11 SPAM UNQ9424/PRO34591	Homo sapiens (Human)	detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; interphotoreceptor matrix [GO:0033165]; microtubule organizing center [GO:0005815]; photoreceptor outer segment [GO:0001750]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; interphotoreceptor matrix [GO:0033165]; microtubule organizing center [GO:0005815]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403]	calcium ion binding [GO:0005509]	GO:0001750; GO:0005509; GO:0005737; GO:0005815; GO:0033165; GO:0043403; GO:0050908; GO:0070062	LKGMHTVNSK	6.860000134	0.925359726	0.925359726	0.232203853	1109.998254	15.07514	15.2763	15.14359	13.27707	14.80567	13.92739	0	13.69607	0	14.14205	14.01195	15.97682	0	0	9.934797	14.49382	13.53947	15.89488	0	0	0	0	0	0	0	9.138339	0	15.2537	0	0	16.07633	0	13.02332	0	0	0	0	15.18254	0	0	0	0	0	0	0	14.87241	15.50679	15.55713
Q5T1M5	FKB15_HUMAN	"FK506-binding protein 15, FKBP-15 (133 kDa FK506-binding protein, 133 kDa FKBP, FKBP-133) (WASP- and FKBP-like protein, WAFL)"	FKBP15 KIAA0674	Homo sapiens (Human)	endocytosis [GO:0006897]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; endocytosis [GO:0006897]	actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426	FGAGDEDDTDFLSPSGGAR	2.170000076	0.000194994	0.000194994	0.607680733	1913.51839	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.39569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.35262	0	0
Q5T1R4	ZEP3_HUMAN	"Transcription factor HIVEP3 (Human immunodeficiency virus type I enhancer-binding protein 3) (Kappa-B and V(D)J recombination signal sequences-binding protein) (Kappa-binding protein 1, KBP-1) (Zinc finger protein ZAS3)"	HIVEP3 KBP1 KIAA1555 KRC ZAS3	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0035914; GO:0045893; GO:0046872	SAPPGK	2.859999895	0.071430929	0.071430929	0.086302458	555.9717503	16.07331	13.59132	12.04061	0	0	0	14.88646	13.10974	16.65371	14.71955	0	0	16.77994	16.25863	13.88305	14.2977	0	0	15.20804	13.69782	12.74674	0	14.34007	16.77746	17.82327	15.4568	0	0	0	14.33304	15.305	15.03392	14.7633	14.67073	13.06156	0	13.28288	14.18893	18.32822	0	15.18181	14.62137	0	17.53111	0	13.9532	0	15.90756
Q5T1V6	DDX59_HUMAN	"Probable ATP-dependent RNA helicase DDX59, EC 3.6.4.13 (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5)"	DDX59 ZNHIT5	Homo sapiens (Human)		cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0046872	LGADLLSEAVQK	11.5	1	1	0.187395412	1244.104516	0	16.61286	0	0	15.0545	13.412	14.14563	0	13.94682	0	0	0	0	0	0	0	0	14.78207	0	0	0	0	0	0	0	16.49687	16.52001	0	14.88943	0	0	0	0	0	0	0	15.13233	0	0	0	0	0	0	0	0	0	15.8671	0
Q5T200	ZC3HD_HUMAN	Zinc finger CCCH domain-containing protein 13	ZC3H13 KIAA0853	Homo sapiens (Human)	mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0036396; GO:0046872; GO:0080009; GO:2000036	SGDDQSGRK	2.480000019	0.544772863	0.544772863	0.101728097	950.6304485	17.43193	14.36421	11.49959	0	0	12.31312	14.29029	15.09715	16.11111	15.71312	12.03738	0	0	0	0	0	14.44634	15.27958	14.65869	15.50222	0	15.12457	16.82183	0	16.16623	12.51621	0	0	16.7539	12.94706	14.96783	0	18.31588	17.55277	0	0	18.58989	0	14.3091	0	0	0	15.26201	0	16.75251	0	16.5527	0
Q5T230	UTF1_HUMAN	Undifferentiated embryonic cell transcription factor 1	UTF1	Homo sapiens (Human)	male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0006357; GO:0008584; GO:0045944	GPGSPPPPPAR	1.110000014	1	1	0.121033085	1029.911906	17.12337	0	0	12.00217	15.65661	0	14.43906	17.80592	15.39186	0	0	0	16.89882	15.45971	0	0	0	14.17989	0	0	0	0	0	13.78091	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.21767	0	0	0	0	19.56815	0	0	15.21435	0
Q5T2D2	TRML2_HUMAN	"Trem-like transcript 2 protein, TLT-2 (Triggering receptor expressed on myeloid cells-like protein 2)"	TREML2 C6orf76 TLT2 UNQ6268/PRO20473	Homo sapiens (Human)	T cell activation [GO:0042110]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; T cell activation [GO:0042110]	signaling receptor activity [GO:0038023]	GO:0005886; GO:0009986; GO:0016021; GO:0038023; GO:0042110	SGDLSTRSPTTGLCLTSR	8.75	1	1	7.04E-13	1909.833828	12.14591	0	11.89011	0	0	15.74146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5T2S8	ODAD2_HUMAN	Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4)	ODAD2 ARMC4	Homo sapiens (Human)	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]	axoneme [GO:0005930]; ciliary base [GO:0097546]	axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]		GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546	CCMWGR	7.809999943	1	1	0.245032469	868.4670817	0	0	0	0	0	0	12.87742	15.65335	15.0049	0	0	14.41245	0	0	15.27978	0	0	0	0	0	15.41381	0	0	13.75839	0	0	0	13.89504	0	0	13.97912	0	0	14.15525	15.98715	0	0	0	0	0	11.67831	17.32595	0	15.2225	0	0	0	0
Q5T2T1	MPP7_HUMAN	MAGUK p55 subfamily member 7	MPP7	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; establishment of cell polarity [GO:0030010]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; lateral plasma membrane [GO:0016328]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; lateral plasma membrane [GO:0016328]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; signaling adaptor activity [GO:0035591]; bicellular tight junction assembly [GO:0070830]; establishment of cell polarity [GO:0030010]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896]	cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; signaling adaptor activity [GO:0035591]	GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0016328; GO:0019904; GO:0030010; GO:0030054; GO:0031334; GO:0035591; GO:0045296; GO:0060090; GO:0070830; GO:0071896; GO:0097025	DEQTGAIIVARIMR	13.85000038	1	1	0.510846798	1589.087214	0	0	0	0	16.0624	0	15.2312	0	16.01649	0	0	0	0	0	0	16.02648	0	0	9.279874	0	0	0	15.86819	14.48806	0	0	0	0	0	16.15914	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.50788	0	0
Q5T3F8	CSCL2_HUMAN	CSC1-like protein 2 (Transmembrane protein 63B)	TMEM63B C6orf110	Homo sapiens (Human)		actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760]	calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760]	GO:0005227; GO:0005886; GO:0008381; GO:0015629; GO:0016021; GO:1990760	LALVTDADR	4.539999962	1	1	0.153911002	972.5382496	0	16.7067	14.13245	0	15.87633	16.0872	13.8091	12.97621	0	0	17.84883	13.20789	0	0	13.8425	16.91477	0	0	0	16.36333	0	0	0	0	13.88185	0	16.83326	0	0	0	16.50558	0	16.91387	17.86523	12.15565	0	0	15.88356	0	0	0	0	14.31185	0	10.98093	0	16.8531	15.37631
Q5T3J3	LRIF1_HUMAN	"Ligand-dependent nuclear receptor-interacting factor 1 (HP1-binding protein enriched in inactive X chromosome protein 1, HBiX1) (Receptor-interacting factor 1)"	LRIF1 C1orf103 RIF1	Homo sapiens (Human)	"dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of transcription, DNA-templated [GO:0006355]"	Barr body [GO:0001740]; centriolar satellite [GO:0034451]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	"Barr body [GO:0001740]; centriolar satellite [GO:0034451]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; retinoic acid receptor binding [GO:0042974]; dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of transcription, DNA-templated [GO:0006355]"	retinoic acid receptor binding [GO:0042974]	GO:0001740; GO:0005654; GO:0006355; GO:0009048; GO:0016363; GO:0034451; GO:0042974	NLLQLLPIPK	27.45000076	0.280804098	0.280804098	0.356906237	1149.92075	18.52009	18.55627	0	0	18.44576	19.03811	17.80246	18.74449	18.0723	18.63309	0	17.60476	16.61523	18.66683	19.02698	0	16.87167	0	18.25172	15.73176	0	17.85702	17.17397	15.80028	18.53225	18.0015	19.33125	19.34163	12.75833	10.83088	18.54176	15.79602	17.07169	18.55457	0	17.0864	17.52436	18.74297	19.52128	16.77618	18.20291	16.58562	17.89134	17.974	18.11471	17.93946	18.60833	15.20077
Q5T3U5	MRP7_HUMAN	"ATP-binding cassette sub-family C member 10, EC 7.6.2.2, EC 7.6.2.3 (Multidrug resistance-associated protein 7)"	ABCC10 MRP7 SIMRP7	Homo sapiens (Human)	leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]	ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]	GO:0005524; GO:0005765; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0015431; GO:0016020; GO:0016021; GO:0016323; GO:0042626; GO:0043225; GO:0055085; GO:0071716; GO:0140359	CYLALGLLK	3.680000067	1	1	0.075690564	1051.514062	12.78025	0	0	13.81365	0	13.97452	0	0	0	0	0	0	13.95515	14.28722	15.01635	0	15.40941	0	0	0	0	14.59235	0	0	12.82453	0	0	14.05878	11.02505	0	0	12.43676	12.52755	0	0	15.7556	0	0	0	0	0	0	0	0	0	0	0	0
Q5T447	HECD3_HUMAN	"E3 ubiquitin-protein ligase HECTD3, EC 2.3.2.26 (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3)"	HECTD3	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	perinuclear region of cytoplasm [GO:0048471]	perinuclear region of cytoplasm [GO:0048471]; syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0019905; GO:0043161; GO:0048471	EQVAAMQAGLLKVVPQAVLDLLTWQELEK	2.5	1	1	0.046223988	3236.705827	11.40325	14.34015	13.84776	12.29848	14.9752	14.19077	14.5969	0	10.37886	13.73029	12.43023	0	0	0	0	0	0	0	12.15709	0	0	0	14.19182	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.94284	14.27806	0	0	0	0	0	0
Q5T4B2	GT253_HUMAN	Inactive glycosyltransferase 25 family member 3 (Cerebral endothelial cell adhesion molecule)	CERCAM CEECAM1 GLT25D3 KIAA1502	Homo sapiens (Human)	cell adhesion [GO:0007155]; leukocyte cell-cell adhesion [GO:0007159]	endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]	endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; leukocyte cell-cell adhesion [GO:0007159]	identical protein binding [GO:0042802]	GO:0005788; GO:0005886; GO:0007155; GO:0007159; GO:0042802	TAEYFPTK	2.930000067	1	1	0.196180978	957.0648021	14.72995	13.85904	12.56055	16.80995	16.49625	0	0	14.65589	0	16.87846	14.48845	0	14.09115	15.16489	0	14.91708	0	0	0	0	0	15.23252	0	0	0	16.00302	0	0	0	13.08404	0	16.35261	17.23032	0	15.77384	16.30467	15.69044	15.59959	14.65148	0	13.57494	13.36218	0	13.88669	13.9763	14.5159	13.36657	0
Q5T4F4	ZFY27_HUMAN	Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27)	ZFYVE27 SPG33	Homo sapiens (Human)	endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]	GO:0005654; GO:0005783; GO:0005829; GO:0016192; GO:0030176; GO:0030424; GO:0030425; GO:0031175; GO:0032584; GO:0042802; GO:0043231; GO:0043621; GO:0045773; GO:0046872; GO:0048011; GO:0055038; GO:0071782; GO:0071787; GO:0072659	ARLPDSELMR	7.039999962	1	1	0.178396321	1202.484685	0	13.48115	0	0	13.16869	0	0	0	14.92501	0	0	0	16.00092	15.40184	16.09779	0	0	0	15.82169	16.60596	0	0	0	0	0	0	0	14.40813	0	15.64061	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84333	0
Q5T4S7	UBR4_HUMAN	"E3 ubiquitin-protein ligase UBR4, EC 2.3.2.27 (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa, RBAF600, p600) (Zinc finger UBR1-type protein 1)"	UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1	Homo sapiens (Human)	ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ubiquitin-dependent protein catabolic process [GO:0006511]	calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0035579; GO:0061630; GO:0070821; GO:0101003	EGVGSPK	5.730000019	0.000511107	0.000511107	0.200418468	669.7337564	0	14.97293	0	0	0	0	0	0	16.12749	0	0	16.1776	0	14.63274	15.90235	15.52143	0	15.71421	16.65845	0	0	16.04495	0	16.25413	0	0	15.95615	0	0	0	0	0	0	0	16.18464	0	0	0	16.53415	16.94326	15.47267	14.94009	17.24663	15.35225	14.91946	16.32324	17.16412	0
Q5T4T6	SYC2L_HUMAN	"Synaptonemal complex protein 2-like, SCP-2-like (145 kDa nucleolar protein homolog, hsNO145)"	SYCP2L C6orf177 NO145	Homo sapiens (Human)	meiotic nuclear division [GO:0140013]; negative regulation of cell death [GO:0060548]	"condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]"	"condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; meiotic nuclear division [GO:0140013]; negative regulation of cell death [GO:0060548]"		GO:0000779; GO:0000800; GO:0005654; GO:0060548; GO:0140013	EDEPLLIRQGLIPK	9.390000343	1	1	0.367915902	1620.772567	0	0	16.32525	17.05383	0	0	0	0	0	0	0	0	19.14178	0	0	0	0	0	0	0	0	0	0	0	0	17.67994	0	0	0	0	0	0	0	0	19.35342	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5T4W7	ARTN_HUMAN	Artemin (Enovin) (Neublastin)	ARTN EVN	Homo sapiens (Human)	axon guidance [GO:0007411]; induction of positive chemotaxis [GO:0050930]; lymphocyte migration into lymphoid organs [GO:0097021]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; Peyer's patch morphogenesis [GO:0061146]; signal transduction [GO:0007165]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; induction of positive chemotaxis [GO:0050930]; lymphocyte migration into lymphoid organs [GO:0097021]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; Peyer's patch morphogenesis [GO:0061146]; signal transduction [GO:0007165]	glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007405; GO:0007411; GO:0007422; GO:0008083; GO:0030116; GO:0030971; GO:0050930; GO:0061146; GO:0097021	GGRAAR	5.260000229	0.77080673	0.77080673	1.15E-13	586.363128	0	0	0	16.26766	0	15.75085	13.14356	0	0	0	15.58649	0	15.12245	0	0	0	0	15.99938	16.40829	15.13462	0	12.90829	16.14717	0	0	0	16.66851	0	0	0	0	0	0	0	16.27153	0	16.27145	0	0	0	0	0	0	0	15.62451	16.31493	0	15.72344
Q5T5C0	STXB5_HUMAN	Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1)	STXBP5 LLGL3	Homo sapiens (Human)	exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807]	acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]	acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807]	GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]	GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0050708; GO:0098674; GO:0098686; GO:2000300	MLCIAGVSAHVIIYRFSK	2.609999895	1	1	0.328861094	2082.762014	0	13.85191	14.05936	15.50162	15.92026	15.39689	0	12.42939	10.32671	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.60818	0	0	0	16.25427	12.98911	11.58135	0	14.2679	0	0	0	0	0	0	0	16.35239	0	0	0	0	0	0	0	0
Q5T5F5	A4AS1_HUMAN	Uncharacterized protein ADAMTSL4-AS1 (ADAMTSL4 antisense RNA 1) (ADAMTSL4 antisense gene protein 1)	ADAMTSL4-AS1 C1orf138	Homo sapiens (Human)						AGLEK	14.39000034	0.077620283	0.077620283	0.256949936	516.8553149	0	0	0	0	0	0	14.42843	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.32854	0	0	17.01466	0	0	18.03145	0	0	0	17.3446	22.10998	17.58446	0	21.3911	0	0	0	0	0	0	0	0	20.97008	0	0	0
Q5T5J6	SWT1_HUMAN	Transcriptional protein SWT1	SWT1 C1orf26	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634	ESCGK	1.059999943	1	1	0.190910969	579.6805194	15.51439	14.46382	13.23897	0	15.21673	14.78646	11.99956	13.26358	0	15.59359	0	10.67239	14.85323	0	11.85766	0	0	12.48022	0	0	0	0	0	15.55742	0	17.02624	0	15.29152	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32786	0	0
Q5T5M9	CCNJ_HUMAN	Cyclin-J	CCNJ	Homo sapiens (Human)	mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0016538; GO:0044772	HLAVYLLDLFMDR	6.329999924	1	1	0.114637258	1621.895082	14.88005	15.43251	13.38602	0	0	0	0	0	0	0	0	13.19592	0	13.18508	0	0	16.35938	0	15.24671	0	0	0	0	0	0	0	16.51221	0	15.80503	0	0	0	0	14.82277	0	0	0	16.81455	0	15.8795	14.82316	16.25147	0	0	0	0	0	0
Q5T5N4	CF118_HUMAN	Uncharacterized protein C6orf118	C6orf118	Homo sapiens (Human)						QDLLKNDFTGSK	3.369999886	3.00E-05	3.00E-05	0.452037594	1365.173149	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.31764	0	18.82403	0	0	0	0	0	0	0	17.9582	0	0	0	0	0	0	0	0	0	0	0	0	17.60849	0	0
Q5T5P2	SKT_HUMAN	Sickle tail protein homolog	KIAA1217 SKT	Homo sapiens (Human)	embryonic skeletal system development [GO:0048706]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; embryonic skeletal system development [GO:0048706]		GO:0005737; GO:0048706	AQNGSSSK	7.739999771	0.058135662	0.058135662	0.299803105	779.2979701	0	18.34143	16.48369	0	17.28367	0	0	14.32678	0	18.99311	15.03538	18.43933	0	15.47965	17.03368	16.56652	0	16.05593	17.32196	0	0	19.23062	15.59017	18.23704	16.31594	18.04648	17.74771	0	17.08493	15.89967	18.02363	16.81722	15.20679	17.1241	18.25056	17.86457	18.4939	0	17.05334	17.76918	18.1742	18.43637	16.46732	17.869	15.85487	18.54689	18.20993	17.57213
Q5T5U3	RHG21_HUMAN	Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21)	ARHGAP21 ARHGAP10 KIAA1424	Homo sapiens (Human)	establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030659; GO:0051056; GO:0051645; GO:0051683; GO:0051684; GO:0072384	IADSQK	7.159999847	0.370355517	0.370355517	0.301414739	657.8850043	0	0	0	17.10826	0	17.3631	0	17.3577	18.33687	0	0	19.12444	0	0	18.46626	0	0	0	20.13054	0	17.59215	0	17.45433	0	0	0	0	0	0	0	0	0	0	0	18.49316	0	0	0	0	19.02788	0	0	0	0	19.01976	0	0	0
Q5T5Y3	CAMP1_HUMAN	Calmodulin-regulated spectrin-associated protein 1	CAMSAP1	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113]	calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]	GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0051011	APIKMSAHMAMVDALMMAYTVEMISIEK	6.909999847	1	1	3.66E-12	3143.384658	13.07171	15.39031	0	11.82069	15.737	0	12.82914	0	11.61634	17.66104	14.51678	12.57156	0	0	0	0	10.86697	0	0	0	13.79766	0	0	0	0	0	15.49326	16.22846	0	0	0	0	14.60487	0	9.212381	0	0	0	15.41991	14.9198	14.05977	0	15.20199	0	12.9799	0	0	13.65984
Q5T601	AGRF1_HUMAN	Adhesion G-protein coupled receptor F1 (G protein-coupled receptor 110) (G protein-coupled receptor KPG_012) (G protein-coupled receptor PGR19)	ADGRF1 GPR110 PGR19	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; neuron projection development [GO:0031175]; positive regulation of CREB transcription factor activity [GO:0032793]; synapse assembly [GO:0007416]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; neuron projection development [GO:0031175]; positive regulation of CREB transcription factor activity [GO:0032793]; synapse assembly [GO:0007416]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005576; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007613; GO:0016021; GO:0031175; GO:0032793	GIPVNK	6.909999847	1	1	0.157023278	627.5635212	15.44368	15.24774	0	14.36357	0	0	0	0	0	0	15.2143	0	0	15.2739	0	16.99882	0	15.83158	0	0	0	0	0	16.82574	0	16.47224	0	15.98434	16.96593	15.86256	15.7736	15.75937	0	0	17.22379	16.75983	17.144	17.92104	17.94748	16.24039	15.11415	16.81141	18.53492	17.32557	18.01036	17.78208	0	17.10707
Q5T653	RM02_HUMAN	"39S ribosomal protein L2, mitochondrial, L2mt, MRP-L2 (Mitochondrial large ribosomal subunit protein uL2m)"	MRPL2 CGI-22	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0032543	SGGRDHTGR	5.820000172	0	0	0.284626057	943.5631921	16.67854	15.30481	0	12.19596	16.79771	0	16.02196	15.04106	15.49493	16.28643	0	15.58677	16.17845	15.46976	14.61561	13.41457	0	0	0	0	15.29133	15.70779	15.58395	0	9.342497	14.2936	15.44608	12.46828	14.91101	13.31954	16.78702	14.50083	0	0	0	0	0	0	0	15.11724	0	0	0	16.78481	0	0	14.93203	15.14804
Q5T655	CFA58_HUMAN	Cilia- and flagella-associated protein 58 (Coiled-coil domain-containing protein 147)	CFAP58 C10orf80 CCDC147	Homo sapiens (Human)	cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]	centrosome [GO:0005813]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]	centrosome [GO:0005813]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]		GO:0005615; GO:0005813; GO:0005856; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317	HVLARQPGPEAAEQLK	6.739999771	1	1	0.42610016	1743.626319	18.83387	0	0	0	0	0	0	17.81318	0	0	0	18.50637	0	0	0	0	0	0	0	0	17.4257	0	0	0	18.93377	0	19.46106	0	0	0	0	0	0	0	0	18.09106	17.60762	0	0	0	0	0	0	0	0	0	0	0
Q5T681	CJ062_HUMAN	Uncharacterized protein C10orf62	C10orf62	Homo sapiens (Human)						MLWVQR	8.640000343	1	1	0.154600155	834.4465563	14.58722	15.26525	10.74567	14.64948	14.48714	14.16751	15.29096	0	0	16.54147	13.67034	14.88037	0	11.35108	14.61963	16.30345	0	16.15036	16.15395	12.77585	0	14.10805	14.63307	15.75786	14.30083	0	16.81727	16.07953	15.24348	0	16.233	14.82207	15.3457	16.62019	11.06691	0	0	0	0	0	15.63216	15.25329	0	0	0	0	13.04434	0
Q5T6C5	AT7L2_HUMAN	Ataxin-7-like protein 2	ATXN7L2	Homo sapiens (Human)						EPSGTR	2.059999943	1	1	0.267010911	646.6313054	0	0	17.26174	0	18.04275	0	0	0	0	0	0	0	17.22313	0	16.76872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.17119	0	0	0	0	0	0	0
Q5T6F0	DCA12_HUMAN	DDB1- and CUL4-associated factor 12 (Centrosome-related protein TCC52) (Testis cancer centrosome-related protein) (WD repeat-containing protein 40A)	DCAF12 KIAA1892 TCC52 WDR40A	Homo sapiens (Human)	regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]	centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]	centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]	ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0005737; GO:0005813; GO:0010506; GO:0080008; GO:0140627; GO:1990756	ALAFNNKNK	10.28999996	0.306640238	0.306640238	0.15191484	1019.717814	0	18.65409	16.24964	0	13.88793	14.4744	0	15.19794	0	13.59602	0	17.89384	19.24922	0	0	0	16.12727	13.7355	15.53863	16.44871	8.704863	15.68357	15.0392	14.40207	0	16.51631	14.47781	16.19917	14.72893	0	15.40121	19.37144	15.31499	13.93507	16.14523	0	13.15733	16.66172	16.37173	18.85824	16.00818	13.70291	0	18.57976	14.51662	0	14.35357	0
Q5T6F2	UBAP2_HUMAN	"Ubiquitin-associated protein 2, UBAP-2"	UBAP2 KIAA1491	Homo sapiens (Human)	regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; regulation of gene expression [GO:0010468]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0010468; GO:0045296	SQPEPSPVLSQLSQR	5.659999847	1	1	0.027248086	1653.810364	14.68818	14.44455	0	13.37397	15.55607	15.566	0	0	14.26883	15.2405	14.6234	11.60657	0	0	0	0	0	0	0	13.66627	0	0	0	0	0	0	0	0	14.94859	0	0	0	0	0	0	0	0	0	0	15.38219	0	0	14.46684	0	13.68481	0	0	0
Q5T6J7	GNTK_HUMAN	"Probable gluconokinase, EC 2.7.1.12 (Gluconate kinase)"	IDNK C9orf103	Homo sapiens (Human)	D-gluconate catabolic process [GO:0046177]		ATP binding [GO:0005524]; gluconokinase activity [GO:0046316]; D-gluconate catabolic process [GO:0046177]	ATP binding [GO:0005524]; gluconokinase activity [GO:0046316]	GO:0005524; GO:0046177; GO:0046316	DGVALKCEESGK	13.53999996	1	1	0.234616915	1290.937329	0	0	0	0	0	0	0	0	0	0	0	0	15.80112	0	0	17.8578	0	0	0	0	0	0	0	0	0	0	15.47876	19.42177	0	0	0	0	0	0	0	15.46127	0	0	0	0	0	0	0	0	15.2337	0	0	0
Q5T6L9	EMARD_HUMAN	"Endoplasmic reticulum membrane-associated RNA degradation protein, ER membrane-associated RNA degradation protein"	ERMARD C6orf70	Homo sapiens (Human)		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021	IMLPYWEVALVKFK	10.07999992	1	1	0.279212641	1737.285897	0	15.50597	0	14.68731	0	0	0	0	0	15.01187	10.89475	14.6317	14.56975	0	0	0	15.62776	13.99197	0	15.41165	0	15.99832	0	0	0	16.30818	0	0	0	0	0	0	0	16.49441	16.66246	18.14678	14.88507	17.21866	16.12363	0	15.3164	15.59863	14.37376	15.92132	0	11.78372	0	0
Q5T6S3	PHF19_HUMAN	"PHD finger protein 19 (Polycomb-like protein 3, hPCL3)"	PHF19 PCL3	Homo sapiens (Human)	"chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"	ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0019827; GO:0035064; GO:0035098; GO:0046872; GO:0048863; GO:0061087	KGAIAR	10.02000046	0.435852855	0.435852855	0.150009358	616.4787152	16.40009	16.26182	15.38645	0	0	15.66154	0	0	15.51726	15.08897	0	15.7228	16.44142	15.6264	0	16.51633	14.90581	15.5259	16.0313	15.90674	16.74854	0	15.18227	0	17.26293	15.54156	16.49987	16.50058	16.15114	14.04033	16.13341	15.91989	16.06196	15.48546	16.08676	16.4607	0	16.78479	15.98722	16.99467	16.15417	16.18419	15.98866	16.26114	0	17.02619	16.8034	15.61576
Q5T6V5	QSPP_HUMAN	Queuosine salvage protein	C9orf64	Homo sapiens (Human)	tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]		tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]		GO:0006400; GO:0101030	ALHELNPR	2.789999962	0.395761967	0.395761967	0.245750928	948.3006403	16.67653	15.5008	16.45609	0	15.29753	12.31942	14.68463	16.35526	15.2767	0	16.02544	15.20152	15.87433	15.28697	17.26664	16.15795	9.611901	13.71442	0	15.26943	16.40914	14.33082	15.15794	16.59318	15.76499	0	14.99716	0	14.73159	0	0	0	0	15.61744	15.58042	0	0	0	18.13202	15.8738	15.53554	0	0	15.97114	14.96055	0	15.44469	0
Q5T6X5	GPC6A_HUMAN	"G-protein coupled receptor family C group 6 member A, hGPRC6A (G-protein coupled receptor GPCR33, hGPCR33)"	GPRC6A	Homo sapiens (Human)	response to amino acid [GO:0043200]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; response to amino acid [GO:0043200]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005887; GO:0043200	SATWQKSK	8.920000076	0.380686462	0.380686462	0.260760154	937.9739978	15.1511	15.18299	13.3034	15.15323	14.92275	13.17486	14.11654	0	14.34743	0	0	16.0547	14.91356	15.53354	0	15.49969	0	0	16.02279	0	0	0	0	0	0	13.74992	14.93779	0	0	0	0	0	15.05378	0	0	0	0	0	15.83624	14.92144	0	0	0	0	0	0	15.1549	0
Q5T749	KPRP_HUMAN	"Keratinocyte proline-rich protein, hKPRP"	KPRP C1orf45	Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]		GO:0005737; GO:0070062	IEISSPCCPRQVPPQR	1.159999967	1	1	0.336355742	1928.270434	12.5612	0	0	13.78908	0	13.6035	0	0	0	0	0	15.54237	0	13.48495	0	0	0	0	0	0	0	0	0	15.65269	0	0	0	0	0	16.31779	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5T7B8	KIF24_HUMAN	Kinesin-like protein KIF24	KIF24 C9orf48	Homo sapiens (Human)	cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0032991; GO:0042802; GO:0060271; GO:1902018	AALDHSCSPSK	7.46999979	1	1	0.171069056	1173.005853	14.88321	14.47133	13.29573	0	14.92376	0	0	13.63412	0	15.70187	0	11.54237	14.02036	0	0	14.85725	0	0	0	16.1167	0	0	14.77466	0	0	0	0	0	0	0	0	0	0	0	0	17.12315	0	0	0	0	0	0	0	0	0	0	0	0
Q5T7M9	DIK1A_HUMAN	Divergent protein kinase domain 1A (Protein FAM69A)	DIPK1A FAM69A	Homo sapiens (Human)		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021	FSYVRMK	5.75	1	1	0.161502668	947.1665156	0	0	0	0	0	0	0	0	14.9889	0	0	15.74471	0	0	0	13.39798	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.54287	0	0	0	0	0	0	0	0	0	0	15.40698	0	0	0	0	0	0
Q5T7N2	LITD1_HUMAN	LINE-1 type transposase domain-containing protein 1 (ES cell-associated protein 11)	L1TD1 ECAT11	Homo sapiens (Human)	"transposition, RNA-mediated [GO:0032197]"	intracellular membrane-bounded organelle [GO:0043231]; ribonucleoprotein complex [GO:1990904]	"intracellular membrane-bounded organelle [GO:0043231]; ribonucleoprotein complex [GO:1990904]; single-stranded RNA binding [GO:0003727]; transposition, RNA-mediated [GO:0032197]"	single-stranded RNA binding [GO:0003727]	GO:0003727; GO:0032197; GO:0043231; GO:1990904	MSDVSTSVQSK	8.899999619	1	1	0.071020923	1183.406081	0	0	0	0	13.54761	13.56862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5T7N3	KANK4_HUMAN	KN motif and ankyrin repeat domain-containing protein 4 (Ankyrin repeat domain-containing protein 38)	KANK4 ANKRD38	Homo sapiens (Human)	negative regulation of actin filament polymerization [GO:0030837]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; negative regulation of actin filament polymerization [GO:0030837]		GO:0005737; GO:0005829; GO:0005856; GO:0015630; GO:0030837	AERYKPSEEFLNACR	9.640000343	1	1	0.244162454	1870.5755	14.39982	14.83222	12.0256	0	0	14.00596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.02814	0	0	12.49085	0	13.33927	14.82855	14.08064	0	0	14.6137	14.63532	14.87058	13.36358	0	14.46329	15.67901	0	13.53652
Q5T7P8	SYT6_HUMAN	"Synaptotagmin-6 (Synaptotagmin VI, SytVI)"	SYT6	Homo sapiens (Human)	acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001786; GO:0005509; GO:0005829; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0060478; GO:0070382; GO:0071277; GO:0097038	GNMADKLK	2.859999895	1	1	0.037613951	891.8489525	0	16.60094	0	6.697042	12.31943	15.62616	0	0	13.72214	15.92624	13.63732	14.80089	0	0	12.53402	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5T7W0	ZN618_HUMAN	Zinc finger protein 618	ZNF618 KIAA1952	Homo sapiens (Human)	positive regulation of chromatin binding [GO:0035563]	chromatin [GO:0000785]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	chromatin [GO:0000785]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator binding [GO:0001221]; positive regulation of chromatin binding [GO:0035563]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator binding [GO:0001221]	GO:0000785; GO:0001221; GO:0003677; GO:0003700; GO:0005634; GO:0005721; GO:0035563; GO:0042802; GO:0046872	LMFLKSNML	9.93999958	0.744631886	0.744631886	0.159933996	1096.640135	0	0	13.82662	14.44859	13.85723	12.32637	14.25313	0	0	0	0	14.63227	13.95165	7.764138	13.23379	0	0	0	13.70501	13.91735	14.46877	0	0	0	11.68163	0	15.19449	0	10.99015	0	10.81506	16.06358	14.84865	15.43576	16.59956	14.54472	12.09153	14.7259	13.45182	11.43973	14.49554	11.54665	0	0	15.03362	14.62407	14.76466	11.88395
Q5T848	GP158_HUMAN	Probable G-protein coupled receptor 158	GPR158 KIAA1136	Homo sapiens (Human)	protein localization to plasma membrane [GO:0072659]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021; GO:0072659	GLGRSIMR	21.29999924	0.124484904	0.124484904	0.174190761	905.5973244	14.58152	15.46899	15.7111	0	16.1297	14.54313	15.04869	16.7085	0	15.50925	15.15045	16.23677	16.53675	0	17.67462	0	0	15.39769	16.82655	0	17.51571	16.99322	15.53918	16.0851	15.60888	15.4632	0	15.58598	15.80676	16.11436	16.52707	16.06709	14.86578	15.29211	14.70682	15.06536	16.16975	16.78757	16.52065	13.01277	15.62945	15.73079	15.0922	16.59243	14.68585	18.21727	17.71188	14.64015
Q5T890	ER6L2_HUMAN	"DNA excision repair protein ERCC-6-like 2, EC 3.6.4.- (DNA repair and recombination protein RAD26-like)"	ERCC6L2 C9orf102 RAD26L	Homo sapiens (Human)	cellular response to reactive oxygen species [GO:0034614]; interstrand cross-link repair [GO:0036297]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901]; cellular response to reactive oxygen species [GO:0034614]; interstrand cross-link repair [GO:0036297]	ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901]	GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0140658	ELWCVMDWAVPGLLGSGTYFK	10.02999973	1	1	0.125474115	2445.348832	14.55711	0	15.21718	15.39159	0	15.92816	0	0	0	0	16.69733	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.01149	0	0	0	0	0	0	0	0	0	0	0	17.21849	0	0
Q5T8A7	PPR26_HUMAN	Protein phosphatase 1 regulatory subunit 26	PPP1R26 KIAA0649	Homo sapiens (Human)	negative regulation of phosphatase activity [GO:0010923]	nucleolus [GO:0005730]	nucleolus [GO:0005730]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]	protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0005730; GO:0010923	GDPVPPR	3.950000048	0.211265802	0.211265802	0.220510029	738.273685	0	0	17.23803	0	0	16.77951	0	17.09013	0	0	0	18.56001	18.14085	0	17.14452	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.38753	0	0	0	18.1241	0	0	0	0	0	0	0	0	15.4944	16.76769	0	16.5947	16.40658
Q5T8I3	F102B_HUMAN	Protein FAM102B	FAM102B	Homo sapiens (Human)						EDTASEK	4.78000021	1	1	0.289145264	781.1563555	14.99586	0	15.20239	15.41948	15.32496	14.35946	12.64013	0	14.31144	15.27579	14.57327	15.66217	13.1387	13.75078	14.74096	15.59915	0	15.50279	15.03256	15.35847	0	13.99976	15.94532	0	14.96574	0	16.45333	0	0	0	0	0	0	0	15.80637	0	15.81629	0	16.18913	0	0	15.15222	0	14.83652	0	15.36077	16.1505	0
Q5T8P6	RBM26_HUMAN	RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26)	RBM26 C13orf10 PRO1777	Homo sapiens (Human)	mRNA processing [GO:0006397]	nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0006397; GO:0046872	GAVHGR	8.319999695	1	1	0.232807639	596.3473554	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.68112	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.35396	0	0	0	0	0	0	0	0	0	18.87844	0	0	0	0	0	0	0	0
Q5T8R8	DOAS1_HUMAN	Uncharacterized protein DOCK8-AS1 (DOCK8 antisense RNA 1)	DOCK8-AS1 C9orf66	Homo sapiens (Human)						AGSGGR	1.529999971	0.000191442	0.000191442	0.14149035	503.321221	18.42366	17.52191	17.99291	18.03959	17.95881	17.8388	17.99337	17.80389	17.76775	17.22877	17.92227	18.14055	17.6329	18.48133	16.71551	18.27015	17.94565	17.34595	17.61685	18.0123	18.3536	18.26725	18.38695	17.6206	17.81301	17.5923	16.7608	18.48531	18.05369	17.18165	13.23161	18.76088	18.67551	19.37707	18.10049	17.17686	17.23219	17.85894	17.89736	17.89728	19.07886	18.75412	18.32906	18.90002	17.546	18.10116	17.08606	17.85203
Q5T9A4	ATD3B_HUMAN	ATPase family AAA domain-containing protein 3B (AAA-TOB3)	ATAD3B KIAA1273 TOB3	Homo sapiens (Human)	mitochondrion organization [GO:0007005]	ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mitochondrion organization [GO:0007005]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005739; GO:0005743; GO:0005886; GO:0007005; GO:0016887; GO:0030667; GO:0101003	ICSWMGTGLCPGPLSPR	1.980000019	1	1	0.092589085	1904.995916	0	16.08963	14.65949	0	0	0	13.67297	16.03629	0	15.10654	0	0	13.62768	13.49497	15.37008	0	0	0	0	0	0	0	0	0	15.0754	0	0	16.74989	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5T9C2	F102A_HUMAN	Protein FAM102A (Early estrogen-induced gene 1 protein)	FAM102A C9orf132 EEIG1	Homo sapiens (Human)						MAFLMKK	7.78000021	0.768185377	0.768185377	0.234292392	887.6177309	0	0	17.06049	15.91477	0	14.73579	16.13753	0	15.12116	14.95979	0	0	0	16.05887	0	0	0	0	0	0	0	0	0	0	0	15.15421	0	0	0	14.39429	14.58631	0	0	0	0	0	0	17.2451	0	15.05481	16.13083	15.60757	0	0	15.15573	0	13.84704	0
Q5T9S5	CCD18_HUMAN	Coiled-coil domain-containing protein 18 (Sarcoma antigen NY-SAR-24)	CCDC18	Homo sapiens (Human)						SSMQTGAGLNQGENV	7.78000021	1	1	0.188998809	1508.776154	14.46466	0	15.42305	10.90624	0	0	13.05424	15.58837	0	15.39685	13.22674	15.241	0	0	15.15827	14.80106	15.86389	0	9.712244	13.0085	0	15.13522	14.6967	0	15.68068	0	0	0	0	0	0	0	0	0	0	0	0	0	16.3378	0	0	0	0	0	0	0	0	0
Q5TA45	INT11_HUMAN	"Integrator complex subunit 11, Int11, EC 3.1.27.- (Cleavage and polyadenylation-specific factor 3-like protein, CPSF3-like protein) (Protein related to CPSF subunits of 68 kDa, RC-68)"	INTS11 CPSF3L RC68	Homo sapiens (Human)	snRNA processing [GO:0016180]	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; snRNA processing [GO:0016180]	endoribonuclease activity [GO:0004521]	GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016180; GO:0032039; GO:0072562	LVSSEQALK	11.22999954	1	1	0.482702934	974.4026732	0	0	0	0	0	0	0	0	0	0	0	0	0	16.0336	18.1945	0	0	17.48329	18.20457	0	18.19391	0	17.26734	0	0	0	0	0	0	0	0	17.35462	0	17.39799	0	17.6323	0	0	0	0	17.69577	0	0	0	0	0	0	0
Q5TA89	HES5_HUMAN	"Transcription factor HES-5 (Class B basic helix-loop-helix protein 38, bHLHb38) (Hairy and enhancer of split 5)"	HES5 BHLHB38	Homo sapiens (Human)	"anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; central nervous system myelination [GO:0022010]; comma-shaped body morphogenesis [GO:0072049]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glial cell fate commitment [GO:0021781]; inner ear receptor cell stereocilium organization [GO:0060122]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte development [GO:0014003]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of cell differentiation [GO:0045595]; regulation of epithelial cell proliferation [GO:0050678]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; specification of loop of Henle identity [GO:0072086]; telencephalon development [GO:0021537]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; central nervous system myelination [GO:0022010]; comma-shaped body morphogenesis [GO:0072049]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glial cell fate commitment [GO:0021781]; inner ear receptor cell stereocilium organization [GO:0060122]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte development [GO:0014003]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of cell differentiation [GO:0045595]; regulation of epithelial cell proliferation [GO:0050678]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; specification of loop of Henle identity [GO:0072086]; telencephalon development [GO:0021537]"	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0007155; GO:0007219; GO:0007224; GO:0007420; GO:0008284; GO:0009952; GO:0014003; GO:0021537; GO:0021781; GO:0021861; GO:0021915; GO:0022010; GO:0030513; GO:0031641; GO:0042531; GO:0043010; GO:0045595; GO:0045608; GO:0045665; GO:0045747; GO:0045893; GO:0045944; GO:0046427; GO:0046983; GO:0048469; GO:0048661; GO:0048708; GO:0048712; GO:0048715; GO:0050678; GO:0050767; GO:0051216; GO:0060122; GO:0065003; GO:0072049; GO:0072050; GO:0072086; GO:0072282; GO:0090162; GO:0097150; GO:1990837; GO:2000737; GO:2000974; GO:2000978	HQPNSK	9.890000343	1	1	0.185259967	710.3786085	15.87037	10.9434	13.13724	14.65599	15.22285	13.45801	14.6221	13.50207	16.49502	14.21316	15.09213	13.44219	0	0	13.99797	17.14637	15.03118	0	0	16.39808	0	16.90903	0	0	0	15.85015	15.39721	17.38565	0	15.70497	14.74888	15.4756	16.22668	16.8205	15.42172	0	17.37279	16.06296	0	16.40098	0	0	15.83858	0	16.81133	17.28811	15.56279	16.82325
Q5TAA0	TTC22_HUMAN	"Tetratricopeptide repeat protein 22, TPR repeat protein 22"	TTC22	Homo sapiens (Human)						AKMGLGGMPDR	2.859999895	1	1	0.216381739	1148.222198	0	14.30453	0	0	0	0	0	0	0	15.22986	0	16.52716	0	12.89753	0	0	0	0	0	0	0	0	0	0	13.54636	0	0	0	0	14.87462	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.68863	0	0
Q5TAB7	RIPP2_HUMAN	Protein ripply2	RIPPLY2 C6orf159	Homo sapiens (Human)	bone morphogenesis [GO:0060349]; determination of left/right symmetry [GO:0007368]; embryonic pattern specification [GO:0009880]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; ossification [GO:0001503]; post-anal tail morphogenesis [GO:0036342]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]	nucleus [GO:0005634]	nucleus [GO:0005634]; bone morphogenesis [GO:0060349]; determination of left/right symmetry [GO:0007368]; embryonic pattern specification [GO:0009880]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; ossification [GO:0001503]; post-anal tail morphogenesis [GO:0036342]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]		GO:0000122; GO:0001503; GO:0001756; GO:0005634; GO:0007219; GO:0007368; GO:0009880; GO:0032525; GO:0036342; GO:0060349	KEEETPNHAAEAMPDGPGMTAASGK	9.270000458	1	1	2.30E-12	2542.234338	15.34198	0	0	14.19057	0	0	11.07841	0	11.20955	0	0	0	13.30665	0	0	14.22147	12.73615	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.62847	0	0	0	0	0	0	0
Q5TAH2	SL9C2_HUMAN	"Sodium/hydrogen exchanger 11 (Na(+)/H(+) exchanger 11, NHE-11) (Solute carrier family 9 member 11) (Solute carrier family 9 member C2)"	SLC9C2 SLC9A11	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719	DVVIALKTK	3.470000029	1	1	0.104451223	984.2686151	12.35159	12.85059	14.8849	14.13822	13.62603	15.38946	14.32594	15.66977	6.895161	13.65913	12.48796	16.24809	0	0	0	0	13.0045	0	0	0	0	17.54546	0	0	0	0	0	0	0	0	16.28816	15.6173	0	0	0	0	0	0	16.80523	0	0	0	0	0	0	0	0	0
Q5TAP6	UT14C_HUMAN	U3 small nucleolar RNA-associated protein 14 homolog C	UTP14C KIAA0266	Homo sapiens (Human)	cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]		GO:0005730; GO:0005829; GO:0006364; GO:0007283; GO:0030154; GO:0032040; GO:0051321	QAMQEQLAKNK	5.579999924	0.64642489	0.64642489	0.395606067	1287.556555	14.85046	13.72163	12.7261	13.89699	13.90883	14.48996	14.1496	10.50176	12.02306	15.37341	0	0	0	0	0	15.26597	15.93413	14.2283	0	0	0	0	16.54585	15.54784	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.73493	16.11106	0	0	0	0	16.80349	0	16.06402	16.18945
Q5TAQ9	DCAF8_HUMAN	DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A)	DCAF8 H326 WDR42A	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]		GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016567; GO:0080008	FLPNSGDSTLAMCAR	6.78000021	1	1	6.89E-13	1639.997905	15.40582	15.89155	15.92003	14.7443	0	15.04495	15.7029	15.81757	15.10426	15.99108	15.25933	0	14.32099	0	0	15.11894	0	14.60974	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.28147	0	0	0	0	0
Q5TAT6	CODA1_HUMAN	Collagen alpha-1(XIII) chain (COLXIIIA1)	COL13A1	Homo sapiens (Human)	cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; morphogenesis of a branching structure [GO:0001763]; notochord development [GO:0030903]; skeletal system development [GO:0001501]	cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen type XIII trimer [GO:0005600]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen type XIII trimer [GO:0005600]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; morphogenesis of a branching structure [GO:0001763]; notochord development [GO:0030903]; skeletal system development [GO:0001501]	extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]	GO:0001501; GO:0001763; GO:0001958; GO:0005201; GO:0005576; GO:0005581; GO:0005600; GO:0005615; GO:0005788; GO:0005886; GO:0005911; GO:0007160; GO:0008201; GO:0030154; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0045211; GO:0062023; GO:0098609	GFPGFPGPIGLDGKPGHPGPK	5.210000038	1	1	0.111010021	2028.231191	14.53088	13.34712	15.2674	0	0	14.92994	15.63093	12.53309	11.33173	0	12.8434	0	14.49024	13.9075	0	10.12945	0	0	0	0	0	0	0	0	13.12952	15.30689	16.53963	14.30462	0	11.23602	0	15.09934	0	0	0	0	0	15.63891	0	15.27849	0	0	15.37882	0	0	0	0	0
Q5TAX3	TUT4_HUMAN	"Terminal uridylyltransferase 4, TUTase 4, EC 2.7.7.52 (Zinc finger CCHC domain-containing protein 11)"	TUT4 KIAA0191 ZCCHC11	Homo sapiens (Human)	"miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]"	miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]	GO:0000289; GO:0001556; GO:0003723; GO:0005615; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0016779; GO:0019827; GO:0031054; GO:0031123; GO:0035198; GO:0036464; GO:0050265; GO:0070062; GO:0071076; GO:1990074	TETDNQSNAMKEK	6.949999809	1	1	0.251535911	1511.955404	15.67501	0	14.12867	0	0	11.36215	0	15.35994	0	0	0	0	0	19.26869	17.62308	16.60926	0	0	0	0	0	0	16.04565	17.47859	0	0	0	0	13.88334	0	19.37048	17.78332	15.01351	17.02127	0	19.16969	16.43545	16.11564	14.37446	18.08202	20.85248	0	15.4759	16.53839	0	14.51428	0	0
Q5TB30	DEP1A_HUMAN	DEP domain-containing protein 1A	DEPDC1 DEPDC1A	Homo sapiens (Human)	"intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]"	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0017053; GO:0035556; GO:0045892	MESQGVPPGPYRATK	3.940000057	1	1	0	1618.061854	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5TB80	CE162_HUMAN	"Centrosomal protein of 162 kDa, Cep162 (Protein QN1 homolog)"	CEP162 C6orf84 KIAA1009 QN1	Homo sapiens (Human)	cilium assembly [GO:0060271]	axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cilium assembly [GO:0060271]		GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0060271	IKQMEMR	6.070000172	1	1	0.165401912	951.3476384	15.51417	15.29364	13.58309	0	14.02628	13.56185	15.32469	13.08501	0	15.39776	16.14578	0	0	0	15.04114	0	0	0	0	0	14.85662	0	0	0	11.4894	14.37054	15.90695	14.32967	0	14.91871	0	0	0	16.74065	15.30024	0	13.53269	0	16.52353	0	16.45564	0	0	0	14.5032	0	13.00479	0
Q5TBA9	FRY_HUMAN	Protein furry homolog	FRY C13orf14	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175]	cell cortex [GO:0005938]; microtubule organizing center [GO:0005815]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922]	cell cortex [GO:0005938]; microtubule organizing center [GO:0005815]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922]; enzyme inhibitor activity [GO:0004857]; cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175]	enzyme inhibitor activity [GO:0004857]	GO:0000902; GO:0000922; GO:0004857; GO:0005815; GO:0005938; GO:0030427; GO:0031175; GO:1904428	DPKMAR	6.179999828	1	1	0.235170686	716.6414371	16.42619	15.02352	16.25651	15.47928	16.13382	0	12.8681	14.07637	16.59912	14.87254	14.47889	16.4503	14.94163	0	14.9402	16.56866	15.6495	15.51736	16.74945	15.38694	15.66767	15.59958	0	0	16.56997	16.01978	0	16.63494	0	14.88199	14.69967	0	0	0	16.12777	15.66642	13.98898	15.71352	16.02917	16.14975	16.64758	0	15.56183	17.38502	0	16.99552	15.04737	0
Q5TC79	ZBT37_HUMAN	Zinc finger and BTB domain-containing protein 37	ZBTB37	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0006357; GO:0046872; GO:1990837	VTPNLNRSLSPR	8.779999733	1	1	3.43E-12	1352.711988	0	13.18955	0	9.493533	0	9.853085	0	12.05631	12.41497	8.068188	0	17.19782	0	13.06651	0	0	11.27251	0	9.37573	0	0	0	0	0	11.67134	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5TCQ9	MAGI3_HUMAN	"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3, MAGI-3)"	MAGI3 KIAA1634	Homo sapiens (Human)	apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]	bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; molecular adaptor activity [GO:0060090]	GO:0004385; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0006915; GO:0007165; GO:0016020; GO:0030054; GO:0035556; GO:0046328; GO:0060090	SASPKK	7.170000076	0.620313466	0.620313466	0.281039105	614.8400662	16.16865	0	15.78049	0	0	13.84714	0	0	0	0	15.75033	0	0	0	0	0	0	15.48075	0	16.35539	0	0	16.53953	16.40771	16.62875	14.31171	16.07299	16.56929	15.92677	15.28055	15.55554	0	16.34392	16.62087	15.26054	15.99774	16.72455	15.91883	15.41452	16.15583	16.59163	15.84841	16.77719	15.92806	16.36279	15.66712	16.67029	16.15717
Q5TCS8	KAD9_HUMAN	"Adenylate kinase 9, AK 9, EC 2.7.4.4, EC 2.7.4.6 (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2)"	AK9 AKD1 AKD2 C6orf199 C6orf224	Homo sapiens (Human)	AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]	GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006174; GO:0006186; GO:0006756; GO:0006757; GO:0031965; GO:0050145; GO:0061508; GO:0061565; GO:0061566; GO:0061567; GO:0061568; GO:0061569; GO:0061570; GO:0061571	AMNAAGCLKPK	7.21999979	1	1	0.25636843	1177.102074	0	0	0	0	15.37041	12.8567	0	0	15.14398	0	0	0	0	0	0	11.17007	0	0	0	0	0	0	0	0	0	0	0	0	0	14.25539	0	17.16745	0	12.33886	0	0	0	0	0	0	16.71187	0	16.89778	0	0	0	16.56465	0
Q5TCX8	M3K21_HUMAN	"Mitogen-activated protein kinase kinase kinase 21, EC 2.7.11.25 (Mitogen-activated protein kinase kinase kinase MLK4) (Mixed lineage kinase 4)"	MAP3K21 KIAA1804 MLK4	Homo sapiens (Human)	protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004706; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0042803; GO:0046777; GO:0106310	EARLFAMLR	2.390000105	1	1	0.228783316	1122.878062	0	13.76618	13.67471	0	0	0	0	0	15.9222	0	0	10.82431	0	0	0	0	0	0	0	16.65714	0	0	0	0	0	14.9523	15.73017	13.23679	0	0	14.51906	0	0	0	0	0	0	0	0	14.55575	0	16.01252	0	16.50839	0	14.26147	14.69374	0
Q5TCY1	TTBK1_HUMAN	"Tau-tubulin kinase 1, EC 2.7.11.1 (Brain-derived tau kinase)"	TTBK1 BDTK KIAA1855	Homo sapiens (Human)	learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0006468; GO:0007165; GO:0007611; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0021762; GO:0032091; GO:0032273; GO:0043025; GO:0048156; GO:0048471; GO:0050321; GO:0061890; GO:0106310; GO:1903980; GO:1904031; GO:2001056	AQPDGTPSPGGSK	6.989999771	1	1	0.263842691	1197.630895	15.43756	15.14964	11.68917	0	0	13.83176	15.67829	0	15.076	0	15.23804	0	0	0	0	12.37323	0	12.16909	0	15.12239	14.87571	15.8907	0	0	0	0	16.59959	15.92079	0	13.63702	14.44026	0	0	0	12.11475	13.47723	14.83363	0	15.78507	0	0	0	0	14.55355	13.85253	0	11.77591	0
Q5TCZ1	SPD2A_HUMAN	SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains)	SH3PXD2A FISH KIAA0418 SH3MD1 TKS5	Homo sapiens (Human)	in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; podosome [GO:0002102]	"cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; podosome [GO:0002102]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protease binding [GO:0002020]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]"	"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protease binding [GO:0002020]; superoxide-generating NADPH oxidase activator activity [GO:0016176]"	GO:0001701; GO:0002020; GO:0002102; GO:0005546; GO:0005737; GO:0005829; GO:0006801; GO:0010314; GO:0016176; GO:0030054; GO:0032266; GO:0042554; GO:0042995; GO:0043325; GO:0070273; GO:0072675	GTPKVR	3.880000114	1	1	0.241130005	658.4944348	0	0	0	0	0	0	0	0	0	0	0	16.45092	0	0	0	0	0	0	0	15.5615	0	0	0	0	0	0	0	0	0	0	0	0	16.99387	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5TD94	RSH4A_HUMAN	Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3)	RSPH4A RSHL3	Homo sapiens (Human)	axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177]	axoneme [GO:0005930]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]	axoneme [GO:0005930]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177]		GO:0001534; GO:0001535; GO:0003341; GO:0005654; GO:0005730; GO:0005930; GO:0031514; GO:0035082; GO:0060294; GO:0062177; GO:0120221	MAHFSKK	6.849999905	1	1	0.147681733	848.8114496	17.92382	0	0	0	0	0	0	0	0	0	0	0	15.97081	12.62062	15.34129	12.62576	0	15.90788	0	0	16.17089	0	0	0	0	0	0	15.36441	15.89431	16.45671	0	0	0	0	0	0	0	15.64567	16.06074	0	0	0	0	0	0	0	0	12.84641
Q5TDH0	DDI2_HUMAN	"Protein DDI1 homolog 2, EC 3.4.23.-"	DDI2	Homo sapiens (Human)	cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]	aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]	GO:0004190; GO:0005654; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0043130; GO:0072711; GO:0097752	SLASYGLKDGDVVILR	2.099999905	1	1	0.533070188	1707.187359	0	0	0	19.58573	0	0	0	0	0	0	0	0	0	16.42529	0	0	0	0	0	0	0	0	0	17.84255	18.06969	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.57101	0	0	16.75413	0	0	17.44236	0
Q5TDP6	LGSN_HUMAN	Lengsin (Glutamate-ammonia ligase domain-containing protein 1) (Lens glutamine synthase-like)	LGSN GLULD1 LGS	Homo sapiens (Human)	nitrogen compound metabolic process [GO:0006807]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; nitrogen compound metabolic process [GO:0006807]	catalytic activity [GO:0003824]	GO:0003824; GO:0005737; GO:0005886; GO:0006807; GO:0016020	ATCFNSDIVLMPELSTFR	4.929999828	1	1	0.113961481	2101.48212	0	0	13.37628	10.59748	15.76578	0	0	0	0	18.43439	13.92286	0	0	16.1342	0	12.84192	0	0	0	0	0	0	0	0	12.91379	0	0	0	13.73061	0	0	0	0	0	0	0	0	0	0	14.78067	0	0	0	14.59162	0	0	0	0
Q5TEA3	DAAF9_HUMAN	"Dynein axonemal assembly factor 9, DNAAF9"	DNAAF9 C20orf194	Homo sapiens (Human)						RLHSSAQK	3.130000114	0.024489934	0.024489934	0.271120465	927.6374246	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.8127	0	17.78927	0	0	0	0	0	0	0	0	0	18.13543	0	0	0	0	0	0
Q5TEA6	SE1L2_HUMAN	"Protein sel-1 homolog 2 (Suppressor of lin-12-like protein 2, Sel-1L2)"	SEL1L2 C20orf50	Homo sapiens (Human)	ERAD pathway [GO:0036503]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ERAD pathway [GO:0036503]		GO:0005789; GO:0016021; GO:0036503	AADMGNLK	8.170000076	0.38476941	0.38476941	0.054971269	838.6169082	17.16334	0	14.89258	14.32023	14.63478	16.02754	14.79904	14.91587	17.31492	14.37882	14.44349	0	16.11726	15.25422	0	15.98042	17.66917	11.54349	16.83456	15.31943	17.00146	15.9065	17.79032	15.87219	13.43685	15.81067	13.23042	16.83652	16.11589	0	18.31495	14.60341	17.68945	17.65809	16.87287	0	15.79425	14.95946	17.02501	12.55215	14.27562	14.63268	12.67434	17.96884	12.31894	0	14.49399	15.77514
Q5TEC6	H37_HUMAN	Histone H3-7	H3-7 H3-2 HIST2H3PS2	Homo sapiens (Human)		nucleosome [GO:0000786]; nucleus [GO:0005634]	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0046982	DIQLVSRIR	1.460000038	0.318796754	0.318796754	0.31744068	1101.006082	0	0	0	0	0	0	0	0	0	0	0	0	0	17.11571	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5TEU4	NDUF5_HUMAN	"Arginine-hydroxylase NDUFAF5, mitochondrial, EC 1.-.-.- (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5) (Putative methyltransferase NDUFAF5, EC 2.1.1.-)"	NDUFAF5 C20orf7	Homo sapiens (Human)	methylation [GO:0032259]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine hydroxylation [GO:0030961]	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; methylation [GO:0032259]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine hydroxylation [GO:0030961]	methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005743; GO:0008168; GO:0016491; GO:0030961; GO:0031314; GO:0032259; GO:0032981	REVTSGVSPR	1.340000033	0.244490623	0.244490623	0.199198721	1089.154771	13.81223	13.85154	0	14.50526	14.11782	0	0	14.85847	0	0	0	0	0	0	0	14.4156	13.75161	15.34002	0	12.55727	15.36501	0	0	0	0	0	0	0	0	17.01863	0	16.97173	0	0	9.794019	0	16.73706	0	0	14.64443	0	0	0	0	0	0	16.27039	14.12564
Q5TF58	IFFO2_HUMAN	Intermediate filament family orphan 2	IFFO2	Homo sapiens (Human)		intermediate filament [GO:0005882]	intermediate filament [GO:0005882]		GO:0005882	GLMSDPMTDLDTKIQEK	5.150000095	0.420786858	0.420786858	0.1093404	1938.378073	14.02792	16.64416	0	15.69469	0	0	16.0503	0	11.49697	0	0	0	0	17.23782	0	0	11.98023	17.72917	0	0	11.44151	0	0	18.67805	12.90635	0	12.58015	15.35146	14.80027	13.08224	15.28315	16.84426	15.66668	0	0	16.45452	0	0	14.60342	16.29483	14.42319	0	0	14.31734	0	16.90192	0	0
Q5TFG8	ZC21B_HUMAN	Zinc finger C2HC domain-containing protein 1B	ZC2HC1B C6orf94 FAM164B	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	DQSSRR	5.78000021	0.58754921	0.58754921	0.119783977	750.459333	0	16.16336	16.41058	0	0	15.55696	16.87423	17.43858	0	0	0	0	0	0	0	0	0	0	0	12.47594	16.82133	11.98009	18.23984	15.75282	12.30716	16.26526	13.09326	0	0	14.08714	18.46116	0	0	16.18761	16.11991	17.24588	16.53366	0	16.43763	16.09344	0	13.50059	0	0	17.98483	0	0	15.4693
Q5TG53	SEAS1_HUMAN	Putative uncharacterized protein SERTAD4-AS1 (SERTAD4 antisense RNA 1) (SERTAD4 antisense gene protein 1)	SERTAD4-AS1 C1orf133	Homo sapiens (Human)						VSATASIPFSCK	6.960000038	1	1	0.340997734	1267.28649	0	0	0	0	0	0	15.03167	16.72058	13.73429	13.40363	11.95864	13.70711	0	14.69854	0	15.66866	0	0	16.41885	0	0	0	14.42686	15.5346	0	0	0	0	0	0	0	0	0	0	0	0	0	16.03656	0	0	0	0	0	0	16.91686	0	0	0
Q5TGI4	SAMD5_HUMAN	"Sterile alpha motif domain-containing protein 5, SAM domain-containing protein 5"	SAMD5 SAMDC1	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	CTNIVYEWLK	9	0.142464548	0.142464548	0.451720598	1325.811925	15.60749	0	0	0	0	14.52328	15.61576	0	16.3969	14.94104	14.95887	15.64569	0	15.61827	15.7152	12.98641	0	15.38031	16.75038	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.17704	17.07301	0	0	15.04269	0	0	0	16.78429	0	0	15.96604
Q5TGJ6	HDGL1_HUMAN	Hepatoma-derived growth factor-like protein 1 (PWWP domain-containing protein 1)	HDGFL1 PWWP1	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	double-stranded DNA binding [GO:0003690]; transcription coregulator activity [GO:0003712]	GO:0003690; GO:0003712; GO:0005634; GO:0006357	SGDLVFAK	5.159999847	0.860842168	0.860842168	0.259065299	834.7288738	15.3821	0	17.11728	13.77355	15.70149	16.29337	15.16531	13.89466	0	15.9953	14.42244	16.85297	15.54362	16.1048	15.01016	0	0	16.02674	15.48133	0	0	16.02196	15.81487	18.12115	0	15.57673	0	0	0	15.61331	15.63221	16.02336	0	16.04107	14.11749	15.08175	15.98966	17.1869	0	16.15364	15.71881	16.0236	0	15.72307	13.93372	0	0	0
Q5TGP6	MROH9_HUMAN	Maestro heat-like repeat-containing protein family member 9	MROH9 C1orf129	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	DSSYLQERIMVIINK	3.970000029	1	1	0.258845387	1814.478668	0	15.33364	0	0	15.21033	14.21735	15.19125	14.90638	0	0	0	14.78861	0	0	12.22829	15.09414	0	0	14.92335	0	0	0	0	0	14.10185	0	0	0	0	0	0	16.08772	0	0	15.49352	0	12.95933	0	16.02776	0	14.3466	0	0	0	0	16.10557	0	0
Q5TGY3	AHDC1_HUMAN	AT-hook DNA-binding motif-containing protein 1	AHDC1	Homo sapiens (Human)			DNA binding [GO:0003677]	DNA binding [GO:0003677]	GO:0003677	AAETFPK	9.380000114	0.782700002	0.782700002	0.304664487	763.7917861	0	19.23786	18.66798	19.3162	0	0	0	18.95703	0	0	19.9864	0	16.56975	0	0	0	18.51092	0	0	0	17.87945	0	0	0	18.03547	17.64516	19.22546	19.30318	0	19.85841	20.52652	19.27379	18.94767	0	0	19.79759	19.0349	0	0	0	0	0	0	18.24669	0	19.02925	18.88405	0
Q5TH69	BIG3_HUMAN	Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3)	ARFGEF3 BIG3 C6orf92 KIAA1244	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012]	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]	integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0016021; GO:0030036; GO:0030658; GO:0032012	EHMGESLSLKAGGGDLLLPPSPK	7.760000229	1	1	2.29E-12	2357.727344	13.62603	13.38863	0	0	12.94593	14.24859	14.32403	13.47906	0	15.96965	15.4192	8.937363	0	14.27429	13.39478	14.27809	0	15.09699	13.15828	11.14545	12.06071	0	0	14.84452	0	0	0	0	0	0	0	0	0	14.02924	0	0	0	0	0	15.51845	0	14.52097	0	0	0	0	0	0
Q5THJ4	VP13D_HUMAN	Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D)	VPS13D KIAA0453	Homo sapiens (Human)	mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]		GO:0006623; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526	GGLLSTDDK	17.53000069	1	1	0.326743045	908.2047746	0	0	0	16.94085	0	0	0	0	0	0	16.37132	0	0	0	0	16.57173	0	0	0	18.4613	0	18.16528	0	15.89639	0	0	0	0	0	0	0	0	0	0	16.44703	0	16.8569	0	0	0	17.47425	0	0	0	0	0	0	0
Q5THK1	PR14L_HUMAN	Protein PRR14L (Proline rich 14-like protein)	PRR14L C22orf30	Homo sapiens (Human)						EEKYIR	8.850000381	0.277132481	0.277132481	0.230618164	837.0499807	0	0	13.01876	0	0	15.94547	0	0	15.67715	0	13.9702	0	13.79782	15.85173	0	12.90229	0	15.33007	14.499	17.16068	0	0	15.50547	0	15.84041	0	0	15.56545	14.96201	0	14.89734	0	0	0	16.59913	0	16.34012	15.30133	0	14.69816	15.01103	16.27344	15.05453	16.35663	0	0	0	16.57379
Q5THR3	EFCB6_HUMAN	"EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein, DJBP)"	EFCAB6 DJBP KIAA1672	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005654	FSSETAATPMATGDSAVAQR	9.359999657	1	1	0.068197986	1998.455291	0	16.39025	0	0	0	0	11.83153	0	0	0	8.857583	0	9.328116	0	0	16.98736	15.67225	0	0	0	0	0	0	0	14.02692	15.64992	0	0	0	0	14.92409	0	0	14.39033	12.0488	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5TIA1	MEI1_HUMAN	Meiosis inhibitor protein 1 (Meiosis defective protein 1)	MEI1	Homo sapiens (Human)	meiosis I [GO:0007127]		meiosis I [GO:0007127]		GO:0007127	DHQSTPPVQYGELQALLEAMLNR	1.830000043	1	1	0.497097658	2610.750761	0	0	0	0	0	0	19.18279	0	18.00491	0	15.34189	0	0	0	0	0	0	0	0	0	15.10987	0	0	20.119	0	0	0	0	0	0	15.02855	0	0	0	17.59419	0	18.81648	0	0	0	0	0	0	0	0	0	0	0
Q5TID7	CC181_HUMAN	Coiled-coil domain-containing protein 181	CCDC181 C1orf114	Homo sapiens (Human)		cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]	cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]	microtubule binding [GO:0008017]	GO:0002177; GO:0005737; GO:0005874; GO:0008017; GO:0036126	TILVERDGK	13.88000011	1	1	0.26054647	1029.526068	0	0	0	14.51012	14.93349	15.76891	0	0	14.32113	0	0	0	0	0	0	14.22173	0	0	0	0	0	0	0	14.68673	0	0	16.82961	0	0	0	0	0	0	0	0	0	0	0	16.42451	0	0	0	0	0	0	0	0	0
Q5TKA1	LIN9_HUMAN	"Protein lin-9 homolog, HuLin-9, hLin-9 (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein)"	LIN9 BARA TGS	Homo sapiens (Human)	"cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]"	nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]	"nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]"	DNA binding [GO:0003677]	GO:0000003; GO:0003677; GO:0005654; GO:0006351; GO:0006357; GO:0007049; GO:0017053; GO:0051726; GO:0071897	EMNTEAEKLK	2.359999895	0.234929413	0.234929413	0.07554179	1193.149371	13.93036	0	15.69822	0	15.15341	13.18353	12.69396	16.89369	0	14.96362	0	0	0	14.53954	0	0	12.93554	0	14.39487	0	13.80053	16.26685	16.31989	13.89646	0	0	0	15.42124	13.73915	16.03313	16.40831	14.5745	15.38313	13.88681	15.17489	17.63016	0	0	0	0	12.75753	0	0	15.82504	13.12173	0	10.66209	16.44762
Q5TYW1	ZN658_HUMAN	Zinc finger protein 658	ZNF658	Homo sapiens (Human)	"cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0042254; GO:0045892; GO:0046872; GO:0071294	CGKTFSQK	8.550000191	1	1	0.417999419	954.5783338	0	0	0	0	0	0	0	13.58183	14.8905	12.71653	0	13.63002	7.779477	14.22341	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.36433	0	0	0	0	0
Q5TYW2	A20A1_HUMAN	Ankyrin repeat domain-containing protein 20A1	ANKRD20A1 ANKRD20A	Homo sapiens (Human)		plasma membrane [GO:0005886]	plasma membrane [GO:0005886]		GO:0005886	HSESVK	21.65999985	0.879861772	0.879861772	0.257706371	685.6922584	18.23535	18.76257	17.15574	0	0	0	0	18.28341	19.28328	17.53461	17.35962	18.46827	18.23203	0	17.63128	18.78704	0	18.78812	0	0	17.42327	0	0	17.68877	0	0	17.87271	0	17.69325	17.11644	0	19.22432	0	0	19.09856	0	0	0	0	18.03231	0	0	16.77605	18.84082	18.0126	0	0	18.62426
Q5TZA2	CROCC_HUMAN	Rootletin (Ciliary rootlet coiled-coil protein)	CROCC KIAA0445	Homo sapiens (Human)	centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]	9+2 motile cilium [GO:0097729]; actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219]	9+2 motile cilium [GO:0097729]; actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219]; actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]	actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051656; GO:0070062; GO:0097729; GO:0120219; GO:1903566	AEAALEK	6.449999809	0.087849662	0.087849662	0.238801283	730.90886	0	14.79949	14.83658	0	0	0	15.15442	18.18345	0	16.96422	0	15.8689	0	16.65157	0	14.27718	13.51048	0	18.28854	17.03178	15.82403	17.37817	15.09973	16.14679	0	0	0	0	0	0	17.4631	0	0	16.91735	0	16.75849	0	0	0	18.72159	0	0	0	0	0	16.5731	15.0896	16.59716
Q5U5R9	HECD2_HUMAN	"Probable E3 ubiquitin-protein ligase HECTD2, EC 2.3.2.26 (HECT domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECTD2)"	HECTD2	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005829	GIINSLLR	10.31999969	1	1	0.277580853	885.1116955	15.00805	0	15.08123	13.81788	14.71793	15.55513	15.32195	0	0	15.25249	0	17.13446	14.82351	15.26418	16.98054	0	16.2631	0	15.09577	0	0	0	15.16032	0	0	14.54786	0	14.15007	15.51162	0	0	15.4372	16.62196	0	14.15914	16.37319	0	15.8168	16.62636	0	0	0	14.78397	0	0	16.68642	15.98224	14.89322
Q5U5X0	LYRM7_HUMAN	Complex III assembly factor LYRM7 (LYR motif-containing protein 7)	LYRM7 C5orf31 MZM1L	Homo sapiens (Human)	cellular respiration [GO:0045333]; mitochondrial respiratory chain complex III assembly [GO:0034551]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]	mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; cellular respiration [GO:0045333]; mitochondrial respiratory chain complex III assembly [GO:0034551]		GO:0005759; GO:0031966; GO:0034551; GO:0045333	SETSSK	10.02999973	1	1	0.202114172	638.7073375	0	15.30877	15.99605	14.08834	14.26359	0	0	15.39133	0	14.77904	0	13.64797	16.28588	0	15.73317	0	0	15.86451	17.08606	15.66385	0	16.913	0	0	17.27327	16.36954	0	15.36652	15.64	0	16.66009	0	14.09957	0	15.98162	14.02331	0	16.23182	0	0	0	14.96508	0	0	16.377	0	12.56215	0
Q5U5X8	F222A_HUMAN	Protein FAM222A	FAM222A C12orf34	Homo sapiens (Human)						VPQHKHLSR	8.739999771	0.358312875	0.358312875	0.108322287	1100.644479	0	0	0	0	11.88644	0	0	12.50858	0	16.74991	0	0	17.99549	0	15.59962	17.14349	16.62278	0	0	0	15.01071	0	0	0	17.12528	0	0	0	14.32702	0	0	0	0	0	0	0	0	0	0	0	13.97666	17.22178	0	0	9.701971	0	0	0
Q5U623	MCAF2_HUMAN	"Activating transcription factor 7-interacting protein 2, ATF7-interacting protein 2 (MBD1-containing chromatin-associated factor 2)"	ATF7IP2 MCAF2	Homo sapiens (Human)	"positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription coregulator activity [GO:0003712]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of transcription, DNA-templated [GO:0006355]"	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0005667; GO:0006355; GO:0090309	TRDTLPPQKPELK	1.00999999	1	1	0	1523.835284	18.00911	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5UCC4	EMC10_HUMAN	ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1)	EMC10 C19orf63 INM02 UNQ764/PRO1556	Homo sapiens (Human)	angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]	EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		GO:0001525; GO:0001938; GO:0005576; GO:0005789; GO:0010595; GO:0016021; GO:0030176; GO:0045050; GO:0045766; GO:0071816; GO:0072546; GO:1900745	LLLLLLMAVAAPSRAR	4.789999962	1	1	0.407738683	1724.469953	14.50104	13.38031	0	13.62629	0	0	0	13.73253	15.99292	0	0	15.69638	16.15677	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.79851	0	0	0	0	14.07406	0	0	16.3872	0	16.16599	0	0	15.99114	0	0	0	0	0	0	0
Q5UE93	PI3R6_HUMAN	"Phosphoinositide 3-kinase regulatory subunit 6 (Phosphoinositide 3-kinase gamma adapter protein of 87 kDa) (p84 PI3K adapter protein, p84 PIKAP) (p87 PI3K adapter protein, p87PIKAP)"	PIK3R6 C17orf38	Homo sapiens (Human)	angiogenesis [GO:0001525]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of T cell differentiation [GO:0045582]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]	"cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]"	"cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; angiogenesis [GO:0001525]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of T cell differentiation [GO:0045582]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]"	"1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]"	GO:0001525; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006955; GO:0007186; GO:0016020; GO:0042269; GO:0043406; GO:0045582; GO:0045766; GO:0046934; GO:0046935	TLEHYFHAVVAALEQMASEASPSR	3.349999905	1	1	0.004287192	2659.243203	15.98002	0	0	13.54303	0	12.35291	13.13154	14.31166	13.23014	13.52519	16.20725	14.16681	7.235061	0	14.3681	16.02155	15.18247	11.28747	11.95539	0	0	0	16.87781	16.29256	12.69478	15.42511	0	15.59647	0	0	0	14.85482	0	0	0	10.15122	0	15.47406	0	15.00478	16.94428	14.01623	15.56608	0	0	17.07201	0	0
Q5UIP0	RIF1_HUMAN	Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog)	RIF1	Homo sapiens (Human)	"cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; subtelomeric heterochromatin assembly [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]"	"chromatin [GO:0000785]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]"	"chromatin [GO:0000785]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; subtelomeric heterochromatin assembly [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]"		GO:0000122; GO:0000723; GO:0000785; GO:0000793; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006281; GO:0006974; GO:0007049; GO:0016604; GO:0019827; GO:0031509; GO:0031965; GO:0035861; GO:0043247; GO:0045814; GO:0045830; GO:0051233; GO:0051574; GO:0140445; GO:1990830; GO:2000042; GO:2001034	HNTTSAKGFLSPGSR	12.98999977	1	1	0.157522176	1562.681627	0	0	0	0	0	0	0	0	0	0	0	0	11.90286	13.84651	16.33229	0	15.60447	0	0	13.24347	0	15.67291	14.54252	15.85223	0	0	0	15.42109	0	12.41384	0	0	14.37007	15.25828	0	15.311	0	15.08099	0	15.27748	14.50733	0	0	0	15.40601	0	0	0
Q5VIY5	ZN468_HUMAN	Zinc finger protein 468	ZNF468	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	CEECCK	1.49000001	1	1	0.232730764	885.8143967	0	0	15.35498	0	15.32081	15.59213	15.67074	0	14.91403	0	14.97643	0	15.24998	15.61555	14.68438	0	15.8818	16.03367	0	14.115	0	17.0179	0	0	15.8837	16.48568	0	0	14.2341	15.29339	14.87224	17.29898	16.03308	15.81506	15.75923	15.78746	16.61126	16.89164	16.4596	16.12338	16.34637	15.47241	0	0	13.8089	16.40665	13.65951	0
Q5VSG8	MANEL_HUMAN	"Glycoprotein endo-alpha-1,2-mannosidase-like protein, EC 3.2.1.-"	MANEAL	Homo sapiens (Human)		Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]	alpha-mannosidase activity [GO:0004559]	GO:0000139; GO:0004559; GO:0005794; GO:0016021	ISASYPR	15.35999966	0.511272907	0.511272907	0.227247277	793.9401668	16.91185	19.96799	16.12896	18.30274	17.09788	16.18547	0	15.69435	15.32695	16.21243	14.68721	0	0	0	16.38635	17.3693	13.50718	0	16.92581	0	18.70619	17.06744	18.61162	17.60418	22.08652	17.4244	15.89431	17.48141	16.45212	17.55867	19.31471	22.14936	20.74445	19.81432	17.05985	16.18849	19.12667	19.35246	19.30707	17.37049	17.69289	18.60329	16.74942	16.28979	17.1939	15.81935	18.50718	15.63115
Q5VSL9	STRP1_HUMAN	Striatin-interacting protein 1 (Protein FAM40A)	STRIP1 FAM40A KIAA1761	Homo sapiens (Human)	cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]	protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]	GO:0005634; GO:0005829; GO:0007010; GO:0019901; GO:0022604; GO:0030866; GO:0031267; GO:0070062	DEVMPPPLQHPQTDRLTCPK	13.68999958	1	1	0.522039716	2375.107007	0	0	16.24279	0	16.72041	0	0	0	0	0	16.84039	17.3482	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.59715	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5VSP4	LC1L1_HUMAN	Putative lipocalin 1-like protein 1 (Lipocalin 1-like pseudogene 1)	LCN1P1 LCN1L1	Homo sapiens (Human)		extracellular space [GO:0005615]	extracellular space [GO:0005615]; small molecule binding [GO:0036094]	small molecule binding [GO:0036094]	GO:0005615; GO:0036094	AAGARGLSTESILIPR	7.53000021	1	1	2.29E-13	1611.440433	0	15.58534	0	0	0	0	0	0	18.5019	0	0	0	0	0	0	16.43408	17.07747	0	0	0	0	0	0	0	14.81875	16.38585	0	0	0	0	0	0	0	0	0	0	0	15.40085	0	0	0	0	0	0	0	0	0	0
Q5VST9	OBSCN_HUMAN	"Obscurin, EC 2.7.11.1 (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase, Obscurin-MLCK)"	OBSCN KIAA1556 KIAA1639	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; protein localization to M-band [GO:0036309]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214]	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; M band [GO:0031430]; myofibril [GO:0030016]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; M band [GO:0031430]; myofibril [GO:0030016]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cell-cell adhesion [GO:0098609]; protein localization to M-band [GO:0036309]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214]"	"ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]"	GO:0004674; GO:0004712; GO:0005085; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0008307; GO:0010314; GO:0016604; GO:0030016; GO:0030018; GO:0030506; GO:0031430; GO:0031432; GO:0032266; GO:0036309; GO:0042383; GO:0043325; GO:0045214; GO:0046872; GO:0050839; GO:0051056; GO:0070273; GO:0098609; GO:0106310	APTRSSPEPTPWEDIGQVSLVQIR	4.389999866	1	1	4.12E-12	2662.470631	13.73085	15.16875	0	0	13.0946	0	0	0	15.15485	0	0	14.414	0	7.933332	0	0	0	0	0	0	14.65299	0	14.82996	0	0	0	0	0	0	14.9395	0	16.21524	0	0	0	0	11.91264	0	0	0	0	0	15.26339	0	0	0	0	0
Q5VT06	CE350_HUMAN	"Centrosome-associated protein 350, Cep350 (Centrosome-associated protein of 350 kDa)"	CEP350 CAP350 KIAA0480 GM133	Homo sapiens (Human)	microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]	cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]	cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]	microtubule binding [GO:0008017]	GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0008017; GO:0016020; GO:0034453; GO:0042995; GO:0071539; GO:1905515	DIHEQK	5.25	1	1	0.16905505	768.5739941	16.98533	14.38044	16.59826	0	0	14.70739	14.49412	0	14.68302	16.45868	0	0	14.55113	15.43754	15.05865	0	0	0	15.48639	0	12.7186	0	0	0	0	0	0	15.49255	0	15.54419	0	0	0	0	15.88501	0	0	0	0	0	0	0	0	15.98376	15.14449	0	15.47621	0
Q5VT25	MRCKA_HUMAN	"Serine/threonine-protein kinase MRCK alpha, EC 2.7.11.1 (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha, MRCK alpha, Myotonic dystrophy protein kinase-like alpha)"	CDC42BPA KIAA0451	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0006468; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0042641; GO:0042802; GO:0070062; GO:0106310	DVLVNGDNK	8.989999771	0.712771833	0.712771833	0.196746296	972.7846704	10.65823	15.80762	15.36401	0	12.21322	12.42273	17.27429	0	0	16.39051	15.33902	16.59296	15.69232	14.10559	14.21103	0	0	0	0	0	15.31439	0	0	17.19746	14.21383	15.02844	0	0	12.78086	0	16.16728	16.23587	17.0987	15.50245	14.8711	16.95707	0	0	0	0	14.52472	0	0	0	0	0	16.33401	0
Q5VT28	FAM27_HUMAN	Protein FAM27A/B/C	FAM27B FAM27A FAM27A1 FAM27A2; FAM27C FAM27A3	Homo sapiens (Human)						EDACIFSR	4.210000038	1	1	0.316914205	996.8879866	0	17.343	0	0	0	0	0	0	0	0	0	0	0	0	0	17.60805	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.16423	0	0	0	0	0	0	0	0	0	0	0	0	0	18.3467	0	0	0
Q5VT52	RPRD2_HUMAN	Regulation of nuclear pre-mRNA domain-containing protein 2	RPRD2 KIAA0460 HSPC099	Homo sapiens (Human)	mRNA 3'-end processing [GO:0031124]	"nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]"	"nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]"	RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0005654; GO:0016591; GO:0031124	DPSVSK	2.480000019	0.277001679	0.277001679	0.308537338	631.4977366	0	0	0	0	0	0	0	0	0	0	0	17.79483	0	0	0	0	0	0	0	0	0	0	0	17.6275	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5VT66	MARC1_HUMAN	"Mitochondrial amidoxime-reducing component 1, mARC1, EC 1.7.-.- (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1, MOSC domain-containing protein 1, Moco sulfurase C-terminal domain-containing protein 1)"	MTARC1 MARC1 MOSC1	Homo sapiens (Human)	cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958]	"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]; cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]"	"molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]"	GO:0005739; GO:0005741; GO:0006809; GO:0008940; GO:0016021; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809; GO:1903958	DLLLPIK	27.45000076	0.028124491	0.028124491	0.219403301	811.8148532	20.08244	19.86635	19.00977	17.56266	15.13689	18.99162	17.35976	19.43639	17.95198	16.31389	17.09111	19.07445	0	0	19.18021	0	17.71633	17.93519	18.70953	17.87787	0	19.10674	0	19.90526	20.43973	16.73001	21.96197	16.88286	0	18.21433	21.95201	22.05439	0	14.2649	0	19.82451	21.1017	20.94867	0	0	18.87481	18.55483	0	0	0	0	20.04529	20.4097
Q5VT97	SYDE2_HUMAN	"Rho GTPase-activating protein SYDE2 (Synapse defective protein 1 homolog 2, Protein syd-1 homolog 2)"	SYDE2	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0016477; GO:0051056; GO:0090630	GAAYR	5.079999924	1	1	0.241267538	537.3795378	19.14417	0	17.6857	0	0	18.14813	0	0	17.70769	0	0	0	0	0	17.02626	0	0	0	0	18.92616	0	0	0	0	17.8354	0	19.34042	0	0	0	16.89028	17.93538	19.976	0	0	0	19.12174	0	0	0	0	0	0	0	16.93616	19.0144	0	0
Q5VTH2	FLTOP_HUMAN	Protein Flattop (Cilia- and flagella-associated protein 126)	CFAP126 C1orf192 FLTP	Homo sapiens (Human)	cilium organization [GO:0044782]	apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]	apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium organization [GO:0044782]		GO:0005737; GO:0005929; GO:0016324; GO:0036064; GO:0044782	MATNYSANQYEK	6.659999847	1	1	0.41904268	1436.992346	12.8915	17.44657	0	0	0	0	0	0	0	0	0	0	0	16.5479	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.50941	0	0	0	0	0	0	0	0	18.29662	0	0	0	0	0	0
Q5VTH9	DNAI4_HUMAN	Dynein axonemal intermediate chain 4 (WD repeat-containing protein 78)	DNAI4 WDR78	Homo sapiens (Human)	axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; motile cilium [GO:0031514]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; motile cilium [GO:0031514]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]	GO:0002244; GO:0003341; GO:0005858; GO:0005930; GO:0007018; GO:0031514; GO:0045503; GO:0045504; GO:0070286; GO:0120293	FTTILFAK	2.319999933	1	1	0.164664966	939.6467675	18.3858	13.02574	0	16.6438	0	18.77534	0	0	15.75431	0	18.58334	16.00923	0	15.7252	16.29313	0	0	0	0	0	0	0	16.36197	0	0	16.41718	0	17.60596	17.83734	0	19.43168	16.94658	17.91882	16.99826	15.75624	15.04692	17.28599	14.0728	14.65256	19.91211	16.81297	0	0	16.79578	0	0	0	0
Q5VTJ3	KLD7A_HUMAN	Kelch domain-containing protein 7A	KLHDC7A	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	LGSEPK	20.35000038	0.330959886	0.330959886	0.235051678	630.2345713	0	15.57532	0	15.13846	14.76381	5.903064	15.56075	0	15.085	0	15.53642	0	14.24496	15.02758	16.12865	0	16.85107	15.89042	0	15.57851	0	15.5625	16.23104	16.45055	15.92578	0	0	0	0	0	0	0	15.46085	0	15.68585	0	0	0	16.87998	0	16.87453	0	0	16.43336	0	16.33624	0	0
Q5VTL8	PR38B_HUMAN	Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)	PRPF38B	Homo sapiens (Human)	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	precatalytic spliceosome [GO:0071011]	precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]	GO:0003723; GO:0006397; GO:0008380; GO:0071011	AGGGCVMTIGEMLR	4.300000191	1	1	0.351984622	1466.964474	16.39409	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.04921	0	0	0	0	0	0	0	0
Q5VTM2	AGAP9_HUMAN	"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9, AGAP-9 (Centaurin-gamma-like family member 6)"	AGAP9 CTGLF6	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005634; GO:0046872	SSKSK	10.47999954	0.792694747	0.792694747	0.298030447	536.7345151	0	14.21614	15.73828	16.25813	15.8799	15.56535	14.03213	15.54661	15.57273	0	15.3112	0	15.22243	16.00102	15.34585	0	15.77165	15.65671	0	13.19478	14.17335	16.05881	0	16.36707	0	0	16.41839	15.26163	16.1955	14.03072	15.6236	16.06571	0	0	15.72941	0	0	16.12935	0	15.03665	16.83614	16.07506	0	0	14.76951	15.76011	16.49287	16.44734
Q5VTR2	BRE1A_HUMAN	"E3 ubiquitin-protein ligase BRE1A, BRE1-A, hBRE1, EC 2.3.2.27 (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A)"	RNF20 BRE1A	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of cell migration [GO:0030336]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	"HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of cell migration [GO:0030336]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0002039; GO:0003682; GO:0003713; GO:0003730; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006511; GO:0010390; GO:0030336; GO:0031062; GO:0031625; GO:0033503; GO:0033523; GO:0042393; GO:0042802; GO:0045893; GO:0046872; GO:0061630; GO:0071894; GO:1900364; GO:2001168	DMFNFK	10.67000008	0.856389523	0.856389523	0.320984212	800.737437	13.40211	15.60146	15.08468	0	14.78494	14.82087	14.50171	15.61647	15.94365	15.51002	0	0	19.17927	14.72015	15.29635	14.57496	14.63127	17.12143	16.50534	19.96277	18.60971	18.73611	17.9085	18.92355	18.68038	14.1998	15.01344	18.58092	15.88797	14.5842	17.92667	18.0814	19.43676	0	20.00881	19.29714	15.48146	20.5271	21.02655	19.40408	16.68738	19.67143	15.42635	19.72765	19.49338	17.476	19.92069	19.72279
Q5VTT5	MYOM3_HUMAN	Myomesin-3 (Myomesin family member 3)	MYOM3	Homo sapiens (Human)	muscle contraction [GO:0006936]	M band [GO:0031430]	M band [GO:0031430]; actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803]; muscle contraction [GO:0006936]	actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803]	GO:0006936; GO:0031430; GO:0042803; GO:0051015	VSDLQPGK	2.650000095	1	1	0.032266024	842.6584839	0	0	0	0	0	14.56353	10.79607	13.31364	15.45498	14.69003	14.96108	15.56829	14.94447	0	0	0	14.91936	0	0	0	0	0	0	13.02241	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.90867
Q5VTY9	HHAT_HUMAN	"Protein-cysteine N-palmitoyltransferase HHAT, EC 2.3.1.- (Hedgehog acyltransferase) (Melanoma antigen recognized by T-cells 2, MART-2) (Skinny hedgehog protein 1)"	HHAT MART2 SKI1	Homo sapiens (Human)	N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acyltransferase activity [GO:0016746]; GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224]	acyltransferase activity [GO:0016746]; GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409]	GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0008374; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345	YLVLFGVPALLMRLDGLTPPALPR	5.510000229	1	1	4.58E-12	2623.425467	0	0	11.53933	0	13.90797	13.24402	13.17207	0	0	15.9674	0	0	0	0	14.67937	0	0	0	11.77144	14.79026	11.14117	0	0	0	0	12.70098	0	13.18229	9.724465	12.91898	0	0	0	0	0	0	15.21981	0	0	0	0	0	0	0	0	0	0	0
Q5VU43	MYOME_HUMAN	Myomegalin (Cardiomyopathy-associated protein 2) (Phosphodiesterase 4D-interacting protein)	PDE4DIP CMYA2 KIAA0454 KIAA0477 MMGL	Homo sapiens (Human)	astral microtubule organization [GO:0030953]; positive regulation of microtubule nucleation [GO:0090063]; protein-containing complex assembly [GO:0065003]; regulation of Golgi organization [GO:1903358]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; myofibril [GO:0030016]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; myofibril [GO:0030016]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090]; astral microtubule organization [GO:0030953]; positive regulation of microtubule nucleation [GO:0090063]; protein-containing complex assembly [GO:0065003]; regulation of Golgi organization [GO:1903358]	enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090]	GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0019899; GO:0030016; GO:0030953; GO:0060090; GO:0065003; GO:0090063; GO:1903358	LVQALMER	10.31000042	1	1	0	972.7332587	0	0	14.1523	0	15.03249	0	12.91783	14.71466	0	0	0	0	13.6057	11.19493	0	14.83259	0	0	0	0	0	19.19296	0	0	0	0	0	0	0	0	0	0	0	0	14.78022	0	0	0	15.27559	0	0	17.10488	0	0	0	0	0	15.1385
Q5VU57	CBPC6_HUMAN	"Cytosolic carboxypeptidase 6, EC 3.4.17.24 (ATP/GTP-binding protein-like 4) (Protein deglutamylase CCP6)"	AGBL4 CCP6	Homo sapiens (Human)	anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958]	metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0008270; GO:0008285; GO:0015631; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607; GO:0098957; GO:0098958; GO:0120222; GO:1904115; GO:2000060	AGTGRR	1.169999957	1	1	0.273964328	618.7379253	15.06578	15.37382	12.78575	13.8963	14.5378	15.36271	13.94883	14.12517	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.764	0	0	0	0	0	0	0	17.65085	0	15.82891	16.42506	0	0	0	0	0	15.10791	16.29004	14.99327	0	15.6237	0	17.05664	0	15.2847
Q5VU65	P210L_HUMAN	Nuclear pore membrane glycoprotein 210-like (Nucleoporin 210 kDa-like) (Nucleoporin Nup210-like)	NUP210L	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nuclear pore [GO:0005643]	integral component of membrane [GO:0016021]; nuclear pore [GO:0005643]		GO:0005643; GO:0016021	AVRILAAATR	10.38000011	0.569455266	0.569455266	0.228510204	1038.539188	0	0	0	0	0	0	0	0	0	0	0	14.95007	0	0	15.57862	0	0	0	0	13.95392	0	16.23124	16.37998	0	16.64065	15.23042	0	0	13.12292	0	0	16.0624	17.0634	0	15.33736	17.62549	0	0	0	0	18.514	0	0	0	0	15.82063	15.4635	0
Q5VU92	DC121_HUMAN	DDB1- and CUL4-associated factor 12-like protein 1 (WD repeat-containing protein 40B)	DCAF12L1 WDR40B	Homo sapiens (Human)		Cul4-RING E3 ubiquitin ligase complex [GO:0080008]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]		GO:0080008	AGSALSR	10.31000042	0.90943104	0.90943104	0.265623636	660.0706905	0	17.64853	0	18.28395	0	17.22184	0	18.12252	0	18.96063	17.05788	0	0	17.50789	16.60753	16.77254	0	15.96678	16.59039	0	17.07056	0	16.72911	17.7334	18.43777	17.85332	0	17.10301	0	0	0	18.60874	0	19.03456	17.6478	0	18.55071	18.17285	17.80381	0	0	0	0	0	0	0	0	0
Q5VU97	CAHD1_HUMAN	"VWFA and cache domain-containing protein 1, Cache domain-containing protein 1"	CACHD1 KIAA1573 VWCD1	Homo sapiens (Human)		voltage-gated calcium channel complex [GO:0005891]	voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245]	voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005891	DSSEEDK	8.93999958	1	1	0.275761554	808.4869899	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.21792	0	0	0	0	0	0	0	0	0	0	0	0	0	17.96973	0	0	0	0	0
Q5VUA4	ZN318_HUMAN	Zinc finger protein 318 (Endocrine regulatory protein)	ZNF318 HRIHFB2436	Homo sapiens (Human)	"meiotic cell cycle [GO:0051321]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005654; GO:0005829; GO:0008270; GO:0042803; GO:0045892; GO:0045893; GO:0051321	DDGGGGPR	7.110000134	0.654793203	0.654793203	0.260469259	731.2820331	16.70827	16.10206	15.42471	14.80823	15.61316	15.17216	15.59022	15.50996	13.76238	15.97433	15.59872	15.918	16.06287	13.99362	16.09131	0	16.14904	16.01933	15.46903	15.91597	16.63844	16.71885	0	17.06439	16.97876	0	16.46449	15.03662	0	0	16.19133	16.34165	17.84272	17.2163	16.69311	16.62078	0	18.71052	17.98681	16.63305	16.64833	17.1759	17.52668	16.42451	17.17122	17.65309	16.86623	15.89757
Q5VUD6	DIK1B_HUMAN	Divergent protein kinase domain 1B (Protein FAM69B)	DIPK1B C9orf136 FAM69B PP6977	Homo sapiens (Human)		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021	DNRVSLAEAK	10.93000031	0.839510202	0.839510202	0.271240729	1101.168403	0	17.32604	14.06889	0	0	0	0	0	0	16.76172	0	12.90051	0	0	16.37285	16.97033	0	0	0	15.90212	0	15.0941	0	15.66102	17.38639	17.40149	16.55327	15.08683	0	0	10.65613	16.92708	0	0	0	17.3467	16.2703	17.20153	18.21778	0	0	0	16.15151	15.81007	15.53169	17.1375	16.00702	15.97988
Q5VUJ6	LRCH2_HUMAN	Leucine-rich repeat and calponin homology domain-containing protein 2	LRCH2 KIAA1495	Homo sapiens (Human)						IAAQLLQQEQK	13.13000011	1	1	0.45385775	1268.526297	20.85432	19.51933	17.60905	0	18.29157	0	0	0	21.08597	0	15.48922	19.63176	21.34248	0	0	22.32721	0	0	0	0	18.20491	21.26782	21.43849	21.88809	0	17.45029	0	18.42421	0	0	0	0	20.73981	0	18.33267	0	18.69942	17.22582	0	0	0	20.68539	21.02118	17.25467	0	18.76678	17.09119	17.74279
Q5VV41	ARHGG_HUMAN	Rho guanine nucleotide exchange factor 16 (Ephexin-4)	ARHGEF16 EPHEXIN4 NBR	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; positive regulation of protein localization to plasma membrane [GO:1903078]	cytosol [GO:0005829]	cytosol [GO:0005829]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; positive regulation of protein localization to plasma membrane [GO:1903078]	cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005829; GO:0030165; GO:0030971; GO:0031267; GO:0045296; GO:0060326; GO:0090630; GO:1903078	AKTPAR	3.680000067	1	1	0.152570234	642.3242969	14.15699	15.60341	0	15.37464	0	14.51805	0	15.7501	0	14.90893	16.02322	15.2176	15.10053	16.02127	0	14.84127	0	0	0	0	0	0	0	0	0	17.08711	0	0	0	0	0	0	16.83192	0	0	0	0	0	15.52025	0	0	0	17.58726	0	0	0	0	0
Q5VV42	CDKAL_HUMAN	"Threonylcarbamoyladenosine tRNA methylthiotransferase, EC 2.8.4.5 (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)"	CDKAL1	Homo sapiens (Human)	maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]"	GO:0005783; GO:0005789; GO:0005791; GO:0016020; GO:0016021; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712; GO:1990145	KAQEENK	32.54999924	0.002631636	0.002631636	0.224547484	847.4821178	19.52641	18.80006	19.04523	18.28552	0	19.7895	19.74642	0	19.55707	0	20.15391	0	18.73356	0	16.96095	19.1093	0	0	19.92968	0	20.07459	0	0	0	0	19.55328	19.1722	0	18.96715	19.9271	20.38153	19.35649	20.90938	15.22709	0	18.63491	0	19.23407	19.28727	0	19.11868	0	18.02724	19.29931	0	0	20.26118	19.01508
Q5VV43	K0319_HUMAN	Dyslexia-associated protein KIAA0319	KIAA0319	Homo sapiens (Human)	multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996]		GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016021; GO:0030517; GO:0030669; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:2000171	HVLVLPNNSITLDGSR	4.460000038	1	1	0.084156323	1738.322181	13.17624	13.56178	0	0	0	0	0	0	0	0	0	0	0	0	0	12.78565	11.95005	0	12.29671	0	0	12.52815	0	0	11.85601	15.88616	15.92192	0	15.46609	14.63199	14.79597	13.70686	14.57245	15.78923	13.05189	0	13.66987	13.67958	0	0	0	0	13.88888	0	15.2854	0	0	13.21566
Q5VV63	ATRN1_HUMAN	Attractin-like protein 1	ATRNL1 KIAA0534	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	carbohydrate binding [GO:0030246]	GO:0005604; GO:0007186; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0030246; GO:0034446	AVLHGK	7.050000191	1	1	0.267331519	623.914692	0	14.97682	15.28578	0	0	0	0	13.39013	0	15.81713	0	0	0	0	0	16.64693	0	0	0	0	0	0	0	16.13916	15.77725	0	0	0	15.94675	0	0	0	0	0	0	0	0	0	0	0	16.23014	0	0	14.65469	16.35039	0	0	16.50577
Q5VVW2	GARL3_HUMAN	GTPase-activating Rap/Ran-GAP domain-like protein 3	GARNL3	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0051056; GO:0090630	QMHVLETLDLLVLRADK	5.389999866	0.942818165	0.942818165	0.132965788	1994.485107	0	14.99749	16.28909	16.53054	15.22626	0	15.08181	0	15.69114	16.81705	0	16.53149	0	16.33158	12.55485	14.28541	16.27522	0	15.69159	13.68344	13.29745	13.84885	15.58945	0	16.91218	0	15.84793	0	15.37204	13.39827	15.62813	15.61102	15.58844	14.67826	0	15.69327	0	0	15.89495	14.52762	0	15.19772	16.80773	13.37753	15.71165	14.97945	15.9492	16.80457
Q5VVX9	UBE2U_HUMAN	"Ubiquitin-conjugating enzyme E2 U, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme U) (Ubiquitin carrier protein U) (Ubiquitin-protein ligase U)"	UBE2U	Homo sapiens (Human)	DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]	HULC complex [GO:0033503]	HULC complex [GO:0033503]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0005524; GO:0006281; GO:0016574; GO:0033503; GO:0043161; GO:0061631	TTSFSDYYQTWSR	3.480000019	1	1	0.248830642	1639.702727	0	0	14.98711	15.5625	0	0	0	0	0	0	0	15.01165	0	16.51267	0	0	0	0	0	0	0	0	0	0	0	0	0	15.25142	15.41292	0	16.29965	0	14.87787	17.08475	0	16.31924	0	17.86992	0	0	0	0	0	0	0	0	0	0
Q5VW38	GP107_HUMAN	Protein GPR107 (Lung seven transmembrane receptor 1)	GPR107 KIAA1624 LUSTR1	Homo sapiens (Human)	clathrin-dependent endocytosis [GO:0072583]	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583]	clathrin heavy chain binding [GO:0032050]	GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030136; GO:0032050; GO:0072583	MAALAPVGSPASRGPR	11.93999958	1	1	0.502664969	1554.972376	0	0	0	0	0	0	0	0	0	0	17.93008	20.17197	0	21.01993	0	0	0	21.40844	21.30387	0	0	0	0	0	0	0	0	19.84221	0	0	0	0	21.9315	0	0	0	0	0	0	0	0	0	0	0	0	22.2768	0	0
Q5VWG9	TAF3_HUMAN	"Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit, TAF(II)140, TAF140, TAFII-140, TAFII140)"	TAF3	Homo sapiens (Human)	maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulator inhibitor activity [GO:0140416]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]	metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulator inhibitor activity [GO:0140416]	GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005669; GO:0006468; GO:0016251; GO:0031965; GO:0042789; GO:0043433; GO:0046872; GO:0046982; GO:0051123; GO:0051457; GO:0060261; GO:0140416	LLSTKGDTLDVVLLEAR	2.980000019	1	1	0.231090913	1836.287926	13.53326	12.87063	0	0	14.23985	0	13.09257	12.22996	0	15.00002	0	14.07513	14.17762	0	14.26381	0	0	13.85735	0	0	0	0	0	0	0	0	16.75228	0	0	0	0	0	0	0	0	0	0	0	0	17.79603	0	0	0	0	0	0	0	0
Q5VWI1	TCRGL_HUMAN	Transcription elongation regulator 1-like protein	TCERG1L	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; RNA polymerase binding [GO:0070063]; transcription coregulator activity [GO:0003712]	RNA polymerase binding [GO:0070063]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0070063	LLEESKVSPR	6.320000172	1	1	0.342191171	1156.701914	0	12.76362	0	0	0	0	14.0782	0	12.70441	14.71553	14.98771	0	14.89102	0	0	15.06961	0	0	16.05509	14.47675	14.07935	15.95436	0	15.25449	0	0	0	0	0	16.0428	0	0	0	0	0	0	0	16.94754	0	0	0	0	15.27576	0	0	0	0	0
Q5VWJ9	SNX30_HUMAN	Sorting nexin-30	SNX30	Homo sapiens (Human)	positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phosphatidylinositol binding [GO:0035091]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]	phosphatidylinositol binding [GO:0035091]	GO:0005769; GO:0015031; GO:0031901; GO:0035091; GO:2000786	ALPSTGPHSLR	6.289999962	1	1	4.71E-13	1135.298728	0	0	0	0	0	0	0	0	0	0	15.45203	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5VWK5	IL23R_HUMAN	"Interleukin-23 receptor, IL-23 receptor, IL-23R"	IL23R	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-23-mediated signaling pathway [GO:0038155]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]	external side of plasma membrane [GO:0009897]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	external side of plasma membrane [GO:0009897]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-23-mediated signaling pathway [GO:0038155]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]	GO:0001916; GO:0002230; GO:0002827; GO:0004896; GO:0005886; GO:0006954; GO:0006955; GO:0009897; GO:0010536; GO:0019221; GO:0019955; GO:0032496; GO:0032693; GO:0032725; GO:0032729; GO:0032735; GO:0032740; GO:0032819; GO:0034341; GO:0038155; GO:0042102; GO:0042104; GO:0042509; GO:0042531; GO:0043235; GO:0043382; GO:0045672; GO:0046427; GO:0050829; GO:0051135; GO:0051142; GO:0072536; GO:2000318; GO:2000330	ILLLIPK	34.68000031	1	1	0.314040272	810.6053763	19.08963	20.45534	16.32932	16.0902	15.8445	21.39779	20.09955	20.43065	20.41722	18.16706	0	21.29852	20.62179	20.87066	20.40854	20.46861	20.63404	0	20.40341	19.69969	0	18.22191	20.2105	18.00417	0	0	20.66004	0	19.28505	18.05676	20.15426	20.84419	0	0	18.68554	0	0	0	19.39395	0	0	0	21.71539	20.32608	0	0	20.34338	0
Q5VWM3	PRA18_HUMAN	PRAME family member 18	PRAMEF18	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"		GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892	GRVILELLTPLQAELMR	1.220000029	1	1	0.123891809	1967.2731	17.51693	0	14.80964	0	14.07568	0	0	13.92092	0	0	0	12.6661	14.66202	0	0	13.89714	0	0	0	12.28765	10.73667	16.38619	13.97482	0	11.66725	16.28447	0	0	0	0	18.27514	17.14724	0	14.91672	0	16.28008	17.54921	11.69871	0	16.97381	0	15.82815	12.8842	12.31181	15.86858	17.16175	14.9716	14.44499
Q5VWM4	PRAM8_HUMAN	PRAME family member 8	PRAMEF8 PRAMEF24	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"		GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892	ASACIPPDNK	5.28000021	1	1	0.248030899	1072.992757	13.86623	0	0	0	0	12.56137	0	0	0	0	0	0	0	0	0	14.55152	0	15.13971	0	0	0	0	0	0	0	0	0	14.90695	0	13.85805	0	15.3254	15.19815	14.73163	0	15.76424	0	14.58081	0	16.07866	0	0	0	0	0	15.15402	0	10.85944
Q5VWM6	PRA13_HUMAN	Putative PRAME family member 13	PRAMEF13	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]"		GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892	NCMSMGALK	5.869999886	1	1	0.166002005	1010.409065	14.43573	12.12184	14.65084	13.29781	14.20141	0	0	14.61738	0	0	16.61549	17.35691	0	0	0	0	14.03373	0	0	0	0	0	0	0	0	15.6123	14.68099	0	0	0	0	0	16.39022	0	0	0	0	0	0	0	0	0	0	14.82245	0	0	0	0
Q5VWN6	TASO2_HUMAN	Protein TASOR 2	TASOR2 C10orf18 FAM208B KIAA2006	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005829	DGEVGVNSDMHYELSGDSDLDLLGDCRNPR	3.170000076	1	1	3.21E-12	3350.98006	10.46612	12.03624	5.601154	13.47002	14.65165	12.65511	0	0	0	0	0	14.55572	13.25781	13.07917	0	0	11.13793	0	12.63164	15.55261	0	0	0	15.39258	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.51587	14.99929	0	0	0	0	0	0	0
Q5VWP2	TET5C_HUMAN	"Terminal nucleotidyltransferase 5C, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46C)"	TENT5C FAM46C	Homo sapiens (Human)	in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]; negative regulation of cell differentiation [GO:0045596]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]; negative regulation of cell differentiation [GO:0045596]	polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]	GO:0001701; GO:0003723; GO:0004652; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0045596; GO:0048255; GO:1990817	DNGLGCK	16.37000084	0.228005409	0.228005409	0.219444052	761.3389357	15.67649	15.36401	16.30027	0	0	0	0	0	0	0	0	16.06635	16.69024	16.78556	0	16.7333	15.05792	0	0	17.1808	17.77309	0	15.85142	16.91661	17.71998	0	16.24122	0	16.9954	16.06967	16.02099	0	16.456	16.30178	16.85889	0	16.84677	17.2716	17.04157	16.64992	17.13719	15.82504	15.76794	17.36307	16.91631	17.17983	15.79225	17.13281
Q5VWP3	MLIP_HUMAN	"Muscular LMNA-interacting protein (Cardiac Isl1-interacting protein, CIP) (Muscular-enriched A-type laminin-interacting protein)"	MLIP C6orf142 Cip	Homo sapiens (Human)	negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcolemma [GO:0042383]	nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcolemma [GO:0042383]; lamin binding [GO:0005521]; transcription corepressor activity [GO:0003714]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]	lamin binding [GO:0005521]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005521; GO:0005634; GO:0005635; GO:0010614; GO:0016605; GO:0031981; GO:0042383; GO:0045944; GO:1903243	SNDYLTLNAGSQQERDQAK	5.610000134	1	1	0.127639101	2138.49429	0	13.50196	0	0	14.09549	13.59552	14.02569	0	14.39224	0	0	12.18324	13.67302	14.50294	0	13.55802	0	0	16.38677	15.81188	15.69497	0	14.58937	0	16.33706	16.41062	0	15.66617	0	15.37384	16.16214	15.27938	16.18316	0	15.14298	15.53757	15.09548	14.73439	14.90139	16.40995	15.02502	0	0	0	0	0	0	0
Q5VWQ0	RSBN1_HUMAN	"Lysine-specific demethylase 9, KDM9, EC 1.14.11.- (Round spermatid basic protein 1)"	RSBN1	Homo sapiens (Human)	chromatin organization [GO:0006325]	nucleus [GO:0005634]	nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]	dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]	GO:0005634; GO:0006325; GO:0046872; GO:0051213	AGPMR	13.56000042	0.90100342	0.90100342	0.177552687	547.300654	0	16.99402	16.38782	16.9895	17.51817	16.96028	16.85191	17.03525	16.29026	17.00143	16.68938	0	16.32708	16.89457	16.25322	16.85501	15.8818	16.85955	17.35267	16.75479	17.03264	16.36513	17.01256	17.13478	16.94686	0	0	17.84723	16.4553	17.50233	17.09893	16.80073	18.26361	0	17.7443	17.76448	17.40681	17.6388	0	17.41999	16.77757	17.04728	18.83968	17.87971	17.57344	0	18.66833	17.09331
Q5VWQ8	DAB2P_HUMAN	"Disabled homolog 2-interacting protein, DAB2 interaction protein, DAB2-interacting protein (ASK-interacting protein 1, AIP-1) (DOC-2/DAB-2 interactive protein)"	DAB2IP AF9Q34 AIP1 KIAA1743	Homo sapiens (Human)	"angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell cycle [GO:0051726]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]"	AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]	"AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell cycle [GO:0051726]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]"	14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	GO:0000122; GO:0001525; GO:0001933; GO:0005096; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007049; GO:0007252; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0014067; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032088; GO:0032266; GO:0032809; GO:0034144; GO:0034260; GO:0034620; GO:0035148; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0038026; GO:0040008; GO:0042059; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043124; GO:0043184; GO:0043254; GO:0043407; GO:0043410; GO:0043507; GO:0043539; GO:0043548; GO:0043553; GO:0044257; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045296; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050680; GO:0051721; GO:0051726; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0071901; GO:0071902; GO:0072577; GO:0090090; GO:0090129; GO:1900006; GO:1900744; GO:1900747; GO:1901800; GO:1903363; GO:1903896; GO:1990032; GO:1990597; GO:2001224; GO:2001235	ARYQTITILPMEMYK	3.880000114	0.589540601	0.589540601	0.343149598	1890.586091	15.55756	0	14.82188	0	12.99419	0	0	0	0	0	0	0	0	0	15.44251	0	15.60782	0	15.78972	0	0	0	0	0	0	0	0	13.1566	0	0	15.66323	15.83175	15.15053	0	0	14.94589	15.70793	15.82039	0	0	15.74686	0	0	15.68086	0	0	0	0
Q5VWW1	C1QL3_HUMAN	"Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13, C1q/TNF-related protein 13)"	C1QL3 CTRP13	Homo sapiens (Human)	regulation of synapse organization [GO:0050807]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; regulation of synapse organization [GO:0050807]	identical protein binding [GO:0042802]	GO:0005581; GO:0005615; GO:0042802; GO:0050807	LDGGKAHGGNNNK	19.95999908	0.934963465	0.934963465	0.376840095	1282.939536	16.30172	0	17.1233	0	16.93791	0	0	0	0	16.2042	16.45483	17.58757	15.81598	0	12.46072	13.49903	16.84596	0	0	17.12172	0	0	0	0	0	0	0	0	0	0	0	0	14.5193	0	0	0	0	0	0	16.37996	0	15.62958	0	0	17.47077	0	11.49241	0
Q5VWX1	KHDR2_HUMAN	"KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1, SLM-1, hSLM-1)"	KHDRBS2 SLM1	Homo sapiens (Human)	"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]	GO:0000381; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024	GVLTPRGSTVTR	1.960000038	1	1	0.154548443	1244.42678	13.70142	0	12.10484	13.50784	12.64814	0	12.1058	0	0	12.96116	0	0	16.00086	0	13.655	0	12.32751	13.89463	0	0	0	0	0	0	15.74421	16.77135	0	0	0	0	0	0	13.43134	0	0	0	0	0	0	0	0	0	0	0	15.17592	0	12.81956	0
Q5VWZ2	LYPL1_HUMAN	"Lysophospholipase-like protein 1, EC 3.1.2.22"	LYPLAL1	Homo sapiens (Human)	protein depalmitoylation [GO:0002084]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084]	carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0004622; GO:0005737; GO:0005829; GO:0008474; GO:0052689	SLGVTTKFHSFPNVYHELSK	6.989999771	1	1	0.168830944	2290.401067	0	0	16.11652	0	0	0	0	0	18.03085	0	0	16.00702	0	0	0	0	0	0	0	0	16.34816	0	0	0	0	17.22121	0	0	0	0	19.14232	0	0	0	16.94522	0	0	0	18.54005	0	0	0	0	15.87804	0	0	0	0
Q5VX52	SPAT1_HUMAN	Spermatogenesis-associated protein 1 (Sperm-specific protein SP-2)	SPATA1	Homo sapiens (Human)		acrosomal vesicle [GO:0001669]	acrosomal vesicle [GO:0001669]		GO:0001669	MKLIVEVK	10.71000004	1	1	0.20683329	974.5294764	0	0	0	0	17.94626	16.0139	17.8901	0	0	0	16.49651	0	0	18.75021	18.91793	17.17839	18.03811	18.38092	18.44985	16.42043	17.63695	16.94206	17.2965	16.06183	0	0	17.39986	17.36121	16.14973	16.40546	18.10366	18.67313	0	18.14323	16.14659	0	18.45687	19.23331	17.77362	17.95879	18.26707	0	18.58773	17.95635	18.59254	17.7303	18.96377	17.29999
Q5VX71	SUSD4_HUMAN	Sushi domain-containing protein 4	SUSD4 UNQ196/PRO222	Homo sapiens (Human)	"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]"	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]"		GO:0005576; GO:0006958; GO:0016021; GO:0030449; GO:0045087; GO:0045957; GO:0045959	MFQTKFK	2.329999924	0.468210965	0.468210965	0.099636494	944.2702928	0	0	14.38122	13.36178	0	14.96303	0	0	0	0	0	0	0	14.89228	0	0	0	14.69792	0	0	0	0	13.98456	0	0	0	0	16.32339	0	0	0	0	15.72878	0	0	0	0	0	0	13.93842	15.18189	0	0	0	0	0	0	0
Q5VXT5	SYPL2_HUMAN	Synaptophysin-like protein 2	SYPL2	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; substantia nigra development [GO:0021762]; T-tubule organization [GO:0033292]	integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]	integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; substantia nigra development [GO:0021762]; T-tubule organization [GO:0033292]		GO:0006874; GO:0007507; GO:0016021; GO:0021762; GO:0030672; GO:0033292	VLQWLFAIFAFGSCGSYSGETGAMVR	3.900000095	0.581546366	0.581546366	0.04948583	2854.083516	15.16796	0	0	0	0	15.99731	0	14.48074	0	0	13.89697	0	16.30922	16.68717	0	13.88382	0	0	16.66619	15.50712	0	13.14725	0	15.62011	0	0	14.30948	12.07134	0	14.64889	15.08572	15.96205	0	16.03665	14.68267	0	14.21933	15.05352	13.79484	13.47177	14.8771	0	15.88265	14.41692	17.06452	0	0	13.76579
Q5VYJ5	MALR1_HUMAN	MAM and LDL-receptor class A domain-containing protein 1	MALRD1 C10orf112 DIET1	Homo sapiens (Human)	cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]		GO:0005794; GO:0016021; GO:0030659; GO:0042632; GO:0070858	LGSPVLTK	13.46000004	1	1	0.067494904	814.5546843	0	11.67152	16.08923	0	16.20046	15.75685	14.26145	12.71785	17.19996	12.68686	13.44359	0	0	17.70961	0	16.33673	17.38795	15.84862	20.1092	0	0	14.52161	14.71076	0	0	14.22328	16.15536	14.32872	0	0	0	15.85415	0	14.50557	0	0	17.60225	18.16068	0	0	16.20922	0	0	14.97999	0	15.57622	0	14.986
Q5VYK3	ECM29_HUMAN	Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog)	ECPAS ECM29 KIAA0368	Homo sapiens (Human)	proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433]	centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]	centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]; proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433]	molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]	GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0030433; GO:0031410; GO:0043248; GO:0060090; GO:0070628	AAMDSARLSAAK	2.940000057	1	1	0.174906194	1206.774289	0	0	15.76401	0	13.20897	12.4489	13.74291	0	13.44624	0	13.9055	0	0	0	14.74828	14.57743	0	0	0	0	0	0	13.52653	15.84445	0	11.92481	0	0	0	0	0	0	0	0	14.80633	0	0	0	0	0	12.49352	11.46761	0	13.96277	0	0	14.53557	15.02403
Q5VYM1	CI131_HUMAN	Uncharacterized protein C9orf131	C9orf131	Homo sapiens (Human)						SMGVLSDSEARCGDIQK	2.180000067	1	1	0.277150707	1868.625498	14.57362	16.07343	0	0	13.68337	0	0	13.58415	0	0	14.13746	12.08586	0	14.15328	11.87227	7.961958	15.12926	0	16.87181	6.668258	0	16.63089	0	0	0	0	12.11102	14.92488	0	14.68852	0	15.50674	0	0	12.67118	0	0	0	0	0	0	0	14.61988	13.82277	15.52351	0	16.55096	0
Q5VYP0	S31A3_HUMAN	Spermatogenesis-associated protein 31A3 (Protein FAM75A3)	SPATA31A3 FAM75A3	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		GO:0007283; GO:0016021; GO:0030154	KPNCQGSCK	4.960000038	0.209843755	0.209843755	0.227196068	1074.674887	0	14.83128	0	0	0	0	0	0	0	0	15.98578	0	15.74973	13.00913	14.38091	0	0	15.60091	0	16.07463	0	0	0	14.68357	0	0	0	15.30123	15.46329	0	14.46329	14.97794	15.50141	14.02116	15.45626	15.05348	0	15.46865	15.81134	15.10985	13.52788	15.13187	14.17488	15.81078	8.333624	11.95278	14.55446	11.08348
Q5VYS8	TUT7_HUMAN	"Terminal uridylyltransferase 7, TUTase 7, EC 2.7.7.52 (Zinc finger CCHC domain-containing protein 6)"	TUT7 HS2 KIAA1711 ZCCHC6	Homo sapiens (Human)	"miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]"	miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]	GO:0000289; GO:0001556; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0016779; GO:0031054; GO:0031123; GO:0035198; GO:0050265; GO:0070569; GO:0071076; GO:1990074	GHGSK	3.839999914	0.210399553	0.210399553	0.234419928	485.1529203	13.87724	15.92391	15.38367	16.21622	16.23964	15.09474	0	15.29443	0	0	15.80426	14.4016	16.53025	15.75403	15.41284	14.36207	0	16.38073	0	0	0	14.79099	0	0	15.79216	0	0	14.74673	15.71379	16.09698	14.47066	13.34343	14.49552	15.63995	16.45675	15.27032	14.97592	17.54874	0	13.62489	17.47426	17.0558	16.09658	15.98222	12.3451	15.82039	16.30858	16.74192
Q5VYV7	SLX4I_HUMAN	Protein SLX4IP (SLX4-interacting protein)	SLX4IP C20orf94	Homo sapiens (Human)						EIIVEK	7.429999828	1	1	0.28544911	731.2885345	18.93632	16.43324	0	16.02925	0	0	0	16.97088	18.35566	17.3262	0	0	17.38645	0	0	17.27956	0	0	0	0	15.49622	17.08161	0	16.38025	16.98477	0	0	17.58095	0	0	17.27247	19.76835	0	0	0	0	17.4753	0	0	18.55457	0	0	0	0	0	0	0	0
Q5VZ18	SHE_HUMAN	SH2 domain-containing adapter protein E	SHE	Homo sapiens (Human)			phosphotyrosine residue binding [GO:0001784]	phosphotyrosine residue binding [GO:0001784]	GO:0001784	AKPGGGGGK	12.07999992	1	1	0.168151467	728.629308	0	15.28349	16.48616	0	16.38296	14.94012	13.70055	15.97687	14.48472	0	0	16.6201	0	0	0	0	0	0	0	0	0	0	0	0	0	16.43187	0	0	16.03894	0	0	15.8171	0	0	16.33452	0	0	0	0	13.63646	14.21611	0	0	0	0	0	0	0
Q5VZ19	TDR10_HUMAN	Tudor domain-containing protein 10	TDRD10 UNQ9380/PRO34205	Homo sapiens (Human)	P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]	P granule [GO:0043186]	P granule [GO:0043186]; RNA binding [GO:0003723]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]	RNA binding [GO:0003723]	GO:0003723; GO:0030719; GO:0034587; GO:0043186	AAFFAVPLEMRGSFLVLLLR	9.090000153	1	1	0.28258147	2265.682424	0	15.8261	13.18366	14.67128	13.87416	12.14724	14.44539	0	12.96626	13.35504	0	13.45682	9.910794	12.7787	14.7832	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.72589	0	0	0	0
Q5VZ46	K1614_HUMAN	Uncharacterized protein KIAA1614	KIAA1614	Homo sapiens (Human)	centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341]	apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; nucleus [GO:0005634]	apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein kinase C binding [GO:0005080]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341]	protein kinase C binding [GO:0005080]	GO:0005080; GO:0005634; GO:0005938; GO:0007098; GO:0007163; GO:0016324; GO:0060341	APPVPRTLQELQAACGMER	5.639999866	1	1	0.160873185	2140.684921	15.94539	11.41855	17.80346	14.90283	13.17719	0	14.55455	0	14.76551	0	0	0	15.17045	0	0	0	0	0	9.220171	0	0	16.27474	17.26203	0	9.189033	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.59843	0	14.95124	0
Q5VZ66	JKIP3_HUMAN	Janus kinase and microtubule-interacting protein 3 (Neuroendocrine long coiled-coil protein 2)	JAKMIP3 C10orf14 C10orf39 JAMIP3 NECC2	Homo sapiens (Human)		Golgi apparatus [GO:0005794]	Golgi apparatus [GO:0005794]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]	kinase binding [GO:0019900]; microtubule binding [GO:0008017]	GO:0005794; GO:0008017; GO:0019900	IAELSAIIR	6.769999981	1	1	0.297973616	985.8792201	17.66757	0	16.19171	17.35336	0	0	0	16.60836	0	0	0	16.79917	0	0	0	0	0	0	0	0	0	0	0	0	0	17.70681	0	0	0	0	0	19.08694	18.62972	0	0	18.31468	0	0	0	0	0	16.90775	16.83123	0	0	0	0	0
Q5VZ72	IZUM3_HUMAN	Izumo sperm-egg fusion protein 3	IZUMO3 C9orf134	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]	protein homodimerization activity [GO:0042803]	GO:0005886; GO:0016021; GO:0042803	VSHSDK	1.879999995	1	1	1.19E-13	674.0281805	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.45954	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.57858	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5VZ89	DEN4C_HUMAN	DENN domain-containing protein 4C	DENND4C C9orf55 C9orf55B	Homo sapiens (Human)	cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483]	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; retromer complex [GO:0030904]	cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; retromer complex [GO:0030904]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005794; GO:0005829; GO:0005886; GO:0015031; GO:0030659; GO:0030904; GO:0031410; GO:0032483; GO:0032593; GO:0032869; GO:0043231; GO:0072659	AGLIFR	20.98999977	1	1	0.197372217	677.1485999	15.55361	15.94791	0	0	16.24016	0	0	0	0	0	0	0	15.56919	15.69584	15.69037	0	0	16.47916	0	0	0	0	17.51159	0	0	0	0	16.66474	0	0	17.25842	0	16.58438	17.07639	0	0	17.16279	17.09461	16.14882	17.30905	0	15.77787	17.10383	0	17.2335	16.65206	0	17.8118
Q5VZK9	CARL1_HUMAN	"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)"	CARMIL1 CARMIL LRRC16 LRRC16A	Homo sapiens (Human)	actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415]	protein-containing complex binding [GO:0044877]	GO:0005654; GO:0005829; GO:0005886; GO:0007015; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813	RYGVQVMGSGLLAEMK	1.75999999	1	1	0.360972512	1755.644203	16.22297	15.78853	0	15.18355	14.2506	12.40432	14.35576	0	0	16.50611	15.51244	0	14.25272	14.72636	0	0	15.09643	15.85897	0	0	0	0	0	0	0	17.11339	0	15.11771	0	16.36226	0	18.41051	15.86907	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.23775
Q5VZL5	ZMYM4_HUMAN	Zinc finger MYM-type protein 4 (Zinc finger protein 262)	ZMYM4 KIAA0425 ZNF262	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]		DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0007010; GO:0007275; GO:0008270; GO:0022604	SDPLGSTQDHALSQESSEPGCRVR	3.809999943	1	1	1.83E-12	2612.872797	15.27942	0	0	14.87541	14.16427	15.61255	0	12.92303	0	17.01347	0	0	0	0	0	0	0	15.44072	0	0	0	0	0	0	0	0	0	14.92069	0	0	0	0	0	0	16.09754	0	0	0	0	0	0	0	0	0	17.8041	0	0	0
Q5VZQ5	TEX36_HUMAN	Testis-expressed protein 36	TEX36 C10orf122	Homo sapiens (Human)						EAMVVSSFRR	7.860000134	0.655876756	0.655876756	0.05701275	1181.161869	13.02378	0	13.27234	0	15.96567	14.72759	14.76	13.13749	15.40777	14.22789	14.34049	11.55332	17.20847	11.69877	0	17.06529	13.8619	14.93564	15.30721	0	13.5748	16.77072	15.47642	0	15.90492	16.43427	15.05583	14.76195	14.60135	15.9844	0	15.57499	14.19176	0	13.0744	14.46859	17.06078	14.91751	15.36317	14.19051	12.6722	13.15107	0	16.06367	10.68416	16.50002	16.06568	14.59172
Q5W041	ARMC3_HUMAN	"Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81, CT81) (KU-CT-1)"	ARMC3	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]		GO:0070062	KEVEPPPK	5.400000095	0.81779176	0.81779176	0.213823007	922.8711719	0	12.38547	0	17.23442	19.02973	15.08633	16.08416	16.85808	18.50584	0	0	0	0	0	0	13.62213	0	15.82321	16.09091	0	0	0	17.52119	0	0	0	0	0	0	0	0	0	13.84815	15.81202	0	0	0	0	17.8801	0	0	0	17.4938	14.00489	14.38926	0	0	16.13057
Q5W0A0	ERI6B_HUMAN	Glutamate-rich protein 6B (Protein FAM194B)	ERICH6B FAM194B	Homo sapiens (Human)						KMLSK	7.840000153	0.802198172	0.802198172	0.262384413	607.6024377	16.60259	18.90455	18.15739	0	18.90004	0	19.19646	16.84586	20.30989	18.60837	19.26254	0	0	0	0	0	17.41648	18.49349	0	17.14685	0	18.79364	0	19.4744	18.57734	19.07586	19.32244	0	18.99636	0	0	20.8939	18.3757	0	20.36215	19.38874	0	19.69377	0	18.16726	17.98426	18.26006	18.10489	0	0	17.18171	18.54433	0
Q5W0N0	CI057_HUMAN	Uncharacterized protein C9orf57	C9orf57	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	IVFAGVILFR	33.84000015	0.934809864	0.934809864	0.294564353	1133.722785	0	0	0	17.4704	14.86192	0	0	16.74542	0	0	16.49043	0	0	19.42741	20.91481	19.53902	0	0	21.88821	0	0	0	0	19.25277	0	18.82888	0	0	20.16601	0	19.9492	0	0	0	20.73057	18.65561	0	0	0	20.86996	0	0	0	20.95292	0	20.53535	20.84351	0
Q5W0Q7	USPL1_HUMAN	"SUMO-specific isopeptidase USPL1, EC 3.4.22.- (Ubiquitin-specific peptidase-like protein 1, USP-like 1)"	USPL1 C13orf22 D13S106	Homo sapiens (Human)	Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]; snRNA transcription [GO:0009301]	Cajal body [GO:0015030]; extracellular space [GO:0005615]	Cajal body [GO:0015030]; extracellular space [GO:0005615]; SUMO binding [GO:0032183]; SUMO-specific isopeptidase activity [GO:0070140]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]; snRNA transcription [GO:0009301]	SUMO binding [GO:0032183]; SUMO-specific isopeptidase activity [GO:0070140]	GO:0005615; GO:0008283; GO:0009301; GO:0015030; GO:0016926; GO:0030576; GO:0032183; GO:0070140	LAALMSSPQSRTVR	5.579999924	1	1	0.329408435	1533.212658	14.23141	0	13.08449	0	0	0	0	0	13.48896	0	13.86457	0	0	15.21722	0	0	15.52107	0	0	16.66749	0	0	0	0	16.08405	14.5015	0	0	15.16803	0	0	0	0	14.14974	15.36211	0	0	14.00929	0	16.06039	0	0	13.98773	0	13.5928	13.94677	14.67589	14.69455
Q5XG92	EST4A_HUMAN	"Carboxylesterase 4A, EC 3.1.1.-"	CES4A CES8 UNQ440/PRO873	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689]	carboxylic ester hydrolase activity [GO:0052689]	GO:0005576; GO:0052689	KMAFWMSLYQSQRPEK	4.610000134	1	1	0.129672608	2046.991168	0	12.85971	13.7308	0	14.01693	11.60216	12.75972	13.00709	13.18868	14.3287	11.53729	15.28718	11.3222	12.06159	15.00152	14.99747	0	14.68583	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5XKE5	K2C79_HUMAN	"Keratin, type II cytoskeletal 79 (Cytokeratin-79, CK-79) (Keratin-6-like, Keratin-6L) (Keratin-79, K79) (Type-II keratin Kb38)"	KRT79 K6L KB38 KRT6L	Homo sapiens (Human)		cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; enzyme binding [GO:0019899]	enzyme binding [GO:0019899]	GO:0005829; GO:0019899; GO:0045095; GO:0070062	AFMGQGAGR	8.430000305	0.654155016	0.654155016	0.061075976	911.125651	0	0	14.88655	0	0	15.44778	14.74569	0	0	14.13444	15.17839	13.01327	16.13931	0	0	0	14.26527	0	0	16.89037	0	0	14.30826	16.37757	15.95211	0	0	0	0	12.89865	12.38872	0	18.42123	17.47218	0	13.17981	17.29233	16.98213	0	0	12.26816	16.1423	0	0	11.18535	0	14.79471	0
Q5XKK7	F219B_HUMAN	Protein FAM219B	FAM219B C15orf17	Homo sapiens (Human)						APGAAGPPSGQIGNRALR	5.170000076	1	1	0.246731321	1689.17505	15.62379	15.01783	0	0	0	15.03038	0	15.58532	0	0	0	0	18.49288	0	0	0	13.86632	0	0	0	0	0	0	0	0	0	0	0	0	0	16.65142	0	0	0	0	0	0	0	16.38284	0	0	0	0	0	0	0	17.22549	0
Q5XKP0	MIC13_HUMAN	MICOS complex subunit MIC13 (Protein P117)	MICOS13 C19orf70 MIC13 QIL1	Homo sapiens (Human)	cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]	MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401]	MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]		GO:0001401; GO:0005654; GO:0005739; GO:0005743; GO:0007007; GO:0042407; GO:0044284; GO:0061617; GO:0140275	VWSLMR	10.80000019	1	1	0.150115682	804.8969794	0	0	14.98148	15.25693	14.11081	16.72917	0	17.24603	0	0	15.99629	16.89424	0	0	0	15.45062	0	14.86757	0	0	16.45009	0	0	17.1485	15.71858	16.83288	0	15.71305	0	0	0	16.96119	19.21264	17.12444	0	15.90061	16.86794	0	17.92814	16.18383	14.66191	0	0	17.65722	0	15.70988	11.40701	15.62509
Q5XKR4	OTP_HUMAN	Homeobox protein orthopedia	OTP	Homo sapiens (Human)	forebrain neuron differentiation [GO:0021879]; hypothalamus cell differentiation [GO:0021979]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurohypophysis development [GO:0021985]; neuron differentiation [GO:0030182]; positive regulation of neuroblast proliferation [GO:0002052]	chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; forebrain neuron differentiation [GO:0021879]; hypothalamus cell differentiation [GO:0021979]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurohypophysis development [GO:0021985]; neuron differentiation [GO:0030182]; positive regulation of neuroblast proliferation [GO:0002052]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0002052; GO:0003677; GO:0005654; GO:0016604; GO:0021879; GO:0021979; GO:0021985; GO:0030182	DAAELLGHR	7.860000134	0.945163131	0.945163131	0.196176947	981.2696715	15.47874	0	12.91438	0	0	0	0	16.60702	0	0	0	0	0	0	0	13.55062	14.64697	0	0	15.10621	0	14.12999	0	15.12241	16.98505	20.34049	0	0	0	0	0	14.34557	16.02411	0	0	17.97917	12.3753	0	0	16.28588	0	16.22406	0	0	0	0	15.29942	0
Q5XPI4	RN123_HUMAN	"E3 ubiquitin-protein ligase RNF123, EC 2.3.2.27 (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)"	RNF123 KPC1 FP1477	Homo sapiens (Human)	proteolysis involved in cellular protein catabolic process [GO:0051603]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in cellular protein catabolic process [GO:0051603]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603	LLLDNKDDNGGEASR	7.550000191	1	1	0.266576766	1621.370041	15.53908	0	13.68734	12.42012	15.55209	14.39892	0	0	0	0	16.01135	14.90975	0	15.93177	15.07328	0	14.14585	0	0	0	0	0	0	0	17.19016	0	13.65583	0	0	0	0	16.48917	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q5XX13	FBW10_HUMAN	F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor)	FBXW10	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829	INLSKK	15.64000034	1	1	0.150975813	698.627909	15.30733	0	0	0	0	0	0	11.89037	0	14.95507	0	14.58772	0	13.89887	15.76493	0	0	0	17.85298	14.62258	0	13.93272	17.04298	0	0	0	0	0	0	0	0	15.33616	16.23701	0	0	0	0	0	17.7741	0	0	0	0	16.74798	0	0	0	0
Q5YKI7	GGNB1_HUMAN	Putative gametogenetin-binding protein 1	GGNBP1	Homo sapiens (Human)	cell differentiation [GO:0030154]; mitochondrial fission [GO:0000266]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; cell differentiation [GO:0030154]; mitochondrial fission [GO:0000266]; spermatogenesis [GO:0007283]		GO:0000266; GO:0005737; GO:0005794; GO:0007283; GO:0016020; GO:0030154	LLGMQQESR	11.52999973	1	1	4.58E-13	1061.284253	13.114	13.68264	12.7379	0	0	11.08942	0	11.82514	0	15.22331	0	0	0	0	0	0	0	0	0	12.81352	0	0	15.21653	0	0	0	15.72617	0	14.00125	0	0	0	0	0	0	0	0	0	0	0	0	0	15.47488	0	0	0	0	0
Q5ZPR3	CD276_HUMAN	"CD276 antigen (4Ig-B7-H3) (B7 homolog 3, B7-H3) (Costimulatory molecule) (CD antigen CD276)"	CD276 B7H3 PSEC0249 UNQ309/PRO352	Homo sapiens (Human)	positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell proliferation [GO:0042102]; regulation of cytokine production [GO:0001817]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell proliferation [GO:0042102]; regulation of cytokine production [GO:0001817]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]	signaling receptor binding [GO:0005102]	GO:0001817; GO:0005102; GO:0009897; GO:0016021; GO:0032729; GO:0042102; GO:0042110; GO:0050776; GO:0050852	NPVLQQDAHSSVTITPQR	3.940000057	1	1	0.023658591	1986.906201	0	0	0	7.680967	12.61416	0	11.95259	0	0	15.52345	0	0	14.8727	0	0	10.87767	14.51262	0	0	0	13.37795	0	16.64032	0	0	0	0	14.70801	0	0	0	0	0	0	17.98343	14.96579	0	0	0	0	0	0	0	0	15.62488	14.15196	16.014	0
Q60I27	AL2CL_HUMAN	ALS2 C-terminal-like protein	ALS2CL	Homo sapiens (Human)	endosome organization [GO:0007032]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; endosome organization [GO:0007032]	GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]	GO:0005096; GO:0005829; GO:0007032; GO:0042802	YTGHWER	7.289999962	0.684146523	0.684146523	0.085083148	947.6013187	0	14.09991	14.17024	15.27371	0	0	12.08167	15.6799	0	11.77091	0	0	0	0	11.90688	9.661605	16.02856	0	0	0	14.52956	14.73777	13.95501	0	14.77004	0	15.44201	0	14.28043	15.03629	0	0	15.48911	0	0	0	0	16.11394	0	0	0	0	0	0	11.55303	0	12.5211	11.09577
Q63HK3	ZKSC2_HUMAN	Zinc finger protein with KRAB and SCAN domains 2 (Zinc finger protein 694)	ZKSCAN2 ZNF694	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	KEPWTLGLHSSNK	5.880000114	0.527576327	0.527576327	0.11333575	1497.037599	14.42141	17.78155	0	15.75753	0	0	0	17.98785	15.34381	17.3838	16.06783	13.77096	11.89625	12.08274	15.51575	15.77843	0	13.003	0	12.92584	14.03341	16.58737	0	16.01932	15.39647	0	15.17787	15.23121	9.732815	16.70348	15.95819	14.45265	16.23627	15.83701	16.54255	0	14.41708	0	16.80128	15.86133	0	0	0	0	0	14.13262	0	0
Q63HK5	TSH3_HUMAN	Teashirt homolog 3 (Zinc finger protein 537)	TSHZ3 KIAA1474 TSH3 ZNF537	Homo sapiens (Human)	"long-term synaptic potentiation [GO:0060291]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromatin [GO:0000785]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; long-term synaptic potentiation [GO:0060291]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000785; GO:0000981; GO:0002087; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0030426; GO:0045892; GO:0046872; GO:0051968; GO:0060291	ATPSPCSSEVGEPIK	3.660000086	0.235588297	0.235588297	0.391933476	1558.983901	13.23669	15.47277	15.14045	14.91136	16.18638	13.88719	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.90718	0	0	0	0	0	0	17.5454	0	0	0	0	16.79731	0	0	15.68933	0	0	0	0	0	0	0	0
Q63HN8	RN213_HUMAN	"E3 ubiquitin-protein ligase RNF213, EC 2.3.2.27, EC 3.6.4.- (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213, EC 2.3.2.-) (Mysterin) (RING finger protein 213)"	RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR	Homo sapiens (Human)	angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]	ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001525; GO:0002040; GO:0004842; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051	CLRENSDVK	6.050000191	0.173961937	0.173961937	0.282450062	1121.364477	14.07312	12.66844	0	0	0	13.2945	0	15.45093	15.15583	14.1092	13.66018	13.75256	0	0	0	0	15.68516	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.12642	15.35042	0	0	0	0	0	0
Q63HQ0	AP1AR_HUMAN	"AP-1 complex-associated regulatory protein (2c18) (Adaptor-related protein complex 1-associated regulatory protein) (Gamma-1-adaptin brefeldin A resistance protein, GBAR, Gamma-BAR) (Gamma-A1-adaptin and kinesin interactor, Gadkin)"	AP1AR C4orf16 PRO0971	Homo sapiens (Human)	"cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting, trans-Golgi to endosome [GO:0048203]"	cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting, trans-Golgi to endosome [GO:0048203]"	AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]	GO:0001920; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0015031; GO:0019894; GO:0030133; GO:0034315; GO:0034613; GO:0035650; GO:0048203; GO:1900025; GO:2000146	VGGGGGSKYFR	5.03000021	1	1	0.285407516	1084.253293	10.30375	0	14.37786	8.639108	13.93401	9.994537	0	0	13.02641	0	0	0	0	15.90386	15.32484	16.04933	15.23214	0	13.04686	17.52306	16.90903	0	13.92407	0	0	0	16.27971	14.38097	14.68043	14.5671	14.19138	14.08247	0	0	0	16.34937	17.03267	17.16552	15.84725	0	0	0	14.6352	0	14.97688	0	0	15.44117
Q63HQ2	EGFLA_HUMAN	"Pikachurin (Agrin-like protein) (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)"	EGFLAM AGRINL AGRNL PIKA	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; tissue development [GO:0009888]	basement membrane [GO:0005604]; cell projection [GO:0042995]; interstitial matrix [GO:0005614]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]	basement membrane [GO:0005604]; cell projection [GO:0042995]; interstitial matrix [GO:0005614]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; tissue development [GO:0009888]	calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]	GO:0005509; GO:0005539; GO:0005604; GO:0005614; GO:0009887; GO:0009888; GO:0010811; GO:0019800; GO:0030198; GO:0042995; GO:0043083; GO:0048786	TGKSPGMMR	3.519999981	1	1	0.300115583	964.6925706	0	17.7237	0	0	0	0	0	19.14874	16.64494	0	0	17.41557	0	0	16.45103	0	0	0	0	16.55219	0	0	0	0	0	0	0	0	0	17.82811	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q63HR2	TNS2_HUMAN	"Tensin-2, EC 3.1.3.48 (C1 domain-containing phosphatase and tensin homolog, C1-TEN) (Tensin-like C1 domain-containing phosphatase)"	TNS2 KIAA1075 TENC1	Homo sapiens (Human)	cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850]	dendrite [GO:0030425]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	dendrite [GO:0030425]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850]	identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001822; GO:0004725; GO:0005886; GO:0005925; GO:0008285; GO:0014850; GO:0019725; GO:0019900; GO:0030425; GO:0032963; GO:0035264; GO:0035335; GO:0042802; GO:0043025; GO:0046627; GO:0046872; GO:0048871; GO:0098794	AASRPRK	6.760000229	1	1	0.218093575	785.2977445	14.97263	16.57297	14.49142	15.01301	16.68451	13.76585	0	14.70647	0	16.07442	15.59814	14.25328	14.95248	14.18385	15.55539	0	15.56572	15.151	15.39263	15.51129	0	0	17.28374	16.06657	0	0	0	0	0	15.54366	16.55834	0	0	16.72151	0	16.23875	0	0	0	0	0	15.87853	15.48193	0	16.02828	0	0	0
Q63ZY3	KANK2_HUMAN	"KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein, SIP, SRC-interacting protein, SRC1-interacting protein)"	KANK2 ANKRD25 KIAA1518 MXRA3 SIP	Homo sapiens (Human)	apoptotic process [GO:0006915]; glomerular visceral epithelial cell migration [GO:0090521]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; regulation of Rho protein signal transduction [GO:0035023]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; glomerular visceral epithelial cell migration [GO:0090521]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; regulation of Rho protein signal transduction [GO:0035023]		GO:0000122; GO:0005737; GO:0005739; GO:0006915; GO:0008285; GO:0033147; GO:0035023; GO:0043069; GO:0070563; GO:0072073; GO:0090521; GO:2000134	LSSLPR	17.17000008	1	1	0.178401812	672.4566567	19.89695	19.10624	18.82956	0	19.56014	18.16038	19.22329	19.01825	19.43449	18.50932	18.47764	17.70446	19.29564	18.22975	19.53402	0	0	18.28147	18.89141	19.60438	18.66148	18.86986	0	0	0	0	19.73877	19.89805	19.23481	17.59036	0	18.13711	19.09272	0	19.32512	19.88904	18.03028	19.64742	21.32901	18.66902	17.99525	19.91841	19.04842	0	20.01741	19.32694	18.9047	20.02425
Q63ZY6	NSN5C_HUMAN	"Putative methyltransferase NSUN5C, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 5C) (Williams-Beuren syndrome chromosomal region 20C protein)"	NSUN5P2 NSUN5C WBSCR20B WBSCR20C	Homo sapiens (Human)	RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]	nucleolus [GO:0005730]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]	GO:0001510; GO:0003723; GO:0005730; GO:0008168; GO:0070475	VEMPTSASQAK	7.550000191	1	1	0.527687671	1152.563679	0	0	15.72705	0	14.67619	0	14.76987	13.53257	0	16.44301	0	0	0	15.48071	15.1086	0	0	14.76676	0	0	0	0	0	0	0	0	0	15.90001	0	0	0	0	0	0	0	0	0	0	0	0	0	15.17853	0	0	16.8495	15.36033	0	0
Q658L1	SAXO2_HUMAN	Stabilizer of axonemal microtubules 2	SAXO2 FAM154B	Homo sapiens (Human)	microtubule anchoring [GO:0034453]	axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]	axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453]	microtubule binding [GO:0008017]	GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0034453; GO:0036064; GO:0036126	RSTAPFNGITSHR	1.639999986	1	1	0.087837172	1444.869611	14.91204	16.35013	16.02512	13.722	0	12.18239	14.76592	0	0	14.91616	14.26126	10.20494	0	0	0	12.99672	0	0	0	0	0	0	14.68907	0	0	14.34194	0	0	0	0	0	0	0	0	0	0	0	0	0	15.04145	0	15.7069	0	0	13.57688	0	0	0
Q659A1	ICE2_HUMAN	Little elongation complex subunit 2 (Interactor of little elongator complex ELL subunit 2) (NMDA receptor-regulated protein 2)	ICE2 BRCC1 NARG2 UNQ3101/PRO10100	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]		GO:0000791; GO:0005654; GO:0005829; GO:0008023; GO:0015030; GO:0016604; GO:0035363; GO:0042795; GO:0042796; GO:0045945	ASDGK	5.590000153	0.772803545	0.772803545	0.290600888	476.1039029	0	15.13353	15.31531	15.30799	16.40722	14.44611	15.24168	15.7021	13.65388	15.85385	15.68077	16.31985	15.69687	16.30119	15.38575	14.96562	15.1891	15.03359	15.06978	14.82858	16.2915	0	16.14888	0	17.13525	16.3977	0	0	0	16.6905	16.17535	16.2217	15.55627	16.44602	16.32479	16.14037	0	15.5654	0	16.12928	15.23152	16.40767	15.25647	0	0	0	15.2445	14.71106
Q659C4	LAR1B_HUMAN	La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2)	LARP1B LARP2	Homo sapiens (Human)	positive regulation of translation [GO:0045727]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005829; GO:0010494; GO:0045727	KLNLISK	6.730000019	1	1	0.263218293	814.9090609	0	17.70156	0	15.30876	0	16.64095	0	18.47851	21.35466	17.84613	0	18.30256	17.82101	0	0	17.86503	0	0	18.14322	0	0	0	0	16.86695	0	0	19.65489	0	0	0	0	0	18.28946	0	18.6034	0	19.04431	19.55481	19.39822	0	17.01911	0	18.72193	0	0	0	0	16.97795
Q66GS9	CP135_HUMAN	"Centrosomal protein of 135 kDa, Cep135 (Centrosomal protein 4)"	CEP135 CEP4 KIAA0635	Homo sapiens (Human)	centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857]	protein C-terminus binding [GO:0008022]	GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008022; GO:0010457; GO:1902857; GO:1904951	MRLEHGIK	2.75	1	1	0.225858436	998.7529174	0	0	0	0	20.31903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.29338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q66K14	TBC9B_HUMAN	TBC1 domain family member 9B	TBC1D9B KIAA0676	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]	calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]	GO:0005096; GO:0005509; GO:0016021; GO:0090630	QPGSIGSR	5.400000095	1	1	0.367624498	800.8975108	18.65587	0	0	0	17.52671	0	0	0	19.16137	20.7762	0	0	19.90485	0	0	0	0	18.97478	17.66192	0	0	19.18697	19.06618	0	0	0	0	0	18.84701	16.99753	0	0	0	0	19.62496	0	0	0	0	18.05052	0	0	0	0	0	0	0	0
Q66K41	Z385C_HUMAN	Zinc finger protein 385C	ZNF385C	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005634; GO:0008270	GHKHAR	9.069999695	0.01706502	0.01706502	0.148307787	705.0820907	14.04684	15.66395	0	9.771791	0	0	0	11.29576	15.5251	17.06691	0	15.81439	0	15.23655	14.12627	14.3494	0	16.95925	16.17758	16.53602	14.59756	0	16.33055	14.81424	0	0	17.67132	15.13573	17.91333	0	15.15039	0	18.49872	15.7106	15.40807	18.55685	10.85851	14.02622	18.86034	16.10095	15.85128	16.9362	14.60611	14.58005	0	0	0	0
Q66K74	MAP1S_HUMAN	"Microtubule-associated protein 1S, MAP-1S (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1, VCY2-interacting protein 1, VCY2IP-1) [Cleaved into: MAP1S heavy chain; MAP1S light chain ]"	MAP1S BPY2IP1 C19orf5 MAP8 VCY2IP1	Homo sapiens (Human)	apoptotic process [GO:0006915]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite development [GO:0016358]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; regulation of chromatin disassembly [GO:0010848]; regulation of microtubule depolymerization [GO:0031114]	cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; synapse [GO:0045202]	cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite development [GO:0016358]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; regulation of chromatin disassembly [GO:0010848]; regulation of microtubule depolymerization [GO:0031114]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]	GO:0000226; GO:0001578; GO:0003677; GO:0003779; GO:0005634; GO:0005654; GO:0005730; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0006914; GO:0006915; GO:0007399; GO:0007409; GO:0007420; GO:0008017; GO:0010848; GO:0015631; GO:0016358; GO:0030054; GO:0030425; GO:0031114; GO:0042802; GO:0042995; GO:0043025; GO:0045202; GO:0047497; GO:0048471; GO:0048487; GO:0048812; GO:0051015	AAAPKATPVAAAK	8.279999733	1	1	0.086166325	1167.260366	0	15.27363	16.49378	0	0	16.85091	14.02017	13.39937	0	0	17.38679	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.13448	14.4837	10.71215	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q66K79	CBPZ_HUMAN	"Carboxypeptidase Z, CPZ, EC 3.4.17.-"	CPZ	Homo sapiens (Human)	peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0006508; GO:0006518; GO:0008270; GO:0016055; GO:0016485	GVVTDK	1.5	1	1	0	618.7323626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q66K80	RUAS1_HUMAN	Putative uncharacterized protein RUSC1-AS1 (RUSC1 antisense RNA 1) (RUSC1 antisense gene protein 1)	RUSC1-AS1 C1orf104	Homo sapiens (Human)						GGALAQPTLR	8.550000191	1	1	0.194263735	981.8139108	13.30154	15.75204	14.82248	0	15.09769	16.68921	0	16.57233	15.27198	16.45601	0	14.7567	0	0	0	0	0	0	0	0	0	0	0	15.03654	15.36105	14.9485	0	0	0	0	14.99784	0	15.54736	0	16.20429	16.53205	15.5994	15.77962	17.04814	15.25936	0	0	16.58963	15.00588	15.1849	13.71498	12.83682	0
Q66K89	E4F1_HUMAN	"Transcription factor E4F1, EC 2.3.2.27 (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (p120E4F) (p50E4F)"	E4F1 E4F	Homo sapiens (Human)	"cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription by RNA polymerase II [GO:0006357]"	"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transferase activity [GO:0016740]"	GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0005737; GO:0005819; GO:0006260; GO:0006357; GO:0007049; GO:0009794; GO:0010564; GO:0016567; GO:0016740; GO:0035497; GO:0040008; GO:0045944; GO:0046872; GO:0051301; GO:0051726; GO:0061629	LCGASFR	19.70000076	1	1	0.277783777	811.0711972	0	16.44172	0	0	0	15.23886	0	0	16.43135	17.29986	0	14.85246	0	0	0	0	16.28788	16.0531	16.11312	0	0	0	0	0	16.80521	0	17.56658	0	17.14802	15.39206	15.65709	0	0	0	0	0	0	0	0	0	0	0	17.45119	0	0	0	0	0
Q66LE6	2ABD_HUMAN	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PP2A subunit B isoform B55-delta) (PP2A subunit B isoform PR55-delta) (PP2A subunit B isoform R2-delta) (PP2A subunit B isoform delta)	PPP2R2D KIAA1541	Homo sapiens (Human)	cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0000278; GO:0005829; GO:0010458; GO:0019888; GO:0051301; GO:0070262	VPILKPMDLMVEASPRR	8.140000343	0.514770746	0.514770746	4.57E-12	1968.346732	15.29339	14.07045	10.78754	14.36586	0	14.76328	0	13.36683	0	14.08043	0	0	14.79712	0	0	0	0	0	0	13.65796	0	0	15.1616	0	0	0	0	0	12.76797	0	0	15.90977	0	0	0	0	0	15.89654	0	13.39348	15.20224	0	12.67854	0	8.610801	0	14.44672	0
Q674X7	KAZRN_HUMAN	Kazrin	KAZN C1orf196 KAZ KIAA1026 HRIHFB2003	Homo sapiens (Human)	keratinization [GO:0031424]	cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; keratinization [GO:0031424]		GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0031424	AAELDHHWVAK	4.820000172	1	1	4.61E-13	1275.704589	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.6559	0	0	0	16.09661	0	0	0	0	0	0	0	14.75846	0	0	0	16.48415	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q676U5	A16L1_HUMAN	Autophagy-related protein 16-1 (APG16-like 1)	ATG16L1 APG16L UNQ9393/PRO34307	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; lysosomal microautophagy [GO:0016237]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; lysosomal microautophagy [GO:0016237]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792]	GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787]	GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0051020; GO:0051607; GO:0061739; GO:0097225; GO:0098792; GO:0120095	LLATGGMDRR	2.180000067	1	1	2.35E-13	1089.837468	17.85423	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q685J3	MUC17_HUMAN	"Mucin-17, MUC-17 (Small intestinal mucin-3, MUC-3)"	MUC17 MUC3	Homo sapiens (Human)	cellular homeostasis [GO:0019725]	apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent, lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]; cellular homeostasis [GO:0019725]"	"extracellular matrix constituent, lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]"	GO:0005576; GO:0005796; GO:0005886; GO:0009897; GO:0016021; GO:0016324; GO:0019725; GO:0030165; GO:0030197; GO:0062023	MSTPSEGSSSLTTMLLSSTYVTSSEASTPSTPSVDR	1.49000001	1	1	1.38E-12	3680.604484	13.90074	14.09596	0	0	0	0	10.24421	0	0	8.770654	9.177488	12.83278	0	0	0	0	0	0	0	0	0	12.69893	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q68CK6	ACS2B_HUMAN	"Acyl-coenzyme A synthetase ACSM2B, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 2B) (Benzoate--CoA ligase, EC 6.2.1.25) (Butyrate--CoA ligase 2B) (Butyryl-coenzyme A synthetase 2B) (Middle-chain acyl-CoA synthetase 2B) (Xenobiotic/medium-chain fatty acid-CoA ligase HXM-A)"	ACSM2B ACSM2 HYST1046	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; xenobiotic metabolic process [GO:0006805]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; xenobiotic metabolic process [GO:0006805]	ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]	GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0006805; GO:0015645; GO:0016405; GO:0018858; GO:0046872; GO:0047760; GO:0102391	VAVMLPR	9.289999962	1	1	2.34E-13	800.7140169	0	0	0	0	0	0	0	13.09647	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.62663	19.47503	0	0	0	17.2539	0	0	0	0	0	0	0
Q68CP4	HGNAT_HUMAN	"Heparan-alpha-glucosaminide N-acetyltransferase, EC 2.3.1.78 (Transmembrane protein 76)"	HGSNAT TMEM76	Homo sapiens (Human)	lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]	acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]	GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0051259; GO:0070821	SGQARAAER	10.76000023	5.94E-11	5.94E-11	0.239921462	946.0384095	0	0	18.37799	0	0	17.90559	15.45705	0	15.97615	0	17.56751	0	0	16.94477	0	14.64554	0	17.06329	17.58571	11.72539	13.7806	0	0	0	18.02979	0	16.61407	0	0	0	0	18.44853	0	0	0	15.53738	15.81475	0	19.0814	0	16.25942	15.13206	0	14.65756	0	15.84935	16.21457	12.87581
Q68CP9	ARID2_HUMAN	"AT-rich interactive domain-containing protein 2, ARID domain-containing protein 2 (BRG1-associated factor 200, BAF200) (Zinc finger protein with activation potential) (Zipzap/p200)"	ARID2 BAF200 KIAA1557	Homo sapiens (Human)	cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0046872; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:1905168; GO:2000045; GO:2000781; GO:2000819	EGPITKHIR	5.289999962	0.432848692	0.432848692	0.265391952	1050.233601	0	0	0	0	0	0	15.77351	0	0	0	0	12.33427	0	14.59951	0	0	14.99117	15.26456	0	14.92757	0	16.78462	14.98948	0	15.02858	16.91148	15.61882	14.47264	11.62346	14.73394	14.44926	16.14463	15.8765	15.6594	13.05311	15.91654	16.15462	14.77572	15.95848	15.8972	16.94431	15.02821	15.71662	14.94829	13.78315	15.52883	14.24351	14.63232
Q68CQ1	MROH7_HUMAN	Maestro heat-like repeat-containing protein family member 7 (HEAT repeat-containing protein 8)	MROH7 C1orf175 HEATR8	Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]		GO:0005615; GO:0005737; GO:0016021	DLLDLLLGSLK	6.190000057	1	1	0.543511035	1200.127464	0	15.32545	14.50171	0	0	0	0	0	17.56681	0	0	0	0	0	0	0	0	0	0	0	0	19.06149	0	0	0	0	0	19.63733	0	0	0	0	18.85232	0	0	0	0	18.46231	0	0	0	20.08461	0	0	0	0	0	16.49215
Q68CQ4	UTP25_HUMAN	U3 small nucleolar RNA-associated protein 25 homolog (Digestive organ expansion factor homolog) (UTP25 small subunit processor component)	UTP25 C1orf107 DEF DIEXF	Homo sapiens (Human)	"embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]; embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]"	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511; GO:0040019; GO:0048568; GO:1902570	ELFLIMNSYR	8.659999847	1	1	0.440859249	1300.989415	0	0	14.14405	0	0	0	0	0	0	7.809146	15.27031	0	0	0	0	0	0	0	16.52566	0	0	0	0	14.04601	0	12.40351	0	17.23166	0	0	17.26208	16.94345	0	16.62159	0	0	0	16.29254	0	0	0	0	12.20953	15.90335	0	17.11695	15.32179	16.3443
Q68CR1	SE1L3_HUMAN	"Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3, Sel-1L3)"	SEL1L3 KIAA0746	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]		GO:0005654; GO:0016021	YGRPSMCR	9.079999924	1	1	0.242559719	1026.125786	0	16.5592	0	0	0	0	16.40863	0	0	0	0	0	0	14.83257	0	0	0	15.80181	0	0	16.30994	17.15371	0	0	0	0	17.01622	0	0	0	0	0	0	0	0	0	14.09255	0	0	0	0	0	0	16.55835	0	0	0	14.87916
Q68CZ1	FTM_HUMAN	"Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein, RPGRIP1-like protein)"	RPGRIP1L FTM KIAA1005 NPHP8	Homo sapiens (Human)	cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548]	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]	axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548]	thromboxane A2 receptor binding [GO:0031870]	GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0008589; GO:0021532; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0090102; GO:1905515	DIAYGTK	2.970000029	0.825017095	0.825017095	0.228055505	764.7919961	0	0	15.9017	13.77508	0	12.33847	0	0	15.77408	15.80907	15.12765	15.67569	0	0	14.72714	0	0	0	15.99279	0	0	15.25918	0	0	0	0	15.87643	0	16.0846	0	0	0	0	0	14.45032	0	0	16.6015	0	0	0	0	0	0	0	0	0	0
Q68CZ6	HAUS3_HUMAN	HAUS augmin-like complex subunit 3	HAUS3 C4orf15	Homo sapiens (Human)	cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]		GO:0005813; GO:0005829; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:0072686; GO:1990498	ASNSSMK	9.279999733	0.663388431	0.663388431	0.149490563	737.6559256	16.73264	17.96909	0	0	0	16.32306	14.16681	0	16.46053	0	16.49541	10.81549	17.70119	0	12.86088	17.76896	15.6041	15.92599	0	13.03525	13.85764	19.33252	15.52408	17.74377	16.50255	17.65232	0	11.37002	17.06466	16.86672	0	18.1251	0	16.30071	13.75946	0	17.8804	18.35157	18.75556	15.09883	16.92833	12.93704	0	0	0	16.35662	15.3104	0
Q68D10	SPT2_HUMAN	Protein SPT2 homolog (Protein KU002155) (SPT2 domain-containing protein 1)	SPTY2D1	Homo sapiens (Human)	"histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase I core binding [GO:0001042]; histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase I core binding [GO:0001042]	GO:0001042; GO:0003677; GO:0005654; GO:0005730; GO:0006334; GO:0006355; GO:0010847; GO:0042393; GO:0043486	EQQKEEAK	10.22000027	0.791187942	0.791187942	0.256105292	988.9945493	0	13.51544	15.2986	15.1915	15.39122	0	0	0	0	0	0	13.83467	14.10195	15.04433	0	13.72747	0	0	15.36598	17.15682	0	16.55124	0	16.12952	0	14.73552	13.90731	0	12.46308	0	16.5493	0	15.24986	0	0	0	16.11132	15.68969	0	14.93544	15.96911	0	18.10015	0	15.95905	15.60151	14.61813	16.46269
Q68D51	DEN2C_HUMAN	DENN domain-containing protein 2C	DENND2C	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005654	LHSYTGKELPPTK	1.629999995	1	1	0.120774928	1471.515833	12.03641	14.56832	13.1923	0	0	14.42458	16.25329	15.13064	0	0	13.61018	16.59159	0	0	0	0	0	0	0	0	0	0	0	0	0	15.73994	0	0	0	0	0	0	0	15.19813	17.16426	0	0	0	0	13.41079	16.57693	14.24846	0	0	15.58824	0	14.89391	0
Q68DA7	FMN1_HUMAN	Formin-1 (Limb deformity protein homolog)	FMN1 FMN LD	Homo sapiens (Human)	actin nucleation [GO:0045010]; forelimb morphogenesis [GO:0035136]; gene expression [GO:0010467]; hindlimb morphogenesis [GO:0035137]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of actin nucleation [GO:0051127]; positive regulation of focal adhesion assembly [GO:0051894]; skeletal system morphogenesis [GO:0048705]; ureteric bud invasion [GO:0072092]	actin filament [GO:0005884]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	actin filament [GO:0005884]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; SH3 domain binding [GO:0017124]; actin nucleation [GO:0045010]; forelimb morphogenesis [GO:0035136]; gene expression [GO:0010467]; hindlimb morphogenesis [GO:0035137]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of actin nucleation [GO:0051127]; positive regulation of focal adhesion assembly [GO:0051894]; skeletal system morphogenesis [GO:0048705]; ureteric bud invasion [GO:0072092]	actin binding [GO:0003779]; microtubule binding [GO:0008017]; SH3 domain binding [GO:0017124]	GO:0003779; GO:0005634; GO:0005737; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0010467; GO:0017124; GO:0030838; GO:0035136; GO:0035137; GO:0045010; GO:0048705; GO:0051127; GO:0051894; GO:0072092	AGQPR	5.010000229	0.448863924	0.448863924	0.082218477	527.1161414	17.80946	17.07802	13.05361	15.11588	15.35553	17.23098	0	16.80739	17.05993	12.05089	0	0	0	16.02454	15.38072	15.95853	0	17.72722	14.45082	0	0	9.485068	16.94537	16.5053	15.65882	15.16132	13.63811	14.76178	14.84698	0	14.9984	0	15.673	0	16.17698	13.23598	0	16.41156	16.7819	0	17.17942	0	15.84803	0	14.8367	0	11.76271	16.03957
Q68DC2	ANKS6_HUMAN	"Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6, SAM domain-containing protein 6)"	ANKS6 ANKRD14 PKDR1 SAMD6	Homo sapiens (Human)	determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]	ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737]	ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]		GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0097543	DNGPGSTR	8.390000343	1	1	0.06615466	802.7747625	16.12766	17.793	0	17.26157	17.74951	16.81528	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q68DI1	ZN776_HUMAN	Zinc finger protein 776	ZNF776	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	GTSFVK	5.400000095	0.288175374	0.288175374	0.321748001	636.9615604	16.00871	0	0	14.14647	0	15.93254	0	0	15.425	15.39643	0	16.27562	15.45157	15.85357	0	15.26919	14.56309	15.65634	0	15.89826	17.48886	17.57215	18.69042	17.55911	0	13.1417	0	0	16.87957	0	16.64171	16.23372	0	0	0	16.31121	0	16.00051	16.7328	0	15.68097	0	15.22393	16.09769	16.391	16.10664	16.15439	15.87553
Q68DK2	ZFY26_HUMAN	"Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein, FYVE-CENT) (Spastizin)"	ZFYVE26 KIAA0321	Homo sapiens (Human)	autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]	centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496]	centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]	GO:0000281; GO:0000724; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:0046872; GO:1905037	ADEVEWILDLK	2.710000038	1	1	0.243343532	1330.656028	16.00303	0	0	15.04245	0	0	15.30778	14.25255	13.74073	0	17.04142	14.43902	0	0	0	14.33712	0	0	0	15.98571	0	14.41733	0	0	0	0	0	0	16.29599	0	0	0	16.79562	0	0	0	0	17.23251	0	0	0	0	0	0	0	0	0	0
Q68DN1	CB016_HUMAN	Uncharacterized protein C2orf16	C2orf16	Homo sapiens (Human)		extracellular exosome [GO:0070062]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; nucleus [GO:0005634]		GO:0005634; GO:0070062	ILPGSPVK	12.55000019	0.097189315	0.097189315	0.183624841	809.5558858	16.53548	16.93541	17.66014	17.25839	16.09769	16.77414	16.94757	16.19675	16.43701	18.64729	16.22933	15.3063	15.84649	17.45888	16.21392	15.77136	16.57911	16.4579	15.69934	16.3645	16.12924	16.64168	17.14956	16.28041	16.54455	17.1514	0	13.71614	15.8166	16.31659	0	16.66195	14.31026	0	16.34741	15.9235	15.59204	17.45766	0	15.38879	16.3508	17.23893	14.97369	16.22888	14.63695	0	16.32673	15.50191
Q68DQ2	CRBG3_HUMAN	"Very large A-kinase anchor protein, vlAKAP (Beta/gamma crystallin domain-containing protein 3)"	CRYBG3	Homo sapiens (Human)	lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601]	protein-containing complex [GO:0032991]	protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601]	carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212]	GO:0002088; GO:0005212; GO:0007601; GO:0030246; GO:0032991; GO:0051018	DGGKTEVMPLALEVVNTYQK	6.440000057	1	1	0	2207.832522	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q68DU8	KCD16_HUMAN	BTB/POZ domain-containing protein KCTD16 (Potassium channel tetramerization domain-containing protein 16)	KCTD16 KIAA1317	Homo sapiens (Human)	protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]	cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]	cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]		GO:0008277; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260	DTANDLAK	4.980000019	0.595747352	0.595747352	0.247484354	847.7508805	17.46345	18.6585	17.85468	0	17.88025	0	17.60055	0	18.18549	0	0	0	0	0	0	0	17.74724	18.25092	18.58144	0	0	0	0	0	0	0	0	0	0	0	0	0	20.32128	0	0	0	0	0	18.43078	0	0	0	0	0	0	0	16.89657	0
Q68DX3	FRPD2_HUMAN	FERM and PDZ domain-containing protein 2 (PDZ domain-containing protein 4) (PDZ domain-containing protein 5C)	FRMPD2 PDZD5C PDZK4 PDZK5C	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; 1-phosphatidylinositol binding [GO:0005545]; bicellular tight junction assembly [GO:0070830]	1-phosphatidylinositol binding [GO:0005545]	GO:0005545; GO:0005737; GO:0005856; GO:0005923; GO:0016323; GO:0070830	HTFVTDSAK	5.630000114	1	1	2.30E-13	1006.829423	13.89024	14.82744	0	13.23632	0	0	13.79239	10.40975	0	15.53624	0	14.54183	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.83262	0	0	0
Q68DY1	ZN626_HUMAN	Zinc finger protein 626	ZNF626	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	GCISVDECKVHK	9.039999962	1	1	0.05547526	1430.923632	15.22114	0	0	0	0	0	0	0	0	0	0	0	16.40932	0	0	0	0	0	0	0	16.70115	0	15.23212	0	0	0	0	0	0	0	0	0	16.76081	0	0	0	0	0	16.07265	0	0	0	0	0	0	0	0	0
Q68E01	INT3_HUMAN	"Integrator complex subunit 3, Int3 (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A, SOSS-A, Sensor of ssDNA subunit A)"	INTS3 C1orf193 C1orf60	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180]		GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0010212; GO:0016180; GO:0032039; GO:0035861; GO:0044818; GO:0070876	SSSSK	3.289999962	1	1	0.116163021	494.1702749	14.99391	10.61788	9.872809	0	14.72827	13.83696	14.32735	0	15.27875	0	15.14988	0	0	13.38232	15.37104	10.17117	16.15505	0	16.12482	14.87645	0	17.20319	17.82026	15.68493	14.59552	14.92838	0	13.612	0	15.39304	17.06513	0	0	0	0	0	0	0	0	0	0	0	0	15.22092	0	15.46962	15.07743	0
Q68EA5	ZNF57_HUMAN	Zinc finger protein 57 (Zinc finger protein 424)	ZNF57 ZNF424	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	MHTGQKSHECQSYSK	3.890000105	1	1	0.211764076	1822.954904	14.95329	13.64717	0	0	0	0	0	14.97507	0	0	0	0	0	0	0	0	15.11187	14.83272	0	0	0	0	0	0	0	0	0	15.45814	15.12061	14.45007	13.81448	0	0	0	0	0	14.3969	14.69371	0	0	0	0	0	0	0	0	11.81325	0
Q68EM7	RHG17_HUMAN	"Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1, RICH-1)"	ARHGAP17 RICH1 MSTP066 MSTP110	Homo sapiens (Human)	actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165]	bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]	GO:0005096; GO:0005829; GO:0005886; GO:0005923; GO:0007015; GO:0007165; GO:0017124; GO:0017156; GO:0032956; GO:0035020	RPASMAVMEGDLVK	1.809999943	1	1	0.10524596	1519.424149	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.76649	15.79537	0	0	0	0	0	0	13.14031	0	13.92507	0	15.17458	12.94601	11.36009	12.67246	0	0	15.8372	0	0	0	0	0	0	0	0	0	0
Q68EN5	K895L_HUMAN	Uncharacterized protein KIAA0895-like	KIAA0895L	Homo sapiens (Human)						YRQQLEHIMATNR	3.730000019	1	1	0.176877561	1675.659938	0	12.07529	13.77859	0	0	0	0	13.29143	0	13.1605	0	0	0	0	0	0	0	12.9091	0	0	0	0	0	0	0	0	0	0	16.49354	0	0	0	0	0	15.12634	0	0	0	0	0	0	0	0	0	0	0	0	0
Q693B1	KCD11_HUMAN	BTB/POZ domain-containing protein KCTD11 (KCASH1 protein) (Potassium channel tetramerization domain-containing protein 11) (RING-type E3 ubiquitin transferase subunit KCTD11)	KCTD11 C17orf36 REN	Homo sapiens (Human)	cell cycle [GO:0007049]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]		identical protein binding [GO:0042802]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]	identical protein binding [GO:0042802]; transferase activity [GO:0016740]	GO:0007049; GO:0016567; GO:0016740; GO:0040008; GO:0042802; GO:0045666; GO:0051260	GYGETALLR	3.75999999	1	1	0.01065912	979.187679	15.11596	13.8117	12.55464	14.75714	10.74814	13.78337	9.836652	0	15.45202	15.71195	14.99293	15.52826	0	0	0	0	0	13.06031	13.01569	0	0	0	17.0347	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q69YH5	CDCA2_HUMAN	"Cell division cycle-associated protein 2 (Recruits PP1 onto mitotic chromatin at anaphase protein, Repo-Man)"	CDCA2	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]		GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0007059; GO:0007088; GO:0035307; GO:0051301; GO:0051983	DANSK	9.279999733	1	1	0.278168613	535.6335824	14.96402	0	15.85694	14.16151	12.21996	0	0	0	0	16.31286	16.02349	15.40227	0	14.24136	0	15.36885	0	0	0	0	0	15.64673	15.97154	16.45164	0	0	0	15.86658	15.89254	0	0	0	15.93878	16.4107	16.48663	16.01223	15.23258	0	16.25806	0	15.44769	0	16.94328	0	0	0	0	15.73039
Q69YN2	C19L1_HUMAN	"CWF19-like protein 1, C19L1"	CWF19L1	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	post-mRNA release spliceosomal complex [GO:0071014]	"post-mRNA release spliceosomal complex [GO:0071014]; RNA lariat debranching enzyme activator activity [GO:0061632]; mRNA splicing, via spliceosome [GO:0000398]"	RNA lariat debranching enzyme activator activity [GO:0061632]	GO:0000398; GO:0061632; GO:0071014	SSTGRDSK	4.880000114	1	1	0.196659934	839.6058453	0	0	14.92634	0	13.55721	0	14.52513	13.28638	15.14845	14.81927	15.59719	0	0	16.36938	0	0	0	0	0	13.9952	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.69132	0	0	0	0	0	0	16.03556	0	0	0	0	0	0
Q69YN4	VIR_HUMAN	Protein virilizer homolog	VIRMA KIAA1429 MSTP054	Homo sapiens (Human)	mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396; GO:0080009; GO:0110104	GGFSGNRGGR	3.440000057	0.437619388	0.437619388	0.138400154	963.0602248	0	15.58375	0	0	16.91679	0	10.97896	17.10583	0	0	0	0	0	0	0	0	0	15.65916	0	13.00493	12.13929	0	0	0	18.33303	13.7752	15.41886	0	14.7983	0	17.69222	17.57172	11.98651	12.76546	0	14.39696	0	15.26153	0	0	15.00806	16.04997	15.74615	0	0	16.60533	17.10818	8.456114
Q69YQ0	CYTSA_HUMAN	"Cytospin-A (Renal carcinoma antigen NY-REN-22) (Sperm antigen with calponin homology and coiled-coil domains 1-like, SPECC1-like protein)"	SPECC1L CYTSA KIAA0376	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]		GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007049; GO:0007155; GO:0015629; GO:0030036; GO:0031941; GO:0051301	ISTGTASSTK	5.179999828	0.43517077	0.43517077	0.127518929	951.5585602	16.57243	13.99968	0	0	15.32001	0	14.35971	0	0	0	16.03931	17.45038	0	16.76324	16.40989	13.89484	0	0	0	0	0	0	0	0	0	0	16.62108	14.33502	16.3115	14.41264	14.61425	14.23947	0	0	15.29627	15.8235	16.24975	15.54928	14.46589	14.42626	0	0	16.00136	16.67727	0	15.25455	15.45134	16.07037
Q6A162	K1C40_HUMAN	"Keratin, type I cytoskeletal 40 (Cytokeratin-40, CK-40) (Keratin-40, K40) (Type I hair keratin Ka36)"	KRT40 KA36	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109	EDLLCLKK	28.67000008	1	1	0.395708697	1018.409575	0	17.64908	0	17.54828	16.97825	0	0	0	17.47125	0	0	0	0	17.82542	0	0	18.37277	0	0	0	0	0	0	0	0	17.48835	16.00408	0	0	0	0	16.73854	0	0	17.06046	0	0	0	0	0	0	18.29955	17.41688	18.44966	0	17.73554	16.80716	0
Q6A163	K1C39_HUMAN	"Keratin, type I cytoskeletal 39 (Cytokeratin-39, CK-39) (Keratin-39, K39) (Type I hair keratin Ka35)"	KRT39 KA35	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109	ATKCEPSPWTSCK	2.789999962	1	1	0.06714556	1551.515542	0	13.81214	0	16.6504	16.08223	16.27222	16.31781	17.17967	15.23943	15.85537	0	0	0	0	0	14.7423	16.98096	0	0	0	0	0	0	16.24103	16.48519	0	0	0	0	0	0	17.10933	17.54276	0	0	0	0	18.10338	17.09439	0	14.5158	0	0	0	0	0	0	0
Q6AHZ1	Z518A_HUMAN	Zinc finger protein 518A	ZNF518A KIAA0335 ZNF518	Homo sapiens (Human)	chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006325; GO:0006357; GO:0046872	AEEEGVKMSAK	5.159999847	1	1	0.377147386	1190.362774	0	15.64351	13.57195	15.99621	15.44693	0	15.12119	0	0	0	0	15.6372	0	15.00091	0	15.05219	14.46637	15.56336	0	0	16.90173	0	0	0	0	0	16.45447	0	0	14.45287	17.23755	0	0	0	0	14.44987	15.12495	0	16.08966	0	16.09623	0	16.09599	16.47136	16.45938	17.01471	15.45053	16.62153
Q6AI14	SL9A4_HUMAN	"Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4, NHE-4) (Solute carrier family 9 member 4)"	SLC9A4 NHE4	Homo sapiens (Human)	epithelial cell development [GO:0002064]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; response to salt stress [GO:0009651]; sodium ion import across plasma membrane [GO:0098719]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; epithelial cell development [GO:0002064]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; response to salt stress [GO:0009651]; sodium ion import across plasma membrane [GO:0098719]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0001696; GO:0002064; GO:0005774; GO:0005886; GO:0006811; GO:0009651; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0031410; GO:0051453; GO:0055075; GO:0071805; GO:0098719	QEAQEIIPMKSLHR	6.869999886	0.283288658	0.283288658	0.388319972	1696.876945	16.12084	0	0	0	17.19308	0	18.01103	16.40667	0	16.61931	0	16.30913	0	0	0	15.77665	0	0	17.17127	0	0	0	0	0	0	0	18.44863	0	0	0	0	0	17.32705	0	0	0	0	0	0	0	0	0	0	16.5341	0	0	15.36189	16.63614
Q6AZY7	SCAR3_HUMAN	Scavenger receptor class A member 3 (Cellular stress response gene protein)	SCARA3 CSR	Homo sapiens (Human)	response to oxidative stress [GO:0006979]; UV protection [GO:0009650]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; response to oxidative stress [GO:0006979]; UV protection [GO:0009650]	scavenger receptor activity [GO:0005044]	GO:0000139; GO:0005044; GO:0005581; GO:0005615; GO:0005783; GO:0005789; GO:0006979; GO:0009650; GO:0016021; GO:0062023	GAMGPK	15.94999981	0.117282085	0.117282085	0.224743281	575.0720209	15.20685	16.77394	0	0	0	0	0	0	16.99537	0	0	0	15.83663	0	0	0	0	16.6828	0	0	0	19.85054	17.15951	19.54807	0	0	0	0	0	16.54385	0	0	16.34309	0	14.89611	16.94366	16.70715	0	16.79292	0	15.99551	0	0	0	0	0	0	0
Q6B0I6	KDM4D_HUMAN	"Lysine-specific demethylase 4D, EC 1.14.11.66 (JmjC domain-containing histone demethylation protein 3D) (Jumonji domain-containing protein 2D) ([histone H3]-trimethyl-L-lysine(9) demethylase 4D)"	KDM4D JHDM3D JMJD2D	Homo sapiens (Human)	cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of protein phosphorylation [GO:0001932]	blood microparticle [GO:0072562]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]	blood microparticle [GO:0072562]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]; cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of protein phosphorylation [GO:0001932]	chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]	GO:0000724; GO:0001932; GO:0003684; GO:0005634; GO:0005654; GO:0005721; GO:0006338; GO:0031490; GO:0032452; GO:0032454; GO:0033169; GO:0035563; GO:0035861; GO:0046872; GO:0071479; GO:0072562; GO:0140684; GO:1900113; GO:2001034	ASGCSWAPVP	6.630000114	0.064332515	0.064332515	0.101654165	1031.3805	13.44915	10.83329	15.06541	13.84062	13.41216	15.86932	13.488	0	13.48112	16.06463	15.87924	15.90137	13.35347	13.46747	13.70365	13.99266	14.07987	0	0	15.4992	13.27458	0	14.99311	0	0	0	0	0	0	0	0	0	0	12.06052	0	17.5496	0	0	0	15.18957	0	14.06619	0	0	0	0	0	0
Q6BCY4	NB5R2_HUMAN	"NADH-cytochrome b5 reductase 2, b5R.2, EC 1.6.2.2"	CYB5R2	Homo sapiens (Human)	bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]	"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]"	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0005634; GO:0005789; GO:0015701; GO:0016020; GO:0016126; GO:0071949	KTLADHLGMIAGGTGITPMLQLIR	1.600000024	1	1	0.650300978	2525.181119	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6BEB4	SP5_HUMAN	Transcription factor Sp5	SP5	Homo sapiens (Human)	bone morphogenesis [GO:0060349]; cellular response to organic cyclic compound [GO:0071407]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; bone morphogenesis [GO:0060349]; cellular response to organic cyclic compound [GO:0071407]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0036342; GO:0046872; GO:0060349; GO:0071407	TPSASPDLGK	8.920000076	0.300967753	0.300967753	0.140676115	973.5933366	0	16.07717	15.30133	17.19214	0	0	14.17537	14.28337	14.84897	14.86358	12.07567	15.68808	16.24993	16.31512	15.50619	16.30773	17.4073	14.74725	0	14.76576	15.7684	18.07051	18.7606	0	14.918	16.20992	17.05956	13.54834	16.94076	17.01574	0	17.81488	16.06048	0	16.74935	14.47964	17.70737	17.22715	16.83266	0	11.56801	14.58489	16.14917	18.35185	9.097556	15.55047	17.12475	0
Q6DHV5	C2D2B_HUMAN	Protein CC2D2B	CC2D2B C10orf130 C10orf131	Homo sapiens (Human)	non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]	ciliary transition zone [GO:0035869]	ciliary transition zone [GO:0035869]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]		GO:0035869; GO:1904491; GO:1905515	DMMPR	12.18000031	0.197220445	0.197220445	0.09837642	664.5805599	16.24249	14.51281	17.02871	16.43006	12.49537	0	0	12.22379	15.69814	0	14.01079	15.86577	16.04955	16.98386	0	13.75224	17.31429	12.46069	16.42437	0	0	17.0721	16.43699	0	18.41252	0	16.3703	0	16.78117	16.88266	17.08883	16.67519	0	13.67713	16.25043	18.60586	0	17.53374	16.65031	16.96204	17.88832	16.26248	13.15712	18.48044	14.62968	15.74602	15.1373	16.67472
Q6DHV7	ADAL_HUMAN	"Adenosine deaminase-like protein, EC 3.5.4.- (Adenosine deaminase-like protein isoform 1) (N6-mAMP deaminase, HsMAPDA) (N6-methyl-AMP aminohydrolase)"	ADAL ADAL1	Homo sapiens (Human)	adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	cytosol [GO:0005829]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-mAMP deaminase activity [GO:0062154]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]	adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-mAMP deaminase activity [GO:0062154]	GO:0004000; GO:0005829; GO:0006154; GO:0009117; GO:0046103; GO:0046872; GO:0062154	KLIAQKPDLK	1.49000001	0.004274439	0.004274439	0.20703109	1150.36254	13.01312	14.56696	14.63705	0	14.33872	12.9589	0	15.05609	0	0	0	0	0	0	15.82819	13.93858	0	14.65407	0	0	14.62225	0	0	0	0	0	12.53514	11.71323	0	12.51808	0	0	0	0	0	0	0	14.57679	0	0	0	0	0	12.10724	16.38848	0	0	0
Q6DKI2	LEG9C_HUMAN	"Galectin-9C, Gal-9C (Galectin-9-like protein B)"	LGALS9C	Homo sapiens (Human)	"negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]"	cytosol [GO:0005829]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]"	carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936]	GO:0005634; GO:0005829; GO:0010628; GO:0016936; GO:0030246; GO:0032689; GO:2000562	NLPTINKLEVGGDIQLTHVQT	1.169999957	1	1	0.162581639	2290.040776	15.2269	14.33165	12.40053	0	0	0	14.16949	15.93464	0	0	11.06105	0	13.71686	0	0	12.69161	0	0	0	0	0	0	14.25909	15.86516	9.669819	15.31348	13.95518	0	0	0	0	0	0	0	14.62988	0	15.72359	0	0	0	0	14.71806	0	0	0	0	15.00788	0
Q6DKK2	TTC19_HUMAN	"Tetratricopeptide repeat protein 19, mitochondrial, TPR repeat protein 19"	TTC19	Homo sapiens (Human)	mitochondrial respiratory chain complex III assembly [GO:0034551]; mitotic cytokinesis [GO:0000281]	centrosome [GO:0005813]; midbody [GO:0030496]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]	centrosome [GO:0005813]; midbody [GO:0030496]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitotic cytokinesis [GO:0000281]		GO:0000281; GO:0005739; GO:0005743; GO:0005813; GO:0030496; GO:0034551; GO:0070469	ASDLAR	15.06000042	0.202782109	0.202782109	1.60E-12	634.3364315	16.01473	0	17.94377	16.35841	17.30051	0	17.72043	0	16.22901	18.0749	0	0	0	16.41612	0	0	0	0	0	17.99745	0	0	17.89135	17.31028	17.0732	0	0	0	0	0	0	14.86635	0	17.47928	0	0	0	18.75758	0	0	0	0	0	15.67414	0	0	0	18.49458
Q6DN03	H2B2C_HUMAN	"Putative histone H2B type 2-C (H2B-clustered histone 20 pseudogene) (Histone H2B.t, H2B/t)"	H2BC20P HIST2H2BC	Homo sapiens (Human)	nucleosome assembly [GO:0006334]	nucleosome [GO:0000786]; nucleus [GO:0005634]	nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0046982	AHNTKHR	12.22999954	0.136646941	0.136646941	0.269359923	859.9035324	16.34246	15.00128	15.28168	16.20679	14.91409	14.61695	14.66391	0	0	0	15.93129	15.9521	0	0	15.3811	0	0	0	16.00669	16.58329	16.67104	16.69076	0	16.84546	15.63378	16.09793	0	15.95096	15.40593	14.8559	12.02337	15.35143	14.83278	14.56966	16.02279	14.97974	0	16.53777	14.44663	16.49939	16.33289	15.18437	15.11048	15.84537	15.08868	14.67502	15.48799	15.93213
Q6DN12	MCTP2_HUMAN	Multiple C2 and transmembrane domain-containing protein 2	MCTP2	Homo sapiens (Human)	calcium-mediated signaling [GO:0019722]; regulation of neurotransmitter secretion [GO:0046928]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; regulation of neurotransmitter secretion [GO:0046928]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005654; GO:0005829; GO:0016020; GO:0016021; GO:0019722; GO:0030672; GO:0046928	GVIYLEMDLIYNPVKASIR	4.369999886	1	1	2.29E-12	2207.532633	14.46491	0	14.60632	0	0	13.747	0	14.45717	14.18927	14.68106	13.04531	0	0	13.84772	0	15.53915	0	16.38597	0	0	0	0	0	0	13.95986	0	15.8901	15.12005	0	16.02669	13.34273	14.16662	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6DN14	MCTP1_HUMAN	Multiple C2 and transmembrane domain-containing protein 1	MCTP1	Homo sapiens (Human)	calcium-mediated signaling [GO:0019722]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005789; GO:0016021; GO:0019722; GO:0030336; GO:0030672; GO:0045806; GO:0046928; GO:0048168; GO:0055037; GO:1902883	DVTMLMR	10.76000023	0.273836136	0.273836136	1.71E-12	898.0213221	0	0	0	18.27935	0	0	0	0	0	0	10.8321	17.01277	15.89716	0	0	0	18.32619	15.67947	0	17.17027	0	0	0	0	0	17.81764	16.56459	0	0	14.50526	0	0	0	0	0	0	0	17.59266	0	17.61142	0	0	16.64715	15.79556	0	19.07815	0	0
Q6DN72	FCRL6_HUMAN	"Fc receptor-like protein 6, FcR-like protein 6, FcRL6 (Fc receptor homolog 6, FcRH6) (IFGP6)"	FCRL6 FCRH6	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; MHC class II protein binding [GO:0042289]; phosphatase binding [GO:0019902]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]	MHC class II protein binding [GO:0042289]; phosphatase binding [GO:0019902]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007166; GO:0009897; GO:0019902; GO:0019903; GO:0042289	ENQTLSMGAATVQSR	4.360000134	1	1	1.15E-12	1593.339406	13.52618	0	13.53428	0	0	14.31199	0	0	0	0	0	15.83926	0	0	0	12.36783	0	0	10.6607	14.60937	0	0	0	0	0	13.42774	0	0	0	0	15.53184	0	0	13.39851	0	10.55046	0	0	0	0	0	0	0	0	15.2639	0	0	0
Q6DT37	MRCKG_HUMAN	"Serine/threonine-protein kinase MRCK gamma, EC 2.7.11.1 (CDC42-binding protein kinase gamma) (DMPK-like gamma) (Myotonic dystrophy kinase-related CDC42-binding kinase gamma, MRCK gamma, MRCKG, Myotonic dystrophy protein kinase-like gamma) (Myotonic dystrophy protein kinase-like alpha)"	CDC42BPG DMPK2	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]	cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0018107; GO:0031032; GO:0031252; GO:0031532; GO:0034451; GO:0106310	KHQEALHAPTDHR	19.87999916	1	1	0.454516571	1539.745682	0	0	0	0	0	0	17.59581	0	0	0	0	0	0	0	0	19.30613	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6E0U4	DMKN_HUMAN	Dermokine (Epidermis-specific secreted protein SK30/SK89)	DMKN UNQ729/PRO1411	Homo sapiens (Human)	cornified envelope assembly [GO:1903575]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; cornified envelope assembly [GO:1903575]		GO:0005615; GO:1903575	AIGKEAGGAAGSK	8.340000153	1	1	0.398651611	1115.704618	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.59478	0	0	0	0	0	0	0	0	0	0	18.36724	0	0	0	0	0
Q6E213	AWAT2_HUMAN	"Acyl-CoA wax alcohol acyltransferase 2, EC 2.3.1.75 (11-cis-specific retinyl-ester synthase, 11-cis-RE-synthase) (Acyl-CoA retinol O-fatty-acyltransferase, ARAT, Retinol O-fatty-acyltransferase, EC 2.3.1.76) (Diacylglycerol O-acyltransferase 2-like protein 4) (Diacylglycerol O-acyltransferase candidate 4, hDC4) (Long-chain-alcohol O-fatty-acyltransferase 2) (Multifunctional O-acyltransferase) (Wax synthase, hWS)"	AWAT2 DC4 DGAT2L4 MFAT WS	Homo sapiens (Human)	acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; retinol O-fatty-acyltransferase activity [GO:0050252]; acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025]	2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; retinol O-fatty-acyltransferase activity [GO:0050252]	GO:0001523; GO:0003846; GO:0005789; GO:0006629; GO:0006640; GO:0010025; GO:0016021; GO:0036155; GO:0047196; GO:0050252; GO:0102966	LLPSKK	12.88000011	1	1	0.248053289	685.5486213	0	0	0	0	15.69601	0	0	0	0	17.64765	0	0	0	0	0	0	0	0	16.75829	0	0	0	0	0	19.73228	0	0	0	17.14418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6EMB2	TTLL5_HUMAN	"Tubulin polyglutamylase TTLL5, EC 6.3.2.- (SRC1 and TIF2-associated modulatory protein, STAMP protein) (Tubulin--tyrosine ligase-like protein 5)"	TTLL5 KIAA0998 STAMP	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041]	centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0060041; GO:0070740	LSRPSSAKAGSCYLNK	5.150000095	0.928852797	0.928852797	0.351949064	1739.179193	13.31028	12.66334	10.64134	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.7166	14.19889	0	0	0	0	15.50467	0	9.983346	0	0	19.29135	0	14.31699	0	0	0	0	0	0	0	0	0	0	0
Q6EMK4	VASN_HUMAN	Vasorin (Protein slit-like 2)	VASN SLITL2 UNQ314/PRO357/PRO1282	Homo sapiens (Human)	cellular response to hypoxia [GO:0071456]; cellular response to redox state [GO:0071461]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; transforming growth factor beta binding [GO:0050431]; cellular response to hypoxia [GO:0071456]; cellular response to redox state [GO:0071461]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	cadherin binding [GO:0045296]; transforming growth factor beta binding [GO:0050431]	GO:0005615; GO:0005739; GO:0005765; GO:0005886; GO:0009986; GO:0010719; GO:0016021; GO:0030512; GO:0031012; GO:0045296; GO:0050431; GO:0070062; GO:0071456; GO:0071461	LERLYLGK	10.57999992	1	1	0.15279034	993.0694092	16.01543	15.03452	14.89873	0	0	0	0	0	0	0	0	0	15.31376	0	0	0	0	0	14.6897	0	0	0	0	0	0	0	14.39472	0	13.44853	0	0	0	15.63356	15.32687	12.02171	14.76254	13.13038	0	0	13.44139	0	15.27446	13.68083	0	15.0023	0	0	0
Q6F5E7	TR3N_HUMAN	"Putative uncharacterized protein TXNRD3NB (Thioredoxin reductase 2 intronic transcript 1) (Thioredoxin reductase 3 intronic transcript 1) (Thioredoxin reductase 3 neighbor gene protein, TXNRD3 neighbor gene protein) (Thioredoxin reductase 3 new transcript 1)"	TXNRD3NB TR2IT1 TXNRD3IT1 TXNRD3NT1	Homo sapiens (Human)						VFGQGFPSPLEEIK	8.779999733	1	1	0.054236185	1548.941557	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6F5E8	CARL2_HUMAN	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]	GO:0001726; GO:0005543; GO:0005737; GO:0005886; GO:0007163; GO:0010592; GO:0015629; GO:0016020; GO:0030011; GO:0030027; GO:0030335; GO:0031234; GO:0031252; GO:0044319; GO:0044354; GO:0044877; GO:0045111; GO:0051639; GO:0061339; GO:0090091; GO:1900029; GO:1902745; GO:2000813	GGGPNP	3.769999981	0.284782678	0.284782678	0.134387431	497.3533039	17.06143	19.74316	16.72191	16.82312	16.43101	18.488	16.83303	17.9656	16.05551	16.53855	19.11399	18.75991	15.93064	18.23887	16.66786	17.78551	17.76175	18.06266	16.39683	19.96182	19.13431	0	17.70674	16.97375	20.25429	18.13402	16.60684	18.29175	0	19.40796	20.02437	0	19.47085	18.52452	17.37117	0	0	0	17.43435	19.86382	0	17.14726	18.17115	18.11383	17.69233	0	0	17.69965
Q6GMR7	FAAH2_HUMAN	"Fatty-acid amide hydrolase 2, EC 3.5.1.99 (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)"	FAAH2 AMDD	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]	anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]	GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073	EAFQLQGMPNSSGLMNRR	10.43999958	1	1	0.12212775	2036.247213	0	0	0	0	0	0	0	14.21634	13.90895	0	0	0	0	14.84853	14.66253	13.78409	0	13.6452	12.75896	12.70672	11.11769	14.90105	0	0	15.45869	11.94185	0	12.7632	15.50936	13.74007	0	0	9.725576	0	13.53775	14.60558	0	0	12.5613	12.93859	0	13.32166	0	0	12.54973	0	0	12.03436
Q6GQQ9	OTU7B_HUMAN	"OTU domain-containing protein 7B, EC 3.4.19.12 (Cellular zinc finger anti-NF-kappa-B protein, Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne)"	OTUD7B ZA20D1	Homo sapiens (Human)	adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]	cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]	GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947; GO:1900181; GO:1990380	IMNGGIGGGPPPAK	4.710000038	1	1	6.88E-13	1265.833586	11.56612	15.73054	0	0	14.78614	11.87966	0	15.07615	0	13.35748	0	15.71606	14.06528	14.33696	0	0	16.11546	15.6611	0	14.50379	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.75621	0
Q6GTX8	LAIR1_HUMAN	"Leukocyte-associated immunoglobulin-like receptor 1, LAIR-1, hLAIR1 (CD antigen CD305)"	LAIR1 CD305	Homo sapiens (Human)	adaptive immune response [GO:0002250]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; adaptive immune response [GO:0002250]		GO:0002250; GO:0005886; GO:0016021; GO:0035579; GO:0070821	EGNAGLYR	6.590000153	0.862052262	0.862052262	0.174679216	879.1469119	0	0	0	18.28131	17.39338	12.70125	0	15.78858	0	15.04291	0	15.73829	18.58228	16.47399	12.25309	16.30534	16.83136	13.37966	0	0	15.67353	18.9289	14.64044	16.42506	12.92419	17.49598	11.08781	11.97055	15.79689	18.59087	16.96947	0	19.05242	16.33401	16.66691	18.06155	0	0	17.27792	12.90222	17.78656	16.40717	17.66341	0	17.03976	17.56519	13.52133	16.45958
Q6GYQ0	RGPA1_HUMAN	"Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12, GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240)"	RALGAPA1 GARNL1 KIAA0884 TULIP1	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]	GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630	EPFIKAR	7.429999828	1	1	0.226387593	860.6621603	15.53589	0	0	0	0	0	14.8999	0	0	0	15.18563	0	0	0	17.05012	15.30751	12.69323	15.8903	0	16.68265	0	0	0	0	18.48582	0	14.96787	0	0	0	0	16.07922	0	0	17.47039	0	16.04035	0	0	16.42729	0	14.32132	16.37091	0	17.59085	17.12325	17.34412	0
Q6H3X3	ULBP5_HUMAN	UL-16 binding protein 5 (Retinoic acid early transcript 1G protein)	RAET1G ULBP5	Homo sapiens (Human)	natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell cytokine production [GO:0002729]	anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell cytokine production [GO:0002729]	natural killer cell lectin-like receptor binding [GO:0046703]	GO:0002729; GO:0005576; GO:0005615; GO:0005783; GO:0005886; GO:0009897; GO:0016021; GO:0031225; GO:0042267; GO:0043231; GO:0046703	VLWSDSYQIAKRPLSGGHVTR	6.340000153	1	1	3.65E-12	2369.598404	13.95193	16.62369	16.06646	15.77721	14.54682	0	18.59506	16.98191	17.40237	16.3295	16.41119	16.834	13.35643	15.04588	18.04211	0	15.41276	13.59476	16.94285	12.84689	13.60153	0	0	11.70499	16.8646	0	0	15.03493	0	14.04772	0	0	14.79583	9.776876	0	15.85939	16.05402	16.15145	0	16.74656	11.7162	15.24263	0	0	15.13546	0	15.21381	0
Q6H8Q1	ABLM2_HUMAN	"Actin-binding LIM protein 2, abLIM-2 (Actin-binding LIM protein family member 2)"	ABLIM2 KIAA1808	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]"	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]"	actin filament binding [GO:0051015]; metal ion binding [GO:0046872]	GO:0005737; GO:0006351; GO:0015629; GO:0030032; GO:0030036; GO:0046872; GO:0051015	HFHVPDTGVK	2.670000076	1	1	0.105196559	1136.938843	0	9.026956	0	0	0	0	0	15.21137	0	14.43277	0	0	0	0	15.26474	0	14.18768	0	0	0	0	0	0	0	0	0	17.02075	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6IA86	ELP2_HUMAN	"Elongator complex protein 2, ELP2 (SHINC-2) (STAT3-interacting protein 1, StIP1)"	ELP2 STATIP1	Homo sapiens (Human)	regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein kinase binding [GO:0019901]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	protein kinase binding [GO:0019901]	GO:0002098; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0006417; GO:0008023; GO:0019901; GO:0033588; GO:0046425	LLSASMDK	4.349999905	0.43176353	0.43176353	0.215333169	882.8312074	17.68966	15.05351	16.26138	13.83154	17.10429	0	13.73455	0	0	17.0498	18.10334	16.20663	15.97503	0	16.9716	0	0	15.07351	17.9778	16.19667	13.79116	13.6403	0	0	18.37698	0	14.50813	16.67053	17.41105	0	17.24509	17.72607	18.39298	17.44131	16.23042	11.26392	18.8422	18.04633	18.32044	15.37573	16.33652	17.83194	16.36994	0	14.08509	0	15.23841	14.27153
Q6IAN0	DRS7B_HUMAN	"Dehydrogenase/reductase SDR family member 7B, EC 1.1.-.- (Short-chain dehydrogenase/reductase family 32C member 1, Protein SDR32C1)"	DHRS7B SDR32C1 CGI-93 UNQ212/PRO238	Homo sapiens (Human)	adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; ether lipid biosynthetic process [GO:0008611]; inflammatory response [GO:0006954]; negative regulation of protein binding [GO:0032091]; neutrophil differentiation [GO:0030223]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of cold-induced thermogenesis [GO:0120161]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; transcription regulator complex [GO:0005667]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; transcription regulator complex [GO:0005667]; acylglycerone-phosphate reductase activity [GO:0000140]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; ether lipid biosynthetic process [GO:0008611]; inflammatory response [GO:0006954]; negative regulation of protein binding [GO:0032091]; neutrophil differentiation [GO:0030223]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of cold-induced thermogenesis [GO:0120161]	acylglycerone-phosphate reductase activity [GO:0000140]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]	GO:0000140; GO:0003714; GO:0005634; GO:0005667; GO:0005778; GO:0005789; GO:0006656; GO:0006954; GO:0008611; GO:0016020; GO:0016021; GO:0030223; GO:0032091; GO:0050873; GO:0060612; GO:0120161; GO:0140297	MVSPATRK	4.28000021	0.75069195	0.75069195	0.257594312	890.1473095	14.71547	15.09326	0	13.08659	0	0	15.97117	15.04107	11.47899	15.11	0	15.88978	0	15.71432	16.1405	15.20864	0	0	0	15.9815	15.32466	0	15.76423	0	0	0	15.33347	16.55844	0	0	15.58715	15.17502	16.35735	0	0	15.78429	0	16.32891	16.82153	0	0	0	0	0	15.16339	0	0	15.56329
Q6IB77	GLYAT_HUMAN	"Glycine N-acyltransferase, EC 2.3.1.13 (Acyl-CoA:glycine N-acyltransferase, AAc) (Aralkyl acyl-CoA N-acyltransferase) (Aralkyl acyl-CoA:amino acid N-acyltransferase) (Benzoyl-coenzyme A:glycine N-acyltransferase) (Glycine N-benzoyltransferase, EC 2.3.1.71) (HRP-1(CLP))"	GLYAT ACGNAT CAT GAT	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; benzoyl-CoA metabolic process [GO:1901787]; glycine metabolic process [GO:0006544]; monocarboxylic acid metabolic process [GO:0032787]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyltransferase activity [GO:0016746]; glycine N-acyltransferase activity [GO:0047961]; glycine N-benzoyltransferase activity [GO:0047962]; N-acyltransferase activity [GO:0016410]; acyl-CoA metabolic process [GO:0006637]; benzoyl-CoA metabolic process [GO:1901787]; glycine metabolic process [GO:0006544]; monocarboxylic acid metabolic process [GO:0032787]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	acyltransferase activity [GO:0016746]; glycine N-acyltransferase activity [GO:0047961]; glycine N-benzoyltransferase activity [GO:0047962]; N-acyltransferase activity [GO:0016410]	GO:0005739; GO:0005759; GO:0006544; GO:0006637; GO:0006805; GO:0009636; GO:0016410; GO:0016746; GO:0032787; GO:0047961; GO:0047962; GO:1901787	ELTPFLLKSK	12.01000023	1	1	0.099497458	1176.887897	15.07526	10.42387	0	13.86208	14.22925	0	0	0	0	0	15.93458	15.16943	16.28163	0	15.26638	0	14.78798	15.78923	0	0	14.99065	0	0	14.82892	0	0	0	0	0	0	0	0	0	0	0	0	0	17.18217	0	0	0	16.33241	0	0	0	0	0	0
Q6IBS0	TWF2_HUMAN	"Twinfilin-2 (A6-related protein, hA6RP) (Protein tyrosine kinase 9-like) (Twinfilin-1-like protein)"	TWF2 PTK9L MSTP011	Homo sapiens (Human)	actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; cell projection organization [GO:0030030]; cellular response to growth factor stimulus [GO:0071363]; cellular response to retinoic acid [GO:0071300]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of axon extension [GO:0045773]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of lamellipodium assembly [GO:0010591]; regulation of microvillus length [GO:0032532]; sequestering of actin monomers [GO:0042989]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]	"actin filament [GO:0005884]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; cell projection organization [GO:0030030]; cellular response to growth factor stimulus [GO:0071363]; cellular response to retinoic acid [GO:0071300]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of axon extension [GO:0045773]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of lamellipodium assembly [GO:0010591]; regulation of microvillus length [GO:0032532]; sequestering of actin monomers [GO:0042989]"	"actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]"	GO:0003723; GO:0003785; GO:0005080; GO:0005524; GO:0005546; GO:0005737; GO:0005884; GO:0010591; GO:0010592; GO:0010976; GO:0030016; GO:0030027; GO:0030030; GO:0030042; GO:0030175; GO:0030426; GO:0030837; GO:0032420; GO:0032532; GO:0032956; GO:0042989; GO:0045296; GO:0045773; GO:0048471; GO:0051015; GO:0051016; GO:0070062; GO:0071300; GO:0071363	HQTLQGLAFPLQPEAQR	5.570000172	1	1	0.146683919	1934.078901	0	0	0	0	15.7379	0	0	0	0	0	0	0	0	15.25	0	0	0	0	0	0	0	0	0	0	0	0	0	14.59399	15.61292	16.17819	0	0	15.55202	0	13.26527	16.75959	16.0341	0	0	0	14.31798	0	0	0	0	0	0	0
Q6IBW4	CNDH2_HUMAN	"Condensin-2 complex subunit H2 (Chromosome-associated protein H2, hCAP-H2) (Kleisin-beta) (Non-SMC condensin II complex subunit H2)"	NCAPH2 CAPH2	Homo sapiens (Human)	female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077]	cell junction [GO:0030054]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cell junction [GO:0030054]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077]	chromatin binding [GO:0003682]	GO:0000794; GO:0000796; GO:0003682; GO:0005634; GO:0005654; GO:0007076; GO:0010032; GO:0016020; GO:0030054; GO:0033077; GO:0045171; GO:0051306; GO:0051309; GO:0051984; GO:1905820	FQTYAAPSMAQP	3.029999971	1	1	0.422211479	1326.452758	0	16.49964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.4691	15.80781	0	0	0	0	16.85198	17.47805	0	0	15.89304	0	15.25908	0	0	0	0	17.30239	0	15.55328	0	0	12.69373	0	15.66921	0	16.48667	0	0	0	0	0
Q6ICC9	RTL6_HUMAN	Retrotransposon Gag-like protein 6 (Leucine zipper protein down-regulated in cancer cells-like) (Mammalian retrotransposon-derived protein 6) (Protein LDOC1L)	RTL6 LDOC1L MAR6 MART6	Homo sapiens (Human)						NNYQGFLAELRR	9.550000191	1	1	0.439545809	1480.551452	0	13.43148	13.21787	14.78807	0	0	16.22794	14.86168	0	0	0	0	0	0	16.1132	18.11279	14.73227	0	0	0	0	15.66681	16.17716	14.93978	0	0	0	17.87416	0	0	16.45114	0	0	18.73583	16.00229	0	20.13876	14.39041	16.96163	18.35744	0	0	15.45961	0	16.84695	19.19452	15.57934	0
Q6ICG8	WBP2L_HUMAN	Postacrosomal sheath WW domain-binding protein (WW domain-binding protein 2-like)	WBP2NL PAWP	Homo sapiens (Human)	"egg activation [GO:0007343]; female pronucleus assembly [GO:0035038]; male pronucleus assembly [GO:0035039]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleus [GO:0005634]; perinuclear theca [GO:0033011]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]	"nucleus [GO:0005634]; perinuclear theca [GO:0033011]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; WW domain binding [GO:0050699]; egg activation [GO:0007343]; female pronucleus assembly [GO:0035038]; male pronucleus assembly [GO:0035039]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]"	chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; WW domain binding [GO:0050699]	GO:0003713; GO:0005634; GO:0007343; GO:0031490; GO:0033011; GO:0035038; GO:0035039; GO:0036126; GO:0045893; GO:0050699; GO:0051321; GO:0061827	AASAAAR	9.510000229	0.401728749	0.401728749	0.304791469	615.7634657	16.48917	16.11967	16.0088	15.21714	15.94204	14.84788	15.44063	14.78245	15.21913	0	16.25876	0	0	0	0	13.96111	0	15.92313	0	0	0	15.71586	15.64868	0	15.93776	15.43338	15.0083	16.96322	15.33653	14.99172	0	15.24263	15.58944	0	16.24503	0	0	0	0	0	0	16.29449	0	16.62019	0	0	0	16.71269
Q6ICL7	S35E4_HUMAN	Solute carrier family 35 member E4	SLC35E4	Homo sapiens (Human)		Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]	antiporter activity [GO:0015297]	GO:0005794; GO:0015297; GO:0016021	CPPEHHDGR	5.429999828	1	1	0.169428166	1104.498801	0	0	12.36709	14.14918	16.24891	0	14.39928	14.22126	0	0	0	15.55517	0	0	0	16.36263	12.34925	0	15.68434	15.47928	14.44509	12.51531	15.55002	14.60196	0	14.69006	15.17019	14.71095	0	0	0	0	0	0	14.12468	0	14.35116	0	0	0	0	0	0	0	16.29801	0	0	0
Q6IE81	JADE1_HUMAN	Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17)	JADE1 KIAA1807 PHF17	Homo sapiens (Human)	"apoptotic process [GO:0006915]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromosome [GO:0005694]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]	GO:0000123; GO:0001558; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0006275; GO:0006355; GO:0006357; GO:0006915; GO:0016570; GO:0016607; GO:0030308; GO:0036064; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0046872; GO:0051726; GO:0090090; GO:2000134; GO:2000278	KGGAMKPTR	11.51000023	0.299252272	0.299252272	0.06158778	958.215206	0	12.96196	0	12.41478	0	13.57403	15.90974	0	0	15.81736	0	0	0	13.73329	0	16.90331	17.42189	13.27117	15.86917	15.80611	11.78966	14.35981	13.52086	15.88406	16.56567	0	0	14.83536	0	16.30863	11.55573	13.57718	0	0	0	9.021918	18.21734	15.65064	0	9.555106	0	13.31643	14.19872	16.5215	15.57845	16.20846	13.17985	13.4917
Q6IEE7	T132E_HUMAN	Transmembrane protein 132E	TMEM132E	Homo sapiens (Human)	posterior lateral line neuromast hair cell development [GO:0035677]	cell body [GO:0044297]; integral component of membrane [GO:0016021]	cell body [GO:0044297]; integral component of membrane [GO:0016021]; posterior lateral line neuromast hair cell development [GO:0035677]		GO:0016021; GO:0035677; GO:0044297	APGMSGR	8.199999809	0.635077953	0.635077953	0.030513364	674.8727271	0	16.81867	0	0	0	0	12.67287	0	11.23521	17.47688	0	13.73757	15.28397	15.09379	0	0	0	0	0	0	14.507	0	0	0	17.23723	0	0	14.82022	0	0	0	16.28994	0	0	0	0	0	14.47085	0	0	17.93902	15.2421	16.12841	0	0	0	0	0
Q6IEE8	SN12L_HUMAN	Schlafen family member 12-like	SLFN12L SLFN5	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	VTLGENNRK	4.860000134	0.279488593	0.279488593	0.183515445	1032.403683	0	0	0	0	0	15.40583	0	0	0	0	10.9756	0	16.15252	14.4559	0	0	0	15.85838	0	11.65664	0	0	0	0	0	13.69568	9.835728	0	13.92913	14.73255	16.28239	14.81536	0	16.55927	15.75406	0	16.10747	0	0	0	0	14.50832	11.86436	14.8114	12.83932	0	15.87531	15.66116
Q6IEZ7	OR2T5_HUMAN	Olfactory receptor 2T5 (Olfactory receptor OR1-62)	OR2T5	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	ANITRMANHTGK	18.98999977	1	1	0.419974658	1313.166745	0	0	11.46878	0	14.86112	13.37146	12.73016	0	12.47571	0	14.61701	14.58726	14.68336	16.23563	0	0	15.4725	15.4751	15.66259	0	0	0	0	14.57817	0	0	0	0	0	0	0	0	0	0	0	16.90333	0	0	17.6287	0	0	0	0	0	0	0	0	0
Q6IF82	O4A47_HUMAN	Olfactory receptor 4A47 (Olfactory receptor OR11-113)	OR4A47	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	TFPIDK	4.46999979	1	1	0.031060724	718.3598064	0	0	0	0	0	0	0	18.53103	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6IMI4	ST6B1_HUMAN	"Sulfotransferase 6B1, ST6B1 (Thyroxine sulfotransferase, EC 2.8.2.n2)"	SULT6B1	Homo sapiens (Human)	sulfation [GO:0051923]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923]	sulfotransferase activity [GO:0008146]	GO:0005737; GO:0005829; GO:0008146; GO:0051923	HLDGDNVK	8.960000038	1	1	0.267961212	897.8300713	13.1639	8.267688	15.46573	13.59661	0	0	0	0	0	17.17948	0	0	0	15.40929	0	0	14.34261	0	12.78394	0	0	0	11.01556	10.79853	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6IMN6	CAPR2_HUMAN	Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (Gastric cancer multidrug resistance-associated protein) (Protein EEG-1) (RNA granule protein 140)	CAPRIN2 C1QDC1 EEG1 KIAA1873 RNG140	Homo sapiens (Human)	negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]	GO:0003723; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0017148; GO:0030308; GO:0032092; GO:0033138; GO:0043235; GO:0045944; GO:0046872; GO:0050775; GO:0061003; GO:0090263	DFKGGLNGAVYLPSK	2.619999886	1	1	0.241137213	1566.782339	0	15.72456	0	0	0	0	15.53348	0	0	0	0	0	0	14.53541	0	14.09529	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.69039	0	15.61442	0	0	16.32997	0	14.81218	15.17542	0	0	0	0	0
Q6IN84	MRM1_HUMAN	"rRNA methyltransferase 1, mitochondrial, EC 2.1.1.- (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase)"	MRM1	Homo sapiens (Human)	rRNA 2'-O-methylation [GO:0000451]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451]	RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]	GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0070039	DIPVLRPR	9.199999809	1	1	0.03602259	966.6656094	14.61311	0	13.91093	0	0	15.93779	0	14.72429	0	0	0	0	14.57801	0	0	0	0	0	0	0	0	0	0	0	0	14.96023	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.9196	13.71073
Q6IN85	P4R3A_HUMAN	Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1)	PPP4R3A KIAA2010 PP4R3A SMEK1 MSTP033	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470]	protein phosphatase activator activity [GO:0072542]	GO:0005654; GO:0005815; GO:0005829; GO:0006470; GO:0006974; GO:0016607; GO:0030289; GO:0072542	GMSLLVR	11.51000023	1	1	0.185733166	774.3540291	0	0	0	13.47558	16.15542	15.11799	0	0	0	0	0	0	0	17.19192	16.20614	16.9083	16.12721	16.06655	0	0	17.28006	0	15.62124	0	17.01065	16.48104	14.66307	15.01039	18.2298	14.73645	0	15.78482	16.16265	16.2189	15.75903	15.2268	0	16.55799	17.22283	14.6533	16.13756	17.15434	14.41912	16.06973	15.9493	16.11765	0	0
Q6IN97	FRP2L_HUMAN	Putative protein FRMPD2-like (FERM and PDZ domain-containing protein 2 pseudogene 1) (FERM and PDZ domain-containing protein 2B pseudogene) (PDZ domain-containing protein 5A)	FRMPD2B FRMPD2L1 FRMPD2L2 FRMPD2P1 FRMPD2P2 PDZD5A PDZD5B PDZK5A PDZK5B	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; 1-phosphatidylinositol binding [GO:0005545]; bicellular tight junction assembly [GO:0070830]	1-phosphatidylinositol binding [GO:0005545]	GO:0005545; GO:0005923; GO:0016323; GO:0070830	LGRYSFSSPLTR	5.130000114	1	1	0.037467604	1384.15896	0	0	15.63975	0	15.89561	0	12.52019	0	0	0	13.27692	0	15.29887	0	14.48487	13.61717	0	0	0	0	14.71178	0	17.10273	0	0	0	11.59869	10.81996	15.11329	16.56491	0	0	0	0	0	0	0	15.38874	0	0	15.6818	0	13.46645	0	0	16.60574	0	0
Q6IPM2	IQCE_HUMAN	IQ domain-containing protein E	IQCE KIAA1023	Homo sapiens (Human)	limb morphogenesis [GO:0035108]	ciliary membrane [GO:0060170]; cilium [GO:0005929]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; limb morphogenesis [GO:0035108]		GO:0005929; GO:0035108; GO:0060170	MGSALLSLSRSVQELTEENQSLK	2.109999895	1	1	0.158095263	2519.925707	12.18143	0	0	11.08676	7.960487	10.47317	9.632308	10.01641	0	0	11.48942	0	0	10.44884	0	0	0	0	0	0	14.47072	0	0	0	0	0	0	0	0	0	0	0	0	0	14.92829	0	15.49194	0	0	0	0	0	0	0	0	0	0	0
Q6IPX3	TCAL6_HUMAN	"Transcription elongation factor A protein-like 6, TCEA-like protein 6 (Transcription elongation factor S-II protein-like 6)"	TCEAL6	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; WW domain binding [GO:0050699]	WW domain binding [GO:0050699]	GO:0005634; GO:0050699	DVQDPFAPR	12.81999969	1	1	0.160840783	1040.929883	0	0	14.85857	15.73315	15.60505	0	0	14.19182	0	0	0	0	0	15.16543	13.82057	13.48153	14.6648	0	0	0	14.01074	0	15.85644	0	0	0	0	0	0	0	0	0	0	0	0	0	16.09998	0	0	16.05269	16.46912	15.71205	15.42105	16.02653	0	0	0	0
Q6IQ23	PKHA7_HUMAN	"Pleckstrin homology domain-containing family A member 7, PH domain-containing family A member 7"	PLEKHA7	Homo sapiens (Human)	cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell-cell adhesion [GO:0090136]; pore complex assembly [GO:0046931]; zonula adherens maintenance [GO:0045218]	cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; pore complex [GO:0046930]; zonula adherens [GO:0005915]	cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; pore complex [GO:0046930]; zonula adherens [GO:0005915]; delta-catenin binding [GO:0070097]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell-cell adhesion [GO:0090136]; pore complex assembly [GO:0046931]; zonula adherens maintenance [GO:0045218]	delta-catenin binding [GO:0070097]	GO:0005654; GO:0005813; GO:0005829; GO:0005915; GO:0030054; GO:0044331; GO:0045218; GO:0046930; GO:0046931; GO:0070062; GO:0070097; GO:0090136	LSIFCEQDR	19.76000023	1	1	0.709120494	1166.72248	21.1292	0	0	0	21.12919	0	0	0	0	0	0	0	0	0	18.68142	0	0	0	0	0	0	22.44216	0	0	0	21.55191	0	0	0	0	0	0	0	0	20.97509	0	0	22.81601	0	0	20.6398	0	0	0	21.108	18.85257	0	0
Q6IQ26	DEN5A_HUMAN	"DENN domain-containing protein 5A (Rab6-interacting protein 1, Rab6IP1)"	DENND5A KIAA1091 RAB6IP1	Homo sapiens (Human)	"negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]"	guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0000139; GO:0005085; GO:0005802; GO:0005829; GO:0010977; GO:0031267; GO:0042147	DQSSMEDGEDTPVTKLQR	9.170000076	1	1	0.134729385	2051.611809	12.95024	15.05669	16.02296	12.67905	12.25028	0	15.18727	15.6138	12.66513	12.7959	13.76304	14.29183	0	13.69172	0	0	0	0	0	0	0	15.3557	0	13.29148	0	0	14.56954	0	13.52991	12.87865	16.27495	0	0	0	0	0	0	0	0	14.4688	0	0	0	0	0	0	0	0
Q6IQ55	TTBK2_HUMAN	"Tau-tubulin kinase 2, EC 2.7.11.1"	TTBK2 KIAA0847	Homo sapiens (Human)	cerebellar granular layer development [GO:0021681]; cerebellar granule cell precursor tangential migration [GO:0021935]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein localization to microtubule [GO:1902817]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule plus-end binding [GO:0051010]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; cerebellar granular layer development [GO:0021681]; cerebellar granule cell precursor tangential migration [GO:0021935]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein localization to microtubule [GO:1902817]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]	ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule plus-end binding [GO:0051010]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0007026; GO:0007165; GO:0007224; GO:0018105; GO:0019894; GO:0021549; GO:0021681; GO:0021935; GO:0030334; GO:0035869; GO:0036064; GO:0048156; GO:0050321; GO:0051010; GO:0060271; GO:0106310; GO:1902817; GO:1904527	DVWEEMDANK	3.210000038	1	1	1.60E-12	1237.25159	13.53373	12.53813	11.96296	14.90073	0	0	12.04939	0	0	13.48883	12.63945	0	0	14.48875	12.27359	14.65052	11.41461	15.54279	12.88855	0	0	0	16.22324	0	12.95627	14.35608	0	0	0	0	0	0	0	0	0	0	13.96614	0	0	0	12.78382	14.47397	0	0	0	0	0	0
Q6IS24	GLT17_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 17, EC 2.4.1.41 (Polypeptide GalNAc transferase-like protein 3, GalNAc-T-like protein 3, pp-GaNTase-like protein 3) (Protein-UDP acetylgalactosaminyltransferase-like protein 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3) (Williams-Beuren syndrome chromosomal region 17 protein)"	GALNT17 WBSCR17	Homo sapiens (Human)	protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006486; GO:0016021; GO:0030246; GO:0046872	VKSSLYK	9.020000458	0.366568983	0.366568983	0.257531581	825.0847229	17.47761	17.31817	17.55732	15.02066	17.46319	14.04814	17.1659	14.93367	15.18138	16.60976	16.9809	0	13.42953	0	15.56773	13.07226	15.75235	16.95288	18.90747	16.49703	14.65304	16.60536	16.81745	16.86115	16.58265	16.67369	17.35242	16.855	18.19324	16.95701	17.3356	0	16.59521	15.68637	16.69381	16.17635	14.38143	16.81805	11.86998	16.08977	0	16.40466	17.14695	17.11347	17.54589	16.611	16.27431	14.7459
Q6ISB3	GRHL2_HUMAN	Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3)	GRHL2 BOM TFCP2L3	Homo sapiens (Human)	anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte differentiation [GO:0045617]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]	cell-cell junction [GO:0005911]; chromatin [GO:0000785]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cell-cell junction [GO:0005911]; chromatin [GO:0000785]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte differentiation [GO:0045617]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000785; GO:0000978; GO:0000981; GO:0001161; GO:0001228; GO:0001843; GO:0003208; GO:0003382; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006357; GO:0007155; GO:0007420; GO:0008283; GO:0008544; GO:0016020; GO:0021915; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0043010; GO:0043565; GO:0044030; GO:0045617; GO:0045944; GO:0048701; GO:0051973; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132	SVVMVVFSEDK	8.25	1	1	0.251571322	1255.39467	0	0	0	16.60181	0	0	0	16.14992	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.78625	14.70317	0	0	0	0	0	0	14.80776	16.04548	0	0	0	0	0	0	0	0	0	0	0	13.86908	0	0	0
Q6IV72	ZN425_HUMAN	Zinc finger protein 425	ZNF425	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0045892; GO:0046872	EKPSSL	6.059999943	1	1	0.231487902	659.9933199	0	0	17.05978	0	0	0	0	0	0	0	18.57	18.87379	0	0	0	0	0	0	0	0	0	19.96108	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.93174	0	18.7768	0	19.00995	0	18.32242	0	0	0	0	0
Q6IWH7	ANO7_HUMAN	"Anoctamin-7 (Dresden transmembrane protein of the prostate, D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G)"	ANO7 NGEP PCANAP5 TMEM16G	Homo sapiens (Human)	calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0006821; GO:0016021; GO:0030054; GO:0034220; GO:0046983; GO:0055085; GO:0061588; GO:1902476	WAMTSETSSGSHCAR	5.909999847	1	1	9.26E-13	1683.630724	14.43641	0	0	13.90244	0	0	0	0	0	0	14.50066	0	0	0	0	0	0	0	0	15.23492	0	16.99747	16.91844	0	0	0	0	0	0	16.46933	0	13.95196	0	16.83021	14.82087	16.04101	0	0	0	0	0	0	0	0	0	0	0	0
Q6JBY9	CPZIP_HUMAN	CapZ-interacting protein (Protein kinase substrate CapZIP) (RCSD domain-containing protein 1)	RCSD1 CAPZIP	Homo sapiens (Human)	cellular hyperosmotic response [GO:0071474]; skeletal muscle contraction [GO:0003009]	actin filament [GO:0005884]	actin filament [GO:0005884]; actin filament binding [GO:0051015]; cellular hyperosmotic response [GO:0071474]; skeletal muscle contraction [GO:0003009]	actin filament binding [GO:0051015]	GO:0003009; GO:0005884; GO:0051015; GO:0071474	LQANLTFDPAALLPGASPK	2.220000029	1	1	0.104468801	1924.789524	14.51633	0	15.40628	11.94876	0	13.27001	12.90022	16.57665	14.74883	13.417	12.72176	13.07525	14.78084	0	0	0	10.22367	0	0	0	0	13.66704	14.9619	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6JEL2	KLH10_HUMAN	Kelch-like protein 10	KLHL10	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]		GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873	AYMFILHNFEEMVK	8.340000153	1	1	0.502477807	1787.864344	17.56701	0	0	18.83107	0	16.70258	18.59185	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.40295	0	0
Q6JQN1	ACD10_HUMAN	"Acyl-CoA dehydrogenase family member 10, ACAD-10, EC 1.3.99.-"	ACAD10	Homo sapiens (Human)	fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003995; GO:0005739; GO:0005759; GO:0006635; GO:0050660	ENMVLGPGR	2.640000105	1	1	0.141220998	989.7171881	0	0	16.70448	12.87957	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.45807	0	0	0	0	16.29082	0	0	0	15.4423	0	0	0	0	0	0	0	0	15.90002	12.24327	0	0	0
Q6JVE6	LCN10_HUMAN	Epididymal-specific lipocalin-10	LCN10	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; small molecule binding [GO:0036094]	small molecule binding [GO:0036094]	GO:0005576; GO:0036094	KLGASVVK	7.179999828	1	1	0.235947358	801.3249204	0	0	0	0	0	0	18.14934	0	0	0	17.81054	0	17.65589	0	0	0	0	0	0	0	15.6136	0	0	0	0	0	0	0	16.12477	0	0	0	0	0	0	17.35911	18.32562	0	0	0	0	0	0	0	18.52059	0	0	16.35815
Q6KC79	NIPBL_HUMAN	Nipped-B-like protein (Delangin) (SCC2 homolog)	NIPBL IDN3 SCC2	Homo sapiens (Human)	"brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic cohesin loading [GO:0061780]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038]"	chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]	"chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic cohesin loading [GO:0061780]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038]"	chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]	GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008022; GO:0019827; GO:0031065; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0034613; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045892; GO:0045944; GO:0045995; GO:0047485; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061780; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0071921; GO:0090694; GO:1990414; GO:1990841; GO:2001224	AAMYDIISSPSK	5.239999771	1	1	0.41147977	1299.34919	0	15.99167	0	0	0	0	0	13.12474	0	0	0	0	0	0	16.4533	0	0	0	0	0	0	0	0	0	0	0	14.5654	0	0	16.29479	15.31836	0	0	0	0	0	0	15.94789	17.18402	0	14.74029	0	0	0	0	15.70581	0	0
Q6KCM7	SCMC2_HUMAN	Calcium-binding mitochondrial carrier protein SCaMC-2 (Mitochondrial ATP-Mg/Pi carrier protein 3) (Mitochondrial Ca(2+)-dependent solute carrier protein 3) (Small calcium-binding mitochondrial carrier protein 2) (Solute carrier family 25 member 25)	SLC25A25 APC3 KIAA1896 MCSC3 SCAMC2 UNQ549/PRO1106	Homo sapiens (Human)	adipose tissue development [GO:0060612]; ATP metabolic process [GO:0046034]; calcium ion transmembrane transport [GO:0070588]; camera-type eye development [GO:0043010]; cellular respiration [GO:0045333]; multicellular organism growth [GO:0035264]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to food [GO:0032094]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; adipose tissue development [GO:0060612]; ATP metabolic process [GO:0046034]; calcium ion transmembrane transport [GO:0070588]; camera-type eye development [GO:0043010]; cellular respiration [GO:0045333]; multicellular organism growth [GO:0035264]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to food [GO:0032094]	ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]	GO:0002021; GO:0005347; GO:0005509; GO:0005743; GO:0014823; GO:0016021; GO:0032094; GO:0035264; GO:0043010; GO:0045333; GO:0046034; GO:0060612; GO:0070588	MQAQASIEGAPEVTMSSLFK	5.110000134	1	1	0.254127726	2140.296991	13.56446	5.862149	14.38931	0	12.6616	0	15.24694	0	15.20493	0	0	0	15.6853	10.55819	0	14.83831	0	15.43017	0	0	0	0	15.61578	14.90598	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.11424	0	0	0	0	0	0
Q6KF10	GDF6_HUMAN	"Growth/differentiation factor 6, GDF-6 (Bone morphogenetic protein 13, BMP-13) (Growth/differentiation factor 16)"	GDF6 BMP13 GDF16	Homo sapiens (Human)	"activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]"	extracellular space [GO:0005615]	"extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]"	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	GO:0001656; GO:0005125; GO:0005615; GO:0006915; GO:0008083; GO:0010862; GO:0030509; GO:0032332; GO:0032924; GO:0035788; GO:0042802; GO:0045444; GO:0045666; GO:0045893; GO:0060389; GO:0060395; GO:1900745; GO:1990009	LTPISILYIDAGNNVVYK	5.480000019	1	1	0.479571609	1993.420413	0	0	0	0	16.80633	0	0	0	0	0	0	0	0	19.01725	0	17.92337	0	0	0	0	0	0	18.30079	0	0	0	0	0	0	0	0	21.18885	0	0	17.28053	0	0	20.83076	0	0	0	0	0	0	0	0	0	0
Q6L8Q7	PDE12_HUMAN	"2',5'-phosphodiesterase 12, 2'-PDE, 2-PDE, EC 3.1.4.- (Mitochondrial deadenylase, EC 3.1.13.4)"	PDE12	Homo sapiens (Human)	"cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; oligoribonucleotidase activity [GO:0034611]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]"	3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; oligoribonucleotidase activity [GO:0034611]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0005829; GO:0006397; GO:0034611; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0051607; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503	AALRVIR	13.01000023	1	1	0.146949193	799.2297436	0	0	13.77792	0	0	0	14.1429	12.48627	0	17.03194	0	0	14.95889	15.57187	0	16.72681	13.6814	15.97526	0	11.6708	14.87241	0	0	0	0	0	0	0	0	0	0	0	0	11.81753	0	15.35984	0	15.6183	0	0	0	0	0	15.25168	17.39211	0	0	0
Q6L9T8	FA72D_HUMAN	Protein FAM72D (Gastric cancer up-regulated protein 2)	FAM72D GCUD2	Homo sapiens (Human)		cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]		GO:0005829; GO:0043231	LKDIACLK	7.53000021	1	1	0	960.2140831	15.41843	13.28494	15.39221	13.51879	0	14.21783	0	0	0	14.48196	0	12.83587	14.63777	0	0	0	0	0	14.6891	0	0	0	0	0	0	0	0	0	15.23808	0	0	0	0	0	0	0	0	0	0	13.76655	15.27926	0	0	0	0	0	0	0
Q6MZM0	HPHL1_HUMAN	"Ferroxidase HEPHL1, EC 1.16.3.1 (Hephaestin-like protein 1)"	HEPHL1	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]	copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]	GO:0004322; GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0016021; GO:0016491; GO:0055072	DAVFQR	12.27999973	3.59E-06	3.59E-06	0.277894245	735.5075982	17.70469	17.63661	13.98259	17.4132	0	17.35682	17.37838	0	0	0	17.85796	0	0	16.55288	16.47315	0	17.55909	0	0	17.27901	16.73534	0	0	0	0	0	0	18.87434	0	15.59545	17.68385	0	0	0	0	18.62376	19.76644	0	0	16.30861	18.34599	16.1397	0	0	0	0	16.63248	0
Q6MZP7	LIN54_HUMAN	Protein lin-54 homolog (CXC domain-containing protein 1)	LIN54 CXCDC1 KIAA2037	Homo sapiens (Human)	"cell cycle [GO:0007049]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067]; cell cycle [GO:0007049]; nucleosome positioning [GO:0016584]; regulation of transcription, DNA-templated [GO:0006355]"	metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067]	GO:0001067; GO:0003680; GO:0005634; GO:0005654; GO:0006355; GO:0007049; GO:0016584; GO:0046872	IGKGK	2.430000067	0.895844162	0.895844162	0.116976599	503.2839663	16.96917	17.33594	17.57676	16.19227	17.05814	16.94612	16.71264	16.423	16.7622	16.13437	17.20624	17.29727	18.50425	16.51161	17.20647	17.57894	17.01962	18.98146	17.69918	18.62185	16.86489	16.23232	17.91996	14.9175	16.87905	18.788	16.39041	0	14.84788	16.54661	17.6267	16.88062	18.10743	0	17.48413	16.51533	0	16.4055	16.38985	15.57466	16.95413	17.59779	15.82127	16.26121	16.95513	16.7228	0	16.37367
Q6MZQ0	PRR5L_HUMAN	"Proline-rich protein 5-like (Protein observed with Rictor-2, Protor-2)"	PRR5L PROTOR2	Homo sapiens (Human)	cellular response to oxidative stress [GO:0034599]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; regulation of fibroblast migration [GO:0010762]; TORC2 signaling [GO:0038203]	TORC2 complex [GO:0031932]	TORC2 complex [GO:0031932]; ubiquitin protein ligase binding [GO:0031625]; cellular response to oxidative stress [GO:0034599]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; regulation of fibroblast migration [GO:0010762]; TORC2 signaling [GO:0038203]	ubiquitin protein ligase binding [GO:0031625]	GO:0001933; GO:0001934; GO:0009968; GO:0010762; GO:0014068; GO:0031625; GO:0031932; GO:0034599; GO:0038203; GO:0061014; GO:0090316	CLLLPPSFPPPHR	14.81000042	0.012079632	0.012079632	0.539260309	1531.518071	0	0	0	0	0	0	0	0	17.06806	0	0	0	0	0	0	18.6974	0	0	0	0	0	0	0	0	0	0	17.26172	0	0	0	0	0	20.35211	0	0	0	0	0	0	18.44212	18.32572	18.73615	0	0	0	18.22297	18.0437	0
Q6MZT1	R7BP_HUMAN	Regulator of G-protein signaling 7-binding protein (R7 family-binding protein)	RGS7BP R7BP	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of postsynaptic membrane potential [GO:0060078]	anchored component of postsynaptic density membrane [GO:0099031]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynapse [GO:0098794]	anchored component of postsynaptic density membrane [GO:0099031]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of postsynaptic membrane potential [GO:0060078]		GO:0005634; GO:0005737; GO:0007186; GO:0009968; GO:0030424; GO:0043005; GO:0043198; GO:0043204; GO:0044327; GO:0060078; GO:0098794; GO:0098978; GO:0099026; GO:0099031	MSSAPNGRK	3.940000057	1	1	0.132937789	946.3089005	13.13955	13.25656	13.7153	14.30231	14.12762	13.67084	0	0	0	0	0	0	14.18556	0	0	14.30237	0	0	0	0	0	0	0	16.9182	0	13.89122	0	0	13.37703	14.18751	14.92966	14.39459	0	0	16.27175	13.31507	0	0	0	0	0	0	0	0	0	0	0	0
Q6MZW2	FSTL4_HUMAN	Follistatin-related protein 4 (Follistatin-like protein 4)	FSTL4 KIAA1061	Homo sapiens (Human)	cell differentiation [GO:0030154]; negative regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031549]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]	extracellular region [GO:0005576]; secretory granule [GO:0030141]	extracellular region [GO:0005576]; secretory granule [GO:0030141]; brain-derived neurotrophic factor binding [GO:0048403]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; negative regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031549]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]	brain-derived neurotrophic factor binding [GO:0048403]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0030141; GO:0030154; GO:0031549; GO:0048403; GO:0048671; GO:0061000	QLSLLANGSELHISSVR	1.00999999	1	1	0.432001616	1824.65204	0	0	0	0	17.70703	0	0	0	0	0	18.34258	0	0	0	0	0	0	0	0	0	0	17.91216	0	0	0	0	0	0	0	0	0	0	19.71649	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6MZZ7	CAN13_HUMAN	"Calpain-13, EC 3.4.22.- (Calcium-activated neutral proteinase 13, CANP 13)"	CAPN13	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; negative regulation of apoptotic process [GO:0043066]; proteolysis [GO:0006508]	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0043066	IFLKMPDSDR	10.51000023	1	1	0	1237.032284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6N021	TET2_HUMAN	"Methylcytosine dioxygenase TET2, EC 1.14.11.n2"	TET2 KIAA1546 Nbla00191	Homo sapiens (Human)	5-methylcytosine catabolic process [GO:0006211]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; histone H3-K4 trimethylation [GO:0080182]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; response to organic cyclic compound [GO:0014070]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; histone H3-K4 trimethylation [GO:0080182]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; response to organic cyclic compound [GO:0014070]	DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]	GO:0002521; GO:0003677; GO:0005634; GO:0006211; GO:0006325; GO:0006493; GO:0007049; GO:0008198; GO:0008270; GO:0014070; GO:0030099; GO:0035511; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0080182	TMSVTTDSTVTTSPYAFTR	13.65999985	1	1	0.06713109	2080.801954	15.66148	14.8192	0	14.25321	0	13.35669	0	0	12.76172	13.57224	11.92153	0	13.6555	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.08993	0	0	12.8292	0	0	0	0	0	0	0	0	16.4484	0	15.47129	0	0
Q6N043	Z280D_HUMAN	Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634)	ZNF280D KIAA1584 SUHW4 ZNF634	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	SKVNTALR	7.880000114	1	1	0.239359277	888.9243627	0	0	15.39544	0	0	0	0	0	0	10.1827	17.0503	14.10633	0	0	0	15.68763	0	13.24211	0	0	0	0	0	0	0	0	0	14.82736	12.88939	14.89588	0	0	0	0	0	0	0	0	0	0	0	0	12.94251	0	0	0	15.20446	0
Q6NS38	ALKB2_HUMAN	"DNA oxidative demethylase ALKBH2, EC 1.14.11.33 (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1)"	ALKBH2 ABH2	Homo sapiens (Human)	DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; oxidative DNA demethylase activity [GO:0035516]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]	cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; oxidative DNA demethylase activity [GO:0035516]	GO:0005654; GO:0006307; GO:0008198; GO:0035511; GO:0035516; GO:0043734; GO:0051747; GO:0070989; GO:0080111	DRFLVK	4.239999771	1	1	0.109203239	778.090638	13.5187	15.64011	0	0	14.29749	12.75667	14.99961	0	15.25354	0	0	15.09325	0	0	0	0	0	0	14.24317	0	0	0	0	0	15.68434	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6NSI3	FA53A_HUMAN	Protein FAM53A (Dorsal neural-tube nuclear protein)	FAM53A	Homo sapiens (Human)	protein import into nucleus [GO:0006606]	nucleus [GO:0005634]	nucleus [GO:0005634]; protein import into nucleus [GO:0006606]		GO:0005634; GO:0006606	MVTLITEK	9.930000305	0.964940071	0.964940071	0.282195263	951.1888347	17.02522	16.13771	17.16081	18.11317	16.3731	0	16.73918	18.00137	0	18.70007	17.31473	18.19193	17.00075	0	16.71021	0	0	0	17.69619	0	17.12948	0	16.88624	0	17.67247	0	0	17.47775	0	16.96056	0	17.96928	0	0	18.12586	0	0	0	18.75824	16.48268	0	0	0	16.92521	16.49088	0	16.08024	0
Q6NSI4	RADX_HUMAN	"RPA-related protein RADX (RPA-related and RAD51-antagonist, X-chromosome)"	RADX CXorf57	Homo sapiens (Human)	negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA repair [GO:0006282]	nuclear speck [GO:0016607]; replication fork [GO:0005657]	nuclear speck [GO:0016607]; replication fork [GO:0005657]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA repair [GO:0006282]	RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003723; GO:0005657; GO:0006282; GO:0016607; GO:2000042	RAGSQGPR	11.47999954	1	1	0.043187901	825.5514086	0	13.47308	13.43731	12.70475	14.69505	12.79343	12.93127	15.10552	15.05499	15.4948	15.62875	15.05287	0	0	13.15569	0	14.73857	0	15.39497	0	14.48646	0	15.19298	14.53168	13.74601	12.8612	15.5481	15.2239	13.81772	14.98805	0	0	0	0	0	0	0	15.75438	0	0	15.05236	0	0	0	0	0	13.35763	0
Q6NSJ0	MYORG_HUMAN	"Myogenesis-regulating glycosidase, EC 3.2.1.- (Uncharacterized family 31 glucosidase KIAA1161)"	MYORG KIAA1161	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]"	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897	AAAPELSYR	8.539999962	1	1	0.174529705	977.3828751	15.27143	15.13913	14.8625	0	17.40555	14.05175	10.44374	0	13.89384	14.88959	0	0	0	0	15.35828	0	13.9646	15.94484	15.55178	0	0	0	0	0	15.27462	0	0	0	0	0	0	0	14.72622	0	0	15.51964	0	0	0	0	0	0	0	14.43136	0	0	0	0
Q6NSJ5	LRC8E_HUMAN	Volume-regulated anion channel subunit LRRC8E (Leucine-rich repeat-containing protein 8E)	LRRC8E	Homo sapiens (Human)	anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]	cytoplasm [GO:0005737]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]	volume-sensitive anion channel activity [GO:0005225]	GO:0005225; GO:0005737; GO:0005886; GO:0005887; GO:0006884; GO:0015810; GO:0030176; GO:0034702; GO:0071470; GO:0098656; GO:0140361; GO:1905103	AATLESLR	13.26000023	0.54183048	0.54183048	0.248723778	858.2325325	14.92441	16.86854	15.9427	16.11834	16.21099	0	14.88661	0	0	0	14.9709	14.10054	14.72518	12.75568	13.39204	14.05565	14.91448	15.17831	17.37673	16.09931	16.06584	15.73621	15.48752	0	15.99838	14.61873	17.19801	18.03503	16.24772	14.87993	12.13565	16.78436	14.5495	14.37533	14.42643	15.68952	13.92115	16.32668	0	0	0	0	15.70108	0	0	15.10824	15.96461	15.95244
Q6NSW5	DE10B_HUMAN	Putative DENN domain-containing protein 10 B (DENND10 pseudogene 1) (Putative protein FAM45B)	DENND10P1 FAM45 FAM45BP HT011	Homo sapiens (Human)	protein transport [GO:0015031]; regulation of early endosome to late endosome transport [GO:2000641]	late endosome [GO:0005770]	late endosome [GO:0005770]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; protein transport [GO:0015031]; regulation of early endosome to late endosome transport [GO:2000641]	guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005770; GO:0015031; GO:0031267; GO:2000641	AAAELADTQLMLGVGLIEK	15.02000046	1	1	0.376978672	1958.826185	14.3877	0	11.62118	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6NSW7	NANP8_HUMAN	Homeobox protein NANOGP8	NANOGP8	Homo sapiens (Human)	positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0008284; GO:0043231; GO:1902808	QPTSAENSVAK	2.779999971	1	1	0.184504712	1129.871703	0	16.58748	15.14763	0	0	0	15.19127	14.91145	14.38996	0	0	0	0	14.86098	0	0	13.72155	0	0	0	0	0	0	15.76202	0	0	0	0	13.21245	14.88235	15.80119	0	0	0	0	15.56312	0	15.18394	15.88696	0	11.12362	0	14.73688	0	0	12.06115	0	0
Q6NSZ9	ZSC25_HUMAN	Zinc finger and SCAN domain-containing protein 25 (Zinc finger protein 498)	ZSCAN25 ZNF498	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	LKEHPEMAEAPQQQLGIPVVK	9.010000229	0.939745903	0.939745903	0.233553194	2341.49301	0	0	0	0	0	13.74198	0	0	14.17185	0	17.62578	0	0	0	0	0	13.75655	0	15.90923	0	0	0	15.12187	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.75866	0	0	0	0	0	0	0	0	19.56022	0
Q6NT04	TIGD7_HUMAN	Tigger transposable element-derived protein 7	TIGD7	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]	DNA binding [GO:0003677]	GO:0003677; GO:0005634	DICLPGK	15.73999977	1	1	0.142390437	802.9364439	0	0	0	16.25271	0	15.75461	0	0	0	14.26962	0	0	0	0	0	14.80013	15.00405	0	0	0	0	0	17.55302	0	0	0	0	16.44409	0	0	0	0	16.70114	0	16.25813	0	0	17.06128	15.46001	0	0	0	15.95483	18.68639	18.14326	0	0	0
Q6NT55	CP4FN_HUMAN	"Ultra-long-chain fatty acid omega-hydroxylase, EC 1.14.14.177 (Cytochrome P450 4F22)"	CYP4F22	Homo sapiens (Human)	ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690]"	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016021; GO:0016705; GO:0020037; GO:0046513	CVFSYNSNCQEK	4.909999847	1	1	0.373836051	1535.234455	0	0	13.06747	0	0	16.27856	15.55341	0	0	0	0	13.91397	15.78512	12.35159	15.35566	0	0	15.36892	14.54531	0	16.94625	17.25945	17.41418	16.99784	0	0	0	0	0	0	0	13.37553	15.35636	0	15.93163	15.93729	16.08143	0	16.27205	15.46485	15.65194	14.12193	15.09342	15.71104	0	0	0	14.49259
Q6NTE8	MRNIP_HUMAN	MRN complex-interacting protein (MRN-interacting protein)	MRNIP C5orf45	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032	KSSHVDSEQPR	9.390000343	0.174714312	0.174714312	0.184681196	1266.0731	14.32131	15.28862	15.05749	15.13815	0	14.55599	0	16.04017	17.65603	13.41455	15.81935	15.73889	0	0	0	0	15.48848	0	0	0	0	0	0	0	16.8242	0	17.45811	16.33497	0	0	0	0	0	0	0	0	0	18.38881	0	0	0	0	17.23311	0	17.07364	17.92846	18.60773	18.06542
Q6NUI2	GPAT2_HUMAN	"Glycerol-3-phosphate acyltransferase 2, mitochondrial, GPAT-2, EC 2.3.1.15 (1-acylglycerol-3-phosphate O-acyltransferase GPAT2, EC 2.3.1.51) (xGPAT1)"	GPAT2	Homo sapiens (Human)	CDP-diacylglycerol biosynthetic process [GO:0016024]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; piRNA biosynthetic process [GO:1990511]; triglyceride biosynthetic process [GO:0019432]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; piRNA biosynthetic process [GO:1990511]; triglyceride biosynthetic process [GO:0019432]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0003841; GO:0004366; GO:0005739; GO:0005741; GO:0006072; GO:0006631; GO:0006654; GO:0008654; GO:0016021; GO:0016024; GO:0019432; GO:0031966; GO:0102420; GO:1990511	LAISAVWTFR	8.550000191	1	1	0.452846432	1163.86673	0	13.21164	0	0	0	0	0	0	18.55483	0	0	0	16.63918	0	0	0	18.40037	0	0	0	16.20931	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.596	0	0	0	0	16.7695	17.39846	16.90146	0	17.88724	0	0
Q6NUI6	CHADL_HUMAN	Chondroadherin-like protein	CHADL SLRR4B	Homo sapiens (Human)	negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of collagen fibril organization [GO:1904027]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of collagen fibril organization [GO:1904027]	collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]	GO:0005518; GO:0005615; GO:0030021; GO:0031012; GO:0032331; GO:0062023; GO:0098633; GO:1904027	LDLQGNLLK	17.04999924	0.311291307	0.311291307	0.14140759	1012.461036	17.18458	15.0663	16.3662	16.16453	0	0	0	0	0	0	12.40299	0	0	0	11.09169	0	0	0	12.23745	0	0	0	0	15.57859	0	0	17.10555	0	0	0	14.20447	18.15797	17.54192	14.42878	0	17.10947	0	15.53871	0	0	0	16.15809	0	0	12.7701	0	0	0
Q6NUK1	SCMC1_HUMAN	Calcium-binding mitochondrial carrier protein SCaMC-1 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2+)-dependent solute carrier protein 1) (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24)	SLC25A24 APC1 MCSC1 SCAMC1	Homo sapiens (Human)	ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941]	ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]	GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0010941; GO:0015867; GO:0016021; GO:0034599; GO:0071277	TGQYSGIYDCAKK	2.950000048	1	1	0.358980081	1492.661475	15.30165	13.39377	0	0	15.06415	7.770059	0	0	0	0	0	15.62975	0	0	0	0	0	0	14.94516	0	15.29583	0	16.27657	0	0	0	0	0	13.27368	0	15.33849	0	0	12.84288	0	0	0	0	0	16.12141	0	0	0	0	0	0	0	16.21897
Q6NUK4	REEP3_HUMAN	Receptor expression-enhancing protein 3	REEP3 C10orf74	Homo sapiens (Human)	cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]	cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule binding [GO:0008017]; cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998]	microtubule binding [GO:0008017]	GO:0005789; GO:0005881; GO:0006998; GO:0007084; GO:0008017; GO:0016020; GO:0016021; GO:0051301; GO:0071782; GO:0071786	MVSWMISRAVVLVFGMLYPAYYSYK	4.75	1	1	0.817608201	2990.942041	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6NUN0	ACSM5_HUMAN	"Acyl-coenzyme A synthetase ACSM5, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 5)"	ACSM5 MACS3	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]	ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]	GO:0004321; GO:0005524; GO:0005525; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0031956; GO:0046872; GO:0047760	HLVLQALRNSR	20.98999977	1	1	0.29112758	1302.536164	0	0	0	0	0	0	0	0	0	0	20.25207	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.47415	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6NUQ1	RINT1_HUMAN	"RAD50-interacting protein 1 (RAD50 interactor 1, HsRINT-1, RINT-1)"	RINT1	Homo sapiens (Human)	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	"cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"		GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0006890; GO:0007095; GO:0015031; GO:0060628; GO:0070939	IFWQMLVEK	5.369999886	1	1	0	1192.699776	0	11.38133	9.662509	14.52969	0	0	0	13.7467	0	13.65044	8.118926	14.8882	14.19495	0	9.9596	0	0	0	0	0	0	0	0	0	0	0	16.70033	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.32892	0	0	0
Q6NV74	CRCDL_HUMAN	CRACD-like protein	CRACDL C2orf55 KIAA1211L	Homo sapiens (Human)						AASPAGPR	6.71999979	0.240788519	0.240788519	0.301373547	726.9367431	14.53765	13.35359	15.45341	16.01474	16.11207	15.50838	14.36365	0	0	15.55581	15.40521	15.83615	15.3593	15.37549	15.36205	13.6639	14.52873	15.55078	0	15.04452	14.75359	15.55445	15.34794	12.98921	15.82686	13.86798	0	16.08762	14.86381	0	0	15.68899	0	15.70545	0	0	15.53758	0	0	0	16.59231	15.8488	17.18626	0	16.32989	17.04379	16.46153	15.03923
Q6NVU6	UFSP1_HUMAN	"Inactive Ufm1-specific protease 1, UfSP1"	UFSP1	Homo sapiens (Human)						MGDKPPGFR	14.65999985	1	1	0.178710872	1004.237064	13.03438	16.3611	15.08659	13.55547	12.65564	14.19839	16.92614	12.16015	0	0	16.04837	17.58771	14.73434	15.74691	15.41908	14.96101	0	12.06005	17.60576	0	15.68827	15.98179	16.68833	16.62053	19.4167	0	15.72878	0	0	0	18.0593	12.81955	0	17.12776	14.98695	0	16.2807	15.56873	17.05258	0	0	14.56658	13.20029	13.69598	16.00452	0	18.52205	8.133441
Q6NVY1	HIBCH_HUMAN	"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, EC 3.1.2.4 (3-hydroxyisobutyryl-coenzyme A hydrolase, HIB-CoA hydrolase, HIBYL-CoA-H)"	HIBCH	Homo sapiens (Human)	branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574]	3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]	GO:0003860; GO:0005739; GO:0005759; GO:0006574; GO:0009083	QLMEGSSKTLQEVLTMEYR	2.299999952	1	1	2.75E-12	2264.060729	12.67769	12.31408	0	0	0	9.028734	0	0	0	12.80045	15.89683	0	0	0	0	13.86214	0	0	0	0	0	0	0	13.17573	0	11.14414	0	0	0	0	0	0	0	0	0	0	10.8616	0	0	0	9.373373	12.05435	0	0	0	0	0	0
Q6NW34	NEPRO_HUMAN	Nucleolus and neural progenitor protein	NEPRO C3orf17	Homo sapiens (Human)	negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747]	nucleolus [GO:0005730]; nucleus [GO:0005634]	nucleolus [GO:0005730]; nucleus [GO:0005634]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747]		GO:0005634; GO:0005730; GO:0045665; GO:0045747	SATDTSAK	5.409999847	1	1	0.096820897	778.5302192	0	0	0	0	0	0	0	0	0	0	0	0	17.77209	0	0	0	0	0	0	0	0	18.49545	0	16.22717	0	0	12.31241	0	17.35779	16.80163	0	16.32689	0	16.861	0	0	0	17.42529	17.62488	0	0	0	0	0	0	16.57073	0	0
Q6NWY9	PR40B_HUMAN	Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C)	PRPF40B HYPC	Homo sapiens (Human)	"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	"nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]"	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005685; GO:0016607; GO:0045292; GO:0071004	AAALDAGNIK	4.079999924	1	1	3.46E-13	938.3479287	15.86613	0	0	0	15.20793	0	0	0	0	0	0	0	0	0	0	14.00374	0	0	0	0	0	0	14.60703	0	0	0	11.75462	0	0	0	0	0	0	0	0	12.29759	0	0	0	0	0	0	0	0	0	0	0	0
Q6NXE6	ARMC6_HUMAN	Armadillo repeat-containing protein 6	ARMC6	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]	cytosol [GO:0005829]	cytosol [GO:0005829]; hematopoietic progenitor cell differentiation [GO:0002244]		GO:0002244; GO:0005829	AGVLPLLTGAITHHGHHTDVVR	12.64000034	0.405379534	0.405379534	0.050392472	2297.527731	0	0	0	0	0	0	0	0	0	0	0	0	0	14.19358	10.11527	11.90915	0	13.60531	10.26345	0	0	0	0	0	15.66743	13.67618	12.23563	13.10507	15.52539	0	12.28493	13.9821	0	0	0	14.91636	12.42031	0	0	0	14.26807	0	0	0	0	0	0	0
Q6NXG1	ESRP1_HUMAN	Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A)	ESRP1 RBM35A	Homo sapiens (Human)	mRNA processing [GO:0006397]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016604; GO:0042669; GO:0043484; GO:1990904	NGEALVR	3.589999914	1	1	0.33627627	757.2647363	0	17.16591	13.9744	15.46792	0	0	16.56918	0	0	15.87705	17.39516	0	16.43188	16.37906	16.20143	16.78686	16.55127	16.67324	16.72252	17.93727	17.6415	17.21863	17.22798	15.22198	16.51579	16.85548	16.95184	16.54867	17.28171	16.80861	15.16996	16.50672	17.07208	17.26165	16.17767	15.49609	17.36241	17.19347	17.43064	16.49109	17.44729	16.83901	17.43944	16.15374	17.41414	17.23875	18.07078	17.60279
Q6NXP0	EFC12_HUMAN	EF-hand calcium-binding domain-containing protein 12	EFCAB12 C3orf25	Homo sapiens (Human)			calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509	IIMVPR	5.400000095	1	1	0.299049973	744.1020184	0	0	0	0	0	0	17.62666	0	0	0	0	0	0	0	0	17.97645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.90785	0	0	18.51917	0	0	0	20.6315	0	19.23901	0	19.62309	17.26878	17.58227	18.75226	0	0	0
Q6NXP6	NXRD1_HUMAN	"NADP-dependent oxidoreductase domain-containing protein 1, EC 1.-.-.- (Pyrroline-5-carboxylate reductase-like protein C14orf148)"	NOXRED1 C14orf148	Homo sapiens (Human)	L-proline biosynthetic process [GO:0055129]		pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0055129	AYGKNLSQERPFPWFDLTAVQLK	5.809999943	1	1	4.57E-12	2708.733232	13.81406	0	15.18261	16.65239	14.48257	12.67904	11.34123	0	15.98982	15.40819	15.33317	0	0	9.809332	0	14.72719	0	15.56845	0	16.44144	13.93113	0	13.25091	0	14.10491	13.83836	0	0	0	14.11438	0	13.5033	0	0	0	0	0	0	0	13.18455	16.31248	0	14.83514	15.88165	14.10684	0	0	15.03283
Q6NXR4	TTI2_HUMAN	TELO2-interacting protein 2	TTI2 C8orf41	Homo sapiens (Human)	positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]	ASTRA complex [GO:0070209]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TTT complex [GO:0110078]	ASTRA complex [GO:0070209]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TTT complex [GO:0110078]; positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]		GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0050821; GO:0070209; GO:0110078; GO:2000003	VKGLLAK	1.129999995	1	1	0.032512795	727.6363886	0	0	0	0	0	0	0	0	0	18.49818	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.40177	0	0	0	0
Q6NXT1	ANR54_HUMAN	Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein)	ANKRD54 LIAR	Homo sapiens (Human)	nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859]	protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]	GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:0045859; GO:1902531	ASGGAQSPLR	7.809999943	1	1	0.177291945	944.5036118	13.69717	0	13.28151	0	14.81832	12.29329	14.86117	14.30262	0	0	0	14.54748	15.09451	0	16.35418	15.45696	14.28456	15.04063	0	16.01893	14.74439	16.54314	16.22153	14.1804	0	0	15.13049	13.99303	13.70923	14.34949	16.29012	17.07398	15.11365	15.65893	15.40396	14.71058	14.34327	15.5432	0	16.26971	14.82348	0	15.59464	14.33813	0	16.16953	15.93159	15.28481
Q6NYC8	PPR18_HUMAN	Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18)	PPP1R18 HKMT1098 KIAA1949	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; phosphatase binding [GO:0019902]	actin binding [GO:0003779]; phosphatase binding [GO:0019902]	GO:0003779; GO:0005737; GO:0005856; GO:0019902	ATIPDWKLQLLAR	10.35999966	1	1	0.20930222	1524.721054	15.79148	17.09308	0	13.82893	16.6155	13.49303	0	14.79102	0	0	15.92191	0	0	13.26926	0	14.16137	15.77149	0	0	0	16.83536	0	0	0	14.4168	0	15.4895	0	0	0	13.97055	0	0	0	14.56258	16.47388	15.95647	0	17.76868	0	0	0	0	0	0	0	0	0
Q6NZ67	MZT2B_HUMAN	Mitotic-spindle organizing protein 2B (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2B)	MZT2B FAM128B MOZART2B	Homo sapiens (Human)		centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; nucleoplasm [GO:0005654]; spindle [GO:0005819]		GO:0000931; GO:0005654; GO:0005813; GO:0005819; GO:0005829	SSREGSSQR	5.420000076	0.603614986	0.603614986	0.252911082	992.9695922	15.12062	14.11254	0	14.42779	0	0	16.82159	0	0	14.99754	0	0	17.39615	0	0	14.89611	16.11301	0	0	16.25649	17.92226	0	0	0	15.99431	14.57907	16.07697	15.84489	15.31512	15.04615	16.15604	14.00523	14.71394	16.30681	15.49926	13.03743	14.11432	16.19969	14.97153	15.72086	15.28393	14.14019	15.88059	13.68997	17.65189	15.28664	16.31644	16.33587
Q6NZI2	CAVN1_HUMAN	Caveolae-associated protein 1 (Cavin-1) (Polymerase I and transcript release factor)	CAVIN1 PTRF FKSG13	Homo sapiens (Human)	positive regulation of cell motility [GO:2000147]; protein secretion [GO:0009306]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]; positive regulation of cell motility [GO:2000147]; protein secretion [GO:0009306]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005901; GO:0006361; GO:0006363; GO:0009303; GO:0009306; GO:0032991; GO:0042134; GO:0042802; GO:0043231; GO:0045121; GO:2000147	VSVNVK	1.960000038	1	1	0.153648828	641.5303798	15.36792	16.11559	0	0	0	16.24932	16.53407	16.45682	0	0	0	0	0	0	0	0	0	0	17.69531	16.88408	0	16.68903	0	0	0	0	0	16.00704	0	16.4469	16.44451	0	16.49297	0	17.25447	0	0	0	0	16.13017	0	15.95576	15.85543	0	16.90085	17.28759	0	0
Q6NZY7	BORG3_HUMAN	Cdc42 effector protein 5 (Binder of Rho GTPases 3)	CDC42EP5 BORG3 CEP5	Homo sapiens (Human)	JNK cascade [GO:0007254]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; small GTPase binding [GO:0031267]; JNK cascade [GO:0007254]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]	small GTPase binding [GO:0031267]	GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007254; GO:0007266; GO:0008360; GO:0012505; GO:0016020; GO:0030838; GO:0031267; GO:0031274	RPDRGALSISAPLGDFR	9.470000267	1	1	6.90E-13	1828.823572	0	13.02702	13.69562	0	0	0	0	0	0	0	0	0	11.69364	0	0	0	14.43679	0	0	0	0	0	0	15.33301	0	0	15.73265	0	0	0	0	13.93651	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6P087	RUSD3_HUMAN	"Mitochondrial mRNA pseudouridine synthase RPUSD3, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 3)"	RPUSD3	Homo sapiens (Human)	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0000455; GO:0003723; GO:0005739; GO:0005759; GO:0006397; GO:0009982; GO:0035770; GO:0070131	IQAALK	7	1	1	0.265493993	644.6431003	19.39307	17.86772	17.04242	0	0	17.0484	0	17.41405	19.74829	0	0	0	18.95799	0	0	0	18.8272	17.92151	0	0	17.66746	18.52784	0	0	19.82463	17.78163	0	0	18.32067	16.73155	0	18.52016	19.64355	0	0	0	17.90144	0	18.16357	19.09169	0	0	0	0	19.07573	0	18.20727	0
Q6P093	ADCL2_HUMAN	"Arylacetamide deacetylase-like 2, EC 3.1.1.-"	AADACL2	Homo sapiens (Human)		extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]	carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]	GO:0005576; GO:0016021; GO:0016787; GO:0052689	YGVDPTR	13.75	0.003120581	0.003120581	0.290810614	805.7248115	18.53893	0	0	0	0	0	0	0	17.25941	0	0	15.87272	17.46617	0	17.89965	0	0	0	0	16.16418	0	0	0	0	0	0	0	0	18.10606	15.88747	19.29062	17.84414	0	0	0	0	21.49607	0	20.64265	0	17.96289	18.2008	0	0	0	0	0	16.92444
Q6P0N0	M18BP_HUMAN	"Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog, HsKNL-2) (P243)"	MIS18BP1 C14orf106 KIAA1903 KNL2 M18BP1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]	"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]"	"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]"	DNA binding [GO:0003677]	GO:0000775; GO:0003677; GO:0005654; GO:0007049; GO:0051301	GKGSQK	10.23999977	1	1	0.244411844	605.2015809	15.66226	13.89662	14.91701	0	0	0	16.57512	0	0	15.0138	14.86053	0	16.12982	0	15.04105	0	0	16.14592	16.36452	17.10524	18.32544	12.89966	16.02746	17.38482	16.12369	16.51731	17.33504	16.15365	0	15.68074	16.61043	0	13.79812	15.19454	16.28327	16.35941	16.24384	16.30084	0	15.6886	16.40807	14.64363	16.64312	17.52464	16.07296	15.15029	14.87531	16.69823
Q6P0Q8	MAST2_HUMAN	"Microtubule-associated serine/threonine-protein kinase 2, EC 2.7.11.1"	MAST2 KIAA0807 MAST205	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310	GKDGQESR	5.429999828	0.854440391	0.854440391	0.07371308	876.7814788	0	11.85334	0	0	0	14.52691	14.40673	13.42608	15.75769	17.71375	0	0	0	0	13.23081	0	13.32947	16.70426	14.25976	17.33435	11.09171	0	14.84153	16.21903	15.53143	16.17827	15.78044	0	0	16.93121	0	15.50363	11.3429	15.44917	12.50717	18.62007	16.21234	15.48479	16.13866	17.31319	12.1408	16.66184	13.62849	0	15.78464	14.48166	17.91773	0
Q6P158	DHX57_HUMAN	"Putative ATP-dependent RNA helicase DHX57, EC 3.6.4.13 (DEAH box protein 57)"	DHX57	Homo sapiens (Human)			ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0046872	GGRSHASK	10.32999992	1	1	0.268653884	798.3368025	18.08296	16.32261	18.00706	17.56958	13.43591	18.5948	0	18.61309	18.73955	0	0	21.13614	15.73111	0	0	0	0	0	17.52464	0	16.35172	18.17257	0	0	17.61765	0	18.9124	19.21701	17.27378	0	0	18.0915	18.21	18.39862	0	18.69701	0	19.56718	0	18.50236	0	18.03054	0	0	0	18.42756	0	18.98572
Q6P161	RM54_HUMAN	"39S ribosomal protein L54, mitochondrial, L54mt, MRP-L54 (Mitochondrial large ribosomal subunit protein mL54)"	MRPL54	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543	KPVMKGAK	24.38999939	0.616825402	0.616825402	5.74E-13	857.5612737	14.31131	15.68402	15.03038	16.40695	0	0	0	14.82394	0	0	0	7.044021	0	0	0	0	0	0	15.34243	15.69201	0	0	15.09363	15.9739	0	0	0	0	0	0	0	0	0	15.03606	14.82392	15.88381	0	0	0	17.00543	0	0	0	0	0	0	0	0
Q6P179	ERAP2_HUMAN	"Endoplasmic reticulum aminopeptidase 2, EC 3.4.11.- (Leukocyte-derived arginine aminopeptidase, L-RAP)"	ERAP2 LRAP	Homo sapiens (Human)	adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0002250; GO:0002474; GO:0004175; GO:0004177; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0070006	LLDFYEK	13.25	0.701947391	0.701947391	0.242436998	925.0958782	15.51777	15.90729	14.9648	13.92518	15.85505	16.56729	14.84775	14.20742	0	15.94691	18.45436	16.17902	0	16.11036	15.65629	14.75887	15.0748	15.00379	0	0	16.32793	0	15.54771	16.79949	16.49374	16.45798	0	14.35534	0	0	0	17.09378	0	0	15.55413	0	16.91708	16.91208	0	0	15.59917	16.11365	15.87784	16.01125	15.908	15.685	13.1119	15.58556
Q6P1J6	PLB1_HUMAN	"Phospholipase B1, membrane-associated, Phospholipase B, hPLB (Lysophospholipase, EC 3.1.1.5) (Phospholipase A2, EC 3.1.1.4) (Phospholipase B/lipase, PLB/LIP) (Triacylglycerol lipase, EC 3.1.1.3)"	PLB1 PLB	Homo sapiens (Human)	diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]; diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433]	calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]	GO:0001523; GO:0004620; GO:0004622; GO:0004623; GO:0004806; GO:0005886; GO:0006644; GO:0016021; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0036151; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:0102545; GO:2000344	HKFENK	6.179999828	0.071385041	0.071385041	0.298100581	800.8982977	0	16.41982	0	17.31685	18.07819	0	0	16.57794	0	0	16.83722	0	17.86428	0	0	0	18.01011	0	0	0	0	0	18.04433	0	19.56863	0	18.79661	0	0	19.69644	19.09291	0	17.50256	19.66542	16.60457	19.30072	17.65773	19.37347	0	0	0	0	16.58516	0	17.35882	0	0	0
Q6P1J9	CDC73_HUMAN	Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein)	CDC73 C1orf28 HRPT2	Homo sapiens (Human)	cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	"Cdc73/Paf1 complex [GO:0016593]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"Cdc73/Paf1 complex [GO:0016593]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]"	RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000781; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016055; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134	KTQTPAAQPVPRPVSQARPPPNQK	2.809999943	1	1	3.20E-12	2594.327743	0	0	10.45669	0	0	11.54907	0	0	0	0	0	0	12.99585	0	0	12.78719	0	0	13.21291	0	0	11.745	13.05427	10.03175	0	0	13.1814	10.26729	11.23758	0	0	13.31626	0	8.760623	13.9366	13.28067	13.18525	0	0	0	9.820259	0	0	0	13.79989	0	0	0
Q6P1K8	T2H2L_HUMAN	General transcription factor IIH subunit 2-like protein (General transcription factor IIH polypeptide 2-like protein)	GTF2H2C; GTF2H2C_2 GTF2H2D	Homo sapiens (Human)	"nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	"nuclear speck [GO:0016607]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	zinc ion binding [GO:0008270]	GO:0000439; GO:0005675; GO:0006289; GO:0006351; GO:0006357; GO:0008270; GO:0016607	YCELPVECK	3.920000076	1	1	0.149391792	1197.890906	0	14.21492	14.42708	15.83423	0	0	13.6869	0	11.60786	0	0	0	0	15.13216	13.80298	0	0	0	0	15.36846	0	15.79489	0	0	15.26333	0	0	0	0	0	15.70699	15.54246	14.48605	14.51419	0	14.49483	16.33775	15.71394	0	0	0	16.18745	14.40604	0	0	16.68668	14.83077	14.80701
Q6P1L5	F117B_HUMAN	Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein)	FAM117B ALS2CR13	Homo sapiens (Human)						NKVNFIPK	2.680000067	0.609150231	0.609150231	0.193043012	958.6360871	0	16.98396	0	17.02506	0	14.39889	0	16.13132	0	12.94678	14.19747	0	13.26632	12.62458	17.52779	0	0	16.08161	0	0	0	14.94414	0	17.0121	0	0	0	14.3391	15.07069	0	13.39861	15.61961	18.51409	0	14.15614	14.8268	0	0	0	15.30391	16.79897	0	0	0	0	0	0	0
Q6P1M0	S27A4_HUMAN	"Long-chain fatty acid transport protein 4, FATP-4, Fatty acid transport protein 4 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4, ACSVL4, EC 6.2.1.-)"	SLC27A4 ACSVL4 FATP4	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0062003]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport across blood-brain barrier [GO:0150104]; very long-chain fatty acid catabolic process [GO:0042760]"	brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	"brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; activation of GTPase activity [GO:0090630]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0062003]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport across blood-brain barrier [GO:0150104]; very long-chain fatty acid catabolic process [GO:0042760]"	arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0005902; GO:0006631; GO:0007584; GO:0015245; GO:0015908; GO:0015909; GO:0016020; GO:0016021; GO:0031526; GO:0031957; GO:0042760; GO:0043065; GO:0043588; GO:0044381; GO:0044539; GO:0046627; GO:0047676; GO:0062003; GO:0090433; GO:0090434; GO:0090630; GO:0150104; GO:1901480; GO:1990379	AGMAAVASPTGNCDLER	9.770000458	1	1	2.06E-12	1735.053163	15.01466	0	13.39808	0	0	0	0	11.96982	13.95908	0	0	0	11.76621	13.24695	11.76074	13.08778	15.14754	14.00804	0	14.52259	15.40928	13.85719	0	0	7.834656	14.17964	0	0	0	15.57526	11.33706	14.13503	0	14.9279	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6P1M3	L2GL2_HUMAN	LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2)	LLGL2	Homo sapiens (Human)	cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; leucine transport [GO:0015820]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708]	adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; leucine transport [GO:0015820]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708]	GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]	GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0008593; GO:0015820; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0043231; GO:0045159; GO:0045197; GO:0050708; GO:0051294; GO:0051301	LKLTALEGSR	6.400000095	1	1	0.18501495	1088.475016	14.06407	0	14.38164	0	0	13.28665	0	0	0	0	0	0	0	0	0	0	0	16.91287	0	17.20753	0	0	0	0	13.37877	0	13.56729	14.71609	0	0	15.28544	0	0	14.64222	0	0	0	0	0	0	15.24683	0	0	0	0	0	0	0
Q6P1M9	ARMX5_HUMAN	Armadillo repeat-containing X-linked protein 5	ARMCX5	Homo sapiens (Human)						AMPMSR	2.75	1	1	0.227734617	707.0666221	15.34475	15.54433	0	0	0	0	0	15.91865	10.95241	0	0	0	0	0	0	0	0	0	0	0	0	17.1917	0	16.45507	0	0	0	0	0	0	0	16.22651	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6P1N0	C2D1A_HUMAN	"Coiled-coil and C2 domain-containing protein 1A (Akt kinase-interacting protein 1) (Five prime repressor element under dual repression-binding protein 1, FRE under dual repression-binding protein 1, Freud-1) (Putative NF-kappa-B-activating protein 023N)"	CC2D1A AKI1	Homo sapiens (Human)	negative regulation of snRNA transcription by RNA polymerase II [GO:1905381]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of snRNA transcription by RNA polymerase II [GO:1905381]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357]"	"cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001227; GO:0001650; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0006357; GO:0016020; GO:0043123; GO:0045296; GO:0070062; GO:1905381	FEVVHK	1.360000014	1	1	0.249711293	759.7653925	0	0	15.2485	14.95189	15.16839	15.57771	0	0	0	14.73092	13.43133	0	0	14.94155	0	0	0	0	0	0	15.56807	0	0	0	0	0	15.94349	15.76049	0	0	0	14.74129	0	15.49489	0	15.63187	0	0	15.69596	15.32286	0	15.58954	0	0	0	16.21692	16.33505	0
Q6P1N9	TATD1_HUMAN	"Deoxyribonuclease TATDN1, EC 3.1.21.- (Hepatocarcinoma high expression protein)"	TATDN1 CDA11	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; metal ion binding [GO:0046872]	3'-5'-exodeoxyribonuclease activity [GO:0008296]; metal ion binding [GO:0046872]	GO:0005654; GO:0008296; GO:0046872	TEANLEVLK	11.51000023	1	1	0.299239068	1016.924127	0	0	0	15.68417	0	18.0696	0	14.79102	17.18286	14.66697	0	0	15.27442	17.95372	14.27684	15.16137	15.77149	17.38407	0	0	16.25525	0	0	15.63773	17.91701	17.19849	14.39742	14.59255	15.87336	16.68789	13.97055	0	17.87836	0	0	18.47065	0	0	0	16.99565	14.75677	0	0	0	16.57195	0	18.2447	0
Q6P1Q9	MET2B_HUMAN	"tRNA N(3)-methylcytidine methyltransferase METTL2B, EC 2.1.1.- (Methyltransferase-like protein 2B)"	METTL2B	Homo sapiens (Human)	tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; tRNA (cytosine) methyltransferase activity [GO:0016427]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA methylation [GO:0030488]	tRNA (cytosine) methyltransferase activity [GO:0016427]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]	GO:0005737; GO:0016427; GO:0030488; GO:0052735	CSSKSLEHK	3.390000105	0.795054972	0.795054972	0.303092417	1076.643899	0	0	0	0	0	0	15.98571	13.22897	14.90743	15.78888	0	0	0	0	0	14.62722	0	0	0	0	16.4163	0	0	0	11.2307	0	0	15.65904	0	0	0	15.71843	0	0	0	0	0	0	0	0	0	0	0	0	0	17.27271	18.98283	0
Q6P1R4	DUS1L_HUMAN	"tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like, EC 1.3.1.88 (tRNA-dihydrouridine synthase 1-like)"	DUS1L	Homo sapiens (Human)			flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]	flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]	GO:0017150; GO:0050660	YAKCDQCGNPK	13.64000034	1	1	0.253828918	1340.905214	0	0	14.22403	0	0	0	0	0	0	0	0	0	0	17.26841	0	0	17.36732	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.07216	0	0	0	0	0	0	0	0	0	18.14128	0	0	0	0	0
Q6P1W5	CA094_HUMAN	Uncharacterized protein C1orf94	C1orf94	Homo sapiens (Human)						ADPAVERHHLMEWSPGTK	7.5	1	1	0.160732142	2077.62747	15.19874	0	0	0	0	0	0	0	0	0	0	0	13.37382	0	15.34947	11.2022	0	0	12.39031	14.34535	14.95573	14.47902	12.7764	14.28084	15.34875	0	0	14.1921	13.53719	0	12.12936	12.0599	0	0	11.82444	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6P1X5	TAF2_HUMAN	"Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit, TAF(II)150, TAFII-150, TAFII150)"	TAF2 CIF150 TAF2B	Homo sapiens (Human)	"G2/M transition of mitotic cell cycle [GO:0000086]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976]	GO:0000086; GO:0000976; GO:0003682; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006357; GO:0006367; GO:0006468; GO:0014070; GO:0016251; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043966; GO:0045893; GO:0051123; GO:0060261	ESTASK	6.5	1	1	0.174855123	622.4225515	0	13.37412	0	15.35801	15.52759	0	16.21599	0	15.67397	13.63521	14.21669	14.0981	0	0	0	17.04239	0	16.22866	0	0	0	15.63189	16.53195	0	17.09948	15.26965	16.67938	0	0	0	15.36385	14.0806	14.64411	0	0	15.67542	16.18037	15.50597	0	0	15.37327	16.64856	0	0	0	0	15.46523	0
Q6P280	ZN529_HUMAN	Zinc finger protein 529	ZNF529 KIAA1615	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	VHAQLTR	8.399999619	1	1	0.305124686	823.1513954	16.51592	21.06928	0	0	0	0	0	0	16.0729	18.52922	0	0	0	0	0	0	16.77684	0	16.8935	0	0	18.47875	17.70835	0	0	0	0	0	16.54869	16.97434	19.14706	0	0	0	0	0	0	0	0	0	17.97495	0	0	18.10416	0	0	0	0
Q6P2C8	MED27_HUMAN	"Mediator of RNA polymerase II transcription subunit 27 (Cofactor required for Sp1 transcriptional activation subunit 8, CRSP complex subunit 8) (Mediator complex subunit 27) (P37 TRAP/SMCC/PC2 subunit) (Transcriptional coactivator CRSP34)"	MED27 CRSP34 CRSP8	Homo sapiens (Human)	positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]	core mediator complex [GO:0070847]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151]	core mediator complex [GO:0070847]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]	transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0006357; GO:0006367; GO:0016592; GO:0019827; GO:0032968; GO:0051123; GO:0060261; GO:0061630; GO:0070847	DGMRNK	10.35000038	1	1	0.168549028	720.5570188	14.45335	14.8772	16.41758	15.92192	0	0	0	0	14.54338	0	0	0	0	0	13.88605	16.65244	13.00239	14.01676	0	0	16.65429	0	0	0	0	0	0	15.81995	0	17.7135	15.42232	0	0	15.20651	0	0	0	0	16.86255	15.95826	0	0	0	0	0	0	0	0
Q6P2D0	ZFP1_HUMAN	"Zinc finger protein 1 homolog, Zfp-1 (Zinc finger protein 475)"	ZFP1 ZNF475	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	ADDQMER	14.96000004	1	1	0.168004068	864.674005	0	13.61394	15.80556	0	0	0	0	0	0	0	0	0	0	0	0	0	15.6333	0	0	0	0	0	0	15.71239	0	0	16.4938	0	16.12882	14.99665	16.88462	0	0	15.66484	0	14.08342	0	15.65949	13.55381	14.92607	15.78641	0	0	0	0	0	0	0
Q6P2H3	CEP85_HUMAN	"Centrosomal protein of 85 kDa, Cep85 (Coiled-coil domain-containing protein 21)"	CEP85 CCDC21	Homo sapiens (Human)	chromosome segregation [GO:0007059]; negative regulation of protein kinase activity [GO:0006469]; regulation of mitotic centrosome separation [GO:0046602]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; chromosome segregation [GO:0007059]; negative regulation of protein kinase activity [GO:0006469]; regulation of mitotic centrosome separation [GO:0046602]		GO:0000242; GO:0000922; GO:0005730; GO:0005794; GO:0005813; GO:0005829; GO:0006469; GO:0007059; GO:0046602	QSVEETSGEGPEVEMESWQKR	4.03000021	1	1	0.479876586	2438.554654	12.56683	13.25266	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6P2H8	TMM53_HUMAN	Transmembrane protein 53	TMEM53	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nucleus [GO:0005634]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]		GO:0005634; GO:0016021	RGCIVIR	5.769999981	0.164215788	0.164215788	0.25846167	871.9908243	16.36	14.56489	15.62003	15.83626	14.98379	11.94598	13.51728	0	0	16.20338	15.14004	0	16.0651	13.89497	15.12491	14.44615	15.59239	0	0	15.81812	12.95192	16.31854	0	0	15.7614	0	0	14.73403	0	0	0	14.53798	0	0	0	0	0	17.6142	0	16.52423	15.26107	0	15.21443	0	15.02783	0	0	0
Q6P2Q9	PRP8_HUMAN	Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220)	PRPF8 PRPC8	Homo sapiens (Human)	"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157	ALHVNNDR	3.470000029	0.208428234	0.208428234	0.087063297	939.0230198	19.8176	13.02574	17.48122	0	16.16026	0	14.39664	0	0	6.461735	9.055608	0	14.33708	15.7252	13.94558	0	0	15.60075	9.72191	0	13.04429	0	15.63296	0	0	0	0	0	17.4236	0	15.98185	17.80664	17.63494	0	16.17952	16.11577	0	15.40359	15.28289	16.66204	13.52701	0	0	0	0	0	17.25414	16.67258
Q6P3S1	DEN1B_HUMAN	DENN domain-containing protein 1B (Connecdenn 2) (Protein FAM31B)	DENND1B C1orf218 FAM31B	Homo sapiens (Human)	endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852]	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005829; GO:0006897; GO:0015031; GO:0016607; GO:0030136; GO:0031267; GO:0032456; GO:0043231; GO:0043547; GO:0050776; GO:0050852; GO:1901981; GO:2000553	KGGALFNTAMTK	15.39000034	0.999265134	0.999265134	0.388868897	1254.866314	18.44925	15.51566	0	0	0	22.08054	17.47045	0	0	17.38152	0	0	19.30884	18.83101	20.82459	0	19.40603	0	19.80889	20.63904	0	20.7459	19.3684	18.19027	20.41587	20.30836	0	17.63655	0	20.93267	0	0	22.31053	0	20.31872	22.17795	21.39582	21.82349	22.26907	0	0	0	0	20.38372	21.42039	0	21.66185	0
Q6P3S6	FBX42_HUMAN	F-box only protein 42 (Just one F-box and Kelch domain-containing protein)	FBXO42 FBX42 JFK KIAA1332	Homo sapiens (Human)						AMSSK	13.31999969	0.007549284	0.007549284	0.271267568	522.890166	16.25674	17.99255	16.21461	0	0	16.05542	16.14415	16.1898	15.64529	0	0	0	15.1367	15.72089	16.54324	0	0	16.17384	14.97789	16.11402	16.06726	16.13982	14.9887	16.81468	16.58999	0	15.3693	15.39418	14.801	16.1656	16.18601	16.40793	16.06931	16.84089	16.09493	0	16.21357	15.90755	16.09893	16.03103	15.30547	0	16.49702	15.41423	16.34809	16.35537	16.18307	16.81773
Q6P3W7	SCYL2_HUMAN	SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa)	SCYL2 CVAK104 KIAA1360	Homo sapiens (Human)	brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]	clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]	clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]	GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0090090; GO:2000286; GO:2000370	LKSQQPLKPQVHTPVATVK	2.519999981	1	1	4.59E-13	2100.208866	12.9311	13.51503	9.54168	0	0	0	13.95093	0	0	0	15.46684	0	0	0	0	13.54861	0	13.88407	0	0	0	0	0	0	0	13.81995	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.84756	0	0	0
Q6P3X3	TTC27_HUMAN	"Tetratricopeptide repeat protein 27, TPR repeat protein 27"	TTC27	Homo sapiens (Human)						MWTPELAILR	6.179999828	0.714890897	0.714890897	0.246965343	1246.762076	17.04455	16.42047	0	16.40164	15.13954	0	13.85839	15.1793	0	14.45041	0	0	15.56466	16.03804	0	0	0	15.17559	0	0	0	0	13.42023	0	16.03263	0	0	0	14.80499	0	0	14.89474	0	0	0	0	16.03844	15.80833	0	15.38877	0	0	0	0	0	0	0	0
Q6P3X8	PGBD2_HUMAN	PiggyBac transposable element-derived protein 2	PGBD2	Homo sapiens (Human)			sequence-specific DNA binding [GO:0043565]	sequence-specific DNA binding [GO:0043565]	GO:0043565	VFTSVKLMSILR	4.730000019	1	1	0.145881934	1394.38047	15.43136	0	0	0	15.59992	0	0	0	0	0	0	12.75685	0	16.59694	0	14.16627	0	0	14.56851	15.58792	0	0	0	14.88447	0	0	15.17225	0	12.80507	0	14.47759	0	14.49318	0	0	16.07975	0	0	0	14.91773	0	0	15.0322	0	0	0	16.15107	0
Q6P444	MTFR2_HUMAN	Mitochondrial fission regulator 2 (DUF729 domain-containing protein 1)	MTFR2 DUFD1 FAM54A	Homo sapiens (Human)	aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]		GO:0000266; GO:0005739; GO:0007005; GO:0009060	EEMVNTK	7.5	1	1	0.112343748	864.7319967	0	0	0	0	0	15.4162	0	0	0	0	16.11494	0	0	0	0	0	0	15.47124	0	0	0	0	16.92764	14.61972	0	0	15.42222	0	0	0	16.1965	0	18.03753	0	0	0	0	0	17.06904	0	0	0	0	0	0	0	0	0
Q6P4A7	SFXN4_HUMAN	Sideroflexin-4 (Breast cancer resistance marker 1)	SFXN4 BCRM1	Homo sapiens (Human)	amino acid transport [GO:0006865]; mitochondrial transmembrane transport [GO:1990542]	integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; mitochondrial transmembrane transport [GO:1990542]	ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005739; GO:0006865; GO:0015075; GO:0022857; GO:0031305; GO:0043231; GO:1990542	AVRETLASR	14.39999962	0.677349508	0.677349508	0.257565448	1002.481184	0	16.91375	14.95092	15.33064	15.83458	16.05773	16.83464	16.08006	0	16.70286	16.38268	16.54732	13.68171	15.58064	15.51468	14.40747	0	15.97488	16.25968	0	0	0	15.00886	0	0	16.01112	0	0	0	0	16.33345	16.02202	15.56141	0	0	0	15.4381	16.38797	0	14.93042	15.85259	0	0	15.235	0	14.49541	15.70409	0
Q6P4A8	PLBL1_HUMAN	"Phospholipase B-like 1, EC 3.1.1.- (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C ]"	PLBD1	Homo sapiens (Human)	phospholipid catabolic process [GO:0009395]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; phospholipase activity [GO:0004620]; phospholipid catabolic process [GO:0009395]	phospholipase activity [GO:0004620]	GO:0004620; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0009395	GDPCNTICCREDLNSPNPSPGGCYDTK	8.68999958	1	1	0.079756107	3083.728343	0	12.33721	0	15.54117	11.49431	12.50553	0	12.42422	0	14.10303	13.8857	0	15.71316	13.87492	14.06709	15.00214	15.17431	0	13.21816	0	12.40508	0	0	0	0	0	0	0	0	0	0	17.01513	0	0	14.73777	0	0	0	0	0	0	14.34119	0	0	0	0	0	0
Q6P4E1	GOLM2_HUMAN	"Protein GOLM2 (Cancer susceptibility candidate gene 4 protein, CASC4) (Golgi membrane protein 2)"	GOLM2 CASC4 UNQ2573/PRO6308	Homo sapiens (Human)		Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]		GO:0005794; GO:0016021	QIDQKEADYGR	3.480000019	1	1	4.67E-13	1322.221916	0	0	0	0	0	14.59153	0	0	0	0	0	0	0	0	0	0	0	0	15.56544	16.6241	0	0	0	0	0	0	0	0	0	0	0	14.46235	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6P4F2	FDX2_HUMAN	"Ferredoxin-2, mitochondrial (Adrenodoxin-like protein) (Ferredoxin-1-like protein)"	FDX2 FDX1L	Homo sapiens (Human)	electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]	iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]"	GO:0005739; GO:0005759; GO:0009055; GO:0016226; GO:0022900; GO:0046872; GO:0051353; GO:0051537; GO:0140647; GO:1990229	MHVMAASMAR	5.710000038	1	1	0.272354554	1121.916214	14.15375	14.54776	0	14.69911	12.7221	0	12.752	0	15.67697	15.60447	0	16.71317	0	14.54567	0	0	14.63798	14.49555	14.58811	0	0	0	0	0	0	0	0	15.30424	15.64418	15.84877	14.32419	0	0	0	0	0	0	15.24933	0	0	14.59782	0	0	0	14.19177	0	0	0
Q6P4F7	RHGBA_HUMAN	Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A)	ARHGAP11A KIAA0013	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056	SFLKMR	14.68999958	1	1	3.48E-13	796.359397	14.40692	0	0	0	0	0	0	0	0	0	0	0	0	0	16.01761	0	0	0	0	0	15.99238	17.27534	0	0	0	0	0	0	0	15.75965	16.10215	13.83473	0	15.94472	15.45798	0	0	0	0	0	0	0	0	0	0	0	16.92465	0
Q6P4Q7	CNNM4_HUMAN	Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4)	CNNM4 ACDP4 KIAA1592	Homo sapiens (Human)	enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]; enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0032991; GO:0043231; GO:0050896; GO:0055065; GO:0070166	LMEMLKVTEPYNDLVK	1.570000052	1	1	0.089153202	1922.88537	14.09469	11.77199	12.81483	14.95449	0	0	0	0	12.64894	0	0	0	0	0	0	0	0	0	0	0	14.33772	0	16.57961	0	0	0	0	0	0	0	13.31523	15.33794	0	14.23949	0	0	0	0	0	0	11.87487	0	0	15.34307	0	0	0	0
Q6P4R8	NFRKB_HUMAN	Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G)	NFRKB INO80G	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]"	Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]"	DNA binding [GO:0003677]; protease binding [GO:0002020]	GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0042766; GO:0045893; GO:0051726; GO:0060382	EWRTQQR	5.989999771	1	1	0.219238376	1003.514368	15.87618	15.06873	17.90745	16.18782	14.81871	15.65324	14.62518	15.17349	13.49354	16.30042	15.96666	15.16127	13.59175	16.28288	13.17648	0	14.82861	0	0	0	16.37984	16.02468	15.45176	0	14.94479	0	0	0	0	0	16.77275	0	0	0	15.02826	14.2797	0	0	0	15.84591	0	0	0	0	15.12255	0	0	14.90406
Q6P575	BGP11_HUMAN	Putative inactive beta-glucuronidase protein GUSBP11 (Beta-glucuronidase pseudogene 11)	GUSBP11	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]		"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]"	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005975	DAVSPR	4.96999979	0.695370913	0.695370913	0.257962973	643.6815489	0	15.80607	16.23515	14.79204	15.26717	0	0	0	0	14.85068	16.84868	14.29342	16.76098	14.86557	15.34047	10.95589	16.56723	14.89872	0	15.74951	0	0	13.97371	0	0	0	16.03617	16.09821	16.55226	15.73324	0	0	16.75786	16.78693	16.09366	15.92111	14.35936	17.09036	0	0	0	15.08644	16.33679	17.06316	15.40169	0	0	0
Q6P582	MZT2A_HUMAN	Mitotic-spindle organizing protein 2A (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2A)	MZT2A FAM128A MOZART2A	Homo sapiens (Human)		centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin large complex [GO:0000931]; nucleoplasm [GO:0005654]; spindle [GO:0005819]		GO:0000931; GO:0005654; GO:0005813; GO:0005819; GO:0005829	LPKGGGPGK	17.95000076	0.317417681	0.317417681	0.118016055	807.3587139	17.64289	0	15.79565	15.87453	0	15.82203	17.07387	16.94637	17.06944	0	17.65343	17.22709	15.9389	14.95126	17.40232	14.89406	0	16.83362	16.66141	14.28048	0	15.84107	0	16.75263	16.2425	16.93816	16.95291	0	15.89013	15.86334	0	15.68486	16.24484	0	16.0975	18.01443	16.57544	18.1016	0	16.80447	14.4045	16.87002	16.397	17.27789	17.08366	0	15.98689	17.83003
Q6P587	FAHD1_HUMAN	"Acylpyruvase FAHD1, mitochondrial, EC 3.7.1.5 (Fumarylacetoacetate hydrolase domain-containing protein 1, FAH domain-containing protein 1) (Oxaloacetate decarboxylase, OAA decarboxylase, EC 4.1.1.112) (YisK-like protein)"	FAHD1 C16orf36 YISKL	Homo sapiens (Human)		cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]	acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621	DVQDECKK	5.789999962	0.039389513	0.039389513	0.211061354	1021.229213	15.6744	15.81966	13.92194	12.65668	14.3702	0	0	0	13.30597	0	15.58042	15.17175	14.53292	0	14.84935	15.48195	15.23943	16.02605	15.74277	0	0	0	13.61438	0	0	0	0	17.29308	0	9.694593	0	15.2664	0	0	0	0	13.72607	0	0	15.81177	0	0	0	0	0	0	14.93009	0
Q6P597	KLC3_HUMAN	Kinesin light chain 3 (KLC2-like) (kinesin light chain 2)	KLC3 KLC2 KLC2L	Homo sapiens (Human)	axo-dendritic transport [GO:0008088]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]	ciliary rootlet [GO:0035253]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuron projection [GO:0043005]	ciliary rootlet [GO:0035253]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; axo-dendritic transport [GO:0008088]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]	kinesin binding [GO:0019894]; microtubule binding [GO:0008017]	GO:0005739; GO:0005871; GO:0005874; GO:0007283; GO:0007286; GO:0008017; GO:0008088; GO:0019894; GO:0031514; GO:0035253; GO:0043005; GO:0120317	GEAAAGAAGMK	7.239999771	1	1	0.003788089	929.6941224	14.4395	15.72373	0	0	0	0	0	0	14.14324	0	14.55609	0	0	0	0	0	0	0	0	0	15.57153	0	0	0	14.5576	15.8288	0	0	16.50127	0	0	0	0	0	0	0	0	0	0	15.44027	0	0	14.6054	0	0	0	0	15.88748
Q6P5Q4	LMOD2_HUMAN	"Leiomodin-2 (Cardiac leiomodin, C-LMOD) (Leiomodin)"	LMOD2	Homo sapiens (Human)	actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of actin filament polymerization [GO:0030838]; sarcomere organization [GO:0045214]	actin filament [GO:0005884]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]	actin filament [GO:0005884]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of actin filament polymerization [GO:0030838]; sarcomere organization [GO:0045214]	actin binding [GO:0003779]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523]	GO:0003779; GO:0003785; GO:0005523; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0007015; GO:0030016; GO:0030017; GO:0030041; GO:0030239; GO:0030838; GO:0031430; GO:0045010; GO:0045214; GO:0051694	GTPSSSPYVSPR	8.020000458	0.580409288	0.580409288	0.18164943	1236.145836	0	0	14.09577	0	12.45214	0	14.09278	12.65137	12.88671	17.6431	0	11.08877	0	14.40395	0	15.62459	14.29349	0	0	0	0	0	0	0	0	15.72135	0	0	0	0	0	0	0	0	15.24031	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6P5S2	LEG1H_HUMAN	Protein LEG1 homolog	LEG1 C6orf58	Homo sapiens (Human)		extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]		GO:0005615; GO:0070062	SSFPETMNK	7.320000172	0.423205435	0.423205435	0.120496241	1057.201807	14.3389	0	0	17.8845	11.99424	12.77104	0	0	15.5421	16.59718	0	11.70402	0	0	0	0	0	0	15.67118	14.16585	0	0	14.42134	17.54429	0	7.481563	0	12.06103	0	14.71361	19.05261	18.39206	0	0	17.38736	11.46747	17.63614	14.26339	0	0	16.84514	15.4314	14.97686	0	0	14.06873	17.26704	19.0717
Q6P5Z2	PKN3_HUMAN	"Serine/threonine-protein kinase N3, EC 2.7.11.13 (Protein kinase PKN-beta) (Protein-kinase C-related kinase 3)"	PKN3 PKNBETA	Homo sapiens (Human)	epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; small GTPase binding [GO:0031267]	GO:0004672; GO:0004674; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0010631; GO:0018105; GO:0031267; GO:0035556; GO:0048471; GO:0106310	TPLGEEMTPPPKPPR	4.25	1	1	0.19858711	1643.798194	0	11.29179	13.31194	0	15.25006	0	0	16.14466	16.4782	15.84521	14.222	16.72346	9.181613	15.97412	17.57879	0	15.91166	17.21427	11.62016	16.83442	13.6893	0	0	16.39393	12.79108	0	14.04783	0	15.87979	15.03492	0	16.62894	0	0	0	0	0	16.44541	0	0	0	11.35815	0	17.38342	0	12.80181	0	17.02148
Q6P6B1	ERIC5_HUMAN	Glutamate-rich protein 5	ERICH5 C8orf47	Homo sapiens (Human)						VSEGAETK	15.75	0.380966663	0.380966663	0.227893435	820.4097973	0	0	15.03171	16.09449	16.17031	13.95022	16.09332	16.63471	14.04294	17.09199	0	15.54771	0	15.73212	15.00845	14.41386	15.64938	0	15.59055	14.26736	15.22456	16.0498	15.84828	0	0	0	0	0	0	0	0	0	15.01241	15.59535	16.50237	0	16.60203	17.23109	0	16.48388	15.41086	0	0	16.14655	16.24734	0	0	16.07054
Q6P995	F171B_HUMAN	Protein FAM171B	FAM171B KIAA1946 NPD019	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	SATLPR	7.21999979	1	1	0.123023738	644.2210472	0	14.80889	0	15.95021	0	0	14.10235	14.64544	12.71568	0	0	15.55686	0	14.21251	0	15.95661	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.11833	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6P996	PDXD1_HUMAN	"Pyridoxal-dependent decarboxylase domain-containing protein 1, EC 4.1.1.-"	PDXDC1 KIAA0251	Homo sapiens (Human)	carboxylic acid metabolic process [GO:0019752]	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; cadherin binding [GO:0045296]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; carboxylic acid metabolic process [GO:0019752]	cadherin binding [GO:0045296]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]	GO:0005794; GO:0016831; GO:0019752; GO:0030170; GO:0043231; GO:0045296	QLVPASGLTVMDLEAEGTCLR	9.619999886	0.355924845	0.355924845	0.185175735	2253.508143	0	14.04737	15.59097	15.04003	15.47309	0	13.86546	0	12.40375	16.30002	16.03227	12.64507	11.20289	0	14.47517	9.872174	0	0	0	0	15.15047	13.90285	15.08623	0	13.34506	0	0	0	14.56748	0	0	0	0	0	0	0	0	15.21577	0	0	14.27346	0	13.06454	12.02293	12.51867	0	0	0
Q6P9A2	GLT18_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 18, EC 2.4.1.41 (Polypeptide GalNAc transferase 18, GalNAc-T18) (Polypeptide GalNAc transferase-like protein 4, GalNAc-T-like protein 4, pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4)"	GALNT18 GALNTL4	Homo sapiens (Human)	protein O-linked glycosylation [GO:0006493]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0030246; GO:0046872	QEGLIR	3.49000001	1	1	0.048982947	717.6507782	0	0	14.8924	0	0	0	0	0	14.26467	0	0	0	0	0	0	14.51654	0	12.35353	0	0	15.95565	0	0	0	0	15.82483	15.65364	0	13.65745	0	13.70687	14.08557	14.481	15.407	0	14.83626	0	14.02384	0	15.86113	0	15.17276	0	0	15.42805	0	0	0
Q6P9A3	ZN549_HUMAN	Zinc finger protein 549	ZNF549	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	VHITEEP	18.06999969	0.567886174	0.567886174	0.101198322	823.6404986	16.88754	16.43574	16.84373	15.54505	17.71031	15.16517	15.31541	16.32411	17.31212	19.61145	16.77595	16.98591	16.82496	16.20269	0	15.70348	18.45031	17.81937	16.11653	18.845	17.53468	17.85904	17.67683	0	14.83778	16.50915	18.43143	16.48658	12.83216	14.9036	19.18459	15.7411	15.25734	18.13926	20.04023	17.46164	17.17012	0	16.97584	14.41081	14.36209	13.04478	0	13.59228	0	17.24353	14.57946	0
Q6P9B9	INT5_HUMAN	"Integrator complex subunit 5, Int5"	INTS5 KIAA1698	Homo sapiens (Human)	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472	VLSCGLK	14.77999973	0.327866137	0.327866137	0.233998413	776.5969715	16.3117	0	0	16.18409	15.31352	0	12.78172	16.78585	16.92399	16.36207	0	15.20728	0	0	16.06999	14.92439	0	0	0	15.83729	15.76133	0	0	15.25792	0	18.09537	0	15.63179	13.30092	15.54463	0	0	0	0	14.94092	0	0	16.42897	0	0	16.57495	0	16.12569	16.15186	0	0	0	15.27345
Q6P9F0	CCD62_HUMAN	Coiled-coil domain-containing protein 62 (Protein TSP-NY) (Protein aaa)	CCDC62	Homo sapiens (Human)	blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; positive regulation of transcription by RNA polymerase II [GO:0045944]	estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]	GO:0001835; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0030331; GO:0030374; GO:0045944; GO:0071392	MNPPAAFLAGR	12.53999996	1	1	0.512560818	1144.230429	18.65942	18.44252	18.47938	0	0	17.06423	18.68826	0	0	0	18.79253	0	0	0	0	0	0	0	18.54982	0	18.74824	18.50955	0	0	0	18.0682	0	19.59583	0	0	0	0	0	0	20.47515	0	0	18.85363	0	19.60686	16.77062	0	0	17.26666	0	0	0	18.97723
Q6P9G9	ZN449_HUMAN	Zinc finger protein 449 (Zinc finger and SCAN domain-containing protein 19)	ZNF449 ZSCAN19	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]; spermatogonial cell division [GO:0007284]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogonial cell division [GO:0007284]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007284; GO:0046872; GO:1990837	KSPGEKPHR	11.43999958	1	1	0.186294364	1035.8272	13.45483	13.59764	14.73481	0	0	14.68534	13.49928	0	0	13.85796	16.40115	15.10348	13.61903	0	0	0	15.72771	0	15.79914	0	16.78382	0	0	0	14.85215	15.19061	0	0	14.33723	16.23993	15.91099	0	0	17.23019	0	15.28337	0	0	15.15699	15.81093	0	15.74879	15.62857	15.25381	15.28395	0	15.70386	15.35143
Q6PB30	CSAG1_HUMAN	"Putative chondrosarcoma-associated gene 1 protein (Cancer/testis antigen 24.1, CT24.1) (Cancer/testis antigen CSAGE)"	CSAG1 CSAGE	Homo sapiens (Human)						EVPGTK	7.599999905	0.920771658	0.920771658	0.198383641	631.5269265	15.29179	0	17.48828	15.52028	0	0	0	9.013974	0	0	0	15.86712	16.28063	16.74372	0	16.19671	0	16.18108	0	0	17.10216	0	17.17318	0	17.03155	17.22217	16.01464	17.05724	16.90419	0	15.31618	0	0	17.52832	16.54555	17.90378	0	18.84859	18.64092	0	17.95276	0	17.7153	17.66275	17.97791	0	0	17.72596
Q6PCB0	VWA1_HUMAN	von Willebrand factor A domain-containing protein 1	VWA1	Homo sapiens (Human)	behavioral response to pain [GO:0048266]; extracellular matrix organization [GO:0030198]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; identical protein binding [GO:0042802]; behavioral response to pain [GO:0048266]; extracellular matrix organization [GO:0030198]	identical protein binding [GO:0042802]	GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0030198; GO:0042802; GO:0048266; GO:0062023; GO:0070062	GSILDAMRPQQLHATEITSSGFR	10.82999992	0.335223109	0.335223109	0.478396404	2532.642159	18.92678	0	0	0	0	0	0	0	0	0	17.09218	0	0	18.11129	0	0	0	0	0	0	0	0	0	0	0	0	0	18.78438	15.56789	18.17287	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.07667	0	0	0
Q6PCB8	EMB_HUMAN	Embigin	EMB	Homo sapiens (Human)	axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; plasma membrane lactate transport [GO:0035879]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; plasma membrane lactate transport [GO:0035879]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0035879; GO:0045202; GO:0070593; GO:0098632	FTIINSKQMGSYSCFFR	9.069999695	1	1	0.093891442	2102.160297	0	0	0	15.99365	15.70294	0	0	0	0	16.00179	0	0	15.81154	0	0	16.19218	16.88913	0	17.47086	0	16.88564	0	0	0	0	0	0	15.32783	0	16.31803	0	0	0	0	0	0	15.94144	0	0	0	0	0	18.08455	0	16.75389	0	0	0
Q6PCD5	RFWD3_HUMAN	"E3 ubiquitin-protein ligase RFWD3, EC 2.3.2.27 (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201)"	RFWD3 RNF201	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; chromosome breakage [GO:0031052]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin protein ligase activity [GO:0061630]; cellular response to DNA damage stimulus [GO:0006974]; chromosome breakage [GO:0031052]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212]	MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin protein ligase activity [GO:0061630]	GO:0000724; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0010212; GO:0016567; GO:0016605; GO:0031052; GO:0031297; GO:0031571; GO:0036297; GO:0046872; GO:0061630; GO:0090734; GO:0097371; GO:2000001	EQMLRK	10.53999996	0.533596277	0.533596277	0.286460103	819.2936529	23.90294	0	18.91689	18.08719	0	0	18.48287	18.23017	18.69993	14.60921	18.10563	0	0	0	17.63368	0	0	0	0	0	0	0	0	0	19.49573	0	0	0	0	0	0	0	19.16706	0	19.24308	18.3825	0	19.55145	19.64716	20.80047	0	19.38449	0	0	17.90512	0	0	0
Q6PCE3	PGM2L_HUMAN	"Glucose 1,6-bisphosphate synthase, EC 2.7.1.106 (PMMLP) (Phosphoglucomutase-2-like 1)"	PGM2L1 BM32A	Homo sapiens (Human)	glucose metabolic process [GO:0006006]	cytosol [GO:0005829]	"cytosol [GO:0005829]; glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular transferase activity, phosphotransferases [GO:0016868]; metal ion binding [GO:0046872]; glucose metabolic process [GO:0006006]"	"glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular transferase activity, phosphotransferases [GO:0016868]; metal ion binding [GO:0046872]"	GO:0005829; GO:0006006; GO:0016868; GO:0046872; GO:0047933	DVTTGYDSSQPNKK	3.75	1	1	0.529756166	1539.5898	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.66622	0	0	0	0	14.41359	0	0	0	0	0	17.63296	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.90467	0	0
Q6PCT2	FXL19_HUMAN	F-box/LRR-repeat protein 19 (F-box and leucine-rich repeat protein 19)	FBXL19 FBL19	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]	cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; histone demethylase activity [GO:0032452]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]	histone demethylase activity [GO:0032452]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	GO:0003712; GO:0005829; GO:0006357; GO:0006482; GO:0008270; GO:0019005; GO:0032452; GO:0043161; GO:0045322	EAGNEPPTPRK	5.840000153	0.37096864	0.37096864	0.097131123	1196.135193	12.09365	0	0	0	0	0	0	0	0	16.5827	15.69342	0	14.6438	0	0	12.38143	0	0	0	0	0	0	0	0	15.14701	0	0	0	0	0	9.79639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.92438	0
Q6PEY0	CXB7_HUMAN	"Gap junction beta-7 protein (Connexin-25, Cx25)"	GJB7 CX25	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; transmembrane transport [GO:0055085]	connexin complex [GO:0005922]; integral component of membrane [GO:0016021]	connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; transmembrane transport [GO:0055085]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005922; GO:0007267; GO:0016021; GO:0055085	KPQVLSV	3.859999895	0.94654876	0.94654876	0.125533099	769.4740806	0	14.72773	15.37652	0	15.33585	0	15.31925	0	0	0	0	14.82353	0	0	0	0	0	0	16.63897	0	0	0	0	0	0	0	12.37533	0	16.26601	15.36563	16.09115	16.63001	15.84352	0	15.41577	0	16.36528	14.70073	0	0	0	15.44649	0	0	15.80097	14.67956	16.40679	15.237
Q6PF15	KLH35_HUMAN	Kelch-like protein 35	KLHL35	Homo sapiens (Human)						LLEHVR	3.170000076	1	1	0.172988497	767.3663171	15.21939	0	0	0	0	0	14.2675	0	0	13.95589	0	0	0	14.85553	0	0	15.92819	0	0	15.12836	0	0	0	15.83144	15.14249	0	15.71567	0	0	14.82933	0	0	0	0	0	0	0	16.16349	0	14.25565	13.57495	15.62315	0	14.94725	0	0	0	0
Q6PG37	ZN790_HUMAN	Zinc finger protein 790	ZNF790	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	MAHLMMFR	22.73999977	1	1	0.167854109	1036.669649	18.82532	18.88725	18.43911	19.18722	19.1727	19.21227	18.06862	17.8157	18.23406	18.23123	16.98812	20.13183	18.95589	18.78086	18.3388	14.97103	15.47253	17.06332	16.91773	17.77884	16.49544	17.30619	17.47107	17.51807	0	17.43413	15.87036	17.3198	15.24278	18.15973	18.16374	16.54722	16.95093	12.76997	18.34444	16.0411	17.75365	17.32664	17.13474	13.2693	17.09819	15.71696	19.00359	14.15638	17.73519	17.06188	17.27196	17.1767
Q6PGN9	PSRC1_HUMAN	Proline/serine-rich coiled-coil protein 1	PSRC1 DDA3 FP3214	Homo sapiens (Human)	"cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell growth [GO:0030308]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic spindle organization [GO:0060236]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell growth [GO:0030308]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic spindle organization [GO:0060236]"	microtubule binding [GO:0008017]	GO:0000922; GO:0001578; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007080; GO:0008017; GO:0015630; GO:0030308; GO:0030496; GO:0031116; GO:0045737; GO:0045893; GO:0051301; GO:0060236	RPSNMKR	6.659999847	0.039006185	0.039006185	0.183623886	901.6813998	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.75928	16.18338	0	15.86252	0	0	0	0	16.93434	0	0	15.76765	0	16.33559	0	15.56665	14.602	16.74439	15.2509	0	16.55952	0	0	17.58061	0	14.12185	13.93615	16.68591	0	0	15.16452	12.04549	0	0
Q6PGP7	TTC37_HUMAN	"Tetratricopeptide repeat protein 37, TPR repeat protein 37 (SKI3 homolog, Ski3) (Tricho-hepatic-enteric syndrome protein, Thespin)"	TTC37 KIAA0372	Homo sapiens (Human)	"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]"		GO:0000791; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0034427; GO:0055087	AEALIK	1.190000057	1	1	0.031284628	644.4903975	0	0	0	11.68947	16.24188	0	0	0	0	0	0	14.59366	0	0	0	0	0	0	0	0	0	0	0	0	15.5662	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88474	0	0	0	13.40392	0
Q6PHW0	IYD1_HUMAN	"Iodotyrosine deiodinase 1, IYD-1, EC 1.21.1.1 (Iodotyrosine dehalogenase 1)"	IYD C6orf71 DEHAL1	Homo sapiens (Human)	thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570]	cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491]; thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570]	FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491]	GO:0005654; GO:0005886; GO:0005887; GO:0006570; GO:0010181; GO:0016491; GO:0030659; GO:0042403; GO:0140616	DPDVKHK	6.519999981	1	1	0.144878623	837.7690579	14.46315	0	12.38623	0	15.60988	16.78912	14.27588	0	15.43426	16.11058	14.43423	0	12.80479	14.1431	0	15.40532	0	0	0	0	0	0	0	0	14.72812	0	17.06363	14.07292	15.56638	14.24043	0	0	0	0	0	0	0	0	0	0	0	0	0	13.95677	0	0	13.16403	0
Q6PI47	KCD18_HUMAN	BTB/POZ domain-containing protein KCTD18	KCTD18	Homo sapiens (Human)	protein homooligomerization [GO:0051260]		protein homooligomerization [GO:0051260]		GO:0051260	EAGNNVQYIWSYYSVAELK	5.460000038	0.130742982	0.130742982	0.140935255	2236.181888	17.45407	16.35296	0	13.69518	0	16.05844	15.02038	13.80236	0	0	0	0	16.90619	16.07759	11.45117	0	0	0	0	0	0	18.34645	15.54022	15.45873	14.07958	0	0	13.46103	15.40477	11.69769	0	18.01562	15.75778	0	8.468326	0	17.66325	0	0	0	14.23333	0	0	0	0	14.57402	0	16.17422
Q6PI48	SYDM_HUMAN	"Aspartate--tRNA ligase, mitochondrial, EC 6.1.1.12 (Aspartyl-tRNA synthetase, AspRS)"	DARS2	Homo sapiens (Human)	aspartyl-tRNA aminoacylation [GO:0006422]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; aspartyl-tRNA aminoacylation [GO:0006422]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039]	aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	GO:0000049; GO:0004815; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006422; GO:0042803; GO:0043039; GO:0050560; GO:0070145	LRSQMVMK	7.389999866	1	1	9.22E-13	1009.719278	0	0	14.49228	13.12497	11.56961	18.35164	14.93902	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6PI77	BHLH9_HUMAN	"Protein BHLHb9, bHLHb9 (Transcription regulator of 60 kDa, p60TRP)"	BHLHB9 KIAA1701	Homo sapiens (Human)	learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neurogenesis [GO:0050769]; positive regulation of synapse assembly [GO:0051965]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neurogenesis [GO:0050769]; positive regulation of synapse assembly [GO:0051965]	protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005737; GO:0007611; GO:0042803; GO:0043524; GO:0050769; GO:0051965; GO:0061003; GO:0070062	AGAER	4.650000095	0.315870196	0.315870196	0.242861284	503.4656959	17.44161	16.1847	0	0	16.8049	16.11167	14.77215	0	16.45865	16.36924	16.15166	15.78334	15.54211	0	0	16.1387	16.1118	16.2281	0	0	0	0	0	16.53245	0	17.18776	0	17.53899	0	16.78585	0	0	0	16.68919	0	17.20903	0	16.95314	0	16.94563	0	16.18961	0	0	15.46448	0	16.68038	0
Q6PI78	TMM65_HUMAN	Transmembrane protein 65	TMEM65	Homo sapiens (Human)	cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779]	integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779]		GO:0003231; GO:0005739; GO:0005743; GO:0005886; GO:0014704; GO:0016021; GO:1903779	GLLALAPPGGLPGGPR	1.919999957	1	1	0.486507757	1442.194097	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.63572	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.66529	0	0	0	0	0	18.03783	0	0	0	0	0	0	0	0	0	0
Q6PI98	IN80C_HUMAN	"INO80 complex subunit C (IES6 homolog, hIes6)"	INO80C C18orf37	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]"	Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]	"Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]"		GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0042766; GO:0045893; GO:0051726; GO:0060382; GO:0071339	ATSIVP	10.34000015	1	1	0.136870312	584.6499311	17.36497	0	0	0	16.49865	16.55994	0	14.86211	16.27554	0	0	0	0	0	0	0	0	0	0	0	16.37899	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6PIF6	MYO7B_HUMAN	Unconventional myosin-VIIb	MYO7B	Homo sapiens (Human)	actin filament organization [GO:0007015]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0005524; GO:0005737; GO:0005902; GO:0005903; GO:0007015; GO:0007423; GO:0007605; GO:0015629; GO:0016459; GO:0030050; GO:0030154; GO:0031982; GO:0051015; GO:0090651; GO:1904970	AGNHLFK	3.24000001	1	1	0.276498304	785.7657141	16.77899	18.00566	13.05649	0	17.34338	16.97186	0	17.82016	0	17.91169	0	0	0	17.31824	0	0	18.16058	16.59949	0	0	0	0	17.76906	0	19.26399	17.5144	18.14741	0	0	16.53763	0	0	18.81757	18.51593	0	17.12828	18.74031	19.66612	0	0	18.79366	0	18.34477	16.69201	17.62358	0	17.45109	18.32072
Q6PII3	CC174_HUMAN	Coiled-coil domain-containing protein 174	CCDC174 C3orf19	Homo sapiens (Human)		nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654	KEMEASGAHR	8.630000114	0.217960984	0.217960984	0.070189563	1114.969479	0	0	15.13138	0	0	0	17.72447	16.71527	12.75495	16.37626	0	10.68019	9.476319	13.67763	13.46715	15.90295	0	0	14.36712	0	13.72859	15.21519	15.65342	0	17.65468	0	17.03137	0	15.83064	17.13752	0	19.04433	15.60602	16.41198	17.73299	0	19.51026	15.29315	15.813	18.19915	16.89874	0	16.66475	0	16.692	15.5581	0	14.72233
Q6PIJ6	FBX38_HUMAN	F-box only protein 38	FBXO38 SP329	Homo sapiens (Human)	adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		GO:0002250; GO:0002842; GO:0005634; GO:0005737; GO:0005829; GO:0010976; GO:0019005; GO:0031146; GO:0070936	AARDIPEK	32.45000076	0.011235616	0.011235616	0.125352485	898.4895042	18.09955	17.04915	20.52061	17.9824	18.70264	18.07162	17.55125	19.54553	18.28521	19.59923	19.56573	14.16041	0	17.55793	19.45147	13.3296	16.04407	17.89807	19.67428	18.40168	17.524	0	15.66848	0	17.83288	16.2431	18.0115	0	16.87898	18.73155	0	15.55435	18.4646	18.67862	18.08057	18.43711	19.12685	17.20353	15.00395	0	18.36672	19.41323	20.13505	19.37761	17.86144	18.78371	19.19921	0
Q6PIL6	KCIP4_HUMAN	"Kv channel-interacting protein 4, KChIP4 (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4)"	KCNIP4 CALP KCHIP4	Homo sapiens (Human)	protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]	calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0043025; GO:0072659; GO:1901379	QHVETFFQK	14.82999992	1	1	0.551734526	1164.313689	18.65769	0	0	0	0	0	0	0	18.30523	0	0	0	0	20.61697	0	0	0	0	0	0	20.92309	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6PIV2	FOXR1_HUMAN	Forkhead box protein R1 (Forkhead box protein N5)	FOXR1 FOXN5 DLNB13	Homo sapiens (Human)		chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000981; GO:0005634; GO:1990837	LTEEGHR	3.029999971	1	1	0.278990348	841.9530059	12.56236	0	12.31084	17.52958	15.91714	0	16.03274	16.15215	0	14.98078	16.14886	16.64466	15.92947	15.02298	15.06291	15.00749	0	0	0	0	0	0	0	0	0	16.0689	16.83273	16.23371	0	0	16.33741	13.04477	17.29746	0	0	0	0	0	17.17262	15.60137	18.41825	16.37118	16.01385	0	13.62506	0	0	16.53141
Q6PIW4	FIGL1_HUMAN	"Fidgetin-like protein 1, EC 3.6.4.-"	FIGNL1	Homo sapiens (Human)	ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]; ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule-severing ATPase activity [GO:0008568]	GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243	EQLWVDQQK	5.179999828	1	1	0.064901801	1173.78861	12.45952	14.8191	0	0	14.17794	0	0	0	0	0	0	13.9909	0	16.9744	0	0	14.82594	0	0	15.90929	0	0	0	15.10678	0	0	0	0	16.68503	16.02904	17.57464	0	16.85422	0	0	17.83767	17.77756	0	0	0	15.90595	16.73938	0	0	0	17.54741	0	17.71447
Q6PIY5	ARMD1_HUMAN	Armadillo-like helical domain containing protein 1 (p40)	ARMH1 C1orf228 NCRNA00082	Homo sapiens (Human)						GLMAAMGNTDHSNSQR	3.029999971	1	1	4.61E-13	1721.19169	14.84157	12.78883	13.41039	0	0	0	0	15.03708	13.00632	0	0	14.40584	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.44187	0	0	0	0	15.55394	0	0	0	0	0	0	16.51567
Q6PJ61	FBX46_HUMAN	F-box only protein 46 (F-box only protein 34-like)	FBXO46 FBX46 FBXO34L	Homo sapiens (Human)						ASSMK	2.190000057	0.800792634	0.800792634	0.158607751	523.2187161	16.98425	16.46223	16.07808	17.2168	15.54644	15.66276	16.03934	16.45969	15.73204	16.03123	16.70956	16.95375	15.12517	16.18216	15.78251	15.78802	16.37757	16.11736	16.18729	15.65448	17.4195	0	15.01126	16.69845	15.66224	16.43081	16.44748	16.7792	0	16.69407	0	16.27861	16.37887	17.04463	0	16.0996	15.65586	16.11631	16.20521	16.96226	17.12933	16.53922	15.4605	15.31599	17.50777	16.73816	15.75742	16.00643
Q6PJF5	RHDF2_HUMAN	"Inactive rhomboid protein 2, iRhom2 (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6)"	RHBDF2 IRHOM2 RHBDL5 RHBDL6	Homo sapiens (Human)	negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708]	endoplasmic reticulum membrane [GO:0005789]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; protein transporter activity [GO:0140318]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708]	growth factor binding [GO:0019838]; protein transporter activity [GO:0140318]	GO:0002862; GO:0005789; GO:0005796; GO:0005886; GO:0015031; GO:0016021; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0140318	SVSLQEPRSR	5.21999979	1	1	0.018110957	1157.643159	16.51575	0	0	0	0	0	0	0	0	17.81683	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6PJG2	MDEAS_HUMAN	Mitotic deacetylase-associated SANT domain protein (ELM2 and SANT domain-containing protein 1)	MIDEAS C14orf117 C14orf43 ELMSAN1	Homo sapiens (Human)	"histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0003677; GO:0003714; GO:0005654; GO:0005667; GO:0006357; GO:0016575; GO:0045892	LAPNGRER	11.36999989	0.352380633	0.352380633	0.28580623	913.1725872	15.44372	16.11529	0	14.36685	15.77792	13.2745	14.90841	15.34337	13.86734	17.75504	15.66438	15.86611	17.76046	14.93074	16.04636	15.55359	15.38479	17.01236	14.22401	15.47443	15.98705	0	17.05517	0	14.91681	0	13.57354	0	15.07283	15.15633	15.55066	0	16.9238	0	14.31131	0	15.51147	16.03429	0	15.77896	16.86027	16.74172	0	15.4154	16.45422	0	14.9026	15.09242
Q6PJG9	LRFN4_HUMAN	Leucine-rich repeat and fibronectin type-III domain-containing protein 4	LRFN4 SALM3	Homo sapiens (Human)	regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]	cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]		GO:0005886; GO:0009986; GO:0098978; GO:0098982; GO:0099061; GO:0099151; GO:0099560; GO:1905606	SHSVHGGLLGAGCR	4.659999847	0.658822536	0.658822536	0.006405524	1408.282368	13.94508	15.1115	11.67058	11.07319	12.98696	14.82718	13.94536	13.89663	13.15124	14.81241	13.25359	15.45047	0	12.79347	16.17117	15.43332	0	0	16.02466	15.13518	15.76379	15.69932	15.44423	0	13.94119	0	13.27759	10.65701	12.91519	14.47989	0	0	0	0	0	0	15.01799	0	0	0	16.53676	15.13552	0	0	16.41298	17.00544	14.87631	14.89186
Q6PJI9	WDR59_HUMAN	GATOR complex protein WDR59 (WD repeat-containing protein 59)	WDR59 KIAA1923 FP977	Homo sapiens (Human)	cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]	GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]		GO:0005765; GO:0032008; GO:0034198; GO:0061700; GO:1904262; GO:1904263	KPSTAVEYLAAHLSK	6.869999886	1	1	0.452360317	1615.847073	17.10491	0	15.28267	0	0	18.81984	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.48164	0	0	0	0	0	0	0	0	20.33094	0	20.94303	0	0	0	20.30991	0	0	0	0	0	0	0	19.14947	18.69966	0	0
Q6PJP8	DCR1A_HUMAN	"DNA cross-link repair 1A protein (Beta-lactamase DCLRE1A, EC 3.5.2.6) (SNM1 homolog A, hSNM1, hSNM1A)"	DCLRE1A KIAA0086 SNM1 SNM1A	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]	fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]	5'-3' exodeoxyribonuclease activity [GO:0035312]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]	GO:0001650; GO:0003684; GO:0005654; GO:0006303; GO:0007049; GO:0008800; GO:0031848; GO:0035312; GO:0036297; GO:0046872; GO:0051301	IADVIPQTK	6.670000076	1	1	0.226747962	983.800423	16.80407	0	17.0913	0	0	14.98386	0	0	0	14.98759	16.21231	0	0	14.54632	0	0	14.68167	0	0	0	15.25625	0	0	14.87174	17.01912	14.71606	15.71015	15.40001	14.99834	0	0	14.61017	0	16.49854	0	0	14.74314	15.3159	15.2579	0	16.19425	15.52013	13.06198	12.69819	0	16.06829	14.50752	0
Q6PJT7	ZC3HE_HUMAN	"Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2, MSUT-2) (Renal carcinoma antigen NY-REN-37)"	ZC3H14	Homo sapiens (Human)	negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]	metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0008143; GO:0016607; GO:0032839; GO:0043488; GO:0046872; GO:1900364; GO:1904115; GO:1990904	RPSLPPSK	10.56000042	0.603862941	0.603862941	0.242250706	882.6234741	18.00555	19.73678	15.95649	20.08429	21.61817	18.42215	18.48806	17.91386	16.7747	0	18.38763	0	16.77231	17.46345	0	18.0442	18.04988	17.26859	0	17.75121	15.49084	18.18966	0	0	0	17.81777	0	0	0	18.48263	18.53748	17.09171	19.81221	0	18.72677	0	20.58224	18.4185	19.76163	18.82887	17.63519	17.53409	20.39337	17.48133	19.26714	0	0	0
Q6PJW8	CNST_HUMAN	Consortin	CNST C1orf71	Homo sapiens (Human)	positive regulation of Golgi to plasma membrane protein transport [GO:0042998]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; connexin binding [GO:0071253]; phosphatase binding [GO:0019902]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]	connexin binding [GO:0071253]; phosphatase binding [GO:0019902]	GO:0005802; GO:0005886; GO:0016020; GO:0016021; GO:0019902; GO:0030133; GO:0032991; GO:0042998; GO:0043231; GO:0071253	GFNGEDFER	5.25	1	1	0.22696161	1069.250642	14.63341	14.81151	15.54089	16.01972	15.6636	12.63074	0	14.48441	0	0	15.25913	0	15.55631	14.08477	13.51873	0	0	0	16.20398	0	0	17.5656	0	0	16.55671	0	15.32549	0	15.83894	0	15.02376	0	0	0	15.14808	0	15.03483	0	0	17.73476	15.80308	0	0	0	16.17882	0	0	0
Q6PK04	CC137_HUMAN	Coiled-coil domain-containing protein 137	CCDC137 cPERP-B	Homo sapiens (Human)		chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]	chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0001650; GO:0003723; GO:0005634; GO:0005694; GO:0005730	KKPEPQL	11.98999977	1	1	1.23E-13	836.2445948	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6PK81	ZN773_HUMAN	Zinc finger protein 773 (Zinc finger protein 419B)	ZNF773 ZNF419B	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	CNECGRFFSENSSLVK	6.510000229	0.96572417	0.96572417	0.233147504	1934.407354	14.332	0	14.74905	11.98554	13.27036	15.84844	0	0	0	0	0	0	0	0	10.27792	0	16.38576	13.52865	0	0	11.94344	0	0	0	14.08102	15.19138	0	11.59342	15.59876	14.17136	13.54557	15.9095	12.78369	0	13.53925	0	0	0	0	0	0	0	0	10.4079	14.67515	14.83235	0	14.89458
Q6PKC3	TXD11_HUMAN	Thioredoxin domain-containing protein 11 (EF-hand-binding protein 1)	TXNDC11 EFP1	Homo sapiens (Human)		endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0016021	GPMSAVYIEKFVR	4.880000114	1	1	0.286359144	1512.826636	14.6275	14.66459	0	0	0	0	14.17968	0	0	0	0	13.26825	16.82482	0	16.4596	14.18712	0	0	0	15.13152	0	0	15.61888	0	0	0	14.82537	0	0	16.34602	0	0	0	0	0	0	0	0	0	16.25488	0	0	0	0	0	0	0	0
Q6PKG0	LARP1_HUMAN	La-related protein 1 (La ribonucleoprotein domain family member 1)	LARP1 KIAA0731 LARP	Homo sapiens (Human)	cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; posttranscriptional regulation of gene expression [GO:0010608]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; cadherin binding [GO:0045296]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]; cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; posttranscriptional regulation of gene expression [GO:0010608]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413]	cadherin binding [GO:0045296]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]	GO:0000339; GO:0000340; GO:0003723; GO:0003730; GO:0005737; GO:0005829; GO:0006413; GO:0008190; GO:0008283; GO:0008494; GO:0010494; GO:0010608; GO:0016020; GO:0016239; GO:0017148; GO:0031369; GO:0031929; GO:0038202; GO:0043024; GO:0045070; GO:0045296; GO:0045727; GO:0045947; GO:0045948; GO:0048027; GO:0048255; GO:0072752; GO:1990928	GEPGPNDVR	4.110000134	1	1	0.203767341	939.9843812	14.03205	15.76805	14.40138	16.10911	15.10096	16.24475	14.93702	16.54195	15.15499	14.36504	14.51851	15.44448	13.65824	15.70326	8.545734	15.51086	14.90542	14.78744	15.7759	14.18288	0	14.72445	0	13.35596	15.21434	0	0	0	0	15.02573	0	0	0	0	0	16.12236	14.53883	0	0	0	0	15.15842	0	0	0	15.26998	0	0
Q6PL18	ATAD2_HUMAN	"ATPase family AAA domain-containing protein 2, EC 3.6.1.- (AAA nuclear coregulator cancer-associated protein, ANCCA)"	ATAD2 L16 PRO2000	Homo sapiens (Human)	"chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0016887; GO:0042393; GO:0045893; GO:0045944; GO:0070062	SSHKAK	4.099999905	0.449039638	0.449039638	0.196738591	657.2081532	13.67869	13.2136	0	16.76691	15.82677	0	0	13.42228	0	0	15.73015	15.63169	15.73338	0	0	0	0	15.53496	0	0	0	0	16.40352	14.5276	0	0	15.97684	16.76217	15.01244	0	0	0	16.14936	0	15.4889	0	0	15.64647	16.44953	0	0	0	0	14.49775	0	0	0	0
Q6PML9	ZNT9_HUMAN	"Zinc transporter 9, ZnT-9 (Human embryonic lung protein, HuEL) (Solute carrier family 30 member 9)"	SLC30A9 C4orf1 HUEL	Homo sapiens (Human)	cellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; zinc ion transport [GO:0006829]	cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cation transmembrane transporter activity [GO:0008324]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; cellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; zinc ion transport [GO:0006829]	cation transmembrane transporter activity [GO:0008324]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]	GO:0003682; GO:0005634; GO:0005783; GO:0005856; GO:0006289; GO:0006829; GO:0006882; GO:0008324; GO:0016021; GO:0016922; GO:0030374; GO:0031410; GO:0045944	AAACNPSDR	2.460000038	1	1	0.203799289	960.8683452	0	14.72114	15.02333	15.07233	15.00917	0	0	15.68822	0	0	0	9.395177	0	14.25661	16.06102	14.15871	16.066	0	0	0	0	0	0	0	0	0	16.99944	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.47488	0	0	0
Q6PRD1	GP179_HUMAN	"Probable G-protein coupled receptor 179 (Probable G-protein coupled receptor 158-like 1, GPR158-like)"	GPR179 GPR158L GPR158L1	Homo sapiens (Human)	visual perception [GO:0007601]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; visual perception [GO:0007601]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007601; GO:0016021	AKAAMASLVR	5.909999847	1	1	0.106924264	1034.572833	15.41439	0	0	0	0	13.9463	0	0	0	14.05055	0	0	0	0	0	14.85372	14.9058	0	0	15.46667	17.12968	0	0	0	0	14.23172	16.15512	11.57444	0	0	13.26637	14.27641	9.3755	13.96162	0	14.86615	0	15.07425	0	0	15.09427	0	14.52501	14.8902	14.11029	15.76957	11.58227	15.92076
Q6Q759	SPG17_HUMAN	Sperm-associated antigen 17 (Projection protein PF6 homolog)	SPAG17	Homo sapiens (Human)	axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]	acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514]	acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]		GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953	VKHYEFYK	6.320000172	0.306501716	0.306501716	0.16138975	1111.712482	13.64581	0	0	15.78431	12.34119	13.28534	16.20596	14.61469	15.17972	13.28509	15.56322	16.67239	0	15.00299	13.63803	11.34801	15.4812	0	0	0	0	0	14.20211	17.57353	14.46624	14.75766	16.33238	0	0	0	0	0	15.02831	0	15.95559	14.5059	0	0	0	0	13.696	0	0	0	0	14.6678	0	0
Q6R2W3	SCND3_HUMAN	SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9)	ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452	Homo sapiens (Human)	DNA integration [GO:0015074]; positive regulation of cell cycle [GO:0045787]; positive regulation of epithelial cell proliferation [GO:0050679]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; positive regulation of cell cycle [GO:0045787]; positive regulation of epithelial cell proliferation [GO:0050679]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634; GO:0005737; GO:0015074; GO:0045787; GO:0050679	KSSELK	3.960000038	1	1	0.215400288	691.0624651	0	16.36621	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.05085	0	16.88099	0	0	0	0	0	0	0	15.79274	18.46572	0	17.68784	0	0	0
Q6R327	RICTR_HUMAN	"Rapamycin-insensitive companion of mTOR (AVO3 homolog, hAVO3)"	RICTOR KIAA1999	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of protein kinase B signaling [GO:0051896]; TORC2 signaling [GO:0038203]	cytosol [GO:0005829]; TORC2 complex [GO:0031932]	cytosol [GO:0005829]; TORC2 complex [GO:0031932]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; actin cytoskeleton reorganization [GO:0031532]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of protein kinase B signaling [GO:0051896]; TORC2 signaling [GO:0038203]	protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]	GO:0005829; GO:0007010; GO:0009792; GO:0010468; GO:0016310; GO:0018105; GO:0019901; GO:0030307; GO:0030838; GO:0031532; GO:0031669; GO:0031932; GO:0032008; GO:0032956; GO:0033135; GO:0038203; GO:0043022; GO:0043066; GO:0043087; GO:0043539; GO:0050727; GO:0050731; GO:0051896; GO:0051897; GO:2000114	ADVELER	10.07999992	0.000128558	0.000128558	0.320283789	833.0658117	18.52969	17.70075	17.6392	0	0	17.61724	17.47441	0	0	16.58109	0	0	0	16.87232	0	0	0	0	0	0	15.6636	0	0	0	0	0	0	0	17.88622	0	0	0	18.77769	18.77735	0	0	0	0	0	0	0	0	0	0	0	17.4511	0	0
Q6SA08	TSSK4_HUMAN	"Testis-specific serine/threonine-protein kinase 4, TSK-4, TSSK-4, Testis-specific kinase 4, EC 2.7.11.1 (Serine/threonine-protein kinase 22E)"	TSSK4 C14orf20 STK22E TSSK5	Homo sapiens (Human)	fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]	acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]	acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]	GO:0000287; GO:0001669; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0018105; GO:0030317; GO:0032793; GO:0035556; GO:0036126; GO:0042803; GO:0044877; GO:0106310; GO:1990443	RATILDIIK	7.590000153	1	1	0.027848458	1041.560261	0	0	15.65549	0	14.96116	15.20503	14.0664	0	14.35847	13.84226	16.63761	16.02676	0	16.74976	0	0	0	0	0	0	13.34047	0	0	15.05154	13.48532	14.93848	0	0	0	0	17.57441	14.21424	16.55251	0	0	0	13.16822	12.5119	0	0	15.16131	0	9.786716	0	15.21587	0	0	13.3646
Q6SJ93	F111B_HUMAN	"Serine protease FAM111B, EC 3.4.21.- (Cancer-associated nucleoprotein)"	FAM111B CANP	Homo sapiens (Human)	DNA replication [GO:0006260]	chromatin [GO:0000785]; nucleus [GO:0005634]	chromatin [GO:0000785]; nucleus [GO:0005634]; peptidase activity [GO:0008233]; DNA replication [GO:0006260]	peptidase activity [GO:0008233]	GO:0000785; GO:0005634; GO:0006260; GO:0008233	DTVMKQTHADTPVDHCLSGIR	3.019999981	0.047762264	0.047762264	0.120325638	2381.817479	14.39164	13.2378	9.662509	0	13.63951	15.9201	0	17.46379	0	15.11577	8.118926	14.55659	13.6961	0	11.14702	0	0	0	12.24814	0	0	0	0	0	0	0	0	13.43902	0	7.780546	14.07915	0	0	0	0	0	12.30994	15.48697	0	12.01926	0	0	0	12.96969	0	0	0	0
Q6SPF0	SAMD1_HUMAN	"Sterile alpha motif domain-containing protein 1, SAM domain-containing protein 1 (Atherin)"	SAMD1	Homo sapiens (Human)	"chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]"	chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634]	"chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle binding [GO:0030169]; chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle binding [GO:0030169]	GO:0000122; GO:0003682; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0030169; GO:0034439; GO:0042393; GO:0045892; GO:0051260; GO:0090077; GO:0090308	GPQSAK	7.360000134	1	1	0.124831252	587.3093125	16.17981	14.60601	15.26258	15.42726	14.69845	0	13.722	0	0	0	0	0	15.27333	14.61352	0	15.64447	15.13496	16.90217	0	0	17.07903	0	0	0	0	0	0	0	0	0	0	16.0999	0	16.05155	0	0	0	0	0	0	0	17.17743	0	0	0	0	0	16.92613
Q6STE5	SMRD3_HUMAN	"SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 (60 kDa BRG-1/Brm-associated factor subunit C) (BRG1-associated factor 60C, BAF60C)"	SMARCD3 BAF60C	Homo sapiens (Human)	"cardiac right ventricle formation [GO:0003219]; chromatin remodeling [GO:0006338]; muscle cell differentiation [GO:0042692]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein binding [GO:0043393]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary heart field specification [GO:0003139]"	brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	"brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA-binding transcription factor binding [GO:0140297]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221]; cardiac right ventricle formation [GO:0003219]; chromatin remodeling [GO:0006338]; muscle cell differentiation [GO:0042692]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein binding [GO:0043393]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary heart field specification [GO:0003139]"	DNA-binding transcription factor binding [GO:0140297]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221]	GO:0000785; GO:0001221; GO:0002052; GO:0003139; GO:0003219; GO:0003407; GO:0003712; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0016514; GO:0016922; GO:0030071; GO:0030374; GO:0035060; GO:0042692; GO:0043393; GO:0045582; GO:0045597; GO:0045663; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140297; GO:2000045; GO:2000781; GO:2000819	EYINGDK	2.039999962	1	1	0.040306355	838.5757681	16.75098	0	16.11043	14.89139	0	14.18993	14.38838	0	0	0	0	15.8862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84134	0	0	0	0	0	0	14.59944	13.90423	14.73966	0	0	0	0
Q6SZW1	SARM1_HUMAN	"NAD(+) hydrolase SARM1, NADase SARM1, hSARM1, EC 3.2.2.6 (NADP(+) hydrolase SARM1, EC 3.2.2.-) (Sterile alpha and Armadillo repeat protein) (Sterile alpha and TIR motif-containing protein 1) (Sterile alpha motif domain-containing protein 2, MyD88-5, SAM domain-containing protein 2) (Tir-1 homolog, HsTIR)"	SARM1 KIAA0524 SAMD2 SARM	Homo sapiens (Human)	cell differentiation [GO:0030154]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; nervous system development [GO:0007399]; positive regulation of neuron death [GO:1901216]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; signal transduction [GO:0007165]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; synapse [GO:0045202]	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; synapse [GO:0045202]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; nervous system development [GO:0007399]; positive regulation of neuron death [GO:1901216]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; signal transduction [GO:0007165]"	"identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]"	GO:0003953; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0007165; GO:0007399; GO:0009749; GO:0019677; GO:0030154; GO:0030424; GO:0030425; GO:0031315; GO:0034128; GO:0035591; GO:0042802; GO:0042981; GO:0045087; GO:0045202; GO:0048678; GO:0048814; GO:0050135; GO:0061809; GO:1901214; GO:1901216	EQQVDGDLLLR	1.139999986	1	1	0.055006355	1282.734667	13.31992	0	0	13.39734	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.442521	0	0	0	9.789652	0	0	0	0	14.53026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6T4P5	PLPR3_HUMAN	"Phospholipid phosphatase-related protein type 3 (Inactive phospholipid phosphatase PLPPR3) (Lipid phosphate phosphatase-related protein type 3) (PAP-2-like protein 2) (Plasticity-related gene 2 protein, PRG-2)"	PLPPR3 LPPR3 PHP2 PRG2	Homo sapiens (Human)	phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]	GO:0005887; GO:0006644; GO:0007165; GO:0008195; GO:0042577; GO:0046839	LLQVIAMSK	7.289999962	0.78703618	0.78703618	0.26644696	1017.249539	0	0	14.16791	0	13.82288	14.88469	14.96341	0	15.61074	0	0	16.2712	0	0	14.0531	15.36937	15.20333	14.75271	15.10551	15.02571	14.79708	15.35126	15.60367	15.74625	15.3728	0	0	0	13.70803	0	15.41062	0	15.84033	0	0	14.66353	0	14.15703	0	0	0	15.55664	16.38634	14.14849	0	14.32299	16.68611	15.30923
Q6TFL3	CC171_HUMAN	Coiled-coil domain-containing protein 171	CCDC171 C9orf93	Homo sapiens (Human)						ADPNSR	13.51000023	0.348925442	0.348925442	0.188052324	658.4736429	0	16.05063	13.75046	15.34412	15.94424	15.6387	15.73528	15.12611	14.93827	15.70742	13.3517	12.89439	15.76871	15.39286	15.80927	13.6036	15.69234	14.0175	0	15.74848	15.10198	16.98292	0	16.34069	17.06963	0	15.89684	16.15975	0	15.6965	15.01184	0	0	16.48273	15.64318	0	15.25791	15.78293	16.01941	0	0	0	15.96101	0	0	16.74394	0	16.53906
Q6TFL4	KLH24_HUMAN	"Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6, KRIP6) (Protein DRE1)"	KLHL24 DRE1	Homo sapiens (Human)	intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]	adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312]		GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312	AVLSACSSYFR	5.849999905	1	1	0.065444221	1259.536991	0	0	0	0	0	0	13.90827	0	14.51703	0	0	0	0	0	0	0	0	0	0	0	0	0	15.75087	0	13.26993	0	0	0	0	14.1914	15.46624	15.97865	16.10181	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6TGC4	PADI6_HUMAN	"Protein-arginine deiminase type-6, EC 3.5.3.15 (Peptidyl arginine deiminase-like protein) (Peptidylarginine deiminase VI, hPADVI) (Protein-arginine deiminase type VI)"	PADI6 PAD6	Homo sapiens (Human)	cytoplasm organization [GO:0007028]; cytoskeleton organization [GO:0007010]; embryonic cleavage [GO:0040016]; histone citrullination [GO:0036414]; regulation of translation by machinery localization [GO:0043143]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668]; cytoplasm organization [GO:0007028]; cytoskeleton organization [GO:0007010]; embryonic cleavage [GO:0040016]; histone citrullination [GO:0036414]; regulation of translation by machinery localization [GO:0043143]	calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668]	GO:0004668; GO:0005509; GO:0005634; GO:0005737; GO:0007010; GO:0007028; GO:0036414; GO:0040016; GO:0043143; GO:0045111; GO:0060473	AMSKTLR	4.679999828	0.230643332	0.230643332	0.236537499	806.7222292	16.6663	0	0	13.42376	16.14215	0	17.4233	0	18.55639	14.52851	18.03776	15.25845	0	16.9331	16.81789	15.09195	16.80938	15.06133	0	0	17.07004	19.14771	18.52409	17.43624	0	0	17.43613	16.65274	16.31135	0	0	0	16.75853	16.05065	17.44545	16.82909	17.02735	0	16.79856	0	0	0	15.06651	0	0	0	16.57891	17.3359
Q6UB35	C1TM_HUMAN	"Monofunctional C1-tetrahydrofolate synthase, mitochondrial, EC 6.3.4.3 (Formyltetrahydrofolate synthetase)"	MTHFD1L FTHFSDC1	Homo sapiens (Human)	10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; tetrahydrofolate interconversion [GO:0035999]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; tetrahydrofolate interconversion [GO:0035999]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]	GO:0001843; GO:0004329; GO:0004488; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006760; GO:0009257; GO:0015942; GO:0016020; GO:0035999; GO:0042803; GO:0048702; GO:0048703	TPAAR	6.239999771	1	1	0.14358802	514.0235824	0	0	0	0	0	0	0	14.70428	12.51123	14.84457	15.67743	0	0	0	0	15.37214	14.54417	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.67057	0	0	13.38323	0	0	0	0	0	15.87507	13.35247	14.82849	12.94778	15.37698
Q6UB98	ANR12_HUMAN	Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein)	ANKRD12 ANCO2 KIAA0874	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005829	DDKSTK	4.96999979	0.039619911	0.039619911	0.047381796	692.6675478	0	0	15.4997	0	17.39872	10.27106	15.65574	0	17.39233	0	0	12.03685	15.11751	17.68824	15.42719	0	16.75475	17.13656	13.19251	12.85898	0	15.46519	0	17.0643	0	16.05801	16.45601	15.59662	12.85259	0	16.76065	14.11733	18.91358	16.03967	13.14271	15.86134	15.64755	16.28869	17.23609	0	15.32539	13.39279	16.50828	0	10.35956	0	16.73279	16.31697
Q6UB99	ANR11_HUMAN	Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1)	ANKRD11 ANCO1	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anatomical structure morphogenesis [GO:0009653]; face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705]		GO:0005634; GO:0005654; GO:0005829; GO:0009653; GO:0042475; GO:0048705; GO:0060325	ETKSNSFISIPK	2.319999933	1	1	0.508619896	1350.916876	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.2203	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UE05	TM270_HUMAN	Transmembrane protein 270 (Williams-Beuren syndrome chromosomal region 28 protein)	TMEM270 WBSCR28	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	MEALPPVR	9.640000343	0.348894179	0.348894179	0.035990724	931.3821536	13.29412	12.14953	14.65194	15.7772	12.4632	12.10128	14.98806	16.54233	13.98887	0	15.79603	15.30472	16.49433	16.09963	15.60833	15.73819	0	13.6417	16.73788	16.70285	13.16658	15.2474	12.191	16.42744	16.39796	14.39222	0	14.81975	15.04163	10.69293	14.0804	15.26636	17.24488	13.84673	17.90407	14.96693	15.9925	16.79678	18.47128	16.8859	17.76674	15.22701	16.09661	12.98684	17.26837	17.51769	15.76125	16.76237
Q6UN15	FIP1_HUMAN	"Pre-mRNA 3'-end-processing factor FIP1, hFip1 (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia)"	FIP1L1 FIP1 RHE	Homo sapiens (Human)	mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005829; GO:0005847; GO:0006378; GO:0098789	ANSSVGK	9.800000191	1	1	6.90E-13	661.415749	14.48945	15.75347	15.05742	16.28757	0	13.35261	15.95256	0	0	0	0	0	0	0	0	14.65106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.82971	15.45653	14.44841	0	15.72762	0	0	0
Q6UVK1	CSPG4_HUMAN	Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan)	CSPG4 MCSP	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; tissue remodeling [GO:0048771]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; lysosomal lumen [GO:0043202]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; lysosomal lumen [GO:0043202]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; tissue remodeling [GO:0048771]	coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901]	GO:0001525; GO:0001726; GO:0005576; GO:0005654; GO:0005796; GO:0005886; GO:0005887; GO:0005925; GO:0006929; GO:0008283; GO:0008347; GO:0009986; GO:0015026; GO:0016324; GO:0019901; GO:0031258; GO:0035556; GO:0043202; GO:0043410; GO:0048008; GO:0048771; GO:0050731; GO:0062023; GO:0070062; GO:0097178	MQSGPRPPLPAPGLALALTLTMLAR	1.889999986	1	1	0.217145183	2604.606108	0	15.0157	14.71128	0	0	0	0	0	14.51456	0	12.01201	15.3882	15.30388	0	0	0	0	0	0	14.78057	0	15.99832	0	0	0	0	0	0	0	0	0	16.05696	16.11064	0	0	14.02349	16.45144	0	15.73361	13.79141	14.05488	0	0	15.75086	0	11.78372	0	14.32189
Q6UVY6	MOXD1_HUMAN	"DBH-like monooxygenase protein 1, EC 1.14.17.- (Monooxygenase X)"	MOXD1 MOX UNQ2493/PRO5780	Homo sapiens (Human)	dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]	endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]	endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]	copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]	GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0016021; GO:0030667; GO:0042420; GO:0042421	AEPLVCGTSSSSSLHR	7.170000076	0.686009288	0.686009288	0.53306871	1686.353822	14.17347	18.08923	18.83547	19.03954	18.44077	15.59075	19.86034	0	0	0	0	0	0	0	0	0	16.45604	0	19.57111	17.90893	17.63999	18.51531	19.95581	0	0	20.37344	20.46441	18.79248	0	0	20.7683	0	20.12368	18.08858	0	20.21374	0	21.31727	20.42492	0	19.94992	0	17.86604	0	17.0735	0	20.25491	18.67821
Q6UW49	SPESP_HUMAN	"Sperm equatorial segment protein 1, SP-ESP (Equatorial segment protein, ESP) (Glycosylated 38 kDa sperm protein C-7/8)"	SPESP1 UNQ732/PRO1418	Homo sapiens (Human)	acrosome reaction [GO:0007340]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; acrosome reaction [GO:0007340]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036]		GO:0001669; GO:0005654; GO:0005829; GO:0007340; GO:0007342; GO:0009566; GO:0035036; GO:0043231	AATVFNTLKNMCR	6.78000021	1	1	6.89E-13	1541.636636	0	0	13.19212	0	12.58622	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.5036	15.50339	0	0	0	14.78768	14.4163	16.17953	16.72897	0	15.99159	14.79566	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UWE0	LRSM1_HUMAN	"E3 ubiquitin-protein ligase LRSAM1, EC 2.3.2.27 (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase, hTAL)"	LRSAM1 TAL UNQ6496/PRO21356	Homo sapiens (Human)	autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0046872; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786	EHTQLLQQSSSQKDEILQTVK	10.86999989	1	1	0.634158683	2440.775088	0	0	0	0	0	0	0	0	0	0	0	16.92127	17.53014	0	0	0	0	0	17.35664	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.11275	0	0	0	0	0	0	0	0	0
Q6UWF7	NXPE4_HUMAN	NXPE family member 4 (Protein FAM55D)	NXPE4 C11orf33 FAM55D UNQ3018/PRO9799	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]		GO:0070062	ARMSSPALMAGASGK	5.900000095	1	1	1.61E-12	1450.401668	0	0	14.6743	0	0	13.76831	0	0	15.47075	0	13.55017	0	15.77159	0	13.31742	15.11027	14.22482	0	15.50157	14.15654	0	14.34013	13.65113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UWH4	GAK1B_HUMAN	Golgi-associated kinase 1B (Expressed in nerve and epithelium during development) (Protein FAM198B)	GASK1B C4orf18 ENED FAM198B AD021 UNQ2512/PRO6001	Homo sapiens (Human)		Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]		GO:0000139; GO:0005794; GO:0016021	TLPSVSR	9.210000038	0.001261604	0.001261604	0.049315034	758.9710661	16.59358	17.16833	16.34805	0	18.50069	16.32287	13.96509	17.2187	13.79406	14.72008	18.63695	16.55283	15.72326	17.27503	15.72467	0	14.48408	15.86668	0	15.9685	0	17.74562	15.32694	14.96053	17.73872	11.20809	18.01875	15.179	13.26027	10.21271	16.15241	0	15.91676	17.15614	14.0821	0	16.13257	16.01215	0	0	17.84374	16.26308	0	12.95311	16.9513	13.95909	15.7076	13.17897
Q6UWI2	PARM1_HUMAN	"Prostate androgen-regulated mucin-like protein 1, PARM-1"	PARM1 UNQ1879/PRO4322	Homo sapiens (Human)	positive regulation of telomerase activity [GO:0051973]	cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; positive regulation of telomerase activity [GO:0051973]		GO:0000139; GO:0005654; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0016021; GO:0043231; GO:0051973	TPPTTVSGK	5.760000229	0.639854074	0.639854074	8.02E-13	887.7533948	15.79758	14.13053	0	0	14.41874	13.90974	11.43636	0	13.45279	14.93556	0	13.11806	12.62386	12.44104	15.39686	13.96047	14.54752	0	13.10264	14.65872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.66151	0	0	0	0	0	0	0	0
Q6UWI4	SHSA2_HUMAN	Protein shisa-2 homolog (Transmembrane protein 46)	SHISA2 C13orf13 TMEM46 UNQ9166/PRO28631	Homo sapiens (Human)	negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of Wnt signaling pathway [GO:0030178]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of Wnt signaling pathway [GO:0030178]		GO:0005783; GO:0005789; GO:0016021; GO:0030178; GO:0040037	APGGNR	3.799999952	1	1	0.14037914	571.2843303	0	0	16.57288	13.64205	0	15.85408	0	15.71465	16.01923	0	0	0	0	0	0	0	0	0	0	0	0	15.67472	0	0	0	14.43972	0	16.75334	0	16.42157	16.34421	0	14.30352	15.6886	13.66232	15.86264	13.76381	15.21406	3.114474	0	15.68369	14.587	15.3984	15.05886	15.86141	15.24953	16.14474	15.5002
Q6UWJ1	TMCO3_HUMAN	Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein)	TMCO3 C13orf11 UNQ2419/PRO4976	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]	potassium:proton antiporter activity [GO:0015386]	GO:0015386; GO:0016021	SVKGVNFEAVLR	4.940000057	1	1	0.151714618	1319.493106	0	0	0	0	0	11.86229	0	14.00038	10.02768	0	0	0	0	9.019891	14.54812	0	0	0	14.60996	0	0	0	13.73756	0	0	0	0	0	0	0	0	12.98758	0	0	0	0	0	0	0	0	0	0	14.02637	0	0	14.56924	0	15.1266
Q6UWL6	KIRR2_HUMAN	Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3)	KIRREL2 NEPH3 UNQ5827/PRO19646	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]	cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]	cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933]	cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]	GO:0001933; GO:0005886; GO:0005887; GO:0005911; GO:0007155; GO:0016021; GO:0036057; GO:0042802; GO:0050839; GO:0098609	DPTNGYYK	17.46999931	0.843445539	0.843445539	0.072296279	958.2849045	0	12.55343	15.88863	14.84877	15.24144	14.06604	16.50039	16.16005	0	15.88853	13.69639	15.61666	0	15.68435	15.49696	14.33641	15.00501	0	16.32421	15.90359	0	0	0	14.29226	0	17.06549	0	15.05173	15.95225	15.94625	0	15.48888	17.77515	16.10381	0	0	15.43588	17.74286	18.80096	15.28412	14.88478	14.42977	15.23293	14.50551	16.76706	0	15.93382	16.13025
Q6UWM7	LCTL_HUMAN	Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein)	LCTL KLPH UNQ3022/PRO9820	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; lens morphogenesis in camera-type eye [GO:0002089]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; lens morphogenesis in camera-type eye [GO:0002089]; response to stimulus [GO:0050896]; visual perception [GO:0007601]"	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0002089; GO:0004553; GO:0005789; GO:0005903; GO:0005975; GO:0007601; GO:0016021; GO:0050896	LLPTGIR	3.799999952	0.509981215	0.509981215	0.232793894	767.6274684	13.80003	15.2861	15.91572	14.74495	0	16.33103	15.77383	15.16718	15.48385	0	15.08208	16.3288	0	15.97059	15.74201	16.04213	15.19358	15.28427	16.12245	15.19593	14.52191	16.96897	17.54101	16.2446	15.68779	15.80676	16.91624	15.71397	16.37525	15.40535	0	17.14626	15.86542	17.37353	0	16.82311	17.14091	16.40619	16.85328	15.17757	16.52986	16.36865	15.35004	16.06082	15.28783	17.28091	16.52634	15.64039
Q6UWP8	SBSN_HUMAN	Suprabasin	SBSN UNQ698/PRO1343	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]		GO:0070062	ETEKFGQGVHHAASQFGK	13.39000034	1.30E-08	1.30E-08	0.161854921	1958.259479	15.96294	0	0	0	0	16.58893	15.96812	0	18.33809	16.54064	15.03358	0	0	0	0	16.43302	0	0	0	0	0	16.88355	0	0	18.36299	15.04941	0	17.67412	0	0	0	17.98528	19.04607	18.01592	16.07826	18.4054	17.49035	0	0	0	0	0	16.8553	0	14.14025	0	16.93347	0
Q6UWS5	PT117_HUMAN	"Protein PET117 homolog, mitochondrial"	PET117 UNQ607/PRO1194	Homo sapiens (Human)	mitochondrial cytochrome c oxidase assembly [GO:0033617]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; mitochondrial cytochrome c oxidase assembly [GO:0033617]		GO:0005739; GO:0033617	LRDGVIR	11.80000019	0.528396606	0.528396606	0.161974737	828.1605349	18.70465	14.22753	16.30816	17.70536	14.57407	14.47783	0	14.10135	17.32232	18.04958	0	16.71474	12.43109	0	13.62101	15.35296	15.90435	16.32981	17.41746	17.05916	13.73829	18.44993	16.22407	17.41452	0	15.55758	16.59392	17.36122	0	12.7824	16.67509	17.58545	19.11972	0	16.1154	0	17.42108	0	15.9089	0	0	14.57759	13.8132	0	0	18.14396	16.42819	14.42538
Q6UWU2	GLB1L_HUMAN	"Beta-galactosidase-1-like protein, EC 3.2.1.-"	GLB1L UNQ229/PRO262	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]	extracellular region [GO:0005576]; vacuole [GO:0005773]	extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005576; GO:0005773; GO:0005975	LGSKLDILVENMGR	6.039999962	1	1	0.176535927	1559.792417	0	0	16.2416	0	0	0	0	0	17.73672	0	17.67025	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.1474	0	18.42236	0	0	0	0	0	0	0	0	0
Q6UWV6	ENPP7_HUMAN	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 7, E-NPP 7, NPP-7, EC 3.1.4.12 (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase, Alk-SMase)"	ENPP7 UNQ3077/PRO9912	Homo sapiens (Human)	fatty acid homeostasis [GO:0055089]; glycosphingolipid metabolic process [GO:0006687]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; fatty acid homeostasis [GO:0055089]; glycosphingolipid metabolic process [GO:0006687]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]	phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]	GO:0004767; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0006684; GO:0006685; GO:0006687; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0016020; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755	RAGDLVEFHK	13.10999966	1	1	0.491605383	1171.379574	0	0	0	0	0	0	0	0	0	0	18.5073	0	0	17.25369	18.25811	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.22082	0	0	0	0	0	0	0	17.83817
Q6UWW8	EST3_HUMAN	"Carboxylesterase 3, EC 3.1.1.1 (Liver carboxylesterase 31 homolog)"	CES3 UNQ869/PRO1887	Homo sapiens (Human)	low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805]	carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]	GO:0005788; GO:0005829; GO:0006805; GO:0034383; GO:0052689; GO:0070062; GO:0080030	EGEELVLSK	5.320000172	0.163011149	0.163011149	0.239770788	1002.243084	14.94651	15.47558	14.1519	0	0	0	18.18212	0	15.24741	16.63722	11.90608	15.93732	0	0	0	0	0	14.89857	0	0	0	0	0	16.42678	0	0	0	0	0	0	0	16.56538	0	0	0	0	0	0	0	0	16.77376	0	0	0	0	0	16.23761	0
Q6UWX4	HIPL2_HUMAN	HHIP-like protein 2	HHIPL2 HHIP3 KIAA1822L UNQ841/PRO1779	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; catalytic activity [GO:0003824]	catalytic activity [GO:0003824]	GO:0003824; GO:0005576	AGSHGKR	4.929999828	1	1	0.208464908	713.8625513	0	0	0	0	13.31311	14.16926	15.05151	0	15.38918	0	0	15.67792	0	14.98213	0	0	0	13.85628	0	0	0	14.75984	14.78826	0	0	0	15.60299	0	15.07891	13.53477	0	14.97979	0	17.29719	0	0	0	15.71644	16.80725	15.15698	0	0	0	16.95559	15.88744	16.83597	15.66148	0
Q6UWY5	OLFL1_HUMAN	Olfactomedin-like protein 1	OLFML1 UNQ564/PRO1126	Homo sapiens (Human)	signal transduction [GO:0007165]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; signal transduction [GO:0007165]		GO:0005615; GO:0007165	VLEQGLEK	4.320000172	0.222374469	0.222374469	0.20675592	915.756034	0	0	16.55803	0	0	0	0	0	15.21733	0	0	17.00009	14.65232	15.49258	13.79684	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.7706	0	14.97177	16.1734	0	0	0	16.00749	16.57956	0	0	0	0	15.56626	0	0	0
Q6UX01	LMBRL_HUMAN	"Protein LMBR1L (Limb region 1 protein homolog-like) (Lipocalin-1-interacting membrane receptor, LIMR)"	LMBR1L KIAA1174 LIMR UNQ458/PRO783	Homo sapiens (Human)	hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055]	transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005789; GO:0005886; GO:0005887; GO:0006898; GO:0007165; GO:0016055; GO:0030217; GO:0042098; GO:0060218; GO:0070231; GO:0090090	LPLPVSGFPQASR	8.409999847	1	1	0.451965627	1369.340914	0	0	17.40772	0	0	0	0	0	0	0	14.61742	0	0	0	18.72656	0	0	0	17.96338	0	17.29489	0	0	0	0	17.32862	0	0	0	0	15.76122	0	0	0	19.32836	19.28983	0	0	16.61428	0	0	0	16.39978	0	0	18.83219	17.47886	0
Q6UX06	OLFM4_HUMAN	"Olfactomedin-4, OLM4 (Antiapoptotic protein GW112) (G-CSF-stimulated clone 1 protein, hGC-1) (hOLfD)"	OLFM4 GW112 UNQ362/PRO698	Homo sapiens (Human)	cell adhesion [GO:0007155]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cadherin binding [GO:0045296]; catalytic activity [GO:0003824]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]	cadherin binding [GO:0045296]; catalytic activity [GO:0003824]; structural molecule activity [GO:0005198]	GO:0003824; GO:0005198; GO:0005576; GO:0005615; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0007155; GO:0007165; GO:0032991; GO:0035580; GO:0042581; GO:0045171; GO:0045296; GO:0048471; GO:0070062; GO:1900026; GO:1904724	LETLDKNNVLAIR	1.320000052	1	1	2.32E-13	1498.030949	0	0	17.34545	0	0	0	0	0	0	0	0	16.61124	0	0	0	17.33804	0	0	0	0	15.12116	0	0	0	0	0	0	0	0	0	0	0	0	0	20.193	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UX46	ALKL2_HUMAN	"ALK and LTK ligand 2 (Augmentor alpha, AUG-alpha)"	ALKAL2 FAM150B UNQ542/PRO1097	Homo sapiens (Human)	positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976]	receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971]	GO:0005576; GO:0010976; GO:0030298; GO:0030971; GO:0070374; GO:0070378	GGAEPR	5.809999943	0.270650804	0.270650804	0.208358791	587.8639092	0	14.96529	0	15.44288	14.93251	14.54676	0	16.22361	0	0	0	16.29336	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.45448	0	0	0	16.56986	0	0	0	0
Q6UX52	IL40_HUMAN	"Protein IL-40 (Interleukin-40, IL-40)"	C17orf99 IL40 UNQ464/PRO809	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; mature B cell differentiation involved in immune response [GO:0002313]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; regulation of immune response [GO:0050776]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; cytokine activity [GO:0005125]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; mature B cell differentiation involved in immune response [GO:0002313]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; regulation of immune response [GO:0050776]	cytokine activity [GO:0005125]; transmembrane signaling receptor activity [GO:0004888]	GO:0002250; GO:0002313; GO:0004888; GO:0005125; GO:0005615; GO:0005887; GO:0007166; GO:0050776; GO:2000558	VLEVFPKGR	5.75	0.13822417	0.13822417	0.228487595	1044.3965	15.87572	16.30144	16.90049	17.56484	16.03488	15.84408	16.36321	18.29455	0	18.10237	17.12084	15.44495	17.19101	16.15795	16.22674	14.57713	15.07604	0	0	17.01497	16.12366	15.82955	16.62904	0	16.06868	16.88191	17.05202	15.2345	16.75112	16.47879	16.31964	0	0	17.23831	17.66546	17.75315	16.23608	16.21961	0	15.9463	0	16.28389	16.43451	16.07377	15.86636	15.81958	16.66114	15.27988
Q6UX53	MET7B_HUMAN	"Thiol S-methyltransferase METTL7B (Methyltransferase-like protein 7B, EC 2.1.1.9)"	METTL7B UNQ594/PRO1180	Homo sapiens (Human)	methylation [GO:0032259]	endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]	endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; thiol S-methyltransferase activity [GO:0018708]; methylation [GO:0032259]	methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; thiol S-methyltransferase activity [GO:0018708]	GO:0005789; GO:0005811; GO:0008168; GO:0008757; GO:0018708; GO:0032259	DLENAQFSEIQMER	7.190000057	0.544333398	0.544333398	0.509142406	1725.314421	0	16.39577	15.82391	0	0	0	0	18.62643	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.08124	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UX65	DRAM2_HUMAN	DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77)	DRAM2 TMEM77 PSEC0031 UNQ154/PRO180	Homo sapiens (Human)	apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]		GO:0001917; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0043231; GO:0045494	QVHALSPEENVIIK	8.979999542	1	1	0.392920147	1577.261838	0	0	0	0	0	0	19.99823	0	0	0	17.72134	0	20.19864	0	0	19.99743	0	18.3146	0	0	19.58213	0	0	0	0	0	0	0	0	17.96352	18.70092	0	0	0	0	0	20.93593	0	20.24464	0	0	0	0	18.05769	0	0	0	0
Q6UX72	B3GN9_HUMAN	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, BGnT-9, Beta-1,3-Gn-T9, Beta-1,3-N-acetylglucosaminyltransferase 9, Beta3Gn-T9, EC 2.4.1.-"	B3GNT9 UNQ1922/PRO4397	Homo sapiens (Human)	poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]	glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]	GO:0000139; GO:0006486; GO:0008194; GO:0016021; GO:0016757; GO:0016758; GO:0030311	SVAEDFER	9.329999924	1	1	0.159083254	951.3548499	14.16227	15.21472	14.79443	16.71444	15.25828	0	0	14.35852	14.15712	0	12.24731	13.36743	0	0	0	0	15.4951	0	0	12.70294	0	0	15.0736	16.74946	0	0	14.87468	14.97189	15.06212	0	14.74087	11.70554	15.49125	16.43602	0	13.56363	15.37296	0	0	0	0	0	0	0	0	0	0	0
Q6UX82	LYPD8_HUMAN	Ly6/PLAUR domain-containing protein 8	LYPD8 UNQ511/PRO1026	Homo sapiens (Human)	defense response to Gram-negative bacterium [GO:0050829]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; defense response to Gram-negative bacterium [GO:0050829]		GO:0005576; GO:0005615; GO:0005886; GO:0031225; GO:0050829	NDIESKSLVLK	3.789999962	1	1	0.032018897	1246.496613	15.10036	0	0	14.28523	0	14.94217	0	0	16.70699	0	16.91635	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.46521	0	0	0	0	0	0	0	0	0	0	0	0	15.97404	0	0	14.61236	0	0	0	0	0
Q6UXA7	CF015_HUMAN	Uncharacterized protein C6orf15 (Protein STG)	C6orf15 STG UNQ1840/PRO3566	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix organization [GO:0030198]		GO:0005576; GO:0030198; GO:0031012	SNDLARVPLK	1.00999999	1	1	0.063129742	1111.840341	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.14627	0	0	0	0	17.62407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UXB4	CLC4G_HUMAN	"C-type lectin domain family 4 member G (Liver and lymph node sinusoidal endothelial cell C-type lectin, LSECtin)"	CLEC4G UNQ431/PRO792	Homo sapiens (Human)	negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of viral life cycle [GO:1903902]; viral entry into host cell [GO:0046718]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; fructose binding [GO:0070061]; glycosylated region protein binding [GO:0140081]; mannose binding [GO:0005537]; polysaccharide binding [GO:0030247]; virus coreceptor activity [GO:0120274]; virus receptor activity [GO:0001618]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of viral life cycle [GO:1903902]; viral entry into host cell [GO:0046718]	carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; fructose binding [GO:0070061]; glycosylated region protein binding [GO:0140081]; mannose binding [GO:0005537]; polysaccharide binding [GO:0030247]; virus coreceptor activity [GO:0120274]; virus receptor activity [GO:0001618]	GO:0001618; GO:0002710; GO:0005537; GO:0005886; GO:0005887; GO:0009897; GO:0030246; GO:0030247; GO:0042130; GO:0046718; GO:0070061; GO:0097367; GO:0120274; GO:0140081; GO:1903902	DGWICEK	9.520000458	1	1	0.217536645	907.8792183	15.9591	13.63089	16.02654	15.7229	14.20318	0	0	0	0	0	0	0	15.33363	14.47261	0	0	14.62304	15.6941	14.96549	0	0	15.42483	15.60501	0	0	0	14.7599	0	0	15.44359	16.41655	15.49809	0	0	0	16.33006	16.79255	0	0	0	0	0	0	14.91316	0	14.40361	0	16.51675
Q6UXG2	ELAP1_HUMAN	Endosome/lysosome-associated apoptosis and autophagy regulator 1 (Estrogen-induced gene 121 protein)	ELAPOR1 EIG121 KIAA1324 UNQ2426/PRO4985	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of vacuole organization [GO:0044090]	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of vacuole organization [GO:0044090]	RNA binding [GO:0003723]	GO:0000045; GO:0003723; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0009267; GO:0016021; GO:0031902; GO:0044090; GO:0070062; GO:2000786	IPEGESGFSK	1.730000019	0.3272641	0.3272641	0.06582226	1050.179803	0	0	15.53268	0	0	0	13.41587	16.11157	12.07367	15.99368	15.97872	16.00671	13.82749	0	0	13.79108	0	15.89713	16.52637	8.562593	15.2272	17.95484	0	18.12738	0	17.3046	0	16.88264	0	0	14.25672	14.45597	15.08871	17.75337	18.06039	0	0	17.27238	18.12736	14.13744	16.14081	0	16.37925	0	11.53864	16.54271	14.91386	14.13634
Q6UXH8	CCBE1_HUMAN	Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein homolog)	CCBE1 KIAA1983 UNQ1921/PRO4395	Homo sapiens (Human)	lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845]	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020]	GO:0001946; GO:0002020; GO:0002040; GO:0003016; GO:0005509; GO:0005518; GO:0005581; GO:0005615; GO:0010575; GO:0010595; GO:0010954; GO:0030324; GO:0031012; GO:0045766; GO:0048845; GO:1900748; GO:1901492	GSMGPMGPSPDLSHIK	4.96999979	1	1	0.262291167	1626.060299	13.22794	12.00204	0	0	10.64624	0	14.55571	15.38904	12.41357	12.27504	15.7435	9.380159	0	0	0	14.24597	0	0	0	0	0	0	13.51769	0	15.77919	15.43851	0	0	0	0	0	0	0	0	0	0	17.1067	0	15.74014	0	15.93964	0	0	0	0	0	0	0
Q6UXI7	VITRN_HUMAN	Vitrin	VIT UNQ647/PRO1277	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; glycosaminoglycan binding [GO:0005539]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510]	glycosaminoglycan binding [GO:0005539]	GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198; GO:0062023	TVLQFVTNLTK	1.350000024	1	1	0.212159887	1263.422676	0	0	15.98508	14.41382	0	13.18783	0	0	0	0	0	0	0	0	0	13.48902	0	0	15.43593	0	0	16.13658	0	0	0	0	15.89665	0	13.32087	14.0717	0	0	16.50104	15.02435	0	13.30628	0	0	0	0	16.13478	0	0	0	0	0	0	0
Q6UXI9	NPNT_HUMAN	Nephronectin (Preosteoblast EGF-like repeat protein with MAM domain) (Protein EGFL6-like)	NPNT EGFL6L POEM UNQ295/PRO334	Homo sapiens (Human)	branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to tumor necrosis factor [GO:0071356]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; pilomotor reflex [GO:0097195]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; ureteric bud development [GO:0001657]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; smooth muscle contractile fiber [GO:0030485]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; smooth muscle contractile fiber [GO:0030485]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to tumor necrosis factor [GO:0071356]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; pilomotor reflex [GO:0097195]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; ureteric bud development [GO:0001657]	calcium ion binding [GO:0005509]; integrin binding [GO:0005178]	GO:0001657; GO:0001658; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0007160; GO:0010694; GO:0010811; GO:0016020; GO:0030198; GO:0030485; GO:0030511; GO:0033631; GO:0045184; GO:0045669; GO:0045987; GO:0062023; GO:0070062; GO:0070374; GO:0071356; GO:0097195; GO:2000721	QTQITLR	12.09000015	1	1	1.16E-13	859.8465158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.73318	0	0	0	0	17.0218	0	0	0	0	0	0	0	0	17.99565	0	0	0	17.11909	0	0	0	0	16.16434	0	0	0	0
Q6UXK2	ISLR2_HUMAN	Immunoglobulin superfamily containing leucine-rich repeat protein 2 (Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein)	ISLR2 KIAA1465 LINX UNQ1885/PRO4329	Homo sapiens (Human)	positive regulation of axon extension [GO:0045773]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; positive regulation of axon extension [GO:0045773]		GO:0005886; GO:0009986; GO:0016021; GO:0045773	HAPGAGGEPDGQAPTSERK	2.940000057	1	1	0.21759267	1858.416573	15.91628	11.59664	15.13503	0	0	0	0	0	0	15.90016	0	0	0	0	0	14.31215	8.723572	0	15.86883	0	0	15.86269	0	0	0	15.57082	15.81801	0	14.60505	12.79835	0	17.17542	0	0	0	16.74127	0	0	0	12.4435	0	0	15.72133	0	0	15.85508	13.45238	0
Q6UXM1	LRIG3_HUMAN	"Leucine-rich repeats and immunoglobulin-like domains protein 3, LIG-3"	LRIG3 LIG3 UNQ287/PRO326/PRO335	Homo sapiens (Human)	otolith morphogenesis [GO:0032474]	cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474]		GO:0005615; GO:0005886; GO:0016021; GO:0030659; GO:0031012; GO:0032474	DNELLHDAEMENYAHLR	3.819999933	1	1	1.38E-12	2069.637453	14.59246	0	0	0	0	0	0	11.12028	0	0	0	0	0	0	0	11.42122	0	0	14.52832	0	16.04659	0	0	0	0	13.0373	0	0	0	0	0	0	0	0	0	0	14.66814	0	0	0	13.5237	0	0	0	0	0	0	0
Q6UXN2	TRML4_HUMAN	"Trem-like transcript 4 protein, TLT-4 (Triggering receptor expressed on myeloid cells-like protein 4)"	TREML4 TLT4 UNQ9425/PRO34675	Homo sapiens (Human)	innate immune response [GO:0045087]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]	cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; innate immune response [GO:0045087]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]	signaling receptor activity [GO:0038023]	GO:0005576; GO:0005886; GO:0009986; GO:0034157; GO:0038023; GO:0045087	APACLGSGGPR	5.210000038	1	1	0	1040.506001	0	0	14.47176	0	14.13525	14.88395	0	0	13.38194	13.67788	14.15469	12.5581	0	13.64983	0	14.50287	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.74182	16.22625	0	0	0	0	0	0	0
Q6UXP9	YO001_HUMAN	Putative uncharacterized protein UNQ9370/PRO34162	UNQ9370/PRO34162	Homo sapiens (Human)						AGSNR	2.339999914	1	1	0.223352562	504.6031493	0	17.01043	14.95847	15.38553	15.73464	0	15.77043	16.85379	0	0	0	0	0	0	0	0	15.66859	0	0	0	0	0	0	0	15.82163	0	0	0	16.51459	0	0	0	0	16.929	0	17.25961	16.54092	19.5383	0	0	0	0	0	15.70084	0	0	0	0
Q6UXR4	SPA13_HUMAN	Putative serpin A13	SERPINA13P SERPINA13 UNQ6121/PRO20043	Homo sapiens (Human)	negative regulation of endopeptidase activity [GO:0010951]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615; GO:0010951	EKASHR	5.579999924	1	1	0.036907552	727.1874589	0	0	0	0	0	15.2821	0	0	0	0	0	0	0	0	0	14.21127	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.72662	15.46324	0	0	0	0	0	0	0	0	0	15.03048	0	0	0
Q6UXV0	GFRAL_HUMAN	GDNF family receptor alpha-like	GFRAL C6orf144 UNQ9356/PRO34128	Homo sapiens (Human)	glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; stress-activated protein kinase signaling cascade [GO:0031098]	actin cytoskeleton [GO:0015629]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	actin cytoskeleton [GO:0015629]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; stress-activated protein kinase signaling cascade [GO:0031098]	glial cell-derived neurotrophic factor receptor activity [GO:0016167]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]	GO:0002023; GO:0005654; GO:0005886; GO:0005925; GO:0007399; GO:0009897; GO:0015629; GO:0016021; GO:0016167; GO:0030971; GO:0031098; GO:0035860; GO:0038023; GO:0043235; GO:0043410; GO:0043524; GO:0051897; GO:2001240	DPSSIQIPGEL	10.47000027	0.344974816	0.344974816	0.115473179	1158.325095	17.28708	15.02211	0	11.56284	14.84174	14.2877	0	17.41162	13.8271	12.31008	15.3992	0	15.92433	0	14.55821	16.21655	0	14.69722	14.62675	14.75682	12.92593	0	17.17676	16.60139	19.05237	15.32489	14.57135	15.34853	17.27974	14.16215	16.36568	16.60965	12.08653	13.18341	17.19616	0	17.14488	16.46857	15.05994	14.98451	13.71411	15.99649	15.75705	12.80115	0	16.86244	13.83495	0
Q6UXV1	IZUM2_HUMAN	Izumo sperm-egg fusion protein 2	IZUMO2 C19orf41 SCRL UNQ6978/PRO21961	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	AGAVLMGMEGPFFR	6.380000114	1	1	0.416480544	1513.923853	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.26886	0	0	0	0	0	0	0	0	0	0	18.43375	0	0	0	0	0	0	0	18.82049	0	0	0	0	0
Q6UXX5	ITIH6_HUMAN	"Inter-alpha-trypsin inhibitor heavy chain H6 (Inter-alpha-trypsin inhibitor heavy chain H5-like protein, Inter-alpha inhibitor H5-like protein)"	ITIH6 ITIH5L UNQ6369/PRO21074	Homo sapiens (Human)	hyaluronan metabolic process [GO:0030212]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0030212	HQGQYQLVVSLRPGQLVK	4.269999981	1	1	1.83E-12	2051.277103	0	14.90664	12.18171	0	0	0	0	14.95438	0	0	0	0	0	0	0	0	0	0	0	0	0	16.44507	0	16.10446	0	0	13.95591	15.91937	15.64807	14.7337	0	0	14.75212	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UXY1	BI2L2_HUMAN	"Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2, BAI1-associated protein 2-like protein 2 (Planar intestinal- and kidney-specific BAR domain protein, Pinkbar)"	BAIAP2L2 UNQ9336/PRO34007	Homo sapiens (Human)	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]	cell-cell contact zone [GO:0044291]; clathrin complex [GO:0071439]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	cell-cell contact zone [GO:0044291]; clathrin complex [GO:0071439]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; phospholipid binding [GO:0005543]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]	phospholipid binding [GO:0005543]	GO:0005543; GO:0005654; GO:0005829; GO:0005886; GO:0007009; GO:0012506; GO:0030659; GO:0030838; GO:0044291; GO:0051017; GO:0051764; GO:0061024; GO:0071439; GO:2000251	LHAQMQAFVSESQR	2.130000114	1	1	0.124038748	1647.64033	15.50357	0	0	0	13.73621	0	0	13.48193	0	0	0	0	0	0	0	0	0	14.27334	0	0	0	0	0	0	0	0	0	0	0	0	0	16.21372	15.57427	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UXY8	TMC5_HUMAN	Transmembrane channel-like protein 5	TMC5 UNQ8238/PRO33604	Homo sapiens (Human)		extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381]	mechanosensitive ion channel activity [GO:0008381]	GO:0005887; GO:0008381; GO:0070062	ANLNHPGSR	3.930000067	1	1	3.47E-13	967.2095042	16.46292	14.60819	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.55202	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6UXZ4	UNC5D_HUMAN	Netrin receptor UNC5D (Protein unc-5 homolog 4) (Protein unc-5 homolog D)	UNC5D KIAA1777 UNC5H4 UNQ6012/PRO34692	Homo sapiens (Human)	apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222]	netrin receptor activity [GO:0005042]	GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0009986; GO:0016021; GO:0021859; GO:0098742; GO:2001222	LSDSGNYTCMAANIVAK	3.640000105	1	1	0.159522808	1830.768813	0	15.02233	0	0	0	15.31939	0	14.2191	0	0	0	0	13.07308	0	0	13.7661	14.59892	13.26552	14.66612	12.95097	0	0	0	12.75296	13.20631	0	0	15.3369	13.90151	0	0	0	14.85156	13.7085	0	13.00255	0	0	0	0	0	0	0	0	0	0	0	0
Q6UY01	LRC31_HUMAN	Leucine-rich repeat-containing protein 31	LRRC31 UNQ9367/PRO34156	Homo sapiens (Human)						VGGNLPLILQKFQK	8.029999733	0.441472054	0.441472054	0.167557314	1555.526993	14.49148	15.98099	14.42824	0	14.52463	12.73474	0	0	14.98892	0	0	0	11.342	0	0	13.86418	14.81069	14.78468	15.73926	14.61683	0	0	0	0	16.11815	14.81258	13.76407	0	16.64421	0	16.39961	14.9369	15.05258	0	0	0	16.07936	16.14441	0	15.62728	14.04	0	0	0	0	0	0	0
Q6UY18	LIGO4_HUMAN	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 (Leucine-rich repeat neuronal protein 6D)	LINGO4 LRRN6D UNQ9248/PRO34002	Homo sapiens (Human)		extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]		GO:0005615; GO:0016021; GO:0031012	MDAATAPK	7.309999943	1	1	1.14E-13	803.3255192	15.43186	0	15.02045	0	15.58415	0	14.98785	0	15.36255	15.14172	0	0	0	14.42053	0	0	15.85488	0	0	14.51147	16.10784	0	0	0	0	12.93135	0	0	0	0	12.6901	0	0	0	0	0	0	0	0	0	0	0	13.93894	0	0	0	0	0
Q6UYE1	LEU7_HUMAN	Leukemia-associated protein 7 (Deleted in lymphocytic leukemia 7)	DLEU7 LEU7	Homo sapiens (Human)						DPDHVSTAPAR	3.960000038	1	1	0.596911895	1164.874436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.70004	0	0	0	0	0	0	0	0	0	0	0	0	16.37992	0	0	0	0	0	0	0
Q6V0I7	FAT4_HUMAN	"Protocadherin Fat 4, hFat4 (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)"	FAT4 CDHF14 FATJ Nbla00548	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609	HTGIIQTAAILDR	9.590000153	1	1	0.094579144	1407.616956	16.55875	14.48831	14.29705	0	13.65273	14.60173	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.87312	16.89718	15.69389	0	0	0	0	0	0	0	0	0	14.49553	0	16.78787	0	0	0	0	0	0	15.38319	0	17.44599	0
Q6V1X1	DPP8_HUMAN	"Dipeptidyl peptidase 8, DP8, EC 3.4.14.5 (Dipeptidyl peptidase IV-related protein 1, DPRP-1) (Dipeptidyl peptidase VIII, DPP VIII) (Prolyl dipeptidase DPP8)"	DPP8 DPRP1 MSTP097 MSTP135 MSTP141	Homo sapiens (Human)	apoptotic process [GO:0006915]; immune response [GO:0006955]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; immune response [GO:0006955]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006955; GO:0008236; GO:0008239	FEGAFKYK	8.06000042	0.791704237	0.791704237	0.213510133	988.4498157	0	0	12.69952	16.59276	18.84229	15.30196	17.11765	12.51983	0	0	0	0	14.98983	13.4579	0	14.40788	13.33821	0	0	0	16.09031	0	0	15.73011	14.46538	0	0	0	0	17.03609	14.32922	0	0	16.06605	16.55513	0	0	15.38596	0	14.65441	0	0	0	16.35468	0	0	14.37807	0
Q6VEQ5	WASH2_HUMAN	WAS protein family homolog 2 (CXYorf1-like protein on chromosome 2) (Protein FAM39B)	WASH2P FAM39B	Homo sapiens (Human)	"Arp2/3 complex-mediated actin nucleation [GO:0034314]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]"	autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]	"autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]"	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]	GO:0003779; GO:0005769; GO:0005770; GO:0005776; GO:0005814; GO:0005829; GO:0006887; GO:0015031; GO:0016197; GO:0031901; GO:0032456; GO:0034314; GO:0034315; GO:0042147; GO:0043014; GO:0043015; GO:0055037; GO:0055038; GO:0071203	LQEYGSIFTGAQDPGLQR	2.25999999	0.276869595	0.276869595	0.181260511	1979.555144	0	0	11.04852	15.33091	0	0	0	0	0	0	0	0	17.96926	0	0	14.75757	15.76549	0	0	0	17.41991	0	0	14.68451	0	0	18.23936	0	0	0	0	16.31679	0	17.27872	0	15.80052	0	0	0	0	0	0	0	0	0	0	0	0
Q6VUC0	AP2E_HUMAN	"Transcription factor AP-2-epsilon, AP2-epsilon (Activating enhancer-binding protein 2-epsilon)"	TFAP2E	Homo sapiens (Human)	anatomical structure development [GO:0048856]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0042127; GO:0042802; GO:0048856; GO:1990837	ALGLDPR	5.420000076	0.771043003	0.771043003	0.250456209	742.5971702	15.49367	16.13576	15.57315	0	18.49169	0	17.50511	0	0	0	0	0	18.14687	16.54368	0	0	0	0	0	17.4035	0	0	0	0	0	0	0	0	0	0	0	0	18.59527	0	0	0	0	0	18.15725	0	0	0	0	0	0	0	0	0
Q6VY07	PACS1_HUMAN	"Phosphofurin acidic cluster sorting protein 1, PACS-1"	PACS1 KIAA1175	Homo sapiens (Human)	protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]	COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; transmembrane transporter binding [GO:0044325]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]	transmembrane transporter binding [GO:0044325]	GO:0005794; GO:0005829; GO:0030137; GO:0034067; GO:0044325; GO:0072659	MAERGGAGGGPGGAGGGSGQR	7.550000191	1	1	0.110088968	1742.918798	13.89795	0	0	0	16.01516	15.23173	0	0	0	0	0	0	14.75176	11.20905	15.16807	0	0	0	15.2619	0	0	13.39062	0	15.98876	0	14.90061	0	0	0	15.91555	15.76119	0	14.35631	0	0	0	15.25952	13.21536	13.10089	0	15.11453	0	0	0	0	0	0	0
Q6W2J9	BCOR_HUMAN	"BCL-6 corepressor, BCoR"	BCOR KIAA1575	Homo sapiens (Human)	"blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]"	BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]"	DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000415; GO:0000976; GO:0000977; GO:0001835; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007507; GO:0030502; GO:0031072; GO:0035518; GO:0042476; GO:0042826; GO:0045892; GO:0051572; GO:0060021; GO:0065001; GO:0070171; GO:0140261; GO:0140297	DGSSPPLLEK	5.920000076	1	1	0.302925254	1041.459872	0	0	0	0	18.75028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.44971	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6W3E5	GDPD4_HUMAN	"Glycerophosphodiester phosphodiesterase domain-containing protein 4, EC 3.1.-.- (Glycerophosphodiester phosphodiesterase 6) (UgpQ)"	GDPD4 GDE6 UGPQ	Homo sapiens (Human)	lipid metabolic process [GO:0006629]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]	glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]	GO:0006629; GO:0008889; GO:0016020; GO:0016021; GO:0046872	NAVTPLKPGK	4.119999886	0.546487808	0.546487808	0.228658725	1022.277991	14.45132	13.96698	0	0	14.79698	14.84342	0	13.85988	15.34997	13.75074	0	11.68529	0	14.43869	0	0	15.60049	14.255	0	0	0	12.6632	14.85905	0	0	14.2078	0	15.10999	15.05959	13.73691	13.68987	0	0	12.25804	15.28517	13.80485	0	0	16.04646	0	0	0	0	12.96089	0	16.21065	12.74347	14.31713
Q6WCQ1	MPRIP_HUMAN	"Myosin phosphatase Rho-interacting protein, M-RIP (Rho-interacting protein 3, RIP3) (p116Rip)"	MPRIP KIAA0864 MRIP RHOIP3	Homo sapiens (Human)	actin filament organization [GO:0007015]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin filament organization [GO:0007015]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]	GO:0005829; GO:0005925; GO:0007015; GO:0015629; GO:0045296; GO:0051015	AETKEIVSGWLEMLMVYPR	6.579999924	1	1	0.098141806	2263.758386	0	0	0	0	0	12.64372	0	0	0	0	0	0	15.28016	0	16.4846	0	15.36825	13.73495	0	14.988	16.62605	15.27312	13.63401	0	15.41032	15.34872	0	0	0	13.75702	0	15.17296	0	0	14.44021	0	0	0	0	0	17.62498	16.27159	0	0	0	18.48013	0	16.189
Q6WKZ4	RFIP1_HUMAN	"Rab11 family-interacting protein 1, Rab11-FIP1 (Rab-coupling protein)"	RAB11FIP1 RCP	Homo sapiens (Human)	negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; small GTPase binding [GO:0031267]; negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]	small GTPase binding [GO:0031267]	GO:0005829; GO:0015031; GO:0030670; GO:0031267; GO:0043231; GO:0045055; GO:0055037; GO:0070164	HLFSSTENLAAGSWKEPAEGGGLSSDR	4.5	1	1	0.146875742	2803.855125	11.53757	15.70844	12.73258	0	14.95162	14.29889	0	14.51153	12.97294	11.90201	14.11833	10.69358	11.43251	0	0	15.60289	0	11.81742	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.9461	0	0	0	0	0	0
Q6WRI0	IGS10_HUMAN	"Immunoglobulin superfamily member 10, IgSF10 (Calvaria mechanical force protein 608, CMF608)"	IGSF10 CMF608	Homo sapiens (Human)	cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222]		GO:0001503; GO:0005576; GO:0030154; GO:2001222	GSSEK	4.449999809	1.70E-05	1.70E-05	0.275812567	506.0839762	0	0	16.38748	0	17.52319	18.20059	0	18.51494	0	0	16.86442	16.70251	18.18683	18.40617	17.46915	0	18.71647	19.02491	18.69774	0	17.77015	19.32516	0	0	0	0	0	18.90374	0	18.7832	0	0	20.43825	19.34698	0	19.49708	0	19.27006	0	18.14378	17.32632	0	0	18.9945	17.80961	18.89889	19.57865	15.813
Q6XPR3	RPTN_HUMAN	Repetin	RPTN	Homo sapiens (Human)		cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular region [GO:0005576]	cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	GO:0001533; GO:0005509; GO:0005576; GO:0005829; GO:0046914	AQLLNSILSVIDVFHKYAK	6.170000076	1	1	0.671277068	2159.71998	0	0	0	0	0	0	18.75612	0	0	0	0	0	0	0	0	0	0	0	16.65285	0	18.75894	0	0	0	0	0	17.53175	0	0	0	0	0	0	0	0	0	0	22.59741	0	0	0	0	0	0	0	0	0	0
Q6XPS3	TPTE2_HUMAN	"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2, EC 3.1.3.67 (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)"	TPTE2 TPIP	Homo sapiens (Human)	cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; protein tyrosine phosphatase activity [GO:0004725]; cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896]"	"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0000139; GO:0004725; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008285; GO:0014065; GO:0016021; GO:0016311; GO:0016314; GO:0042995; GO:0046856; GO:0048870; GO:0051800; GO:0051896	VQVVMEK	9.590000153	1	1	0.164963967	844.6695348	0	0	0	0	0	0	0	0	0	0	18.2625	0	0	0	0	0	0	0	0	0	0	18.29497	0	0	0	18.61324	0	0	0	0	20.56726	0	0	0	0	18.31793	20.56922	0	0	0	0	0	0	0	0	0	0	0
Q6XUX3	DUSTY_HUMAN	"Dual serine/threonine and tyrosine protein kinase, EC 2.7.12.1 (Dusty protein kinase, Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496, SgK496)"	DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P	Homo sapiens (Human)	cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0030054; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070374; GO:0106310	CSHNHTCLSSLTGGGGAER	2.519999981	0.979844928	0.979844928	0.238580321	2001.364792	15.62529	11.92363	14.11884	0	13.7078	14.38886	11.57501	13.81629	0	15.20715	14.89463	0	0	0	0	0	0	0	14.53176	0	0	0	15.64216	0	10.36578	13.12017	16.4549	0	0	0	0	0	0	0	0	0	15.54572	0	0	15.04076	0	0	0	0	0	0	0	0
Q6XYB7	LBX2_HUMAN	Transcription factor LBX2 (Ladybird homeobox 2) (Ladybird homeobox protein homolog 2)	LBX2 LP3727	Homo sapiens (Human)	muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000981; GO:0005634; GO:0006357; GO:0042692; GO:1904105; GO:1990837; GO:2000052	DGLATR	10.57999992	1	1	0.232744281	632.6772229	16.43287	17.81182	0	14.74766	15.27058	0	0	16.11497	15.95339	15.40515	16.21359	16.92778	14.87104	16.31395	15.03147	16.7324	17.08116	16.68543	16.15167	15.17891	17.27275	18.23389	16.26904	15.40177	18.99784	15.39341	14.88395	11.64417	15.59412	15.73112	16.20026	16.20394	17.88219	16.59785	17.95115	16.71704	16.37959	17.50385	16.86443	16.2013	17.47345	17.72055	16.75053	16.89709	16.44775	17.37976	15.39257	0
Q6XZB0	LIPI_HUMAN	"Lipase member I, LIPI, EC 3.1.1.- (Cancer/testis antigen 17, CT17) (LPD lipase) (Membrane-associated phosphatidic acid-selective phospholipase A1-beta, mPA-PLA1 beta)"	LIPI LPDL PRED5	Homo sapiens (Human)	fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; triglyceride catabolic process [GO:0019433]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase activity [GO:0004620]; fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; triglyceride catabolic process [GO:0019433]	heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase activity [GO:0004620]	GO:0004465; GO:0004620; GO:0005615; GO:0005886; GO:0006633; GO:0006654; GO:0008201; GO:0016042; GO:0016298; GO:0019433	LYEKNKPFYK	9.649999619	0.837644398	0.837644398	0.366161318	1329.725496	11.56434	14.92938	15.80241	0	0	15.03545	0	0	14.06702	0	0	0	0	0	0	0	0	14.38657	0	16.23441	15.83991	0	0	0	0	0	15.96276	15.65062	14.92272	0	14.35821	15.25375	11.41867	14.98037	15.941	15.1947	0	0	15.54045	0	0	16.35937	16.45747	0	16.19731	0	15.41404	15.44533
Q6XZF7	DNMBP_HUMAN	Dynamin-binding protein (Scaffold protein Tuba)	DNMBP ARHGEF36 KIAA1010 TUBA	Homo sapiens (Human)	aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]	cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005794; GO:0005795; GO:0005829; GO:0005856; GO:0005911; GO:0007568; GO:0008360; GO:0035556; GO:0045202; GO:0051056; GO:0098793	EMTLLSSQSSSLVAPSGSVSAENPEQR	2.609999895	0.999980748	0.999980748	0.02013646	2791.620063	15.85518	0	0	0	13.99978	16.73124	15.36292	0	14.21468	14.25227	14.53817	14.15942	0	15.37962	0	0	0	0	0	0	14.54696	0	14.57564	0	11.04031	15.1067	0	13.39855	0	14.60747	0	0	0	0	13.79071	0	0	15.44457	0	0	14.04686	0	0	14.9244	12.17417	0	15.38848	15.39377
Q6Y2X3	DJC14_HUMAN	"DnaJ homolog subfamily C member 14 (DnaJ protein homolog 3) (Dopamine receptor-interacting protein of 78 kDa, DRIP78) (Human DnaJ protein 3, hDj-3)"	DNAJC14 DRIP78 HDJ3	Homo sapiens (Human)	protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein transport [GO:0015031]		GO:0005789; GO:0015031; GO:0016020; GO:0016021	VSSGK	6.25	0.75527513	0.75527513	0.114570722	476.3494365	19.88541	15.39395	18.23203	19.47218	18.59406	19.54048	18.19934	19.07242	19.17399	17.83376	0	17.87159	18.86889	0	18.11916	0	19.95098	0	19.49607	19.61438	18.88979	19.96566	19.47626	19.82408	19.51436	19.72345	17.33669	19.38234	17.0302	19.3711	17.73658	19.09253	18.42495	19.30035	19.65263	20.01072	19.19575	0	19.06137	19.43703	18.54702	19.42544	18.94615	18.06308	20.47588	19.24813	19.92913	19.78106
Q6YN16	HSDL2_HUMAN	"Hydroxysteroid dehydrogenase-like protein 2, EC 1.-.-.- (Short chain dehydrogenase/reductase family 13C member 1)"	HSDL2 C9orf99 SDR13C1	Homo sapiens (Human)		membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]	oxidoreductase activity [GO:0016491]	GO:0005739; GO:0005777; GO:0016020; GO:0016491	LMNQMNAR	4.650000095	1	1	0.190029415	1009.465513	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.99229	19.1514	0	0	0	0	0	0	0	0	0	0
Q6YP21	KAT3_HUMAN	"Kynurenine--oxoglutarate transaminase 3, EC 2.6.1.7 (Cysteine-S-conjugate beta-lyase 2, EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III, KATIII) (Kynurenine--glyoxylate transaminase, EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III)"	KYAT3 CCBL2 KAT3	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053]	cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189; GO:0097053	DSTLDAAEEIIK	8.109999657	1	1	0.259657368	1304.6522	16.4563	15.13202	15.05812	0	0	14.68768	16.0029	15.86721	15.48975	15.84695	0	14.69665	0	0	0	14.87259	0	0	14.4478	0	0	0	13.19046	0	0	14.67194	0	17.31127	14.17721	13.45207	0	15.95776	0	0	0	0	0	0	0	15.31239	15.43074	0	17.18439	0	0	0	0	16.42661
Q6ZMH5	S39A5_HUMAN	"Zinc transporter ZIP5 (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5, ZIP-5)"	SLC39A5 ZIP5	Homo sapiens (Human)	"BMP signaling pathway [GO:0030509]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; eye development [GO:0001654]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neural precursor cell proliferation [GO:0061351]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; zinc ion import across plasma membrane [GO:0071578]"	basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	"basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; BMP signaling pathway [GO:0030509]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; eye development [GO:0001654]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neural precursor cell proliferation [GO:0061351]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; zinc ion import across plasma membrane [GO:0071578]"	zinc ion transmembrane transporter activity [GO:0005385]	GO:0001654; GO:0005385; GO:0005887; GO:0006882; GO:0016323; GO:0030509; GO:0034224; GO:0048026; GO:0061351; GO:0070062; GO:0070315; GO:0071578	LGQHGPLTGR	5.610000134	1	1	0.202727813	1036.514287	0	18.6214	0	18.04491	0	0	18.18083	17.50788	17.63156	0	0	20.19158	0	17.93926	0	0	16.45391	0	16.0226	0	0	0	0	18.27463	17.98511	0	19.58295	0	0	0	18.5331	18.29679	18.9081	17.81596	0	0	0	0	19.19103	17.99221	0	17.62256	16.86606	17.5131	0	17.8938	0	16.74514
Q6ZMI0	PPR21_HUMAN	Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1)	PPP1R21 CCDC128 KLRAQ1	Homo sapiens (Human)		early endosome [GO:0005769]; membrane [GO:0016020]	early endosome [GO:0005769]; membrane [GO:0016020]		GO:0005769; GO:0016020	EALTEEMK	1.070000052	1	1	0.179231956	967.4810407	0	0	14.30791	11.58116	14.84433	0	14.41224	0	0	0	0	0	0	0	0	0	11.71068	15.98741	16.04863	0	13.73386	15.64382	0	0	0	0	13.74931	13.88608	14.94879	0	15.55265	0	15.10612	0	0	0	0	0	0	0	15.43898	0	0	0	0	0	0	0
Q6ZMI3	GLDN_HUMAN	Gliomedin [Cleaved into: Gliomedin shedded ectodomain ]	GLDN COLM UNQ9339/PRO34011	Homo sapiens (Human)	clustering of voltage-gated sodium channels [GO:0045162]; microvillus organization [GO:0032528]; signal transduction [GO:0007165]	axon [GO:0030424]; cell surface [GO:0009986]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	axon [GO:0030424]; cell surface [GO:0009986]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; clustering of voltage-gated sodium channels [GO:0045162]; microvillus organization [GO:0032528]; signal transduction [GO:0007165]	protein binding involved in heterotypic cell-cell adhesion [GO:0086080]	GO:0005581; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0016021; GO:0030424; GO:0032528; GO:0045162; GO:0086080	GGSNTLVR	5.539999962	0.969047904	0.969047904	0.230310853	804.0435335	0	18.23165	16.81208	0	0	0	0	0	0	0	19.90372	0	0	17.71589	0	0	0	0	18.35584	0	0	0	0	17.53105	0	0	0	17.26346	0	0	0	0	0	0	19.61825	0	0	0	0	0	18.35658	0	17.79231	0	0	0	0	0
Q6ZMJ2	SCAR5_HUMAN	Scavenger receptor class A member 5 (Scavenger receptor hlg)	SCARA5 UNQ2938/PRO28700	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; cellular response to heat [GO:0034605]; endocytosis [GO:0006897]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; ferritin receptor activity [GO:0070287]; scavenger receptor activity [GO:0005044]; cellular iron ion homeostasis [GO:0006879]; cellular response to heat [GO:0034605]; endocytosis [GO:0006897]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207]	ferritin receptor activity [GO:0070287]; scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005887; GO:0006879; GO:0006897; GO:0009897; GO:0034605; GO:0034755; GO:0070207; GO:0070287	FGQGTGR	11.43999958	0.988149881	0.988149881	0.16306197	724.3357967	15.53252	14.12286	0	14.24412	0	0	0	13.58724	14.76769	15.97935	0	0	13.29537	0	16.87322	0	0	16.25792	0	0	0	16.18153	16.55386	17.05498	17.42308	15.95772	16.59417	14.08924	0	14.35392	14.19779	16.35894	16.96027	0	15.58999	17.71916	15.58698	15.73068	15.63873	15.68828	15.84945	15.41197	16.37968	0	16.29956	0	16.04126	15.45748
Q6ZMJ4	IL34_HUMAN	"Interleukin-34, IL-34"	IL34 C16orf77	Homo sapiens (Human)	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-34-mediated signaling pathway [GO:0061514]; microglial cell proliferation [GO:0061518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-34-mediated signaling pathway [GO:0061514]; microglial cell proliferation [GO:0061518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]	GO:0001934; GO:0005125; GO:0005157; GO:0005576; GO:0005615; GO:0006954; GO:0008083; GO:0008284; GO:0010628; GO:0010759; GO:0042802; GO:0043406; GO:0045087; GO:0045651; GO:0045657; GO:0048714; GO:0061098; GO:0061514; GO:0061518; GO:0120041	AQGEGLLP	1.75999999	1	1	0.1997302	784.6670286	12.25625	15.0568	16.14116	15.44788	14.29137	12.0634	15.88301	15.55599	15.09626	14.32722	15.03689	0	0	0	16.37828	15.30198	0	0	0	0	0	0	0	0	0	0	0	0	0	15.79369	0	16.87126	0	0	16.07307	16.08935	0	0	16.61503	0	0	0	0	14.57042	0	0	0	14.83204
Q6ZMP0	THSD4_HUMAN	"Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6, ADAMTS-like protein 6, ADAMTSL-6)"	THSD4 UNQ9334/PRO34005	Homo sapiens (Human)	elastic fiber assembly [GO:0048251]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]; hydrolase activity [GO:0016787]; elastic fiber assembly [GO:0048251]	hydrolase activity [GO:0016787]	GO:0001527; GO:0016787; GO:0048251; GO:0062023; GO:0070062	GGQRPGAPAR	3.140000105	1	1	0.225362205	966.0910417	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41303	0	0	0	0	0	0	0	19.56046
Q6ZMS4	ZN852_HUMAN	Zinc finger protein 852	ZNF852	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	NMMESSELTPK	7.460000038	0.851217747	0.851217747	0.475945268	1283.619266	0	0	0	0	15.03548	15.58706	0	14.55075	0	0	0	0	0	0	0	15.78171	13.80298	0	15.15326	0	16.96557	0	0	0	14.14773	0	16.01922	0	0	0	15.179	16.25313	14.57775	16.9112	17.39978	16.4164	18.53027	0	0	0	0	0	17.35078	16.88588	17.02922	16.71126	17.81105	17.08427
Q6ZMS7	ZN783_HUMAN	Zinc finger protein 783	ZNF783	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0042802	NRPGGPSR	11.31999969	1	1	0.26034785	837.2964795	19.37145	14.92237	0	0	0	0	18.9014	17.68141	19.57246	19.81334	18.40099	17.78484	18.71585	0	0	0	0	0	17.17703	0	17.99417	0	0	0	17.51092	0	0	0	0	0	0	0	19.47417	18.37764	0	0	18.7757	0	18.71913	0	18.96354	0	0	18.16187	19.5661	0	0	0
Q6ZMT1	STAC2_HUMAN	SH3 and cysteine-rich domain-containing protein 2 (24b2/STAC2) (Src homology 3 and cysteine-rich domain-containing protein 2)	STAC2	Homo sapiens (Human)	positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]; metal ion binding [GO:0046872]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]	metal ion binding [GO:0046872]	GO:0003009; GO:0005829; GO:0031234; GO:0042383; GO:0046872; GO:1901387; GO:1903078	ENEPDDAATHSPPGTVSALQETK	1.320000052	1	1	2.74E-12	2393.046594	13.33499	13.24389	0	12.20123	11.53032	0	0	0	15.46464	15.1699	0	0	12.11878	0	0	0	12.42504	15.48958	0	12.65614	0	0	12.20378	0	0	0	11.39095	0	0	0	0	14.18455	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZMT4	KDM7A_HUMAN	"Lysine-specific demethylase 7A (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7) ([histone H3]-dimethyl-L-lysine9 demethylase 7A, EC 1.14.11.65)"	KDM7A JHDM1D KDM7 KIAA1718	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]"	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0008270; GO:0016706; GO:0030901; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0051864; GO:0070544; GO:0071557; GO:0071558; GO:0140683	NLLETLKELR	4.539999962	1	1	0.449147815	1229.621787	19.15606	17.82323	17.96379	0	0	0	18.00679	17.2826	19.11306	0	17.53553	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.34624	0	0	0	0	18.16497	0	19.05362	15.70194	17.3261	0	0	0	0	0	0	17.49058	16.93753	0	0	0	18.42563	0
Q6ZMT9	DTHD1_HUMAN	Death domain-containing protein 1	DTHD1	Homo sapiens (Human)	signal transduction [GO:0007165]		signal transduction [GO:0007165]		GO:0007165	GTCASVKVYK	8.130000114	1	1	0.370295066	1112.170986	0	0	0	0	0	0	0	0	0	0	0	17.4569	0	0	0	0	0	0	0	15.67446	16.79182	0	0	0	0	15.65838	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.87063	0	18.60455	0	0	0	0
Q6ZMV5	P4R3C_HUMAN	Protein PPP4R3C (SMEK homolog 3) (Serine/threonine-protein phosphatase 4 regulatory subunit 3C)	PPP4R3C PPP4R3CP SMEK3P	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470]	nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]	nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470]	protein phosphatase activator activity [GO:0072542]	GO:0005654; GO:0006470; GO:0006974; GO:0030289; GO:0072542	EDETSPK	13.81999969	1	1	0.224999546	805.5689811	13.7312	15.38124	15.26924	11.92994	12.56594	14.66236	15.66826	15.04517	0	15.54588	12.79998	15.97293	0	0	0	0	0	0	0	15.93852	0	15.83053	0	0	0	0	0	0	0	0	0	16.50715	0	14.62718	0	0	0	16.03622	15.23924	0	0	0	0	0	16.11145	18.47098	15.22183	0
Q6ZMV7	LEKR1_HUMAN	Protein LEKR1	LEKR1	Homo sapiens (Human)						AMEKEMK	5.46999979	1	1	2.30E-13	897.4407193	14.91072	0	0	12.89285	0	15.79099	0	0	0	0	0	0	0	15.33448	16.01661	13.60588	14.17546	0	0	14.99733	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZMV8	ZN730_HUMAN	Putative zinc finger protein 730	ZNF730	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	GALTFR	4.170000076	1	1	0.216947166	663.8245054	0	0	16.75937	0	0	0	0	0	0	0	0	12.51753	0	0	0	0	0	15.68414	0	0	0	19.19586	19.46737	19.69497	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6807	16.86986	16.47275	17.56417	0	0	0	0	0	0
Q6ZMV9	KIF6_HUMAN	Kinesin-like protein KIF6	KIF6 C6orf102	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887	LEVGADMR	22.95999908	1	1	0.266353557	905.6269997	0	17.95393	0	0	0	0	18.26311	0	0	18.00732	18.63911	18.85257	0	17.52856	0	0	0	0	0	17.57106	0	0	17.09691	0	17.60749	17.67107	18.12384	0	18.24765	17.59577	0	17.85389	0	0	18.09223	0	19.23143	17.97295	0	0	18.38266	0	0	0	0	17.47842	0	17.5672
Q6ZMW2	ZN782_HUMAN	Zinc finger protein 782	ZNF782	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	AHPGD	1.179999948	0.271086961	0.271086961	0.187922573	497.2735227	15.98213	16.7364	0	15.59683	15.74116	16.19472	14.47655	0	15.54762	16.5865	16.56359	15.85213	15.03318	14.04282	16.00668	16.51904	14.9955	15.82873	12.86346	15.64413	15.22059	15.67534	15.93473	13.14081	15.23112	10.55119	15.83676	13.54257	0	15.79852	14.83209	15.18852	14.84438	15.40745	15.52937	14.47514	0	0	0	16.92082	16.21165	0	15.45689	16.61504	16.20319	15.84148	15.52307	16.60115
Q6ZMY3	SPOC1_HUMAN	SPOC domain-containing protein 1	SPOCD1	Homo sapiens (Human)	"cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]"	chromosome [GO:0005694]; nucleus [GO:0005634]	"chromosome [GO:0005694]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]"		GO:0005634; GO:0005694; GO:0006306; GO:0006351; GO:0007283; GO:0010529; GO:0030154; GO:0031047	LVQALPTVIR	1.879999995	0.457767218	0.457767218	0.249042143	1110.925618	15.47276	0	0	12.89322	0	0	0	15.73653	13.27297	13.81524	15.9949	0	15.40205	13.53535	12.46087	0	0	15.67516	14.26071	16.10136	13.8124	13.09673	0	0	0	0	0	15.13545	15.52681	0	15.31881	0	0	0	0	14.9434	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZMZ3	SYNE3_HUMAN	"Nesprin-3 (KASH domain-containing protein 3, KASH3) (Nuclear envelope spectrin repeat protein 3)"	SYNE3 C14orf139 C14orf49 LINC00341	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; establishment of protein localization to membrane [GO:0090150]; nuclear migration [GO:0007097]; regulation of cell shape [GO:0008360]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; rough endoplasmic reticulum [GO:0005791]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; rough endoplasmic reticulum [GO:0005791]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; cytoskeleton organization [GO:0007010]; establishment of protein localization to membrane [GO:0090150]; nuclear migration [GO:0007097]; regulation of cell shape [GO:0008360]	actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]	GO:0005635; GO:0005640; GO:0005737; GO:0005791; GO:0007010; GO:0007097; GO:0008360; GO:0016020; GO:0016021; GO:0031965; GO:0034993; GO:0051015; GO:0090150; GO:0140444	MEVDSGK	1.269999981	1	1	0.187523824	779.0529084	14.03006	14.55278	0	0	0	14.33679	0	0	0	0	15.93755	15.15933	16.54176	0	0	15.06856	0	0	0	0	0	0	15.38752	15.15436	0	0	12.63075	15.5693	14.31814	0	16.19948	0	0	15.62217	14.80713	14.8499	15.43268	14.20698	15.60359	14.91496	0	0	0	0	0	14.15478	0	0
Q6ZN04	MEX3B_HUMAN	RNA-binding protein MEX3B (RING finger and KH domain-containing protein 3) (RING finger protein 195)	MEX3B KIAA2009 RKHD3 RNF195	Homo sapiens (Human)	protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	calcium ion binding [GO:0005509]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005509; GO:0005654; GO:0005829; GO:0006468; GO:0046777	KEDVAMAR	1.409999967	1	1	1.16E-13	936.1005313	0	0	16.37633	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.29703	0	0	0	0	0	0	13.33729	0	0	0	0	0	0	12.40666	0	15.13945	14.19002	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZN17	LN28B_HUMAN	"Protein lin-28 homolog B, Lin-28B"	LIN28B CSDD2	Homo sapiens (Human)	miRNA catabolic process [GO:0010587]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of primary miRNA processing [GO:2000635]; positive regulation of miRNA catabolic process [GO:2000627]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA destabilization [GO:0050779]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of primary miRNA processing [GO:2000635]; positive regulation of miRNA catabolic process [GO:2000627]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA destabilization [GO:0050779]	RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0008270; GO:0010587; GO:0031054; GO:0031123; GO:0050779; GO:1990837; GO:2000627; GO:2000632; GO:2000635	SPQEASSTK	5.269999981	1	1	0.252551318	934.4727222	17.78372	17.30377	17.38899	17.72744	0	0	17.02946	0	17.22	0	18.44346	17.88331	0	0	0	0	18.44079	18.60336	0	16.24532	0	18.05649	15.95818	0	17.35153	0	18.50425	0	17.16495	16.86428	18.25651	18.9515	18.48635	0	0	0	17.8253	0	0	17.56307	0	0	0	0	0	0	0	16.71247
Q6ZN19	ZN841_HUMAN	Zinc finger protein 841	ZNF841	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	VFSYYSCLAR	8.779999733	0.287344337	0.287344337	0.570676736	1265.543441	0	0	0	0	18.33156	0	0	0	0	0	0	0	0	17.13891	0	0	0	0	0	0	0	0	0	0	0	0	0	18.39185	0	17.85265	19.69151	18.73642	0	0	0	0	0	19.13866	0	0	17.42623	0	18.03236	0	0	0	0	0
Q6ZN28	MACC1_HUMAN	Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5)	MACC1	Homo sapiens (Human)	positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]	growth factor activity [GO:0008083]	GO:0005634; GO:0005737; GO:0005739; GO:0008083; GO:0045944; GO:0051781	IAQSMSEANLIDMEAGK	6.03000021	1	1	0.18734869	1822.93191	0	0	0	0	0	14.62397	0	13.96572	0	16.3367	0	0	0	0	0	0	0	0	0	0	13.78738	0	0	0	13.08323	17.47635	0	0	16.38726	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.53605
Q6ZN30	BNC2_HUMAN	Zinc finger protein basonuclin-2	BNC2	Homo sapiens (Human)	"endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; rDNA binding [GO:0000182]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]"	metal ion binding [GO:0046872]; rDNA binding [GO:0000182]	GO:0000182; GO:0000785; GO:0003416; GO:0005634; GO:0005654; GO:0006355; GO:0043586; GO:0046872; GO:0060021; GO:0060485	SSMPVK	3.74000001	1	1	0.158823882	662.0285147	0	0	0	0	0	0	0	0	0	0	16.70401	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.41265	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZN54	DEFI8_HUMAN	"Differentially expressed in FDCP 8 homolog, DEF-8"	DEF8	Homo sapiens (Human)	lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]		metal ion binding [GO:0046872]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]	metal ion binding [GO:0046872]	GO:0032418; GO:0045780; GO:0046872; GO:1900029	EAMEARLLLQLQDR	1.929999948	1	1	0.588171077	1702.117442	0	0	0	0	0	0	0	17.87071	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZN55	ZN574_HUMAN	Zinc finger protein 574	ZNF574	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	LQAHEAAHAAAGPGEVLAK	11.89999962	1	1	1.61E-12	1841.749596	17.29191	15.41738	0	11.93419	0	12.92878	13.56121	0	12.50117	0	0	14.6837	14.6678	13.91865	13.3923	13.84575	0	0	13.87975	12.73864	15.41817	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZN66	GBP6_HUMAN	"Guanylate-binding protein 6, EC 3.6.5.- (GTP-binding protein 6, GBP-6) (Guanine nucleotide-binding protein 6)"	GBP6	Homo sapiens (Human)	cellular response to interferon-gamma [GO:0071346]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]	cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]	cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0006955; GO:0031410; GO:0042742; GO:0042832; GO:0050830; GO:0070062; GO:0071346	IEQDYWQVPR	4.789999962	1	1	0.400071536	1333.493634	12.34773	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.54026	0	0	15.69221	0	0	0	16.17866	0	15.12734	0	0	14.44791	14.88549	15.13994	0	0	0	16.06053	0	16.803	0	16.44305	0	17.14915	15.66847	0	0	16.53778	0	0	0	0
Q6ZN84	CCD81_HUMAN	Coiled-coil domain-containing protein 81	CCDC81	Homo sapiens (Human)		centrosome [GO:0005813]; cytoplasm [GO:0005737]	centrosome [GO:0005813]; cytoplasm [GO:0005737]		GO:0005737; GO:0005813	EHLADRTAELER	2.130000114	1	1	0.33808538	1440.309549	14.3848	16.34142	0	0	0	0	0	0	0	0	0	0	0	0	0	16.01819	0	0	16.22533	0	17.56364	0	0	0	0	0	0	0	17.32249	0	0	14.2421	15.03777	15.91738	0	0	17.22061	0	16.26769	14.9726	16.99956	0	15.38977	16.07169	16.39536	14.05786	16.53552	17.17672
Q6ZN92	DUTL_HUMAN	"Putative inactive deoxyuridine 5'-triphosphate nucleotidohydrolase-like protein FLJ16323, dUTPase-like protein"		Homo sapiens (Human)	dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]		dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]	dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0004170; GO:0006226; GO:0046081	MPVIPALGEAK	5.710000038	0.987504363	0.987504363	0.238724375	1140.910696	0	0	0	0	0	15.15489	13.73746	0	0	0	0	0	0	0	0	16.02236	16.13251	16.13864	0	0	0	0	0	0	15.65603	0	0	0	0	0	17.04853	15.53795	0	0	0	0	14.12291	0	0	0	0	0	0	0	11.82625	0	0	0
Q6ZNA4	RN111_HUMAN	"E3 ubiquitin-protein ligase Arkadia, EC 2.3.2.27 (RING finger protein 111, hRNF111) (RING-type E3 ubiquitin transferase Arkadia)"	RNF111	Homo sapiens (Human)	"global genome nucleotide-excision repair [GO:0070911]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630]; global genome nucleotide-excision repair [GO:0070911]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]"	metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0007389; GO:0016567; GO:0016605; GO:0030511; GO:0030579; GO:0031398; GO:0032184; GO:0032991; GO:0045893; GO:0046332; GO:0046872; GO:0061630; GO:0070911	EVLARR	4.53000021	1	1	0.216326958	742.6326297	15.38414	15.66181	11.47904	15.73384	16.50628	14.60631	15.33285	17.11176	0	0	0	0	0	15.05389	0	0	0	0	0	0	0	15.23876	0	0	15.58572	14.88526	13.34185	0	14.97731	0	0	14.1928	0	0	0	14.87529	12.43778	0	0	0	15.29399	14.46276	16.81742	14.95922	0	0	0	0
Q6ZNA5	FRRS1_HUMAN	"Ferric-chelate reductase 1, EC 1.-.-.- (Stromal cell-derived receptor 2, SDR-2)"	FRRS1 SDFR2 SDR2	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]	integral component of membrane [GO:0016021]	"integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]; cellular iron ion homeostasis [GO:0006879]"	"metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]"	GO:0006879; GO:0016021; GO:0016722; GO:0046872	GFLLEAR	6.440000057	1	1	0.156893908	803.4904085	0	11.03274	0	12.10163	0	0	12.3059	0	12.67185	15.24376	12.70609	16.31647	0	0	15.21957	0	0	14.94321	16.0502	0	0	0	0	13.64825	0	14.73997	14.79501	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.07051	0	0
Q6ZNB6	NFXL1_HUMAN	"NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein, hOZFP)"	NFXL1 OZFP	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]	"chromatin [GO:0000785]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006355; GO:0008270; GO:0016020; GO:0016021	KITTADVNEK	10.14999962	0.937030971	0.937030971	0.166745901	1118.855991	0	15.73119	13.4548	0	13.28611	0	15.24537	14.38774	15.89131	0	15.61868	0	10.51893	16.11676	13.59138	13.59448	14.42321	14.95776	14.15452	14.58116	0	0	14.99854	14.77673	0	0	14.98255	14.86102	0	0	0	0	13.60324	0	0	0	12.23449	14.83661	15.83929	0	0	0	0	0	0	0	0	0
Q6ZNE9	RUFY4_HUMAN	RUN and FYVE domain-containing protein 4	RUFY4	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; cellular response to interleukin-4 [GO:0071353]; positive regulation of macroautophagy [GO:0016239]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; cellular response to interleukin-4 [GO:0071353]; positive regulation of macroautophagy [GO:0016239]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000045; GO:0005776; GO:0016239; GO:0031410; GO:0032266; GO:0046872; GO:0071353	EQEGELQALREQLSR	5.949999809	1	1	0.547402159	1785.170517	0	0	0	0	0	0	0	18.76529	0	17.19944	19.01527	0	0	0	0	18.66643	0	0	0	0	0	0	0	0	0	19.33578	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZNG1	ZN600_HUMAN	Zinc finger protein 600	ZNF600	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	STLESHKR	1.879999995	0.046104979	0.046104979	0.213126054	957.4649389	14.3922	14.67816	0	16.31802	16.39114	14.26418	0	0	15.52929	0	0	0	0	0	0	15.57854	15.34696	16.35687	15.65102	16.36901	15.26543	14.94419	0	16.13031	16.98499	0	16.67529	14.72159	16.16991	13.26001	15.57617	16.22253	16.5397	16.71991	14.75634	15.16774	14.96581	16.14425	14.74488	11.99363	0	0	14.76684	15.04108	15.53138	15.82453	16.30046	14.97716
Q6ZNG9	KRBA2_HUMAN	KRAB-A domain-containing protein 2	KRBA2	Homo sapiens (Human)	"DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]"		"nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]"	nucleic acid binding [GO:0003676]	GO:0003676; GO:0006355; GO:0015074	YHPGQSQGSLEGASR	7.099999905	1	1	0.500064173	1571.885067	0	0	0	0	0	0	0	0	0	0	0	17.7582	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.07748	0	0	0
Q6ZNI0	GCNT7_HUMAN	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7, EC 2.4.1.-"	GCNT7 C20orf105	Homo sapiens (Human)	protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; protein glycosylation [GO:0006486]	acetylglucosaminyltransferase activity [GO:0008375]	GO:0000139; GO:0006486; GO:0008375; GO:0016021	SGLVVR	3.220000029	0.714221954	0.714221954	0.146811862	630.0413954	15.36921	0	16.03163	14.68951	0	12.09084	13.42761	0	13.30351	19.21861	17.71853	16.89226	16.42257	0	0	0	16.38452	15.88396	14.41585	14.64788	14.83216	0	12.19012	15.94664	15.59192	16.61783	15.45549	15.91249	8.854975	14.83602	16.51988	16.42504	16.26769	0	15.27001	16.35806	0	14.35812	15.98771	16.59914	16.69357	0	0	14.82258	14.03326	0	0	0
Q6ZNJ1	NBEL2_HUMAN	Neurobeachin-like protein 2	NBEAL2 KIAA0540 UNQ253/PRO290	Homo sapiens (Human)	platelet formation [GO:0030220]; protein localization [GO:0008104]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; protein kinase binding [GO:0019901]; platelet formation [GO:0030220]; protein localization [GO:0008104]	protein kinase binding [GO:0019901]	GO:0005783; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0019901; GO:0030220; GO:0070821; GO:0101003	DVVNCVGGMGALLPLLER	6.699999809	1	1	0.391302468	1929.358425	0	14.87446	0	13.88015	0	13.01012	0	14.19505	0	0	13.95365	0	0	14.18105	14.46962	0	0	0	0	0	0	0	15.47151	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.60923
Q6ZNL6	FGD5_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 5 (Zinc finger FYVE domain-containing protein 23)"	FGD5 ZFYVE23	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]	GO:0001726; GO:0005085; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0032587; GO:0043087; GO:0046847; GO:0046872; GO:0051056	AVPGLMR	2.170000076	1	1	0.168159717	761.0574967	0	12.93935	0	14.47044	0	12.78782	15.4345	15.14927	15.7721	13.85138	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZNM6	TEX43_HUMAN	Testis-expressed protein 43	TEX43 C5orf48	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]		flagellated sperm motility [GO:0030317]		GO:0030317	ENMIFR	12.36999989	1	1	0.186786959	808.5740448	0	15.23769	16.326	16.58782	0	0	17.44071	0	0	15.54048	14.40764	16.48022	16.02804	16.06938	0	16.07013	0	0	16.44324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.31796	18.06227	0	0	0	0	0	0	0	17.02512	0
Q6ZNQ3	LRC69_HUMAN	Leucine-rich repeat-containing protein 69	LRRC69	Homo sapiens (Human)	signal transduction [GO:0007165]		signal transduction [GO:0007165]		GO:0007165	MPSALGK	13.40999985	1	1	0.251854177	704.1266466	16.53142	0	15.3281	0	0	15.88932	0	15.05034	15.2485	0	16.20963	0	0	15.01586	0	0	16.73772	0	0	13.66178	0	0	16.45446	0	14.89583	15.738	16.45079	14.26431	15.17425	0	0	15.48659	0	0	0	0	0	0	0	16.28007	0	0	0	0	16.50941	0	16.61475	0
Q6ZP01	RBM44_HUMAN	RNA-binding protein 44 (RNA-binding motif protein 44)	RBM44	Homo sapiens (Human)		cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]	cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0042803; GO:0045171	ENLLLSSNGCDEVK	3.460000038	1	1	0.394884801	1576.183017	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.05607	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZP82	CC141_HUMAN	Coiled-coil domain-containing protein 141 (Coiled-coil protein associated with myosin II and DISC1)	CCDC141 CAMDI	Homo sapiens (Human)	centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]		GO:0005737; GO:0005813; GO:0021799; GO:0043005; GO:0051642	NLQEQSLGSSLSDNEDR	5.179999828	1	1	0.183492127	1890.522817	0	0	0	0	0	0	14.6757	12.85071	14.61105	0	0	0	16.1228	0	0	0	15.08638	14.81607	16.18638	15.48838	0	16.87744	0	0	0	0	0	0	0	0	0	0	0	16.4117	15.99488	0	0	0	0	15.29507	0	16.3686	0	0	0	16.9928	0	16.30993
Q6ZPD9	D19L3_HUMAN	"Probable C-mannosyltransferase DPY19L3, EC 2.4.1.- (Dpy-19-like protein 3) (Protein dpy-19 homolog 3)"	DPY19L3	Homo sapiens (Human)	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005637; GO:0016021; GO:0018406	FGLGATR	1.090000033	1	1	0.198499041	722.0585683	12.90528	0	15.81135	0	0	0	14.74241	0	0	18.72041	0	0	0	0	15.32775	14.94706	0	0	0	17.10483	0	0	0	0	0	0	0	0	15.28695	0	0	15.55452	0	0	0	0	16.26067	14.61485	15.8329	0	0	14.56842	0	15.86564	16.28413	0	15.71353	0
Q6ZQQ2	S31D1_HUMAN	Spermatogenesis-associated protein 31D1 (Protein FAM75D1)	SPATA31D1 FAM75D1	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		GO:0007283; GO:0016021; GO:0030154	IHESLSLLRPQSK	9.539999962	1	1	0.443838658	1507.701457	17.11801	0	0	0	0	0	0	17.11862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.88385	0	0	0	0	0	0	0	0	0	0	0	0	18.81694	0	0	0	0	0	0	18.08196	0	0	17.38021	0	0
Q6ZQQ6	WDR87_HUMAN	WD repeat-containing protein 87 (Testis development protein NYD-SP11)	WDR87	Homo sapiens (Human)						DLASKGNLEWLHLAK	8.590000153	1	1	0.462342582	1695.816133	0	19.07167	18.2895	19.49729	16.55384	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.92593	17.79589	0	17.76499	0	21.25944	20.66252	0	0	0	0	0	20.05061	17.56072	0	0	0	0	0	0	17.93069	0	17.16499	0	19.15076	0	0	0	0
Q6ZQW0	I23O2_HUMAN	"Indoleamine 2,3-dioxygenase 2, IDO-2, EC 1.13.11.- (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1)"	IDO2 INDOL1	Homo sapiens (Human)	'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; immune system process [GO:0002376]; tryptophan catabolic process to kynurenine [GO:0019441]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; immune system process [GO:0002376]; tryptophan catabolic process to kynurenine [GO:0019441]"	"heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]"	GO:0002376; GO:0004833; GO:0005737; GO:0005829; GO:0019441; GO:0020037; GO:0033754; GO:0034354; GO:0046872	TLGQMHDYVDPDIFYAGIR	3.309999943	1	1	2.29E-12	2228.234921	11.57133	14.07743	14.19972	12.06888	12.37487	14.19105	14.95985	14.07666	0	13.83628	0	0	0	11.60963	14.05363	14.37977	14.90501	0	0	11.84183	0	0	0	0	0	14.77956	16.1454	0	0	0	0	0	0	0	0	0	0	0	0	0	14.53232	0	0	0	13.81695	0	0	0
Q6ZQX7	LIAT1_HUMAN	Protein LIAT1 (Ligand of ATE1 protein)	LIAT1 C17orf97	Homo sapiens (Human)	protein arginylation [GO:0016598]		protein arginylation [GO:0016598]		GO:0016598	HQSQSLK	9.090000153	1	1	0.202147417	826.8173045	15.92867	15.67363	0	0	15.02283	0	15.67924	0	16.01167	16.38154	16.66221	15.71844	15.75007	0	15.92125	0	16.529	0	15.39505	16.2915	0	16.18652	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6079	0	0	0
Q6ZQY2	LR74B_HUMAN	Leucine-rich repeat-containing protein 74B	LRRC74B	Homo sapiens (Human)						ISAMGALSLGLGLR	5.420000076	0.81687516	0.81687516	0.083624417	1369.524379	14.47793	14.99819	11.60061	0	14.54095	0	0	0	0	13.45996	14.94085	9.316155	13.7991	12.08907	11.87899	12.95603	0	0	0	0	15.13678	0	0	0	0	0	13.48448	0	14.1727	13.63854	0	0	0	0	12.59304	0	0	0	0	0	16.00937	0	0	0	11.83557	16.86595	13.61713	0
Q6ZR08	DYH12_HUMAN	Dynein axonemal heavy chain 12 (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein axonemal heavy chain 7-like) (Dynein heavy chain domain-containing protein 2)	DNAH12 DHC3 DLP12 DNAH12L DNAH7L DNAHC3 DNHD2 HDHC3 HL19	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]	cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; minus-end-directed microtubule motor activity [GO:0008569]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286	EIYDSKEPHNAK	4.059999943	1	1	6.89E-13	1430.851216	13.60365	15.91366	14.65573	14.34304	0	15.39054	0	0	0	0	14.87341	11.32011	11.46222	13.78264	15.15165	0	0	0	14.21144	12.66419	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.64509	0	0	0	0	0	0	0
Q6ZRF8	RN207_HUMAN	RING finger protein 207	RNF207 C1orf188	Homo sapiens (Human)	cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]	perinuclear region of cytoplasm [GO:0048471]	perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270]	GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901018; GO:1901207; GO:1902261; GO:1903762; GO:1903954	NNAASAR	6.019999981	1	1	0.245510173	703.9150358	15.67337	15.31946	15.97153	14.84503	15.40576	14.54138	0	15.34091	14.0801	15.06277	13.40683	0	14.43247	13.66616	15.0191	15.50653	14.56077	0	16.8862	0	16.28952	0	0	16.5298	15.33868	14.81421	14.67272	0	0	0	0	0	0	16.08638	0	0	0	0	0	16.28608	14.98925	17.80222	0	0	0	17.0612	0	0
Q6ZRI0	OTOG_HUMAN	Otogelin	OTOG OTGN	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605]	apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; alpha-L-arabinofuranosidase activity [GO:0046556]; structural molecule activity [GO:0005198]; adult locomotory behavior [GO:0008344]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605]	alpha-L-arabinofuranosidase activity [GO:0046556]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005615; GO:0007605; GO:0008344; GO:0016324; GO:0031012; GO:0046373; GO:0046556	VLGKGPYQLSSLAAGGALVGMK	8.229999542	1	1	1.37E-12	2133.139393	15.72857	14.26614	0	0	0	15.04062	14.93032	0	13.228	15.99417	14.01045	14.42035	16.43643	14.50166	13.28195	14.98019	0	0	0	0	0	0	14.66635	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.45324	0	0	0	0	0	15.85855	0
Q6ZRI6	CO039_HUMAN	Uncharacterized protein C15orf39	C15orf39 FP6578	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829	QLGDFDTEAGAVSSSEPTVAR	5.949999809	1	1	0.163927966	2137.562045	0	0	14.97934	0	0	0	0	16.20918	0	0	13.71102	15.83357	0	0	14.01317	12.59428	0	14.88674	0	0	0	16.22662	0	0	14.99956	0	0	0	0	11.94382	0	0	0	15.37911	0	0	0	0	0	0	0	14.18224	0	0	0	0	0	0
Q6ZRI8	RHG36_HUMAN	Rho GTPase-activating protein 36	ARHGAP36	Homo sapiens (Human)	signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0007165	ISFPIGQRLLGSK	1.879999995	0.799538791	0.799538791	0.124766707	1415.320243	0	0	14.41303	11.1648	0	11.97877	0	0	0	0	0	0	0	0	0	12.33008	0	0	0	14.64504	0	0	0	0	0	0	0	0	13.73907	0	13.7493	12.93078	0	0	0	0	13.76864	0	0	0	0	13.87063	0	0	0	0	0	0
Q6ZRK6	CCD73_HUMAN	Coiled-coil domain-containing protein 73 (Sarcoma antigen NY-SAR-79)	CCDC73	Homo sapiens (Human)						DVKTAVHMK	10.18000031	1	1	0.204988788	1044.360918	14.72969	15.08146	0	0	0	0	16.28897	0	15.68115	15.09363	0	0	14.91053	16.04436	15.70846	15.26095	0	0	0	15.20046	15.8984	0	15.13705	14.33215	15.79343	16.81698	15.9563	0	15.08479	15.04513	16.62061	0	0	16.0883	0	0	0	0	0	15.74008	14.94246	14.99097	0	16.64967	0	0	0	0
Q6ZRQ5	MMS22_HUMAN	Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like)	MMS22L C6orf167	Homo sapiens (Human)	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]		GO:0000724; GO:0005654; GO:0005829; GO:0031297; GO:0043596	LLFNLSEVKSIFSK	9.119999886	1	1	0.484675441	1623.568231	19.26542	0	17.52936	0	18.4668	0	0	19.16281	0	0	0	18.5892	18.80451	18.18488	18.91621	0	19.01184	19.8435	17.59909	0	0	18.47396	19.31864	0	0	18.26397	0	0	0	0	20.33347	0	0	19.88074	0	20.97002	0	0	0	18.34888	0	0	20.24595	0	16.62329	0	0	0
Q6ZRR7	LRRC9_HUMAN	Leucine-rich repeat-containing protein 9	LRRC9	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	MEGLESCINLEELTLDGNCISK	1.889999986	1	1	4.57E-12	2525.013892	0	0	0	16.11699	17.13676	0	0	0	14.56587	13.98207	0	0	19.11106	0	0	0	0	13.12517	0	0	0	0	16.3509	0	0	0	14.77195	14.86243	0	0	16.89776	16.44039	17.77619	0	16.366	0	0	0	0	0	0	0	0	0	16.23685	0	0	0
Q6ZRS2	SRCAP_HUMAN	"Helicase SRCAP, EC 3.6.4.- (Domino homolog 2) (Snf2-related CBP activator)"	SRCAP KIAA0309	Homo sapiens (Human)	"histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]	"Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]	GO:0000786; GO:0000812; GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0016604; GO:0016887; GO:0032991; GO:0042393; GO:0043486; GO:0048471; GO:0140658	SPADAGR	4.539999962	1	1	0.270693051	670.9825551	14.92453	0	0	0	0	17.15028	0	14.83025	15.37295	0	16.17673	16.5896	0	0	15.2082	0	0	0	0	0	0	0	0	0	0	15.4916	0	15.17224	15.94536	0	16.07818	0	14.18029	14.54539	16.27881	16.0591	16.37721	16.41011	0	14.18353	13.79009	15.47002	15.88373	15.39917	16.72136	0	0	16.67621
Q6ZS17	RIPR1_HUMAN	Rho family-interacting cell polarization regulator 1	RIPOR1 FAM65A KIAA1930	Homo sapiens (Human)	cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506]; 14-3-3 protein binding [GO:0071889]; cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]	14-3-3 protein binding [GO:0071889]	GO:0005737; GO:0005794; GO:0007266; GO:0009267; GO:0009611; GO:0012506; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0070062; GO:0071889; GO:0090316; GO:1990869; GO:2001107	ASTVTK	17.17000008	1	1	0.266825491	607.2605138	16.57853	0	0	0	0	16.94742	0	17.63538	18.36505	0	0	19.01068	0	17.4906	0	0	0	0	0	0	18.57503	0	16.82645	0	0	0	0	0	18.08046	17.51166	0	0	0	0	0	19.55922	0	0	0	18.16818	17.76488	0	0	17.64777	18.30966	0	0	0
Q6ZS30	NBEL1_HUMAN	Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein)	NBEAL1 ALS2CR16 ALS2CR17	Homo sapiens (Human)	protein localization [GO:0008104]	cytosol [GO:0005829]; membrane [GO:0016020]	cytosol [GO:0005829]; membrane [GO:0016020]; protein kinase binding [GO:0019901]; protein localization [GO:0008104]	protein kinase binding [GO:0019901]	GO:0005829; GO:0008104; GO:0016020; GO:0019901	DREGGESK	1.850000024	0.447268397	0.447268397	0.163314236	878.2881817	0	0	0	0	0	0	15.13271	15.85631	0	0	0	0	0	0	0	0	16.34282	14.09173	0	16.7251	0	0	0	0	0	0	0	0	0	14.96677	0	0	0	0	0	0	0	0	19.06042	0	0	0	0	0	0	0	16.19872	0
Q6ZS46	YF009_HUMAN	Putative uncharacterized protein FLJ45840		Homo sapiens (Human)						AGLPEGKGPGGR	6.429999828	0.502664387	0.502664387	0.203663525	1098.820485	0	0	16.13989	14.64968	13.44408	13.56956	0	11.50507	14.30847	0	0	0	0	0	0	0	0	0	0	0	0	12.1957	0	0	0	14.0506	0	13.83502	9.030363	14.88587	0	0	0	0	0	14.97198	0	14.12544	0	0	0	14.55003	14.91798	0	0	16.39381	0	0
Q6ZS81	WDFY4_HUMAN	WD repeat- and FYVE domain-containing protein 4	WDFY4 C10orf64 KIAA1607	Homo sapiens (Human)	"antigen processing and presentation [GO:0019882]; autophagy [GO:0006914]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; antigen processing and presentation [GO:0019882]; autophagy [GO:0006914]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]"		GO:0005769; GO:0005783; GO:0006914; GO:0019882; GO:0036037; GO:0098586	ILVTPK	4.389999866	1	1	0.042559992	670.5409878	0	0	0	0	0	0	0	0	0	0	0	0	0	16.1168	0	15.1572	0	0	0	0	0	14.9452	0	16.03288	0	0	0	0	16.84643	0	0	0	0	0	0	16.79763	0	17.09657	0	0	0	0	0	0	0	0	0	0
Q6ZS82	R9BP_HUMAN	Regulator of G-protein signaling 9-binding protein (RGS9-anchoring protein)	RGS9BP R9AP	Homo sapiens (Human)	detection of light stimulus involved in visual perception [GO:0050908]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750]	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750]; detection of light stimulus involved in visual perception [GO:0050908]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]		GO:0001750; GO:0007186; GO:0009968; GO:0016021; GO:0043005; GO:0050908	DRGLAADER	20.96999931	1	1	0.427900772	1002.272915	0	0	19.08243	0	19.80266	0	16.46565	0	20.26145	19.12283	19.15325	19.57714	0	0	0	0	0	0	0	18.92135	0	0	0	0	19.05546	0	0	19.13809	0	0	0	19.96567	0	0	0	19.19428	19.84891	0	19.70995	0	0	0	0	18.83263	17.90948	18.71238	19.14541	0
Q6ZS86	GLPK5_HUMAN	"Putative glycerol kinase 5, GK 5, Glycerokinase 5, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 5)"	GK5	Homo sapiens (Human)	glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]	mitochondrion [GO:0005739]	"mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]"	"ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]"	GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167	AAGIQMNQIVGLGISTQR	4.309999943	1	1	0.309783014	1856.369268	14.64969	14.72286	0	0	0	0	0	0	0	0	0	15.18801	15.46449	15.31541	16.31688	0	0	0	0	16.74529	16.00215	16.14178	17.03504	0	0	0	16.19985	0	15.99505	16.69434	0	0	15.22113	16.58323	15.62219	0	0	16.37067	14.4207	15.07193	0	15.97686	15.23595	0	0	16.46063	0	16.19981
Q6ZS92	YD022_HUMAN	Putative uncharacterized protein FLJ45721		Homo sapiens (Human)						VRLSIGLADFGLPGIAR	10.14000034	1	1	0.251337867	1754.693721	15.7468	0	13.44449	18.23376	15.01731	0	2.407135	0	17.80356	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.39239	0	0	16.47338	0	0	0	0	0	18.06248	16.74146	0	0	15.55502	0	0	0	0	0	0	0	0	0	0
Q6ZSC3	RBM43_HUMAN	RNA-binding protein 43 (RNA-binding motif protein 43)	RBM43 C2orf38	Homo sapiens (Human)			RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723	APERTVVVAGLPVDLFSDQLLAVLVK	5.570000172	1	1	3.21E-12	2749.640429	14.59717	0	8.62534	11.69773	0	0	0	11.59902	0	0	0	0	0	0	0	12.35711	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.51415	0	0	0
Q6ZSG2	INSY2_HUMAN	"Inhibitory synaptic factor 2A, InSyn2"	INSYN2A C10orf141 FAM196A INSYN2	Homo sapiens (Human)	inhibitory postsynaptic potential [GO:0060080]	postsynaptic density [GO:0014069]	postsynaptic density [GO:0014069]; inhibitory postsynaptic potential [GO:0060080]		GO:0014069; GO:0060080	YMTVPAR	5.789999962	1	1	0.178537549	853.1153199	0	0	13.28305	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.56045	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZSK4	NTAS1_HUMAN	Putative uncharacterized protein NTM-AS1 (NTM antisense RNA 1) (NTM antisense gene protein 1)	NTM-AS1 C11orf39	Homo sapiens (Human)						GEGCTDPEIK	7.710000038	0.885463953	0.885463953	0.183637956	1106.254628	14.64123	12.69474	0	10.06859	16.15438	0	0	0	13.01526	0	17.94948	0	0	0	14.49682	0	0	0	0	0	0	0	0	0	0	0	15.22591	0	0	0	0	16.08982	0	14.31792	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZSN1	YI023_HUMAN	Putative uncharacterized protein FLJ45355		Homo sapiens (Human)						GGRGAGSQSLPR	17.48999977	0.127023533	0.127023533	0.062753535	1141.523326	0	0	16.42623	13.68972	0	0	12.3242	13.27086	0	16.94868	0	13.66331	14.97583	0	13.75908	0	8.281269	0	11.87022	15.95285	12.55318	13.66723	12.41319	14.37772	15.40558	0	0	0	0	14.23922	17.42662	17.6692	11.08839	15.41175	15.6077	15.26148	12.33652	16.4263	0	0	0	0	0	0	14.51708	0	0	0
Q6ZSZ5	ARHGI_HUMAN	"Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor, p114-Rho-GEF, p114RhoGEF) (Septin-associated RhoGEF, SA-RhoGEF)"	ARHGEF18 KIAA0521	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]	GO:0005085; GO:0005829; GO:0005856; GO:0005886; GO:0007264; GO:0008360; GO:0016324; GO:0030036; GO:0030054; GO:0035023; GO:0045177; GO:0046872; GO:0051497; GO:0070062; GO:0150105	MGDDQEDDFPRR	12.03999996	1	1	0.178151254	1479.676618	0	0	0	0	0	15.09223	0	13.5075	0	0	0	13.93791	0	13.72513	0	0	0	0	0	15.59949	16.5167	0	0	0	0	15.56191	14.89402	0	16.90973	17.61514	0	0	0	0	0	0	17.70733	15.92266	14.78777	0	0	0	15.45961	0	16.62905	15.43505	0	15.05058
Q6ZSZ6	TSH1_HUMAN	Teashirt homolog 1 (Antigen NY-CO-33) (Serologically defined colon cancer antigen 33)	TSHZ1 SDCCAG33 TSH1	Homo sapiens (Human)	anterior/posterior pattern specification [GO:0009952]; middle ear morphogenesis [GO:0042474]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; anterior/posterior pattern specification [GO:0009952]; middle ear morphogenesis [GO:0042474]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0009952; GO:0042474; GO:0046872; GO:0060023	SNVSAMEELVEKVTGK	1.980000019	1	1	0.025850825	1736.743669	14.6196	0	15.01561	0	15.47177	14.04147	13.16917	13.36036	0	15.15164	15.47662	16.07176	15.13454	15.63184	14.48059	0	0	0	0	0	15.25142	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.06622	0
Q6ZT07	TBCD9_HUMAN	TBC1 domain family member 9 (TBC1 domain family member 9A)	TBC1D9 KIAA0882 TBC1D9A	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]		calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]	calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]	GO:0005096; GO:0005509; GO:0090630	ADLIEQMRFK	14.97000027	1	1	0.107616558	1249.534829	10.23698	17.03383	16.74157	17.43629	0	0	16.5572	16.95363	18.74621	16.64306	16.01186	0	18.21175	0	18.76781	0	0	17.62837	0	16.39122	17.44315	18.96471	0	18.68389	17.88995	17.52231	17.90289	17.2462	17.41199	0	16.26155	0	17.82115	18.43197	18.66026	0	18.82049	19.75104	20.25979	18.29682	18.14811	19.1514	18.40311	17.61248	16.09509	0	16.93706	16.99449
Q6ZT12	UBR3_HUMAN	"E3 ubiquitin-protein ligase UBR3, EC 2.3.2.27 (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650)"	UBR3 KIAA2024 ZNF650	Homo sapiens (Human)	embryo development ending in birth or egg hatching [GO:0009792]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016021; GO:0016567; GO:0061630; GO:0071596	APVFEPGGSMQQGMYTPK	2.99000001	1	1	0.440953261	1939.041451	0	13.37307	14.97023	0	14.26654	0	0	14.93647	10.71993	15.37802	14.89547	0	0	11.53692	0	14.18612	0	15.83798	15.58923	0	0	0	0	0	0	0	0	0	0	0	16.66981	0	15.79432	0	0	16.09658	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZT52	FA43B_HUMAN	Protein FAM43B	FAM43B	Homo sapiens (Human)						FVLVEDEAK	2.289999962	1	1	0.080729037	1050.628898	16.4636	0	15.28905	0	16.06334	0	13.95093	0	12.68248	0	0	0	14.16006	0	0	15.78391	15.24726	13.35949	0	0	12.79211	16.62968	0	0	0	14.49337	13.96705	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.87677	0	0	0
Q6ZT62	BGIN_HUMAN	Bargin (Chimeric SH3BP1-PDXP protein)	BARGIN	Homo sapiens (Human)	negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]	cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; GTPase activator activity [GO:0005096]; linear polyubiquitin binding [GO:1990450]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; linear polyubiquitin binding [GO:1990450]	GO:0005096; GO:0005829; GO:0007165; GO:0019897; GO:0032956; GO:0035020; GO:0043547; GO:0051058; GO:1990450	NSGSSQGLGGSPGSHSHTTMANKVETLK	4.989999771	1	1	0	2785.702372	14.9278	15.38184	15.43609	13.63883	0	0	0	15.06309	14.18325	0	15.4447	0	12.7437	0	15.25105	14.41257	4.854673	0	0	16.04261	14.91606	0	0	0	0	0	14.29612	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZT89	S2548_HUMAN	Solute carrier family 25 member 48	SLC25A48	Homo sapiens (Human)	acyl carnitine transport [GO:0006844]; amino acid transport [GO:0006865]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; acyl carnitine transmembrane transporter activity [GO:0015227]; acyl carnitine transport [GO:0006844]; amino acid transport [GO:0006865]	acyl carnitine transmembrane transporter activity [GO:0015227]	GO:0005743; GO:0006844; GO:0006865; GO:0015227; GO:0016021	CGEPEASPPR	17.30999947	1	1	0.250678488	1099.600528	0	0	0	0	0	0	16.80916	0	17.7522	0	17.81127	0	0	0	0	16.78181	0	17.18298	0	0	0	0	17.18567	16.52233	0	0	0	0	16.58593	0	19.11614	19.27787	0	0	16.64335	0	0	0	17.80469	0	17.28564	16.75884	0	17.86063	0	0	17.67035	0
Q6ZTA4	TRI67_HUMAN	Tripartite motif-containing protein 67 (TRIM9-like protein)	TRIM67 TNL	Homo sapiens (Human)	negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of protein localization [GO:0032880]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; zinc ion binding [GO:0008270]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of protein localization [GO:0032880]	zinc ion binding [GO:0008270]	GO:0005737; GO:0005856; GO:0008270; GO:0010976; GO:0032880; GO:0046580; GO:2000060	DMMLGK	4.53000021	0.035720307	0.035720307	0.138090305	709.8827728	17.71333	0	0	6.131516	16.74289	13.45485	0	0	0	14.86641	13.82303	0	0	16.84002	12.57641	16.4242	16.54847	0	0	0	0	15.83774	16.20512	15.85202	16.5295	11.67822	13.49796	0	15.76949	12.03296	15.26247	18.58058	17.2294	16.66606	15.61117	12.64308	13.81985	0	15.36498	0	17.25154	16.79212	17.46376	16.24484	0	16.10708	12.99115	17.07151
Q6ZTK2	YP015_HUMAN	Putative uncharacterized protein LOC400499		Homo sapiens (Human)						GPQQELNLTAAYR	1.909999967	1	1	0.222468549	1460.43653	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZTQ3	RASF6_HUMAN	Ras association domain-containing protein 6	RASSF6	Homo sapiens (Human)	apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]		apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]		GO:0006915; GO:0007165; GO:0042981	DEPDSPVLYRTMSEAALVR	4.010000229	0.526928902	0.526928902	0.132120513	2165.203127	0	13.5006	11.87158	0	15.82312	0	0	0	0	0	18.34391	0	0	0	15.52834	0	0	0	15.45818	16.5121	14.8563	16.90638	17.12586	0	0	0	13.44595	0	13.89829	15.39756	14.66779	17.91672	15.02667	0	14.60386	0	12.70259	16.1084	14.36803	15.26881	15.389	16.127	0	14.71174	15.14856	15.62151	15.77832	11.60833
Q6ZTQ4	CDHR3_HUMAN	Cadherin-related family member 3 (Cadherin-like protein 28)	CDHR3 CDH28	Homo sapiens (Human)	adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; virus receptor activity [GO:0001618]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; virus receptor activity [GO:0001618]	GO:0000902; GO:0001618; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742	DPLTQMPK	3.599999905	1	1	0.231687113	932.8506109	16.14562	17.04727	14.3072	0	0	17.325	0	15.57812	13.55672	14.82473	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.70586	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZTR5	CFA47_HUMAN	Cilia- and flagella-associated protein 47	CFAP47 CHDC2 CXorf22 CXorf30 CXorf59	Homo sapiens (Human)	sperm axoneme assembly [GO:0007288]	sperm connecting piece [GO:0097224]	sperm connecting piece [GO:0097224]; sperm axoneme assembly [GO:0007288]		GO:0007288; GO:0097224	AATIRSK	6.130000114	1	1	0.147667335	743.3083783	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.41508	0	15.4403	0	0	15.70448	0	18.86607	0	0	0	0	0	0	0	17.03285	0	0	0	0	0	0	0
Q6ZTR7	CBAR2_HUMAN	CBY1-interacting BAR domain-containing protein 2 (Protein FAM92B)	CIBAR2 FAM92B	Homo sapiens (Human)	cilium assembly [GO:0060271]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]		GO:0005737; GO:0005814; GO:0035869; GO:0036064; GO:0060271	TTLQLEETVDGFQR	3.119999886	1	1	0.351685738	1632.321471	12.58185	0	0	0	0	0	0	0	0	18.27727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZTW0	TPGS1_HUMAN	"Tubulin polyglutamylase complex subunit 1, PGs1"	TPGS1 C19orf20	Homo sapiens (Human)	adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648]	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; motile cilium [GO:0031514]; synapse [GO:0045202]	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; motile cilium [GO:0031514]; synapse [GO:0045202]; microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648]	microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0005737; GO:0005813; GO:0005874; GO:0007268; GO:0007288; GO:0008017; GO:0018095; GO:0030424; GO:0030425; GO:0030534; GO:0031514; GO:0045202; GO:0051648; GO:0070740	AVGGR	4.71999979	0.074935265	0.074935265	0.137536851	459.286538	16.30457	16.66527	16.96683	16.34553	16.67539	16.55744	16.26052	16.92389	16.43576	16.41677	0	17.17624	16.93756	16.94053	16.37537	17.1463	17.14258	16.51504	17.02778	16.67157	15.70344	16.24898	16.64541	16.99088	17.5435	17.19239	16.9296	15.89563	17.26243	16.46993	17.3497	16.56559	16.30093	16.53043	16.45664	17.34058	16.82299	17.07184	15.8299	16.27344	16.73277	0	16.73513	16.36543	15.39498	16.49528	16.90985	17.0647
Q6ZTY9	CG065_HUMAN	Putative uncharacterized protein LINC02902 (Long intergenic non-protein coding RNA 2902)	LINC02902 C7orf65	Homo sapiens (Human)						ADAESFR	10.47999954	1	1	0.03143856	795.0837883	14.13276	0	0	16.74038	0	0	10.57512	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.51349	0	0	0	0	0	0	0	0	13.65004	0	0	0	13.99213	0	13.61932	0	0	0	16.12917	0	0	0	0	0	0
Q6ZU35	CRACD_HUMAN	Capping protein-inhibiting regulator of actin dynamics (Cancer-related regulator of actin dynamics)	CRACD CRAD KIAA1211	Homo sapiens (Human)	epithelial structure maintenance [GO:0010669]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]	cytosol [GO:0005829]	cytosol [GO:0005829]; epithelial structure maintenance [GO:0010669]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]		GO:0005829; GO:0010669; GO:0030277; GO:0030838; GO:2000813	TLQQQLGK	8.710000038	1	1	0.187273194	914.5269121	17.82125	14.78856	0	0	16.09562	14.17055	12.38867	0	15.22083	0	0	0	0	0	0	15.39617	0	0	0	0	0	0	0	0	0	0	0	0	14.13734	16.06498	0	0	0	0	0	0	12.84831	13.78161	0	0	0	0	0	0	15.20769	15.74203	0	15.56778
Q6ZU45	CL20A_HUMAN	Putative C-type lectin domain family 20 member A	CLEC20A	Homo sapiens (Human)			carbohydrate binding [GO:0030246]	carbohydrate binding [GO:0030246]	GO:0030246	DLVLVKEALSWYDAQQHCR	2.619999886	1	1	0.189398261	2330.343463	0	16.59768	12.43365	12.4951	12.45574	0	0	15.54961	11.24922	13.78668	13.19464	0	13.24353	0	0	0	14.50353	8.572876	0	14.37768	0	7.29533	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZU65	UBN2_HUMAN	Ubinuclein-2	UBN2 KIAA2030	Homo sapiens (Human)	DNA replication-independent chromatin assembly [GO:0006336]	extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA replication-independent chromatin assembly [GO:0006336]		GO:0005615; GO:0005634; GO:0005654; GO:0006336	GWMQAR	9.890000343	0.152033672	0.152033672	0.328206855	763.8555775	0	0	13.23003	19.45932	0	16.09226	20.16281	0	0	0	20.02765	0	0	16.59673	0	17.33409	0	17.10117	17.13148	17.23437	16.33104	17.08505	19.51339	19.29848	18.01084	0	18.40878	0	16.22442	0	19.48282	0	17.57823	18.39183	18.63085	0	17.1503	19.53702	0	0	0	17.31101	16.78645	16.59109	17.35044	17.48446	16.74777	17.46474
Q6ZU69	F205A_HUMAN	Protein FAM205A	FAM205A C9orf144B	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nucleus [GO:0005634]	integral component of membrane [GO:0016021]; nucleus [GO:0005634]		GO:0005634; GO:0016021	LLEVHVK	2.829999924	1	1	0.042973867	837.3456067	0	0	0	15.69159	0	0	0	13.32347	15.22747	0	0	14.67798	12.11188	13.93947	0	0	0	0	0	0	0	0	0	0	0	11.83839	15.57684	0	0	14.52994	10.4673	0	0	0	12.69316	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZU80	CE128_HUMAN	"Centrosomal protein of 128 kDa, Cep128"	CEP128 C14orf145 C14orf61	Homo sapiens (Human)	protein localization [GO:0008104]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; protein localization [GO:0008104]		GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0008104; GO:0120103	SDAETK	2.960000038	1	1	0.102194475	650.0272917	0	0	14.46783	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.84996	14.13218	0	16.35403	0	0	0	0	0	0	0	16.03148	14.63817	20.20364	0	0	0	0	0	0	0	0	0	0	0	0	0	16.25558	0
Q6ZUA9	MROH5_HUMAN	Maestro heat-like repeat family member 5	MROH5	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	IGQLVGILGMLCQDPDRATQR	12.35999966	1	1	0.261289603	2341.016975	14.28608	16.74374	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.73384	0	0	0	0	0	0	0	0	0	0
Q6ZUB1	S31E1_HUMAN	Spermatogenesis-associated protein 31E1 (Protein FAM75E1)	SPATA31E1 C9orf79 FAM75E1	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		GO:0007283; GO:0016021; GO:0030154	SSREPQR	11.43000031	1	1	0.09159735	859.6324452	16.65439	14.96011	0	15.22362	0	0	0	15.9	0	0	0	0	0	0	0	0	0	14.94534	0	12.67252	15.01149	0	0	0	0	0	12.60542	0	15.36533	0	0	0	13.65045	0	0	0	15.5365	0	15.33977	0	0	0	0	0	0	0	0	0
Q6ZUG5	YC006_HUMAN	Uncharacterized protein FLJ43738		Homo sapiens (Human)						DLLPSSAMIK	4.699999809	1	1	0.682682424	1090.316075	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.68363	0	0	0	0	0	18.46575	0	0	0	20.07911	0	0	0	0	0	19.58618	0	0	19.21659	0	0	0	0	0	18.92083	0	0	0	20.46021
Q6ZUI0	TPRG1_HUMAN	Tumor protein p63-regulated gene 1 protein (Protein FAM79B)	TPRG1 FAM79B	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	IPLSAVYRICLGK	2.430000067	1	1	0.237425403	1489.293055	0	15.57981	14.23413	0	8.825101	13.79769	0	0	13.37817	14.7785	13.23327	0	0	0	0	0	13.29112	14.29129	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.58837
Q6ZUJ8	BCAP_HUMAN	Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1)	PIK3AP1 BCAP	Homo sapiens (Human)	positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; NAD+ nucleosidase activity [GO:0003953]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]	identical protein binding [GO:0042802]; NAD+ nucleosidase activity [GO:0003953]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]	GO:0003953; GO:0005102; GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042802; GO:0050727	LLCGVR	2.99000001	1	1	0.073224504	716.3179824	16.35178	14.53118	0	14.8659	16.1602	0	14.76891	0	14.66901	16.39295	0	15.40631	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZUL3	CH086_HUMAN	Uncharacterized protein C8orf86	C8orf86	Homo sapiens (Human)						TGSSK	2.200000048	1	1	0.270359363	479.5463827	0	0	17.95674	18.26741	18.10785	0	0	0	0	0	0	0	18.8627	0	0	0	0	0	0	0	0	0	0	0	0	17.91138	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZUT1	NKAP1_HUMAN	Uncharacterized protein NKAPD1 (NKAP domain containing protein 1)	NKAPD1 C11orf57	Homo sapiens (Human)			identical protein binding [GO:0042802]	identical protein binding [GO:0042802]	GO:0042802	KMLPSSSSR	6.880000114	0.395253122	0.395253122	0.285033804	1007.955398	0	13.8253	15.05814	15.83361	0	0	0	0	0	0	0	0	15.46637	0	0	0	0	0	0	13.75006	0	16.82284	17.47781	15.05987	14.55299	0	12.38048	0	15.65389	0	17.07262	14.81848	0	0	0	13.70631	16.21284	17.23983	16.64428	15.73086	0	0	0	16.70141	0	0	0	0
Q6ZUT3	FRMD7_HUMAN	FERM domain-containing protein 7	FRMD7	Homo sapiens (Human)	negative regulation of protein binding [GO:0032091]; negative regulation of stress fiber assembly [GO:0051497]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of protein binding [GO:0032091]; negative regulation of stress fiber assembly [GO:0051497]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005615; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007399; GO:0010592; GO:0010975; GO:0030426; GO:0032091; GO:0043005; GO:0043025; GO:0051057; GO:0051497	NPKEIVFK	17.90999985	0.376471668	0.376471668	0.427884156	974.4188968	22.3336	0	0	0	0	0	0	21.25266	21.32881	18.5955	21.85181	0	0	0	0	21.3841	20.19238	18.88089	0	0	0	0	21.32854	0	17.94667	0	18.17265	19.02022	21.9392	0	0	22.84021	20.89825	0	17.60467	0	21.65978	0	0	18.49442	21.89057	16.97899	21.75065	0	0	17.69584	0	21.90387
Q6ZUT6	CCD9B_HUMAN	Coiled-coil domain-containing protein 9B	CCDC9B C15orf52	Homo sapiens (Human)			RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723	SGAQQGLAPR	3.579999924	0.922941029	0.922941029	0.306482886	984.8717526	0	0	0	0	0	0	0	0	0	0	0	16.89562	0	16.07688	14.90162	17.52901	0	16.81808	0	0	0	0	16.84633	0	0	0	0	16.58147	0	0	0	0	19.04016	0	0	17.66159	16.93863	17.56065	18.79334	0	0	0	0	18.4953	0	0	0	0
Q6ZUT9	DEN5B_HUMAN	DENN domain-containing protein 5B (Rab6IP1-like protein)	DENND5B	Homo sapiens (Human)	positive regulation of triglyceride transport [GO:1905885]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of triglyceride transport [GO:1905885]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0016021; GO:1905885	GIDDGSLERILIGELMTSASDEDLVK	4.889999866	0.820491374	0.820491374	3.65E-12	2775.71167	0	18.12572	0	0	18.23672	16.09851	18.11197	0	0	19.87391	0	14.91613	15.49309	0	16.76287	0	15.52327	0	0	16.53874	14.96701	17.1415	0	0	0	0	0	18.11157	15.84119	19.50868	18.41109	19.62405	19.31964	15.04897	18.69855	17.63298	0	17.19058	0	18.32005	16.6207	16.47598	17.74457	18.27644	17.55182	15.925	0	15.95909
Q6ZUV0	BACHL_HUMAN	"Putative cytosolic acyl coenzyme A thioester hydrolase-like, EC 3.1.2.2 (Acyl-CoA thioesterase 7-like)"	ACOT7L BACHL	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; palmitic acid biosynthetic process [GO:1900535]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; palmitic acid biosynthetic process [GO:1900535]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0005654; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0036042; GO:0047617; GO:0052689; GO:0102991; GO:1900535	AASVFT	5.889999866	1	1	0.263007112	593.6866399	0	16.73267	15.4886	14.35016	14.57037	0	11.99897	16.38728	0	0	15.49316	0	0	15.99224	16.94184	0	15.46564	14.93243	15.89614	14.45962	0	16.65059	0	16.86031	0	15.17543	0	14.87952	15.68502	0	15.1887	0	0	0	0	16.86818	0	0	0	0	0	16.74353	0	0	0	0	16.207	0
Q6ZUX3	TGRM2_HUMAN	TOG array regulator of axonemal microtubules protein 2 (Crescerin-2)	TOGARAM2 FAM179A	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]	cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]	microtubule binding [GO:0008017]	GO:0000226; GO:0005815; GO:0005876; GO:0005881; GO:0005929; GO:0008017; GO:0072686; GO:0090307	QQGIEDNDELPSAK	7.659999847	1	1	0.207945554	1538.819516	15.57591	15.08508	14.7857	0	0	0	13.56656	0	0	0	14.53178	0	0	0	0	0	0	0	0	0	0	0	18.09162	17.16617	0	15.20114	0	0	15.01786	0	0	0	11.79424	0	14.96552	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZV29	PLPL7_HUMAN	"Patatin-like phospholipase domain-containing protein 7, EC 3.1.1.-, EC 3.1.1.5"	PNPLA7 C9orf111	Homo sapiens (Human)	phosphatidylcholine catabolic process [GO:0034638]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylcholine catabolic process [GO:0034638]	lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]	GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0016021; GO:0034638; GO:0102545	EPPPSLLEADLTEFDVK	4.159999847	1	1	0.437915302	1901.989439	14.36602	0	15.93386	0	0	0	0	0	0	0	0	0	0	0	0	0	16.44291	0	0	0	0	0	0	0	0	0	0	0	14.50646	0	15.99895	15.96717	15.99527	10.27897	0	0	0	0	15.70629	0	14.92614	0	0	0	16.43499	0	0	0
Q6ZV65	FA47E_HUMAN	Protein FAM47E	FAM47E	Homo sapiens (Human)	epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; positive regulation of histone methylation [GO:0031062]; protein localization to chromatin [GO:0071168]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; positive regulation of histone methylation [GO:0031062]; protein localization to chromatin [GO:0071168]	enzyme activator activity [GO:0008047]	GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0031062; GO:0045815; GO:0071168	EGVNCR	6.949999809	1	1	4.62E-13	734.4036566	15.68047	15.15368	15.02542	17.04957	0	0	0	0	0	0	0	0	0	0	0	16.63575	0	0	0	0	0	0	0	16.50074	0	0	0	0	0	0	0	0	0	0	16.48916	0	18.3066	0	0	0	0	0	0	0	0	0	0	0
Q6ZV73	FGD6_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)"	FGD6 KIAA1362 ZFYVE24	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]	GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872	DEWLEAISRAIEEYAK	6.179999828	0.637321532	0.637321532	0.316592746	1923.064417	0	0	0	0	13.29369	0	0	15.45689	14.45308	0	15.07755	11.93909	0	0	0	0	0	0	0	0	16.2948	0	0	0	0	0	14.60846	0	0	0	0	0	0	17.8326	0	0	0	0	0	0	0	0	0	0	0	0	0	17.03984
Q6ZVC0	NYAP1_HUMAN	Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1	NYAP1 C7orf51	Homo sapiens (Human)	neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065]		neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065]		GO:0014065; GO:0048812	SSSKEVAPAGSAGPAAGQGPGVR	3.190000057	1	1	0.004965332	2038.834252	0	0	0	0	0	0	12.65344	14.29481	18.41111	14.64851	0	14.11855	0	15.55865	0	12.86319	15.48954	13.81287	0	12.67995	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.95511	0	0	13.72221	0	0	0	0	0
Q6ZVF9	GRIN3_HUMAN	"G protein-regulated inducer of neurite outgrowth 3, GRIN3"	GPRIN3 KIAA2027	Homo sapiens (Human)	neuron projection development [GO:0031175]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; neuron projection development [GO:0031175]		GO:0005886; GO:0031175	LSDSCGSISKADHSGSLDPTNK	5.699999809	0.429237872	0.429237872	0.136874264	2275.447331	15.54188	0	12.22313	14.04134	11.95829	14.61349	13.97619	0	0	13.84348	13.69305	0	14.62666	0	0	14.70645	15.70661	14.69756	0	0	13.32621	0	18.47619	15.05736	15.70837	17.44087	15.54208	0	0	0	0	0	15.52441	17.60631	15.33575	0	0	16.05776	0	0	0	0	0	0	0	0	0	0
Q6ZVH7	ESPNL_HUMAN	Espin-like protein	ESPNL	Homo sapiens (Human)	actin filament bundle assembly [GO:0051017]; sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; stereocilium tip [GO:0032426]	cytoplasm [GO:0005737]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; actin filament bundle assembly [GO:0051017]; sensory perception of sound [GO:0007605]	actin filament binding [GO:0051015]	GO:0005737; GO:0007605; GO:0032426; GO:0051015; GO:0051017	AIMAHVPAR	4.760000229	1	1	0	979.9640113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZVK8	NUD18_HUMAN	"8-oxo-dGDP phosphatase NUDT18, EC 3.6.1.58 (2-hydroxy-dADP phosphatase) (7,8-dihydro-8-oxoguanine phosphatase) (MutT homolog 3) (Nucleoside diphosphate-linked moiety X motif 18, Nudix motif 18)"	NUDT18 MTH3	Homo sapiens (Human)	dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule metabolic process [GO:0055086]	cytosol [GO:0005829]	cytosol [GO:0005829]; 8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287]; dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule metabolic process [GO:0055086]	8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005829; GO:0044715; GO:0044716; GO:0044717; GO:0046057; GO:0046067; GO:0046712; GO:0055086	GLLGLQHLGR	11.61999989	0.457744539	0.457744539	0.071459468	1063.219817	0	0	14.88936	15.46951	0	16.52292	14.81014	13.04002	0	0	0	0	17.46747	0	0	0	0	18.30168	17.69894	18.57106	0	0	17.44713	0	17.67333	0	0	0	16.29133	17.27598	0	16.52565	0	0	18.0852	0	0	0	0	0	0	0	0	12.27255	17.23741	0	0	0
Q6ZVL6	K154L_HUMAN	UPF0606 protein KIAA1549L	KIAA1549L C11orf41 C11orf69	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	GYYDFPAVETSKGLTER	1.960000038	0.004611395	0.004611395	2.51E-12	1932.996884	14.37803	0	0	12.37434	0	12.8259	0	0	11.32578	0	15.06049	0	13.32508	0	0	0	14.58117	0	14.64822	16.37766	12.70856	16.00384	16.11058	0	0	13.34951	14.48973	0	16.66338	0	0	15.43117	16.38329	0	0	15.92921	16.23086	0	0	0	14.41994	0	13.31867	0	13.91539	0	16.38839	11.92846
Q6ZVL8	YP033_HUMAN	Putative uncharacterized protein FLJ42384		Homo sapiens (Human)						GMHTGGIIR	4.889999866	1	1	0.216199397	940.7398914	14.59854	14.37323	12.90972	14.48163	14.14485	15.85126	15.89454	0	14.65621	13.13361	0	15.52674	0	0	15.73369	12.12729	15.09715	0	0	0	0	0	0	0	0	12.31283	0	0	0	0	17.02855	0	12.80879	14.67987	0	15.48987	16.67349	0	0	0	16.20529	0	0	0	0	0	0	0
Q6ZVS7	F183B_HUMAN	Protein FAM183BP (Testis highly expressed protein 6)	FAM183BP FAM183B THEG6	Homo sapiens (Human)		ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0097546	KPMSWHDNLEEPADAR	1.600000024	1	1	2.78E-13	1896.276472	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZVT6	CF20D_HUMAN	Protein CFAP20DC (Uncharacterized protein C3orf67)	CFAP20DC C3orf67	Homo sapiens (Human)						EMNPPSPSNPR	3.910000086	1	1	0.305203478	1241.182886	16.09911	12.64433	13.07555	0	0	0	0	16.27569	0	0	0	0	0	14.8364	15.21068	0	0	0	0	15.4478	15.96703	0	0	4.615199	0	0	0	0	16.42633	15.37683	0	12.56342	14.6459	0	14.12106	16.60032	0	15.08204	0	15.12733	16.81376	0	0	0	16.33598	16.18262	0	15.04987
Q6ZVU0	YK022_HUMAN	Putative uncharacterized protein FLJ42102		Homo sapiens (Human)						CTWMLGASGFPPR	1.059999943	1	1	0.233949528	1494.563026	15.60994	15.53775	14.6094	0	0	0	0	0	0	0	0	0	0	11.39128	0	14.46371	0	15.66823	0	0	0	0	0	0	0	0	13.04418	15.32109	0	14.0425	0	13.62622	13.20161	0	0	0	0	0	0	16.52009	0	0	0	0	0	0	0	0
Q6ZVW7	I17EL_HUMAN	"Putative interleukin-17 receptor E-like, IL-17 receptor E-like, IL-17RE-like"	IL17REL	Homo sapiens (Human)			interleukin-17 receptor activity [GO:0030368]	interleukin-17 receptor activity [GO:0030368]	GO:0030368	SVLEALTSSTAMQCVPSDGCAMLLR	2.769999981	1	1	0.222441579	2714.242956	0	0	0	0	15.16369	14.88616	14.30186	15.17913	13.73945	0	0	15.09432	14.08836	13.74728	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZVX9	PAQR9_HUMAN	"Membrane progestin receptor epsilon, mPR epsilon (Membrane progesterone P4 receptor epsilon) (Membrane progesterone receptor epsilon) (Progesterone and adipoQ receptor family member 9) (Progestin and adipoQ receptor family member 9) (Progestin and adipoQ receptor family member IX)"	PAQR9	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]	signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]	GO:0005496; GO:0005886; GO:0016021; GO:0038023	DPPASAKPLLR	4.019999981	1	1	6.94E-13	1165.607076	0	0	0	0	0	0	0	0	0	0	0	0	0	13.59274	0	13.80653	14.07513	0	0	0	0	0	0	0	0	0	0	15.88345	14.10787	0	16.22147	0	14.99205	0	12.62456	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZVZ8	ASB18_HUMAN	"Ankyrin repeat and SOCS box protein 18, ASB-18"	ASB18	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]	cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		GO:0005829; GO:0016567; GO:0035556	DEMEWQVK	14.53999996	0.006158316	0.006158316	1.37E-12	1061.708075	0	16.22561	9.820671	17.00011	0	0	15.97275	0	16.98054	15.88266	0	12.55808	0	0	14.63697	0	0	0	0	10.60577	11.52354	17.63244	17.97571	14.45851	0	16.06999	16.35486	14.45756	11.91454	17.51524	14.52072	13.6515	16.15812	16.88576	16.11794	16.81713	0	16.25925	15.26116	0	12.85745	0	15.83175	17.46182	17.68004	14.97717	0	19.2916
Q6ZW05	PTHD4_HUMAN	Patched domain-containing protein 4 (p53-regulated patched protein)	PTCHD4 C6orf138 PTCH53	Homo sapiens (Human)		integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021	ENLPFKDR	23.37999916	1	1	1.15E-13	1021.434488	0	13.07627	16.3945	16.53489	14.42901	15.39766	16.31315	0	0	15.62292	0	0	0	0	16.00045	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZW31	SYDE1_HUMAN	"Rho GTPase-activating protein SYDE1 (Synapse defective protein 1 homolog 1, Protein syd-1 homolog 1)"	SYDE1	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of cytoskeleton organization [GO:0051493]; signal transduction [GO:0007165]		GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of cytoskeleton organization [GO:0051493]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]	GO:0005096; GO:0007165; GO:0016477; GO:0030695; GO:0031532; GO:0051493; GO:0090630; GO:1901165	YHLDSSVGGPGPAAGPGGTRSPR	3.539999962	1	1	0.242221955	2193.635068	13.91905	14.70187	14.60387	15.09564	12.93948	14.78861	13.3592	0	0	13.19924	15.85511	0	0	0	0	0	0	0	15.13617	0	0	0	0	11.04886	0	0	0	0	14.56026	0	0	0	0	16.02558	0	0	9.915959	0	0	0	12.18781	9.870347	10.32971	0	13.6741	0	0	0
Q6ZW49	PAXI1_HUMAN	PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein)	PAXIP1 PAXIP1L PTIP CAGF28	Homo sapiens (Human)	"adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]"	chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]"		GO:0000416; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035066; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0051568; GO:0051571; GO:0060261; GO:0060612; GO:0060717; GO:1902749; GO:2001022	KLYILGGEVAESAQK	11.22000027	1	1	0.392307189	1606.469385	19.97192	15.78636	13.16648	0	0	0	0	0	0	0	0	0	0	0	0	18.43786	0	0	0	0	0	0	0	0	19.25356	0	0	0	17.39784	0	0	0	0	0	0	0	0	0	0	0	0	0	17.36726	0	0	0	0	16.87469
Q6ZW61	BBS12_HUMAN	Bardet-Biedl syndrome 12 protein	BBS12 C4orf24	Homo sapiens (Human)	chaperone-mediated protein complex assembly [GO:0051131]; eating behavior [GO:0042755]; intraciliary transport [GO:0042073]; negative regulation of fat cell differentiation [GO:0045599]; photoreceptor cell maintenance [GO:0045494]	cilium [GO:0005929]	cilium [GO:0005929]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone-mediated protein complex assembly [GO:0051131]; eating behavior [GO:0042755]; intraciliary transport [GO:0042073]; negative regulation of fat cell differentiation [GO:0045599]; photoreceptor cell maintenance [GO:0045494]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005929; GO:0016887; GO:0042073; GO:0042755; GO:0045494; GO:0045599; GO:0051131	VEADNNTSRTLK	2.849999905	1	1	0.064431528	1347.821418	13.07138	10.84022	14.96774	12.19019	0	13.92601	0	0	0	0	0	0	11.85337	13.9254	0	0	0	12.04826	0	0	0	0	0	0	0	0	0	0	0	13.69743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZWE6	PKHM3_HUMAN	"Pleckstrin homology domain-containing family M member 3, PH domain-containing family M member 3 (Differentiation associated protein)"	PLEKHM3 DAPR PLEKHM1L	Homo sapiens (Human)	myoblast differentiation [GO:0045445]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myoblast differentiation [GO:0045445]	metal ion binding [GO:0046872]	GO:0005737; GO:0005794; GO:0005886; GO:0045445; GO:0046872	MVDTVLYDNTQLQLK	1.00999999	1	1	0.234213327	1796.399882	17.86165	0	0	14.71625	0	0	0	14.72519	0	0	0	0	0	0	15.10558	0	0	0	0	0	16.02149	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.21328	0	0	0	0	0	14.8938	0	11.495	0	0	0
Q6ZWH5	NEK10_HUMAN	"Serine/threonine-protein kinase Nek10, EC 2.7.11.1 (Never in mitosis A-related kinase 10, NimA-related protein kinase 10)"	NEK10	Homo sapiens (Human)	mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372]	extracellular region [GO:0005576]; protein kinase complex [GO:1902911]	extracellular region [GO:0005576]; protein kinase complex [GO:1902911]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911	LILPNK	12.32999992	0.905802965	0.905802965	0.279136919	697.8754535	15.32251	15.1516	15.97679	15.75181	0	15.44871	0	14.26729	0	16.79328	0	14.74201	0	0	16.12435	13.87298	15.02831	0	17.01896	0	0	15.60694	16.25499	14.92727	15.91718	14.81652	0	16.20757	0	15.18696	14.21646	14.32513	16.69717	0	16.46204	14.93087	15.89825	14.86867	15.89176	16.31733	0	17.06636	14.82291	17.13502	0	15.99951	15.98825	0
Q6ZWI9	RFPLB_HUMAN	Ret finger protein-like 4B (RING finger protein 211)	RFPL4B RNF211	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	AMCPLCRDVVK	8.06000042	0.680192769	0.680192769	0.456946941	1365.709529	17.34228	20.14988	16.20037	17.62051	18.91634	0	0	19.01077	0	18.15157	18.2449	0	0	0	0	0	17.96222	0	0	0	18.5796	0	0	0	18.70853	0	0	18.95419	0	0	0	0	19.96143	0	0	0	0	0	0	0	0	0	0	19.14575	0	0	0	0
Q6ZWK6	TM11F_HUMAN	"Transmembrane protease serine 11F, EC 3.4.21.- (Airway trypsin-like protease 4)"	TMPRSS11F HATL4	Homo sapiens (Human)	regulation of water loss via skin [GO:0033561]	cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]	cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; regulation of water loss via skin [GO:0033561]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005887; GO:0009986; GO:0033561	IFRHSSVGGR	9.920000076	1	1	0.38378871	1115.643928	17.24786	17.64102	0	14.07662	0	16.81569	0	15.8556	0	0	0	16.90354	17.73781	0	16.06527	14.36318	17.33867	0	15.86957	17.48245	16.42552	15.95764	0	0	0	0	0	14.84258	0	15.3555	15.73941	16.39146	0	16.3934	0	0	0	17.46435	17.00592	0	16.59428	0	15.63293	0	0	17.54598	0	0
Q6ZWT7	MBOA2_HUMAN	"Lysophospholipid acyltransferase 2, LPLAT 2, EC 2.3.1.- (1-acylglycerophosphate O-acyltransferase MBOAT2, EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase MBOAT2, EC 2.3.1.23) (1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase, EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase, LPAAT, Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase, LPCAT, Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4, Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase, LPEAT, Lyso-PE acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 2, O-acyltransferase domain-containing protein 2)"	MBOAT2 LPCAT4 OACT2	Homo sapiens (Human)	lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]	GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016021; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047184; GO:0106262; GO:0106263	HSSLKQ	1.440000057	1	1	0.140907332	699.0434792	15.8024	0	0	15.99948	15.60038	14.06595	0	0	0	16.14875	0	0	0	15.84585	0	16.73536	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q6ZXV5	TMTC3_HUMAN	"Protein O-mannosyl-transferase TMTC3, EC 2.4.1.109 (Protein SMILE) (Transmembrane and TPR repeat-containing protein 3)"	TMTC3	Homo sapiens (Human)	positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0034976; GO:0035269; GO:1901800	VCKLFLDNK	2.960000038	0.820084035	0.820084035	0.250891982	1137.210596	0	13.01861	13.87501	0	0	14.38063	0	14.54678	15.24047	0	17.43528	12.79686	0	0	12.58911	13.64752	12.05505	12.82325	16.03311	15.50911	0	14.19503	0	0	0	0	0	0	0	0	0	0	15.34319	0	0	0	15.83925	15.52422	0	14.91092	14.88664	14.99967	0	0	14.39007	0	15.77684	0
Q709C8	VP13C_HUMAN	Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C)	VPS13C KIAA1421	Homo sapiens (Human)	Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; Golgi to endosome transport [GO:0006895]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]		GO:0005737; GO:0005741; GO:0005829; GO:0006623; GO:0006895; GO:0007005; GO:0019898; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090	DPMEMR	8.470000267	0.199030161	0.199030161	0.119776761	778.4763651	18.47135	0	13.29171	13.32874	13.49082	0	17.3477	12.7592	0	13.30072	0	0	9.973505	16.01664	12.44112	16.67957	0	0	0	15.56998	14.14846	12.64481	15.96156	16.75593	0	0	16.334	16.63703	14.01439	0	0	17.91471	19.21229	17.99778	17.08432	0	17.17801	16.62738	16.1102	13.29589	15.36853	15.19795	0	0	15.66785	6.729833	0	0
Q709F0	ACD11_HUMAN	"Acyl-CoA dehydrogenase family member 11, ACAD-11, EC 1.3.8.-"	ACAD11	Homo sapiens (Human)	fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]	acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0005777; GO:0006635; GO:0017099; GO:0031966; GO:0033539; GO:0050660; GO:0070991	SNPTFYLQK	1.559999943	1	1	0.29294701	1093.919407	17.71836	0	16.09328	0	0	0	0	0	0	0	0	0	0	18.55931	0	0	0	0	16.13964	0	0	0	17.34013	0	18.51008	16.91467	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.87016	0	0	0
Q70CQ1	UBP49_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 49, EC 3.4.19.12 (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49)"	USP49	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]	GO:0000398; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0006325; GO:0006511; GO:0008270; GO:0016579; GO:0035616; GO:0042393	FTETEALEGR	14.01000023	1	1	0.183838749	1152.672495	0	15.19127	0	12.68224	14.9444	13.04502	0	0	0	0	0	0	0	10.96853	13.66747	0	0	0	13.65805	13.23559	0	14.93531	13.97639	0	12.04482	16.2506	0	0	0	14.76742	14.48667	14.55222	0	0	0	0	0	0	0	0	0	0	13.79923	0	0	16.20491	0	0
Q70CQ2	UBP34_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 34, EC 3.4.19.12 (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34)"	USP34 KIAA0570 KIAA0729	Homo sapiens (Human)	positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016055; GO:0016579; GO:0071108; GO:0090263	DDEGATPIK	6.289999962	1	1	0.251090279	945.3662264	15.74988	13.56056	16.33802	14.78584	15.95872	0	15.57072	15.93117	14.75671	16.21476	0	16.9942	0	0	13.10034	0	0	0	15.65363	0	0	17.37731	14.45041	0	0	16.66095	18.1743	0	14.97278	14.89696	18.39866	0	17.82689	0	17.06259	0	15.79541	0	0	16.62956	15.65645	17.05007	0	15.67037	0	16.66309	14.93501	16.54884
Q70CQ4	UBP31_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 31, EC 3.4.19.12 (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31)"	USP31 KIAA1203	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]	nucleus [GO:0005634]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	thiol-dependent deubiquitinase [GO:0004843]	GO:0004843; GO:0005634; GO:0006511; GO:0016579	AGGSSVK	4.289999962	1	1	0.12420909	607.427388	0	14.51867	0	16.30708	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q70EK8	UBP53_HUMAN	Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53)	USP53 KIAA1350	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; protein deubiquitination [GO:0016579]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]		GO:0005911; GO:0005923; GO:0007605; GO:0010996; GO:0016579	CPSNCGQK	9.319999695	1	1	0.124984355	949.6734073	16.66742	0	0	0	0	0	0	15.67045	0	0	0	14.96983	15.10276	0	16.53971	14.33437	16.11224	0	0	0	14.73656	14.56432	16.33809	0	0	14.39111	12.29744	15.54216	13.69148	0	11.54567	15.64662	15.0511	15.60606	13.88493	17.45784	0	0	0	0	13.97147	0	14.03469	0	11.89205	0	0	0
Q70EK9	UBP51_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 51, EC 3.4.19.12 (Deubiquitinating enzyme 51) (Ubiquitin thioesterase 51) (Ubiquitin-specific-processing protease 51)"	USP51	Homo sapiens (Human)	DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; protein deubiquitination [GO:0016579]; regulation of cell cycle process [GO:0010564]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of response to DNA damage stimulus [GO:2001020]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]	chromosome [GO:0005694]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; protein deubiquitination [GO:0016579]; regulation of cell cycle process [GO:0010564]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of response to DNA damage stimulus [GO:2001020]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]	GO:0003682; GO:0004843; GO:0005694; GO:0006281; GO:0006511; GO:0008270; GO:0010564; GO:0010569; GO:0016578; GO:0016579; GO:0042393; GO:2001020; GO:2001032	AKSCICHVCSTHMNR	6.900000095	0.69062376	0.69062376	0.008649508	1875.990869	0	14.41662	14.9308	11.27988	13.38149	11.26838	9.445975	13.98279	13.4319	0	0	0	14.90389	0	14.51069	14.98448	0	0	15.28847	15.43206	0	11.86424	0	0	0	13.83642	13.72721	0	14.98359	0	0	0	0	0	0	0	0	16.79671	0	16.23978	16.29905	0	0	15.66783	14.11939	0	0	14.89499
Q70EL2	UBP45_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 45, EC 3.4.19.12 (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45)"	USP45	Homo sapiens (Human)	cell migration [GO:0016477]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; neural retina development [GO:0003407]; photoreceptor cell maintenance [GO:0045494]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; neural retina development [GO:0003407]; photoreceptor cell maintenance [GO:0045494]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]	GO:0001917; GO:0003407; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006511; GO:0008270; GO:0016477; GO:0016579; GO:0045494; GO:0070911	GPLSPK	1.24000001	1	1	0.26448427	599.548463	15.37454	0	13.70223	15.23401	16.17962	14.92933	12.95183	15.76363	15.21297	0	12.32949	15.29689	0	15.60602	14.64807	0	0	0	0	16.09295	16.01244	0	15.01221	15.55216	0	0	16.1129	16.61505	15.62679	0	0	0	15.4425	15.52144	15.47425	0	16.6709	15.64078	15.5993	0	0	0	15.57205	15.80314	0	0	0	0
Q70EL4	UBP43_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 43, EC 3.4.19.12 (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43)"	USP43	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; ISG15-specific protease activity [GO:0019785]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	ISG15-specific protease activity [GO:0019785]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004843; GO:0005654; GO:0006511; GO:0016579; GO:0019785; GO:0019985	AEVTEQLAALVR	10.07999992	1	1	0.403886441	1295.764128	14.3131	14.03307	14.56071	0	0	0	0	0	0	0	15.25844	0	0	0	0	0	0	0	0	17.74664	0	15.09713	0	0	0	0	16.5638	0	0	15.7362	0	0	14.99187	15.89066	0	0	0	11.6701	0	0	0	0	16.25757	0	0	0	16.04673	0
Q70IA8	MOB3C_HUMAN	MOB kinase activator 3C (Mob1 homolog 2C) (Mps one binder kinase activator-like 2C)	MOB3C MOBKL2C	Homo sapiens (Human)	positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165]	metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]	GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0030295; GO:0046872	RPAKLSAPR	7.400000095	0.852916837	0.852916837	0.230142742	994.7018043	0	0	16.10583	0	15.0914	0	14.59863	0	0	0	0	0	0	0	16.37222	13.3368	14.40616	12.01832	15.9183	0	0	16.68385	15.92468	0	15.74123	14.28283	14.28559	0	15.75607	15.36661	12.98756	0	15.2099	15.52189	14.26316	16.05716	15.94823	15.16118	14.09262	0	15.15732	15.55396	0	14.25205	15.97634	14.1255	15.19797	13.5668
Q70SY1	CR3L2_HUMAN	"Cyclic AMP-responsive element-binding protein 3-like protein 2, cAMP-responsive element-binding protein 3-like protein 2 (BBF2 human homolog on chromosome 7) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2 ]"	CREB3L2 BBF2H7	Homo sapiens (Human)	"cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to wounding [GO:0009611]"	chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]	"chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]; cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to wounding [GO:0009611]"	"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000981; GO:0001228; GO:0002062; GO:0005634; GO:0005654; GO:0005783; GO:0005789; GO:0006357; GO:0006888; GO:0009611; GO:0010628; GO:0010976; GO:0016021; GO:0030968; GO:0034976; GO:0035497; GO:0045893; GO:0051216; GO:0097038	AAPRAPSALSSSPLLTAPHK	3.089999914	1	1	0.092968432	1972.355058	0	13.13233	0	0	0	16.14715	0	0	10.53417	0	15.8414	0	0	0	0	0	0	12.17717	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q70YC5	ZN365_HUMAN	Protein ZNF365 (DISC1-binding zinc-finger protein) (Protein su48)	ZNF365 DBZ KIAA0844	Homo sapiens (Human)	cerebellar molecular layer morphogenesis [GO:0021687]; dendrite arborization [GO:0140059]; dendritic spine morphogenesis [GO:0060997]; negative regulation of neuron projection development [GO:0010977]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA strand resection involved in replication fork processing [GO:0110026]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neuron projection development [GO:0010975]; telomere maintenance [GO:0000723]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cerebellar molecular layer morphogenesis [GO:0021687]; dendrite arborization [GO:0140059]; dendritic spine morphogenesis [GO:0060997]; negative regulation of neuron projection development [GO:0010977]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA strand resection involved in replication fork processing [GO:0110026]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neuron projection development [GO:0010975]; telomere maintenance [GO:0000723]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0000723; GO:0005737; GO:0005813; GO:0010569; GO:0010975; GO:0010977; GO:0021687; GO:0034451; GO:0042802; GO:0046872; GO:0048714; GO:0060997; GO:0110026; GO:0140059	KPKCLSR	7.53000021	0.539095163	0.539095163	0.181205149	888.4441477	0	15.79598	0	16.87542	16.32711	15.9664	12.71914	0	17.90336	18.01021	11.02642	17.08856	0	16.99145	14.15681	0	0	0	11.95539	17.73845	0	0	16.59238	14.4184	17.63057	16.48835	15.79484	14.15736	0	14.90837	16.32116	16.84118	18.01334	16.59684	16.95082	15.95871	16.6418	16.87386	17.30511	0	15.94245	0	16.46266	12.63486	0	20.09158	17.17188	16.06478
Q70Z44	5HT3D_HUMAN	"5-hydroxytryptamine receptor 3D, 5-HT3-D, 5-HT3D (Serotonin receptor 3D)"	HTR3D	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165]	neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0098662; GO:1904602	ATSNTISQCGWSASANWTPSISPSMDR	5.840000153	1	1	4.59E-13	2928.517026	13.25812	13.84486	14.97763	0	0	11.79483	12.33522	0	0	13.67562	14.13891	13.20742	12.15687	14.8686	0	15.19024	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q70Z53	F10C1_HUMAN	Protein FRA10AC1	FRA10AC1 C10orf4 PRO2972	Homo sapiens (Human)	dephosphorylation [GO:0016311]	nucleus [GO:0005634]	nucleus [GO:0005634]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]	phosphatase activity [GO:0016791]	GO:0005634; GO:0016311; GO:0016791	GHSSSK	6.96999979	1	1	0.10693427	602.4528548	0	16.84685	14.32562	17.17904	14.52116	0	0	15.31254	14.71072	15.00929	0	11.42849	0	0	14.85304	0	0	0	0	0	0	0	0	0	0	16.28769	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.92979	0	0	0	15.4218	0
Q711Q0	CEFIP_HUMAN	Cardiac-enriched FHL2-interacting protein	CEFIP C10orf71	Homo sapiens (Human)	positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]	Z disc [GO:0030018]	Z disc [GO:0030018]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]		GO:0030018; GO:0070886	QEPVSNGVILPNGLEESPPNELSK	2.480000019	1	1	0.327920061	2546.579038	17.22966	16.55221	0	17.35796	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q719I0	AHSA2_HUMAN	Putative activator of 90 kDa heat shock protein ATPase homolog 2 (Activator of HSP90 ATPase homolog 2 pseudogene)	AHSA2P AHSA2	Homo sapiens (Human)	positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]	GO:0001671; GO:0005829; GO:0006457; GO:0032781; GO:0051087; GO:0051879	VREALGDYLK	7.320000172	0.396435946	0.396435946	0.08311241	1163.58602	22.14839	21.75786	21.44054	21.03477	22.10328	18.80104	21.6919	21.74143	21.24086	20.67356	22.3799	19.21469	21.489	21.64971	20.56483	21.15978	22.70564	22.75673	20.51762	20.54139	20.35574	21.07916	21.4619	20.4756	22.61626	22.0837	22.36385	22.23279	20.61868	20.46471	22.65867	21.59605	21.96822	22.82849	22.76707	23.35804	22.57523	22.17839	22.12879	20.58021	21.7978	21.86054	22.51384	22.3238	21.5309	21.27598	20.34525	20.70212
Q71F56	MD13L_HUMAN	Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like)	MED13L KIAA1025 PROSIT240 THRAP2 TRAP240L	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0006357; GO:0016592	NAMSIFSSATKTDVR	1.629999995	1	1	0.020604438	1644.321497	15.77209	0	0	0	16.61367	0	16.41875	0	15.85985	0	0	0	0	0	16.01638	0	0	0	0	0	0	17.19994	0	0	0	0	0	0	0	0	0	0	0	16.4857	15.39968	0	0	0	17.06329	0	0	0	17.67761	0	0	0	0	0
Q71H61	ILDR2_HUMAN	Immunoglobulin-like domain-containing receptor 2 (Angulin-3)	ILDR2 C1orf32	Homo sapiens (Human)	cell differentiation [GO:0030154]; homeostasis of number of cells within a tissue [GO:0048873]; insulin secretion [GO:0030073]; negative regulation of T cell activation [GO:0050868]; pancreas development [GO:0031016]; regulation of RNA splicing [GO:0043484]; response to glucose [GO:0009749]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; tight junction [GO:0070160]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; tight junction [GO:0070160]; cell differentiation [GO:0030154]; homeostasis of number of cells within a tissue [GO:0048873]; insulin secretion [GO:0030073]; negative regulation of T cell activation [GO:0050868]; pancreas development [GO:0031016]; regulation of RNA splicing [GO:0043484]; response to glucose [GO:0009749]		GO:0005789; GO:0009749; GO:0016020; GO:0016021; GO:0030073; GO:0030154; GO:0031016; GO:0043484; GO:0048873; GO:0050868; GO:0070160	GPSYRGR	3.650000095	1	1	0.236366875	793.2656245	17.11888	0	0	18.58844	0	0	17.27697	18.29802	0	0	0	0	0	0	16.6214	0	0	0	0	0	0	0	0	0	0	0	0	18.05249	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q75N90	FBN3_HUMAN	Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide ]	FBN3 KIAA1776	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; anatomical structure morphogenesis [GO:0009653]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0031012; GO:0062023	CELCPLPGTSAYR	7.909999847	1	1	0.428109507	1522.898327	15.72189	0	19.72808	16.32852	0	0	21.50361	0	0	0	0	0	0	0	0	0	0	0	0	0	18.30539	0	0	0	0	0	0	18.66555	18.1079	0	0	0	0	20.72789	20.67109	0	0	21.68622	20.80803	0	0	0	0	0	0	0	18.44874	0
Q75QN2	INT8_HUMAN	"Integrator complex subunit 8, Int8 (Protein kaonashi-1)"	INTS8 C8orf52	Homo sapiens (Human)	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	integrator complex [GO:0032039]; nucleoplasm [GO:0005654]	integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		GO:0005654; GO:0016180; GO:0032039; GO:0034472	ESTLGIMYR	7.96999979	0.345079184	0.345079184	0.179675644	1090.156927	0	14.77341	12.36764	0	0	0	0	0	13.85815	0	14.894	0	6.294082	0	15.02169	14.78835	12.29913	0	0	0	0	0	15.30933	15.10861	15.84642	15.11515	13.59719	0	11.91378	12.3018	15.20701	0	12.13084	15.30612	13.91979	0	0	11.80704	0	0	0	15.04555	0	13.02981	0	15.70115	13.24604	14.86788
Q75T13	PGAP1_HUMAN	"GPI inositol-deacylase, EC 3.1.-.- (Post-GPI attachment to proteins factor 1, hPGAP1)"	PGAP1 UNQ3024/PRO9822	Homo sapiens (Human)	anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185]; anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]"	"hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185]"	GO:0005783; GO:0005789; GO:0006505; GO:0006888; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0016021; GO:0016255; GO:0016788; GO:0021871; GO:0050185; GO:1902953	EEITSIYR	4.650000095	0.707232833	0.707232833	0.230431528	1009.840884	9.3578	0	13.96915	15.67422	16.01597	0	0	0	0	14.23585	13.39974	0	15.07189	0	15.25574	0	14.22303	15.18347	16.63057	13.72962	0	0	15.6155	16.27929	13.35698	15.10578	14.74975	0	17.15752	13.64378	16.2191	0	15.79625	14.55234	13.09904	13.45745	16.21327	0	16.1153	0	0	0	0	0	0	0	0	15.37614
Q75V66	ANO5_HUMAN	Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E)	ANO5 GDD1 TMEM16E	Homo sapiens (Human)	chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0006821; GO:0016021; GO:0031982; GO:0034220; GO:0046983; GO:0055085; GO:1902476	HVMIEENKAQLAK	6.210000038	1	1	0.335766133	1511.933385	16.14461	15.25881	0	0	0	0	0	0	0	0	15.35241	15.68875	0	0	17.61771	16.63025	15.44382	15.80906	16.42636	16.07726	0	15.94311	12.26647	0	0	13.99953	0	16.18358	17.44414	15.5812	16.99119	15.71199	0	0	15.54712	0	16.57296	16.17684	17.81819	16.54694	17.09763	0	0	19.071	0	0	0	17.81672
Q75VX8	GARE2_HUMAN	GRB2-associated and regulator of MAPK protein 2 (GRB2-associated and regulator of MAPK1-like)	GAREM2 FAM59B GAREML KIAA2038 HRIHFB2063	Homo sapiens (Human)						LCLPAPRAPGLAR	13.65999985	1	1	2.32E-13	1391.18379	14.44552	16.62008	16.65266	0	0	22.68799	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q76FK4	NOL8_HUMAN	Nucleolar protein 8 (Nucleolar protein Nop132)	NOL8 C9orf34 NOP132	Homo sapiens (Human)	protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	chromosome [GO:0005694]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]	GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:1902570	GSKSPK	8.06000042	0.02069889	0.02069889	0.222247712	603.3939569	16.9589	19.81638	19.59083	15.85349	18.08511	17.5288	16.23813	15.62836	16.6309	19.78811	18.96115	19.53055	15.81951	15.9979	17.86736	16.56021	18.62062	17.92335	17.105	17.01737	15.48691	19.47501	18.88804	19.07565	18.15206	18.51929	18.42521	17.90394	16.31745	18.66764	17.90647	15.26022	19.29607	15.07264	19.49563	18.74227	20.237	17.7569	19.27807	16.38685	16.52057	15.63553	19.4806	16.27719	0	17.89697	19.46078	18.68698
Q76G19	PDZD4_HUMAN	PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein)	PDZD4 KIAA1444 PDZK4 PDZRN4L	Homo sapiens (Human)		cell cortex [GO:0005938]	cell cortex [GO:0005938]		GO:0005938	AREQR	8.170000076	0.117379315	0.117379315	0.192349229	659.7187175	14.27116	0	0	0	0	0	0	0	15.68832	15.58627	15.1572	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.09131	0	0	0	0	0	15.6557	16.62275	0	14.85009	0	0	0	0	0	16.19196	18.39731	16.47868	0	0	0	0	0
Q76I76	SSH2_HUMAN	"Protein phosphatase Slingshot homolog 2, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 2, SSH-2L, hSSH-2L)"	SSH2 KIAA1725 SSH2L	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]	actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0006470; GO:0008138; GO:0030036; GO:0030837	GDILPNPCHTPK	5.590000153	1	1	0.105544881	1348.492032	0	0	14.75816	0	0	0	0	0	0	0	0	0	16.24596	0	0	0	0	0	0	0	0	0	0	0	0	16.03174	0	16.97923	0	0	0	0	16.64482	17.11467	0	0	0	0	0	14.81001	16.98789	0	0	17.0213	0	0	0	0
Q76KD6	SPERI_HUMAN	Speriolin (Spermatogenesis and centriole-associated protein 1) (Spermatogenesis-associated protein 15) (Spermatogenic cell-specific Cdc20-binding protein)	SPATC1 SPATA15 SPRN	Homo sapiens (Human)		centrosome [GO:0005813]; cytoplasm [GO:0005737]	centrosome [GO:0005813]; cytoplasm [GO:0005737]		GO:0005737; GO:0005813	ENHELKSAIK	5.309999943	0.578192234	0.578192234	0.201868005	1168.373037	12.59505	9.54282	17.00309	15.82929	14.18734	13.2444	15.28522	0	0	0	13.38448	14.60069	10.35795	13.37574	16.09353	0	0	0	16.10725	0	0	0	0	14.07246	0	0	14.89002	0	0	0	16.44871	0	0	15.17788	0	14.76589	0	0	0	14.42117	0	0	14.67875	0	0	0	0	0
Q76KX8	ZN534_HUMAN	Zinc finger protein 534 (KRAB domain only protein 3)	ZNF534 KRBO3	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	RDPWTLQSEVK	7.239999771	1	1	0.441043126	1358.332858	0	0	0	0	0	0	0	0	18.65967	0	17.6462	0	0	16.39446	0	18.19692	0	0	0	0	0	0	0	0	0	0	0	0	17.32359	17.91006	18.36883	0	17.83077	0	18.20832	0	0	0	0	17.73689	0	0	0	0	16.22887	0	0	17.03036
Q76L83	ASXL2_HUMAN	Putative Polycomb group protein ASXL2 (Additional sex combs-like protein 2)	ASXL2 ASXH2 KIAA1685	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleoplasm [GO:0005654]; PR-DUB complex [GO:0035517]	nucleoplasm [GO:0005654]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]; animal organ morphogenesis [GO:0009887]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]	GO:0003677; GO:0003682; GO:0005654; GO:0009887; GO:0035360; GO:0035517; GO:0042975; GO:0045600; GO:0045944; GO:0046872	AGPSK	1.99000001	0.942426801	0.942426801	0.100690038	459.3108585	15.52051	16.63708	16.03483	16.38389	16.54305	16.5214	17.24749	16.39134	16.65743	16.8187	16.87171	17.86024	0	16.53282	17.47936	15.69712	16.62427	16.46859	0	15.79975	17.27793	17.23209	16.91054	17.39378	0	16.96124	16.96577	16.36198	0	17.21748	0	16.81067	0	0	16.40824	0	16.81521	17.11679	0	0	16.65129	0	0	16.93086	0	15.82179	0	17.09026
Q76LX8	ATS13_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 13, ADAM-TS 13, ADAM-TS13, ADAMTS-13, EC 3.4.24.87 (von Willebrand factor-cleaving protease, vWF-CP, vWF-cleaving protease)"	ADAMTS13 C9orf8 UNQ6102/PRO20085	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; extracellular matrix organization [GO:0030198]; glycoprotein metabolic process [GO:0009100]; integrin-mediated signaling pathway [GO:0007229]; peptide catabolic process [GO:0043171]; platelet activation [GO:0030168]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amine [GO:0014075]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; extracellular matrix organization [GO:0030198]; glycoprotein metabolic process [GO:0009100]; integrin-mediated signaling pathway [GO:0007229]; peptide catabolic process [GO:0043171]; platelet activation [GO:0030168]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amine [GO:0014075]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636]	calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005178; GO:0005509; GO:0005615; GO:0005788; GO:0006508; GO:0007160; GO:0007229; GO:0008237; GO:0008270; GO:0009100; GO:0009636; GO:0009986; GO:0014075; GO:0016485; GO:0030168; GO:0030198; GO:0031012; GO:0035864; GO:0043171; GO:0071222; GO:0071346; GO:0071353; GO:0071356	AGLAWSPCSRR	6.900000095	0.801054239	0.801054239	0.255495038	1256.376314	13.65882	14.38506	13.79897	14.07459	14.19297	14.3929	0	14.34762	14.94701	0	16.54998	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.70249	0	0	0	0	0	0	0	0	0	0	18.92673	0	15.80549	14.25559	0	14.88276	0	0	0	0	14.12646	0
Q76MJ5	ERN2_HUMAN	"Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2, hIRE2p) (Ire1-beta, IRE1b) [Includes: Serine/threonine-protein kinase, EC 2.7.11.1; Endoribonuclease, EC 3.1.26.- ]"	ERN2 IRE2	Homo sapiens (Human)	"apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]"	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; unfolded protein binding [GO:0051082]; apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]"	ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; unfolded protein binding [GO:0051082]	GO:0000287; GO:0004519; GO:0004521; GO:0004674; GO:0004712; GO:0005524; GO:0005783; GO:0005829; GO:0006397; GO:0006468; GO:0016021; GO:0016075; GO:0030263; GO:0034976; GO:0036498; GO:0043507; GO:0044322; GO:0045892; GO:0051082; GO:0070059; GO:0106310; GO:1990604	MASAVR	3.799999952	0.084246837	0.084246837	0.336249493	634.8895557	15.8106	0	16.40613	14.97916	16.41057	0	0	16.59903	16.58436	0	0	13.68882	16.46548	0	0	0	14.96935	0	0	0	0	0	0	0	0	0	0	0	16.34887	0	16.38601	0	0	16.72514	0	0	0	0	0	16.26266	17.2393	0	0	17.62372	17.05839	0	0	16.53414
Q76N32	CEP68_HUMAN	"Centrosomal protein of 68 kDa, Cep68"	CEP68 KIAA0582	Homo sapiens (Human)	centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; protein localization to organelle [GO:0033365]	cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; protein localization to organelle [GO:0033365]	protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]	GO:0005654; GO:0005813; GO:0005829; GO:0007098; GO:0010457; GO:0019901; GO:0019904; GO:0030054; GO:0033365; GO:0034451	HLDMGSPQLR	1.480000019	1	1	0.148602801	1153.84349	13.04763	17.36078	0	15.43013	14.43448	14.35359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.51477	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q76N89	HECW1_HUMAN	"E3 ubiquitin-protein ligase HECW1, EC 2.3.2.26 (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1, hNEDL1)"	HECW1 KIAA0322 NEDL1	Homo sapiens (Human)	negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]	ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005737; GO:0005829; GO:0016567; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:0090090; GO:2000650	EGSLSPVNSQKITLLLQSPAVK	4.610000134	1	1	0.102819966	2308.932199	0	0	16.20339	16.09704	0	17.1468	12.75268	14.83539	15.44326	15.52504	0	0	15.38974	0	0	0	15.78958	15.36915	15.76997	0	15.87507	0	15.91929	14.90373	0	15.21548	0	15.50005	14.7047	13.76262	0	0	0	15.48018	15.05347	12.79716	16.97165	0	16.17991	0	0	14.99214	14.01587	15.52115	0	0	0	15.23901
Q76NI1	KNDC1_HUMAN	"Kinase non-catalytic C-lobe domain-containing protein 1, KIND domain-containing protein 1 (Cerebral protein 9) (Protein very KIND, v-KIND) (Ras-GEF domain-containing family member 2)"	KNDC1 C10orf23 KIAA1768 RASGEF2 VKIND hucep-9	Homo sapiens (Human)	cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264]	dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]	dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; guanyl-nucleotide exchange factor activity [GO:0005085]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001934; GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773	GPRASPTK	6.840000153	0.592758417	0.592758417	0.107476669	814.0647617	11.3542	14.28141	14.15944	0	11.35416	0	14.23001	0	15.30878	0	0	0	14.25156	11.01938	0	13.70013	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.49358	0	0	0	0	14.43972	0	0	0
Q7KZ85	SPT6H_HUMAN	"Transcription elongation factor SPT6, hSPT6 (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein, Tat-CT2 protein)"	SUPT6H KIAA0162 SPT6H	Homo sapiens (Human)	blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368]	euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368]	DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0000791; GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0010793; GO:0031491; GO:0032968; GO:0034728; GO:0042393; GO:0042789; GO:0045191; GO:0050684; GO:0051028; GO:0051147; GO:0061086	QRTMAIER	21.10000038	1	1	0.434336216	1022.472384	0	0	0	20.66632	21.23092	0	17.41531	22.21412	21.87521	20.85174	0	21.68407	16.94446	0	0	21.80252	15.91057	0	22.00946	0	20.43753	0	20.46163	0	21.05898	22.08837	21.19319	21.09175	0	20.19082	0	19.27542	19.1086	19.59084	19.23552	21.27039	22.12183	20.8905	0	22.02777	16.65891	0	0	17.15402	18.14521	0	0	0
Q7KZF4	SND1_HUMAN	"Staphylococcal nuclease domain-containing protein 1, EC 3.1.31.1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator)"	SND1 TDRD11	Homo sapiens (Human)	gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564]	cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]	cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]; cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564]	cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0001649; GO:0003712; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005829; GO:0006402; GO:0010564; GO:0010587; GO:0016020; GO:0016442; GO:0031047; GO:0042470; GO:0045296; GO:0070062; GO:0097433; GO:1905172	LMENMR	14.93999958	0.823036253	0.823036253	0.2735576	805.6349032	18.30179	17.99337	17.34898	18.03698	0	18.48126	0	0	17.08132	0	14.58187	17.96755	0	17.93112	0	0	17.08294	0	17.16442	0	17.80724	18.98872	18.3254	0	18.20473	0	0	0	0	0	0	0	0	0	19.42852	18.2081	20.07772	21.07743	20.48856	0	0	17.68151	17.70211	16.91879	0	17.88634	18.53716	18.41736
Q7KZI7	MARK2_HUMAN	"Serine/threonine-protein kinase MARK2, EC 2.7.11.1, EC 2.7.11.26 (ELKL motif kinase 1, EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b, Par-1b, Par1b)"	MARK2 EMK1	Homo sapiens (Human)	activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0000422; GO:0001764; GO:0003723; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005884; GO:0005886; GO:0006468; GO:0008289; GO:0010976; GO:0016020; GO:0016055; GO:0016328; GO:0018105; GO:0018107; GO:0030010; GO:0030295; GO:0030425; GO:0032147; GO:0035556; GO:0045197; GO:0045296; GO:0046777; GO:0048156; GO:0050321; GO:0050770; GO:0051493; GO:0051646; GO:0061564; GO:0070507; GO:0071963; GO:0097427; GO:0106310; GO:1904526	FTWSMKTTSSMEPNEMMR	2.880000114	1	1	2.75E-12	2209.219849	15.71775	0	0	14.24732	13.95858	15.38964	0	13.29449	15.10835	0	14.87439	15.5696	12.61907	0	0	14.23946	0	0	15.32222	0	0	0	15.85584	13.51596	16.29622	0	0	0	0	0	0	15.10853	0	0	15.70519	0	15.60605	0	0	0	15.48474	0	0	0	16.45247	0	0	0
Q7L014	DDX46_HUMAN	"Probable ATP-dependent RNA helicase DDX46, EC 3.6.4.13 (DEAD box protein 46) (PRP5 homolog)"	DDX46 KIAA0801	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0015030; GO:0016020; GO:0016607; GO:0016887	ILNSLKK	17.98999977	1	1	0.254869734	818.0457889	0	14.60902	0	15.91542	16.30417	0	0	16.2803	12.82876	15.43398	0	16.45792	15.98034	16.05252	0	16.52728	16.05529	0	0	16.36729	13.4093	0	0	16.95231	17.0589	0	0	15.44327	16.41385	0	14.82996	15.33988	0	0	17.62491	16.95796	17.42401	18.2382	15.23148	0	15.82608	0	0	0	16.12047	16.03751	0	16.49695
Q7L0R7	RNF44_HUMAN	RING finger protein 44	RNF44 KIAA1100	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	ASAPAGGSPR	5.980000019	0.168337956	0.168337956	0.216670462	866.5721024	12.351	10.25263	13.6462	0	12.93184	14.44262	10.49767	0	0	12.77374	0	0	0	12.46511	0	14.34985	0	10.28371	0	0	0	0	0	0	0	0	0	0	0	0	15.90165	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7L0X0	TRIL_HUMAN	TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644)	TRIL KIAA0644	Homo sapiens (Human)	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; lipopolysaccharide binding [GO:0001530]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142]	lipopolysaccharide binding [GO:0001530]	GO:0001530; GO:0002718; GO:0005615; GO:0006954; GO:0031012; GO:0034142; GO:0045087; GO:0046696	LLLVVCGCLALPPLAEPVCPER	7.380000114	1	1	4.58E-13	2475.43472	0	14.09999	14.61192	11.88546	0	14.50915	15.4193	14.77661	0	0	0	15.57142	12.56366	0	11.87933	0	0	0	14.57917	14.51398	0	0	0	0	13.9922	0	0	0	0	0	0	0	0	0	17.54314	0	0	0	0	0	0	14.6867	0	0	0	0	0	0
Q7L190	DPPA4_HUMAN	Developmental pluripotency-associated protein 4	DPPA4	Homo sapiens (Human)	lung-associated mesenchyme development [GO:0060484]; system development [GO:0048731]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; lung-associated mesenchyme development [GO:0060484]; system development [GO:0048731]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0048731; GO:0060484	MLRGSASSTSMEK	2.25999999	1	1	0.020250742	1416.768974	16.37524	0	0	0	0	0	0	0	14.09762	0	0	0	0	0	0	14.63413	0	15.31526	0	0	0	0	15.83899	0	0	0	0	15.56087	0	0	0	0	0	16.31104	0	15.39298	0	0	0	0	0	0	0	0	14.09138	0	0	14.20867
Q7L1I2	SV2B_HUMAN	Synaptic vesicle glycoprotein 2B	SV2B KIAA0735	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]	acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]	transmembrane transporter activity [GO:0022857]	GO:0001669; GO:0005886; GO:0006836; GO:0007268; GO:0008021; GO:0016020; GO:0016021; GO:0022857; GO:0030672; GO:0043005	GQTDLMAER	4.449999809	1	1	0.260561589	1036.644104	17.30624	18.12989	0	0	0	0	0	16.93941	0	0	17.33876	0	0	17.06204	14.83458	0	16.39468	0	16.83009	0	15.98343	0	0	0	0	0	0	17.72353	0	0	0	0	0	0	18.1675	0	16.75005	0	0	18.82907	0	0	16.59214	0	16.1695	0	0	0
Q7L1Q6	5MP2_HUMAN	eIF5-mimic protein 2 (Basic leucine zipper and W2 domain-containing protein 1) (Protein Orf)	BZW1 5MP2 BZAP45 KIAA0005	Homo sapiens (Human)	regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; regulation of translational initiation [GO:0006446]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0006446; GO:0016020; GO:0045296	KEELVAEQAIK	6.400000095	1	1	0	1257.394189	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7L1S5	CHST9_HUMAN	"Carbohydrate sulfotransferase 9, EC 2.8.2.- (GalNAc-4-O-sulfotransferase 2, GalNAc-4-ST2, GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)"	CHST9 UNQ2549/PRO6175	Homo sapiens (Human)	carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446; GO:0047756	IMSTEK	1.029999971	1	1	0.269308246	723.7940318	0	13.91743	15.29786	15.94017	13.00323	0	14.08596	13.40646	15.01852	0	14.11437	0	0	15.28942	0	0	0	0	15.40416	0	0	15.59966	16.83121	0	0	0	0	0	16.18835	0	0	16.27026	0	0	0	0	17.59387	0	0	15.81598	17.34831	16.85679	0	17.08681	0	15.83605	0	0
Q7L1T6	NB5R4_HUMAN	"Cytochrome b5 reductase 4, EC 1.6.2.2 (Flavohemoprotein b5/b5R, b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R)"	CYB5R4 NCB5OR	Homo sapiens (Human)	bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]"	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]"	GO:0003032; GO:0004128; GO:0005783; GO:0005789; GO:0006091; GO:0006801; GO:0015701; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0072593	VLNGMLPKSQVTDTLAK	10.44999981	0.359869689	0.359869689	0.2553776	1832.603973	10.46975	0	0	0	0	0	0	0	0	15.37059	15.21598	0	19.68565	0	0	0	0	19.35424	0	0	0	19.29671	18.33298	19.75491	0	18.23157	0	18.58504	0	0	0	19.69489	0	0	20.41202	0	0	0	0	0	0	0	0	0	0	0	20.69832	0
Q7L1V2	MON1B_HUMAN	Vacuolar fusion protein MON1 homolog B (HSV-1 stimulation-related gene 1 protein) (HSV-I stimulating-related protein)	MON1B HSRG1 KIAA0872 SAND2	Homo sapiens (Human)	early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Mon1-Ccz1 complex [GO:0035658]	cytoplasm [GO:0005737]; Mon1-Ccz1 complex [GO:0035658]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192]		GO:0005737; GO:0006623; GO:0016192; GO:0019085; GO:0019086; GO:0035658	GELLAVHAQIVSTLTR	4.840000153	0.792838931	0.792838931	0.196585059	1707.455304	0	0	0	16.84548	14.89314	14.91352	18.13238	0	12.86163	17.24547	13.14889	0	19.19097	16.27255	15.96871	17.07162	0	0	17.77534	0	0	0	0	16.27619	0	17.44042	0	16.95903	12.99564	0	0	0	15.98259	14.56809	0	0	18.03027	14.40839	0	14.43201	0	15.17757	14.93135	11.6671	16.057	0	0	0
Q7L1W4	LRC8D_HUMAN	"Volume-regulated anion channel subunit LRRC8D (Leucine-rich repeat-containing protein 5) (Leucine-rich repeat-containing protein 8D, HsLRRC8D)"	LRRC8D LRRC5 UNQ213/PRO239	Homo sapiens (Human)	anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular glucose homeostasis [GO:0001678]; cellular response to osmotic stress [GO:0071470]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular glucose homeostasis [GO:0001678]; cellular response to osmotic stress [GO:0071470]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734]	volume-sensitive anion channel activity [GO:0005225]	GO:0001678; GO:0005225; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0015734; GO:0015810; GO:0016020; GO:0016021; GO:0034214; GO:0034702; GO:0071470; GO:0098656	LVIHNDGTK	13.35000038	0.889745414	0.889745414	0.33972418	997.3894491	14.53315	0	0	15.13001	0	0	0	0	0	0	0	0	15.83493	15.96827	16.49687	16.05121	15.99655	16.65974	16.76073	15.19878	17.0582	0	0	0	16.50792	15.48647	16.21344	13.31579	12.79437	14.10626	14.3027	13.58959	13.10638	15.55641	14.81117	13.52816	16.11608	14.28508	16.64075	16.36314	0	0	0	16.66264	0	14.49983	0	13.80114
Q7L2J0	MEPCE_HUMAN	"7SK snRNA methylphosphate capping enzyme, MePCE, EC 2.1.1.- (Bicoid-interacting protein 3 homolog, Bin3 homolog)"	MEPCE BCDIN3	Homo sapiens (Human)	negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]	7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]	7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]	GO:0000122; GO:0001510; GO:0003723; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0035562; GO:0040031; GO:0097322; GO:0120259; GO:1900087; GO:1904871; GO:1905382; GO:1990276; GO:1990904	GGTER	3.230000019	1	1	0.102261421	518.6967174	16.87954	0	14.12108	0	11.91149	15.07143	0	0	0	16.96295	0	14.9731	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.76076	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.50401	0	0	0	0
Q7L3T8	SYPM_HUMAN	"Probable proline--tRNA ligase, mitochondrial, EC 6.1.1.15 (Prolyl-tRNA synthetase, ProRS)"	PARS2	Homo sapiens (Human)	prolyl-tRNA aminoacylation [GO:0006433]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433]	ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]	GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433	AMEKLVR	22.32999992	0.515793622	0.515793622	0.26062175	863.1090178	17.81955	17.6691	19.3712	16.76957	16.75442	18.87612	17.96438	15.61933	20.16656	16.16806	16.94743	18.22171	15.88713	18.6841	13.38056	16.5503	17.21864	18.86233	16.09723	0	18.08504	19.57262	18.40848	18.29975	18.22508	17.54087	19.36866	17.59746	17.21463	15.7838	16.37566	0	16.82389	19.7989	20.03634	19.2037	18.54416	19.33297	18.77434	18.41569	17.59027	18.26865	14.21758	16.95696	0	17.50496	17.17006	15.82511
Q7L523	RRAGA_HUMAN	"Ras-related GTP-binding protein A, Rag A, RagA, EC 3.6.5.- (Adenovirus E3 14.7 kDa-interacting protein 1) (FIP-1)"	RRAGA	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; negative regulation of cytolysis [GO:0045918]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; negative regulation of cytolysis [GO:0045918]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]	GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006915; GO:0008219; GO:0009267; GO:0010506; GO:0010507; GO:0031625; GO:0032008; GO:0033209; GO:0034198; GO:0034613; GO:0042803; GO:0045918; GO:0046982; GO:0051219; GO:0071230; GO:1904263; GO:1990131	MPNTAMK	9.890000343	1	1	0.127565681	808.1870884	0	15.49934	17.82728	0	0	0	0	0	0	0	0	0	0	0	0	0	15.22944	14.99102	0	0	16.39108	0	16.53222	16.25473	15.19669	18.57864	0	0	0	0	17.01153	16.60793	16.32834	0	0	15.60724	0	0	0	0	0	0	0	0	0	0	0	0
Q7L576	CYFP1_HUMAN	"Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1, Sra-1) (p140sra-1)"	CYFIP1 KIAA0068	Homo sapiens (Human)	"axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]"	axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]	"axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]; actin filament binding [GO:0051015]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; translation regulator activity [GO:0045182]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]"	actin filament binding [GO:0051015]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; translation regulator activity [GO:0045182]	GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005845; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0010592; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0030833; GO:0031209; GO:0031267; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0034774; GO:0035580; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0044294; GO:0044295; GO:0045182; GO:0045202; GO:0045773; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0070062; GO:0090724; GO:0090725; GO:0097484; GO:0099563; GO:0099578; GO:1900006; GO:1900029; GO:1903422; GO:1904724; GO:1905274; GO:2000601	FALVEVIAMIK	10.01000023	1	1	0.310250226	1250.024633	12.17779	14.82515	0	0	0	13.65198	0	0	0	0	0	14.2632	0	0	16.42532	15.93091	14.89495	0	15.4848	0	0	0	0	0	0	15.68591	0	13.81237	14.21631	14.93703	15.80813	15.37717	15.94261	13.28603	0	0	0	0	0	0	15.12345	15.31021	0	0	0	16.07088	0	14.31795
Q7L590	MCM10_HUMAN	"Protein MCM10 homolog, HsMCM10"	MCM10 PRO2249	Homo sapiens (Human)	cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]	DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005730; GO:0006270; GO:0006974; GO:0008283; GO:0019899; GO:0031298; GO:0042802; GO:0046872	VLPAPAPRR	2.579999924	1	1	0.28911481	977.1804085	0	0	0	0	0	0	0	0	0	0	0	17.10323	17.98859	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7L591	DOK3_HUMAN	Docking protein 3 (Downstream of tyrosine kinase 3)	DOK3	Homo sapiens (Human)	Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		GO:0005737; GO:0005886; GO:0007169; GO:0007265; GO:0030667; GO:0101003	KVWALLYAGGPSGVAR	18.59000015	1	1	0.318607866	1645.826294	0	0	0	0	0	0	0	0	0	0	16.00407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.97432	0	0	0	0	0	0	0	19.47822	0	19.8641	0
Q7L5L3	GDPD3_HUMAN	"Lysophospholipase D GDPD3, EC 3.1.4.- (Glycerophosphodiester phosphodiesterase 7) (Glycerophosphodiester phosphodiesterase domain-containing protein 3)"	GDPD3 GDE7	Homo sapiens (Human)	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phosphatidylcholine catabolic process [GO:0034638]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phosphatidylcholine catabolic process [GO:0034638]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016021; GO:0034638; GO:0046475; GO:0046872; GO:0048471; GO:0070062; GO:0070291	RPHLLHTPR	3.220000029	0.54271841	0.54271841	0.179955587	1126.253605	14.93779	13.76108	0	13.47835	14.85776	15.61831	0	0	13.02042	18.23165	13.11253	14.72333	13.00922	0	12.3275	8.02264	0	0	0	0	0	0	15.59283	0	15.74398	0	0	0	0	0	15.22313	0	0	0	15.03601	0	0	13.94319	0	0	0	0	0	0	0	16.508	0	13.79878
Q7L5Y1	ENOF1_HUMAN	"Mitochondrial enolase superfamily member 1, EC 4.2.1.68 (Antisense RNA to thymidylate synthase, rTS) (L-fuconate dehydratase)"	ENOSF1 RTS TYMSAS	Homo sapiens (Human)	carbohydrate catabolic process [GO:0016052]; cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; hydro-lyase activity [GO:0016836]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; carbohydrate catabolic process [GO:0016052]; cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275]	hydro-lyase activity [GO:0016836]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005739; GO:0009063; GO:0016052; GO:0016836; GO:0016853; GO:0044275; GO:0050023	ASYMPPK	4.46999979	1	1	0.195856142	808.3523463	0	0	17.21217	15.10306	0	0	17.3656	0	15.9416	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.23449	15.79082	0	0	0	0	0	0	0	0	0	17.27219	0	0	0	0	0	16.95416	0	0	0	0
Q7L622	G2E3_HUMAN	"G2/M phase-specific E3 ubiquitin-protein ligase, EC 2.3.2.26 (G2/M phase-specific HECT-type E3 ubiquitin transferase)"	G2E3 KIAA1333	Homo sapiens (Human)	apoptotic process [GO:0006915]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0043231; GO:0046872	CCVCKK	5.039999962	0.65266788	0.65266788	0.175464871	854.3702569	14.44962	0	0	13.57576	15.05714	13.27255	0	0	15.32049	0	15.13591	0	0	0	0	0	15.37884	15.93519	0	0	0	16.45947	0	16.20273	16.96726	0	0	16.65392	16.40272	0	0	0	0	13.00229	0	13.3113	0	15.25746	15.14933	0	0	14.74353	14.85899	15.70672	0	0	0	0
Q7L775	EPMIP_HUMAN	EPM2A-interacting protein 1 (Laforin-interacting protein)	EPM2AIP1 KIAA0766 My007	Homo sapiens (Human)	positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634]	cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]	identical protein binding [GO:0042802]	GO:0005634; GO:0032868; GO:0042802; GO:0045725; GO:0098554; GO:2000467	AARAGLGLCR	9.430000305	0.214339375	0.214339375	0.305699907	1045.595667	16.46296	15.39045	15.57261	15.96107	14.41743	0	0	16.8921	13.25267	16.53203	14.73659	16.31418	16.6911	15.97654	16.00692	16.60982	17.01796	16.33859	0	0	16.82327	14.35331	17.22832	0	15.94813	0	0	15.94901	16.34253	16.36816	15.8005	16.19166	0	17.25627	17.07183	16.4515	18.14634	17.19913	16.87795	17.11796	0	0	0	16.80596	15.88265	16.5906	16.52502	16.9515
Q7L7V1	DHX32_HUMAN	"Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32, EC 3.6.4.13 (DEAD/H box 32) (DEAD/H helicase-like protein 1, DHLP1) (DEAH box protein 32) (HuDDX32)"	DHX32 DDX32	Homo sapiens (Human)		mitochondrion [GO:0005739]; spliceosomal complex [GO:0005681]	mitochondrion [GO:0005739]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005739; GO:0016887	QILGSSSSGK	5.409999847	1	1	0.124839469	964.0785765	13.17213	0	13.53998	0	0	12.30034	0	0	0	0	0	0	0	14.91145	14.82144	0	14.6597	10.25881	0	9.504245	13.66785	0	0	0	0	0	15.75601	0	14.8197	14.53523	13.3866	13.30853	9.985357	15.28812	11.22709	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7L7X3	TAOK1_HUMAN	"Serine/threonine-protein kinase TAO1, EC 2.7.11.1 (Kinase from chicken homolog B, hKFC-B) (MARK Kinase, MARKK) (Prostate-derived sterile 20-like kinase 2, PSK-2, PSK2, Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1, TAOK1, hTAOK1)"	TAOK1 KIAA1361 MAP3K16 MARKK	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of MAPK cascade [GO:0043408]; regulation of microtubule cytoskeleton organization [GO:0070507]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of MAPK cascade [GO:0043408]; regulation of microtubule cytoskeleton organization [GO:0070507]	alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740]	GO:0000165; GO:0000226; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006281; GO:0006468; GO:0006974; GO:0007026; GO:0007095; GO:0015630; GO:0016301; GO:0016310; GO:0016740; GO:0032874; GO:0032956; GO:0035556; GO:0043014; GO:0043408; GO:0043539; GO:0046330; GO:0046777; GO:0048156; GO:0048471; GO:0048487; GO:0048812; GO:0050321; GO:0051493; GO:0070050; GO:0070062; GO:0070507; GO:0097194; GO:0106310; GO:1901985	QHQKQLMTLENK	2.039999962	0.149781153	0.149781153	0.181094585	1513.09881	0	0	0	0	0	0	16.005	0	13.44588	0	0	16.64903	0	18.53643	17.44929	18.83105	0	14.55184	16.43967	0	12.56182	16.83515	18.75552	0	15.40603	14.99402	0	15.904	0	16.77177	0	0	17.69953	18.21948	0	17.79204	0	0	0	0	0	15.42395	0	0	17.74022	0	0	15.24961
Q7L804	RFIP2_HUMAN	"Rab11 family-interacting protein 2, Rab11-FIP2 (NRip11)"	RAB11FIP2 KIAA0941	Homo sapiens (Human)	establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; regulated exocytosis [GO:0045055]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]	cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038]	cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; regulated exocytosis [GO:0045055]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]	GO:0001891; GO:0005654; GO:0005768; GO:0006909; GO:0019901; GO:0030010; GO:0030659; GO:0031267; GO:0035669; GO:0035773; GO:0042802; GO:0042803; GO:0042995; GO:0043231; GO:0043547; GO:0045055; GO:0055038	AGKFSNS	1.669999957	1	1	0.013482149	711.3650527	0	0	0	0	0	0	0	14.09854	15.34741	15.51038	0	0	14.2736	0	0	17.63179	0	15.17195	0	14.15964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7L8A9	VASH1_HUMAN	"Tubulinyl-Tyr carboxypeptidase 1, EC 3.4.17.17 (Tubulin carboxypeptidase 1) (Tyrosine carboxypeptidase 1, TTCP 1) (Vasohibin-1)"	VASH1 KIAA1036 VASH	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell cycle [GO:0007049]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of lymphangiogenesis [GO:1901491]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; regulation of cellular senescence [GO:2000772]; response to wounding [GO:0009611]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of lymphangiogenesis [GO:1901491]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; regulation of cellular senescence [GO:2000772]; response to wounding [GO:0009611]	actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]	GO:0001525; GO:0001937; GO:0003779; GO:0004181; GO:0005615; GO:0005737; GO:0005783; GO:0006508; GO:0007049; GO:0009611; GO:0010596; GO:0016525; GO:0043537; GO:0045177; GO:0045765; GO:0060716; GO:1901491; GO:2000772	DGGVPFFVNR	5.809999943	1	1	0.129032941	1106.755323	16.97305	16.62768	15.73648	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7L8J4	3BP5L_HUMAN	"SH3 domain-binding protein 5-like, SH3BP-5-like"	SH3BP5L KIAA1720 UNQ2766/PRO7133	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]	guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]	GO:0004860; GO:0005085; GO:0005737; GO:0035556; GO:0061099	CDSVEHLR	3.470000029	1	1	0.188618955	1015.083107	15.26825	0	0	0	14.76056	0	0	0	14.5376	0	13.73058	0	0	0	0	0	0	0	0	0	15.66047	0	0	0	13.48951	9.50865	0	14.45317	0	11.733	15.09881	12.64053	13.0345	0	0	0	0	0	0	14.49922	14.27046	0	0	15.76016	0	15.89496	13.38279	15.42745
Q7L8W6	DPH6_HUMAN	"Diphthine--ammonia ligase, EC 6.3.1.14 (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)"	DPH6 ATPBD4	Homo sapiens (Human)	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]	GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0017178; GO:0017183	FLELHLEDK	7.800000191	1	1	0.316198851	1144.18525	16.85581	0	0	0	0	0	0	0	0	16.67981	0	16.14904	0	0	17.80585	17.85792	0	0	17.36713	0	0	0	0	16.55579	0	0	0	0	0	0	17.49671	18.06894	0	0	0	18.31843	0	0	0	0	0	0	16.57562	0	0	0	16.89952	17.20087
Q7L945	ZN627_HUMAN	Zinc finger protein 627	ZNF627	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	GGVPYKCK	4.730000019	0.823989213	0.823989213	0.181169736	908.6604774	18.73137	0	16.86284	0	14.01455	0	15.44159	0	15.51137	0	0	0	0	0	0	13.99058	0	0	0	0	17.92951	0	16.06094	16.3748	16.21988	0	14.38275	15.16349	0	15.05693	0	0	0	17.60187	13.14807	0	0	0	0	0	14.96889	16.17971	16.30256	0	4.919318	0	0	0
Q7L985	LIGO2_HUMAN	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C)	LINGO2 LERN3 LRRN6C UNQ9234/PRO31993	Homo sapiens (Human)	positive regulation of synapse assembly [GO:0051965]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]		GO:0005615; GO:0016021; GO:0031012; GO:0051965	SNGRATVLGDGTLEIR	3.019999981	0.38166526	0.38166526	0.304000372	1660.303606	15.97901	0	0	0	0	14.3153	0	0	11.07383	0	0	0	0	0	0	17.57565	0	0	0	0	13.17672	0	0	0	15.13943	15.54444	16.79932	0	13.78744	0	0	16.46161	0	17.03752	14.81101	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7LFX5	CHSTF_HUMAN	"Carbohydrate sulfotransferase 15, EC 2.8.2.33 (B-cell RAG-associated gene protein, hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase, GalNAc4S-6ST)"	CHST15 BRAG GALNAC4S6ST KIAA0598	Homo sapiens (Human)	chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]	GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659	LEDHASNVKYTMHK	5.920000076	1	1	0.269487092	1687.570523	0	15.62957	15.91934	0	0	0	0	0	14.26152	0	0	0	0	0	15.28326	0	14.6713	14.49539	0	0	0	0	15.40722	0	0	12.81936	0	0	0	0	0	0	0	0	16.1603	0	0	0	0	0	0	0	0	0	0	0	16.04525	0
Q7LGA3	HS2ST_HUMAN	"Heparan sulfate 2-O-sulfotransferase 1, 2-O-sulfotransferase, 2OST, EC 2.8.2.-"	HS2ST1 HS2ST KIAA0448	Homo sapiens (Human)	"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]"	heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0004394; GO:0006024; GO:0008146; GO:0015014; GO:0015015; GO:0016020; GO:0016021	FGDDYRPGLRR	9.229999542	1	1	2.06E-12	1351.074104	0	0	13.01723	14.68416	15.69499	0	13.63718	0	0	0	11.28783	14.6916	15.10683	0	14.63289	0	0	14.25564	15.94738	0	0	0	14.2852	0	13.28611	0	0	13.97079	0	12.7558	13.90433	9.920076	0	0	0	0	0	14.64177	0	13.97612	0	0	0	15.11779	13.3372	0	15.97098	14.30041
Q7LGC8	CHST3_HUMAN	"Carbohydrate sulfotransferase 3, EC 2.8.2.17, EC 2.8.2.21 (Chondroitin 6-O-sulfotransferase 1, C6ST-1) (Chondroitin 6-sulfotransferase, C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0, GST-0)"	CHST3	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]	chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]	GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0016021; GO:0030206	DPRAVLASR	4.929999828	1	1	0.285883444	981.6065118	9.631454	13.28698	11.29166	11.5199	0	0	0	13.70994	0	13.38207	15.3326	12.34975	0	11.48971	0	11.19189	13.81921	8.245331	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7M4L6	SHF_HUMAN	SH2 domain-containing adapter protein F	SHF	Homo sapiens (Human)	apoptotic process [GO:0006915]		phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915]	phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0006915	SCLSPGREEK	3.700000048	1	1	0.118463186	1162.811888	13.08705	11.18699	0	15.51685	14.50917	14.01231	0	0	0	0	0	13.0906	0	0	0	13.0079	13.86162	0	0	16.23847	13.51949	15.08918	15.1697	12.32598	17.02458	16.85903	0	0	0	0	0	0	0	0	0	0	15.0635	0	15.62101	0	0	0	14.91006	0	17.04212	0	0	12.22369
Q7RTP0	NIPA1_HUMAN	Magnesium transporter NIPA1 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 1) (Spastic paraplegia 6 protein)	NIPA1 SPG6	Homo sapiens (Human)	magnesium ion transport [GO:0015693]; transmembrane transport [GO:0055085]	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; transmembrane transport [GO:0055085]	magnesium ion transmembrane transporter activity [GO:0015095]	GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016020; GO:0016021; GO:0055085	MGTAAAAAAAAAAAAAGEGAR	6.730000019	1	1	0.095537471	1702.197708	0	0	0	0	13.33664	0	0	0	13.94758	0	15.97133	0	0	0	14.5852	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.49984	0	0	0	0	0	0	17.35018	0	0	0	0	0	0	0	0
Q7RTP6	MICA3_HUMAN	"[F-actin]-monooxygenase MICAL3, EC 1.14.13.225 (Molecule interacting with CasL protein 3, MICAL-3)"	MICAL3 KIAA0819 KIAA1364	Homo sapiens (Human)	actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]	cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]	"cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; small GTPase binding [GO:0031267]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]"	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; small GTPase binding [GO:0031267]"	GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0007049; GO:0016709; GO:0030042; GO:0031267; GO:0042995; GO:0045171; GO:0046872; GO:0051015; GO:0051301; GO:0071949; GO:0090543	GPSQATSPIR	8.140000343	1	1	0.540227048	1013.082027	0	0	0	0	0	0	0	0	0	0	0	0	16.37212	0	0	0	0	0	0	0	0	0	17.6545	0	0	0	0	0	0	0	0	0	0	0	0	17.85198	0	0	0	0	0	0	0	0	0	17.66195	0	0
Q7RTR0	NLRP9_HUMAN	"NACHT, LRR and PYD domains-containing protein 9 (Nucleotide-binding oligomerization domain protein 6) (PYRIN and NACHT-containing protein 12)"	NLRP9 NALP9 NOD6 PAN12	Homo sapiens (Human)	defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-18 production [GO:0032741]; pyroptosis [GO:0070269]	inflammasome complex [GO:0061702]	inflammasome complex [GO:0061702]; ATP binding [GO:0005524]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-18 production [GO:0032741]; pyroptosis [GO:0070269]	ATP binding [GO:0005524]	GO:0005524; GO:0006954; GO:0032741; GO:0045087; GO:0051607; GO:0061702; GO:0070269	AGSQSFPPK	8.789999962	1	1	0.194077162	917.550155	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59247	0	0	0	0	0	0	0	0	0	0	0	0	18.32078	17.58218	0	0	0	0	0	0	0	0
Q7RTR2	NLRC3_HUMAN	"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2, CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)"	NLRC3 NOD3	Homo sapiens (Human)	I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]	ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]	GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223	ALADALKINR	5.679999828	1	1	0.378626629	1083.674753	0	17.0273	0	0	0	0	0	0	15.59499	0	0	0	0	0	0	0	0	0	0	18.20442	0	0	0	0	0	0	15.24604	0	16.62305	0	15.74339	0	0	0	0	0	0	0	0	0	16.56373	0	0	0	16.39122	0	0	16.11992
Q7RTS5	OTOP3_HUMAN	Proton channel OTOP3 (Otopetrin-3)	OTOP3	Homo sapiens (Human)	proton transmembrane transport [GO:1902600]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600]	proton channel activity [GO:0015252]	GO:0005886; GO:0015252; GO:0016021; GO:1902600	AAATRPR	15.92000008	0.521158755	0.521158755	0.318521011	741.015574	14.71008	15.37873	0	15.59242	0	0	0	15.19981	0	14.8008	16.97	0	0	0	15.50566	14.31774	0	0	0	14.87294	0	0	0	0	0	0	14.73743	0	13.84004	15.80489	0	0	0	14.73359	16.1231	16.12818	16.9402	0	17.04649	16.60321	0	15.49943	0	0	0	0	16.71519	0
Q7RTS7	K2C74_HUMAN	"Keratin, type II cytoskeletal 74 (Cytokeratin-74, CK-74) (Keratin-5c, K5C) (Keratin-74, K74) (Type II inner root sheath-specific keratin-K6irs4) (Type-II keratin Kb37)"	KRT74 K6IRS4 KB37 KRT5C KRT6IRS4	Homo sapiens (Human)	intermediate filament cytoskeleton organization [GO:0045104]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; keratin filament binding [GO:1990254]; intermediate filament cytoskeleton organization [GO:0045104]	keratin filament binding [GO:1990254]	GO:0005737; GO:0005829; GO:0045095; GO:0045104; GO:0070062; GO:1990254	STPASIPAR	3.809999943	0.269407839	0.269407839	0.137078238	900.58227	18.39003	17.17452	15.68477	0	0	16.79432	10.86889	16.56138	16.05654	11.85941	11.37306	15.21954	16.91738	17.39836	0	0	15.62935	13.5071	16.09162	17.38293	0	17.96667	0	18.46375	15.82012	0	17.22321	17.69597	0	14.77624	13.8675	16.99975	15.8248	13.56223	16.75002	11.5025	16.48759	17.49582	13.04088	0	15.30074	15.09674	14.26409	16.91875	15.26639	15.12591	15.69686	0
Q7RTT9	S29A4_HUMAN	"Equilibrative nucleoside transporter 4, hENT4 (Plasma membrane monoamine transporter) (Solute carrier family 29 member 4)"	SLC29A4 ENT4 PMAT PSEC0113	Homo sapiens (Human)	cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]	cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0001692; GO:0005326; GO:0005337; GO:0005342; GO:0005886; GO:0006836; GO:0008324; GO:0008504; GO:0015101; GO:0015562; GO:0015695; GO:0015844; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098655; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1903825	GRPGLGR	7.179999828	1	1	0.168997851	712.460231	0	14.80138	14.92679	15.73566	14.90139	0	0	0	0	0	0	0	0	15.22723	0	0	16.30463	15.45811	17.10608	16.79063	15.92567	16.93768	16.46657	0	16.30464	16.82681	0	16.91361	15.07213	0	16.06292	16.69412	16.54378	17.60009	16.56867	17.11371	17.59156	17.3656	0	16.79445	17.0225	16.72769	16.65845	17.04309	0	16.78555	17.32509	17.59128
Q7RTU0	TCF24_HUMAN	"Transcription factor 24, TCF-24"	TCF24	Homo sapiens (Human)	developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0032502; GO:0046983	DSRPGRTGPGPAGPGGGSR	2.819999933	1	1	0.022346433	1734.89564	0	13.21426	0	10.28451	0	0	15.102	13.22486	15.06424	15.27129	0	11.55172	11.58835	0	0	9.524519	14.60904	14.46606	0	14.53082	14.47076	11.96808	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7RTU9	STRC_HUMAN	Stereocilin	STRC	Homo sapiens (Human)	auditory receptor cell stereocilium organization [GO:0060088]; cell-matrix adhesion [GO:0007160]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]	cell surface [GO:0009986]; kinocilium [GO:0060091]; stereocilium tip [GO:0032426]	cell surface [GO:0009986]; kinocilium [GO:0060091]; stereocilium tip [GO:0032426]; auditory receptor cell stereocilium organization [GO:0060088]; cell-matrix adhesion [GO:0007160]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]		GO:0007160; GO:0009986; GO:0032426; GO:0050910; GO:0060088; GO:0060091	ASQPSAHISPR	8.43999958	1	1	0.195091991	1146.86652	0	0	0	14.57748	0	0	13.45569	15.32954	15.33705	0	15.5165	14.36292	0	0	0	0	0	13.5631	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7RTX0	TS1R3_HUMAN	Taste receptor type 1 member 3 (Sweet taste receptor T1R3)	TAS1R3 T1R3 TR3	Homo sapiens (Human)	detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sweet taste receptor complex [GO:1903767]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sweet taste receptor complex [GO:1903767]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917]	G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]	GO:0001582; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008527; GO:0016021; GO:0050916; GO:0050917; GO:1903767	FSSNGLLWALAMKMAVEEINNK	1.929999948	1	1	0.442232904	2483.842589	15.24009	18.44106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7RTX7	CTSR4_HUMAN	"Cation channel sperm-associated protein 4, CatSper4"	CATSPER4	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240]	acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]	acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240]	calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]	GO:0001669; GO:0005227; GO:0005245; GO:0005886; GO:0006814; GO:0030317; GO:0034765; GO:0036128; GO:0048240; GO:0097228	MGFGGAVAALR	4.309999943	1	1	0.094373208	1050.095754	0	0	0	0	13.05199	0	15.47023	18.57141	13.53526	18.98104	0	0	17.11824	0	0	0	0	0	0	0	0	0	0	0	0	16.00208	11.95447	15.09149	0	0	0	13.69364	0	0	0	0	0	0	0	0	0	0	0	15.99311	14.42208	0	0	14.53643
Q7RTY5	PRS48_HUMAN	"Serine protease 48, EC 3.4.21.- (Epidermis-specific serine protease-like protein)"	PRSS48 ESSPL	Homo sapiens (Human)	proteolysis [GO:0006508]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0006508	WINATISR	8.550000191	0.065615766	0.065615766	0.220420473	959.3642273	15.93267	16.23007	0	15.71384	15.56375	15.62669	14.43295	11.92011	15.75965	0	16.1508	0	12.84052	14.81205	13.78008	16.99261	0	0	0	0	0	0	0	15.34682	15.57331	14.15887	15.17082	15.15975	0	16.69774	14.91707	16.23508	16.83	17.38036	0	14.60106	17.39783	16.38875	13.75042	0	16.00836	0	13.68921	0	15.28391	14.97127	16.49183	0
Q7RTY7	OVCH1_HUMAN	"Ovochymase-1, EC 3.4.21.-"	OVCH1	Homo sapiens (Human)		extracellular region [GO:0005576]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005886; GO:0046872	VMIFLDWIQSKINGPASLQTNNK	6.679999828	1	1	0.21818046	2632.242154	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.93501	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7RTY8	TMPS7_HUMAN	"Transmembrane protease serine 7, EC 3.4.21.- (Matriptase-3)"	TMPRSS7	Homo sapiens (Human)	proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0016021	MDKENSDVSAAPADLK	3.599999905	1	1	0.297194256	1706.487408	16.35701	0	0	0	0	15.25616	0	0	0	14.40436	15.58174	14.22799	0	0	0	0	16.29163	16.0434	15.72517	0	0	0	0	0	0	14.46824	16.30478	15.03805	0	14.96671	0	0	0	12.77783	0	0	0	0	0	16.54238	15.96276	16.1741	15.01179	0	17.16714	16.15568	0	0
Q7Z2D5	PLPR4_HUMAN	"Phospholipid phosphatase-related protein type 4 (Brain-specific phosphatidic acid phosphatase-like protein 1) (Inactive 2-lysophosphatidate phosphatase PLPPR4) (Lipid phosphate phosphatase-related protein type 4) (Plasticity-related gene 1 protein, PRG-1)"	PLPPR4 KIAA0455 LPPR4 PHP1 PRG1	Homo sapiens (Human)	"axonogenesis [GO:0007409]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; lipid import into cell [GO:0140354]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]"	glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]	"glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; axonogenesis [GO:0007409]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; lipid import into cell [GO:0140354]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]"	lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]	GO:0005886; GO:0005887; GO:0006644; GO:0007165; GO:0007186; GO:0007409; GO:0008195; GO:0042577; GO:0046839; GO:0048839; GO:0051966; GO:0098839; GO:0098978; GO:0099061; GO:0140354	IMQVIAMSK	4.409999847	1	1	0.030300785	1037.294428	15.28022	0	0	0	0	0	15.9177	0	0	15.88346	0	14.9731	14.6393	0	16.36285	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.08672	15.60129	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32911	16.18039
Q7Z2K6	ERMP1_HUMAN	"Endoplasmic reticulum metallopeptidase 1, EC 3.4.-.- (Felix-ina)"	ERMP1 FXNA KIAA1815	Homo sapiens (Human)	cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508]	metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235]	GO:0005783; GO:0005789; GO:0006508; GO:0008235; GO:0016020; GO:0016021; GO:0030968; GO:0034599; GO:0046872	YDTADR	6.829999924	1	1	0.149466239	740.853859	0	0	0	0	0	15.19174	15.99435	0	17.1132	0	17.42046	0	0	0	0	0	0	17.06427	15.36619	0	0	0	0	0	0	18.62164	0	0	0	0	16.91202	0	0	0	14.40139	0	0	0	19.30563	16.74185	0	0	0	0	0	0	0	0
Q7Z2K8	GRIN1_HUMAN	"G protein-regulated inducer of neurite outgrowth 1, GRIN1"	GPRIN1 KIAA1893	Homo sapiens (Human)	neuron projection development [GO:0031175]	growth cone [GO:0030426]; plasma membrane [GO:0005886]	growth cone [GO:0030426]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; neuron projection development [GO:0031175]	phosphoprotein binding [GO:0051219]	GO:0005886; GO:0030426; GO:0031175; GO:0051219	MDPMCSGKPELLSPGQAERVSVGK	6.380000114	1	1	0.245655387	2588.529336	15.05169	13.9395	16.0277	0	0	0	0	11.51309	0	0	0	12.77438	15.505	13.06638	14.79543	14.4514	0	0	12.67665	0	0	0	0	0	13.65137	14.79818	15.53094	0	0	0	0	0	17.63924	0	0	0	12.65331	0	0	0	15.66523	13.99709	0	0	0	0	0	0
Q7Z2W4	ZCCHV_HUMAN	"Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13, ARTD13) (Inactive Poly [ADP-ribose] polymerase 13, PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein, ZAP)"	ZC3HAV1 ZC3HDC2 PRO1677	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]	cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0009615; GO:0032727; GO:0032728; GO:0043123; GO:0045071; GO:0045087; GO:0045296; GO:0046872; GO:0051607; GO:0061014; GO:1900246	IADDADPR	4.190000057	0.730724752	0.730724752	0.191811507	872.5450628	14.4844	0	0	0	15.23736	15.27249	14.24642	0	0	0	15.20494	0	13.85794	0	0	0	15.39237	14.91031	0	0	0	0	15.75338	0	14.47164	8.412798	14.91434	10.64304	15.18157	14.79827	16.39144	16.09519	16.57824	13.63353	14.07944	14.41924	15.39457	16.22461	13.01128	13.75239	15.63681	15.88821	14.09682	13.62816	15.01366	13.52882	15.01348	14.77324
Q7Z2W7	TRPM8_HUMAN	"Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6, LTrpC-6, LTrpC6) (Transient receptor potential p8, Trp-p8)"	TRPM8 LTRPC6 TRPP8	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; thermoception [GO:0050955]	endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; thermoception [GO:0050955]	calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]	GO:0005261; GO:0005262; GO:0005789; GO:0005886; GO:0005887; GO:0006874; GO:0009409; GO:0009897; GO:0016048; GO:0042802; GO:0045121; GO:0050955; GO:0070588; GO:0098655; GO:0099604; GO:0120162	NFALKPRMR	6.900000095	1	1	0.192249005	1149.071289	0	14.41083	0	0	14.04118	0	15.01486	14.10392	14.99481	15.21896	12.35966	15.09878	14.34147	14.9812	0	17.76555	14.65798	14.39005	0	15.98747	0	0	0	16.86433	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.48044	0	0	0	0	0	0	15.03203	0
Q7Z2Y5	NRK_HUMAN	"Nik-related protein kinase, EC 2.7.11.1"	NRK	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0031532; GO:0035556; GO:0043408; GO:0048812; GO:0106310	GIPLIFER	3.160000086	0.650114357	0.650114357	0.17320794	942.4112413	16.01144	0	0	12.94706	0	0	0	0	0	0	0	0	16.26448	13.02496	13.38678	16.00453	0	0	16.59793	0	0	0	14.60591	0	0	0	0	0	13.79093	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.81568	0	0	0	14.78687
Q7Z2Y8	GVIN1_HUMAN	Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1)	GVINP1 GVIN1 VLIG1	Homo sapiens (Human)		cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005829	EFTSPQAEFMFTQMVEK	3.440000057	0.980145335	0.980145335	1.83E-12	2066.874718	14.28537	15.63161	14.04499	16.25514	15.25151	0	0	12.338	13.21351	12.28989	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.01281	0	12.64134	15.73839	13.70112	0	0	0	15.83121	0	0	0	0	0	0	0	0	0
Q7Z2Z1	TICRR_HUMAN	"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)"	TICRR C15orf42	Homo sapiens (Human)	DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0007095; GO:0010212; GO:0030174; GO:0033314; GO:0043231	RGVPR	10.07999992	1	1	0.005757297	584.8557968	0	0	0	0	0	0	13.90973	0	0	0	0	16.3901	0	0	0	16.34481	0	15.52398	15.76211	0	0	12.08631	0	0	0	0	0	0	0	0	0	17.4845	15.57283	0	0	0	0	15.16901	0	15.86816	0	0	16.22252	0	15.51861	0	0	0
Q7Z2Z2	EFL1_HUMAN	Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A)	EFL1 EFTUD1 FAM42A	Homo sapiens (Human)	GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]	ribonucleoprotein complex [GO:1990904]	ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904	VLQEEMK	1.789999962	0.002647907	0.002647907	0.309040588	874.0617811	18.66705	16.8921	16.02437	0	0	17.22157	18.61434	0	17.0761	0	0	0	16.25	15.3496	0	16.99967	18.93468	0	16.45393	16.78648	0	0	0	17.40867	0	0	0	17.72179	0	0	0	0	0	18.95945	0	0	16.759	17.35857	18.65442	17.01924	0	0	17.5376	0	16.28857	18.07086	16.73946	16.79083
Q7Z333	SETX_HUMAN	"Probable helicase senataxin, EC 3.6.4.- (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)"	SETX ALS4 KIAA0625 SCAR1	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806	CLHLLWVSSQQWVEAVVK	2.839999914	1	1	3.66E-12	2180.447936	0	15.50229	12.49126	0	11.45803	0	14.80495	0	0	0	0	0	0	13.71005	13.99571	0	13.74037	0	0	12.64048	14.72103	0	16.14968	0	0	14.40982	0	0	0	13.46188	0	14.81212	0	0	14.85614	13.80757	15.66362	0	17.50636	15.75577	16.36163	0	0	16.71434	0	17.5011	0	0
Q7Z340	ZN551_HUMAN	Zinc finger protein 551 (Zinc finger protein KOX23)	ZNF551 KOX23	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	VHTEERP	9.079999924	1	1	0.340470112	868.5725086	14.78547	0	15.70222	14.86607	15.89643	0	0	0	0	14.90416	12.15397	0	0	14.34295	11.96215	0	15.01179	15.64879	0	0	0	16.21262	0	0	0	0	0	0	0	0	0	0	0	15.48483	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z353	HDX_HUMAN	Highly divergent homeobox	HDX CXorf43	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357	EEDHHAVTTDNVK	6.800000191	1	1	0.527456571	1494.595735	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.21674	0	0	19.30973	0	0	0	19.24675	0	0	0	0	17.46315	0	0	0	0	0	20.04005	0	17.83285	19.35899	0	0	0	0	0
Q7Z388	D19L4_HUMAN	"Probable C-mannosyltransferase DPY19L4, EC 2.4.1.- (Dpy-19-like protein 4) (Protein dpy-19 homolog 4)"	DPY19L4	Homo sapiens (Human)	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]	integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]	mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0005637; GO:0016021; GO:0018406	GSFVAK	4.670000076	0.273962587	0.273962587	0.016536454	608.7224546	11.85044	0	14.08867	15.58527	16.27881	10.64795	15.16935	17.37144	0	15.29365	0	15.1393	15.25998	13.68986	15.51507	12.8763	16.44745	16.34914	16.56932	14.66584	14.18808	13.94124	16.05442	15.87952	16.95469	12.74206	15.20601	14.85006	15.11799	13.27726	15.3407	13.86283	13.78907	16.08843	16.43932	0	14.14115	11.12757	14.99747	16.83703	14.97176	13.56579	15.55594	16.60247	14.52556	15.14363	13.39958	8.498507
Q7Z392	TPC11_HUMAN	Trafficking protein particle complex subunit 11	TRAPPC11 C4orf41	Homo sapiens (Human)	constitutive secretory pathway [GO:0045054]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; regulation of protein complex stability [GO:0061635]; vesicle tethering [GO:0099022]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; constitutive secretory pathway [GO:0045054]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; regulation of protein complex stability [GO:0061635]; vesicle tethering [GO:0099022]		GO:0005737; GO:0005794; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0045054; GO:0048208; GO:0061635; GO:0099022; GO:1990072	CHKDETVTIETVFPFDVAVK	1.940000057	1	1	0.036958955	2334.17241	13.31365	0	13.99973	12.69167	13.2771	0	0	13.55181	13.8212	16.36237	0	0	15.65953	0	0	0	0	0	13.27978	0	0	0	0	0	0	0	0	0	15.39863	0	0	0	0	0	0	0	0	16.09339	0	0	0	0	0	0	0	0	12.83107	0
Q7Z3B3	KANL1_HUMAN	"KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1, hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog)"	KANSL1 CENP-36 KIAA1267 MSL1V1 NSL1	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]"	histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]"	histone acetyltransferase binding [GO:0035035]	GO:0000123; GO:0000776; GO:0005634; GO:0005654; GO:0006325; GO:0035035; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0051571; GO:0071339	TSGSK	7.820000172	1	1	0.132375454	478.2916593	0	0	0	0	0	0	16.01954	0	20.72891	0	18.04763	0	0	0	0	0	0	0	0	0	17.87988	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.95215	0	0	0	0	0	0	0	0	0	0	0
Q7Z3D4	LYSM3_HUMAN	LysM and putative peptidoglycan-binding domain-containing protein 3	LYSMD3	Homo sapiens (Human)	Golgi organization [GO:0007030]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Golgi organization [GO:0007030]		GO:0005794; GO:0005886; GO:0007030; GO:0016021	RENLNEVVSALTAQQMR	5.690000057	0.550551474	0.550551474	0.233946346	1973.145268	0	0	0	0	0	14.22817	0	13.72285	0	0	14.48177	0	0	0	0	0	0	0	0	0	0	0	0	13.96218	0	0	0	0	0	0	0	0	12.42935	0	0	16.7381	0	0	15.45182	0	0	0	0	0	0	0	11.8204	0
Q7Z3D6	GLUCM_HUMAN	"D-glutamate cyclase, mitochondrial, EC 4.2.1.48"	DGLUCY C14orf159 UNQ2439/PRO5000	Homo sapiens (Human)	glutamate metabolic process [GO:0006536]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; D-glutamate cyclase activity [GO:0047820]; glutamate metabolic process [GO:0006536]	D-glutamate cyclase activity [GO:0047820]	GO:0005759; GO:0006536; GO:0047820	APGDQAWTQALPSVIK	2.839999914	1	1	0.07336935	1681.145845	16.91613	0	0	17.33587	15.38779	0	0	0	0	16.95479	14.54001	0	14.77457	13.10478	0	0	0	14.72594	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z3E2	CC186_HUMAN	Coiled-coil domain-containing protein 186 (CTCL tumor antigen HD-CL-01/L14-2)	CCDC186 C10orf118	Homo sapiens (Human)	insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; response to bacterium [GO:0009617]; vesicle cytoskeletal trafficking [GO:0099518]	trans-Golgi network [GO:0005802]	trans-Golgi network [GO:0005802]; small GTPase binding [GO:0031267]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; response to bacterium [GO:0009617]; vesicle cytoskeletal trafficking [GO:0099518]	small GTPase binding [GO:0031267]	GO:0005802; GO:0009617; GO:0031267; GO:0035773; GO:0099518	EAMVMK	8.470000267	1	1	0.124858449	709.4209819	0	0	14.38145	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.01133	0	0	0	0	0	0	0	0	17.08518	16.59523	0	17.95201	0	0	0	15.63663
Q7Z3E5	ARMC9_HUMAN	LisH domain-containing protein ARMC9 (Armadillo repeat-containing protein 9) (Melanoma/melanocyte-specific tumor antigen KU-MEL-1) (NS21)	ARMC9 KIAA1868	Homo sapiens (Human)	cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880]		GO:0005737; GO:0005814; GO:0036064; GO:0045880; GO:0060271; GO:0070062; GO:0097542	KGLANVQWSGDEPLQRPVTPGGHR	2.130000114	1	1	2.74E-12	2600.34787	15.50489	13.25755	0	13.23215	14.14063	13.79956	0	0	13.37855	14.97249	14.47587	14.69565	0	13.95104	11.95024	15.39926	11.81875	0	0	15.38865	14.66834	0	0	0	0	14.73582	14.53614	0	0	0	0	0	0	0	0	0	14.45502	0	0	0	0	15.10479	11.55672	0	0	0	0	0
Q7Z3F1	GP155_HUMAN	Integral membrane protein GPR155 (G-protein coupled receptor PGR22)	GPR155 PGR22	Homo sapiens (Human)	cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085]		GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062	DTQNASQNK	3.74000001	1	1	0.419224097	1009.262186	16.11531	15.54634	14.21053	15.60726	0	0	15.69242	14.23082	14.50693	15.96953	14.20014	14.2288	0	0	0	0	15.4042	16.96301	0	15.96136	0	0	15.31056	0	0	0	0	0	16.32544	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z3G6	PRIC2_HUMAN	Prickle-like protein 2	PRICKLE2	Homo sapiens (Human)	"Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; zinc ion binding [GO:0008270]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0031965; GO:0060071	GSIQVPK	2.160000086	1	1	0.272095777	727.504264	0	18.6265	18.51076	0	17.61967	0	18.62847	17.05516	0	0	0	0	18.20308	16.81873	0	0	17.47444	0	0	15.44539	0	0	0	0	19.28304	17.95201	18.4873	17.07492	17.35152	0	19.48388	0	0	0	18.89432	0	0	0	18.13394	0	16.00934	18.58832	17.7343	0	0	0	0	17.23084
Q7Z3I7	ZN572_HUMAN	Zinc finger protein 572	ZNF572	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042802; GO:0046872	SFGLSSHLIR	5.579999924	1	1	0.148853857	1116.227236	0	15.32014	0	0	16.14758	15.23032	12.02528	12.49921	0	17.78717	14.54371	14.10744	0	13.42872	0	0	14.89757	14.24998	14.40945	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.63245	0	0	16.3682	0	0	0	0	0	0	0	0
Q7Z3J2	VP35L_HUMAN	VPS35 endosomal protein-sorting factor-like (Esophageal cancer-associated protein)	VPS35L C16orf62 101F10.2	Homo sapiens (Human)	endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]	endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]		GO:0005768; GO:0005886; GO:0006893; GO:0015031; GO:0016021; GO:0032456; GO:0101003	DDNSVVGSDFEPWTNK	16.98999977	1	1	0.304947479	1810.241417	0	0	0	0	0	0	16.01805	0	0	0	0	0	0	0	16.14931	0	15.07759	0	0	0	0	0	16.33334	0	17.7226	0	16.8024	0	0	15.27175	14.79322	16.26538	0	0	15.25667	17.47045	0	13.09514	13.13311	16.7215	13.10699	15.30776	13.13711	17.28236	15.01584	13.53963	15.4703	13.74964
Q7Z3K3	POGZ_HUMAN	Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635)	POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003	Homo sapiens (Human)	cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007064; GO:0010468; GO:0045944; GO:0046872; GO:0051301; GO:0051382; GO:1905168	MIHEDTR	3.579999924	0.911760092	0.911760092	0.135891091	917.4079275	11.71482	0	14.3692	0	13.45429	14.17275	14.25333	14.69174	13.30608	15.19913	0	0	0	14.73993	15.34308	13.07765	0	0	15.47213	13.97248	0	16.18078	16.15801	0	0	0	0	0	0	0	14.2031	0	15.9406	0	0	0	0	0	0	14.75231	0	0	0	14.89884	0	16.56512	0	0
Q7Z3T8	ZFY16_HUMAN	Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosome-associated FYVE domain protein)	ZFYVE16 KIAA0305	Homo sapiens (Human)	endosomal transport [GO:0016197]; protein targeting to lysosome [GO:0006622]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]; vesicle organization [GO:0016050]	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; endosomal transport [GO:0016197]; protein targeting to lysosome [GO:0006622]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]; vesicle organization [GO:0016050]"	"1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]"	GO:0005545; GO:0005547; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0016050; GO:0016197; GO:0030100; GO:0031901; GO:0043231; GO:0046872	MMSPTGSNLK	3	1	1	0.078437832	1065.35129	0	0	12.00731	15.00827	0	0	15.79547	14.3854	0	0	0	0	0	0	0	0	0	12.71646	0	15.41978	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.75428	0	0	0	0	0	0
Q7Z3U7	MON2_HUMAN	Protein MON2 homolog (Protein SF21)	MON2 KIAA1040 SF21	Homo sapiens (Human)	Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		GO:0005829; GO:0006895; GO:0015031; GO:0031901; GO:0070062	LLETGLVNMHR	8.510000229	1	1	0.048485103	1296.590667	0	13.39787	0	0	0	0	0	0	14.76721	0	0	0	13.02928	0	0	0	0	0	14.96035	0	0	10.23922	0	0	0	0	0	13.41429	0	0	0	11.60635	0	0	14.44546	0	0	0	13.00162	12.19864	0	9.719749	14.37441	0	0	0	0	0
Q7Z3V5	ZN571_HUMAN	Zinc finger protein 571	ZNF571 HSPC059	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	RINHHLQYNGLGDNMECK	6.829999924	1	1	0.765222154	2198.520651	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.01595	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z3Y7	K1C28_HUMAN	"Keratin, type I cytoskeletal 28 (Cytokeratin-28, CK-28) (Keratin-25D, K25D) (Keratin-28, K28) (Type I inner root sheath-specific keratin-K25irs4)"	KRT28 KRT25D	Homo sapiens (Human)		cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0070062	DAEAWFNEK	47.47999954	1	1	0.477230832	1109.181504	17.01352	0	18.09337	0	0	18.31317	0	18.8695	0	0	0	0	0	0	0	0	0	0	0	18.94892	0	0	0	16.8221	0	0	0	0	0	0	0	18.24003	0	18.96683	0	0	0	0	0	0	0	0	0	0	0	0	0	18.43433
Q7Z3Y8	K1C27_HUMAN	"Keratin, type I cytoskeletal 27 (Cytokeratin-27, CK-27) (Keratin-25C, K25C) (Keratin-27, K27) (Type I inner root sheath-specific keratin-K25irs3)"	KRT27 KRT25C	Homo sapiens (Human)	hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0031069; GO:0045109; GO:0070062	FSSTSRR	5.929999828	1	1	0.108151356	841.4724484	0	16.01776	17.89967	17.44514	0	12.82239	14.71086	14.25617	0	0	0	16.99214	10.32795	0	0	0	13.65197	13.92676	15.69435	15.63444	16.52386	0	0	0	0	15.48254	18.30172	16.9637	9.801312	0	0	0	0	15.81749	0	0	0	18.14631	16.25413	18.12015	0	18.20204	17.78744	0	16.45115	18.05205	16.766	14.45107
Q7Z3Z0	K1C25_HUMAN	"Keratin, type I cytoskeletal 25 (Cytokeratin-25, CK-25) (Keratin-25, K25) (Keratin-25A, K25A) (Type I inner root sheath-specific keratin-K25irs1)"	KRT25 KRT25A	Homo sapiens (Human)	aging [GO:0007568]; cytoskeleton organization [GO:0007010]; hair cycle [GO:0042633]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; protein heterodimerization activity [GO:0046982]; structural molecule activity [GO:0005198]; aging [GO:0007568]; cytoskeleton organization [GO:0007010]; hair cycle [GO:0042633]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]	protein heterodimerization activity [GO:0046982]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0005856; GO:0007010; GO:0007568; GO:0031069; GO:0042633; GO:0045095; GO:0045109; GO:0046982; GO:0070062	DPAKAIVVK	6.670000076	1	1	0.023576165	941.6315464	0	0	14.16824	0	0	0	0	0	0	0	0	0	0	0	0	0	15.33448	12.80777	0	0	0	0	0	15.1007	15.95433	11.75076	0	0	0	0	0	18.2242	0	14.72676	0	0	0	0	0	0	0	0	0	0	16.30361	0	0	0
Q7Z3Z3	PIWL3_HUMAN	Piwi-like protein 3	PIWIL3	Homo sapiens (Human)	cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; piRNA binding [GO:0034584]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]	piRNA binding [GO:0034584]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0006417; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0043186; GO:0051321	MGGALWK	7.599999905	0.897135675	0.897135675	0.193612592	763.4885281	15.83858	15.70902	16.27003	13.89652	15.83478	14.95828	16.35273	0	15.07667	0	15.68931	15.15379	15.99544	0	0	0	16.09045	15.46768	0	17.25453	16.45197	15.40597	0	0	16.40264	17.3268	0	16.80286	15.85325	15.24902	17.02417	14.7305	0	16.9245	17.92751	16.72029	15.75632	16.76765	16.9846	16.19937	16.07838	16.25885	12.22822	15.16367	15.98744	17.12355	16.45715	16.84443
Q7Z3Z4	PIWL4_HUMAN	Piwi-like protein 4	PIWIL4 HIWI2 PIWI	Homo sapiens (Human)	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; epithelial structure maintenance [GO:0010669]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547]; piRNA binding [GO:0034584]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; epithelial structure maintenance [GO:0010669]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]	piRNA binding [GO:0034584]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006417; GO:0007283; GO:0010529; GO:0010669; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0043046; GO:0043186; GO:0051321; GO:0071547	LSMYQIGRNFYNPSEPMEIPQHK	3.230000019	1	1	0.044306634	2811.426019	0	15.57482	0	0	0	14.78669	0	0	0	0	14.21193	15.12936	0	15.35118	0	0	0	0	0	14.56017	0	16.10839	15.26877	14.31115	0	13.72902	15.04045	11.85681	17.05722	15.37702	16.33454	0	14.66908	0	0	0	0	14.59778	13.52778	13.07367	0	0	0	0	0	0	0	0
Q7Z401	MYCPP_HUMAN	C-myc promoter-binding protein (DENN domain-containing protein 4A)	DENND4A IRLB MYCPBP	Homo sapiens (Human)	"regulation of Rab protein signal transduction [GO:0032483]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Rab protein signal transduction [GO:0032483]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483	SAHKIAK	3.630000114	1	1	0.247024644	754.842966	0	18.73511	17.02201	0	0	18.6	20.47419	17.79655	18.72829	0	17.79357	0	0	19.07642	18.07131	0	19.49018	19.85083	17.45247	18.09448	17.96474	19.17739	17.30285	18.57686	0	17.56785	0	0	0	0	0	0	18.88222	19.17477	19.79107	19.36769	20.60894	18.66521	19.65805	20.60879	19.30529	17.73981	17.64548	20.29675	17.27807	19.39991	0	0
Q7Z402	TMC7_HUMAN	Transmembrane channel-like protein 7	TMC7	Homo sapiens (Human)		integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381]	mechanosensitive ion channel activity [GO:0008381]	GO:0005887; GO:0008381	SVEGFK	5.449999809	0.656583071	0.656583071	0.058142453	665.296161	19.31923	0	15.85282	0	0	15.82478	0	0	0	16.22884	14.69857	0	12.46746	12.545	0	16.38227	0	0	13.85636	0	0	0	0	16.19174	15.392	0	0	16.56284	16.56516	14.01912	11.52928	0	0	15.66905	0	13.34196	17.18116	0	0	15.33022	16.41569	17.1461	18.08848	0	0	0	15.72485	14.68251
Q7Z403	TMC6_HUMAN	Transmembrane channel-like protein 6 (Epidermodysplasia verruciformis protein 1) (Protein LAK-4)	TMC6 EVER1 EVIN1	Homo sapiens (Human)		cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; mechanosensitive ion channel activity [GO:0008381]	mechanosensitive ion channel activity [GO:0008381]	GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0008381; GO:0031965; GO:0035579; GO:0070062; GO:0070821	FLVMDFVLMLLDTLFGELVWR	11.18000031	1	1	5.03E-12	2572.69227	0	15.11625	14.57221	0	13.89666	0	14.33595	0	14.30249	0	0	0	12.92725	0	0	14.23442	0	13.59343	0	0	0	0	0	15.49227	12.72294	16.28283	13.7841	13.54984	15.08745	10.1522	0	0	15.44087	0	14.71242	15.88381	0	0	0	0	16.15008	0	0	17.47705	0	0	0	15.67478
Q7Z404	TMC4_HUMAN	Transmembrane channel-like protein 4	TMC4	Homo sapiens (Human)		extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381]	mechanosensitive ion channel activity [GO:0008381]	GO:0005887; GO:0008381; GO:0070062	LCGPFR	15.32999992	1	1	0.234382958	750.3398688	21.63213	20.69674	0	17.79132	20.48217	17.94249	0	21.26868	20.06476	21.72096	21.74741	16.92853	20.65842	20.91765	20.28852	22.70156	20.84529	20.53139	21.19975	19.24191	18.7745	19.8833	19.04214	20.42764	20.17844	20.2001	21.0523	20.7596	20.45959	20.46053	18.83929	20.64618	21.28294	20.377	22.15408	21.22981	20.50368	19.42005	18.19624	22.64665	0	22.71243	19.81089	19.93475	0	21.94159	18.97932	19.82255
Q7Z406	MYH14_HUMAN	"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc, NMHC II-C)"	MYH14 KIAA2034 FP17425	Homo sapiens (Human)	actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion morphogenesis [GO:0070584]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625]	actomyosin [GO:0042641]; brush border [GO:0005903]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725]	actomyosin [GO:0042641]; brush border [GO:0005903]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; membrane [GO:0016020]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion morphogenesis [GO:0070584]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0001725; GO:0003009; GO:0005516; GO:0005524; GO:0005829; GO:0005903; GO:0007519; GO:0007605; GO:0008360; GO:0016020; GO:0016460; GO:0019228; GO:0030048; GO:0030426; GO:0031032; GO:0042641; GO:0051015; GO:0070062; GO:0070584; GO:0071625; GO:0097513	LVLDQLR	7.369999886	1	1	4.58E-13	854.5096715	15.6617	14.82651	0	14.23925	0	0	14.80098	0	0	0	0	14.7694	0	0	0	0	0	0	0	13.13218	0	0	0	0	0	0	0	0	0	13.98193	15.09341	0	0	15.0681	0	16.52869	15.94384	0	0	14.64757	15.01347	0	0	16.86435	0	0	0	0
Q7Z407	CSMD3_HUMAN	CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)	CSMD3 KIAA1894	Homo sapiens (Human)	regulation of dendrite development [GO:0050773]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of dendrite development [GO:0050773]		GO:0005886; GO:0016021; GO:0050773	AIDFKSR	7.769999981	0.867275834	0.867275834	0.139842681	837.0538544	0	0	13.6569	0	0	0	0	0	0	0	15.70917	0	0	0	0	0	0	0	0	0	0	0	0	0	16.9771	0	16.5355	0	0	0	0	0	0	0	0	0	17.52505	0	0	0	0	0	0	0	0	0	0	0
Q7Z408	CSMD2_HUMAN	CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2)	CSMD2 KIAA1884	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021	ITCLGGRR	4.71999979	1	1	0.006678421	933.3571382	13.20465	12.39562	12.65256	14.05825	13.46547	0	15.32793	0	0	0	15.10134	14.36345	0	0	14.87093	13.48821	12.88283	15.9544	0	0	0	0	15.00413	15.60486	15.00472	0	0	13.61013	14.88012	0	16.71832	15.80325	0	0	0	0	0	13.57481	0	0	0	14.37587	0	0	0	0	0	0
Q7Z410	TMPS9_HUMAN	"Transmembrane protease serine 9, EC 3.4.21.- (Polyserase-I) (Polyserine protease 1, Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3 ]"	TMPRSS9	Homo sapiens (Human)		integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005887	IVGGSAAGR	4.429999828	1	1	0.339570075	787.1603392	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.63205	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z417	NUFP2_HUMAN	"Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein, 82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2)"	NUFIP2 KIAA1321 PIG1	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0016604; GO:0042788	YETGPGGTSRGKPAVGDMLR	2.559999943	1	1	0.104157325	2065.009452	12.47242	14.30516	0	0	0	0	0	14.0666	13.97807	15.01268	13.78821	16.68116	0	0	0	10.46259	11.13698	17.38622	14.30733	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z418	KCNKI_HUMAN	Potassium channel subfamily K member 18 (TWIK-related individual potassium channel) (TWIK-related spinal cord potassium channel)	KCNK18 TRESK TRIK	Homo sapiens (Human)	cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322]	calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]	GO:0005886; GO:0005887; GO:0006813; GO:0015269; GO:0015271; GO:0022841; GO:0030322; GO:0071467; GO:0071805; GO:0097623	CCPEALGK	9.329999924	1	1	0.019282786	933.8603412	0	0	0	0	13.87935	14.67572	15.94715	0	15.7104	0	0	0	14.12195	0	0	14.3873	0	0	0	0	0	16.26064	0	0	0	15.38889	0	0	0	15.90787	0	15.58096	0	0	0	13.85707	16.48918	0	15.52509	15.4306	0	0	0	0	0	0	0	0
Q7Z442	PK1L2_HUMAN	Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)	PKD1L2 KIAA1879 PC1L2	Homo sapiens (Human)	detection of mechanical stimulus [GO:0050982]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]	GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982	DPAEQK	3.650000095	1	1	0.307756177	686.4252663	0	0	17.96114	0	0	0	0	0	0	19.25929	0	0	0	0	0	18.57167	0	0	0	0	17.69909	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z444	RASE_HUMAN	"GTPase ERas, E-Ras, EC 3.6.5.2 (Embryonic stem cell-expressed Ras)"	ERAS HRAS2 HRASP	Homo sapiens (Human)	Ras protein signal transduction [GO:0007265]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265]	G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003	ELTLDSGDCILNVLDTAGQAIHRALR	5.309999943	1	1	0.397464213	2852.316413	0	0	19.00007	0	0	0	17.25892	0	0	0	20.55801	0	0	0	0	0	0	0	0	0	0	0	0	19.92363	0	0	0	0	0	0	20.49091	0	0	19.25929	0	0	0	0	18.4354	20.83854	0	0	0	0	0	0	0	0
Q7Z460	CLAP1_HUMAN	"CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1, hOrbit1)"	CLASP1 KIAA0622 MAST1	Homo sapiens (Human)	"astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]"	basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	"basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]"	dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0000226; GO:0000776; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005815; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0072686; GO:0090091; GO:0090162; GO:0090307; GO:1903690; GO:1904261	DHSIR	10.18999958	1	1	0.223437001	627.6019641	17.07342	0	15.78234	15.44522	0	0	0	0	16.50906	0	16.01214	0	16.12667	17.14868	17.17793	15.71602	0	16.7318	0	16.57154	0	18.38163	16.60043	17.1307	16.5515	16.72926	17.39567	16.36762	17.22646	16.46007	16.60014	17.69507	16.49763	17.31194	16.21232	17.21939	16.90015	0	17.42096	16.3272	16.00417	17.19935	16.62104	17.15796	17.56363	16.26248	0	17.09231
Q7Z478	DHX29_HUMAN	"ATP-dependent RNA helicase DHX29, EC 3.6.4.13 (DEAH box protein 29) (Nucleic acid helicase DDXx)"	DHX29 DDX29	Homo sapiens (Human)	formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; ribosome assembly [GO:0042255]	cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 43S preinitiation complex [GO:0016282]	cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 43S preinitiation complex [GO:0016282]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; nucleoside-triphosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation activator activity [GO:0008494]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; ribosome assembly [GO:0042255]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; nucleoside-triphosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation activator activity [GO:0008494]; translation initiation factor activity [GO:0003743]	GO:0001731; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0008494; GO:0016282; GO:0016887; GO:0017111; GO:0022627; GO:0042255; GO:0043024; GO:0045296; GO:0045948	FEGFMDYSVPEILR	10.07999992	0.083743282	0.083743282	0.127087468	1718.618945	0	0	0	0	12.50044	0	15.88191	15.30357	10.23371	0	15.06417	10.9977	16.99131	17.83834	15.01482	16.80576	14.55188	0	0	17.26103	0	15.45885	0	0	12.19891	13.93196	15.45196	18.95079	16.22281	18.32656	16.81478	15.86579	0	14.91998	15.69131	13.41554	10.14713	13.69411	12.92007	13.94293	16.99351	14.67404	13.29008	0	14.90615	17.2004	15.06461	17.46883
Q7Z4H3	HDDC2_HUMAN	"5'-deoxynucleotidase HDDC2, EC 3.1.3.89 (HD domain-containing protein 2) (Hepatitis C virus NS5A-transactivated protein 2, HCV NS5A-transactivated protein 2)"	HDDC2 C6orf74 NS5ATP2 CGI-130	Homo sapiens (Human)			5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872]	5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872]	GO:0002953; GO:0046872	EEEAMK	8.18999958	1	1	0.221305764	753.3192108	0	0	14.59773	15.4784	14.76961	15.13527	16.23155	16.0659	15.70352	14.55971	15.95084	0	14.17956	0	14.84894	15.71074	14.99688	0	0	0	0	0	0	0	0	15.67083	0	0	0	16.02031	0	0	0	0	0	0	16.01841	0	16.26948	14.92621	0	0	16.09581	0	0	0	0	14.62769
Q7Z4H7	HAUS6_HUMAN	HAUS augmin-like complex subunit 6	HAUS6 DGT6 FAM29A KIAA1574	Homo sapiens (Human)	cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; spindle assembly [GO:0051225]	microtubule binding [GO:0008017]	GO:0000226; GO:0005813; GO:0005829; GO:0007098; GO:0008017; GO:0051225; GO:0051301; GO:0070652; GO:1990498	MGTPK	4.829999924	1	1	0.255376821	550.0852616	16.94831	16.16497	17.88436	16.40051	0	0	0	18.07461	0	0	0	0	0	0	0	0	0	17.84358	0	0	0	0	0	0	0	0	0	0	16.89965	17.41152	18.60154	0	0	0	18.89034	0	0	0	0	0	17.4667	0	0	0	0	0	0	0
Q7Z4I7	LIMS2_HUMAN	"LIM and senescent cell antigen-like-containing domain protein 2 (LIM-like protein 2) (Particularly interesting new Cys-His protein 2, PINCH-2)"	LIMS2 PINCH2	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0043066; GO:0045216; GO:0046872; GO:0098609; GO:1900026; GO:2000178; GO:2000346; GO:2001046	FPLELKK	7.659999847	1	1	0.231052247	875.6502684	0	16.01691	17.71964	17.11601	0	16.25445	0	16.59023	0	0	16.45675	16.17808	16.46926	15.51443	15.55546	0	15.47985	0	0	15.39799	0	15.40341	0	0	15.44917	0	17.83619	13.79638	0	0	16.6787	15.9882	16.09475	12.91782	15.18852	16.46177	0	0	0	0	15.63025	0	16.49562	0	17.2298	0	0	0
Q7Z4K8	TRI46_HUMAN	"Tripartite motif-containing protein 46 (Gene Y protein, GeneY) (Tripartite, fibronectin type-III and C-terminal SPRY motif protein)"	TRIM46 TRIFIC	Homo sapiens (Human)	anterograde synaptic vesicle transport [GO:0048490]; axonogenesis [GO:0007409]; microtubule bundle formation [GO:0001578]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; positive regulation of anterograde dense core granule transport [GO:1901953]; protein localization to axon [GO:0099612]; regulation of protein localization [GO:0032880]	axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoskeleton [GO:0005856]; main axon [GO:0044304]; proximal neuron projection [GO:1990769]	axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoskeleton [GO:0005856]; main axon [GO:0044304]; proximal neuron projection [GO:1990769]; zinc ion binding [GO:0008270]; anterograde synaptic vesicle transport [GO:0048490]; axonogenesis [GO:0007409]; microtubule bundle formation [GO:0001578]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; positive regulation of anterograde dense core granule transport [GO:1901953]; protein localization to axon [GO:0099612]; regulation of protein localization [GO:0032880]	zinc ion binding [GO:0008270]	GO:0001578; GO:0001764; GO:0005856; GO:0007409; GO:0008270; GO:0030517; GO:0032880; GO:0043194; GO:0044304; GO:0048490; GO:0099612; GO:1901953; GO:1904115; GO:1990769	TLPKPDR	4.269999981	1	1	0.116321332	825.9757456	0	0	13.85321	0	0	0	0	0	0	0	0	0	0	0	0	0	15.02947	13.01277	0	0	0	0	0	0	0	16.99322	0	0	0	0	0	15.40881	14.89346	14.19579	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z4L5	TT21B_HUMAN	"Tetratricopeptide repeat protein 21B, TPR repeat protein 21B (Intraflagellar transport 139 homolog)"	TTC21B IFT139 KIAA1992 Nbla10696	Homo sapiens (Human)	Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; chromatin binding [GO:0003682]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591]	chromatin binding [GO:0003682]	GO:0003682; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799	EFEAIKNK	1.279999971	1	1	0.184842311	977.4994609	15.41121	15.37537	0	14.20599	14.57736	0	14.68746	14.85262	0	14.82587	14.27651	15.01236	12.94598	13.74211	14.2722	13.12875	0	0	15.51122	13.16227	6.75904	14.30916	15.36434	14.68845	0	15.37065	16.54981	13.27043	14.70835	13.23151	0	16.03475	14.09812	14.97816	14.31675	13.02594	16.29008	14.43642	0	0	0	15.1936	15.59658	17.94252	15.1016	0	11.95926	14.55813
Q7Z4P5	GDF7_HUMAN	"Growth/differentiation factor 7, GDF-7"	GDF7	Homo sapiens (Human)	"activin receptor signaling pathway [GO:0032924]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching morphogenesis of an epithelial tube [GO:0048754]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; forebrain morphogenesis [GO:0048853]; gland morphogenesis [GO:0022612]; midbrain development [GO:0030901]; morphogenesis of an epithelial fold [GO:0060571]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription, DNA-templated [GO:0045893]; reproductive structure development [GO:0048608]; roof plate formation [GO:0021509]; SMAD protein signal transduction [GO:0060395]; spinal cord association neuron differentiation [GO:0021527]"	extracellular space [GO:0005615]	"extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; activin receptor signaling pathway [GO:0032924]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching morphogenesis of an epithelial tube [GO:0048754]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; forebrain morphogenesis [GO:0048853]; gland morphogenesis [GO:0022612]; midbrain development [GO:0030901]; morphogenesis of an epithelial fold [GO:0060571]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription, DNA-templated [GO:0045893]; reproductive structure development [GO:0048608]; roof plate formation [GO:0021509]; SMAD protein signal transduction [GO:0060395]; spinal cord association neuron differentiation [GO:0021527]"	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	GO:0005125; GO:0005615; GO:0007411; GO:0008083; GO:0010628; GO:0010862; GO:0021509; GO:0021527; GO:0022612; GO:0030509; GO:0030855; GO:0030901; GO:0032924; GO:0042802; GO:0045165; GO:0045666; GO:0045893; GO:0048608; GO:0048754; GO:0048853; GO:0060389; GO:0060395; GO:0060571; GO:2001051	RLGFGWPGGGGSAAEER	3.359999895	1	1	6.89E-13	1703.289465	12.29656	13.76098	14.57491	0	13.99588	0	0	14.74658	16.36316	0	0	0	13.09374	0	0	0	0	0	0	0	0	0	0	0	16.09679	0	0	0	14.39382	15.06745	0	0	0	0	0	0	0	15.9143	0	0	0	0	13.15622	0	15.00874	0	0	0
Q7Z4Q2	HEAT3_HUMAN	HEAT repeat-containing protein 3	HEATR3	Homo sapiens (Human)	protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273]		unfolded protein binding [GO:0051082]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273]	unfolded protein binding [GO:0051082]	GO:0006606; GO:0042273; GO:0051082	EDGTLETLK	4.53000021	0.348137587	0.348137587	0.103016405	1002.779037	0	12.96428	13.45948	0	17.29222	17.08094	16.29008	15.60734	0	14.97389	16.2984	15.47021	15.295	17.05543	15.54487	16.43489	15.57659	17.03156	0	14.80658	14.67421	15.07758	17.3422	16.46488	18.17477	0	0	10.54445	13.64159	15.29503	14.91378	0	0	14.3414	15.39728	14.14777	0	15.00831	14.83846	16.65998	17.10507	14.65536	15.78239	11.54594	13.14531	14.93974	0	15.38848
Q7Z4S6	KI21A_HUMAN	Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62)	KIF21A KIAA1708 KIF2	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887; GO:0030424; GO:0030425; GO:0071532	LCGEVKPK	6.5	1	1	0.240155763	930.871632	15.7535	15.45296	16.18876	0	16.72108	0	0	16.18905	15.14067	15.84143	15.77987	16.10863	0	15.77168	15.56475	14.81544	16.46197	0	0	16.29514	16.75413	0	0	0	0	14.16486	0	15.22726	14.81619	14.28597	17.07182	0	14.64454	15.23162	14.68044	15.39052	14.45437	15.74701	16.45507	15.80594	0	0	0	15.40257	15.93769	13.39289	13.63678	14.64942
Q7Z4T9	CFA91_HUMAN	"Cilia- and flagella-associated protein 91, CFAP91 (AMY-1-associating protein expressed in testis 1, AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1)"	CFAP91 AAT1 C3orf15 MAATS1	Homo sapiens (Human)	axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]	axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283]		GO:0003341; GO:0005739; GO:0005930; GO:0007283; GO:0031514; GO:1904158	VVQNMMFEGK	3.869999886	1	1	0.184289907	1181.50444	0	0	12.84007	15.36458	13.4201	11.88797	0	10.51608	14.48972	0	0	13.95551	16.15164	0	12.77583	0	14.00082	0	0	14.65565	0	0	0	0	14.87947	0	0	14.60679	0	0	15.07731	0	16.11166	0	0	0	0	0	0	0	0	0	0	0	0	0	14.41797	0
Q7Z4V0	ZN438_HUMAN	Zinc finger protein 438	ZNF438	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0045892; GO:0046872	TMTNLSPTILGNAVQLISSVPK	3.630000114	1	1	0.164027847	2284.458649	12.87558	14.08271	13.69081	0	0	0	16.34986	0	13.37065	0	0	12.17619	0	14.53409	0	0	0	0	0	12.90341	0	13.26868	0	15.46585	0	12.15289	15.67274	0	13.53156	10.60953	16.54142	0	15.47909	0	13.07157	13.47792	12.00244	10.71976	16.50546	15.19286	13.85064	15.63691	0	15.38015	0	0	0	0
Q7Z4V5	HDGR2_HUMAN	"Hepatoma-derived growth factor-related protein 2, HDGF-related protein 2, HRP-2 (Hepatoma-derived growth factor 2, HDGF-2)"	HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604	Homo sapiens (Human)	muscle cell differentiation [GO:0042692]; positive regulation of cell growth [GO:0030307]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; H3K27me3 modified histone binding [GO:0061628]; H3K9me3 modified histone binding [GO:0062072]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; muscle cell differentiation [GO:0042692]; positive regulation of cell growth [GO:0030307]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403]	double-stranded DNA binding [GO:0003690]; H3K27me3 modified histone binding [GO:0061628]; H3K9me3 modified histone binding [GO:0062072]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]	GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0030307; GO:0035064; GO:0042692; GO:0043403; GO:0061628; GO:0062072; GO:1905168	AAEVYTRLK	6.210000038	1	1	0.096219105	1051.020503	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.46957	0	0	0	0	0	0	0	0	0	0	13.9338	14.03691	0	0	0	13.62746	0	0	0	0	0	15.19827	14.40197	0	0	0	0	0	0	0	0
Q7Z553	MDGA2_HUMAN	MAM domain-containing glycosylphosphatidylinositol anchor protein 2 (MAM domain-containing protein 1)	MDGA2 MAMDC1 UNQ8188/PRO23197	Homo sapiens (Human)	nervous system development [GO:0007399]; spinal cord motor neuron differentiation [GO:0021522]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; nervous system development [GO:0007399]; spinal cord motor neuron differentiation [GO:0021522]		GO:0005576; GO:0005886; GO:0007399; GO:0021522; GO:0031225	EGDTIELQCQVTGKPKPIILWSRADK	4.920000076	1	1	2.29E-12	2982.96764	16.7496	15.01785	14.75592	0	0	14.69468	15.21146	12.18643	13.39729	0	11.19816	14.66636	0	0	0	13.18136	0	0	0	0	0	0	0	13.77477	15.09114	0	15.0636	0	0	0	0	16.36109	0	0	0	0	15.56194	0	0	16.19142	0	0	12.79583	0	0	0	0	0
Q7Z569	BRAP_HUMAN	"BRCA1-associated protein, EC 2.3.2.27 (BRAP2) (Impedes mitogenic signal propagation, IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)"	BRAP RNF52	Homo sapiens (Human)	MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265]	identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630	RSAMLCILTVPAAMTSHDLMK	1.690000057	0.136027113	0.136027113	0.040808059	2361.703072	17.02494	0	15.96449	0	0	0	15.93552	0	0	0	17.04066	15.75711	0	0	0	0	16.40508	0	0	0	14.07706	0	16.86122	0	9.907558	0	0	0	0	0	0	0	16.01674	0	15.7957	0	14.87696	0	0	0	14.71413	13.99232	0	0	14.28368	0	0	0
Q7Z570	Z804A_HUMAN	Zinc finger protein 804A	ZNF804A C2orf10	Homo sapiens (Human)	positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; regulation of neuron projection development [GO:0010975]	cytoplasm [GO:0005737]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	cytoplasm [GO:0005737]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; metal ion binding [GO:0046872]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; regulation of neuron projection development [GO:0010975]	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0005886; GO:0010628; GO:0010975; GO:0010976; GO:0030426; GO:0043025; GO:0043197; GO:0043198; GO:0046872; GO:0098793; GO:0098794; GO:1901588; GO:1902952	EVSSEK	6.53000021	1	1	0.279142627	678.652206	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.69257	0	0	0	0	0	0	0	0	0	0	0	0	19.86104	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z572	SPT21_HUMAN	Spermatogenesis-associated protein 21	SPATA21	Homo sapiens (Human)			calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509	DFLAVMTDTR	5.150000095	1	1	0.459153932	1185.171964	0	17.94358	0	0	0	0	19.03964	18.41613	18.25734	0	18.27768	0	0	0	0	0	0	0	0	0	17.01133	17.96428	0	0	0	0	0	0	17.48385	0	0	0	0	0	19.05095	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z589	EMSY_HUMAN	BRCA2-interacting transcriptional repressor EMSY	EMSY C11orf30 GL002	Homo sapiens (Human)	"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]	"nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	identical protein binding [GO:0042802]	GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0042802	MASTRLPSPK	5.460000038	0.669987798	0.669987798	0.175446639	1103.753559	15.42841	0	14.69602	13.84711	16.07088	12.11882	14.33472	14.17019	15.72997	16.34089	13.89135	13.20596	14.6688	13.3437	13.78753	13.57082	13.03136	10.58705	0	0	0	0	0	15.03608	0	0	0	10.97961	0	15.17473	0	0	15.64721	0	12.336	0	0	0	16.47598	13.91537	14.67851	13.4677	15.07885	0	16.07941	14.9099	14.6245	0
Q7Z591	AKNA_HUMAN	Microtubule organization protein AKNA (AT-hook-containing transcription factor)	AKNA KIAA1968	Homo sapiens (Human)	delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]	DNA binding [GO:0003677]	GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234	TLAAEMAVPGSEFEGHK	2.839999914	1	1	0	1790.308487	13.60765	16.50337	0	16.00546	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z5A7	TAFA5_HUMAN	Chemokine-like protein TAFA-5	TAFA5 FAM19A5 UNQ5208/PRO34524	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular wound healing [GO:0061044]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; G protein-coupled receptor binding [GO:0001664]; receptor ligand activity [GO:0048018]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular wound healing [GO:0061044]	cytokine activity [GO:0005125]; G protein-coupled receptor binding [GO:0001664]; receptor ligand activity [GO:0048018]	GO:0001664; GO:0005125; GO:0005615; GO:0005737; GO:0007186; GO:0048018; GO:0061044; GO:1904706; GO:1904753	MAPSPR	6.389999866	1	1	0.132660645	657.1492671	0	14.18343	0	0	0	12.30288	13.17019	0	0	16.52242	0	14.5302	14.79423	16.28023	0	0	0	0	0	0	0	0	0	0	0	16.47827	15.83012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z5B4	RIC3_HUMAN	Protein RIC-3 (Resistant to inhibitor of cholinesterase 3)	RIC3 UNQ720/PRO1385	Homo sapiens (Human)	"positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	"endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; acetylcholine receptor binding [GO:0033130]; protein folding chaperone [GO:0044183]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine receptor binding [GO:0033130]; protein folding chaperone [GO:0044183]	GO:0000139; GO:0005789; GO:0007204; GO:0007271; GO:0016021; GO:0033130; GO:0034394; GO:0043005; GO:0043025; GO:0043231; GO:0044183; GO:0045202; GO:2000010	MAYSTVQRVALASGLVLALSLLLPK	6.300000191	0.297984123	0.297984123	0.038213391	2613.486107	16.15983	0	0	16.0466	18.13993	0	17.26002	0	13.14751	14.90687	0	17.49491	18.5306	14.75493	9.743142	0	14.07203	16.99574	0	0	0	0	0	15.78746	17.21135	0	0	13.21843	18.24458	0	17.81162	19.03243	18.07632	0	16.35575	18.03657	16.95644	15.1296	15.56856	18.18755	0	16.35355	16.70935	0	0	11.37156	0	14.72696
Q7Z5H3	RHG22_HUMAN	Rho GTPase-activating protein 22 (Rho-type GTPase-activating protein 22)	ARHGAP22 RHOGAP2	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0001525; GO:0005096; GO:0005634; GO:0005829; GO:0005925; GO:0007165; GO:0030154; GO:0051056; GO:0090630; GO:0098978; GO:0099175	ASSGDR	9.420000076	6.56E-11	6.56E-11	0.269519118	593.5578251	16.62502	16.64426	17.89576	0	18.27651	16.42868	0	17.54014	19.87751	0	0	0	0	0	0	0	19.46369	15.99964	0	0	17.41731	0	16.70644	0	0	0	18.01354	17.21534	18.99178	18.21314	18.02748	16.95931	0	17.62218	19.81977	0	18.77386	0	16.92139	16.91597	0	0	17.61591	0	18.81423	0	0	0
Q7Z5J1	DHI1L_HUMAN	"Hydroxysteroid 11-beta-dehydrogenase 1-like protein, EC 1.1.1.- (11-beta-hydroxysteroid dehydrogenase type 3, 11-DH3, 11-beta-HSD3) (Short chain dehydrogenase/reductase family 26C member 2) (Short-chain dehydrogenase/reductase 10)"	HSD11B1L HSD3 SCDR10 SDR26C2	Homo sapiens (Human)		extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; oxidoreductase activity [GO:0016491]	oxidoreductase activity [GO:0016491]	GO:0005576; GO:0005654; GO:0016491; GO:0043231	TEKNDGHLEPVTAWEVQVPR	1.389999986	1	1	0.191862127	2305.010062	15.2896	14.51325	15.28896	0	13.45009	12.25691	12.03808	13.45231	8.709785	0	13.84187	14.33934	0	0	0	0	0	0	0	0	0	0	13.37777	0	0	0	0	0	0	0	0	0	0	0	0	0	14.09134	0	0	11.2381	0	0	13.94678	0	14.11464	0	0	0
Q7Z5J4	RAI1_HUMAN	Retinoic acid-induced protein 1	RAI1 KIAA1820	Homo sapiens (Human)	"circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]"	metal ion binding [GO:0046872]	GO:0001501; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0032922; GO:0040015; GO:0045893; GO:0046872	YISSCK	5.119999886	1	1	0.284276445	757.0975435	0	20.00138	17.90802	0	19.5157	0	0	0	0	16.82154	0	0	0	0	0	0	0	0	0	0	0	0	0	19.79237	0	19.19418	0	0	0	0	0	0	0	0	0	19.43135	0	0	19.77705	0	0	0	0	0	0	0	0	18.31459
Q7Z5K2	WAPL_HUMAN	Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor)	WAPL FOE KIAA0261 WAPAL	Homo sapiens (Human)	cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of chromosome segregation [GO:0051983]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of chromosome segregation [GO:0051983]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]"		GO:0000278; GO:0000775; GO:0000785; GO:0000795; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0009636; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0048146; GO:0051301; GO:0051983; GO:0060623; GO:0071168; GO:0071922; GO:0072686	APAPPSK	4.710000038	1	1	0.241494742	667.0271672	0	14.18913	16.12671	15.54686	15.0912	0	0	0	0	0	14.37177	0	0	15.89001	0	15.93385	15.00811	16.33343	14.91613	16.60847	13.38896	15.11382	15.0699	14.6774	0	0	0	0	0	15.09797	0	0	0	16.38999	0	0	16.35122	0	0	0	0	0	15.43378	15.5038	0	0	0	0
Q7Z5M8	AB12B_HUMAN	"Protein ABHD12B, EC 3.-.-.- (Abhydrolase domain-containing protein 12B) (Alpha/beta hydrolase domain-containing protein 12B)"	ABHD12B C14orf29	Homo sapiens (Human)	monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]	acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0004622; GO:0005789; GO:0006660; GO:0008474; GO:0016020; GO:0047372; GO:0052651	LYEIAR	14.85999966	1	1	0.313523947	764.1122742	0	0	17.10463	0	0	17.30376	0	0	0	0	0	0	0	18.47323	0	0	0	17.45484	0	0	0	0	19.52754	0	0	0	0	0	0	0	21.40524	0	20.57392	16.93357	0	0	0	18.7985	0	0	0	0	0	18.28606	0	0	0	18.9673
Q7Z5N4	SDK1_HUMAN	Protein sidekick-1	SDK1	Homo sapiens (Human)	behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	identical protein binding [GO:0042802]	GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0042802; GO:0045202; GO:0048148; GO:0060998	AGPGRPR	3.369999886	1.33E-05	1.33E-05	0.292836811	710.8776716	16.38211	0	0	0	16.4638	0	17.73583	0	0	0	17.68885	16.67187	0	0	0	16.97201	16.58586	0	16.48421	0	16.45104	0	17.91094	17.63177	0	0	0	0	0	16.74862	0	0	16.85438	18.87487	0	17.72556	17.82341	17.31291	0	0	0	0	0	0	16.15449	0	0	17.61026
Q7Z5P9	MUC19_HUMAN	"Mucin-19, MUC-19"	MUC19	Homo sapiens (Human)		extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]		GO:0005576; GO:0005796; GO:0005886	YGAGFSSSGASLDVGFGWGISDEK	1.710000038	0.029665867	0.029665867	0.070547539	2393.737694	0	0	12.88365	14.54686	0	12.92742	0	0	9.926513	15.30504	0	9.502404	0	0	0	0	0	0	0	0	0	0	0	0	13.98755	0	18.70836	0	0	10.05353	16.06298	18.82426	15.66951	0	0	14.59442	0	0	0	0	0	0	0	15.90449	0	0	16.71815	0
Q7Z5Q5	DPOLN_HUMAN	"DNA polymerase nu, EC 2.7.7.7"	POLN	Homo sapiens (Human)	DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985]	cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006302; GO:0019985; GO:0030332; GO:0036297	DLHPLPK	8.529999733	0.133853212	0.133853212	0.136618153	819.3596573	16.5938	0	13.53522	0	0	0	10.75603	14.76042	14.67769	15.01343	0	16.02302	11.52004	13.00522	16.42904	0	14.54362	14.81453	16.87144	0	17.03402	0	0	0	0	15.67653	16.04994	14.68267	14.83929	0	0	0	0	16.86641	9.904092	14.59332	0	0	0	0	0	0	12.23958	0	14.18526	0	0	0
Q7Z5R6	AB1IP_HUMAN	"Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1-interacting protein 1) (Proline-rich EVH1 ligand 1, PREL-1) (Proline-rich protein 73) (Rap1-GTP-interacting adapter molecule, RIAM) (Retinoic acid-responsive proline-rich protein 1, RARP-1)"	APBB1IP PREL1 RARP1 RIAM	Homo sapiens (Human)	positive regulation of cell adhesion [GO:0045785]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; positive regulation of cell adhesion [GO:0045785]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]		GO:0002291; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007165; GO:0030027; GO:0042101; GO:0045785	RQENPGHPGGAGGGEQDFMSDLMK	10.19999981	0.520694435	0.520694435	0.014067359	2530.129871	14.95833	17.04821	14.81936	0	0	14.79716	11.5957	14.46267	13.43682	0	0	0	0	0	15.11365	0	0	0	0	0	0	0	15.74893	0	16.71267	16.25505	0	0	0	16.37068	0	19.61181	0	0	0	0	0	15.83596	0	14.52174	17.70097	0	15.64501	11.92062	12.64575	0	0	0
Q7Z5V6	PPR32_HUMAN	Protein phosphatase 1 regulatory subunit 32	PPP1R32 C11orf66	Homo sapiens (Human)		ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; phosphatase binding [GO:0019902]	phosphatase binding [GO:0019902]	GO:0005737; GO:0019902; GO:0036064	SIGAK	10.72000027	1	1	0.283883369	475.8369371	0	0	0	0	0	0	19.85439	18.22932	18.28337	18.47775	0	0	17.67975	0	0	0	0	0	0	0	0	0	19.40921	0	0	18.29931	0	0	0	0	18.34253	0	17.62797	19.83553	0	0	17.21164	0	19.81868	0	0	0	0	17.69851	0	0	16.9093	0
Q7Z5W3	BN3D2_HUMAN	"RNA 5'-monophosphate methyltransferase, EC 2.1.1.- (BCDIN3 domain-containing protein)"	BCDIN3D	Homo sapiens (Human)	miRNA 2'-O-methylation [GO:0061715]; miRNA metabolic process [GO:0010586]; negative regulation of pre-miRNA processing [GO:2000632]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]; tRNA methyltransferase activity [GO:0008175]; miRNA 2'-O-methylation [GO:0061715]; miRNA metabolic process [GO:0010586]; negative regulation of pre-miRNA processing [GO:2000632]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]	O-methyltransferase activity [GO:0008171]; RNA methyltransferase activity [GO:0008173]; tRNA methyltransferase activity [GO:0008175]	GO:0001510; GO:0005654; GO:0005737; GO:0005829; GO:0008171; GO:0008173; GO:0008175; GO:0010586; GO:0030488; GO:0061715; GO:2000632	MAVPTELDGGSVK	2.470000029	0.124114424	0.124114424	0.070772922	1318.821773	15.48512	16.32254	8.801674	14.9335	0	0	0	0	12.24708	0	10.04285	0	12.47568	0	15.32416	0	0	0	0	13.30949	0	0	14.46725	0	16.3252	16.36736	0	13.57731	0	16.41861	13.45132	0	18.12612	0	17.21218	0	13.69156	16.1291	14.23853	0	0	13.59737	15.85719	0	15.78544	14.47457	14.41356	11.10067
Q7Z601	GP142_HUMAN	Probable G-protein coupled receptor 142 (G-protein coupled receptor PGR2)	GPR142 PGR2	Homo sapiens (Human)		cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005829; GO:0005886; GO:0016021; GO:0030054	VFVMLYHMYVAPVHR	2.859999895	1	1	0.546177882	1878.893741	15.23631	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.13387	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z628	ARHG8_HUMAN	Neuroepithelial cell-transforming gene 1 protein (Proto-oncogene p65 Net1) (Rho guanine nucleotide exchange factor 8)	NET1 ARHGEF8	Homo sapiens (Human)	cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001558; GO:0005085; GO:0005634; GO:0005829; GO:0007165; GO:0035025; GO:0035556; GO:0043065; GO:0043547; GO:0051056; GO:0051451; GO:0070301; GO:0071479	QEAIYEMSRGEQDLIEDLK	11.07999992	0.775666475	0.775666475	0.380651124	2283.207735	18.14637	15.08256	18.18045	0	0	0	20.04127	19.23872	0	0	0	0	0	0	0	18.39153	0	0	0	0	0	0	0	18.75496	20.574	18.84642	0	16.34277	0	0	0	18.53787	0	0	19.89418	0	0	19.83831	19.38435	0	0	0	0	0	0	0	0	0
Q7Z695	ADCK2_HUMAN	"Uncharacterized aarF domain-containing protein kinase 2, EC 2.7.11.-"	ADCK2 AARF	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524; GO:0016021	LESNFASIVFAIMVLEGLGR	2.900000095	1	1	0.267795511	2163.003392	12.82157	14.55169	10.21056	0	14.20579	0	16.03613	14.38124	12.89512	0	0	0	0	0	0	0	0	13.17596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.68141	0
Q7Z6E9	RBBP6_HUMAN	"E3 ubiquitin-protein ligase RBBP6, EC 2.3.2.27 (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1, RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis)"	RBBP6 P2PR PACT RBQ1 My038	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]	protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001701; GO:0003723; GO:0004842; GO:0005634; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016567; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630	SNSSPSR	6.46999979	0.679065108	0.679065108	0.215850263	734.2128076	16.47383	0	14.4996	15.14078	16.67289	14.6498	15.31864	15.96145	16.7287	14.449	16.57512	16.17873	0	0	14.98865	14.1513	15.33788	0	16.01971	0	0	0	15.16296	16.02858	0	0	16.38245	16.30596	16.60951	0	16.11235	15.35603	0	0	16.15662	16.72277	0	14.90279	15.39112	16.5007	15.37173	0	0	17.11061	0	16.21768	0	16.81745
Q7Z6G8	ANS1B_HUMAN	"Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1, AIDA-1) (E2A-PBX1-associated protein, EB-1)"	ANKS1B	Homo sapiens (Human)	ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]	Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]	ephrin receptor binding [GO:0046875]	GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013; GO:1900383	ILASLGDRLHDDPPQKPPR	16.42000008	0.182077408	0.182077408	1.82E-12	2124.72823	14.29512	14.30241	13.02403	0	0	0	14.80642	0	0	14.11161	14.40437	0	0	0	0	15.84128	0	15.61373	0	9.976824	0	14.34073	16.35636	15.82861	12.45352	15.78178	11.71186	15.16132	0	0	0	15.93535	15.48437	13.28894	13.82639	0	0	0	0	13.41967	0	0	15.78732	14.33487	15.59994	17.02264	14.37013	0
Q7Z6I6	RHG30_HUMAN	Rho GTPase-activating protein 30 (Rho-type GTPase-activating protein 30)	ARHGAP30	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007264; GO:0031410; GO:0043231; GO:0051056	SNKGTLRPAK	2.25	1	1	0.152993452	1070.684893	0	14.2881	0	0	13.23854	0	0	0	11.7524	15.66487	0	15.03648	15.91553	0	12.96061	14.95547	11.40144	0	0	0	0	0	17.31166	0	0	0	0	0	15.38316	15.7511	16.75755	0	0	0	15.37489	15.55767	0	17.02802	14.87071	0	0	14.885	0	15.7454	0	0	0	0
Q7Z6J0	SH3R1_HUMAN	"E3 ubiquitin-protein ligase SH3RF1, EC 2.3.2.27 (Plenty of SH3s, Protein POSH) (RING finger protein 142) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2)"	SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]"	MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0001764; GO:0005078; GO:0005794; GO:0005829; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043154; GO:0043370; GO:0046330; GO:0046872; GO:0048471; GO:0051865; GO:0061630; GO:2000564; GO:2001237	MDESALLDLLECPVCLER	8.420000076	1	1	0.197553432	2162.183451	0	0	0	0	0	0	0	0	0	0	0	14.18497	15.92157	0	16.13091	15.78396	15.50111	15.57252	0	0	0	16.64628	15.94798	13.64515	17.03214	16.74253	15.10802	16.39462	17.08333	0	15.22004	14.6789	15.36673	0	14.76437	0	16.0254	0	15.77924	14.04166	15.08675	16.04799	0	18.47422	0	0	0	15.38846
Q7Z6J4	FGD2_HUMAN	"FYVE, RhoGEF and PH domain-containing protein 2 (Zinc finger FYVE domain-containing protein 4)"	FGD2 ZFYVE4	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; positive regulation of JUN kinase activity [GO:0043507]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; positive regulation of JUN kinase activity [GO:0043507]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]	GO:0001726; GO:0005085; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0031901; GO:0032587; GO:0043087; GO:0043507; GO:0046847; GO:0046872; GO:0051056; GO:1901981	TRIDVAGMK	8.81000042	0.493010223	0.493010223	0.402077021	1005.418564	15.66433	15.7111	16.3679	16.69434	16.84982	0	16.02423	17.07469	16.61107	0	15.34805	16.64272	16.23315	0	0	16.33252	16.61268	16.75096	0	0	17.21469	0	16.43095	15.95649	16.30489	18.07167	16.81884	17.30912	16.48892	0	0	0	0	0	0	16.9904	16.73004	18.06606	0	17.41454	16.91099	16.95627	18.10688	0	0	0	16.99473	18.8799
Q7Z6J9	SEN54_HUMAN	"tRNA-splicing endonuclease subunit Sen54 (SEN54 homolog, HsSEN54) (tRNA-intron endonuclease Sen54)"	TSEN54 SEN54	Homo sapiens (Human)	"mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]"		GO:0000214; GO:0000379; GO:0005654; GO:0005730; GO:0006388; GO:0006397	AENGVTGAGK	1.669999957	1	1	0.163813218	903.731816	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.24125	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.32124	0	0	0	0	0
Q7Z6K5	ARPIN_HUMAN	Arpin (Arp2/3 inhibition protein)	ARPIN C15orf38	Homo sapiens (Human)	directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336]; negative regulation of lamellipodium morphogenesis [GO:2000393]	lamellipodium [GO:0030027]	lamellipodium [GO:0030027]; directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336]; negative regulation of lamellipodium morphogenesis [GO:2000393]		GO:0030027; GO:0030336; GO:0033058; GO:0051126; GO:2000393	TGASWTDNIMAQK	6.21999979	1	1	0.163909377	1432.975307	14.62953	0	0	0	0	0	14.81255	0	14.19784	0	0	0	0	0	0	0	0	14.99518	0	14.84821	0	0	0	0	0	14.60311	0	0	17.17473	0	0	0	15.83849	16.26602	16.25505	0	0	0	0	13.11651	14.84675	0	0	15.22172	0	0	0	0
Q7Z6M1	RABEK_HUMAN	Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40)	RABEPK RAB9P40	Homo sapiens (Human)	receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904]	cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]	cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904]		GO:0005768; GO:0005829; GO:0006898; GO:0006904; GO:0010008; GO:0030133; GO:0032588	YEHASFIPSCTPDR	7.309999943	1	1	0.320364193	1679.843596	0	14.00931	14.20496	0	0	0	15.22935	0	0	0	0	0	15.19007	0	15.92422	0	15.00576	15.71113	0	0	0	16.35445	0	0	0	0	15.12193	16.92812	14.79663	0	14.90264	14.28742	15.61888	0	17.75641	13.87525	16.49387	0	17.79979	14.58231	16.55279	0	0	0	0	0	14.53638	0
Q7Z6M2	FBX33_HUMAN	F-box only protein 33	FBXO33 FBX33	Homo sapiens (Human)	positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	SCF ubiquitin ligase complex [GO:0019005]	SCF ubiquitin ligase complex [GO:0019005]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		GO:0016567; GO:0019005; GO:0031146; GO:0031398	MLLFLSVPQPRPPGAR	5.610000134	1	1	0.249657333	1779.141121	14.71547	13.91052	15.37033	15.81029	14.63216	14.95501	0	0	0	0	0	0	13.7682	0	0	13.8688	0	0	14.45385	0	0	16.38117	14.66681	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z6M3	MILR1_HUMAN	"Allergin-1 (Allergy inhibitory receptor 1) (Mast cell antigen 32, MCA-32) (Mast cell immunoglobulin-like receptor 1)"	MILR1 C17orf60 MCA32	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; mast cell degranulation [GO:0043303]; negative regulation of mast cell activation [GO:0033004]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; mast cell degranulation [GO:0043303]; negative regulation of mast cell activation [GO:0033004]	transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005887; GO:0007166; GO:0033004; GO:0043303; GO:0098742	AMRNNVPR	14.09000015	1	1	0.09962788	956.0332074	14.14535	14.586	15.66444	12.80018	14.58907	14.62494	13.84838	13.78336	13.71653	0	13.98403	0	0	0	13.85965	14.3983	0	0	0	0	15.3703	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z6P3	RAB44_HUMAN	Ras-related protein Rab-44	RAB44	Homo sapiens (Human)		azurophil granule membrane [GO:0035577]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	azurophil granule membrane [GO:0035577]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005509; GO:0005525; GO:0005886; GO:0035577; GO:0035579	EAFLAFMEQLGTGHLLPK	9.899999619	0.341908485	0.341908485	0.394781045	2002.123062	15.10366	20.09239	19.41194	10.56781	21.42293	20.36637	0	0	0	0	0	0	0	0	0	19.79064	19.29001	17.99085	17.84131	16.87321	0	16.79256	0	19.40523	0	19.86382	0	19.26267	0	18.83615	0	0	0	0	0	0	0	0	0	20.40279	17.86726	19.2423	0	17.88747	19.19082	0	0	0
Q7Z6Z7	HUWE1_HUMAN	"E3 ubiquitin-protein ligase HUWE1, EC 2.3.2.26 (ARF-binding protein 1, ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9, HectH9) (Large structure of UREB1, LASU1) (Mcl-1 ubiquitin ligase E3, Mule) (Upstream regulatory element-binding protein 1, URE-B1, URE-binding protein 1)"	HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272	Homo sapiens (Human)	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0045732; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813	DLHMMK	4.550000191	0.002040365	0.002040365	0.270576175	789.1633679	17.82602	0	19.62053	14.93092	17.2936	20.53169	0	0	18.20017	0	0	0	17.59065	21.026	19.86191	0	21.03372	16.89048	20.86552	0	0	0	0	0	0	20.45478	0	16.79033	0	0	17.69124	22.28149	0	0	0	0	0	0	21.89129	22.0541	18.17561	0	0	0	21.41603	18.06512	19.09207	19.73013
Q7Z736	PKHH3_HUMAN	"Pleckstrin homology domain-containing family H member 3, PH domain-containing family H member 3"	PLEKHH3	Homo sapiens (Human)	signal transduction [GO:0007165]	cytoskeleton [GO:0005856]; extracellular space [GO:0005615]	cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; signal transduction [GO:0007165]		GO:0005615; GO:0005856; GO:0007165	QTSGPAGPPGLPATQDPAALR	3.349999905	0.309961349	0.309961349	0.431936398	2001.114608	0	0	0	14.66241	0	0	0	0	0	0	0	0	0	0	19.65502	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z745	MRO2B_HUMAN	"Maestro heat-like repeat-containing protein family member 2B (HEAT repeat-containing protein 7B2) (Sperm PKA-interacting factor, SPIF)"	MROH2B HEATR7B2	Homo sapiens (Human)	cell differentiation [GO:0030154]; protein kinase A signaling [GO:0010737]; spermatogenesis [GO:0007283]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; protein kinase A signaling [GO:0010737]; spermatogenesis [GO:0007283]		GO:0001669; GO:0005737; GO:0007283; GO:0010737; GO:0030154; GO:0036126; GO:0097225	IVMGDLSTKVR	7.269999981	1	1	0.412521164	1235.003693	0	0	0	0	17.77637	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.11251	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6741	0
Q7Z7A1	CNTRL_HUMAN	"Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa, Cep110)"	CNTRL CEP1 CEP110	Homo sapiens (Human)	aorta development [GO:0035904]; cell cycle [GO:0007049]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281]	centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]	centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; cytoskeletal protein binding [GO:0008092]; aorta development [GO:0035904]; cell cycle [GO:0007049]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281]	cytoskeletal protein binding [GO:0008092]	GO:0001822; GO:0003281; GO:0005813; GO:0005815; GO:0005829; GO:0007049; GO:0008092; GO:0016020; GO:0034451; GO:0035904; GO:0048471; GO:0051301; GO:0051493; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103	DAEANQLK	16.15999985	1	1	0.331925228	889.4575832	0	13.31143	12.67448	16.16827	0	0	13.74739	13.82484	0	14.33771	12.3428	0	13.13206	14.80087	17.15729	0	0	10.44036	0	0	0	0	0	0	0	0	0	0	0	0	16.29181	0	0	16.80054	0	0	0	16.62908	0	0	0	0	0	0	0	15.62411	0	0
Q7Z7A4	PXK_HUMAN	"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase, MONaKA)"	PXK	Homo sapiens (Human)	inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ion transport [GO:0043271]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ion transport [GO:0043271]	actin binding [GO:0003779]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]	GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0043271; GO:0050804	GALLSSIQNFQKGTLR	3.869999886	0.785314023	0.785314023	0.274273955	1737.616641	0	12.2378	0	16.80634	0	15.71082	0	13.54926	11.3094	0	17.34712	17.66214	15.67748	15.97137	0	16.53249	15.55789	14.11138	0	16.78409	15.4485	15.79712	0	17.67335	0	16.37343	17.59596	17.2049	14.98098	18.06837	16.31331	0	16.90851	0	17.75545	0	16.75753	15.01325	0	15.92778	16.23396	14.9125	0	17.02538	14.81207	15.40952	16.45022	17.04428
Q7Z7B0	FLIP1_HUMAN	"Filamin-A-interacting protein 1, FILIP"	FILIP1 KIAA1275	Homo sapiens (Human)		actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]		GO:0005730; GO:0005829; GO:0005886; GO:0015629	DELIGK	15.90999985	0.213374898	0.213374898	0.290114217	674.1813053	16.37055	0	16.31546	0	0	0	0	0	16.93566	0	15.40888	15.38447	17.06488	0	17.12103	17.02103	0	0	15.1517	0	0	18.28259	0	0	18.40214	18.21528	18.33925	18.34068	17.47886	0	0	19.28442	0	17.71258	17.28217	0	18.2143	19.02894	0	0	0	17.13662	16.88876	18.41568	0	16.63878	0	0
Q7Z7C8	TAF8_HUMAN	"Transcription initiation factor TFIID subunit 8 (Protein taube nuss) (TBP-associated factor 43 kDa) (TBP-associated factor 8) (Transcription initiation factor TFIID 43 kDa subunit, TAFII-43, TAFII43, hTAFII43)"	TAF8 TAFII43 TBN	Homo sapiens (Human)	cell differentiation [GO:0030154]; DNA-templated transcription open complex formation [GO:0001112]; inner cell mass cell proliferation [GO:0001833]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of fat cell differentiation [GO:0045598]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIID complex [GO:0005669]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; cell differentiation [GO:0030154]; DNA-templated transcription open complex formation [GO:0001112]; inner cell mass cell proliferation [GO:0001833]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of fat cell differentiation [GO:0045598]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]	protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0001112; GO:0001833; GO:0005634; GO:0005654; GO:0005669; GO:0006367; GO:0006468; GO:0016251; GO:0030154; GO:0042789; GO:0045598; GO:0046982; GO:0048471; GO:0051123; GO:0051457; GO:0060261	EPVSDYQVLREK	2.279999971	0.076859027	0.076859027	0.381963048	1462.769332	0	0	15.00525	12.9738	0	0	0	0	0	0	0	0	0	14.48783	0	0	0	0	16.82673	16.50274	16.70755	0	15.88327	0	0	0	0	14.95042	15.00023	14.70884	0	0	16.25466	16.21164	0	0	14.92669	0	0	16.23477	0	0	16.56478	16.75048	0	14.43479	14.60821	0
Q7Z7G0	TARSH_HUMAN	"Target of Nesh-SH3, Tarsh (ABI gene family member 3-binding protein) (Nesh-binding protein, NeshBP)"	ABI3BP NESHBP TARSH	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]		GO:0005576; GO:0005615; GO:0010811; GO:0030198; GO:0062023	KSCSGK	5.860000134	0.014526759	0.014526759	0.2310238	667.2317623	15.35866	14.53348	0	0	14.99969	0	0	0	0	0	15.63136	15.00204	16.41805	15.1465	16.19429	15.79033	16.96848	16.44699	16.08475	18.23143	0	0	17.06872	0	17.40504	16.88467	14.66724	0	18.11287	0	16.96841	16.24615	16.2346	16.12347	15.64281	15.78359	15.22722	18.10886	17.2489	17.04493	17.86327	17.94193	15.17875	15.62349	16.41756	19.69172	15.74699	0
Q7Z7G8	VP13B_HUMAN	Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B)	VPS13B CHS1 COH1 KIAA0532	Homo sapiens (Human)	protein transport [GO:0015031]		protein transport [GO:0015031]		GO:0015031	LVSSDLWR	12.25	1	1	0.446003327	976.0807001	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.34844	0	0	0	0	0	0	0	19.29511	0	0	0	0	0	0	0	0	0	17.92803	0	0
Q7Z7H8	RM10_HUMAN	"39S ribosomal protein L10, mitochondrial, L10mt, MRP-L10 (39S ribosomal protein L8, mitochondrial, L8mt, MRP-L8) (Mitochondrial large ribosomal subunit protein uL10m)"	MRPL10 MRPL8 RPML8	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0032543; GO:1990904	AAAVAGMLR	5.909999847	0.968715072	0.968715072	0.202302522	861.677679	0	0	0	0	0	14.70292	15.24355	0	0	0	14.98398	0	0	0	16.95251	17.48577	15.97472	17.34222	17.49238	16.77632	18.3937	17.46027	16.53704	16.30806	0	17.79921	16.91419	0	17.56268	17.86684	17.72801	15.89187	17.05648	18.03609	16.37477	17.17857	18.30663	17.87221	17.91209	17.58614	15.88866	16.28527	0	18.08555	15.46757	16.56918	17.5008	14.36009
Q7Z7J5	DPPA2_HUMAN	Developmental pluripotency-associated protein 2 (Pluripotent embryonic stem cell-related gene 1 protein)	DPPA2 PESCRG1	Homo sapiens (Human)	system development [GO:0048731]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; system development [GO:0048731]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0048731	DTLRDWCQQLGLSTNGK	8.979999542	1	1	1.83E-12	1990.987237	0	14.44084	11.76475	14.08877	9.408435	0	0	14.3838	0	0	14.42862	0	0	13.91204	12.28586	15.8655	0	16.36715	9.577834	13.66778	15.3426	0	14.07341	0	0	0	0	0	0	0	0	16.42202	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z7K6	CENPV_HUMAN	"Centromere protein V, CENP-V (Nuclear protein p30) (Proline-rich protein 6)"	CENPV PRR6	Homo sapiens (Human)	ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]	cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]	carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]	GO:0000776; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0031965; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301	RSASQAGSK	6.849999905	1	1	0.058105944	891.5320116	14.44394	13.44741	17.19307	11.77145	16.96012	16.1553	13.56221	0	15.3995	0	18.20789	0	17.54588	16.26171	0	0	15.38058	0	14.86703	17.58214	11.36506	0	0	0	13.31829	14.67161	0	0	15.8943	0	17.15674	17.87435	18.03231	16.31146	0	16.11481	0	0	0	0	13.21942	10.76976	14.9779	0	0	0	15.2391	0
Q7Z7L1	SLN11_HUMAN	"Schlafen family member 11, EC 3.6.-.-"	SLFN11	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of DNA replication [GO:0008156]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell death [GO:0010942]; replication fork arrest [GO:0043111]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; tRNA binding [GO:0000049]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of DNA replication [GO:0008156]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell death [GO:0010942]; replication fork arrest [GO:0043111]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; tRNA binding [GO:0000049]	GO:0000049; GO:0002376; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0008156; GO:0010942; GO:0016887; GO:0043111; GO:0051607; GO:0090734; GO:2000134	EVLGCAKENVDPDSLR	14.85999966	1	1	0	1802.189716	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q7Z7L9	ZSCA2_HUMAN	"Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog, Zfp-29) (Zinc finger protein 854)"	ZSCAN2 ZFP29 ZNF854	Homo sapiens (Human)	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0030154; GO:0046872	SHLITHER	13.5	8.11E-07	8.11E-07	0.244940508	996.1032728	13.75014	16.97454	14.51666	0	14.57108	14.68577	0	16.09222	13.48753	0	15.13321	15.49122	14.49027	0	0	0	0	0	0	0	0	0	15.54268	0	15.8081	0	13.60225	14.27212	0	14.82758	14.0105	12.42355	15.25761	15.52479	14.27997	13.70201	13.4028	14.32007	17.01236	15.05616	0	15.75012	0	13.72134	15.57475	14.25639	17.20319	12.22546
Q7Z7M0	MEGF8_HUMAN	"Multiple epidermal growth factor-like domains protein 8, Multiple EGF-like domains protein 8 (Epidermal growth factor-like protein 4, EGF-like protein 4)"	MEGF8 C19orf49 EGFL4 KIAA0817	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]	calcium ion binding [GO:0005509]	GO:0003143; GO:0005509; GO:0005634; GO:0009887; GO:0009888; GO:0010468; GO:0016021; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0070062; GO:0071907; GO:0097094; GO:0097155	AGGSCFR	5.460000038	1	1	0.235693642	754.1823742	0	0	13.34833	0	16.93778	0	15.34727	0	0	0	0	0	0	0	0	0	0	16.20272	19.24985	0	16.70172	16.79759	15.07335	15.39742	16.52506	0	0	0	15.84352	0	16.11384	16.4568	16.21126	0	0	0	0	17.06468	16.31092	16.0349	13.05929	13.19542	0	0	15.90111	0	16.84881	17.25074
Q7Z7M1	AGRD2_HUMAN	Adhesion G-protein coupled receptor D2 (G-protein coupled receptor 144) (G-protein coupled receptor PGR24)	ADGRD2 GPR144 PGR24	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021	TAGGVCK	14.31000042	0.375900805	0.375900805	0.285340579	691.8134874	15.74744	0	14.98454	0	15.38696	13.33407	0	15.01767	15.26827	0	0	0	16.3743	17.03907	17.22241	17.17853	15.73779	17.24857	17.10931	16.22024	0	0	15.74315	17.2502	16.35755	17.6165	15.90101	17.72988	17.33234	16.57958	16.8103	17.19308	17.79941	17.2863	16.74454	16.71394	17.70215	18.04662	17.27438	0	18.60152	18.19506	18.96741	16.63293	16.56739	16.51046	15.07624	0
Q7Z7M9	GALT5_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 5, EC 2.4.1.41 (Polypeptide GalNAc transferase 5, GalNAc-T5, pp-GaNTase 5) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)"	GALNT5	Homo sapiens (Human)	glycosaminoglycan biosynthetic process [GO:0006024]; O-glycan processing [GO:0016266]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; glycosaminoglycan biosynthetic process [GO:0006024]; O-glycan processing [GO:0016266]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006024; GO:0016021; GO:0016266; GO:0030246; GO:0046872	TDGRGTKPEASSHQGTPK	9.630000114	0.834431231	0.834431231	0.453051279	1856.043673	17.24603	0	0	0	0	0	0	14.92395	15.33406	15.39735	15.68724	0	15.69333	0	0	0	0	0	0	0	0	0	0	15.33313	15.02059	0	15.64766	0	0	0	15.52309	0	15.3147	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86SE9	PCGF5_HUMAN	Polycomb group RING finger protein 5 (RING finger protein 159)	PCGF5 RNF159	Homo sapiens (Human)	histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genomic imprinting [GO:0060819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]	centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]; metal ion binding [GO:0046872]; histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genomic imprinting [GO:0060819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]	GO:0000805; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0006357; GO:0031519; GO:0035102; GO:0036353; GO:0045944; GO:0046872; GO:0060819	MATQRK	3.529999971	0.964306116	0.964306116	0.183685747	749.9995839	14.60936	15.56091	16.79165	0	15.12868	14.97215	0	0	0	16.5858	0	15.37012	0	0	0	0	0	0	0	0	0	0	0	0	15.16837	0	0	15.05445	15.68696	0	16.45604	15.90637	0	16.54227	0	0	0	0	16.54843	15.27262	15.54448	16.98553	16.20817	0	16.14319	0	0	0
Q86SF2	GALT7_HUMAN	"N-acetylgalactosaminyltransferase 7, EC 2.4.1.41 (Polypeptide GalNAc transferase 7, GalNAc-T7, pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7)"	GALNT7	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; carbohydrate metabolic process [GO:0005975]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0005975; GO:0006493; GO:0016020; GO:0016021; GO:0016266; GO:0030246; GO:0046872; GO:0070062	FTHIPSGK	6.960000038	0.106758446	0.106758446	0.144934026	886.3237839	14.20332	0	14.12098	0	0	11.47296	0	0	0	0	16.33505	0	16.33673	15.68487	16.71976	14.53509	0	17.35505	0	17.43695	16.84458	0	16.61524	13.37404	15.95685	13.68114	15.10218	0	14.32092	13.51152	15.499	16.68643	14.34581	15.36392	15.94594	15.03019	15.56928	13.7205	15.55238	14.50611	0	0	14.56534	14.34991	15.01658	14.02915	16.0465	0
Q86SK9	SCD5_HUMAN	"Stearoyl-CoA desaturase 5, EC 1.14.19.1 (Acyl-CoA-desaturase 4) (HSCD5) (Stearoyl-CoA 9-desaturase) (Stearoyl-CoA desaturase 2)"	SCD5 ACOD4 SCD2 SCD4	Homo sapiens (Human)	monounsaturated fatty acid biosynthetic process [GO:1903966]; unsaturated fatty acid biosynthetic process [GO:0006636]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]; monounsaturated fatty acid biosynthetic process [GO:1903966]; unsaturated fatty acid biosynthetic process [GO:0006636]	iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]	GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016021; GO:0016491; GO:1903966	RATKPMIEAR	4.369999886	1	1	0.316409877	1187.815426	0	0	17.40014	0	0	17.52645	0	0	0	0	0	0	13.66108	0	0	0	0	0	0	0	0	0	0	0	0	0	18.63655	0	0	0	17.44063	0	0	0	0	0	18.63561	0	0	0	0	0	0	0	0	0	15.71568	0
Q86SP6	GP149_HUMAN	Probable G-protein coupled receptor 149 (G-protein coupled receptor PGR10)	GPR149 PGR10	Homo sapiens (Human)	antral ovarian follicle growth [GO:0001547]; negative regulation of ovulation [GO:0060280]; neuropeptide signaling pathway [GO:0007218]; preantral ovarian follicle growth [GO:0001546]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]	integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; antral ovarian follicle growth [GO:0001547]; negative regulation of ovulation [GO:0060280]; neuropeptide signaling pathway [GO:0007218]; preantral ovarian follicle growth [GO:0001546]	G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]	GO:0001546; GO:0001547; GO:0004930; GO:0005887; GO:0007218; GO:0042277; GO:0042923; GO:0043005; GO:0060280	DAFSDKTGGDINYEETTFSEGPER	3.410000086	0.721816421	0.721816421	4.58E-13	2665.393754	14.25951	13.40422	0	0	0	0	0	16.15968	0	15.79528	9.725824	0	13.18383	0	0	15.879	0	17.11736	0	0	0	0	0	8.847219	0	0	0	0	0	0	0	15.09282	0	0	16.344	0	0	15.72344	14.16769	0	0	0	0	0	13.75015	15.13458	15.40223	0
Q86SQ0	PHLB2_HUMAN	Pleckstrin homology-like domain family B member 2 (Protein LL5-beta)	PHLDB2 LL5B	Homo sapiens (Human)	"establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]"	basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]	"basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]"	cadherin binding [GO:0045296]	GO:0000226; GO:0005829; GO:0005886; GO:0010470; GO:0010717; GO:0031252; GO:0045111; GO:0045180; GO:0045184; GO:0045296; GO:0051497; GO:0051895; GO:0070507; GO:1903690; GO:1904261	TPEGISEEQR	8.399999619	1	1	0.527359169	1145.218626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.47353	0	0	18.05924	0	18.01403	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86SQ3	AGRE4_HUMAN	Putative adhesion G protein-coupled receptor E4P (EGF-like module receptor 4) (EGF-like module-containing mucin-like hormone receptor-like 4) (G-protein coupled receptor 127) (G-protein coupled receptor PGR16)	ADGRE4P EMR4 EMR4P GPR127 PGR16	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005509; GO:0005576; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021	MGSRFLLVLLSGASCPPCPK	4.079999924	0.695588827	0.695588827	0.498741823	2207.170896	16.41267	16.43772	0	0	16.61036	0	17.4599	17.32971	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.2226	0	0	0	0	0	0	0	0	0	0	0	17.77706	0	0	0	0	0	0	0	0	0	0	0
Q86SR1	GLT10_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 10, EC 2.4.1.41 (Polypeptide GalNAc transferase 10, GalNAc-T10, pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)"	GALNT10	Homo sapiens (Human)	O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872	IAWDLPK	16.02000046	1	1	0.203318199	841.7657346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86SS6	SYT9_HUMAN	"Synaptotagmin-9 (Synaptotagmin IX, SytIX)"	SYT9	Homo sapiens (Human)	calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192]	clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	"clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192]"	"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030667; GO:0030669; GO:0031045; GO:0042802; GO:0045956; GO:0050796; GO:0070382; GO:0071277; GO:0098686; GO:0099502	VSLMCDGR	5.630000114	1	1	0.177662839	937.4880604	15.33222	0	15.17029	14.96648	0	0	0	0	0	0	0	0	0	0	0	0	17.01099	0	0	0	0	0	0	16.07418	0	0	0	0	0	0	16.36764	0	14.44776	14.83354	0	15.11669	14.48674	0	13.52778	0	11.35415	16.50694	0	0	0	0	15.99861	0
Q86T13	CLC14_HUMAN	"C-type lectin domain family 14 member A (Epidermal growth factor receptor 5, EGFR-5)"	CLEC14A C14orf27 EGFR5 UNQ236/PRO269	Homo sapiens (Human)	cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; lymphangiogenesis [GO:0001946]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor-3 signaling pathway [GO:0036325]	collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]	collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; lymphangiogenesis [GO:0001946]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor-3 signaling pathway [GO:0036325]	carbohydrate binding [GO:0030246]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]	GO:0001946; GO:0002042; GO:0009897; GO:0016021; GO:0016477; GO:0030246; GO:0036324; GO:0036325; GO:0050840; GO:0062023; GO:1990430	CAVLQATGGVEPAGWK	1.159999967	0.2366243	0.2366243	0.494302261	1644.343621	17.34557	17.78758	18.43851	0	0	0	0	0	0	0	0	0	16.94647	0	0	0	0	0	0	0	17.19444	18.27783	0	17.78506	0	0	0	0	0	17.31005	0	0	19.42507	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86T24	KAISO_HUMAN	Transcriptional regulator Kaiso (Zinc finger and BTB domain-containing protein 33)	ZBTB33 KAISO ZNF348	Homo sapiens (Human)	"intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008327; GO:0016055; GO:0035556; GO:0043565; GO:0045892; GO:0046872; GO:1990837	DDGIGYK	5.730000019	0.482929528	0.482929528	0.005563619	767.3793539	0	13.78494	18.10309	15.59094	0	0	16.36255	0	0	15.75744	15.10035	0	0	0	15.08063	17.57637	15.28952	15.20246	15.86174	18.12153	13.09191	15.2667	17.23869	14.67271	17.65166	19.89828	0	15.92663	0	0	17.49155	14.54077	18.58354	0	0	0	15.61288	15.39227	15.33376	0	20.1627	13.07894	15.74977	14.55476	11.91322	16.4323	17.23346	16.3288
Q86T82	UBP37_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 37, EC 3.4.19.12 (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37)"	USP37 KIAA1594	Homo sapiens (Human)	cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent deubiquitinase [GO:0004843]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; thiol-dependent deubiquitinase [GO:0004843]	GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006275; GO:0006511; GO:0016579; GO:0019901; GO:0035871; GO:0051301; GO:0071108	AMTDPSR	4.920000076	0.046446294	0.046446294	0.185414708	775.7878281	11.50207	14.54233	14.40648	0	15.06221	15.24386	13.45564	16.50446	0	15.04035	0	0	14.3571	14.48717	13.19519	0	0	15.73355	0	15.05049	14.96917	0	0	17.04373	0	0	16.79446	0	0	14.79356	0	0	0	0	16.15343	0	17.83456	0	0	0	11.94866	0	0	0	0	15.00422	0	0
Q86TB3	ALPK2_HUMAN	"Alpha-protein kinase 2, EC 2.7.11.1 (Heart alpha-protein kinase)"	ALPK2 HAK	Homo sapiens (Human)	cardiac muscle cell development [GO:0055013]; epicardium morphogenesis [GO:1905223]; establishment of cell polarity [GO:0030010]; heart morphogenesis [GO:0003007]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]	basolateral plasma membrane [GO:0016323]	basolateral plasma membrane [GO:0016323]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cardiac muscle cell development [GO:0055013]; epicardium morphogenesis [GO:1905223]; establishment of cell polarity [GO:0030010]; heart morphogenesis [GO:0003007]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0003007; GO:0003308; GO:0004674; GO:0004712; GO:0005524; GO:0010468; GO:0016323; GO:0030010; GO:0042981; GO:0055013; GO:0106310; GO:1905223	ESHKGEEPTISVHWR	2.849999905	1	1	0.416433072	1791.844801	0	17.8786	13.16731	0	0	0	0	0	0	0	0	18.68411	18.74405	0	0	0	0	0	0	16.32813	0	0	0	0	17.73966	19.20672	0	0	18.9383	0	0	0	0	19.98275	0	0	0	0	0	0	0	0	0	0	0	16.71984	0	17.92457
Q86TE4	LUZP2_HUMAN	Leucine zipper protein 2	LUZP2 UNQ2566/PRO6246	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	NKLLSGNK	4.820000172	0.058554936	0.058554936	0.251076498	874.228533	16.24505	0	0	15.2624	15.7556	14.14588	16.72947	16.77656	15.71937	0	0	12.75484	14.48525	14.46002	15.38108	15.2484	15.50369	14.63934	15.23738	15.24796	14.49054	0	16.45417	0	15.62065	0	16.15956	15.18026	15.83705	14.82344	0	16.83263	0	15.05189	14.9118	16.48326	16.379	0	17.09493	15.65294	15.74005	16.13538	16.70989	15.71506	14.77953	15.25225	14.78729	15.47481
Q86TH1	ATL2_HUMAN	"ADAMTS-like protein 2, ADAMTSL-2"	ADAMTSL2 KIAA0605	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril binding [GO:0050436]; extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	microfibril binding [GO:0050436]	GO:0005576; GO:0030198; GO:0030512; GO:0031012; GO:0050436; GO:0060481	DGTSCK	5.550000191	0.209781393	0.209781393	0.294817478	667.116783	15.67688	0	16.71641	15.31684	15.4171	14.38521	0	0	0	15.3722	16.46402	15.46225	16.70589	15.86476	16.43171	16.48126	0	0	17.00317	15.70518	15.67858	16.8654	0	0	0	16.86328	17.38868	17.15969	16.44144	16.06797	14.54503	16.42245	15.42237	16.78619	17.09694	16.45335	15.39081	16.43328	17.6461	16.35115	0	17.1858	16.873	17.60529	14.69244	17.4483	16.00125	16.89222
Q86TI0	TBCD1_HUMAN	TBC1 domain family member 1	TBC1D1 KIAA1108	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of protein localization [GO:0032880]	nucleus [GO:0005634]	nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of protein localization [GO:0032880]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0032880; GO:0090630	IEGMNSSK	13	1	1	0.135252717	881.6656101	14.78168	15.11541	15.74495	14.44093	15.25166	0	14.45667	13.68178	0	15.20174	15.02216	15.34025	0	15.57169	0	15.41516	0	0	15.88966	14.61878	0	0	0	0	0	15.90967	15.54068	14.85202	14.81014	14.72369	0	0	0	15.95406	0	0	15.65817	15.40738	16.85366	0	13.88505	0	15.98407	15.92841	0	0	0	0
Q86TI2	DPP9_HUMAN	"Dipeptidyl peptidase 9, DP9, EC 3.4.14.5 (Dipeptidyl peptidase IV-related protein 2, DPRP-2) (Dipeptidyl peptidase IX, DPP IX) (Dipeptidyl peptidase-like protein 9, DPLP9)"	DPP9 DPRP2	Homo sapiens (Human)	pyroptosis [GO:0070269]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236]; pyroptosis [GO:0070269]	aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005634; GO:0005829; GO:0005874; GO:0008236; GO:0008239; GO:0031252; GO:0042802; GO:0070269	TQCSGPR	5.420000076	1	1	0.115455932	803.9210302	14.0433	15.77215	16.17553	13.74414	0	0	0	0	0	0	0	14.79825	0	14.15984	13.36294	15.69386	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86TI4	WDR86_HUMAN	WD repeat-containing protein 86	WDR86	Homo sapiens (Human)						GAPRPPPPMRSLSR	9.119999886	0.219525233	0.219525233	0.501241803	1518.350129	14.91956	19.1395	9.932972	0	20.79274	0	14.51807	0	0	0	0	0	16.99208	0	0	0	19.21416	0	0	0	0	0	0	17.55284	0	0	0	0	0	0	0	0	0	17.88345	20.43052	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86TJ2	TAD2B_HUMAN	"Transcriptional adapter 2-beta (ADA2-like protein beta, ADA2-beta)"	TADA2B ADA2B	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0000124; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006338; GO:0006357; GO:0008270; GO:0035066; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0070461	YHGYQLVDGGRFTLWGPEAEGGWTSR	2.25	1	1	0.104534341	2939.733344	15.54916	0	0	13.82767	8.990589	13.81932	0	14.80867	12.38532	0	0	0	0	15.64494	12.94185	0	0	12.68784	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86TJ5	ZN554_HUMAN	Zinc finger protein 554	ZNF554	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005730; GO:0006357; GO:0046872	MAAGYLPR	6.630000114	1	1	0.229938856	879.5734433	0	0	0	18.38222	15.78124	0	16.07296	13.11742	13.3739	18.82269	16.48866	13.53472	16.35155	13.29949	14.61688	10.82964	13.42103	16.08622	0	15.86641	15.06153	15.97341	0	0	15.28142	0	16.14036	0	16.10914	14.58563	16.40488	0	0	15.57774	0	0	16.27751	0	16.44062	0	0	16.86036	0	0	16.03881	15.88133	16.18328	11.48647
Q86TL2	STIMA_HUMAN	Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110)	STIMATE TMEM110	Homo sapiens (Human)	activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel regulator activity [GO:0005246]; activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]	calcium channel regulator activity [GO:0005246]	GO:0005246; GO:0005789; GO:0016020; GO:0016021; GO:0032237; GO:0032541; GO:0035584; GO:0070886; GO:0140268	RLTPLKPVK	4.630000114	1	1	0.283679432	1052.732939	0	0	0	0	0	0	0	0	0	19.95966	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.46051	0	0	0	0	0	0	0
Q86TP1	PRUN1_HUMAN	"Exopolyphosphatase PRUNE1, EC 3.6.1.1 (Drosophila-related expressed sequence 17, DRES-17, DRES17) (HTcD37) (Protein prune homolog 1, hPrune)"	PRUNE1 PRUNE	Homo sapiens (Human)	regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]	exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]	GO:0004309; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767	GDIVFFLQK	9.489999771	1	1	0.19705457	1066.416724	14.27213	15.40512	15.0639	0	14.85631	14.69218	0	16.91405	14.05188	0	14.24949	0	15.9528	14.04578	0	9.538822	15.73551	14.24984	15.41924	14.71267	17.59575	13.45351	17.3994	10.95144	0	14.2756	15.38382	0	16.79546	0	0	0	0	17.76521	0	0	15.91332	0	0	0	0	15.59926	15.48382	0	0	15.51297	16.70269	0
Q86TU6	CN070_HUMAN	Putative uncharacterized protein encoded by LINC00523	LINC00523 C14orf70	Homo sapiens (Human)						GIGTGHTSMNK	3.390000105	1	1	0.12857459	1100.566525	13.41301	0	0	0	14.56088	12.56096	0	0	0	0	0	0	0	0	0	0	0	9.142589	0	0	0	0	12.69434	0	0	0	0	0	0	0	0	0	0	13.84754	0	0	0	0	0	15.74601	0	0	0	0	15.45466	0	0	0
Q86TU7	SETD3_HUMAN	"Actin-histidine N-methyltransferase, EC 2.1.1.85 (Protein-L-histidine N-tele-methyltransferase) (SET domain-containing protein 3, hSETD3)"	SETD3 C14orf154	Homo sapiens (Human)	"actin modification [GO:0030047]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of uterine smooth muscle contraction [GO:0070472]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; actin modification [GO:0030047]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of uterine smooth muscle contraction [GO:0070472]"	actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]	GO:0000785; GO:0003713; GO:0003779; GO:0005654; GO:0005737; GO:0010452; GO:0018021; GO:0018023; GO:0018026; GO:0018027; GO:0018064; GO:0030047; GO:0042800; GO:0045893; GO:0045944; GO:0046975; GO:0051149; GO:0061629; GO:0070472	CSSPAPGPGK	4.019999981	0.001795161	0.001795161	0.282385317	957.6261104	0	0	0	0	17.47208	0	17.74945	0	0	0	0	17.00619	18.35973	0	0	0	17.87596	0	0	0	18.51595	16.44518	18.1158	0	0	0	0	17.1929	0	16.55768	0	19.14613	0	0	0	18.24551	18.42207	0	18.08888	0	17.90491	17.98632	0	17.6516	18.02589	18.63694	0	0
Q86TV6	TTC7B_HUMAN	"Tetratricopeptide repeat protein 7B, TPR repeat protein 7B (Tetratricopeptide repeat protein 7-like-1, TPR repeat protein 7-like-1)"	TTC7B TTC7L1	Homo sapiens (Human)	phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]		GO:0005829; GO:0005886; GO:0046854; GO:0072659	LIANDDMAELLLGESKLEQYLK	1.659999967	1	1	0.387268005	2521.397736	16.81797	19.40401	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86TZ1	TTC6_HUMAN	"Tetratricopeptide repeat protein 6, TPR repeat protein 6"	TTC6 C14orf25 NCRNA00291	Homo sapiens (Human)						ALCYTK	6.849999905	7.38E-06	7.38E-06	0.321847198	756.8371479	0	0	0	0	0	17.91004	18.29761	19.09469	0	18.82498	18.4975	0	0	0	18.963	0	0	17.65228	0	18.76649	0	0	0	0	0	0	0	0	0	0	17.41796	19.19261	0	0	0	0	0	0	0	0	17.88416	17.37853	0	16.79453	17.31084	0	0	0
Q86U06	RBM23_HUMAN	"Probable RNA-binding protein 23 (CAPER beta, CAPERbeta) (RNA-binding motif protein 23) (RNA-binding region-containing protein 4) (Splicing factor SF2)"	RBM23 RNPC4 PP239	Homo sapiens (Human)	"mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]"	membrane [GO:0016020]; nucleus [GO:0005634]	"membrane [GO:0016020]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]"	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016020; GO:0045893; GO:0048024	SPHFREK	7.820000172	1	1	0.173471199	900.7494809	0	0	14.15519	14.91502	14.3883	13.38495	15.61283	0	13.0951	15.03594	15.85601	15.41609	0	14.43118	0	0	0	15.81788	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.22035	0	0	0	0	0
Q86U42	PABP2_HUMAN	"Polyadenylate-binding protein 2, PABP-2, Poly(A)-binding protein 2 (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II, PABII) (Polyadenylate-binding nuclear protein 1)"	PABPN1 PAB2 PABP2	Homo sapiens (Human)	cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; muscle contraction [GO:0006936]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; muscle contraction [GO:0006936]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; RNA processing [GO:0006396]	RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0000165; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0006936; GO:0016607; GO:0016973; GO:0042405; GO:0070063; GO:0071222; GO:1904247; GO:1990904	GSGPGR	1.570000052	0.013975806	0.013975806	0.155181219	530.6513101	18.247	17.89511	0	13.53049	18.01346	14.93957	17.23436	0	0	15.36203	0	14.42649	14.09049	13.76573	15.50975	14.74775	18.23073	16.87605	16.85672	15.39278	18.67249	14.38177	17.06309	18.04084	14.78257	18.6649	0	14.78497	14.14157	14.81847	0	0	0	0	19.42548	17.02382	16.67536	19.39273	17.96362	17.90986	17.28508	16.84301	13.30472	16.00438	19.31258	16.47843	8.78833	16.51626
Q86U86	PB1_HUMAN	"Protein polybromo-1, hPB1 (BRG1-associated factor 180, BAF180) (Polybromo-1D)"	PBRM1 BAF180 PB1	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005654; GO:0006338; GO:0006357; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819	DVPLPVVR	2.349999905	1	1	0.012666071	894.925613	0	0	0	0	0	13.82507	0	0	0	15.03689	0	14.24543	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.41049	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86UB9	TM135_HUMAN	"Transmembrane protein 135 (Peroxisomal membrane protein 52, PMP52)"	TMEM135	Homo sapiens (Human)	peroxisome organization [GO:0007031]; regulation of mitochondrial fission [GO:0090140]; response to cold [GO:0009409]; response to food [GO:0032094]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; peroxisome organization [GO:0007031]; regulation of mitochondrial fission [GO:0090140]; response to cold [GO:0009409]; response to food [GO:0032094]		GO:0005777; GO:0005778; GO:0005811; GO:0007031; GO:0009409; GO:0016021; GO:0031966; GO:0032094; GO:0090140	VLDVFGTGASK	4.119999886	1	1	0.016361526	1092.744932	14.97091	14.85669	0	17.9167	0	0	12.36449	15.02566	14.54962	0	16.22039	0	15.71518	0	0	15.38318	0	13.62711	16.04358	16.35652	0	16.03277	0	0	0	14.24903	14.79789	0	14.05485	0	0	0	15.50929	0	15.21123	14.33428	0	0	0	14.9749	15.74069	0	0	0	13.89992	17.52925	16.91992	14.13855
Q86UC2	RSPH3_HUMAN	Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2)	RSPH3 RSHL2 RSP3	Homo sapiens (Human)		cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005856; GO:0005929	ELLGQDEETAMR	7.659999847	1	1	0.139631063	1390.810892	0	0	0	0	0	0	0	0	15.38715	0	17.09659	0	0	0	0	0	0	0	0	0	12.98028	0	0	0	18.98203	14.3058	0	17.37409	0	0	17.62949	0	16.49574	0	0	0	0	0	0	0	0	0	0	0	0	0	16.64256	18.28843
Q86UD0	SAPC2_HUMAN	"Suppressor APC domain-containing protein 2 (Tumor specificity and mitosis phase-dependent expression protein, TS/MDEP) (p42.3)"	SAPCD2 C9orf140	Homo sapiens (Human)	establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725]	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725]		GO:0000132; GO:0005654; GO:0005730; GO:0005829; GO:0005923; GO:0008284; GO:0016324; GO:0043296; GO:0045179; GO:0090175; GO:0098725; GO:1904777	LLPKVQEVAR	6.289999962	0.668801188	0.668801188	0.233678328	1152.140165	14.03002	10.64594	0	14.44578	0	0	0	0	0	12.62894	0	18.55796	0	13.93923	0	0	0	0	0	0	0	0	0	0	14.61398	0	0	15.37542	0	0	0	0	14.99846	0	14.29265	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86UD4	ZN329_HUMAN	Zinc finger protein 329	ZNF329	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	LFRNIAGLIR	17.10000038	1	1	0.127047423	1170.804175	13.94232	0	0	0	0	0	0	0	15.04277	0	0	0	15.69157	15.13022	0	0	0	15.65497	0	0	0	0	16.16982	15.8383	0	14.98436	0	0	14.91214	0	0	0	0	16.55955	0	0	0	0	0	0	0	0	16.70633	14.00754	15.37152	0	0	16.42204
Q86UE3	ZN546_HUMAN	Zinc finger protein 546 (Zinc finger protein 49)	ZNF546 ZNF49	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	HQMGCVSQMLIQK	3.059999943	1	1	0.350588255	1593.16597	14.07632	14.44099	13.85912	12.92458	0	14.71328	13.30494	14.59473	14.78824	14.80509	15.02723	14.17661	9.448749	14.58602	15.10929	0	12.2777	0	14.68804	10.81085	0	13.19248	14.2007	14.5561	0	14.68301	15.93572	0	0	0	0	0	0	15.04732	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86UE4	LYRIC_HUMAN	"Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein, AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein)"	MTDH AEG1 LYRIC	Homo sapiens (Human)	lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of transcription by RNA polymerase II [GO:0006357]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of transcription by RNA polymerase II [GO:0006357]	double-stranded RNA binding [GO:0003725]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000122; GO:0001650; GO:0003712; GO:0003713; GO:0003723; GO:0003725; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005923; GO:0006357; GO:0010508; GO:0016021; GO:0016324; GO:0016604; GO:0031663; GO:0031965; GO:0043066; GO:0043123; GO:0045766; GO:0046581; GO:0048471; GO:0051059; GO:0051092; GO:0051897; GO:0061629	QPPEIDK	12.35000038	1	1	0.119346278	825.919707	16.17979	13.87749	15.40183	0	0	12.8069	15.80017	13.69095	13.70594	11.96683	0	13.93636	13.10211	0	0	0	0	0	14.78664	12.74788	0	14.59658	0	0	0	14.24149	0	0	12.65688	13.7948	12.3518	0	0	0	0	0	0	0	0	13.06511	11.94324	0	15.1708	0	13.78282	0	14.08624	14.21917
Q86UF2	CTGE6_HUMAN	"cTAGE family member 6, Protein cTAGE-6"	CTAGE6 CTAGE6P	Homo sapiens (Human)	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]		GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971	IMTEFYQEDEMK	5.75	0.694542587	0.694542587	0.162655548	1578.523799	13.62586	14.85439	10.67012	15.22027	13.83619	0	11.34233	11.7108	13.02138	15.5588	14.67752	14.48093	0	0	0	0	0	0	0	0	12.61449	0	0	0	11.70063	0	16.96639	0	0	0	0	0	16.46195	0	0	0	0	16.49433	0	0	0	0	0	13.692	0	0	0	13.40676
Q86UF4	CC190_HUMAN	Coiled-coil domain-containing protein 190	CCDC190 C1orf110	Homo sapiens (Human)						MAQDTCKSK	1.450000048	1	1	0.024801455	1071.309156	16.02621	0	17.97229	0	13.52555	0	0	0	14.78463	15.5318	0	13.78792	0	0	0	0	0	0	13.55828	0	0	0	0	0	0	0	0	0	0	0	0	16.41277	0	0	0	0	0	0	16.41223	0	16.57106	0	0	0	13.4027	0	0	0
Q86UG4	SO6A1_HUMAN	"Solute carrier organic anion transporter family member 6A1 (Cancer/testis antigen 48, CT48) (Gonad-specific transporter, GST) (Organic anion-transporting polypeptide 6A1) (Organic anion-transporting polypeptide I, OATP-I) (Solute carrier family 21 member 19)"	SLCO6A1 OATP6A1 SLC21A19	Homo sapiens (Human)	sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; sodium-independent organic anion transport [GO:0043252]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005887; GO:0015347; GO:0043252	KEETDL	6.820000172	1	1	0.296430053	734.9530964	12.76061	14.88581	15.24402	15.36727	14.84592	14.57901	0	0	0	15.29745	0	16.27983	0	14.52251	0	8.401042	0	0	15.58832	14.53441	16.08774	16.01567	15.41101	15.49765	0	15.03897	0	0	16.02413	0	16.8969	0	16.58762	0	0	0	16.65606	0	16.19048	16.31724	0	17.15523	0	0	17.78354	0	0	0
Q86UK0	ABCAC_HUMAN	"Glucosylceramide transporter ABCA12, EC 7.6.2.1 (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12, ATP-binding cassette 12)"	ABCA12 ABC12	Homo sapiens (Human)	cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]; cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129]	ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]	GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016021; GO:0019725; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010	ILGLEKLLK	2.359999895	1	1	0.273820739	1025.974943	0	16.5311	17.5069	0	0	0	20.29499	17.26037	17.60985	0	0	0	17.18918	0	18.06172	16.08078	0	0	0	0	0	0	0	0	0	18.72437	17.48778	17.22879	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.36436	0	0	17.74353
Q86UK5	LBN_HUMAN	"Limbin (Ellis-van Creveld syndrome protein 2, EVC2)"	EVC2 LBN	Homo sapiens (Human)	smoothened signaling pathway [GO:0007224]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane protein complex [GO:0098797]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane protein complex [GO:0098797]; smoothened signaling pathway [GO:0007224]		GO:0005634; GO:0005737; GO:0005856; GO:0005929; GO:0007224; GO:0016021; GO:0060170; GO:0098797	ALGMD	5.820000172	0.357789725	0.357789725	0.250088916	509.5731745	16.24414	16.9344	16.5824	0	17.11209	0	0	0	17.10175	0	16.4409	17.40698	16.04039	16.62663	17.34444	0	0	0	16.41	16.78238	0	0	0	15.9505	17.56207	16.96909	0	17.39178	15.92513	17.30273	17.60588	17.32335	16.43531	18.19222	16.85902	16.16711	16.40268	16.96523	15.92465	17.37892	17.67604	16.74952	16.98653	15.7463	16.69309	16.991	17.14115	15.54758
Q86UK7	ZN598_HUMAN	"E3 ubiquitin-protein ligase ZNF598, EC 2.3.2.27 (Zinc finger protein 598)"	ZNF598	Homo sapiens (Human)	protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	cytosol [GO:0005829]	cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0003723; GO:0005829; GO:0006417; GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344; GO:1990116	DFLQSDEAR	5.449999809	1	1	0.121186822	1081.968847	13.51242	15.13003	0	0	0	15.23624	0	0	0	0	0	0	15.88792	0	0	13.9228	0	0	0	15.63222	0	0	0	0	0	0	0	0	0	0	0	0	13.0757	0	0	0	0	0	12.02068	0	0	0	0	0	0	0	0	0
Q86UL3	GPAT4_HUMAN	"Glycerol-3-phosphate acyltransferase 4, EC 2.3.1.15 (1-acylglycerol-3-phosphate O-acyltransferase 6, 1-AGP acyltransferase 6, 1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta, LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7, TSARG7)"	GPAT4 AGPAT6 TSARG7 UNQ551/PRO1108	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]	GO:0002071; GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006654; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016021; GO:0016024; GO:0019432; GO:0040014; GO:0046339; GO:0102420	ALTAIITYHDRENRPR	1.809999943	0.620627642	0.620627642	0.474285137	1926.471058	16.59006	0	0	16.99041	17.62093	16.46851	0	18.68858	0	0	0	0	0	0	17.39543	0	15.84506	0	17.79288	0	0	0	0	0	0	18.16338	0	16.0444	0	16.25618	19.40443	0	0	18.72167	0	0	0	0	0	16.76052	0	0	16.85437	0	0	16.99028	0	0
Q86UP0	CAD24_HUMAN	Cadherin-24	CDH24 CDH11L UNQ2834/PRO34009	Homo sapiens (Human)	adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]	GO:0000902; GO:0005509; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007156; GO:0008013; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045294; GO:0045296; GO:0070097; GO:0098609; GO:0098742	VEATNTLIDPAYLR	8.409999847	1	1	0.26428041	1575.653277	14.64426	0	0	15.44041	0	14.26627	0	16.27534	15.65669	0	0	0	0	0	0	0	10.02448	0	0	0	0	0	0	0	0	14.86698	0	15.54248	0	0	0	13.73597	15.16851	15.52406	11.71359	0	15.65711	16.61023	0	0	15.88859	15.70048	0	14.50229	0	15.61851	0	14.10437
Q86UP2	KTN1_HUMAN	Kinectin (CG-1 antigen) (Kinesin receptor)	KTN1 CG1 KIAA0004	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; protein transport [GO:0015031]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031]	cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723]	GO:0003723; GO:0005783; GO:0005788; GO:0005789; GO:0005887; GO:0007018; GO:0015031; GO:0016020; GO:0016021; GO:0019894; GO:0030176; GO:0045296	EDAAATK	6.289999962	1	1	0.106485188	704.2347938	12.84764	14.32348	14.12301	15.23948	15.09792	15.20784	14.63342	14.75398	13.21424	13.64968	14.58621	14.52139	14.88633	14.24061	13.96668	0	0	0	0	0	0	14.21912	16.11394	11.71255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86UP3	ZFHX4_HUMAN	"Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4, ZFH-4)"	ZFHX4	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270	HMQKYQLVAHIK	19.59000015	1	1	0.534466513	1495.745613	0	18.64878	0	0	0	0	16.36351	0	0	0	0	0	0	0	0	0	18.90956	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.07722	0	0	19.80132	0	0	0	0	0	0
Q86UQ0	ZN589_HUMAN	Zinc finger protein 589 (Stem cell zinc finger protein 1)	ZNF589 SZF1	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0046872	QKAVTAEK	4.610000134	1	1	0.208256595	872.9448591	14.00619	13.83134	14.73663	17.42183	15.79213	14.30344	13.57094	0	0	0	15.57852	14.77806	0	0	0	14.19671	11.29993	16.1546	14.87159	0	13.00355	0	0	0	16.75243	0	16.19608	16.36694	0	0	0	15.81383	0	0	0	0	0	0	15.96926	16.41891	0	0	0	0	0	16.16673	0	0
Q86UQ4	ABCAD_HUMAN	"ATP-binding cassette sub-family A member 13, EC 7.6.2.-"	ABCA13	Homo sapiens (Human)	ceramide transport [GO:0035627]; lipid transport [GO:0006869]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of synaptic vesicle endocytosis [GO:1900244]	azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; ceramide transport [GO:0035627]; lipid transport [GO:0006869]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of synaptic vesicle endocytosis [GO:1900244]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0030667; GO:0032376; GO:0035577; GO:0035627; GO:0042626; GO:0043231; GO:0097708; GO:0140359; GO:1900244	MNLEDMR	19.20999908	1	1	0.402480095	923.4435747	14.35308	0	0	0	0	0	0	0	0	0	0	0	0	0	17.68363	0	0	20.16604	0	0	0	17.6766	0	0	0	0	0	0	19.00573	0	0	0	0	17.14929	0	0	0	0	0	0	18.35825	0	0	19.89567	0	0	16.11802	0
Q86UR1	NOXA1_HUMAN	"NADPH oxidase activator 1, NOX activator 1 (Antigen NY-CO-31) (NCF2-like protein) (P67phox-like factor) (p51-nox)"	NOXA1 P51NOX	Homo sapiens (Human)	regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of respiratory burst [GO:0060263]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	cytosol [GO:0005829]; NADPH oxidase complex [GO:0043020]	cytosol [GO:0005829]; NADPH oxidase complex [GO:0043020]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of respiratory burst [GO:0060263]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; superoxide-generating NADPH oxidase activator activity [GO:0016176]	GO:0005829; GO:0006801; GO:0010310; GO:0016176; GO:0017124; GO:0019899; GO:0031267; GO:0042554; GO:0042802; GO:0043020; GO:0060263	RGADLSSLR	6.829999924	0.377216637	0.377216637	0.250491947	973.4706368	0	0	0	0	0	0	0	17.13381	16.66191	0	0	0	0	16.24581	16.56684	17.49578	0	0	0	17.09907	16.86658	0	0	0	17.06562	0	0	0	17.08063	0	18.20173	19.03812	17.3775	17.61886	0	0	0	0	19.07547	0	0	0	0	0	0	16.68122	0	0
Q86UR5	RIMS1_HUMAN	"Regulating synaptic membrane exocytosis protein 1 (Rab-3-interacting molecule 1, RIM 1) (Rab-3-interacting protein 2)"	RIMS1 KIAA0340 RAB3IP2 RIM1 Nbla00761	Homo sapiens (Human)	acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; protein-containing complex assembly [GO:0065003]; regulated exocytosis [GO:0045055]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic plasticity [GO:0048167]; response to stimulus [GO:0050896]; secretion [GO:0046903]; synaptic vesicle exocytosis [GO:0016079]; visual perception [GO:0007601]	cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]	cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; GTPase regulator activity [GO:0030695]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; protein-containing complex assembly [GO:0065003]; regulated exocytosis [GO:0045055]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic plasticity [GO:0048167]; response to stimulus [GO:0050896]; secretion [GO:0046903]; synaptic vesicle exocytosis [GO:0016079]; visual perception [GO:0007601]	GTPase regulator activity [GO:0030695]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]	GO:0003723; GO:0005829; GO:0005886; GO:0006886; GO:0007601; GO:0010628; GO:0016079; GO:0017156; GO:0030154; GO:0030695; GO:0031267; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0045055; GO:0046872; GO:0046903; GO:0046928; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0050896; GO:0060478; GO:0061025; GO:0065003; GO:0097151; GO:1903861; GO:2000463	HSDVALPRTEAGAALPEGK	1.779999971	1	1	0.288871651	1919.674832	13.97453	0	0	13.57043	14.05581	0	15.92609	9.859631	13.5145	15.72116	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.66085	15.14683	14.77248	11.04628	0	0	15.7333	0	0	0	0	0	0	0	0	0	0	15.21368	0	0	15.75074	0	0	0
Q86US8	EST1A_HUMAN	"Telomerase-binding protein EST1A, EC 3.1.-.- (Ever shorter telomeres 1A, hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a)"	SMG6 C17orf31 EST1A KIAA0732	Homo sapiens (Human)	"mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomerase activity [GO:0051972]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomerase activity [GO:0051972]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]"	DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0006406; GO:0032204; GO:0032210; GO:0035303; GO:0042162; GO:0043021; GO:0046872; GO:0051972; GO:0070034; GO:0070182; GO:1904354	DEIVNDR	4.860000134	1	1	0.167040903	860.3076878	9.26422	15.59723	12.75432	14.49308	15.30949	14.21194	13.89523	0	12.2693	0	14.7722	14.4249	0	0	0	0	16.07526	0	0	15.81599	17.85512	15.52193	16.66343	0	15.89931	0	0	0	15.8585	0	17.66039	0	0	0	13.43761	0	0	17.05144	0	0	16.28257	0	0	0	15.77833	0	0	0
Q86UT5	NHRF4_HUMAN	"Na(+)/H(+) exchange regulatory cofactor NHE-RF4, NHERF-4 (Intestinal and kidney-enriched PDZ protein) (Natrium-phosphate cotransporter IIa C-terminal-associated protein 2, Na/Pi cotransporter C-terminal-associated protein 2, NaPi-Cap2) (PDZ domain-containing protein 2) (PDZ domain-containing protein 3) (Sodium-hydrogen exchanger regulatory factor 4)"	PDZD3 IKEPP NHERF4 PDZK2 DLNB27	Homo sapiens (Human)	ion transport [GO:0006811]; negative regulation of cGMP-mediated signaling [GO:0010754]; protein localization to plasma membrane [GO:0072659]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to toxic substance [GO:0009636]; water transport [GO:0006833]	apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytosol [GO:0005829]	apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytosol [GO:0005829]; guanylate cyclase inhibitor activity [GO:0030251]; ion channel inhibitor activity [GO:0008200]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-specific protease binding [GO:1990381]; ion transport [GO:0006811]; negative regulation of cGMP-mediated signaling [GO:0010754]; protein localization to plasma membrane [GO:0072659]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to toxic substance [GO:0009636]; water transport [GO:0006833]	guanylate cyclase inhibitor activity [GO:0030251]; ion channel inhibitor activity [GO:0008200]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-specific protease binding [GO:1990381]	GO:0005829; GO:0005903; GO:0006811; GO:0006833; GO:0007168; GO:0008022; GO:0008200; GO:0009636; GO:0010754; GO:0016324; GO:0030251; GO:0043296; GO:0043495; GO:0045177; GO:0072659; GO:1990381	FFSMVR	3.440000057	0.395589113	0.395589113	0.147935084	801.8078068	0	13.51271	14.69581	15.00851	12.4415	12.71537	0	0	0	0	14.98444	0	13.44242	13.78569	0	0	15.49034	0	0	0	0	0	0	0	0	0	0	0	0	0	15.98135	14.90425	0	0	14.41894	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86UT6	NLRX1_HUMAN	"NLR family member X1 (Caterpiller protein 11.3, CLR11.3) (Nucleotide-binding oligomerization domain protein 26) (Nucleotide-binding oligomerization domain protein 5) (Nucleotide-binding oligomerization domain protein 9)"	NLRX1 NOD26 NOD5 NOD9	Homo sapiens (Human)	innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of RIG-I signaling pathway [GO:0039536]	cell junction [GO:0030054]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of RIG-I signaling pathway [GO:0039536]	ATP binding [GO:0005524]	GO:0005524; GO:0005739; GO:0005741; GO:0005886; GO:0030054; GO:0032688; GO:0032715; GO:0035556; GO:0039536; GO:0043124; GO:0045087; GO:0045824; GO:0050728	GATLNPWR	3.549999952	1	1	0.086247128	914.3959531	11.05704	0	0	0	0	0	0	17.06462	6.929166	0	0	0	11.69364	0	0	14.78578	14.8958	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.9411	0
Q86UU0	BCL9L_HUMAN	"B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, BCL9-like protein (Protein BCL9-2)"	BCL9L DLNB11	Homo sapiens (Human)	canonical Wnt signaling pathway [GO:0060070]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604]	beta-catenin-TCF complex [GO:1990907]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	beta-catenin-TCF complex [GO:1990907]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604]	beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0008013; GO:0010718; GO:0022604; GO:0030512; GO:0045944; GO:0060070; GO:1990907	SMGMQRPLGMAGSGMGQSMEMER	13.64999962	1	1	2.75E-12	2507.789812	15.90895	11.27243	16.87725	15.11324	14.935	0	13.61587	15.84625	14.34325	0	14.83847	0	14.58044	10.66204	14.57716	14.40401	0	12.9091	10.63137	14.74156	0	14.78363	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86UV5	UBP48_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 48, EC 3.4.19.12 (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific peptidase 48) (Ubiquitin-specific protease 48) (Ubiquitin-specific-processing protease 48)"	USP48 USP31	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006511; GO:0016579	LQQYFPK	3.450000048	1	1	0.332455679	924.2485383	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.59799	0	0	0	0	0	0	0	0	0	0
Q86UW2	OSTB_HUMAN	"Organic solute transporter subunit beta, OST-beta (Solute carrier family 51 subunit beta)"	SLC51B OSTB	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of protein stability [GO:0031647]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of protein stability [GO:0031647]	bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]	GO:0005886; GO:0015125; GO:0015721; GO:0016021; GO:0016323; GO:0031647; GO:0032782; GO:0032991; GO:0046982; GO:0060050; GO:0070863; GO:0090314	MQPPEKETPEVLHLDEAK	1.429999948	1	1	0.055553418	2107.926762	8.935024	0	12.2966	0	0	0	13.20398	0	0	13.66723	13.08594	16.73185	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.23487	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86UW6	N4BP2_HUMAN	"NEDD4-binding protein 2, N4BP2, EC 3.-.-.- (BCL-3-binding protein)"	N4BP2 B3BP KIAA1413	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ubiquitin binding [GO:0043130]	ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ubiquitin binding [GO:0043130]	GO:0004519; GO:0005524; GO:0005829; GO:0043130; GO:0046404	KTANPK	7.139999866	3.47E-11	3.47E-11	0.307133097	656.6965417	19.63434	17.75402	0	18.6795	0	0	0	17.49667	20.43552	18.34665	0	16.77197	0	17.59852	0	18.86467	0	0	0	0	0	19.88413	0	20.54555	0	0	18.55215	20.27379	16.73241	19.31657	0	0	0	20.064	0	0	0	0	0	0	17.70209	18.79817	19.70593	0	0	0	0	0
Q86UW7	CAPS2_HUMAN	"Calcium-dependent secretion activator 2 (Calcium-dependent activator protein for secretion 2, CAPS-2)"	CADPS2 CAPS2 KIAA1591	Homo sapiens (Human)	dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079]	cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; presynapse [GO:0098793]	cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079]	lipid binding [GO:0008289]; metal ion binding [GO:0046872]	GO:0005654; GO:0006887; GO:0008289; GO:0015031; GO:0016079; GO:0030659; GO:0043231; GO:0045921; GO:0046872; GO:0098793; GO:0098978; GO:1990504	NIANSLPNVALPK	13.53999996	0.595837533	0.595837533	0.443865574	1349.634227	0	17.94865	19.09063	14.99098	0	0	18.48061	0	19.34063	19.74292	16.16097	0	0	17.14661	18.27255	17.90302	0	0	0	0	0	0	0	0	0	0	19.13242	0	17.39118	0	0	20.32188	0	0	0	19.16363	0	0	0	16.8954	0	0	0	18.00838	0	0	18.54663	18.673
Q86UX2	ITIH5_HUMAN	"Inter-alpha-trypsin inhibitor heavy chain H5, ITI heavy chain H5, ITI-HC5, Inter-alpha-inhibitor heavy chain 5"	ITIH5 KIAA1953 PP14776 UNQ311/PRO354	Homo sapiens (Human)	hyaluronan metabolic process [GO:0030212]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005576; GO:0030212; GO:0062023	DALFTILHDLRPQDR	10.52999973	1	1	0.411810604	1810.75626	0	0	0	0	14.39747	0	0	15.42658	0	0	15.91344	0	0	0	14.12712	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86UX6	ST32C_HUMAN	"Serine/threonine-protein kinase 32C, EC 2.7.11.1 (PKE) (Yet another novel kinase 3)"	STK32C YANK3	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]		ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0018105; GO:0035556; GO:0046872; GO:0106310	MGSSMSAATAR	5.909999847	1	1	0.113754347	1100.963858	0	16.03261	0	0	0	0	0	14.13642	12.04455	14.1489	0	0	0	0	0	0	0	0	0	0	14.23917	0	0	0	0	17.10012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.73894
Q86UY8	NT5D3_HUMAN	"5'-nucleotidase domain-containing protein 3, EC 3.1.3.- (GRP94-neighboring nucleotidase)"	NT5DC3 GNN TU12B1-TY	Homo sapiens (Human)		receptor complex [GO:0043235]	receptor complex [GO:0043235]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	GO:0008253; GO:0043235; GO:0046872	GIMYRAIEADIEK	9.300000191	1	1	0.321314886	1525.815	17.1493	15.14605	14.55542	0	10.91042	0	0	14.71472	14.16178	0	15.46952	0	0	14.99607	15.44328	16.29839	0	17.78105	0	0	0	0	15.55217	0	13.66889	0	15.3847	15.14363	10.98888	8.723024	0	0	17.31971	0	17.02967	0	0	0	0	15.20767	0	0	13.19636	0	0	15.47782	0	0
Q86V15	CASZ1_HUMAN	Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693)	CASZ1 CST SRG ZNF693	Homo sapiens (Human)	"positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]"	chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0043231; GO:0045664; GO:0045893; GO:0045944; GO:0046872	DLGTAEGTR	9.479999542	0.251146674	0.251146674	0.251400948	920.0275103	16.89636	0	16.85331	0	0	0	14.68904	0	12.71925	0	0	17.06981	0	0	0	0	12.5708	14.6361	16.43782	0	16.30545	17.44055	0	0	15.04015	0	17.25	13.95023	17.1719	0	16.36296	18.02738	15.32486	17.15072	16.10477	15.20667	0	16.88109	0	16.46155	0	17.20634	0	16.20174	13.85196	0	11.54941	0
Q86V21	AACS_HUMAN	"Acetoacetyl-CoA synthetase, EC 6.2.1.16 (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog)"	AACS ACSF1	Homo sapiens (Human)	fatty acid metabolic process [GO:0006631]; ketone body biosynthetic process [GO:0046951]; positive regulation of insulin secretion [GO:0032024]	cytosol [GO:0005829]	cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]; ketone body biosynthetic process [GO:0046951]; positive regulation of insulin secretion [GO:0032024]	acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006631; GO:0030729; GO:0032024; GO:0046951	MGLSAR	2.119999886	1	1	0.274267036	651.4543413	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.76673	17.2012	0	0	0	0	0	0	0	0
Q86V25	VASH2_HUMAN	"Tubulinyl-Tyr carboxypeptidase 2, EC 3.4.17.17 (Vasohibin-2) (Vasohibin-like protein)"	VASH2 VASHL	Homo sapiens (Human)	axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; microtubule binding [GO:0008017]; axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768]	actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; microtubule binding [GO:0008017]	GO:0000768; GO:0001938; GO:0003779; GO:0004181; GO:0005576; GO:0005737; GO:0005856; GO:0006508; GO:0008017; GO:0045765; GO:0045766; GO:0060716; GO:0061564; GO:0140253	YGSLGMSR	7.46999979	0.991523385	0.991523385	0.277042038	870.8576554	16.08146	18.17101	0	19.75238	16.47158	15.71589	0	0	0	0	18.3515	17.16631	0	16.37949	17.36562	18.01862	0	18.54336	17.00052	0	18.11595	0	0	20.10446	0	17.66287	18.60007	0	16.68611	0	0	0	17.00643	0	0	0	19.03795	19.16961	0	0	0	18.82718	0	0	0	0	0	0
Q86V48	LUZP1_HUMAN	Leucine zipper protein 1	LUZP1	Homo sapiens (Human)	artery development [GO:0060840]; neural fold bending [GO:0021503]; ventricular septum development [GO:0003281]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; artery development [GO:0060840]; neural fold bending [GO:0021503]; ventricular septum development [GO:0003281]		GO:0003281; GO:0005634; GO:0016020; GO:0021503; GO:0060840; GO:0070062	MAELEKLEEAFSR	12.28999996	1	1	0.001025621	1565.620502	0	0	21.45498	19.52531	0	0	20.62684	0	21.38259	20.07569	21.61653	21.1353	0	20.11634	18.65487	0	0	0	0	19.41315	0	0	0	19.28862	19.61084	20.44916	0	0	0	0	0	0	0	21.46863	0	0	0	0	19.23594	0	0	0	0	0	0	0	18.19424	0
Q86V59	PNM8A_HUMAN	Paraneoplastic antigen-like protein 8A (PNMA-like protein 1)	PNMA8A PNMAL1	Homo sapiens (Human)						GPGSRR	7.460000038	0.022944313	0.022944313	0.015614826	627.4071598	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.4853	0	0	0	15.44345	0	0	0	17.90238	17.91752	18.25251	17.20314	0	0	15.50101	0	15.9105	15.85454	16.3574	0	0	0	0	0	0
Q86V71	ZN429_HUMAN	Zinc finger protein 429	ZNF429	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AFSRYSTLTTHK	3.630000114	1	1	0	1410.550766	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86V81	THOC4_HUMAN	"THO complex subunit 4, Tho4 (Ally of AML-1 and LEF-1) (Aly/REF export factor) (Transcriptional coactivator Aly/REF) (bZIP-enhancing factor BEF)"	ALYREF ALY BEF THOC4	Homo sapiens (Human)	"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; replication fork processing [GO:0031297]; RNA export from nucleus [GO:0006405]; viral mRNA export from host cell nucleus [GO:0046784]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; replication fork processing [GO:0031297]; RNA export from nucleus [GO:0006405]; viral mRNA export from host cell nucleus [GO:0046784]"	C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000018; GO:0000346; GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0031297; GO:0032786; GO:0046784; GO:0062153; GO:0070062; GO:0071013	GAGRNSK	4.659999847	1	1	0.124864317	687.1634103	11.15018	10.84075	0	0	0	0	15.52631	0	0	0	16.14469	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.51706	0	17.60016	16.26276	15.30494	14.93492	0	0	0	15.11514	0	0
Q86V85	GP180_HUMAN	Integral membrane protein GPR180 (Intimal thickness-related receptor)	GPR180 ITR	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236]		GO:0007186; GO:0016021; GO:0019236	ICLALSLGCGLYQIITVERSTLK	5.099999905	1	1	0.434546337	2610.334983	0	22.34264	20.48881	0	0	0	0	0	18.37894	0	0	0	0	0	0	0	0	0	0	0	0	20.95002	0	0	0	0	0	0	20.34644	0	0	0	0	0	16.92929	22.07083	17.12452	0	0	0	0	0	0	0	0	0	0	0
Q86V97	KBTB6_HUMAN	Kelch repeat and BTB domain-containing protein 6	KBTBD6	Homo sapiens (Human)	negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of Rac protein signal transduction [GO:0035020]; response to unfolded protein [GO:0006986]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of Rac protein signal transduction [GO:0035020]; response to unfolded protein [GO:0006986]		GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0009968; GO:0031463; GO:0035020; GO:0043161; GO:0070936	LLLITSR	32.77000046	0.01453375	0.01453375	0.123980205	814.5465898	19.5871	19.09072	19.77551	20.42334	19.64107	19.8422	20.94309	19.5554	20.20392	19.50278	18.19854	19.2459	19.43987	18.07378	20.32199	20.09239	18.46221	20.28653	19.53281	18.58245	19.45719	19.3869	19.71839	19.67782	17.55202	20.50107	20.5781	18.81751	20.57493	19.58163	20.37407	19.6212	19.62672	19.71169	18.58654	18.67335	20.06515	19.22756	18.87544	19.39186	16.64973	19.06248	18.82372	19.87605	20.47217	20.15578	17.99725	18.84708
Q86VB7	C163A_HUMAN	"Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163, sCD163 ]"	CD163 M130	Homo sapiens (Human)	acute-phase response [GO:0006953]	cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]	scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0006953; GO:0009897; GO:0030666; GO:0097110	RWGHSECGHK	1.659999967	1	1	0.092023243	1254.516643	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.46414	0	0
Q86VD1	MORC1_HUMAN	"MORC family CW-type zinc finger protein 1 (Cancer/testis antigen 33, CT33)"	MORC1 MORC	Homo sapiens (Human)	"behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; DNA hypermethylation [GO:0044026]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of transposition [GO:0010529]; regulation of gene expression, epigenetic [GO:0040029]; spermatogenesis [GO:0007283]"	male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]	"male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; DNA hypermethylation [GO:0044026]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of transposition [GO:0010529]; regulation of gene expression, epigenetic [GO:0040029]; spermatogenesis [GO:0007283]"	zinc ion binding [GO:0008270]	GO:0001662; GO:0001673; GO:0005634; GO:0007283; GO:0008270; GO:0010529; GO:0030154; GO:0031047; GO:0040029; GO:0043046; GO:0044026; GO:2000143	TSLSSAK	4.300000191	1	1	0.331177385	691.0890337	0	0	16.36336	0	0	0	0	16.81474	0	16.53332	0	17.38679	0	0	0	0	0	0	17.27677	0	0	0	0	0	16.59123	0	17.60304	17.70173	0	17.29432	0	0	0	0	0	0	17.74226	17.39161	0	0	0	0	0	17.85443	0	0	0	0
Q86VD7	S2542_HUMAN	Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42)	SLC25A42	Homo sapiens (Human)	ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]	adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]	GO:0005347; GO:0005634; GO:0005739; GO:0005743; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0016021; GO:0035349; GO:0043262; GO:0080121; GO:0080122	TAVAPLDR	19.55999947	1	1	0.609890458	843.6118624	0	0	0	0	0	0	0	0	15.79557	0	18.1211	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.42684	0	0	0	15.94874	0	0	0	18.61447	0	0	0	17.63718	0	0	0	0	0	0	0	0	0
Q86VD9	PIGZ_HUMAN	"GPI mannosyltransferase 4, EC 2.4.1.- (GPI mannosyltransferase IV, GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein, PIG-Z) (SMP3 homolog, hSMP3)"	PIGZ SMP3	Homo sapiens (Human)	GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]"	"alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]"	GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016021; GO:0016254	EPAPGPR	6.960000038	0.679856002	0.679856002	0.171183063	723.4545482	14.83883	14.12558	15.68107	15.76105	15.02565	15.22548	0	0	15.99448	0	0	15.18805	15.53608	16.62541	14.73483	0	14.83508	15.2155	15.94245	14.3565	16.14594	15.92255	0	16.45219	17.11477	0	15.55042	15.85663	15.88073	14.88732	16.55504	15.12685	16.13308	15.05731	0	16.84579	14.76342	17.04625	17.67757	16.37517	14.31302	16.62974	0	15.68968	16.73722	0	16.43571	17.05527
Q86VE3	SATL1_HUMAN	"Spermidine/spermine N(1)-acetyltransferase-like protein 1, EC 2.3.1.-"	SATL1	Homo sapiens (Human)			N-acetyltransferase activity [GO:0008080]	N-acetyltransferase activity [GO:0008080]	GO:0008080	QTSMDYFQIRHAEAGDCPEILR	3.349999905	1	1	0.235792872	2653.910133	12.3071	12.51434	15.41113	0	15.03284	0	14.31471	15.35318	14.71568	15.22651	12.85376	0	0	0	15.02462	0	9.000342	0	0	0	0	0	15.18565	0	0	15.4259	17.50836	0	0	0	0	0	0	0	0	0	0	0	0	14.28674	15.07546	0	0	0	0	0	14.3642	0
Q86VE9	SERC5_HUMAN	Serine incorporator 5	SERINC5 C5orf12	Homo sapiens (Human)	defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; myelination [GO:0042552]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; L-serine transmembrane transporter activity [GO:0015194]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; myelination [GO:0042552]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]	L-serine transmembrane transporter activity [GO:0015194]	GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006564; GO:0006658; GO:0006665; GO:0008654; GO:0009597; GO:0015194; GO:0016020; GO:0016021; GO:0042552; GO:0043209; GO:0043231; GO:0045087; GO:0048471; GO:0051607; GO:0070062; GO:1904219; GO:1904222	AGDTCEK	5.070000172	0.606594801	0.606594801	0.051786512	779.5964342	0	0	14.36211	0	0	0	15.81308	0	15.22113	17.56745	9.91701	0	17.56092	14.16355	15.61433	0	14.88755	15.3083	12.46669	12.95488	15.72864	14.38775	11.67954	17.55465	16.62864	8.935303	0	0	14.01824	0	0	17.88492	15.37751	17.66058	14.17442	0	16.60802	0	15.59949	0	15.22652	12.84327	17.22969	0	15.04594	16.34067	10.71596	16.64852
Q86VF7	NRAP_HUMAN	"Nebulin-related-anchoring protein, N-RAP"	NRAP	Homo sapiens (Human)	cardiac muscle thin filament assembly [GO:0071691]	fascia adherens [GO:0005916]; muscle tendon junction [GO:0005927]; Z disc [GO:0030018]	fascia adherens [GO:0005916]; muscle tendon junction [GO:0005927]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; vinculin binding [GO:0017166]; cardiac muscle thin filament assembly [GO:0071691]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; vinculin binding [GO:0017166]	GO:0003779; GO:0005916; GO:0005927; GO:0017166; GO:0030018; GO:0046872; GO:0051015; GO:0051371; GO:0071691	FHLPMDMVNIRHAK	4.360000134	1	1	0.419304219	1725.203489	0	14.66403	13.3037	0	13.60516	14.16461	0	13.1228	15.62317	0	13.90629	0	0	14.58639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.99325	0	14.9203	16.5717	0	0	0	0	0	0	14.4421	0	0	0	15.37367
Q86VH2	KIF27_HUMAN	Kinesin-like protein KIF27	KIF27	Homo sapiens (Human)	cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0060271	ELRQISALELSLR	15.52999973	0.388335645	0.388335645	0.200095178	1527.556112	15.82739	15.35796	0	0	0	15.39208	0	0	0	0	0	15.13229	16.33448	14.01282	0	0	0	15.34982	16.66802	0	0	16.44819	13.81516	0	0	0	0	0	0	15.59922	0	16.24985	16.09333	16.4316	0	0	0	0	0	15.31928	16.52942	0	0	16.79361	0	0	0	0
Q86VH4	LRRT4_HUMAN	Leucine-rich repeat transmembrane neuronal protein 4	LRRTM4 UNQ3075/PRO9907	Homo sapiens (Human)		extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]		GO:0005615; GO:0016021; GO:0031012; GO:0045211	VFQDCR	7.590000153	1	1	0.19081818	821.4034286	14.54391	0	0	13.76702	15.94857	15.70992	0	0	0	0	0	0	0	13.97198	15.65708	0	0	0	0	0	0	0	0	0	14.81771	0	0	14.8404	0	15.39431	16.04586	0	0	0	0	0	0	0	0	0	0	15.66956	0	0	0	0	0	0
Q86VI3	IQGA3_HUMAN	Ras GTPase-activating-like protein IQGAP3	IQGAP3	Homo sapiens (Human)	cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; small GTPase binding [GO:0031267]; cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; small GTPase binding [GO:0031267]	GO:0000082; GO:0001934; GO:0005096; GO:0005516; GO:0005737; GO:0005829; GO:0005911; GO:0007265; GO:0008361; GO:0010628; GO:0010629; GO:0016328; GO:0031267; GO:0032956; GO:0033601; GO:0043087; GO:0043410; GO:0051015; GO:0070371; GO:0070856; GO:0071310	FQLHYQDLLQLQYEGVAVMKLFNK	5.880000114	0.245503888	0.245503888	0.146122984	2943.731681	0	0	14.85362	11.59485	0	0	12.74575	0	13.15013	0	17.84801	17.86219	17.99588	16.35288	0	0	12.20528	17.27757	0	0	0	15.99193	15.04563	0	0	6.204323	18.28988	0	0	0	0	14.36273	15.41584	0	0	0	0	0	0	0	16.28029	0	0	12.96317	0	11.74323	14.29918	0
Q86VI4	LAP4B_HUMAN	Lysosomal-associated transmembrane protein 4B (Lysosome-associated transmembrane protein 4-beta)	LAPTM4B PSEC0001	Homo sapiens (Human)	endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of transforming growth factor beta1 production [GO:0032911]; regulation of lysosomal membrane permeability [GO:0097213]; regulation of lysosome organization [GO:1905671]	"cell projection [GO:0042995]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]"	"cell projection [GO:0042995]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; ceramide binding [GO:0097001]; kinase binding [GO:0019900]; phosphatidylinositol bisphosphate binding [GO:1902936]; ubiquitin protein ligase binding [GO:0031625]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of transforming growth factor beta1 production [GO:0032911]; regulation of lysosomal membrane permeability [GO:0097213]; regulation of lysosome organization [GO:1905671]"	ceramide binding [GO:0097001]; kinase binding [GO:0019900]; phosphatidylinositol bisphosphate binding [GO:1902936]; ubiquitin protein ligase binding [GO:0031625]	GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007032; GO:0016021; GO:0019900; GO:0031625; GO:0031902; GO:0032509; GO:0032585; GO:0032911; GO:0042995; GO:0097001; GO:0097213; GO:0097487; GO:1902936; GO:1905166; GO:1905671	GTDPAEAR	16.55999947	1	1	2.31E-13	815.0376027	0	0	0	0	0	0	0	0	0	0	0	16.97991	0	0	0	0	0	16.90946	0	0	0	0	0	0	16.35912	17.22972	17.37786	17.62465	0	0	0	0	0	18.91991	0	0	0	18.02761	0	0	18.79531	0	0	0	0	0	0	0
Q86VM9	ZCH18_HUMAN	Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1)	ZC3H18 NHN1	Homo sapiens (Human)	RNA destabilization [GO:0050779]	nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; RNA destabilization [GO:0050779]	metal ion binding [GO:0046872]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]	GO:0003723; GO:0016607; GO:0030674; GO:0032991; GO:0046872; GO:0050779; GO:0140262; GO:1990904	IPRDVR	4.230000019	1	1	0.152982368	756.720383	0	0	0	14.77214	15.08993	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.448	0	0	0	17.56192	0	0	16.41386	0	0	0	0	15.79053	0	0	0	0	0	0	0	0
Q86VP3	PACS2_HUMAN	"Phosphofurin acidic cluster sorting protein 2, PACS-2 (PACS1-like protein)"	PACS2 KIAA0602 PACS1L	Homo sapiens (Human)	apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; transmembrane transporter binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]	transmembrane transporter binding [GO:0044325]	GO:0000045; GO:0005739; GO:0005783; GO:0006915; GO:0032469; GO:0034497; GO:0044325; GO:0072659; GO:1990456	VVALLR	2.130000114	0.000593443	0.000593443	0.006911559	672.476935	0	0	16.41425	0	12.6314	16.05783	0	0	0	0	15.65513	15.28072	16.52117	16.21941	14.09558	0	0	12.7756	15.00463	14.26544	0	0	18.8604	0	16.50477	17.54912	0	0	0	0	0	0	17.5866	15.35827	15.77784	0	0	0	0	17.66972	0	16.36518	13.15882	15.89428	14.2907	14.72573	15.20415	14.49363
Q86VQ0	LCA5_HUMAN	Lebercilin (Leber congenital amaurosis 5 protein)	LCA5 C6orf152	Homo sapiens (Human)	intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex binding [GO:0044877]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]	protein-containing complex binding [GO:0044877]	GO:0005929; GO:0005930; GO:0015031; GO:0032391; GO:0036064; GO:0042073; GO:0044877; GO:0045494	KDTDLVTK	17.03000069	0.327021867	0.327021867	0.166337029	919.5509055	18.25322	17.3033	0	18.29043	19.88006	18.78308	0	19.10381	19.10521	0	19.59212	17.58303	18.4805	17.85716	19.55084	18.70917	17.68803	0	0	19.49722	17.98518	18.1955	20.41511	0	19.83436	18.71554	19.79643	20.13412	17.55346	17.96275	19.5932	19.19271	19.993	20.00914	21.07989	19.45567	0	20.62624	19.77221	19.42515	19.43639	19.5465	16.409	18.63895	18.39033	17.76412	18.83091	19.26723
Q86VQ1	GLCI1_HUMAN	Glucocorticoid-induced transcript 1 protein	GLCCI1	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	MSTASSSSSSSSSQTPHPPSQRMR	2.230000019	1	1	0.146053943	2523.616653	12.0858	0	14.68058	13.27588	13.47561	11.5396	0	0	0	11.77775	0	10.42463	12.69294	0	0	7.93563	0	13.09165	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86VQ6	TRXR3_HUMAN	"Thioredoxin reductase 3, EC 1.8.1.9 (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2)"	TXNRD3 TGR TRXR3	Homo sapiens (Human)	cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; flavin adenine dinucleotide binding [GO:0050660]; glutathione oxidoreductase activity [GO:0097573]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283]	flavin adenine dinucleotide binding [GO:0050660]; glutathione oxidoreductase activity [GO:0097573]; thioredoxin-disulfide reductase activity [GO:0004791]	GO:0004791; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0007283; GO:0030154; GO:0045454; GO:0050660; GO:0097573	SPPQSPGPGKAGDAPNR	5.010000229	0.787204802	0.787204802	0.289249005	1632.528865	16.08733	0	0	17.79159	0	0	0	14.67614	15.37028	0	0	0	11.99404	0	0	0	0	14.97341	0	0	0	0	0	0	0	0	0	16.43039	16.52523	14.60007	0	0	0	0	15.67445	0	0	0	0	0	14.38198	14.9716	0	0	15.32667	0	0	0
Q86VR8	FJX1_HUMAN	Four-jointed box protein 1 (Four-jointed protein homolog)	FJX1	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842]		GO:0005615; GO:0007267; GO:0010842	MRGAAATAGLWLLALGSLLALWGGLLPPR	6.670000076	1	1	6.41E-12	2962.238527	13.68358	14.21648	0	0	0	12.03866	9.585228	14.60763	15.42273	11.96074	16.23654	15.59308	10.95505	13.04036	11.99467	0	13.18889	11.05955	11.03284	0	0	14.01978	0	13.10115	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86VS8	HOOK3_HUMAN	"Protein Hook homolog 3, h-hook3, hHK3"	HOOK3	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]	dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]	GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005829; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719	AKSVIR	8.409999847	0.544336319	0.544336319	0.250280087	670.9233709	0	14.67868	16.55521	15.71797	16.55957	14.05464	14.72215	14.94277	16.14607	14.77983	15.98203	14.60503	15.6957	0	16.71814	16.32966	15.8618	16.53823	16.58601	16.67083	0	17.12609	15.48288	17.22534	15.8828	15.41826	15.31897	16.34494	16.16133	0	0	15.9149	16.03674	15.83253	16.20361	0	0	0	0	0	0	0	16.59478	17.10846	16.86281	0	15.32895	0
Q86VV4	RNB3L_HUMAN	Ran-binding protein 3-like	RANBP3L	Homo sapiens (Human)	mesenchymal cell differentiation involved in bone development [GO:1901706]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of myoblast differentiation [GO:0045663]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; SMAD binding [GO:0046332]; mesenchymal cell differentiation involved in bone development [GO:1901706]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of myoblast differentiation [GO:0045663]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790]	SMAD binding [GO:0046332]	GO:0005643; GO:0005737; GO:0006611; GO:0045663; GO:0045668; GO:0046332; GO:0050790; GO:1901706	EKTNNK	8.270000458	0.385006338	0.385006338	0.172916368	734.1613153	12.20506	17.8403	0	17.31651	15.42122	15.44119	0	0	15.51228	0	0	13.80443	15.08709	15.62199	17.69517	17.28715	12.20153	12.6417	15.74157	0	10.33875	0	15.77882	16.11716	17.90903	0	16.54892	0	11.59745	0	16.97931	12.82613	16.71356	16.89985	16.33278	0	0	16.96819	0	14.70783	13.97493	13.59327	14.60116	0	0	17.611	15.9654	14.32204
Q86VV8	RTTN_HUMAN	Rotatin	RTTN	Homo sapiens (Human)	centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]		GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0032053; GO:0036064	LAFGDGK	3.559999943	1	1	0.25679355	704.9974109	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.11909	0	0	0	19.00687	0	0	0	19.90709	0	0	0	19.45426	0	0	0	0	0	0	0	0	0
Q86VX9	MON1A_HUMAN	Vacuolar fusion protein MON1 homolog A	MON1A SAND1	Homo sapiens (Human)	protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; Mon1-Ccz1 complex [GO:0035658]	cytosol [GO:0005829]; Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0006623; GO:0009306; GO:0016192; GO:0035658	AHNASRPLK	7.980000019	1	1	0.350495132	993.3844191	0	14.99778	0	14.7594	0	16.67528	16.54795	0	17.08771	16.18385	0	15.85353	0	14.59457	0	14.80231	17.10972	14.75111	15.29542	17.92069	0	0	0	15.26299	17.22273	0	0	0	15.24057	14.56929	0	15.22318	14.43374	13.38997	13.67449	11.99934	15.82516	0	0	13.14889	15.21556	16.13156	14.52343	14.12294	13.41279	14.3366	14.77398	0
Q86VY4	TSYL5_HUMAN	"Testis-specific Y-encoded-like protein 5, TSPY-like protein 5"	TSPYL5 KIAA1750	Homo sapiens (Human)	cellular response to gamma radiation [GO:0071480]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008]	chromatin [GO:0000785]; nucleus [GO:0005634]	chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; cellular response to gamma radiation [GO:0071480]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0008284; GO:0031398; GO:0040008; GO:0042393; GO:0051897; GO:0071480	KGAAGENTSVSAGEEK	13.31999969	1	1	2.74E-12	1535.732116	0	0	15.1405	10.69378	13.30966	12.14441	0	14.19229	13.97609	0	0	14.03899	15.85934	0	0	14.23955	12.26849	0	0	0	0	17.06311	0	15.40924	0	10.50611	0	14.04668	15.95679	0	15.61411	15.67472	0	0	14.60659	12.68736	0	12.58222	0	0	13.99624	14.54457	0	0	0	0	0	0
Q86VY9	T200A_HUMAN	Transmembrane protein 200A	TMEM200A KIAA1913 HBE61	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	NNSKGYMK	2.880000114	1	1	0	957.6126157	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86VZ2	WDR5B_HUMAN	WD repeat-containing protein 5B	WDR5B	Homo sapiens (Human)	histone H3-K4 methylation [GO:0051568]	Set1C/COMPASS complex [GO:0048188]	Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; histone H3-K4 methylation [GO:0051568]	histone binding [GO:0042393]	GO:0042393; GO:0048188; GO:0051568	FSPNGK	4.25	1	1	0.266660745	648.3290425	0	14.87019	0	17.87021	0	0	0	16.52973	0	0	17.96921	0	0	0	0	0	17.58723	0	0	17.11063	0	0	0	0	0	0	18.27953	0	0	0	0	0	0	0	0	0	0	18.78995	18.44877	16.47719	18.57342	0	16.24371	0	0	0	0	0
Q86VZ4	LRP11_HUMAN	"Low-density lipoprotein receptor-related protein 11, LRP-11"	LRP11	Homo sapiens (Human)	multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414]	phosphoprotein binding [GO:0051219]	GO:0005886; GO:0009408; GO:0009409; GO:0009414; GO:0009612; GO:0016021; GO:0033555; GO:0035902; GO:0042594; GO:0051219	APAAVRGWR	7.820000172	0.810056806	0.810056806	0.160675015	983.5341828	0	0	13.1346	14.01441	0	15.59578	15.1192	12.71551	15.00939	15.11646	0	0	15.13514	0	0	14.71102	15.79289	0	0	0	0	0	14.82945	16.13437	0	15.11875	0	0	12.90454	13.27692	0	16.78089	0	0	0	0	14.19462	15.95987	0	15.52057	0	0	0	0	0	0	0	0
Q86VZ5	SMS1_HUMAN	"Phosphatidylcholine:ceramide cholinephosphotransferase 1, EC 2.7.8.27 (Medulla oblongata-derived protein, Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23)"	SGMS1 MOB SMS1 TMEM23	Homo sapiens (Human)	apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]	ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]	GO:0000138; GO:0000139; GO:0002950; GO:0005634; GO:0005783; GO:0005886; GO:0005887; GO:0006686; GO:0006915; GO:0016020; GO:0016301; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:2001242	CITMYVTTLPVPGMHFNCSPK	5.269999981	1	1	4.58E-13	2484.134525	14.2661	0	0	12.39946	0	12.5267	15.50773	14.39757	0	14.2031	0	0	9.766802	0	0	0	13.21503	0	0	0	13.46667	0	0	0	0	0	16.71106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.76765	0	0	0	0	0
Q86W10	CP4Z1_HUMAN	"Cytochrome P450 4Z1, EC 1.14.14.1 (CYPIVZ1) (Laurate 7-monooxygenase, EC 1.14.14.130)"	CYP4Z1 UNQ3060/PRO9882	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; lauric acid metabolic process [GO:0048252]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; aromatase activity [GO:0070330]; fatty acid in-chain hydroxylase activity [GO:0052722]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; lauric acid metabolic process [GO:0048252]"	"arachidonic acid 14,15-epoxygenase activity [GO:0008404]; aromatase activity [GO:0070330]; fatty acid in-chain hydroxylase activity [GO:0052722]; heme binding [GO:0020037]; iron ion binding [GO:0005506]"	GO:0005506; GO:0005789; GO:0008404; GO:0016021; GO:0019369; GO:0020037; GO:0048252; GO:0052722; GO:0070330	NCIGQHFAIIECK	8.340000153	1	1	0.409257134	1590.190723	0	0	0	12.47706	0	13.77529	16.05942	0	0	15.97639	0	0	0	0	0	0	16.80049	16.09676	0	17.6949	0	16.30611	0	17.5435	0	15.87667	0	0	0	0	16.19594	0	0	0	15.51343	0	16.99636	0	0	0	0	16.39981	0	0	0	16.53466	16.78775	16.34655
Q86W24	NAL14_HUMAN	"NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)"	NLRP14 NALP14 NOD5	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]	GO:0005524; GO:0005737; GO:0007283; GO:0030154	SLLQSTSYK	2.630000114	1	1	0.21246744	1025.317723	0	0	12.21839	0	15.43628	17.11341	0	0	0	0	0	0	0	0	0	0	0	15.44181	0	0	0	0	16.04573	0	0	0	0	16.49065	14.60737	0	0	0	0	0	0	0	17.65252	0	0	0	0	15.88151	0	0	17.53074	16.82341	0	0
Q86W28	NALP8_HUMAN	"NACHT, LRR and PYD domains-containing protein 8 (Nucleotide-binding oligomerization domain protein 16) (PYRIN and NACHT-containing protein 4)"	NLRP8 NALP8 NOD16 PAN4	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524; GO:0005737	SLDLSFNSLK	4.380000114	1	1	0.131445605	1121.650973	14.2965	12.85566	13.07039	0	16.11427	0	10.93372	0	12.28156	14.44689	13.42707	14.89231	13.3034	0	13.21381	0	0	0	0	0	0	0	0	0	0	14.88048	0	0	0	0	0	14.56448	0	0	0	0	0	0	0	0	0	0	14.3741	0	0	0	0	0
Q86W33	TPRA1_HUMAN	Transmembrane protein adipocyte-associated 1 (Integral membrane protein GPR175) (Transmembrane protein 227)	TPRA1 GPR175 TMEM227 PP6566	Homo sapiens (Human)	aging [GO:0007568]; embryonic cleavage [GO:0040016]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of mitotic cell cycle phase transition [GO:1901991]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; aging [GO:0007568]; embryonic cleavage [GO:0040016]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of mitotic cell cycle phase transition [GO:1901991]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0006629; GO:0007186; GO:0007568; GO:0016021; GO:0040016; GO:1901991	CQVDETEEPDVHLPQPYAVAR	1.279999971	1	1	3.67E-12	2452.587589	0	12.71216	14.4808	0	11.779	9.657674	14.26877	13.27113	0	12.15808	14.03015	9.570735	11.59693	11.86935	10.89595	0	0	9.313341	0	9.475618	13.69693	13.67036	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86W34	AMZ2_HUMAN	"Archaemetzincin-2, EC 3.4.-.- (Archeobacterial metalloproteinase-like protein 2)"	AMZ2 BM-014	Homo sapiens (Human)			metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]	metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]	GO:0008237; GO:0046872	CLAVLQK	11.68000031	0.006296034	0.006296034	0.291851519	828.9121329	19.12793	0	17.54093	0	18.51088	0	18.78335	18.67567	19.61042	0	19.66876	0	16.52307	0	17.0864	0	17.4993	0	17.91724	16.11033	0	0	0	19.87721	18.70455	19.5963	0	16.49123	18.00703	18.30494	18.96959	0	0	0	0	18.53656	19.68434	19.40848	19.75668	0	0	16.60184	17.44353	20.63305	17.52413	16.77504	0	19.41809
Q86W50	MET16_HUMAN	"RNA N6-adenosine-methyltransferase METTL16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16, EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase, EC 2.1.1.346)"	METTL16 METT10D	Homo sapiens (Human)	"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]"	23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]	GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0080009; GO:0120048; GO:0120049; GO:1905869	DLMNQLCTYIR	10.11999989	0.428631902	0.428631902	0.821760204	1427.510829	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.24283	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.24341	0	0	0	0	0	0	0	0	0	0	0	0
Q86W54	SPA24_HUMAN	Spermatogenesis-associated protein 24 (Testis protein T6441 homolog)	SPATA24	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007283; GO:0030154	NVMVLQDENFVSKEEFQAVEK	1.789999962	1	1	0.28186944	2498.692869	17.32944	18.9386	15.36809	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.53622	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.65498	0
Q86W56	PARG_HUMAN	"Poly(ADP-ribose) glycohydrolase, EC 3.2.1.143"	PARG	Homo sapiens (Human)	"ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair, gap-filling [GO:0006287]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair, gap-filling [GO:0006287]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]"	poly(ADP-ribose) glycohydrolase activity [GO:0004649]	GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0005975; GO:0006282; GO:0006287; GO:0009225; GO:0031056; GO:0043231; GO:1990966	DVVYFTFGDSELMR	1.50999999	1	1	0.108084239	1694.518834	13.89226	9.074371	13.84828	12.72754	15.40058	14.95843	14.80477	15.35415	15.23352	0	17.63412	16.93015	14.40366	0	15.70687	0	16.79115	15.25331	0	10.13904	12.53248	12.72018	15.84744	0	0	15.15101	11.19805	17.26769	9.593304	14.87759	14.58857	16.76303	17.20308	17.43314	16.95082	13.39436	16.43046	0	15.10864	0	14.005	13.03535	16.06273	0	14.12744	14.43964	0	14.82859
Q86W92	LIPB1_HUMAN	"Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1, PTPRF-interacting protein-binding protein 1) (hSGT2)"	PPFIBP1 KIAA1230	Homo sapiens (Human)	cell adhesion [GO:0007155]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808]	cadherin binding [GO:0045296]	GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007528; GO:0045296; GO:0048786; GO:0050808	ALEYSNGIFDCQSPTSPFMGSLR	3.940000057	1	1	0.323404793	2578.038766	0	0	15.20408	0	0	14.44632	0	0	0	0	0	0	16.77151	16.69294	15.80442	0	11.87591	15.09625	0	17.43616	0	0	16.26132	15.61039	15.3687	0	0	0	0	14.10698	15.71373	14.79314	15.00764	13.4865	13.31487	0	0	0	0	0	0	17.92204	0	0	0	0	0	0
Q86WA8	LONP2_HUMAN	"Lon protease homolog 2, peroxisomal, EC 3.4.21.53 (Lon protease-like protein 2, Lon protease 2) (Peroxisomal Lon protease, pLon)"	LONP2 LONP	Homo sapiens (Human)	peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]	GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0016558; GO:0016887; GO:0019899; GO:0031998	TSSMPEQAHKVCVK	2.25	0.981836438	0.981836438	0.135397852	1602.186646	14.41878	0	14.80882	14.33901	15.74938	14.58078	15.4783	0	10.68551	0	12.89198	18.1348	15.92388	12.26541	14.51535	15.1104	13.71637	14.85821	0	0	8.013034	15.26269	14.17513	13.90189	17.03204	0	16.87015	12.26115	13.94424	0	0	17.58464	15.88498	11.48491	16.25418	0	15.98982	15.61175	15.86755	11.32638	15.79277	14.29186	16.06092	0	16.39565	15.71035	0	0
Q86WB0	ZC3C1_HUMAN	"Zinc finger C3HC-type protein 1 (Nuclear-interacting partner of ALK, hNIPA) (Nuclear-interacting partner of anaplastic lymphoma kinase)"	ZC3HC1 NIPA HSPC216	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567]	protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005654; GO:0007049; GO:0008270; GO:0016567; GO:0019901; GO:0031965; GO:0051301; GO:2001240	TRPVTRSMGTGDTPGLEVPSSPLR	12.56999969	1	1	2.29E-12	2527.529649	13.8426	13.8384	0	13.97902	14.4347	12.30972	13.46612	14.23864	15.85508	14.062	0	0	13.52185	13.88789	9.227702	0	14.78859	14.87451	13.44788	14.6296	0	0	13.76518	10.13795	0	0	0	0	0	0	16.38614	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86WG5	MTMRD_HUMAN	Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2)	SBF2 CMT4B2 KIAA1766 MTMR13	Homo sapiens (Human)	autophagy [GO:0006914]; myelination [GO:0042552]; regulation of GTPase activity [GO:0043087]	axon [GO:0030424]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]	axon [GO:0030424]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091]; autophagy [GO:0006914]; myelination [GO:0042552]; regulation of GTPase activity [GO:0043087]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091]	GO:0005085; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0043087; GO:0048471	DWDDTPFPQGIELFCQPGGWQLSRER	5.909999847	1	1	0.156518178	3133.268397	15.07878	0	0	0	18.42634	17.78488	17.01044	20.10204	18.82707	15.62774	15.92425	0	12.82854	18.1291	16.67527	18.11105	0	17.42185	16.15425	0	17.1237	0	14.24492	0	17.15918	0	0	0	17.07409	0	0	0	18.30223	18.94387	0	17.37517	0	0	17.59625	16.48546	17.08586	0	0	0	18.52024	17.12041	0	0
Q86WI3	NLRC5_HUMAN	"Protein NLRC5 (Caterpiller protein 16.1, CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4)"	NLRC5 NOD27 NOD4	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of kinase activity [GO:0043549]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of kinase activity [GO:0043549]	ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0032088; GO:0035556; GO:0043549; GO:0045087; GO:0045345; GO:0045944; GO:0051607; GO:0060335; GO:0060339; GO:0060340	GISHLVK	8.699999809	1	1	0.026345976	750.4060766	0	15.80841	14.86182	0	0	0	0	0	0	0	0	0	0	0	0	0	16.87336	0	0	16.129	0	0	0	0	0	0	15.67011	15.61055	0	14.60286	0	0	0	0	0	0	0	16.82229	0	0	0	0	0	0	0	0	0	0
Q86WJ1	CHD1L_HUMAN	"Chromodomain-helicase-DNA-binding protein 1-like, EC 3.6.4.12 (Amplified in liver cancer protein 1)"	CHD1L ALC1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006338; GO:0006974; GO:0016887; GO:0140658	ACLQQDLK	9.579999924	0.565570533	0.565570533	0.233119547	976.6175084	16.85428	14.43666	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.22617	0	0	18.00985	18.68813	17.70408	0	0	16.04866	0	18.59425	0	0	18.99823	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86WQ0	NR2CA_HUMAN	Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein)	NR2C2AP TRA16	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	VLGEKV	9.270000458	0.709814072	0.709814072	0.058596301	644.8768695	14.09303	14.80621	14.97785	16.62912	13.01285	0	14.17602	16.16921	14.56877	14.72909	11.83792	16.24209	0	15.7619	17.17484	5.46996	13.79926	15.05873	0	14.72161	16.32003	0	16.79287	17.31371	17.26305	14.30058	14.81231	0	14.18257	15.56991	13.09766	15.42291	18.89362	0	17.58342	15.00759	17.04003	17.64437	16.41451	17.8322	19.67109	16.74098	16.17735	0	13.82029	18.02088	17.55077	0
Q86WR0	CCD25_HUMAN	Coiled-coil domain-containing protein 25	CCDC25	Homo sapiens (Human)	positive regulation of cell motility [GO:2000147]	endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]	endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; DNA binding [GO:0003677]; positive regulation of cell motility [GO:2000147]	DNA binding [GO:0003677]	GO:0003677; GO:0005887; GO:0012505; GO:2000147	FPDLAAEK	5.380000114	0.675664902	0.675664902	0.236855661	890.0932685	13.47762	0	14.75087	0	11.20422	14.69878	15.95959	14.14566	0	0	0	15.01313	13.95046	0	12.98414	13.8688	14.19017	0	0	15.03	0	14.46138	14.66681	16.19588	0	0	0	16.6795	0	0	0	15.80308	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86WR7	PRSR2_HUMAN	Proline and serine-rich protein 2	PROSER2 C10orf47	Homo sapiens (Human)						SDASDMNSDTSPSCR	4.519999981	0.996935666	0.996935666	4.58E-13	1646.5218	14.54745	13.53718	14.125	13.58603	13.5234	15.99361	0	0	11.73432	0	15.21726	0	16.01908	0	0	0	15.07159	0	0	0	0	0	0	15.44855	0	0	0	0	0	0	15.46276	15.38262	14.41158	0	0	0	0	0	15.04329	0	17.13993	0	13.52112	0	0	0	0	0
Q86WS4	CL040_HUMAN	Uncharacterized protein C12orf40	C12orf40	Homo sapiens (Human)						MTIKTK	21.84000015	1.01E-05	1.01E-05	0.290560387	737.5025155	18.17354	0	0	0	16.14198	17.99203	0	0	0	0	0	0	0	17.50998	0	0	0	0	0	19.36367	0	0	16.05653	0	0	0	17.33464	0	16.32007	0	19.76948	0	0	0	0	0	0	0	19.65088	0	0	19.9516	17.42973	0	0	17.99245	17.83216	17.68995
Q86WU2	LDHD_HUMAN	"Probable D-lactate dehydrogenase, mitochondrial, DLD, Lactate dehydrogenase D, EC 1.1.2.4"	LDHD	Homo sapiens (Human)	lactate catabolic process [GO:1903457]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457]	D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]	GO:0004458; GO:0005739; GO:0005743; GO:0008720; GO:0050660; GO:0071949; GO:1903457	AVLDPQGLMNPGKVL	13.10000038	1	1	0.469583436	1551.152956	16.77986	0	0	0	0	0	0	17.45392	0	0	0	0	0	0	0	0	0	0	0	0	0	17.72222	17.45581	0	0	0	0	0	17.64443	0	0	0	19.93955	0	0	0	0	0	18.55449	0	0	0	0	0	0	0	0	17.22718
Q86WV6	STING_HUMAN	"Stimulator of interferon genes protein, hSTING (Endoplasmic reticulum interferon stimulator, ERIS) (Mediator of IRF3 activation, hMITA) (Transmembrane protein 173)"	STING1 ERIS MITA STING TMEM173	Homo sapiens (Human)	activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; reticulophagy [GO:0061709]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990701]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine/threonine protein kinase complex [GO:1902554]; STING complex [GO:1990231]	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990701]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine/threonine protein kinase complex [GO:1902554]; STING complex [GO:1990231]; 2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-di-GMP binding [GO:0035438]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; reticulophagy [GO:0061709]"	"2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-di-GMP binding [GO:0035438]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000045; GO:0000421; GO:0002218; GO:0002230; GO:0005654; GO:0005741; GO:0005768; GO:0005776; GO:0005777; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0016239; GO:0019901; GO:0030176; GO:0030659; GO:0030667; GO:0031625; GO:0032092; GO:0032481; GO:0032728; GO:0035438; GO:0035458; GO:0042802; GO:0042803; GO:0045087; GO:0045944; GO:0048471; GO:0050727; GO:0051091; GO:0051259; GO:0051607; GO:0060340; GO:0061507; GO:0061629; GO:0061709; GO:0071360; GO:0071407; GO:1902554; GO:1990231; GO:1990701	GAVSQR	2.029999971	1	1	0.033900762	617.3313446	15.54978	15.92615	0	0	0	0	0	0	0	0	0	0	0	0	16.03077	15.96621	15.13149	0	0	0	0	0	0	0	0	15.769	0	0	0	0	0	0	0	0	14.04317	0	0	15.78342	0	16.24063	0	0	0	0	0	0	0	0
Q86WZ0	HEAT4_HUMAN	HEAT repeat-containing protein 4	HEATR4	Homo sapiens (Human)			oxidoreductase activity [GO:0016491]	oxidoreductase activity [GO:0016491]	GO:0016491	EAWLLPPEKEAR	9.180000305	0.492427081	0.492427081	0.231349612	1438.49072	0	0	0	0	0	0	0	0	0	0	0	15.69582	0	0	0	0	15.48354	0	0	0	0	0	0	0	17.97118	0	16.21079	0	0	18.19857	17.00717	18.15306	15.84849	16.10188	16.69499	16.55007	0	16.30714	16.28466	17.23582	0	15.89483	14.50389	16.13728	17.53189	0	16.43096	15.80778
Q86X10	RLGPB_HUMAN	Ral GTPase-activating protein subunit beta (p170)	RALGAPB KIAA1219	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]		GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]	GO:0005096; GO:0046982; GO:0051056; GO:0090630	EMVANWR	6.239999771	0.726544142	0.726544142	0.180623487	922.5780375	0	12.22153	16.59706	14.73853	0	12.4511	0	14.89987	14.81293	0	14.93923	0	0	14.02464	0	0	13.47235	15.55743	16.48881	14.32886	0	0	14.69533	0	15.87989	15.94978	15.27529	13.92168	16.90605	0	17.03582	0	15.60378	14.8375	15.83318	11.6024	13.27188	15.86507	16.73828	15.91823	15.39858	14.70667	14.9999	14.56371	0	16.21023	14.4294	15.42627
Q86X24	HORM1_HUMAN	"HORMA domain-containing protein 1 (Cancer/testis antigen 46, CT46) (Newborn ovary HORMA protein)"	HORMAD1 NOHMA	Homo sapiens (Human)	blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]	chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]		GO:0000795; GO:0001824; GO:0005634; GO:0005694; GO:0007130; GO:0007283; GO:0042138; GO:0048477; GO:0051177; GO:0051321; GO:0051598; GO:0060629	MATAQLQRTPMSALVFPNK	4.849999905	0.424136847	0.424136847	1.39E-12	2135.063199	15.57786	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.91443	0	0	0	0	0	0	0	14.8817	0	0	0	0	0	0	0	0	0	0	0
Q86X29	LSR_HUMAN	Lipolysis-stimulated lipoprotein receptor (Angulin-1)	LSR ILDR3 LISCH	Homo sapiens (Human)	epithelial structure maintenance [GO:0010669]; establishment of blood-brain barrier [GO:0060856]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; maintenance of blood-brain barrier [GO:0035633]; protein localization to tricellular tight junction [GO:0061833]; tricellular tight junction assembly [GO:1904274]	chylomicron [GO:0042627]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689]; very-low-density lipoprotein particle [GO:0034361]	chylomicron [GO:0042627]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689]; very-low-density lipoprotein particle [GO:0034361]; epithelial structure maintenance [GO:0010669]; establishment of blood-brain barrier [GO:0060856]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; maintenance of blood-brain barrier [GO:0035633]; protein localization to tricellular tight junction [GO:0061833]; tricellular tight junction assembly [GO:1904274]		GO:0001889; GO:0005886; GO:0010669; GO:0016020; GO:0016021; GO:0034361; GO:0034362; GO:0035633; GO:0042627; GO:0060856; GO:0061436; GO:0061689; GO:0061833; GO:0070062; GO:0070160; GO:1904274	DNGSRSGDLPYDGR	6.889999866	1	1	0.445323258	1509.577844	14.04189	0	0	0	0	0	0	15.37801	0	0	0	0	0	16.08886	0	13.65456	0	0	0	0	0	0	16.96018	0	0	0	0	0	0	14.34846	14.97694	14.35719	16.66214	0	15.26152	14.58946	0	15.77112	16.89087	0	17.59152	0	14.57923	0	16.0899	0	0	0
Q86X51	EZHIP_HUMAN	EZH inhibitory protein	EZHIP CXorf67	Homo sapiens (Human)	negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K27 trimethylation [GO:1902465]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K27 trimethylation [GO:1902465]		GO:0005634; GO:0005654; GO:0005829; GO:0061086; GO:1902465	RGCDSAPGPAR	3.819999933	1	1	0.222155672	1144.300518	16.44087	0	15.68425	13.98235	14.16137	0	13.96315	16.84959	0	0	0	0	0	14.01196	13.40852	15.28612	0	12.39418	0	0	0	0	15.47858	0	13.85055	16.00147	0	0	11.89527	15.70294	16.16492	18.32006	0	0	0	0	0	15.67786	0	14.81121	0	0	0	0	13.74112	0	15.40522	14.82534
Q86X52	CHSS1_HUMAN	"Chondroitin sulfate synthase 1, EC 2.4.1.175, EC 2.4.1.226 (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1, ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1)"	CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487	Homo sapiens (Human)	bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923]	extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]	GO:0000139; GO:0002063; GO:0005576; GO:0008376; GO:0009954; GO:0016020; GO:0016021; GO:0030206; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0051923; GO:0060349	DLHNSK	9.079999924	1	1	0.18225222	712.6653493	15.26246	0	15.75812	14.42072	0	12.96398	0	0	0	0	0	13.16728	0	0	0	0	19.42927	16.5585	0	0	16.36523	0	0	0	0	0	0	0	0	0	15.79977	14.04296	0	16.26077	15.94468	14.12982	16.23736	0	0	14.46046	0	0	16.97094	0	16.41428	15.92335	15.57084	0
Q86X53	ERIC1_HUMAN	Glutamate-rich protein 1	ERICH1 HSPC319	Homo sapiens (Human)						QHTDGTTISKNK	16.70000076	1	1	2.29E-13	1330.5459	13.82734	14.96327	12.29151	9.663583	0	0	13.59124	0	13.5526	11.93428	17.0503	0	13.34016	14.3776	0	14.37236	0	0	0	9.6728	13.39002	0	0	0	13.31159	0	14.65871	0	12.80708	0	0	0	0	0	0	0	0	16.2481	0	0	0	0	0	14.98165	13.35022	0	0	0
Q86X55	CARM1_HUMAN	"Histone-arginine methyltransferase CARM1, EC 2.1.1.319 (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4)"	CARM1 PRMT4	Homo sapiens (Human)	"aging [GO:0007568]; chromatin organization [GO:0006325]; histone H3-R17 methylation [GO:0034971]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of dendrite development [GO:2000171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of mRNA binding [GO:1902415]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor coactivator activity [GO:0030374]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; aging [GO:0007568]; chromatin organization [GO:0006325]; histone H3-R17 methylation [GO:0034971]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of dendrite development [GO:2000171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of mRNA binding [GO:1902415]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]"	beta-catenin binding [GO:0008013]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor coactivator activity [GO:0030374]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]	GO:0000976; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006355; GO:0007568; GO:0008013; GO:0008276; GO:0008284; GO:0008469; GO:0016274; GO:0016571; GO:0030374; GO:0033146; GO:0034970; GO:0034971; GO:0035242; GO:0035642; GO:0042054; GO:0045600; GO:0051591; GO:0070577; GO:1902415; GO:2000171	AGDTLSGTCLLIANK	11.10000038	0.446781725	0.446781725	0.095123662	1532.916768	15.02156	14.99727	14.07498	10.1268	15.14812	13.84334	16.76504	11.68383	0	16.17874	0	0	16.10983	15.96337	16.28658	13.60086	15.97008	0	15.45022	14.84135	15.92342	15.17017	0	15.36366	0	15.00655	0	0	10.78912	9.965697	14.70273	11.40843	15.26578	0	0	0	16.89975	17.93784	15.85628	18.22058	15.44178	15.19785	11.27292	11.04341	15.03406	14.25463	15.7042	17.12661
Q86X83	COMD2_HUMAN	COMM domain-containing protein 2	COMMD2 HSPC042 My004	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	IAVEFLR	9.5	1	1	0.217808675	847.699269	15.18027	0	14.50868	0	14.86465	15.11601	0	14.43215	0	0	14.43123	0	0	14.4465	15.56571	12.20883	0	0	0	16.07295	0	0	0	0	14.98391	0	17.41596	0	16.52676	15.57476	17.23597	17.04859	0	0	0	0	14.14108	15.7502	17.32304	0	15.68586	15.43161	14.83316	0	13.30001	14.82011	16.73506	0
Q86X95	CIR1_HUMAN	Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor) (Recepin)	CIR1 CIR	Homo sapiens (Human)	"in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]"	histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0001701; GO:0003714; GO:0005634; GO:0005737; GO:0005815; GO:0006397; GO:0008380; GO:0016607; GO:0019901; GO:0032991; GO:0042826; GO:0044877; GO:0045892	HSPEKR	10.68000031	1	1	0.196870792	753.5958222	15.48306	15.56701	0	0	15.74529	16.86712	15.04124	15.83504	0	14.24463	15.20416	15.62012	16.90899	0	18.49436	15.62025	15.90859	15.87541	16.84793	18.03529	17.71224	0	0	0	16.47656	16.67238	15.25047	15.41801	16.99594	16.13854	16.25038	16.38137	0	16.30798	16.41796	16.34383	18.11689	16.4476	17.04431	17.11664	17.79131	16.70013	16.60398	0	14.69332	18.10433	16.05853	17.40704
Q86XA9	HTR5A_HUMAN	HEAT repeat-containing protein 5A	HEATR5A C14orf125 KIAA1316	Homo sapiens (Human)	"endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]	"cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]"		GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147	ARLEAAIK	1.74000001	1	1	0.373808417	871.9384194	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86XD8	ZFAN4_HUMAN	AN1-type zinc finger protein 4 (AN1-type zinc finger and ubiquitin domain-containing protein-like 1)	ZFAND4 ANUBL1	Homo sapiens (Human)			zinc ion binding [GO:0008270]	zinc ion binding [GO:0008270]	GO:0008270	CFEFGK	2.279999971	0.462404281	0.462404281	0.144853079	787.261569	0	11.20423	0	16.50227	0	15.10078	0	14.79681	0	13.26351	0	0	11.37855	18.9216	0	16.9324	0	17.35587	14.74822	14.34563	13.71373	15.88191	15.17464	16.72688	18.32788	13.06832	15.86111	0	18.07799	0	0	17.11082	0	13.83099	0	15.85765	16.61276	0	16.97909	0	0	16.47389	13.50537	0	16.30448	16.11882	17.91963	0
Q86XE0	SNX32_HUMAN	Sorting nexin-32 (Sorting nexin-6B)	SNX32 SNX6B	Homo sapiens (Human)	"protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; endosome [GO:0005768]	"cytosol [GO:0005829]; endosome [GO:0005768]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]"	phosphatidylinositol binding [GO:0035091]	GO:0005768; GO:0005829; GO:0015031; GO:0016241; GO:0035091; GO:0042147	NLIELAELELKHAK	12.85000038	0.494017065	0.494017065	0.08099431	1621.27961	0	0	16.59867	15.43755	15.36025	0	0	15.7901	0	16.35296	17.0427	18.09818	0	0	16.29744	16.13845	15.5005	0	16.42857	17.99828	16.5263	0	17.20711	0	15.99141	15.17286	0	0	16.80128	0	14.17465	16.43911	12.58446	14.73735	14.89323	15.53581	16.99164	16.49838	15.6919	0	0	0	0	0	9.584064	16.53769	16.73118	16.53318
Q86XH1	DRC11_HUMAN	Dynein regulatory complex protein 11 (IQ and AAA domain-containing protein 1)	IQCA1 DRC11 IQCA	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005737; GO:0005856; GO:0016887; GO:0031514	IQVDELMR	27.44000053	1	1	0.161383688	1015.382645	0	0	0	0	0	0	0	0	0	0	0	0	0	15.68567	0	0	13.57653	0	0	0	0	0	15.93639	15.30404	0	0	0	14.55362	0	0	0	0	0	0	0	0	15.52002	14.60105	14.88001	0	0	11.14081	0	13.42578	0	11.92439	0	16.50575
Q86XJ0	CAHM3_HUMAN	Calcium homeostasis modulator protein 3 (Protein A)	CALHM3 FAM26A	Homo sapiens (Human)	ATP transport [GO:0015867]; protein heterooligomerization [GO:0051291]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; voltage-gated ion channel activity [GO:0005244]; ATP transport [GO:0015867]; protein heterooligomerization [GO:0051291]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909]	cation channel activity [GO:0005261]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005261; GO:0005887; GO:0015867; GO:0016323; GO:0050896; GO:0050909; GO:0051291	FLDFANMTPSQVQLFLAKVPCK	7.559999943	1	1	0.173010442	2571.146664	0	14.31928	0	0	0	0	16.46214	0	12.72192	0	0	13.62845	0	14.07123	0	11.79375	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.1931	0	0	0	14.29331	15.28806	0	0	0	9.610691	0	0	0	16.78582	0	12.3758	0	12.46278
Q86XJ1	GA2L3_HUMAN	GAS2-like protein 3 (Growth arrest-specific protein 2-like 3)	GAS2L3	Homo sapiens (Human)	actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; microtubule cytoskeleton organization [GO:0000226]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; microtubule cytoskeleton organization [GO:0000226]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]	GO:0000226; GO:0003779; GO:0005737; GO:0005874; GO:0005884; GO:0008017; GO:0008093; GO:0015629; GO:0015630; GO:0030036; GO:0051015; GO:0051764	TQTAPK	5.059999943	6.35E-10	6.35E-10	0.302128996	646.111302	0	0	0	0	0	0	0	0	0	18.75362	0	0	0	0	0	0	0	16.89061	0	0	0	0	0	17.94988	0	18.18537	0	0	0	0	0	0	19.58849	0	19.14345	0	18.09135	17.49979	0	0	0	0	18.33426	0	0	0	0	17.35418
Q86XK2	FBX11_HUMAN	"F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1, VIT-1)"	FBXO11 FBX11 PRMT9 VIT1 UG063H01	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]	protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006464; GO:0006511; GO:0007605; GO:0008270; GO:0016274; GO:0016567; GO:0042981	FYQINPEEYEHPNPWK	4.5	1	1	0.158862823	2091.17286	0	0	14.21089	0	0	0	0	0	13.8851	0	0	14.88201	15.97095	0	14.21486	13.96321	14.98426	0	15.20044	0	15.02637	0	0	0	16.58643	15.43406	0	0	0	16.40257	0	0	15.17942	0	0	0	15.30668	16.4552	17.16005	16.27029	16.07816	0	0	15.13926	0	14.69973	14.62252	0
Q86XL3	ANKL2_HUMAN	Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4)	ANKLE2 KIAA0692 LEM4	Homo sapiens (Human)	cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790]	protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]	GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0030176; GO:0035307; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721	YGGSPR	1.409999967	1	1	0.175765612	633.0289528	0	15.02223	0	0	0	0	0	16.68017	0	0	0	0	13.6521	16.6657	0	0	0	14.91078	0	0	16.58017	0	0	0	16.07972	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.51469	0	0	15.5461	0	0	0	16.25001	0
Q86XN6	ZN761_HUMAN	Zinc finger protein 761	ZNF761 KIAA2033	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	LTGITER	10.13000011	1	1	0.255167886	788.8794971	18.08376	18.0856	0	0	0	0	0	0	0	18.90765	18.08092	0	17.367	0	0	0	17.44068	0	0	0	0	16.87285	17.91487	0	0	19.01454	0	0	0	0	0	18.98186	0	0	0	0	0	0	0	0	0	0	0	17.55945	0	0	0	0
Q86XN8	MEX3D_HUMAN	RNA-binding protein MEX3D (RING finger and KH domain-containing protein 1) (RING finger protein 193) (TINO)	MEX3D KIAA2031 RKHD1 RNF193	Homo sapiens (Human)	mRNA destabilization [GO:0061157]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; mRNA destabilization [GO:0061157]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]	metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0010609; GO:0035925; GO:0046872; GO:0048471; GO:0061157	KEDVEMAK	5.289999962	1	1	0.282368375	964.7101065	0	0	0	0	15.99676	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.47058	0	0	18.71551	19.35666	0	0	0	0	0	0	0	17.7215	0
Q86XP1	DGKH_HUMAN	"Diacylglycerol kinase eta, DAG kinase eta, EC 2.7.1.107 (Diglyceride kinase eta, DGK-eta)"	DGKH	Homo sapiens (Human)	diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of catalytic activity [GO:0043086]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; SAM domain binding [GO:0032093]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of catalytic activity [GO:0043086]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]	ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; SAM domain binding [GO:0032093]	GO:0003951; GO:0004143; GO:0005524; GO:0005737; GO:0005768; GO:0005886; GO:0006654; GO:0007205; GO:0015629; GO:0019900; GO:0030168; GO:0032093; GO:0032991; GO:0035556; GO:0042802; GO:0043086; GO:0043231; GO:0046339; GO:0046473; GO:0046834; GO:0046872	ENLPVLNTR	4.809999943	1	1	0.166590637	1056.16039	13.66946	0	0	14.51756	12.92468	13.7797	0	13.61879	0	0	16.86613	0	0	14.08812	0	0	15.29076	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.31811	0	0	0	0	0	0	0	0	0	0	0	0
Q86XP3	DDX42_HUMAN	"ATP-dependent RNA helicase DDX42, EC 3.6.4.13 (DEAD box protein 42) (RNA helicase-like protein, RHELP) (RNA helicase-related protein, RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein, SF3b125)"	DDX42	Homo sapiens (Human)	protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008104; GO:0015030; GO:0016020; GO:0016607; GO:0016887; GO:0042981	DMIGIAKTGSGK	6.449999809	0.20294717	0.20294717	0.156542111	1194.739254	0	15.55365	0	13.11031	0	10.08306	12.95088	13.75235	12.18459	13.59094	15.56637	15.6621	0	7.126432	11.78128	12.19358	13.09022	18.0659	0	12.93933	0	0	0	0	0	0	0	0	0	13.51921	14.92171	0	0	0	0	0	0	11.71698	0	0	15.79702	0	0	0	0	14.20568	0	0
Q86XR2	NIBA3_HUMAN	Protein Niban 3 (B-cell novel protein 1) (Niban-like protein 2) (Protein FAM129C)	NIBAN3 BCNP1 FAM129C	Homo sapiens (Human)						SGFHR	10.19999981	1	1	3.45E-13	602.3589682	0	0	17.28153	0	0	0	0	0	0	0	0	0	0	0	0	16.30872	0	0	0	16.24858	0	0	0	15.87567	0	0	0	15.60367	16.5288	0	16.97754	16.42073	0	17.46023	0	18.19878	0	16.65173	0	0	0	0	0	0	0	0	0	0
Q86XR5	PRIMA_HUMAN	"Proline-rich membrane anchor 1, PRiMA"	PRIMA1	Homo sapiens (Human)	neurotransmitter catabolic process [GO:0042135]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; neurotransmitter catabolic process [GO:0042135]		GO:0005886; GO:0016021; GO:0042135; GO:0045202	LLRDLVLR	3.380000114	0.716371953	0.716371953	0.289664994	996.8838472	12.47084	14.57985	10.14314	0	14.6501	14.50166	17.06392	14.12657	0	0	16.37787	0	14.80666	0	13.39723	0	0	0	0	0	0	0	15.2773	0	0	0	0	14.64695	0	15.01526	0	0	0	0	0	0	0	16.17609	16.36728	0	0	0	0	0	0	0	0	0
Q86XT2	VP37D_HUMAN	Vacuolar protein sorting-associated protein 37D (ESCRT-I complex subunit VPS37D) (Williams-Beuren syndrome chromosomal region 24 protein)	VPS37D WBSCR24	Homo sapiens (Human)	macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]	endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]	endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]		GO:0000813; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0070062	SFPAAAVLPTGAARGPPAVPR	1.5	1	1	0.139569186	2003.326276	0	14.49133	15.31889	0	0	15.40988	0	0	15.80049	0	0	0	0	12.02446	15.85342	0	0	0	0	0	14.58249	0	0	12.32728	0	13.7606	14.38587	0	14.24569	0	14.89502	12.04138	8.171821	0	0	12.39262	0	13.70415	0	12.9633	0	0	13.00159	9.702353	16.33918	0	0	13.2375
Q86XX4	FRAS1_HUMAN	Extracellular matrix organizing protein FRAS1 (Fraser syndrome 1 protein)	FRAS1 KIAA1500	Homo sapiens (Human)	cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588]	extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]	GO:0002009; GO:0003338; GO:0005201; GO:0005604; GO:0005886; GO:0007154; GO:0015031; GO:0016021; GO:0030326; GO:0043588; GO:0046872; GO:0060021	GMSAASR	4.760000229	1	1	0.228366282	694.3388453	0	15.36877	12.13238	15.03426	0	0	14.48661	0	0	0	15.31162	15.22482	16.459	0	0	0	15.87761	0	17.57873	18.05809	17.5293	0	0	0	16.6805	0	0	17.87748	0	17.15333	16.78994	17.09114	17.24714	0	16.92397	16.39896	0	17.81305	17.70438	18.10809	18.42678	17.70231	18.68838	17.64391	18.46441	17.65468	17.34176	0
Q86XZ4	SPAS2_HUMAN	Spermatogenesis-associated serine-rich protein 2 (Serine-rich spermatocytes and round spermatid 59 kDa protein) (p59scr)	SPATS2 SCR59 SPATA10 Nbla00526	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005829	AIVPNK	4.510000229	1	1	6.89E-13	641.417512	15.0076	0	0	0	15.79681	0	0	0	0	0	0	0	0	0	0	14.83827	16.22504	0	15.08636	15.79883	0	15.04461	17.54657	0	0	15.69547	16.25899	16.58433	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86Y22	CONA1_HUMAN	Collagen alpha-1(XXIII) chain	COL23A1	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	cell surface [GO:0009986]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]	GO:0005201; GO:0005581; GO:0005615; GO:0005788; GO:0005886; GO:0008201; GO:0009986; GO:0016021; GO:0030198; GO:0031012; GO:0042802; GO:0062023	GNAAGGGGGGR	12.81999969	1	1	0.002173535	831.5341443	15.54571	15.65686	15.43455	13.69562	14.4877	14.72118	15.41071	15.47773	14.33043	14.16407	12.77964	0	0	10.59576	0	14.84192	13.97576	12.72319	15.23139	15.6291	12.71073	0	14.20051	13.49742	12.62654	15.27279	13.42775	0	15.29294	0	0	0	0	0	0	0	0	0	0	0	0	16.32041	18.09118	0	0	18.00324	0	0
Q86Y26	NUTM1_HUMAN	NUT family member 1 (Nuclear protein in testis)	NUTM1 C15orf55 NUT	Homo sapiens (Human)		cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737	THRSADR	9.119999886	0.274120301	0.274120301	0.094128661	842.2881905	0	16.10092	15.00327	13.85116	16.47422	16.40424	14.98174	18.41749	14.30181	18.25357	16.58783	13.87389	15.15034	0	16.0361	16.73936	14.57645	16.88846	14.82433	0	13.73627	15.91592	18.189	0	12.02394	0	16.17258	17.00155	15.03328	16.76424	16.69215	17.16545	16.70524	0	15.58797	17.97868	17.36376	17.31758	0	14.92135	16.75418	15.35019	17.23242	12.79165	16.18492	0	16.97859	17.40512
Q86Y37	CACL1_HUMAN	CDK2-associated and cullin domain-containing protein 1 (Cdk-associated cullin 1)	CACUL1 C10orf46 CAC1	Homo sapiens (Human)	G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511]		protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase activity [GO:0045860]; ubiquitin-dependent protein catabolic process [GO:0006511]	protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]	GO:0000082; GO:0006511; GO:0008284; GO:0019901; GO:0031625; GO:0045860	ELIQNGFTRGDQSR	6.320000172	1	1	0.379268786	1621.053164	0	11.86613	0	15.75733	15.46827	0	15.14719	0	14.91222	0	17.15226	0	0	0	0	0	0	14.79688	0	16.45738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86Y38	XYLT1_HUMAN	"Xylosyltransferase 1, EC 2.4.2.26 (Peptide O-xylosyltransferase 1) (Xylosyltransferase I, XT-I, XylT-I)"	XYLT1 XT1	Homo sapiens (Human)	chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166]	extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166]	metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]	GO:0000137; GO:0000139; GO:0005615; GO:0006024; GO:0015012; GO:0016021; GO:0030158; GO:0030166; GO:0030203; GO:0030206; GO:0043931; GO:0046872; GO:0048706; GO:0050650	NFGGLLGPMDEPVGMQKWGK	5.090000153	1	1	0.045818797	2161.369433	14.84891	0	15.88119	0	16.29508	0	15.76299	0	0	13.53499	0	0	15.56094	0	0	14.00123	15.60846	0	0	0	0	0	0	0	16.26152	0	0	0	0	0	0	15.54575	17.33363	17.77807	16.69765	0	0	0	14.97392	0	0	0	0	0	12.44412	0	0	0
Q86Y46	K2C73_HUMAN	"Keratin, type II cytoskeletal 73 (Cytokeratin-73, CK-73) (Keratin-73, K73) (Type II inner root sheath-specific keratin-K6irs3) (Type-II keratin Kb36)"	KRT73 K6IRS3 KB36 KRT6IRS3	Homo sapiens (Human)		cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0045095; GO:0070062	GDCALK	12.69999981	0.363138348	0.363138348	0.258557772	663.1991452	19.11005	17.59958	18.45091	19.52602	17.60752	17.06342	17.27338	19.39987	17.43558	17.56927	17.85942	17.03381	0	17.21272	0	0	18.12119	0	16.74305	16.93838	0	0	0	18.75773	0	0	0	17.47919	0	17.10979	19.95621	21.78458	0	17.19184	0	0	18.6429	18.69975	18.35515	18.02376	17.70578	0	16.25306	16.62909	0	0	0	17.97975
Q86Y79	PTH_HUMAN	"Probable peptidyl-tRNA hydrolase, PTH, EC 3.1.1.29"	PTRH1 C9orf115	Homo sapiens (Human)			aminoacyl-tRNA hydrolase activity [GO:0004045]; RNA binding [GO:0003723]	aminoacyl-tRNA hydrolase activity [GO:0004045]; RNA binding [GO:0003723]	GO:0003723; GO:0004045	GHNGVR	5.110000134	1	1	0.29223372	638.9124415	14.70525	0	0	0	16.45915	15.82776	0	16.10534	0	0	0	16.26034	0	0	0	0	14.18939	0	16.91512	16.9142	17.09136	16.4948	0	0	17.2083	0	0	14.35168	0	0	0	0	0	17.29809	16.4866	0	0	0	16.49685	16.63046	16.76832	0	0	0	0	19.48628	0	0
Q86Y91	KI18B_HUMAN	Kinesin-like protein KIF18B	KIF18B	Homo sapiens (Human)	cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302]	astral microtubule [GO:0000235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule end [GO:1990752]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	astral microtubule [GO:0000235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule end [GO:1990752]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0000070; GO:0000235; GO:0000278; GO:0003774; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0008574; GO:0016604; GO:0016887; GO:0019894; GO:0035371; GO:0051301; GO:0051302; GO:0061673; GO:1990023; GO:1990752	TSGLAR	3.940000057	1	1	0.310933908	605.7202787	17.3412	0	0	0	0	0	0	0	0	17.8133	0	0	0	0	16.94835	0	18.3983	0	0	0	16.77458	0	0	0	17.96295	17.28665	0	0	0	17.63296	0	0	0	0	17.72688	0	0	0	17.99245	0	17.46918	17.97454	16.0605	0	0	0	0	18.15182
Q86YA3	ZGRF1_HUMAN	Protein ZGRF1 (GRF-type zinc finger domain-containing protein 1)	ZGRF1 C4orf21	Homo sapiens (Human)	replication fork reversal [GO:0071932]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; 5'-flap endonuclease activity [GO:0017108]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; replication fork reversal [GO:0071932]	5'-flap endonuclease activity [GO:0017108]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0004386; GO:0005737; GO:0008270; GO:0016021; GO:0017108; GO:0071932	AILYDDKGACLESLFLK	14.31000042	1	1	0.318287295	1955.980289	18.65487	21.01493	20.06779	0	20.20901	15.34513	0	0	17.35358	20.73949	0	20.43964	0	0	19.80384	17.50702	16.29572	17.67447	18.88301	20.04976	0	20.47632	18.99099	0	20.02572	21.15234	0	20.18394	17.86386	20.95913	20.41599	20.49008	18.70266	21.47472	21.29285	18.08274	18.987	20.20673	0	0	20.09047	0	19.70997	0	19.49054	0	18.04612	0
Q86YC2	PALB2_HUMAN	Partner and localizer of BRCA2	PALB2 FANCN	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; inner cell mass cell proliferation [GO:0001833]; mesoderm development [GO:0007498]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; post-anal tail morphogenesis [GO:0036342]; somitogenesis [GO:0001756]	DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; animal organ morphogenesis [GO:0009887]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; inner cell mass cell proliferation [GO:0001833]; mesoderm development [GO:0007498]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; post-anal tail morphogenesis [GO:0036342]; somitogenesis [GO:0001756]	DNA binding [GO:0003677]	GO:0000724; GO:0001756; GO:0001833; GO:0003677; GO:0005634; GO:0005654; GO:0007498; GO:0009887; GO:0032991; GO:0035264; GO:0036342; GO:0043066; GO:0048568; GO:1990391	IKHSIK	6.25	0.2580975	0.2580975	0.118151239	725.0364602	0	12.96745	16.20285	15.79831	0	0	13.72244	16.53725	15.50833	17.51853	14.3148	16.95675	14.90183	12.93618	16.37407	17.92172	0	16.24557	15.8909	0	13.8661	15.04033	0	16.68231	0	17.39183	0	14.38619	13.85919	16.50686	17.06969	0	15.35548	15.73261	16.17097	0	14.32316	0	15.68534	17.24378	13.09927	16.87484	14.99554	0	15.65472	16.59049	14.3703	16.51216
Q86YD1	PTOV1_HUMAN	"Prostate tumor-overexpressed gene 1 protein, PTOV-1 (Activator interaction domain-containing protein 2)"	PTOV1 ACID2 PP642 UNQ6127/PRO20092	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]	nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; positive regulation of transcription by RNA polymerase II [GO:0045944]		GO:0005654; GO:0005667; GO:0005886; GO:0045944; GO:0048471	GPQPPRIR	9.93999958	1	1	0.35826155	920.8769497	0	0	15.02115	0	0	0	0	0	15.77025	15.94446	0	16.21605	0	15.68681	0	0	14.89799	0	0	0	0	0	0	0	0	0	0	0	0	13.27155	12.13611	14.88618	16.47135	16.14143	13.44188	15.33222	14.86167	13.83654	14.91788	0	14.87326	14.26375	0	15.32409	0	0	0	0
Q86YD3	TMM25_HUMAN	Transmembrane protein 25	TMEM25 UNQ2531/PRO6030	Homo sapiens (Human)	negative regulation of excitatory postsynaptic potential [GO:0090394]; regulation of protein stability [GO:0031647]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; negative regulation of excitatory postsynaptic potential [GO:0090394]; regulation of protein stability [GO:0031647]		GO:0005576; GO:0005764; GO:0005770; GO:0005886; GO:0016021; GO:0031647; GO:0090394	QMAQNNSRPELLDPEPGGLLTSQGFIR	2.609999895	0.153177559	0.153177559	0	2967.360496	0	11.98469	0	0	0	0	0	13.89322	0	0	0	13.95773	0	0	14.01746	13.50249	0	0	0	0	0	0	15.05736	0	0	13.18409	12.09901	15.03638	13.29561	14.8518	13.37242	0	14.00486	0	0	11.89766	0	0	0	14.52504	12.46756	0	0	0	14.74232	0	0	15.34209
Q86YE8	ZN573_HUMAN	Zinc finger protein 573	ZNF573	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AYSTGSNLIQHR	6.360000134	0.441058338	0.441058338	0.076446918	1346.09401	0	0	14.21301	0	0	13.83825	13.55006	14.67973	0	16.26431	13.57707	0	15.75165	17.27654	0	14.65722	16.07727	0	15.98132	19.57332	12.45743	16.52804	14.01258	17.55562	0	15.75483	12.84879	16.98456	0	13.79764	0	0	16.13214	15.34486	0	15.2039	10.97151	16.34144	15.97881	0	0	10.24855	14.37263	18.78088	10.81641	0	14.3318	0
Q86YJ6	THNS2_HUMAN	"Threonine synthase-like 2, TSH2, EC 4.2.3.- (Secreted osteoclastogenic factor of activated T-cells, SOFAT)"	THNSL2	Homo sapiens (Human)	2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; cytokine activity [GO:0005125]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; 2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071]	cytokine activity [GO:0005125]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]	GO:0005125; GO:0005615; GO:0009071; GO:0016311; GO:0016829; GO:0030170; GO:0046360; GO:0070905	TVFADVAFVKK	6.340000153	1	1	0.18708529	1223.554731	13.83652	7.499741	13.22875	14.6185	15.74312	12.89158	16.47494	13.99696	11.89721	11.60451	0	0	0	0	0	11.73411	0	10.95626	0	0	0	13.74899	0	0	0	0	0	16.14838	0	16.07038	0	0	15.53613	0	0	0	0	0	0	16.60254	0	0	0	0	0	0	0	0
Q86YJ7	AN13B_HUMAN	Ankyrin repeat domain-containing protein 13B	ANKRD13B	Homo sapiens (Human)	negative regulation of receptor internalization [GO:0002091]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091]	ubiquitin-dependent protein binding [GO:0140036]	GO:0002091; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0043231; GO:0048471; GO:0140036	KGPEGK	5.650000095	1	1	0.199516932	615.7802019	17.515	18.46916	15.86759	13.99969	15.0456	14.90531	15.51962	0	13.54576	0	14.19415	14.34967	0	0	0	0	0	0	0	0	0	14.33284	0	0	14.68556	16.83146	0	16.81556	15.69105	14.04701	0	16.72556	0	0	17.07673	0	16.86107	18.60175	16.18552	0	15.7214	0	0	0	0	15.67735	16.5145	0
Q86YL5	TDRP_HUMAN	Testis development-related protein (Protein INM01)	TDRP C8orf42	Homo sapiens (Human)	spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; spermatogenesis [GO:0007283]		GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0043231	SGFWDNLVLK	2.690000057	1	1	1.15E-12	1181.517014	14.0407	0	0	0	0	8.077859	13.97535	0	0	0	16.41252	0	0	0	0	0	0	0	14.71774	0	14.87342	0	0	0	0	0	0	0	14.15399	0	0	0	16.64143	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86YP4	P66A_HUMAN	"Transcriptional repressor p66-alpha, Hp66alpha (GATA zinc finger domain-containing protein 2A)"	GATAD2A	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; sequence-specific DNA binding [GO:0043565]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]"	metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; sequence-specific DNA binding [GO:0043565]	GO:0000122; GO:0005634; GO:0005654; GO:0006306; GO:0006338; GO:0016575; GO:0016581; GO:0016607; GO:0030674; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:2000736	GTQNIPAGKPSLQTSSAR	7.960000038	1	1	0.356439025	1813.031647	16.22284	15.92149	10.37686	13.5119	14.03634	14.66098	13.17137	13.75839	0	15.40851	15.11177	13.23411	0	0	13.06126	0	0	0	0	0	0	0	0	0	0	16.44904	0	0	0	0	0	0	15.73949	0	16.45454	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86YR5	GPSM1_HUMAN	G-protein-signaling modulator 1 (Activator of G-protein signaling 3)	GPSM1 AGS3	Homo sapiens (Human)	cell differentiation [GO:0030154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; cell differentiation [GO:0030154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239]	GDP-dissociation inhibitor activity [GO:0005092]	GO:0000139; GO:0005092; GO:0005789; GO:0005829; GO:0005886; GO:0007399; GO:0016239; GO:0030154; GO:0032991; GO:0034260; GO:1905098	MGEAKASGNLGNTLK	9.56000042	1	1	0.160515448	1507.28631	0	0	16.16658	0	0	16.07639	0	0	0	15.18803	0	15.98849	0	0	0	15.6098	16.72655	0	0	0	0	16.30778	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86YR7	MF2L2_HUMAN	Probable guanine nucleotide exchange factor MCF2L2 (Dbs-related Rho family guanine nucleotide exchange factor) (MCF2-transforming sequence-like protein 2)	MCF2L2 DRG KIAA0861	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005737	CAENPELLAHCFLKR	15.5	1	1	0.456854365	1856.771996	0	15.35701	16.48737	0	0	16.0951	16.54066	0	0	0	0	15.10278	0	15.04102	0	0	0	15.7808	0	0	16.16839	0	0	0	16.40576	0	0	0	0	0	0	0	0	15.75254	0	17.36481	0	0	0	0	0	0	15.11321	15.72386	0	0	0	0
Q86YS3	RFIP4_HUMAN	"Rab11 family-interacting protein 4, FIP4-Rab11, Rab11-FIP4 (Arfophilin-2)"	RAB11FIP4 ARFO2 KIAA1821	Homo sapiens (Human)	endocytic recycling [GO:0032456]; regulation of cytokinesis [GO:0032465]	cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]	cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; regulation of cytokinesis [GO:0032465]	calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	GO:0005509; GO:0005615; GO:0005768; GO:0005815; GO:0005819; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0055038	VERVAALGLR	8.050000191	0.717615783	0.717615783	0.126208023	1082.659164	0	0	0	0	15.62866	15.79345	0	12.60537	0	0	0	0	14.96419	14.18467	0	15.30268	0	0	0	0	12.33787	16.69631	16.25485	14.10042	0	0	0	0	0	0	0	0	16.02234	0	0	0	0	0	0	0	0	0	0	0	14.99503	0	0	0
Q86YS7	C2CD5_HUMAN	C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa)	C2CD5 CDP138 KIAA0528	Homo sapiens (Human)	cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]	cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]	GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0065002; GO:0072659; GO:0090314	ASDLTDAFVEVK	9.300000191	1	1	0.202218528	1295.453896	0	15.75428	13.91136	14.24579	12.03748	0	14.90166	0	0	12.82533	0	13.65301	10.15792	0	0	0	0	0	0	0	0	14.78465	0	0	0	16.83996	0	0	0	0	0	0	0	0	0	0	17.18591	0	0	0	0	0	0	0	0	0	0	0
Q86YT6	MIB1_HUMAN	"E3 ubiquitin-protein ligase MIB1, EC 2.3.2.27 (DAPK-interacting protein 1, DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)"	MIB1 DIP1 KIAA1323 ZZANK2	Homo sapiens (Human)	blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]	ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0045665; GO:0045807	EQVQSRTK	6.579999924	1	1	0.095603114	974.0517933	0	0	0	14.84295	0	0	0	0	13.66607	13.72338	0	0	0	18.46811	18.92131	0	0	0	0	0	0	0	0	0	0	18.41728	0	0	0	0	0	17.41938	0	0	0	0	0	0	18.51763	0	0	18.63536	0	0	0	0	18.0154	0
Q86YV0	RASL3_HUMAN	RAS protein activator like-3	RASAL3	Homo sapiens (Human)	negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of NK T cell proliferation [GO:0051142]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of NK T cell proliferation [GO:0051142]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]	GO:0005096; GO:0005737; GO:0005829; GO:0005938; GO:0007165; GO:0016020; GO:0042802; GO:0043087; GO:0046580; GO:0051142; GO:0070062; GO:0098562	TEPETAGPNQVHNVRGLLK	2.039999962	1	1	1.38E-12	2060.446245	0	12.6281	0	0	11.42301	13.97646	12.24565	13.68803	0	16.84542	14.75157	14.1612	12.08537	14.50791	12.61614	13.99266	14.08173	0	0	0	13.16639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q86YV5	PRAG1_HUMAN	"Inactive tyrosine-protein kinase PRAG1 (PEAK1-related kinase-activating pseudokinase 1) (Pragmin) (Sugen kinase 223, SgK223)"	PRAG1 SGK223	Homo sapiens (Human)	cell migration [GO:0016477]; negative regulation of neuron projection development [GO:0010977]; positive regulation of Rho protein signal transduction [GO:0035025]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; cell migration [GO:0016477]; negative regulation of neuron projection development [GO:0010977]; positive regulation of Rho protein signal transduction [GO:0035025]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593]	identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006468; GO:0008360; GO:0008593; GO:0010977; GO:0016477; GO:0035025; GO:0042802; GO:2000145	QEDAPVVYLGSFRGVQKPAGPSTSPDGNSR	2.700000048	1	1	3.66E-12	3115.417218	0	14.85845	15.11465	0	0	0	0	14.41581	0	0	15.42541	13.58535	0	0	15.92457	12.40579	14.15574	13.889	0	0	0	0	0	14.14932	15.87467	0	13.19778	0	15.59087	0	0	13.77028	12.71405	10.5138	0	0	13.34456	0	0	0	11.47384	0	0	0	0	0	0	0
Q86YV9	HPS6_HUMAN	"Hermansky-Pudlak syndrome 6 protein (Ruby-eye protein homolog, Ru)"	HPS6	Homo sapiens (Human)	blood coagulation [GO:0007596]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155]; protein localization to membrane [GO:0072657]	BLOC-2 complex [GO:0031084]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	BLOC-2 complex [GO:0031084]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; GTP-dependent protein binding [GO:0030742]; small GTPase binding [GO:0031267]; blood coagulation [GO:0007596]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155]; protein localization to membrane [GO:0072657]	GTP-dependent protein binding [GO:0030742]; small GTPase binding [GO:0031267]	GO:0005765; GO:0005769; GO:0005783; GO:0006996; GO:0007596; GO:0016020; GO:0030318; GO:0030742; GO:0031084; GO:0031267; GO:0031901; GO:0032418; GO:0046907; GO:0060155; GO:0072657; GO:1903232	HSSTFR	2.940000057	1	1	0.169555272	735.4343416	0	17.24743	0	0	0	0	0	0	0	0	17.97598	0	18.13889	0	0	0	0	0	0	0	0	0	0	16.0286	14.19543	18.2218	14.91095	15.96525	0	0	0	0	0	0	0	12.73447	0	0	16.76547	0	0	0	0	0	0	0	0	0
Q86YW9	MD12L_HUMAN	Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like)	MED12L KIAA1635 TNRC11L TRALP TRALPUSH PRO0314	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	mediator complex [GO:0016592]	mediator complex [GO:0016592]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]	beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0006357; GO:0008013; GO:0016592	EGLLTSLQNQVNQILSNWR	1.379999995	1	1	0.153292285	2210.323309	16.07147	14.69453	12.76219	10.66615	11.07494	0	17.35913	14.96705	11.87303	14.68781	0	13.5029	13.21709	0	13.46181	0	0	0	11.80023	0	12.33534	15.4145	11.45958	0	0	15.65314	0	15.27698	0	9.132486	0	0	0	0	0	0	0	16.33321	0	13.35021	14.52211	0	0	0	12.70908	0	0	15.18186
Q86YZ3	HORN_HUMAN	Hornerin	HRNR S100A18	Homo sapiens (Human)	cell envelope organization [GO:0043163]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424]	azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; cell envelope organization [GO:0043163]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424]	calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	GO:0001533; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0031424; GO:0035578; GO:0036457; GO:0043163; GO:0046914; GO:0048471; GO:0061436; GO:0062023; GO:0070062	QGSGSGHSPSR	7.349999905	1	1	0.220567664	1057.225493	16.12914	0	15.01458	14.22026	14.70635	0	0	15.40334	13.32331	15.3813	15.82905	12.94659	0	0	12.21191	14.07624	15.51118	0	15.63213	0	0	15.04981	16.14025	0	0	14.0014	16.36404	0	0	14.42497	0	0	0	0	0	0	16.12309	0	13.84471	15.54542	16.46105	0	0	0	0	0	0	0
Q86Z02	HIPK1_HUMAN	"Homeodomain-interacting protein kinase 1, EC 2.7.11.1 (Nuclear body-associated kinase 2)"	HIPK1 KIAA0630 MYAK NBAK2	Homo sapiens (Human)	adherens junction assembly [GO:0034333]; anterior/posterior pattern specification [GO:0009952]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; retina layer formation [GO:0010842]; smoothened signaling pathway [GO:0007224]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; adherens junction assembly [GO:0034333]; anterior/posterior pattern specification [GO:0009952]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; retina layer formation [GO:0010842]; smoothened signaling pathway [GO:0007224]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0001654; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007224; GO:0008284; GO:0009952; GO:0010803; GO:0010842; GO:0016605; GO:0016607; GO:0018105; GO:0018107; GO:0030182; GO:0034333; GO:0042771; GO:0045766; GO:0048596; GO:0060059; GO:0060216; GO:0060235; GO:0061072; GO:0072577; GO:0097191; GO:0106310	RVHMYDTVSQIK	5.199999809	1	1	0.304399803	1493.414738	0	12.95286	0	0	12.52627	0	12.33273	13.77663	11.83312	9.442307	16.56704	13.47082	13.73362	0	0	15.04219	0	0	0	0	0	15.6432	17.50673	0	0	0	0	0	0	0	0	0	0	0	13.38811	0	16.50507	0	0	0	16.3595	0	16.43362	14.498	17.81286	0	0	0
Q86Z14	KLOTB_HUMAN	"Beta-klotho, BKL, BetaKlotho (Klotho beta-like protein)"	KLB	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]"	"fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]"	GO:0004553; GO:0005104; GO:0005886; GO:0005975; GO:0008284; GO:0008543; GO:0016021; GO:0017134; GO:0090080	LSDIYNR	4.699999809	1	1	0.116061646	879.2581658	0	15.86135	16.37478	14.95383	0	0	0	15.59387	16.55862	0	0	15.92302	0	0	0	16.38334	0	0	12.22308	0	0	0	0	16.76066	15.56404	15.95081	0	15.9725	0	9.267852	15.83868	0	17.17396	0	17.7641	0	0	0	0	0	0	0	0	12.84923	14.28219	17.43165	0	0
Q8HWS3	RFX6_HUMAN	DNA-binding protein RFX6 (Regulatory factor X 6) (Regulatory factor X domain-containing protein 1)	RFX6 RFXDC1	Homo sapiens (Human)	"endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104	VDTLIMMYK	3.839999914	0.602782965	0.602782965	0.185222047	1128.590763	15.09059	14.17261	0	13.77001	15.4289	14.40015	14.99859	15.42847	12.5894	14.79507	15.35185	13.31723	15.37066	0	13.83456	0	12.1212	0	16.33888	14.40508	0	0	15.61977	0	16.17645	0	0	0	0	16.07061	0	0	0	15.16835	15.16441	0	15.99774	16.41816	16.76285	16.34836	16.64484	13.87858	16.39199	15.92208	14.84597	16.32591	9.294958	15.94873
Q8IU53	CASC2_HUMAN	"Protein CASC2, isoforms 1/2 (Cancer susceptibility candidate gene 2 protein isoforms 1/2)"	CASC2 C10orf5	Homo sapiens (Human)						MAGTRGLMLLGPGPVAGPR	11.59000015	1	1	0.296214664	1867.12844	0	0	14.77342	13.76082	12.03612	0	0	0	0	13.53595	0	14.66148	0	13.41371	0	0	0	11.57702	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IU68	TMC8_HUMAN	Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2)	TMC8 EVER2 EVIN2	Homo sapiens (Human)	negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069]	mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]	GO:0001558; GO:0005615; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0008381; GO:0031333; GO:0031965; GO:0032091; GO:0043120; GO:0055069; GO:0070062; GO:0140311; GO:1902041	GSGTPVRGLPYAMMDK	1.960000038	1	1	0.107332786	1695.340114	14.11618	13.85485	15.30814	15.02444	15.32967	0	0	0	15.00905	0	0	0	0	0	0	13.89241	0	16.19909	0	0	0	0	0	0	0	0	0	0	0	0	15.06987	0	0	0	0	0	14.8974	14.99976	0	0	15.71759	0	0	0	0	0	0	12.68412
Q8IU80	TMPS6_HUMAN	"Transmembrane protease serine 6, EC 3.4.21.- (Matriptase-2)"	TMPRSS6 UNQ354/PRO618	Homo sapiens (Human)	"cellular iron ion homeostasis [GO:0006879]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; self proteolysis [GO:0097264]"	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; cellular iron ion homeostasis [GO:0006879]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; self proteolysis [GO:0097264]"	metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]	GO:0000122; GO:0004222; GO:0004252; GO:0005615; GO:0005886; GO:0006879; GO:0016021; GO:0022617; GO:0030514; GO:0030574; GO:0033619; GO:0045892; GO:0045944; GO:0055072; GO:0097264	ATFQCK	2.160000086	1	1	0.295235883	753.1203964	0	18.67281	20.33567	0	0	17.19247	18.83683	17.29955	0	0	0	0	20.3547	17.12481	0	0	0	0	16.53256	17.28259	16.74371	18.03851	17.83758	16.8917	17.30057	0	17.76989	0	0	16.98511	0	19.56568	0	0	0	18.90101	0	0	0	17.67652	0	18.39749	17.16474	18.10289	17.89643	0	0	0
Q8IU81	I2BP1_HUMAN	"Interferon regulatory factor 2-binding protein 1, IRF-2-binding protein 1, IRF-2BP1 (Probable E3 ubiquitin-protein ligase IRF2BP1, EC 2.3.2.27) (Probable RING-type E3 ubiquitin transferase IRF2BP1)"	IRF2BP1	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]	GO:0000122; GO:0000209; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0046872; GO:0061630	ATSSGR	5.869999886	1	1	1.15E-13	578.2181545	14.26464	14.73083	13.56742	14.43164	0	11.8604	0	0	0	0	0	0	0	0	0	0	0	0	0	15.77503	15.86771	0	0	0	12.09848	14.17964	0	0	15.24893	16.19275	14.85343	0	0	15.48553	11.77433	0	0	0	0	0	0	0	16.03769	0	0	0	0	0
Q8IUC8	GLT13_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 13, EC 2.4.1.41 (Polypeptide GalNAc transferase 13, GalNAc-T13, pp-GaNTase 13) (Protein-UDP acetylgalactosaminyltransferase 13) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13)"	GALNT13 KIAA1918	Homo sapiens (Human)	O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030246; GO:0046872	AVLIPK	17.45999908	1	1	0.297866761	639.6243652	0	0	0	0	0	0	0	0	0	17.31922	0	0	0	18.6388	16.1825	0	17.52081	0	0	0	0	0	0	19.03428	21.55595	21.80117	19.00088	0	0	0	0	20.41023	0	18.05215	0	20.57495	0	19.45261	0	0	0	0	0	0	19.72641	0	0	0
Q8IUD2	RB6I2_HUMAN	"ELKS/Rab6-interacting/CAST family member 1, ERC-1 (Rab6-interacting protein 2)"	ERC1 ELKS KIAA1081 RAB6IP2	Homo sapiens (Human)	"I-kappaB phosphorylation [GO:0007252]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; retrograde transport, endosome to Golgi [GO:0042147]"	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton of presynaptic active zone [GO:0048788]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]	"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton of presynaptic active zone [GO:0048788]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; I-kappaB phosphorylation [GO:0007252]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; retrograde transport, endosome to Golgi [GO:0042147]"	cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]	GO:0000139; GO:0005737; GO:0005813; GO:0006355; GO:0007252; GO:0007274; GO:0008385; GO:0015031; GO:0030165; GO:0031267; GO:0036064; GO:0042147; GO:0042734; GO:0045202; GO:0045296; GO:0048167; GO:0048788; GO:0048790; GO:0051092; GO:0098882	EMVLAQEESARTNAEK	1.200000048	0.795149922	0.795149922	0.305815124	1803.886414	0	0	0	17.56155	0	0	0	0	0	0	0	0	0	0	16.38341	15.8601	15.91056	12.92868	0	0	0	0	12.99503	0	0	17.31723	0	16.16677	0	0	0	15.61669	0	0	0	0	0	15.4975	0	0	0	0	0	0	15.37426	0	0	0
Q8IUE1	TF2LX_HUMAN	"Homeobox protein TGIF2LX (TGF-beta-induced transcription factor 2-like protein) (TGFB-induced factor 2-like protein, X-linked) (TGIF-like on the X)"	TGIF2LX TGIFLX	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:1990837	EKQPDPESAPSQK	12.59000015	1	1	0.405447237	1441.483548	16.87099	0	0	0	0	0	0	16.91613	0	13.53499	0	0	0	14.98954	0	13.86221	13.84155	0	0	0	0	0	17.43106	16.13271	0	0	0	0	16.31798	0	0	0	0	17.54925	16.07034	0	0	0	14.97392	0	0	0	0	0	12.44412	0	15.27184	0
Q8IUF8	RIOX2_HUMAN	"Ribosomal oxygenase 2 (60S ribosomal protein L27a histidine hydroxylase) (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA, EC 1.14.11.-) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) (Mineral dust-induced gene protein) (Nucleolar protein 52) (Ribosomal oxygenase MINA, ROX)"	RIOX2 MDIG MINA MINA53 NO52	Homo sapiens (Human)	histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; ribosome biogenesis [GO:0042254]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0016706; GO:0032452; GO:0032453; GO:0034720; GO:0042254; GO:0042802; GO:0046872; GO:0051864; GO:0070544	ELLSSDMK	14.02999973	0.201442569	0.201442569	0.196503286	919.7506535	14.78136	15.17725	15.14122	15.20292	15.48493	16.21941	0	0	0	15.73366	0	14.18018	0	13.14005	0	14.35989	12.9039	14.17483	14.93286	0	0	0	0	15.78369	0	15.75595	0	0	0	0	0	0	0	0	0	0	0	0	0	15.19885	12.46811	14.91365	0	0	14.89824	0	0	0
Q8IUH3	RBM45_HUMAN	"RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1, RB-1) (RNA-binding motif protein 45)"	RBM45 DRB1 DRBP1	Homo sapiens (Human)	cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0007399; GO:0030154; GO:0042802; GO:1990904	IFLVISK	15.07999992	0.19946374	0.19946374	0.249932194	820.3825678	0	15.65025	0	16.78145	14.95064	15.54722	0	15.69207	15.36445	16.93278	15.17893	0	0	0	15.18822	15.02217	14.69181	0	0	15.35331	0	15.47598	16.5004	16.68974	15.1281	15.91693	17.8293	0	16.34561	0	0	16.83736	0	0	0	0	16.89489	18.99202	0	16.73705	16.72306	15.57479	15.97237	15.99721	16.37452	16.35947	15.34305	16.19318
Q8IUH8	SPP2C_HUMAN	"Signal peptide peptidase-like 2C, SPP-like 2C, SPPL2c, EC 3.4.23.- (Intramembrane protease 5, IMP-5)"	SPPL2C IMP5	Homo sapiens (Human)	membrane protein proteolysis [GO:0033619]	endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]	"endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein proteolysis [GO:0033619]"	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"	GO:0005765; GO:0005789; GO:0030660; GO:0033619; GO:0042500; GO:0042803; GO:0071458; GO:0071556	KSMSTQAPL	4.829999924	1	1	0.195541993	977.4870828	14.4818	14.52014	14.90002	0	15.7093	0	13.62299	16.35666	16.2504	14.99748	15.4266	16.36312	13.8976	14.79594	14.79474	12.87216	0	13.37422	0	11.61738	14.86621	0	0	16.65145	0	0	0	16.70919	0	16.37526	15.3796	0	0	0	0	0	0	0	15.15328	0	0	0	0	0	0	15.84343	0	16.04956
Q8IUL8	CILP2_HUMAN	"Cartilage intermediate layer protein 2, CILP-2 [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2 ]"	CILP2	Homo sapiens (Human)		extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]		GO:0005615; GO:0070062	ADGKPYSGPVEARVTFVDPR	3.789999962	0.532295525	0.532295525	0.173339942	2160.672613	10.82316	14.95428	0	0	14.10962	8.959558	0	0	12.84433	0	12.6834	11.51908	8.591025	11.21587	13.18202	0	0	0	0	0	0	0	12.36674	0	14.72024	11.70859	16.1639	0	14.4571	0	0	0	0	0	14.70291	0	16.90981	0	0	15.78239	14.21828	0	0	12.59148	0	0	14.6829	13.79768
Q8IUM7	NPAS4_HUMAN	"Neuronal PAS domain-containing protein 4, Neuronal PAS4 (Class E basic helix-loop-helix protein 79, bHLHe79) (HLH-PAS transcription factor NXF) (PAS domain-containing protein 10)"	NPAS4 BHLHE79 NXF PASD10	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]"	chromatin [GO:0000785]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0007612; GO:0007614; GO:0007616; GO:0030154; GO:0032228; GO:0035176; GO:0044877; GO:0045944; GO:0046982; GO:0048167; GO:0060079; GO:0060080; GO:0071386; GO:0098794; GO:1904862	GASKAR	8.369999886	0.933829784	0.933829784	0.244827229	588.6021222	15.09531	14.9881	15.27444	15.98143	15.77846	13.72536	15.54639	15.38933	15.74428	0	13.99784	0	14.78197	0	0	0	15.30891	0	17.14677	15.9809	17.00467	12.09915	0	0	16.22138	16.39629	0	15.73255	15.8097	15.21048	15.613	0	0	14.33874	13.28387	16.5748	0	16.73284	16.24294	14.90809	16.27512	0	0	15.19359	16.75891	0	16.79951	0
Q8IUR0	TPPC5_HUMAN	Trafficking protein particle complex subunit 5	TRAPPC5	Homo sapiens (Human)	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022]		GO:0005737; GO:0005783; GO:0005829; GO:0006888; GO:0006901; GO:0030008; GO:0048208; GO:0099022; GO:1990070; GO:1990071; GO:1990072	GTTLMIK	19.42000008	1	1	0.164783807	762.2986819	0	0	0	0	0	18.00883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.60726	0	0	0	0	0	0	0	0	0	0	21.19327	0	0	0	0	0	0	0	0	0	0	0	0
Q8IUW3	SPA2L_HUMAN	"Spermatogenesis-associated protein 2-like protein, SPATA2-like protein"	SPATA2L C16orf76	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	AQMDTLLYNSPGARP	20.71999931	0.135294735	0.135294735	0.425945546	1648.945309	18.10694	14.23644	21.81012	16.05322	17.61917	19.34448	0	21.42664	20.32375	22.11121	18.47913	17.66929	0	0	21.68099	22.12629	21.97642	22.1517	0	0	21.45802	21.09884	18.73045	0	0	21.50354	18.74991	19.37635	18.3658	18.02654	23.45083	22.15372	18.32727	23.79829	19.77817	24.24259	16.27339	21.36255	0	20.29842	22.20187	18.99468	18.36348	0	0	22.33081	18.47435	21.13243
Q8IUX1	T126B_HUMAN	"Complex I assembly factor TMEM126B, mitochondrial (Transmembrane protein 126B)"	TMEM126B HT007	Homo sapiens (Human)	mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]		GO:0005739; GO:0005743; GO:0016021; GO:0032981	LFVIDALYSDNISK	7.820000172	1	1	0.324074335	1596.668379	14.46239	13.48534	0	0	0	0	0	15.58538	0	15.01589	0	0	0	0	17.99802	0	17.90826	18.60692	18.48053	15.21558	18.58292	0	0	15.32008	16.2935	15.19393	18.01332	0	13.34249	0	16.46449	15.62891	12.96095	15.04465	15.40815	14.8301	0	16.28016	0	12.92456	10.99993	0	0	0	11.17205	13.59285	16.71364	15.85975
Q8IUX8	EGFL6_HUMAN	"Epidermal growth factor-like protein 6, EGF-like protein 6 (MAM and EGF domains-containing gene protein)"	EGFL6 MAEG PP648 UNQ281/PRO320	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	calcium ion binding [GO:0005509]; integrin binding [GO:0005178]	GO:0005178; GO:0005509; GO:0005604; GO:0005615; GO:0007155; GO:0010811; GO:0016020; GO:0030154; GO:0030198	GGNSHGGKK	15.35999966	1	1	0.022421452	842.535722	16.36844	16.00115	0	0	0	14.45759	14.51941	0	16.8204	0	14.47131	15.51048	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.35651	0	0	0	0	0	0	0	0	0	0	0	13.11979	15.88218	0	0	0	0	0	0	0
Q8IV03	LUR1L_HUMAN	Leucine rich adaptor protein 1-like	LURAP1L C9orf150 HYST0841	Homo sapiens (Human)	positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]		GO:0043123	MEDSPLPDLR	4.190000057	0.050966844	0.050966844	0.376014594	1185.274652	12.83228	0	0	0	0	11.99739	0	0	0	0	0	0	0	0	0	0	0	0	0	16.14558	0	0	0	17.37337	0	0	0	0	11.60081	0	13.71256	0	0	13.86338	0	0	0	0	0	0	16.89681	0	0	0	0	0	0	0
Q8IV32	CCD71_HUMAN	Coiled-coil domain-containing protein 71	CCDC71	Homo sapiens (Human)						VARTLAK	7.559999943	0.380064666	0.380064666	0.140966892	757.4387346	17.10141	16.57789	0	16.21269	16.08165	16.00696	0	14.6753	15.35197	16.58299	15.8552	0	11.30952	18.16323	17.55721	15.80375	17.8315	0	16.30962	17.40962	16.03915	0	0	0	17.30039	0	15.80376	17.1956	17.68546	0	0	16.83983	17.19141	16.20163	17.16551	17.79204	0	13.91735	17.32701	15.66811	0	15.84997	15.57871	16.44335	17.74022	16.41628	17.22598	16.18822
Q8IV38	ANKY2_HUMAN	Ankyrin repeat and MYND domain-containing protein 2	ANKMY2	Homo sapiens (Human)		cilium [GO:0005929]	cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	GO:0005929; GO:0019899; GO:0046872	DMNEVLAMK	9.979999542	1	1	0.030894742	1066.315018	15.93901	14.01571	0	0	15.03669	0	13.57017	13.89574	13.82223	0	15.41391	14.46863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42361	0
Q8IV45	UN5CL_HUMAN	UNC5C-like protein (Protein unc-5 homolog C-like) (ZU5 and death domain-containing protein)	UNC5CL ZUD	Homo sapiens (Human)	positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; netrin receptor activity [GO:0005042]; peptidase activity [GO:0008233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]	netrin receptor activity [GO:0005042]; peptidase activity [GO:0008233]	GO:0005042; GO:0005737; GO:0008233; GO:0016020; GO:0016021; GO:0043123; GO:0046330	DNQGLELDEK	7.019999981	1	1	0.168865112	1160.900445	14.49441	0	0	0	10.61735	13.69016	14.49062	0	0	13.82176	0	13.91814	0	15.54124	0	14.79753	0	0	0	0	14.16012	0	0	0	0	16.0384	15.93749	0	13.68121	0	0	13.94496	0	0	0	0	0	0	0	0	15.17148	0	14.14561	0	0	0	0	0
Q8IV53	DEN1C_HUMAN	DENN domain-containing protein 1C (Connecdenn 3) (Protein FAM31C)	DENND1C FAM31C	Homo sapiens (Human)	endocytic recycling [GO:0032456]; endocytosis [GO:0006897]	centrosome [GO:0005813]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]	GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0006897; GO:0030136; GO:0032456; GO:0043231; GO:1901981	GVQSLLMYK	3.25	0.235389039	0.235389039	0.047739894	1038.434731	17.65093	16.99385	14.69457	16.99037	13.71024	0	13.02963	0	14.11905	14.88605	15.07268	0	10.72847	0	13.55501	14.54953	0	14.06764	15.157	15.8769	14.93438	15.76301	0	16.9189	15.50448	15.39432	16.1877	0	16.07874	0	15.95626	17.22866	17.60687	14.88696	14.64446	9.53383	17.43889	0	17.338	16.12226	0	15.69574	14.74194	0	13.08496	15.48025	9.900425	12.71562
Q8IV61	GRP3_HUMAN	Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1)	RASGRP3 GRP3 KIAA0846	Homo sapiens (Human)	MAPK cascade [GO:0000165]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; small GTPase binding [GO:0031267]; MAPK cascade [GO:0000165]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264]	calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; small GTPase binding [GO:0031267]	GO:0000165; GO:0005085; GO:0005096; GO:0005509; GO:0005886; GO:0005887; GO:0007264; GO:0007265; GO:0019900; GO:0019992; GO:0031267; GO:0032045; GO:0043547; GO:0048471	IVLLMHR	7.349999905	0.568655074	0.568655074	0.23563476	896.4949138	17.01848	0	0	0	17.73194	0	0	0	15.16272	0	18.25534	19.85053	0	0	17.09968	0	0	0	0	0	0	0	0	0	0	19.04762	0	0	18.06278	0	0	0	0	0	0	0	0	0	0	0	0	0	18.31855	0	0	0	0	0
Q8IVB5	LIX1L_HUMAN	LIX1-like protein	LIX1L	Homo sapiens (Human)	autophagosome maturation [GO:0097352]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352]		GO:0005737; GO:0097352	EAVEAVVR	7.46999979	0.74929744	0.74929744	0.09269869	872.3183567	0	18.53753	16.65164	16.32913	0	0	19.95509	16.07391	15.78292	16.97628	19.17265	15.4683	13.17398	16.81769	0	0	0	0	18.17116	0	0	18.2561	0	18.53595	18.519	17.53881	14.38062	12.67662	17.31985	0	0	0	16.76001	18.43306	0	14.86686	18.60637	0	16.42126	18.84493	18.04664	17.32023	18.32861	15.97864	15.68683	18.83883	10.40463	16.97424
Q8IVC4	ZN584_HUMAN	Zinc finger protein 584	ZNF584	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	VHTPERR	7.349999905	1	1	0.220179283	895.0367605	0	0	15.4863	0	0	14.44269	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.64101	0	0	0	0	0	0	0	0	0	0	0	17.11321	0	0	0	0	0	0	0	0	0	0	0
Q8IVD9	NUDC3_HUMAN	NudC domain-containing protein 3	NUDCD3 KIAA1068	Homo sapiens (Human)	cilium assembly [GO:0060271]; protein folding [GO:0006457]; protein localization to pericentriolar material [GO:1905793]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; unfolded protein binding [GO:0051082]; cilium assembly [GO:0060271]; protein folding [GO:0006457]; protein localization to pericentriolar material [GO:1905793]	unfolded protein binding [GO:0051082]	GO:0005737; GO:0005868; GO:0006457; GO:0051082; GO:0060271; GO:1905793	VLMEGKLTHK	3.569999933	1	1	0.164743696	1170.7071	0	0	14.92801	14.19369	0	0	0	0	0	0	13.48574	14.24825	11.32965	15.23363	13.15924	14.39255	0	0	0	0	0	0	0	0	0	14.64258	0	0	0	0	0	16.81563	0	17.03168	0	0	0	15.84531	0	0	0	0	14.93715	12.5454	0	0	0	0
Q8IVE3	PKHH2_HUMAN	Pleckstrin homology domain-containing family H member 2	PLEKHH2 KIAA2028	Homo sapiens (Human)	negative regulation of actin filament depolymerization [GO:0030835]	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; negative regulation of actin filament depolymerization [GO:0030835]	actin binding [GO:0003779]	GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0016604; GO:0030027; GO:0030835; GO:0030864	ALNSPLGK	10.81000042	0.141342625	0.141342625	0.17324138	800.481182	14.77254	0	0	0	0	14.26442	0	13.89967	0	15.50404	14.64157	0	16.04697	15.09436	18.984	19.00421	16.15409	18.85196	17.41912	17.92977	17.96548	0	19.43061	18.70732	16.36596	15.6086	17.67407	16.63536	19.87818	19.10268	18.98632	18.07844	14.99358	14.76544	17.70514	17.77365	17.79577	17.00017	16.40266	17.09948	18.67475	13.48555	20.63865	16.8926	17.96962	17.64137	17.3914	18.51189
Q8IVF2	AHNK2_HUMAN	Protein AHNAK2	AHNAK2 C14orf78 KIAA2019	Homo sapiens (Human)	regulation of RNA splicing [GO:0043484]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; regulation of RNA splicing [GO:0043484]		GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0030315; GO:0042383; GO:0043484	AGPGSQRR	6.309999943	1	1	0.220561172	828.6559357	16.68268	0	15.81554	15.63038	0	15.16555	0	16.51085	0	0	13.43816	0	17.38399	16.91557	0	18.38278	17.80014	15.41036	17.18971	17.7728	17.04633	16.46916	16.95418	16.32959	17.05029	16.72956	17.4004	17.47536	17.91676	15.80057	16.85028	17.6566	16.64009	16.74041	17.34101	18.48435	18.32285	17.53059	18.7849	17.29887	17.99684	16.33991	17.62842	18.01126	18.03157	17.11574	17.92362	17.53315
Q8IVF4	DYH10_HUMAN	Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10)	DNAH10 KIAA2017	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]	axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959	ATEVSEKLK	6.769999981	1	1	0.222131138	1005.413717	0	15.11355	13.74625	14.2624	0	15.31318	15.40192	15.15407	0	12.74519	13.3628	14.35412	15.75568	0	16.0381	14.99174	15.81428	14.5434	14.19669	15.53353	0	14.52096	0	0	0	0	15.96982	15.24433	12.48688	16.51873	13.3365	0	0	0	15.48903	15.78436	0	15.58606	13.89767	0	15.13587	14.27904	0	14.6359	15.51494	14.18975	14.18159	15.3196
Q8IVF5	TIAM2_HUMAN	"Rho guanine nucleotide exchange factor TIAM2 (SIF and TIAM1-like exchange factor) (T-lymphoma invasion and metastasis-inducing protein 2, TIAM-2)"	TIAM2 KIAA2016 STEF	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; positive regulation of axonogenesis [GO:0050772]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perikaryon [GO:0043204]; synapse [GO:0045202]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perikaryon [GO:0043204]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; positive regulation of axonogenesis [GO:0050772]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0016020; GO:0030027; GO:0030175; GO:0030426; GO:0043204; GO:0045202; GO:0050772; GO:0051056; GO:0070062; GO:0090630	AMEKVASHINEMQK	1.769999981	1	1	6.96E-13	1647.231763	0	0	0	0	0	0	0	0	16.69086	0	0	0	0	0	0	0	0	0	0	14.8813	0	0	0	14.38509	0	0	0	0	0	0	0	0	16.50015	0	0	0	0	0	16.83932	0	16.93467	0	0	0	0	0	0	0
Q8IVF6	AN18A_HUMAN	Ankyrin repeat domain-containing protein 18A	ANKRD18A KIAA2015	Homo sapiens (Human)						MITKTVAR	11.85000038	1	1	0.276353202	917.2301446	17.75291	17.21385	15.78974	0	17.79114	0	17.77509	0	0	0	19.31224	17.5653	0	0	17.58873	18.28426	0	0	16.13276	0	0	0	0	0	18.18462	0	0	0	0	16.77301	19.42018	18.77169	0	0	0	0	0	20.32819	18.60856	19.87132	0	16.33122	0	15.55896	0	16.36603	18.75611	0
Q8IVG5	SAM9L_HUMAN	"Sterile alpha motif domain-containing protein 9-like, SAM domain-containing protein 9-like"	SAMD9L C7orf6 DRIF2 KIAA2005 UEF	Homo sapiens (Human)		cytoplasm [GO:0005737]; early endosome [GO:0005769]	cytoplasm [GO:0005737]; early endosome [GO:0005769]		GO:0005737; GO:0005769	HFYIKEK	5.679999828	0.278196096	0.278196096	0.126118253	964.3604334	0	15.50818	13.62148	12.8944	15.96909	14.39384	11.58035	14.70023	13.42933	16.18445	14.65975	15.54237	0	0	14.87046	0	12.39364	0	0	0	0	0	15.37043	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.36139	0	0	0	0	0	0	0	0
Q8IVH2	FOXP4_HUMAN	Forkhead box protein P4 (Fork head-related protein-like A)	FOXP4 FKHLA	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	VQMQVVQQLEIQLAK	9.970000267	0.336612612	0.336612612	0.06567743	1769.913573	0	17.99823	13.37679	0	14.1094	15.53512	0	0	0	0	13.52789	0	17.99442	14.29196	18.23474	12.43575	0	14.60425	0	15.81355	0	13.78636	13.8056	0	0	0	15.98765	19.38055	0	16.75633	0	0	0	0	0	0	18.19813	13.33528	0	20.53962	0	15.64051	16.59177	0	0	12.78586	17.10261	0
Q8IVH4	MMAA_HUMAN	"Methylmalonic aciduria type A protein, mitochondrial, EC 3.6.-.-"	MMAA	Homo sapiens (Human)	cobalamin metabolic process [GO:0009235]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metallochaperone activity [GO:0016530]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metallochaperone activity [GO:0016530]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009235; GO:0016530; GO:0042802; GO:0042803	MKDFQDLMLASGELTAK	4.039999962	1	1	0.619193356	1912.758589	17.91545	0	0	0	0	0	18.74029	18.60336	0	0	0	0	0	0	0	18.37653	0	0	0	0	0	0	0	0	0	19.38443	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.34395	0	0
Q8IVH8	M4K3_HUMAN	"Mitogen-activated protein kinase kinase kinase kinase 3, EC 2.7.11.1 (Germinal center kinase-related protein kinase, GLK) (MAPK/ERK kinase kinase kinase 3, MEK kinase kinase 3, MEKKK 3)"	MAP4K3 RAB8IPL1	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]		ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0034612; GO:0035556; GO:0106310	GTNLSRK	5.71999979	0.949284256	0.949284256	0.126746863	770.4734279	0	0	0	0	0	0	0	0	0	16.23019	0	15.61847	0	16.46534	0	16.94044	0	15.58903	0	0	0	0	0	0	14.94228	17.54913	0	14.0561	16.93311	14.57377	16.99168	17.29992	0	16.78862	14.96471	15.71499	0	15.37068	15.40588	0	17.01105	0	18.47654	18.03996	15.63101	17.05802	0	15.5897
Q8IVJ1	S41A1_HUMAN	Solute carrier family 41 member 1	SLC41A1	Homo sapiens (Human)	cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857]; cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001]	inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0010961; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0022890; GO:0030001; GO:0032991; GO:0061768; GO:0071286; GO:1903830	GPAPPSPLK	1.350000024	1	1	0.038409919	864.9831307	15.90743	14.04363	13.33524	15.22458	12.93085	15.67308	0	14.39701	14.23751	15.27101	0	16.75352	14.46059	13.96043	13.6367	16.57435	0	14.6265	0	0	0	15.81711	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.56633	0	15.43572	0
Q8IVJ8	APRG1_HUMAN	APRG1 tumor suppressor candidate (AP20 region protein 1)	APRG1 C3orf35	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	MKTMATR	5.429999828	0.245229974	0.245229974	0.145436217	838.4010604	17.05647	0	0	15.36624	0	0	0	17.25961	16.72134	13.43867	0	0	13.79003	0	12.65281	13.9568	0	0	18.5046	0	0	0	0	0	0	17.46573	0	18.18437	17.03233	13.90788	0	19.71805	11.8053	16.3252	14.6933	0	0	0	17.34262	17.87928	0	1.17742	0	16.19902	0	0	0	14.36446
Q8IVL0	NAV3_HUMAN	"Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1) (Steerin-3) (Unc-53 homolog 3, unc53H3)"	NAV3 KIAA0938 POMFIL1 STEERIN3	Homo sapiens (Human)	negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]	nuclear outer membrane [GO:0005640]	nuclear outer membrane [GO:0005640]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]	GO:0005524; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0016887; GO:0022008; GO:0030336; GO:0031116; GO:0032703	AISHSGSFR	4.769999981	0.453248352	0.453248352	0.250551188	961.7639749	15.94425	17.37635	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.78279	0	0	0	0	0	17.46429	0	0	0	0	0	17.26927	0	0	0	0	18.88847	0	0	18.57962	0	0	0	0	0	0	0	16.83939	18.16127	0
Q8IVL1	NAV2_HUMAN	"Neuron navigator 2, EC 3.6.4.12 (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2, unc53H2)"	NAV2 HELAD1 KIAA1419 POMFIL2 RAINB1 STEERIN2	Homo sapiens (Human)	glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]	interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]	interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heparin binding [GO:0008201]	GO:0003025; GO:0005524; GO:0005614; GO:0005654; GO:0007399; GO:0007605; GO:0007608; GO:0007626; GO:0008201; GO:0016887; GO:0021554; GO:0021563; GO:0021564; GO:0022008; GO:0043138	SLPRPSKSNSR	3.099999905	1	1	0.213380967	1229.772853	0	16.18501	7.598227	0	0	0	0	0	0	0	0	19.00956	0	0	0	0	16.91685	0	0	0	0	0	0	0	0	0	0	0	0	0	17.02225	19.2659	0	0	20.12163	0	0	0	0	0	0	19.44869	0	0	0	16.79793	19.76552	0
Q8IVM0	CCD50_HUMAN	Coiled-coil domain-containing protein 50 (Protein Ymer)	CCDC50 C3orf6	Homo sapiens (Human)	sensory perception of sound [GO:0007605]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase binding [GO:0031625]; sensory perception of sound [GO:0007605]	ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005829; GO:0007605; GO:0031625	ELQEEKK	13.84000015	0.122403063	0.122403063	0.213890952	902.2331803	0	14.03156	14.9935	0	0	0	15.19492	0	0	14.85742	0	0	0	0	0	0	0	0	16.2451	0	15.18977	0	16.71952	16.85101	0	15.71643	0	0	16.10088	13.22471	0	0	15.79491	0	15.19024	0	0	17.59185	0	0	0	0	0	0	0	0	0	0
Q8IVM8	S22A9_HUMAN	Solute carrier family 22 member 9 (Organic anion transporter 7)	SLC22A9 hOAT4 OAT7 UST3	Homo sapiens (Human)	hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; hormone transport [GO:0009914]; organic anion transport [GO:0015711]; short-chain fatty acid import [GO:0015913]; sodium-independent organic anion transport [GO:0043252]	anion:anion antiporter activity [GO:0015301]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0009914; GO:0015301; GO:0015347; GO:0015636; GO:0015711; GO:0015913; GO:0016021; GO:0016323; GO:0043252	AAHRSGMK	10.68999958	0.744733274	0.744733274	0.237530675	860.1071716	0	15.27487	16.05213	16.45152	0	15.14856	16.85544	14.29433	13.65702	12.60885	15.5496	17.05785	17.88814	0	0	0	14.75363	0	0	0	12.94174	0	0	16.38001	14.95442	14.92902	15.85448	16.0472	14.79429	14.66306	0	0	17.08416	16.63617	0	14.86703	0	0	0	0	0	0	14.70631	0	0	0	0	0
Q8IVN3	MSTN1_HUMAN	Musculoskeletal embryonic nuclear protein 1	MUSTN1	Homo sapiens (Human)	chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; tissue regeneration [GO:0042246]	nucleus [GO:0005634]	nucleus [GO:0005634]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; tissue regeneration [GO:0042246]		GO:0002062; GO:0005634; GO:0035988; GO:0042246	MSQAGAQEAPIK	3.160000086	0.772103071	0.772103071	0.108725296	1231.346005	17.47216	17.44083	16.61995	17.54318	0	15.43257	17.45012	16.5871	13.22725	16.92971	0	16.92137	15.53043	13.98988	0	17.04191	15.2744	0	15.40247	0	0	0	18.43831	14.03438	14.89787	0	0	0	14.92794	16.25996	0	15.89887	0	17.62724	17.36073	0	0	15.42505	9.498008	0	13.69559	15.93142	15.55074	0	12.50751	15.94865	0	17.35119
Q8IVQ6	ZDH21_HUMAN	"Palmitoyltransferase ZDHHC21, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 21, DHHC-21) (Zinc finger DHHC domain-containing protein 21)"	ZDHHC21	Homo sapiens (Human)	adrenergic receptor signaling pathway [GO:0071875]; hair follicle development [GO:0001942]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of leukocyte adhesion to arterial endothelial cell [GO:1904997]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of vascular associated smooth muscle contraction [GO:0003056]; sebaceous gland development [GO:0048733]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; adrenergic receptor signaling pathway [GO:0071875]; hair follicle development [GO:0001942]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of leukocyte adhesion to arterial endothelial cell [GO:1904997]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of vascular associated smooth muscle contraction [GO:0003056]; sebaceous gland development [GO:0048733]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0001942; GO:0003056; GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0048733; GO:0050999; GO:0071875; GO:1903140; GO:1904997	CNLMRPKR	11.5	1	1	0.218197001	1073.831124	15.03668	0	16.18379	14.96454	0	0	0	14.1868	15.88486	0	15.50355	0	0	14.98839	15.57562	12.75011	12.06567	0	16.01072	14.90687	16.39526	0	16.9108	16.56403	0	0	12.21434	0	14.47965	0	15.2553	14.7743	0	14.68251	15.63982	0	0	14.79678	0	13.33338	0	14.15709	0	0	0	0	0	0
Q8IVT2	MISP_HUMAN	Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein)	MISP C19orf21	Homo sapiens (Human)	cell division [GO:0051301]; cell migration [GO:0016477]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic spindle assembly [GO:0090307]; organelle localization [GO:0051640]; regulation of protein localization to cell cortex [GO:1904776]	actin filament [GO:0005884]; cell cortex [GO:0005938]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]	actin filament [GO:0005884]; cell cortex [GO:0005938]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; actin filament binding [GO:0051015]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic spindle assembly [GO:0090307]; organelle localization [GO:0051640]; regulation of protein localization to cell cortex [GO:1904776]	actin filament binding [GO:0051015]	GO:0000132; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0016477; GO:0031616; GO:0043231; GO:0051015; GO:0051301; GO:0051640; GO:0051660; GO:0090307; GO:1904776	EGLHVGRASTPDWVSEGPQPGLR	5.880000114	1	1	0.243285575	2441.8198	14.68936	16.20768	15.11609	0	13.99019	13.06631	0	15.18456	15.3577	0	15.46106	0	16.90972	14.90155	0	14.96368	15.95706	15.80688	0	0	17.06204	17.08217	16.58349	15.00086	0	15.89702	0	0	15.88547	0	17.05001	16.51648	16.53284	0	0	0	0	0	0	0	0	0	0	0	0	0	17.01512	0
Q8IVT5	KSR1_HUMAN	"Kinase suppressor of Ras 1, EC 2.7.11.1"	KSR1 KSR	Homo sapiens (Human)	cAMP-mediated signaling [GO:0019933]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cAMP-mediated signaling [GO:0019933]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; signal transduction [GO:0007165]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005078; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0007165; GO:0007265; GO:0008022; GO:0016020; GO:0019933; GO:0032587; GO:0032991; GO:0042127; GO:0043231; GO:0043405; GO:0043410; GO:0046872; GO:0071889; GO:0106310	CGASGDECGRLQYALTCLR	3.769999981	1	1	0.159602225	2182.008971	14.21677	13.66067	15.28071	0	16.02468	0	0	12.61316	0	0	13.51627	0	0	0	15.06071	0	15.1244	14.14578	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IVU1	IGDC3_HUMAN	Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule)	IGDCC3 PUNC	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; neuromuscular process controlling balance [GO:0050885]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; cell-cell adhesion [GO:0098609]; neuromuscular process controlling balance [GO:0050885]		GO:0005887; GO:0050885; GO:0098609	NGQVLGPGGHVRLK	15.03999996	1	1	0.109639458	1426.47027	0	13.53295	15.48962	0	0	14.88497	0	0	14.25989	0	0	15.74853	0	0	0	13.74788	0	14.96047	15.78549	17.33	0	15.67229	0	16.09555	14.42344	15.23484	13.01549	0	13.22371	0	16.16634	13.79104	16.28594	15.98379	15.18544	12.73317	15.46414	0	0	0	0	0	0	0	17.06594	0	0	0
Q8IVU3	HERC6_HUMAN	"Probable E3 ubiquitin-protein ligase HERC6, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 6) (HECT-type E3 ubiquitin transferase HERC6)"	HERC6	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]; response to bacterium [GO:0009617]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; hematopoietic progenitor cell differentiation [GO:0002244]; response to bacterium [GO:0009617]	ubiquitin-protein transferase activity [GO:0004842]	GO:0002244; GO:0004842; GO:0005654; GO:0005829; GO:0009617	AVCEMSK	3.559999943	1	1	0.118581608	840.9876909	0	15.47252	0	0	0	15.21378	0	0	0	15.51806	16.03852	13.18742	0	0	0	0	0	0	0	0	0	0	0	0	16.42104	0	0	14.77802	0	0	0	18.98129	0	0	0	0	0	0	0	0	15.61757	0	0	0	0	0	0	0
Q8IVV2	LOXH1_HUMAN	Lipoxygenase homology domain-containing protein 1	LOXHD1	Homo sapiens (Human)	sensory perception of sound [GO:0007605]	stereocilium [GO:0032420]	stereocilium [GO:0032420]; sensory perception of sound [GO:0007605]		GO:0007605; GO:0032420	EQNDTFIMEILDIAPFTKMR	2.470000029	0.603762448	0.603762448	0.266827911	2428.544722	12.72657	0	15.35317	0	13.17754	15.08602	15.49002	0	0	0	0	0	14.5727	0	0	16.0877	15.08408	0	0	0	0	14.34669	0	16.30238	14.80302	11.78849	13.34096	0	13.29911	11.41603	16.27384	13.78723	14.5578	0	0	16.26469	0	0	16.57727	15.16802	0	0	0	0	0	0	0	0
Q8IW19	APLF_HUMAN	"Aprataxin and PNK-like factor, EC 3.1.-.- (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1)"	APLF C2orf13 PALF XIP1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA ligation [GO:0051106]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA ligation [GO:0051106]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012]	3'-5' exonuclease activity [GO:0008408]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006303; GO:0006974; GO:0008408; GO:0035861; GO:0045191; GO:0046872; GO:0051106	DGGPRVALAPGETVIGR	8.420000076	0.884688497	0.884688497	0.188485146	1663.320838	13.30448	0	17.96829	13.37873	15.52492	14.98051	0	0	0	0	0	14.43716	14.98681	15.21085	13.84017	13.39222	10.89544	0	14.46511	14.86039	10.5302	0	14.40914	0	16.40298	15.34576	16.04663	0	15.88036	13.84868	0	16.67718	0	14.05013	17.22626	13.97836	0	16.31269	8.541345	15.15143	0	15.73524	0	14.56998	0	0	0	0
Q8IW35	CEP97_HUMAN	"Centrosomal protein of 97 kDa, Cep97 (Leucine-rich repeat and IQ domain-containing protein 2)"	CEP97 LRRIQ2	Homo sapiens (Human)	cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; calmodulin binding [GO:0005516]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0030030; GO:0032991; GO:1901673; GO:1902018	MAPAYLPR	11.34000015	0.507045925	0.507045925	0.203728671	919.3179901	15.73703	14.98298	12.6241	0	14.70061	15.02459	0	0	16.15276	0	0	15.93756	14.49442	12.29517	16.54069	13.88831	15.39858	12.69071	0	0	14.16697	15.78015	15.24211	0	16.0382	12.46777	12.93782	15.17518	13.04523	13.6624	15.73806	14.68119	0	14.85021	15.23475	11.74864	12.71648	16.77643	14.98527	12.4823	12.99817	15.17087	14.203	14.71294	12.61183	15.42421	14.44814	0
Q8IW40	CC103_HUMAN	Coiled-coil domain-containing protein 103	CCDC103	Homo sapiens (Human)	axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; protein homodimerization activity [GO:0042803]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]	protein homodimerization activity [GO:0042803]	GO:0001947; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036158; GO:0036159; GO:0042803; GO:0060287; GO:0070286; GO:0071907	LQAMGNPRSVK	17.18000031	1	1	0.077711207	1216.915151	21.47741	0	0	0	0	0	0	0	0	0	0	0	0	0	19.24067	0	0	0	0	0	0	18.62115	18.29243	0	0	0	0	16.81721	0	0	19.22125	20.10713	18.85697	0	0	19.5776	20.08517	0	0	0	0	0	19.179	20.47506	0	0	0	0
Q8IW93	ARHGJ_HUMAN	Rho guanine nucleotide exchange factor 19 (Ephexin-2)	ARHGEF19	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"	cytosol [GO:0005829]	"cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005829; GO:0032956; GO:0042060; GO:0051056; GO:0060071; GO:0090630	LGEAPV	7.239999771	1	1	0.099794186	585.4821604	18.9101	17.92037	15.4109	16.22185	18.22447	18.71526	15.4394	0	16.34802	17.81496	0	16.43106	16.59317	16.25891	18.81176	16.22074	17.67701	19.35972	14.90863	0	16.98583	16.08147	15.22217	0	0	0	0	17.4412	15.33691	0	17.26747	18.43864	0	17.18616	18.09617	16.86107	0	18.87599	17.91873	16.62238	19.53184	0	15.91198	18.35868	16.72311	17.4739	15.59881	0
Q8IWA0	WDR75_HUMAN	WD repeat-containing protein 75 (U3 small nucleolar RNA-associated protein 17 homolog)	WDR75 UTP17	Homo sapiens (Human)	positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0045943; GO:2000234	DVPESFTSEAYQWLNR	1.129999995	1	1	0.048012872	1941.137795	14.05938	14.46649	12.93297	0	13.10125	0	13.63332	15.00153	14.34594	12.74335	0	14.83731	15.00059	0	14.71437	0	14.08064	13.51884	15.41418	0	0	0	0	13.63113	13.25681	12.42065	0	0	0	13.77168	0	0	0	14.85405	11.5209	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IWA4	MFN1_HUMAN	"Mitofusin-1, EC 3.6.5.- (Fzo homolog) (Transmembrane GTPase MFN1)"	MFN1	Homo sapiens (Human)	GTP metabolic process [GO:0046039]; mitochondrial fusion [GO:0008053]; mitochondrial membrane fusion [GO:1990613]; mitochondrion localization [GO:0051646]; positive regulation of mitochondrial membrane potential [GO:0010918]	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799]	integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; GTP metabolic process [GO:0046039]; mitochondrial fusion [GO:0008053]; mitochondrial membrane fusion [GO:1990613]; mitochondrion localization [GO:0051646]; positive regulation of mitochondrial membrane potential [GO:0010918]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]	GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0008053; GO:0010918; GO:0016021; GO:0031306; GO:0031307; GO:0042802; GO:0046039; GO:0051646; GO:0098799; GO:1990613	HIEDGMGR	3.410000086	1	1	0.17151087	928.7524015	0	0	0	0	15.67988	0	0	0	15.67394	0	0	0	0	15.49622	15.73888	0	16.32416	0	0	17.41454	0	17.21885	0	0	0	15.50635	0	14.43886	0	0	16.56784	0	0	15.21218	16.7245	0	15.80228	16.61483	16.70189	0	11.51557	14.01533	14.62465	9.397943	16.37024	14.88144	16.86987	16.34378
Q8IWA5	CTL2_HUMAN	Choline transporter-like protein 2 (Solute carrier family 44 member 2)	SLC44A2 CTL2 PSEC0210	Homo sapiens (Human)	choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; transmembrane transport [GO:0055085]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; transmembrane transport [GO:0055085]	choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0005765; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0022857; GO:0035579; GO:0043123; GO:0055085; GO:0070062	LLNKTNK	8.909999847	0.379900038	0.379900038	0.285947159	828.8089889	16.7211	15.99703	16.65182	0	0	0	0	15.99014	15.26388	16.23663	16.11371	16.72031	16.44976	14.17684	0	0	0	12.62245	15.79181	12.60513	14.52533	16.34811	16.2204	13.26031	14.89888	15.25546	14.70331	16.40107	17.38462	14.65065	15.09825	17.12089	15.50591	17.18923	15.66668	0	18.2741	16.80075	16.77335	0	16.28034	16.37898	0	16.99682	0	0	16.55525	0
Q8IWA6	CCD60_HUMAN	Coiled-coil domain-containing protein 60	CCDC60	Homo sapiens (Human)						MEILMK	12.10000038	0.00556007	0.00556007	0.299359355	796.961293	18.41567	0	17.99296	0	0	17.46308	0	0	0	0	0	0	0	0	0	0	16.26974	0	0	0	0	17.70769	0	0	0	21.64119	0	0	0	0	22.10584	0	0	0	0	0	0	0	0	0	18.30863	18.20799	0	17.43393	0	20.46197	17.84857	17.15745
Q8IWB1	IPRI_HUMAN	"Inositol 1,4,5-trisphosphate receptor-interacting protein (Protein DANGER)"	ITPRIP DANGER KIAA1754	Homo sapiens (Human)	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; protein kinase inhibitor activity [GO:0004860]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]	protein kinase inhibitor activity [GO:0004860]	GO:0004860; GO:0005640; GO:0005886; GO:0016020; GO:0016021; GO:1902042	MAMGLFR	5.989999771	1	1	0.164847963	840.842196	0	14.83676	13.35652	13.38197	14.25279	12.73895	0	14.35032	13.63194	14.66526	15.55316	15.84834	0	0	0	0	16.2305	0	14.30755	0	0	0	14.29787	0	0	0	0	0	0	0	0	16.4489	0	0	0	0	0	0	0	0	0	16.71298	14.91345	0	0	0	0	0
Q8IWB9	TEX2_HUMAN	Testis-expressed protein 2 (Transmembrane protein 96)	TEX2 KIAA1738 TMEM96	Homo sapiens (Human)	lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665]	lipid binding [GO:0008289]	GO:0005783; GO:0005789; GO:0006665; GO:0006869; GO:0007165; GO:0008289; GO:0016021; GO:0031965	ARPKLGER	9.090000153	0.451999784	0.451999784	0.147986626	926.7918263	14.75737	15.69103	15.53697	15.69506	12.83298	16.42113	15.07578	13.70194	12.98875	15.54869	0	13.77157	14.53823	15.99736	15.49699	15.11041	0	15.9655	13.01754	15.96252	16.80741	16.42824	13.96982	0	16.97092	14.07613	0	16.51597	16.64491	16.94003	15.90546	14.84889	15.79497	15.85233	15.1427	16.06611	15.33673	16.1678	0	16.58456	15.66749	15.55834	17.36288	14.61266	17.28754	16.45951	16.30797	0
Q8IWC1	MA7D3_HUMAN	MAP7 domain-containing protein 3	MAP7D3 MDP3	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]	cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]	cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]	microtubule binding [GO:0008017]; tubulin binding [GO:0015631]	GO:0000226; GO:0005737; GO:0005819; GO:0008017; GO:0015630; GO:0015631; GO:0016020; GO:0046785	HMIYEESGNK	1.720000029	0.196203887	0.196203887	0.185026988	1211.227023	11.72544	11.73984	0	0	10.29301	12.71147	0	0	0	11.32157	14.39102	0	0	0	0	0	0	0	0	0	0	0	15.29846	16.09597	14.21856	13.50294	0	0	15.11517	13.37128	0	0	0	0	0	0	0	0	0	0	0	0	13.89468	0	0	0	0	0
Q8IWE2	NXP20_HUMAN	Protein NOXP20 (Nervous system overexpressed protein 20) (Protein FAM114A1)	FAM114A1 NOXP20	Homo sapiens (Human)		cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005794; GO:0005829	MLTELLFELHVAATPDKLNK	10.89999962	1	1	0.146515139	2300.000356	14.97803	17.86225	16.18891	0	17.78773	0	17.18882	0	17.00426	0	14.6479	0	0	0	0	15.87982	0	19.11349	0	17.73998	0	0	15.16152	0	0	0	0	17.6535	17.96155	0	0	0	0	0	0	16.42408	17.79664	0	0	0	0	0	0	0	0	18.73037	0	19.69622
Q8IWE5	PKHM2_HUMAN	"Pleckstrin homology domain-containing family M member 2, PH domain-containing family M member 2 (Salmonella-induced filaments A and kinesin-interacting protein, SifA and kinesin-interacting protein)"	PLEKHM2 KIAA0842 SKIP	Homo sapiens (Human)	Golgi organization [GO:0007030]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880]	endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]	endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; kinesin binding [GO:0019894]; Golgi organization [GO:0007030]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880]	kinesin binding [GO:0019894]	GO:0005765; GO:0007030; GO:0010008; GO:0019894; GO:0032418; GO:0032880; GO:0042267; GO:1903527	EEAQALDPPDACTELEVIR	2.74000001	1	1	2.75E-12	2155.506184	0	15.26215	10.70192	0	14.87642	0	13.35387	0	11.86952	11.10282	11.09803	12.76144	11.94513	0	0	11.56732	0	0	0	0	0	0	0	0	15.47025	0	14.17074	0	0	0	0	0	0	0	0	0	14.11044	15.31598	0	15.26375	0	0	0	13.83188	13.47992	0	0	12.59693
Q8IWF9	CCD83_HUMAN	Coiled-coil domain-containing protein 83	CCDC83 HSD9	Homo sapiens (Human)						EENSGTEFGDTDMK	5.5	1	1	0.433592997	1560.733716	0	15.95797	0	14.33604	0	0	0	0	0	0	0	16.37451	15.16778	15.39713	16.00436	0	0	0	0	15.95044	0	0	0	0	0	16.91522	16.98165	0	0	15.07652	17.21869	16.5103	16.33463	0	0	17.55115	0	0	17.81601	16.75246	0	17.04103	17.47783	0	18.29283	16.92426	0	17.06338
Q8IWG1	DNAI3_HUMAN	Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63)	DNAI3 WDR63	Homo sapiens (Human)	cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669]	axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]	axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669]	Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]	GO:0005737; GO:0005858; GO:0007018; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933	FFVGTEEGEVIYTDWKMEK	7.039999962	1	1	4.12E-12	2323.390856	15.41168	12.9311	0	10.59813	13.38659	12.83969	0	12.93477	0	12.63377	0	14.54699	16.76455	13.72447	12.04425	15.06409	14.2231	14.70482	12.43511	13.97045	0	0	9.391733	0	0	0	0	0	0	0	0	0	0	0	0	0	16.10855	0	0	0	0	11.67004	0	0	0	0	0	0
Q8IWI9	MGAP_HUMAN	MAX gene-associated protein (MAX dimerization protein 5)	MGA KIAA0518 MAD5	Homo sapiens (Human)	cell fate specification [GO:0001708]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell fate specification [GO:0001708]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0005654; GO:0006357; GO:0046983; GO:0071339	AFSEIQGLTDQADK	4.510000229	0.618424535	0.618424535	0.12476369	1518.780686	12.90709	15.65947	16.21163	0	17.61941	16.43249	0	0	15.64813	12.49319	14.57185	14.88318	14.24184	0	15.64493	12.55138	19.15369	14.34152	12.46382	16.07979	0	16.52691	10.86561	14.98966	15.41731	14.95477	14.58091	17.12892	15.85872	12.91869	14.21326	0	14.2084	13.25536	15.91138	15.06793	17.34577	0	14.94065	0	15.96259	0	13.52653	0	15.95416	15.47206	0	13.69637
Q8IWJ2	GCC2_HUMAN	"GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein, GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4, RanBP2L4) (Renal carcinoma antigen NY-REN-53)"	GCC2 KIAA0336 RANBP2L4	Homo sapiens (Human)	"Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]"	identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]	GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0016020; GO:0031023; GO:0031267; GO:0034067; GO:0034453; GO:0034499; GO:0042147; GO:0042802; GO:0070861; GO:0071955; GO:0090161	DQLSASMR	21.94000053	0.413854986	0.413854986	0.163220123	922.6440328	18.6907	20.54091	19.28699	19.47714	0	18.75418	19.00074	20.18049	20.21017	19.37689	20.2829	19.50648	19.29325	18.10639	19.39669	20.2499	16.42558	18.06045	16.69028	20.53484	18.46813	17.59347	19.55547	20.20307	18.83865	15.83289	19.12701	19.61588	17.44764	17.81702	10.64862	15.81276	0	19.91334	20.24982	19.12989	19.63742	15.61022	19.05559	18.7662	16.63849	16.95416	19.32585	15.45129	18.89076	19.44088	19.74767	17.88284
Q8IWN7	RP1L1_HUMAN	Retinitis pigmentosa 1-like 1 protein	RP1L1	Homo sapiens (Human)	axoneme assembly [GO:0035082]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	axoneme [GO:0005930]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]	axoneme [GO:0005930]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; axoneme assembly [GO:0035082]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]		GO:0001750; GO:0005874; GO:0005930; GO:0007601; GO:0032391; GO:0035082; GO:0035556; GO:0042461; GO:0045494; GO:0060041	EAPGTSSSR	7.909999847	0.325853348	0.325853348	0.183340695	891.8456339	0	16.20154	10.16829	13.3435	19.42758	13.52253	15.29258	12.93015	15.47852	15.29182	17.5729	17.33485	0	0	16.08454	15.26572	14.24447	14.095	0	17.51664	11.51799	15.55787	15.85612	17.84342	13.29528	14.36679	0	16.09103	0	14.52281	15.24691	17.43106	17.7665	15.76624	15.53936	0	16.11537	16.56701	17.50976	0	0	13.77027	0	0	17.54806	15.91279	0	15.85311
Q8IWQ3	BRSK2_HUMAN	"Serine/threonine-protein kinase BRSK2, EC 2.7.11.1 (Brain-selective kinase 2, EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2, BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A)"	BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12	Homo sapiens (Human)	"actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]"	ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000086; GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0018105; GO:0019901; GO:0030010; GO:0030182; GO:0031532; GO:0035556; GO:0036503; GO:0042149; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807	DKPLSSIK	8.569999695	1	1	0.081084596	886.1077585	0	0	0	0	0	0	0	0	14.71074	0	0	0	0	14.10394	0	0	0	0	13.47481	0	14.43513	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.87529	0	0	0	0	0	0	0	0	0	0
Q8IWR0	Z3H7A_HUMAN	Zinc finger CCCH domain-containing protein 7A	ZC3H7A ZC3H7 ZC3HDC7 HSPC055	Homo sapiens (Human)	posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]	nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]	metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0010608; GO:0035196; GO:0035198; GO:0046872	DLSTSTSR	4.079999924	1	1	0.115397278	866.9594984	0	0	0	0	14.72671	0	15.42092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.67765	0	17.22134	15.51606	0	0	16.5714	0	0	0	0	0	16.86946	16.6807	0	0	0	0	0	0	0	0
Q8IWS0	PHF6_HUMAN	PHD finger protein 6 (PHD-like zinc finger protein)	PHF6 CENP-31 KIAA1823	Homo sapiens (Human)	blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tubulin binding [GO:0015631]; blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tubulin binding [GO:0015631]	GO:0000122; GO:0000776; GO:0001835; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0015631; GO:0019899; GO:0042393; GO:0042826; GO:0043021; GO:0046872; GO:0051219; GO:0097110	TYHYHCGVQDK	7.179999828	1	1	0.431705697	1405.267707	16.82807	15.66851	14.14075	0	0	0	0	0	0	0	0	0	16.62551	14.66335	0	0	12.58195	0	0	16.02386	0	0	0	15.21597	16.13513	15.60232	0	16.204	15.93101	0	12.93034	13.18146	0	0	15.60865	13.54475	0	0	0	0	12.88761	0	0	0	0	0	15.92945	0
Q8IWT3	CUL9_HUMAN	"Cullin-9, CUL-9 (UbcH7-associated protein 1) (p53-associated parkin-like cytoplasmic protein)"	CUL9 H7AP1 KIAA0708 PARC	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]	cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]	GO:0000226; GO:0005524; GO:0005829; GO:0006511; GO:0007088; GO:0016567; GO:0016740; GO:0031461; GO:0031625; GO:0046872	CNHGFCWR	1.75	1	1	2.31E-13	1137.400183	14.80681	17.05095	18.3315	16.61422	15.65743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IWT6	LRC8A_HUMAN	"Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A, HsLRRC8A) (Swelling protein 1)"	LRRC8A KIAA1437 LRRC8 SWELL1 UNQ221/PRO247	Homo sapiens (Human)	anion transmembrane transport [GO:0098656]; anion transport [GO:0006820]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular glucose homeostasis [GO:0001678]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transport [GO:0015734]	cell surface [GO:0009986]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; anion transport [GO:0006820]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular glucose homeostasis [GO:0001678]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transport [GO:0015734]	cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]	GO:0001678; GO:0002329; GO:0005225; GO:0005886; GO:0005887; GO:0006820; GO:0006884; GO:0006970; GO:0007283; GO:0009986; GO:0015734; GO:0015810; GO:0016020; GO:0016021; GO:0032024; GO:0034214; GO:0034702; GO:0042802; GO:0045663; GO:0098656; GO:0140360; GO:0140361; GO:1902476; GO:1905103	ALHLGNNVLQSLPSR	6.210000038	0.003921647	0.003921647	0.419184443	1617.954059	0	19.43821	16.86327	17.25839	16.1252	0	16.76196	15.43109	16.65359	0	13.78251	15.618	0	16.25145	0	15.05901	0	0	0	0	15.19479	15.36426	14.82646	0	0	0	18.12019	0	0	16.83935	0	0	0	17.11856	18.15696	0	15.59204	17.08024	15.42145	16.80795	18.16003	0	17.39358	0	16.50351	0	16.32673	16.50191
Q8IWU2	LMTK2_HUMAN	"Serine/threonine-protein kinase LMTK2, EC 2.7.11.1 (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase, hBREK) (CDK5/p35-regulated kinase, CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2)"	LMTK2 AATYK2 BREK KIAA1079 KPI2 LMR2	Homo sapiens (Human)	axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]	cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001881; GO:0004674; GO:0004712; GO:0004864; GO:0005524; GO:0005769; GO:0005794; GO:0005829; GO:0005887; GO:0006468; GO:0007169; GO:0007409; GO:0016021; GO:0018105; GO:0018107; GO:0030426; GO:0032456; GO:0033572; GO:0033674; GO:0043025; GO:0043235; GO:0045022; GO:0046777; GO:0048471; GO:0055037; GO:0070853; GO:0106310	MPGPPALR	9.090000153	0.366959244	0.366959244	0.186892587	855.8099008	17.12122	15.97006	0	0	15.38312	0	0	15.80314	15.7888	0	16.733	16.41463	15.58212	16.83453	16.74247	0	17.61625	14.22071	0	0	0	0	17.16566	15.90579	17.60258	11.71756	9.349394	16.71121	16.57315	0	15.80816	0	0	16.51501	17.97737	16.65019	0	15.55265	11.39832	15.32427	16.67497	17.02449	15.63811	15.8622	0	16.4316	17.38922	0
Q8IWU5	SULF2_HUMAN	"Extracellular sulfatase Sulf-2, hSulf-2, EC 3.1.6.-"	SULF2 KIAA1247 UNQ559/PRO1120	Homo sapiens (Human)	bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]	arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]	GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384	LSLAGRR	13.23999977	0.066551328	0.066551328	0.143605857	772.4226265	16.00722	15.37938	15.55687	14.4362	0	15.17175	14.15084	0	0	14.21033	15.31168	16.36583	21.21947	16.16093	17.32104	0	17.39765	16.86801	17.3039	17.29291	16.48296	15.89475	0	0	0	0	16.864	16.28997	22.64449	15.43729	14.34685	21.19089	0	17.70458	0	0	15.34351	0	0	0	17.20763	0	23.01636	0	0	16.23072	0	0
Q8IWU6	SULF1_HUMAN	"Extracellular sulfatase Sulf-1, hSulf-1, EC 3.1.6.-"	SULF1 KIAA1077	Homo sapiens (Human)	apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]	GO:0001822; GO:0001937; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005794; GO:0005795; GO:0005886; GO:0006915; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0032836; GO:0035860; GO:0040036; GO:0040037; GO:0045121; GO:0048010; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686	EKHGFDYAK	3.440000057	1	1	0.215674221	1095.067649	14.49807	0	14.95472	14.84818	14.03339	14.4572	0	14.92835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.55077	0	0	0	15.19247	0	13.55934	0	0	0	0	0	15.9299	0	13.94099	0	15.56786	14.83168	0	0	0
Q8IWU9	TPH2_HUMAN	"Tryptophan 5-hydroxylase 2, EC 1.14.16.4 (Neuronal tryptophan hydroxylase) (Tryptophan 5-monooxygenase 2)"	TPH2 NTPH	Homo sapiens (Human)	aromatic amino acid family metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427]	cytosol [GO:0005829]; neuron projection [GO:0043005]	cytosol [GO:0005829]; neuron projection [GO:0043005]; iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]; aromatic amino acid family metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427]	iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]	GO:0004510; GO:0005506; GO:0005829; GO:0007623; GO:0009072; GO:0014823; GO:0031667; GO:0042427; GO:0043005; GO:0043627; GO:0051384; GO:0051592; GO:0071285	HALSDK	4.78000021	1	1	0.205145443	671.4642963	15.95913	14.89611	14.0245	15.2841	15.76956	0	0	14.99812	0	0	13.72026	14.26091	15.50535	15.56235	0	16.33397	15.63558	16.56925	0	15.53241	0	17.41713	0	16.02958	16.57528	16.68729	0	0	16.36164	16.19192	14.50112	14.55217	16.57403	0	15.39314	0	16.01093	16.16471	17.44212	0	0	16.13463	16.90415	0	16.93216	16.65335	15.40977	0
Q8IWV1	LAX1_HUMAN	Lymphocyte transmembrane adapter 1 (Linker for activation of X cells) (Membrane-associated adapter protein LAX)	LAX1 LAX	Homo sapiens (Human)	adaptive immune response [GO:0002250]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell activation [GO:0042113]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; lymphocyte activation [GO:0046649]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of T cell activation [GO:0050868]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; adaptive immune response [GO:0002250]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell activation [GO:0042113]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; lymphocyte activation [GO:0046649]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of T cell activation [GO:0050868]	protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]	GO:0002250; GO:0005794; GO:0005829; GO:0005886; GO:0006955; GO:0016020; GO:0016021; GO:0019901; GO:0035556; GO:0042113; GO:0042169; GO:0043407; GO:0046649; GO:0050851; GO:0050868	QEDLGR	4.289999962	1	1	1.03E-12	715.4289075	0	0	13.97128	0	15.4363	0	16.02685	0	0	0	0	0	0	14.57026	0	14.12615	0	0	0	0	0	0	0	13.82897	0	0	15.97182	0	17.31175	0	0	0	16.22003	0	0	16.23024	15.79081	0	0	0	15.87111	16.5621	0	0	0	0	0	0
Q8IWV7	UBR1_HUMAN	"E3 ubiquitin-protein ligase UBR1, EC 2.3.2.27 (N-recognin-1) (RING-type E3 ubiquitin transferase UBR1) (Ubiquitin-protein ligase E3-alpha-1) (Ubiquitin-protein ligase E3-alpha-I)"	UBR1	Homo sapiens (Human)	cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000502; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0032007; GO:0061630; GO:0070728; GO:0071233; GO:0071596	CLVLVAQVVAEMWRR	13.17000008	1	1	0.111610688	1846.174014	0	0	0	0	0	15.07189	15.08689	13.6828	16.33415	16.8204	0	15.99729	16.51625	0	17.13309	16.96772	15.86355	15.96362	0	0	16.20711	17.42214	17.59669	17.39816	19.03789	16.15924	0	12.83953	16.27217	17.09673	13.82364	15.53987	15.19856	18.35597	0	0	17.53763	14.09194	0	0	16.05018	17.87372	0	0	0	0	16.65406	19.13649
Q8IWV8	UBR2_HUMAN	"E3 ubiquitin-protein ligase UBR2, EC 2.3.2.27 (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)"	UBR2 C6orf133 KIAA0349	Homo sapiens (Human)	cellular response to leucine [GO:0071233]; heterochromatin assembly [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; heterochromatin assembly [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]	leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0031507; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596	GPNPFPQK	1.909999967	0.780125737	0.780125737	0.20780334	883.5367831	0	15.00134	14.49158	13.96996	14.28511	14.52412	15.49286	0	12.32566	0	15.09956	0	16.41111	14.68419	14.87461	16.17425	0	14.11174	0	17.45646	15.42943	14.93004	0	0	0	14.71837	19.34715	0	0	0	18.29015	16.99145	16.26019	15.63797	0	0	0	15.88579	0	16.12113	0	15.76488	15.13309	0	16.23466	0	0	15.17604
Q8IWW6	RHG12_HUMAN	Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12)	ARHGAP12	Homo sapiens (Human)	"actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]	"cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]"	GTPase activator activity [GO:0005096]	GO:0001891; GO:0002011; GO:0005096; GO:0005737; GO:0006911; GO:0007015; GO:0007165; GO:0043087; GO:0051058	ALMPPVKQVAGLPNNSTK	4.010000229	0.000616866	0.000616866	0.173204419	1881.224737	15.44026	14.78184	17.24544	0	14.24045	12.86541	14.94401	16.11463	15.44022	16.35586	0	14.51314	0	13.6054	14.69826	12.60257	9.813562	15.71608	17.01157	0	14.95976	14.65648	15.58994	15.32095	0	18.43744	0	0	16.21538	17.55587	16.64806	18.39242	16.39049	0	12.67717	17.6816	0	15.91688	15.57063	11.32515	14.76756	10.43545	16.89319	14.76158	14.03361	15.80184	0	12.73632
Q8IWW8	HOT_HUMAN	"Hydroxyacid-oxoacid transhydrogenase, mitochondrial, HOT, EC 1.1.99.24 (Alcohol dehydrogenase iron-containing protein 1, ADHFe1) (Fe-containing alcohol dehydrogenase)"	ADHFE1 HMFT2263	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]; lipid metabolic process [GO:0006629]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; 2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]; lipid metabolic process [GO:0006629]	alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]	GO:0004022; GO:0005739; GO:0005759; GO:0006103; GO:0006539; GO:0006629; GO:0046872; GO:0047988	NVCLMTDK	2.210000038	0.183746785	0.183746785	0.252301409	996.2543506	16.64228	11.77066	14.82553	13.02775	14.7423	0	0	0	14.99586	18.03303	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97106	15.22389	15.53057	0	0	0	0	15.15806	0	0	0	0	16.55084	0	0	16.43667	0	16.94772	0	0	15.81769	0	15.7795
Q8IWX7	UN45B_HUMAN	"Protein unc-45 homolog B, Unc-45B (SMUNC45)"	UNC45B CMYA4 UNC45	Homo sapiens (Human)	cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]	cytosol [GO:0005829]	cytosol [GO:0005829]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]	Hsp90 protein binding [GO:0051879]	GO:0002088; GO:0005829; GO:0007517; GO:0030154; GO:0051879; GO:0061077	KWLCNMSIDTR	2.349999905	1	1	0.166534095	1440.38509	0	0	16.05995	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97901	0	0	0	0	0	0	0	0	0	15.1813	17.14793	0	0	13.6789	0	16.01017	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IWY9	CDAN1_HUMAN	Codanin-1	CDAN1 UNQ664/PRO1295	Homo sapiens (Human)	chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; protein localization [GO:0008104]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; protein localization [GO:0008104]		GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0008104; GO:0008156; GO:0012505; GO:0016021; GO:0031497	SLSKPK	2.190000057	1	1	0.013304745	659.5559445	0	0	0	0	0	0	0	0	0	0	0	13.3425	0	14.58696	0	16.28293	0	0	0	0	0	14.80637	0	0	15	0	0	0	0	0	0	0	15.95626	0	0	13.84458	0	0	0	0	16.07622	15.95923	14.6801	0	0	0	0	0
Q8IWZ3	ANKH1_HUMAN	"Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain, hMASK)"	ANKHD1 KIAA1085 MASK VBARP PP2500	Homo sapiens (Human)	innate immune response [GO:0045087]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0045087	DQQAAEANKNASILLK	2.049999952	1	1	0.252433226	1713.797293	15.1837	0	0	0	14.14245	0	0	0	14.35078	12.04098	0	14.18345	12.71679	0	0	0	0	0	0	0	0	0	0	0	0	16.27037	0	0	0	14.70279	14.30744	0	0	0	0	0	12.00025	0	0	0	0	0	0	0	0	0	0	0
Q8IWZ8	SUGP1_HUMAN	SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4)	SUGP1 SF4	Homo sapiens (Human)	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380	MEMDKTR	5.800000191	1	1	0.091897685	927.1254071	16.92826	0	14.66237	15.08129	14.59015	0	15.78674	16.27293	15.59406	14.85547	15.34438	0	14.75998	0	0	0	0	0	0	0	0	0	0	0	0	13.3731	0	15.76841	17.04335	0	0	0	0	0	15.4109	0	0	0	0	0	0	0	16.19967	17.22838	0	0	0	0
Q8IX01	SUGP2_HUMAN	"SURP and G-patch domain-containing protein 2 (Arginine/serine-rich-splicing factor 14) (Splicing factor, arginine/serine-rich 14)"	SUGP2 KIAA0365 SFRS14	Homo sapiens (Human)	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0006397; GO:0008380; GO:0016604	AMLYSR	17.95000076	1	1	2.29E-13	755.3407485	0	0	0	16.20692	0	0	0	0	14.06877	0	0	13.289	14.55404	15.85109	14.69818	0	0	0	0	14.43563	0	0	0	16.2643	12.646	15.66902	0	0	0	0	0	17.42797	0	14.8292	0	0	0	0	16.13288	0	0	15.64169	0	0	0	0	14.56581	0
Q8IX03	KIBRA_HUMAN	"Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein, KIBRA) (WW domain-containing protein 1)"	WWC1 KIAA0869	Homo sapiens (Human)	"cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; transcription coactivator activity [GO:0003713]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386]; regulation of transcription, DNA-templated [GO:0006355]"	kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0032991; GO:0035330; GO:0035331; GO:0043410; GO:0046621; GO:0048471; GO:0060090	EELLKEMR	3.579999924	1	1	0.205867526	1067.437034	14.67167	15.18246	0	0	15.69005	0	15.55664	14.5125	13.72817	0	14.30301	13.79825	16.20743	15.01446	0	15.37931	16.09569	15.76019	15.05857	15.56216	0	11.58274	14.67833	13.51245	0	14.89264	0	15.29533	14.86783	0	0	16.11968	0	0	16.14008	0	15.20136	0	18.2424	16.00185	0	0	15.88868	16.11333	0	0	0	0
Q8IX06	GOR_HUMAN	"Putative exonuclease GOR, EC 3.1.-.- (Antigen GOR homolog) (RNA exonuclease 1 homolog-like 1)"	REXO1L1P GOR REXO1L1	Homo sapiens (Human)		cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004527; GO:0005634; GO:0005737	GSKVGR	12.82999992	1	1	0.093932771	602.4682516	17.17768	15.69936	17.80781	16.20473	17.4666	16.83053	17.16739	15.65947	17.47085	16.43879	16.99246	16.64928	16.52993	15.24851	16.90436	16.7456	17.34244	17.80282	17.3868	17.36307	17.19746	16.87284	16.47988	16.41432	17.60886	15.26532	16.96141	16.77265	16.90421	16.51648	17.47952	17.63677	17.40188	0	16.98374	18.246	17.43227	14.79296	16.33056	17.62461	18.13021	16.27514	17.28188	15.77026	16.24715	18.17533	17.73018	18.59078
Q8IX15	HOMEZ_HUMAN	Homeobox and leucine zipper protein Homez (Homeodomain leucine zipper-containing factor)	HOMEZ KIAA1443	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]"	GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357	HNSVPGRVGPTEYLSPDMQR	4.699999809	1	1	4.61E-13	2255.57001	0	0	0	0	0	0	0	0	0	11.21022	15.92723	0	0	11.53032	13.45659	0	0	0	0	0	0	0	0	0	0	0	0	11.15446	0	13.28976	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IX21	SLF2_HUMAN	SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1)	SLF2 C10orf6 FAM178A	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]"	protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]	GO:0000724; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0006974; GO:0016925; GO:0030915; GO:0031334; GO:0031625; GO:0032204; GO:0034184; GO:0035861; GO:0043231; GO:0044877; GO:1990166; GO:2000781	RPDGPHQK	9.159999847	1	1	0.20183905	933.8977226	0	0	0	0	0	0	14.65975	16.22973	15.95379	0	0	0	15.92016	15.74346	0	12.68219	12.12574	15.90778	0	16.17911	13.84382	0	0	0	14.27824	16.12227	0	0	14.85644	0	0	0	0	0	0	0	0	0	14.65152	15.48863	0	0	0	15.65347	0	0	0	13.568
Q8IX29	FBX16_HUMAN	F-box only protein 16	FBXO16 FBX16	Homo sapiens (Human)						MAFAPPKNTDGPK	10.48999977	0.299701869	0.299701869	0.183205836	1388.834441	15.94628	0	12.13238	0	0	0	0	0	14.78611	0	0	14.83891	14.68256	0	14.54739	0	0	0	0	0	17.40814	0	0	0	0	0	0	0	0	0	0	0	0	17.11833	0	0	0	0	0	0	0	0	0	0	0	0	0	16.36141
Q8IX30	SCUB3_HUMAN	"Signal peptide, CUB and EGF-like domain-containing protein 3"	SCUBE3 CEGF3	Homo sapiens (Human)	positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165]	cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165]	BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]	GO:0005509; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0030513; GO:0036122; GO:0042802; GO:0045669; GO:0070700	AEPMESCRPGQHR	1.350000024	1	1	0.261346469	1555.465488	14.21148	14.69479	0	0	0	13.60046	0	0	15.49878	0	14.79824	0	0	0	0	15.01988	0	15.88761	0	0	0	0	16.67737	0	0	14.72776	0	15.56585	0	13.65016	14.31868	13.08912	0	0	0	14.58904	0	0	12.6792	0	0	0	14.52944	16.69422	14.99743	14.15478	13.23416	14.54316
Q8IX94	CTGE4_HUMAN	"cTAGE family member 4, Protein cTAGE-4"	CTAGE4	Homo sapiens (Human)	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]		GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971	MTSLDK	15.18999958	0.539557099	0.539557099	0.260656353	693.7920532	0	18.10361	16.65041	15.82683	16.46612	16.91569	0	18.46214	17.04218	0	0	16.77824	17.21018	16.67676	0	15.78747	0	16.84789	18.81589	0	16.63954	17.85742	0	0	0	16.06006	17.51988	0	15.8907	16.31746	12.79957	0	0	16.54958	16.21846	0	0	16.91477	0	0	0	0	18.335	0	0	16.34962	17.98737	0
Q8IXB1	DJC10_HUMAN	"DnaJ homolog subfamily C member 10, EC 1.8.4.- (Endoplasmic reticulum DNA J domain-containing protein 5, ER-resident protein ERdj5, ERdj5) (Macrothioredoxin, MTHr)"	DNAJC10 ERDJ5 UNQ495/PRO1012	Homo sapiens (Human)	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase activity [GO:0015035]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]"	"ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase activity [GO:0015035]"	GO:0001671; GO:0001933; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0051087; GO:0051117; GO:0051787; GO:0070059	DDYIRDLK	16.19000053	1	1	0.553757254	1036.993126	22.47825	0	0	0	0	18.77416	0	0	18.24224	0	0	0	0	20.67164	0	0	0	0	20.19276	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.70252	0	0	0	0	0	0	0	19.506	0	0	0	0
Q8IXF0	NPAS3_HUMAN	"Neuronal PAS domain-containing protein 3, Neuronal PAS3 (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12, bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6)"	NPAS3 BHLHE12 MOP6 PASD6	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982	DSDSAGEAGAQASSK	5.480000019	1	1	0.281403797	1379.301146	12.74281	11.43402	15.68914	14.9815	12.41616	0	10.78084	0	0	0	15.05573	14.86182	0	0	0	13.57036	13.98228	0	13.33597	14.3734	14.6221	13.64668	15.25501	13.80936	0	15.48964	0	0	0	0	0	16.1545	0	0	0	0	0	0	0	15.95648	0	0	0	0	0	15.96282	15.85063	0
Q8IXH7	NELFD_HUMAN	"Negative elongation factor C/D, NELF-C/D (TH1-like protein)"	NELFCD NELFD TH1 TH1L HSPC130	Homo sapiens (Human)	negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]	membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]	membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0016020; GO:0032021; GO:0034244	YIHILAYAASVVETWK	4.21999979	0.823179305	0.823179305	0.28433949	1865.991384	0	0	0	15.75148	14.25793	0	14.46962	14.63375	13.93819	0	14.71737	13.70215	0	14.90379	14.10655	13.78474	13.98966	14.87602	12.8455	0	0	0	0	14.43443	9.502902	0	0	0	0	0	0	16.1843	0	0	0	0	0	0	0	0	14.33327	0	0	0	0	0	12.29372	0
Q8IXH8	CAD26_HUMAN	Cadherin-like protein 26 (Cadherin-like protein VR20)	CDH26	Homo sapiens (Human)	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]"	catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	"catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]"	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178]	GO:0005178; GO:0005509; GO:0005886; GO:0007156; GO:0008013; GO:0015630; GO:0016021; GO:0016342; GO:0035710; GO:0045294; GO:0045296; GO:0070097; GO:0098742	MAMRSGR	6.650000095	1	1	0.032812652	841.2446757	0	0	8.708381	0	0	0	0	0	0	15.17805	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.89086	0	0	0	0	0	14.48674	16.56864	11.37627	11.59389	13.24671	0	0	0	15.20169	0	0	0	0	14.43483	0	0	0
Q8IXI1	MIRO2_HUMAN	"Mitochondrial Rho GTPase 2, MIRO-2, hMiro-2, EC 3.6.5.- (Ras homolog gene family member T2)"	RHOT2 ARHT2 C16orf39	Homo sapiens (Human)	cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264]	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264]	calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0007264; GO:0010821; GO:0016020; GO:0019725; GO:0031307; GO:0047497; GO:0097345	GLLGVVGAAVAAVLSFSLYR	1.779999971	1	1	0.178489003	1961.68683	16.07063	13.2525	11.97564	0	0	0	14.98537	0	0	0	15.59012	0	0	0	0	0	0	0	0	0	13.12248	0	0	0	0	0	0	0	0	0	0	0	0	0	15.00844	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IXI2	MIRO1_HUMAN	"Mitochondrial Rho GTPase 1, MIRO-1, hMiro-1, EC 3.6.5.- (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1)"	RHOT1 ARHT1	Homo sapiens (Human)	cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264]	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264]	calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0007264; GO:0010821; GO:0016020; GO:0019725; GO:0031307; GO:0047497; GO:0097345	ILLVGEPR	2.839999914	1	1	0.236040861	897.0734317	0	14.58606	0	0	0	0	0	0	0	15.30577	0	0	0	14.88164	0	0	0	0	16.14824	15.46753	0	15.88051	0	0	0	0	0	0	15.06492	0	13.70368	13.98033	13.97316	14.06358	0	16.54045	14.07979	0	0	16.00456	14.88325	16.56331	0	0	0	16.42106	0	14.84447
Q8IXK0	PHC2_HUMAN	"Polyhomeotic-like protein 2, hPH2 (Early development regulatory protein 2)"	PHC2 EDR2 PH2	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0008270; GO:0031519; GO:0035102; GO:0042393; GO:0042802; GO:0045892	EEGAPLKLK	4.639999866	1	1	0.122531409	985.5691682	13.87877	15.08297	14.62183	0	13.30041	15.85872	0	0	0	0	0	0	13.33274	0	0	0	0	14.40042	0	0	0	16.16768	0	0	15.20276	0	0	0	16.93529	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.56255	0	0	0	0
Q8IXK2	GLT12_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 12, EC 2.4.1.41 (Polypeptide GalNAc transferase 12, GalNAc-T12, pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12)"	GALNT12	Homo sapiens (Human)	O-glycan processing [GO:0016266]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0016266; GO:0030246; GO:0046872	EALLVLLALLALAGLGSVLRAQR	4.25	1	1	0.125630632	2360.29162	0	0	14.81653	0	0	0	0	11.7515	12.86451	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.71768	0	0	14.9839	0	0	0	0	0	0	12.35985	14.46668	0	11.52974	0	0	0	13.91335	0	16.35768	13.9492	0	0	15.89415
Q8IXM2	BAP18_HUMAN	Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa)	BAP18 C17orf49	Homo sapiens (Human)	chromatin organization [GO:0006325]	cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]	cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; chromatin organization [GO:0006325]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]	GO:0003677; GO:0005654; GO:0005829; GO:0006325; GO:0016589; GO:0042802; GO:0071339	MTSASTKVGEIFSAAGAAFTK	6.679999828	1	1	0.253338833	2091.720111	0	13.88657	14.83355	13.57793	16.25468	14.85571	14.23896	14.49853	0	14.92695	13.23815	15.50575	0	14.68632	0	0	0	0	0	0	0	0	15.65945	12.97533	0	11.79479	0	0	0	0	0	0	0	15.59946	0	0	10.11269	0	0	0	0	10.99591	13.10021	0	0	0	0	0
Q8IXM3	RM41_HUMAN	"39S ribosomal protein L41, mitochondrial, L41mt, MRP-L41 (39S ribosomal protein L27 homolog) (Bcl-2-interacting mitochondrial ribosomal protein L41) (Cell proliferation-inducing gene 3 protein) (MRP-L27 homolog) (Mitochondrial large ribosomal subunit protein mL41)"	MRPL41 BMRP MRPL27 RPML27 PIG3	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0006915; GO:0007049; GO:0032543; GO:1990904	GIGFLTSGWR	8.529999733	0.151917517	0.151917517	0.441272442	1093.603555	17.67553	16.82862	17.61135	0	0	0	17.62276	15.87046	15.87433	17.64161	16.85358	0	16.29965	16.52178	0	16.69259	16.55036	17.02467	17.64527	0	0	17.02539	0	18.08013	0	17.2898	16.66125	0	16.78482	0	0	18.14634	0	0	0	0	0	17.16622	0	17.01417	17.11038	16.4847	16.46406	17.05049	0	0	16.70694	0
Q8IXM7	OD3L1_HUMAN	Outer dense fiber protein 3-like protein 1	ODF3L1	Homo sapiens (Human)		cytoskeleton [GO:0005856]	cytoskeleton [GO:0005856]		GO:0005856	GPGPAK	3.349999905	0.621449947	0.621449947	0.290209484	526.8138034	0	13.10724	16.58728	0	0	0	0	0	16.10199	15.9587	0	0	16.45412	15.52308	0	0	15.55207	0	0	14.4331	16.47249	0	0	16.46811	0	17.51852	0	15.81895	16.66984	0	0	14.989	0	17.02758	18.00386	15.53991	16.40745	13.66012	0	14.08786	16.58862	15.76145	0	13.98857	17.07267	15.20394	16.4172	16.26152
Q8IXN7	RIMKA_HUMAN	"N-acetylaspartylglutamate synthase A, NAAG synthetase A, NAAGS, EC 6.3.2.41 (N-acetylaspartylglutamylglutamate synthase A, EC 6.3.2.42) (Ribosomal protein S6 modification-like protein A)"	RIMKLA FAM80A	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; glutamine family amino acid metabolic process [GO:0009064]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; metal ion binding [GO:0046872]; N-acetyl-L-aspartate-L-glutamate ligase activity [GO:0072590]; cellular protein modification process [GO:0006464]; glutamine family amino acid metabolic process [GO:0009064]"	"ATP binding [GO:0005524]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; metal ion binding [GO:0046872]; N-acetyl-L-aspartate-L-glutamate ligase activity [GO:0072590]"	GO:0005524; GO:0005737; GO:0005829; GO:0006464; GO:0009064; GO:0016879; GO:0046872; GO:0072590	IASELK	12.25	1	1	0.277813904	658.7919732	14.63027	0	15.39657	15.71438	15.5999	16.03074	0	16.42299	14.86433	16.00656	15.21982	14.01114	0	16.80469	0	0	0	14.90199	0	14.71017	17.96614	0	15.78317	15.55175	0	16.474	0	15.78991	0	15.11428	16.13143	15.29632	15.83076	0	15.45034	15.86269	0	16.73362	0	15.85088	15.58179	14.46119	15.75461	0	0	0	15.35218	0
Q8IXQ5	KLHL7_HUMAN	Kelch-like protein 7	KLHL7	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein ubiquitination [GO:0016567]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0016567; GO:0031463; GO:0042802; GO:0042803; GO:0048471	EEAKLLAGFMGVMNNMR	9.470000267	1	1	0.117818525	1921.956565	0	17.47632	13.18183	0	15.39671	17.52423	0	17.94979	0	16.82269	12.92934	12.36704	15.04525	0	16.68525	0	0	0	0	15.63283	17.42763	0	0	18.35208	17.14404	15.10182	14.98746	16.12992	0	16.88853	15.39596	0	16.11242	0	0	0	0	16.94323	0	14.58822	0	14.60662	13.60307	0	15.40512	14.00103	16.9485	17.3697
Q8IXQ8	PDZD9_HUMAN	PDZ domain-containing protein 9	PDZD9 C16orf65	Homo sapiens (Human)						LQPGDVLISVGHANVLGYTLR	7.300000191	1	1	1.83E-12	2223.109339	0	12.77836	0	0	0	13.5919	0	0	0	13.98633	16.30296	0	15.28491	0	0	0	0	0	0	0	15.26799	0	16.0032	13.66846	13.18389	0	15.69804	0	0	0	0	0	18.92821	13.73477	0	0	0	16.307	0	0	0	0	0	0	15.03995	0	14.42033	0
Q8IXS2	DRC2_HUMAN	Dynein regulatory complex subunit 2 (Coiled-coil domain-containing protein 65) (Testis development protein NYD-SP28)	CCDC65 DRC2	Homo sapiens (Human)	axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352]		GO:0003352; GO:0005858; GO:0005930; GO:0031514; GO:0036064; GO:0060271; GO:0060285; GO:0070286	DEKSSK	7.059999943	1	1	0.163347459	693.5654293	16.81948	16.88134	0	0	0	14.9584	14.77735	13.38872	15.50774	15.0121	16.7136	15.80173	0	14.98331	16.58309	16.98756	14.57918	16.00134	15.8539	16.27999	17.9178	0	13.8449	16.26481	16.56321	16.8761	16.37181	16.92719	16.97038	0	16.38949	16.75571	16.21238	18.20683	14.88066	14.88401	18.21173	18.70713	18.38032	17.63921	17.09701	15.38945	16.72365	16.85509	17.3554	16.89315	17.93453	17.51129
Q8IXS8	F126B_HUMAN	Protein FAM126B	FAM126B	Homo sapiens (Human)	phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]		GO:0005829; GO:0005886; GO:0046854; GO:0072659	ELLSPGAPLTK	9.090000153	0.238190427	0.238190427	0.212165182	1125.460984	14.39739	0	0	0	0	14.73049	14.95408	0	0	0	0	15.54975	13.97499	14.55822	0	0	0	0	14.85888	0	15.58789	0	0	0	14.84498	14.69059	10.7676	0	15.39284	0	0	14.88929	12.21188	14.73917	0	15.37633	14.14436	11.83286	11.63343	13.14395	14.62311	13.67785	13.60959	0	0	15.42999	0	15.10939
Q8IXT2	DMRTD_HUMAN	Doublesex- and mab-3-related transcription factor C2	DMRTC2	Homo sapiens (Human)	germ cell development [GO:0007281]; male meiosis I [GO:0007141]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; spermatid nucleus elongation [GO:0007290]	chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741]	"chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; spermatid nucleus elongation [GO:0007290]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001741; GO:0005634; GO:0006357; GO:0007141; GO:0007281; GO:0007290; GO:0007548; GO:0042802; GO:0046872; GO:1900111; GO:1900114; GO:1990837	APNHFR	1.370000005	0.455157638	0.455157638	0.09828528	741.9445672	13.95231	15.87855	16.77444	15.67734	14.50104	0	0	17.85354	14.28822	15.68328	0	16.77879	0	14.90831	0	14.31353	0	15.43012	0	14.3513	13.96091	17.22161	14.32157	0	0	13.37396	15.60546	16.50674	16.98691	15.51504	0	15.81559	12.33082	13.73321	14.51851	16.27622	17.16509	0	15.96911	0	17.50013	0	0	14.55871	0	14.37462	11.61253	14.29528
Q8IXT5	RB12B_HUMAN	RNA-binding protein 12B (RNA-binding motif protein 12B)	RBM12B	Homo sapiens (Human)	regulation of RNA splicing [GO:0043484]	nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; regulation of RNA splicing [GO:0043484]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0043484; GO:1990904	EAPEEDPR	4.380000114	1	1	0.180522169	943.4459232	15.03582	0	15.32024	11.43554	15.1771	14.14921	16.41401	16.27425	14.069	17.69688	0	15.71041	14.07984	0	14.39505	0	0	0	13.91062	0	0	0	0	0	14.77222	15.83264	0	16.27431	0	0	0	16.51511	0	0	15.94234	0	0	0	0	16.30616	17.5908	13.48696	0	0	0	0	0	0
Q8IXV7	KLD8B_HUMAN	Kelch domain-containing protein 8B	KLHDC8B FP17659	Homo sapiens (Human)	mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]	cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]	cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813]		GO:0005737; GO:0005829; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410	DGMVYALGGMGPDTAPQAQVR	4.099999905	1	1	2.75E-12	2133.626211	0	0	8.974174	0	16.51683	0	0	0	15.30968	0	0	0	0	0	0	0	13.16266	0	0	0	0	0	0	14.1979	0	14.42566	0	0	0	0	0	0	0	0	0	0	0	0	14.86826	0	0	0	0	0	13.06305	0	0	0
Q8IXW0	LMTD2_HUMAN	Lamin tail domain-containing protein 2	LMNTD2 C11orf35	Homo sapiens (Human)	regulation of chromatin assembly [GO:0010847]	lamin filament [GO:0005638]	lamin filament [GO:0005638]; structural constituent of chromatin [GO:0030527]; regulation of chromatin assembly [GO:0010847]	structural constituent of chromatin [GO:0030527]	GO:0005638; GO:0010847; GO:0030527	FPPGTLLAPR	4.920000076	0.72964406	0.72964406	0.141853398	1069.019015	0	14.39921	0	12.02343	15.70288	0	0	12.92237	0	0	0	0	0	0	0	0	13.95039	0	0	0	0	0	0	0	14.43118	14.19503	0	0	0	0	13.42614	0	0	0	0	0	16.11506	0	0	0	0	0	16.29628	0	0	0	15.5415	0
Q8IXW5	RPAP2_HUMAN	"Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2, EC 3.1.3.16 (RNA polymerase II-associated protein 2)"	RPAP2 C1orf82	Homo sapiens (Human)	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; metal ion binding [GO:0046872]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]"	metal ion binding [GO:0046872]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]	GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008420; GO:0009301; GO:0016591; GO:0043175; GO:0046872; GO:0070940	HPDFQLLK	12.06999969	0.157687306	0.157687306	0.221112467	999.0222857	0	14.45893	11.90507	14.57218	14.61826	15.68314	0	16.26884	14.40794	16.11435	15.73791	16.68042	0	16.41393	0	0	14.59723	0	0	15.74417	14.75703	16.77445	14.96288	17.57579	0	0	0	16.49768	14.72276	0	0	16.9542	0	0	13.65422	0	13.50591	0	0	0	0	0	0	15.69846	0	17.91797	0	0
Q8IXZ2	ZC3H3_HUMAN	Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor)	ZC3H3 KIAA0150 SMICL ZC3HDC3	Homo sapiens (Human)	mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]	GO:0003677; GO:0005634; GO:0005847; GO:0031124; GO:0032927; GO:0046872; GO:0051028; GO:0070412; GO:1900363	EGEGEPPR	9.920000076	0.430024505	0.430024505	0.214147886	868.7579759	0	0	0	15.4115	0	0	14.59092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.05463	0	0	0	0	0	0	0	17.03389	0	17.08235	0	0	0	0	0	0	0	0	0	0
Q8IY17	PLPL6_HUMAN	"Patatin-like phospholipase domain-containing protein 6, EC 3.1.1.5 (Neuropathy target esterase)"	PNPLA6 NTE	Homo sapiens (Human)	glycerophospholipid catabolic process [GO:0046475]; phosphatidylcholine metabolic process [GO:0046470]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; glycerophospholipid catabolic process [GO:0046475]; phosphatidylcholine metabolic process [GO:0046470]	lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]	GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0016021; GO:0046470; GO:0046475; GO:0102545	LFPSPGLPTRTSPVR	6.489999771	0.651815474	0.651815474	2.28E-13	1625.22498	15.18252	15.35752	13.44247	11.35616	15.09224	14.85646	13.88258	0	0	14.11215	15.94795	10.91399	16.02154	15.77269	0	0	0	13.77535	0	15.13174	16.16392	0	13.47806	0	15.88655	15.2428	12.42487	0	14.56937	14.77094	0	0	0	0	0	0	0	0	0	16.04134	15.81833	0	14.64118	16.51099	14.97688	0	13.45477	15.29058
Q8IY18	SMC5_HUMAN	"Structural maintenance of chromosomes protein 5, SMC protein 5, SMC-5, hSMC5"	SMC5 KIAA0594 SMC5L1	Homo sapiens (Human)	"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"	"cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0007059; GO:0016605; GO:0016607; GO:0016887; GO:0016925; GO:0018393; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0032204; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0051301; GO:0051984; GO:0071459; GO:0090398	DPSSEVPSK	7.289999962	0.619521797	0.619521797	0.061177267	947.4500483	15.74403	0	15.52056	14.05657	16.0664	0	0	0	0	0	17.22846	15.65478	9.832493	0	0	13.85074	14.48948	16.88095	18.3017	18.10794	17.96969	11.28518	0	16.91072	15.88347	13.05134	0	15.63014	0	16.98412	0	11.95506	13.52166	17.49476	19.63058	15.17319	0	0	15.28196	16.46511	0	0	15.76663	15.64945	0	17.03588	15.36962	13.36464
Q8IY21	DDX60_HUMAN	"Probable ATP-dependent RNA helicase DDX60, EC 3.6.4.13 (DEAD box protein 60)"	DDX60	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]	GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246	QLVEILFR	12.89000034	1	1	0.141287523	1018.622381	0	15.25758	13.8921	12.53855	17.23306	15.36415	15.53808	0	0	14.39619	0	0	0	0	0	0	0	0	0	0	0	0	0	14.83226	0	14.81532	0	0	0	0	0	0	14.87799	0	0	0	0	0	17.07389	0	0	15.86335	0	0	14.73092	0	0	0
Q8IY33	MILK2_HUMAN	"MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2, MICAL-L2)"	MICALL2 JRAB	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725]	bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]	GO:0001725; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:1903955	ATGEPGTFVCTSHLPAAASASPK	4.96999979	1	1	0.279922768	2259.65522	14.41155	0	15.20576	10.20134	0	14.47048	0	15.53189	0	0	12.68186	8.414618	12.89188	13.68804	0	14.86753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IY34	S15A3_HUMAN	Solute carrier family 15 member 3 (Osteoclast transporter) (Peptide transporter 3) (Peptide/histidine transporter 2)	SLC15A3 OCTP PHT2 PTR3	Homo sapiens (Human)	dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; protein transport [GO:0015031]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; protein transport [GO:0015031]	dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]	GO:0005765; GO:0006811; GO:0010008; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016021; GO:0043231; GO:0045087; GO:0070434; GO:0071916; GO:0140206	YERASQGPASHSR	8.609999657	1	1	1.37E-12	1445.401757	0	0	0	0	14.85611	0	0	0	15.40372	0	0	0	0	0	0	0	13.4356	14.93678	0	0	0	0	0	16.27305	0	0	0	0	14.07122	11.151	14.90674	0	0	13.08643	13.67412	0	0	0	13.36689	15.54272	0	12.82218	0	13.8638	0	14.99905	0	0
Q8IY37	DHX37_HUMAN	"Probable ATP-dependent RNA helicase DHX37, EC 3.6.4.13 (DEAH box protein 37)"	DHX37 DDX37 KIAA1517	Homo sapiens (Human)	"brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]"	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511]; brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511]	GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0007420; GO:0016887; GO:0031965; GO:0034511; GO:0042254; GO:0042255; GO:2000020	ISSLSGAHR	1.279999971	1	1	0.281245402	926.7499547	0	0	0	0	0	0	0	0	0	0	0	0	0	15.64617	17.46867	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.1265	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42507
Q8IY47	KBTB2_HUMAN	Kelch repeat and BTB domain-containing protein 2 (BTB and kelch domain-containing protein 1)	KBTBD2 BKLHD1 KIAA1489 CGI-73	Homo sapiens (Human)	gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; phosphatidylinositol 3-kinase signaling [GO:0014065]; response to insulin [GO:0032868]		gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; phosphatidylinositol 3-kinase signaling [GO:0014065]; response to insulin [GO:0032868]		GO:0006006; GO:0006629; GO:0010467; GO:0014065; GO:0032868	AMFMSGLSESKQTHVHLR	5.110000134	1	1	0.297195312	2074.014537	0	15.80943	15.56022	0	0	0	14.50394	0	12.10637	0	0	14.34075	13.94911	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97529	0	0	17.79241	0	0	0	0	0	0	0	0	14.40678	0	15.73116	0	0	0	0
Q8IY49	PAQRA_HUMAN	Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X)	MMD2 PAQR10	Homo sapiens (Human)	positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]	integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471]	integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471]; protein kinase activity [GO:0004672]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880]	protein kinase activity [GO:0004672]	GO:0004672; GO:0030173; GO:0032880; GO:0045666; GO:0045860; GO:0046579; GO:0048471	VPAHKR	3.220000029	1	1	0.311146749	706.6279437	17.02417	0	0	0	15.90342	16.6724	0	0	17.42491	16.13181	0	17.54452	0	0	0	0	16.65015	18.40859	0	0	16.53757	18.16752	0	0	0	0	18.0585	17.50163	0	0	19.94492	17.34056	17.61009	18.94978	0	0	0	19.18726	16.06783	0	17.41591	0	0	15.29673	0	0	0	0
Q8IY50	S35F3_HUMAN	Putative thiamine transporter SLC35F3 (Solute carrier family 35 member F3)	SLC35F3	Homo sapiens (Human)	thiamine transport [GO:0015888]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; thiamine transport [GO:0015888]		GO:0015888; GO:0016021	LLLGSAK	36.33000183	0.267932445	0.267932445	0.129476106	701.5109694	16.26839	16.99774	16.56437	16.28792	16.05625	16.87129	16.4661	17.286	16.35731	16.5659	16.33013	16.27061	15.67997	16.57895	16.83744	17.21928	15.60869	16.38868	16.80918	16.87643	16.43545	17.14534	16.48021	16.49055	17.26557	16.70345	16.77094	17.4353	16.87669	16.39897	15.52472	16.74058	17.06464	16.7319	16.78409	16.75987	17.1391	16.41587	17.2003	16.86161	16.98139	16.89306	17.27934	16.75636	17.24088	16.86293	17.02747	16.34242
Q8IY51	TIGD4_HUMAN	Tigger transposable element-derived protein 4	TIGD4	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]	DNA binding [GO:0003677]	GO:0003677; GO:0005634	CSNGWLDRFK	7.309999943	1	1	0.000272173	1282.01965	14.85243	15.24896	12.65435	0	0	0	0	0	15.61808	0	0	0	0	0	0	0	0	14.26089	0	0	0	0	0	12.76864	17.21045	14.50517	15.89106	14.39186	15.86417	0	0	14.45383	0	16.60545	0	0	16.65783	15.95254	16.5551	16.46211	0	0	0	16.25962	0	0	0	14.23206
Q8IY57	YAF2_HUMAN	YY1-associated factor 2	YAF2	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0003677; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0045892; GO:0045893; GO:0046872	CMMCDVR	6.079999924	1	1	0.325239824	1003.30803	16.67501	16.95222	15.01668	15.55164	16.25472	15.76237	15.98885	15.7929	15.90021	15.24851	0	0	0	16.25246	15.91051	16.54752	0	15.08228	0	0	0	0	0	0	0	16.31316	0	0	0	0	0	16.73131	0	0	0	0	0	0	0	15.87172	0	0	0	0	0	0	0	0
Q8IY67	RAVR1_HUMAN	Ribonucleoprotein PTB-binding 1 (Protein raver-1)	RAVER1 KIAA1978	Homo sapiens (Human)	"regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737	VSFCAPGPPGR	3.789999962	1	1	6.90E-13	1145.670841	15.38865	0	16.62898	10.27316	0	14.82577	0	0	13.01416	14.82816	13.98012	13.98574	0	0	0	0	0	0	0	0	0	0	0	13.57932	0	0	15.75044	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.04854	0	0	0	0	15.99085	0
Q8IY82	DRC7_HUMAN	Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog)	DRC7 C16orf50 CCDC135	Homo sapiens (Human)	cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]		GO:0005737; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0031514; GO:0048870	LMEAEKAKPDALHGLR	1.730000019	0.222337648	0.222337648	0.523529421	1793.915761	0	0	15.7869	0	0	0	0	17.83551	0	0	0	18.37788	0	0	0	0	0	0	18.48224	0	0	0	0	0	0	19.9516	17.7754	0	0	0	0	0	0	0	0	19.13645	19.11914	18.74563	20.34546	18.58257	0	18.11236	17.65235	0	0	0	0	0
Q8IY84	NIM1_HUMAN	"Serine/threonine-protein kinase NIM1, EC 2.7.11.1 (NIM1 serine/threonine-protein kinase)"	NIM1K NIM1	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0035556; GO:0042149; GO:0106310	TAVYMNGGGLVNPHYARWDR	1.25	1	1	1.37E-12	2293.250889	0	15.51104	0	0	0	0	0	0	0	0	0	0	12.36957	14.89123	7.705428	13.97682	0	0	13.85715	14.07683	0	0	0	0	0	9.931844	0	0	0	0	0	0	0	0	0	0	13.0015	0	0	12.91201	0	0	0	0	0	0	0	0
Q8IY85	EFC13_HUMAN	EF-hand calcium-binding domain-containing protein 13	EFCAB13 C17orf57	Homo sapiens (Human)						KHSSLQK	16.28000069	1	1	0.011977137	826.7297353	16.21986	0	14.5925	0	0	0	15.89204	15.07916	0	0	0	0	12.06354	0	0	0	0	11.76879	0	13.43478	14.64423	0	0	0	0	0	0	0	0	0	12.33698	0	15.19198	14.47086	15.85379	10.9917	0	0	0	0	16.51384	15.32255	0	0	0	0	0	0
Q8IY92	SLX4_HUMAN	Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12)	SLX4 BTBD12 KIAA1784 KIAA1987	Homo sapiens (Human)	DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]	"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]"	"cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]"	DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	GO:0000706; GO:0000712; GO:0000724; GO:0000781; GO:0003677; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0010792; GO:0019899; GO:0030054; GO:0032206; GO:0033557; GO:0036297; GO:0046872; GO:0061820; GO:0072429; GO:0090656; GO:1904357; GO:1904431	TGQMMDESDEDFKELCASFFQR	5.769999981	1	1	0.008777833	2702.731014	0	0	0	0	0	0	0	0	0	0	0	12.5171	0	16.77634	16.53811	0	0	15.57687	15.61806	0	0	0	0	15.45951	14.95583	14.5366	14.34578	14.39616	13.36541	0	15.41608	15.3593	0	12.55875	11.15244	14.67695	0	0	16.1918	0	0	0	0	0	0	10.10843	0	0
Q8IY95	TM192_HUMAN	Transmembrane protein 192	TMEM192	Homo sapiens (Human)		endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803]	protein homodimerization activity [GO:0042803]	GO:0005654; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0016021; GO:0042803; GO:0048471	HNALLSK	5.400000095	1	1	0.169056876	782.6616496	15.38869	15.53337	0	0	0	0	15.24831	0	15.77506	0	15.15175	0	0	0	0	0	0	0	0	18.43776	0	0	0	0	16.81046	0	15.75139	16.90586	0	0	17.98839	0	0	0	17.92138	18.85506	17.35185	0	16.16354	0	16.35353	0	15.56478	16.6366	0	17.50821	17.42305	16.90576
Q8IYA6	CKP2L_HUMAN	"Cytoskeleton-associated protein 2-like (Radial fiber and mitotic spindle protein, Radmis)"	CKAP2L	Homo sapiens (Human)		centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]		GO:0000922; GO:0005813; GO:0005829; GO:0015630; GO:0072686	CFIFR	11.19999981	0.697775304	0.697775304	0.165052053	744.7715308	14.84175	14.045	0	0	0	17.30403	14.47905	11.56697	0	0	0	17.73787	15.0359	13.2764	0	15.32733	17.91696	0	0	15.77984	0	0	14.38756	17.86615	17.08135	0	0	0	18.44441	19.21395	0	0	0	0	0	16.72123	17.75504	0	0	14.34379	17.10398	16.67681	17.21011	0	15.69393	16.49261	17.09069	0
Q8IYA7	MKX_HUMAN	Homeobox protein Mohawk	MKX C10orf48 IRXL1	Homo sapiens (Human)	cell development [GO:0048468]; muscle organ development [GO:0007517]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell development [GO:0048468]; muscle organ development [GO:0007517]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007517; GO:0048468	YLNDSLR	1.860000014	0.954927325	0.954927325	0.164449158	880.9787699	16.62661	16.932	14.43624	14.49256	13.88841	0	14.06955	0	0	0	0	0	14.44472	15.20347	0	0	0	14.58732	0	0	0	0	0	0	0	0	16.67054	0	15.40076	0	0	17.4944	17.32635	0	14.78331	16.65556	15.07962	0	0	0	0	15.19324	0	13.89065	13.05309	0	13.28424	10.01099
Q8IYB1	M21D2_HUMAN	"Nucleotidyltransferase MB21D2, EC 2.7.7.- (Mab-21 domain-containing protein 2, hMB21D2)"	MB21D2 C3orf59	Homo sapiens (Human)			cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]	cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]	GO:0044877; GO:0045296	MKMAAPTANK	6.960000038	0.749589801	0.749589801	0.276490771	1079.015902	18.1594	15.69476	17.56477	0	0	0	0	0	15.47637	13.92654	13.46234	17.06814	0	0	0	17.09543	17.30742	0	15.61424	0	0	17.49391	17.62106	0	0	0	0	0	0	0	18.23613	0	0	0	18.03139	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYB3	SRRM1_HUMAN	"Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa, SRm160) (Ser/Arg-related nuclear matrix protein)"	SRRM1 SRM160	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000375; GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0008380; GO:0016363; GO:0016607; GO:0048024; GO:0071013	AVAAAAAAAVTPAAIAAATTTLAQEEPVAAPEPKK	1.279999971	1	1	3.20E-12	3241.732204	14.81762	16.10613	11.97868	14.54408	8.193334	17.16228	0	12.39857	13.73004	15.57748	0	13.73786	0	0	14.02518	0	0	0	0	0	14.74602	0	12.49499	0	9.835664	16.46603	15.79247	0	15.47556	0	0	0	0	0	13.36701	0	0	0	0	0	0	0	0	0	0	0	0	14.58968
Q8IYB8	SUV3_HUMAN	"ATP-dependent RNA helicase SUPV3L1, mitochondrial, EC 3.6.4.13 (Suppressor of var1 3-like protein 1, SUV3-like protein 1)"	SUPV3L1 SUV3	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0016887; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:2000827	GTKALGSK	7.739999771	1	1	0.149561455	758.7965678	12.52337	14.29281	14.34602	0	0	14.01456	14.77947	0	0	0	0	15.64681	0	0	0	0	15.5546	0	0	0	0	0	0	0	0	16.20072	0	0	0	0	0	17.7891	15.40359	0	0	16.25514	16.25862	15.35822	15.37623	0	0	0	0	0	0	15.12088	0	17.04936
Q8IYD1	ERF3B_HUMAN	"Eukaryotic peptide chain release factor GTP-binding subunit ERF3B, Eukaryotic peptide chain release factor subunit 3b, eRF3b (G1 to S phase transition protein 2 homolog)"	GSPT2 ERF3B	Homo sapiens (Human)	"cell cycle [GO:0007049]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]"	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	"cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; cell cycle [GO:0007049]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]"	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]	GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0007049; GO:0018444	GGQTR	8.489999771	1	1	0.213896697	519.2130628	14.07186	16.36498	15.19135	0	14.64584	15.93431	15.65587	0	16.21817	15.52787	16.06731	15.9761	16.5537	16.36583	16.33268	0	15.78386	15.57138	0	0	16.47056	0	0	0	16.1204	16.24715	16.24692	15.45358	16.86926	16.3489	18.07666	16.89429	14.36779	16.54782	16.74238	17.03234	15.50632	16.28292	15.93748	14.88895	17.08429	16.02318	16.01493	17.13777	16.7992	17.24966	14.5935	15.52966
Q8IYD8	FANCM_HUMAN	"Fanconi anemia group M protein, Protein FACM, EC 3.6.4.13 (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa, FAAP250) (Protein Hef ortholog)"	FANCM KIAA1596	Homo sapiens (Human)	double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; resolution of meiotic recombination intermediates [GO:0000712]	chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]	chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; resolution of meiotic recombination intermediates [GO:0000712]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]	GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:0071932; GO:1902527	YKMIHK	7.710000038	1	1	0.217082097	835.8197884	0	0	0	14.90259	0	14.60966	0	0	0	0	0	0	0	0	0	0	15.39841	0	0	15.02382	0	15.37008	0	0	17.60436	15.52704	0	15.91611	15.57915	13.4207	0	15.27003	0	15.03592	15.80058	0	15.79799	13.51064	0	14.76662	0	16.47505	0	0	0	0	0	0
Q8IYD9	LAS2_HUMAN	Lung adenoma susceptibility protein 2	LAS2 C18orf54	Homo sapiens (Human)	negative regulation of cell population proliferation [GO:0008285]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; negative regulation of cell population proliferation [GO:0008285]		GO:0005576; GO:0008285	HHGPVEALK	4.989999771	1	1	0.269074575	987.3697864	17.09965	19.39764	18.61867	0	0	18.00855	0	17.92905	17.38786	15.25962	15.96091	0	0	0	16.25726	17.23952	17.05481	0	0	0	17.38071	0	0	17.92521	18.32539	0	0	15.60012	18.65276	17.94385	0	0	0	16.80493	17.76595	0	0	0	17.8877	17.95009	0	17.45461	0	0	16.16764	18.15755	17.09867	15.97475
Q8IYE0	CC146_HUMAN	Coiled-coil domain-containing protein 146	CCDC146 KIAA1505	Homo sapiens (Human)		centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]		GO:0005737; GO:0005814; GO:0005856	KMNGYQR	4.130000114	0.517726481	0.517726481	0.221674038	913.8119846	14.56074	0	13.77881	0	13.46803	14.52326	13.96838	15.08002	15.46297	15.17921	0	0	13.44844	0	0	15.28345	0	0	14.63151	0	0	16.59243	0	14.91829	15.06773	0	0	0	14.11896	14.60799	16.41048	0	15.02138	14.78677	16.52287	12.48246	0	0	0	14.75429	0	0	0	14.7336	0	15.26608	15.02626	14.72973
Q8IYE1	CCD13_HUMAN	Coiled-coil domain-containing protein 13	CCDC13	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515]	cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515]		GO:0005654; GO:0005813; GO:0005829; GO:0006974; GO:0031122; GO:0034451; GO:0042995; GO:1905515	GATDAGAKPPRAQMGDR	5.139999866	1	1	0.353318816	1714.43833	13.75278	13.67974	14.00223	0	0	0	0	0	14.78949	0	15.98335	0	0	14.12662	0	15.72333	0	0	0	15.79303	0	14.77016	0	15.57299	0	0	0	15.98114	0	0	0	0	0	13.96765	0	16.36007	0	0	0	0	17.05174	0	0	0	0	0	10.39456	0
Q8IYF1	ELOA2_HUMAN	"Elongin-A2, EloA2 (RNA polymerase II transcription factor SIII subunit A2) (Transcription elongation factor B polypeptide 3B)"	ELOA2 TCEB3B TCEB3L	Homo sapiens (Human)	"regulation of DNA-templated transcription, elongation [GO:0032784]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	elongin complex [GO:0070449]; nucleoplasm [GO:0005654]	"elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"		GO:0005654; GO:0006366; GO:0006368; GO:0032784; GO:0070449	LSALPMTADILAETGIR	8.359999657	1	1	0.375389747	1772.007871	0	0	15.19282	14.10687	0	0	0	0	0	0	0	0	0	13.27431	15.87307	0	12.85935	12.27131	15.94124	0	0	15.57737	0	10.03815	0	0	0	0	0	0	0	14.25551	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYF3	TEX11_HUMAN	"Testis-expressed protein 11 (Protein ZIP4 homolog, ZIP4H)"	TEX11 ZIP4	Homo sapiens (Human)	chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130]	central element [GO:0000801]; chromosome [GO:0005694]	central element [GO:0000801]; chromosome [GO:0005694]; chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130]		GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0043066; GO:0051026	LIMMNMR	16.32999992	1	1	0.274469463	923.4851048	16.93802	16.55089	17.91126	19.01082	19.08541	19.33922	17.7518	19.84729	18.50415	19.58538	19.63299	15.24797	19.55209	16.56142	18.62521	0	16.45427	19.96918	0	19.15051	0	18.61632	16.71002	0	16.58267	16.68497	18.89369	19.07453	17.11251	19.62861	0	19.7377	19.01367	17.36308	17.63331	20.11666	19.82494	19.0545	17.66173	19.18742	17.49658	18.14212	18.92729	19.49375	19.39614	19.13579	18.78408	17.18986
Q8IYH5	ZZZ3_HUMAN	ZZ-type zinc finger-containing protein 3	ZZZ3	Homo sapiens (Human)	"histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]"	ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]"	DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0006357; GO:0008270; GO:0031063; GO:0035064; GO:0043966; GO:0043967; GO:0044154; GO:0045995; GO:0051302; GO:0051726; GO:0070577; GO:0072686; GO:0090043; GO:0140672	GLSSSEK	10.06000042	1	1	0.065445507	705.4564746	15.59861	14.74674	16.17634	16.37894	0	12.79736	16.13112	14.51141	9.70986	15.6558	16.60322	16.54779	12.92453	0	16.08039	0	0	16.04212	15.32506	14.76326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYI6	EXOC8_HUMAN	Exocyst complex component 8 (Exocyst complex 84 kDa subunit)	EXOC8	Homo sapiens (Human)	cellular protein localization [GO:0034613]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; exocyst [GO:0000145]; growth cone [GO:0030426]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; exocyst [GO:0000145]; growth cone [GO:0030426]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; cellular protein localization [GO:0034613]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]	GO:0000145; GO:0000281; GO:0005770; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0007032; GO:0008104; GO:0015031; GO:0016020; GO:0016241; GO:0022617; GO:0030426; GO:0031252; GO:0031267; GO:0034613; GO:0035091; GO:0048471; GO:0090148; GO:0090522	GGPKATR	2.420000076	1	1	0.105667237	686.3750953	15.16856	0	0	0	0	0	0	15.61405	0	0	0	0	0	0	0	15.74298	0	0	0	0	0	0	15.95617	0	0	15.80764	15.94734	0	15.74286	15.19334	0	15.7801	0	14.29601	15.42631	16.20929	0	0	0	0	0	0	17.31149	13.27494	17.10903	0	15.3861	0
Q8IYJ2	CJ067_HUMAN	"Uncharacterized protein C10orf67, mitochondrial"	C10orf67 LINC01552	Homo sapiens (Human)		mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739	HYQQNEDKMR	13.81000042	0.394869924	0.394869924	0.091334362	1348.995891	20.34969	0	0	0	18.77741	17.78386	0	0	0	0	0	0	0	0	17.98005	0	0	0	19.18964	0	18.05052	0	0	0	0	0	0	18.65257	18.17483	0	0	0	0	0	0	0	19.31574	0	18.67064	0	0	0	0	0	0	19.94312	17.71627	18.47954
Q8IYJ3	SYTL1_HUMAN	Synaptotagmin-like protein 1 (Exophilin-7) (Protein JFC1)	SYTL1 SLP1 SB146	Homo sapiens (Human)	exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]	exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; neurexin family protein binding [GO:0042043]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]	neurexin family protein binding [GO:0042043]; small GTPase binding [GO:0031267]	GO:0005886; GO:0006886; GO:0006887; GO:0019897; GO:0031267; GO:0031528; GO:0042043; GO:0042470; GO:0070062; GO:0070382	NLNPVFNETLRYSVPQAELQGR	1.840000033	1	1	0.110449957	2544.542991	13.38765	0	0	12.46781	0	0	0	0	14.15594	9.463132	0	14.64006	13.14424	0	12.21615	0	13.94228	0	0	12.82782	0	0	0	0	13.51454	14.59151	11.77441	8.2451	14.78286	14.69208	11.58421	0	0	0	10.58027	0	0	12.83845	0	0	0	0	14.49277	0	14.9127	0	0	0
Q8IYK2	CC105_HUMAN	Coiled-coil domain-containing protein 105	CCDC105	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]		GO:0070062	EAAQAMAR	5.320000172	0.836568475	0.836568475	0.100215534	862.941795	12.98061	0	16.54743	15.3759	15.49459	14.02847	17.56654	0	12.13009	14.34496	0	13.47284	18.0856	0	15.17698	0	0	17.21695	0	16.87863	13.60154	16.35611	0	13.13336	15.5276	0	18.10398	0	11.52387	0	12.97833	15.54073	15.72345	0	16.95004	0	12.42926	18.81599	15.77964	13.35893	15.2867	15.88766	13.18762	0	15.73814	18.67947	14.53846	0
Q8IYK4	GT252_HUMAN	"Procollagen galactosyltransferase 2, EC 2.4.1.50 (Collagen beta(1-O)galactosyltransferase 2, ColGalT 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2)"	COLGALT2 C1orf17 GLT25D2 KIAA0584	Homo sapiens (Human)	collagen fibril organization [GO:0030199]	endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]; collagen fibril organization [GO:0030199]	procollagen galactosyltransferase activity [GO:0050211]	GO:0005788; GO:0030199; GO:0050211	ALNTSQLK	2.49000001	0.14666824	0.14666824	0.21308412	874.3838313	0	15.90398	14.893	14.59933	0	13.97401	0	15.44475	0	14.986	15.3697	15.78825	14.88166	13.8367	15.53205	15.43525	0	15.5712	0	14.71136	0	15.06594	16.6925	12.18558	15.52098	0	14.18081	15.20794	16.58304	12.79993	16.27907	15.52065	16.63245	0	15.51386	14.84794	0	15.81777	0	14.75686	0	16.40068	0	16.33003	14.92175	0	0	14.5282
Q8IYK8	REM2_HUMAN	GTP-binding protein REM 2 (Rad and Gem-like GTP-binding protein 2)	REM2	Homo sapiens (Human)		plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	calcium channel regulator activity [GO:0005246]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005246; GO:0005525; GO:0005886	DGIFKVMLVGESGVGK	3.579999924	1	1	1.38E-12	1651.668952	15.68245	17.83895	8.857656	0	7.741599	16.1347	14.82475	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.64535	0	0	0	14.75828	0	14.89346	0	0	16.77825	19.49865	0	0	0	0	0	0	0	0	0	0	0
Q8IYL3	CA174_HUMAN	UPF0688 protein C1orf174	C1orf174	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	TACLTSSSHK	1.470000029	1	1	0.277868392	1092.417786	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYM0	F186B_HUMAN	Protein FAM186B	FAM186B C12orf25	Homo sapiens (Human)		protein-containing complex [GO:0032991]	protein-containing complex [GO:0032991]		GO:0032991	ACVPLQMAR	9.520000458	0.38786149	0.38786149	0.181592446	1045.777082	15.00848	0	15.10982	0	14.93469	16.41417	0	0	0	16.65635	15.92828	0	0	20.73166	21.78869	0	0	21.7451	21.49634	0	0	0	0	0	20.84075	20.61169	20.94863	21.23848	21.24993	0	0	20.91238	0	21.89695	0	0	21.35624	18.62008	0	0	0	21.88945	0	20.65444	0	21.79197	0	21.83565
Q8IYM2	SLN12_HUMAN	"Ribonuclease SLFN12, EC 3.1.-.- (Schlafen family member 12)"	SLFN12	Homo sapiens (Human)						MPVHHFCMEKK	6.630000114	0.36606282	0.36606282	0.431091542	1474.472794	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.84852	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYP9	ZDH23_HUMAN	"Palmitoyltransferase ZDHHC23, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 23, DHHC-23, zDHHC23)"	ZDHHC23	Homo sapiens (Human)	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659	MTQKGSMKPVK	9.06000042	1	1	0.05177682	1250.726952	11.15342	0	14.72995	12.31417	15.08322	0	14.40478	15.7491	15.34315	0	0	13.95511	0	0	14.71824	15.2998	0	0	0	0	15.36608	0	0	0	14.72132	0	0	0	14.98359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.94624	0	0	0	0
Q8IYQ7	THNS1_HUMAN	"Threonine synthase-like 1, TSH1"	THNSL1	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	IAVVAFFPENGVSDFQK	5.570000172	1	1	1.84E-12	1868.272464	13.80665	0	0	0	11.77233	15.43472	12.70553	10.63443	13.22208	0	14.21549	0	0	14.64493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYR2	SMYD4_HUMAN	"SET and MYND domain-containing protein 4, EC 2.1.1.-"	SMYD4 KIAA1936	Homo sapiens (Human)	heart development [GO:0007507]; methylation [GO:0032259]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; heart development [GO:0007507]; methylation [GO:0032259]	metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0032259; GO:0046872	DYTGAAVLYSK	7.5	1	1	0.194522813	1187.076543	12.92342	0	9.516332	14.70714	14.25067	10.45767	15.31426	12.66282	8.172881	11.02335	0	13.91615	13.91326	12.31077	12.58161	0	15.88363	0	0	0	0	0	0	0	14.54137	0	0	0	0	0	0	0	13.69039	0	0	16.70162	15.84588	0	0	17.71687	0	0	0	0	0	0	0	0
Q8IYR6	TEFF1_HUMAN	"Tomoregulin-1, TR-1 (H7365) (Transmembrane protein with EGF-like and one follistatin-like domain)"	TMEFF1 C9orf2	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005604; GO:0005886; GO:0008045; GO:0009887; GO:0009888; GO:0016021; GO:0016358	ASNQPPGGGGGSGGDCPGGKGK	11.02000046	0.070521109	0.070521109	0.144946163	1899.800407	18.45027	12.07302	0	18.84328	18.31859	17.22532	16.62479	18.88244	17.50191	0	14.0574	0	14.54744	0	0	17.8634	17.10784	17.33019	0	0	0	0	0	16.89796	16.55247	15.79627	16.24304	0	0	0	18.87461	0	0	0	17.95494	0	0	15.60393	18.43573	13.52606	0	0	0	0	0	0	17.78062	0
Q8IYS1	P20D2_HUMAN	"Xaa-Arg dipeptidase, EC 3.4.13.4 (Beta-Ala-Lys dipeptidase)"	PM20D2 ACY1L2	Homo sapiens (Human)	proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802]	GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0032268; GO:0042802	QQMKPTWRVHGIIK	4.71999979	0.461029828	0.461029828	0.274420666	1722.122403	14.77971	9.51987	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.86253	0	16.18317	0	0	15.30988	0	0	15.26105	0	15.6065	15.16551	14.66697	0	14.33866	14.78956	14.68536	16.1837	14.38062	0	0	0	0	18.28717	0	0	16.07403	0	15.15517	0	0
Q8IYT1	GAR4_HUMAN	"Golgi associated RAB2 interactor protein 4 (Golgi-associated Rab2B interactor-like 4, GARI-L4)"	GARIN4 FAM71A	Homo sapiens (Human)	Golgi organization [GO:0007030]	Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; Golgi organization [GO:0007030]		GO:0005634; GO:0005794; GO:0007030	VRMVTMGIAR	10.75	0.619184434	0.619184434	0.337466987	1149.690232	0	15.5	16.03678	0	0	15.49918	0	0	0	0	0	0	0	10.54105	0	16.53396	16.11386	0	0	17.0385	15.19988	18.97415	17.69485	16.36654	16.23312	14.99681	15.69601	0	13.74521	0	16.49328	15.73134	14.33408	16.35605	15.81636	15.00362	16.32979	14.36016	17.00833	0	16.07826	15.80742	13.32519	12.42058	0	14.50429	13.40602	16.85289
Q8IYT2	CMTR2_HUMAN	"Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2, EC 2.1.1.296 (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2, HMTr2, MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog)"	CMTR2 AFT FTSJD1	Homo sapiens (Human)	7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310]	mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]	GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0097309; GO:0097310	MTLNFGTEMKR	10.13000011	1	1	0	1358.7515	0	17.61405	16.17949	16.5581	17.0936	16.44705	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYT3	CC170_HUMAN	Coiled-coil domain-containing protein 170	CCDC170 C6orf97	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]	ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]	ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]	microtubule binding [GO:0008017]	GO:0000226; GO:0005794; GO:0008017; GO:0036064	AASCTEEKEK	10.19999981	1	1	0.116557868	1151.116253	0	13.14384	0	0	0	16.51408	14.84278	11.87235	0	14.53945	0	16.60047	0	14.80908	0	0	16.25755	14.22841	16.55509	0	15.84903	15.31634	16.34822	13.97981	15.94047	15.1762	15.13833	15.01253	14.98126	15.22475	14.01714	15.0437	11.88114	0	0	16.92581	15.94514	16.09022	14.95482	14.83812	14.163	0	16.13884	15.38492	15.91592	13.74732	16.76431	15.53755
Q8IYT4	KATL2_HUMAN	"Katanin p60 ATPase-containing subunit A-like 2, Katanin p60 subunit A-like 2, EC 5.6.1.1 (p60 katanin-like 2)"	KATNAL2	Homo sapiens (Human)		cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000922; GO:0005524; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008568; GO:0016853; GO:0016887	MKTELLVQMDGLAR	3.650000095	1	1	0.137074548	1613.717038	11.89007	15.43002	0	0	14.72698	0	0	0	14.54246	0	0	0	0	0	15.45994	0	0	0	0	15.66244	0	16.04371	0	15.45572	0	0	0	15.74233	0	0	0	0	0	0	16.8436	0	17.28439	16.24032	0	0	0	0	0	14.60323	15.51004	0	0	15.31562
Q8IYT8	ULK2_HUMAN	"Serine/threonine-protein kinase ULK2, EC 2.7.11.1 (Unc-51-like kinase 2)"	ULK2 KIAA0623	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; late nucleophagy [GO:0044805]; negative regulation of collateral sprouting [GO:0048671]; peptidyl-serine phosphorylation [GO:0018105]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; phagophore assembly site membrane [GO:0034045]	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; phagophore assembly site membrane [GO:0034045]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; late nucleophagy [GO:0044805]; negative regulation of collateral sprouting [GO:0048671]; peptidyl-serine phosphorylation [GO:0018105]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000045; GO:0000422; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006914; GO:0007165; GO:0010508; GO:0018105; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0044805; GO:0046777; GO:0048671; GO:0048675; GO:0061709; GO:0106310	SGKLSPSTAVK	10.97000027	1	1	0.151260695	1073.756252	14.33386	15.29292	15.97509	0	13.79485	13.12001	14.64099	0	13.88345	0	0	0	0	0	16.40021	0	0	0	0	0	15.60026	0	0	0	13.86297	16.22049	0	15.89268	0	0	14.25119	15.62167	0	0	0	0	0	16.74951	0	14.98169	0	0	0	15.5673	0	15.00451	0	16.60847
Q8IYU2	HACE1_HUMAN	"E3 ubiquitin-protein ligase HACE1, EC 2.3.2.26 (HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1) (HECT-type E3 ubiquitin transferase HACE1)"	HACE1 KIAA1320	Homo sapiens (Human)	cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nuclear body [GO:0016604]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nuclear body [GO:0016604]; nucleus [GO:0005634]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511]	small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000139; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005783; GO:0006511; GO:0007030; GO:0007049; GO:0016567; GO:0016601; GO:0016604; GO:0030334; GO:0031267; GO:0032580; GO:0043161; GO:0045732; GO:0061025; GO:0061630; GO:0070936	ILTSLAEVATTNGHKLLSLSSNYDAQMK	3.170000076	1	1	0.308032507	3020.826594	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYV9	IZUM1_HUMAN	"Izumo sperm-egg fusion protein 1 (Oocyte binding/fusion factor, OBF) (Sperm-specific protein izumo)"	IZUMO1	Homo sapiens (Human)	cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heterotypic cell-cell adhesion [GO:0034113]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]	acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heterotypic cell-cell adhesion [GO:0034113]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036]	identical protein binding [GO:0042802]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0002080; GO:0005102; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0016021; GO:0034113; GO:0035036; GO:0042802; GO:0042803; GO:0086080	CGVMLQTLIWCK	11.57999992	0.264094263	0.264094263	0.544237443	1524.176093	0	19.17615	0	0	0	0	0	18.97248	0	0	0	0	18.18741	19.67805	0	0	0	0	0	17.00509	0	0	0	0	19.65691	0	0	0	0	0	0	20.20724	19.48103	18.83237	20.05641	0	0	19.0771	18.92244	0	0	0	0	0	0	0	0	0
Q8IYW2	CFA46_HUMAN	Cilia- and flagella-associated protein 46 (Tetratricopeptide repeat protein 40)	CFAP46 C10orf123 C10orf124 C10orf92 C10orf93 TTC40	Homo sapiens (Human)	axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294]	axoneme [GO:0005930]	axoneme [GO:0005930]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294]		GO:0005930; GO:0035082; GO:0060294	ALEMGIK	4.039999962	1	1	0.243145041	776.0135055	0	17.08127	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.57712	0	0	0	0	0	0
Q8IYW4	ENTD1_HUMAN	ENTH domain-containing protein 1 (Epsin-2B)	ENTHD1	Homo sapiens (Human)	endocytosis [GO:0006897]	clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; plasma membrane [GO:0005886]	clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897]	clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0030125; GO:0030276	EREVACR	8	1	1	0.083484452	919.9158107	14.92825	0	0	16.6091	13.39004	15.09534	13.51022	14.12724	16.49911	16.57951	15.69409	0	14.93185	11.92207	14.40039	9.161159	13.9564	0	0	0	0	0	0	0	16.61635	0	17.32219	0	0	0	0	0	0	15.01624	17.33595	0	0	0	0	0	0	12.54568	0	0	0	0	0	14.79445
Q8IYW5	RN168_HUMAN	"E3 ubiquitin-protein ligase RNF168, hRNF168, EC 2.3.2.27 (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168)"	RNF168	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006325; GO:0006511; GO:0006974; GO:0010212; GO:0016567; GO:0031491; GO:0032991; GO:0034244; GO:0035518; GO:0035861; GO:0036297; GO:0036351; GO:0036352; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0046872; GO:0070530; GO:0070534; GO:0070535	QEEQDRLLALQLQK	12.14999962	1	1	0.476884272	1711.527297	0	0	0	0	0	0	19.63036	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYX1	TBC21_HUMAN	TBC1 domain family member 21 (Male germ cell Rab GTPase-activating protein)	TBC1D21 MGCRABGAP	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]	acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; sperm midpiece [GO:0097225]	acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; sperm midpiece [GO:0097225]; actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]	actin binding [GO:0003779]; GTPase activator activity [GO:0005096]	GO:0001669; GO:0003779; GO:0005096; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0070062; GO:0090630; GO:0097225; GO:0120317	ALCQMYEK	6.289999962	1	1	0.149480481	1058.603371	0	0	0	0	14.60309	10.3156	13.88371	0	14.55241	14.648	14.07573	15.00152	13.65264	0	11.42743	11.13292	0	13.18188	13.89847	14.23127	14.79563	13.97927	14.50709	14.19981	0	0	0	0	0	0	16.21472	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IYX3	CC116_HUMAN	Coiled-coil domain-containing protein 116	CCDC116	Homo sapiens (Human)		centrosome [GO:0005813]; cytoplasm [GO:0005737]	centrosome [GO:0005813]; cytoplasm [GO:0005737]		GO:0005737; GO:0005813	IHLSSETHR	5.829999924	1	1	0.210638884	1080.248657	0	0	0	0	0	0	0	0	0	0	0	0	0	14.68648	0	0	15.6002	0	0	0	0	0	0	0	16.44299	0	15.47156	0	0	0	16.24199	15.10161	15.12558	0	0	0	16.55273	0	0	0	0	0	0	0	16.40012	0	0	0
Q8IYX4	DND1_HUMAN	"Dead end protein homolog 1 (RNA-binding motif, single-stranded-interacting protein 4)"	DND1 RBMS4	Homo sapiens (Human)	3'-UTR-mediated mRNA destabilization [GO:0061158]; germ cell development [GO:0007281]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; germ cell development [GO:0007281]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; spermatogenesis [GO:0007283]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0007281; GO:0007283; GO:0048255; GO:0060965; GO:0061158	GAQAAIATLHNHPLRPSCPLLVCR	5.730000019	0.507140458	0.507140458	2.28E-12	2652.475134	16.86653	0	15.75567	0	16.88697	14.15742	13.38514	0	13.90077	17.60226	0	0	8.807484	14.00615	17.13961	0	14.74243	14.96096	0	15.86726	14.93807	14.75089	17.4593	15.85665	16.58397	14.53426	13.00252	15.72511	16.51793	0	0	0	0	13.77688	0	0	0	16.70504	0	14.06406	0	16.45979	0	15.6609	0	14.22267	12.73558	16.20966
Q8IYX7	SAXO1_HUMAN	Stabilizer of axonemal microtubules 1	SAXO1 C9orf138 FAM154A	Homo sapiens (Human)	cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821]	axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]	axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821]	microtubule binding [GO:0008017]	GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0034453; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417	EMGRCLASYPEPPGYTFEEVDALGHR	3.589999914	0.97533983	0.97533983	1.38E-12	2980.793225	0	0	0	0	12.61416	15.63212	11.95259	0	0	0	0	0	0	0	0	0	0	0	0	0	13.37795	0	0	13.79353	0	0	0	14.48129	0	0	0	0	0	0	0	14.96579	0	12.82989	0	0	0	0	0	0	0	14.15196	15.59076	0
Q8IYY4	DZI1L_HUMAN	Cilium assembly protein DZIP1L (DAZ-interacting zinc finger protein 1-like)	DZIP1L	Homo sapiens (Human)	ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]	axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]	axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]	metal ion binding [GO:0046872]	GO:0005737; GO:0005814; GO:0005930; GO:0007224; GO:0021532; GO:0032880; GO:0033504; GO:0036064; GO:0046872; GO:0060271; GO:0061512; GO:1905349	KVEGIHK	17.60000038	1	1	0	810.5941905	0	16.79169	0	0	0	0	0	20.84605	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IZ02	LRC34_HUMAN	Leucine-rich repeat-containing protein 34	LRRC34	Homo sapiens (Human)	cell differentiation [GO:0030154]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; cell differentiation [GO:0030154]		GO:0005730; GO:0005737; GO:0030154	SMGSSREAAR	5.829999924	0.055541225	0.055541225	0.210571551	1067.791109	16.07092	15.83173	12.88386	0	13.34115	16.2772	14.79171	14.47279	0	0	0	14.88447	17.97277	0	9.467688	12.19091	12.63421	9.438167	0	16.10357	0	0	0	0	0	0	0	0	0	14.33899	0	15.17737	0	14.86957	16.6392	0	15.77908	0	0	0	0	0	13.47721	0	15.07742	0	0	0
Q8IZ13	ZBED8_HUMAN	Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8)	ZBED8 Buster3 C5orf54	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	EKLSAFVR	1.200000048	1	1	0.24214682	949.0046191	14.83375	15.20679	14.83872	14.10719	12.16752	13.40517	16.18585	14.50085	15.43231	16.71238	14.4064	16.46309	13.38556	14.34603	0	14.23105	15.95439	0	0	0	0	0	12.0782	0	15.55319	14.7834	0	0	0	0	0	0	0	0	0	0	14.56265	0	0	16.03988	0	0	14.6415	0	15.44003	0	0	0
Q8IZ41	RASEF_HUMAN	Ras and EF-hand domain-containing protein (Ras-related protein Rab-45)	RASEF RAB45	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]	calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]	GO:0003924; GO:0005509; GO:0005525; GO:0005737; GO:0005829; GO:0019003; GO:0042802; GO:0048471	ALCTELR	8.210000038	1	1	0.247426192	862.9821823	0	0	17.65401	0	0	17.28576	0	0	0	16.9194	0	0	16.54633	17.86631	15.74933	0	0	0	0	0	0	0	0	0	17.77968	18.28546	0	0	0	0	0	0	0	0	0	15.21046	16.80091	0	0	0	0	0	0	16.75125	16.54289	16.97945	0	0
Q8IZ52	CHSS2_HUMAN	"Chondroitin sulfate synthase 2, EC 2.4.1.175, EC 2.4.1.226 (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor, ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2)"	CHPF CSS2 UNQ651/PRO1281	Homo sapiens (Human)	chondroitin sulfate biosynthetic process [GO:0030206]	cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]	cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206]	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]	GO:0000139; GO:0005759; GO:0005829; GO:0008376; GO:0016021; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510	GMEYTLDLQLEALTPQGGR	5.539999962	1	1	0.205230734	2108.245967	0	14.37674	0	13.22304	13.48404	13.54366	13.82531	13.74973	0	0	14.41359	13.00825	0	12.94209	0	11.21127	0	0	0	0	0	0	0	0	0	0	0	0	0	15.43162	0	13.91602	0	0	13.03996	0	14.59114	0	0	0	0	0	0	0	0	15.49666	0	0
Q8IZ57	NRSN1_HUMAN	"Neurensin-1 (Neuro-p24) (Vesicular membrane protein of 24 kDa, Vesicular membrane protein p24)"	NRSN1 VMP	Homo sapiens (Human)	nervous system development [GO:0007399]	cytoplasmic vesicle [GO:0031410]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]	cytoplasmic vesicle [GO:0031410]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; nervous system development [GO:0007399]		GO:0007399; GO:0016021; GO:0030133; GO:0030426; GO:0031410; GO:0043005; GO:0043025	SSCSNVCGSRQAQAAAEGGYQR	1.389999986	1	1	0.230883102	2343.972692	13.41899	12.14048	0	13.28331	0	14.26541	0	13.08756	12.65991	0	15.1551	15.91903	0	12.5952	14.98209	12.81326	0	0	0	0	13.25329	0	0	0	0	0	0	0	0	0	0	15.58164	0	12.28707	12.90633	0	12.68101	0	0	0	0	0	15.90241	0	0	0	0	0
Q8IZ73	RUSD2_HUMAN	"Pseudouridylate synthase RPUSD2, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 2)"	RPUSD2 C15orf19	Homo sapiens (Human)	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]		pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0000455; GO:0003723; GO:0009982; GO:1990481	EPILVVSYKVGVCR	13.77000046	0.453158438	0.453158438	0.195424782	1617.803113	0	0	19.96881	0	0	16.45789	17.43793	19.02074	0	0	17.45562	0	0	17.59604	14.34042	17.29176	0	0	0	0	0	17.47034	0	0	18.27859	0	0	18.48827	0	15.9063	15.52641	15.76807	13.91761	0	17.9027	0	0	16.67873	19.76082	0	18.05405	0	0	0	16.61617	0	0	0
Q8IZA3	H18_HUMAN	"Histone H1.8 (Histone H1oo) (Oocyte-specific histone H1) (Oocyte-specific linker histone H1, osH1)"	H1-8 H1FOO H1OO OSH1	Homo sapiens (Human)	chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]; negative regulation of DNA recombination [GO:0045910]; negative regulation of stem cell differentiation [GO:2000737]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of DNA methylation [GO:0044030]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]; negative regulation of DNA recombination [GO:0045910]; negative regulation of stem cell differentiation [GO:2000737]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of DNA methylation [GO:0044030]	double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]	GO:0000786; GO:0003690; GO:0005634; GO:0005737; GO:0006334; GO:0016584; GO:0030261; GO:0031492; GO:0044030; GO:0045910; GO:0051321; GO:0070062; GO:2000737	NGAASPTK	2.410000086	1	1	0.177774577	745.5218854	0	0	14.55189	14.57477	15.90339	15.36147	0	14.28511	15.71631	0	14.37516	15.88898	0	14.67752	0	15.28391	15.42153	15.6289	15.13563	15.03431	0	16.85274	0	16.40695	15.60287	0	0	15.55032	14.23969	15.50291	0	16.71395	14.94746	13.38593	15.38486	15.02239	16.54428	16.72448	0	0	16.57062	16.75356	16.29946	15.73067	15.56977	16.82267	0	15.60686
Q8IZC4	RTKN2_HUMAN	"Rhotekin-2 (Pleckstrin homology domain-containing family K member 1, PH domain-containing family K member 1)"	RTKN2 PLEKHK1	Homo sapiens (Human)	hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]		GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030097; GO:0051092; GO:1901224; GO:2001243	MEGPSLR	5.03000021	1	1	0.195056834	789.0445738	13.22105	15.23752	0	17.58315	14.8872	0	14.73792	13.08531	9.256167	13.16244	13.00121	17.28813	0	15.17814	14.86293	12.98867	12.07554	0	0	14.45695	15.74925	0	16.15661	0	0	15.50554	0	12.28163	0	15.33936	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IZC6	CORA1_HUMAN	Collagen alpha-1(XXVII) chain	COL27A1 KIAA1870	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte development [GO:0003431]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte development [GO:0003431]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]	GO:0003431; GO:0005201; GO:0005576; GO:0005583; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023	AWNGQIFEAGGQFRPEVSMDGCKVQDGR	4.190000057	1	1	0.042831634	3155.437417	0	11.41701	17.96441	15.66316	6.443247	0	12.37731	0	0	13.35297	12.37023	12.01278	0	12.91967	11.68229	9.220152	0	0	0	0	14.71829	0	15.59425	0	0	10.66012	0	0	0	0	0	0	0	0	14.6765	0	15.09082	0	0	15.89806	0	0	9.158997	0	12.91676	0	0	0
Q8IZD0	SAM14_HUMAN	"Sterile alpha motif domain-containing protein 14, SAM domain-containing protein 14"	SAMD14	Homo sapiens (Human)	actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; neuron projection development [GO:0031175]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; neuron projection development [GO:0031175]	actin filament binding [GO:0051015]	GO:0005737; GO:0007015; GO:0014069; GO:0015629; GO:0019722; GO:0030425; GO:0031175; GO:0051015	GSNRLSMGSR	4.699999809	1	1	0.357773922	1081.104611	0	0	0	0	0	0	16.15159	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.62603	0	15.59483	15.08934	15.46279	0	0	0	0	0	0	0	0
Q8IZD9	DOCK3_HUMAN	"Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein, PBP)"	DOCK3 KIAA0299 MOCA	Homo sapiens (Human)	positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]	GO:0005085; GO:0005829; GO:0007264; GO:0017124; GO:0051056; GO:1903997	HFAGALAYK	1.639999986	1	1	0.223731274	976.6976361	0	17.00281	0	0	0	0	15.67155	0	17.287	0	0	0	0	0	0	0	16.41216	0	0	0	13.52067	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IZF0	NALCN_HUMAN	Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1)	NALCN VGCNL1	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]	cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0005244; GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0016021; GO:0022840; GO:0034220; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805	GRLEVDLDK	12.56999969	0.129867584	0.129867584	0.043719073	1046.573449	17.2768	16.08558	0	13.08487	0	0	0	0	0	0	0	14.93695	17.21885	16.59996	15.24582	14.44368	16.35864	14.77262	14.60966	17.47463	15.43697	16.09399	0	14.09328	12.58859	16.01691	0	15.76505	18.42612	14.21278	12.81247	16.24895	10.51361	16.78906	14.62615	14.37876	17.76034	0	16.24364	0	16.21498	16.87482	14.25402	7.31095	14.29397	0	15.597	15.1098
Q8IZF2	AGRF5_HUMAN	Adhesion G protein-coupled receptor F5 (G-protein coupled receptor 116)	ADGRF5 GPR116 KIAA0758	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; energy reserve metabolic process [GO:0006112]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular filtration [GO:0003094]; glucose homeostasis [GO:0042593]; negative regulation of macrophage activation [GO:0043031]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of phospholipid biosynthetic process [GO:0071073]; surfactant homeostasis [GO:0043129]	apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; energy reserve metabolic process [GO:0006112]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular filtration [GO:0003094]; glucose homeostasis [GO:0042593]; negative regulation of macrophage activation [GO:0043031]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of phospholipid biosynthetic process [GO:0071073]; surfactant homeostasis [GO:0043129]	G protein-coupled receptor activity [GO:0004930]	GO:0003094; GO:0004930; GO:0005886; GO:0006112; GO:0007166; GO:0007186; GO:0009986; GO:0016021; GO:0031410; GO:0042593; GO:0043031; GO:0043129; GO:0045177; GO:0045444; GO:0048821; GO:0061626; GO:0071073	TDLETAFRK	4.460000038	0.853598654	0.853598654	0.243220855	1081.499603	14.09284	0	16.69482	0	0	14.37345	15.07786	15.32968	0	0	16.54647	0	0	0	14.80468	0	0	0	12.42374	0	15.65534	16.0872	0	15.39789	14.74681	14.01518	17.10596	17.02204	16.84011	16.15442	15.39954	0	0	16.4233	0	0	17.23064	0	0	0	16.17835	0	16.8266	16.42334	16.17884	15.48414	16.01876	14.58968
Q8IZF6	AGRG4_HUMAN	Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)	ADGRG4 GPR112	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021	KMILHDLK	11.68000031	0.284540147	0.284540147	0.145648979	1015.133447	16.87521	0	0	0	0	0	0	0	0	0	15.56962	15.33068	0	12.23556	16.45203	15.92686	16.17492	14.99135	14.77755	16.16453	0	0	16.82566	18.39539	0	15.05584	16.37722	13.86447	0	0	13.91817	14.47804	0	16.05242	15.19757	0	15.79423	0	15.87295	14.47531	0	0	14.40188	17.07445	0	15.84097	0	16.93962
Q8IZH2	XRN1_HUMAN	"5'-3' exoribonuclease 1, EC 3.1.13.- (Strand-exchange protein 1 homolog)"	XRN1 SEP1	Homo sapiens (Human)	"cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"	cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"	5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0045202; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:0090503; GO:1905795	VQEIITWLK	21.04000092	0.2499502	0.2499502	0.165312675	1129.051917	19.29514	20.44705	18.93113	19.81992	19.43012	0	18.83857	20.00221	0	19.36876	19.77277	0	17.90063	19.4565	18.95982	18.76954	18.67673	0	18.37224	18.85287	19.20129	18.96172	19.1935	19.67562	18.33774	19.06189	18.81273	0	0	18.95837	19.38184	19.2291	19.96045	0	18.14216	19.18102	18.96082	19.60488	18.27062	19.9707	19.40984	18.11655	19.4818	19.6344	19.22276	0	15.37762	18.25151
Q8IZJ4	RGDSR_HUMAN	"Ral-GDS-related protein, hRGR (Ral guanine nucleotide dissociation stimulator-like 4, RalGDS-like 4)"	RGL4 RGR	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]	cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]	cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005886; GO:0007265; GO:0031410; GO:0043547	MEQLSDK	8.159999847	0.567822516	0.567822516	0.224273477	865.4148891	17.42472	0	16.12107	0	0	0	15.88921	0	15.17741	16.10624	16.03541	15.76693	12.03466	0	14.35955	14.3087	16.36742	14.81581	0	0	0	15.87162	0	0	0	14.98726	0	15.47987	15.98745	14.16101	17.00824	15.70338	15.23802	13.24549	12.72728	15.57755	13.7528	17.32822	0	16.70878	0	0	15.12454	15.4467	16.61217	0	0	13.95053
Q8IZK6	MCLN2_HUMAN	"Mucolipin-2 (Transient receptor potential channel mucolipin 2, TRPML2)"	MCOLN2	Homo sapiens (Human)	adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; protein transport [GO:0015031]	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; protein transport [GO:0015031]	calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345]	GO:0002250; GO:0005262; GO:0005764; GO:0005886; GO:0015031; GO:0016020; GO:0016021; GO:0031902; GO:0042802; GO:0045087; GO:0055038; GO:0070588; GO:0071639; GO:0071642; GO:0071651; GO:0072345; GO:1905517; GO:1990266; GO:2000343	RQIPWK	11.97000027	1	1	0.318524107	828.9524618	0	18.40409	19.01018	17.13241	16.69874	18.39082	16.01539	0	18.51381	16.93164	18.31639	17.68542	0	17.85783	16.05934	16.42545	17.19123	17.17543	18.69105	0	16.60106	0	17.65838	16.67312	16.34544	17.56993	16.71351	0	14.60841	14.43401	17.33733	0	0	0	17.54317	16.67983	0	16.31763	17.1325	17.78958	17.18371	18.40466	18.0148	15.06355	17.64105	15.64189	0	16.31406
Q8IZN3	ZDH14_HUMAN	"Palmitoyltransferase ZDHHC14, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 14, DHHC-14) (NEW1 domain-containing protein, NEW1CP) (Zinc finger DHHC domain-containing protein 14)"	ZDHHC14	Homo sapiens (Human)	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580	MPPGGGGPMK	10.85999966	0.401574582	0.401574582	0.249011346	959.5531021	0	19.16788	17.23934	0	16.69999	0	0	0	14.4366	15.62237	0	0	17.31495	16.13892	0	0	17.4387	0	16.39808	0	0	17.91331	0	17.38371	0	0	20.01326	17.50402	0	16.68647	0	18.50091	17.06714	0	18.06396	19.11956	19.31067	19.35082	19.9591	0	17.18104	0	0	16.54531	0	15.69102	17.62776	0
Q8IZP0	ABI1_HUMAN	"Abl interactor 1 (Abelson interactor 1, Abi-1) (Abl-binding protein 4, AblBP4) (Eps8 SH3 domain-binding protein, Eps8-binding protein) (Nap1-binding protein, Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1)"	ABI1 SSH3BP1	Homo sapiens (Human)	actin polymerization or depolymerization [GO:0008154]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-tyrosine phosphorylation [GO:0018108]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; actin polymerization or depolymerization [GO:0008154]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-tyrosine phosphorylation [GO:0018108]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]	GO:0001756; GO:0005634; GO:0005783; GO:0005829; GO:0005856; GO:0007169; GO:0008092; GO:0008154; GO:0008285; GO:0014069; GO:0017124; GO:0018108; GO:0030027; GO:0030296; GO:0030426; GO:0031209; GO:0032433; GO:0035591; GO:0035855; GO:0045296; GO:0048813; GO:0070062; GO:0072673	HNSTTSSTSSGGYR	6.139999866	0.554276109	0.554276109	5.25E-12	1442.093381	14.82598	8.028003	0	15.65931	12.15193	0	15.85404	12.47569	12.09802	14.42828	14.53929	12.66658	13.01085	0	0	14.48626	7.853102	13.54593	0	0	16.6639	0	10.60192	0	14.55186	11.4891	13.72936	14.1932	0	14.42245	14.77135	14.60168	14.55329	11.1577	0	16.78289	15.94686	14.78034	13.55523	12.14166	0	0	11.98303	0	12.85236	0	0	15.92809
Q8IZP6	R113B_HUMAN	RING finger protein 113B (Zinc finger protein 183-like 1)	RNF113B RNF161 ZNF183L1	Homo sapiens (Human)	snoRNA splicing [GO:0034247]	U2-type spliceosomal complex [GO:0005684]	U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; snoRNA splicing [GO:0034247]	metal ion binding [GO:0046872]	GO:0005684; GO:0034247; GO:0046872	AAPPSPGR	4.139999866	0.625798345	0.625798345	0.25722063	752.9539519	18.16502	0	0	16.672	14.79106	0	16.42568	16.04355	15.74496	0	15.0205	0	0	17.59535	0	15.42263	15.48949	16.92236	0	18.04987	0	0	16.13794	0	0	0	0	14.95642	16.14893	15.43864	14.59215	16.47046	0	14.84025	0	15.49487	15.97483	0	0	0	16.71412	17.22427	0	14.46866	0	15.31114	15.12863	0
Q8IZP7	H6ST3_HUMAN	"Heparan-sulfate 6-O-sulfotransferase 3, HS6ST-3, EC 2.8.2.-"	HS6ST3	Homo sapiens (Human)	"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]"	integral component of membrane [GO:0016021]	"integral component of membrane [GO:0016021]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]"	heparan sulfate 6-O-sulfotransferase activity [GO:0017095]	GO:0015015; GO:0016021; GO:0017095	DHQWPK	9.090000153	0.190801665	0.190801665	0.233802822	809.3633692	0	16.58959	14.83021	15.05827	16.14284	16.38059	0	15.54533	15.3096	0	14.34684	15.36681	17.69098	14.53394	0	0	0	0	0	17.00097	17.11794	0	15.82499	0	16.22754	14.34435	16.26355	15.22922	15.68913	15.18932	16.06077	15.82553	16.21104	17.56966	15.92758	16.12896	17.12817	15.51336	12.85134	15.57659	14.24771	0	16.00121	14.63092	16.47948	13.98078	16.72337	16.33397
Q8IZQ1	WDFY3_HUMAN	"WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein, Alfy)"	WDFY3 KIAA0993	Homo sapiens (Human)	aggrephagy [GO:0035973]	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]	autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973]	1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]	GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635	GEALAPTTQSKLSR	6	0.700247943	0.700247943	0.373049503	1459.196052	0	0	0	0	0	16.67225	0	0	0	0	0	0	0	0	0	17.22128	0	17.0077	0	0	0	0	0	14.71313	0	0	16.93465	0	0	0	0	0	0	0	15.628	0	18.1111	0	0	0	0	0	0	0	0	0	0	0
Q8IZQ8	MYCD_HUMAN	Myocardin	MYOCD MYCD	Homo sapiens (Human)	"cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; cardiocyte differentiation [GO:0035051]; cellular component maintenance [GO:0043954]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; lung alveolus development [GO:0048286]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of skeletal muscle cell differentiation [GO:2001015]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac vascular smooth muscle cell differentiation [GO:2000724]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003257]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of histone acetylation [GO:0035065]; regulation of myoblast differentiation [GO:0045661]; regulation of phenotypic switching [GO:1900239]; regulation of smooth muscle cell differentiation [GO:0051150]; response to hypoxia [GO:0001666]; smooth muscle cell differentiation [GO:0051145]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell differentiation [GO:0055012]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; cardiocyte differentiation [GO:0035051]; cellular component maintenance [GO:0043954]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; lung alveolus development [GO:0048286]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of skeletal muscle cell differentiation [GO:2001015]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac vascular smooth muscle cell differentiation [GO:2000724]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003257]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of histone acetylation [GO:0035065]; regulation of myoblast differentiation [GO:0045661]; regulation of phenotypic switching [GO:1900239]; regulation of smooth muscle cell differentiation [GO:0051150]; response to hypoxia [GO:0001666]; smooth muscle cell differentiation [GO:0051145]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell differentiation [GO:0055012]"	DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]	GO:0000122; GO:0000785; GO:0001560; GO:0001570; GO:0001666; GO:0003231; GO:0003257; GO:0003713; GO:0005634; GO:0008284; GO:0008285; GO:0010628; GO:0010667; GO:0010832; GO:0030511; GO:0035035; GO:0035051; GO:0035065; GO:0035886; GO:0042826; GO:0043388; GO:0043954; GO:0045661; GO:0045736; GO:0045893; GO:0045944; GO:0045987; GO:0048286; GO:0048565; GO:0051091; GO:0051145; GO:0051150; GO:0051152; GO:0055007; GO:0055012; GO:0060065; GO:0060157; GO:0060354; GO:0061629; GO:0070412; GO:0097070; GO:0140297; GO:1900222; GO:1900239; GO:1902895; GO:1904706; GO:1904753; GO:2000587; GO:2000721; GO:2000724; GO:2000727; GO:2001015	DPKPK	6.559999943	0.848833382	0.848833382	0.136162403	583.2211221	0	0	0	16.71318	18.0348	0	16.56482	0	0	15.97513	0	16.75529	16.88004	0	17.12157	0	17.36531	15.9363	19.78975	15.18019	14.97127	17.46902	16.02854	16.42416	0	12.68842	14.6226	0	15.01476	0	17.3889	15.57477	0	18.39658	0	14.5203	15.78209	16.91769	0	0	14.37253	13.8157	16.64359	11.90451	0	16.76359	0	16.46091
Q8IZR5	CKLF4_HUMAN	CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4)	CMTM4 CKLFSF4	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	LDTFSYSTNVTVRK	5	1	1	0.045331404	1632.174293	15.83694	16.04615	13.1883	0	0	11.84553	0	13.62348	15.32995	0	0	0	13.94483	0	0	16.20397	0	11.21749	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IZT6	ASPM_HUMAN	"Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog, Asp homolog)"	ASPM MCPH5	Homo sapiens (Human)	cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051]	apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]	apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051]	calmodulin binding [GO:0005516]	GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0007283; GO:0008584; GO:0016324; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431	FRSLLVR	8.619999886	0.025295736	0.025295736	0.186240499	890.8967434	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.79913	0	0	0	0	0	0	0	0	0	0	0	17.2035	0	0	0	0	0
Q8IZT8	HS3S5_HUMAN	"Heparan sulfate glucosamine 3-O-sulfotransferase 5, EC 2.8.2.23 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5, 3-OST-5, Heparan sulfate 3-O-sulfotransferase 5, h3-OST-5)"	HS3ST5 3OST5 HS3OST5	Homo sapiens (Human)	"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]"	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]	GO:0000139; GO:0006024; GO:0006477; GO:0008467; GO:0015015; GO:0016021; GO:0046596; GO:0050656; GO:0050819	AIIIGVRK	7.570000172	1	1	0.183977209	870.524176	0	15.8778	0	15.86671	15.09386	13.53507	0	15.45881	14.71257	0	0	14.98872	0	0	0	15.52705	15.08775	13.86687	14.65915	15.4027	0	15.37274	0	0	15.5436	16.01465	16.48586	0	16.0617	0	0	0	0	16.09411	14.53048	0	0	0	0	15.10987	0	0	14.94268	0	0	16.47829	0	0
Q8IZT9	FAM9C_HUMAN	Protein FAM9C	FAM9C	Homo sapiens (Human)	meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]	synaptonemal complex [GO:0000795]	synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]		GO:0000795; GO:0007286; GO:0051321	DEEGDGEK	2.690000057	1	1	0.143301982	876.9710171	15.79403	0	15.30019	13.45108	0	16.4809	0	14.40156	0	0	0	0	0	0	0	14.15941	0	0	0	0	0	0	0	0	0	0	16.95887	15.59916	14.76085	15.33799	0	0	13.67212	15.23326	15.4625	16.54898	15.39868	0	0	15.26479	0	13.68006	14.94105	14.79856	0	14.39138	0	0
Q8IZU0	FAM9B_HUMAN	Protein FAM9B	FAM9B	Homo sapiens (Human)	meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]	nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]	nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]		GO:0000795; GO:0005654; GO:0007286; GO:0051321	MDKTCSK	4.659999847	1	1	0.202623801	869.9520368	11.28937	15.72038	12.44685	14.58449	15.22621	16.10437	16.75306	16.52069	0	0	15.90877	0	0	0	0	13.88526	14.81525	0	0	12.55613	0	0	0	15.65057	0	0	0	0	0	0	15.98513	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IZU1	FAM9A_HUMAN	Protein FAM9A	FAM9A	Homo sapiens (Human)	meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]	nucleolus [GO:0005730]; synaptonemal complex [GO:0000795]	nucleolus [GO:0005730]; synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]		GO:0000795; GO:0005730; GO:0007286; GO:0051321	AAPAKK	1.539999962	0.283433348	0.283433348	0.128182922	584.3712969	14.93128	14.95236	14.6335	15.278	14.29858	0	0	0	14.01994	15.69025	0	0	0	0	16.37097	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IZU2	WDR17_HUMAN	WD repeat-containing protein 17	WDR17	Homo sapiens (Human)						IWDYTQDACINILNGHTAPVR	4.039999962	1	1	0.325644664	2457.482305	0	15.0578	0	0	0	0	0	0	14.82216	0	0	0	15.96818	16.0068	0	13.56389	14.74044	0	0	17.23529	13.15075	0	0	16.64522	0	0	0	0	15.88105	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8IZU3	SYCP3_HUMAN	"Synaptonemal complex protein 3, SCP-3"	SYCP3 SCP3	Homo sapiens (Human)	"cell division [GO:0051301]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	"chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]"	"chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; cell division [GO:0051301]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	DNA binding [GO:0003677]	GO:0000775; GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0007141; GO:0007286; GO:0035093; GO:0051301; GO:0051321	ILNMFR	15.46000004	1	1	0.221599705	808.4730611	17.31795	11.653	15.82257	0	0	0	17.32657	0	18.54622	19.01499	0	0	0	0	0	17.9208	18.42958	16.97256	17.65115	0	18.29871	0	0	19.19116	20.4865	0	19.26486	0	0	0	0	0	0	0	0	0	0	0	18.82019	18.1557	19.20532	0	0	0	0	0	0	0
Q8IZW8	TENS4_HUMAN	Tensin-4 (C-terminal tensin-like protein)	TNS4 CTEN PP14434	Homo sapiens (Human)	apoptotic process [GO:0006915]; protein localization [GO:0008104]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; apoptotic process [GO:0006915]; protein localization [GO:0008104]	actin binding [GO:0003779]	GO:0003779; GO:0005829; GO:0005856; GO:0005925; GO:0006915; GO:0008104	FCGMDPEQRK	1.460000038	0.122449026	0.122449026	3.19E-12	1282.851922	13.75678	11.57608	12.77396	13.52884	0	0	0	0	0	0	0	0	13.29601	0	15.18114	0	12.5225	0	12.55313	0	14.03595	14.90266	0	15.66369	0	0	0	13.79878	13.27603	11.15504	0	14.81433	14.89535	13.97815	13.28121	15.15837	12.08525	15.14344	14.95187	0	14.56008	16.19662	0	14.51821	13.35778	11.95483	12.78169	0
Q8IZX4	TAF1L_HUMAN	Transcription initiation factor TFIID subunit 1-like (TAF(II)210) (TBP-associated factor 1-like) (TBP-associated factor 210 kDa) (Transcription initiation factor TFIID 210 kDa subunit)	TAF1L	Homo sapiens (Human)	"male meiotic nuclear division [GO:0007140]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]"	nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]	"nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; male meiotic nuclear division [GO:0007140]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]"	DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]	GO:0003677; GO:0004402; GO:0004674; GO:0005654; GO:0005669; GO:0006357; GO:0007140; GO:0016251; GO:0017025; GO:0045893; GO:0051123; GO:0070577	AFIAAMK	4.480000019	0.500626087	0.500626087	0.216791326	751.3618831	0	15.99248	15.63618	0	0	0	0	0	0	0	0	0	15.69965	17.05174	16.62303	16.43587	16.52779	0	0	0	0	17.91923	19.18538	18.18232	0	0	0	0	0	0	0	0	0	17.12905	0	17.02005	16.51489	0	0	0	15.78787	16.53219	15.91642	16.02627	0	0	17.50383	16.45247
Q8IZY2	ABCA7_HUMAN	"Phospholipid-transporting ATPase ABCA7, EC 7.6.2.1 (ABCA-SSN) (ATP-binding cassette sub-family A member 7) (Autoantigen SS-N) (Macrophage ABC transporter)"	ABCA7	Homo sapiens (Human)	amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta formation [GO:0034205]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle assembly [GO:0034380]; lipid transport [GO:0006869]; memory [GO:0007613]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of endocytosis [GO:0045806]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; plasma membrane raft organization [GO:0044857]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to nucleus [GO:0034504]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of lipid metabolic process [GO:0019216]; visual learning [GO:0008542]	cell junction [GO:0030054]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cell junction [GO:0030054]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor activity [GO:0034188]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta formation [GO:0034205]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle assembly [GO:0034380]; lipid transport [GO:0006869]; memory [GO:0007613]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of endocytosis [GO:0045806]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; plasma membrane raft organization [GO:0044857]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to nucleus [GO:0034504]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of lipid metabolic process [GO:0019216]; visual learning [GO:0008542]	ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor activity [GO:0034188]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]	GO:0000139; GO:0001891; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005794; GO:0005886; GO:0006869; GO:0006909; GO:0007613; GO:0008542; GO:0009986; GO:0010875; GO:0016021; GO:0018149; GO:0019216; GO:0030054; GO:0031901; GO:0032587; GO:0033344; GO:0033700; GO:0034188; GO:0034205; GO:0034380; GO:0034504; GO:0038027; GO:0042626; GO:0042985; GO:0043231; GO:0043409; GO:0044857; GO:0045332; GO:0045806; GO:0050766; GO:0070374; GO:0090554; GO:0090556; GO:0097386; GO:0140328; GO:0140359; GO:0150094; GO:1900223; GO:1901076; GO:1902430; GO:1902991; GO:1902995; GO:1903898; GO:2000010	DRLPAGGR	12.51000023	1	1	0.195882171	842.6099394	22.86216	22.22369	0	0	21.11715	0	19.06855	21.85618	0	15.61104	21.11623	21.72476	20.06869	22.38105	0	22.28155	20.43009	18.6064	20.56639	0	18.97435	17.64074	18.80636	0	22.31722	19.66999	0	21.0331	22.8849	0	0	0	22.75377	0	22.22496	0	22.62389	0	22.37291	19.30613	17.12875	18.6203	0	0	0	22.15048	22.7999	20.1095
Q8MH63	LAT1N_HUMAN	"Putative L-type amino acid transporter 1-like protein MLAS (hLAT1 3-transmembrane protein MLAS, hLAT1 3TM MLAS)"	SLC7A5P1 MLAS	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; L-amino acid transmembrane transporter activity [GO:0015179]	L-amino acid transmembrane transporter activity [GO:0015179]	GO:0015179; GO:0016021	ALAAPVAEEK	16.03000069	1	1	0.27703988	998.5048305	0	0	17.98428	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.42119	0	0	18.25554	0	0	0	0	0	0	0	0	0	0	0	0	0	17.55532	0	0	0	0	0	0	18.34999	0	16.31284	0	17.17101	0
Q8N0S2	SYCE1_HUMAN	"Synaptonemal complex central element protein 1 (Cancer/testis antigen 76, CT76)"	SYCE1 C10orf94	Homo sapiens (Human)	cell division [GO:0051301]; synaptonemal complex assembly [GO:0007130]	central element [GO:0000801]; chromosome [GO:0005694]; synaptonemal complex [GO:0000795]	central element [GO:0000801]; chromosome [GO:0005694]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; synaptonemal complex assembly [GO:0007130]		GO:0000795; GO:0000801; GO:0005694; GO:0007130; GO:0051301	ESEAHR	11.90999985	1	1	0.145648201	728.8427701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.77798	0	17.58235	16.5176	0	16.72664	0	0	0	16.29182	15.82876	0	0	15.86254	16.83745	0	0	0	0	0	17.51876	17.4109	0	0	0	17.61751
Q8N0S6	CENPL_HUMAN	"Centromere protein L, CENP-L (Interphase centromere complex protein 33)"	CENPL C1orf155 ICEN33	Homo sapiens (Human)		"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]"		GO:0000775; GO:0005654; GO:0005829	VAFLLHK	1.370000005	9.99E-07	9.99E-07	0.29217752	827.01708	17.37483	0	0	0	0	0	0	0	0	0	0	18.34487	0	0	0	17.30597	17.44102	0	0	0	0	0	0	0	0	0	0	0	17.8857	16.9084	0	0	0	18.00961	0	0	19.48198	0	0	0	17.19714	18.27483	0	0	0	0	0	0
Q8N0T1	RBIS_HUMAN	Ribosomal biogenesis factor	RBIS C8orf59	Homo sapiens (Human)	ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254]		GO:0005654; GO:0005730; GO:0005829; GO:0042254	AFVNVQK	5.340000153	1	1	0.288244238	806.5948324	12.90669	0	0	0	0	0	0	18.82258	18.35198	0	0	18.36418	17.5624	0	0	0	0	0	0	0	16.74668	18.3133	0	17.81955	20.22055	0	0	0	0	18.03707	21.61802	0	0	0	17.86395	0	0	18.76489	0	17.24914	0	0	0	0	0	0	17.18445	0
Q8N0U7	CA087_HUMAN	Uncharacterized protein C1orf87	C1orf87	Homo sapiens (Human)						APAPPMEPEVPEMSQSKTEHMK	7.550000191	1	1	4.58E-13	2466.744155	15.20293	0	10.16301	0	12.39567	13.49631	0	0	13.23164	0	0	0	0	0	13.42123	0	0	14.68812	15.71558	13.68406	0	0	13.03252	0	0	0	17.21969	0	0	14.55139	11.5723	12.64859	0	0	0	0	13.57702	0	0	0	12.8737	0	0	14.8938	0	0	14.38133	15.07257
Q8N0V5	GNT2A_HUMAN	"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, N-acetylglucosaminyltransferase, EC 2.4.1.150 (I-branching enzyme) (IGNT)"	GCNT2 GCNT5 II NACGT1	Homo sapiens (Human)	glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; posttranscriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; posttranscriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"	GO:0000139; GO:0005794; GO:0006024; GO:0006486; GO:0007179; GO:0007275; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0010812; GO:0016020; GO:0016021; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374	IPGVPGSMPNASWTGNLRAIK	1.059999943	1	1	4.11E-12	2184.695721	0	0	0	14.76037	15.26747	15.15286	0	11.76453	14.81201	0	0	16.68143	0	0	14.36864	14.53033	0	0	0	0	0	0	0	16.025	18.43553	0	16.73077	0	0	18.638	0	0	0	8.585806	19.54846	0	15.44994	0	12.89989	0	0	16.07431	0	17.37191	17.04037	15.34237	16.95041	17.79765
Q8N0W3	FCSK_HUMAN	"L-fucose kinase, Fucokinase, EC 2.7.1.52"	FCSK FUK	Homo sapiens (Human)	carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350]	ATP binding [GO:0005524]; fucokinase activity [GO:0050201]	GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350	ARHVLEAR	4.869999886	1	1	0.071774287	952.412896	0	0	14.72445	14.43797	0	12.37562	0	6.129736	0	0	0	0	15.99446	0	0	0	0	0	14.98736	16.76536	0	14.56279	15.15811	0	12.81783	0	0	0	0	0	0	0	0	0	0	0	16.49294	0	0	0	14.64842	0	0	0	16.63808	0	0	14.19514
Q8N0X2	SPG16_HUMAN	Sperm-associated antigen 16 protein (Pf20 protein homolog)	SPAG16 PF20	Homo sapiens (Human)	axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288]	axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]	axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288]		GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716	DILVSCGEDR	4.840000153	1	1	0.495549206	1162.352749	0	0	0	0	0	0	0	0	17.89091	0	0	0	17.57853	0	17.91673	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N0Z2	ABRA_HUMAN	"Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling, STARS)"	ABRA	Homo sapiens (Human)	positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]	actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]	actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]	actin binding [GO:0003779]	GO:0003779; GO:0005886; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045944; GO:0051091	EMMDMCFIICTMAR	10.11999989	1	1	0.16757913	1856.879038	0	15.00693	14.65385	15.69023	0	0	15.419	16.85522	0	0	0	0	0	0	0	0	0	0	13.03364	0	0	0	15.32681	15.45991	14.55739	0	0	0	0	0	0	0	0	0	0	0	14.49221	0	0	0	15.11841	13.54867	0	0	0	0	14.46822	16.2354
Q8N0Z3	SPICE_HUMAN	Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52) (Spindle and centriole-associated protein)	SPICE1 CCDC52 SPICE	Homo sapiens (Human)	cell division [GO:0051301]; metaphase plate congression [GO:0051310]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle [GO:0005819]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle [GO:0005819]; cell division [GO:0051301]; metaphase plate congression [GO:0051310]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599]		GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0046599; GO:0051301; GO:0051310; GO:0090307	KPNLHALSKPKK	14.39000034	1	1	0.763665191	1356.073463	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.84629	0	16.74856	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N0Z6	TTC5_HUMAN	"Tetratricopeptide repeat protein 5, TPR repeat protein 5 (Stress-responsive activator of p300, Protein Strap)"	TTC5	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]	GO:0003677; GO:0003682; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006974; GO:0009267; GO:0031410; GO:0043022; GO:0045944; GO:0061014	LAVQMDVHDGR	4.980000019	0.254412115	0.254412115	0.131964092	1256.04913	15.4038	15.32962	0	14.50201	0	0	12.76039	15.33414	0	0	0	15.95385	0	0	0	13.40603	9.432482	0	0	0	11.5428	15.72043	0	0	0	0	14.38973	0	0	16.66004	0	0	14.65486	0	15.10509	0	0	0	0	0	14.10723	0	14.44341	0	0	0	0	0
Q8N103	TAGAP_HUMAN	T-cell activation Rho GTPase-activating protein (T-cell activation GTPase-activating protein)	TAGAP TAGAP1 FKSG15	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005829; GO:0007165; GO:0051056	MLEAHCLLPPLPPAHHVEDSR	11.14999962	1	1	4.12E-12	2435.289332	0	0	0	14.5368	0	14.95222	0	13.33438	0	13.02728	15.30158	0	16.71728	0	0	0	13.6315	0	0	0	0	0	0	0	15.24987	17.00488	0	15.4916	0	0	14.20781	9.878799	15.08508	0	0	0	0	13.98595	0	0	0	0	0	0	14.85582	17.54616	0	0
Q8N104	D106A_HUMAN	"Beta-defensin 106 (Beta-defensin 6, BD-6, DEFB-6) (Defensin, beta 106)"	DEFB106A BD6 DEFB106 DEFB6; DEFB106B	Homo sapiens (Human)	antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]	extrinsic component of membrane [GO:0019898]; microvesicle [GO:1990742]; nucleus [GO:0005634]	extrinsic component of membrane [GO:0019898]; microvesicle [GO:1990742]; nucleus [GO:0005634]; CCR2 chemokine receptor binding [GO:0031727]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]	CCR2 chemokine receptor binding [GO:0031727]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]	GO:0001530; GO:0005634; GO:0008201; GO:0019898; GO:0031727; GO:0045087; GO:0050829; GO:0050830; GO:0061760; GO:1990742	RTFLFLFAVLFFLTPAK	2.519999981	1	1	0.053923729	2031.507902	14.98011	15.01235	12.99994	14.03505	13.66391	0	16.79333	0	12.84442	0	12.96394	13.87376	11.28748	13.70469	13.96049	11.02292	12.98981	0	13.19205	0	0	0	15.51918	14.40587	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N122	RPTOR_HUMAN	"Regulatory-associated protein of mTOR, Raptor (p150 target of rapamycin (TOR)-scaffold protein)"	RPTOR KIAA1303 RAPTOR	Homo sapiens (Human)	cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	14-3-3 protein binding [GO:0071889]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]	GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006974; GO:0008361; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0010800; GO:0016310; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0035176; GO:0038202; GO:0043025; GO:0044877; GO:0045821; GO:0045945; GO:0046889; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0071889; GO:0071902; GO:1900087; GO:1905857	EQELEVAAINPNHPLAQMPLPPSMK	9.600000381	1	1	0.068679406	2754.485752	0	12.77757	12.6241	0	0	0	0	14.65891	12.35215	0	0	0	0	0	14.79285	0	14.55071	0	13.62962	0	0	0	14.89338	0	0	12.75333	14.5399	14.66521	11.41178	0	13.51557	0	15.53683	9.756865	16.36452	0	15.47816	12.05688	0	0	15.0838	0	14.05135	0	0	0	0	17.14539
Q8N129	CNPY4_HUMAN	Protein canopy homolog 4	CNPY4 PSEC0237 UNQ1909/PRO4354	Homo sapiens (Human)	positive regulation of protein localization to plasma membrane [GO:1903078]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; positive regulation of protein localization to plasma membrane [GO:1903078]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:1903078	TGSHPK	5.21999979	1	1	0.239135627	625.6418331	0	0	0	18.20941	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.31506	0	0	0	0	0	0	20.40438	0	0	0	0	18.99604	18.80956	0	0	0	0	0	0	0	0	0	0
Q8N130	NPT2C_HUMAN	"Sodium-dependent phosphate transport protein 2C, Sodium-phosphate transport protein 2C (Na(+)-dependent phosphate cotransporter 2C) (Sodium/inorganic phosphate cotransporter IIC) (Sodium/phosphate cotransporter 2C, Na(+)/Pi cotransporter 2C, NaPi-2c) (Solute carrier family 34 member 3)"	SLC34A3 NPT2C NPTIIC	Homo sapiens (Human)	cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]; sodium-dependent phosphate transport [GO:0044341]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]; sodium-dependent phosphate transport [GO:0044341]	sodium:phosphate symporter activity [GO:0005436]	GO:0005436; GO:0005886; GO:0005903; GO:0006814; GO:0006817; GO:0016021; GO:0016324; GO:0030643; GO:0031526; GO:0031982; GO:0044341	LLNSVLR	20.98999977	0.244070947	0.244070947	0.225549421	814.4572499	15.55594	15.58735	16.66314	15.69159	16.21535	16.20954	16.19515	16.81288	0	15.76259	17.75571	15.75237	16.2202	16.05502	16.70707	17.78677	16.92481	15.953	16.25469	16.61115	16.34045	16.37416	17.75296	16.10321	16.9534	16.54544	17.10131	15.83054	16.22789	16.51098	16.28195	16.68994	17.32134	16.15159	16.09112	16.75356	17.26244	16.0696	16.39327	16.87703	16.21728	16.18717	16.30043	16.21107	17.22477	16.88108	18.48926	17.2118
Q8N135	LGI4_HUMAN	Leucine-rich repeat LGI family member 4 (LGI1-like protein 3) (Leucine-rich glioma-inactivated protein 4)	LGI4 LGIL3 UNQ6515/PRO21485	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; glial cell proliferation [GO:0014009]; myelination in peripheral nervous system [GO:0022011]; neuron maturation [GO:0042551]; regulation of myelination [GO:0031641]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; adult locomotory behavior [GO:0008344]; glial cell proliferation [GO:0014009]; myelination in peripheral nervous system [GO:0022011]; neuron maturation [GO:0042551]; regulation of myelination [GO:0031641]		GO:0005576; GO:0005615; GO:0008344; GO:0014009; GO:0022011; GO:0031641; GO:0042551	YIGDSMVMR	6.690000057	1	1	0.415003945	1104.440186	15.48496	0	11.9616	15.49663	0	15.29741	0	15.14694	0	15.59952	0	11.69698	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.07725	0	0	0	0	0	15.68273	0	0	0	0	0	0	0	17.72171	0	0	0	0	15.00141	0	0
Q8N145	LGI3_HUMAN	Leucine-rich repeat LGI family member 3 (LGI1-like protein 4) (Leucine-rich glioma-inactivated protein 3)	LGI3 LGIL4 UNQ8190/PRO23199	Homo sapiens (Human)	exocytosis [GO:0006887]; regulation of exocytosis [GO:0017157]	extracellular region [GO:0005576]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]	extracellular region [GO:0005576]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; catalytic activity [GO:0003824]; exocytosis [GO:0006887]; regulation of exocytosis [GO:0017157]	catalytic activity [GO:0003824]	GO:0003824; GO:0005576; GO:0006887; GO:0008021; GO:0017157; GO:0043005	AFCYMPAGDAQLLLAPSFK	3.220000029	0.756844044	0.756844044	4.60E-13	2100.401268	0	0	12.56212	13.0953	0	0	12.23511	0	13.3682	0	0	0	0	0	0	0	0	0	0	0	13.92645	0	14.83446	0	0	0	0	0	0	0	0	0	0	0	15.28703	0	0	0	0	0	0	0	12.49282	0	0	0	0	0
Q8N158	GPC2_HUMAN	Glypican-2 [Cleaved into: Secreted glypican-2 ]	GPC2	Homo sapiens (Human)	cell migration [GO:0016477]; neuron differentiation [GO:0030182]; positive regulation of neuron projection development [GO:0010976]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; smoothened signaling pathway [GO:0007224]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell migration [GO:0016477]; neuron differentiation [GO:0030182]; positive regulation of neuron projection development [GO:0010976]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; smoothened signaling pathway [GO:0007224]		GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0007224; GO:0009966; GO:0009986; GO:0010976; GO:0016477; GO:0030182; GO:0043202; GO:0045202; GO:0046658; GO:0062023; GO:1905475	MAADASLEAAPCWTGAGR	4.5	0.001381578	0.001381578	0.064401051	1834.205578	0	0	0	14.15629	0	15.59389	16.96111	0	15.95359	17.73002	0	15.65108	0	12.90655	13.14254	0	14.85727	14.41447	0	14.56004	16.56554	0	0	0	0	15.33913	0	0	19.96435	0	0	16.21552	0	13.3778	16.05701	0	14.57864	16.79635	0	0	17.44141	0	0	0	15.12499	0	13.15291	14.79798
Q8N159	NAGS_HUMAN	"N-acetylglutamate synthase, mitochondrial, EC 2.3.1.1 (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form ]"	NAGS	Homo sapiens (Human)	arginine biosynthetic process [GO:0006526]; glutamate metabolic process [GO:0006536]; urea cycle [GO:0000050]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; arginine binding [GO:0034618]; methione N-acyltransferase activity [GO:0103045]; arginine biosynthetic process [GO:0006526]; glutamate metabolic process [GO:0006536]; urea cycle [GO:0000050]	acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; arginine binding [GO:0034618]; methione N-acyltransferase activity [GO:0103045]	GO:0000050; GO:0004042; GO:0005739; GO:0005759; GO:0006526; GO:0006536; GO:0034618; GO:0103045	ERQQMR	10.44999981	0.259719908	0.259719908	0.18080533	865.1044298	15.03226	14.58456	14.54551	0	15.46241	17.68692	18.2728	15.16642	12.12038	0	13.91434	16.65145	18.43125	18.0302	0	0	17.58546	0	13.96015	0	14.65647	15.31621	17.57475	15.13883	18.45311	16.95559	0	16.95468	0	18.65716	18.0429	17.57384	19.37138	0	0	0	16.78196	18.26634	0	17.717	0	17.13909	0	16.92426	15.85171	16.98476	17.17894	13.77742
Q8N163	CCAR2_HUMAN	"Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein, DBC-1, DBC.1) (NET35) (p30 DBC)"	CCAR2 DBC1 KIAA1967	Homo sapiens (Human)	"cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055]"	enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]	GO:0000785; GO:0000993; GO:0003723; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005819; GO:0006355; GO:0006397; GO:0006974; GO:0007049; GO:0008380; GO:0009411; GO:0016055; GO:0019899; GO:0030308; GO:0030374; GO:0031647; GO:0032435; GO:0032784; GO:0042752; GO:0043065; GO:0043086; GO:0043653; GO:0044609; GO:0045892; GO:0048511; GO:0090263; GO:0090311; GO:1902230; GO:2000003	ILLTLGIR	12.86999989	1	1	8.07E-13	899.0338649	0	14.93602	0	0	0	13.1317	0	0	0	0	0	0	0	15.10635	0	0	0	15.09422	0	0	15.35145	0	0	0	0	0	12.35964	11.42839	0	14.95557	0	0	0	0	0	16.44758	0	16.13524	0	0	0	0	0	0	0	0	0	0
Q8N183	NDUF2_HUMAN	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 (B17.2-like, B17.2L) (Mimitin) (Myc-induced mitochondrial protein, MMTN) (NDUFA12-like protein)"	NDUFAF2 NDUFA12L	Homo sapiens (Human)	mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex binding [GO:0044877]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]	protein-containing complex binding [GO:0044877]	GO:0005739; GO:0005743; GO:0032981; GO:0044877; GO:0061179	SQDFYEK	8.100000381	0.267772943	0.267772943	0.06009764	916.2031342	0	16.36396	0	13.84352	14.10598	13.79499	0	15.50704	14.34047	0	0	0	14.65047	14.92007	17.44113	0	14.46236	17.4892	0	13.4192	15.93574	0	0	14.62534	0	15.98502	17.03728	0	0	0	18.17141	0	17.21994	12.52089	16.45781	14.43472	13.35768	15.17135	16.66512	0	16.57229	0	0	16.27931	0	0	16.72937	10.43655
Q8N184	ZN567_HUMAN	Zinc finger protein 567	ZNF567	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872	AFRMK	6.400000095	1	1	0.07014117	668.5488106	13.13873	0	0	0	0	15.79306	0	0	15.20171	13.12864	0	15.83892	0	0	16.83442	0	0	0	0	0	16.61158	15.87059	0	15.38078	15.7486	0	0	0	0	0	0	15.50424	14.3753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N187	CARTF_HUMAN	"Calcium-responsive transcription factor (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein) (Calcium-response factor, CaRF) (Testis development protein NYD-SP24)"	CARF ALS2CR8	Homo sapiens (Human)	cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; positive regulation of transcription from RNA polymerase II promoter in response to calcium ion [GO:0061400]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]	granular component [GO:0001652]; nucleus [GO:0005634]	"granular component [GO:0001652]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; positive regulation of transcription from RNA polymerase II promoter in response to calcium ion [GO:0061400]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001228; GO:0001652; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0035865; GO:0051090; GO:0061400; GO:0071277	NLVDAGGVLR	11.39999962	1	1	0.137296256	1013.919353	0	13.66193	14.67918	0	0	0	0	0	0	0	0	12.21659	13.18279	14.218	0	14.69726	0	0	15.96815	15.35476	13.80438	0	0	0	0	13.00297	0	13.27978	14.89859	15.78447	15.80212	15.49815	14.09426	15.10472	13.67142	13.67126	16.22811	15.61689	15.85445	16.10938	15.15454	0	0	15.908	0	15.95911	0	0
Q8N1B4	VPS52_HUMAN	Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein)	VPS52 SACM2L	Homo sapiens (Human)	"ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]	"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"	syntaxin binding [GO:0019905]	GO:0000938; GO:0005794; GO:0005829; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:1990745	SRNTIFTLGTR	2.230000019	1	1	0.388822526	1266.009564	14.42791	0	16.27409	12.93776	15.07902	0	0	16.73804	0	15.10536	15.92111	0	0	0	0	16.23938	0	0	0	0	16.81851	0	15.52115	0	0	0	16.1374	0	15.85084	0	0	0	16.15697	0	0	0	0	0	0	16.39309	18.25693	16.67764	0	0	0	0	18.0714	0
Q8N1C3	GBRG1_HUMAN	Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1)	GABRG1	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	"chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0004890; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:1902476; GO:1902711; GO:1904315	DAVPAR	6.619999886	0.151061341	0.151061341	0.193346567	628.5380241	14.33189	15.52698	0	15.87381	13.00383	12.54427	15.30337	0	15.30108	15.82621	0	15.94344	12.66094	15.47095	14.86304	14.78183	13.4054	15.79734	15.87574	17.35278	16.82644	15.47984	0	14.04289	16.34706	15.6305	16.60237	16.23934	15.41353	15.69867	14.96474	15.71327	0	0	0	16.7179	14.96072	0	19.0621	0	16.19617	0	0	16.68371	0	0	16.19718	0
Q8N1D5	CF107_HUMAN	Protein CFAP107 (Cilia- and flagella-associated protein 107)	CFAP107 C1orf158	Homo sapiens (Human)						HGYNPGLPPLR	6.199999809	1	1	0.083602008	1219.75494	12.57801	0	13.33669	12.92183	12.72536	0	0	0	14.24198	0	14.24934	0	15.36622	13.5257	0	0	0	11.10951	12.19215	0	0	0	0	0	0	0	0	0	13.39338	0	0	0	0	13.38511	14.29301	0	0	0	0	0	0	0	0	0	0	14.18709	0	0
Q8N1F7	NUP93_HUMAN	Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93)	NUP93 KIAA0095	Homo sapiens (Human)	nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606]; SMAD protein signal transduction [GO:0060395]	centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]	centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606]; SMAD protein signal transduction [GO:0060395]	structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0005813; GO:0005829; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0016973; GO:0017056; GO:0031965; GO:0034399; GO:0051292; GO:0060391; GO:0060395	NMALSIAER	20.46999931	1	1	0.421800406	1020.607016	16.80181	0	0	17.69942	0	16.10609	0	0	0	0	18.79128	0	0	0	0	0	18.95164	17.91553	0	0	16.05305	18.84879	21.2075	0	0	18.87463	0	17.67227	0	18.30086	15.67374	0	0	0	18.02599	0	0	0	17.87192	20.05856	18.83577	17.42203	0	0	17.78061	0	0	0
Q8N1G0	ZN687_HUMAN	Zinc finger protein 687	ZNF687 KIAA1441	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005654; GO:0005829; GO:0046872	AVVLPGGTATSPKMIAK	3.339999914	1	1	0.284937234	1656.973228	0	17.8989	0	0	0	0	0	0	0	0	0	0	0	15.82166	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.71849	0	0	0	0	0	0
Q8N1G1	REXO1_HUMAN	"RNA exonuclease 1 homolog, EC 3.1.-.- (Elongin-A-binding protein 1, EloA-BP1) (Transcription elongation factor B polypeptide 3-binding protein 1)"	REXO1 ELOABP1 KIAA1138 TCEB3BP1	Homo sapiens (Human)		nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604	GLAPSAVPGLSKTSGR	7.010000229	1	1	0.318185027	1498.073938	0	0	14.1096	0	0	14.65233	0	14.66248	14.35286	14.89278	0	14.38802	15.20616	12.35252	14.81755	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.12562	0	0	15.74617	0	0	0
Q8N1G2	CMTR1_HUMAN	"Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1, EC 2.1.1.57 (Cap methyltransferase 1) (Cap1 2'O-ribose methyltransferase 1, MTr1, hMTr1) (FtsJ methyltransferase domain-containing protein 2) (Interferon-stimulated gene 95 kDa protein, ISG95)"	CMTR1 FTSJD2 KIAA0082 MTR1	Homo sapiens (Human)	7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009]	mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004483; GO:0005634; GO:0005654; GO:0005737; GO:0006370; GO:0043231; GO:0080009; GO:0097309	NFVLDNTDR	6.53000021	1	1	0.438435751	1093.058906	18.89803	16.97416	16.23957	0	0	0	0	19.51992	18.70577	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.0741	0	0	0	0	0	0	0
Q8N1G4	LRC47_HUMAN	Leucine-rich repeat-containing protein 47	LRRC47 KIAA1185	Homo sapiens (Human)	phenylalanyl-tRNA aminoacylation [GO:0006432]		phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]	phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0003723; GO:0004826; GO:0006432	LKEINFR	22.5	1	1	0.271794508	919.7462992	15.24151	0	15.9492	0	13.13579	18.57391	0	18.16107	0	0	16.82561	16.93178	15.06442	15.01864	17.33399	13.69746	17.40637	18.50588	14.96526	0	15.37265	16.53076	12.11384	0	16.52317	17.40196	15.44303	0	17.41896	17.23927	15.27724	15.6233	0	16.45309	15.89418	0	17.59209	0	17.72498	15.37379	18.03419	15.75353	16.76618	15.75527	18.77182	16.87918	16.39596	17.24179
Q8N1H7	S6OS1_HUMAN	Protein SIX6OS1 (Six6 opposite strand transcript 1)	SIX6OS1 C14orf39	Homo sapiens (Human)	homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; oogenesis [GO:0048477]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]	central element [GO:0000801]; chromosome [GO:0005694]	central element [GO:0000801]; chromosome [GO:0005694]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; oogenesis [GO:0048477]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]		GO:0000801; GO:0005694; GO:0007129; GO:0007283; GO:0010705; GO:0048477; GO:0051090	ESPGLSFLMSYTSR	5.090000153	1	1	0.514536233	1592.571855	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.4158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N1I0	DOCK4_HUMAN	Dedicator of cytokinesis protein 4	DOCK4 KIAA0716	Homo sapiens (Human)	cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005096; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0016020; GO:0017124; GO:0030165; GO:0030971; GO:0031267; GO:0032420; GO:0032421; GO:0060326; GO:1904694; GO:1904754	ITGCLSK	11.15999985	0.106829152	0.106829152	0.243895479	778.2576437	15.73084	16.01294	0	17.39506	15.16256	15.17862	15.55359	0	15.52236	15.24605	15.45456	15.89814	15.70044	16.69615	16.22163	15.5578	15.54639	0	16.74921	17.77216	16.20029	0	15.26805	18.54448	16.37467	0	0	16.23482	15.91794	15.55257	17.02547	17.19077	15.49403	16.53548	0	17.07457	17.29107	0	17.71053	15.03761	15.3389	0	16.76575	17.61908	17.26324	16.59089	16.32714	17.10469
Q8N1K5	THMS1_HUMAN	Protein THEMIS (Thymocyte-expressed molecule involved in selection)	THEMIS C6orf190 C6orf207	Homo sapiens (Human)	adaptive immune response [GO:0002250]; negative T cell selection [GO:0043383]; positive T cell selection [GO:0043368]; T cell receptor signaling pathway [GO:0050852]	cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; adaptive immune response [GO:0002250]; negative T cell selection [GO:0043383]; positive T cell selection [GO:0043368]; T cell receptor signaling pathway [GO:0050852]		GO:0002250; GO:0005634; GO:0005737; GO:0005911; GO:0008180; GO:0043368; GO:0043383; GO:0050852	TIVIHKK	6.25	1	1	0.224536302	839.2961333	14.17924	0	15.39407	0	16.30921	0	11.92764	0	15.55395	0	0	0	0	0	15.5575	0	14.2067	0	0	14.90584	0	16.65081	0	0	16.18313	0	0	16.10364	14.97656	14.41346	0	0	0	0	14.1908	0	14.49589	0	16.17886	16.03545	0	0	14.61623	15.62735	0	0	0	0
Q8N1L4	CP4Z2_HUMAN	Putative inactive cytochrome P450 family member 4Z2	CYP4Z2P	Homo sapiens (Human)		integral component of membrane [GO:0016021]	"integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]"	GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037	SAVSHK	3.829999924	0.915351927	0.915351927	0.128556946	629.3711251	16.65345	0	0	0	0	14.76093	0	0	16.07969	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.35519	15.95104	0	15.48938	0	16.05552	0	18.33037	0	17.46419	17.83289	18.34329	0	0	0	0	15.21789	0	0	0	0	0	0	0
Q8N1N2	DYNAP_HUMAN	"Dynactin-associated protein, Full"	DYNAP C18orf26	Homo sapiens (Human)	activation of protein kinase B activity [GO:0032148]; cellular response to ergosterol [GO:1901625]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; activation of protein kinase B activity [GO:0032148]; cellular response to ergosterol [GO:1901625]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981]		GO:0000139; GO:0005794; GO:0005886; GO:0008284; GO:0016021; GO:0032148; GO:0042981; GO:1901625	MVADIK	16.45000076	1	1	0.210082313	693.411885	15.52557	0	0	17.0856	0	16.72246	0	17.92164	0	0	16.0603	17.07458	17.48241	17.34071	18.79007	16.03773	16.70864	17.53143	17.46598	17.629	17.31231	0	18.7054	17.27022	15.91565	0	0	19.21596	17.15047	17.03961	18.96444	0	17.89493	18.96992	0	0	18.39362	17.81811	18.12304	0	17.5116	0	17.66588	15.4256	0	0	16.82894	17.68435
Q8N1N4	K2C78_HUMAN	"Keratin, type II cytoskeletal 78 (Cytokeratin-78, CK-78) (Keratin-5b) (Keratin-78, K78) (Type-II keratin Kb40)"	KRT78 K5B KB40	Homo sapiens (Human)		cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]		GO:0005615; GO:0005829; GO:0045095; GO:0070062	YEEEAHRR	13.13000011	0.406527847	0.406527847	0.239525122	1089.738879	0	17.1321	15.34592	0	0	0	0	15.36605	0	0	16.52511	0	0	0	20.71329	20.60037	20.15539	20.03974	19.35692	21.50039	21.5315	19.12506	0	20.07107	0	19.26628	0	0	20.05091	0	19.10743	0	0	20.69809	0	19.82595	0	19.29789	20.49682	20.39685	0	19.5224	20.6628	21.71882	21.80173	20.60803	0	0
Q8N1P7	CRBG2_HUMAN	Beta/gamma crystallin domain-containing protein 2 (Absent in melanoma 1-like protein)	CRYBG2 AIM1L	Homo sapiens (Human)			carbohydrate binding [GO:0030246]	carbohydrate binding [GO:0030246]	GO:0030246	GPGAPAASSPTQKEVVK	10.27000046	0.201691419	0.201691419	0.434687558	1622.357476	20.05361	9.928284	17.05505	0	17.65482	0	0	19.43639	15.87882	19.40016	15.76285	0	0	18.59633	0	0	0	0	0	0	0	19.68216	19.66778	0	0	20.25284	0	0	0	19.68766	19.75616	0	0	0	0	0	0	21.73887	20.83613	18.48938	18.87481	18.55483	18.0866	18.51923	17.98171	0	19.84424	18.89369
Q8N1T3	MYO1H_HUMAN	Unconventional myosin-Ih (Myosin-1H)	MYO1H	Homo sapiens (Human)	actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0031982; GO:0051015	INSSLVNK	8.670000076	0.992633462	0.992633462	0.27401751	874.0011701	14.66865	0	15.72382	0	13.81557	0	16.62788	16.10719	0	0	0	0	15.3399	0	13.55658	15.72204	0	15.14408	0	0	15.83244	15.94926	0	13.18557	15.17878	14.30944	15.89326	0	15.02356	0	0	0	0	0	0	15.46967	17.55729	0	16.26687	0	0	15.77034	0	0	0	15.19881	14.29008	0
Q8N1V2	CFA52_HUMAN	Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16) (WD40-repeat protein up-regulated in HCC)	CFAP52 WDR16 WDRPUH	Homo sapiens (Human)	cilium assembly [GO:0060271]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium assembly [GO:0060271]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]		GO:0005930; GO:0030317; GO:0060271; GO:0061966; GO:0097729	LLTDVGPAK	2.299999952	1	1	0.12640455	913.6091825	0	0	0	13.30462	15.53898	0	14.29221	0	14.01783	12.86132	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.07286	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N1W1	ARG28_HUMAN	"Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor, p190-RhoGEF, p190RhoGEF) (Rho guanine nucleotide exchange factor)"	ARHGEF28 KIAA1998 RGNEF	Homo sapiens (Human)	cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; ephrin receptor signaling pathway [GO:0048013]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; ephrin receptor signaling pathway [GO:0048013]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000902; GO:0003723; GO:0005085; GO:0005829; GO:0005886; GO:0030154; GO:0035023; GO:0046872; GO:0048013; GO:0051056	QRSLPAVLLPGGPEVMELNR	6.809999943	1	1	0	2191.358193	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N1W2	ZN710_HUMAN	Zinc finger protein 710	ZNF710	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872	FNLKGNLSR	3.029999971	1	1	0.181145492	1049.213078	12.02602	0	13.48101	17.95693	0	14.47653	0	0	0	0	0	13.45427	17.22942	15.5657	0	0	0	0	0	0	0	0	0	0	0	0	16.28084	0	14.13786	0	18.2708	17.63213	16.44034	0	16.9763	0	12.27947	14.04815	0	0	0	0	0	0	0	0	0	0
Q8N1X5	YF001_HUMAN	Uncharacterized protein FLJ37310		Homo sapiens (Human)						AAAGVTAKAGGGTSAAAASLIR	5.909999847	1	1	0.334651671	1871.874152	17.34169	16.3863	13.47596	14.18578	0	0	0	14.41379	0	0	12.82167	0	12.57682	0	0	7.961958	0	0	0	6.668258	13.74246	14.63112	15.18207	0	0	0	0	0	0	17.88692	0	0	16.66577	0	0	0	0	16.7315	0	0	13.86724	0	0	0	0	0	0	0
Q8N201	INT1_HUMAN	"Integrator complex subunit 1, Int1"	INTS1 KIAA1440 UNQ1821/PRO3434	Homo sapiens (Human)	snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474]	integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474]		GO:0005654; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034474	LLAVQK	8.93999958	0.657904387	0.657904387	0.245938998	670.1163697	17.27638	0	0	0	15.85844	15.27936	0	16.06374	0	15.74322	14.45278	0	0	15.8082	17.1715	12.457	0	0	0	17.43946	0	0	16.89978	14.7496	15.73815	16.32483	14.96758	0	0	0	17.62959	17.58724	0	0	0	0	0	0	0	16.5512	0	16.36651	15.68888	16.68505	0	15.38219	0	0
Q8N205	SYNE4_HUMAN	"Nesprin-4 (KASH domain-containing protein 4, KASH4) (Nuclear envelope spectrin repeat protein 4)"	SYNE4 C19orf46	Homo sapiens (Human)	establishment of epithelial cell apical/basal polarity [GO:0045198]	integral component of nuclear outer membrane [GO:0031309]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]	integral component of nuclear outer membrane [GO:0031309]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; establishment of epithelial cell apical/basal polarity [GO:0045198]		GO:0031309; GO:0034993; GO:0045198	LARHQR	2.339999914	1	1	0.005576183	781.3443668	0	12.56112	13.38539	0	0	0	0	14.7298	14.64382	0	13.9027	10.86914	0	0	0	0	0	0	16.22293	0	0	0	15.77303	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.80474	0	0	0	0	0	0
Q8N228	SCML4_HUMAN	Sex comb on midleg-like protein 4	SCML4	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005634; GO:0042393; GO:0045892	GRPSLHSTPMK	1.980000019	0.448222756	0.448222756	0.170252396	1226.787999	0	0	16.47368	0	0	0	18.73167	0	0	0	15.51508	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.3942	0	0	0	0	0	15.28786	0	15.68507	0	0	0	0	0	0	0	0	0
Q8N239	KLH34_HUMAN	Kelch-like protein 34	KLHL34	Homo sapiens (Human)		extracellular space [GO:0005615]	extracellular space [GO:0005615]		GO:0005615	VPEAR	11.72999954	1	1	0.303521881	571.6630303	17.05521	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.14544	0	0	0	0	0	0	0	0	0	0
Q8N264	RHG24_HUMAN	"Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP, FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa, RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)"	ARHGAP24 FILGAP	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]"	adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]	"adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]"	GTPase activator activity [GO:0005096]	GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0090630; GO:1900028	DRMTANHESYLLMASTQNDMEDWVK	2.00999999	1	1	3.66E-12	3018.09234	0	13.11536	0	0	12.53662	14.59669	0	0	0	13.64676	0	0	0	0	0	0	0	0	0	0	0	0	15.74272	0	0	0	15.50611	18.60488	0	0	0	16.43816	0	13.04377	0	0	0	0	14.20734	0	0	0	0	0	17.20246	11.56682	0	0
Q8N271	PROM2_HUMAN	"Prominin-2, PROM-2 (Prominin-like protein 2, hPROML2)"	PROM2 PROML2 UNQ2521/PRO6014	Homo sapiens (Human)	negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; prominosome [GO:0071914]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; prominosome [GO:0071914]; cholesterol binding [GO:0015485]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087]	cholesterol binding [GO:0015485]	GO:0001934; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016323; GO:0016324; GO:0031346; GO:0031410; GO:0031528; GO:0042995; GO:0043087; GO:0044393; GO:0048550; GO:0060170; GO:0070062; GO:0071914; GO:2001287	AVAQQPEGVR	12.64999962	0.100369535	0.100369535	0.162946964	1056.540477	0	14.19895	0	0	15.09661	13.78161	0	0	14.70557	0	0	0	14.96737	14.63434	0	13.83548	0	12.23727	0	0	14.34578	0	14.17331	0	16.46828	14.45467	0	13.66474	14.55653	0	14.35999	0	0	0	15.42771	15.08555	0	0	0	0	0	15.14501	16.16499	13.0714	13.71574	0	13.34991	0
Q8N283	ANR35_HUMAN	Ankyrin repeat domain-containing protein 35	ANKRD35	Homo sapiens (Human)						EAVAEER	28.70000076	0.471229553	0.471229553	0.297728314	803.8903782	0	18.88345	18.19049	0	0	0	16.63418	16.08384	0	0	18.22803	0	0	0	0	17.74199	0	18.17934	0	17.19188	17.84348	0	0	0	0	0	0	17.33251	0	16.4727	0	20.04125	18.59233	0	19.75361	0	0	18.74352	0	0	19.11523	0	0	0	16.39158	16.44694	18.63777	17.58184
Q8N2C7	UNC80_HUMAN	Protein unc-80 homolog	UNC80 C2orf21 KIAA1843	Homo sapiens (Human)	cation homeostasis [GO:0055080]	axon [GO:0030424]; cation channel complex [GO:0034703]; plasma membrane [GO:0005886]	axon [GO:0030424]; cation channel complex [GO:0034703]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]	cation channel activity [GO:0005261]	GO:0005261; GO:0005886; GO:0030424; GO:0034703; GO:0055080	DSGMLK	7.110000134	1	1	0.102116232	649.1344679	0	15.93564	0	0	13.7329	13.90875	0	15.94314	15.11032	12.09253	14.69502	0	0	15.66403	0	0	0	0	15.25134	13.71188	15.10074	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N2E2	VWDE_HUMAN	von Willebrand factor D and EGF domain-containing protein	VWDE	Homo sapiens (Human)	anatomical structure development [GO:0048856]	cell surface [GO:0009986]; extracellular region [GO:0005576]	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0009986; GO:0048856	EGYTGRR	9.010000229	1	1	6.89E-13	838.709882	0	12.47657	12.52751	13.43037	0	11.36339	15.02799	16.66388	13.97424	12.89228	12.98456	14.40602	0	0	0	0	0	0	13.05337	15.70256	0	16.0641	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N2H3	PYRD2_HUMAN	"Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2, EC 1.-.-.-"	PYROXD2 C10orf33	Homo sapiens (Human)	mitochondrion organization [GO:0007005]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]; mitochondrion organization [GO:0007005]	oxidoreductase activity [GO:0016491]	GO:0005759; GO:0007005; GO:0016491	CLLLGTDMAENQKQIAQFSQK	6.25	0.29807201	0.29807201	0.090701664	2438.60394	14.69463	0	0	12.62662	0	0	0	0	0	14.60435	0	0	0	0	0	0	15.01148	0	0	0	0	0	0	0	13.98433	12.75421	15.91276	13.54068	0	0	13.56916	0	0	0	0	15.0787	0	0	0	13.92077	0	8.998926	13.34926	14.4182	0	0	0	15.99183
Q8N2I2	ZN619_HUMAN	Zinc finger protein 619	ZNF619	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	SDIPAGARR	4.329999924	0.145331755	0.145331755	0.2244301	941.7982804	0	14.65277	11.88866	11.31207	14.56659	13.86283	15.18013	13.55487	13.74435	0	15.06952	15.3636	14.23801	15.99238	0	11.73984	0	0	14.85429	15.23809	17.25232	0	0	0	16.48778	0	0	0	0	0	0	16.02014	0	0	0	0	16.69022	0	17.83247	15.6929	0	0	0	0	15.29022	0	0	15.67505
Q8N2I9	STK40_HUMAN	"Serine/threonine-protein kinase 40, EC 2.7.11.1 (SINK-homologous serine/threonine-protein kinase) (Sugen kinase 495, SgK495)"	STK40 SGK495 SHIK	Homo sapiens (Human)	glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0003016; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0010468; GO:0035264; GO:0043066; GO:0043408; GO:0048286; GO:0060425; GO:0106310	LGHDAQPMTSLDTAILAQR	10.23999977	0.738556027	0.738556027	9.18E-13	2034.271419	0	0	0	0	13.83454	0	15.16713	0	0	0	0	14.56167	0	0	16.16119	13.49185	0	0	0	0	0	0	16.0218	0	14.35346	13.40315	0	15.16382	14.66817	0	0	0	0	0	0	0	0	13.74084	0	0	0	0	0	14.53649	12.91087	0	13.73379	14.04979
Q8N2K0	ABD12_HUMAN	"Lysophosphatidylserine lipase ABHD12, EC 3.1.-.- (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12, hABHD12) (Monoacylglycerol lipase ABHD12, EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12, EC 3.1.-.-)"	ABHD12 C20orf22	Homo sapiens (Human)	acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]	AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996]	acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0002084; GO:0004620; GO:0004622; GO:0005789; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0009395; GO:0010996; GO:0016020; GO:0016021; GO:0019369; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0050727; GO:0052651	CAADAGMK	2.380000114	0.172512159	0.172512159	0.103408945	840.4014643	14.44663	0	14.60821	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.68456	0	0	0	0	0	0	16.16204	16.21892	0	0	0	0	0	0	0	0	0	0	16.5007	16.70729	16.95838	15.75579	15.83095	0	16.67878	0	0	0	0	0
Q8N2M8	CLASR_HUMAN	"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)"	CLASRP SFRS16 SWAP2 UNQ2428/PRO4988	Homo sapiens (Human)	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]		GO:0005654; GO:0006397; GO:0008380	GGYGPRR	3.339999914	0.601350844	0.601350844	8.06E-13	763.3614031	10.0564	16.11996	10.1534	0	0	0	12.50853	0	16.60669	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.32315	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N2N9	AN36B_HUMAN	Ankyrin repeat domain-containing protein 36B (CLL-associated antigen KW-1)	ANKRD36B	Homo sapiens (Human)			identical protein binding [GO:0042802]	identical protein binding [GO:0042802]	GO:0042802	EGQQSGTVSPQKQSAQK	3.950000048	1	1	9.17E-13	1788.809852	14.98924	15.51521	13.93414	0	14.84602	15.35013	14.90709	15.10941	8.629694	17.1676	0	14.20539	12.10446	15.3153	16.01523	0	0	12.10735	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.06358	0	0	0	0	0	0	0	0	0	15.1606	0	0	0	0	0
Q8N2R0	OSR2_HUMAN	Protein odd-skipped-related 2	OSR2	Homo sapiens (Human)	"bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; head development [GO:0060322]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; osteoblast proliferation [GO:0033687]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; urogenital system development [GO:0001655]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; head development [GO:0060322]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; osteoblast proliferation [GO:0033687]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; urogenital system development [GO:0001655]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0001655; GO:0001656; GO:0001823; GO:0002062; GO:0005634; GO:0006357; GO:0008284; GO:0009792; GO:0010628; GO:0030154; GO:0030501; GO:0033687; GO:0035115; GO:0035116; GO:0036023; GO:0042474; GO:0042476; GO:0042733; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0048704; GO:0050679; GO:0060021; GO:0060272; GO:0060322; GO:0060349; GO:0061029; GO:0072498; GO:1990837	HSLTHTPR	9.68999958	1	1	0.219635609	949.5049479	0	15.65638	14.50472	0	0	0	0	0	15.43024	0	0	16.34943	0	15.0628	15.86852	0	12.69521	0	11.62431	14.00507	15.28753	0	13.87851	13.29064	13.44889	0	12.93291	14.75529	14.81497	15.74024	13.51279	0	16.90403	0	15.71409	15.9591	0	0	16.74587	16.65396	15.28507	16.84405	15.66687	16.21061	0	0	0	0
Q8N2W9	PIAS4_HUMAN	"E3 SUMO-protein ligase PIAS4, EC 2.3.2.27 (PIASy) (Protein inhibitor of activated STAT protein 4) (Protein inhibitor of activated STAT protein gamma, PIAS-gamma)"	PIAS4 PIASG	Homo sapiens (Human)	"central nervous system development [GO:0007417]; double-strand break repair [GO:0006302]; hair follicle development [GO:0001942]; limb epidermis development [GO:0060887]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vitamin D metabolic process [GO:0042359]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transferase complex [GO:1990234]	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transferase complex [GO:1990234]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; double-strand break repair [GO:0006302]; hair follicle development [GO:0001942]; limb epidermis development [GO:0060887]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vitamin D metabolic process [GO:0042359]; Wnt signaling pathway [GO:0016055]"	DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000122; GO:0001942; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0006357; GO:0007417; GO:0008022; GO:0008270; GO:0010804; GO:0016055; GO:0016363; GO:0016605; GO:0016925; GO:0019789; GO:0031625; GO:0032088; GO:0033235; GO:0042359; GO:0045892; GO:0060887; GO:0061665; GO:1902174; GO:1902231; GO:1905168; GO:1990234	SGLKHELVTR	4.159999847	1	1	0.102304288	1140.495418	0	0	0	16.04395	0	0	0	17.39466	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.22797	17.64247	0	0	0	0	0	0	0
Q8N2Y8	RUSC2_HUMAN	"AP-4 complex accessory subunit RUSC2 (Interacting protein of Rab1, Iporin) (RUN and SH3 domain-containing protein 2)"	RUSC2 KIAA0375	Homo sapiens (Human)		cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; small GTPase binding [GO:0031267]	small GTPase binding [GO:0031267]	GO:0005829; GO:0031267; GO:0031410; GO:0070062	GLVKAVNIAVDLIVAHFGTSR	7.28000021	1	1	0.028058237	2180.20172	0	0	0	0	16.08091	0	13.30112	13.21707	13.26287	0	0	14.96101	0	0	0	13.56412	14.32932	0	0	0	0	0	0	0	0	0	0	0	14.0172	0	0	0	14.81629	0	9.365597	0	14.02146	0	0	0	0	0	0	12.52073	0	0	0	0
Q8N300	SVBP_HUMAN	Small vasohibin-binding protein (Coiled coil domain-containing protein 23)	SVBP CCDC23	Homo sapiens (Human)	axon development [GO:0061564]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein ubiquitination [GO:0031397]; protein secretion [GO:0009306]; proteolysis [GO:0006508]; regulation of metallopeptidase activity [GO:1905048]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; microtubule binding [GO:0008017]; axon development [GO:0061564]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein ubiquitination [GO:0031397]; protein secretion [GO:0009306]; proteolysis [GO:0006508]; regulation of metallopeptidase activity [GO:1905048]	microtubule binding [GO:0008017]	GO:0005576; GO:0005737; GO:0005856; GO:0006508; GO:0008017; GO:0009306; GO:0010596; GO:0031397; GO:0045177; GO:0061564; GO:1905048	QRAEIYALNR	6.440000057	1	1	0.319371703	1232.828306	0	14.37581	0	13.82914	13.5217	14.79668	14.08212	0	12.19508	15.15904	15.32132	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42469	0	0	0	15.31384	0	0	0	0	0	0	0	0	0	0	0	16.22698	0	0	0
Q8N302	AGGF1_HUMAN	"Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q, hVG5Q) (G patch domain-containing protein 7) (Vasculogenesis gene on 5q protein)"	AGGF1 GPATC7 GPATCH7 VG5Q	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; nucleic acid binding [GO:0003676]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]	nucleic acid binding [GO:0003676]	GO:0001525; GO:0001570; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0045766; GO:0048471	DLNSEDQK	5.699999809	0.774256825	0.774256825	0.184148096	949.3597252	16.23045	18.51422	11.1612	15.13495	15.76408	13.56019	0	0	0	0	18.56796	17.8646	14.24873	0	0	15.71619	0	12.79801	0	0	0	0	0	14.70284	0	0	0	0	0	0	15.95223	15.67201	13.50457	0	0	0	16.62628	0	0	0	0	0	0	0	14.28006	15.10752	0	15.73106
Q8N307	MUC20_HUMAN	"Mucin-20, MUC-20"	MUC20 KIAA1359 UNQ2782/PRO7170	Homo sapiens (Human)	hepatocyte growth factor receptor signaling pathway [GO:0048012]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; hepatocyte growth factor receptor signaling pathway [GO:0048012]	identical protein binding [GO:0042802]	GO:0005576; GO:0005796; GO:0005886; GO:0009925; GO:0016323; GO:0016324; GO:0031528; GO:0042802; GO:0048012	VAERLMQQLHR	6.360000134	1	1	0.297225102	1396.096761	14.87589	14.27289	0	14.72236	0	14.74814	0	0	0	0	0	0	0	13.92194	12.744	0	0	11.70796	0	0	0	0	0	0	0	0	16.57943	0	0	0	0	0	0	0	16.53699	0	17.51532	0	0	0	0	0	0	0	0	0	16.17473	0
Q8N319	CF223_HUMAN	Uncharacterized protein C6orf223	C6orf223	Homo sapiens (Human)						IAGARLMR	14.84000015	0.567214251	0.567214251	0.229753658	902.7009413	15.84153	14.07961	15.23505	0	0	13.98448	15.30309	15.83945	0	14.79609	0	0	15.02668	15.14073	16.87109	0	15.88194	0	16.29941	0	15.13341	15.27075	16.85314	16.02475	16.96908	14.99393	16.09522	13.68687	16.64382	0	15.89708	14.28654	0	16.25484	15.71065	16.33239	15.86784	13.05758	17.1522	16.68892	17.07289	14.67268	0	0	0	0	17.24595	16.54234
Q8N323	NXPE1_HUMAN	NXPE family member 1 (Protein FAM55A)	NXPE1 FAM55A	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	MSSNTMLQK	2.890000105	1	1	0.357679279	1054.689846	0	0	0	0	0	0	0	0	15.0477	0	0	0	0	15.14353	0	0	0	0	0	0	0	15.06232	0	16.19624	14.44118	0	15.62448	0	0	0	15.31497	15.57558	16.08361	0	13.94062	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N336	ELMD1_HUMAN	ELMO domain-containing protein 1	ELMOD1	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]		GTPase activator activity [GO:0005096]; positive regulation of GTPase activity [GO:0043547]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0043547	ICYNTKPGASRTMK	2.980000019	1	1	0.242324912	1627.645974	0	0	16.9305	0	0	0	0	0	0	0	13.20777	0	0	0	0	0	0	0	14.73051	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53047	0	14.68176	0	0	0	0	0	0	0	0	0	16.33064	0	0
Q8N349	OR2LD_HUMAN	Olfactory receptor 2L13 (Olfactory receptor 2L14)	OR2L13 OR2L14	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	NKEVLGAMR	7.340000153	1	1	0.036584803	1034.292629	0	14.74383	0	0	0	0	0	0	0	14.6114	12.97405	0	15.07611	0	0	0	0	0	15.02854	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.90897	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N365	CIART_HUMAN	"Circadian-associated transcriptional repressor (ChIP-derived repressor of network oscillator, Chrono) (Computationally highlighted repressor of the network oscillator)"	CIART C1orf51	Homo sapiens (Human)	"circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]; PML body [GO:0016605]	"nucleus [GO:0005634]; PML body [GO:0016605]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; negative regulation of transcription, DNA-templated [GO:0045892]"	E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0005634; GO:0016605; GO:0032922; GO:0045475; GO:0045892; GO:0070888	KMTIGHR	11.72999954	1	1	0.183536464	858.713486	14.24196	13.50222	0	16.70564	15.35836	11.88936	13.33297	0	14.75969	15.84868	15.5629	14.26348	14.54061	12.74763	0	0	0	0	0	0	0	15.25626	15.62542	0	13.8258	0	15.3476	0	0	0	0	0	0	0	0	0	0	15.4829	14.1911	0	15.99223	0	0	0	14.56631	0	15.049	0
Q8N371	KDM8_HUMAN	"Bifunctional peptidase and arginyl-hydroxylase JMJD5, EC 1.14.11.73, EC 3.4.-.- (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8)"	KDM8 JMJD5	Homo sapiens (Human)	"chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]"	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; peptidyl-arginine 3-dioxygenase activity [GO:0106157]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]"	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; peptidyl-arginine 3-dioxygenase activity [GO:0106157]	GO:0000086; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0016706; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0051864; GO:0070544; GO:0106157	LEKTVPR	13.10000038	1	1	0.256385398	842.9329606	17.57477	0	0	0	0	0	18.49207	0	0	0	0	0	0	18.23646	0	17.72478	0	0	21.91941	0	17.05809	0	0	16.99331	0	20.32665	0	0	0	0	19.39095	0	0	0	0	0	0	0	0	0	18.85262	0	0	0	0	0	0	0
Q8N392	RHG18_HUMAN	Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18)	ARHGAP18	Homo sapiens (Human)	regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]	GO:0001726; GO:0005096; GO:0005737; GO:0005829; GO:0005881; GO:0005886; GO:0007264; GO:0008360; GO:0016607; GO:0030833; GO:0032956; GO:0045296; GO:0051056; GO:2000145	IGDLAPQDMK	1.850000024	1	1	0.153560088	1104.398192	0	14.26373	13.66213	0	0	0	0	0	0	0	0	0	0	16.21139	13.92908	0	0	0	16.05893	0	16.55814	0	14.65744	0	0	0	0	13.07119	0	14.89959	0	0	0	0	0	0	0	0	0	0	0	16.80538	0	0	0	0	0	0
Q8N394	TMTC2_HUMAN	"Protein O-mannosyl-transferase TMTC2, EC 2.4.1.109 (Transmembrane and TPR repeat-containing protein 2)"	TMTC2	Homo sapiens (Human)	calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269]	dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]	GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0016021; GO:0035269; GO:0055074	LIEAAEMAK	10.82999992	1	1	0.230861988	978.5075791	15.08665	14.67729	14.63222	15.61843	14.96187	14.98185	0	0	0	14.77836	13.11584	15.62516	0	0	0	0	0	0	0	14.64839	15.02593	0	0	0	0	0	15.64133	0	0	0	0	15.48324	0	16.09194	15.32098	0	0	0	0	0	0	15.47229	0	18.02912	0	15.71995	0	0
Q8N398	VW5B2_HUMAN	von Willebrand factor A domain-containing protein 5B2	VWA5B2	Homo sapiens (Human)						AALAGR	8.850000381	0.68293339	0.68293339	0.112797901	558.4422287	17.12834	18.21461	17.58725	17.41101	15.97976	17.84256	17.59091	17.38354	17.45908	17.82002	18.55255	18.2555	17.6342	16.48046	17.95102	17.51979	17.52467	17.90031	17.15506	0	18.21548	17.55234	17.58192	18.22763	17.23393	18.3071	17.02819	17.09485	17.43585	16.92643	15.87774	17.4946	18.03132	17.76616	18.03008	17.92411	18.29554	17.96487	17.54109	17.58188	17.79374	17.89681	17.76058	16.5147	18.09912	17.97909	18.50379	17.8714
Q8N3A8	PARP8_HUMAN	"Protein mono-ADP-ribosyltransferase PARP8, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 16, ARTD16) (Poly [ADP-ribose] polymerase 8, PARP-8)"	PARP8	Homo sapiens (Human)	protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]		NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0003950; GO:0006471; GO:0070213; GO:0140289; GO:1990404	CIPVRDR	9.850000381	0.140408218	0.140408218	0.479014728	914.9523351	18.53577	0	16.14328	0	0	0	0	0	14.53744	0	0	0	0	0	0	0	0	0	0	0	15.57712	0	0	0	0	0	0	0	0	17.62002	0	0	18.29436	19.73738	17.39022	0	0	0	0	18.8653	0	0	0	0	0	0	0	0
Q8N3C0	ASCC3_HUMAN	"Activating signal cointegrator 1 complex subunit 3, EC 3.6.4.12 (ASC-1 complex subunit p200, ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)"	ASCC3 HELIC1 RQT2	Homo sapiens (Human)	cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006307; GO:0008283; GO:0016020; GO:0016607; GO:0016887; GO:0032508; GO:0043138; GO:0072344; GO:0099053; GO:1990116	TASHYYIK	6.800000191	0.397880197	0.397880197	0.243036131	983.1183302	0	0	16.99479	0	0	16.13996	13.05705	0	16.02158	0	16.66375	14.80337	0	0	15.78231	13.25775	0	12.3515	0	14.96964	0	0	14.20881	0	0	0	0	13.32692	0	15.64398	0	17.03301	16.81002	16.10646	15.44788	15.41371	0	15.52091	16.48218	0	0	0	17.2834	0	0	0	16.3213	14.58708
Q8N3D4	EH1L1_HUMAN	EH domain-binding protein 1-like protein 1	EHBP1L1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]	endosome [GO:0005768]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]	endosome [GO:0005768]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; actin cytoskeleton organization [GO:0030036]		GO:0005768; GO:0005815; GO:0016020; GO:0030036; GO:0031941	AAEVEMQLR	6.099999905	0.466410995	0.466410995	0.192807604	1046.722146	15.18264	13.95041	0	15.66885	9.411106	14.90321	15.79136	0	0	0	8.196527	15.08138	14.42611	15.93877	14.44854	0	0	15.40258	16.10114	15.18587	11.93343	0	0	0	0	0	0	0	13.85493	0	0	17.39845	0	0	0	0	15.79655	17.65862	15.44811	14.10323	0	12.30744	16.5172	15.3651	0	0	0	13.93768
Q8N3F8	MILK1_HUMAN	"MICAL-like protein 1 (Molecule interacting with Rab13, MIRab13)"	MICALL1 KIAA1668 MIRAB13	Homo sapiens (Human)	endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458]	extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]	extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]	GO:0005770; GO:0006612; GO:0006897; GO:0006898; GO:0019898; GO:0031175; GO:0031267; GO:0031902; GO:0032456; GO:0032458; GO:0036010; GO:0042802; GO:0045296; GO:0046872; GO:0055038; GO:0070300; GO:0097320	GGLNEGR	23.07999992	0.405714601	0.405714601	0.250965068	698.8574702	15.5116	0	13.38524	13.53099	17.1565	14.512	16.38987	15.15808	0	0	0	16.87883	15.64442	15.7291	17.00766	15.13769	16.8764	16.39746	14.86447	15.85506	16.53231	16.04115	15.1552	15.83651	0	15.15589	0	0	0	15.97878	0	16.89531	16.14276	0	0	16.17412	16.38797	17.93021	0	15.50836	16.23359	15.19017	0	0	0	0	15.59208	0
Q8N3H0	TAFA2_HUMAN	Chemokine-like protein TAFA-2	TAFA2 FAM19A2	Homo sapiens (Human)	memory [GO:0007613]; visual learning [GO:0008542]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; receptor ligand activity [GO:0048018]; memory [GO:0007613]; visual learning [GO:0008542]	receptor ligand activity [GO:0048018]	GO:0005615; GO:0005634; GO:0005737; GO:0007613; GO:0008542; GO:0048018	CCNKNK	7.309999943	1	1	0.159194132	823.4408025	0	0	13.94449	0	14.99707	12.59686	13.95963	0	15.16195	15.68675	0	15.28841	0	0	0	14.20401	13.80813	0	16.63092	15.94493	12.52115	0	0	0	0	0	0	0	0	0	15.03992	15.11187	14.89005	13.86188	13.26575	0	0	16.44627	0	0	0	15.51324	0	0	0	0	0	0
Q8N3I7	BBS5_HUMAN	Bardet-Biedl syndrome 5 protein	BBS5	Homo sapiens (Human)	cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]	axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]	GO:0001947; GO:0005829; GO:0005930; GO:0007601; GO:0015031; GO:0032266; GO:0032402; GO:0034451; GO:0034464; GO:0036064; GO:0044458; GO:0046907; GO:0050896; GO:0060170; GO:0060271; GO:0061629	EINSLHK	4.53000021	1	1	0.229253208	838.7496451	13.91339	14.95038	15.48876	15.34463	16.34894	13.36681	16.00999	0	15.56835	0	0	0	0	14.53583	15.54945	15.34319	0	0	0	0	0	0	0	0	0	16.29645	0	15.60195	0	15.39249	15.77578	16.67078	15.44566	15.76341	0	15.51776	0	15.50142	0	16.36387	16.44906	14.90321	15.53093	17.23123	13.19287	15.31624	16.68874	15.84429
Q8N3J2	METL4_HUMAN	"N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4, EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4, EC 2.1.1.-)"	METTL4	Homo sapiens (Human)	chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]	methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347]	GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0006325; GO:0008168; GO:0008173; GO:0009007; GO:0032775; GO:0043484; GO:0090296; GO:0106347; GO:0120049; GO:1902275; GO:1903108	EDLMNGVK	8.640000343	1	1	0.221097697	921.8045788	16.29038	0	0	0	15.00226	0	13.54095	13.61726	13.908	15.55812	0	0	14.87214	14.81212	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.04616	0	16.4847	0	0	0	16.65642	0	0	0	0	0	0	0	0	0	0	0	15.22751	0
Q8N3J5	PPM1K_HUMAN	"Protein phosphatase 1K, mitochondrial, EC 3.1.3.16 (PP2C domain-containing protein phosphatase 1K) (PP2C-like mitochondrial protein) (PP2C-type mitochondrial phosphoprotein phosphatase, PTMP) (Protein phosphatase 2C isoform kappa, PP2C-kappa)"	PPM1K PP2CM	Homo sapiens (Human)		mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005739; GO:0005759; GO:0046872	GKPMK	15.86999989	0.07181827	0.07181827	0.203879225	575.2324618	0	0	0	0	0	16.89894	15.51884	15.19928	15.91783	0	0	15.70114	16.64319	0	0	16.15842	0	16.75167	0	0	0	20.00675	17.89969	18.76777	15.86833	16.06026	0	15.61608	16.78927	0	15.43569	15.27354	16.70972	18.33115	16.63522	15.64448	16.97007	16.60743	16.01055	0	15.39201	15.17458	17.06757	14.59306	14.72656	0	16.15171	17.73804
Q8N3K9	CMYA5_HUMAN	Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76)	CMYA5 C5orf10 DTNBP2 SPRYD2 TRIM76	Homo sapiens (Human)		cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; M band [GO:0031430]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; M band [GO:0031430]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]		GO:0005634; GO:0005829; GO:0005886; GO:0016529; GO:0016607; GO:0031430; GO:0043231; GO:0048471	EIEPSSSTTTASVTK	1.779999971	1	1	0.378075551	1537.456004	10.77763	12.99725	0	0	14.23016	15.1568	0	0	15.60989	14.87755	0	14.80075	15.73141	14.88877	14.10148	14.49401	0	0	0	0	0	0	0	16.41339	0	0	0	0	0	14.89547	15.66025	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N3S3	PHTF2_HUMAN	Protein PHTF2	PHTF2	Homo sapiens (Human)		endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]		GO:0005783; GO:0016021	ADMSVLEISGMIMNR	5.090000153	1	1	6.89E-13	1682.21793	0	0	14.86118	0	15.27774	0	0	11.53553	12.92563	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.91894	0	0	0	0	0	0	0	0	0	14.40976	0	0	17.25006	0	0	0	14.77208	0
Q8N3T1	GLT15_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 15, EC 2.4.1.41 (Polypeptide GalNAc transferase-like protein 2, GalNAc-T-like protein 2, pp-GaNTase-like protein 2) (Polypeptide N-acetylgalactosaminyltransferase-like protein 2) (Protein-UDP acetylgalactosaminyltransferase-like protein 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2)"	GALNT15 GALNTL2 UNQ770/PRO1564	Homo sapiens (Human)	O-glycan processing [GO:0016266]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0016266; GO:0030133; GO:0030246; GO:0046872	RLGAIR	8.180000305	1	1	0.09987587	686.6390541	0	0	15.88382	0	0	0	0	0	0	0	0	0	0	15.36673	15.51494	0	0	0	0	15.3057	0	0	0	0	17.08651	0	17.14914	14.48262	0	16.05644	0	15.52586	15.93403	17.29927	15.4433	15.68334	17.1549	15.99137	16.90046	0	15.12559	15.7904	0	15.22659	0	15.42891	0	0
Q8N3U4	STAG2_HUMAN	Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2)	STAG2 SA2	Homo sapiens (Human)	cell division [GO:0051301]; establishment of meiotic sister chromatid cohesion [GO:0034089]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; establishment of meiotic sister chromatid cohesion [GO:0034089]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0007062; GO:0008278; GO:0016020; GO:0016363; GO:0034089; GO:0034991; GO:0051301; GO:0090307; GO:0097431	NSLLAGGDDDTMSVISGISSR	4.369999886	1	1	4.67E-13	2096.181463	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N3V7	SYNPO_HUMAN	Synaptopodin	SYNPO KIAA1029	Homo sapiens (Human)	modification of dendritic spine [GO:0098886]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of stress fiber assembly [GO:0051492]; spine apparatus assembly [GO:1905355]	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spine apparatus [GO:0097444]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spine apparatus [GO:0097444]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; modification of dendritic spine [GO:0098886]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of stress fiber assembly [GO:0051492]; spine apparatus assembly [GO:1905355]	actin binding [GO:0003779]	GO:0001725; GO:0003779; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0014069; GO:0015629; GO:0030018; GO:0032233; GO:0043197; GO:0043204; GO:0051492; GO:0097444; GO:0098886; GO:1905355	SPRPQRHIMSR	3.529999971	1	1	0.321799502	1380.162956	16.35724	14.77156	0	12.42069	0	12.80662	0	15.39489	0	15.40786	14.13154	0	0	0	14.67597	0	0	0	0	0	0	0	0	0	0	15.80113	0	14.88704	0	14.66195	15.04481	0	0	16.4088	0	0	0	0	0	0	0	0	0	0	15.44595	0	0	0
Q8N3Y3	LARG2_HUMAN	"Xylosyl- and glucuronyltransferase LARGE2, EC 2.4.-.- (Glycosyltransferase-like 1B) (LARGE xylosyl- and glucuronyltransferase 2) [Includes: Alpha-1,3-xylosyltransferase LARGE2, EC 2.4.2.-; Beta-1,3-glucuronyltransferase LARGE2, EC 2.4.1.- ]"	LARGE2 GYLTL1B PP5656	Homo sapiens (Human)	muscle cell cellular homeostasis [GO:0046716]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]; muscle cell cellular homeostasis [GO:0046716]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]	glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]	GO:0000139; GO:0005794; GO:0006493; GO:0015020; GO:0016021; GO:0030145; GO:0035252; GO:0035269; GO:0042285; GO:0046716	EPGGR	5.360000134	0.823099256	0.823099256	0.088468002	518.8263281	15.06978	14.04486	16.67555	16.42905	16.6083	15.94476	16.95902	0	15.91766	15.50439	16.77445	17.03203	16.25223	15.44412	18.27296	16.70697	15.89664	16.81199	17.88981	16.65174	16.71539	14.84114	0	15.72993	16.67331	17.62725	13.98365	15.19438	15.2263	15.58799	15.60222	15.12947	12.14652	17.10737	16.10777	17.40784	16.6314	15.74739	16.30915	0	16.21968	16.7147	14.53164	0	10.68148	17.28688	15.58405	14.63755
Q8N3Y7	RDHE2_HUMAN	"Epidermal retinol dehydrogenase 2, EPHD-2, RDH-E2, EC 1.1.1.105 (Retinal short-chain dehydrogenase reductase 2, retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5)"	SDR16C5 RDHE2	Homo sapiens (Human)	keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor binding [GO:0140297]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]"	"DNA-binding transcription factor binding [GO:0140297]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]"	GO:0000122; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0016021; GO:0016616; GO:0017053; GO:0031065; GO:0035067; GO:0042572; GO:0042574; GO:0043616; GO:0061629; GO:0140297	IVEAILQEK	3.549999952	1	1	0.118908381	1043.529791	15.65149	15.14503	14.85179	0	0	0	0	0	15.08338	0	16.19674	0	15.64986	15.04307	14.3519	0	0	0	0	16.44167	0	0	0	0	0	0	0	0	0	14.93248	0	15.22002	0	16.50219	0	0	13.0356	13.94405	16.32809	16.54548	14.1005	15.21396	15.05197	0	15.79243	15.56759	14.97827	0
Q8N3Z3	GTPB8_HUMAN	GTP-binding protein 8	GTPBP8	Homo sapiens (Human)		mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0005525; GO:0005739; GO:0046872	KPGHTK	4.179999828	0.73464644	0.73464644	3.43E-13	667.696506	0	17.07251	0	12.73083	0	0	14.90245	0	9.552724	0	8.501308	0	0	0	0	16.3167	0	16.63148	14.3271	9.336699	0	12.14405	14.95468	0	15.15452	13.66577	15.93276	0	0	0	0	0	15.5587	0	16.41814	0	15.39996	15.16765	0	15.49869	0	0	15.93264	0	0	14.84684	14.99918	9.720037
Q8N414	PGBD5_HUMAN	"PiggyBac transposable element-derived protein 5, EC 3.1.-.- (PiggyBac domain-related protein 5) (PiggyBac transposase 5)"	PGBD5	Homo sapiens (Human)	"non-replicative transposition, DNA-mediated [GO:0098038]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; transposase activity [GO:0004803]; non-replicative transposition, DNA-mediated [GO:0098038]"	endonuclease activity [GO:0004519]; transposase activity [GO:0004803]	GO:0004519; GO:0004803; GO:0005634; GO:0005654; GO:0098038	SLALVMSQAR	8.979999542	1	1	0.21949943	1076.023126	12.15991	12.12645	0	0	14.68455	15.6186	14.47614	0	14.41405	15.23307	10.55202	13.76421	0	0	0	16.04258	12.59144	0	0	0	0	0	0	0	15.7605	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.98707
Q8N423	LIRB2_HUMAN	"Leukocyte immunoglobulin-like receptor subfamily B member 2, LIR-2, Leukocyte immunoglobulin-like receptor 2 (CD85 antigen-like family member D) (Immunoglobulin-like transcript 4, ILT-4) (Monocyte/macrophage immunoglobulin-like receptor 10, MIR-10) (CD antigen CD85d)"	LILRB2 ILT4 LIR2 MIR10	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; heterotypic cell-cell adhesion [GO:0034113]; immune response [GO:0006955]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; interleukin-10-mediated signaling pathway [GO:0140105]; learning or memory [GO:0007611]; negative regulation of antigen processing and presentation [GO:0002578]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of postsynaptic density organization [GO:1905875]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of T cell costimulation [GO:2000524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; regulation of dendritic cell differentiation [GO:2001198]; regulation of long-term synaptic potentiation [GO:1900271]; signal transduction [GO:0007165]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; heterotypic cell-cell adhesion [GO:0034113]; immune response [GO:0006955]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; interleukin-10-mediated signaling pathway [GO:0140105]; learning or memory [GO:0007611]; negative regulation of antigen processing and presentation [GO:0002578]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of postsynaptic density organization [GO:1905875]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of T cell costimulation [GO:2000524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; regulation of dendritic cell differentiation [GO:2001198]; regulation of long-term synaptic potentiation [GO:1900271]; signal transduction [GO:0007165]	amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]	GO:0001540; GO:0002250; GO:0002578; GO:0002645; GO:0002666; GO:0002767; GO:0002774; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006955; GO:0006968; GO:0007165; GO:0007166; GO:0007267; GO:0007611; GO:0008157; GO:0009986; GO:0016020; GO:0019221; GO:0023025; GO:0023029; GO:0032396; GO:0032755; GO:0034113; GO:0035307; GO:0042102; GO:0042130; GO:0042288; GO:0042803; GO:0044877; GO:0045591; GO:0050839; GO:0051248; GO:0051926; GO:0070821; GO:0071222; GO:0101003; GO:0140105; GO:1900271; GO:1900454; GO:1905875; GO:2000524; GO:2001198	AGAADAPLR	9.739999771	0.581162035	0.581162035	0.22457309	839.3004736	15.33278	0	13.9047	0	14.76025	16.31593	0	0	15.67277	0	0	0	16.71028	16.07458	15.45251	16.18339	16.00192	15.49757	16.98829	15.79114	0	14.05568	16.77922	17.26669	18.07399	15.69105	15.44567	0	17.59831	16.58271	0	16.7558	0	17.42495	15.67168	16.44044	14.50923	16.37154	16.9402	16.44942	0	0	13.59066	17.66685	14.28788	16.72761	15.72726	14.86347
Q8N427	TXND3_HUMAN	"Thioredoxin domain-containing protein 3 (NM23-H8) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2, Sptrx-2)"	NME8 SPTRX2 TXNDC3	Homo sapiens (Human)	cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; microtubule binding [GO:0008017]; cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]	microtubule binding [GO:0008017]	GO:0005634; GO:0005737; GO:0005829; GO:0005930; GO:0007283; GO:0008017; GO:0016607; GO:0030154; GO:0030317; GO:0034614; GO:0036157; GO:0060271; GO:0097225; GO:0097228; GO:0097598	KDDVLR	8.319999695	1	1	0.16521632	742.6118743	0	13.0837	13.11263	0	14.39006	0	0	15.74182	14.5431	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84624	15.57616	11.88902	13.4129	14.10864	15.08046	15.12809	14.22142	13.59946	15.97519	15.05886	0	15.27524	13.11407	16.71132	16.54154	0	0	15.74339	15.74262	0	14.70233	0	0	0
Q8N428	GLT16_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 16, EC 2.4.1.41 (Polypeptide GalNAc transferase 16, GalNAc-T16) (Polypeptide GalNAc transferase-like protein 1, GalNAc-T-like protein 1, pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1)"	GALNT16 GALNTL1 KIAA1130	Homo sapiens (Human)	protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0016021; GO:0018242; GO:0018243; GO:0030246; GO:0046872	AHAASSGGR	10.69999981	0.052050501	0.052050501	0.248089413	810.7510401	17.70818	0	17.98445	0	14.19164	15.14648	17.37493	13.8869	0	0	0	16.70769	0	0	0	17.02618	0	15.49423	0	0	16.78449	13.35506	0	0	0	17.77011	15.60102	0	0	0	18.64187	0	13.77994	15.25393	0	16.76399	16.9417	0	0	0	14.3059	0	14.34221	15.01168	0	0	16.2026	0
Q8N436	CPXM2_HUMAN	Inactive carboxypeptidase-like protein X2	CPXM2 CPX2 UNQ676/PRO1310	Homo sapiens (Human)	peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0006518; GO:0008270; GO:0016485	TANDGDYWR	6.369999886	1	1	0.295438974	1096.5739	0	9.130994	0	0	0	0	0	0	14.81507	0	0	0	15.92837	0	0	14.49725	0	0	0	0	0	0	0	0	0	0	15.33562	0	0	0	0	0	0	14.15228	0	14.06053	0	0	0	0	0	0	0	0	15.59406	0	0	0
Q8N443	RIBC1_HUMAN	RIB43A-like with coiled-coils protein 1	RIBC1	Homo sapiens (Human)						MYNIKQSTDTK	7.670000076	1	1	0.575638936	1345.179473	0	17.62523	0	0	0	0	0	0	0	0	0	0	0	0	18.06667	0	0	0	0	0	0	0	0	0	0	0	0	18.5391	17.51472	0	18.86063	19.92841	0	0	18.69958	0	18.6402	0	0	0	0	0	0	0	18.04755	0	0	0
Q8N448	LNX2_HUMAN	Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1)	LNX2 PDZRN1	Homo sapiens (Human)			identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0030165; GO:0042802; GO:0046872	DGVIAR	15.43999958	0.646909356	0.646909356	5.70E-13	630.6318436	0	16.20357	16.50258	15.55969	0	13.34445	14.8235	14.96037	15.91874	0	0	15.70835	14.90829	14.8729	15.62452	17.13149	15.73603	16.92275	14.78898	15.28949	16.40039	16.97976	16.66925	14.78906	14.60126	0	17.41596	14.72192	0	17.59102	18.55237	0	17.10536	16.818	0	0	13.92155	15.0181	16.23047	0	14.92432	13.67915	16.51564	13.58666	15.66419	15.85215	14.96281	14.38044
Q8N474	SFRP1_HUMAN	"Secreted frizzled-related protein 1, FRP-1, sFRP-1 (Secreted apoptosis-related protein 2, SARP-2)"	SFRP1 FRP FRP1 SARP2	Homo sapiens (Human)	"bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to BMP stimulus [GO:0071773]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000080]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; neural crest cell fate commitment [GO:0014034]; osteoblast differentiation [GO:0001649]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of angiogenesis [GO:0045765]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; somatic stem cell population maintenance [GO:0035019]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to BMP stimulus [GO:0071773]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000080]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; neural crest cell fate commitment [GO:0014034]; osteoblast differentiation [GO:0001649]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of angiogenesis [GO:0045765]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; somatic stem cell population maintenance [GO:0035019]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244]"	cysteine-type endopeptidase activity [GO:0004197]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]	GO:0001649; GO:0001657; GO:0001954; GO:0002244; GO:0004197; GO:0005109; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0008201; GO:0008284; GO:0008285; GO:0008584; GO:0008585; GO:0009267; GO:0009410; GO:0009950; GO:0009986; GO:0010564; GO:0010629; GO:0010719; GO:0010975; GO:0014034; GO:0014070; GO:0017147; GO:0030177; GO:0030178; GO:0030279; GO:0030307; GO:0030308; GO:0030336; GO:0030514; GO:0033689; GO:0035019; GO:0042802; GO:0043065; GO:0043066; GO:0043508; GO:0043547; GO:0044344; GO:0044345; GO:0045578; GO:0045600; GO:0045668; GO:0045671; GO:0045765; GO:0045880; GO:0045892; GO:0045893; GO:0046676; GO:0046851; GO:0048147; GO:0048546; GO:0050679; GO:0050680; GO:0050732; GO:0051496; GO:0051894; GO:0060070; GO:0060218; GO:0060346; GO:0060527; GO:0060687; GO:0060766; GO:0062023; GO:0070062; GO:0071305; GO:0071347; GO:0071356; GO:0071363; GO:0071380; GO:0071391; GO:0071392; GO:0071456; GO:0071481; GO:0071504; GO:0071542; GO:0071560; GO:0071773; GO:0090090; GO:0090179; GO:0090244; GO:0090246; GO:0090263; GO:1902043; GO:1904956; GO:2000041; GO:2000052; GO:2000054; GO:2000080; GO:2000270; GO:2000271	MGIGRSEGGR	6.46999979	0.873770475	0.873770475	0.252097998	1020.158829	11.55849	14.74969	12.63097	15.01599	0	0	12.25713	14.77985	13.66971	16.4326	16.06412	15.92692	0	0	14.36517	0	0	13.34378	0	0	0	15.1577	0	15.74986	0	0	14.80591	0	15.55071	0	0	17.36746	0	0	15.49373	16.62162	0	0	0	0	15.18896	0	14.51187	0	0	0	0	0
Q8N475	FSTL5_HUMAN	Follistatin-related protein 5 (Follistatin-like protein 5)	FSTL5 KIAA1263	Homo sapiens (Human)	cell differentiation [GO:0030154]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0030154	EGGYGLKSYQPLMR	8.229999542	0.783851445	0.783851445	0.166856113	1613.847179	19.85783	18.50859	18.48547	19.23091	18.95293	0	0	18.36223	0	18.21289	18.05972	18.80766	18.74528	19.5578	19.12991	18.82008	19.5418	17.31164	0	18.784	19.6444	18.2904	19.9239	19.78041	0	17.86959	0	0	17.73758	18.51956	17.87142	18.54353	18.882	17.68589	18.6182	18.63426	19.09564	18.39851	17.88832	18.76183	0	19.34268	0	18.50775	18.67097	18.00611	17.01111	17.98705
Q8N488	RYBP_HUMAN	"RING1 and YY1-binding protein (Apoptin-associating protein 1, APAP-1) (Death effector domain-associated factor, DED-associated factor) (YY1 and E4TF1-associated factor 1)"	RYBP DEDAF YEAF1	Homo sapiens (Human)	"apoptotic process [GO:0006915]; histone H2A monoubiquitination [GO:0035518]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; histone H2A monoubiquitination [GO:0035518]; multicellular organism development [GO:0007275]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006915; GO:0007275; GO:0032435; GO:0035518; GO:0043065; GO:0045893; GO:0046872	INSQLVAQQVAQQYATPPPPK	2.299999952	1	1	3.20E-12	2278.595734	9.276822	13.66541	12.8028	12.77194	11.96674	0	13.04208	0	0	0	6.078761	12.74166	0	0	0	10.43099	0	14.02042	0	0	0	0	0	0	0	12.69439	0	0	0	0	0	14.75995	0	0	13.89602	0	0	0	0	10.29063	12.57131	13.91779	0	0	11.91965	0	0	0
Q8N4A0	GALT4_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 4, EC 2.4.1.41 (Polypeptide GalNAc transferase 4, GalNAc-T4, pp-GaNTase 4) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4)"	GALNT4	Homo sapiens (Human)	O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0048471; GO:0070062	ELGSRR	6.440000057	0.253284752	0.253284752	0.266853512	717.0045119	0	14.70293	15.9768	15.46463	15.53743	16.14213	16.22794	15.48008	16.03134	16.50648	14.38598	16.37875	14.94498	15.29231	15.70878	15.34776	0	16.02678	15.69839	16.58451	17.40425	14.91743	16.31189	0	16.00762	16.09114	0	0	14.6099	16.06376	0	0	16.3029	15.90548	15.79937	0	0	0	0	0	16.88327	0	0	0	0	14.79527	15.98788	0
Q8N4B4	FBX39_HUMAN	F-box only protein 39	FBXO39 FBX39	Homo sapiens (Human)	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	SCF ubiquitin ligase complex [GO:0019005]	SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		GO:0019005; GO:0031146	LTVEQGCQILDSLSYMR	12.93000031	1	1	0.039100663	2027.977151	0	15.22338	15.90433	0	0	17.02027	0	0	13.71571	0	18.49036	17.23859	0	0	0	17.23015	0	0	0	0	17.36786	20.11544	0	0	14.95833	0	17.22706	13.61477	16.68553	0	0	0	14.91779	0	0	17.55438	0	0	14.25825	17.45378	17.30109	0	0	0	0	16.12468	0	17.65495
Q8N4C6	NIN_HUMAN	"Ninein, hNinein (Glycogen synthase kinase 3 beta-interacting protein, GSK3B-interacting protein)"	NIN KIAA1565	Homo sapiens (Human)	centriole-centriole cohesion [GO:0010457]; centrosome localization [GO:0051642]; centrosome-templated microtubule nucleation [GO:0090222]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of axonogenesis [GO:0050772]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasmic microtubule [GO:0005881]; dendrite [GO:0030425]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]	apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasmic microtubule [GO:0005881]; dendrite [GO:0030425]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; microtubule minus-end binding [GO:0051011]; centriole-centriole cohesion [GO:0010457]; centrosome localization [GO:0051642]; centrosome-templated microtubule nucleation [GO:0090222]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of axonogenesis [GO:0050772]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]	calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; microtubule minus-end binding [GO:0051011]	GO:0000242; GO:0000922; GO:0005509; GO:0005525; GO:0005654; GO:0005730; GO:0005813; GO:0005814; GO:0005881; GO:0005886; GO:0008104; GO:0010457; GO:0019900; GO:0021540; GO:0021957; GO:0030425; GO:0031116; GO:0034454; GO:0044295; GO:0045177; GO:0048668; GO:0050772; GO:0051011; GO:0051642; GO:0072686; GO:0090222; GO:0097431; GO:0097539; GO:0120103	ATCETADR	4.809999943	0.336298257	0.336298257	0.276045639	924.197065	14.68402	0	15.97882	0	0	0	0	0	0	0	16.18279	0	0	15.89385	15.46004	0	0	0	14.65624	0	16.40519	0	15.48255	0	13.51482	15.78678	0	14.31267	0	16.80533	15.46489	17.18264	16.01951	14.47855	10.28437	16.13332	0	14.96914	15.39243	16.19619	15.78184	0	16.08808	16.23721	14.32561	14.15812	13.19803	16.39928
Q8N4C8	MINK1_HUMAN	"Misshapen-like kinase 1, EC 2.7.11.1 (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6, MEK kinase kinase 6, MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6)"	MINK1 B55 MAP4K6 MINK YSK2 ZC3	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of MAPK cascade [GO:0043408]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of MAPK cascade [GO:0043408]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0001952; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007254; GO:0007268; GO:0007420; GO:0014069; GO:0022407; GO:0030334; GO:0030424; GO:0030425; GO:0031532; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048812; GO:0048813; GO:0070062; GO:0106310; GO:1900745; GO:2000311	KGSVVNVNPTNTR	3.470000029	1	1	1.15E-12	1387.021482	0	15.73827	0	12.79704	0	12.6456	0	14.38415	14.32146	14.79222	0	11.80456	0	0	0	16.5725	0	0	0	0	0	0	0	0	16.83665	0	0	0	0	13.62454	0	15.47244	0	0	0	0	0	0	0	14.30917	14.80828	0	0	0	0	0	0	0
Q8N4F4	S22AO_HUMAN	Steroid transmembrane transporter SLC22A24 (Solute carrier family 22 member 24)	SLC22A24	Homo sapiens (Human)	organic anion transport [GO:0015711]; steroid metabolic process [GO:0008202]; sterol transmembrane transport [GO:0035382]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; organic anion transport [GO:0015711]; steroid metabolic process [GO:0008202]; sterol transmembrane transport [GO:0035382]	transmembrane transporter activity [GO:0022857]	GO:0008202; GO:0015711; GO:0016021; GO:0022857; GO:0035382	SMVQSLFMAGSLLGGLIYGHLSDR	4.960000038	1	1	0.147187631	2552.899915	0	8.159921	13.43628	0	12.56841	13.18783	13.22884	13.7143	0	13.4806	0	14.87241	10.63401	12.70739	14.98416	13.91901	0	9.066246	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.54358	0	15.77572	0	0	0	0	0	0	0
Q8N4F7	RN175_HUMAN	RING finger protein 175	RNF175	Homo sapiens (Human)	ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-dependent ERAD pathway [GO:0030433]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0000139; GO:0005789; GO:0016021; GO:0030433; GO:0046872; GO:0061630	MAAGTAAR	8.029999733	0.008020496	0.008020496	0.275621444	748.8604423	0	15.63777	16.15498	14.76394	15.357	14.14633	0	16.58388	14.68803	15.70732	0	0	0	15.6253	17.07586	16.08129	16.46576	0	15.0333	0	0	16.81024	0	17.06584	17.02892	15.81883	0	16.12082	15.49676	14.61431	15.89184	17.31128	0	14.28337	16.20972	16.46147	16.22446	15.35449	15.80453	15.96812	0	0	13.94925	15.85296	16.54991	16.49305	14.40266	0
Q8N4G2	ARL14_HUMAN	ADP-ribosylation factor-like protein 14 (ADP-ribosylation factor 7)	ARL14 ARF7	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]	cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0016192; GO:0031410	QAQVLLLGLDSAGKSTLLYK	3.960000038	1	1	4.58E-13	2118.185519	15.55535	0	14.65033	14.92373	14.18904	0	0	0	0	14.92839	15.78741	14.12676	15.89995	0	0	13.99862	0	12.23182	0	11.82176	0	0	0	0	0	0	15.73367	0	0	14.12177	0	0	0	0	0	0	0	0	0	0	0	0	13.76989	0	14.07081	0	0	0
Q8N4L1	T151A_HUMAN	Transmembrane protein 151A	TMEM151A TMEM151	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	LATVPR	5.079999924	0.448733002	0.448733002	0.068994462	657.394317	14.7891	0	13.24143	16.87675	14.05763	15.06139	0	0	0	14.33465	15.85996	13.52204	15.92981	13.56917	16.54427	0	15.18466	12.87005	13.57213	16.06697	17.82724	13.3333	13.7068	16.92924	0	14.96517	12.403	12.65174	15.4403	0	9.907684	15.28942	15.40167	15.57224	0	12.17086	17.5426	15.39815	14.05616	16.03274	15.18059	7.027355	0	13.62597	0	15.30616	0	17.5305
Q8N4N3	KLH36_HUMAN	Kelch-like protein 36	KLHL36 C16orf44	Homo sapiens (Human)	protein ubiquitination [GO:0016567]		cullin family protein binding [GO:0097602]; protein ubiquitination [GO:0016567]	cullin family protein binding [GO:0097602]	GO:0016567; GO:0097602	AIAGGSACVCALEPRPEDK	2.960000038	1	1	0.318988535	2000.682006	13.46311	13.05542	15.91374	0	10.54582	0	0	14.52406	0	0	0	0	0	0	0	13.37417	0	0	0	0	0	0	0	0	0	0	0	0	16.48603	0	17.72829	0	0	0	0	0	0	16.90219	15.61074	14.30589	15.80677	0	0	0	0	0	0	0
Q8N4N8	KIF2B_HUMAN	Kinesin-like protein KIF2B	KIF2B	Homo sapiens (Human)	cell division [GO:0051301]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; regulation of chromosome segregation [GO:0051983]	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle [GO:0005819]	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; regulation of chromosome segregation [GO:0051983]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000776; GO:0003777; GO:0005524; GO:0005730; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0015630; GO:0016887; GO:0045171; GO:0051301; GO:0051310; GO:0051983; GO:0072686	VPSKPCLMK	1.320000052	1	1	0.146473985	1059.05139	0	17.73394	16.71233	14.71683	14.28578	15.26021	0	0	16.82708	0	13.58532	0	0	0	0	13.01788	14.34571	15.86827	16.25037	15.8386	14.03115	17.61972	0	13.80878	11.15778	0	15.88096	0	0	16.88897	17.29887	0	0	13.32284	0	0	0	13.65341	16.73149	18.32103	15.88607	16.88141	18.09391	13.60552	0	0	14.90958	17.84976
Q8N4P6	LRC71_HUMAN	Leucine-rich repeat-containing protein 71	LRRC71 C1orf92	Homo sapiens (Human)						CLPPLTQLQAINLWK	3.849999905	1	1	0.102629318	1794.115111	0	19.78252	0	0	0	18.75373	0	17.01103	14.53334	18.30493	0	0	0	17.85732	15.88597	0	17.88678	0	0	0	0	0	0	17.44155	13.74307	0	14.09984	16.58558	15.70372	0	0	16.29491	0	16.58174	0	14.67187	0	15.02243	0	0	16.27111	0	0	0	9.393864	0	18.56819	16.09175
Q8N4Q0	PTGR3_HUMAN	"Prostaglandin reductase 3, PRG-3, EC 1.3.1.48 (Zinc-binding alcohol dehydrogenase domain-containing protein 2)"	PTGR3 ZADH2	Homo sapiens (Human)	negative regulation of fat cell differentiation [GO:0045599]	peroxisome [GO:0005777]	peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599]	13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]	GO:0005777; GO:0008270; GO:0036132; GO:0045599; GO:0047522	ELGGLSEGKK	32.04000092	0.83245188	0.83245188	0.407703125	1018.465573	0	20.28625	0	18.77163	0	0	0	0	0	18.63689	21.67447	0	0	0	0	0	21.83966	0	17.92331	0	0	0	0	0	20.12248	20.3965	0	21.94986	23.60411	23.88306	0	0	23.85394	0	0	0	0	0	19.92829	0	0	0	0	0	0	20.23562	22.70664	17.67826
Q8N4T0	CBPA6_HUMAN	"Carboxypeptidase A6, EC 3.4.17.-"	CPA6 CPAH	Homo sapiens (Human)	proteolysis [GO:0006508]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0006508; GO:0008270	SDPAMRK	20.94000053	0.892264724	0.892264724	0.280844604	821.0585342	18.986	0	0	20.70131	0	0	0	0	17.90038	0	0	0	18.62037	0	0	0	0	17.54763	0	0	0	0	17.80028	0	0	0	16.34392	0	0	0	18.01755	20.40455	18.21659	0	19.53728	0	18.07281	19.00332	0	17.77354	0	0	21.32233	0	20.98505	0	0	0
Q8N4U5	T11L2_HUMAN	T-complex protein 11-like protein 2	TCP11L2	Homo sapiens (Human)	signal transduction [GO:0007165]		signal transduction [GO:0007165]		GO:0007165	QCVGEDQPSDSDSSR	3.00999999	0.29813078	0.29813078	0.069628255	1665.672785	0	0	0	17.30342	16.72856	15.68256	0	14.88424	16.72035	17.85953	0	15.51521	15.50388	0	0	18.86021	15.03358	13.39171	15.63322	0	15.30708	0	17.06987	0	16.1339	17.44367	17.48072	0	0	0	17.30844	16.7684	16.21056	0	16.80053	15.93475	0	0	0	14.72433	0	0	0	0	0	15.36972	0	18.68362
Q8N4V2	SVOP_HUMAN	"Synaptic vesicle 2-related protein, SV2-related protein"	SVOP	Homo sapiens (Human)		integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]	transmembrane transporter activity [GO:0022857]	GO:0008021; GO:0016021; GO:0022857; GO:0030672	EWGQEMVGRGMHGAGVTR	1.570000052	1	1	0.248822989	1974.979856	14.7582	14.21725	0	0	0	0	0	0	0	0	0	0	0	0	0	14.30944	0	12.38103	0	0	16.27303	0	0	0	15.53979	13.465	14.67448	0	0	0	0	0	12.78585	0	0	12.58338	0	0	0	0	0	14.79641	0	0	0	0	0	0
Q8N4X5	AF1L2_HUMAN	"Actin filament-associated protein 1-like 2, AFAP1-like protein 2"	AFAP1L2 KIAA1914 XB130	Homo sapiens (Human)	"inflammatory response [GO:0006954]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of interleukin-6 production [GO:0032675]; regulation of mitotic cell cycle [GO:0007346]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein tyrosine kinase activator activity [GO:0030296]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; inflammatory response [GO:0006954]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of interleukin-6 production [GO:0032675]; regulation of mitotic cell cycle [GO:0007346]"	protein tyrosine kinase activator activity [GO:0030296]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]	GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007346; GO:0017124; GO:0030296; GO:0032675; GO:0032757; GO:0035591; GO:0042169; GO:0045742; GO:0045893	ETLLKCTDK	6.940000057	1	1	0.17391282	1108.614528	14.00723	15.20856	10.32008	0	12.32229	14.5434	0	15.76553	0	0	14.88815	15.23533	0	14.00119	15.70347	0	15.39799	0	11.93038	0	0	0	0	17.27762	0	0	16.05995	0	0	0	0	17.10568	15.53967	0	16.93082	0	15.5351	0	0	17.15832	14.38202	12.2027	0	0	0	0	0	0
Q8N4Y2	EFC4A_HUMAN	"EF-hand calcium-binding domain-containing protein 4A (Calcium release-activated calcium channel regulator 2B, CRAC channel regulator 2B) (Calcium release-activated channel regulator 2B)"	CRACR2B EFCAB4A	Homo sapiens (Human)	cellular protein localization [GO:0034613]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; cellular protein localization [GO:0034613]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115]	calcium ion binding [GO:0005509]	GO:0002115; GO:0005509; GO:0005737; GO:0034613; GO:2001256	AHEALR	4.21999979	0.425103247	0.425103247	0.265587367	696.3595123	15.632	13.45064	16.50528	14.84461	14.38682	16.34611	16.71963	16.68717	0	0	0	0	0	14.59604	0	0	0	14.90897	0	0	14.32614	0	0	0	0	0	16.8979	0	0	14.57694	0	0	16.76793	14.08233	0	0	17.2283	0	0	0	15.12947	17.48866	0	0	16.1932	14.75768	0	0
Q8N531	FBXL6_HUMAN	F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A)	FBXL6 FBL6	Homo sapiens (Human)	entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	ubiquitin-protein transferase activity [GO:0004842]	GO:0000086; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0019005; GO:0031146; GO:0043153; GO:0051726	LTLAKEGSPFLTQK	4.239999771	1	1	2.34E-13	1533.613966	14.29998	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.31417	0	0	0	0	0	0	0	0	0	0	14.84218	13.8144	15.40109	14.0878	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N543	OGFD1_HUMAN	"Prolyl 3-hydroxylase OGFOD1, EC 1.14.11.- (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (Termination and polyadenylation 1 homolog) (uS12 prolyl 3-hydroxylase)"	OGFOD1 KIAA1612 TPA1	Homo sapiens (Human)	cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]	GO:0005506; GO:0005654; GO:0005737; GO:0005829; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0019511; GO:0031418; GO:0031543; GO:0031544; GO:0034063	ELMNLDFHEK	20.39999962	1	1	0.217790222	1291.567422	0	0	0	19.01557	0	0	17.02772	0	0	0	18.0199	0	0	17.6058	0	0	0	16.63266	0	0	0	0	0	0	17.34284	0	0	19.33541	0	0	0	16.87839	17.85583	18.17845	0	16.80926	0	16.94897	0	0	0	0	0	0	16.75735	0	0	0
Q8N556	AFAP1_HUMAN	"Actin filament-associated protein 1 (110 kDa actin filament-associated protein, AFAP-110)"	AFAP1 AFAP	Homo sapiens (Human)	regulation of cytoskeleton organization [GO:0051493]; regulation of signal transduction [GO:0009966]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; regulation of cytoskeleton organization [GO:0051493]; regulation of signal transduction [GO:0009966]	actin binding [GO:0003779]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]	GO:0003779; GO:0005829; GO:0005925; GO:0009966; GO:0015629; GO:0017124; GO:0042169; GO:0051493	ADPAAVVKR	13.63000011	1	1	0.272274853	925.1665297	0	0	0	0	0	16.81421	0	0	0	18.48104	0	0	0	16.26165	0	0	0	0	0	0	0	18.08136	0	0	0	17.85053	0	17.35516	0	0	0	0	0	0	17.73263	0	0	0	0	0	17.43578	16.80253	0	0	0	18.07841	0	0
Q8N568	DCLK2_HUMAN	"Serine/threonine-protein kinase DCLK2, EC 2.7.11.1 (CaMK-like CREB regulatory kinase 2, CL2, CLICK-II, CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2)"	DCLK2 DCAMKL2 DCDC3B DCK2	Homo sapiens (Human)	hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; pyramidal neuron development [GO:0021860]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; pyramidal neuron development [GO:0021860]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000226; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005856; GO:0008017; GO:0018105; GO:0021766; GO:0021860; GO:0035556; GO:0106310; GO:1900181	GGTSR	9.460000038	1	1	0.108902613	475.7583968	15.15736	0	16.26635	0	11.51143	15.24562	0	17.1355	16.2901	15.94515	0	0	0	16.305	0	0	16.19437	15.97173	0	14.09364	0	16.15978	14.71292	15.79883	0	0	0	14.63532	0	14.36731	0	0	0	0	0	0	0	0	0	0	13.97147	0	0	0	13.88842	0	0	0
Q8N584	TT39C_HUMAN	"Tetratricopeptide repeat protein 39C, TPR repeat protein 39C"	TTC39C C18orf17	Homo sapiens (Human)	cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]		cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474]		GO:0032474; GO:0060271	IINLLGFPGDR	16.13999939	1	1	0.241067383	1214.594702	0	0	13.18516	15.83517	15.74804	0	14.47324	0	14.10564	15.44551	14.6822	13.94184	0	13.88056	15.605	14.09801	0	0	0	0	14.58879	0	15.56432	0	0	0	0	0	0	14.75069	0	0	0	0	0	0	0	0	0	0	13.17786	16.38171	0	0	0	0	0	0
Q8N5A5	ZGPAT_HUMAN	Zinc finger CCCH-type with G patch domain-containing protein (G patch domain-containing protein 6) (Zinc finger CCCH domain-containing protein 9) (Zinc finger and G patch domain-containing protein)	ZGPAT GPATC6 GPATCH6 KIAA1847 ZC3H9 ZC3HDC9 ZIP	Homo sapiens (Human)	"negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0007175; GO:0043565; GO:0045892; GO:0046872	DMYHASK	10.97999954	1	1	0.204428917	868.2002607	0	0	0	0	0	0	0	16.69913	0	0	0	0	0	0	0	0	0	0	0	15.58819	0	0	0	0	0	0	0	0	0	0	15.44605	0	0	0	0	0	16.964	17.45405	0	0	0	0	0	16.25634	0	0	0	0
Q8N5C6	SRBD1_HUMAN	S1 RNA-binding domain-containing protein 1	SRBD1	Homo sapiens (Human)	nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]		mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	GO:0003729; GO:0003735; GO:0006139; GO:0006412	AMLNCK	9.840000153	1	1	0.010115704	752.6486426	0	0	0	0	0	14.30307	0	0	0	0	0	0	0	0	17.0133	16.29771	16.90362	0	0	14.62787	0	0	0	0	17.08393	0	0	0	0	0	0	0	0	0	0	16.87211	0	16.98364	0	0	0	0	17.4739	0	0	0	0	0
Q8N5D0	WDTC1_HUMAN	WD and tetratricopeptide repeats protein 1	WDTC1 KIAA1037	Homo sapiens (Human)	cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]	enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]	GO:0000122; GO:0001701; GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0045717; GO:0055082; GO:0080008	SYDYQFR	10.5	0.330490172	0.330490172	0.147104618	978.2519677	0	15.43989	18.6248	15.74861	0	0	16.69005	13.31217	15.58063	14.41022	15.37296	15.85798	15.3549	15.40012	13.74205	0	0	0	14.49611	13.08092	0	16.95268	0	0	15.08808	16.98116	17.30622	15.39712	14.28133	13.53517	13.2932	13.97885	13.89813	15.10594	17.00775	0	14.45147	0	15.76991	0	0	0	15.15407	11.53119	11.60078	14.21629	17.19569	12.90161
Q8N5H7	SH2D3_HUMAN	"SH2 domain-containing protein 3C (Cas/HEF1-associated signal transducer, Chat-H) (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1, SHEP1)"	SH2D3C NSP3 UNQ272/PRO309/PRO34088	Homo sapiens (Human)	JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	axon [GO:0030424]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]	axon [GO:0030424]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0005085; GO:0005829; GO:0007254; GO:0007264; GO:0030424; GO:0032587; GO:0033138	AALLHK	10.18999958	0.54372263	0.54372263	0.007459612	651.5859713	14.76624	17.17743	14.83508	0	15.80205	14.62146	16.8352	17.30552	0	14.32579	0	0	14.60013	15.46911	15.08022	15.00157	15.18821	0	17.20512	17.73026	12.8664	16.73243	17.28431	17.2618	0	17.27687	12.86487	16.7298	15.855	15.96612	12.38124	0	14.75216	18.41664	17.12432	16.22678	18.46661	15.34542	14.7899	17.48275	14.36348	16.93244	18.91242	12.11302	17.14797	16.41112	17.0634	0
Q8N5I2	ARRD1_HUMAN	Arrestin domain-containing protein 1 (Alpha-arrestin 1)	ARRDC1	Homo sapiens (Human)	extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886]; arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005886; GO:0006511; GO:0006858; GO:0015031; GO:0016567; GO:0031410; GO:0031625; GO:0042802; GO:0045746; GO:0070062; GO:0140112; GO:1903561; GO:1990756; GO:1990763	RWIHDVR	12.39999962	0.510746479	0.510746479	0.199422984	982.302628	19.91998	17.57869	18.73722	16.63136	16.89567	18.96782	17.10315	12.8888	15.07044	0	0	0	10.08666	16.92329	0	16.05044	16.71864	15.40302	17.20213	16.76677	18.6871	18.51689	16.33249	13.94963	0	16.15531	0	0	16.53899	16.4395	4.211888	0	0	15.42757	14.16879	16.53259	19.84901	15.64676	19.7932	0	16.0201	14.94095	0	0	15.5612	0	19.56428	0
Q8N5M4	TTC9C_HUMAN	"Tetratricopeptide repeat protein 9C, TPR repeat protein 9C"	TTC9C	Homo sapiens (Human)						DAVSR	16.12000084	1	1	0.164946604	546.754447	0	0	0	18.74961	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N5M9	JAGN1_HUMAN	Protein jagunal homolog 1	JAGN1	Homo sapiens (Human)	cellular response to tunicamycin [GO:1904577]; defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; exocytosis [GO:0006887]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cellular response to tunicamycin [GO:1904577]; defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; exocytosis [GO:0006887]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]		GO:0002446; GO:0005783; GO:0005789; GO:0006887; GO:0007029; GO:0015031; GO:0016021; GO:0016192; GO:0030223; GO:0038158; GO:0050832; GO:0061179; GO:1904577; GO:1990266	VAMHYQMSVTLKYEIK	9.289999962	1	1	0.287836398	1956.877433	0	12.87324	11.9393	12.66965	0	0	0	14.69704	0	0	0	0	0	0	0	11.33896	0	0	0	0	0	0	0	0	0	12.96929	0	0	15.8547	16.15707	0	15.55547	13.48271	0	14.70868	14.69482	13.94586	0	0	9.44357	14.27987	0	13.6469	13.83602	0	0	0	15.87621
Q8N5N4	CC022_HUMAN	Uncharacterized protein C3orf22	C3orf22	Homo sapiens (Human)						IQAQENFAKK	6.800000191	0.050392438	0.050392438	0.122107461	1176.570556	16.66269	15.27162	0	0	8.50181	0	16.48819	15.94488	0	0	0	0	17.2626	0	15.79475	0	14.99914	0	18.11834	0	11.57259	17.68171	17.24749	16.94263	16.67712	0	14.23462	0	13.90621	12.891	18.19779	19.71504	14.60828	17.37053	0	18.88161	15.46848	17.90533	16.30363	0	0	0	0	13.92524	0	16.06812	18.0027	15.86169
Q8N5N7	RM50_HUMAN	"39S ribosomal protein L50, mitochondrial, L50mt, MRP-L50 (Mitochondrial large ribosomal subunit protein mL50)"	MRPL50	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543]		GO:0005739; GO:0005743; GO:0005762; GO:0005829; GO:0032543	AYTPPEDLQSRLESYVK	8.359999657	0.163725168	0.163725168	0.191498253	1996.555492	0	0	15.02909	14.54621	0	12.83712	16.91134	0	7.33361	0	0	16.09736	15.82467	12.68531	0	0	0	0	0	0	10.23152	0	15.50249	15.93373	15.21952	11.21461	0	0	0	0	14.17888	0	17.80372	0	13.84364	12.44776	17.03777	12.03922	15.2883	0	0	0	15.89593	0	0	17.08187	12.24817	0
Q8N5P1	ZC3H8_HUMAN	Zinc finger CCCH domain-containing protein 8	ZC3H8 ZC3HDC8	Homo sapiens (Human)	"apoptotic process [GO:0006915]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase III [GO:0045945]; response to antibiotic [GO:0046677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; T cell homeostasis [GO:0043029]"	Cajal body [GO:0015030]; chromatin [GO:0000785]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]	"Cajal body [GO:0015030]; chromatin [GO:0000785]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; apoptotic process [GO:0006915]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase III [GO:0045945]; response to antibiotic [GO:0046677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; T cell homeostasis [GO:0043029]"	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]"	GO:0000785; GO:0000791; GO:0001162; GO:0001227; GO:0003723; GO:0005634; GO:0005654; GO:0006915; GO:0008023; GO:0015030; GO:0016604; GO:0033085; GO:0035363; GO:0042795; GO:0042796; GO:0043029; GO:0045892; GO:0045945; GO:0046677; GO:0046872; GO:0070245	DTPQAAKQK	7.190000057	0.438833058	0.438833058	2.17E-12	988.7994838	0	15.78042	15.7961	13.5942	14.91627	10.49266	15.76151	17.23325	0	15.59568	13.91697	0	13.18773	0	0	14.93841	14.98888	12.35257	16.22624	16.33192	15.30457	14.8633	17.81224	16.89557	15.24873	14.34281	0	15.8854	14.19315	8.314504	0	16.84986	13.66237	15.9172	13.13407	0	15.32955	14.10333	15.19055	10.53474	15.60952	0	0	0	12.19722	14.91132	16.56182	15.56705
Q8N5Q1	GAR5B_HUMAN	Golgi associated RAB2 interactor protein 5B	GARIN5B C19orf16 FAM71E2	Homo sapiens (Human)						RVSQEPMR	7.150000095	1	1	0.201817978	1018.596422	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.82608	0	17.18965	0	0	0	17.58591	0	0	19.06847	0	0	0	0	0	0	0	0	0	17.652	0	0	0	0	0	19.94409	18.01583	0	0	17.94786	19.39604	19.90163	18.94147	0
Q8N5R6	CCD33_HUMAN	"Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61, CT61)"	CCDC33	Homo sapiens (Human)		peroxisome [GO:0005777]	peroxisome [GO:0005777]		GO:0005777	QELLSYKIPIK	6.820000172	1	1	9.16E-13	1335.667571	0	0	0	0	0	0	0	0	0	14.28576	13.06066	14.33998	0	0	0	0	12.28176	11.01788	13.26501	0	0	12.76665	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N5S1	S2541_HUMAN	"Mitochondrial carrier protein SCaMC-3L (Mitochondrial ATP-Mg/Pi carrier protein SLC25A41) (Small calcium-binding mitochondrial carrier protein 3-like, SCaMC-3-like, SCaMC-3L) (Solute carrier family 25 member 41)"	SLC25A41	Homo sapiens (Human)	ADP transport [GO:0015866]; ATP transport [GO:0015867]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]	ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]	GO:0005347; GO:0005739; GO:0005743; GO:0015217; GO:0015866; GO:0015867; GO:0016021; GO:0140021; GO:1990544	FLLSGAMAGAVSRTGTAPLDR	5.679999828	1	1	9.14E-13	2090.451353	13.90299	15.01737	14.31405	14.07404	14.57351	12.49222	13.4147	13.27699	0	0	10.94263	14.70948	14.3232	10.79781	14.82492	0	0	0	12.40263	11.90882	7.070092	0	12.90759	13.91454	0	0	0	0	14.0263	14.79074	0	0	0	0	0	0	0	0	0	0	15.69592	0	0	0	0	0	0	0
Q8N5S9	KKCC1_HUMAN	"Calcium/calmodulin-dependent protein kinase kinase 1, CaM-KK 1, CaM-kinase kinase 1, CaMKK 1, EC 2.7.11.17 (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha, CaM-KK alpha, CaM-kinase kinase alpha, CaMKK alpha)"	CAMKK1 CAMKKA	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0035556; GO:0045860; GO:0106310	SMSAPGNLLVK	24.70999908	1	1	0.549006644	1132.391934	18.81718	18.68677	19.31841	0	0	18.87266	0	0	0	18.22721	0	19.14821	0	0	0	17.7807	0	0	0	18.031	0	0	0	0	0	0	0	0	17.02924	17.1286	0	0	17.90761	0	0	0	0	0	0	18.19785	0	18.26609	0	17.87709	0	0	0	17.17203
Q8N5U0	CK042_HUMAN	Uncharacterized protein C11orf42	C11orf42	Homo sapiens (Human)						SLPVAFSCLK	5.489999771	1	1	0.183000821	1122.894569	0	13.51985	14.73825	12.38126	15.74839	15.25546	15.59751	12.94466	12.84387	13.43555	14.87968	0	14.87634	0	12.59632	16.0273	0	0	0	0	15.34615	0	0	16.61752	0	0	0	15.72712	15.00596	0	15.88114	0	0	16.02817	15.15901	0	14.95804	15.79418	14.46991	0	17.08027	15.29671	14.89804	0	14.46208	16.22998	0	0
Q8N5U6	RNF10_HUMAN	RING finger protein 10	RNF10 KIAA0262 RIE2	Homo sapiens (Human)	"negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autoubiquitination [GO:0051865]"	cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autoubiquitination [GO:0051865]"	metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]	GO:0000976; GO:0005634; GO:0005737; GO:0010626; GO:0031643; GO:0045893; GO:0045944; GO:0046872; GO:0051865; GO:0061630; GO:0098978; GO:0099147; GO:0099527	EKGVLVALPK	1.980000019	0.505338669	0.505338669	0.056583047	1053.890715	13.37233	14.89081	0	0	14.85559	0	0	0	0	0	13.97009	15.4392	13.99815	0	14.00004	13.3863	0	13.16901	0	0	0	0	0	16.31702	0	0	16.07135	0	0	0	0	0	0	0	0	0	0	0	0	16.44969	14.51377	14.22433	0	0	0	0	0	0
Q8N5V2	NGEF_HUMAN	Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor)	NGEF	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]	cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0043087; GO:0048013; GO:0051056; GO:0061002; GO:0090630	FVSFTSR	14.25	1	1	0.07132961	842.6353315	0	0	14.58987	15.3078	15.51662	0	14.59059	15.02458	0	0	15.27795	13.7961	15.35878	0	0	15.66712	14.10472	0	14.90614	13.75614	13.55525	14.60361	15.39059	15.17594	0	0	15.13877	14.96075	14.91689	13.94397	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N5Z5	KCD17_HUMAN	BTB/POZ domain-containing protein KCTD17	KCTD17	Homo sapiens (Human)	cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]	cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]	GO:0005737; GO:0005783; GO:0030030; GO:0031463; GO:0032469; GO:0042802; GO:0043161; GO:0045724; GO:0051260; GO:0097602	DMAEEGVLEEAEFYNIGPLIRIIK	1.220000029	0.386464596	0.386464596	1.37E-12	2749.665439	0	15.27569	0	17.22329	0	0	0	0	0	0	0	0	0	0	0	0	0	13.3191	16.46729	0	0	10.85742	17.03271	0	16.41333	14.70247	0	0	0	0	0	0	17.93635	0	14.77608	0	17.33969	16.57475	0	0	18.46323	0	16.39928	0	0	17.31712	16.65644	13.39294
Q8N609	TR1L1_HUMAN	Translocating chain-associated membrane protein 1-like 1	TRAM1L1	Homo sapiens (Human)	"protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	integral component of endoplasmic reticulum membrane [GO:0030176]	"integral component of endoplasmic reticulum membrane [GO:0030176]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"		GO:0006616; GO:0030176; GO:0045048	RMQFTK	3.930000067	0.01816834	0.01816834	0.275962945	810.7002401	0	0	0	16.13705	17.11039	0	17.2983	0	0	17.27808	0	16.48385	0	0	0	0	16.65167	0	0	0	16.46967	0	0	17.33764	0	17.5348	18.06605	0	0	0	17.36146	0	0	0	0	16.42391	0	0	0	0	0	0	0	0	0	17.95108	15.95779	0
Q8N612	FHI1B_HUMAN	"FHF complex subunit HOOK interacting protein 1B, FHIP1B (FTS and Hook-interacting protein, FHIP)"	FHIP1B C11orf56 FAM160A2 KIAA1759	Homo sapiens (Human)	early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]	cytosol [GO:0005829]; FHF complex [GO:0070695]	cytosol [GO:0005829]; FHF complex [GO:0070695]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]		GO:0005829; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0045022; GO:0070695; GO:1905719	SLLQVLGSVK	9.970000267	1	1	0.254840378	1044.094219	9.953814	15.70865	15.15474	0	14.34403	14.79257	15.92978	0	14.43451	16.25069	15.18278	0	0	0	0	0	0	0	0	16.49456	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.26856	0	0	0	0	0	0	0	0	0
Q8N614	TM156_HUMAN	Transmembrane protein 156	TMEM156	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	ETQIIMR	15.67000008	1	1	3.44E-13	907.5041232	14.51026	14.15927	14.17959	13.22869	0	13.64725	0	0	0	0	0	0	0	0	12.22829	14.82613	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.84679	15.18154	0	0	0	0	0	15.47352	0	15.0196	0	14.53309	0	0	0	0	0	0
Q8N668	COMD1_HUMAN	COMM domain-containing protein 1 (Protein Murr1)	COMMD1 C2orf5 MURR1	Homo sapiens (Human)	copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037]	"Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]; copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]"	"copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]"	GO:0005507; GO:0005546; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006289; GO:0006893; GO:0010008; GO:0015031; GO:0019871; GO:0031398; GO:0031462; GO:0032088; GO:0032434; GO:0042802; GO:0042803; GO:0043325; GO:0048227; GO:0055037; GO:0055070; GO:0070300; GO:0080025; GO:1902306; GO:2000009	SIASADMDFNQLEAFLTAQTK	13.69999981	1	1	0.235708908	2316.941921	14.68812	14.74265	10.00151	0	0	0	0	0	0	0	0	0	17.07282	0	17.09859	0	17.36332	0	17.07829	17.91193	17.4544	15.08229	17.01957	16.11172	15.63135	13.2646	0	0	0	15.83041	0	17.45813	17.20274	0	16.35112	19.15409	21.44876	21.59987	0	15.14291	13.10675	0	18.95079	22.13668	20.02573	16.7616	17.55241	18.14772
Q8N693	ESX1_HUMAN	"Homeobox protein ESX1 (Extraembryonic, spermatogenesis, homeobox 1) [Cleaved into: Homeobox protein ESX1-N; Homeobox protein ESX1-C ]"	ESX1 ESX1L ESX1R	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0006357; GO:0016607; GO:0043565; GO:0045892; GO:0051726; GO:1990837	LTVTSLMAR	6.650000095	1	1	0.504710151	1008.928099	19.51631	18.10751	17.83894	0	0	0	0	0	0	17.24963	0	0	0	19.10912	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.24767	0	0	0	0	0	0	0	0	0	0
Q8N697	S15A4_HUMAN	"Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1, hPHT1)"	SLC15A4 PHT1 PTR4 FP12591	Homo sapiens (Human)	dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]	early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]	dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]	GO:0005290; GO:0005765; GO:0005886; GO:0006811; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0031303; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0035579; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206; GO:1905103	APLLGARR	10.26000023	0.773017585	0.773017585	2.28E-13	851.5288555	15.00336	0	13.07699	16.50648	0	16.70219	14.88017	16.89886	16.80022	0	16.83117	0	16.08574	0	0	15.22744	0	15.15984	0	14.39497	0	16.28697	14.67581	0	15.71276	15.0759	16.80371	0	14.0441	0	15.14076	15.13878	15.97486	0	13.99199	0	17.08246	13.47318	0	13.33272	16.65586	0	0	0	14.48247	12.98345	11.64269	15.45512
Q8N6C7	PGSF1_HUMAN	Putative uncharacterized protein encoded by MIR7-3HG (Pituitary gland-specific factor 1)	MIR7-3HG C19orf30 LINC00306 NCRNA00306 PGSF1	Homo sapiens (Human)						SVLTFS	7.71999979	1	1	0.126779934	654.0449243	0	16.08578	0	0	15.27306	0	0	0	0	0	0	16.21694	16.2289	0	0	15.42032	0	0	0	0	0	0	0	0	0	14.43561	0	0	15.69944	16.11154	16.20832	16.43877	0	12.91599	11.44303	15.12662	0	0	0	0	0	0	0	15.49988	0	14.84049	15.08126	15.8073
Q8N6G5	CGAT2_HUMAN	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2, EC 2.4.1.174 (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2, Beta4GalNAcT-2, GalNAcT-2)"	CSGALNACT2 CHGN2 GALNACT2 PRO0082	Homo sapiens (Human)	"chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]"	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]	"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]"	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]	GO:0000139; GO:0008376; GO:0016020; GO:0030166; GO:0030173; GO:0030206; GO:0032580; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050652; GO:0050653	DVCIHQDKK	9.779999733	1	1	0.142256155	1141.523295	12.94848	14.64076	16.51552	13.19339	14.22199	17.35033	0	14.51031	11.39887	14.61884	14.03908	13.4627	13.45489	0	0	0	0	0	0	0	0	16.23757	0	0	12.35821	17.56975	0	13.17739	0	0	0	13.48645	0	0	0	0	0	0	0	0	15.78441	12.94757	0	0	14.8173	0	0	0
Q8N6K0	TEX29_HUMAN	Testis-expressed protein 29	TEX29 C13orf16	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	LGLKPASPGPPSAGPSMK	4.269999981	1	1	0.17934306	1708.095039	16.51447	14.48084	0	13.07725	0	0	0	0	0	0	12.42269	0	14.71333	0	15.01894	0	12.22016	13.39198	0	0	0	0	14.66107	0	14.36829	0	13.70431	14.10362	0	0	11.04467	12.66031	14.53682	15.49217	13.95839	0	11.73408	16.39129	0	14.2939	8.833574	15.4503	0	0	0	0	0	0
Q8N6L0	KASH5_HUMAN	Protein KASH5 (Coiled-coil domain-containing protein 155) (KASH domain-containing protein 5)	KASH5 CCDC155	Homo sapiens (Human)	actin filament organization [GO:0007015]; chromosome localization to nuclear envelope involved in homologous chromosome segregation [GO:0090220]; double-strand break repair via homologous recombination [GO:0000724]; homologous chromosome pairing at meiosis [GO:0007129]; microtubule cytoskeleton organization involved in homologous chromosome segregation [GO:0090172]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]; spindle localization [GO:0051653]; telomere localization [GO:0034397]	"chromosome, telomeric region [GO:0000781]; integral component of membrane [GO:0016021]; lateral element [GO:0000800]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; meiotic spindle pole [GO:0090619]; nuclear outer membrane [GO:0005640]"	"chromosome, telomeric region [GO:0000781]; integral component of membrane [GO:0016021]; lateral element [GO:0000800]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; meiotic spindle pole [GO:0090619]; nuclear outer membrane [GO:0005640]; dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; actin filament organization [GO:0007015]; chromosome localization to nuclear envelope involved in homologous chromosome segregation [GO:0090220]; double-strand break repair via homologous recombination [GO:0000724]; homologous chromosome pairing at meiosis [GO:0007129]; microtubule cytoskeleton organization involved in homologous chromosome segregation [GO:0090172]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]; spindle localization [GO:0051653]; telomere localization [GO:0034397]"	dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]	GO:0000724; GO:0000781; GO:0000800; GO:0005640; GO:0007015; GO:0007129; GO:0007283; GO:0016021; GO:0034397; GO:0034993; GO:0042802; GO:0048477; GO:0051225; GO:0051653; GO:0070840; GO:0090172; GO:0090220; GO:0090619	ELQQALVPVMKK	12.86999989	0.95057869	0.95057869	6.86E-13	1399.796133	0	0	0	0	17.68289	0	0	17.77771	18.33348	17.66421	0	0	0	0	0	0	0	0	0	0	18.63003	0	0	0	0	16.42781	0	0	0	19.22631	0	0	0	15.80837	0	17.97833	15.51087	17.00369	0	0	0	15.61977	0	0	0	0	16.72502	17.15044
Q8N6M3	FITM2_HUMAN	"Acyl-coenzyme A diphosphatase FITM2, EC 3.6.1.- (Fat storage-inducing transmembrane protein 2) (Fat-inducing protein 2)"	FITM2 C20orf142 FIT2	Homo sapiens (Human)	cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; fatty-acyl-CoA catabolic process [GO:0036115]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129]; cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; fatty-acyl-CoA catabolic process [GO:0036115]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730]	acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129]	GO:0005789; GO:0007010; GO:0008654; GO:0010866; GO:0010890; GO:0010945; GO:0017129; GO:0019915; GO:0019992; GO:0022604; GO:0030176; GO:0030730; GO:0034389; GO:0035356; GO:0036115; GO:0055088; GO:0106399; GO:0140042	RYLPWALVASMLAGSLLK	3.099999905	1	1	0.276728691	2005.701123	6.898997	0	0	0	14.98681	16.6077	14.65798	0	9.654253	14.81438	13.17158	15.35065	0	13.52461	0	0	0	12.85085	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.38587	0
Q8N6M8	IQCF1_HUMAN	IQ domain-containing protein F1	IQCF1	Homo sapiens (Human)	positive regulation of acrosome reaction [GO:2000344]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]	acrosomal vesicle [GO:0001669]	acrosomal vesicle [GO:0001669]; calmodulin binding [GO:0005516]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]	calmodulin binding [GO:0005516]	GO:0001669; GO:0005516; GO:0060474; GO:2000344	LILSKILK	17.32999992	1	1	0.119789425	927.6657059	16.49504	16.26269	15.28366	15.46597	16.51459	15.1805	14.58748	16.71841	15.79995	15.88749	0	0	13.6812	14.46968	16.69993	0	15.74273	15.74119	15.30954	15.27784	15.17428	16.60669	16.95383	0	15.40562	0	16.07717	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N6N6	NATD1_HUMAN	Protein NATD1 (N-acetyltransferase domain-containing protein 1)	NATD1 C17orf103 GTLF3B	Homo sapiens (Human)						GIAKHLAK	5.849999905	1	1	0.24246301	837.9802672	16.33814	14.70676	16.46097	0	0	12.84467	0	0	0	0	15.69433	16.63288	0	0	0	0	0	0	0	0	0	0	0	0	15.86188	0	0	0	0	16.10424	0	0	0	0	0	0	0	14.96614	0	0	0	0	14.92576	0	0	0	0	0
Q8N6P7	I22R1_HUMAN	"Interleukin-22 receptor subunit alpha-1, IL-22 receptor subunit alpha-1, IL-22R-alpha-1, IL-22RA1 (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9, CRF2-9) (ZcytoR11)"	IL22RA1 IL22R	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interferon receptor activity [GO:0004904]; interleukin-20 binding [GO:0042015]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]	cytokine receptor activity [GO:0004896]; interferon receptor activity [GO:0004904]; interleukin-20 binding [GO:0042015]	GO:0004896; GO:0004904; GO:0005886; GO:0005887; GO:0019221; GO:0042015; GO:0050829	SATKMTDR	4.039999962	0.401144475	0.401144475	0.129493758	926.0843475	0	13.93696	15.87288	0	15.69052	0	0	0	0	0	0	0	0	0	0	0	14.85081	0	0	0	0	0	0	0	14.51594	0	0	0	16.17781	0	0	0	12.77963	15.69196	0	11.86008	19.90975	0	0	0	0	0	0	0	0	0	0	0
Q8N6Q8	MET25_HUMAN	"Probable methyltransferase-like protein 25, EC 2.1.1.-"	METTL25 C12orf26	Homo sapiens (Human)	methylation [GO:0032259]		methyltransferase activity [GO:0008168]; methylation [GO:0032259]	methyltransferase activity [GO:0008168]	GO:0008168; GO:0032259	AVEFMNMKK	5.119999886	1	1	0.078305423	1097.677878	15.50562	0	0	0	0	12.4186	14.63745	0	13.18455	0	0	14.97084	0	0	0	0	0	0	0	0	0	0	0	0	0	14.51073	0	0	0	0	0	13.59121	0	0	0	0	0	0	0	0	0	0	0	13.86837	0	0	0	0
Q8N6R0	EFNMT_HUMAN	"eEF1A lysine and N-terminal methyltransferase, eEF1A-KNMT (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase, EC 2.1.1.-; eEF1A N-terminal methyltransferase, EC 2.1.1.- ]"	METTL13 EEF1AKNMT FEAT KIAA0859 CGI-01	Homo sapiens (Human)	methylation [GO:0032259]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]	methyltransferase activity [GO:0008168]	GO:0000122; GO:0005634; GO:0005737; GO:0005739; GO:0008168; GO:0032259; GO:1902807	DVSHK	4.329999924	0.3779293	0.3779293	0.131365642	585.0039964	0	0	0	0	0	16.81905	16.79966	0	13.00588	0	0	16.4143	14.70102	16.71026	15.8977	16.14422	16.44939	14.69395	18.42908	17.48561	14.67232	16.85127	17.07678	16.62189	16.45603	18.05282	13.70484	0	16.61176	0	14.79479	0	15.69111	17.94674	17.20238	15.12338	16.57743	14.63281	17.49683	17.19329	17.03886	12.42724	14.5688	17.6659	19.70485	15.8954	0	0
Q8N6S4	AN13C_HUMAN	Ankyrin repeat domain-containing protein 13C	ANKRD13C	Homo sapiens (Human)	protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of signaling receptor activity [GO:0010469]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor binding [GO:0005102]; protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of signaling receptor activity [GO:0010469]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006621; GO:0010469; GO:0048471; GO:2000209	AIMESLSK	1.340000033	1	1	0.244413809	894.8334505	17.43517	0	0	0	0	0	16.89126	0	0	0	15.91679	18.41573	0	0	0	0	18.31373	0	0	0	15.53703	0	0	0	15.9717	0	0	0	0	0	0	0	16.49191	0	0	0	0	0	0	0	0	0	0	0	17.25739	0	0	0
Q8N6T0	TO6BL_HUMAN	"Type 2 DNA topoisomerase 6 subunit B-like (Type 2 DNA topoisomerase VI subunit B-like, TOPOVIBL)"	TOP6BL C11orf80	Homo sapiens (Human)	meiotic DNA double-strand break formation [GO:0042138]; reciprocal meiotic recombination [GO:0007131]	chromosome [GO:0005694]	chromosome [GO:0005694]; meiotic DNA double-strand break formation [GO:0042138]; reciprocal meiotic recombination [GO:0007131]		GO:0005694; GO:0007131; GO:0042138	GALLEGQLVISIEGLNSK	15.09000015	1	1	0.196995729	1839.911571	0	0	11.85645	14.35321	0	14.81761	0	0	0	0	0	0	0	0	0	15.08955	13.16522	0	0	0	0	0	0	0	13.77108	11.93175	0	0	0	0	0	0	13.75046	0	0	14.45461	0	13.59805	0	0	0	0	0	0	10.81926	0	0	0
Q8N6Y0	USBP1_HUMAN	"Usher syndrome type-1C protein-binding protein 1, USH1C-binding protein 1 (AIE-75-binding protein) (MCC-2) (Mutated in colon cancer protein 2)"	USHBP1 AIEBP MCC2	Homo sapiens (Human)			PDZ domain binding [GO:0030165]	PDZ domain binding [GO:0030165]	GO:0030165	EPWETQDSFSLAHPLLRR	1.639999986	1	1	0.216043972	2181.5746	0	0	15.55688	0	0	0	15.36219	0	0	0	16.49168	15.09314	0	0	0	0	0	0	0	0	16.37279	0	0	0	17.69253	15.92132	0	0	0	0	0	0	0	0	0	0	14.11318	0	0	0	0	0	0	11.95046	0	0	0	0
Q8N715	CC185_HUMAN	Coiled-coil domain-containing protein 185	CCDC185 C1orf65	Homo sapiens (Human)						AGFSHFSQPPYR	1.070000052	1	1	0.290547344	1394.178386	16.6658	0	0	15.46818	0	16.60631	10.62934	0	0	0	0	0	0	0	0	0	0	0	0	0	12.14475	0	16.76167	12.13958	0	0	15.36842	0	0	0	0	0	0	0	0	17.42909	0	0	0	0	0	0	0	0	0	0	15.70477	0
Q8N720	ZN655_HUMAN	Zinc finger protein 655 (Vav-interacting Krueppel-like protein)	ZNF655 VIK	Homo sapiens (Human)	negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0046872; GO:2000134	VLRIQNTDDNDK	2.150000095	1	1	0.355511194	1429.981081	0	0	13.91485	0	15.85741	0	0	0	0	0	0	0	0	0	15.16799	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.86166	0	0	0	0	0	0	15.85272	0	0	0	0	0	0	0	0
Q8N729	NPW_HUMAN	"Neuropeptide W (Preproprotein L8, hPPL8) [Cleaved into: Neuropeptide W-23, NPW23, hL8; Neuropeptide W-30, NPW30, hL8C ]"	NPW PPL8 PPNPW	Homo sapiens (Human)	feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	G protein-coupled receptor binding [GO:0001664]	GO:0001664; GO:0005576; GO:0007186; GO:0007218; GO:0007631	YHTVGRAAGLLMGLR	2.74000001	1	1	0.165035614	1614.645669	0	0	15.5513	14.2783	0	0	15.37233	0	14.40314	0	13.53992	12.21372	0	0	0	15.49009	0	0	0	0	0	0	0	0	0	0	0	0	0	15.27019	0	0	13.79867	0	0	14.20365	15.56495	15.64746	0	0	0	0	15.49818	0	16.39555	0	0	0
Q8N766	EMC1_HUMAN	ER membrane protein complex subunit 1	EMC1 KIAA0090 PSEC0263	Homo sapiens (Human)	protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]	EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		GO:0005789; GO:0016021; GO:0030176; GO:0032991; GO:0045050; GO:0071816; GO:0072546	DEFNLQKMMVMVTASGK	17.15999985	1	1	0.354459591	1927.872728	20.89802	0	19.45049	0	0	0	0	20.75126	20.73716	0	19.32063	0	18.00563	0	20.56624	0	0	0	19.48294	0	21.11379	21.09945	0	19.94386	0	21.25922	21.04999	0	19.50341	0	20.58906	20.02289	0	21.88432	20.47241	20.99307	17.66665	21.00307	0	17.59417	0	0	0	21.58656	19.81869	19.57541	0	0
Q8N7C3	TRIMM_HUMAN	"Probable E3 ubiquitin-protein ligase TRIML2, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TRIML2) (SPRY domain-containing protein 6) (Tripartite motif family-like protein 2)"	TRIML2 SPRYD6	Homo sapiens (Human)	innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0051092; GO:0061630	ASEQVR	1.710000038	0.000907174	0.000907174	0.121356995	688.5905511	15.46575	0	0	16.61345	0	16.04455	0	0	17.37956	15.88311	0	14.9714	16.78704	0	0	16.42082	0	0	0	0	0	0	0	13.59606	0	0	16.20634	0	0	0	0	0	18.03501	0	0	0	0	0	0	16.9316	0	0	0	0	0	0	0	0
Q8N7F7	UBL4B_HUMAN	Ubiquitin-like protein 4B	UBL4B	Homo sapiens (Human)	positive regulation of protein targeting to mitochondrion [GO:1903955]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; positive regulation of protein targeting to mitochondrion [GO:1903955]		GO:0005737; GO:1903955	MFLTVKLLLGQR	2.220000029	1	1	0.23406827	1435.446707	15.00158	0	0	0	0	0	0	0	0	0	16.64859	0	0	13.24494	13.51427	0	0	0	0	0	14.92344	0	0	0	0	0	0	0	0	0	12.02061	0	15.39623	0	0	0	0	0	0	0	15.96596	0	0	0	0	0	0	0
Q8N7H1	CL061_HUMAN	Putative uncharacterized protein encoded by LINC01465	LINC01465 C12orf61	Homo sapiens (Human)						MGGKSAVR	2.599999905	0.357782185	0.357782185	0.236712133	820.7534621	17.11768	16.95447	0	15.72701	15.14038	15.07223	0	0	0	15.16889	16.84036	17.83593	16.8683	13.78005	0	14.68878	15.543	0	0	0	0	0	0	0	15.72244	0	0	15.09265	15.6054	13.86128	0	16.94365	0	14.20442	11.9102	0	0	0	0	0	16.95143	16.01834	0	15.52867	17.48518	0	14.68932	0
Q8N7J2	AMER2_HUMAN	"APC membrane recruitment protein 2, Amer2 (Protein FAM123A)"	AMER2 FAM123A	Homo sapiens (Human)	ectoderm development [GO:0007398]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	plasma membrane [GO:0005886]	"plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ectoderm development [GO:0007398]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]"	"beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0005546; GO:0005886; GO:0007398; GO:0008013; GO:0016055; GO:0060828; GO:0090090	IPVSK	10.18999958	0.519546628	0.519546628	0.304159294	541.8144935	0	17.55054	0	17.34657	17.39017	18.72062	0	0	18.24923	0	0	0	18.99796	0	16.78269	19.10685	19.54716	18.27144	17.48505	0	18.73078	0	17.90819	0	0	18.46676	0	0	0	0	0	20.43003	0	0	20.8062	0	17.61826	0	19.1863	0	19.26432	17.75334	0	17.10544	18.12075	0	0	0
Q8N7L0	F216B_HUMAN	Protein FAM216B	FAM216B C13orf30	Homo sapiens (Human)						TSAMTRR	6.989999771	0.618450701	0.618450701	0.254545324	838.0693274	0	14.30857	12.16018	15.55884	0	15.297	0	0	0	0	0	15.18049	16.3435	16.5206	0	0	16.84108	14.94279	0	0	0	0	15.20195	0	14.49077	15.1561	16.49614	15.28996	16.69328	16.12658	17.40768	15.1355	14.26652	17.24049	0	15.15401	0	0	14.59229	15.51535	15.82185	15.51181	15.71584	14.09316	14.2205	0	15.05534	15.49666
Q8N7M2	ZN283_HUMAN	Zinc finger protein 283 (Zinc finger protein HZF19)	ZNF283	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AFFWGSSLAK	2.029999971	1	1	0.079478541	1112.890783	15.52757	0	7.148802	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.34728	0	0	0	0	0	0	0	0	0	14.35765	13.73043	0	14.75492	14.65649	16.30972	0	16.97117	0	0	0	0	0	0	0	0	0	15.9803	0	0	0
Q8N7P1	PLD5_HUMAN	"Inactive phospholipase D5, Inactive PLD 5 (Inactive choline phosphatase 5) (Inactive phosphatidylcholine-hydrolyzing phospholipase D5) (PLDc)"	PLD5	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; catalytic activity [GO:0003824]	catalytic activity [GO:0003824]	GO:0003824; GO:0016021	NHTFPR	4.170000076	0.408070862	0.408070862	0.24198017	769.6536346	18.19982	14.88858	14.07395	13.06595	0	0	15.59912	0	14.8514	0	14.89476	15.76456	15.43433	15.09608	13.49944	0	0	16.11002	14.15585	14.69105	11.97752	0	16.76322	15.23008	16.23088	15.99105	15.25717	15.13778	0	0	0	17.4173	0	14.72585	0	0	0	0	0	15.71129	16.18417	0	15.50478	15.15085	16.86351	0	0	0
Q8N7R1	P1L12_HUMAN	POM121-like protein 12	POM121L12	Homo sapiens (Human)	protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]	nuclear pore [GO:0005643]	nuclear pore [GO:0005643]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]	nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]	GO:0005643; GO:0006405; GO:0006606; GO:0008139; GO:0017056	RPALPGETALGR	7.199999809	1	1	0.246548645	1238.352008	15.51327	0	15.02212	16.53862	15.7062	0	13.8255	14.75859	0	15.1836	16.75079	0	0	16.09604	15.62735	15.67224	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N7U6	EFHB_HUMAN	EF-hand domain-containing family member B	EFHB	Homo sapiens (Human)	calcium ion transport [GO:0006816]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; calcium ion sensor activity [GO:0061891]; calcium ion transport [GO:0006816]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256]	calcium ion sensor activity [GO:0061891]	GO:0005737; GO:0006816; GO:0032091; GO:0061891; GO:0070884; GO:2001256	GLEMGLERQNISR	2.789999962	0.177569062	0.177569062	0.376354715	1503.394496	0	0	15.58021	0	0	0	0	0	0	14.6399	0	0	0	16.82172	17.50777	0	15.89375	14.84888	0	16.50313	0	17.24837	0	0	16.96015	0	0	17.06017	16.55526	0	0	13.95077	16.07577	15.22276	12.63413	0	0	0	15.40852	15.62191	17.26707	16.12391	13.3154	0	15.45499	0	0	13.69145
Q8N7U7	TPRX1_HUMAN	Tetra-peptide repeat homeobox protein 1	TPRX1	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357	LLLDL	10.5	0.022635339	0.022635339	0.248480718	582.5648826	15.37582	16.37504	15.77333	14.94758	15.54045	0	15.91386	16.03831	0	16.34328	16.59447	16.39651	14.07774	16.0132	16.46146	15.34073	15.4845	16.17491	16.9181	16.67555	16.73505	16.29594	15.3332	15.5406	14.74126	15.67306	15.44331	14.83181	16.03287	15.85676	0	16.26923	15.86676	16.21346	16.15681	16.00636	16.61036	17.10098	15.91641	17.08476	0	16.14234	17.59575	0	0	16.88023	15.89203	0
Q8N7W2	BEND7_HUMAN	BEN domain-containing protein 7	BEND7 C10orf30	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]; DNA binding [GO:0003677]	DNA binding [GO:0003677]	GO:0003677; GO:0070062	ETQPIFLGDESMEIKK	2.079999924	1	1	4.61E-13	1880.782068	14.53496	0	0	0	0	0	0	0	13.96501	0	0	0	0	0	0	13.88302	0	13.0427	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.87937	0	0	0	0	0	0	13.5254	0	14.35798	0	15.77068	0	0	0
Q8N7X0	ADGB_HUMAN	Androglobin (Calpain-7-like protein)	ADGB C6orf103 CAPN7L	Homo sapiens (Human)			calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825]	GO:0004198; GO:0019825; GO:0020037	EKSSEK	7.510000229	1	1	0.327183006	706.9838131	15.76204	15.64942	0	17.37051	0	15.36693	0	0	13.76871	14.6672	17.11727	0	0	15.91296	0	0	0	16.29743	17.10531	0	0	18.01476	17.77551	16.25496	0	16.82956	0	15.15064	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.98316	0	0	15.5343	0
Q8N7X8	SIGL1_HUMAN	SIGLEC family-like protein 1	SIGLECL1 C19orf75	Homo sapiens (Human)	cell adhesion [GO:0007155]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]	sialic acid binding [GO:0033691]	GO:0005886; GO:0007155; GO:0016021; GO:0033691	MLPLLQLVPAK	7.889999866	1	1	2.28E-13	1221.697435	15.14055	15.95124	0	0	14.30013	16.62659	0	13.71785	17.90026	8.51382	0	14.45176	0	17.4804	16.30598	14.71495	0	16.40265	14.86633	0	0	0	14.71076	17.0965	15.39586	0	15.51595	0	14.37209	15.47277	15.79621	16.64971	0	14.50557	17.24762	0	16.09627	18.34933	18.39499	14.89313	17.36627	17.4642	16.53068	15.25471	15.83065	16.19576	14.79899	15.98601
Q8N7Z5	ANR31_HUMAN	Ankyrin repeat domain-containing protein 31	ANKRD31	Homo sapiens (Human)	homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343]	chromatin [GO:0000785]; nucleus [GO:0005634]	chromatin [GO:0000785]; nucleus [GO:0005634]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343]		GO:0000785; GO:0005634; GO:0007129; GO:0010780; GO:1903343	ESMQSSPR	7.480000019	0.679632783	0.679632783	0.135985982	938.5598158	0	0	0	12.27485	16.90626	13.98494	0	0	10.95529	12.77809	12.6882	0	13.70224	14.32233	16.08947	0	0	15.45791	16.00905	0	0	0	0	0	0	0	0	12.88221	15.0896	0	0	0	0	0	0	18.23712	0	0	0	0	15.92988	0	13.64399	17.48608	9.530744	15.60005	0	0
Q8N807	PDILT_HUMAN	Protein disulfide-isomerase-like protein of the testis	PDILT	Homo sapiens (Human)	cell migration [GO:0016477]; protein folding [GO:0006457]; spermatid development [GO:0007286]	endoplasmic reticulum [GO:0005783]	endoplasmic reticulum [GO:0005783]; protein disulfide isomerase activity [GO:0003756]; cell migration [GO:0016477]; protein folding [GO:0006457]; spermatid development [GO:0007286]	protein disulfide isomerase activity [GO:0003756]	GO:0003756; GO:0005783; GO:0006457; GO:0007286; GO:0016477	GPPVQKK	3.890000105	0.842654407	0.842654407	0.176550038	752.3841076	15.3115	0	14.75751	14.67781	14.5236	15.36717	0	0	0	16.54427	17.20656	0	15.55639	14.95581	15.12889	0	0	0	16.68252	0	0	14.5131	0	0	0	14.73254	0	13.65949	16.03001	0	18.04236	0	0	0	0	17.07166	16.39293	16.47198	15.18315	15.21594	0	0	0	0	0	0	0	0
Q8N815	CNTD1_HUMAN	Cyclin N-terminal domain-containing protein 1	CNTD1 CNTD	Homo sapiens (Human)	reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]	chromosome [GO:0005694]; site of double-strand break [GO:0035861]	chromosome [GO:0005694]; site of double-strand break [GO:0035861]; reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]		GO:0005694; GO:0007131; GO:0007283; GO:0035861; GO:0051445	ALKTVASSNT	3.680000067	1	1	3.46E-13	990.8135088	0	13.17101	11.67969	14.17885	14.89995	0	15.46048	14.1164	14.49073	13.35868	13.52922	14.68391	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.44983	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N819	PPM1N_HUMAN	"Probable protein phosphatase 1N, EC 3.1.3.16"	PPM1N	Homo sapiens (Human)	negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of canonical Wnt signaling pathway [GO:0090263]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0030145; GO:0043124; GO:0090263	LRSLWPR	13.60999966	1	1	0.164739644	929.7068162	0	0	15.09802	0	0	0	0	0	14.73177	0	13.92034	14.95401	0	0	0	0	0	0	0	0	0	15.37935	14.97301	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.01816	14.76285	0	0	0	15.68982	0
Q8N823	ZN611_HUMAN	Zinc finger protein 611	ZNF611	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	IHTAKK	13.15999985	0.622527659	0.622527659	0.121470264	696.4860395	0	14.08759	18.23922	17.98418	17.73582	0	15.01739	0	0	15.01667	17.39637	17.80597	17.78455	16.49251	15.51642	11.9796	13.77124	16.93278	16.00624	16.94306	15.07299	15.36368	0	18.21311	17.78552	15.00552	0	17.17712	15.36763	17.82395	15.9427	0	17.58268	17.05301	15.61344	16.06108	0	17.4683	18.82718	0	17.45318	0	15.74775	14.60321	16.90038	17.32721	17.40318	15.67718
Q8N831	TSYL6_HUMAN	"Testis-specific Y-encoded-like protein 6, TSPY-like protein 6"	TSPYL6	Homo sapiens (Human)	nucleosome assembly [GO:0006334]	chromatin [GO:0000785]; nucleus [GO:0005634]	chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0042393	SHGAIK	4.940000057	0.478047609	0.478047609	0.207325642	611.5458355	0	14.28151	0	0	14.59232	15.89336	14.41783	14.41071	15.24915	11.64827	14.15537	16.00149	0	16.21972	17.07609	16.16086	16.75658	14.27361	14.46461	15.66908	15.69497	14.97969	15.22647	12.5674	14.18962	12.97192	13.90792	15.98469	15.38804	14.97273	0	0	16.13246	16.40268	16.79662	17.49723	0	17.25216	18.13266	0	16.19039	0	14.99298	16.22582	17.86812	14.44474	16.20058	16.0499
Q8N841	TTLL6_HUMAN	"Tubulin polyglutamylase TTLL6, EC 6.3.2.- (Protein polyglutamylase TTLL6) (Tubulin--tyrosine ligase-like protein 6)"	TTLL6 TTL.6	Homo sapiens (Human)	microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]	9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]	9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0001578; GO:0003353; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0036064; GO:0046872; GO:0051013; GO:0060296; GO:0070739; GO:0070740; GO:0097731	SHASAMR	13.44999981	0.167534158	0.167534158	0.041946208	762.5350576	17.09195	0	15.87674	14.66169	0	0	17.25779	0	18.11928	17.44318	17.47792	14.62563	0	0	16.57087	16.1149	17.12653	18.06144	16.62572	17.70698	17.96544	0	17.00912	16.13899	0	18.42175	17.79292	0	16.34832	0	15.35031	0	15.78813	18.77285	0	15.98278	0	16.86253	0	0	0	0	17.4148	17.25208	16.69028	16.27676	16.9726	15.01558
Q8N878	FRMD1_HUMAN	FERM domain-containing protein 1	FRMD1	Homo sapiens (Human)	positive regulation of hippo signaling [GO:0035332]	cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856]	cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856]; positive regulation of hippo signaling [GO:0035332]		GO:0005856; GO:0035332; GO:0098592	VRPTLQQLR	8.149999619	1	1	0.098035009	1111.263001	14.29782	0	16.16966	0	13.28268	0	0	0	12.43044	0	0	16.58962	0	0	0	0	0	0	0	0	0	0	0	0	13.35489	0	15.39271	0	14.56467	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.34288
Q8N8A6	DDX51_HUMAN	"ATP-dependent RNA helicase DDX51, EC 3.6.4.13 (DEAD box protein 51)"	DDX51	Homo sapiens (Human)	rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016020; GO:0016887	AGKTGQAFTLLLK	4.320000172	1	1	0.180894389	1346.42736	16.65376	0	15.01769	0	0	0	0	0	0	0	0	14.93034	16.44851	0	0	16.17292	0	14.80653	14.56815	0	15.47758	0	0	0	0	0	0	15.31038	0	0	0	17.10591	0	0	0	0	0	0	16.62132	0	16.26455	0	0	0	0	0	0	0
Q8N8B7	TEANC_HUMAN	Transcription elongation factor A N-terminal and central domain-containing protein (TFIIS central domain-containing protein 1)	TCEANC	Homo sapiens (Human)	"transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; transcription, DNA-templated [GO:0006351]"		GO:0005634; GO:0006351	MSDKNQIAAR	6.239999771	0.581684232	0.581684232	0.12751932	1132.752323	0	0	15.88686	13.15516	0	11.6317	12.5721	13.52368	0	0	0	15.35867	0	15.69088	0	0	0	15.56128	0	13.81953	0	0	0	0	0	0	0	0	13.17381	14.65524	14.23511	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.05964	0
Q8N8C0	ZN781_HUMAN	Zinc finger protein 781	ZNF781	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872	EHILMK	16.03000069	1	1	0.150521125	785.9905504	0	0	0	0	0	0	16.498	11.22613	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.25542	0	0	0	0	0	0	0	16.73261	0	0	14.28385	0	0	0	0	0	0	0	0	0
Q8N8E2	ZN513_HUMAN	Zinc finger protein 513	ZNF513	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]	GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041	QSHPQPVK	5.130000114	0.51661694	0.51661694	0.268896894	920.5613406	16.92791	17.5289	12.80195	15.42021	17.44432	17.71525	18.12405	0	0	16.74181	0	17.48806	17.4243	0	0	0	0	0	16.54802	0	0	0	16.38182	0	0	18.20375	15.45909	0	0	16.45954	18.59297	0	0	17.48007	0	19.0038	0	0	0	0	16.67953	0	15.90407	0	0	0	0	0
Q8N8E3	CE112_HUMAN	"Centrosomal protein of 112 kDa, Cep112 (Coiled-coil domain-containing protein 46)"	CEP112 CCDC46	Homo sapiens (Human)	receptor localization to synapse [GO:0097120]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120]		GO:0005737; GO:0005813; GO:0005886; GO:0060077; GO:0097120	ANSKLK	9.180000305	0.766512573	0.766512573	0.203170605	663.0381966	0	0	0	0	0	0	0	0	0	0	0	0	0	16.69461	0	0	0	0	16.63074	0	0	18.66876	19.09391	18.49784	14.91666	0	0	15.35977	15.06322	14.65786	0	0	0	17.53152	16.40411	15.71586	15.82245	0	0	15.6736	0	14.84309	16.11936	14.06017	0	17.49317	15.25458	17.55521
Q8N8H1	ZN321_HUMAN	Putative protein ZNF321 (Zinc finger protein 321 pseudogene)	ZNF321P ZNF321	Homo sapiens (Human)						HESHHIR	8.800000191	1	1	0.2378926	914.9638405	0	0	0	0	0	0	0	16.2454	0	0	0	0	0	0	0	0	0	16.6539	0	0	0	0	0	0	0	0	0	0	0	15.83664	0	0	0	0	0	0	0	16.04697	13.19742	0	0	0	16.73186	0	0	16.44395	15.44744	0
Q8N8J0	PI4P1_HUMAN	Putative inactive phosphatidylinositol 4-kinase alpha-like protein P1	PI4KAP1	Homo sapiens (Human)	phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; phosphatidylinositol kinase activity [GO:0052742]	GO:0004430; GO:0005737; GO:0005886; GO:0016020; GO:0046854; GO:0048015; GO:0052742	EQLVEENTGSLSGPAK	2.49000001	1	1	0.24341655	1658.047867	17.55539	13.6249	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.22284	0	0	0	0	0	0	17.23074	17.73574	13.76509	18.47159	15.89484	0	16.07238	0	0	16.80368	0	15.94837	0	13.44095	0	0	0	0	0	0	0	0	0	0
Q8N8J6	ZN615_HUMAN	Zinc finger protein 615	ZNF615	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	KNDLITHQR	3.819999933	1	1	0.147252316	1121.431505	13.06973	0	14.85135	0	15.00889	12.75274	0	0	0	0	0	0	0	0	0	15.59075	0	0	0	0	0	0	12.69102	14.42064	0	13.47819	0	0	14.95923	15.47592	14.58701	0	0	12.00361	16.0252	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N8K9	K1958_HUMAN	Uncharacterized protein KIAA1958	KIAA1958	Homo sapiens (Human)						YMYIHRPPTQMEAK	11.14000034	1	1	0.256539329	1766.150406	16.32113	0	0	0	0	0	0	0	13.00381	0	0	14.50703	0	0	0	0	0	15.19897	0	16.10292	16.90183	0	0	0	0	15.10382	0	0	0	0	0	0	0	0	14.79937	0	0	0	16.18478	16.99699	16.51145	16.50098	0	0	0	0	0	0
Q8N8L6	ARL10_HUMAN	ADP-ribosylation factor-like protein 10	ARL10 ARL10A	Homo sapiens (Human)			GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525	DPDLPVVVVANKQDLSEAMSMGELQR	5.090000153	1	1	0.18936985	2858.055442	0	0	16.40379	13.58833	0	13.42679	15.20509	14.70012	14.62202	15.75109	14.66195	15.09471	0	0	0	12.35031	0	0	0	0	0	0	0	0	0	16.34099	14.96486	0	13.21154	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.44731	15.6767	0	16.97774	15.09993
Q8N8N0	RN152_HUMAN	"E3 ubiquitin-protein ligase RNF152, EC 2.3.2.27 (RING finger protein 152) (RING-type E3 ubiquitin transferase RNF152)"	RNF152	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]	integral component of organelle membrane [GO:0031301]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	integral component of organelle membrane [GO:0031301]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]	metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005764; GO:0005765; GO:0006915; GO:0010508; GO:0016567; GO:0031267; GO:0031301; GO:0034198; GO:0046872; GO:0061630; GO:0070534; GO:0070936; GO:1904262	LLPGSQQK	15.22999954	1	1	0.261082492	870.9972718	0	0	17.79234	0	0	0	0	0	0	0	0	16.72801	0	0	15.74893	0	0	0	18.84634	17.52502	0	0	0	0	0	17.39486	18.72407	0	17.20373	0	0	0	19.16525	19.76769	17.59419	0	18.94857	0	18.03501	18.24011	0	18.97963	0	18.45217	17.04643	19.9352	0	0
Q8N8P6	YX004_HUMAN	Putative uncharacterized protein FLJ39060		Homo sapiens (Human)						HSASVPMATGANGLETK	4.010000229	1	1	0.364124318	1687.694494	0	15.6392	0	0	0	0	15.36973	0	15.88413	0	0	0	0	0	16.73018	0	0	0	0	0	17.09798	17.24943	15.67692	0	17.58928	16.40161	0	15.9762	17.66408	0	16.62508	0	0	0	0	17.17813	17.33716	15.85273	15.297	16.64542	0	0	0	15.464	16.68142	0	0	0
Q8N8S7	ENAH_HUMAN	Protein enabled homolog	ENAH MENA	Homo sapiens (Human)	actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]	actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]	GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030054; GO:0030175; GO:0045202; GO:0050699; GO:0070358	QDILDEMR	6.539999962	0.274243206	0.274243206	0.259638867	1037.788355	16.84592	15.68206	15.7529	15.32092	14.95909	16.28994	0	0	0	17.16839	18.45204	16.57783	15.80112	0	0	15.85725	0	16.34309	0	14.37259	16.13617	16.00806	16.52879	15.44118	16.43213	0	0	15.7066	15.7531	16.17745	16.52207	16.13692	0	0	17.69555	17.60853	16.74692	16.62411	0	16.93566	16.50083	14.33901	0	0	0	0	16.755	0
Q8N8V4	ANS4B_HUMAN	"Ankyrin repeat and SAM domain-containing protein 4B (Harmonin-interacting ankyrin repeat-containing protein, Harp)"	ANKS4B HARP	Homo sapiens (Human)	brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; response to endoplasmic reticulum stress [GO:0034976]	brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; response to endoplasmic reticulum stress [GO:0034976]		GO:0005789; GO:0005886; GO:0005902; GO:0005903; GO:0030154; GO:0034976; GO:0065003; GO:1904106; GO:1904970	GGDPDR	3.380000114	0.361933082	0.361933082	0.229044405	616.0951189	15.45292	15.70004	0	14.81024	15.37495	0	0	14.94673	14.9158	0	0	0	14.40507	16.06139	14.30449	0	0	0	0	0	0	15.74795	0	0	0	0	0	0	0	16.03363	0	0	0	0	0	0	0	0	0	15.15106	0	0	0	0	0	0	15.62605	0
Q8N8W4	PLPL1_HUMAN	"Omega-hydroxyceramide transacylase, EC 2.3.1.296 (Patatin-like phospholipase domain-containing protein 1)"	PNPLA1	Homo sapiens (Human)	ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; omega-hydroxyceramide biosynthetic process [GO:0106342]; triglyceride catabolic process [GO:0019433]	cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]	"cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; omega-hydroxyceramide transacylase activity [GO:0106341]; structural constituent of skin epidermis [GO:0030280]; triglyceride lipase activity [GO:0004806]; ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; omega-hydroxyceramide biosynthetic process [GO:0106342]; triglyceride catabolic process [GO:0019433]"	"acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; omega-hydroxyceramide transacylase activity [GO:0106341]; structural constituent of skin epidermis [GO:0030280]; triglyceride lipase activity [GO:0004806]"	GO:0004806; GO:0005737; GO:0005811; GO:0016020; GO:0016747; GO:0019433; GO:0030280; GO:0046513; GO:0055088; GO:0106341; GO:0106342	EWVPKGDGR	6.579999924	0.242534548	0.242534548	0.295043581	1043.624869	0	14.56387	15.92176	15.42098	15.55824	14.76877	0	15.59223	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.96702	0	0	0	0	16.34806	15.64312	0	15.85684	0	0	0	16.89437	0	0	0	0	0	15.58168	0	0	0	0	0	0	0
Q8N8Y5	ZFP41_HUMAN	"Zinc finger protein 41 homolog, Zfp-41"	ZFP41	Homo sapiens (Human)	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0030154; GO:0046872; GO:1990837	MEKPAGR	6.639999866	1.67E-07	1.67E-07	0.285302	787.5507143	18.09867	0	17.26708	17.46839	18.09389	0	0	0	0	0	17.84329	17.38244	17.47265	17.89414	18.03095	0	0	0	0	0	0	0	0	17.31655	18.01679	0	0	0	0	0	18.69037	0	0	18.63088	0	0	0	19.01643	18.48428	18.31625	0	0	0	0	0	0	0	0
Q8N8Z6	DCBD1_HUMAN	"Discoidin, CUB and LCCL domain-containing protein 1"	DCBLD1	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	GGGALARAAGR	1.669999957	1	1	0.103268653	956.2026904	16.16887	0	0	15.04757	15.81569	0	15.8306	0	16.14167	0	15.4414	0	15.7139	17.09914	14.56345	9.818698	15.33017	14.4483	16.42643	0	17.20442	17.25795	12.71364	15.85608	0	15.92105	15.53597	15.4174	13.54684	15.15381	13.76087	0	0	17.50278	15.0521	15.41383	17.8087	17.27729	0	13.57063	15.5143	0	15.28154	0	0	16.69281	15.91278	15.93706
Q8N907	DAND5_HUMAN	"DAN domain family member 5 (Cerberus-like protein 2, Cerl-2) (Cysteine knot superfamily 1, BMP antagonist 3) (Gremlin-3)"	DAND5 CER2 CKTSF1B3 GREM3 SP1	Homo sapiens (Human)	atrial septum development [GO:0003283]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of nodal from receptor via nodal binding [GO:0038101]; signal transduction involved in regulation of gene expression [GO:0023019]; ventricular septum development [GO:0003281]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; morphogen activity [GO:0016015]; atrial septum development [GO:0003283]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of nodal from receptor via nodal binding [GO:0038101]; signal transduction involved in regulation of gene expression [GO:0023019]; ventricular septum development [GO:0003281]	morphogen activity [GO:0016015]	GO:0003140; GO:0003281; GO:0003283; GO:0005576; GO:0005615; GO:0016015; GO:0023019; GO:0030512; GO:0030514; GO:0035582; GO:0038101; GO:0061371; GO:1900108; GO:1900176	ISTMLIEGCHCSPK	7.690000057	0.723415017	0.723415017	0.428342222	1648.372017	14.78301	15.31598	0	0	0	0	15.95724	0	15.44367	0	0	15.13599	0	0	0	15.79789	16.93157	0	0	0	0	0	0	0	16.59723	0	15.53212	17.0388	16.5262	15.80509	17.96345	16.59022	16.26197	16.40804	0	15.58922	16.30198	17.86193	17.04903	17.23908	0	17.58017	0	17.19492	16.93571	0	0	17.10514
Q8N944	AMER3_HUMAN	"APC membrane recruitment protein 3, Amer3 (Protein FAM123C)"	AMER3 FAM123C	Homo sapiens (Human)	regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	plasma membrane [GO:0005886]	"plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]"	"beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0005546; GO:0005886; GO:0008013; GO:0016055; GO:0060828	EPGPPGVLGCFR	1.909999967	1	1	0.195450978	1286.831365	0	0	14.5842	16.82375	15.8631	14.29665	13.87825	0	10.73962	13.90544	0	14.59366	13.66066	12.55565	0	0	0	0	0	0	14.06911	0	0	0	0	0	0	15.42282	14.91294	0	15.85071	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.40392	0
Q8N954	GPT11_HUMAN	G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75)	GPATCH11 CCDC75 CENP-Y	Homo sapiens (Human)		kinetochore [GO:0000776]	kinetochore [GO:0000776]; nucleic acid binding [GO:0003676]	nucleic acid binding [GO:0003676]	GO:0000776; GO:0003676	EEKQQEANLK	4.650000095	1	1	0.190512477	1215.689025	16.45748	10.80651	13.18409	11.74022	0	14.8104	14.4439	0	14.48461	14.76065	14.68444	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N960	CE120_HUMAN	"Centrosomal protein of 120 kDa, Cep120 (Coiled-coil domain-containing protein 100)"	CEP120 CCDC100	Homo sapiens (Human)	astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein C-terminus binding [GO:0008022]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]	protein C-terminus binding [GO:0008022]	GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951	DGKVPAILAGLDPR	20.57999992	0.104295909	0.104295909	0.26898378	1421.980091	18.77778	20.44656	18.87621	20.94823	19.60847	20.24682	18.98517	19.63457	19.86159	18.88795	18.60112	20.24727	0	20.38773	16.33706	20.09073	18.15942	18.67071	17.83606	0	0	0	18.37461	0	0	0	18.90889	0	0	17.77722	0	0	0	18.60762	0	20.16319	0	0	20.34228	0	19.98225	19.67495	19.55635	0	20.17068	0	0	0
Q8N961	ABTB2_HUMAN	Ankyrin repeat and BTB/POZ domain-containing protein 2	ABTB2	Homo sapiens (Human)	cellular response to toxic substance [GO:0097237]		protein heterodimerization activity [GO:0046982]; cellular response to toxic substance [GO:0097237]	protein heterodimerization activity [GO:0046982]	GO:0046982; GO:0097237	ALGVPWK	4.139999866	0.017711479	0.017711479	0.196462383	771.1996592	14.23342	15.46614	12.86566	15.69617	0	15.85169	0	15.51231	15.53497	0	0	0	16.35789	0	0	0	0	0	0	0	0	16.94942	0	0	0	0	0	15.63526	0	0	14.32458	15.22139	15.38675	0	0	17.29347	15.98155	16.45125	0	0	15.22316	0	0	18.03064	15.53478	0	0	0
Q8N966	ZDH22_HUMAN	"Palmitoyltransferase ZDHHC22, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 22, DHHC-22, zDHHC22)"	ZDHHC22 C14orf59	Homo sapiens (Human)	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659	EDPAAAR	2.75	0.00901772	0.00901772	0.121238242	730.4214621	0	16.29153	0	13.88197	0	0	14.49041	16.38867	0	0	0	0	14.84921	0	13.76616	0	0	15.73862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N967	LRTM2_HUMAN	Leucine-rich repeat and transmembrane domain-containing protein 2	LRTM2	Homo sapiens (Human)	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; positive regulation of synapse assembly [GO:0051965]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; positive regulation of synapse assembly [GO:0051965]	heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050919; GO:0051965	HRPASVRR	6.570000172	1	1	5.78E-13	982.1392909	15.02755	0	14.02004	0	0	0	0	16.04074	11.11729	13.74435	0	0	14.23034	0	9.432412	0	0	0	0	0	0	13.99689	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N998	CCD89_HUMAN	Coiled-coil domain-containing protein 89 (Bc8 orange-interacting protein)	CCDC89 BOIP	Homo sapiens (Human)		cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737	VLQLTVR	4.579999924	1	1	0.273721786	828.0908057	0	0	0	0	0	16.50406	0	0	0	0	0	0	0	0	17.85903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.70148	0	0	0	0	0	0	18.0376	0	0	0	0	0	0
Q8N999	CL029_HUMAN	Uncharacterized protein C12orf29	C12orf29	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]		hematopoietic progenitor cell differentiation [GO:0002244]		GO:0002244	DIIFDV	11.27999973	0.591372252	0.591372252	0.24942126	721.7717096	17.3867	14.37946	16.08438	0	17.19331	15.18811	17.77852	17.63572	16.24837	18.37406	0	0	18.91131	17.53305	15.32365	15.91307	16.84809	17.77056	18.93358	20.06613	0	16.7019	0	0	18.38478	18.02645	0	18.23945	17.61672	15.42772	16.94201	16.87858	17.72594	17.19887	17.76847	18.69663	17.43501	18.34874	16.14814	0	19.29264	16.09815	16.08738	16.11449	18.62836	19.1908	18.80095	16.11626
Q8N9C0	IGS22_HUMAN	"Immunoglobulin superfamily member 22, IgSF22"	IGSF22	Homo sapiens (Human)						AMPPPGLTTT	1.350000024	1	1	0.139399513	1000.491777	12.76388	13.65935	10.32025	0	10.94887	0	0	14.39584	0	0	0	0	0	0	12.93918	15.4359	0	0	0	15.983	16.18888	0	0	0	0	0	0	15.1286	15.15659	15.23117	16.44	0	15.30485	0	12.95277	0	0	15.21416	0	0	0	0	0	0	0	0	0	16.11746
Q8N9F7	GDPD1_HUMAN	"Lysophospholipase D GDPD1, EC 3.1.4.- (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)"	GDPD1 GDE4	Homo sapiens (Human)	glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]	lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]	GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291	LKEPHTMSR	2.440000057	1	1	0.067314134	1098.608876	13.37613	0	16.416	0	0	0	0	0	0	14.74324	0	0	14.57277	0	0	0	0	0	0	0	0	0	0	0	0	15.80766	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.38357	0	0	0
Q8N9F8	ZN454_HUMAN	Zinc finger protein 454	ZNF454	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	VNSSLTEHQR	14.39999962	0.682106674	0.682106674	0.32651085	1168.774001	14.46173	15.12433	15.24751	0	14.59696	15.18802	0	16.1769	14.33006	14.80649	14.78848	0	0	0	13.63606	16.84313	16.16313	0	0	0	15.88373	15.66044	0	0	0	17.07262	0	14.65824	10.31189	16.35272	15.1084	0	0	0	0	0	17.60266	0	0	0	0	0	0	0	17.37413	0	0	17.65989
Q8N9H8	MUT7_HUMAN	"Exonuclease mut-7 homolog, EC 3.1.-.- (Exonuclease 3'-5' domain-containing protein 3)"	EXD3 HBE269	Homo sapiens (Human)			3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0008408; GO:0046872	DMMKQLMWLSSHQEGPR	1.190000057	1	1	0.311203224	2090.816965	16.39706	0	13.12157	0	0	0	15.84905	0	14.60078	13.66986	0	16.59958	15.08394	15.27927	13.91895	14.63637	14.82759	0	0	0	0	0	0	0	0	0	0	0	0	14.78091	0	15.7716	0	0	0	0	8.953203	13.98779	0	0	13.16328	0	0	0	13.37041	0	0	0
Q8N9I0	SYT2_HUMAN	"Synaptotagmin-2 (Synaptotagmin II, SytII)"	SYT2	Homo sapiens (Human)	calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	"axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]"	"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]"	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030669; GO:0030672; GO:0031045; GO:0042584; GO:0043533; GO:0048488; GO:0048791; GO:0070382; GO:0071277; GO:1903861	NEAIGKIFVGSNATGTELR	3.789999962	1	1	0.395628751	1976.945183	0	13.28478	0	14.66424	0	0	0	0	0	0	12.35499	14.76167	0	0	0	0	0	0	0	14.1003	0	0	0	0	0	0	15.82982	0	0	0	0	15.30035	0	0	0	0	0	0	0	0	0	0	14.63366	0	0	0	0	0
Q8N9L9	ACOT4_HUMAN	"Peroxisomal succinyl-coenzyme A thioesterase, EC 3.1.2.3 (Acyl-coenzyme A thioesterase 4, Acyl-CoA thioesterase 4, EC 3.1.2.2) (PTE-2b) (Peroxisomal acyl coenzyme A thioester hydrolase Ib) (Peroxisomal long-chain acyl-CoA thioesterase Ib, PTE-Ib)"	ACOT4 PTE2B PTEIB	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; succinyl-CoA hydrolase activity [GO:0004778]; acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; succinyl-CoA hydrolase activity [GO:0004778]	GO:0000038; GO:0001676; GO:0004778; GO:0005777; GO:0005782; GO:0005829; GO:0006104; GO:0006631; GO:0006633; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0043648; GO:0043649; GO:0044466; GO:0046459; GO:0047617; GO:0052689; GO:0102991	QSVRAGR	7.510000229	1	1	0.224524398	773.2520113	14.06519	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.3592	17.94965	0	0	0	16.14308	15.84687	0	0	16.6124	0	0	17.26361	17.22073	0	0	0	18.89433	17.55616	16.48475	16.34607	0	17.20442	16.2017	16.55694	17.56997	17.89931	15.17974	18.30956
Q8N9M5	TM102_HUMAN	"Transmembrane protein 102 (Common beta-chain associated protein, CBAP)"	TMEM102	Homo sapiens (Human)	apoptotic process [GO:0006915]; positive regulation of cell adhesion [GO:0045785]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; apoptotic process [GO:0006915]; positive regulation of cell adhesion [GO:0045785]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]		GO:0005739; GO:0005886; GO:0006915; GO:0007165; GO:0009986; GO:0010820; GO:0016021; GO:0032991; GO:0034097; GO:0042981; GO:0045785; GO:0050730; GO:1901028; GO:2000406	DFVFSLLGLVHR	5.829999924	1	1	0.334803931	1401.76966	16.66157	16.48205	15.50267	0	0	15.32996	0	0	14.92267	0	0	0	0	0	0	15.34741	0	15.62604	0	11.95551	16.61348	13.95606	0	17.1771	15.68172	0	15.8018	15.99184	0	16.24322	0	16.31955	15.19286	15.36493	15.68723	15.65741	12.67978	15.49309	13.78482	0	16.12873	0	0	15.90931	16.23992	16.21111	15.83534	16.01998
Q8N9N2	ASCC1_HUMAN	Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50)	ASCC1 CGI-18	Homo sapiens (Human)	"DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]"	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0006281; GO:0006355; GO:0016607; GO:0031594	VHMKDGSNR	2.74000001	1	1	0.180260426	1056.532553	16.18841	16.4435	16.50823	14.61322	11.19798	0	15.33502	15.99586	11.08527	16.64141	0	0	14.33344	0	0	0	13.31508	15.54157	0	14.61451	15.76692	0	14.49154	0	0	17.08615	15.56722	0	15.12755	16.72183	0	16.82661	0	0	0	15.4815	0	0	0	0	0	0	0	17.08439	0	15.99769	15.85023	0
Q8N9N5	BANP_HUMAN	Protein BANP (BEN domain-containing protein 1) (Btg3-associated nuclear protein) (Scaffold/matrix-associated region-1-binding protein)	BANP BEND1 SMAR1	Homo sapiens (Human)	cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]	GO:0003677; GO:0005654; GO:0006325; GO:0007049; GO:0016604; GO:0034504; GO:0042177; GO:0042802	EVQAVSNLSGQGK	3.74000001	1	1	0.099149954	1315.6206	10.0843	0	0	0	12.60131	10.51083	0	0	11.61483	12.88702	0	0	0	12.21694	13.17851	12.34451	9.817026	0	14.76897	0	0	0	13.8667	0	15.15749	11.83956	12.26499	0	0	0	0	14.2281	0	15.08637	0	0	13.48298	0	0	0	0	0	12.80673	0	0	14.13947	0	0
Q8N9N7	LRC57_HUMAN	Leucine-rich repeat-containing protein 57	LRRC57	Homo sapiens (Human)		extracellular exosome [GO:0070062]; membrane [GO:0016020]	extracellular exosome [GO:0070062]; membrane [GO:0016020]		GO:0016020; GO:0070062	AHVETAQK	4.949999809	0.019140432	0.019140432	0.23364529	883.9783156	14.76923	0	14.76177	14.71072	0	13.16353	15.12532	13.90435	15.84103	14.85116	13.24848	14.04379	0	14.65785	11.29519	14.93016	15.13583	15.00961	15.36831	15.11209	15.51056	16.16312	16.44777	15.34176	16.30724	15.7827	13.31658	14.79336	14.26696	15.92191	15.76606	0	0	0	0	0	0	0	0	16.3123	0	0	15.45596	16.12396	0	13.16358	14.41446	0
Q8N9R6	CDRT4_HUMAN	CMT1A duplicated region transcript 4 protein	CDRT4	Homo sapiens (Human)						KPMMRMLPTVR	6.929999828	1	1	0.477199957	1392.193586	17.74091	0	0	0	19.15492	0	0	0	0	0	0	18.59587	0	0	0	0	0	0	0	19.74281	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N9T8	KRI1_HUMAN	Protein KRI1 homolog	KRI1	Homo sapiens (Human)	"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"	90S preribosome [GO:0030686]; nucleolus [GO:0005730]	"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"	RNA binding [GO:0003723]	GO:0000447; GO:0003723; GO:0005730; GO:0030686	QQGPKNSS	11.94999981	1	1	0.086095803	845.5163561	0	16.38761	0	0	0	0	0	0	0	0	0	0	0	0	15.90554	0	13.7746	0	0	15.75363	0	0	16.3134	0	0	0	17.12866	15.997	0	15.91354	0	0	16.33608	15.87211	0	15.86979	0	17.30842	15.98554	15.51259	15.18153	0	17.61185	0	0	0	0	0
Q8N9V3	WSDU1_HUMAN	"WD repeat, SAM and U-box domain-containing protein 1"	WDSUB1 WDSAM1	Homo sapiens (Human)			ubiquitin-protein transferase activity [GO:0004842]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842	CLHSEK	2.980000019	1	1	1.18E-13	773.1124487	16.64347	17.40013	17.85337	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N9V7	TOPZ1_HUMAN	Protein TOPAZ1 (Testis- and ovary-specific PAZ domain-containing protein 1)	TOPAZ1 C3orf77	Homo sapiens (Human)	apoptotic process [GO:0006915]; ncRNA transcription [GO:0098781]; positive regulation of meiotic cell cycle phase transition [GO:1901995]; spermatid development [GO:0007286]; spermatocyte division [GO:0048137]	cytosol [GO:0005829]	cytosol [GO:0005829]; apoptotic process [GO:0006915]; ncRNA transcription [GO:0098781]; positive regulation of meiotic cell cycle phase transition [GO:1901995]; spermatid development [GO:0007286]; spermatocyte division [GO:0048137]		GO:0005829; GO:0006915; GO:0007286; GO:0048137; GO:0098781; GO:1901995	VDKGVLGR	5.119999886	1	1	0.259731487	844.3050677	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.73471	0	0	0	0	0	0
Q8N9W4	GG6L2_HUMAN	Golgin subfamily A member 6-like protein 2	GOLGA6L2	Homo sapiens (Human)						MWPQPHLPPHPMMSEKTR	2.650000095	0.071393877	0.071393877	0.490403314	2232.195395	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.49565	0	0	0	0	0	0	0	0	0	20.055	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8N9W5	DAAF3_HUMAN	Dynein axonemal assembly factor 3	DNAAF3 C19orf51	Homo sapiens (Human)	axonemal dynein complex assembly [GO:0070286]; motile cilium assembly [GO:0044458]	dynein axonemal particle [GO:0120293]	dynein axonemal particle [GO:0120293]; axonemal dynein complex assembly [GO:0070286]; motile cilium assembly [GO:0044458]		GO:0044458; GO:0070286; GO:0120293	HMLIFSLALEEPEK	4.730000019	1	1	0.372541242	1656.89092	0	15.64896	17.62985	0	15.21824	16.27705	18.73955	0	19.05157	17.42714	0	0	0	0	0	18.90648	17.53803	17.93559	0	17.09778	16.80336	17.68865	0	18.35422	0	0	0	0	0	15.68018	17.39151	18.63237	0	0	16.60783	0	0	0	0	17.14522	0	0	0	0	0	16.99303	17.04582	17.20742
Q8N9W7	YO010_HUMAN	Putative transmembrane protein FLJ36131		Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	LSSLLTTTSYSVS	2.130000114	1	1	6.88E-13	1357.716132	0	0	0	10.18091	13.48369	0	0	12.32392	12.2933	0	0	0	0	0	0	10.6741	0	9.288009	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.0692	0	12.29533	0	13.19447	0	0	0
Q8N9W8	GAR2_HUMAN	Golgi associated RAB2 interactor protein 2	GARIN2 C14orf54 FAM71D	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]	sperm midpiece [GO:0097225]	sperm midpiece [GO:0097225]; flagellated sperm motility [GO:0030317]		GO:0030317; GO:0097225	GESIYLHNR	2.75999999	1	1	0.210580257	1088.536292	13.29778	12.09289	0	14.81723	13.38455	14.43448	12.9927	13.13043	14.10462	14.22571	14.0174	16.69895	14.33838	15.0191	0	14.70599	13.9199	13.82987	15.50288	0	11.3228	17.6943	15.90983	15.45507	0	0	14.7823	0	0	0	15.69777	15.45676	0	14.03235	0	0	15.50548	0	0	0	0	0	0	0	0	0	0	0
Q8N9Z2	CC71L_HUMAN	Coiled-coil domain-containing protein 71L	CCDC71L C7orf74	Homo sapiens (Human)	cellular lipid metabolic process [GO:0044255]; positive regulation of fat cell differentiation [GO:0045600]		cellular lipid metabolic process [GO:0044255]; positive regulation of fat cell differentiation [GO:0045600]		GO:0044255; GO:0045600	GGDFR	8.130000114	1	1	0.11653641	550.2055078	0	16.39676	15.21253	0	0	0	14.21827	0	0	13.92307	0	0	0	16.64421	0	0	13.60087	15.88901	16.24306	0	0	15.32313	0	0	15.87341	0	15.51863	0	0	0	0	16.168	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NA03	FSIP1_HUMAN	Fibrous sheath-interacting protein 1	FSIP1 HSD10	Homo sapiens (Human)						ALTGHNMSEALVTEAENMK	1.470000029	1	1	0.11615255	2061.035178	12.24773	14.98641	0	0	0	0	0	0	13.45652	0	0	14.21285	0	14.66494	0	11.03454	0	0	0	0	0	0	0	0	0	0	0	0	14.28413	0	0	0	0	0	14.43818	0	0	14.06017	0	0	15.02042	13.66219	0	10.23367	15.60006	0	0	0
Q8NA31	TERB1_HUMAN	Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79)	TERB1 CCDC79	Homo sapiens (Human)	homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]	"chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187]"	"chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]"		GO:0000781; GO:0005637; GO:0007129; GO:0045141; GO:0070187; GO:0070197	EIGGLMFVK	6.980000019	0.597271204	0.597271204	0.173212185	990.0153987	13.36375	14.16806	0	0	14.64177	19.20677	13.11785	0	0	0	0	0	0	0	0	0	14.9944	0	0	16.9256	15.67607	15.29912	0	17.44123	0	14.35982	0	0	0	0	15.26171	16.21957	13.76552	0	0	0	0	0	0	0	0	0	0	0	13.42683	0	0	0
Q8NA47	CCD63_HUMAN	Coiled-coil domain-containing protein 63	CCDC63	Homo sapiens (Human)	cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]	axoneme [GO:0005930]	axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286]		GO:0003341; GO:0005930; GO:0007286; GO:0036158	NYMELR	10.39000034	1	1	0.498863748	841.8710113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NA54	IQUB_HUMAN	IQ and ubiquitin-like domain-containing protein	IQUB	Homo sapiens (Human)	cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224]	acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]	acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224]		GO:0001669; GO:0007224; GO:0031514; GO:0060271	WKYHSDTTPK	4.25	1	1	0.270208887	1261.142974	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.32602	14.89522	14.81607	0	15.48838	0	0	0	0	0	15.84757	0	0	0	0	0	0	16.26365	0	0	0	17.20929	0	0	15.32134	16.38491	16.39228	0	0	0	15.41647	0	16.31544
Q8NA57	CL050_HUMAN	Uncharacterized protein C12orf50	C12orf50	Homo sapiens (Human)	poly(A)+ mRNA export from nucleus [GO:0016973]		mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973]	mRNA binding [GO:0003729]	GO:0003729; GO:0016973	EPKPNLSPDK	12.72999954	1	1	0.301567473	1123.98795	0	15.17297	15.0285	15.68951	15.546	15.16688	0	16.14531	14.50659	15.20206	0	13.435	0	0	0	15.60245	0	0	0	15.96606	0	0	0	15.72889	0	0	16.65886	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95699	0	0	0	16.68027	0	0
Q8NA61	CBY2_HUMAN	Protein chibby homolog 2 (Spermatid-associated protein)	CBY2 SPERT	Homo sapiens (Human)		cytoplasmic vesicle [GO:0031410]	cytoplasmic vesicle [GO:0031410]; identical protein binding [GO:0042802]	identical protein binding [GO:0042802]	GO:0031410; GO:0042802	TLQVLRAEHR	3.650000095	1	1	0.22226131	1223.199601	15.80083	14.6815	11.72738	0	0	14.70811	0	0	0	0	0	0	0	0	0	15.81028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.10913	0	0	0	0	0	0	0	0	15.6014	0	0	0	0	0	0	0	15.78369
Q8NA69	TEX45_HUMAN	Testis-expressed protein 45	TEX45 C19orf45	Homo sapiens (Human)						LHEGTMR	1.539999962	0.252387404	0.252387404	0.223418893	844.3108937	0	0	0	17.29879	0	0	17.93107	0	0	0	0	0	0	16.9125	0	0	0	0	18.61971	0	0	18.36174	18.99623	0	0	0	0	17.31121	17.02307	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.43843	17.64886	18.74377	0
Q8NA70	FA47B_HUMAN	Protein FAM47B	FAM47B	Homo sapiens (Human)						RAAPHSYSAQR	5.309999943	1	1	0.420278677	1244.414771	14.11737	13.70183	14.06952	12.71473	16.02678	13.19287	14.35934	12.33121	0	16.02431	12.24177	0	0	0	15.13461	17.0469	11.49808	16.41373	0	0	0	0	0	0	0	16.68603	0	0	0	0	0	0	0	0	0	0	0	16.94467	0	0	0	16.12463	0	0	0	0	16.99396	0
Q8NA72	POC5_HUMAN	"Centrosomal protein POC5 (Protein of centriole 5, hPOC5)"	POC5 C5orf37	Homo sapiens (Human)	cell cycle [GO:0007049]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]		GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007049	AGRTITAR	3.859999895	0.835357547	0.835357547	0.263147946	846.7611633	0	16.75422	14.63421	0	14.46674	0	6.9701	14.47549	16.04112	0	0	0	0	15.63325	0	0	0	0	16.75727	0	0	0	0	0	15.86863	0	0	0	0	0	0	0	15.8392	0	0	0	0	0	0	0	0	16.13383	0	0	16.58696	0	0	0
Q8NA75	DC4L2_HUMAN	DDB1- and CUL4-associated factor 4-like protein 2 (WD repeat-containing protein 21C)	DCAF4L2 WDR21C	Homo sapiens (Human)						VGLNAPSMLR	9.069999695	1	1	0.306175158	1073.901132	14.78654	0	15.54516	13.26503	0	0	15.62351	14.63832	0	13.42653	15.28239	0	0	0	11.55577	14.39468	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.07642	0	0	0	0	0	0	0	0	0	0
Q8NA82	MARHA_HUMAN	"Probable E3 ubiquitin-protein ligase MARCHF10, EC 2.3.2.27 (Membrane-associated RING finger protein 10) (Membrane-associated RING-CH protein X, MARCH-X) (RING finger protein 190) (RING-type E3 ubiquitin transferase MARCHF10)"	MARCHF10 MARCH10 RNF190	Homo sapiens (Human)	protein ubiquitination [GO:0016567]		transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]	transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0008270; GO:0016567; GO:0016740	RPNQER	4.760000229	1	1	0.277036544	799.9328838	13.99271	0	0	0	0	0	0	0	14.97709	0	0	15.41058	17.94929	16.97105	15.26958	16.24714	0	15.23105	15.87223	0	16.69337	0	0	18.01551	14.67007	0	0	0	0	0	0	18.84679	0	0	16.24934	15.1089	13.79415	15.04394	0	0	19.94016	19.43026	0	14.97072	15.73813	16.0291	15.57708	0
Q8NAA5	LR75A_HUMAN	Leucine-rich repeat-containing protein 75A (Leucine-rich repeat-containing protein FAM211A)	LRRC75A C17orf76 FAM211A	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	GSLAERASPGAAPGPR	1.120000005	1	1	4.66E-13	1493.810807	0	0	0	0	0	0	16.72398	0	0	0	0	0	0	0	0	0	0	0	0	0	14.97284	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NAF0	ZN579_HUMAN	Zinc finger protein 579	ZNF579	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000976; GO:0000981; GO:0003723; GO:0005634; GO:0006357; GO:0046872	ASGARNSAK	2.630000114	0.5444538	0.5444538	0.188548318	860.4952183	14.87033	13.32479	12.41462	13.35493	0	13.39665	15.46507	14.88203	14.9879	0	0	16.18354	14.94668	16.06724	17.31596	16.09241	16.21593	0	16.98503	16.76503	16.03967	17.26564	16.78432	16.9731	17.95951	16.75422	0	0	16.66725	16.23074	16.60534	17.89901	0	17.46968	17.25634	16.9833	16.98582	17.60569	16.08954	16.98803	16.95091	16.22053	18.02002	16.74724	14.93394	17.49201	15.75464	16.62302
Q8NAJ2	CI106_HUMAN	Putative uncharacterized protein encoded by LINC02913	LINC02913 C9orf106	Homo sapiens (Human)						ALMPGGHCPLCVPCKR	1.580000043	1	1	6.93E-13	1852.006072	15.33215	0	15.8111	0	0	0	0	15.69786	15.36313	0	0	0	0	0	0	0	0	0	0	0	0	0	15.45883	15.42637	0	15.98462	0	0	0	0	14.35117	0	0	0	0	11.86008	0	0	0	0	0	0	0	0	0	0	0	0
Q8NAM6	ZSCA4_HUMAN	Zinc finger and SCAN domain-containing protein 4 (Zinc finger protein 494)	ZSCAN4 ZNF494	Homo sapiens (Human)	negative regulation of mitotic recombination [GO:0045950]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of mitotic recombination [GO:0045950]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000781; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0010833; GO:0045950; GO:0046872; GO:1990837	VHQIIHTGK	6.429999828	1	1	0.104893456	1032.489923	0	0	0	0	0	14.72518	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.5901	0	16.28358	14.2361	0	12.28326	0	16.03441	0	0	0	13.4846	8.256381	14.79286	0	0	0	0	0	0	0	0	0	0
Q8NAN2	MIGA1_HUMAN	Mitoguardin 1 (Protein FAM73A)	MIGA1 FAM73A	Homo sapiens (Human)	mitochondrial fusion [GO:0008053]	integral component of plasma membrane [GO:0005887]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	integral component of plasma membrane [GO:0005887]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; mitochondrial fusion [GO:0008053]	protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005739; GO:0005741; GO:0005887; GO:0008053; GO:0042803; GO:0046982	ILSALIVK	7.519999981	0.812632561	0.812632561	0.467319058	856.6155127	17.85473	0	0	18.30014	0	17.83738	0	0	0	19.45803	0	0	0	0	0	0	0	0	0	0	0	0	17.86113	0	0	17.76327	0	18.73843	18.31192	0	0	0	0	0	0	0	0	0	0	0	0	17.29427	0	0	0	0	18.5224	0
Q8NAP3	ZBT38_HUMAN	Zinc finger and BTB domain-containing protein 38	ZBTB38	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of transcription, DNA-templated [GO:0006355]"	blood microparticle [GO:0072562]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"blood microparticle [GO:0072562]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0006355; GO:0006974; GO:0008327; GO:0042803; GO:0045892; GO:0045944; GO:0046872; GO:0072562	SYVTLSSLRR	4.860000134	1	1	0.130028311	1181.210458	15.27681	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95435	15.01674	0	0	0	13.09511	0	0	0	16.81847	0	15.21332	16.3415	0	0	0	15.68716	0	0	0	17.75182	0	0	0	0
Q8NAT1	PMGT2_HUMAN	"Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2, POMGnT2, EC 2.4.1.312 (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2)"	POMGNT2 AGO61 C3orf39 EOGTL GTDC2	Homo sapiens (Human)	neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; protein O-GlcNAc transferase activity [GO:0097363]; neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]	acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; protein O-GlcNAc transferase activity [GO:0097363]	GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0008375; GO:0016021; GO:0016757; GO:0035269; GO:0097363	GRPGPR	1.159999967	0.261570424	0.261570424	0.097643716	638.521843	13.13924	0	12.34503	15.56174	0	0	14.73022	0	16.31117	0	15.89433	16.29353	12.99319	0	15.52745	15.31858	16.65215	10.73761	17.0394	0	15.11435	0	15.59478	15.97244	11.56912	14.30687	17.12564	11.91174	14.14787	0	11.85961	15.71983	16.9492	15.64273	17.91545	16.00686	15.36606	0	0	16.00695	16.14286	15.21046	10.04891	0	14.59891	13.7011	0	0
Q8NAT2	TDRD5_HUMAN	Tudor domain-containing protein 5	TDRD5 TUDOR3	Homo sapiens (Human)	DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]	chromatoid body [GO:0033391]; P granule [GO:0043186]; pi-body [GO:0071546]	chromatoid body [GO:0033391]; P granule [GO:0043186]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]		GO:0007283; GO:0007286; GO:0030719; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0071546	AGSLLMLKK	5.820000172	1	1	0.240662309	975.7433406	16.24417	0	0	0	13.68266	14.89711	15.79927	15.3238	0	0	0	0	0	0	0	0	15.59764	0	0	16.45878	15.06304	0	14.61792	16.17057	0	0	0	14.94119	0	0	0	15.39409	0	0	0	0	0	15.75173	15.12683	0	0	0	0	15.20598	0	15.07435	0	0
Q8NAV1	PR38A_HUMAN	Pre-mRNA-splicing factor 38A	PRPF38A	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0071005; GO:0071011	DLDKPRR	18.93000031	1	1	0.337335428	901.0020988	16.03812	15.63773	15.36709	17.29518	13.93114	14.01565	15.33992	14.08889	0	0	0	0	0	13.64298	16.05719	0	15.96399	15.47403	14.24752	15.16723	0	16.11549	15.8582	18.36436	0	16.14405	0	0	0	0	17.74262	0	0	0	0	0	0	0	0	15.17011	0	0	0	0	16.09289	0	0	0
Q8NAV2	CH058_HUMAN	Uncharacterized protein C8orf58	C8orf58	Homo sapiens (Human)						LPTAPTSLSGQHR	1.269999981	0.01669029	0.01669029	0.086429756	1365.633856	0	13.53261	13.23394	0	0	8.242704	0	10.59642	0	0	14.0119	13.9925	0	0	0	14.13652	0	13.46499	8.907818	14.70321	13.67983	15.44928	15.74722	0	15.82182	14.74625	15.15791	0	10.83864	0	0	15.9886	15.18902	16.23489	14.65512	16.25726	15.14805	0	0	15.00656	13.96828	8.637056	14.26293	9.893558	0	13.52726	14.07803	15.29724
Q8NB14	UBP38_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 38, EC 3.4.19.12 (Deubiquitinating enzyme 38) (HP43.8KD) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38)"	USP38 KIAA1891	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579	RQVLSLNLNGCNSLMK	3.980000019	1	1	0.393620037	1846.02968	0	16.89694	16.32253	14.94793	16.11339	0	13.01864	15.69996	13.89067	17.70887	0	0	15.96054	11.66231	14.16738	0	15.22021	16.37479	0	15.97566	0	14.29648	0	0	0	0	16.47312	16.37292	14.925	17.46813	0	0	0	16.20782	16.32158	0	19.21119	0	0	0	0	0	0	16.0676	0	17.87839	13.58005	14.84863
Q8NB16	MLKL_HUMAN	"Mixed lineage kinase domain-like protein, hMLKL"	MLKL	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]	GO:0004672; GO:0004706; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0019901; GO:0030054; GO:0042802; GO:0044877; GO:0051607; GO:0070207; GO:0070266; GO:0097527; GO:0097528	HIITLGQVIHKR	16.27000046	6.47E-05	6.47E-05	0.397734709	1414.014616	21.25636	22.72854	19.87634	0	0	0	20.22952	0	0	0	20.71379	19.69677	0	0	19.40286	21.27619	20.57525	20.80894	0	0	19.55734	0	20.93444	19.94204	0	0	21.60603	0	19.50533	20.65223	22.26306	22.38037	21.69942	22.34213	21.15059	0	20.07103	18.58255	21.74085	19.80852	0	0	21.23573	0	0	0	18.39968	0
Q8NB25	F184A_HUMAN	Protein FAM184A	FAM184A C6orf60	Homo sapiens (Human)		extracellular space [GO:0005615]	extracellular space [GO:0005615]		GO:0005615	FELEDEGKAMLASLR	4.059999943	1	1	0.33614041	1725.243593	13.37678	0	0	0	0	15.10346	0	0	14.28954	0	14.76721	16.83293	0	13.24141	0	15.92682	0	14.64847	16.64179	0	0	0	0	16.27176	14.34737	11.29423	0	14.10751	14.42017	0	0	16.52386	15.29152	0	0	16.24031	0	0	16.43575	0	0	13.98854	0	15.08533	0	16.31772	16.34275	0
Q8NB46	ANR52_HUMAN	"Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C, PP6-ARS-C, Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C (Ankyrin repeat domain-containing protein 52)"	ANKRD52	Homo sapiens (Human)						DVEEVRSLLSQK	17.04000092	1	1	0.594561963	1401.793286	0	19.61415	0	0	0	19.61329	20.11841	0	17.73759	17.96274	0	0	0	0	0	0	0	0	0	0	16.70225	0	0	0	0	0	0	0	17.28415	0	17.62146	0	0	0	0	19.74034	0	17.87537	0	0	0	0	20.14322	0	0	0	18.94154	0
Q8NB66	UN13C_HUMAN	Protein unc-13 homolog C (Munc13-3)	UNC13C	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"	calyx of Held [GO:0044305]; neuromuscular junction [GO:0031594]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	"calyx of Held [GO:0044305]; neuromuscular junction [GO:0031594]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]	GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007268; GO:0007528; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030672; GO:0031594; GO:0031914; GO:0035249; GO:0042734; GO:0043195; GO:0044305; GO:0048786; GO:0061789; GO:0098688; GO:0098831; GO:0099525	STQSLSGYEDSGSSLMGRFR	4.340000153	1	1	0	2180.768554	0	14.88008	16.73835	11.02352	12.62179	15.27371	0	0	0	14.70468	0	13.52529	14.63229	0	14.05604	0	10.86786	0	0	14.55843	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NB78	KDM1B_HUMAN	"Lysine-specific histone demethylase 1B, EC 1.14.99.66 (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2)"	KDM1B AOF1 C6orf193 LSD2	Homo sapiens (Human)	DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genomic imprinting [GO:0006349]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-4 FAD-dependent demethylase activity [GO:0140682]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genomic imprinting [GO:0006349]	chromatin binding [GO:0003682]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-4 FAD-dependent demethylase activity [GO:0140682]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000786; GO:0003682; GO:0005634; GO:0005654; GO:0006349; GO:0008270; GO:0016491; GO:0032452; GO:0034720; GO:0042393; GO:0043046; GO:0044030; GO:0045944; GO:0050660; GO:0071949; GO:0140682	AALSVHVPGMNR	3.779999971	0.843665242	0.843665242	0.316360291	1267.540638	16.47939	0	0	15.27087	0	0	0	0	0	16.32403	0	14.7531	0	0	0	16.80427	0	0	0	0	0	17.2704	0	0	0	0	0	0	0	0	0	0	0	17.08138	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NB90	AFG2H_HUMAN	"ATPase family protein 2 homolog, EC 3.6.4.10 (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)"	SPATA5 AFG2 SPAF	Homo sapiens (Human)	brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; spindle [GO:0005819]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0007283; GO:0007420; GO:0016887; GO:0030154	IIYVPLPDAATR	5.809999943	1	1	4.57E-13	1329.876985	0	14.13896	14.26303	12.6347	0	0	14.26209	7.900814	14.04371	5.838625	16.26046	12.96381	0	0	0	13.80743	14.78291	14.47956	15.84763	15.79322	16.37941	16.96475	0	0	16.0651	0	15.97218	0	0	0	0	0	0	0	0	0	0	0	0	15.12568	0	16.31551	0	0	0	0	0	0
Q8NBB2	STAS1_HUMAN	Putative uncharacterized protein ST20-AS1 (ST20 antisense RNA 1) (ST20 antisense gene protein 1)	ST20-AS1 C15orf37	Homo sapiens (Human)						PRPASESWSPIQSRIPAYK	1.529999971	1	1	0.203709226	2169.506573	16.262	15.50501	12.55872	11.98099	0	13.30359	0	14.90194	0	14.24092	0	0	0	0	0	11.92853	9.607883	0	0	0	0	0	0	0	0	15.12047	15.37184	10.48058	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.51857	0	0	0
Q8NBI3	DRAXI_HUMAN	Draxin (Dorsal inhibitory axon guidance protein) (Dorsal repulsive axon guidance protein) (Neucrin)	DRAXIN C1orf187 PSEC0258 UNQ3119/PRO10268	Homo sapiens (Human)	anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; commissural neuron differentiation in spinal cord [GO:0021528]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; negative regulation of axon extension [GO:0030517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of neuron apoptotic process [GO:0043524]; Wnt signaling pathway [GO:0016055]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; commissural neuron differentiation in spinal cord [GO:0021528]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; negative regulation of axon extension [GO:0030517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of neuron apoptotic process [GO:0043524]; Wnt signaling pathway [GO:0016055]		GO:0005576; GO:0007411; GO:0016055; GO:0021516; GO:0021528; GO:0021960; GO:0030517; GO:0030900; GO:0043524; GO:0090090	ALVRGPSSLMK	2.00999999	1	1	0.292599963	1174.160254	0	0	0	0	0	0	0	0	0	0	15.37877	0	0	0	0	0	0	0	0	15.71831	15.9296	16.74082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.02695	0	0	0	0	15.44505	0	0	0	0	0	0
Q8NBI5	S43A3_HUMAN	Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3)	SLC43A3 ENBT1 PSEC0252	Homo sapiens (Human)	hypoxanthine transport [GO:0035344]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910]; hypoxanthine transport [GO:0035344]	adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0015207; GO:0015208; GO:0015245; GO:0016021; GO:0016323; GO:0035344; GO:0042910	LFGLVMALSAVVSLLQFPIFTLIK	6.039999962	1	1	0.335534611	2637.737304	0	0	14.08432	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.34962	0	0	0	0	0	15.34825	0	12.52353	14.20416	16.33061	15.23349	0	15.0787	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NBI6	XXLT1_HUMAN	"Xyloside xylosyltransferase 1, EC 2.4.2.62 (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)"	XXYLT1 C3orf21 PSEC0251	Homo sapiens (Human)	O-glycan processing [GO:0016266]	integral component of endoplasmic reticulum membrane [GO:0030176]	"integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560]; O-glycan processing [GO:0016266]"	"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560]"	GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252; GO:0140560	AMARLGAVR	4.639999866	1	1	0.255182344	958.7154601	14.08135	0	14.97775	13.41711	14.89487	15.22923	12.28786	14.05727	15.0603	12.07184	15.91905	0	14.82179	14.40003	14.35854	0	14.82063	0	0	12.32918	16.374	0	13.85935	0	15.42461	14.34429	15.66135	14.78609	16.6346	0	15.52784	15.98065	0	15.27693	14.84829	0	15.08188	16.31927	0	15.00126	0	16.33485	0	0	0	0	0	0
Q8NBJ4	GOLM1_HUMAN	Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2)	GOLM1 C9orf155 GOLPH2 PSEC0242 UNQ686/PRO1326	Homo sapiens (Human)	nucleus organization [GO:0006997]; regulation of lipid metabolic process [GO:0019216]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus organization [GO:0006997]; regulation of lipid metabolic process [GO:0019216]		GO:0005615; GO:0005788; GO:0005794; GO:0005887; GO:0006997; GO:0019216	AAAERGAVELK	5.909999847	1	1	0.101886347	1113.45334	13.83009	15.32337	0	0	0	13.4469	16.10779	16.15119	14.24913	13.49199	0	14.36711	0	0	9.775922	15.08213	0	0	14.08087	0	0	13.75045	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NBJ5	GT251_HUMAN	"Procollagen galactosyltransferase 1, EC 2.4.1.50 (Collagen beta(1-O)galactosyltransferase 1, ColGalT 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1)"	COLGALT1 GLT25D1 PSEC0241	Homo sapiens (Human)	collagen fibril organization [GO:0030199]; positive regulation of collagen fibril organization [GO:1904028]	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; procollagen galactosyltransferase activity [GO:0050211]; collagen fibril organization [GO:0030199]; positive regulation of collagen fibril organization [GO:1904028]	procollagen galactosyltransferase activity [GO:0050211]	GO:0005788; GO:0016020; GO:0030199; GO:0050211; GO:1904028	LMNLMR	19.78000069	1	1	0.158576729	796.4936762	15.6695	14.5773	14.22289	0	14.8802	9.83789	14.00721	15.22244	14.58051	15.87475	8.534503	15.55185	0	0	16.25716	0	12.2777	15.68075	15.1256	15.444	0	0	0	15.76489	0	16.89592	14.34779	0	15.62233	0	0	0	16.2281	16.67161	0	15.68129	0	17.10403	0	0	0	0	0	0	0	0	15.56824	0
Q8NBL3	T178A_HUMAN	Transmembrane protein 178A	TMEM178A TMEM178 PSEC0131 UNQ5926/PRO19820	Homo sapiens (Human)	negative regulation of osteoclast differentiation [GO:0045671]; regulation of cytosolic calcium ion concentration [GO:0051480]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; negative regulation of osteoclast differentiation [GO:0045671]; regulation of cytosolic calcium ion concentration [GO:0051480]		GO:0005789; GO:0016020; GO:0016021; GO:0045671; GO:0051480	DIDTLILK	3.920000076	1	1	0.041491696	930.6476824	17.67805	15.47618	0	0	0	0	0	0	0	0	0	0	0	0	17.4337	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.69022	0	0	0	0	0	0	0
Q8NBM4	UBAC2_HUMAN	"Ubiquitin-associated domain-containing protein 2, UBA domain-containing protein 2 (Phosphoglycerate dehydrogenase-like protein 1)"	UBAC2 PHGDHL1 PSEC0110	Homo sapiens (Human)	"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]"		GO:0005783; GO:0005789; GO:0016021; GO:0016055; GO:0070972; GO:0090090; GO:1904153	FTSTGSSGLYKAPLSK	4.099999905	0.068924062	0.068924062	0.134062825	1644.598512	0	14.34429	18.67327	16.5359	17.42454	13.64347	15.25307	17.71627	0	0	0	16.5378	0	17.9743	16.30917	16.77988	0	17.50589	16.72537	16.80523	16.28321	0	0	14.92642	0	16.97686	17.27968	9.620028	17.14562	0	13.01175	18.84443	17.96514	14.52392	15.84336	16.24505	0	17.30561	18.01022	16.94575	0	15.8511	16.65125	14.38779	17.81974	14.27656	0	14.03552
Q8NBM8	PCYXL_HUMAN	"Prenylcysteine oxidase-like, EC 1.8.3.-"	PCYOX1L PSEC0105	Homo sapiens (Human)	prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]	extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]	prenylcysteine oxidase activity [GO:0001735]	GO:0001735; GO:0005576; GO:0016020; GO:0030327; GO:0030328; GO:0031093	LQMWVEEVMEKFMR	8.670000076	1	1	0.217839826	1871.466629	14.05733	0	0	0	14.93793	0	0	14.3618	0	0	0	9.970335	12.65893	0	0	15.23857	0	0	0	0	0	0	0	0	0	16.81297	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53972	0	0	0	0
Q8NBN7	RDH13_HUMAN	"Retinol dehydrogenase 13, EC 1.1.1.300 (Short chain dehydrogenase/reductase family 7C member 3)"	RDH13 SDR7C3 PSEC0082 UNQ736/PRO1430	Homo sapiens (Human)	eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]	mitochondrial inner membrane [GO:0005743]	mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574]	NADP-retinol dehydrogenase activity [GO:0052650]	GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650	SRYLLPLSALGTVAGAAVLLK	8.699999809	1	1	0.191618992	2113.099838	15.47194	11.58941	13.37034	14.21459	12.53896	11.84888	0	12.40669	0	14.1298	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.66357	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NBP0	TTC13_HUMAN	"Tetratricopeptide repeat protein 13, TPR repeat protein 13"	TTC13 PSEC0076	Homo sapiens (Human)						AMGLAALEVMQAVQRTWTNSK	7.869999886	1	1	0.070896894	2338.304212	12.73272	0	0	12.86629	0	0	0	11.52214	12.63954	13.24878	13.82598	9.426271	11.89346	0	0	9.490721	15.15974	0	0	0	0	15.31971	0	14.60607	12.00378	0	0	14.3275	0	0	0	11.90215	11.02676	13.96667	0	0	0	0	15.50641	0	0	0	0	0	0	0	0	0
Q8NBP5	MFSD9_HUMAN	Major facilitator superfamily domain-containing protein 9	MFSD9 PSEC0066	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]	transmembrane transporter activity [GO:0022857]	GO:0016021; GO:0022857	MELGGHWDMNSAPR	10.68999958	1	1	9.22E-13	1633.818641	0	0	0	0	8.512427	0	0	0	0	0	13.79948	13.3985	0	0	0	14.81383	0	0	0	0	0	0	0	0	13.7496	0	0	0	0	0	0	0	0	0	0	0	0	0	15.29875	0	0	0	0	0	0	0	0	0
Q8NBP7	PCSK9_HUMAN	"Proprotein convertase subtilisin/kexin type 9, EC 3.4.21.- (Neural apoptosis-regulated convertase 1, NARC-1) (Proprotein convertase 9, PC9) (Subtilisin/kexin-like protease PC9)"	PCSK9 NARC1 PSEC0052	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; kidney development [GO:0001822]; lipoprotein metabolic process [GO:0042157]; liver development [GO:0001889]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; lysosomal transport [GO:0007041]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of low-density lipoprotein particle receptor binding [GO:1905596]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of receptor internalization [GO:0002091]; negative regulation of receptor recycling [GO:0001920]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; phospholipid metabolic process [GO:0006644]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of receptor internalization [GO:0002092]; protein autoprocessing [GO:0016540]; regulation of neuron apoptotic process [GO:0043523]; regulation of signaling receptor activity [GO:0010469]; triglyceride metabolic process [GO:0006641]	cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; PCSK9-AnxA2 complex [GO:1990667]; PCSK9-LDLR complex [GO:1990666]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]	cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; PCSK9-AnxA2 complex [GO:1990667]; PCSK9-LDLR complex [GO:1990666]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor binding [GO:0034190]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; signaling receptor inhibitor activity [GO:0030547]; sodium channel inhibitor activity [GO:0019871]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor binding [GO:0070326]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; kidney development [GO:0001822]; lipoprotein metabolic process [GO:0042157]; liver development [GO:0001889]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; lysosomal transport [GO:0007041]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of low-density lipoprotein particle receptor binding [GO:1905596]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of receptor internalization [GO:0002091]; negative regulation of receptor recycling [GO:0001920]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; phospholipid metabolic process [GO:0006644]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of receptor internalization [GO:0002092]; protein autoprocessing [GO:0016540]; regulation of neuron apoptotic process [GO:0043523]; regulation of signaling receptor activity [GO:0010469]; triglyceride metabolic process [GO:0006641]	apolipoprotein binding [GO:0034185]; apolipoprotein receptor binding [GO:0034190]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; signaling receptor inhibitor activity [GO:0030547]; sodium channel inhibitor activity [GO:0019871]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor binding [GO:0070326]	GO:0001822; GO:0001889; GO:0001920; GO:0002091; GO:0002092; GO:0003723; GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005791; GO:0005794; GO:0005886; GO:0006641; GO:0006644; GO:0006915; GO:0007041; GO:0008203; GO:0009267; GO:0009986; GO:0010469; GO:0010989; GO:0016540; GO:0019871; GO:0022008; GO:0030134; GO:0030169; GO:0030182; GO:0030547; GO:0031232; GO:0032802; GO:0032805; GO:0032869; GO:0034185; GO:0034189; GO:0034190; GO:0036020; GO:0042157; GO:0042632; GO:0043523; GO:0043525; GO:0043621; GO:0048471; GO:0050750; GO:0070326; GO:1905596; GO:1905598; GO:1905601; GO:1990666; GO:1990667; GO:2000650	MEAQGGKLVCR	8.140000343	1	1	0.539793045	1263.255356	0	0	0	0	18.80409	18.32131	0	19.25282	0	0	0	0	0	0	18.97446	0	0	0	0	0	0	0	0	18.62116	0	0	0	0	0	0	0	0	0	0	0	17.77853	0	0	0	0	18.15482	17.3075	0	18.9959	0	0	0	0
Q8NBR0	P5I13_HUMAN	Tumor protein p53-inducible protein 13 (Damage-stimulated cytoplasmic protein 1)	TP53I13 DSCP1	Homo sapiens (Human)	negative regulation of cell cycle [GO:0045786]; response to organic cyclic compound [GO:0014070]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of cell cycle [GO:0045786]; response to organic cyclic compound [GO:0014070]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410]		GO:0005737; GO:0005886; GO:0009410; GO:0009411; GO:0014070; GO:0016021; GO:0045786	QPSSSGAK	10.07999992	0.829382658	0.829382658	0.278700732	761.7520883	14.63832	15.98825	0	15.03956	15.43908	15.4346	0	15.85285	16.29516	0	0	15.27683	16.42468	15.71701	0	16.4716	0	0	16.17839	17.75068	16.54172	14.40893	16.05953	0	17.49521	16.05703	16.06124	15.64986	16.15333	16.55886	16.79189	16.80276	17.12529	16.93789	16.80349	16.12735	16.63474	17.24249	16.38902	17.03518	16.07505	15.81827	16.39731	17.55134	15.15748	17.333	17.19513	16.64664
Q8NBS3	S4A11_HUMAN	"Solute carrier family 4 member 11 (Sodium borate cotransporter 1, NaBC1)"	SLC4A11 BTR1	Homo sapiens (Human)	bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; proton transmembrane transporter activity [GO:0015078]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; water transmembrane transporter activity [GO:0005372]; bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]	active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; proton transmembrane transporter activity [GO:0015078]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; water transmembrane transporter activity [GO:0005372]	GO:0005272; GO:0005372; GO:0005452; GO:0005886; GO:0006814; GO:0012506; GO:0015078; GO:0015106; GO:0015252; GO:0015293; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0030003; GO:0034599; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0050801; GO:0051881; GO:0055085; GO:0071476; GO:1902600; GO:2000739	MAAATR	3.839999914	0.959017634	0.959017634	0.256169537	636.7684362	0	0	0	0	0	0	18.937	0	17.65919	17.05723	18.38239	19.35918	0	18.34732	0	0	0	0	15.76084	0	0	16.22628	17.65117	0	0	0	0	0	0	0	0	19.28638	0	0	0	0	17.74806	0	0	0	0	0	0	0	0	19.42176	0	0
Q8NBS9	TXND5_HUMAN	"Thioredoxin domain-containing protein 5, EC 1.8.4.-, EC 5.3.4.1 (Endoplasmic reticulum resident protein 46, ER protein 46, ERp46) (Thioredoxin-like protein p46)"	TXNDC5 TLP46 UNQ364/PRO700	Homo sapiens (Human)	apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; apoptotic cell clearance [GO:0043277]; negative regulation of apoptotic process [GO:0043066]	protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]	GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0015035; GO:0035578; GO:0043066; GO:0043202; GO:0043277; GO:0070062	FVLSQAKDEL	6.980000019	1	1	0.093506112	1149.238963	0	0	14.53681	16.32895	12.86337	0	9.721788	14.4909	12.22493	16.10906	0	0	0	0	0	0	0	0	0	14.17137	0	0	0	0	13.94171	12.55267	0	0	11.96304	13.89318	0	0	0	0	0	0	0	0	0	0	17.34521	14.35234	0	0	0	0	0	0
Q8NBU5	ATAD1_HUMAN	"Outer mitochondrial transmembrane helix translocase, EC 7.4.2.- (ATPase family AAA domain-containing protein 1, hATAD1) (Thorase)"	ATAD1 FNP001	Homo sapiens (Human)	"extraction of mislocalized protein from mitochondrial outer membrane [GO:0140570]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]"	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; transmembrane protein dislocase activity [GO:0140567]; extraction of mislocalized protein from mitochondrial outer membrane [GO:0140570]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; transmembrane protein dislocase activity [GO:0140567]	GO:0002092; GO:0005524; GO:0005741; GO:0005778; GO:0005829; GO:0007612; GO:0007613; GO:0016020; GO:0016021; GO:0016887; GO:0045211; GO:0051967; GO:0140567; GO:0140570	QAEKLMK	22.37000084	1	1	0.275494471	847.247809	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.81076	0	0	0	0	0	0
Q8NBV4	PLPP7_HUMAN	Inactive phospholipid phosphatase 7 (Phosphatidic acid phosphatase type 2 domain-containing protein 3)	PLPP7 C9orf67 PPAPDC3	Homo sapiens (Human)	negative regulation of myotube differentiation [GO:0010832]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; negative regulation of myotube differentiation [GO:0010832]	sphingosine-1-phosphate phosphatase activity [GO:0042392]	GO:0005635; GO:0005789; GO:0010832; GO:0016020; GO:0016021; GO:0042392	GGPEPR	3.150000095	1	1	0.074159011	611.3600504	13.83513	11.77972	14.43882	12.47732	14.99477	13.90087	12.65873	15.59084	15.20365	15.66682	16.29104	14.17135	15.26156	0	0	15.40173	0	15.48405	0	15.14859	0	16.11488	0	0	0	0	0	15.98136	0	15.3686	0	0	0	0	0	0	15.90159	13.08243	0	14.19909	15.83526	16.41382	0	0	0	0	0	0
Q8NBZ0	IN80E_HUMAN	INO80 complex subunit E (Coiled-coil domain-containing protein 95)	INO80E CCDC95	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]"	Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]"		GO:0000723; GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0042766; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507	NGPADGEVDYK	7.199999809	1	1	0.072509313	1163.04429	14.17182	16.12729	9.780681	13.42592	13.14022	0	0	0	0	0	15.70893	11.32236	0	0	12.10273	0	0	0	0	0	0	0	15.78854	0	0	14.634	0	15.03513	0	14.89046	0	0	0	0	0	0	12.27989	0	0	0	0	0	0	0	0	0	0	0
Q8NBZ9	NEAS1_HUMAN	Putative uncharacterized protein NEXN-AS1 (NEXN antisense RNA 1)	NEXN-AS1 C1orf118	Homo sapiens (Human)						QGSPGPGPAR	5.559999943	1	1	0.189247019	922.8689521	14.79727	16.29256	15.01698	15.79171	15.08589	15.06056	0	0	0	0	18.58444	0	0	0	0	15.59359	15.28636	0	0	0	15.61053	0	15.47064	0	16.58877	0	0	0	0	0	0	0	0	16.01336	17.68802	0	0	17.52935	0	0	15.18334	0	0	0	0	0	0	0
Q8NC01	CLC1A_HUMAN	"C-type lectin domain family 1 member A (C-type lectin-like receptor 1, CLEC-1)"	CLEC1A CLEC1 UNQ569/PRO1131	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952]	integral component of plasma membrane [GO:0005887]; intracellular anatomical structure [GO:0005622]	integral component of plasma membrane [GO:0005887]; intracellular anatomical structure [GO:0005622]; carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952]	carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005622; GO:0005887; GO:0006952; GO:0007166; GO:0030246	RAGMVKPESLHVPPETLGEGD	8.039999962	1	1	0.168702783	2218.952363	0	14.76126	12.50623	0	5.327851	15.09223	0	13.5075	15.69827	0	0	11.73211	16.02572	13.72513	0	14.05106	14.38686	14.35665	0	15.59949	16.50155	0	0	0	0	0	0	0	18.78771	16.41059	18.10768	18.38273	17.53077	18.80124	0	0	0	15.72333	0	0	15.95388	0	0	0	16.23361	15.43505	0	16.02764
Q8NC26	ZN114_HUMAN	Zinc finger protein 114	ZNF114	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	extracellular exosome [GO:0070062]; nucleus [GO:0005634]	"extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0042802; GO:0046872; GO:0070062	TFPEANR	5.610000134	0.016497718	0.016497718	0.226482001	834.6724967	0	16.07333	12.05143	0	0	12.34142	14.87105	14.89549	14.27791	14.79778	0	15.78189	11.1538	0	15.23069	0	15.54656	16.2221	0	16.27827	0	0	0	0	0	0	0	15.18407	0	0	0	0	0	0	0	0	16.91904	0	15.68757	0	0	0	14.98635	0	0	0	0	0
Q8NC51	PAIRB_HUMAN	"Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1, PAI-RBP1) (SERPINE1 mRNA-binding protein 1)"	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488]	cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]	GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0030578; GO:0032183; GO:0043022; GO:0043488; GO:0045296; GO:0048471; GO:0070062	EEGPK	4.320000172	1	1	0.233740949	559.8320901	0	0	0	0	0	0	0	0	0	0	0	0	16.63923	15.48681	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.77958	14.83443	0	16.70374	0	0	0	0	0
Q8NC56	LEMD2_HUMAN	"LEM domain-containing protein 2, hLEM2"	LEMD2	Homo sapiens (Human)	heart formation [GO:0060914]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; neurogenesis [GO:0022008]; nuclear envelope organization [GO:0006998]; protein localization to chromatin [GO:0071168]; skeletal muscle cell differentiation [GO:0035914]	integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]	integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; chromatin DNA binding [GO:0031490]; heart formation [GO:0060914]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; neurogenesis [GO:0022008]; nuclear envelope organization [GO:0006998]; protein localization to chromatin [GO:0071168]; skeletal muscle cell differentiation [GO:0035914]	chromatin DNA binding [GO:0031490]	GO:0005635; GO:0005637; GO:0005639; GO:0006998; GO:0016020; GO:0016021; GO:0022008; GO:0030514; GO:0031490; GO:0031965; GO:0035914; GO:0043409; GO:0051898; GO:0060914; GO:0071168	ARPAAASPR	1.409999967	1	1	0.130229392	896.7605426	16.90845	0	0	0	14.5825	0	0	0	17.81216	15.72495	19.19844	0	0	0	0	0	0	15.33008	0	0	17.16319	0	0	15.58838	0	0	0	0	0	0	0	0	0	19.41256	0	18.39983	0	16.43467	17.64539	0	0	0	0	0	15.0667	0	0	0
Q8NC67	NETO2_HUMAN	Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2)	NETO2 BTCL2 UNQ1926/PRO4401	Homo sapiens (Human)	regulation of kainate selective glutamate receptor activity [GO:2000312]	integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]	integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; ionotropic glutamate receptor binding [GO:0035255]; regulation of kainate selective glutamate receptor activity [GO:2000312]	ionotropic glutamate receptor binding [GO:0035255]	GO:0014069; GO:0016021; GO:0035255; GO:2000312	AKFCSTVANDVMLK	7.679999828	1	1	0.201144646	1599.763813	0	0	0	15.91277	0	6.512053	0	0	13.36625	12.96662	0	13.78736	0	0	0	0	0	0	0	0	15.41398	0	0	0	9.260201	14.43004	16.87201	0	15.7019	0	0	0	0	0	0	0	15.02267	0	0	0	15.14014	0	0	0	0	0	13.46569	0
Q8NC74	RB8NL_HUMAN	RBBP8 N-terminal-like protein	RBBP8NL C20orf151	Homo sapiens (Human)		extracellular space [GO:0005615]	extracellular space [GO:0005615]		GO:0005615	ASRPSAMTHEAPK	5.739999771	1	1	0.477116631	1381.123245	15.69918	15.27976	14.59294	0	0	11.63343	0	14.97093	0	0	0	15.41621	0	15.51916	13.71263	0	0	0	0	0	0	0	15.70317	0	0	0	0	0	0	0	15.59569	0	0	0	0	0	15.93741	0	0	0	0	0	15.07764	0	0	0	0	0
Q8NCD3	HJURP_HUMAN	Holliday junction recognition protein (14-3-3-associated AKT substrate) (Fetal liver-expressing gene 1 protein) (Up-regulated in lung cancer 9)	HJURP FAKTS FLEG1 URLC9	Homo sapiens (Human)	cell cycle [GO:0007049]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA binding [GO:0051101]; regulation of protein-containing complex assembly [GO:0043254]	"chromosome, centromeric region [GO:0000775]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]"	"chromosome, centromeric region [GO:0000775]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; cell cycle [GO:0007049]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA binding [GO:0051101]; regulation of protein-containing complex assembly [GO:0043254]"	DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]	GO:0000775; GO:0000776; GO:0003677; GO:0005654; GO:0005730; GO:0005739; GO:0007049; GO:0007059; GO:0034080; GO:0042393; GO:0042802; GO:0043254; GO:0051101	RLSLPSSK	4.050000191	1	1	0.165342216	887.7015965	0	0	15.71901	0	0	0	0	0	0	0	15.96914	14.46059	0	0	0	0	16.84395	15.84171	0	0	0	15.76873	0	14.97352	0	0	14.22807	0	0	16.33453	16.56549	15.29098	17.19196	16.08927	14.57304	15.88104	16.66679	15.98488	16.2877	16.7865	17.16953	15.1523	15.38439	16.96929	14.145	15.65361	0	0
Q8NCE0	SEN2_HUMAN	"tRNA-splicing endonuclease subunit Sen2, EC 4.6.1.16 (tRNA-intron endonuclease Sen2, HsSen2)"	TSEN2 SEN2	Homo sapiens (Human)	"mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]"	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]	"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]"	lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]	GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0006388; GO:0006397; GO:0016829	ELMLCYLIKPSTMTDKEMESPECMK	5.059999943	0.468453676	0.468453676	0.149153146	3096.164368	14.48787	15.57204	14.148	16.4319	15.61338	16.28002	13.6446	0	14.57256	14.20956	0	14.75267	16.68514	0	0	14.18793	0	0	8.616723	0	0	0	15.84044	0	12.33528	0	15.55368	0	0	0	0	0	0	0	0	0	13.2703	0	0	0	15.07989	0	0	0	0	0	0	0
Q8NCF5	NF2IP_HUMAN	"NFATC2-interacting protein (45 kDa NF-AT-interacting protein, 45 kDa NFAT-interacting protein) (Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein)"	NFATC2IP NIP45	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944]		GO:0005634; GO:0005737; GO:0045944	GRWSGGSGAGR	8.210000038	1	1	0.076745636	1046.591499	14.6133	14.89587	0	0	0	0	0	0	0	0	13.31084	0	0	0	0	0	0	0	14.77987	0	0	0	14.65139	0	0	0	15.13644	0	0	0	15.91717	0	0	0	14.68307	0	12.67026	0	0	0	13.53881	0	0	0	0	0	0	0
Q8NCH0	CHSTE_HUMAN	"Carbohydrate sulfotransferase 14, EC 2.8.2.35 (Dermatan 4-sulfotransferase 1, D4ST-1, hD4ST1)"	CHST14 D4ST1 UNQ1925/PRO4400	Homo sapiens (Human)	carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]	extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655]	N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030208; GO:0042301; GO:0050655; GO:0070062	DPWDLPVGQR	4.539999962	0.252966404	0.252966404	0.041813463	1182.746061	14.9158	0	17.74426	0	4.520619	15.78047	13.36515	0	0	0	0	0	0	0	0	0	0	0	14.23013	0	13.78765	0	9.683378	16.75773	0	0	14.66479	18.48545	16.357	0	13.96893	15.22858	0	12.37493	16.21254	0	16.23035	0	0	0	17.1701	15.6847	0	0	0	0	17.22438	15.50855
Q8NCI6	GLBL3_HUMAN	"Beta-galactosidase-1-like protein 3, EC 3.2.1.-"	GLB1L3	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]	vacuole [GO:0005773]	vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975]	beta-galactosidase activity [GO:0004565]	GO:0004565; GO:0005773; GO:0005975	MMSGSDIK	2.690000057	1	1	0.226214488	868.0240211	0	0	0	0	7.797433	0	15.46832	0	14.31986	0	15.90699	14.6699	0	0	0	15.55761	0	0	0	0	0	0	0	0	0	16.2814	0	17.30631	0	14.37293	0	0	0	0	0	0	0	0	0	0	0	14.98065	15.41826	0	0	0	17.79751	0
Q8NCJ5	SPRY3_HUMAN	SPRY domain-containing protein 3	SPRYD3	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]		GO:0005737; GO:0007010; GO:0007166	EDDSVMMVDSYEDEWGR	6.730000019	1	1	0.285423998	2079.069759	13.45186	17.17576	0	0	0	0	0	14.53838	15.55541	0	0	14.32346	0	0	0	0	14.80673	0	0	0	15.2035	12.26429	0	0	0	7.544382	0	13.77569	0	0	0	0	0	11.3244	0	0	0	12.04058	13.22606	13.41605	0	15.05086	0	0	0	0	0	0
Q8NCM8	DYHC2_HUMAN	"Cytoplasmic dynein 2 heavy chain 1 (Cytoplasmic dynein 2 heavy chain) (Dynein cytoplasmic heavy chain 2) (Dynein heavy chain 11, hDHC11) (Dynein heavy chain isotype 1B)"	DYNC2H1 DHC1B DHC2 DNCH2 DYH1B KIAA1997	Homo sapiens (Human)	cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; forebrain development [GO:0030900]; Golgi organization [GO:0007030]; intraciliary retrograde transport [GO:0035721]; kidney development [GO:0001822]; microtubule-based movement [GO:0007018]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to cilium [GO:0061512]; protein processing [GO:0016485]; spinal cord motor neuron differentiation [GO:0021522]	apical part of cell [GO:0045177]; axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; forebrain development [GO:0030900]; Golgi organization [GO:0007030]; intraciliary retrograde transport [GO:0035721]; kidney development [GO:0001822]; microtubule-based movement [GO:0007018]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to cilium [GO:0061512]; protein processing [GO:0016485]; spinal cord motor neuron differentiation [GO:0021522]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0001822; GO:0003774; GO:0005524; GO:0005794; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0005930; GO:0007018; GO:0007030; GO:0007368; GO:0008569; GO:0009953; GO:0016485; GO:0021522; GO:0030286; GO:0030326; GO:0030900; GO:0031514; GO:0035721; GO:0045177; GO:0045505; GO:0045880; GO:0051959; GO:0060271; GO:0060976; GO:0061512; GO:0070062; GO:0097542; GO:1905515	ADSQQK	2.529999971	0.395219415	0.395219415	0.140203899	677.5508567	19.18733	18.59005	0	17.36237	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.39044	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NCN2	ZBT34_HUMAN	Zinc finger and BTB domain-containing protein 34	ZBTB34 KIAA1993	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0006357; GO:0046872	LCDIIVHIQGQPFRAHK	4.760000229	1	1	0.132791905	2031.018154	14.93995	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.98184	18.02279	0	0	0	0	0	0	0	16.33967	0	0	0	0	14.20284	0	16.50234	0	0	0	0	0	0	0	0	0
Q8NCN5	PDPR_HUMAN	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial, PDPr"	PDPR KIAA1990	Homo sapiens (Human)	positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0045253]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0045253]; oxidoreductase activity [GO:0016491]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470]	oxidoreductase activity [GO:0016491]	GO:0005737; GO:0005739; GO:0005759; GO:0006470; GO:0016491; GO:0045253; GO:1904184	GQVTGVETDK	1.720000029	1	1	0.118560528	1034.478869	15.72571	13.87054	15.11148	14.24616	0	0	13.84733	0	0	0	0	0	15.22629	0	0	0	15.96731	0	14.57053	14.53196	0	15.26401	0	13.68699	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NCP5	ZBT44_HUMAN	Zinc finger and BTB domain-containing protein 44 (BTB/POZ domain-containing protein 15) (Zinc finger protein 851)	ZBTB44 BTBD15 ZNF851	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872	VQDKIFR	26	1	1	0.537421559	905.3895803	0	0	0	0	18.09468	0	0	0	0	0	18.32818	0	0	0	0	18.38516	0	0	0	0	0	0	0	0	18.63576	0	0	17.8587	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.74921	0	0	0	0	0
Q8NCQ3	NC301_HUMAN	Putative uncharacterized protein encoded by LINC00301	LINC00301 C11orf64 NCRNA00301	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	ELQLLVR	8.520000458	0.714058995	0.714058995	0.275702308	869.8429456	0	18.34459	16.63148	0	17.24977	0	16.60092	19.18727	18.92255	0	0	0	0	0	18.17782	0	0	0	16.12918	0	0	0	0	0	19.13181	16.68657	0	0	0	0	19.2217	0	0	0	19.19495	19.92804	19.40797	18.79422	0	0	0	0	0	0	0	0	18.32154	0
Q8NCQ5	FBX15_HUMAN	F-box only protein 15	FBXO15 FBX15	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829	GGGAAR	1.629999995	0.0259117	0.0259117	0.272458713	486.8718696	15.49008	16.33393	15.88882	15.16634	16.34266	16.09096	15.42902	16.21174	0	15.88975	15.42431	0	0	0	0	15.97435	15.67464	0	0	15.9275	0	18.52556	18.32357	16.43356	0	0	0	0	0	16.06966	16.15005	16.43849	16.59601	0	16.50854	14.27154	15.94393	13.79624	15.6662	16.4423	16.8039	15.43817	0	15.66025	0	14.99583	0	0
Q8NCQ7	PRCA1_HUMAN	Protein PROCA1 (Protein interacting with cyclin A1)	PROCA1	Homo sapiens (Human)	arachidonic acid secretion [GO:0050482]; phospholipid metabolic process [GO:0006644]		cyclin binding [GO:0030332]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; phospholipid metabolic process [GO:0006644]	cyclin binding [GO:0030332]; phospholipase A2 activity [GO:0004623]	GO:0004623; GO:0006644; GO:0030332; GO:0050482	GHLLAGVASSTDVSTFSEGGDCK	5.559999943	1	1	0.513447765	2295.074077	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.98793	15.94448	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NCR6	SMRP1_HUMAN	Spermatid-specific manchette-related protein 1 (Ciliated bronchial epithelial protein 1) (Testis development protein NYD-SP22)	SMRP1 C9orf24 CBE1	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; manchette [GO:0002177]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; manchette [GO:0002177]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	alpha-tubulin binding [GO:0043014]	GO:0002177; GO:0005634; GO:0005654; GO:0005829; GO:0007283; GO:0030154; GO:0043014; GO:0048471	METAVRGMPLECPPRPER	2.559999943	1	1	3.65E-12	2140.958462	14.76821	0	0	0	12.91543	11.42295	14.92488	14.22894	0	9.191272	0	11.54147	13.58279	16.58951	13.76858	0	0	13.60585	14.30809	0	15.00682	0	0	0	15.30712	13.9713	11.36834	13.5327	13.72345	0	0	0	0	0	0	0	13.69345	14.4576	0	0	14.25618	0	0	12.61125	13.16867	0	14.88626	14.43702
Q8NCU1	CC197_HUMAN	Uncharacterized protein CCDC197 (Coiled-coil domain-containing protein 197)	CCDC197 C14orf48 LINC00521	Homo sapiens (Human)						AAMDTGQRADPSNPGDK	9.640000343	0.733387411	0.733387411	0.571253007	1730.289692	0	0	0	17.98589	19.57555	19.65829	0	0	20.03675	0	19.42155	0	0	18.54688	0	0	18.69706	17.90925	0	19.4887	0	0	0	19.54136	20.13625	0	0	0	0	0	0	0	0	17.71363	0	0	19.90048	20.53144	0	0	0	20.43722	19.50298	0	19.88704	19.80473	0	0
Q8NCU4	CC191_HUMAN	Coiled-coil domain-containing protein 191	CCDC191 KIAA1407	Homo sapiens (Human)						ILAEKK	17.87000084	1	1	0.138849891	703.3328152	17.03198	0	0	0	15.45343	0	0	0	0	0	0	13.97481	0	14.36525	0	0	0	0	14.2852	0	15.52023	14.61712	0	0	14.80278	0	15.4205	15.29564	0	15.36673	15.36851	13.23302	14.63569	14.54209	11.87401	14.50775	0	0	0	17.72402	0	14.85311	0	0	0	0	0	0
Q8NCX0	CC150_HUMAN	Coiled-coil domain-containing protein 150	CCDC150	Homo sapiens (Human)						ALDEANFR	4.739999771	0.800928056	0.800928056	0.225619047	935.817036	0	0	15.7662	0	14.79958	0	0	14.75755	14.01769	0	0	15.58083	0	13.89499	0	14.70277	0	14.35444	15.896	0	14.29858	15.76605	0	16.75823	15.87747	11.28845	14.11758	10.00666	14.97355	0	15.04822	0	14.01291	14.67568	0	0	0	14.9732	16.39521	14.6137	14.63532	16.14076	0	15.26932	14.46329	14.72086	14.86018	13.0437
Q8ND04	SMG8_HUMAN	Nonsense-mediated mRNA decay factor SMG8 (Amplified in breast cancer gene 2 protein) (Protein smg-8 homolog)	SMG8 ABC2 C17orf71	Homo sapiens (Human)	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]"	cytosol [GO:0005829]	"cytosol [GO:0005829]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]"		GO:0000184; GO:0005829; GO:0045859	FMCSGPDKVMK	4.690000057	1	1	0.084982663	1315.519237	14.35747	15.4143	13.1046	10.57537	0	14.91478	0	0	0	0	0	10.39951	0	0	0	0	0	0	0	13.6253	0	0	0	0	0	0	16.03646	13.21946	0	15.56156	14.69445	0	0	0	0	0	0	0	0	0	15.30449	0	0	0	0	0	13.41572	14.36034
Q8ND23	CARL3_HUMAN	"Capping protein, Arp2/3 and myosin-I linker protein 3 (Capping protein regulator and myosin 1 linker protein 3) (Leucine-rich repeat-containing protein 16B)"	CARMIL3 C14orf121 LRRC16B	Homo sapiens (Human)		cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]		GO:0005737; GO:0005886	LCPLEPVQDELLYAR	6.789999962	1	1	0.043361516	1816.412435	14.99181	12.13362	0	13.21644	0	14.13494	0	15.6227	0	14.56677	12.80278	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41535	0	0	0	0	0	0	16.14483	14.44176	0	0	0	0	0	0	0
Q8ND24	RN214_HUMAN	RING finger protein 214	RNF214	Homo sapiens (Human)			metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0046872	AQMTNILQQIK	10.27000046	1	1	0.247452815	1286.612164	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53818	0	17.55572	0	0	0	0	0	0	0	0	0	0	0	0	0	16.55142
Q8ND30	LIPB2_HUMAN	"Liprin-beta-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2, PTPRF-interacting protein-binding protein 2)"	PPFIBP2	Homo sapiens (Human)	neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808]	cytosol [GO:0005829]; extracellular space [GO:0005615]; presynaptic active zone [GO:0048786]	cytosol [GO:0005829]; extracellular space [GO:0005615]; presynaptic active zone [GO:0048786]; identical protein binding [GO:0042802]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808]	identical protein binding [GO:0042802]	GO:0005615; GO:0005829; GO:0007528; GO:0042802; GO:0048786; GO:0050808	SPPTICQPDATGSSLLRLR	2.430000067	1	1	0.210343137	2068.052066	9.730255	13.06931	0	10.79053	0	0	0	14.49599	11.66544	13.2289	0	0	0	0	12.78521	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.20854	0	0	0	16.35465	15.68801	0	0	0	0
Q8ND56	LS14A_HUMAN	"Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein, AlphaSNBP) (RNA-associated protein 55A, hRAP55, hRAP55A)"	LSM14A C19orf13 FAM61A RAP55 RAP55A	Homo sapiens (Human)	mitotic spindle assembly [GO:0090307]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; RIG-I signaling pathway [GO:0039529]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitotic spindle [GO:0072686]; P-body [GO:0000932]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitotic spindle [GO:0072686]; P-body [GO:0000932]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mitotic spindle assembly [GO:0090307]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; RIG-I signaling pathway [GO:0039529]; stress granule assembly [GO:0034063]	double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0000932; GO:0003690; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0005737; GO:0005829; GO:0010494; GO:0017148; GO:0033962; GO:0034063; GO:0036464; GO:0039529; GO:0060340; GO:0072686; GO:0090307; GO:1990124	GGGRGGTFTAPR	1.75999999	0.124045856	0.124045856	0.066354144	1134.907029	0	12.31252	14.9678	0	0	14.41619	0	0	0	0	0	0	12.99516	0	0	15.98329	0	10.86556	0	0	0	15.43265	13.19371	15.69255	18.06765	15.86168	13.40703	0	12.10132	14.24922	0	0	0	13.05078	14.7383	0	18.71628	0	14.34429	0	19.34821	13.9078	0	0	10.97675	15.99737	14.04502	0
Q8ND61	CC020_HUMAN	Uncharacterized protein C3orf20	C3orf20	Homo sapiens (Human)		cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]		GO:0005737; GO:0016021	THQETLNR	4.369999886	0.187427625	0.187427625	0.237369262	996.6917049	0	15.96027	14.89449	15.38387	13.05432	16.57695	17.07891	14.18716	15.37147	13.73707	14.84664	16.81495	0	0	12.88014	0	15.75748	15.44282	14.06292	15.25899	0	17.02271	17.02672	13.84615	0	16.51338	15.54215	14.28041	0	16.27285	0	15.50962	0	0	15.85683	0	15.63257	16.17088	17.61343	17.01338	15.3581	0	15.01395	15.31639	16.48309	16.15671	16.91585	0
Q8ND76	CCNY_HUMAN	"Cyclin-Y, Cyc-Y (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X)"	CCNY C10orf9 CBCP1 CFP1	Homo sapiens (Human)	cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859]; Wnt signaling pathway [GO:0016055]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859]; Wnt signaling pathway [GO:0016055]	cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000086; GO:0000307; GO:0000308; GO:0005634; GO:0005886; GO:0016055; GO:0016538; GO:0019901; GO:0045737; GO:0045859; GO:0051301; GO:0060828; GO:0061575	WSPAIIS	7.150000095	1	1	0.24701849	773.8928708	11.46617	0	0	16.17008	11.91305	14.53078	12.80656	15.16146	13.11866	15.64115	12.9188	13.6734	0	14.72776	0	15.90505	0	0	0	16.59665	0	0	16.44734	0	16.14655	0	13.69268	14.27335	15.81544	14.06717	16.04893	0	0	0	16.46899	16.86243	0	0	16.31012	18.73742	0	0	14.21129	14.8391	13.90456	13.11339	0	15.01682
Q8NDA2	HMCN2_HUMAN	Hemicentin-2	HMCN2	Homo sapiens (Human)	response to stimulus [GO:0050896]	cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005615; GO:0031012; GO:0032154; GO:0050896; GO:0062023	AGLYR	9.569999695	0.483003646	0.483003646	0.264958717	578.1973198	16.50213	0	16.84598	18.03376	16.26863	0	0	0	0	17.38283	0	0	16.97545	17.09641	16.14877	0	17.26636	16.94472	0	15.66495	16.11945	0	0	0	0	17.17785	0	17.312	0	16.52618	18.62322	0	0	0	0	0	0	0	18.56604	16.13829	0	0	17.5403	0	16.39997	0	0	16.68075
Q8NDA8	MROH1_HUMAN	Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A)	MROH1 HEATR7A KIAA1833	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	DPKADSVR	4.369999886	1	1	0.149385906	887.167341	15.44607	14.85325	6.700792	14.42431	16.25773	11.70541	15.23858	15.66058	16.52117	15.7622	13.99535	13.3726	0	13.27431	15.20694	14.1548	0	0	14.00907	0	0	15.72619	14.9402	0	0	0	0	0	15.42882	0	0	0	0	16.99153	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NDB2	BANK1_HUMAN	B-cell scaffold protein with ankyrin repeats	BANK1	Homo sapiens (Human)	B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; negative regulation of B cell activation [GO:0050869]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translational initiation [GO:0045947]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; response to bacterium [GO:0009617]	perinuclear region of cytoplasm [GO:0048471]	perinuclear region of cytoplasm [GO:0048471]; NAD+ nucleosidase activity [GO:0003953]; phospholipase binding [GO:0043274]; protease binding [GO:0002020]; protein tyrosine kinase binding [GO:1990782]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; negative regulation of B cell activation [GO:0050869]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translational initiation [GO:0045947]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; response to bacterium [GO:0009617]	NAD+ nucleosidase activity [GO:0003953]; phospholipase binding [GO:0043274]; protease binding [GO:0002020]; protein tyrosine kinase binding [GO:1990782]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]	GO:0002020; GO:0003953; GO:0005102; GO:0009617; GO:0032715; GO:0035591; GO:0042113; GO:0043274; GO:0043410; GO:0045947; GO:0048471; GO:0050731; GO:0050853; GO:0050869; GO:0051898; GO:1990782	FCGLPK	9.93999958	0.920250475	0.920250475	0.313693763	720.9226736	14.72281	0	14.67315	15.91473	16.43233	14.97162	15.7475	0	0	14.60926	14.8844	13.97547	15.66573	15.16368	0	16.33381	0	15.24712	0	0	0	16.49114	0	0	0	0	0	14.80032	16.18044	15.85344	16.82415	0	15.55141	15.17296	15.69404	16.28214	15.23068	16.17402	16.41848	15.90727	0	0	0	16.21144	0	16.44829	14.61064	16.35217
Q8NDB6	FA156_HUMAN	Protein FAM156A/FAM156B (Transmembrane protein 29/29B)	FAM156A TMEM29 PP12994 PRO0659; FAM156B TMEM29B	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]	integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; methylated histone binding [GO:0035064]	methylated histone binding [GO:0035064]	GO:0005635; GO:0016021; GO:0035064	MDPLQK	2.349999905	1	1	0.165634301	732.3360929	0	0	0	0	0	15.24365	0	0	0	0	0	0	15.74383	0	16.32186	0	0	0	0	0	0	0	0	0	0	0	16.13516	0	0	15.15432	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NDF8	PAPD5_HUMAN	"Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5, EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase, EC 2.7.7.-) (Terminal uridylyltransferase 3, TUTase 3) (Topoisomerase-related function protein 4-2, TRF4-2)"	TENT4B GLD4 PAPD5 TRF4-2 TUT3	Homo sapiens (Human)	carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364]; sno(s)RNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364]; sno(s)RNA polyadenylation [GO:0071050]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0003677; GO:0003723; GO:0003887; GO:0004652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006364; GO:0006378; GO:0007049; GO:0010587; GO:0031123; GO:0031499; GO:0032211; GO:0033500; GO:0043629; GO:0043630; GO:0046872; GO:0051301; GO:0060212; GO:0070034; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870	ASGGR	1.940000057	0.520370007	0.520370007	0.271231991	448.9618625	16.69889	0	0	0	0	0	0	0	16.10671	0	0	17.23285	17.75133	15.0802	0	0	0	0	0	0	0	0	0	17.70391	17.9632	17.94516	0	0	16.15083	14.50701	15.59279	0	17.42935	13.79038	13.32515	18.1207	11.28162	11.19963	14.29036	0	0	17.27352	17.76367	0	13.12528	17.78387	17.51494	13.78029
Q8NDH2	CC168_HUMAN	Leucine-rich repeat transmembrane protein CCDC168 (Coiled-coil domain-containing protein 168)	CCDC168 C13orf40	Homo sapiens (Human)						ADTLR	7.679999828	1	1	0.162272311	576.3090067	15.23773	13.58498	0	15.55409	0	0	15.92705	16.31428	0	0	15.28148	0	15.16883	0	16.34096	0	0	16.30827	17.01187	0	14.80823	0	16.15478	0	0	0	15.63838	0	0	13.95791	16.14492	17.46618	0	16.57774	16.48147	0	0	17.27297	0	0	0	0	16.3727	15.35009	14.5081	0	0	17.32758
Q8NDH6	ICA1L_HUMAN	Islet cell autoantigen 1-like protein (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein)	ICA1L ALS2CR14 ALS2CR15	Homo sapiens (Human)	regulation of transport [GO:0051049]	Golgi apparatus [GO:0005794]	Golgi apparatus [GO:0005794]; protein domain specific binding [GO:0019904]; regulation of transport [GO:0051049]	protein domain specific binding [GO:0019904]	GO:0005794; GO:0019904; GO:0051049	MMDATGK	6.610000134	1	1	0.229964423	753.3381965	16.0241	14.87431	0	14.31873	16.38711	15.17958	14.61458	15.34172	0	15.57483	15.46193	11.91957	14.38113	15.11222	15.1894	12.543	15.79251	15.48728	0	13.81329	0	15.25227	15.99485	0	0	15.21725	0	15.53301	15.90708	0	0	16.24883	15.74279	0	0	0	0	17.20131	16.70063	0	0	0	16.234	15.13804	0	16.09922	0	0
Q8NDI1	EHBP1_HUMAN	EH domain-binding protein 1	EHBP1 KIAA0903 NACSIN	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]	cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]		GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941	ALATSSINMK	2.640000105	1	1	0.351561489	1050.816926	0	0	0	0	15.75933	0	0	0	17.73686	0	18.16534	0	0	0	17.13467	0	0	15.47658	0	0	0	0	17.35937	0	0	0	0	0	0	0	0	18.04777	0	0	0	0	0	17.20298	0	0	16.60771	0	0	0	0	0	0	0
Q8NDL9	CBPC5_HUMAN	"Cytosolic carboxypeptidase-like protein 5, EC 3.4.17.-, EC 3.4.17.24 (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5)"	AGBL5 CCP5	Homo sapiens (Human)	C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]	metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0045171; GO:0051607; GO:0072686	GGMPGK	3.119999886	1	1	0.08744495	559.4792676	13.89415	13.65758	13.81928	15.49702	0	15.48584	15.55844	0	0	15.00968	13.80845	16.97681	0	0	15.95598	0	14.19428	0	16.78497	0	14.81254	16.08339	16.80891	14.96411	0	10.86757	0	16.24257	15.06259	16.10931	12.9297	0	0	0	16.27312	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NDM7	CFA43_HUMAN	Cilia- and flagella-associated protein 43 (WD repeat-containing protein 96)	CFAP43 C10orf79 WDR96	Homo sapiens (Human)	brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288]		GO:0003356; GO:0005576; GO:0005930; GO:0007288; GO:0007420; GO:0060271; GO:0090660; GO:0097729; GO:0120197	LRALMDMMGGVLEVK	3.660000086	0.360584706	0.360584706	0.315955532	1662.326577	19.55972	0	18.35034	0	15.97141	15.28163	19.02718	17.04858	0	18.61965	0	0	0	13.24469	15.45651	0	16.97647	17.47331	18.85095	17.79294	0	0	16.91213	0	0	0	15.53751	15.52942	14.23654	17.53471	0	0	0	15.90001	16.83204	0	15.92809	16.30407	18.57829	15.53659	14.84526	17.99885	0	15.03372	18.45802	0	17.74141	13.38573
Q8NDT2	RB15B_HUMAN	"Putative RNA-binding protein 15B (One-twenty two protein 3, HsOTT3, HuOTT3) (RNA-binding motif protein 15B)"	RBM15B OTT3	Homo sapiens (Human)	"dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]"	nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	"nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0001510; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0009048; GO:0016607; GO:0036396	AKVAMSGR	1.419999957	1	1	0.111590221	836.2571645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.57008	0	0	0	0	0	0	0	0	0	0	0	0	14.76346	0
Q8NDV2	GPR26_HUMAN	G-protein coupled receptor 26	GPR26	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0016021	IDVITMQTLVLLVDLHPSVR	2.609999895	0.423344135	0.423344135	4.58E-13	2278.145964	0	16.31188	0	0	0	0	0	0	13.60304	0	15.77445	0	0	0	0	0	0	0	13.93865	0	0	13.92152	14.70257	0	0	0	0	0	0	0	0	0	16.87204	0	15.34358	0	0	0	0	12.62694	16.80699	0	15.73109	0	16.48298	0	16.14504	0
Q8NDV3	SMC1B_HUMAN	"Structural maintenance of chromosomes protein 1B, SMC protein 1B, SMC-1-beta, SMC-1B"	SMC1B SMC1L2	Homo sapiens (Human)	meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]	"chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]	GO:0000775; GO:0000800; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007062; GO:0008278; GO:0016887; GO:0030893; GO:0034991; GO:0051321	EHGMLTR	6.21999979	6.75E-05	6.75E-05	0.311122343	859.8346905	0	17.66076	0	16.59475	20.48347	0	0	19.21067	0	0	0	0	17.79294	0	0	0	0	0	0	16.42696	18.17855	17.9987	0	0	19.66222	0	0	0	0	0	17.28776	20.18348	0	19.96624	0	0	0	0	0	17.67004	17.19595	0	0	17.2449	18.11837	0	0	0
Q8NDW8	TT21A_HUMAN	"Tetratricopeptide repeat protein 21A, TPR repeat protein 21A (Stress-inducible protein 2)"	TTC21A STI2	Homo sapiens (Human)	flagellated sperm motility [GO:0030317]; intraciliary retrograde transport [GO:0035721]; protein localization to cilium [GO:0061512]; spermatid development [GO:0007286]	cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]	cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; flagellated sperm motility [GO:0030317]; intraciliary retrograde transport [GO:0035721]; protein localization to cilium [GO:0061512]; spermatid development [GO:0007286]		GO:0005929; GO:0007286; GO:0030317; GO:0030991; GO:0035721; GO:0061512	EGNMTTVSSLKTQK	6.380000114	1	1	0.42843835	1524.885776	12.06309	15.70699	16.31562	0	0	0	0	15.34131	0	0	0	0	0	0	0	15.80039	16.30028	13.96887	16.68049	0	0	13.67188	0	0	16.01724	0	0	0	16.28871	0	0	15.60338	0	0	15.6704	0	0	0	16.00073	15.99583	14.67179	0	14.40411	15.76318	0	0	0	0
Q8NDX1	PSD4_HUMAN	"PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B, Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein)"	PSD4 EFA6B TIC	Homo sapiens (Human)	regulation of ARF protein signal transduction [GO:0032012]	membrane [GO:0016020]; ruffle membrane [GO:0032587]	membrane [GO:0016020]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; regulation of ARF protein signal transduction [GO:0032012]	guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]	GO:0005085; GO:0005543; GO:0016020; GO:0032012; GO:0032587	KPHVFQLRTADWR	5.369999886	0.821484864	0.821484864	0.385872389	1652.737359	14.41731	0	12.62691	0	0	15.48907	14.16555	15.21726	0	0	0	0	0	0	16.37701	0	15.04822	14.93912	0	17.83444	16.47958	0	14.89219	0	0	0	0	0	0	0	0	0	16.43557	0	0	0	14.45354	16.56405	16.93272	0	0	16.26787	0	0	15.66874	16.15863	0	0
Q8NDX2	VGLU3_HUMAN	"Vesicular glutamate transporter 3, VGluT3 (Solute carrier family 17 member 8)"	SLC17A8 VGLUT3	Homo sapiens (Human)	"anion transport [GO:0006820]; brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]"	apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672]	"apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium ion transport [GO:0006814]; synaptic transmission, glutamatergic [GO:0035249]"	L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0003407; GO:0005313; GO:0005326; GO:0005771; GO:0006811; GO:0006814; GO:0006820; GO:0007420; GO:0007605; GO:0015293; GO:0016021; GO:0022857; GO:0030285; GO:0030672; GO:0035249; GO:0043204; GO:0043679; GO:0050803; GO:0060076; GO:0090102; GO:0097440; GO:0097441; GO:0097451; GO:0098700; GO:1990030	ILKPGK	6.039999962	1	1	0.245743327	656.0003252	14.77278	0	0	15.62175	0	16.7778	0	15.8139	16.53914	0	16.23153	16.39893	0	16.35522	0	16.53932	15.82586	0	16.95066	16.76418	18.50132	0	0	0	17.27492	0	15.79185	15.51071	0	15.54335	0	0	0	0	16.33076	0	0	16.0322	16.02113	0	16.40868	16.05538	16.2432	17.16295	16.64365	0	0	0
Q8NDX9	LY65B_HUMAN	Lymphocyte antigen 6 complex locus protein G5b	LY6G5B C6orf19 G5B	Homo sapiens (Human)		external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]	identical protein binding [GO:0042802]	GO:0005576; GO:0009897; GO:0032991; GO:0042802	VPVPDIR	1.600000024	1	1	0.129737624	797.3457853	14.08058	0	0	13.70608	0	0	0	0	0	0	0	14.83385	0	0	0	13.21704	15.5414	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NDZ2	SIMC1_HUMAN	SUMO-interacting motif-containing protein 1 (Platform element for inhibition of autolytic degradation)	SIMC1 C5orf25 PLEIAD	Homo sapiens (Human)	negative regulation of peptidase activity [GO:0010466]	cytoplasm [GO:0005737]; sarcomere [GO:0030017]	cytoplasm [GO:0005737]; sarcomere [GO:0030017]; peptidase inhibitor activity [GO:0030414]; SUMO polymer binding [GO:0032184]; negative regulation of peptidase activity [GO:0010466]	peptidase inhibitor activity [GO:0030414]; SUMO polymer binding [GO:0032184]	GO:0005737; GO:0010466; GO:0030017; GO:0030414; GO:0032184	LEPIPHRR	28	1	1	0.108476486	1019.417914	0	0	0	19.03304	0	0	0	0	0	0	0	0	0	23.46776	0	0	0	0	0	0	0	0	0	0	23.87607	0	0	0	0	0	17.85794	0	23.42533	0	0	0	0	0	21.01682	0	0	0	0	0	0	0	0	0
Q8NDZ6	T161B_HUMAN	Transmembrane protein 161B	TMEM161B UNQ679/PRO1313	Homo sapiens (Human)	regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate [GO:0002027]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate [GO:0002027]		GO:0002027; GO:0005886; GO:0016021; GO:0098901	ESIPLMTEATFDTLR	3.269999981	0.96923846	0.96923846	0.226553841	1735.700727	15.80108	12.83333	0	16.5314	0	15.80196	0	14.27438	0	0	0	17.27658	16.23966	15.7226	15.55638	12.01648	0	9.572886	0	15.78316	17.1932	18.65577	16.96889	17.00174	18.1547	14.89787	6.579021	16.98658	0	16.25727	0	18.50595	0	14.12612	0	14.00674	16.38105	0	17.08576	16.396	16.02771	16.37267	15.74817	0	0	15.42644	16.49297	14.85509
Q8NE01	CNNM3_HUMAN	Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3)	CNNM3 ACDP3	Homo sapiens (Human)	ion transport [GO:0006811]; magnesium ion homeostasis [GO:0010960]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]; magnesium ion homeostasis [GO:0010960]	transmembrane transporter activity [GO:0022857]	GO:0005886; GO:0006811; GO:0010960; GO:0016020; GO:0016021; GO:0022857; GO:0043231	ESGSEAER	3.019999981	0.315634966	0.315634966	0.105424937	865.1867945	0	12.46519	12.3944	17.09895	14.93989	16.45161	17.15209	14.15893	0	0	17.33822	15.5062	17.99907	12.47693	13.36843	15.89893	16.61239	16.10465	11.32125	0	14.39421	0	14.92977	0	14.62391	16.75932	0	17.16649	13.7797	16.16952	0	17.80699	0	15.12681	13.0825	15.20424	18.06446	15.13442	18.09218	14.50354	15.20879	0	0	0	14.17247	15.74891	0	16.81662
Q8NE09	RGS22_HUMAN	"Regulator of G-protein signaling 22, RGS22"	RGS22	Homo sapiens (Human)	negative regulation of signal transduction [GO:0009968]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; G-protein alpha-subunit binding [GO:0001965]; negative regulation of signal transduction [GO:0009968]	G-protein alpha-subunit binding [GO:0001965]	GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629	ASSSTMSLKK	2.75999999	1	1	0.147502172	1040.148986	15.26318	0	15.52125	8.644258	14.49382	0	0	17.74726	0	17.29719	0	0	13.38537	14.76193	13.89328	14.51067	0	0	0	0	14.93712	0	0	0	0	16.41425	0	0	0	14.22775	0	0	0	0	0	0	0	0	0	16.10214	0	0	0	0	0	0	0	0
Q8NE18	NSUN7_HUMAN	"Putative methyltransferase NSUN7, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 7)"	NSUN7	Homo sapiens (Human)	methylation [GO:0032259]		methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; methylation [GO:0032259]	methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]	GO:0003723; GO:0008168; GO:0032259	DPDLKTLFTK	3.099999905	1	1	0.173490683	1178.199184	0	0	0	0	13.2032	0	17.98737	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.74679	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NE22	SETD9_HUMAN	"SET domain-containing protein 9, EC 2.1.1.-"	SETD9 C5orf35	Homo sapiens (Human)	methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; lysine N-methyltransferase activity [GO:0016278]; methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796]	lysine N-methyltransferase activity [GO:0016278]	GO:0005654; GO:0016278; GO:0032259; GO:1901796	SCNGRDR	2.950000048	0.275471389	0.275471389	0.288006722	863.845527	0	18.08094	0	16.57185	0	0	14.47514	0	18.26553	17.70074	0	0	0	0	0	0	0	0	0	18.49618	16.11267	0	0	0	0	18.81313	0	0	16.7437	0	0	17.70045	0	16.60061	20.16531	17.97688	16.1479	16.78964	15.64682	0	0	17.77056	0	16.5503	17.86182	0	0	0
Q8NE28	STKL1_HUMAN	Serine/threonine kinase-like domain-containing protein STKLD1 (Serine/threonine kinase-like domain-containing protein 1) (Sugen kinase 071)	STKLD1 C9orf96 SGK071	Homo sapiens (Human)			ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005524	LGPGSNRR	12.84000015	1	1	0.063685322	857.1808701	15.75167	14.53023	11.83033	14.2529	15.31639	15.08389	12.65412	13.52479	0	13.23324	14.19879	13.69517	0	16.64497	17.07996	0	13.75944	0	16.31906	15.65663	0	0	0	0	15.2036	15.97459	12.53888	14.16965	0	15.01421	0	0	0	0	0	0	0	12.62585	0	0	0	0	14.53572	0	0	0	0	0
Q8NE62	CHDH_HUMAN	"Choline dehydrogenase, mitochondrial, CDH, CHD, EC 1.1.99.1"	CHDH	Homo sapiens (Human)	choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]	mitochondrial inner membrane [GO:0005743]	mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]	choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0042426; GO:0050660	EIDAFVRAK	9.159999847	1	1	0.029679645	1048.278334	16.12027	0	12.26799	0	0	17.77871	0	15.90899	12.84695	14.74764	17.63899	16.61228	0	12.60129	16.74648	0	15.93214	13.17765	0	17.4087	14.27761	15.05617	0	0	15.21727	15.11785	16.53937	0	0	14.95992	15.71853	16.54016	14.56497	0	0	0	16.60733	16.21118	15.32874	0	0	0	15.84854	0	0	18.19857	16.54664	0
Q8NE63	HIPK4_HUMAN	"Homeodomain-interacting protein kinase 4, EC 2.7.11.1"	HIPK4	Homo sapiens (Human)	histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of signal transduction by p53 class mediator [GO:1901796]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of signal transduction by p53 class mediator [GO:1901796]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0016572; GO:0018105; GO:0018107; GO:0046777; GO:0106310; GO:1901796	KPPAGSK	9.350000381	0.962692499	0.962692499	0.23137053	684.72582	15.48991	15.17494	12.90463	15.03312	0	15.65095	14.86352	14.45995	0	16.04308	15.91942	0	14.81013	15.48889	15.62203	0	0	17.07591	17.42025	0	16.2975	0	0	0	15.5787	15.96843	16.04835	16.1814	15.74178	15.95095	15.18437	16.53199	17.03671	16.6975	16.42879	17.38176	16.62217	17.78322	17.11856	0	17.43397	16.84601	16.22675	17.07353	17.17723	16.84907	0	16.5676
Q8NE65	ZN738_HUMAN	Zinc finger protein 738	ZNF738	Homo sapiens (Human)	"protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0006355	VMLENFR	18.82999992	0.579600334	0.579600334	0.064941535	908.6171546	13.68798	14.89283	0	13.51549	11.84469	0	0	0	0	0	16.39403	0	14.9637	0	12.46477	0	12.45646	17.34521	15.33374	0	14.42729	0	12.17163	16.45825	11.96636	13.51938	0	0	14.16338	15.08645	0	14.53087	9.635116	13.9437	0	0	15.81862	14.27389	0	13.54316	14.9355	0	15.7993	12.80051	18.0022	0	0	0
Q8NE71	ABCF1_HUMAN	ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein)	ABCF1 ABC50	Homo sapiens (Human)	inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]"	"ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0042788; GO:0043022; GO:0045727	GKTTLLK	8.430000305	1	1	0.036391166	761.5140913	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NE79	POPD1_HUMAN	"Blood vessel epicardial substance, hBVES (Popeye domain-containing protein 1, Popeye protein 1)"	BVES POP1 POPDC1	Homo sapiens (Human)	cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192]	bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cAMP binding [GO:0030552]; structural molecule activity [GO:0005198]; cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192]	cAMP binding [GO:0030552]; structural molecule activity [GO:0005198]	GO:0001921; GO:0002027; GO:0002244; GO:0002931; GO:0005198; GO:0005886; GO:0005901; GO:0005923; GO:0007507; GO:0007517; GO:0007519; GO:0008360; GO:0016021; GO:0016192; GO:0016328; GO:0030054; GO:0030552; GO:0031253; GO:0034446; GO:0040017; GO:0042383; GO:0042391; GO:0043087; GO:0048278; GO:0051146; GO:0060931; GO:0060973; GO:0090136; GO:2001135	IEKELSGMYR	3.880000114	0.815625966	0.815625966	0.110770676	1241.57327	17.17579	0	16.68487	0	15.34111	0	13.19229	0	0	0	15.71578	15.1246	11.68098	15.43221	16.01211	17.6146	17.59768	16.03705	0	13.87903	0	12.68939	15.33523	17.21999	14.21629	15.7684	14.53327	15.86896	16.70939	11.32278	13.92886	15.81104	14.80733	16.58286	15.43147	14.92202	16.62338	16.1765	14.83037	16.24378	15.05074	15.20529	15.23801	15.08126	0	12.20097	0	17.0989
Q8NEA6	GLIS3_HUMAN	Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515)	GLIS3 ZNF515	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0045944; GO:0046872	AMNAANLNIPPSDTRSLISR	4.840000153	0.194128692	0.194128692	0.173347531	2157.65089	0	0	0	0	0	0	0	17.34221	13.31693	0	0	12.75953	0	14.90452	0	11.73637	16.08014	14.02466	0	13.75862	0	0	0	0	11.36491	0	0	13.80925	0	14.66894	0	0	0	13.08747	17.23222	0	0	0	15.76748	0	14.84675	0	0	0	0	0	0	0
Q8NEA9	GMCL2_HUMAN	Germ cell-less protein-like 2 (Germ cell-less protein-like 1-like)	GMCL2 GCL GMCL1L GMCL1P1	Homo sapiens (Human)	germ cell development [GO:0007281]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	nuclear matrix [GO:0016363]; nucleus [GO:0005634]	nuclear matrix [GO:0016363]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; germ cell development [GO:0007281]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]	cullin family protein binding [GO:0097602]	GO:0005634; GO:0007281; GO:0007283; GO:0016363; GO:0016567; GO:0097602	VLGQPRR	9.020000458	0.558201849	0.558201849	0.055455635	823.4484488	0	0	0	16.80439	0	15.80708	15.25796	0	0	14.53003	0	0	14.63454	16.1867	16.62483	12.5023	14.25972	14.92124	17.89902	14.95393	0	15.26833	0	15.42355	0	15.83156	15.12361	16.49294	16.60078	0	16.81064	0	0	0	0	0	14.42435	16.42575	0	11.29606	0	15.72182	0	17.24747	16.90098	0	0	7.942005
Q8NEB9	PK3C3_HUMAN	"Phosphatidylinositol 3-kinase catalytic subunit type 3, PI3-kinase type 3, PI3K type 3, PtdIns-3-kinase type 3, EC 2.7.1.137 (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34)"	PIK3C3 VPS34	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; protein targeting to lysosome [GO:0006622]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]"	"autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; protein targeting to lysosome [GO:0006622]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]	GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0005930; GO:0006468; GO:0006497; GO:0006622; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0010506; GO:0016020; GO:0016236; GO:0016241; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0030670; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742; GO:0097352	TPGRTSSTLSEDQMSR	2.319999933	1	1	6.91E-13	1768.434989	16.69258	12.22541	0	0	0	0	14.05874	13.91956	0	0	0	12.38049	0	12.91189	14.20061	0	0	0	0	0	0	0	0	0	0	0	17.47232	0	0	0	0	0	0	0	0	0	0	0	0	16.93728	0	0	0	0	0	0	0	0
Q8NEC5	CTSR1_HUMAN	"Cation channel sperm-associated protein 1, CatSper1, hCatSper"	CATSPER1	Homo sapiens (Human)	calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of ion transmembrane transport [GO:0034765]; spermatogenesis [GO:0007283]	CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]	CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of ion transmembrane transport [GO:0034765]; spermatogenesis [GO:0007283]	calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]	GO:0005227; GO:0005245; GO:0005886; GO:0006816; GO:0007283; GO:0030154; GO:0030317; GO:0034765; GO:0036128; GO:0060296; GO:0097228	TGVFPYHVAHPRGSAHSMTR	2.849999905	1	1	0.085023939	2224.874537	11.68474	12.38917	0	17.06453	14.33409	0	16.10779	13.29882	0	0	0	0	0	11.96664	0	13.46023	0	0	13.27098	10.56302	0	13.42428	15.238	14.51122	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NEC7	GSTCD_HUMAN	Glutathione S-transferase C-terminal domain-containing protein	GSTCD	Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]		GO:0005737; GO:0070062	NNMIVGVPI	11.61999989	0.371739566	0.371739566	0.254444668	970.1116586	12.13828	16.4327	15.18531	15.12546	15.84045	0	15.40584	14.52125	0	16.61447	16.1466	0	0	15.71129	0	0	0	15.57242	0	0	14.2892	17.1334	0	0	0	0	0	14.89142	0	14.2388	0	0	0	0	0	0	0	0	15.84267	0	0	15.96787	0	15.38062	0	15.73725	0	0
Q8NEE8	TTC16_HUMAN	"Tetratricopeptide repeat protein 16, TPR repeat protein 16"	TTC16	Homo sapiens (Human)						AEGAQGKSQGMSSTSSK	5.110000134	1	1	0.015428153	1656.68202	0	18.52686	0	0	17.21688	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.57191	0	0	0	0	0	0	19.47612	0	15.53786	0	0	0	0	0	0	0	0	0	0	0	15.58026	13.74309	0
Q8NEF3	CC112_HUMAN	Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1)	CCDC112 MBC1	Homo sapiens (Human)						SIEMSMK	3.380000114	0.067416996	0.067416996	0.184196824	857.4963037	13.75278	15.16507	14.82497	16.22091	0	0	14.83127	14.78944	15.12534	0	15.33171	0	15.29875	17.33313	17.12817	16.46768	16.66263	16.21925	17.50915	0	16.84383	16.6465	15.95672	17.1109	16.80935	16.17845	17.57493	15.9439	16.89233	16.7321	15.9799	15.24404	16.12983	16.65264	16.67943	16.84525	17.14729	17.54947	17.81313	15.11466	17.3772	16.01789	14.73805	15.94906	15.72704	17.36755	16.93426	17.63542
Q8NEF9	SRFB1_HUMAN	Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP)	SRFBP1	Homo sapiens (Human)	maturation of SSU-rRNA [GO:0030490]	90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0030490; GO:0030686; GO:0048471	TPADPK	2.059999943	0.792409956	0.792409956	0.133121667	627.3166566	14.58069	16.48837	15.31932	0	0	14.23148	0	16.00524	0	14.64695	15.10287	13.70842	0	0	0	0	0	0	0	0	0	0	16.69785	0	0	0	15.73202	0	0	14.62016	0	0	0	0	0	0	17.55292	15.26793	0	0	16.65838	14.23495	8.215543	15.31295	0	14.38197	0	0
Q8NEG0	GAR6_HUMAN	Golgi associated RAB2 interactor protein 6	GARIN6 FAM71C	Homo sapiens (Human)						ARMVTMGIVR	2.519999981	1	1	0.242627059	1154.182518	13.90489	0	15.62042	14.43184	0	0	13.49084	16.01341	0	13.53739	15.38514	14.57869	14.572	15.6635	0	13.21255	14.82378	13.19209	15.40966	15.17733	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.82038	0	0	0	16.60159	0	0	0	0	0	0	0	0
Q8NEG7	DEN6B_HUMAN	Protein DENND6B (DENN domain-containing protein 6B)	DENND6B FAM116B	Homo sapiens (Human)		cytosol [GO:0005829]; recycling endosome [GO:0055037]	cytosol [GO:0005829]; recycling endosome [GO:0055037]; guanyl-nucleotide exchange factor activity [GO:0005085]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0055037	DALLGTGPR	5.409999847	1	1	0.442977488	900.2500069	14.04375	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.49791	15.81485	0	0	17.08052	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NEH6	MNS1_HUMAN	Meiosis-specific nuclear structural protein 1	MNS1	Homo sapiens (Human)	cilium organization [GO:0044782]; left/right axis specification [GO:0070986]; meiotic cell cycle [GO:0051321]; positive regulation of cilium assembly [GO:0045724]; sperm axoneme assembly [GO:0007288]	axoneme [GO:0005930]; intermediate filament [GO:0005882]; motile cilium [GO:0031514]; nuclear envelope [GO:0005635]; sperm flagellum [GO:0036126]	axoneme [GO:0005930]; intermediate filament [GO:0005882]; motile cilium [GO:0031514]; nuclear envelope [GO:0005635]; sperm flagellum [GO:0036126]; identical protein binding [GO:0042802]; cilium organization [GO:0044782]; left/right axis specification [GO:0070986]; meiotic cell cycle [GO:0051321]; positive regulation of cilium assembly [GO:0045724]; sperm axoneme assembly [GO:0007288]	identical protein binding [GO:0042802]	GO:0005635; GO:0005882; GO:0005930; GO:0007288; GO:0031514; GO:0036126; GO:0042802; GO:0044782; GO:0045724; GO:0051321; GO:0070986	NVNSQIR	9.090000153	0.441634655	0.441634655	0.188864079	831.4321229	17.41646	0	17.04546	0	0	0	0	0	0	0	0	0	15.59667	15.40244	13.76688	13.24318	0	0	0	0	14.23039	0	0	15.30019	0	0	13.70716	16.44637	14.63268	0	0	0	0	14.28205	11.38293	0	0	0	0	16.84732	0	0	14.25938	0	15.39912	16.41278	0	0
Q8NEK8	TET5D_HUMAN	"Terminal nucleotidyltransferase 5D, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46D)"	TENT5D FAM46D	Homo sapiens (Human)	mRNA stabilization [GO:0048255]		polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; mRNA stabilization [GO:0048255]	polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]	GO:0004652; GO:0048255; GO:1990817	GSNGMS	7.820000172	1	1	0.198799966	568.3145053	0	0	16.486	17.34215	17.87832	0	0	15.44971	0	0	0	0	0	15.10096	0	0	14.07846	15.23223	0	0	0	0	0	0	0	0	0	13.48452	16.09915	0	17.08894	0	16.35111	15.21313	0	0	0	18.40761	0	0	0	15.94648	0	0	0	0	0	0
Q8NEL9	DDHD1_HUMAN	"Phospholipase DDHD1, EC 3.1.1.- (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1 homolog, PA-PLA1)"	DDHD1 KIAA1705	Homo sapiens (Human)	lipid catabolic process [GO:0016042]; positive regulation of mitochondrial fission [GO:0090141]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]; positive regulation of mitochondrial fission [GO:0090141]	metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]	GO:0004620; GO:0005737; GO:0005829; GO:0016042; GO:0046872; GO:0090141	NTAMMR	9.680000305	1	1	0.297416368	740.147996	0	0	15.04717	0	0	0	0	0	0	0	0	0	17.81066	0	0	0	16.88453	0	0	15.94827	0	0	17.21468	0	0	0	0	0	0	0	0	0	17.83278	0	18.21638	0	20.17542	0	19.82649	18.54577	18.67738	15.99037	18.63023	17.41784	19.37386	19.25798	19.01054	19.34033
Q8NEM2	SHCBP_HUMAN	SHC SH2 domain-binding protein 1	SHCBP1	Homo sapiens (Human)	fibroblast growth factor receptor signaling pathway [GO:0008543]; regulation of neural precursor cell proliferation [GO:2000177]	cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]	cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; SH2 domain binding [GO:0042169]; fibroblast growth factor receptor signaling pathway [GO:0008543]; regulation of neural precursor cell proliferation [GO:2000177]	SH2 domain binding [GO:0042169]	GO:0005737; GO:0005819; GO:0008543; GO:0030496; GO:0042169; GO:2000177	MADGSLTGGGLEAAAMAPER	1.980000019	1	1	0.185094315	1920.140838	15.65547	0	0	15.72168	15.24184	0	0	11.92011	0	0	0	0	12.66616	0	0	0	0	0	15.1453	0	0	0	0	0	0	0	0	0	0	0	0	0	15.99199	0	0	0	0	0	0	0	17.52846	14.68808	13.98569	0	16.0802	0	0	0
Q8NEM7	SP20H_HUMAN	"Transcription factor SPT20 homolog (p38-interacting protein, p38IP)"	SUPT20H C13orf19 FAM48A FP757	Homo sapiens (Human)	"autophagy [GO:0006914]; gastrulation [GO:0007369]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]"	SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]	"SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; transcription coregulator activity [GO:0003712]; autophagy [GO:0006914]; gastrulation [GO:0007369]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]"	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0003712; GO:0006282; GO:0006357; GO:0006914; GO:0007369; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0070461	HRPPPIK	1.299999952	1	1	0.22160242	843.5920047	0	0	0	0	0	0	17.29598	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NEM8	CBPC3_HUMAN	"Cytosolic carboxypeptidase 3, EC 3.4.17.- (ATP/GTP-binding protein-like 3) (Protein deglutamylase CCP3)"	AGBL3 CCP3	Homo sapiens (Human)	protein side chain deglutamylation [GO:0035610]	cytosol [GO:0005829]	cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005829; GO:0008270; GO:0035610	ELEEMERHITLEK	4.429999828	0.445106298	0.445106298	0.267436619	1672.094458	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.66105	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NEP3	DAAF1_HUMAN	Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50)	DNAAF1 LRRC50	Homo sapiens (Human)	axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; left/right pattern formation [GO:0060972]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]	axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; dynein complex binding [GO:0070840]; axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; left/right pattern formation [GO:0060972]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]	dynein complex binding [GO:0070840]	GO:0000922; GO:0001947; GO:0003341; GO:0003356; GO:0005576; GO:0005737; GO:0005829; GO:0005886; GO:0005930; GO:0016607; GO:0030324; GO:0035469; GO:0036158; GO:0036159; GO:0044458; GO:0060271; GO:0060287; GO:0060972; GO:0070286; GO:0070840; GO:0071907; GO:0071910	MTKSSLQK	4.170000076	1	1	0.084215693	922.28491	0	0	0	0	0	0	0	0	14.50312	0	0	13.8544	0	0	0	0	0	0	0	0	0	0	0	0	15.18233	14.98226	16.98479	0	0	14.77894	14.21959	16.1332	14.99594	14.15825	14.37329	15.09683	0	0	16.11316	0	14.54833	13.04331	15.44312	10.18089	0	0	0	0
Q8NEP7	KLDC9_HUMAN	Kelch domain-containing protein 9 (Kelch/ankyrin repeat-containing cyclin A1-interacting protein)	KLHDC9 KARCA1	Homo sapiens (Human)			cyclin binding [GO:0030332]	cyclin binding [GO:0030332]	GO:0030332	MAVAVPPGR	4.199999809	1	1	0.213823044	912.6497782	0	15.39067	17.02141	16.38571	0	0	14.35446	14.91565	14.04488	16.84389	0	16.44771	0	14.6075	15.00245	0	16.3883	0	0	0	0	0	0	0	14.94851	17.94011	16.90215	15.28392	0	16.8954	0	0	0	0	0	0	18.67256	0	0	16.63674	18.04802	15.32562	0	15.89231	15.4298	0	0	0
Q8NEP9	ZN555_HUMAN	Zinc finger protein 555	ZNF555	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	EHVRMHPEDK	5.070000172	1	1	1.38E-12	1276.262988	0	14.61155	12.82645	12.80772	0	12.76545	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.04794	0	14.43269	15.91576	12.98954	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NER1	TRPV1_HUMAN	"Transient receptor potential cation channel subfamily V member 1, TrpV1 (Capsaicin receptor) (Osm-9-like TRP channel 1, OTRPC1) (Vanilloid receptor 1)"	TRPV1 VR1	Homo sapiens (Human)	behavioral response to pain [GO:0048266]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to temperature stimulus [GO:0071502]; cellular response to tumor necrosis factor [GO:0071356]; chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; diet induced thermogenesis [GO:0002024]; fever generation [GO:0001660]; glutamate secretion [GO:0014047]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; negative regulation of establishment of blood-brain barrier [GO:0090212]; negative regulation of heart rate [GO:0010459]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide secretion [GO:0002790]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]; response to peptide hormone [GO:0043434]; sensory perception of mechanical stimulus [GO:0050954]; smooth muscle contraction involved in micturition [GO:0060083]; thermoception [GO:0050955]	cytosol [GO:0005829]; dendritic spine membrane [GO:0032591]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	cytosol [GO:0005829]; dendritic spine membrane [GO:0032591]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; chloride channel regulator activity [GO:0017081]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphoprotein binding [GO:0051219]; temperature-gated ion channel activity [GO:0097603]; transmembrane signaling receptor activity [GO:0004888]; voltage-gated calcium channel activity [GO:0005245]; behavioral response to pain [GO:0048266]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to temperature stimulus [GO:0071502]; cellular response to tumor necrosis factor [GO:0071356]; chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; diet induced thermogenesis [GO:0002024]; fever generation [GO:0001660]; glutamate secretion [GO:0014047]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; negative regulation of establishment of blood-brain barrier [GO:0090212]; negative regulation of heart rate [GO:0010459]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide secretion [GO:0002790]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]; response to peptide hormone [GO:0043434]; sensory perception of mechanical stimulus [GO:0050954]; smooth muscle contraction involved in micturition [GO:0060083]; thermoception [GO:0050955]	ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; chloride channel regulator activity [GO:0017081]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphoprotein binding [GO:0051219]; temperature-gated ion channel activity [GO:0097603]; transmembrane signaling receptor activity [GO:0004888]; voltage-gated calcium channel activity [GO:0005245]	GO:0000122; GO:0001660; GO:0001774; GO:0002024; GO:0002790; GO:0003085; GO:0004888; GO:0005216; GO:0005230; GO:0005231; GO:0005245; GO:0005262; GO:0005516; GO:0005524; GO:0005739; GO:0005829; GO:0005886; GO:0005887; GO:0006629; GO:0007166; GO:0007635; GO:0009897; GO:0010459; GO:0010917; GO:0014047; GO:0015278; GO:0016021; GO:0017081; GO:0031226; GO:0032591; GO:0034605; GO:0035091; GO:0042802; GO:0043025; GO:0043065; GO:0043434; GO:0045211; GO:0045429; GO:0046872; GO:0048266; GO:0050954; GO:0050955; GO:0050960; GO:0050965; GO:0050968; GO:0051219; GO:0051289; GO:0060083; GO:0060454; GO:0070588; GO:0071312; GO:0071318; GO:0071356; GO:0071468; GO:0071502; GO:0090212; GO:0097603; GO:0098703; GO:1901594; GO:1990090	KGMTPLALAAGTGK	11.27999973	0.158562258	0.158562258	0.035652493	1332.932016	0	0	14.31754	0	0	0	0	11.6694	10.20918	11.67764	13.14045	9.606188	13.10164	0	0	12.64872	0	0	12.62376	0	0	0	0	0	0	14.83058	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.51879	0
Q8NET4	RTL9_HUMAN	Retrotransposon Gag-like protein 9 (Retrotransposon gag domain-containing protein 1) (Tumor antigen BJ-HCC-23)	RTL9 KIAA1318 RGAG1	Homo sapiens (Human)						GMSTPLMRASGPGTMSTPQTAFGVMSTPEIK	6.340000153	1	1	0.017125822	3200.539291	0	11.90969	15.78876	0	0	14.79406	0	0	0	13.40843	0	0	12.35103	13.76978	0	13.43736	0	11.5402	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.07898
Q8NET6	CHSTD_HUMAN	"Carbohydrate sulfotransferase 13, EC 2.8.2.5 (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3, C4ST-3, C4ST3)"	CHST13	Homo sapiens (Human)	carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166]	chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756	AYLAFLFVR	8.399999619	1	1	9.21E-13	1101.414506	15.36575	5.492909	15.40907	0	16.75423	0	0	0	13.6731	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.41224	0	0	0	0	0	0	15.91895	0	15.14166	0	0	0	0	0	14.86737	0	0	0	0	0	0	0	0	0
Q8NET8	TRPV3_HUMAN	"Transient receptor potential cation channel subfamily V member 3, TrpV3 (Vanilloid receptor-like 3, VRL-3)"	TRPV3	Homo sapiens (Human)	calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; negative regulation of hair cycle [GO:0042636]; positive regulation of calcium ion import [GO:0090280]; response to heat [GO:0009408]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; negative regulation of hair cycle [GO:0042636]; positive regulation of calcium ion import [GO:0090280]; response to heat [GO:0009408]	calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]	GO:0005216; GO:0005262; GO:0005886; GO:0005887; GO:0009408; GO:0042636; GO:0042802; GO:0043235; GO:0070588; GO:0090280; GO:0098703	TDFNK	4.78000021	1	1	0.015636466	625.4186986	0	15.72658	14.87422	16.44158	14.04038	15.06451	0	0	0	0	0	0	16.15203	0	0	0	0	16.03606	0	0	0	0	0	0	16.16135	0	0	0	0	15.07503	15.86223	15.13529	14.84298	16.14301	14.99413	15.20822	17.07965	0	0	16.42124	0	0	0	15.51622	0	0	0	14.92534
Q8NEU8	DP13B_HUMAN	"DCC-interacting protein 13-beta, Dip13-beta (Adapter protein containing PH domain, PTB domain and leucine zipper motif 2)"	APPL2 DIP13B	Homo sapiens (Human)	"adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cold acclimation [GO:0009631]; diet induced thermogenesis [GO:0002024]; glucose homeostasis [GO:0042593]; negative regulation of cellular response to insulin stimulus [GO:1900077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of glucose import [GO:0046325]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of phagocytosis, engulfment [GO:0060100]; protein homotetramerization [GO:0051289]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of innate immune response [GO:0045088]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; early phagosome membrane [GO:0036186]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]	"cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; early phagosome membrane [GO:0036186]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cold acclimation [GO:0009631]; diet induced thermogenesis [GO:0002024]; glucose homeostasis [GO:0042593]; negative regulation of cellular response to insulin stimulus [GO:1900077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of glucose import [GO:0046325]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of phagocytosis, engulfment [GO:0060100]; protein homotetramerization [GO:0051289]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of innate immune response [GO:0045088]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]	GO:0001726; GO:0001786; GO:0002024; GO:0005634; GO:0005768; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0009631; GO:0010008; GO:0010762; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0031982; GO:0032009; GO:0032587; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0036186; GO:0042593; GO:0042802; GO:0042803; GO:0044354; GO:0044877; GO:0045088; GO:0046322; GO:0046325; GO:0050768; GO:0051289; GO:0060100; GO:0070062; GO:0120162; GO:1900016; GO:1900077; GO:1905303; GO:1905451; GO:2000045; GO:2000178	NSEMENENDKIVPK	5.179999828	1	1	0.387284172	1661.303767	13.19147	15.49439	16.43158	0	15.39372	15.26918	0	0	0	14.75555	0	14.7354	13.53652	0	0	0	0	0	0	0	0	0	0	16.73092	0	0	0	15.15441	0	0	13.94519	14.42503	0	0	0	0	0	0	0	13.83938	15.75949	0	0	16.1885	0	0	0	0
Q8NEV4	MYO3A_HUMAN	"Myosin-IIIa, EC 2.7.11.1"	MYO3A	Homo sapiens (Human)	cochlea morphogenesis [GO:0090103]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]	cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cochlea morphogenesis [GO:0090103]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000146; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0030175; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0050896; GO:0060002; GO:0090103; GO:0106310	HQRIVTTPTEVAR	5.670000076	1	1	6.91E-13	1507.8403	13.93275	14.32079	11.50212	0	0	13.99732	13.99254	0	15.70164	15.44184	0	0	14.90064	15.01159	0	0	0	15.21776	0	15.15746	16.4905	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.40779	0	0	0	0	0	0	0	0	0	0	0
Q8NEV8	EXPH5_HUMAN	"Exophilin-5 (Synaptotagmin-like protein homolog lacking C2 domains b, SlaC2-b, Slp homolog lacking C2 domains b)"	EXPH5 KIAA0624 SLAC2B	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; keratinocyte development [GO:0003334]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]	endosome [GO:0005768]	endosome [GO:0005768]; small GTPase binding [GO:0031267]; intracellular protein transport [GO:0006886]; keratinocyte development [GO:0003334]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]	small GTPase binding [GO:0031267]	GO:0003334; GO:0005768; GO:0006886; GO:0031267; GO:0045921; GO:0050714; GO:0071985	KGPLPFLINR	7.329999924	1	1	0.263171207	1154.27854	14.19921	0	14.69212	0	0	16.02612	0	14.10534	14.16208	13.75776	15.45801	0	0	0	0	13.18834	0	0	15.91179	0	0	15.66417	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.93643	0	0	15.1389	0	15.60572	0	0	0
Q8NEX5	WFDC9_HUMAN	Protein WFDC9	WFDC9 WAP9	Homo sapiens (Human)	antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0004867; GO:0005615; GO:0019731; GO:0045087	DPFLDMIR	6.150000095	1	1	0.099906957	1023.083789	0	12.08151	16.88982	16.26308	15.21951	0	0	0	13.50287	14.28966	16.62698	0	0	15.19003	13.59065	17.09389	15.81645	15.169	0	0	0	16.25665	15.49303	15.80898	17.49951	0	0	14.69031	15.92667	14.44563	14.29123	17.42895	13.3183	15.00131	15.16463	16.57999	16.42481	0	14.02149	16.5933	15.89666	13.16254	14.63058	16.37166	9.923353	16.60618	17.49308	0
Q8NEY1	NAV1_HUMAN	"Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1, unc53H1)"	NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1	Homo sapiens (Human)	microtubule bundle formation [GO:0001578]; nervous system development [GO:0007399]; neuron migration [GO:0001764]	axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule bundle formation [GO:0001578]; nervous system development [GO:0007399]; neuron migration [GO:0001764]		GO:0001578; GO:0001764; GO:0005737; GO:0005874; GO:0007399; GO:0015630; GO:0043194	APGGGGGMAK	3.599999905	1	1	5.76E-13	802.6318919	0	0	0	0	0	0	0	0	0	10.99452	15.6815	0	13.13608	14.32478	15.25889	0	0	0	0	15.60787	14.06418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.47449	0	0	0	14.18081	0	0	0
Q8NEY8	PPHLN_HUMAN	"Periphilin-1 (CDC7 expression repressor, CR) (Gastric cancer antigen Ga50)"	PPHLN1 HSPC206 HSPC232	Homo sapiens (Human)	"keratinization [GO:0031424]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]"	chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	"chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; keratinization [GO:0031424]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]"	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005694; GO:0005794; GO:0005829; GO:0031424; GO:0045814; GO:0045892; GO:0090309; GO:0097355	SFSHDR	5.949999809	1	1	0.203299758	748.5522722	0	15.54238	14.8978	8.947333	0	0	0	14.41513	0	14.64917	14.50319	0	0	0	15.00928	14.68614	0	0	15.34783	15.56234	0	0	15.41196	0	15.34428	0	0	15.50184	0	0	0	0	0	0	0	0	0	0	15.00683	0	0	0	0	0	0	0	0	0
Q8NEZ2	VP37A_HUMAN	"Vacuolar protein sorting-associated protein 37A, hVps37A (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1)"	VPS37A HCRP1	Homo sapiens (Human)	macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]	centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]		GO:0000813; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043231	MSWLFPLTK	4.980000019	1	1	0.530551583	1122.25535	0	0	0	0	0	0	19.11779	0	0	0	0	0	0	0	0	19.19706	0	0	0	17.65599	0	17.87271	0	0	0	0	0	0	0	0	0	0	0	0	0	17.99211	17.35271	0	0	19.82345	0	0	18.84933	0	0	0	0	0
Q8NEZ3	WDR19_HUMAN	WD repeat-containing protein 19 (Intraflagellar transport 144 homolog)	WDR19 IFT144 KIAA1638	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein-containing complex assembly [GO:0065003]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]	ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein-containing complex assembly [GO:0065003]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]		GO:0000902; GO:0001701; GO:0001750; GO:0005737; GO:0005856; GO:0005929; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060830; GO:0060831; GO:0061055; GO:0065003; GO:0097542; GO:0097730; GO:1903441	RIGNVGIVMSLEQIK	3.180000067	0.501076579	0.501076579	0.02356078	1657.845046	14.88896	0	16.18907	0	0	0	0	0	0	19.61828	0	16.28818	0	0	14.9707	16.62466	0	15.39224	0	17.17333	0	16.86601	16.36447	15.65658	0	0	17.85735	13.97132	0	0	0	18.70383	0	0	0	0	17.21986	0	14.59078	0	15.71649	0	0	0	0	0	17.56328	0
Q8NEZ4	KMT2C_HUMAN	"Histone-lysine N-methyltransferase 2C, Lysine N-methyltransferase 2C, EC 2.1.1.364 (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)"	KMT2C HALR KIAA1506 MLL3	Homo sapiens (Human)	chromatin organization [GO:0006325]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]	acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045944; GO:0046872; GO:0051568; GO:0097692	ADVFQR	4.5	1	1	0.131866863	732.3771183	0	0	0	0	0	15.50803	0	0	0	0	0	0	16.18375	0	0	0	0	0	0	0	0	0	0	0	16.24019	14.70973	15.18888	0	14.84499	0	0	15.34075	16.04069	17.68525	16.73535	0	0	0	0	0	0	0	0	0	0	16.07768	0	0
Q8NF37	PCAT1_HUMAN	"Lysophosphatidylcholine acyltransferase 1, LPC acyltransferase 1, LPCAT-1, LysoPC acyltransferase 1, EC 2.3.1.23 (1-acylglycerol-3-phosphate O-acyltransferase, EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase, EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase, EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase, Acetyl-CoA:lyso-PAF acetyltransferase, Lyso-PAF acetyltransferase, LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3)"	LPCAT1 AYTL2 PFAAP3	Homo sapiens (Human)	negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129]	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]	azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0050200]; negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0050200]	GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006654; GO:0008654; GO:0016020; GO:0016021; GO:0035577; GO:0036148; GO:0036151; GO:0043129; GO:0045732; GO:0047144; GO:0047159; GO:0047184; GO:0047191; GO:0047192; GO:0050200; GO:0060041; GO:2001246	GLGLKPEK	14.52000046	1	1	0.575489005	842.6974802	0	0	0	0	0	0	0	0	0	0	0	0	0	16.5589	19.88791	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.45571	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NF50	DOCK8_HUMAN	Dedicator of cytokinesis protein 8	DOCK8	Homo sapiens (Human)	cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001771; GO:0005085; GO:0005737; GO:0005829; GO:0007264; GO:0016020; GO:0031252; GO:0031256; GO:0031258; GO:0036336; GO:0043547; GO:0051056; GO:0061485; GO:0070233; GO:1903905; GO:1990869; GO:2000406	ENEQAEK	23.67000008	1	1	0.249302092	844.8450653	0	17.90007	0	0	0	16.83732	15.5556	16.86524	0	0	15.05281	0	12.50084	14.75109	0	14.87184	0	0	0	18.45702	0	15.85641	15.43582	16.40111	0	0	14.90339	0	0	15.48558	14.48267	17.19968	17.0539	0	16.70047	0	18.42102	0	0	0	0	0	15.81669	0	13.87631	15.78706	0	16.75505
Q8NF64	ZMIZ2_HUMAN	Zinc finger MIZ domain-containing protein 2 (PIAS-like protein Zimp7)	ZMIZ2 KIAA1886 ZIMP7 HRIHFB2007	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear receptor coactivator activity [GO:0030374]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008270; GO:0030374; GO:0043596; GO:0045944	EEPDGPALK	3.079999924	1	1	0.085378641	955.1406314	13.74116	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.06172	15.50732	0	13.99799	0	15.57289	0	0	0	0	0	0	0	15.75631	0	0	14.44702	0	0	11.29079
Q8NF86	PRS33_HUMAN	"Serine protease 33, EC 3.4.21.- (Serine protease EOS)"	PRSS33	Homo sapiens (Human)	protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0070528	GDLALLQLRRPVPLSAR	2.900000095	1	1	4.72E-13	1874.08094	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38649	0	0	0	18.78081	0	0	0	0	0	0	0	0	0	0	0
Q8NF91	SYNE1_HUMAN	"Nesprin-1 (Enaptin) (KASH domain-containing protein 1, KASH1) (Myocyte nuclear envelope protein 1, Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1, Syne-1)"	SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1	Homo sapiens (Human)	Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090292; GO:0140444	AATNK	3.519999981	0.001509666	0.001509666	0.131357449	503.2945446	16.83229	16.78294	16.14368	16.5942	0	16.22338	17.86131	17.52398	16.9987	16.86116	17.02152	16.37874	16.59636	16.23844	15.79686	16.05587	16.807	17.30902	16.75058	17.71894	16.60917	16.66774	16.72951	17.38396	16.06288	15.87855	16.63404	16.06478	16.60367	16.16417	16.746	17.04929	16.89365	16.98079	17.33525	16.96665	17.98638	16.93803	16.2381	17.03914	17.51138	17.21984	16.63986	17.87624	16.65922	16.76388	17.14224	15.41209
Q8NF99	ZN397_HUMAN	Zinc finger protein 397 (Zinc finger and SCAN domain-containing protein 15) (Zinc finger protein 47)	ZNF397 ZNF47 ZSCAN15	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0015630; GO:0042803; GO:0045892; GO:0046872; GO:0046982	AFRQSSELITHQR	9.829999924	1	1	0.133906164	1573.385442	14.83858	14.53283	14.46523	13.48164	7.4904	0	13.11041	0	14.92253	13.54814	14.9072	0	15.67008	14.84018	10.64579	14.58387	0	0	0	14.50165	0	0	14.89546	0	14.34208	11.0407	0	15.23449	12.11979	0	15.16201	0	0	0	14.24981	0	0	16.14039	0	12.94833	14.54572	0	0	0	9.518812	0	0	13.9061
Q8NFD5	ARI1B_HUMAN	"AT-rich interactive domain-containing protein 1B, ARID domain-containing protein 1B (BRG1-associated factor 250b, BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2, hOsa2) (p250R)"	ARID1B BAF250B DAN15 KIAA1235 OSA2	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514]	"bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]	GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819	GSPVSSLPAVGK	6.269999981	0.470381796	0.470381796	0.20130312	1097.855774	0	14.65783	0	0	14.4249	0	0	0	0	0	0	0	0	0	16.5443	13.7941	0	0	14.04479	0	12.91846	16.22812	12.42375	14.79718	15.32537	14.12585	14.26219	15.63279	15.77524	0	15.91773	14.98485	14.08384	16.12495	15.21688	0	12.82899	14.8306	14.46456	0	0	15.94613	0	11.37861	0	15.19205	15.66485	11.95225
Q8NFF2	NCKX4_HUMAN	Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4)	SLC24A4 NCKX4	Homo sapiens (Human)	amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; ion transport [GO:0006811]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signaling receptor activity [GO:0010469]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]	apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	"apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]; amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; ion transport [GO:0006811]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signaling receptor activity [GO:0010469]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]"	"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]"	GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010469; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834	TASASK	1.929999948	1	1	0.241888951	563.9608179	0	21.02821	0	0	0	0	0	0	0	0	17.14021	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.88233	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NFF5	FAD1_HUMAN	"FAD synthase, EC 2.7.7.2 (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region ]"	FLAD1 PP591	Homo sapiens (Human)	FAD biosynthetic process [GO:0006747]; riboflavin metabolic process [GO:0006771]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; identical protein binding [GO:0042802]; FAD biosynthetic process [GO:0006747]; riboflavin metabolic process [GO:0006771]	ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; identical protein binding [GO:0042802]	GO:0003919; GO:0005524; GO:0005759; GO:0005829; GO:0005886; GO:0006747; GO:0006771; GO:0042802	GWDLGTRLFQR	15.19999981	1	1	0.518311199	1350.083004	15.9979	16.10444	0	0	0	0	0	0	0	17.22528	0	0	0	18.78345	0	0	0	0	17.53756	0	0	17.8359	0	16.37481	18.85331	0	0	0	0	18.73724	0	18.84978	0	17.84152	0	0	18.63506	0	0	0	16.71599	0	0	16.1385	0	0	0	0
Q8NFG4	FLCN_HUMAN	Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein)	FLCN BHD	Homo sapiens (Human)	cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]	GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0009267; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0032465; GO:0034198; GO:0035024; GO:0035065; GO:0043065; GO:0043547; GO:0044877; GO:0045785; GO:0045944; GO:0046578; GO:0051898; GO:0070373; GO:0072686; GO:0097009; GO:0120163; GO:1900181; GO:1901723; GO:1901856; GO:1901859; GO:1901862; GO:1901874; GO:1903444; GO:1904263; GO:2000973; GO:2001170; GO:2001244	KLPVFK	1.019999981	0.391373783	0.391373783	0.05423108	730.7076445	14.4823	15.43186	0	16.99547	17.46952	0	14.08097	16.43572	16.41241	8.712402	15.59443	14.2198	14.17043	15.35854	16.12217	0	15.89996	15.35355	16.98906	0	17.18595	16.72658	14.96471	16.5554	17.07405	0	16.73952	16.02037	0	16.4654	14.55462	14.21562	15.47435	0	15.82368	16.38899	17.62482	16.69023	16.95373	15.70837	16.05696	0	15.53003	15.65936	16.64143	0	13.41538	16.10228
Q8NFH5	NUP35_HUMAN	"Nucleoporin NUP35 (35 kDa nucleoporin) (Mitotic phosphoprotein 44, MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53)"	NUP35 MP44 NUP53	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; regulation of transcription, DNA-templated [GO:0006355]"	identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]	GO:0003697; GO:0005543; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0006607; GO:0006913; GO:0006999; GO:0017056; GO:0031965; GO:0042802; GO:0044613; GO:0044615; GO:0051028; GO:1990830	YQSKLQAR	2.420000076	1	1	0.17013241	993.9117038	15.40211	15.42807	14.58221	15.84097	0	0	0	12.5654	0	0	0	13.8744	0	0	16.24894	0	14.98881	0	12.66291	16.00114	0	16.37539	14.50047	0	0	0	15.06321	0	0	14.64022	0	15.68276	0	15.7064	8.467731	12.69609	0	15.94253	0	0	12.46004	0	0	13.47251	10.84836	12.66245	11.30933	0
Q8NFI3	ENASE_HUMAN	"Cytosolic endo-beta-N-acetylglucosaminidase, ENGase, EC 3.2.1.96"	ENGASE	Homo sapiens (Human)	protein deglycosylation [GO:0006517]; protein folding [GO:0006457]	cytosol [GO:0005829]	"cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; protein deglycosylation [GO:0006517]; protein folding [GO:0006457]"	"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]"	GO:0004553; GO:0005829; GO:0006457; GO:0006517; GO:0033925	MEAAAVTVTR	4.309999943	1	1	0.100413298	1065.89916	0	14.54214	0	12.1247	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.44391	0	0	0	0	15.45586	0	0	0	0	0	14.99616	16.20036	15.7591	0	0	0	0	0	15.55028	0	0	0	0	0	0	0	0	0
Q8NFJ8	BHE22_HUMAN	"Class E basic helix-loop-helix protein 22, bHLHe22 (Class B basic helix-loop-helix protein 5, bHLHb5) (Trinucleotide repeat-containing gene 20 protein)"	BHLHE22 BHLHB5 TNRC20	Homo sapiens (Human)	neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0046983; GO:1990837	AGVADPR	5.03000021	1	1	0.113127171	683.9595941	16.20355	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.27331	0	0	0	16.09223	0	0	0	15.51136	0	0	0	0	0	0	0	0	0	0	14.56098	0	0	0	0	0	0
Q8NFJ9	BBS1_HUMAN	Bardet-Biedl syndrome 1 protein (BBS2-like protein 2)	BBS1 BBS2L2	Homo sapiens (Human)	cilium assembly [GO:0060271]; Golgi to plasma membrane protein transport [GO:0043001]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein localization to cilium [GO:0061512]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]	axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]	axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; patched binding [GO:0005113]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; smoothened binding [GO:0005119]; cilium assembly [GO:0060271]; Golgi to plasma membrane protein transport [GO:0043001]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein localization to cilium [GO:0061512]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]	patched binding [GO:0005113]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; smoothened binding [GO:0005119]	GO:0005113; GO:0005119; GO:0005813; GO:0005829; GO:0005930; GO:0007601; GO:0007608; GO:0034464; GO:0043001; GO:0045494; GO:0050896; GO:0060170; GO:0060271; GO:0061512; GO:0061629; GO:1905515	EMLESIRETAEEPLSIQSLR	3.309999943	1	1	0.216550771	2346.273528	10.65773	15.23608	0	12.32378	0	0	0	0	0	0	11.88912	0	0	0	0	14.21081	0	0	0	0	15.02446	0	0	0	0	12.31498	0	0	0	0	0	0	0	0	0	0	12.44621	17.08439	0	13.37011	13.06472	0	0	0	8.558591	0	13.87519	0
Q8NFK1	CXG3_HUMAN	"Gap junction gamma-3 protein (Connexin-30.2, Cx30.2) (Connexin-31.3, Cx31.3) (Gap junction epsilon-1 protein)"	GJC3 GJE1	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; myelination [GO:0042552]; sensory perception of sound [GO:0007605]	connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]	connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; cell-cell signaling [GO:0007267]; myelination [GO:0042552]; sensory perception of sound [GO:0007605]	gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]	GO:0005243; GO:0005922; GO:0007267; GO:0007605; GO:0016021; GO:0042552; GO:0042802; GO:0043209	LLLPVLLGFR	4.090000153	1	1	0.002349562	1141.843946	14.09025	14.20674	0	0	0	10.69138	13.63056	0	13.56683	13.16936	15.00009	15.65909	14.42037	14.13124	16.93699	0	14.25676	0	15.24864	0	0	14.10416	15.97147	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NFL0	B3GN7_HUMAN	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7, BGnT-7, Beta-1,3-Gn-T7, Beta-1,3-N-acetylglucosaminyltransferase 7, Beta3Gn-T7, EC 2.4.1.-"	B3GNT7	Homo sapiens (Human)	keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]"	"acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]"	GO:0000139; GO:0008194; GO:0008375; GO:0008499; GO:0008532; GO:0016021; GO:0016266; GO:0016757; GO:0018146; GO:0030311	LLPPELLAMWGLVHSNLTCSR	16.56999969	0.472982943	0.472982943	4.57E-12	2422.482771	0	0	0	18.43822	0	0	19.50761	18.87553	17.43143	0	18.30763	19.04647	0	0	0	0	0	0	0	0	0	18.1855	19.97136	20.47799	0	0	17.90029	18.57334	0	0	0	18.30241	0	17.95319	0	18.53872	0	0	0	0	0	18.51382	0	18.23251	18.37653	19.26471	0	0
Q8NFN8	GP156_HUMAN	Probable G-protein coupled receptor 156 (G-protein coupled receptor PGR28) (GABAB-related G-protein coupled receptor)	GPR156 GABABL PGR28	Homo sapiens (Human)	gamma-aminobutyric acid signaling pathway [GO:0007214]	G protein-coupled receptor heterodimeric complex [GO:0038039]; plasma membrane [GO:0005886]	G protein-coupled receptor heterodimeric complex [GO:0038039]; plasma membrane [GO:0005886]; G protein-coupled GABA receptor activity [GO:0004965]; transmembrane signaling receptor activity [GO:0004888]; gamma-aminobutyric acid signaling pathway [GO:0007214]	G protein-coupled GABA receptor activity [GO:0004965]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004965; GO:0005886; GO:0007214; GO:0038039	MEPEINCSELCDSFPGQELDR	5.449999809	1	1	0.012467689	2541.218602	0	0	0	0	0	13.47117	0	0	0	14.78231	0	14.60303	0	0	0	15.01023	0	13.92433	15.97302	0	0	0	0	0	0	15.3349	0	14.03279	14.11259	0	0	0	16.20079	0	0	0	0	0	0	0	15.92541	0	0	0	0	0	0	0
Q8NFP4	MDGA1_HUMAN	"MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (GPI and MAM protein, GPIM) (Glycosylphosphatidylinositol-MAM) (MAM domain-containing protein 3)"	MDGA1 MAMDC3	Homo sapiens (Human)	brain development [GO:0007420]; cerebral cortex radially oriented cell migration [GO:0021799]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; spinal cord association neuron differentiation [GO:0021527]	anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; brain development [GO:0007420]; cerebral cortex radially oriented cell migration [GO:0021799]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; spinal cord association neuron differentiation [GO:0021527]		GO:0001764; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0007399; GO:0007420; GO:0021527; GO:0021799; GO:0046658; GO:0098982; GO:0099179; GO:1905606	LTPYTTFGAGDMASR	7.21999979	1	1	0.247850461	1603.59025	14.6973	11.66523	15.17999	0	0	14.29731	0	12.92264	10.99225	14.24833	0	14.44268	9.25215	0	14.8856	15.68102	0	0	0	0	0	0	0	0	0	14.61962	0	0	0	0	0	0	0	0	16.76035	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NFP9	NBEA_HUMAN	Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B)	NBEA BCL8B KIAA1544 LYST2	Homo sapiens (Human)	protein localization [GO:0008104]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; protein kinase binding [GO:0019901]; protein localization [GO:0008104]	protein kinase binding [GO:0019901]	GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901	DTSDVK	1.799999952	0.990711451	0.990711451	0.280090805	662.5337292	0	0	18.15756	0	17.39282	0	16.90643	0	0	0	0	0	0	0	17.4579	0	0	0	0	15.93171	0	0	0	0	18.71161	0	0	0	0	16.49627	0	0	0	18.25069	17.144	17.48827	0	0	0	18.00024	0	0	0	0	16.49833	16.50208	0	0
Q8NFQ5	BPIB6_HUMAN	BPI fold-containing family B member 6 (Bactericidal/permeability-increasing protein-like 3)	BPIFB6 BPIL3	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; lipid binding [GO:0008289]	lipid binding [GO:0008289]	GO:0005576; GO:0008289	MAAEAGK	10.27000046	3.20E-05	3.20E-05	0.283148571	693.8333322	0	0	0	16.73659	17.96264	18.30388	0	17.29953	19.02755	18.93645	18.39841	17.04449	16.08658	18.44455	0	18.27237	18.34634	17.26943	18.7191	0	19.16801	18.71237	0	19.30984	18.44398	18.72579	17.441	19.50513	0	0	0	19.33245	0	19.19326	0	0	19.26633	18.343	20.18926	0	0	18.15337	18.58952	16.16792	0	0	0	0
Q8NFQ6	BPIFC_HUMAN	"BPI fold-containing family C protein (Bactericidal/permeability-increasing protein-like 2, BPI-like 2)"	BPIFC BPIL2	Homo sapiens (Human)		extracellular space [GO:0005615]	extracellular space [GO:0005615]; lipopolysaccharide binding [GO:0001530]; phospholipid binding [GO:0005543]	lipopolysaccharide binding [GO:0001530]; phospholipid binding [GO:0005543]	GO:0001530; GO:0005543; GO:0005615	LALPESNRSNIEVLR	1.090000033	1	1	0.462187871	1711.318315	0	0	0	0	0	0	0	0	18.624	0	0	0	0	0	0	18.13528	0	0	0	0	0	0	0	19.69074	0	20.91103	19.22031	0	19.31653	0	20.67903	0	0	0	18.89949	0	0	0	0	0	19.12045	19.54129	18.26544	0	0	0	21.04473	21.37416
Q8NFQ8	TOIP2_HUMAN	Torsin-1A-interacting protein 2 (Lumenal domain-like LAP1)	TOR1AIP2 IFRG15 LULL1	Homo sapiens (Human)	endoplasmic reticulum organization [GO:0007029]; membrane organization [GO:0061024]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; endoplasmic reticulum organization [GO:0007029]; membrane organization [GO:0061024]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]	ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]	GO:0001671; GO:0005783; GO:0005789; GO:0007029; GO:0016020; GO:0016021; GO:0031965; GO:0032781; GO:0051117; GO:0061024; GO:0090435	CLSHHVADAYTSSQK	2.390000105	0.054532997	0.054532997	0.353679412	1704.464782	14.06252	14.80276	0	16.30301	15.05524	0	0	13.86471	16.70971	14.28182	15.97595	15.90461	14.05404	0	0	0	0	0	0	0	0	0	0	0	0	17.04446	0	0	0	16.86955	16.90217	0	0	0	15.5504	0	0	0	0	0	0	0	0	0	0	0	12.5824	0
Q8NFR7	CC148_HUMAN	Coiled-coil domain-containing protein 148	CCDC148	Homo sapiens (Human)						ALTEAKK	8.779999733	1	1	0.261195744	760.7982797	0	0	19.27638	0	18.19016	0	0	0	18.7306	0	0	17.28347	16.7277	0	0	18.42081	0	17.10934	0	0	16.97689	0	0	0	0	17.15975	0	0	0	0	18.19583	0	0	19.1187	19.15662	0	20.31706	18.99152	18.09739	19.02224	0	18.27023	0	18.59643	17.20934	0	18.59297	0
Q8NFT2	STEA2_HUMAN	"Metalloreductase STEAP2, EC 1.16.1.- (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer, PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1)"	STEAP2 PCANAP1 STAMP1 UNQ6507/PRO23203	Homo sapiens (Human)	copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; iron ion import across plasma membrane [GO:0098711]; regulated exocytosis [GO:0045055]; response to hormone [GO:0009725]	cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]	cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; iron ion import across plasma membrane [GO:0098711]; regulated exocytosis [GO:0045055]; response to hormone [GO:0009725]	cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; metal ion binding [GO:0046872]	GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006893; GO:0006897; GO:0008823; GO:0009725; GO:0010008; GO:0015677; GO:0030140; GO:0030173; GO:0045055; GO:0046872; GO:0052851; GO:0098705; GO:0098711	ILIDVSNNMR	10.47999954	1	1	0.327487958	1189.725916	0	14.03991	15.62142	0	0	0	0	0	13.53302	0	0	15.54883	13.90599	15.84502	16.6741	0	15.31431	16.17974	16.27357	14.23085	15.93249	16.30998	0	0	16.83915	0	0	0	0	15.50519	16.60269	15.51264	14.72825	18.10252	17.31736	14.07175	18.00042	18.10086	0	0	0	16.26598	0	0	0	18.45825	18.33948	15.25269
Q8NFT6	DBF4B_HUMAN	"Protein DBF4 homolog B (Activator of S phase kinase-like protein 1, ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1)"	DBF4B ASKL1 DRF1	Homo sapiens (Human)	cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]	cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]	nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0007049; GO:0008270; GO:0008284; GO:0010571; GO:0010971; GO:0019901; GO:0030295; GO:0031431; GO:0043231; GO:0043539; GO:1901987	DGEPSPRSAAHTMPR	4.019999981	1	1	0.57070329	1625.634543	0	0	0	0	0	17.50962	0	0	0	0	0	0	0	0	18.51472	0	0	0	0	0	0	0	0	18.62142	0	0	17.33698	0	0	0	0	18.49844	0	0	0	0	17.82875	0	0	0	0	16.8931	16.74779	17.17129	0	0	0	0
Q8NFT8	DNER_HUMAN	Delta and Notch-like epidermal growth factor-related receptor	DNER BET UNQ262/PRO299	Homo sapiens (Human)	central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416]	dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416]	calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]	GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0016021; GO:0030276; GO:0030425; GO:0043025; GO:0048741	SIVALR	4.519999981	1	1	0.123053194	660.435788	14.17271	15.91707	0	15.86292	14.72667	0	0	0	11.91175	0	0	0	0	0	15.2533	0	0	0	0	0	0	0	16.96803	0	14.55289	0	0	14.57414	15.25955	0	14.47229	0	0	0	0	0	0	0	0	0	15.67718	14.48147	15.43088	0	15.93297	16.14933	15.8324	12.38243
Q8NFU3	TSTD1_HUMAN	"Thiosulfate:glutathione sulfurtransferase, TST, EC 2.8.1.-"	TSTD1 KAT	Homo sapiens (Human)	"glucose metabolic process [GO:0006006]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; thiosulfate-thiol sulfurtransferase activity [GO:0050337]; glucose metabolic process [GO:0006006]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; thiosulfate-thiol sulfurtransferase activity [GO:0050337]"	GO:0000981; GO:0003690; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0036464; GO:0042802; GO:0043565; GO:0044877; GO:0045944; GO:0048471; GO:0050337; GO:0070221	SLGYTGAR	12.26000023	1	1	0.356277169	823.2932257	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.41974	0	0	0	0	0	0	0	0	0
Q8NFU5	IPMK_HUMAN	"Inositol polyphosphate multikinase, EC 2.7.1.140, EC 2.7.1.151, EC 2.7.1.153 (Inositol 1,3,4,6-tetrakisphosphate 5-kinase)"	IPMK IMPK	Homo sapiens (Human)	inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]"	"ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]"	GO:0000823; GO:0000824; GO:0000825; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008440; GO:0016301; GO:0032957; GO:0032958; GO:0043647; GO:0046872; GO:0046934; GO:0047326; GO:0051765; GO:0052812; GO:0070266; GO:0097243; GO:0102732	MATEPPSPLRVEAPGPPEMR	5.519999981	1	1	0.211321632	2175.445407	15.68855	0	0	15.40332	0	14.95903	14.16647	15.41318	15.12376	15.36468	14.04283	0	0	0	0	0	15.70278	16.42665	0	0	0	16.30385	17.03812	16.20588	16.98438	0	15.36778	0	0	0	0	16.86296	17.60758	17.44016	15.34731	0	0	0	0	0	0	0	0	0	14.34899	14.77904	0	0
Q8NFU7	TET1_HUMAN	"Methylcytosine dioxygenase TET1, EC 1.14.11.n2 (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein)"	TET1 CXXC6 KIAA1676 LCX	Homo sapiens (Human)	5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oxidative demethylation [GO:0070989]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; stem cell population maintenance [GO:0019827]	nucleus [GO:0005634]; Sin3 complex [GO:0016580]	nucleus [GO:0005634]; Sin3 complex [GO:0016580]; DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oxidative demethylation [GO:0070989]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; stem cell population maintenance [GO:0019827]	DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]	GO:0000122; GO:0001826; GO:0003677; GO:0005506; GO:0005634; GO:0006211; GO:0006325; GO:0006493; GO:0008270; GO:0008284; GO:0008327; GO:0016580; GO:0019827; GO:0030336; GO:0030512; GO:0031062; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0090310; GO:1902455; GO:1902459	CGHGEEQK	1.039999962	1	1	0.321210742	945.3097356	14.32539	15.14054	15.54735	0	0	14.65171	0	14.86818	14.38973	0	0	15.37537	0	13.97256	14.91383	14.41559	0	14.98697	14.93949	0	0	13.62308	16.8454	15.54786	12.36149	0	0	14.70048	14.86125	10.32903	11.07561	15.39019	13.83595	15.87212	14.76313	13.9034	16.41491	13.14939	12.18577	16.25244	12.85061	0	0	0	0	12.4451	13.77504	16.6372
Q8NFV4	ABHDB_HUMAN	"Protein ABHD11, EC 3.-.-.- (Alpha/beta hydrolase domain-containing protein 11, Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein)"	ABHD11 WBSCR21 PP1226	Homo sapiens (Human)		mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; hydrolase activity [GO:0016787]	hydrolase activity [GO:0016787]	GO:0005739; GO:0016787	LADEQLSSVIQDMAVR	1.850000024	1	1	0.328795488	1791.612998	15.7836	0	12.43209	0	0	0	0	0	0	0	0	0	15.34381	0	14.46401	15.09686	11.19257	14.9936	0	16.6382	16.35332	0	0	0	0	0	0	13.22939	13.62303	14.75948	15.22681	14.61692	14.96237	0	11.96352	0	0	16.54107	0	13.34938	0	0	0	0	13.69905	0	0	0
Q8NFW1	COMA1_HUMAN	Collagen alpha-1(XXII) chain	COL22A1	Homo sapiens (Human)	angiogenesis [GO:0001525]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]	collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; angiogenesis [GO:0001525]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]	extracellular matrix structural constituent [GO:0005201]	GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030198; GO:0031012	DGPNGPPGPPGTK	4.239999771	1	1	0.149668323	1189.602777	12.61265	13.10002	12.73503	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.72435	0	11.02862	14.69984	0	0	13.07322	14.68239	0	13.72146	11.80851	14.28206	11.9969	10.00202	14.24112	0	14.37844	14.56867	13.8058	13.76041	12.05807	0	14.20025	0	13.89238	0	0	0	0	0
Q8NFW5	DMBX1_HUMAN	Diencephalon/mesencephalon homeobox protein 1 (Orthodenticle homolog 3) (Paired-like homeobox protein DMBX1)	DMBX1 MBX OTX3 PAXB	Homo sapiens (Human)	"adult feeding behavior [GO:0008343]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; central nervous system development [GO:0007417]; developmental growth [GO:0048589]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adult feeding behavior [GO:0008343]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; central nervous system development [GO:0007417]; developmental growth [GO:0048589]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007417; GO:0007420; GO:0008343; GO:0008344; GO:0042802; GO:0043565; GO:0045892; GO:0048589; GO:1990837	SRTAFTAQQLEALEK	4.820000172	1	1	9.20E-13	1693.893065	0	0	0	14.86062	0	0	0	0	14.31152	16.89529	0	0	0	0	0	0	0	0	0	15.30941	0	0	0	0	17.20343	16.72917	0	0	0	0	0	17.67082	0	0	0	0	0	0	16.87373	0	0	16.02549	0	0	0	0	0	0
Q8NFW8	NEUA_HUMAN	"N-acylneuraminate cytidylyltransferase, EC 2.7.7.43 (CMP-N-acetylneuraminic acid synthase, CMP-NeuNAc synthase)"	CMAS	Homo sapiens (Human)	N-acetylneuraminate metabolic process [GO:0006054]	membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acetylneuraminate metabolic process [GO:0006054]	N-acylneuraminate cytidylyltransferase activity [GO:0008781]	GO:0005634; GO:0005654; GO:0006054; GO:0008781; GO:0016020	MAYYEMR	6.239999771	1	1	3.45E-13	978.8071891	0	0	0	0	0	0	0	0	0	0	0	13.97961	16.849	0	0	0	16.06928	0	0	0	16.83921	17.44436	0	0	0	0	0	0	0	0	0	0	0	17.18506	0	19.18645	0	12.71785	0	0	0	0	0	0	0	0	0	17.9708
Q8NFW9	MYRIP_HUMAN	"Rab effector MyRIP (Exophilin-8) (Myosin-VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C, SlaC2-c, Slp homolog lacking C2 domains c)"	MYRIP SLAC2C	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; positive regulation of insulin secretion [GO:0032024]	cortical actin cytoskeleton [GO:0030864]; dense core granule [GO:0031045]; exocyst [GO:0000145]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202]; transport vesicle [GO:0030133]	cortical actin cytoskeleton [GO:0030864]; dense core granule [GO:0031045]; exocyst [GO:0000145]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; myosin binding [GO:0017022]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; intracellular protein transport [GO:0006886]; positive regulation of insulin secretion [GO:0032024]	actin binding [GO:0003779]; myosin binding [GO:0017022]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	GO:0000145; GO:0001750; GO:0003779; GO:0006886; GO:0008270; GO:0017022; GO:0030133; GO:0030864; GO:0031045; GO:0031267; GO:0032024; GO:0042470; GO:0045202; GO:0048471; GO:0051018	GMFPRGTDQVR	3.099999905	0.492906123	0.492906123	1.60E-12	1263.74219	16.37142	0	0	0	0	0	0	13.74736	14.27641	15.81882	0	0	0	0	0	11.62845	0	0	0	0	0	0	0	0	0	0	0	15.2958	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.29618	0	0	0
Q8NFY4	SEM6D_HUMAN	Semaphorin-6D	SEMA6D KIAA1479	Homo sapiens (Human)	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of smooth muscle cell migration [GO:0014911]; semaphorin-plexin signaling pathway [GO:0071526]; ventricular system development [GO:0021591]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of smooth muscle cell migration [GO:0014911]; semaphorin-plexin signaling pathway [GO:0071526]; ventricular system development [GO:0021591]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0005615; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0007411; GO:0009986; GO:0014911; GO:0014912; GO:0021591; GO:0030215; GO:0030335; GO:0030517; GO:0045499; GO:0048843; GO:0050919; GO:0071526	CSAENEEDKK	5.389999866	1	1	0.127178159	1209.245691	0	8.868517	13.53663	0	12.73383	12.38475	0	0	0	13.55896	0	0	15.7528	13.67217	12.0992	0	0	0	0	0	14.59213	0	13.84014	0	0	14.79234	0	15.0707	0	0	13.23471	0	17.77242	0	14.77832	0	0	0	0	0	0	0	0	0	0	15.43531	12.58132	15.21347
Q8NFY9	KBTB8_HUMAN	"Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein, TA-KRP)"	KBTBD8 KIAA1842 TAKRP	Homo sapiens (Human)	neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417]		GO:0005794; GO:0005819; GO:0005829; GO:0006417; GO:0006513; GO:0014029; GO:0014032; GO:0031463	LWDLGRHFECAVAK	4.559999943	1	1	0.212656195	1701.346141	17.81047	16.20069	14.24333	13.8747	13.57212	0	0	14.93298	0	14.63653	14.31041	0	13.2136	11.99834	0	15.61366	0	0	0	0	0	0	17.27962	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NFZ0	FBH1_HUMAN	"F-box DNA helicase 1, hFBH1, EC 3.6.4.12 (F-box only protein 18)"	FBH1 FBX18 FBXO18	Homo sapiens (Human)	"cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	"chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]"	3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042	QNLVIKDK	9.569999695	0.180544466	0.180544466	0.055398486	957.1214453	0	13.41236	0	15.67031	0	0	0	15.15823	11.71395	0	13.01319	14.48523	17.12663	16.14384	0	14.69755	17.55872	0	13.2687	14.30411	0	16.22692	16.70378	16.98477	0	0	11.21774	14.14145	13.61457	15.29074	17.2841	0	16.86562	15.52346	14.65314	13.20894	17.22706	15.59456	17.12142	12.6527	0	16.05796	14.71725	6.678573	16.04135	16.24435	15.83091	15.47727
Q8NFZ3	NLGNY_HUMAN	"Neuroligin-4, Y-linked, Neuroligin Y"	NLGN4Y KIAA0951	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]"	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"	cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099060	VGCNMLDTTDMVECLKNK	2.99000001	1	1	0.23604663	2143.300676	0	0	0	0	0	14.11641	0	0	13.60501	0	0	0	0	0	15.88236	0	0	0	15.705	13.18897	14.57611	0	0	0	0	14.94206	16.41014	14.88227	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.36883	17.88559	11.28819	0	0	14.08984
Q8NFZ4	NLGN2_HUMAN	Neuroligin-2	NLGN2 KIAA1366	Homo sapiens (Human)	"brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to cell surface [GO:0034394]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic transmission, GABAergic [GO:0051932]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]"	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]"	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to cell surface [GO:0034394]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic transmission, GABAergic [GO:0051932]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]"	cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]	GO:0001966; GO:0002087; GO:0005737; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007416; GO:0007420; GO:0007630; GO:0008284; GO:0009986; GO:0016020; GO:0019233; GO:0032024; GO:0032230; GO:0034394; GO:0035176; GO:0035418; GO:0035641; GO:0038023; GO:0042043; GO:0042734; GO:0042802; GO:0043198; GO:0045202; GO:0045211; GO:0045217; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0050885; GO:0051932; GO:0051965; GO:0051968; GO:0060076; GO:0060077; GO:0060999; GO:0072553; GO:0072578; GO:0089717; GO:0097104; GO:0097105; GO:0097116; GO:0097119; GO:0097151; GO:0097470; GO:0098609; GO:0098690; GO:0098691; GO:0098983; GO:0099054; GO:0099055; GO:0099060; GO:1901142; GO:1902474; GO:1904034; GO:1904862; GO:1905606; GO:2000311; GO:2000463; GO:2000809	DEATLNPPDTDIRDPGK	2.920000076	1	1	0.243177331	1853.972505	0	16.63039	18.08514	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NG08	HELB_HUMAN	"DNA helicase B, hDHB, EC 3.6.4.12"	HELB	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]"	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]	GO:0000462; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006260; GO:0006269; GO:0006281; GO:0006974; GO:0016887; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042	GGCGK	3.380000114	1	1	0.284707234	477.8352091	18.09105	0	17.19794	17.86814	19.22245	0	19.74823	0	0	0	18.38394	0	0	0	19.31128	18.5539	19.44123	16.70304	0	0	0	0	0	18.00004	0	20.48185	0	0	0	0	19.75352	17.25979	19.60422	18.17653	18.69807	0	19.01214	0	18.11659	18.84989	17.89977	0	0	0	0	19.0961	0	0
Q8NG27	PJA1_HUMAN	"E3 ubiquitin-protein ligase Praja-1, Praja1, EC 2.3.2.27 (RING finger protein 70) (RING-type E3 ubiquitin transferase Praja-1)"	PJA1 RNF70	Homo sapiens (Human)	protein catabolic process [GO:0030163]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein catabolic process [GO:0030163]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0030163; GO:0046872; GO:0061630	SLAGPPPHFSSFSR	6.260000229	0.004529997	0.004529997	0.148997712	1486.797081	17.50968	14.97254	16.96315	14.99164	15.08373	17.38585	11.68874	0	13.22956	15.06043	16.7263	15.32612	15.06034	13.45791	0	14.72903	15.10908	14.4026	10.85843	0	14.62359	15.65603	13.42908	15.35468	15.69998	0	12.79276	0	15.34239	13.30611	0	17.0361	12.35565	14.85127	0	15.16165	16.3298	14.36271	15.84142	10.61386	0	11.51586	0	0	15.26771	14.37462	16.78095	0
Q8NG48	LINES_HUMAN	Protein Lines homolog 1 (Wnt-signaling molecule Lines homolog 1)	LINS1 LINS WINS1	Homo sapiens (Human)	cognition [GO:0050890]		cognition [GO:0050890]		GO:0050890	AVMSK	3.470000029	1	1	0.183595044	552.3813725	14.82948	0	0	15.31588	15.97046	14.71075	15.88161	0	0	0	8.881319	0	14.6869	14.6602	16.22388	15.73207	15.955	15.387	0	14.43723	0	0	15.41516	0	0	0	0	15.18657	0	15.46939	0	0	0	0	0	16.04501	0	16.8064	0	0	15.96735	0	0	0	0	0	0	0
Q8NG66	NEK11_HUMAN	"Serine/threonine-protein kinase Nek11, EC 2.7.11.1 (Never in mitosis A-related kinase 11, NimA-related protein kinase 11)"	NEK11	Homo sapiens (Human)	chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006468; GO:0007059; GO:0016572; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990	EPTLQNHL	9.890000343	1	1	0.111888246	953.6622754	12.92837	0	15.95826	0	0	0	0	0	0	0	15.35704	14.62938	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41178	0	0	0	0	17.92368	0	0	0	0	0	0	16.26665	0	0	0	0	0	0	0	0	0
Q8NG75	OR5T1_HUMAN	Olfactory receptor 5T1 (Olfactory receptor OR11-179)	OR5T1 OR5T1P	Homo sapiens (Human)		integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005887	MQSAEGRR	5.420000076	0.685964525	0.685964525	0.074041043	934.6873291	17.6311	0	12.67325	0	16.26812	14.76192	13.18509	14.11683	13.71927	16.21432	16.26668	0	0	0	0	0	0	12.77489	17.12341	14.30555	14.17386	16.55249	13.7274	15.83719	16.37735	15.60963	13.98276	13.92009	0	0	0	17.42712	12.90001	17.26114	16.6895	13.22931	0	12.75928	0	12.82762	14.82635	13.90704	15.75925	0	16.78682	14.76453	12.0386	15.31806
Q8NG76	O2T33_HUMAN	Olfactory receptor 2T33 (Olfactory receptor OR1-56)	OR2T33	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	WLGTCVNIK	1.899999976	1	1	0.151684824	1088.881725	0	0	0	14.56538	0	0	0	0	14.89826	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.83287	0	0	0	0	13.35954	13.02647	15.91378	0	13.74636	13.79372	0	0	0	0	0	14.25971	0	0	0	0	0	14.26467
Q8NGA1	OR1M1_HUMAN	"Olfactory receptor 1M1 (Olfactory receptor 19-6, OR19-6) (Olfactory receptor OR19-5)"	OR1M1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	EKASAVMYTAVTPMLNPFIYSLR	2.970000029	1	1	5.03E-12	2617.283378	0	13.02523	12.24265	13.21406	0	13.55658	10.67101	14.30081	0	0	0	0	0	0	13.40513	14.0816	14.34037	14.96981	13.52529	0	0	0	0	0	0	0	15.41825	0	0	0	0	0	0	0	0	0	16.65932	0	0	0	15.49544	12.35192	13.07932	0	0	0	0	0
Q8NGB8	O4F15_HUMAN	Olfactory receptor 4F15 (Olfactory receptor OR15-14)	OR4F15	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	LAHFTKIL	8.779999733	1	1	0.227417826	942.2625169	0	15.23804	0	0	0	0	0	0	16.22638	16.49289	0	0	16.5484	0	0	0	0	14.56014	0	0	0	0	16.21954	15.05383	16.71303	0	0	15.62017	0	0	0	17.13464	0	0	0	0	0	0	16.12136	0	17.5756	0	0	0	15.01967	0	0	0
Q8NGC5	OR6J1_HUMAN	Olfactory receptor 6J1 (Olfactory receptor 6J2)	OR6J1 OR6J2	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	GVFEKR	7.170000076	0.194044396	0.194044396	0.153213938	735.3342086	16.79948	18.19866	0	0	0	0	0	0	15.82906	0	0	7.987227	18.14645	10.1449	15.46085	0	15.6041	0	17.08008	17.60282	0	0	16.23836	16.70794	13.43703	0	0	18.61351	16.82789	16.62255	16.26405	17.12563	16.95288	17.67579	15.88561	16.45444	0	0	0	0	0	0	18.17162	0	17.32549	16.52249	15.75324	17.30602
Q8NGE0	O10AD_HUMAN	Olfactory receptor 10AD1 (Olfactory receptor OR12-1)	OR10AD1 OR10AD1P	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	ALLFALFLALYSLTMAMNGLIIFITSWTDPK	3.420000076	0.921778977	0.921778977	0.178119335	3490.666333	14.85419	0	10.97891	0	0	0	0	0	0	0	13.30289	0	13.52953	0	0	13.98189	15.02766	11.26667	0	0	14.90282	0	0	8.408895	0	0	0	11.00037	15.69656	0	14.28996	14.41899	0	14.8048	13.6957	0	13.04743	14.14305	0	14.97531	0	0	0	0	0	0	0	0
Q8NGF1	O52R1_HUMAN	Olfactory receptor 52R1 (Olfactory receptor OR11-22)	OR52R1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	LVCADTSISR	6.420000076	0.390847802	0.390847802	0.330593202	1121.797941	0	0	0	0	0	0	15.96725	0	0	0	17.11238	0	0	0	20.33398	20.24526	19.20216	17.05758	15.90748	0	0	0	18.39412	19.56125	16.13074	0	16.72982	0	0	0	0	0	0	0	0	0	0	18.66831	0	0	0	0	0	0	17.50074	0	0	0
Q8NGF3	O51D1_HUMAN	Olfactory receptor 51D1 (Olfactory receptor OR11-14)	OR51D1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	IGLSALTR	8.31000042	1	1	1.19E-13	829.2351557	0	0	0	0	0	17.10092	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.36628	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NGI1	O56B2_HUMAN	Putative olfactory receptor 56B2	OR56B2P	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	LGVKGT	2.210000038	1	1	0.176708596	575.7382149	16.36747	16.12454	0	14.60522	0	0	0	0	0	0	15.09584	0	0	0	0	0	0	0	0	0	14.24031	0	0	0	0	17.00413	0	17.00078	16.36713	0	0	0	0	0	16.56419	0	0	0	0	16.28773	15.3515	0	0	0	0	0	0	0
Q8NGI3	O56B1_HUMAN	Olfactory receptor 56B1 (Olfactory receptor OR11-65)	OR56B1 OR56B1P	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	MNHMSASLKISNSSK	6.309999943	1	1	0.320722516	1650.345331	0	0	15.79328	0	14.96462	0	0	0	0	0	14.99745	0	0	15.11047	0	16.38164	0	0	16.34894	15.23111	16.46326	15.76836	0	0	16.41576	0	16.43023	17.25054	14.9321	0	16.21777	0	15.45526	0	0	0	0	0	0	17.6064	16.48664	0	17.15066	15.62852	0	16.4226	0	15.53041
Q8NGI4	OR4DB_HUMAN	Olfactory receptor 4D11	OR4D11 OR4D11P	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	ELGNVTRVK	1.870000005	1	1	0.29219027	1015.838973	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.15523	0	0	0	0	0	0	0	0	0	0	0	0	17.93426	0	0	0	0	0	15.27236	0	0	0	19.32884	0	0
Q8NGI9	OR5A2_HUMAN	Olfactory receptor 5A2 (Olfactory receptor OR11-248)	OR5A2	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021	EIKNAMR	6.159999847	0.4893336	0.4893336	0.199844897	862.687715	15.38357	13.95793	0	13.69495	15.08685	13.42162	0	13.10072	13.9891	15.03671	14.91651	0	17.07758	0	0	15.23267	15.41478	15.38731	14.50145	15.76304	15.33496	16.67469	15.12733	15.68598	0	0	0	0	16.07201	0	0	0	0	15.52128	0	0	0	15.82487	16.21099	16.46877	14.63034	0	0	15.24174	0	0	15.17472	16.52808
Q8NGJ0	OR5A1_HUMAN	Olfactory receptor 5A1 (OST181) (Olfactory receptor OR11-249)	OR5A1 OR5A1P	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021	YAAISSPLLYPTIMTQGLCTR	4.380000114	1	1	0.142341954	2371.763813	14.04268	15.94633	0	0	12.16449	11.68422	13.8958	10.94339	12.50282	12.94506	10.24326	4.075396	12.6254	9.157925	12.47514	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NGJ9	O51T1_HUMAN	Olfactory receptor 51T1 (Olfactory receptor OR11-26)	OR51T1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	TVLGIVARK	6.550000191	1	1	0.018601735	954.5096027	15.81598	14.89733	15.41636	0	0	15.53142	0	0	14.27465	0	0	0	14.62601	0	0	0	0	12.28496	14.28687	0	0	0	0	0	0	16.17681	0	17.63188	13.99879	15.08876	0	0	0	0	14.71841	0	0	0	0	0	0	0	0	0	0	15.99813	0	13.92397
Q8NGL3	OR5DE_HUMAN	Olfactory receptor 5D14 (Olfactory receptor OR11-141) (Olfactory receptor OR11-150)	OR5D14	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021	FVAICNPLLYTVAMSQR	1.399999976	0.679116666	0.679116666	0.183512567	1999.903534	17.9063	0	0	0	0	15.16244	0	14.68141	0	0	15.97901	0	0	0	13.66547	0	0	0	0	0	0	0	15.47313	0	0	0	17.05471	15.61083	15.10397	0	0	16.38766	0	0	0	0	14.78153	0	0	0	0	0	0	15.27576	0	0	0	0
Q8NGL6	O4A15_HUMAN	Olfactory receptor 4A15 (Olfactory receptor OR11-118)	OR4A15	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	HLSPTPSEEHMK	4.539999962	1	1	0.248798288	1409.362742	11.48303	0	14.0654	0	13.12794	15.71382	14.85007	0	0	13.75287	0	0	0	0	10.49732	0	0	0	16.09409	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.99904	0	0	0	0	0	0	0	0	0	0	0
Q8NGL9	OR4CG_HUMAN	Olfactory receptor 4C16 (Olfactory receptor OR11-135)	OR4C16	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	KLITDDK	9.960000038	0.42115435	0.42115435	0.303766235	831.8973833	16.10101	18.42504	0	0	0	18.22804	0	16.86324	19.03564	0	0	0	0	16.7148	16.42396	17.56874	0	0	0	0	0	0	0	0	19.15072	20.07875	0	0	0	0	0	0	0	19.25742	0	0	0	20.02872	0	0	0	0	0	0	0	18.2915	0	0
Q8NGN0	OR4D5_HUMAN	Olfactory receptor 4D5 (Olfactory receptor OR11-276)	OR4D5	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	AVSVLYTIVTPMLNPAIYTLR	3.24000001	1	1	0	2350.41003	15.64475	17.35285	17.84499	10.36672	15.03263	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.42341
Q8NGP3	OR5M9_HUMAN	Olfactory receptor 5M9 (Olfactory receptor OR11-190)	OR5M9	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021	DVKEAVNK	6.96999979	1	1	0.161025036	901.7387072	14.48008	16.14688	13.48163	0	14.46128	14.98246	15.34868	11.73149	0	13.87828	13.45455	15.76625	0	0	0	0	0	0	0	0	0	16.04989	15.24225	0	15.13607	0	0	0	0	0	0	0	15.418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NGQ6	OR9I1_HUMAN	Olfactory receptor 9I1 (Olfactory receptor OR11-228)	OR9I1	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021	SSGGR	3.5	1	1	0.226683944	462.4835237	15.80965	15.58921	15.04691	15.8992	17.13382	14.67466	15.26137	11.92104	15.29654	16.04277	14.58027	14.95393	16.38957	15.79896	15.92122	15.61323	16.52737	15.00277	16.58448	15.70328	0	15.06139	15.24099	17.10817	16.49502	0	14.08243	0	0	14.71132	16.14432	15.95331	14.84136	16.33405	0	16.65946	16.22355	15.47511	15.9703	16.16887	0	16.24995	15.29898	0	15.25527	0	15.67769	0
Q8NGS0	OR1N1_HUMAN	"Olfactory receptor 1N1 (Olfactory receptor 1-26, OR1-26) (Olfactory receptor 1N3) (Olfactory receptor OR9-22)"	OR1N1 OR1N3	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	SIVSS	9.93999958	1	1	0.262327196	492.6787842	0	20.12928	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.0576	0	0	19.9101	20.53351	0	0	0	0	0	0	0	0	0	17.84041	0	0	19.93264	19.31016	0	0	0	0	18.89099	0	0	0	0	0	0	17.18236
Q8NGS2	OR1J2_HUMAN	Olfactory receptor 1J2 (HSA5) (HTPCRX15) (OST044) (Olfactory receptor 1J3) (Olfactory receptor 1J5) (Olfactory receptor OR9-19)	OR1J2 OR1J3 OR1J5	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	DMKEALGK	8.800000191	0.410874605	0.410874605	0.277704373	906.6813572	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.73105	0	17.0506	0	0	0	0	0	17.27028	0	0	18.45187	0	0	0	0	0	18.27713	0	0	18.38548	18.3647	0	0	17.82278	0	0
Q8NGU2	OR9A4_HUMAN	Olfactory receptor 9A4 (Olfactory receptor OR7-1)	OR9A4	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	SNVVNNFFCDR	8.989999771	1	1	0.118135722	1372.1065	11.5973	0	14.13998	0	0	0	11.5347	13.71132	13.37003	0	12.30695	13.62567	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.51727	9.896397	0	15.53028	0	0	0	0	13.45808	0	0	0	0	0	0
Q8NGY3	OR6K3_HUMAN	Olfactory receptor 6K3 (Olfactory receptor OR1-18)	OR6K3	Homo sapiens (Human)	detection of chemical stimulus involved in sensory perception of smell [GO:0050911]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911	NKDMNNAIK	8.420000076	0.369807243	0.369807243	0.113368866	1064.559941	15.19441	16.98384	18.07832	14.595	0	13.54086	0	14.8761	0	0	14.22406	17.19141	13.47941	0	0	0	15.52642	16.01439	14.10501	0	14.70924	0	14.86985	0	0	0	16.50197	13.20319	0	18.3559	14.16151	18.72232	0	14.75091	16.88958	14.37835	17.10119	12.67274	0	0	0	0	15.4281	17.34791	0	0	15.5853	0
Q8NH00	OR2T4_HUMAN	Olfactory receptor 2T4 (Olfactory receptor OR1-60)	OR2T4	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	DVMGALKK	6.119999886	0.018367356	0.018367356	0.139590457	861.0016457	16.83533	14.81522	13.84252	0	12.28104	10.37085	0	16.18136	16.53256	15.07771	14.16817	0	15.11476	0	0	16.32256	0	0	19.71271	13.44803	17.39168	17.4691	17.86035	0	0	17.34216	17.29659	17.64904	0	17.60797	15.05122	17.77976	0	12.16101	15.76532	15.73424	13.91222	14.53791	17.91632	0	0	0	11.03226	0	15.02745	17.4472	18.53832	14.6464
Q8NH48	OR5B3_HUMAN	Olfactory receptor 5B3 (Olfactory receptor 5B13) (Olfactory receptor OR11-239)	OR5B3 OR5B13	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021	MAPVFYTMVIPMLNPLVYSLR	4.480000019	1	1	0.286955988	2471.589459	14.47745	14.56388	15.25115	0	0	0	0	14.7378	0	0	0	14.06719	0	0	0	14.29554	0	0	0	0	0	0	17.20183	15.31129	15.93868	0	16.24872	0	0	0	0	0	0	0	0	0	0	0	0	15.41682	0	14.86673	16.43797	0	0	0	0	0
Q8NH59	O51Q1_HUMAN	Olfactory receptor 51Q1	OR51Q1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	NILGTATWAER	4.409999847	1	1	0.301893023	1231.505252	16.11076	0	10.41548	0	0	0	14.9158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.63599	14.95779	15.43168	16.52322	14.34009	15.22659	14.38455	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NH61	O51F2_HUMAN	Olfactory receptor 51F2 (Olfactory receptor OR11-23)	OR51F2	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	VLIQKHSK	3.650000095	1	1	0.122871389	952.3822553	0	0	13.9251	13.58138	0	10.92689	0	10.33571	14.42296	12.73005	0	0	0	0	0	0	0	0	0	0	15.0956	0	0	0	0	15.60266	0	0	15.62089	0	15.62986	0	0	0	0	0	0	16.67534	0	0	15.95455	0	0	0	0	0	0	15.06067
Q8NH72	OR4C6_HUMAN	Olfactory receptor 4C6 (Olfactory receptor OR11-138)	OR4C6	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	AMAVSDSIITPMLNPLIYTLRNAEVK	4.869999886	1	1	3.66E-12	2875.503634	12.76775	14.64179	0	0	0	14.5729	0	13.48813	14.04089	0	0	0	0	12.40161	0	0	13.83423	0	0	0	12.08591	0	0	11.68659	16.71675	0	0	0	0	13.29452	14.69795	0	0	10.68146	0	0	0	16.00505	0	0	14.71529	12.67964	0	11.68368	0	0	0	0
Q8NH76	O56B4_HUMAN	Olfactory receptor 56B4 (Olfactory receptor OR11-67)	OR56B4	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	LNSAEAMSK	1.450000048	1	1	0.259011743	966.4609001	0	0	16.40199	0	0	0	0	0	0	16.87176	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.41533	0	0	0	15.59225	17.57338	0	18.17322	0	17.74036	0	0	0	18.21219	19.24012	0	16.92784	0	0	0	0	0	0	0
Q8NH87	OR9G1_HUMAN	Olfactory receptor 9G1 (Olfactory receptor 9G5) (Olfactory receptor OR11-114)	OR9G1 OR9G5	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	ISSSK	12.14999962	0.849684656	0.849684656	0.206335138	521.5274224	0	15.13375	16.61545	0	0	0	16.16324	0	16.51393	0	0	0	15.88151	0	16.71904	15.99749	0	15.76914	16.42682	0	16.62631	0	16.22574	0	16.06667	16.22973	16.98014	0	16.1653	16.15593	16.25411	0	17.07405	16.70139	16.14857	16.78255	16.0884	15.43074	16.3885	16.38796	15.95237	15.72684	15.88292	0	16.25285	0	0	0
Q8NHC5	O14AG_HUMAN	Olfactory receptor 14A16 (Olfactory receptor 5AT1) (Olfactory receptor OR1-45)	OR14A16 OR5AT1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021	VALGMLIK	3.940000057	1	1	0.318178683	844.7451298	15.23938	12.19818	14.31482	0	0	0	16.24934	14.30338	16.48208	15.81575	14.49755	0	16.70966	0	0	0	0	15.81872	0	14.42761	0	0	15.66878	15.31489	0	0	16.16066	0	12.27732	0	0	0	0	0	15.08965	0	0	0	0	0	0	0	13.37962	14.81461	0	10.86714	0	15.58673
Q8NHC8	OR2T6_HUMAN	Olfactory receptor 2T6 (OST703) (Olfactory receptor 2T9)	OR2T6 OR2T6P OR2T9	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	ILITVHQMTSAEGRK	4.099999905	1	1	0.475324466	1699.306923	15.60757	15.374	13.43421	0	0	13.52354	15.96646	11.2973	0	15.10924	15.08853	16.47974	0	0	0	0	0	0	0	0	0	0	0	0	0	16.33156	0	0	0	0	0	0	0	0	0	0	0	16.12434	0	15.07873	15.71322	0	0	0	0	0	0	16.42317
Q8NHH9	ATLA2_HUMAN	"Atlastin-2, EC 3.6.5.- (ADP-ribosylation factor-like protein 6-interacting protein 2, ARL-6-interacting protein 2, Aip-2)"	ATL2 ARL6IP2	Homo sapiens (Human)	endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]	GO:0003924; GO:0005525; GO:0005783; GO:0007029; GO:0007030; GO:0016020; GO:0016021; GO:0042802; GO:0051260; GO:0098826; GO:1990809	IYQGEELPHPKSMLQATAEANNLAAVAGAR	5.150000095	1	1	1.83E-12	3165.911607	14.2198	12.47084	12.5677	15.04633	0	0	0	13.44536	15.36809	0	0	0	0	0	0	11.30717	0	10.79281	0	12.6688	15.33252	13.20987	13.69219	0	0	8.95488	0	0	0	0	14.75237	13.97567	0	0	0	0	12.98702	0	0	10.3239	11.95483	0	0	0	0	0	0	0
Q8NHM5	KDM2B_HUMAN	"Lysine-specific demethylase 2B, EC 1.14.11.27 (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein, Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B)"	KDM2B CXXC2 FBL10 FBXL10 JHDM1B NDY1 PCCX2	Homo sapiens (Human)	chromatin organization [GO:0006325]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]	DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000978; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0007283; GO:0008270; GO:0019843; GO:0021555; GO:0021592; GO:0021670; GO:0021678; GO:0021993; GO:0030307; GO:0030900; GO:0030901; GO:0030902; GO:0032452; GO:0035518; GO:0043524; GO:0045322; GO:0048596; GO:0051864; GO:0070544; GO:0140680; GO:1902459; GO:2000178	KPKAPALR	8.840000153	1	1	0.616698894	878.746372	0	0	0	0	18.98269	18.58655	0	0	0	0	18.13585	0	0	0	0	0	16.51742	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.88981	0	0	0	18.67394	0	0	18.33709	0	0	0	0
Q8NHP1	ARK74_HUMAN	"Aflatoxin B1 aldehyde reductase member 4, EC 1.-.-.- (AFB1 aldehyde reductase 3, AFB1-AR 3) (Aldoketoreductase 7-like)"	AKR7L AFAR3 AKR7A4	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldo-keto reductase (NADP) activity [GO:0004033]	aldo-keto reductase (NADP) activity [GO:0004033]	GO:0004033; GO:0005737; GO:0005829; GO:0070062	ARPATVLGAMEMGR	3.890000105	0.479316264	0.479316264	0.490209594	1475.605784	10.71179	13.20141	16.14068	15.15782	15.38175	14.11727	0	0	15.73198	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.12955	16.07228	15.88439	0	17.06097	0	17.18105	0	0	17.49113	0	0	17.93539	0	16.60938	17.46573	16.34888	0	0	16.8377	16.12091	15.82469
Q8NHP6	MSPD2_HUMAN	Motile sperm domain-containing protein 2	MOSPD2	Homo sapiens (Human)	chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]		GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006935; GO:0016020; GO:0035579; GO:0044232; GO:0090023; GO:0090026; GO:0140284	YHVKDQK	1.210000038	1	1	0.212903167	917.9400077	13.84597	14.40931	15.07742	15.38029	14.80561	14.1171	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NHQ1	CEP70_HUMAN	"Centrosomal protein of 70 kDa, Cep70 (p10-binding protein)"	CEP70 BITE	Homo sapiens (Human)	cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507]	centrosome [GO:0005813]; cytosol [GO:0005829]	centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507]	gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]	GO:0005813; GO:0005829; GO:0042802; GO:0043015; GO:0060271; GO:0070507	RVPHTVLDR	4.949999809	1	1	0.623661774	1092.373904	17.23188	0	0	0	0	0	0	0	0	0	0	0	0	0	17.87436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.48878	0	0	0	0
Q8NHQ9	DDX55_HUMAN	"ATP-dependent RNA helicase DDX55, EC 3.6.4.13 (DEAD box protein 55)"	DDX55 KIAA1595	Homo sapiens (Human)		cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887	LEDMFR	20.45000076	0.332799613	0.332799613	0.206634137	810.7718936	0	20.77423	21.17211	19.37641	17.56013	17.65058	17.50826	16.17527	17.1593	17.18993	18.71129	17.79763	0	17.75574	0	16.54154	0	0	17.96041	0	18.09383	0	0	0	18.57244	16.76759	0	17.10678	0	0	17.8002	0	0	0	0	0	0	17.95463	18.6671	18.67322	17.79892	18.06501	18.11425	17.73173	16.60547	18.58229	18.3726	0
Q8NHS4	CLHC1_HUMAN	Clathrin heavy chain linker domain-containing protein 1	CLHC1 C2orf63	Homo sapiens (Human)						KAILCLCK	4.059999943	0.529860497	0.529860497	0.242901741	1005.391359	13.7559	14.78775	15.05686	0	15.10602	0	13.68038	0	12.70295	15.70647	15.72393	13.57048	14.092	15.05521	12.97391	0	0	15.51255	0	0	0	0	15.1536	16.37011	16.40869	15.7225	14.36494	14.85869	0	15.49031	0	0	16.92891	15.00933	0	14.38529	0	17.05588	15.9032	0	15.15063	16.05738	0	0	0	15.93875	15.22866	15.28056
Q8NHU6	TDRD7_HUMAN	"Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2, Trap)"	TDRD7 PCTAIRE2BP	Homo sapiens (Human)	lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283]	mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]	GO:0002089; GO:0003729; GO:0005737; GO:0005759; GO:0007283; GO:0010608; GO:0030719; GO:0033391; GO:0034587; GO:0035770; GO:0043186; GO:0047485; GO:0070306	GNSVGVKPDAEMSPYMLHTTLGNEAFK	3.529999971	1	1	5.03E-12	2909.958347	0	0	0	17.92217	0	0	13.94271	0	0	0	13.95831	10.99418	0	14.41362	0	0	0	15.22083	0	0	0	0	15.70174	0	0	17.95292	0	8.473534	14.89456	0	0	0	0	0	0	17.15109	0	18.18614	0	16.49824	0	0	15.69855	15.16484	15.7881	0	14.63142	16.54904
Q8NHX4	SPTA3_HUMAN	Spermatogenesis-associated protein 3 (Testis and spermatogenesis cell-related protein 1) (Testis spermatocyte apoptosis-related protein 1)	SPATA3 TSARG1	Homo sapiens (Human)						NCGCGSGGSR	7.400000095	1	1	0.000189343	1010.634509	0	15.94841	0	16.55575	16.08092	13.4781	0	0	16.45144	0	0	0	13.45479	0	0	0	0	0	0	0	15.89838	0	0	0	0	0	0	12.39572	0	0	17.55278	15.15423	18.52455	0	0	15.31429	0	0	0	0	0	0	0	0	14.85714	0	0	0
Q8NHX9	TPC2_HUMAN	Two pore channel protein 2 (Two pore calcium channel protein 2)	TPCN2 TPC2	Homo sapiens (Human)	calcium-mediated signaling [GO:0019722]; cellular calcium ion homeostasis [GO:0006874]; endocytosis involved in viral entry into host cell [GO:0075509]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; ion transmembrane transport [GO:0034220]; lysosome organization [GO:0007040]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of ion transmembrane transport [GO:0034765]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725]	cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; cellular calcium ion homeostasis [GO:0006874]; endocytosis involved in viral entry into host cell [GO:0075509]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; ion transmembrane transport [GO:0034220]; lysosome organization [GO:0007040]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of ion transmembrane transport [GO:0034765]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725]"	"identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]"	GO:0005245; GO:0005764; GO:0005765; GO:0005829; GO:0006874; GO:0006939; GO:0007040; GO:0010008; GO:0010506; GO:0015280; GO:0016021; GO:0017157; GO:0019065; GO:0019722; GO:0019901; GO:0031902; GO:0034220; GO:0034765; GO:0035725; GO:0036020; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0090117; GO:0097682	VQLDSSHK	6.829999924	1	1	1.03E-12	912.3330881	14.57777	0	0	13.54338	0	14.44071	14.66255	13.08461	14.99671	14.23536	0	14.75193	13.75991	13.24443	0	14.32464	13.20238	14.71319	0	0	0	0	15.38128	15.20375	14.44093	13.9182	15.43674	14.4328	14.75359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8NHY2	COP1_HUMAN	"E3 ubiquitin-protein ligase COP1, EC 2.3.2.27 (Constitutive photomorphogenesis protein 1 homolog, hCOP1) (RING finger and WD repeat domain protein 2) (RING finger protein 200) (RING-type E3 ubiquitin transferase RFWD2)"	COP1 RFWD2 RNF200	Homo sapiens (Human)	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005829; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630	MSGSR	9.550000191	0.403381765	0.403381765	0.213470018	537.7311808	15.58307	18.99248	15.63805	15.57303	14.44469	15.74539	15.79765	0	14.89287	16.65062	18.01513	13.95032	0	16.39257	15.37109	13.28395	15.92298	15.2389	14.68375	15.627	0	0	0	0	0	0	0	13.02861	13.85933	0	15.51199	0	0	0	0	0	17.99129	0	17.13295	14.18794	15.68202	0	17.90009	0	0	0	16.08782	16.35764
Q8NHY5	HUS1B_HUMAN	"Checkpoint protein HUS1B, hHUS1B"	HUS1B	Homo sapiens (Human)	double-strand break repair via homologous recombination [GO:0000724]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; telomere maintenance [GO:0000723]	checkpoint clamp complex [GO:0030896]; nucleolus [GO:0005730]; site of double-strand break [GO:0035861]	checkpoint clamp complex [GO:0030896]; nucleolus [GO:0005730]; site of double-strand break [GO:0035861]; double-strand break repair via homologous recombination [GO:0000724]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; telomere maintenance [GO:0000723]		GO:0000723; GO:0000724; GO:0005730; GO:0006289; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778	AARSAAGASSLK	16.29000092	0.529487967	0.529487967	0.235295086	1090.149863	0	15.1292	15.19864	14.29068	15.47994	0	15.58898	12.05241	12.20151	15.79359	13.79746	13.21457	17.52066	0	0	0	0	15.20166	0	0	0	16.65655	0	0	0	0	0	14.67597	13.49984	0	15.49237	14.83804	16.27555	16.7292	14.60859	0	15.00127	0	0	15.99707	16.3334	0	0	0	0	13.80082	13.19356	14.91053
Q8NHY6	ZFP28_HUMAN	"Zinc finger protein 28 homolog, Zfp-28 (Krueppel-like zinc finger factor X6)"	ZFP28 KIAA1431	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	EPTPLPGRGAPR	22.43000031	0.64673543	0.64673543	0.397149428	1248.03885	0	0	0	18.42428	0	0	0	0	0	16.79492	14.26286	0	0	0	0	0	0	0	0	0	16.836	0	18.0828	0	0	0	0	0	0	0	0	0	0	18.43954	0	18.68909	0	0	0	0	18.6549	18.47647	0	18.21035	0	0	0	18.39868
Q8NI08	NCOA7_HUMAN	Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1)	NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993	Homo sapiens (Human)	negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979]	nucleus [GO:0005634]	nucleus [GO:0005634]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979]	nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]	GO:0005634; GO:0006357; GO:0006979; GO:0016922; GO:0030374; GO:0045944; GO:1900408; GO:1902083; GO:1903204	ETSHGSPTVTK	4.260000229	1	1	0.404349267	1143.254313	0	0	15.36957	0	0	14.96756	0	15.56975	0	14.72944	15.2373	0	0	13.40468	0	0	0	17.04504	0	0	0	0	0	0	0	16.91998	0	0	17.09864	15.47164	0	0	0	0	0	0	16.93496	0	0	0	0	15.51523	0	0	0	0	0	0
Q8NI27	THOC2_HUMAN	"THO complex subunit 2, Tho2 (hTREX120)"	THOC2 CXorf3	Homo sapiens (Human)	generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; mRNA binding [GO:0003729]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]	mRNA binding [GO:0003729]	GO:0000346; GO:0000347; GO:0000445; GO:0003729; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0016973; GO:0046784; GO:0048666; GO:0048699	NETYNSHPLLVKVK	14.02999973	1	1	0	1642.426594	0	0	15.16949	0	0	0	14.53677	13.70632	0	0	16.08287	15.48786	0	0	0	0	13.54845	0	0	0	0	15.97419	0	0	0	0	14.89761	0	14.70364	0	0	15.20848	0	0	0	0	0	0	0	0	14.11361	0	0	0	12.33657	0	0	0
Q8NI32	LPD6B_HUMAN	Ly6/PLAUR domain-containing protein 6B	LYPD6B	Homo sapiens (Human)		anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; acetylcholine receptor regulator activity [GO:0030548]	acetylcholine receptor regulator activity [GO:0030548]	GO:0005576; GO:0005886; GO:0030548; GO:0031225	STSITKK	5.769999981	1	1	0.094816129	764.3053715	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.80334	0	0	0	14.9463	0	0	0	14.95501	15.77342	0	0	0	14.70902	15.08178	15.07806	16.31335	14.57244	0	0	14.71135	0	0	0	0	16.54611	0	0	0	0	0
Q8NI35	INADL_HUMAN	"InaD-like protein, Inadl protein, hINADL (Channel-interacting PDZ domain-containing protein) (Pals1-associated tight junction protein) (Protein associated to tight junctions)"	PATJ CIPP INADL	Homo sapiens (Human)	establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule organizing center organization [GO:0031023]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192]	apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule organizing center organization [GO:0031023]; regulation of microtubule cytoskeleton organization [GO:0070507]; tight junction assembly [GO:0120192]		GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0016324; GO:0030054; GO:0031023; GO:0034451; GO:0035089; GO:0035556; GO:0043296; GO:0045177; GO:0045197; GO:0048471; GO:0070062; GO:0070507; GO:0120192	GGAADLDGR	11.22000027	1	1	0.159000095	833.5327277	15.50249	0	0	0	0	0	0	0	15.43678	0	0	0	0	0	0	15.25048	0	0	16.11684	0	0	0	0	0	16.16653	0	0	14.59359	14.57317	13.04711	0	0	0	14.81718	14.52123	14.65084	16.08287	0	0	0	14.88069	15.94179	14.49789	0	0	0	15.46016	14.85488
Q8NI36	WDR36_HUMAN	"WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein, TA-WDRP)"	WDR36	Homo sapiens (Human)	response to stimulus [GO:0050896]; rRNA processing [GO:0006364]; visual perception [GO:0007601]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; response to stimulus [GO:0050896]; rRNA processing [GO:0006364]; visual perception [GO:0007601]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0050896	KLINQMR	13.5	0.983242869	0.983242869	0.189003735	917.3647942	17.97239	17.49106	17.26583	0	18.21901	16.89772	16.87239	16.10705	15.139	17.42126	0	14.67516	15.27208	14.98073	15.80897	0	16.05233	0	18.64904	0	0	18.04987	0	16.03576	0	14.45539	16.08033	0	0	17.08501	15.06964	16.41506	15.05043	14.92817	0	0	0	16.73358	0	15.8434	17.27298	18.55781	17.64362	0	0	17.27856	17.37079	0
Q8NI60	COQ8A_HUMAN	"Atypical kinase COQ8A, mitochondrial, EC 2.7.-.- (Chaperone activity of bc1 complex-like, Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)"	COQ8A ADCK3 CABC1 PP265	Homo sapiens (Human)	phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]	GO:0005524; GO:0005739; GO:0006744; GO:0016021; GO:0016301; GO:0016310; GO:0031314; GO:0043531	IGRLANFGGLAVGLGFGALAEVAK	5.869999886	1	1	0.236403052	2299.445699	0	0	0	0	0	13.0021	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.91638	0	12.66416	0	0	0	0	0	12.13398	0	0	8.49739	0	0	11.49863	0	15.3624	0	0	0	0	0	0
Q8NI77	KI18A_HUMAN	"Kinesin-like protein KIF18A (Marrow stromal KIF18A, MS-KIF18A)"	KIF18A OK/SW-cl.108	Homo sapiens (Human)	cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]	caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520]	actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463]	GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023	HSMPVPSMVPSYMAMTTAAK	2.380000114	1	1	0.225016908	2147.04313	17.04313	0	0	0	17.56128	0	16.10745	0	12.56298	15.01201	0	0	0	0	0	0	0	0	11.82652	0	15.60026	0	0	0	13.86297	0	15.60367	0	14.44631	11.0175	13.99504	15.62167	15.69655	0	0	0	0	0	0	0	0	0	11.24052	15.5673	0	0	10.79859	14.18564
Q8TA86	RP9_HUMAN	"Retinitis pigmentosa 9 protein (Pim-1-associated protein, PAP-1)"	RP9	Homo sapiens (Human)	cognition [GO:0050890]; RNA splicing [GO:0008380]	nucleus [GO:0005634]; signal recognition particle receptor complex [GO:0005785]	nucleus [GO:0005634]; signal recognition particle receptor complex [GO:0005785]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cognition [GO:0050890]; RNA splicing [GO:0008380]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005785; GO:0008380; GO:0046872; GO:0050890	EDVGAAGAR	8.670000076	1	1	0.15284888	846.5268097	12.91017	0	0	0	15.68289	0	14.69535	0	15.48174	18.18818	0	18.36215	0	15.20568	16.45511	0	15.2597	15.03151	0	0	14.92202	15.23842	0	17.85408	16.20265	0	17.62711	0	0	0	14.8018	18.09722	17.71051	16.5959	0	15.45854	0	0	14.22211	15.90266	14.4426	15.55262	14.3337	14.40312	13.69946	17.17776	0	0
Q8TA94	ZN563_HUMAN	Zinc finger protein 563	ZNF563	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AFFWPSLLRMHER	4.300000191	1	1	0.041682264	1706.470566	11.70058	0	11.97317	0	15.38984	0	0	14.34365	13.15133	0	0	0	14.12049	15.19084	0	0	13.1719	13.20691	0	0	13.03343	14.45461	0	15.01029	14.49461	11.39088	0	14.44728	0	14.42422	13.11337	0	12.90245	15.51003	0	15.72927	0	0	0	13.75415	0	0	12.29729	0	0	0	0	0
Q8TAE7	KCNG3_HUMAN	Potassium voltage-gated channel subfamily G member 3 (Voltage-gated potassium channel subunit Kv10.1) (Voltage-gated potassium channel subunit Kv6.3)	KCNG3	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805	ERNEYFFDR	2.640000105	1	1	0.135578166	1278.532	14.34616	16.07056	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.69493	0	0	0	0	0	0	13.13928	0	0	0	0	14.77902	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TAF3	WDR48_HUMAN	WD repeat-containing protein 48 (USP1-associated factor 1) (WD repeat endosomal protein) (p80)	WDR48 KIAA1449 UAF1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein deubiquitination [GO:1903003]; protein deubiquitination [GO:0016579]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein deubiquitination [GO:1903003]; protein deubiquitination [GO:0016579]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]	GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005654; GO:0005764; GO:0005770; GO:0005829; GO:0006974; GO:0007283; GO:0007338; GO:0016579; GO:0035264; GO:0043130; GO:0043231; GO:0043588; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1903003; GO:1905168	DAGFSSPDGSDPK	5.519999981	1	1	0.225463647	1280.142376	16.26552	14.96824	0	0	0	0	12.87854	13.80185	0	0	0	14.51928	14.81147	14.55559	0	12.87543	13.88307	0	14.49313	0	16.23118	0	0	0	14.10362	0	16.03476	0	16.10647	12.68017	0	0	0	15.89477	0	0	0	17.63071	18.25272	0	16.48476	14.88556	15.6694	0	0	17.60317	17.40467	18.42287
Q8TAF5	LQK1_HUMAN	Putative uncharacterized protein LQK1 (FLVCR1 antisense RNA 1) (FLVCR1 divergent transcript)	FLVCR1-DT FLVCR1-AS1 LQK1	Homo sapiens (Human)						FIGIYSVR	15.10999966	1	1	0.356175601	954.4228993	0	0	0	0	0	0	15.57136	0	0	0	14.87665	0	15.31922	0	0	15.85047	9.039984	16.02124	14.94721	11.50332	15.99109	0	17.01192	0	0	0	0	0	0	0	17.26243	13.52748	0	0	0	0	0	0	0	14.56879	0	15.24146	0	0	0	12.03552	14.5831	0
Q8TAG6	VEXIN_HUMAN	Vexin	VXN C8orf46	Homo sapiens (Human)	neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]	nucleus [GO:0005634]; plasma membrane [GO:0005886]	nucleus [GO:0005634]; plasma membrane [GO:0005886]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]		GO:0005634; GO:0005886; GO:0022008; GO:0030182	GAVLMRGSR	12.44999981	1	1	0.150327568	946.0925401	15.13187	14.35992	11.23982	10.38137	15.25039	16.0461	11.07284	14.12371	15.3985	14.94829	15.66984	0	14.39163	13.28853	14.89319	15.6406	12.36329	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TAG9	EXOC6_HUMAN	Exocyst complex component 6 (Exocyst complex component Sec15A) (SEC15-like protein 1)	EXOC6 SEC15A SEC15L SEC15L1	Homo sapiens (Human)	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]		GO:0000145; GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0030426; GO:0048471; GO:0090148; GO:0090522; GO:0090543	DARHAAEGEIYTK	2.289999962	1	1	0.054445999	1460.4397	14.70742	16.71503	15.75755	0	0	0	15.4873	0	0	15.31792	16.02514	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84268	0	0	0	0	0	0	0	0	16.01122	0	0	15.36584	0	0	0	0	0	0	0	0	0	15.21045	0
Q8TAI1	TYMOS_HUMAN	TYMS opposite strand protein	TYMSOS C18orf56	Homo sapiens (Human)						ASHVPNGTLR	5.829999924	1	1	0.213337892	1051.388837	0	17.68228	15.73403	0	0	0	13.6273	0	0	14.55842	17.75939	15.56067	14.09285	0	13.25896	13.06477	14.93036	0	17.64344	0	0	16.72034	16.51349	14.95738	17.06849	15.43964	0	0	0	0	0	0	16.70987	0	0	17.31168	0	0	15.64984	0	15.99457	0	0	0	0	0	0	0
Q8TAK5	GABP2_HUMAN	"GA-binding protein subunit beta-2, GABP subunit beta-2, GABPB-2"	GABPB2	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]	identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]	GO:0000976; GO:0005634; GO:0042802; GO:0045944	RLLEAAR	11	0.655627549	0.655627549	0.091270294	827.4857592	17.37493	16.16544	16.72934	17.20539	14.83822	15.78085	15.21908	16.48438	16.6865	16.93592	16.57144	16.9708	18.01571	17.42733	18.23469	14.6922	16.0145	0	0	15.80953	14.23319	17.79035	14.69594	0	18.27505	17.25101	0	16.09277	17.69635	16.70089	0	0	17.14087	15.94805	0	0	0	17.97737	17.34159	17.78364	0	17.89793	16.56139	17.0584	17.35433	0	17.9857	17.42284
Q8TAL6	FIBIN_HUMAN	Fin bud initiation factor homolog	FIBIN PSEC0235	Homo sapiens (Human)	protein kinase C signaling [GO:0070528]; response to dexamethasone [GO:0071548]; response to manganese ion [GO:0010042]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; protein homodimerization activity [GO:0042803]; protein kinase C signaling [GO:0070528]; response to dexamethasone [GO:0071548]; response to manganese ion [GO:0010042]	protein homodimerization activity [GO:0042803]	GO:0005576; GO:0005783; GO:0005794; GO:0010042; GO:0042803; GO:0070528; GO:0071548	SHGTRLGR	16.44000053	1	1	0.308661305	883.8347238	19.75295	17.78186	19.0912	0	0	19.37636	16.16838	18.91673	0	0	19.46648	0	0	0	0	0	0	0	0	0	0	17.4455	0	0	17.63265	17.89202	0	0	19.1456	0	18.403	0	0	20.42745	19.0465	0	16.38853	19.50125	0	18.60605	0	0	0	0	0	0	0	0
Q8TAM1	BBS10_HUMAN	Bardet-Biedl syndrome 10 protein	BBS10 C12orf58	Homo sapiens (Human)	chaperone-mediated protein complex assembly [GO:0051131]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of protein-containing complex assembly [GO:0043254]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cilium [GO:0005929]	cilium [GO:0005929]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; chaperone-mediated protein complex assembly [GO:0051131]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of protein-containing complex assembly [GO:0043254]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]	GO:0005524; GO:0005929; GO:0007601; GO:0016887; GO:0043254; GO:0045494; GO:0050896; GO:0051131; GO:0061629; GO:1905515	CHQSEETMVSMIIANALLGIPK	5.420000076	1	1	0.566956396	2458.07807	0	19.39477	0	13.24426	0	0	0	0	0	0	0	0	0	18.65652	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TAP6	CEP76_HUMAN	"Centrosomal protein of 76 kDa, Cep76"	CEP76 C18orf9	Homo sapiens (Human)	regulation of centriole replication [GO:0046599]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; regulation of centriole replication [GO:0046599]		GO:0005813; GO:0005814; GO:0005829; GO:0032991; GO:0046599	LLDTPR	3.410000086	0.194086403	0.194086403	0.102615467	713.5743772	15.31262	13.22381	0	13.77377	0	0	0	15.70576	0	0	14.00934	0	0	19.63386	12.56283	0	16.48159	0	14.01329	17.21692	10.69314	0	17.80613	16.55492	0	18.23302	17.4397	0	12.75049	0	0	14.45042	0	0	12.96733	13.32943	0	0	17.33196	16.95376	0	15.81318	16.6783	0	0	0	0	0
Q8TAQ5	ZN420_HUMAN	Zinc finger protein 420	ZNF420	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872	ECGIDFSHGSQVYM	10.88000011	1	1	0.383964326	1645.315126	14.07388	15.69937	0	16.64614	0	13.38634	0	14.52254	0	0	17.47818	0	16.08318	0	0	0	0	0	15.61969	0	0	0	15.93271	0	0	16.5305	0	13.32084	14.38837	15.75562	0	18.3194	0	0	17.4417	0	0	18.65889	0	0	0	0	0	13.20502	0	0	0	0
Q8TAQ9	SUN3_HUMAN	SUN domain-containing protein 3 (Sad1/unc-84 domain-containing protein 1)	SUN3 SUNC1	Homo sapiens (Human)	nuclear envelope organization [GO:0006998]	integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]	integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; protein-membrane adaptor activity [GO:0043495]; nuclear envelope organization [GO:0006998]	protein-membrane adaptor activity [GO:0043495]	GO:0005635; GO:0005639; GO:0006998; GO:0034993; GO:0043495	VHGTPGKHI	3.569999933	1	1	0.237122647	945.9597019	13.82147	14.15541	13.08154	13.32567	12.84988	14.01453	0	15.07165	14.11051	13.54539	15.11345	14.30844	13.07203	0	0	0	0	0	0	14.69016	0	0	0	0	0	0	0	0	0	0	0	0	0	16.28181	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TAV0	FA76A_HUMAN	Protein FAM76A	FAM76A	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	EEVATLK	4.239999771	1	1	0.262123155	789.0129727	0	15.74549	15.73123	16.66732	0	14.83306	0	16.02888	14.60035	15.60603	16.10244	0	0	0	14.45464	0	0	0	0	0	0	17.81861	15.72859	16.68314	16.46865	16.81095	0	15.63511	0	15.45806	16.34579	17.5778	0	0	0	0	16.3851	15.70525	0	0	16.71907	15.16657	0	16.25474	16.64878	0	0	0
Q8TAV3	CP2W1_HUMAN	"Cytochrome P450 2W1, EC 1.14.14.- (CYPIIW1)"	CYP2W1	Homo sapiens (Human)	aflatoxin metabolic process [GO:0046222]; organic acid metabolic process [GO:0006082]; phospholipid metabolic process [GO:0006644]; retinoic acid catabolic process [GO:0034653]; xenobiotic metabolic process [GO:0006805]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; all-trans retinal binding [GO:0005503]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; steroid hydroxylase activity [GO:0008395]; aflatoxin metabolic process [GO:0046222]; organic acid metabolic process [GO:0006082]; phospholipid metabolic process [GO:0006644]; retinoic acid catabolic process [GO:0034653]; xenobiotic metabolic process [GO:0006805]"	"all-trans retinal binding [GO:0005503]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; steroid hydroxylase activity [GO:0008395]"	GO:0001972; GO:0004497; GO:0005503; GO:0005506; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006082; GO:0006644; GO:0006805; GO:0008395; GO:0008401; GO:0009986; GO:0016712; GO:0020037; GO:0034653; GO:0043231; GO:0046222; GO:1904768	SLMELSER	8.079999924	1	1	0.562728524	979.6125778	0	0	0	0	0	0	18.60159	0	0	0	0	0	16.4166	0	0	0	0	0	0	0	0	0	16.66746	0	18.20544	0	0	17.77826	0	0	0	0	0	0	0	0	0	0	0	16.47724	0	0	0	0	0	18.00081	0	0
Q8TAV4	STML3_HUMAN	"Stomatin-like protein 3, SLP-3"	STOML3	Homo sapiens (Human)	signal transduction [GO:0007165]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; signal transduction [GO:0007165]		GO:0005886; GO:0005929; GO:0007165; GO:0016021; GO:0045121	DSRVSSPEK	7.440000057	1	1	0.273301713	1006.327436	16.10325	0	17.01509	16.33927	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.43537	0	0	0	0	0	0	0	0
Q8TAW3	ZN671_HUMAN	Zinc finger protein 671	ZNF671	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872	HTLVLHQR	9.989999771	0.719304502	0.719304502	0.620556498	1005.363799	0	0	0	17.37102	18.03941	0	16.89104	0	0	0	0	18.05671	0	0	17.46065	0	0	0	0	18.99778	17.11748	0	0	0	0	0	0	18.28878	0	0	19.28038	0	0	0	0	0	0	0	0	0	0	19.08985	0	0	0	0	0	0
Q8TAX9	GSDMB_HUMAN	"Gasdermin-B (Gasdermin-like protein) [Cleaved into: Gasdermin-B, N-terminal, GSDMB-NT, p30; Gasdermin-B, C-terminal, GSDMB-CT, p16 ]"	GSDMB GSDML PP4052 PRO2521	Homo sapiens (Human)	cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; defense response to bacterium [GO:0042742]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; pyroptosis [GO:0070269]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; wide pore channel activity [GO:0022829]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; defense response to bacterium [GO:0042742]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; pyroptosis [GO:0070269]"	"phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; wide pore channel activity [GO:0022829]"	GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0016021; GO:0019835; GO:0022829; GO:0042742; GO:0070269; GO:0070273; GO:0140507; GO:1902483	DGASSCLGK	2.900000095	1	1	0.281349681	891.3794526	0	19.06055	0	0	0	0	0	0	18.1044	18.26342	0	0	0	16.88712	16.69344	0	0	0	0	0	0	0	17.70253	0	18.20173	0	0	0	0	0	0	19.34623	18.58458	0	0	0	0	0	0	17.08727	16.65127	0	17.59018	0	0	0	17.30066	17.05124
Q8TAZ6	CKLF2_HUMAN	CKLF-like MARVEL transmembrane domain-containing protein 2 (Chemokine-like factor superfamily member 2)	CMTM2 CKLFSF2	Homo sapiens (Human)	chemotaxis [GO:0006935]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; cytokine activity [GO:0005125]; chemotaxis [GO:0006935]	cytokine activity [GO:0005125]	GO:0005125; GO:0005615; GO:0006935; GO:0016021	AVQDHK	9.470000267	0.405497104	0.405497104	0.250497101	695.3259092	17.16839	0	16.68953	16.05479	15.42034	15.73161	15.80905	16.41935	14.67277	14.0944	15.87234	16.10349	0	0	17.3056	0	0	16.63387	0	0	17.48769	0	17.15491	17.01836	0	0	0	16.54552	16.22196	0	17.51975	16.84684	16.15909	0	17.97098	17.87667	0	17.11191	18.20503	16.97693	17.34119	17.42287	16.46041	17.35063	16.84131	17.0464	17.39651	17.11144
Q8TB24	RIN3_HUMAN	Ras and Rab interactor 3 (Ras interaction/interference protein 3)	RIN3	Homo sapiens (Human)	endocytosis [GO:0006897]; negative regulation of mast cell chemotaxis [GO:0060755]; negative regulation of receptor internalization [GO:0002091]; regulation of vesicle size [GO:0097494]; signal transduction [GO:0007165]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; vesicle [GO:0031982]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; negative regulation of mast cell chemotaxis [GO:0060755]; negative regulation of receptor internalization [GO:0002091]; regulation of vesicle size [GO:0097494]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0002091; GO:0005085; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006897; GO:0007165; GO:0030139; GO:0030424; GO:0030425; GO:0031267; GO:0031410; GO:0031982; GO:0043025; GO:0060755; GO:0097494	VVAGMFLVR	14.05000019	0.362090141	0.362090141	0.183731307	1009.010415	0	16.07716	0	17.36697	0	0	0	17.28959	15.89843	17.15039	0	17.19423	16.61692	17.73586	0	17.03905	15.37459	13.88758	0	0	14.89032	12.26824	0	0	16.38527	0	16.47612	0	16.14258	0	0	0	0	13.26906	0	15.4687	16.52211	15.73588	17.13467	15.79937	0	15.83163	17.42728	17.58116	0	0	17.63964	0
Q8TB37	NUBPL_HUMAN	Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1)	NUBPL C14orf127	Homo sapiens (Human)	iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]"	GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0016887; GO:0032981; GO:0046872; GO:0051539; GO:0070584	GLMVMSAIEK	3.390000105	1	1	0.134559892	1093.775872	9.710573	15.06657	13.17191	0	0	12.79751	14.02157	0	11.30793	0	0	14.07967	13.95415	14.34082	11.46899	14.68158	13.90619	14.38244	0	0	14.17803	0	0	0	15.81428	14.25186	0	0	0	0	0	0	0	0	0	0	0	0	16.94173	0	0	0	0	0	0	0	0	0
Q8TB52	FBX30_HUMAN	F-box only protein 30	FBXO30 FBX30	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0061630	VPCLNSDFGCPFTMARNK	1.169999957	1	1	0.243476856	2114.242237	0	0	0	0	13.43165	0	0	0	0	0	13.06757	0	19.72366	0	0	0	0	12.92909	0	0	0	0	0	0	0	0	16.09099	15.85949	14.69287	0	0	0	0	0	0	0	0	0	0	0	14.04295	0	0	0	0	0	0	16.48941
Q8TB72	PUM2_HUMAN	"Pumilio homolog 2, Pumilio-2"	PUM2 KIAA0235 PUMH2	Homo sapiens (Human)	adipose tissue development [GO:0060612]; chromosome organization [GO:0051276]; hair follicle development [GO:0001942]; mitochondrion organization [GO:0007005]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; respiratory electron transport chain [GO:0022904]; skeletal system development [GO:0001501]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pumilio-response element binding [GO:0062104]; RNA binding [GO:0003723]; adipose tissue development [GO:0060612]; chromosome organization [GO:0051276]; hair follicle development [GO:0001942]; mitochondrion organization [GO:0007005]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; respiratory electron transport chain [GO:0022904]; skeletal system development [GO:0001501]; stress granule assembly [GO:0034063]	lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pumilio-response element binding [GO:0062104]; RNA binding [GO:0003723]	GO:0001501; GO:0001942; GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007005; GO:0010494; GO:0010608; GO:0022904; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051276; GO:0051983; GO:0060612; GO:0060964; GO:0062104; GO:0106222; GO:1900246; GO:2000637	IVSEIRGK	3.160000086	1	1	0.138128039	900.6203596	13.91935	15.3283	15.2886	13.90716	13.63031	15.06251	0	0	12.50656	0	0	0	0	0	14.08491	0	0	0	0	0	0	0	0	16.21351	0	15.92416	0	14.58601	0	12.99098	15.60794	14.60629	0	0	15.21601	0	0	0	0	0	12.77264	0	0	0	12.12737	0	0	0
Q8TB92	HMGC2_HUMAN	"3-hydroxy-3-methylglutaryl-CoA lyase, cytoplasmic, EC 4.1.3.4 (3-hydroxy-3-methylglutaryl-CoA lyase-like protein 1, HMGCL-like 1) (Endoplasmic reticulum 3-hydroxy-3-methylglutaryl-CoA lyase, er-cHL)"	HMGCLL1	Homo sapiens (Human)	ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]	hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]	GO:0004419; GO:0005783; GO:0005789; GO:0005829; GO:0006552; GO:0006629; GO:0016020; GO:0046872; GO:0046951; GO:0048471	SARHMNIPAR	4.340000153	1	1	0.124427395	1149.464082	0	0	14.17623	13.18806	14.42926	15.30405	0	0	0	19.25436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.73863	0	0	0	0	0	0	0	14.84243	0	14.27412	0	0	0
Q8TBA6	GOGA5_HUMAN	Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein)	GOLGA5 RETII RFG5 PIG31	Homo sapiens (Human)	"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"	cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]	"cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]"	protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0016021; GO:0030133; GO:0031267; GO:0031985; GO:0042803; GO:0048193	TKNTLQSR	5.130000114	1	1	0.058446685	947.1663108	0	13.44383	15.11874	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TBB5	KLDC4_HUMAN	Kelch domain-containing protein 4	KLHDC4	Homo sapiens (Human)						TAAKMEK	1.379999995	1	1	0.297838912	794.9550934	0	14.03522	14.02504	18.51094	17.87656	0	18.10499	0	17.8019	0	0	0	0	0	0	0	19.49185	17.718	0	17.68467	16.71932	0	17.43803	0	0	18.97768	0	0	0	0	0	0	0	17.73852	0	0	0	18.87863	0	17.73527	0	0	0	0	0	17.19086	18.02681	0
Q8TBB6	S7A14_HUMAN	Probable cationic amino acid transporter (Solute carrier family 7 member 14)	SLC7A14 KIAA1613	Homo sapiens (Human)	amino acid transport [GO:0006865]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transport [GO:0006865]	amino acid transmembrane transporter activity [GO:0015171]	GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0006865; GO:0015171; GO:0016021; GO:0043231	MSGFFTSLDPR	2.5	1	1	0.082182283	1269.422082	15.30259	10.31174	0	0	0	14.55427	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.02955	0	0	0	0	0	0	0	0	0	0	0	14.72295	15.02438	0	0	0	16.0915	0	0	0	0	16.46165	0	0	0	0	0
Q8TBC5	ZSC18_HUMAN	Zinc finger and SCAN domain-containing protein 18 (Zinc finger protein 447)	ZSCAN18 ZNF447	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	SKEQMLELLVLEQFLGILPDK	1.330000043	0.862228811	0.862228811	3.66E-12	2443.596307	12.6187	0	0	0	0	0	0	10.9744	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.42719	14.13892	0	0	0	0	0	15.73101	0	10.77617	13.75868	0	0	15.15942	0	0	0	0	0	0	0	0	13.10433	0
Q8TBE0	BAHD1_HUMAN	"Bromo adjacent homology domain-containing 1 protein, BAH domain-containing protein 1"	BAHD1 KIAA0945	Homo sapiens (Human)	"heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]"	chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]	"chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]"	chromatin binding [GO:0003682]	GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892	RPLVPEKPKACK	1.419999957	1	1	0.306217905	1422.116894	14.92344	14.72041	14.41754	12.35897	14.46137	11.96507	14.53674	14.2906	0	14.11205	13.79736	14.27693	0	12.16271	0	0	0	0	0	0	0	0	0	0	0	16.13244	0	0	0	0	0	0	0	16.06045	0	0	0	0	17.10703	0	15.45601	0	0	0	0	0	0	0
Q8TBE3	FNDC9_HUMAN	Fibronectin type III domain-containing protein 9	FNDC9 C5orf40	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	EEDLQGLPLVEMPRK	9.029999733	0.105896346	0.105896346	0.147745025	1767.630852	0	16.66701	0	0	18.36206	0	0	0	12.77889	0	16.94762	14.36376	17.99442	18.3933	14.47499	0	0	17.19504	17.08977	0	15.73943	0	0	15.27271	14.68512	0	17.86399	19.61029	13.09184	14.46486	0	0	19.14957	0	0	0	18.3122	18.57761	16.02197	16.55326	0	0	17.7121	0	14.44517	14.57081	15.12393	16.68327
Q8TBF5	PIGX_HUMAN	"Phosphatidylinositol-glycan biosynthesis class X protein, PIG-X"	PIGX	Homo sapiens (Human)	GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]		GO:0005789; GO:0006506; GO:0016021	SDAGIRAMCSEIILR	7.079999924	1	1	6.89E-13	1705.433758	15.06892	12.5294	13.29642	0	0	0	0	0	0	15.2359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.70659	0	0	0	0	14.28532	0	0	0	0	0	0	0	0	15.13145	0	0	0	0	0	0	0	0	0
Q8TBF8	FA81A_HUMAN	Protein FAM81A	FAM81A	Homo sapiens (Human)						DDIVNSLQKMQNK	7.869999886	1	1	0.265638143	1549.434428	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.74404	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TBG4	AT2L1_HUMAN	"Ethanolamine-phosphate phospho-lyase, EC 4.2.3.2 (Alanine--glyoxylate aminotransferase 2-like 1)"	ETNPPL AGXT2L1	Homo sapiens (Human)		mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0005759; GO:0008483; GO:0030170; GO:0050459	CELYSK	7.329999924	1	1	0.118513007	798.2964803	0	0	0	0	15.23474	15.95206	0	0	14.40177	0	14.52464	14.92289	0	12.20752	0	11.07672	15.39657	0	0	15.24137	0	0	0	0	15.88006	0	0	0	0	0	0	0	0	0	0	14.79226	0	0	0	0	0	0	16.2479	0	0	0	0	0
Q8TBJ5	FEZF2_HUMAN	Fez family zinc finger protein 2 (Forebrain embryonic zinc finger-like protein 2) (Zinc finger protein 312) (Zinc finger protein Fez-like)	FEZF2 FEZL ZNF312 FKSG36	Homo sapiens (Human)	axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]	nucleus [GO:0005634]	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0007413; GO:0007626; GO:0008285; GO:0010468; GO:0016358; GO:0021542; GO:0021797; GO:0021853; GO:0021902; GO:0043697; GO:0045665; GO:0045666; GO:0046872; GO:0048664; GO:0050767; GO:1902667	KLHDSVGPAAPSAK	10.05000019	1	1	0.254677444	1372.904934	0	0	0	0	0	14.55559	0	0	0	0	0	0	0	0	16.61087	15.34953	15.62773	16.9053	0	0	13.99824	16.37033	0	0	17.29677	17.94785	15.85658	0	0	0	0	0	17.23495	16.90879	0	14.95152	0	0	0	0	0	0	0	0	14.75625	15.5771	0	0
Q8TBM8	DJB14_HUMAN	DnaJ homolog subfamily B member 14	DNAJB14 UNQ9427/PRO34683	Homo sapiens (Human)	cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433]	Hsp70 protein binding [GO:0030544]	GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030433; GO:0030544; GO:0031965; GO:0051085; GO:0065003; GO:0071218	DQVDGVLSINKCK	3.079999924	1	1	0.287458168	1472.531117	0	0	0	0	0	0	0	15.14841	15.61535	0	0	0	16.19775	12.86347	0	15.52382	0	0	0	0	0	0	0	0	0	0	0	0	16.45719	0	0	0	17.26506	0	0	0	16.42831	17.59876	0	14.22581	16.22842	16.90014	17.24568	18.01349	17.12364	17.78014	17.89973	0
Q8TBN0	R3GEF_HUMAN	"Guanine nucleotide exchange factor for Rab-3A (Rab-3A-interacting-like protein 1, Rab3A-interacting-like protein 1) (Rabin3-like 1)"	RAB3IL1	Homo sapiens (Human)	exocytosis [GO:0006887]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi to plasma membrane transport vesicle [GO:0070319]	cytosol [GO:0005829]; Golgi to plasma membrane transport vesicle [GO:0070319]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; exocytosis [GO:0006887]; protein transport [GO:0015031]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]	GO:0005085; GO:0005829; GO:0006887; GO:0015031; GO:0042802; GO:0070319	KGHSR	4.789999962	1	1	0.245845267	580.9992645	0	0	13.98101	17.31399	0	0	17.10054	0	0	0	0	0	0	0	18.19327	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.62005	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TBP0	TBC16_HUMAN	TBC1 domain family member 16	TBC1D16	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of receptor recycling [GO:0001919]	cytosol [GO:0005829]; early endosome [GO:0005769]	cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of receptor recycling [GO:0001919]	GTPase activator activity [GO:0005096]	GO:0001919; GO:0005096; GO:0005769; GO:0005829; GO:0090630	YCTEMQLKDQQVAPDK	1.220000029	1	1	0.453150033	1969.181377	0	4.348106	0	17.45901	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TBX8	PI42C_HUMAN	"Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma, EC 2.7.1.149 (Phosphatidylinositol 5-phosphate 4-kinase type II gamma, PI(5)P 4-kinase type II gamma, PIP4KII-gamma)"	PIP4K2C PIP5K2C	Homo sapiens (Human)	"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]"	autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular organelle [GO:0043229]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular organelle [GO:0043229]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]"	1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005654; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0010506; GO:0016308; GO:0016309; GO:0042802; GO:0043229; GO:0046627; GO:0046854; GO:0070062; GO:0090217; GO:1902635; GO:2000786	ASSKIK	3.069999933	1	1	0.238066848	632.9469896	0	15.01138	16.75399	15.99328	13.41905	16.00648	16.07788	16.24775	0	15.84793	14.93266	0	0	0	0	15.51365	0	15.33997	15.33346	0	0	0	15.61932	0	0	18.12412	16.5489	0	16.19642	16.5081	0	0	17.01471	0	0	16.31566	0	0	0	0	0	0	0	0	0	0	0	0
Q8TBY9	CF251_HUMAN	Cilia- and flagella-associated protein 251 (WD repeat-containing protein 66)	CFAP251 WDR66	Homo sapiens (Human)	cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]	axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]	axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]		GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126	AGISR	6.400000095	0.335156232	0.335156232	0.128062141	503.3010025	16.35207	16.84654	16.44268	16.53467	16.46835	15.76608	16.0919	16.84079	16.50061	16.10692	16.48801	16.86619	16.68068	15.87824	17.65995	16.85344	16.99933	16.90847	17.32349	16.8262	17.27573	17.87873	17.09871	16.45637	16.37835	16.87367	17.3528	16.61314	17.37782	16.66068	16.30291	16.89494	16.27318	16.81673	16.90899	16.97071	16.94217	17.48369	18.35822	17.17672	17.93389	17.41462	16.58365	17.25933	17.18876	17.45375	16.97715	17.03066
Q8TBZ2	MYBPP_HUMAN	"MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1, AMAP-1)"	MYCBPAP AMAP1	Homo sapiens (Human)	cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202]	cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; spermatogenesis [GO:0007283]		GO:0005737; GO:0007268; GO:0007283; GO:0016020; GO:0030154; GO:0045202	LEYLGDEMTGLVMTK	1.789999962	1	1	0.340127652	1715.558202	18.54248	14.70509	15.40463	0	0	0	0	0	0	17.8404	0	0	0	0	17.13801	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TC05	MDM1_HUMAN	Nuclear protein MDM1	MDM1	Homo sapiens (Human)	negative regulation of centriole replication [GO:0046600]; retina development in camera-type eye [GO:0060041]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600]; retina development in camera-type eye [GO:0060041]	microtubule binding [GO:0008017]	GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0008017; GO:0034451; GO:0046600; GO:0060041	GNMPNQVK	8.699999809	1	1	0.176523286	887.9290678	0	0	15.5995	0	0	12.3705	11.89934	0	0	0	0	12.8998	0	0	0	13.6659	16.14333	0	0	0	14.73422	0	0	0	11.77349	0	13.60647	0	0	0	0	0	15.08249	0	0	0	0	16.4319	17.67755	0	16.8457	15.81967	0	0	0	0	0	0
Q8TC12	RDH11_HUMAN	"Retinol dehydrogenase 11, EC 1.1.1.300 (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1, RalR1) (Short chain dehydrogenase/reductase family 7C member 1)"	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	Homo sapiens (Human)	cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]"	"11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]"	GO:0001523; GO:0004745; GO:0005789; GO:0016021; GO:0016616; GO:0042572; GO:0042574; GO:0052650; GO:0102354; GO:0110095	VVVVTGANTGIGK	8.140000343	0.258479983	0.258479983	0.00690937	1214.962863	0	12.4191	0	0	0	15.04306	0	13.1768	14.81985	14.0656	0	0	0	14.58968	0	0	0	0	0	12.42393	14.56137	0	0	14.36442	0	14.96592	13.31672	0	15.58098	0	0	11.50792	15.3726	0	0	11.777	15.40942	14.4911	0	0	0	0	0	14.05205	14.09325	15.07994	13.43705	0
Q8TC21	ZN596_HUMAN	Zinc finger protein 596	ZNF596	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	KAMNM	5.03000021	1	1	0.075319712	593.1923466	14.40336	15.29923	15.12306	10.62025	10.76812	13.66863	14.95856	0	0	15.20155	0	15.4654	15.31511	0	14.78282	16.84486	15.46245	0	14.9486	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.73547	0	0	0	0
Q8TC27	ADA32_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 32, ADAM 32"	ADAM32 UNQ5982/PRO21340	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]	metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0007155; GO:0007339; GO:0016021	NLICGR	3.859999895	1	1	4.60E-13	732.7499133	0	13.4219	0	0	14.57606	14.75037	14.80952	0	0	0	0	0	15.16625	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.54941	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.98824	0
Q8TC44	POC1B_HUMAN	POC1 centriolar protein homolog B (Pix1) (Proteome of centriole protein 1B) (WD repeat-containing protein 51B)	POC1B WDR51B	Homo sapiens (Human)	cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; retina homeostasis [GO:0001895]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; retina homeostasis [GO:0001895]		GO:0000922; GO:0001895; GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0008283; GO:0036064; GO:0060271	LHFDSPPHLLDIYPR	7.039999962	0.830417037	0.830417037	0.148364027	1818.979876	15.27773	0	0	0	15.26502	0	0	0	15.03375	14.28998	0	0	0	0	13.31165	0	0	0	0	0	0	0	0	0	16.80274	0	15.1668	0	0	0	16.69936	0	0	0	0	0	0	17.61796	0	0	15.28592	0	14.71619	16.31237	0	0	0	15.05766
Q8TC57	M1AP_HUMAN	Meiosis 1 arrest protein (Meiosis 1-arresting protein) (Meiosis 1-associated protein) (Spermatogenesis-associated protein 37)	M1AP C2orf65 SPATA37	Homo sapiens (Human)	cell differentiation [GO:0030154]; chromatin assembly [GO:0031497]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; chromatin assembly [GO:0031497]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]	identical protein binding [GO:0042802]	GO:0005737; GO:0006396; GO:0007127; GO:0007283; GO:0007292; GO:0016021; GO:0030154; GO:0031497; GO:0042802; GO:0051308	MPAASK	10.81000042	0.112931758	0.112931758	0.225130509	605.4760299	14.61262	15.3076	16.17458	0	0	14.46095	14.09565	15.42969	14.8251	15.94396	15.838	12.44139	0	14.97613	14.01844	15.01236	14.49926	15.88307	14.86659	15.01304	15.98504	0	0	14.9808	0	15.47991	0	15.02148	16.53842	16.44195	0	0	14.705	16.80407	16.25068	17.02871	0	0	16.20081	0	0	0	0	0	0	16.30574	15.57332	0
Q8TC59	PIWL2_HUMAN	"Piwi-like protein 2, EC 3.1.26.- (Cancer/testis antigen 80, CT80)"	PIWIL2 HILI	Homo sapiens (Human)	DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transposition [GO:0010529]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of meiosis I [GO:0060903]; positive regulation of translation [GO:0045727]; rhythmic process [GO:0048511]; RNA 5'-end processing [GO:0000966]; spermatogenesis [GO:0007283]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; perinucleolar chromocenter [GO:0010370]; PET complex [GO:1990923]; pi-body [GO:0071546]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; perinucleolar chromocenter [GO:0010370]; PET complex [GO:1990923]; pi-body [GO:0071546]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transposition [GO:0010529]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of meiosis I [GO:0060903]; positive regulation of translation [GO:0045727]; rhythmic process [GO:0048511]; RNA 5'-end processing [GO:0000966]; spermatogenesis [GO:0007283]	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; RNA binding [GO:0003723]	GO:0000966; GO:0003723; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0007283; GO:0010370; GO:0010529; GO:0030718; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0042754; GO:0043046; GO:0043186; GO:0045727; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060903; GO:0071442; GO:0071546; GO:0097433; GO:1905538; GO:1990511; GO:1990923; GO:2000617	AAGGISR	9.220000267	1	1	0.1189465	630.4796792	13.13777	15.0307	0	15.26281	0	15.61786	0	14.90328	13.67746	14.8213	15.09955	0	0	0	0	15.51673	0	15.40236	0	0	16.54476	0	0	0	0	0	0	0	0	0	16.05606	0	0	0	0	0	0	0	19.10727	0	0	0	0	16.75133	16.91796	18.73892	0	0
Q8TC84	FANK1_HUMAN	Fibronectin type 3 and ankyrin repeat domains protein 1	FANK1 HSD13 UNQ6504/PRO21382	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]"	ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]"		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0036064; GO:0042981; GO:0043065; GO:0043066; GO:0045893; GO:0051091; GO:0097546	MEPQKIMPPSKPHPPVVGK	2.910000086	1	1	1.37E-12	2130.159493	13.10647	11.26327	0	11.50944	14.791	0	15.20616	14.38833	12.0619	14.92952	0	0	0	13.69481	0	0	0	0	0	0	0	0	0	0	15.28987	16.23543	0	0	0	14.2719	0	12.1682	0	0	0	0	0	16.22841	0	0	15.13491	0	13.19146	15.89952	13.03484	0	0	0
Q8TC99	FNDC8_HUMAN	Fibronectin type III domain-containing protein 8	FNDC8	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634	GLPLASK	4.010000229	1	1	0.252612094	685.6147736	12.16092	15.72284	14.46422	14.40861	15.55046	0	0	15.81584	0	15.00734	0	15.56014	15.19037	15.942	0	14.27755	0	0	13.61423	15.663	0	0	0	16.04181	16.02886	0	0	14.21149	0	0	0	0	0	0	16.22561	0	0	0	0	0	15.04307	0	0	0	0	0	0	15.89274
Q8TCC7	S22A8_HUMAN	"Solute carrier family 22 member 8 (Organic anion transporter 3, hOAT3)"	SLC22A8 OAT3	Homo sapiens (Human)	response to toxic substance [GO:0009636]; transport across blood-brain barrier [GO:0150104]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; response to toxic substance [GO:0009636]; transport across blood-brain barrier [GO:0150104]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]	GO:0005452; GO:0005886; GO:0009636; GO:0015301; GO:0016021; GO:0016323; GO:0016324; GO:0070062; GO:0150104	SSKALK	10.64000034	1	1	0.051969542	636.6305366	15.19012	15.47856	14.45317	0	14.50128	9.668531	13.57489	14.48513	15.00507	0	15.17748	16.2331	14.44115	0	0	0	13.98141	15.62301	17.05043	17.36993	16.63566	15.53495	15.62405	0	0	0	16.06153	0	0	0	15.66542	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TCF1	ZFAN1_HUMAN	AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1)	ZFAND1	Homo sapiens (Human)	cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]; cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617]	proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]	GO:0005737; GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843	MAATQK	5.829999924	1	1	0.067613895	664.8168562	0	15.12811	13.83053	0	14.85565	14.80216	15.84757	0	0	0	15.43354	0	0	0	0	0	16.03123	0	0	15.5209	0	0	16.44872	16.38561	0	0	0	0	16.34649	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TCG1	CIP2A_HUMAN	Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen)	CIP2A KIAA1524	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]	cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]	GO:0005737; GO:0005829; GO:0005886; GO:0016021; GO:0042803; GO:0045296	DPDSSSK	11.32999992	0.701355517	0.701355517	0.319776363	735.9442314	0	14.92314	0	14.95197	0	0	0	0	0	15.3773	13.04531	0	17.12453	0	0	16.41602	0	16.65405	15.72827	17.65853	0	15.18617	0	16.87683	16.616	0	16.24127	16.89169	16.91039	0	0	17.45144	0	16.79061	0	16.22759	18.25087	14.60982	18.96352	0	0	17.43034	0	0	17.23873	12.7551	16.32306	0
Q8TCG2	P4K2B_HUMAN	"Phosphatidylinositol 4-kinase type 2-beta, EC 2.7.1.67 (Phosphatidylinositol 4-kinase type II-beta, PI4KII-BETA)"	PI4K2B	Homo sapiens (Human)	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]	GO:0000139; GO:0004430; GO:0005524; GO:0005768; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0031901; GO:0046854	IVHLSNSFTQTVNCR	5.349999905	0.817293346	0.817293346	0.29945092	1776.159618	0	0	0	0	15.42528	13.94072	0	0	11.40873	0	0	0	0	0	0	0	15.25873	0	0	0	0	0	0	0	16.72283	0	12.94481	13.82883	0	13.48174	12.15224	0	0	14.6198	13.01873	18.0456	13.82236	0	19.2911	15.20562	0	0	6.793787	13.20364	0	15.0579	0	16.28421
Q8TCI5	PIFO_HUMAN	Protein pitchfork	PIFO C1orf88	Homo sapiens (Human)	cilium organization [GO:0044782]; embryonic heart tube left/right pattern formation [GO:0060971]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344]	ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]	ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; gamma-tubulin binding [GO:0043015]; kinesin binding [GO:0019894]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cilium organization [GO:0044782]; embryonic heart tube left/right pattern formation [GO:0060971]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344]	beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; gamma-tubulin binding [GO:0043015]; kinesin binding [GO:0019894]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]	GO:0005634; GO:0005802; GO:0008092; GO:0019894; GO:0019901; GO:0031267; GO:0031344; GO:0031410; GO:0033674; GO:0036064; GO:0043015; GO:0044782; GO:0048487; GO:0060971	GYTLGAR	6.550000191	0.021808356	0.021808356	0.254926136	738.10289	16.34102	15.65921	17.43496	15.88232	14.27868	14.8792	16.43623	0	17.0162	16.01588	15.76867	15.6483	15.07322	0	14.17316	16.19494	16.90329	16.06439	15.65293	15.30486	0	16.51535	16.21544	0	15.87245	16.7763	16.61494	16.47174	15.08474	0	16.81849	0	17.39788	16.52913	16.52363	15.56295	16.40722	17.63088	17.28185	15.84463	16.63709	14.25961	0	0	16.00076	15.25296	16.24287	0
Q8TCJ0	FBX25_HUMAN	F-box only protein 25	FBXO25 FBX25	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]	actin binding [GO:0003779]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0016567; GO:0019005	QVNNGLTLSDLPLHMLNNILYR	5.170000076	1	1	0.416412996	2537.937302	14.10965	0	0	0	0	17.03706	0	0	0	19.54744	0	19.27054	0	0	0	0	0	0	0	0	0	19.72465	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.1098	0	0	0	0	0	0
Q8TCJ2	STT3B_HUMAN	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, Oligosaccharyl transferase subunit STT3B, STT3-B, EC 2.4.99.18 (Source of immunodominant MHC-associated peptides homolog)"	STT3B SIMP	Homo sapiens (Human)	co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]	dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]	GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872	IAEGEHPK	3.650000095	1	1	1.15E-12	880.0150717	15.84884	0	13.60134	11.12806	12.53586	13.27667	15.12658	0	0	0	0	16.50212	0	0	0	0	0	0	0	0	14.73446	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95382	15.65087	0	0	0	0	0	15.13818	0
Q8TCN5	ZN507_HUMAN	Zinc finger protein 507	ZNF507 KIAA1084	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872	SQKCLLIGK	6.639999866	1	1	4.58E-13	1046.359661	13.73115	12.97482	14.57596	13.72889	13.84526	13.38315	13.32081	15.16822	13.59157	0	15.25517	0	11.8271	14.59583	14.3381	15.10871	0	11.66999	14.59366	0	0	0	0	13.50858	0	14.487	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TCP9	F200A_HUMAN	Protein FAM200A	FAM200A C7orf38	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	TPESR	2.589999914	0.77814424	0.77814424	0.205763467	588.7709544	12.88859	15.31742	0	15.89995	13.64431	0	16.09799	0	0	16.08248	15.70099	0	0	0	0	0	16.05835	0	0	15.37608	0	0	0	0	16.43047	0	0	14.68843	14.62626	0	15.29874	0	0	0	0	0	0	0	17.32011	15.88781	0	0	0	0	0	0	0	0
Q8TCS8	PNPT1_HUMAN	"Polyribonucleotide nucleotidyltransferase 1, mitochondrial, EC 2.7.7.8 (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1, PNPase 1) (Polynucleotide phosphorylase-like protein)"	PNPT1 PNPASE	Homo sapiens (Human)	cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion morphogenesis [GO:0070584]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cell cycle [GO:0051726]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion morphogenesis [GO:0070584]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cell cycle [GO:0051726]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928]	3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]	GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0051726; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772	ALWSSAGSR	13.19999981	1	1	0.280979088	933.2701461	16.07443	15.24414	18.27845	0	0	0	0	15.86635	0	0	13.21226	15.21403	17.33488	14.35171	0	16.15065	14.37046	15.40017	13.14812	17.19142	0	0	0	18.30627	18.41099	0	14.79645	17.65886	15.72814	0	16.766	15.5072	16.5449	16.57867	0	15.26025	16.507	0	14.20133	0	15.37504	14.47443	0	0	17.15316	16.10555	0	0
Q8TCT0	CERK1_HUMAN	"Ceramide kinase, hCERK, EC 2.7.1.138 (Acylsphingosine kinase) (Lipid kinase 4, LK4)"	CERK KIAA1646	Homo sapiens (Human)	ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665]	ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]	GO:0000287; GO:0001727; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006665; GO:0006672; GO:0006687; GO:0016021; GO:0016310; GO:0102773	SAGVDQNHPR	4.53000021	1	1	0.288523876	1082.309079	14.54288	0	14.73298	13.81701	15.97608	0	13.75345	15.02216	0	15.365	0	0	0	0	0	0	14.8125	15.41753	16.05939	0	0	0	14.33083	0	0	0	0	0	0	0	0	0	0	0	16.02638	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TCT1	PHOP1_HUMAN	"Phosphoethanolamine/phosphocholine phosphatase, EC 3.1.3.75"	PHOSPHO1	Homo sapiens (Human)	bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; endochondral ossification [GO:0001958]; regulation of bone mineralization [GO:0030500]	cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]	cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphocholine phosphatase activity [GO:0052731]; phosphoethanolamine phosphatase activity [GO:0052732]; pyrophosphatase activity [GO:0016462]; bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; endochondral ossification [GO:0001958]; regulation of bone mineralization [GO:0030500]	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphocholine phosphatase activity [GO:0052731]; phosphoethanolamine phosphatase activity [GO:0052732]; pyrophosphatase activity [GO:0016462]	GO:0001958; GO:0005829; GO:0016462; GO:0016791; GO:0030282; GO:0030500; GO:0031012; GO:0035630; GO:0046872; GO:0052731; GO:0052732; GO:0065010	CPANMCK	4.539999962	1	1	0.302403251	897.0399517	0	0	17.66017	0	0	15.60572	19.52979	0	0	20.57155	0	0	0	0	0	0	0	0	18.42408	16.55342	0	0	0	17.98188	20.08363	18.59729	0	0	17.22932	0	0	17.71325	0	0	0	0	0	0	0	17.77034	16.43046	18.2951	0	16.8521	0	0	0	0
Q8TCT7	SPP2B_HUMAN	"Signal peptide peptidase-like 2B, SPP-like 2B, SPPL2b, EC 3.4.23.- (Intramembrane protease 4, IMP-4) (Presenilin homologous protein 4, PSH4) (Presenilin-like protein 1)"	SPPL2B IMP4 KIAA1532 PSL1	Homo sapiens (Human)	membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]	actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]"	"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0010803; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0071458; GO:0071556	VRLAQGSGAR	1.389999986	1	1	0.178640632	1015.276885	0	0	0	0	15.43332	0	15.48472	11.3992	14.50672	17.76293	15.82216	13.84629	0	0	0	15.47433	0	0	13.37614	13.11517	0	14.51424	0	0	15.69511	0	15.07627	0	16.92862	0	16.22215	0	16.19332	0	0	16.57061	0	0	0	0	0	0	18.05144	11.06105	0	0	14.50906	16.55053
Q8TCU4	ALMS1_HUMAN	Alstrom syndrome protein 1	ALMS1 KIAA0328	Homo sapiens (Human)	endosomal transport [GO:0016197]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of stress fiber assembly [GO:0051492]	centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; endosomal transport [GO:0016197]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of stress fiber assembly [GO:0051492]	microtubule binding [GO:0008017]	GO:0000922; GO:0005813; GO:0005829; GO:0005929; GO:0008017; GO:0016197; GO:0046599; GO:0051492; GO:0120162	AKHVNLSASLDQNNSHFK	6.519999981	0.687035501	0.687035501	0.093787065	2009.961941	15.14036	0	0	0	0	14.41151	0	0	13.09694	0	0	0	12.34081	13.45802	15.04582	14.21266	0	0	0	16.68387	0	0	15.39091	0	15.29977	0	0	0	11.66188	15.2064	0	15.68479	0	0	13.94083	0	13.98617	0	0	15.2488	14.77399	0	0	0	0	0	0	15.12339
Q8TCU6	PREX1_HUMAN	"Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein, P-Rex1, PtdIns(3,4,5)-dependent Rac exchanger 1"	PREX1 KIAA1415	Homo sapiens (Human)	actin filament polymerization [GO:0030041]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of small GTPase mediated signal transduction [GO:0051056]; superoxide metabolic process [GO:0006801]; T cell differentiation [GO:0030217]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; actin filament polymerization [GO:0030041]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of small GTPase mediated signal transduction [GO:0051056]; superoxide metabolic process [GO:0006801]; T cell differentiation [GO:0030217]	enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]	GO:0005085; GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0006801; GO:0007186; GO:0019899; GO:0030041; GO:0030217; GO:0030593; GO:0035556; GO:0042119; GO:0043547; GO:0051056; GO:1900026	TPGKHPDHPAVQSALQAMK	10.27999973	1	1	0.460041314	2013.065307	17.86068	0	15.57006	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.68207	17.4043	0	0	0	0	0	0	0	19.45517	18.45407	0	0	0	0	0	0	0	18.48836	0	0	0	0	17.6916	17.97167	0	0
Q8TCX1	DC2L1_HUMAN	"Cytoplasmic dynein 2 light intermediate chain 1, Dynein 2 light intermediate chain"	DYNC2LI1 D2LIC LIC3 CGI-60	Homo sapiens (Human)	determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017]	apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]	apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; dynein heavy chain binding [GO:0045504]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017]	dynein heavy chain binding [GO:0045504]	GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005929; GO:0005930; GO:0007368; GO:0031514; GO:0035721; GO:0035735; GO:0035869; GO:0036064; GO:0045177; GO:0045504; GO:0097542; GO:1902017	SHVDKVIMK	13.59000015	0.335257381	0.335257381	0.281690436	1073.927128	17.52438	18.1919	17.76598	0	16.66889	0	0	17.46065	0	0	16.44457	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.68093	0	0	17.50896	17.97905	19.00114	0	17.77517	0	0	17.76596	0	17.63853	0	0	0	0
Q8TCX5	RHPN1_HUMAN	Rhophilin-1 (GTP-Rho-binding protein 1)	RHPN1 KIAA1929	Homo sapiens (Human)	negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]		GO:0005829; GO:0007165; GO:0051497	EELEELSGGVDPGRHGSEAVTVPMIPLGLK	3.910000086	0.351955891	0.351955891	0.284894929	3133.42029	0	14.86875	0	0	14.38184	0	14.41987	16.05383	0	15.568	0	0	13.76786	11.42242	13.53166	14.92031	15.29342	11.15787	0	0	0	14.17538	0	11.20104	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.67738	0	0	0	0	0	0	0	0
Q8TCY9	URGCP_HUMAN	Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein) (HBxAg up-regulated gene 4 protein)	URGCP KIAA1507 URG4	Homo sapiens (Human)	cell cycle [GO:0007049]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; cell cycle [GO:0007049]	GTP binding [GO:0005525]	GO:0005525; GO:0005634; GO:0005829; GO:0007049	RVSVEDMAHAAR	7.21999979	1	1	0.120024168	1340.016972	0	0	0	0	15.68687	0	0	0	0	0	0	0	0	0	0	0	0	16.16977	0	0	0	12.8859	0	0	0	0	17.03106	0	14.77904	0	0	0	0	15.19112	14.4931	14.84934	0	0	0	0	0	0	0	0	0	0	0	0
Q8TD07	RAE1E_HUMAN	"Retinoic acid early transcript 1E (Lymphocyte effector toxicity activation ligand) (NKG2D ligand 4, N2DL-4, NKG2DL4) (RAE-1-like transcript 4) (UL16-binding protein 4)"	RAET1E LETAL N2DL4 ULBP4 UNQ1867/PRO4303	Homo sapiens (Human)	natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]	natural killer cell lectin-like receptor binding [GO:0046703]	GO:0005615; GO:0005886; GO:0009897; GO:0016021; GO:0042267; GO:0045954; GO:0046703	LSKGDCDHWLR	5.570000172	1	1	0.166195481	1384.733877	16.1109	14.2065	0	12.43657	0	12.66953	0	15.92134	15.71118	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.67459	15.56586	17.40425	14.90388	0	15.23624	0	0	16.12901	0	15.97222	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TD08	MK15_HUMAN	"Mitogen-activated protein kinase 15, MAP kinase 15, MAPK 15, EC 2.7.11.24 (Extracellular signal-regulated kinase 7, ERK-7) (Extracellular signal-regulated kinase 8, ERK-8)"	MAPK15 ERK7 ERK8	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; dopamine uptake [GO:0090494]; endoplasmic reticulum organization [GO:0007029]; intracellular signal transduction [GO:0035556]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of metaphase/anaphase transition of meiosis I [GO:1905188]; positive regulation of spindle assembly [GO:1905832]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to ciliary transition zone [GO:1904491]; regulation of autophagy [GO:0010506]; regulation of cilium assembly [GO:1902017]; regulation of COPII vesicle coating [GO:0003400]	autophagosome [GO:0005776]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]	autophagosome [GO:0005776]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; SH3 domain binding [GO:0017124]; cellular response to DNA damage stimulus [GO:0006974]; dopamine uptake [GO:0090494]; endoplasmic reticulum organization [GO:0007029]; intracellular signal transduction [GO:0035556]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of metaphase/anaphase transition of meiosis I [GO:1905188]; positive regulation of spindle assembly [GO:1905832]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to ciliary transition zone [GO:1904491]; regulation of autophagy [GO:0010506]; regulation of cilium assembly [GO:1902017]; regulation of COPII vesicle coating [GO:0003400]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; SH3 domain binding [GO:0017124]	GO:0003400; GO:0003682; GO:0004672; GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005776; GO:0005794; GO:0005814; GO:0005911; GO:0005923; GO:0006974; GO:0007029; GO:0008284; GO:0010506; GO:0016301; GO:0017124; GO:0030336; GO:0031410; GO:0032212; GO:0035556; GO:0036064; GO:0046777; GO:0051973; GO:0072687; GO:0090494; GO:0106310; GO:1902017; GO:1904355; GO:1904491; GO:1905188; GO:1905832	RMFSTSALQGAQGGAR	2.420000076	1	1	9.23E-13	1649.395151	16.80287	0	0	0	0	0	16.46107	0	9.909394	0	0	0	0	14.34838	0	14.16784	0	0	0	0	0	0	0	0	15.71605	0	0	14.96881	15.8005	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.08361	0	0	0	0
Q8TD16	BICD2_HUMAN	"Protein bicaudal D homolog 2, Bic-D 2"	BICD2 KIAA0699	Homo sapiens (Human)	"centrosome localization [GO:0051642]; microtubule anchoring at microtubule organizing center [GO:0072393]; microtubule-based movement [GO:0007018]; minus-end-directed organelle transport along microtubule [GO:0072385]; mRNA transport [GO:0051028]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]	"annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein light intermediate chain binding [GO:0051959]; small GTPase binding [GO:0031267]; centrosome localization [GO:0051642]; microtubule anchoring at microtubule organizing center [GO:0072393]; microtubule-based movement [GO:0007018]; minus-end-directed organelle transport along microtubule [GO:0072385]; mRNA transport [GO:0051028]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein light intermediate chain binding [GO:0051959]; small GTPase binding [GO:0031267]	GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006890; GO:0007018; GO:0008093; GO:0015031; GO:0031267; GO:0031410; GO:0033365; GO:0034067; GO:0034452; GO:0051028; GO:0051642; GO:0051959; GO:0070507; GO:0070840; GO:0072385; GO:0072393	SEMEQLK	9.109999657	0.605595708	0.605595708	0.183295849	879.3412088	16.43767	17.12313	15.24043	16.65477	17.17879	15.84906	15.59508	15.07036	15.92773	15.84636	17.13406	16.49585	16.39933	0	16.19513	15.11018	17.23181	15.46912	16.55922	16.24661	16.68383	16.00318	0	15.86724	16.69668	16.72475	15.82052	15.89054	16.4075	14.60166	15.57034	14.89334	17.624	14.16453	14.9823	15.68038	12.86386	13.90638	17.89897	0	16.91393	15.55022	16.59487	17.05752	15.20684	15.61557	16.21581	14.70637
Q8TD19	NEK9_HUMAN	"Serine/threonine-protein kinase Nek9, EC 2.7.11.1 (Nercc1 kinase) (Never in mitosis A-related kinase 9, NimA-related protein kinase 9) (NimA-related kinase 8, Nek8)"	NEK9 KIAA1995 NEK8 NERCC	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; cell division [GO:0051301]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0007049; GO:0019901; GO:0046872; GO:0051301; GO:0106310	AGILHRDIK	6.159999847	1	1	0.146945461	1022.226655	15.18355	14.58583	0	0	12.31437	14.47405	13.83228	15.58258	15.35046	15.28033	15.49156	0	0	14.45542	0	16.72498	5.800009	13.13231	0	0	0	11.64495	14.02703	13.70685	15.02718	14.48296	0	14.25243	0	0	0	0	0	0	0	0	0	0	0	0	0	16.00804	0	0	0	0	0	14.48804
Q8TD20	GTR12_HUMAN	"Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12, GLUT-12)"	SLC2A12 GLUT12	Homo sapiens (Human)	hexose transmembrane transport [GO:0008645]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; hexose transmembrane transport [GO:0008645]	D-glucose transmembrane transporter activity [GO:0055056]	GO:0005886; GO:0008645; GO:0012505; GO:0016021; GO:0048471; GO:0055056	GCSLEQISMELAK	5.639999866	0.415431887	0.415431887	0.324447443	1482.402395	12.665	0	13.27989	0	0	0	15.65377	0	0	0	15.2922	0	0	0	0	0	0	16.7342	0	15.63645	0	16.63647	16.34128	16.17381	0	0	14.61605	17.50946	0	0	17.67051	0	15.62694	16.25699	0	0	0	0	0	0	10.42837	0	0	0	0	16.32295	18.37879	0
Q8TD30	ALAT2_HUMAN	"Alanine aminotransferase 2, ALT2, EC 2.6.1.2 (Glutamate pyruvate transaminase 2, GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)"	GPT2 AAT2 ALT2	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]	L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]	GO:0004021; GO:0005759; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853	EKESVLGNLAK	11.68999958	1	1	1.83E-12	1185.81842	14.64062	14.24808	15.52276	0	14.39675	13.21802	0	0	0	0	0	0	0	13.75876	0	0	0	0	0	15.54355	0	0	0	0	0	14.69783	0	0	0	0	14.17005	0	0	17.15592	17.36579	0	0	0	0	0	15.70025	0	0	0	0	0	0	0
Q8TD43	TRPM4_HUMAN	"Transient receptor potential cation channel subfamily M member 4, hTRPM4 (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4, LTrpC-4, LTrpC4) (Melastatin-4)"	TRPM4 LTRPC4	Homo sapiens (Human)	adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transmembrane transport [GO:0098655]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; sodium channel activity [GO:0005272]; adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transmembrane transport [GO:0098655]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310]	ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; sodium channel activity [GO:0005272]	GO:0002250; GO:0002407; GO:0002724; GO:0005227; GO:0005261; GO:0005272; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0007204; GO:0008284; GO:0010460; GO:0016925; GO:0019722; GO:0030502; GO:0034706; GO:0035774; GO:0042310; GO:0042802; GO:0043025; GO:0044214; GO:0045600; GO:0045668; GO:0045907; GO:0051289; GO:0070588; GO:0071318; GO:0086045; GO:0086047; GO:0086048; GO:0086091; GO:0089717; GO:0090263; GO:0098655; GO:0098662; GO:0098719; GO:0098911; GO:0099604; GO:1903949; GO:1904179; GO:1904199	LLISHGLSLGHFLTPMR	3.410000086	1	1	0.319050606	1908.064156	16.31234	15.48776	0	0	0	0	18.54104	0	0	15.82985	14.24853	14.84352	0	0	0	0	0	0	0	0	0	16.02689	0	0	0	15.71634	0	14.09261	0	0	0	17.322	0	0	0	0	0	0	0	15.54433	16.38716	0	16.80718	16.88084	15.51602	0	16.18625	0
Q8TD55	PKHO2_HUMAN	"Pleckstrin homology domain-containing family O member 2, PH domain-containing family O member 2 (Pleckstrin homology domain-containing family Q member 1, PH domain-containing family Q member 1)"	PLEKHO2 PLEKHQ1 PP9099	Homo sapiens (Human)	macrophage apoptotic process [GO:0071888]	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; macrophage apoptotic process [GO:0071888]		GO:0005576; GO:0071888; GO:1904813	SSGGLLGFWK	1.460000038	1	1	0.208493384	1051.632719	0	0	15.39883	0	13.7861	0	0	0	0	15.82952	18.25525	0	0	0	0	0	0	14.43269	0	0	0	0	0	0	13.40846	0	14.00084	0	14.98098	0	0	0	0	14.63841	0	17.1544	0	0	0	0	0	0	13.94038	11.61578	9.235785	0	0	0
Q8TD57	DYH3_HUMAN	"Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3, HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)"	DNAH3 DNAHC3B	Homo sapiens (Human)	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]	axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]	axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285	ADIVEK	7.03000021	1	1	0	671.4981047	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TD84	DSCL1_HUMAN	Down syndrome cell adhesion molecule-like protein 1 (Down syndrome cell adhesion molecule 2)	DSCAML1 DSCAM2 KIAA1132	Homo sapiens (Human)	axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	axon [GO:0030424]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]	axon [GO:0030424]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]	GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007411; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0016021; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632	DVFISSSERSFK	11	0.247435316	0.247435316	0.427160309	1401.883615	16.32287	17.10176	0	16.5701	15.70294	0	0	0	0	0	0	0	16.51046	16.93587	16.49928	0	17.06455	0	0	0	0	0	0	16.46707	17.27596	17.52847	16.93537	0	0	15.89714	0	0	0	0	17.03212	16.93188	18.65726	17.91803	0	18.32088	16.71653	16.80357	17.61308	17.02879	16.75389	17.68921	0	0
Q8TDB6	DTX3L_HUMAN	"E3 ubiquitin-protein ligase DTX3L, EC 2.3.2.27 (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2, Rhysin2)"	DTX3L BBAP	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]"	enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]	GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006325; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034	KPLSQQERDSCISPSEPETK	3.160000086	0.050530575	0.050530575	0.34350938	2315.600906	19.16304	0	0	18.63871	0	18.69721	0	0	0	0	0	0	18.70347	0	18.51	18.93075	17.86902	18.80663	0	17.80412	0	18.88157	18.63997	0	19.76582	20.17484	17.65652	19.2803	17.61223	0	19.08593	0	19.72489	19.42716	0	18.87216	16.48692	0	0	0	0	0	18.51071	19.00558	17.2036	17.32978	0	19.72456
Q8TDB8	GTR14_HUMAN	"Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14, GLUT-14)"	SLC2A14 GLUT14	Homo sapiens (Human)	cell differentiation [GO:0030154]; dehydroascorbic acid transport [GO:0070837]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; monosaccharide transmembrane transport [GO:0015749]; spermatogenesis [GO:0007283]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; cell differentiation [GO:0030154]; dehydroascorbic acid transport [GO:0070837]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; monosaccharide transmembrane transport [GO:0015749]; spermatogenesis [GO:0007283]	D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]	GO:0005355; GO:0005634; GO:0005886; GO:0005887; GO:0007283; GO:0015149; GO:0015749; GO:0016020; GO:0030154; GO:0033300; GO:0046323; GO:0055056; GO:0070837; GO:1904659	KEENATR	10.36999989	1	1	0.125795282	846.8381557	15.9595	0	0	0	0	0	0	0	14.22855	0	0	0	0	0	0	15.13125	0	0	16.5819	0	14.92321	0	0	0	16.4101	0	16.57187	15.51615	0	0	16.53274	0	0	0	15.08708	17.50836	15.6646	13.9937	15.13732	15.49432	15.15337	15.76736	16.52943	15.62059	15.2863	0	0	12.67853
Q8TDD1	DDX54_HUMAN	"ATP-dependent RNA helicase DDX54, EC 3.6.4.13 (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54)"	DDX54	Homo sapiens (Human)	intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016020; GO:0016070; GO:0016887; GO:0030331; GO:0030520	GPAAGPR	4.260000229	1	1	0.308281605	624.6402463	18.91857	0	0	0	18.31209	16.86449	0	0	17.91423	0	0	0	0	16.78446	0	0	0	0	18.58508	17.83259	0	0	0	0	0	18.41788	0	17.61168	0	17.98194	0	0	18.85188	0	0	0	0	0	18.8719	0	18.25465	17.36314	18.0849	0	0	0	0	18.37728
Q8TDD5	MCLN3_HUMAN	"Mucolipin-3 (Transient receptor potential channel mucolipin 3, TRPML3)"	MCOLN3	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626]	autophagosome membrane [GO:0000421]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	autophagosome membrane [GO:0000421]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; calcium ion transmembrane transport [GO:0070588]; inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626]	calcium channel activity [GO:0005262]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]	GO:0000421; GO:0005262; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0016020; GO:0016021; GO:0031901; GO:0031902; GO:0042491; GO:0070588; GO:0072345	DLPNSGK	6.619999886	1	1	0.265316229	731.0741885	0	0	18.18301	0	0	0	0	0	18.63192	0	0	0	0	0	23.29911	0	17.6091	0	0	0	0	0	20.29884	0	18.87464	0	0	0	0	0	0	0	0	0	0	19.40411	0	0	0	0	0	0	0	0	0	22.77874	0	0
Q8TDG4	HELQ_HUMAN	"Helicase POLQ-like, EC 3.6.4.12 (Mus308-like helicase) (POLQ-like helicase)"	HELQ HEL308	Homo sapiens (Human)	double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; double-strand break repair via homologous recombination [GO:0000724]; rRNA processing [GO:0006364]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]	GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0006364; GO:0016887; GO:1990518	NAMTGNAKAQTPIFSR	8.979999542	1	1	0.275732828	1723.652867	10.87353	15.83435	14.44276	15.65078	15.11525	14.3857	13.19976	14.69852	0	14.47778	10.5267	0	0	0	0	14.79646	0	0	13.67135	16.79175	0	0	0	12.74123	0	15.80237	15.55547	0	0	0	0	0	0	0	0	0	0	0	0	14.83191	0	0	13.28959	14.48642	14.95306	0	0	0
Q8TDI0	CHD5_HUMAN	"Chromodomain-helicase-DNA-binding protein 5, CHD-5, EC 3.6.4.12 (ATP-dependent helicase CHD5)"	CHD5 KIAA0444	Homo sapiens (Human)	"cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	"cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; metal ion binding [GO:0046872]	GO:0000792; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008285; GO:0016020; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035093; GO:0043967; GO:0046872; GO:0061628; GO:0098532; GO:0140658; GO:1901798	APPSPEQLPR	1.129999995	1	1	0.19553437	1091.156155	13.95941	12.27062	12.89274	13.96531	0	0	0	0	0	0	14.18663	14.55047	15.04747	0	14.52425	0	0	16.66263	15.01608	0	12.26036	0	0	14.35025	15.67654	0	12.20805	12.65875	0	12.63391	0	13.98532	13.70195	12.86382	15.19426	13.83162	0	16.2202	0	11.41152	15.36804	14.76477	0	11.92533	0	16.44921	12.98186	15.49604
Q8TDI8	TMC1_HUMAN	Transmembrane channel-like protein 1 (Transmembrane cochlear-expressed protein 1)	TMC1	Homo sapiens (Human)	auditory receptor cell development [GO:0060117]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426]; mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245]; auditory receptor cell development [GO:0060117]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005]	mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005887; GO:0008381; GO:0009897; GO:0032426; GO:0050910; GO:0060005; GO:0060117; GO:1903169	AAAAAGRQ	3.269999981	1	1	0.279931699	715.7685687	0	0	14.81861	15.97304	0	15.29367	14.3401	15.84215	0	15.98454	14.77867	0	0	15.57785	14.74167	15.41678	16.40452	15.30994	15.66574	16.53908	14.53561	0	16.00243	16.35716	0	17.36122	0	0	0	0	0	0	16.46755	15.44988	16.52538	0	17.01969	0	0	0	17.08521	15.60599	15.89241	15.09558	0	0	14.87131	0
Q8TDJ6	DMXL2_HUMAN	DmX-like protein 2 (Rabconnectin-3)	DMXL2 KIAA0856	Homo sapiens (Human)	vacuolar acidification [GO:0007035]	extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; small GTPase binding [GO:0031267]; vacuolar acidification [GO:0007035]	small GTPase binding [GO:0031267]	GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0098992	DRYLIPNIK	22.60000038	1	1	0.447940277	1131.48055	14.68608	0	16.29254	0	0	16.28823	0	0	0	17.33159	17.23052	0	0	0	0	16.30646	0	14.35219	0	0	16.62721	0	0	0	17.46776	0	16.25823	0	0	0	0	0	0	0	15.82915	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TDM5	SACA4_HUMAN	Sperm acrosome membrane-associated protein 4 (Sperm acrosomal membrane-associated protein 14)	SPACA4 SAMP14 UNQ3046/PRO9862	Homo sapiens (Human)	cell adhesion [GO:0007155]	acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]		GO:0001669; GO:0005576; GO:0005886; GO:0007155; GO:0031225	GCLRATSCGLEEPVSYR	8.819999695	1	1	0.144123938	1955.362406	10.61158	0	0	13.389	0	12.69088	12.91256	0	0	13.44531	0	0	13.11225	0	0	0	0	0	0	15.73355	0	0	13.62768	0	12.31644	10.88567	0	0	14.06237	0	6.886953	17.13215	14.76317	14.14705	15.27563	0	0	0	0	13.93666	0	0	15.66814	0	0	0	0	14.0932
Q8TDM6	DLG5_HUMAN	Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG)	DLG5 KIAA0583 PDLG	Homo sapiens (Human)	apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]	beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159]	GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609	IDYLLPGPGPAHSPQPSK	2.75	1	1	0.105460323	1873.87267	0	0	13.45215	0	14.67292	0	0	0	14.97821	15.95899	0	15.70401	13.71255	17.98226	12.948	12.88863	15.61197	14.92767	12.32803	16.1803	14.78202	15.85524	18.6683	15.57619	0	13.52975	0	14.62345	14.84335	12.31483	0	15.81522	16.34957	0	13.87949	15.23276	15.48888	14.92111	15.44909	0	0	8.747839	0	14.77553	0	15.57425	16.87635	16.479
Q8TDN1	KCNG4_HUMAN	Potassium voltage-gated channel subfamily G member 4 (Voltage-gated potassium channel subunit Kv6.4)	KCNG4 KCNG3	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	delayed rectifier potassium channel activity [GO:0005251]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005654; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0044325; GO:0051260; GO:0071805	ILYVMR	19.94000053	1	1	0.153403711	809.5115764	0	20.13599	0	20.74759	21.03032	20.75462	0	19.58412	17.54395	20.17444	18.93725	0	17.00015	20.22911	19.77697	21.23927	19.81938	17.44132	0	17.6695	19.76809	20.05876	20.51023	20.37867	0	19.08692	17.5072	0	0	20.25195	19.02717	18.77915	19.29958	17.50742	19.87067	19.68164	0	19.65912	20.23559	20.06116	19.52041	18.018	0	0	0	20.04546	0	17.454
Q8TDN4	CABL1_HUMAN	"CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1, Ik3-1)"	CABLES1 CABLES	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726]		GO:0005634; GO:0005829; GO:0007049; GO:0007399; GO:0051301; GO:0051726	LVQSS	10.46000004	0.58992821	0.58992821	0.244811307	532.5493496	15.90934	17.8764	17.49142	0	15.31659	16.5303	15.9829	0	15.899	17.36788	17.54342	17.06741	0	15.47209	16.80923	15.80783	14.84117	14.36759	0	17.01032	16.6498	0	17.20847	17.04842	13.57532	16.73534	0	0	15.95705	15.95479	0	16.1057	15.05271	17.40909	16.26926	15.89704	15.45611	18.00137	16.29979	16.31428	17.71532	16.26768	15.09373	17.90796	16.92286	15.14803	16.49427	12.93996
Q8TDR0	MIPT3_HUMAN	"TRAF3-interacting protein 1 (Interleukin-13 receptor alpha 1-binding protein 1) (Intraflagellar transport protein 54 homolog) (Microtubule-interacting protein associated with TRAF3, MIP-T3)"	TRAF3IP1 IFT54 MIPT3	Homo sapiens (Human)	cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type I interferon production [GO:0032480]; regulation of microtubule cytoskeleton organization [GO:0070507]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type I interferon production [GO:0032480]; regulation of microtubule cytoskeleton organization [GO:0070507]	microtubule binding [GO:0008017]	GO:0001738; GO:0001822; GO:0001933; GO:0005813; GO:0005929; GO:0005930; GO:0008017; GO:0030992; GO:0031333; GO:0032480; GO:0035720; GO:0035869; GO:0036064; GO:0042073; GO:0050687; GO:0060271; GO:0070507; GO:0097542; GO:0097546	LQQSPKPGEK	6.079999924	0.000341502	0.000341502	0.086491343	1112.623504	11.7907	17.30545	14.80459	14.17133	0	12.66168	13.23084	0	14.5846	16.92553	14.77744	0	14.95606	15.81464	15.87354	13.05693	15.53864	0	0	13.16844	14.59233	16.64536	14.48149	12.87518	17.50613	16.42326	15.23752	14.07249	13.02833	16.18395	19.27069	15.73502	16.32412	0	0	16.10221	17.28006	0	20.17052	13.72554	15.43886	15.27537	13.15953	14.93071	0	12.49508	15.57241	0
Q8TDR2	STK35_HUMAN	"Serine/threonine-protein kinase 35, EC 2.7.11.1 (CLP-36-interacting kinase 1, CLIK-1) (PDLIM1-interacting kinase 1) (Serine/threonine-protein kinase 35 L1)"	STK35 CLIK1 PDIK1 STK35L1	Homo sapiens (Human)	meiotic cell cycle [GO:0051321]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; meiotic cell cycle [GO:0051321]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016604; GO:0051321; GO:0106310	AATSRAAR	9.140000343	0.232363254	0.232363254	0.301338987	803.945781	16.04567	14.75369	0	0	0	0	13.66988	15.78452	10.92346	15.65005	16.00931	0	0	14.83038	0	15.47501	0	0	0	0	0	15.01175	16.01236	0	0	14.40727	0	15.51445	0	16.02918	15.49148	16.84851	0	15.42925	0	0	16.56279	16.73078	0	0	0	16.81606	14.81723	15.97206	0	0	16.04178	0
Q8TDS7	MRGRD_HUMAN	Mas-related G-protein coupled receptor member D (Beta-alanine receptor) (G-protein coupled receptor TGR7)	MRGPRD MRGD	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005615; GO:0005886; GO:0007186; GO:0016021	VHELMKR	6.980000019	1	1	0.17043171	913.5840186	13.33833	0	13.69035	14.94099	0	0	0	0	11.53045	0	0	12.06772	16.10824	15.08544	0	0	0	14.04543	12.91499	0	0	0	11.77254	14.25328	13.18639	0	14.52116	0	0	14.55114	13.20295	0	14.45639	14.88481	0	15.26322	15.97032	0	17.63487	15.51696	0	0	0	0	0	15.86271	0	0
Q8TDW0	LRC8C_HUMAN	Volume-regulated anion channel subunit LRRC8C (Factor for adipocyte differentiation 158) (Leucine-rich repeat-containing protein 8C)	LRRC8C AD158 FAD158	Homo sapiens (Human)	anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; fat cell differentiation [GO:0045444]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; fat cell differentiation [GO:0045444]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734]	volume-sensitive anion channel activity [GO:0005225]	GO:0005225; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0015734; GO:0015810; GO:0016020; GO:0034214; GO:0034702; GO:0045444; GO:0071470; GO:0098656; GO:0140361	ELPPWMYGLR	18.95000076	0.579352736	0.579352736	0.190152322	1262.479583	15.21237	15.1441	15.57856	0	0	15.03403	0	0	16.00945	0	14.12562	15.57917	0	0	0	14.31909	0	0	0	15.23043	14.91069	0	15.33568	0	0	15.65774	0	0	0	0	0	0	0	0	15.47637	0	14.56435	0	0	14.73203	15.70367	0	0	13.50111	15.77485	0	16.04107	0
Q8TDW7	FAT3_HUMAN	"Protocadherin Fat 3, hFat3 (Cadherin family member 15) (FAT tumor suppressor homolog 3)"	FAT3 CDHF15 KIAA1989	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005886; GO:0007156; GO:0016021; GO:0098609	DKGSPQK	8.899999619	1	1	0.219874389	758.1963402	0	16.92364	0	16.60888	14.54763	15.38398	12.79552	13.03091	14.33571	16.86621	15.46266	15.24894	16.50242	0	0	0	0	16.2219	0	0	0	17.07147	0	0	0	0	18.07904	0	0	9.988763	0	15.98729	0	0	0	0	0	16.52693	0	0	0	0	0	0	0	0	0	0
Q8TDX6	CGAT1_HUMAN	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1, CsGalNAcT-1, EC 2.4.1.174 (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1, Beta4GalNAcT-1)"	CSGALNACT1 CHGN GALNACT1 UNQ656/PRO1287	Homo sapiens (Human)	"cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]	"Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]; cartilage development [GO:0051216]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"	acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]	GO:0000139; GO:0001958; GO:0008376; GO:0008955; GO:0015014; GO:0015020; GO:0019276; GO:0030166; GO:0030173; GO:0030198; GO:0030206; GO:0030210; GO:0032580; GO:0046398; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050653; GO:0051216	LILFRPFGPIMK	3.670000076	1	1	0.237452223	1431.243301	0	14.15488	0	0	0	14.18811	0	0	0	0	0	0	0	12.03644	0	0	0	13.33	0	0	0	0	0	0	16.53439	14.59749	15.53332	0	0	0	0	0	0	15.60044	14.91321	0	14.95437	18.07516	0	15.67576	15.12354	15.93044	0	0	0	12.67806	0	0
Q8TDX7	NEK7_HUMAN	"Serine/threonine-protein kinase Nek7, EC 2.7.11.1 (Never in mitosis A-related kinase 7, NimA-related protein kinase 7)"	NEK7	Homo sapiens (Human)	cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000922; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032212; GO:0035865; GO:0046872; GO:0051225; GO:0051973; GO:0106310; GO:1900227; GO:1904355	QLVNMCINPDPEK	10.77000046	1	1	0.242353409	1573.403311	0	0	18.46668	0	0	0	18.59229	0	19.01768	19.28768	17.01111	0	19.09958	0	0	0	0	0	0	0	19.11231	0	0	0	0	19.32209	0	0	0	0	17.60864	0	0	0	16.5188	0	0	0	19.05249	0	0	0	0	17.50686	0	0	17.48807	0
Q8TDX9	PK1L1_HUMAN	Polycystic kidney disease protein 1-like 1 (PC1-like 1 protein) (Polycystin-1L1)	PKD1L1 UNQ5785/PRO19563	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986]	calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]	calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; calcium channel activity [GO:0005262]; cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986]	calcium channel activity [GO:0005262]	GO:0003127; GO:0005262; GO:0005929; GO:0016020; GO:0034704; GO:0050982; GO:0060170; GO:0070986; GO:0097730; GO:0098609	APARLTSK	12.52999973	1	1	0.029134956	842.3313627	14.19963	14.7767	15.6013	0	14.86143	0	0	0	0	0	0	0	0	0	15.6963	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TDY2	RBCC1_HUMAN	"RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa, FIP200)"	RB1CC1 KIAA0203 RBICC	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; reticulophagy [GO:0061709]	Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; reticulophagy [GO:0061709]	molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]	GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0001889; GO:0001934; GO:0005764; GO:0005789; GO:0005829; GO:0006468; GO:0006914; GO:0007049; GO:0007507; GO:0008285; GO:0010508; GO:0019898; GO:0019901; GO:0030242; GO:0031965; GO:0034045; GO:0034727; GO:0045793; GO:0046330; GO:0046777; GO:0060090; GO:0061709; GO:0061723; GO:1903059; GO:1990316; GO:2001237	CFDSMSR	7.010000229	1	1	0.291944089	918.0643916	0	0	0	16.39437	0	0	0	0	15.27579	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.00496	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TDY4	ASAP3_HUMAN	"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 (Development and differentiation-enhancing factor-like 1) (Protein up-regulated in liver cancer 1)"	ASAP3 DDEFL1 UPLC1	Homo sapiens (Human)	cell migration [GO:0016477]; positive regulation of GTPase activity [GO:0043547]; regulation of stress fiber assembly [GO:0051492]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cell migration [GO:0016477]; positive regulation of GTPase activity [GO:0043547]; regulation of stress fiber assembly [GO:0051492]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0001726; GO:0005096; GO:0005654; GO:0005829; GO:0005925; GO:0016477; GO:0043231; GO:0043547; GO:0046872; GO:0051492	CFDLVTHNR	6.050000191	1	1	0.140314493	1162.235896	11.17728	15.0922	14.97553	13.55942	13.67183	14.25416	13.18302	0	10.90459	0	0	0	0	11.0505	0	0	0	0	0	0	0	0	0	14.09227	0	0	0	0	0	0	0	0	9.056863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TDY8	IGDC4_HUMAN	"Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36, hDDM36)"	IGDCC4 DDM36 KIAA1628 NOPE	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion [GO:0098609]		GO:0005886; GO:0016021; GO:0098609	MARGDAGR	12.18999958	0.001351809	0.001351809	0.082454562	849.4250625	0	16.58228	16.11173	13.93285	0	15.91951	16.40915	13.81233	8.133709	12.8503	14.25709	16.05602	16.5856	0	15.09345	15.75173	16.34545	15.34151	16.52417	17.38664	17.10845	0	15.82578	0	17.11922	14.78808	15.61301	14.37889	15.87973	14.59309	15.67543	15.33964	0	13.07388	16.23683	15.76749	15.39309	0	15.29304	16.27057	0	17.08583	15.57667	16.0782	17.2165	0	18.13985	15.47138
Q8TDZ2	MICA1_HUMAN	"[F-actin]-monooxygenase MICAL1, EC 1.14.13.225, EC 1.6.3.1 (Molecule interacting with CasL protein 1, MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains)"	MICAL1 MICAL NICAL	Homo sapiens (Human)	actin filament bundle assembly [GO:0051017]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; intermediate filament [GO:0005882]; midbody [GO:0030496]; plasma membrane [GO:0005886]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; intermediate filament [GO:0005882]; midbody [GO:0030496]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin filament bundle assembly [GO:0051017]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417]"	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]"	GO:0001933; GO:0003779; GO:0005737; GO:0005829; GO:0005882; GO:0005886; GO:0007010; GO:0007165; GO:0015629; GO:0016174; GO:0016709; GO:0017124; GO:0019417; GO:0019901; GO:0030042; GO:0030496; GO:0031267; GO:0043154; GO:0045171; GO:0046872; GO:0051015; GO:0051017; GO:0071949; GO:1903305; GO:1990026	LLLGLVGDCLVEPFWPLGTGVAR	9.989999771	1	1	0.165560342	2483.018451	15.10071	0	13.8914	0	0	0	13.25285	0	16.05996	0	0	0	14.68258	0	0	0	0	12.87556	0	0	0	15.8265	0	0	0	0	16.09099	0	16.98783	0	16.79307	0	15.17884	14.16339	15.886	0	0	0	13.98377	0	15.13101	15.2253	0	0	0	15.00719	0	0
Q8TE04	PANK1_HUMAN	"Pantothenate kinase 1, hPanK, hPanK1, EC 2.7.1.33 (Pantothenic acid kinase 1)"	PANK1 PANK	Homo sapiens (Human)	coenzyme A biosynthetic process [GO:0015937]	cell periphery [GO:0071944]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; recycling endosome [GO:0055037]	cell periphery [GO:0071944]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803]; coenzyme A biosynthetic process [GO:0015937]	acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803]	GO:0004594; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0015937; GO:0030136; GO:0042803; GO:0055037; GO:0071944; GO:1905502	FIQMGSEK	6.769999981	0.516967356	0.516967356	0.244192104	956.4874686	16.16474	14.20439	15.08012	16.13005	0	16.65525	14.44478	0	0	16.8529	16.19786	16.11118	16.14778	16.32191	0	0	0	15.34992	15.2942	0	16.28665	16.49405	0	17.45062	17.31873	0	16.51346	15.67794	16.91068	14.97647	17.0073	16.06874	13.28098	15.80163	0	14.01193	14.33738	16.56282	13.81921	0	16.32978	16.45491	15.44288	15.84772	15.19622	15.3171	15.5075	16.7918
Q8TE23	TS1R2_HUMAN	Taste receptor type 1 member 2 (G-protein coupled receptor 71) (Sweet taste receptor T1R2)	TAS1R2 GPR71 T1R2 TR2	Homo sapiens (Human)	detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytokinesis [GO:0032467]; sensory perception of sweet taste [GO:0050916]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sweet taste receptor complex [GO:1903767]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sweet taste receptor complex [GO:1903767]; G protein-coupled receptor activity [GO:0004930]; sweet taste receptor activity [GO:0033041]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytokinesis [GO:0032467]; sensory perception of sweet taste [GO:0050916]	G protein-coupled receptor activity [GO:0004930]; sweet taste receptor activity [GO:0033041]; taste receptor activity [GO:0008527]	GO:0001582; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008527; GO:0016021; GO:0032467; GO:0033041; GO:0043235; GO:0050916; GO:1903767	STCTKR	3.319999933	1	1	0.200344758	754.4989976	0	0	0	0	13.81578	0	0	0	0	0	13.19112	16.64236	0	14.25589	0	0	0	16.50818	14.95438	0	0	0	15.6403	17.04819	0	15.39191	0	0	15.63986	17.64411	15.85571	17.22101	0	0	0	0	0	0	0	0	0	0	0	16.14584	13.36235	13.57628	14.92873	16.60017
Q8TE49	OTU7A_HUMAN	"OTU domain-containing protein 7A, EC 3.4.19.12 (Zinc finger protein Cezanne 2)"	OTUD7A C15orf16 CEZANNE2 OTUD7	Homo sapiens (Human)	negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]	DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]	GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0016579; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947	LAHLILSLEAK	12.18999958	0.214168325	0.214168325	0.406729302	1208.503324	12.55387	0	0	11.08895	15.06038	14.35829	15.05594	15.16307	14.20216	13.64739	0	15.64723	16.22289	14.63476	15.37539	15.88073	0	0	0	0	0	15.92919	0	0	15.21316	0	0	0	0	0	0	13.24914	15.65174	0	14.52311	0	15.99454	0	16.11612	0	0	0	17.15427	15.57552	0	0	0	0
Q8TE56	ATS17_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 17, ADAM-TS 17, ADAM-TS17, ADAMTS-17, EC 3.4.24.-"	ADAMTS17	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005576; GO:0030198; GO:0031012; GO:0046872	DFYANKMR	8.470000267	1	1	0.141846866	1041.660139	16.49144	0	14.9462	14.59325	15.93838	0	16.1431	15.58598	15.52094	15.33441	15.54493	15.96228	16.0624	15.30424	15.2801	14.92524	0	15.91259	14.73446	15.53007	13.14162	0	0	0	0	15.23269	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.7683	0	15.19982	16.83657	0	0	0	0
Q8TE57	ATS16_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 16, ADAM-TS 16, ADAM-TS16, ADAMTS-16, EC 3.4.24.-"	ADAMTS16 KIAA2029	Homo sapiens (Human)	branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017	MMQNHGHENITTYVLTILNMVSALFK	9.539999962	1	1	0.13634033	3056.972592	14.39001	0	0	0	0	15.04827	0	0	14.58524	13.26791	13.11746	0	0	14.74919	0	0	0	0	0	0	13.88544	0	0	0	0	13.27711	0	0	13.07232	10.01367	0	12.83105	0	0	0	0	0	11.76329	0	14.1776	0	0	0	0	13.26834	0	0	0
Q8TE58	ATS15_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 15, ADAM-TS 15, ADAM-TS15, ADAMTS-15, EC 3.4.24.-"	ADAMTS15	Homo sapiens (Human)	extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]	endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005615; GO:0007520; GO:0008201; GO:0008270; GO:0009986; GO:0022617; GO:0030198; GO:0031012; GO:0050840; GO:0062023	DSGPK	17.46999931	0.221255839	0.221255839	0.133997337	503.300997	16.56945	16.64106	16.87164	16.46061	16.72318	16.37738	15.71325	16.18946	16.44351	16.53051	16.08587	16.68821	16.51105	0	16.32083	16.76011	17.32802	15.95105	16.66728	17.02571	17.02974	17.09129	18.39037	16.79289	18.23936	16.24955	16.25414	16.94776	15.79244	16.52396	17.13725	16.00481	17.30342	15.63207	15.98984	16.07772	16.90418	16.89466	14.70961	16.51072	15.59386	17.1069	17.26913	17.00226	18.12878	17.19694	17.09869	18.39899
Q8TE67	ES8L3_HUMAN	"Epidermal growth factor receptor kinase substrate 8-like protein 3, EPS8-like protein 3 (Epidermal growth factor receptor pathway substrate 8-related protein 3, EPS8-related protein 3)"	EPS8L3 EPS8R3	Homo sapiens (Human)	positive regulation of ruffle assembly [GO:1900029]; regulation of hair cycle [GO:0042634]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; positive regulation of ruffle assembly [GO:1900029]; regulation of hair cycle [GO:0042634]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005886; GO:0007266; GO:0032587; GO:0035023; GO:0042634; GO:1900029	MLGISP	4.639999866	1	1	0.032382503	616.7676866	0	0	0	0	15.1558	14.55559	0	0	0	0	0	14.36029	15.45438	0	0	0	0	0	15.32663	0	16.68366	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.97606	0	0	0	0	0	0	0	0	0	0	0	0
Q8TE68	ES8L1_HUMAN	"Epidermal growth factor receptor kinase substrate 8-like protein 1, EPS8-like protein 1 (Epidermal growth factor receptor pathway substrate 8-related protein 1, EPS8-related protein 1)"	EPS8L1 DRC3 EPS8R1 PP10566	Homo sapiens (Human)	positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; T cell receptor binding [GO:0042608]; positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; T cell receptor binding [GO:0042608]	GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0032587; GO:0032991; GO:0035023; GO:0042608; GO:0045296; GO:0050790; GO:0070062; GO:1900029	AVPGPR	3.140000105	1	1	0.10139276	596.4259217	0	16.89377	17.19362	0	0	0	0	14.83942	0	0	0	0	0	17.37925	0	15.77369	12.76365	16.18572	16.54184	0	0	0	0	15.8716	17.0913	15.62008	0	0	0	16.32821	0	0	17.26969	17.84556	0	0	0	0	0	15.21115	0	0	0	0	16.1174	17.05973	0	0
Q8TE73	DYH5_HUMAN	Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)	DNAH5 DNAHC5 HL1 KIAA1603	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0097729	AVLAVLAAAK	11.93999958	0.104840428	0.104840428	0.277290624	927.2239006	17.80235	0	18.51057	17.69089	0	17.55509	19.31564	19.83901	0	20.24221	17.41334	0	17.59331	17.70084	0	17.76688	0	16.51608	17.45742	0	0	17.53378	17.08668	0	18.40882	18.56997	19.41413	18.24942	18.60291	16.77703	19.07138	19.92961	17.46701	0	0	20.67403	18.53264	18.30394	0	0	17.61625	17.12069	18.58105	0	16.78748	0	17.04395	19.32232
Q8TE76	MORC4_HUMAN	MORC family CW-type zinc finger protein 4 (Zinc finger CW-type coiled-coil domain protein 2) (Zinc finger CW-type domain protein 4)	MORC4 ZCW4 ZCWCC2	Homo sapiens (Human)		nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP hydrolysis activity [GO:0016887]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	ATP hydrolysis activity [GO:0016887]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005654; GO:0008270; GO:0016887; GO:0035064	GPFVAVVGVAKGVR	10.97000027	1	1	0.299661062	1356.249284	0	0	0	0	0	0	20.02043	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TE77	SSH3_HUMAN	"Protein phosphatase Slingshot homolog 3, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 3, SSH-3L, hSSH-3L)"	SSH3 SSH3L	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]	actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0008138; GO:0030036; GO:0030837	SPPGSGASTPVGPWDQAVQRR	2.359999895	1	1	2.30E-12	2145.638137	14.88529	15.02227	0	0	12.4876	0	0	9.559211	0	0	0	0	0	0	0	14.67459	13.75355	0	0	0	0	0	0	0	0	0	0	13.13845	0	0	16.08685	15.83161	0	0	13.1886	14.20297	14.60721	13.37778	0	15.04665	0	0	0	0	0	0	0	0
Q8TE82	S3TC1_HUMAN	SH3 domain and tetratricopeptide repeat-containing protein 1	SH3TC1	Homo sapiens (Human)						SSLISMQGPVSELESAIFLNEEEK	2.900000095	1	1	0.222890633	2637.730268	15.70691	14.1219	14.21744	14.8911	14.27733	0	0	11.97334	0	0	0	13.2992	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TE85	GRHL3_HUMAN	Grainyhead-like protein 3 homolog (Sister of mammalian grainyhead) (Transcription factor CP2-like 4)	GRHL3 SOM TFCP2L4	Homo sapiens (Human)	central nervous system development [GO:0007417]; cochlea morphogenesis [GO:0090103]; ectoderm development [GO:0007398]; epidermis development [GO:0008544]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; eyelid development in camera-type eye [GO:0061029]; gene expression [GO:0010467]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; central nervous system development [GO:0007417]; cochlea morphogenesis [GO:0090103]; ectoderm development [GO:0007398]; epidermis development [GO:0008544]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; eyelid development in camera-type eye [GO:0061029]; gene expression [GO:0010467]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060]"	"chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001736; GO:0001843; GO:0005634; GO:0005654; GO:0006357; GO:0007389; GO:0007398; GO:0007417; GO:0008544; GO:0010467; GO:0010628; GO:0031490; GO:0032956; GO:0042060; GO:0043547; GO:0043565; GO:0045944; GO:0061029; GO:0061436; GO:0090103; GO:0090179	GLALSSNKVK	7.96999979	1	1	0.513697616	1017.4865	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.31338	0	0	0	0	18.92066	0	0	0	0	0	0	0	0	0	0	0	0	19.3937	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TE96	DQX1_HUMAN	"ATP-dependent RNA helicase DQX1, EC 3.6.4.12 (DEAQ box polypeptide 1)"	DQX1	Homo sapiens (Human)		spliceosomal complex [GO:0005681]	spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]	GO:0003678; GO:0003723; GO:0005524; GO:0005681; GO:0016887	SVYNPR	11.02999973	0.752141774	0.752141774	0.185024702	738.3188334	13.89997	15.37183	16.76664	16.47644	15.74157	0	0	0	14.41747	15.28968	16.31939	14.93841	0	0	0	15.79163	0	0	0	16.75343	17.50976	16.0811	0	15.65609	0	16.39473	16.12955	0	0	15.46397	17.16299	15.92384	0	0	0	0	15.98299	15.79186	15.71075	16.78268	0	0	0	14.94135	16.71176	16.6564	13.12476	0
Q8TE99	PXYP1_HUMAN	"2-phosphoxylose phosphatase 1, EC 3.1.3.- (Acid phosphatase-like protein 2) (Xylosyl phosphatase) (epididymis luminal protein 124)"	PXYLP1 ACPL2 HEL124 XYLP UNQ370/PRO706	Homo sapiens (Human)	chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]	phosphatase activity [GO:0016791]	GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650	NGMSSK	8.06000042	0.392581314	0.392581314	0.222121475	639.6196281	15.49713	14.62225	15.76488	0	0	0	0	0	14.66878	16.46972	0	14.78605	16.43305	16.63189	16.5031	15.08926	16.19436	16.67245	17.3604	16.17033	16.79427	16.22281	17.78685	0	16.84155	0	0	14.92598	16.32606	16.1818	16.13745	16.85212	15.42033	17.11849	16.07221	17.28319	17.84859	16.7387	18.41598	17.25022	0	17.26208	18.72656	17.30162	16.47283	0	17.60077	18.29008
Q8TEA7	TBCK_HUMAN	TBC domain-containing protein kinase-like protein	TBCK TBCKL HSPC302	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; regulation of TOR signaling [GO:0032006]	cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]	cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; regulation of TOR signaling [GO:0032006]	ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]	GO:0004672; GO:0005096; GO:0005524; GO:0005737; GO:0008283; GO:0030036; GO:0030496; GO:0032006; GO:0072686; GO:0090630	VDIPPLMR	14.75	1	1	0.23180386	941.65918	0	0	14.79589	0	0	16.06113	15.69044	16.29679	0	0	14.71311	16.10786	15.45835	0	0	15.36082	0	0	0	0	0	0	0	0	15.54536	0	16.22896	0	0	0	0	0	0	0	14.67247	0	0	0	16.44816	17.2517	16.90639	16.12325	15.66068	14.43826	15.77399	0	0	0
Q8TEB9	RHBL4_HUMAN	"Rhomboid-related protein 4, RRP4, EC 3.4.21.105 (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4)"	RHBDD1 RHBDL4 HSD-50 HSD50	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]"	endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]	GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0030176; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211	ALQASLWDR	1.75999999	1	1	0.125491124	1060.01064	0	14.1253	0	14.48575	12.38816	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.95979	0	0	0	15.45587	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TEC5	SH3R2_HUMAN	"E3 ubiquitin-protein ligase SH3RF2, EC 2.3.2.27 (Heart protein phosphatase 1-binding protein, HEPP1) (POSH-eliminating RING protein) (Protein phosphatase 1 regulatory subunit 39) (RING finger protein 158) (RING-type E3 ubiquitin transferase SH3RF2) (SH3 domain-containing RING finger protein 2)"	SH3RF2 POSH3 POSHER PPP1R39 RNF158	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]	metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; ubiquitin protein ligase activity [GO:0061630]	GO:0004864; GO:0005634; GO:0005654; GO:0008157; GO:0016567; GO:0019902; GO:0030335; GO:0031397; GO:0032436; GO:0043066; GO:0046329; GO:0046330; GO:0046872; GO:0051865; GO:0061630	GRSSMR	8.68999958	1	1	3.44E-13	708.5153085	0	15.0624	0	17.0663	17.81117	0	16.38017	0	0	0	0	14.89173	0	0	0	15.75856	16.47604	0	0	0	0	0	0	0	0	0	0	15.01039	0	0	15.39327	0	16.44941	0	16.35826	0	0	15.94842	0	0	0	0	0	0	0	0	0	0
Q8TED0	UTP15_HUMAN	U3 small nucleolar RNA-associated protein 15 homolog	UTP15	Homo sapiens (Human)	positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]	GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0006364; GO:0045943; GO:2000234	EISHVLNFLIRNLSQPR	5.659999847	1	1	0.408592461	2035.686739	0	0	0	0	0	0	0	0	0	0	0	0	0	19.73301	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TED9	AF1L1_HUMAN	"Actin filament-associated protein 1-like 1, AFAP1-like protein 1"	AFAP1L1	Homo sapiens (Human)		cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; podosome [GO:0002102]	cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; podosome [GO:0002102]; SH3 domain binding [GO:0017124]	SH3 domain binding [GO:0017124]	GO:0002102; GO:0005829; GO:0017124; GO:0030054; GO:0042995	HQWPSEEASMHLVR	11.32999992	0.014918661	0.014918661	0.551537532	1723.36964	18.63997	14.03703	0	0	17.41491	0	0	0	0	0	0	18.65936	0	18.28901	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.33466	18.95541	0	0	0	0	0	0	0	0	0	0	18.32132	0	0	17.56869	0	0	18.15465
Q8TEK3	DOT1L_HUMAN	"Histone-lysine N-methyltransferase, H3 lysine-79 specific, EC 2.1.1.360 (DOT1-like protein) (Histone H3-K79 methyltransferase, H3-K79-HMTase) (Lysine N-methyltransferase 4)"	DOT1L KIAA1814 KMT4	Homo sapiens (Human)	DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin assembly [GO:0031507]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin assembly [GO:0031507]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200]	DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]	GO:0000077; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0008284; GO:0010467; GO:0018024; GO:0031151; GO:0031507; GO:0032200; GO:0032991; GO:0034729; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:2000677	ALTYNDLIQAQK	5.829999924	1	1	0.327856048	1379.701063	0	0	0	0	15.18888	0	0	16.15025	0	0	0	0	0	0	0	0	14.13286	16.09439	0	0	0	0	0	0	0	0	0	0	0	0	0	15.18484	0	14.84879	0	16.56213	0	0	0	0	8.791348	0	16.7087	0	14.28946	0	16.47789	0
Q8TEL6	TP4AP_HUMAN	"Short transient receptor potential channel 4-associated protein, Trp4-associated protein, Trpc4-associated protein (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein, Protein TRUSS)"	TRPC4AP C20orf188 TRRP4AP	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]	calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0005262; GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0070588; GO:0080008; GO:0140627; GO:1990756	ILAVTISEMDTGNDDK	5.260000229	1	1	0.273136641	1737.919826	14.20364	13.90382	15.39972	0	0	0	0	14.45096	15.53821	0	0	15.92622	0	13.06591	15.27644	14.67101	0	14.32341	0	14.8415	0	15.58951	0	0	15.26662	12.82298	15.43725	0	11.8613	0	0	0	0	16.95353	16.41256	12.80984	15.12099	15.55473	16.39544	14.67541	0	0	0	0	16.12436	16.2067	0	0
Q8TEM1	PO210_HUMAN	"Nuclear pore membrane glycoprotein 210, Nuclear pore protein gp210 (Nuclear envelope pore membrane protein POM 210, POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)"	NUP210 KIAA0906 PSEC0245	Homo sapiens (Human)	mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]		GO:0005635; GO:0005643; GO:0005789; GO:0006913; GO:0015031; GO:0016020; GO:0016021; GO:0031965; GO:0051028	QVVPVSSHR	10.59000015	0.326304048	0.326304048	0.445867451	1008.575027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97681	0	0	0	0	0	0	0	0	0	16.70813	11.67314	15.05638	15.23223	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.48071	0
Q8TEP8	CE192_HUMAN	"Centrosomal protein of 192 kDa, Cep192, Cep192/SPD-2"	CEP192 KIAA1569 PP8407	Homo sapiens (Human)	centriole replication [GO:0007099]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; centriole replication [GO:0007099]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617]	phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]	GO:0000242; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0009617; GO:0019901; GO:0019902; GO:0071539; GO:0090222; GO:0090307; GO:0120098; GO:0120099	ATSISTPSDSYSSVRNPR	7.019999981	1	1	5.25E-12	1921.347508	13.71037	14.86115	13.35138	11.6598	13.52153	14.37617	0	12.84079	0	12.21614	16.1369	12.53916	0	14.82531	14.70818	14.59259	14.19187	14.75235	0	15.55748	15.10823	13.94681	14.27351	16.12405	14.02837	15.72334	14.49738	15.31029	15.8431	14.91412	0	0	0	0	11.12461	0	13.59388	14.19388	0	14.83289	16.25475	0	14.42259	0	15.62839	0	0	0
Q8TEQ0	SNX29_HUMAN	Sorting nexin-29 (RUN domain-containing protein 2A)	SNX29 RUNDC2A	Homo sapiens (Human)			phosphatidylinositol binding [GO:0035091]	phosphatidylinositol binding [GO:0035091]	GO:0035091	GLALTAAAIK	2.940000057	0.446825057	0.446825057	0.178571466	928.9742289	0	0	0	12.117	14.7479	15.32773	13.75718	0	0	0	0	0	0	0	0	0	0	0	0	15.48923	0	0	0	0	14.78586	0	14.26393	0	0	0	0	0	0	0	0	16.33303	0	0	0	15.37651	0	0	0	0	0	0	0	0
Q8TEQ6	GEMI5_HUMAN	"Gem-associated protein 5, Gemin5"	GEMIN5	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]"	mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]	GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0065003; GO:0097504	YGNTKTYR	2.980000019	0.518285334	0.518285334	0.283567397	1002.966232	14.11532	0	0	21.25613	0	16.80761	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.175	0	0	18.50963	0	0	0	16.26668	20.60842	16.70977	17.71792	0	0	17.37402	0	0	0	0	0	0	0	0	0	17.95763	0	0
Q8TEQ8	PIGO_HUMAN	"GPI ethanolamine phosphate transferase 3, EC 2.-.-.- (Phosphatidylinositol-glycan biosynthesis class O protein, PIG-O)"	PIGO UNQ632/PRO1249	Homo sapiens (Human)	GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; GPI anchor biosynthetic process [GO:0006506]	mannose-ethanolamine phosphotransferase activity [GO:0051377]	GO:0005789; GO:0006506; GO:0016020; GO:0016021; GO:0051377	GAEATLPTVIAELQQFLRGAR	1.25999999	1	1	0.176732573	2242.400578	0	13.33617	11.84314	14.78666	0	11.15152	10.92742	12.45012	0	15.23952	12.61775	13.09317	13.82605	8.948967	0	16.94199	0	0	0	11.68055	0	0	9.370547	0	8.97318	0	14.02681	0	10.99315	0	0	0	0	0	0	0	16.67431	0	15.76407	13.25676	0	0	0	0	12.53512	0	11.89709	0
Q8TER0	SNED1_HUMAN	"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1, IRE-BP1)"	SNED1	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]	GO:0005112; GO:0005509; GO:0005576; GO:0007160; GO:0031012	EATDPAMLRR	4.630000114	1	1	0.082648888	1176.753664	14.59551	15.9258	0	0	0	0	15.41407	0	13.02441	0	12.19311	9.525046	15.74467	0	0	0	0	0	0	13.88467	0	0	0	0	0	0	15.93376	15.16683	0	0	0	0	12.23094	0	0	0	12.9281	0	14.59564	11.49137	12.56503	14.02729	0	0	0	0	0	0
Q8TER5	ARH40_HUMAN	Rho guanine nucleotide exchange factor 40 (Protein SOLO)	ARHGEF40 SOLO	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0005886; GO:0051056	CLAPGGGR	2.650000095	0.999322534	0.999322534	0.237611349	786.349484	15.65167	15.80911	14.18294	14.33985	0	0	0	13.77845	15.23705	15.4972	0	15.27263	0	14.88815	15.42273	16.17827	0	0	0	0	15.28285	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.52367	0	0	0	0	15.26618	0	0	0	0	0	16.14542	0
Q8TES7	FBF1_HUMAN	"Fas-binding factor 1, FBF-1 (Protein albatross)"	FBF1 ALB KIAA1863	Homo sapiens (Human)	apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162]	cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; spindle pole [GO:0000922]	cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; spindle pole [GO:0000922]; apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162]		GO:0000922; GO:0005813; GO:0005814; GO:0005829; GO:0030054; GO:0036064; GO:0043297; GO:0060271; GO:0090162; GO:0097539	AESMQRALEEQR	6.769999981	1	1	0.537984305	1464.323094	0	0	0	19.93709	0	0	0	0	0	0	0	0	0	0	0	18.65257	0	18.60157	0	0	0	0	0	0	19.16693	19.37957	18.29626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.28528	0	0	0	0
Q8TET4	GANC_HUMAN	"Neutral alpha-glucosidase C, EC 3.2.1.20"	GANC	Homo sapiens (Human)	N-glycan processing [GO:0006491]		"alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; N-glycan processing [GO:0006491]"	"alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]"	GO:0004553; GO:0004558; GO:0006491; GO:0030246; GO:0032450; GO:0090599	QYSHLTGTQAMPPLFSLGYHQCR	4.050000191	1	1	0.067222311	2692.609169	0	0	9.238907	0	0	0	0	0	0	0	0	0	0	0	0	19.82388	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.49998	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TEU7	RPGF6_HUMAN	"Rap guanine nucleotide exchange factor 6 (PDZ domain-containing guanine nucleotide exchange factor 2, PDZ-GEF2) (RA-GEF-2)"	RAPGEF6 PDZGEF2	Homo sapiens (Human)	microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087]	apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087]	GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005813; GO:0005829; GO:0005886; GO:0007265; GO:0016324; GO:0030033; GO:0030139; GO:0030742; GO:0031267; GO:0043087; GO:0043547; GO:0070300; GO:0072659	ANTVSGGR	4.139999866	1	1	0.174247064	762.5047497	11.74875	14.81814	0	0	0	13.3884	0	16.4794	17.25594	0	0	16.22809	15.65602	0	0	0	15.99014	15.42762	15.57086	0	16.05106	0	14.5086	0	14.84519	0	0	0	0	16.34877	15.76246	0	0	0	16.66505	0	17.81771	17.49529	16.99806	17.04287	15.44553	0	16.38727	16.4709	0	16.66547	16.20063	0
Q8TEU8	WFKN2_HUMAN	"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 (Growth and differentiation factor-associated serum protein 1, GASP-1, hGASP-1) (WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing-related protein) (WFIKKN-related protein)"	WFIKKN2 GASP1 WFIKKNRP UNQ9235/PRO31996	Homo sapiens (Human)	muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]	metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	GO:0001501; GO:0004867; GO:0005615; GO:0007179; GO:0008191; GO:0030512; GO:0032091; GO:0043392; GO:0048019; GO:0050431; GO:0055001; GO:0060021	LREVMHK	8.380000114	1	1	0.498420288	929.0238539	0	0	0	0	0	0	17.00144	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.74788	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TEV9	SMCR8_HUMAN	Guanine nucleotide exchange protein SMCR8 (Smith-Magenis syndrome chromosomal region candidate gene 8 protein)	SMCR8	Homo sapiens (Human)	autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of exocytosis [GO:0045920]; negative regulation of gene expression [GO:0010629]; negative regulation of immune response [GO:0050777]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]	Atg1/ULK1 kinase complex [GO:1990316]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793]	Atg1/ULK1 kinase complex [GO:1990316]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of exocytosis [GO:0045920]; negative regulation of gene expression [GO:0010629]; negative regulation of immune response [GO:0050777]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]	guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]	GO:0000785; GO:0004860; GO:0005085; GO:0005654; GO:0005737; GO:0006469; GO:0006914; GO:0010506; GO:0010629; GO:0016242; GO:0019901; GO:0032008; GO:0032045; GO:0043547; GO:0045920; GO:0050777; GO:0098793; GO:0098794; GO:1901098; GO:1902902; GO:1903432; GO:1990316	IPSAYPAGLSSDRHK	5.400000095	1	1	0.233892461	1599.184211	0	0	13.77792	0	17.95931	0	0	11.51496	15.62582	0	0	0	0	0	16.56394	16.36204	17.68144	10.34422	0	0	14.81524	0	0	0	16.21354	15.81617	0	15.71314	0	0	0	13.63947	14.12454	0	0	0	0	0	15.77447	0	0	0	0	0	0	16.99869	0	0
Q8TEW0	PARD3_HUMAN	"Partitioning defective 3 homolog, PAR-3, PARD-3 (Atypical PKC isotype-specific-interacting protein, ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha)"	PARD3 PAR3 PAR3A	Homo sapiens (Human)	asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; tight junction [GO:0070160]	"adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]"	"phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000226; GO:0005546; GO:0005547; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007155; GO:0007163; GO:0007205; GO:0007409; GO:0008104; GO:0008356; GO:0010801; GO:0012505; GO:0016324; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0033269; GO:0035091; GO:0043296; GO:0045197; GO:0051660; GO:0065003; GO:0070160; GO:0070830; GO:0090162; GO:0120157	GAAIQDGRLK	2.119999886	0.523690879	0.523690879	0	1025.99713	0	14.69765	0	0	0	0	14.12495	0	0	17.52412	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.22804	15.98691	0	15.78015	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TEW8	PAR3L_HUMAN	"Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein) (PAR3-beta) (Partitioning defective 3-like protein, PAR3-L protein)"	PARD3B ALS2CR19 PAR3B PAR3L	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; protein localization [GO:0008104]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; endomembrane system [GO:0012505]; protein-containing complex [GO:0032991]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; endomembrane system [GO:0012505]; protein-containing complex [GO:0032991]; phosphatidylinositol binding [GO:0035091]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; protein localization [GO:0008104]	phosphatidylinositol binding [GO:0035091]	GO:0000226; GO:0005912; GO:0005923; GO:0005938; GO:0007049; GO:0007155; GO:0008104; GO:0012505; GO:0016324; GO:0030010; GO:0030054; GO:0032991; GO:0035091; GO:0043296; GO:0045197; GO:0051301; GO:0051660	GFGAMLR	1.570000052	1	1	0.212847591	750.1233038	14.66766	15.53673	12.41709	0	15.26414	0	16.17571	14.03493	13.8673	16.58254	0	15.96217	0	0	0	0	0	15.56929	0	0	0	17.08916	0	0	15.48211	16.49153	16.82567	14.03051	0	17.09102	16.72412	0	0	14.8904	16.45088	0	16.08615	0	15.44731	15.76803	16.01759	0	0	0	0	15.63182	0	0
Q8TEY7	UBP33_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 33, EC 3.4.19.12 (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33) (VHL-interacting deubiquitinating enzyme 1, hVDU1)"	USP33 KIAA1097 VDU1	Homo sapiens (Human)	axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; negative regulation of protein binding [GO:0032091]; positive regulation of protein binding [GO:0032092]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; VCB complex [GO:0030891]	cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; VCB complex [GO:0030891]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; small GTPase binding [GO:0031267]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; negative regulation of protein binding [GO:0032091]; positive regulation of protein binding [GO:0032092]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; small GTPase binding [GO:0031267]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]	GO:0001664; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0009267; GO:0010506; GO:0016477; GO:0016579; GO:0030891; GO:0031267; GO:0032091; GO:0032092; GO:0044297; GO:0048471; GO:0050821; GO:0051298; GO:0070536; GO:0071108	EKMCNK	10.10000038	1	1	1.21E-13	826.4491774	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TF01	PNISR_HUMAN	"Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130, SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)"	PNISR C6orf111 SFRS18 SRRP130 HSPC261 HSPC306	Homo sapiens (Human)		cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016607; GO:0048786	QEPPQIDAVK	2.019999981	1.22E-05	1.22E-05	0.283660187	1124.735467	0	20.18651	17.46281	18.50309	0	17.35165	20.3693	0	19.24895	0	0	17.52437	18.11378	18.29048	21.03248	0	18.74127	0	18.63799	18.87059	18.59578	19.46684	0	20.20609	0	17.67901	0	0	0	0	19.09214	18.39883	20.03595	0	19.91899	0	0	18.80013	0	0	0	21.08394	0	0	20.56229	19.41624	20.89969	17.53142
Q8TF05	PP4R1_HUMAN	Serine/threonine-protein phosphatase 4 regulatory subunit 1	PPP4R1 MEG1 PP4R1	Homo sapiens (Human)	protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	protein phosphatase 4 complex [GO:0030289]	protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	protein phosphatase regulator activity [GO:0019888]	GO:0006468; GO:0006470; GO:0007165; GO:0019888; GO:0030289	MAPMVGK	6.300000191	0.717386782	0.717386782	0.242040325	750.0966825	0	15.86352	0	0	15.91328	0	0	0	15.38605	0	0	13.09426	13.84919	0	16.08796	16.21313	15.11016	0	0	0	0	0	0	0	0	14.6777	0	15.72521	15.74441	16.62186	16.86094	0	16.30299	15.71812	14.67633	0	16.36376	0	15.86507	14.44935	16.77736	16.48769	14.88441	15.22976	15.43171	0	15.44747	0
Q8TF09	DLRB2_HUMAN	"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2)"	DYNLRB2 DNCL2B DNLC2B ROBLD2	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0045505; GO:0097542	KHEIMVAPDK	2.609999895	1	1	0.27567704	1183.461439	0	0	0	15.1584	0	0	0	0	0	0	0	0	0	15.27525	0	0	0	0	0	0	0	0	0	17.1153	0	10.67537	0	15.14048	0	0	16.66038	0	0	0	0	0	0	15.93715	0	0	0	0	0	0	0	0	0	0
Q8TF17	S3TC2_HUMAN	SH3 domain and tetratricopeptide repeat-containing protein 2	SH3TC2 KIAA1985 PP12494	Homo sapiens (Human)	peripheral nervous system myelin maintenance [GO:0032287]; regulation of ERBB signaling pathway [GO:1901184]; regulation of intracellular protein transport [GO:0033157]	plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of ERBB signaling pathway [GO:1901184]; regulation of intracellular protein transport [GO:0033157]		GO:0005886; GO:0032287; GO:0033157; GO:0055037; GO:1901184	CFLPQNINPDLTLSFCVK	1.519999981	1	1	0.201690884	2166.53747	11.72418	14.50118	13.327	0	0	11.84793	0	0	0	14.9322	0	0	0	13.9762	0	15.87842	0	0	0	14.91058	11.9608	0	0	0	15.01016	0	13.13631	0	0	0	0	0	0	0	0	0	0	16.27621	0	0	0	0	0	0	0	0	0	0
Q8TF20	ZN721_HUMAN	Zinc finger protein 721	ZNF721 KIAA1982	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	AFRQSAILYVHR	6.429999828	1	1	0.050563398	1458.930361	17.051	17.90167	15.57557	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TF21	ANR24_HUMAN	Ankyrin repeat domain-containing protein 24	ANKRD24 KIAA1981	Homo sapiens (Human)						QSVVPASEHR	3.710000038	1	1	0.185233823	1111.903359	0	0	13.26582	6.691679	14.44095	0	0	0	0	0	15.68603	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.26745	10.45381	15.97773	14.26221	0	13.58111	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TF27	AGA11_HUMAN	"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11, AGAP-11 (Centaurin-gamma-like protein KIAA1975)"	AGAP11 KIAA1975	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005634; GO:0046872	WPSLATSACAPISSSK	1.289999962	1	1	6.92E-13	1662.234518	16.96	15.23095	0	0	0	0	0	0	0	0	0	15.56068	12.59678	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.35475	0	16.67137	15.7237	0	0	0	0	0	15.07631	0	0	0	13.00656	0	0	0	0
Q8TF39	ZN483_HUMAN	Zinc finger protein 483 (Zinc finger protein with KRAB and SCAN domains 16)	ZNF483 KIAA1962 ZKSCAN16	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AFRQNSCLTR	6.21999979	1	1	0.405025969	1252.05232	0	13.52827	0	15.45906	13.82574	0	0	0	13.90574	0	11.46046	0	0	0	0	15.82318	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.71692	0	0	0	0	0	17.6797	0	0	0	0	0	0	17.32411	0	0
Q8TF40	FNIP1_HUMAN	Folliculin-interacting protein 1	FNIP1 KIAA1961	Homo sapiens (Human)	cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]	ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0000122; GO:0001932; GO:0001934; GO:0002327; GO:0002904; GO:0005085; GO:0005737; GO:0005765; GO:0005829; GO:0008285; GO:0009267; GO:0019899; GO:0031334; GO:0031929; GO:0032007; GO:0032008; GO:0033138; GO:0042030; GO:0043154; GO:0051087; GO:2000973	CSSDANMLGEMMFGSVAMSYKGSTLK	3.180000067	0.620553792	0.620553792	1.83E-12	2835.000887	15.15857	0	14.11681	12.20256	11.85872	14.59538	11.80924	14.51297	10.71229	0	0	0	0	0	0	0	0	0	14.61601	0	0	0	16.38462	13.93407	15.25685	0	0	0	0	0	0	0	0	0	15.01797	0	15.91522	0	0	14.13863	0	12.11839	0	0	0	0	15.11202	0
Q8TF44	C2C4C_HUMAN	C2 calcium-dependent domain-containing protein 4C (Nuclear-localized factor 3) (Protein FAM148C)	C2CD4C FAM148C KIAA1957 NLF3	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829	LRGSGENGAAR	8.880000114	1	1	0.230968499	1087.344179	0	12.18599	14.86105	14.7585	9.745162	15.05015	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TF46	DI3L1_HUMAN	"DIS3-like exonuclease 1, EC 3.1.13.-"	DIS3L DIS3L1 KIAA1955	Homo sapiens (Human)	RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; plasma membrane [GO:0005886]; 3'-5'-exoribonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	3'-5'-exoribonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]	GO:0000175; GO:0000177; GO:0000178; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0006396; GO:0006401; GO:0016075; GO:0019899	ASYEIKK	8.020000458	1	1	0.1632404	838.6746607	13.91872	0	0	0	16.26965	0	0	0	0	15.86428	12.98134	0	0	0	0	0	17.49028	0	16.84267	17.29238	0	14.678	0	0	0	0	15.03628	0	0	13.86599	15.92095	0	15.70083	15.66412	14.9643	0	15.37338	14.88555	0	16.6319	14.27929	16.34021	0	0	15.58778	0	0	0
Q8TF61	FBX41_HUMAN	F-box only protein 41	FBXO41 FBX41 KIAA1940	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829	SQPPRSSGLR	8.069999695	1	1	0.176749685	1084.45556	10.70522	0	0	0	0	0	0	14.85565	0	17.30588	0	0	0	17.16118	14.86113	15.53003	16.14236	16.03819	18.19436	17.60502	0	16.00906	15.67859	15.49377	0	16.25404	17.5858	0	16.38659	0	15.24861	14.47893	0	16.79835	0	0	0	17.27327	16.7487	16.88456	16.91425	0	17.71693	0	17.19516	15.51149	18.11634	16.51365
Q8TF62	AT8B4_HUMAN	"Probable phospholipid-transporting ATPase IM, EC 7.6.2.1 (ATPase class I type 8B member 4) (P4-ATPase flippase complex alpha subunit ATP8B4)"	ATP8B4 KIAA1939	Homo sapiens (Human)	Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0016887; GO:0035579; GO:0045332; GO:0070821; GO:0140326; GO:1990531	FQYADNR	5.389999866	0.466278821	0.466278821	0.219977535	911.8542122	19.23459	20.17556	17.48154	17.49083	18.34047	19.49113	19.39013	17.6592	20.0731	18.04986	16.52233	0	0	17.89277	17.62963	18.0049	17.11371	18.56087	18.29356	16.50742	16.64792	18.33845	0	17.44213	16.22035	16.39655	17.4765	16.85129	15.64993	16.19389	18.42308	18.51113	16.86398	19.31487	17.68313	17.59494	19.50945	19.17057	16.16736	0	17.20166	19.52893	18.83045	17.94995	16.53936	0	18.44033	14.71756
Q8TF64	GIPC3_HUMAN	PDZ domain-containing protein GIPC3	GIPC3 C19orf64	Homo sapiens (Human)						MEGAAAR	3.99000001	0.906974554	0.906974554	0.259055445	721.0761161	14.40794	14.64338	0	0	0	0	0	14.8337	0	15.83349	0	15.70579	0	0	0	0	0	0	15.00253	0	0	15.81922	14.61728	14.36136	16.87479	14.88962	0	0	15.75324	9.469991	16.76161	14.34413	15.89106	0	14.31638	15.85751	0	0	0	0	16.48056	14.31432	0	0	0	0	0	15.04059
Q8TF65	GIPC2_HUMAN	PDZ domain-containing protein GIPC2	GIPC2	Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]	identical protein binding [GO:0042802]	GO:0005737; GO:0042802; GO:0070062	IKDGGVIDSVK	4.139999866	0.482271671	0.482271671	0.243307659	1131.039564	16.25142	12.80506	0	0	15.777	0	0	0	0	0	0	14.42892	0	0	0	15.02089	0	0	15.82552	15.92262	0	0	13.93441	14.83618	0	15.28901	0	15.70066	0	0	0	0	0	15.80839	15.35194	0	13.49928	0	15.30132	15.09815	0	9.548111	14.39829	12.55774	12.8737	14.54415	13.7008	15.6902
Q8TF68	ZN384_HUMAN	"Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4, Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein)"	ZNF384 CAGH1 CIZ NMP4 TNRC1	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872; GO:1990837	KVASTLTEEGGGGGGGGGSVAPKPPR	1.139999986	1	1	4.75E-13	2322.415185	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.72828	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8TF72	SHRM3_HUMAN	"Protein Shroom3 (Shroom-related protein, hShrmL)"	SHROOM3 KIAA1481 SHRML MSTP013	Homo sapiens (Human)	actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360]	actin filament binding [GO:0051015]	GO:0000902; GO:0001843; GO:0002064; GO:0005856; GO:0005874; GO:0005912; GO:0007015; GO:0007389; GO:0008360; GO:0016324; GO:0030864; GO:0043296; GO:0043482; GO:0045176; GO:0051015	ADTLSSK	14.39999962	1	1	0.222103411	722.3476355	0	0	14.56186	14.52337	15.92391	16.90268	17.23861	15.9839	16.33677	16.41523	16.24384	0	14.56604	0	0	17.08383	16.58845	18.61184	0	0	0	16.76233	18.83716	0	17.27712	17.29791	0	0	0	0	16.83886	0	17.40278	15.46552	9.170922	0	0	0	0	0	0	16.99493	0	16.37634	15.60988	16.79642	0	0
Q8TF74	WIPF2_HUMAN	WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein)	WIPF2 WICH WIRE PP10631	Homo sapiens (Human)	actin filament-based movement [GO:0030048]	actin filament [GO:0005884]; cytosol [GO:0005829]	actin filament [GO:0005884]; cytosol [GO:0005829]; actin binding [GO:0003779]; actin filament-based movement [GO:0030048]	actin binding [GO:0003779]	GO:0003779; GO:0005829; GO:0005884; GO:0030048	APAYNR	6.46999979	0.506570458	0.506570458	0.174052691	690.9861254	0	17.18192	18.32459	0	16.93614	17.79268	17.73892	14.14747	14.67989	16.5255	16.99343	0	13.97086	0	16.43065	13.84924	0	17.11136	17.24848	0	0	17.20751	0	0	17.38833	0	0	15.16751	0	0	17.35721	0	0	18.1786	0	16.81105	16.51669	10.60988	17.7763	0	15.96778	16.81748	13.81458	0	0	16.5496	15.96015	0
Q8TF76	HASP_HUMAN	"Serine/threonine-protein kinase haspin, EC 2.7.11.1 (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase)"	HASPIN GSG2	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]"	centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	"centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chromatin organization [GO:0006325]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]"	ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000278; GO:0004672; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0006325; GO:0006468; GO:0007064; GO:0035556; GO:0071459; GO:0072354; GO:0106310; GO:2000751	CNTPAMK	4.230000019	0.985543132	0.985543132	0.183206367	837.7265994	14.72234	15.68693	0	14.30918	0	0	0	0	0	0	15.58578	14.13949	15.68565	15.49229	15.03022	15.84451	14.03079	13.58507	15.97047	0	0	0	0	17.3416	16.7388	14.87017	0	15.8721	0	14.80207	13.18462	14.86775	16.30205	15.87858	15.90671	15.56257	17.47711	15.49652	15.55554	15.83858	15.4834	13.44672	15.63218	13.03006	0	16.1653	15.25887	17.13889
Q8WTP8	AEN_HUMAN	"Apoptosis-enhancing nuclease, EC 3.1.-.- (Interferon-stimulated 20 kDa exonuclease-like 1)"	AEN ISG20L1 SBBI58	Homo sapiens (Human)	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; response to ionizing radiation [GO:0010212]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; response to ionizing radiation [GO:0010212]	exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0010212; GO:0031965; GO:0042771	CVAIDCEMVGTGPR	10.27999973	0.818094432	0.818094432	0.108675001	1564.796745	15.57595	17.54299	15.97025	13.64525	15.30384	14.79837	15.29842	14.06371	0	14.12568	15.28275	18.02493	14.33414	11.91045	0	11.70342	0	16.27394	0	0	0	13.39092	16.3361	16.69094	16.24643	0	16.67013	11.44082	0	12.18932	12.46042	0	16.85346	12.6222	0	16.15808	15.85049	16.47842	11.95853	11.49494	15.87372	17.40136	13.60968	0	15.83344	14.32982	10.79269	13.88051
Q8WTQ4	CP078_HUMAN	Uncharacterized protein C16orf78	C16orf78	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634	SEQQMDLK	7.380000114	0.44999972	0.44999972	0.163106957	977.2196663	16.83918	0	0	18.73964	16.18335	15.87039	16.16222	0	0	15.74413	0	0	18.20649	18.27702	15.43541	13.45172	0	12.54286	16.5767	0	0	17.28111	0	0	0	17.36338	15.39004	0	15.11873	0	0	19.80445	16.0997	0	0	18.3366	0	18.25759	18.61393	10.47756	16.71793	16.40446	11.56421	0	0	15.38235	16.27468	16.09149
Q8WTQ7	GRK7_HUMAN	"Rhodopsin kinase GRK7, EC 2.7.11.14 (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7)"	GRK7 GPRK7	Homo sapiens (Human)	protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381]	cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]; visual perception [GO:0007601]	ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]	GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0007601; GO:0009966; GO:0022400; GO:0046777; GO:0050254; GO:0097381	GGEKMALLEK	9.449999809	0.310029179	0.310029179	0.263371431	1092.25701	13.62028	12.01378	15.69486	13.2967	13.63802	14.06533	15.51397	0	0	0	13.52762	16.17562	0	0	13.93234	0	15.59983	14.54809	15.34703	0	0	0	0	0	0	0	15.90093	0	0	14.31706	0	0	14.36793	0	15.85433	0	0	16.12713	15.31989	0	0	0	0	0	16.40341	14.79502	0	14.52723
Q8WTS6	SETD7_HUMAN	"Histone-lysine N-methyltransferase SETD7, EC 2.1.1.364 (Histone H3-K4 methyltransferase SETD7, H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9)"	SETD7 KIAA1717 KMT7 SET7 SET9	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription, DNA-templated [GO:0006355]"	histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0002039; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0051570; GO:0070828	FIDGEMIEGK	5.75	0.815376937	0.815376937	0.14645	1158.413076	0	10.79946	14.33033	12.73627	16.73457	13.09583	13.97927	16.37049	15.67277	16.18836	14.0776	16.09428	14.42337	14.47663	14.03354	13.75177	15.02213	0	0	0	0	0	0	0	15.58432	0	0	14.61893	0	15.01997	16.31983	0	14.19066	14.36246	0	0	0	0	14.78627	14.14125	0	0	0	16.28465	0	0	0	0
Q8WTT2	NOC3L_HUMAN	"Nucleolar complex protein 3 homolog, NOC3 protein homolog (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)"	NOC3L AD24 C10orf117 FAD24	Homo sapiens (Human)	DNA replication initiation [GO:0006270]; fat cell differentiation [GO:0045444]	mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; DNA replication initiation [GO:0006270]; fat cell differentiation [GO:0045444]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0003682; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006270; GO:0016607; GO:0045444	KPIPLENPK	25.95000076	0.597402036	0.597402036	0.268558354	1036.866239	19.8218	19.0121	16.89846	20.2161	20.71198	20.17376	20.09872	19.23336	19.62961	19.29621	19.6266	20.13905	17.40374	19.47473	17.94315	18.35254	19.53417	18.18746	18.24645	16.89761	18.15755	0	18.1173	18.33877	19.32202	18.44417	18.77619	14.76479	17.40246	19.291	15.99777	17.16077	17.73906	15.51648	16.78304	17.33458	17.11914	17.41	17.73962	16.64339	11.5864	0	18.44341	17.16291	16.32534	17.94224	0	19.8049
Q8WTU0	DDI1_HUMAN	"Protein DDI1 homolog 1, EC 3.4.23.-"	DDI1	Homo sapiens (Human)	cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]		aspartic-type endopeptidase activity [GO:0004190]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647]	aspartic-type endopeptidase activity [GO:0004190]	GO:0004190; GO:0010498; GO:0031647; GO:0072711; GO:0097752	CNIMRLVDR	10.89999962	1	1	0.308040141	1191.790335	14.1445	15.98001	0	14.82151	12.62724	11.9935	15.0369	0	12.56925	15.55012	14.24021	0	15.33858	14.62371	0	14.69682	15.87346	0	13.85876	0	0	0	0	0	0	12.28572	0	0	0	15.44338	0	13.82761	0	0	0	0	16.85892	0	0	0	16.51201	0	0	11.89727	0	0	14.64284	0
Q8WTU2	SRB4D_HUMAN	Scavenger receptor cysteine-rich domain-containing group B protein (Four scavenger receptor cysteine-rich domains-containing protein) (S4D-SRCRB)	SSC4D SRCRB4D	Homo sapiens (Human)		extracellular region [GO:0005576]; membrane [GO:0016020]	extracellular region [GO:0005576]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]	scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005576; GO:0016020	SEGSVR	6.960000038	1	1	0.175889279	635.4550072	14.00113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.17108	17.19258	0	0	0	0	0	0	0	0	0	18.10476	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WTV0	SCRB1_HUMAN	"Scavenger receptor class B member 1, SRB1 (CD36 and LIMPII analogous 1, CLA-1) (CD36 antigen-like 1) (Collagen type I receptor, thrombospondin receptor-like 1) (SR-BI) (CD antigen CD36)"	SCARB1 CD36L1 CLA1	Homo sapiens (Human)	adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phagocytosis [GO:0050764]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]; wound healing [GO:0042060]	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; 1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; scavenger receptor activity [GO:0005044]; transporter activity [GO:0005215]; virus receptor activity [GO:0001618]; adhesion of symbiont to host [GO:0044406]; blood vessel endothelial cell migration [GO:0043534]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; detection of lipopolysaccharide [GO:0032497]; endothelial cell proliferation [GO:0001935]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal absorption [GO:0050892]; lipopolysaccharide transport [GO:0015920]; low-density lipoprotein particle clearance [GO:0034383]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of triglyceride biosynthetic process [GO:0010867]; recognition of apoptotic cell [GO:0043654]; regulation of phagocytosis [GO:0050764]; regulation of phosphatidylcholine catabolic process [GO:0010899]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; vitamin transmembrane transport [GO:0035461]; wound healing [GO:0042060]	1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor activity [GO:0070506]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; scavenger receptor activity [GO:0005044]; transporter activity [GO:0005215]; virus receptor activity [GO:0001618]	GO:0001530; GO:0001540; GO:0001618; GO:0001786; GO:0001875; GO:0001935; GO:0005044; GO:0005215; GO:0005545; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0005901; GO:0006707; GO:0008035; GO:0008289; GO:0009986; GO:0010595; GO:0010867; GO:0010886; GO:0010899; GO:0015914; GO:0015920; GO:0030169; GO:0030666; GO:0032497; GO:0033344; GO:0034185; GO:0034186; GO:0034375; GO:0034381; GO:0034383; GO:0034384; GO:0035461; GO:0042060; GO:0042632; GO:0043231; GO:0043534; GO:0043654; GO:0043691; GO:0044406; GO:0050764; GO:0050892; GO:0051000; GO:0070062; GO:0070328; GO:0070506; GO:0070508	IDPSSLSFNMWK	4.260000229	0.548928797	0.548928797	0.048882552	1425.107528	0	0	0	0	0	0	0	0	0	0	13.66507	0	0	11.04957	0	0	0	0	14.0672	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.83304	0	0	0	0	0	0	0	0	0	0	0	0
Q8WTV1	THAP3_HUMAN	THAP domain-containing protein 3	THAP3	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]		DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0045944; GO:0046872	EKVLPEAGAGEDSPGR	3.00999999	0.567455292	0.567455292	0.042819814	1611.74579	18.20928	15.50106	0	11.69082	10.12704	13.18136	13.80369	14.70369	0	14.80322	14.10561	0	0	0	13.83578	15.85079	0	0	14.73272	0	14.44464	15.67831	14.40664	15.50194	14.40448	0	16.24499	12.01375	0	0	0	15.16736	0	11.88645	0	17.48491	17.18015	14.97173	15.82953	0	15.06767	16.07852	16.52575	9.771217	13.08591	12.38627	14.59776	0
Q8WTX7	CAST1_HUMAN	Cytosolic arginine sensor for mTORC1 subunit 1 (Cellular arginine sensor for mTORC1 protein 1) (GATS-like protein 3)	CASTOR1 GATSL3	Homo sapiens (Human)	cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531]	cytosol [GO:0005829]	cytosol [GO:0005829]; arginine binding [GO:0034618]; identical protein binding [GO:0042802]; cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531]	arginine binding [GO:0034618]; identical protein binding [GO:0042802]	GO:0005829; GO:0034618; GO:0042802; GO:1902531; GO:1903577; GO:1904262	EVGGEPVPVTR	10.77999973	0.476069897	0.476069897	0.345684023	1137.620382	15.26994	0	0	15.37819	13.50004	16.05665	0	0	14.81688	15.40114	12.55409	15.0946	15.55444	0	15.27078	15.17984	9.731052	12.99952	14.88954	15.10311	0	14.81499	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.64138	15.7813	0	0	0	0	0	15.49366	0	0	0
Q8WU10	PYRD1_HUMAN	"Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1, EC 1.8.1.-"	PYROXD1	Homo sapiens (Human)	cellular response to oxidative stress [GO:0034599]	nucleus [GO:0005634]; sarcomere [GO:0030017]	nucleus [GO:0005634]; sarcomere [GO:0030017]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; cellular response to oxidative stress [GO:0034599]	flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]	GO:0005634; GO:0016491; GO:0030017; GO:0034599; GO:0050660	IAHKR	3.980000019	1	1	0.168690219	625.0879294	0	0	0	0	0	14.77249	13.2881	0	15.72227	0	0	0	15.7756	0	0	15.63871	0	0	0	0	18.08931	0	0	0	0	0	0	0	0	0	0	15.64839	0	0	0	16.37202	0	0	0	0	0	0	16.21021	0	15.37907	0	0	0
Q8WU20	FRS2_HUMAN	"Fibroblast growth factor receptor substrate 2, FGFR substrate 2 (FGFR-signaling adaptor SNT) (Suc1-associated neurotrophic factor target 1, SNT-1)"	FRS2	Homo sapiens (Human)	"anterior/posterior axis specification, embryo [GO:0008595]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; ventricular septum development [GO:0003281]"	adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatase activator activity [GO:0019211]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; anterior/posterior axis specification, embryo [GO:0008595]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; ventricular septum development [GO:0003281]"	fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatase activator activity [GO:0019211]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001702; GO:0001759; GO:0003281; GO:0005068; GO:0005104; GO:0005168; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0007169; GO:0007185; GO:0007186; GO:0007405; GO:0008543; GO:0008595; GO:0012505; GO:0016020; GO:0019211; GO:0030900; GO:0042981; GO:0043410; GO:0046619; GO:0050678; GO:0060527; GO:0070307; GO:0070372; GO:1904707; GO:2000726	HNSTDLPM	15.71000004	0.256775886	0.256775886	0.200126153	929.9210988	0	0	0	0	14.97187	14.39646	14.94214	15.36582	12.95702	14.99572	16.07656	14.08324	0	0	0	15.03043	0	17.03903	0	0	0	14.05441	14.68898	11.26441	0	16.64642	0	16.3827	16.95842	13.76173	15.03908	17.97954	0	17.06371	13.95492	0	14.39097	0	0	0	0	0	0	0	0	16.26122	0	15.34627
Q8WU39	MZB1_HUMAN	"Marginal zone B- and B1-cell-specific protein (Mesenteric estrogen-dependent adipose 7, MEDA-7) (Plasma cell-induced resident endoplasmic reticulum protein, Plasma cell-induced resident ER protein, pERp1) (Proapoptotic caspase adapter protein)"	MZB1 MEDA7 PACAP HSPC190	Homo sapiens (Human)	apoptotic process [GO:0006915]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; apoptotic process [GO:0006915]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626]		GO:0002639; GO:0005576; GO:0005737; GO:0005788; GO:0006915; GO:0008284; GO:0030888; GO:0033622; GO:0034663; GO:0042127; GO:0046626	LHTSNSGGRR	8.760000229	1	1	9.16E-13	1085.688721	14.70528	0	0	14.1475	14.73128	0	15.79284	0	0	13.81852	0	0	0	0	0	0	16.19551	0	16.81618	0	0	12.5271	0	0	0	0	0	0	0	15.04828	0	15.02673	15.63781	15.719	0	0	0	16.31097	0	16.14947	17.0047	16.1457	0	0	0	0	0	0
Q8WU66	TSEAR_HUMAN	"Thrombospondin-type laminin G domain and EAR repeat-containing protein, TSP-EAR"	TSPEAR C21orf29	Homo sapiens (Human)	hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]	cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]	cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]; hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]		GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170	IFSQCDLFPEEFSIVVTLR	4.119999886	1	1	4.57E-13	2299.031588	0	16.03821	0	13.65759	14.13151	0	15.40047	15.56012	13.42708	0	15.20462	13.66428	15.39518	15.17231	16.00204	13.41305	0	13.62827	0	14.45696	16.30642	16.28647	16.80564	15.48691	0	0	0	14.28381	13.618	0	15.46299	14.03766	0	13.10902	0	14.40683	14.05804	14.60765	0	16.0505	14.10911	14.9405	11.86235	0	14.795	0	0	0
Q8WU90	ZC3HF_HUMAN	Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4)	ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730	Homo sapiens (Human)	cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547]	cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0002181; GO:0003723; GO:0005634; GO:0005829; GO:0019221; GO:0043547; GO:0045296; GO:0046872	ERSALGPNVTK	7.579999924	0.487134397	0.487134397	0.148136777	1171.528725	13.41899	12.14048	0	0	0	14.16897	14.87907	15.69018	0	16.26497	15.1551	15.91903	15.19378	9.443712	13.4989	12.59515	0	0	16.40676	0	0	0	15.76994	0	0	0	0	0	0	0	0	0	14.98543	0	0	0	12.56859	0	0	0	0	0	0	0	0	0	0	0
Q8WUA7	TB22A_HUMAN	TBC1 domain family member 22A	TBC1D22A C22orf4	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]		14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; activation of GTPase activity [GO:0090630]	14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]	GO:0005096; GO:0042803; GO:0071889; GO:0090630	YLQFAFRWMNNLLMR	16.59000015	1	1	0.237358612	2038.47945	0	0	16.15609	0	15.46867	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88334	16.63647	0	0	0	0	0	0	0	0	16.46509	0	0	16.45755	0	0	0	0	0	0
Q8WUA8	TSK_HUMAN	Tsukushi (E2-induced gene 4 protein) (Leucine-rich repeat-containing protein 54)	TSKU E2IG4 LRRC54 TSK UNQ850/PRO1788	Homo sapiens (Human)	anterior commissure morphogenesis [GO:0021960]; bone growth [GO:0098868]; camera-type eye development [GO:0043010]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; ciliary body morphogenesis [GO:0061073]; corpus callosum morphogenesis [GO:0021540]; energy homeostasis [GO:0097009]; growth plate cartilage chondrocyte development [GO:0003431]; hippocampus development [GO:0021766]; inner ear receptor cell stereocilium organization [GO:0060122]; lateral ventricle development [GO:0021670]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of hair cycle [GO:0042635]; regulation of gene expression [GO:0010468]; wound healing [GO:0042060]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; transforming growth factor beta binding [GO:0050431]; anterior commissure morphogenesis [GO:0021960]; bone growth [GO:0098868]; camera-type eye development [GO:0043010]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; ciliary body morphogenesis [GO:0061073]; corpus callosum morphogenesis [GO:0021540]; energy homeostasis [GO:0097009]; growth plate cartilage chondrocyte development [GO:0003431]; hippocampus development [GO:0021766]; inner ear receptor cell stereocilium organization [GO:0060122]; lateral ventricle development [GO:0021670]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of hair cycle [GO:0042635]; regulation of gene expression [GO:0010468]; wound healing [GO:0042060]	transforming growth factor beta binding [GO:0050431]	GO:0003431; GO:0005615; GO:0008203; GO:0010468; GO:0010977; GO:0021540; GO:0021670; GO:0021766; GO:0021960; GO:0030178; GO:0032911; GO:0033344; GO:0042060; GO:0042632; GO:0042635; GO:0043010; GO:0050431; GO:0060122; GO:0061073; GO:0097009; GO:0098868; GO:1904761	RPGSSPK	13.5	1	1	0.226777788	728.6581653	0	17.21187	0	15.36407	16.89386	12.36458	15.74531	0	0	16.19461	0	16.52412	0	0	0	0	0	0	0	16.03614	0	0	15.01775	0	15.81821	0	0	0	14.60269	0	0	15.83208	0	0	0	16.68166	0	0	0	15.93109	0	0	0	0	0	0	0	0
Q8WUB8	PHF10_HUMAN	"PHD finger protein 10 (BRG1-associated factor 45a, BAF45a) (XAP135)"	PHF10 BAF45A	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]	"chromatin [GO:0000785]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0000776; GO:0000785; GO:0003712; GO:0005654; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045944; GO:0046872; GO:0070316; GO:0071564; GO:1902459; GO:2000045; GO:2000781; GO:2000819	VLPTERTK	6.730000019	1	1	0.085719529	944.7484824	14.72662	14.84242	11.73716	0	0	0	0	0	0	14.28869	12.89097	0	0	0	0	14.46834	0	0	0	0	15.95359	0	16.18908	16.18196	0	14.44572	9.861358	15.7377	0	14.27296	15.10072	14.74894	0	13.44882	0	0	12.40479	0	0	15.53102	14.42784	0	10.05668	0	14.49062	0	0	14.99412
Q8WUF5	IASPP_HUMAN	"RelA-associated inhibitor (Inhibitor of ASPP protein, Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein)"	PPP1R13L IASPP NKIP1 PPP1R13BL RAI	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cardiac right ventricle morphogenesis [GO:0003215]; embryonic camera-type eye development [GO:0031076]; hair cycle [GO:0042633]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; ventricular cardiac muscle tissue development [GO:0003229]"	cell junction [GO:0030054]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cell junction [GO:0030054]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cardiac right ventricle morphogenesis [GO:0003215]; embryonic camera-type eye development [GO:0031076]; hair cycle [GO:0042633]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; ventricular cardiac muscle tissue development [GO:0003229]"	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0000122; GO:0003215; GO:0003229; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006357; GO:0006915; GO:0008134; GO:0009791; GO:0030054; GO:0031076; GO:0035264; GO:0042633; GO:0042802; GO:0045171; GO:0045296; GO:0045597; GO:0048871; GO:0060048	AGSPR	3.160000086	5.62E-14	5.61E-14	0.206401928	486.1877511	15.58675	14.76451	0	0	0	0	0	15.48697	0	15.9795	0	0	15.16168	17.2035	15.18138	0	16.53809	14.73958	17.50389	17.17124	15.07348	0	0	0	15.10504	16.32215	15.90279	15.28192	0	14.69064	14.90476	15.16812	15.63607	15.3118	14.90516	17.2797	17.31368	14.52107	0	0	16.24577	18.07529	0	0	0	15.89572	16.31594	16.34473
Q8WUG5	S22AH_HUMAN	"Solute carrier family 22 member 17 (24p3 receptor, 24p3R) (Brain-type organic cation transporter) (Lipocalin-2 receptor) (Neutrophil gelatinase-associated lipocalin receptor, NgalR)"	SLC22A17 BOCT BOIT	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; siderophore transport [GO:0015891]	integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; transmembrane signaling receptor activity [GO:0004888]; transmembrane transporter activity [GO:0022857]; cellular iron ion homeostasis [GO:0006879]; siderophore transport [GO:0015891]	transmembrane signaling receptor activity [GO:0004888]; transmembrane transporter activity [GO:0022857]	GO:0004888; GO:0005774; GO:0005886; GO:0005887; GO:0006879; GO:0015891; GO:0022857; GO:0031301	KLLPEVLR	10	0.360266179	0.360266179	9.12E-13	968.1935581	16.33028	12.04459	0	16.14658	0	11.56823	14.40993	13.57023	0	0	0	0	0	0	0	13.28137	11.04544	0	14.23171	0	14.34847	13.97468	0	0	0	0	11.51048	15.91364	0	0	12.98673	16.17232	12.8483	14.96699	15.88286	0	0	0	15.35477	14.83047	0	15.46927	13.76405	13.0177	15.06257	13.16713	0	14.21418
Q8WUJ1	NEUFC_HUMAN	Neuferricin (Cytochrome b5 domain-containing protein 2)	CYB5D2	Homo sapiens (Human)	nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]	endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020]	endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020]; heme binding [GO:0020037]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]	heme binding [GO:0020037]	GO:0005576; GO:0007399; GO:0012505; GO:0016020; GO:0020037; GO:0045666	DWIGVPR	7.090000153	1	1	0.273897317	841.5333239	0	0	0	0	0	0	0	0	0	19.62055	0	0	0	18.11343	0	0	0	0	0	0	0	0	0	0	18.16627	0	0	0	0	0	18.46864	0	0	18.27769	0	0	19.05164	0	0	19.27644	0	0	0	0	0	0	0	0
Q8WUJ3	CEMIP_HUMAN	"Cell migration-inducing and hyaluronan-binding protein, EC 3.2.1.35"	CEMIP KIAA1199	Homo sapiens (Human)	hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; sensory perception of sound [GO:0007605]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; ER retention sequence binding [GO:0046923]; hyaluronic acid binding [GO:0005540]; hyalurononglucosaminidase activity [GO:0004415]; hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; sensory perception of sound [GO:0007605]	clathrin heavy chain binding [GO:0032050]; ER retention sequence binding [GO:0046923]; hyaluronic acid binding [GO:0005540]; hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005540; GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005886; GO:0005905; GO:0007605; GO:0010800; GO:0030213; GO:0030214; GO:0030335; GO:0030665; GO:0032050; GO:0045334; GO:0046923; GO:0051281; GO:0090314; GO:1900020	FAFCSMK	7.789999962	1	1	3.46E-13	910.4997351	16.5153	0	0	0	0	0	13.98416	13.80117	0	16.73108	0	0	0	0	0	0	0	0	16.28723	0	0	0	17.71412	0	0	0	0	17.27649	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.13964	0	0	0	0	0
Q8WUM4	PDC6I_HUMAN	"Programmed cell death 6-interacting protein, PDCD6-interacting protein (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95)"	PDCD6IP AIP1 ALIX KIAA1375	Homo sapiens (Human)	actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]	actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]	actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]	calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]	GO:0000281; GO:0000915; GO:0001772; GO:0005768; GO:0005815; GO:0005829; GO:0005923; GO:0005925; GO:0006915; GO:0010824; GO:0015031; GO:0016020; GO:0031871; GO:0036258; GO:0039702; GO:0042470; GO:0042641; GO:0042803; GO:0045199; GO:0046755; GO:0048306; GO:0051260; GO:0061952; GO:0070062; GO:0070830; GO:0070971; GO:0071985; GO:0090543; GO:0090559; GO:0090611; GO:1903543; GO:1903551; GO:1903553; GO:1903561	ATRDK	6.139999866	1	1	0.287512261	590.7554534	17.48787	18.33466	0	0	18.58647	16.91282	0	0	19.01013	0	0	15.9082	0	17.28343	17.6388	18.67418	0	0	0	0	0	0	0	16.04009	0	0	0	18.27242	18.44224	17.96252	0	0	18.97744	18.98594	0	18.79538	19.88218	18.0798	18.9105	17.68375	0	0	18.80167	17.79164	18.53416	0	19.12056	18.10191
Q8WUQ7	CATIN_HUMAN	Cactin (Renal carcinoma antigen NY-REN-24)	CACTIN C19orf29	Homo sapiens (Human)	"cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]"	RNA binding [GO:0003723]	GO:0000398; GO:0001933; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0043124; GO:0045087; GO:0045292; GO:0045824; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356	SDSEEER	3.579999924	1	1	0.025610511	851.559723	12.74378	15.13796	12.31067	14.62653	14.97915	0	14.48616	14.60286	15.84377	14.26131	11.63213	15.97271	0	15.11996	0	0	0	0	0	0	0	0	0	0	14.56277	17.35814	0	0	0	0	0	0	0	0	15.33482	0	15.62464	0	0	0	0	0	0	0	0	0	0	0
Q8WUR7	CO040_HUMAN	UPF0235 protein C15orf40	C15orf40	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	SDVVLDKGGK	10.18999958	1	1	0.072446972	1017.172597	15.67031	15.0843	13.86632	13.50552	14.27771	14.54543	11.98274	14.94004	10.34111	15.36539	12.50153	16.29938	14.68112	0	0	13.43878	14.66124	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WUT9	S2543_HUMAN	Solute carrier family 25 member 43	SLC25A43	Homo sapiens (Human)	transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transport [GO:0055085]		GO:0005743; GO:0016021; GO:0055085	GPWATGHRVWR	7.71999979	0.281042844	0.281042844	0.050015727	1322.106324	12.8227	0	12.16988	0	0	12.72443	0	0	13.98106	12.56097	12.01585	11.68734	13.11397	0	0	11.86807	0	9.320042	0	11.59799	0	0	0	0	11.52595	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.36657	0	0	13.71281	0	0	0	13.03106	15.96692
Q8WUU4	ZN296_HUMAN	"Zinc finger protein 296, ZFP296 (Zinc finger protein 342)"	ZNF296 ZNF342	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0007283; GO:0045944; GO:0046872; GO:1990837	EELKALSCLR	7.849999905	1	1	1.14E-12	1219.824728	0	0	0	0	0	14.62792	0	0	0	0	0	0	14.75318	0	0	0	15.05676	0	13.95177	0	12.33053	0	16.69604	15.58533	13.80183	0	14.56929	10.62141	0	12.2066	15.15775	11.58172	13.89267	14.22006	13.00678	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WUU5	GATD1_HUMAN	GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein)	GATAD1 ODAG	Homo sapiens (Human)	"chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription, DNA-templated [GO:0006355]"	sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005654; GO:0006325; GO:0006338; GO:0006355; GO:0008270; GO:0043565	SAPAAEK	11.85000038	1	1	0.28785135	674.287116	0	20.45217	18.11038	0	19.90973	0	0	18.33957	0	19.72423	20.55769	0	0	0	0	0	18.88356	0	0	0	0	0	21.31235	0	0	0	0	20.99685	0	18.09677	0	0	0	21.57409	0	20.99271	17.99736	21.2803	0	0	0	21.12351	0	0	0	20.53527	19.12209	0
Q8WUX1	S38A5_HUMAN	Sodium-coupled neutral amino acid transporter 5 (Solute carrier family 38 member 5) (System N transporter 2)	SLC38A5 JM24 SN2 SNAT5 PP7194	Homo sapiens (Human)	amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transmembrane transport [GO:1903713]; glutamine transport [GO:0006868]; glycine transport [GO:0015816]; L-alanine transmembrane transport [GO:1904557]; L-histidine transmembrane transport [GO:0089709]; L-serine transport [GO:0015825]; serine transport [GO:0032329]; transport across blood-brain barrier [GO:0150104]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transmembrane transport [GO:1903713]; glutamine transport [GO:0006868]; glycine transport [GO:0015816]; L-alanine transmembrane transport [GO:1904557]; L-histidine transmembrane transport [GO:0089709]; L-serine transport [GO:0015825]; serine transport [GO:0032329]; transport across blood-brain barrier [GO:0150104]	alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]	GO:0003333; GO:0005290; GO:0005886; GO:0005887; GO:0006865; GO:0006868; GO:0015171; GO:0015182; GO:0015186; GO:0015187; GO:0015194; GO:0015816; GO:0015825; GO:0022858; GO:0022889; GO:0032329; GO:0089709; GO:0150104; GO:1903713; GO:1904557	MNGALPSDAVGYR	7.53000021	1	1	0.102593823	1353.097907	0	0	10.98634	0	9.517805	0	8.167038	0	0	0	0	12.93555	0	0	15.87855	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WUY3	PRUN2_HUMAN	Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1)	PRUNE2 BMCC1 BNIPXL C9orf65 KIAA0367	Homo sapiens (Human)	apoptotic process [GO:0006915]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; apoptotic process [GO:0006915]	metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]	GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0016462; GO:0046872	DVQTGMSADNLQPK	4.599999905	1	1	4.72E-13	1520.49506	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.49661	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WV28	BLNK_HUMAN	"B-cell linker protein (B-cell adapter containing a SH2 domain protein) (B-cell adapter containing a Src homology 2 domain protein) (Cytoplasmic adapter protein) (Src homology 2 domain-containing leukocyte protein of 65 kDa, SLP-65)"	BLNK BASH SLP65	Homo sapiens (Human)	B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of gene expression [GO:0010628]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of gene expression [GO:0010628]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	enzyme binding [GO:0019899]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0005068; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006959; GO:0007169; GO:0010628; GO:0016020; GO:0019899; GO:0019901; GO:0030183; GO:0035556; GO:0035591; GO:0042169; GO:0043231; GO:0043274; GO:0050853; GO:1990782	GEYIDNRSSQR	3.569999933	1	1	0.206767028	1324.395068	0	14.04586	14.66317	14.18519	0	14.48055	14.75034	13.52803	15.50436	0	15.08512	0	15.93952	0	0	14.87494	0	0	0	16.23501	0	0	16.32777	0	16.92097	15.9	15.9728	0	0	0	16.50219	14.36264	0	0	0	0	13.62418	0	0	0	0	0	13.99242	0	14.83017	0	0	0
Q8WV35	LRC29_HUMAN	Leucine-rich repeat-containing protein 29 (F-box and leucine-rich repeat protein 9) (F-box protein FBL9) (F-box/LRR-repeat protein 9)	LRRC29 FBL9 FBXL9	Homo sapiens (Human)						GCPSLEHLALSHCSRLSDK	10.10999966	0.960474491	0.960474491	0.204053329	2167.675109	15.08602	15.51656	0	0	0	15.25628	0	0	0	0	0	14.67029	16.71499	0	15.56551	0	15.18381	14.39746	0	0	15.18807	0	18.02238	16.94601	0	16.35483	15.60633	0	0	14.67895	15.72785	0	0	13.93822	15.42276	13.5506	0	0	0	16.33257	14.88804	15.51749	0	15.0028	0	14.94652	0	0
Q8WV44	TRI41_HUMAN	"E3 ubiquitin-protein ligase TRIM41, EC 2.3.2.27 (RING finger-interacting protein with C kinase, RINCK) (Tripartite motif-containing protein 41)"	TRIM41 RINCK	Homo sapiens (Human)	cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; defense response to virus [GO:0051607]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; defense response to virus [GO:0051607]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]	identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005730; GO:0005737; GO:0006513; GO:0008270; GO:0016567; GO:0016604; GO:0042802; GO:0051091; GO:0051607; GO:0060340; GO:0061630; GO:0071222; GO:0071225	MFCQAAR	3.099999905	1	1	0.207102753	882.5139532	0	0	0	0	0	15.03137	0	0	0	0	0	18.93148	0	0	0	15.85975	0	0	14.72751	0	0	0	0	17.82992	0	0	0	16.19607	0	0	14.90855	15.68084	0	0	0	0	0	0	0	0	0	0	0	0	0	15.18811	15.58333	0
Q8WV93	AFG1L_HUMAN	"AFG1-like ATPase (Lactation elevated protein 1, EC 3.6.-.-) (Protein AFG1 homolog)"	AFG1L AFG1 LACE1	Homo sapiens (Human)	"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]"	cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	"cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005737; GO:0005739; GO:0006123; GO:0007005; GO:0016887; GO:0031966; GO:0035694	GLYVYGDVGTGK	3.279999971	1	1	0.187784148	1229.054677	0	0	12.84483	0	0	0	0	0	0	0	0	14.19117	0	0	0	0	0	15.09752	14.62488	0	0	0	0	13.40771	0	13.79164	15.4895	0	13.77658	9.877111	12.97914	11.08293	11.23558	14.87918	10.07879	13.32862	12.05206	15.75956	15.43658	14.65231	0	0	13.70391	0	14.38925	0	0	0
Q8WVC0	LEO1_HUMAN	RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein)	LEO1 RDL	Homo sapiens (Human)	endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	GO:0001650; GO:0001711; GO:0005634; GO:0005654; GO:0005813; GO:0006368; GO:0006378; GO:0010390; GO:0016055; GO:0016593; GO:0019827; GO:0031442; GO:0032968; GO:0033523; GO:0045638; GO:1990269	CSKTQK	10.76000023	1	1	0.222370689	750.3700543	0	16.12556	15.49144	0	0	15.54078	14.747	14.71154	0	0	0	0	14.68399	0	0	17.65671	16.42961	16.48788	15.46189	0	0	15.06489	0	0	0	0	0	0	16.9128	0	15.71006	0	15.00393	0	0	0	0	17.00302	16.25235	0	14.53726	15.81239	0	15.70896	0	16.84897	0	0
Q8WVE0	EFMT1_HUMAN	"EEF1A lysine methyltransferase 1, EC 2.1.1.- (N(6)-adenine-specific DNA methyltransferase 2) (Protein-lysine N-methyltransferase N6AMT2) (eEF1A-KMT)"	EEF1AKMT1 N6AMT2	Homo sapiens (Human)	peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]	cytosol [GO:0005829]	cytosol [GO:0005829]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]	methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0003676; GO:0005829; GO:0006479; GO:0008168; GO:0016279; GO:0018022	ENFSIYIFEYDK	13.48999977	0.15347825	0.15347825	0.422069807	1567.810805	21.15903	0	21.78462	18.37662	17.48005	0	17.17558	19.59192	17.4467	19.71365	21.74035	21.51366	20.67287	20.27238	0	18.06525	18.56209	18.60113	19.27747	19.80836	20.21569	20.25318	20.30772	0	18.84659	0	19.32137	18.88202	19.59962	19.06008	21.32681	21.20005	23.18063	20.05097	22.17712	20.71697	19.87787	19.57749	20.46098	19.61868	20.07487	18.04765	21.06591	21.27672	19.15353	18.80553	0	20.73573
Q8WVE6	TM171_HUMAN	Transmembrane protein 171	TMEM171	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	TPTSEGAASER	6.21999979	1	1	0.061007358	1104.723447	14.17276	14.37255	0	0	15.48691	0	0	0	0	0	0	0	0	0	15.72236	16.15497	0	14.53129	15.58594	0	16.07039	16.06104	0	0	15.77073	0	0	0	0	0	0	14.9325	0	0	0	0	16.71327	0	0	0	16.04045	15.7088	0	0	0	0	0	0
Q8WVF2	UCMA_HUMAN	"Unique cartilage matrix-associated protein [Cleaved into: Unique cartilage matrix-associated protein C-terminal fragment, Ucma-C (Gla-rich protein, GRP) ]"	UCMA C10orf49	Homo sapiens (Human)	embryonic skeletal system development [GO:0048706]; negative regulation of biomineralization [GO:0110150]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of SMAD protein signal transduction [GO:0060392]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; embryonic skeletal system development [GO:0048706]; negative regulation of biomineralization [GO:0110150]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of SMAD protein signal transduction [GO:0060392]	BMP binding [GO:0036122]	GO:0005615; GO:0005737; GO:0031012; GO:0036122; GO:0045668; GO:0048706; GO:0060392; GO:0110150	IFMQESDASNFLKR	4.679999828	1	1	0.323206129	1701.506182	0	13.42377	15.17956	0	15.61776	0	15.14514	11.20656	0	0	15.25416	13.08436	0	16.1394	0	0	14.87689	0	0	0	15.36876	14.53765	14.75592	15.53092	16.07441	0	0	0	13.20092	0	0	0	0	14.38009	0	0	0	0	0	0	0	0	0	0	0	0	14.15039	0
Q8WVF5	KCTD4_HUMAN	BTB/POZ domain-containing protein KCTD4	KCTD4	Homo sapiens (Human)	protein homooligomerization [GO:0051260]		protein homooligomerization [GO:0051260]		GO:0051260	HNSLEDTDQGK	10.02999973	1	1	0.217841615	1243.784319	0	14.99218	0	0	0	0	0	0	16.34589	0	0	0	0	0	16.19872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WVL7	ANR49_HUMAN	Ankyrin repeat domain-containing protein 49 (Fetal globin-inducing factor)	ANKRD49 FGIF	Homo sapiens (Human)	"cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]"	cytosol [GO:0005829]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]"		GO:0005634; GO:0005829; GO:0007283; GO:0030154; GO:0045893	DSKDTLELLLMNR	4.059999943	0.576443017	0.576443017	0.049879306	1547.070694	17.91617	16.24334	13.68432	0	0	13.17817	0	0	0	0	14.83826	13.28241	0	13.74394	0	14.41714	0	0	12.65869	14.10558	13.44721	14.94863	13.07301	0	12.61752	12.78778	15.32542	13.82261	13.72104	14.07543	0	13.03297	0	0	14.18432	0	0	15.11	0	14.01144	15.1209	0	0	13.1633	12.41901	0	15.0141	0
Q8WVM0	TFB1M_HUMAN	"Dimethyladenosine transferase 1, mitochondrial, EC 2.1.1.- (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1, h-mtTFB, h-mtTFB1, hTFB1M, mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)"	TFB1M CGI-75	Homo sapiens (Human)	rRNA methylation [GO:0031167]; rRNA modification [GO:0000154]; transcription initiation from mitochondrial promoter [GO:0006391]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]	"mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; DNA binding [GO:0003677]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; rRNA methylation [GO:0031167]; rRNA modification [GO:0000154]; transcription initiation from mitochondrial promoter [GO:0006391]"	"DNA binding [GO:0003677]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000154; GO:0000179; GO:0003677; GO:0003723; GO:0005759; GO:0006391; GO:0031167; GO:0034246; GO:0042645	FIPGLQMLSDAAPGKLR	1.850000024	1	1	0.207553909	1830.130224	0	0	0	0	0	0	0	0	0	14.12125	0	0	0	0	0	0	0	0	0	0	0	0	15.65962	0	16.18455	15.937	13.76183	17.70497	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WVM8	SCFD1_HUMAN	"Sec1 family domain-containing protein 1 (SLY1 homolog, Sly1p) (Syntaxin-binding protein 1-like 2)"	SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23	Homo sapiens (Human)	"cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle-mediated transport [GO:0016192]"	cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]	"cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle-mediated transport [GO:0016192]"	protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]	GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0009636; GO:0016192; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0051223; GO:0060628; GO:1901998; GO:1902902	MCQDLR	2.670000076	1	1	0.176578205	838.2455662	0	0	0	14.42779	15.70063	0	0	0	17.09259	0	0	0	0	0	0	0	0	14.58972	0	0	0	0	0	0	13.6643	0	0	0	0	0	0	17.31094	0	0	0	15.72391	0	15.91506	0	0	0	14.4147	0	14.42205	13.34177	15.74463	0	15.32743
Q8WVQ1	CANT1_HUMAN	"Soluble calcium-activated nucleotidase 1, SCAN-1, EC 3.6.1.6 (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107)"	CANT1 SHAPY	Homo sapiens (Human)	positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteoglycan biosynthetic process [GO:0030166]	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteoglycan biosynthetic process [GO:0030166]	adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]	GO:0004382; GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030166; GO:0032580; GO:0035580; GO:0042803; GO:0043123; GO:0043262; GO:0045134; GO:0070062; GO:1904724; GO:1904813	GRGMELSDLIVFNGK	7.230000019	0.902347445	0.902347445	0.184707677	1635.725171	14.58877	0	16.26715	13.37242	14.18188	15.40285	18.92625	18.30475	14.7551	16.8849	18.58939	15.25739	14.16969	19.72664	0	13.52032	16.51725	13.87558	18.59444	15.68389	0	13.75032	19.85823	0	0	0	18.57378	19.69432	18.43872	19.10602	0	0	13.26861	0	18.56485	17.07901	17.41389	17.41918	14.73936	0	0	0	0	15.91898	0	18.13625	0	12.83245
Q8WVR3	TPC14_HUMAN	Trafficking protein particle complex subunit 14 (Microtubule-associated protein 11)	TRAPPC14 C7orf43 MAP11	Homo sapiens (Human)	cilium assembly [GO:0060271]; regulation of cell population proliferation [GO:0042127]	centriolar satellite [GO:0034451]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; TRAPPII protein complex [GO:1990071]	centriolar satellite [GO:0034451]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; TRAPPII protein complex [GO:1990071]; alpha-tubulin binding [GO:0043014]; cilium assembly [GO:0060271]; regulation of cell population proliferation [GO:0042127]	alpha-tubulin binding [GO:0043014]	GO:0005886; GO:0030496; GO:0034451; GO:0042127; GO:0043014; GO:0043231; GO:0060271; GO:0072686; GO:1990071	EGLEVPLIAVVQWSTPK	7.900000095	1	1	0.110202582	1866.778898	13.78413	15.80735	15.92556	0	13.85867	0	0	0	14.57781	0	0	14.1474	0	0	0	0	0	0	14.39578	13.88406	0	0	15.97897	0	0	0	14.92957	0	11.60355	14.63428	0	0	0	0	0	0	0	16.56217	0	0	14.27568	0	0	8.196934	0	0	14.0004	15.11123
Q8WVS4	DC2I1_HUMAN	Cytoplasmic dynein 2 intermediate chain 1 (Dynein 2 intermediate chain 1) (WD repeat-containing protein 60)	DYNC2I1 WDR60	Homo sapiens (Human)	cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary plasm [GO:0097014]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242]	centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary plasm [GO:0097014]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]	GO:0000242; GO:0005615; GO:0005813; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0042073; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097014; GO:0097542; GO:0097546	NRGASSK	6.269999981	0.378266424	0.378266424	0.185287287	719.4468789	0	15.8407	0	14.82338	0	0	0	14.29863	0	15.65872	14.4336	0	15.36708	15.9406	15.44781	13.28897	15.89303	16.04809	15.81545	16.08127	15.99282	0	0	0	16.13549	15.8288	16.48891	13.56116	16.42609	14.48995	16.24376	15.85598	15.28084	16.11597	13.62973	16.3921	16.59633	16.33772	17.24401	14.28197	15.25945	15.74697	16.24302	16.92315	16.68933	16.57492	16.57311	15.84997
Q8WVT3	TPC12_HUMAN	"Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15, TPR repeat protein 15, TTC-15) (Trafficking of membranes and mitosis)"	TRAPPC12 TRAMM TTC15 CGI-87	Homo sapiens (Human)	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle tethering [GO:0099022]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle tethering [GO:0099022]		GO:0000776; GO:0005634; GO:0005654; GO:0005737; GO:0005793; GO:0005794; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0048208; GO:0051310; GO:0090234; GO:0099022; GO:1905342; GO:1990072	ENLTMPGLR	4.380000114	1	1	0.262199573	1046.588476	18.26424	0	0	0	16.47842	0	0	18.36108	0	0	0	0	0	0	0	0	17.13984	0	0	17.79429	0	0	0	0	0	18.17183	0	0	17.16261	0	0	17.18703	0	0	0	0	16.77989	0	0	0	0	0	0	0	0	17.10631	16.42401	0
Q8WVV4	POF1B_HUMAN	Protein POF1B (Premature ovarian failure protein 1B)	POF1B	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; epithelial cell morphogenesis [GO:0003382]	actin filament [GO:0005884]; adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; desmosome [GO:0030057]	actin filament [GO:0005884]; adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; desmosome [GO:0030057]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; epithelial cell morphogenesis [GO:0003382]	actin filament binding [GO:0051015]	GO:0003382; GO:0005884; GO:0005912; GO:0005923; GO:0007015; GO:0030036; GO:0030057; GO:0051015; GO:0070830	TYSGPMNK	6.679999828	1	1	4.59E-13	913.519427	13.54828	0	13.32439	0	13.79268	13.32805	0	0	14.32106	14.76124	13.67744	11.68659	14.12042	14.09707	14.40521	14.91907	14.01602	14.27943	15.10975	12.66637	0	15.85985	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.14785	0
Q8WVV5	BT2A2_HUMAN	Butyrophilin subfamily 2 member A2	BTN2A2 BT2.2 BTF2	Homo sapiens (Human)	negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852]	signaling receptor binding [GO:0005102]	GO:0001817; GO:0001818; GO:0005102; GO:0005886; GO:0009897; GO:0014067; GO:0016021; GO:0045591; GO:0046007; GO:0050852; GO:0050860; GO:0051898; GO:0070373; GO:2000134	SYDEAILR	5.829999924	0.348208308	0.348208308	0.200945805	966.8615271	0	11.0453	15.65942	0	15.43907	14.97339	12.5006	13.25517	0	17.21319	0	0	0	16.73079	0	15.79224	0	15.09342	0	0	0	0	17.58903	15.88896	14.75457	16.49104	0	13.89514	0	0	13.5279	0	0	15.72873	0	16.54657	0	0	0	0	0	0	12.84993	16.37543	0	0	15.32539	0
Q8WVV9	HNRLL_HUMAN	"Heterogeneous nuclear ribonucleoprotein L-like, hnRNPLL (Stromal RNA-regulating factor)"	HNRNPLL HNRPLL SRRF BLOCK24	Homo sapiens (Human)	mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of RNA splicing [GO:0043484]	membrane [GO:0016020]; nucleus [GO:0005634]	membrane [GO:0016020]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of RNA splicing [GO:0043484]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0016020; GO:0033120; GO:0043484	NNRFTSAGQASK	14.30000019	1	1	0.193932973	1282.031051	0	16.12548	0	17.90075	0	0	0	0	0	0	0	0	0	18.32879	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WVX9	FACR1_HUMAN	"Fatty acyl-CoA reductase 1, EC 1.2.1.84 (Male sterility domain-containing protein 2)"	FAR1 MLSTD2 UNQ2423/PRO4981	Homo sapiens (Human)	ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]	integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]	alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; oxidoreductase activity [GO:0016491]	GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0016491; GO:0035336; GO:0043231; GO:0046474; GO:0080019; GO:0102965	VEEVLSGKLFDR	2.119999886	1	1	0.38483214	1391.82424	16.31752	0	15.35177	0	17.14773	15.66388	0	0	17.06455	0	0	15.87039	15.74569	15.74772	0	0	0	0	17.20238	14.10917	0	0	15.1967	0	0	0	0	16.54979	12.88972	15.15124	13.80116	15.11238	0	17.12818	16.84297	0	0	15.59302	0	0	0	0	0	0	0	15.93115	14.44966	0
Q8WW24	TEKT4_HUMAN	Tektin-4	TEKT4	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]	microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]	microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]		GO:0005634; GO:0015630; GO:0036126; GO:0060271; GO:0060294	NLEDIHMSLEKDIAAMTNSLFIDR	4.690000057	1	1	2.75E-12	2807.234972	0	0	13.12764	10.29137	0	13.37082	0	15.29608	12.61542	15.57857	12.72678	0	12.60412	15.33074	0	0	13.13888	0	14.42184	0	0	0	0	0	0	11.8134	0	0	0	0	0	0	0	0	14.38588	0	0	0	0	0	0	14.47194	0	0	0	0	0	0
Q8WW33	GTSF1_HUMAN	Gametocyte-specific factor 1 (Protein FAM112B)	GTSF1 FAM112B	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	metal ion binding [GO:0046872]	GO:0005737; GO:0007283; GO:0030154; GO:0046872	NNLASGMR	2.480000019	0.531582355	0.531582355	0.054632875	861.3933383	17.52258	14.91904	15.00581	17.27226	16.11393	16.3739	14.41621	18.34515	0	0	15.71274	16.75581	0	14.68254	0	0	17.8494	12.90624	13.61074	13.21963	0	13.74662	14.96011	17.30587	16.65268	12.55532	16.25076	13.40248	15.57918	0	11.52658	0	16.40132	0	13.51567	11.74787	16.64209	17.98093	17.05951	0	15.57759	15.78854	15.89748	0	11.39327	14.28715	13.86719	13.69845
Q8WW36	ZCH13_HUMAN	Zinc finger CCHC domain-containing protein 13	ZCCHC13	Homo sapiens (Human)	positive regulation of cytoplasmic translation [GO:2000767]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767]	mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]	GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767	GGGHGR	2.75999999	0.303523004	0.303523004	0.124097958	541.4047869	15.73418	17.61238	15.86667	16.25254	17.71126	16.72999	0	16.89101	15.63078	16.22329	16.84429	16.8842	17.23513	15.47681	17.02685	16.4395	16.75575	0	18.42922	0	17.55272	16.0328	16.52011	16.42323	0	16.62566	17.7473	15.71186	16.13164	16.94748	16.26423	0	16.62494	17.39148	17.52734	16.39732	16.80037	16.34565	0	0	18.14256	16.65454	16.01374	16.68602	17.02246	16.96084	0	0
Q8WW38	FOG2_HUMAN	"Zinc finger protein ZFPM2 (Friend of GATA protein 2, FOG-2, Friend of GATA 2, hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2)"	ZFPM2 FOG2 ZNF89B	Homo sapiens (Human)	"cell differentiation [GO:0030154]; embryonic organ development [GO:0048568]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; embryonic organ development [GO:0048568]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]"	DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000785; GO:0001570; GO:0001701; GO:0003148; GO:0003221; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007506; GO:0007507; GO:0008270; GO:0030154; GO:0030324; GO:0045599; GO:0045892; GO:0045944; GO:0048568; GO:0060045; GO:0060412; GO:0060548; GO:0061629; GO:2000020; GO:2000195	AMQTKDASSDTELDK	9.75	1	1	0.214284253	1640.314116	0	0	14.05443	15.61342	0	14.35991	0	0	14.38454	0	13.5789	0	0	0	0	0	0	14.31965	0	0	0	0	14.77341	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WW52	F151A_HUMAN	Protein FAM151A	FAM151A C1orf179 UNQ3034/PRO9836	Homo sapiens (Human)		extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0005615; GO:0016020; GO:0016021; GO:0070062	MHELVGGVPQR	3.970000029	1	1	0.120901654	1239.654911	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.25852	0	0	0	0	0	0	0	0
Q8WWC4	MAIP1_HUMAN	"m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1)"	MAIP1 C2orf47	Homo sapiens (Human)	calcium import into the mitochondrion [GO:0036444]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ribosome binding [GO:0043022]; calcium import into the mitochondrion [GO:0036444]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]	ribosome binding [GO:0043022]	GO:0005743; GO:0005759; GO:0007007; GO:0032979; GO:0036444; GO:0043022; GO:0051204; GO:0051560	EVLHALK	5.21999979	0.00020578	0.00020578	0.284374262	809.5765193	16.43505	0	18.03819	0	0	16.55724	16.03791	0	17.7765	17.63085	17.22279	17.19782	0	0	0	18.71051	0	0	0	0	16.08313	0	0	17.57518	17.01563	18.59878	17.34859	0	16.70166	18.08585	0	16.99766	0	17.27098	0	0	0	19.19392	18.31467	0	0	18.6294	0	0	17.98975	18.3204	16.7915	0
Q8WWH5	TRUB1_HUMAN	"Pseudouridylate synthase TRUB1, EC 5.4.99.- (TruB pseudouridine synthase homolog 1) (tRNA pseudouridine 55 synthase TRUB1, Psi55 synthase TRUB1, EC 5.4.99.25)"	TRUB1 PUS4	Homo sapiens (Human)	mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005739; GO:0005829; GO:0006400; GO:0009982; GO:1990481	LSTLMK	8.220000267	1	1	0.096858678	691.7955155	0	14.24513	12.84412	0	0	0	0	0	0	0	16.49543	15.55035	17.95782	17.78577	0	0	0	0	0	14.37025	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.73579	16.72129	0	0	0	17.59903	0	18.41644	0	18.63895	0	0
Q8WWI1	LMO7_HUMAN	"LIM domain only protein 7, LMO-7 (F-box only protein 20) (LOMP)"	LMO7 FBX20 FBXO20 KIAA0858	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872	AFEDFRK	5.369999886	0.76615864	0.76615864	0.229134932	912.2595123	0	17.29595	15.85135	15.03545	0	0	0	15.86882	17.92174	16.3669	17.10731	16.52239	17.48109	16.00245	16.70675	14.96836	0	0	0	0	14.99805	16.30607	16.6866	17.83603	16.74204	17.84395	0	16.32397	16.00136	0	0	15.22686	0	0	15.05499	16.46009	18.35124	15.31553	16.22266	16.9916	0	15.52936	16.5301	16.41417	16.0772	17.38493	0	15.33191
Q8WWI5	CTL1_HUMAN	Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92)	SLC44A1 CD92 CDW92 CTL1	Homo sapiens (Human)	choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]	GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0022857; GO:0042426; GO:0055085; GO:0070062; GO:0150104	MGCCSSASSAAQSSK	10.11999989	0.879242241	0.879242241	0.293793212	1536.156917	15.45367	13.97048	15.15206	0	0	14.3745	0	0	0	0	0	0	16.34073	15.74638	18.11711	15.26661	13.02262	0	0	0	0	0	18.04888	0	0	0	0	16.31968	14.05606	0	0	0	0	0	0	0	0	0	0	0	0	15.96427	0	0	16.68738	0	0	0
Q8WWK9	CKAP2_HUMAN	Cytoskeleton-associated protein 2 (CTCL tumor antigen se20-10) (Tumor- and microtubule-associated protein)	CKAP2 LB1 TMAP	Homo sapiens (Human)	apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of transcription by RNA polymerase II [GO:0045944]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of transcription by RNA polymerase II [GO:0045944]		GO:0000281; GO:0000922; GO:0005737; GO:0005813; GO:0005874; GO:0006915; GO:0007026; GO:0015630; GO:0045944; GO:0072686	DESSAATK	7.03000021	1	1	0.070053995	807.3034283	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.60355	0	0	15.47947	0	15.65709	0	13.53586	0	15.73734	0	0	14.51889	12.27043	0	0	13.92579	0	14.95227	0	0	0	0	0	15.10594	0	0	15.71418	0	16.39555	13.42221	0	0
Q8WWL2	SPIR2_HUMAN	"Protein spire homolog 2, Spir-2"	SPIRE2 KIAA1832 SPIR2	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	actin binding [GO:0003779]	GO:0003779; GO:0005829; GO:0005856; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030041; GO:0030659; GO:0032154; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0048193; GO:0051295; GO:0051639; GO:0070649; GO:2000781	ELFSSLKK	21.03000069	2.62E-05	2.62E-05	0.277980971	951.3520809	0	0	0	0	18.24807	0	19.42447	0	18.94842	0	0	0	0	20.68094	16.96647	0	0	0	0	0	0	18.9917	0	0	0	0	0	0	0	18.04679	19.36376	0	0	0	0	20.09491	19.09344	0	0	0	17.68981	0	0	0	0	18.03519	17.19275	17.63255
Q8WWL7	CCNB3_HUMAN	G2/mitotic-specific cyclin-B3	CCNB3 CYCB3	Homo sapiens (Human)	cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]	GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0010389; GO:0016538; GO:0016607; GO:0019901; GO:0044772; GO:0051301; GO:0051321	KPKTEESIPTHK	8.93999958	0.021952821	0.021952821	0.187784879	1395.578562	14.57667	14.4176	13.07192	15.12181	0	0	0	0	13.69495	0	17.46324	13.12284	13.00561	14.52585	13.5812	0	0	13.67185	0	0	12.98787	11.57613	0	0	0	0	15.21691	15.90206	0	0	0	0	0	0	0	0	15.62652	0	0	0	0	0	0	0	0	0	0	0
Q8WWM7	ATX2L_HUMAN	Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein)	ATXN2L A2D A2LG A2LP A2RP	Homo sapiens (Human)	mRNA metabolic process [GO:0016071]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; stress granule assembly [GO:0034063]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0005829; GO:0010494; GO:0016020; GO:0016071; GO:0016607; GO:0034063; GO:0045296	CSSSRGGRPGLSSLPPR	8.670000076	0.166345596	0.166345596	0.123928503	1771.730202	0	15.75238	16.08103	15.30138	0	14.70121	0	13.64524	15.63814	15.69701	15.39198	15.07403	14.52517	16.94747	0	16.02953	0	0	0	16.57512	15.97392	0	0	0	15.65946	0	16.63535	0	15.34561	0	0	16.32775	0	0	15.17446	0	17.39754	0	0	16.84208	17.17147	0	0	16.79965	16.36804	0	16.99271	17.29171
Q8WWM9	CYGB_HUMAN	"Cytoglobin (Histoglobin, HGb) (Stellate cell activation-associated protein)"	CYGB STAP	Homo sapiens (Human)	fatty acid oxidation [GO:0019395]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of hepatic stellate cell activation [GO:2000490]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]	cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; catalase activity [GO:0004096]; fatty acid peroxidase activity [GO:0047888]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; peroxidase activity [GO:0004601]; fatty acid oxidation [GO:0019395]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of hepatic stellate cell activation [GO:2000490]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]	catalase activity [GO:0004096]; fatty acid peroxidase activity [GO:0047888]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; peroxidase activity [GO:0004601]	GO:0001666; GO:0004096; GO:0004601; GO:0005344; GO:0005506; GO:0005829; GO:0006979; GO:0010764; GO:0015671; GO:0019395; GO:0019825; GO:0020037; GO:0032966; GO:0043005; GO:0043025; GO:0047888; GO:2000490	KAVQAMWAR	8.399999619	0.867286384	0.867286384	0.19590787	1075.536098	14.38238	14.86746	14.4921	14.56973	15.40256	14.06843	0	16.04698	14.49335	14.97548	13.90389	0	0	15.69423	0	15.82765	14.34996	13.6074	15.11159	16.3591	13.80801	14.4288	0	0	0	15.67885	16.34122	12.52701	15.05133	15.47109	15.43744	11.21655	15.58543	15.1334	15.84297	15.70818	15.64585	12.90875	12.55354	13.88212	15.60617	14.79778	12.99542	12.71063	12.94472	0	14.73476	12.94112
Q8WWN8	ARAP3_HUMAN	"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 (Centaurin-delta-3, Cnt-d3)"	ARAP3 CENTD3	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; cytoskeleton organization [GO:0007010]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]"	"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]"	GO:0001726; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005886; GO:0007010; GO:0007165; GO:0016192; GO:0030027; GO:0043325; GO:0043547; GO:0046872	SSPQAR	6.840000153	0.486129671	0.486129671	0.068249868	647.138194	13.34528	0	0	16.838	15.44937	15.65073	0	0	14.26821	0	16.52032	0	0	14.889	0	14.42664	0	9.866041	12.63871	16.21707	12.80995	14.73431	13.87626	14.49408	0	13.25347	14.0497	0	17.36236	0	0	15.15774	0	13.60312	15.63976	0	0	17.37976	0	16.57926	0	15.89367	0	0	0	0	14.32155	0
Q8WWQ0	PHIP_HUMAN	"PH-interacting protein, PHIP (DDB1- and CUL4-associated factor 14) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11)"	PHIP DCAF14 WDR11	Homo sapiens (Human)	"cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577]; cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]"	insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577]	GO:0001932; GO:0005158; GO:0005634; GO:0006357; GO:0007010; GO:0008284; GO:0008286; GO:0008360; GO:0022604; GO:0043066; GO:0043568; GO:0045840; GO:0045893; GO:0045944; GO:0070577; GO:2001237	DQTCYNIIPLYNSMKK	5.380000114	1	1	0.425291291	2004.323307	0	0	0	0	0	0	0	0	0	0	22.58535	0	0	0	0	18.05327	0	0	0	19.49454	0	0	0	0	0	0	0	0	0	15.86917	21.99156	21.42952	0	0	0	0	0	0	0	0	0	20.94732	0	21.46167	0	0	0	0
Q8WWQ2	HPSE2_HUMAN	"Inactive heparanase-2, Hpa2"	HPSE2 HPA2	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cell population proliferation [GO:0008284]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; heparanase activity [GO:0030305]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cell population proliferation [GO:0008284]	heparan sulfate proteoglycan binding [GO:0043395]; heparanase activity [GO:0030305]	GO:0005576; GO:0005886; GO:0006027; GO:0008284; GO:0030198; GO:0030305; GO:0031012; GO:0043395	NPAKSR	18.45999908	0.27088058	0.27088058	0.304395863	673.1065739	15.52655	16.07796	16.37469	15.57237	15.95676	0	14.98265	14.74724	15.18456	0	12.23871	14.9306	14.47163	15.92157	16.6285	0	0	0	16.90125	14.54856	0	15.59276	16.21636	17.29294	15.98526	0	16.21874	16.93853	15.17941	14.09642	16.71553	0	0	14.76491	0	16.24852	0	0	16.05281	0	0	0	16.28283	0	16.40611	0	16.06865	0
Q8WWQ8	STAB2_HUMAN	"Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2, FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis) ]"	STAB2 FEEL2 FELL FEX2 HARE	Homo sapiens (Human)	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; receptor-mediated endocytosis [GO:0006898]	cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; receptor-mediated endocytosis [GO:0006898]	calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044]	GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0005887; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030666; GO:0042742; GO:0050830	CGAGR	4.659999847	0.482469499	0.482469499	0.054764894	521.9448667	0	13.51775	16.51694	17.0697	19.19829	16.40514	15.3662	13.22672	0	17.48537	16.62228	0	0	0	0	0	0	0	0	0	0	16.73596	15.5107	0	0	12.42122	0	11.43771	0	0	0	16.36683	16.90192	0	18.33481	17.17536	16.51376	19.83204	17.50942	17.90171	18.10177	17.98313	15.31542	0	16.36329	0	0	17.2946
Q8WWR8	NEUR4_HUMAN	"Sialidase-4, EC 3.2.1.18 (N-acetyl-alpha-neuraminidase 4)"	NEU4 LP5125	Homo sapiens (Human)	ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; negative regulation of neuron projection development [GO:0010977]; oligosaccharide catabolic process [GO:0009313]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; organelle inner membrane [GO:0019866]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; organelle inner membrane [GO:0019866]; plasma membrane [GO:0005886]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; negative regulation of neuron projection development [GO:0010977]; oligosaccharide catabolic process [GO:0009313]	exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]	GO:0004308; GO:0005737; GO:0005741; GO:0005743; GO:0005764; GO:0005789; GO:0005886; GO:0006516; GO:0006689; GO:0009313; GO:0010977; GO:0016020; GO:0019866; GO:0043005; GO:0043202; GO:0043231; GO:0052794; GO:0052795; GO:0052796	TGLTYR	1.830000043	1	1	0.154411343	710.5807431	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WWT9	S13A3_HUMAN	"Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3, NaDC-3, hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)"	SLC13A3 NADC3 SDCT2	Homo sapiens (Human)	anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104]	basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104]	alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]	GO:0005310; GO:0005886; GO:0006835; GO:0015137; GO:0015139; GO:0015141; GO:0015362; GO:0015746; GO:0016021; GO:0016323; GO:0017153; GO:0034634; GO:0034775; GO:0070062; GO:0071422; GO:0098656; GO:0150104	MAALAAAAK	1.149999976	0.104497865	0.104497865	0.317096942	832.6145852	0	19.50847	0	16.47867	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WWU5	TCP11_HUMAN	T-complex protein 11 homolog	TCP11	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; germ cell development [GO:0007281]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]	acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]	acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; germ cell development [GO:0007281]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]		GO:0001669; GO:0007165; GO:0007189; GO:0007281; GO:0007283; GO:0010737; GO:0016021; GO:0036126; GO:0097225; GO:1902490	NMGLVALSSDNTASLMGQLQNIAK	5.519999981	1	1	0	2493.044974	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WWU7	ITLN2_HUMAN	Intelectin-2 (Endothelial lectin HL-2)	ITLN2 UNQ2789/PRO7179	Homo sapiens (Human)		extracellular space [GO:0005615]	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]	metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]	GO:0005615; GO:0046872; GO:0070492	NGVVYQTFCDMTSGGGGWTLVASVHENDMR	9.220000267	1	1	3.65E-12	3303.28852	0	0	0	16.03044	16.76285	0	17.29507	17.47554	16.2014	17.59808	12.36298	15.38327	0	0	0	13.30702	0	17.40401	18.01793	0	16.61032	14.72781	0	14.73713	15.9146	15.23612	15.11517	13.76905	16.48642	16.82998	14.33958	16.47264	15.13238	18.19535	0	0	12.73425	16.43442	0	0	0	0	10.30849	0	0	0	17.0641	16.18717
Q8WWV6	FCAMR_HUMAN	High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor (Fc alpha/mu receptor) (CD antigen CD351)	FCAMR FKSG87	Homo sapiens (Human)	adaptive immune response [GO:0002250]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]	transmembrane signaling receptor activity [GO:0004888]	GO:0002250; GO:0004888; GO:0005886; GO:0016021	REMTTTK	2.579999924	1	1	0.215116884	879.9449706	0	0	14.15539	0	0	16.1252	0	15.52192	15.87292	15.44985	0	0	0	0	0	0	0	0	0	0	14.92179	0	0	0	16.21098	0	0	0	15.37038	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WWX8	SC5AB_HUMAN	"Sodium/myo-inositol cotransporter 2, Na(+)/myo-inositol cotransporter 2 (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2, SMIT2) (Solute carrier family 5 member 11)"	SLC5A11 KST1 SLGTX SMIT2	Homo sapiens (Human)	apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]; regulation of transporter activity [GO:0032409]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166]; apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]; regulation of transporter activity [GO:0032409]	glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166]	GO:0005412; GO:0005886; GO:0006915; GO:0015166; GO:0015798; GO:0016021; GO:0032409	GGALMAAYLK	2.480000019	0.396217644	0.396217644	0.208800758	1008.972288	0	12.21276	0	0	15.04749	0	13.43369	0	12.13213	12.86365	0	0	14.71422	0	0	15.53939	0	0	0	0	0	0	0	0	0	17.18294	16.2556	0	0	0	0	17.57725	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WWY3	PRP31_HUMAN	"U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein, Protein 61K, hPrp31)"	PRPF31 PRP31	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]	"Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]"	identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]	GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030621; GO:0030622; GO:0042802; GO:0043021; GO:0046540; GO:0070990; GO:0071005; GO:0071011; GO:0071166; GO:0071339; GO:0097526	ARISK	5.889999866	1	1	0.217691625	575.7656527	0	16.60186	0	0	0	0	0	0	0	0	0	0	0	18.91838	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.23708	0	0	0	0	0	0	0	0	0
Q8WWZ1	IL1FA_HUMAN	"Interleukin-1 family member 10, IL-1F10 (Family of interleukin 1-theta, FIL1 theta) (Interleukin-1 HY2, IL-1HY2) (Interleukin-1 theta, IL-1 theta) (Interleukin-38, IL-38)"	IL1F10 FIL1T IL1HY2 IL38 FKSG75 UNQ6119/PRO20041	Homo sapiens (Human)	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of gene expression [GO:0010628]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of gene expression [GO:0010628]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	GO:0002437; GO:0005125; GO:0005149; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0010628; GO:0019221; GO:0071222	MCSLPMAR	4.820000172	1	1	0.023193131	963.6496917	0	0	0	0	0	0	0	0	15.49553	0	16.22384	0	14.98511	0	0	0	0	13.13057	0	0	0	0	0	0	0	17.22618	16.89663	15.48015	0	0	0	15.91493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.39703
Q8WWZ4	ABCAA_HUMAN	"ATP-binding cassette sub-family A member 10, EC 7.6.2.-"	ABCA10	Homo sapiens (Human)	lipid transport [GO:0006869]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]	GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0042626; GO:0043231; GO:0140359	CSDQGIR	7.679999828	1	1	0.126423002	834.270939	15.0307	14.35223	14.40133	0	14.32113	12.65249	0	0	0	0	0	12.75184	0	0	0	10.46366	0	0	14.90098	12.92261	0	0	0	0	0	0	12.74285	0	14.24496	12.92162	0	14.75681	0	0	12.89386	0	0	0	13.02983	0	0	0	0	0	0	0	0	0
Q8WWZ7	ABCA5_HUMAN	"Cholesterol transporter ABCA5, EC 7.6.2.- (ATP-binding cassette sub-family A member 5)"	ABCA5 KIAA1888	Homo sapiens (Human)	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]	GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016021; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0140359; GO:1903064	GEILGLLGPNGAGK	8.039999962	1	1	0.07603941	1295.845809	0	0	0	14.81031	13.72218	0	0	15.56564	0	0	0	0	15.40882	0	0	10.36509	15.62009	0	0	0	0	0	0	0	0	0	0	0	17.31689	0	17.68412	0	18.44578	0	15.61991	15.18296	0	16.72664	0	0	0	18.39524	0	0	0	16.60707	15.25925	0
Q8WWZ8	OIT3_HUMAN	Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein)	OIT3 LZP UNQ826/PRO1753	Homo sapiens (Human)	urate homeostasis [GO:1903118]	cell surface [GO:0009986]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]	cell surface [GO:0009986]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; urate homeostasis [GO:1903118]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005615; GO:0005635; GO:0009986; GO:1903118	EALPTLK	2.470000029	1	1	0.268524459	770.6493596	19.1948	0	0	0	0	0	0	0	18.13919	0	0	0	0	0	0	0	16.53949	0	16.73369	0	0	17.92409	0	0	0	0	0	0	0	0	0	0	18.24294	0	0	0	0	0	0	18.27332	0	0	0	0	0	0	0	0
Q8WX93	PALLD_HUMAN	Palladin (SIH002) (Sarcoma antigen NY-SAR-77)	PALLD KIAA0992 CGI-151	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334]	actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371]	GO:0001725; GO:0001726; GO:0002102; GO:0003334; GO:0003382; GO:0003779; GO:0005634; GO:0005739; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007010; GO:0007156; GO:0007411; GO:0015629; GO:0016477; GO:0030018; GO:0030027; GO:0030036; GO:0030424; GO:0030426; GO:0051371; GO:0060076; GO:0070593; GO:0098632	VYLECRVTGNPTPR	2.24000001	1	1	0.364895493	1660.863551	0	15.54904	0	0	0	12.61786	0	0	0	0	0	0	0	14.63521	0	0	0	11.68163	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.21181	0	0	0	16.0644	0	0	0	0	0	0
Q8WXA3	RUFY2_HUMAN	RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related)	RUFY2 KIAA1537 RABIP4R	Homo sapiens (Human)	regulation of endocytosis [GO:0030100]	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100]	metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005737; GO:0005768; GO:0017124; GO:0030100; GO:0046872	HSRQGLDEMYNEAR	1.110000014	0.737509608	0.737509608	0.287991495	1723.278945	0	0	0	15.76982	16.48579	17.28297	0	0	0	0	0	0	0	0	0	0	15.49237	15.9058	0	0	0	0	0	0	14.27608	13.06571	0	0	0	0	0	17.81953	0	0	0	0	0	14.41317	0	0	0	0	10.60352	0	0	0	15.52644	0
Q8WXB1	MT21A_HUMAN	"Protein N-lysine methyltransferase METTL21A, EC 2.1.1.- (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A)"	METTL21A FAM119A HCA557B	Homo sapiens (Human)	peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]	ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0008276; GO:0016279; GO:0018022; GO:0030544; GO:0031072; GO:0032991; GO:0051117	VALEFLK	4	0.182122365	0.182122365	0.192013671	820.3758168	0	15.13047	15.90482	0	16.50011	15.29402	0	16.29174	0	15.65151	16.40907	0	0	0	0	0	0	0	0	15.97686	0	0	0	0	0	14.83344	0	0	0	15.47046	16.29965	0	0	17.06258	0	16.31924	15.61213	15.95958	16.35564	17.00953	16.10262	0	0	17.03813	0	0	0	0
Q8WXB4	ZN606_HUMAN	Zinc finger protein 606 (Zinc finger protein 328)	ZNF606 KIAA1852 ZNF328	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	DQLEMYHMNQSTAMR	4.639999866	0.253666967	0.253666967	0.181793467	1885.853801	15.43002	0	18.43013	14.54585	15.96784	0	0	0	0	0	0	0	0	17.30894	0	0	16.87539	0	0	0	0	0	14.61888	13.63263	0	0	17.97164	0	19.1753	15.49478	12.75001	19.73335	17.87007	0	14.81526	15.75111	17.36746	0	14.09995	0	15.42233	18.03166	13.07512	15.07268	0	0	15.10792	15.45979
Q8WXD9	CSKI1_HUMAN	Caskin-1 (CASK-interacting protein 1)	CASKIN1 KIAA1306	Homo sapiens (Human)	signal transduction [GO:0007165]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; identical protein binding [GO:0042802]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]	GO:0005737; GO:0007165; GO:0016020; GO:0042802	TLSGPVTGLLATARR	5.820000172	0.127831399	0.127831399	0.328506147	1514.788456	13.49834	0	12.83786	14.48019	16.13793	12.98193	17.345	14.11555	15.11603	12.29261	0	11.81943	0	0	0	13.99463	0	15.45943	0	0	0	0	0	0	0	0	0	12.49569	0	14.77668	16.24788	0	0	0	0	0	14.33006	0	0	0	0	14.78876	0	0	0	0	16.10711	0
Q8WXE1	ATRIP_HUMAN	ATR-interacting protein (ATM and Rad3-related-interacting protein)	ATRIP AGS1	Homo sapiens (Human)	DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779]	ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779]	K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]	GO:0000077; GO:0005634; GO:0005654; GO:0006139; GO:0006281; GO:0070310; GO:0070530; GO:2000779	LLDGMSK	2.230000019	1	1	1.15E-13	780.4895217	14.87865	14.40863	16.51995	0	13.69747	14.26012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WXF7	ATLA1_HUMAN	"Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)"	ATL1 GBP3 SPG3A	Homo sapiens (Human)	axonogenesis [GO:0007409]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; protein homooligomerization [GO:0051260]	axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; axonogenesis [GO:0007409]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; protein homooligomerization [GO:0051260]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]	GO:0000137; GO:0000139; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007029; GO:0007409; GO:0016021; GO:0030424; GO:0042802; GO:0051260; GO:0071782; GO:0098826; GO:1990809	EINGNK	5.03000021	0.842133403	0.842133403	0.24788126	675.3225208	0	0	0	0	0	0	0	17.35033	16.49872	0	0	0	18.82083	18.78345	19.15184	0	18.63463	18.03291	19.00422	15.0771	15.88107	18.23973	16.62224	17.33791	0	18.64428	0	17.06334	17.454	18.97825	18.91072	18.97711	0	18.20607	17.27276	18.36675	0	18.6509	19.72139	17.82098	0	18.55486	17.85542	19.06645	19.48483	18.65571	19.72791	20.10325
Q8WXF8	DEDD2_HUMAN	DNA-binding death effector domain-containing protein 2 (DED-containing protein FLAME-3) (FADD-like anti-apoptotic molecule 3)	DEDD2 FLAME3 PSEC0004	Homo sapiens (Human)	"apoptotic nuclear changes [GO:0030262]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; signaling receptor complex adaptor activity [GO:0030159]; apoptotic nuclear changes [GO:0030262]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]"	DNA binding [GO:0003677]; signaling receptor complex adaptor activity [GO:0030159]	GO:0003677; GO:0005654; GO:0005730; GO:0006396; GO:0008625; GO:0016075; GO:0019725; GO:0030159; GO:0030262; GO:0035556; GO:0045892; GO:2001238	RPQALARQLDVFGQATAVLR	1.029999971	1	1	0.080130306	2209.727946	0	0	13.73789	0	0	0	0	0	0	0	0	0	12.98072	0	0	0	13.05149	0	12.7663	0	12.81455	7.163099	0	13.37923	0	0	10.96859	13.55111	0	13.85382	0	0	15.92675	13.60293	7.953599	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WXG1	RSAD2_HUMAN	"Radical S-adenosyl methionine domain-containing protein 2, EC 4.2.-.- (Cytomegalovirus-induced gene 5 protein) (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible)"	RSAD2 CIG5	Homo sapiens (Human)	"CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]"	GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0043621; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553	QPLSSLWR	3.769999981	1	1	0.164875309	986.0559641	0	0	13.36323	14.89934	0	12.81266	13.5487	0	13.34381	0	0	14.75521	13.13054	0	14.94105	0	0	0	0	0	8.919705	13.97002	15.99806	0	0	0	14.19796	0	0	0	0	0	0	0	0	0	0	0	0	10.34211	0	0	0	0	0	0	14.66236	0
Q8WXG6	MADD_HUMAN	"MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor, RabGEF) (Rab3 GDP/GTP exchange protein, Rab3GEP)"	MADD DENN IG20 KIAA0358	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase activator activity [GO:0030295]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483]	death receptor binding [GO:0005123]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase activator activity [GO:0030295]	GO:0005085; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0016021; GO:0030295; GO:0030424; GO:0032483; GO:0042981; GO:0043410; GO:0051726; GO:0097194; GO:1902041; GO:2001236	ELYYCVKDSMER	4.940000057	1	1	0.080061599	1590.653409	13.08187	11.58747	16.4058	13.82089	13.73423	13.70844	12.30992	0	13.95961	0	14.29322	13.63078	0	14.2383	13.33409	14.78736	0	15.16195	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WXG9	AGRV1_HUMAN	"Adhesion G-protein coupled receptor V1, ADGRV1, EC 3.4.-.- (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta ]"	ADGRV1 GPR98 KIAA0686 KIAA1943 MASS1 VLGR1	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]	GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016021; GO:0016787; GO:0030501; GO:0031647; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696	CAQMEPNALPFR	4.900000095	1	1	0.147146797	1450.928713	13.44088	15.49193	13.77348	12.3937	10.79333	14.2797	15.0303	13.37449	0	14.45132	14.58823	13.96792	0	0	0	0	0	15.4779	0	0	13.68604	0	15.37974	0	0	0	0	0	15.8364	14.81384	0	0	0	0	0	0	0	0	0	0	15.09191	0	0	0	0	0	0	0
Q8WXH0	SYNE2_HUMAN	"Nesprin-2 (KASH domain-containing protein 2, KASH2) (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein, Protein NUANCE) (Synaptic nuclear envelope protein 2, Syne-2)"	SYNE2 KIAA1011 NUA	Homo sapiens (Human)	centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]	GO:0003779; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005737; GO:0005739; GO:0005925; GO:0007097; GO:0016021; GO:0016529; GO:0021817; GO:0030018; GO:0030335; GO:0031022; GO:0031258; GO:0031527; GO:0031965; GO:0031981; GO:0033017; GO:0034993; GO:0045111; GO:0051015; GO:0051642; GO:0070062; GO:0140444; GO:1902017	DSAVEMAMSK	1.590000033	1	1	0.119037553	1084.807008	14.31163	11.83629	0	0	0	0	14.99139	0	0	0	0	14.74056	14.33893	14.78369	8.850767	0	0	0	0	0	0	15.46749	0	0	0	0	15.78002	15.39345	0	0	0	16.27812	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WXH2	JPH3_HUMAN	"Junctophilin-3, JP-3 (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein)"	JPH3 JP3 TNRC22	Homo sapiens (Human)	calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167]		GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0014701; GO:0016021; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060314; GO:0060402	QSVPYGMAAVIR	10.59000015	1	1	0.614240419	1308.250377	0	0	0	19.00357	0	0	0	0	18.12627	0	0	0	0	0	0	0	0	0	0	0	19.5521	0	0	0	0	0	0	17.61845	0	0	0	19.10092	0	0	0	0	0	0	0	17.53709	0	0	0	0	0	0	18.57924	0
Q8WXI2	CNKR2_HUMAN	"Connector enhancer of kinase suppressor of ras 2, Connector enhancer of KSR 2 (CNK homolog protein 2, CNK2)"	CNKSR2 CNK2 KIAA0902 KSR2	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; regulation of signal transduction [GO:0009966]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; regulation of signal transduction [GO:0009966]	identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005886; GO:0009966; GO:0019901; GO:0035556; GO:0042802; GO:0043005; GO:0043025; GO:0070062; GO:0098978; GO:0099147; GO:0099173	ISGDQLLRITHQELEDLGVSR	8.25	1	1	0.117668169	2379.940036	0	14.41908	13.87058	0	0	14.52864	0	0	0	0	8.459628	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.60496	15.5006	15.77566	0	0	15.17158	15.3498	16.35462	14.76536	0	0	0	0	0	0	0	0	0	0	16.93336	15.12253	0
Q8WXI7	MUC16_HUMAN	"Mucin-16, MUC-16 (Ovarian cancer-related tumor marker CA125, CA-125) (Ovarian carcinoma antigen CA125)"	MUC16 CA125	Homo sapiens (Human)	cell adhesion [GO:0007155]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cell adhesion [GO:0007155]		GO:0005796; GO:0005886; GO:0007155; GO:0016021; GO:0019898; GO:0031982; GO:0070062	DGAATK	7.949999809	0.51345706	0.51345706	0.112944905	562.4388582	14.7138	15.15249	16.8247	11.57712	15.4204	15.15771	12.04037	15.36526	0	14.70128	16.03143	0	17.88041	16.26047	15.02471	19.15364	18.45814	18.19002	0	15.80916	16.75216	15.78781	15.56236	15.9118	0	13.05643	15.72733	14.97917	0	0	15.06201	13.46426	16.70792	17.19646	15.24028	17.10933	17.79132	16.42373	17.01842	19.16624	0	0	15.78989	13.05037	16.92892	17.96086	0	17.81237
Q8WXI9	P66B_HUMAN	Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68)	GATAD2B KIAA1150	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]"	sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000781; GO:0000785; GO:0005654; GO:0006338; GO:0008270; GO:0016575; GO:0016581; GO:0016607; GO:0032991; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:2000736	GIEERQQLIK	8.18999958	1	1	0.110962008	1214.422593	0	18.90455	17.06432	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.10272	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WXJ9	ASB17_HUMAN	"Ankyrin repeat and SOCS box protein 17, ASB-17"	ASB17	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]	cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		GO:0005829; GO:0016567; GO:0035556	ELADIHEDAK	13.60000038	1	1	0.231542328	1140.034285	0	13.24009	14.94075	0	0	15.1088	0	0	0	14.15183	14.3363	0	0	15.46507	13.74926	0	0	0	0	16.22764	15.23662	14.75902	0	0	15.52795	12.67152	0	15.67491	0	0	16.16601	14.83177	0	0	0	0	0	16.60132	0	0	15.34719	0	0	0	0	0	0	0
Q8WXQ8	CBPA5_HUMAN	"Carboxypeptidase A5, EC 3.4.17.-"	CPA5	Homo sapiens (Human)	proteolysis [GO:0006508]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0006508; GO:0008270	FSTGGSR	7.579999924	0.579537928	0.579537928	0.262313831	708.5650605	16.40671	16.3853	17.82808	0	0	0	19.31493	0	0	16.41847	16.70553	16.17712	17.45989	0	0	0	0	0	17.25559	17.52889	17.65837	0	0	0	0	18.06207	17.7484	0	0	16.83719	21.11614	19.54718	19.08179	0	0	17.96562	17.73334	0	18.31338	0	0	0	0	0	0	17.1349	0	17.23222
Q8WXR4	MYO3B_HUMAN	"Myosin-IIIb, EC 2.7.11.1"	MYO3B	Homo sapiens (Human)	cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0003774; GO:0003779; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0032426; GO:0050896; GO:0090103; GO:0106310	RQTVASYFR	1.059999943	0.607401252	0.607401252	0.192848323	1126.95816	14.29405	15.49333	14.08317	0	0	0	15.20267	13.88845	0	0	14.10209	11.80057	16.42082	0	15.97147	0	13.97832	0	16.62148	0	0	15.69647	15.48929	0	14.76356	11.16645	0	0	13.01016	9.947998	13.77961	0	15.65035	0	15.70819	14.84894	0	0	16.4816	12.64617	0	0	14.61943	11.45265	0	13.26722	13.81683	0
Q8WXS5	CCG8_HUMAN	"Voltage-dependent calcium channel gamma-8 subunit (Neuronal voltage-gated calcium channel gamma-8 subunit) (Transmembrane AMPAR regulatory protein gamma-8, TARP gamma-8)"	CACNG8 CACNG6	Homo sapiens (Human)	"calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]"	AMPA glutamate receptor complex [GO:0032281]; endocytic vesicle membrane [GO:0030666]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]	"AMPA glutamate receptor complex [GO:0032281]; endocytic vesicle membrane [GO:0030666]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]"	calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005246; GO:0005886; GO:0005891; GO:0006816; GO:0014069; GO:0016247; GO:0019226; GO:0030666; GO:0032281; GO:0051968; GO:0098839; GO:0098943; GO:0098970; GO:0099590; GO:1990454; GO:2000311	MESLKR	6.28000021	0.322948039	0.322948039	0.199198869	780.622572	0	14.40053	16.03556	0	14.57434	16.40738	15.76356	15.52295	15.9443	0	0	0	16.8581	15.33369	15.86826	16.97282	17.17467	16.29083	16.18654	0	16.34995	17.30782	15.69154	16.98325	16.03026	17.29869	17.45775	17.03118	17.23775	16.78291	16.43339	17.45587	16.99581	17.34565	17.6287	0	18.44156	17.75864	16.82802	16.97634	17.32236	17.76695	18.58678	17.90368	18.33973	0	17.92842	17.32579
Q8WXS8	ATS14_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 14, ADAM-TS 14, ADAM-TS14, ADAMTS-14, EC 3.4.24.-"	ADAMTS14	Homo sapiens (Human)	collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0005576; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0046872	CELICQSADTGDVVFMNQVVHDGTR	7.260000229	1	1	0.798383737	2865.797921	0	0	0	0	0	19.3372	0	21.58989	0	0	0	0	0	0	0	0	21.12457	0	21.50592	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WXU2	DAAF4_HUMAN	Dynein axonemal assembly factor 4 (Dyslexia susceptibility 1 candidate gene 1 protein)	DNAAF4 DYX1C1 EKN1	Homo sapiens (Human)	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; estrogen receptor binding [GO:0030331]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136]	estrogen receptor binding [GO:0030331]	GO:0001764; GO:0003341; GO:0003351; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0030331; GO:0033146; GO:0036158; GO:0036159; GO:0043005; GO:0061136; GO:0097730; GO:0120293	LKEDSIPAPR	3.450000048	1	1	0.506318653	1125.509234	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.49431	0	0	0	0	17.04634	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88307	0	0
Q8WXW3	PIBF1_HUMAN	"Progesterone-induced-blocking factor 1, PIBF (Centrosomal protein of 90 kDa, CEP90)"	PIBF1 C13orf24 PIBF	Homo sapiens (Human)	activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; interleukin-4 receptor binding [GO:0005136]; activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539]	interleukin-4 receptor binding [GO:0005136]	GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515	EAPEWSKK	4.739999771	1	1	0.272253184	974.9858842	0	13.61846	12.85912	13.97085	0	0	0	0	0	0	0	15.38224	12.972	14.91832	15.14748	0	0	14.80376	14.66773	14.52464	0	15.52649	15.16399	16.34498	0	0	16.63486	0	0	13.6353	13.422	0	0	0	15.9193	15.42658	0	15.18322	16.63174	0	0	0	0	0	0	0	0	0
Q8WXX0	DYH7_HUMAN	Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)	DNAH7 KIAA0944	Homo sapiens (Human)	cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]	axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285	DVLSSLVK	7.760000229	1	1	0.439030978	860.9711916	0	15.63535	15.05588	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.49604	0	0	0	15.09939	16.5181	0	0	0	0	0	0	0	0	0	0	0	16.80935	0	13.80031	0	0	14.90052	0	15.93492	0	0	15.97324
Q8WXX5	DNJC9_HUMAN	"DnaJ homolog subfamily C member 9, HDJC9 (DnaJ protein SB73)"	DNAJC9	Homo sapiens (Human)	nucleosome assembly [GO:0006334]; positive regulation of ATP-dependent activity [GO:0032781]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334]; positive regulation of ATP-dependent activity [GO:0032781]	chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393]	GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006334; GO:0031072; GO:0032781; GO:0042393; GO:0051087; GO:0101031	EMDNFLAQMEAKYCK	1.149999976	1	1	0.317155119	1893.267348	0	12.40962	13.31116	0	12.49933	14.59888	0	0	14.7785	0	14.29506	10.17755	0	14.59898	12.93161	0	0	0	0	0	16.21198	0	15.85256	0	0	15.92543	0	0	0	0	0	0	0	0	14.48498	0	0	0	17.10032	0	16.82082	0	0	0	0	0	0	0
Q8WXX7	AUTS2_HUMAN	Autism susceptibility gene 2 protein	AUTS2 KIAA0442	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin binding [GO:0003682]	GO:0001764; GO:0003682; GO:0005634; GO:0005737; GO:0005856; GO:0010592; GO:0030426; GO:0031532; GO:0035022; GO:0045944; GO:0048675; GO:0051571; GO:0097484; GO:2000620	AAGEEAKQLAR	5.800000191	1	1	0.165866822	1142.392834	14.04101	15.153	13.77785	0	16.15608	16.53896	0	0	14.38748	12.47465	14.72644	16.15768	14.16041	13.87319	14.86245	0	11.37104	14.61261	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.05321	0
Q8WY21	SORC1_HUMAN	"VPS10 domain-containing receptor SorCS1, hSorCS"	SORCS1 SORCS	Homo sapiens (Human)	neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuropeptide receptor activity [GO:0008188]; neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892]	neuropeptide receptor activity [GO:0008188]	GO:0005794; GO:0006892; GO:0007218; GO:0008188; GO:0016020; GO:0016021	RGSAGAQYAI	2.380000114	0.52594018	0.52594018	0.17117068	994.8684441	12.19222	14.61281	16.92172	0	15.34148	0	14.96417	14.3656	0	0	0	0	14.89951	0	10.50814	0	0	15.56978	13.41528	0	0	0	16.31904	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.40621	0	0	0	0	0	0	0	0	0	0
Q8WY36	BBX_HUMAN	HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2)	BBX HBP2	Homo sapiens (Human)	bone development [GO:0060348]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; bone development [GO:0060348]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0060348; GO:1990837	DLPSPKK	2.00999999	1	1	0.251326176	783.4937994	18.53224	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.82702	18.36204	0	0	0	0	0	0	0	0	0	0	0	0	0	17.87351
Q8WY54	PPM1E_HUMAN	"Protein phosphatase 1E, EC 3.1.3.16 (Ca(2+)/calmodulin-dependent protein kinase phosphatase N, CaMKP-N) (CaMKP-nucleus, CaMKN) (Partner of PIX 1) (Partner of PIX-alpha, Partner of PIXA)"	PPM1E CAMKN KIAA1072 POPX1	Homo sapiens (Human)	cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006469; GO:0006470; GO:0032991; GO:0035970; GO:0046872; GO:0051496; GO:0071466	GNMLHVAWVGDSQVMLVR	3.369999886	1	1	0.571681978	2044.230743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WY64	MYLIP_HUMAN	"E3 ubiquitin-protein ligase MYLIP, EC 2.3.2.27 (Inducible degrader of the LDL-receptor, Idol) (Myosin regulatory light chain interacting protein, MIR) (RING-type E3 ubiquitin transferase MYLIP)"	MYLIP BZF1 IDOL BM-023 PP5242	Homo sapiens (Human)	cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005829; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0046872; GO:0061630	NNQSPSHSPLK	2.319999933	1	1	0.060028884	1205.933914	6.715851	13.62964	0	0	0	9.437288	0	0	0	0	0	12.96986	0	0	0	0	0	0	11.74844	0	0	14.63907	0	0	0	0	0	0	0	0	0	15.0645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WYA0	IFT81_HUMAN	"Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1, CDV-1)"	IFT81 CDV1	Homo sapiens (Human)	cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]	tubulin binding [GO:0015631]	GO:0005737; GO:0005813; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542; GO:0120316	NEPIEGKLSLYR	6.880000114	1	1	0.164136144	1417.800143	0	0	0	0	15.09749	0	0	0	13.57292	0	14.69401	0	13.69787	0	14.60489	0	0	14.94283	0	0	0	16.20165	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.31092	0	0	0	0	0	0	0	0	0	0	0
Q8WYA1	BMAL2_HUMAN	"Aryl hydrocarbon receptor nuclear translocator-like protein 2 (Basic-helix-loop-helix-PAS protein MOP9) (Brain and muscle ARNT-like 2) (CYCLE-like factor, CLIF) (Class E basic helix-loop-helix protein 6, bHLHe6) (Member of PAS protein 9) (PAS domain-containing protein 9)"	ARNTL2 BHLHE6 BMAL2 CLIF MOP9 PASD9	Homo sapiens (Human)	"circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0006357; GO:0007623; GO:0009649; GO:0032922; GO:0034751; GO:0042753; GO:0045893; GO:0045944; GO:0046983; GO:0070888; GO:1990513	EKLIDAK	16.45000076	7.85E-05	7.85E-05	0.224064392	816.5397926	17.80877	17.52484	19.21719	0	0	17.3886	0	0	0	19.13024	0	17.74981	0	16.19703	16.65453	0	16.77104	0	15.83427	0	0	18.28183	0	0	0	17.38296	18.0113	17.59169	0	16.57409	19.09161	17.63833	0	0	17.86236	17.87115	0	18.15944	17.06914	17.62234	0	0	0	0	15.52491	0	17.59555	0
Q8WYA6	CTBL1_HUMAN	"Beta-catenin-like protein 1 (Nuclear-associated protein, NAP) (Testis development protein NYD-SP19)"	CTNNBL1 C20orf33 PP8304	Homo sapiens (Human)	"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]"	centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]	"centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; enzyme binding [GO:0019899]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]"	enzyme binding [GO:0019899]	GO:0000398; GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016020; GO:0016445; GO:0019899; GO:0043065	IEGEKHDMVR	5.400000095	1	1	2.31E-13	1228.795197	0	0	0	0	0	14.26197	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.54858	0	0	0	6.676742	0	0	0	0	0	0	0	0	0	0	0	0	11.78617	0	0	0	0	0	0	0	13.7318
Q8WYB5	KAT6B_HUMAN	"Histone acetyltransferase KAT6B, EC 2.3.1.48 (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4, MYST-4) (Monocytic leukemia zinc finger protein-related factor)"	KAT6B KIAA0383 MORF MOZ2 MYST4	Homo sapiens (Human)	"histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]"	MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]	"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]"	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]	GO:0000786; GO:0003677; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0016407; GO:0016573; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050793; GO:0061629; GO:0070776; GO:1903706	HISIKAISR	7.869999886	1	1	0.121009769	1023.628681	0	14.06411	14.32448	11.3055	0	0	0	15.2087	13.83254	16.08874	14.84803	14.31691	0	0	14.82712	17.53389	0	13.87554	0	14.27525	0	11.32998	0	15.35242	0	0	0	0	0	0	0	0	0	0	0	0	0	16.30713	0	0	0	0	0	0	0	0	0	0
Q8WYH8	ING5_HUMAN	Inhibitor of growth protein 5 (p28ING5)	ING5	Homo sapiens (Human)	"chromatin organization [GO:0006325]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000123; GO:0001558; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006275; GO:0006325; GO:0006355; GO:0006473; GO:0008285; GO:0016570; GO:0035064; GO:0043065; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045893; GO:0045926; GO:0046872; GO:0050793; GO:0051726; GO:0070776; GO:1903706; GO:2000278; GO:2001235	VQLAMQTYEMVDKHIR	3.089999914	1	1	0.225499668	1993.637167	15.93272	14.183	12.79511	0	0	0	0	0	14.69844	0	0	0	0	12.30627	14.5423	0	13.32531	0	0	0	0	0	14.83549	0	0	0	0	14.92484	0	0	14.99172	13.96531	13.87552	15.04624	12.9945	0	15.11515	0	0	0	0	0	0	0	0	16.51791	0	0
Q8WYJ6	SEPT1_HUMAN	Septin-1 (LARP) (Peanut-like protein 3) (Serologically defined breast cancer antigen NY-BR-24)	SEPTIN1 DIFF6 PNUTL3 SEPT1	Homo sapiens (Human)	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0003924; GO:0005525; GO:0005815; GO:0005940; GO:0008021; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0034613; GO:0042802; GO:0060090; GO:0061640	QVPEASAR	1.190000057	0.777749002	0.777749002	0.06029636	857.7726607	17.99942	0	16.99453	12.3718	14.53669	11.63729	15.04171	13.022	14.65597	0	15.86281	12.87615	15.60885	0	16.76157	11.16883	14.3463	13.62876	16.91354	14.61064	0	14.73629	0	16.12903	17.08627	16.33894	0	0	16.04872	16.45132	15.91727	14.31985	0	13.71658	16.88659	0	15.67685	17.05052	15.70811	16.06314	0	0	0	14.14688	0	15.25075	15.58077	15.50279
Q8WYK1	CNTP5_HUMAN	Contactin-associated protein-like 5 (Cell recognition molecule Caspr5)	CNTNAP5 CASPR5	Homo sapiens (Human)	cell adhesion [GO:0007155]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]		GO:0007155; GO:0016021	HTQHFR	7.949999809	1	1	0.181670034	825.6791171	14.12691	11.93294	13.98667	0	0	13.46674	0	0	15.14015	0	0	12.54204	15.33166	12.96188	0	15.23753	15.24794	0	14.92768	0	0	15.28809	15.24762	16.65929	0	15.79224	15.94885	14.38377	15.67709	14.25078	13.59575	0	13.38739	16.17926	15.38022	15.22422	0	15.32703	16.29044	0	0	15.38071	0	16.80041	0	17.44951	0	16.44063
Q8WYL5	SSH1_HUMAN	"Protein phosphatase Slingshot homolog 1, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 1, SSH-1L, hSSH-1L)"	SSH1 KIAA1298 SSH1L	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; cellular response to ATP [GO:0071318]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; regulation of cellular protein metabolic process [GO:0032268]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; plasma membrane [GO:0005886]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; cellular response to ATP [GO:0071318]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; regulation of cellular protein metabolic process [GO:0032268]	actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0000902; GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005737; GO:0005856; GO:0005886; GO:0006470; GO:0008138; GO:0030027; GO:0030036; GO:0030496; GO:0030837; GO:0032154; GO:0032268; GO:0071318	QRTQEIETR	7.820000172	1	1	0.256798668	1159.725851	0	0	0	0	0	0	0	18.72843	0	0	0	18.01064	0	0	0	0	0	0	0	17.54629	16.7994	0	0	0	0	0	0	0	0	16.93907	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38274	0	0	0
Q8WYP3	RIN2_HUMAN	Ras and Rab interactor 2 (Ras association domain family 4) (Ras inhibitor JC265) (Ras interaction/interference protein 2)	RIN2 RASSF4	Homo sapiens (Human)	endocytosis [GO:0006897]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; small GTPase mediated signal transduction [GO:0007264]	GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005096; GO:0005829; GO:0006897; GO:0007264; GO:0010595; GO:0030139; GO:0030695; GO:0031267; GO:1904906; GO:2001214	STKMQK	13.96000004	0.224074885	0.224074885	0.142765	722.039778	17.03507	17.16279	13.83602	11.33803	13.34351	17.47029	16.33422	14.23722	17.58947	14.85276	12.60822	16.27901	13.17381	16.26168	14.8131	14.14104	13.12107	13.72988	15.54025	15.2578	17.21764	16.17231	15.42996	16.04162	13.11986	16.93398	0	13.12141	15.96662	18.01436	10.82406	17.253	19.32731	15.40167	15.31435	16.84284	14.32202	15.60239	0	15.58939	16.3122	0	14.6732	14.60604	15.84793	16.63379	14.18252	14.37176
Q8WYP5	ELYS_HUMAN	Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1)	AHCTF1 ELYS TMBS62 MSTP108	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]	DNA binding [GO:0003677]	GO:0000776; GO:0003677; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0007049; GO:0015031; GO:0016363; GO:0031965; GO:0032465; GO:0051028; GO:0051292; GO:0051301; GO:0070062	HMYEVCQEMGLMEDLLK	4.860000134	1	1	0.174380972	2125.998438	0	0	0	0	14.96274	12.90698	0	0	0	0	0	0	0	0	0	0	14.71159	16.41685	0	0	0	0	0	0	0	14.68443	0	0	0	0	0	15.97316	14.28956	15.63809	0	0	0	0	0	0	0	0	0	0	0	15.62199	0	0
Q8WYQ4	CV015_HUMAN	Uncharacterized protein C22orf15 (Protein N27C7-3)	C22orf15	Homo sapiens (Human)						IIKGEDMASTR	12.72999954	1	1	2.36E-13	1229.919166	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WYQ5	DGCR8_HUMAN	Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8)	DGCR8 C22orf12 DGCRK6 LP4941	Homo sapiens (Human)	primary miRNA processing [GO:0031053]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-RNA adaptor activity [GO:0140517]; primary miRNA processing [GO:0031053]	double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-RNA adaptor activity [GO:0140517]	GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0016604; GO:0020037; GO:0031053; GO:0042802; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0140517	GSFSKGR	2.720000029	1	1	0.234549878	738.9901544	0	0	0	6.39463	14.61422	15.54881	0	0	15.99627	15.46039	12.87579	15.93516	16.5747	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.85557	16.14485	0	0	0	0	0	16.4554	15.41136	0	14.89047	0	16.32885	0	0
Q8WYQ9	ZCH14_HUMAN	Zinc finger CCHC domain-containing protein 14 (BDG-29)	ZCCHC14 KIAA0579	Homo sapiens (Human)			nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270]	nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0035091	GSADMK	9.529999733	0.001094674	0.001094674	0.159511307	622.2208477	17.72236	0	15.99044	0	15.36656	14.09927	13.62146	0	0	18.58613	0	0	18.18282	0	0	0	0	16.37434	0	16.66196	0	0	14.29154	17.70412	17.46215	13.8423	0	0	14.02877	16.27209	0	16.86969	0	17.03724	0	0	0	14.78099	17.75843	0	13.43403	0	14.27366	0	14.40409	16.71215	0	16.97717
Q8WZ42	TITIN_HUMAN	"Titin, EC 2.7.11.1 (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)"	TTN	Homo sapiens (Human)	cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018]	condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]	actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]	GO:0000794; GO:0002020; GO:0003300; GO:0004674; GO:0004712; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733	AEGGK	9.210000038	0.97248888	0.97248888	0.317457129	462.879855	16.48178	0	15.60743	16.13548	15.23758	0	16.09977	16.73797	16.22259	16.60384	16.31387	14.61548	15.80146	16.2731	16.66769	15.63956	15.6334	15.9097	16.5074	16.01224	14.74375	14.63676	0	0	16.44362	15.44707	16.37677	16.60459	16.70648	17.46128	0	15.32026	15.62217	0	0	0	15.87402	16.38001	14.90153	15.91189	0	14.61609	16.38798	15.55732	0	16.58674	0	0
Q8WZ59	TM190_HUMAN	Transmembrane protein 190	TMEM190 MDAC1	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]	inner acrosomal membrane [GO:0002079]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	inner acrosomal membrane [GO:0002079]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; protein self-association [GO:0043621]; hematopoietic progenitor cell differentiation [GO:0002244]	protein self-association [GO:0043621]	GO:0002079; GO:0002244; GO:0005634; GO:0016021; GO:0043621	RDVLHMPGFLAGPCDMSK	3.829999924	1	1	2.75E-12	2046.483317	15.89292	0	11.2831	0	0	14.50802	15.95857	0	11.87154	0	12.35585	0	0	0	0	0	0	0	0	0	0	0	14.25018	0	13.54081	13.16403	0	0	0	0	0	17.70987	0	0	0	0	0	0	0	0	14.74852	0	13.26558	0	0	0	14.28512	0
Q8WZ60	KLHL6_HUMAN	Kelch-like protein 6	KLHL6	Homo sapiens (Human)	B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617]		B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617]		GO:0002467; GO:0009617; GO:0050853	MLMAGQRGAWTMGDVVEK	4.139999866	1	1	0.348823206	2028.057294	0	7.738597	13.31211	0	14.50706	16.61062	17.16034	0	0	15.68457	0	0	16.95699	0	0	11.35248	0	0	0	0	0	0	0	17.07046	0	0	0	0	0	0	14.8077	0	0	0	0	0	0	0	17.88151	0	0	0	0	0	0	0	16.16327	0
Q8WZ64	ARAP2_HUMAN	"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 (Centaurin-delta-1, Cnt-d1) (Protein PARX)"	ARAP2 CENTD1 KIAA0580	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]"	"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]"	GO:0005096; GO:0005547; GO:0005737; GO:0007165; GO:0043547; GO:0046872	IGISPTGHRR	11.22999954	1	1	0.370498245	1093.705333	16.54746	16.77908	0	0	16.35665	16.42852	0	0	16.94175	16.30645	17.8577	16.03091	0	17.26242	0	0	0	0	0	0	18.06498	0	0	16.74	16.51019	0	16.88187	0	0	0	17.65717	16.94416	17.11241	17.52365	16.38495	18.34849	19.05302	17.43512	19.26603	0	19.45396	18.8536	18.40493	0	0	0	17.01167	0
Q8WZ73	RFFL_HUMAN	"E3 ubiquitin-protein ligase rififylin, EC 2.3.2.27 (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2, CARP-2) (FYVE-RING finger protein Sakura, Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like) (RING-type E3 ubiquitin transferase rififylin)"	RFFL RNF189 RNF34L	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of TOR signaling [GO:0032006]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of TOR signaling [GO:0032006]; ubiquitin-dependent protein catabolic process [GO:0006511]	metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]	GO:0002020; GO:0002039; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0010008; GO:0010762; GO:0010804; GO:0016020; GO:0019901; GO:0031625; GO:0032006; GO:0043161; GO:0046872; GO:0055038; GO:0061630; GO:0070936; GO:1901796; GO:1901797; GO:1902042; GO:2001271	MQAYSNPGYSSFPSPTGLEPSCK	10.14999962	1	1	4.57E-12	2522.274069	0	15.04106	14.13084	0	14.32509	14.90573	0	0	0	16.70994	16.03246	14.56881	0	0	0	15.12074	14.29397	14.48584	13.82649	0	16.39149	14.99801	16.45243	0	15.4197	16.09851	0	14.72986	17.37293	0	18.36417	0	16.54077	13.06788	17.44596	0	0	16.75732	12.92583	15.98552	14.93889	0	16.3718	0	0	0	0	15.35763
Q8WZ74	CTTB2_HUMAN	"Cortactin-binding protein 2, CortBP2"	CTTNBP2 C7orf8 CORTBP2 KIAA1758	Homo sapiens (Human)	brain development [GO:0007420]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]	cell cortex [GO:0005938]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic actin cytoskeleton [GO:0098871]; synaptic vesicle [GO:0008021]	cell cortex [GO:0005938]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic actin cytoskeleton [GO:0098871]; synaptic vesicle [GO:0008021]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]	SH3 domain binding [GO:0017124]	GO:0005938; GO:0007420; GO:0008021; GO:0017124; GO:0043197; GO:0098871; GO:0098978; GO:1905274	QMAAGFSCEIVR	4.260000229	1	1	0.283821092	1386.350997	13.7297	16.0686	15.29422	15.15851	0	15.95052	0	0	15.10179	0	0	15.19487	0	0	0	15.93063	0	14.24372	0	16.88458	0	0	0	0	0	0	0	0	16.72802	16.34415	16.99383	0	0	17.27956	0	0	0	0	18.55361	0	16.75266	0	0	0	17.04268	0	0	17.49952
Q8WZ75	ROBO4_HUMAN	Roundabout homolog 4 (Magic roundabout)	ROBO4 UNQ421/PRO3674	Homo sapiens (Human)	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]	axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]	cell-cell adhesion mediator activity [GO:0098632]; signaling receptor activity [GO:0038023]	GO:0001525; GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0030334; GO:0030424; GO:0038023; GO:0061028; GO:0070062; GO:0070593; GO:0098632	STSGSRDLSSSSSLSSR	3.710000038	1	1	0.306799117	1704.522621	16.0972	15.087	14.55542	15.26581	13.01132	0	10.8517	0	12.11526	15.59264	0	0	0	14.8024	15.10636	0	14.96664	0	13.09445	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WZ92	OR5P2_HUMAN	Olfactory receptor 5P2 (Olfactory receptor-like protein JCG3)	OR5P2	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021	TSNNDIT	1.639999986	1	1	0.208225275	764.9217156	0	0	17.9647	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q8WZA0	LZIC_HUMAN	Protein LZIC (Leucine zipper and CTNNBIP1 domain-containing protein) (Leucine zipper and ICAT homologous domain-containing protein)	LZIC	Homo sapiens (Human)			beta-catenin binding [GO:0008013]	beta-catenin binding [GO:0008013]	GO:0008013	QPGQLRTR	8.5	0.047125209	0.047125209	0.086839847	955.6622408	0	0	0	17.41454	0	12.56791	16.02086	11.2561	17.17977	13.75003	13.69458	16.08143	13.91667	0	16.16681	14.42936	17.8011	15.91854	14.5377	0	16.95356	14.35635	0	13.68512	0	0	10.26961	15.24748	13.42415	0	0	0	0	13.19243	16.6502	15.90384	14.22227	16.62599	0	16.15872	0	0	15.33672	0	0	0	8.79074	16.8944
Q8WZA1	PMGT1_HUMAN	"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1, POMGnT1, EC 2.4.1.- (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2, GnT I.2)"	POMGNT1 MGAT1.2 UNQ746/PRO1475	Homo sapiens (Human)	O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]"	"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]"	GO:0000139; GO:0006493; GO:0008375; GO:0016021; GO:0016266; GO:0030145; GO:0030173; GO:0047223	LLSEAEVLDHSK	3.700000048	0.689407289	0.689407289	0.467972689	1340.379833	0	18.21741	0	16.66738	0	0	0	0	0	0	18.28543	0	0	0	0	0	0	0	0	0	0	0	0	0	19.19649	0	19.97056	18.16102	0	0	0	0	18.87937	0	0	0	0	18.97894	0	0	0	18.01298	0	0	0	0	0	0
Q8WZB0	CI130_HUMAN	Putative uncharacterized protein ERCC6L2-AS1 (ERCC6L2 antisense RNA 1) (Nasopharyngeal carcinoma-associated gene 12 protein)	ERCC6L2-AS1 C9orf130 LINC00476 NAG12	Homo sapiens (Human)						GIPAKVATK	2.00999999	0.000619961	0.000619961	0.278087535	883.6488942	0	0	0	0	0	0	0	0	0	20.38905	0	0	0	17.79109	17.57072	0	0	17.47842	0	0	16.54377	0	0	19.56706	0	0	20.7271	19.14252	0	0	0	18.10797	0	0	20.50316	0	0	0	0	0	0	0	16.26767	0	17.07752	0	0	0
Q92185	SIA8A_HUMAN	"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase, EC 2.4.99.8 (Alpha-2,8-sialyltransferase 8A) (Ganglioside GD3 synthase) (Ganglioside GT3 synthase) (Sialyltransferase 8A, SIAT8-A) (Sialyltransferase St8Sia I, ST8SiaI)"	ST8SIA1 SIAT8 SIAT8A	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; cellular response to heat [GO:0034605]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; positive regulation of cell population proliferation [GO:0008284]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]; carbohydrate metabolic process [GO:0005975]; cellular response to heat [GO:0034605]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; positive regulation of cell population proliferation [GO:0008284]; protein glycosylation [GO:0006486]"	"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]"	GO:0000139; GO:0003828; GO:0005975; GO:0006486; GO:0006491; GO:0006688; GO:0008284; GO:0008373; GO:0009311; GO:0016021; GO:0034605	KSGCGR	8.170000076	1	1	0.293349324	664.9631683	0	0	17.54246	0	0	0	0	0	20.86227	0	0	0	0	0	0	19.91826	0	0	0	16.80654	0	20.8801	18.18279	0	18.83417	21.82355	0	18.54815	0	0	19.54991	0	19.1168	0	0	17.82056	0	0	0	0	0	0	0	0	0	0	0	0
Q92499	DDX1_HUMAN	"ATP-dependent RNA helicase DDX1, EC 3.6.4.13 (DEAD box protein 1) (DEAD box protein retinoblastoma, DBP-RB)"	DDX1	Homo sapiens (Human)	"defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	"cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	GO:0000245; GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0003725; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006446; GO:0008143; GO:0010494; GO:0016020; GO:0016887; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904	LGKSHIR	12.68000031	1	1	0.119571085	809.0746724	0	16.89331	0	0	16.09954	0	17.28424	0	15.70555	0	0	0	0	0	16.09405	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53918	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92503	S14L1_HUMAN	SEC14-like protein 1	SEC14L1 SEC14L	Homo sapiens (Human)	choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536]	RIG-I binding [GO:0039552]	GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087	RSPQPPK	8.180000305	1	1	0.247758345	809.5593192	0	18.65308	17.1371	0	17.21484	0	0	0	0	19.98959	0	0	0	0	18.70925	0	0	0	17.89729	16.78501	0	18.03469	0	0	0	0	18.93923	0	0	0	0	20.5251	0	0	0	0	0	21.75088	0	0	0	0	17.37375	0	0	0	17.12209	18.37161
Q92504	S39A7_HUMAN	"Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7, ZIP7)"	SLC39A7 HKE4 RING5	Homo sapiens (Human)	cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]	zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0006882; GO:0016020; GO:0016021; GO:0071577	EASPLQSLLEVLGLLGGVIMMVLIAHLE	3.900000095	1	1	4.57E-13	2977.230044	14.79686	0	0	0	13.60652	14.21678	0	13.09695	0	13.6031	13.96597	12.66834	13.57366	0	0	0	0	14.00842	11.60835	15.94016	14.11826	0	14.30286	13.67755	0	8.964761	0	14.51054	13.44011	14.72532	0	0	0	0	0	0	0	15.77772	0	0	14.84943	14.38586	12.02861	0	0	0	0	0
Q92508	PIEZ1_HUMAN	"Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment, Mib) (Protein FAM38A)"	PIEZO1 FAM38A KIAA0233	Homo sapiens (Human)	cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0016020; GO:0016021; GO:0031258; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260	MAGVNTDR	7.880000114	1	1	1.15E-13	878.3233144	0	0	0	0	0	0	11.7845	0	0	0	0	0	16.52965	0	0	0	16.26808	0	0	0	0	0	0	0	0	0	15.6145	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92519	TRIB2_HUMAN	"Tribbles homolog 2, TRB-2"	TRIB2 TRB2	Homo sapiens (Human)	negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]	mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]	GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006469; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629	CLIRSILR	9.819999695	0.481147856	0.481147856	0.160790946	1030.422201	14.87401	8.863749	0	0	0	0	0	0	0	0	0	0	14.43414	14.58733	16.87955	0	10.61946	0	0	0	0	12.3022	0	15.37055	0	15.24226	12.44362	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.01094	16.51881	0	0	0
Q92520	FAM3C_HUMAN	Protein FAM3C (Interleukin-like EMT inducer)	FAM3C ILEI GS3786	Homo sapiens (Human)	negative regulation of gluconeogenesis [GO:0045721]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089]; cytokine activity [GO:0005125]; negative regulation of gluconeogenesis [GO:0045721]	cytokine activity [GO:0005125]	GO:0005125; GO:0005576; GO:0005615; GO:0005794; GO:0031089; GO:0045721; GO:0070062	LIADLGSTSITNLGFR	5.050000191	0.418883264	0.418883264	0.02050179	1677.929843	0	16.09701	17.77161	17.58355	13.24672	15.8003	0	16.16068	14.44259	0	15.79677	0	14.74687	16.78671	15.83724	0	14.77305	14.15269	19.91124	15.43588	16.52386	0	16.09466	17.64274	0	0	0	15.71604	0	15.70865	0	18.66306	0	0	15.64476	17.04626	0	18.72279	19.47734	0	13.23397	0	18.01609	17.21582	14.56786	14.44651	16.77786	0
Q92527	ANKR7_HUMAN	Ankyrin repeat domain-containing protein 7 (Testis-specific protein TSA806)	ANKRD7	Homo sapiens (Human)		centrosome [GO:0005813]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005813	DSENKSPLIK	1.389999986	1	1	0.229467899	1129.771444	16.33839	0	0	16.03625	11.86379	11.48816	0	0	0	15.28527	14.50734	16.82826	0	11.99127	14.9549	15.16985	0	0	0	0	15.11513	0	0	0	15.83763	0	15.56935	14.41019	15.90239	0	15.80937	0	0	0	0	0	0	0	0	0	0	0	0	16.48296	0	0	0	0
Q92529	SHC3_HUMAN	"SHC-transforming protein 3 (Neuronal Shc, N-Shc) (Protein Rai) (SHC-transforming protein C) (Src homology 2 domain-containing-transforming protein C3, SH2 domain protein C3)"	SHC3 NSHC SHCC	Homo sapiens (Human)	central nervous system development [GO:0007417]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; central nervous system development [GO:0007417]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]	GO:0001784; GO:0005829; GO:0005886; GO:0007169; GO:0007173; GO:0007417; GO:0019901; GO:0030971; GO:0035556	APAMSAAR	2.329999924	0.558652997	0.558652997	0.30384326	775.0511713	15.13773	16.57634	0	14.31415	0	13.59528	12.16524	0	0	16.29097	15.34833	14.66763	15.71618	15.03923	0	15.87071	16.18103	0	15.24224	16.00643	14.33458	15.68061	16.63584	17.40408	16.35568	16.86597	16.66529	0	15.47156	15.34203	15.23958	15.04885	17.53783	0	15.76639	16.33637	17.25513	16.21977	13.2802	0	16.07263	14.77957	15.51037	16.10807	16.73538	15.21091	15.29323	16.09497
Q92538	GBF1_HUMAN	"Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1, BFA-resistant GEF 1"	GBF1 KIAA0248	Homo sapiens (Human)	"cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; cilium assembly [GO:0060271]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	"cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; cilium assembly [GO:0060271]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	"guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]"	GO:0000139; GO:0002263; GO:0005085; GO:0005547; GO:0005793; GO:0005794; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006888; GO:0006890; GO:0006892; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0016020; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0060271; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008	FVGTDPASDEVVLMKILQVLR	1.00999999	1	1	0.020135944	2347.132829	0	14.294	0	10.00188	11.65655	13.15966	0	0	12.8356	12.64634	0	0	0	13.2466	0	0	0	14.19898	0	0	0	0	0	0	0	14.05489	12.61084	0	0	0	0	0	0	0	0	0	12.87462	0	0	11.87948	0	0	0	0	0	0	0	0
Q92540	SMG7_HUMAN	"Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog, hSMG-7)"	SMG7 C1orf16 EST1C KIAA0250	Homo sapiens (Human)	"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]"	protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0035303; GO:0042162; GO:0045111; GO:0051721; GO:0070034	QNVAVQVK	12.56000042	0.866149724	0.866149724	0.253100938	886.3127801	15.69776	15.06133	15.72361	14.35103	15.62804	15.79989	15.8539	15.84113	0	15.31009	16.47122	16.22906	14.1942	16.01023	15.05853	0	0	14.3656	15.76662	16.50178	15.70452	14.52343	15.37249	15.87475	16.67526	16.40275	14.93065	0	0	15.03503	14.91362	15.6356	17.10805	0	0	0	0	0	0	14.60477	0	0	14.54421	15.023	15.22185	15.07448	0	16.03726
Q92541	RTF1_HUMAN	RNA polymerase-associated protein RTF1 homolog	RTF1 KIAA0252	Homo sapiens (Human)	blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]	GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0051571; GO:0080182; GO:1990269	AMAEDLGDQDK	10.52999973	0.551635206	0.551635206	0.295381283	1207.985608	15.15685	0	0	15.44678	0	0	0	0	11.89367	0	16.15261	0	0	0	0	0	0	14.57376	0	16.55615	0	0	0	16.69977	0	0	0	0	15.20759	15.6146	0	0	0	0	0	0	16.1986	15.36267	17.48644	18.92861	0	16.60346	0	0	0	0	0	0
Q92543	SNX19_HUMAN	Sorting nexin-19	SNX19 KIAA0254	Homo sapiens (Human)	chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]	cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]	cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]	phosphatidylinositol binding [GO:0035091]	GO:0002062; GO:0005737; GO:0006887; GO:0030073; GO:0031901; GO:0035091; GO:0043231; GO:1990502	TETVPPFQETPAGSSCHLNNLLSSRK	2.660000086	1	1	0.195024039	2871.045738	0	0	0	0	0	12.44796	0	14.54371	0	0	0	0	10.00373	0	0	13.89702	12.44817	13.57408	12.07747	0	0	12.68277	15.05975	0	0	0	0	0	0	0	15.52336	14.77083	0	14.80703	0	13.6646	0	13.81098	15.88311	14.01569	0	0	10.81004	0	17.34438	0	0	0
Q92545	TM131_HUMAN	Transmembrane protein 131 (Protein RW1)	TMEM131 KIAA0257 RW1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]		GO:0016020; GO:0016021	LTKAASLPGK	8.859999657	1	1	0.243693847	984.7559424	12.68069	16.26805	13.41486	0	15.33476	13.54461	15.91301	14.22519	14.70499	17.32816	16.22661	16.08346	15.18116	14.88835	15.73444	0	0	15.04776	16.64359	16.98228	14.19557	16.90403	15.02736	16.32646	0	15.5114	0	0	15.02413	0	15.31069	13.78939	0	14.21393	14.23904	0	16.98914	0	17.09891	15.54807	14.89255	0	15.29979	15.85186	0	13.94054	14.05702	0
Q92547	TOPB1_HUMAN	"DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1, TopBP1) (DNA topoisomerase II-binding protein 1)"	TOPBP1 KIAA0259	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication initiation [GO:0006270]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication initiation [GO:0006270]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; response to ionizing radiation [GO:0010212]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0042802; GO:0043231; GO:0070532	ESAPSNGSGK	4.550000191	0.001367114	0.001367114	0.285401558	933.1878594	16.90391	16.33356	18.07201	0	0	16.689	18.94517	0	14.93346	17.61236	0	0	0	0	0	0	15.89181	0	0	16.50692	17.75397	17.15289	0	19.02401	18.42695	0	17.24045	0	0	17.44251	18.57345	18.79001	16.72696	16.27053	0	0	0	0	0	16.49012	17.31075	0	0	18.18223	16.76018	0	0	0
Q92552	RT27_HUMAN	"28S ribosomal protein S27, mitochondrial, MRP-S27, S27mt (Mitochondrial ribosomal protein S27) (Mitochondrial small ribosomal subunit protein mS27)"	MRPS27 KIAA0264	Homo sapiens (Human)	cell population proliferation [GO:0008283]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; cell population proliferation [GO:0008283]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]	GO:0000049; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005763; GO:0008283; GO:0019843; GO:0032543; GO:0070131; GO:0097177	AAKASA	4.139999866	1	1	0.281620008	519.7184585	16.25224	15.48991	16.25913	16.03843	13.87748	0	16.44602	0	16.4912	0	0	0	0	0	0	0	0	0	15.11924	0	0	0	0	0	0	0	0	16.29208	0	0	0	0	0	0	15.90339	0	0	0	0	0	0	16.75451	0	0	0	0	16.23755	16.00423
Q92556	ELMO1_HUMAN	Engulfment and cell motility protein 1 (Protein ced-12 homolog)	ELMO1 KIAA0281	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of catalytic activity [GO:0050790]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of catalytic activity [GO:0050790]"	SH3 domain binding [GO:0017124]	GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0050790	EKGALK	12.43999958	0.405509353	0.405509353	0.307362967	642.6980509	15.38751	16.08564	16.08367	14.90389	15.60226	17.18653	16.2686	0	13.9202	0	16.13592	0	16.0491	15.91778	14.87233	15.49092	0	15.95303	15.52466	16.39857	16.28662	16.33931	0	15.63887	15.57003	0	15.70862	0	0	17.29413	16.14023	0	16.02027	0	16.29536	0	0	0	0	16.19675	16.16844	0	16.36403	0	17.01619	0	0	16.68511
Q92560	BAP1_HUMAN	"Ubiquitin carboxyl-terminal hydrolase BAP1, EC 3.4.19.12 (BRCA1-associated protein 1) (Cerebral protein 6)"	BAP1 KIAA0272 hucep-6	Homo sapiens (Human)	"cellular protein modification process [GO:0006464]; chromatin organization [GO:0006325]; macrophage homeostasis [GO:0061519]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of inflammatory response [GO:0050727]; response to inorganic substance [GO:0010035]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; peptidase activity [GO:0008233]; thiol-dependent deubiquitinase [GO:0004843]; cellular protein modification process [GO:0006464]; chromatin organization [GO:0006325]; macrophage homeostasis [GO:0061519]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of inflammatory response [GO:0050727]; response to inorganic substance [GO:0010035]; ubiquitin-dependent protein catabolic process [GO:0006511]"	chromatin binding [GO:0003682]; peptidase activity [GO:0008233]; thiol-dependent deubiquitinase [GO:0004843]	GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006464; GO:0006511; GO:0008233; GO:0008285; GO:0010035; GO:0016579; GO:0035517; GO:0035520; GO:0035522; GO:0045892; GO:0050727; GO:0051726; GO:0061519; GO:0071108; GO:1900015; GO:1903955	EVVEATDSR	17.51000023	1	1	0.232375176	1004.974819	12.74335	17.22516	0	0	12.22568	16.1607	17.25777	13.60601	10.17261	15.49332	14.84063	16.72843	15.37881	14.06457	0	0	17.07745	0	0	17.45246	0	0	17.08832	0	15.79134	18.788	0	17.37114	0	15.36744	14.61776	15.48421	0	0	17.04121	14.017	13.08321	0	13.98015	14.60183	13.11836	17.37712	14.89185	18.84724	16.39604	16.06966	0	17.16679
Q92562	FIG4_HUMAN	"Polyphosphoinositide phosphatase, EC 3.1.3.-, EC 3.1.3.36, EC 3.1.3.86 (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4, EC 3.1.3.16)"	FIG4 KIAA0274 SAC3	Homo sapiens (Human)	locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; protein dephosphorylation [GO:0006470]; vacuole organization [GO:0007033]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]	"early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; protein dephosphorylation [GO:0006470]; vacuole organization [GO:0007033]"	"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]"	GO:0000139; GO:0004438; GO:0004439; GO:0005783; GO:0005811; GO:0006470; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037	DIMQTLSR	3.559999943	1	1	0.253722645	963.2003361	16.50519	16.37955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92565	RPGF5_HUMAN	"Rap guanine nucleotide exchange factor 5 (Guanine nucleotide exchange factor for Rap1) (M-Ras-regulated Rap GEF, MR-GEF) (Related to Epac, Repac)"	RAPGEF5 GFR KIAA0277 MRGEF	Homo sapiens (Human)	nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264]	GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005634; GO:0005654; GO:0005886; GO:0007264; GO:0007265; GO:0007399; GO:0016604; GO:0030742; GO:0043547	HTVDEYSPQKK	5.920000076	1	1	0.43395725	1332.887917	13.33498	0	15.84051	0	15.59689	15.14406	14.97221	0	0	11.62807	15.47106	13.47307	0	0	0	0	0	0	0	0	0	0	0	15.18047	0	15.42701	15.81758	0	0	16.11994	0	16.2398	0	0	15.49575	16.08401	0	0	0	15.207	15.40743	15.71667	0	0	0	0	15.62918	15.36108
Q92569	P55G_HUMAN	"Phosphatidylinositol 3-kinase regulatory subunit gamma, PI3-kinase regulatory subunit gamma, PI3K regulatory subunit gamma, PtdIns-3-kinase regulatory subunit gamma (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma, PI3-kinase subunit p55-gamma, PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK)"	PIK3R3	Homo sapiens (Human)	B cell differentiation [GO:0030183]; cell migration involved in sprouting angiogenesis [GO:0002042]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; T cell differentiation [GO:0030217]	"cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]"	"cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]; B cell differentiation [GO:0030183]; cell migration involved in sprouting angiogenesis [GO:0002042]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; T cell differentiation [GO:0030217]"	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]	GO:0001784; GO:0001934; GO:0002042; GO:0005829; GO:0005942; GO:0005943; GO:0006955; GO:0008286; GO:0010628; GO:0016303; GO:0030183; GO:0030217; GO:0030335; GO:0043491; GO:0043551; GO:0046854; GO:0046935; GO:2000811	DASTKMQGDYTLTLR	1.889999986	1	1	0.053978861	1715.663028	0	15.61249	0	0	0	0	0	0	0	0	0	0	0	17.5615	0	15.21168	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.83552	0	0	13.82555	10.87614	0	17.22783	12.10253	14.07952	0	13.67388	13.32718	0	0	0	0
Q92576	PHF3_HUMAN	PHD finger protein 3	PHF3 KIAA0244	Homo sapiens (Human)	"transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription, DNA-templated [GO:0006351]"	metal ion binding [GO:0046872]	GO:0005634; GO:0006351; GO:0046872	HREGEK	9.130000114	0.757260561	0.757260561	0.203388587	755.5651458	0	16.37456	14.64774	10.86839	16.16614	14.25487	0	15.51785	0	0	15.08424	0	0	14.10052	15.19161	15.46191	15.02654	15.11939	0	15.21317	0	0	14.90556	0	16.48189	15.44749	13.39342	0	15.11805	0	16.57531	16.48753	15.82392	0	0	16.92258	0	15.52203	0	0	0	0	0	0	16.6769	16.67316	16.46288	0
Q92598	HS105_HUMAN	Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein)	HSPH1 HSP105 HSP110 KIAA0201	Homo sapiens (Human)	chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; response to unfolded protein [GO:0006986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; response to unfolded protein [GO:0006986]	adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006986; GO:0016887; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682	NGGVGIK	9.760000229	1	1	0.169366928	644.7509906	0	14.21986	0	14.37965	0	15.33172	0	15.36673	0	0	0	12.93079	14.87695	15.56496	0	0	16.19989	0	0	0	0	0	0	0	0	0	14.8314	0	0	0	14.95528	15.60829	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.51301	0
Q92608	DOCK2_HUMAN	Dedicator of cytokinesis protein 2	DOCK2 KIAA0209	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; T cell receptor binding [GO:0042608]; actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; T cell receptor binding [GO:0042608]	GO:0001766; GO:0001768; GO:0001771; GO:0002277; GO:0005085; GO:0005096; GO:0005576; GO:0005829; GO:0005856; GO:0006935; GO:0007264; GO:0016020; GO:0030036; GO:0035580; GO:0042608; GO:0044351; GO:0045059; GO:0045060; GO:0046633; GO:0050766; GO:0051056; GO:0070062	MDLKDTGAK	10.05000019	1	1	0.112746927	995.9917754	0	17.31569	0	0	0	0	15.52653	0	0	0	0	0	15.16091	0	0	0	0	0	0	0	0	0	0	0	13.94686	0	16.22371	0	0	0	0	0	0	0	0	0	0	0	0	0	15.68843	0	0	0	15.03544	0	0	0
Q92609	TBCD5_HUMAN	TBC1 domain family member 5	TBC1D5 KIAA0210	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]"	autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]	"autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]"	AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394]	GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:0090630; GO:1905394	GADLMNKSR	3.25999999	1	1	0.047736588	1005.508219	16.59126	0	0	0	0	12.10239	14.16757	0	13.72392	0	15.5549	12.8331	0	0	0	0	0	0	0	11.05792	0	0	14.51484	0	16.37288	15.71634	0	0	14.42194	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92610	ZN592_HUMAN	Zinc finger protein 592	ZNF592 KIAA0211	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872	VPTEPPATSVAARSSSLPSGR	5.820000172	1	1	0.057169408	2070.327016	13.45483	0	14.48889	10.99589	0	15.23896	0	12.82042	0	0	0	0	0	0	0	0	15.28596	0	0	0	0	0	0	0	0	0	0	14.30062	0	0	0	0	0	15.13379	0	12.85654	14.32836	15.38087	0	0	14.23729	0	0	14.78383	0	0	0	0
Q92613	JADE3_HUMAN	Protein Jade-3 (Jade family PHD finger protein 3) (PHD finger protein 16)	JADE3 KIAA0215 PHF16	Homo sapiens (Human)	histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; regulation of cell cycle [GO:0051726]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]	histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]	histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; regulation of cell cycle [GO:0051726]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]	GO:0000123; GO:0005654; GO:0006275; GO:0006357; GO:0016570; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0046872; GO:0051726; GO:2000278	KDLISAMK	26.69000053	0.327433974	0.327433974	0.219900277	921.8300055	16.48532	17.17877	18.28394	0	15.15207	17.76944	17.39176	17.31439	0	16.77118	0	17.09865	19.5141	17.4849	15.89567	16.02733	17.23403	0	18.33472	16.81931	16.9069	0	16.80524	18.25707	17.80903	16.82632	0	16.99996	17.6384	16.21573	16.14623	0	16.77914	15.06136	0	17.43606	15.02529	17.34208	17.43656	17.44819	17.47126	14.83728	18.33405	15.69882	0	16.85333	12.83011	0
Q92614	MY18A_HUMAN	"Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus, MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210, SP-R210)"	MYO18A CD245 KIAA0216 MYSPDZ TIAF1	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]	actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]	"actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]"	"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; RNA binding [GO:0003723]"	GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0008094; GO:0009986; GO:0016020; GO:0016459; GO:0016477; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028	AAVAQASR	2.710000038	0.718945146	0.718945146	0.002898312	774.0747368	14.85918	15.45249	15.00851	13.96578	14.58381	0	17.0562	0	0	14.69671	14.76292	0	15.65389	0	0	0	18.48737	13.98372	16.62709	14.90965	0	15.50991	15.26195	0	0	0	16.3789	14.83859	11.37983	17.66287	18.06074	0	0	0	0	0	0	8.398017	0	0	15.22939	14.40753	14.54456	13.09498	0	0	17.09134	17.55012
Q92616	GCN1_HUMAN	"eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1, HsGCN1)"	GCN1 GCN1L1 KIAA0219	Homo sapiens (Human)	cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]"	"cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]"	GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0006417; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253	ALGAMVK	4	0.737196982	0.737196982	0.253728476	684.7752634	13.44243	14.04136	16.52035	16.50547	0	16.99167	0	15.62242	15.36865	0	13.63343	0	14.93198	0	0	14.93774	15.31233	15.733	15.43941	0	17.08115	0	0	16.04164	0	0	15.01863	15.14812	12.80977	0	0	16.9907	16.36095	0	0	0	0	0	0	0	15.63857	0	15.55106	0	15.72375	0	0	15.79075
Q92617	NPIB3_HUMAN	Nuclear pore complex-interacting protein family member B3 (Nuclear pore complex-interacting protein-like 3) (Protein pps22-1)	NPIPB3 KIAA0220 NPIPL3	Homo sapiens (Human)		integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]		GO:0005654; GO:0016021	MIISR	4.650000095	0.615680993	0.615680993	0.30453089	636.7161222	16.08992	14.40082	15.40997	14.87649	0	14.17028	16.60436	0	15.68284	0	0	0	15.38489	15.09046	0	0	15.71776	16.84326	16.21951	0	0	16.44159	15.6144	0	0	0	16.3378	15.18768	0	0	0	0	0	18.03404	0	15.09433	0	0	0	0	0	0	0	17.54925	16.64577	0	17.00384	0
Q92618	ZN516_HUMAN	Zinc finger protein 516	ZNF516 KIAA0222	Homo sapiens (Human)	"adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162; GO:0140297	AASMPK	8.159999847	1	1	0.281227449	619.8260081	16.34196	15.01713	16.01623	16.35204	16.66876	14.80961	0	17.06317	0	0	16.15403	15.91984	15.86603	15.43488	16.87453	17.27519	15.36877	16.58509	0	0	17.55099	18.07427	18.91678	17.7244	0	16.82586	0	16.42668	0	15.59191	16.48418	0	13.43441	16.37306	16.70067	0	17.69428	15.92128	15.66753	15.33421	17.0115	15.06798	17.22461	16.11832	15.78141	0	0	18.3205
Q92619	HMHA1_HUMAN	"Rho GTPase-activating protein 45 [Cleaved into: Minor histocompatibility antigen HA-1, mHag HA-1 ]"	ARHGAP45 HMHA1 KIAA0223	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005576; GO:0005829; GO:0005886; GO:0007165; GO:0016020; GO:0032587; GO:0034774; GO:0035578; GO:0046872; GO:0051056; GO:0090630	TTLEMEFAK	1.230000019	1	1	0.252323066	1086.452757	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.04711	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92620	PRP16_HUMAN	"Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16, EC 3.6.4.13 (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)"	DHX38 DDX38 KIAA0224 PRP16	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	"catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0016020; GO:0016887; GO:0071013	KEQGEPMTPR	4.150000095	1	1	0.121153841	1188.65071	0	0	0	0	0	0	0	0	15.21842	0	0	12.54589	14.89708	0	0	0	14.89108	0	0	0	0	0	0	0	0	14.48109	13.30821	13.27836	13.74517	12.62907	15.26199	15.92414	10.71773	0	13.28473	0	14.51971	13.73705	15.88363	14.72471	12.33445	0	10.82028	15.44772	11.9529	0	0	0
Q92621	NU205_HUMAN	Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205)	NUP205 C7orf14 KIAA0225	Homo sapiens (Human)	mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]	structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0005829; GO:0006913; GO:0006999; GO:0015031; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0044611; GO:0051028; GO:0051292	DLPSADSVQYRHLPSR	4.010000229	0.611885071	0.611885071	0.437053685	1840.700139	0	0	15.60899	15.02159	15.88083	14.56591	0	0	0	17.25552	16.35347	15.07555	0	0	0	0	0	0	0	0	0	0	0	15.77568	0	14.88532	0	0	0	0	0	0	0	0	0	0	0	0	17.45374	0	0	0	16.87979	0	0	17.01172	0	0
Q92622	RUBIC_HUMAN	"Run domain Beclin-1-interacting and cysteine-rich domain-containing protein, Rubicon (Beclin-1 associated RUN domain containing protein, Baron)"	RUBCN KIAA0226	Homo sapiens (Human)	autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909]	cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; phosphatidylinositol phosphate binding [GO:1901981]; autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909]	phosphatidylinositol phosphate binding [GO:1901981]	GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006909; GO:0006914; GO:0010507; GO:0043231; GO:0043553; GO:0045806; GO:0071985; GO:1901097; GO:1901981	MRPEGAGMELGGGEER	7.690000057	1	1	0.29012561	1691.645894	17.29365	17.13425	14.12077	16.18299	14.85191	0	0	0	15.66602	0	16.18391	14.84587	0	0	0	0	14.98308	0	0	13.23138	0	0	14.30073	0	15.36846	0	0	16.14327	17.05828	0	0	0	0	0	0	0	0	15.59898	0	0	14.4672	15.84381	0	0	0	0	0	0
Q92624	APBP2_HUMAN	"Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2, APP-BP2) (Protein interacting with APP tail 1)"	APPBP2 KIAA0228 PAT1	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	microtubule motor activity [GO:0003777]; ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0003777; GO:0005634; GO:0005654; GO:0005737; GO:0005874; GO:0005875; GO:0006886; GO:0030659; GO:0031462; GO:0043161; GO:0046907; GO:1990756	DHFGSK	3.579999924	0.540738344	0.540738344	0.225071409	687.70341	15.863	16.1811	0	0	13.94642	14.24705	15.45047	0	15.88828	0	16.32262	0	16.33218	14.85377	15.72303	0	15.30316	16.11413	0	16.01806	0	16.02514	16.16393	0	16.46977	0	14.42183	16.58227	16.07643	14.79678	16.62935	0	14.95173	16.92865	16.50401	0	0	16.13704	16.04809	0	15.40954	14.48385	0	16.99832	13.65967	14.981	15.79051	15.99104
Q92625	ANS1A_HUMAN	Ankyrin repeat and SAM domain-containing protein 1A (Odin)	ANKS1A ANKS1 KIAA0229 ODIN	Homo sapiens (Human)	ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929]	cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929]	ephrin receptor binding [GO:0046875]	GO:0005654; GO:0005829; GO:0006929; GO:0016322; GO:0043005; GO:0046875; GO:0048013; GO:1901187	LEKSPSFASEWDEIEK	7.650000095	1	1	6.88E-13	1894.255969	13.98429	12.72388	0	13.7722	14.27754	12.00012	0	13.46386	14.87826	13.85201	0	0	0	0	0	13.48902	0	0	0	0	0	15.61997	0	0	0	0	15.89665	0	0	0	0	0	0	0	16.63097	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92628	K0232_HUMAN	Uncharacterized protein KIAA0232	KIAA0232	Homo sapiens (Human)			ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524	DLYMENRK	9.289999962	0.601846099	0.601846099	0.138393167	1081.623496	0	0	0	13.90756	0	0	0	0	15.344	16.34331	0	0	0	0	15.78783	14.37127	13.01481	8.792977	0	0	0	0	17.31905	0	16.0208	0	0	0	0	0	13.60258	0	0	0	14.21511	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92633	LPAR1_HUMAN	"Lysophosphatidic acid receptor 1, LPA receptor 1, LPA-1 (Lysophosphatidic acid receptor Edg-2)"	LPAR1 EDG2 LPA1	Homo sapiens (Human)	activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of metabolic process [GO:0019222]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of metabolic process [GO:0019222]	G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915]	GO:0004930; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007193; GO:0007202; GO:0007204; GO:0008360; GO:0009986; GO:0010977; GO:0019222; GO:0022008; GO:0035025; GO:0035727; GO:0043123; GO:0043410; GO:0051482; GO:0051496; GO:0060326; GO:0070915	DTMMSLLK	3.349999905	1	1	5.79E-13	971.5768842	0	0	0	0	0	0	14.56668	0	15.83465	0	13.9374	0	0	0	0	0	0	0	0	0	13.32937	0	0	0	0	18.53009	0	0	0	0	15.07961	0	0	0	0	0	18.00055	0	0	0	0	0	0	0	0	0	0	0
Q92636	FAN_HUMAN	"Protein FAN (Factor associated with neutral sphingomyelinase activation, Factor associated with N-SMase activation)"	NSMAF FAN	Homo sapiens (Human)	ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]	sphingomyelin phosphodiesterase activator activity [GO:0016230]	GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016230; GO:0043065	MAFIRK	13.81000042	1	1	0.253891313	766.1074411	0	0	18.50399	0	0	0	0	0	0	0	0	18.77558	0	0	0	0	16.11873	0	18.72795	0	17.83846	0	18.02468	18.05736	0	0	0	0	0	18.26789	0	0	0	0	0	0	0	0	18.72863	17.70733	0	0	0	0	0	0	17.20115	0
Q92665	RT31_HUMAN	"28S ribosomal protein S31, mitochondrial, MRP-S31, S31mt (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)"	MRPS31 IMOGN38	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0019904; GO:0032543	ISFSNIISDMKVAR	22.12999916	1	1	0.089237808	1581.693285	16.91859	16.59265	0	17.01469	17.15144	0	16.91686	0	16.99022	18.08496	0	15.92993	17.1345	0	16.85267	16.73272	0	16.38634	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.29819	16.32967
Q92667	AKAP1_HUMAN	"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa, AKAP 149) (Dual specificity A-kinase-anchoring protein 1, D-AKAP-1) (Protein kinase A-anchoring protein 1, PRKA1) (Spermatid A-kinase anchor protein 84, S-AKAP84)"	AKAP1 AKAP149 PRKA1	Homo sapiens (Human)	antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]	protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]	GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0034237; GO:0140374	LELALTGGEAK	8.279999733	0.805916548	0.805916548	0.209573084	1101.979451	16.67626	17.9623	14.88122	13.14914	0	0	0	15.10966	13.55824	0	17.38532	0	18.32543	12.19048	15.23556	16.74974	0	13.34114	0	15.97266	14.97051	0	0	16.61213	14.37151	12.35041	0	0	8.263093	12.53321	20.76685	0	0	17.58029	14.55343	0	0	17.87462	0	0	15.35845	0	0	0	14.68288	14.58493	0	13.16511
Q92670	ZN75C_HUMAN	Putative zinc finger protein 75C (Zinc finger protein 75C pseudogene)	ZNF75CP ZNF75C	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	GTTVAPGFK	5.360000134	1	1	0.092710947	877.67721	14.69975	0	15.41459	13.08738	0	14.10373	13.65305	13.26412	12.93291	11.71642	14.05064	15.39587	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92673	SORL_HUMAN	"Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats, LDLR relative with 11 ligand-binding repeats, LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats, SorLA)"	SORL1 C11orf32	Homo sapiens (Human)	adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]	cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]	cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; neuropeptide binding [GO:0042923]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]	amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; neuropeptide binding [GO:0042923]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]	GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005041; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0008283; GO:0009986; GO:0010008; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0016477; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032091; GO:0032585; GO:0034067; GO:0038020; GO:0042923; GO:0043025; GO:0043407; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0051604; GO:0055037; GO:0055038; GO:0070062; GO:0070863; GO:0097356; GO:1900168; GO:1901215; GO:1902430; GO:1902771; GO:1902948; GO:1902953; GO:1902955; GO:1902960; GO:1902963; GO:1902966; GO:1902997; GO:1904179; GO:1990845; GO:2001137	AAQFVTR	9.130000114	0.103398941	0.103398941	0.266363551	792.0134836	19.68638	18.31146	18.60253	18.20602	18.10332	17.69473	17.66722	18.99152	19.19018	0	16.36448	16.39927	0	0	0	17.81496	0	0	16.67878	18.54111	17.84585	17.1997	17.90317	18.19494	17.79928	18.85821	16.81465	15.38395	15.16018	17.47396	19.27366	19.99809	19.63591	19.60453	18.45456	18.88009	17.3981	17.58348	17.88705	0	18.81495	18.78991	18.94481	0	0	15.95972	19.37935	19.39507
Q92729	PTPRU_HUMAN	"Receptor-type tyrosine-protein phosphatase U, R-PTP-U, EC 3.1.3.48 (Pancreatic carcinoma phosphatase 2, PCP-2) (Protein-tyrosine phosphatase J, PTP-J, hPTP-J) (Protein-tyrosine phosphatase pi, PTP pi) (Protein-tyrosine phosphatase receptor omicron, PTP-RO) (Receptor-type protein-tyrosine phosphatase psi, R-PTP-psi)"	PTPRU FMI PCP2 PTPRO	Homo sapiens (Human)	animal organ regeneration [GO:0031100]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; response to glucocorticoid [GO:0051384]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; animal organ regeneration [GO:0031100]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; response to glucocorticoid [GO:0051384]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	beta-catenin binding [GO:0008013]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0006470; GO:0007155; GO:0007185; GO:0008013; GO:0008285; GO:0030154; GO:0030336; GO:0031100; GO:0034109; GO:0034394; GO:0051384; GO:0090090; GO:2000049	RFLATFPLAAVSR	4.5	1	1	0.557527789	1446.422993	15.87338	17.61331	0	0	0	17.22845	0	0	16.81862	0	0	0	0	0	18.45861	0	0	0	0	0	16.3016	0	0	0	0	0	18.73429	0	0	0	18.82565	0	0	0	0	0	0	18.69888	0	0	0	0	0	0	18.12359	0	0	0
Q92736	RYR2_HUMAN	"Ryanodine receptor 2, RYR-2, RyR2, hRYR-2 (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor)"	RYR2	Homo sapiens (Human)	calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to epinephrine stimulus [GO:0071872]; detection of calcium ion [GO:0005513]; embryonic heart tube morphogenesis [GO:0003143]; establishment of protein localization to endoplasmic reticulum [GO:0072599]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of heart rate [GO:0010460]; positive regulation of sequestering of calcium ion [GO:0051284]; positive regulation of the force of heart contraction [GO:0098735]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to muscle stretch [GO:0035994]; response to redox state [GO:0051775]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; type B pancreatic cell apoptotic process [GO:0097050]; ventricular cardiac muscle cell action potential [GO:0086005]	calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]	calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein self-association [GO:0043621]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; suramin binding [GO:0043924]; transmembrane transporter binding [GO:0044325]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to epinephrine stimulus [GO:0071872]; detection of calcium ion [GO:0005513]; embryonic heart tube morphogenesis [GO:0003143]; establishment of protein localization to endoplasmic reticulum [GO:0072599]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of heart rate [GO:0010460]; positive regulation of sequestering of calcium ion [GO:0051284]; positive regulation of the force of heart contraction [GO:0098735]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to muscle stretch [GO:0035994]; response to redox state [GO:0051775]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; type B pancreatic cell apoptotic process [GO:0097050]; ventricular cardiac muscle cell action potential [GO:0086005]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein self-association [GO:0043621]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; suramin binding [GO:0043924]; transmembrane transporter binding [GO:0044325]	GO:0001666; GO:0002027; GO:0003143; GO:0003220; GO:0003300; GO:0005219; GO:0005262; GO:0005509; GO:0005513; GO:0005516; GO:0005790; GO:0005886; GO:0006816; GO:0006874; GO:0010460; GO:0010881; GO:0010882; GO:0014701; GO:0014808; GO:0014850; GO:0015278; GO:0016020; GO:0016529; GO:0019722; GO:0019899; GO:0030018; GO:0030659; GO:0031000; GO:0032991; GO:0033017; GO:0034236; GO:0034237; GO:0034704; GO:0035584; GO:0035994; GO:0042383; GO:0042802; GO:0043621; GO:0043924; GO:0044325; GO:0048763; GO:0051209; GO:0051284; GO:0051480; GO:0051775; GO:0055117; GO:0060048; GO:0060402; GO:0070296; GO:0071313; GO:0071872; GO:0072599; GO:0086005; GO:0086029; GO:0086064; GO:0097050; GO:0098735; GO:0098904; GO:0098907; GO:0098910; GO:0098911; GO:1901896	AAMVLFLDR	10.80000019	0.356092066	0.356092066	0.185489512	1051.389843	16.1272	15.81045	16.08691	16.54439	15.58122	16.92079	14.79489	14.67476	17.17809	14.29475	17.13747	15.60072	16.24803	15.46969	17.29147	15.85078	15.94224	16.24617	0	17.01233	14.58203	16.24424	15.37116	15.30366	16.67695	14.11676	0	0	0	15.65229	17.34024	16.60393	13.86106	16.7873	15.63509	14.22519	15.04456	14.83237	15.09987	14.03746	16.14375	15.24819	16.09816	15.28322	17.10042	16.82469	14.97716	16.25181
Q92737	RSLAA_HUMAN	"Ras-like protein family member 10A, EC 3.6.5.2 (Ras-like protein RRP22) (Ras-related protein on chromosome 22)"	RASL10A RRP22	Homo sapiens (Human)	small GTPase mediated signal transduction [GO:0007264]	nucleolus [GO:0005730]; plasma membrane [GO:0005886]	nucleolus [GO:0005730]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264]	G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0003925; GO:0005525; GO:0005730; GO:0005886; GO:0007264	QRIAETRPAGAPEAPILVVGNK	4.630000114	1	1	0.415105126	2285.784438	0	0	0	0	0	18.2559	0	0	18.50603	0	16.47506	0	0	0	0	0	0	0	0	0	15.46922	0	17.69498	0	0	18.13718	0	0	0	0	17.27516	0	0	0	0	0	0	0	18.95734	0	0	0	0	0	0	0	18.1142	0
Q92738	US6NL_HUMAN	"USP6 N-terminal-like protein (Related to the N-terminus of tre, RN-tre)"	USP6NL KIAA0019	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]"	GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]	GO:0005096; GO:0005829; GO:0005886; GO:0007030; GO:0019068; GO:0031267; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358	ARGCSPDIR	4.639999866	1	1	0	1030.917341	0	0	0	0	0	0	0	0	17.63594	15.87174	0	0	0	0	0	15.38292	0	0	0	0	12.39378	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.19223	0	0	0	0	0	0	0	0
Q92743	HTRA1_HUMAN	"Serine protease HTRA1, EC 3.4.21.- (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11)"	HTRA1 HTRA PRSS11	Homo sapiens (Human)	chorionic trophoblast cell differentiation [GO:0060718]; dentinogenesis [GO:0097187]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of defense response to virus [GO:0050687]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation [GO:0050679]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]	collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; chorionic trophoblast cell differentiation [GO:0060718]; dentinogenesis [GO:0097187]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of defense response to virus [GO:0050687]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation [GO:0050679]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]	growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0001890; GO:0004252; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006508; GO:0008236; GO:0012501; GO:0019838; GO:0030512; GO:0030514; GO:0042802; GO:0043065; GO:0050679; GO:0050687; GO:0060718; GO:0062023; GO:0070062; GO:0097187	IDHQGK	7.010000229	1	1	0.08797757	697.993966	0	0	15.15333	0	0	0	0	0	0	0	0	0	0	0	16.15337	0	0	13.98477	0	0	0	0	0	0	0	13.5503	15.62064	15.19476	0	16.22483	15.72857	0	0	16.32065	0	0	0	0	0	0	0	0	0	0	0	15.37148	16.49157	0
Q92750	TAF4B_HUMAN	"Transcription initiation factor TFIID subunit 4B (Transcription initiation factor TFIID 105 kDa subunit, TAF(II)105, TAFII-105, TAFII105)"	TAF4B TAF2C2 TAFII105	Homo sapiens (Human)	mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367]	DNA binding [GO:0003677]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	GO:0001650; GO:0003677; GO:0005654; GO:0005669; GO:0005737; GO:0006367; GO:0006468; GO:0007283; GO:0016251; GO:0042789; GO:0046982; GO:0048477; GO:0051059; GO:0060261	VSSGPRLPAPQIVAVK	13.36999989	1	1	0.35319679	1619.306907	14.23778	15.03858	0	0	16.14178	0	0	16.3614	15.2109	17.41371	15.60717	15.74979	0	0	0	0	0	0	0	13.43952	0	0	0	15.81452	0	0	13.33625	0	0	0	0	0	0	0	0	17.05188	15.70206	14.10194	0	0	16.60237	16.6448	0	0	0	0	0	0
Q92752	TENR_HUMAN	"Tenascin-R, TN-R (Janusin) (Restrictin)"	TNR	Homo sapiens (Human)	"associative learning [GO:0008306]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029]"	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733]	"cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733]; signaling receptor binding [GO:0005102]; associative learning [GO:0008306]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029]"	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0005615; GO:0007155; GO:0007158; GO:0007411; GO:0008306; GO:0009986; GO:0022029; GO:0022408; GO:0030198; GO:0030334; GO:0035641; GO:0045121; GO:0048692; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0062023; GO:0072534; GO:0090733; GO:0098685; GO:0098978	MGADGETVVLKNMLIGINLILLGSMIKPSECQLEVTTER	5.860000134	0.440896302	0.440896302	1.10E-11	4305.756168	0	12.14531	12.74463	0	0	0	0	0	0	0	11.75665	14.00995	0	0	0	0	0	0	0	0	0	0	0	0	15.03755	0	0	0	0	0	0	0	0	0	0	0	14.89964	0	0	9.393974	13.69159	0	0	0	0	0	0	0
Q92753	RORB_HUMAN	Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta)	RORB NR1F2 RZRB	Homo sapiens (Human)	"amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007601; GO:0008270; GO:0008502; GO:0035881; GO:0042462; GO:0042752; GO:0045668; GO:0045892; GO:0045893; GO:0045944; GO:0046548; GO:0046549; GO:0048511; GO:0060041; GO:0071300; GO:1990837	AYQSKSR	14.5	0.145675421	0.145675421	0.148204298	841.2537768	15.04426	15.69825	14.79613	16.91378	14.7313	0	0	0	18.23295	12.06368	0	9.690296	16.53672	15.23282	19.37621	16.77249	19.38812	15.03457	0	15.43915	0	18.68921	14.14704	0	0	0	15.97474	15.97733	0	0	19.82884	9.008538	16.02208	14.92822	0	0	15.59234	17.131	13.43901	15.50756	0	17.74279	13.0192	0	0	0	0	0
Q92754	AP2C_HUMAN	"Transcription factor AP-2 gamma, AP2-gamma (Activating enhancer-binding protein 2 gamma) (Transcription factor ERF-1)"	TFAP2C	Homo sapiens (Human)	"anatomical structure development [GO:0048856]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0007267; GO:0008584; GO:0040029; GO:0042127; GO:0045944; GO:0048856; GO:1990837	HDGSSNGNPR	8.729999542	1	1	0.413165175	1039.834263	13.75937	0	0	0	0	0	0	0	0	0	0	19.15176	0	19.33337	0	0	0	0	0	0	0	0	0	0	0	17.26862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95823
Q92765	SFRP3_HUMAN	"Secreted frizzled-related protein 3, sFRP-3 (Frezzled) (Fritz) (Frizzled-related protein 1) (FrzB-1)"	FRZB FIZ FRE FRP FRZB1 SFRP3	Homo sapiens (Human)	canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; skeletal system development [GO:0001501]; somite development [GO:0061053]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; skeletal system development [GO:0001501]; somite development [GO:0061053]	Wnt-protein binding [GO:0017147]	GO:0001501; GO:0005615; GO:0005737; GO:0008285; GO:0010721; GO:0014033; GO:0016020; GO:0017147; GO:0030178; GO:0030308; GO:0043065; GO:0045600; GO:0060029; GO:0060070; GO:0061037; GO:0061053; GO:0070367; GO:0090090; GO:0090103	SGRNSNPR	4.550000191	1	1	0.268967091	887.9367285	16.24688	14.53612	0	14.84629	0	15.46671	0	0	0	0	0	0	0	16.13618	0	0	0	0	0	0	18.09968	0	0	0	0	0	0	17.92044	0	0	0	0	16.19254	0	0	0	0	0	0	0	0	0	0	18.31859	0	0	0	18.12094
Q92766	RREB1_HUMAN	"Ras-responsive element-binding protein 1, RREB-1 (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1, Zep-1)"	RREB1 FINB	Homo sapiens (Human)	"multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0001650; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0006366; GO:0007265; GO:0007275; GO:0010634; GO:0016604; GO:0016607; GO:0033601; GO:0045893; GO:0045944; GO:0046872; GO:0070062; GO:0090336; GO:1900026; GO:1903691; GO:2000394	ALRIHMR	4.800000191	0.266185403	0.266185403	0.32708282	912.5274376	12.90576	14.72865	13.17028	0	13.74107	0	0	0	0	0	0	0	0	16.18184	0	16.34766	0	0	15.52669	0	0	0	13.58939	0	0	11.43841	0	0	12.51503	0	0	0	15.11227	0	0	15.77449	0	0	0	0	0	0	0	0	15.93038	0	0	0
Q92769	HDAC2_HUMAN	"Histone deacetylase 2, HD2, EC 3.5.1.98 (Protein deacylase HDAC2, EC 3.5.1.-)"	HDAC2	Homo sapiens (Human)	"behavioral response to ethanol [GO:0048149]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin organization [GO:0070828]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]"	"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; behavioral response to ethanol [GO:0048149]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin organization [GO:0070828]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]"	chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]	GO:0000118; GO:0000122; GO:0000781; GO:0000785; GO:0001975; GO:0003300; GO:0003682; GO:0003723; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006357; GO:0008284; GO:0009410; GO:0009913; GO:0010718; GO:0010977; GO:0016358; GO:0016575; GO:0016580; GO:0016581; GO:0019213; GO:0019899; GO:0030336; GO:0030512; GO:0031000; GO:0031072; GO:0032496; GO:0032732; GO:0032760; GO:0032922; GO:0032967; GO:0032991; GO:0033558; GO:0034605; GO:0035094; GO:0035098; GO:0042220; GO:0042475; GO:0042531; GO:0042659; GO:0042733; GO:0042826; GO:0043066; GO:0043392; GO:0043433; GO:0043565; GO:0045347; GO:0045862; GO:0045892; GO:0045893; GO:0045944; GO:0048149; GO:0048714; GO:0051059; GO:0055093; GO:0060789; GO:0061000; GO:0061029; GO:0061198; GO:0061629; GO:0070301; GO:0070828; GO:0070932; GO:0070933; GO:0071300; GO:0071560; GO:0160009; GO:0160010; GO:1902437; GO:1902455; GO:1902459; GO:1903351; GO:1990841; GO:2000273; GO:2000736; GO:2000757	ISIRASDK	6.260000229	0.229105905	0.229105905	0.097759927	888.0985306	16.72137	17.30225	17.32524	15.2028	0	15.10076	16.32745	16.85694	15.01273	0	17.54846	15.57797	14.52988	16.78554	18.23726	14.781	13.83853	17.03007	13.38678	0	0	18.23895	11.29254	18.2083	16.28922	13.99054	17.60193	14.64012	14.98877	14.83802	18.42974	16.37587	14.6827	16.29358	17.00119	15.54885	13.72804	17.53741	15.98601	17.58996	16.93914	0	15.82333	17.81394	14.24894	16.51003	16.26003	17.6642
Q92772	CDKL2_HUMAN	"Cyclin-dependent kinase-like 2, EC 2.7.11.22 (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE)"	CDKL2	Homo sapiens (Human)	protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; signal transduction [GO:0007165]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0007165; GO:0007548; GO:0106310	DIKPENILVSQSGVVK	15.59000015	1	1	0.57666687	1724.741096	13.92326	16.60186	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.16809	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.95043	17.81023	0	0	0	0	0	0
Q92777	SYN2_HUMAN	Synapsin-2 (Synapsin II)	SYN2	Homo sapiens (Human)	calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; neurotransmitter secretion [GO:0007269]; synaptic vesicle clustering [GO:0097091]	glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]	glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; neurotransmitter secretion [GO:0007269]; synaptic vesicle clustering [GO:0097091]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]	GO:0005524; GO:0005886; GO:0007268; GO:0007269; GO:0014069; GO:0017156; GO:0030672; GO:0031201; GO:0042802; GO:0045202; GO:0097091; GO:0098685; GO:0098978	IGHAHSGMGKVK	13.82999992	1	1	0.256144143	1219.531682	11.98595	14.10849	0	14.22529	0	12.76391	0	0	0	0	0	0	0	0	0	0	0	0	0	15.18729	0	0	0	0	0	16.45916	10.12882	15.82853	16.53378	16.00772	0	16.94696	16.27763	0	0	0	0	16.7415	0	17.16803	15.06198	16.44547	15.33535	15.03338	17.69222	0	16.04714	15.51799
Q92783	STAM1_HUMAN	"Signal transducing adapter molecule 1, STAM-1"	STAM STAM1	Homo sapiens (Human)	macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165]	phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0005829; GO:0007165; GO:0016236; GO:0031901; GO:0033565; GO:0035091; GO:0036258; GO:0043130; GO:0043231; GO:0043328; GO:0044389; GO:1903543; GO:1903551	DPGTVANKK	8.829999924	1	1	0.255686397	930.2802137	15.91058	16.13818	16.57472	0	15.47116	15.63419	16.63554	15.67879	0	0	14.34935	16.51125	15.74649	0	0	16.78753	16.37145	0	0	16.12582	0	16.61098	15.15589	0	15.48505	0	0	0	15.17074	15.08141	16.78187	17.71859	0	0	0	0	0	16.21041	16.93888	0	14.49314	15.69523	0	0	15.06785	0	17.23625	16.04744
Q92784	DPF3_HUMAN	"Zinc finger protein DPF3 (BRG1-associated factor 45C, BAF45C) (Zinc finger protein cer-d4)"	DPF3 BAF45C CERD4	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]	"brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000785; GO:0003712; GO:0005654; GO:0006338; GO:0006357; GO:0007399; GO:0008270; GO:0016514; GO:0030071; GO:0035060; GO:0042393; GO:0045597; GO:0045663; GO:0045892; GO:0045944; GO:0070316; GO:0071565; GO:2000045; GO:2000781; GO:2000819	GSAGGRR	8.449999809	1	1	0.26107156	659.9013735	14.99542	15.17103	15.44941	15.0244	13.4273	15.91033	14.13463	13.58418	14.10435	16.17992	14.17223	15.43578	14.25621	15.29579	0	16.27094	0	0	16.3793	15.40188	15.76548	16.11169	0	15.52273	0	16.3457	16.61775	0	0	15.09093	0	15.26828	15.70869	15.77869	16.08595	0	14.71338	18.33241	15.88147	17.42932	0	16.55372	0	15.33739	14.61431	16.79534	12.94989	14.81869
Q92785	REQU_HUMAN	"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D, BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)"	DPF2 BAF45D REQ UBID4	Homo sapiens (Human)	"apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	"centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000785; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006338; GO:0006357; GO:0006915; GO:0007399; GO:0016514; GO:0030071; GO:0042393; GO:0043231; GO:0045892; GO:0045944; GO:0046872; GO:0062072; GO:0070316; GO:0070577; GO:0071565; GO:0097190; GO:1902459; GO:1905454; GO:2000045; GO:2000781; GO:2000819	LSFPSIKPDTDQTLKK	2.440000057	1	1	0.333365465	1818.966793	15.28523	15.04455	13.68841	0	0	13.47616	0	14.75845	0	15.53903	0	0	0	0	15.18589	0	0	0	15.07986	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.81794	0	0	0	0	0	0	0	0	0
Q92786	PROX1_HUMAN	"Prospero homeobox protein 1 (Homeobox prospero-like protein PROX1, PROX-1)"	PROX1	Homo sapiens (Human)	"acinar cell differentiation [GO:0090425]; aorta smooth muscle tissue morphogenesis [GO:0060414]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; brain development [GO:0007420]; branching involved in pancreas morphogenesis [GO:0061114]; cell fate determination [GO:0001709]; cerebellar granule cell differentiation [GO:0021707]; circadian rhythm [GO:0007623]; dentate gyrus development [GO:0021542]; dorsal spinal cord development [GO:0021516]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endocardium formation [GO:0060214]; hepatocyte cell migration [GO:0002194]; hepatocyte differentiation [GO:0070365]; hepatocyte proliferation [GO:0072574]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lens placode formation involved in camera-type eye formation [GO:0046619]; liver development [GO:0001889]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; lymphatic endothelial cell fate commitment [GO:0060838]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; olfactory placode formation [GO:0030910]; otic placode formation [GO:0043049]; pancreas development [GO:0031016]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell cycle checkpoint [GO:1901978]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of forebrain neuron differentiation [GO:2000979]; positive regulation of heart growth [GO:0060421]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle thin filament assembly [GO:0030240]; venous blood vessel morphogenesis [GO:0048845]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; acinar cell differentiation [GO:0090425]; aorta smooth muscle tissue morphogenesis [GO:0060414]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; brain development [GO:0007420]; branching involved in pancreas morphogenesis [GO:0061114]; cell fate determination [GO:0001709]; cerebellar granule cell differentiation [GO:0021707]; circadian rhythm [GO:0007623]; dentate gyrus development [GO:0021542]; dorsal spinal cord development [GO:0021516]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endocardium formation [GO:0060214]; hepatocyte cell migration [GO:0002194]; hepatocyte differentiation [GO:0070365]; hepatocyte proliferation [GO:0072574]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lens placode formation involved in camera-type eye formation [GO:0046619]; liver development [GO:0001889]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; lymphatic endothelial cell fate commitment [GO:0060838]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; olfactory placode formation [GO:0030910]; otic placode formation [GO:0043049]; pancreas development [GO:0031016]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell cycle checkpoint [GO:1901978]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of forebrain neuron differentiation [GO:2000979]; positive regulation of heart growth [GO:0060421]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle thin filament assembly [GO:0030240]; venous blood vessel morphogenesis [GO:0048845]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]"	"DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0001822; GO:0001889; GO:0001938; GO:0001946; GO:0002088; GO:0002194; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007420; GO:0007623; GO:0008284; GO:0008285; GO:0010468; GO:0010595; GO:0016922; GO:0021516; GO:0021542; GO:0021707; GO:0021915; GO:0030240; GO:0030324; GO:0030910; GO:0031016; GO:0031667; GO:0042752; GO:0043049; GO:0043433; GO:0045071; GO:0045737; GO:0045787; GO:0045892; GO:0045944; GO:0046619; GO:0048845; GO:0050692; GO:0050693; GO:0055005; GO:0055009; GO:0055010; GO:0060042; GO:0060059; GO:0060214; GO:0060298; GO:0060412; GO:0060414; GO:0060421; GO:0060836; GO:0060838; GO:0061114; GO:0070309; GO:0070365; GO:0070858; GO:0072574; GO:0090425; GO:0097150; GO:1901978; GO:1990837; GO:2000179; GO:2000979	MPDHDSTALLSRQTK	3.529999971	0.583663762	0.583663762	0.296919061	1713.274007	0	16.7034	14.14948	15.84674	0	0	14.39333	13.42487	0	0	16.7457	17.59115	0	0	0	13.57793	15.66755	0	0	0	17.72489	0	0	13.3222	13.66625	0	14.9027	15.05763	0	0	15.8043	15.15829	0	0	0	15.09231	0	13.31379	0	0	0	0	0	0	0	0	0	0
Q92791	SC65_HUMAN	Endoplasmic reticulum protein SC65 (Leprecan-like protein 4) (Nucleolar autoantigen No55) (Prolyl 3-hydroxylase family member 4) (Synaptonemal complex protein SC65)	P3H4 LEPREL4 NOL55 SC65	Homo sapiens (Human)	bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]; synaptonemal complex assembly [GO:0007130]	catalytic complex [GO:1902494]; condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; synaptonemal complex [GO:0000795]	catalytic complex [GO:1902494]; condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; synaptonemal complex [GO:0000795]; bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]; synaptonemal complex assembly [GO:0007130]		GO:0000794; GO:0000795; GO:0005730; GO:0005783; GO:0007130; GO:0017185; GO:0030199; GO:0032964; GO:0043231; GO:0046849; GO:1902494	VAWGLLWLLLGSAGAQYEK	4.489999771	1	1	0.194431251	2076.175981	14.38311	0	0	14.60847	14.10474	12.69849	14.48866	14.42787	17.26489	0	15.76517	0	17.18801	15.61221	0	12.89798	8.815741	0	0	0	0	16.26803	0	0	0	0	0	0	0	0	0	16.4955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92793	CBP_HUMAN	"CREB-binding protein (Histone lysine acetyltransferase CREBBP, EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP, EC 2.3.1.-)"	CREBBP CBP	Homo sapiens (Human)	"cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"	acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006473; GO:0007165; GO:0008270; GO:0008589; GO:0016407; GO:0016573; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0034212; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0045893; GO:0045944; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0140297; GO:1900034; GO:1990258	VVASSDKTVEVKPGMK	14.77000046	1	1	0.245282149	1674.399976	0	0	17.20025	0	0	0	19.06531	0	13.80292	0	13.94828	0	0	0	0	0	0	0	0	0	15.03151	0	0	0	0	0	0	0	0	0	0	0	0	0	18.42925	0	0	0	16.30323	0	0	0	0	0	0	0	0	0
Q92794	KAT6A_HUMAN	"Histone acetyltransferase KAT6A, EC 2.3.1.48 (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3, MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)"	KAT6A MOZ MYST3 RUNXBP2 ZNF220	Homo sapiens (Human)	"cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]	"cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; cellular senescence [GO:0090398]; DNA packaging [GO:0006323]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]"	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000786; GO:0003677; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006323; GO:0006334; GO:0006355; GO:0006473; GO:0008270; GO:0010484; GO:0010485; GO:0010628; GO:0016407; GO:0016573; GO:0016605; GO:0016607; GO:0030099; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0050793; GO:0061629; GO:0070776; GO:0090398; GO:0140297; GO:1901796; GO:1903706	DMELFR	8.819999695	1	1	0.252512898	810.575409	0	0	0	0	0	0	0	0	0	0	0	0	17.8992	16.42322	0	0	0	0	0	0	0	0	0	0	0	0	0	17.15411	0	0	0	0	0	17.58257	18.61062	0	0	0	20.46226	0	17.84771	0	0	0	0	0	18.0508	0
Q92796	DLG3_HUMAN	"Disks large homolog 3 (Neuroendocrine-DLG) (Synapse-associated protein 102, SAP-102, SAP102) (XLMR)"	DLG3 KIAA1232	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]	adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; ubiquitin protein ligase binding [GO:0031625]; cell-cell adhesion [GO:0098609]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]	kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; ubiquitin protein ligase binding [GO:0031625]	GO:0001736; GO:0005615; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008285; GO:0016323; GO:0019900; GO:0019902; GO:0030054; GO:0031625; GO:0032281; GO:0043113; GO:0045197; GO:0061098; GO:0097120; GO:0098609; GO:0098978; GO:0099072	EAGPVVR	6.039999962	1	1	0.042468225	728.3919134	12.24965	13.35543	0	15.83987	0	14.19782	0	0	15.67325	0	0	14.32142	0	0	13.95054	0	0	0	0	0	0	0	0	0	13.99876	0	0	0	0	14.79369	0	0	0	0	0	0	0	0	0	13.79907	0	0	0	0	0	0	0	0
Q92797	SYMPK_HUMAN	Symplekin	SYMPK SPK	Homo sapiens (Human)	cell adhesion [GO:0007155]; mRNA polyadenylation [GO:0006378]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA polyadenylation [GO:0006378]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]		GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006378; GO:0007155; GO:0016604; GO:0032091; GO:0035307; GO:0097165	QCKEEPK	7.809999943	0.00050136	0.00050136	0.222953046	918.2262466	0	0	0	0	0	14.39783	0	0	0	0	0	0	0	16.17988	0	0	0	0	0	0	0	0	15.02423	0	15.78213	0	16.61879	0	0	0	0	17.78566	18.38622	15.21421	16.20244	16.34352	18.35533	0	0	0	0	0	0	0	0	0	0	0
Q92800	EZH1_HUMAN	"Histone-lysine N-methyltransferase EZH1, EC 2.1.1.356 (ENX-2) (Enhancer of zeste homolog 1)"	EZH1 KIAA0388	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; subtelomeric heterochromatin assembly [GO:0031509]	"chromosome, telomeric region [GO:0000781]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]"	"chromosome, telomeric region [GO:0000781]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; transcription corepressor activity [GO:0003714]; anatomical structure morphogenesis [GO:0009653]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; subtelomeric heterochromatin assembly [GO:0031509]"	chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000781; GO:0000792; GO:0003682; GO:0003714; GO:0005654; GO:0006338; GO:0009653; GO:0018024; GO:0021766; GO:0031507; GO:0031509; GO:0035098; GO:0045944; GO:0070734	TQILNEEWKK	8.949999809	1	1	0.016514756	1287.834538	13.72396	0	13.93259	0	0	13.732	13.55151	16.1719	15.48079	16.19445	0	13.27368	15.81148	16.55387	14.84245	0	0	14.56955	15.37374	16.24759	0	13.37473	0	0	13.82369	19.4073	0	14.30769	0	0	13.34701	0	0	16.61086	12.97412	13.22577	16.27819	17.56179	13.2309	17.69201	0	14.43763	13.05632	0	14.59834	17.25559	0	0
Q92804	RBP56_HUMAN	"TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor, TAF(II)68, TAFII68) (RNA-binding protein 56)"	TAF15 RBP56 TAF2N	Homo sapiens (Human)	"mRNA stabilization [GO:0048255]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA splicing [GO:0008380]"	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; mRNA stabilization [GO:0048255]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA splicing [GO:0008380]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0008380; GO:0045893; GO:0046872; GO:0048255	GRGGYR	2.279999971	0.569984853	0.569984853	0.285904411	664.8380909	0	18.72915	0	18.30598	18.24564	0	18.61346	0	0	0	0	0	16.40056	15.95206	0	17.28244	0	0	0	0	0	0	0	18.58679	0	0	0	0	0	17.24722	0	18.2231	0	0	0	0	0	0	0	0	0	16.63998	0	16.36373	0	0	0	0
Q92805	GOGA1_HUMAN	Golgin subfamily A member 1 (Golgin-97)	GOLGA1	Homo sapiens (Human)		acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]	acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]		GO:0000139; GO:0001669; GO:0005794; GO:0005802; GO:0005829; GO:0048471	TQEELMNSNQMSSDLSQK	9.350000381	1	1	0.221773221	2102.436169	0	0	0	14.52472	16.7769	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41155	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.26497	0	18.09315	0	0	0	0	0
Q92817	EVPL_HUMAN	Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210)	EVPL	Homo sapiens (Human)	epidermis development [GO:0008544]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; wound healing [GO:0042060]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; structural molecule activity [GO:0005198]; epidermis development [GO:0008544]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; wound healing [GO:0042060]	cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; structural molecule activity [GO:0005198]	GO:0001533; GO:0005198; GO:0005737; GO:0005829; GO:0008544; GO:0016020; GO:0018149; GO:0019215; GO:0030057; GO:0030216; GO:0031424; GO:0042060; GO:0045104; GO:0045111; GO:0045296; GO:0070062	EVTQEVVR	11.10999966	1	1	0.220948953	962.6544981	0	14.23295	14.52957	12.19863	14.1794	13.59459	13.05597	0	15.62839	0	0	0	10.84419	14.93531	0	15.79326	0	16.17205	13.70666	0	0	14.98928	0	12.57647	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92819	HYAS2_HUMAN	"Hyaluronan synthase 2, EC 2.4.1.212 (Hyaluronate synthase 2) (Hyaluronic acid synthase 2, HA synthase 2)"	HAS2	Homo sapiens (Human)	atrioventricular canal development [GO:0036302]; bone morphogenesis [GO:0060349]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; endocardial cushion to mesenchymal transition [GO:0090500]; estrous cycle [GO:0044849]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; hyaluronan biosynthetic process [GO:0030213]; kidney development [GO:0001822]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of urine volume [GO:0035810]; regulation of extracellular matrix assembly [GO:1901201]; renal water absorption [GO:0070295]; vasculogenesis [GO:0001570]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802]; atrioventricular canal development [GO:0036302]; bone morphogenesis [GO:0060349]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; endocardial cushion to mesenchymal transition [GO:0090500]; estrous cycle [GO:0044849]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; hyaluronan biosynthetic process [GO:0030213]; kidney development [GO:0001822]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of urine volume [GO:0035810]; regulation of extracellular matrix assembly [GO:1901201]; renal water absorption [GO:0070295]; vasculogenesis [GO:0001570]	hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802]	GO:0001570; GO:0001822; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0008284; GO:0010838; GO:0014911; GO:0030213; GO:0030335; GO:0031410; GO:0035810; GO:0036120; GO:0036302; GO:0042802; GO:0044849; GO:0044853; GO:0045226; GO:0050501; GO:0051549; GO:0060349; GO:0070295; GO:0071347; GO:0071356; GO:0071498; GO:0085029; GO:0090500; GO:1900026; GO:1900127; GO:1900625; GO:1901201	YTARSK	5.900000095	1	1	0.268066787	724.3353888	15.18919	16.32612	13.68851	0	20.19498	16.55641	0	0	16.9734	0	0	17.78072	0	0	0	0	16.55891	0	0	0	0	16.88888	16.5959	0	0	17.71342	16.39718	0	0	0	20.01539	0	0	0	0	0	0	18.38867	0	0	18.42698	0	16.34033	16.58742	0	17.77283	0	0
Q92820	GGH_HUMAN	"Gamma-glutamyl hydrolase, EC 3.4.19.9 (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)"	GGH	Homo sapiens (Human)	tetrahydrofolylpolyglutamate metabolic process [GO:0046900]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]; exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900]	exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]	GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724	SDYAKVAK	6.039999962	0.54041934	0.54041934	0.338300716	881.0004433	14.60396	0	12.75759	0	15.26605	0	15.21455	0	0	0	0	14.11983	0	0	14.00861	0	14.49719	0	15.78291	0	16.6907	15.92043	12.55292	15.32995	0	14.51705	13.56612	11.86067	0	0	13.19783	14.71495	0	0	10.45657	0	0	0	15.85389	16.34057	0	15.95503	0	15.28732	0	14.90654	0	0
Q92823	NRCAM_HUMAN	"Neuronal cell adhesion molecule, Nr-CAM (Neuronal surface protein Bravo, hBravo) (NgCAM-related cell adhesion molecule, Ng-CAM-related)"	NRCAM KIAA0343	Homo sapiens (Human)	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]; synapse assembly [GO:0007416]	axon [GO:0030424]; axon initial segment [GO:0043194]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	axon [GO:0030424]; axon initial segment [GO:0043194]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ankyrin binding [GO:0030506]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]; synapse assembly [GO:0007416]	ankyrin binding [GO:0030506]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]	GO:0001525; GO:0001764; GO:0005576; GO:0005886; GO:0005887; GO:0007409; GO:0007411; GO:0007413; GO:0007416; GO:0007417; GO:0007420; GO:0008104; GO:0009897; GO:0010975; GO:0019227; GO:0030424; GO:0030506; GO:0030516; GO:0031290; GO:0043005; GO:0043194; GO:0045162; GO:0045666; GO:0086080; GO:0098609; GO:0098632; GO:0098978; GO:0099061; GO:0099175	GHLQGYR	3.599999905	1	1	0.302642124	829.8049616	0	0	17.29414	0	19.4399	0	0	0	0	18.66186	17.54228	0	17.6947	0	0	0	0	0	0	0	17.02698	0	0	0	0	0	0	0	0	17.4154	0	0	0	0	0	17.97925	0	18.70062	0	0	0	0	17.56624	0	0	0	0	0
Q92824	PCSK5_HUMAN	"Proprotein convertase subtilisin/kexin type 5, EC 3.4.21.- (Proprotein convertase 5, PC5) (Proprotein convertase 6, PC6, hPC6) (Subtilisin/kexin-like protease PC5)"	PCSK5 PC5 PC6	Homo sapiens (Human)	anterior/posterior pattern specification [GO:0009952]; cell-cell signaling [GO:0007267]; cytokine precursor processing [GO:0140447]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cell-cell signaling [GO:0007267]; cytokine precursor processing [GO:0140447]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058]	endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]	GO:0001822; GO:0002001; GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005794; GO:0005796; GO:0005802; GO:0006465; GO:0007267; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030173; GO:0030323; GO:0035108; GO:0042277; GO:0043043; GO:0048566; GO:0048706; GO:0051004; GO:0140447	SYSSYK	13.35000038	1	1	0.12839257	735.5367075	0	0	0	16.23897	0	0	0	0	0	18.84881	16.39124	15.2983	0	0	16.94223	18.87405	17.01361	17.48118	0	0	18.08053	17.5856	0	0	0	17.36909	18.13323	14.61281	14.083	15.4593	0	0	17.67056	16.45835	18.26294	16.70124	17.99666	19.69959	17.72445	0	18.07321	16.82837	17.38215	17.0182	17.73799	17.7016	0	17.357
Q92830	KAT2A_HUMAN	"Histone acetyltransferase KAT2A, EC 2.3.1.48 (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5, hGCN5) (Histone glutaryltransferase KAT2A, EC 2.3.1.-) (Histone succinyltransferase KAT2A, EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)"	KAT2A GCN5 GCN5L2	Homo sapiens (Human)	"alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]"	ATAC complex [GO:0140672]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]	"ATAC complex [GO:0140672]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; alpha-tubulin acetylation [GO:0071929]; cell population proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]"	chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]	GO:0000123; GO:0000124; GO:0000785; GO:0001701; GO:0001756; GO:0001819; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006282; GO:0006338; GO:0006355; GO:0006357; GO:0007507; GO:0007616; GO:0008283; GO:0010484; GO:0014070; GO:0016573; GO:0016578; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0031063; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0035521; GO:0035522; GO:0042826; GO:0043484; GO:0043966; GO:0043997; GO:0044154; GO:0045589; GO:0045722; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048167; GO:0048312; GO:0050863; GO:0051302; GO:0051726; GO:0060173; GO:0061035; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0090043; GO:0106077; GO:0106078; GO:0106227; GO:0106229; GO:0140297; GO:0140672; GO:1903010; GO:1990090; GO:2000036; GO:2000727	DETARLEER	6.53000021	1	1	0.364083432	1119.648844	16.39593	15.6407	14.18347	11.34738	0	16.04762	0	13.80865	14.15316	14.44075	15.85684	0	0	0	0	15.4649	0	0	0	0	0	0	0	0	0	16.43574	0	0	0	0	0	0	0	0	0	15.80365	0	0	0	0	0	0	0	0	15.92432	0	0	0
Q92831	KAT2B_HUMAN	"Histone acetyltransferase KAT2B, EC 2.3.1.48 (Histone acetyltransferase PCAF, Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor, P/CAF) (Spermidine acetyltransferase KAT2B, EC 2.3.1.57)"	KAT2B PCAF	Homo sapiens (Human)	"cell cycle [GO:0007049]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; negative regulation of rRNA processing [GO:2000233]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"	A band [GO:0031672]; actomyosin [GO:0042641]; ATAC complex [GO:0140672]; centrosome [GO:0005813]; cytosol [GO:0005829]; I band [GO:0031674]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]	"A band [GO:0031672]; actomyosin [GO:0042641]; ATAC complex [GO:0140672]; centrosome [GO:0005813]; cytosol [GO:0005829]; I band [GO:0031674]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cell cycle [GO:0007049]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; negative regulation of rRNA processing [GO:2000233]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]"	"acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"	GO:0000124; GO:0000776; GO:0000977; GO:0003682; GO:0003712; GO:0003713; GO:0004145; GO:0004402; GO:0004468; GO:0004861; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006282; GO:0006338; GO:0006355; GO:0006473; GO:0007049; GO:0007507; GO:0008285; GO:0010835; GO:0016407; GO:0016573; GO:0018076; GO:0018393; GO:0018394; GO:0019901; GO:0031672; GO:0031674; GO:0032869; GO:0032991; GO:0042641; GO:0042826; GO:0043484; GO:0043966; GO:0043970; GO:0045722; GO:0045815; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048511; GO:0051726; GO:0060173; GO:0061733; GO:0072686; GO:0140297; GO:0140672; GO:1902425; GO:2000233	EAGLIDK	3.369999886	1	1	0.159147242	747.5808798	16.25837	12.14617	15.41604	13.45262	14.73939	13.76247	13.66344	12.99333	15.40449	14.02193	14.80865	13.96782	0	0	0	15.53142	0	0	0	16.49235	0	0	0	14.81892	0	0	0	0	15.68666	0	0	0	14.64778	15.16737	0	0	0	0	16.7568	0	0	0	0	16.13678	0	0	0	0
Q92833	JARD2_HUMAN	Protein Jumonji (Jumonji/ARID domain-containing protein 2)	JARID2 JMJ	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; dosage compensation by inactivation of X chromosome [GO:0009048]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; protein localization to pericentric heterochromatin [GO:1902682]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538]"	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; ubiquitin binding [GO:0043130]; ubiquitin modification-dependent histone binding [GO:0061649]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; dosage compensation by inactivation of X chromosome [GO:0009048]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; protein localization to pericentric heterochromatin [GO:1902682]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; ubiquitin binding [GO:0043130]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0000122; GO:0001889; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005739; GO:0006338; GO:0007417; GO:0009048; GO:0010614; GO:0031061; GO:0032452; GO:0035097; GO:0035098; GO:0043130; GO:0045892; GO:0048536; GO:0048538; GO:0048863; GO:0051574; GO:0060044; GO:0061649; GO:1902682; GO:1990830	LADMLR	3.180000067	0.642022789	0.642022789	0.064868742	718.6092401	15.46676	0	15.49638	15.40256	14.71394	15.45103	16.165	0	0	13.75195	14.12426	14.87615	13.32262	13.36095	14.91075	0	15.75977	0	15.35446	17.39327	14.18062	0	16.21638	14.65203	16.54412	15.85339	0	17.18319	0	14.24357	17.46014	0	16.31558	14.56445	14.02034	14.71361	17.44398	16.94252	17.7709	0	16.71299	16.00934	0	15.54211	0	0	13.95923	15.50812
Q92834	RPGR_HUMAN	X-linked retinitis pigmentosa GTPase regulator	RPGR RP3 XLRP3	Homo sapiens (Human)	cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0001750; GO:0003723; GO:0005085; GO:0005794; GO:0005813; GO:0006886; GO:0007601; GO:0036064; GO:0036126; GO:0042073; GO:0050896; GO:0060271	SLKLSPVQK	9.670000076	0.387821317	0.387821317	0.163183472	1002.503652	0	0	0	15.85341	0	0	15.8842	15.39913	16.70068	16.01599	17.88916	0	0	0	0	16.60941	0	0	0	0	19.0602	0	0	0	18.38533	0	15.85945	15.42013	14.96703	15.46566	0	0	0	0	0	0	0	0	0	14.91692	0	0	0	0	0	0	0	0
Q92835	SHIP1_HUMAN	"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1, EC 3.1.3.86 (Inositol polyphosphate-5-phosphatase D, EC 3.1.3.56) (Inositol polyphosphate-5-phosphatase of 145 kDa, SIP-145) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (SH2 domain-containing inositol 5'-phosphatase 1, SH2 domain-containing inositol phosphatase 1, SHIP-1) (p150Ship, hp51CN)"	INPP5D SHIP SHIP1	Homo sapiens (Human)	apoptotic process [GO:0006915]; determination of adult lifespan [GO:0008340]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of bone resorption [GO:0045779]; negative regulation of immune response [GO:0050777]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of signal transduction [GO:0009968]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	"cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; determination of adult lifespan [GO:0008340]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of bone resorption [GO:0045779]; negative regulation of immune response [GO:0050777]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of signal transduction [GO:0009968]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]"	"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]"	GO:0004439; GO:0004445; GO:0005829; GO:0005856; GO:0005886; GO:0006661; GO:0006796; GO:0006915; GO:0007165; GO:0008340; GO:0009968; GO:0016064; GO:0016314; GO:0017124; GO:0030889; GO:0032715; GO:0034485; GO:0035556; GO:0043065; GO:0045121; GO:0045579; GO:0045648; GO:0045656; GO:0045659; GO:0045671; GO:0045779; GO:0046856; GO:0050777; GO:0050852; GO:0052658; GO:0052659	TGKDGSFLVR	6.5	1	1	1.37E-12	1080.360078	12.03673	13.85405	15.7667	0	0	14.10276	0	13.26441	13.92396	12.88991	13.16303	12.02445	11.07162	12.38742	13.54969	13.03255	6.986639	13.82037	0	14.24954	10.8784	15.29103	0	0	13.59996	0	0	13.61539	15.25634	13.32688	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92844	TANK_HUMAN	"TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein, I-TRAF)"	TANK ITRAF TRAF2	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of ubiquitin-specific protease activity [GO:2000158]; proteolysis [GO:0006508]; signal transduction [GO:0007165]; type I interferon signaling pathway [GO:0060337]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554]	cytosol [GO:0005829]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554]; deubiquitinase activator activity [GO:0035800]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of ubiquitin-specific protease activity [GO:2000158]; proteolysis [GO:0006508]; signal transduction [GO:0007165]; type I interferon signaling pathway [GO:0060337]	deubiquitinase activator activity [GO:0035800]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]	GO:0005829; GO:0006508; GO:0006974; GO:0007165; GO:0007249; GO:0031625; GO:0032991; GO:0035800; GO:0043124; GO:0046872; GO:0051607; GO:0060337; GO:0071347; GO:0071356; GO:0071479; GO:1902554; GO:1903003; GO:2000158	DKNIGEQLNK	8.529999733	0.773422837	0.773422837	0.062024183	1157.991897	0	19.04686	0	0	0	0	18.41027	0	19.02962	0	19.35223	0	18.04968	15.55146	0	16.47001	0	0	0	16.26499	0	0	16.87254	15.47682	0	0	17.75403	0	19.39958	17.9532	0	17.84549	18.84041	0	16.93565	17.75973	16.89722	15.90193	15.36651	15.71538	0	0	0	17.90126	17.0551	0	19.62545	18.98714
Q92845	KIFA3_HUMAN	"Kinesin-associated protein 3, KAP-3, KAP3 (Smg GDS-associated protein)"	KIFAP3 KIF3AP SMAP	Homo sapiens (Human)	cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165]	intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]	GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0007017; GO:0007018; GO:0007165; GO:0008104; GO:0008285; GO:0015630; GO:0016939; GO:0019894; GO:0019903; GO:0032391; GO:0035869; GO:0036064; GO:0043066; GO:0044782; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:0120170; GO:1990075	NKNIVHMLVK	9.159999847	1	1	1.120003611	1212.051992	0	0	0	0	0	0	0	0	0	0	0	18.22383	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.29102	0	0	0	0	0	0	0	0	0	0
Q92847	GHSR_HUMAN	"Growth hormone secretagogue receptor type 1, GHS-R (GH-releasing peptide receptor, GHRP) (Ghrelin receptor)"	GHSR	Homo sapiens (Human)	actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]	cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; negative regulation of appetite [GO:0032099]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of eating behavior [GO:1904000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of gastric motility [GO:1905333]; regulation of growth hormone secretion [GO:0060123]; regulation of hindgut contraction [GO:0043134]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synapse assembly [GO:0051963]; regulation of transmission of nerve impulse [GO:0051969]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to monosodium glutamate [GO:1904008]; spermatogenesis [GO:0007283]	G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]	GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0007283; GO:0007611; GO:0008154; GO:0008343; GO:0009725; GO:0009755; GO:0009986; GO:0010700; GO:0016520; GO:0017046; GO:0030252; GO:0032094; GO:0032099; GO:0032100; GO:0032354; GO:0032355; GO:0032691; GO:0032715; GO:0032720; GO:0032869; GO:0036321; GO:0040018; GO:0042802; GO:0043005; GO:0043134; GO:0043568; GO:0045121; GO:0045923; GO:0046676; GO:0046697; GO:0050728; GO:0051963; GO:0051969; GO:0060123; GO:0060416; GO:0071222; GO:0071548; GO:0090327; GO:0097067; GO:0098685; GO:0098696; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099699; GO:0120058; GO:1903672; GO:1904000; GO:1904008; GO:1904349; GO:1905333; GO:1905564; GO:1990314; GO:2000110	RGDAVVGASLR	10.02000046	1	1	0.172783493	1100.478331	16.15584	16.48177	0	0	13.67656	13.99884	0	13.15041	8.833724	0	14.78893	16.33678	0	13.21879	0	0	0	0	12.64869	0	0	0	16.9671	0	0	0	0	0	0	0	14.21094	17.2866	16.36134	0	15.55793	16.44725	0	0	14.87359	0	17.25567	11.72331	0	0	0	0	0	0
Q92851	CASPA_HUMAN	"Caspase-10, CASP-10, EC 3.4.22.63 (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2, FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12 ]"	CASP10 MCH4	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]	CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]	CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]	GO:0004197; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0031265; GO:0031625; GO:0035877; GO:0042981; GO:0043123; GO:0097153; GO:0097199; GO:0097200; GO:0097342	TEMTSLSFLAFLEK	5.070000172	0.755443394	0.755443394	0.133858501	1632.737527	17.16123	13.56841	0	14.40263	15.57943	10.77368	17.36182	16.50807	14.44656	19.4342	15.96647	14.59613	16.66891	12.46034	16.93742	16.21227	0	15.08622	15.84572	0	0	18.79776	16.18781	0	16.57632	16.20968	0	11.20415	0	0	15.52663	18.61932	0	0	15.9717	0	0	17.80317	18.22888	0	16.64848	0	17.01206	0	10.86221	16.03927	16.44048	12.74334
Q92859	NEO1_HUMAN	Neogenin (Immunoglobulin superfamily DCC subclass member 2)	NEO1 IGDCC2 NGN	Homo sapiens (Human)	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; iron ion homeostasis [GO:0055072]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]	axonal growth cone [GO:0044295]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]	axonal growth cone [GO:0044295]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; iron ion homeostasis [GO:0055072]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]	co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]	GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0009986; GO:0030513; GO:0038023; GO:0039706; GO:0044295; GO:0055072; GO:0098609; GO:0098797	ADSSDK	7.739999771	1	1	1.37E-12	622.6210947	13.73124	0	14.0407	16.55061	14.55872	14.41809	14.75723	0	15.17361	16.39685	13.4519	14.26529	16.56598	16.82322	16.54088	16.37509	0	15.61762	17.40444	16.59051	0	16.50899	0	13.86353	14.28123	0	15.60837	0	16.21795	15.11152	0	0	0	0	0	0	16.56841	0	0	16.26173	0	16.52274	0	0	0	0	0	0
Q92878	RAD50_HUMAN	"DNA repair protein RAD50, hRAD50, EC 3.6.-.-"	RAD50	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]	"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; membrane [GO:0016020]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]"	"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; membrane [GO:0016020]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]	GO:0000019; GO:0000722; GO:0000723; GO:0000729; GO:0000781; GO:0000794; GO:0003677; GO:0003691; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006302; GO:0006310; GO:0006974; GO:0007004; GO:0007131; GO:0016020; GO:0016887; GO:0030674; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042802; GO:0043047; GO:0044818; GO:0046872; GO:0051880; GO:0070192; GO:0070533; GO:0090305; GO:0098687; GO:0110025; GO:1904354	EMMIVMR	3.24000001	1	1	0.127271294	940.5834007	0	0	0	0	0	13.61888	0	14.13297	14.53813	0	0	14.9197	0	0	0	12.94516	15.70146	14.81594	0	0	0	0	0	0	16.55124	12.21576	15.57549	0	0	0	0	0	16.65758	0	0	15.59618	15.10002	0	15.60114	0	0	15.6988	0	0	0	0	0	0
Q92888	ARHG1_HUMAN	"Rho guanine nucleotide exchange factor 1 (115 kDa guanine nucleotide exchange factor, p115-RhoGEF, p115RhoGEF) (Sub1.5)"	ARHGEF1	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0001664; GO:0003723; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007266; GO:0051056	AVEVHVLLLDDLLLLLQR	13.22000027	1	1	0.0742946	2072.264107	12.92782	13.66751	13.47153	0	0	13.98246	0	0	14.51406	0	0	0	0	0	0	0	14.19441	0	0	0	17.75773	15.98706	0	16.87916	0	0	14.61142	15.3764	15.33347	13.88161	0	15.62902	13.35329	16.03086	15.04745	14.19109	0	0	0	0	0	0	0	0	0	0	0	0
Q92889	XPF_HUMAN	"DNA repair endonuclease XPF, EC 3.1.-.- (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)"	ERCC4 ERCC11 XPF	Homo sapiens (Human)	"cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"	"chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]"	damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990841	MESGQPAR	5.130000114	0.197534427	0.197534427	0.238449675	891.9868917	13.85376	14.28406	15.71058	14.58546	16.13309	0	0	14.70954	14.80603	0	0	0	0	15.28595	0	16.01211	0	15.49793	0	16.44352	0	0	14.89674	15.00635	15.88191	16.56734	14.32143	14.79131	16.29201	14.84801	14.7929	13.87947	15.74883	15.86454	16.96474	16.74141	16.4104	16.16016	15.67165	16.37829	15.56361	0	15.48211	13.96217	16.0446	15.41683	15.36772	14.39273
Q92896	GSLG1_HUMAN	"Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1, ESL-1) (Golgi sialoglycoprotein MG-160)"	GLG1 CFR1 ESL1 MG160	Homo sapiens (Human)	bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330]	cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102]; bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330]	fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102]	GO:0000139; GO:0005102; GO:0005794; GO:0005856; GO:0005886; GO:0010955; GO:0016020; GO:0016021; GO:0017134; GO:0030512; GO:0031012; GO:0032330; GO:0060349; GO:0070062	LNLTTDPK	7.570000172	1	1	0.55984815	902.2160207	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.89938	0	0	0	0
Q92901	RL3L_HUMAN	60S ribosomal protein L3-like (Large ribosomal subunit protein uL3-like)	RPL3L	Homo sapiens (Human)	ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; ribosome [GO:0005840]	cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005840; GO:0006412; GO:0016020; GO:0022625	EVHRPGLK	2.710000038	1	1	0.072888693	935.567742	13.63207	0	13.95078	0	0	0	11.86915	0	0	0	0	0	0	0	0	15.53089	0	15.43665	0	0	13.84382	0	0	0	0	0	0	0	0	0	18.55274	0	0	0	14.1052	0	0	0	0	0	0	0	17.83397	0	0	0	0	0
Q92905	CSN5_HUMAN	"COP9 signalosome complex subunit 5, SGN5, Signalosome subunit 5, EC 3.4.-.- (Jun activation domain-binding protein 1)"	COPS5 CSN5 JAB1	Homo sapiens (Human)	exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; regulation of protein neddylation [GO:2000434]; translation [GO:0006412]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]	COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]; exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; regulation of protein neddylation [GO:2000434]; translation [GO:0006412]	enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]	GO:0000338; GO:0003713; GO:0003743; GO:0004222; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006412; GO:0008021; GO:0008180; GO:0008237; GO:0016579; GO:0019784; GO:0019899; GO:0035718; GO:0043066; GO:0043687; GO:0045116; GO:0045944; GO:0046328; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0070122; GO:0140492; GO:1903894; GO:1990182; GO:2000434	ISALALLKMVMHAR	4.539999962	1	1	0.149300159	1570.300192	0	0	14.02099	0	0	0	0	0	0	0	0	0	0	0	0	10.11773	0	0	13.33048	14.77981	0	15.29528	0	0	0	0	12.80317	0	0	13.85804	15.19804	15.90006	15.90863	0	13.69287	0	0	14.96001	14.9608	14.67806	15.5016	0	0	0	0	0	13.37977	0
Q92913	FGF13_HUMAN	"Fibroblast growth factor 13, FGF-13 (Fibroblast growth factor homologous factor 2, FHF-2)"	FGF13 FHF2	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814]	beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]	GO:0000165; GO:0001764; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006814; GO:0007026; GO:0007165; GO:0007267; GO:0007399; GO:0007612; GO:0007613; GO:0008017; GO:0008083; GO:0014704; GO:0016328; GO:0017080; GO:0021766; GO:0021795; GO:0030175; GO:0030295; GO:0030424; GO:0030425; GO:0030426; GO:0043005; GO:0044325; GO:0045200; GO:0046785; GO:0048487; GO:0048671; GO:0072659; GO:0098909; GO:1904862; GO:1905150	NKPAAHFLPKPLK	9.380000114	1	1	0.239012997	1457.93669	0	0	0	0	0	0	17.45812	0	18.19274	0	15.8914	0	0	0	0	0	0	0	0	0	14.46505	0	0	0	0	23.2248	0	0	0	0	23.91766	0	0	0	18.99002	0	18.01603	0	0	0	17.37215	0	0	0	0	0	0	0
Q92918	M4K1_HUMAN	"Mitogen-activated protein kinase kinase kinase kinase 1, EC 2.7.11.1 (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1, MEK kinase kinase 1, MEKKK 1)"	MAP4K1 HPK1	Homo sapiens (Human)	cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	membrane [GO:0016020]	membrane [GO:0016020]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0007254; GO:0008283; GO:0008349; GO:0016020; GO:0018105; GO:0043410; GO:0046777; GO:0106310; GO:1904628	GLILDLLDK	7.119999886	0.002862959	0.002862959	0.296860963	999.3372414	16.17974	14.47952	0	0	16.19008	0	0	0	0	0	17.59508	0	0	16.26787	16.79788	0	17.86776	17.68688	0	16.15116	0	0	0	0	0	0	17.90898	0	15.22641	0	18.38741	0	17.51836	0	0	17.93241	0	0	17.08535	0	15.65484	0	0	0	16.95774	0	0	0
Q92922	SMRC1_HUMAN	"SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155, BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1)"	SMARCC1 BAF155	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell differentiation [GO:0045596]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]	"brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; animal organ morphogenesis [GO:0009887]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell differentiation [GO:0045596]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]	GO:0000776; GO:0000785; GO:0001741; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0008286; GO:0009887; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032435; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045893; GO:0045944; GO:0047485; GO:0070316; GO:0071564; GO:0071565; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819	ASANAR	1.99000001	0.788591623	0.788591623	0.200950079	587.8795547	17.16597	0	0	13.43384	15.90368	0	0	0	0	0	0	18.2801	18.20651	20.11948	20.95321	0	21.26957	20.24766	16.45297	16.58162	15.59858	0	20.32017	0	0	19.36662	19.04367	16.88364	19.29754	0	0	0	0	0	18.19677	0	18.86598	0	0	17.60279	0	0	0	18.915	0	19.63671	0	20.24311
Q92935	EXTL1_HUMAN	"Exostosin-like 1, EC 2.4.1.224 (Exostosin-L) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostosis-like protein)"	EXTL1 EXTL	Homo sapiens (Human)	protein glycosylation [GO:0006486]; skeletal system development [GO:0001501]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; protein glycosylation [GO:0006486]; skeletal system development [GO:0001501]	acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]	GO:0001501; GO:0005789; GO:0005794; GO:0006486; GO:0008375; GO:0015020; GO:0016021; GO:0016757; GO:0050508	SLWLALSASWLLLVLLGGFSLLR	4.610000134	1	1	4.86E-13	2528.986672	0	0	0	0	0	0	0	0	0	0	18.34076	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q92945	FUBP2_HUMAN	"Far upstream element-binding protein 2, FUSE-binding protein 2 (KH type-splicing regulatory protein, KSRP) (p75)"	KHSRP FUBP2	Homo sapiens (Human)	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]"	DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000375; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006397; GO:0008380; GO:0010468; GO:0010586; GO:0010989; GO:0016020; GO:0035925; GO:0043488; GO:0045019; GO:0051028; GO:0061014; GO:0061158; GO:0071345	AINQQTGAFVEISR	13.17000008	0.071707539	0.071707539	0.332445527	1533.923806	14.37913	14.95051	14.58594	12.49084	0	0	16.08247	15.21341	13.11845	9.764253	15.02687	0	14.55904	0	0	0	17.29485	0	13.75715	14.43311	0	0	0	15.94431	0	0	0	18.64132	0	0	0	0	15.76627	0	0	17.07384	0	0	0	0	0	0	0	0	0	0	0	0
Q92947	GCDH_HUMAN	"Glutaryl-CoA dehydrogenase, mitochondrial, GCD, EC 1.3.8.6"	GCDH	Homo sapiens (Human)	fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660	LMPRILLANR	29.77000046	0.137987137	0.137987137	2.28E-12	1212.631241	0	16.65482	18.80388	0	0	19.62114	0	0	18.97035	0	18.60969	16.19843	17.89705	17.63131	19.35187	0	0	0	0	18.61109	18.98303	17.25475	19.12989	17.98138	0	18.69403	18.39622	0	18.35764	0	0	19.15022	18.71829	19.0745	19.44089	10.90061	0	0	18.99496	0	18.96774	18.59259	0	19.40185	0	0	0	16.49859
Q92953	KCNB2_HUMAN	Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2)	KCNB2	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940]	delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006940; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659	KDSSQEGCK	3.170000076	1	1	0.13040947	1038.675216	0	12.16466	0	0	13.7224	0	0	0	0	14.31472	0	14.58207	14.80976	0	0	0	15.8209	0	0	0	0	0	0	0	0	0	0	0	0	0	16.91578	0	0	14.8973	0	0	15.8343	0	0	0	0	15.92553	0	0	0	17.50114	0	0
Q92954	PRG4_HUMAN	Proteoglycan 4 (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Cleaved into: Proteoglycan 4 C-terminal part ]	PRG4 MSF SZP	Homo sapiens (Human)	immune response [GO:0006955]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955]	polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005615; GO:0006955; GO:0030247; GO:0062023	ALENSPK	16.43000031	1.72E-06	1.72E-06	0.291078036	759.8247987	17.52956	17.54889	0	0	0	0	0	0	18.30655	0	0	0	17.07817	0	0	18.77479	0	0	0	0	0	19.19245	18.08776	18.74247	0	0	19.90419	17.47558	0	18.00594	0	19.08619	18.37949	0	0	0	20.84249	0	20.92208	19.26096	19.45543	0	20.20066	18.17549	0	20.41961	19.81656	17.95396
Q92966	SNPC3_HUMAN	"snRNA-activating protein complex subunit 3, SNAPc subunit 3 (Proximal sequence element-binding transcription factor subunit beta, PSE-binding factor subunit beta, PTF subunit beta) (Small nuclear RNA-activating complex polypeptide 3) (snRNA-activating protein complex 50 kDa subunit, SNAPc 50 kDa subunit)"	SNAPC3 SNAP50	Homo sapiens (Human)	snRNA transcription [GO:0009301]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]; bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; snRNA transcription [GO:0009301]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]	bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]	GO:0000995; GO:0001006; GO:0003677; GO:0003681; GO:0005634; GO:0005654; GO:0005730; GO:0006366; GO:0006383; GO:0009301; GO:0016604; GO:0019185; GO:0042795; GO:0042796	LRGAGDLSLR	3.420000076	1	1	0.166594867	1057.297109	16.24261	11.58941	14.93475	14.04873	12.53896	11.84888	0	0	0	0	13.1361	13.07023	0	15.71156	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.54184	0	0	0	0	0	0	0	0	0	0
Q92973	TNPO1_HUMAN	"Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein, MIP)"	TNPO1 KPNB2 MIP1 TRN	Homo sapiens (Human)	protein import into nucleus [GO:0006606]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006606; GO:0008139; GO:0031267; GO:0061608; GO:0070062	MDRLLPHMHNIVEYMLQR	6.869999886	0.960776329	0.960776329	0.079572731	2328.563097	0	14.68334	15.15625	15.1457	15.25434	0	11.53588	0	14.68979	14.01561	13.92587	13.30707	14.67579	11.33427	0	0	0	13.4447	12.08304	15.03695	15.44812	0	11.56043	0	13.33908	11.77973	15.06781	12.28839	0	0	0	0	0	0	0	0	0	12.08014	0	16.22417	11.94866	0	14.88117	13.33814	0	0	13.52052	15.12337
Q92974	ARHG2_HUMAN	"Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1, GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40)"	ARHGEF2 KIAA0651 LFP40	Homo sapiens (Human)	actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell cycle [GO:0007049]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell cycle [GO:0007049]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	GO:0000902; GO:0005085; GO:0005737; GO:0005794; GO:0005819; GO:0005829; GO:0005856; GO:0005874; GO:0005923; GO:0005925; GO:0006886; GO:0007015; GO:0007026; GO:0007049; GO:0008017; GO:0008270; GO:0031267; GO:0031410; GO:0031982; GO:0032587; GO:0032755; GO:0032760; GO:0032991; GO:0035023; GO:0042127; GO:0045087; GO:0045666; GO:0045944; GO:0050731; GO:0051056; GO:0051092; GO:0055059; GO:0060546; GO:0071225; GO:0071356; GO:0071474; GO:1902042; GO:1902219; GO:2001224	ARIDR	4.860000134	1	1	0.270727666	630.5781632	18.46749	17.09835	0	0	0	0	17.19062	0	17.82137	0	0	0	0	17.90952	17.46798	18.17671	0	17.92412	0	0	0	16.14319	18.62663	0	0	0	17.28164	16.86283	0	0	0	18.13625	19.25588	18.76312	15.92992	16.92277	18.61053	0	0	0	17.16365	16.81559	0	0	0	18.00839	0	16.72255
Q92997	DVL3_HUMAN	"Segment polarity protein dishevelled homolog DVL-3, Dishevelled-3 (DSH homolog 3)"	DVL3 KIAA0208	Homo sapiens (Human)	"canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein localization [GO:0032880]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	chromatin [GO:0000785]; cytosol [GO:0005829]	"chromatin [GO:0000785]; cytosol [GO:0005829]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein localization [GO:0032880]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]	GO:0000785; GO:0001934; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0031267; GO:0032880; GO:0035556; GO:0035567; GO:0038031; GO:0043507; GO:0043547; GO:0045893; GO:0045944; GO:0050821; GO:0060070; GO:0060071; GO:0090179; GO:0150012	QSFRMAMGNPSEFFVDVM	3.559999943	1	1	0.165488193	2125.226809	14.16112	14.43857	11.49131	14.03221	13.96172	0	14.89466	0	14.31659	15.44288	0	13.68819	15.35027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q93008	USP9X_HUMAN	"Probable ubiquitin carboxyl-terminal hydrolase FAF-X, EC 3.4.19.12 (Deubiquitinating enzyme FAF-X) (Fat facets in mammals, hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)"	USP9X DFFRX FAM USP9	Homo sapiens (Human)	amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent deubiquitinase [GO:0004843]; amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]	co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent deubiquitinase [GO:0004843]	GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0032092; GO:0032435; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0061578; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:1901537; GO:1904515; GO:1990000; GO:1990380	ASYDTLCVLDGDK	4.320000172	1	1	0.376978101	1455.122425	15.44039	12.32205	0	0	0	0	0	0	12.26572	15.5446	0	15.37969	0	0	0	16.65981	0	0	0	0	16.53618	0	16.4389	0	16.67113	0	16.94785	16.42719	15.09582	14.91509	16.62373	0	15.9904	0	15.99875	14.99246	16.90117	17.27621	0	17.00327	0	15.81749	16.10294	16.97364	15.99967	16.79323	17.25522	17.73969
Q93009	UBP7_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 7, EC 3.4.19.12 (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7)"	USP7 HAUSP	Homo sapiens (Human)	"histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gluconeogenesis [GO:0006111]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]"	chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]	"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gluconeogenesis [GO:0006111]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent deubiquitinase [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]	GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006111; GO:0006283; GO:0006511; GO:0008022; GO:0010216; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031625; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0035616; GO:0042752; GO:0048511; GO:0050821; GO:0051090; GO:0070536; GO:0101005; GO:1901537; GO:1901796; GO:1904353; GO:1905279; GO:1990380	FYPDRPHQK	4.820000172	1	1	0	1188.237813	14.55029	0	13.43089	0	14.1605	16.38371	12.54418	14.04935	9.345576	0	12.27568	16.08752	0	15.26242	14.23354	15.32705	0	0	0	14.63705	0	0	0	0	0	0	0	0	0	0	0	12.68365	0	0	0	0	0	13.78478	0	0	0	17.04176	0	0	15.71444	0	0	0
Q93015	NAA80_HUMAN	"N-alpha-acetyltransferase 80, HsNAAA80, EC 2.3.1.- (N-acetyltransferase 6) (Protein fusion-2, Protein fus-2)"	NAA80 FUS2 NAT6	Homo sapiens (Human)	actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064]	acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]	GO:0004596; GO:0005737; GO:0005829; GO:0006473; GO:0008064; GO:0008080; GO:0017190; GO:0018002; GO:0030047; GO:1905502	APNLTAQAAPRGPK	10.82999992	1	1	0.237904384	1391.306677	15.90844	13.88638	15.74524	0	15.61005	15.80559	0	13.18751	0	12.81925	16.40792	16.33648	14.59531	13.76185	15.53876	0	12.94767	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.91063	0	0	16.2526	0	0	0	0	0	16.14851	16.21603	0	0	0	0	0	0
Q93033	IGSF2_HUMAN	"Immunoglobulin superfamily member 2, IgSF2 (Cell surface glycoprotein V7) (Glu-Trp-Ile EWI motif-containing protein 101, EWI-101) (CD antigen CD101)"	CD101 EWI101 IGSF2 V7	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; cell surface receptor signaling pathway [GO:0007166]"	"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]"	GO:0005886; GO:0007166; GO:0016021; GO:0016812; GO:0070062	QQVVWEGETLAFLCK	24.84000015	1	1	1.15E-12	1808.301247	16.37502	0	15.47311	0	0	0	0	15.8124	0	0	0	0	0	0	0	0	0	15.83395	0	0	0	0	0	15.15054	0	0	0	0	0	0	16.18484	0	0	0	15.21121	16.45362	16.80833	0	0	0	0	0	0	0	0	0	0	14.84528
Q93034	CUL5_HUMAN	"Cullin-5, CUL-5 (Vasopressin-activated calcium-mobilizing receptor 1, VACM-1)"	CUL5 VACM1	Homo sapiens (Human)	ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734]; calcium channel activity [GO:0005262]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	calcium channel activity [GO:0005262]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0004842; GO:0005262; GO:0005829; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031466; GO:0031625; GO:0038023; GO:0038128; GO:0090734; GO:0097193	RNETEK	3.049999952	1	1	0.137351001	775.7927865	0	13.84666	15.89455	0	13.93705	15.34554	14.46982	0	15.69377	0	14.16283	0	13.36102	14.30252	0	13.90616	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.22413	0	15.8643	0	0	0	0
Q93052	LPP_HUMAN	Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma)	LPP	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]	metal ion binding [GO:0046872]	GO:0001725; GO:0005634; GO:0005829; GO:0005886; GO:0005925; GO:0046872; GO:0098609	RMVIPNQPPLTATK	7.940000057	1	1	0.158650718	1581.734905	16.14665	0	0	14.96042	15.34319	0	0	16.44113	0	0	0	14.50075	16.95008	0	13.69368	16.85483	17.73143	16.82168	14.14925	13.67662	0	0	18.17165	12.76305	12.62465	17.59661	15.81449	0	0	17.02485	15.55294	16.59625	15.43449	0	0	0	0	0	0	0	15.76956	17.33673	15.82524	12.43884	15.13546	15.98309	0	11.64762
Q93063	EXT2_HUMAN	"Exostosin-2, EC 2.4.1.224, EC 2.4.1.225 (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2) (Putative tumor suppressor protein EXT2)"	EXT2	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; cell differentiation [GO:0030154]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311]"	glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]	GO:0000139; GO:0001503; GO:0001707; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006487; GO:0007165; GO:0008217; GO:0010467; GO:0015012; GO:0015014; GO:0015020; GO:0016020; GO:0016021; GO:0016757; GO:0030154; GO:0030210; GO:0033692; GO:0042044; GO:0042311; GO:0042328; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0051923; GO:0055078; GO:0060047; GO:0060350; GO:0070062	MCASVKYNIR	8.779999733	0.880464256	0.880464256	2.28E-12	1256.567157	16.82959	0	12.8481	0	9.411029	15.90951	0	0	0	14.75005	0	13.24315	0	0	15.80794	11.78236	0	16.86661	15.63397	16.00409	0	15.91348	0	16.04589	0	0	0	0	16.44098	15.6478	0	14.62411	14.79475	0	13.1262	0	0	13.6104	11.96572	0	16.23073	15.98766	18.01974	0	0	10.42628	14.43002	15.54126
Q93073	SBP2L_HUMAN	"Selenocysteine insertion sequence-binding protein 2-like, SECIS-binding protein 2-like"	SECISBP2L KIAA0256	Homo sapiens (Human)	selenocysteine incorporation [GO:0001514]	ribonucleoprotein complex [GO:1990904]	ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514]	mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]	GO:0001514; GO:0003723; GO:0003730; GO:0035368; GO:0043021; GO:1990904	LVMGLR	6.230000019	0.810303509	0.810303509	0.206438074	689.4015173	0	14.38117	13.31207	0	13.26299	14.47125	15.18811	15.38274	14.57262	14.61849	16.78986	0	16.15325	16.32816	15.3386	15.19365	16.56287	14.85581	16.1979	16.38603	16.53041	0	15.84464	16.28498	16.18464	0	0	0	14.54038	0	0	0	16.69499	14.32181	0	0	15.77121	15.84529	0	15.35178	16.06145	15.23929	15.00325	15.02915	0	0	15.35895	0
Q93074	MED12_HUMAN	"Mediator of RNA polymerase II transcription subunit 12 (Activator-recruited cofactor 240 kDa component, ARC240) (CAG repeat protein 45) (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component, Trap230) (Trinucleotide repeat-containing gene 11 protein)"	MED12 ARC240 CAGH45 HOPA KIAA0192 TNRC11 TRAP230	Homo sapiens (Human)	"axis elongation involved in somitogenesis [GO:0090245]; canonical Wnt signaling pathway [GO:0060070]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; oligodendrocyte development [GO:0014003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord development [GO:0021510]; stem cell population maintenance [GO:0019827]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	"mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]; axis elongation involved in somitogenesis [GO:0090245]; canonical Wnt signaling pathway [GO:0060070]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; oligodendrocyte development [GO:0014003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord development [GO:0021510]; stem cell population maintenance [GO:0019827]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]	GO:0000151; GO:0000978; GO:0001843; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0007492; GO:0007507; GO:0008013; GO:0008022; GO:0014003; GO:0014044; GO:0016020; GO:0016592; GO:0019827; GO:0019904; GO:0021510; GO:0030374; GO:0036342; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0048702; GO:0060070; GO:0060071; GO:0060261; GO:0061630; GO:0090245; GO:1990403	DILKVLNR	3.359999895	0.705258787	0.705258787	0.06672156	968.1666238	0	15.3954	0	0	14.39542	0	0	0	15.24894	16.18763	0	0	0	0	0	0	0	0	0	0	0	0	0	14.20112	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q93075	TATD2_HUMAN	"Putative deoxyribonuclease TATDN2, EC 3.1.21.-"	TATDN2 KIAA0218	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	metal ion binding [GO:0046872]; nuclease activity [GO:0004518]	GO:0004518; GO:0005654; GO:0046872	DQPLSLTLAALR	11.51000023	0.23804535	0.23804535	0.455557327	1298.586903	0	0	13.89928	0	0	0	0	0	0	0	0	0	0	16.3883	0	0	0	0	18.4584	0	16.12307	16.02674	14.42623	16.69045	17.24074	15.27114	15.86793	17.29282	16.81607	16.48334	17.39184	16.57386	17.79537	17.88761	16.34705	17.25494	17.04206	18.63052	17.51543	16.62059	17.48285	0	17.99163	16.75234	18.22972	15.62454	18.34991	18.26566
Q93097	WNT2B_HUMAN	Protein Wnt-2b (Protein Wnt-13)	WNT2B WNT13	Homo sapiens (Human)	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; chondrocyte differentiation [GO:0002062]; cornea development in camera-type eye [GO:0061303]; forebrain regionalization [GO:0021871]; hematopoietic stem cell proliferation [GO:0071425]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; male gonad development [GO:0008584]; mesenchymal-epithelial cell signaling [GO:0060638]; neuron differentiation [GO:0030182]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; chondrocyte differentiation [GO:0002062]; cornea development in camera-type eye [GO:0061303]; forebrain regionalization [GO:0021871]; hematopoietic stem cell proliferation [GO:0071425]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; male gonad development [GO:0008584]; mesenchymal-epithelial cell signaling [GO:0060638]; neuron differentiation [GO:0030182]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	GO:0002062; GO:0002088; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0008584; GO:0009267; GO:0021871; GO:0030182; GO:0043231; GO:0045165; GO:0060070; GO:0060492; GO:0060638; GO:0061072; GO:0061303; GO:0062023; GO:0071425; GO:0090190	AEWLDQT	8.260000229	1	1	0.131669164	860.2591647	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.29712	0	0	0	0	0	0	0	0
Q93099	HGD_HUMAN	"Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)"	HGD HGO	Homo sapiens (Human)	L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]"	"homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0004411; GO:0005829; GO:0006559; GO:0006572; GO:0042802; GO:0046872; GO:0070062	NPAEPN	8.159999847	1	1	0.277596379	641.9409951	0	0	0	0	18.47102	17.7318	19.06816	0	0	0	0	0	0	18.16243	0	0	0	0	0	0	18.33675	19.61547	17.67752	0	0	0	18.45472	0	17.96712	0	0	0	19.38125	0	0	0	0	0	0	0	19.39794	0	0	17.20416	0	18.38865	0	17.35202
Q969D9	TSLP_HUMAN	Thymic stromal lymphopoietin	TSLP	Homo sapiens (Human)	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-C motif) ligand 1 production [GO:0071654]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-7 receptor binding [GO:0005139]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-C motif) ligand 1 production [GO:0071654]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	cytokine activity [GO:0005125]; interleukin-7 receptor binding [GO:0005139]	GO:0001961; GO:0005125; GO:0005139; GO:0005576; GO:0005615; GO:0008284; GO:0032722; GO:0032733; GO:0032736; GO:0032754; GO:0032755; GO:0033005; GO:0042531; GO:0043066; GO:0050729; GO:0050829; GO:0050832; GO:0061844; GO:0071654; GO:0071657; GO:1904894	EMFAMKTK	7.130000114	0.554800928	0.554800928	0.159584699	1002.61152	14.23583	14.48283	16.30966	0	0	15.25142	0	14.13808	0	16.11101	0	13.1622	0	0	0	0	14.98348	11.33662	11.34853	0	0	0	0	0	11.86884	0	16.35855	13.39788	14.75804	14.83549	15.61653	14.95494	16.05464	0	15.63563	14.47852	0	16.90287	15.59011	15.46367	15.17407	14.81849	15.2226	13.8567	14.67416	12.17971	13.19308	14.4509
Q969E1	LEAP2_HUMAN	"Liver-expressed antimicrobial peptide 2, LEAP-2"	LEAP2	Homo sapiens (Human)	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]		GO:0005576; GO:0042742; GO:0050832; GO:0061844	MTPFWRGVSLRPIGASCR	3.529999971	1	1	9.16E-13	2107.0384	13.37233	0	0	11.5582	14.3037	0	14.32893	15.05684	13.41887	0	15.6213	0	12.60066	0	12.84024	10.83144	13.14449	13.16901	16.13827	10.90838	0	0	0	0	0	0	15.72411	0	0	0	0	0	0	0	0	0	0	0	0	15.58541	0	0	0	0	0	0	15.04366	0
Q969F2	NKD2_HUMAN	"Protein naked cuticle homolog 2, Naked-2, hNkd2"	NKD2	Homo sapiens (Human)	exocytosis [GO:0006887]; Golgi vesicle fusion to target membrane [GO:0048210]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein processing [GO:0010954]; protein localization to plasma membrane [GO:0072659]; Wnt signaling pathway [GO:0016055]	basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; myosin heavy chain binding [GO:0032036]; ubiquitin protein ligase binding [GO:0031625]; exocytosis [GO:0006887]; Golgi vesicle fusion to target membrane [GO:0048210]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein processing [GO:0010954]; protein localization to plasma membrane [GO:0072659]; Wnt signaling pathway [GO:0016055]	ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; myosin heavy chain binding [GO:0032036]; ubiquitin protein ligase binding [GO:0031625]	GO:0005509; GO:0005737; GO:0005886; GO:0006887; GO:0010954; GO:0016055; GO:0016323; GO:0016328; GO:0019838; GO:0030178; GO:0031410; GO:0031625; GO:0032036; GO:0032436; GO:0048210; GO:0051117; GO:0070382; GO:0071944; GO:0072659; GO:0090090; GO:1903078	LTVSPEPSSK	16.28000069	1	1	0.137557627	1045.471704	15.49942	15.05814	16.36864	15.62453	14.51343	0	14.37945	12.80057	13.18271	16.06708	14.52153	14.47209	16.00893	15.87346	0	15.91776	0	0	0	0	0	0	0	0	0	0	16.72172	0	0	0	0	0	15.16308	0	0	14.31858	17.61944	13.98779	15.49131	0	15.44321	15.42936	16.2202	16.42534	16.68222	0	0	0
Q969F9	HPS3_HUMAN	Hermansky-Pudlak syndrome 3 protein	HPS3	Homo sapiens (Human)	intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155]	BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; early endosome [GO:0005769]	BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155]		GO:0005737; GO:0005769; GO:0006996; GO:0031084; GO:0046907; GO:0060155; GO:1903232	AAVALK	2.940000057	1	1	0.274096751	572.9491787	0	0	0	0	0	0	0	0	0	0	0	0	16.87618	0	0	0	0	0	0	0	0	0	17.06077	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969G9	NKD1_HUMAN	"Protein naked cuticle homolog 1, Naked-1, hNkd, hNkd1"	NKD1 NKD PP7246	Homo sapiens (Human)	"eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of convergent extension involved in axis elongation [GO:1901233]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of non-canonical Wnt signaling pathway via JNK cascade [GO:1901231]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; PDZ domain binding [GO:0030165]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of convergent extension involved in axis elongation [GO:1901233]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of non-canonical Wnt signaling pathway via JNK cascade [GO:1901231]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; Wnt signaling pathway [GO:0016055]"	calcium ion binding [GO:0005509]; PDZ domain binding [GO:0030165]	GO:0000159; GO:0001754; GO:0005509; GO:0005737; GO:0005886; GO:0007525; GO:0016055; GO:0030165; GO:0030178; GO:0045732; GO:0090090; GO:0090249; GO:1901231; GO:1901233; GO:2000096	TDGLGSGDEK	6.940000057	1	1	0.087633819	979.5343869	9.641736	0	0	0	0	0	0	0	15.41709	0	0	0	0	0	0	14.30253	14.75247	0	14.24832	0	0	0	15.46487	15.80492	0	0	0	0	13.98623	0	0	0	15.61108	13.18998	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969K7	TMM54_HUMAN	Transmembrane protein 54 (Beta-casein-like protein) (Protein CAC-1)	TMEM54 BCLP CAC1	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	LGGLSVGDFR	17.57999992	1	1	0.147011395	1015.234322	0	10.69738	13.64149	14.7349	0	14.71429	14.71353	0	13.91286	0	13.79368	0	11.41986	0	15.58699	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969L4	LSM10_HUMAN	U7 snRNA-associated Sm-like protein LSm10	LSM10	Homo sapiens (Human)	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380]	Cajal body [GO:0015030]; cytoplasmic U snRNP body [GO:0071254]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683]	Cajal body [GO:0015030]; cytoplasmic U snRNP body [GO:0071254]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683]; histone pre-mRNA DCP binding [GO:0071208]; U7 snRNA binding [GO:0071209]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380]	histone pre-mRNA DCP binding [GO:0071208]; U7 snRNA binding [GO:0071209]	GO:0005654; GO:0005683; GO:0006398; GO:0008380; GO:0015030; GO:0016604; GO:0071208; GO:0071209; GO:0071254; GO:1900087	NFGGKGQGR	5.159999847	1	1	0.058858441	919.454185	14.48189	0	15.3666	0	13.85671	0	14.53354	13.62613	16.07614	15.85095	0	13.87645	0	15.0786	13.78887	12.31722	13.30106	0	0	14.12751	0	14.91447	15.14431	0	0	0	0	0	0	0	0	15.85955	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969M1	TM40L_HUMAN	Mitochondrial import receptor subunit TOM40B (Protein TOMM40-like)	TOMM40L TOMM40B	Homo sapiens (Human)	ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]	mitochondrial outer membrane translocase complex [GO:0005742]; pore complex [GO:0046930]; protein-containing complex [GO:0032991]	mitochondrial outer membrane translocase complex [GO:0005742]; pore complex [GO:0046930]; protein-containing complex [GO:0032991]; mitochondrion targeting sequence binding [GO:0030943]; porin activity [GO:0015288]; preprotein binding [GO:0070678]; protein transmembrane transporter activity [GO:0008320]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]	mitochondrion targeting sequence binding [GO:0030943]; porin activity [GO:0015288]; preprotein binding [GO:0070678]; protein transmembrane transporter activity [GO:0008320]	GO:0005742; GO:0006811; GO:0008320; GO:0015288; GO:0030150; GO:0030943; GO:0032991; GO:0046930; GO:0070678	GNTLGLAPMGTLPR	5.110000134	1	1	0.287275094	1413.192653	14.57416	12.80338	13.32261	15.24578	14.52179	14.73765	0	0	0	15.61877	0	0	0	14.34051	13.02439	13.53177	15.55901	0	14.81883	0	0	0	0	14.92761	0	13.44247	0	0	0	0	0	0	0	0	0	0	0	0	16.96591	15.69456	15.3334	13.77741	0	0	15.83672	0	0	0
Q969M2	CXA10_HUMAN	"Gap junction alpha-10 protein (Connexin-62, Cx62)"	GJA10 CX62	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; detection of light stimulus involved in visual perception [GO:0050908]; gamete generation [GO:0007276]; synapse assembly [GO:0007416]	connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; detection of light stimulus involved in visual perception [GO:0050908]; gamete generation [GO:0007276]; synapse assembly [GO:0007416]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005886; GO:0005922; GO:0007267; GO:0007276; GO:0007416; GO:0016021; GO:0050908	SKTMWQIPQPR	13.78999996	1	1	0	1388.432551	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969N2	PIGT_HUMAN	GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein)	PIGT CGI-06 PSEC0163 UNQ716/PRO1379	Homo sapiens (Human)	attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]		GO:0005789; GO:0016020; GO:0016255; GO:0030176; GO:0030182; GO:0031410; GO:0042765; GO:0051402	AGLSVLLKADR	8.420000076	0.2479617	0.2479617	0.519551231	1139.251914	0	0	18.22997	0	0	0	0	0	17.42146	0	18.17111	18.78292	14.37199	0	0	0	0	0	0	0	0	0	0	19.45516	0	0	0	18.01183	0	0	20.58559	0	0	0	0	0	0	0	19.80231	17.24622	0	0	0	16.24536	18.99016	0	19.21294	0
Q969P0	IGSF8_HUMAN	"Immunoglobulin superfamily member 8, IgSF8 (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2, EWI-2) (Keratinocytes-associated transmembrane protein 4, KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein, PGRL) (CD antigen CD316)"	IGSF8 CD81P3 EWI2 KCT4	Homo sapiens (Human)	cell motility [GO:0048870]; nervous system development [GO:0007399]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell motility [GO:0048870]; nervous system development [GO:0007399]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]		GO:0005886; GO:0007338; GO:0007399; GO:0007519; GO:0016020; GO:0016021; GO:0043231; GO:0048870; GO:0070062	GRQAPTSPPR	3.400000095	1	1	0.025389155	1067.542909	14.86112	14.8109	0	13.0332	12.61164	16.90412	13.14403	10.99159	0	0	13.97145	0	16.0365	13.44742	12.53306	0	0	0	13.99048	14.56063	12.62377	11.94971	0	0	13.77818	0	0	13.68018	17.07149	15.05764	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969P5	FBX32_HUMAN	"F-box only protein 32 (Atrogin-1) (Muscle atrophy F-box protein, MAFbx)"	FBXO32	Homo sapiens (Human)	cellular response to dexamethasone stimulus [GO:0071549]; protein ubiquitination [GO:0016567]; response to denervation involved in regulation of muscle adaptation [GO:0014894]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018]; cellular response to dexamethasone stimulus [GO:0071549]; protein ubiquitination [GO:0016567]; response to denervation involved in regulation of muscle adaptation [GO:0014894]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0014894; GO:0016567; GO:0019005; GO:0030018; GO:0071549	DMLNSKTK	7.960000038	0.528506577	0.528506577	0.274500383	952.7410629	14.28934	15.02483	10.20539	14.05484	15.77398	0	16.61847	16.09826	16.27953	0	16.12787	16.05868	16.00567	11.72507	0	0	16.95495	15.34611	16.23061	12.84366	14.50528	13.28535	16.34157	16.71576	15.34272	15.35986	15.17257	0	15.36814	13.42526	0	0	14.8942	0	0	0	16.01037	16.04294	0	0	14.44803	16.03675	0	14.04655	14.75885	0	14.20014	0
Q969P6	TOP1M_HUMAN	"DNA topoisomerase I, mitochondrial, TOP1mt, EC 5.6.2.1"	TOP1MT	Homo sapiens (Human)	DNA replication [GO:0006260]; DNA topological change [GO:0006265]	chromosome [GO:0005694]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"chromosome [GO:0005694]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]"	"DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]"	GO:0003677; GO:0003917; GO:0005654; GO:0005694; GO:0005739; GO:0006260; GO:0006265; GO:0042645	EQVAEARAELR	9.109999657	1	1	0.399366284	1271.61237	18.54137	20.10151	0	17.2115	0	19.45351	0	0	19.61919	21.15152	18.78039	0	0	0	0	0	0	19.50782	0	0	0	0	0	0	0	0	0	0	0	17.03929	0	0	20.30001	0	0	19.81306	0	21.23689	0	0	0	0	0	0	19.64143	17.96291	0	19.92907
Q969Q6	P2R3C_HUMAN	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C)	PPP2R3C C14orf10 G5PR	Homo sapiens (Human)	activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]	metal ion binding [GO:0046872]	GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0030865; GO:0032147; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900	NTNEFYK	10.18000031	1	1	0.48902247	917.0701898	12.07152	14.41262	11.90234	0	0	0	0	0	17.15605	0	0	0	0	20.81236	0	0	0	0	0	0	19.43362	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969R5	LMBL2_HUMAN	"Lethal(3)malignant brain tumor-like protein 2, H-l(3)mbt-like protein 2, L(3)mbt-like protein 2"	L3MBTL2	Homo sapiens (Human)	"chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]	GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0008270; GO:0035064; GO:0042393; GO:0045892	AKEATK	1.029999971	0.329477757	0.329477757	0.286985795	647.7136351	15.27797	16.18765	15.91201	17.21143	12.18674	0	18.786	0	19.05697	0	0	0	0	16.72617	18.44452	0	0	17.51586	0	0	16.54622	18.15252	18.1399	0	0	0	18.34194	19.29426	0	18.52847	19.36172	19.76764	0	18.36926	0	18.9761	0	0	20.16343	0	16.97468	18.44439	0	0	0	16.88342	17.07103	18.47767
Q969S3	ZN622_HUMAN	Zinc finger protein 622 (Zinc finger-like protein 9)	ZNF622 ZPR9	Homo sapiens (Human)	intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]"	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0008270; GO:0008631; GO:0030687; GO:0033674; GO:0042273; GO:0043065; GO:0043410; GO:0046330	ALGWTGSTGAALMR	7.050000191	1	1	2.52E-12	1391.835188	0	0	14.87471	15.10752	0	0	15.14163	14.44775	15.04992	15.37786	14.49445	0	0	0	0	13.43193	14.63399	0	0	0	15.32625	0	0	0	0	0	0	15.59617	0	0	14.88259	13.53303	0	0	0	0	0	0	0	14.37341	0	0	12.5369	0	0	0	0	0
Q969S8	HDA10_HUMAN	"Polyamine deacetylase HDAC10, EC 3.5.1.48, EC 3.5.1.62 (Histone deacetylase 10, HD10)"	HDAC10	Homo sapiens (Human)	"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]"	acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006325; GO:0006355; GO:0006476; GO:0008270; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048	QRGLEQR	4.849999905	0.890584588	0.890584588	0.178548543	884.2599443	13.67157	15.17416	11.13127	13.28307	0	0	0	0	12.77411	0	0	0	16.68126	15.90018	16.31915	0	15.78955	15.70932	0	16.66097	0	15.00266	0	0	16.22016	15.07164	0	15.77538	0	13.07534	15.08966	14.7381	15.63152	14.21114	14.19891	14.44051	0	13.76263	15.18427	11.79764	14.5967	0	15.69216	12.80233	15.64854	17.17498	13.41109	14.80624
Q969V4	TEKT1_HUMAN	Tektin-1	TEKT1	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]		GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0031514; GO:0060271; GO:0060294	VMEEIASQEK	5.320000172	0.063481443	0.063481443	0.010475892	1178.880834	11.70101	0	0	17.14472	13.68981	13.42362	0	0	0	0	12.3946	0	14.89009	0	14.39884	0	11.85099	13.16401	0	0	0	17.71401	15.29676	0	15.87907	13.6672	16.44722	0	13.26359	0	0	17.69137	15.50334	15.33673	0	0	0	0	0	0	15.06559	0	0	0	15.19628	13.55869	15.35557	10.35659
Q969V6	MRTFA_HUMAN	"Myocardin-related transcription factor A, MRTF-A (MKL/myocardin-like protein 1) (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein)"	MRTFA KIAA1438 MAL MKL1	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription via serum response element binding [GO:0010735]; smooth muscle cell differentiation [GO:0051145]; wound healing, spreading of cells [GO:0044319]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription via serum response element binding [GO:0010735]; smooth muscle cell differentiation [GO:0051145]; wound healing, spreading of cells [GO:0044319]"	actin binding [GO:0003779]; actin monomer binding [GO:0003785]; leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0003779; GO:0003785; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010735; GO:0030036; GO:0043522; GO:0044319; GO:0045944; GO:0051145; GO:1902895	SAGEALGSSGTPPVR	8.960000038	1	1	0.098576633	1386.230968	0	0	14.95657	0	0	13.93078	0	0	4.261875	0	0	0	12.44202	0	0	12.52695	10.97653	0	0	0	0	0	0	14.42966	0	0	0	0	0	13.24275	13.04829	0	0	0	0	0	0	0	0	0	9.299935	11.62114	15.04278	0	15.36715	0	0	0
Q969W3	F104A_HUMAN	Protein FAM104A	FAM104A	Homo sapiens (Human)						ARGGGR	8.619999886	0.424759597	0.424759597	0.276825742	573.5977758	0	16.47015	15.95188	16.8274	0	13.13451	15.41889	15.47455	0	14.1755	16.38424	16.32968	0	0	15.66103	16.08106	0	0	0	0	0	16.48474	0	0	15.5088	0	0	14.7817	0	0	0	16.955	14.8731	0	15.54935	16.13615	15.82951	0	16.64058	0	0	0	0	16.62888	0	0	0	0
Q969X0	RIPL2_HUMAN	RILP-like protein 2 (Rab-interacting lysosomal protein-like 2) (p40phox-binding protein)	RILPL2 RLP2	Homo sapiens (Human)	cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]	identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]	GO:0003382; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0016020; GO:0036064; GO:0042802; GO:0046983; GO:0060271; GO:1903445	MERDHLR	6.059999943	1	1	0.190513999	956.1167505	0	15.36037	14.48325	16.43715	13.94319	15.59675	0	0	15.38606	0	15.99378	0	0	0	0	0	0	13.55408	14.03366	15.34735	0	0	16.25755	13.73963	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.27372	0	0	0	14.79367	0	0	0	0
Q969X2	SIA7F_HUMAN	"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, EC 2.4.99.- (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI, ST6GalNAcVI, hST6GalNAc VI) (Sialyltransferase 7F, SIAT7-F)"	ST6GALNAC6 SIAT7F UNQ708/PRO1359	Homo sapiens (Human)	cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]"	"alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]"	GO:0000139; GO:0001574; GO:0001665; GO:0005737; GO:0005886; GO:0006486; GO:0006677; GO:0006687; GO:0008373; GO:0009100; GO:0009311; GO:0009312; GO:0009988; GO:0016021	HLPLSR	2.809999943	1	1	0.091788003	722.5895426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.09752	0	0	0	0	0	16.92488	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969Z0	FAKD4_HUMAN	"FAST kinase domain-containing protein 4 (Cell cycle progression restoration protein 2, Cell cycle progression protein 2) (Protein TBRG4) (Transforming growth factor beta regulator 4)"	TBRG4 CPR2 FASTKD4 KIAA0948	Homo sapiens (Human)	mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial mRNA stability [GO:0044528]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial mRNA stability [GO:0044528]	RNA binding [GO:0003723]	GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0008284; GO:0016071; GO:0035770; GO:0044528; GO:0051726; GO:0090615	LLGSLYALGIPK	3.390000105	1	1	0.177476715	1243.709505	13.94144	0	7.691537	13.27129	13.96747	0	0	0	0	18.23077	14.57209	13.78867	0	6.43672	0	0	15.15005	0	12.31772	14.26388	0	14.07183	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q969Z3	MARC2_HUMAN	"Mitochondrial amidoxime reducing component 2, mARC2, EC 1.7.-.- (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2, MOSC domain-containing protein 2, Moco sulfurase C-terminal domain-containing protein 2)"	MTARC2 MARC2 MOSC2	Homo sapiens (Human)	cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	"mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]; cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]"	"molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]"	GO:0005739; GO:0005741; GO:0005777; GO:0006809; GO:0008940; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809	VGDPVYRMV	6.78000021	1	1	0.240281993	1051.175318	0	16.79167	0	0	15.41158	13.57157	0	0	15.52606	0	11.56882	13.82117	0	0	0	0	0	0	0	0	0	0	0	16.40951	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.17649	0	0	0	0	0	0	0	0	0
Q96A05	VATE2_HUMAN	"V-type proton ATPase subunit E 2, V-ATPase subunit E 2 (Vacuolar proton pump subunit E 2)"	ATP6V1E2 ATP6E1 ATP6EL2 ATP6V1EL2	Homo sapiens (Human)	regulation of macroautophagy [GO:0016241]	"acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]"	"acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]"	"proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0001669; GO:0005829; GO:0016241; GO:0033178; GO:0046961	LLEPVMIVR	2.480000019	1	1	0.203796487	1086.07454	12.37603	14.5506	15.57322	0	15.26498	0	0	12.5612	16.01445	0	14.82085	0	0	12.44894	0	14.25894	0	0	13.88695	16.47009	16.12867	0	0	0	0	15.91884	16.38839	0	0	0	0	0	0	15.65476	0	0	0	0	14.71867	0	0	0	15.09568	0	0	0	0	14.83696
Q96A08	H2B1A_HUMAN	"Histone H2B type 1-A (Histone H2B, testis, TSH2B.1, hTSH2B) (Testis-specific histone H2B)"	H2BC1 HIST1H2BA TSH2B	Homo sapiens (Human)	"nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	GO:0000781; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0035093; GO:0046982	MPEVSSKGATISK	5.619999886	1	1	0.033551424	1350.392682	0	0	0	0	0	0	0	15.02603	0	0	15.51599	0	14.95279	0	0	0	0	0	0	0	0	0	0	14.24934	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.22469	15.13327	0	0
Q96A09	TET5B_HUMAN	"Terminal nucleotidyltransferase 5B, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46B)"	TENT5B FAM46B	Homo sapiens (Human)	mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of translation [GO:0045727]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of translation [GO:0045727]	polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]	GO:0004652; GO:0005634; GO:0005737; GO:0008285; GO:0043066; GO:0045727; GO:0045786; GO:0048255; GO:1990817	FVDSVRR	4.170000076	1	1	0.084718471	876.1630033	12.14523	13.93307	15.54062	13.30927	15.11929	12.78711	0	0	14.16914	0	0	0	0	0	0	0	15.44419	0	0	0	0	0	0	0	0	0	0	0	15.44647	15.53763	0	0	14.23561	0	0	15.13622	14.58486	0	0	0	0	0	0	0	0	0	0	0
Q96A11	G3ST3_HUMAN	"Galactose-3-O-sulfotransferase 3, Gal3ST-3, EC 2.8.2.- (Beta-galactose-3-O-sulfotransferase 3, Gal3ST3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)"	GAL3ST3	Homo sapiens (Human)	glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146]	GO:0001733; GO:0005996; GO:0006790; GO:0008146; GO:0009247; GO:0009311; GO:0016021; GO:0030166; GO:0030246; GO:0030309; GO:0032580; GO:0050656; GO:0050694; GO:0050698	LAAIPAALARAAR	9	1	1	0.341346355	1261.559886	13.98625	12.91556	15.7613	13.20586	0	0	0	0	0	15.16813	0	0	0	0	0	0	0	15.78646	16.38371	0	0	0	0	16.82129	15.33647	16.20896	15.89664	0	15.64158	0	17.59546	14.95619	16.25532	16.03947	0	0	17.52194	15.90667	0	0	0	17.16225	0	0	0	0	17.5472	0
Q96A19	C102A_HUMAN	Coiled-coil domain-containing protein 102A	CCDC102A	Homo sapiens (Human)		myosin complex [GO:0016459]	myosin complex [GO:0016459]		GO:0016459	MAELRGEMER	7.960000038	1	1	0.253072045	1237.519335	15.77609	0	14.0877	0	0	0	0	12.15815	14.17974	0	0	14.40114	0	16.16848	0	0	0	0	0	0	0	0	0	17.8805	0	16.86163	0	0	0	15.90657	16.69871	15.19961	0	0	0	16.49036	0	16.91367	0	0	0	0	17.00217	0	0	16.993	17.62994	0
Q96A22	CK052_HUMAN	Uncharacterized protein C11orf52	C11orf52	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]		GO:0070062	YDSKNGTLV	6	1	1	0.04442681	997.553355	0	0	0	15.76539	14.48196	14.92373	0	0	12.37027	0	12.34279	0	13.25792	13.17684	0	0	0	0	0	0	16.02403	0	15.59048	0	14.73481	0	0	14.88741	14.11917	15.33066	0	15.26358	0	0	0	0	0	0	0	0	0	0	0	0	15.42149	0	0	0
Q96A25	T106A_HUMAN	Transmembrane protein 106A	TMEM106A	Homo sapiens (Human)	CD80 biosynthetic process [GO:0035780]; CD86 biosynthetic process [GO:0035781]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of nitric oxide metabolic process [GO:1904407]; positive regulation of tumor necrosis factor production [GO:0032760]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; CD80 biosynthetic process [GO:0035780]; CD86 biosynthetic process [GO:0035781]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of nitric oxide metabolic process [GO:1904407]; positive regulation of tumor necrosis factor production [GO:0032760]		GO:0005886; GO:0016021; GO:0032731; GO:0032755; GO:0032760; GO:0035780; GO:0035781; GO:0042116; GO:0043123; GO:0043410; GO:0045087; GO:0045348; GO:1904407	IPQELEKQLVALIPYGDQR	4.71999979	1	1	0.12472716	2209.169348	0	0	14.71515	15.21455	0	17.28242	15.18663	0	15.25391	16.38299	14.8657	15.66198	17.16199	15.23094	17.50965	0	0	0	0	0	0	0	17.71319	16.40029	16.01056	0	0	0	0	0	0	0	0	18.65369	0	16.96231	18.07997	0	18.21328	0	14.56333	0	0	16.96086	15.13054	0	17.90984	0
Q96A28	SLAF9_HUMAN	"SLAM family member 9 (CD2 family member 10, CD2F-10) (CD84 homolog 1, CD84-H1)"	SLAMF9 CD2F10 UNQ1938/PRO4421	Homo sapiens (Human)	T cell activation [GO:0042110]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; T cell activation [GO:0042110]		GO:0009897; GO:0009986; GO:0016021; GO:0042110	SLATVVPGK	12.17000008	1	1	0.306721326	870.9052658	0	0	16.74056	17.46116	0	0	11.44733	0	0	0	16.33963	17.11569	0	0	0	12.88577	16.64994	16.67364	17.4445	18.74328	0	0	0	16.91485	17.08821	17.45042	0	0	18.05273	0	0	0	0	18.32208	0	15.02251	19.04412	16.34762	0	0	0	0	0	17.56806	16.48711	0	0	0
Q96A29	FUCT1_HUMAN	GDP-fucose transporter 1 (Solute carrier family 35 member C1)	SLC35C1 FUCT1	Homo sapiens (Human)	carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066]	antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]	GO:0000139; GO:0005457; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0030259; GO:0036066; GO:0036085; GO:0045746	NRAPLK	4.679999828	0.134676769	0.134676769	0.257495125	698.1888963	16.33213	0	0	0	0	0	15.73562	12.25165	0	0	0	13.68669	0	0	0	0	0	14.52763	0	0	0	0	16.40145	0	0	14.46901	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96A46	MFRN2_HUMAN	"Mitoferrin-2 (Mitochondrial RNA-splicing protein 3/4 homolog, MRS3/4, hMRS3/4) (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28)"	SLC25A28 MFRN2 NPD016	Homo sapiens (Human)	iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]	iron ion transmembrane transporter activity [GO:0005381]	GO:0005381; GO:0005743; GO:0016021; GO:0048250; GO:0055072	ELEGRGAGGVAGGPAAGPGR	2.75999999	1	1	0.286013463	1735.783594	0	15.59402	14.10838	14.53929	15.29439	15.01052	0	0	11.78866	15.6085	15.77578	0	0	0	11.45944	0	0	0	0	0	17.18421	0	16.75867	17.57627	0	0	15.90613	0	16.75341	0	0	13.02279	0	0	0	0	0	14.95177	15.16985	14.09999	0	0	0	0	0	0	0	0
Q96A47	ISL2_HUMAN	"Insulin gene enhancer protein ISL-2, Islet-2"	ISL2	Homo sapiens (Human)	axonogenesis [GO:0007409]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; peripheral nervous system neuron development [GO:0048935]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord motor neuron cell fate specification [GO:0021520]; visceral motor neuron differentiation [GO:0021524]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]; axonogenesis [GO:0007409]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; peripheral nervous system neuron development [GO:0048935]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord motor neuron cell fate specification [GO:0021520]; visceral motor neuron differentiation [GO:0021524]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000981; GO:0000987; GO:0003677; GO:0005634; GO:0006357; GO:0007409; GO:0021520; GO:0021524; GO:0031290; GO:0045665; GO:0046872; GO:0048665; GO:0048666; GO:0048935; GO:1990837	CAKCQVGFSSSDLVMR	8.960000038	1	1	0.004991723	1844.333685	11.71926	15.07689	14.82205	0	0	15.36182	0	8.710751	0	0	0	0	0	13.81454	0	0	12.38107	14.16417	13.155	13.53509	0	13.66278	13.32217	14.36601	14.16774	16.56715	16.89829	14.85548	14.41087	0	12.88304	16.36971	13.89729	0	10.55528	14.49913	0	13.80215	0	0	14.69304	0	0	0	0	0	0	0
Q96A65	EXOC4_HUMAN	Exocyst complex component 4 (Exocyst complex component Sec8)	EXOC4 KIAA1699 SEC8 SEC8L1	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; paraxial mesoderm formation [GO:0048341]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; synapse [GO:0045202]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; paraxial mesoderm formation [GO:0048341]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]	GO:0000145; GO:0000281; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006887; GO:0006893; GO:0006904; GO:0007268; GO:0015031; GO:0016020; GO:0016241; GO:0030165; GO:0031267; GO:0032584; GO:0035748; GO:0045202; GO:0047485; GO:0048341; GO:0090148; GO:0090522; GO:0090543	LLLELLELLFDK	4.489999771	1	1	0.436866488	1457.810704	14.68487	15.21355	0	0	0	15.26719	0	0	11.40742	0	0	0	0	15.60115	16.78558	0	16.87931	16.008	0	0	16.67233	0	16.58777	16.74306	0	0	0	0	0	0	16.38098	0	0	16.90405	15.63418	0	17.89004	16.66054	0	0	0	0	0	0	0	0	16.89454	0
Q96A83	COQA1_HUMAN	"Collagen alpha-1(XXVI) chain (Alpha-1 type XXVI collagen) (EMI domain-containing protein 2) (Emilin and multimerin domain-containing protein 2, Emu2)"	COL26A1 EMID2 EMU2	Homo sapiens (Human)	positive regulation of cell-substrate adhesion [GO:0010811]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; positive regulation of cell-substrate adhesion [GO:0010811]		GO:0005576; GO:0005581; GO:0005788; GO:0005794; GO:0005886; GO:0010811; GO:0062023	GTVGPSGEPGVK	5.170000076	1	1	0.142323735	1084.361483	14.33684	15.44285	0	0	13.15033	15.11805	14.55781	12.65292	0	0	10.82838	15.2094	0	14.54213	14.73005	0	13.19472	0	0	0	0	0	0	16.14274	0	0	0	0	0	0	0	0	0	0	0	0	0	17.22713	14.83763	15.18545	15.44476	15.94282	15.8052	14.80915	0	0	17.54577	0
Q96A99	PTX4_HUMAN	Pentraxin-4	PTX4 C16orf38	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005576; GO:0046872	ALDLTLGER	7.510000229	0.517896295	0.517896295	0.209459474	987.5938053	15.43669	15.62361	16.20823	15.87577	16.07044	15.1411	17.0275	15.96085	16.32245	0	17.20973	16.67724	0	16.41408	15.04159	16.48944	15.74441	0	15.23917	15.11499	0	0	0	15.39695	17.35988	15.89205	15.96952	16.5815	0	15.27315	15.44483	12.65962	13.2843	14.75905	15.8438	15.64822	0	14.60353	16.02117	0	15.0417	15.93683	16.51241	14.85554	14.86272	13.31705	0	13.65144
Q96AA8	JKIP2_HUMAN	Janus kinase and microtubule-interacting protein 2 (CTCL tumor antigen HD-CL-04) (Neuroendocrine long coiled-coil protein 1)	JAKMIP2 JAMIP2 KIAA0555 NECC1	Homo sapiens (Human)		Golgi apparatus [GO:0005794]	Golgi apparatus [GO:0005794]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]	kinase binding [GO:0019900]; microtubule binding [GO:0008017]	GO:0005794; GO:0008017; GO:0019900	EKITSHPPLK	4.559999943	1	1	0.275458629	1147.113115	12.8105	15.29574	14.03839	0	0	0	0	0	16.06375	0	13.71412	0	0	0	0	12.81097	0	15.07257	13.56353	0	17.37651	0	0	0	0	16.25241	15.37037	0	0	14.69958	0	15.19709	0	16.56248	0	0	15.07372	17.26836	15.37062	14.97314	17.19619	17.32432	0	0	16.85368	16.44321	0	0
Q96AB6	NTAN1_HUMAN	"Protein N-terminal asparagine amidohydrolase, EC 3.5.1.121 (Protein NH2-terminal asparagine amidohydrolase, PNAA) (Protein NH2-terminal asparagine deamidase, PNAD, Protein N-terminal Asn amidase, Protein N-terminal asparagine amidase, Protein NTN-amidase)"	NTAN1	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511]	protein-N-terminal asparagine amidohydrolase activity [GO:0008418]	GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418	EENENHFPVIYGIAVNIK	2.309999943	1	1	0.180073784	2085.428633	0	11.91253	16.23673	0	0	12.23254	11.83374	13.93317	14.53692	13.07886	15.30583	0	0	11.39786	0	0	13.32695	0	11.82102	14.01345	0	15.62326	0	0	0	14.80147	0	0	14.51096	0	0	13.00393	0	15.27313	13.4722	10.79983	0	0	0	13.21681	13.63457	0	0	0	0	0	0	0
Q96AC6	KIFC2_HUMAN	Kinesin-like protein KIFC2	KIFC2	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0072686; GO:0090307	ATAATAMNQR	4.449999809	1	1	0.21951174	1049.771887	0	0	9.54168	0	0	13.29379	0	0	0	13.19433	0	17.52421	0	0	0	0	0	0	16.70074	0	0	16.2864	0	0	0	0	0	0	0	0	14.57604	0	0	0	0	0	14.3054	0	0	0	16.81039	0	0	0	0	15.03864	0	0
Q96AG4	LRC59_HUMAN	"Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34, p34) [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed ]"	LRRC59 PRO1855	Homo sapiens (Human)	positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]	cadherin binding [GO:0045296]; RNA binding [GO:0003723]	GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0007165; GO:0016020; GO:0016021; GO:0042645; GO:0045296; GO:0046579	LDGNELDLSLSDLNEVPVK	3.99000001	1	1	0.225073643	2071.187284	0	14.62044	0	12.93696	0	10.63005	0	0	13.98739	0	0	0	0	0	0	0	0	0	15.46501	0	0	0	0	15.47828	14.31457	12.73042	14.912	0	0	0	0	0	0	0	15.28839	0	13.15204	0	0	13.83661	12.24485	14.19698	0	0	0	0	13.68031	0
Q96AH0	SOSB2_HUMAN	"SOSS complex subunit B2 (Nucleic acid-binding protein 1) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2A) (Sensor of single-strand DNA complex subunit B2) (Sensor of ssDNA subunit B2, SOSS-B2) (Single-stranded DNA-binding protein 2, hSSB2)"	NABP1 OBFC2A SSB2	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212]	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]"	"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0010212; GO:0035861; GO:0044818; GO:0070876	NRVNDPLIFIR	25.28000069	1	1	0.218458675	1356.489096	20.66305	19.78203	0	0	0	0	0	0	20.14062	0	20.01096	19.36683	19.79935	0	0	0	0	0	20.12233	0	19.23111	20.10517	0	19.85901	20.02607	0	0	19.41439	20.15789	21.62799	21.18921	0	20.63888	0	0	20.1687	0	0	0	19.47803	0	0	0	20.55499	21.26851	0	19.97858	18.43129
Q96AJ1	CLUA1_HUMAN	Clusterin-associated protein 1 (Qilin)	CLUAP1 KIAA0643	Homo sapiens (Human)	cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]		GO:0005654; GO:0005813; GO:0005929; GO:0030992; GO:0035720; GO:0043231; GO:0060271; GO:0097542	GMEGSEIVEEDVNK	5.159999847	1	1	0.145035533	1538.395186	0	15.33106	0	0	16.15998	0	0	16.31663	0	15.10057	16.53486	15.9552	16.29109	0	0	0	0	18.05631	0	0	15.7201	0	0	0	0	0	18.09717	0	14.65905	0	0	0	16.9497	15.48018	17.59125	16.61545	16.47052	0	0	0	16.61331	15.74304	0	16.52115	0	17.17918	0	16.05903
Q96AN5	TM143_HUMAN	Transmembrane protein 143	TMEM143 UNQ5922/PRO19813	Homo sapiens (Human)		integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]		GO:0005739; GO:0016021	ALLNLMLVVSGVAIFVNVGMVVLTDLK	4.349999905	1	1	0.238281613	2860.491058	0	0	12.76887	0	0	0	14.9961	15.2705	0	0	13.12453	0	14.09685	13.38575	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96AP4	ZUP1_HUMAN	"Zinc finger-containing ubiquitin peptidase 1, EC 3.4.19.12 (Lys-63-specific deubiquitinase ZUFSP, DUB) (Zinc finger with UFM1-specific peptidase domain protein)"	ZUP1 C6orf113 ZUFSP	Homo sapiens (Human)	regulation of gene expression [GO:0010468]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]; regulation of gene expression [GO:0010468]	metal ion binding [GO:0046872]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0010468; GO:0046872	NSAQNLTKDSTLK	7.71999979	1	1	0.266568374	1418.772524	16.00114	16.17611	0	0	0	15.25524	0	15.79926	0	0	0	0	0	0	0	15.95894	0	0	0	0	17.01067	0	0	0	0	0	0	0	0	0	15.32446	0	0	15.7547	0	0	0	16.06385	0	16.56889	16.09661	0	0	0	0	0	0	0
Q96AQ1	CC74A_HUMAN	Coiled-coil domain-containing protein 74A	CCDC74A	Homo sapiens (Human)						KCLSPPVAER	11.61999989	0.012595458	0.012595458	0.329876352	1157.512012	15.78724	14.77668	11.72916	0	0	13.10579	15.60596	13.60863	13.79836	0	15.50595	14.37606	0	0	0	16.54496	0	0	16.33669	15.52539	0	0	15.86141	0	0	0	15.67485	15.26909	0	0	15.63809	0	0	16.50526	15.90021	15.71523	0	0	16.61972	14.42077	15.73448	0	15.61328	16.31454	15.85036	0	15.95106	0
Q96AQ8	MCUR1_HUMAN	"Mitochondrial calcium uniporter regulator 1, MCU regulator 1 (Coiled-coil domain-containing protein 90A, mitochondrial)"	MCUR1 C6orf79 CCDC90A	Homo sapiens (Human)	calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]		GO:0005739; GO:0006851; GO:0031305; GO:0036444; GO:0051561; GO:0070509	DMIILEK	18.90999985	1	1	0.288150753	861.6684941	0	0	0	19.01791	0	17.10544	15.6992	18.01128	0	18.98214	17.94501	0	17.8175	18.03083	18.30545	0	0	16.81989	19.05835	0	16.33453	0	0	0	16.17941	0	0	0	18.51705	0	0	17.77452	0	0	18.21517	0	0	18.04324	17.10586	14.4556	16.65941	18.8215	0	0	0	0	0	0
Q96AV8	E2F7_HUMAN	"Transcription factor E2F7, E2F-7"	E2F7	Homo sapiens (Human)	"chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]"	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0006357; GO:0008285; GO:0016607; GO:0030330; GO:0032466; GO:0032877; GO:0042802; GO:0045944; GO:0060707; GO:0060718; GO:0070365; GO:0071930; GO:0090575; GO:1990837; GO:2000134	LEIPSGGAD	11.27999973	1	1	0.257144777	858.9359481	16.34977	0	17.50994	0	0	0	18.8148	17.56032	20.57144	0	0	17.51937	0	0	0	0	0	17.59654	19.61957	18.63761	17.70668	0	20.58068	20.69668	0	19.78983	19.90367	0	15.8555	0	0	0	0	19.12218	0	0	0	0	19.61514	18.17053	0	17.07972	18.41717	17.22377	0	17.46392	0	18.28479
Q96AX1	VP33A_HUMAN	"Vacuolar protein sorting-associated protein 33A, hVPS33A"	VPS33A	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192]		GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005776; GO:0006886; GO:0008333; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0034058; GO:0035542; GO:0035751; GO:0048070; GO:0048471; GO:0097352	MAAHLSYGRVNLNVLR	10.56000042	1	1	0.046825088	1813.787089	0	0	13.22151	0	15.27569	0	0	14.88375	13.83792	0	14.0424	13.22006	0	0	0	0	14.63244	14.96552	0	14.54371	0	0	0	0	14.42931	0	0	15.50639	0	14.66526	0	0	0	0	0	0	15.89481	0	0	0	15.07769	13.52399	0	0	0	0	0	0
Q96AX9	MIB2_HUMAN	"E3 ubiquitin-protein ligase MIB2, EC 2.3.2.27 (Mind bomb homolog 2) (Novel zinc finger protein, Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1)"	MIB2 SKD ZZANK1	Homo sapiens (Human)	Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein ubiquitination [GO:0016567]	actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0043123; GO:0061630	ALDLLRR	9.390000343	1	1	8.03E-13	856.8258089	12.98233	13.49856	0	14.84102	12.55101	13.36837	13.78264	14.83688	15.6951	15.25495	15.21688	14.26397	0	12.94806	0	14.49907	15.71627	0	15.05417	14.94918	0	15.15705	0	13.34515	0	0	0	0	0	0	0	0	0	0	15.28725	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96AY2	EME1_HUMAN	"Crossover junction endonuclease EME1, EC 3.1.22.- (MMS4 homolog, hMMS4)"	EME1 MMS4	Homo sapiens (Human)	double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]	endodeoxyribonuclease complex [GO:1905347]; heterochromatin [GO:0000792]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	endodeoxyribonuclease complex [GO:1905347]; heterochromatin [GO:0000792]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]	DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]	GO:0000712; GO:0000792; GO:0003677; GO:0004519; GO:0005654; GO:0005730; GO:0006302; GO:0031297; GO:0031573; GO:0043596; GO:0046872; GO:0048476; GO:0072429; GO:1905347	QNLLADIQVR	7.170000076	1	1	0.461160839	1170.783606	0	0	16.33711	0	0	0	16.78587	0	0	0	0	0	0	0	0	16.99719	0	0	0	0	16.91648	0	0	0	0	0	0	0	0	0	0	19.4969	0	19.04725	17.44471	0	0	0	0	0	0	0	0	0	0	0	16.6009	17.67896
Q96AY3	FKB10_HUMAN	"Peptidyl-prolyl cis-trans isomerase FKBP10, PPIase FKBP10, EC 5.2.1.8 (65 kDa FK506-binding protein, 65 kDa FKBP, FKBP-65) (FK506-binding protein 10, FKBP-10) (Immunophilin FKBP65) (Rotamase)"	FKBP10 FKBP65 PSEC0056	Homo sapiens (Human)	aorta morphogenesis [GO:0035909]; collagen fibril organization [GO:0030199]; extracellular matrix assembly [GO:0085029]; in utero embryonic development [GO:0001701]; peptidyl-lysine hydroxylation [GO:0017185]; peptidyl-proline modification [GO:0018208]; wound healing [GO:0042060]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; aorta morphogenesis [GO:0035909]; collagen fibril organization [GO:0030199]; extracellular matrix assembly [GO:0085029]; in utero embryonic development [GO:0001701]; peptidyl-lysine hydroxylation [GO:0017185]; peptidyl-proline modification [GO:0018208]; wound healing [GO:0042060]	calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0001701; GO:0003755; GO:0005509; GO:0005528; GO:0005758; GO:0005783; GO:0005788; GO:0016020; GO:0017185; GO:0018208; GO:0030199; GO:0035909; GO:0042060; GO:0085029	NTLVAIVVGVGR	2.079999924	1	1	0.169902516	1196.803732	0	0	12.01332	15.31569	0	0	12.88964	0	14.14497	12.45317	13.60341	13.59012	13.63214	13.2266	7.463736	0	14.99524	13.12646	15.16383	13.7414	0	12.21891	0	0	14.81881	13.94763	14.21668	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.50146	0	0
Q96AY4	TTC28_HUMAN	"Tetratricopeptide repeat protein 28, TPR repeat protein 28 (TPR repeat-containing big gene cloned at Keio)"	TTC28 KIAA1043 TPRBK	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]	kinase binding [GO:0019900]	GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301	ASAALGEAMK	7.869999886	1	1	0.196589068	965.562762	17.23235	15.21966	14.94577	0	15.78222	15.96679	0	15.74327	15.02107	15.48527	15.39341	11.43808	14.43765	0	16.06729	10.39913	0	0	15.17016	0	15.86683	15.88735	15.72984	15.4688	14.24697	13.89785	14.80961	17.41732	14.23649	14.07999	16.64357	15.414	14.99069	14.93501	12.63148	14.42398	13.43259	14.87595	13.30026	12.3538	0	15.15469	15.53241	16.05263	14.47806	14.15969	16.47727	0
Q96B01	R51A1_HUMAN	"RAD51-associated protein 1, HsRAD51AP1 (RAD51-interacting protein)"	RAD51AP1 PIR51	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of double-strand break repair via homologous recombination [GO:0010569]	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; D-loop DNA binding [GO:0062037]; DNA binding [GO:0003677]; DNA secondary structure binding [GO:0000217]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of double-strand break repair via homologous recombination [GO:0010569]"	D-loop DNA binding [GO:0062037]; DNA binding [GO:0003677]; DNA secondary structure binding [GO:0000217]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0000217; GO:0000724; GO:0000781; GO:0000785; GO:0003677; GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006974; GO:0010569; GO:0010845; GO:0032991; GO:0036297; GO:0051321; GO:0062037; GO:0071479; GO:1905168	SPNQSLR	6.429999828	1	1	0.238418401	800.1739156	0	13.61365	0	15.02338	14.03782	10.47083	15.78691	13.69106	17.04499	0	0	14.85403	0	0	15.25985	14.86282	0	15.29324	0	0	0	0	0	0	0	0	0	16.34177	0	15.24006	15.75311	0	0	0	0	14.71302	0	0	0	15.47502	14.89	0	0	0	0	0	0	0
Q96B18	DACT3_HUMAN	Dapper homolog 3 (Antagonist of beta-catenin Dapper homolog 3) (Arginine-rich region 1 protein) (Dapper antagonist of catenin 3)	DACT3 RRR1	Homo sapiens (Human)	negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; delta-catenin binding [GO:0070097]; identical protein binding [GO:0042802]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]	delta-catenin binding [GO:0070097]; identical protein binding [GO:0042802]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]	GO:0005080; GO:0005737; GO:0010719; GO:0016055; GO:0030178; GO:0030308; GO:0042802; GO:0051018; GO:0070097; GO:0090090	GAGQPRTSPGGADGGPR	1.470000029	1	1	4.11E-12	1537.956177	16.5669	13.27347	0	0	0	0	0	0	12.0655	15.61649	16.75722	0	15.21146	8.849787	14.47329	15.71861	0	14.60231	0	0	13.68801	12.85781	14.70045	13.89077	14.56647	15.82746	14.698	0	12.44922	0	13.78347	13.51806	0	17.78131	16.84013	0	14.44417	16.93516	15.96089	8.09943	0	0	15.11259	0	14.513	13.46116	12.55133	16.27982
Q96B26	EXOS8_HUMAN	"Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2, OIP-2) (Ribosomal RNA-processing protein 43) (p9)"	EXOSC8 OIP2 RRP43	Homo sapiens (Human)	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]"	identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042; GO:0101019	EDLCISPGK	24.59000015	0.157936171	0.157936171	0.444436681	1018.554973	16.37432	16.98091	15.85953	16.56307	17.39847	17.19885	16.72612	16.82294	15.35297	16.76894	16.1972	16.83263	16.33661	16.36258	15.9974	0	16.70679	17.23448	16.55802	15.12096	16.30953	16.05385	15.58471	17.1039	17.33759	16.63069	16.28189	16.11975	17.19021	15.39974	16.35737	15.49575	17.06042	17.28213	16.76437	16.32121	0	16.1657	17.14323	16.84474	15.85571	16.1739	16.39296	17.11362	16.31594	15.83636	17.16043	15.34512
Q96B36	AKTS1_HUMAN	Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate)	AKT1S1 PRAS40	Homo sapiens (Human)	negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]		GO:0005654; GO:0005737; GO:0005829; GO:0006469; GO:0032007; GO:0042981; GO:0043523; GO:0045792; GO:0048011	IAASMR	16.30999947	0.897420943	0.897420943	0.270431473	663.1057459	15.54895	0	14.03741	0	15.10469	0	13.06483	14.95813	14.35789	15.25503	16.02257	11.29471	0	15.71349	16.36697	0	16.18638	14.9244	15.48481	0	0	19.0771	17.02145	18.40764	16.5608	0	16.0205	16.02491	15.42866	15.67886	16.76783	15.56303	15.57812	17.85738	15.96173	15.73993	17.20109	16.32846	15.88427	16.42806	16.00838	16.80127	0	16.07408	16.65431	15.37408	16.94219	16.02674
Q96B70	LENG9_HUMAN	Leukocyte receptor cluster member 9	LENG9	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	ASRTDLVFGSGSAAGR	1.679999948	1	1	0.261274096	1552.362173	16.73013	16.0083	16.61885	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96B77	TM186_HUMAN	Transmembrane protein 186	TMEM186 C16orf51	Homo sapiens (Human)	mitochondrial respiratory chain complex I assembly [GO:0032981]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]		GO:0005739; GO:0005743; GO:0016021; GO:0032981	MAALLRAVR	15.93000031	1	1	0.446142702	1000.431554	0	0	0	0	0	0	0	19.61436	0	0	18.83589	0	17.22595	0	18.42716	0	0	19.30233	0	0	0	0	0	0	0	0	0	19.66895	0	0	0	19.77212	0	19.85416	0	0	0	18.81872	0	0	0	18.32876	18.19005	0	0	0	0	0
Q96B97	SH3K1_HUMAN	"SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3, CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1, HSB-1)"	SH3KBP1 CIN85	Homo sapiens (Human)	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360]	SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]	GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0045202; GO:0050871	TEEKERPER	7.289999962	1	1	0.605740163	1174.884327	0	0	0	0	0	0	0	0	0	0	16.42888	0	0	0	0	0	0	0	0	17.83028	0	0	0	0	0	0	20.01787	0	0	17.21552	0	0	0	0	0	0	0	0	20.24637	0	0	16.73291	0	0	0	0	0	0
Q96BD0	SO4A1_HUMAN	"Solute carrier organic anion transporter family member 4A1, OATP4A1 (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1, OATP-RP1, OATPRP1, POAT) (Organic anion-transporting polypeptide E, OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)"	SLCO4A1 OATP1 OATP4A1 OATPE SLC21A12	Homo sapiens (Human)	sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; sodium-independent organic anion transport [GO:0043252]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0005886; GO:0005887; GO:0015347; GO:0015349; GO:0043252	QLPGSQR	5.989999771	0.087998062	0.087998062	0.225549665	784.5907658	16.33136	16.15788	14.175	14.43594	15.01046	14.53296	15.63817	15.36816	14.48832	17.65502	15.7461	15.22825	14.60413	14.97565	14.90657	15.31672	13.06465	0	15.95594	0	14.02905	16.07895	0	14.85756	16.13784	14.70579	15.1747	15.71214	15.11805	15.11069	15.65726	0	0	0	14.82383	14.79505	16.57742	0	15.78795	15.64365	15.63064	16.26927	15.82696	15.57269	17.02739	17.23747	17.50262	14.90372
Q96BD5	PF21A_HUMAN	PHD finger protein 21A (BHC80a) (BRAF35-HDAC complex protein BHC80)	PHF21A BHC80 KIAA1696 BM-006	Homo sapiens (Human)	chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]	DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]	DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000118; GO:0000122; GO:0003677; GO:0003682; GO:0005654; GO:0006325; GO:0046872; GO:1990391	EMHSSLEK	6.550000191	0.475027978	0.475027978	0.262163346	962.0439932	15.6741	16.28229	15.98257	14.546	16.04732	15.26139	18.4855	16.56862	15.52913	0	16.50951	15.29452	0	13.91769	0	12.89608	15.23327	0	16.45802	0	15.88488	0	16.47299	0	0	0	17.16221	0	0	0	0	0	17.48311	0	16.2448	15.85041	0	15.62767	0	15.31272	0	15.13527	0	0	0	16.42979	0	16.63502
Q96BF6	NACC2_HUMAN	"Nucleus accumbens-associated protein 2, NAC-2 (BTB/POZ domain-containing protein 14A) (Repressor with BTB domain and BEN domain)"	NACC2 BTBD14A NAC2 RBB	Homo sapiens (Human)	"negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [GO:1900477]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein homooligomerization [GO:0051260]; protein-containing complex localization [GO:0031503]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [GO:1900477]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein homooligomerization [GO:0051260]; protein-containing complex localization [GO:0031503]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005730; GO:0005739; GO:0006357; GO:0008285; GO:0031503; GO:0042803; GO:0042826; GO:0044877; GO:0045892; GO:0051260; GO:1900477; GO:1902231	SSTSDPSR	11.85000038	0.012325908	0.012325908	0.132876843	836.4664821	0	17.77806	0	17.8453	16.6381	0	0	0	0	16.5206	16.734	17.96015	16.23594	15.80742	0	12.97711	0	0	16.15409	17.63827	17.98112	12.62611	0	15.09834	0	15.39446	0	0	0	18.94037	16.84455	0	0	0	0	15.58077	17.0025	16.25858	16.30055	0	0	0	0	0	0	16.58817	18.5885	16.07739
Q96BH1	RNF25_HUMAN	"E3 ubiquitin-protein ligase RNF25, EC 2.3.2.27 (RING finger protein 25) (RING-type E3 ubiquitin transferase RNF25)"	RNF25	Homo sapiens (Human)	positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]	metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630	ESLGLESK	8.020000458	1	1	0.269518208	862.2973519	14.95856	18.54901	19.98418	16.27651	15.46722	14.4498	18.09668	0	16.38759	0	15.5154	0	0	18.55754	0	0	18.56676	0	18.95968	17.65008	17.65485	0	0	18.03801	0	18.48039	19.07207	18.01293	0	0	0	0	17.79219	0	0	19.09708	17.48841	0	0	0	19.3356	0	18.01719	0	0	17.70498	0	0
Q96BJ3	AIDA_HUMAN	"Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)"	AIDA C1orf80	Homo sapiens (Human)	determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333]	phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]	GO:0005737; GO:0009953; GO:0016020; GO:0019904; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264	HLQKEAQAQHNNSEFTEEQK	7.21999979	1	1	0.035214635	2396.167404	15.13095	0	0	14.36874	0	15.07475	0	14.07102	14.82156	18.11682	15.49405	15.86075	0	0	16.25338	0	0	16.15063	15.19593	10.4864	0	0	0	12.18704	14.09233	16.66952	0	0	16.86694	11.53289	0	0	16.07863	13.57227	17.93084	15.46018	0	0	18.30273	9.886115	16.00158	0	12.68851	0	0	0	15.41398	0
Q96BJ8	ELMO3_HUMAN	Engulfment and cell motility protein 3	ELMO3	Homo sapiens (Human)	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis [GO:0006909]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis [GO:0006909]	SH3 domain binding [GO:0017124]	GO:0005737; GO:0006909; GO:0006915; GO:0007015; GO:0017124; GO:0048870	LVPLASDMIFAREVISR	1.190000057	1	1	0.106737567	1916.472386	0	0	14.46706	14.37655	13.38992	10.48545	0	14.81948	14.55072	0	0	0	14.54307	0	0	0	0	14.26941	13.23497	0	0	17.2591	16.78058	0	15.09568	16.09607	0	14.75451	0	0	0	16.77932	0	0	10.81244	0	0	0	0	15.37418	12.84397	0	14.12857	0	0	0	0	0
Q96BM1	ANKR9_HUMAN	Ankyrin repeat domain-containing protein 9	ANKRD9	Homo sapiens (Human)	cellular copper ion homeostasis [GO:0006878]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]	Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; cellular copper ion homeostasis [GO:0006878]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0005829; GO:0006878; GO:0016567; GO:0031410; GO:0031466; GO:0043161; GO:1990756	RPGGGADGGPEASGAAR	10.25	6.51E-12	6.51E-12	0.273049132	1483.25085	16.91781	14.44318	13.16346	13.89825	12.90913	0	12.71245	15.07513	0	14.10652	4.898625	10.7132	0	0	0	0	0	0	0	0	0	0	0	0	11.75338	14.14428	16.2288	15.44667	14.98589	15.20758	0	0	0	0	0	0	0	0	0	0	14.19793	0	14.90474	10.70571	0	0	0	15.21309
Q96BN2	TADA1_HUMAN	"Transcriptional adapter 1 (SPT3-associated factor 42, STAF42) (Transcriptional adapter 1-like protein)"	TADA1 TADA1L	Homo sapiens (Human)	"histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]"	transcription coactivator activity [GO:0003713]	GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006282; GO:0006357; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893	QRLAAK	4.590000153	0.769454598	0.769454598	0.16339087	685.4532527	16.37596	14.51565	15.43368	14.13285	0	15.25075	0	15.66049	0	16.27955	15.60474	16.31588	15.18329	15.03617	14.57594	15.09014	14.65766	14.07811	13.72577	14.1319	16.09072	14.63083	15.68913	15.38386	16.06071	14.87805	15.18221	15.25864	15.61511	16.2529	14.95167	0	15.23958	15.68723	14.35108	16.64259	0	15.5079	13.16962	16.5639	0	0	15.95563	0	0	0	0	15.94996
Q96BN6	F149B_HUMAN	Primary cilium assembly protein FAM149B1	FAM149B1 KIAA0974	Homo sapiens (Human)	cilium assembly [GO:0060271]; protein localization to cilium [GO:0061512]	cilium [GO:0005929]	cilium [GO:0005929]; cilium assembly [GO:0060271]; protein localization to cilium [GO:0061512]		GO:0005929; GO:0060271; GO:0061512	SQSGGRPVSR	5.670000076	1	1	0.216705522	1030.701424	0	0	0	15.6443	0	15.11973	15.8616	14.17127	15.44342	14.20123	0	12.27265	17.5256	16.042	13.8901	14.88262	14.8888	9.816337	15.94539	14.02257	0	16.20489	0	15.15618	0	15.285	0	0	14.39921	15.76119	0	0	16.15	0	15.32667	0	0	0	0	16.68871	17.01326	15.62987	0	15.28043	0	0	0	15.08496
Q96BN8	OTUL_HUMAN	"Ubiquitin thioesterase otulin, EC 3.4.19.12 (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)"	OTULIN FAM105B	Homo sapiens (Human)	innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent deubiquitinase [GO:0004843]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent deubiquitinase [GO:0004843]	GO:0002040; GO:0004843; GO:0005737; GO:0005829; GO:0008234; GO:0010803; GO:0016055; GO:0016567; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:0071797; GO:1990108	GASEPR	5.380000114	1	1	0.221445562	615.3584634	17.75851	18.31265	18.63378	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.05104	0	0	16.18027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.97638	0
Q96BP3	PPWD1_HUMAN	"Peptidylprolyl isomerase domain and WD repeat-containing protein 1, EC 5.2.1.8 (Spliceosome-associated cyclophilin)"	PPWD1 KIAA0073	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]"	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	"catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]"	cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0016018; GO:0016604; GO:0071013	IFIYDGR	8.5	0.856645048	0.856645048	0.261846923	882.7099461	16.67124	0	18.26475	17.41035	14.56311	0	19.82656	18.68235	0	0	16.68834	17.44043	17.26186	0	0	0	0	17.29894	16.77785	0	17.22886	16.45719	19.06492	0	0	19.21502	0	0	17.82213	18.57455	20.41769	20.69205	0	0	18.79724	16.90027	18.41668	0	18.78271	0	17.81604	17.81267	18.56132	16.66814	17.10979	0	17.77889	18.02374
Q96BQ1	FAM3D_HUMAN	Protein FAM3D	FAM3D UNQ567/PRO1130	Homo sapiens (Human)	negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin secretion [GO:0046676]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin secretion [GO:0046676]	cytokine activity [GO:0005125]	GO:0005125; GO:0005576; GO:0005615; GO:0046676; GO:0070093	CGLIKPCPANYFAFK	2.24000001	1	1	0.105262979	1784.464423	0	0	0	0	0	0	0	0	0	0	0	15.16588	0	0	0	0	0	0	0	0	0	0	0	14.28673	14.22018	0	14.80405	15.56707	0	0	0	13.73262	0	13.5106	11.05652	0	0	17.05868	0	0	0	0	0	0	0	0	0	0
Q96BR1	SGK3_HUMAN	"Serine/threonine-protein kinase Sgk3, EC 2.7.11.1 (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)"	SGK3 CISK SGKL	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]	cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]	ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]	GO:0001558; GO:0004672; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0035091; GO:0035556; GO:0042127; GO:0051090; GO:0055037; GO:0106310	QFPAMALKIPAK	1.909999967	1	1	0.295118839	1326.851245	0	14.67686	0	13.40857	0	0	14.08727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.94149	12.61429	16.86597	17.38199	0	15.79126	0	0	16.26322	0	17.90981	0	0	16.55484	15.75002	0	0	0	0	15.76148	16.54911	0	0	0	0	0
Q96BS2	CHP3_HUMAN	"Calcineurin B homologous protein 3 (Tescalcin, TSC)"	TESC CHP3	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of sodium:proton antiporter activity [GO:0032417]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of cell adhesion mediated by integrin [GO:0033628]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase inhibitor activity [GO:0019212]; protein homodimerization activity [GO:0042803]; protein kinase inhibitor activity [GO:0004860]; cell differentiation [GO:0030154]; cellular response to retinoic acid [GO:0071300]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of sodium:proton antiporter activity [GO:0032417]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of cell adhesion mediated by integrin [GO:0033628]"	calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase inhibitor activity [GO:0019212]; protein homodimerization activity [GO:0042803]; protein kinase inhibitor activity [GO:0004860]	GO:0000287; GO:0001726; GO:0004860; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008285; GO:0010628; GO:0015031; GO:0019212; GO:0030027; GO:0030154; GO:0030854; GO:0032417; GO:0032587; GO:0033628; GO:0042803; GO:0045654; GO:0045893; GO:0050821; GO:0051604; GO:0071300; GO:0072659	ITLEEYR	4.75	1	1	0.053968723	924.4798412	0	0	0	15.28308	0	0	0	0	0	0	0	13.11261	0	15.62845	0	0	0	0	0	0	0	0	0	0	0	0	0	15.4773	0	0	0	0	15.79624	0	13.98105	14.43684	13.35381	16.02507	0	0	0	0	0	0	0	0	0	0
Q96BT1	CC049_HUMAN	Putative uncharacterized protein C3orf49	C3orf49	Homo sapiens (Human)						KSDLTVGK	1.99000001	1	1	0.37586916	847.6014647	0	0	17.73361	0	0	0	19.08554	0	18.02697	0	16.61068	0	0	0	0	0	0	18.10351	0	0	0	0	0	0	18.94566	18.11778	0	0	0	0	0	0	19.41142	0	0	0	18.70491	0	0	0	0	0	0	0	0	0	0	0
Q96BT7	ALKB8_HUMAN	"Alkylated DNA repair protein alkB homolog 8 (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8, EC 2.1.1.229)"	ALKBH8 ABH8	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0008270; GO:0016300; GO:0016604; GO:0016706; GO:0030488; GO:0106335	LLRPGGK	19.78000069	1	1	0.154564349	741.6465643	0	0	0	13.60766	14.04134	0	15.24381	0	12.60535	14.3984	0	0	0	0	0	12.00988	0	15.99736	0	0	0	0	0	0	0	0	15.59362	0	0	15.31063	0	14.25803	0	0	15.09251	0	0	16.14948	0	0	0	0	16.08149	0	0	0	15.98701	0
Q96BU1	S1PBP_HUMAN	S100P-binding protein (S100P-binding protein Riken)	S100PBP S100PBPR	Homo sapiens (Human)		cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; calcium-dependent protein binding [GO:0048306]	calcium-dependent protein binding [GO:0048306]	GO:0005634; GO:0005829; GO:0016607; GO:0048306	NGGSHK	5.190000057	1	1	0.2417389	598.6704349	15.86275	14.35947	13.74976	0	16.49344	0	0	14.44653	0	16.89811	16.05649	16.85214	0	15.76759	0	15.20166	15.78635	16.03732	16.10562	15.64332	16.0737	0	0	0	0	0	0	0	0	16.30755	0	0	0	16.67253	0	0	0	0	0	0	0	15.78956	16.23574	0	0	15.6489	0	16.29044
Q96BW1	UPP_HUMAN	Uracil phosphoribosyltransferase homolog	UPRT	Homo sapiens (Human)	female pregnancy [GO:0007565]; lactation [GO:0007595]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; female pregnancy [GO:0007565]; lactation [GO:0007595]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222]	GTP binding [GO:0005525]	GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0006222; GO:0007565; GO:0007595; GO:0032868; GO:0043231	GDFMFSADR	1.75	0.542421758	0.542421758	0.204379795	1062.548207	0	15.11345	0	0	0	15.12836	0	0	15.48089	0	0	0	0	0	0	14.24423	0	0	0	0	0	0	0	14.18478	0	0	13.55872	14.38941	0	0	0	0	0	0	12.55929	0	14.52988	0	15.89646	0	8.983258	0	0	0	0	12.93804	0	0
Q96BX8	MOB3A_HUMAN	MOB kinase activator 3A (MOB-LAK) (Mob1 homolog 2A) (Mps one binder kinase activator-like 2A)	MOB3A MOBKL2A	Homo sapiens (Human)	positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165]	metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]	GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0030295; GO:0046872	ILSRLFR	20.86000061	0.458074808	0.458074808	0.194600834	907.8215767	15.40252	15.41949	15.37702	14.83391	15.28359	14.49692	0	0	14.61649	15.25801	0	0	0	0	15.98404	15.9911	15.08144	15.44643	0	14.29088	16.89767	0	15.65261	0	16.68213	14.62927	14.24116	15.66936	14.67004	14.88108	15.76615	0	0	0	14.90846	15.51671	0	16.38765	16.28001	13.98879	16.31997	14.9246	0	15.92407	14.15211	0	0	15.30021
Q96BY6	DOC10_HUMAN	Dedicator of cytokinesis protein 10 (Zizimin-3)	DOCK10 KIAA0694 ZIZ3	Homo sapiens (Human)	B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001782; GO:0002315; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007264; GO:0016020; GO:0030334; GO:0043197; GO:0043547; GO:0060997; GO:0070062	VNAGPMAYARAFLEETNAK	2.25	1	1	0.077775711	2069.57567	0	0	0	11.62176	0	14.54556	0	12.73405	0	0	0	0	0	14.21388	15.47433	0	13.29024	0	0	14.19536	0	0	0	0	0	14.57082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96BY7	ATG2B_HUMAN	Autophagy-related protein 2 homolog B	ATG2B C14orf103	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709]	endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709]	lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0000045; GO:0000407; GO:0000422; GO:0005789; GO:0005811; GO:0019898; GO:0032266; GO:0034045; GO:0034727; GO:0044805; GO:0061709; GO:0120013	AAMQEK	5.179999828	0.303779423	0.303779423	0.287278284	693.4186603	18.03223	0	16.01035	0	16.76494	0	0	0	0	0	18.44408	0	0	0	0	0	0	0	18.07116	0	16.02936	18.47079	0	18.52325	0	18.37707	0	0	0	0	0	18.30264	0	0	22.29671	0	0	0	0	0	0	18.98365	0	0	0	0	0	0
Q96BZ4	PLD4_HUMAN	"5'-3' exonuclease PLD4, EC 3.1.16.1 (Choline phosphatase 4) (Phosphatidylcholine-hydrolyzing phospholipase D4) (Phospholipase D family member 4) (Phospholipase D4, PLD 4)"	PLD4 C14orf175 UNQ2488/PRO5775	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015]	single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0002244; GO:0005634; GO:0005769; GO:0005783; GO:0005789; GO:0006909; GO:0006954; GO:0016021; GO:0032588; GO:0045087; GO:0045145; GO:0045335; GO:1900015	AAVAPTWPCSMPPR	9.420000076	1	1	0.20250714	1555.959178	0	0	16.7762	0	0	0	18.23589	0	13.73157	0	0	0	15.31989	0	0	0	0	15.45525	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.57621	0	14.52459	0	0	12.19828	0	14.65736	15.08511	16.48525	0	0	0	0	0	0
Q96C11	FGGY_HUMAN	"FGGY carbohydrate kinase domain-containing protein (D-ribulokinase FGGY, EC 2.7.1.47)"	FGGY	Homo sapiens (Human)	carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321]		D-ribulokinase activity [GO:0019150]; carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321]	D-ribulokinase activity [GO:0019150]	GO:0019150; GO:0019321; GO:0046835; GO:0070050	YYVGVDVGTGSVR	3.519999981	1	1	0.34104988	1371.44368	11.92731	0	13.81608	0	14.19684	13.0375	0	14.96996	0	0	0	0	0	0	14.99094	16.407	13.96913	15.0276	0	0	15.48802	0	0	0	0	0	0	0	17.39312	0	0	0	0	0	0	0	0	15.38434	0	0	0	0	0	0	0	0	0	0
Q96C28	ZN707_HUMAN	Zinc finger protein 707	ZNF707	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872	LDTDDGQLPR	11.81000042	1	1	0.41921244	1129.3037	20.04399	0	0	0	0	19.36336	18.06747	21.76447	0	0	19.94097	0	0	0	0	20.21942	18.69264	0	0	17.78967	0	18.35845	18.16283	19.54823	20.86103	0	0	0	17.29128	0	0	0	19.73253	20.30238	0	0	21.90199	0	20.86134	0	0	19.60369	20.35514	0	18.75895	0	20.58008	19.02336
Q96C74	ROP1L_HUMAN	"Ropporin-1-like protein, ROPN1-like protein (AKAP-associated sperm protein)"	ROPN1L ASP RSPH11	Homo sapiens (Human)	epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; regulation of protein phosphorylation [GO:0001932]; sperm capacitation [GO:0048240]	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]	cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; identical protein binding [GO:0042802]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; regulation of protein phosphorylation [GO:0001932]; sperm capacitation [GO:0048240]	identical protein binding [GO:0042802]	GO:0001932; GO:0003351; GO:0005576; GO:0005737; GO:0005929; GO:0030317; GO:0031514; GO:0042802; GO:0048240	MPLPDTMFCAQQIHIPPELPDILKQFTK	1.620000005	0.767131984	0.767131984	9.15E-13	3325.198982	14.41043	0	11.56558	15.05855	0	0	0	12.32295	0	14.71552	0	0	0	0	0	0	0	0	0	0	12.96218	0	0	0	13.98177	13.63425	0	0	0	12.04903	0	0	0	0	0	0	0	13.224	0	0	0	0	0	0	10.17272	0	11.77979	0
Q96C86	DCPS_HUMAN	"m7GpppX diphosphatase, EC 3.6.1.59 (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5, HINT-5) (Scavenger mRNA-decapping enzyme DcpS)"	DCPS DCS1 HINT5 HSPC015	Homo sapiens (Human)	"cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; methylguanosine-cap decapping [GO:0110156]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; exoribonuclease activity [GO:0004532]; identical protein binding [GO:0042802]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; methylguanosine-cap decapping [GO:0110156]; mRNA cis splicing, via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]"	exoribonuclease activity [GO:0004532]; identical protein binding [GO:0042802]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]	GO:0000288; GO:0000290; GO:0000340; GO:0000932; GO:0004532; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0036245; GO:0042802; GO:0043069; GO:0043928; GO:0045292; GO:0050072; GO:0110156	TLTFALR	11.10000038	1	1	0	820.8596378	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96CA5	BIRC7_HUMAN	"Baculoviral IAP repeat-containing protein 7, EC 2.3.2.27 (Kidney inhibitor of apoptosis protein, KIAP) (Livin) (Melanoma inhibitor of apoptosis protein, ML-IAP) (RING finger protein 50) (RING-type E3 ubiquitin transferase BIRC7) [Cleaved into: Baculoviral IAP repeat-containing protein 7 30kDa subunit, Truncated livin, p30-Livin, tLivin ]"	BIRC7 KIAP LIVIN MLIAP RNF50 UNQ5800/PRO19607/PRO21344	Homo sapiens (Human)	lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of natural killer cell apoptotic process [GO:0070247]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of natural killer cell apoptotic process [GO:0070247]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0002088; GO:0004842; GO:0004869; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0010804; GO:0016567; GO:0019899; GO:0031398; GO:0042127; GO:0042981; GO:0043027; GO:0043066; GO:0046330; GO:0046872; GO:0051726; GO:0061630; GO:0070247	GPAFPGMGSEELR	7.71999979	1	1	0.41998523	1364.070046	19.95767	18.40411	0	0	0	0	18.24525	0	0	19.21607	0	0	0	0	0	0	16.66455	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96CB5	CH044_HUMAN	Putative uncharacterized protein C8orf44	C8orf44	Homo sapiens (Human)						GSLAIFCWSFQGGCVSK	5.809999943	1	1	0.343329121	1904.556336	13.30374	17.93372	0	0	0	0	0	13.78053	16.89605	0	15.28266	11.10915	0	0	12.30064	0	0	0	0	0	0	13.15108	13.61662	0	0	0	0	0	0	0	0	0	0	0	0	0	15.58373	15.88345	17.04859	15.50382	0	0	0	15.0793	0	0	0	0
Q96CB9	NSUN4_HUMAN	"5-methylcytosine rRNA methyltransferase NSUN4, EC 2.1.1.- (5-methylcytosine tRNA methyltransferase NSUN4, EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4)"	NSUN4	Homo sapiens (Human)	RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; rRNA binding [GO:0019843]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]	methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; rRNA binding [GO:0019843]	GO:0001510; GO:0005759; GO:0005762; GO:0008168; GO:0009383; GO:0019843; GO:0031167	CFTFDR	5.670000076	1	1	0.153859192	845.140042	15.05647	0	20.4272	0	0	0	0	0	18.46273	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.98681	0	0	18.15875	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96CD0	FBXL8_HUMAN	F-box/LRR-repeat protein 8 (F-box and leucine-rich repeat protein 8) (F-box protein FBL8)	FBXL8 FBL8	Homo sapiens (Human)	entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		GO:0000086; GO:0005634; GO:0005829; GO:0019005; GO:0031146; GO:0043153; GO:0051726	VLQPAVPVAALR	6.070000172	0.619063854	0.619063854	0.339100763	1233.640122	0	15.87611	0	0	12.18753	0	0	15.12419	15.06067	0	14.275	14.03618	13.96543	15.73255	0	13.73854	0	0	12.87495	15.03979	0	15.07651	0	16.60297	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.62442	0	0	0	15.46568	0	0
Q96CF2	CHM4C_HUMAN	"Charged multivesicular body protein 4c (Chromatin-modifying protein 4c, CHMP4c) (SNF7 homolog associated with Alix 3) (SNF7-3, hSnf7-3) (Vacuolar protein sorting-associated protein 32-3, Vps32-3, hVps32-3)"	CHMP4C SHAX3	Homo sapiens (Human)	abscission [GO:0009838]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]	amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]	amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; abscission [GO:0009838]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]	protein homodimerization activity [GO:0042803]	GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0009838; GO:0009898; GO:0010824; GO:0015031; GO:0016236; GO:0030496; GO:0031468; GO:0032466; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0042803; GO:0043162; GO:0044878; GO:0046761; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1902774; GO:1904930	SRAASSQR	5.659999847	1	1	0.200772213	862.6021431	12.45475	14.70572	0	12.85394	15.11582	15.79587	11.44949	15.57205	11.57984	14.73865	0	0	0	0	0	0	15.07409	0	0	16.56047	0	0	0	0	15.06009	0	0	15.16513	0	0	15.36646	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96CJ1	EAF2_HUMAN	ELL-associated factor 2 (Testosterone-regulated apoptosis inducer and tumor suppressor protein)	EAF2 TRAITS BM-040	Homo sapiens (Human)	"apoptotic process [GO:0006915]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; transcription elongation regulator activity [GO:0003711]; apoptotic process [GO:0006915]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]"	transcription elongation regulator activity [GO:0003711]	GO:0003711; GO:0005654; GO:0006915; GO:0008023; GO:0016607; GO:0030308; GO:0032783; GO:0034243; GO:0045893; GO:0045944; GO:0060770	HSPSEDKMSPASPIDDIER	2.75	1	1	0.286502457	2127.062991	12.5929	0	0	15.49355	0	0	14.04539	14.14691	15.43791	14.23014	13.38191	12.57124	14.83543	12.85869	14.49059	15.7567	13.28658	0	14.43197	0	15.69922	0	16.23944	0	15.95369	0	13.99692	0	0	15.36695	0	0	0	0	15.49986	0	0	0	0	0	0	0	0	15.12521	0	0	0	16.37089
Q96CK0	ZN653_HUMAN	Zinc finger protein 653 (67 kDa zinc finger protein) (Zinc finger protein Zip67)	ZNF653 ZIP67	Homo sapiens (Human)	extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of transcription by RNA polymerase II [GO:0006357]	extracellular region [GO:0005576]; nucleus [GO:0005634]	extracellular region [GO:0005576]; nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of transcription by RNA polymerase II [GO:0006357]	AF-2 domain binding [GO:0050682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0003677; GO:0003712; GO:0003714; GO:0005576; GO:0005634; GO:0006357; GO:0046872; GO:0050682; GO:0140297; GO:1900116; GO:1903507	EDLCLLKK	21.61000061	1	1	0.311011435	1018.26458	16.31038	0	17.20859	0	0	0	0	16.68109	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.72098	0	0	0	0	0	0	0	0
Q96CM3	RUSD4_HUMAN	"Pseudouridylate synthase RPUSD4, mitochondrial, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 4)"	RPUSD4	Homo sapiens (Human)	enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]; mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]	GO:0000049; GO:0000455; GO:0003723; GO:0005654; GO:0005739; GO:0005759; GO:0009982; GO:0035770; GO:0070131; GO:0070902; GO:1990400	MDDGKMVK	10.72000027	0.485410303	0.485410303	0.167736441	923.5917966	15.51276	15.27864	0	14.35781	14.88106	14.22429	0	15.95481	15.10584	0	16.17204	14.3555	14.83571	14.69763	16.02505	15.46239	13.28598	14.28185	0	16.0964	15.28148	13.21898	14.58857	0	15.57111	14.46101	16.3075	13.92627	14.93361	0	0	13.55491	15.76455	16.23407	15.76346	13.9364	15.53971	11.85603	14.50184	14.15823	12.44595	13.33504	13.83814	14.82576	14.8939	12.40183	15.93444	0
Q96CN4	EVI5L_HUMAN	EVI5-like protein (Ecotropic viral integration site 5-like protein)	EVI5L	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547]		GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547]	GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]	GO:0005096; GO:0031267; GO:0043547; GO:0090630; GO:1902018	EGQAVASTR	4.239999771	1	1	0.23926652	916.6187042	0	14.30429	14.67672	14.60892	0	15.2858	16.07529	0	14.55308	16.1948	15.45182	0	15.41144	16.4186	14.74139	14.79885	0	13.98486	0	15.79337	14.42532	16.42472	16.27857	14.77313	0	15.53992	0	0	0	0	16.26358	0	16.39259	0	0	0	16.39427	0	0	16.38885	0	15.38987	0	0	0	14.94707	0	0
Q96CN5	LRC45_HUMAN	Leucine-rich repeat-containing protein 45	LRRC45	Homo sapiens (Human)		centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		GO:0005654; GO:0005813; GO:0005829; GO:0005886	NLLLQNQVDELER	17.01000023	1	1	9.24E-13	1581.360664	17.58759	17.47118	16.53829	0	0	0	0	0	17.7344	0	0	0	17.04173	0	0	0	0	0	0	0	0	0	0	17.23694	0	0	18.32735	0	0	0	0	0	0	0	0	0	0	0	0	0	17.31389	0	0	0	0	0	0	0
Q96CN9	GCC1_HUMAN	GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1)	GCC1	Homo sapiens (Human)		cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; small GTPase binding [GO:0031267]	small GTPase binding [GO:0031267]	GO:0000138; GO:0000139; GO:0005794; GO:0005829; GO:0031267	EALAGR	11.22999954	1	1	0.116044318	615.2266033	14.89695	15.19139	15.72288	15.12928	15.61604	15.972	0	0	15.55029	13.77032	15.33861	14.10091	14.6556	0	0	0	13.10346	0	15.37663	0	0	12.62835	0	15.71979	0	16.9783	0	0	14.38157	13.94306	0	0	14.95421	0	16.03431	0	0	0	0	0	15.19077	0	14.73788	0	0	0	15.15516	0
Q96CP2	FWCH2_HUMAN	FLYWCH family member 2	FLYWCH2	Homo sapiens (Human)			RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723	KGVHCVMSLGVPGPATLAK	4.849999905	1	1	0.045434163	1936.98136	18.80808	0	13.83427	0	18.73361	17.79157	0	0	17.93566	0	16.99182	0	15.80112	0	0	0	18.11906	17.77022	0	18.69911	0	0	0	0	17.35292	0	0	0	0	0	0	0	0	17.15562	17.98039	15.46127	0	16.06606	0	0	0	0	0	0	15.2337	15.36832	16.59146	0
Q96CP6	ASTRA_HUMAN	Protein Aster-A (GRAM domain-containing protein 1A)	GRAMD1A KIAA1533	Homo sapiens (Human)	autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]	autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]	GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006914; GO:0015485; GO:0016021; GO:0031227; GO:0031234; GO:0031410; GO:0032366; GO:0032934; GO:0044232; GO:0071397; GO:0120015; GO:0120020; GO:0140268	STPSSSPSLRK	8.279999733	0.587246001	0.587246001	0.21392392	1146.549588	14.02135	14.51165	14.22358	15.94339	14.87503	13.83181	14.0765	14.06359	0	0	0	15.16117	16.93435	14.8576	0	15.82606	11.30989	0	8.825397	0	15.38778	11.37788	14.72578	13.30924	0	0	15.01841	13.51918	0	0	0	0	0	0	0	15.1972	0	0	0	15.33922	13.97977	0	0	0	0	0	0	0
Q96CP7	TLCD1_HUMAN	TLC domain-containing protein 1 (Calfacilitin)	TLCD1	Homo sapiens (Human)	lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035]		GO:0005886; GO:0007009; GO:0016021; GO:0055088; GO:0055091; GO:0071709; GO:0097035	MMMKISNAQDHLLYR	9.270000458	1	1	2.36E-13	1850.210255	0	0	0	0	0	0	18.33378	0	0	0	17.09324	16.48423	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96CQ1	S2536_HUMAN	Solute carrier family 25 member 36	SLC25A36	Homo sapiens (Human)	mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881]	pyrimidine nucleotide transmembrane transporter activity [GO:0015218]	GO:0000002; GO:0005739; GO:0005743; GO:0006864; GO:0007005; GO:0015218; GO:0016021; GO:0051881; GO:1990519	TASTMENDEESVKEASDFVGMMLAAATSK	3.700000048	0.454063833	0.454063833	3.66E-12	3093.764591	0	14.63213	14.29312	12.14627	14.39085	0	14.72857	15.09856	17.38904	11.28536	8.937592	0	13.1111	0	11.08618	14.47476	0	0	0	0	0	14.50879	16.19505	0	14.50941	13.14086	15.44383	14.84763	0	14.83516	0	12.72107	0	0	13.30036	0	0	0	0	14.05485	12.64277	0	13.09969	0	0	0	13.63887	11.25296
Q96CS4	ZN689_HUMAN	Zinc finger protein 689	ZNF689	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0035914; GO:0046872	RSGSLAIHR	6.619999886	0.276673913	0.276673913	0.210379494	994.0351898	0	16.32014	15.58684	19.35073	0	15.63212	15.97783	15.28845	17.02302	0	0	0	0	0	0	10.87767	14.51262	0	0	0	17.20709	0	15.7499	16.58623	0	0	0	15.17043	0	0	0	0	0	0	0	17.90791	0	0	0	16.21059	0	0	16.78932	0	0	17.22361	0	0
Q96CT2	KLH29_HUMAN	Kelch-like protein 29 (Kelch repeat and BTB domain-containing protein 9)	KLHL29 KBTBD9 KIAA1921	Homo sapiens (Human)						FERDYR	8.489999771	1	1	0.304447217	885.2186972	13.98831	15.73139	15.88723	14.93972	15.59998	15.94266	12.28024	15.69444	0	0	0	0	14.23545	15.12542	0	15.00764	14.63975	0	0	0	0	0	0	0	0	0	14.78574	0	0	0	0	0	0	0	15.01522	0	0	0	16.92884	0	15.46584	0	0	0	0	15.54663	12.93427	0
Q96CT7	CC124_HUMAN	Coiled-coil domain-containing protein 124	CCDC124	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; transcription by RNA polymerase II [GO:0006366]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; cell division [GO:0051301]; transcription by RNA polymerase II [GO:0006366]	RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0003723; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0006366; GO:0007049; GO:0030496; GO:0051301	GGKAPR	11.47000027	0.004848767	0.004848767	0.146790815	586.2614674	13.89369	15.36863	0	16.77785	0	0	14.18909	17.82682	0	0	14.82134	0	13.6872	16.402	12.14462	13.83166	17.042	0	20.25343	17.24664	15.53688	17.61586	13.41197	16.88955	0	18.97372	14.99899	16.41303	0	17.45745	17.24734	12.45238	16.43594	15.71594	17.01785	12.39565	16.72195	18.94944	16.89499	18.7995	17.5211	14.41238	17.07866	0	0	16.36334	15.72764	17.22009
Q96CV9	OPTN_HUMAN	"Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7, HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein, TFIIIA-IntP)"	OPTN FIP2 GLC1E HIP7 HYPL NRP	Homo sapiens (Human)	autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to unfolded protein [GO:0034620]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of receptor recycling [GO:0001920]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy [GO:0010508]; positive regulation of xenophagy [GO:1904417]; protein localization to Golgi apparatus [GO:0034067]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein C-terminus binding [GO:0008022]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to unfolded protein [GO:0034620]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of receptor recycling [GO:0001920]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy [GO:0010508]; positive regulation of xenophagy [GO:1904417]; protein localization to Golgi apparatus [GO:0034067]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein C-terminus binding [GO:0008022]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]	GO:0000139; GO:0001920; GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005794; GO:0005802; GO:0005829; GO:0006914; GO:0007030; GO:0007165; GO:0008022; GO:0008219; GO:0010508; GO:0030674; GO:0031267; GO:0031593; GO:0034067; GO:0034620; GO:0042802; GO:0043001; GO:0043122; GO:0043124; GO:0045087; GO:0046872; GO:0048471; GO:0050829; GO:0055038; GO:0061734; GO:0070530; GO:0090161; GO:1904417	AEAEQEK	3.74000001	1	1	0.009860794	805.2666849	0	0	0	15.56996	0	16.99239	15.12938	0	0	16.61196	15.18917	13.98543	0	0	13.66441	0	0	0	0	0	0	0	0	0	0	0	0	0	14.37148	15.42209	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.60842
Q96CW5	GCP3_HUMAN	"Gamma-tubulin complex component 3, GCP-3, hGCP3 (Gamma-ring complex protein 104 kDa, h104p, hGrip104) (Spindle pole body protein Spc98 homolog, hSpc98)"	TUBGCP3 GCP3	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; single fertilization [GO:0007338]; spindle assembly [GO:0051225]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; polar microtubule [GO:0005827]; spindle [GO:0005819]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; polar microtubule [GO:0005827]; spindle [GO:0005819]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; single fertilization [GO:0007338]; spindle assembly [GO:0051225]	gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0000278; GO:0000923; GO:0000930; GO:0005198; GO:0005200; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0007020; GO:0007338; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321	EGDTGGTMEITEAALVR	3.049999952	1	1	0.368639216	1766.953093	15.54725	16.91111	0	0	0	14.55733	0	14.86466	0	13.29414	14.53387	11.38049	0	0	0	0	0	0	0	0	0	0	0	0	15.97966	0	17.04305	16.12062	0	0	0	0	0	0	0	0	18.59149	0	0	0	0	0	0	14.95008	0	0	0	16.46068
Q96CW9	NTNG2_HUMAN	Netrin-G2 (Laminet-2)	NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic specialization assembly [GO:0098698]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888]	anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic specialization assembly [GO:0098698]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888]		GO:0005576; GO:0005886; GO:0007409; GO:0009887; GO:0009888; GO:0010975; GO:0016477; GO:0030424; GO:0034446; GO:0043256; GO:0046658; GO:0050804; GO:0070831; GO:0098685; GO:0098698; GO:0098978; GO:0099029; GO:0099560; GO:0150011; GO:1905606; GO:2001222	CNLHANLCSMR	9.069999695	0.969753921	0.969753921	0.076939305	1392.297726	0	14.08759	18.23922	0	17.24883	0	0	0	0	15.01667	15.57632	16.67648	17.78455	0	0	11.9796	0	16.44862	16.00624	16.61766	15.07299	15.36368	0	18.7226	14.14941	15.00552	0	0	15.46143	0	16.00802	8.468799	0	16.90838	0	17.7951	0	0	18.82718	16.83177	16.49351	0	0	14.09687	9.760975	0	0	16.15578
Q96D31	CRCM1_HUMAN	Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A)	ORAI1 CRACM1 TMEM142A	Homo sapiens (Human)	adaptive immune response [GO:0002250]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; mammary gland epithelium development [GO:0061180]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]	basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]	basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; store-operated calcium channel activity [GO:0015279]; adaptive immune response [GO:0002250]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; mammary gland epithelium development [GO:0061180]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115]	calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0002250; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0015279; GO:0016020; GO:0016323; GO:0034704; GO:0042802; GO:0044853; GO:0045121; GO:0045762; GO:0051924; GO:0051928; GO:0061180; GO:0070509; GO:0070588	SSPELPPSGGSTTSGSRR	2.460000038	1	1	0.181801487	1762.272208	16.69291	0	14.36696	14.21289	14.04549	14.21305	13.53755	16.35697	13.65788	15.81465	16.17558	0	0	0	0	0	0	0	0	0	0	0	17.06823	0	0	0	0	0	0	0	0	0	0	0	0	0	14.69309	0	0	0	0	0	0	0	0	0	0	0
Q96D46	NMD3_HUMAN	"60S ribosomal export protein NMD3, hNMD3"	NMD3 CGI-07	Homo sapiens (Human)	positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; protein transport [GO:0015031]; ribosomal large subunit export from nucleus [GO:0000055]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; protein transport [GO:0015031]; ribosomal large subunit export from nucleus [GO:0000055]	protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]	GO:0000055; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0015031; GO:0016020; GO:0030674; GO:0032092; GO:0043023; GO:1902680; GO:1904751	RAAGAGMISK	3.880000114	1	1	0.122833254	978.6275804	15.47874	0	0	0	0	0	13.25708	13.26609	0	0	0	0	0	0	0	0	0	0	0	0	15.0965	0	0	0	0	0	0	0	0	0	17.16713	12.79498	14.75956	0	11.23566	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96DA6	TIM14_HUMAN	Mitochondrial import inner membrane translocase subunit TIM14 (DnaJ homolog subfamily C member 19)	DNAJC19 TIM14 TIMM14	Homo sapiens (Human)	genitalia development [GO:0048806]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of cardiolipin metabolic process [GO:1900208]; visual perception [GO:0007601]	"inner mitochondrial membrane protein complex [GO:0098800]; integral component of membrane [GO:0016021]; matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405]; protein-containing complex [GO:0032991]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]"	"inner mitochondrial membrane protein complex [GO:0098800]; integral component of membrane [GO:0016021]; matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405]; protein-containing complex [GO:0032991]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATPase activator activity [GO:0001671]; genitalia development [GO:0048806]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of cardiolipin metabolic process [GO:1900208]; visual perception [GO:0007601]"	ATPase activator activity [GO:0001671]	GO:0001405; GO:0001671; GO:0005739; GO:0005743; GO:0005744; GO:0006457; GO:0006626; GO:0006886; GO:0007601; GO:0016021; GO:0030150; GO:0032991; GO:0048806; GO:0098800; GO:0099617; GO:1900208	INEAKDLLEGQAK	4.28000021	1	1	0.153940329	1430.290616	16.76312	0	15.15883	0	0	0	16.29663	0	0	0	0	0	0	0	0	0	0	0	0	0	17.30655	0	0	0	0	0	15.4577	0	0	0	0	17.44635	15.96099	15.08419	15.61087	0	0	0	15.38308	0	15.87111	16.5621	0	0	0	0	0	14.17254
Q96DB5	RMD1_HUMAN	"Regulator of microtubule dynamics protein 1, RMD-1, hRMD-1 (Protein FAM82B)"	RMDN1 FAM82B CGI-90	Homo sapiens (Human)	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; mitotic spindle organization [GO:0007052]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; mitotic spindle organization [GO:0007052]	microtubule binding [GO:0008017]	GO:0005737; GO:0005876; GO:0007052; GO:0008017; GO:0051315; GO:0097431	LLPFRR	11.22999954	0.775526285	0.775526285	0.201287339	801.1507314	15.71442	16.85034	14.69602	0	0	0	12.29287	0	14.03083	17.84754	0	15.01732	0	0	0	0	0	0	0	0	0	15.82668	0	0	0	0	0	16.98613	0	15.19236	17.04952	0	14.24753	0	0	0	0	0	0	0	0	0	0	0	0	0	15.76924	0
Q96DF8	ESS2_HUMAN	"Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H, DGS-H) (Protein ES2)"	ESS2 DGCR13 DGCR14 DGSH DGSI ES2	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]	"catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]"		GO:0000398; GO:0005634; GO:0007399; GO:0071013	NSLMYYPEGVPDEEQLFK	1.620000005	1	1	1.39E-12	2177.19373	0	0	0	0	0	10.99409	0	0	16.07892	16.03123	0	10.50738	0	0	0	0	0	11.63737	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.81793	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96DG6	CMBL_HUMAN	"Carboxymethylenebutenolidase homolog, EC 3.1.-.-"	CMBL	Homo sapiens (Human)	xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787]; xenobiotic metabolic process [GO:0006805]	hydrolase activity [GO:0016787]	GO:0005829; GO:0006805; GO:0016787; GO:0070062	DSEDIYNLK	8.550000191	0.60588032	0.60588032	0.218947697	1096.845789	14.65669	12.66468	17.17407	14.96318	14.29491	15.97206	0	0	13.23264	13.7628	16.2919	15.89118	14.70993	17.29286	12.79235	16.71583	15.19045	0	0	0	0	14.90476	0	0	13.62737	0	15.5733	0	0	0	14.29798	0	0	0	14.74621	0	9.915959	17.85221	15.99992	0	0	0	14.59458	14.1541	13.90073	0	0	0
Q96DH6	MSI2H_HUMAN	"RNA-binding protein Musashi homolog 2, Musashi-2"	MSI2	Homo sapiens (Human)	stem cell development [GO:0048864]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; polysome [GO:0005844]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; polysome [GO:0005844]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; stem cell development [GO:0048864]	identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005829; GO:0005844; GO:0008266; GO:0042802; GO:0043231; GO:0048864	AQPKMVTR	8.100000381	0.426941454	0.426941454	0.259419568	944.1447152	0	0	17.56402	17.51383	0	16.47816	13.50691	17.00334	16.75543	13.80229	15.92399	13.23288	15.60568	13.49038	11.83785	16.8892	15.19542	0	0	16.91622	15.83594	0	0	0	0	16.58775	0	15.06507	16.8265	0	17.36186	17.697	18.16629	15.8959	16.40065	14.85255	0	17.01129	0	15.37569	16.09061	17.05616	0	0	14.72327	0	0	0
Q96DM1	PGBD4_HUMAN	PiggyBac transposable element-derived protein 4	PGBD4	Homo sapiens (Human)						AMIPRQR	2.359999895	1	1	0.154392623	871.2351121	14.88819	11.64945	13.91753	13.62587	14.70438	12.08945	15.35781	0	14.84596	15.2742	15.6597	15.56172	0	0	0	0	0	0	0	0	0	0	0	16.98517	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.59601	0	0	0	15.03754	0	0	0
Q96DM3	RMC1_HUMAN	"Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1, Mic-1) (WD repeat-containing protein 98)"	RMC1 C18orf8 MIC1 WDR98	Homo sapiens (Human)	autophagy [GO:0006914]; regulation of autophagy [GO:0010506]	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]	late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]		GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658	AGTMSK	2.910000086	1	1	0.119202937	594.3468211	15.22049	13.74553	14.1871	14.15782	15.05404	14.11591	0	14.41991	13.09022	14.17094	0	14.31491	16.02415	0	0	0	0	0	0	17.50119	0	16.04402	14.95617	0	0	0	0	0	0	0	0	0	0	0	0	17.50348	0	17.22237	0	0	0	15.71411	0	0	0	0	16.07467	0
Q96DN0	ERP27_HUMAN	"Endoplasmic reticulum resident protein 27, ER protein 27, ERp27 (Inactive protein disulfide-isomerase 27)"	ERP27 C12orf46 UNQ781/PRO1575	Homo sapiens (Human)	protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]		GO:0005783; GO:0005788; GO:0006457; GO:0006986; GO:0034976	MEAAPSR	3.839999914	1	1	0	780.7357063	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.91691	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96DN2	VWCE_HUMAN	von Willebrand factor C and EGF domain-containing protein (HBV X protein up-regulated gene 11 protein) (HBxAg up-regulated gene 11 protein)	VWCE URG11	Homo sapiens (Human)	cellular response to virus [GO:0098586]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cellular response to virus [GO:0098586]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005737; GO:0098586	GEESTM	8.159999847	1	1	0.002816315	653.3363245	16.11475	15.02143	15.81486	17.47254	0	0	16.80678	0	0	0	0	15.73959	0	16.15538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.04277	0	0	0	0	0	0	16.32087	0	0	0	0	16.36349	0	17.34097	0	16.47011	0	0
Q96DP5	FMT_HUMAN	"Methionyl-tRNA formyltransferase, mitochondrial, MtFMT, EC 2.1.2.9"	MTFMT FMT FMT1	Homo sapiens (Human)	conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951]	methionyl-tRNA formyltransferase activity [GO:0004479]	GO:0004479; GO:0005739; GO:0071951	DGWIGVRSVMLK	3.75	1	1	6.89E-13	1376.691326	16.16463	16.57452	15.25526	0	0	0	14.04518	0	13.73748	0	0	14.03551	0	0	14.31051	11.94281	0	0	0	0	0	0	15.41805	0	0	15.97164	15.26414	16.13879	0	0	0	0	0	0	0	0	0	0	0	0	15.99149	0	0	14.41966	0	0	0	13.09859
Q96DR4	STAR4_HUMAN	"StAR-related lipid transfer protein 4 (START domain-containing protein 4, StARD4)"	STARD4	Homo sapiens (Human)	cholesterol import [GO:0070508]; cholesterol transport involved in cholesterol storage [GO:0010879]; intracellular cholesterol transport [GO:0032367]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of cholesterol esterification [GO:0010873]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol import [GO:0070508]; cholesterol transport involved in cholesterol storage [GO:0010879]; intracellular cholesterol transport [GO:0032367]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of cholesterol esterification [GO:0010873]	cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]	GO:0005737; GO:0005783; GO:0005829; GO:0010873; GO:0010879; GO:0015485; GO:0031410; GO:0032367; GO:0070508; GO:0070859; GO:0120020	EGLSDVASFATK	3.660000086	1	1	6.89E-13	1226.193676	11.7812	0	0	14.14133	0	0	0	0	0	11.91897	15.44852	0	11.86368	0	0	12.42301	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96DR7	ARHGQ_HUMAN	Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor)	ARHGEF26 SGEF HMFN1864	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; endothelial cell morphogenesis [GO:0001886]; ruffle assembly [GO:0097178]	cytosol [GO:0005829]; ruffle [GO:0001726]	cytosol [GO:0005829]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; endothelial cell morphogenesis [GO:0001886]; ruffle assembly [GO:0097178]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0001726; GO:0001886; GO:0005085; GO:0005829; GO:0090630; GO:0097178	AVPGGSPK	4.389999866	0.122821838	0.122821838	0.290469802	708.9855475	0	15.36438	0	13.74972	14.34143	12.90325	15.96317	14.802	15.87275	15.55002	0	0	0	14.34824	14.47147	0	0	0	14.69898	0	0	0	16.48567	0	0	0	0	0	0	15.52272	0	16.2519	15.51738	0	15.08049	0	0	0	0	15.88551	15.44864	0	0	15.9837	0	0	0	0
Q96DT5	DYH11_HUMAN	Dynein axonemal heavy chain 11 (Axonemal beta dynein heavy chain 11) (Ciliary dynein heavy chain 11)	DNAH11	Homo sapiens (Human)	cardiac septum morphogenesis [GO:0060411]; cilium movement [GO:0003341]; determination of left/right asymmetry in nervous system [GO:0035545]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; learning or memory [GO:0007611]; microtubule-based movement [GO:0007018]; protein localization to motile cilium [GO:0120229]; regulation of cilium beat frequency [GO:0003356]	9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; proximal portion of axoneme [GO:0120134]	9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; proximal portion of axoneme [GO:0120134]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cardiac septum morphogenesis [GO:0060411]; cilium movement [GO:0003341]; determination of left/right asymmetry in nervous system [GO:0035545]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; learning or memory [GO:0007611]; microtubule-based movement [GO:0007018]; protein localization to motile cilium [GO:0120229]; regulation of cilium beat frequency [GO:0003356]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003341; GO:0003356; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007611; GO:0008569; GO:0030286; GO:0030317; GO:0031514; GO:0035545; GO:0045505; GO:0051959; GO:0060287; GO:0060411; GO:0097728; GO:0097729; GO:0120134; GO:0120229	VIQQTMR	21.39999962	0.339390397	0.339390397	1.03E-12	891.4565194	0	16.82888	0	17.66907	15.97095	16.96347	16.70596	0	16.15324	18.2077	0	15.427	0	14.0429	0	16.21626	16.68782	14.50055	0	0	13.59039	0	0	19.29081	17.56378	11.59124	15.36332	14.04552	14.66299	14.70757	13.64309	18.18132	0	15.55909	17.40676	17.05638	15.91984	0	14.26826	0	14.34391	11.49734	14.5989	16.73582	18.0782	16.49311	0	12.57
Q96DT6	ATG4C_HUMAN	"Cysteine protease ATG4C, EC 3.4.22.- (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3, Autophagin-3) (Autophagy-related protein 4 homolog C, HsAPG4C)"	ATG4C APG4C AUTL1 AUTL3	Homo sapiens (Human)	autophagy [GO:0006914]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; autophagy [GO:0006914]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0051697	MEATGTDEVDK	9.100000381	1	1	0.079025322	1193.116723	14.57517	13.5896	0	16.84187	13.32648	12.48089	0	0	0	13.94707	0	0	0	9.754203	0	0	0	0	0	0	0	14.8246	0	0	14.80196	10.62357	0	0	15.73744	0	0	0	0	0	0	0	0	0	0	0	0	0	12.30493	0	0	16.12218	0	0
Q96DT7	ZBT10_HUMAN	Zinc finger and BTB domain-containing protein 10 (Zinc finger protein RIN ZF)	ZBTB10 RINZF RINZFC	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; telomeric DNA binding [GO:0042162]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; telomeric DNA binding [GO:0042162]"	GO:0000122; GO:0000781; GO:0000977; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042162; GO:0046872	SFSEMNRR	5.300000191	1	1	0.138764503	1042.17595	12.93273	15.93118	15.6908	14.85298	0	0	0	0	0	0	0	0	0	14.0897	0	0	0	0	14.96584	0	15.29049	0	0	0	14.95597	12.82703	0	15.24049	0	0	0	15.17561	15.90824	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96DU3	SLAF6_HUMAN	"SLAM family member 6 (Activating NK receptor) (NK-T-B-antigen, NTB-A) (CD antigen CD352)"	SLAMF6 KALI UNQ6123/PRO20080	Homo sapiens (Human)	innate immune response [GO:0045087]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]		GO:0005886; GO:0009897; GO:0016021; GO:0032729; GO:0032740; GO:0042110; GO:0045087; GO:0045954; GO:0070062; GO:0072540	LSSYTLR	7.480000019	1	1	1.22E-13	837.3731345	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.69978	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96DU9	PABP5_HUMAN	"Polyadenylate-binding protein 5, PABP-5, Poly(A)-binding protein 5"	PABPC5 PABP5	Homo sapiens (Human)		cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]	GO:0003723; GO:0003730; GO:0005634; GO:0005759; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:1990904	YETHEAAQK	8.050000191	1	1	6.93E-13	1074.988497	0	0	0	0	0	0	0	17.38932	0	0	0	19.57368	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.93294	0	0	0	18.45504	0	0	0	0	0	0	0	0	0	0	0	0	17.59422	0
Q96DV4	RM38_HUMAN	"39S ribosomal protein L38, mitochondrial, L38mt, MRP-L38 (Mitochondrial large ribosomal subunit protein mL38)"	MRPL38 HSPC262	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543]		GO:0005739; GO:0005743; GO:0005762; GO:0032543	TFDFYKK	1.179999948	1	1	0.186515036	948.0585318	16.71735	14.60891	12.60359	0	13.53065	0	11.82025	0	14.18467	0	0	0	0	0	15.07891	0	0	0	0	0	8.893752	14.18136	0	0	0	0	17.29277	15.43718	14.02993	0	0	0	0	0	0	15.45802	0	0	0	14.46048	0	0	11.80944	16.75503	0	0	12.60822	0
Q96DY2	DRC10_HUMAN	Dynein regulatory complex protein 10 (IQ domain-containing protein D)	IQCD DRC10	Homo sapiens (Human)		ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]		GO:0005737; GO:0031514; GO:0036064	EDMEGMLGEDVMR	7.480000019	0.759675145	0.759675145	0.167198683	1543.201646	15.61754	0	16.22944	0	15.33227	0	16.03561	13.45649	14.37696	15.7993	16.33455	16.27808	15.21318	12.32551	0	10.875	15.00114	0	14.66324	15.05101	15.14034	16.37912	0	15.17899	13.97033	14.22831	10.24512	16.48535	15.85828	18.93288	0	15.85869	0	0	16.45745	15.49374	14.55941	15.02679	15.8114	15.29123	14.57798	0	15.22839	12.46851	14.97522	15.63812	0	0
Q96DY7	MTBP_HUMAN	"Mdm2-binding protein, hMTBP"	MTBP	Homo sapiens (Human)	cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089]	chromatin [GO:0000785]; kinetochore [GO:0000776]	chromatin [GO:0000785]; kinetochore [GO:0000776]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089]		GO:0000776; GO:0000785; GO:0007049; GO:0007089; GO:0008285; GO:0031396; GO:0034501; GO:0045839	LKDYLPTVGALK	6.670000076	1	1	0.123852894	1318.000297	12.04962	0	17.19493	0	0	0	14.40353	12.39292	0	0	0	12.55358	0	0	0	13.62	0	13.27528	0	13.13588	0	15.49603	0	0	0	0	0	0	13.55134	9.919089	14.00879	14.67926	12.45414	13.32481	12.72791	14.0269	13.88839	13.54449	13.54539	12.81236	12.98031	11.34718	0	0	0	14.47095	0	0
Q96DZ1	ERLEC_HUMAN	"Endoplasmic reticulum lectin 1 (ER lectin, Erlectin) (XTP3-transactivated gene B protein)"	ERLEC1 C2orf30 XTP3TPB UNQ1878/PRO4321	Homo sapiens (Human)	"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]	"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; ubiquitin-dependent ERAD pathway [GO:0030433]"	unfolded protein binding [GO:0051082]	GO:0005788; GO:0030433; GO:0030968; GO:0036503; GO:0044322; GO:0051082; GO:1904153	NIEGQMTPYYPVGMGNGTPCSLKQNRPR	2.650000095	1	1	0.072554028	3182.457639	0	13.59998	11.82911	0	15.1812	14.30111	0	14.91759	14.63839	14.2218	14.33762	12.65368	15.9286	10.8399	0	0	0	13.89976	0	0	0	14.06771	0	0	0	0	0	0	0	0	0	15.55728	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96DZ5	CLIP3_HUMAN	"CAP-Gly domain-containing linker protein 3 (Cytoplasmic linker protein 170-related 59 kDa protein, CLIP-170-related 59 kDa protein, CLIPR-59)"	CLIP3 CLIPR59	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein transport along microtubule [GO:0098840]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein transport along microtubule [GO:0098840]	ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0001934; GO:0005634; GO:0005737; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0008017; GO:0010828; GO:0018230; GO:0031115; GO:0031122; GO:0031901; GO:0032588; GO:0035371; GO:0035594; GO:0043065; GO:0044091; GO:0045121; GO:0045444; GO:0045807; GO:0051010; GO:0055038; GO:0098840; GO:1903078	TDFAPGYWYGIELDQPTGK	7.610000134	1	1	0.225361099	2158.306721	14.01918	0	15.12841	0	0	0	0	0	16.96845	0	16.19035	16.46737	0	0	0	0	0	15.97901	0	0	0	16.68691	0	14.02059	0	0	15.5646	14.12921	16.82826	14.63836	0	0	0	15.43923	0	15.90792	0	0	16.59818	0	15.44563	0	0	0	0	0	0	0
Q96DZ7	T4S19_HUMAN	Transmembrane 4 L6 family member 19 (Osteoclast maturation-associated gene 4 protein) (Tetraspan membrane protein OCTM4)	TM4SF19 OCTM4	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	NYLYDR	14.30000019	0.440084755	0.440084755	0.39998465	841.9770936	16.32374	16.0596	0	0	0	16.15045	15.42427	16.07396	15.67432	16.1979	0	0	16.18136	17.08325	0	15.96006	0	0	0	15.78063	16.72993	0	17.02032	0	15.08527	16.41273	15.1172	15.36242	16.3329	0	15.34612	14.64525	16.27247	0	13.66513	0	13.84899	13.47205	17.70284	13.18682	16.32829	15.97034	15.24174	0	15.32425	14.53878	14.6314	14.41417
Q96E11	RRFM_HUMAN	"Ribosome-recycling factor, mitochondrial, RRF (Ribosome-releasing factor, mitochondrial)"	MRRF	Homo sapiens (Human)	ribosome disassembly [GO:0032790]; translation [GO:0006412]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; ribosome disassembly [GO:0032790]; translation [GO:0006412]	ribosomal large subunit binding [GO:0043023]	GO:0005739; GO:0005759; GO:0006412; GO:0032790; GO:0043023	MVHPTFR	5.96999979	1	1	0.081773443	888.8006221	0	0	0	0	0	0	0	14.78431	0	0	0	0	15.60352	0	17.57183	0	0	14.82366	0	0	0	0	0	0	15.25237	0	0	15.35454	0	0	0	15.98349	0	0	0	0	17.33931	15.22024	15.68559	15.74076	15.74155	12.36987	0	0	0	0	0	0
Q96E14	RMI2_HUMAN	"RecQ-mediated genome instability protein 2, hRMI2 (BLM-associated protein of 18 kDa, BLAP18)"	RMI2 C16orf75	Homo sapiens (Human)	DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; maintenance of rDNA [GO:0043007]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of sister chromatid segregation [GO:0033045]; resolution of recombination intermediates [GO:0071139]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; maintenance of rDNA [GO:0043007]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of sister chromatid segregation [GO:0033045]; resolution of recombination intermediates [GO:0071139]	DNA binding [GO:0003677]	GO:0000724; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0016607; GO:0031422; GO:0033045; GO:0043007; GO:0071139; GO:2000042	VVMADR	16.59000015	1	1	0.204223877	704.8941661	17.56442	0	0	16.96595	15.77704	0	15.54011	17.13331	16.25538	14.61727	0	0	14.71535	15.2549	0	0	0	0	0	17.28509	16.0328	15.00385	14.48463	0	0	0	17.52845	0	0	0	17.90462	0	0	14.83983	0	0	18.74999	0	0	0	16.79796	16.15836	0	0	15.47338	0	14.91459	0
Q96E52	OMA1_HUMAN	"Metalloendopeptidase OMA1, mitochondrial, EC 3.4.24.- (Metalloprotease-related protein 1, MPRP-1) (Overlapping with the m-AAA protease 1 homolog)"	OMA1 MPRP1	Homo sapiens (Human)	cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638]	lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0008289; GO:0010637; GO:0016020; GO:0016021; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0034982; GO:0042407; GO:0042981; GO:0043065; GO:0046872; GO:0051603; GO:0097009; GO:0120162; GO:0140467; GO:0140468; GO:1903850	EVTAVPSLSVLHPLSPASIR	5.210000038	0.372760385	0.372760385	0.425042933	2072.200689	0	0	0	0	0	0	10.39061	14.51811	12.78816	17.26218	17.1544	14.84643	0	0	11.92493	0	0	12.34458	18.23214	0	14.95013	0	17.29077	0	0	0	16.59431	17.07914	0	15.72124	0	18.99254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.99976
Q96EA4	SPDLY_HUMAN	"Protein Spindly, hSpindly (Arsenite-related gene 1 protein) (Coiled-coil domain-containing protein 99) (Rhabdomyosarcoma antigen MU-RMS-40.4A) (Spindle apparatus coiled-coil domain-containing protein 1)"	SPDL1 CCDC99	Homo sapiens (Human)	cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]	cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]; enzyme binding [GO:0019899]; kinetochore binding [GO:0043515]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]	enzyme binding [GO:0019899]; kinetochore binding [GO:0043515]	GO:0000132; GO:0000922; GO:0000940; GO:0005634; GO:0005815; GO:0005829; GO:0007080; GO:0007094; GO:0016477; GO:0019899; GO:0034501; GO:0043515; GO:0051301	EGKETSSK	13.98999977	1	1	0.0337895	866.5633844	0	15.76233	13.58432	16.28248	16.46733	0	0	17.30934	0	0	0	0	0	0	0	0	0	15.67928	0	0	0	0	0	0	0	0	0	0	0	0	15.17387	16.56565	0	0	0	15.06636	17.59866	0	15.4593	0	0	15.52733	0	0	0	0	0	0
Q96EB1	ELP4_HUMAN	"Elongator complex protein 4, hELP4 (PAX6 neighbor gene protein)"	ELP4 C11orf19 PAXNEB	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098]	phosphorylase kinase regulator activity [GO:0008607]	GO:0002098; GO:0005654; GO:0005737; GO:0006357; GO:0006368; GO:0006417; GO:0008023; GO:0008607; GO:0033588	YQLLPKMEIGPVSSSR	3.829999924	1	1	0.253304511	1820.825573	15.86502	0	0	0	12.73281	13.96199	0	13.96572	0	0	0	0	16.97367	0	0	10.72701	0	0	0	12.57272	13.03068	14.86895	0	0	0	0	16.74895	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96EB6	SIR1_HUMAN	"NAD-dependent protein deacetylase sirtuin-1, hSIRT1, EC 2.3.1.286 (NAD-dependent protein deacylase sirtuin-1, EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1, hSIR2) [Cleaved into: SirtT1 75 kDa fragment, 75SirT1 ]"	SIRT1 SIR2L1	Homo sapiens (Human)	"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone methylation [GO:0031062]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]"	chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]	"chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cell aging [GO:0007569]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone methylation [GO:0031062]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]"	bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006346; GO:0006476; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007569; GO:0008022; GO:0008284; GO:0009267; GO:0010629; GO:0010824; GO:0010875; GO:0010883; GO:0010906; GO:0014068; GO:0016239; GO:0016567; GO:0016575; GO:0016605; GO:0016922; GO:0017136; GO:0018394; GO:0019213; GO:0019899; GO:0030225; GO:0030308; GO:0030512; GO:0031062; GO:0031065; GO:0031393; GO:0031507; GO:0031648; GO:0032007; GO:0032071; GO:0032088; GO:0032868; GO:0032922; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0034983; GO:0035356; GO:0035358; GO:0042127; GO:0042149; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043280; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0050872; GO:0051019; GO:0051097; GO:0051152; GO:0051574; GO:0051898; GO:0055089; GO:0060766; GO:0060907; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0070932; GO:0071356; GO:0071441; GO:0071456; GO:0071479; GO:0071900; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0160012; GO:1900034; GO:1900113; GO:1901215; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000480; GO:2000481; GO:2000619; GO:2000655; GO:2000757; GO:2000773; GO:2000774	KCWPNR	5.409999847	1	1	0.094450323	861.4100671	14.77971	9.51987	0	0	0	0	0	0	0	0	0	0	0	16.84798	0	0	0	0	16.6235	18.49624	0	0	0	17.00596	15.24375	16.17831	0	15.51352	14.91649	14.93449	15.92415	15.81732	15.94273	0	0	0	0	0	0	0	0	0	0	0	0	18.61333	16.85796	0
Q96ED9	HOOK2_HUMAN	"Protein Hook homolog 2, h-hook2, hHK2"	HOOK2	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; trans-Golgi network [GO:0005802]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; trans-Golgi network [GO:0005802]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]	dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]	GO:0005737; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0006897; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0042802; GO:0043231; GO:0045022; GO:0051959; GO:0070695; GO:1905719	QEEAMK	7.239999771	1	1	0.206341053	735.1466747	0	0	15.47159	0	0	0	0	0	0	0	0	0	0	0	17.47566	0	0	17.08309	0	0	0	0	0	0	0	0	0	0	0	0	16.34434	0	0	0	0	16.81762	17.30931	0	17.56268	0	16.98659	0	0	0	0	0	0	0
Q96EE3	SEH1_HUMAN	Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein)	SEH1L SEC13L SEH1	Homo sapiens (Human)	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of TORC1 signaling [GO:1904262]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]	cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of TORC1 signaling [GO:1904262]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]	structural molecule activity [GO:0005198]	GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005765; GO:0005829; GO:0006913; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0031503; GO:0032008; GO:0034198; GO:0035859; GO:0050830; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904262; GO:1904263	FAPKHMGLMLATCSADGIVR	4.25	1	1	0.235173552	2191.648592	14.04607	0	10.8073	0	0	0	0	13.29687	15.31227	0	11.10312	8.337968	0	15.16024	15.4063	0	14.32748	0	0	15.00206	13.54918	0	16.13629	14.75251	0	0	15.06326	12.8308	15.06221	0	14.87555	3.395534	11.65924	10.15689	0	15.36137	15.12105	0	15.4676	15.02382	0	0	9.94556	13.02896	14.83168	0	0	0
Q96EG3	ZN837_HUMAN	Zinc finger protein 837	ZNF837	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872	GAAGGR	10.47000027	1	1	0.190283364	487.2579229	17.61952	17.84656	17.67155	22.01005	17.40205	18.87593	0	17.9041	0	17.60967	0	19.0196	18.43511	17.61537	17.79892	18.58638	16.96482	0	17.16362	0	18.58418	18.64291	18.44212	18.58068	18.87773	0	19.49118	0	18.12511	18.47096	19.71178	18.51175	0	0	0	19.05132	0	0	0	0	18.41899	17.71021	0	16.90556	18.72785	18.68929	0	19.20479
Q96EI5	TCAL4_HUMAN	"Transcription elongation factor A protein-like 4, TCEA-like protein 4 (Transcription elongation factor S-II protein-like 4)"	TCEAL4 NPD017	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; WW domain binding [GO:0050699]	WW domain binding [GO:0050699]	GO:0005634; GO:0050699	EFDNMAKVQDEK	1.840000033	1	1	0.408000019	1452.291162	0	0	0	0	0	0	0	0	17.59195	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84027	0	0	0	0	0	0	0	0	0	0	18.54862	0	0	0	0	0	0	0	0	0
Q96EK5	KBP_HUMAN	KIF-binding protein (KIF1-binding protein) (Kinesin family binding protein)	KIFBP KBP KIAA1279 KIF1BP	Homo sapiens (Human)	cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]	cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]	cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; kinesin binding [GO:0019894]; cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399]	kinesin binding [GO:0019894]	GO:0001701; GO:0005739; GO:0005856; GO:0006839; GO:0007399; GO:0019894; GO:0030154	NPEKEPYK	1.529999971	1	1	0.082508846	1002.728727	14.26569	0	14.13181	0	0	0	15.26979	0	15.60234	16.54912	13.17064	11.85363	13.55757	13.59433	13.81792	13.35527	12.61826	16.03442	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.67411	0	0	0
Q96EK7	F120B_HUMAN	"Constitutive coactivator of peroxisome proliferator-activated receptor gamma, Constitutive coactivator of PPAR-gamma, Constitutive coactivator of PPARG (PPARG constitutive coactivator 1, PGCC1) (Protein FAM120B)"	FAM120B CCPG KIAA1838	Homo sapiens (Human)	fat cell differentiation [GO:0045444]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]	nucleus [GO:0005634]	nucleus [GO:0005634]; fat cell differentiation [GO:0045444]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]		GO:0005634; GO:0035357; GO:0045444	GVRGLQGFVGSTCPHICTVVNFK	2.460000038	1	1	2.74E-12	2533.821802	11.60649	13.88015	0	0	11.84597	7.998786	0	0	0	13.30669	13.11667	0	0	10.71694	0	0	0	13.04129	11.70364	9.524589	0	12.3961	13.43273	0	0	0	0	0	0	0	0	0	0	15.93489	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96EK9	KTI12_HUMAN	Protein KTI12 homolog	KTI12 SBBI81	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]		ATP binding [GO:0005524]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]	ATP binding [GO:0005524]	GO:0002098; GO:0005524; GO:0006357	EESGAAESPALVTPDSEK	9.210000038	0.66855067	0.66855067	0.211822432	1816.231255	15.70246	11.5385	15.83244	12.57753	14.12146	0	0	0	0	0	12.81475	0	16.71399	0	0	0	0	0	0	0	12.35426	0	15.47335	0	15.85436	17.96969	0	0	0	13.2794	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96EM0	T3HPD_HUMAN	"Trans-3-hydroxy-L-proline dehydratase, EC 4.2.1.77 (Trans-L-3-hydroxyproline dehydratase)"	L3HYPDH C14orf149	Homo sapiens (Human)			hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346]	hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346]	GO:0016836; GO:0050346	MESALAVPR	2.349999905	0.623421907	0.623421907	0.279538737	990.0417998	17.66587	18.53963	0	0	0	0	0	0	18.25704	16.34116	0	0	17.19813	0	0	17.70348	16.58525	0	0	0	16.8211	0	17.39436	0	0	0	0	0	16.94237	0	0	0	0	0	0	0	0	0	0	0	0	18.34556	0	16.99194	16.55196	0	0	18.12046
Q96EN8	MOCOS_HUMAN	"Molybdenum cofactor sulfurase, MCS, MOS, MoCo sulfurase, hMCS, EC 2.8.1.9 (Molybdenum cofactor sulfurtransferase)"	MOCOS	Homo sapiens (Human)	Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545]	cytosol [GO:0005829]	cytosol [GO:0005829]; lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545]	lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]	GO:0005829; GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0032324; GO:0043545; GO:0102867	DPSAPR	3.869999886	0.06630493	0.06630493	0.245609268	642.902395	0	14.80933	0	15.82007	0	14.2739	15.0564	0	14.40637	13.30138	15.41111	0	0	0	0	0	16.1887	14.56328	0	17.31251	16.0894	0	16.00525	0	0	16.40914	0	0	15.58272	15.82843	0	17.17448	0	0	15.16295	0	16.11536	16.85626	16.31947	0	16.29114	15.85276	16.17614	0	14.52747	0	0	0
Q96EN9	REX1B_HUMAN	Required for excision 1-B domain-containing protein	REX1BD C19orf60	Homo sapiens (Human)						LGTVALLQLMETPELAGQEDAVR	7.130000114	0.436993808	0.436993808	5.02E-12	2470.782411	15.4613	16.14546	0	0	15.19557	15.94138	15.25796	0	0	0	15.0491	15.62336	15.36777	13.24421	0	0	14.25972	14.84866	17.38863	13.6199	12.19528	15.26833	14.82493	14.69919	13.66183	16.83156	15.2694	14.57746	14.73958	12.02657	17.81575	16.7627	15.88368	0	17.92997	16.91615	0	16.62555	15.26681	0	0	14.09761	0	17.0075	0	16.7491	0	14.12502
Q96EP1	CHFR_HUMAN	"E3 ubiquitin-protein ligase CHFR, EC 2.3.2.27 (Checkpoint with forkhead and RING finger domains protein) (RING finger protein 196) (RING-type E3 ubiquitin transferase CHFR)"	CHFR RNF196	Homo sapiens (Human)	cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic G2/M transition checkpoint [GO:0044818]; modification-dependent protein catabolic process [GO:0019941]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634]; PML body [GO:0016605]	nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic G2/M transition checkpoint [GO:0044818]; modification-dependent protein catabolic process [GO:0019941]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000166; GO:0000209; GO:0004842; GO:0005634; GO:0006511; GO:0016567; GO:0016605; GO:0019941; GO:0031398; GO:0031648; GO:0032436; GO:0044779; GO:0044818; GO:0046872; GO:0051301; GO:0061630	AEREQDPR	9.279999733	0.294627815	0.294627815	0.140513271	1001.481676	18.12476	0	16.48975	13.94004	0	15.72834	16.21728	15.94571	15.30187	9.339234	17.75797	15.53025	0	0	0	0	0	14.6809	0	17.31607	14.05648	13.45581	17.63529	17.30203	16.16464	0	16.09444	18.99745	0	0	18.49949	0	18.66315	16.18258	15.61769	16.77008	15.85281	0	0	15.80788	0	0	17.0372	0	15.70358	17.88956	17.88459	12.66348
Q96ER9	MITOK_HUMAN	"Mitochondrial potassium channel, MITOK (Coiled-coil domain-containing protein 51)"	CCDC51 MITOK	Homo sapiens (Human)	cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial ATP-gated potassium channel activity [GO:0062156]; cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]	mitochondrial ATP-gated potassium channel activity [GO:0062156]	GO:0005743; GO:0006884; GO:0031305; GO:0062156; GO:0062157; GO:0071805; GO:0140141	LPALGRALGHSIQQR	4.179999828	1	1	0.175461574	1617.298246	0	16.60639	0	16.47013	0	0	0	0	14.92047	0	0	0	0	0	0	0	0	0	0	0	15.90884	0	0	0	0	0	12.03162	0	0	14.99902	0	0	0	0	0	0	0	17.08076	0	14.99254	0	0	0	0	0	0	0	0
Q96ES6	MFSD3_HUMAN	Major facilitator superfamily domain-containing protein 3	MFSD3	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; solute:proton symporter activity [GO:0015295]	solute:proton symporter activity [GO:0015295]	GO:0015295; GO:0016021	VLYAPWLLKLAWAPLVDAQGSAR	2.079999924	1	1	0.256178096	2538.614077	0	0	0	0	0	0	0	0	19.57774	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96EV2	RBM33_HUMAN	RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33)	RBM33 PRR8	Homo sapiens (Human)			RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723	EGTIIR	9.020000458	0.979525506	0.979525506	0.279826705	688.0543009	15.75397	0	0	13.48272	14.99299	0	13.47401	16.21072	16.61281	12.58751	14.93967	15.003	14.46713	14.71446	0	16.53933	0	15.91605	16.74242	0	15.85199	14.93726	14.8553	15.65197	0	0	16.3023	15.39736	16.81337	15.47828	0	16.47124	0	0	16.15191	0	16.59288	0	17.01314	16.52066	16.21749	0	15.99901	16.82516	0	16.09335	16.78768	15.35054
Q96EX2	RNFT2_HUMAN	RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118)	RNFT2 TMEM118	Homo sapiens (Human)	positive regulation of ERAD pathway [GO:1904294]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of ERAD pathway [GO:1904294]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0016021; GO:0046872; GO:0061630; GO:1904294	SFDICGR	5.760000229	0.311293423	0.311293423	0.163514072	854.3155612	0	0	17.39488	19.03567	16.9919	16.49171	18.53633	15.79242	0	0	15.97028	0	0	0	0	16.48459	0	15.28325	0	0	0	0	0	0	0	0	0	13.92171	0	0	17.44682	13.66383	17.50077	14.29557	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96EY1	DNJA3_HUMAN	"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1, hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)"	DNAJA3 HCA57 TID1	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]	ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082]	GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006469; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0106137; GO:0140297	MGGKGIPR	9.630000114	0.291900754	0.291900754	0.255479031	831.5880164	19.61098	0	0	17.83191	17.85978	20.10213	19.06733	17.8308	17.37343	19.04143	17.74682	18.14244	16.73892	0	14.54841	17.29938	0	18.02843	18.99825	18.64815	19.0561	0	19.77496	17.61838	18.63885	19.22218	18.92113	18.41811	15.96745	0	0	18.59613	18.39313	0	18.30774	0	18.62796	20.41512	18.54667	18.33686	17.28028	17.59566	18.07228	18.24177	17.70149	0	0	18.72341
Q96EY4	TMA16_HUMAN	Translation machinery-associated protein 16	TMA16 C4orf43	Homo sapiens (Human)		nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005730	KAAQITR	5.769999981	1	1	0.049163439	787.6715488	0	13.26556	0	0	14.80323	0	0	15.82777	15.20946	0	0	15.81699	0	0	0	15.33014	0	14.55408	0	0	15.46193	0	0	0	11.83924	0	0	0	15.06548	0	0	0	0	16.89646	0	14.35013	0	0	0	0	15.80034	15.80107	0	0	0	0	0	0
Q96EY5	MB12A_HUMAN	Multivesicular body subunit 12A (CIN85/CD2AP family-binding protein) (ESCRT-I complex subunit MVB12A) (Protein FAM125A)	MVB12A CFBP FAM125A	Homo sapiens (Human)	endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; virus maturation [GO:0019075]	centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; vesicle [GO:0031982]	centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; vesicle [GO:0031982]; lipid binding [GO:0008289]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; virus maturation [GO:0019075]	lipid binding [GO:0008289]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130]	GO:0000813; GO:0005634; GO:0005813; GO:0005829; GO:0008289; GO:0010008; GO:0015031; GO:0016236; GO:0017124; GO:0019075; GO:0031902; GO:0031982; GO:0032510; GO:0032801; GO:0036258; GO:0039702; GO:0042058; GO:0043130; GO:0043162; GO:0043231; GO:0046755; GO:0070062	DMQGLSLDAASQPSKGGLLER	1.75	1	1	0.195690909	2172.993747	16.92561	14.13634	15.80714	15.90587	13.26512	13.30359	0	12.98713	12.78462	0	0	0	14.12976	0	0	0	0	0	0	0	13.31801	0	0	0	0	13.30163	13.16259	14.13031	0	13.51502	13.17479	17.35327	0	0	0	0	0	15.75165	0	15.91234	0	0	0	15.45637	0	0	0	15.00056
Q96EY7	PTCD3_HUMAN	"Pentatricopeptide repeat domain-containing protein 3, mitochondrial (28S ribosomal protein S39, mitochondrial, MRP-S39) (Mitochondrial small ribosomal subunit protein mS39) (Transformation-related gene 15 protein, TRG-15)"	PTCD3 MRPS39 TRG15	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]	ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0003723; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0005829; GO:0005886; GO:0006417; GO:0019843; GO:0032543; GO:0043024	MLGLFRK	4.989999771	1	1	0.075044219	881.6233291	15.191	0	14.92834	13.25677	12.63397	0	14.87119	0	14.43174	13.43577	0	0	0	0	12.42449	0	0	0	0	0	0	0	0	0	16.70214	0	0	0	0	0	0	0	0	17.44867	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96EY8	MMAB_HUMAN	"Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)"	MMAB	Homo sapiens (Human)	cobalamin metabolic process [GO:0009235]	mitochondrial matrix [GO:0005759]	"mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]; cobalamin metabolic process [GO:0009235]"	"ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]"	GO:0005524; GO:0005759; GO:0008817; GO:0009235; GO:0031419	FLNRLSDYLFTLAR	2.50999999	1	1	0.315939644	1726.561232	15.8249	0	16.35443	0	11.50786	14.13314	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.58121	0	0	0	0	0	0	15.48965	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96EY9	ADAT3_HUMAN	Probable inactive tRNA-specific adenosine deaminase-like protein 3 (tRNA-specific adenosine-34 deaminase subunit ADAT3)	ADAT3 TAD3	Homo sapiens (Human)	tRNA processing [GO:0008033]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]; tRNA processing [GO:0008033]	catalytic activity [GO:0003824]; metal ion binding [GO:0046872]	GO:0003824; GO:0005654; GO:0008033; GO:0046872	MEPAPGLVEQPK	3.769999981	1	1	0.049215942	1294.532532	14.43292	14.21765	14.53874	12.74669	12.23756	12.26809	19.02709	0	0	9.444305	0	13.54452	0	0	14.13575	0	0	0	0	0	0	14.53934	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96EZ8	MCRS1_HUMAN	Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)	MCRS1 INO80Q MSP58	Homo sapiens (Human)	"cellular protein modification process [GO:0006464]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; cellular protein modification process [GO:0006464]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]"	G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]	GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006464; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0042766; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051571; GO:0051726; GO:0051974; GO:0060382; GO:0071339; GO:1900095; GO:1904357; GO:1904507; GO:1904751	QPLQVTK	6.460000038	1	1	0.08307379	813.2680738	0	0	0	0	0	0	18.29485	0	0	18.47347	0	0	0	0	0	0	0	0	0	0	17.71093	0	0	0	0	0	0	0	0	0	0	18.39337	0	0	0	0	0	0	0	0	0	0	17.00374	0	0	0	0	0
Q96F07	CYFP2_HUMAN	Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121)	CYFIP2 KIAA1168 PIR121	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202]; small GTPase binding [GO:0031267]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]	small GTPase binding [GO:0031267]	GO:0000902; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016020; GO:0030833; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0070062; GO:0097202; GO:0097484; GO:0098609	GLQVLMGRMESVFNQAIR	7.650000095	1	1	0.200444034	2066.144009	12.645	12.30715	0	0	0	14.14154	0	0	12.66838	0	0	0	13.44895	12.71772	15.32557	14.65911	15.03327	0	0	14.26106	14.32438	13.35578	15.49705	15.35673	0	14.14031	0	15.16017	14.97122	14.2705	15.27462	13.4011	12.7236	12.60218	0	0	0	17.42334	0	15.00446	0	0	14.83633	10.50489	14.94558	12.10049	0	0
Q96F10	SAT2_HUMAN	"Thialysine N-epsilon-acetyltransferase, EC 2.3.1.- (Diamine acetyltransferase 2, EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2, SSAT-2)"	SAT2 SSAT2	Homo sapiens (Human)	nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919]	diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]	GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204; GO:0070062	GQGIGSKIIK	5.989999771	1	1	0.03447605	1001.536065	13.69673	0	0	0	14.02515	15.53651	15.73197	15.91726	12.94427	0	14.90493	16.66673	16.89744	16.285	0	0	17.80528	17.35817	17.64536	19.0343	0	0	17.37516	18.18558	0	17.62169	17.21873	16.7797	17.00757	0	16.96414	18.86204	16.33334	16.657	0	16.71015	18.14226	0	17.6952	18.86383	17.04067	0	16.92029	0	17.89312	0	0	0
Q96F45	ZN503_HUMAN	Zinc finger protein 503	ZNF503 NOLZ1	Homo sapiens (Human)	"G1 to G0 transition involved in cell differentiation [GO:0070315]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neural precursor cell proliferation [GO:0061351]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; metal ion binding [GO:0046872]; G1 to G0 transition involved in cell differentiation [GO:0070315]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neural precursor cell proliferation [GO:0061351]"	metal ion binding [GO:0046872]	GO:0005634; GO:0008285; GO:0010629; GO:0045892; GO:0046872; GO:0061351; GO:0070315	KEPGGGGGGGGGGGGGGGGVSSEK	8.989999771	1	1	0.188747016	1815.046569	14.00447	0	15.01703	15.72755	15.1773	0	13.94451	14.37669	14.65782	14.36265	15.28061	12.87418	16.10872	14.51188	15.49489	12.79602	0	0	16.48783	0	0	0	0	0	15.98389	0	0	16.87501	0	15.75548	0	0	0	0	0	0	17.58472	0	0	0	0	0	0	0	0	0	0	0
Q96F81	DISP1_HUMAN	Protein dispatched homolog 1	DISP1 DISPA	Homo sapiens (Human)	determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; peptide transmembrane transporter activity [GO:1904680]; determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708]	peptide transmembrane transporter activity [GO:1904680]	GO:0007225; GO:0007368; GO:0009880; GO:0009953; GO:0015833; GO:0016021; GO:0016323; GO:0050708; GO:0060539; GO:0070207; GO:1904680	GPKSELEHEFYELEPLASHSCTAPEK	4.949999809	1	1	0.111311763	2985.601643	14.47954	0	12.57913	0	13.75288	12.17773	9.979993	11.4099	14.98096	15.33569	14.74246	13.56833	13.98832	15.06976	0	9.870968	0	0	0	13.55626	0	0	14.9247	12.45474	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96F85	CNRP1_HUMAN	"CB1 cannabinoid receptor-interacting protein 1, CRIP-1"	CNRIP1 C2orf32	Homo sapiens (Human)	negative regulation of signaling receptor activity [GO:2000272]; regulation of signaling receptor activity [GO:0010469]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; type 1 cannabinoid receptor binding [GO:0031718]; negative regulation of signaling receptor activity [GO:2000272]; regulation of signaling receptor activity [GO:0010469]	protein C-terminus binding [GO:0008022]; type 1 cannabinoid receptor binding [GO:0031718]	GO:0005737; GO:0005886; GO:0008022; GO:0010469; GO:0031718; GO:2000272	SLMWVNKESFL	2.569999933	1	1	0.262171358	1370.379993	0	0	0	0	0	0	0	14.60495	0	0	0	0	0	14.75392	0	14.752	0	0	0	0	0	0	0	0	16.34467	0	16.82317	0	0	0	0	14.40575	0	17.16602	14.75033	0	16.20021	0	0	16.04936	0	0	0	0	0	0	0	0
Q96FB5	MT25B_HUMAN	Methyltransferase-like protein 25B (Protein RRNAD1) (Ribosomal RNA adenine dimethylase domain-containing protein 1)	METTL25B C1orf66 RRNAD1 CGI-41	Homo sapiens (Human)		integral component of membrane [GO:0016021]	"integral component of membrane [GO:0016021]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	"rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0016021	PGISAR	1.700000048	0.127493098	0.127493098	0.254785378	600.5774933	0	15.70618	17.03413	15.42136	18.02021	0	0	16.1056	18.28632	0	0	0	0	0	0	0	16.92185	0	0	0	0	0	16.8427	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.89084	0	0	0	0	15.85511	0
Q96FC7	PHIPL_HUMAN	Phytanoyl-CoA hydroxylase-interacting protein-like	PHYHIPL KIAA1796 UNQ6309/PRO20934	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	ENKNSNK	10.71000004	1	1	0.155178811	832.831062	0	14.369	0	16.74356	0	13.09397	0	16.43089	12.46099	0	13.27288	13.90937	0	0	14.93319	0	17.12083	0	13.98166	0	12.38869	17.07455	0	12.7062	0	0	0	8.43131	14.70672	0	10.98799	11.71565	11.65154	14.97336	9.06757	14.41105	15.43229	0	0	14.87667	15.6652	17.18931	0	16.27045	0	0	0	15.60228
Q96FC9	DDX11_HUMAN	"ATP-dependent DNA helicase DDX11, EC 3.6.4.12 (CHL1-related protein 1, hCHLR1) (DEAD/H-box protein 11) (Keratinocyte growth factor-regulated gene 2 protein, KRG-2)"	DDX11 CHL1 CHLR1 KRG2	Homo sapiens (Human)	cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; G-quadruplex DNA unwinding [GO:0044806]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	"centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; triplex DNA binding [GO:0045142]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; establishment of sister chromatid cohesion [GO:0034085]; G-quadruplex DNA unwinding [GO:0044806]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; triplex DNA binding [GO:0045142]"	GO:0000785; GO:0000922; GO:0003677; GO:0003678; GO:0003682; GO:0003688; GO:0003690; GO:0003697; GO:0003727; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0007062; GO:0008094; GO:0008186; GO:0016887; GO:0030496; GO:0031297; GO:0032079; GO:0032091; GO:0032508; GO:0034085; GO:0035563; GO:0043139; GO:0044806; GO:0045142; GO:0045876; GO:0046872; GO:0051539; GO:0051880; GO:0070062; GO:0072711; GO:0072719; GO:1901838; GO:1904976; GO:1990700; GO:2000781	EMLETGPEAER	7.710000038	1	1	0.456518015	1280.869936	13.03905	14.40767	0	0	0	0	0	14.73135	11.67502	0	0	0	0	0	0	0	0	15.67851	16.59019	15.55748	16.50573	0	0	16.23178	0	16.36388	16.11883	15.07266	0	0	0	11.5102	14.43218	0	15.54758	17.29734	0	15.66325	0	17.14165	16.36389	0	16.40279	15.13755	0	12.10547	17.282	0
Q96FE5	LIGO1_HUMAN	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A)	LINGO1 LERN1 LRRN6A UNQ201/PRO227	Homo sapiens (Human)		extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]	epidermal growth factor receptor binding [GO:0005154]	GO:0005154; GO:0005615; GO:0005886; GO:0016021; GO:0031012	HLNINAIRDYSFK	3.890000105	1	1	0.401406092	1592.445486	14.88103	16.0474	14.2841	14.92536	0	13.83533	14.39031	0	16.21436	0	16.5021	0	16.24489	0	0	15.90509	0	0	14.62861	0	0	0	0	15.00177	15.62603	0	0	0	0	0	16.61606	0	17.93159	0	0	0	0	0	0	0	15.36066	15.3743	11.99555	0	0	0	0	15.99713
Q96FJ0	STALP_HUMAN	"AMSH-like protease, AMSH-LP, EC 3.4.19.- (STAM-binding protein-like 1)"	STAMBPL1 AMSHLP KIAA1373	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]	cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]	isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004843; GO:0005768; GO:0005829; GO:0016020; GO:0016579; GO:0046872; GO:0061578; GO:0070122; GO:0070536; GO:0140492	KLAAMPDHTDVSLSPEER	4.440000057	1	1	0.466827814	2009.955702	16.88764	14.00999	17.24275	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96FJ2	DYL2_HUMAN	"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b, DLC8b) (Dynein light chain LC8-type 2)"	DYNLL2 DLC2	Homo sapiens (Human)	cilium assembly [GO:0060271]; microtubule-based process [GO:0007017]	9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; microtubule-based process [GO:0007017]	dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]	GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0007017; GO:0016020; GO:0030286; GO:0031475; GO:0045505; GO:0051959; GO:0060271; GO:0097542; GO:0097731; GO:0098794; GO:0098978	NADMSEDMQQDAVDCATQAMEK	13.44999981	1	1	0.130042515	2519.62495	0	13.37088	16.79506	0	0	16.07099	0	16.82682	0	17.56014	11.19493	15.25166	14.30524	16.37536	15.88364	15.73341	0	0	0	14.20557	14.76135	16.56123	11.43241	16.29423	15.82951	0	0	0	15.0434	15.93431	0	19.22248	0	16.49585	0	17.79177	0	19.50831	0	0	18.7919	0	0	17.21582	0	0	0	17.90007
Q96FL8	S47A1_HUMAN	"Multidrug and toxin extrusion protein 1, MATE-1, hMATE-1 (Solute carrier family 47 member 1)"	SLC47A1 MATE1	Homo sapiens (Human)	amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; amide transmembrane transporter activity [GO:0042887]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; solute:proton antiporter activity [GO:0015299]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]	amide transmembrane transporter activity [GO:0042887]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; solute:proton antiporter activity [GO:0015299]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005886; GO:0015179; GO:0015299; GO:0015695; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0031982; GO:0042887; GO:0042908; GO:0042910; GO:0055085; GO:0061459; GO:0089718; GO:0097638; GO:1902475; GO:1990961	ALLVLAGPAFLVQLMVFLISFISSVFCGHLGK	3.579999924	1	1	0.192260074	3448.294155	11.36827	0	13.58993	15.00672	0	12.87456	0	13.33115	0	0	0	0	0	0	14.46399	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96FM1	PGAP3_HUMAN	"Post-GPI attachment to proteins factor 3 (COS16 homolog, hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1)"	PGAP3 CAB2 PERLD1 UNQ546/PRO1100	Homo sapiens (Human)	GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; hydrolase activity, acting on ester bonds [GO:0016788]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]"	"hydrolase activity, acting on ester bonds [GO:0016788]"	GO:0000139; GO:0006505; GO:0006506; GO:0016021; GO:0016788; GO:0031227	DTDLTEK	9.930000305	1	1	0.270725522	822.5823991	0	17.82744	19.15094	15.07575	18.17711	0	0	17.14523	0	0	0	0	17.83936	17.61615	17.98396	0	0	0	0	0	16.43432	0	0	0	0	17.73353	17.60039	16.96354	17.14915	0	0	0	0	0	0	17.3072	0	0	18.71678	16.84367	16.54647	18.66814	0	0	0	0	0	0
Q96FN5	KIF12_HUMAN	Kinesin-like protein KIF12	KIF12	Homo sapiens (Human)	microtubule-based movement [GO:0007018]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0070062	ASGLSGAR	10.90999985	0.054469205	0.054469205	0.240287841	717.6114371	0	14.92394	13.84995	12.53892	13.85178	16.56534	15.73384	15.89919	15.84629	16.08731	15.84567	15.92239	15.98885	15.56221	0	13.85312	16.22084	16.78447	16.64787	16.83643	15.06012	17.42612	14.91799	16.11235	16.22414	16.18912	0	0	0	14.61243	17.43883	0	15.48946	17.23318	0	16.67537	16.82393	15.46179	15.74102	15.58029	15.93648	18.06451	14.37714	0	0	15.14504	16.64489	0
Q96FV2	SCRN2_HUMAN	Secernin-2	SCRN2	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]; cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]	cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]	GO:0016805; GO:0070004; GO:0070062	IQEGAR	6.690000057	0.000277902	0.000277902	0.271948107	674.4777368	18.12501	20.61987	16.76476	0	0	19.11824	0	0	0	19.72164	20.77119	0	17.4116	0	17.98295	0	19.5731	0	0	0	0	0	18.13336	20.79307	0	17.46533	19.33006	20.74395	0	0	17.70333	0	19.88685	0	19.73272	0	17.80769	21.34578	21.38844	0	20.86139	21.16157	0	0	0	0	19.13321	0
Q96FV9	THOC1_HUMAN	"THO complex subunit 1, Tho1 (Nuclear matrix protein p84, p84N5) (hTREX84)"	THOC1 HPR1	Homo sapiens (Human)	"apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]"	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]	"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]	GO:0000018; GO:0000346; GO:0000347; GO:0000445; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0031297; GO:0032784; GO:0032786; GO:0046784; GO:0048297; GO:2000002	LMDLQLSDSNFR	11.35999966	0.084962703	0.084962703	0.149831642	1453.619352	13.2655	0	15.79795	0	0	0	0	13.6634	15.71649	0	11.44971	14.20523	0	13.5993	0	14.26551	0	0	0	10.73503	0	0	14.35201	14.46653	13.82491	14.68013	17.71889	0	18.09375	0	15.91761	10.62143	16.00318	19.00689	14.61079	0	13.71584	14.59646	15.51098	0	0	18.69205	0	0	14.27124	0	0	0
Q96FZ7	CHMP6_HUMAN	"Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20, Vps20, hVps20)"	CHMP6 VPS20	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex assembly [GO:1904902]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]	amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]	amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex assembly [GO:1904902]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]	protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]	GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0007175; GO:0010008; GO:0015031; GO:0016020; GO:0016236; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0042176; GO:0043162; GO:0044877; GO:0046761; GO:0047485; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904902; GO:1904930	MHQVMSIEEVER	4.28000021	1	1	0	1503.423148	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96G01	BICD1_HUMAN	"Protein bicaudal D homolog 1, Bic-D 1"	BICD1	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; RNA processing [GO:0006396]; stress granule assembly [GO:0034063]; viral process [GO:0016032]	centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802]	centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; small GTPase binding [GO:0031267]; structural constituent of cytoskeleton [GO:0005200]; anatomical structure morphogenesis [GO:0009653]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; RNA processing [GO:0006396]; stress granule assembly [GO:0034063]; viral process [GO:0016032]	cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; small GTPase binding [GO:0031267]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005856; GO:0006396; GO:0008093; GO:0008298; GO:0009653; GO:0016020; GO:0016032; GO:0019901; GO:0031267; GO:0031410; GO:0031871; GO:0033365; GO:0034063; GO:0034452; GO:0045505; GO:0048260; GO:0048471; GO:0070507; GO:0070840; GO:0072385; GO:0072393; GO:0099503; GO:1900275; GO:1900276; GO:1900737; GO:1904781	AMVTETMTK	10.65999985	1	1	0.162832551	1026.528728	0	13.8364	13.38642	12.00217	0	15.13973	0	0	0	0	0	0	11.67324	0	0	14.77615	15.81245	0	0	0	0	0	0	0	0	0	16.92837	14.72605	14.57374	13.5077	15.54297	0	16.89273	14.84156	0	15.19441	0	0	16.33644	0	0	0	0	17.41241	0	17.59139	16.28471	0
Q96G03	PGM2_HUMAN	"Phosphopentomutase, EC 5.4.2.7 (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphoglucomutase-2, EC 5.4.2.2)"	PGM2 MSTP006	Homo sapiens (Human)	deoxyribose phosphate catabolic process [GO:0046386]; glucose metabolic process [GO:0006006]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; glucose metabolic process [GO:0006006]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]	GO:0000287; GO:0004614; GO:0005576; GO:0005829; GO:0006006; GO:0008973; GO:0034774; GO:0046386; GO:0070062; GO:1904813	GVLTLSFALADK	4.550000191	1	1	0.206537378	1234.061217	15.32558	0	0	12.19369	14.80606	15.16784	0	13.64873	12.95331	0	0	0	15.53829	0	0	0	0	0	0	0	0	18.82102	19.00424	0	0	0	0	15.40093	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.72994	0	0
Q96G21	IMP4_HUMAN	"U3 small nucleolar ribonucleoprotein protein IMP4, U3 snoRNP protein IMP4 (Brix domain-containing protein 4)"	IMP4 BXDC4	Homo sapiens (Human)	rRNA processing [GO:0006364]	fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]	fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]	rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]	GO:0001650; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0030684; GO:0032040; GO:0034457; GO:0042134	DPSSR	2.640000105	1	1	0.111452974	561.2438853	0	0	15.59324	0	13.27359	16.0331	15.33009	0	0	14.43231	0	0	14.62651	0	14.58278	0	15.62956	0	15.80464	0	0	0	0	0	16.11242	0	16.51121	0	0	0	0	0	0	0	0	0	0	0	16.30292	0	0	0	0	0	0	0	0	0
Q96G28	CFA36_HUMAN	Cilia- and flagella-associated protein 36 (Coiled-coil domain-containing protein 104)	CFAP36 CCDC104 UNQ163/PRO189	Homo sapiens (Human)		axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; motile cilium [GO:0031514]; nucleus [GO:0005634]	axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein N-terminus binding [GO:0047485]	protein N-terminus binding [GO:0047485]	GO:0005634; GO:0005930; GO:0031514; GO:0035869; GO:0047485; GO:0097546	LMSMRK	2.690000057	1	1	0.240009836	782.1534517	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.12918	0	0	16.9423	0	17.26964	0	18.59216	0	0	0	0	0	0	0	0	18.84089	0	0	0	0	0	0	0	0	17.52321	16.68375	0	0	0
Q96G42	KLD7B_HUMAN	Kelch domain-containing protein 7B	KLHDC7B	Homo sapiens (Human)						YNTVTGSWSR	2.599999905	1	1	0.208089551	1170.090187	0	0	0	14.06078	15.33452	14.16249	13.7701	13.88266	15.35328	15.30189	14.47179	12.10015	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.44373	0	0	0	0	16.97219	0	0	0	0	0	0	0	0	0
Q96G91	P2Y11_HUMAN	"P2Y purinoceptor 11, P2Y11"	P2RY11	Homo sapiens (Human)	activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; neuronal signal transduction [GO:0023041]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled ATP receptor activity [GO:0045031]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; neuronal signal transduction [GO:0023041]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]	G protein-coupled ATP receptor activity [GO:0045031]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0005887; GO:0006952; GO:0007186; GO:0007190; GO:0007200; GO:0019722; GO:0023041; GO:0030594; GO:0038023; GO:0045031; GO:0071318	SPGMTVAEK	1.730000019	1	1	0.225156766	919.5654953	15.99572	12.28808	0	0	0	0	0	0	0	0	0	14.71813	17.29554	0	0	0	0	0	0	0	0	0	16.76681	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.48539	0	15.97836	0	16.01985	0	0	0	0	0	0
Q96GA3	LTV1_HUMAN	Protein LTV1 homolog	LTV1 C6orf93	Homo sapiens (Human)	ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]"		GO:0000056; GO:0005634; GO:0005654; GO:0005829; GO:0030688; GO:0042274	DPLAADESAPQRVLLPTQK	2.519999981	1	1	9.25E-13	2050.241872	11.35301	0	0	14.83692	0	14.64407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96GC5	RM48_HUMAN	"39S ribosomal protein L48, mitochondrial, L48mt, MRP-L48 (Mitochondrial large ribosomal subunit protein mL48)"	MRPL48 CGI-118 HSPC290	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543]		GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543	LSVKEHTEEDFK	4.96999979	0.415730715	0.415730715	0.344948785	1460.651497	17.73284	15.20645	15.90885	0	0	0	16.62873	0	18.44847	15.83635	14.71019	16.85169	14.57428	14.04954	15.36856	14.30343	15.02562	15.60243	16.08028	13.34035	16.63918	17.06694	16.52411	16.81351	15.96921	15.94724	16.1953	13.59009	15.47318	0	13.60515	17.14385	16.8767	0	0	0	13.07437	0	0	0	16.84661	16.65451	16.53947	15.77216	17.04917	0	15.96198	15.05744
Q96GC6	ZN274_HUMAN	"Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274) (Zinc finger protein HFB101) (Zinc finger protein with KRAB and SCAN domains 19) (Zinc finger protein zfp2, Zf2)"	ZNF274 ZKSCAN19 SP2114	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005730; GO:0005737; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1900112; GO:1990837	TFSRSTK	2.809999943	9.84E-05	9.84E-05	0.243151958	827.442948	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.556	0	16.69986	18.07683	0	17.93999	0	0	0	0	18.17616	0	0	18.29094	0	0	18.92637	0	18.66173	0	16.30616	0	0	0	0	0	0	0
Q96GD0	PLPP_HUMAN	"Chronophin, EC 3.1.3.16, EC 3.1.3.74 (Pyridoxal phosphate phosphatase, PLP phosphatase)"	PDXP CIN PLP PLPP	Homo sapiens (Human)	actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; dephosphorylation [GO:0016311]; positive regulation of actin filament depolymerization [GO:0030836]; protein dephosphorylation [GO:0006470]; pyridoxal phosphate catabolic process [GO:0032361]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]	cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]; glycerol-3-phosphatase activity [GO:0043136]; heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; protein serine/threonine phosphatase activity [GO:0004722]; pyridoxal phosphatase activity [GO:0033883]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; dephosphorylation [GO:0016311]; positive regulation of actin filament depolymerization [GO:0030836]; protein dephosphorylation [GO:0006470]; pyridoxal phosphate catabolic process [GO:0032361]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088]	glycerol-3-phosphatase activity [GO:0043136]; heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; protein serine/threonine phosphatase activity [GO:0004722]; pyridoxal phosphatase activity [GO:0033883]	GO:0000287; GO:0004721; GO:0004722; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0006470; GO:0007088; GO:0016311; GO:0016791; GO:0030836; GO:0031072; GO:0031247; GO:0031258; GO:0032361; GO:0032465; GO:0032587; GO:0033883; GO:0042803; GO:0043136; GO:0071318	LGFGGLR	13.57999992	1	1	0.2103356	721.308033	0	0	14.0561	0	0	0	0	0	14.24434	15.79062	0	0	15.66954	0	0	0	0	15.07171	15.93173	0	0	0	0	0	0	0	0	0	14.77848	0	0	0	0	0	0	0	0	0	0	16.29303	0	0	0	0	0	0	0	15.78927
Q96GD3	SCMH1_HUMAN	Polycomb protein SCMH1 (Sex comb on midleg homolog 1)	SCMH1	Homo sapiens (Human)	"anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"	chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0007283; GO:0009952; GO:0010369; GO:0031507; GO:0042393; GO:0045892	DMESFWK	7.179999828	1	1	0.11397135	943.0121252	14.48133	0	0	0	0	0	0	0	14.33862	0	0	0	0	14.37722	15.69207	0	14.85995	0	0	0	0	0	0	0	12.27899	0	14.03411	0	0	0	0	15.0664	15.61036	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96GE4	CEP95_HUMAN	"Centrosomal protein of 95 kDa, Cep95 (Coiled-coil domain-containing protein 45)"	CEP95 CCDC45 CEP45	Homo sapiens (Human)		centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]		GO:0000922; GO:0005737; GO:0005813	ALASPSSK	10.13000011	0.270523071	0.270523071	0.296906877	761.7365942	0	0	17.90497	0	0	0	0	0	18.25345	19.42377	0	0	0	0	0	19.1053	0	0	0	17.99991	0	0	0	0	19.77677	0	0	0	0	0	0	0	19.43603	0	0	0	0	0	0	0	0	0	0	0	18.8378	0	16.95076	0
Q96GE5	ZN799_HUMAN	Zinc finger protein 799 (Zinc finger protein 842)	ZNF799 ZNF842	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	HMVMHTR	2.450000048	1	1	0.236816178	943.3427387	17.8352	14.71921	15.8266	19.21576	17.53349	0	14.2812	13.0187	0	0	0	16.283	0	16.84534	0	0	0	16.89925	0	14.11973	0	16.65082	0	16.08267	0	0	0	0	0	0	0	17.2242	0	14.61563	0	0	14.69933	15.77274	14.77389	14.44175	0	16.3654	0	0	0	0	0	0
Q96GE6	CALL4_HUMAN	Calmodulin-like protein 4 (Serologically defined breast cancer antigen NY-BR-20)	CALML4	Homo sapiens (Human)			calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]	GO:0005509; GO:0030234	IKATDLMVAMR	8.899999619	1	1	4.60E-13	1263.69839	16.17159	14.93246	15.14233	0	0	0	14.51941	0	0	0	14.47131	15.36418	0	0	0	0	0	0	0	0	0	0	0	0	15.93393	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.07679	0	0	0	0	14.90132	0
Q96GJ1	TRM2B_HUMAN	"tRNA (uracil-5-)-methyltransferase homolog B, EC 2.1.1.35 (TRM2 homolog B) (rRNA (uracil-5-)-methyltransferase TRMT2B, EC 2.1.1.-)"	TRMT2B CXorf34	Homo sapiens (Human)			S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]	S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]	GO:0030697	STFSVNR	10.59000015	0.073178686	0.073178686	0.301217666	808.0501014	13.83926	16.30978	16.79796	16.57206	0	0	16.39669	16.66919	0	0	0	0	16.08763	0	0	16.33377	16.22481	15.49669	15.37582	17.19595	0	0	15.71343	15.61814	15.41313	0	15.70134	15.9339	14.01022	15.24917	0	0	16.87603	16.95908	15.9956	14.4655	16.9614	16.52715	16.24314	0	16.22547	16.24689	17.22552	16.22783	17.25731	14.94005	15.32149	16.60966
Q96GM1	PLPR2_HUMAN	"Phospholipid phosphatase-related protein type 2 (Inactive phospholipid phosphatase PLPPR2) (Lipid phosphate phosphatase-related protein type 2) (Plasticity-related gene 4 protein, PRG-4)"	PLPPR2 LPPR2 PRG4	Homo sapiens (Human)	phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]	GO:0005887; GO:0006644; GO:0007165; GO:0008195; GO:0042577; GO:0046839	NPRSAGR	8.869999886	1	1	0.022540749	756.3226401	0	15.24867	0	0	14.75976	15.22613	14.89753	14.18467	15.45156	0	0	13.27052	0	20.02162	0	15.59911	0	14.5564	0	0	0	18.78004	19.30831	18.9628	16.888	0	14.62457	13.89993	15.88368	14.94217	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96GM8	TOE1_HUMAN	Target of EGR1 protein 1	TOE1	Homo sapiens (Human)	"RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]"	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]"	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]	GO:0000175; GO:0003723; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472; GO:0046872; GO:0090503	KQVCGDSIKPEETEQEVAADETR	1.779999971	1	1	2.29E-12	2618.952905	13.94164	15.15004	0	13.70784	13.70119	14.86642	0	14.09962	14.36935	0	0	0	0	0	13.95749	14.03237	14.27908	14.79769	15.41722	14.87339	0	0	14.87885	0	11.97159	14.58101	0	0	15.0365	13.38317	16.23353	0	13.65287	0	11.56982	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96GN5	CDA7L_HUMAN	Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2)	CDCA7L HR1 JPO2 R1	Homo sapiens (Human)	"positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]"		GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284	AFSEGQITR	4.349999905	0.411497593	0.411497593	0.238678031	1008.132975	14.19668	13.28301	12.59932	14.97712	0	0	14.29608	11.77129	14.76218	15.49373	14.35389	16.51213	0	14.42157	14.95889	0	13.96246	15.73785	14.76214	14.97927	14.5373	0	0	0	0	0	14.12215	13.47013	14.31139	11.18494	0	16.41519	12.77454	13.93366	14.28568	0	0	14.86886	0	15.06013	15.8175	14.53108	12.06131	8.279663	12.07738	15.23016	13.66915	0
Q96GP6	SREC2_HUMAN	"Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein, SREC-II)"	SCARF2 SREC2 SREPCR	Homo sapiens (Human)	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]	focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]	scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005925; GO:0007157; GO:0016021	MEGAGPRGAGPAR	6.699999809	1	1	0.157909387	1243.483231	14.34449	0	12.47736	14.58591	14.7256	12.86185	0	15.42937	13.4679	14.10102	10.05108	10.97814	0	0	0	17.04239	0	0	0	12.10134	0	0	15.97952	0	0	0	15.28386	0	15.28314	14.78812	0	0	0	0	0	0	0	14.79046	0	15.51382	0	16.18062	0	0	0	0	0	0
Q96GQ7	DDX27_HUMAN	"Probable ATP-dependent RNA helicase DDX27, EC 3.6.4.13 (DEAD box protein 27)"	DDX27 cPERP-F RHLP HSPC259 PP3241	Homo sapiens (Human)	rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364; GO:0016887	GEMTAEER	5.119999886	1	1	0.050041569	937.5851352	0	0	0	16.2959	0	0	0	0	0	0	0	0	0	0	16.63622	0	0	15.60875	0	15.06401	0	0	0	0	14.50531	0	0	0	17.2258	0	16.99286	0	14.66908	0	0	0	0	0	0	16.07112	12.44764	15.92521	0	0	0	0	0	14.96921
Q96GR2	ACBG1_HUMAN	"Long-chain-fatty-acid--CoA ligase ACSBG1, EC 6.2.1.3 (Acyl-CoA synthetase bubblegum family member 1, hBG1, hsBG, hsBGM) (Lipidosin)"	ACSBG1 BGM KIAA0631 LPD	Homo sapiens (Human)	long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; myelination [GO:0042552]; ovarian follicle atresia [GO:0001552]; response to glucocorticoid [GO:0051384]; very long-chain fatty acid metabolic process [GO:0000038]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; myelination [GO:0042552]; ovarian follicle atresia [GO:0001552]; response to glucocorticoid [GO:0051384]; very long-chain fatty acid metabolic process [GO:0000038]	ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]	GO:0000038; GO:0001552; GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0016405; GO:0031410; GO:0031957; GO:0035338; GO:0042552; GO:0042759; GO:0051384	WEHISYSQYYLLAR	10.68999958	1	1	0.178115758	1827.550916	0	16.02164	16.96832	0	0	0	19.5794	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96GX1	TECT2_HUMAN	Tectonic-2	TCTN2 C12orf38 TECT2	Homo sapiens (Human)	cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]	ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]		GO:0005737; GO:0005856; GO:0007224; GO:0016021; GO:0036038; GO:0060170; GO:0060271; GO:1904491	DFADFGYKQGDPIMTVK	6.230000019	1	1	0.360802007	1948.702344	0	0	17.53803	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96GX5	GWL_HUMAN	"Serine/threonine-protein kinase greatwall, GW, GWL, hGWL, EC 2.7.11.1 (Microtubule-associated serine/threonine-protein kinase-like, MAST-L)"	MASTL GW GWL THC2	Homo sapiens (Human)	cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000086; GO:0000278; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0007147; GO:0016301; GO:0018105; GO:0032154; GO:0032515; GO:0035556; GO:0051301; GO:0051721; GO:0051726; GO:0106310; GO:1904668	DALALSK	7.5	0.409932941	0.409932941	0.238707259	716.8179583	13.32964	0	0	0	0	14.24421	0	15.42079	0	0	0	0	15.93911	15.72784	0	0	14.99842	0	0	13.88217	0	16.0356	15.29031	15.93947	15.89493	0	16.56911	0	0	0	14.59095	14.20173	15.4265	0	0	13.89831	16.8773	16.02763	17.28634	15.15444	0	16.44559	0	0	16.01663	0	0	16.0719
Q96GX9	MTNB_HUMAN	"Methylthioribulose-1-phosphate dehydratase, MTRu-1-P dehydratase, EC 4.2.1.109 (APAF1-interacting protein, hAPIP)"	APIP CGI-29	Homo sapiens (Human)	apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372]	identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005829; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0042802; GO:0043066; GO:0046570; GO:0051289; GO:0070269; GO:0070372	MSGCDAR	1.25999999	0.944618642	0.944618642	4.60E-13	796.3019734	12.77164	0	0	0	0	0	0	0	0	0	0	0	15.0628	0	0	0	0	0	0	0	0	0	0	0	14.85922	0	16.72091	15.72319	0	0	0	0	0	18.91552	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96GY3	LIN37_HUMAN	Protein lin-37 homolog (Antolefinin)	LIN37 MSTP064	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]	Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005654; GO:0017053; GO:0031523	LPPPTPPGPPGDACRSR	7.380000114	1	1	1.84E-12	1771.215077	0	15.72584	15.35781	12.45039	16.00597	15.13163	15.15335	15.12416	0	16.24285	0	15.20897	10.88632	13.63704	0	15.56299	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96H12	MSD3_HUMAN	Myb/SANT-like DNA-binding domain-containing protein 3	MSANTD3 C9orf30 L8	Homo sapiens (Human)						IMAHER	10.44999981	1	1	0.011447876	771.4663408	0	0	0	0	0	0	0	0	0	0	0	0	0	15.76146	0	14.39207	0	0	0	0	0	17.6529	15.65479	0	15.91517	0	0	0	0	0	15.39168	0	0	15.85305	0	15.22467	0	17.11789	0	16.53457	15.96967	0	0	0	0	0	0	0
Q96H20	SNF8_HUMAN	"Vacuolar-sorting protein SNF8 (ELL-associated protein of 30 kDa) (ESCRT-II complex subunit VPS22, hVps22)"	SNF8 EAP30	Homo sapiens (Human)	early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of protein catabolic process [GO:0042176]; regulation of protein complex stability [GO:0061635]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral budding via host ESCRT complex [GO:1903772]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transcription regulator complex [GO:0005667]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transcription regulator complex [GO:0005667]; channel regulator activity [GO:0016247]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of protein catabolic process [GO:0042176]; regulation of protein complex stability [GO:0061635]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral budding via host ESCRT complex [GO:1903772]	channel regulator activity [GO:0016247]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]	GO:0000814; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0008022; GO:0010008; GO:0010628; GO:0016020; GO:0016236; GO:0016247; GO:0031902; GO:0032456; GO:0036258; GO:0042176; GO:0042803; GO:0043328; GO:0045022; GO:0045732; GO:0047485; GO:0048471; GO:0055037; GO:0061635; GO:0070062; GO:0071985; GO:0090148; GO:1903543; GO:1903772	GVGAGAIAK	3.180000067	1	1	0.116375781	742.9220436	0	0	0	0	0	0	15.35064	0	14.86841	0	16.30296	0	16.38877	0	0	0	15.54641	0	0	0	0	0	0	0	15.0485	16.13659	15.26123	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.11818	0	16.78459	0	0
Q96H35	RBM18_HUMAN	Probable RNA-binding protein 18 (RNA-binding motif protein 18)	RBM18	Homo sapiens (Human)		cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005829; GO:0045171	SGALEGQPR	8.93999958	1	1	0.043626975	914.7392571	15.25567	15.32326	0	16.3097	0	0	12.52097	16.30135	14.85351	0	0	15.06392	0	0	0	0	13.56735	0	16.36667	14.50806	0	13.45038	14.86462	14.49172	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96H78	S2544_HUMAN	Solute carrier family 25 member 44	SLC25A44 KIAA0446	Homo sapiens (Human)	branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; branched-chain amino acid transmembrane transporter activity [GO:0015658]; branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161]	branched-chain amino acid transmembrane transporter activity [GO:0015658]	GO:0005739; GO:0009083; GO:0015658; GO:0015803; GO:0016021; GO:0031966; GO:0120161	ADGITGLYR	7.409999847	0.409967333	0.409967333	0.168199028	965.0901998	16.82496	0	15.96504	12.12081	11.28561	17.49134	0	16.185	15.49248	16.22111	0	0	9.459302	18.95432	19.79841	12.02991	0	0	14.63864	16.47681	0	19.67877	15.8437	17.46838	16.8954	15.94714	15.76928	18.52976	16.48774	0	16.54843	18.93801	0	0	16.539	16.66421	14.81613	0	0	0	18.76817	18.06736	13.54337	18.1359	19.24377	0	14.68516	17.71539
Q96H79	ZCCHL_HUMAN	Zinc finger CCCH-type antiviral protein 1-like	ZC3HAV1L C7orf39	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829	VVAVSSVRLCAR	2.180000067	1	1	0.120552666	1317.570714	14.1174	14.22768	0	0	0	0	0	14.2117	12.99169	14.22578	0	10.86613	0	0	0	13.70037	0	13.98046	0	12.87808	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.93051	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96H86	ZN764_HUMAN	Zinc finger protein 764	ZNF764	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	QSSEMAAHRR	6.150000095	0.41761747	0.41761747	0.314945122	1187.271151	14.77083	13.08563	15.68855	0	0	7.173616	0	0	0	0	0	0	0	0	0	0	16.01438	0	0	0	0	0	13.57956	15.7892	16.91265	0	16.55501	0	14.20253	0	0	15.24722	13.61803	0	15.86427	14.08229	0	0	0	0	0	0	0	0	0	0	0	17.61038
Q96H96	COQ2_HUMAN	"4-hydroxybenzoate polyprenyltransferase, mitochondrial, 4-HB polyprenyltransferase, EC 2.5.1.39 (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog, hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase, PHB:PPT, PHB:polyprenyltransferase)"	COQ2 CL640	Homo sapiens (Human)	glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]	"integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; 4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]"	"4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]"	GO:0002083; GO:0004659; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0016765; GO:0031305; GO:0047293	MLGSRAAGFAR	2.220000029	1	1	0.089232084	1152.027774	0	0	0	0	0	0	14.10421	0	0	0	16.66824	0	0	0	0	0	0	18.2028	0	0	0	0	0	0	0	16.07835	0	0	0	0	19.37876	0	0	0	19.26503	0	15.54519	0	17.78839	0	0	0	17.47706	0	17.4669	0	0	0
Q96HA7	TONSL_HUMAN	"Tonsoku-like protein (Inhibitor of kappa B-related protein, I-kappa-B-related protein, IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2)"	TONSL IKBR NFKBIL2	Homo sapiens (Human)	double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297]	histone binding [GO:0042393]	GO:0000724; GO:0005654; GO:0005737; GO:0016604; GO:0031297; GO:0042393; GO:0043596	GVGSAQSRLGPGPPR	9.159999847	0.586380482	0.586380482	0.496741695	1435.934114	0	0	0	0	0	0	0	0	0	0	0	0	19.19699	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.91231	0	0	0	21.2932	0	0	0	0	0	0	0
Q96HA9	PX11C_HUMAN	"Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma, PEX11-gamma)"	PEX11G PEX11C	Homo sapiens (Human)	peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375]	integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]	integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375]		GO:0005777; GO:0005778; GO:0005779; GO:0016559; GO:0031231; GO:0032991; GO:0044375	LRSPTAPFTSPLPR	5.869999886	1	1	0.323327837	1537.803222	0	14.64328	15.45933	14.40941	0	0	15.12094	14.79731	0	13.55187	0	0	0	15.16143	16.72798	15.15737	0	13.99198	16.34202	16.16213	0	0	0	0	15.7715	16.19345	0	14.99136	15.39363	13.86868	16.79737	16.08052	17.37704	15.85874	14.75176	13.8743	15.22425	15.53369	14.28742	0	16.19234	15.81493	14.30382	0	15.92407	13.16856	15.09744	16.14375
Q96HC4	PDLI5_HUMAN	PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein)	PDLIM5 ENH L9	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; cell growth involved in cardiac muscle cell development [GO:0061049]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]; actin cytoskeleton organization [GO:0030036]; cell growth involved in cardiac muscle cell development [GO:0061049]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963]	actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]	GO:0001725; GO:0003779; GO:0005080; GO:0005829; GO:0005912; GO:0007507; GO:0014069; GO:0015629; GO:0016020; GO:0030018; GO:0030036; GO:0031941; GO:0042805; GO:0042995; GO:0046872; GO:0051371; GO:0051963; GO:0061001; GO:0061049; GO:0061061; GO:0098641; GO:0098793	HIVER	7.050000191	1	1	0.193616628	651.4006568	0	16.14937	14.91317	0	0	0	0	0	0	0	0	0	0	0	16.81285	0	15.3861	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.85511	17.60746	15.49416	17.58604	0	0	0	0	15.76276	0	0	0	0	0	0	0
Q96HD9	ACY3_HUMAN	"N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming), EC 3.5.1.114 (Acylase III) (Aminoacylase-3, ACY-3) (Aspartoacylase-2) (Hepatitis C virus core-binding protein 1, HCBP1, HCV core-binding protein 1)"	ACY3 ASPA2	Homo sapiens (Human)		apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	"aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0004046; GO:0005829; GO:0016324; GO:0016788; GO:0016811; GO:0042802; GO:0046872; GO:0070062	SSHEVFAMHLCR	6.340000153	1	1	0.035752556	1490.594985	0	0	15.72512	0	0	0	0	0	0	0	0	0	0	0	0	14.4905	0	0	0	17.44437	0	0	0	0	15.20007	0	10.49354	0	0	0	15.64365	14.91931	0	0	0	0	0	19.08335	0	0	0	0	0	0	16.3954	0	0	0
Q96HE9	PRR11_HUMAN	Proline-rich protein 11	PRR11	Homo sapiens (Human)	regulation of cell cycle [GO:0051726]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; regulation of cell cycle [GO:0051726]		GO:0005634; GO:0005737; GO:0016020; GO:0051726	KLIPSPK	5.989999771	1	1	0.220835741	781.4578765	16.31995	14.96631	0	0	0	11.88846	14.27214	15.6876	0	16.42687	0	15.18064	0	0	15.09247	14.90925	16.04246	15.43148	13.52177	15.2373	15.89943	0	14.80334	16.15408	0	0	0	16.23698	16.77473	15.67057	15.76628	16.86502	0	16.68337	16.41209	15.30732	0	0	17.57371	0	17.26451	16.20041	14.98538	0	15.17879	16.16835	15.96118	15.37461
Q96HH4	TM169_HUMAN	Transmembrane protein 169	TMEM169	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	EEPTAVEGQVQLPSPHQGSLR	1.110000014	1	1	0.101485993	2260.079582	14.94712	0	14.5477	0	0	13.80892	0	0	0	0	0	0	0	0	11.9408	0	0	0	0	0	0	9.500045	13.93441	0	0	11.21881	0	0	11.72174	12.95625	0	0	0	0	10.54299	13.12665	0	0	0	0	0	0	0	0	0	0	0	0
Q96HH9	GRM2B_HUMAN	GRAM domain-containing protein 2B (HCV NS3-transactivated protein 2)	GRAMD2B GRAMD3 NS3TP2	Homo sapiens (Human)		cytoplasmic microtubule [GO:0005881]	cytoplasmic microtubule [GO:0005881]; identical protein binding [GO:0042802]	identical protein binding [GO:0042802]	GO:0005881; GO:0042802	SQVQFNVEVLCQELTANIVKLEK	2.849999905	1	1	0.08801773	2689.256578	0	14.60042	16.29452	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.82674	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96HN2	SAHH3_HUMAN	"Adenosylhomocysteinase 3, AdoHcyase 3, EC 3.3.1.1 (IP(3)Rs binding protein released with IP(3) 2, IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2)"	AHCYL2 KIAA0828	Homo sapiens (Human)	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353]	hydrolase activity [GO:0016787]	GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005	MSVQVVSAAAAAKVPEVELK	4.75	0.807428837	0.807428837	0.294958309	2042.555054	0	0	0	0	0	0	0	17.24587	0	0	0	0	0	0	0	0	0	12.67445	0	0	0	17.82592	14.98663	13.15874	15.74166	0	0	15.90496	0	0	0	0	0	0	0	0	0	14.77346	0	0	0	0	0	0	0	0	17.63098	0
Q96HP0	DOCK6_HUMAN	Dedicator of cytokinesis protein 6	DOCK6 KIAA1395	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0043547; GO:0048471	EETVLTPVEVAIEDMQK	4.579999924	1	1	0.256615519	1946.207145	15.24891	14.58224	12.83641	0	15.3965	14.48033	0	0	0	0	0	0	14.72581	0	16.33156	14.54373	15.25614	0	11.00419	12.87285	0	15.19252	0	0	0	0	13.99869	0	9.716815	14.56017	13.85125	15.85034	14.58801	0	14.09008	12.85604	0	0	0	10.07718	0	14.95685	0	0	0	0	0	0
Q96HQ0	ZN419_HUMAN	Zinc finger protein 419	ZNF419 ZNF419A	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	ENSTLVR	17.02000046	0.267310172	0.267310172	0.202430729	818.6736944	15.76775	0	15.34627	0	16.17043	15.72166	16.83644	13.76439	15.91055	0	0	15.3906	0	0	16.62316	16.20331	15.87438	16.79729	17.70565	15.96769	0	15.98167	0	0	15.83127	0	16.96235	16.1163	14.98701	17.02612	16.63202	14.15305	0	15.97086	15.3027	15.85645	15.63516	16.59195	17.6233	16.27484	0	16.31123	15.82063	16.2977	0	15.89879	15.76552	14.97368
Q96HR8	NAF1_HUMAN	"H/ACA ribonucleoprotein complex non-core subunit NAF1, hNAF1"	NAF1	Homo sapiens (Human)	box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	GO:0000454; GO:0000493; GO:0003723; GO:0005654; GO:0005732; GO:0005737; GO:0032212; GO:0042254; GO:0042802; GO:0043489; GO:0051973; GO:0070034; GO:0090669; GO:1904358; GO:1904874; GO:1905323	GSDASWK	1.039999962	0.721570075	0.721570075	1.48E-12	749.2075786	15.33938	0	0	17.4717	0	10.60932	16.65899	12.24025	16.38985	0	17.21273	14.82845	15.50827	14.33631	0	15.93874	0	15.11144	15.68537	13.53618	0	17.07682	12.83023	15.26411	0	15.012	16.16281	15.03895	16.0524	17.96435	0	0	16.4327	15.47672	0	17.00982	15.38802	18.25867	0	16.28984	17.19297	0	14.33768	0	17.97189	14.71586	16.18714	15.4488
Q96HY7	DHTK1_HUMAN	"2-oxoadipate dehydrogenase complex component E1, E1a, OADC-E1, OADH-E1, EC 1.2.4.- (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase, Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)"	DHTKD1 KIAA1630	Homo sapiens (Human)	generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099]	oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]	GO:0002244; GO:0004591; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976	RYGGEGAESMMGFFHELLK	2.839999914	1	1	1.37E-12	2173.814644	0	13.21424	0	0	10.61216	7.725059	14.65975	0	15.45698	0	0	13.54486	0	0	0	11.42896	0	11.63737	0	0	0	0	11.00575	0	0	10.48392	0	15.17935	13.16233	0	0	15.51874	13.0213	0	11.81793	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96I34	PP16A_HUMAN	Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3)	PPP1R16A MYPT3	Homo sapiens (Human)	regulation of protein dephosphorylation [GO:0035304]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; regulation of protein dephosphorylation [GO:0035304]	myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]	GO:0005886; GO:0008157; GO:0017020; GO:0019888; GO:0035304	RPCCLLM	12.86999989	1	1	0.166611951	949.2934394	0	0	0	0	0	0	0	0	0	20.99633	0	0	0	0	0	0	0	0	17.47826	0	0	0	0	0	0	0	0	0	0	0	0	0	18.54483	0	0	0	0	0	0	19.03365	0	0	0	0	0	0	0	0
Q96I51	RCC1L_HUMAN	"RCC1-like G exchanging factor-like protein, RCC1-like (Williams-Beuren syndrome chromosomal region 16 protein)"	RCC1L WBSCR16	Homo sapiens (Human)	mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial membrane fusion [GO:1990613]; positive regulation of mitochondrial translation [GO:0070131]	GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0003723; GO:0005085; GO:0005525; GO:0005743; GO:0019843; GO:0031966; GO:0070131; GO:1990613	ALVALVAGARLGR	8.529999733	0.408701777	0.408701777	0.18802652	1262.378546	0	0	8.288651	0	0	0	18.17418	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.01149	13.05459	0	16.07889	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96I59	SYNM_HUMAN	"Probable asparagine--tRNA ligase, mitochondrial, EC 6.1.1.22 (Asparaginyl-tRNA synthetase, AsnRS)"	NARS2	Homo sapiens (Human)	asparaginyl-tRNA aminoacylation [GO:0006421]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421]	asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0004816; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006421	HKPSAK	3.130000114	1	1	0.074456594	667.6119853	16.02701	0	16.37337	0	14.46485	15.52606	16.02344	13.98632	0	0	0	16.54109	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.3237	0	15.37855	15.24237	14.95729	0	0	16.89264	0	16.37821	17.49655	0	15.93239	17.67877	15.93403	15.08646	0	0	0	0
Q96I76	GPTC3_HUMAN	G patch domain-containing protein 3	GPATCH3 GPATC3	Homo sapiens (Human)	"negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]"	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032480; GO:0039536; GO:0045893	RGLGYHGEK	3.650000095	1	1	0.052118682	1015.601166	0	0	0	0	0	0	0	0	13.07026	0	0	14.19254	0	0	13.89503	15.50314	13.98395	0	0	0	0	0	0	15.50692	0	0	13.14468	0	12.60256	13.15249	15.88375	0	0	0	8.231363	0	0	0	14.26172	0	14.452	0	15.75639	0	0	0	0	14.99179
Q96I82	KAZD1_HUMAN	Kazal-type serine protease inhibitor domain-containing protein 1	KAZALD1 FKSG28 FKSG40 UNQ2945/PRO21184	Homo sapiens (Human)	cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]	extracellular region [GO:0005576]; interstitial matrix [GO:0005614]	extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; insulin-like growth factor binding [GO:0005520]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]	insulin-like growth factor binding [GO:0005520]	GO:0001503; GO:0001558; GO:0005520; GO:0005576; GO:0005614; GO:0009966; GO:0030154; GO:0030198	GCLAGRVR	5.989999771	0.83120662	0.83120662	0.218636393	891.7524407	16.63694	0	0	11.69074	13.75816	15.57574	16.99642	16.39345	18.02446	17.02304	16.36514	14.6178	15.44622	14.79963	12.35558	15.43534	11.94885	15.38423	0	15.2093	15.5992	15.90591	15.12862	15.80734	14.37552	15.54226	0	15.88811	0	14.94553	13.76477	16.46419	15.75885	0	0	0	16.90838	0	0	16.46955	0	0	0	14.62003	0	14.86526	15.46797	16.35002
Q96I99	SUCB2_HUMAN	"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial, EC 6.2.1.4 (GTP-specific succinyl-CoA synthetase subunit beta, G-SCS, GTPSCS) (Succinyl-CoA synthetase beta-G chain, SCS-betaG)"	SUCLG2	Homo sapiens (Human)	succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]	GO:0000287; GO:0004775; GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0005759; GO:0005886; GO:0006099; GO:0006104; GO:0042709; GO:0045244; GO:1901289	DPNVVGQLAKQMIGYNLATK	2.049999952	1	1	0.218576879	2160.435054	11.57835	0	0	14.31352	13.24368	14.01643	0	0	14.65979	13.47999	0	0	0	13.46618	0	0	0	0	0	0	0	0	0	0	0	13.86546	15.87076	0	0	0	0	0	0	0	0	0	14.90628	0	0	12.33548	0	0	0	0	15.4543	0	0	0
Q96IC2	REXO5_HUMAN	"RNA exonuclease 5, EC 3.1.-.- (Exonuclease NEF-sp)"	REXO5 44M2.3	Homo sapiens (Human)		extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]	exonuclease activity [GO:0004527]; RNA binding [GO:0003723]	GO:0003723; GO:0004527; GO:0005634; GO:0005730; GO:0070062	AGDLPK	5.710000038	0.000718088	0.000718088	0.31728852	600.6160872	19.31972	0	0	17.84486	16.85232	15.83789	0	0	0	0	0	0	0	0	0	0	0	18.44326	0	0	0	0	0	0	19.21029	0	0	0	19.85044	0	0	0	0	0	0	18.67239	0	20.66021	19.60345	0	0	0	0	0	18.30127	15.92973	16.72191	0
Q96II8	LRCH3_HUMAN	DISP complex protein LRCH3 (Leucine-rich repeat and calponin homology domain-containing protein 3)	LRCH3	Homo sapiens (Human)	septin cytoskeleton organization [GO:0032185]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; septin cytoskeleton organization [GO:0032185]		GO:0005737; GO:0005829; GO:0032185	EQLVER	22.01000023	0.171360523	0.171360523	0.207719164	773.3157428	0	0	15.39237	0	0	17.45848	0	0	0	0	16.14004	13.96572	17.53651	0	0	0	0	16.58163	0	0	0	0	0	15.32243	0	0	0	0	15.52043	0	0	0	16.11998	16.5766	0	0	0	0	0	0	16.00917	16.83504	0	0	15.33256	0	16.48571	0
Q96IJ6	GMPPA_HUMAN	"Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A, GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)"	GMPPA	Homo sapiens (Human)	biosynthetic process [GO:0009058]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058]	nucleotidyltransferase activity [GO:0016779]	GO:0005737; GO:0009058; GO:0016779; GO:0070062	GVTVGEGVR	4.289999962	1	1	0.176478521	873.5186004	0	0	0	0	13.2715	14.08497	0	14.16133	0	15.82233	0	0	14.67366	0	0	12.64255	0	13.57957	0	15.56728	0	0	0	0	0	14.86213	0	0	0	0	0	0	16.46677	0	0	0	0	0	15.80028	0	0	0	0	0	0	0	0	14.76273
Q96IK5	GMCL1_HUMAN	Germ cell-less protein-like 1 (Spermatogenesis-associated protein 29)	GMCL1 BTBD13 GCL SPATA29	Homo sapiens (Human)	germ cell development [GO:0007281]; spermatogenesis [GO:0007283]	nuclear matrix [GO:0016363]; nucleus [GO:0005634]	nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; germ cell development [GO:0007281]; spermatogenesis [GO:0007283]	identical protein binding [GO:0042802]	GO:0005634; GO:0007281; GO:0007283; GO:0016363; GO:0042802	EELEGNSMR	8.130000114	0.302191645	0.302191645	0.111166623	1079.484242	12.44587	15.90059	16.59267	12.22848	0	0	17.51805	11.86073	12.20457	16.34971	0	0	15.87392	14.14608	16.31455	10.42612	15.83258	18.37747	14.89183	15.89736	16.28084	13.12624	0	14.72558	16.29364	14.85484	15.31874	17.57655	15.03675	17.68756	10.76444	0	0	13.76568	17.87124	14.54297	16.08281	17.40589	15.41669	16.64557	16.87247	0	0	15.65439	17.59936	16.32884	17.15939	13.92992
Q96IM9	DYDC2_HUMAN	DPY30 domain-containing protein 2	DYDC2	Homo sapiens (Human)	histone H3-K4 methylation [GO:0051568]	MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]	MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568]		GO:0044666; GO:0048188; GO:0051568	EAFQHEVAHEMPPGSKSPF	1.090000033	1	1	0	2125.015204	15.47955	14.20068	12.25075	15.97803	0	13.84884	14.89973	15.8064	16.26931	0	0	0	0	0	0	15.39995	0	0	0	0	0	0	0	0	0	0	16.16909	0	15.67851	13.78109	0	13.42293	0	15.78114	16.25908	0	17.24551	14.78006	0	0	15.62416	0	0	17.7997	0	0	0	15.0979
Q96IR2	ZN845_HUMAN	Zinc finger protein 845	ZNF845	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	NSHEAPMTEIKQLTGSTNR	8.640000343	1	1	0.073541186	2129.520533	0	0	0	15.26539	0	0	0	0	0	0	0	12.49214	16.11291	15.24946	16.75977	0	12.82225	15.18994	0	0	0	17.01612	0	14.85391	0	0	14.9861	0	15.70073	15.21961	15.01997	0	11.47225	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96IR7	HPDL_HUMAN	"4-hydroxyphenylpyruvate dioxygenase-like protein, HPD-like protein, EC 1.13.-.- (Glyoxalase domain-containing protein 1)"	HPDL GLOXD1	Homo sapiens (Human)	aromatic amino acid family metabolic process [GO:0009072]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; aromatic amino acid family metabolic process [GO:0009072]	4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]	GO:0003868; GO:0005739; GO:0009072; GO:0046872	AAPALR	2.769999981	0.000944733	0.000944733	0.039553929	599.4035457	0	15.89309	15.75238	14.24346	16.23426	18.56141	9.634744	14.01096	15.12389	0	15.94407	10.11293	14.95326	0	14.8733	11.86568	15.78306	14.24887	13.55556	12.23084	13.31292	16.34545	15.94918	16.53776	13.56847	14.0031	13.9686	14.75461	14.03132	16.03916	14.56286	17.3625	14.34521	15.53848	14.78496	12.58811	12.69104	15.84528	17.44973	16.2315	12.9166	14.83233	15.07499	0	10.3289	0	0	14.09092
Q96IT1	ZN496_HUMAN	Zinc finger protein 496 (Zinc finger protein with KRAB and SCAN domains 17)	ZNF496 ZKSCAN17	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0045893; GO:0046872	SLPASHR	2.900000095	1	1	0.173108862	766.7562541	16.35727	16.21329	13.03933	14.28605	15.14974	15.35357	15.22647	15.44026	15.05634	14.67427	13.80961	16.10734	12.15887	15.76995	0	15.44381	14.11007	15.57992	0	13.96237	14.33856	15.39648	0	0	0	0	0	0	0	0	0	0	0	12.19837	15.5097	0	0	0	18.53322	0	0	0	0	0	0	0	0	0
Q96IX5	ATPMK_HUMAN	"ATP synthase membrane subunit K, mitochondrial (ATP synthase membrane subunit DAPIT, mitochondrial) (Diabetes-associated protein in insulin-sensitive tissues) (HCV F-transactivated protein 2) (Up-regulated during skeletal muscle growth protein 5)"	ATP5MK ATP5MD DAPIT HCVFTP2 USMG5 PD04912	Homo sapiens (Human)	ATP synthesis coupled proton transport [GO:0015986]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; ATP synthesis coupled proton transport [GO:0015986]		GO:0005739; GO:0005743; GO:0005753; GO:0015986; GO:0016021	KTPAVK	9.68999958	0.800463438	0.800463438	0.301426108	644.2055794	0	15.85375	15.50101	14.3901	14.28457	14.11246	15.57492	0	0	14.68451	15.15273	0	14.9436	14.61007	15.7188	0	0	0	0	16.84596	0	0	16.58287	15.90297	15.70636	0	15.86249	0	0	0	14.36502	15.92518	0	16.84946	0	15.81945	15.78889	16.58721	17.58035	16.77326	15.41183	0	15.27919	0	16.46035	16.44564	16.19912	16.14673
Q96IX9	A26L1_HUMAN	Putative ankyrin repeat domain-containing protein 26-like 1 (Ankyrin repeat domain-containing protein 36B pseudogene 1)	ANKRD36BP1 ANKRD26L1	Homo sapiens (Human)						QNGEKSTK	10.63000011	0.97162658	0.97162658	1.15E-12	893.8535825	0	14.39361	0	0	12.95494	15.70603	15.21745	14.1216	0	0	15.2033	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.4429	12.06871	14.06244	0	0	0	0	0	0	0	0	10.39127	0	0	0	0	0	0	0	0	14.15157	13.51119
Q96IY1	NSL1_HUMAN	Kinetochore-associated protein NSL1 homolog	NSL1 C1orf48 DC31 DC8 MIS14	Homo sapiens (Human)	cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]	cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear speck [GO:0016607]	cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear speck [GO:0016607]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]		GO:0000070; GO:0000444; GO:0000776; GO:0005829; GO:0016607; GO:0031617; GO:0051301	INLDT	6.21999979	1	1	0.314888128	573.9494716	0	18.94774	0	0	17.76649	18.16301	0	17.75954	0	0	18.30534	17.89312	0	18.843	0	0	0	0	0	0	0	0	19.16113	0	0	0	0	0	0	0	0	0	0	18.70111	18.21983	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96IZ5	RBM41_HUMAN	RNA-binding protein 41 (RNA-binding motif protein 41)	RBM41	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	U12-type spliceosomal complex [GO:0005689]	"U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; mRNA splicing, via spliceosome [GO:0000398]"	pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]	GO:0000398; GO:0005689; GO:0030626; GO:0097157	REMEIEK	1.200000048	1	1	0.139342588	950.5735315	0	0	0	0	15.82949	0	0	12.60367	0	0	0	16.10163	13.8539	15.2146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.09226	0	0	0	0	0	0	0	0	0	0	0	14.35911	0	0	0
Q96IZ6	MET2A_HUMAN	"tRNA N(3)-methylcytidine methyltransferase METTL2A, EC 2.1.1.- (Methyltransferase-like protein 2A)"	METTL2A METTL2 HSPC266	Homo sapiens (Human)	tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA methylation [GO:0030488]	tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]	GO:0005737; GO:0030488; GO:0052735	MAGSYPEGAPAVLADKR	6.110000134	1	1	0.381485396	1747.94383	15.70607	0	15.51877	0	14.30299	0	14.73195	0	11.02468	15.18262	0	0	12.94645	0	0	14.78078	0	0	0	0	0	15.25452	0	16.59484	0	0	0	0	0	16.32354	0	0	0	0	15.23389	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96J02	ITCH_HUMAN	"E3 ubiquitin-protein ligase Itchy homolog, Itch, EC 2.3.2.26 (Atrophin-1-interacting protein 4, AIP4) (HECT-type E3 ubiquitin transferase Itchy homolog) (NFE2-associated polypeptide 1, NAPP1)"	ITCH	Homo sapiens (Human)	apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of apoptotic process [GO:0043066]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of protein deubiquitination [GO:0090085]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; arrestin family protein binding [GO:1990763]; CXCR chemokine receptor binding [GO:0045236]; ligase activity [GO:0016874]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of apoptotic process [GO:0043066]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of protein deubiquitination [GO:0090085]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]	arrestin family protein binding [GO:1990763]; CXCR chemokine receptor binding [GO:0045236]; ligase activity [GO:0016874]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0001558; GO:0002669; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006915; GO:0006954; GO:0016020; GO:0016567; GO:0016874; GO:0019787; GO:0031410; GO:0031901; GO:0032088; GO:0032480; GO:0032991; GO:0035519; GO:0043021; GO:0043066; GO:0043161; GO:0043231; GO:0044389; GO:0045087; GO:0045236; GO:0045732; GO:0046329; GO:0046642; GO:0046718; GO:0050687; GO:0051607; GO:0051865; GO:0061630; GO:0070062; GO:0070423; GO:0070534; GO:0070936; GO:0090085; GO:1902036; GO:1990763; GO:2000646	DETRVSTNGSDDPEDAGAGENR	1.929999948	1	1	0.151851379	2292.008421	0	14.02915	11.07246	11.93722	11.98811	14.72175	14.16837	0	0	14.36167	13.569	13.55984	14.47768	0	0	14.90499	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96J65	MRP9_HUMAN	ATP-binding cassette sub-family C member 12 (Multidrug resistance-associated protein 9)	ABCC12 MRP9	Homo sapiens (Human)	transmembrane transport [GO:0055085]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]	GO:0005524; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0042626; GO:0055085; GO:0140359	AMAEANVSLR	5.840000153	1	1	0.186290593	1057.371426	0	0	0	17.48491	0	0	18.53662	0	16.68089	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.51066	0
Q96J84	KIRR1_HUMAN	Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1)	KIRREL1 KIRREL NEPH1	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; glomerular filtration [GO:0003094]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]; renal protein absorption [GO:0097017]	cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; glomerular filtration [GO:0003094]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]; renal protein absorption [GO:0097017]	cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022]	GO:0001933; GO:0003094; GO:0005886; GO:0005887; GO:0005911; GO:0017022; GO:0030838; GO:0043198; GO:0045217; GO:0048471; GO:0050839; GO:0097017; GO:0098609	DGTQQEGAVASTELLKDGK	10.46000004	0.060107436	0.060107436	7.52E-12	1947.947587	0	15.8418	0	0	0	10.73546	13.65057	13.97472	0	0	0	0	16.9894	18.25171	0	13.62285	15.69304	17.52164	13.83577	16.81303	0	0	12.91603	0	0	15.74333	12.79395	0	15.4047	12.30905	0	15.81047	0	13.50998	14.97946	0	14.9394	17.76111	16.46085	17.24055	16.50291	16.49958	0	0	14.79239	0	13.61484	15.50674
Q96J87	CELF6_HUMAN	"CUGBP Elav-like family member 6, CELF-6 (Bruno-like protein 6) (CUG-BP- and ETR-3-like factor 6) (RNA-binding protein BRUNOL-6)"	CELF6 BRUNOL6	Homo sapiens (Human)	"mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:1990904	LTGLHK	3.460000038	1	1	0.090639577	666.0128498	0	0	15.36099	13.3006	0	0	15.64282	0	0	14.42043	0	0	0	15.27722	0	0	0	0	0	0	0	0	0	0	0	0	16.97954	0	0	0	0	0	0	0	0	0	0	0	0	0	15.10688	0	0	0	0	0	0	0
Q96J92	WNK4_HUMAN	"Serine/threonine-protein kinase WNK4, EC 2.7.11.1 (Protein kinase lysine-deficient 4) (Protein kinase with no lysine 4)"	WNK4 PRKWNK4	Homo sapiens (Human)	cellular cation homeostasis [GO:0030003]; chloride transport [GO:0006821]; distal tubule morphogenesis [GO:0072156]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; renal sodium ion absorption [GO:0070294]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular cation homeostasis [GO:0030003]; chloride transport [GO:0006821]; distal tubule morphogenesis [GO:0072156]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; renal sodium ion absorption [GO:0070294]	ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005923; GO:0006468; GO:0006811; GO:0006821; GO:0008104; GO:0010766; GO:0016020; GO:0019869; GO:0019870; GO:0030003; GO:0035556; GO:0050801; GO:0070294; GO:0072156; GO:0090188; GO:0106310; GO:1903288; GO:2000651	GSFPTSRR	3.25999999	1	1	0.293329014	904.3251587	0	0	0	0	16.13308	17.94354	0	0	0	17.71816	16.16045	0	0	0	18.30746	0	15.59039	0	0	0	0	0	0	0	0	0	0	15.70115	0	0	0	0	0	0	0	19.75215	0	0	0	0	0	0	0	0	0	0	0	0
Q96J94	PIWL1_HUMAN	"Piwi-like protein 1, EC 3.1.26.-"	PIWIL1 HIWI	Homo sapiens (Human)	"gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]	"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]"	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0003723; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007283; GO:0007286; GO:0010529; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0035093; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:1905538	TYRVDDIDWDQNPK	9.710000038	1	1	0.049709981	1766.001606	15.72461	12.02608	0	0	0	14.64821	14.60868	12.89603	0	14.68174	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JA3	PKHA8_HUMAN	"Pleckstrin homology domain-containing family A member 8, PH domain-containing family A member 8 (Phosphatidylinositol-four-phosphate adapter protein 2, FAPP-2, Phosphoinositol 4-phosphate adapter protein 2, hFAPP2) (Serologically defined breast cancer antigen NY-BR-86)"	PLEKHA8 FAPP2	Homo sapiens (Human)	ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031]	ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; phosphatidylinositol-4-phosphate binding [GO:0070273]	GO:0000139; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006869; GO:0015031; GO:0017089; GO:0035621; GO:0035627; GO:0051861; GO:0070273; GO:0097001; GO:0120009; GO:1902387; GO:1902388	TLEECMQIANAAFTSELLYR	3.430000067	0.673340201	0.673340201	0.130327748	2375.489511	11.67452	0	0	15.5458	0	14.96557	0	13.47116	0	0	0	0	0	0	0	13.20969	0	0	0	0	0	0	10.88382	11.61727	14.49366	0	0	0	0	0	0	0	0	0	0	0	15.96704	0	0	0	0	0	0	0	0	0	0	0
Q96JA4	M4A14_HUMAN	Membrane-spanning 4-domains subfamily A member 14 (Testis development protein NYD-SP21)	MS4A14 MS4A13 MS4A16	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166]		GO:0005886; GO:0007166; GO:0016021	NPLTG	3.180000067	0.525250256	0.525250256	0.125809874	500.4937905	0	18.82604	12.13038	0	16.13691	15.70592	11.7161	16.1594	17.01273	18.51636	17.80875	17.46279	17.35536	18.83225	15.75272	20.20746	16.0375	16.72757	15.89605	15.40751	17.27452	14.94736	16.50285	13.72366	14.02346	14.34376	15.85836	16.11989	17.51594	15.25021	14.81054	15.76665	17.79547	10.48965	0	14.57518	16.91057	16.95034	17.02347	17.18757	16.46238	16.80346	17.48751	18.8414	13.53658	18.45735	15.27963	18.00397
Q96JB1	DYH8_HUMAN	Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)	DNAH8	Homo sapiens (Human)	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	AVIRQYNK	22.95000076	0.937243938	0.937243938	0.246382335	991.3390289	0	15.28102	15.22783	0	14.5497	16.13774	14.19805	0	15.14017	15.23173	15.60921	14.93329	7.08172	14.4468	0	15.33889	14.39647	15.50932	0	0	15.42993	0	0	0	15.60001	0	0	14.41252	14.95465	15.60974	16.58326	0	0	0	0	14.95565	0	14.98165	16.43836	15.68016	0	0	0	15.95493	16.00277	0	14.92684	0
Q96JB3	HIC2_HUMAN	"Hypermethylated in cancer 2 protein, Hic-2 (HIC1-related gene on chromosome 22 protein) (Hic-3) (Zinc finger and BTB domain-containing protein 30)"	HIC2 HRG22 KIAA1020 ZBTB30	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0008022; GO:0045892; GO:0046872	EAGPKGPCPGEEGEGVGDR	2.519999981	1	1	0.214382089	1898.074866	12.60008	0	15.32621	0	14.93885	13.59507	17.02993	15.83136	0	16.19878	15.72759	0	0	13.42221	0	15.50805	0	0	14.51769	0	0	0	0	0	0	0	17.20599	0	15.53351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JB8	MPP4_HUMAN	MAGUK p55 subfamily member 4 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 5 protein) (Discs large homolog 6)	MPP4 ALS2CR5 DLG6	Homo sapiens (Human)	protein localization to synapse [GO:0035418]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein localization to synapse [GO:0035418]		GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0015629; GO:0032991; GO:0035418	GTIMFK	10.01000023	1	1	0.246143432	711.0626793	16.61037	13.87567	17.97519	0	0	0	13.36109	15.78106	0	0	15.64357	0	15.37603	14.78918	14.74877	14.56567	0	0	0	14.82302	16.79316	0	0	0	17.66718	0	17.30644	0	14.35788	0	16.35936	17.42441	0	16.42017	0	16.58068	17.74656	17.45708	0	0	16.54018	14.97011	0	0	16.01517	16.56874	17.20287	0
Q96JD6	AKCL2_HUMAN	"1,5-anhydro-D-fructose reductase, AF reductase, EC 1.1.1.263 (Aldo-keto reductase family 1 member C-like protein 2) (Aldo-keto reductase family 1 member E2) (LoopADR) (Testis aldo-keto reductase, htAKR) (Testis-specific protein, hTSP)"	AKR1E2 AKR1CL2 AKRDC1	Homo sapiens (Human)		cytosol [GO:0005829]	"cytosol [GO:0005829]; 1,5-anhydro-D-fructose reductase activity [GO:0050571]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]"	"1,5-anhydro-D-fructose reductase activity [GO:0050571]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]"	GO:0004032; GO:0005829; GO:0016491; GO:0050571	SPAQILIR	7.570000172	1	1	0.141696147	896.3099347	16.13596	0	14.41366	15.39557	15.28219	0	0	14.64729	0	0	13.50201	16.69737	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.74946	0	0	17.91952	0	16.13984	0	0	0	17.08163	0	0	0	0	0	0	0	0	0
Q96JE7	SC16B_HUMAN	"Protein transport protein Sec16B (Leucine zipper transcription regulator 2) (Regucalcin gene promoter region-related protein p117, RGPR-p117) (SEC16 homolog B)"	SEC16B KIAA1928 LZTR2 RGPR SEC16S	Homo sapiens (Human)	autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; positive regulation of gene expression [GO:0010628]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein transport [GO:0015031]	cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]	cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; positive regulation of gene expression [GO:0010628]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein transport [GO:0015031]		GO:0000139; GO:0005789; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0007031; GO:0010628; GO:0012507; GO:0015031; GO:0016559; GO:0043231; GO:0048208; GO:0070863; GO:0070971; GO:0070973	ESSDEADK	5.210000038	1	1	0.20640864	879.9545973	0	0	0	0	0	0	16.14264	0	14.35812	0	16.05158	0	0	0	15.60555	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.92299	0	0	0	0	0	0	0	0	0	0	15.47485	0	13.72987	15.45934	0	0	0	0
Q96JF6	ZN594_HUMAN	Zinc finger protein 594 (Zinc finger protein HZF18)	ZNF594 KIAA1871	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872	SGLTEHQK	6.650000095	0.607458711	0.607458711	0.276385735	899.7718315	0	16.00671	14.33548	15.97128	0	14.3562	0	0	15.3119	16.53023	0	15.00436	15.81582	14.35242	14.36203	0	15.35934	15.65115	0	0	16.45599	16.36376	0	14.45574	14.98174	0	15.94753	0	15.6532	0	16.82298	0	0	0	0	0	15.96338	14.41466	0	15.53699	15.75796	0	0	0	0	0	0	0
Q96JG6	VPS50_HUMAN	Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50)	VPS50 CCDC132 KIAA1861	Homo sapiens (Human)	endocytic recycling [GO:0032456]; protein transport [GO:0015031]	EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]	EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE binding [GO:0000149]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]	SNARE binding [GO:0000149]	GO:0000149; GO:0015031; GO:0016020; GO:0032456; GO:0048471; GO:0055037; GO:0070062; GO:1990745	VQQAYRLLGK	1.230000019	0.466427177	0.466427177	0.132046224	1174.659315	13.09964	12.20269	16.63693	13.65206	15.91304	14.74289	11.38092	0	0	0	15.96465	15.07681	0	0	0	0	9.324491	15.08606	0	0	0	0	0	0	0	0	15.36767	12.48326	0	13.9445	14.42465	0	16.26991	0	0	0	0	17.70514	0	0	0	0	0	15.10171	0	0	0	0
Q96JH7	VCIP1_HUMAN	"Deubiquitinating protein VCPIP1, EC 3.4.19.12 (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135, VCP/p47 complex-interacting 135-kDa protein)"	VCPIP1 KIAA1850 VCIP135	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; Golgi stack [GO:0005795]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; thiol-dependent deubiquitinase [GO:0004843]; cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634]	thiol-dependent deubiquitinase [GO:0004843]	GO:0000278; GO:0004843; GO:0005634; GO:0005737; GO:0005788; GO:0005795; GO:0006974; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0071108; GO:0090168; GO:0106300; GO:1905634	DRSGSLLYLHDTLEDIK	9.489999771	1	1	0.169456891	1976.018963	0	14.73155	14.54557	10.38215	13.31174	12.60981	14.87081	0	0	14.10211	14.67549	0	0	0	0	0	0	0	0	0	0	0	13.51594	0	13.88898	15.84045	0	0	0	0	0	0	0	14.2278	15.01329	0	0	0	0	0	0	14.11939	0	0	15.92396	0	0	0
Q96JI7	SPTCS_HUMAN	Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein)	SPG11 KIAA1840	Homo sapiens (Human)	autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; walking behavior [GO:0090659]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein kinase binding [GO:0019901]; autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; walking behavior [GO:0090659]	protein kinase binding [GO:0019901]	GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0048489; GO:0048675; GO:0048741; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256	HYFEVLMR	1.75999999	1	1	0.282963246	1109.480371	15.36286	0	0	0	0	0	0	0	0	0	0	15.50883	14.76058	14.4606	0	16.653	0	0	0	14.42993	0	0	16.18997	0	0	15.53791	15.60707	0	0	0	0	0	0	0	15.83465	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JJ3	ELMO2_HUMAN	"Engulfment and cell motility protein 2 (Protein ced-12 homolog A, hCed-12A)"	ELMO2 CED12A KIAA1834	Homo sapiens (Human)	actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909]	cytosol [GO:0005829]; membrane [GO:0016020]	cytosol [GO:0005829]; membrane [GO:0016020]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909]	receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]	GO:0005829; GO:0006909; GO:0006915; GO:0007015; GO:0016020; GO:0017124; GO:0030971; GO:0048870; GO:0060326; GO:0098609	QLMERTQSSNMETR	2.529999971	0.874669611	0.874669611	0.396765782	1725.690723	0	16.16407	14.67484	0	15.45613	14.74494	15.61277	0	0	0	0	15.84912	0	0	0	0	0	12.72434	0	0	0	16.80774	0	0	0	0	16.25008	13.02521	0	17.77654	0	0	18.44634	0	0	17.63489	13.64559	18.09529	0	0	15.73568	0	0	0	11.92113	0	0	0
Q96JJ7	TMX3_HUMAN	"Protein disulfide-isomerase TMX3, EC 5.3.4.1 (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3)"	TMX3 KIAA1830 TXNDC10	Homo sapiens (Human)	peptidyl-cysteine oxidation [GO:0018171]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; peptidyl-cysteine oxidation [GO:0018171]	protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]	GO:0003756; GO:0005783; GO:0005789; GO:0005886; GO:0009986; GO:0015035; GO:0016021; GO:0018171; GO:0031092	LVALAVIDEK	6.900000095	1	1	0.433507716	1067.857535	15.08347	0	0	0	0	0	0	16.90687	0	0	0	0	0	0	0	15.87342	0	0	0	16.14584	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JK9	MAML3_HUMAN	"Mastermind-like protein 3, Mam-3"	MAML3 KIAA1816	Homo sapiens (Human)	Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0007219; GO:0007221; GO:0016607; GO:0045944	SLQGMPGR	5.360000134	1	1	0.040495899	841.7547416	0	14.97279	0	0	0	0	0	16.77673	15.49156	0	0	0	16.99439	14.66193	15.90054	0	0	0	14.89563	0	0	0	0	0	0	0	16.09731	0	16.61843	0	0	0	0	0	0	16.70797	0	0	18.01979	16.69242	16.60803	0	0	0	0	0	0	0
Q96JL9	ZN333_HUMAN	Zinc finger protein 333	ZNF333 KIAA1806	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	NGSLPLSMSHPYCGPLAN	11.42000008	1	1	4.57E-13	1930.56119	13.86331	14.47119	13.75643	13.12228	15.70191	0	13.17984	0	0	16.64549	12.91387	0	13.67879	0	0	0	0	15.78945	0	0	0	0	16.90639	14.61456	0	17.42224	0	0	0	0	16.16648	15.43801	17.8991	14.02788	0	0	0	8.79956	0	0	0	0	0	0	0	15.39876	0	0
Q96JM2	ZN462_HUMAN	"Zinc finger protein 462 (Zinc finger PBX1-interacting protein, ZFPIP)"	ZNF462 KIAA1803	Homo sapiens (Human)	chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006325; GO:0010468; GO:0043392; GO:0045944; GO:0046872	AEDRELMR	12.35000038	0.678183496	0.678183496	0.011712723	1032.618592	16.12914	0	17.43584	0	11.35813	16.4703	15.79673	13.06811	0	0	17.21076	15.44649	15.82099	10.53979	8.605556	0	0	15.57108	16.63921	15.7326	0	0	12.93369	0	12.7466	16.9493	15.74897	15.44475	17.5678	0	15.82549	16.06218	16.71936	13.49888	13.58525	16.54537	0	14.44964	0	12.6726	14.43605	17.28827	0	0	0	16.11827	0	0
Q96JM3	CHAP1_HUMAN	Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828)	CHAMP1 C13orf8 CAMP CHAMP KIAA1802 ZNF828	Homo sapiens (Human)	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134]	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134]	metal ion binding [GO:0046872]	GO:0000776; GO:0000793; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0016604; GO:0031134; GO:0034501; GO:0035372; GO:0046872; GO:0051315; GO:0090543	HALFPELPK	20.54000092	1	1	0.101764233	1052.623598	14.86525	0	0	0	0	15.61599	15.62204	0	15.10964	0	0	0	0	0	0	0	0	0	0	0	0	0	17.04675	0	16.17022	0	15.72963	0	14.15831	0	0	15.08917	0	0	0	0	0	0	0	0	0	0	0	0	13.83242	0	0	14.63054
Q96JM4	LRIQ1_HUMAN	Leucine-rich repeat and IQ domain-containing protein 1	LRRIQ1 KIAA1801	Homo sapiens (Human)						DTTANEK	10.59000015	0.000994453	0.000994453	0.29746309	778.1462596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JM7	LMBL3_HUMAN	"Lethal(3)malignant brain tumor-like protein 3, H-l(3)mbt-like protein 3, L(3)mbt-like protein 3, L3mbt-like 3 (MBT-1)"	L3MBTL3 KIAA1798 MBT1	Homo sapiens (Human)	"chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0008270; GO:0030225; GO:0030851; GO:0042393; GO:0042802; GO:0043249; GO:0045892; GO:0090308	RNPMFIR	1.5	0.810964525	0.810964525	0.112388994	949.4428308	0	18.46753	0	0	0	0	14.05393	0	15.15258	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JN2	CC136_HUMAN	Coiled-coil domain-containing protein 136 (Nasopharyngeal carcinoma-associated gene 6 protein)	CCDC136 KIAA1793 NAG6	Homo sapiens (Human)	acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]	acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]	acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]		GO:0001675; GO:0002080; GO:0007283; GO:0007338; GO:0016021	LLMEQMQALQVMYDAGQAK	9.470000267	0.678143919	0.678143919	0.077924272	2187.565753	0	18.62399	0	0	0	0	0	0	0	0	0	0	0	0	0	13.60983	13.60799	0	0	0	0	11.8533	0	9.866829	15.17993	12.3582	0	0	9.922878	0	15.05805	0	0	0	0	0	0	15.07583	0	14.00182	0	0	0	0	0	0	0	14.30966
Q96JN8	NEUL4_HUMAN	Neuralized-like protein 4	NEURL4 KIAA1787	Homo sapiens (Human)		centriole [GO:0005814]; cytoplasm [GO:0005737]	centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]	ubiquitin protein ligase activity [GO:0061630]	GO:0005737; GO:0005814; GO:0061630	GDEAHR	11.57999992	0.143872499	0.143872499	0.129274967	684.9574035	19.54757	0	0	17.31023	0	0	0	16.24977	0	17.35176	15.76617	0	16.46592	13.93058	16.35824	0	0	0	14.07502	0	15.96364	0	15.93813	0	16.90476	0	11.27787	0	11.28226	17.62564	0	0	16.53185	15.759	0	12.45472	0	0	17.79025	0	15.31164	0	0	0	0	0	14.1096	0
Q96JP2	MY15B_HUMAN	Unconventional myosin-XVB (Myosin XVBP) (Unconventional myosin-15B)	MYO15B KIAA1783 MYO15BP	Homo sapiens (Human)		cytoplasm [GO:0005737]; myosin complex [GO:0016459]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]	ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]	GO:0003774; GO:0005524; GO:0005737; GO:0016459	IDPKDEALAK	8.479999542	0.484379768	0.484379768	0.359203078	1101.449818	13.85154	12.82012	13.92438	0	15.10724	15.53298	0	13.62455	14.55212	14.23624	0	12.82564	15.5683	0	0	0	0	14.43389	0	16.63579	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.69754	0	0	0	0
Q96JP5	ZFP91_HUMAN	"E3 ubiquitin-protein ligase ZFP91, EC 2.3.2.27 (RING-type E3 ubiquitin transferase ZFP91) (Zinc finger protein 757) (Zinc finger protein 91 homolog, Zfp-91)"	ZFP91 ZNF757 FKSG11	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0007250; GO:0046872; GO:0070534	ETPKPRR	5.71999979	1	1	0.056226264	883.8750017	0	16.0581	15.94106	0	15.83157	14.45293	0	17.24472	14.92938	0	0	0	14.87029	0	16.29402	18.16863	14.69281	0	0	13.21513	13.67776	0	0	16.03071	16.35078	0	0	16.72247	0	15.99836	0	0	0	0	0	16.64438	18.60313	16.07811	0	13.96889	0	16.94851	14.6653	0	16.14587	14.22267	0	14.27153
Q96JP9	CDHR1_HUMAN	"Cadherin-related family member 1 (Photoreceptor cadherin, prCAD) (Protocadherin-21)"	CDHR1 KIAA1775 PCDH21 PRCAD	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845]	integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622]	integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0008594; GO:0035845; GO:0042622; GO:0045494	KSVHNK	2.960000038	1	1	0.202882692	709.879215	13.01906	14.82369	12.12703	0	14.62004	0	12.93051	0	0	0	16.12673	0	0	0	0	13.48299	0	0	14.41625	0	0	15.63347	15.89597	0	0	0	0	0	0	0	0	0	0	15.86888	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JQ0	PCD16_HUMAN	Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1)	DCHS1 CDH19 CDH25 FIB1 KIAA1773 PCDH16	Homo sapiens (Human)	adherens junction organization [GO:0034332]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	adherens junction [GO:0005912]; apical part of cell [GO:0045177]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0000902; GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0007157; GO:0007389; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0021915; GO:0022008; GO:0034332; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0045296; GO:0048565; GO:0072137; GO:0072659; GO:0090102; GO:0098742	AGLLLPGAGATLYR	12.65999985	1	1	0	1372.859725	17.79578	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JT2	S45A3_HUMAN	Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein)	SLC45A3 PCANAP6 PRST	Homo sapiens (Human)	hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]; hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770]	sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]	GO:0005886; GO:0008506; GO:0008645; GO:0010907; GO:0015770; GO:0016020; GO:0016021; GO:0045723; GO:0048713; GO:0051119	EKQVFLPK	2.819999933	0.553469419	0.553469419	0.138447682	986.543719	17.04893	14.79872	0	17.36968	0	0	0	13.7867	0	0	0	0	16.20098	15.26719	17.11481	12.13881	13.46536	0	18.61959	0	18.2278	18.28836	15.98955	16.08028	0	0	17.1862	18.23528	15.8868	0	0	17.82449	15.70172	0	18.38658	15.6025	14.40813	18.0136	0	0	0	0	0	0	17.18101	7.62311	0	17.95359
Q96JX3	SRAC1_HUMAN	Protein SERAC1 (Serine active site-containing protein 1)	SERAC1	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; intracellular cholesterol transport [GO:0032367]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]	endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]	endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; extracellular matrix organization [GO:0030198]; intracellular cholesterol transport [GO:0032367]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]		GO:0005739; GO:0005783; GO:0008654; GO:0016021; GO:0030198; GO:0031012; GO:0032367; GO:0036148; GO:0044233	ADVLFIHGLMGAAFK	1.929999948	1	1	0	1604.013057	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96JZ2	HSH2D_HUMAN	"Hematopoietic SH2 domain-containing protein, Hematopoietic SH2 protein (Adaptor in lymphocytes of unknown function X)"	HSH2D ALX	Homo sapiens (Human)	negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of mitochondrial depolarization [GO:0051902]; signal transduction [GO:0007165]; T cell activation [GO:0042110]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of mitochondrial depolarization [GO:0051902]; signal transduction [GO:0007165]; T cell activation [GO:0042110]	protein-macromolecule adaptor activity [GO:0030674]	GO:0002903; GO:0005634; GO:0005739; GO:0005829; GO:0007165; GO:0030674; GO:0042110; GO:0051902	ELLTQPCR	17.77000046	1	1	0.193323477	1016.835784	0	0	17.25757	16.90894	0	0	14.9021	14.55587	12.74219	15.84203	15.79392	15.96794	16.29012	12.80043	16.16119	0	0	0	0	0	15.6713	12.38543	0	0	14.10945	16.08222	0	13.04263	0	15.00553	0	0	16.56729	16.07032	16.84229	0	0	0	16.92698	14.26414	0	0	15.88142	0	0	0	0	0
Q96K30	RITA1_HUMAN	RBPJ-interacting and tubulin-associated protein 1 (RBPJ-interacting and tubulin-associated protein)	RITA1 C12orf52 RITA PSEC0043	Homo sapiens (Human)	negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; nuclear export [GO:0051168]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tubulin binding [GO:0015631]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; nuclear export [GO:0051168]	tubulin binding [GO:0015631]	GO:0000122; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0007219; GO:0015631; GO:0022008; GO:0045746; GO:0051168	GVGKEASK	2.380000114	1	1	0.168774396	774.6864273	15.39434	16.11843	13.37653	16.59356	0	0	0	14.32985	0	0	15.03158	0	13.80454	0	0	0	0	0	0	0	0	0	0	0	0	15.12441	0	16.04073	0	15.21206	0	0	14.54018	0	0	0	0	0	0	16.75019	12.00943	0	0	14.1117	0	0	0	0
Q96K49	TM87B_HUMAN	Transmembrane protein 87B	TMEM87B	Homo sapiens (Human)	"retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]"		GO:0000139; GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0042147	LLVIIVSLGYGIVKPR	6.489999771	1	1	0.400276374	1739.119704	15.19322	15.46047	13.30579	15.56044	0	0	0	0	15.10104	0	0	0	0	0	15.66474	0	0	0	0	17.78325	0	0	0	0	15.02518	0	15.03273	14.42789	0	15.00072	0	0	0	16.59646	0	16.79529	16.83576	12.70452	16.19087	0	15.05671	12.1069	0	12.3003	16.33592	0	16.9578	0
Q96K58	ZN668_HUMAN	Zinc finger protein 668	ZNF668	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872	QPADLAMHRR	1.399999976	1	1	1.37E-12	1209.710126	0	12.23851	0	14.20242	13.50493	15.55318	0	14.75598	0	13.3219	15.72378	14.91005	0	14.46912	0	0	0	0	16.26344	0	0	0	0	14.40077	0	0	0	0	0	13.91791	0	0	0	0	0	0	0	0	0	0	0	0	13.46937	0	0	0	15.35301	0
Q96K75	ZN514_HUMAN	Zinc finger protein 514	ZNF514	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	FHTGEKPYKCNK	3.799999952	0.351550937	0.351550937	0.438160031	1508.947177	15.60444	15.84161	10.55472	13.199	14.07056	0	0	15.30026	14.16254	0	17.77196	15.3732	0	0	0	0	15.97177	0	0	0	0	16.89925	0	16.23402	0	0	0	9.536364	15.38137	0	16.38139	0	0	0	0	0	0	0	0	0	16.38365	0	4.657876	0	0	16.17538	0	0
Q96K76	UBP47_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 47, EC 3.4.19.12 (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47)"	USP47	Homo sapiens (Human)	"base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to xenobiotic stimulus [GO:0009410]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; thiol-dependent deubiquitinase [GO:0004843]; WD40-repeat domain binding [GO:0071987]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to xenobiotic stimulus [GO:0009410]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; thiol-dependent deubiquitinase [GO:0004843]; WD40-repeat domain binding [GO:0071987]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006974; GO:0009410; GO:0010972; GO:0016579; GO:0019005; GO:0030307; GO:0031647; GO:0034644; GO:0035520; GO:0043066; GO:0043154; GO:0045892; GO:0071987; GO:0090263; GO:0101005; GO:1902230	AEGFFR	7.849999905	0.920211196	0.920211196	0.279781588	727.0315548	15.63481	14.46864	15.94636	0	0	14.8415	15.14676	0	0	0	15.45816	16.3789	13.81113	14.28302	15.90896	0	0	0	16.65575	0	0	17.02248	16.20619	0	15.28608	15.61049	14.63732	15.62918	14.68952	15.17339	16.33844	16.43547	15.67968	15.70671	14.83835	14.67376	16.1169	15.75585	15.78196	16.45099	15.36043	16.83218	0	16.10393	16.42854	16.40085	15.914	0
Q96K78	AGRG7_HUMAN	Adhesion G-protein coupled receptor G7 (G-protein coupled receptor 128)	ADGRG7 GPR128	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021	GTDGFLR	10.39000034	0.726861119	0.726861119	1.60E-12	765.2979323	16.52541	15.88943	0	16.20015	17.5542	15.63158	0	14.55474	13.65589	0	14.78095	15.81444	15.78953	0	0	15.52439	16.29669	15.12809	15.36427	15.54857	16.63188	14.96997	0	0	16.23424	14.75859	17.36428	0	14.09291	0	12.35688	0	18.18805	0	15.97268	15.74958	15.15556	15.54079	0	17.14405	0	19.10365	16.99916	16.87659	14.39406	15.85847	16.54128	14.83053
Q96K83	ZN521_HUMAN	Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3)	ZNF521 EHZF LIP3	Homo sapiens (Human)	neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0019904; GO:0046872; GO:0048663	ISPSQSDEK	10	0.601685762	0.601685762	0.06652196	989.0746062	15.97433	0	14.69359	0	0	13.27357	0	12.38595	11.93642	0	0	0	13.6313	15.04433	0	13.87265	14.22454	14.90057	0	16.82431	14.28733	17.38956	16.94084	16.70645	12.82125	13.75606	14.77116	0	14.20527	12.70449	16.74278	11.52562	0	15.19495	13.48017	15.8284	15.44897	14.20239	0	0	0	15.70938	14.89373	15.99819	15.46995	16.38311	0	15.37466
Q96KA5	CLP1L_HUMAN	"Cleft lip and palate transmembrane protein 1-like protein, CLPTM1-like protein (Cisplatin resistance-related protein 9, CRR9p)"	CLPTM1L CRR9	Homo sapiens (Human)	apoptotic process [GO:0006915]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]		GO:0006915; GO:0016020; GO:0016021	TVNVSVPKK	11.10000038	0.138891801	0.138891801	0.180800869	970.9346101	0	18.33842	17.34194	16.69201	0	15.93766	0	0	0	10.86832	0	13.51238	15.06064	14.7793	16.01918	0	15.35705	15.40245	0	12.32028	0	17.17954	0	16.91503	15.45187	0	18.86122	16.11493	13.25359	0	0	20.86685	18.59538	15.44799	17.13156	15.16542	18.84905	15.49443	15.46642	0	19.6216	12.98634	14.66927	14.82943	15.78852	0	13.62867	16.63247
Q96KD3	GAR1B_HUMAN	Golgi associated RAB2 interactor protein 1B (Testis development protein NYD-SP18)	GARIN1B FAM137A FAM71F1	Homo sapiens (Human)	acrosome assembly [GO:0001675]; acrosome reaction [GO:0007340]	Golgi apparatus [GO:0005794]	Golgi apparatus [GO:0005794]; acrosome assembly [GO:0001675]; acrosome reaction [GO:0007340]		GO:0001675; GO:0005794; GO:0007340	LSSFPHR	3.779999971	1	1	0.243597662	843.8688422	13.80617	14.81526	14.54531	14.67816	15.34658	15.86897	15.41763	15.18112	15.5453	0	15.76565	14.9994	16.81399	0	16.34465	10.71929	15.4487	15.08998	14.40281	15.44124	12.97316	15.39104	0	16.39833	14.34281	0	15.50042	0	0	0	15.5561	16.66351	16.92592	15.86005	16.23662	0	0	0	16.51168	15.86758	0	0	15.38763	14.46933	14.06252	16.30639	0	16.32208
Q96KG7	MEG10_HUMAN	"Multiple epidermal growth factor-like domains protein 10, Multiple EGF-like domains protein 10"	MEGF10 KIAA1780	Homo sapiens (Human)	apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]	complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]	GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288	CEQGTYGNDCHQR	8.470000267	1	1	0.000636411	1623.828685	0	17.71361	17.19379	16.37023	16.80123	18.11694	0	0	17.45711	16.49739	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.84775	0	0	0	17.44595	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96KG9	SCYL1_HUMAN	N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)	SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019	Homo sapiens (Human)	"cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"	cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]	"cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; cellular protein localization [GO:0034613]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]"	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]	GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0016020; GO:0021522; GO:0030126; GO:0034613; GO:0045296; GO:0048666	APGGFMSNR	2.329999924	1	1	0.319938836	953.0891753	0	12.93974	0	0	0	0	0	0	0	0	0	0	16.75751	0	0	0	0	0	0	0	16.41308	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96KM6	Z512B_HUMAN	Zinc finger protein 512B	ZNF512B KIAA1196	Homo sapiens (Human)	negative regulation of miRNA transcription [GO:1902894]	nucleoplasm [GO:0005654]	"nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of miRNA transcription [GO:1902894]"	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0001227; GO:0005654; GO:0046872; GO:1902894	LPMLHDPPKMGMPVVR	3.170000076	1	1	0.242847056	1848.960916	13.40214	14.90435	14.21977	0	0	13.72291	0	16.13553	14.56969	0	15.50934	11.57794	13.96543	12.83628	15.13381	13.73854	0	14.58188	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.05631	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96KN3	PKNX2_HUMAN	Homeobox protein PKNOX2 (Homeobox protein PREP-2) (PBX/knotted homeobox 2)	PKNOX2 PREP2	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]	"actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0003785; GO:0005654; GO:0005737; GO:0006357; GO:0015629; GO:0015630; GO:0045171; GO:0051015; GO:1990837	TKMHSDNLLR	2.640000105	1	1	0.400183962	1229.924946	0	15.05754	14.66705	13.95907	14.26725	13.68998	0	0	0	11.19927	15.17653	14.5326	15.56009	14.59822	16.26906	0	15.60133	14.86043	0	17.22181	14.70021	17.2312	0	0	15.63004	0	0	15.81306	15.97753	0	0	0	0	15.97892	15.6928	15.67665	0	0	0	0	16.17688	0	0	0	16.51959	0	16.71297	0
Q96KN4	LRAT1_HUMAN	"Protein LRATD1 (LRAT domain-containing 1) (Neurologic sensory protein 1, NSE1) (Protein FAM84A)"	LRATD1 FAM84A NSE1	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; cell motility [GO:0048870]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]		GO:0000902; GO:0005737; GO:0048870	GQECIFSK	7.440000057	0.004971648	0.004971648	0.057701303	968.2368709	0	16.59231	0	0	0	0	14.4012	14.16649	13.72198	0	15.42507	0	0	0	15.42595	0	15.92866	9.554057	14.95337	0	0	15.89966	0	0	0	0	0	0	0	12.3898	13.1938	0	0	0	15.92659	0	16.72026	14.88487	0	0	15.35363	15.95778	14.36698	0	16.65789	0	12.67681	0
Q96KN7	RPGR1_HUMAN	"X-linked retinitis pigmentosa GTPase regulator-interacting protein 1, RPGR-interacting protein 1"	RPGRIP1	Homo sapiens (Human)	neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]	axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]	axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]		GO:0005930; GO:0007601; GO:0032391; GO:0035869; GO:0046548; GO:0050896; GO:0061351; GO:0120206; GO:1905515	DMLILQRK	1.289999962	0.579428136	0.579428136	0.317698807	1032.969111	0	0	0	0	0	16.55829	0	17.44825	0	0	0	0	0	0	0	0	0	0	0	16.70457	0	0	0	0	0	0	0	0	0	16.95798	0	0	18.96323	0	0	0	0	0	0	0	0	0	17.63609	0	17.6868	0	0	0
Q96KN8	PLAT5_HUMAN	"Phospholipase A and acyltransferase 5 (Ca(2+)-independent N-acyltransferase, iNAT, EC 2.3.1.-, EC 3.1.1.32, EC 3.1.1.4) (H-rev107-like protein 5) (HRAS-like suppressor 5, HRSL5)"	PLAAT5 HRASLS5 HRLP5	Homo sapiens (Human)	N-acylphosphatidylethanolamine metabolic process [GO:0070292]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]	1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]	GO:0004623; GO:0005737; GO:0005829; GO:0008970; GO:0016410; GO:0052739; GO:0052740; GO:0070292	VNNKLDGTYLPLPVDK	1.179999948	1	1	0.151708094	1785.16902	0	14.06073	14.02947	13.93366	0	0	13.09302	14.83455	12.92388	13.61362	0	14.28802	0	0	0	0	0	18.10439	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.24931	0	0
Q96KN9	CXD4_HUMAN	"Gap junction delta-4 protein (Connexin-40.1, Cx40.1)"	GJD4 CX40.1	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014717]	connexin complex [GO:0005922]; integral component of membrane [GO:0016021]	connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014717]	gap junction channel activity [GO:0005243]	GO:0005243; GO:0005922; GO:0007267; GO:0014717; GO:0016021	QSGASGHAEGR	12.15999985	1	1	0.333291236	1054.901783	0	14.86896	0	14.02796	0	14.75538	0	14.41114	13.05464	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.45962	13.32204	15.31572	0	15.41718	0	14.5138	13.22202	16.08306	15.39144	0	0	15.28844	0	0	0	0	0	0	0	0	13.48988	0	0
Q96KP1	EXOC2_HUMAN	Exocyst complex component 2 (Exocyst complex component Sec5)	EXOC2 SEC5 SEC5L1	Homo sapiens (Human)	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]	GO:0000145; GO:0000281; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0019901; GO:0031267; GO:0047485; GO:0090148; GO:0090522; GO:0090543; GO:2000535	GDYDVVINDYEK	10.42000008	0.74138087	0.74138087	0.273250733	1429.441546	13.43748	0	12.50439	15.48735	15.29425	14.1339	13.80509	13.67591	0	15.6565	13.58238	0	15.54467	11.66402	14.30145	15.16032	0	0	15.27973	16.40708	0	16.09402	0	11.87889	13.84709	0	0	0	0	0	0	0	0	0	15.60916	0	0	0	0	0	0	0	0	14.69285	14.58096	0	12.8086	0
Q96KP6	TNIP3_HUMAN	"TNFAIP3-interacting protein 3 (A20-binding inhibitor of NF-kappa-B activation 3, ABIN-3) (Listeria-induced gene protein)"	TNIP3 ABIN3 LIND	Homo sapiens (Human)	cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 4 signaling pathway [GO:0034142]	cytosol [GO:0005829]	cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 4 signaling pathway [GO:0034142]	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0002756; GO:0005829; GO:0006357; GO:0006954; GO:0031593; GO:0034142; GO:0043124; GO:0071222	NTLANKEK	3.660000086	1	1	0.211477979	916.7879523	14.84379	0	0	0	13.35336	0	14.53057	0	12.87143	15.66236	14.08702	14.53456	0	0	14.86977	15.16464	13.78105	0	16.14681	14.38988	0	13.8001	0	15.45933	0	14.90733	0	0	0	0	0	0	0	15.21445	0	0	0	0	0	0	0	14.20952	0	0	0	16.35814	0	0
Q96KQ4	ASPP1_HUMAN	Apoptosis-stimulating of p53 protein 1 (Protein phosphatase 1 regulatory subunit 13B)	PPP1R13B ASPP1 KIAA0771	Homo sapiens (Human)	intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; p53 binding [GO:0002039]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]	p53 binding [GO:0002039]	GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0045786; GO:0072332	AMRGQVDYSK	12.27000046	0.132703856	0.132703856	0.108245946	1170.341051	14.64262	0	0	0	15.59891	0	11.02011	0	0	0	11.876	0	0	14.21624	15.45002	0	0	0	0	0	13.64599	0	0	0	0	11.80609	11.08836	0	0	13.64977	0	15.09091	0	0	0	14.1608	17.32454	0	16.85294	14.71001	15.44783	13.87857	13.63566	0	15.22544	0	0	0
Q96KQ7	EHMT2_HUMAN	"Histone-lysine N-methyltransferase EHMT2, EC 2.1.1.-, EC 2.1.1.367 (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3, H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a)"	EHMT2 BAT8 C6orf30 G9A KMT1C NG36	Homo sapiens (Human)	behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]	C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0006325; GO:0007130; GO:0007286; GO:0007616; GO:0008270; GO:0009267; GO:0009566; GO:0010424; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0035265; GO:0036166; GO:0044030; GO:0045471; GO:0046974; GO:0046976; GO:0048148; GO:0048665; GO:0051569; GO:0051570; GO:0060992; GO:0070742; GO:0071314; GO:0071466; GO:1902902; GO:1990841	ALVIQESER	6.230000019	1	1	6.89E-13	1045.51652	16.94814	0	0	0	0	0	0	0	0	0	9.009329	0	0	0	0	0	15.39526	13.14755	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.38731	15.25762	0	0	0	0	0	0	0	0	0	0	0	0
Q96KR7	PHAR3_HUMAN	"Phosphatase and actin regulator 3 (Scaffold-associated PP1-inhibiting protein, Scapinin)"	PHACTR3 C20orf101 SCAPIN1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton organization [GO:0030036]	actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]	GO:0003779; GO:0004864; GO:0005654; GO:0008157; GO:0016363; GO:0030036	TPPVRR	5.789999962	1	1	0.110223477	723.2631806	16.07147	0	0	0	0	14.19267	0	0	0	0	0	0	0	0	0	0	0	15.67256	0	0	15.37322	0	0	0	16.16357	0	16.6706	13.16758	16.0106	15.41144	12.85876	15.42097	15.74227	13.77559	15.81657	15.93062	0	0	0	0	0	0	15.88148	0	14.95112	0	0	0
Q96KV6	BT2A3_HUMAN	Putative butyrophilin subfamily 2 member A3	BTN2A3P BTN2A3	Homo sapiens (Human)	regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852]	signaling receptor binding [GO:0005102]	GO:0001817; GO:0005102; GO:0009897; GO:0016021; GO:0050852	NVSCSINDTLLGQK	19.51000023	1	1	0.198368245	1548.729637	14.05512	0	12.4529	0	12.14257	12.53325	10.81501	14.42192	13.32213	12.34295	0	12.03296	0	0	0	0	0	0	0	16.63364	0	0	0	16.22201	16.01188	0	0	0	0	0	16.729	18.29597	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96KV7	WDR90_HUMAN	WD repeat-containing protein 90	WDR90 C16orf15 C16orf16 C16orf17 C16orf18 C16orf19 KIAA1924	Homo sapiens (Human)	cilium assembly [GO:0060271]	centriole [GO:0005814]; cytoplasm [GO:0005737]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]		GO:0005737; GO:0005814; GO:0060271	GAVTGLTATPDGR	10.59000015	1	1	0.299836514	1215.104478	12.5008	13.14199	14.35557	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.56678	13.56277	15.43107	0	0	0	13.30119	0	15.19875	0	0	0	0	0	0	0	0	15.33268	0	0	0
Q96KX1	CD036_HUMAN	Uncharacterized protein C4orf36	C4orf36	Homo sapiens (Human)						ERPAGLR	5.409999847	1	1	0.233523705	799.4217651	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.19903	0	16.27338	16.76435	16.26974	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.95453	0	0
Q96L34	MARK4_HUMAN	"MAP/microtubule affinity-regulating kinase 4, EC 2.7.11.1 (MAP/microtubule affinity-regulating kinase-like 1)"	MARK4 KIAA1860 MARKL1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; cilium organization [GO:0044782]; intracellular signal transduction [GO:0035556]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; positive regulation of cell cycle [GO:0045787]; positive regulation of cilium assembly [GO:0045724]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein localization to centrosome [GO:1904781]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; gamma-tubulin complex [GO:0000930]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; neuron projection [GO:0043005]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; gamma-tubulin complex [GO:0000930]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium organization [GO:0044782]; intracellular signal transduction [GO:0035556]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; positive regulation of cell cycle [GO:0045787]; positive regulation of cilium assembly [GO:0045724]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein localization to centrosome [GO:1904781]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]	ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin binding [GO:0043130]	GO:0000226; GO:0000930; GO:0001578; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0007049; GO:0007399; GO:0008017; GO:0015630; GO:0030425; GO:0030496; GO:0035556; GO:0036064; GO:0043005; GO:0043015; GO:0043068; GO:0043130; GO:0044782; GO:0045724; GO:0045787; GO:0046605; GO:0048156; GO:0050321; GO:0051301; GO:0106310; GO:1904781	ESLTSQK	3.799999952	0.111685395	0.111685395	0.311144427	792.3180359	0	0	0	17.63132	0	19.39362	0	0	0	0	0	18.43726	0	0	0	18.89458	0	0	0	0	17.5732	18.66308	0	0	0	0	0	0	17.27262	0	0	18.79388	0	17.71088	18.01614	0	0	17.8791	19.82281	0	0	0	0	0	0	17.4104	18.31057	18.91685
Q96L42	KCNH8_HUMAN	"Potassium voltage-gated channel subfamily H member 8 (ELK1, hElk1) (Ether-a-go-go-like potassium channel 3, ELK channel 3, ELK3) (Voltage-gated potassium channel subunit Kv12.1)"	KCNH8	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005886; GO:0005887; GO:0034765; GO:0042391; GO:0071805	LLQKLDR	12.10000038	1	1	0.082135221	885.8023548	0	14.46914	13.05356	14.15609	15.34927	0	0	0	0	0	0	14.54131	0	0	12.48154	0	0	0	0	0	0	0	0	0	0	0	0	15.72116	0	15.97669	0	16.80836	0	0	0	0	16.66035	0	0	0	0	0	0	0	0	0	0	0
Q96L50	LLR1_HUMAN	"Leucine-rich repeat protein 1 (4-1BB-mediated-signaling molecule) (4-1BBlrr) (LRR-repeat protein 1, LRR-1) (Peptidylprolyl isomerase-like 5)"	LRR1 PPIL5	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	cytosol [GO:0005829]	cytosol [GO:0005829]; protein ubiquitination [GO:0016567]		GO:0005829; GO:0016567	NLKLDDNELIQFPCK	7.829999924	0.554613531	0.554613531	0.502140518	1846.489913	15.29544	0	15.20064	0	0	0	18.85787	18.88449	0	19.58538	0	0	0	0	0	0	0	0	0	19.25317	0	0	19.13079	19.23498	0	18.24827	0	0	0	0	0	0	19.60672	0	0	0	0	19.47506	0	0	17.82155	0	0	0	0	0	0	0
Q96L58	B3GT6_HUMAN	"Beta-1,3-galactosyltransferase 6, Beta-1,3-GalTase 6, Beta3Gal-T6, Beta3GalT6, EC 2.4.1.134 (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6)"	B3GALT6	Homo sapiens (Human)	chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]; UDP-glycosyltransferase activity [GO:0008194]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]"	"galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]; UDP-glycosyltransferase activity [GO:0008194]"	GO:0000139; GO:0005794; GO:0005797; GO:0006024; GO:0006486; GO:0008194; GO:0008499; GO:0015012; GO:0016020; GO:0016021; GO:0016757; GO:0030166; GO:0030203; GO:0030206; GO:0032580; GO:0035250; GO:0047220	ADDDSFAR	5.869999886	1	1	0.305297112	896.6959123	0	0	0	0	11.83966	0	13.25119	0	0	0	0	0	0	14.49537	0	12.553	0	0	0	15.36817	0	11.58539	0	13.14459	16.24648	0	14.71576	14.98776	14.29187	15.9988	0	15.52973	0	0	0	16.8081	0	0	0	17.57697	0	0	0	0	0	0	0	0
Q96L73	NSD1_HUMAN	"Histone-lysine N-methyltransferase, H3 lysine-36 specific, EC 2.1.1.357 (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1, NR-binding SET domain-containing protein)"	NSD1 ARA267 KMT3B	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription, DNA-templated [GO:0006355]"	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000414; GO:0000785; GO:0000978; GO:0003682; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0008270; GO:0016571; GO:0018024; GO:0030331; GO:0033135; GO:0042799; GO:0042974; GO:0045893; GO:0046965; GO:0046966; GO:0046975; GO:0050681; GO:1903025	FSTLLMMLKDMHDSK	2.140000105	1	1	0.562428489	1814.920729	0	0	0	0	0	0	0	0	0	0	0	0	0	16.68151	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96L91	EP400_HUMAN	"E1A-binding protein p400, EC 3.6.4.- (CAG repeat protein 32) (Domino homolog, hDomino) (Trinucleotide repeat-containing gene 12 protein) (p400 kDa SWI2/SNF2-related protein)"	EP400 CAGH32 KIAA1498 KIAA1818 TNRC12	Homo sapiens (Human)	"histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]"	NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812]	"NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein antigen binding [GO:1990405]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]"	ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein antigen binding [GO:1990405]	GO:0000786; GO:0000812; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005654; GO:0016573; GO:0016607; GO:0016787; GO:0035267; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:0140658; GO:1905168; GO:1990405; GO:2000779	IYRSSK	10.05000019	0.904504955	0.904504955	0.238085031	751.6950391	0	0	0	0	14.90456	0	0	16.09067	0	15.18883	16.11045	15.9338	15.65129	0	16.33937	0	0	0	0	16.4513	16.5515	18.61381	19.72167	17.92809	16.71878	16.354	16.5904	0	15.40918	15.74157	16.78792	15.94925	16.89041	16.56571	0	15.32898	17.61855	17.14803	17.74979	17.14729	16.57154	16.96125	15.76142	17.63315	16.22338	17.74643	15.83649	16.20773
Q96L93	KI16B_HUMAN	Kinesin-like protein KIF16B (Sorting nexin-23)	KIF16B C20orf23 KIAA1590 SNX23	Homo sapiens (Human)	early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]"	GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025	ASVKVAVR	4.900000095	1	1	0.252145371	829.0827637	0	16.91686	15.04309	14.34097	14.72634	0	0	16.68647	16.91857	0	0	0	0	16.26745	0	0	17.86815	0	0	0	0	0	0	0	0	17.58448	0	16.89964	0	15.73069	17.27102	0	16.77894	0	0	0	16.75043	15.94825	0	0	0	0	0	0	0	0	0	15.2802
Q96L96	ALPK3_HUMAN	"Alpha-protein kinase 3, EC 2.7.11.1 (Muscle alpha-protein kinase)"	ALPK3 KIAA1330 MAK	Homo sapiens (Human)	cardiac muscle cell development [GO:0055013]; heart development [GO:0007507]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cardiac muscle cell development [GO:0055013]; heart development [GO:0007507]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0007507; GO:0055013; GO:0106310	GPQSSGPVEAK	4.460000038	1	1	0.330921748	1057.202757	13.88241	0	14.86197	15.71385	14.82733	13.39584	15.89567	0	0	0	0	13.93764	15.62887	14.24453	13.3174	14.68009	0	0	0	15.68352	0	0	16.76101	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.99435	15.71991	0
Q96LA9	MRGX4_HUMAN	Mas-related G-protein coupled receptor member X4 (Sensory neuron-specific G-protein coupled receptor 5/6)	MRGPRX4 MRGX4 SNSR5 SNSR6	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007186; GO:0016021	DPTVPVFGTK	5.5	1	1	0.095992761	1062.608375	0	0	14.18648	12.28813	14.68338	14.08745	0	0	0	0	0	0	16.14502	0	0	15.63741	0	0	0	0	0	0	0	0	16.34668	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.17352	0	0	0	0	0
Q96LB0	MRGX3_HUMAN	Mas-related G-protein coupled receptor member X3 (Sensory neuron-specific G-protein coupled receptor 1/2)	MRGPRX3 MRGX3 SNSR1 SNSR2	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0007186; GO:0016021	MDSTIPVLGTELTPINGR	6.21999979	1	1	3.66E-12	1929.504969	13.63747	14.24932	16.02336	13.55774	13.04544	15.27106	0	0	0	0	0	15.09268	0	12.9389	14.83596	0	15.19713	0	0	0	0	16.286	16.09139	14.75973	0	14.72013	15.41243	14.0098	0	0	0	0	16.81834	15.02788	0	14.45984	14.50527	0	0	14.50125	0	15.92762	0	0	0	0	0	0
Q96LB3	IFT74_HUMAN	"Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein, CMG-1) (Coiled-coil domain-containing protein 2)"	IFT74 CCDC2 CMG1	Homo sapiens (Human)	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944]	beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]	GO:0003334; GO:0003682; GO:0005634; GO:0005813; GO:0005929; GO:0007219; GO:0007368; GO:0007507; GO:0030992; GO:0031410; GO:0031514; GO:0033630; GO:0035720; GO:0035735; GO:0045944; GO:0048487; GO:0050680; GO:0060271; GO:0097542; GO:1905515	RAETLAVEIK	11.35000038	1	1	0.216014514	1130.746944	0	16.57306	15.45278	0	0	15.93441	0	0	14.14659	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.91446	0	17.34198	0	0	15.4145	0	16.84631	0	16.65293	16.5509	17.27449	15.62034	0	0	0	0	0	0	16.0101
Q96LC7	SIG10_HUMAN	"Sialic acid-binding Ig-like lectin 10, Siglec-10 (Siglec-like protein 2)"	SIGLEC10 SLG2 UNQ477/PRO940	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; negative regulation of inflammatory response to wounding [GO:0106015]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; SH2 domain binding [GO:0042169]; sialic acid binding [GO:0033691]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; negative regulation of inflammatory response to wounding [GO:0106015]	carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; SH2 domain binding [GO:0042169]; sialic acid binding [GO:0033691]	GO:0002250; GO:0005576; GO:0005886; GO:0007155; GO:0016021; GO:0019902; GO:0030246; GO:0033691; GO:0042169; GO:0045087; GO:0106015	LLPLLLSSLLGGSQAMDGR	9.319999695	1	1	0.15476286	1953.094928	15.75826	14.58353	15.07795	13.54893	13.29492	14.38941	14.4277	14.85679	14.44254	11.21464	12.36713	15.21031	13.28378	15.33711	13.7262	15.71075	15.98872	15.03485	11.67371	13.76517	15.87225	14.51011	14.69372	15.37449	14.98886	14.75852	14.61801	14.72349	15.42518	15.09925	0	0	0	0	0	0	0	0	0	13.90876	15.22007	14.90101	15.71042	0	14.50252	0	0	0
Q96LD8	SENP8_HUMAN	"Sentrin-specific protease 8, EC 3.4.22.- (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8)"	SENP8 DEN1 NEDP1 PRSC2 FKSG8	Homo sapiens (Human)	post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]	cytosol [GO:0005829]; NEDD8-specific protease activity [GO:0019784]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]	NEDD8-specific protease activity [GO:0019784]	GO:0005829; GO:0016579; GO:0019784; GO:0043687	LEAFLGR	1.779999971	1	1	0.124839455	803.5275224	0	0	14.71828	14.60842	16.18938	14.83702	0	15.16351	0	16.38054	15.4238	0	0	15.83125	0	15.63156	15.69247	15.99179	15.3592	0	15.35053	16.66812	0	0	13.89178	0	15.62676	16.39256	16.38046	15.59046	14.15588	16.41208	0	15.6081	0	0	0	16.12274	16.17688	16.04042	16.45869	0	15.26401	16.03954	16.9898	15.66241	0	0
Q96LI5	CNO6L_HUMAN	"CCR4-NOT transcription complex subunit 6-like, EC 3.1.13.4 (Carbon catabolite repressor protein 4 homolog B)"	CNOT6L CCR4B	Homo sapiens (Human)	gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872	HTVEFNQVAMANSDGSEAMLNR	8.130000114	1	1	0.196868928	2421.198306	0	14.42407	13.37368	11.51949	0	0	0	15.08043	0	0	0	14.74133	0	14.60737	0	0	0	0	0	0	15.65709	0	13.53586	13.07018	0	9.826068	0	0	12.24604	15.78985	16.01649	0	15.24812	0	0	0	0	0	15.98226	0	0	0	0	0	0	0	0	0
Q96LI9	CX058_HUMAN	Uncharacterized protein CXorf58	CXorf58	Homo sapiens (Human)						MNRSSNVPR	9.340000153	0.953131795	0.953131795	0.159432798	1075.751444	14.18334	13.49248	0	15.98175	12.6634	0	0	16.22296	14.89109	0	0	0	17.59044	0	0	0	14.86739	15.20151	0	13.48732	17.0333	14.67408	16.35942	14.50363	16.97889	16.21246	16.8475	13.30186	17.85864	0	0	0	14.3164	0	17.04556	8.78279	17.60283	0	0	0	18.00826	18.20164	0	18.195	17.67849	17.24334	17.92681	0
Q96LK0	CEP19_HUMAN	"Centrosomal protein of 19 kDa, Cep19"	CEP19 C3orf34 HSD5	Homo sapiens (Human)	"cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]"	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]"		GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0034454; GO:0036064; GO:0060271; GO:0097712	KSIMDELFEK	4.170000076	0.180954844	0.180954844	0.08346022	1254.484586	0	9.382357	0	13.79287	14.21675	10.24666	10.94638	12.84856	14.18652	15.71461	0	7.775369	13.80758	0	10.19506	14.88513	14.00411	9.23816	0	0	0	0	13.97573	0	0	0	0	0	0	0	0	0	0	0	0	0	12.22883	0	0	0	0	0	0	0	0	0	0	0
Q96LM1	CL037_HUMAN	Putative uncharacterized protein encoded by LINC00615	LINC00615 C12orf37	Homo sapiens (Human)						AGRELPGR	3.640000105	1	1	0.183042743	855.6512785	14.16341	14.4203	13.68774	12.76603	14.15769	0	0	0	0	15.27414	0	0	0	0	0	15.76759	0	0	0	0	14.59542	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96LM5	CD045_HUMAN	Uncharacterized protein C4orf45	C4orf45	Homo sapiens (Human)						DYLPK	4.619999886	1	1	0.286146609	635.3134217	0	0	0	0	0	0	18.66415	0	0	0	0	0	0	18.58487	0	22.43553	18.59815	0	19.87972	0	0	0	0	0	19.01252	0	0	0	0	0	0	0	0	0	0	19.39776	0	0	0	0	17.52382	0	0	18.75389	0	0	0	0
Q96LQ0	PPR36_HUMAN	Protein phosphatase 1 regulatory subunit 36	PPP1R36 C14orf50	Homo sapiens (Human)	negative regulation of phosphatase activity [GO:0010923]		phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]	phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0010923; GO:0019902	MMAKRPAIK	2.339999914	1	1	0.253349096	1079.092097	16.89582	17.83842	16.98604	16.43983	18.09782	16.91468	16.4723	18.96417	18.09831	18.5543	0	0	0	0	17.3868	0	17.66191	16.85851	0	0	0	0	16.74204	19.05366	0	17.13631	0	18.19336	16.71016	18.11077	18.33324	0	17.76193	17.69888	18.31035	0	0	17.40156	16.7341	17.91043	0	16.35534	0	18.68682	0	16.72399	18.19588	0
Q96LR5	UB2E2_HUMAN	"Ubiquitin-conjugating enzyme E2 E2, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2)"	UBE2E2 UBCH8	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]	ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087	EQVQPK	6.53000021	0.591926634	0.591926634	0.142753351	728.9650403	18.06817	0	16.45742	0	0	0	11.50132	0	14.25899	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59249	17.28607	0	0	17.24551	18.85013	0	14.97405	0	0	0	0	18.2815	0	0	16.80232	0
Q96LW1	Z354B_HUMAN	Zinc finger protein 354B	ZNF354B	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0046872	DSSGVSSLGCK	10.19999981	0.172295898	0.172295898	0.261527014	1096.890487	17.28955	0	12.40735	0	0	0	0	13.13295	17.97536	0	18.32912	11.37948	0	12.47896	14.96696	16.73302	0	15.20139	0	16.84105	0	14.72856	17.02341	0	13.60581	14.77163	15.36846	0	17.14559	13.18599	19.40914	15.10169	0	19.23266	15.81047	0	16.17577	0	17.69462	16.14064	0	0	0	15.92026	0	0	15.69802	0
Q96LW2	KS6R_HUMAN	"Ribosomal protein S6 kinase-related protein, EC 2.7.11.1 (Sugen kinase 494)"	RSKR SGK494	Homo sapiens (Human)	protein phosphorylation [GO:0006468]		ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0106310	ILGLVAKGSFGTVLK	8.109999657	1	1	0.330678253	1500.664333	0	15.5143	8.860643	0	0	15.29675	0	15.82329	0	0	0	0	0	0	0	16.35442	0	0	0	0	0	0	0	0	16.89069	16.78238	17.08429	14.83741	16.33233	13.57904	15.02144	15.10406	0	15.80976	14.48984	12.3984	13.42042	0	0	15.13891	14.97676	0	0	0	0	0	0	0
Q96LW4	PRIPO_HUMAN	"DNA-directed primase/polymerase protein, hPrimpol1, EC 2.7.7.- (Coiled-coil domain-containing protein 111)"	PRIMPOL CCDC111	Homo sapiens (Human)	error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop disassembly [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; replication fork [GO:0005657]	mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; replication fork [GO:0005657]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]; error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop disassembly [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]	chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]	GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005657; GO:0005759; GO:0006264; GO:0008270; GO:0009411; GO:0019985; GO:0030145; GO:0031297; GO:0042276; GO:0043504; GO:0062176	LYKSSK	4.730000019	0.682883739	0.682883739	0.202699615	723.886582	15.45317	0	12.25991	0	0	14.91652	0	15.52946	16.40879	15.5226	0	15.0613	0	0	0	0	14.94713	0	0	0	0	17.26076	17.32842	18.0197	13.58598	0	15.46009	0	0	0	15.70546	0	14.99768	0	15.97204	16.31919	14.93866	16.75344	15.84983	0	14.72623	18.39857	14.99975	0	0	0	0	0
Q96LX7	CCD17_HUMAN	Coiled-coil domain-containing protein 17	CCDC17	Homo sapiens (Human)						TGLARDGR	10.46000004	0.235735223	0.235735223	0.235837024	845.343255	14.52405	15.75978	16.47966	14.79672	0	16.49277	15.79285	0	15.92175	16.00466	16.16067	0	0	15.36727	13.60427	15.64434	0	0	0	14.88036	0	16.19268	14.8127	16.41896	0	15.12366	0	0	14.80069	0	0	15.2673	0	0	16.80139	0	16.52201	15.9716	13.29341	0	15.03393	14.43682	15.83911	0	0	0	16.88496	0
Q96M20	CNBD2_HUMAN	Cyclic nucleotide-binding domain-containing protein 2	CNBD2 C20orf152	Homo sapiens (Human)	spermatogenesis [GO:0007283]	cytosol [GO:0005829]	cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]	cAMP binding [GO:0030552]	GO:0005829; GO:0007283; GO:0030552	KELGLYQLAMDIIIMIR	26.62999916	1	1	0.477071479	2037.299559	17.40733	16.57208	17.0299	0	0	0	0	0	0	0	0	0	16.94741	17.47795	17.11256	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96M27	PRRC1_HUMAN	Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1)	PRRC1	Homo sapiens (Human)	activation of protein kinase A activity [GO:0034199]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; protein kinase A regulatory subunit binding [GO:0034237]; activation of protein kinase A activity [GO:0034199]	protein kinase A regulatory subunit binding [GO:0034237]	GO:0005737; GO:0005794; GO:0034199; GO:0034237	RQMIYSAAR	14.35999966	0.359621167	0.359621167	0.256020824	1112.894134	0	15.70256	16.98563	14.16245	14.61491	13.55186	15.5804	13.13166	11.66718	0	15.93579	14.59568	15.48501	15.59672	10.15784	0	0	12.9937	0	0	0	0	15.58458	0	0	0	16.11257	0	0	13.51349	0	0	0	0	0	0	16.16764	16.37791	0	0	0	0	0	0	0	0	14.078	15.55801
Q96M29	TEKT5_HUMAN	Tektin-5	TEKT5	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]	microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]	microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]		GO:0005634; GO:0015630; GO:0036126; GO:0060271; GO:0060294	KTFPCTPR	4.929999828	1	1	0.218126106	1005.980016	14.4609	17.32217	17.00667	16.59394	17.71229	0	0	0	17.24352	0	0	0	0	16.5486	0	0	0	0	0	0	0	16.94865	0	0	18.34565	17.35108	0	0	0	0	0	0	0	17.40797	0	0	0	0	0	0	0	0	0	0	0	0	0	16.78817
Q96M32	KAD7_HUMAN	"Adenylate kinase 7, AK 7, EC 2.7.4.3, EC 2.7.4.6 (ATP-AMP transphosphorylase 7)"	AK7	Homo sapiens (Human)	cell projection organization [GO:0030030]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; cell projection organization [GO:0030030]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]	GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006165; GO:0009142; GO:0030030; GO:0031514	DLTQDCLDHLLVNLR	6.25	1	1	0.339751528	1824.034605	15.16489	0	17.31573	15.03545	13.79229	16.31064	0	15.32664	15.10646	16.3669	0	13.40124	0	0	0	0	14.95653	0	0	0	0	0	0	17.83603	15.27172	0	15.57095	0	0	17.12325	0	0	16.13856	0	17.00275	16.78651	16.1952	0	0	0	0	15.52936	15.0559	0	0	0	16.22049	0
Q96M34	TEX55_HUMAN	"Testis-specific expressed protein 55 (Testis-specific conserved, cAMP-dependent type II PK-anchoring protein)"	TEX55 C3orf30 TSCPA	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634	RSSEK	7.449999809	0.516742408	0.516742408	0.279718439	605.7543211	15.27665	14.94312	15.23776	15.74059	14.28916	14.06102	16.73602	15.44171	14.84994	0	0	14.60739	15.88996	12.9158	15.09819	13.86919	16.45325	17.49912	17.05058	16.51284	16.77905	0	15.55075	15.7735	16.26142	15.57061	16.87707	16.55564	14.8246	17.16501	16.31276	15.60185	16.04862	17.24322	0	0	18.11856	16.32958	17.96184	0	16.96916	18.10288	16.74235	16.83447	16.47292	16.99604	17.70915	16.72307
Q96M42	CU129_HUMAN	Putative uncharacterized protein encoded by LINC00479	LINC00479 C21orf129 PRED76	Homo sapiens (Human)						KSGSTGNICSVMLNVATGCVR	9.319999695	1	1	0.38963033	2212.428633	14.84492	15.07709	16.20256	18.34293	0	0	0	0	0	0	0	0	0	0	20.49862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96M53	TBATA_HUMAN	"Protein TBATA (Protein SPATIAL) (Stromal protein associated with thymii and lymph node homolog) (Thymus, brain and testes-associated protein)"	TBATA C10orf27 SPATIAL	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	ciliary basal body [GO:0036064]; cytosol [GO:0005829]	ciliary basal body [GO:0036064]; cytosol [GO:0005829]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		GO:0005829; GO:0007283; GO:0030154; GO:0036064	ATDVQLADYPLMSPKAELK	10.73999977	1	1	0.04243748	2105.789084	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.65382	0	15.24793	0	0	0	14.57329	0	0	0	0	0	0	12.73555	14.54184	0	13.74072	0	0	14.83593	0	0	0	13.28023	0	12.18138	0	0	0	0	0	15.01547
Q96M60	F227B_HUMAN	Protein FAM227B	FAM227B C15orf33	Homo sapiens (Human)						AGPGK	2.119999886	5.94E-05	5.94E-05	0.264537566	428.7490405	0	21.3618	20.27014	0	0	18.05683	16.46176	0	0	18.33824	20.51941	17.62313	17.98331	0	17.02871	21.5129	0	0	0	0	0	19.38122	0	22.03967	0	21.63684	0	0	0	19.34237	0	18.73886	16.09705	18.31839	0	21.05051	19.92652	0	0	22.17628	0	0	20.80024	0	0	0	20.70973	17.64501
Q96M63	ODAD1_HUMAN	Outer dynein arm-docking complex subunit 1 (Coiled-coil domain-containing protein 114)	ODAD1 CCDC114	Homo sapiens (Human)	cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]	axoneme [GO:0005930]; cilium [GO:0005929]; outer dynein arm [GO:0036157]	axoneme [GO:0005930]; cilium [GO:0005929]; outer dynein arm [GO:0036157]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]		GO:0003341; GO:0005929; GO:0005930; GO:0036157; GO:0036158	AKMGLLR	13.78999996	1	1	1.03E-12	803.8229032	0	14.69178	13.0968	15.82991	0	13.50683	0	14.16183	15.08326	0	0	0	15.03947	0	14.04645	0	0	11.8429	0	10.82847	16.33077	13.43612	16.12156	17.12136	0	13.70968	14.46541	0	0	0	15.76548	0	0	0	0	0	16.28654	0	0	0	0	0	0	11.20461	0	0	0	0
Q96M69	LRGUK_HUMAN	Leucine-rich repeat and guanylate kinase domain-containing protein	LRGUK	Homo sapiens (Human)	axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]	acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]	GO:0001669; GO:0002177; GO:0004385; GO:0005524; GO:0005829; GO:0007283; GO:0030154; GO:0035082; GO:0042995	YILVVPMNKEK	9.710000038	0.408554167	0.408554167	0.328554716	1332.914364	13.00873	14.55277	12.13382	15.44825	0	13.94606	0	0	0	14.68261	13.72157	15.91484	15.45197	13.72649	0	0	0	0	15.5824	0	0	0	0	0	0	17.37987	18.06184	15.0901	15.20401	0	15.98974	0	10.75176	0	0	0	0	0	15.39518	0	0	16.82635	0	0	16.20189	0	16.68193	15.293
Q96M83	CCDC7_HUMAN	Coiled-coil domain-containing protein 7 (Protein BIOT2)	CCDC7 BIOT2 C10orf68	Homo sapiens (Human)						DIIKGPISAQLK	7.619999886	0.624375463	0.624375463	0.427916027	1283.995892	14.77192	0	14.80134	14.15295	13.11167	17.09624	0	15.36317	15.70475	0	0	0	14.91864	0	16.11356	0	0	0	0	0	16.71721	0	14.76596	0	16.9027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96M86	DNHD1_HUMAN	Dynein heavy chain domain-containing protein 1 (Dynein heavy chain domain 1-like protein) (Protein CCDC35)	DNHD1 C11orf47 CCDC35 DHCD1 DNHD1L UNQ5781/PRO12970	Homo sapiens (Human)	cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]	dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156]	dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003341; GO:0005524; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0070062	ALARGLVR	7.099999905	1	1	0.144685359	854.3817727	0	12.93914	15.40037	0	12.39455	14.42395	13.99179	15.77359	14.17127	15.22935	12.5129	12.45872	0	0	15.35792	0	0	14.92241	10.27036	0	0	0	0	14.0082	0	0	0	0	0	0	0	0	14.73682	0	0	0	16.21801	0	0	0	0	16.22868	0	0	0	16.57747	0	0
Q96M89	CC138_HUMAN	Coiled-coil domain-containing protein 138	CCDC138	Homo sapiens (Human)						FLSTLIVLK	3.460000038	0.30627802	0.30627802	0.062484143	1033.335746	14.26096	15.61067	16.29324	0	14.11428	14.4555	13.3714	0	14.97675	16.20331	0	0	0	14.75426	0	12.44355	15.00901	0	0	0	0	0	13.77214	15.07127	14.89492	16.2687	15.18846	15.4511	14.11029	0	13.80558	0	0	0	0	0	13.45873	0	0	0	0	0	0	0	0	0	0	0
Q96M91	CFA53_HUMAN	Cilia- and flagella-associated protein 53 (Coiled-coil domain-containing protein 11)	CFAP53 CCDC11	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]	cilium [GO:0005929]; extracellular region [GO:0005576]	cilium [GO:0005929]; extracellular region [GO:0005576]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]		GO:0003341; GO:0005576; GO:0005929; GO:0007368; GO:0060271; GO:0060287	HNAILASIK	4.110000134	0.236725301	0.236725301	0.139325636	966.9403302	0	0	15.29735	0	17.4931	13.077	0	0	0	0	0	16.28139	0	0	12.50727	0	10.79827	0	0	12.00067	0	0	0	16.80621	0	0	15.32508	0	14.61831	7.219273	18.2858	0	0	17.1788	0	13.49214	0	18.76105	0	16.22642	0	16.97892	17.38953	16.52481	0	17.38006	0	0
Q96M93	ADAD1_HUMAN	Adenosine deaminase domain-containing protein 1 (Testis nuclear RNA-binding protein)	ADAD1 TENR	Homo sapiens (Human)	adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286]	double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251]	GO:0003725; GO:0003726; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0007286; GO:0008251	DGVNRISSMSSSDK	1.850000024	1	1	0.551822531	1499.945026	17.44725	0	0	0	0	0	0	0	0	0	0	0	0	0	17.53034	15.94228	0	0	16.35553	0	15.26489	17.43754	0	0	17.84911	0	0	0	0	0	0	0	0	18.58582	0	0	0	0	0	0	0	17.50191	0	0	0	0	0	0
Q96M95	CCD42_HUMAN	Coiled-coil domain-containing protein 42	CCDC42 CCDC42A	Homo sapiens (Human)	spermatid development [GO:0007286]		spermatid development [GO:0007286]		GO:0007286	TLLLGTIK	6.159999847	1	1	0.151130512	857.3297246	11.80649	0	14.46269	0	0	0	0	0	0	0	0	0	0	0	0	0	15.42812	0	0	0	0	0	0	0	0	0	0	0	0	0	14.77326	0	0	0	0	0	14.96195	16.48502	16.54133	16.6365	0	16.56537	0	0	0	0	0	0
Q96MC4	C295L_HUMAN	CEP295 N-terminal-like protein (KIAA1731 N-terminal like protein)	CEP295NL KIAA1731NL	Homo sapiens (Human)	regulation of centriole replication [GO:0046599]	centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]	centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule binding [GO:0008017]; regulation of centriole replication [GO:0046599]	microtubule binding [GO:0008017]	GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0008017; GO:0046599	MADPEMLPAGEPR	14.61999989	1	1	0.447801214	1445.212977	0	0	9.535025	0	0	0	0	0	0	15.37691	0	0	13.42406	0	15.26308	13.6687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.67867	0	0	16.64168	0	0	0	16.31113	0	0	15.35607	0	0	17.06212	0	0
Q96MD7	CI085_HUMAN	Uncharacterized protein C9orf85	C9orf85	Homo sapiens (Human)						FDKSVQTK	3.369999886	1	1	2.30E-13	952.5513848	16.07612	15.62749	13.58902	0	0	0	13.31461	0	14.97156	0	0	14.83119	0	13.69727	0	0	9.837444	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96ME7	ZN512_HUMAN	Zinc finger protein 512	ZNF512 KIAA1805	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872	KHMENCK	5.309999943	1	1	0.316913435	946.2989553	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96MF0	YO028_HUMAN	Putative uncharacterized protein LOC100506887		Homo sapiens (Human)						MPFKTK	21.36000061	0.363423705	0.363423705	0.184147688	751.4748956	19.0862	15.69012	15.35528	17.3869	15.3552	14.27156	15.17885	16.11678	14.83643	16.24649	17.63544	0	14.31544	16.09641	15.11305	13.94382	17.5918	14.50751	0	15.86254	0	15.71145	16.54752	17.51145	15.45208	0	17.70963	19.92294	0	17.65857	0	14.58754	0	14.59737	0	0	0	0	0	17.97861	0	0	0	0	15.87233	18.95223	0	17.90121
Q96MF6	CQ10A_HUMAN	"Coenzyme Q-binding protein COQ10 homolog A, mitochondrial"	COQ10A UNQ6192/PRO20219	Homo sapiens (Human)	cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744]	ubiquinone binding [GO:0048039]	GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039	SFMGFAAPFTNK	11.02000046	1	1	0.092116444	1313.603955	14.29942	0	12.99714	14.35231	12.22677	0	13.6995	13.3061	11.3745	0	12.54347	14.13404	0	15.13296	14.56055	9.308627	14.99741	0	0	13.64952	14.37599	9.655631	0	14.79402	14.92458	12.86664	0	13.62925	14.53667	14.35637	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.69878	0	0
Q96MF7	NSE2_HUMAN	"E3 SUMO-protein ligase NSE2, EC 2.3.2.- (E3 SUMO-protein transferase NSE2) (MMS21 homolog, hMMS21) (Non-structural maintenance of chromosomes element 2 homolog, Non-SMC element 2 homolog)"	NSMCE2 C8orf36 MMS21	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722]	"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]"	"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722]"	SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]	GO:0000722; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0007049; GO:0008270; GO:0016604; GO:0016605; GO:0016925; GO:0019789; GO:0030915; GO:0032204; GO:0034184; GO:0045842; GO:0051301; GO:0061665; GO:0090398	KSDLIQDEALR	24.40999985	1	1	0.264579042	1287.891749	17.8918	21.65588	20.89721	20.67719	21.46579	21.27564	17.57216	19.40845	21.09014	20.66092	21.37836	0	20.21671	19.87253	20.21438	19.18151	21.12086	20.70384	19.41602	0	19.05863	0	0	17.538	20.95082	21.03233	19.75466	18.80599	0	19.17148	20.9283	20.66885	20.1857	0	0	21.42854	0	20.24581	0	19.99237	20.49204	21.48476	19.89378	0	19.85573	0	0	20.85984
Q96MG7	NSE3_HUMAN	"Non-structural maintenance of chromosomes element 3 homolog, Non-SMC element 3 homolog (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2)"	NSMCE3 HCA4 MAGEG1 NDNL2	Homo sapiens (Human)	cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein sumoylation [GO:0016925]; regulation of growth [GO:0040008]; regulation of telomere maintenance [GO:0032204]	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; protein dimerization activity [GO:0046983]; cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein sumoylation [GO:0016925]; regulation of growth [GO:0040008]; regulation of telomere maintenance [GO:0032204]"	protein dimerization activity [GO:0046983]	GO:0000122; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0016925; GO:0030915; GO:0031398; GO:0032204; GO:0034644; GO:0040008; GO:0046983; GO:0071478; GO:0072711	RLGVYPTK	2.880000114	1	1	0.141757631	932.0808388	0	0	0	14.50559	14.73375	0	14.85262	0	0	0	14.17047	0	15.61598	0	0	12.84291	0	0	0	0	0	16.47548	0	0	0	0	14.39219	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.54201	0	0	0	0	0
Q96MH2	HEXI2_HUMAN	Protein HEXIM2 (Hexamethylene bis-acetamide-inducible protein 2)	HEXIM2 L3	Homo sapiens (Human)	"negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; snRNA binding [GO:0017069]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"	7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; snRNA binding [GO:0017069]	GO:0000122; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0017069; GO:0042802; GO:0045736; GO:0045892; GO:0097322	MESHSEDEDLAGAVGGLGWNSR	11.64000034	1	1	0.408056134	2331.873778	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.83713	0	21.32719	0	0	0	0	0	0	0	21.69984	0	0	0	22.64508	0	0	0	22.45814	0	0
Q96MI6	PPM1M_HUMAN	"Protein phosphatase 1M, EC 3.1.3.16 (Protein phosphatase 2C isoform eta, PP2C-eta, PP2CE)"	PPM1M PPM1E	Homo sapiens (Human)	protein dephosphorylation [GO:0006470]	nucleus [GO:0005634]	nucleus [GO:0005634]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]	manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0006470; GO:0030145	SPARGR	6.550000191	0.570306182	0.570306182	0.261725235	643.6996447	14.38591	0	15.77094	16.26879	15.20205	15.3108	16.83072	15.18501	15.73814	13.7806	15.39211	15.45403	15.64489	14.80354	0	15.86465	15.72686	15.81678	16.66978	15.99403	15.43433	14.76811	16.12598	16.68863	16.24285	15.35302	14.595	16.30449	16.43354	16.07728	16.37846	0	17.08568	0	15.90846	14.97959	15.61575	16.44467	0	15.88966	15.88096	0	15.28797	0	17.00903	15.99438	14.87994	16.06119
Q96MK2	RIPR3_HUMAN	RIPOR family member 3	RIPOR3 C20orf175 C20orf176 FAM65C	Homo sapiens (Human)						SASFAGFSSAQSR	7.480000019	0.254267275	0.254267275	0.364898866	1302.169447	11.80313	14.10605	0	15.97878	15.23419	15.64136	16.35643	15.50209	14.41255	14.14779	14.59169	13.63445	0	0	0	0	0	0	0	15.97394	0	0	0	0	0	15.8819	0	0	0	0	0	0	0	0	0	16.63044	0	16.711	0	0	0	0	0	0	0	0	0	0
Q96MM3	ZFP42_HUMAN	"Zinc finger protein 42 homolog, Zfp-42 (Reduced expression protein 1, REX-1, hREX-1) (Zinc finger protein 754)"	ZFP42 REX1 ZNF754	Homo sapiens (Human)	female gonad development [GO:0008585]; male gonad development [GO:0008584]; meiotic cell cycle [GO:0051321]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]	"cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; meiotic cell cycle [GO:0051321]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0003700; GO:0005667; GO:0005737; GO:0006357; GO:0008584; GO:0008585; GO:0031519; GO:0046872; GO:0051321; GO:1990837	KPPINK	13.81000042	0.265909225	0.265909225	0.300203799	695.9420784	19.7343	0	18.32492	0	0	0	18.67646	16.91716	17.31181	15.67115	0	0	0	0	0	0	0	0	0	18.65884	18.60261	0	19.37976	0	18.90226	19.67797	0	0	17.77996	19.75504	0	20.10801	0	0	0	0	0	0	0	0	0	0	19.08549	0	17.90214	0	19.76243	19.88579
Q96MM6	HS12B_HUMAN	Heat shock 70 kDa protein 12B	HSPA12B C20orf60	Homo sapiens (Human)			ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524	WEGGDPGVAHQK	3.950000048	0.895786643	0.895786643	0.226952968	1280.365041	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.76779	0	0	14.78449	15.1463	0	15.69894	14.9524	14.98478	0	13.67645	14.84224	14.22452	0	14.91226	0	12.70035	0	0	0	14.55184	0	0	0	0	0	0	0	16.09016	0	0	0	0	0
Q96MN2	NALP4_HUMAN	"NACHT, LRR and PYD domains-containing protein 4 (Cancer/testis antigen 58, CT58) (PAAD and NACHT-containing protein 2, PAN2) (PYRIN and NACHT-containing protein 2) (PYRIN-containing APAF1-like protein 4, PYPAF4) (Ribonuclease inhibitor 2)"	NLRP4 NALP4 PAN2 PYPAF4 RNH2	Homo sapiens (Human)	inflammatory response [GO:0006954]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; inflammatory response [GO:0006954]	ATP binding [GO:0005524]	GO:0005524; GO:0005829; GO:0006954	DQVTISEIYQPR	8.100000381	1	1	0	1449.421404	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.245988	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.91242	0	0	0	0	0	0	12.74121	0
Q96MN9	ZN488_HUMAN	Zinc finger protein 488	ZNF488	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006355; GO:0014003; GO:0031643; GO:0045892; GO:0046872; GO:0048714	QSAFTELPRMK	8.520000458	1	1	4.58E-13	1307.328855	14.33727	13.98183	12.1881	0	12.50841	15.12646	0	0	14.35796	11.06763	16.01338	0	0	0	15.34789	0	0	0	0	0	0	0	0	13.05232	0	16.51154	0	0	15.12828	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.06167	0	0	13.86987
Q96MR6	CFA57_HUMAN	Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65)	CFAP57 WDR65	Homo sapiens (Human)						AQVMLELKTR	4.46999979	0.583907187	0.583907187	0.185332644	1203.624558	15.07876	0	18.25908	14.02294	14.94708	13.9596	0	13.59445	0	14.91021	15.77621	13.00269	0	0	0	0	0	0	0	15.20723	0	14.15367	13.73762	0	15.1538	14.52047	0	0	15.00816	12.09485	16.28362	17.26868	16.02321	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.27772
Q96MS0	ROBO3_HUMAN	Roundabout homolog 3 (Roundabout-like protein 3)	ROBO3	Homo sapiens (Human)	axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0016199; GO:0030424; GO:0070593; GO:0098632	GDPPPRLR	4.150000095	0.109690495	0.109690495	0.234588331	906.6513452	18.78382	0	0	15.80429	16.24405	14.68784	0	0	0	0	0	0	0	16.78913	0	16.01426	0	15.60789	0	16.93089	16.38348	17.65294	19.10637	18.60865	0	0	16.81487	16.99573	0	0	0	0	0	0	0	0	0	0	16.9062	0	15.50737	17.99919	15.92531	15.95365	16.45856	0	16.15903	15.94665
Q96MS3	GL1D1_HUMAN	"Glycosyltransferase 1 domain-containing protein 1, EC 2.4.-.-"	GLT1D1	Homo sapiens (Human)		cytosol [GO:0005829]; extracellular region [GO:0005576]	cytosol [GO:0005829]; extracellular region [GO:0005576]; glycosyltransferase activity [GO:0016757]	glycosyltransferase activity [GO:0016757]	GO:0005576; GO:0005829; GO:0016757	FAVAFTESMK	6.25	0.393981189	0.393981189	0.214677188	1131.212627	10.50871	0	16.55478	16.07738	0	17.68946	9.540174	14.37884	11.08865	0	12.74292	12.37299	14.87139	13.97687	14.08461	15.90031	9.926808	14.94664	0	0	0	14.36174	0	15.59133	0	0	13.37467	0	0	0	0	14.97242	0	0	0	0	10.8616	0	0	0	0	15.5507	0	13.89018	0	0	0	0
Q96MT3	PRIC1_HUMAN	Prickle-like protein 1 (REST/NRSF-interacting LIM domain protein 1)	PRICKLE1 RILP	Homo sapiens (Human)	"aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell myoblast differentiation [GO:2000691]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell myoblast differentiation [GO:2000691]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	zinc ion binding [GO:0008270]	GO:0001843; GO:0005634; GO:0005829; GO:0006606; GO:0008270; GO:0031398; GO:0031965; GO:0032436; GO:0035904; GO:0045892; GO:0060071; GO:0060976; GO:0090090; GO:2000691	PLEMEPK	3.49000001	0.199386984	0.199386984	0.244014496	858.9934692	16.21183	0	0	16.36863	14.50075	15.1322	15.5754	0	17.60842	16.5935	0	16.1681	0	13.67817	0	16.78478	0	0	0	0	14.19031	0	17.31105	14.21408	16.2043	14.59103	17.04093	15.63196	15.52208	15.04523	0	16.22048	0	0	0	16.3338	16.35838	18.84142	16.13572	0	17.24404	17.47237	17.22668	0	0	0	15.08282	15.55901
Q96MT7	CFA44_HUMAN	Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52)	CFAP44 WDR52	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; microtubule cytoskeleton organization [GO:0000226]; sperm axoneme assembly [GO:0007288]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; peptidase activity [GO:0008233]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; microtubule cytoskeleton organization [GO:0000226]; sperm axoneme assembly [GO:0007288]	peptidase activity [GO:0008233]	GO:0000226; GO:0005737; GO:0005856; GO:0007288; GO:0008233; GO:0031514; GO:0060271; GO:0060285	AFSQEVFK	8.279999733	1	1	0.569080564	955.6071891	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38788	0	0	0	0	16.1914	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96MT8	CEP63_HUMAN	"Centrosomal protein of 63 kDa, Cep63"	CEP63	Homo sapiens (Human)	cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint signaling [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; spindle pole [GO:0000922]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; spindle pole [GO:0000922]; cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint signaling [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225]		GO:0000077; GO:0000922; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0042770; GO:0051225; GO:0051301; GO:0098535	MEAHNNEYK	3.25	1	1	0.115718311	1136.559402	15.57339	0	0	14.61357	13.67823	13.57509	0	0	0	13.5684	9.352005	0	0	0	14.22485	0	0	0	0	0	0	0	12.80575	0	15.34901	13.68716	12.58686	0	14.66097	0	0	0	0	0	14.32651	0	14.17824	15.37862	0	0	15.74553	0	0	0	0	0	0	16.07968
Q96MU6	ZN778_HUMAN	Zinc finger protein 778	ZNF778	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	SFTVSSSLTEHAR	12.64999962	1	1	0.124124011	1422.086904	16.11586	14.98803	13.21135	13.94357	0	0	0	14.94287	0	0	0	0	15.89943	0	0	15.61902	0	0	16.58302	16.29692	0	0	15.88121	0	16.99223	0	16.08562	15.17566	14.78862	14.98215	10.78797	14.73617	0	14.97412	17.05251	0	0	15.72943	15.77616	15.4628	16.74524	16.35498	16.08518	14.97084	16.64384	15.60901	0	17.1319
Q96MU7	YTDC1_HUMAN	"YTH domain-containing protein 1 (Splicing factor YT521, YT521-B)"	YTHDC1 KIAA1966 YT521	Homo sapiens (Human)	"dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; posttranscriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; posttranscriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]"	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]	GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0110104; GO:1990247	MLGGVFK	13.90999985	1	1	0.025875307	767.4560281	16.14824	0	13.11857	0	0	0	16.13992	15.65236	0	0	15.33496	15.05501	14.61447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96MU8	KREM1_HUMAN	Kremen protein 1 (Dickkopf receptor) (Kringle domain-containing transmembrane protein 1) (Kringle-containing protein marking the eye and the nose)	KREMEN1 KREMEN KRM1	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell communication [GO:0007154]; limb development [GO:0060173]; negative regulation of axon regeneration [GO:0048681]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915]; cell communication [GO:0007154]; limb development [GO:0060173]; negative regulation of axon regeneration [GO:0048681]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]		GO:0005886; GO:0006915; GO:0007154; GO:0016020; GO:0016021; GO:0016055; GO:0030279; GO:0043025; GO:0048681; GO:0060173; GO:0060828; GO:0090090	NPLVSD	2.289999962	1	1	0.130850218	642.7182698	16.42447	18.71486	0	0	0	15.90085	14.99204	11.89684	16.88012	14.81055	0	14.07407	0	0	0	13.11387	16.86379	16.59516	17.34129	14.91324	0	15.13157	17.52422	15.67269	15.67394	0	15.34814	14.48762	13.21573	0	0	0	0	17.95175	16.81943	0	0	0	17.85474	0	17.76383	16.36201	0	0	15.77285	16.6316	0	15.04293
Q96MV8	ZDH15_HUMAN	"Palmitoyltransferase ZDHHC15, EC 2.3.1.225 (Acyltransferase ZDHHC15, EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 15, DHHC-15)"	ZDHHC15 UNQ1969/PRO4501	Homo sapiens (Human)	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to postsynapse [GO:0062237]; protein palmitoylation [GO:0018345]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; regulation of dendritic spine morphogenesis [GO:0061001]; synaptic vesicle maturation [GO:0016188]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to postsynapse [GO:0062237]; protein palmitoylation [GO:0018345]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; regulation of dendritic spine morphogenesis [GO:0061001]; synaptic vesicle maturation [GO:0016188]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008270; GO:0014069; GO:0016188; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0030173; GO:0061001; GO:0062237; GO:0072657; GO:0098794; GO:0140439; GO:0140450; GO:1900006	GELPSVR	1.379999995	0.029039923	0.029039923	0.304739435	756.9378439	0	16.30906	0	0	13.49195	15.33303	0	14.92551	0	15.56895	0	13.2282	0	14.19905	15.18965	0	0	0	0	16.88288	14.59474	0	15.51577	0	0	15.71618	0	0	0	0	15.36713	16.20959	0	0	0	0	0	16.86918	0	0	0	15.37879	0	15.59275	0	0	0	0
Q96MX3	ZNF48_HUMAN	Zinc finger protein 48 (Zinc finger protein 553)	ZNF48 ZNF553	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0042802; GO:0046872	ARPPAQGPPK	22.81999969	1	1	0.038583156	1021.041154	0	0	15.80911	0	14.37932	14.73996	0	14.90255	14.56322	15.20602	14.23815	0	0	0	16.30211	0	15.86099	0	0	0	0	0	15.5158	0	0	0	0	0	0	0	0	0	0	15.41236	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96MX6	DAA10_HUMAN	Dynein axonemal assembly factor 10 (WD repeat-containing protein 92) (WD repeat-containing protein Monad)	DNAAF10 WDR92	Homo sapiens (Human)	apoptotic process [GO:0006915]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821]	dynein axonemal particle [GO:0120293]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]	dynein axonemal particle [GO:0120293]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821]	ubiquitin binding [GO:0043130]	GO:0006915; GO:0043130; GO:0050821; GO:0070286; GO:0120293; GO:1990062	VLIVTKLNK	3.720000029	1	1	0.127030006	1027.308142	14.85371	15.31106	13.68243	13.1191	0	0	0	0	0	13.85074	0	0	11.23077	14.4425	13.64334	12.83969	14.9436	13.94839	16.82441	0	13.05476	13.96887	16.42262	15.46969	11.51927	13.59502	13.55678	14.04194	14.0713	15.50981	0	0	0	0	0	15.7664	0	0	0	15.22455	0	15.03458	0	0	0	0	0	0
Q96MY1	NOL4L_HUMAN	Nucleolar protein 4-like	NOL4L C20orf112 C20orf113	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005829	LPPATALGTASYPSDGCGADGLR	12.77999973	1	1	0.176480655	2246.052904	17.16512	15.96383	15.34541	13.48867	0	15.18026	0	15.76856	0	14.27299	13.92912	0	0	0	0	15.15665	14.25486	14.12705	0	0	0	0	15.16941	15.04735	0	14.7116	14.68658	0	0	0	0	0	0	13.78459	0	0	0	0	12.02116	0	0	0	0	0	0	12.58103	15.27635	0
Q96MY7	F161B_HUMAN	Protein FAM161B	FAM161B C14orf44	Homo sapiens (Human)	cilium organization [GO:0044782]	cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630]	cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630]; cilium organization [GO:0044782]		GO:0005881; GO:0015630; GO:0044782	DRGMVQVQCPQALR	1.570000052	0.732243001	0.732243001	0.294748291	1657.801842	0	0	0	0	17.50346	9.185408	0	0	0	0	0	0	0	0	0	14.05886	0	0	0	0	0	0	0	0	0	0	17.09204	16.31913	16.16487	15.88612	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96MZ4	F218A_HUMAN	Protein FAM218A	FAM218A C4orf39	Homo sapiens (Human)						HGSVSLLR	23.03000069	1	1	0.285731619	869.6952623	0	0	0	0	16.84177	16.85592	0	0	18.9632	18.17405	0	0	0	0	0	0	16.95985	0	0	0	16.49126	18.07749	0	0	20.69605	0	0	0	0	0	19.46738	0	0	0	0	0	0	0	0	18.62187	16.61959	0	0	0	0	0	18.70428	0
Q96N16	JKIP1_HUMAN	"Janus kinase and microtubule-interacting protein 1 (GABA-B receptor-binding protein) (Multiple alpha-helices and RNA-linker protein 1, Marlin-1)"	JAKMIP1 GABABRBP JAMIP1 MARLIN1	Homo sapiens (Human)	cognition [GO:0050890]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; microtubule [GO:0005874]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; microtubule [GO:0005874]; ribonucleoprotein complex [GO:1990904]; GABA receptor binding [GO:0050811]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; cognition [GO:0050890]; protein transport [GO:0015031]	GABA receptor binding [GO:0050811]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005874; GO:0008017; GO:0015031; GO:0019898; GO:0019900; GO:0050811; GO:0050890; GO:1990904	LQVLEQQHVIDDLSLER	12.30000019	1	1	2.34E-13	2035.443352	0	0	20.74082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.83582	0	0	0	0	0	0	0	0	20.04074	0	0	0	0	0	0	0	0	0	0	0	18.04381	0
Q96N22	ZN681_HUMAN	Zinc finger protein 681	ZNF681	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	NIHTEEKPYK	3.390000105	1	1	0.090271811	1259.764841	14.56069	14.11712	0	14.10882	14.92865	13.63378	13.82529	14.83482	12.14112	13.54432	0	15.26612	0	0	14.62539	0	14.79238	0	15.2244	14.89135	0	0	0	13.033	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.17492	0	0
Q96N23	CFA54_HUMAN	Cilia- and flagella-associated protein 54	CFAP54 C12orf55 C12orf63	Homo sapiens (Human)	cell differentiation [GO:0030154]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; mucociliary clearance [GO:0120197]; spermatogenesis [GO:0007283]	axoneme [GO:0005930]; extracellular region [GO:0005576]	axoneme [GO:0005930]; extracellular region [GO:0005576]; cell differentiation [GO:0030154]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; mucociliary clearance [GO:0120197]; spermatogenesis [GO:0007283]		GO:0005576; GO:0005930; GO:0007283; GO:0030154; GO:0060271; GO:0060294; GO:0090660; GO:0120197	ATGKMK	5.309999943	1	1	0.06242876	650.5503226	17.21886	13.44566	14.67522	16.39196	13.55424	14.97357	16.85834	0	15.01051	16.39011	14.50055	14.15882	17.0173	18.12155	15.97101	12.57138	15.698	0	0	13.40522	0	16.78712	0	0	13.90797	15.42403	15.28017	17.52779	9.956991	0	17.74165	16.27856	15.94747	15.35768	15.11737	0	15.22394	17.66363	15.80171	16.20956	0	16.60377	16.59068	15.52992	13.48338	15.26148	0	17.96116
Q96N38	ZN714_HUMAN	Zinc finger protein 714	ZNF714	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	AFNVSSHLTTHK	10.43000031	0.428289771	0.428289771	0.362336564	1342.925028	15.23365	16.2815	0	0	0	0	15.31606	0	0	0	0	0	0	15.95044	0	0	15.00374	12.08005	17.48193	0	18.08797	0	16.65868	0	15.28273	16.41427	17.01346	15.51949	17.10493	17.45655	17.86994	16.80376	17.51921	0	17.70446	0	16.71884	17.0616	15.47747	17.79283	16.95245	18.2257	0	0	17.4371	15.35335	18.89643	17.30921
Q96N64	PWP2A_HUMAN	PWWP domain-containing protein 2A	PWWP2A KIAA1935 MST101	Homo sapiens (Human)	"negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of histone H3-K9 acetylation [GO:2000616]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of DNA-templated transcription, initiation [GO:2000142]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NuRD complex binding [GO:0120325]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of histone H3-K9 acetylation [GO:2000616]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of DNA-templated transcription, initiation [GO:2000142]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NuRD complex binding [GO:0120325]	GO:0003682; GO:0005634; GO:0032968; GO:0035064; GO:0035067; GO:0042393; GO:0120325; GO:1901675; GO:2000142; GO:2000616	EVLKIAK	16.62999916	0.031974386	0.031974386	0.290060946	801.3333981	0	0	0	9.963675	15.50163	14.07105	0	0	0	0	0	16.60207	15.95502	16.06871	16.27481	15.7303	0	17.48297	16.52612	19.27014	17.44145	16.64483	0	0	17.12988	0	15.88942	15.1475	17.46413	16.57711	16.60084	15.03441	16.83203	0	16.97215	17.57082	17.47535	19.08789	17.51112	17.74229	17.38736	17.7126	17.25492	17.85502	17.93173	17.6417	18.27935	17.34514
Q96N66	MBOA7_HUMAN	"Lysophospholipid acyltransferase 7, LPLAT 7, EC 2.3.1.- (1-acylglycerophosphatidylinositol O-acyltransferase) (Bladder and breast carcinoma-overexpressed gene 1 protein) (Leukocyte receptor cluster member 4) (Lysophosphatidylinositol acyltransferase, LPIAT, Lyso-PI acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 7, O-acyltransferase domain-containing protein 7, h-mboa-7)"	MBOAT7 BB1 LENG4 OACT7	Homo sapiens (Human)	layer formation in cerebral cortex [GO:0021819]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207]; ventricular system development [GO:0021591]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374]; layer formation in cerebral cortex [GO:0021819]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207]; ventricular system development [GO:0021591]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374]	GO:0003841; GO:0005783; GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0016021; GO:0016746; GO:0021591; GO:0021819; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0047144; GO:0071617; GO:0090207	KEMASGFSK	6.920000076	1	1	5.72E-13	984.0223774	14.8806	0	9.979915	13.36217	14.99046	15.23707	15.89442	13.77852	15.41308	0	13.14361	16.22386	0	13.84267	13.6353	0	14.84968	12.741	0	0	0	0	0	14.06725	14.79309	0	0	0	0	14.5483	0	0	0	0	0	0	0	0	0	0	0	0	16.1166	0	0	0	0	0
Q96N67	DOCK7_HUMAN	Dedicator of cytokinesis protein 7	DOCK7 KIAA1771	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]	axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]	guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0031267; GO:0033138; GO:0043005; GO:0043547; GO:0045178; GO:0045200; GO:0050767; GO:0090630; GO:0120163; GO:1904754	SMSIDDTPR	5.480000019	1	1	0.165141734	1036.793473	15.99779	15.87837	15.41392	14.99423	0	15.40171	0	0	14.48284	14.80016	12.94271	0	13.47858	15.41035	0	11.9132	10.56135	15.78468	0	0	0	0	15.1015	15.73567	15.92527	0	0	0	0	14.18619	13.92832	0	14.14696	9.489473	11.77434	13.93569	15.92057	0	0	9.021073	0	13.36459	0	0	0	0	0	0
Q96N76	HUTU_HUMAN	"Urocanate hydratase, Urocanase, EC 4.2.1.49 (Imidazolonepropionate hydrolase)"	UROC1	Homo sapiens (Human)	histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]	cytosol [GO:0005829]	cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]	urocanate hydratase activity [GO:0016153]	GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557	LQYMDNIR	5.389999866	1	1	0.204614927	1069.644606	15.66819	12.91526	15.87359	14.78503	14.83179	11.99905	11.61776	14.94523	0	0	16.12791	0	16.16512	14.40887	0	0	17.354	15.24613	13.51108	0	15.0706	0	14.17938	0	0	15.46081	0	0	0	0	0	0	17.02707	17.22341	0	0	0	15.87284	0	0	13.6638	0	0	15.47338	0	0	15.23858	15.73002
Q96N87	S6A18_HUMAN	Inactive sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3)	SLC6A18 XTRP2	Homo sapiens (Human)	amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293]	GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0015171; GO:0015293; GO:0016324; GO:0031526; GO:0035725	LYPGWAR	9.529999733	1	1	0.021733812	863.5829876	0	0	0	0	0	0	0	0	11.00003	0	0	0	0	0	0	0	0	16.38564	18.74657	0	0	16.11697	16.13795	0	16.75686	0	0	0	0	0	0	0	16.31401	17.65241	16.29854	15.63269	16.30479	17.41886	0	17.36731	0	0	0	13.60792	0	11.12966	16.20675	16.33716
Q96N95	ZN396_HUMAN	Zinc finger protein 396 (Zinc finger and SCAN domain-containing protein 14)	ZNF396 ZSCAN14	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0042803; GO:0045892; GO:0046872; GO:0046982; GO:1990837	ELDGPK	5.130000114	1	1	0.146446162	657.5704652	15.15471	14.2964	16.55882	0	15.73966	0	0	13.49006	13.42509	0	0	0	0	16.68771	0	15.7619	0	0	17.02549	0	0	15.59676	0	16.38957	0	0	0	0	15.17613	15.73863	0	0	0	0	14.68609	0	0	0	0	0	0	16.70268	0	15.92478	14.59266	0	0	0
Q96N96	SPT13_HUMAN	"Spermatogenesis-associated protein 13 (APC-stimulated guanine nucleotide exchange factor 2, Asef2)"	SPATA13	Homo sapiens (Human)	cell migration [GO:0016477]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; cell migration [GO:0016477]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]	GO:0005085; GO:0005654; GO:0005737; GO:0005829; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0030334; GO:0032587; GO:0042802; GO:0046847; GO:0051056	DCNLSVKNAFK	6.090000153	0.003523319	0.003523319	0.406997001	1295.487944	17.074	16.85986	0	0	16.51261	0	0	0	0	0	0	0	0	16.61971	0	17.73009	16.24041	0	0	16.08237	0	0	0	0	0	0	0	0	0	0	18.39173	17.14493	18.25139	0	18.22298	0	0	16.62348	0	0	17.8727	0	0	0	0	0	0	0
Q96NA8	TSNA1_HUMAN	t-SNARE domain-containing protein 1	TSNARE1	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]	GO:0000149; GO:0005484; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0048278	ALLPMAQRGSK	5.309999943	0.135168165	0.135168165	0.055749564	1188.166617	11.4787	16.71837	0	0	14.50441	12.44952	0	0	10.14005	13.73997	0	12.99162	14.72643	0	0	0	14.22527	0	0	0	0	0	10.71721	15.54472	0	12.39393	0	0	0	0	0	0	0	0	0	13.16597	0	0	14.51335	15.00612	0	15.4889	13.73123	0	16.55368	17.54552	14.98795	17.77832
Q96NB1	CEP20_HUMAN	Centrosomal protein 20 (FGFR1OP N-terminal-like protein) (FOP-related protein of 20 kDa) (LisH domain-containing protein FOPNL)	CEP20 C16orf63 FOPNL FOR20 PHSECRG2	Homo sapiens (Human)	cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453]	identical protein binding [GO:0042802]	GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0031514; GO:0034451; GO:0034453; GO:0036064; GO:0042802; GO:0060271	GPSLQPSDPSLGR	8.960000038	1	1	0.207050603	1307.899844	15.38842	14.67622	0	0	0	0	0	16.84361	0	0	0	0	0	0	0	0	0	0	17.81134	0	17.55766	0	0	0	14.67811	0	0	0	16.77405	0	0	0	0	17.29611	0	0	0	0	0	0	0	15.22485	0	0	0	0	0	17.0703
Q96NB2	SFXN2_HUMAN	Sideroflexin-2	SFXN2	Homo sapiens (Human)	mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300]	serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542	MNVIGR	19.45000076	1	1	0.201774274	689.4484564	0	0	0	18.30636	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.97296	0	0	0	18.79525	0	0	0	0	0	0	0	0	0	18.75161	0
Q96NB3	ZN830_HUMAN	Zinc finger protein 830 (Coiled-coil domain-containing protein 16)	ZNF830 CCDC16	Homo sapiens (Human)	blastocyst growth [GO:0001832]; cell division [GO:0051301]; chromosome organization [GO:0051276]; intestinal epithelial structure maintenance [GO:0060729]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic DNA replication checkpoint signaling [GO:0033314]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; nuclear DNA replication [GO:0033260]; ovarian follicle development [GO:0001541]; preantral ovarian follicle growth [GO:0001546]; replication fork protection [GO:0048478]; RNA splicing [GO:0008380]	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; blastocyst growth [GO:0001832]; cell division [GO:0051301]; chromosome organization [GO:0051276]; intestinal epithelial structure maintenance [GO:0060729]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic DNA replication checkpoint signaling [GO:0033314]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; nuclear DNA replication [GO:0033260]; ovarian follicle development [GO:0001541]; preantral ovarian follicle growth [GO:0001546]; replication fork protection [GO:0048478]; RNA splicing [GO:0008380]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0001541; GO:0001546; GO:0001832; GO:0003676; GO:0005634; GO:0005654; GO:0005681; GO:0005694; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0033260; GO:0033314; GO:0043066; GO:0044773; GO:0048478; GO:0051276; GO:0051301; GO:0060729	TPAGK	2.369999886	0.332477748	0.332477748	0.196090062	471.8981588	0	15.98972	0	15.83243	14.42552	0	17.12504	0	0	0	14.18129	15.54743	0	0	0	14.91916	0	15.35365	15.70197	0	0	16.74786	14.73121	16.68335	16.23173	0	0	0	0	0	0	0	0	15.76391	0	0	0	0	0	0	0	0	0	16.5736	0	0	0	0
Q96NC0	ZMAT2_HUMAN	Zinc finger matrin-type protein 2	ZMAT2	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	"nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]"	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0000398; GO:0003677; GO:0005634; GO:0008270; GO:0046540; GO:0071005	RAEEDLTFEEDDEMAAVMGFSGFGSTK	3.329999924	0.256569713	0.256569713	4.11E-12	2985.058377	0	0	0	0	0	0	10.70727	0	14.51993	10.23933	0	0	14.41896	14.95319	15.78993	14.59916	15.39552	0	12.18702	0	0	15.97585	0	0	15.28471	13.66952	0	0	0	15.29021	0	0	14.02565	17.96762	15.14084	16.08563	0	18.06229	16.28957	0	11.38285	16.36651	0	0	15.2722	17.62453	13.42936	15.15491
Q96NE9	FRMD6_HUMAN	FERM domain-containing protein 6 (Willin)	FRMD6 C14orf31	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; cellular protein localization [GO:0034613]; regulation of actin filament-based process [GO:0032970]	apical junction complex [GO:0043296]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]	apical junction complex [GO:0043296]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; cellular protein localization [GO:0034613]; regulation of actin filament-based process [GO:0032970]		GO:0003383; GO:0005737; GO:0005856; GO:0005886; GO:0031032; GO:0032970; GO:0034613; GO:0043296	ASGSSAGSMK	5.510000229	1	1	0.176397894	894.4047931	14.46515	15.08873	0	14.43685	14.84806	0	0	17.34652	0	15.50206	0	15.35011	0	13.68128	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.3881	14.75482	0	0	14.35273	0	0	0	13.86211	0	0	0	0	13.87274	0	0	15.12983
Q96NG3	ODAD4_HUMAN	"Outer dynein arm-docking complex subunit 4 (Tetratricopeptide repeat protein 25, TPR repeat protein 25)"	ODAD4 TTC25	Homo sapiens (Human)	brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; lung development [GO:0030324]; mucociliary clearance [GO:0120197]; outer dynein arm assembly [GO:0036158]; protein localization to motile cilium [GO:0120229]	9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228]	9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; lung development [GO:0030324]; mucociliary clearance [GO:0120197]; outer dynein arm assembly [GO:0036158]; protein localization to motile cilium [GO:0120229]		GO:0003341; GO:0005576; GO:0005737; GO:0005930; GO:0007420; GO:0007507; GO:0030324; GO:0036158; GO:0060287; GO:0090660; GO:0097728; GO:0097729; GO:0120197; GO:0120228; GO:0120229	KTNYVENLK	7.010000229	1	1	0.133115757	1107.302922	0	0	0	0	0	0	11.69485	13.28752	14.73306	0	16.53615	11.05574	0	0	17.74494	13.07921	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96NG8	ZN582_HUMAN	Zinc finger protein 582	ZNF582	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	TLSHDSTTVQPQR	4.300000191	1	1	0.401183993	1470.095535	0	17.89238	0	17.05505	17.26905	0	0	15.77511	0	0	0	0	18.00396	0	0	0	16.90414	0	0	0	0	0	16.06479	0	17.56278	0	0	14.89486	0	0	0	0	14.54029	0	0	0	0	15.21266	0	0	0	0	0	0	0	0	16.17447	0
Q96NH3	BROMI_HUMAN	Protein broad-minded (TBC1 domain family member 32)	TBC1D32 BROMI C6orf170 C6orf171	Homo sapiens (Human)	determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]	cilium [GO:0005929]; cytoplasm [GO:0005737]	cilium [GO:0005929]; cytoplasm [GO:0005737]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]		GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007368; GO:0007507; GO:0042733; GO:0060021; GO:0060831; GO:0061512; GO:1905515	NIMIAVVESMINK	1.179999948	1	1	0.235278115	1478.301375	0	12.73043	14.33324	0	0	15.27423	0	0	0	0	0	14.79731	15.86501	0	0	15.07244	0	0	0	0	0	0	0	0	13.04489	0	15.43237	0	14.8537	0	0	16.10767	0	0	0	0	0	0	15.37807	0	15.30167	0	0	0	15.205	0	0	0
Q96NJ5	KLH32_HUMAN	Kelch-like protein 32 (BTB and kelch domain-containing protein 5)	KLHL32 BKLHD5 KIAA1900	Homo sapiens (Human)						AVIDFLVKHLSELLK	6.619999886	1	1	9.17E-13	1723.967481	0	13.22181	14.45736	14.30725	15.89153	0	10.87763	12.65528	15.16588	0	0	0	13.02892	13.28399	14.87789	13.56481	0	14.62249	0	14.26846	0	15.50442	0	15.71295	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96NJ6	ZFP3_HUMAN	"Zinc finger protein 3 homolog, Zfp-3 (Zinc finger protein 752)"	ZFP3 ZNF752	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	GTENKEVIPK	4.960000038	1	1	0.171210336	1113.583821	13.03805	12.7316	13.98756	0	15.08335	15.17946	0	16.17382	0	14.82499	0	0	0	0	14.30738	13.13502	0	0	15.43192	0	0	0	0	0	0	0	0	0	0	0	16.29022	0	15.88787	15.28994	0	14.67492	15.34056	12.46341	13.44532	12.08432	10.30455	10.56465	14.63488	0	0	11.70338	14.58097	14.32764
Q96NL0	RUN3B_HUMAN	"RUN domain-containing protein 3B (Rap2-binding protein 9) (Rap2-interacting protein 9, RPIP-9)"	RUNDC3B RPIB9 RPIP9	Homo sapiens (Human)						SNDYLASPTTEMTSPGLTPS	7.519999981	0.315660506	0.315660506	0.136757839	2084.407469	15.37949	0	0	0	13.68509	0	0	0	12.99917	0	0	15.14407	14.68256	12.88254	14.22318	15.58456	0	14.44064	15.56727	16.22019	0	0	14.95928	14.97446	0	0	0	0	0	0	16.88859	0	0	0	0	0	15.78936	15.94874	14.88	15.17202	0	0	0	13.87033	0	0	0	0
Q96NL6	SCLT1_HUMAN	Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1)	SCLT1 SAP1	Homo sapiens (Human)	cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; clathrin binding [GO:0030276]; protein C-terminus binding [GO:0008022]; sodium channel regulator activity [GO:0017080]; cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162]	clathrin binding [GO:0030276]; protein C-terminus binding [GO:0008022]; sodium channel regulator activity [GO:0017080]	GO:0005813; GO:0005814; GO:0005829; GO:0008022; GO:0017080; GO:0030276; GO:0045162; GO:0060271; GO:0071439; GO:0097539	LEEMHQR	12.14000034	1	1	0.125432327	943.501308	15.59748	16.22267	17.61813	15.4421	16.71367	15.01045	0	0	0	13.79641	15.35778	16.45245	0	0	16.95789	0	0	0	16.22458	19.96385	0	18.111	0	16.6524	19.16121	19.45143	18.11499	17.60919	18.67546	18.57422	17.53532	0	0	18.22117	17.46655	0	0	0	15.52323	17.75158	0	0	0	0	0	0	0	16.98892
Q96NR7	WWAS2_HUMAN	Putative uncharacterized protein WWC2-AS2 (WWC2 antisense RNA 2) (WWC2 antisense gene protein 2)	WWC2-AS2 C4orf38	Homo sapiens (Human)						TSAETASR	6.090000153	0.306082189	0.306082189	0.215173181	822.4259193	0	16.49234	0	0	0	0	0	13.78664	15.49613	0	0	15.39237	0	0	17.36082	15.66263	0	16.36832	16.87259	16.71255	16.54242	14.93831	0	0	17.40392	15.85388	15.76089	14.36655	16.75923	15.0964	16.26859	17.33456	14.78593	17.23405	17.02897	16.01423	17.30351	16.74965	14.50303	16.09172	14.75328	17.1263	15.12973	10.5299	16.71401	16.93709	11.99669	16.29487
Q96NR8	RDH12_HUMAN	"Retinol dehydrogenase 12, EC 1.1.1.300 (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2)"	RDH12 SDR7C2	Homo sapiens (Human)	cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]	endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; 11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]	11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0102354; GO:0110095	MLVTLGLLTSFFSFLYMVAPSIR	3.779999971	1	1	5.47E-12	2622.898076	16.89122	0	0	12.09941	17.88364	0	19.53238	14.79131	12.68041	18.43681	15.99622	14.03078	0	0	0	17.03096	14.73647	0	0	11.1036	15.54523	13.45729	0	0	16.89274	19.00568	16.4703	16.51722	14.90523	15.5971	15.51537	17.41405	15.58429	15.19713	16.50219	17.2885	14.66252	16.58246	10.54406	16.1163	0	13.45922	0	15.01569	13.7112	16.28587	0	0
Q96NS8	CLUP3_HUMAN	Putative protein CLUHP3 (Clustered mitochondria (cluA/CLU1) homolog pseudogene 3) (KIAA0664-like protein 3)	CLUHP3 C16orf67 KIAA0664L3	Homo sapiens (Human)						EPEGGRR	16.68000031	1	1	1.15E-13	801.1159298	0	14.77882	12.14441	0	16.25554	0	0	15.27487	14.29131	15.48996	12.04138	15.37842	9.451344	13.65046	0	0	0	0	14.48252	14.00799	0	0	0	14.24112	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96NT0	CC115_HUMAN	Coiled-coil domain-containing protein 115	CCDC115	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; lysosome [GO:0005764]; membrane [GO:0016020]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]	COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; lysosome [GO:0005764]; membrane [GO:0016020]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; unfolded protein binding [GO:0051082]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	unfolded protein binding [GO:0051082]	GO:0005764; GO:0005768; GO:0005783; GO:0005793; GO:0006879; GO:0007042; GO:0016020; GO:0016471; GO:0030137; GO:0036295; GO:0042406; GO:0051082; GO:0070072; GO:1905146	QLEPGAA	3.059999943	0.905618906	0.905618906	0.237832332	686.254415	0	0	16.22342	15.40944	0	0	15.28499	0	0	0	16.37921	15.03958	0	0	16.3132	15.621	15.66191	14.92385	0	16.85577	16.55206	0	0	0	17.73079	15.35585	16.582	0	15.56066	15.25953	16.23475	16.45131	16.45655	0	0	0	0	16.10418	18.08945	15.58944	16.22412	0	16.85489	0	16.6683	17.62329	16.07929	18.24705
Q96NT3	GUCD1_HUMAN	Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4)	GUCD1 C22orf13 LLN4	Homo sapiens (Human)						ACKVLVEK	8.039999962	0.573828936	0.573828936	0.29381743	947.1354319	0	18.46774	0	17.06507	0	0	0	21.44325	0	17.93489	18.84247	0	0	0	0	17.4287	0	18.1591	0	0	0	0	16.85111	17.76505	19.71168	0	0	0	0	16.52472	0	18.71216	19.13437	18.04295	0	20.07839	18.43199	22.71785	0	20.67165	16.54088	0	0	17.44409	0	0	0	0
Q96NW4	ANR27_HUMAN	Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein)	ANKRD27 PP12899	Homo sapiens (Human)	early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]	cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]	cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]	GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0016020; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0043231; GO:0045022; GO:0048812; GO:0050775; GO:0097422	MLAKQEAQMNLMK	4.949999809	1	1	0.120666664	1567.182647	15.76793	14.11986	0	0	15.7076	15.38576	15.61178	0	0	16.39924	16.92794	0	0	15.556	16.50441	15.61325	0	0	0	0	0	0	15.93189	0	0	0	0	0	0	0	0	16.59833	0	0	0	0	0	0	0	0	15.59556	0	0	0	0	0	0	0
Q96NW7	LRRC7_HUMAN	"Leucine-rich repeat-containing protein 7 (Densin-180, Densin) (Protein LAP1)"	LRRC7 KIAA1365 LAP1	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]	axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; postsynaptic density [GO:0014069]; specific granule lumen [GO:0035580]	axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; postsynaptic density [GO:0014069]; specific granule lumen [GO:0035580]; cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]		GO:0005576; GO:0005829; GO:0010976; GO:0014069; GO:0016323; GO:0030054; GO:0035580; GO:0043113; GO:0043194; GO:0045197; GO:0097120; GO:0098609	AGSHIQTLMGSQSLQHRSR	3.099999905	1	1	9.25E-13	2109.178845	16.26022	17.66921	16.59403	0	15.37259	16.08857	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96NX5	KCC1G_HUMAN	"Calcium/calmodulin-dependent protein kinase type 1G, EC 2.7.11.17 (CaM kinase I gamma, CaM kinase IG, CaM-KI gamma, CaMKI gamma, CaMKIG) (CaMK-like CREB kinase III, CLICK III)"	CAMK1G CLICK3 VWS1	Homo sapiens (Human)	peptidyl-serine phosphorylation [GO:0018105]	calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; peptidyl-serine phosphorylation [GO:0018105]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000139; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005886; GO:0005954; GO:0018105; GO:0043005; GO:0106310	AGQTGVCLIM	3.410000086	0.384673566	0.384673566	0.175710724	1065.485429	16.01097	14.42203	17.77826	15.13279	17.5016	15.04194	0	15.4915	15.20042	15.80931	0	0	0	0	0	13.9517	13.76901	0	0	0	0	0	0	0	16.31268	0	13.53614	0	0	0	0	0	0	0	0	0	0	0	0	0	14.26404	0	0	0	14.0074	0	15.7293	14.90551
Q96NY7	CLIC6_HUMAN	Chloride intracellular channel protein 6 (Parchorin)	CLIC6 CLIC1L	Homo sapiens (Human)	chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]	chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; D2 dopamine receptor binding [GO:0031749]; D3 dopamine receptor binding [GO:0031750]; D4 dopamine receptor binding [GO:0031751]; voltage-gated ion channel activity [GO:0005244]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]	chloride channel activity [GO:0005254]; D2 dopamine receptor binding [GO:0031749]; D3 dopamine receptor binding [GO:0031750]; D4 dopamine receptor binding [GO:0031751]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005254; GO:0005737; GO:0005886; GO:0006821; GO:0031749; GO:0031750; GO:0031751; GO:0034707; GO:0034765; GO:0070062	IEEFLEEK	6.670000076	1	1	0.12498726	1037.430674	15.83454	0	0	0	0	0	0	0	0	0	0	14.48878	0	0	15.99042	0	0	14.26235	0	0	0	0	0	0	0	14.07623	0	0	0	15.38572	0	0	0	0	10.26534	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96P09	BIRC8_HUMAN	"Baculoviral IAP repeat-containing protein 8 (Inhibitor of apoptosis-like protein 2, IAP-like protein 2, ILP-2) (Testis-specific inhibitor of apoptosis)"	BIRC8 ILP2	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; regulation of cell cycle [GO:0051726]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein ubiquitination [GO:0031398]; regulation of cell cycle [GO:0051726]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0005634; GO:0005737; GO:0005876; GO:0031398; GO:0043027; GO:0043066; GO:0046872; GO:0051726; GO:0061630; GO:0090263	EISPEEPLRR	7.800000191	1	1	0.37849792	1226.652195	13.52337	0	0	0	12.55354	14.14402	0	0	15.2952	0	13.44475	13.5109	0	0	0	0	0	0	15.8872	0	0	0	0	0	0	0	0	0	15.91253	0	0	0	0	0	0	0	16.56006	0	0	0	16.04794	19.75795	0	0	0	0	16.03274	0
Q96P16	RPR1A_HUMAN	Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein)	RPRD1A P15RS	Homo sapiens (Human)	dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]	"nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]"	"nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]; identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]"	identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0005654; GO:0016591; GO:0031124; GO:0042802; GO:0070940	AKPNRK	1.539999962	1	1	0.240466522	714.0992464	0	0	15.462	0	0	14.48839	0	13.96099	15.20186	0	0	0	0	0	0	0	17.07731	0	17.00944	0	15.4818	16.89112	17.23105	15.85224	0	0	0	15.8274	0	0	0	0	14.24984	17.14588	0	15.34049	0	16.15292	0	0	0	0	0	0	0	0	0	0
Q96P20	NLRP3_HUMAN	"NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1, CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1)"	NLRP3 C1orf7 CIAS1 NALP3 PYPAF1	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; pyroptosis [GO:0070269]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; peptidoglycan binding [GO:0042834]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; pyroptosis [GO:0070269]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; peptidoglycan binding [GO:0042834]; sequence-specific DNA binding [GO:0043565]	GO:0000139; GO:0002221; GO:0002674; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006915; GO:0006952; GO:0006954; GO:0007165; GO:0007231; GO:0009595; GO:0032088; GO:0032691; GO:0032731; GO:0032753; GO:0042802; GO:0042834; GO:0043280; GO:0043565; GO:0044546; GO:0045087; GO:0045630; GO:0045944; GO:0050728; GO:0050729; GO:0051092; GO:0070269; GO:0071222; GO:0072559; GO:0098586; GO:0140297; GO:1901223; GO:2000553	EGRTNVPGSR	2.599999905	1	1	6.90E-13	1073.416024	8.450943	0	17.87431	14.94861	0	13.47638	14.97259	0	15.45348	0	0	0	0	15.0097	0	0	13.36897	0	0	0	0	0	13.06871	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96P26	5NT1B_HUMAN	"Cytosolic 5'-nucleotidase 1B, cN1B, EC 3.1.3.5 (Autoimmune infertility-related protein) (Cytosolic 5'-nucleotidase IB, cN-IB)"	NT5C1B AIRP FKSG85	Homo sapiens (Human)	adenosine metabolic process [GO:0046085]; purine nucleotide catabolic process [GO:0006195]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; adenosine metabolic process [GO:0046085]; purine nucleotide catabolic process [GO:0006195]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000287; GO:0005634; GO:0005829; GO:0006195; GO:0008253; GO:0046085	LPSSSTSSR	5.75	1	1	0.121050325	921.479938	0	0	0	0	0	0	0	0	0	0	0	18.01985	15.81894	0	16.03431	0	0	17.61362	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.52338	0	0	0	18.18726	17.32217	0	0	0	0	9.860026	0	0	13.03659	0
Q96P44	COLA1_HUMAN	Collagen alpha-1(XXI) chain	COL21A1 COL1AL FP633	Homo sapiens (Human)		collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]		GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0005829; GO:0062023	GAIGSKGESGVDGLMGPAGPK	1.860000014	1	1	4.60E-13	1901.251101	14.00131	14.57073	15.86778	13.86809	12.04054	0	0	0	0	15.56112	0	15.94558	0	13.89626	16.05868	0	13.86879	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96P48	ARAP1_HUMAN	"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2, Cnt-d2)"	ARAP1 CENTD2 KIAA0782	Homo sapiens (Human)	actin filament reorganization involved in cell cycle [GO:0030037]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; regulation of cellular component movement [GO:0051270]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; actin filament reorganization involved in cell cycle [GO:0030037]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; regulation of cellular component movement [GO:0051270]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"	"GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]"	GO:0005096; GO:0005547; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008360; GO:0030037; GO:0031410; GO:0032580; GO:0043231; GO:0043547; GO:0046872; GO:0051056; GO:0051270; GO:0051491; GO:0051497	AVTPNGEIR	7.920000076	0.986490011	0.986490011	0.242955938	960.429873	18.46446	15.3135	15.87025	18.41711	16.6517	14.90827	0	16.52092	0	16.00338	16.22032	15.03731	0	0	15.39423	14.30076	14.93498	15.17052	14.3065	15.83013	0	16.31094	14.26825	0	0	16.23204	0	16.58765	0	0	0	0	0	18.36492	17.0183	0	15.60086	17.26294	16.07153	14.90695	0	0	15.85779	0	16.64804	17.4848	0	0
Q96P50	ACAP3_HUMAN	"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 (Centaurin-beta-5, Cnt-b5)"	ACAP3 CENTB5 KIAA1716	Homo sapiens (Human)	neuron migration [GO:0001764]; regulation of neuron projection development [GO:0010975]	growth cone [GO:0030426]	growth cone [GO:0030426]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; neuron migration [GO:0001764]; regulation of neuron projection development [GO:0010975]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0001764; GO:0005096; GO:0010975; GO:0030426; GO:0046872	AYVSTSR	3.400000095	0.954659641	0.954659641	0.231605571	783.0276624	0	0	0	15.29856	13.59557	0	13.17984	15.0244	15.03198	0	15.84816	0	0	0	0	0	13.40359	15.02653	0	16.78936	0	0	0	0	0	16.49573	16.35213	0	0	0	0	0	0	0	16.78168	15.7056	15.78227	0	0	0	16.33073	14.99328	0	0	0	0	15.71016	0
Q96P65	QRFPR_HUMAN	Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)	QRFPR GPR103	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]	GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0007186; GO:0016021	ENPVEETK	11.43999958	0.688990057	0.688990057	0.100149916	944.8549754	0	15.38509	17.93564	15.20573	0	0	13.99729	0	13.26081	0	13.4882	8.435581	0	10.36005	0	0	0	0	0	14.32973	14.45844	0	0	0	0	16.19916	16.87202	14.62945	13.61034	0	0	0	0	0	0	0	0	0	0	17.26762	0	0	14.07698	0	8.461637	0	0	15.54476
Q96P88	GNRR2_HUMAN	"Putative gonadotropin-releasing hormone II receptor, GnRH II receptor, GnRH-II-R (Type II GnRH receptor)"	GNRHR2	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; peptide binding [GO:0042277]	GO:0004930; GO:0004968; GO:0005886; GO:0005887; GO:0007186; GO:0042277	GHQELSIDSSK	14.43000031	1	1	0.27090224	1200.003123	14.0465	0	0	14.55881	0	12.05793	0	0	0	0	0	0	14.98003	0	9.822898	9.597157	0	0	0	0	0	0	11.22406	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.01126	0
Q96PC5	MIA2_HUMAN	"Melanoma inhibitory activity protein 2, MIA protein 2 (CTAGE family member 5 ER export factor) (Cutaneous T-cell lymphoma-associated antigen 5) (Meningioma-expressed antigen 6/11)"	MIA2 CTAGE5 MEA11 MEA6 MGEA11 MGEA6	Homo sapiens (Human)	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cargo receptor activity [GO:0038024]; enzyme activator activity [GO:0008047]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]	cargo receptor activity [GO:0038024]; enzyme activator activity [GO:0008047]	GO:0005783; GO:0005789; GO:0006888; GO:0008047; GO:0009306; GO:0016020; GO:0016021; GO:0032527; GO:0035459; GO:0038024; GO:0042953; GO:0070971; GO:0070973	VMTELYQENEMKLHR	4.480000019	1	1	0.167788941	1954.079735	15.69492	14.56293	15.37063	14.91831	14.50848	16.2084	13.81148	0	0	15.31071	15.9895	14.90072	0	0	0	14.56835	0	0	14.00548	0	0	0	16.10994	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.95678	16.89136	0	15.49719	0	15.57255	0	0	0
Q96PD7	DGAT2_HUMAN	"Diacylglycerol O-acyltransferase 2, EC 2.3.1.20 (Acyl-CoA retinol O-fatty-acyltransferase, ARAT, Retinol O-fatty-acyltransferase, EC 2.3.1.76) (Diglyceride acyltransferase 2)"	DGAT2 HMFN1045 UNQ738/PRO1433	Homo sapiens (Human)	bile acid signaling pathway [GO:0038183]; cellular response to oleic acid [GO:0071400]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; diacylglycerol biosynthetic process [GO:0006651]; diacylglycerol metabolic process [GO:0046339]; fat pad development [GO:0060613]; fatty acid homeostasis [GO:0055089]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; low-density lipoprotein particle clearance [GO:0034383]; monoacylglycerol biosynthetic process [GO:0006640]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cholesterol metabolic process [GO:0090181]; regulation of lipoprotein metabolic process [GO:0050746]; regulation of plasma lipoprotein particle levels [GO:0097006]; triglyceride biosynthetic process [GO:0019432]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; protein homodimerization activity [GO:0042803]; retinol O-fatty-acyltransferase activity [GO:0050252]; bile acid signaling pathway [GO:0038183]; cellular response to oleic acid [GO:0071400]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; diacylglycerol biosynthetic process [GO:0006651]; diacylglycerol metabolic process [GO:0046339]; fat pad development [GO:0060613]; fatty acid homeostasis [GO:0055089]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; low-density lipoprotein particle clearance [GO:0034383]; monoacylglycerol biosynthetic process [GO:0006640]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cholesterol metabolic process [GO:0090181]; regulation of lipoprotein metabolic process [GO:0050746]; regulation of plasma lipoprotein particle levels [GO:0097006]; triglyceride biosynthetic process [GO:0019432]	2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; protein homodimerization activity [GO:0042803]; retinol O-fatty-acyltransferase activity [GO:0050252]	GO:0003846; GO:0004144; GO:0005739; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0010867; GO:0016021; GO:0019432; GO:0019915; GO:0030176; GO:0034383; GO:0035336; GO:0035356; GO:0038183; GO:0042632; GO:0042803; GO:0043231; GO:0045722; GO:0046322; GO:0046339; GO:0048471; GO:0050252; GO:0050746; GO:0055089; GO:0060613; GO:0071400; GO:0090181; GO:0097006; GO:1990578	NWAVWRYFR	10.93000031	0.041099444	0.041099444	0.048131352	1298.301389	14.03369	0	0	0	0	12.197	0	0	0	0	15.37852	0	0	0	0	0	0	0	0	0	0	13.14502	15.24858	13.79869	14.08562	14.91934	12.34784	9.934078	0	14.33108	14.23427	0	0	0	0	0	0	0	0	0	16.51285	17.39745	0	0	17.5646	0	0	0
Q96PE1	AGRA2_HUMAN	Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5)	ADGRA2 GPR124 KIAA1531 TEM5	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; central nervous system development [GO:0007417]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]; regulation of chemotaxis [GO:0050920]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]	cell surface [GO:0009986]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; central nervous system development [GO:0007417]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]; regulation of chemotaxis [GO:0050920]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	G protein-coupled receptor activity [GO:0004930]	GO:0002040; GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007417; GO:0009986; GO:0010595; GO:0016021; GO:0016055; GO:0030175; GO:0043542; GO:0045765; GO:0050920; GO:0090210; GO:0090263; GO:1900747; GO:1990909	AGNSR	6.360000134	0.060192674	0.060192674	0.171764241	503.2575807	15.03505	17.83058	17.03955	15.98069	16.87576	17.08662	15.77275	16.30149	16.43428	16.13601	16.6966	16.85338	16.28165	16.74792	16.46047	16.70742	15.9823	16.28524	16.6985	16.69421	17.26352	17.17666	17.51847	16.75458	16.70978	17.18551	15.55519	16.8021	17.36896	16.92482	15.72759	17.1829	16.33401	17.74879	16.67576	16.24463	16.94352	16.51157	16.34536	17.65278	16.75137	16.74426	17.65667	16.76085	16.35271	16.48357	17.12393	17.29129
Q96PE2	ARHGH_HUMAN	"Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor, p164-RhoGEF, p164RhoGEF) (Tumor endothelial marker 4)"	ARHGEF17 KIAA0337 TEM4	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0030036; GO:0051056	DGGVLPAAAEEAAEGPAR	3.24000001	1	1	0.303217803	1682.593385	10.9547	0	15.40946	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.40981	0	19.32605	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96PE3	INP4A_HUMAN	"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase, EC 3.1.3.66)"	INPP4A	Homo sapiens (Human)	inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165]"	"inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]"	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0031965; GO:0034597; GO:0043647; GO:0052828; GO:0055038	VDKLLQK	21.52000046	1	1	0.258079543	844.0900351	0	17.9481	18.94762	19.64652	17.95181	17.33087	19.99719	0	18.7397	18.39228	18.34705	19.94404	0	17.56316	0	0	0	19.26145	19.60533	0	17.63999	18.29074	19.22667	0	21.3326	0	18.48632	18.69222	17.35215	15.14934	21.42808	20.70774	0	20.47758	19.60599	0	16.50845	0	20.42492	0	16.52435	20.21988	0	0	18.0332	19.57005	20.25491	17.93733
Q96PE7	MCEE_HUMAN	"Methylmalonyl-CoA epimerase, mitochondrial, EC 5.1.99.1 (DL-methylmalonyl-CoA racemase)"	MCEE	Homo sapiens (Human)	L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626]	metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]	GO:0004493; GO:0005759; GO:0019626; GO:0046491; GO:0046872	ARVLK	3.410000086	1	1	0.240325203	585.9833157	0	17.11188	14.89706	16.46553	14.37643	0	16.84654	0	0	15.98138	14.77872	0	0	0	0	0	14.37863	0	0	18.4501	15.39755	0	17.63652	0	17.83531	16.98804	16.18217	16.0428	14.55438	0	14.65679	16.04536	18.59675	0	18.23129	16.35907	0	17.01971	0	16.38506	16.32557	0	17.19747	0	16.82491	0	17.27295	0
Q96PF2	TSSK2_HUMAN	"Testis-specific serine/threonine-protein kinase 2, TSK-2, TSK2, TSSK-2, Testis-specific kinase 2, EC 2.7.11.1 (DiGeorge syndrome protein G, DGS-G) (Serine/threonine-protein kinase 22B)"	TSSK2 DGSG SPOGA2 STK22B	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]	acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]	GO:0000287; GO:0001669; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007286; GO:0018105; GO:0035556; GO:0044877; GO:0046777; GO:0106310	ATSSASFKR	2.630000114	1	1	0.025583227	955.4635856	13.5331	14.14748	11.32228	0	0	0	0	11.87363	0	0	0	0	0	0	0	15.62117	0	0	0	0	0	0	0	0	0	0	0	14.47805	0	0	0	12.79478	0	14.30584	0	8.443032	0	0	0	0	0	0	0	0	0	0	0	0
Q96PI1	SPRR4_HUMAN	Small proline-rich protein 4	SPRR4	Homo sapiens (Human)	keratinization [GO:0031424]	cell cortex [GO:0005938]	cell cortex [GO:0005938]; keratinization [GO:0031424]		GO:0005938; GO:0031424	CQETCAPK	7.489999771	1	1	0.269312123	993.8451985	0	16.25745	15.76355	0	0	15.38208	16.48193	14.13616	15.30475	16.94982	16.8703	0	13.96757	0	15.44461	13.73373	15.81057	14.01596	17.19276	15.97245	14.28841	14.2033	17.02417	14.5523	16.04299	15.12889	16.29644	0	14.926	16.26016	17.47089	17.52679	16.87119	15.74564	0	0	0	16.11447	18.05418	0	15.67981	14.66778	15.33878	0	14.81184	16.49589	16.95191	14.34762
Q96PK6	RBM14_HUMAN	"RNA-binding protein 14 (Paraspeckle protein 2, PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein, SYT-interacting protein)"	RBM14 SIP	Homo sapiens (Human)	"activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725]; SMAD protein signal transduction [GO:0060395]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription regulator complex [GO:0005667]	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription regulator complex [GO:0005667]; mRNA binding [GO:0003729]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725]; SMAD protein signal transduction [GO:0060395]"	mRNA binding [GO:0003729]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]	GO:0000398; GO:0002218; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0009725; GO:0016575; GO:0016607; GO:0030374; GO:0045087; GO:0045944; GO:0046600; GO:0060395; GO:0098534; GO:1990904	TRLSPPR	14.07999992	1	1	0.314615513	825.9546913	0	0	0	0	0	0	0	17.73462	0	0	0	0	22.41349	0	0	17.78212	0	0	17.34968	0	0	0	16.46508	0	0	0	0	0	17.77741	0	0	0	0	0	0	0	0	21.39632	0	0	0	17.74963	22.03078	0	0	0	0	0
Q96PL1	SG3A2_HUMAN	"Secretoglobin family 3A member 2 (Pneumo secretory protein 1, PnSP-1) (Uteroglobin-related protein 1)"	SCGB3A2 PNSP1 UGRP1 UNQ566/PRO1128	Homo sapiens (Human)		endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]		GO:0005576; GO:0005615; GO:0071682	CVNELGPEASEAVK	3.50999999	1	1	0.416321687	1503.383871	15.87526	0	0	0	0	0	12.60921	17.09692	16.40371	0	0	14.75425	16.70322	16.49494	0	15.96569	0	16.52276	0	0	16.71867	18.31997	0	0	0	0	0	0	16.69719	16.34215	16.04994	17.83224	0	16.58109	14.9533	16.08135	17.03113	0	0	15.33101	0	17.66186	15.48404	0	16.78733	17.04237	0	0
Q96PL5	ERMAP_HUMAN	"Erythroid membrane-associated protein, hERMAP (Radin blood group antigen) (Scianna blood group antigen)"	ERMAP RD SC	Homo sapiens (Human)	regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852]	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852]	signaling receptor binding [GO:0005102]	GO:0001817; GO:0005102; GO:0005794; GO:0005829; GO:0005886; GO:0009897; GO:0016021; GO:0050852	VNSSLLPPK	4.53000021	1	1	0.285203012	953.7963497	15.5627	0	14.88631	0	15.687	14.98186	16.48482	16.55322	14.74324	0	0	0	0	15.41914	0	0	13.90242	15.08479	14.83108	0	0	15.94744	0	0	0	0	0	0	14.5295	0	0	0	0	16.66925	15.04581	0	0	16.10424	15.94493	0	0	0	15.25452	0	0	0	13.59508	13.77763
Q96PN6	ADCYA_HUMAN	"Adenylate cyclase type 10, EC 4.6.1.1 (AH-related protein) (Adenylate cyclase homolog) (Germ cell soluble adenylyl cyclase, hsAC, sAC) (Testicular soluble adenylyl cyclase)"	ADCY10 SAC	Homo sapiens (Human)	cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; spermatogenesis [GO:0007283]	apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; spermatogenesis [GO:0007283]	adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]	GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005929; GO:0006171; GO:0007283; GO:0016324; GO:0030145; GO:0030425; GO:0030426; GO:0035556; GO:0043025; GO:0043065; GO:0045178; GO:0048471; GO:0051117; GO:0071241; GO:0071890	ELQKALK	13.68999958	0.896615267	0.896615267	0.35155412	829.4834953	16.09822	17.63326	17.70076	0	15.97444	16.78062	15.60171	15.40589	0	15.69044	16.35976	0	0	17.29871	16.95215	0	17.08821	17.15459	0	0	16.54344	17.01309	0	16.79832	15.77738	0	0	0	0	15.80485	0	0	0	0	16.54334	0	16.70173	0	16.58439	15.94924	17.13367	17.01456	0	16.69411	15.67246	0	16.60742	17.00604
Q96PN7	TREF1_HUMAN	Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132)	TRERF1 BCAR2 RAPA TREP132	Homo sapiens (Human)	"cellular response to progesterone stimulus [GO:0071393]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; cellular response to progesterone stimulus [GO:0071393]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0016575; GO:0030374; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050847; GO:0071393	ALATYSK	4.570000172	1	1	0.109744249	752.5830805	15.95397	0	0	0	0	0	0	14.74539	0	0	16.74418	0	0	0	0	0	0	16.72258	0	0	0	0	0	0	15.92745	0	0	0	0	0	0	15.76061	0	15.26655	15.23105	15.92283	17.30671	18.14124	16.48352	0	0	15.61423	17.54906	15.23666	16.55961	16.59138	17.2436	17.11774
Q96PN8	TSSK3_HUMAN	"Testis-specific serine/threonine-protein kinase 3, TSK-3, TSSK-3, Testis-specific kinase 3, EC 2.7.11.1 (Serine/threonine-protein kinase 22C)"	TSSK3 SPOGA3 STK22C	Homo sapiens (Human)	cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]		ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0007283; GO:0030154; GO:0035556; GO:0106310	CENALLQGFNLK	16.85000038	1	1	0.378342226	1407.500726	13.13821	0	0	14.07502	14.02739	13.50184	0	14.17396	14.95596	0	0	0	14.98083	15.07362	0	0	0	0	0	0	0	0	0	0	15.85118	0	0	0	0	0	0	0	0	0	0	0	16.52132	0	0	15.86401	0	0	0	0	16.5171	0	0	15.78233
Q96PP4	TSG13_HUMAN	Testis-specific gene 13 protein	TSGA13	Homo sapiens (Human)						MYPQLTFAPVHERDMR	1.549999952	1	1	1.15E-12	2007.759867	12.64281	0	0	0	0	13.07543	13.86124	15.37179	13.42139	15.34585	16.32151	9.242854	0	13.26941	0	0	0	0	0	13.19477	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.60465	0	0	0	0	0	0	0
Q96PQ0	SORC2_HUMAN	VPS10 domain-containing receptor SorCS2 [Cleaved into: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain ]	SORCS2 KIAA1329	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; neuropeptide signaling pathway [GO:0007218]	cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perikaryon [GO:0043204]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]	cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perikaryon [GO:0043204]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; neuropeptide receptor activity [GO:0008188]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; neuropeptide signaling pathway [GO:0007218]	neuropeptide receptor activity [GO:0008188]	GO:0005829; GO:0005887; GO:0006886; GO:0007218; GO:0008188; GO:0016020; GO:0016021; GO:0031901; GO:0043197; GO:0043204; GO:0043231; GO:0055038; GO:0060292; GO:0098839	SPPAGR	4.230000019	0.421875477	0.421875477	0.087778687	584.4969091	16.07589	0	0	0	0	0	0	15.60806	0	16.80048	0	16.39433	15.78177	13.61229	16.47116	0	0	0	16.25274	15.20252	0	0	17.18718	0	0	0	0	16.82546	16.81854	0	0	17.86336	16.94071	19.6033	0	17.1478	0	17.13629	0	0	17.65432	17.68416	0	17.75544	18.56611	17.03666	0	16.7199
Q96PQ1	SIG12_HUMAN	"Sialic acid-binding Ig-like lectin 12, Siglec-12 (Sialic acid-binding Ig-like lectin-like 1, Siglec-L1)"	SIGLEC12 SIGLECL1 SLG UNQ9215/PRO34042	Homo sapiens (Human)	cell adhesion [GO:0007155]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]	carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]	GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0033691	SARPAVGVGDTGMEDANAVR	3.819999933	0.14735128	0.14735128	0.295229733	1989.362822	14.77689	17.41592	0	0	0	0	0	16.15665	0	0	0	14.94533	0	12.20377	14.41124	0	0	0	13.47626	0	0	13.57638	0	0	15.20177	0	0	0	0	0	0	15.29883	0	15.45895	0	8.774716	0	0	0	0	0	0	0	0	15.79438	0	0	0
Q96PQ6	ZN317_HUMAN	Zinc finger protein 317	ZNF317 KIAA1588	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	SHVKTHR	14.02000046	1	1	0.083980953	865.4679805	12.02661	0	0	0	13.46299	0	14.10204	0	0	0	0	12.50369	0	0	11.08845	11.34294	0	0	14.82968	12.07076	16.05251	0	0	9.75059	0	0	0	9.934078	13.54945	0	14.23427	15.55132	14.89786	0	14.7546	0	0	0	0	0	16.50366	17.19179	0	15.96764	0	0	0	15.9197
Q96PQ7	KLHL5_HUMAN	Kelch-like protein 5	KLHL5	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005856	MEGVEPNSLWSLIQYAYTGRLELK	5.360000134	0.083184212	0.083184212	0.075605037	2812.557535	0	17.56397	0	13.89376	16.15122	14.99045	15.41242	17.65707	10.79994	12.94314	16.60785	14.94087	0	0	15.37364	13.42897	14.7113	12.33387	17.19052	0	0	17.85365	0	0	17.44325	16.30979	16.20974	16.44442	15.9343	15.36201	16.60678	17.86017	15.12951	14.26981	0	0	0	16.94098	0	13.88345	0	0	0	15.43557	13.31193	0	17.27469	15.98547
Q96PS1	FACOS_HUMAN	FANCD2 opposite strand protein (Fanconi anemia group D2 protein opposite strand transcript protein)	FANCD2OS C3orf24 HSD19	Homo sapiens (Human)						CTFALQHSK	7.039999962	0.515179753	0.515179753	0.293635194	1090.774552	0	0	15.41088	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.30333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.24702	17.33609	0	0	0	0	0	0	0
Q96PU5	NED4L_HUMAN	"E3 ubiquitin-protein ligase NEDD4-like, EC 2.3.2.26, EC 2.3.2.36 (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2)"	NEDD4L KIAA0439 NEDL3	Homo sapiens (Human)	cell differentiation [GO:0030154]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005]	potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0003254; GO:0004842; GO:0005654; GO:0005737; GO:0005771; GO:0005794; GO:0005829; GO:0006511; GO:0015459; GO:0016567; GO:0017080; GO:0019870; GO:0019871; GO:0030154; GO:0031647; GO:0034220; GO:0034765; GO:0042391; GO:0043161; GO:0044325; GO:0045732; GO:0048814; GO:0060306; GO:0061630; GO:0070062; GO:0070936; GO:0086005; GO:1901016; GO:1901017; GO:1901380; GO:1902305; GO:1902306; GO:1903861; GO:2000009; GO:2000650; GO:2001288	EPSSR	2.829999924	0.11134731	0.11134731	0.303409093	574.7190977	0	0	0	0	0	0	0	0	17.4952	17.9825	0	0	0	0	0	0	18.09677	0	0	0	16.23146	0	0	0	0	17.9309	0	0	0	0	19.00059	16.68146	0	17.92148	0	20.24474	0	17.60698	0	0	0	0	0	0	18.29755	16.88419	0	17.52985
Q96PV0	SYGP1_HUMAN	"Ras/Rap GTPase-activating protein SynGAP (Neuronal RasGAP) (Synaptic Ras GTPase-activating protein 1, Synaptic Ras-GAP 1)"	SYNGAP1 KIAA1938	Homo sapiens (Human)	dendrite development [GO:0016358]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of axonogenesis [GO:0050771]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; pattern specification process [GO:0007389]; Ras protein signal transduction [GO:0007265]; receptor clustering [GO:0043113]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542]	cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; dendrite development [GO:0016358]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of axonogenesis [GO:0050771]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; pattern specification process [GO:0007389]; Ras protein signal transduction [GO:0007265]; receptor clustering [GO:0043113]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542]	GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]	GO:0005096; GO:0005829; GO:0005886; GO:0007265; GO:0007389; GO:0008542; GO:0014069; GO:0016358; GO:0017124; GO:0043087; GO:0043113; GO:0043198; GO:0043408; GO:0043524; GO:0046580; GO:0048167; GO:0048169; GO:0050771; GO:0050803; GO:0098880; GO:0098978	EALLKLGPLPR	2.140000105	0.157556698	0.157556698	1.15E-12	1207.624571	0	14.22654	13.1327	11.53353	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.23241	0	12.68476	0	12.0243	15.40848	14.9672	0	0	0	0	13.62874	0	7.242949	0	0	0	0
Q96PV4	PNMA5_HUMAN	Paraneoplastic antigen-like protein 5 (Tumor antigen BJ-HCC-25)	PNMA5 KIAA1934	Homo sapiens (Human)	positive regulation of apoptotic process [GO:0043065]		identical protein binding [GO:0042802]; positive regulation of apoptotic process [GO:0043065]	identical protein binding [GO:0042802]	GO:0042802; GO:0043065	GMDMDPRK	5.900000095	1	1	0.262520929	980.6927657	16.80033	0	17.00759	0	16.48492	18.27445	16.70403	0	0	0	0	0	0	15.93901	0	17.69764	0	17.60799	16.6963	15.81522	0	0	0	0	0	18.17647	0	0	0	0	0	0	19.4911	0	18.47344	0	0	0	0	16.63446	15.98921	16.52061	0	0	0	0	0	18.196
Q96PV6	LENG8_HUMAN	Leukocyte receptor cluster member 8	LENG8 KIAA1932	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634	DNSSSSSTDSR	12.25	1	1	0.32955029	1142.034898	0	14.28611	15.02967	0	10.89827	0	0	0	0	0	0	15.15021	0	0	0	0	15.97441	14.61161	0	0	15.14541	15.48061	15.5022	0	0	16.93045	0	0	0	0	0	0	0	0	15.14503	0	0	16.37055	16.25217	16.45291	0	11.76709	16.60941	0	17.12446	15.85108	0	0
Q96PV7	F193B_HUMAN	Protein FAM193B	FAM193B IRIZIO KIAA1931	Homo sapiens (Human)		cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016607	GPHPPWTEVRGPPPGIVPENGLVR	1.450000048	1	1	0.179217864	2558.173967	0	15.22641	12.5134	14.854	13.17947	16.33812	0	0	0	0	14.77729	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96PX6	CC85A_HUMAN	Coiled-coil domain-containing protein 85A	CCDC85A KIAA1912	Homo sapiens (Human)		adherens junction [GO:0005912]	adherens junction [GO:0005912]		GO:0005912	VSAMLDHSNLIR	3.059999943	1	1	0.099369874	1354.583417	11.95301	0	12.99015	0	9.323339	11.39026	0	0	13.79216	0	0	0	0	0	0	17.59583	11.96925	14.40691	0	0	0	11.2117	0	11.80008	0	0	14.63828	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.65279	0	0	0	0	0
Q96PX9	PKH4B_HUMAN	"Pleckstrin homology domain-containing family G member 4B, PH domain-containing family G member 4B"	PLEKHG4B KIAA1909	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0051056	HQKPPSFPSTDSGGGAWEPAQPLSGLPGR	5.179999828	1	1	0.222841898	2957.260711	13.77218	13.20107	10.23913	0	0	11.83035	0	12.96298	0	0	11.3091	14.68067	15.47091	12.77314	0	0	0	0	0	0	0	0	14.44686	0	0	15.43113	0	0	0	0	0	0	0	0	0	0	0	0	0	16.74849	15.60681	16.23097	0	0	0	0	14.88603	0
Q96PY0	K1908_HUMAN	Putative uncharacterized protein PSMG3-AS1 (PSMG3 antisense RNA 1)	PSMG3-AS1 KIAA1908	Homo sapiens (Human)						SSPGAPEAAERVESAETR	10.22999954	1	1	0.069429293	1844.738019	0	0	17.96379	0	0	0	17.11604	0	17.05155	0	13.94185	0	0	0	0	0	0	0	0	0	15.95152	0	0	0	0	15.72396	0	0	0	0	0	0	0	0	17.3261	0	17.21313	0	17.20885	0	0	0	0	0	0	0	0	0
Q96PY5	FMNL2_HUMAN	Formin-like protein 2 (Formin homology 2 domain-containing protein 2)	FMNL2 FHOD2 KIAA1902	Homo sapiens (Human)	cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]	cytosol [GO:0005829]	cytosol [GO:0005829]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267]	GO:0005829; GO:0007010; GO:0008360; GO:0016477; GO:0022604; GO:0030866; GO:0031267; GO:0045296; GO:0051015	FAIVLNAMNLPPDKAR	10.64000034	0.867957532	0.867957532	0.638377249	1769.476482	18.73903	20.63809	0	18.78835	19.04931	0	0	0	0	19.42322	0	0	0	18.49313	0	20.13799	0	0	0	18.91159	0	18.42972	17.82868	18.57927	0	0	20.68493	18.71423	0	0	19.40987	20.94355	19.42506	20.11463	21.82839	0	20.58704	21.53213	0	18.75665	17.84745	19.12061	18.76435	0	19.33102	18.20993	0	18.90501
Q96PY6	NEK1_HUMAN	"Serine/threonine-protein kinase Nek1, EC 2.7.11.1 (Never in mitosis A-related kinase 1, NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)"	NEK1 KIAA1901	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0000242; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310	AWGKSPTDSVLK	13.39999962	0.543632865	0.543632865	0.147836373	1287.616879	19.3304	19.4307	14.92559	18.52638	17.41114	17.47056	17.63256	18.59722	18.36349	14.51701	19.01532	16.68555	17.04231	18.71674	17.5547	17.80961	18.98005	19.27185	15.88496	16.90752	15.78037	16.79911	0	0	0	17.67639	0	17.76945	0	0	18.70913	17.6671	0	18.89138	0	17.8908	0	18.28366	18.67248	16.60272	18.10599	0	0	18.57736	18.14008	0	17.12033	18.25674
Q96PZ0	PUS7_HUMAN	"Pseudouridylate synthase 7 homolog, EC 5.4.99.-"	PUS7 KIAA1897	Homo sapiens (Human)	mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	nucleus [GO:0005634]	nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0001522; GO:0003723; GO:0005634; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380	GYLVK	1.590000033	0.730456531	0.730456531	0.229747792	578.4846278	0	0	14.6109	15.90043	15.0495	16.41591	16.69441	15.8616	15.60162	16.24965	16.16142	15.83893	14.25298	15.58087	14.9079	14.72988	16.4217	0	16.57957	0	0	14.88107	15.68114	0	0	17.24712	0	0	0	16.15832	0	16.30069	16.18746	0	0	16.74793	17.22291	0	0	0	16.43739	16.9764	0	0	0	16.61406	0	16.95846
Q96PZ7	CSMD1_HUMAN	CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)	CSMD1 KIAA1890 UNQ5952/PRO19863	Homo sapiens (Human)	conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]		GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016021; GO:0035846; GO:0042593; GO:0060745; GO:1990708	EVNETVTK	5.449999809	0.486185819	0.486185819	0.047741113	918.6130481	13.83284	0	16.11692	16.60272	16.54411	10.43184	10.87751	12.30625	14.46797	16.35782	15.69183	14.92047	14.57646	16.40608	16.4927	14.39125	5.017852	13.39276	14.96501	0	0	0	15.19717	16.38688	15.43106	15.2187	14.07603	0	17.23473	14.23412	0	0	14.26777	0	0	16.96086	16.78699	17.28904	16.30321	14.14421	12.1067	16.65963	0	15.91785	15.04628	0	18.10673	17.30075
Q96Q04	LMTK3_HUMAN	"Serine/threonine-protein kinase LMTK3, EC 2.7.11.1 (Lemur tyrosine kinase 3)"	LMTK3 KIAA1883 TYKLM3	Homo sapiens (Human)	protein phosphorylation [GO:0006468]	axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000139; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0006468; GO:0016021; GO:0030424; GO:0030425; GO:0046872; GO:0106310	RAPETGGAPR	8.609999657	1	1	0.249348169	1011.546777	0	0	15.19206	0	0	0	0	16.90423	0	0	0	17.87859	0	17.56862	0	18.93886	0	0	0	0	0	0	0	16.79681	0	19.7751	0	0	0	15.86651	19.05933	0	19.83419	0	0	0	0	18.98014	0	0	0	17.48915	0	0	0	0	0	0
Q96Q05	TPPC9_HUMAN	Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein) (Tularik gene 1 protein)	TRAPPC9 KIAA1882 NIBP T1	Homo sapiens (Human)	cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022]		GO:0005737; GO:0005783; GO:0005802; GO:0005829; GO:0006888; GO:0006901; GO:0021987; GO:0030008; GO:0030182; GO:0051092; GO:0099022; GO:1990071	AVRVLAIQK	7.650000095	0.945565701	0.945565701	0.213027116	999.49454	16.51224	15.99016	15.95611	0	16.27464	0	15.59303	0	15.10367	10.4193	0	0	0	0	0	14.73895	0	15.1201	14.3187	16.69142	0	15.8349	11.90159	15.56076	0	15.47878	14.44288	16.08805	14.46736	14.24806	15.00996	15.63392	0	16.85108	15.116	0	15.58917	15.33281	0	16.10543	14.2383	0	15.58347	13.05512	0	15.18424	17.0839	13.513
Q96Q06	PLIN4_HUMAN	Perilipin-4 (Adipocyte protein S3-12)	PLIN4 KIAA1881	Homo sapiens (Human)		cytosol [GO:0005829]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]		GO:0005811; GO:0005829; GO:0005886	AVLMGTK	6.599999905	1	1	0.222663261	734.2971623	0	17.63068	16.57856	0	0	0	0	15.68603	15.4453	0	0	0	0	0	0	0	17.44379	0	0	17.36653	0	0	0	0	18.70733	0	0	15.66647	16.03926	16.33998	0	0	16.23964	16.89087	0	15.76818	17.13215	16.21389	0	0	16.65174	0	14.65599	14.44217	0	17.00872	0	0
Q96Q07	BTBD9_HUMAN	BTB/POZ domain-containing protein 9	BTBD9 KIAA1880	Homo sapiens (Human)	"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]"		"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]"		GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050804; GO:0050951; GO:0060586; GO:1900242	DMDLNYRGMLIPEENIATMK	18.27000046	1	1	0.236224626	2369.550356	0	15.78869	0	0	12.50103	15.75853	0	16.06518	16.7087	14.3984	15.01112	16.64881	0	16.973	11.45494	16.57529	14.26296	0	16.55524	0	16.25657	0	15.63946	0	0	0	0	0	0	0	0	0	0	0	0	0	15.32507	0	0	0	0	0	0	0	16.77809	0	0	0
Q96Q15	SMG1_HUMAN	"Serine/threonine-protein kinase SMG1, SMG-1, hSMG-1, EC 2.7.11.1 (Lambda/iota protein kinase C-interacting protein, Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)"	SMG1 ATX KIAA0421 LIP	Homo sapiens (Human)	"DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]"	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	"chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020	LMYNAYEGCANALTSPPK	3.900000095	1	1	0.515156007	2015.032996	0	0	0	0	19.05868	0	0	0	0	0	17.32783	0	0	17.11884	0	0	0	17.70102	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.52364	0	0	0	17.60952	0
Q96Q42	ALS2_HUMAN	Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein)	ALS2 ALS2CR6 KIAA1563	Homo sapiens (Human)	"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]"	centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]	"centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]"	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267]	GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016197; GO:0016601; GO:0030027; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035022; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260	EEETEGGSR	5.449999809	1	1	0.026956728	993.9784369	0	0	15.03042	0	0	0	0	0	13.56984	0	0	14.53143	0	0	0	0	0	13.339	0	0	0	0	0	0	15.04917	16.52694	15.95233	0	0	13.45584	16.57089	0	0	0	0	0	0	0	0	0	0	0	0	0	15.67054	0	0	0
Q96Q45	TM237_HUMAN	Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein)	TMEM237 ALS2CR4	Homo sapiens (Human)	cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111]	ciliary transition zone [GO:0035869]; cone photoreceptor outer segment [GO:0120199]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; rod photoreceptor outer segment [GO:0120200]	ciliary transition zone [GO:0035869]; cone photoreceptor outer segment [GO:0120199]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; rod photoreceptor outer segment [GO:0120200]; cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111]		GO:0016020; GO:0016021; GO:0030111; GO:0032391; GO:0035869; GO:0060271; GO:0120199; GO:0120200	EIKASS	10.90999985	0.047029808	0.047029808	0.270292857	635.2265686	16.23999	15.58606	17.0647	14.50638	14.89654	15.56309	17.73397	16.89926	15.88696	0	15.97574	16.7798	16.48405	15.45062	15.47869	15.78197	15.94908	16.08265	15.75765	16.99256	16.48123	16.48066	17.22632	13.2338	17.09733	16.91392	17.60273	15.83564	17.68727	16.46904	16.84742	16.09751	17.00306	17.92881	17.07644	17.13299	16.99067	17.62747	18.70203	16.49316	17.11751	18.03236	16.46392	18.29462	16.88085	16.47797	18.37806	18.81201
Q96Q89	KI20B_HUMAN	"Kinesin-like protein KIF20B (Cancer/testis antigen 90, CT90) (Kinesin family member 20B) (Kinesin-related motor interacting with PIN1) (M-phase phosphoprotein 1, MPP1)"	KIF20B KRMP1 MPHOSPH1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron migration [GO:2001224]; protein localization to microtubule [GO:0035372]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic nuclear division [GO:0007088]	centrosome [GO:0005813]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]	centrosome [GO:0005813]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein homodimerization activity [GO:0042803]; WW domain binding [GO:0050699]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron migration [GO:2001224]; protein localization to microtubule [GO:0035372]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic nuclear division [GO:0007088]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein homodimerization activity [GO:0042803]; WW domain binding [GO:0050699]	GO:0001843; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007049; GO:0007088; GO:0008017; GO:0008284; GO:0008574; GO:0016887; GO:0030426; GO:0030496; GO:0032467; GO:0035372; GO:0042803; GO:0045171; GO:0048471; GO:0048812; GO:0050699; GO:0051233; GO:0051301; GO:0051726; GO:0070938; GO:0090316; GO:0097431; GO:1903438; GO:1990023; GO:2000114; GO:2001224	DQLVAALEIQLK	2.140000105	1	1	0.312516286	1337.969701	14.13672	14.58397	12.22268	14.7576	0	13.95082	0	12.18394	12.45508	13.27571	0	0	11.28516	14.87573	11.09453	16.40505	15.1228	15.03979	0	15.41816	0	0	0	15.02811	0	0	0	0	0	0	0	0	15.26621	0	0	0	0	0	0	0	14.70004	0	0	0	15.26497	0	0	0
Q96QA5	GSDMA_HUMAN	"Gasdermin-A (Gasdermin-1) [Cleaved into: Gasdermin-A, N-terminal, GSDMA-NT; Gasdermin-A, C-terminal, GSDMA-CT ]"	GSDMA GSDM GSDM1 FKSG9	Homo sapiens (Human)	apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269]"	"phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]"	GO:0001786; GO:0005546; GO:0005829; GO:0005886; GO:0006915; GO:0016021; GO:0042742; GO:0048471; GO:0070269; GO:0070273	ILPVQLK	14.39000034	1	1	0.261473407	809.073767	15.17047	14.82151	15.42255	0	0	0	14.82938	16.8684	16.10645	17.41371	15.50445	0	15.2841	0	14.887	0	15.88653	15.84397	0	0	17.02397	0	0	0	0	16.11577	15.36704	16.34404	16.06059	14.54767	15.64726	16.45028	0	16.42324	16.76957	16.108	16.3609	14.38957	16.07912	16.39379	15.96806	17.08376	15.21392	14.26992	16.36437	16.09246	15.53593	15.70308
Q96QA6	YPEL2_HUMAN	Protein yippee-like 2	YPEL2 FKSG4	Homo sapiens (Human)		nucleolus [GO:0005730]	nucleolus [GO:0005730]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005730; GO:0046872	MVKMTR	7.150000095	0.08313293	0.08313293	0.196908387	767.5685931	14.32317	15.97274	16.40852	11.66987	15.26457	0	15.14097	0	17.28928	0	16.87769	14.69213	16.13582	14.56161	14.48396	14.49044	16.45898	15.30522	14.83771	15.16352	0	0	0	0	0	16.01813	17.02914	0	0	0	0	0	0	16.05599	0	16.17824	0	0	0	16.31844	16.50099	0	15.85054	0	13.00708	0	0	0
Q96QB1	RHG07_HUMAN	"Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein, DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12, StARD12) (StAR-related lipid transfer protein 12)"	DLC1 ARHGAP7 KIAA1723 STARD12	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; heart morphogenesis [GO:0003007]; hindbrain morphogenesis [GO:0021575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]	caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; SH2 domain binding [GO:0042169]; actin cytoskeleton organization [GO:0030036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; heart morphogenesis [GO:0003007]; hindbrain morphogenesis [GO:0021575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; SH2 domain binding [GO:0042169]	GO:0001843; GO:0003007; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005901; GO:0005925; GO:0006915; GO:0006919; GO:0007165; GO:0008285; GO:0008289; GO:0008360; GO:0021575; GO:0030036; GO:0030336; GO:0030864; GO:0030900; GO:0032587; GO:0032956; GO:0035023; GO:0035024; GO:0035307; GO:0042169; GO:0045121; GO:0048041; GO:0051056; GO:0051497; GO:0051895; GO:1900119	AAIMLLPDENR	19.85000038	1	1	4.60E-13	1258.626192	0	0	16.61085	0	0	0	17.04376	0	15.21558	0	17.26593	16.84706	14.9153	0	0	0	0	0	0	0	11.40563	0	0	0	0	16.04561	0	0	0	0	15.80042	0	0	0	16.37955	0	0	0	18.93546	0	0	0	0	0	0	0	14.41468	0
Q96QC0	PP1RA_HUMAN	Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53) (PP1-binding protein of 114 kDa) (Phosphatase 1 nuclear targeting subunit) (Protein FB19) (p99)	PPP1R10 CAT53 FB19 PNUTS	Homo sapiens (Human)	negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitotic DNA damage checkpoint [GO:1904290]; positive regulation of telomere maintenance [GO:0032206]; protein import into nucleus [GO:0006606]	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitotic DNA damage checkpoint [GO:1904290]; positive regulation of telomere maintenance [GO:0032206]; protein import into nucleus [GO:0006606]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]	GO:0000785; GO:0003677; GO:0003723; GO:0004864; GO:0005634; GO:0005654; GO:0006606; GO:0008157; GO:0010667; GO:0016604; GO:0032206; GO:0046872; GO:0072357; GO:1904290	QNNTAK	5.320000172	0.844044089	0.844044089	0.269981263	674.8529554	0	15.57357	16.04737	13.74294	14.76681	15.06324	0	0	15.50691	0	15.4062	0	0	0	0	16.58972	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.27598	0	0	16.14048	17.56663	17.1784	0	0	15.74081	15.51523	16.19266	16.59327	0	0	0	16.00377
Q96QD5	DEPD7_HUMAN	DEP domain-containing protein 7 (Protein TR2/D15)	DEPDC7	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]		intracellular signal transduction [GO:0035556]		GO:0035556	IPGTLHK	2.049999952	1	1	0.208259085	769.0700886	0	0	15.47424	0	0	17.09802	18.36761	17.57894	0	15.92786	0	0	0	0	15.90234	0	0	0	0	17.1475	14.63574	17.42758	0	0	17.67481	14.11453	16.57774	14.61055	15.97589	17.45743	16.2429	17.96744	14.3224	0	0	18.17268	17.24682	14.96025	15.77249	0	0	0	0	0	15.37436	15.61692	15.94463	0
Q96QD9	UIF_HUMAN	"UAP56-interacting factor (Forty-two-three domain-containing protein 1, Protein 40-2-3)"	FYTTD1 UIF	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005654; GO:0006406; GO:0016607	KPVAVLK	13.40999985	0.037499353	0.037499353	0.280994037	755.0851453	0	20.31639	16.927	19.86914	19.25495	19.2655	17.21632	18.67763	18.6448	16.65535	17.8625	0	0	0	18.73158	18.27101	18.34772	19.71863	16.77194	18.15162	0	17.3574	17.21962	18.54938	0	18.04258	0	19.19054	0	16.38181	18.48337	0	19.47049	18.95554	0	19.11049	19.93559	18.88806	19.49958	0	17.04444	0	20.78625	0	0	0	0	0
Q96QE3	ATAD5_HUMAN	ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein)	ATAD5 C17orf41 FRAG1	Homo sapiens (Human)	cell population proliferation [GO:0008283]; DNA clamp unloading [GO:0090618]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]; cell population proliferation [GO:0008283]; DNA clamp unloading [GO:0090618]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]	GO:0003677; GO:0005524; GO:0005634; GO:0008283; GO:0016887; GO:0030890; GO:0031391; GO:0033260; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:0090305; GO:0090618; GO:1901990; GO:1902166; GO:1902751	DVGAEEPSR	9.430000305	0.948831499	0.948831499	0.136675461	959.4513545	12.13262	16.74454	0	0	0	0	14.1172	13.79566	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.63451	15.55705	16.36979	14.43863	0	0	16.36476	15.85038	16.15985	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96QF7	GCNA_HUMAN	Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear acidic peptidase) (Germ cell nuclear antigen)	GCNA ACRC	Homo sapiens (Human)	protein-DNA covalent cross-linking repair [GO:0106300]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; SUMO polymer binding [GO:0032184]; protein-DNA covalent cross-linking repair [GO:0106300]	SUMO polymer binding [GO:0032184]	GO:0005634; GO:0005654; GO:0016605; GO:0032184; GO:0106300	NIVEPPR	8.210000038	1	1	0.577516412	825.1011914	16.41937	16.06354	11.64303	0	0	0	0	0	0	0	0	0	17.86439	18.06541	0	0	0	0	0	0	0	0	17.57198	18.75411	0	0	0	0	0	0	0	0	0	0	18.77893	0	0	0	20.45382	0	17.48229	0	0	0	0	16.8159	17.54427	0
Q96QG7	MTMR9_HUMAN	Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9)	MTMR9 C8orf9 MTMR8	Homo sapiens (Human)	endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]	enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]	GO:0004438; GO:0005737; GO:0005783; GO:0005829; GO:0006897; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304	FVGSLGTIIIK	3.160000086	1	1	0.179796552	1148.513915	15.60763	17.59542	16.64774	0	0	15.99961	0	0	12.50002	19.23779	0	0	8.012565	13.20444	0	0	0	0	0	0	0	12.13754	15.47597	0	0	0	0	12.23894	0	0	0	13.13483	0	0	15.57218	0	0	0	0	0	16.05877	16.64377	15.11244	0	14.77589	0	0	15.04326
Q96QH2	PRAM_HUMAN	"PML-RARA-regulated adapter molecule 1, PRAM, PRAM-1"	PRAM1	Homo sapiens (Human)	integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; regulation of neutrophil degranulation [GO:0043313]; T cell receptor signaling pathway [GO:0050852]	plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; regulation of neutrophil degranulation [GO:0043313]; T cell receptor signaling pathway [GO:0050852]	lipid binding [GO:0008289]; protein kinase binding [GO:0019901]	GO:0005886; GO:0007229; GO:0008289; GO:0019901; GO:0032991; GO:0043313; GO:0050852; GO:0072659	KPLQPEVGEAPLK	1.480000019	1	1	0.261996248	1405.710197	0	0	14.66115	0	0	0	0	12.49068	15.46224	0	0	0	14.98908	0	0	12.18364	14.08859	16.13646	0	0	0	0	0	0	16.16634	15.19791	0	0	0	0	0	16.12564	0	12.88498	9.845115	0	0	0	0	0	0	0	0	0	0	15.90936	0	15.60155
Q96QK1	VPS35_HUMAN	"Vacuolar protein sorting-associated protein 35, hVPS35 (Maternal-embryonic 3) (Vesicle protein sorting 35)"	VPS35 MEM3 TCCCTA00141	Homo sapiens (Human)	"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]"	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]"	D1 dopamine receptor binding [GO:0031748]	GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0007416; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016055; GO:0016241; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032268; GO:0032456; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0060548; GO:0061357; GO:0070062; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903364; GO:1903828; GO:1905166; GO:1905606; GO:2000331	AELAELPLR	7.349999905	1	1	0.187229781	1011.769652	12.18815	15.53622	15.94501	12.63443	0	0	14.48815	14.46837	15.07862	12.80299	15.4097	16.54626	0	0	0	0	0	0	15.62127	0	0	0	0	0	0	14.89083	0	0	0	0	0	0	0	0	0	0	14.94674	0	0	0	0	0	0	0	15.25379	0	0	14.81779
Q96QT4	TRPM7_HUMAN	"Transient receptor potential cation channel subfamily M member 7, EC 2.7.11.1 (Channel-kinase 1) (Long transient receptor potential channel 7, LTrpC-7, LTrpC7)"	TRPM7 CHAK1 LTRPC7	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-matrix adhesion [GO:0016340]; cation transmembrane transport [GO:0098655]; cellular magnesium ion homeostasis [GO:0010961]; divalent inorganic cation homeostasis [GO:0072507]; necroptotic process [GO:0070266]; protein autophosphorylation [GO:0046777]; protein tetramerization [GO:0051262]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actomyosin structure organization [GO:0031032]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-matrix adhesion [GO:0016340]; cation transmembrane transport [GO:0098655]; cellular magnesium ion homeostasis [GO:0010961]; divalent inorganic cation homeostasis [GO:0072507]; necroptotic process [GO:0070266]; protein autophosphorylation [GO:0046777]; protein tetramerization [GO:0051262]	actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001726; GO:0003779; GO:0004674; GO:0004712; GO:0005261; GO:0005262; GO:0005524; GO:0005886; GO:0005887; GO:0006816; GO:0010961; GO:0016340; GO:0017022; GO:0031032; GO:0046777; GO:0046872; GO:0051262; GO:0070266; GO:0070588; GO:0072507; GO:0098655; GO:0106310	DQETVCSK	1.350000024	1	1	0.296373578	966.9185887	0	0	0	0	0	17.86707	0	0	0	17.99039	0	0	0	0	0	0	0	0	0	0	16.67174	0	0	0	0	0	0	0	0	15.9694	0	0	0	0	0	0	0	0	0	0	0	0	17.12903	0	0	0	0	0
Q96QU1	PCD15_HUMAN	Protocadherin-15	PCDH15 USH1F	Homo sapiens (Human)	cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; synapse [GO:0045202]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]	calcium ion binding [GO:0005509]	GO:0001750; GO:0005509; GO:0005576; GO:0005615; GO:0005887; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0045202; GO:0045494; GO:0048839; GO:0050953; GO:0050957	SAHVDGSLK	6.639999866	0.07869149	0.07869149	0.208690683	913.4163444	0	12.97594	12.40551	16.19627	0	13.54062	0	0	15.40604	15.59498	14.20981	0	0	15.14729	0	0	14.51784	0	0	0	0	0	0	0	0	0	15.53236	0	16.2377	15.46897	16.25596	0	0	15.01752	16.03453	0	0	16.09384	0	0	0	0	0	15.98061	0	0	0	0
Q96QU6	1A1L1_HUMAN	"1-aminocyclopropane-1-carboxylate synthase-like protein 1, ACC synthase-like protein 1"	ACCS PHACS	Homo sapiens (Human)	biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]		identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]	identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]	GO:0006520; GO:0008483; GO:0009058; GO:0030170; GO:0042802	SVLSLER	9.609999657	0.510819435	0.510819435	0.231748504	805.36389	13.58397	15.31091	16.00128	15.49771	14.42431	15.20693	15.01503	12.89026	14.74314	15.09963	0	14.60554	13.34744	16.12436	13.75307	0	16.15026	0	15.17577	16.00851	0	16.75197	14.7994	15.71471	0	15.05358	15.40603	0	16.73272	0	0	15.72703	0	16.23322	0	0	0	15.82407	0	0	0	15.86656	0	0	15.7553	15.76265	0	0
Q96QV1	HHIP_HUMAN	"Hedgehog-interacting protein, HHIP, HIP"	HHIP HIP UNQ5825/PRO19644	Homo sapiens (Human)	dorsal/ventral pattern formation [GO:0009953]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of apoptotic process [GO:0043066]; negative regulation of signal transduction [GO:0009968]; negative regulation of smoothened signaling pathway [GO:0045879]; neuroblast proliferation [GO:0007405]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]	cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]	cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; catalytic activity [GO:0003824]; hedgehog family protein binding [GO:0097108]; zinc ion binding [GO:0008270]; dorsal/ventral pattern formation [GO:0009953]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of apoptotic process [GO:0043066]; negative regulation of signal transduction [GO:0009968]; negative regulation of smoothened signaling pathway [GO:0045879]; neuroblast proliferation [GO:0007405]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]	catalytic activity [GO:0003824]; hedgehog family protein binding [GO:0097108]; zinc ion binding [GO:0008270]	GO:0003824; GO:0005576; GO:0005634; GO:0005737; GO:0005887; GO:0007165; GO:0007405; GO:0008270; GO:0009953; GO:0009968; GO:0009986; GO:0040036; GO:0043066; GO:0045879; GO:0048705; GO:0060170; GO:0060441; GO:0097108	CAVDRHPTDININLTILCSDSNGK	5.380000114	0.080236688	0.080236688	0.281837566	2714.16361	0	17.40583	16.09467	0	16.03017	0	0	0	16.16342	0	0	16.60884	15.86033	15.98932	15.68014	0	0	0	0	0	0	0	15.48837	0	0	16.24295	16.96802	15.57755	0	15.95668	0	0	0	0	16.23026	0	0	0	0	0	0	17.04696	0	15.60138	0	18.70544	15.5892	0
Q96QZ7	MAGI1_HUMAN	"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (Atrophin-1-interacting protein 3, AIP-3) (BAI1-associated protein 1, BAP-1) (Membrane-associated guanylate kinase inverted 1, MAGI-1) (Trinucleotide repeat-containing gene 19 protein) (WW domain-containing protein 3, WWP3)"	MAGI1 AIP3 BAIAP1 BAP1 TNRC19	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell-cell adhesion [GO:0022409]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell-cell adhesion [GO:0022409]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165]	alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]	GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007155; GO:0007165; GO:0007166; GO:0008022; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0060090; GO:0065003; GO:0071944	GGLPVPK	3.450000048	0.067223087	0.067223087	0.226060754	666.4287392	17.2583	10.91641	13.89048	16.78679	0	12.99866	0	0	15.82559	0	17.16351	0	0	0	0	15.79115	0	10.38391	15.94221	15.85699	0	14.38509	0	15.43384	16.37197	0	16.25661	0	0	0	0	0	0	16.94894	0	0	0	0	0	0	17.5541	0	0	0	0	15.9712	0	0
Q96R06	SPAG5_HUMAN	"Sperm-associated antigen 5 (Astrin) (Deepest) (Mitotic spindle-associated protein p126, MAP126)"	SPAG5	Homo sapiens (Human)	cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of metaphase plate congression [GO:0090235]; spindle organization [GO:0007051]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of metaphase plate congression [GO:0090235]; spindle organization [GO:0007051]	microtubule binding [GO:0008017]	GO:0000070; GO:0000776; GO:0005737; GO:0005829; GO:0007051; GO:0007059; GO:0008017; GO:0016604; GO:0030496; GO:0032388; GO:0034451; GO:0035371; GO:0051301; GO:0051988; GO:0071539; GO:0072686; GO:0090235; GO:0097431; GO:1905832	EEVAPCMGDR	3.819999933	1	1	0.103720552	1180.418688	13.40816	0	0	0	14.497	15.93245	0	0	12.17503	0	0	0	0	0	0	14.05974	0	0	0	11.29303	0	0	14.3622	0	0	0	0	11.71188	0	10.99039	0	0	0	0	15.3593	0	0	0	0	0	12.54766	0	0	0	0	0	12.32621	0
Q96R08	OR5BC_HUMAN	Olfactory receptor 5B12 (Olfactory receptor 5B16) (Olfactory receptor OR11-241)	OR5B12 OR5B12P OR5B16	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021	SPEGR	9.550000191	1	1	0.341033829	546.915001	16.73036	15.85777	0	0	0	0	0	16.73835	17.12585	0	16.38834	0	0	0	17.31344	0	16.30392	17.44203	0	0	0	17.11591	17.6125	17.13396	0	17.28076	0	16.48783	0	0	0	17.25404	17.76729	0	15.95784	0	0	0	0	17.92294	17.7703	0	0	18.07381	16.75058	0	17.50575	0
Q96RG2	PASK_HUMAN	"PAS domain-containing serine/threonine-protein kinase, PAS-kinase, PASKIN, hPASK, EC 2.7.11.1"	PASK KIAA0135	Homo sapiens (Human)	energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0045727; GO:0046777; GO:0070092; GO:0097009; GO:0106310	DQQITALGREEPVAIESPGQDLLGESR	8.31000042	0.664814115	0.664814115	6.86E-12	2908.39857	13.24535	14.8387	0	0	15.50169	0	0	0	0	0	15.41539	0	0	0	0	0	0	0	0	0	0	0	0	13.90691	8.919384	0	0	0	0	0	15.07672	14.83089	16.51787	15.2293	0	19.14079	0	0	10.97441	0	0	0	0	0	0	0	0	0
Q96RJ6	FER3L_HUMAN	"Fer3-like protein (Basic helix-loop-helix protein N-twist) (Class A basic helix-loop-helix protein 31, bHLHa31) (Nephew of atonal 3) (Neuronal twist)"	FERD3L BHLHA31 NATO3 NTWIST	Homo sapiens (Human)	"cell development [GO:0048468]; developmental process [GO:0032502]; floor plate development [GO:0033504]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; developmental process [GO:0032502]; floor plate development [GO:0033504]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032502; GO:0033504; GO:0045892; GO:0046983; GO:0048468; GO:0050767; GO:1990837	GVSLLGRPK	13.06999969	0.787758887	0.787758887	0.192298867	926.4113676	0	0	16.18424	0	15.04028	16.29918	15.58239	0	16.6819	15.09485	0	16.52567	14.68413	0	16.65582	0	15.14446	15.50371	0	0	15.58534	0	0	16.7161	15.8273	15.83658	15.64937	0	15.67007	14.76837	16.97304	15.71592	16.94936	15.82946	14.69007	0	0	0	15.02391	0	17.09263	16.01009	0	16.25268	0	0	0	0
Q96RK0	CIC_HUMAN	Protein capicua homolog	CIC KIAA0306	Homo sapiens (Human)	"brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]"	chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0007420; GO:0007612; GO:0007613; GO:0035176; GO:0043231; GO:0045892	AHPDWK	2.539999962	0.000907103	0.000907103	0.278959772	754.3144531	16.5576	0	0	15.77753	0	16.8754	15.8968	0	0	0	0	0	0	0	0	0	0	0	0	0	17.88278	17.49589	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96RK4	BBS4_HUMAN	Bardet-Biedl syndrome 4 protein	BBS4	Homo sapiens (Human)	adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]	BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]	alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]	GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010629; GO:0015031; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034260; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:1902855; GO:1903546; GO:1905515	VSLLKDNSSLEFDSEMVEMAQK	4.110000134	1	1	0.214928613	2532.409324	0	0	0	10.12517	9.894779	12.11235	0	0	13.12007	11.01571	0	0	15.8751	0	12.57012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96RL7	VP13A_HUMAN	Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein) (Chorein) (Vacuolar protein sorting-associated protein 13A)	VPS13A CHAC KIAA0986	Homo sapiens (Human)	autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; Golgi to endosome transport [GO:0006895]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225]; autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; Golgi to endosome transport [GO:0006895]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382]		GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0006623; GO:0006895; GO:0006914; GO:0007399; GO:0007626; GO:0008104; GO:0010008; GO:0019898; GO:0030317; GO:0030382; GO:0031966; GO:0035176; GO:0045053; GO:0097225; GO:0099013; GO:1905146	ADGIHR	8.890000343	1	1	0.305683016	667.7498827	18.49546	18.59407	16.85027	0	17.91345	0	0	0	16.57388	0	15.62307	0	0	16.84011	0	0	0	0	17.71932	0	0	17.79827	17.9369	0	18.53526	0	0	0	0	0	0	16.77077	0	18.98648	0	18.50257	0	0	16.31712	0	17.16631	0	0	16.59169	0	18.65963	0	0
Q96RN1	S26A8_HUMAN	Testis anion transporter 1 (Anion exchange transporter) (Solute carrier family 26 member 8)	SLC26A8 TAT1	Homo sapiens (Human)	anion transport [GO:0006820]; chloride transport [GO:0006821]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oxalate transport [GO:0019532]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; anion transport [GO:0006820]; chloride transport [GO:0006821]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oxalate transport [GO:0019532]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]	anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005254; GO:0005886; GO:0005887; GO:0006820; GO:0006821; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0019531; GO:0019532; GO:0030317; GO:0048240; GO:0051321	AQLERSAISGFSSK	2.980000019	1	1	0.086437835	1481.609317	14.22247	15.93213	0	0	14.82129	12.2498	0	0	0	0	0	0	0	0	13.89064	11.00988	0	0	0	0	15.88099	10.95688	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96RN5	MED15_HUMAN	"Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component, ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein, PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein, TIG-1) (Trinucleotide repeat-containing gene 7 protein)"	MED15 ARC105 CTG7A PCQAP TIG1 TNRC7	Homo sapiens (Human)	positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]	core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827]	transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016592; GO:0019827; GO:0032968; GO:0051123; GO:0060261; GO:0070847	DIHNKK	9.819999695	1	1	0.043596544	754.4759413	11.14231	15.20116	12.50403	14.0428	16.92606	0	11.27378	0	15.08904	14.7549	0	11.00718	0	0	0	0	16.46969	0	0	0	0	0	0	0	0	0	0	0	17.1048	0	0	0	0	0	0	0	0	0	0	0	0	16.79213	0	0	0	0	16.42841	0
Q96RP9	EFGM_HUMAN	"Elongation factor G, mitochondrial, EF-Gmt (Elongation factor G 1, mitochondrial, mEF-G 1) (Elongation factor G1, hEFG1)"	GFM1 EFG EFG1 GFM	Homo sapiens (Human)	mitochondrial translational elongation [GO:0070125]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005759; GO:0070125	FVLQDGAHHMVDSNEISFIR	5.78000021	0.692224503	0.692224503	0.043368459	2329.930365	16.39815	13.65814	0	0	15.1069	0	0	13.49265	14.76931	14.67626	16.03262	0	13.27497	0	0	14.04444	16.67069	13.29428	0	0	11.11206	0	17.00082	14.28784	16.85775	0	0	0	10.45704	15.12459	15.60628	16.61116	14.26531	0	16.75977	0	13.38046	15.84953	15.39929	15.0996	15.46471	11.71917	15.33525	0	14.16784	11.93472	15.29408	0
Q96RQ3	MCCA_HUMAN	"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial, MCCase subunit alpha, EC 6.4.1.4 (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)"	MCCC1 MCCA	Homo sapiens (Human)	biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]"	"3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]"	ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202	EGAQANR	3.25999999	1	1	0.096345899	745.1622289	0	14.55389	0	0	0	14.10566	0	0	0	0	0	15.53908	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.98219	0	15.01819	0	15.35862	0	0	0	0	14.70534	0	14.12871	0	0	0	0	0	0	0	14.56664	0	0
Q96RQ9	OXLA_HUMAN	"L-amino-acid oxidase, LAAO, LAO, EC 1.4.3.2, EC 1.4.3.25 (Interleukin-4-induced protein 1, IL4-induced protein 1, hIL4I1) (Protein Fig-1, hFIG1)"	IL4I1 FIG1 UNQ636/PRO1265	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cellular amino acid catabolic process [GO:0009063]; L-phenylalanine catabolic process [GO:0006559]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell differentiation [GO:0045577]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to indole-3-acetate [GO:0019440]; tyrosine catabolic process [GO:0006572]	acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; sperm midpiece [GO:0097225]	acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; sperm midpiece [GO:0097225]; L-amino-acid oxidase activity [GO:0001716]; L-phenylalaine oxidase activity [GO:0106329]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; adaptive immune response [GO:0002250]; cellular amino acid catabolic process [GO:0009063]; L-phenylalanine catabolic process [GO:0006559]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell differentiation [GO:0045577]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to indole-3-acetate [GO:0019440]; tyrosine catabolic process [GO:0006572]	L-amino-acid oxidase activity [GO:0001716]; L-phenylalaine oxidase activity [GO:0106329]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]	GO:0001669; GO:0001716; GO:0001772; GO:0002250; GO:0002819; GO:0002841; GO:0005576; GO:0005764; GO:0006559; GO:0006569; GO:0006572; GO:0009063; GO:0016491; GO:0019440; GO:0042130; GO:0045577; GO:0045591; GO:0045944; GO:0046592; GO:0050868; GO:0097225; GO:0106329	DQNTGWIGELGAMR	3.50999999	0.745299101	0.745299101	1.83E-12	1560.945427	0	0	0	16.02733	0	10.13715	13.45659	14.2183	0	0	0	15.07978	14.72212	0	13.90612	0	12.4409	0	0	13.22606	16.81295	15.14803	14.62738	0	0	14.38526	0	11.95991	0	16.28201	9.281772	14.24986	0	0	0	13.32256	14.31382	16.84454	14.65702	0	14.34494	0	0	15.88293	0	13.22132	14.44812	17.92929
Q96RR1	PEO1_HUMAN	"Twinkle mtDNA helicase, EC 3.6.4.12 (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)"	TWNK C10orf2 PEO1	Homo sapiens (Human)	cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]; cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]	GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005759; GO:0006264; GO:0006268; GO:0006390; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333	LVTGPGK	9.210000038	0.591022015	0.591022015	0.061752726	671.6111954	15.70056	16.31119	0	15.91393	0	0	15.09916	11.97528	13.77825	0	16.59989	14.29872	12.83001	15.18396	0	0	12.6501	12.68561	0	14.27297	0	13.08539	15.07582	0	15.98958	15.81273	15.95341	0	13.5602	0	15.52721	17.2032	0	0	14.93792	0	16.79572	15.43298	0	14.76706	16.26691	16.46478	15.40903	14.35938	16.57383	0	15.45235	15.52317
Q96RR4	KKCC2_HUMAN	"Calcium/calmodulin-dependent protein kinase kinase 2, CaM-KK 2, CaM-kinase kinase 2, CaMKK 2, EC 2.7.11.17 (Calcium/calmodulin-dependent protein kinase kinase beta, CaM-KK beta, CaM-kinase kinase beta, CaMKK beta)"	CAMKK2 CAMKKB KIAA0787	Homo sapiens (Human)	"calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]"	cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]"	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0000165; GO:0001934; GO:0004683; GO:0004712; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0019722; GO:0034614; GO:0043005; GO:0045859; GO:0045893; GO:0046777; GO:0061762; GO:0106310; GO:1903599	RQPPGHRPAPR	3.440000057	1	1	1.37E-12	1269.028359	10.98062	13.95328	15.28281	9.27204	6.496202	15.85831	13.79899	11.34265	11.98254	13.61245	11.80385	0	0	10.0169	0	0	0	0	0	0	0	0	0	0	14.03988	0	14.50357	0	0	0	0	0	0	0	13.50944	0	13.84489	0	0	12.66824	0	0	0	0	0	0	0	0
Q96RS6	NUDC1_HUMAN	NudC domain-containing protein 1 (Chronic myelogenous leukemia tumor antigen 66) (Tumor antigen CML66)	NUDCD1 CML66	Homo sapiens (Human)	immune system process [GO:0002376]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; immune system process [GO:0002376]		GO:0002376; GO:0005654; GO:0005829	ESNSLEISLIK	3.74000001	1	1	6.86E-13	1233.784818	0	0	13.06576	14.93418	0	0	0	0	13.63858	14.41376	16.07081	14.62479	16.88667	0	12.51128	0	0	0	0	15.23038	0	0	16.51826	0	0	15.21508	0	0	0	0	0	15.34036	0	14.65071	0	0	0	0	13.82399	0	14.69724	0	0	0	0	0	13.57676	0
Q96RT1	ERBIN_HUMAN	Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2)	ERBIN ERBB2IP KIAA1225 LAP2	Homo sapiens (Human)	basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; positive regulation of Ras protein signal transduction [GO:0046579]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165]	basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; positive regulation of Ras protein signal transduction [GO:0046579]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165]	ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]	GO:0005102; GO:0005176; GO:0005200; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0006605; GO:0007155; GO:0007165; GO:0007173; GO:0007229; GO:0009925; GO:0016323; GO:0016607; GO:0030054; GO:0030056; GO:0031965; GO:0032088; GO:0032495; GO:0032496; GO:0045104; GO:0045175; GO:0045197; GO:0046579; GO:0070433; GO:0071356; GO:0071638; GO:0098794; GO:0098978; GO:0099072	HIEAKK	4.630000114	0.358743131	0.358743131	0.305874074	724.6920008	16.13137	15.77234	15.19372	12.82301	15.33523	14.19137	15.27038	0	9.881262	14.50461	0	16.86325	14.72575	15.39606	17.00359	14.84798	14.97276	0	14.8843	15.3043	0	16.18277	16.01595	16.98275	15.27336	16.31222	0	0	0	15.85604	16.99117	14.75816	0	17.11351	0	0	14.66174	14.28981	15.34387	16.57476	0	0	0	16.20553	0	15.88365	15.71196	16.38605
Q96RT6	CTGE2_HUMAN	"cTAGE family member 2, Protein cTAGE-2 (Cancer/testis antigen 21.2, CT21.2)"	CTAGE1 CTAGE2	Homo sapiens (Human)	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]		GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971	SFNMPSLDK	5.829999924	1	1	0.111392974	1040.784977	15.26548	15.79167	15.05122	16.28523	16.7243	16.27213	15.93737	17.95631	15.79134	16.61292	18.65613	12.48734	16.25355	10.75951	15.07442	16.03095	15.98283	0	0	13.38738	0	16.97792	15.27508	15.43223	16.59374	16.59237	0	0	15.87217	12.58646	13.79294	15.91653	16.71986	17.29678	15.84086	13.74419	16.65074	16.11854	16.55622	18.50599	16.03995	15.01472	16.43048	0	0	15.52485	0	15.06931
Q96RT7	GCP6_HUMAN	"Gamma-tubulin complex component 6, GCP-6"	TUBGCP6 GCP6 KIAA1669	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321	VAYNALFTNLFQDETQQLQPDMSK	3.710000038	1	1	4.58E-12	2817.864039	14.79089	13.54546	12.40839	7.565321	0	0	11.91343	14.50856	0	10.95154	13.96026	0	13.50575	10.972	0	11.46082	0	0	0	0	0	0	16.95701	12.49467	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96RT8	GCP5_HUMAN	"Gamma-tubulin complex component 5, GCP-5"	TUBGCP5 GCP5 KIAA1899	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; microtubule [GO:0005874]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0031122; GO:0043015; GO:0051225; GO:0051321	EDSGIQVDR	4.360000134	0.73765415	0.73765415	0.214626967	1020.099057	15.18769	14.32119	15.76901	0	14.10661	15.96028	0	0	14.90496	15.31868	14.11565	0	14.73929	14.13966	14.48416	0	0	13.40203	10.26766	0	0	0	16.20248	0	14.57754	14.95861	0	13.61829	14.29985	13.47078	13.93451	13.29389	15.95114	15.54482	14.12583	0	0	12.77248	0	16.7018	15.19198	15.09867	13.86844	0	15.82347	14.75663	0	11.81223
Q96RU8	TRIB1_HUMAN	"Tribbles homolog 1, TRB-1 (G-protein-coupled receptor-induced gene 2 protein, GIG-2) (SKIP1)"	TRIB1 C8FW GIG2 TRB1	Homo sapiens (Human)	JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496]	mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]	GO:0004860; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0007254; GO:0014912; GO:0031434; GO:0031625; GO:0031665; GO:0032436; GO:0032496; GO:0043405; GO:0043433; GO:0045645; GO:0045651; GO:0045659; GO:0048662; GO:0055106; GO:0061629	IADYLLLPLAER	8.050000191	1	1	0.017824164	1385.873234	16.78188	16.58784	16.72416	18.27604	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96RV3	PCX1_HUMAN	Pecanex-like protein 1 (Pecanex homolog protein 1)	PCNX1 KIAA0805 KIAA0995 PCNX PCNXL1	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	LKAGR	2.880000114	1	1	0.278004211	543.2485563	0	20.5731	17.36781	16.51984	0	17.26852	18.95025	18.76805	0	17.05386	0	0	0	0	0	0	17.52077	0	0	0	0	0	18.31536	0	0	0	0	0	18.28863	0	0	0	0	0	0	0	0	0	0	0	0	0	17.98711	0	0	16.56304	0	16.55676
Q96RW7	HMCN1_HUMAN	"Hemicentin-1 (Fibulin-6, FIBL-6)"	HMCN1 FIBL6	Homo sapiens (Human)	actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]	adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527	AIVESIR	2.630000114	1	1	0.260429502	788.8506133	0	0	0	0	0	0	18.75312	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.4004	20.82538	0	0	0	0	0	0	0	0	18.55664	0	0	21.84766	0	18.02425	0	0	0	0	0	0	0
Q96RY5	CRML_HUMAN	Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein)	CRAMP1 C16orf34 CRAMP1L HN1L KIAA1426	Homo sapiens (Human)	pattern specification process [GO:0007389]	nucleus [GO:0005634]	nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; pattern specification process [GO:0007389]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	GO:0003677; GO:0003682; GO:0005634; GO:0007389	CPRSGAEGK	7.46999979	0.490418285	0.490418285	0.070337271	960.8222059	0	0	0	0	0	0	0	16.03264	16.52279	0	0	0	12.612	0	16.93018	16.84417	16.36393	17.33912	17.84674	0	0	17.33586	18.18736	17.51948	17.14404	0	0	0	0	0	0	0	16.11242	0	17.11288	17.57797	0	0	14.28873	0	0	0	0	0	15.40512	16.46831	0	0
Q96RY7	IF140_HUMAN	Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2)	IFT140 KIAA0590 WDTC2	Homo sapiens (Human)	cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]	axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]		GO:0001750; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097542; GO:1902017; GO:1905515; GO:1990403	GRVAMWR	12.39000034	1	1	0.155691551	890.5283628	0	0	0	16.29333	18.77903	0	0	0	14.09124	14.4964	0	0	14.70416	15.08313	0	0	13.0245	16.99046	0	0	0	0	0	13.93243	0	16.66434	0	0	0	0	0	0	15.95499	0	18.58183	16.80708	0	0	0	13.94795	0	0	0	15.68536	0	0	0	0
Q96S07	PRR25_HUMAN	Proline-rich protein 25	PRR25 gs64	Homo sapiens (Human)						APSHK	4.239999771	0.303009421	0.303009421	0.18895109	539.3587027	0	17.40725	16.85532	0	19.07813	0	0	17.12169	0	16.02677	16.48391	0	19.31361	17.90567	0	0	17.54667	0	16.38752	17.40187	16.6707	17.49533	17.98218	17.00245	17.92808	16.27794	17.94334	16.12704	16.70947	16.59599	18.2582	18.23448	16.19765	16.0168	16.14469	16.94123	15.85575	17.5268	16.33521	0	18.86763	0	0	16.80551	17.13024	18.04294	17.50832	16.20423
Q96S19	MTL26_HUMAN	Methyltransferase-like 26	METTL26 JFP2 C16orf13	Homo sapiens (Human)						LVAAAAERNK	13.21000004	1	1	0.23028507	1041.821052	0	16.61744	0	0	15.58078	15.47421	18.31667	0	0	16.76577	15.4719	0	17.18115	0	15.02533	0	16.47676	0	0	0	15.2772	0	0	0	0	17.50571	18.40803	0	16.67106	0	0	17.5364	0	0	0	17.66357	17.47519	16.75557	0	0	0	0	0	0	0	16.28529	15.05744	0
Q96S21	RB40C_HUMAN	Ras-related protein Rab-40C (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3)	RAB40C RARL RASL8C	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]	endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0072659	SFSMANGMNAVMMHGR	5.730000019	0.911000013	0.911000013	0.175734238	1740.977748	0	0	0	0	0	16.06022	0	0	0	0	0	0	0	0	0	6.11677	0	15.44072	0	0	0	0	16.57515	0	0	17.75695	0	0	0	0	0	0	0	16.51082	0	0	0	0	0	0	0	0	0	0	0	16.28316	15.92706	0
Q96S38	KS6C1_HUMAN	"Ribosomal protein S6 kinase delta-1, S6K-delta-1, EC 2.7.11.1 (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein)"	RPS6KC1 RPK118	Homo sapiens (Human)	signal transduction [GO:0007165]	early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]	early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0007165; GO:0016020; GO:0035091; GO:0106310	TEGNGVDTK	10.28999996	0.971950829	0.971950829	0.250906693	920.3631013	0	0	0	13.99242	15.55183	12.20423	0	17.58697	0	0	0	0	0	0	0	16.64551	0	0	0	13.65823	13.07855	0	13.70263	0	0	0	16.08714	15.27891	0	0	0	16.57946	16.01626	14.461	0	0	0	0	16.20814	0	0	15.44356	0	14.95887	0	0	0	0
Q96S55	WRIP1_HUMAN	"ATPase WRNIP1, EC 3.6.1.- (Werner helicase-interacting protein 1)"	WRNIP1 WHIP	Homo sapiens (Human)	DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA helicase activity [GO:0017116]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-dependent DNA replication initiation [GO:0030174]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA helicase activity [GO:0017116]	GO:0000731; GO:0003677; GO:0005524; GO:0005634; GO:0006261; GO:0006282; GO:0008047; GO:0016020; GO:0016887; GO:0017116; GO:0030174; GO:0042802; GO:0045087; GO:0046872; GO:0048471	SSSPGR	4.960000038	0.270875603	0.270875603	0.198796935	589.4431411	0	0	0	0	16.52182	0	18.04091	17.15721	12.29719	17.77265	17.82215	16.49366	21.08745	20.33983	20.53712	0	16.36317	18.92221	21.11167	21.07621	20.5849	20.36367	21.01041	0	20.36866	17.53742	20.22149	19.61874	17.38667	19.17567	18.71462	0	20.03448	20.19569	20.82879	18.9829	21.40565	20.28275	20.83413	17.15159	20.37288	19.70316	20.16759	0	17.61368	19.09914	17.40028	20.93467
Q96S59	RANB9_HUMAN	"Ran-binding protein 9, RanBP9 (BPM-L) (BPM90) (Ran-binding protein M, RanBPM) (RanBP7)"	RANBP9 RANBPM	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; protein-containing complex assembly [GO:0065003]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; enzyme binding [GO:0019899]; small GTPase binding [GO:0031267]; cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; protein-containing complex assembly [GO:0065003]	enzyme binding [GO:0019899]; small GTPase binding [GO:0031267]	GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007010; GO:0007020; GO:0007166; GO:0016604; GO:0019899; GO:0031267; GO:0065003; GO:0070373; GO:1902993	STDQTVLEELASIK	6.909999847	0.936648905	0.936648905	0.149359547	1537.101937	15.27952	14.32776	10.41399	14.45811	14.03985	13.87245	14.09305	12.78119	13.07953	11.81522	0	12.11851	10.99522	0	15.62578	15.29865	0	12.09602	14.21923	13.62428	15.24174	0	0	0	0	15.09571	0	15.33407	15.81475	12.51458	0	13.48117	0	0	0	0	0	15.3798	0	15.26056	15.02163	0	11.60947	0	0	0	13.56068	0
Q96S66	CLCC1_HUMAN	Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1)	CLCC1 KIAA0761 MCLC	Homo sapiens (Human)	chloride transport [GO:0006821]	chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nuclear membrane [GO:0031965]	chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nuclear membrane [GO:0031965]; chloride channel activity [GO:0005254]; chloride transport [GO:0006821]	chloride channel activity [GO:0005254]	GO:0000139; GO:0005254; GO:0005783; GO:0005789; GO:0006821; GO:0016020; GO:0031965; GO:0034707; GO:0043231; GO:0044233	LAFAQHQAEVAKMEPLNNVCAK	8.479999542	1	1	0.231356321	2484.502101	0	17.62841	0	0	16.97786	0	0	0	0	17.1471	14.65931	17.77365	0	0	0	18.061	0	0	18.15069	0	0	0	0	0	17.57191	19.41339	13.30984	0	0	0	0	0	18.11098	15.53786	16.56873	0	0	0	17.49703	0	0	0	0	0	0	0	13.74309	0
Q96S79	RSLAB_HUMAN	"Ras-like protein family member 10B, EC 3.6.5.2 (Ras-like protein VTS58635) (Ras-related protein 17, RRP17)"	RASL10B	Homo sapiens (Human)	positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]	G protein activity [GO:0003925]; GTP binding [GO:0005525]	GO:0003050; GO:0003925; GO:0005525; GO:0005886; GO:0090277	GVGKSAIVR	11.52999973	0.530512333	0.530512333	0.303017589	887.9032171	0	0	17.38903	0	0	0	0	0	0	18.04989	17.4973	17.04066	16.11793	18.17517	18.29242	0	0	17.33017	0	0	18.55495	0	0	18.29915	18.30184	0	18.63243	0	0	0	19.14858	18.86005	18.63622	0	16.36559	0	0	0	17.61594	0	15.47041	0	0	0	18.48289	0	0	19.34677
Q96S90	LYSM1_HUMAN	LysM and putative peptidoglycan-binding domain-containing protein 1	LYSMD1 SB145	Homo sapiens (Human)		nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]		GO:0005654	SYGSLVQSACSPVR	2.150000095	1	1	0.269300597	1510.350618	0	15.72773	13.42897	0	0	0	0	14.87053	0	0	15.39044	13.2282	0	0	15.32595	0	0	0	0	0	0	0	16.82746	15.50476	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96S94	CCNL2_HUMAN	Cyclin-L2 (Paneth cell-enhanced expression protein)	CCNL2 SB138	Homo sapiens (Human)	regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	GO:0000307; GO:0005634; GO:0005654; GO:0006357; GO:0016538; GO:0016607; GO:0042981; GO:0043231; GO:0043484; GO:0046605; GO:0051726	ADNPGK	18.65999985	1	1	4.60E-13	601.3613386	0	0	0	0	0	12.86339	0	0	14.98291	0	0	0	16.15667	0	0	0	0	15.44882	16.30536	0	0	0	0	0	0	0	0	0	14.87085	0	0	14.34394	0	13.00723	16.71574	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96S96	PEBP4_HUMAN	"Phosphatidylethanolamine-binding protein 4, PEBP-4, hPEBP4 (Protein cousin-of-RKIP 1)"	PEBP4 CORK1 UNQ1933/PRO4408	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]		GO:0070062	GADLKK	8.93999958	1	1	0.111527217	631.1762051	0	15.77912	15.5648	0	0	0	0	0	0	0	0	0	15.83311	0	0	0	0	15.12917	0	16.39205	0	0	0	0	16.11968	0	0	0	0	0	0	0	0	0	11.34912	15.47275	0	0	17.14627	0	0	0	17.77306	15.76693	17.34082	0	0	0
Q96S97	MYADM_HUMAN	Myeloid-associated differentiation marker (Protein SB135)	MYADM UNQ553/PRO1110	Homo sapiens (Human)	establishment of endothelial barrier [GO:0061028]; membrane raft organization [GO:0031579]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of protein kinase C signaling [GO:0090038]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]	cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; establishment of endothelial barrier [GO:0061028]; membrane raft organization [GO:0031579]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of protein kinase C signaling [GO:0090038]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane [GO:0072659]		GO:0001726; GO:0001933; GO:0005886; GO:0005911; GO:0010629; GO:0016021; GO:0030335; GO:0030837; GO:0030864; GO:0031579; GO:0034115; GO:0045121; GO:0061028; GO:0072659; GO:0090038; GO:1900026	DVSCSR	2.069999933	1	1	0.130294593	721.8006974	15.26962	14.79517	0	0	14.24597	0	0	13.93464	0	0	15.63505	11.09944	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.20454	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96S99	PKHF1_HUMAN	"Pleckstrin homology domain-containing family F member 1, PH domain-containing family F member 1 (Lysosome-associated apoptosis-inducing protein containing PH and FYVE domains, Apoptosis-inducing protein) (PH and FYVE domain-containing protein 1) (Phafin-1) (Zinc finger FYVE domain-containing protein 15)"	PLEKHF1 APPD LAPF ZFYVE15	Homo sapiens (Human)	apoptotic process [GO:0006915]; endosome organization [GO:0007032]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; vesicle organization [GO:0016050]	endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; apoptotic process [GO:0006915]; endosome organization [GO:0007032]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; vesicle organization [GO:0016050]	metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]	GO:0005634; GO:0005764; GO:0005765; GO:0006915; GO:0007032; GO:0010008; GO:0010314; GO:0010508; GO:0016050; GO:0032266; GO:0035091; GO:0046872; GO:0048471; GO:0070273; GO:0072659; GO:2001244	ATDICMR	2.74000001	1	1	0.190116451	867.068803	15.5297	0	0	16.03974	0	0	0	15.18839	13.55598	0	12.33811	15.11909	0	0	17.37009	0	0	0	0	0	0	0	0	17.57055	0	0	17.26797	0	16.1292	0	16.21218	16.35348	16.88141	0	14.97111	0	15.62398	16.76866	0	16.28853	15.46963	0	0	16.39125	17.43627	0	0	0
Q96SB8	SMC6_HUMAN	"Structural maintenance of chromosomes protein 6, SMC protein 6, SMC-6, hSMC6"	SMC6 SMC6L1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722]	"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"	"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722]"	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]	GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006974; GO:0016605; GO:0016607; GO:0016925; GO:0030915; GO:0031625; GO:0032204; GO:0035061; GO:0035861; GO:0051984; GO:0090398; GO:0097431	ATQLEQMK	9.18999958	1	1	2.29E-13	947.9222914	15.31949	12.47379	11.00044	0	14.2323	0	13.78626	0	0	0	0	0	0	0	0	0	14.63021	0	0	0	0	0	0	14.96844	0	0	0	0	0	0	0	0	0	14.05538	0	0	0	0	0	13.91659	0	0	0	0	0	15.28677	15.4224	0
Q96SE0	ABHD1_HUMAN	"Protein ABHD1, EC 3.1.1.- (Alpha/beta hydrolase domain-containing protein 1, Abhydrolase domain-containing protein 1) (Lung alpha/beta hydrolase 1)"	ABHD1 LABH1	Homo sapiens (Human)	cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]	acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338]	GO:0008126; GO:0016021; GO:0034338; GO:0044255; GO:0047372; GO:0051792; GO:0051793	SLETPLNSLLFNQPLTAGLCQLVERNR	2.059999943	0.599841416	0.599841416	0.131556537	3083.428633	16.75657	17.07102	15.9504	0	14.31354	0	13.47725	13.85929	15.15331	16.70962	10.50878	10.13145	10.02977	0	13.94253	0	0	0	0	0	10.7707	0	0	0	11.7487	0	14.50843	0	14.65458	12.98879	0	16.35893	0	0	14.53845	0	0	16.12487	0	0	0	0	0	0	0	0	14.12709	14.82086
Q96SE7	ZN347_HUMAN	Zinc finger protein 347 (Zinc finger protein 1111)	ZNF347 ZNF1111	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	CNECGKAFSQTSK	8.199999809	1	1	0.298758484	1517.245952	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96SI1	KCD15_HUMAN	BTB/POZ domain-containing protein KCTD15 (Potassium channel tetramerization domain-containing protein 15)	KCTD15	Homo sapiens (Human)	protein homooligomerization [GO:0051260]		identical protein binding [GO:0042802]; protein homooligomerization [GO:0051260]	identical protein binding [GO:0042802]	GO:0042802; GO:0051260	QHYFIDRDGEIFR	16.87999916	1	1	0.202848357	1693.658509	14.3044	15.58041	15.44211	0	0	0	0	16.49517	16.70099	0	0	0	15.69006	15.50015	0	14.77938	0	16.24109	0	0	0	0	0	0	16.87111	0	15.45028	15.47368	15.63458	0	0	15.87916	0	0	15.86123	15.15381	0	0	0	0	0	0	0	0	0	0	0	0
Q96SI9	STRBP_HUMAN	Spermatid perinuclear RNA-binding protein	STRBP SPNR	Homo sapiens (Human)	mechanosensory behavior [GO:0007638]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mechanosensory behavior [GO:0007638]; spermatid development [GO:0007286]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	GO:0002177; GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005737; GO:0007286; GO:0007638; GO:0008017	DGENVSMK	7.099999905	1	1	0.261751803	896.1442586	17.72326	14.5416	17.29631	18.45393	10.22477	17.37814	16.58452	15.43011	16.84069	15.87522	16.59006	17.63683	14.47468	11.77258	14.99778	16.18056	16.17727	16.48198	15.18269	0	14.53541	0	14.99592	15.33337	15.86331	14.58824	14.58508	13.05041	13.07309	15.30068	15.63536	17.67016	15.41707	17.2534	0	16.56513	17.03634	0	15.36529	15.73541	16.30481	0	14.93664	14.0878	13.97335	0	16.48612	0
Q96SL4	GPX7_HUMAN	"Glutathione peroxidase 7, GPx-7, GSHPx-7, EC 1.11.1.9 (CL683)"	GPX7 GPX6 UNQ469/PRO828	Homo sapiens (Human)	cellular response to oxidative stress [GO:0034599]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599]	catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]	GO:0004096; GO:0004601; GO:0004602; GO:0005576; GO:0005783; GO:0005788; GO:0034599	EIESFARR	9.859999657	1	1	0.367024306	1008.145246	0	17.97035	17.59513	19.16829	0	0	0	0	19.65768	18.78472	19.52823	0	0	18.69123	18.75334	17.05803	0	18.04609	16.87219	0	0	0	0	0	0	0	0	17.2795	18.24667	0	18.02516	0	0	0	0	19.21132	0	19.16334	0	19.21898	0	0	19.25046	16.79088	0	0	17.73784	0
Q96SL8	FIZ1_HUMAN	Flt3-interacting zinc finger protein 1 (Zinc finger protein 798)	FIZ1 ZNF798	Homo sapiens (Human)	positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]	metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]	GO:0000785; GO:0001934; GO:0003713; GO:0005634; GO:0005737; GO:0030971; GO:0045944; GO:0046872; GO:0061629	EPASGEPPSGSGR	5.039999962	1	1	0.109948659	1226.912283	15.67289	15.15608	12.67229	13.42191	0	12.75235	12.38848	14.424	14.86943	13.43784	15.11152	12.78512	0	12.52028	0	0	0	0	14.33319	0	0	0	0	0	0	0	15.35902	0	15.19522	13.63452	0	15.55783	0	0	0	0	0	0	0	11.8382	0	0	0	0	0	0	0	0
Q96SM3	CPXM1_HUMAN	"Probable carboxypeptidase X1, EC 3.4.17.- (Metallocarboxypeptidase CPX-1)"	CPXM1 CPX1 CPXM UNQ3015/PRO9782	Homo sapiens (Human)	peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0006518; GO:0008270; GO:0016485	AVIKWMK	5.179999828	0.497409791	0.497409791	0.159511272	891.4334585	13.54905	14.03239	12.98184	15.87752	0	0	15.39211	0	0	15.10494	0	0	0	0	15.84776	11.40079	0	0	0	14.9667	0	16.50886	15.60512	15.71248	0	0	0	0	0	0	15.85237	11.69096	12.92892	15.85312	0	11.66874	15.19145	15.13971	16.53371	13.92436	0	15.15163	0	0	0	0	11.83354	14.69322
Q96SN7	ORAI2_HUMAN	Protein orai-2 (CAP-binding protein complex-interacting protein 2) (Transmembrane protein 142B)	ORAI2 C7orf19 CBCIP2 TMEM142B PP1729	Homo sapiens (Human)	store-operated calcium entry [GO:0002115]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; store-operated calcium channel activity [GO:0015279]; store-operated calcium entry [GO:0002115]	store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0015279; GO:0016020; GO:0016021	EIEELHK	5.559999943	1	1	0.291485642	898.9332896	15.6368	14.60042	0	0	17.85645	0	0	17.08809	19.07053	0	0	0	0	0	0	0	18.65363	17.60496	15.66645	16.67428	0	0	0	16.07788	18.72415	0	0	17.94973	16.78736	0	0	19.11083	16.7224	18.54508	17.43733	0	0	0	0	0	0	0	0	0	0	0	17.89318	0
Q96SN8	CK5P2_HUMAN	CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215)	CDK5RAP2 CEP215 KIAA1633	Homo sapiens (Human)	"brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]	"cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]"	calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]	GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044877; GO:0045664; GO:0045665; GO:0045736; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431	EMDSDQQR	11.84000015	1	1	0.213825838	1007.804298	15.52174	0	0	15.17843	14.88437	0	11.86898	0	0	0	0	0	0	0	0	0	0	0	14.79735	0	15.59648	15.84309	0	0	16.38095	16.83051	18.07153	15.40231	0	14.28755	0	16.7475	0	0	0	0	0	0	0	14.2852	0	0	0	0	16.89055	14.18045	0	15.80095
Q96SQ7	ATOH8_HUMAN	"Transcription factor ATOH8 (Class A basic helix-loop-helix protein 21, bHLHa21) (Helix-loop-helix protein hATH-6, hATH6) (Protein atonal homolog 8)"	ATOH8 ATH6 BHLHA21	Homo sapiens (Human)	"formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; tube formation [GO:0035148]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; tube formation [GO:0035148]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001704; GO:0001937; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010595; GO:0010629; GO:0016607; GO:0030182; GO:0035148; GO:0045603; GO:0045892; GO:0045893; GO:0046983; GO:0051450; GO:0060395; GO:0070888; GO:0140297; GO:1902895	KRPGEATAASSEIK	5.769999981	0.26878503	0.26878503	0.186783953	1445.660263	16.66556	13.59684	0	15.49148	16.22759	0	0	18.85066	15.79321	12.62696	15.63031	14.88519	14.82375	13.25026	13.66591	16.0058	15.52424	15.73658	0	16.8588	15.53324	0	14.07691	0	16.46077	15.25827	10.7288	16.93447	11.35421	16.84392	17.64842	15.39421	12.72631	14.89924	15.62415	15.01542	18.93878	13.18177	0	0	15.5371	15.95812	15.61308	0	14.00331	0	15.41927	13.98227
Q96SQ9	CP2S1_HUMAN	"Cytochrome P450 2S1, EC 1.14.14.- (CYPIIS1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152) (Thromboxane-A synthase, EC 5.3.99.5)"	CYP2S1 UNQ891/PRO1906	Homo sapiens (Human)	epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; organic acid metabolic process [GO:0006082]; prostaglandin metabolic process [GO:0006693]; retinoic acid metabolic process [GO:0042573]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]	"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydro-lyase activity [GO:0016836]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; thromboxane-A synthase activity [GO:0004796]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; organic acid metabolic process [GO:0006082]; prostaglandin metabolic process [GO:0006693]; retinoic acid metabolic process [GO:0042573]; xenobiotic metabolic process [GO:0006805]"	"12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydro-lyase activity [GO:0016836]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; thromboxane-A synthase activity [GO:0004796]"	GO:0004497; GO:0004796; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006693; GO:0006805; GO:0008392; GO:0008395; GO:0008401; GO:0016712; GO:0016836; GO:0019373; GO:0020037; GO:0036134; GO:0042573; GO:0043231; GO:0106256	ELGAGQAPSLGDR	7.690000057	1	1	0.221498581	1271.42605	0	0	13.62265	13.38288	13.73647	15.41212	0	0	12.14648	0	0	0	0	16.74075	0	0	0	0	0	15.91962	0	0	0	0	0	0	0	15.86833	0	0	0	15.65176	0	0	0	0	0	0	0	0	16.12254	0	0	16.21391	15.81791	0	0	0
Q96SR6	ZN382_HUMAN	"Zinc finger protein 382 (KRAB/zinc finger suppressor protein 1, KS1) (Multiple zinc finger and krueppel-associated box protein KS1)"	ZNF382	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872	NISPIK	9.800000191	1	1	0.265918646	671.3170224	0	0	0	16.66912	0	0	0	18.76792	0	0	17.69208	17.92773	18.34469	0	0	0	17.61824	0	0	0	15.71303	18.41014	0	18.18984	0	18.5273	0	0	0	17.07749	19.18982	0	0	0	0	19.70863	16.54165	0	0	0	19.05301	17.2536	0	0	0	16.41957	16.23256	0
Q96ST2	IWS1_HUMAN	Protein IWS1 homolog (IWS1-like protein)	IWS1 IWS1L	Homo sapiens (Human)	mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]		GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0010793; GO:0016973; GO:0050684; GO:0090239; GO:2001253	EQRDLEQMPQR	6.650000095	1	1	0.528592974	1446.560338	0	17.07082	0	0	0	0	0	0	0	0	0	19.50903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.8513	0	0	0	0	0	0	0	17.40829	0	0	0	0	0	0
Q96ST3	SIN3A_HUMAN	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	Homo sapiens (Human)	"activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]	GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031453; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0061629; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1902455; GO:1902459; GO:1903351; GO:2000678	AEQLMSDENCFK	6.619999886	1	1	0.425375314	1486.919999	0	0	0	0	0	0	0	0	20.205	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.66527
Q96ST8	CEP89_HUMAN	"Centrosomal protein of 89 kDa, Cep89 (Centrosomal protein 123, Cep123) (Coiled-coil domain-containing protein 123)"	CEP89 CCDC123	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; synapse [GO:0045202]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; synapse [GO:0045202]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515]		GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007005; GO:0007268; GO:0031514; GO:0045202; GO:0060271; GO:0097539; GO:0097730; GO:1905515	EESLNIEGLPSKGPIPPWLLDIK	3.200000048	1	1	0	2546.119868	14.43563	13.07532	12.53251	12.13734	14.55888	0	14.58655	0	15.82404	15.67295	0	15.24282	15.97853	0	0	15.19269	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.25316	0	0	0	0	0	0	14.73586	0
Q96SW2	CRBN_HUMAN	Protein cereblon	CRBN AD-006	Homo sapiens (Human)	locomotory exploration behavior [GO:0035641]; negative regulation of large conductance calcium-activated potassium channel activity [GO:1902607]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; locomotory exploration behavior [GO:0035641]; negative regulation of large conductance calcium-activated potassium channel activity [GO:1902607]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]	metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]	GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016567; GO:0031333; GO:0031334; GO:0031464; GO:0035641; GO:0043161; GO:0044325; GO:0046872; GO:0048471; GO:1902607	FTATKK	4.480000019	1	1	0.301726427	692.1001404	12.60059	12.38813	0	15.7069	14.98878	13.5714	0	14.45198	0	15.80679	15.78736	0	13.87046	15.70273	0	0	16.04939	14.8371	15.08657	16.22285	16.07194	12.82401	14.62371	15.94733	0	0	0	15.79876	0	0	16.44646	0	0	15.56726	0	16.65672	15.92037	16.00451	0	0	0	0	0	14.88862	16.80204	0	15.76425	0
Q96SZ6	CK5P1_HUMAN	"Mitochondrial tRNA methylthiotransferase CDK5RAP1, EC 2.8.4.3 (CDK5 activator-binding protein C42) (CDK5 regulatory subunit-associated protein 1) (mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase) (mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase)"	CDK5RAP1 C20orf34 CGI-05 HSPC167	Homo sapiens (Human)	brain development [GO:0007420]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of neuron differentiation [GO:0045664]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of neuron differentiation [GO:0045664]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein kinase binding [GO:0019901]"	GO:0005739; GO:0005829; GO:0007420; GO:0019901; GO:0035597; GO:0045664; GO:0045736; GO:0045903; GO:0046872; GO:0051539; GO:0070131; GO:0070900	IGILGCMAER	6.710000038	1	1	0.118224667	1135.76628	16.36651	15.23431	14.85616	0	0	0	0	0	0	12.53231	0	0	0	0	0	0	0	13.81719	0	0	0	0	0	0	0	13.29267	0	0	0	12.79492	0	0	0	0	0	0	0	0	0	0	0	0	0	15.33061	0	0	0	0
Q96T23	RSF1_HUMAN	"Remodeling and spacing factor 1, Rsf-1 (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex)"	RSF1 HBXAP XAP8	Homo sapiens (Human)	"chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of transcription, DNA-templated [GO:0006355]"	histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	GO:0003712; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0016584; GO:0031213; GO:0031497; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434	DISTITGHR	3.410000086	1	1	0.181941443	1001.847774	0	14.49133	15.13993	0	0	0	0	15.42573	0	0	0	0	0	0	0	13.78088	13.74926	0	0	11.32166	0	0	0	0	0	12.98721	16.11982	12.65382	0	12.99958	15.13828	14.85141	15.99914	16.11287	0	13.93956	15.43191	0	15.87872	0	15.79628	0	0	0	15.10901	0	11.66641	0
Q96T37	RBM15_HUMAN	RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15)	RBM15 OTT OTT1	Homo sapiens (Human)	"branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]"	nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	"nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0001510; GO:0001569; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0007221; GO:0009048; GO:0016607; GO:0031965; GO:0036396; GO:0038163; GO:0045638; GO:0045652; GO:0048536; GO:0060412; GO:0060674	GDDLR	6.539999962	0.496027619	0.496027619	0.181562555	575.365418	16.10862	0	12.75184	15.81387	15.19718	14.70358	16.19475	15.75039	0	15.59441	15.40921	15.20984	16.05683	15.90582	15.39076	16.34107	15.62669	14.90904	16.7959	14.11327	16.23496	19.48204	15.79876	17.82492	0	15.55127	15.81007	14.09708	0	13.87694	15.04842	15.73134	15.20498	16.19562	15.41819	0	16.55387	14.86275	16.15246	0	0	17.04159	0	16.55139	0	16.29192	14.97682	16.06903
Q96T49	PP16B_HUMAN	"Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein, hTIMAP)"	PPP1R16B ANKRD4 KIAA0823	Homo sapiens (Human)	establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670]	cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670]	myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]	GO:0001938; GO:0005634; GO:0005886; GO:0008157; GO:0014066; GO:0016607; GO:0017020; GO:0019888; GO:0035304; GO:0035307; GO:0035308; GO:0042995; GO:0048471; GO:0051489; GO:0061028; GO:1902309; GO:1903589; GO:1903670	FKAPIEEMEEK	4.119999886	1	1	0.327672672	1350.327825	14.61365	14.5841	0	11.77175	0	0	13.21395	0	0	15.16936	13.90962	9.41734	13.90473	0	15.53368	0	0	0	0	0	16.52857	0	0	0	0	0	16.02178	0	0	0	0	0	0	0	0	0	0	16.66595	0	0	0	14.89741	0	0	0	0	0	0
Q96T58	MINT_HUMAN	Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog)	SPEN KIAA0929 MINT SHARP	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357]"	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357]"	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0045892; GO:0050769; GO:0061629; GO:0070062	EVSGFRGGGGGPAYGPPPSLHAR	6.579999924	1	1	0.005715284	2222.311972	0	15.11695	13.17962	0	0	14.19291	0	0	15.73882	0	14.9683	0	16.23098	0	0	0	13.33037	15.20945	0	13.03905	12.75838	0	0	12.34701	15.25301	14.60282	14.39942	0	15.49703	15.53049	0	15.92843	14.74467	15.57299	17.34275	14.9592	0	14.82701	0	15.17581	10.42837	0	0	14.84374	0	15.25805	0	0
Q96T60	PNKP_HUMAN	"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]"	PNKP	Homo sapiens (Human)	"base-excision repair, gap-filling [GO:0006287]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair, DNA damage removal [GO:0000718]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]"	membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	"membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]; base-excision repair, gap-filling [GO:0006287]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair, DNA damage removal [GO:0000718]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]"	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]	GO:0000718; GO:0003684; GO:0003690; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006261; GO:0006281; GO:0006287; GO:0006303; GO:0006979; GO:0009314; GO:0010836; GO:0016020; GO:0017076; GO:0032212; GO:0035861; GO:0046403; GO:0046404; GO:0046939; GO:0051103; GO:0051973; GO:1904355; GO:2001034	EMTDSSHIPVSDMVMYGYRK	6.179999828	0.514945686	0.514945686	1.37E-12	2347.223539	0	0	11.25953	8.171785	14.92719	0	0	15.04627	0	0	10.20333	0	0	0	0	0	11.87121	14.35869	0	0	0	0	0	0	0	11.89386	14.33433	0	0	0	0	10.30581	0	11.17291	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96T66	NMNA3_HUMAN	"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3, NMN/NaMN adenylyltransferase 3 (Nicotinamide-nucleotide adenylyltransferase 3, NMN adenylyltransferase 3) (Nicotinate-nucleotide adenylyltransferase 3, NaMN adenylyltransferase 3, EC 2.7.7.18) (Pyridine nucleotide adenylyltransferase 3, PNAT-3, EC 2.7.7.1)"	NMNAT3 FKSG76	Homo sapiens (Human)	NAD biosynthetic process [GO:0009435]; nucleotide biosynthetic process [GO:0009165]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; NAD biosynthetic process [GO:0009435]; nucleotide biosynthetic process [GO:0009165]	ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]	GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0009165; GO:0009435	MFEVAR	3.099999905	0.45243305	0.45243305	0.185062888	753.1419922	0	15.88004	0	0	0	14.97457	15.07377	15.81154	0	0	13.2945	15.53693	0	0	0	0	0	0	0	0	0	16.51317	0	0	0	0	0	0	0	0	0	0	0	16.79811	0	0	16.65221	0	0	0	0	0	0	0	0	0	0	0
Q96T68	SETB2_HUMAN	"Histone-lysine N-methyltransferase SETDB2, EC 2.1.1.366 (Chronic lymphocytic leukemia deletion region gene 8 protein) (Lysine N-methyltransferase 1F) (SET domain bifurcated 2)"	SETDB2 C13orf4 CLLD8 KMT1F	Homo sapiens (Human)	"cell division [GO:0051301]; chromosome segregation [GO:0007059]; heart looping [GO:0001947]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; left/right axis specification [GO:0070986]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]"	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; heart looping [GO:0001947]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; left/right axis specification [GO:0070986]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]"	DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]	GO:0000278; GO:0001947; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007059; GO:0008270; GO:0010629; GO:0018024; GO:0045892; GO:0046974; GO:0051301; GO:0051567; GO:0070828; GO:0070986; GO:0090309	EHLNSK	3.170000076	1	1	0.23110508	726.2478564	0	14.84746	0	0	14.95415	0	13.00793	0	13.96753	16.03053	0	14.47085	0	0	0	0	0	0	0	17.26587	0	0	0	17.32068	0	0	15.28501	15.66145	0	0	0	14.68196	15.42152	0	13.07135	17.30405	14.22715	16.31206	16.41601	15.69855	18.8393	15.6053	0	0	16.26752	14.69668	12.6578	0
Q96T76	MMS19_HUMAN	"MMS19 nucleotide excision repair protein homolog, hMMS19 (MET18 homolog) (MMS19-like protein)"	MMS19 MMS19L	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; nucleotide-excision repair [GO:0006289]; phosphorelay signal transduction system [GO:0000160]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to hormone [GO:0009725]; transcription, DNA-templated [GO:0006351]"	CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]	"CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor complex adaptor activity [GO:0030159]; transcription coactivator activity [GO:0003713]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; nucleotide-excision repair [GO:0006289]; phosphorelay signal transduction system [GO:0000160]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to hormone [GO:0009725]; transcription, DNA-templated [GO:0006351]"	enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor complex adaptor activity [GO:0030159]; transcription coactivator activity [GO:0003713]	GO:0000160; GO:0003713; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0006259; GO:0006281; GO:0006289; GO:0006351; GO:0006974; GO:0007059; GO:0009725; GO:0016020; GO:0016226; GO:0019899; GO:0030159; GO:0030331; GO:0030674; GO:0045893; GO:0071817; GO:0097361; GO:0097428; GO:1905168	AGHAEVR	2.029999971	1	1	0.199851047	739.7790991	0	18.81296	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q96T92	INSM2_HUMAN	Insulinoma-associated protein 2 (Zinc finger protein IA-6)	INSM2 IA6 Nbla106	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of cell cycle process [GO:0010564]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of cell cycle process [GO:0010564]"	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001227; GO:0005634; GO:0005737; GO:0010564; GO:0017053; GO:0030182; GO:0046872	APTDCASGPAAAGIK	4.639999866	1	1	0.29860001	1388.091746	14.16959	9.892215	11.24663	0	0	0	0	0	14.39146	0	0	15.43289	0	17.33592	0	0	0	14.95545	15.79589	16.39163	15.18178	0	13.04356	14.95298	16.08754	0	0	16.16347	15.72042	0	15.83796	0	15.4786	17.39938	0	0	0	17.08297	18.09404	0	0	13.96257	0	0	15.88286	12.84362	10.85791	0
Q96TA0	PCDBI_HUMAN	"Putative protocadherin beta-18, PCDH-beta-18 (PCDH-psi2)"	PCDHB18P PCDHB18	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156	DSEMEKAPPF	7.510000229	1	1	0.15797786	1151.152956	0	0	13.64977	16.35867	17.02487	0	0	0	15.30784	0	17.12866	0	0	14.73598	0	0	18.21362	19.04873	15.22183	0	16.57934	16.27866	18.32946	19.30219	17.62154	0	0	17.82822	18.25268	15.91468	0	0	16.49941	0	16.89879	0	0	0	0	17.51923	0	0	0	17.238	0	0	0	0
Q96TA2	YMEL1_HUMAN	"ATP-dependent zinc metalloprotease YME1L1, EC 3.4.24.- (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease, PAMP) (YME1-like protein 1)"	YME1L1 FTSH1 YME1L UNQ1868/PRO4304	Homo sapiens (Human)	cell population proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell population proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006508; GO:0006515; GO:0007005; GO:0008283; GO:0016020; GO:0016021; GO:0016604; GO:0016887; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872	AQALTQK	2.599999905	0.424447805	0.424447805	0.239080084	759.2813942	0	0	15.44431	14.6431	15.51435	13.9886	14.86959	0	0	0	15.11673	0	16.04613	15.69711	0	16.08986	14.18406	16.50471	14.72933	16.39733	15.44743	15.85407	16.13712	15.9109	15.45753	12.15497	0	15.89315	0	0	0	16.07516	15.45364	0	16.32187	0	16.94535	0	0	17.02253	0	0	17.1867	0	0	16.08475	0	15.07495
Q96TC7	RMD3_HUMAN	"Regulator of microtubule dynamics protein 3, RMD-3, hRMD-3 (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51)"	RMDN3 FAM82A2 FAM82C PTPIP51 hucep-10 UNQ3122/PRO10274	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; organelle membrane contact site [GO:0044232]; spindle microtubule [GO:0005876]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; organelle membrane contact site [GO:0044232]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874]	microtubule binding [GO:0008017]	GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005876; GO:0006874; GO:0006915; GO:0008017; GO:0016021; GO:0030154; GO:0044232; GO:0045171; GO:0097431	AEELQPGFSK	6.71999979	1	1	0.226141945	1106.730134	14.85175	0	0	0	0	0	0	10.8392	0	0	0	0	0	0	0	0	0	0	0	16.72335	0	14.67104	0	0	0	0	0	11.43155	0	0	15.42751	0	13.24428	0	15.45373	0	0	16.71289	0	0	0	0	0	0	0	0	0	0
Q99062	CSF3R_HUMAN	"Granulocyte colony-stimulating factor receptor, G-CSF receptor, G-CSF-R (CD antigen CD114)"	CSF3R GCSFR	Homo sapiens (Human)	cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; neutrophil chemotaxis [GO:0030593]; regulation of myeloid cell differentiation [GO:0045637]; signal transduction [GO:0007165]	endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; neutrophil chemotaxis [GO:0030593]; regulation of myeloid cell differentiation [GO:0045637]; signal transduction [GO:0007165]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; signaling receptor activity [GO:0038023]	GO:0004896; GO:0005576; GO:0005765; GO:0005886; GO:0005887; GO:0006952; GO:0007155; GO:0007165; GO:0009897; GO:0019221; GO:0019955; GO:0030593; GO:0030666; GO:0038023; GO:0043235; GO:0045637; GO:0051916	LGAELQPGGR	6.519999981	1	1	0.055745571	997.6324718	0	11.56724	10.38225	0	0	0	0	14.37028	13.84537	0	0	0	15.05363	0	0	15.58352	0	16.64899	0	0	15.12561	0	14.81675	15.04362	0	0	14.50421	0	15.72975	14.00825	16.5709	15.76704	0	0	16.11844	16.23436	16.58177	15.53652	0	0	16.61169	14.54531	0	0	0	17.32607	0	15.84271
Q99250	SCN2A_HUMAN	Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2)	SCN2A NAC2 SCN2A1 SCN2A2	Homo sapiens (Human)	cellular response to hypoxia [GO:0071456]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; membrane depolarization during action potential [GO:0086010]; memory [GO:0007613]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]	axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cellular response to hypoxia [GO:0071456]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; membrane depolarization during action potential [GO:0086010]; memory [GO:0007613]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0007399; GO:0007613; GO:0008627; GO:0014704; GO:0016020; GO:0019228; GO:0030315; GO:0030424; GO:0031226; GO:0033268; GO:0033270; GO:0034706; GO:0034765; GO:0035725; GO:0042552; GO:0051402; GO:0071456; GO:0086010; GO:0098978; GO:0099056	GKAISR	2.400000095	1	1	0.059460775	630.4319503	0	14.23196	0	17.00305	0	0	15.90102	0	17.34574	0	0	0	0	0	0	0	0	15.77993	0	0	0	0	0	14.87364	0	0	0	0	0	0	0	0	17.04792	0	16.92716	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99259	DCE1_HUMAN	"Glutamate decarboxylase 1, EC 4.1.1.15 (67 kDa glutamic acid decarboxylase, GAD-67) (Glutamate decarboxylase 67 kDa isoform)"	GAD1 GAD GAD67	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; glutamate catabolic process [GO:0006538]; glutamate decarboxylation to succinate [GO:0006540]; locomotory exploration behavior [GO:0035641]; neurotransmitter biosynthetic process [GO:0042136]; protein-pyridoxal-5-phosphate linkage [GO:0018352]; social behavior [GO:0035176]	axon terminus [GO:0043679]; cell cortex [GO:0005938]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; vesicle membrane [GO:0012506]	axon terminus [GO:0043679]; cell cortex [GO:0005938]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; vesicle membrane [GO:0012506]; glutamate decarboxylase activity [GO:0004351]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; chemical synaptic transmission [GO:0007268]; glutamate catabolic process [GO:0006538]; glutamate decarboxylation to succinate [GO:0006540]; locomotory exploration behavior [GO:0035641]; neurotransmitter biosynthetic process [GO:0042136]; protein-pyridoxal-5-phosphate linkage [GO:0018352]; social behavior [GO:0035176]	glutamate decarboxylase activity [GO:0004351]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]	GO:0004351; GO:0005886; GO:0005938; GO:0006538; GO:0006540; GO:0007268; GO:0012506; GO:0018352; GO:0030170; GO:0035176; GO:0035641; GO:0042136; GO:0042802; GO:0043679; GO:0048786; GO:0060077; GO:0061202	GVPDSPQR	4.449999809	0.339106143	0.339106143	0.225893559	854.719655	15.5365	15.60865	0	0	13.11221	16.55284	0	0	0	15.81161	15.60134	14.38773	0	0	0	15.65294	0	0	0	15.24115	0	15.09781	0	14.804	0	15.62419	15.73444	0	0	0	16.98518	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99418	CYH2_HUMAN	"Cytohesin-2 (ARF exchange factor) (ARF nucleotide-binding site opener, Protein ARNO) (PH, SEC7 and coiled-coil domain-containing protein 2)"	CYTH2 ARNO PSCD2 PSCD2L	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; regulation of ARF protein signal transduction [GO:0032012]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; regulation of ARF protein signal transduction [GO:0032012]"	"guanyl-nucleotide exchange factor activity [GO:0005085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; lipid binding [GO:0008289]"	GO:0000139; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0006897; GO:0008289; GO:0016020; GO:0030036; GO:0030426; GO:0032012; GO:0070679	EVDDPR	2.099999905	1	1	0.110054925	731.703487	14.9433	0	0	0	0	15.79822	0	0	0	0	0	0	0	0	0	16.56117	0	0	16.64965	0	0	0	0	17.45789	17.58957	0	16.68913	15.27598	15.49581	0	16.83485	15.88559	0	16.25574	17.15572	15.0973	0	0	0	0	0	0	0	0	0	0	0	15.08083
Q99426	TBCB_HUMAN	Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B)	TBCB CG22 CKAP1	Homo sapiens (Human)	cell differentiation [GO:0030154]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]		GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0015630; GO:0030154	QDTVRSFLK	2.309999943	0.000389812	0.000389812	0.350279574	1095.109555	0	0	0	15.63289	0	0	0	0	16.48969	0	0	0	0	0	0	0	0	0	0	0	16.78938	0	0	0	0	17.19356	0	17.30042	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99442	SEC62_HUMAN	"Translocation protein SEC62 (Translocation protein 1, TP-1, hTP-1)"	SEC62 TLOC1	Homo sapiens (Human)	"cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]"	signaling receptor activity [GO:0038023]	GO:0005783; GO:0005791; GO:0006613; GO:0006620; GO:0016020; GO:0016021; GO:0030176; GO:0031204; GO:0038023	GPKADLK	4.989999771	1	1	0.272586812	726.8799299	0	0	0	17.06337	0	0	16.79407	0	17.2271	17.17302	0	0	16.3794	0	16.79053	16.14866	0	0	0	14.53417	0	16.57111	0	16.01122	0	0	0	0	0	0	0	18.88105	0	0	0	0	18.00143	0	0	0	0	0	0	0	0	16.41781	0	16.62786
Q99447	PCY2_HUMAN	"Ethanolamine-phosphate cytidylyltransferase, EC 2.7.7.14 (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)"	PCYT2	Homo sapiens (Human)	phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]	endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654]	ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]	GO:0004306; GO:0005789; GO:0006646; GO:0008654	QAGRYR	3.779999971	1	1	0.158052415	749.0238528	14.44598	15.11425	16.03572	0	0	0	0	16.1591	0	14.97732	0	0	0	16.10628	0	0	0	0	0	0	0	0	0	17.32222	0	0	0	16.01217	0	0	0	0	0	13.76589	15.60659	16.42676	0	0	0	13.95107	15.67092	0	0	0	0	0	0	0
Q99463	NPY6R_HUMAN	"Putative neuropeptide Y receptor type 6, NPY6-R (NPY Y1-like receptor) (Putative pancreatic polypeptide receptor 2, PP2)"	NPY6R NPY1RL Y2B	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; pancreatic polypeptide receptor activity [GO:0001602]	pancreatic polypeptide receptor activity [GO:0001602]	GO:0001602; GO:0016021	ISSMSSLTGIMR	13.82999992	1	1	0.055768181	1282.250497	0	0	13.07208	0	12.31004	14.1344	0	11.52377	0	13.37843	0	13.19618	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.5121	0	0	0	0	0	0	0	0	0	0	0	0
Q99469	STAC_HUMAN	SH3 and cysteine-rich domain-containing protein (Src homology 3 and cysteine-rich domain-containing protein)	STAC STAC1	Homo sapiens (Human)	cellular response to heat [GO:0034605]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; T-tubule [GO:0030315]	cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; T-tubule [GO:0030315]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; cellular response to heat [GO:0034605]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]	metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]	GO:0003009; GO:0005829; GO:0007165; GO:0030315; GO:0031234; GO:0034605; GO:0044325; GO:0046872; GO:1901387; GO:1903078; GO:2001259	CMGKLPK	1.960000038	0.00067882	0.00067882	0.296011346	850.2685648	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.30853	0	0	0	0	0	18.20616	0	0	0	18.54761	0	18.00315	0	17.48296	0	0	0	0	0
Q99487	PAFA2_HUMAN	"Platelet-activating factor acetylhydrolase 2, cytoplasmic, EC 3.1.1.47 (PAF:lysophospholipid transacetylase) (PAF:sphingosine transacetylase) (Platelet-activating factor acetyltransferase PAFAH2, EC 2.3.1.149) (Serine-dependent phospholipase A2, SD-PLA2, hSD-PLA2)"	PAFAH2	Homo sapiens (Human)	blood coagulation [GO:0007596]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; phospholipid binding [GO:0005543]; platelet-activating factor acetyltransferase activity [GO:0047179]; blood coagulation [GO:0007596]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]	1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; phospholipid binding [GO:0005543]; platelet-activating factor acetyltransferase activity [GO:0047179]	GO:0003847; GO:0005543; GO:0005737; GO:0005789; GO:0006629; GO:0007596; GO:0016042; GO:0047179	RVEEGEK	5.480000019	0.039549917	0.039549917	0.248874404	847.1361552	14.96477	0	0	0	14.59943	15.826	0	14.39307	15.27345	0	13.60296	13.58682	0	15.53655	15.58777	13.82506	15.73811	14.19783	15.27577	0	0	16.47417	15.17219	15.89504	16.5086	0	15.14253	15.63979	0	15.10509	15.23756	12.79453	15.77136	17.10289	14.52625	16.59603	15.83035	15.02666	0	14.48053	0	0	12.76186	13.66751	14.22534	15.28902	15.41813	14.98699
Q99489	OXDD_HUMAN	"D-aspartate oxidase, DASOX, DDO, EC 1.4.3.1"	DDO	Homo sapiens (Human)	aspartate catabolic process [GO:0006533]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]	D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]	GO:0003884; GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949	TPIPKSNL	6.989999771	1	1	0.458694095	869.9863487	15.03331	0	15.64797	13.84799	0	15.23333	15.49231	0	14.80091	16.19643	0	0	0	0	0	0	14.28696	16.10464	15.41069	16.16118	0	16.01905	0	0	15.14019	17.01012	0	0	16.0749	16.34154	0	0	15.94452	0	0	16.55605	0	16.63892	0	0	0	0	0	0	16.20482	0	0	0
Q99490	AGAP2_HUMAN	"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2, AGAP-2 (Centaurin-gamma-1, Cnt-g1) (GTP-binding and GTPase-activating protein 2, GGAP2) (Phosphatidylinositol 3-kinase enhancer, PIKE)"	AGAP2 CENTG1 KIAA0167	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; endosomal transport [GO:0016197]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of protein kinase activity [GO:0045860]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; endosomal transport [GO:0016197]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of protein kinase activity [GO:0045860]; protein transport [GO:0015031]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]	GO:0003924; GO:0005096; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0015031; GO:0016020; GO:0016197; GO:0019901; GO:0030036; GO:0030295; GO:0035014; GO:0042177; GO:0043524; GO:0045860; GO:0046872; GO:0061903; GO:0070062; GO:0090543	ALCADMKR	5.840000153	1	1	0.26419946	984.1667855	0	17.40865	17.95711	17.73765	14.82196	0	16.90535	15.85218	14.41056	16.55701	17.24355	14.35006	17.18886	14.32158	13.16109	0	18.89861	0	0	0	17.88183	16.26713	0	0	14.91726	0	0	14.9604	15.86687	0	0	0	0	0	0	16.59896	16.2612	0	0	15.76535	0	0	0	0	16.24704	0	0	0
Q99497	PARK7_HUMAN	"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)"	PARK7	Homo sapiens (Human)	"activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]"	adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]	"adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]"	"androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]"	GO:0000785; GO:0001933; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0005912; GO:0006281; GO:0006469; GO:0006517; GO:0006914; GO:0006954; GO:0007005; GO:0007265; GO:0007338; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016570; GO:0016605; GO:0016684; GO:0019249; GO:0019826; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031334; GO:0031397; GO:0032091; GO:0032148; GO:0032435; GO:0032757; GO:0033138; GO:0033182; GO:0033234; GO:0033864; GO:0034599; GO:0035065; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0061727; GO:0070062; GO:0070301; GO:0070994; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:0140297; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1905259; GO:1990381; GO:1990422; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268	APLVLK	2.769999981	1	1	0.262336258	640.0244082	0	17.15436	17.31517	0	0	0	18.19912	18.0933	0	0	18.42806	15.94003	0	0	0	0	16.30639	0	15.75586	16.02877	0	17.43422	0	18.19842	0	0	18.18834	18.0911	0	18.74436	19.11944	0	20.07329	0	18.34597	0	19.04756	17.2856	18.96141	0	0	0	0	0	0	18.76913	19.3167	18.86085
Q99500	S1PR3_HUMAN	"Sphingosine 1-phosphate receptor 3, S1P receptor 3, S1P3 (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3, S1P receptor Edg-3)"	S1PR3 C9orf108 C9orf47 EDG3	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of establishment of endothelial barrier [GO:1903141]; Notch signaling pathway [GO:0007219]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of interleukin-1 beta production [GO:0032651]; regulation of metabolic process [GO:0019222]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of establishment of endothelial barrier [GO:1903141]; Notch signaling pathway [GO:0007219]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of interleukin-1 beta production [GO:0032651]; regulation of metabolic process [GO:0019222]	G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036]	GO:0004930; GO:0005178; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007189; GO:0007193; GO:0007204; GO:0007219; GO:0008284; GO:0008289; GO:0009653; GO:0019222; GO:0032651; GO:0038036; GO:1903141	LAGRLK	12.81000042	1	1	0.237127261	658.0622805	15.50883	15.21017	14.42753	13.84792	0	15.3785	15.57774	0	0	0	0	0	14.27234	0	15.0568	0	15.91023	16.63318	17.10951	14.4028	16.03766	16.16901	17.73439	17.83935	16.16299	0	0	0	16.5837	0	0	15.40529	15.79981	0	16.35203	0	0	18.26272	16.91385	16.01517	15.91206	19.50437	15.6731	17.95812	0	0	0	16.64032
Q99501	GA2L1_HUMAN	GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1)	GAS2L1 GAR22	Homo sapiens (Human)	actin crosslink formation [GO:0051764]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; protein localization to microtubule plus-end [GO:1904825]; regulation of cell cycle [GO:0051726]; regulation of microtubule polymerization or depolymerization [GO:0031110]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; thyroid hormone receptor binding [GO:0046966]; actin crosslink formation [GO:0051764]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; protein localization to microtubule plus-end [GO:1904825]; regulation of cell cycle [GO:0051726]; regulation of microtubule polymerization or depolymerization [GO:0031110]	actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; thyroid hormone receptor binding [GO:0046966]	GO:0001578; GO:0005737; GO:0005856; GO:0007026; GO:0008017; GO:0008093; GO:0009267; GO:0010629; GO:0030308; GO:0031110; GO:0045647; GO:0046966; GO:0051015; GO:0051726; GO:0051764; GO:0097067; GO:1904825	DGQHSWVPR	9.43999958	1	1	0	1077.736922	0	0	0	0	16.35946	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.20007	0	0	0	0	14.09928	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99518	FMO2_HUMAN	"Flavin-containing monooxygenase 2, EC 1.14.13.- (Dimethylaniline oxidase 2) (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2, FMO 2)"	FMO2	Homo sapiens (Human)	NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]"	"flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]"	GO:0004497; GO:0004499; GO:0005789; GO:0006082; GO:0006739; GO:0006805; GO:0009404; GO:0016020; GO:0016021; GO:0050660; GO:0050661; GO:0070995; GO:0072592	LLCGAIK	13.28999996	1	1	0.184922729	773.3732746	16.37632	17.22218	17.84869	16.19581	0	17.31921	20.00756	15.10123	17.24944	15.84177	15.57987	15.58158	14.13125	15.17932	0	15.7864	16.58859	16.66384	22.66763	17.86189	0	0	0	17.6378	15.84688	0	16.10298	17.71408	16.44581	16.22989	0	0	0	16.18952	15.9133	0	0	22.01288	0	0	19.1563	19.0225	0	0	14.74366	14.54809	15.3932	0
Q99519	NEUR1_HUMAN	"Sialidase-1, EC 3.2.1.18 (Acetylneuraminyl hydrolase) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1)"	NEU1 NANH	Homo sapiens (Human)	ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313]	alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]	GO:0004308; GO:0005576; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0016020; GO:0016997; GO:0030054; GO:0035580; GO:0043202; GO:0043231; GO:0052794; GO:0052795; GO:0052796; GO:0070062	TGERPSTALPDR	7.619999886	1	1	0.070854083	1297.14694	0	0	0	0	0	0	12.97056	0	0	16.056	0	14.69105	0	0	0	16.31539	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.93239	15.64842	0	0	0	0	15.4209	0	0	0	0	0	0	0	0
Q99536	VAT1_HUMAN	"Synaptic vesicle membrane protein VAT-1 homolog, EC 1.-.-.-"	VAT1	Homo sapiens (Human)	negative regulation of mitochondrial fusion [GO:0010637]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; negative regulation of mitochondrial fusion [GO:0010637]	oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]	GO:0005576; GO:0005741; GO:0008270; GO:0010637; GO:0016021; GO:0016491; GO:0035578; GO:0070062	VVTYGMANLLTGPK	14.02999973	0.288584381	0.288584381	0.490505336	1477.35124	18.08107	0	17.88606	0	0	0	0	19.33868	18.68879	0	0	0	0	0	0	0	17.36578	0	16.03168	0	0	0	0	0	20.78897	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99538	LGMN_HUMAN	"Legumain, EC 3.4.22.34 (Asparaginyl endopeptidase) (Protease, cysteine 1)"	LGMN PRSC1	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity [GO:0097202]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156]; activation of cysteine-type endopeptidase activity [GO:0097202]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359]	cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156]	GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0019886; GO:0032801; GO:0035729; GO:0036021; GO:0040015; GO:0042359; GO:0043202; GO:0043524; GO:0045177; GO:0045931; GO:0048156; GO:0048471; GO:0051603; GO:0070062; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028	TISTMK	14.90999985	0.488323301	0.488323301	0.081585966	693.6708117	17.2633	18.27721	14.52725	16.90097	15.48426	17.1559	0	15.87164	0	0	16.34316	0	0	17.21665	14.80925	0	18.6086	16.1131	16.62598	15.77321	17.78979	16.82313	14.80763	0	15.76349	14.58992	0	0	15.29683	16.48477	0	0	0	15.99254	0	0	12.86843	17.93559	0	15.97799	0	0	0	0	16.51029	15.34962	0	0
Q99541	PLIN2_HUMAN	"Perilipin-2 (Adipophilin) (Adipose differentiation-related protein, ADRP)"	PLIN2 ADFP	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; long-chain fatty acid transport [GO:0015909]; positive regulation of sequestering of triglyceride [GO:0010890]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; long-chain fatty acid transport [GO:0015909]; positive regulation of sequestering of triglyceride [GO:0010890]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]		GO:0005576; GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0005886; GO:0009410; GO:0010890; GO:0014070; GO:0015909; GO:0019915; GO:0042149; GO:1905691	GAVTGSVEKTK	4.300000191	1	1	0.148637257	1076.482638	0	15.39531	16.42288	13.34754	17.22496	0	13.97047	15.24595	17.15166	0	16.48424	0	13.90391	0	12.40051	15.21317	15.21714	0	14.53774	14.84055	12.88161	15.23517	0	0	0	0	0	0	0	0	0	16.53739	0	14.56574	0	0	16.16786	0	0	0	0	11.64413	0	0	0	0	0	0
Q99549	MPP8_HUMAN	"M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM, Twa3)"	MPHOSPH8 MPP8	Homo sapiens (Human)	"negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of DNA methylation [GO:0044030]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of DNA methylation [GO:0044030]"	chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]	GO:0000786; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0035064; GO:0044030; GO:0045814; GO:0045869; GO:0045892; GO:0090309	EQVAEGAR	9.18999958	0.207073703	0.207073703	0.250898799	859.0371112	0	0	16.69864	0	0	0	0	0	17.45775	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.39053	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99550	MPP9_HUMAN	M-phase phosphoprotein 9	MPHOSPH9 MPP9	Homo sapiens (Human)	negative regulation of cilium assembly [GO:1902018]	centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]	centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; negative regulation of cilium assembly [GO:1902018]		GO:0000139; GO:0005794; GO:0005813; GO:0005814; GO:0016020; GO:1902018	KSSTPTK	1.970000029	0.621762037	0.621762037	0.056137749	748.3128821	0	16.49648	14.55244	13.95147	0	14.972	14.09484	16.1517	13.74582	12.72591	16.82715	13.99336	15.70118	14.50468	14.09186	16.78964	14.58253	15.53193	0	14.7297	15.88523	13.4791	0	17.4583	16.51746	14.80463	13.31518	14.15285	15.32085	15.65928	15.42025	0	0	0	13.84452	15.43572	15.82855	16.73652	19.70504	12.77582	14.4835	0	14.98275	12.62973	14.80946	16.17373	14.03368	15.49183
Q99551	MTEF1_HUMAN	"Transcription termination factor 1, mitochondrial (Mitochondrial transcription termination factor 1, mTERF, mTERF1)"	MTERF1 MTERF	Homo sapiens (Human)	"DNA geometric change [GO:0032392]; DNA-templated transcription, termination [GO:0006353]; regulation of transcription, DNA-templated [GO:0006355]; termination of mitochondrial transcription [GO:0006393]"	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	"mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; DNA geometric change [GO:0032392]; DNA-templated transcription, termination [GO:0006353]; regulation of transcription, DNA-templated [GO:0006355]; termination of mitochondrial transcription [GO:0006393]"	double-stranded DNA binding [GO:0003690]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0003676; GO:0003690; GO:0003723; GO:0005739; GO:0005759; GO:0006353; GO:0006355; GO:0006393; GO:0032392; GO:0042645	GLNYLTIMAPGNLWHMR	5.210000038	0.103814729	0.103814729	0.23596252	2019.437721	17.1706	16.98886	13.49093	15.53922	0	16.41166	15.5503	0	0	15.5864	0	0	0	0	0	17.03663	0	0	0	17.88554	0	0	18.97056	0	17.9866	0	17.87069	17.69579	0	0	0	17.64873	0	0	17.46054	0	0	17.34433	0	0	0	0	0	0	14.57743	17.60545	15.92996	0
Q99569	PKP4_HUMAN	Plakophilin-4 (p0071)	PKP4	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155]	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155]	cadherin binding [GO:0045296]	GO:0000922; GO:0001533; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007267; GO:0009898; GO:0014069; GO:0030054; GO:0030057; GO:0030155; GO:0030496; GO:0032467; GO:0043547; GO:0045296; GO:0048471; GO:0051233; GO:0072686; GO:0098609	RSGMTAVPQHLGPSLQR	1.440000057	1	1	0.356541902	1851.183239	0	16.10419	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6552	0	0	0	0	0	15.35521	15.79357	0	0	17.73626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99572	P2RX7_HUMAN	"P2X purinoceptor 7, P2X7 (ATP receptor) (P2Z receptor) (Purinergic receptor)"	P2RX7	Homo sapiens (Human)	apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; cellular response to ATP [GO:0071318]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion organization [GO:0007005]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid transfer to membrane [GO:0006649]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of lymphocyte apoptotic process [GO:0070230]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of another organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; vesicle budding from membrane [GO:0006900]	bleb [GO:0032059]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	bleb [GO:0032059]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; cellular response to ATP [GO:0071318]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion organization [GO:0007005]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid transfer to membrane [GO:0006649]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of lymphocyte apoptotic process [GO:0070230]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of another organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; vesicle budding from membrane [GO:0006900]	ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]	GO:0000902; GO:0001530; GO:0001614; GO:0001845; GO:0001916; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005524; GO:0005639; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006468; GO:0006509; GO:0006649; GO:0006900; GO:0006954; GO:0007005; GO:0007166; GO:0009410; GO:0009612; GO:0009897; GO:0010043; GO:0010524; GO:0010628; GO:0014049; GO:0014054; GO:0016020; GO:0016079; GO:0016485; GO:0017121; GO:0019233; GO:0030163; GO:0030501; GO:0031594; GO:0031668; GO:0032059; GO:0032060; GO:0032308; GO:0032496; GO:0032730; GO:0032731; GO:0032755; GO:0032963; GO:0033198; GO:0034405; GO:0034767; GO:0035585; GO:0035590; GO:0042098; GO:0042802; GO:0043025; GO:0043029; GO:0043132; GO:0043406; GO:0043409; GO:0045779; GO:0045794; GO:0045821; GO:0046513; GO:0046931; GO:0048705; GO:0048873; GO:0050714; GO:0050830; GO:0051209; GO:0051495; GO:0051592; GO:0051602; GO:0051709; GO:0051899; GO:0051901; GO:0070230; GO:0070588; GO:0071318; GO:0071359; GO:0072593; GO:0097190; GO:0097191; GO:0098793; GO:0098794; GO:1904172; GO:1905114	EPVISSVHTK	2.119999886	1	1	0	1096.053699	0	0	13.28727	0	0	0	0	0	0	0	0	0	0	0	0	0	14.92147	0	0	0	13.33818	8.787059	0	0	0	0	0	14.666	0	0	0	17.30954	0	0	14.33126	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99576	T22D3_HUMAN	"TSC22 domain family protein 3 (DSIP-immunoreactive peptide, Protein DIP, hDIP) (Delta sleep-inducing peptide immunoreactor) (Glucocorticoid-induced leucine zipper protein, GILZ) (TSC-22-like protein) (TSC-22-related protein, TSC-22R)"	TSC22D3 DSIPI GILZ	Homo sapiens (Human)	negative regulation of activation-induced cell death of T cells [GO:0070236]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of activation-induced cell death of T cells [GO:0070236]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]		GO:0005634; GO:0005829; GO:0006357; GO:0006970; GO:0070236	LDNSASGASVVAIDNKIEQAMDLVK	4.260000229	1	1	0	2604.776773	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.66829	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99578	RIT2_HUMAN	"GTP-binding protein Rit2, EC 3.6.5.2 (Ras-like protein expressed in neurons) (Ras-like without CAAX protein 2)"	RIT2 RIN ROC2	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic tree [GO:0097447]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic tree [GO:0097447]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]	calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]	GO:0001932; GO:0003682; GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007189; GO:0007264; GO:0007265; GO:0007268; GO:0010976; GO:0010977; GO:0019003; GO:0030100; GO:0030215; GO:0032489; GO:0032507; GO:0035556; GO:0043005; GO:0043410; GO:0044297; GO:0045121; GO:0045202; GO:0045944; GO:0050848; GO:0097447	VVMLGAGGVGK	4.159999847	0.458579034	0.458579034	0.195692751	1003.837454	0	15.07052	15.32743	0	0	0	0	0	0	15.35077	12.67008	14.33173	0	0	0	13.09683	0	10.86837	14.54949	0	0	15.50592	15.44735	0	0	9.234185	14.41487	15.37726	14.17651	0	14.27763	11.79835	10.33805	15.48963	13.05048	14.1054	15.60813	15.44332	15.70507	13.7298	12.55162	14.43395	0	13.56757	13.54138	14.72651	15.32549	15.44991
Q99590	SCAFB_HUMAN	"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129, SRrp129)"	SCAF11 CASP11 SFRS2IP SIP1 SRSF2IP	Homo sapiens (Human)	"mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]"	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0000245; GO:0000375; GO:0003723; GO:0005654; GO:0005730; GO:0006397; GO:0008380; GO:0016604; GO:0046872	DTIDKTK	4.070000172	0.859884024	0.859884024	0.202842867	819.4801245	15.528	15.32496	0	0	0	0	13.21186	16.06754	16.01184	16.11901	0	15.43921	0	0	13.76339	0	0	0	0	0	0	14.12971	0	0	0	0	0	0	0	0	16.57763	15.38368	0	16.17471	0	16.7307	0	17.22785	0	0	0	0	15.96562	0	0	0	0	0
Q99594	TEAD3_HUMAN	"Transcriptional enhancer factor TEF-5 (DTEF-1) (TEA domain family member 3, TEAD-3)"	TEAD3 TEAD5 TEF5	Homo sapiens (Human)	asymmetric neuroblast division [GO:0055059]; embryonic organ development [GO:0048568]; female pregnancy [GO:0007565]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; asymmetric neuroblast division [GO:0055059]; embryonic organ development [GO:0048568]; female pregnancy [GO:0007565]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]"	GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0005667; GO:0006357; GO:0007565; GO:0035329; GO:0045944; GO:0048568; GO:0055059; GO:0061629	AMNLDQVSK	7.710000038	1	1	0.091486776	1004.363009	0	13.25789	9.002148	0	0	0	0	16.76864	0	15.44645	15.29143	0	0	0	0	0	0	0	0	0	13.18827	0	0	0	0	0	14.67894	0	0	0	14.74633	0	17.61572	0	12.3562	15.49078	0	0	0	0	0	0	0	0	0	0	0	0
Q99608	NECD_HUMAN	Necdin	NDN	Homo sapiens (Human)	axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; central nervous system development [GO:0007417]; genomic imprinting [GO:0071514]; glial cell migration [GO:0008347]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of protein deacetylation [GO:0090312]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; respiratory system process [GO:0003016]; sensory perception of pain [GO:0019233]	cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]	"cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; gamma-tubulin binding [GO:0043015]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; central nervous system development [GO:0007417]; genomic imprinting [GO:0071514]; glial cell migration [GO:0008347]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of protein deacetylation [GO:0090312]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; respiratory system process [GO:0003016]; sensory perception of pain [GO:0019233]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; gamma-tubulin binding [GO:0043015]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0001228; GO:0001764; GO:0003016; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007413; GO:0007417; GO:0008285; GO:0008347; GO:0009791; GO:0019233; GO:0032991; GO:0040008; GO:0042995; GO:0043015; GO:0043204; GO:0043433; GO:0048011; GO:0048675; GO:0048871; GO:0071514; GO:0090312; GO:1990841	ASREITK	6.659999847	1	1	0.099950308	805.1763934	15.10352	15.16709	11.07058	12.51997	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.03175	0	0	0	0	0	0	15.77406	0	0	17.53036	0	0	0	0	0	0	0	0	0	0	0
Q99611	SPS2_HUMAN	"Selenide, water dikinase 2, EC 2.7.9.3 (Selenium donor protein 2) (Selenophosphate synthase 2)"	SEPHS2 SPS2	Homo sapiens (Human)	selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; selenocysteine metabolic process [GO:0016259]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; selenide, water dikinase activity [GO:0004756]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; selenocysteine metabolic process [GO:0016259]"	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; selenide, water dikinase activity [GO:0004756]"	GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0005829; GO:0016259; GO:0016260; GO:0046872	EEVELAYQEAMFNMATLNR	8.229999542	0.183590993	0.183590993	0.070599432	2259.380982	0	0	17.25431	0	0	0	0	16.06777	0	16.57876	0	0	0	14.14858	0	11.80723	0	14.32912	0	11.92807	11.5223	0	0	0	10.26107	13.75078	12.92505	11.49706	0	20.47301	16.72891	0	12.60931	0	12.05321	0	13.65288	12.36671	15.50639	0	14.67612	0	0	0	0	0	0	0
Q99613	EIF3C_HUMAN	"Eukaryotic translation initiation factor 3 subunit C, eIF3c (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)"	EIF3C EIF3S8	Homo sapiens (Human)	formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0043022; GO:0045727; GO:1902416	SEAPSGESR	8.949999809	0.840363145	0.840363145	0.251670311	917.760156	14.52315	14.36885	15.2058	15.46571	12.48423	14.27138	0	9.072755	15.24103	15.80744	14.94068	15.4537	0	13.39471	14.94012	15.18925	0	14.67022	0	16.0524	15.83404	16.41612	0	15.52489	16.91188	0	15.8296	15.83374	14.3683	0	0	16.05266	14.81377	14.89845	0	15.94671	16.18253	17.24368	0	17.44276	0	15.89164	0	0	14.5315	13.98787	14.84109	0
Q99618	CDCA3_HUMAN	"Cell division cycle-associated protein 3 (Gene-rich cluster protein C8) (Trigger of mitotic entry protein 1, TOME-1)"	CDCA3 C8 GRCC8 TOME1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]	adherens junction [GO:0005912]; cytosol [GO:0005829]	adherens junction [GO:0005912]; cytosol [GO:0005829]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]		GO:0005829; GO:0005912; GO:0007049; GO:0016567; GO:0051301	SSGSMR	5.260000229	1	1	0.222337096	639.6462684	0	0	14.81886	15.86132	0	16.1582	16.42959	0	16.23126	14.30124	0	15.83311	15.50285	15.8343	15.55443	0	15.67123	0	16.71378	0	16.86103	17.72651	17.65691	16.91131	16.6742	14.52286	0	0	16.63257	16.10141	16.67659	16.13944	14.08755	17.37148	16.61285	15.83678	15.50897	15.33138	17.94196	17.39248	15.66555	0	16.22616	16.94489	16.20688	16.4123	17.51502	16.72414
Q99643	C560_HUMAN	"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1, QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit, CYBL)"	SDHC CYB560 SDH3	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]"	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]"	"integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]"	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]	GO:0000104; GO:0005739; GO:0005743; GO:0005749; GO:0006099; GO:0006121; GO:0009055; GO:0009060; GO:0016021; GO:0020037; GO:0042776; GO:0046872	AALLLR	1.110000014	0.198980808	0.198980808	0.120049226	656.2573964	14.3535	17.48726	14.92874	13.55193	0	16.4453	0	16.3485	12.21511	9.501802	12.53487	13.33297	19.85471	14.97842	12.79725	11.69682	0	0	17.23424	0	0	0	0	18.02144	15.06491	0	17.58501	0	0	0	0	16.02301	17.92673	0	17.90075	0	15.2414	15.26751	0	12.37242	16.04395	15.31719	15.85958	17.17098	14.00496	10.31091	0	0
Q99653	CHP1_HUMAN	Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22)	CHP1 CHP	Homo sapiens (Human)	cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; potassium ion transport [GO:0006813]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; potassium channel regulator activity [GO:0015459]; protein kinase inhibitor activity [GO:0004860]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; potassium ion transport [GO:0006813]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]; small GTPase mediated signal transduction [GO:0007264]	calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; potassium channel regulator activity [GO:0015459]; protein kinase inhibitor activity [GO:0004860]	GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005886; GO:0005925; GO:0006469; GO:0006611; GO:0006813; GO:0007264; GO:0008017; GO:0010923; GO:0015459; GO:0015630; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070062; GO:0070885; GO:0071073; GO:0071468; GO:0090314; GO:1901214	MGSRASTLLR	7.539999962	1	1	0	1090.872497	16.31943	0	0	0	0	16.25904	0	16.82335	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99666	RGPD5_HUMAN	"RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2, RanBP2-like 1/2, RanBP2L1, RanBP2L2) (Sperm membrane protein BS-63)"	RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6	Homo sapiens (Human)	NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790]		GO:0005643; GO:0005737; GO:0006607; GO:0050790	LPHETSR	14.93000031	1	1	0.577565365	837.8538513	16.94533	0	0	0	0	17.15353	16.43909	0	0	0	0	0	17.09921	16.62	0	0	0	0	0	0	0	0	0	0	0	17.17947	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.62017
Q99683	M3K5_HUMAN	"Mitogen-activated protein kinase kinase kinase 5, EC 2.7.11.25 (Apoptosis signal-regulating kinase 1, ASK-1) (MAPK/ERK kinase kinase 5, MEK kinase 5, MEKK 5)"	MAP3K5 ASK1 MAPKKK5 MEKK5	Homo sapiens (Human)	"apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; wound healing [GO:0042060]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; wound healing [GO:0042060]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007254; GO:0008631; GO:0009897; GO:0010666; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0038066; GO:0042060; GO:0042802; GO:0042803; GO:0043065; GO:0043280; GO:0043507; GO:0045087; GO:0045663; GO:0045860; GO:0045893; GO:0046330; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0090398; GO:0097190; GO:0097300; GO:0106310; GO:1900745; GO:1901216; GO:1902170; GO:1902911; GO:1904707; GO:1990604	EIICQK	33.40000153	0.020905772	0.020905772	0.132072729	789.3197692	15.77493	15.7938	15.09456	15.88375	0	15.51864	14.02187	0	15.50238	16.77638	0	0	0	13.25384	0	18.35281	0	0	0	15.74855	0	0	0	0	0	0	0	16.34295	0	0	0	0	0	0	0	16.08059	0	0	0	0	0	17.6227	0	0	0	0	0	0
Q99684	GFI1_HUMAN	Zinc finger protein Gfi-1 (Growth factor independent protein 1) (Zinc finger protein 163)	GFI1 ZNF163	Homo sapiens (Human)	"cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000083; GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0010956; GO:0010957; GO:0010977; GO:0016032; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0032088; GO:0034121; GO:0045892; GO:0046872; GO:0051569; GO:0070105; GO:0071222; GO:1990837	ICGKSFK	8.199999809	1	1	0.285967261	840.0337176	0	16.42481	16.3741	0	0	0	0	0	0	0	0	0	0	16.32598	0	0	0	0	0	0	0	14.19585	16.37046	0	0	16.63047	0	0	0	0	15.48453	13.2076	0	16.14553	0	16.32924	16.64664	17.49558	0	0	0	16.29776	0	17.0835	0	0	0	0
Q99689	FEZ1_HUMAN	Fasciculation and elongation protein zeta-1 (Zygin I) (Zygin-1)	FEZ1	Homo sapiens (Human)	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; establishment of cell polarity [GO:0030010]; establishment of mitochondrion localization [GO:0051654]; hippocampus development [GO:0021766]; mitochondrion morphogenesis [GO:0070584]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; positive regulation of anterograde axonal transport of mitochondrion [GO:0061881]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; establishment of cell polarity [GO:0030010]; establishment of mitochondrion localization [GO:0051654]; hippocampus development [GO:0021766]; mitochondrion morphogenesis [GO:0070584]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; positive regulation of anterograde axonal transport of mitochondrion [GO:0061881]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]	gamma-tubulin binding [GO:0043015]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]	GO:0005080; GO:0005737; GO:0005739; GO:0005794; GO:0005813; GO:0005874; GO:0005886; GO:0007155; GO:0007399; GO:0007411; GO:0010976; GO:0021766; GO:0030010; GO:0030424; GO:0030425; GO:0030426; GO:0043015; GO:0043025; GO:0045666; GO:0047485; GO:0051654; GO:0061881; GO:0070584; GO:0071363; GO:1902902	KASPPSVEDLQMLTNILFAMK	5.53000021	1	1	1.83E-12	2354.801803	0	12.99359	15.09773	14.26882	0	13.18981	0	0	14.47285	0	0	0	13.60008	0	13.24387	0	0	0	0	0	15.87759	0	0	0	12.84889	15.24871	0	16.02634	0	16.36351	0	0	0	15.85544	0	13.57497	0	11.53815	0	0	0	0	0	12.67364	0	0	0	0
Q99698	LYST_HUMAN	Lysosomal-trafficking regulator (Beige homolog)	LYST CHS CHS1	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031]	cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]	cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; protein kinase binding [GO:0019901]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031]	protein kinase binding [GO:0019901]	GO:0005829; GO:0006909; GO:0007040; GO:0008104; GO:0015031; GO:0015630; GO:0016020; GO:0019901; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607	ADLIKMIK	7.860000134	0.887892485	0.887892485	0.149485409	948.5425526	15.64313	15.68359	14.9797	16.3145	0	13.37635	16.92254	14.90559	16.01219	16.18091	0	16.55764	15.13065	12.57904	0	0	14.60103	0	16.30125	16.09441	16.8194	15.51352	14.08911	14.87376	0	0	0	0	0	0	0	0	0	0	0	0	0	16.07761	14.08395	16.60081	0	0	0	14.94197	14.87783	0	0	0
Q99700	ATX2_HUMAN	Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein)	ATXN2 ATX2 SCA2 TNRC13	Homo sapiens (Human)	negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063]	epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0002091; GO:0003723; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005844; GO:0006417; GO:0008022; GO:0010494; GO:0016020; GO:0016070; GO:0033962; GO:0034063; GO:0048471; GO:0050658; GO:1990904	MSSEGPPR	6.429999828	0.821037471	0.821037471	0.215061914	863.2567908	16.35249	0	14.42416	14.40744	15.42922	0	0	13.77577	16.47651	18.73385	14.07606	14.91216	14.47699	15.97981	16.95937	15.29633	13.65945	17.43797	17.30338	0	13.21074	0	14.10064	15.26675	13.37746	17.07154	15.49077	17.0856	16.56236	0	16.54735	0	12.70537	16.59661	16.05208	17.63489	13.64559	16.81382	16.93164	17.63143	15.73568	0	0	0	11.92113	16.41039	16.80589	14.93626
Q99704	DOK1_HUMAN	Docking protein 1 (Downstream of tyrosine kinase 1) (p62(dok)) (pp62)	DOK1	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell surface receptor signaling pathway [GO:0007166]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]		GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007166; GO:0007169; GO:0007265; GO:0038145; GO:0048471	SHLLAADAPSSAAWVQTLCR	5.599999905	0.241539165	0.241539165	0.452645013	2153.096058	9.025551	0	17.08461	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.94655	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.70169	0	0	0	0	0	0	0	0	0
Q99705	MCHR1_HUMAN	"Melanin-concentrating hormone receptor 1, MCH receptor 1, MCH-R1, MCHR-1 (G-protein coupled receptor 24) (MCH-1R, MCH1R, MCHR) (SLC-1) (Somatostatin receptor-like protein)"	MCHR1 GPR24 SLC1	Homo sapiens (Human)	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]	ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanin-concentrating hormone receptor activity [GO:0030273]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanin-concentrating hormone receptor activity [GO:0030273]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]	GO:0004930; GO:0005102; GO:0005886; GO:0005887; GO:0005929; GO:0006091; GO:0007166; GO:0007186; GO:0007193; GO:0007204; GO:0007218; GO:0007631; GO:0008022; GO:0008188; GO:0030273; GO:0042277; GO:0042562; GO:0042923; GO:0043005; GO:0051928; GO:0060170; GO:0097730	ILQRMTSSVAPASQR	1.519999981	1	1	0.241634325	1646.859066	0	17.5278	17.63218	17.51039	17.80157	17.26893	0	16.4812	16.39954	15.40059	15.34496	16.90905	15.68034	0	17.10468	17.97322	0	16.01808	16.50033	0	17.3625	0	0	17.66839	17.33447	16.94045	16.33125	0	0	15.13766	14.741	17.99896	14.60975	16.66353	0	17.70267	0	18.73915	16.21067	16.35178	18.47523	16.82917	0	14.90246	16.57032	16.9393	17.24652	17.94555
Q99707	METH_HUMAN	"Methionine synthase, MS, EC 2.1.1.13 (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)"	MTR	Homo sapiens (Human)	axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]	cytosol [GO:0005829]	cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678]	cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]	GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732	VIDLGVMTPCDKILK	3.119999886	1	1	0.108598261	1718.381761	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1129	0	0	0	0	0	15.63122	0	14.94007	0	0	0	0	0	0	0	0	15.87637	14.36857	0	0	0	0	0	0	0	0	0	0	0	0	15.53987	0
Q99708	CTIP_HUMAN	"DNA endonuclease RBBP8, EC 3.1.-.- (CtBP-interacting protein, CtIP) (Retinoblastoma-binding protein 8, RBBP-8) (Retinoblastoma-interacting protein and myosin-like, RIM) (Sporulation in the absence of SPO11 protein 2 homolog, SAE2)"	RBBP8 CTIP	Homo sapiens (Human)	blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous recombination [GO:0035825]; meiotic cell cycle [GO:0051321]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357]	BRCA1-C complex [GO:0070533]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; transcription repressor complex [GO:0017053]	BRCA1-C complex [GO:0070533]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; transcription repressor complex [GO:0017053]; damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714]; Y-form DNA binding [GO:0000403]; blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous recombination [GO:0035825]; meiotic cell cycle [GO:0051321]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357]	damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714]; Y-form DNA binding [GO:0000403]	GO:0000014; GO:0000082; GO:0000403; GO:0000406; GO:0000724; GO:0001835; GO:0003684; GO:0003690; GO:0003697; GO:0003714; GO:0005634; GO:0005654; GO:0006281; GO:0006357; GO:0010792; GO:0017053; GO:0035825; GO:0035861; GO:0042802; GO:0043231; GO:0044818; GO:0051301; GO:0051321; GO:0061629; GO:0070336; GO:0070533; GO:0110025; GO:1905168	MDVTVIDTK	5.039999962	0.463662922	0.463662922	0.195395065	1020.403746	14.47524	0	15.36988	14.68664	0	0	0	0	14.15128	0	14.69331	0	15.01657	0	0	0	0	14.04415	0	0	0	0	16.06642	0	0	0	0	15.4278	16.15287	16.6719	0	0	15.37465	0	15.9476	0	0	14.66558	0	16.66892	13.84771	11.35094	13.42777	0	15.79787	15.26069	12.48464	10.31788
Q99714	HCD2_HUMAN	"3-hydroxyacyl-CoA dehydrogenase type-2, EC 1.1.1.35 (17-beta-estradiol 17-dehydrogenase, EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase, MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+)), EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase, EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase, EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase, EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2, Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)"	HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2	Homo sapiens (Human)	androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; lipid metabolic process [GO:0006629]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; tRNA methyltransferase complex [GO:0043527]	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; tRNA methyltransferase complex [GO:0043527]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; RNA binding [GO:0003723]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; lipid metabolic process [GO:0006629]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289]"	"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; RNA binding [GO:0003723]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]"	GO:0000049; GO:0003723; GO:0003857; GO:0004303; GO:0005737; GO:0005739; GO:0005759; GO:0005886; GO:0006550; GO:0006629; GO:0006631; GO:0006635; GO:0006699; GO:0007005; GO:0008207; GO:0008209; GO:0008210; GO:0008709; GO:0030283; GO:0030678; GO:0042645; GO:0043527; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0051289; GO:0062173; GO:0070901; GO:0097745; GO:0106281; GO:0106282; GO:0106283; GO:1990180	LDGAIR	6.150000095	1	1	0.097695235	643.9603894	0	0	0	0	0	15.88673	0	0	0	0	0	0	0	0	0	0	15.63407	0	0	0	0	0	16.86846	0	0	0	0	0	0	0	0	0	0	17.25424	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99715	COCA1_HUMAN	Collagen alpha-1(XII) chain	COL12A1 COL12A1L	Homo sapiens (Human)	cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]	collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]	collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0035987; GO:0062023; GO:0070062; GO:1903561	DELLAAIK	20.72999954	0.473447621	0.473447621	0.267543882	871.3360669	0	17.65811	17.1463	0	0	0	18.64458	18.35094	0	0	0	0	0	0	16.35095	0	0	0	16.96341	0	0	16.83279	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.11355	0	0	17.96266	0	0	0	0	0	0	0
Q99719	SEPT5_HUMAN	"Septin-5 (Cell division control-related protein 1, CDCrel-1) (Peanut-like protein 1)"	SEPTIN5 PNUTL1 SEPT5	Homo sapiens (Human)	adult behavior [GO:0030534]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; social behavior [GO:0035176]; synaptic vesicle targeting [GO:0016080]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; adult behavior [GO:0030534]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; social behavior [GO:0035176]; synaptic vesicle targeting [GO:0016080]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]	GO:0003924; GO:0005198; GO:0005525; GO:0005886; GO:0005940; GO:0008021; GO:0015630; GO:0016080; GO:0017157; GO:0030534; GO:0031105; GO:0032153; GO:0034613; GO:0035176; GO:0042802; GO:0060090; GO:0061640; GO:2000300	NMLIRTHMHDLK	1.879999995	1	1	0.563893494	1525.23161	0	17.54034	19.27233	0	0	0	0	0	0	0	0	0	18.55212	0	0	0	0	0	0	17.23421	0	0	0	0	0	0	0	0	18.2307	0	0	0	0	0	18.15515	0	0	0	0	0	18.4207	0	0	0	0	0	0	0
Q99728	BARD1_HUMAN	"BRCA1-associated RING domain protein 1, BARD-1, EC 2.3.2.27 (RING-type E3 ubiquitin transferase BARD1)"	BARD1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894]	BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894]	kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000152; GO:0000209; GO:0001894; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006282; GO:0006974; GO:0016567; GO:0016607; GO:0019900; GO:0031436; GO:0031441; GO:0035518; GO:0035825; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0044818; GO:0045732; GO:0045786; GO:0046826; GO:0046872; GO:0046982; GO:0051726; GO:0051865; GO:0070531; GO:0070532; GO:0070533; GO:0070537; GO:0071479; GO:0085020; GO:0110025; GO:2000001	SAPAMEPDGR	4.789999962	1	1	0.234539516	1030.373726	18.88144	0	0	0	0	0	17.47631	15.13026	17.66413	16.39019	14.26929	14.07657	14.78182	15.89955	0	0	0	15.73296	0	0	0	17.51502	0	16.65255	0	0	0	15.34524	15.22593	0	0	0	0	0	17.09718	16.55068	0	15.82434	0	16.09855	16.91075	13.75974	15.00086	0	16.29813	15.63823	0	19.57297
Q99729	ROAA_HUMAN	"Heterogeneous nuclear ribonucleoprotein A/B, hnRNP A/B (APOBEC1-binding protein 1, ABBP-1)"	HNRNPAB ABBP1 HNRPAB	Homo sapiens (Human)	"cellular response to amino acid stimulus [GO:0071230]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]"	cytoplasm [GO:0005737]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]	"cytoplasm [GO:0005737]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to amino acid stimulus [GO:0071230]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]"	mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]	GO:0001837; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0016556; GO:0030425; GO:0044877; GO:0045293; GO:0045893; GO:0071230; GO:0071598; GO:0090575; GO:1901537; GO:1904580; GO:1990124; GO:1990837; GO:1990904; GO:2000623	FHTVSGSK	14.85999966	0.290684432	0.290684432	0.229803454	861.4242361	15.21117	12.62123	15.09089	14.74577	15.70227	14.81097	15.60251	16.00845	14.32115	15.87943	15.68062	15.50935	17.38212	16.05792	0	16.71735	0	14.8683	15.75889	17.71874	16.34018	16.07515	15.94483	16.12567	18.26269	16.56278	16.11135	15.39919	15.06525	0	15.11457	0	16.5445	16.77564	17.96402	16.20839	18.57886	16.57118	18.35754	17.64194	0	16.50973	18.95345	16.02616	16.03518	16.98137	16.34649	17.52656
Q99733	NP1L4_HUMAN	"Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2, NAP-2)"	NAP1L4 NAP2	Homo sapiens (Human)	nucleosome assembly [GO:0006334]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; nucleosome assembly [GO:0006334]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005737; GO:0006334; GO:0031491; GO:0042393; GO:0051082	NASNTEK	10.60000038	1	1	0.123018829	762.4514567	0	0	0	14.61873	0	0	0	13.00465	0	15.55782	0	0	0	0	0	0	0	14.63047	0	0	0	16.91441	0	0	0	0	0	14.45238	0	0	0	0	16.22117	0	0	0	0	0	0	15.08665	0	0	15.48212	0	0	0	15.18035	0
Q99735	MGST2_HUMAN	"Microsomal glutathione S-transferase 2, Microsomal GST-2, EC 2.5.1.18 (Glutathione peroxidase MGST2, EC 1.11.1.-) (Leukotriene C4 synthase MGST2, EC 4.4.1.20) (Microsomal glutathione S-transferase II, Microsomal GST-II)"	MGST2 GST2	Homo sapiens (Human)	glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; positive regulation of inflammatory response [GO:0050729]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; positive regulation of inflammatory response [GO:0050729]	enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]	GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006629; GO:0006750; GO:0008047; GO:0016020; GO:0016021; GO:0019370; GO:0042802; GO:0043231; GO:0043295; GO:0046466; GO:0050729	MAGNSILLAAVSILSACQQSYFALQVGK	10.63000011	1	1	0.028084466	2956.032672	12.76385	0	10.72632	13.73602	0	13.12907	0	0	0	0	0	0	10.71445	15.58566	12.28418	11.8374	14.42622	11.7106	0	0	0	13.22231	0	15.51757	0	0	15.20268	5.785031	0	13.61478	7.347967	12.50659	13.73351	0	0	0	0	14.06494	0	0	0	14.54827	0	0	0	0	0	0
Q99742	NPAS1_HUMAN	"Neuronal PAS domain-containing protein 1, Neuronal PAS1 (Basic-helix-loop-helix-PAS protein MOP5) (Class E basic helix-loop-helix protein 11, bHLHe11) (Member of PAS protein 5) (PAS domain-containing protein 5)"	NPAS1 BHLHE11 MOP5 PASD5	Homo sapiens (Human)	"central nervous system development [GO:0007417]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; startle response [GO:0001964]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; central nervous system development [GO:0007417]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; startle response [GO:0001964]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001964; GO:0003700; GO:0005634; GO:0006357; GO:0007417; GO:0042711; GO:0045892; GO:0046982	SRNAAR	5.659999847	0.285797775	0.285797775	0.047593204	674.0025167	0	0	0	0	0	0	0	14.17075	0	13.12068	0	12.29259	0	0	0	0	0	15.1165	13.99205	16.8743	14.05325	17.60124	15.81357	0	17.12201	0	14.34266	0	14.29571	0	16.05303	17.17757	0	17.50367	0	15.16646	0	16.52969	0	16.68079	0	0	14.14373	13.80182	17.15682	0	12.60946	13.94426
Q99755	PI51A_HUMAN	"Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha, PIP5K1-alpha, PtdIns(4)P-5-kinase 1 alpha, EC 2.7.1.68 (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha, PIP5KIalpha)"	PIP5K1A	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	"cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165]"	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]"	GO:0000285; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0006650; GO:0006661; GO:0006909; GO:0007165; GO:0008654; GO:0010761; GO:0014066; GO:0016308; GO:0016477; GO:0016607; GO:0019900; GO:0030027; GO:0030216; GO:0031532; GO:0032587; GO:0046854; GO:0048041; GO:0052810; GO:0052812; GO:0060326; GO:0072659; GO:0090630; GO:0097178	FQRFMCNTVFK	6.139999866	0.021857779	0.021857779	0.185615989	1477.019518	0	0	16.67617	0	0	0	0	0	0	0	0	0	0	0	0	16.35601	0	0	0	15.53469	0	0	0	0	0	0	0	0	0	0	0	15.60418	0	0	0	15.98722	0	0	0	0	0	0	0	0	0	0	0	0
Q99758	ABCA3_HUMAN	"Phospholipid-transporting ATPase ABCA3, EC 7.6.2.1 (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3, ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3, EC 7.6.2.2) [Cleaved into: 150 Kda mature form ]"	ABCA3 ABC3	Homo sapiens (Human)	cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]	alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]	ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019]	GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016021; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0044267; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140	LTIFNILSGIATFLMVTIMRIPAVK	5.460000038	1	1	1.38E-12	2778.968207	0	0	0	0	15.80482	0	0	0	0	0	0	14.74472	16.11918	0	0	0	0	0	0	0	0	0	0	0	16.46075	16.44227	15.50481	16.42107	0	0	0	15.47596	0	0	0	0	0	15.71189	0	0	0	0	0	0	0	0	0	15.50255
Q99759	M3K3_HUMAN	"Mitogen-activated protein kinase kinase kinase 3, EC 2.7.11.25 (MAPK/ERK kinase kinase 3, MEK kinase 3, MEKK 3)"	MAP3K3 MAPKKK3 MEKK3	Homo sapiens (Human)	blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0001568; GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0035556; GO:0043123; GO:0046777; GO:0046872; GO:0071864; GO:0090050; GO:0106310; GO:1900745; GO:2000773	HQGNLFTLVPSSR	5.760000229	1	1	0.178379279	1456.057767	14.06275	13.18919	0	13.47911	13.08352	0	0	0	0	0	0	0	0	0	0	0	15.45173	16.71746	0	0	0	0	0	0	0	16.08932	0	0	16.01884	15.34406	0	0	0	16.62133	14.91039	0	16.61679	0	17.09795	0	0	16.79947	0	14.90266	0	6.1723	17.02579	0
Q99784	NOE1_HUMAN	Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1)	OLFM1 NOE1 NOEL1	Homo sapiens (Human)	atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165]	axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]	axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165]		GO:0003190; GO:0005615; GO:0005783; GO:0007165; GO:0007399; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030424; GO:0030516; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0045202; GO:0060317	FGSWMTDPLAPEGDNRVWYMDGYHNNR	3.890000105	1	1	4.57E-13	3261.471942	13.54229	15.33938	0	0	13.89544	0	14.2338	0	0	15.47495	0	13.26957	0	15.0731	14.9819	16.63143	0	0	0	0	0	0	0	9.165971	13.47793	14.15619	15.26787	0	0	0	0	0	0	0	0	0	12.56709	0	0	0	0	15.05129	14.46715	0	0	0	0	0
Q99788	CML1_HUMAN	Chemerin-like receptor 1 (Chemokine-like receptor 1) (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ)	CMKLR1 CHEMR23 DEZ	Homo sapiens (Human)	chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; regulation of calcium-mediated signaling [GO:0050848]; skeletal system development [GO:0001501]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; chemokine receptor activity [GO:0004950]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; regulation of calcium-mediated signaling [GO:0050848]; skeletal system development [GO:0001501]	adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; chemokine receptor activity [GO:0004950]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]	GO:0001501; GO:0002430; GO:0004875; GO:0004930; GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007200; GO:0007204; GO:0010759; GO:0016021; GO:0032088; GO:0032695; GO:0038023; GO:0045600; GO:0050848; GO:0097003; GO:0097004; GO:0120162	MSSMNER	7.960000038	1	1	0.335266144	870.056302	16.06142	0	14.40649	0	0	15.057	14.96979	15.01964	0	14.58527	16.18601	12.75054	0	14.17592	0	0	14.5314	16.05201	15.37469	0	0	15.81213	15.97364	15.17388	0	14.10241	0	0	0	15.94759	0	0	0	0	0	16.61755	0	0	0	0	0	0	0	0	16.16848	0	0	0
Q99801	NKX31_HUMAN	Homeobox protein Nkx-3.1 (Homeobox protein NK-3 homolog A)	NKX3-1 NKX3.1 NKX3A	Homo sapiens (Human)	"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; androgen receptor signaling pathway [GO:0030521]; branching involved in prostate gland morphogenesis [GO:0060442]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal aorta development [GO:0035907]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; heart development [GO:0007507]; male gonad development [GO:0008584]; metanephros development [GO:0001656]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of transcription, DNA-templated [GO:0045892]; pharyngeal system development [GO:0060037]; positive regulation of androgen secretion [GO:2000836]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell death [GO:0010942]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to testosterone [GO:0033574]; salivary gland development [GO:0007431]; somitogenesis [GO:0001756]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; MADS box domain binding [GO:0097162]; nuclear receptor activity [GO:0004879]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; androgen receptor signaling pathway [GO:0030521]; branching involved in prostate gland morphogenesis [GO:0060442]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal aorta development [GO:0035907]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; heart development [GO:0007507]; male gonad development [GO:0008584]; metanephros development [GO:0001656]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of transcription, DNA-templated [GO:0045892]; pharyngeal system development [GO:0060037]; positive regulation of androgen secretion [GO:2000836]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell death [GO:0010942]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to testosterone [GO:0033574]; salivary gland development [GO:0007431]; somitogenesis [GO:0001756]"	"cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; MADS box domain binding [GO:0097162]; nuclear receptor activity [GO:0004879]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]"	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001656; GO:0001756; GO:0001934; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0006919; GO:0007431; GO:0007507; GO:0008284; GO:0008285; GO:0008584; GO:0008656; GO:0010628; GO:0010629; GO:0010942; GO:0014068; GO:0030154; GO:0030331; GO:0030521; GO:0032880; GO:0033574; GO:0035907; GO:0042826; GO:0043280; GO:0043491; GO:0043565; GO:0043569; GO:0043621; GO:0045892; GO:0045893; GO:0045931; GO:0045944; GO:0048754; GO:0050680; GO:0051091; GO:0051781; GO:0060037; GO:0060442; GO:0060664; GO:0060770; GO:0071347; GO:0071356; GO:0071383; GO:0071456; GO:0071466; GO:0090734; GO:0097162; GO:0140297; GO:0140416; GO:1902807; GO:1990837; GO:2000836; GO:2001022; GO:2001235; GO:2001244	AGAQNDQLSTGPRAAPEEAETLAETEPER	7.559999943	0.729641438	0.729641438	4.12E-12	3038.620103	9.899951	0	0	0	13.4268	0	0	13.7398	0	0	16.04195	13.72593	0	0	14.59289	0	13.86228	14.30718	0	0	0	0	0	10.62911	14.10439	0	0	0	0	0	15.57687	0	0	13.06211	0	0	0	0	0	0	0	0	0	0	0	0	13.52057	0
Q99807	COQ7_HUMAN	"5-demethoxyubiquinone hydroxylase, mitochondrial, DMQ hydroxylase, EC 1.14.99.60 (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)"	COQ7	Homo sapiens (Human)	determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]	extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142]	"extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142]; 3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]"	"3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]"	GO:0000122; GO:0003682; GO:0005634; GO:0005739; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0031314; GO:0045944; GO:0046872; GO:0110142; GO:2000377	MSCAGAAAAPR	3.890000105	1	1	0.183444752	1078.213704	18.09816	11.11349	0	0	0	0	0	0	19.16415	13.84204	0	0	0	0	0	13.80137	0	0	0	0	0	0	0	0	14.45217	0	16.8295	0	0	0	0	0	0	0	14.21511	15.42622	18.24426	0	0	16.11905	0	0	13.36402	0	15.78438	0	0	14.29243
Q99814	EPAS1_HUMAN	"Endothelial PAS domain-containing protein 1, EPAS-1 (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73, bHLHe73) (HIF-1-alpha-like factor, HLF) (Hypoxia-inducible factor 2-alpha, HIF-2-alpha, HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2)"	EPAS1 BHLHE73 HIF2A MOP2 PASD2	Homo sapiens (Human)	angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; mRNA transcription by RNA polymerase II [GO:0042789]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart rate [GO:0002027]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; visual perception [GO:0007601]	chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; mRNA transcription by RNA polymerase II [GO:0042789]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart rate [GO:0002027]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; visual perception [GO:0007601]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001525; GO:0001666; GO:0001892; GO:0001974; GO:0002027; GO:0003677; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0007005; GO:0007165; GO:0007601; GO:0016607; GO:0030218; GO:0030324; GO:0042415; GO:0042789; GO:0043129; GO:0043619; GO:0045944; GO:0046982; GO:0048469; GO:0048625; GO:0055072; GO:0061629; GO:0071456; GO:0120162; GO:2000434	ASLPPCCGQASTPLSSMGGR	4.559999943	1	1	0.149425984	2049.387563	12.67525	0	13.02739	0	14.06776	12.22095	8.974989	13.24967	10.35921	14.4021	0	0	9.242476	0	0	0	0	0	0	0	0	12.93738	0	11.88184	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99816	TS101_HUMAN	Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101)	TSG101	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]	GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007049; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0016236; GO:0019076; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043405; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090543; GO:0097352; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397	KTAGLSDLY	5.460000038	0.556079507	0.556079507	0.019934182	966.843462	10.82227	15.16877	16.02209	16.85012	13.42287	0	18.18344	14.8701	17.62455	18.2307	17.33856	16.46993	15.18486	14.64103	14.69287	13.80116	12.56077	15.62275	14.98227	17.67236	16.78376	16.25967	14.25908	17.21682	17.57372	16.27421	17.44054	9.222054	0	0	0	15.02247	16.10803	0	11.71799	0	17.49127	16.05927	13.19909	16.20137	12.25782	0	16.53041	15.12861	14.80718	0	14.62365	12.59706
Q99848	EBP2_HUMAN	Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40)	EBNA1BP2 EBP2	Homo sapiens (Human)	ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	"chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	"chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"	RNA binding [GO:0003723]	GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273	KGPSAK	3.089999914	0.27955395	0.27955395	0.117460931	585.4465167	17.25609	15.8977	16.79807	17.79923	17.07274	16.6041	16.77289	16.84908	17.12623	18.58368	15.40586	16.5678	19.07529	17.47807	17.40916	18.89329	17.38999	16.77315	17.28733	17.99192	18.34137	18.48311	17.23227	17.69144	19.32461	15.8072	18.94095	16.52991	18.68549	18.19609	17.62451	16.63056	18.32323	19.53698	18.32609	19.61903	18.08017	17.09546	17.49663	18.09908	19.38037	18.94012	16.19455	17.79836	17.26202	18.75685	18.47131	17.19741
Q99856	ARI3A_HUMAN	"AT-rich interactive domain-containing protein 3A, ARID domain-containing protein 3A (B-cell regulator of IgH transcription, Bright) (Dead ringer-like protein 1) (E2F-binding protein 1)"	ARID3A DRIL1 DRIL3 DRX E2FBP1	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003682; GO:0003712; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0042802; GO:0045121; GO:0045944	KLQAVMETLLQR	11.72999954	0.639745533	0.639745533	0.501808317	1430.335323	0	0	0	0	0	0	0	0	17.99738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.2775	0	0	16.56105	18.00574	0	18.83116	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99909	SSX3_HUMAN	"Protein SSX3 (Cancer/testis antigen 5.3, CT5.3)"	SSX3	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]"		GO:0005634; GO:0006355	AILPSFMR	10.61999989	0.545287251	0.545287251	0.204782769	933.6443238	0	15.46482	0	16.42201	13.60787	17.56673	14.06061	16.65972	0	0	15.48268	15.78162	14.10629	16.12667	0	0	0	14.65142	0	0	0	11.92854	15.78993	16.54332	0	12.7084	12.71796	12.65712	0	13.74191	16.17073	16.70761	0	17.5467	0	16.07007	17.44373	15.57571	15.30691	16.19059	0	16.31678	0	0	9.259784	15.9991	14.72044	0
Q99928	GBRG3_HUMAN	Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3)	GABRG3	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]	"chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]"	GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0004890; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0009410; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0098794; GO:0098982; GO:0099699; GO:1902476; GO:1902711; GO:1904315	FNSTMKILTLNSNMVGLIWIPDTIFR	11.67000008	1	1	3.66E-12	3057.76349	0	0	0	0	0	0	0	20.3201	0	0	0	19.20319	19.71059	18.03391	19.61465	0	0	18.36651	0	0	19.73451	0	0	0	20.56536	18.03177	0	0	0	19.79266	18.21318	18.71545	19.69528	19.36914	0	19.67203	0	19.75019	18.63871	0	0	20.36535	0	0	0	0	18.29548	16.78796
Q99929	ASCL2_HUMAN	"Achaete-scute homolog 2, ASH-2, hASH2 (Class A basic helix-loop-helix protein 45, bHLHa45) (Mash2)"	ASCL2 BHLHA45 HASH2	Homo sapiens (Human)	negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]; spongiotrophoblast differentiation [GO:0060708]; spongiotrophoblast layer development [GO:0060712]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]; spongiotrophoblast differentiation [GO:0060708]; spongiotrophoblast layer development [GO:0060712]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001666; GO:0001890; GO:0005634; GO:0005737; GO:0006357; GO:0007423; GO:0010626; GO:0030182; GO:0035019; GO:0045944; GO:0046983; GO:0050767; GO:0060708; GO:0060712; GO:0070888; GO:0090575; GO:1990837	DGGTLPR	9.659999847	1	1	0.213216883	714.4380091	16.72747	0	16.51958	0	0	0	0	0	0	0	0	0	0	0	0	0	17.74709	0	0	0	0	0	16.65651	0	0	18.88522	0	0	0	17.93729	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q99941	ATF6B_HUMAN	"Cyclic AMP-dependent transcription factor ATF-6 beta, cAMP-dependent transcription factor ATF-6 beta (Activating transcription factor 6 beta, ATF6-beta) (Protein G13) (cAMP response element-binding protein-related protein, Creb-rp) (cAMP-responsive element-binding protein-like 1) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 beta ]"	ATF6B CREBL1 G13	Homo sapiens (Human)	ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]"	"cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0005789; GO:0005794; GO:0006357; GO:0007165; GO:0030176; GO:0030968; GO:0032993; GO:0035497; GO:0036500; GO:0045944; GO:0090575; GO:1903892; GO:1990440; GO:1990837	SIVPAPMPGNSCPPEVDAK	2.410000086	1	1	0.306016675	1964.003214	12.17952	15.46195	14.00673	0	0	13.87575	0	0	0	0	0	0	0	0	0	11.37385	0	15.39166	0	15.32936	0	0	0	0	0	0	0	0	0	0	0	0	0	14.95565	0	16.34067	0	0	0	0	0	0	0	0	0	0	0	0
Q99943	PLCA_HUMAN	"1-acyl-sn-glycerol-3-phosphate acyltransferase alpha, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 1, 1-AGP acyltransferase 1, 1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha, LPAAT-alpha) (Protein G15)"	AGPAT1 G15	Homo sapiens (Human)	CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]	GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0016024	GGGDYLKKPGGGG	7.329999924	1	1	2.30E-13	1162.734073	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.72451	0	0	14.94989	0	0	0	0	0	14.84106	14.93292	0	15.09486	15.35964	0	15.20611	15.59671	0	0	0	0	0	0	0	0	0	17.16586	0	0	0
Q99952	PTN18_HUMAN	"Tyrosine-protein phosphatase non-receptor type 18, EC 3.1.3.48 (Brain-derived phosphatase)"	PTPN18 BDP1	Homo sapiens (Human)	blastocyst formation [GO:0001825]; negative regulation of ERBB signaling pathway [GO:1901185]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; blastocyst formation [GO:0001825]; negative regulation of ERBB signaling pathway [GO:1901185]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]	non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001825; GO:0004725; GO:0004726; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0035335; GO:1901185	DVLPYDQTR	7.820000172	1	1	0.236399338	1107.070288	18.26674	17.59528	0	18.39993	0	0	0	0	19.49449	0	0	0	0	0	17.00142	0	0	0	0	0	0	0	20.50918	0	0	0	0	0	0	0	0	0	0	0	0	17.12591	0	0	19.49497	0	0	18.92476	20.45344	0	0	17.4597	0	0
Q99959	PKP2_HUMAN	Plakophilin-2	PKP2	Homo sapiens (Human)	bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling involved in cardiac conduction [GO:0086019]; desmosome assembly [GO:0002159]; desmosome organization [GO:0002934]; heart development [GO:0007507]; intermediate filament bundle assembly [GO:0045110]; maintenance of animal organ identity [GO:0048496]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; ventricular cardiac muscle cell action potential [GO:0086005]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; intermediate filament binding [GO:0019215]; molecular adaptor activity [GO:0060090]; protein kinase C binding [GO:0005080]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling involved in cardiac conduction [GO:0086019]; desmosome assembly [GO:0002159]; desmosome organization [GO:0002934]; heart development [GO:0007507]; intermediate filament bundle assembly [GO:0045110]; maintenance of animal organ identity [GO:0048496]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; ventricular cardiac muscle cell action potential [GO:0086005]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; intermediate filament binding [GO:0019215]; molecular adaptor activity [GO:0060090]; protein kinase C binding [GO:0005080]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]	GO:0001533; GO:0002159; GO:0002934; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005882; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007507; GO:0010765; GO:0014704; GO:0016021; GO:0017080; GO:0019215; GO:0030054; GO:0030057; GO:0044325; GO:0045110; GO:0045294; GO:0045296; GO:0048496; GO:0055010; GO:0060090; GO:0072659; GO:0086002; GO:0086005; GO:0086019; GO:0086064; GO:0086073; GO:0086083; GO:0086091; GO:0098609; GO:0098911	AGTTSR	5.190000057	0.059020668	0.059020668	0.299396414	594.0722154	15.11763	0	15.15864	0	15.0867	15.44779	16.55372	15.77905	0	0	0	14.62865	15.20439	14.97108	15.78386	0	0	15.62539	16.57727	16.09712	0	16.13859	16.29451	15.67907	15.92303	0	15.28397	15.51799	15.58293	15.95227	16.20215	14.76811	14.72641	15.06285	0	16.14175	0	15.20498	17.89598	0	0	16.64512	0	0	0	0	16.67415	0
Q99961	SH3G1_HUMAN	"Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein, EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1)"	SH3GL1 CNSA1 SH3D2B	Homo sapiens (Human)	central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]	GO:0002102; GO:0005737; GO:0005829; GO:0007165; GO:0007417; GO:0008289; GO:0016191; GO:0031901; GO:0042802; GO:0042995; GO:0045296; GO:0098793; GO:0098978	VGGAEGTK	4.920000076	0.281477094	0.281477094	0.232812281	720.0444563	16.38273	14.82561	16.01767	16.52049	16.30952	0	0	17.34053	0	0	0	0	17.79363	17.00086	14.48918	0	16.00626	0	0	0	0	0	0	0	15.96651	16.62498	0	15.38488	0	0	13.90785	18.98062	0	0	0	16.70855	17.42158	0	0	0	0	17.38888	17.26169	0	0	15.23901	14.89274	0
Q99963	SH3G3_HUMAN	Endophilin-A3 (EEN-B2) (Endophilin-3) (SH3 domain protein 2C) (SH3 domain-containing GRB2-like protein 3)	SH3GL3 CNSA3 SH3D2C	Homo sapiens (Human)	central nervous system development [GO:0007417]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; positive regulation of neuron differentiation [GO:0045666]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]	"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endosome [GO:0098845]; presynapse [GO:0098793]"	"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endosome [GO:0098845]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein C-terminus binding [GO:0008022]; central nervous system development [GO:0007417]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; positive regulation of neuron differentiation [GO:0045666]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]"	identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein C-terminus binding [GO:0008022]	GO:0001669; GO:0005737; GO:0007165; GO:0007417; GO:0008022; GO:0008289; GO:0016191; GO:0031901; GO:0042802; GO:0045666; GO:0098793; GO:0098845; GO:0098978; GO:0099092; GO:1900186	ASQLFSEK	4.619999886	1	1	0.142783362	910.4138961	0	0	14.93618	15.94457	14.98893	0	13.74055	14.05652	14.06098	13.62081	16.30751	17.22725	14.24107	13.89818	14.2219	15.28651	0	13.3051	14.79288	13.64659	13.49625	18.00311	17.38916	0	0	0	0	0	0	0	0	0	0	16.45659	0	0	0	0	15.27049	0	0	0	14.67175	0	0	0	0	0
Q99965	ADAM2_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 2, ADAM 2 (Cancer/testis antigen 15, CT15) (Fertilin subunit beta) (PH-30, PH30) (PH30-beta)"	ADAM2 FTNB	Homo sapiens (Human)	adult behavior [GO:0030534]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; positive regulation of gene expression [GO:0010628]; visual learning [GO:0008542]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; adult behavior [GO:0030534]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; positive regulation of gene expression [GO:0010628]; visual learning [GO:0008542]	integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005178; GO:0005886; GO:0005887; GO:0007155; GO:0007339; GO:0007342; GO:0008237; GO:0008542; GO:0009986; GO:0010628; GO:0030534; GO:0032991	LDPFFKQQAVCGNAK	8.510000229	0.211133182	0.211133182	0.193450373	1723.363557	0	0	0	17.5228	16.93191	0	0	0	0	0	0	0	0	0	0	0	16.16542	17.79023	0	0	0	0	0	0	0	16.09831	0	0	0	17.54976	0	16.66134	18.30433	17.8378	0	0	0	16.40028	16.11942	0	0	0	16.47308	0	0	12.28981	0	0
Q99967	CITE2_HUMAN	"Cbp/p300-interacting transactivator 2 (MSG-related protein 1, MRG-1) (P35srj)"	CITED2 MRG1	Homo sapiens (Human)	"adrenal cortex formation [GO:0035802]; bone morphogenesis [GO:0060349]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; cranial nerve morphogenesis [GO:0021602]; decidualization [GO:0046697]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endocardial cushion development [GO:0003197]; erythrocyte development [GO:0048821]; granulocyte differentiation [GO:0030851]; heart development [GO:0007507]; heart looping [GO:0001947]; hematopoietic progenitor cell differentiation [GO:0002244]; left/right axis specification [GO:0070986]; left/right pattern formation [GO:0060972]; lens morphogenesis in camera-type eye [GO:0002089]; liver development [GO:0001889]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; peripheral nervous system development [GO:0007422]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of gene expression [GO:0010628]; positive regulation of male gonad development [GO:2000020]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pulmonary artery morphogenesis [GO:0061156]; regulation of animal organ formation [GO:0003156]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sex determination [GO:0007530]; skeletal muscle cell differentiation [GO:0035914]; spleen development [GO:0048536]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; LBD domain binding [GO:0050693]; protein domain specific binding [GO:0019904]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; adrenal cortex formation [GO:0035802]; bone morphogenesis [GO:0060349]; cardiac neural crest cell development involved in heart development [GO:0061308]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; cranial nerve morphogenesis [GO:0021602]; decidualization [GO:0046697]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endocardial cushion development [GO:0003197]; erythrocyte development [GO:0048821]; granulocyte differentiation [GO:0030851]; heart development [GO:0007507]; heart looping [GO:0001947]; hematopoietic progenitor cell differentiation [GO:0002244]; left/right axis specification [GO:0070986]; left/right pattern formation [GO:0060972]; lens morphogenesis in camera-type eye [GO:0002089]; liver development [GO:0001889]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; peripheral nervous system development [GO:0007422]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of gene expression [GO:0010628]; positive regulation of male gonad development [GO:2000020]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pulmonary artery morphogenesis [GO:0061156]; regulation of animal organ formation [GO:0003156]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sex determination [GO:0007530]; skeletal muscle cell differentiation [GO:0035914]; spleen development [GO:0048536]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]"	chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; LBD domain binding [GO:0050693]; protein domain specific binding [GO:0019904]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000785; GO:0001570; GO:0001666; GO:0001829; GO:0001843; GO:0001889; GO:0001892; GO:0001947; GO:0002089; GO:0002244; GO:0003151; GO:0003156; GO:0003197; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007179; GO:0007368; GO:0007417; GO:0007422; GO:0007507; GO:0007530; GO:0007569; GO:0008283; GO:0008584; GO:0009612; GO:0010628; GO:0010629; GO:0019904; GO:0021602; GO:0022409; GO:0030336; GO:0030511; GO:0030851; GO:0032991; GO:0034405; GO:0035035; GO:0035360; GO:0035802; GO:0035914; GO:0043066; GO:0043627; GO:0045787; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046697; GO:0048536; GO:0048538; GO:0048596; GO:0048821; GO:0050693; GO:0060044; GO:0060136; GO:0060349; GO:0060412; GO:0060971; GO:0060972; GO:0061156; GO:0061308; GO:0061428; GO:0061629; GO:0070986; GO:1900164; GO:2000020	MADHMMAMNHGR	4.389999866	1	1	0.202128494	1419.200867	19.63597	0	0	18.77969	0	0	17.93781	14.81969	0	12.37714	15.54626	16.50064	15.63002	16.14724	17.74701	15.854	15.0286	14.42101	0	0	14.89851	0	0	0	14.52249	18.14045	15.2285	0	16.71605	0	0	0	17.63294	0	15.10872	13.61295	16.35136	0	17.38037	13.3692	0	7.714822	0	17.06114	0	0	0	15.03699
Q99972	MYOC_HUMAN	"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]"	MYOC GLC1A TIGR	Homo sapiens (Human)	bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; skeletal muscle hypertrophy [GO:0014734]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791]; fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971]; bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; skeletal muscle hypertrophy [GO:0014734]	fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971]	GO:0001649; GO:0001953; GO:0001968; GO:0005109; GO:0005615; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005791; GO:0005794; GO:0005929; GO:0007165; GO:0014068; GO:0014734; GO:0022011; GO:0030335; GO:0030971; GO:0031175; GO:0031410; GO:0032027; GO:0033268; GO:0035024; GO:0038031; GO:0038133; GO:0043408; GO:0045162; GO:0046872; GO:0051496; GO:0051497; GO:0051894; GO:0051897; GO:0051901; GO:0060348; GO:0062023; GO:0070062; GO:1900026	SELTEVPASR	9.550000191	0.728838027	0.728838027	0.284952125	1089.476742	12.72346	15.16481	15.39279	13.35832	12.62421	13.36088	0	14.26557	0	14.51762	11.85381	0	14.80649	0	16.53799	15.1765	16.09825	15.87253	14.82096	0	0	14.44002	0	0	0	14.68381	0	0	0	0	0	0	0	0	0	0	17.45564	0	0	14.92661	0	0	0	0	0	15.60517	0	0
Q99973	TEP1_HUMAN	"Telomerase protein component 1 (Telomerase-associated protein 1, Telomerase protein 1) (p240) (p80 telomerase homolog)"	TEP1 TLP1 TP1	Homo sapiens (Human)	telomere maintenance via recombination [GO:0000722]	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]"	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]	GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904	DLGAPGASIR	5.28000021	1	1	0.102344507	953.858353	14.90277	14.16509	15.69359	0	0	0	0	0	0	0	16.32467	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.61368	0	0	0	0	0	0	0	0	0
Q99990	VGLL1_HUMAN	"Transcription cofactor vestigial-like protein 1, Vgl-1 (Protein TONDU)"	VGLL1 TDU	Homo sapiens (Human)	"regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0006357	ENGNPGQIAGSTGLLFNLPPGSVHYKK	3.420000076	1	1	0.216766401	2796.49239	14.79036	15.44893	0	0	0	15.14368	0	0	15.20337	0	0	0	13.81746	0	0	0	14.57438	12.31982	15.513	0	0	0	13.84941	14.30408	0	14.37317	0	0	0	0	0	16.04984	0	0	0	0	0	0	0	0	0	0	0	0	0	16.70687	0	15.81361
Q99996	AKAP9_HUMAN	"A-kinase anchor protein 9, AKAP-9 (A-kinase anchor protein 350 kDa, AKAP 350, hgAKAP 350) (A-kinase anchor protein 450 kDa, AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein, CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9, PRKA9) (Protein yotiao)"	AKAP9 AKAP350 AKAP450 KIAA0803	Homo sapiens (Human)	cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]	centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]	DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]	GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007194; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0033138; GO:0034237; GO:0034705; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098962; GO:0098978; GO:0099147; GO:1901018; GO:1903358	ETNFKMNQLTQELFSLK	3.059999943	0.410833925	0.410833925	0.096544771	2086.62615	15.92847	12.36023	0	0	15.8199	0	0	15.76141	16.0849	0	13.19928	0	0	0	0	0	0	0	0	0	0	17.10402	0	11.85761	15.45797	0	15.82252	0	0	0	0	15.95288	17.44073	16.12984	0	0	0	16.34274	0	0	0	0	0	0	13.78122	0	14.75264	0
Q9BPX7	CG025_HUMAN	UPF0415 protein C7orf25	C7orf25	Homo sapiens (Human)						IAIAKELIK	20.44000053	1	1	0.216702006	997.4756309	0	0	0	20.1177	0	0	0	22.67866	0	0	0	16.93844	0	0	16.76109	0	0	0	0	0	0	0	0	18.01437	0	17.63417	0	0	18.50162	18.77164	20.05702	21.16154	0	17.22603	0	0	19.83122	0	0	19.20434	18.11245	21.00252	0	15.03431	19.96417	0	16.52127	0
Q9BPY3	F118B_HUMAN	Protein FAM118B	FAM118B	Homo sapiens (Human)	Cajal body organization [GO:0030576]	Cajal body [GO:0015030]	Cajal body [GO:0015030]; identical protein binding [GO:0042802]; Cajal body organization [GO:0030576]	identical protein binding [GO:0042802]	GO:0015030; GO:0030576; GO:0042802	LTCEISTRGTSAGMVR	5.889999866	1	1	0.10898597	1739.504598	13.4156	0	0	0	16.64356	0	0	0	0	0	10.62215	0	0	0	0	0	14.93938	0	0	0	0	0	0	15.85233	0	0	0	0	0	16.4444	0	0	0	0	0	7.361927	0	12.8832	0	0	0	15.31557	0	13.98599	0	0	0	15.28917
Q9BPZ7	SIN1_HUMAN	"Target of rapamycin complex 2 subunit MAPKAP1, TORC2 subunit MAPKAP1 (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1, SAPK-interacting protein 1, mSIN1)"	MAPKAP1 MIP1 SIN1	Homo sapiens (Human)	cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Ras protein signal transduction [GO:0046580]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; substantia nigra development [GO:0021762]; TORC2 signaling [GO:0038203]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]	"cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Ras protein signal transduction [GO:0046580]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; substantia nigra development [GO:0021762]; TORC2 signaling [GO:0038203]"	"phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]"	GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0016310; GO:0019901; GO:0021762; GO:0030307; GO:0031267; GO:0031410; GO:0031669; GO:0031932; GO:0033138; GO:0038203; GO:0043066; GO:0043325; GO:0046580; GO:0070300; GO:0080025; GO:1900407	EKPPISGKQSILSVR	5.599999905	1	1	0.714927217	1639.343515	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.63213	17.59921	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.42064	0	0	0	0	18.14623	0	0	0	0	0	0
Q9BQ13	KCD14_HUMAN	BTB/POZ domain-containing protein KCTD14	KCTD14	Homo sapiens (Human)	protein homooligomerization [GO:0051260]		protein homooligomerization [GO:0051260]		GO:0051260	AVLDNSDLMHCLEMDIK	1.629999995	1	1	0.306139344	2020.855304	0	13.96765	0	0	16.17111	0	0	14.66417	14.14421	0	0	14.72343	14.63469	0	7.543853	0	12.24416	12.52824	0	0	0	0	15.54724	0	0	14.35613	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BQ24	ZFY21_HUMAN	"Zinc finger FYVE domain-containing protein 21, ZF21"	ZFYVE21	Homo sapiens (Human)		endosome [GO:0005768]; focal adhesion [GO:0005925]	endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005768; GO:0005925; GO:0046872	LVRSPSGLR	9.130000114	0.535209656	0.535209656	0.159557991	984.5638704	0	15.92293	0	11.17598	15.13219	14.44515	0	12.84391	14.16954	13.28949	15.04184	14.49179	13.58441	15.83974	15.5441	15.25624	12.76333	15.247	10.90746	15.02334	15.28669	17.45204	16.92546	0	0	14.50724	13.90521	13.97033	0	0	16.23555	15.52091	0	15.35081	11.25255	16.47363	16.09034	14.63687	16.68554	13.35841	12.83583	12.51983	0	0	0	14.0042	13.68929	0
Q9BQ39	DDX50_HUMAN	"ATP-dependent RNA helicase DDX50, EC 3.6.4.13 (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)"	DDX50	Homo sapiens (Human)		membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005886; GO:0016020; GO:0016887	KNVTEMAMNPHIK	1.679999948	1	1	0.229375391	1512.811832	0	0	11.85447	13.07148	0	13.3478	0	15.40837	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.13221	0	14.14808	14.2622	0	10.08254	0	0	0	0	15.8943	0	0	0	0	17.00412	0	0	0	0	0	0	0
Q9BQ61	TRIR_HUMAN	"Telomerase RNA component interacting RNase, EC 3.1.13.- (Exoribonuclease TRIR)"	TRIR C19orf43	Homo sapiens (Human)	"RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"		"3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]"	3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; RNA binding [GO:0003723]	GO:0003723; GO:0008408; GO:0008409; GO:0016075; GO:0090503	EAPGPAGGGGGGSR	6.96999979	0.067634672	0.067634672	0.200727069	1127.829389	15.16254	13.54386	0	14.8358	13.52039	13.17556	13.06029	13.82305	0	0	0	0	13.32089	13.02328	0	0	14.43108	12.34658	0	16.14039	11.19578	16.06877	0	17.05264	0	0	16.32084	0	0	15.72503	0	16.21981	0	0	0	0	15.00264	15.29466	0	0	0	0	0	0	0	0	0	0
Q9BQ89	F110A_HUMAN	Protein FAM110A	FAM110A C20orf55 F10	Homo sapiens (Human)		cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]	cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]		GO:0000922; GO:0005737; GO:0005815	SSVTVEERAR	10.69999981	1	1	0.097976393	1132.710706	12.61818	0	8.333874	13.50259	12.91068	5.172613	14.7091	0	15.07603	0	0	13.9201	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.28853	0	0	0	0	0	0	0	15.25274	13.65839	0	0	14.21749	0	0	0	0	0	0	0	0
Q9BQ95	ECSIT_HUMAN	"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (Protein SITPEC)"	ECSIT	Homo sapiens (Human)	innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635]		GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005829; GO:0032981; GO:0045087; GO:0051341; GO:0061635	DLAVYNQLLNIFPKEVFRPR	2.359999895	1	1	0.392731867	2433.108036	0	0	0	17.00268	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.87902	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BQA1	MEP50_HUMAN	"Methylosome protein 50, MEP-50 (Androgen receptor cofactor p44) (WD repeat-containing protein 77) (p44/Mep50)"	WDR77 MEP50 WD45 HKMT1069 Nbla10071	Homo sapiens (Human)	"histone H4-R3 methylation [GO:0043985]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; nuclear receptor coactivator activity [GO:0030374]; histone H4-R3 methylation [GO:0043985]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]"	methyl-CpG binding [GO:0008327]; nuclear receptor coactivator activity [GO:0030374]	GO:0000387; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0007309; GO:0008284; GO:0008327; GO:0030374; GO:0034709; GO:0043985; GO:0048026; GO:0060528; GO:0060770	DICIK	3.859999895	0.070328228	0.070328228	0.093405765	648.1041461	19.03044	0	13.52418	17.14813	0	14.88488	12.9975	15.88545	14.55201	12.15144	0	16.142	15.13684	14.02908	9.285678	15.91841	15.68613	0	0	0	10.78546	18.17724	16.91499	12.37945	12.29433	15.36297	0	16.49805	0	0	16.35044	0	0	13.33383	16.91676	13.72032	15.29438	15.95281	16.24492	18.03437	12.22902	14.66291	16.98797	0	14.94581	14.21688	0	0
Q9BQA9	CYBC1_HUMAN	"Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein, Eros)"	CYBC1 C17orf62 EROS	Homo sapiens (Human)	innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728]		GO:0005783; GO:0005789; GO:0016021; GO:0045087; GO:0045728	GYMVVLR	5.179999828	0.687174618	0.687174618	0.068454413	852.9692368	0	0	0	0	15.9715	0	0	0	0	0	0	0	0	0	13.444	10.39464	15.77243	10.79127	12.156	14.75824	13.7947	0	14.28471	16.42479	17.02257	0	10.28696	15.96964	13.2081	14.76526	15.58971	15.43659	0	15.50121	14.04658	0	0	17.00928	0	15.64093	0	0	16.13047	0	15.76139	0	16.21232	0
Q9BQC6	RT63_HUMAN	"Ribosomal protein 63, mitochondrial, hMRP63 (Mitochondrial large ribosomal subunit protein mL63) (Mitochondrial ribosomal protein 63) (Mitochondrial ribosomal protein L57)"	MRPL57 MRP63	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543	GHAAVRR	2.819999933	0.113558896	0.113558896	0.267243846	766.1214589	15.94298	15.45392	15.11137	16.28538	12.97371	15.81667	0	0	15.61347	14.78096	13.41909	0	0	15.49989	14.11893	13.84362	0	15.785	0	0	0	15.71933	16.47875	15.98139	0	0	0	15.55208	0	16.68579	0	16.97769	16.33945	0	15.63834	0	0	0	0	16.89283	0	0	0	15.6802	16.11456	0	0	0
Q9BQD3	KXDL1_HUMAN	KxDL motif-containing protein 1	KXD1 C19orf50	Homo sapiens (Human)	lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]; vesicle-mediated transport [GO:0016192]	BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]	BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]; vesicle-mediated transport [GO:0016192]		GO:0016192; GO:0032418; GO:0051036; GO:0062196; GO:0072384; GO:0098574; GO:0099078	ILSMVNTDDVNAIILAQK	7.329999924	0.200255573	0.200255573	0.213954134	1956.878586	0	0	0	15.44443	14.14727	17.09755	0	0	0	16.80384	0	17.9168	0	13.99958	15.70814	14.27996	0	0	14.40486	0	0	0	17.60066	17.52407	14.0537	17.85828	14.50829	14.84233	0	13.20868	15.6605	0	14.84308	0	0	16.23614	0	0	0	13.13143	0	0	15.77906	0	13.871	11.60004	16.844	0
Q9BQE4	SELS_HUMAN	"Selenoprotein S, SelS (VCP-interacting membrane protein)"	SELENOS SELS VIMP AD-015 SBBI8	Homo sapiens (Human)	"cell redox homeostasis [GO:0045454]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; establishment of protein localization [GO:0045184]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of gluconeogenesis [GO:0006111]; regulation of nitric oxide metabolic process [GO:0080164]; response to glucose [GO:0009749]; response to redox state [GO:0051775]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]	"cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; antioxidant activity [GO:0016209]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin-specific protease binding [GO:1990381]; cell redox homeostasis [GO:0045454]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; establishment of protein localization [GO:0045184]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of gluconeogenesis [GO:0006111]; regulation of nitric oxide metabolic process [GO:0080164]; response to glucose [GO:0009749]; response to redox state [GO:0051775]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]"	antioxidant activity [GO:0016209]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin-specific protease binding [GO:1990381]	GO:0002865; GO:0005783; GO:0005789; GO:0005881; GO:0005886; GO:0006111; GO:0006983; GO:0009749; GO:0016209; GO:0019899; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0032715; GO:0032720; GO:0032869; GO:0034361; GO:0034362; GO:0034599; GO:0036502; GO:0036513; GO:0038023; GO:0045184; GO:0045454; GO:0045719; GO:0046325; GO:0050728; GO:0051117; GO:0051771; GO:0051775; GO:0071222; GO:0080164; GO:1902236; GO:1990381; GO:2000110	QEALAAAR	4.590000153	1	1	0.207658975	828.5961664	15.65729	16.48683	15.82786	0	0	0	15.56694	14.39757	14.33293	14.2031	0	17.41381	15.35174	0	15.16314	0	0	0	0	16.66779	14.92721	0	15.84107	15.17749	0	0	0	0	0	0	0	0	16.01636	0	0	15.75754	0	15.78584	0	15.64167	0	0	14.71593	0	0	16.38077	16.14916	0
Q9BQG0	MBB1A_HUMAN	Myb-binding protein 1A	MYBBP1A P160	Homo sapiens (Human)	"cellular response to glucose starvation [GO:0042149]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]"	B-WICH complex [GO:0110016]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"B-WICH complex [GO:0110016]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to glucose starvation [GO:0042149]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]"	E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	GO:0001649; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0006355; GO:0008134; GO:0016020; GO:0022904; GO:0032922; GO:0035066; GO:0042149; GO:0042254; GO:0042564; GO:0043231; GO:0043565; GO:0045892; GO:0045943; GO:0045944; GO:0045945; GO:0070888; GO:0072332; GO:0110016; GO:1903450; GO:2000210	SPLSALAR	7.71999979	1	1	0.083364371	814.4424919	15.63782	13.25603	0	0	0	0	0	0	0	0	0	0	16.80381	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.7096	13.12417	0	15.53047	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BQG2	NUD12_HUMAN	"NAD-capped RNA hydrolase NUDT12, DeNADding enzyme NUDT12, EC 3.6.1.- (NADH pyrophosphatase NUDT12, EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12, Nudix motif 12)"	NUDT12	Homo sapiens (Human)	circadian regulation of gene expression [GO:0032922]; methylguanosine-cap decapping [GO:0110156]; mRNA catabolic process [GO:0006402]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; phosphodiesterase decapping endonuclease activity [GO:1990174]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; methylguanosine-cap decapping [GO:0110156]; mRNA catabolic process [GO:0006402]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]	magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; phosphodiesterase decapping endonuclease activity [GO:1990174]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270]	GO:0000210; GO:0000287; GO:0005634; GO:0005737; GO:0005777; GO:0005782; GO:0006402; GO:0006734; GO:0006742; GO:0008270; GO:0019677; GO:0032922; GO:0034356; GO:0035529; GO:0110153; GO:0110155; GO:0110156; GO:1990174	EAGVVAQAR	2.069999933	0.248183057	0.248183057	0.065763034	900.3672023	0	0	17.1484	15.40184	0	0	16.03422	16.38433	15.17421	17.33764	0	13.4931	16.96854	15.68985	16.56245	0	12.6534	18.17895	0	0	0	0	16.38006	0	16.53312	15.63251	0	0	14.54053	16.78921	0	0	16.41959	14.45995	0	0	14.92471	0	12.89511	0	0	14.3738	16.33681	13.41486	13.60162	12.40221	0	15.00811
Q9BQI0	AIF1L_HUMAN	Allograft inflammatory factor 1-like (Ionized calcium-binding adapter molecule 2)	AIF1L C9orf58 IBA2 UNQ672/PRO1306	Homo sapiens (Human)	actin filament bundle assembly [GO:0051017]; ruffle assembly [GO:0097178]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; ruffle assembly [GO:0097178]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005737; GO:0005925; GO:0015629; GO:0032587; GO:0051015; GO:0051017; GO:0070062; GO:0097178	ANESSPKPVGPPPER	6.090000153	1	1	0.021877681	1555.913566	0	0	17.47232	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.41239	0	0	0	15.80059	0	0	0	0	0	0	0	0	0
Q9BQI3	E2AK1_HUMAN	"Eukaryotic translation initiation factor 2-alpha kinase 1, EC 2.7.11.1 (Heme-controlled repressor, HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor, hHRI) (Hemin-sensitive initiation factor 2-alpha kinase)"	EIF2AK1 HRI KIAA1369 PRO1362	Homo sapiens (Human)	acute inflammatory response [GO:0002526]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; acute inflammatory response [GO:0002526]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641]	ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0002526; GO:0004672; GO:0004694; GO:0004712; GO:0005524; GO:0005737; GO:0006909; GO:0008285; GO:0010999; GO:0020037; GO:0030225; GO:0042803; GO:0045993; GO:0046501; GO:0046777; GO:0046986; GO:0055072; GO:0106310; GO:0140467; GO:0140468; GO:1990641	GVRDDGK	8.729999542	2.22E-07	2.22E-07	0.26566671	746.0171015	0	0	0	17.3826	0	0	17.51831	0	0	0	18.13218	0	0	17.81042	0	0	0	0	0	0	16.55695	0	0	0	17.82486	17.56604	0	0	17.17812	17.06566	18.05028	0	0	0	0	19.49069	0	0	17.35662	0	0	19.0418	16.83645	0	0	16.80016	0	0
Q9BQI5	SGIP1_HUMAN	SH3-containing GRB2-like protein 3-interacting protein 1 (Endophilin-3-interacting protein)	SGIP1	Homo sapiens (Human)	clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; energy homeostasis [GO:0097009]; positive regulation of feeding behavior [GO:2000253]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to dietary excess [GO:0002021]	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; SH3 domain binding [GO:0017124]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; energy homeostasis [GO:0097009]; positive regulation of feeding behavior [GO:2000253]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to dietary excess [GO:0002021]	microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; SH3 domain binding [GO:0017124]	GO:0002021; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0008017; GO:0017124; GO:0030122; GO:0030136; GO:0048260; GO:0048268; GO:0072583; GO:0097009; GO:2000253	IPDISQKSENGGVGSLLAR	2.609999895	0.321368247	0.321368247	1.82E-12	1942.572565	0	0	0	0	12.35704	12.18432	0	0	0	0	14.14631	11.41614	0	0	0	0	14.1847	16.08638	0	15.81214	0	17.829	0	15.33343	14.60969	0	17.90924	14.2677	14.37926	0	0	0	17.34177	14.74887	0	13.75476	13.932	0	0	9.891138	0	0	0	14.82943	11.7199	0	10.57247	17.27706
Q9BQI6	SLF1_HUMAN	SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) (Smc5/6 localization factor 1)	SLF1 ANKRD32 BRCTD1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"	"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]"	protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]	GO:0000724; GO:0000781; GO:0000786; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0016925; GO:0030915; GO:0031334; GO:0031625; GO:0032204; GO:0034184; GO:0035861; GO:0042405; GO:0044877; GO:1990166; GO:2000781	GELPLDYVVSPQIKEELFAITK	1.389999986	1	1	0.150260878	2489.11376	0	12.46135	14.11964	0	0	0	0	12.60602	9.861869	0	16.2147	0	13.40214	0	0	0	0	14.01245	13.5256	0	0	9.517795	0	0	15.36232	14.31705	0	0	12.63421	13.09123	15.28071	0	14.7312	0	10.7408	0	0	0	0	15.21087	0	15.74568	0	0	0	0	0	0
Q9BQN1	FA83C_HUMAN	Protein FAM83C	FAM83C C20orf128	Homo sapiens (Human)	signal transduction [GO:0007165]		protein kinase binding [GO:0019901]; signal transduction [GO:0007165]	protein kinase binding [GO:0019901]	GO:0007165; GO:0019901	GRIVEDFDR	10.48999977	1	1	0.082251181	1107.035904	0	0	13.40134	0	0	13.29885	0	0	0	0	0	0	14.12907	0	0	0	18.24642	17.51439	0	17.15404	18.49958	0	16.64017	16.26982	15.102	0	0	16.2756	0	0	16.20843	0	18.46012	18.15193	16.2631	15.94299	16.25207	16.99906	17.88248	17.72132	18.01227	17.3824	0	0	0	15.97147	15.9913	16.27411
Q9BQR3	PRS27_HUMAN	"Serine protease 27, EC 3.4.21.- (Marapsin) (Pancreasin)"	PRSS27 MPN UNQ1884/PRO4327	Homo sapiens (Human)		extracellular region [GO:0005576]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005886	ILQKLAVPIIDTPK	1.720000029	0.063319862	0.063319862	0.113566123	1549.347188	0	10.83256	16.31825	13.65595	0	13.85775	17.05121	0	0	0	13.81258	17.2012	0	14.49499	10.64	0	10.45808	0	18.14917	13.38973	12.21528	0	0	0	0	0	0	0	0	14.94498	12.15776	17.43619	14.28607	15.90339	16.09454	11.0729	17.33811	0	14.17896	7.084331	0	0	14.131	0	15.40215	0	15.90803	0
Q9BQS2	SYT15_HUMAN	"Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV, SytXV)"	SYT15	Homo sapiens (Human)	calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277	WHALCRTTEP	13.34000015	1	1	0.281861735	1270.157719	0	0	0	0	0	0	0	0	0	18.83118	0	0	17.39095	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BQS7	HEPH_HUMAN	"Hephaestin, EC 1.-.-.-"	HEPH KIAA0698 UNQ2562/PRO6242	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]	copper ion binding [GO:0005507]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]	GO:0004322; GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0008198; GO:0016021; GO:0016323; GO:0016491; GO:0048471; GO:0055072	DGLLGSR	6.96999979	0.275770187	0.275770187	0.172702144	717.3318992	15.23438	15.08152	11.28772	13.90449	14.65589	15.07486	15.5815	0	14.00957	14.58186	0	15.6654	0	0	0	0	0	15.70436	0	0	0	17.90726	0	0	15.91456	0	0	15.73316	15.0852	0	0	17.05607	0	0	0	15.88355	0	0	0	15.66307	15.26355	16.17867	0	16.11514	14.61627	0	15.1007	13.53591
Q9BQS8	FYCO1_HUMAN	FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7)	FYCO1 ZFYVE7	Homo sapiens (Human)	plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098]	autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]	autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; metal ion binding [GO:0046872]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098]	metal ion binding [GO:0046872]	GO:0005764; GO:0005770; GO:0005776; GO:0005794; GO:0016020; GO:0043231; GO:0046872; GO:0072383; GO:1901098	EDLERTQK	7.769999981	1	1	0.20385174	1018.987586	14.95894	0	11.40007	0	0	14.67757	0	0	0	0	14.52515	14.78031	14.73929	14.84853	14.66253	0	14.52059	14.26443	0	0	0	0	15.41473	0	16.62436	13.54948	0	0	12.64231	0	13.63773	14.72684	14.59799	0	16.06846	14.96584	0	0	12.69085	0	14.55208	13.28763	0	0	11.88411	15.96975	0	0
Q9BQT8	ODC_HUMAN	Mitochondrial 2-oxodicarboxylate carrier (Solute carrier family 25 member 21)	SLC25A21 ODC	Homo sapiens (Human)	lysine catabolic process [GO:0006554]; mitochondrial alpha-ketoglutarate transmembrane transport [GO:1990550]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; lysine catabolic process [GO:0006554]; mitochondrial alpha-ketoglutarate transmembrane transport [GO:1990550]	alpha-ketoglutarate transmembrane transporter activity [GO:0015139]	GO:0005743; GO:0006554; GO:0015139; GO:0016021; GO:1990550	NMIPVNK	26.05999947	0.605986536	0.605986536	0.208839931	814.5098454	18.89432	18.69645	18.91441	18.44375	19.84648	18.60047	19.11598	19.65436	17.29776	18.8302	18.88264	19.70072	20.04104	19.66741	19.98263	18.47716	19.02178	17.60675	18.65509	19.36619	19.47496	18.6279	18.523	19.29461	19.35214	18.55652	18.40143	17.90326	19.48423	19.43938	19.34128	0	0	18.99314	18.21761	0	19.02546	18.15839	19.65829	18.01	18.99715	0	18.24685	19.09878	18.20369	17.68924	17.29867	0
Q9BR39	JPH2_HUMAN	"Junctophilin-2, JP-2 (Junctophilin type 2) [Cleaved into: Junctophilin-2 N-terminal fragment, JP2NT ]"	JPH2 JP2	Homo sapiens (Human)	"calcium ion homeostasis [GO:0055074]; calcium ion transport into cytosol [GO:0060402]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle tissue development [GO:0055024]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]; calcium ion homeostasis [GO:0055074]; calcium ion transport into cytosol [GO:0060402]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle tissue development [GO:0055024]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]"	"core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]"	GO:0000122; GO:0001046; GO:0001227; GO:0001786; GO:0003677; GO:0005546; GO:0005547; GO:0005634; GO:0005789; GO:0005886; GO:0010314; GO:0014701; GO:0016021; GO:0016529; GO:0030018; GO:0030314; GO:0032266; GO:0045892; GO:0055024; GO:0055074; GO:0060314; GO:0060316; GO:0060402; GO:0070273; GO:0070300; GO:0080025	APKGGGLFQR	5.769999981	1	1	0.273836052	1031.484729	12.35846	13.75842	16.23166	16.21777	0	0	15.60644	15.23954	13.02306	0	0	0	14.42793	0	14.79206	16.23491	0	14.89232	15.47586	0	0	0	14.16128	0	0	15.54839	0	0	0	0	0	0	0	0	0	0	0	16.27695	0	0	0	0	0	0	0	0	0	0
Q9BR76	COR1B_HUMAN	Coronin-1B (Coronin-2)	CORO1B	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; wound healing [GO:0042060]	actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; wound healing [GO:0042060]	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]	GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007015; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034315; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0045296; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:1902463; GO:2000394	GDSSIR	3.180000067	1	1	0.027073261	633.6971814	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.55883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.87799	0
Q9BR77	CCD77_HUMAN	Coiled-coil domain-containing protein 77	CCDC77	Homo sapiens (Human)		centrosome [GO:0005813]; membrane [GO:0016020]	centrosome [GO:0005813]; membrane [GO:0016020]		GO:0005813; GO:0016020	EEEGMRR	13.13000011	1	1	0.234256485	921.6091241	0	14.98049	0	14.12367	14.52514	14.08576	15.16287	14.09147	17.03741	14.73799	0	15.29833	15.46265	0	0	0	0	15.13438	0	12.54363	0	15.96299	0	11.66668	0	0	0	0	0	0	14.08658	0	0	14.41978	16.30008	0	0	0	17.30865	0	15.15024	0	14.5624	0	15.2836	14.55508	15.53434	16.59588
Q9BR84	ZN559_HUMAN	Zinc finger protein 559	ZNF559	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	SSFLIRHLR	8.460000038	1	1	0.29619816	1128.167916	15.91229	15.91622	0	0	0	15.21919	0	0	0	0	14.90906	0	0	0	14.71563	14.17449	0	0	17.1599	0	0	15.69088	15.2013	14.4976	0	0	0	16.42814	17.09371	0	17.13675	0	0	15.52601	15.4764	0	15.60945	16.38304	0	0	0	0	0	0	0	16.57116	0	0
Q9BRA2	TXD17_HUMAN	"Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein, TRP14) (Protein 42-9-9) (Thioredoxin-like protein 5)"	TXNDC17 TXNL5	Homo sapiens (Human)	tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxidase activity [GO:0004601]; protein-disulfide reductase (NAD(P)) activity [GO:0047134]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	peroxidase activity [GO:0004601]; protein-disulfide reductase (NAD(P)) activity [GO:0047134]	GO:0004601; GO:0005829; GO:0033209; GO:0047134; GO:0070062	AVEQHNGK	6.619999886	0.756079257	0.756079257	0.255431453	880.7017346	19.28523	17.47406	19.68227	0	21.71657	17.6572	17.55758	19.30346	0	0	18.67809	0	0	16.80175	17.76786	0	0	17.69896	0	0	0	0	17.27076	0	18.70997	18.90048	0	16.78061	0	16.53297	0	18.8608	19.45979	0	18.6527	18.551	16.92883	0	0	0	18.29181	0	0	0	0	16.64771	0	17.36294
Q9BRB3	PIGQ_HUMAN	"Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein, PIG-Q)"	PIGQ GPI1	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; carbohydrate metabolic process [GO:0005975]; GPI anchor biosynthetic process [GO:0006506]	phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]	GO:0000506; GO:0005783; GO:0005789; GO:0005975; GO:0006506; GO:0016021; GO:0017176	FDEGPVR	8.920000076	0.167715967	0.167715967	0.209626449	818.719096	0	0	0	0	15.42977	15.38184	0	0	0	0	0	0	15.39202	0	0	0	14.75146	0	0	0	13.07283	15.35096	0	0	0	15.58986	14.1595	0	14.85627	17.24023	0	0	0	14.86247	16.16545	0	0	0	0	17.98483	0	0	0	0	0	0	0	0
Q9BRD0	BUD13_HUMAN	BUD13 homolog	BUD13	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RES complex [GO:0070274]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0070274; GO:0071005	HDSSDTSPPRR	4.659999847	1	1	0.319791807	1254.077388	14.36518	14.99309	14.9283	0	0	17.44457	0	0	15.55379	0	0	15.00918	16.19545	15.69639	15.10632	0	15.50444	15.83158	16.40444	17.27057	17.59871	0	17.68379	16.12546	0	0	17.05741	16.25259	16.54568	14.17389	0	17.22369	0	16.89755	16.99483	16.47734	16.675	18.11909	0	14.89281	17.19803	0	16.98101	0	17.0622	16.69768	18.11934	16.67023
Q9BRF8	CPPED_HUMAN	"Serine/threonine-protein phosphatase CPPED1, EC 3.1.3.16 (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1)"	CPPED1 CSTP1	Homo sapiens (Human)		azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005576; GO:0005829; GO:0005886; GO:0035578; GO:0046872	LNPKPK	10.07999992	0.104187526	0.104187526	0.290250681	698.0453113	16.09571	14.65312	0	15.74192	0	0	0	0	14.40776	0	16.32135	0	0	15.03884	0	14.65707	0	0	0	0	15.43381	0	15.74914	0	15.8026	0	0	0	0	0	0	0	15.77349	0	0	0	0	0	0	15.36402	0	0	16.15662	0	16.05104	16.58735	0	0
Q9BRH9	ZN251_HUMAN	Zinc finger protein 251	ZNF251	Homo sapiens (Human)	hematopoietic stem cell homeostasis [GO:0061484]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hematopoietic stem cell homeostasis [GO:0061484]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:0061484	RSSTLVQHR	1.379999995	1	1	0.125524213	1084.360345	0	0	0	14.79514	0	14.91311	0	0	14.37971	15.61414	0	0	0	14.64868	14.95527	0	15.57979	14.14368	0	14.13207	0	11.97331	0	0	0	0	14.02313	0	16.0358	0	0	0	0	0	0	0	0	0	0	0	15.56519	0	0	0	0	0	0	0
Q9BRI3	ZNT2_HUMAN	"Zinc transporter 2, ZnT-2 (Solute carrier family 30 member 2)"	SLC30A2 ZNT2	Homo sapiens (Human)	positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]; positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577]	identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0005385; GO:0005737; GO:0005765; GO:0005770; GO:0005886; GO:0010043; GO:0016021; GO:0042802; GO:0043231; GO:0061088; GO:0061090; GO:0071577	TASSRLQGK	5.139999866	0.712170601	0.712170601	0.222082256	946.7841387	0	0	0	0	0	14.90872	0	11.69085	0	16.17951	13.57748	0	0	16.45943	0	0	14.70526	15.09351	0	0	15.5006	0	0	15.87284	15.14915	13.74372	0	0	0	0	0	0	0	0	0	0	0	0	0	17.78142	0	0	0	0	0	0	17.46555	0
Q9BRJ7	TIRR_HUMAN	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1 SDOS TIRR	Homo sapiens (Human)	negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]	nucleus [GO:0005634]	nucleus [GO:0005634]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0003723; GO:0005634; GO:0030515; GO:2001033	STAAVPELK	1.820000052	1	1	0.284359641	915.9791464	16.86981	17.29006	0	17.22935	16.89729	0	18.22568	0	0	18.08412	12.67972	0	17.23145	0	0	0	0	16.92536	0	0	0	0	0	0	0	18.54694	18.31649	17.84683	15.93007	0	18.93637	18.34967	17.82478	0	19.00527	0	0	0	21.1261	0	16.89521	0	16.89416	0	0	0	0	16.31476
Q9BRK0	REEP2_HUMAN	Receptor expression-enhancing protein 2	REEP2 C5orf19 SGC32445	Homo sapiens (Human)	endoplasmic reticulum tubular network organization [GO:0071786]; protein transport into membrane raft [GO:0032596]; regulation of intracellular transport [GO:0032386]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]	cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule binding [GO:0008017]; taste receptor binding [GO:0031883]; endoplasmic reticulum tubular network organization [GO:0071786]; protein transport into membrane raft [GO:0032596]; regulation of intracellular transport [GO:0032386]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]	microtubule binding [GO:0008017]; taste receptor binding [GO:0031883]	GO:0005783; GO:0005789; GO:0005881; GO:0005887; GO:0008017; GO:0016020; GO:0031883; GO:0032386; GO:0032596; GO:0050913; GO:0050916; GO:0071782; GO:0071786	RAKPIK	3.779999971	0.697186768	0.697186768	0.302139015	712.7464074	0	0	18.42693	0	0	0	0	0	17.79689	17.37942	18.9185	0	19.17712	0	0	0	0	17.64417	0	0	0	17.86697	16.27088	0	19.39063	0	0	0	0	0	0	0	0	19.35544	0	0	0	0	17.78221	17.73701	0	0	0	18.3034	16.93767	17.5983	0	0
Q9BRP4	PAAF1_HUMAN	Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71)	PAAF1 WDR71	Homo sapiens (Human)		proteasome complex [GO:0000502]	proteasome complex [GO:0000502]		GO:0000502	APVQVIHRSGAPVLSLLSVR	1.370000005	1	1	0.231186598	2102.87616	11.66003	15.91182	0	0	13.8101	0	13.82073	0	13.78654	0	0	11.22195	16.40027	14.33386	12.87904	0	0	0	15.88339	12.63534	0	13.9208	0	0	0	0	0	0	0	0	0	0	0	0	0	15.74235	0	0	15.46014	0	0	0	0	0	0	0	0	0
Q9BRQ0	PYGO2_HUMAN	Pygopus homolog 2	PYGO2 PP7910	Homo sapiens (Human)	brain development [GO:0007420]; canonical Wnt signaling pathway [GO:0060070]; developmental growth [GO:0048589]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; mammary gland development [GO:0030879]; positive regulation of chromatin binding [GO:0035563]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; roof of mouth development [GO:0060021]; spermatid nucleus differentiation [GO:0007289]	beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]	beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone acetyltransferase regulator activity [GO:0035034]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; brain development [GO:0007420]; canonical Wnt signaling pathway [GO:0060070]; developmental growth [GO:0048589]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; mammary gland development [GO:0030879]; positive regulation of chromatin binding [GO:0035563]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; roof of mouth development [GO:0060021]; spermatid nucleus differentiation [GO:0007289]	chromatin binding [GO:0003682]; histone acetyltransferase regulator activity [GO:0035034]; histone binding [GO:0042393]; metal ion binding [GO:0046872]	GO:0001822; GO:0002088; GO:0003682; GO:0005654; GO:0007289; GO:0007420; GO:0030879; GO:0033599; GO:0035034; GO:0035563; GO:0042393; GO:0046872; GO:0048589; GO:0051569; GO:0060021; GO:0060070; GO:1990907	AELGPPSLSQR	4.820000172	1	1	2.33E-13	1155.080575	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.4694	0	0	0	0	0	0	0	0	0	0	0	0	0	15.98406	0	0	0	0	0	0	0	0	0	0	0	14.4963	0	0	0	0	0	0	0
Q9BRQ5	ORAI3_HUMAN	Protein orai-3 (Transmembrane protein 142C)	ORAI3 TMEM142C	Homo sapiens (Human)	store-operated calcium entry [GO:0002115]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; store-operated calcium channel activity [GO:0015279]; store-operated calcium entry [GO:0002115]	store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0005886; GO:0015279; GO:0016020; GO:0016021	SLVAHK	6.269999981	1	1	0.163195854	652.986538	0	0	0	0	14.15689	0	13.79117	15.4873	0	0	0	0	0	0	0	0	0	0	0	14.89907	15.88349	0	0	0	0	0	0	0	0	0	0	0	16.01062	0	0	0	0	0	0	14.05221	0	15.10201	0	0	0	0	0	0
Q9BRQ6	MIC25_HUMAN	MICOS complex subunit MIC25 (Coiled-coil-helix cristae morphology protein 1) (Coiled-coil-helix-coiled-coil-helix domain-containing protein 6)	CHCHD6 CHCM1 MIC25	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]	cytosol [GO:0005829]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]	cytosol [GO:0005829]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; cellular response to DNA damage stimulus [GO:0006974]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]		GO:0001401; GO:0005739; GO:0005743; GO:0005829; GO:0006974; GO:0007007; GO:0042407; GO:0044284; GO:0061617; GO:0140275	ESTLPRSGSSGGQQPSGMK	6.199999809	1	1	0.23317251	1891.897114	14.09194	0	0	0	12.99958	0	0	0	0	0	0	0	0	13.58843	0	0	0	0	0	0	0	15.99848	0	14.37439	16.42396	13.73546	0	14.78073	13.84184	14.18751	0	0	0	0	0	0	0	0	0	0	0	14.36757	0	0	0	0	0	0
Q9BRR9	RHG09_HUMAN	Rho GTPase-activating protein 9 (Rho-type GTPase-activating protein 9)	ARHGAP9	Homo sapiens (Human)	regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; secretory granule lumen [GO:0034774]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]"	"GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]"	GO:0005096; GO:0005547; GO:0005576; GO:0005737; GO:0005829; GO:0007165; GO:0034774; GO:0043087; GO:0051056	LRFLVDR	7.769999981	1	1	3.47E-13	919.1006835	0	0	0	0	14.11901	0	0	0	0	0	0	0	14.32765	0	0	0	0	0	0	0	0	0	0	15.09987	0	0	14.06117	0	0	0	0	0	16.21925	0	0	0	0	12.70881	15.91233	0	0	0	0	0	0	0	0	0
Q9BRS2	RIOK1_HUMAN	"Serine/threonine-protein kinase RIO1, EC 2.7.11.1, EC 3.6.3.- (RIO kinase 1)"	RIOK1 RIO1	Homo sapiens (Human)	maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]	"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]"	"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]"	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:0106310; GO:2000234	VVPGQFDDADSSDSENR	5.929999828	0.932536721	0.932536721	0.212773129	1837.426306	11.74669	15.94945	0	0	0	0	0	16.66212	0	0	0	0	0	15.13414	12.35217	0	0	11.773	13.65751	0	15.63997	0	11.13795	15.77169	16.12564	16.13602	15.83901	0	14.2626	15.18218	14.68612	0	14.61875	0	14.17878	15.34749	14.06864	15.69475	0	13.90584	15.42001	0	0	0	0	13.41649	0	14.49025
Q9BRS8	LARP6_HUMAN	"La-related protein 6 (Acheron, Achn) (La ribonucleoprotein domain family member 6)"	LARP6	Homo sapiens (Human)	positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]	GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005844; GO:0006396; GO:0017022; GO:0032967; GO:0035613; GO:0045727; GO:0048027; GO:1902416; GO:1990825; GO:1990904	HAATNK	3.910000086	0.180687249	0.180687249	0.174438625	642.2227925	0	0	15.8829	0	15.90831	16.15159	0	14.55075	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.70248	0	0	0	0	0	15.816	14.58673	15.78617	0	0	16.38321	15.42829	16.71549	15.7764	0	14.7178	0	0	16.20126	17.32926	0	18.29748
Q9BRV3	SWET1_HUMAN	"Sugar transporter SWEET1, HsSWEET1 (RAG1-activating protein 1) (Solute carrier family 50 member 1) (Stromal cell protein)"	SLC50A1 RAG1AP1 SCP	Homo sapiens (Human)	carbohydrate transport [GO:0008643]; hexose transmembrane transport [GO:0008645]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucoside transmembrane transporter activity [GO:0042947]; sugar transmembrane transporter activity [GO:0051119]; carbohydrate transport [GO:0008643]; hexose transmembrane transport [GO:0008645]	glucoside transmembrane transporter activity [GO:0042947]; sugar transmembrane transporter activity [GO:0051119]	GO:0000139; GO:0005794; GO:0005886; GO:0008643; GO:0008645; GO:0012505; GO:0016021; GO:0042947; GO:0051119	DPYIMVSNFPGIVTSFIR	3.779999971	0.00972545	0.00972545	0.237142543	2071.406896	13.22779	0	9.64876	11.48907	12.78473	0	0	15.01057	0	15.52444	0	0	0	0	0	0	0	0	0	0	13.4199	0	0	0	14.45524	14.23172	0	13.78963	10.09973	13.13808	12.65131	13.77137	11.46494	0	0	14.20409	0	13.23852	0	11.18785	0	14.07446	15.12521	13.94435	0	0	0	15.3487
Q9BRX8	PXL2A_HUMAN	"Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes, Protein PAMM) (Redox-regulatory protein FAM213A)"	PRXL2A C10orf58 FAM213A PAMM PRO2290 PSEC0139 UNQ611/PRO1198	Homo sapiens (Human)	regulation of osteoclast differentiation [GO:0045670]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; antioxidant activity [GO:0016209]; regulation of osteoclast differentiation [GO:0045670]	antioxidant activity [GO:0016209]	GO:0005576; GO:0005737; GO:0016209; GO:0045670	VNLLSVLEAAK	10.82999992	0.434509337	0.434509337	2.29E-13	1155.496066	0	14.87515	0	13.5422	0	0	0	0	10.58764	0	12.15299	0	0	0	0	0	0	0	17.29611	0	0	0	9.787851	0	15.15944	0	0	0	0	0	0	0	0	0	13.53709	0	0	0	0	13.89266	0	0	14.6316	0	13.70241	0	0	0
Q9BRY0	S39A3_HUMAN	"Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3, ZIP-3)"	SLC39A3 ZIP3	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577]	zinc ion transmembrane transporter activity [GO:0005385]	GO:0000902; GO:0001701; GO:0005385; GO:0005886; GO:0016020; GO:0016021; GO:0043029; GO:0048701; GO:0060173; GO:0071577	ASPVR	10.93000031	0.795818925	0.795818925	0.248988828	528.5732884	15.31307	17.19752	15.89738	15.01872	15.84814	15.12438	15.56481	15.90793	16.61793	16.1106	17.0625	15.0071	14.79926	0	15.40305	15.6106	0	0	15.34334	0	16.23939	0	16.24936	0	17.24864	17.32029	15.02797	17.13714	14.34326	16.63924	15.13893	14.31997	15.3163	15.63644	14.9599	16.04003	14.17829	15.92013	16.78528	15.0601	13.87037	16.16144	15.11327	15.94392	15.27793	0	15.80028	15.62471
Q9BRZ2	TRI56_HUMAN	"E3 ubiquitin-protein ligase TRIM56, EC 2.3.2.27 (RING finger protein 109) (Tripartite motif-containing protein 56)"	TRIM56 RNF109	Homo sapiens (Human)	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340]"	RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000785; GO:0003723; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0008270; GO:0032479; GO:0032728; GO:0034340; GO:0045087; GO:0045893; GO:0051607; GO:0060340; GO:0061630; GO:0070534	AAAAFARR	11.76000023	1	1	0.158260672	834.549859	18.22674	9.805451	13.21211	0	0	0	0	15.87299	0	0	15.92782	16.19102	0	14.84279	0	14.96073	13.31345	14.55156	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.13814	0	0	0	0	0	0	15.72066	15.35067	0	0	0
Q9BS31	ZN649_HUMAN	Zinc finger protein 649	ZNF649	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	extracellular space [GO:0005615]; nucleus [GO:0005634]	extracellular space [GO:0005615]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005615; GO:0005634; GO:0006357; GO:0046872	AFLTKTMLIVHHR	17.37000084	1	1	0.412609679	1583.747664	17.12949	0	0	16.87736	0	16.4105	0	0	0	0	0	18.06796	16.71445	16.78454	0	16.16908	0	0	0	0	0	0	0	0	0	16.36223	0	16.25953	0	16.18687	16.77916	17.14136	0	0	0	16.59218	15.89307	0	0	0	0	0	0	0	0	16.75088	0	16.35627
Q9BS34	ZN670_HUMAN	Zinc finger protein 670	ZNF670	Homo sapiens (Human)	cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006629; GO:0044255; GO:0046872	DSVSFEDVAVAFTQEEWALLDPSQK	4.539999962	1	1	2.29E-12	2811.4768	15.41282	0	0	0	16.59456	13.65418	0	15.25132	0	0	15.95497	0	0	0	0	13.27402	0	0	0	0	0	0	0	0	0	14.7561	0	0	0	0	0	13.36147	0	0	14.33966	0	0	0	0	0	0	0	0	0	13.64587	0	0	0
Q9BS40	LXN_HUMAN	"Latexin (Endogenous carboxypeptidase inhibitor, ECI) (Protein MUM) (Tissue carboxypeptidase inhibitor, TCI)"	LXN	Homo sapiens (Human)	detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; heparin binding [GO:0008201]; metalloendopeptidase inhibitor activity [GO:0008191]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]	heparin binding [GO:0008201]; metalloendopeptidase inhibitor activity [GO:0008191]	GO:0005615; GO:0005737; GO:0006954; GO:0008191; GO:0008201; GO:0050965	VKQASMEDIPGR	7.21999979	0.353792906	0.353792906	0.161590705	1330.074608	0	0	15.63331	16.11506	0	14.78676	12.55284	11.11618	0	0	14.61082	17.02908	13.73782	11.72692	0	12.97967	15.71739	0	15.93352	15.66899	0	18.27982	15.76212	0	15.80193	0	0	15.82263	0	15.6979	15.38092	0	13.94784	0	18.3117	0	0	0	14.96152	15.58763	10.32186	13.38083	14.97312	0	0	0	14.16957	15.17908
Q9BSB4	ATGA1_HUMAN	Autophagy-related protein 101	ATG101 C12orf44 PP894	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407]	Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; autophagosome assembly [GO:0000045]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]	identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]	GO:0000045; GO:0000407; GO:0005789; GO:0005829; GO:0006468; GO:0008285; GO:0010508; GO:0042802; GO:0044877; GO:0046777; GO:1903059; GO:1990316	EGTYSIGTVGTQDVDCDFIDFTYVR	4.070000172	1	1	0.199662518	2859.053068	14.96536	0	14.81334	0	14.76229	0	0	15.28455	15.51895	0	13.02663	13.93362	0	0	0	0	15.14718	0	0	0	0	0	0	0	0	15.14066	0	0	0	15.10627	15.5068	15.46584	0	0	13.81707	0	0	0	0	13.57287	0	0	0	0	0	0	0	0
Q9BSC4	NOL10_HUMAN	Nucleolar protein 10	NOL10	Homo sapiens (Human)	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	"nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	RNA binding [GO:0003723]	GO:0000462; GO:0003723; GO:0005730; GO:0032040	LLNPLVSK	4.340000153	0.776547015	0.776547015	0.03847673	886.2907166	14.9435	14.88546	9.851804	0	15.81349	16.71016	0	0	0	0	16.06603	0	0	15.06705	15.9747	15.46849	0	14.32204	15.67445	14.69659	15.96189	15.066	0	17.77613	17.39845	0	14.22298	0	0	13.14919	14.09235	0	16.61996	16.67078	16.67105	13.83854	0	14.40643	16.1794	13.20396	14.78644	0	14.3476	16.41773	0	0	0	16.86773
Q9BSE2	TMM79_HUMAN	Transmembrane protein 79 (Mattrin)	TMEM79 MATT	Homo sapiens (Human)	cornification [GO:0070268]; cuticle development [GO:0042335]; epithelial cell maturation [GO:0002070]; establishment of skin barrier [GO:0061436]; hair follicle morphogenesis [GO:0031069]; positive regulation of epidermis development [GO:0045684]; regulated exocytosis [GO:0045055]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; identical protein binding [GO:0042802]; cornification [GO:0070268]; cuticle development [GO:0042335]; epithelial cell maturation [GO:0002070]; establishment of skin barrier [GO:0061436]; hair follicle morphogenesis [GO:0031069]; positive regulation of epidermis development [GO:0045684]; regulated exocytosis [GO:0045055]	identical protein binding [GO:0042802]	GO:0002070; GO:0005765; GO:0016021; GO:0031069; GO:0032588; GO:0042335; GO:0042802; GO:0045055; GO:0045684; GO:0061436; GO:0070268	EVEIHR	11.5	1	1	3.50E-13	783.1202003	0	0	0	14.47575	0	0	0	0	15.14373	0	0	0	14.863	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BSE4	HERP2_HUMAN	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein	HERPUD2	Homo sapiens (Human)	endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283]		GO:0007283; GO:0016021; GO:0030968	DQSGMEIPVTLIIKAPNQK	5.920000076	1	1	0.173340664	2096.764736	13.28898	0	0	0	0	0	0	13.9163	0	0	0	0	11.89485	9.708404	0	0	0	13.65976	0	0	14.26918	0	15.53815	0	0	0	0	15.11196	12.51287	13.80169	0	13.09573	14.60487	12.92794	11.11737	0	14.58058	16.40744	0	14.12048	14.09113	13.73043	0	0	0	0	0	0
Q9BSH3	NICN1_HUMAN	"Nicolin-1 (NPCEDRG) (Tubulin polyglutamylase complex subunit 5, PGs5)"	NICN1	Homo sapiens (Human)		microtubule [GO:0005874]; nucleoplasm [GO:0005654]	microtubule [GO:0005874]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005874	GSVALQVGDVR	7.349999905	1	1	0.021127951	1096.467602	14.85415	0	13.58008	12.19099	0	0	15.95584	0	0	0	18.01477	15.7914	0	17.57914	16.17592	0	18.06587	17.32729	0	22.08512	0	16.07884	15.76383	0	16.87032	15.94785	13.75475	17.40129	0	0	16.19614	18.10273	17.38576	16.56435	0	0	0	17.83125	15.0388	14.55363	15.5365	0	0	18.18194	0	12.75684	0	0
Q9BSI4	TINF2_HUMAN	TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2)	TINF2 TIN2	Homo sapiens (Human)	"negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of telomere maintenance [GO:0032206]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance via telomere lengthening [GO:1904356]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]"	"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; perinucleolar chromocenter [GO:0010370]; shelterin complex [GO:0070187]"	"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; perinucleolar chromocenter [GO:0010370]; shelterin complex [GO:0070187]; telomeric DNA binding [GO:0042162]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of telomere maintenance [GO:0032206]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance via telomere lengthening [GO:1904356]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]"	telomeric DNA binding [GO:0042162]	GO:0000781; GO:0000783; GO:0005654; GO:0010370; GO:0010836; GO:0016233; GO:0016363; GO:0016604; GO:0032202; GO:0032206; GO:0032211; GO:0042162; GO:0050680; GO:0070187; GO:0070198; GO:1904356	ERPTVMLFPFR	5.190000057	1	1	0.017416101	1388.338252	13.43741	0	0	0	0	14.48454	0	0	0	0	14.04318	0	13.96507	15.21153	0	13.3632	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.49293	0	0	0	0
Q9BSJ2	GCP2_HUMAN	"Gamma-tubulin complex component 2, GCP-2, hGCP2 (Gamma-ring complex protein 103 kDa, h103p, hGrip103) (Spindle pole body protein Spc97 homolog, hSpc97)"	TUBGCP2 GCP2	Homo sapiens (Human)	brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]	gamma-tubulin binding [GO:0043015]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005813; GO:0005815; GO:0005829; GO:0005881; GO:0007020; GO:0007420; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0065003	DCMLTNPELLK	4.070000172	1	1	0.593911938	1348.93396	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BSJ6	PIMRE_HUMAN	Protein PIMREG (CALM-interactor expressed in thymus and spleen) (PICALM-interacting mitotic regulator) (Regulator of chromosome segregation protein 1)	PIMREG CATS FAM64A RCS1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]		GO:0005654; GO:0005730; GO:0007049; GO:0051301	AGPSWK	7.429999828	0.259282172	0.259282172	0.244598609	644.5286913	15.42811	0	0	14.74904	0	0	0	0	16.93649	19.06794	0	16.99998	0	0	0	0	17.05807	0	0	15.83264	0	0	0	0	15.91698	17.0099	18.77136	0	0	18.18847	15.60263	18.62428	0	0	18.14546	0	16.73949	0	0	0	18.77079	0	0	0	0	0	0	0
Q9BSQ5	CCM2_HUMAN	Cerebral cavernous malformations 2 protein (Malcavernin)	CCM2 C7orf22 PP10187	Homo sapiens (Human)	blood vessel endothelial cell differentiation [GO:0060837]; cell-cell junction organization [GO:0045216]; endothelial cell development [GO:0001885]; endothelial tube morphogenesis [GO:0061154]; endothelium development [GO:0003158]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; multicellular organism growth [GO:0035264]; pericardium development [GO:0060039]; regulation of angiogenesis [GO:0045765]; stress-activated MAPK cascade [GO:0051403]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; blood vessel endothelial cell differentiation [GO:0060837]; cell-cell junction organization [GO:0045216]; endothelial cell development [GO:0001885]; endothelial tube morphogenesis [GO:0061154]; endothelium development [GO:0003158]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; multicellular organism growth [GO:0035264]; pericardium development [GO:0060039]; regulation of angiogenesis [GO:0045765]; stress-activated MAPK cascade [GO:0051403]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]		GO:0001570; GO:0001701; GO:0001885; GO:0003158; GO:0005737; GO:0005739; GO:0007229; GO:0007507; GO:0032991; GO:0035264; GO:0045216; GO:0045765; GO:0048839; GO:0048845; GO:0051403; GO:0060039; GO:0060837; GO:0061154	LLSDYIEK	4.599999905	1	1	0.129314076	981.0865761	0	0	15.30001	0	0	0	0	0	0	0	0	0	0	0	12.54056	0	0	0	0	0	0	0	16.50782	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.50834	0	0	0	0
Q9BSW7	SYT17_HUMAN	"Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII, SytXVII)"	SYT17	Homo sapiens (Human)	calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192]	calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]	GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005802; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0070382; GO:0071277; GO:1903861	AKQLLQTDVSQGSDPFVK	3.170000076	0.430446804	0.430446804	0.313765183	1961.497006	17.33958	0	0	0	0	0	0	0	0	0	0	0	16.66965	0	0	13.17326	0	0	0	0	0	0	0	0	0	16.0825	0	0	14.39454	0	13.25518	0	13.3634	12.28534	10.8253	15.40997	15.53434	0	0	15.05221	0	0	15.25635	0	0	0	0	0
Q9BT09	CNPY3_HUMAN	Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein)	CNPY3 CTG4A ERDA5 PRAT4A TNRC5 HSPC084 UNQ1934/PRO4409	Homo sapiens (Human)	innate immune response [GO:0045087]	endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; signaling receptor binding [GO:0005102]; innate immune response [GO:0045087]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005788; GO:0045087	KGDTAALGGK	7.349999905	1	1	0.020495821	915.9676612	0	0	0	11.67255	0	0	0	0	13.56646	0	0	0	0	0	0	0	0	0	15.24352	0	11.25338	0	0	13.51327	0	11.09606	0	14.24772	13.28802	15.06557	13.60635	0	14.85156	0	0	0	14.34674	0	0	0	14.40696	0	0	0	0	0	0	0
Q9BT17	MTG1_HUMAN	Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) (Mitochondrial GTPase 1)	MTG1 GTPBP7	Homo sapiens (Human)	regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005761; GO:0044065; GO:0070129	MQSSLK	2.869999886	1	1	1.15E-13	692.5169487	0	0	12.73233	0	0	15.48591	0	0	0	0	0	0	15.50108	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.38779	0	0	14.95653	0	0	0	0	0	0	0	0	15.5084	0	0	0
Q9BT25	HAUS8_HUMAN	HAUS augmin-like complex subunit 8 (HEC1/NDC80-interacting centrosome-associated protein 1) (Sarcoma antigen NY-SAR-48)	HAUS8 HICE1	Homo sapiens (Human)	cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]	microtubule binding [GO:0008017]	GO:0000922; GO:0005737; GO:0005813; GO:0005829; GO:0005880; GO:0007098; GO:0008017; GO:0051225; GO:0051301; GO:0070652; GO:1990498	KPESTSFSAPRK	10.35000038	0.458201647	0.458201647	0.594582238	1334.928882	0	0	0	17.61222	0	0	17.5357	0	0	0	0	0	0	18.68968	0	0	0	19.56864	0	0	17.26285	0	17.52617	0	0	0	0	19.96974	0	0	19.29279	0	0	0	0	19.15021	0	0	19.13324	0	0	0	20.58467	18.92571	0	0	0	0
Q9BT40	INP5K_HUMAN	"Inositol polyphosphate 5-phosphatase K, EC 3.1.3.56 (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase, EC 3.1.3.86) (Phosphatidylinositol-4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (Skeletal muscle and kidney-enriched inositol phosphatase)"	INPP5K PPS SKIP	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; ruffle assembly [GO:0097178]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; lipid phosphatase activity [GO:0042577]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]; actin cytoskeleton organization [GO:0030036]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; ruffle assembly [GO:0097178]"	"inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; lipid phosphatase activity [GO:0042577]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]"	GO:0001701; GO:0001726; GO:0001933; GO:0004439; GO:0004445; GO:0005000; GO:0005634; GO:0005737; GO:0005783; GO:0005802; GO:0005829; GO:0005886; GO:0005979; GO:0006469; GO:0006661; GO:0007186; GO:0010801; GO:0010829; GO:0016020; GO:0016311; GO:0016312; GO:0030036; GO:0032587; GO:0032869; GO:0032870; GO:0033137; GO:0034485; GO:0034594; GO:0034595; GO:0035305; GO:0035810; GO:0042577; GO:0042593; GO:0043005; GO:0043407; GO:0043922; GO:0045719; GO:0045869; GO:0045892; GO:0045893; GO:0046030; GO:0046627; GO:0046855; GO:0046856; GO:0048471; GO:0051497; GO:0051898; GO:0051926; GO:0052658; GO:0052659; GO:0071320; GO:0071356; GO:0071364; GO:0072659; GO:0090315; GO:0097178; GO:2000466; GO:2001153	GGVNICLK	18.51000023	1	1	0.025694179	859.3536441	14.93203	0	0	18.65019	0	0	0	0	14.01467	0	0	0	15.37117	0	16.12938	17.74558	0	17.03684	0	16.11045	0	0	0	13.8252	0	13.66611	0	9.919522	14.16562	13.17119	14.48148	17.00264	13.49828	0	0	16.22323	13.25096	14.88524	12.34113	0	13.67228	10.85326	14.31338	14.37441	10.93953	15.92643	0	13.84882
Q9BTA9	WAC_HUMAN	WW domain-containing adapter protein with coiled-coil	WAC KIAA1844	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]"	chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003682; GO:0005634; GO:0005654; GO:0005681; GO:0006325; GO:0006974; GO:0010390; GO:0010506; GO:0016239; GO:0016607; GO:0031571; GO:0032435; GO:0045893; GO:0071894; GO:1904263	REVMQATATSGFASGMEDK	3.849999905	1	1	1.61E-12	2028.442031	0	15.83589	0	12.881	0	13.47334	0	0	12.07182	13.75286	14.73068	13.98488	14.50143	13.66265	12.31661	0	0	0	0	10.49895	0	0	0	0	0	15.70892	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.74362	0	0	0
Q9BTC0	DIDO1_HUMAN	"Death-inducer obliterator 1, DIO-1, hDido1 (Death-associated transcription factor 1, DATF-1)"	DIDO1 C20orf158 DATF1 KIAA0333	Homo sapiens (Human)	"apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]"	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0046872; GO:0097190	GPSPSYLGGPRGVAPSQFEER	1.799999952	1	1	0.226565598	2189.042689	12.58817	0	14.81476	0	13.5219	15.40661	0	12.3915	13.11382	13.30332	14.52928	14.78421	0	0	0	10.46316	0	0	0	0	0	14.9917	0	0	0	0	16.26755	0	0	0	0	0	0	13.55901	13.79959	0	14.59937	0	0	13.09282	14.79756	0	0	0	13.73619	0	0	0
Q9BTC8	MTA3_HUMAN	Metastasis-associated protein MTA3	MTA3 KIAA1266	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]"	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003682; GO:0003713; GO:0003714; GO:0005654; GO:0005737; GO:0006338; GO:0008284; GO:0010971; GO:0016575; GO:0016581; GO:0042659; GO:0042826; GO:0043231; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0046872; GO:2000736	KPNVIR	2.789999962	1	1	0.020741727	727.4887889	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.58113	0	0	16.91704	0	0	0	0	0	15.99142	0	0	16.62396	14.67536	15.37133	0	15.41824	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BTD3	TM121_HUMAN	Transmembrane protein 121	TMEM121 HHOLE	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	AANMALFRDSR	6.360000134	1	1	0.33404825	1266.306204	0	12.07302	16.75148	0	0	0	0	0	0	0	0	0	0	0	0	12.83421	0	0	0	0	0	0	0	0	16.32102	0	0	17.48669	16.57197	0	0	18.43589	15.70107	16.15742	0	17.67038	0	0	0	16.24837	0	0	0	0	0	0	0	0
Q9BTE1	DCTN5_HUMAN	Dynactin subunit 5 (Dynactin subunit p25)	DCTN5	Homo sapiens (Human)	aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; ventricular septum development [GO:0003281]	centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; ventricular septum development [GO:0003281]		GO:0000776; GO:0003281; GO:0005654; GO:0005813; GO:0005829; GO:0031965; GO:0035904; GO:0060976	MELGELLYNK	11.32999992	1	1	0.328268954	1225.053345	0	18.36084	18.22387	0	16.73898	16.25925	17.12227	0	0	0	0	16.86218	14.89392	0	0	0	17.07623	0	0	0	0	0	0	0	0	18.69691	0	0	17.52934	18.2395	16.92044	0	0	0	18.94806	0	0	19.66512	0	0	0	0	0	0	0	0	17.2091	17.62659
Q9BTE3	MCMBP_HUMAN	"Mini-chromosome maintenance complex-binding protein, MCM-BP, MCM-binding protein"	MCMBP C10orf119	Homo sapiens (Human)	cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062]	cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006261; GO:0007062; GO:0030054; GO:0051301	FTVNLSGCPR	6.880000114	1	1	0	1151.412933	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BTL4	IER2_HUMAN	Immediate early response gene 2 protein (Protein ETR101)	IER2 ETR101 PIP92	Homo sapiens (Human)	cell motility [GO:0048870]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to fibroblast growth factor [GO:0071774]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell motility [GO:0048870]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to fibroblast growth factor [GO:0071774]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0030182; GO:0045944; GO:0048870; GO:0071774	SLQLSLVMRSAR	19.78000069	1	1	0.235741863	1375.880838	0	0	17.06797	0	0	0	0	0	16.19414	0	0	0	0	0	16.92801	0	16.72767	0	0	18.15743	0	17.64295	0	0	15.70251	15.58443	0	0	0	16.16343	16.61137	0	0	0	14.68331	0	18.13365	0	0	0	0	0	0	0	0	0	0	0
Q9BTP6	ZBED2_HUMAN	Zinc finger BED domain-containing protein 2	ZBED2	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0045618; GO:0046872	GDLEMK	1.74000001	1	1	0.011630971	707.3849579	0	0	0	15.66864	14.54278	13.696	0	0	0	14.7155	13.66543	16.23513	13.5835	0	14.67316	0	0	0	0	0	0	17.71005	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BTT6	LRRC1_HUMAN	Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein)	LRRC1 LANO	Homo sapiens (Human)		cytosol [GO:0005829]; membrane [GO:0016020]	cytosol [GO:0005829]; membrane [GO:0016020]		GO:0005829; GO:0016020	LLHLPLSLTALKLK	3.640000105	1	1	0.530617156	1561.219194	17.23126	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.10012	0	0	18.05563	0	0	0	0	18.27681	0	0	0	0	0	0	17.04721	0	18.00299	0	17.07461	17.83455
Q9BTU6	P4K2A_HUMAN	"Phosphatidylinositol 4-kinase type 2-alpha, EC 2.7.1.67 (Phosphatidylinositol 4-kinase type II-alpha)"	PI4K2A	Homo sapiens (Human)	endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]	GO:0000139; GO:0000287; GO:0004430; GO:0005524; GO:0005739; GO:0005765; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0030425; GO:0031224; GO:0031410; GO:0031901; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0045121; GO:0046854	LELNIVPRTK	4.150000095	0.363611996	0.363611996	0.197982592	1183.294837	0	0	0	14.6665	12.83167	0	13.21523	0	0	10.96656	13.68137	13.28852	14.6957	0	0	0	0	0	0	0	0	0	14.18173	0	0	0	0	0	0	0	13.79847	0	0	0	0	0	0	0	15.02132	0	0	0	0	0	0	0	0	0
Q9BTV5	FSD1_HUMAN	Fibronectin type III and SPRY domain-containing protein 1 (MID1-related protein 1) (Microtubule-associated protein GLFND)	FSD1 GLFND MIR1 VLP27	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of mitotic spindle organization [GO:0060236]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]	centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of mitotic spindle organization [GO:0060236]	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]	GO:0005634; GO:0005737; GO:0005813; GO:0005874; GO:0007049; GO:0008017; GO:0031122; GO:0032154; GO:0032465; GO:0042802; GO:0051301; GO:0051302; GO:0060236	MPSGRGGR	4.710000038	1	1	0.131617981	833.0848795	17.0925	0	17.22772	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BTV6	DPH7_HUMAN	"Diphthine methyltransferase, EC 3.1.1.97 (Diphthamide biosynthesis protein 7) (WD repeat-containing protein 85)"	DPH7 C9orf112 WDR85	Homo sapiens (Human)	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]		diphthine methylesterase activity [GO:0061685]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]	diphthine methylesterase activity [GO:0061685]	GO:0017183; GO:0061685	EHILATGSYDEHILLWDTRNMK	5.039999962	1	1	1.39E-12	2658.525712	16.81362	16.16452	18.01802	16.76972	14.84472	15.04349	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BTW9	TBCD_HUMAN	"Tubulin-specific chaperone D (Beta-tubulin cofactor D, tfcD) (SSD-1) (Tubulin-folding cofactor D)"	TBCD KIAA0988 SSD1 TFCD PP1096	Homo sapiens (Human)	adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]	beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]	GO:0000226; GO:0000278; GO:0005096; GO:0005737; GO:0005813; GO:0005874; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0051087; GO:0070830	FITRPDVKQSK	11.31000042	1	1	0.578870381	1315.786833	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.18622	0	0	0	0
Q9BTX1	NDC1_HUMAN	"Nucleoporin NDC1, hNDC1 (Transmembrane protein 48)"	NDC1 TMEM48	Homo sapiens (Human)	homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056]; homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]	protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056]	GO:0005635; GO:0005643; GO:0005737; GO:0005886; GO:0006913; GO:0006999; GO:0007129; GO:0007283; GO:0015031; GO:0015629; GO:0016020; GO:0016021; GO:0017056; GO:0030674; GO:0031965; GO:0051028; GO:0051292; GO:0051664; GO:0070762	TSLFSSK	7.130000114	1	1	0.120057541	770.3788937	13.28734	0	0	0	15.44779	0	0	0	13.3717	0	0	15.30454	0	0	0	0	0	0	17.42123	0	15.72461	16.36875	0	0	0	0	0	0	16.615	15.79479	0	0	0	0	0	0	0	0	17.46828	0	0	16.02362	0	18.40385	0	0	0	0
Q9BTY7	HGH1_HUMAN	Protein HGH1 homolog	HGH1 C8orf30A C8orf30B FAM203A FAM203B	Homo sapiens (Human)						KMLVEAIMLLTATAPGR	4.829999924	1	1	0.138274783	1831.409171	13.07374	0	0	11.23814	15.85993	0	0	0	15.24718	0	0	15.5485	15.71528	0	11.55222	3.768908	11.90878	15.31291	15.14706	0	0	14.58415	0	14.81333	0	17.07516	14.9962	0	0	15.90222	0	0	0	17.65402	18.04867	0	15.73173	17.26723	16.32214	15.58211	0	15.18923	14.28669	13.3756	0	0	0	0
Q9BTZ2	DHRS4_HUMAN	"Dehydrogenase/reductase SDR family member 4, EC 1.1.1.184 (NADPH-dependent carbonyl reductase, CR) (NADPH-dependent retinol dehydrogenase/reductase, NRDR, humNRDR) (Peroxisomal short-chain alcohol dehydrogenase, PSCD) (SCAD-SRL) (Short chain dehydrogenase/reductase family 25C member 2, Protein SDR25C2) (Short-chain dehydrogenase/reductase family member 4)"	DHRS4 SDR25C2 UNQ851/PRO1800	Homo sapiens (Human)	alcohol metabolic process [GO:0006066]; cellular ketone metabolic process [GO:0042180]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; retinal metabolic process [GO:0042574]; steroid metabolic process [GO:0008202]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 3-keto sterol reductase activity [GO:0000253]; alcohol dehydrogenase [NAD(P)+] activity [GO:0018455]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; alcohol metabolic process [GO:0006066]; cellular ketone metabolic process [GO:0042180]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; retinal metabolic process [GO:0042574]; steroid metabolic process [GO:0008202]"	"3-keto sterol reductase activity [GO:0000253]; alcohol dehydrogenase [NAD(P)+] activity [GO:0018455]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]"	GO:0000253; GO:0004090; GO:0005634; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005789; GO:0005829; GO:0006066; GO:0008202; GO:0016655; GO:0018455; GO:0042180; GO:0042574; GO:0042802; GO:0052650; GO:2000379	MASSGMTRR	10.61999989	0.925852835	0.925852835	0.200774405	1013.934592	15.73709	0	15.09396	0	0	13.78817	0	15.74665	0	0	0	0	16.93181	15.80131	0	16.0344	0	0	15.38563	0	0	0	0	0	0	0	0	0	16.56126	13.94113	0	17.70535	0	0	0	0	0	0	0	0	14.70552	0	0	18.35607	15.27664	0	16.45505	13.96186
Q9BU23	LMF2_HUMAN	Lipase maturation factor 2 (Transmembrane protein 112B) (Transmembrane protein 153)	LMF2 TMEM112B TMEM153	Homo sapiens (Human)	protein maturation [GO:0051604]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein maturation [GO:0051604]		GO:0005789; GO:0016020; GO:0016021; GO:0051604	AGSRLPR	2.329999924	1	1	0.136502871	755.2290561	13.65898	16.00002	0	14.20099	13.57301	14.83449	17.98147	13.50988	15.34906	16.629	15.38964	16.20771	0	13.74984	0	0	0	0	0	0	0	0	15.70519	0	0	0	17.14547	0	0	0	0	0	0	0	0	0	17.31041	0	0	0	0	0	0	0	0	0	0	0
Q9BU76	MMTA2_HUMAN	"Multiple myeloma tumor-associated protein 2, hMMTAG2"	MMTAG2 C1orf35	Homo sapiens (Human)		extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005576; GO:0034774; GO:1904813	EALLAALGYKNVK	9.529999733	1	1	0.155519713	1390.587291	15.06851	0	0	0	15.53841	0	0	15.17008	14.30809	12.21403	0	15.51766	0	13.80962	14.23216	13.62363	0	0	0	15.96602	0	13.45773	0	0	14.87435	0	16.86969	0	0	0	0	0	0	0	0	0	0	0	0	13.14721	13.93894	15.38168	0	16.93913	16.42341	0	15.44895	16.54975
Q9BUA6	MYL10_HUMAN	"Myosin regulatory light chain 10 (Myosin light chain 2, lymphocyte-specific) (Precursor lymphocyte-specific regulatory light chain)"	MYL10 MYLC2PL PLRLC	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005737; GO:0005739; GO:0005829	LMTQADRFSEEEVK	10.02999973	1	1	0.12552589	1681.949878	0	16.01569	15.45778	12.41714	14.76629	10.50476	0	0	13.86633	0	0	10.82431	0	13.76521	0	14.13039	10.83975	0	0	0	13.81304	0	15.73505	0	15.28765	12.42645	0	12.32269	13.5184	12.8542	13.31322	13.11704	0	16.39461	13.0838	0	0	0	0	0	0	16.72403	0	0	0	0	0	0
Q9BUB5	MKNK1_HUMAN	"MAP kinase-interacting serine/threonine-protein kinase 1, EC 2.7.11.1 (MAP kinase signal-integrating kinase 1, MAPK signal-integrating kinase 1, Mnk1)"	MKNK1 MNK1	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]	ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872; GO:0106310	DWAHISSEAK	3.289999962	1	1	0.562862724	1142.765247	18.34437	0	0	18.62745	0	0	18.28209	0	18.60342	0	0	0	0	0	19.01534	0	19.28076	0	0	0	0	0	0	0	0	0	0	0	0	0	18.81926	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BUE6	ISCA1_HUMAN	"Iron-sulfur cluster assembly 1 homolog, mitochondrial (HESB-like domain-containing protein 2) (Iron-sulfur assembly protein IscA, hIscA)"	ISCA1 HBLD2 GK004	Homo sapiens (Human)	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	"cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]"	GO:0005737; GO:0005739; GO:0005759; GO:0016226; GO:0046872; GO:0051537; GO:0097428	SASLVR	6.050000191	0.523242772	0.523242772	0.164939433	634.280629	17.44539	19.08487	0	15.42378	16.82224	16.10571	14.09293	14.0161	16.75745	0	17.19193	0	19.29363	16.53622	16.30095	16.32191	16.43823	19.73213	19.8127	17.63591	0	16.60821	18.61335	0	0	17.46216	16.34085	15.47794	17.71674	17.92731	16.05139	17.46144	18.18059	17.67241	0	17.23634	17.68622	16.71264	15.85725	19.12674	0	16.24689	16.66269	16.69045	0	0	15.81624	16.23469
Q9BUF5	TBB6_HUMAN	Tubulin beta-6 chain (Tubulin beta class V)	TUBB6	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0045171; GO:0070062; GO:0072686	GPMSMK	3.220000029	1	1	0.093164836	683.6410763	11.20641	0	0	15.0188	0	0	13.84894	14.92226	12.87107	0	11.53729	11.68027	14.31343	14.39835	14.83579	0	0	0	0	0	0	0	0	0	0	16.63616	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BUG6	ZSA5A_HUMAN	Zinc finger and SCAN domain-containing protein 5A (Zinc finger protein 495)	ZSCAN5A ZNF495 ZSCAN5	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837	THPEATSQ	4.110000134	0.065337665	0.065337665	0.141644247	870.9704318	15.88325	15.66047	17.35836	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BUM1	G6PC3_HUMAN	"Glucose-6-phosphatase 3, G-6-Pase 3, G6Pase 3, EC 3.1.3.9 (Glucose-6-phosphatase beta, G6Pase-beta) (Ubiquitous glucose-6-phosphatase catalytic subunit-related protein)"	G6PC3 UGRP	Homo sapiens (Human)	gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760]	glucose-6-phosphatase activity [GO:0004346]	GO:0004346; GO:0005783; GO:0005789; GO:0006094; GO:0015760; GO:0016020; GO:0016021; GO:0051156	RAQLGNGQK	3.279999971	1	1	0.243494255	972.2859208	15.57472	0	14.83241	13.29325	13.52071	12.79364	15.56832	14.97449	13.58544	0	15.36549	14.3642	14.7698	0	14.69338	0	13.64195	0	15.11647	0	0	0	15.53248	0	0	15.50392	15.78311	0	0	15.87129	0	0	15.98568	15.021	0	15.91901	16.43954	0	0	0	0	0	16.83202	0	0	15.30597	0	14.79711
Q9BUN1	MENT_HUMAN	Protein MENT (Methylated in normal thymocytes protein)	MENT C1orf56 UNQ547/PRO1104	Homo sapiens (Human)	regulation of cell population proliferation [GO:0042127]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; regulation of cell population proliferation [GO:0042127]		GO:0005576; GO:0042127	LTSSLPR	4.050000191	0.39532876	0.39532876	0.067411253	772.3369884	15.10742	0	15.58899	15.17995	14.64917	0	13.1147	13.23729	15.87782	0	15.51606	14.2351	0	0	0	0	0	0	0	12.5403	14.11742	15.90078	0	0	0	0	0	0	0	0	0	16.41561	15.27102	0	0	0	0	16.78335	0	0	0	15.2144	0	0	0	0	0	0
Q9BUP0	EFHD1_HUMAN	EF-hand domain-containing protein D1 (EF-hand domain-containing protein 1) (Swiprosin-2)	EFHD1 SWS2 PP3051	Homo sapiens (Human)	neuron projection development [GO:0031175]; regulation of cellular hyperosmotic salinity response [GO:1900069]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; neuron projection development [GO:0031175]; regulation of cellular hyperosmotic salinity response [GO:1900069]	calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]	GO:0005509; GO:0005739; GO:0005743; GO:0031175; GO:0061891; GO:1900069	LSEIDVALEGVK	4.349999905	1	1	0.122476425	1278.022461	0	14.33021	14.83418	0	0	13.16625	15.16676	12.96389	0	0	0	13.95501	12.63564	0	14.37037	14.13149	0	0	0	15.45022	0	0	0	15.26202	0	0	0	0	0	0	0	0	0	0	15.90127	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BUP3	HTAI2_HUMAN	"Oxidoreductase HTATIP2, EC 1.1.1.- (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2)"	HTATIP2 CC3 TIP30	Homo sapiens (Human)	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; negative regulation of apoptotic process [GO:0043066]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; negative regulation of apoptotic process [GO:0043066]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of transcription by RNA polymerase II [GO:0006357]	oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]	GO:0001525; GO:0003713; GO:0004674; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006357; GO:0006915; GO:0016020; GO:0016491; GO:0030154; GO:0043066; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170	GEVEAK	11.53999996	0.535352111	0.535352111	1.37E-12	631.7145869	16.18656	12.64406	14.51332	0	0	0	0	15.69066	14.2353	0	15.99597	16.31594	19.5566	18.92479	17.92103	0	17.78405	16.90295	0	0	18.40769	0	17.8492	17.43015	0	16.89706	17.54243	16.48954	16.33902	17.23119	0	0	17.51559	0	19.10093	17.28132	0	0	0	17.90901	0	17.42681	19.43938	12.75009	0	18.254	17.41855	0
Q9BUU2	MET22_HUMAN	"Methyltransferase-like protein 22, EC 2.1.1.-"	METTL22 C16orf68 LP8272	Homo sapiens (Human)	protein methylation [GO:0006479]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; protein methylation [GO:0006479]	heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005634; GO:0005654; GO:0005730; GO:0006479; GO:0008276; GO:0016279; GO:0031072; GO:0032991	VQLAPAAAMDEVTFR	15.03999996	0.709371328	0.709371328	0.474956143	1617.983052	15.81629	15.57703	0	16.30956	14.58768	0	16.62061	15.72473	16.78442	0	0	0	15.73859	0	16.36175	16.29909	0	0	0	0	0	0	0	0	16.7986	0	0	16.35735	0	16.00515	0	17.18002	17.16577	0	0	0	15.73455	0	16.98764	0	16.34156	0	16.64069	0	0	0	0	0
Q9BUY5	ZN426_HUMAN	Zinc finger protein 426	ZNF426	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	AFAVSSNLSGHLRTHTEEK	3.75	1	1	0.070085408	2083.979581	0	0	0	0	0	0	18.74705	0	18.31027	0	0	19.57162	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.32097	0	18.78987	0	17.43244	0	0	0	0	17.26341	0	0	0	0
Q9BV10	ALG12_HUMAN	"Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, EC 2.4.1.260 (Asparagine-linked glycosylation protein 12 homolog, hALG12) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog) (Membrane protein SB87)"	ALG12 PP14673	Homo sapiens (Human)	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase [GO:0052917]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]"	"alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase [GO:0052917]; mannosyltransferase activity [GO:0000030]"	GO:0000009; GO:0000030; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006487; GO:0006488; GO:0016020; GO:0016021; GO:0052917	FYSQLIVR	19.23999977	0.251205146	0.251205146	0.388436081	1025.902657	17.60797	18.76365	17.55775	0	0	0	0	0	0	19.24364	0	19.37771	17.3279	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.34995	0	0	18.37973	0	0	0	20.36245	19.04472	0	0	0	0	0	0	0	0	0	0	0	0
Q9BV19	CA050_HUMAN	Uncharacterized protein C1orf50	C1orf50	Homo sapiens (Human)			identical protein binding [GO:0042802]	identical protein binding [GO:0042802]	GO:0042802	KVLEDAHR	7.829999924	0.722158194	0.722158194	0.208233868	967.3841031	16.89153	0	15.07475	0	0	0	12.592	0	13.82006	0	16.46619	15.04415	15.02475	18.50131	15.42627	0	16.53351	15.29456	0	14.35451	14.58787	0	0	0	13.81515	9.660505	13.62371	0	0	0	15.36997	14.85122	16.73801	13.69832	0	17.42207	16.93164	0	14.89993	0	11.07756	16.27202	0	0	14.48948	0	0	0
Q9BV20	MTNA_HUMAN	"Methylthioribose-1-phosphate isomerase, M1Pi, MTR-1-P isomerase, EC 5.3.1.23 (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein)"	MRI1 MRDI UNQ6390/PRO21135	Homo sapiens (Human)	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]	GO:0001650; GO:0005654; GO:0005829; GO:0019284; GO:0019509; GO:0042802; GO:0042995; GO:0046523	DLADVAAR	7.300000191	1	1	0.102609501	830.7777174	16.35663	16.01382	0	0	0	12.09934	0	18.14682	0	16.3638	16.66043	18.32016	0	0	14.48859	16.80152	0	16.32981	0	16.24745	13.2832	17.715	17.76717	17.69004	14.06527	0	15.6871	0	0	14.61818	18.00218	15.96556	18.09229	16.69991	0	19.65359	12.80748	16.92798	0	0	0	16.50375	16.50541	0	0	17.60396	14.54025	14.85796
Q9BV35	SCMC3_HUMAN	Calcium-binding mitochondrial carrier protein SCaMC-3 (Mitochondrial ATP-Mg/Pi carrier protein 2) (Mitochondrial Ca(2+)-dependent solute carrier protein 2) (Small calcium-binding mitochondrial carrier protein 3) (Solute carrier family 25 member 23)	SLC25A23 APC2 MCSC2 SCAMC3	Homo sapiens (Human)	calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274]	ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]	GO:0002082; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006851; GO:0016021; GO:0036444; GO:0051282; GO:0051561; GO:0071277; GO:0097274; GO:1900069	LNILGGLR	10.89000034	0.499964952	0.499964952	0.276468453	856.0592557	18.40501	16.57351	17.24938	16.74614	17.78635	0	0	15.83706	0	18.65113	17.57612	17.81589	16.81892	0	17.28692	17.37387	0	16.50646	18.47042	15.51758	0	0	19.06463	16.67204	0	17.25011	17.16211	18.11123	16.3868	16.78877	17.32382	19.32669	19.12282	18.32352	19.50122	18.58364	16.82688	17.61165	0	0	0	0	18.45868	0	0	17.2438	19.36977	17.74611
Q9BV73	CP250_HUMAN	"Centrosome-associated protein CEP250 (250 kDa centrosomal protein, Cep250) (Centrosomal Nek2-associated protein 1, C-Nap1) (Centrosomal protein 2)"	CEP250 CEP2 CNAP1	Homo sapiens (Human)	centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; mitotic cell cycle [GO:0000278]; non-motile cilium assembly [GO:1905515]; positive regulation of protein localization to centrosome [GO:1904781]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of centriole-centriole cohesion [GO:0030997]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; protein-containing complex [GO:0032991]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; protein-containing complex [GO:0032991]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; mitotic cell cycle [GO:0000278]; non-motile cilium assembly [GO:1905515]; positive regulation of protein localization to centrosome [GO:1904781]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of centriole-centriole cohesion [GO:0030997]	protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]	GO:0000278; GO:0001750; GO:0001917; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0008022; GO:0008104; GO:0010457; GO:0019901; GO:0019904; GO:0030997; GO:0032991; GO:0033365; GO:0036064; GO:0048471; GO:0050908; GO:0060271; GO:0070062; GO:1904781; GO:1905515	AAHEKEVNQLR	2.099999905	1	1	0.109524631	1291.84096	14.46041	10.80285	12.20857	0	0	0	0	0	0	0	0	0	0	13.00269	0	8.254153	13.47696	0	10.75612	12.45031	0	14.54359	0	0	0	6.235654	14.99127	0	11.34837	0	13.85589	0	14.05194	10.08095	11.66026	13.85421	0	0	0	12.63277	0	14.1219	0	0	0	0	15.83626	0
Q9BV94	EDEM2_HUMAN	ER degradation-enhancing alpha-mannosidase-like protein 2	EDEM2 C20orf31 C20orf49 UNQ573/PRO1135	Homo sapiens (Human)	"carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]; viral protein processing [GO:0019082]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]; viral protein processing [GO:0019082]"	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006986; GO:0016020; GO:0019082; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:0097466; GO:1904154; GO:1904382	WVAQDAGIGAGVDSYFEYLVKGAILLQDK	4.760000229	1	1	0.092782531	3125.528712	13.56718	0	0	0	13.78177	13.74303	0	0	9.602267	0	0	12.8068	15.13841	0	14.17623	0	0	13.45064	10.8559	0	0	15.30595	0	0	14.28965	11.17691	0	0	0	0	14.10116	12.1881	13.67988	0	13.42855	14.57414	13.58685	12.82651	13.70316	0	0	0	0	0	0	0	0	0
Q9BV97	ZN747_HUMAN	Zinc finger protein 747	ZNF747	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"		"regulation of transcription, DNA-templated [GO:0006355]"		GO:0006355	DPNGAGSEWR	4.900000095	0.337019533	0.337019533	0.109726366	1087.964469	10.27942	14.47868	15.61097	15.31216	11.94768	14.07055	14.96724	0	15.47349	0	0	15.93827	16.15017	17.65603	13.42038	14.09787	15.96492	0	15.26774	17.44623	15.9677	15.00901	15.49934	14.41059	14.30472	14.75109	12.70245	14.72728	0	0	15.42177	15.47213	17.49533	15.10844	15.5147	15.70842	18.17508	16.91852	16.54048	13.43585	17.9768	16.03661	15.79208	16.1402	12.90063	16.61527	0	16.1788
Q9BVA0	KTNB1_HUMAN	"Katanin p80 WD40 repeat-containing subunit B1, Katanin p80 subunit B1 (p80 katanin)"	KATNB1	Homo sapiens (Human)	cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; mitotic chromosome movement towards spindle pole [GO:0007079]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of cell death [GO:0010942]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; protein targeting [GO:0006605]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; katanin complex [GO:0008352]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; katanin complex [GO:0008352]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATPase regulator activity [GO:0060590]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; mitotic chromosome movement towards spindle pole [GO:0007079]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of cell death [GO:0010942]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; protein targeting [GO:0006605]	ATPase regulator activity [GO:0060590]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]	GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006605; GO:0007019; GO:0007026; GO:0007079; GO:0008017; GO:0008352; GO:0010942; GO:0010976; GO:0015630; GO:0016020; GO:0030426; GO:0030496; GO:0031117; GO:0043025; GO:0046982; GO:0051013; GO:0051301; GO:0060590; GO:0070840	ASGRLLATGGDDCR	10.40999985	1	1	0.083993642	1449.40929	15.31586	0	12.00557	0	0	0	15.51245	0	14.89429	0	0	0	14.49167	14.38814	7.355372	0	15.69621	12.05026	0	7.84413	12.80744	10.85635	15.31527	0	0	0	0	14.84522	13.51429	12.619	14.35885	0	9.985357	12.68563	12.48996	0	0	0	0	0	15.7073	0	0	0	0	0	0	0
Q9BVC3	DCC1_HUMAN	Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog)	DSCC1 DCC1 UNQ9337/PRO34008	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]"	DNA binding [GO:0003677]	GO:0000775; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006275; GO:0031390; GO:0032508; GO:0034088; GO:0034421; GO:1900264	IADTSNMLLFIPGCK	4.28000021	1	1	0.53358204	1695.073255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BVC4	LST8_HUMAN	"Target of rapamycin complex subunit LST8, TORC subunit LST8 (G protein beta subunit-like, Gable, Protein GbetaL) (Mammalian lethal with SEC13 protein 8, mLST8)"	MLST8 GBL LST8	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]	protein serine/threonine kinase activator activity [GO:0043539]	GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0007010; GO:0010507; GO:0016310; GO:0030307; GO:0030838; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0032008; GO:0032956; GO:0038202; GO:0043066; GO:0043087; GO:0043539; GO:0045821; GO:0046889; GO:0050731; GO:0071456; GO:0071470; GO:1905857	NIASVGFHEDGR	7.980000019	0.618199646	0.618199646	0.149920942	1300.05144	15.97205	12.92818	0	0	0	10.90547	0	0	0	16.39011	0	0	0	13.52139	15.91981	0	0	18.10717	0	0	0	14.96222	0	0	13.74888	15.42403	11.02239	16.0612	14.74194	0	17.29066	0	15.94747	13.62008	15.8648	17.19669	17.54304	16.45163	17.48211	0	13.18373	15.39906	18.31541	0	13.31928	18.49424	17.21897	0
Q9BVC5	ASHWN_HUMAN	Ashwin	C2orf49	Homo sapiens (Human)	embryonic morphogenesis [GO:0048598]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; embryonic morphogenesis [GO:0048598]		GO:0005634; GO:0005654; GO:0048598; GO:0072669	KSPSGPVK	4.760000229	0.295726985	0.295726985	0.16650892	798.2622188	14.11764	13.4738	15.21589	14.63663	17.68377	13.89919	14.49193	0	13.58051	16.61058	15.14258	16.04113	13.03664	12.97195	0	8.015192	0	15.27527	0	15.63042	15.93358	15.81522	16.21311	17.4882	19.00033	12.14792	16.89435	13.60346	0	18.21394	0	19.50239	14.28602	16.03067	14.58877	15.56679	16.54825	17.54905	17.22754	0	15.73131	17.03805	0	0	17.33195	15.85714	16.40077	15.52767
Q9BVG4	PBDC1_HUMAN	Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1)	PBDC1 CXorf26	Homo sapiens (Human)						SGEKAM	6.449999809	0.806668818	0.806668818	0.23732912	637.8409274	0	0	0	21.62963	20.02836	0	0	0	19.43167	0	15.5828	17.40898	19.38211	0	18.28906	0	18.23539	0	18.27353	19.29787	18.27077	19.1178	20.38349	18.24495	0	17.76191	19.95778	16.35326	0	0	18.78403	18.71667	20.50284	14.20606	0	0	20.50162	21.2273	0	20.30792	20.73437	18.62444	17.55513	18.13911	18.6252	19.87321	17.42993	17.39959
Q9BVG8	KIFC3_HUMAN	Kinesin-like protein KIFC3	KIFC3	Homo sapiens (Human)	epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218]	centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]	centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003777; GO:0005524; GO:0005794; GO:0005813; GO:0005871; GO:0005874; GO:0005915; GO:0007018; GO:0007030; GO:0007601; GO:0008017; GO:0008569; GO:0030659; GO:0042802; GO:0045218; GO:0070062; GO:0090136	LTYLLQDSLSGDSK	2.650000095	0.692679107	0.692679107	0.301074967	1539.452883	11.50115	0	15.1308	13.82954	0	14.20416	11.14068	13.12288	14.59527	15.86148	17.04775	14.2027	15.40962	0	0	0	0	0	0	0	0	17.05883	0	0	0	0	0	0	0	0	0	0	0	0	16.04526	0	0	0	0	0	0	0	15.5986	0	0	0	0	0
Q9BVI0	PHF20_HUMAN	PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP)	PHF20 C20orf104 GLEA2 HCA58 NZF TZP	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of transcription by RNA polymerase II [GO:0006357]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0000123; GO:0003677; GO:0005654; GO:0005829; GO:0006325; GO:0006357; GO:0016573; GO:0031965; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0046872; GO:0051571; GO:0071339; GO:1900095	GSALDDAVNPLHENGDDSLSPR	4.28000021	1	1	2.29E-12	2278.826847	0	13.90257	0	12.75597	13.44503	11.54795	0	13.67563	13.67312	13.61177	0	0	12.95159	0	0	0	0	0	0	0	0	0	13.40409	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BVJ6	UT14A_HUMAN	U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16)	UTP14A SDCCAG16	Homo sapiens (Human)	rRNA processing [GO:0006364]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0032040	ASSEGTIPQVQR	4.559999943	1	1	0.156725316	1273.50701	15.08901	14.7836	0	10.53771	15.08935	0	0	14.34213	0	0	0	14.35163	0	0	0	11.56545	0	0	0	15.49434	0	0	0	0	0	14.13327	17.13262	0	0	0	0	0	16.15675	16.34412	0	0	0	0	0	16.02427	0	15.72581	0	0	0	0	0	0
Q9BVL4	SELO_HUMAN	"Protein adenylyltransferase SelO, mitochondrial, EC 2.7.7.-, EC 2.7.7.n1 (Selenoprotein O, SelO)"	SELENOO SELO	Homo sapiens (Human)	protein adenylylation [GO:0018117]	chromosome [GO:0005694]; mitochondrion [GO:0005739]	chromosome [GO:0005694]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein adenylyltransferase activity [GO:0070733]; protein adenylylation [GO:0018117]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein adenylyltransferase activity [GO:0070733]	GO:0005524; GO:0005694; GO:0005739; GO:0018117; GO:0046872; GO:0070733	SSIREFLCSEAMFHLGVPTTR	4.909999847	1	1	0.502838686	2454.994531	0	20.03485	20.00949	20.00817	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BVS4	RIOK2_HUMAN	"Serine/threonine-protein kinase RIO2, EC 2.7.11.1 (RIO kinase 2)"	RIOK2 RIO2	Homo sapiens (Human)	cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]"	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]"	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234	MGKVNVAK	4.409999847	1	1	0.351456708	863.577439	14.05159	0	16.08109	15.04339	14.64255	0	14.55559	0	0	15.34398	15.23935	0	14.22589	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.05049	15.99258	0	0	0	15.00915	0	0	0	0	0	0	0	0	0	0	0
Q9BVV2	FND11_HUMAN	Fibronectin type III domain-containing protein 11	FNDC11 C20orf195	Homo sapiens (Human)						KASAAHQDWAR	2.289999962	1	1	1.15E-12	1240.111529	0	12.92724	0	15.0867	0	0	0	14.0896	0	6.227137	10.0209	12.55682	0	0	0	0	0	0	12.66642	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.79409	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BVW5	TIPIN_HUMAN	TIMELESS-interacting protein	TIPIN	Homo sapiens (Human)	cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411]	DNA binding [GO:0003677]	GO:0000076; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0008284; GO:0009411; GO:0031298; GO:0031573; GO:0033262; GO:0043111; GO:0044770; GO:0048478; GO:0051301	GHEAEDLKMLIR	3.019999981	1	1	2.30E-13	1411.616099	0	14.86133	0	14.1005	0	0	0	0	0	0	0	0	0	0	0	13.75591	0	0	15.02212	0	0	0	0	0	0	0	16.57288	14.97159	0	14.63615	12.4804	0	16.67715	0	0	16.29198	0	17.0575	15.17225	0	0	0	0	0	0	0	0	0
Q9BW19	KIFC1_HUMAN	Kinesin-like protein KIFC1 (Kinesin-like protein 2) (Kinesin-related protein HSET)	KIFC1 HSET KNSL2	Homo sapiens (Human)	cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]	early endosome [GO:0005769]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]	early endosome [GO:0005769]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000070; GO:0003777; GO:0005524; GO:0005634; GO:0005769; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0016020; GO:0016887; GO:0051301; GO:0072686; GO:0090307	LDPGLALGPGER	7.679999828	0.30624938	0.30624938	0.201260551	1194.543414	0	13.63182	12.44434	0	15.51278	13.83465	13.46793	14.55217	0	0	15.15151	0	0	16.52192	13.38958	15.06542	17.41408	15.57975	16.94712	17.79719	12.53817	15.52851	0	16.75305	0	14.10101	0	16.49771	0	12.301	17.26013	0	15.34612	17.34964	15.87641	16.40884	15.93818	15.02373	16.74495	16.74364	15.36641	14.75397	15.68197	19.38012	15.04612	17.11454	16.96691	0
Q9BW27	NUP85_HUMAN	Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (FROUNT) (Nucleoporin Nup75) (Nucleoporin Nup85) (Pericentrin-1)	NUP85 NUP75 PCNT1	Homo sapiens (Human)	"lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]"	cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819]	"cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; structural constituent of nuclear pore [GO:0017056]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]"	structural constituent of nuclear pore [GO:0017056]	GO:0000776; GO:0005635; GO:0005643; GO:0005654; GO:0005819; GO:0005829; GO:0006406; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0030032; GO:0031080; GO:0031965; GO:0045893; GO:0048246; GO:0072006	IMLGDEAALLEQK	4.840000153	1	1	0.423352729	1430.765622	18.50371	0	15.28815	0	0	0	0	18.44091	0	0	0	18.61571	18.03645	0	0	18.30259	19.29537	0	0	0	16.80288	18.51988	0	0	19.35583	0	0	0	0	0	20.28671	0	19.96123	0	0	0	0	0	0	0	19.75831	20.1561	0	0	0	0	19.0927	0
Q9BW30	TPPP3_HUMAN	Tubulin polymerization-promoting protein family member 3 (TPPP/p20)	TPPP3 CGI-38	Homo sapiens (Human)	decidualization [GO:0046697]; embryo implantation [GO:0007566]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]	cytoplasm [GO:0005737]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; tubulin binding [GO:0015631]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273]	tubulin binding [GO:0015631]	GO:0001578; GO:0005737; GO:0005874; GO:0007566; GO:0015631; GO:0032273; GO:0046697; GO:0046785	AKTGGAVDR	2.049999952	1	1	0.236502206	873.6217189	0	0	0	0	0	15.12944	0	0	0	18.08317	0	0	0	0	0	0	0	0	0	0	0	0	0	15.87398	0	0	0	0	0	22.2303	19.30532	0	0	18.43824	0	0	0	21.51879	0	0	0	0	0	0	18.41903	0	0	0
Q9BW62	KATL1_HUMAN	"Katanin p60 ATPase-containing subunit A-like 1, Katanin p60 subunit A-like 1, EC 5.6.1.1 (p60 katanin-like 1)"	KATNAL1	Homo sapiens (Human)	microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]	GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0015630; GO:0016853; GO:0016887; GO:0042802; GO:0051013	EMAGVGARGPVGR	7.550000191	1	1	0.322638183	1257.825496	0	0	15.25446	14.36339	0	0	0	0	0	0	0	0	14.55824	0	15.59918	0	15.37877	15.21954	0	0	0	15.06447	0	16.0645	18.30276	14.67705	15.51923	15.06894	12.14571	0	17.66127	13.40823	18.16728	16.45166	0	0	0	17.15876	16.33926	16.17985	15.57087	0	0	16.70888	0	17.23003	0	0
Q9BW66	CINP_HUMAN	"Cyclin-dependent kinase 2-interacting protein, CDK2-interacting protein"	CINP	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260]	nucleus [GO:0005634]	nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260]		GO:0005634; GO:0006260; GO:0006281; GO:0007049; GO:0051301	MEAKTLGTVTPR	12.02999973	1	1	1.094575748	1304.665288	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.50809	0	0	0	0
Q9BW71	HIRP3_HUMAN	HIRA-interacting protein 3	HIRIP3	Homo sapiens (Human)	chromatin assembly or disassembly [GO:0006333]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin assembly or disassembly [GO:0006333]		GO:0005634; GO:0005654; GO:0005730; GO:0006333	GEDHPAVMR	4.559999943	1	1	0.222053307	1011.068494	0	0	15.45938	15.46709	16.26173	13.53328	0	16.20328	13.69992	0	15.03252	15.56191	14.6564	12.31259	10.97038	16.19586	15.49837	15.86691	16.73254	14.18678	15.92907	13.34453	14.95318	16.46857	0	18.12514	14.20875	13.26278	14.99026	0	19.24732	17.31943	17.03999	15.48011	17.05226	11.22034	0	13.90791	14.66042	0	0	0	0	0	0	15.7471	0	17.41079
Q9BW72	HIG2A_HUMAN	"HIG1 domain family member 2A, mitochondrial (RCF1 homolog B, RCF1b)"	HIGD2A	Homo sapiens (Human)	mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respirasome assembly [GO:0097250]; negative regulation of apoptotic process [GO:0043066]		GO:0005739; GO:0005743; GO:0016021; GO:0043066; GO:0070469; GO:0097250	SQLMMR	13.06999969	3.49E-06	3.49E-06	0.237387442	781.0732459	20.80226	18.47031	15.88466	18.7448	0	20.12341	17.46461	0	20.85673	20.66644	19.33421	0	0	0	0	18.75797	19.10536	21.14708	0	0	16.67331	0	0	0	20.464	21.18296	0	18.42211	0	0	20.49946	21.16803	0	0	20.82169	0	20.63708	0	0	18.31515	0	0	0	15.8063	0	16.37736	20.14479	0
Q9BW92	SYTM_HUMAN	"Threonine--tRNA ligase, mitochondrial, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase-like 1)"	TARS2 TARSL1	Homo sapiens (Human)	mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]; mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]	GO:0002161; GO:0004829; GO:0005524; GO:0005759; GO:0006435; GO:0042803; GO:0070159	EPRTIK	6.880000114	1	1	0.156734784	742.2558848	14.59697	0	0	0	0	0	0	0	0	0	0	0	0	15.28995	0	0	0	0	0	0	0	0	0	0	0	0	0	14.70167	0	0	16.82206	0	0	0	15.9638	15.31897	16.61231	15.44286	14.98778	0	0	0	0	0	16.22423	15.75821	13.89713	13.13108
Q9BWC9	CC106_HUMAN	Coiled-coil domain-containing protein 106	CCDC106	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]		GO:0005654; GO:0005829	LAEVGEFDPSKER	2.930000067	0.117826335	0.117826335	0.314084604	1476.346542	15.43911	14.76679	13.47722	0	15.38819	0	0	14.23498	15.43065	0	15.22847	15.09047	11.99572	0	12.75828	0	12.91738	0	0	15.30881	0	15.23298	14.70306	14.21396	0	0	16.14369	0	0	0	17.09582	0	0	0	0	0	0	0	0	0	0	0	17.07606	0	0	0	0	0
Q9BWE0	REPI1_HUMAN	Replication initiator 1 (60 kDa origin-specific DNA-binding protein) (60 kDa replication initiation region protein) (ATT-binding protein) (DHFR oribeta-binding protein RIP60) (Zinc finger protein 464)	REPIN1 RIP60 ZNF464	Homo sapiens (Human)	DNA replication [GO:0006260]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]	chromosome [GO:0005694]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005654; GO:0005664; GO:0005694; GO:0006260; GO:0006357; GO:0043035; GO:0046872	HKPYLAAHRR	5.260000229	0.254324466	0.254324466	0.146433578	1246.158726	14.67405	10.32518	12.34384	0	0	0	0	0	0	0	0	0	11.73304	0	0	0	12.23004	0	0	0	0	14.81834	0	0	0	14.57581	0	11.25483	0	0	0	0	0	0	0	0	0	0	0	14.43486	0	0	0	0	0	13.95331	0	0
Q9BWF2	TRAIP_HUMAN	"E3 ubiquitin-protein ligase TRAIP, EC 2.3.2.27 (RING finger protein 206) (TRAF-interacting protein)"	TRAIP RNF206 TRIP	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; replication fork processing [GO:0031297]; signal transduction [GO:0007165]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; site of DNA damage [GO:0090734]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; site of DNA damage [GO:0090734]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; replication fork processing [GO:0031297]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005730; GO:0006915; GO:0006974; GO:0007165; GO:0010804; GO:0016567; GO:0031297; GO:0032088; GO:0032688; GO:0042802; GO:0046872; GO:0048471; GO:0061630; GO:0090734; GO:0106300	ASGEVADKLR	6.309999943	3.83E-06	3.83E-06	0.058137498	1045.514976	0	15.00945	0	0	0	0	0	15.66326	0	0	0	0	0	16.38507	0	13.89584	0	17.61425	16.5313	16.58563	15.41685	15.49233	0	14.9309	17.24831	0	0	0	18.26761	0	0	0	0	0	19.11959	0	17.25068	16.58608	0	0	16.07816	0	14.84611	16.13391	0	0	14.62252	0
Q9BWG6	SCNM1_HUMAN	Sodium channel modifier 1	SCNM1	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleus [GO:0005634]	"nuclear speck [GO:0016607]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; alternative mRNA splicing, via spliceosome [GO:0000380]; RNA splicing [GO:0008380]"	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	GO:0000380; GO:0005634; GO:0008380; GO:0016607; GO:0019899; GO:0046872	YRPEAPGPSVSLSPMPPSEVKLQSGK	1.769999981	0.543985188	0.543985188	0.039716951	2754.50038	15.33524	0	9.580771	13.55344	14.86845	0	0	0	12.34459	14.31651	0	0	0	14.11451	12.94592	8.520136	0	0	0	0	0	0	0	0	0	0	16.58266	13.96585	14.89663	12.43425	0	15.10947	0	0	15.72189	0	0	0	0	0	0	0	13.60629	0	11.71275	0	0	8.588675
Q9BWH6	RPAP1_HUMAN	RNA polymerase II-associated protein 1	RPAP1 KIAA1403	Homo sapiens (Human)	transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase II [GO:0006366]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]	GO:0003677; GO:0003899; GO:0005634; GO:0006366	DTSSVAVNLPVPSGVAFPAVFLRSR	7.210000038	1	1	0.625421165	2586.965545	16.17661	14.76517	13.21012	0	0	0	0	0	17.55706	0	0	0	0	0	0	0	0	0	0	0	0	18.2792	0	18.4039	0	0	0	0	0	0	0	0	0	0	0	17.88952	0	0	0	0	0	0	0	0	0	0	0	0
Q9BWJ5	SF3B5_HUMAN	"Splicing factor 3B subunit 5, SF3b5 (Pre-mRNA-splicing factor SF3b 10 kDa subunit)"	SF3B5 SF3B10	Homo sapiens (Human)	"histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]"	RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	GO:0000124; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0005689; GO:0006282; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0071005; GO:0071011; GO:1990935	FNLMEKMLQPCGPPADKPEEN	1.129999995	1	1	0.135633461	2460.202887	16.47216	15.76302	0	16.41129	16.52323	0	0	17.91594	16.18949	0	0	0	0	13.98988	0	0	15.2744	0	15.40247	0	0	15.16574	0	0	14.89787	12.02803	0	0	0	0	16.22371	15.89887	17.53945	17.62724	0	0	14.99984	15.42505	0	0	13.69559	0	15.55074	0	13.55811	15.94865	0	0
Q9BWK5	CYREN_HUMAN	"Cell cycle regulator of non-homologous end joining, Cell cycle regulator of NHEJ (Modulator of retrovirus infection homolog)"	CYREN C7orf49 MRI	Homo sapiens (Human)	double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]		GO:0005634; GO:0005737; GO:0006303; GO:0033152; GO:0035861; GO:2001033	MRMAAVPVAAAR	2.859999895	1	1	0.198762427	1259.360296	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.05096	0	16.70901	0	0	0	0	17.11772	0	0	0	0	0	17.36441	0	0	0	0	0	0	0	0	16.85292	0	0	0	0	0	0	0	0	0	0	16.41797
Q9BWN1	PRR14_HUMAN	Proline-rich protein 14	PRR14	Homo sapiens (Human)	muscle organ development [GO:0007517]	chromosome [GO:0005694]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]	chromosome [GO:0005694]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; muscle organ development [GO:0007517]		GO:0005652; GO:0005654; GO:0005694; GO:0007517	DQVLSEPETKTMGK	21.44000053	1	1	0.290465244	1574.443313	19.36572	18.13218	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.14295	0	19.32637	0	0	0	0	0	0	0	0	0
Q9BWS9	CHID1_HUMAN	"Chitinase domain-containing protein 1 (Stabilin-1-interacting chitinase-like protein, SI-CLP)"	CHID1 GL008 PSEC0104 SB139	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]	chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]	GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0005770; GO:0005802; GO:0005975; GO:0008061; GO:0016020; GO:0043202; GO:0045087; GO:0070062; GO:0070492; GO:1900016	AESVVLEHR	1.100000024	1	1	0.063633407	1040.603379	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.20886	0	0	0	15.16993	0	0	0	0	16.20686	0	0	0	0	16.01555	11.5322	0	17.06459	0	0	0	10.44867	0	0	0	0	0	0	0	0	0	0
Q9BWT3	PAPOG_HUMAN	"Poly(A) polymerase gamma, PAP-gamma, EC 2.7.7.19 (Neo-poly(A) polymerase, Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme, SRP RNA-adenylating enzyme)"	PAPOLG PAP2 PAPG	Homo sapiens (Human)	mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872	AVKLWAK	1.690000057	1	1	0.140791024	815.6610582	0	0	15.12171	0	14.99669	0	0	0	0	0	0	0	0	0	16.67891	0	13.20363	15.38726	0	0	0	17.59438	0	14.9025	0	0	16.88198	0	0	0	0	0	0	0	0	0	0	0	14.15338	0	0	0	0	0	0	0	0	15.82943
Q9BWT7	CAR10_HUMAN	"Caspase recruitment domain-containing protein 10 (CARD-containing MAGUK protein 3, Carma 3)"	CARD10 CARMA3	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]	CBM complex [GO:0032449]; cytoplasm [GO:0005737]	CBM complex [GO:0032449]; cytoplasm [GO:0005737]; CARD domain binding [GO:0050700]; signaling receptor complex adaptor activity [GO:0030159]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]	CARD domain binding [GO:0050700]; signaling receptor complex adaptor activity [GO:0030159]	GO:0005737; GO:0007250; GO:0030159; GO:0032449; GO:0042981; GO:0050700; GO:0065003; GO:0090051; GO:1900182	AQPATPGLGSR	5.519999981	1	1	0.158117555	1053.534199	13.62938	16.37392	14.71968	0	0	13.89439	12.98911	11.82836	0	13.89731	0	14.38962	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.34398	0	0	0	0	0	0	0	0	0
Q9BWU0	NADAP_HUMAN	"Kanadaptin (Human lung cancer oncogene 3 protein, HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein)"	SLC4A1AP HLC3	Homo sapiens (Human)		cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]	mRNA binding [GO:0003729]	GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231	GGSKFK	4.539999962	0.417971879	0.417971879	0.039053495	622.7991397	12.53911	15.37955	0	0	15.16046	16.49551	13.93111	16.63684	0	0	0	0	16.9635	15.32542	14.15299	16.65677	16.79187	15.95437	13.27757	14.00003	15.62502	13.48259	16.7035	13.8866	14.77941	11.57431	14.16443	15.18813	0	12.18092	14.47769	14.74238	14.83363	15.70522	14.52313	16.81939	16.67346	0	9.463867	15.65193	17.1942	14.73318	13.78962	16.76068	15.31737	12.34655	0	0
Q9BWU1	CDK19_HUMAN	"Cyclin-dependent kinase 19, EC 2.7.11.22 (CDC2-related protein kinase 6) (Cell division cycle 2-like protein kinase 6) (Cell division protein kinase 19) (Cyclin-dependent kinase 11) (Death-preventing kinase)"	CDK19 CDC2L6 CDK11 KIAA1028	Homo sapiens (Human)	cellular response to lipopolysaccharide [GO:0071222]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; protein phosphorylation [GO:0006468]	cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cellular response to lipopolysaccharide [GO:0071222]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006468; GO:0008353; GO:0016592; GO:0043065; GO:0048471; GO:0050729; GO:0071222; GO:0106310	TTYANSSLIK	4.019999981	0.470173568	0.470173568	0.226691617	1098.998206	0	0	0	15.56928	14.69427	11.25416	13.6507	14.94181	12.69144	0	14.76307	0	0	0	0	14.30086	15.43446	9.020459	15.37887	13.92405	15.0637	0	13.75073	0	0	0	14.56775	0	14.07139	0	0	14.97557	14.15389	0	0	0	0	0	0	0	0	14.60249	0	0	0	14.27751	0	0
Q9BWV3	CDAC1_HUMAN	"Cytidine and dCMP deaminase domain-containing protein 1, EC 3.5.4.5 (Cytidine deaminase) (Testis development protein NYD-SP15)"	CDADC1	Homo sapiens (Human)	cytidine deamination [GO:0009972]; DNA cytosine deamination [GO:0070383]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; importin-alpha family protein binding [GO:0061676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; DNA cytosine deamination [GO:0070383]	cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; importin-alpha family protein binding [GO:0061676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0004126; GO:0005634; GO:0005737; GO:0008270; GO:0009972; GO:0042803; GO:0047844; GO:0061676; GO:0070383	EAGQMQNLESAR	7.889999866	1	1	0.095781081	1331.508815	15.53522	0	13.66241	0	0	0	0	0	0	0	0	0	0	0	0	0	17.18875	0	0	0	0	0	0	0	0	0	16.24648	0	14.49933	13.82254	0	14.93219	14.24644	14.81036	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BWV7	TTLL2_HUMAN	"Probable tubulin polyglutamylase TTLL2, EC 6.-.-.- (Testis-specific protein NYD-TSPG) (Tubulin--tyrosine ligase-like protein 2)"	TTLL2 C6orf104	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]	cilium [GO:0005929]	cilium [GO:0005929]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]	GO:0000226; GO:0005524; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0070740	LQEAGVSIPPRR	13.26000023	1	1	0.299109588	1322.070523	0	13.70858	14.11052	0	0	0	0	0	16.65307	15.16306	0	0	16.20357	0	16.65151	0	0	0	0	17.01369	0	0	0	0	16.99254	0	0	13.34377	15.40455	14.73045	16.21107	0	0	0	0	15.67922	17.87981	0	17.36695	0	15.43723	0	18.34477	15.5134	16.53123	17.72618	17.6897	15.05036
Q9BWW9	APOL5_HUMAN	"Apolipoprotein L5 (Apolipoprotein L-V, ApoL-V)"	APOL5	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]	high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]	GO:0005576; GO:0005737; GO:0006629; GO:0006869; GO:0008035; GO:0008289; GO:0042157	DSMPDGNLSEEEK	11.19999981	1	1	0.330970784	1452.519635	13.72641	0	0	0	0	0	15.94361	12.7732	14.46761	15.07851	11.62716	12.43816	8.773106	12.56102	0	0	0	0	0	0	0	16.45422	0	0	0	0	14.3777	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.3996	15.37723
Q9BWX1	PHF7_HUMAN	PHD finger protein 7 (Testis development protein NYD-SP6)	PHF7	Homo sapiens (Human)		cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0016607; GO:0046872	LPQRGQSNR	6.539999962	1	1	0.137658803	1056.141328	13.46953	15.66616	15.78892	14.23108	0	0	15.35408	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.77708	13.69219	0	0	0	0	16.01182	0	15.88808	0	0	0	0	0	13.85413	0	0	14.38429	14.42558	0	0	0	0	17.59045	0	0	15.28167
Q9BX10	GTPB2_HUMAN	GTP-binding protein 2	GTPBP2	Homo sapiens (Human)	translational elongation [GO:0006414]	extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]	extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802	MAEKVGADITVLR	4.909999847	1	1	0.21267601	1419.178172	0	0	14.89681	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.15982	0	0	0	0	0	0	0	0	0	0	0	14.17	0	0	15.11483	0	16.47842	14.63033	0	0	16.68509	0	0	0	15.0581	0	0
Q9BX26	SYCP2_HUMAN	"Synaptonemal complex protein 2, SCP-2 (Synaptonemal complex lateral element protein, hsSCP2)"	SYCP2 SCP2	Homo sapiens (Human)	cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; meiotic nuclear division [GO:0140013]; negative regulation of apoptotic process [GO:0043066]; synaptonemal complex assembly [GO:0007130]	lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; meiotic nuclear division [GO:0140013]; negative regulation of apoptotic process [GO:0043066]; synaptonemal complex assembly [GO:0007130]	DNA binding [GO:0003677]	GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0007130; GO:0007140; GO:0007143; GO:0009566; GO:0043066; GO:0048808; GO:0051301; GO:0140013	HIKTAK	10.47000027	0.128373727	0.128373727	0.156788032	696.6472338	0	12.9747	14.84735	0	16.17339	0	0	15.52821	0	0	0	0	15.07773	0	0	15.62804	0	0	0	0	0	17.19476	0	0	16.15658	0	0	0	0	0	17.12215	0	17.57692	16.51396	0	0	0	0	0	0	0	0	17.18603	0	14.06901	13.21847	0	0
Q9BX40	LS14B_HUMAN	"Protein LSM14 homolog B (RNA-associated protein 55B, hRAP55B)"	LSM14B C20orf40 FAM61B RAP55B	Homo sapiens (Human)	regulation of translation [GO:0006417]		mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of translation [GO:0006417]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0006417	AEKGEEK	6.880000114	0.402568102	0.402568102	0.290111456	791.1320612	0	17.23	16.84339	0	0	0	18.33433	17.99806	0	20.47346	19.43274	0	0	0	0	0	19.90332	0	0	0	18.28628	0	0	17.49567	0	0	18.54251	0	18.03713	0	18.97047	0	19.74859	0	0	0	0	19.423	0	0	0	0	18.87147	17.90494	17.97875	0	19.71593	20.07227
Q9BX63	FANCJ_HUMAN	"Fanconi anemia group J protein, Protein FACJ, EC 3.6.4.13 (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1, BRCA1-interacting protein 1)"	BRIP1 BACH1 FANCJ	Homo sapiens (Human)	cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]	BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]"	GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0016887; GO:0031965; GO:0035825; GO:0043139; GO:0046872; GO:0051026; GO:0051539; GO:0070532; GO:0071295; GO:0071456; GO:0072520; GO:1904385; GO:1990918	NGLLVLPK	7.21999979	1	1	0.194984213	853.2254351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.29344	0	16.25066	0	0	0	0	0	0	0	0	18.35018	0	0	0	0	0	0	0	0	0	0	19.58806	0	0	0	0	0	19.03654	17.25943	0	0	0	0
Q9BX66	SRBS1_HUMAN	"Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein, CAP)"	SORBS1 KIAA0894 KIAA1296 SH3D5	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; stress fiber assembly [GO:0043149]	adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; zonula adherens [GO:0005915]	adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; stress fiber assembly [GO:0043149]	actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159]	GO:0001725; GO:0003779; GO:0005158; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005912; GO:0005915; GO:0005925; GO:0007160; GO:0008092; GO:0008286; GO:0016363; GO:0016600; GO:0030055; GO:0030159; GO:0031589; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046628; GO:0046889; GO:0048041; GO:1903078	HRGGEQAGR	2.930000067	1	1	0.175593567	966.459897	15.80968	16.69163	0	0	0	13.98508	0	15.00618	15.81644	0	15.74656	0	13.60203	15.05551	15.16681	14.78431	12.79381	13.73482	0	16.22493	14.61151	15.66975	0	14.97469	0	14.3523	0	0	15.71603	14.1836	14.38057	0	16.48367	14.64681	13.53925	16.04703	0	0	0	0	0	15.90912	0	0	0	0	0	0
Q9BX79	STRA6_HUMAN	Receptor for retinol uptake STRA6 (Retinol-binding protein receptor STRA6) (Stimulated by retinoic acid gene 6 protein homolog)	STRA6 PP14296 UNQ3126/PRO10282/PRO19578	Homo sapiens (Human)	adrenal gland development [GO:0030325]; alveolar primary septum development [GO:0061143]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cognition [GO:0050890]; developmental growth [GO:0048589]; diaphragm development [GO:0060539]; digestive tract morphogenesis [GO:0048546]; ductus arteriosus closure [GO:0097070]; ear development [GO:0043583]; embryonic camera-type eye formation [GO:0060900]; embryonic digestive tract development [GO:0048566]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; feeding behavior [GO:0007631]; female genitalia development [GO:0030540]; head development [GO:0060322]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; kidney development [GO:0001822]; learning [GO:0007612]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; neuromuscular process [GO:0050905]; nose morphogenesis [GO:0043585]; paramesonephric duct development [GO:0061205]; positive regulation of behavior [GO:0048520]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; response to retinoic acid [GO:0032526]; retinol transport [GO:0034633]; smooth muscle tissue development [GO:0048745]; uterus morphogenesis [GO:0061038]; ventricular septum development [GO:0003281]; vitamin A import [GO:0071939]; vocal learning [GO:0042297]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]; adrenal gland development [GO:0030325]; alveolar primary septum development [GO:0061143]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cognition [GO:0050890]; developmental growth [GO:0048589]; diaphragm development [GO:0060539]; digestive tract morphogenesis [GO:0048546]; ductus arteriosus closure [GO:0097070]; ear development [GO:0043583]; embryonic camera-type eye formation [GO:0060900]; embryonic digestive tract development [GO:0048566]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; feeding behavior [GO:0007631]; female genitalia development [GO:0030540]; head development [GO:0060322]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; kidney development [GO:0001822]; learning [GO:0007612]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; neuromuscular process [GO:0050905]; nose morphogenesis [GO:0043585]; paramesonephric duct development [GO:0061205]; positive regulation of behavior [GO:0048520]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; response to retinoic acid [GO:0032526]; retinol transport [GO:0034633]; smooth muscle tissue development [GO:0048745]; uterus morphogenesis [GO:0061038]; ventricular septum development [GO:0003281]; vitamin A import [GO:0071939]; vocal learning [GO:0042297]	retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]	GO:0001568; GO:0001822; GO:0003184; GO:0003281; GO:0005886; GO:0005887; GO:0007507; GO:0007612; GO:0007631; GO:0016918; GO:0019841; GO:0030324; GO:0030325; GO:0030540; GO:0032526; GO:0032991; GO:0034632; GO:0034633; GO:0038023; GO:0042297; GO:0043010; GO:0043583; GO:0043585; GO:0048286; GO:0048520; GO:0048546; GO:0048566; GO:0048589; GO:0048745; GO:0048844; GO:0050890; GO:0050905; GO:0060322; GO:0060323; GO:0060325; GO:0060426; GO:0060539; GO:0060900; GO:0061029; GO:0061038; GO:0061143; GO:0061156; GO:0061205; GO:0071939; GO:0097070	NLLLFR	36.66999817	0.335997224	0.335997224	0.184276711	774.7708223	0	16.84487	0	18.82724	0	0	0	0	0	17.408	13.52402	0	0	0	0	10.69656	0	0	15.90951	19.43177	0	18.72158	16.50455	15.30824	0	0	17.23206	0	17.64882	0	12.46559	13.57422	17.44364	0	0	13.21964	17.06332	0	0	19.38956	0	16.99864	16.70317	0	19.14885	17.36874	0	16.13673
Q9BX82	ZN471_HUMAN	Zinc finger protein 471 (EZFIT-related protein 1)	ZNF471 ERP1 KIAA1396	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	VYVGKK	4.630000114	0.327991486	0.327991486	0.196786737	693.7150806	0	15.21955	13.69812	0	14.83544	0	13.77508	0	15.21174	15.90962	13.18424	0	0	16.87461	15.54319	14.86461	0	0	15.56629	13.28014	15.12678	0	15.75869	0	0	0	0	15.55399	0	16.65409	15.6722	0	0	13.0718	15.064	16.10102	0	0	16.89407	0	0	16.72256	0	0	0	0	0	0
Q9BX84	TRPM6_HUMAN	"Transient receptor potential cation channel subfamily M member 6, EC 2.7.11.1 (Channel kinase 2) (Melastatin-related TRP cation channel 6)"	TRPM6 CHAK2	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636]	ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005261; GO:0005262; GO:0005524; GO:0005886; GO:0005887; GO:0009636; GO:0016324; GO:0031526; GO:0046872; GO:0051262; GO:0070588; GO:0098655; GO:0106310	AVIACILYR	5.75	1	1	0.197199191	1077.25511	0	0	15.48457	0	0	14.50089	16.46525	12.42881	10.71104	0	0	14.23921	0	15.84399	0	0	0	0	0	15.96914	0	17.56857	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BXA9	SALL3_HUMAN	"Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3, hSALL3)"	SALL3 ZNF796	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	KMTDPNQCVICHR	12.03999996	0.410939097	0.410939097	0.434447979	1675.373348	0	0	17.24085	0	0	0	0	0	0	0	0	0	0	0	0	18.31675	0	0	0	0	0	0	0	0	0	19.38066	0	18.45194	0	0	0	18.39175	0	0	0	18.95556	0	0	0	17.82739	0	0	17.85746	0	0	17.39769	0	0
Q9BXB1	LGR4_HUMAN	Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48)	LGR4 GPR48	Homo sapiens (Human)	"activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]"	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]	GO:0001649; GO:0001818; GO:0001942; GO:0004888; GO:0004930; GO:0005886; GO:0005887; GO:0007189; GO:0007190; GO:0007283; GO:0008528; GO:0009755; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0036335; GO:0045087; GO:0045892; GO:0045893; GO:0046849; GO:0048565; GO:0061290; GO:0072202; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013	ALSGLK	3.339999914	0.975753903	0.975753903	0.229455062	587.9268659	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.55032	0	0	0	0	0	0	0	0	0	0	17.31768	0	19.2905	0	0	0	17.60527	0	0	0	0	0	0	0	0	0	0	0	16.51912
Q9BXB4	OSB11_HUMAN	"Oxysterol-binding protein-related protein 11, ORP-11, OSBP-related protein 11"	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890]	sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005654; GO:0005794; GO:0005829; GO:0010890; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444	QGGEPVSTMK	16.20000076	0.781404674	0.781404674	0.406312549	1031.942295	0	15.77646	18.51226	16.43176	13.67535	16.12926	15.2695	0	13.60959	17.1774	15.05013	15.86978	0	15.87016	18.29992	9.776059	15.74343	0	12.65869	15.18309	15.68739	17.46939	18.69785	18.16427	18.59927	0	0	0	16.6216	0	18.45356	14.8276	0	0	15.5952	0	0	18.22023	0	0	19.0939	13.69856	0	17.51967	16.60231	16.82099	15.0141	15.19614
Q9BXB5	OSB10_HUMAN	"Oxysterol-binding protein-related protein 10, ORP-10, OSBP-related protein 10"	OSBPL10 ORP10 OSBP9	Homo sapiens (Human)	phosphatidylserine acyl-chain remodeling [GO:0036150]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; phosphatidylserine acyl-chain remodeling [GO:0036150]	cholesterol binding [GO:0015485]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005829; GO:0005856; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0036150; GO:0043231	QGPMESR	8.899999619	1	1	0.25654222	819.4877713	0	0	15.02535	0	0	0	0	0	16.60437	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.72728	0	0	0	0	0	0	0	0	0	0	0	0	18.70657	18.52605	18.49661	17.619	17.92956	17.38477	0	0	0	0	0	0
Q9BXC0	HCAR1_HUMAN	Hydroxycarboxylic acid receptor 1 (G-protein coupled receptor 104) (G-protein coupled receptor 81)	HCAR1 GPR104 GPR81 HCA1 FKSG80	Homo sapiens (Human)	negative regulation of lipid catabolic process [GO:0050995]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; negative regulation of lipid catabolic process [GO:0050995]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021; GO:0050995	QPGHSK	2.200000048	1	1	0.170577679	653.7196855	0	0	0	0	0	0	17.92757	0	0	11.09299	0	0	0	17.80638	15.25853	0	0	17.28388	18.32321	0	16.70611	0	0	0	18.20705	17.12843	18.5077	15.07338	0	0	18.61438	17.11572	18.84303	0	16.69643	19.04168	18.67768	18.8875	18.76978	19.10577	18.71285	19.3466	0	17.38817	18.81559	19.52898	0	0
Q9BXC9	BBS2_HUMAN	Bardet-Biedl syndrome 2 protein	BBS2	Homo sapiens (Human)	adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; visual perception [GO:0007601]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; neuron projection [GO:0043005]	BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; visual perception [GO:0007601]	RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]	GO:0005829; GO:0007288; GO:0007601; GO:0008104; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032402; GO:0033365; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0043001; GO:0043005; GO:0045444; GO:0045494; GO:0048854; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515	VGTASS	4.960000038	0.804889202	0.804889202	0.206941837	520.2348492	0	15.58462	16.98973	15.63608	16.41982	0	0	15.85561	15.22788	0	0	16.43863	16.50207	15.63896	0	15.70137	15.91797	17.17443	16.06191	16.85013	16.5564	15.26731	17.03514	16.54557	15.67472	15.4574	15.33256	16.40523	14.13936	15.64983	16.91833	16.41322	14.99704	14.40132	15.91928	15.84655	15.9913	16.08229	16.65614	0	14.72649	0	15.72979	0	17.93984	16.86525	16.26448	16.27256
Q9BXF3	CECR2_HUMAN	Cat eye syndrome critical region protein 2	CECR2 KIAA1740	Homo sapiens (Human)	apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]	CERF complex [GO:0090537]; nucleus [GO:0005634]	CERF complex [GO:0090537]; nucleus [GO:0005634]; ATP-dependent chromatin remodeler activity [GO:0140658]; apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192]	ATP-dependent chromatin remodeler activity [GO:0140658]	GO:0005634; GO:0006309; GO:0006338; GO:0007010; GO:0007338; GO:0016192; GO:0061640; GO:0090537; GO:0097194; GO:0140658	QPFTMQPPVGINSLR	4.659999847	1	1	2.29E-13	1685.635339	14.90706	0	0	14.0598	15.39488	14.22574	14.56885	0	0	13.81529	0	14.13049	17.76033	0	0	14.20004	0	14.03893	13.56764	13.81395	16.21358	16.66846	16.06498	0	16.60079	14.86147	13.02486	0	0	0	0	0	0	0	0	0	0	0	0	14.75996	14.87534	0	0	0	0	0	0	0
Q9BXF6	RFIP5_HUMAN	"Rab11 family-interacting protein 5, Rab11-FIP5 (Gamma-SNAP-associated factor 1, Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11)"	RAB11FIP5 GAF1 KIAA0857 RIP11	Homo sapiens (Human)	cellular response to acidic pH [GO:0071468]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of adiponectin secretion [GO:0070164]; regulated exocytosis [GO:0045055]; regulation of protein localization to cell surface [GO:2000008]	centriolar satellite [GO:0034451]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658]	centriolar satellite [GO:0034451]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658]; gamma-tubulin binding [GO:0043015]; small GTPase binding [GO:0031267]; cellular response to acidic pH [GO:0071468]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of adiponectin secretion [GO:0070164]; regulated exocytosis [GO:0045055]; regulation of protein localization to cell surface [GO:2000008]	gamma-tubulin binding [GO:0043015]; small GTPase binding [GO:0031267]	GO:0000139; GO:0005739; GO:0005741; GO:0005769; GO:0005794; GO:0030141; GO:0030658; GO:0031267; GO:0031901; GO:0034451; GO:0035773; GO:0043015; GO:0043231; GO:0045055; GO:0045335; GO:0055037; GO:0055038; GO:0070164; GO:0071468; GO:2000008	FLGQATVALDEVFGAGRAQHTQWYK	5.349999905	0.551383913	0.551383913	0.041399976	2792.704604	16.5262	16.05247	0	16.29716	16.60154	16.96204	13.31556	16.37855	12.27845	0	0	0	16.57427	0	15.47638	14.95142	15.85481	12.43683	0	0	16.31314	0	14.90074	0	0	14.78152	14.57117	15.83751	12.86134	0	15.24259	0	15.22898	0	15.88304	15.10808	15.1303	14.63364	17.16667	15.47917	11.86665	0	16.68157	0	0	0	0	15.57191
Q9BXG8	SPZ1_HUMAN	Spermatogenic leucine zipper protein 1 (Testis-specific protein 1) (Testis-specific protein NYD-TSP1)	SPZ1 TSP1	Homo sapiens (Human)		cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]	GO:0003677; GO:0003700; GO:0005634; GO:0005737	SAEMPTISK	7.409999847	0.737800479	0.737800479	0.168749598	982.1231682	0	17.49044	14.7149	15.05391	14.76308	0	0	0	0	0	13.97079	14.35006	0	0	15.39912	0	0	0	0	0	0	0	13.57946	0	0	0	0	0	0	17.22164	16.00252	0	0	0	0	0	0	0	0	0	0	0	0	14.60494	0	0	16.77201	0
Q9BXH1	BBC3_HUMAN	"Bcl-2-binding component 3, isoforms 1/2 (JFY-1) (p53 up-regulated modulator of apoptosis)"	BBC3 PUMA	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; determination of adult lifespan [GO:0008340]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of growth [GO:0045926]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of thymocyte apoptotic process [GO:0070245]; release of cytochrome c from mitochondria [GO:0001836]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; toxin transport [GO:1901998]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; PUMA-BCL-xl complex [GO:0097143]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; PUMA-BCL-xl complex [GO:0097143]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; determination of adult lifespan [GO:0008340]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of growth [GO:0045926]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of thymocyte apoptotic process [GO:0070245]; release of cytochrome c from mitochondria [GO:0001836]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; toxin transport [GO:1901998]		GO:0001836; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006919; GO:0006974; GO:0008340; GO:0031334; GO:0032464; GO:0032471; GO:0034976; GO:0042771; GO:0043525; GO:0045926; GO:0051209; GO:0070059; GO:0070245; GO:0071456; GO:0071479; GO:0090200; GO:0097143; GO:0097190; GO:0097194; GO:1900740; GO:1901998; GO:1902237; GO:1903896; GO:2001056; GO:2001244	WPGGPR	5	1	1	0.27420355	668.1742502	0	0	0	16.08065	0	14.74775	14.66884	15.74339	0	0	0	16.4493	0	16.51481	0	0	15.86907	15.97568	16.16258	0	16.71328	0	0	0	0	15.67984	14.84674	0	0	15.46771	16.05245	15.2607	16.08084	16.0146	17.169	16.90183	0	15.67188	16.73801	16.14228	16.3424	15.93199	0	18.11501	16.39264	15.87504	16.64718	16.33742
Q9BXI2	ORNT2_HUMAN	Mitochondrial ornithine transporter 2 (Solute carrier family 25 member 2)	SLC25A2 ORNT2	Homo sapiens (Human)	mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; L-ornithine transmembrane transporter activity [GO:0000064]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050]	L-ornithine transmembrane transporter activity [GO:0000064]	GO:0000050; GO:0000064; GO:0005743; GO:0016021; GO:1990575	MMMKQLEAY	4.690000057	1	1	1.15E-12	1189.539008	13.72033	0	13.86897	13.60618	0	0	11.06016	15.30439	0	0	0	0	0	0	0	0	13.55563	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BXJ0	C1QT5_HUMAN	Complement C1q tumor necrosis factor-related protein 5	C1QTNF5 CTRP5 UNQ303/PRO344	Homo sapiens (Human)	inner ear development [GO:0048839]; protein secretion [GO:0009306]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell projection [GO:0042995]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell projection [GO:0042995]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; identical protein binding [GO:0042802]; inner ear development [GO:0048839]; protein secretion [GO:0009306]	identical protein binding [GO:0042802]	GO:0005581; GO:0005615; GO:0005886; GO:0005923; GO:0009306; GO:0016324; GO:0016328; GO:0030133; GO:0042802; GO:0042995; GO:0048839	DGAPGAPGEK	1.970000029	0.979932129	0.979932129	0.264824353	899.2618565	15.69002	15.10378	14.7633	16.96807	0	17.08171	0	0	0	0	0	0	0	0	18.15997	19.19427	0	0	17.48382	15.44236	0	0	0	18.90977	0	18.59711	19.13531	18.08005	17.09775	16.99703	0	19.40046	0	0	17.54828	0	18.54517	18.6648	20.4204	0	0	0	19.06177	0	17.40946	0	0	17.24408
Q9BXJ1	C1QT1_HUMAN	"Complement C1q tumor necrosis factor-related protein 1 (G protein-coupled receptor-interacting protein, GIP)"	C1QTNF1 CTRP1 UNQ310/PRO353	Homo sapiens (Human)	negative regulation of platelet activation [GO:0010544]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose metabolic process [GO:0010906]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; negative regulation of platelet activation [GO:0010544]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose metabolic process [GO:0010906]	collagen binding [GO:0005518]; identical protein binding [GO:0042802]	GO:0005518; GO:0005581; GO:0005615; GO:0005887; GO:0007204; GO:0010544; GO:0010628; GO:0010906; GO:0042802; GO:0043410; GO:0051897; GO:0090331; GO:2000860	GDRGLQGK	5.710000038	1	1	0.221523255	830.9006962	0	15.86352	0	0	0	0	0	0	15.36963	0	0	12.67798	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.79497	11.10371	0	0	0	0	16.27923	0	0	0	0	0	0	0	15.83135	0	18.13704	15.77172	0
Q9BXJ9	NAA15_HUMAN	"N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100)"	NAA15 GA19 NARG1 NATH TBDN100	Homo sapiens (Human)	"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]"	ribosome binding [GO:0043022]; RNA binding [GO:0003723]	GO:0001525; GO:0003723; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006474; GO:0016020; GO:0016604; GO:0017196; GO:0030154; GO:0031415; GO:0043022; GO:0043066; GO:0043231; GO:0045893; GO:0050821	GCPPVFNTLR	3.99000001	0.843101978	0.843101978	0.198480332	1157.131838	11.64155	12.83406	15.31389	11.65289	15.46939	13.7297	0	0	0	16.54897	0	0	14.38319	0	0	0	13.94343	0	15.92973	0	0	12.6273	0	0	0	0	14.18646	13.76162	0	0	0	0	0	0	0	0	0	0	0	0	15.80643	0	0	0	0	0	0	0
Q9BXK1	KLF16_HUMAN	"Krueppel-like factor 16 (Basic transcription element-binding protein 4, BTE-binding protein 4) (Novel Sp1-like zinc finger transcription factor 2) (Transcription factor BTEB4) (Transcription factor NSLP2)"	KLF16 BTEB4 NSLP2	Homo sapiens (Human)	dopamine receptor signaling pathway [GO:0007212]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; dopamine receptor signaling pathway [GO:0007212]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007212; GO:0046872; GO:1990837	SDHLAKHAR	4.809999943	1	1	0.181081649	1034.8624	0	15.98646	16.27981	0	0	0	0	0	14.66757	0	0	0	17.06215	15.03527	0	16.00419	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.51259	0	0	0	0	0	16.82802	18.22858	0	0
Q9BXL5	HEMGN_HUMAN	"Hemogen (Erythroid differentiation-associated gene protein, EDAG-1) (Hemopoietic gene protein) (Negative differentiation regulator protein)"	HEMGN EDAG NDR PRO1037 PRO1620	Homo sapiens (Human)	cell differentiation [GO:0030154]; regulation of osteoblast differentiation [GO:0045667]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; cell differentiation [GO:0030154]; regulation of osteoblast differentiation [GO:0045667]		GO:0005654; GO:0030154; GO:0045667	EIVEKALAPIEK	8.069999695	1	1	0.183280692	1340.755078	15.19984	0	15.20166	15.72282	16.50081	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.47026	0	0	15.42814	0	0	14.79813	0	0	16.32045	0	0	11.4853	0	0	0	0	0	0	0	16.7469
Q9BXL6	CAR14_HUMAN	"Caspase recruitment domain-containing protein 14 (CARD-containing MAGUK protein 2, Carma 2)"	CARD14 CARMA2	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; CARD domain binding [GO:0050700]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	CARD domain binding [GO:0050700]	GO:0001934; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007250; GO:0016235; GO:0033209; GO:0043066; GO:0050700; GO:0051092	ASPLRLSFDR	3.269999981	1	1	0.126820786	1161.088178	12.53922	0	13.65997	12.99308	14.92843	0	0	0	0	0	0	10.6967	0	0	13.88593	0	0	0	13.06083	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BXM0	PRAX_HUMAN	Periaxin	PRX KIAA1620	Homo sapiens (Human)	axon ensheathment [GO:0008366]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of RNA splicing [GO:0043484]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; axon ensheathment [GO:0008366]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of RNA splicing [GO:0043484]		GO:0005634; GO:0005737; GO:0005886; GO:0008366; GO:0030054; GO:0032287; GO:0043484	LPKVPEAALPEVR	7.119999886	1	1	0.283026896	1423.012096	15.13859	0	13.01939	0	0	14.59418	0	14.02712	14.14295	15.0474	0	0	0	0	0	0	0	0	0	16.44568	18.29739	0	0	0	0	0	0	16.83318	14.37179	0	14.37832	13.81313	0	0	11.727	0	16.58169	17.40457	0	0	0	0	0	0	15.82677	0	0	18.9561
Q9BXM7	PINK1_HUMAN	"Serine/threonine-protein kinase PINK1, mitochondrial, EC 2.7.11.1 (BRPK) (PTEN-induced putative kinase protein 1)"	PINK1	Homo sapiens (Human)	"activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]"	astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; establishment of protein localization to mitochondrion [GO:0072655]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]"	ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]	GO:0000287; GO:0000422; GO:0000423; GO:0000785; GO:0001934; GO:0002020; GO:0002082; GO:0002931; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006979; GO:0007005; GO:0010310; GO:0010629; GO:0010821; GO:0010857; GO:0010952; GO:0016020; GO:0016239; GO:0016242; GO:0016301; GO:0016504; GO:0016567; GO:0018105; GO:0022904; GO:0030097; GO:0030424; GO:0030426; GO:0031307; GO:0031396; GO:0031398; GO:0031625; GO:0032148; GO:0032226; GO:0033138; GO:0033603; GO:0034599; GO:0035307; GO:0035556; GO:0036289; GO:0038203; GO:0042981; GO:0043123; GO:0043254; GO:0043422; GO:0043524; GO:0044297; GO:0044877; GO:0045727; GO:0046329; GO:0048471; GO:0050821; GO:0051091; GO:0051443; GO:0051881; GO:0051897; GO:0055131; GO:0061136; GO:0071456; GO:0072655; GO:0072656; GO:0090141; GO:0090200; GO:0090258; GO:0097237; GO:0097413; GO:0097449; GO:0098779; GO:0099074; GO:0106310; GO:1900407; GO:1901525; GO:1901727; GO:1902803; GO:1902902; GO:1902958; GO:1903146; GO:1903202; GO:1903204; GO:1903214; GO:1903298; GO:1903384; GO:1903751; GO:1903852; GO:1903955; GO:1904544; GO:1904783; GO:1904841; GO:1904881; GO:2000377; GO:2000378; GO:2001171; GO:2001243	GGNGCLMAPEVSTARPGPR	8.5	1	1	0.586947924	1942.979329	17.67823	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.43106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BXP5	SRRT_HUMAN	Serrate RNA effector molecule homolog (Arsenite-resistance protein 2)	SRRT ARS2 ASR2	Homo sapiens (Human)	"mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of neurogenesis [GO:0050769]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]"	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of neurogenesis [GO:0050769]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]"	DNA binding [GO:0003677]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005654; GO:0005737; GO:0006355; GO:0006397; GO:0016604; GO:0030674; GO:0031053; GO:0032991; GO:0046685; GO:0050769; GO:0097150; GO:0140262; GO:1990904	AGAGLGDGER	9.789999962	1	1	0.077681454	902.8315887	0	12.42253	15.01292	17.44996	0	0	15.91584	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.16677	0	0	0	16.13721	0	0	0	11.58275	0	16.52926	0	0	0	0	0	0	0	16.09389	0	0
Q9BXP8	PAPP2_HUMAN	"Pappalysin-2, EC 3.4.24.- (Pregnancy-associated plasma protein A2, PAPP-A2) (Pregnancy-associated plasma protein E1, PAPP-E)"	PAPPA2 PLAC3	Homo sapiens (Human)	bone morphogenesis [GO:0060349]; cellular protein metabolic process [GO:0044267]; proteolysis [GO:0006508]; regulation of cell growth [GO:0001558]; response to salt stress [GO:0009651]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; bone morphogenesis [GO:0060349]; cellular protein metabolic process [GO:0044267]; proteolysis [GO:0006508]; regulation of cell growth [GO:0001558]; response to salt stress [GO:0009651]	metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0001558; GO:0004222; GO:0005576; GO:0005829; GO:0006508; GO:0008237; GO:0008270; GO:0009651; GO:0016324; GO:0044267; GO:0060349; GO:0070062	AYSSHEDK	2.99000001	1	1	0.240444654	934.9922149	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.44543	0	0	0	0	0	0
Q9BXR0	TGT_HUMAN	"Queuine tRNA-ribosyltransferase catalytic subunit 1, EC 2.4.2.64 (Guanine insertion enzyme) (tRNA-guanine transglycosylase)"	QTRT1 TGT TGUT	Homo sapiens (Human)	tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]	mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005634; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030; GO:1990234	MAGAATQASLESAPR	2.940000057	0.380175799	0.380175799	0.124052621	1476.688273	15.5165	13.05399	18.72025	16.36752	16.68084	15.52564	0	16.52074	15.12618	16.60163	0	0	15.31681	0	15.9835	16.05989	0	0	13.54702	0	14.76441	15.67012	14.83229	13.25999	15.47635	0	13.77353	14.98914	14.84988	14.37347	14.54629	16.04935	18.14248	13.51853	14.55822	18.37867	14.27507	0	0	15.1659	15.30274	11.92833	11.60068	0	13.2069	15.65336	0	14.36155
Q9BXS0	COPA1_HUMAN	"Collagen alpha-1(XXV) chain (Alzheimer disease amyloid-associated protein, AMY) (CLAC-P) [Cleaved into: Collagen-like Alzheimer amyloid plaque component, CLAC ]"	COL25A1	Homo sapiens (Human)		collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]	amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]	GO:0001540; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0005886; GO:0005887; GO:0008201; GO:0016021; GO:0042802; GO:0062023	GDKGEQGDQGPR	4.539999962	0.003347597	0.003347597	0.149723863	1244.074697	0	0	0	0	0	0	0	0	15.14117	0	0	0	11.73304	13.07349	13.19251	10.42919	0	13.40026	0	14.08036	0	14.41639	10.9958	0	0	0	0	14.16257	16.81997	14.16877	9.400979	14.90274	14.49104	15.09594	0	0	0	0	0	0	0	14.38538	0	0	0	0	0	0
Q9BXS9	S26A6_HUMAN	"Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1, Pendrin-L1)"	SLC26A6	Homo sapiens (Human)	angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; mannitol transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; mannitol transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633]	anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]	GO:0005254; GO:0005452; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0008271; GO:0008272; GO:0012506; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015499; GO:0015562; GO:0015660; GO:0015701; GO:0015724; GO:0015797; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019531; GO:0019532; GO:0030165; GO:0030321; GO:0030659; GO:0031526; GO:0031982; GO:0034707; GO:0038166; GO:0042045; GO:0042802; GO:0046724; GO:0048240; GO:0050892; GO:0051453; GO:0051454; GO:0070528; GO:0070633; GO:0071320; GO:0071332; GO:0071346; GO:0097225; GO:2001150	APDGSTLK	9.920000076	0.303871393	0.303871393	0.307143765	787.8779793	15.72134	16.88719	17.96645	0	16.64029	16.20493	0	17.37644	0	0	0	0	0	15.61229	0	17.93767	17.01743	0	0	16.45831	0	16.99144	0	0	17.28377	18.14651	0	0	0	18.56018	0	0	19.21177	0	17.92211	18.78252	0	0	0	0	18.86889	16.31445	0	0	0	0	0	0
Q9BXT2	CCG6_HUMAN	Voltage-dependent calcium channel gamma-6 subunit (Neuronal voltage-gated calcium channel gamma-6 subunit)	CACNG6	Homo sapiens (Human)	calcium ion transport [GO:0006816]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]	L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]	L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]	calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005246; GO:0005886; GO:0005891; GO:0006816; GO:1902514; GO:1990454	GAAGRR	6.690000057	1	1	0.158262496	586.2958619	13.39154	15.42359	14.50283	15.64246	14.58479	15.0694	14.6701	14.85545	0	13.42266	15.27629	0	16.34135	0	0	15.45847	0	17.13958	16.50169	0	16.17693	16.68946	0	16.24202	16.06773	15.02946	16.30474	16.57437	15.92577	15.10561	15.472	15.56728	0	16.21525	16.0049	15.17901	17.41458	0	16.3772	0	0	17.7755	16.47541	17.42097	15.78963	17.64817	0	0
Q9BXT5	TEX15_HUMAN	"Testis-expressed protein 15 (Cancer/testis antigen 42, CT42)"	TEX15	Homo sapiens (Human)	cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; regulation of double-strand break repair via homologous recombination [GO:0010569]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; regulation of double-strand break repair via homologous recombination [GO:0010569]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]		GO:0005634; GO:0005737; GO:0006281; GO:0006306; GO:0007130; GO:0007140; GO:0007283; GO:0010529; GO:0010569; GO:0030154; GO:0031047	GPLPK	7.949999809	0.000121112	0.000121112	0.301369614	510.2834942	0	17.71961	0	0	16.72469	0	0	0	18.20465	20.35292	0	0	0	0	17.67567	0	19.74805	0	0	0	0	0	0	17.93805	0	0	0	0	16.60745	0	0	0	17.73363	0	0	0	0	0	0	0	0	0	16.68328	0	0	0	18.78736	0
Q9BXT6	M10L1_HUMAN	"RNA helicase Mov10l1, EC 3.6.4.13 (Moloney leukemia virus 10-like protein 1, MOV10-like protein 1)"	MOV10L1	Homo sapiens (Human)	DNA methylation involved in gamete generation [GO:0043046]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA metabolic process [GO:0034587]; post-transcriptional gene silencing by RNA [GO:0035194]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]	cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA methylation involved in gamete generation [GO:0043046]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA metabolic process [GO:0034587]; post-transcriptional gene silencing by RNA [GO:0035194]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043046; GO:0043186; GO:0071546	SSGQSTSKK	2.089999914	1	1	0.154588444	909.8055811	14.96751	13.54066	15.63679	14.25008	16.86308	0	13.66048	14.72981	0	15.82407	0	13.96494	0	0	15.34411	0	14.76548	0	15.1684	13.27079	0	16.12699	0	0	16.74175	0	0	0	0	14.26379	15.83425	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BXU1	STK31_HUMAN	"Serine/threonine-protein kinase 31, EC 2.7.11.1 (Serine/threonine-protein kinase NYD-SPK) (Sugen kinase 396, SgK396)"	STK31 SGK396	Homo sapiens (Human)		acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001669; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0106310	EEFTSVR	12.82999992	0.069794543	0.069794543	0.176155487	866.5863866	15.45717	14.95181	15.70778	0	0	14.91193	14.96669	15.34721	0	0	0	0	12.99119	14.51352	0	0	14.12848	0	14.40059	0	16.2	0	16.11954	16.07867	0	15.74343	15.25685	14.7957	16.16725	15.83065	15.13618	15.55367	15.40782	0	14.86694	13.21027	14.62147	15.64756	14.08586	16.39679	16.92352	16.77977	0	16.98057	17.54866	0	0	15.5255
Q9BXU7	UBP26_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 26, EC 3.4.19.12 (Deubiquitinating enzyme 26) (Ubiquitin thioesterase 26) (Ubiquitin-specific-processing protease 26)"	USP26	Homo sapiens (Human)	G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579	QQQKYLGK	3.970000029	1	1	0.267247442	993.9416016	0	14.92614	0	11.87368	0	15.3677	16.31168	16.64966	0	18.80459	0	14.79764	0	0	0	14.72212	15.79613	0	0	0	0	16.86954	16.50043	0	16.56657	15.3863	16.84381	15.455	10.9083	12.13286	17.75139	17.00553	17.29028	17.17672	15.7605	12.67117	16.8799	15.68698	14.77844	15.4512	0	17.95066	15.66161	0	14.37296	15.23795	14.19011	14.84278
Q9BXU9	CABP8_HUMAN	"Calcium-binding protein 8, CaBP8 (Calneuron I) (Calneuron-1)"	CALN1 CABP8	Homo sapiens (Human)		integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]	integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005886; GO:0016021; GO:0032588; GO:0048471	EAFRVLDR	9.600000381	1	1	0.264467828	1006.369874	0	0	0	0	18.39058	0	0	0	0	0	0	0	15.32987	0	15.87296	16.77596	0	18.62919	16.67147	0	0	0	0	0	0	0	0	0	0	16.05303	18.13142	20.42278	17.65901	17.53839	18.69956	16.9319	0	0	0	0	17.29216	0	0	0	0	17.05705	16.68713	0
Q9BXW6	OSBL1_HUMAN	"Oxysterol-binding protein-related protein 1, ORP-1, OSBP-related protein 1"	OSBPL1A ORP1 OSBP8 OSBPL1 OSBPL1B	Homo sapiens (Human)	bile acid biosynthetic process [GO:0006699]; cholesterol metabolic process [GO:0008203]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]	cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; phospholipid binding [GO:0005543]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; cholesterol metabolic process [GO:0008203]; vesicle-mediated transport [GO:0016192]	cholesterol binding [GO:0015485]; phospholipid binding [GO:0005543]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005543; GO:0005768; GO:0005770; GO:0005829; GO:0006699; GO:0008203; GO:0015248; GO:0015485; GO:0016020; GO:0016192; GO:0032934; GO:0043231; GO:0044232; GO:0070062	CVLNFKPCGLFGK	3.420000076	1	1	0.258245802	1534.01229	0	15.95724	0	13.54999	13.14323	15.89687	14.4965	14.84699	0	15.3176	16.11862	13.43495	13.59364	0	12.49369	15.09914	16.61307	0	0	16.42333	13.50452	15.65516	0	0	13.55413	15.35759	0	15.38197	0	0	0	16.96269	18.62028	0	0	0	10.51902	13.18945	0	15.11687	0	0	0	0	12.96739	0	15.37107	0
Q9BXW9	FACD2_HUMAN	"Fanconi anemia group D2 protein, Protein FACD2"	FANCD2 FACD	Homo sapiens (Human)	brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]	DNA polymerase binding [GO:0070182]	GO:0000785; GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990391; GO:1990918; GO:2000348	YKLIGIIGAVTMAGIMAADR	8.06000042	0.157224372	0.157224372	4.58E-13	2095.950968	14.60982	12.72333	9.401235	15.19753	0	15.80929	0	14.85635	0	0	16.35323	0	14.81094	0	0	17.1534	14.0467	0	0	0	0	0	14.97401	0	0	16.87415	15.97261	16.8678	0	0	0	0	15.21204	0	0	14.50418	0	16.70495	15.04564	0	0	0	0	0	0	0	15.39753	0
Q9BXX0	EMIL2_HUMAN	"EMILIN-2 (Elastin microfibril interface-located protein 2, Elastin microfibril interfacer 2) (Protein FOAP-10)"	EMILIN2	Homo sapiens (Human)	cell adhesion mediated by integrin [GO:0033627]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood coagulation [GO:0030194]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of platelet aggregation [GO:1901731]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood coagulation [GO:0030194]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of platelet aggregation [GO:1901731]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]	extracellular matrix constituent conferring elasticity [GO:0030023]	GO:0005576; GO:0005581; GO:0008217; GO:0030023; GO:0030194; GO:0030336; GO:0033627; GO:0042127; GO:0043065; GO:0045766; GO:0062023; GO:1900426; GO:1901731	HVSSLWNCVRQMNGTLR	5.28000021	0.891814888	0.891814888	0.19552762	2073.898982	14.7136	12.93072	12.81412	17.06433	12.84691	11.94751	0	0	0	0	0	0	0	0	0	13.79323	15.09551	0	0	0	0	0	0	13.63396	0	0	12.80169	0	0	0	0	0	0	13.78538	0	0	0	0	0	0	0	0	0	0	0	15.01686	0	0
Q9BXX3	AN30A_HUMAN	Ankyrin repeat domain-containing protein 30A (Serologically defined breast cancer antigen NY-BR-1)	ANKRD30A	Homo sapiens (Human)						ETVSQK	6.519999981	1	1	0.090727142	689.6012475	0	0	17.11778	0	0	0	17.03144	0	0	0	18.19219	0	0	0	0	0	0	0	0	0	0	17.79892	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BXY4	RSPO3_HUMAN	"R-spondin-3 (Protein with TSP type-1 repeat, hPWTSR) (Roof plate-specific spondin-3, hRspo3) (Thrombospondin type-1 domain-containing protein 2)"	RSPO3 PWTSR THSD2	Homo sapiens (Human)	"blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]"	extracellular region [GO:0005576]	"extracellular region [GO:0005576]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]"	frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	GO:0001974; GO:0002040; GO:0005102; GO:0005109; GO:0005576; GO:0008201; GO:0016055; GO:0030177; GO:0060670; GO:0090263; GO:2000052; GO:2000096	GKTCGFK	3.829999924	1	1	0.081564536	798.0075088	15.90248	0	10.62508	13.15671	0	14.64544	0	14.17429	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.35534	0	0	0	0	15.28725	0
Q9BY12	SCAPE_HUMAN	"S phase cyclin A-associated protein in the endoplasmic reticulum, S phase cyclin A-associated protein in the ER (Zinc finger protein 291)"	SCAPER KIAA1454 ZNF291 MSTP063	Homo sapiens (Human)	antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0072520; GO:1990917	FPQQAWEEARQFFLK	5.480000019	0.364623427	0.364623427	0.109987908	1925.102343	17.02888	0	0	0	16.12192	0	0	0	17.10621	0	0	16.89998	0	0	0	0	0	16.68907	0	13.98087	0	16.49165	0	17.09365	0	0	14.30316	0	14.41713	0	17.20154	17.3278	14.81014	0	17.61214	0	0	0	17.2098	15.41426	13.43764	14.70139	0	0	11.49717	0	13.54716	15.97256
Q9BY15	AGRE3_HUMAN	Adhesion G protein-coupled receptor E3 (EGF-like module receptor 3) (EGF-like module-containing mucin-like hormone receptor-like 3)	ADGRE3 EMR3 UNQ683/PRO1562	Homo sapiens (Human)	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005509; GO:0005576; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021; GO:0030667; GO:0101003	STGQGSQWSR	8.649999619	0.079187259	0.079187259	0.102482614	1093.964617	18.8547	16.4222	18.08272	16.439	0	12.45052	15.35668	0	0	0	0	0	0	18.15518	0	0	0	16.66735	15.72889	15.58531	16.05626	0	0	15.6431	10.91409	13.01008	14.00549	0	14.37008	0	17.57267	17.04204	0	12.74605	0	0	0	16.73592	17.49146	0	0	9.892998	10.61809	0	0	0	17.43609	0
Q9BY21	GPR87_HUMAN	G-protein coupled receptor 87 (G-protein coupled receptor 95)	GPR87 GPR95 FKSG78	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]	G protein-coupled purinergic nucleotide receptor activity [GO:0045028]	GO:0005886; GO:0007186; GO:0007194; GO:0016021; GO:0045028	VVKPFGDSRMYSITFTK	14.76000023	1	1	0.535463122	1991.467495	21.0956	18.7754	0	19.31037	0	19.51314	19.91716	0	0	0	0	15.84121	0	0	17.80154	0	17.60723	0	0	0	18.97794	16.69857	18.61105	0	19.38062	18.2018	19.01996	19.17196	0	19.15978	19.35414	19.79065	19.14865	22.04194	0	20.52259	20.58831	20.33236	18.36544	20.81603	19.94443	17.62084	19.40672	18.22218	20.43156	18.60205	19.02787	0
Q9BY31	ZN717_HUMAN	Zinc finger protein 717 (Krueppel-like factor X17)	ZNF717	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	LFSYKSSLIIHQR	4.179999828	1	1	0.331332334	1590.660483	0	13.99185	14.91448	0	0	0	0	0	0	14.78439	0	0	16.24925	0	0	0	0	0	0	0	0	0	0	0	0	0	16.97926	15.1648	16.4996	0	16.69979	0	15.21404	0	13.87417	14.86319	0	0	15.98616	0	0	0	0	16.26103	17.11922	14.14233	0	0
Q9BY32	ITPA_HUMAN	"Inosine triphosphate pyrophosphatase, ITPase, Inosine triphosphatase, EC 3.6.1.9 (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase, NTPase) (Putative oncogene protein hlc14-06-p)"	ITPA C20orf37 My049 OK/SW-cl.9	Homo sapiens (Human)	chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]	dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005654; GO:0005737; GO:0005829; GO:0006193; GO:0009143; GO:0009204; GO:0035529; GO:0035870; GO:0036218; GO:0042802; GO:0043231; GO:0046872; GO:0047429; GO:0051276	MAASLVGKK	1.159999967	1	1	0	921.5008482	0	0	0	0	0	0	0	0	0	0	16.52721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.5491	0	17.65562	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BY41	HDAC8_HUMAN	"Histone deacetylase 8, HD8, EC 3.5.1.98 (Protein deacetylase HDAC8, EC 3.5.1.-) (Protein decrotonylase HDAC8, EC 3.5.1.-)"	HDAC8 HDACL1 CDA07	Homo sapiens (Human)	chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cohesin loading [GO:0071922]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; regulation of transcription by RNA polymerase II [GO:0006357]; sister chromatid cohesion [GO:0007062]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone decrotonylase activity [GO:0160009]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; chromatin assembly or disassembly [GO:0006333]; chromatin organization [GO:0006325]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cohesin loading [GO:0071922]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; regulation of transcription by RNA polymerase II [GO:0006357]; sister chromatid cohesion [GO:0007062]	DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone decrotonylase activity [GO:0160009]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]	GO:0000118; GO:0000122; GO:0000228; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006333; GO:0006357; GO:0007062; GO:0030544; GO:0031397; GO:0031647; GO:0032204; GO:0046872; GO:0051879; GO:0071922; GO:0140297; GO:0160009	ASMVHSLIEAYALHK	3.5	1	1	0.051730003	1686.531976	16.25077	16.05534	17.28029	15.26766	16.71099	15.5464	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.70438	0	0	0	0	0
Q9BY42	RTF2_HUMAN	"Replication termination factor 2, RTF2 (Replication termination factor 2 domain-containing protein 1)"	RTF2 C20orf43 RTFDC1 AD-007 CDA05 HSPC164 HSPC169	Homo sapiens (Human)	cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]	nucleus [GO:0005634]; replication fork [GO:0005657]	nucleus [GO:0005634]; replication fork [GO:0005657]; DNA binding [GO:0003677]; cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005657; GO:0072711; GO:0097752; GO:1902979	TRMEER	7.960000038	1	1	0.151903321	821.4808596	16.0734	0	16.07925	15.55166	16.79008	15.43777	0	16.09545	15.43027	15.98864	0	0	0	0	15.42422	14.84622	0	16.24289	15.89605	0	17.38453	0	17.0005	0	0	16.08358	16.40773	16.1475	16.23097	15.41044	0	0	15.65488	0	14.62241	16.20721	0	17.89533	16.07599	16.36656	15.13365	16.44914	16.62994	15.80532	0	15.23421	14.97925	16.22626
Q9BY50	SC11C_HUMAN	"Signal peptidase complex catalytic subunit SEC11C, EC 3.4.21.89 (Microsomal signal peptidase 21 kDa subunit, SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21)"	SEC11C SEC11L3 SPC21 SPCS4C	Homo sapiens (Human)	signal peptide processing [GO:0006465]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465]	peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021	QLYYQVLNFAMIVSSALMIWK	8.729999542	1	1	0.232301129	2533.761464	0	16.488	0	0	0	16.31305	15.6431	16.74882	0	0	15.11819	16.18052	0	17.15458	0	0	0	16.10738	0	15.72795	0	14.67858	0	18.63164	0	0	0	14.68153	0	16.80957	0	19.97322	0	0	0	17.8273	0	17.953	0	0	0	0	17.42277	17.401	0	19.02849	17.54087	0
Q9BY66	KDM5D_HUMAN	"Lysine-specific demethylase 5D, EC 1.14.11.67 (Histocompatibility Y antigen, H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)"	KDM5D HY HYA JARID1D KIAA0234 SMCY	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]; T cell antigen processing and presentation [GO:0002457]	fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]; T cell antigen processing and presentation [GO:0002457]	androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; metal ion binding [GO:0046872]	GO:0001650; GO:0002457; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0046872; GO:0050681; GO:0060765	CILAECK	4.769999981	1	1	0.160783018	893.1242609	13.16806	0	0	0	0	0	0	0	0	16.7359	0	0	0	0	17.13934	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BY77	PDIP3_HUMAN	"Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein, p46) (S6K1 Aly/REF-like target, SKAR)"	POLDIP3 KIAA1649 PDIP46	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]	mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0016607; GO:0016973; GO:0036464; GO:0044877; GO:0045727	VTEEDIVELFCVCGALKR	2.400000095	0.924656451	0.924656451	4.58E-13	2142.087205	13.73733	13.25993	0	16.86187	12.81848	0	15.20623	13.62161	11.91396	0	13.19285	9.234415	0	0	15.20044	0	0	0	0	0	0	0	0	0	12.65609	14.7109	11.91481	12.68787	13.62743	0	0	0	0	0	14.10418	0	0	15.52816	0	15.43783	0	0	0	13.44529	0	0	10.98347	0
Q9BY78	RNF26_HUMAN	"E3 ubiquitin-protein ligase RNF26, EC 2.3.2.27 (RING finger protein 26)"	RNF26	Homo sapiens (Human)	endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]; ubiquitin-dependent protein catabolic process [GO:0006511]	ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005789; GO:0006511; GO:0007032; GO:0008270; GO:0016021; GO:0016567; GO:0032479; GO:0050687; GO:0061630; GO:0070979; GO:1905719	TVLLLPCR	10.68999958	0.561867774	0.561867774	0.134097606	972.1711957	17.46401	13.73786	16.55041	16.24666	15.68079	14.65127	17.73337	12.65325	0	14.66683	15.24456	12.14526	10.66208	0	10.97638	16.79346	15.317	0	13.69754	17.4472	16.19842	17.46714	12.67989	16.67611	15.28553	17.17827	16.26275	15.70772	18.02719	0	18.97034	18.42539	16.75219	0	17.57681	16.52105	17.5003	17.38216	14.0602	0	16.0545	16.93393	14.72739	18.29607	14.34231	15.4184	0	16.0926
Q9BY89	K1671_HUMAN	Uncharacterized protein KIAA1671	KIAA1671	Homo sapiens (Human)						KCISLFR	12.28999996	1	1	0.226021863	924.1271986	15.58953	16.22368	13.5932	0	0	14.60787	14.79671	0	0	13.0191	0	15.33728	15.11391	15.75058	0	16.27351	0	15.59886	0	16.84945	0	0	0	0	0	14.46101	15.57925	14.37276	15.71777	14.19318	12.82024	13.54566	0	15.50067	15.71685	13.40446	14.78483	0	16.92856	15.50305	15.93794	14.78411	0	0	15.73412	0	13.40169	0
Q9BYB0	SHAN3_HUMAN	"SH3 and multiple ankyrin repeat domains protein 3, Shank3 (Proline-rich synapse-associated protein 2, ProSAP2)"	SHANK3 KIAA1650 PROSAP2 PSAP2	Homo sapiens (Human)	"adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]"	ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]	"ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]"	actin binding [GO:0003779]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160]; zinc ion binding [GO:0008270]	GO:0000165; GO:0003779; GO:0005829; GO:0007416; GO:0007612; GO:0007613; GO:0008022; GO:0008270; GO:0014069; GO:0017124; GO:0021773; GO:0030160; GO:0030534; GO:0031234; GO:0032232; GO:0035176; GO:0035255; GO:0042297; GO:0043005; GO:0043197; GO:0043621; GO:0044309; GO:0045794; GO:0048170; GO:0048854; GO:0051835; GO:0051968; GO:0060170; GO:0060997; GO:0060999; GO:0061001; GO:0071625; GO:0097107; GO:0097110; GO:0097113; GO:0097114; GO:0097117; GO:1900271; GO:1900273; GO:1900451; GO:1900452; GO:2000463; GO:2000969	ETPSYAKR	9.380000114	1	1	0.241706771	952.0149727	14.64713	15.48471	16.97895	0	0	13.65028	17.05241	0	0	16.81163	15.8784	0	0	0	0	0	15.82293	0	14.78014	0	0	16.77967	0	17.10953	0	17.5304	0	18.09543	0	15.94731	0	0	0	0	18.16512	0	0	14.33852	0	0	0	14.51597	14.0358	0	0	0	0	16.83241
Q9BYC2	SCOT2_HUMAN	"Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial, EC 2.8.3.5 (3-oxoacid CoA-transferase 2A) (Testis-specific succinyl-CoA:3-oxoacid CoA-transferase, SCOT-t)"	OXCT2 FKSG25	Homo sapiens (Human)	cellular ketone body metabolic process [GO:0046950]; ketone body catabolic process [GO:0046952]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; cellular ketone body metabolic process [GO:0046950]; ketone body catabolic process [GO:0046952]	3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]	GO:0005739; GO:0005759; GO:0008260; GO:0008410; GO:0031514; GO:0046950; GO:0046952	AALRLLASVLGR	5.21999979	0.201072454	0.201072454	0.084136673	1240.028034	0	0	16.43688	15.20451	0	0	0	0	0	0	0	16.78758	15.90032	0	0	0	12.14643	0	0	0	13.57295	12.05558	0	0	17.01484	0	0	0	0	0	0	0	17.75404	15.47308	8.803907	0	0	0	0	12.93454	16.12579	0	13.93597	14.32136	15.6699	0	0	11.54191
Q9BYC5	FUT8_HUMAN	"Alpha-(1,6)-fucosyltransferase, Alpha1-6FucT, EC 2.4.1.68 (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)"	FUT8	Homo sapiens (Human)	cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral protein processing [GO:0019082]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; cell migration [GO:0016477]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral protein processing [GO:0019082]	alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]	GO:0000139; GO:0001701; GO:0005794; GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0009312; GO:0010468; GO:0016020; GO:0016021; GO:0016477; GO:0017124; GO:0018279; GO:0019082; GO:0032580; GO:0033578; GO:0036071; GO:0042355; GO:0043112; GO:0046368; GO:0046921; GO:0070062; GO:1900407	EIEEATKK	3.039999962	1	1	0.21907328	945.9060087	0	13.27476	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.76335	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BYC9	RM20_HUMAN	"39S ribosomal protein L20, mitochondrial, L20mt, MRP-L20 (Mitochondrial large ribosomal subunit protein bL20m)"	MRPL20	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; ribosomal large subunit assembly [GO:0000027]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal large subunit assembly [GO:0000027]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000027; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0019843; GO:0032543	CTKAR	1.580000043	1	1	0.171108666	631.9035094	15.25219	0	16.14757	0	14.393	0	16.11528	14.87277	15.39152	12.79361	17.299	14.41363	0	0	0	0	0	0	0	0	0	0	16.93641	0	0	16.97076	0	0	0	0	0	16.90157	0	17.33986	0	0	0	0	0	0	0	0	16.56642	0	0	13.69381	0	0
Q9BYD1	RM13_HUMAN	"39S ribosomal protein L13, mitochondrial, L13mt, MRP-L13 (Mitochondrial large ribosomal subunit protein uL13m)"	MRPL13	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003729; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0005840; GO:0006412; GO:0017148; GO:0032543	RTMMER	8.489999771	0.152769521	0.152769521	0.232369915	840.0406364	13.13656	0	12.54161	0	0	0	0	0	0	16.38582	0	13.87893	0	0	15.34733	0	16.09937	0	18.69893	0	16.11115	0	16.32031	17.10491	15.48106	14.02568	14.3788	14.91451	0	15.1682	18.02052	0	0	0	0	0	0	17.76611	0	0	0	16.62391	18.30806	0	0	16.97715	0	0
Q9BYD6	RM01_HUMAN	"39S ribosomal protein L1, mitochondrial, L1mt, MRP-L1 (Mitochondrial large ribosomal subunit protein uL1m)"	MRPL1 BM-022	Homo sapiens (Human)	maturation of LSU-rRNA [GO:0000470]; mitochondrial translation [GO:0032543]	cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]	cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; mitochondrial translation [GO:0032543]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0000470; GO:0003723; GO:0003735; GO:0005743; GO:0005762; GO:0022625; GO:0032543	IDPLLPK	1.450000048	0.296695113	0.296695113	0.047376741	796.6577718	18.39324	0	17.88527	15.52991	0	16.72301	16.60483	17.5373	0	0	16.75445	0	17.22685	14.53558	13.92186	0	11.55883	17.64527	17.07475	0	0	0	0	15.20477	18.44626	17.44545	16.64286	0	0	0	0	19.55168	0	18.73139	19.87556	0	0	0	0	17.161	0	0	0	16.04556	15.16388	0	14.72686	12.12866
Q9BYE2	TMPSD_HUMAN	"Transmembrane protease serine 13, EC 3.4.21.- (Membrane-type mosaic serine protease, Mosaic serine protease)"	TMPRSS13 MSP TMPRSS11	Homo sapiens (Human)		blood microparticle [GO:0072562]; integral component of membrane [GO:0016021]	blood microparticle [GO:0072562]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005044; GO:0016021; GO:0072562	SAPATRATR	11.27000046	0.471103489	0.471103489	0.154016059	931.8106107	14.65738	15.37023	14.37801	0	0	0	13.89089	15.40556	0	0	0	0	12.57606	16.97413	0	10.17004	15.51676	0	0	16.79717	0	13.39798	16.86447	16.02783	14.61516	16.09435	14.84503	12.66351	12.61782	14.47004	14.96447	16.28139	0	15.686	13.22619	14.39681	15.02425	16.03024	15.07598	13.21822	16.22669	14.21445	16.48875	16.06283	14.56347	14.97155	0	13.93148
Q9BYG0	B3GN5_HUMAN	"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase, EC 2.4.1.206 (Lactotriaosylceramide synthase, Lc(3)Cer synthase, Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5, BGnT-5, Beta-1,3-Gn-T5, Beta-1,3-N-acetylglucosaminyltransferase 5, Beta3Gn-T5)"	B3GNT5	Homo sapiens (Human)	brain development [GO:0007420]; central nervous system development [GO:0007417]; glycolipid biosynthetic process [GO:0009247]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; brain development [GO:0007420]; central nervous system development [GO:0007417]; glycolipid biosynthetic process [GO:0009247]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]"	"beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]"	GO:0000139; GO:0006486; GO:0007417; GO:0007420; GO:0008457; GO:0008499; GO:0009247; GO:0016021; GO:0016266; GO:0016757; GO:0047256	NATDPK	10.52000046	1	1	0.125415498	645.9141339	0	19.84267	15.77469	0	0	15.19518	0	0	0	15.49536	15.48554	0	13.87067	12.35043	15.71858	0	11.70802	0	0	16.64533	17.6197	16.84713	15.83835	0	0	19.59645	15.06631	0	14.74223	0	0	0	0	0	0	16.15093	16.85267	15.88312	0	16.22873	0	0	0	17.95366	0	0	13.45101	16.29408
Q9BYG5	PAR6B_HUMAN	"Partitioning defective 6 homolog beta, PAR-6 beta, PAR-6B"	PARD6B PAR6B	Homo sapiens (Human)	axonogenesis [GO:0007409]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; protein kinase C binding [GO:0005080]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341]	protein kinase C binding [GO:0005080]	GO:0005080; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007043; GO:0007098; GO:0007163; GO:0007409; GO:0016324; GO:0030334; GO:0032991; GO:0051301; GO:0060341; GO:0065003; GO:0070062; GO:0070160	IFIQKK	5.769999981	0.08803267	0.08803267	0.249120514	775.9896535	17.99671	18.04521	0	0	0	0	0	18.40521	18.17091	17.06947	0	0	0	0	18.20161	18.14891	18.05744	0	0	0	0	17.95311	0	17.21456	18.39204	0	0	0	0	0	0	0	0	18.04948	0	0	0	0	0	0	0	17.45012	0	0	0	17.67769	0	0
Q9BYG7	MSTRO_HUMAN	Protein maestro (Male-specific transcription in the developing reproductive organs) (Protein B29)	MRO B29 C18orf3	Homo sapiens (Human)		nucleolus [GO:0005730]	nucleolus [GO:0005730]		GO:0005730	GLGSFFIDITLQTRTLLDDENDSLR	7.78000021	1	1	0.211550996	2839.963931	15.6571	12.47379	0	15.32067	13.10645	14.53377	0	11.69085	0	13.80048	0	0	15.07672	0	0	0	13.96739	0	0	0	0	0	0	14.44996	0	0	0	0	0	0	0	0	0	0	0	13.70347	0	0	0	0	0	0	0	0	0	13.96838	15.4224	0
Q9BYG8	GSDMC_HUMAN	"Gasdermin-C (Melanoma-derived leucine zipper-containing extranuclear factor) [Cleaved into: Gasdermin-C, N-terminal, GSDMC-NT; Gasdermin-C, C-terminal, GSDMC-CT ]"	GSDMC MLZE	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269]"	"phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]"	GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0016021; GO:0042742; GO:0070269; GO:0070273	MPSMLERISK	8.550000191	0.165579632	0.165579632	0.126467769	1190.770468	11.4787	15.14026	0	14.14173	15.93246	12.44952	0	0	0	15.41625	0	0	0	0	0	11.92121	0	17.02592	15.02334	13.96224	17.5401	11.52266	0	0	12.92964	17.397	10.47651	0	0	16.5161	0	0	0	0	0	0	11.84335	17.515	0	18.48139	16.34167	17.62786	13.73123	0	0	18.63242	18.14025	13.91118
Q9BYH8	IKBZ_HUMAN	"NF-kappa-B inhibitor zeta (I-kappa-B-zeta, IkB-zeta, IkappaBzeta) (IL-1 inducible nuclear ankyrin-repeat protein, INAP) (Molecule possessing ankyrin repeats induced by lipopolysaccharide, MAIL)"	NFKBIZ IKBZ INAP MAIL	Homo sapiens (Human)	inflammatory response [GO:0006954]; positive regulation of inflammatory response [GO:0050729]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; regulation of gene expression [GO:0010468]; T cell receptor signaling pathway [GO:0050852]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; inflammatory response [GO:0006954]; positive regulation of inflammatory response [GO:0050729]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; regulation of gene expression [GO:0010468]; T cell receptor signaling pathway [GO:0050852]		GO:0005634; GO:0006954; GO:0010468; GO:0016607; GO:0036464; GO:0050729; GO:0050852; GO:2000321	CLIQMGAAVEAK	8.430000305	0.635154545	0.635154545	0.308943775	1288.402768	15.40938	15.0025	14.78221	0	0	0	0	0	0	0	15.07651	0	0	0	12.05501	15.17224	15.48207	0	0	0	0	0	0	0	0	15.15905	0	14.93391	12.39917	13.74913	12.46514	0	15.48321	16.94533	15.61178	15.83782	15.677	15.58778	0	0	16.0772	16.66718	0	15.05515	0	17.5754	0	0
Q9BYJ0	FGFP2_HUMAN	"Fibroblast growth factor-binding protein 2, FGF-BP2, FGF-binding protein 2, FGFBP-2 (37 kDa killer-specific secretory protein, Ksp37) (HBp17-related protein, HBp17-RP)"	FGFBP2 KSP37 UNQ425/PRO1065	Homo sapiens (Human)	cell-cell signaling [GO:0007267]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; growth factor binding [GO:0019838]; cell-cell signaling [GO:0007267]	growth factor binding [GO:0019838]	GO:0005615; GO:0007267; GO:0019838	GSPEPNQQPEAGTPSLRPK	3.75999999	1	1	0.19532372	1989.510049	0	12.91994	15.57769	0	0	15.47359	0	0	0	0	0	0	0	0	0	0	14.10053	0	0	0	0	0	16.45749	15.69648	14.66751	0	15.8754	17.96504	0	0	0	0	16.57434	0	0	0	0	0	0	0	0	0	0	0	17.19906	0	0	0
Q9BYJ4	TRI34_HUMAN	Tripartite motif-containing protein 34 (Interferon-responsive finger protein 1) (RING finger protein 21)	TRIM34 IFP1 RNF21	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0051091; GO:0051092; GO:0051607; GO:0061630	FAEAEDELVQQKQLVR	5.46999979	0.686119378	0.686119378	0.098853292	1904.259237	0	15.36695	15.77985	12.93776	14.38843	0	0	15.88463	0	0	0	0	0	14.85896	14.44178	15.88176	0	0	0	0	16.73299	0	15.27819	0	17.23951	17.0874	0	0	14.37983	15.57683	0	15.77313	0	0	16.92814	0	0	0	0	0	18.779	0	0	0	16.79818	0	18.36033	18.76764
Q9BYJ9	YTHD1_HUMAN	"YTH domain-containing family protein 1, DF1 (Dermatomyositis associated with cancer putative autoantigen 1, DACA-1)"	YTHDF1 C20orf21	Homo sapiens (Human)	immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; mRNA destabilization [GO:0061157]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of mRNA stability [GO:0043488]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; mRNA destabilization [GO:0061157]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of mRNA stability [GO:0043488]; stress granule assembly [GO:0034063]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]	GO:0000932; GO:0002376; GO:0002577; GO:0003723; GO:0003729; GO:0005737; GO:0007612; GO:0007613; GO:0010494; GO:0034063; GO:0043022; GO:0043488; GO:0045727; GO:0045948; GO:0061157; GO:0070925; GO:1900271; GO:1902667; GO:1990247	QVLKIISSYK	7.849999905	1	1	0.346703677	1177.755675	0	14.85324	0	0	0	0	0	0	0	0	0	0	16.57034	15.71668	15.6415	0	0	16.38021	0	16.50726	0	0	0	0	0	0	13.48159	0	15.09355	0	16.84681	0	0	16.46418	14.60581	0	15.82128	15.68697	17.61826	14.52513	0	17.23559	14.98876	15.68516	15.34294	0	0	16.43312
Q9BYK8	HELZ2_HUMAN	"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1, PDIP1, PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein, EC 3.6.4.-)"	HELZ2 KIAA1769 PRIC285	Homo sapiens (Human)	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0016020; GO:0030374; GO:0045944; GO:0046872	LHLLASLWK	6	1	1	0.41941486	1081.796062	0	0	0	19.14285	0	0	0	0	16.57394	18.04188	18.46034	0	0	0	0	0	0	0	0	0	0	0	0	16.77711	18.88531	19.1414	0	0	17.84752	0	18.14883	0	0	0	0	18.88495	0	19.51172	0	0	0	0	0	0	17.55738	0	0	0
Q9BYN7	ZN341_HUMAN	Zinc finger protein 341	ZNF341	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872	RAHLAEHQR	1.429999948	1	1	0.13236683	1118.785109	0	0	0	15.40281	0	12.63913	0	14.91808	14.37929	0	0	0	0	15.41781	0	11.89339	0	13.6121	0	0	0	0	0	0	0	0	0	12.00563	15.22009	0	0	15.77684	14.59691	0	0	14.31053	0	0	13.63362	0	0	0	0	0	0	0	0	14.1388
Q9BYN8	RT26_HUMAN	"28S ribosomal protein S26, mitochondrial, MRP-S26, S26mt (28S ribosomal protein S13, mitochondrial, MRP-S13, S13mt) (Mitochondrial small ribosomal subunit protein mS26)"	MRPS26 C20orf193 RPMS13	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543	VNMPPAVDPAEFFVLMER	4.010000229	0.341480553	0.341480553	0.243626514	2078.597853	0	0	12.07629	0	0	14.38776	0	0	14.56423	0	0	14.55378	15.46033	14.44391	15.92816	15.06716	14.97388	14.23832	16.43282	17.03893	0	15.47374	14.29586	0	0	0	0	0	0	0	13.72587	10.70544	14.40589	0	13.2184	15.55537	18.11551	0	0	0	0	0	0	0	0	0	0	18.31601
Q9BYP7	WNK3_HUMAN	"Serine/threonine-protein kinase WNK3, EC 2.7.11.1 (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3)"	WNK3 KIAA1566 PRKWNK3	Homo sapiens (Human)	cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062]	ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005912; GO:0005923; GO:0006468; GO:0006884; GO:0007231; GO:0010765; GO:0010766; GO:0010800; GO:0018107; GO:0019869; GO:0019870; GO:0032414; GO:0035556; GO:0035633; GO:0043066; GO:0046777; GO:0050801; GO:0051928; GO:0072659; GO:0090279; GO:0106310; GO:1903078; GO:1903288; GO:1904062; GO:2000651	FCINQTIR	3.720000029	1	1	0.071127638	1051.369899	0	13.90896	15.38979	0	16.87597	0	0	12.84058	15.49918	0	0	0	0	16.1342	14.07029	0	0	0	0	0	13.92645	0	0	0	0	16.33768	0	0	13.5826	14.94504	0	0	16.11915	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BYR6	KRA33_HUMAN	Keratin-associated protein 3-3 (High sulfur keratin-associated protein 3.3) (Keratin-associated protein 3.3)	KRTAP3-3 KAP3.3 KRTAP3.3	Homo sapiens (Human)		cytosol [GO:0005829]; keratin filament [GO:0045095]	cytosol [GO:0005829]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0045095	MDCCASRGCSVPTGPATTICSSDK	2.900000095	1	1	0.184461244	2634.10437	0	13.85688	11.34901	0	0	0	0	16.44075	0	13.97296	0	0	10.61118	0	0	0	0	0	15.54723	0	0	0	0	0	15.45784	0	15.87374	0	0	0	0	18.23234	0	0	0	0	16.18275	0	0	0	0	12.42952	15.73736	0	0	0	0	0
Q9BYR7	KRA32_HUMAN	Keratin-associated protein 3-2 (High sulfur keratin-associated protein 3.2) (Keratin-associated protein 3.2)	KRTAP3-2 KAP3.2 KRTAP3.2	Homo sapiens (Human)		cytosol [GO:0005829]; keratin filament [GO:0045095]	cytosol [GO:0005829]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0045095	DCCASR	3	0.511363804	0.511363804	0.239161131	768.3244212	15.68533	15.63985	0	0	15.26413	14.89088	15.37126	0	15.40976	16.33777	16.29554	0	15.30512	0	15.75502	0	15.91347	15.92068	16.31578	16.79314	16.56619	15.95143	16.04906	15.86592	0	16.33894	17.29892	14.98931	15.03357	16.0313	0	16.75281	16.11029	16.80022	0	16.4199	16.85515	0	16.4737	15.19102	16.68367	17.23711	15.48054	15.11664	17.5269	16.7758	15.63382	16.38385
Q9BYS8	LRRC2_HUMAN	Leucine-rich repeat-containing protein 2	LRRC2	Homo sapiens (Human)	signal transduction [GO:0007165]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005737; GO:0007165; GO:0043231	FVSLMDNPIDNAQCEDGNEIMESERDR	3.849999905	0.288506359	0.288506359	4.11E-12	3201.221698	14.79764	10.82165	0	13.66082	14.54744	13.95566	14.61766	16.28405	15.11657	0	9.794621	13.64139	0	0	12.81996	0	14.85469	14.87114	0	0	14.7872	0	0	11.76768	0	15.08987	14.88822	0	13.8757	0	0	13.94958	14.28734	0	13.70278	0	0	0	0	0	0	0	0	0	0	0	0	14.56272
Q9BYT1	S17A9_HUMAN	Solute carrier family 17 member 9	SLC17A9 C20orf59	Homo sapiens (Human)	ADP transport [GO:0015866]; ATP export [GO:1904669]; ATP transport [GO:0015867]; exocytosis [GO:0006887]; guanine nucleotide transmembrane transport [GO:1903790]	chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021]	chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; guanine nucleotide transmembrane transporter activity [GO:0001409]; ADP transport [GO:0015866]; ATP export [GO:1904669]; ATP transport [GO:0015867]; exocytosis [GO:0006887]; guanine nucleotide transmembrane transport [GO:1903790]	ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; guanine nucleotide transmembrane transporter activity [GO:0001409]	GO:0001409; GO:0005347; GO:0006887; GO:0015217; GO:0015866; GO:0015867; GO:0016021; GO:0042584; GO:1903790; GO:1904669	SSMPICTVSMSQDFGWNKK	9.210000038	0.801959813	0.801959813	0.045333211	2218.313073	0	0	0	0	11.60526	0	0	0	0	0	0	16.51048	0	0	0	13.51375	14.3936	0	0	0	0	0	0	0	0	15.68976	13.70205	15.46499	0	0	0	0	0	0	0	0	0	13.42558	0	0	0	0	0	14.8515	0	0	0	0
Q9BYT3	STK33_HUMAN	"Serine/threonine-protein kinase 33, EC 2.7.11.1"	STK33	Homo sapiens (Human)	mitotic DNA damage checkpoint signaling [GO:0044773]; protein autophosphorylation [GO:0046777]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; mitotic DNA damage checkpoint signaling [GO:0044773]; protein autophosphorylation [GO:0046777]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0044773; GO:0046777; GO:0048471; GO:0106310	YPAKSGALSR	2.660000086	1	1	0.230733542	1050.89214	0	0	0	0	0	0	18.77273	0	0	0	0	0	18.82064	0	0	0	17.79017	0	0	0	16.75844	0	0	0	17.14222	0	0	0	0	0	18.42912	0	0	0	0	0	0	0	0	16.55214	0	0	16.55899	0	16.61317	0	0	0
Q9BYT8	NEUL_HUMAN	"Neurolysin, mitochondrial, EC 3.4.24.16 (Angiotensin-binding protein) (Microsomal endopeptidase, MEP) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase)"	NLN AGTBP KIAA1226	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; regulation of gluconeogenesis [GO:0006111]; regulation of skeletal muscle fiber differentiation [GO:1902809]	extracellular region [GO:0005576]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; regulation of gluconeogenesis [GO:0006111]; regulation of skeletal muscle fiber differentiation [GO:1902809]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]	GO:0004222; GO:0005576; GO:0005758; GO:0005886; GO:0006111; GO:0006508; GO:0006518; GO:0007186; GO:0042277; GO:0046872; GO:1902809	EGIMNPEVGMK	5.010000229	1	1	0.198107613	1219.908974	14.84043	12.16696	14.16129	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.54825	0	0	0	14.72659	15.14354	0	0	15.0584	16.7508	15.198	0	17.37044	0	0	15.81684	0	0	0	0	0	0	0	0
Q9BYT9	ANO3_HUMAN	Anoctamin-3 (Transmembrane protein 16C)	ANO3 C11orf25 TMEM16C GENX-3947	Homo sapiens (Human)	calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005886; GO:0016021; GO:0016048; GO:0017128; GO:0034220; GO:0046983; GO:0050982; GO:0055085; GO:0061590; GO:0061591; GO:1902476	GLHDR	10.10999966	1	1	0.28028734	597.2806228	0	0	16.79433	0	0	17.18293	0	0	16.97709	0	0	17.92311	17.6489	0	17.069	0	17.73268	0	0	0	16.86249	18.30298	18.52481	0	0	18.20247	0	0	0	0	0	0	0	17.96444	0	0	0	0	18.76934	0	17.14989	0	0	0	17.86332	0	0	18.03116
Q9BYU1	PBX4_HUMAN	Pre-B-cell leukemia transcription factor 4 (Homeobox protein PBX4)	PBX4	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741]	"chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000785; GO:0000978; GO:0000981; GO:0001654; GO:0001741; GO:0005634; GO:0006357; GO:0007420; GO:0009887; GO:0043565; GO:0045893; GO:0048568; GO:0048666	AAPPRPAPSPPAPRR	2.720000029	1	1	0.103256059	1536.694454	0	0	0	0	0	0	14.37024	0	11.7974	13.95896	0	0	13.80139	0	0	0	0	0	0	0	0	0	0	0	16.33695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BYV2	TRI54_HUMAN	"Tripartite motif-containing protein 54 (Muscle-specific RING finger protein, MuRF) (Muscle-specific RING finger protein 3, MuRF-3, MuRF3) (RING finger protein 30)"	TRIM54 MURF MURF3 RNF30	Homo sapiens (Human)	cell differentiation [GO:0030154]; microtubule-based process [GO:0007017]; negative regulation of microtubule depolymerization [GO:0007026]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; Z disc [GO:0030018]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; Z disc [GO:0030018]; microtubule binding [GO:0008017]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; microtubule-based process [GO:0007017]; negative regulation of microtubule depolymerization [GO:0007026]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]	microtubule binding [GO:0008017]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005874; GO:0005875; GO:0007017; GO:0007026; GO:0007165; GO:0008017; GO:0008270; GO:0016567; GO:0030018; GO:0030154; GO:0061630	GELLQALAR	8.069999695	0.129575863	0.129575863	0.267929761	968.9859649	15.57684	16.7139	15.49539	15.3572	14.61015	16.29078	14.98855	0	17.05927	16.17315	13.91817	13.92471	16.17804	13.66506	0	15.68063	12.21837	0	15.24944	14.88066	14.75855	0	0	16.56941	0	0	16.37157	0	0	15.08473	0	0	17.21306	0	14.14936	15.41968	16.13081	0	0	17.79446	0	0	14.46406	16.05954	0	0	0	17.00395
Q9BYV6	TRI55_HUMAN	"Tripartite motif-containing protein 55 (Muscle-specific RING finger protein 2, MuRF-2, MuRF2) (RING finger protein 29)"	TRIM55 MURF2 RNF29	Homo sapiens (Human)	diapedesis [GO:0050904]; leukocyte migration involved in inflammatory response [GO:0002523]; macrophage migration [GO:1905517]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; diapedesis [GO:0050904]; leukocyte migration involved in inflammatory response [GO:0002523]; macrophage migration [GO:1905517]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0002523; GO:0005634; GO:0005737; GO:0005874; GO:0007165; GO:0008270; GO:0016567; GO:0042802; GO:0050904; GO:0061630; GO:1905517	SDQPMCEEHEEER	7.300000191	1	1	0.362754211	1691.92626	0	17.11849	13.11431	0	0	14.1285	16.64462	14.33119	0	0	0	12.88201	0	0	0	0	0	0	0	0	0	0	0	17.21244	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.22202	0	0	0	0	0	0	0	0	0
Q9BYV9	BACH2_HUMAN	Transcription regulator protein BACH2 (BTB and CNC homolog 2)	BACH2	Homo sapiens (Human)	import into nucleus [GO:0051170]; primary adaptive immune response involving T cells and B cells [GO:0090721]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; import into nucleus [GO:0051170]; primary adaptive immune response involving T cells and B cells [GO:0090721]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0051170; GO:0090575; GO:0090721; GO:1990837	NDFQMMIK	12.14999962	1	1	0.395420125	1041.370543	0	15.91742	16.06199	16.58322	14.90219	15.73133	0	0	15.62025	16.82557	16.4771	16.59506	15.34403	0	0	16.55318	0	0	0	0	0	0	0	0	0	16.65519	14.40952	16.55223	0	15.36263	16.0415	16.76512	0	0	0	0	0	0	17.34324	0	16.07707	0	0	0	15.46362	17.01446	0	0
Q9BYW2	SETD2_HUMAN	"Histone-lysine N-methyltransferase SETD2, EC 2.1.1.359 (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1, HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2, EC 2.1.1.-) (SET domain-containing protein 2, hSET2) (p231HBP)"	SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069	Homo sapiens (Human)	"angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634	LQSVVVVPK	4.309999943	1	1	0.203442128	968.8596182	15.71224	14.81136	0	0	0	0	12.65628	11.95984	14.67225	15.67411	0	0	0	15.91885	14.67736	0	0	15.85318	0	0	0	16.85157	0	17.98215	0	0	16.69241	0	0	0	0	0	17.35312	0	15.94913	0	17.16036	0	16.06934	17.81912	0	0	0	0	0	0	0	0
Q9BYX2	TBD2A_HUMAN	"TBC1 domain family member 2A (Armus) (Prostate antigen recognized and identified by SEREX 1, PARIS-1)"	TBC1D2 PARIS1 PP8997 TBC1D2A	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; positive regulation of GTPase activity [GO:0043547]	cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; positive regulation of GTPase activity [GO:0043547]	cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]	GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0030054; GO:0031410; GO:0043547; GO:0045296; GO:0090630	MEGAGENAPESSSSAPGSEESAR	3.960000038	1	1	0.108184567	2253.364559	14.16439	13.28568	14.89367	14.78663	12.10472	14.39267	15.47047	0	0	0	0	0	13.65513	0	0	12.91601	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.77771	15.1764	12.04876	0	0	12.85244	0	0	0
Q9BYX4	IFIH1_HUMAN	"Interferon-induced helicase C domain-containing protein 1, EC 3.6.4.13 (Clinically amyopathic dermatomyositis autoantigen 140 kDa, CADM-140 autoantigen) (Helicase with 2 CARD domains, Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5, MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2, RLR-2) (RNA helicase-DEAD box protein 116)"	IFIH1 MDA5 RH116	Homo sapiens (Human)	cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0039528; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051607; GO:0060760; GO:0071360; GO:0098586	IAAAENNGNESGVR	7.579999924	0.398094296	0.398094296	0.141830504	1401.329652	17.59407	16.92676	15.96128	0	0	0	16.40933	17.43552	17.70935	0	17.41675	17.23427	16.36767	17.2873	14.40793	12.96603	0	0	15.53313	0	0	0	0	0	17.06517	15.99897	16.73993	12.92045	0	0	0	19.32111	11.70379	17.60519	16.93551	0	14.52672	11.82465	0	16.38371	15.97501	0	10.95133	18.6476	16.34325	15.03675	0	15.73096
Q9BZ19	ANR60_HUMAN	Ankyrin repeat domain-containing protein 60	ANKRD60 C20orf86	Homo sapiens (Human)						MTMTPH	11.27000046	0.360418677	0.360418677	0.119564224	733.2636525	17.43927	0	0	0	0	0	0	0	15.31668	0	13.94001	0	0	17.9484	0	14.88451	0	0	17.57132	16.50616	0	0	16.45096	16.7186	18.12055	17.75834	16.40307	0	0	0	12.72778	16.56039	0	0	0	17.03846	0	14.95022	0	15.88546	0	14.0711	0	13.69441	0	0	11.87116	0
Q9BZ29	DOCK9_HUMAN	"Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1, Zizimin-1)"	DOCK9 KIAA1058 ZIZ1	Homo sapiens (Human)	positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264]	cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0043547; GO:0045296	QGCTAFR	6.909999847	0.262567699	0.262567699	0.214328934	838.6076853	14.89222	15.86594	10.54986	15.92227	12.49074	15.10404	13.82128	0	0	16.03801	16.88563	15.81754	15.03654	0	15.27105	15.01694	15.39815	13.26712	17.25804	13.08716	15.05233	15.78323	15.41286	16.74427	14.88979	16.41138	14.75611	12.82903	0	0	0	0	0	15.12639	0	0	0	0	15.56597	15.82307	0	15.37236	15.37825	14.97546	0	15.52708	0	15.04029
Q9BZ68	FR8P1_HUMAN	Putative FERM domain-containing protein FRMD8P1 (FERM domain-containing 8 pseudogene 1)	FRMD8P1 FKSG43	Homo sapiens (Human)	negative regulation of canonical Wnt signaling pathway [GO:0090090]	cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090]		GO:0005856; GO:0005886; GO:0090090	DSGVTPVNKLLK	11.01000023	1	1	0.494790956	1270.934663	0	0	0	14.25621	13.99058	15.20604	0	0	0	15.81064	0	0	0	14.84437	15.90059	15.06259	15.17097	0	0	0	0	0	15.99424	0	0	0	0	16.62416	16.34208	0	0	0	0	0	16.33458	0	0	17.31267	0	16.54126	0	16.4915	17.21999	0	0	0	0	0
Q9BZ71	PITM3_HUMAN	"Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3, PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1, NIR-1)"	PITPNM3 NIR1	Homo sapiens (Human)	phosphatidylinositol biosynthetic process [GO:0006661]	cell body [GO:0044297]; cell projection [GO:0042995]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cell body [GO:0044297]; cell projection [GO:0042995]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phospholipase activity [GO:0004620]; receptor tyrosine kinase binding [GO:0030971]; phosphatidylinositol biosynthetic process [GO:0006661]	calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phospholipase activity [GO:0004620]; receptor tyrosine kinase binding [GO:0030971]	GO:0004620; GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008289; GO:0008526; GO:0012505; GO:0016020; GO:0030134; GO:0030971; GO:0042995; GO:0044297	DSPPLLDAPASPPQASR	1.909999967	1	1	0.207138165	1718.138094	0	0	0	0	0	0	16.57747	0	16.92117	17.89757	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.74617	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BZ72	PITM2_HUMAN	"Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2, PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3, NIR-3)"	PITPNM2 KIAA1457 NIR3	Homo sapiens (Human)	phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]	calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]	GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091; GO:0048015	TQSQADGEQR	4.760000229	1	1	0.317797409	1120.681347	13.82766	0	0	0	0	0	0	0	0	0	15.89881	0	15.34626	0	11.8201	0	0	16.49106	16.06743	0	15.82087	0	15.58615	15.1487	0	0	0	0	0	0	0	0	0	0	0	0	14.9634	0	0	0	0	0	0	0	0	0	14.0441	0
Q9BZ76	CNTP3_HUMAN	Contactin-associated protein-like 3 (Cell recognition molecule Caspr3)	CNTNAP3 CASPR3 KIAA1714	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell recognition [GO:0008037]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell recognition [GO:0008037]		GO:0005576; GO:0005886; GO:0007155; GO:0008037; GO:0016021	INREEAVVMVEVNQSTK	17.44000053	0.299618125	0.299618125	0.027685768	1945.962973	0	0	15.30133	0	14.60544	0	13.17537	12.17005	14.47115	12.7309	14.04089	15.39255	15.5125	13.00795	12.88662	19.79235	10.74278	14.74725	17.7369	12.58523	15.57922	15.67207	12.41834	0	16.22997	0	0	14.36584	0	16.20968	14.50061	14.03587	15.06048	14.17141	16.19846	14.47964	16.59644	17.15589	17.84064	0	10.81031	0	16.01662	0	0	0	0	0
Q9BZ81	MAGB5_HUMAN	"Melanoma-associated antigen B5 (Cancer/testis antigen 3.3, CT3.3) (MAGE-B5 antigen)"	MAGEB5	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]		GO:0000122; GO:0005634	FSSFSQPY	4.889999866	0.659533203	0.659533203	0.217336586	961.7384038	0	0	15.55457	0	0	0	0	0	0	0	15.54107	9.458288	0	0	12.10882	0	0	0	0	0	11.11651	15.57649	0	0	0	0	0	0	15.63955	18.10306	0	0	17.01753	0	0	0	15.22427	0	0	0	0	0	0	0	16.31056	0	0	0
Q9BZ95	NSD3_HUMAN	"Histone-lysine N-methyltransferase NSD3, EC 2.1.1.370, EC 2.1.1.371 (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1, WHSC1-like protein 1)"	NSD3 WHSC1L1 DC28	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone methylation [GO:0016571]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulator activator activity [GO:0140537]; chromatin organization [GO:0006325]; histone methylation [GO:0016571]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]"	histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulator activator activity [GO:0140537]	GO:0000785; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016571; GO:0018024; GO:0045893; GO:0046872; GO:0046975; GO:0140537; GO:2001255	QIVWVKLGNYR	6.119999886	0.746450663	0.746450663	0.262450945	1376.089039	14.3947	0	0	0	14.70059	0	0	0	14.01101	0	0	0	13.57687	0	15.29863	14.16454	16.02346	14.45849	0	15.70531	0	0	0	0	0	14.73975	0	0	0	0	14.94177	0	0	0	16.35973	0	15.17259	14.21463	15.89981	15.84414	0	0	16.25662	16.01081	14.83993	12.69299	15.09018	15.59484
Q9BZA8	PC11Y_HUMAN	"Protocadherin-11 Y-linked, Protocadherin-11 (Protocadherin on the Y chromosome, PCDH-Y) (Protocadherin prostate cancer, Protocadherin-PC) (Protocadherin-22)"	PCDH11Y PCDH11 PCDH22 PCDHY	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283]	integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]	integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007283; GO:0030177; GO:0061827; GO:0097225	NMQNSEWATPNPENR	2.779999971	1	1	0.376479024	1804.375528	15.21413	0	0	0	15.42855	0	0	15.73403	0	0	0	0	0	16.62266	0	15.98871	0	15.22176	0	16.97508	0	0	0	0	0	0	14.67782	15.87217	0	13.08946	0	0	15.24845	11.93555	13.36058	0	16.28959	0	0	10.55647	11.51993	15.04088	0	0	0	0	16.73765	0
Q9BZD4	NUF2_HUMAN	"Kinetochore protein Nuf2, hNuf2, hNuf2R, hsNuf2 (Cell division cycle-associated protein 1)"	NUF2 CDCA1 NUF2R	Homo sapiens (Human)	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]"	"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]"	protein-containing complex binding [GO:0044877]	GO:0000775; GO:0000776; GO:0005654; GO:0005829; GO:0007052; GO:0007059; GO:0007094; GO:0008608; GO:0016020; GO:0031262; GO:0031617; GO:0044877; GO:0045132; GO:0051301; GO:0051315; GO:0051383	IVDSPEKLK	6.739999771	0.871160686	0.871160686	0.237257151	1027.55078	0	16.76309	17.2783	13.45935	14.44261	15.98661	0	0	16.33796	17.59117	0	0	13.79362	0	16.25751	17.00631	0	0	14.61168	14.6127	0	0	14.94994	15.51172	0	16.91451	0	15.01469	0	0	0	15.35211	15.31027	14.28989	0	0	16.53332	0	17.04679	0	0	0	0	16.51923	16.84043	0	17.73716	15.14733
Q9BZE0	GLIS2_HUMAN	Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein)	GLIS2 NKL	Homo sapiens (Human)	"cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in kidney development [GO:0060994]"	cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in kidney development [GO:0060994]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007417; GO:0016607; GO:0043433; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0060994; GO:0061005; GO:0061484; GO:0097730; GO:1900182; GO:1990837	YSNSSDR	10.39000034	4.92E-06	4.92E-06	0.227969596	829.1059188	18.565	19.15961	17.68074	16.14001	0	16.32834	18.75474	17.29023	0	16.97449	17.6968	16.85105	0	0	0	18.53204	0	17.7306	0	17.54643	0	0	18.48916	0	17.1207	0	0	0	0	17.29824	18.31715	17.3391	0	0	18.593	16.33351	17.86321	0	0	16.55527	0	0	18.28273	16.89499	16.95247	16.86691	0	17.38506
Q9BZE1	RM37_HUMAN	"39S ribosomal protein L37, mitochondrial, L37mt, MRP-L37 (39S ribosomal protein L2, mitochondrial, L2mt, MRP-L2) (Mitochondrial large ribosomal subunit protein mL37)"	MRPL37 MRPL2 RPML2 HSPC235	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543	LIEGLPEK	31.30999947	0.012489175	0.012489175	0.13385921	898.5100558	17.89804	17.5968	20.45692	13.69515	18.62366	17.85242	17.25886	19.49377	18.16353	19.52041	19.53728	18.7021	18.86353	17.38105	19.3656	0	0	17.70651	19.5757	20.48758	17.33955	0	17.76438	19.04164	0	18.16412	17.96286	19.83149	16.6	18.51022	0	18.25235	18.21078	18.54188	17.77496	18.24788	19.04797	17.03989	0	19.089	18.05242	19.30525	20.07911	19.28094	17.61366	18.68851	19.10295	0
Q9BZE4	GTPB4_HUMAN	GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1)	GTPBP4 CRFG NOG1	Homo sapiens (Human)	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]"	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]	GO:0000079; GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0048471; GO:0050821	GEADR	16.10000038	0.445928246	0.445928246	0.238450837	547.5096041	17.44601	16.42754	16.6904	0	0	16.67052	16.72844	17.06077	16.18236	0	16.51825	16.0696	15.85257	0	17.53949	16.09987	17.04557	16.53094	16.54132	16.29815	17.00121	0	16.57098	16.58653	17.48125	0	16.81026	17.04648	16.24238	16.55807	17.21529	16.86085	16.19155	16.76685	0	0	16.84234	17.54891	0	0	15.98048	17.1199	0	16.42101	17.64205	16.88948	0	17.79983
Q9BZE7	EVG1_HUMAN	UPF0193 protein EVG1	C22orf23	Homo sapiens (Human)						HIMDIMKR	3	1	1	2.32E-13	1061.109997	0	16.24747	0	12.38917	0	0	12.43222	12.80156	13.77384	0	14.30109	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BZF1	OSBL8_HUMAN	"Oxysterol-binding protein-related protein 8, ORP-8, OSBP-related protein 8"	OSBPL8 KIAA1451 ORP8 OSBP10	Homo sapiens (Human)	activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204]	cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343	WYLSGFYK	6.449999809	1	1	0.214044296	1066.775365	0	0	0	13.42615	14.79004	15.34206	10.46135	0	0	0	0	13.71365	0	0	0	14.36029	0	0	0	0	14.63022	0	0	0	13.24727	13.86578	15.73783	15.27798	16.28914	14.52461	14.79377	16.10312	15.1194	13.42516	14.1337	14.07741	0	16.0633	14.84373	16.48408	0	0	14.89942	0	16.71206	0	0	16.14254
Q9BZF9	UACA_HUMAN	Uveal autoantigen with coiled-coil domains and ankyrin repeats	UACA KIAA1561	Homo sapiens (Human)	apoptotic signaling pathway [GO:0097190]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic signaling pathway [GO:0097190]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]		GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0043280; GO:0070062; GO:0097190; GO:1901223	IQESAK	14.48999977	0.030028956	0.030028956	0.260848985	674.1764753	0	0	17.27713	15.4346	0	0	0	0	0	0	0	16.39555	0	16.07861	0	0	0	0	0	0	17.53287	0	0	0	0	0	0	17.21726	15.94519	15.20468	17.28943	0	16.90639	16.64377	0	0	17.60902	0	0	18.22698	16.02289	16.22091	17.19464	16.9836	17.53427	17.17548	17.58638	16.27063
Q9BZH6	WDR11_HUMAN	WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15)	WDR11 BRWD2 KIAA1351 WDR15	Homo sapiens (Human)	cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041]		GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005829; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041	ACLVTTVTSSGPSQSTIK	6.519999981	1	1	0.033678909	1836.263122	15.07296	13.29732	0	0	14.92672	0	0	12.52514	0	14.38652	0	14.76401	0	0	0	0	0	0	0	13.0075	0	0	13.45602	0	0	0	14.68563	14.78394	0	0	0	0	0	0	16.7171	0	0	0	0	0	15.0838	0	13.34426	0	0	0	0	0
Q9BZJ0	CRNL1_HUMAN	"Crooked neck-like protein 1 (Crooked neck homolog, hCrn)"	CRNKL1 CRN CGI-201 MSTP021	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]"	RNA binding [GO:0003723]	GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014	AITTLPR	4.590000153	0.370510697	0.370510697	0.249831431	771.2295934	0	15.64103	15.25566	14.43481	13.87263	14.56427	12.37451	15.2938	16.16392	15.65602	15.07154	14.75009	15.61189	14.26183	13.78571	16.02108	15.45929	15.67371	16.1816	14.54411	15.27874	16.79194	0	0	0	13.80683	15.57911	0	14.58368	16.65832	15.03512	0	0	0	0	16.16814	15.64943	16.98987	15.87073	15.88254	16.7095	15.08548	15.90118	0	15.89058	0	16.83551	0
Q9BZJ4	S2539_HUMAN	Probable mitochondrial glutathione transporter SLC25A39 (Solute carrier family 25 member 39)	SLC25A39 CGI-69 PRO2163	Homo sapiens (Human)	heme biosynthetic process [GO:0006783]; mitochondrial transmembrane transport [GO:1990542]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; heme biosynthetic process [GO:0006783]; mitochondrial transmembrane transport [GO:1990542]		GO:0005743; GO:0006783; GO:0016021; GO:1990542	LQSQRPSMASELMPSSR	1.320000052	1	1	6.93E-13	1922.822938	11.7796	0	0	14.95051	0	0	0	13.45876	0	0	15.9738	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.96478	15.51614	0	0	0	0	0	0
Q9BZJ6	GPR63_HUMAN	Probable G-protein coupled receptor 63 (PSP24-2) (PSP24-beta)	GPR63 PSP24B	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007186; GO:0016021; GO:0043235	LGLMSLQRPFQMSIDMGFK	1.460000038	1	1	0.208023314	2215.226372	0	14.55236	11.78604	12.83725	0	7.750369	0	14.2973	0	13.34631	0	12.28679	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.43916	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BZL6	KPCD2_HUMAN	"Serine/threonine-protein kinase D2, EC 2.7.11.13 (nPKC-D2)"	PRKD2 PKD2 HSPC187	Homo sapiens (Human)	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001525; GO:0001938; GO:0002250; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007155; GO:0008219; GO:0010595; GO:0018105; GO:0018107; GO:0030148; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0035556; GO:0035924; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0061154; GO:0070374; GO:0089700; GO:0106310; GO:1901727; GO:1902533; GO:2000573; GO:2001028	GRLPER	4.690000057	1	1	0.182258799	727.7253542	0	13.66067	15.44444	0	0	15.09565	14.24901	15.97587	0	14.97423	12.6473	0	15.7578	14.132	0	14.1195	14.01149	14.85736	0	15.28389	0	14.72261	0	14.55238	0	0	0	0	0	16.12156	0	0	0	0	0	0	16.53109	0	0	16.06034	0	0	0	0	17.12674	0	0	0
Q9BZM2	PA2GF_HUMAN	"Group IIF secretory phospholipase A2, GIIF sPLA2, sPLA2-IIF, EC 3.1.1.4 (Phosphatidylcholine 2-acylhydrolase 2F)"	PLA2G2F	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; innate immune response [GO:0045087]; lipid catabolic process [GO:0016042]; negative regulation of T cell proliferation [GO:0042130]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644]	cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; innate immune response [GO:0045087]; lipid catabolic process [GO:0016042]; negative regulation of T cell proliferation [GO:0042130]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644]	calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]	GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005829; GO:0005886; GO:0006644; GO:0016042; GO:0019369; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0042130; GO:0045087; GO:0047498; GO:0050482	NMVLCLMNQTYREEYR	2.829999924	1	1	0.258544005	2135.67743	14.47473	11.22534	9.039421	0	0	14.09081	0	12.32425	0	0	10.17719	14.39961	13.67426	13.06117	14.27618	14.83126	0	0	0	0	0	0	0	0	0	0	0	14.83389	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BZM3	GSX2_HUMAN	GS homeobox 2 (Genetic-screened homeobox 2) (Homeobox protein GSH-2)	GSX2 GSH2	Homo sapiens (Human)	forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; hindbrain morphogenesis [GO:0021575]; neuron fate specification [GO:0048665]; olfactory bulb interneuron differentiation [GO:0021889]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of cell migration [GO:0030334]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; spinal cord association neuron differentiation [GO:0021527]; subpallium neuron fate commitment [GO:0060163]; telencephalon regionalization [GO:0021978]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; hindbrain morphogenesis [GO:0021575]; neuron fate specification [GO:0048665]; olfactory bulb interneuron differentiation [GO:0021889]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of cell migration [GO:0030334]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; spinal cord association neuron differentiation [GO:0021527]; subpallium neuron fate commitment [GO:0060163]; telencephalon regionalization [GO:0021978]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000981; GO:0002087; GO:0005634; GO:0005737; GO:0021527; GO:0021575; GO:0021798; GO:0021889; GO:0021978; GO:0030334; GO:0045747; GO:0048665; GO:0048714; GO:0048853; GO:0060163; GO:1990837	NSHAGCK	3.430000067	1	1	0.216395264	773.0171034	13.95419	0	0	0	0	0	16.40251	0	15.15777	0	0	0	0	16.26326	0	0	0	0	0	0	0	16.19688	14.39695	0	0	16.03692	0	0	14.75677	0	15.40942	16.12417	17.38546	16.19713	0	16.67658	17.33554	15.98321	0	17.1386	16.59937	16.63083	15.23186	15.64271	15.38239	17.04665	16.69192	0
Q9BZQ2	SHP1L_HUMAN	Testicular spindle-associated protein SHCBP1L (SHC SH2 domain-binding protein 1-like protein)	SHCBP1L C1orf14	Homo sapiens (Human)	cell differentiation [GO:0030154]; male meiosis cytokinesis [GO:0007112]; positive regulation of chromosome organization [GO:2001252]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]	cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; cell differentiation [GO:0030154]; male meiosis cytokinesis [GO:0007112]; positive regulation of chromosome organization [GO:2001252]; spermatogenesis [GO:0007283]		GO:0005737; GO:0007112; GO:0007283; GO:0030154; GO:0072687; GO:2001252	GEKSASAVSGDTAAATTLK	10.73999977	1	1	0.235787043	1765.722788	0	12.46538	0	0	15.86329	0	0	13.57498	0	15.25577	13.63043	0	16.36297	0	0	0	14.98426	14.96995	14.45314	0	0	0	15.0031	0	0	0	15.53799	0	0	0	0	0	0	15.96139	16.10546	0	0	0	0	18.20764	0	0	15.08663	0	0	0	0	0
Q9BZR6	RTN4R_HUMAN	"Reticulon-4 receptor (Nogo receptor, NgR) (Nogo-66 receptor)"	RTN4R NOGOR UNQ330/PRO526	Homo sapiens (Human)	axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; corpus callosum development [GO:0022038]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]; neuronal signal transduction [GO:0023041]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025]	anchored component of external side of plasma membrane [GO:0031362]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	anchored component of external side of plasma membrane [GO:0031362]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; chondroitin sulfate binding [GO:0035374]; ganglioside GM1 binding [GO:1905573]; ganglioside GT1b binding [GO:1905576]; heparin binding [GO:0008201]; neuregulin receptor activity [GO:0038131]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; corpus callosum development [GO:0022038]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]; neuronal signal transduction [GO:0023041]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025]	chondroitin sulfate binding [GO:0035374]; ganglioside GM1 binding [GO:1905573]; ganglioside GT1b binding [GO:1905576]; heparin binding [GO:0008201]; neuregulin receptor activity [GO:0038131]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]	GO:0005783; GO:0005886; GO:0005887; GO:0007166; GO:0007409; GO:0008201; GO:0009986; GO:0010977; GO:0022038; GO:0023041; GO:0030517; GO:0031362; GO:0035025; GO:0035374; GO:0038023; GO:0038131; GO:0043005; GO:0043025; GO:0043198; GO:0043204; GO:0043547; GO:0044295; GO:0044877; GO:0045121; GO:0048681; GO:0070062; GO:0098793; GO:0098978; GO:1905573; GO:1905576	LAGRDLK	9.659999847	1	1	0.124433602	772.8287363	14.03727	14.93633	15.7057	13.93226	0	0	6.417267	14.20998	0	0	0	0	15.63989	0	14.79655	15.85608	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9BZR9	TRIM8_HUMAN	"E3 ubiquitin-protein ligase TRIM8, EC 2.3.2.27 (Glioblastoma-expressed RING finger protein) (RING finger protein 27) (RING-type E3 ubiquitin transferase TRIM8) (Tripartite motif-containing protein 8)"	TRIM8 GERP RNF27	Homo sapiens (Human)	innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to nucleus [GO:1900182]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; suppression of viral release by host [GO:0044790]	cytosol [GO:0005829]; PML body [GO:0016605]	cytosol [GO:0005829]; PML body [GO:0016605]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to nucleus [GO:1900182]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; suppression of viral release by host [GO:0044790]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0003713; GO:0005829; GO:0008270; GO:0010508; GO:0016567; GO:0016605; GO:0016740; GO:0019827; GO:0032897; GO:0042802; GO:0042803; GO:0043123; GO:0044790; GO:0045087; GO:0046597; GO:0051091; GO:0051092; GO:1900182	AQAKFCSENAAQALHLGER	2.299999952	1	1	0.108326993	2101.314583	15.49459	0	0	0	0	14.01301	0	14.01486	0	14.2936	0	0	0	13.95368	11.81306	12.23812	0	0	0	0	14.21092	0	14.82918	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97424	0	0	0	0	0	0	0	0	0	0	0
Q9BZV1	UBXN6_HUMAN	UBX domain-containing protein 6 (UBX domain-containing protein 1)	UBXN6 UBXD1 UBXDC2	Homo sapiens (Human)	endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]		GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005815; GO:0005829; GO:0016236; GO:0019898; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503; GO:0070062	ESVGEK	4.400000095	1	1	0.226141095	648.4821867	17.33686	16.85783	14.48145	17.66205	0	16.52183	0	17.99044	18.22489	16.2833	15.07633	16.84138	16.72785	0	0	0	16.74978	16.00455	15.58707	13.92033	16.34933	14.98978	0	0	17.52515	17.16473	18.24794	0	16.27739	16.57608	18.11571	0	18.25139	16.7317	17.37215	17.28064	0	0	17.02309	0	0	0	0	15.94851	0	0	15.68576	0
Q9BZW7	TSG10_HUMAN	Testis-specific gene 10 protein (Testis development protein NYD-SP7)	TSGA10 CEP4L	Homo sapiens (Human)	spermatogenesis [GO:0007283]	centriole [GO:0005814]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]	centriole [GO:0005814]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; spermatogenesis [GO:0007283]		GO:0005737; GO:0005814; GO:0007283; GO:0031514	MAIQSRDVAQFR	17.90999985	0.902242959	0.902242959	0.45068124	1438.927274	0	0	18.41865	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.72435	0	0	19.52428	0	0	0	19.7023	0	18.59582	18.85273	0	0	0	19.49637	0	17.72602	0	0	0	0	0	0	16.67463	0
Q9BZX2	UCK2_HUMAN	"Uridine-cytidine kinase 2, UCK 2, EC 2.7.1.48 (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2)"	UCK2 UMPK	Homo sapiens (Human)	CTP salvage [GO:0044211]; UMP salvage [GO:0044206]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; identical protein binding [GO:0042802]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206]	ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; identical protein binding [GO:0042802]; uridine kinase activity [GO:0004849]	GO:0004849; GO:0005524; GO:0005737; GO:0005829; GO:0042802; GO:0043771; GO:0044206; GO:0044211	DLFQMK	3.25999999	1	1	0.247990776	796.7721084	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.8354	0	0	0	18.75062	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.10663
Q9BZZ5	API5_HUMAN	"Apoptosis inhibitor 5, API-5 (Antiapoptosis clone 11 protein, AAC-11) (Cell migration-inducing gene 8 protein) (Fibroblast growth factor 2-interacting factor, FIF) (Protein XAGL)"	API5 MIG8	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270]	fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0006915; GO:0016020; GO:0016607; GO:0017134; GO:0043066; GO:2000270	ITNNINVLIK	16.18000031	0.229130402	0.229130402	0.009013897	1140.812257	17.75655	0	18.69499	14.15435	17.14853	12.80938	0	17.09161	14.63013	0	0	0	11.69083	0	11.21437	0	0	0	15.71681	14.74342	0	16.56327	0	12.62021	0	10.45975	10.39637	14.605	0	18.26002	15.69859	16.67763	0	0	15.51559	0	16.56921	16.06668	0	0	0	17.61076	0	0	0	0	15.81307	14.47457
Q9C019	TRI15_HUMAN	Tripartite motif-containing protein 15 (RING finger protein 93) (Zinc finger protein 178) (Zinc finger protein B7)	TRIM15 RNF93 ZNF178 ZNFB7	Homo sapiens (Human)	innate immune response [GO:0045087]; mesodermal cell fate determination [GO:0007500]; negative regulation of intracellular transport of viral material [GO:1901253]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; mesodermal cell fate determination [GO:0007500]; negative regulation of intracellular transport of viral material [GO:1901253]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790]	transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0003713; GO:0005737; GO:0007500; GO:0008270; GO:0010468; GO:0016567; GO:0032481; GO:0044790; GO:0045087; GO:0051091; GO:0051092; GO:0061630; GO:1900246; GO:1901253	SVRYTR	3.609999895	0.377132744	0.377132744	0.217273638	783.3565411	0	17.72385	0	15.81457	16.14315	0	0	0	16.61575	13.56035	16.68293	0	17.11497	14.51371	14.6967	15.28694	15.67547	16.99384	0	17.1468	0	16.92258	16.24571	14.80699	0	15.78778	16.38362	0	0	16.45004	17.60398	0	0	16.94477	16.67878	16.76208	17.62391	16.60634	0	17.53479	16.19135	0	0	16.73307	0	17.33283	14.8335	0
Q9C035	TRIM5_HUMAN	"Tripartite motif-containing protein 5, EC 2.3.2.27 (RING finger protein 88) (RING-type E3 ubiquitin transferase TRIM5)"	TRIM5 RNF88	Homo sapiens (Human)	activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; suppression of viral release by host [GO:0044790]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; suppression of viral release by host [GO:0044790]	identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0000932; GO:0002218; GO:0003713; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0030674; GO:0031664; GO:0032880; GO:0038187; GO:0042802; GO:0042803; GO:0043123; GO:0043410; GO:0044790; GO:0045087; GO:0046596; GO:0046597; GO:0051091; GO:0051092; GO:0051607; GO:0061630; GO:0070534	EEKASWK	7.039999962	0.418731928	0.418731928	0.145194229	878.2252813	17.09639	0	16.17545	14.44913	15.87901	14.05318	16.24809	0	13.82602	14.48615	14.87808	17.73209	17.2763	11.48836	0	0	14.95008	17.87341	12.22308	0	0	18.60209	0	16.03572	12.31129	15.01856	16.89332	14.76313	0	0	11.39758	14.43475	0	0	18.22876	13.89556	16.98241	15.66499	15.37374	0	0	13.41812	13.62849	15.22137	16.74794	16.55303	0	0
Q9C037	TRIM4_HUMAN	"E3 ubiquitin-protein ligase TRIM4, EC 2.3.2.27 (RING finger protein 87) (RING-type E3 ubiquitin transferase TRIM4) (Tripartite motif-containing protein 4)"	TRIM4 RNF87	Homo sapiens (Human)	innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]	identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0010468; GO:0016567; GO:0042802; GO:0045087; GO:0061630	EDVMGITDRSK	8.649999619	1	1	4.61E-13	1251.619921	14.72455	0	0	11.97507	0	15.63735	0	0	15.85465	0	15.39485	14.36159	13.26976	15.13607	0	0	0	0	0	16.6908	15.01565	0	0	0	0	0	0	0	0	0	0	0	0	0	17.1779	0	0	0	0	0	0	0	0	0	17.15427	0	0	0
Q9C040	TRIM2_HUMAN	"Tripartite motif-containing protein 2, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2)"	TRIM2 KIAA0517 RNF86	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630	ENPIEDDLIFR	21.37999916	1	1	2.29E-13	1360.168484	19.7559	19.3224	16.25511	0	16.5525	18.31836	18.4603	0	0	10.16259	16.62531	22.16212	0	0	0	0	19.56161	0	16.94574	15.49798	0	0	17.21304	0	22.0292	0	21.4037	0	0	0	0	0	0	0	0	0	0	20.06813	20.4963	0	18.98875	0	0	0	0	0	22.06654	22.21267
Q9C075	K1C23_HUMAN	"Keratin, type I cytoskeletal 23 (Cytokeratin-23, CK-23) (Keratin-23, K23)"	KRT23	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109	SSMKVSATPK	8.869999886	1	1	0.181092617	1052.634325	13.23338	0	15.91272	0	0	0	0	0	0	0	15.60595	16.62343	0	0	0	0	0	0	0	14.64711	14.97921	0	16.11452	0	0	0	0	0	0	0	0	15.71037	0	14.74013	15.86494	14.7795	16.49388	15.02237	14.50845	15.60423	16.15374	0	16.05084	17.1216	15.41838	15.75533	15.64674	0
Q9C086	IN80B_HUMAN	"INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog, hIes2) (PAP-1-associated protein 1, PAPA-1) (Zinc finger HIT domain-containing protein 4)"	INO80B HMGA1L4 PAPA1 ZNHIT4	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]"	Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]"	metal ion binding [GO:0046872]	GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0016604; GO:0031011; GO:0033044; GO:0042766; GO:0045893; GO:0046872; GO:0051726; GO:0060382	IKLGGQVLGTK	4.139999866	1	1	0.104801439	1114.391957	0	0	0	17.6523	0	9.558174	0	0	0	0	0	14.11026	0	0	15.40574	11.61119	0	0	10.65875	0	0	0	0	0	0	0	0	0	0	0	16.42303	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9C091	GRB1L_HUMAN	GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein)	GREB1L C18orf6 KIAA1772	Homo sapiens (Human)	branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065]		GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0061205; GO:0072177	TLSEMR	8.529999733	1	1	0.145972255	751.1871012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.32753	17.814	0	0	0	0	0	13.69235	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9C098	DCLK3_HUMAN	"Serine/threonine-protein kinase DCLK3, EC 2.7.11.1 (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)"	DCLK3 DCAMKL3 DCDC3C KIAA1765	Homo sapiens (Human)	peptidyl-serine phosphorylation [GO:0018105]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; peptidyl-serine phosphorylation [GO:0018105]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0106310	DLKPENLLVQRNEDK	13.72000027	1	1	0.391778663	1810.13374	0	0	16.60531	16.44356	16.05413	0	15.59756	14.72573	15.82355	12.97175	16.42405	14.13365	17.31632	0	0	15.67922	0	0	0	0	0	0	17.08731	15.37673	0	0	16.40998	0	16.83217	0	15.98493	0	16.32554	16.38304	16.30247	0	0	0	0	0	0	16.14145	0	0	0	0	0	15.64757
Q9C099	LRCC1_HUMAN	Leucine-rich repeat and coiled-coil domain-containing protein 1 (Centrosomal leucine-rich repeat and coiled-coil domain-containing protein)	LRRCC1 CLERC KIAA1764	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]		GO:0005737; GO:0005813; GO:0005814; GO:0007049; GO:0051301	HALIWAQRK	14.64999962	0.075615376	0.075615376	1.60E-12	1122.740369	0	0	0	0	14.3165	0	0	0	0	0	15.97195	0	0	13.39883	15.62904	15.86768	17.41054	0	0	0	0	0	14.50926	12.9006	15.1911	13.05643	0	0	14.48951	0	0	0	0	0	0	0	16.33013	0	0	18.60043	0	15.85291	0	0	16.92892	0	0	0
Q9C0A0	CNTP4_HUMAN	Contactin-associated protein-like 4 (Cell recognition molecule Caspr4)	CNTNAP4 CASPR4 KIAA1763	Homo sapiens (Human)	"cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]"	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]	"cell projection [GO:0042995]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]; cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]"		GO:0007155; GO:0016021; GO:0032225; GO:0032228; GO:0042734; GO:0042995; GO:2000821	GEFNLMNLDYEISFGGIPAPGK	1.120000005	1	1	0.057188044	2370.886552	15.88349	0	12.44078	0	0	0	0	0	11.11044	0	0	16.88576	12.66844	0	0	0	0	0	0	0	0	0	14.43528	0	0	0	0	0	0	0	0	0	0	0	15.2599	0	16.09921	0	0	12.44389	0	0	0	0	0	0	13.81396	0
Q9C0A1	ZFHX2_HUMAN	"Zinc finger homeobox protein 2 (Zinc finger homeodomain protein 2, ZFH-2)"	ZFHX2 KIAA1056 KIAA1762 ZNF409	Homo sapiens (Human)	adult behavior [GO:0030534]; brain development [GO:0007420]; regulation of neuron differentiation [GO:0045664]; regulation of sensory perception of pain [GO:0051930]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; brain development [GO:0007420]; regulation of neuron differentiation [GO:0045664]; regulation of sensory perception of pain [GO:0051930]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007420; GO:0008270; GO:0030534; GO:0045664; GO:0051930	TQMSSLQLKIMK	9.220000267	0.231500417	0.231500417	0.139790996	1424.813911	18.13661	0	0	0	0	13.21178	13.76075	16.38008	15.74613	0	12.83095	13.46546	0	0	0	15.89985	0	15.66256	9.758357	0	0	0	0	17.48887	13.46579	16.93847	13.95595	0	16.57741	16.62614	0	16.12979	11.41437	17.32064	17.42836	12.49795	16.39375	16.12234	17.35871	16.23215	0	14.93653	0	16.16888	12.63573	0	0	16.6248
Q9C0B2	CFA74_HUMAN	Cilia- and flagella-associated protein 74	CFAP74 C1orf222 KIAA1751	Homo sapiens (Human)	axoneme assembly [GO:0035082]	axoneme [GO:0005930]	axoneme [GO:0005930]; axoneme assembly [GO:0035082]		GO:0005930; GO:0035082	KPVGGTK	17.60000038	1.57E-08	1.57E-08	0.240093737	684.6975483	18.70909	17.9688	17.77129	0	0	15.69644	18.06475	0	17.62543	0	0	0	16.81203	0	18.72656	18.99304	18.2745	0	16.64099	16.96196	0	16.55844	0	0	0	17.69769	0	18.6957	18.24798	0	0	0	0	0	0	0	18.03658	0	17.83932	17.41547	17.69209	0	0	19.0411	0	18.87523	18.32398	16.6978
Q9C0B5	ZDHC5_HUMAN	"Palmitoyltransferase ZDHHC5, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 5, DHHC-5) (Zinc finger protein 375)"	ZDHHC5 KIAA1748 ZNF375	Homo sapiens (Human)	positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0005886; GO:0016020; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030425; GO:0045335; GO:0062208; GO:1903078; GO:1905171	DEVQLKTTYSK	1.49000001	0.208910525	0.208910525	0.07394009	1310.734929	0	0	0	0	0	0	0	0	0	0	0	0	0	14.06237	0	0	0	0	0	14.94425	0	0	0	0	13.2611	0	0	0	0	0	0	0	14.23304	0	0	14.04888	0	0	11.87983	12.96325	13.81174	0	0	0	13.37654	0	0	0
Q9C0B7	TNG6_HUMAN	Transport and Golgi organization protein 6 homolog (Transmembrane and coiled-coil domain-containing protein 7)	TANGO6 KIAA1746 TMCO7	Homo sapiens (Human)	protein secretion [GO:0009306]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; protein secretion [GO:0009306]		GO:0009306; GO:0016021	DLYHLLK	7.070000172	0.281803548	0.281803548	0.278676045	902.0703912	16.052	0	15.00625	0	0	0	0	17.2172	0	0	0	0	0	0	18.03366	0	17.53401	0	0	16.13785	0	0	0	0	0	0	0	0	0	0	17.1009	17.94848	17.81982	0	16.76258	0	20.496	0	0	18.92749	0	0	0	0	0	0	0	0
Q9C0C2	TB182_HUMAN	182 kDa tankyrase-1-binding protein	TNKS1BP1 KIAA1741 TAB182	Homo sapiens (Human)	cellular response to ionizing radiation [GO:0071479]; double-strand break repair [GO:0006302]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein autophosphorylation [GO:0031954]; telomere maintenance via telomerase [GO:0007004]	adherens junction [GO:0005912]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ankyrin repeat binding [GO:0071532]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair [GO:0006302]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein autophosphorylation [GO:0031954]; telomere maintenance via telomerase [GO:0007004]	ankyrin repeat binding [GO:0071532]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]	GO:0000289; GO:0000792; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006302; GO:0007004; GO:0010800; GO:0019899; GO:0030014; GO:0031954; GO:0033138; GO:0044877; GO:0045296; GO:0071479; GO:0071532	ASPEPPGPESSSR	4.75	1	1	0.171345649	1295.231602	14.70724	0	0	0	0	0	0	16.1621	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95553	0	0	0	16.82346	0	0	15.31448	13.49716	0	16.39243	0	0	0	0	0	0	0
Q9C0C7	AMRA1_HUMAN	Activating molecule in BECN1-regulated autophagy protein 1 (DDB1- and CUL4-associated factor 3)	AMBRA1 DCAF3 KIAA1736	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; mitophagy [GO:0000423]; nervous system development [GO:0007399]; positive regulation of autophagy [GO:0010508]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to mitochondrial depolarisation [GO:0098780]	autophagosome [GO:0005776]; axoneme [GO:0005930]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	autophagosome [GO:0005776]; axoneme [GO:0005930]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTPase binding [GO:0051020]; protein phosphatase binding [GO:0019903]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; mitophagy [GO:0000423]; nervous system development [GO:0007399]; positive regulation of autophagy [GO:0010508]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to mitochondrial depolarisation [GO:0098780]	GTPase binding [GO:0051020]; protein phosphatase binding [GO:0019903]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]	GO:0000045; GO:0000209; GO:0000422; GO:0000423; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0005930; GO:0006914; GO:0007049; GO:0007399; GO:0010508; GO:0019903; GO:0030154; GO:0031410; GO:0031625; GO:0035307; GO:0043231; GO:0043552; GO:0045591; GO:0048471; GO:0051020; GO:0080008; GO:0098780; GO:1901526; GO:1904544; GO:1990756; GO:2000045	GLLPEAGQLAERGLSPR	10.32999992	1	1	0.328349411	1764.857055	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.19222	0
Q9C0D0	PHAR1_HUMAN	Phosphatase and actin regulator 1	PHACTR1 KIAA1733 RPEL1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; regulation of neuron migration [GO:2001222]; stress fiber assembly [GO:0043149]	cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]	cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; regulation of neuron migration [GO:2001222]; stress fiber assembly [GO:0043149]	actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]	GO:0003779; GO:0004864; GO:0005634; GO:0005829; GO:0008157; GO:0021987; GO:0030036; GO:0031032; GO:0031532; GO:0043149; GO:0045202; GO:0048870; GO:0140059; GO:2001222	RATLLLPPTLMAASSEDDIDR	5.829999924	0.044106487	0.044106487	0.471504889	2300.733299	0	0	0	0	0	0	0	17.48361	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.37492	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9C0D2	CE295_HUMAN	Centrosomal protein of 295 kDa	CEP295 KIAA1731	Homo sapiens (Human)	centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599]	microtubule binding [GO:0008017]	GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0007099; GO:0008017; GO:0010825; GO:0046599; GO:1901985; GO:1903724; GO:1904951; GO:1990498	EALLVEK	6.039999962	0.734583616	0.734583616	0.159515621	802.6354355	16.64119	0	18.19316	15.31392	15.77447	0	19.92321	0	14.41194	17.05688	16.74561	18.7886	15.5733	16.96721	18.0001	17.55529	0	0	17.44347	0	15.29024	17.81496	13.44469	13.79197	0	18.58144	0	0	16.55721	0	0	19.1461	15.76864	18.98641	0	0	0	16.30732	14.2675	0	18.41679	18.50344	16.89055	0	15.08511	0	16.96044	16.54255
Q9C0D4	Z518B_HUMAN	Zinc finger protein 518B	ZNF518B KIAA1729	Homo sapiens (Human)	chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006325; GO:0006357; GO:0046872	SERGPIDMSPNIETPLRPK	5.699999809	1	1	0.126788921	2152.390338	0	13.73948	14.63363	16.50296	0	0	14.80681	0	0	15.13818	14.29314	14.4255	0	14.96763	14.5082	0	0	0	0	0	0	0	0	14.73252	0	0	0	0	0	0	0	15.57419	0	0	0	0	0	0	0	0	0	11.64413	0	0	0	0	0	0
Q9C0D5	TANC1_HUMAN	"Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)"	TANC1 KIAA1728	Homo sapiens (Human)	dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; visual learning [GO:0008542]	axon terminus [GO:0043679]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]	axon terminus [GO:0043679]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; visual learning [GO:0008542]		GO:0007520; GO:0008542; GO:0014069; GO:0030425; GO:0043025; GO:0043679; GO:0097062	AGIGKSLR	5.099999905	0.247464523	0.247464523	0.028154948	801.8326323	15.30611	15.68957	0	0	10.08007	14.53306	15.04623	0	15.6375	0	15.52345	14.04237	14.79032	16.25141	0	0	18.17619	16.47269	15.09874	17.29403	14.5513	17.88502	15.89857	15.44565	15.55243	15.54704	15.01115	15.69203	17.03287	15.57335	13.04678	16.9854	15.88459	18.03918	17.6247	17.12613	16.08662	13.30306	17.19588	15.30274	14.4217	0	0	17.09095	16.35091	16.13389	14.53693	15.25451
Q9C0D6	FHDC1_HUMAN	FH2 domain-containing protein 1 (Inverted formin-1)	FHDC1 INF1 KIAA1727	Homo sapiens (Human)	cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149]	cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]	cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149]	actin binding [GO:0003779]; microtubule binding [GO:0008017]	GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005929; GO:0008017; GO:0043149; GO:0060271; GO:0090161	IEAMVLK	25.43000031	0.609657586	0.609657586	0.272219231	819.3422031	19.3265	0	18.70525	0	20.29032	19.93098	21.9325	19.08885	17.63119	19.11049	19.16088	22.24	19.06745	0	17.75036	0	0	18.14081	22.70841	17.97645	0	19.4964	18.45012	18.59559	0	19.93748	17.83159	0	17.78312	0	18.04712	19.04624	20.64791	21.44698	0	18.72319	0	19.19645	0	19.36288	0	0	19.73941	0	18.34152	19.41393	0	0
Q9C0D7	ZC12C_HUMAN	"Probable ribonuclease ZC3H12C, EC 3.1.-.- (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C)"	ZC3H12C KIAA1726 MCPIP3	Homo sapiens (Human)	"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]	"cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]	GO:0003729; GO:0004521; GO:0005634; GO:0036464; GO:0046872; GO:0090502	NNFMGLK	1.970000029	0.911140561	0.911140561	0.207336281	840.4422004	0	15.90184	0	0	0	0	18.17213	0	0	0	0	17.25492	0	0	0	0	0	17.22477	0	0	0	0	0	0	18.01126	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.50693	0	0	0	0	0	0
Q9C0D9	EPT1_HUMAN	"Ethanolaminephosphotransferase 1, hEPT1, EC 2.7.8.1 (Selenoprotein I, SelI)"	SELENOI EPT1 KIAA1724 SELI	Homo sapiens (Human)	phosphatidylethanolamine biosynthetic process [GO:0006646]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphatidylethanolamine biosynthetic process [GO:0006646]	ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]	GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0016021; GO:0046872	AGYEYVSPEQLAGFDK	7.139999866	1	1	0.237372405	1774.581175	0	13.61758	14.01826	0	0	0	0	0	0	15.66051	0	12.82695	0	0	0	0	0	0	0	0	0	0	0	0	14.05103	0	15.54411	0	0	0	0	0	0	0	0	14.22635	0	13.83432	0	0	14.41706	0	13.92248	0	14.95515	0	0	16.3007
Q9C0E2	XPO4_HUMAN	"Exportin-4, Exp4"	XPO4 KIAA1721	Homo sapiens (Human)	positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]	nuclear export signal receptor activity [GO:0005049]	GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827	DQFSDQLASVGMLGR	8.5	1	1	0.30084041	1639.499558	0	15.18335	12.22327	0	16.17786	15.19342	15.64843	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.81694	16.6141	0	16.57812	16.34561	15.05883	0	0	0	0	0	0	15.07245	17.31585	0	0	17.3457	15.42323	0	0	0	0	0	0
Q9C0F0	ASXL3_HUMAN	Putative Polycomb group protein ASXL3 (Additional sex combs-like protein 3)	ASXL3 KIAA1713	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; negative regulation of lipid biosynthetic process [GO:0051055]; positive regulation of transcription by RNA polymerase II [GO:0045944]	PR-DUB complex [GO:0035517]	PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]; animal organ morphogenesis [GO:0009887]; negative regulation of lipid biosynthetic process [GO:0051055]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]	GO:0003677; GO:0003682; GO:0009887; GO:0035517; GO:0042975; GO:0045944; GO:0046872; GO:0051055	AMIVCK	6.880000114	1	1	5.75E-13	718.4221402	0	14.04271	16.01217	11.25795	14.29516	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.90062	0	0	0	0	0	16.56107	16.14251	0	0	0	16.64678	0	0	0	0	0	0	0	0	0	0	0	0	0	15.76496
Q9C0F1	CEP44_HUMAN	"Centrosomal protein of 44 kDa, Cep44 (HBV PreS1-transactivated protein 3, PS1TP3)"	CEP44 KIAA1712	Homo sapiens (Human)	centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]	microtubule binding [GO:0008017]	GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0007099; GO:0008017; GO:0010457; GO:0030496	MERMK	5.889999866	1	1	0.077868677	711.0684918	0	0	14.95916	0	0	0	0	0	0	0	0	12.49214	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.06882	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9C0G0	ZN407_HUMAN	Zinc finger protein 407	ZNF407 KIAA1703	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0008270; GO:0010468; GO:0045944	DCAQGVK	11.26000023	1	1	0.143702141	774.7363307	0	11.87251	12.03169	15.73003	0	15.83899	0	0	12.93891	0	0	14.94579	0	0	0	0	0	0	0	0	0	0	12.37038	0	11.881	0	0	0	13.34023	14.78665	0	0	0	0	0	0	0	0	14.1299	16.15937	0	0	0	18.09201	13.88857	0	0	0
Q9C0G6	DYH6_HUMAN	Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)	DNAH6 DNAHC6 DNHL1 HL2 KIAA1697	Homo sapiens (Human)	cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]	axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]	axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060285	FGADK	6.349999905	0.64611578	0.64611578	0.264244243	536.6756857	15.95953	14.06797	14.86317	0	13.8451	0	15.19144	15.31834	0	14.39789	0	0	16.19678	0	13.95391	0	0	17.30665	15.38676	12.83193	0	0	17.20067	14.2951	0	0	0	0	15.4527	0	15.6668	0	15.72864	14.04772	15.06049	0	0	16.31747	0	15.2237	14.50312	0	14.20892	0	0	0	17.23709	0
Q9C0H5	RHG39_HUMAN	Rho GTPase-activating protein 39	ARHGAP39 KIAA1688	Homo sapiens (Human)	postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173	HTQGLFRR	5.679999828	0.81179148	0.81179148	0.18270181	1014.452755	0	0	15.42205	0	0	0	0	17.04145	0	0	16.09892	0	15.04636	15.88141	14.40645	0	0	0	15.13773	16.31025	0	15.43477	0	0	0	15.40972	0	14.35052	0	13.8718	14.3866	15.44306	15.63249	15.06798	12.66156	14.29569	13.85588	15.69404	14.12961	0	14.65547	13.40753	15.88036	10.39617	16.38126	17.09949	15.00801	14.65198
Q9C0H9	SRCN1_HUMAN	"SRC kinase signaling inhibitor 1 (SNAP-25-interacting protein, SNIP) (p130Cas-associated protein) (p140Cap)"	SRCIN1 KIAA1684 P140 SNIP	Homo sapiens (Human)	exocytosis [GO:0006887]; negative regulation of protein secretion [GO:0050709]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; exocytosis [GO:0006887]; negative regulation of protein secretion [GO:0050709]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; substrate adhesion-dependent cell spreading [GO:0034446]	protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]	GO:0005737; GO:0006887; GO:0014069; GO:0015629; GO:0019901; GO:0019904; GO:0030027; GO:0030175; GO:0030334; GO:0030424; GO:0030425; GO:0034446; GO:0043025; GO:0045202; GO:0050709; GO:0061001; GO:0061098; GO:0061099; GO:0098793	QSLPLSR	12.17000008	0.199365705	0.199365705	0.267794976	800.0274383	15.11761	14.38572	0	0	0	16.59556	17.75237	14.50678	0	0	0	15.89116	14.20014	0	0	0	16.2514	0	17.70541	15.48578	16.7605	16.22137	16.7791	0	17.84048	18.59284	0	14.68911	15.95354	14.8725	15.98612	18.75872	0	17.68551	0	0	16.4581	0	0	15.55505	15.74073	0	15.36245	14.86522	0	17.03998	15.98017	16.29005
Q9C0I3	CCSE1_HUMAN	Serine-rich coiled-coil domain-containing protein 1 (Coiled-coil serine-rich protein 1)	CCSER1 FAM190A KIAA1680	Homo sapiens (Human)						HSVGFSSSR	3.059999943	1	1	0	963.5960938	14.81801	15.79909	0	14.9202	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9C0J8	WDR33_HUMAN	pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa)	WDR33 WDC146	Homo sapiens (Human)	mRNA polyadenylation [GO:0006378]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]	collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283]	RNA binding [GO:0003723]	GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0006378; GO:0007283	GPPDR	9.989999771	0.002808307	0.002808307	0.23401731	539.2164216	12.77304	0	16.44562	15.53282	15.58455	15.50452	15.82076	16.27178	0	0	15.5137	14.62811	16.63005	16.29108	15.33562	0	14.4173	15.81221	15.636	15.26269	16.19482	16.11746	15.61611	17.29475	15.74674	16.16997	0	0	13.92714	16.55085	14.70019	0	0	15.81001	15.81802	16.14365	16.89777	0	0	0	0	15.15567	15.63109	15.75603	16.0709	15.72522	16.44755	0
Q9GZK7	O11A1_HUMAN	Olfactory receptor 11A1 (Hs6M1-18) (Olfactory receptor 11A2) (Olfactory receptor OR6-30)	OR11A1 OR11A2	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0016021	ILCIKQTETLD	6.869999886	1	1	0.106091307	1333.254211	13.25091	0	14.80776	0	0	13.04311	0	15.55317	13.60429	0	0	13.47674	14.55241	0	13.31506	0	11.91435	0	0	0	0	13.76514	14.55285	15.86341	0	0	0	0	10.69781	12.23936	0	0	0	0	0	0	13.44839	0	0	15.76611	15.50734	15.08451	0	0	16.36927	0	0	0
Q9GZL7	WDR12_HUMAN	Ribosome biogenesis protein WDR12 (WD repeat-containing protein 12)	WDR12	Homo sapiens (Human)	"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]"	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]"	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]"	ribonucleoprotein complex binding [GO:0043021]	GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0007219; GO:0030687; GO:0042273; GO:0043021; GO:0051726; GO:0070545	ALHCCRGHAGSVDSIAVDGSGTK	1.710000038	1	1	0.159885422	2354.510021	12.67568	0	12.24294	0	0	0	0	13.95785	13.02441	0	0	9.525046	0	12.49566	12.49176	11.44444	14.4727	0	0	13.88467	0	0	0	0	11.50228	14.09212	11.32822	0	0	12.75259	0	0	13.51062	0	0	15.00695	0	14.16756	13.07899	15.28078	0	15.02146	0	13.23131	0	0	0	0
Q9GZM3	RPB1B_HUMAN	"DNA-directed RNA polymerase II subunit RPB11-b1, RNA polymerase II subunit B11-b1, RPB11b1 (DNA-directed RNA polymerase II subunit J2)"	POLR2J2	Homo sapiens (Human)		"RNA polymerase II, core complex [GO:0005665]"	"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]"	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]	GO:0001055; GO:0003677; GO:0005665; GO:0046983	DTKVPK	12.85000038	1	1	0.26258823	687.2700067	0	0	0	0	0	17.92403	0	0	0	0	0	17.12362	17.17497	0	0	0	0	0	0	0	15.80573	0	0	0	0	0	0	0	15.9882	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9GZN1	ARP6_HUMAN	"Actin-related protein 6, hArp6 (hARPX)"	ACTR6 CDA12	Homo sapiens (Human)	"histone exchange [GO:0043486]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; regulation of transcription, DNA-templated [GO:0006355]"	nucleosome binding [GO:0031491]	GO:0000786; GO:0000812; GO:0005634; GO:0005737; GO:0005856; GO:0006355; GO:0031491; GO:0043486	DMDIAKLK	11.56000042	0.697051406	0.697051406	0.286675832	953.1458424	15.35748	12.5783	15.68298	15.81355	14.64834	16.27061	0	0	13.46408	0	0	15.69637	14.99199	0	16.65912	15.65604	0	0	0	14.36962	0	0	0	0	0	0	0	0	0	0	0	15.12618	0	15.83509	16.1043	0	0	16.50933	0	15.92584	16.42496	15.55854	15.79387	15.39184	14.43083	15.1661	15.69783	0
Q9GZN2	TGIF2_HUMAN	"Homeobox protein TGIF2 (5'-TG-3'-interacting factor 2) (TGF-beta-induced transcription factor 2, TGFB-induced factor 2)"	TGIF2	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of neuron differentiation [GO:0045666]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0010470; GO:0038092; GO:0045666; GO:0060041; GO:1990837	MSDSDLGEDEGLLSLAGK	9.850000381	0.759569824	0.759569824	0.278902935	1848.447236	15.44741	14.58483	13.38413	15.28797	0	0	12.02183	14.60381	0	11.61806	14.92191	14.22008	14.30164	13.8221	0	0	0	0	15.40179	0	0	0	15.53305	15.44516	0	11.21565	0	15.32513	0	0	15.29748	0	0	0	0	16.3269	15.30952	0	0	15.63168	0	0	0	13.76062	14.56781	0	0	0
Q9GZN6	S6A16_HUMAN	Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 (Solute carrier family 6 member 16)	SLC6A16 NTT5	Homo sapiens (Human)	neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]	neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]	GO:0005326; GO:0005887; GO:0006836; GO:0015293; GO:0035725	FGLQQLVVAK	5.869999886	0.78649056	0.78649056	0.162405178	1103.603115	18.41	0	15.44053	0	15.18398	0	0	0	0	0	0	0	0	0	0	0	0	17.38836	18.30041	15.12958	14.73948	0	0	0	18.03741	0	0	15.73021	0	0	0	0	0	0	0	0	0	0	0	0	16.63087	0	18.13249	15.7875	15.66491	0	16.76493	0
Q9GZP1	NRSN2_HUMAN	Neurensin-2	NRSN2 C20orf98	Homo sapiens (Human)	nervous system development [GO:0007399]	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; nervous system development [GO:0007399]		GO:0005886; GO:0007399; GO:0016021; GO:0030133; GO:0043005; GO:0043025	MMPSCNR	3.49000001	1	1	0.220221798	896.1065635	16.10111	15.87516	0	15.38239	0	15.67584	15.25374	16.2639	14.64504	15.52384	15.07372	0	0	12.09712	0	15.09686	0	15.10304	0	14.11351	0	0	0	0	0	14.08057	16.06526	13.22939	13.62303	0	0	0	16.86452	11.48464	11.96352	11.56399	0	0	15.86372	0	0	0	0	0	16.08867	0	0	0
Q9GZP9	DERL2_HUMAN	"Derlin-2 (Degradation in endoplasmic reticulum protein 2, DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)"	DERL2 DER2 FLANA CGI-101 SBBI53	Homo sapiens (Human)	"endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]"	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]	"early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]"	misfolded protein binding [GO:0051787]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; ubiquitin-specific protease binding [GO:1990381]	GO:0000839; GO:0001967; GO:0005047; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044877; GO:0051787; GO:1904153; GO:1990381	MAYQSLR	4.96999979	0.8180058	0.8180058	0.242582782	868.3435885	15.41088	15.34183	15.83812	14.44714	14.99385	14.87022	14.36782	12.52746	14.37113	15.25347	12.71079	13.69865	0	15.68771	13.69385	14.63905	13.7977	0	15.82235	14.29329	0	0	16.93841	14.45871	0	14.64118	15.44652	15.66133	0	0	0	16.24438	15.40192	0	0	0	0	0	16.45335	0	14.93676	15.84347	16.00015	0	15.47258	15.65948	15.96923	0
Q9GZQ3	COMD5_HUMAN	"COMM domain-containing protein 5 (Hypertension-related calcium-regulated gene protein, HCaRG)"	COMMD5 HT002	Homo sapiens (Human)		cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005829	VDVAISTSALAR	14.03999996	0.760036707	0.760036707	0.359921759	1203.65988	0	0	17.0097	0	0	0	16.75196	0	0	0	0	16.64928	0	0	16.51181	15.87314	0	0	0	0	0	0	0	0	0	16.70504	16.96141	15.14923	0	0	15.56703	16.18923	0	0	16.93937	16.73826	0	16.33306	0	0	0	14.74699	15.15032	14.72293	0	0	15.73891	18.43184
Q9GZQ4	NMUR2_HUMAN	"Neuromedin-U receptor 2, NMU-R2 (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1)"	NMUR2 NMU2R TGR1	Homo sapiens (Human)	activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; activation of phospholipase A2 activity by calcium-mediated signaling [GO:0043006]; arachidonic acid secretion [GO:0050482]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265]	G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellular calcium activated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]	GO:0001607; GO:0002023; GO:0004930; GO:0005229; GO:0005525; GO:0005886; GO:0006816; GO:0006940; GO:0007186; GO:0007200; GO:0007204; GO:0007218; GO:0007267; GO:0007417; GO:0007625; GO:0007631; GO:0008188; GO:0016021; GO:0019722; GO:0042924; GO:0043006; GO:0048016; GO:0048265; GO:0050482; GO:0051930	DKSLEADEGNANIQRPCR	3.150000095	0.539970398	0.539970398	0.201177785	2071.289178	0	0	0	0	0	0	0	0	0	0	15.03368	0	12.27421	0	0	0	0	0	0	0	0	0	0	0	0	14.63728	0	0	0	0	0	14.3544	0	0	13.70112	0	0	15.43765	0	0	0	0	0	0	15.07919	0	14.88989	0
Q9GZQ6	NPFF1_HUMAN	Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022)	NPFFR1 GPR147 NPFF1	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]	GO:0004930; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0008188; GO:0042277	EEHHFMVDAR	12.89999962	0.677590728	0.677590728	0.202355845	1287.363356	17.76531	17.36333	0	0	16.04494	0	15.4788	10.59948	14.82053	0	0	14.83165	13.28907	0	12.84544	13.57014	14.14677	14.73877	0	0	14.16197	0	0	0	14.69068	11.93333	16.33197	0	14.74344	0	0	13.85342	0	11.79415	15.83321	0	0	13.94691	13.84406	16.04096	0	13.84306	12.99664	14.51249	9.684146	0	15.59922	0
Q9GZR1	SENP6_HUMAN	"Sentrin-specific protease 6, EC 3.4.22.- (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6)"	SENP6 KIAA0797 SSP1 SUSP1 FKSG6	Homo sapiens (Human)	protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169]	SUMO-specific endopeptidase activity [GO:0070139]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234	DVMKGSNPK	12.56000042	0.401776969	0.401776969	0.087709998	975.6396759	0	0	15.52787	0	0	0	0	17.24434	15.19264	16.8329	0	0	13.89882	0	0	0	0	0	15.53451	0	15.76775	0	0	0	0	0	0	15.67493	0	14.18892	0	14.70982	0	0	0	0	16.0642	16.8654	14.16719	14.76115	0	15.06222	13.0849	0	16.11714	16.91818	17.27047	17.04493
Q9GZR2	REXO4_HUMAN	"RNA exonuclease 4, EC 3.1.-.- (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog, hPMC2)"	REXO4 PMC2 XPMC2H	Homo sapiens (Human)	"DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]"	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]"	3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0000737; GO:0000738; GO:0003690; GO:0003697; GO:0003723; GO:0004519; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006355; GO:0006364; GO:0008408; GO:0016607	EVAEMLK	4.710000038	1	1	0.193641914	832.8056231	0	15.92908	15.22622	0	0	15.36425	15.0902	0	14.94303	0	0	16.32403	14.53963	12.95926	0	0	14.91206	16.87276	15.10693	12.71432	18.19032	15.14252	15.79872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.1578	15.576	14.03452	0	0	0	0	12.56759	0
Q9GZR5	ELOV4_HUMAN	"Elongation of very long chain fatty acids protein 4, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4, ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)"	ELOVL4	Homo sapiens (Human)	"fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	"endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]"	3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0005783; GO:0006633; GO:0006636; GO:0008020; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102337; GO:0102756	SEKQLMIENGK	3.420000076	1	1	0.15433079	1293.675445	0	0	11.20054	9.734181	0	0	0	0	8.868941	0	11.27504	0	0	14.02817	0	0	0	0	12.94003	0	0	0	0	13.916	13.60743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.27632	0	0	0	0
Q9GZR7	DDX24_HUMAN	"ATP-dependent RNA helicase DDX24, EC 3.6.4.13 (DEAD box protein 24)"	DDX24	Homo sapiens (Human)	RNA metabolic process [GO:0016070]	membrane [GO:0016020]; nucleolus [GO:0005730]	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070; GO:0016887	YMDVVK	2.819999933	1	1	3.47E-13	752.7228348	16.72612	14.12609	0	0	0	14.13128	0	0	0	0	16.10697	15.87158	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.65184	0	13.52023	0	0	14.3462
Q9GZS0	DNAI2_HUMAN	Dynein axonemal intermediate chain 2 (Axonemal dynein intermediate chain 2)	DNAI2	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]	GO:0003341; GO:0003777; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0009897; GO:0036126; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0060271; GO:0120293	EADAIK	12.75	0.02438182	0.02438182	0.345078336	647.0417998	14.0672	0	0	0	0	0	0	0	0	14.85263	15.55427	14.72702	15.22716	16.71901	16.75338	14.90399	14.27439	16.21499	0	0	0	0	16.05185	0	0	0	0	15.70122	0	16.56195	16.12854	15.88889	0	0	0	15.53056	0	0	17.17404	0	16.03656	0	0	0	0	16.83115	0	17.35879
Q9GZS1	RPA49_HUMAN	"DNA-directed RNA polymerase I subunit RPA49, RNA polymerase I subunit A49 (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53)"	POLR1E PAF53 PRAF1	Homo sapiens (Human)	nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation from RNA polymerase I promoter [GO:0006362]	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; RNA polymerase I general transcription initiation factor binding [GO:0001179]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation from RNA polymerase I promoter [GO:0006362]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; RNA polymerase I general transcription initiation factor binding [GO:0001179]	GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005730; GO:0005736; GO:0006362; GO:0042790	SALGPGVPHIINTK	15.75	1	1	0.219415226	1403.981867	0	0	16.16232	0	0	0	0	0	0	0	0	0	14.99322	0	14.69243	0	0	0	0	14.15407	16.10802	0	0	0	0	16.10032	0	15.73595	16.7271	15.38173	16.19217	14.69987	15.51842	15.77315	13.31266	15.28992	0	17.00495	0	15.84159	0	0	0	0	0	16.8004	0	0
Q9GZS9	CHST5_HUMAN	"Carbohydrate sulfotransferase 5, EC 2.8.2.- (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-alpha, GST4-alpha) (Intestinal N-acetylglucosamine-6-O-sulfotransferase, I-GlcNAc6ST, Intestinal GlcNAc-6-sulfotransferase, hIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3, GlcNAc6ST-3, Gn6st-3)"	CHST5	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790]	N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0008146; GO:0016021; GO:0018146; GO:0031228	GTISKQDVCK	9.25	0.457912415	0.457912415	0.153954378	1136.697098	0	0	0	0	16.17536	0	13.36668	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.63175	0	0	0	0	0	0	0	0	0	0	16.54522	0	0	0	0	0	0	0	0	15.58071	0	0	0
Q9GZT4	SRR_HUMAN	"Serine racemase, EC 5.1.1.18 (D-serine ammonia-lyase) (D-serine dehydratase, EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase, EC 4.3.1.17)"	SRR	Homo sapiens (Human)	aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]	GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006563; GO:0007420; GO:0007568; GO:0008721; GO:0009069; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0043278; GO:0045177; GO:0070178; GO:0070179	SLVPDALER	5.400000095	0.414609611	0.414609611	0.229216448	1000.23391	17.02715	19.5539	17.63839	17.27312	16.58006	0	18.62808	16.70123	0	16.39377	15.6747	16.77535	15.41616	15.19502	13.18874	16.84114	14.99386	14.05241	15.37618	0	0	16.4398	16.50283	13.45073	15.83519	0	16.31606	14.35936	0	16.7194	17.59894	0	0	16.49863	16.98695	17.57931	0	0	0	13.48461	0	0	0	0	16.47216	0	14.98193	0
Q9GZT8	NIF3L_HUMAN	NIF3-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein)	NIF3L1 ALS2CR1 MDS015 My018	Homo sapiens (Human)	"negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]"	identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]	GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:0042802; GO:0045893; GO:0061629; GO:1903507	VMSAVK	9.460000038	0.15968217	0.15968217	0.292082303	635.1859529	15.48221	15.81797	15.98189	16.34119	16.6738	0	16.31817	16.22382	14.80838	16.8459	15.69467	15.21108	16.2031	0	16.40471	16.96368	15.84446	17.10665	0	17.82496	16.7738	0	0	16.43944	0	15.65661	15.60093	15.5273	16.89137	16.08741	16.84342	0	0	16.56382	16.79835	16.59256	16.97264	17.5272	18.18423	17.397	16.93438	16.93053	16.77308	0	17.0791	16.19825	16.40549	17.38498
Q9GZU1	MCLN1_HUMAN	"Mucolipin-1, ML1 (MG-2) (Mucolipidin) (Transient receptor potential channel mucolipin 1, TRPML1)"	MCOLN1 ML4 TRPML1 MSTP080	Homo sapiens (Human)	adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; phagosome maturation [GO:0090382]; protein homotetramerization [GO:0051289]; transferrin transport [GO:0033572]	cell projection [GO:0042995]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	"cell projection [GO:0042995]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; iron ion transmembrane transporter activity [GO:0005381]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; phagosome maturation [GO:0090382]; protein homotetramerization [GO:0051289]; transferrin transport [GO:0033572]"	"calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; iron ion transmembrane transporter activity [GO:0005381]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]"	GO:0001891; GO:0002250; GO:0005261; GO:0005262; GO:0005381; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0006812; GO:0008289; GO:0010008; GO:0016020; GO:0016021; GO:0030670; GO:0031902; GO:0033572; GO:0042802; GO:0042995; GO:0043231; GO:0043235; GO:0051289; GO:0070588; GO:0071277; GO:0071467; GO:0072345; GO:0090382; GO:0097352; GO:0097682; GO:0099604	NLTLKFHK	8.710000038	0.975512922	0.975512922	0.173924595	997.8741097	14.93236	13.45307	11.8991	0	15.72537	13.44088	0	15.90743	0	0	0	0	0	0	0	15.10818	0	0	0	0	0	0	0	0	14.94437	11.03064	13.06718	13.59017	14.69532	13.95165	14.41334	14.38493	0	16.4114	0	9.195875	0	0	0	15.66239	15.01678	15.38142	15.05174	0	0	15.20771	14.59855	15.48967
Q9GZU7	CTDS1_HUMAN	"Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1, EC 3.1.3.16 (Nuclear LIM interactor-interacting factor 3, NLI-IF, NLI-interacting factor 3) (Small C-terminal domain phosphatase 1, SCP1, Small CTD phosphatase 1)"	CTDSP1 NIF3 NLIIF SCP1	Homo sapiens (Human)	negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470]; regulation of transcription by RNA polymerase II [GO:0006357]	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]	GO:0001933; GO:0004721; GO:0005634; GO:0005654; GO:0006357; GO:0006470; GO:0008420; GO:0045665; GO:0046872; GO:0050768; GO:0070062; GO:2000134	QPRPGS	1.929999948	0.408535033	0.408535033	0.300323414	641.803403	0	15.74841	0	13.04684	0	15.42739	14.57754	16.73081	15.02726	15.60631	15.94076	16.65716	0	16.3297	15.70159	0	11.88675	15.73143	0	16.83357	0	16.41407	0	16.56926	16.96518	16.00569	17.32729	0	0	0	16.04309	16.72178	15.48748	0	16.13828	17.78235	0	0	15.59516	0	17.06318	0	0	0	17.02736	0	0	0
Q9GZU8	PIP30_HUMAN	PSME3-interacting protein (NEFA-interacting nuclear protein NIP30) (PA28G-interacting protein)	PSME3IP1 C16orf94 FAM192A NIP30 PIP30 CDA018 CDA10	Homo sapiens (Human)	negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein binding [GO:0032091]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein binding [GO:0032091]		GO:0005634; GO:0032091; GO:1901799	LTVKPIETK	11.06000042	0.372963488	0.372963488	0.224518002	1026.359127	16.2508	16.77092	0	0	0	14.81361	13.96666	15.68099	17.5373	17.78691	9.501714	0	14.20851	0	14.26964	0	0	16.04279	17.7688	0	12.55776	0	0	0	13.96031	17.38556	0	18.71832	0	17.64887	17.59422	17.90093	18.27032	0	15.77513	0	16.47782	17.46672	0	14.33614	0	15.04338	14.31169	14.39925	16.08058	15.09833	15.88127	11.19072
Q9GZV8	PRD14_HUMAN	"PR domain zinc finger protein 14, EC 2.1.1.- (PR domain-containing protein 14)"	PRDM14	Homo sapiens (Human)	cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0009566; GO:0010468; GO:0030718; GO:0031490; GO:0034972; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459	MAPPLLSPGLGLQR	2.349999905	1	1	1.60E-12	1465.355835	0	0	13.49898	0	0	14.12915	0	12.40059	0	0	13.44726	13.68064	15.07781	11.75274	14.95439	0	11.44482	14.35694	0	0	15.31258	0	0	14.0261	0	0	0	0	15.88282	12.10318	14.70578	14.46741	14.31597	0	0	0	16.45559	0	0	15.85029	0	0	0	15.91155	0	0	0	0
Q9GZW5	SCND2_HUMAN	Putative SCAN domain-containing protein SCAND2P (SCAN domain-containing protein 2 pseudogene)	SCAND2P SCAND2	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357	EPGRQR	5.53000021	1	1	0.171738078	743.4832608	0	0	0	15.58657	15.51769	14.39421	0	0	15.02742	14.69444	0	0	15.09779	0	15.46198	0	14.02258	15.41823	16.57159	15.05729	15.5425	0	0	0	0	0	0	14.40153	17.02137	14.43271	16.01791	16.37692	0	0	13.00288	0	16.50364	15.92296	0	15.10456	16.6718	16.42514	14.99292	14.77845	16.41351	16.25993	15.74097	16.03503
Q9GZX5	ZN350_HUMAN	Zinc finger protein 350 (KRAB zinc finger protein ZFQR) (Zinc finger and BRCA1-interacting protein with a KRAB domain 1) (Zinc finger protein ZBRK1)	ZNF350 ZBRK1	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]"	GO:0000122; GO:0000978; GO:0001162; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0016363; GO:0016604; GO:0017053; GO:0045892; GO:0046872	NVVLVGQPVVRCAASGDNR	2.059999943	1	1	0.331506737	2010.643604	14.41382	13.37753	6.699728	0	14.67505	11.6804	13.01462	14.13629	0	0	14.94358	13.24947	11.55399	0	0	0	0	14.43338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.4681	0	0	0	0	0	0	0	0	0	0	15.98665
Q9GZX6	IL22_HUMAN	"Interleukin-22, IL-22 (Cytokine Zcyto18) (IL-10-related T-cell-derived-inducible factor, IL-TIF)"	IL22 ILTIF ZCYTO18 UNQ3099/PRO10096	Homo sapiens (Human)	acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; response to glucocorticoid [GO:0051384]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-22 receptor binding [GO:0045518]; acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; response to glucocorticoid [GO:0051384]	cytokine activity [GO:0005125]; interleukin-22 receptor binding [GO:0045518]	GO:0005125; GO:0005576; GO:0005615; GO:0006953; GO:0006954; GO:0045518; GO:0051384	LFHGVSMSERCYLMK	5.28000021	1	1	2.06E-12	1873.697337	0	13.20728	12.08588	0	15.41809	14.5286	0	10.52957	0	0	0	0	0	11.51999	14.22467	0	13.87431	14.11619	0	14.55207	12.86017	13.21731	0	12.87737	12.54325	15.50459	14.67742	14.82208	14.10967	14.10408	0	0	14.7717	13.48483	13.66912	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9GZX7	AICDA_HUMAN	"Single-stranded DNA cytosine deaminase, EC 3.5.4.38 (Activation-induced cytidine deaminase, AID) (Cytidine aminohydrolase)"	AICDA AID	Homo sapiens (Human)	B cell differentiation [GO:0030183]; cellular response to lipopolysaccharide [GO:0071222]; cytidine to uridine editing [GO:0016554]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; isotype switching [GO:0045190]; mRNA processing [GO:0006397]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; regulation of nuclear cell cycle DNA replication [GO:0033262]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; B cell differentiation [GO:0030183]; cellular response to lipopolysaccharide [GO:0071222]; cytidine to uridine editing [GO:0016554]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; isotype switching [GO:0045190]; mRNA processing [GO:0006397]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; regulation of nuclear cell cycle DNA replication [GO:0033262]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446]	cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000932; GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0006397; GO:0008270; GO:0010529; GO:0016445; GO:0016446; GO:0016554; GO:0030183; GO:0031625; GO:0032991; GO:0033262; GO:0042742; GO:0042802; GO:0045190; GO:0045869; GO:0047844; GO:0051607; GO:0070383; GO:0071222; GO:0080111; GO:0090310	AGVQIAIMTFK	9.010000229	0.150648668	0.150648668	0.269862353	1178.014154	13.06302	0	13.34073	0	13.63089	0	12.81255	0	0	0	0	11.90673	0	13.95552	9.150756	0	0	0	0	0	0	0	0	0	14.16207	0	14.09708	0	0	0	15.1392	0	15.45798	0	0	0	0	0	0	0	14.09998	14.84602	0	0	0	0	13.90312	0
Q9GZZ1	NAA50_HUMAN	"N-alpha-acetyltransferase 50, hNaa50p, EC 2.3.1.258 (N-acetyltransferase 13) (N-acetyltransferase 5, hNAT5) (N-acetyltransferase san homolog, hSAN) (N-epsilon-acetyltransferase 50, EC 2.3.1.-) (NatE catalytic subunit)"	NAA50 MAK3 NAT13 NAT5	Homo sapiens (Human)	"establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]"	H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]	GO:0004596; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0010485; GO:0016573; GO:0031415; GO:0034087; GO:0052858; GO:0070062; GO:0071962	LGIGTKMLNHVLNICEK	1.870000005	1	1	0.41142013	1938.887964	16.56183	17.19668	0	0	0	14.45637	15.64454	0	0	0	0	16.68034	17.39896	0	0	0	0	0	0	13.06263	0	0	0	0	0	0	0	16.11626	0	0	0	15.86653	15.88578	14.35519	15.83328	0	14.97033	0	0	15.66564	12.62271	0	0	13.46561	0	0	0	0
Q9GZZ6	ACH10_HUMAN	"Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10, NACHR alpha-10)"	CHRNA10 NACHRA10	Homo sapiens (Human)	"chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]	"acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; neurotransmitter receptor activity [GO:0030594]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]"	acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; neurotransmitter receptor activity [GO:0030594]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005102; GO:0005262; GO:0005887; GO:0005892; GO:0007165; GO:0007204; GO:0007268; GO:0007271; GO:0010996; GO:0016020; GO:0022848; GO:0030424; GO:0030594; GO:0034220; GO:0042127; GO:0042391; GO:0042472; GO:0043005; GO:0043204; GO:0045202; GO:0050877; GO:0050910; GO:0051899; GO:0070373; GO:0098981; GO:0099060	HDGAVR	4.889999866	0.624562085	0.624562085	0.194579868	655.482812	15.82483	17.02465	16.25749	16.49524	14.51961	16.37824	16.8194	0	0	16.58235	16.57196	15.87043	0	15.29807	0	17.12958	0	15.66803	17.82379	0	17.89018	0	0	0	17.20718	15.82733	0	15.13963	16.73313	15.9116	16.07405	16.89565	15.48178	16.85497	16.10456	17.30272	17.23947	0	17.32495	17.332	16.35985	17.43142	19.17821	0	0	17.24043	17.15958	16.35129
Q9GZZ9	UBA5_HUMAN	"Ubiquitin-like modifier-activating enzyme 5, Ubiquitin-activating enzyme 5 (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)"	UBA5 UBE1DC1	Homo sapiens (Human)	erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]	GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0008270; GO:0030218; GO:0030219; GO:0032446; GO:0033146; GO:0034976; GO:0042803; GO:0043231; GO:0050905; GO:0061709; GO:0071566; GO:0071569; GO:1990592	SGDGGGGRVR	8.199999809	1	1	0.153473361	918.1015036	15.33524	0	0	0	0	0	15.75657	0	9.172726	14.91339	14.51215	16.8825	0	14.36978	0	0	16.71535	0	0	0	0	0	17.03204	0	0	14.32848	0	0	0	0	15.6523	0	0	0	0	0	0	16.01858	0	0	0	0	0	0	0	0	0	0
Q9H000	MKRN2_HUMAN	"E3 ubiquitin-protein ligase makorin-2, EC 2.3.2.27 (RING finger protein 62) (RING-type E3 ubiquitin transferase makorin-2)"	MKRN2 RNF62 HSPC070	Homo sapiens (Human)	"negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription factor catabolic process [GO:1901485]; protein kinase B signaling [GO:0043491]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; LIM domain binding [GO:0030274]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription factor catabolic process [GO:1901485]; protein kinase B signaling [GO:0043491]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; transcription, DNA-templated [GO:0006351]"	LIM domain binding [GO:0030274]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0002862; GO:0003723; GO:0005634; GO:0006351; GO:0016567; GO:0030274; GO:0043491; GO:0045944; GO:0046872; GO:0061630; GO:1901223; GO:1901485	ASASER	7.480000019	0.80494231	0.80494231	0.290019253	619.0486496	0	15.74781	14.70691	0	14.47948	15.67846	13.7065	15.25413	14.84827	15.10576	0	15.95052	14.0201	17.01181	15.53121	13.66036	15.7089	14.67598	0	13.99132	16.22932	15.90058	17.25053	16.21004	16.95031	16.29646	16.08285	16.99816	13.61549	15.64916	0	0	15.69801	0	0	0	15.97723	0	0	14.22325	0	0	0	0	0	0	17.38913	0
Q9H013	ADA19_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 19, ADAM 19, EC 3.4.24.- (Meltrin-beta) (Metalloprotease and disintegrin dendritic antigen marker, MADDAM)"	ADAM19 MLTNB FKSG34	Homo sapiens (Human)	amyloid precursor protein catabolic process [GO:0042987]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; protein processing [GO:0016485]	collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; protein processing [GO:0016485]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; SH3 domain binding [GO:0017124]	GO:0001890; GO:0004222; GO:0005634; GO:0005794; GO:0005886; GO:0006509; GO:0010628; GO:0016021; GO:0016485; GO:0017124; GO:0042987; GO:0046872; GO:0062023; GO:1902945; GO:2000049	FYRSLNIR	8.229999542	1	1	0.177388314	1067.876648	0	16.16299	8.484024	0	0	0	12.9901	13.91917	13.27524	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.36576	0	0	0	0	14.09508	13.9339	0	0	0	0	12.34955	0	0	0	0	0	0	0	0	0
Q9H019	MFR1L_HUMAN	Mitochondrial fission regulator 1-like	MTFR1L FAM54B HYST1888 MSTP116	Homo sapiens (Human)	aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]		GO:0000266; GO:0005739; GO:0009060	DFHRMK	8.449999809	0.810491204	0.810491204	0.250122283	849.8129233	0	16.16842	14.9325	15.30795	14.01789	14.79143	11.90189	0	0	14.84684	0	16.10771	15.24498	13.57737	0	14.86863	0	13.11279	14.15309	0	0	0	0	0	15.68937	13.89779	0	0	10.26445	14.36943	15.84932	15.19975	12.44207	17.13771	0	16.65826	14.33632	14.72624	8.81749	11.09503	11.2493	13.15464	14.18037	15.03547	13.62389	13.03656	16.81364	0
Q9H061	T126A_HUMAN	Transmembrane protein 126A	TMEM126A	Homo sapiens (Human)	mitochondrial respiratory chain complex I assembly [GO:0032981]; optic nerve development [GO:0021554]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981]; optic nerve development [GO:0021554]		GO:0005739; GO:0005743; GO:0016021; GO:0021554; GO:0032981	ALQLSEPGKEIH	9.779999733	1	1	0.095129511	1322.525174	14.91821	13.62521	13.86376	14.80894	0	0	0	0	15.10635	0	0	0	0	0	16.56619	0	0	14.90963	0	16.88941	16.06863	0	18.94054	19.09512	0	0	0	0	0	0	15.68973	0	0	0	0	0	0	16.52809	0	0	0	0	0	0	0	0	0	0
Q9H063	MAF1_HUMAN	Repressor of RNA polymerase III transcription MAF1 homolog	MAF1	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]	RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]	GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0016479; GO:0016480; GO:0043231	EPSLSWVVNAVNCSLFSAVREDFK	3.569999933	0.859968662	0.859968662	2.29E-12	2754.029989	0	16.95201	12.51505	16.59333	14.1618	0	0	14.00508	0	0	0	0	14.15344	0	0	0	14.24282	0	0	0	11.76169	0	16.17472	0	0	0	0	13.554	0	0	0	0	16.09551	0	13.95113	0	0	12.70881	14.4845	0	0	0	0	0	0	0	11.34368	0
Q9H074	PAIP1_HUMAN	"Polyadenylate-binding protein-interacting protein 1, PABP-interacting protein 1, PAIP-1, Poly(A)-binding protein-interacting protein 1"	PAIP1	Homo sapiens (Human)	"CRD-mediated mRNA stabilization [GO:0070934]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"	RNA binding [GO:0003723]; translation activator activity [GO:0008494]	GO:0003723; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0008494; GO:0048255; GO:0070934; GO:0106002; GO:1900152; GO:2000767	APPSSQDK	15.67000008	1	1	0.192947182	829.0639436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32447	0	0	0	0	0	0	0	0	0	0	0	0	0	15.4775	0	0	15.57088	15.36306	17.17182	0	15.89367	0	0	16.00074	0	0	0	0	0	0	0
Q9H089	LSG1_HUMAN	"Large subunit GTPase 1 homolog, hLsg1, EC 3.6.1.-"	LSG1	Homo sapiens (Human)	nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054]	Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000054; GO:0003924; GO:0005525; GO:0005654; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0016020; GO:0016604; GO:0051168	APAGGSLGR	10.93999958	0.599353969	0.599353969	0.101360379	784.9228261	0	15.73595	15.61285	14.77239	0	0	14.4603	15.88264	14.95865	0	0	15.13461	0	15.45524	14.37639	16.14413	13.91372	0	15.06304	0	0	0	0	15.24734	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H091	ZMY15_HUMAN	Zinc finger MYND domain-containing protein 15	ZMYND15	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; spermatid development [GO:0007286]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatid development [GO:0007286]"	histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0007286; GO:0042826; GO:0045892; GO:0046872	ELESLVPR	5.28000021	1	1	0.185261547	944.4529152	14.56995	13.01451	14.14954	12.18694	12.86602	0	0	13.02511	15.35671	15.37371	0	12.81818	13.61467	12.90064	13.83961	15.4047	14.13967	15.71221	0	14.87051	14.35636	16.72796	14.28536	0	0	0	0	0	0	0	0	0	0	15.20816	0	0	15.84614	0	0	0	0	0	0	0	14.65531	0	0	0
Q9H095	DRC9_HUMAN	Dynein regulatory complex protein 9 (IQ domain-containing protein G)	IQCG DRC9	Homo sapiens (Human)	cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]	calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544]	GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0030544; GO:0031514; GO:0036126; GO:0044782; GO:0070062	DQLQEMKAK	8.539999962	0.743875027	0.743875027	0.178921813	1090.126009	0	16.52489	14.28607	14.04548	0	0	0	15.9247	16.5704	0	15.44558	14.64957	16.84737	15.60555	12.95718	15.59685	0	0	0	0	16.92753	16.16443	0	14.61573	15.21715	15.35202	15.49622	0	0	15.52481	0	0	16.29128	0	0	16.15243	0	17.55665	0	0	15.89897	15.68368	0	16.89121	17.43942	18.37205	0	0
Q9H0A0	NAT10_HUMAN	"RNA cytidine acetyltransferase, EC 2.3.1.- (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein, hALP)"	NAT10 ALP KIAA1709	Homo sapiens (Human)	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]	"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]"	"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]"	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	GO:0000049; GO:0000154; GO:0000781; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883	NMGKPAQPALSR	8.510000229	1	1	0.587854016	1269.233061	14.00113	0	0	0	0	18.39783	17.22464	0	0	18.25316	0	0	16.57709	17.76476	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.61659	0	19.44019	18.50736	0	0	0	0	18.90069	0	17.71495	0	0	0	17.00126	0	17.11424	16.70055
Q9H0B3	IQCN_HUMAN	IQ domain-containing protein N	IQCN KIAA1683	Homo sapiens (Human)		mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrion [GO:0005739]; nucleus [GO:0005634]		GO:0005634; GO:0005739	NKAVVPPR	8.159999847	0.918161273	0.918161273	0.250945118	880.8853012	17.43479	0	16.49165	16.48267	0	16.95868	0	16.71081	16.21853	17.09992	15.987	0	15.28324	0	0	11.80537	14.10051	13.99651	15.85702	0	11.87164	16.01441	14.00829	12.42791	0	0	0	0	16.37608	0	0	17.15623	16.69764	17.45241	0	14.70534	0	0	16.93371	15.45643	0	16.16653	0	14.87426	15.53392	14.4755	0	16.62177
Q9H0B6	KLC2_HUMAN	"Kinesin light chain 2, KLC 2"	KLC2	Homo sapiens (Human)	lysosome localization [GO:0032418]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; lysosome localization [GO:0032418]	cadherin binding [GO:0045296]; kinesin binding [GO:0019894]	GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0016020; GO:0016938; GO:0019894; GO:0032418; GO:0032991; GO:0045296	DMAGGAGPR	4.309999943	1	1	0.125625106	848.5525278	0	0	15.3596	0	14.9575	15.58085	15.82278	15.37716	0	14.76672	14.93216	16.57422	16.58003	16.11826	0	14.45607	15.32422	15.95961	0	14.71896	0	0	0	15.87165	0	0	0	0	0	0	0	0	0	0	0	0	13.2243	0	0	0	0	14.39032	0	0	0	0	0	0
Q9H0B8	CRLD2_HUMAN	"Cysteine-rich secretory protein LCCL domain-containing 2 (Cysteine-rich secretory protein 11, CRISP-11) (LCCL domain-containing cysteine-rich secretory protein 2)"	CRISPLD2 CRISP11 LCRISP2 UNQ2914/PRO1156/PRO9783	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; lung development [GO:0030324]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; lung development [GO:0030324]	glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]	GO:0005539; GO:0005576; GO:0005615; GO:0008201; GO:0030133; GO:0030198; GO:0030324; GO:0031012; GO:0034774; GO:0060325; GO:0070062; GO:1904813	HGVQSLSK	8.770000458	1	1	0.045084743	855.4008843	14.04383	14.90515	0	0	0	13.96356	16.61639	17.18854	15.15597	0	0	0	17.07934	0	0	13.43235	0	13.32291	0	0	0	15.397	0	0	14.98059	0	0	0	0	0	0	14.57778	0	0	0	0	0	0	0	14.62154	0	0	0	0	13.17863	0	0	14.24863
Q9H0C1	ZMY12_HUMAN	Zinc finger MYND domain-containing protein 12	ZMYND12	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	APQKTIFVLK	4.300000191	0.210415304	0.210415304	0.159620199	1146.715991	15.71357	16.10484	0	10.14774	9.332247	0	0	0	10.48302	16.13523	15.27858	0	0	0	13.95368	13.40371	10.50391	12.5724	0	0	0	0	0	0	0	0	13.57678	0	14.20843	13.71109	0	0	0	15.89622	0	0	0	0	0	0	16.84602	9.163834	14.28783	0	12.81666	0	14.76704	16.00097
Q9H0C2	ADT4_HUMAN	"ADP/ATP translocase 4 (ADP,ATP carrier protein 4) (Adenine nucleotide translocator 4, ANT 4) (Solute carrier family 25 member 31) (Sperm flagellar energy carrier protein)"	SLC25A31 AAC4 ANT4 SFEC	Homo sapiens (Human)	cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; regulation of mitochondrial membrane permeability [GO:0046902]; spermatogenesis [GO:0007283]	membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP:ADP antiporter activity [GO:0005471]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; regulation of mitochondrial membrane permeability [GO:0046902]; spermatogenesis [GO:0007283]	ATP:ADP antiporter activity [GO:0005471]	GO:0005471; GO:0005634; GO:0005739; GO:0005743; GO:0005757; GO:0005886; GO:0007141; GO:0007283; GO:0016020; GO:0030154; GO:0031514; GO:0046902; GO:0140021; GO:1990544	EFFHIDIGGR	5.079999924	0.345462024	0.345462024	4.58E-13	1191.17696	0	14.04699	0	12.29107	0	0	14.93056	0	13.20125	0	0	0	0	0	0	16.31544	0	0	16.41812	0	0	15.98477	17.59159	0	14.05019	12.0799	15.83672	0	0	0	0	0	0	0	13.815	0	16.57137	0	0	0	17.19092	0	17.06402	0	12.44706	0	11.23437	0
Q9H0C5	BTBD1_HUMAN	"BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8, HCV NS5A-transactivated protein 8)"	BTBD1 C15orf1 NS5ATP8	Homo sapiens (Human)	muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; protein-containing complex [GO:0032991]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393]	cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]	GO:0000932; GO:0005654; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0036464; GO:0042802; GO:0043393; GO:0097602	VLGKALSLIR	4.380000114	1	1	0.165106856	1069.174617	0	13.73594	14.18475	14.52371	15.18002	0	15.63004	14.92328	13.87856	0	14.00108	0	0	14.16835	0	12.83358	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.21882	0	0	0	12.14186	0	0	0	0	0	0	0
Q9H0C8	ILKAP_HUMAN	"Integrin-linked kinase-associated serine/threonine phosphatase 2C, ILKAP, EC 3.1.3.16"	ILKAP	Homo sapiens (Human)	protein dephosphorylation [GO:0006470]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0046872	CLLDTFK	9.970000267	1	1	0.22541029	897.4321432	0	0	0	0	0	16.75519	0	0	0	0	0	0	0	0	0	0	0	0	0	16.64096	0	17.83824	0	0	0	18.49714	17.45676	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.50896	0	0	0	0	0	0
Q9H0D2	ZN541_HUMAN	Zinc finger protein 541	ZNF541	Homo sapiens (Human)	"cell differentiation [GO:0030154]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0003714; GO:0005634; GO:0005667; GO:0006357; GO:0007283; GO:0016575; GO:0030154; GO:0045892; GO:0046872	APGLEKR	4.820000172	0.851288795	0.851288795	0.301375201	770.8145597	15.36015	15.7352	14.764	14.73682	14.37032	13.26031	0	15.69923	15.67436	16.09703	0	16.1698	16.27548	16.40188	18.35439	17.16978	16.08699	16.72314	0	17.56962	17.58369	15.99478	17.23993	0	0	15.8219	17.09958	16.90599	15.67656	16.35263	16.91667	16.5294	17.63465	17.46931	16.41787	16.4633	17.25026	16.52509	18.24319	0	18.49311	18.32402	15.44533	18.36598	17.5959	16.86685	17.97766	17.06997
Q9H0D6	XRN2_HUMAN	"5'-3' exoribonuclease 2, EC 3.1.13.- (DHM1-like protein, DHP protein)"	XRN2	Homo sapiens (Human)	"DNA catabolic process, exonucleolytic [GO:0000738]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]"	aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process, exonucleolytic [GO:0000738]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]"	3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	GO:0000175; GO:0000738; GO:0000956; GO:0001147; GO:0003723; GO:0004518; GO:0004534; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006396; GO:0006397; GO:0006401; GO:0007283; GO:0008409; GO:0016020; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0042802; GO:0046872; GO:0060041	ASKEGMEAAVEK	10.68000031	0.013812316	0.013812316	0	1265.100791	0	0	0	0	0	0	0	0	0	0	0	0	15.23914	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H0E2	TOLIP_HUMAN	Toll-interacting protein	TOLLIP	Homo sapiens (Human)	autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"	"interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]"	GO:0005150; GO:0005576; GO:0005737; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0016604; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0032991; GO:0033235; GO:0035325; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0045087; GO:0045321; GO:0048471; GO:0070062; GO:0070498	CSEEDLK	13.09000015	1	1	0.287164534	880.9600942	17.66363	0	0	0	0	0	17.31713	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.27106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.71321	0	0	0
Q9H0E9	BRD8_HUMAN	"Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa, TrCP120) (p120)"	BRD8 SMAP SMAP2	Homo sapiens (Human)	"cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]"	mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812]	"mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812]; nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]"	nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]	GO:0000786; GO:0000812; GO:0005654; GO:0005739; GO:0006325; GO:0007166; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779	IRTMAQFLR	12.22000027	1	1	0.27931616	1151.30857	0	18.82732	16.52691	18.80519	18.25732	0	0	17.08381	0	0	17.9883	0	18.81336	0	0	16.79996	0	0	16.26997	0	16.69205	17.28313	0	0	17.66389	0	0	0	18.33439	20.16133	0	0	19.14732	0	18.88932	0	17.26824	0	0	20.51041	18.61263	18.71498	15.62194	0	0	16.85269	0	0
Q9H0F6	SHRPN_HUMAN	"Sharpin (Shank-associated RH domain-interacting protein) (Shank-interacting protein-like 1, hSIPL1)"	SHARPIN SIPL1 PSEC0216	Homo sapiens (Human)	apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; defense response to bacterium [GO:0042742]; keratinization [GO:0031424]; mitochondrion organization [GO:0007005]; negative regulation of inflammatory response [GO:0050728]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; regulation of CD40 signaling pathway [GO:2000348]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]	cytosol [GO:0005829]; dendrite [GO:0030425]; LUBAC complex [GO:0071797]; postsynaptic density [GO:0014069]; ubiquitin ligase complex [GO:0000151]	cytosol [GO:0005829]; dendrite [GO:0030425]; LUBAC complex [GO:0071797]; postsynaptic density [GO:0014069]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; defense response to bacterium [GO:0042742]; keratinization [GO:0031424]; mitochondrion organization [GO:0007005]; negative regulation of inflammatory response [GO:0050728]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; regulation of CD40 signaling pathway [GO:2000348]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0004842; GO:0005829; GO:0007005; GO:0007420; GO:0010803; GO:0014069; GO:0030262; GO:0030425; GO:0031424; GO:0031593; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0050728; GO:0071797; GO:0097039; GO:2000348	AIAGGDEK	14.21000004	0.233004838	0.233004838	0.245983904	759.5869559	19.01592	19.21	18.77011	18.67752	20.05325	19.31039	18.80353	18.68625	18.31357	20.14748	18.69583	18.57305	16.89666	10.30636	19.37906	18.93717	17.92997	18.76429	18.80968	15.97965	19.07611	18.71085	18.98738	20.85943	19.32279	19.35939	19.07925	20.14248	17.7483	0	19.39909	20.7866	19.56663	17.86197	20.00443	19.95266	16.88657	21.63467	18.49464	0	18.96799	17.79499	17.8399	0	19.69236	0	18.49721	17.8776
Q9H0G5	NSRP1_HUMAN	"Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70, NSrp70)"	NSRP1 CCDC55 NSRP70	Homo sapiens (Human)	"developmental process [GO:0032502]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; developmental process [GO:0032502]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032502; GO:1990904	LLLGKDR	30.29999924	0.485611171	0.485611171	0.281968989	814.8470264	0	0	18.20695	0	18.11944	17.94889	18.46047	18.92677	18.3996	17.62738	19.166	18.96109	15.45549	0	0	18.21522	18.03672	19.34581	20.48925	0	19.22278	19.14331	17.88166	18.47176	18.73318	0	0	0	17.95053	18.33802	0	19.74084	18.40956	19.24829	16.86963	0	18.45974	18.73609	20.58807	18.40497	18.44481	0	18.9876	17.66986	0	16.44547	0	0
Q9H0H0	INT2_HUMAN	"Integrator complex subunit 2, Int2"	INTS2 KIAA1287	Homo sapiens (Human)	snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034472	ETSSSVLWQMR	2.920000076	1	1	0.375506646	1337.673673	0	0	0	0	0	0	0	0	15.67332	0	0	0	0	0	15.345	15.33948	16.08643	16.01019	0	0	0	0	0	14.12747	0	16.4695	15.58875	0	0	13.62244	0	0	0	0	15.47428	16.25363	15.83798	15.22534	16.29635	0	14.59057	16.68668	0	17.48228	16.21315	0	15.33006	0
Q9H0H5	RGAP1_HUMAN	"Rac GTPase-activating protein 1 (Male germ cell RacGap, MgcRacGAP) (Protein CYK4 homolog, CYK4, HsCYK-4)"	RACGAP1 KIAA1478 MGCRACGAP	Homo sapiens (Human)	actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]	acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]	"acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]"	"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]"	GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0007165; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149	SALDVK	9.979999542	1	1	0.11961192	632.4493567	15.40092	16.91081	14.21474	15.54627	15.31279	0	16.08129	16.64241	0	0	0	16.0438	14.85217	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.98304	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H0I3	CC113_HUMAN	Coiled-coil domain-containing protein 113	CCDC113 HSPC065	Homo sapiens (Human)	cilium assembly [GO:0060271]	axoneme [GO:0005930]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; protein-containing complex [GO:0032991]	axoneme [GO:0005930]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271]		GO:0005930; GO:0032991; GO:0034451; GO:0036064; GO:0060271	KGSILATQK	1.799999952	1	1	0.188341372	945.3762128	0	0	13.88961	0	14.61267	16.33751	0	0	0	0	0	15.98518	0	0	0	12.77352	15.38067	0	14.99087	0	0	0	0	0	14.53689	0	0	0	0	0	0	15.36318	0	0	17.96705	0	15.244	0	0	15.82716	0	0	15.41649	14.55069	14.93861	0	0	0
Q9H0I9	TKTL2_HUMAN	"Transketolase-like protein 2, EC 2.2.1.1"	TKTL2	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]	GO:0004802; GO:0005737; GO:0030976; GO:0046872	MMANDAKPDVK	6.320000172	0.961455762	0.961455762	0.408517548	1236.522213	0	0	0	11.40362	0	15.65348	0	0	0	0	0	15.76705	0	16.01462	0	0	0	0	0	15.86097	16.90672	0	0	0	0	0	0	14.86673	0	0	16.61358	14.97382	0	17.25429	0	16.54608	17.59055	16.82141	17.41079	0	0	16.28582	0	15.63766	0	17.85209	17.13502	0
Q9H0K1	SIK2_HUMAN	"Serine/threonine-protein kinase SIK2, EC 2.7.11.1 (Qin-induced kinase) (Salt-inducible kinase 2, SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2)"	SIK2 KIAA0781 QIK SNF1LK2	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0042149; GO:0046626; GO:0046777; GO:0106310	ITKTEVAIK	9.619999886	0.392222553	0.392222553	0.062349437	1003.716447	14.80489	14.98094	12.7535	16.33522	14.65419	0	14.25814	15.15406	13.46065	0	15.00536	0	14.89146	16.59633	15.62088	14.48135	0	14.80781	13.61963	13.75767	14.8551	13.37949	9.178871	13.64829	11.72674	15.84023	16.39966	16.34008	13.22918	13.69073	13.28065	16.35639	18.96231	15.34585	15.46908	9.71436	15.75462	16.82297	12.67268	14.82825	0	12.84651	12.6837	0	15.92213	15.66918	17.16326	0
Q9H0K6	PUS7L_HUMAN	"Pseudouridylate synthase PUS7L, EC 5.4.99.- (Pseudouridylate synthase 7 homolog-like protein)"	PUS7L	Homo sapiens (Human)	pseudouridine synthesis [GO:0001522]	nucleus [GO:0005634]	nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; pseudouridine synthesis [GO:0001522]	pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	GO:0001522; GO:0003723; GO:0005634; GO:0009982	ERALLEALHR	5.619999886	1	1	0.131371523	1209.362044	8.856058	0	9.175364	0	0	0	0	0	0	14.62208	0	0	0	13.75602	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.27389	17.80389	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H0L4	CSTFT_HUMAN	"Cleavage stimulation factor subunit 2 tau variant (CF-1 64 kDa subunit tau variant) (Cleavage stimulation factor 64 kDa subunit tau variant, CSTF 64 kDa subunit tau variant) (TauCstF-64)"	CSTF2T KIAA0689	Homo sapiens (Human)	pre-mRNA cleavage required for polyadenylation [GO:0098789]	intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005654; GO:0005847; GO:0043231; GO:0098789	STGAS	9.840000153	1	1	5.74E-14	422.6194663	18.03576	0	17.66824	0	0	0	0	12.69505	0	0	0	0	0	0	0	0	0	13.2154	0	0	0	15.51478	0	0	0	0	15.24244	0	0	0	0	0	14.91746	0	13.59791	0	0	0	0	15.27276	0	0	0	0	0	0	0	0
Q9H0M0	WWP1_HUMAN	"NEDD4-like E3 ubiquitin-protein ligase WWP1, EC 2.3.2.26 (Atrophin-1-interacting protein 5, AIP5) (HECT-type E3 ubiquitin transferase WWP1) (TGIF-interacting ubiquitin ligase 1, Tiul1) (WW domain-containing protein 1)"	WWP1	Homo sapiens (Human)	"central nervous system development [GO:0007417]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; central nervous system development [GO:0007417]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]"	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007417; GO:0016567; GO:0034220; GO:0043161; GO:0045732; GO:0045892; GO:0046718; GO:0061630; GO:0070062	LYVIFR	17.05999947	0.017740052	0.017740052	0.209467	809.5188359	16.62877	15.42319	0	0	15.29463	0	15.22123	16.10831	15.52451	16.47909	15.29063	0	15.83754	16.18199	15.12598	15.80373	15.84733	15.88391	16.3589	15.34421	0	15.63223	0	16.31364	16.77408	15.56309	15.3991	0	16.39047	15.96503	16.95887	16.5291	15.79342	16.55532	16.30462	16.16704	17.26458	14.39145	16.63798	14.76554	0	15.77979	15.48281	16.63386	16.05791	15.87764	0	15.09424
Q9H0M5	ZN700_HUMAN	Zinc finger protein 700	ZNF700	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	KWSDQNIEYEYQNPR	6.449999809	1	1	6.89E-13	1969.490382	0	0	0	0	0	0	0	0	12.89575	0	0	0	0	0	0	0	14.3154	14.84554	0	14.60872	13.31919	12.4682	0	0	0	0	0	13.63056	13.59171	15.10468	13.99922	0	15.97711	0	14.88264	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H0N5	PHS2_HUMAN	"Pterin-4-alpha-carbinolamine dehydratase 2, PHS 2, EC 4.2.1.96 (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor)"	PCBD2 DCOH2 DCOHM	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; positive regulation of transcription, DNA-templated [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729]"	4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]	GO:0004505; GO:0005634; GO:0006729; GO:0008124; GO:0042802; GO:0045893	LTAEERNQAILDLK	6.130000114	1	1	0.353222036	1614.240321	15.41329	15.82991	14.28023	10.25757	0	0	0	14.305	14.99687	13.88312	0	14.01046	15.05261	0	0	15.39126	15.05638	15.64506	13.81673	0	0	0	0	0	0	16.29208	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H0R6	GATA_HUMAN	"Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial, Glu-AdT subunit A, EC 6.3.5.7 (Glutaminyl-tRNA synthase-like protein 1)"	QRSL1	Homo sapiens (Human)	glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of protein stability [GO:0031647]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]	glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of protein stability [GO:0031647]	ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]	GO:0005524; GO:0005739; GO:0030956; GO:0031647; GO:0032543; GO:0050567; GO:0070681	EGFNDVVRGR	2.299999952	1	1	0.265315615	1149.171248	0	0	17.48808	0	0	0	16.58263	0	0	0	0	0	0	0	0	0	16.29986	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.27371	0	0	0	18.74582	0	0	0	0	0	0	0	0	0	0	0	0
Q9H0T7	RAB17_HUMAN	Ras-related protein Rab-17	RAB17	Homo sapiens (Human)	cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of melanosome localization [GO:0032401]; filopodium assembly [GO:0046847]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; regulation of dendrite development [GO:0050773]; regulation of endocytosis [GO:0030100]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; transcytosis [GO:0045056]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of melanosome localization [GO:0032401]; filopodium assembly [GO:0046847]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; regulation of dendrite development [GO:0050773]; regulation of endocytosis [GO:0030100]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; transcytosis [GO:0045056]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0002415; GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0012505; GO:0016323; GO:0016324; GO:0019003; GO:0030100; GO:0030139; GO:0030425; GO:0032401; GO:0032402; GO:0032456; GO:0042470; GO:0043025; GO:0045056; GO:0046847; GO:0050773; GO:0051489; GO:0051963; GO:0055037; GO:0055038; GO:0060271; GO:0070062	MAQAHR	8.489999771	1	1	0.238780747	729.9781277	0	17.97478	16.80386	17.56268	0	0	17.70718	0	16.58943	20.20324	14.27884	18.62162	18.13648	0	17.69527	0	0	0	0	0	0	0	0	18.07945	19.29135	22.31088	0	17.71157	17.99837	0	0	0	20.40703	0	19.64631	0	0	0	0	0	0	17.837	0	17.87498	0	0	0	0
Q9H0U9	TSYL1_HUMAN	"Testis-specific Y-encoded-like protein 1, TSPY-like protein 1"	TSPYL1 TSPYL	Homo sapiens (Human)	nucleosome assembly [GO:0006334]	chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone binding [GO:0042393]	GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006334; GO:0019899; GO:0042393	MSGLDGVKR	6.340000153	0.236970708	0.236970708	0.156993333	962.721934	13.66215	16.21885	17.44893	14.7994	17.99494	17.04575	18.27511	14.98822	0	17.76183	0	10.64735	15.78389	16.33676	15.92894	13.34032	16.51995	16.03131	15.46127	15.56272	13.9515	16.12687	14.57019	16.36396	17.90945	11.33124	0	16.90522	17.66233	0	18.22022	0	17.58448	0	16.11114	16.94553	18.75885	17.3063	16.574	16.95988	16.61703	16.08987	14.44509	13.93531	8.149832	14.29411	18.15115	0
Q9H0V9	LMA2L_HUMAN	"VIP36-like protein (Lectin mannose-binding 2-like, LMAN2-like protein)"	LMAN2L VIPL PSEC0028 UNQ368/PRO704	Homo sapiens (Human)	endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein folding [GO:0006457]; protein transport [GO:0015031]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein folding [GO:0006457]; protein transport [GO:0015031]	mannose binding [GO:0005537]; metal ion binding [GO:0046872]	GO:0000139; GO:0005537; GO:0005789; GO:0005793; GO:0005794; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0015031; GO:0016021; GO:0030134; GO:0046872	HLTIMMDIDGK	4.190000057	1	1	2.37E-13	1306.754131	14.84793	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H0W5	CCDC8_HUMAN	Coiled-coil domain-containing protein 8	CCDC8	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; regulation of mitotic nuclear division [GO:0007088]	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; microtubule cytoskeleton organization [GO:0000226]; regulation of mitotic nuclear division [GO:0007088]		GO:0000226; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:1990393	VISKPATK	6.610000134	0.550064743	0.550064743	0.273061623	844.3194163	15.96797	0	0	15.94363	14.72144	14.41477	13.49865	0	16.10612	0	0	15.54805	0	17.14102	18.53679	0	0	17.31922	17.75682	15.66145	18.80821	17.62112	0	17.28378	17.95523	17.77566	18.44279	16.77245	11.34125	16.35007	16.47978	16.7847	15.0383	16.38298	17.38696	15.88088	18.93357	18.62912	14.38015	17.97475	16.41158	17.9872	16.99012	15.89064	18.29953	19.0224	18.99348	18.41108
Q9H0W8	SMG9_HUMAN	Nonsense-mediated mRNA decay factor SMG9	SMG9 C19orf61	Homo sapiens (Human)	"brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytosol [GO:0005829]	"cytosol [GO:0005829]; identical protein binding [GO:0042802]; brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	identical protein binding [GO:0042802]	GO:0000184; GO:0001654; GO:0001701; GO:0005829; GO:0007420; GO:0007507; GO:0042802	ERGGNQTSGIDFFITQER	6.28000021	0.160778835	0.160778835	0.330115923	2055.090679	0	13.59133	13.71155	15.75921	0	13.03393	16.46328	15.7805	0	14.79237	0	0	13.07457	0	0	6.732439	0	0	0	14.9147	0	0	0	0	15.89665	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H0X4	F234A_HUMAN	Protein FAM234A (Protein ITFG3)	FAM234A C16orf9 ITFG3	Homo sapiens (Human)		cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]		GO:0009986; GO:0016021; GO:0070062	VVRLGEGGPDSDQAIR	4.650000095	1	1	0.167319846	1668.362731	0	13.62334	0	0	0	13.892	0	0	14.78958	14.88315	14.45317	0	0	0	0	0	10.48284	12.08729	16.45253	0	14.55749	0	14.76772	0	0	0	0	0	15.47902	0	0	0	0	0	0	0	14.32767	15.11425	0	15.53777	14.21812	0	0	0	0	0	0	0
Q9H0Y0	ATG10_HUMAN	"Ubiquitin-like-conjugating enzyme ATG10, EC 2.3.2.- (Autophagy-related protein 10, APG10-like)"	ATG10 APG10L PP12616	Homo sapiens (Human)	autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]	cytosol [GO:0005829]	cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]	Atg12 transferase activity [GO:0019777]	GO:0005829; GO:0006497; GO:0006914; GO:0006983; GO:0015031; GO:0016236; GO:0019777; GO:0031401; GO:0032446	MEEDEFIGEKTFQR	7.480000019	1	1	0.329121194	1756.98659	15.4482	16.08127	16.59998	15.77356	0	14.86251	0	0	16.39693	0	0	14.26653	0	0	14.72296	0	0	0	0	14.26124	0	15.5056	16.13799	0	15.4295	15.59994	14.07611	0	0	13.69849	16.63158	0	13.45254	15.19838	14.99626	14.56317	16.34148	13.77204	0	14.89954	13.71427	6.690953	0	0	0	16.1577	15.49662	15.29762
Q9H114	CSTL1_HUMAN	Cystatin-like 1 (RCET11)	CSTL1	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]	cysteine-type endopeptidase inhibitor activity [GO:0004869]	GO:0004869; GO:0005576	SQMQLTTGVEYIVTVKIGWTK	2.700000048	1	1	1.84E-12	2399.007927	0	17.47472	14.69602	0	14.81452	0	0	0	0	0	0	16.36393	0	0	0	0	0	0	0	0	15.31632	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.3891	0	0	0	0	0	15.18566	0
Q9H116	GZF1_HUMAN	GDNF-inducible zinc finger protein 1 (Zinc finger and BTB domain-containing protein 23) (Zinc finger protein 336)	GZF1 ZBTB23 ZNF336	Homo sapiens (Human)	"branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001658; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0043565; GO:0045892; GO:0046872	ASNGMSSDLPPKK	6.480000019	1	1	0.454404845	1348.305455	0	0	0	0	17.29205	0	0	0	19.69785	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.78655	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H160	ING2_HUMAN	"Inhibitor of growth protein 2 (Inhibitor of growth 1-like protein, ING1Lp) (p32) (p33ING2)"	ING2 ING1L	Homo sapiens (Human)	"chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]"	CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]	"CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]	GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006325; GO:0006355; GO:0007141; GO:0007165; GO:0007283; GO:0007286; GO:0008285; GO:0016580; GO:0016602; GO:0030317; GO:0030336; GO:0030511; GO:0030512; GO:0031065; GO:0035064; GO:0035091; GO:0040008; GO:0044877; GO:0045893; GO:0046872; GO:0048133; GO:0072520; GO:1902166; GO:1902455; GO:1902459; GO:2000772; GO:2001020	AKMDSSQPER	2.480000019	1	1	0.121430816	1163.849215	0	0	0	0	12.26956	0	0	15.7031	14.0023	0	0	9.67966	15.37477	0	0	0	0	0	0	0	8.377573	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.50055	0	0	0	0	0	0	0	13.43899	0	9.840538
Q9H165	BC11A_HUMAN	"B-cell lymphoma/leukemia 11A, BCL-11A (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog, EVI-9) (Zinc finger protein 856)"	BCL11A CTIP1 EVI9 KIAA1809 ZNF856	Homo sapiens (Human)	cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; postsynaptic density [GO:0014069]; SWI/SNF complex [GO:0016514]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; postsynaptic density [GO:0014069]; SWI/SNF complex [GO:0016514]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription regulatory region nucleic acid binding [GO:0001067]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription regulatory region nucleic acid binding [GO:0001067]"	GO:0000122; GO:0000978; GO:0001067; GO:0001227; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016363; GO:0016514; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042382; GO:0042803; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:0140297; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173	VFKNCSNLTVHR	10.67000008	1	1	2.46E-13	1475.031423	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H172	ABCG4_HUMAN	"ATP-binding cassette sub-family G member 4, EC 7.6.2.-"	ABCG4 WHITE2	Homo sapiens (Human)	"cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of transcription, DNA-templated [GO:0006355]"	ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005524; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0016021; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0071403; GO:1990830	ALDVEDAK	1.090000033	1	1	0.199609689	860.9416962	0	15.68062	0	14.71664	0	14.65502	14.8651	14.7251	0	0	0	0	0	17.27331	13.45088	0	0	16.2414	0	13.75232	17.3351	0	0	0	0	0	15.88886	0	0	0	12.42949	0	0	16.47287	0	0	16.0475	17.88317	15.78138	0	16.7379	15.86762	0	0	17.63781	0	0	0
Q9H173	SIL1_HUMAN	"Nucleotide exchange factor SIL1 (BiP-associated protein, BAP)"	SIL1 UNQ545/PRO836	Homo sapiens (Human)	cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]	adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]	GO:0000774; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0006613; GO:0006886; GO:0042802; GO:0051082	LDINTNTYTSQDLKSALAK	7.21999979	0.971170723	0.971170723	0.101346554	2095.89743	0	0	0	15.66901	12.42557	0	0	0	0	0	0	0	14.50679	0	0	11.92928	12.79585	11.53314	0	0	0	0	0	0	0	11.88563	0	0	0	0	0	12.92172	17.10417	0	12.46179	15.2419	0	0	0	0	0	0	0	0	14.12481	0	0	0
Q9H175	CSRN2_HUMAN	"Cysteine/serine-rich nuclear protein 2, CSRNP-2 (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12, TAIP-12)"	CSRNP2 C12orf22 FAM130A1 TAIP12	Homo sapiens (Human)	apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]"	GO:0000785; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0019902; GO:0043565; GO:0045944	THYLHTIMKLELESK	8.199999809	1	1	3.20E-12	1859.305165	13.63206	10.70197	12.24531	13.01493	13.53862	11.34267	14.31274	14.21389	0	14.5528	12.02812	13.47748	16.23491	13.3421	16.38209	13.6079	0	15.35506	14.89346	0	0	16.46389	17.08965	0	0	14.33901	0	13.38195	13.93397	0	13.60275	0	0	0	0	0	0	13.14595	0	13.80426	14.65219	15.608	11.705	0	15.79069	0	0	14.24117
Q9H190	SDCB2_HUMAN	"Syntenin-2 (Similar to TACIP18, SITAC) (Syndecan-binding protein 2)"	SDCBP2 SITAC18	Homo sapiens (Human)	cell population proliferation [GO:0008283]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; nervous system development [GO:0007399]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; nervous system development [GO:0007399]"	"identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"	GO:0005546; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007399; GO:0008022; GO:0008283; GO:0016607; GO:0035556; GO:0042802; GO:0042803; GO:0046907; GO:0046982; GO:0070062	TVTMHK	6.980000019	0.284868926	0.284868926	0.225080622	715.726943	0	0	0	15.34362	0	14.75735	15.12701	14.10261	13.89902	16.05704	15.27638	15.08898	0	0	0	0	16.12565	17.17656	0	0	0	0	16.01222	16.47324	0	0	15.91219	0	0	0	0	0	0	0	17.72182	0	15.22621	17.79735	0	0	15.14899	14.04849	15.81628	15.04561	0	0	0	14.1454
Q9H1A4	APC1_HUMAN	"Anaphase-promoting complex subunit 1, APC1 (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein)"	ANAPC1 TSG24	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; molecular adaptor activity [GO:0060090]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	molecular adaptor activity [GO:0060090]	GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070979	LAPLLLGNPQPMVM	2.359999895	1	1	1.38E-12	1510.627092	0	0	0	0	14.40184	14.33894	14.65515	0	13.82803	14.30873	15.53511	12.92595	0	14.0503	0	0	0	15.65237	0	0	0	0	0	0	14.08651	15.26843	0	0	0	0	0	0	0	0	0	0	0	0	0	16.46193	0	0	0	0	0	0	15.56831	0
Q9H1A7	RPB1C_HUMAN	"DNA-directed RNA polymerase II subunit RPB11-b2, RNA polymerase II subunit B11-b2, RPB11b2 (DNA-directed RNA polymerase II subunit J3)"	POLR2J3	Homo sapiens (Human)		"RNA polymerase II, core complex [GO:0005665]"	"RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]"	DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]	GO:0001055; GO:0003677; GO:0005665; GO:0046983	VPNACLFTMNKEDHTLGNIIK	5.650000095	1	1	0.339464522	2431.970503	0	12.92719	0	14.43237	0	13.73551	14.07667	0	0	15.19523	0	15.12169	11.61789	0	12.79751	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.99532	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H1B5	XYLT2_HUMAN	"Xylosyltransferase 2, EC 2.4.2.26 (Peptide O-xylosyltransferase 1) (Xylosyltransferase II, XT-II, XylT-II)"	XYLT2 XT2 UNQ3058/PRO9878	Homo sapiens (Human)	chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]	extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158]	GO:0000139; GO:0000287; GO:0005615; GO:0006024; GO:0015012; GO:0016021; GO:0030145; GO:0030158; GO:0030203; GO:0030206; GO:0030210; GO:0050650	LSLHHAATAAPPMGTPLCRFEPR	3.119999886	1	1	0	2530.62354	11.57957	15.98624	14.61905	15.60595	0	0	0	0	15.56412	0	0	0	0	0	0	16.06866	0	0	0	0	16.90112	0	0	0	0	0	0	0	0	0	15.90755	0	0	0	0	15.3967	0	0	0	0	0	17.31955	0	0	0	0	0	0
Q9H1B7	I2BPL_HUMAN	"Probable E3 ubiquitin-protein ligase IRF2BPL, EC 2.3.2.27 (Enhanced at puberty protein 1) (Interferon regulatory factor 2-binding protein-like)"	IRF2BPL C14orf4 EAP1 KIAA1865 My039	Homo sapiens (Human)	development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]	GO:0000122; GO:0003714; GO:0005615; GO:0005634; GO:0005654; GO:0006357; GO:0007399; GO:0045944; GO:0046543; GO:0046872; GO:0061630	ASPEPPDSAEGALK	8.729999542	1	1	0.200704982	1369.794802	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H1C0	LPAR5_HUMAN	"Lysophosphatidic acid receptor 5, LPA receptor 5, LPA-5 (G-protein coupled receptor 92) (G-protein coupled receptor 93)"	LPAR5 GPR92 GPR93	Homo sapiens (Human)	behavioral response to pain [GO:0048266]; positive regulation of CREB transcription factor activity [GO:0032793]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; behavioral response to pain [GO:0048266]; positive regulation of CREB transcription factor activity [GO:0032793]	G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0016021; GO:0032793; GO:0048266	GLGTPHRAR	4.710000038	0.914154291	0.914154291	0.051748514	963.8730028	15.39855	0	0	14.70123	13.28864	14.51457	10.97896	0	14.61768	13.4326	14.70831	16.1291	0	15.52787	0	15.82345	13.08101	0	13.38784	16.07475	0	15.99156	13.25349	19.17022	0	15.38943	15.02195	14.35871	15.59797	13.51397	16.56946	16.41857	0	17.35141	14.01852	0	13.1052	17.01584	13.22694	16.11177	15.47782	14.34476	13.36382	0	17.51224	0	17.20313	14.90356
Q9H1C3	GL8D2_HUMAN	"Glycosyltransferase 8 domain-containing protein 2, EC 2.4.1.-"	GLT8D2 GALA4A UNQ1901/PRO4347	Homo sapiens (Human)		Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]	glycosyltransferase activity [GO:0016757]	GO:0005794; GO:0016021; GO:0016757	WIEHSK	5.820000172	0.028309584	0.028309584	0.219544859	799.1207729	16.49601	16.58575	0	15.52088	12.01095	14.56944	15.07868	0	15.58684	16.62771	0	0	16.17398	0	10.58976	15.27841	15.83722	13.79241	13.69703	13.06125	0	14.7612	16.0687	14.02287	0	0	15.03516	15.07495	15.5547	14.61045	0	0	0	0	0	0	0	0	16.03132	15.88748	15.42439	0	0	0	14.78457	0	0	0
Q9H1D0	TRPV6_HUMAN	"Transient receptor potential cation channel subfamily V member 6, TrpV6 (CaT-like, CaT-L) (Calcium transport protein 1, CaT1) (Epithelial calcium channel 2, ECaC2)"	TRPV6 ECAC2	Homo sapiens (Human)	calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592]	calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592]	calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]	GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0017158; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703	AQIVATTVMLERK	11.21000004	1	1	0.176194717	1473.145819	0	18.06448	14.98497	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H1D9	RPC6_HUMAN	"DNA-directed RNA polymerase III subunit RPC6, RNA polymerase III subunit C6 (DNA-directed RNA polymerase III subunit F) (RNA polymerase III 39 kDa subunit, RPC39)"	POLR3F	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383]	DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]	GO:0003690; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607	LLSMGQLDLLRSNTGLLYR	5.03000021	1	1	0.12556679	2180.317984	14.3709	14.10376	0	13.99103	10.99112	0	10.44418	0	12.8084	17.303	0	0	0	0	12.61873	14.81814	16.38981	0	14.39312	12.43923	0	0	0	0	0	0	0	12.22919	0	0	0	0	0	0	0	0	15.22897	0	0	0	0	0	0	0	0	0	13.0726	0
Q9H1H9	KI13A_HUMAN	Kinesin-like protein KIF13A (Kinesin-like protein RBKIN)	KIF13A RBKIN	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]	centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]	centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383	QPQSSGPDR	9.989999771	1	1	0.033757598	970.7811901	14.85335	13.86041	16.00016	15.35284	13.82914	13.79251	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H1I8	ASCC2_HUMAN	Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100)	ASCC2 ASC1P100 RQT3	Homo sapiens (Human)	"DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]"	activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin binding [GO:0043130]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]"	ubiquitin binding [GO:0043130]	GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0016607; GO:0043130; GO:0072344; GO:0099053; GO:1990116	TMADRK	6.010000229	1	1	0.124011235	737.6094845	0	15.12164	0	0	0	15.07835	12.64023	14.26988	0	16.49403	15.07565	14.67565	0	14.7444	0	15.62828	0	0	16.14955	0	0	0	0	0	0	0	0	0	0	0	16.3457	16.73162	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.50712	0
Q9H1J1	REN3A_HUMAN	"Regulator of nonsense transcripts 3A (Nonsense mRNA reducing factor 3A) (Up-frameshift suppressor 3 homolog A, hUpf3)"	UPF3A RENT3A UPF3	Homo sapiens (Human)	"mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]"	RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0017056; GO:0035145; GO:0042162; GO:0043231; GO:0045727; GO:0051028	AYINFRNPDDILLFR	15.51000023	0.690544188	0.690544188	0.079651708	1866.815202	0	15.34391	0	0	0	0	0	17.85833	14.73273	14.18251	15.86353	14.50844	0	0	13.96125	15.07193	0	0	15.40118	0	14.60758	0	15.63945	0	0	17.3193	0	14.94723	0	0	15.67571	13.77767	0	0	0	0	0	0	0	15.08359	16.35606	0	0	14.79403	0	0	15.7961	14.92414
Q9H1J7	WNT5B_HUMAN	Protein Wnt-5b	WNT5B	Homo sapiens (Human)	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fat cell differentiation [GO:0045444]; lens fiber cell development [GO:0070307]; muscle cell differentiation [GO:0042692]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; wound healing [GO:0042060]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fat cell differentiation [GO:0045444]; lens fiber cell development [GO:0070307]; muscle cell differentiation [GO:0042692]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; wound healing [GO:0042060]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]	GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0030182; GO:0030335; GO:0030666; GO:0042060; GO:0042692; GO:0045165; GO:0045444; GO:0060070; GO:0070062; GO:0070307; GO:0071300; GO:1904105; GO:2000052	TSEGMDGCELMCCGR	6.630000114	0.874397159	0.874397159	0.653382028	1758.687171	0	0	0	0	0	0	0	0	17.82404	0	19.76508	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.8727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H1K4	GHC2_HUMAN	"Mitochondrial glutamate carrier 2, GC-2 (Glutamate/H(+) symporter 2) (Solute carrier family 25 member 18)"	SLC25A18 GC2	Homo sapiens (Human)	aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]	amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]	GO:0005280; GO:0005313; GO:0005743; GO:0006811; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0043490	ASFAHSFVSGCVAGSIAAVAVTPLDVLK	3.75999999	1	1	3.66E-12	2775.031356	0	0	13.06017	0	0	0	0	13.10537	0	0	0	14.33302	14.51704	0	0	0	14.9578	0	14.77143	0	14.1938	14.99013	15.27362	16.12513	0	11.03689	0	0	13.80082	15.39141	15.53239	0	16.22072	13.76073	0	0	0	0	0	14.51922	0	15.9146	14.05031	0	14.84367	0	0	0
Q9H1R2	DUS15_HUMAN	"Dual specificity protein phosphatase 15, EC 3.1.3.16, EC 3.1.3.48 (VH1-related member Y) (Vaccinia virus VH1-related dual-specific protein phosphatase Y)"	DUSP15 C20orf57 VHY	Homo sapiens (Human)	dephosphorylation [GO:0016311]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; regulation of oligodendrocyte differentiation [GO:0048713]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; regulation of oligodendrocyte differentiation [GO:0048713]; transforming growth factor beta receptor signaling pathway [GO:0007179]	phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0004722; GO:0004725; GO:0005829; GO:0005886; GO:0007179; GO:0008138; GO:0016311; GO:0016791; GO:0042127; GO:0046330; GO:0048713	EATGRTAQR	8.239999771	1	1	0.144869505	991.4871156	0	12.26747	15.42136	0	14.22795	0	13.8368	15.05502	0	15.69982	0	0	0	14.17779	12.85559	0	14.51492	0	15.0463	15.88781	15.07254	0	0	0	14.99767	14.81508	0	14.20464	16.17645	15.42445	12.95922	14.31463	0	0	8.467731	0	13.84549	16.13758	0	13.71456	12.14535	13.60447	0	0	0	0	0	13.4807
Q9H1R3	MYLK2_HUMAN	"Myosin light chain kinase 2, skeletal/cardiac muscle, MLCK2, EC 2.7.11.18"	MYLK2	Homo sapiens (Human)	cardiac muscle contraction [GO:0060048]; cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of muscle filament sliding [GO:0032971]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; synapse [GO:0045202]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; synapse [GO:0045202]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687]; cardiac muscle contraction [GO:0060048]; cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of muscle filament sliding [GO:0032971]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687]	GO:0004683; GO:0004687; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006941; GO:0007274; GO:0010628; GO:0014816; GO:0018107; GO:0030017; GO:0032027; GO:0032971; GO:0035914; GO:0045202; GO:0046777; GO:0055008; GO:0060048	KISSSGALMALGV	10.21000004	1	1	0.041418521	1249.014861	0	0	0	0	0	15.15887	12.93111	15.83158	15.20975	15.92642	16.64548	17.62223	14.95251	0	18.90784	16.78766	16.19293	15.70187	0	12.76342	17.39785	0	0	15.1684	14.72714	0	0	0	0	0	0	17.91963	0	0	12.28081	16.4364	0	16.89609	16.18886	0	0	0	17.08979	0	14.10012	0	16.54632	0
Q9H1U9	S2551_HUMAN	Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51)	SLC25A51 MCART1	Homo sapiens (Human)	aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD transmembrane transporter activity [GO:0051724]; aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549]	NAD transmembrane transporter activity [GO:0051724]	GO:0005739; GO:0005743; GO:0016021; GO:0019646; GO:0051724; GO:1990549	KLINLFR	27.20999908	0.44640258	0.44640258	0.121819576	902.9543308	16.88802	17.99907	17.48167	17.45041	17.53748	18.7892	17.67192	18.95832	17.33355	16.20312	18.0891	19.12809	17.11414	15.553	0	18.76184	0	22.25785	16.56961	16.40319	0	14.95687	18.15185	17.72357	18.20272	14.24952	20.2333	17.35037	23.72417	18.10652	19.70723	19.66617	16.80838	19.78578	17.37875	20.48249	17.89869	17.80889	17.87788	16.02909	18.16017	19.67735	17.70824	15.87437	18.64359	0	14.27794	22.72392
Q9H1X1	RSPH9_HUMAN	Radial spoke head protein 9 homolog	RSPH9 C6orf206 MRPS18AL1	Homo sapiens (Human)	axonemal central apparatus assembly [GO:1904158]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]; radial spoke assembly [GO:0062177]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; kinocilium [GO:0060091]; motile cilium [GO:0031514]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]; radial spoke assembly [GO:0062177]		GO:0003341; GO:0005930; GO:0031514; GO:0035082; GO:0044458; GO:0060091; GO:0060294; GO:0062177; GO:0097729; GO:1904158	VNEGEK	14.57999992	3.32E-06	3.32E-06	0.25195628	674.1039996	20.65605	20.52758	18.1935	16.15888	0	20.34824	19.34332	18.70576	17.29583	19.96032	20.59048	0	0	0	18.45887	21.80714	17.28886	20.99034	20.21926	0	20.07142	20.87279	21.32685	19.28791	21.54696	20.17049	20.41895	20.98436	0	20.76389	18.85024	0	0	21.57589	21.19347	21.39755	20.58323	20.24975	20.0321	19.82789	18.85635	18.78556	20.16923	19.17173	21.16659	0	17.71118	0
Q9H1Y0	ATG5_HUMAN	Autophagy protein 5 (APG5-like) (Apoptosis-specific protein)	ATG5 APG5L ASP	Homo sapiens (Human)	aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chaperone-mediated autophagy [GO:0061684]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of defense response to virus [GO:0050687]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]	Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chaperone-mediated autophagy [GO:0061684]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of defense response to virus [GO:0050687]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015]		GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006915; GO:0006995; GO:0009410; GO:0009620; GO:0010040; GO:0016020; GO:0016236; GO:0019883; GO:0030424; GO:0030670; GO:0031397; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0043066; GO:0043687; GO:0044233; GO:0044804; GO:0045060; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0055015; GO:0060047; GO:0060548; GO:0061684; GO:0061739; GO:0070257; GO:0071500; GO:1901096; GO:1902017; GO:1902617; GO:1904973; GO:2000378; GO:2000619	SFPEKDLLHCPSK	12.13000011	1	1	0.292589365	1557.366696	0	0	16.80527	0	17.16171	0	16.95651	0	18.33031	0	0	16.23516	15.29762	0	0	0	0	0	0	0	0	0	0	0	0	15.62737	0	0	0	0	16.47423	0	0	0	20.04713	0	0	0	0	0	0	0	0	16.53875	0	0	16.51071	0
Q9H201	EPN3_HUMAN	Epsin-3 (EPS-15-interacting protein 3)	EPN3	Homo sapiens (Human)	endocytosis [GO:0006897]	clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; EH domain binding [GO:1990175]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897]	clathrin binding [GO:0030276]; EH domain binding [GO:1990175]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005905; GO:0006897; GO:0019897; GO:0030125; GO:0030136; GO:0030276; GO:0043231; GO:0048471; GO:0070062; GO:1990175	SWQGDGSPMANGAGAVVHHQRDR	2.720000029	1	1	0.126862591	2448.461627	15.68393	15.01586	14.72465	0	0	14.88717	14.28961	0	15.25872	15.48773	0	13.6718	14.86213	0	0	14.11593	0	0	14.59422	0	0	0	15.68574	0	12.41987	0	0	0	0	0	0	17.02674	0	0	15.46782	0	15.81285	0	0	0	0	14.5258	16.06592	0	14.29202	0	0	0
Q9H221	ABCG8_HUMAN	"ATP-binding cassette sub-family G member 8, EC 7.6.2.- (Sterolin-2)"	ABCG8	Homo sapiens (Human)	bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; triglyceride homeostasis [GO:0070328]	apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; triglyceride homeostasis [GO:0070328]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]	GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0009410; GO:0010949; GO:0014850; GO:0015914; GO:0015918; GO:0016324; GO:0030299; GO:0033344; GO:0038183; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046872; GO:0046982; GO:0070328; GO:0120020; GO:0140359	VRSGQMLAIIGSSGCGR	4.670000076	1	1	2.31E-13	1765.80903	15.12493	9.634257	14.67983	13.377	11.19189	14.44883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H222	ABCG5_HUMAN	"ATP-binding cassette sub-family G member 5, EC 7.6.2.- (Sterolin-1)"	ABCG5	Homo sapiens (Human)	bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; triglyceride homeostasis [GO:0070328]	apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; triglyceride homeostasis [GO:0070328]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]	GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0009410; GO:0010212; GO:0010949; GO:0014850; GO:0015918; GO:0016324; GO:0030299; GO:0033344; GO:0038183; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046872; GO:0046982; GO:0070328; GO:0120020; GO:0140359	RGNPGSFQK	5.079999924	1	1	0.20006019	990.4394643	0	0	18.08224	0	18.39827	0	19.45244	0	0	18.5954	0	0	0	0	0	0	18.4125	0	0	0	0	0	0	18.74948	0	0	0	16.13296	0	0	0	20.65349	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H237	PORCN_HUMAN	"Protein-serine O-palmitoleoyltransferase porcupine, EC 2.3.1.250 (Protein MG61)"	PORCN MG61 PORC PPN	Homo sapiens (Human)	canonical Wnt signaling pathway [GO:0060070]; glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; protein palmitoylation [GO:0018345]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055]	AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; acyltransferase activity [GO:0016746]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; protein palmitoylation [GO:0018345]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055]	acyltransferase activity [GO:0016746]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147]	GO:0005783; GO:0005789; GO:0006497; GO:0009100; GO:0016020; GO:0016055; GO:0016746; GO:0017147; GO:0018345; GO:0030176; GO:0030258; GO:0032281; GO:0045234; GO:0060070; GO:0061355; GO:0098978; GO:0099072; GO:1990698	ARGTMVR	9.029999733	1	1	0.068893906	807.6178298	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.16149	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H239	MMP28_HUMAN	"Matrix metalloproteinase-28, MMP-28, EC 3.4.24.- (Epilysin)"	MMP28 MMP25 UNQ1893/PRO4339	Homo sapiens (Human)	collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of macrophage chemotaxis [GO:0010760]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of macrophage chemotaxis [GO:0010760]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005615; GO:0005737; GO:0008270; GO:0010760; GO:0030198; GO:0030574; GO:0031012; GO:0062023	LQATTSGR	2.059999943	1	1	0.197612804	834.4540412	0	15.93919	15.94127	0	0	14.63639	16.34668	0	0	0	15.79431	16.1297	0	15.98402	0	15.0316	13.34277	14.79221	14.37712	0	15.99968	0	0	16.90726	16.99317	0	0	0	16.93073	16.46603	15.16207	16.47032	17.16808	0	16.44202	15.16237	15.59248	16.2537	14.48672	14.56152	16.03119	14.21036	14.92857	14.72452	14.60457	14.02959	15.95197	15.62975
Q9H251	CAD23_HUMAN	Cadherin-23 (Otocadherin)	CDH23 KIAA1774 KIAA1812 UNQ1894/PRO4340	Homo sapiens (Human)	auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]	catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0001917; GO:0005509; GO:0005813; GO:0006816; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0045296; GO:0045494; GO:0048563; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0098683; GO:0098684; GO:0098742	DAYVGALR	9.890000343	0.352170259	0.352170259	0.198622158	864.0825178	13.88221	13.92824	14.45699	16.60576	14.87474	14.33047	14.92056	14.95006	0	15.14051	14.99735	16.26744	0	0	0	0	14.58307	0	0	0	0	0	0	0	0	17.14864	0	13.56604	13.41364	0	0	17.04358	0	0	0	15.69692	0	16.26485	0	11.08083	0	14.49283	14.60047	0	16.46012	15.47107	0	0
Q9H254	SPTN4_HUMAN	"Spectrin beta chain, non-erythrocytic 4 (Beta-IV spectrin) (Spectrin, non-erythroid beta chain 3)"	SPTBN4 KIAA1642 SPTBN3	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult walking behavior [GO:0007628]; axonogenesis [GO:0007409]; cardiac conduction [GO:0061337]; central nervous system projection neuron axonogenesis [GO:0021952]; clustering of voltage-gated sodium channels [GO:0045162]; fertilization [GO:0009566]; negative regulation of heart rate [GO:0010459]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to plasma membrane [GO:0072659]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of sodium ion transport [GO:0002028]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]; vesicle-mediated transport [GO:0016192]	actin filament [GO:0005884]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; cell body fiber [GO:0070852]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear matrix [GO:0016363]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spectrin [GO:0008091]	actin filament [GO:0005884]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; cell body fiber [GO:0070852]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear matrix [GO:0016363]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein-membrane anchor activity [GO:0106006]; phosphatase binding [GO:0019902]; phospholipid binding [GO:0005543]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult walking behavior [GO:0007628]; axonogenesis [GO:0007409]; cardiac conduction [GO:0061337]; central nervous system projection neuron axonogenesis [GO:0021952]; clustering of voltage-gated sodium channels [GO:0045162]; fertilization [GO:0009566]; negative regulation of heart rate [GO:0010459]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to plasma membrane [GO:0072659]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of sodium ion transport [GO:0002028]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]; vesicle-mediated transport [GO:0016192]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein-membrane anchor activity [GO:0106006]; phosphatase binding [GO:0019902]; phospholipid binding [GO:0005543]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]	GO:0002028; GO:0003779; GO:0005200; GO:0005543; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0007409; GO:0007605; GO:0007628; GO:0008091; GO:0009566; GO:0010459; GO:0014704; GO:0016020; GO:0016192; GO:0016363; GO:0016605; GO:0019226; GO:0019902; GO:0021952; GO:0030036; GO:0030054; GO:0030506; GO:0030507; GO:0030864; GO:0033135; GO:0033268; GO:0033270; GO:0040018; GO:0042995; GO:0043025; GO:0043194; GO:0043203; GO:0045162; GO:0051015; GO:0051693; GO:0061337; GO:0070062; GO:0070852; GO:0072659; GO:0106006	AEELPR	13.81000042	1	1	0.25565547	713.7066182	17.72709	16.34432	13.70852	0	16.30834	15.70607	0	0	0	0	0	0	17.70743	16.65168	0	0	16.94424	16.40064	16.97254	0	16.24788	0	17.81187	0	18.38654	18.15493	17.65232	17.6123	16.18961	0	19.003	0	20.77873	17.88274	17.31119	18.35926	0	17.67775	0	0	0	0	16.03751	18.05418	18.27921	0	17.16416	0
Q9H267	VP33B_HUMAN	"Vacuolar protein sorting-associated protein 33B, hVPS33B"	VPS33B	Homo sapiens (Human)	collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; vacuole [GO:0005773]; vesicle tethering complex [GO:0099023]	clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; vacuole [GO:0005773]; vesicle tethering complex [GO:0099023]; protein-containing complex binding [GO:0044877]; collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	protein-containing complex binding [GO:0044877]	GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005773; GO:0005794; GO:0005829; GO:0006886; GO:0007032; GO:0015031; GO:0016192; GO:0017185; GO:0030136; GO:0030897; GO:0031091; GO:0031901; GO:0031902; GO:0032400; GO:0032418; GO:0032963; GO:0033263; GO:0044877; GO:0046907; GO:0048471; GO:0055037; GO:0061025; GO:0070889; GO:0090385; GO:0099023	VLLNAEDK	8.449999809	0.305293947	0.305293947	0.300171532	902.8834807	15.28268	14.46657	0	0	14.78974	0	15.06365	16.72574	14.9505	0	0	0	15.27087	0	14.31025	15.1299	15.73178	15.13321	0	15.88883	0	0	15.99484	16.59138	0	0	0	16.02419	0	0	15.48137	0	16.42686	0	0	0	0	0	0	15.4833	15.27461	0	0	0	0	0	15.65736	15.78737
Q9H269	VPS16_HUMAN	"Vacuolar protein sorting-associated protein 16 homolog, hVPS16"	VPS16	Homo sapiens (Human)	"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]"	autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]	"autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]"	actin binding [GO:0003779]; actin filament binding [GO:0051015]	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0043025; GO:0051015; GO:0055037; GO:0097352	ASYAAEER	16.61000061	1	1	5.74E-13	895.8318718	0	0	0	0	0	0	0	13.95673	0	0	0	0	0	0	0	0	0	0	18.19853	0	0	0	13.88566	0	0	0	0	13.73385	6.030576	0	13.50536	18.12924	0	0	0	0	0	0	0	12.95613	0	0	13.42368	0	12.03305	0	0	10.44634
Q9H270	VPS11_HUMAN	"Vacuolar protein sorting-associated protein 11 homolog, hVPS11 (RING finger protein 108)"	VPS11 RNF108 PP3476	Homo sapiens (Human)	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]	metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]	GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0016567; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031647; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0035542; GO:0046872; GO:0048284; GO:0061630; GO:1902115; GO:1903364; GO:1903955; GO:2000643	HSKTQILHK	8.710000038	1	1	0.123447237	1092.210794	15.80563	13.71788	11.23163	12.63871	13.95448	12.79784	15.63452	15.43095	12.70741	11.58682	8.531808	14.11465	0	14.20412	11.09117	11.67978	14.17742	14.60481	11.751	13.73637	12.04197	14.97043	0	11.85701	0	0	0	15.59152	0	14.31869	14.33886	13.8619	0	0	0	12.91393	0	0	0	0	0	0	0	0	0	0	0	0
Q9H295	DCSTP_HUMAN	"Dendritic cell-specific transmembrane protein, DC-STAMP, hDC-STAMP (Dendrocyte-expressed seven transmembrane protein) (IL-four-induced protein, FIND) (Transmembrane 7 superfamily member 4)"	DCSTAMP TM7SF4	Homo sapiens (Human)	cellular response to interleukin-4 [GO:0071353]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to tumor necrosis factor [GO:0071356]; membrane fusion [GO:0061025]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell growth [GO:0030308]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of bone resorption [GO:0045780]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of monocyte differentiation [GO:0045657]	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellular response to interleukin-4 [GO:0071353]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to tumor necrosis factor [GO:0071356]; membrane fusion [GO:0061025]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell growth [GO:0030308]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of bone resorption [GO:0045780]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of monocyte differentiation [GO:0045657]		GO:0005789; GO:0005886; GO:0009986; GO:0010008; GO:0016021; GO:0030176; GO:0030308; GO:0030316; GO:0033116; GO:0034241; GO:0036006; GO:0043011; GO:0045657; GO:0045780; GO:0061025; GO:0071353; GO:0071356; GO:0072675	QMDMASADKS	6.829999924	1	1	4.60E-13	1102.75075	13.91443	13.60156	13.06237	11.74653	0	14.32401	12.36652	15.22499	0	0	15.9511	0	15.77792	16.17729	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H299	SH3L3_HUMAN	"SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-binding protein 1, SH3BP-1)"	SH3BGRL3 P1725	Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]		GO:0005737; GO:0016604; GO:0070062	ALAGNPK	18.45999908	1	1	0.269429255	670.7981104	0	0	0	0	15.98716	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.11476	0	0	0	0	0	0	0	0	0	0	18.91438	0	0	0	0	0	18.22527	16.82181	0	15.78841	0	0
Q9H2A9	CHST8_HUMAN	"Carbohydrate sulfotransferase 8, EC 2.8.2.- (GalNAc-4-O-sulfotransferase 1, GalNAc-4-ST1, GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)"	CHST8	Homo sapiens (Human)	carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0006790; GO:0007417; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0042446	FESMEDDANFFLSLIRAPR	8.18999958	1	1	0	2258.446069	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.69754	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H2C0	GAN_HUMAN	Gigaxonin (Kelch-like protein 16)	GAN GAN1 KLHL16	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567]		GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463	AEGSAVSDPQHAAR	6.050000191	1	1	0.314545312	1396.17439	15.78933	15.41755	13.3872	0	0	0	0	0	15.68233	0	15.71229	0	14.5027	0	0	16.38633	0	14.13703	0	16.35497	0	0	0	14.61188	13.66355	16.69263	15.87398	16.55815	15.90226	0	15.08344	15.74908	15.69104	16.21213	0	16.60589	0	0	18.10577	16.82323	17.32988	0	14.99699	0	17.47548	0	0	0
Q9H2C2	ARV1_HUMAN	"Protein ARV1, hARV1"	ARV1 HT035	Homo sapiens (Human)	bile acid metabolic process [GO:0008206]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular sterol transport [GO:0032366]; regulation of cholesterol metabolic process [GO:0090181]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; sterol transporter activity [GO:0015248]; bile acid metabolic process [GO:0008206]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular sterol transport [GO:0032366]; regulation of cholesterol metabolic process [GO:0090181]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125]	sterol transporter activity [GO:0015248]	GO:0005789; GO:0005794; GO:0006665; GO:0006695; GO:0008206; GO:0015248; GO:0016021; GO:0016125; GO:0030301; GO:0032366; GO:0032383; GO:0032541; GO:0090181; GO:0097036	MGNGGRSGLQQGK	8.350000381	1	1	0.145467374	1290.392852	13.65358	0	0	0	0	13.48789	0	13.83049	14.55707	0	0	0	0	16.8551	0	0	0	0	0	0	16.67032	0	0	0	15.27012	0	0	0	0	0	13.86097	0	0	16.56762	0	14.3996	0	0	0	0	0	0	0	0	0	0	0	0
Q9H2D6	TARA_HUMAN	TRIO and F-actin-binding protein (Protein Tara) (Trio-associated repeat on actin)	TRIOBP KIAA1662 TARA HRIHFB2122	Homo sapiens (Human)	actin filament organization [GO:0007015]; actin modification [GO:0030047]; auditory receptor cell stereocilium organization [GO:0060088]; barbed-end actin filament capping [GO:0051016]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; sensory perception of sound [GO:0007605]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; stereocilium base [GO:0120044]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; stereocilium base [GO:0120044]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; actin modification [GO:0030047]; auditory receptor cell stereocilium organization [GO:0060088]; barbed-end actin filament capping [GO:0051016]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; sensory perception of sound [GO:0007605]	actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]	GO:0005634; GO:0005737; GO:0005815; GO:0005925; GO:0007015; GO:0007049; GO:0007605; GO:0015629; GO:0030047; GO:0030496; GO:0031267; GO:0031625; GO:0045159; GO:0051015; GO:0051016; GO:0051301; GO:0060088; GO:0120044; GO:1900026	DDPRASSPNR	6.739999771	0.433170378	0.433170378	0.197304948	1115.285787	0	6.231592	15.77168	16.20981	0	16.35091	15.07489	13.84396	13.29191	14.91353	0	0	0	0	15.08128	0	0	14.7327	0	0	0	0	0	0	0	0	15.44455	0	0	0	0	0	0	13.83247	0	0	0	0	0	0	0	0	0	0	13.92594	0	0	0
Q9H2E6	SEM6A_HUMAN	"Semaphorin-6A (Semaphorin VIA, Sema VIA) (Semaphorin-6A-1, SEMA6A-1)"	SEMA6A KIAA1368 SEMAQ	Homo sapiens (Human)	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytoskeleton organization [GO:0007010]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron migration [GO:2001224]; semaphorin-plexin signaling pathway [GO:0071526]	axon [GO:0030424]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	axon [GO:0030424]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytoskeleton organization [GO:0007010]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron migration [GO:2001224]; semaphorin-plexin signaling pathway [GO:0071526]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0005615; GO:0005887; GO:0006915; GO:0007010; GO:0007166; GO:0007399; GO:0007411; GO:0009887; GO:0016021; GO:0016525; GO:0030215; GO:0030335; GO:0030424; GO:0035924; GO:0045499; GO:0048843; GO:0050919; GO:0070373; GO:0071526; GO:0106089; GO:1900747; GO:1903671; GO:2001224	HLLDSPDSTDPLGAVSSHNHQDKK	3.809999943	0.267268091	0.267268091	0.040397846	2597.89282	16.98957	14.21322	15.04018	16.16522	0	0	10.9209	15.54324	0	0	15.83959	16.40068	14.94078	15.57723	13.23699	0	0	14.14249	0	0	11.0257	16.43146	0	14.54462	17.12484	0	0	0	17.6533	0	16.88713	18.56283	16.20156	17.15267	16.88341	15.59833	16.03635	0	16.1681	14.61509	14.64191	17.10015	17.08924	0	14.45416	17.20997	15.9249	14.86996
Q9H2F9	CCD68_HUMAN	"Coiled-coil domain-containing protein 68 (Cutaneous T-cell lymphoma-associated antigen se57-1, CTCL-associated antigen se57-1)"	CCDC68	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; microtubule anchoring at centrosome [GO:0034454]; protein localization [GO:0008104]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; cytoplasm [GO:0005737]	centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; microtubule anchoring at centrosome [GO:0034454]; protein localization [GO:0008104]		GO:0005737; GO:0005814; GO:0008104; GO:0034454; GO:0035556; GO:0120103	TEGVSPYLMLIR	26.72999954	0.440874696	0.440874696	0.131402718	1394.571363	0	0	18.33469	0	18.55191	0	0	0	15.79752	0	0	18.56637	0	0	16.25778	0	16.91885	0	0	17.25892	19.72427	19.3913	0	15.62916	15.01206	15.94761	16.97066	0	14.61721	12.71055	0	18.89117	19.09364	14.69553	14.15099	17.87745	16.96517	0	0	17.12785	14.97499	15.21805	11.55114	15.11336	0	0	12.97904	16.40754
Q9H2G2	SLK_HUMAN	"STE20-like serine/threonine-protein kinase, STE20-like kinase, hSLK, EC 2.7.11.1 (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase, STE20-related kinase) (Serine/threonine-protein kinase 2)"	SLK KIAA0204 STK2	Homo sapiens (Human)	apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006915; GO:0030334; GO:0031122; GO:0031252; GO:0042802; GO:0042803; GO:0042981; GO:0045296; GO:0046777; GO:0048471; GO:0051893; GO:0070062; GO:0106310	TAVIKENER	6.869999886	1	1	0.004195125	1055.851388	0	15.86507	14.75857	0	12.97826	0	0	15.17554	13.83683	0	0	15.19284	0	0	14.27202	15.0004	0	0	13.82349	0	0	15.53509	0	10.6059	14.37212	12.1517	0	0	14.80717	0	14.86895	13.81091	13.21362	0	0	0	16.95764	0	0	0	0	15.79288	0	15.8726	0	0	0	14.36182
Q9H2G4	TSYL2_HUMAN	"Testis-specific Y-encoded-like protein 2, TSPY-like protein 2 (Cell division autoantigen 1) (Cutaneous T-cell lymphoma-associated antigen se20-4, CTCL-associated antigen se20-4) (Differentially-expressed nucleolar TGF-beta1 target protein) (Nuclear protein of 79 kDa, NP79)"	TSPYL2 CDA1 DENTT TSPX HRIHFB2216	Homo sapiens (Human)	cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA replication [GO:0008156]; nucleosome assembly [GO:0006334]; regulation of protein kinase activity [GO:0045859]; regulation of signal transduction [GO:0009966]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; rDNA binding [GO:0000182]; cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA replication [GO:0008156]; nucleosome assembly [GO:0006334]; regulation of protein kinase activity [GO:0045859]; regulation of signal transduction [GO:0009966]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; rDNA binding [GO:0000182]	GO:0000182; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006334; GO:0007049; GO:0008156; GO:0009966; GO:0030308; GO:0042393; GO:0045786; GO:0045859	DEDIFR	10.22000027	1	1	0.209960934	795.1532206	11.82901	14.71	12.25107	16.21786	13.30218	14.95388	0	15.52321	0	7.76032	0	0	0	0	16.83461	15.08482	16.02701	15.98574	16.26155	0	0	14.09504	17.77158	0	0	16.12163	0	16.34091	0	17.08847	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6518	0
Q9H2G9	GO45_HUMAN	Golgin-45 (Basic leucine zipper nuclear factor 1) (JEM-1) (p45 basic leucine-zipper nuclear factor)	BLZF1 JEM1	Homo sapiens (Human)	Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]	enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]	GO:0000139; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005801; GO:0007030; GO:0019899; GO:0031625; GO:0043001	AAITHDIPNK	1.669999957	0.985527337	0.985527337	0.248616618	1079.809652	0	11.77992	16.24847	0	0	15.57358	0	0	0	0	0	15.05353	15.30875	0	0	0	15.48563	0	0	0	0	0	14.88043	0	0	0	0	0	0	0	0	15.04763	0	0	16.42612	0	0	0	0	0	14.20949	0	0	0	0	16.84679	14.54075	13.95211
Q9H2H8	PPIL3_HUMAN	"Peptidyl-prolyl cis-trans isomerase-like 3, PPIase, EC 5.2.1.8 (Cyclophilin J, CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3)"	PPIL3	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	catalytic step 2 spliceosome [GO:0071013]	"catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000398; GO:0000413; GO:0003755; GO:0006457; GO:0071013	GGNSIWGK	6.03000021	0.396184176	0.396184176	0.057425758	819.1908141	17.86988	0	14.45874	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.33507	17.3197	0	0	0	0	0	0	15.0556	0	0	0	0	0	0	12.39747	0	0
Q9H2I8	LRMDA_HUMAN	Leucine-rich melanocyte differentiation-associated protein	LRMDA C10orf11 CDA017	Homo sapiens (Human)	melanocyte differentiation [GO:0030318]		melanocyte differentiation [GO:0030318]		GO:0030318	EKYLSLSGNHSSNK	6.96999979	1	1	0.463543368	1564.026457	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.73804	16.97883	0	0	18.06113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H2J4	PDCL3_HUMAN	"Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1, VIAF-1)"	PDCL3 PhLP2A VIAF1	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]; protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	GO:0001525; GO:0001938; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006915; GO:0010628; GO:0030036; GO:0032991; GO:0043184; GO:0044183; GO:0045766; GO:0048471; GO:0050730; GO:0050821; GO:0061077; GO:0097356; GO:1903645; GO:2000059	GILPPK	6.510000229	1	1	0.093612629	623.8054376	0	16.12813	15.75522	11.94875	15.3989	15.10789	14.73857	14.1704	0	11.55506	13.28779	14.45503	0	14.64529	0	0	0	0	0	0	15.66651	0	0	0	0	15.98272	0	14.81414	15.56163	0	0	0	0	0	0	0	0	0	0	0	0	0	16.09698	0	0	0	0	0
Q9H2K0	IF3M_HUMAN	"Translation initiation factor IF-3, mitochondrial, IF-3(Mt), IF-3Mt, IF3(mt), IF3mt"	MTIF3 DC38	Homo sapiens (Human)	mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]	mitochondrion [GO:0005739]	"mitochondrion [GO:0005739]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]"	"ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]"	GO:0003743; GO:0005739; GO:0008135; GO:0032790; GO:0043022; GO:0043024; GO:0070124	DHGNDK	8.720000267	1	1	0.296537229	685.8449869	0	14.38284	15.71268	14.14389	0	14.66106	15.06956	15.18949	13.96458	15.43588	15.82119	15.67616	0	14.90864	0	16.27696	15.29981	16.08136	15.20921	16.20754	16.83458	15.89344	12.92636	16.99006	0	15.01788	15.46716	18.14396	16.46139	15.89618	15.71295	16.1078	14.28862	0	14.81192	16.259	16.1629	0	15.27345	0	16.44631	0	15.31596	15.12485	16.99866	15.74153	16.91328	17.02626
Q9H2K2	TNKS2_HUMAN	"Poly [ADP-ribose] polymerase tankyrase-2, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 6, ARTD6) (Poly [ADP-ribose] polymerase 5B) (Protein poly-ADP-ribosyltransferase tankyrase-2, EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2, TANK2) (Tankyrase-like protein) (Tankyrase-related protein)"	TNKS2 PARP5B TANK2 TNKL	Homo sapiens (Human)	"multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]"	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein N-terminus binding [GO:0047485]	GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006471; GO:0016055; GO:0019899; GO:0032212; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404	TQLCALLLAHGADPTLK	2.170000076	1	1	0.322666017	1822.15437	12.46302	0	0	13.52923	15.1392	0	11.89861	15.14809	0	0	15.54774	0	0	11.91373	0	12.91203	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H2K8	TAOK3_HUMAN	"Serine/threonine-protein kinase TAO3, EC 2.7.11.1 (Cutaneous T-cell lymphoma-associated antigen HD-CL-09, CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A, hKFC-A) (Thousand and one amino acid protein 3)"	TAOK3 DPK JIK KDS MAP3K18	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transferase activity [GO:0016740]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408]	ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transferase activity [GO:0016740]	GO:0000165; GO:0004674; GO:0004712; GO:0004860; GO:0005524; GO:0005737; GO:0005886; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0016740; GO:0032874; GO:0035556; GO:0043408; GO:0043507; GO:0046329; GO:0046330; GO:0046777; GO:0048812; GO:0106310	EAKVAAADEK	6.900000095	1	1	0.217189863	1030.281081	13.41381	0	15.91952	14.82554	15.19307	14.63597	16.26683	0	11.3605	14.39085	0	16.10136	0	15.15119	0	0	15.4984	13.83261	0	0	14.67436	0	16.14825	15.34282	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.36696	0	0	0	0	0	0	0	0
Q9H2M3	BHMT2_HUMAN	"S-methylmethionine--homocysteine S-methyltransferase BHMT2, SMM-hcy methyltransferase, EC 2.1.1.10 (Betaine--homocysteine S-methyltransferase 2)"	BHMT2	Homo sapiens (Human)	L-methionine salvage [GO:0071267]; methylation [GO:0032259]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270]; L-methionine salvage [GO:0071267]; methylation [GO:0032259]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477]	S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0032259; GO:0033477; GO:0046500; GO:0061627; GO:0070062; GO:0071267	HGSWGSGLDMHTKPWIRAR	4.949999809	1	1	0.332895875	2208.455743	14.60366	0	0	14.83189	15.35917	14.18498	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H2S1	KCNN2_HUMAN	"Small conductance calcium-activated potassium channel protein 2, SK2, SKCa 2, SKCa2 (KCa2.2)"	KCNN2	Homo sapiens (Human)	ion transport [GO:0006811]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379]	cell surface [GO:0009986]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	cell surface [GO:0009986]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286]; ion transport [GO:0006811]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379]	alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286]	GO:0005242; GO:0005516; GO:0005886; GO:0006811; GO:0006813; GO:0009986; GO:0015269; GO:0016021; GO:0016286; GO:0019904; GO:0030018; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0051393; GO:0071805; GO:0098914; GO:1901379	IDHAKVR	9.479999542	1	1	0.262722417	837.4590686	16.28125	13.76572	15.9908	13.43369	0	13.99343	11.64649	14.43041	14.88491	15.45622	0	15.76822	14.25831	15.69907	14.34339	13.91348	14.05911	14.56357	0	0	14.93071	0	0	0	0	13.17205	0	14.75012	0	0	14.32449	12.50231	0	0	16.26458	15.49068	0	15.20388	0	15.36349	14.81773	14.78279	14.26535	15.77619	14.41472	0	14.98599	0
Q9H2S9	IKZF4_HUMAN	Zinc finger protein Eos (Ikaros family zinc finger protein 4)	IKZF4 KIAA1782 ZNFN1A4	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]"	bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]	GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0016604; GO:0019904; GO:0032991; GO:0043425; GO:0045892; GO:0045944; GO:0051260	GEHKVG	1.610000014	0.877934515	0.877934515	0.086294074	627.0507993	14.20602	0	14.40668	0	16.74318	15.52112	15.28604	17.40584	15.86332	17.03486	0	0	15.89011	0	0	0	13.58484	14.41717	14.04612	0	14.88354	15.87783	0	16.55241	16.48925	17.23085	0	13.72345	0	15.97336	14.25468	15.86608	18.41133	0	17.80006	15.3986	14.4512	15.00548	16.56542	15.70205	14.98361	15.17453	0	11.13898	0	12.72796	14.91946	14.53803
Q9H2T7	RBP17_HUMAN	Ran-binding protein 17	RANBP17	Homo sapiens (Human)	mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]	GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]	GO:0005049; GO:0005525; GO:0005643; GO:0005737; GO:0006606; GO:0006611; GO:0031267; GO:0051028	LNFDVSSPNGILLFR	12.59000015	1	1	0.374464298	1691.921843	15.07368	14.91703	15.81195	14.26854	14.46838	14.83196	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.92152	0	0	0	0	0	0	0	0	0
Q9H2U1	DHX36_HUMAN	"ATP-dependent DNA/RNA helicase DHX36, EC 3.6.4.12, EC 3.6.4.13 (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1, G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein)"	DHX36 DDX36 KIAA1488 MLEL1 RHAU	Homo sapiens (Human)	"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"	"axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription cis-regulatory region binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070062; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1902064; GO:1903843; GO:1904358; GO:1904582; GO:2000767	GRHPGHLK	1.919999957	0.228513256	0.228513256	0.161822432	901.630965	16.49635	16.46186	18.48067	14.53262	15.56972	0	13.97766	13.5904	13.90928	16.81618	0	16.84681	16.23219	14.82102	0	0	11.99407	18.13228	0	16.96675	0	18.83749	0	15.08142	15.82012	17.61789	17.24996	14.90805	0	0	0	0	15.96182	18.64591	0	14.937	0	15.98469	0	0	0	0	15.28125	0	15.73869	14.50149	17.29077	15.91286
Q9H2U2	IPYR2_HUMAN	"Inorganic pyrophosphatase 2, mitochondrial, EC 3.6.1.1 (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2, PPase 2)"	PPA2 HSPC124	Homo sapiens (Human)	diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881]	inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000287; GO:0004427; GO:0004722; GO:0005739; GO:0005759; GO:0005829; GO:0006796; GO:0051881; GO:0071344	CNGGAINCTNVQISDSPFR	1.460000038	1	1	0.202643343	2110.592416	0	14.26525	14.72158	13.67551	0	0	12.27725	0	0	14.56783	0	0	14.88633	13.64609	0	0	11.6863	0	0	0	0	0	16.11394	11.71255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.74729	0	0
Q9H2U6	CO005_HUMAN	Putative uncharacterized protein encoded by LINC00597	LINC00597 C15orf5	Homo sapiens (Human)						CSCGNGK	4.090000153	1	1	0.222957914	782.2051873	17.52362	11.85556	16.90177	12.11874	15.21264	16.18511	15.89456	13.15269	16.3996	0	15.93785	17.43583	15.26696	13.93381	14.67832	0	0	15.29607	0	0	16.58786	0	0	0	17.00103	17.39947	0	0	0	16.22769	0	0	17.08538	0	0	17.19204	0	0	15.22593	0	0	0	14.92003	0	0	17.49107	15.2192	16.30792
Q9H2U9	ADAM7_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 7, ADAM 7 (Sperm maturation-related glycoprotein GP-83)"	ADAM7 GP83	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004175; GO:0004222; GO:0005886; GO:0008237; GO:0016021	TVPGDNESEEDSKIK	4.710000038	1	1	0.37243479	1646.659791	14.95969	19.00648	0	15.68687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.10867	0	0	0	0	0	0	0	0	0	0	0	0	0	21.39651	0	0	18.96378	0	0	0	0	0	0	0	0	0	0	0	17.39708
Q9H2W6	RM46_HUMAN	"39S ribosomal protein L46, mitochondrial, L46mt, MRP-L46 (Mitochondrial large ribosomal subunit protein mL46) (P2ECSL)"	MRPL46 C15orf4 LIECG2	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0030054; GO:0032543	ALLLTGDFSQAGNKGHHVWVTK	3.079999924	1	1	0.169828381	2379.664799	15.42555	10.34069	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.27275	0	0	0	20.82559	0	0	0	0	0	0	0	18.85472	0	0
Q9H2X0	CHRD_HUMAN	Chordin	CHRD UNQ217/PRO243	Homo sapiens (Human)	BMP signaling pathway involved in spinal cord dorsal/ventral patterning [GO:0021919]; floor plate development [GO:0033504]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of cell adhesion [GO:0045785]; positive regulation of mesenchymal cell proliferation [GO:0002053]; skeletal system development [GO:0001501]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; cytokine binding [GO:0019955]; BMP signaling pathway involved in spinal cord dorsal/ventral patterning [GO:0021919]; floor plate development [GO:0033504]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of cell adhesion [GO:0045785]; positive regulation of mesenchymal cell proliferation [GO:0002053]; skeletal system development [GO:0001501]	cytokine binding [GO:0019955]	GO:0001501; GO:0002053; GO:0005615; GO:0019955; GO:0021919; GO:0030336; GO:0030514; GO:0033504; GO:0045668; GO:0045785	DLEPELLR	6.260000229	1	1	1.94E-12	983.6128194	17.51693	0	14.39876	16.97287	0	0	16.21837	0	0	0	0	0	14.66202	0	0	0	12.98419	12.95798	0	12.28765	10.73667	0	0	0	11.66725	15.71167	17.02857	0	15.86998	0	17.65733	17.51865	17.58543	14.91672	16.17823	15.45102	0	11.69871	0	0	0	0	0	17.36982	0	16.75196	0	14.44499
Q9H2X6	HIPK2_HUMAN	"Homeodomain-interacting protein kinase 2, hHIPk2, EC 2.7.11.1"	HIPK2	Homo sapiens (Human)	"adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]"	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575]	"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790]; adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]"	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790]	GO:0000122; GO:0001654; GO:0001934; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006978; GO:0007179; GO:0007224; GO:0007628; GO:0008284; GO:0009952; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0030182; GO:0030218; GO:0030511; GO:0030514; GO:0030578; GO:0032092; GO:0042771; GO:0043388; GO:0043524; GO:0045766; GO:0045893; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051091; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059	YIRPVLQQVATALMK	3.480000019	1	1	0.335104935	1744.074877	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H2X9	S12A5_HUMAN	"Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2, hKCC2) (Neuronal K-Cl cotransporter)"	SLC12A5 KCC2 KIAA1176	Homo sapiens (Human)	cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular pH reduction [GO:0051452]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040]	cell periphery [GO:0071944]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cell periphery [GO:0071944]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular pH reduction [GO:0051452]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040]	ammonium transmembrane transporter activity [GO:0008519]; chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0005886; GO:0005887; GO:0006811; GO:0006873; GO:0006884; GO:0006971; GO:0007268; GO:0007612; GO:0008519; GO:0009410; GO:0015108; GO:0015379; GO:0016021; GO:0019901; GO:0030644; GO:0032590; GO:0035264; GO:0040040; GO:0043005; GO:0043025; GO:0043204; GO:0045202; GO:0051452; GO:0055064; GO:0055075; GO:0060996; GO:0071944; GO:1902476; GO:1990573	NGDENYMEFLEVLTEHLDR	2.470000029	1	1	0.015864635	2323.885079	0	11.89264	12.88249	13.01646	16.01804	10.16333	12.85741	12.44267	8.713937	10.26113	13.27285	0	0	0	12.81411	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H2Y7	ZN106_HUMAN	"Zinc finger protein 106, Zfp-106 (Zinc finger protein 474)"	ZNF106 SH3BP3 ZFP106 ZNF474	Homo sapiens (Human)	insulin receptor signaling pathway [GO:0008286]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]	GO:0003723; GO:0005730; GO:0005829; GO:0008286; GO:0016020; GO:0016607; GO:0017124; GO:0046872	ASRNVEESEK	7.460000038	0.354126483	0.354126483	0.149220225	1149.489747	15.037	13.83938	16.12175	10.46533	11.11469	15.02277	15.21759	0	0	18.04118	0	15.47158	0	0	0	0	0	0	0	0	0	0	0	15.43828	15.59295	0	0	13.99003	13.71999	0	0	0	0	0	13.59837	0	0	0	14.1503	0	0	0	14.81366	0	13.17889	0	0	0
Q9H2Y9	SO5A1_HUMAN	"Solute carrier organic anion transporter family member 5A1 (Organic anion transporter polypeptide-related protein 4, OATP-RP4, OATPRP4) (Solute carrier family 21 member 15)"	SLCO5A1 OATP5A1 SLC21A15	Homo sapiens (Human)	sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; sodium-independent organic anion transport [GO:0043252]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005886; GO:0005887; GO:0015347; GO:0043231; GO:0043252	VDLSKTFSVSSALAMLQER	5.789999962	0.268917382	0.268917382	0.184045873	2098.613049	13.19501	0	0	13.61881	0	16.08351	0	0	0	0	0	13.63808	0	0	15.88678	0	0	0	0	16.21712	15.65556	15.30627	11.84095	0	14.54588	14.04403	0	0	0	0	0	0	13.49117	0	0	0	15.02271	13.61796	13.34767	14.15897	0	0	0	14.77937	0	15.29875	0	0
Q9H307	PININ_HUMAN	"Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein, DRS protein, DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein)"	PNN DRS MEMA	Homo sapiens (Human)	"cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	"catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]	GO:0000398; GO:0003677; GO:0003723; GO:0005198; GO:0005882; GO:0005886; GO:0005911; GO:0007155; GO:0016020; GO:0016607; GO:0030057; GO:0071013	AVAVR	11.03999996	0.166458294	0.166458294	0.269286364	514.9300514	0	14.75514	14.17631	15.74251	0	0	15.60505	0	16.60331	0	0	16.12495	0	0	14.39802	0	14.80238	0	16.76285	15.76318	0	0	0	15.02278	14.75532	14.40707	15.67727	0	13.96036	0	0	0	15.75289	0	0	0	0	16.47415	0	0	16.49856	15.95713	0	15.71887	0	18.13325	14.59339	17.48757
Q9H313	TTYH1_HUMAN	"Protein tweety homolog 1, hTTY1"	TTYH1	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chloride transport [GO:0006821]; filopodium assembly [GO:0046847]; ion transmembrane transport [GO:0034220]; iron ion transport [GO:0006826]; mitotic cell cycle [GO:0000278]	chloride channel complex [GO:0034707]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; synapse [GO:0045202]	chloride channel complex [GO:0034707]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iron ion transmembrane transporter activity [GO:0005381]; volume-sensitive chloride channel activity [GO:0072320]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chloride transport [GO:0006821]; filopodium assembly [GO:0046847]; ion transmembrane transport [GO:0034220]; iron ion transport [GO:0006826]; mitotic cell cycle [GO:0000278]	calcium ion binding [GO:0005509]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iron ion transmembrane transporter activity [GO:0005381]; volume-sensitive chloride channel activity [GO:0072320]	GO:0000278; GO:0005229; GO:0005254; GO:0005381; GO:0005509; GO:0005886; GO:0006821; GO:0006826; GO:0016021; GO:0030868; GO:0031527; GO:0031589; GO:0032433; GO:0034220; GO:0034707; GO:0045202; GO:0046847; GO:0072320; GO:0098609	FVQWQSSI	4.690000057	1	1	0.285018894	994.8213045	13.84519	14.60967	14.80002	0	14.54452	0	14.92447	0	15.15259	15.92591	15.15557	14.29883	14.68128	14.75832	0	0	13.72679	0	0	0	0	0	0	0	0	0	0	0	15.02114	14.94263	0	11.69176	0	0	15.18875	0	0	0	0	0	15.54176	0	0	0	0	0	0	0
Q9H324	ATS10_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 10, ADAM-TS 10, ADAM-TS10, ADAMTS-10, EC 3.4.24.-"	ADAMTS10	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0001527; GO:0004222; GO:0005576; GO:0030198; GO:0031012; GO:0046872; GO:0062023	TELPALR	15.84000015	0.517626405	0.517626405	0.291596124	800.0055193	14.83519	15.16082	0	0	0	0	14.50661	13.42146	14.22093	14.94918	15.10785	13.95332	16.02132	0	10.83899	16.25899	13.72262	14.40102	0	0	16.67321	0	0	0	16.02774	0	15.68685	15.83104	16.46062	0	16.71226	0	16.37837	0	0	0	0	0	15.72663	0	14.83447	0	0	15.2143	16.66911	0	16.50483	15.19227
Q9H329	E41LB_HUMAN	Band 4.1-like protein 4B (Erythrocyte membrane protein band 4.1-like 4B) (FERM-containing protein CG1) (Protein EHM2)	EPB41L4B EHM2 LULU2	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; wound healing [GO:0042060]	apical part of cell [GO:0045177]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; wound healing [GO:0042060]	cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]	GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0008092; GO:0010628; GO:0031032; GO:0042060; GO:0045177; GO:0045785; GO:0051549	RHSTFK	5	1	1	0.074989926	775.0753459	0	14.22458	0	0	14.81319	0	0	0	0	0	0	0	0	0	0	0	0	16.21487	0	0	0	0	0	0	17.2736	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.82173	0	0	0	19.8773	0	0	0
Q9H330	TM245_HUMAN	Transmembrane protein 245 (Protein CG-2)	TMEM245 C9orf5	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	ADGGGPK	12.23999977	1	1	0.145076828	601.271323	0	0	15.18013	15.15645	0	0	0	14.30425	0	0	0	0	13.56203	0	0	0	0	0	0	0	0	0	0	16.71167	0	0	0	0	0	0	0	0	0	0	0	0	17.38802	0	0	0	0	0	0	0	0	0	0	0
Q9H334	FOXP1_HUMAN	"Forkhead box protein P1 (Mac-1-regulated forkhead, MFH)"	FOXP1 HSPC215	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; endothelial cell activation [GO:0042118]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of defense response to bacterium [GO:1900424]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 beta production [GO:0032651]; regulation of interleukin-12 production [GO:0032655]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; T follicular helper cell differentiation [GO:0061470]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to DNA damage stimulus [GO:0006974]; endothelial cell activation [GO:0042118]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of defense response to bacterium [GO:1900424]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 beta production [GO:0032651]; regulation of interleukin-12 production [GO:0032655]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; T follicular helper cell differentiation [GO:0061470]"	"androgen receptor binding [GO:0050681]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001227; GO:0002903; GO:0005634; GO:0005654; GO:0006357; GO:0006974; GO:0010468; GO:0010595; GO:0010629; GO:0030316; GO:0032496; GO:0032651; GO:0032655; GO:0032680; GO:0032745; GO:0036035; GO:0042116; GO:0042117; GO:0042118; GO:0042802; GO:0043621; GO:0045655; GO:0045892; GO:0046872; GO:0048661; GO:0050681; GO:0050727; GO:0050861; GO:0060766; GO:0061470; GO:1900424; GO:1901256; GO:1901509; GO:1990837; GO:2000341	EELNGAMEHTNSNESDSSPGR	4.099999905	1	1	1.83E-12	2276.811117	14.84718	11.38744	0	0	0	0	0	0	14.83901	0	0	0	0	14.24786	15.26062	0	0	15.4417	0	13.92728	14.77086	0	0	0	0	0	15.2247	0	16.56265	14.699	16.95451	13.88083	0	15.1397	15.1061	0	15.4184	0	12.67188	0	0	0	0	0	0	0	0	0
Q9H336	CRLD1_HUMAN	"Cysteine-rich secretory protein LCCL domain-containing 1 (CocoaCrisp) (Cysteine-rich secretory protein 10, CRISP-10) (LCCL domain-containing cysteine-rich secretory protein 1) (Trypsin inhibitor Hl)"	CRISPLD1 CRISP10 LCRISP1 UNQ342/PRO541	Homo sapiens (Human)	face morphogenesis [GO:0060325]; hematopoietic stem cell homeostasis [GO:0061484]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; face morphogenesis [GO:0060325]; hematopoietic stem cell homeostasis [GO:0061484]		GO:0005615; GO:0060325; GO:0061484; GO:0070062	GTTCNR	6.730000019	1	1	0.240143721	709.002545	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.76291	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H341	O51M1_HUMAN	Olfactory receptor 51M1 (Odorant receptor HOR5'beta7) (Olfactory receptor OR11-40)	OR51M1	Homo sapiens (Human)	sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021	TKEIHR	12.34000015	0.412292182	0.412292182	0.086349518	784.5946136	21.39632	22.06487	19.25154	19.85561	20.72772	21.2096	16.7409	0	18.66049	20.327	21.01058	18.43309	18.036	17.93294	18.47264	0	18.50282	0	19.43127	18.11132	16.32931	19.79995	0	20.31249	0	19.10709	18.3955	19.85319	18.29154	18.54111	0	20.10567	21.37706	0	19.49439	19.92867	19.96715	19.8834	18.6674	0	18.48568	0	0	18.30158	19.49486	18.48118	17.16508	15.18705
Q9H344	O51I2_HUMAN	Olfactory receptor 51I2 (Odorant receptor HOR5'beta12) (Olfactory receptor OR11-38)	OR51I2	Homo sapiens (Human)	sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021	SVMATASR	9.180000305	1	1	0.22802509	838.815155	0	0	15.65112	15.94395	0	0	17.07691	0	0	14.46543	0	17.4347	0	0	14.55174	13.96443	13.27603	17.03194	0	0	0	0	14.43175	15.89287	17.21595	0	0	0	17.16403	0	0	16.55293	0	17.78285	18.79251	18.54529	15.62856	0	18.07551	0	15.94574	0	0	0	16.10081	16.36277	0	16.45939
Q9H347	UBQL3_HUMAN	Ubiquilin-3	UBQLN3	Homo sapiens (Human)	ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]	cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin-dependent protein catabolic process [GO:0006511]	polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005829; GO:0006511; GO:0031593	LGLAYR	6.389999866	0.516999424	0.516999424	0.367300815	690.9450657	16.06162	0	15.01692	16.89728	17.60946	16.35135	15.49702	15.91774	16.19794	18.11746	16.04614	18.53292	0	16.73161	16.30558	0	0	0	0	0	0	0	0	17.80221	16.4662	0	0	16.21311	18.31811	16.04276	17.11437	14.10713	14.22476	19.15248	0	17.32433	17.74026	16.58595	16.40045	16.33639	17.17499	17.28291	17.03929	17.04727	16.68095	16.92192	16.50274	18.69573
Q9H3C7	GGNB2_HUMAN	Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403)	GGNBP2 LCRG1 LZK1 ZNF403	Homo sapiens (Human)	cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283]		GO:0005634; GO:0005737; GO:0007283; GO:0008285; GO:0010629; GO:0030154; GO:0031410; GO:0033140; GO:0042532; GO:0060716; GO:0061099	CVCDIPTPLQTADEK	2.930000067	1	1	0.283330805	1747.348037	15.47118	15.14988	0	14.70062	14.62629	12.99811	15.28285	13.51072	13.98843	15.09192	0	14.67599	0	0	15.84818	14.48353	14.14876	0	0	0	0	0	16.50496	0	0	13.88463	0	0	15.07703	12.79993	0	13.35064	17.25262	15.00455	14.91422	0	0	0	0	0	0	15.20224	0	0	0	0	12.20485	0
Q9H3D4	P63_HUMAN	"Tumor protein 63, p63 (Chronic ulcerative stomatitis protein, CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63, TP63) (Tumor protein p73-like, p73L) (p40) (p51)"	TP63 KET P63 P73H P73L TP73L	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WW domain binding [GO:0050699]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485]"	"chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WW domain binding [GO:0050699]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001736; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0006338; GO:0006357; GO:0006915; GO:0006974; GO:0007219; GO:0007283; GO:0007499; GO:0007569; GO:0008283; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0030216; GO:0030425; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0043281; GO:0043589; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048807; GO:0050699; GO:0051262; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0097371; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000773; GO:2001235	VIDAVR	5.130000114	0.11980404	0.11980404	0.120412855	671.6446188	0	0	0	15.71023	14.71288	14.46267	0	0	0	0	14.97656	0	0	15.54393	17.53506	16.99471	0	17.10367	0	16.4179	0	13.44409	12.53132	12.0188	0	18.43249	17.04508	20.13105	13.54468	17.1121	14.68426	18.66404	0	16.94688	16.19455	18.2387	15.57975	15.55146	17.78069	17.93919	0	17.21294	15.40903	15.46171	16.14498	0	16.65505	0
Q9H3E2	SNX25_HUMAN	Sorting nexin-25	SNX25 MSTP043	Homo sapiens (Human)	negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]	endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]	endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801]	phosphatidylinositol binding [GO:0035091]	GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0035091; GO:0043231; GO:0060394	MDKALK	9.06000042	1	1	0.257834707	706.0068642	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.45782	0	15.90747	0	0	0	0	0	18.70016	0	16.1475	0	0	16.20031	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H3F6	BACD3_HUMAN	"BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3, hBACURD3 (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10)"	KCTD10 ULR061 MSTP028	Homo sapiens (Human)	negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	identical protein binding [GO:0042802]; Notch binding [GO:0005112]	GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260	EEMSGESVVSSAVPAAATR	5.630000114	0.275879979	0.275879979	0.164493887	1893.02994	18.70745	17.02778	0	15.30532	14.12353	0	0	12.66405	0	0	0	0	11.42122	0	16.4772	0	0	0	0	0	12.87055	17.07859	18.08763	0	11.95208	0	12.8819	0	14.67448	16.21519	15.42194	17.61394	16.65401	17.04898	0	14.54473	0	0	16.83106	17.99479	0	12.07416	0	15.11949	17.50914	0	0	15.57087
Q9H3G5	CPVL_HUMAN	"Probable serine carboxypeptidase CPVL, EC 3.4.16.- (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein, VCP-like protein, hVLP)"	CPVL VLP PSEC0124 UNQ197/PRO223	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0070062	VIVSLVLLMPGPCDGLFRSLYR	7.369999886	0.232752681	0.232752681	0.031601169	2506.565107	12.46656	0	8.784221	0	13.99129	0	0	0	0	0	0	0	12.76789	0	0	13.28589	0	0	0	0	0	0	0	0	0	0	0	12.08591	0	0	0	13.64083	15.02228	10.52616	0	16.46956	0	0	0	0	0	0	0	0	10.5024	10.69725	0	0
Q9H3H9	TCAL2_HUMAN	"Transcription elongation factor A protein-like 2, TCEA-like protein 2 (Transcription elongation factor S-II protein-like 2)"	TCEAL2 My048 MY0876G0	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; WW domain binding [GO:0050699]	WW domain binding [GO:0050699]	GO:0005634; GO:0050699	EKPESAGKAK	10.56999969	1	1	0.47031885	1045.246138	15.64239	0	15.78776	13.2431	15.30508	16.88868	16.2612	0	16.73469	0	11.87807	16.25274	16.27502	15.90984	0	16.13155	0	0	18.03618	0	0	0	15.73224	17.40932	15.42417	0	15.86147	0	0	0	0	15.8928	15.70382	0	17.0414	16.63769	17.22733	17.78366	0	17.23505	16.22276	16.30786	16.64241	16.11606	0	0	0	17.05985
Q9H3N8	HRH4_HUMAN	"Histamine H4 receptor, H4R, HH4R (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144)"	HRH4 GPCR105	Homo sapiens (Human)	"adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of MAPK cascade [GO:0043408]"	dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of MAPK cascade [GO:0043408]"	G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]	GO:0004969; GO:0004993; GO:0005886; GO:0005887; GO:0006954; GO:0007187; GO:0007197; GO:0007204; GO:0007268; GO:0016907; GO:0030425; GO:0030594; GO:0043408; GO:0045202	EHVELLRAR	6.090000153	1	1	0.179317309	1119.821876	0	0	7.925398	0	9.07116	12.31292	13.88659	0	12.80916	16.08918	14.65307	15.61216	0	0	0	0	0	0	0	0	0	0	0	0	0	14.75422	0	0	16.30553	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.21683	0	0
Q9H3Q1	BORG4_HUMAN	Cdc42 effector protein 4 (Binder of Rho GTPases 4)	CDC42EP4 BORG4 CEP4	Homo sapiens (Human)	cellular response to interferon-gamma [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; cellular response to interferon-gamma [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]	RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	GO:0003723; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0007266; GO:0008360; GO:0012505; GO:0015629; GO:0015630; GO:0030838; GO:0031267; GO:0031274; GO:0045335; GO:0071346	SLSSSPVK	8.789999962	1	1	0.253163485	804.8741355	15.4714	0	14.35839	15.68378	15.96354	15.02731	15.29968	0	0	0	0	0	16.31851	0	15.1029	0	0	0	0	0	0	0	13.90048	15.8773	0	14.61725	15.67663	13.13413	0	16.36621	0	0	18.08878	18.19874	15.84658	0	0	0	0	0	0	0	0	0	15.23968	15.14205	0	15.91694
Q9H3R0	KDM4C_HUMAN	"Lysine-specific demethylase 4C, EC 1.14.11.66 (Gene amplified in squamous cell carcinoma 1 protein, GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C) ([histone H3]-trimethyl-L-lysine(9) demethylase 4C)"	KDM4C GASC1 JHDM3C JMJD2C KIAA0780	Homo sapiens (Human)	blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell population proliferation [GO:0008284]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; zinc ion binding [GO:0008270]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell population proliferation [GO:0008284]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]	androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; zinc ion binding [GO:0008270]	GO:0000785; GO:0001825; GO:0005634; GO:0005654; GO:0005721; GO:0006338; GO:0006357; GO:0008270; GO:0008284; GO:0019827; GO:0019899; GO:0032452; GO:0032454; GO:0033169; GO:0050681; GO:0051864; GO:0060765; GO:0070544; GO:0140684; GO:1900113; GO:2000736	TSKSWR	6.130000114	1	1	0.180544274	763.6374254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H3R5	CENPH_HUMAN	"Centromere protein H, CENP-H (Interphase centromere complex protein 35)"	CENPH ICEN35	Homo sapiens (Human)	chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; kinetochore organization [GO:0051383]; mitotic spindle organization [GO:0007052]	chromosome [GO:0005694]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinetochore binding [GO:0043515]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; kinetochore organization [GO:0051383]; mitotic spindle organization [GO:0007052]	kinetochore binding [GO:0043515]	GO:0000776; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0007052; GO:0007059; GO:0043515; GO:0051382; GO:0051383	EIVLQLEKNVDMM	11.27000046	1	1	7.02E-13	1576.764221	0	0	0	0	0	0	21.13024	0	20.90868	0	0	0	0	0	0	0	0	0	0	0	21.21204	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H3S1	SEM4A_HUMAN	"Semaphorin-4A (Semaphorin-B, Sema B)"	SEMA4A SEMAB SEMB UNQ783/PRO1317	Homo sapiens (Human)	angiogenesis [GO:0001525]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of inhibitory synapse assembly [GO:1905704]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; semaphorin-plexin signaling pathway [GO:0071526]; T-helper 1 cell differentiation [GO:0045063]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of inhibitory synapse assembly [GO:1905704]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; semaphorin-plexin signaling pathway [GO:0071526]; T-helper 1 cell differentiation [GO:0045063]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001525; GO:0001755; GO:0005615; GO:0005886; GO:0005887; GO:0007411; GO:0008360; GO:0010594; GO:0016525; GO:0030215; GO:0030335; GO:0045063; GO:0045499; GO:0048843; GO:0050919; GO:0071526; GO:1904891; GO:1905704	KSECAFK	2.309999943	0.927918375	0.927918375	0.215243014	871.2585807	0	0	15.34287	0	14.30866	0	0	0	15.37656	0	16.80352	0	0	15.15918	0	17.34294	0	14.41748	15.37274	0	16.68831	0	15.83236	16.08956	15.81175	0	0	17.26471	15.36027	0	15.99571	14.65304	0	13.96043	16.11215	15.92342	15.40461	14.36607	13.32282	15.59758	14.94333	17.06092	16.9226	13.67609	16.45116	14.47325	0	15.26859
Q9H3S7	PTN23_HUMAN	"Tyrosine-protein phosphatase non-receptor type 23, EC 3.1.3.48 (His domain-containing protein tyrosine phosphatase, HD-PTP) (Protein tyrosine phosphatase TD14, PTP-TD14)"	PTPN23 KIAA1471	Homo sapiens (Human)	cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]	protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0043231; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:1903387; GO:1903393; GO:2000643	QQLLDRELK	8.18999958	1	1	0.345176749	1137.674477	0	0	0	0	0	0	0	0	17.67004	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H3U1	UN45A_HUMAN	"Protein unc-45 homolog A, Unc-45A (GCUNC-45) (Smooth muscle cell-associated protein 1, SMAP-1)"	UNC45A SMAP1	Homo sapiens (Human)	cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517]	cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]	GO:0005794; GO:0005829; GO:0007517; GO:0016607; GO:0030154; GO:0045296; GO:0048471; GO:0051879; GO:0061077	EDAGAEKIFR	15.59000015	1	1	0.256142186	1135.835853	13.86963	14.68372	0	0	13.81808	0	0	0	0	0	16.31331	0	13.83475	0	0	14.96324	0	0	0	15.75355	0	0	15.97406	0	0	0	0	0	0	0	0	15.72588	0	0	0	0	0	0	0	16.37414	15.77532	0	0	0	0	0	0	0
Q9H3W5	LRRN3_HUMAN	"Leucine-rich repeat neuronal protein 3 (Neuronal leucine-rich repeat protein 3, NLRR-3)"	LRRN3 Nbla10363 UNQ194/PRO220	Homo sapiens (Human)	positive regulation of synapse assembly [GO:0051965]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965]		GO:0005615; GO:0016021; GO:0031012; GO:0051965	EGGLYTCIATNLVGADLK	7.519999981	0.435075581	0.435075581	0.163262036	1895.381265	16.68376	15.76385	15.47011	14.55931	0	14.75296	13.98907	15.78485	14.13833	10.47609	13.49776	15.39667	0	12.4134	14.74285	14.33177	0	0	0	0	0	0	15.92499	0	14.15648	17.13926	0	0	0	15.55276	0	0	0	0	15.26894	0	0	0	0	15.96743	14.10919	0	0	15.14916	0	0	16.18264	15.20105
Q9H3Z7	ABHGB_HUMAN	"Protein ABHD16B, EC 3.-.-.- (Alpha/beta hydrolase domain-containing protein 16B, Abhydrolase domain-containing protein 16B)"	ABHD16B C20orf135	Homo sapiens (Human)	monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]	membrane [GO:0016020]; nucleoplasm [GO:0005654]	membrane [GO:0016020]; nucleoplasm [GO:0005654]; acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]	acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]	GO:0004620; GO:0005654; GO:0006660; GO:0008474; GO:0016020; GO:0047372; GO:0052651	MCVICFVK	5.28000021	1	1	0.179457473	1054.742617	0	17.35353	15.48442	11.87383	12.43156	14.62069	13.18309	14.45593	14.44845	14.94487	16.04367	14.21119	17.91098	0	0	13.77293	0	13.51437	15.03367	11.97909	0	0	0	0	15.7774	0	16.38822	0	0	0	0	15.85968	15.48747	0	0	0	0	15.33535	0	0	0	0	0	0	18.22155	0	0	0
Q9H410	DSN1_HUMAN	Kinetochore-associated protein DSN1 homolog	DSN1 C20orf172 MIS13	Homo sapiens (Human)	cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nuclear MIS12/MIND complex [GO:0000818]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nuclear MIS12/MIND complex [GO:0000818]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]		GO:0000070; GO:0000444; GO:0000776; GO:0000818; GO:0001650; GO:0005576; GO:0005654; GO:0005730; GO:0005829; GO:0016604; GO:0031617; GO:0035578; GO:0051301	ASDFSLEASVAEMK	9.729999542	1	1	2.32E-13	1485.830097	0	0	14.50485	0	0	0	0	0	10.26083	0	16.92467	0	0	0	13.33696	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H422	HIPK3_HUMAN	"Homeodomain-interacting protein kinase 3, EC 2.7.11.1 (Androgen receptor-interacting nuclear protein kinase, ANPK) (Fas-interacting serine/threonine-protein kinase, FIST) (Homolog of protein kinase YAK1)"	HIPK3 DYRK6 FIST3 PKY	Homo sapiens (Human)	apoptotic process [GO:0006915]; mRNA transcription [GO:0009299]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; mRNA transcription [GO:0009299]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0009299; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0043066; GO:0043508; GO:0106310	EFVSLLKK	4.28000021	1	1	0.089126854	962.563861	11.34038	14.72844	12.99856	13.12079	14.51866	0	15.52193	16.29679	14.69544	0	0	15.40535	0	13.97078	0	15.29383	16.01347	0	0	0	14.96976	13.66704	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H425	CA198_HUMAN	Uncharacterized protein C1orf198	C1orf198	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829	SMEKGEK	10.10000038	1	1	0.289334585	823.1232041	0	0	0	0	17.68565	0	0	0	0	0	0	0	0	17.7689	18.1728	0	0	0	0	0	0	0	0	0	0	18.08344	17.74681	0	0	0	0	0	0	0	0	17.78588	0	0	0	0	0	0	0	0	0	0	0	0
Q9H469	FXL15_HUMAN	F-box/LRR-repeat protein 15 (F-box only protein 37)	FBXL15 FBXO37	Homo sapiens (Human)	bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		GO:0000086; GO:0005737; GO:0005829; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146	VGSDGVR	8.029999733	0.019345468	0.019345468	0.160705957	689.861758	0	17.92522	15.57807	0	0	19.71316	18.66567	17.6695	0	0	14.90717	0	0	15.87202	0	16.39057	15.31503	17.4498	12.01269	16.91123	0	14.90893	15.07736	0	0	16.90153	0	16.23815	16.50035	0	12.61431	0	16.65551	13.78336	0	12.72754	0	0	18.38991	0	0	16.37063	0	15.81924	18.24344	16.36209	0	11.05566
Q9H477	RBSK_HUMAN	"Ribokinase, RK, EC 2.7.1.15"	RBKS RBSK	Homo sapiens (Human)	D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872	GANQCVQAARLGAMTSMVCK	1.720000029	1	1	2.29E-12	2168.299521	9.359298	14.36509	0	10.84116	13.08483	14.39449	0	13.86315	12.1328	0	13.33852	14.28184	0	14.10656	0	0	0	0	12.46247	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H479	FN3K_HUMAN	"Fructosamine-3-kinase, EC 2.7.1.171 (Protein-psicosamine 3-kinase FN3K) (Protein-ribulosamine 3-kinase FN3K, EC 2.7.1.172)"	FN3K	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]; fructoselysine metabolic process [GO:0030393]; post-translational protein modification [GO:0043687]; protein deglycation [GO:0036525]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-fructosamine 3-kinase activity [GO:0102194]; protein-ribulosamine 3-kinase activity [GO:0102193]; epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]; fructoselysine metabolic process [GO:0030393]; post-translational protein modification [GO:0043687]; protein deglycation [GO:0036525]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-fructosamine 3-kinase activity [GO:0102194]; protein-ribulosamine 3-kinase activity [GO:0102193]	GO:0005524; GO:0005829; GO:0016301; GO:0030389; GO:0030393; GO:0030855; GO:0036525; GO:0043687; GO:0102193; GO:0102194	EQLLRAELR	14.77999973	1	1	0.405226734	1128.325712	0	16.89314	0	16.86423	16.51686	16.9182	16.23746	0	16.51834	0	0	0	0	0	0	0	0	0	15.69771	0	0	0	15.35132	0	0	17.33722	0	15.52449	16.30719	0	0	16.03976	0	15.99716	0	0	0	0	16.36517	0	16.32978	0	0	16.38404	0	0	16.9004	0
Q9H490	PIGU_HUMAN	"Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1, Protein CDC91-like 1) (GPI transamidase component PIG-U)"	PIGU CDC91L1 PSEC0205 UNQ3055/PRO9875	Homo sapiens (Human)	attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]		GO:0005789; GO:0005886; GO:0006506; GO:0016020; GO:0016255; GO:0034394; GO:0042765; GO:0046425	TPMEMR	13.38000011	1	1	0.276847217	780.6913223	0	19.0808	17.38691	0	12.65408	18.35917	19.39451	17.26169	0	18.04408	18.12267	0	0	17.82247	16.65603	0	0	18.96021	16.72498	0	17.10234	0	0	0	20.60639	18.44724	0	0	19.01163	19.324	18.6787	18.03009	18.28275	0	21.05822	18.73175	19.2377	20.36476	18.87264	19.46641	17.40399	19.04528	17.02069	0	0	18.51066	0	18.06472
Q9H497	TOR3A_HUMAN	Torsin-3A (ATP-dependent interferon-responsive protein) (Torsin family 3 member A)	TOR3A ADIR	Homo sapiens (Human)		endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0016887; GO:0070062	EETLDEIAQMMVYVPK	22.30999947	0.61425066	0.61425066	0.333642749	1895.035099	20.17109	21.78054	22.05582	20.94556	21.20896	20.39619	21.34869	21.30685	21.97995	22.09493	21.33643	21.41161	19.95449	19.5571	18.19385	0	19.9016	21.51257	19.75284	20.52353	20.5665	18.02371	0	19.27639	22.70827	22.1251	22.44854	22.50403	16.97305	18.02596	20.90309	21.50281	19.48501	22.15483	20.90888	21.97758	21.79246	22.65195	20.03365	20.58035	21.24133	21.43222	20.94801	0	20.72797	20.71255	21.80026	0
Q9H4A3	WNK1_HUMAN	"Serine/threonine-protein kinase WNK1, EC 2.7.11.1 (Erythrocyte 65 kDa protein, p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1, hWNK1)"	WNK1 HSN2 KDP KIAA0344 PRKWNK1	Homo sapiens (Human)	cation homeostasis [GO:0055080]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cation homeostasis [GO:0055080]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]	ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0004712; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0007165; GO:0010766; GO:0010820; GO:0016020; GO:0018105; GO:0018107; GO:0019869; GO:0019870; GO:0019901; GO:0019902; GO:0030295; GO:0033633; GO:0034115; GO:0034260; GO:0035556; GO:0038116; GO:0048666; GO:0050801; GO:0050852; GO:0055080; GO:0090188; GO:0090263; GO:0097022; GO:0106310; GO:1903038; GO:1903288; GO:1904062; GO:1990869; GO:2000651	LGAAAADAVTGR	19.98999977	1	1	0.381532123	1072.910288	0	20.4363	19.90175	0	0	0	0	20.03327	0	19.50154	19.16954	18.27576	0	19.19938	17.69023	19.85655	19.72426	0	18.32472	0	0	19.46929	0	19.49175	0	0	0	0	18.24565	18.54362	0	0	0	0	19.1496	0	18.1807	20.93955	19.94752	0	0	0	17.44002	0	18.56843	0	0	19.12009
Q9H4B4	PLK3_HUMAN	"Serine/threonine-protein kinase PLK3, EC 2.7.11.21 (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3, PLK-3) (Proliferation-related kinase)"	PLK3 CNK FNK PRK	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]"	centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	"centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]"	ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0000086; GO:0000122; GO:0000278; GO:0000302; GO:0000922; GO:0002039; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005813; GO:0006468; GO:0006915; GO:0006970; GO:0006974; GO:0006977; GO:0007113; GO:0009314; GO:0030425; GO:0031122; GO:0032465; GO:0043025; GO:0043066; GO:0043491; GO:0044819; GO:0051302; GO:0090166; GO:0090316; GO:0106310; GO:1901796; GO:1904716; GO:2000777	CYEATDTETGSAYAVK	7.150000095	1	1	0.066593543	1766.292651	14.49333	0	13.77016	0	0	0	0	0	0	0	0	0	16.11118	0	0	0	0	0	0	0	0	0	0	0	0	0	14.10905	0	13.31913	0	0	15.44438	14.7098	0	0	0	13.61609	0	0	0	0	0	16.49545	0	0	0	0	0
Q9H4B7	TBB1_HUMAN	Tubulin beta-1 chain	TUBB1	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0015630; GO:0045171; GO:0051225; GO:0070062; GO:0072686	ALSVAELTQQMFDAR	1.480000019	1	1	0.428713136	1679.415662	0	0	0	0	18.62285	0	0	0	18.31335	17.29518	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.68164	0	0	0	0	0	0	0	17.78899	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H4B8	DPEP3_HUMAN	"Dipeptidase 3, EC 3.4.13.19"	DPEP3 UNQ834/PRO1772	Homo sapiens (Human)		acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]	acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]	dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]	GO:0001669; GO:0005886; GO:0016805; GO:0031225; GO:0046872; GO:0070573	GRAQALMR	4.630000114	1	1	0.1988532	918.5098782	13.69383	16.10511	13.0112	13.39472	12.14594	0	0	14.85269	0	14.1749	15.66516	15.0381	13.88784	14.30469	14.52074	13.48752	0	0	0	0	0	16.56081	16.44334	16.57375	15.41601	0	0	0	15.34901	0	0	0	0	0	16.56384	0	0	0	15.25356	15.59775	0	14.95674	0	0	15.9157	15.62069	15.96453	16.02273
Q9H4D0	CSTN2_HUMAN	"Calsyntenin-2 (Alcadein-gamma, Alc-gamma)"	CLSTN2 CS2	Homo sapiens (Human)	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]	cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]	cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]	amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]	GO:0000139; GO:0001540; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0019894; GO:0030425; GO:0042988; GO:0045211; GO:0050806; GO:0051965; GO:0098978; GO:0099061	TSGEGRLR	8.399999619	1	1	0.21801132	874.6989461	0	0	17.09921	17.47961	0	16.5269	0	16.01961	13.34234	15.73585	17.8347	16.71558	14.31882	0	0	0	0	15.4782	0	0	16.54148	0	0	0	0	0	0	0	0	0	0	16.82293	0	0	0	0	0	0	17.23562	15.53194	0	16.46408	0	0	13.30501	0	16.49611	15.33485
Q9H4D5	NXF3_HUMAN	"Nuclear RNA export factor 3 (TAP-like protein 3, TAPL-3)"	NXF3 TAPL3	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasm [GO:0005737]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006406; GO:0016973; GO:0042272	LDIVDSLSALPK	3.630000114	1	1	0.293098986	1270.358222	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H4E7	DEFI6_HUMAN	"Differentially expressed in FDCP 6 homolog, DEF-6 (IRF4-binding protein)"	DEF6 IBP	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0016020; GO:0030175; GO:0048471; GO:0051056	QEWTAAIQMAIR	6.329999924	1	1	0.309591041	1434.499326	0	11.20873	13.40522	12.49759	0	13.98635	0	13.68509	15.62233	15.07949	0	14.54119	0	0	13.82857	15.25477	0	0	0	0	0	0	0	0	0	0	0	15.77953	0	0	15.04593	0	0	0	0	0	15.11383	0	0	0	0	0	0	0	0	0	0	0
Q9H4F8	SMOC1_HUMAN	"SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1, SMOC-1)"	SMOC1	Homo sapiens (Human)	cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667]	basement membrane [GO:0005604]; extracellular space [GO:0005615]	basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667]	calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]	GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173	DPTLGVVHR	3.730000019	1	1	0.084944905	995.1144247	0	14.05689	17.67168	15.72774	15.45485	13.67776	0	0	14.82943	15.37811	0	0	0	14.7899	0	0	0	0	0	0	0	0	0	13.77477	0	0	15.34118	0	0	0	0	0	0	0	0	0	15.9361	0	0	0	0	0	0	15.12522	0	0	0	0
Q9H4G0	E41L1_HUMAN	"Band 4.1-like protein 1 (Erythrocyte membrane protein band 4.1-like 1) (Neuronal protein 4.1, 4.1N)"	EPB41L1 KIAA0338	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]	actin binding [GO:0003779]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005829; GO:0005856; GO:0005886; GO:0030866; GO:0031032	QEFLDKPEDVLLKHQASINELK	2.910000086	1	1	0.586865637	2594.338236	0	19.72787	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H4G4	GAPR1_HUMAN	"Golgi-associated plant pathogenesis-related protein 1, GAPR-1, Golgi-associated PR-1 protein (Glioma pathogenesis-related protein 2, GliPR 2)"	GLIPR2 C9orf19 GAPR1	Homo sapiens (Human)	positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]	protein homodimerization activity [GO:0042803]	GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374	KMGVGK	1.529999971	1	1	2.32E-13	632.1352093	0	0	0	0	0	15.61892	0	0	0	0	0	16.97534	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.0746	0	0	0	0	0	0	0	16.7639	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H4H8	FA83D_HUMAN	Protein FAM83D (Spindle protein CHICA)	FAM83D C20orf129	Homo sapiens (Human)	cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; epithelial to mesenchymal transition [GO:0001837]; metaphase plate congression [GO:0051310]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; protein localization to mitotic spindle [GO:1902480]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein catabolic process [GO:0042176]; regulation of TOR signaling [GO:0032006]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; epithelial to mesenchymal transition [GO:0001837]; metaphase plate congression [GO:0051310]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; protein localization to mitotic spindle [GO:1902480]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein catabolic process [GO:0042176]; regulation of TOR signaling [GO:0032006]; signal transduction [GO:0007165]	kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]	GO:0001837; GO:0005737; GO:0005819; GO:0005829; GO:0007165; GO:0008017; GO:0008283; GO:0015630; GO:0016477; GO:0019894; GO:0019901; GO:0032006; GO:0042176; GO:0045171; GO:0051301; GO:0051310; GO:0070372; GO:0072686; GO:0097431; GO:1902480; GO:1902808	FTLIDGIRVATGSYSFTWTDGK	6.010000229	0.747836888	0.747836888	0.145911139	2434.37154	16.74028	16.05157	0	16.988	0	0	14.83067	0	13.48424	14.16838	15.92225	12.83404	13.43019	0	13.83635	0	0	15.97044	0	12.445	14.40349	0	0	0	13.66805	14.74155	14.24647	15.78386	0	0	0	0	0	0	0	0	0	16.95549	0	15.41118	14.81869	0	13.07686	11.92292	14.59229	0	13.10753	12.07825
Q9H4I0	RD21L_HUMAN	Double-strand-break repair protein rad21-like protein 1	RAD21L1 RAD21L	Homo sapiens (Human)	mitotic sister chromatid cohesion [GO:0007064]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]	chromosome [GO:0005694]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	chromosome [GO:0005694]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; mitotic sister chromatid cohesion [GO:0007064]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]	chromatin binding [GO:0003682]	GO:0000795; GO:0003682; GO:0005634; GO:0005694; GO:0007064; GO:0007130; GO:0030893; GO:0034990; GO:0034991; GO:1990414	MGMQSFSLMK	7.809999943	1	1	0.121581991	1190.857097	0	16.04078	0	0	0	13.25056	0	0	13.81313	0	0	13.54053	0	14.73034	0	0	13.9346	0	0	0	0	0	0	0	0	0	0	0	0	14.65954	0	0	0	15.31873	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H4I8	SEHL2_HUMAN	"Serine hydrolase-like protein 2, EC 3.1.-.-"	SERHL2 SERHL	Homo sapiens (Human)		perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]	perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]	hydrolase activity [GO:0016787]	GO:0005777; GO:0016787; GO:0048471	FSILGHSFGGVVGGMFFCTFPEMVDK	5.28000021	1	1	0.099732571	2870.205569	16.5276	0	14.4128	0	15.4779	14.55616	11.41978	7.894661	0	0	12.83607	13.48198	0	16.78042	0	15.32727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.18458	0	0	0	0	0	0	13.93331	0
Q9H4I9	EMRE_HUMAN	"Essential MCU regulator, mitochondrial (Single-pass membrane protein with aspartate-rich tail 1, mitochondrial)"	SMDT1 C22orf32 EMRE	Homo sapiens (Human)	calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]		GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006851; GO:0031305; GO:0036444; GO:0051560; GO:1990246	SLVPSRSVIVTR	13.55000019	1	1	0.357591854	1313.6961	16.17459	0	13.45165	11.58105	14.88111	0	0	0	0	0	0	0	15.72637	13.19759	0	13.12656	15.14592	15.60325	16.2532	18.40305	18.0248	15.34448	15.76459	15.07628	0	0	0	0	0	0	0	16.66582	16.15362	18.32694	17.10614	17.55692	19.07162	18.08535	0	18.37721	18.13766	19.05258	17.29011	14.68295	19.13718	19.31045	18.62255	17.97448
Q9H4L5	OSBL3_HUMAN	"Oxysterol-binding protein-related protein 3, ORP-3, OSBP-related protein 3"	OSBPL3 KIAA0704 ORP3 OSBP3	Homo sapiens (Human)	bile acid biosynthetic process [GO:0006699]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]	cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]	GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0015248; GO:0015485; GO:0016020; GO:0031965; GO:0032433; GO:0032934; GO:0043231; GO:0097038	GEMNYTQEPPVQKGFLLK	1.700000048	0.040903848	0.040903848	0.154799462	2079.359243	18.56369	16.99385	0	0	0	17.51235	17.25498	0	0	0	0	16.71611	0	0	0	0	0	0	0	0	0	0	11.45318	14.96671	15.1276	0	0	0	0	0	0	17.65548	14.98172	0	9.90793	0	0	0	0	0	0	0	0	0	0	0	13.80657	14.89062
Q9H4L7	SMRCD_HUMAN	"SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1, EC 3.6.4.12 (ATP-dependent helicase 1, hHEL1)"	SMARCAD1 KIAA1122	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]	heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	"heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; ubiquitin binding [GO:0043130]; chromatin remodeling [GO:0006338]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]"	"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; ubiquitin binding [GO:0043130]"	GO:0000018; GO:0000729; GO:0000792; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0008094; GO:0016887; GO:0035861; GO:0043130; GO:0043596; GO:0051304; GO:0070932; GO:0070933; GO:0140658	LNYAIFDEGHMLK	3.680000067	7.65E-05	7.65E-05	3.20E-12	1567.086036	16.12385	14.68634	12.93091	16.49419	17.61588	16.10448	14.25589	15.9878	15.50595	15.58329	0	0	14.79475	0	0	0	0	0	0	0	0	0	0	15.28343	0	0	0	16.2872	0	0	16.9654	16.82261	18.49947	0	0	0	0	0	16.30728	0	0	0	0	0	12.5503	15.92437	0	0
Q9H4M7	PKHA4_HUMAN	"Pleckstrin homology domain-containing family A member 4, PH domain-containing family A member 4 (Phosphoinositol 3-phosphate-binding protein 1, PEPP-1)"	PLEKHA4 PEPP1	Homo sapiens (Human)	"positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]"	cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]"	"identical protein binding [GO:0042802]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0005546; GO:0005737; GO:0005886; GO:0031234; GO:0032266; GO:0042802; GO:0043325; GO:0080025; GO:0090263; GO:2000096	GEEGR	8.880000114	1	1	0.012339315	547.2977616	0	16.11923	0	0	0	0	0	17.22471	16.87264	0	0	0	0	0	0	15.2799	0	0	0	17.01837	16.29615	0	18.00733	17.52089	0	0	0	0	15.63127	16.88554	17.45574	17.22462	0	15.74875	0	0	0	0	0	0	0	0	0	0	0	0	15.71201	0
Q9H4R4	CT191_HUMAN	Putative nuclear receptor corepressor 1-like protein NCOR1P1 (Nuclear receptor corepressor 1 pseudogene 1)	NCOR1P1 C20orf191	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]		thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0006357; GO:0046966	EELIECMDRVDR	15.02999973	1	1	0.381608355	1579.455744	16.71484	13.56231	14.99026	15.75268	14.24262	10.36832	14.31486	16.85294	0	16.61496	14.51737	0	0	0	17.8917	0	0	0	14.00784	0	0	17.68928	15.51009	16.04986	0	17.08349	0	0	17.76966	14.75394	0	0	16.66491	0	0	0	0	0	0	0	15.08802	0	0	0	0	16.54555	0	18.54732
Q9H4W6	COE3_HUMAN	"Transcription factor COE3 (Early B-cell factor 3, EBF-3) (Olf-1/EBF-like 2, O/E-2, OE-2)"	EBF3 COE3	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0045893; GO:0046872	FGIQENIPRGGTTMK	6.150000095	1	1	0.281144831	1665.841647	16.02696	13.42417	14.81275	14.19469	0	14.01659	11.9159	15.022	14.13921	0	17.90326	15.30903	14.1518	13.54216	0	12.80573	0	0	15.68074	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.54139	0	0	0	0	0	0	15.67587	0	0	0	0
Q9H4Y5	GSTO2_HUMAN	"Glutathione S-transferase omega-2, GSTO-2, EC 2.5.1.18 (Glutathione S-transferase omega 2-2, GSTO 2-2) (Glutathione-dependent dehydroascorbate reductase, EC 1.8.5.1) (Monomethylarsonic acid reductase, MMA(V) reductase, EC 1.20.4.2)"	GSTO2	Homo sapiens (Human)	cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; xenobiotic metabolic process [GO:0006805]	glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]	GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0006805; GO:0016491; GO:0019852; GO:0042802; GO:0045174; GO:0050610; GO:0070062; GO:0071243	LWISAMK	2.569999933	1	1	0.296079462	863.6653104	0	0	15.6706	12.51354	15.69538	0	14.91467	14.41669	14.05292	14.28679	0	15.12248	0	0	16.5309	0	0	0	15.63689	15.946	0	0	0	0	0	15.77136	14.18458	12.3925	0	14.84305	0	0	0	0	0	0	12.61943	16.39016	0	0	0	0	16.4462	0	0	15.10951	0	14.87854
Q9H4Z2	ZN335_HUMAN	"Zinc finger protein 335 (NRC-interacting factor 1, NIF-1)"	ZNF335	Homo sapiens (Human)	"brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]"	histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]"	metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]	GO:0000976; GO:0000978; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0045944; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182	ATLLRHMR	1.379999995	1	1	0.226036315	1012.691274	0	15.06131	0	0	0	16.05976	0	18.5037	0	0	17.98173	0	0	16.68854	0	0	0	0	0	0	16.48901	0	0	0	0	0	0	0	0	0	0	17.93093	0	0	0	0	0	0	0	17.38973	0	0	0	0	0	0	0	0
Q9H4Z3	CAPAM_HUMAN	"mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase, EC 2.1.1.62 (Cap-specific adenosine methyltransferase, CAPAM, hCAPAM) (Phosphorylated CTD-interacting factor 1, hPCIF1) (Protein phosphatase 1 regulatory subunit 121)"	PCIF1 C20orf67 CAPAM PPP1R121	Homo sapiens (Human)	mRNA methylation [GO:0080009]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0005634; GO:0005654; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047; GO:1990269	DHSASK	8.109999657	1	1	0.26973358	643.7369946	0	0	18.54098	18.04371	19.46184	0	0	0	19.55257	18.6806	0	18.52489	0	18.04981	17.94742	0	0	18.9022	0	0	0	0	0	0	0	17.97707	20.76636	0	18.96229	0	18.74532	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.41339
Q9H501	ESF1_HUMAN	ESF1 homolog (ABT1-associated protein)	ESF1 ABTAP C20orf6 HDCMC28P	Homo sapiens (Human)	rRNA processing [GO:0006364]	extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]	GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0006364	DVASEVNLTAYKPK	15.69999981	1	1	0.029220762	1535.353991	16.10872	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.629	14.19754	15.30622	0	0	19.42545	0	15.25276	0	0	19.77051	19.1228	0	0	0	0	0	0	20.14061	15.65512	18.37671	0	0	0	0	0	0	0	0	0	0	20.15428	0
Q9H521	YM006_HUMAN	Putative uncharacterized protein LOC645739		Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]	actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein serine/threonine kinase activity [GO:0004674]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]	protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005737; GO:0005856; GO:0016477; GO:0018107; GO:0031032; GO:0042641	VNTMWQES	8.449999809	1	1	0.072877129	1010.84321	13.8263	14.57785	16.49897	13.92786	14.37269	13.70644	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.14937	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H553	ALG2_HUMAN	"Alpha-1,3/1,6-mannosyltransferase ALG2, EC 2.4.1.132, EC 2.4.1.257 (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)"	ALG2 UNQ666/PRO1298	Homo sapiens (Human)	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation in endoplasmic reticulum [GO:0033577]; response to calcium ion [GO:0051592]"	"alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]"	GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0006488; GO:0006490; GO:0016020; GO:0016021; GO:0033577; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704	GAAVCAYVR	2.519999981	1	1	0.072368531	967.5689464	15.30193	0	14.14933	0	0	0	0	0	0	0	0	0	0	0	10.27792	0	8.058535	0	0	0	0	0	13.61548	0	13.97206	0	0	0	0	0	15.15775	0	0	0	0	0	14.71102	0	0	14.31267	14.07046	0	16.75994	0	14.6784	0	0	0
Q9H582	ZN644_HUMAN	"Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2, Zep-2)"	ZNF644 KIAA1221 ZEP2	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]"	GO:0000978; GO:0000981; GO:0001222; GO:0005634; GO:0006357; GO:0046872	DSVVGSSK	7.230000019	1	1	0.121266028	779.4149239	0	0	15.40776	0	0	15.44125	0	14.59904	14.66781	0	0	0	0	0	17.28818	0	16.67066	0	0	0	18.05517	0	0	15.71738	0	15.63651	0	16.78716	15.08841	13.60419	16.41233	15.27697	13.46942	15.44915	15.12275	12.49705	0	14.12149	0	0	0	0	0	17.01114	0	15.97144	15.5354	0
Q9H583	HEAT1_HUMAN	"HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed ]"	HEATR1 BAP28 UTP10	Homo sapiens (Human)	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]"	90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]	"90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]"	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0045943; GO:2000234	INNSK	11.72000027	1	1	0.283854362	574.1127941	0	0	0	17.75894	15.30651	0	0	18.29952	15.55476	0	0	0	0	0	14.46251	16.83956	16.44271	0	16.46716	14.84141	0	14.95199	16.29395	15.90683	0	0	16.32164	0	0	15.81206	0	0	0	0	16.68108	0	0	15.95361	0	0	0	0	16.17768	0	0	16.41951	15.80326	16.37821
Q9H598	VIAAT_HUMAN	"Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter, hVIAAT)"	SLC32A1 VGAT VIAAT	Homo sapiens (Human)	aging [GO:0007568]; hippocampus development [GO:0021766]; ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter secretion [GO:0007269]	cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; dendrite terminus [GO:0044292]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672]	cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; dendrite terminus [GO:0044292]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; glycine transmembrane transporter activity [GO:0015187]; aging [GO:0007568]; hippocampus development [GO:0021766]; ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter secretion [GO:0007269]	amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; glycine transmembrane transporter activity [GO:0015187]	GO:0005886; GO:0006811; GO:0007269; GO:0007568; GO:0009986; GO:0015171; GO:0015187; GO:0015495; GO:0021766; GO:0030285; GO:0030425; GO:0030672; GO:0043005; GO:0044292; GO:0044306; GO:0044316; GO:0048786; GO:0051286; GO:0060077; GO:0061202; GO:0098700; GO:0098982	FYIDVK	5.849999905	6.15E-05	6.15E-05	0.222441483	783.3278619	0	11.68988	0	0	0	0	18.37198	17.10666	0	0	18.1232	15.63485	0	16.06419	0	16.85016	0	0	0	17.798	0	17.48899	0	15.37544	16.55437	17.04969	10.56857	15.48109	16.94757	16.43483	16.12358	0	17.2954	15.17681	0	0	18.99587	0	16.69141	0	0	14.55171	18.06279	17.03963	0	0	0	0
Q9H5I1	SUV92_HUMAN	"Histone-lysine N-methyltransferase SUV39H2, EC 2.1.1.355 (Histone H3-K9 methyltransferase 2, H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2, Su(var)3-9 homolog 2)"	SUV39H2 KMT1B	Homo sapiens (Human)	"cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; S-adenosyl-L-methionine binding [GO:1904047]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]"	histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; S-adenosyl-L-methionine binding [GO:1904047]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000775; GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006333; GO:0006338; GO:0007049; GO:0008270; GO:0018024; GO:0030154; GO:0034968; GO:0036123; GO:0036124; GO:0042754; GO:0045892; GO:0046974; GO:0048511; GO:0071456; GO:1904047	DMEYYLVK	6.110000134	1	1	0.173118249	1075.867846	12.80594	14.23241	14.54008	12.91159	15.09947	0	0	0	0	0	0	0	0	0	0	13.90863	13.76299	0	0	0	0	0	0	0	0	0	0	14.11595	15.52629	0	0	0	0	10.85708	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H5I5	PIEZ2_HUMAN	Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B)	PIEZO2 C18orf30 C18orf58 FAM38B	Homo sapiens (Human)	cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]	cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]	GO:0005261; GO:0005886; GO:0006812; GO:0008381; GO:0009612; GO:0016020; GO:0016021; GO:0042391; GO:0050974; GO:0050982; GO:0071260	IERCMLTR	9.220000267	1	1	0.362738007	1079.094891	0	17.07489	17.72076	17.9663	0	0	17.92564	17.92698	16.75576	0	0	0	0	0	0	0	16.18483	0	0	0	0	17.50892	0	0	0	0	0	0	0	0	18.33682	0	19.86847	18.92545	0	17.99074	0	0	0	0	0	0	18.48633	0	0	0	18.92369	0
Q9H5P4	PDZD7_HUMAN	PDZ domain-containing protein 7	PDZD7 PDZK7	Homo sapiens (Human)	auditory receptor cell development [GO:0060117]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; sensory perception of sound [GO:0007605]	cilium [GO:0005929]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696]	cilium [GO:0005929]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696]; identical protein binding [GO:0042802]; auditory receptor cell development [GO:0060117]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; sensory perception of sound [GO:0007605]	identical protein binding [GO:0042802]	GO:0002141; GO:0002142; GO:0005615; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0007605; GO:0032420; GO:0032426; GO:0042802; GO:0045184; GO:0050910; GO:0060088; GO:0060117; GO:1990696	CGSTPSDTSSEDGVRR	5.28000021	0.001228028	0.001228028	0.252180962	1711.885442	15.47649	11.76058	0	0	0	13.35602	15.10076	16.32167	0	0	0	0	0	0	16.49415	0	15.63226	0	0	0	0	0	0	16.35954	16.90187	0	15.43532	15.78429	15.41191	14.75382	0	14.39491	0	10.97501	14.09743	12.78461	0	15.46452	0	13.15363	0	15.02937	15.88367	15.70118	0	14.77829	15.64139	0
Q9H5Q4	TFB2M_HUMAN	"Dimethyladenosine transferase 2, mitochondrial, EC 2.1.1.- (Hepatitis C virus NS5A-transactivated protein 5, HCV NS5A-transactivated protein 5) (Mitochondrial 12S rRNA dimethylase 2) (Mitochondrial transcription factor B2, h-mtTFB, h-mtTFB2, hTFB2M, mtTFB2) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2)"	TFB2M NS5ATP5	Homo sapiens (Human)	mitochondrial transcription [GO:0006390]; rRNA methylation [GO:0031167]; transcription initiation from mitochondrial promoter [GO:0006391]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	"mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; transcription coregulator activity [GO:0003712]; mitochondrial transcription [GO:0006390]; rRNA methylation [GO:0031167]; transcription initiation from mitochondrial promoter [GO:0006391]"	"mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; transcription coregulator activity [GO:0003712]"	GO:0000179; GO:0003712; GO:0003723; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0031167; GO:0034246; GO:0042645	VLHMEPWSSFDIYTR	2.559999943	0.403865755	0.403865755	5.48E-12	1900.278778	12.98785	0	12.24869	0	0	0	0	15.88013	0	0	0	18.6664	0	16.16756	0	0	0	0	0	15.50222	0	0	18.0487	0	0	0	0	0	14.13319	0	0	0	16.27329	0	0	12.78167	17.62506	0	0	0	0	14.96563	15.47973	0	12.62936	16.90173	0	0
Q9H5V8	CDCP1_HUMAN	"CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein, SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318)"	CDCP1 TRASK UNQ2486/PRO5773	Homo sapiens (Human)		extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005576; GO:0005886; GO:0016021	HITMLSIKSGER	1.769999981	1	1	0.086329914	1370.943484	0	11.99851	9.840518	0	13.9268	0	0	0	0	0	0	0	0	10.82134	0	0	13.27648	0	0	2.48369	0	0	0	13.02607	0	0	0	0	0	0	0	0	0	10.21845	13.53663	12.04708	0	0	0	0	0	0	0	0	0	0	0	0
Q9H5Y7	SLIK6_HUMAN	SLIT and NTRK-like protein 6	SLITRK6	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; auditory behavior [GO:0031223]; auditory receptor cell morphogenesis [GO:0002093]; axonogenesis [GO:0007409]; cochlea development [GO:0090102]; innervation [GO:0060384]; lens development in camera-type eye [GO:0002088]; linear vestibuloocular reflex [GO:0060007]; multicellular organism growth [GO:0035264]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synapse assembly [GO:0007416]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adult locomotory behavior [GO:0008344]; auditory behavior [GO:0031223]; auditory receptor cell morphogenesis [GO:0002093]; axonogenesis [GO:0007409]; cochlea development [GO:0090102]; innervation [GO:0060384]; lens development in camera-type eye [GO:0002088]; linear vestibuloocular reflex [GO:0060007]; multicellular organism growth [GO:0035264]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synapse assembly [GO:0007416]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]		GO:0001964; GO:0002088; GO:0002093; GO:0005886; GO:0005887; GO:0007409; GO:0007416; GO:0007601; GO:0007605; GO:0008344; GO:0009986; GO:0021562; GO:0031223; GO:0035264; GO:0051965; GO:0060007; GO:0060384; GO:0090102; GO:1905606	LYLNGNHLTKLSK	4.329999924	1	1	0.259301063	1502.582974	0	13.36853	14.95175	13.3695	0	0	0	14.59372	15.39236	16.44827	0	0	0	0	0	0	0	0	16.60461	0	0	0	19.52437	0	0	0	14.42877	0	0	14.91521	15.60878	16.23081	0	16.53091	16.29613	0	0	16.43362	16.91253	15.79066	15.45983	0	0	17.57649	0	0	0	17.49454
Q9H5Z1	DHX35_HUMAN	"Probable ATP-dependent RNA helicase DHX35, EC 3.6.4.13 (DEAH box protein 35)"	DHX35 C20orf15 DDX35	Homo sapiens (Human)	"in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]	"catalytic step 2 spliceosome [GO:0071013]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0001701; GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0071013	LTEPLGMR	6.039999962	0.805123508	0.805123508	0.172884175	934.5975005	10.99969	15.57823	13.36007	15.86965	0	14.68068	13.96334	15.80253	0	14.095	14.56203	16.2418	0	0	14.10655	15.06006	15.32989	14.84536	0	0	0	17.29772	0	0	16.26339	14.75114	0	0	0	0	0	0	0	0	0	16.99115	0	0	0	13.10316	0	14.77707	0	0	0	0	0	0
Q9H609	ZN576_HUMAN	Zinc finger protein 576	ZNF576	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872	QMHEVR	5.960000038	1	1	0.171954267	798.278736	14.88243	0	13.80152	13.86766	15.85867	17.18128	0	0	0	0	0	0	17.78705	12.50425	0	16.95438	15.63756	0	0	15.54594	0	0	0	0	14.99478	15.89434	15.91437	14.3235	0	15.24378	16.95971	0	0	0	0	0	0	16.54702	15.78567	0	15.4971	16.28902	16.81159	0	15.70676	0	0	13.03089
Q9H611	PIF1_HUMAN	"ATP-dependent DNA helicase PIF1, EC 3.6.4.12 (DNA repair and recombination helicase PIF1) (PIF1/RRM3 DNA helicase-like protein)"	PIF1 C15orf20	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004]	"chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]"	"chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004]"	5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]	GO:0000002; GO:0000287; GO:0000781; GO:0005524; GO:0005654; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0007004; GO:0010521; GO:0016887; GO:0017116; GO:0032204; GO:0032211; GO:0032508; GO:0033678; GO:0042162; GO:0043139; GO:0051880; GO:0051974	LGAQVMLVK	3.75999999	1	1	8.01E-13	957.5128661	15.92958	11.76999	0	15.25107	14.6827	14.09417	14.50596	14.67925	12.52052	12.58615	0	17.87563	13.7196	15.21426	15.2684	0	0	0	16.30334	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H649	NSUN3_HUMAN	"tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 3)"	NSUN3 MSTP077 UG0651E06	Homo sapiens (Human)	regulation of mitochondrial translation [GO:0070129]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]; tRNA wobble base cytosine methylation [GO:0002127]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; regulation of mitochondrial translation [GO:0070129]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]; tRNA wobble base cytosine methylation [GO:0002127]	methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	GO:0000049; GO:0001510; GO:0002127; GO:0005739; GO:0005759; GO:0005762; GO:0008168; GO:0016428; GO:0031167; GO:0070129	SWSTGK	13.73999977	0.260558605	0.260558605	0.286503949	665.9943861	17.91701	18.27963	17.09849	0	0	17.87397	0	18.44428	17.65686	0	19.12801	17.4498	17.17944	0	0	17.16339	17.26489	18.00768	0	0	0	0	0	19.10587	0	18.41298	0	19.61056	0	18.54988	19.2394	18.69491	17.86634	0	19.45426	19.70638	18.04733	19.33802	19.86284	19.1188	19.03298	0	19.57397	18.57035	18.34343	0	17.15951	20.01159
Q9H668	STN1_HUMAN	CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog)	STN1 OBFC1	Homo sapiens (Human)	negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]	"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]"	single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162]	GO:0000723; GO:0000781; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0010833; GO:0016233; GO:0032211; GO:0042162; GO:0043047; GO:0043231; GO:0045111; GO:0045740; GO:1990879	MQPGSSR	5.78000021	1	1	3.47E-13	763.5097121	0	0	15.02764	0	0	0	0	0	0	15.34084	0	0	15.61756	0	0	0	0	0	0	0	0	0	0	0	0	15.9286	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.28536	0	0	0	0	0	0	0
Q9H672	ASB7_HUMAN	"Ankyrin repeat and SOCS box protein 7, ASB-7"	ASB7	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]	cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		GO:0005829; GO:0016567; GO:0035556	IARLMLESEYR	5.289999962	1	1	4.59E-13	1396.816846	13.4615	13.89453	11.52763	14.28815	13.08293	0	14.52335	16.25277	0	15.18186	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.71787	0	0	0	0	0	14.29308	0	0	0	0	0	0	0	15.03574	15.98924	0	0	0	0	0	12.87533	0
Q9H694	BICC1_HUMAN	"Protein bicaudal C homolog 1, Bic-C"	BICC1	Homo sapiens (Human)	determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; RNA binding [GO:0003723]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090]	RNA binding [GO:0003723]	GO:0001822; GO:0003723; GO:0005737; GO:0007368; GO:0007507; GO:0090090	EMIMSVLDTK	7.989999771	1	1	0.108785829	1166.96926	13.72744	14.01213	10.39277	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.44359	0	7.653265	0	0	15.72935	15.13342	0	0	13.79315	14.78446	14.12075	14.03406	0	15.13702	0	0	0	15.09895	0	0	0	8.10481	0	13.73942	0	0	0	0	0
Q9H6A9	PCX3_HUMAN	Pecanex-like protein 3 (Pecanex homolog protein 3)	PCNX3 PCNXL3	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	VVAPGVR	4.230000019	0.000386235	0.000386235	0.279622965	697.6621313	18.07656	17.54519	17.60489	0	0	0	18.92118	18.83189	19.0599	0	18.01291	0	0	0	16.59164	0	18.08739	0	17.94202	0	0	20.01161	18.76938	16.41343	0	0	16.37255	0	16.27536	17.93844	0	19.17038	18.23833	0	0	0	18.5941	0	0	18.20962	0	0	0	19.00153	0	17.86069	0	0
Q9H6B4	CLMP_HUMAN	"CXADR-like membrane protein (Adipocyte adhesion molecule) (Coxsackie- and adenovirus receptor-like membrane protein, CAR-like membrane protein)"	CLMP ACAM ASAM UNQ318/PRO363	Homo sapiens (Human)	digestive tract development [GO:0048565]	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; digestive tract development [GO:0048565]		GO:0005881; GO:0005886; GO:0005923; GO:0009986; GO:0016021; GO:0048565	MSLLLLLLLVSYYVGTLGTHTEIKR	3.380000114	1	1	0.615473936	2850.494452	0	0	0	18.11317	0	0	0	0	0	0	0	0	0	0	0	0	0	17.74365	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H6D7	HAUS4_HUMAN	HAUS augmin-like complex subunit 4	HAUS4 C14orf94	Homo sapiens (Human)	cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]	centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225]	microtubule minus-end binding [GO:0051011]	GO:0005813; GO:0005829; GO:0007098; GO:0051011; GO:0051225; GO:0051301; GO:0070652; GO:1990498	EQMLLLEKK	5.800000191	1	1	0.152310854	1146.758826	0	4.706577	0	12.60439	11.65837	0	16.06651	14.57754	0	0	0	0	0	0	14.02111	13.09169	0	14.56327	0	0	0	0	0	0	15.05573	0	0	16.18443	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.00239	0	0	0
Q9H6F5	CCD86_HUMAN	Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain)	CCDC86 CYCLON	Homo sapiens (Human)		chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730	DTPLRR	5.360000134	0.164699838	0.164699838	0.114784727	758.1918432	0	18.5085	0	0	19.78575	11.04931	0	17.83964	0	0	0	0	0	18.53643	16.28621	18.83105	17.55805	0	14.79546	13.26887	0	0	15.01162	0	0	0	16.05201	0	17.84825	17.79841	0	12.67286	18.40639	17.78438	15.40538	0	0	0	16.67978	0	14.4777	14.00229	0	0	18.89863	16.41175	0	0
Q9H6K5	PRR36_HUMAN	Proline-rich protein 36	PRR36	Homo sapiens (Human)						AGAAARTPAAR	12.82999992	1	1	0.234589645	1013.151104	0	15.46862	9.229641	0	14.35503	13.38113	0	0	0	14.80414	0	0	13.95008	13.24724	14.55712	14.50201	0	0	14.20525	0	0	14.21789	16.65519	11.76278	0	0	0	0	0	0	0	14.81215	0	0	0	14.82777	14.65769	14.62823	0	15.80634	0	11.66916	12.71184	0	0	0	0	13.50929
Q9H6N6	MYH16_HUMAN	Putative uncharacterized protein MYH16 (Myosin heavy chain 16 pseudogene) (myosin heavy polypeptide 5)	MYH16 MYH5	Homo sapiens (Human)		centriole [GO:0005814]; centrosome [GO:0005813]; myosin complex [GO:0016459]	centriole [GO:0005814]; centrosome [GO:0005813]; myosin complex [GO:0016459]		GO:0005813; GO:0005814; GO:0016459	AMMDAARMAEELR	9.369999886	1	1	0.279275198	1525.699825	0	0	0	0	0	0	18.91475	0	0	0	18.48054	0	0	0	0	0	0	0	0	0	16.76786	0	0	0	0	0	0	0	0	0	0	0	0	19.4562	19.54482	0	19.23449	0	16.87092	0	0	0	0	0	0	0	0	0
Q9H6P5	TASP1_HUMAN	"Threonine aspartase 1, Taspase-1, EC 3.4.25.- [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta ]"	TASP1 C20orf13	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]"	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]"	identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298]	GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604	RQSSEK	1.460000038	1	1	0.234153141	731.1152454	18.27129	17.98479	16.66241	0	17.56911	18.84625	17.5017	15.24566	16.82481	18.18696	17.27002	16.95751	16.82242	16.7847	17.10709	17.65895	17.57764	0	17.14547	17.00586	15.36717	17.38815	17.71003	0	17.40038	18.75652	17.2412	18.6794	0	18.21278	18.0621	18.77598	0	0	17.32507	17.33655	17.36022	16.91454	16.70972	16.50953	17.33961	16.76357	16.06945	17.1728	16.96258	18.18329	16.93475	17.07162
Q9H6R0	DHX33_HUMAN	"ATP-dependent RNA helicase DHX33, EC 3.6.4.13 (DEAH box protein 33)"	DHX33 DDX33	Homo sapiens (Human)	positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227	ENFVNSK	2.930000067	0.714855433	0.714855433	0.068191779	838.5658061	0	0	14.81327	16.57809	0	0	0	0	0	0	0	0	16.81609	12.88585	0	0	0	0	0	0	0	0	0	0	0	14.46255	15.23122	15.84773	0	16.4832	15.69969	17.00385	0	0	0	0	0	0	15.98074	16.79303	16.12439	15.48097	16.64421	15.66982	15.1556	16.03434	0	0
Q9H6R3	ACSS3_HUMAN	"Acyl-CoA synthetase short-chain family member 3, mitochondrial, EC 6.2.1.1 (Acetate--CoA ligase 3) (Acyl-CoA synthetase short-chain family member 3) (Propionate--CoA ligase, EC 6.2.1.17)"	ACSS3	Homo sapiens (Human)	ketone body biosynthetic process [GO:0046951]; lipid metabolic process [GO:0006629]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]; ketone body biosynthetic process [GO:0046951]; lipid metabolic process [GO:0006629]	acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006629; GO:0043231; GO:0046951; GO:0047760; GO:0050218	QQDPGAALGKQYSLTR	15.43000031	1	1	0.13864816	1731.876129	0	0	0	0	0	0	15.45758	0	0	0	0	0	0	0	0	20.5538	0	14.45225	0	0	0	0	0	0	0	21.66145	0	0	0	0	21.87094	0	0	21.72673	0	0	0	19.59542	0	0	0	0	0	0	19.31836	0	0	0
Q9H6R4	NOL6_HUMAN	"Nucleolar protein 6 (Nucleolar RNA-associated protein, Nrap)"	NOL6	Homo sapiens (Human)	rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]	condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]	condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]	RNA binding [GO:0003723]	GO:0000794; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006364; GO:0006409; GO:0032040; GO:0032545; GO:0034456	NSVWTQDGPSAQILQQLVVLAAEALPMLEK	2.799999952	1	1	2.30E-12	3264.538335	15.91819	0	12.83244	0	0	0	0	0	9.847389	0	0	13.60836	0	0	8.996478	0	0	11.48394	0	12.55727	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.39448	0	0	0	0	0	0	0	0
Q9H6R7	WDCP_HUMAN	WD repeat and coiled-coil-containing protein	WDCP C2orf44 PP384	Homo sapiens (Human)	protein complex oligomerization [GO:0051259]		kinase binding [GO:0019900]; protein complex oligomerization [GO:0051259]	kinase binding [GO:0019900]	GO:0019900; GO:0051259	KAVTMTR	9.539999962	0.533571839	0.533571839	0.193355199	807.5362005	15.68262	14.80676	15.56028	13.9927	14.81115	15.66812	14.03169	15.36064	15.27919	15.18729	13.21459	0	15.5307	16.02425	15.13801	13.6392	15.37145	14.78463	16.10304	14.5526	15.99563	16.17488	0	0	15.20414	15.13694	16.1338	0	14.33707	13.76919	14.59392	14.67417	0	15.4038	15.88864	16.59892	15.89276	0	15.54947	13.90289	15.40485	15.34668	15.06734	15.65048	15.47015	16.83919	16.16206	16.2032
Q9H6S0	YTDC2_HUMAN	"3'-5' RNA helicase YTHDC2, EC 3.6.4.13 (YTH domain-containing protein 2, hYTHDC2)"	YTHDC2	Homo sapiens (Human)	"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770]	"endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]"	"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]"	GO:0003723; GO:0005524; GO:0005634; GO:0005783; GO:0007286; GO:0008186; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247	QPAPGGGGGGGPSPCGPGGGGRAK	2.49000001	0.556190372	0.556190372	0.126065012	1988.909693	14.08637	0	16.24112	0	17.05523	16.54009	16.62923	0	15.97959	0	0	12.39999	14.94344	14.4281	0	16.6322	14.92557	16.17204	10.48545	0	0	17.24325	15.02749	16.36881	17.93683	14.96572	0	10.40857	0	0	0	0	14.94077	0	14.74524	0	15.52772	0	16.38364	16.45979	14.94123	15.09731	15.52059	14.80394	17.14485	9.416117	15.32158	16.43636
Q9H6S3	ES8L2_HUMAN	"Epidermal growth factor receptor kinase substrate 8-like protein 2, EPS8-like protein 2 (Epidermal growth factor receptor pathway substrate 8-related protein 2, EPS8-related protein 2)"	EPS8L2 EPS8R2 PP13181	Homo sapiens (Human)	positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605]	actin binding [GO:0003779]; cadherin binding [GO:0045296]	GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0007605; GO:0031982; GO:0032421; GO:0032426; GO:0032587; GO:0032991; GO:0035023; GO:0045296; GO:0050790; GO:0070062; GO:1900029	NANELSVLKDEVLEVLEDGR	2.480000019	1	1	1.38E-12	2243.268455	0	12.85566	0	0	15.98497	0	10.93372	0	0	13.67537	13.42707	14.42934	0	0	0	17.52362	0	15.14034	0	0	0	14.12833	0	13.76447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H6T0	ESRP2_HUMAN	Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B)	ESRP2 RBM35B PP7059	Homo sapiens (Human)	"alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of RNA splicing [GO:0043484]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of RNA splicing [GO:0043484]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000380; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0043484; GO:0050679; GO:0060441; GO:0060445; GO:1990904	GLPWQSSDQDVARFFK	11.31000042	1	1	0.376685468	1880.372752	0	15.63493	15.44321	0	0	0	0	12.98677	0	0	0	0	14.96709	0	11.53274	0	10.70499	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.82536	0	0	0	16.97512	0	0	0	15.0178	0	0	0	0	15.55717	0	0	0
Q9H6T3	RPAP3_HUMAN	RNA polymerase II-associated protein 3	RPAP3	Homo sapiens (Human)	protein stabilization [GO:0050821]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; R2TP complex [GO:0097255]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; R2TP complex [GO:0097255]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; protein stabilization [GO:0050821]		GO:0005829; GO:0050821; GO:0097255; GO:0101031; GO:1990062	MTSANKAIELQLQVK	8.029999733	1	1	0	1690.411959	0	0	0	0	0	0	0	0	0	0	0	14.77829	0	0	0	0	0	0	0	0	0	0	0	0	0	16.28309	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53092	0	0	0
Q9H6Z4	RANB3_HUMAN	"Ran-binding protein 3, RanBP3"	RANBP3	Homo sapiens (Human)	protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R-SMAD binding [GO:0070412]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790]	R-SMAD binding [GO:0070412]; small GTPase binding [GO:0031267]	GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0006611; GO:0031267; GO:0050790; GO:0070412	LILNTK	38.97999954	0.903175652	0.903175652	0.045362113	701.2092435	16.3986	16.32601	15.54001	14.72117	16.588	17.65167	20.13555	16.87239	0	17.44653	16.91319	16.95399	16.33298	0	16.87844	15.68596	16.38055	16.66314	16.76318	16.22383	17.27516	16.93008	18.06012	18.57388	0	15.16741	17.29464	16.46815	16.00808	0	16.83453	18.68752	16.7377	16.18598	17.01129	17.76441	0	0	17.96532	14.78851	17.757	16.32266	0	16.33677	17.1874	17.27326	16.05466	15.20973
Q9H706	GARE1_HUMAN	GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1)	GAREM1 C18orf11 FAM59A GAREM	Homo sapiens (Human)	cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; proline-rich region binding [GO:0070064]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]	proline-rich region binding [GO:0070064]	GO:0005886; GO:0007173; GO:0008284; GO:0051781; GO:0070064; GO:0070374; GO:0071364	LNSISK	5.940000057	1	1	0.181056865	662.4799401	13.65479	0	13.73434	14.64943	0	0	0	0	14.39065	12.23778	0	0	0	0	0	0	0	15.11869	0	0	0	0	17.03797	0	0	0	0	0	0	0	15.10312	16.15504	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H714	PACER_HUMAN	"Protein associated with UVRAG as autophagy enhancer, Pacer (Protein Rubicon-like)"	RUBCNL C13orf18 KIAA0226L	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; autophagosome-endosome fusion [GO:0061910]; autophagosome-lysosome fusion [GO:0061909]; lipid metabolic process [GO:0006629]; regulation of glycogen metabolic process [GO:0070873]; regulation of lipid metabolic process [GO:0019216]	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome maturation [GO:0097352]; autophagosome-endosome fusion [GO:0061910]; autophagosome-lysosome fusion [GO:0061909]; lipid metabolic process [GO:0006629]; regulation of glycogen metabolic process [GO:0070873]; regulation of lipid metabolic process [GO:0019216]	phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]	GO:0000421; GO:0006629; GO:0010314; GO:0019216; GO:0031410; GO:0032266; GO:0043231; GO:0061909; GO:0061910; GO:0070273; GO:0070873; GO:0097352; GO:1901981	KGLLAPLLK	3.589999914	1	1	0.134370837	953.8132933	15.12805	0	0	15.80381	0	15.48747	0	0	0	0	14.45874	14.63914	0	0	0	0	15.35944	0	0	0	0	0	16.63829	0	16.8238	0	0	0	14.99903	0	15.06816	16.50032	14.60943	14.564	14.0949	0	16.6348	15.23783	14.85314	15.48759	0	14.13639	14.0472	16.73116	14.82571	0	0	0
Q9H720	PG2IP_HUMAN	PGAP2-interacting protein (Cell wall biogenesis protein 43 C-terminal homolog)	CWH43 PGAP2IP	Homo sapiens (Human)	GPI anchor biosynthetic process [GO:0006506]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506]		GO:0005783; GO:0006506; GO:0016021	LFLWLLVGVGLLGLGLRHK	1	1	1	0.226870976	2104.987701	14.24782	0	14.07844	14.49365	3.930021	0	14.35315	12.64948	13.98898	0	0	0	12.13684	12.5155	13.09734	11.60543	0	0	0	0	0	0	0	0	0	10.73498	17.7004	0	0	0	0	10.89951	0	0	14.79305	0	0	15.59329	0	0	17.71298	14.77588	0	0	13.63954	0	0	0
Q9H765	ASB8_HUMAN	"Ankyrin repeat and SOCS box protein 8, ASB-8"	ASB8 PP14212	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]	cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		GO:0005829; GO:0016567; GO:0035556	GLGTEK	11.05000019	1	1	0.141226533	604.4253331	16.15488	15.89162	0	15.08088	15.5842	13.29475	14.67075	15.71466	15.66904	0	14.50394	16.1568	0	15.62418	0	15.7313	15.32536	0	15.329	0	0	13.53254	14.27177	0	16.36436	14.31517	16.66716	0	0	0	0	0	0	0	16.65421	0	16.21367	0	0	0	16.57327	0	0	15.73698	16.93492	0	0	17.0117
Q9H773	DCTP1_HUMAN	"dCTP pyrophosphatase 1, EC 3.6.1.12 (Deoxycytidine-triphosphatase 1, dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein)"	DCTPP1 XTP3TPA CDA03	Homo sapiens (Human)	dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]	dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]	GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840	MDINRR	3.650000095	1	1	0.088719013	820.3066919	0	0	0	0	0	0	0	0	0	0	0	0	0	16.5297	0	15.13323	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.01904	14.08625	16.37168	0	17.94087	0	0	16.25312	0	0	0	0	0	0	0
Q9H788	SH24A_HUMAN	SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38)	SH2D4A PPP1R38 SH2A	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatase binding [GO:0019902]	phosphatase binding [GO:0019902]	GO:0005737; GO:0005829; GO:0019902	ANELLLSTGMPGSFLIRVSER	3.25	1	1	4.58E-13	2305.593357	0	0	14.77555	0	0	0	0	0	0	0	0	0	0	0	13.27358	0	13.51929	10.84162	0	0	13.46166	0	0	14.08434	0	0	0	9.890716	0	0	14.82656	0	0	15.1648	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H792	PEAK1_HUMAN	Inactive tyrosine-protein kinase PEAK1 (Pseudopodium-enriched atypical kinase 1) (Sugen kinase 269) (Tyrosine-protein kinase SgK269)	PEAK1 KIAA2002	Homo sapiens (Human)	cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446]	identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]	GO:0004672; GO:0004715; GO:0005737; GO:0005925; GO:0006468; GO:0015629; GO:0016477; GO:0034446; GO:0042802; GO:0046777; GO:0048041; GO:0051893	EIAGLDTAPQIR	5.869999886	1	1	0.240246656	1282.672916	0	0	0	0	0	0	0	13.21917	0	0	0	0	0	0	0	0	15.79161	0	0	0	0	0	0	16.20251	0	0	16.25899	0	0	0	0	0	0	0	0	0	16.7873	15.20545	0	15.90509	0	15.88369	0	0	0	0	0	0
Q9H799	CPLN1_HUMAN	Ciliogenesis and planar polarity effector 1 (Protein JBTS17)	CPLANE1 C5orf42 JBTS17	Homo sapiens (Human)	cilium assembly [GO:0060271]	ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]	ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cilium assembly [GO:0060271]		GO:0016021; GO:0035869; GO:0060271	AGGAK	3.400000095	0.287054479	0.287054479	0.057283855	403.9450421	0	0	15.91118	0	17.94157	0	17.04572	15.27987	0	17.88704	0	18.37921	0	16.20331	10.03321	0	0	17.54913	16.88674	18.42428	18.86169	19.93621	0	0	14.94728	16.54036	19.54287	18.57518	17.44689	0	19.54482	0	0	0	0	0	17.16436	17.65787	17.32055	16.50215	0	18.21164	14.60828	0	17.4365	16.00852	0	0
Q9H7B2	RPF2_HUMAN	Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog)	RPF2 BXDC1	Homo sapiens (Human)	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]"	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]"	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000027; GO:0000463; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0008097; GO:0019843; GO:0042273; GO:1901796; GO:1902570	CPEGTKPMLIFAGDDFDVTEDYR	2.630000114	1	1	2.29E-12	2675.211022	12.50914	14.14194	0	0	0	0	0	0	15.53635	0	0	15.16588	14.10288	0	0	0	14.2879	13.89338	0	14.87386	0	12.79616	0	14.00695	0	14.04367	0	15.8262	13.10626	13.1794	0	0	0	15.07038	10.99247	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H7B4	SMYD3_HUMAN	"Histone-lysine N-methyltransferase SMYD3, EC 2.1.1.354 (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)"	SMYD3 ZMYND1 ZNFN3A1	Homo sapiens (Human)	cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]	histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]	GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0034968; GO:0045184; GO:0045944; GO:0046872; GO:0071549	FATAKR	8.729999542	1	1	0.141927884	693.6498768	15.69126	0	13.9358	0	0	0	0	14.97925	15.03598	0	16.63661	0	0	0	0	17.36333	0	0	0	16.63133	16.57299	0	0	16.22807	0	16.33691	14.87357	0	0	0	0	0	0	0	0	0	0	17.23743	0	16.37568	0	17.31903	17.2889	0	0	0	16.30437	0
Q9H7C4	SYNCI_HUMAN	Syncoilin (Syncoilin intermediate filament 1) (Syncoilin-1)	SYNC SYNC1	Homo sapiens (Human)	intermediate filament-based process [GO:0045103]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; Z disc [GO:0030018]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; intermediate filament-based process [GO:0045103]		GO:0005829; GO:0005882; GO:0030018; GO:0031594; GO:0042383; GO:0045103; GO:0048471	LHAQAELER	5.949999809	1	1	0.217533973	1066.958002	0	0	12.82422	0	0	12.91453	15.11637	0	14.38995	13.51276	0	0	13.85506	14.16784	0	0	0	0	15.57761	0	17.61953	0	0	0	0	0	0	14.27876	0	0	0	16.08509	0	15.79052	0	0	16.39635	0	0	0	0	0	0	0	0	0	16.20481	0
Q9H7C9	AAMDC_HUMAN	Mth938 domain-containing protein (Adipogenesis associated Mth938 domain-containing protein)	AAMDC C11orf67 PTD015	Homo sapiens (Human)	positive regulation of fat cell differentiation [GO:0045600]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; positive regulation of fat cell differentiation [GO:0045600]		GO:0005737; GO:0045600	GMSEALK	5.860000134	1	1	0.013367961	734.3842659	0	0	0	0	0	0	0	0	0	0	0	0	16.77114	16.30562	0	15.67465	0	0	16.93685	0	0	0	0	0	14.52629	0	0	16.3395	0	15.43692	14.7457	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H7D0	DOCK5_HUMAN	Dedicator of cytokinesis protein 5	DOCK5	Homo sapiens (Human)	cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; cell migration [GO:0016477]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0010634; GO:0016477; GO:1900026; GO:1904694; GO:1904754	EAKAPPPPPPK	1.830000043	1	1	0.152796635	1129.243054	0	0	0	0	14.6776	0	0	0	15.80458	0	0	0	0	14.8606	0	0	0	13.31629	0	0	15.58723	0	0	0	0	0	0	13.24538	12.33939	11.97991	0	0	0	0	0	12.3381	0	0	0	7.502865	0	0	0	0	11.62097	0	0	0
Q9H7E2	TDRD3_HUMAN	Tudor domain-containing protein 3	TDRD3	Homo sapiens (Human)	chromatin organization [GO:0006325]; DNA topological change [GO:0006265]	cytosol [GO:0005829]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; DNA topological change [GO:0006265]	chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006265; GO:0006325; GO:0035064; GO:0140225	RGGDGQPR	5.579999924	1	1	0.090130934	842.8327506	11.96844	15.44235	15.9945	13.5118	12.79133	0	0	0	14.49483	13.43969	13.84966	13.9843	17.55827	16.25724	17.80406	0	14.48532	15.12906	17.11116	0	0	17.56454	18.11662	0	0	12.95387	14.53726	14.86209	15.35379	15.28976	0	0	0	0	0	0	0	0	0	0	0	16.28109	0	0	0	0	0	0
Q9H7F0	AT133_HUMAN	"Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase, EC 7.6.2.16)"	ATP13A3 AFURS1	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]	early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]	early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]	ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]	GO:0005524; GO:0006874; GO:0015594; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038	HSAGLTKGMHAYR	6.809999943	1	1	6.95E-13	1428.640991	16.48697	0	0	0	0	0	0	0	0	0	0	12.01494	0	0	0	0	0	15.51407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.06157	0	0	0	0	0	0	0	0	0	0	0
Q9H7L2	KI3X1_HUMAN	Putative killer cell immunoglobulin-like receptor-like protein KIR3DX1 (Leukocyte receptor cluster member 12)	KIR3DX1 KIR3DL0 LENG12	Homo sapiens (Human)		extracellular region [GO:0005576]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; plasma membrane [GO:0005886]		GO:0005576; GO:0005886	KPSLSTQVDPMMR	3.720000029	0.855736315	0.855736315	0.287594725	1489.036356	16.10322	0	15.15513	15.32638	0	0	12.76134	0	13.00913	0	0	16.94789	0	13.84077	0	0	14.93381	0	0	0	0	0	0	15.62726	0	15.06201	0	0	0	0	0	14.2326	0	16.62006	0	0	16.12017	0	16.82973	0	0	0	0	0	0	16.21458	0	0
Q9H7N4	SFR19_HUMAN	"Splicing factor, arginine/serine-rich 19 (SR-related C-terminal domain-associated factor 1, SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor, SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1, SR-A1)"	SCAF1 SFRS19 SRA1	Homo sapiens (Human)	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]	nucleus [GO:0005634]	nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]	GO:0003723; GO:0005634; GO:0006366; GO:0006397; GO:0008380; GO:0019904; GO:0099122	EGSSSSEGR	7.119999886	0.421275288	0.421275288	0.228040888	893.5081312	16.45223	16.82807	0	15.54375	15.74567	15.12847	18.28673	0	15.20164	0	17.02715	12.911	16.44799	14.71212	15.05337	16.24517	0	0	15.63484	15.1314	0	0	16.30944	16.51939	0	0	17.2741	15.25509	0	15.47352	17.40794	17.46001	14.62641	15.4815	0	0	0	17.12894	17.4798	0	15.77762	14.30667	15.75407	17.4715	10.19237	0	0	0
Q9H7T0	CTSRB_HUMAN	"Cation channel sperm-associated auxiliary subunit beta, CatSper-beta"	CATSPERB C14orf161	Homo sapiens (Human)	cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	CatSper complex [GO:0036128]; cilium [GO:0005929]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]	CatSper complex [GO:0036128]; cilium [GO:0005929]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]		GO:0005886; GO:0005929; GO:0007283; GO:0030154; GO:0036128; GO:0097228	ESPLIYVSVLLLNIFEFSSGIVYNK	3.460000038	1	1	4.72E-13	2844.681568	15.80184	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H7T3	CJ095_HUMAN	Uncharacterized protein C10orf95	C10orf95	Homo sapiens (Human)						LPKAEGDK	11.26000023	1	1	0.170251275	857.6961903	0	0	0	0	0	0	0	0	14.63914	0	0	0	16.01236	0	17.39582	0	16.20076	0	0	16.88452	17.02991	0	0	0	0	0	0	15.28729	15.49905	13.49476	15.85235	0	0	14.04362	17.12713	14.16137	0	17.29896	16.81037	0	15.6054	15.02162	0	0	0	0	0	0
Q9H7T9	AUNIP_HUMAN	"Aurora kinase A and ninein-interacting protein, AIBp"	AUNIP C1orf135	Homo sapiens (Human)	double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; spindle organization [GO:0007051]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle pole [GO:0000922]; damaged DNA binding [GO:0003684]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; spindle organization [GO:0007051]	damaged DNA binding [GO:0003684]	GO:0000724; GO:0000922; GO:0003684; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0090734; GO:2001033	VQTHLIKPGTK	2.880000114	1	1	0.194591211	1221.552282	0	18.13774	0	0	0	0	0	0	16.09144	0	0	0	15.76514	0	0	0	0	0	0	0	0	0	0	16.74114	0	0	18.1846	0	0	0	0	17.91101	0	0	0	0	17.97998	17.36376	0	0	15.57917	16.106	0	0	0	0	0	0
Q9H7V2	SYNG1_HUMAN	"Synapse differentiation-inducing gene protein 1, SynDIG1 (Dispanin subfamily C member 2, DSPC2) (Transmembrane protein 90B)"	SYNDIG1 C20orf39 TMEM90B	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; positive regulation of synapse assembly [GO:0051965]; synaptic vesicle clustering [GO:0097091]	cell body [GO:0044297]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synaptic vesicle membrane [GO:0030672]	cell body [GO:0044297]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synaptic vesicle membrane [GO:0030672]; glutamate receptor binding [GO:0035254]; protein homodimerization activity [GO:0042803]; intracellular protein transport [GO:0006886]; positive regulation of synapse assembly [GO:0051965]; synaptic vesicle clustering [GO:0097091]	glutamate receptor binding [GO:0035254]; protein homodimerization activity [GO:0042803]	GO:0005887; GO:0006886; GO:0014069; GO:0016020; GO:0030672; GO:0031901; GO:0035254; GO:0042803; GO:0043197; GO:0043198; GO:0043231; GO:0044297; GO:0051965; GO:0060076; GO:0097091; GO:0098839	YRPNIILYSEGVLR	18.35000038	0.524778605	0.524778605	0.000893391	1693.278671	19.42218	18.42159	18.64211	18.8041	18.92686	20.09193	18.97157	18.0756	0	19.57173	19.66307	18.00222	16.79535	18.75529	0	18.28793	18.9001	0	17.98146	17.47167	17.31401	18.32315	17.99277	19.00757	18.78104	18.65356	18.51383	17.54999	17.71841	18.38372	18.30381	18.08564	18.05624	18.56452	18.4044	0	19.57617	18.7071	18.88569	18.88665	19.23603	19.116	17.45988	18.7012	19.00367	16.65345	16.39655	18.63293
Q9H7X3	ZN696_HUMAN	Zinc finger protein 696	ZNF696	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	CSSDAAK	6.329999924	1	1	0.251949183	738.3517542	0	15.59436	0	0	17.88303	0	0	17.96618	18.42308	0	0	18.02029	0	0	0	0	16.9528	0	0	0	0	19.11738	0	0	0	0	0	17.48608	0	0	17.02022	0	0	0	0	0	0	0	0	0	0	0	15.92684	0	0	0	0	17.62218
Q9H7Y0	DIK2B_HUMAN	Divergent protein kinase domain 2B (Deleted in autism-related protein 1)	DIPK2B CXorf36 DIA1R UNQ1862/PRO3743	Homo sapiens (Human)		extracellular region [GO:0005576]	extracellular region [GO:0005576]		GO:0005576	DASAVGVIDK	6.829999924	1	1	0.07247895	975.4659826	0	0	13.41479	0	0	15.38934	14.3081	15.30454	0	0	0	0	16.75433	0	0	0	17.21755	15.70519	0	0	0	0	0	0	0	0	0	0	0	0	14.05863	0	0	14.07437	18.65355	0	0	0	0	0	0	0	0	0	0	0	13.41095	0
Q9H7Z3	NRDE2_HUMAN	Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog)	NRDE2 C14orf102	Homo sapiens (Human)	cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin assembly by small RNA [GO:0031048]; mitotic cell cycle [GO:0000278]; mRNA processing [GO:0006397]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; heterochromatin assembly by small RNA [GO:0031048]; mitotic cell cycle [GO:0000278]; mRNA processing [GO:0006397]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; RNA interference [GO:0016246]; RNA splicing [GO:0008380]		GO:0000278; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006974; GO:0008380; GO:0016246; GO:0016607; GO:0031048; GO:0046833; GO:0051301; GO:1902369	MYLNFLVSLGNKER	4.460000038	1	1	0.242403492	1701.466896	11.90407	0	0	0	15.60896	14.83443	12.11904	14.19106	0	0	0	0	0	0	0	15.95884	0	0	0	0	0	0	0	0	0	0	0	14.55055	0	0	0	0	0	0	15.10789	0	0	0	0	0	0	15.25744	0	0	15.60648	0	0	0
Q9H7Z6	KAT8_HUMAN	"Histone acetyltransferase KAT8, EC 2.3.1.48 (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1, MYST-1, hMOF)"	KAT8 MOF MYST1 PP7073	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]"	histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]"	enzyme binding [GO:0019899]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000123; GO:0000776; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006325; GO:0010484; GO:0010485; GO:0010506; GO:0016363; GO:0016573; GO:0019899; GO:0030099; GO:0035064; GO:0042393; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046972; GO:0051571; GO:0061629; GO:0071339; GO:0072487; GO:1900095	VSPPTPAR	5.21999979	0.697320402	0.697320402	0.056376679	827.2759204	16.16904	14.86471	16.30816	17.19914	15.01991	15.16834	0	15.98683	14.56052	14.30194	17.50209	16.0368	13.23165	14.97429	14.1297	16.77423	14.15326	17.11227	17.433	13.39808	14.43854	17.18665	15.60965	15.95492	18.07452	14.80961	0	16.16809	0	0	16.42105	13.45753	18.13285	17.74909	16.2688	14.69787	17.09723	15.43093	13.93123	16.42494	12.93862	0	13.22579	0	16.13612	0	16.03935	14.25541
Q9H7Z7	PGES2_HUMAN	"Prostaglandin E synthase 2, EC 5.3.99.3 (Membrane-associated prostaglandin E synthase-2, mPGE synthase-2) (Microsomal prostaglandin E synthase 2, mPGES-2) (Prostaglandin-H(2) E-isomerase) [Cleaved into: Prostaglandin E synthase 2 truncated form ]"	PTGES2 C9orf15 PGES2	Homo sapiens (Human)	"cyclooxygenase pathway [GO:0019371]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; positive regulation of transcription, DNA-templated [GO:0045893]; secretion [GO:0046903]"	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; cyclooxygenase pathway [GO:0019371]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; positive regulation of transcription, DNA-templated [GO:0045893]; secretion [GO:0046903]"	12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]	GO:0000139; GO:0003677; GO:0005576; GO:0005634; GO:0005739; GO:0005829; GO:0006629; GO:0006749; GO:0016021; GO:0016829; GO:0019371; GO:0020037; GO:0035578; GO:0036134; GO:0043295; GO:0045893; GO:0046903; GO:0048471; GO:0050220	KGSPR	5.079999924	4.38E-05	4.38E-05	0.052056325	544.867154	14.42227	0	15.06565	13.76974	11.94768	16.06372	17.06022	14.32705	0	14.6446	16.16505	16.91129	17.14383	15.23822	0	16.50619	17.4052	17.48638	14.17299	18.22219	0	17.64645	16.49713	17.06497	16.00172	16.977	0	16.00683	14.10547	0	16.97638	16.65165	16.69525	0	14.88904	17.33557	16.03323	17.85939	17.04492	0	15.99082	18.11448	17.41123	0	16.32496	16.7755	17.45281	15.44858
Q9H840	GEMI7_HUMAN	"Gem-associated protein 7, Gemin-7 (SIP3)"	GEMIN7	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Sm-like protein family complex [GO:0120114]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Sm-like protein family complex [GO:0120114]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]"		GO:0000387; GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0097504; GO:0120114	GFAPDGRR	4.179999828	1	1	8.01E-13	873.4066542	15.12509	0	15.35356	0	0	0	13.86819	15.26793	0	0	0	0	0	14.21813	14.55205	14.30388	15.41457	0	15.23104	10.19461	0	12.63655	16.52182	0	16.42289	12.25064	0	14.21932	15.8456	12.04211	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H845	ACAD9_HUMAN	"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9, ACAD-9, EC 1.3.8.-)"	ACAD9	Homo sapiens (Human)	long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981]	acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]	GO:0000062; GO:0001676; GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991	ATLSEDK	12.69999981	0.149284229	0.149284229	0.25485628	764.4122898	18.94989	16.6758	19.42533	18.34616	17.8801	17.92339	20.01509	18.12701	0	19.0639	17.71775	20.91054	19.39204	19.46727	19.40896	18.30364	0	0	18.32334	0	0	0	0	0	19.30611	18.55007	19.63647	17.92627	18.93704	18.27213	0	18.57184	19.35036	0	19.26243	19.07183	0	18.94376	0	19.25706	18.75755	18.1086	17.92546	17.78433	18.43575	19.92559	20.1897	19.16897
Q9H857	NT5D2_HUMAN	"5'-nucleotidase domain-containing protein 2, EC 3.1.3.-"	NT5DC2	Homo sapiens (Human)			5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]	GO:0008253; GO:0046872	GLHYDIQK	4.659999847	1	1	0.152154626	972.9379267	15.20864	0	11.69959	0	0	0	0	0	14.00485	15.15567	13.69622	15.54589	15.95257	0	0	14.10351	0	0	0	0	0	0	0	0	0	15.21438	0	0	0	0	0	16.41896	0	0	0	0	0	14.97402	0	0	0	0	0	0	0	0	0	0
Q9H869	YYAP1_HUMAN	YY1-associated protein 1 (Hepatocellular carcinoma susceptibility protein) (Hepatocellular carcinoma-associated protein 2)	YY1AP1 HCCA2 YY1AP	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]"	transcription coregulator activity [GO:0003712]	GO:0001650; GO:0003712; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0008283; GO:0030154; GO:0051726	QLTVRIK	3.720000029	1	1	0.225124724	857.9426559	0	20.77207	0	19.47917	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H871	RMD5A_HUMAN	"E3 ubiquitin-protein transferase RMND5A, EC 2.3.2.27 (P44CTLH) (Protein RMD5 homolog A)"	RMND5A	Homo sapiens (Human)	proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]	cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0034657; GO:0043161; GO:0046872; GO:0061630	AVIEQR	14.36999989	1	1	0.255063356	715.7704144	0	19.77241	0	0	18.52267	18.14802	0	0	0	19.08914	0	19.08254	18.11536	17.87037	19.42748	0	19.29537	0	0	0	0	17.17852	0	0	20.66968	16.57463	18.16127	18.74655	0	0	19.00443	19.01432	0	0	0	19.21029	19.0733	0	0	0	0	0	17.90251	0	18.53997	16.39599	0	0
Q9H892	TTC12_HUMAN	"Tetratricopeptide repeat protein 12, TPR repeat protein 12"	TTC12	Homo sapiens (Human)	axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288]	centrosome [GO:0005813]; cytoplasm [GO:0005737]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288]		GO:0005737; GO:0005813; GO:0007288; GO:0070286	MHNGFSIISDNEVIRR	2.369999886	1	1	0.026715253	1900.787429	0	14.8628	15.71629	10.58293	0	0	15.31369	0	0	0	0	13.96156	0	15.0601	13.79145	16.12169	0	0	0	0	0	0	0	0	17.06946	16.83353	0	16.08854	0	15.57631	0	0	0	0	0	0	0	0	0	0	18.51365	0	0	0	0	0	16.86377	0
Q9H898	ZMAT4_HUMAN	Zinc finger matrin-type protein 4	ZMAT4	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0008270; GO:0042802	GSKHQTNLK	3.410000086	1	1	0.164796986	1012.83331	0	14.44899	0	0	13.50906	13.44677	0	0	0	0	0	0	14.78732	12.94998	14.59289	0	0	0	17.83329	0	0	0	0	0	0	0	0	0	13.11901	0	0	0	0	0	0	0	15.84665	0	0	0	0	0	0	13.67479	0	0	0	0
Q9H8H0	NOL11_HUMAN	Nucleolar protein 11	NOL11 L14	Homo sapiens (Human)	maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; t-UTP complex [GO:0034455]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0034455; GO:1901838	CKAEPSFYPR	8.56000042	1	1	0.29702672	1254.544059	13.74039	0	15.42676	12.13547	0	0	15.06381	0	14.80148	0	12.73826	0	0	0	0	14.15709	0	15.88896	15.3339	0	0	15.15107	14.44608	0	0	14.21805	0	0	0	0	15.25237	0	0	0	0	0	0	0	0	17.15409	0	0	0	17.20957	0	0	0	0
Q9H8H2	DDX31_HUMAN	"Probable ATP-dependent RNA helicase DDX31, EC 3.6.4.13 (DEAD box protein 31) (Helicain)"	DDX31	Homo sapiens (Human)	ribosome biogenesis [GO:0042254]	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0016887; GO:0042254; GO:0043231	GGGAGSSRVPR	8.460000038	1	1	0.117033814	1000.423991	15.01757	14.26302	14.56102	0	12.52282	15.30655	16.0562	13.37257	0	14.31007	0	7.985358	13.14325	0	0	15.37292	14.61797	0	14.06498	13.32102	14.15885	14.62009	0	0	0	13.94436	12.97373	15.78247	14.18729	14.86695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H8J5	MANS1_HUMAN	MANSC domain-containing protein 1 (Loss of heterozygosity 12 chromosomal region 3 protein)	MANSC1 LOH12CR3 UNQ316/PRO361	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	DTLSQK	17.12000084	1	1	0.237231903	691.549515	18.57897	19.32808	19.62235	19.43311	0	17.97603	19.00928	18.85867	18.01414	18.74371	17.96967	17.98002	17.40229	0	18.06643	18.03958	17.58987	0	19.44788	18.97647	0	0	0	0	0	19.16408	20.00217	16.89788	0	17.85473	0	19.45877	18.58955	0	19.54566	19.56705	0	0	17.93711	0	0	0	17.31153	0	0	17.17749	0	0
Q9H8K7	PAAT_HUMAN	"ATPase PAAT, EC 3.6.1.- (Protein associated with ABC transporters, PAAT)"	PAAT C10orf88	Homo sapiens (Human)		cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]	ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]	GO:0005737; GO:0005739; GO:0016887; GO:0042802	HMIGLQSSSTLGTLNK	1.75	1	1	0.058914704	1703.031714	14.74193	0	14.48364	0	0	0	0	15.17165	0	0	0	0	0	0	13.72365	0	0	0	0	0	0	0	14.41552	15.81359	0	0	0	0	13.13187	0	0	0	15.10889	15.01999	0	15.21994	14.89786	0	0	0	12.67111	15.61055	0	0	15.79218	14.8931	12.22577	0
Q9H8M2	BRD9_HUMAN	Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8)	BRD9 UNQ3040/PRO9856	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; lysine-acetylated histone binding [GO:0070577]; nucleic acid binding [GO:0003676]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]	lysine-acetylated histone binding [GO:0070577]; nucleic acid binding [GO:0003676]	GO:0000785; GO:0003676; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0070577; GO:0140288; GO:1902459	LLPGFTTLGFK	5.010000229	1	1	0.056391764	1193.436516	0	13.51318	14.29739	10.40721	0	13.68811	14.74214	12.27973	12.36004	16.23491	13.66428	0	11.1937	12.59192	14.06176	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H8M7	MINY3_HUMAN	"Ubiquitin carboxyl-terminal hydrolase MINDY-3, EC 3.4.19.12 (Dermal papilla-derived protein 5) (Deubiquitinating enzyme MINDY-3) (Protein CARP)"	MINDY3 C10orf97 CARP DERP5 FAM188A MSTP126 My042	Homo sapiens (Human)	apoptotic process [GO:0006915]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]; apoptotic process [GO:0006915]	Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004843; GO:0005654; GO:0006915; GO:0031965; GO:1990380	VGSYLKSPK	7.119999886	1	1	0.209662535	977.1043789	18.56354	0	0	0	0	0	0	0	0	0	0	16.40025	0	0	0	0	16.47451	0	0	0	0	0	0	0	18.74179	0	0	0	0	0	0	0	0	18.36852	0	19.93129	0	0	0	17.22221	0	0	0	16.85583	0	0	0	0
Q9H8N7	ZN395_HUMAN	"Zinc finger protein 395 (HD-regulating factor 2, HDRF-2) (Huntington disease gene regulatory region-binding protein 2, HD gene regulatory region-binding protein 2, HDBP-2) (Papillomavirus regulatory factor 1, PRF-1) (Papillomavirus-binding factor)"	ZNF395 HDBP2 PBF	Homo sapiens (Human)	"positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0016607; GO:0045944; GO:0046872	MASVLSRR	2.079999924	1	1	0.232966194	933.8266135	0	15.72266	10.2841	0	0	14.87118	0	0	0	16.65879	0	15.47838	0	0	0	15.31266	0	0	0	0	16.67256	0	0	0	0	0	0	0	0	0	0	15.21142	13.22588	14.99546	0	13.70452	0	15.58477	16.86581	0	14.48315	0	0	0	16.88882	16.15834	15.79509	0
Q9H8T0	AKTIP_HUMAN	AKT-interacting protein (Ft1) (Fused toes protein homolog)	AKTIP FTS	Homo sapiens (Human)	apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]	cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]	ubiquitin conjugating enzyme activity [GO:0061631]	GO:0000209; GO:0001934; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0032092; GO:0045022; GO:0061631; GO:0070695; GO:1905719	LPGVYVQPSYRSALMWFGVIFIR	5.21999979	1	1	0.21862563	2714.395277	14.84756	15.53115	0	0	0	14.98022	0	13.57371	0	0	15.51215	13.84474	0	16.31159	0	0	16.18624	0	0	0	0	0	0	0	0	0	0	16.61343	0	0	15.69435	16.41271	14.49565	0	14.21504	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H8V3	ECT2_HUMAN	Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)	ECT2	Homo sapiens (Human)	"activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"	bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]"	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	GO:0000281; GO:0000902; GO:0005085; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007399; GO:0015031; GO:0016604; GO:0030154; GO:0030496; GO:0031267; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431	IMEVPVIK	14.64999962	1	1	0.156335822	927.6116237	16.48096	15.7915	16.89288	15.49634	15.65237	15.57193	16.33387	14.79779	15.39814	14.80558	0	16.33915	14.02459	15.76937	16.33115	15.66272	16.38953	15.53967	16.19707	16.33474	16.20693	17.38992	15.42776	17.05075	16.38669	15.65571	16.26174	15.54766	15.91303	0	16.76003	0	0	14.8808	16.05929	0	0	16.40731	17.01785	0	14.61833	16.44237	15.74018	15.71299	0	15.86657	16.39665	0
Q9H8W2	CF155_HUMAN	Putative uncharacterized protein encoded by LINC00472	LINC00472 C6orf155	Homo sapiens (Human)						QPGPQR	4.769999981	0.602841794	0.602841794	0.184509382	684.4166377	15.94207	12.3526	15.56341	16.67393	16.04194	14.12349	0	15.8418	0	0	0	14.15403	0	13.59365	14.77518	0	16.01588	15.48633	15.44689	0	0	0	0	0	0	0	0	0	0	15.61214	0	0	0	16.7826	16.03312	0	15.4921	0	0	16.08576	0	0	15.62114	15.21061	16.21466	0	0	0
Q9H8X9	ZDH11_HUMAN	"Palmitoyltransferase ZDHHC11, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 11, DHHC-11) (Zinc finger protein 399)"	ZDHHC11 ZNF399	Homo sapiens (Human)	antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signaling adaptor activity [GO:0035591]; antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; protein targeting to membrane [GO:0006612]	protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signaling adaptor activity [GO:0035591]	GO:0002230; GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010008; GO:0016021; GO:0018230; GO:0019706; GO:0035591; GO:0140374	LCQFSTR	6.289999962	1	1	0.109354273	910.4516596	0	0	17.19094	16.64613	0	0	0	15.23412	13.85917	0	17.39762	15.55385	0	0	0	0	0	0	0	0	0	0	14.91347	0	0	0	15.63296	17.08309	17.19541	0	0	0	0	0	0	0	0	17.59893	0	0	0	0	0	0	17.04525	0	13.20408	15.45892
Q9H8Y1	VRTN_HUMAN	Vertnin	VRTN C14orf115	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]	chromatin [GO:0000785]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]	sequence-specific DNA binding [GO:0043565]	GO:0000785; GO:0006357; GO:0043565	DVTAVMAPPVGASSEDVEGGPSR	4.670000076	1	1	0.195678497	2227.901002	0	0	11.31253	14.70847	12.37808	0	6.936442	12.87696	10.26083	0	0	11.44096	14.94618	12.68735	13.33696	0	0	12.93297	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H8Y5	ANKZ1_HUMAN	Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744)	ANKZF1 ZNF744	Homo sapiens (Human)	cellular response to hydrogen peroxide [GO:0070301]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; cellular response to hydrogen peroxide [GO:0070301]; ubiquitin-dependent ERAD pathway [GO:0030433]	metal ion binding [GO:0046872]	GO:0005737; GO:0016020; GO:0030433; GO:0046872; GO:0070301	ARPPYTVAADKSTR	2.569999933	1	1	0.049827414	1533.41732	0	0	12.61088	0	0	0	15.60087	0	0	12.6493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H900	ZWILC_HUMAN	"Protein zwilch homolog, hZwilch"	ZWILCH	Homo sapiens (Human)	cell division [GO:0051301]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]	cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; RZZ complex [GO:1990423]	cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; RZZ complex [GO:1990423]; cell division [GO:0051301]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]		GO:0000776; GO:0005828; GO:0005829; GO:0007094; GO:0034501; GO:0051301; GO:1990423	GDIQPWLHSGSNSLLSK	8.43999958	1	1	0.133124407	1839.622089	0	0	15.66328	16.23098	0	0	0	16.49621	11.57911	0	0	0	14.25974	0	0	0	0	12.96135	0	0	0	0	0	0	0	0	16.11965	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H903	MTD2L_HUMAN	"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2, mitochondrial (NADP-dependent methylenetetrahydrofolate dehydrogenase 2-like protein, MTHFD2-like) [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase, EC 1.5.1.15, EC 1.5.1.5; Methenyltetrahydrofolate cyclohydrolase, EC 3.5.4.9 ]"	MTHFD2L	Homo sapiens (Human)	10-formyltetrahydrofolate metabolic process [GO:0009256]; folic acid metabolic process [GO:0046655]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; 10-formyltetrahydrofolate metabolic process [GO:0009256]; folic acid metabolic process [GO:0046655]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]	methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]	GO:0000105; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0005743; GO:0005759; GO:0006164; GO:0009086; GO:0009256; GO:0035999; GO:0046655	APGEPGSAFR	2.599999905	1	1	0.09708832	988.7245122	15.93436	0	16.88289	15.00018	0	15.28534	15.75255	0	0	0	15.08427	0	0	15.23699	15.14783	0	0	14.33579	0	0	0	0	0	0	0	15.53228	0	0	0	15.26454	0	0	14.57204	16.03578	15.39705	0	0	15.51322	13.75901	14.23423	12.06732	12.1918	14.33362	15.32182	13.72815	16.07402	0	0
Q9H930	SP14L_HUMAN	Nuclear body protein SP140-like protein	SP140L	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleus [GO:0005634]	"nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0016604; GO:0046872	ESDQACGK	4.920000076	0.74590838	0.74590838	0.162353614	893.8819316	14.01201	0	0	0	0	0	18.33196	0	13.7524	0	0	12.911	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.21776	15.79044	15.15849	0	15.55646	15.57033	0	0	0	0	0	0	0	0	0	0	16.03677	0	0	0	14.30091	0
Q9H936	GHC1_HUMAN	"Mitochondrial glutamate carrier 1, GC-1 (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22)"	SLC25A22 GC1	Homo sapiens (Human)	aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]	amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]	GO:0005280; GO:0005313; GO:0005743; GO:0006811; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0043490	LQSLQR	10.07999992	1	1	0.083230803	741.5762241	14.37191	13.72643	13.93133	13.2404	14.10389	13.78344	15.15247	0	0	0	0	0	0	0	0	0	0	0	15.47495	0	15.23613	15.43653	0	0	0	0	0	14.17668	13.72853	0	16.66794	0	0	0	0	16.37503	0	0	0	0	16.16997	0	0	0	15.24129	15.68564	12.60892	0
Q9H977	WDR54_HUMAN	WD repeat-containing protein 54	WDR54	Homo sapiens (Human)	negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408]	vesicle [GO:0031982]	vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408]	protein homodimerization activity [GO:0042803]	GO:0002091; GO:0031982; GO:0042058; GO:0042803; GO:0043408	LLSAGEDTFVHIWK	3.970000029	1	1	4.57E-13	1616.765873	0	13.83891	13.99238	14.39279	12.81586	0	14.66794	13.83363	12.49979	0	0	0	15.13514	14.52243	13.09171	14.12945	14.50644	14.74153	14.83181	15.28682	0	0	15.35903	14.71338	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.0351	0	0	0	0	0	0	0
Q9H987	SYP2L_HUMAN	Synaptopodin 2-like protein	SYNPO2L	Homo sapiens (Human)	heart morphogenesis [GO:0003007]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214]	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; heart morphogenesis [GO:0003007]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214]	actin binding [GO:0003779]	GO:0003007; GO:0003779; GO:0005634; GO:0005654; GO:0005829; GO:0015629; GO:0016607; GO:0030018; GO:0030054; GO:0032233; GO:0035025; GO:0045214; GO:0051496	TLPHVTPK	3.269999981	1	1	0.107588762	895.3539782	0	0	0	0	0	0	0	0	0	0	0	13.08025	0	0	0	15.74826	0	0	0	16.69922	12.07093	13.72939	13.11861	0	0	10.8137	13.95248	0	14.42672	0	0	0	0	0	0	0	0	17.15638	0	0	0	0	15.09529	0	11.65278	15.0295	16.29522	0
Q9H992	MARH7_HUMAN	"E3 ubiquitin-protein ligase MARCHF7, EC 2.3.2.27 (Axotrophin) (Membrane-associated RING finger protein 7) (Membrane-associated RING-CH protein VII, MARCH-VII) (RING finger protein 177) (RING-type E3 ubiquitin transferase MARCHF7)"	MARCHF7 AXOT MARCH7 RNF177	Homo sapiens (Human)	"negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein polyubiquitination [GO:1902916]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of tolerance induction [GO:0002643]"	cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; MDM2/MDM4 family protein binding [GO:0097371]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein polyubiquitination [GO:1902916]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of tolerance induction [GO:0002643]"	MDM2/MDM4 family protein binding [GO:0097371]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]	GO:0002643; GO:0005634; GO:0005829; GO:0005886; GO:0006513; GO:0008270; GO:0008284; GO:0016740; GO:0031624; GO:0042130; GO:0043130; GO:0043518; GO:0050821; GO:0051865; GO:0097371; GO:1901799; GO:1902166; GO:1902916; GO:1905524	GSSLNDTYHSR	5.28000021	1	1	0.201541379	1236.786449	15.00394	17.95648	16.60257	0	0	0	0	0	0	16.25652	0	18.72492	0	0	15.53904	0	0	0	0	15.87532	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.96252	0	18.88348	0	0	16.31351	0
Q9H9A5	CNO10_HUMAN	CCR4-NOT transcription complex subunit 10	CNOT10	Homo sapiens (Human)	gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]		GO:0000289; GO:0005634; GO:0005829; GO:0006402; GO:0016020; GO:0017148; GO:0030014; GO:0031047	NQLLPAVK	8.640000343	1.17E-05	1.17E-05	0.20558428	883.4754669	19.3448	18.28142	17.11147	0	0	18.71343	0	0	18.50084	16.92363	19.3124	0	19.08669	18.64178	15.73855	0	0	18.54825	0	17.64371	0	19.89175	0	16.97973	0	19.33512	16.66402	0	16.61853	0	17.79884	0	0	20.12997	20.20342	0	0	0	20.04592	17.60268	0	0	17.57277	18.77718	0	18.10438	0	18.97659
Q9H9A6	LRC40_HUMAN	Leucine-rich repeat-containing protein 40	LRRC40	Homo sapiens (Human)	signal transduction [GO:0007165]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005737; GO:0007165; GO:0016020; GO:0043231	KSGQLNLSGR	5.510000229	1	1	0.283729569	1059.161133	0	0	0	0	0	0	0	17.72489	0	0	0	17.68928	0	18.22708	0	0	17.78973	20.6979	0	0	17.03255	0	17.28593	0	0	0	17.64473	0	18.15305	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.99367	0	0	0
Q9H9B1	EHMT1_HUMAN	"Histone-lysine N-methyltransferase EHMT1, EC 2.1.1.-, EC 2.1.1.367 (Euchromatic histone-lysine N-methyltransferase 1, Eu-HMTase1) (G9a-like protein 1, GLP, GLP1) (Histone H3-K9 methyltransferase 5, H3-K9-HMTase 5) (Lysine N-methyltransferase 1D)"	EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D	Homo sapiens (Human)	"chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]"	chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]"	C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]	GO:0000122; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0045995; GO:0046974; GO:0046976; GO:0070742; GO:0120162	EVTIAKADTTSTVTPVPGQEK	7.400000095	1	1	3.67E-12	2171.384294	14.11466	13.21424	11.9494	12.81309	0	0	0	12.83384	12.93853	0	13.18155	0	0	0	0	0	10.67808	0	14.23825	0	12.33706	0	15.11548	14.98619	0	0	0	0	0	12.12257	14.28658	15.59618	0	0	0	0	0	14.06187	0	0	0	0	0	0	0	0	0	0
Q9H9B4	SFXN1_HUMAN	Sideroflexin-1	SFXN1	Homo sapiens (Human)	D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; D-serine transport [GO:0042942]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300]	D-serine transmembrane transporter activity [GO:0042945]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]	GO:0005739; GO:0006730; GO:0006826; GO:0015194; GO:0015825; GO:0022857; GO:0022889; GO:0030218; GO:0031305; GO:0042942; GO:0042945; GO:0140300; GO:1990542	MILIGRMSAQVPMNMTITGCMMTFYR	5.159999847	1	1	4.12E-12	3101.118418	15.34936	11.73178	18.1756	12.2245	14.0463	0	0	13.46133	0	0	0	0	12.69674	0	0	12.89351	11.59576	0	13.05021	14.96412	0	11.16328	0	0	0	0	0	14.68027	0	14.85055	15.2455	13.34251	11.00147	13.85488	0	12.75764	0	0	0	0	0	0	0	0	0	0	0	0
Q9H9C1	SPE39_HUMAN	"Spermatogenesis-defective protein 39 homolog, hSPE-39 (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)"	VIPAS39 C14orf133 SPE39 VIPAR	Homo sapiens (Human)	cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023]	cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023]; protein-containing complex binding [GO:0044877]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034]	protein-containing complex binding [GO:0044877]	GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0006886; GO:0007034; GO:0007283; GO:0008333; GO:0017185; GO:0030154; GO:0030199; GO:0032963; GO:0043687; GO:0044877; GO:0046907; GO:0055037; GO:0090385; GO:0099023	IDALLSSSQIRWK	1.100000024	1	1	0.267942717	1517.104794	13.88244	0	0	0	0	13.96539	0	0	13.76322	0	0	0	0	0	0	15.42903	14.57248	0	0	16.335	0	0	0	15.37406	0	0	0	0	0	0	0	0	0	16.89739	0	16.7963	15.33074	0	14.85352	0	12.82508	0	0	0	0	0	0	0
Q9H9E3	COG4_HUMAN	"Conserved oligomeric Golgi complex subunit 4, COG complex subunit 4 (Component of oligomeric Golgi complex 4)"	COG4	Homo sapiens (Human)	"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]	"cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; identical protein binding [GO:0042802]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	identical protein binding [GO:0042802]	GO:0000139; GO:0000301; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0042802; GO:0048213; GO:0070085	ADDILDLK	2.039999962	0.236183271	0.236183271	0.041508404	901.8525822	18.52827	15.22949	0	13.42663	0	0	0	14.80478	0	16.40569	0	15.84831	12.95669	0	15.48785	0	15.7739	17.17648	13.19026	12.82112	0	18.19271	15.28663	15.86194	17.16768	0	16.56633	0	15.98077	0	15.06837	19.67918	18.08601	14.33585	16.48078	0	18.69977	15.48816	13.04088	15.65152	16.37302	15.09674	0	13.45857	14.70336	15.3676	0	15.29036
Q9H9F9	ARP5_HUMAN	"Actin-related protein 5, hARP5 (Sarcoma antigen NY-SAR-16)"	ACTR5 ARP5	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of transcription, DNA-templated [GO:0006355]; UV-damage excision repair [GO:0070914]"	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; nucleosome mobilization [GO:0042766]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of transcription, DNA-templated [GO:0006355]; UV-damage excision repair [GO:0070914]"		GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0006302; GO:0006310; GO:0006338; GO:0006355; GO:0031011; GO:0033044; GO:0042766; GO:0045893; GO:0051726; GO:0060382; GO:0070914	ELLEMRPFRSSFQVQLASNPVLDAWYGAR	1.710000038	1	1	4.57E-13	3380.386369	0	12.85339	13.3534	12.85172	0	0	0	0	7.357741	14.28146	15.2009	12.24947	0	0	13.96332	0	0	0	0	0	0	0	0	0	12.67214	0	14.13744	11.15446	14.97989	13.28976	0	0	0	0	0	0	0	10.34199	0	0	0	0	0	16.66947	14.58545	0	8.96288	12.12643
Q9H9G7	AGO3_HUMAN	"Protein argonaute-3, Argonaute3, hAgo3, EC 3.1.26.n2 (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3, eIF-2C 3, eIF2C 3)"	AGO3 EIF2C3	Homo sapiens (Human)	miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of stem cell proliferation [GO:0072091]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of stem cell proliferation [GO:0072091]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]"	"double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]"	GO:0000794; GO:0000932; GO:0003723; GO:0003725; GO:0003727; GO:0004521; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0010501; GO:0010628; GO:0016020; GO:0016246; GO:0016442; GO:0031054; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0036464; GO:0046872; GO:0070578; GO:0072091; GO:0090624; GO:1901224	KPSIAAVVGSMDAHPSR	2.25999999	1	1	0.175455151	1734.49237	0	0	13.50602	0	0	13.86697	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.90582	0	14.28436	16.03102	0	16.1178	14.11804	15.21677	0	15.96283	0	0	0	0	16.82473	0	0	0	0	0	0	0	0	0	0	0	0
Q9H9H4	VP37B_HUMAN	"Vacuolar protein sorting-associated protein 37B, hVps37B (ESCRT-I complex subunit VPS37B)"	VPS37B	Homo sapiens (Human)	macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	calcium-dependent protein binding [GO:0048306]	GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0048306; GO:0070062; GO:1903774	MAGAGSEAR	4.800000191	0.733062923	0.733062923	0.161783556	849.2105385	0	0	0	14.81326	0	16.596	0	14.59936	0	15.1571	15.78089	0	0	0	15.79132	15.42297	0	0	0	0	0	15.06104	15.35424	12.12652	16.8075	0	16.53666	0	14.55345	0	0	13.66854	15.04426	15.82149	0	15.13209	0	0	15.90379	0	13.96475	0	15.16121	16.87068	0	0	14.91805	0
Q9H9J4	UBP42_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 42, EC 3.4.19.12 (Deubiquitinating enzyme 42) (Ubiquitin thioesterase 42) (Ubiquitin-specific-processing protease 42)"	USP42	Homo sapiens (Human)	cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0007283; GO:0016579; GO:0030154; GO:0042981	DPLEEPKAK	11.60000038	0.556329608	0.556329608	0.128315248	1027.261806	12.29778	13.09083	19.3182	16.58782	0	16.44619	8.558544	16.35598	19.44168	16.63768	0	0	15.62842	15.07829	16.69941	16.76309	0	14.37517	17.22058	10.35178	15.19705	0	16.85238	18.5817	12.46428	18.70373	0	0	0	0	17.08915	11.63446	16.55799	0	17.97234	17.04173	16.72427	17.22837	13.49747	13.66669	17.67441	12.66335	14.45556	14.6896	15.32451	0	16.2965	15.75438
Q9H9L7	AKIR1_HUMAN	Akirin-1	AKIRIN1 C1orf108	Homo sapiens (Human)	myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]	chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]	transcription coregulator activity [GO:0003712]	GO:0000785; GO:0003712; GO:0005634; GO:0005654; GO:0010592; GO:0010759; GO:0014839; GO:0031965; GO:0045663; GO:0045944; GO:1902723; GO:1902725	DQPTFTLR	2.359999895	1	1	0.194217585	976.4773449	15.6586	14.87929	15.12824	0	0	0	0	0	14.98797	0	0	0	0	15.19717	0	14.22867	0	0	0	0	0	0	0	14.15216	16.13095	14.80469	14.35977	12.62071	15.54443	15.2497	14.45611	16.71001	15.57116	16.22157	0	15.85333	15.7549	14.90411	15.81726	15.26946	0	12.60946	12.20422	15.65879	12.89396	14.99662	16.12678	13.90259
Q9H9P5	UNKL_HUMAN	"Putative E3 ubiquitin-protein ligase UNKL, EC 2.3.2.- (RING finger protein unkempt-like) (Zinc finger CCCH domain-containing protein 5-like)"	UNKL C16orf28 ZC3H5L ZC3HDC5L	Homo sapiens (Human)	protein ubiquitination [GO:0016567]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567]	metal ion binding [GO:0046872]; transferase activity [GO:0016740]	GO:0005634; GO:0005829; GO:0016567; GO:0016740; GO:0046872	QLDEAKR	9.659999847	0.53864491	0.53864491	0.249123215	858.76351	0	20.88148	0	0	0	16.07721	0	0	19.95879	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.13434	0	0	0	0	15.90901	0	0	0	0	0	0	0	17.91739	0
Q9H9P8	L2HDH_HUMAN	"L-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.2 (Duranin)"	L2HGDH C14orf160	Homo sapiens (Human)	2-oxoglutarate metabolic process [GO:0006103]; small molecule metabolic process [GO:0044281]	integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]; 2-oxoglutarate metabolic process [GO:0006103]; small molecule metabolic process [GO:0044281]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]	GO:0003973; GO:0005739; GO:0005743; GO:0006103; GO:0016021; GO:0031305; GO:0044281; GO:0047545	GIEMAK	13.18000031	1	1	0.184107004	661.5621071	0	0	16.45625	0	0	0	0	15.09335	0	0	0	0	17.02078	0	16.18836	0	0	0	0	0	0	0	0	0	0	0	0	0	16.56527	0	0	16.18542	0	16.0421	0	16.18794	16.6897	16.86881	16.35044	17.37074	17.06448	0	0	17.06059	16.15809	16.66294	16.88208	18.2191
Q9H9Q2	CSN7B_HUMAN	"COP9 signalosome complex subunit 7b, SGN7b, Signalosome subunit 7b (JAB1-containing signalosome subunit 7b)"	COPS7B CSN7B	Homo sapiens (Human)	COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]		GO:0000338; GO:0005654; GO:0005829; GO:0008180; GO:0010387; GO:0045116; GO:2000434	KDINNIVK	7.050000191	1	1	0.09518685	944.0245387	0	15.95597	15.80136	15.53045	0	10.00917	0	15.19816	14.32389	14.14516	14.1482	14.58479	0	0	14.84439	0	0	0	0	0	0	0	0	0	0	0	0	15.02017	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9H9S3	S61A2_HUMAN	"Protein transport protein Sec61 subunit alpha isoform 2, Sec61 alpha-2"	SEC61A2	Homo sapiens (Human)	"posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]	"integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"	protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]	GO:0005048; GO:0005784; GO:0006616; GO:0008320; GO:0016021; GO:0031204; GO:0043022	EQQMVMR	7.059999943	0.985486746	0.985486746	0.195892966	953.3911096	0	0	0	0	0	12.0852	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.34087	0	0	0	0	0	12.89447	14.73621	0	0	0	0	0	0	0	0	0	0	18.12434	0	0	0	0	0	0	0	0	0
Q9H9S4	CB39L_HUMAN	Calcium-binding protein 39-like (Antigen MLAA-34) (MO25beta) (Mo25-like protein)	CAB39L	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]	cytosol [GO:0005829]	cytosol [GO:0005829]; protein serine/threonine kinase activator activity [GO:0043539]; intracellular signal transduction [GO:0035556]	protein serine/threonine kinase activator activity [GO:0043539]	GO:0005829; GO:0035556; GO:0043539	ASEEVSKSLQAMK	8.449999809	0.346239418	0.346239418	0.028449604	1423.442692	16.0937	0	12.05193	0	14.7972	16.29809	0	0	0	15.77628	13.82303	0	17.35653	0	0	0	13.49884	0	0	15.97857	0	12.03729	0	16.04202	16.98137	11.67822	0	0	15.43496	15.53906	0	0	0	15.86666	15.19156	17.46289	0	19.53508	17.63687	13.81305	0	0	0	0	0	0	12.41533	0
Q9H9T3	ELP3_HUMAN	"Elongator complex protein 3, hELP3, EC 2.3.1.- (tRNA uridine(34) acetyltransferase)"	ELP3	Homo sapiens (Human)	central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; N-acetyltransferase activity [GO:0008080]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]; central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; N-acetyltransferase activity [GO:0008080]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]"	GO:0000049; GO:0001764; GO:0002098; GO:0002926; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006417; GO:0007417; GO:0008080; GO:0008607; GO:0016407; GO:0030335; GO:0033588; GO:0046872; GO:0051539; GO:0106261	CIGITIETRPDYCMK	6.639999866	0.002566614	0.002566614	3.42E-12	1870.632764	0	15.42937	0	0	0	15.0986	0	0	15.12399	0	16.79758	0	0	0	0	15.49412	12.48526	0	0	0	0	14.26517	16.82073	0	0	16.91494	16.02536	14.42529	0	17.47988	18.56891	0	0	19.67618	17.68915	17.95056	0	16.66895	15.81433	0	12.71974	0	0	17.17555	0	0	0	0
Q9H9Y6	RPA2_HUMAN	"DNA-directed RNA polymerase I subunit RPA2, RNA polymerase I subunit 2, EC 2.7.7.6 (DNA-directed RNA polymerase I 135 kDa polypeptide, RPA135)"	POLR1B	Homo sapiens (Human)	embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]	chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]	chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005829; GO:0007566; GO:0009303; GO:0014029; GO:0017126; GO:0032549; GO:0046872	HMVSDK	16.46999931	0.11784777	0.11784777	0.270775175	716.0185486	0	14.46567	0	0	0	0	0	0	15.05152	0	15.57456	0	14.92103	0	16.16247	16.20868	0	14.64632	17.36114	16.28279	17.2714	0	16.69663	16.50344	15.82564	14.90888	16.60544	14.85749	16.13439	16.44261	17.79018	15.71542	15.67642	17.14515	16.30476	0	17.68526	18.11893	18.65047	0	18.51634	17.42376	17.94207	17.38087	17.38925	19.25105	16.09722	16.83231
Q9HA38	ZMAT3_HUMAN	Zinc finger matrin-type protein 3 (Zinc finger protein WIG-1) (p53-activated gene 608 protein)	ZMAT3 PAG608 WIG1	Homo sapiens (Human)	apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; protein transport [GO:0015031]; regulation of growth [GO:0040008]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; protein transport [GO:0015031]; regulation of growth [GO:0040008]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0006915; GO:0006974; GO:0008270; GO:0015031; GO:0040008	NYYAANSCPPPAR	5.230000019	1	1	0.415716636	1479.558298	0	0	13.48854	0	15.03398	0	16.40701	14.18843	14.06413	14.14102	13.206	13.55803	14.28982	13.89757	0	15.82109	0	0	0	0	0	0	0	0	0	16.52586	0	0	0	0	0	16.31623	0	0	15.92464	0	0	16.59314	0	0	0	0	14.34596	0	0	0	0	0
Q9HA64	KT3K_HUMAN	"Ketosamine-3-kinase, EC 2.7.1.172 (Fructosamine-3-kinase-related protein, FN3K-RP, FN3K-related protein) (Protein-psicosamine 3-kinase FN3KRP, EC 2.7.1.-)"	FN3KRP	Homo sapiens (Human)	post-translational protein modification [GO:0043687]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-ribulosamine 3-kinase activity [GO:0102193]; post-translational protein modification [GO:0043687]	ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-ribulosamine 3-kinase activity [GO:0102193]	GO:0005524; GO:0005829; GO:0016301; GO:0043687; GO:0102193	APGFEK	6.170000076	1	1	0.152027625	647.6193424	0	0	0	0	0	0	0	0	0	0	19.20673	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.35859	0	0	0	0	0	18.38651	0	0	0	0	0	0	0	0	0
Q9HA72	CAHM2_HUMAN	Calcium homeostasis modulator protein 2 (Protein FAM26B)	CALHM2 FAM26B	Homo sapiens (Human)	positive regulation of apoptotic process [GO:0043065]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; positive regulation of apoptotic process [GO:0043065]	cation channel activity [GO:0005261]	GO:0005261; GO:0005887; GO:0043065	FLSLFFKSK	13.96000004	9.54E-10	9.54E-10	0.110304363	1116.556315	19.15956	20.95244	19.47972	21.19605	21.01677	21.32148	19.69502	20.32273	19.06646	18.83146	20.16353	20.51641	20.13275	20.37956	19.94851	20.19506	19.41908	19.33073	20.03703	20.17378	18.54484	19.68169	20.07229	20.5869	17.73978	19.60809	19.6283	18.94362	20.08143	18.01649	20.16943	20.27654	20.72289	20.69472	19.4788	20.27487	20.39979	20.519	19.155	20.78543	20.79544	21.48625	20.62105	20.30837	19.17352	19.8466	20.40877	20.10591
Q9HA82	CERS4_HUMAN	"Ceramide synthase 4, CerS4, EC 2.3.1.- (LAG1 longevity assurance homolog 4) (Sphingosine N-acyltransferase CERS4, EC 2.3.1.24)"	CERS4 LASS4	Homo sapiens (Human)	ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148]	DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]	GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291	FIGLPLSR	5.5	0.332702249	0.332702249	0.205289332	903.4864691	15.14812	14.12574	15.80018	17.22305	16.1289	0	0	0	0	17.80281	0	16.61702	0	0	15.93876	0	15.997	14.59939	0	16.80692	0	0	0	0	15.96126	0	0	15.87426	0	0	0	0	0	0	0	16.26152	17.82645	15.77858	0	0	0	0	0	0	0	0	0	0
Q9HA92	RSAD1_HUMAN	"Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone)"	RSAD1	Homo sapiens (Human)	porphyrin-containing compound biosynthetic process [GO:0006779]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	"cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; heme binding [GO:0020037]; metal ion binding [GO:0046872]"	GO:0004109; GO:0005737; GO:0005739; GO:0006779; GO:0020037; GO:0046872; GO:0051539	GALPAPDPELAAEMYQRGR	9.140000343	1	1	1.83E-12	2054.205963	0	13.70165	0	0	13.87814	13.91252	13.98728	14.41436	12.79877	0	0	14.01116	14.22921	14.53418	0	0	0	0	0	0	14.9905	0	0	0	0	0	0	0	0	0	0	0	16.28074	16.42333	14.55113	0	13.63598	17.44916	0	0	12.84341	0	0	14.58964	0	0	0	13.01342
Q9HAD4	WDR41_HUMAN	WD repeat-containing protein 41	WDR41 MSTP048	Homo sapiens (Human)	autophagy [GO:0006914]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; positive regulation of GTPase activity [GO:0043547]; regulation of autophagy [GO:0010506]	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; lysosomal membrane [GO:0005765]	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; positive regulation of GTPase activity [GO:0043547]; regulation of autophagy [GO:0010506]		GO:0005737; GO:0005765; GO:0006914; GO:0010506; GO:0032045; GO:0043547; GO:0045920; GO:0050777	ELIIFR	33.25	1	1	0.089060733	788.6640912	16.28412	14.25307	0	0	11.00478	14.99345	15.9697	15.47145	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HAH7	FBRS_HUMAN	Probable fibrosin-1	FBRS FBS FBS1	Homo sapiens (Human)						DRDLPFSRPQLR	12.46000004	1.95E-08	1.95E-08	0.428397272	1499.507634	21.60734	22.03547	20.67441	19.05849	22.22679	0	22.03728	21.25092	21.75005	21.67047	0	20.88567	0	0	0	0	21.98759	20.67343	0	20.51499	21.04568	0	0	0	0	19.82261	0	0	18.85999	0	0	19.17241	21.16174	21.1351	19.98255	21.04573	0	0	0	18.89474	21.81831	22.70914	19.73447	0	0	21.94159	22.97048	0
Q9HAK2	COE2_HUMAN	"Transcription factor COE2 (Early B-cell factor 2, EBF-2)"	EBF2 COE2	Homo sapiens (Human)	adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; cell fate determination [GO:0001709]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; cell fate determination [GO:0001709]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of transcription by RNA polymerase II [GO:0006357]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001709; GO:0003682; GO:0005634; GO:0006357; GO:0035563; GO:0046872; GO:0050873; GO:0060612; GO:0120162	TAGNPRDMR	8.609999657	1	1	0.215687388	1017.631355	0	0	0	0	0	18.14055	0	16.95052	19.85096	19.85658	0	0	18.01362	18.44232	19.32156	21.07973	0	20.45395	0	18.35385	18.77745	19.35932	0	16.56062	17.86653	20.17765	20.66545	0	0	18.40471	0	0	0	20.70062	0	0	18.20591	0	20.19434	18.88657	17.87298	19.1218	19.59911	18.56099	20.09207	0	17.79122	15.96031
Q9HAN9	NMNA1_HUMAN	"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)"	NMNAT1 NMNAT	Homo sapiens (Human)	ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of neuron death [GO:1901215]; nucleotide biosynthetic process [GO:0009165]; response to wounding [GO:0009611]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of neuron death [GO:1901215]; nucleotide biosynthetic process [GO:0009165]; response to wounding [GO:0009611]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]	GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0009165; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:1901215; GO:1990966	VIMAELATK	4.820000172	1	1	0.14322712	977.9979579	16.74721	0	0	15.80642	14.89533	14.6347	0	0	0	16.94511	0	0	0	0	16.61961	0	0	0	0	0	0	0	0	18.70044	0	0	14.72492	16.73823	13.62484	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.19819	16.49447	15.20115
Q9HAP2	MLXIP_HUMAN	"MLX-interacting protein (Class E basic helix-loop-helix protein 36, bHLHe36) (Transcriptional activator MondoA)"	MLXIP BHLHE36 KIAA0867 MIR MONDOA	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]	"chromatin [GO:0000785]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005741; GO:0006357; GO:0045944; GO:0046983	LQQERGQMQEEAR	5.190000057	1	1	0.347875746	1618.283034	0	0	14.41829	12.52811	15.46477	14.65399	0	0	0	0	0	0	0	0	0	0	0	14.69149	16.29036	0	0	0	0	16.86177	14.32232	0	0	0	13.5528	15.14508	0	16.57226	15.26967	16.69917	0	17.19649	0	14.85061	16.54549	0	15.70306	16.72214	16.2635	17.42921	14.98367	0	15.16536	0
Q9HAP6	LIN7B_HUMAN	"Protein lin-7 homolog B, Lin-7B, hLin7B (Mammalian lin-seven protein 2, MALS-2) (Vertebrate lin-7 homolog 2, Veli-2, hVeli2)"	LIN7B MALS2 VELI2 UNQ3116/PRO10200	Homo sapiens (Human)	exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]	L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]	GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0015031; GO:0016323; GO:0019904; GO:0030165; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361	TDEGLGFNIMGGK	3.529999971	1	1	0.56564154	1355.33351	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.54171	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HAS0	NJMU_HUMAN	Protein Njmu-R1	C17orf75	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]	cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]		GO:0005802; GO:0006886; GO:0031410; GO:0099041	GLELFR	9.920000076	0.927943826	0.927943826	0.221433676	734.3055506	14.95696	16.31179	15.31253	0	15.67131	15.61448	16.11216	15.66854	16.45522	0	0	16.01474	17.05628	15.33183	15.02359	16.71826	15.45634	0	15.92974	0	17.99308	0	16.69427	16.26029	15.12192	16.45366	17.58443	16.3954	14.74011	0	17.33265	17.36396	16.40084	16.2145	0	17.27196	17.26332	16.7125	0	15.74129	15.77404	16.97388	15.67011	17.22487	16.61089	18.26549	16.69455	16.51157
Q9HAS3	S28A3_HUMAN	"Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3, CNT 3, hCNT3)"	SLC28A3 CNT3	Homo sapiens (Human)	nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862]	brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]; nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862]	nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]	GO:0005337; GO:0005345; GO:0005415; GO:0005789; GO:0005886; GO:0005887; GO:0015213; GO:0015293; GO:0015389; GO:0015390; GO:0015860; GO:0015862; GO:0015864; GO:0031526; GO:0072531; GO:1901642; GO:1904823	YEHRIDEMLSPGR	5.929999828	1	1	0.558708284	1618.362696	18.15569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.12987	0	19.77307	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HAT2	SIAE_HUMAN	"Sialate O-acetylesterase, EC 3.1.1.53 (H-Lse) (Sialic acid-specific 9-O-acetylesterase)"	SIAE YSG2	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; sialate 4-O-acetylesterase activity [GO:0106331]; sialate 9-O-acetylesterase activity [GO:0106330]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682]	sialate 4-O-acetylesterase activity [GO:0106331]; sialate 9-O-acetylesterase activity [GO:0106330]; sialate O-acetylesterase activity [GO:0001681]	GO:0001681; GO:0002682; GO:0005615; GO:0005764; GO:0005975; GO:0070062; GO:0106330; GO:0106331	SAGIGFR	5.519999981	1	1	0.25709797	705.7739315	15.19787	0	17.71755	13.31058	15.05361	0	15.96595	0	0	13.66	15.0869	0	15.34649	0	0	0	0	16.28084	16.16427	0	0	0	15.75593	17.72915	18.31235	16.47676	17.58319	18.01882	0	16.07367	0	0	0	16.79724	17.50106	0	0	18.24928	0	16.34468	0	17.98372	0	0	0	17.80808	0	0
Q9HAT8	PELI2_HUMAN	"E3 ubiquitin-protein ligase pellino homolog 2, Pellino-2, EC 2.3.2.27 (RING-type E3 ubiquitin transferase pellino homolog 2)"	PELI2	Homo sapiens (Human)	positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592]	cytosol [GO:0005829]	cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630	NPDGHMDGLTTNGVLVMHPR	3.069999933	0.705100358	0.705100358	0.123634781	2177.222325	17.57383	9.769759	0	0	15.45622	0	11.92152	0	14.88236	13.39199	0	0	0	0	0	0	12.52528	11.51551	0	0	0	0	0	0	14.94572	0	0	0	0	0	0	0	0	0	0	16.31302	0	0	0	0	0	0	0	0	0	14.49334	0	0
Q9HAU0	PKHA5_HUMAN	"Pleckstrin homology domain-containing family A member 5, PH domain-containing family A member 5 (Phosphoinositol 3-phosphate-binding protein 2, PEPP-2)"	PLEKHA5 KIAA1686 PEPP2	Homo sapiens (Human)	reproductive system development [GO:0061458]	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]	"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; reproductive system development [GO:0061458]"	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]"	GO:0005654; GO:0005829; GO:0010314; GO:0014069; GO:0016020; GO:0032266; GO:0061458; GO:0070273; GO:0080025; GO:0098978	VVHALEEK	5.880000114	0.892549753	0.892549753	0.068372114	924.9878165	0	0	14.75333	15.39778	0	0	0	16.02999	0	0	0	0	0	0	0	0	0	0	0	0	0	18.59494	0	17.43872	0	0	0	0	0	0	0	0	0	0	0	0	0	16.13781	0	0	0	0	0	0	0	14.79813	0	0
Q9HAU5	RENT2_HUMAN	"Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog, hUpf2)"	UPF2 KIAA1408 RENT2	Homo sapiens (Human)	"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"	RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]	GO:0000184; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006406; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471	AAMDFCMNMNTKANR	8.869999886	1	1	0.257444851	1806.91451	0	0	0	16.81877	0	12.42867	15.58583	0	0	0	16.83803	15.14426	0	0	0	0	18.07311	0	0	0	0	0	0	13.72202	0	0	13.25005	0	0	0	14.84538	0	13.16009	0	15.96683	0	15.5199	0	17.25575	0	0	0	0	0	14.16269	0	0	0
Q9HAU8	RNPL1_HUMAN	"Aminopeptidase RNPEPL1, EC 3.4.11.- (Arginyl aminopeptidase-like 1) (Methionyl aminopeptidase, EC 3.4.11.18)"	RNPEPL1	Homo sapiens (Human)	proteolysis [GO:0006508]		metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]	metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]	GO:0006508; GO:0008270; GO:0070006	FLESQMSR	2.25999999	0.593658447	0.593658447	0.118568031	1013.47364	15.9484	0	0	0	0	0	0	0	14.35452	0	0	0	0	0	12.97217	14.92246	0	0	14.34216	13.86896	13.10946	13.84389	15.93693	16.49075	14.95096	14.25924	0	14.51859	0	0	0	13.04867	13.93454	12.71993	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HAV4	XPO5_HUMAN	"Exportin-5, Exp5 (Ran-binding protein 21)"	XPO5 KIAA1291 RANBP21	Homo sapiens (Human)	miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1900370; GO:1905172	TQVAIVR	7.099999905	0.387168467	0.387168467	0.209602509	786.5271112	0	13.20181	11.25945	14.8942	14.3335	15.10042	14.52028	14.49462	15.48462	15.90166	15.44701	16.35303	16.5627	15.66342	13.50657	15.75746	0	15.96641	0	15.32292	15.56008	0	14.29919	16.17551	16.23851	14.20997	0	14.72803	0	15.26468	0	0	15.75921	16.8714	14.77742	16.31807	16.54849	16.08145	15.88637	0	0	0	16.85941	15.45839	0	0	16.40928	0
Q9HAV5	TNR27_HUMAN	"Tumor necrosis factor receptor superfamily member 27 (X-linked ectodysplasin-A2 receptor, EDA-A2 receptor)"	EDA2R TNFRSF27 XEDAR UNQ2448/PRO5727/PRO34080	Homo sapiens (Human)	ectodermal cell differentiation [GO:0010668]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]; ectodermal cell differentiation [GO:0010668]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]	signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]	GO:0005031; GO:0005886; GO:0005887; GO:0008544; GO:0010668; GO:0016021; GO:0038023; GO:0043123; GO:0046330; GO:0051092; GO:0072332	IGGLQDQECIPCTK	16.45000076	0.276583046	0.276583046	0.429995179	1618.013888	17.68334	0	0	18.11785	0	0	19.99737	0	0	0	18.47927	19.5739	0	0	0	0	0	0	0	0	0	0	17.93197	0	0	0	0	0	18.52208	0	0	19.47444	0	19.74286	0	0	0	0	0	18.20162	0	0	0	0	19.25615	0	18.20214	17.91227
Q9HAW0	BRF2_HUMAN	"Transcription factor IIIB 50 kDa subunit, TFIIIB50, hTFIIIB50 (B-related factor 2, BRF-2) (hBRFU)"	BRF2 BRFU PRO1470	Homo sapiens (Human)	"cellular response to oxidative stress [GO:0034599]; DNA-templated transcription, initiation [GO:0006352]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription preinitiation complex assembly [GO:0070897]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; cellular response to oxidative stress [GO:0034599]; DNA-templated transcription, initiation [GO:0006352]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription preinitiation complex assembly [GO:0070897]"	metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]	GO:0000126; GO:0001006; GO:0005634; GO:0005654; GO:0006352; GO:0006359; GO:0017025; GO:0034599; GO:0046872; GO:0070897; GO:0097550	EVTYSR	2.549999952	1	1	0.232151161	755.4076254	16.72552	0	0	0	0	0	0	0	17.90505	0	0	0	0	0	0	0	0	18.63731	0	0	0	0	0	17.59727	0	19.34078	0	19.97654	0	0	0	0	0	0	0	0	0	18.44866	0	0	0	0	0	0	0	0	0	0
Q9HAW4	CLSPN_HUMAN	"Claspin, hClaspin"	CLSPN	Homo sapiens (Human)	activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105]	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]; activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105]	anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]	GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0007095; GO:0010997; GO:0018105; GO:0032147; GO:0033314	SLLRNPFEAIRPGSAQQVK	5.989999771	1	1	1.38E-12	2112.373091	0	14.15255	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.68514	0	0	0	0	0	0	9.753909	0	0	0	0	0	0	0	13.97567	0	0	0	15.11233	13.85818	11.98917	0	14.34183	0	5.689589	0	0	0	0	0	0
Q9HAY2	MAGF1_HUMAN	"Melanoma-associated antigen F1, MAGE-F1 (MAGE-F1 antigen)"	MAGEF1	Homo sapiens (Human)	negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; protein ubiquitination [GO:0016567]	nucleus [GO:0005634]	nucleus [GO:0005634]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; protein ubiquitination [GO:0016567]		GO:0000122; GO:0005634; GO:0016567; GO:0097428; GO:2000042; GO:2000060	AEASMR	7.300000191	0.287415445	0.287415445	0.276737461	679.3650318	18.14857	17.83247	17.23879	0	17.63013	18.63665	0	0	0	0	0	18.58604	18.21686	0	0	17.11947	0	17.56778	17.61307	0	17.80424	17.56013	0	0	17.4024	0	17.38816	0	0	0	0	0	0	17.67312	0	20.37062	0	0	0	0	19.08698	0	0	16.14594	0	0	0	0
Q9HAZ1	CLK4_HUMAN	"Dual specificity protein kinase CLK4, EC 2.7.12.1 (CDC-like kinase 4)"	CLK4	Homo sapiens (Human)	protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; protein autophosphorylation [GO:0046777]; regulation of RNA splicing [GO:0043484]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]	GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0043484; GO:0046777; GO:0106310	ENSFLPFQIDHIR	6.340000153	1	1	0.364214763	1615.933662	0	0	17.43628	0	0	0	0	0	0	0	18.19326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.03203	0	0	0	17.71042	0	19.22475	0	18.28125	0	0	0	17.87352	0	0	0	0	0
Q9HAZ2	PRD16_HUMAN	"Histone-lysine N-methyltransferase PRDM16, EC 2.1.1.367 (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1, MDS1/EVI1-like gene 1)"	PRDM16 KIAA1675 MEL1 PFM13	Homo sapiens (Human)	"brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; regulation of transcription by RNA polymerase II [GO:0006357]"	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]"	GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016235; GO:0017053; GO:0018024; GO:0030512; GO:0030853; GO:0043457; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0046974; GO:0050873; GO:0070828; GO:0120162; GO:0140297	RADMQIVDGSAQCPGLASEK	10.60999966	1	1	0.048733115	2149.537869	13.1719	15.2795	13.94443	0	16.677	14.31371	14.27423	15.81074	15.76458	12.54355	11.50131	14.78783	12.81342	0	14.82837	14.07683	14.67575	13.35548	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HB07	MYG1_HUMAN	"MYG1 exonuclease, EC 3.1.-.-"	MYG1 C12orf10	Homo sapiens (Human)	locomotory exploration behavior [GO:0035641]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclease activity [GO:0004518]; locomotory exploration behavior [GO:0035641]	nuclease activity [GO:0004518]	GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0035641	TRDPEK	5.46999979	0.669429064	0.669429064	0.287323462	746.0641671	18.81082	19.6992	18.07685	17.2546	17.82597	0	0	18.62125	19.41379	0	17.91409	17.39098	0	17.76619	0	0	16.99152	0	17.95949	17.35998	15.85951	0	0	0	19.09852	17.4368	0	17.08812	0	0	19.80722	18.70943	19.28771	18.65526	0	19.44443	0	0	19.1519	19.21922	17.79466	18.65203	0	0	17.06153	17.28986	18.276	17.94646
Q9HB15	KCNKC_HUMAN	"Potassium channel subfamily K member 12 (Tandem pore domain halothane-inhibited potassium channel 2, THIK-2)"	KCNK12	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322]	potassium ion leak channel activity [GO:0022841]; voltage-gated ion channel activity [GO:0005244]	GO:0005244; GO:0005887; GO:0022841; GO:0030322; GO:0034765; GO:0071805	DLTASNK	14.75	0.138109237	0.138109237	0.185823752	747.4261709	18.11066	15.67366	0	0	0	0	0	0	16.60002	0	18.63546	14.08249	17.28085	0	0	0	0	0	0	0	0	0	14.62103	9.799132	0	0	0	0	0	0	0	15.66088	16.53279	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HB19	PKHA2_HUMAN	"Pleckstrin homology domain-containing family A member 2, PH domain-containing family A member 2 (Tandem PH domain-containing protein 2, TAPP-2)"	PLEKHA2 TAPP2	Homo sapiens (Human)	positive regulation of cell-matrix adhesion [GO:0001954]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; positive regulation of cell-matrix adhesion [GO:0001954]"	"fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]"	GO:0001954; GO:0001968; GO:0005634; GO:0005737; GO:0005886; GO:0008289; GO:0016020; GO:0030165; GO:0032991; GO:0043236; GO:0043325	SGDLLMR	12.42000008	0.932555795	0.932555795	0.297891926	806.7918714	15.55916	15.84479	14.29217	15.53443	15.86424	17.60214	0	14.97531	13.90914	17.62542	16.54501	15.06787	0	13.60594	14.4099	0	17.20479	15.15116	15.99972	0	0	16.06834	0	0	0	15.65886	0	15.51627	0	15.93102	17.69145	0	18.155	0	15.89034	0	15.9917	0	16.72243	17.26667	16.78912	15.0863	16.14323	0	15.01733	0	16.2685	15.77227
Q9HB20	PKHA3_HUMAN	"Pleckstrin homology domain-containing family A member 3, PH domain-containing family A member 3 (Phosphatidylinositol-four-phosphate adapter protein 1, FAPP-1, Phosphoinositol 4-phosphate adapter protein 1)"	PLEKHA3 FAPP1	Homo sapiens (Human)	ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]	ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273]	GO:0000139; GO:0005794; GO:0005829; GO:0035627; GO:0042802; GO:0070273; GO:0120009; GO:1902387; GO:1902388	ACLTDTR	4.300000191	0.25904119	0.25904119	0.046904284	836.8592163	0	16.4974	0	0	0	16.77162	15.95226	13.56551	13.36774	0	16.1133	0	0	0	0	13.72001	16.19257	16.10997	14.92718	16.81314	0	0	18.20277	0	17.77132	0	0	0	16.65988	0	0	13.51568	19.33794	12.78097	12.08562	16.66051	12.65802	9.132615	0	13.11232	0	0	18.96593	16.67439	0	11.76544	0	14.26175
Q9HB40	RISC_HUMAN	"Retinoid-inducible serine carboxypeptidase, EC 3.4.16.- (Serine carboxypeptidase 1)"	SCPEP1 RISC SCP1 MSTP034 UNQ265/PRO302	Homo sapiens (Human)	blood vessel diameter maintenance [GO:0097746]; negative regulation of blood pressure [GO:0045776]; retinoic acid metabolic process [GO:0042573]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; blood vessel diameter maintenance [GO:0097746]; negative regulation of blood pressure [GO:0045776]; retinoic acid metabolic process [GO:0042573]	serine-type carboxypeptidase activity [GO:0004185]	GO:0004185; GO:0005829; GO:0042573; GO:0045776; GO:0070062; GO:0097746	AGHMVPSDQGDMALKMMR	1.100000024	0.251871586	0.251871586	0.147107177	1991.726692	0	0	0	16.09545	13.69962	0	16.19305	12.64662	12.60468	15.55463	15.46396	15.38054	0	18.53627	14.97963	12.76781	15.91915	11.36117	16.23152	13.14743	15.11414	15.62705	17.17261	15.67284	12.77197	0	0	17.28837	15.46214	14.87735	0	15.45575	16.36418	0	15.29168	13.95999	15.384	15.27592	0	14.67863	0	15.62554	14.28234	16.67185	17.45887	16.12178	15.68748	13.95842
Q9HB58	SP110_HUMAN	Sp110 nuclear body protein (Interferon-induced protein 41/75) (Speckled 110 kDa) (Transcriptional coactivator Sp110)	SP110	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]"	GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0046872	LITEMYTVAWFVR	4.289999962	1	1	0.126805729	1628.418308	16.1394	0	14.44446	0	0	0	0	15.55881	15.8082	0	0	0	0	0	0	0	0	16.35677	0	0	0	17.08217	0	0	0	0	0	16.67873	0	0	0	0	0	0	0	0	0	0	17.81414	0	0	0	0	0	0	0	0	0
Q9HBA0	TRPV4_HUMAN	"Transient receptor potential cation channel subfamily V member 4, TrpV4 (Osm-9-like TRP channel 4, OTRPC4) (Transient receptor potential protein 12, TRP12) (Vanilloid receptor-like channel 2) (Vanilloid receptor-like protein 2, VRL-2) (Vanilloid receptor-related osmotically-activated channel, VR-OAC)"	TRPV4 VRL2 VROAC	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion import into cytosol [GO:1902656]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell volume homeostasis [GO:0006884]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; microtubule polymerization [GO:0046785]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of striated muscle contraction [GO:0045989]; positive regulation of vascular permeability [GO:0043117]; regulation of aerobic respiration [GO:1903715]; regulation of response to osmotic stress [GO:0047484]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]; vasopressin secretion [GO:0030103]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	"adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, cation-selective, calcium channel activity [GO:0015275]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion import into cytosol [GO:1902656]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell volume homeostasis [GO:0006884]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; microtubule polymerization [GO:0046785]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of striated muscle contraction [GO:0045989]; positive regulation of vascular permeability [GO:0043117]; regulation of aerobic respiration [GO:1903715]; regulation of response to osmotic stress [GO:0047484]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]; vasopressin secretion [GO:0030103]"	"actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, cation-selective, calcium channel activity [GO:0015275]"	GO:0000122; GO:0002024; GO:0003779; GO:0005034; GO:0005080; GO:0005216; GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005783; GO:0005881; GO:0005886; GO:0005887; GO:0005912; GO:0005925; GO:0005929; GO:0006816; GO:0006874; GO:0006884; GO:0007015; GO:0007043; GO:0007204; GO:0007231; GO:0008017; GO:0008289; GO:0009612; GO:0009986; GO:0010759; GO:0010977; GO:0015275; GO:0016021; GO:0016324; GO:0019901; GO:0030027; GO:0030103; GO:0030175; GO:0030426; GO:0030864; GO:0031117; GO:0031410; GO:0031532; GO:0032587; GO:0032755; GO:0032868; GO:0034605; GO:0042169; GO:0042538; GO:0042593; GO:0042802; GO:0043014; GO:0043117; GO:0043622; GO:0045989; GO:0046330; GO:0046785; GO:0046872; GO:0047484; GO:0048487; GO:0050729; GO:0050891; GO:0051015; GO:0060351; GO:0070374; GO:0070509; GO:0070588; GO:0071470; GO:0071476; GO:0071477; GO:0071639; GO:0071642; GO:0071651; GO:0097009; GO:0097497; GO:0098703; GO:1902656; GO:1903444; GO:1903715; GO:2000340	NDTIPVLLDIAERTGNMR	11.85000038	1	1	0.107501859	2044.153346	0	14.77554	13.87087	0	0	0	0	15.49608	0	0	0	14.0801	0	0	15.78905	15.9944	16.10652	14.77398	16.31585	16.2538	0	0	0	0	15.68652	14.4201	15.90202	15.3608	12.14103	13.33515	14.26156	15.62283	14.75803	15.12946	14.84822	14.81968	0	0	0	0	0	0	0	0	0	0	0	0
Q9HBD1	RC3H2_HUMAN	"Roquin-2, EC 2.3.2.27 (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING finger protein 164) (RING-type E3 ubiquitin transferase Roquin-2)"	RC3H2 MNAB RNF164	Homo sapiens (Human)	"B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-embryonic development [GO:0009791]; protein polyubiquitination [GO:0000209]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; P-body [GO:0000932]	"cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; P-body [GO:0000932]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-embryonic development [GO:0009791]; protein polyubiquitination [GO:0000209]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]"	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0000288; GO:0000932; GO:0001782; GO:0003677; GO:0003723; GO:0003725; GO:0003729; GO:0006511; GO:0009791; GO:0009986; GO:0010494; GO:0016020; GO:0035264; GO:0035613; GO:0042098; GO:0043029; GO:0043231; GO:0046872; GO:0048286; GO:0048535; GO:0048536; GO:0050852; GO:0060173; GO:0061470; GO:0061630; GO:1901224; GO:2000320; GO:2000628	EHDAQIVHIAMEAGLR	3.079999924	0.767127573	0.767127573	2.30E-13	1790.9823	0	14.56706	0	15.03655	0	0	13.1504	14.63126	0	0	0	0	0	0	0	17.99506	0	0	0	0	0	0	15.39223	0	17.71889	0	0	0	0	0	0	0	0	0	0	0	0	17.90981	0	0	0	0	0	0	0	17.37728	0	0
Q9HBE1	PATZ1_HUMAN	"POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)"	PATZ1 PATZ RIAZ ZBTB19 ZNF278 ZSG	Homo sapiens (Human)	"male gonad development [GO:0008584]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; male gonad development [GO:0008584]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]"	GO:0000978; GO:0001227; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0008584; GO:0010596; GO:0030217; GO:0031625; GO:0045892; GO:0045893; GO:0046872	FLLMRSVIEICQEVIK	12.81000042	1	1	0.589450321	1992.404499	0	0	0	0	0	19.01986	0	19.38531	0	0	0	19.06583	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.0271	0	19.96612	0	0	0	0	0	0	0	0	0	20.7338	0	0	0	0	0	0	19.52098	0	0
Q9HBG4	VPP4_HUMAN	"V-type proton ATPase 116 kDa subunit a 4, V-ATPase 116 kDa isoform a 4 (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4) (Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform)"	ATP6V0A4 ATP6N1B ATP6N2	Homo sapiens (Human)	intracellular pH reduction [GO:0051452]; ossification [GO:0001503]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; renal tubular secretion [GO:0097254]; sensory perception of sound [GO:0007605]; vacuolar acidification [GO:0007035]	"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"	"apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; intracellular pH reduction [GO:0051452]; ossification [GO:0001503]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; renal tubular secretion [GO:0097254]; sensory perception of sound [GO:0007605]; vacuolar acidification [GO:0007035]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000220; GO:0001503; GO:0005765; GO:0005768; GO:0005886; GO:0006885; GO:0007035; GO:0007605; GO:0010008; GO:0016021; GO:0016324; GO:0016471; GO:0030670; GO:0031526; GO:0033176; GO:0045177; GO:0046961; GO:0051117; GO:0051452; GO:0070062; GO:0097254; GO:1902600	ICDGFR	5.639999866	1	1	0.216229447	768.2106921	0	0	0	0	0	0	15.75517	19.78875	0	0	0	0	0	0	0	0	15.9684	15.89748	0	17.8337	0	17.29676	0	0	14.78933	0	0	0	17.52066	0	0	14.53046	0	0	0	0	0	0	17.06886	0	13.98242	15.56913	0	0	0	0	20.16063	0
Q9HBG6	IF122_HUMAN	Intraflagellar transport protein 122 homolog (WD repeat-containing protein 10) (WD repeat-containing protein 140)	IFT122 SPG WDR10 WDR140	Homo sapiens (Human)	camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic heart tube development [GO:0035050]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb development [GO:0060173]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]	ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]	ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic heart tube development [GO:0035050]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb development [GO:0060173]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]		GO:0001843; GO:0005737; GO:0005929; GO:0010172; GO:0016020; GO:0030991; GO:0032391; GO:0035050; GO:0035721; GO:0036064; GO:0042073; GO:0045879; GO:0048593; GO:0060173; GO:0060271; GO:0061512; GO:0097542; GO:0097730; GO:1905515	CLDMSASR	5.840000153	0.880013585	0.880013585	0.26242552	938.2129822	16.33276	0	16.7709	0	15.857	0	14.16068	12.75553	14.06767	16.97387	16.36474	14.14372	13.48297	14.94843	14.24686	15.57508	15.89851	0	15.47636	0	0	15.59045	0	0	0	0	17.35074	17.01473	17.27951	16.50244	16.69285	0	0	0	16.29007	17.7161	17.4193	0	16.55877	15.35346	0	0	0	16.25615	14.86443	0	16.81905	0
Q9HBH5	RDH14_HUMAN	"Retinol dehydrogenase 14, EC 1.1.1.300 (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)"	RDH14 PAN2 SDR7C4 UNQ529/PRO1072	Homo sapiens (Human)	osteoblast differentiation [GO:0001649]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 11-cis-retinol dehydrogenase activity [GO:0102354]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649]	11-cis-retinol dehydrogenase activity [GO:0102354]; NADP-retinol dehydrogenase activity [GO:0052650]	GO:0001649; GO:0005634; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0052650; GO:0102354	IVVVSSK	5.5	0.723040342	0.723040342	0.229515858	732.1897546	15.8871	12.99157	0	11.11074	0	16.45389	0	0	13.14072	0	15.54443	0	16.50639	14.12903	15.10973	0	0	0	17.93361	16.02999	16.27675	0	0	0	16.99677	16.03051	16.09867	14.41393	0	15.47531	16.7207	19.13203	14.67874	17.32623	14.51404	14.93407	16.68965	14.65793	15.44079	0	14.70764	0	16.32332	15.67036	15.56593	14.58399	16.48239	11.58698
Q9HBI0	PARVG_HUMAN	Gamma-parvin	PARVG	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of cell polarity [GO:0007163]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of cell polarity [GO:0007163]; substrate adhesion-dependent cell spreading [GO:0034446]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0007160; GO:0007163; GO:0015629; GO:0030031; GO:0031532; GO:0034446	VNAVKEAIVNFVNQK	5.210000038	1	1	0.240683603	1671.884767	0	8.805068	0	15.12153	15.26052	14.29742	15.99011	0	0	0	14.80862	13.37193	13.42043	0	0	13.4686	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HBI1	PARVB_HUMAN	Beta-parvin (Affixin)	PARVB CGI-56	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0030032; GO:0031532; GO:0034446; GO:0071963	TMIDPTSKEDPK	4.099999905	1	1	0.376678308	1377.547816	0	14.03934	0	11.04598	0	11.31892	0	0	14.30045	11.85946	0	0	0	0	0	0	0	0	15.42213	0	0	0	0	0	0	0	0	0	0	0	0	16.61966	0	14.49454	0	0	16.22765	0	0	0	0	0	16.18207	0	15.95996	0	0	0
Q9HBJ0	PLAC1_HUMAN	Placenta-specific protein 1	PLAC1	Homo sapiens (Human)	placenta development [GO:0001890]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; placenta development [GO:0001890]		GO:0001890; GO:0005576	GTPSKFVIPVSCAAPQK	2.279999971	1	1	0.305128596	1786.226464	0	12.96636	0	0	15.69165	0	0	0	0	0	0	14.63997	0	15.90158	15.08798	0	14.42853	0	0	0	0	13.58136	14.6269	0	15.85381	13.28402	0	14.61957	0	0	0	0	0	11.48464	10.63811	13.62082	0	0	0	0	0	0	0	0	0	15.08891	16.12683	0
Q9HBL0	TENS1_HUMAN	Tensin-1	TNS1 TNS	Homo sapiens (Human)		cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]	actin binding [GO:0003779]; RNA binding [GO:0003723]	GO:0003723; GO:0003779; GO:0005737; GO:0005856; GO:0005925; GO:0009986	EDLDDAFK	14.61999989	0.721630156	0.721630156	0.249422866	951.6421602	16.29873	18.29317	14.59711	0	0	0	0	17.5755	17.99557	17.82422	0	18.31271	17.5928	0	17.78108	18.38612	17.31069	0	0	0	0	18.97659	0	17.08348	17.24954	18.44859	17.55999	0	17.28609	0	0	0	0	0	19.58969	19.30357	19.07093	0	19.2432	17.98669	18.19649	18.08246	16.6235	0	17.92054	0	16.1313	17.5579
Q9HBL6	LRTM1_HUMAN	Leucine-rich repeat and transmembrane domain-containing protein 1	LRTM1 HT017	Homo sapiens (Human)	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]	heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050919	ERFDSSPA	2.390000105	1	1	0.096955334	908.585678	0	14.30727	14.08942	14.12926	16.35608	0	14.63024	12.49057	0	15.657	0	0	0	0	0	0	0	13.47275	0	0	0	0	0	0	0	15.5316	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HBM6	TAF9B_HUMAN	"Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7, DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L)"	TAF9B TAF9L	Homo sapiens (Human)	"DNA-templated transcription, initiation [GO:0006352]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein stabilization [GO:0050821]"	nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	"nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein stabilization [GO:0050821]"	protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005654; GO:0005669; GO:0006352; GO:0016251; GO:0030307; GO:0033276; GO:0043066; GO:0046982; GO:0050821; GO:1902166	VINQMLEFAFR	10.14000034	0.47669071	0.47669071	0.489893607	1383.313565	0	16.62187	0	0	0	15.86306	0	0	0	0	0	0	0	0	0	0	0	17.27204	0	17.34181	0	0	0	17.35039	0	0	17.30481	0	0	0	0	0	0	0	0	0	0	0	0	18.45	0	0	0	0	18.09652	0	18.71346	0
Q9HBT6	CAD20_HUMAN	Cadherin-20	CDH20 CDH7L3	Homo sapiens (Human)	adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742	EAQAGAAPK	4.389999866	1	1	0.137808791	842.2682049	0	15.52736	0	0	0	0	0	15.61256	16.06059	0	0	15.232	0	18.61396	0	0	0	0	0	19.44723	0	17.5162	0	17.47312	0	16.07449	0	15.66992	0	0	0	0	0	0	0	0	0	13.29788	0	14.24007	0	0	13.57944	0	0	0	0	0
Q9HBT7	ZN287_HUMAN	Zinc finger protein 287 (Zinc finger protein with KRAB and SCAN domains 13)	ZNF287 ZKSCAN13	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0001817; GO:0005634; GO:0006357; GO:0045893; GO:0046872	AQACTPVEDMSK	5.010000229	1	1	0.233448879	1337.038136	0	15.73366	14.81827	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.86069	0	16.06615	0	0	0	0	15.62831	18.22406	15.71086	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HBU6	EKI1_HUMAN	"Ethanolamine kinase 1, EKI 1, EC 2.7.1.82"	ETNK1 EKI1	Homo sapiens (Human)	phosphatidylethanolamine biosynthetic process [GO:0006646]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]	ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]	GO:0004305; GO:0005524; GO:0005737; GO:0005829; GO:0006646; GO:0016020	IGNSAASR	2.410000086	1	1	0.136754546	774.5240984	10.91107	0	0	0	0	0	15.96168	0	0	0	14.93356	0	0	0	0	0	0	0	11.20431	0	14.86876	0	17.20315	15.68791	0	15.7867	15.8354	0	14.84328	15.71725	0	0	0	0	0	0	13.24466	0	0	15.22927	0	0	0	13.91122	0	15.15554	14.77636	0
Q9HBW1	LRRC4_HUMAN	"Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand, NGL-2)"	LRRC4 BAG NAG14 UNQ554/PRO1111	Homo sapiens (Human)	excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]	dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560]		GO:0005886; GO:0043197; GO:0050804; GO:0060076; GO:0097119; GO:0098685; GO:0098978; GO:0099061; GO:0099560; GO:1904861	CRTPPMSSVK	5.820000172	1	1	0.273946731	1178.34992	0	0	0	0	0	0	0	0	14.98247	0	0	0	14.85546	0	16.3951	0	13.71595	0	15.49766	14.99638	0	0	0	13.8658	15.69763	16.7082	0	0	0	0	0	14.1126	17.30456	0	0	0	0	0	0	0	17.44825	15.64824	0	0	0	0	0	0
Q9HBZ2	ARNT2_HUMAN	"Aryl hydrocarbon receptor nuclear translocator 2, ARNT protein 2 (Class E basic helix-loop-helix protein 1, bHLHe1)"	ARNT2 BHLHE1 KIAA0307	Homo sapiens (Human)	"brain development [GO:0007420]; central nervous system development [GO:0007417]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"	aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; central nervous system development [GO:0007417]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"	"aryl hydrocarbon receptor binding [GO:0017162]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0017162; GO:0034751; GO:0045893; GO:0045944; GO:0046982; GO:1990837	GQVLSVMYR	9.550000191	0.371653765	0.371653765	0.06323044	1067.616961	0	15.85092	15.84835	15.98175	15.97551	0	15.32287	15.35726	15.28707	16.81175	0	13.72272	0	15.49762	0	0	0	14.74287	16.6653	0	15.82955	0	17.48947	16.16944	15.1898	16.91082	16.40548	0	15.69075	17.39028	15.61084	17.0874	17.24863	0	16.9011	14.14373	13.70927	0	14.75202	14.96455	17.02844	14.07342	0	15.18214	17.29846	13.57967	16.37756	15.47173
Q9HC10	OTOF_HUMAN	Otoferlin (Fer-1-like protein 2)	OTOF FER1L2	Homo sapiens (Human)	membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]	basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]	AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]	GO:0000139; GO:0005509; GO:0005789; GO:0005829; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0061025	AGRSVFSAMK	3.220000029	1	1	0.106673119	1070.153521	0	0	15.96146	16.82458	13.59031	0	15.94202	0	12.42276	0	0	0	0	0	15.49961	0	0	0	0	0	0	15.87532	0	0	14.61473	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HC24	LFG4_HUMAN	Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein)	TMBIM4 GAAP LFG4 CGI-119	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848]	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848]		GO:0000139; GO:0005795; GO:0006915; GO:0016020; GO:0016021; GO:0043066; GO:0050848	ADPDPR	6.349999905	1	1	0.203372642	670.3420932	16.35696	15.8692	0	15.72321	16.84867	14.30055	15.18969	13.50804	13.09859	14.65544	15.12218	15.2601	16.32233	14.50255	13.84117	15.302	0	15.06422	16.3795	15.01545	15.81979	15.0355	15.98185	0	15.77213	15.97671	16.71901	16.00445	15.80772	15.49522	16.03878	0	16.05908	0	0	0	16.6201	0	16.84923	0	0	0	0	15.40322	16.01851	0	0	15.80435
Q9HC29	NOD2_HUMAN	Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15) (Inflammatory bowel disease protein 1)	NOD2 CARD15 IBD1	Homo sapiens (Human)	activation of immune response [GO:0002253]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gamma-delta T cell activation [GO:0046645]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to nutrient [GO:0007584]	anchored component of plasma membrane [GO:0046658]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]	anchored component of plasma membrane [GO:0046658]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; activation of immune response [GO:0002253]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gamma-delta T cell activation [GO:0046645]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to nutrient [GO:0007584]	actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]	GO:0002221; GO:0002227; GO:0002253; GO:0002606; GO:0002710; GO:0002720; GO:0002732; GO:0002830; GO:0002862; GO:0002925; GO:0003779; GO:0005524; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006952; GO:0006965; GO:0007584; GO:0009595; GO:0009986; GO:0016045; GO:0016323; GO:0019899; GO:0019901; GO:0030277; GO:0030544; GO:0031982; GO:0032088; GO:0032495; GO:0032498; GO:0032500; GO:0032689; GO:0032695; GO:0032701; GO:0032703; GO:0032720; GO:0032731; GO:0032733; GO:0032735; GO:0032740; GO:0032755; GO:0032757; GO:0032760; GO:0032874; GO:0032991; GO:0034136; GO:0035556; GO:0038187; GO:0042742; GO:0042834; GO:0043123; GO:0043330; GO:0043406; GO:0043552; GO:0044877; GO:0045087; GO:0045089; GO:0045335; GO:0045747; GO:0045944; GO:0046330; GO:0046645; GO:0046658; GO:0050679; GO:0050700; GO:0050727; GO:0050731; GO:0050766; GO:0050830; GO:0050871; GO:0051092; GO:0051353; GO:0051770; GO:0051879; GO:0060585; GO:0070374; GO:0070431; GO:0071222; GO:0071224; GO:0071225; GO:0071407; GO:0071639; GO:0090022; GO:1900017; GO:1901224; GO:1902523; GO:1904417; GO:2000110; GO:2000363	SLYEMQEERLAR	6.070000172	0.93572396	0.93572396	0.046421286	1525.695623	11.82939	0	0	12.07856	17.80255	12.0344	12.50853	0	16.3818	0	0	0	0	16.63174	0	13.83131	14.33613	0	0	0	0	0	16.36771	12.10202	0	0	0	0	0	0	14.05151	0	14.17918	0	0	13.84762	0	0	15.46209	0	0	0	0	0	15.14841	0	0	0
Q9HC35	EMAL4_HUMAN	"Echinoderm microtubule-associated protein-like 4, EMAP-4 (Restrictedly overexpressed proliferation-associated protein) (Ropp 120)"	EML4 C2orf2 EMAPL4	Homo sapiens (Human)	attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]	alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]	GO:0000226; GO:0000278; GO:0005737; GO:0005815; GO:0005829; GO:0005874; GO:0007017; GO:0007080; GO:0008017; GO:0008608; GO:0015630; GO:0016020; GO:0030496; GO:0043014; GO:0048487; GO:0051301; GO:0072686	GPKGVYQISK	8.350000381	1	1	0.302533607	1076.753255	17.04919	0	0	0	0	0	0	17.93051	0	0	0	0	0	0	0	0	0	17.0049	0	0	16.37169	0	0	18.25006	18.30094	0	0	0	0	0	0	19.01645	19.36185	0	0	17.95204	0	0	19.99346	0	0	17.23759	0	0	0	17.56951	0	0
Q9HC36	MRM3_HUMAN	"rRNA methyltransferase 3, mitochondrial, EC 2.1.1.- (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)"	MRM3 RNMTL1 HC90	Homo sapiens (Human)	rRNA 2'-O-methylation [GO:0000451]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]	GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0042802; GO:0070039	MFFFSR	2.890000105	0.970501184	0.970501184	0.199675204	851.3093708	16.56449	0	0	0	14.0987	15.71915	0	14.92312	0	0	0	15.22576	12.43954	14.8442	15.33834	0	14.87689	0	0	14.88331	14.63105	14.27794	0	15.01167	16.07441	0	15.16455	13.66856	14.76573	14.78613	15.43116	15.17291	0	0	14.22613	14.25204	0	15.95802	17.47901	14.83336	13.83465	0	0	13.08669	0	14.95339	16.0626	14.97203
Q9HC38	GLOD4_HUMAN	Glyoxalase domain-containing protein 4	GLOD4 C17orf25 CGI-150 My027	Homo sapiens (Human)		extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]	extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; cadherin binding [GO:0045296]	cadherin binding [GO:0045296]	GO:0005739; GO:0045296; GO:0070062	IAFSCPQK	5.880000114	0.788896203	0.788896203	0.210449677	951.3145302	0	16.30514	0	0	0	0	0	14.41152	0	17.96562	13.22182	17.74264	14.2542	15.35791	17.06988	0	0	0	0	0	15.34087	0	0	15.327	16.04954	0	12.78503	0	14.91439	0	0	0	0	18.91904	0	0	0	0	13.82803	17.16458	0	0	0	0	16.19925	14.46867	0	0
Q9HC52	CBX8_HUMAN	"Chromobox protein homolog 8 (Polycomb 3 homolog, Pc3, hPc3) (Rectachrome 1)"	CBX8 PC3 RC1	Homo sapiens (Human)	chromatin organization [GO:0006325]; histone ubiquitination [GO:0016574]; negative regulation of transcription by RNA polymerase II [GO:0000122]	chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]	chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027]; chromatin organization [GO:0006325]; histone ubiquitination [GO:0016574]; negative regulation of transcription by RNA polymerase II [GO:0000122]	methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027]	GO:0000122; GO:0000785; GO:0000792; GO:0003727; GO:0005634; GO:0005654; GO:0006325; GO:0016574; GO:0031519; GO:0035064; GO:0035102; GO:0097027	QDSDLVQCGVTSPSSAEATGKLAVDTFPAR	6.289999962	1	1	2.75E-12	3106.849406	0	0	0	0	0	0	0	14.72683	0	0	0	0	13.79237	11.97156	14.46996	12.99461	13.76654	0	13.00655	11.13503	13.17955	0	0	11.43779	0	0	0	14.94129	10.12155	15.06233	14.5749	12.22038	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HC56	PCDH9_HUMAN	Protocadherin-9	PCDH9	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]	cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291	EQKDTYVMK	8.739999771	1	1	0.237804325	1158.09324	12.44249	0	14.18743	13.0384	15.29374	11.9466	0	15.012	13.5609	0	15.00904	17.60363	14.88863	13.69907	13.92915	0	11.89015	14.7091	15.18206	15.05935	12.97926	13.88478	0	15.59627	0	0	0	0	14.48415	13.80502	0	0	0	0	0	0	0	15.21315	0	0	0	15.1113	15.63212	0	0	14.4653	0	16.09228
Q9HC62	SENP2_HUMAN	"Sentrin-specific protease 2, EC 3.4.22.- (Axam2) (SMT3-specific isopeptidase 2, Smt3ip2) (Sentrin/SUMO-specific protease SENP2)"	SENP2 KIAA1331	Homo sapiens (Human)	fat cell differentiation [GO:0045444]; heart development [GO:0007507]; labyrinthine layer development [GO:0060711]; mRNA transport [GO:0051028]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein desumoylation [GO:0016926]; protein transport [GO:0015031]; regulation of DNA endoreduplication [GO:0032875]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of Wnt signaling pathway [GO:0030111]; spongiotrophoblast layer development [GO:0060712]; trophoblast giant cell differentiation [GO:0060707]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; SUMO-specific endopeptidase activity [GO:0070139]; SUMO-specific isopeptidase activity [GO:0070140]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; labyrinthine layer development [GO:0060711]; mRNA transport [GO:0051028]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein desumoylation [GO:0016926]; protein transport [GO:0015031]; regulation of DNA endoreduplication [GO:0032875]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of Wnt signaling pathway [GO:0030111]; spongiotrophoblast layer development [GO:0060712]; trophoblast giant cell differentiation [GO:0060707]; Wnt signaling pathway [GO:0016055]	SUMO-specific endopeptidase activity [GO:0070139]; SUMO-specific isopeptidase activity [GO:0070140]	GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0007507; GO:0015031; GO:0016055; GO:0016605; GO:0016926; GO:0030111; GO:0031397; GO:0031398; GO:0031648; GO:0031965; GO:0032875; GO:0035562; GO:0045444; GO:0045944; GO:0051028; GO:0060707; GO:0060711; GO:0060712; GO:0070139; GO:0070140; GO:2000045	MYRWLVR	2.470000029	1	1	4.59E-13	1024.634149	13.90001	0	14.0975	0	15.063	14.68431	0	0	15.42956	0	0	0	0	0	0	0	0	12.17607	0	13.73768	0	0	0	0	0	13.67153	0	0	0	0	15.76592	13.93985	0	0	0	0	11.85764	15.50935	0	15.75871	0	0	12.56887	0	14.59161	0	0	16.15606
Q9HC77	CENPJ_HUMAN	"Centromere protein J, CENP-J (Centrosomal P4.1-associated protein) (LAG-3-associated protein) (LYST-interacting protein 1)"	CENPJ CPAP LAP LIP1	Homo sapiens (Human)	astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centriole replication [GO:0046601]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of spindle assembly [GO:1905832]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleus [GO:0005634]; procentriole replication complex [GO:0120099]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleus [GO:0005634]; procentriole replication complex [GO:0120099]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centriole replication [GO:0046601]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of spindle assembly [GO:1905832]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224]	gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]	GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007099; GO:0007224; GO:0008275; GO:0015631; GO:0019901; GO:0019904; GO:0030954; GO:0036064; GO:0042802; GO:0043015; GO:0044458; GO:0046427; GO:0046599; GO:0046601; GO:0046785; GO:0051301; GO:0060236; GO:0060271; GO:0061511; GO:0120099; GO:1900087; GO:1902857; GO:1903724; GO:1904951; GO:1905515; GO:1905832	DSKAR	2.849999905	1	1	0.132687088	577.3759766	15.90277	0	15.37635	13.43676	13.96901	0	15.10075	0	15.4276	16.76683	0	0	0	15.09435	15.526	0	15.89276	0	0	16.28034	0	0	16.29168	0	0	15.43815	15.37356	16.9906	15.19557	14.45296	0	0	0	0	0	17.133	0	0	0	0	0	0	0	0	0	0	14.59196	0
Q9HC78	ZBT20_HUMAN	Zinc finger and BTB domain-containing protein 20 (Dendritic-derived BTB/POZ zinc finger protein) (Zinc finger protein 288)	ZBTB20 DPZF ZNF288	Homo sapiens (Human)	cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010629; GO:0016604; GO:0032728; GO:0032755; GO:0032760; GO:0045821; GO:0046872; GO:0046889; GO:0055088; GO:0071333; GO:1990837	VSQSEALQILTAASILQIK	9.529999733	1	1	0.101092162	2013.938232	15.24933	0	15.66054	0	0	14.30222	0	0	16.06086	0	0	13.18373	13.11752	0	13.99637	14.41883	14.84425	0	15.09513	16.61755	15.80637	13.85023	16.65868	13.73829	16.44474	0	0	0	13.47709	13.95526	14.07894	15.74937	13.53323	13.89103	0	17.91523	0	0	0	0	0	0	0	0	0	0	0	0
Q9HC84	MUC5B_HUMAN	"Mucin-5B, MUC-5B (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype B, tracheobronchial) (Sublingual gland mucin)"	MUC5B MUC5	Homo sapiens (Human)		extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]		GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0043231; GO:0070062	TGLLVEQSGDYIKVSIR	11.25	1	1	6.92E-13	1879.225555	0	14.23935	14.50869	15.30445	0	15.661	14.1419	0	0	7.856009	13.61345	0	0	0	14.92029	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HC96	CAN10_HUMAN	"Calpain-10, EC 3.4.22.- (Calcium-activated neutral proteinase 10, CANP 10)"	CAPN10 KIAA1845	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to insulin stimulus [GO:0032869]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; type B pancreatic cell apoptotic process [GO:0097050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149]; actin cytoskeleton reorganization [GO:0031532]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to insulin stimulus [GO:0032869]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; type B pancreatic cell apoptotic process [GO:0097050]	calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149]	GO:0000149; GO:0004198; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006508; GO:0006921; GO:0008092; GO:0031532; GO:0032024; GO:0032388; GO:0032869; GO:0046326; GO:0097050; GO:2000676	ALPGAWVKGQSAGGCR	9.350000381	1	1	0.337708776	1613.990809	16.32637	0	14.78772	0	0	0	14.90771	15.70375	0	0	15.11696	0	15.75417	11.27476	14.09526	0	0	0	16.60408	15.91105	0	0	0	0	14.14877	0	0	16.25576	0	0	0	0	16.79082	0	13.0165	0	0	0	15.89105	0	0	17.11814	0	0	16.27168	0	0	0
Q9HCC8	GDPD2_HUMAN	"Glycerophosphoinositol inositolphosphodiesterase GDPD2, EC 3.1.4.43 (Glycerophosphodiester phosphodiesterase 3) (Glycerophosphodiester phosphodiesterase domain-containing protein 2) (Osteoblast differentiation promoting factor)"	GDPD2 GDE3 OBDPF UNQ1935/PRO4418	Homo sapiens (Human)	actin filament reorganization [GO:0090527]; lipid metabolic process [GO:0006629]; positive regulation of osteoblast differentiation [GO:0045669]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol inositolphosphodiesterase activity [GO:0047394]; metal ion binding [GO:0046872]; actin filament reorganization [GO:0090527]; lipid metabolic process [GO:0006629]; positive regulation of osteoblast differentiation [GO:0045669]	glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol inositolphosphodiesterase activity [GO:0047394]; metal ion binding [GO:0046872]	GO:0005737; GO:0005884; GO:0005886; GO:0006629; GO:0008889; GO:0016020; GO:0016021; GO:0030027; GO:0045669; GO:0046872; GO:0047394; GO:0090527	GAPMLAPENTLMSLRK	4.289999962	1	1	0.180519331	1729.056152	10.36305	15.33054	11.36999	0	15.2472	0	0	0	0	0	0	0	0	0	13.49414	0	0	0	15.39229	0	0	0	16.22086	0	0	0	0	12.60934	0	17.17358	0	16.17663	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HCC9	LST2_HUMAN	"Lateral signaling target protein 2 homolog, hLst2 (Zinc finger FYVE domain-containing protein 28)"	ZFYVE28 KIAA1643 LST2	Homo sapiens (Human)	negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]	metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0005829; GO:0007175; GO:0031901; GO:0032266; GO:0042059; GO:0046872	SPTSLDSAVATQEAASEPVAEGMDGGPHK	3.529999971	1	1	1.83E-12	2855.534423	0	12.26644	0	13.03277	0	0	0	14.79824	12.97672	0	14.41515	0	0	0	12.30064	0	0	0	0	0	0	0	11.31002	0	15.4628	0	15.98178	14.16897	0	0	0	0	0	0	15.34876	0	0	16.50093	0	0	0	0	0	15.0793	14.17284	0	15.33165	15.06067
Q9HCD5	NCOA5_HUMAN	"Nuclear receptor coactivator 5, NCoA-5 (Coactivator independent of AF-2, CIA)"	NCOA5 KIAA1637	Homo sapiens (Human)	glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966]	actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003682; GO:0003714; GO:0003723; GO:0005615; GO:0005654; GO:0009966; GO:0015629; GO:0042593; GO:0046627	DPMYDR	3.380000114	1	1	0.137223134	810.3173142	0	12.03435	16.29767	0	0	0	18.34455	0	0	19.63466	0	0	0	0	0	0	0	0	0	0	0	0	0	20.0163	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HCD6	TANC2_HUMAN	"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)"	TANC2 KIAA1148 KIAA1636	Homo sapiens (Human)	dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]	axon [GO:0030424]; dendritic spine [GO:0043197]	axon [GO:0030424]; dendritic spine [GO:0043197]; dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]		GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0099519	EEGEK	10.10999966	0.005362686	0.005362686	0.278159499	591.8606531	18.21108	18.54019	18.47444	18.38247	17.10978	18.39135	0	0	0	0	17.60439	0	0	0	0	0	0	17.86594	0	17.6019	16.29455	0	19.75377	0	0	0	19.47169	0	0	0	18.37872	19.05639	18.28831	17.05825	0	0	0	0	19.25949	17.6957	17.10412	16.22957	16.78975	19.59048	16.16024	17.89926	0	0
Q9HCE0	EPG5_HUMAN	Ectopic P granules protein 5 homolog	EPG5 KIAA1632	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162]	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162]		GO:0005737; GO:0005764; GO:0006862; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786	FLSEDNSDMIFMLLTKFDLK	10.02000046	1	1	0.646887487	2408.091042	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HCE1	MOV10_HUMAN	"Helicase MOV-10, EC 3.6.4.13 (Armitage homolog) (Moloney leukemia virus 10 protein)"	MOV10 KIAA1631	Homo sapiens (Human)	"3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; gene silencing by miRNA [GO:0035195]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]"	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]	"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; gene silencing by miRNA [GO:0035195]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]"	5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005524; GO:0005615; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0051607; GO:0061014; GO:0061158; GO:0150011	EVLTLR	12.60999966	0.135766566	0.135766566	0.291601594	731.0569404	18.97608	20.23087	24.22513	0	19.97938	21.54411	23.77997	19.10321	18.90989	0	24.13568	0	24.22714	18.45254	19.75191	23.55948	18.92104	17.90009	0	0	0	22.68004	17.87761	0	24.00819	24.19469	21.073	19.68977	17.82956	0	24.42336	0	0	21.59782	0	20.94254	18.30861	0	21.34914	0	24.22708	0	18.78632	0	17.29408	21.96404	24.10591	0
Q9HCE3	ZN532_HUMAN	Zinc finger protein 532	ZNF532 KIAA1629	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0046872	ATVISAASVQSASSAIIK	7.460000038	1	1	0.293730337	1703.485734	0	13.95646	0	14.09728	0	0	0	0	14.89229	0	14.17112	0	14.27428	0	0	16.39539	0	0	0	14.59964	0	0	0	15.61916	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HCE5	MET14_HUMAN	"N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14, hMETTL14)"	METTL14 KIAA1627	Homo sapiens (Human)	"forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]"	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729]	GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0006402; GO:0007283; GO:0016422; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0045727; GO:0061157; GO:0080009; GO:1901533	SPPPK	7.409999847	1	1	0.122312051	526.1718978	17.50546	16.73073	16.65143	12.31841	0	17.83208	0	0	0	14.12109	16.93374	0	13.59597	17.8853	0	0	15.94441	0	15.09998	0	18.60912	19.37087	15.34126	15.74681	17.4051	16.6243	0	12.35299	14.36838	15.39076	15.59597	16.22105	0	0	18.19038	0	13.80577	17.81068	14.51811	14.06308	16.5962	16.6155	16.01301	0	0	14.69283	15.45577	15.17761
Q9HCE6	ARGAL_HUMAN	Rho guanine nucleotide exchange factor 10-like protein (GrinchGEF)	ARHGEF10L GRINCHGEF KIAA1626	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; positive regulation of stress fiber assembly [GO:0051496]; regulation of small GTPase mediated signal transduction [GO:0051056]; SREBP signaling pathway [GO:0032933]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; positive regulation of stress fiber assembly [GO:0051496]; regulation of small GTPase mediated signal transduction [GO:0051056]; SREBP signaling pathway [GO:0032933]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005096; GO:0005829; GO:0030036; GO:0032933; GO:0051056; GO:0051496	DILALRVGGR	5.760000229	1	1	0.02940649	1069.528425	12.31742	0	13.60992	14.89379	0	13.44497	15.91833	0	12.65197	0	0	12.65876	11.45477	0	0	0	0	0	0	0	0	0	0	15.09826	0	14.27234	0	0	16.93959	0	0	0	0	0	0	0	0	0	0	0	12.9875	12.02197	0	0	0	14.21071	13.7535	0
Q9HCE7	SMUF1_HUMAN	"E3 ubiquitin-protein ligase SMURF1, hSMURF1, EC 2.3.2.26 (HECT-type E3 ubiquitin transferase SMURF1) (SMAD ubiquitination regulatory factor 1) (SMAD-specific E3 ubiquitin-protein ligase 1)"	SMURF1 KIAA1625	Homo sapiens (Human)	"BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; ectoderm development [GO:0007398]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; activin binding [GO:0048185]; I-SMAD binding [GO:0070411]; phospholipid binding [GO:0005543]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; ectoderm development [GO:0007398]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of dendrite extension [GO:1903861]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	activin binding [GO:0048185]; I-SMAD binding [GO:0070411]; phospholipid binding [GO:0005543]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000209; GO:0004842; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006611; GO:0007398; GO:0016567; GO:0030154; GO:0030424; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0032801; GO:0034394; GO:0043025; GO:0043161; GO:0045732; GO:0048185; GO:0060071; GO:0061630; GO:0061736; GO:0061753; GO:0070062; GO:0070411; GO:0070412; GO:0071211; GO:0072659; GO:1903861; GO:2000060	MRPKDLK	2.539999962	0.523201883	0.523201883	0.240093026	901.6589981	13.81978	0	17.7548	0	0	0	0	15.44093	0	0	0	0	0	0	0	0	0	13.01577	0	0	15.80609	14.57259	0	0	0	14.32781	15.65089	14.94081	0	15.60939	0	15.84864	0	16.68887	0	18.91502	0	0	15.78958	0	16.22278	15.56781	0	0	0	0	0	14.04813
Q9HCF6	TRPM3_HUMAN	"Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3, LTrpC-3, LTrpC3) (Melastatin-2, MLSN2)"	TRPM3 KIAA1616 LTRPC3	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951]	calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]	GO:0005227; GO:0005261; GO:0005262; GO:0005886; GO:0005887; GO:0006812; GO:0016048; GO:0050951; GO:0051262; GO:0070588; GO:0098655	LQESIDPAGEETMSPTSPTLMPR	6.599999905	1	1	2.29E-12	2502.694407	15.95333	11.34188	0	0	0	14.66265	0	0	0	13.68827	13.03137	0	16.13947	0	0	0	14.45137	0	0	0	0	0	0	11.60629	0	14.82946	13.73841	0	0	0	16.10266	14.14501	16.58081	0	0	0	0	13.79434	15.34302	0	0	0	0	0	14.87672	13.90681	0	0
Q9HCG7	GBA2_HUMAN	"Non-lysosomal glucosylceramidase, NLGase, EC 3.2.1.45 (Beta-glucocerebrosidase 2, Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2, EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2, EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase, EC 3.2.1.46) (Non-lysosomal glycosylceramidase)"	GBA2 KIAA1605 SPG46 AD035	Homo sapiens (Human)	bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]	cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113]	beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]	GO:0004348; GO:0005790; GO:0005829; GO:0005886; GO:0005975; GO:0006680; GO:0006687; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0019898; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0042406; GO:0046527; GO:0050295; GO:0090498; GO:0097035	EAMANLSPE	6.96999979	0.652079165	0.652079165	0.248430805	962.0880911	16.88822	17.11466	17.41158	0	0	0	0	0	0	14.94231	16.408	15.65084	0	0	15.95234	0	14.87338	10.26465	0	0	0	15.98533	0	0	15.02905	0	0	0	0	16.60504	18.00795	0	17.38677	0	15.78143	15.63124	16.25443	16.04439	0	16.74965	15.61427	0	0	12.63534	0	16.41138	0	0
Q9HCG8	CWC22_HUMAN	Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb)	CWC22 KIAA1604 NCM	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]"	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0016607; GO:0048024; GO:0071005; GO:0071006; GO:0071007; GO:0071013	SDYEHSR	16.20999908	0.015526625	0.015526625	0.175832643	893.524452	17.54979	19.26308	17.48122	16.76301	0	15.98354	19.25827	0	17.6764	17.26908	19.01527	17.71096	18.08585	17.46196	16.89017	18.3805	15.4613	19.44527	18.85551	16.47137	0	18.85035	0	18.6496	19.67915	17.25716	19.33044	17.36745	19.43208	16.08139	20.78057	18.25714	19.14595	20.95386	18.27198	17.7398	18.08941	19.88253	17.85068	18.8598	0	19.32687	20.03942	18.32696	19.1705	18.75076	17.06088	18.50383
Q9HCH0	NCK5L_HUMAN	"Nck-associated protein 5-like, NCKAP5-like (Centrosomal protein of 169 kDa, Cep169)"	NCKAP5L CEP169 KIAA1602 FP1193	Homo sapiens (Human)	microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]		GO:0001578; GO:0005737; GO:0005813; GO:0007019; GO:0035371	TPGNSSK	11.56999969	0.896979272	0.896979272	0.237197649	692.7478605	0	13.09266	11.55672	16.01811	0	15.04422	0	16.01775	15.72374	0	0	0	16.0569	16.36457	17.36444	0	17.14523	15.79467	17.72096	0	15.83546	0	17.06634	0	15.24161	16.54411	0	17.18087	14.8903	14.55125	15.16774	0	15.33973	15.50622	17.41452	15.75296	16.47393	16.25626	16.33228	17.19751	0	0	18.19541	14.93019	16.49305	18.89459	16.06639	0
Q9HCI6	K1586_HUMAN	"E3 SUMO-protein ligase KIAA1586, EC 2.3.2.- (E3 SUMO-protein transferase KIAA1586)"	KIAA1586	Homo sapiens (Human)	protein sumoylation [GO:0016925]		SUMO ligase activity [GO:0061665]; protein sumoylation [GO:0016925]	SUMO ligase activity [GO:0061665]	GO:0016925; GO:0061665	AHGKIQDLLK	5.139999866	0.341448367	0.341448367	0.091970812	1122.574001	16.37692	13.03753	18.01788	15.26805	16.32011	0	13.36716	14.20322	15.95899	0	12.55085	0	0	0	15.07964	10.64408	14.45703	0	15.03871	16.5084	12.94324	17.03427	13.2005	0	0	0	19.02699	18.4039	0	0	0	16.98318	0	0	10.49804	0	15.92352	16.91223	15.51383	14.35344	13.45804	0	0	0	15.09314	0	0	17.56095
Q9HCJ0	TNR6C_HUMAN	Trinucleotide repeat-containing gene 6C protein	TNRC6C KIAA1582	Homo sapiens (Human)	"gene silencing by miRNA [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005654; GO:0005829; GO:0035195; GO:0035278; GO:0060213; GO:1900153	SPLLGPGR	6.460000038	0.206920952	0.206920952	0.226520655	797.9124712	16.15983	13.83024	0	0	0	15.08448	0	0	0	0	0	0	15.827	0	0	0	0	16.95912	0	16.44284	17.28156	0	0	0	0	16.472	0	16.77816	16.20047	15.89233	0	15.63058	14.71036	16.75554	17.02507	12.95867	17.09494	16.50008	17.323	0	16.96328	0	16.07733	0	16.3151	16.47204	0	0
Q9HCJ1	ANKH_HUMAN	"Progressive ankylosis protein homolog, ANK"	ANKH KIAA1581 UNQ241/PRO274	Homo sapiens (Human)	bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cementum mineralization [GO:0071529]; diphosphate metabolic process [GO:0071344]; gene expression [GO:0010467]; locomotory behavior [GO:0007626]; phosphate ion homeostasis [GO:0055062]; regulation of bone mineralization [GO:0030500]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501]; transmembrane transport [GO:0055085]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; outer membrane [GO:0019867]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; outer membrane [GO:0019867]; plasma membrane [GO:0005886]; inorganic diphosphate transmembrane transporter activity [GO:0030504]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transporter activity [GO:0015114]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cementum mineralization [GO:0071529]; diphosphate metabolic process [GO:0071344]; gene expression [GO:0010467]; locomotory behavior [GO:0007626]; phosphate ion homeostasis [GO:0055062]; regulation of bone mineralization [GO:0030500]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501]; transmembrane transport [GO:0055085]	inorganic diphosphate transmembrane transporter activity [GO:0030504]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transporter activity [GO:0015114]	GO:0001501; GO:0005315; GO:0005576; GO:0005886; GO:0005887; GO:0007626; GO:0010467; GO:0015114; GO:0016021; GO:0019867; GO:0030282; GO:0030500; GO:0030504; GO:0055062; GO:0055074; GO:0055085; GO:0071344; GO:0071529; GO:1904383	EDAVEMLASYGLAYSLMK	4.059999943	0.007324615	0.007324615	0.095855853	2020.28356	14.61152	0	17.34421	0	15.66042	0	0	0	11.45284	0	13.95112	13.30718	0	0	0	0	0	10.38286	0	14.84259	14.51399	10.06178	13.75022	0	0	14.613	0	0	0	0	0	0	0	0	0	0	16.32635	16.95792	0	0	0	0	0	0	14.24097	11.76797	0	0
Q9HCJ2	LRC4C_HUMAN	"Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand, NGL-1)"	LRRC4C KIAA1580 NGL1 UNQ292/PRO331	Homo sapiens (Human)	modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560]	extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560]	cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]	GO:0005615; GO:0005886; GO:0016020; GO:0016021; GO:0050770; GO:0050804; GO:0050839; GO:0098632; GO:0098685; GO:0098978; GO:0099061; GO:0099560	CNTPPNLK	7.78000021	0.47664699	0.47664699	0.06794187	942.3554069	15.44907	17.22239	17.27362	15.08209	15.69831	14.5019	18.90392	14.23111	15.35724	15.76329	17.04107	17.7832	11.39238	15.55258	9.739937	13.41772	19.42465	11.90159	16.70374	17.23955	14.45072	0	17.59166	18.01993	16.8406	12.56747	15.11426	15.72428	14.86037	14.89888	16.17306	17.90876	15.44685	16.66854	16.9796	16.814	14.63262	17.12557	15.64984	16.98084	17.06549	15.6359	16.36725	16.2505	13.85918	17.04628	16.28509	17.32623
Q9HCJ3	RAVR2_HUMAN	Ribonucleoprotein PTB-binding 2 (Protein raver-2)	RAVER2 KIAA1579	Homo sapiens (Human)	"regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737	DFAAKAR	2.200000048	1	1	0.104927513	778.0355445	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.27689	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HCJ6	VAT1L_HUMAN	"Synaptic vesicle membrane protein VAT-1 homolog-like, EC 1.-.-.-"	VAT1L KIAA1576	Homo sapiens (Human)			oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]	oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]	GO:0008270; GO:0016491	AEETEQMIEK	4.699999809	1	1	0.253462973	1224.345632	0	17.22311	0	12.22517	16.19324	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.12329	0	0	0	0	0	17.73471	0	16.65168	16.14496	0	0	0	0	0	17.6047	18.06954	0	0	0	0	18.23371	0	0	0	0	0	0
Q9HCK1	ZDBF2_HUMAN	DBF4-type zinc finger-containing protein 2	ZDBF2 KIAA1571	Homo sapiens (Human)	DNA methylation involved in embryo development [GO:0043045]; genomic imprinting [GO:0071514]		nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA methylation involved in embryo development [GO:0043045]; genomic imprinting [GO:0071514]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0008270; GO:0043045; GO:0071514	KLNPQK	5.289999962	1	1	0.193569376	726.5774303	15.38274	17.19972	17.40808	14.4297	16.5673	0	16.08364	15.77362	0	16.26033	14.83493	14.5561	13.79371	12.84581	13.1995	13.14917	15.31297	13.79841	12.57888	13.03927	0	16.25617	16.96238	14.93047	0	16.97553	0	0	0	0	16.5971	15.35023	16.29039	15.44787	0	13.71947	18.09945	15.11554	16.72916	0	16.77273	0	0	0	15.41208	15.42578	17.10885	0
Q9HCK8	CHD8_HUMAN	"Chromodomain-helicase-DNA-binding protein 8, CHD-8, EC 3.6.4.12 (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1)"	CHD8 HELSNF1 KIAA1564	Homo sapiens (Human)	"brain development [GO:0007420]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]"	MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]"	armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]	GO:0000122; GO:0001701; GO:0002039; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0007420; GO:0008013; GO:0016055; GO:0016887; GO:0032991; GO:0035064; GO:0035176; GO:0042393; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0048565; GO:0060134; GO:0070016; GO:0071339; GO:0090090; GO:0140658; GO:2000270	FLAYMEDR	4.489999771	1	1	0.128850194	1060.176541	13.78746	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.44102	0	0	0	0	0	0	14.00638	0	0	0	0	0	14.99588	0	0	0	15.70316	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HCL0	PCD18_HUMAN	Protocadherin-18	PCDH18 KIAA1562	Homo sapiens (Human)	brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007420	SSYELQLTASDMGVPQR	8.43999958	1	1	0.260031081	1897.259524	14.11432	13.05221	0	14.0514	0	0	0	0	0	0	0	0	0	14.67057	15.31266	0	15.93885	12.90577	0	0	0	0	13.79329	0	17.22178	0	0	0	0	0	0	0	0	0	17.69594	0	0	0	0	0	0	0	0	0	0	0	0	16.87479
Q9HCM1	RESF1_HUMAN	Retroelement silencing factor 1	RESF1 C12orf35 KIAA1551	Homo sapiens (Human)	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]	nucleus [GO:0005634]	nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase binding [GO:1990226]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]	histone binding [GO:0042393]; histone methyltransferase binding [GO:1990226]	GO:0005634; GO:0042393; GO:0045869; GO:0090309; GO:1990226	DLLMAAGCIK	7.159999847	0.868101001	0.868101001	0.116789705	1106.550998	0	0	0	12.98303	0	0	0	0	15.29979	0	0	15.59199	17.24615	17.06855	19.04886	16.72983	17.45806	17.83495	18.22568	17.76434	18.16372	15.88852	15.92122	14.64795	0	16.74509	15.67739	15.9833	18.66919	0	16.03328	0	18.6104	17.92797	16.21311	16.80769	16.49301	0	18.36201	16.26802	18.24898	15.46759	0	0	0	16.6966	16.27168	0
Q9HCM2	PLXA4_HUMAN	Plexin-A4	PLXNA4 KIAA1550 PLXNA4A PLXNA4B UNQ2820/PRO34003	Homo sapiens (Human)	anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0043087; GO:0048485; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:0097492; GO:1902287	GNVASLIMTVLQSK	5.639999866	1	1	0.394192762	1475.384561	0	0	0	15.67978	0	14.66928	0	0	0	0	0	16.16951	0	0	0	0	0	0	0	0	0	0	0	0	16.16658	16.56975	0	13.97308	15.92635	15.73464	15.57903	17.53498	13.24802	0	0	0	17.87173	17.91629	17.63849	17.08388	0	16.34088	17.20288	0	16.65752	15.65532	17.16419	0
Q9HCM3	K1549_HUMAN	UPF0606 protein KIAA1549	KIAA1549	Homo sapiens (Human)		integral component of membrane [GO:0016021]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021; GO:0032391	TPGAVNDGR	8.090000153	1	1	0.171349628	887.4064505	0	14.28331	0	0	13.25035	0	14.11469	0	15.34372	14.21414	15.77394	15.35601	15.01851	13.59331	15.13599	0	0	0	0	0	0	0	16.35502	0	0	0	0	0	0	16.0449	0	15.17512	0	0	15.64493	0	0	16.08286	0	0	0	0	0	14.55188	0	0	15.19871	0
Q9HCM4	E41L5_HUMAN	Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5)	EPB41L5 KIAA1548	Homo sapiens (Human)	"actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm morphogenesis [GO:0048319]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]"	adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	"adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm morphogenesis [GO:0048319]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]"	cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]	GO:0001701; GO:0001837; GO:0001839; GO:0001917; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0031032; GO:0032091; GO:0032092; GO:0032525; GO:0032587; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560	YSGKTEYQTTK	6.929999828	0.006691102	0.006691102	0.348990537	1301.905036	15.64984	14.00056	0	15.9359	14.50573	11.46791	16.20638	0	16.25579	14.45522	15.12912	0	0	15.32706	11.66643	14.56382	0	0	0	0	0	0	16.42478	0	0	0	0	0	0	14.83634	0	14.8561	16.14772	0	14.6011	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HCM7	FBSL_HUMAN	Fibrosin-1-like protein (AUTS2-like protein) (HBV X-transactivated gene 9 protein) (HBV XAg-transactivated protein 9)	FBRSL1 AUTS2L KIAA1545 XTP9	Homo sapiens (Human)			RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723	GLELPRR	13.61999989	1	1	0.221566827	840.7867861	15.26458	0	0	0	0	15.85315	16.26965	0	0	0	0	0	0	14.32476	14.83693	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HCN3	PGAP6_HUMAN	"Post-GPI attachment to proteins factor 6, EC 3.1.1.4 (GPI processing phospholipase A2, GPI-PLA2) (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Transmembrane protein 8A)"	PGAP6 TMEM6 TMEM8 TMEM8A	Homo sapiens (Human)	lipid metabolic process [GO:0006629]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; phospholipase A2 activity [GO:0004623]; lipid metabolic process [GO:0006629]	phospholipase A2 activity [GO:0004623]	GO:0004623; GO:0005765; GO:0005886; GO:0005887; GO:0006629; GO:0070062	AATLLLTLSNLMFLAPIAVSVR	1.860000014	0.977027535	0.977027535	0.228377178	2331.319266	0	0	12.97504	0	14.84011	0	0	0	13.73157	0	14.34171	0	16.65872	0	0	14.20956	15.1382	13.877	0	0	0	0	0	14.97329	13.06661	17.20042	13.28403	0	0	0	0	0	0	0	14.52459	0	0	0	0	0	0	0	0	0	0	10.86203	14.94747	0
Q9HCN4	GPN1_HUMAN	"GPN-loop GTPase 1, EC 3.6.5.- (MBD2-interacting protein, MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1)"	GPN1 MBDIN RPAP4 XAB1 HUSSY-23	Homo sapiens (Human)		cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829	YKEVMK	1.200000048	0.268025815	0.268025815	0.319390683	797.774103	0	0	0	0	0	0	0	0	0	0	0	0	0	16.51995	0	0	0	0	0	0	0	0	0	16.59703	0	0	0	16.17719	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.80605	17.54312	0	0
Q9HCN6	GPVI_HUMAN	"Platelet glycoprotein VI, GPVI (Glycoprotein 6)"	GP6	Homo sapiens (Human)	collagen-activated signaling pathway [GO:0038065]; enzyme linked receptor protein signaling pathway [GO:0007167]; platelet activation [GO:0030168]; positive regulation of platelet aggregation [GO:1901731]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; collagen binding [GO:0005518]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; collagen-activated signaling pathway [GO:0038065]; enzyme linked receptor protein signaling pathway [GO:0007167]; platelet activation [GO:0030168]; positive regulation of platelet aggregation [GO:1901731]	collagen binding [GO:0005518]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005518; GO:0005886; GO:0005887; GO:0007167; GO:0009986; GO:0030168; GO:0038023; GO:0038065; GO:0045121; GO:0070062; GO:0097197; GO:1901731; GO:1990782	MSPSPTALFCLGLCLGR	7.489999771	0.000725279	0.000725279	4.56E-12	1874.072955	0	11.80736	13.32636	13.97445	13.92577	11.12283	0	15.42705	13.26603	0	16.11497	14.91178	14.07889	0	0	13.43761	14.21016	14.97508	15.2735	0	14.66684	11.15746	13.89946	14.54127	15.68917	15.11931	15.30999	13.74903	13.11238	14.88028	15.76347	15.23397	0	15.1692	13.46511	14.12881	16.15346	16.1087	0	15.83734	0	15.27439	0	13.56338	0	0	0	0
Q9HCP0	KC1G1_HUMAN	"Casein kinase I isoform gamma-1, CKI-gamma 1, EC 2.7.11.1"	CSNK1G1	Homo sapiens (Human)	endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0016055; GO:0018105; GO:0090263; GO:0106310	SAHCSRPSGSSSSSGVLMVGPNFR	4.679999828	0.089671962	0.089671962	0.032865049	2480.811419	0	14.2362	11.17453	0	0	14.18776	12.59979	14.0896	12.49967	6.227137	0	12.55682	0	0	0	0	0	0	15.30677	0	0	0	13.00583	0	0	8.97848	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.975563	0	13.06011	0
Q9HCQ5	GALT9_HUMAN	"Polypeptide N-acetylgalactosaminyltransferase 9, EC 2.4.1.41 (Polypeptide GalNAc transferase 9, GalNAc-T9, pp-GaNTase 9) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9)"	GALNT9	Homo sapiens (Human)	O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872	AILYPCHGMSSQLVR	14.27000046	1	1	0.516749481	1731.072245	18.98191	0	0	0	19.83578	0	17.49744	0	0	18.68894	0	17.64595	16.40215	0	0	0	0	16.94142	0	17.46651	18.50244	19.71171	19.64326	0	0	0	0	0	0	0	19.76425	18.65922	19.16877	0	0	20.9076	0	0	19.26871	0	0	0	0	19.00045	0	18.12764	19.07305	0
Q9HCQ7	NPVF_HUMAN	Pro-FMRFamide-related neuropeptide VF [Cleaved into: Neuropeptide NPSF; Neuropeptide RFRP-1; Neuropeptide RFRP-2; Neuropeptide NPVF (Neuropeptide RFRP-3) ]	NPVF C7orf9 RFRP	Homo sapiens (Human)	negative regulation of gonadotropin secretion [GO:0032277]; neuropeptide signaling pathway [GO:0007218]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; negative regulation of gonadotropin secretion [GO:0032277]; neuropeptide signaling pathway [GO:0007218]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005576; GO:0007218; GO:0032277	MEIISSK	12.05000019	0.691195726	0.691195726	0.374728817	823.0652415	15.57841	14.4275	15.15731	14.98947	12.75375	0	15.11557	14.68932	15.38642	0	15.75808	13.54106	0	0	0	15.47132	16.72042	0	16.39773	15.79169	17.31858	15.79211	13.20697	0	12.1523	16.81034	15.54591	14.28009	15.1072	0	0	0	15.23427	15.19086	0	17.78898	16.67772	12.64056	16.15055	15.48459	17.16453	14.9531	0	15.54808	13.5082	0	15.55993	15.90293
Q9HCR9	PDE11_HUMAN	"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, EC 3.1.4.35, EC 3.1.4.53 (cAMP and cGMP phosphodiesterase 11A)"	PDE11A	Homo sapiens (Human)	metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]	cytosol [GO:0005829]; perikaryon [GO:0043204]	"cytosol [GO:0005829]; perikaryon [GO:0043204]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]"	GO:0004112; GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0007165; GO:0008152; GO:0010754; GO:0030553; GO:0043204; GO:0043951; GO:0046872; GO:0047555	CSADAENSFKESMEK	2.950000048	1	1	0.137897022	1747.77737	0	0	0	0	13.38518	0	10.49525	12.81575	0	11.97078	0	0	0	0	0	0	0	0	0	0	13.67614	0	0	0	0	0	0	0	0	0	16.94146	0	14.40197	0	14.70071	17.14439	0	15.6636	0	18.19546	14.1989	17.20065	0	0	17.24163	0	0	0
Q9HCS5	E41LA_HUMAN	Band 4.1-like protein 4A (Erythrocyte membrane protein band 4.1-like 4A) (Protein NBL4)	EPB41L4A EPB41L4	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032]	cytoskeletal protein binding [GO:0008092]	GO:0005737; GO:0005856; GO:0008092; GO:0031032	QENDMVDSAPQWEAVLRR	4.28000021	1	1	2.29E-12	2144.762174	9.115899	15.67089	14.65573	14.34304	0	14.75574	0	13.94187	13.64452	0	13.49179	0	11.46222	11.15653	15.0615	0	0	15.13093	13.90934	11.31452	0	0	14.32276	0	13.84709	14.71502	0	0	0	0	0	0	0	0	0	0	0	0	0	14.88413	12.83489	11.89838	0	0	13.07033	0	12.8086	0
Q9HCS7	SYF1_HUMAN	Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2)	XAB2 HCNP KIAA1177 SYF1 PP3898	Homo sapiens (Human)	"blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"	catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]"		GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014	ATKVNFK	8.340000153	1	1	0.231835645	805.8676189	0	0	14.32816	15.09734	0	13.6173	0	0	15.44978	0	0	0	0	16.08503	0	15.13705	16.82476	0	0	17.13329	16.43159	15.20271	0	0	17.03667	15.73178	16.80107	16.70265	15.49938	15.95577	16.90127	16.59999	15.47444	16.12964	0	15.66818	17.00561	16.70906	17.08106	16.38186	0	15.82305	16.49709	16.90854	16.76259	0	15.39945	16.17546
Q9HCU4	CELR2_HUMAN	"Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2, EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3, Multiple EGF-like domains protein 3)"	CELSR2 CDHF10 EGFL2 KIAA0279 MEGF3	Homo sapiens (Human)	"cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural plate anterior/posterior regionalization [GO:0021999]; neuron migration [GO:0001764]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural plate anterior/posterior regionalization [GO:0021999]; neuron migration [GO:0001764]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0001764; GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0007186; GO:0016021; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060071; GO:0060271; GO:0098609	NATQHTAGYFGSDVK	4.679999828	0.010642715	0.010642715	0.443153744	1596.013864	18.08444	0	0	0	0	0	0	0	0	0	0	0	0	16.65653	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.32157	0	0	0	0	0	0	17.30557	0	0	0	0	17.9	0	0	0	0	0	0
Q9HCU5	PREB_HUMAN	Prolactin regulatory element-binding protein (Mammalian guanine nucleotide exchange factor mSec12)	PREB SEC12	Homo sapiens (Human)	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]	endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400]	DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0003400; GO:0003677; GO:0005085; GO:0005096; GO:0005634; GO:0005789; GO:0006888; GO:0009306; GO:0016020; GO:0030176; GO:0032527; GO:0048208; GO:0051020; GO:0070971	AGSKEQGPR	9.029999733	1	1	0.245329995	929.9380485	15.45462	0	16.00138	13.95542	16.20441	0	0	0	15.01203	0	16.10889	12.57362	14.486	14.91279	0	0	0	0	0	0	0	16.10435	0	0	0	16.37235	0	0	16.55455	0	0	15.70191	0	0	0	0	0	0	0	0	0	0	0	0	15.29382	0	0	15.85811
Q9HCX4	TRPC7_HUMAN	"Short transient receptor potential channel 7, TrpC7 (Transient receptor protein 7, TRP-7, hTRP7)"	TRPC7 TRP7	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]	cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]"	"calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"	GO:0005262; GO:0005635; GO:0005801; GO:0005886; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0048471; GO:0051480; GO:0070588; GO:0070679	TLRSPFMK	12.03999996	1	1	0.239511437	995.9606163	0	15.91168	16.34317	0	0	13.41718	0	0	0	0	0	0	0	0	16.00308	0	17.72115	11.924	0	16.57685	18.19607	0	0	0	16.53343	0	0	0	16.09476	0	0	0	17.33624	0	0	16.95056	17.0786	18.49927	18.09268	0	16.97131	0	16.59558	16.09238	17.12695	17.27654	0	16.4031
Q9HCZ1	ZN334_HUMAN	Zinc finger protein 334	ZNF334	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	TLNLGMNSVPSR	1.629999995	1	1	0.392558278	1304.158855	16.12507	0	15.8274	0	0	14.9121	0	0	15.01403	15.89148	16.50041	0	0	0	14.26624	0	0	15.93379	13.92154	14.64592	0	0	0	0	15.63323	0	0	14.4734	15.22832	0	0	0	0	0	0	0	0	16.9826	0	0	0	0	0	0	16.5041	0	0	0
Q9HD15	SRA1_HUMAN	"Steroid receptor RNA activator 1 (Steroid receptor RNA activator protein, SRAP)"	SRA1 PP7684	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; SCAR complex [GO:0031209]; transcription regulator complex [GO:0005667]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; SCAR complex [GO:0031209]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346]	DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]	GO:0002153; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007346; GO:0015630; GO:0030154; GO:0030374; GO:0031209; GO:0031252; GO:0042981; GO:0045171; GO:0045662; GO:0071391; GO:1990904	RSLFSEEAANEEK	2.579999924	1	1	0.486504469	1505.703428	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.7295	0	0	0	0	0	0	0	0	0	0	0	0	19.58295	0	0	0	0	0	0	0	0	0
Q9HD20	AT131_HUMAN	"Endoplasmic reticulum transmembrane helix translocase, EC 7.4.2.- (Endoplasmic reticulum P5A-ATPase)"	ATP13A1 ATP13A KIAA1825 CGI-152	Homo sapiens (Human)	cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ABC-type manganese transporter activity [GO:0015410]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; transmembrane protein dislocase activity [GO:0140567]; cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]	ABC-type manganese transporter activity [GO:0015410]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; transmembrane protein dislocase activity [GO:0140567]	GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872; GO:0140567; GO:0140569	EIQNASHR	7.25	1	1	0.187955229	952.4176993	0	0	0	0	0	0	0	0	0	0	0	0	16.23664	16.93147	16.19612	15.12139	15.0953	0	15.54765	0	16.2187	0	0	15.70797	0	0	14.33601	16.26487	14.13796	0	0	0	0	15.02703	0	0	0	0	13.086	0	13.67289	0	0	0	14.98724	14.83299	15.06089	0
Q9HD34	LYRM4_HUMAN	LYR motif-containing protein 4	LYRM4 C6orf149 ISD11 CGI-203	Homo sapiens (Human)	iron-sulfur cluster assembly [GO:0016226]	iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; iron-sulfur cluster assembly [GO:0016226]		GO:0005739; GO:0005759; GO:0016226; GO:0016604; GO:1990221; GO:1990229	DLGVIR	7.300000191	0.003571365	0.003571365	0.232521576	671.549017	0	0	0	15.48757	0	0	16.50043	0	0	14.9883	0	0	16.06187	0	0	0	0	17.16126	0	0	0	0	0	13.49232	17.30794	0	0	16.84597	16.66764	17.29445	0	19.13276	0	0	0	0	19.37413	0	0	0	14.66741	0	0	0	0	16.62401	14.71348	0
Q9HD43	PTPRH_HUMAN	"Receptor-type tyrosine-protein phosphatase H, R-PTP-H, EC 3.1.3.48 (Stomach cancer-associated protein tyrosine phosphatase 1, SAP-1) (Transmembrane-type protein-tyrosine phosphatase type H)"	PTPRH SAP1	Homo sapiens (Human)	apoptotic process [GO:0006915]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; apoptotic process [GO:0006915]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]	cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	GO:0004725; GO:0005001; GO:0005737; GO:0005887; GO:0006470; GO:0006915; GO:0016324; GO:0031528; GO:0045296; GO:1990264	APAPNPGR	4.920000076	0.694019496	0.694019496	0.157196238	780.5419185	15.83206	15.63045	15.69007	15.88264	0	0	0	14.99632	14.43179	16.65489	15.51984	13.96877	15.25902	14.90344	16.33206	15.39851	14.08571	16.28207	13.29995	15.84532	16.12076	16.2154	14.47918	14.51742	17.54664	14.20051	14.36395	15.14132	15.47561	0	16.48995	0	0	16.7816	15.76107	0	16.08665	0	15.82078	0	0	0	0	16.03239	0	14.79865	0	0
Q9HD67	MYO10_HUMAN	Unconventional myosin-X (Unconventional myosin-10)	MYO10 KIAA0799	Homo sapiens (Human)	cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]; cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]"	"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]"	GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002	AYISMIVKK	24.40999985	1	1	0.292728026	1052.616235	0	10.84739	10.68881	0	13.3984	16.86818	16.95095	0	13.81279	16.77359	15.53782	15.88461	0	15.62601	16.00942	0	15.91666	0	0	0	16.97566	14.15452	17.15564	0	15.74765	0	16.36405	0	15.59489	0	16.02111	15.36117	0	0	0	16.22462	0	0	0	14.07795	15.61101	16.81204	12.6349	15.86661	0	0	16.88895	0
Q9HDB9	GAK5_HUMAN	"Endogenous retrovirus group K member 5 Gag polyprotein (HERV-K(II) Gag protein) (HERV-K_3q12.3 provirus ancestral Gag polyprotein, Gag polyprotein)"	ERVK-5 ERVK5	Homo sapiens (Human)	viral process [GO:0016032]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032]	nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032	FLVILQLVQAGEETQVGAPARAETR	5.75	1	1	0.171858585	2697.672785	0	14.37853	0	0	13.15143	14.20794	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9HDC5	JPH1_HUMAN	"Junctophilin-1, JP-1 (Junctophilin type 1)"	JPH1 JP1	Homo sapiens (Human)	calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; structural constituent of muscle [GO:0008307]; calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]	structural constituent of muscle [GO:0008307]	GO:0005654; GO:0005789; GO:0005886; GO:0007517; GO:0008307; GO:0014701; GO:0016021; GO:0016529; GO:0030018; GO:0030314; GO:0060314; GO:0060402	GGLFR	7.949999809	0.411065221	0.411065221	0.133326651	550.6882398	9.55911	13.98208	14.97091	15.5748	0	0	13.786	14.55972	0	0	15.18721	16.11012	14.22552	16.2174	0	18.65728	0	17.68673	16.18381	17.39722	13.86783	15.76354	17.59203	13.41755	13.00098	18.78565	0	16.8794	15.65746	0	14.27189	0	13.20172	16.49245	12.89243	15.68739	13.7689	16.58895	16.82285	16.45776	11.76138	15.30385	15.83932	0	0	0	13.7341	16.28213
Q9N2K0	ENH1_HUMAN	"HERV-H_2q24.3 provirus ancestral Env polyprotein (Env protein HERV-H/p62) (Env protein HERV-H19) (Env protein HERV-Hcl.3) (Envelope polyprotein) (HERV-H/env62) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]"		Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021	MIFAGK	12.43999958	0.146804705	0.146804705	0.237276295	666.3006102	15.07537	0	15.53452	11.87408	14.42655	13.5518	14.09517	13.72133	14.30081	15.07959	14.59008	15.36246	16.02334	14.72617	16.28716	17.90165	14.72341	16.78163	18.37953	18.00747	15.69585	17.26544	16.00011	16.46447	16.04318	16.15139	0	14.77545	15.72323	15.05714	16.70647	15.67315	17.48829	17.07567	16.89005	16.84306	16.97169	17.02616	15.72297	16.1458	16.22637	16.50685	16.81641	0	16.32119	17.41785	17.44049	15.73142
Q9NNW5	WDR6_HUMAN	WD repeat-containing protein 6	WDR6	Homo sapiens (Human)	G1 to G0 transition [GO:0070314]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; tRNA methylation [GO:0030488]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; G1 to G0 transition [GO:0070314]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; tRNA methylation [GO:0030488]	RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005829; GO:0005886; GO:0008285; GO:0010507; GO:0030488; GO:0070314	DGQLQPVLR	10.34000015	1	1	0.13715284	1026.377946	0	0	0	0	0	13.36322	0	0	14.90495	16.70044	16.6523	14.95612	14.96863	14.94884	0	0	0	14.13673	14.90602	12.93239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.2033	15.94135	0	0	0	0	0	14.5351	0
Q9NNW7	TRXR2_HUMAN	"Thioredoxin reductase 2, mitochondrial, EC 1.8.1.9 (Selenoprotein Z, SelZ) (TR-beta) (Thioredoxin reductase TR3)"	TXNRD2 KIAA1652 TRXR2	Homo sapiens (Human)	cell redox homeostasis [GO:0045454]; response to hyperoxia [GO:0055093]; response to oxygen radical [GO:0000305]; response to selenium ion [GO:0010269]; response to xenobiotic stimulus [GO:0009410]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; response to hyperoxia [GO:0055093]; response to oxygen radical [GO:0000305]; response to selenium ion [GO:0010269]; response to xenobiotic stimulus [GO:0009410]	flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; thioredoxin-disulfide reductase activity [GO:0004791]	GO:0000305; GO:0004791; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009410; GO:0010269; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0044877; GO:0045454; GO:0050660; GO:0055093	SLNWGHR	7.460000038	1	1	0.108589177	870.4723057	12.48184	15.65693	15.9793	16.9346	0	0	17.37726	0	0	0	0	0	0	17.29701	14.30918	15.1633	14.79308	14.66772	0	0	14.47582	0	0	16.5525	0	0	0	0	0	17.86313	14.83997	16.09327	15.68343	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NNX1	TUFT1_HUMAN	Tuftelin	TUFT1	Homo sapiens (Human)	bone mineralization [GO:0030282]; intracellular signal transduction [GO:0035556]; odontogenesis [GO:0042476]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; structural constituent of tooth enamel [GO:0030345]; bone mineralization [GO:0030282]; intracellular signal transduction [GO:0035556]; odontogenesis [GO:0042476]	structural constituent of tooth enamel [GO:0030345]	GO:0005576; GO:0005737; GO:0030282; GO:0030345; GO:0035556; GO:0042476	AATLEK	3.150000095	1	1	0.24982183	633.6698092	0	0	12.21315	0	0	0	0	0	0	0	0	14.97456	15.90947	15.67072	0	17.74047	0	0	0	0	16.95849	13.055	0	0	0	16.71691	18.89957	0	0	16.39942	17.09472	0	0	0	0	0	0	0	17.63297	0	0	17.21994	0	0	0	0	0	0
Q9NNZ6	PRM3_HUMAN	Protamine-3 (Sperm protamine P3)	PRM3	Homo sapiens (Human)	cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleosome [GO:0000786]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283]	DNA binding [GO:0003677]	GO:0000786; GO:0003677; GO:0005634; GO:0005737; GO:0007283; GO:0030154; GO:0030261; GO:0030317	LLLLEPER	9.869999886	0.811716676	0.811716676	0.246595971	983.9808608	12.15414	0	0	14.1247	12.5367	0	0	0	0	0	0	14.30235	12.75495	0	0	0	0	0	0	0	0	0	0	16.17041	14.86094	16.44396	0	14.71429	11.8435	0	0	0	0	0	13.42273	0	0	15.59792	0	15.71364	0	0	0	15.15754	0	0	0	0
Q9NP50	SHCAF_HUMAN	SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein homolog)	SINHCAF C12orf14 FAM60A L4	Homo sapiens (Human)	negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]	nucleus [GO:0005634]; Sin3 complex [GO:0016580]	nucleus [GO:0005634]; Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]		GO:0000122; GO:0005634; GO:0008284; GO:0016580; GO:0030336; GO:0030512; GO:0045596; GO:1902455; GO:1902459	MFGFHKPK	5.840000153	1	1	0.331820184	1008.67777	12.72942	13.53543	15.68029	0	16.19603	0	0	15.12253	14.69122	16.13231	15.97884	14.34547	0	0	14.5526	11.61408	0	0	0	0	0	0	0	0	0	0	0	15.51926	11.00797	0	11.72567	0	0	0	15.7592	0	0	0	0	0	0	0	0	16.08592	0	0	0	0
Q9NP60	IRPL2_HUMAN	"X-linked interleukin-1 receptor accessory protein-like 2, IL-1 receptor accessory protein-like 2, IL-1-RAPL-2, IL-1RAPL-2, IL1RAPL-2, EC 3.2.2.6 (IL1RAPL-2-related protein) (Interleukin-1 receptor 9, IL-1R-9, IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1, TIGIRR-1)"	IL1RAPL2 IL1R9	Homo sapiens (Human)	central nervous system development [GO:0007417]; regulation of presynapse assembly [GO:1905606]	glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	"glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; interleukin-1 receptor activity [GO:0004908]; interleukin-1, type II, blocking receptor activity [GO:0004910]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; central nervous system development [GO:0007417]; regulation of presynapse assembly [GO:1905606]"	"interleukin-1 receptor activity [GO:0004908]; interleukin-1, type II, blocking receptor activity [GO:0004910]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]"	GO:0004908; GO:0004910; GO:0005886; GO:0007417; GO:0016021; GO:0050135; GO:0061809; GO:0098978; GO:1905606	GWSIFELESRLHNMLVSGEIK	3.700000048	1	1	0.273821006	2460.099723	11.23326	0	14.55341	15.53569	0	13.05218	0	0	14.32425	0	16.59412	0	0	0	0	0	0	0	0	14.25395	0	0	15.72413	15.90424	0	14.15848	0	15.70485	15.81143	0	16.83526	0	14.11737	16.20336	0	0	12.80759	0	0	15.4806	0	15.59023	0	0	0	15.43248	0	0
Q9NP70	AMBN_HUMAN	Ameloblastin	AMBN	Homo sapiens (Human)	biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of cell population proliferation [GO:0042127]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; growth factor activity [GO:0008083]; structural constituent of tooth enamel [GO:0030345]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of cell population proliferation [GO:0042127]	growth factor activity [GO:0008083]; structural constituent of tooth enamel [GO:0030345]	GO:0005576; GO:0005788; GO:0007155; GO:0008083; GO:0030345; GO:0031214; GO:0042127; GO:0042475	QLGSLQR	6.400000095	0.070661649	0.070661649	0.173546804	801.5484761	16.45468	16.13811	13.7189	0	16.31086	0	15.47163	0	15.85458	15.60751	10.36777	15.00781	16.62736	16.968	16.72893	16.48075	17.32023	16.36882	16.7212	17.57993	17.872	16.04599	16.93385	16.85315	17.78614	15.68118	16.53984	17.78114	17.05787	16.32524	16.62643	0	17.09746	17.10126	17.01377	15.80411	18.26978	17.32799	17.51581	17.49804	16.70052	17.53758	15.66761	17.21301	16.40864	17.57667	17.8781	16.54521
Q9NP71	MLXPL_HUMAN	"Carbohydrate-responsive element-binding protein, ChREBP (Class D basic helix-loop-helix protein 14, bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein, WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein)"	MLXIPL BHLHD14 MIO WBSCR14	Homo sapiens (Human)	"anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; triglyceride homeostasis [GO:0070328]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; triglyceride homeostasis [GO:0070328]"	"carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0009653; GO:0010255; GO:0033137; GO:0035538; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009	SQVIHSGHFMVSSPHSDSLPR	3.150000095	1	1	0.013744853	2320.158899	16.04006	13.29443	0	0	11.46944	15.21482	0	14.25639	0	13.75465	16.53909	0	0	0	0	0	0	15.79842	10.99516	14.8398	15.96363	0	16.41743	15.40547	14.81839	12.80536	12.83714	0	10.73697	13.17371	17.00202	14.41132	17.34639	15.48202	13.67594	17.11172	16.06752	16.38635	14.45552	15.66178	16.04591	14.74112	15.60223	0	0	16.25783	0	15.22099
Q9NP73	ALG13_HUMAN	"Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13, EC 2.4.1.141, EC 3.4.19.12 (Asparagine-linked glycosylation 13 homolog) (Glycosyltransferase 28 domain-containing protein 1) (UDP-N-acetylglucosamine transferase subunit ALG13 homolog)"	ALG13 CXorf45 GLT28D1 MDS031	Homo sapiens (Human)		endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum membrane [GO:0005789]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; RNA binding [GO:0003723]; thiol-dependent deubiquitinase [GO:0004843]	N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; RNA binding [GO:0003723]; thiol-dependent deubiquitinase [GO:0004843]	GO:0003723; GO:0004577; GO:0004843; GO:0005789	VDFYPGPGK	4.199999809	1	1	0.031156632	979.8336035	0	12.08215	0	12.49469	15.80042	0	12.8214	15.0385	14.74388	13.27672	11.81154	6.49179	11.06394	15.26502	13.59658	13.38176	13.63026	0	14.65388	13.93473	0	0	14.54496	12.9359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NP74	PALMD_HUMAN	Palmdelphin (Paralemmin-like protein)	PALMD C1orf11 PALML	Homo sapiens (Human)	regulation of cell shape [GO:0008360]	cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; membrane [GO:0016020]	cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; membrane [GO:0016020]; regulation of cell shape [GO:0008360]		GO:0005737; GO:0008360; GO:0016020; GO:0043197	VYDDGQK	7.840000153	1	1	0.108107978	823.5446152	15.23382	0	14.78196	14.52782	14.0719	0	0	15.26324	0	0	0	0	0	0	0	15.63945	0	0	16.33146	0	15.44117	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.58497	0	0	0	0	15.87569	0	0	0
Q9NP81	SYSM_HUMAN	"Serine--tRNA ligase, mitochondrial, EC 6.1.1.11 (SerRSmt) (Seryl-tRNA synthetase, SerRS) (Seryl-tRNA(Ser/Sec) synthetase)"	SARS2 SARSM	Homo sapiens (Human)	mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006434; GO:0070158; GO:0097056	MAASMARR	12.55000019	1	1	0.006497408	893.4567915	14.77652	15.02009	0	14.14081	0	0	14.82228	0	10.97321	16.04249	14.96973	14.51565	14.40417	0	14.37243	13.36119	0	0	0	0	14.93701	10.9935	10.51021	0	13.12652	10.02056	15.15603	14.90392	15.34006	13.92964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NP87	DPOLM_HUMAN	"DNA-directed DNA/RNA polymerase mu, Pol Mu, EC 2.7.7.7 (Terminal transferase)"	POLM polmu	Homo sapiens (Human)	DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006303; GO:0006310; GO:0046872	EGLRTLDDLR	1.460000038	1	1	0.534277818	1188.863123	0	0	0	0	0	0	0	0	17.6794	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.85484	0	18.68031	0	0	0	0	18.36498	0	17.41817	0	0	0	16.87881
Q9NP92	RT30_HUMAN	"39S ribosomal protein S30, mitochondrial, MRP-S30, S30mt (Mitochondrial large ribosomal subunit protein mL65) (Mitochondrial large ribosomal subunit protein mS30) (Programmed cell death protein 9)"	MRPS30 PDCD9 BM-047	Homo sapiens (Human)	apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006915; GO:0032543	MQFMKYMVYPQTFALNADR	1.659999967	1	1	0.086506906	2370.536396	0	0	11.91028	14.45338	0	0	0	0	13.75942	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.65833	13.87742	0	0	9.567358	0	0	0	0	0	0	11.26872	0	0	0	0	0	0	0
Q9NP97	DLRB1_HUMAN	"Dynein light chain roadblock-type 1 (Bithoraxoid-like protein, BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1)"	DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; visual behavior [GO:0007632]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]	centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; visual behavior [GO:0007632]	dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0007632; GO:0016020; GO:0030286; GO:0045505; GO:0097542	DYFLIVIQNPTE	13.52000046	1	1	0.114705884	1450.596989	13.69148	13.46154	14.29657	13.16329	13.25924	12.39599	12.40692	10.57656	0	0	12.76055	13.53956	0	15.90018	14.45222	15.83886	0	0	0	0	0	16.19089	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NP99	TREM1_HUMAN	"Triggering receptor expressed on myeloid cells 1, TREM-1 (Triggering receptor expressed on monocytes 1) (CD antigen CD354)"	TREM1	Homo sapiens (Human)	acute inflammatory response [GO:0002526]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil chemotaxis [GO:0030593]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; acute inflammatory response [GO:0002526]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil chemotaxis [GO:0030593]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]	scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]	GO:0002250; GO:0002526; GO:0005576; GO:0005886; GO:0006959; GO:0016021; GO:0030593; GO:0035556; GO:0038023; GO:0045087; GO:0070945; GO:0097110	IRLVVTK	7.880000114	1	1	0.16057052	827.0654524	0	0	15.73434	11.69328	0	0	0	0	14.76189	0	0	0	0	13.69092	0	14.19399	0	0	0	0	0	0	0	0	0	0	0	13.73042	15.44407	0	0	17.1711	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NPA0	EMC7_HUMAN	ER membrane protein complex subunit 7	EMC7 C11orf3 C15orf24 HT022 UNQ905/PRO1926	Homo sapiens (Human)	protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]	EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	carbohydrate binding [GO:0030246]	GO:0005789; GO:0016021; GO:0030176; GO:0030246; GO:0045050; GO:0071816; GO:0072546	EMEQSMNMLNSNHELPDVSEFMTR	4.480000019	1	1	4.59E-13	2916.796896	8.764138	15.0026	12.32176	11.63458	13.40022	13.40834	13.5933	14.29926	0	12.50561	0	14.46771	7.839444	9.266583	0	0	0	10.82804	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NPA2	MMP25_HUMAN	"Matrix metalloproteinase-25, MMP-25, EC 3.4.24.- (Leukolysin) (Membrane-type matrix metalloproteinase 6, MT-MMP 6, MTMMP6) (Membrane-type-6 matrix metalloproteinase, MT6-MMP, MT6MMP)"	MMP25 MMP20 MMPL1 MT6MMP	Homo sapiens (Human)	collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508]	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005576; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0035579; GO:0060022	MDPGTVATMR	7.78000021	1	1	0.266349317	1096.068642	15.38795	0	0	11.70549	0	0	0	0	0	14.984	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NPB1	NT5M_HUMAN	"5'(3')-deoxyribonucleotidase, mitochondrial, 5',3'-nucleotidase, mitochondrial, EC 3.1.3.- (Deoxy-5'-nucleotidase 2, dNT-2)"	NT5M DNT2	Homo sapiens (Human)	DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]	5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005739; GO:0005759; GO:0006260; GO:0008252; GO:0008253; GO:0009223; GO:0046079; GO:0046872	RGAAGGLGLAGGR	8.539999962	1	1	0.22538825	1112.116562	0	14.6765	16.07055	16.36132	0	0	13.7032	0	16.15446	0	0	0	14.01003	0	14.10812	13.98855	0	14.89063	15.56287	16.72707	0	0	0	0	15.01715	0	14.97171	0	0	15.65062	0	12.11738	0	12.55566	0	15.0318	0	16.39518	15.77531	15.5711	16.99313	13.26545	14.7061	15.00759	0	0	0	0
Q9NPB3	CABP2_HUMAN	"Calcium-binding protein 2, CaBP2"	CABP2	Homo sapiens (Human)	sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; visual perception [GO:0007601]	Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; visual perception [GO:0007601]	calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]	GO:0005246; GO:0005509; GO:0005794; GO:0005886; GO:0007165; GO:0007601; GO:0007605; GO:0048471	DGYIGCR	6.789999962	0.010463141	0.010463141	0.219586089	840.370121	0	0	15.39335	17.26793	18.01663	0	16.14648	16.33539	15.75531	0	0	0	0	0	0	18.06556	16.91159	13.02465	16.49379	17.00489	0	0	0	0	15.10534	0	0	0	19.00235	0	0	19.30331	17.47785	0	0	0	19.86249	16.43583	0	0	18.18645	16.02047	0	0	0	0	16.55824	17.51421
Q9NPB6	PAR6A_HUMAN	"Partitioning defective 6 homolog alpha, PAR-6, PAR-6 alpha, PAR-6A (PAR6C) (Tax interaction protein 40, TIP-40)"	PARD6A PAR6A	Homo sapiens (Human)	cell division [GO:0051301]; cell-cell junction maintenance [GO:0045217]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; viral process [GO:0016032]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; tight junction [GO:0070160]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; tight junction [GO:0070160]; GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; cell division [GO:0051301]; cell-cell junction maintenance [GO:0045217]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; viral process [GO:0016032]	GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	GO:0001726; GO:0001933; GO:0005080; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0008134; GO:0016032; GO:0016324; GO:0030742; GO:0031267; GO:0034451; GO:0045197; GO:0045217; GO:0050714; GO:0051301; GO:0060341; GO:0070160; GO:0120157; GO:1904781	FDAEFR	14.68999958	1	1	0.095345429	783.6151947	15.6022	0	0	15.20351	0	0	0	0	0	0	0	16.44696	0	0	0	0	0	0	16.80886	0	0	15.31798	0	0	0	0	14.76301	0	0	0	0	0	16.47584	0	0	0	0	17.19251	0	0	15.56651	16.14142	15.04568	16.89938	14.32048	0	0	0
Q9NPB9	ACKR4_HUMAN	"Atypical chemokine receptor 4 (C-C chemokine receptor type 11, C-C CKR-11, CC-CKR-11, CCR-11) (CC chemokine receptor-like 1, CCRL1) (CCX CKR)"	ACKR4 CCBP2 CCR11 CCRL1 VSHK1	Homo sapiens (Human)	calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]	C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044]	GO:0004950; GO:0005044; GO:0005769; GO:0005886; GO:0005887; GO:0006935; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0055037; GO:0060326	ITSALYTLNFVSGMQFLACISIDR	1.00999999	1	1	1.83E-12	2736.758757	12.52391	16.38619	0	0	14.66014	0	0	0	0	0	16.58447	0	13.89495	14.19219	0	13.61558	14.44147	15.34562	0	14.35037	16.45396	0	0	0	0	0	0	15.2397	0	0	15.18265	15.36726	0	15.89525	14.6285	0	16.66737	0	0	15.37258	0	0	0	13.30093	0	0	0	13.0975
Q9NPC1	LT4R2_HUMAN	"Leukotriene B4 receptor 2, LTB4-R 2, LTB4-R2 (LTB4 receptor JULF2) (Leukotriene B4 receptor BLT2) (Seven transmembrane receptor BLTR2)"	LTB4R2 BLT2R BLTR2	Homo sapiens (Human)	chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; keratinocyte migration [GO:0051546]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; keratinocyte migration [GO:0051546]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]	G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]	GO:0001632; GO:0004974; GO:0005654; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0007194; GO:0007218; GO:0008528; GO:0016020; GO:0051546	TTPQLKVVGQGR	4.059999943	1	1	0.068421086	1284.577391	12.76273	11.55663	0	0	13.14988	0	11.89363	7.992255	0	17.73384	0	10.67282	12.82916	0	0	12.14086	0	0	0	0	0	0	14.73425	0	0	0	0	0	13.3156	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.74214	12.97792	0	0	0
Q9NPE2	NGRN_HUMAN	Neugrin (Mesenchymal stem cell protein DSC92) (Neurite outgrowth-associated protein) (Spinal cord-derived protein FI58G)	NGRN FI58G HT020	Homo sapiens (Human)	mitochondrial ribosome assembly [GO:0061668]; neuron differentiation [GO:0030182]; positive regulation of mitochondrial translation [GO:0070131]	intercellular bridge [GO:0045171]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	intercellular bridge [GO:0045171]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial ribosome assembly [GO:0061668]; neuron differentiation [GO:0030182]; positive regulation of mitochondrial translation [GO:0070131]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0016604; GO:0019843; GO:0030182; GO:0031966; GO:0045171; GO:0061668; GO:0070131; GO:0072686	GTGSGALPSGQK	7.5	1	1	0.208552883	1060.638236	15.59443	14.21823	13.92678	15.4669	0	0	0	13.37622	15.15648	0	0	0	0	0	0	0	0	14.20964	0	0	15.01587	16.54109	0	0	15.68497	14.34156	0	0	0	15.34943	16.4672	14.81128	0	15.45743	15.09507	0	0	15.54527	12.02685	13.62341	10.66137	0	14.40005	0	14.38238	0	0	14.70537
Q9NPF0	CD320_HUMAN	"CD320 antigen (8D6 antigen) (FDC-signaling molecule 8D6, FDC-SM-8D6) (Transcobalamin receptor, TCblR) (CD antigen CD320)"	CD320 8D6A UNQ198/PRO224	Homo sapiens (Human)	B cell costimulation [GO:0031296]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; positive regulation of B cell proliferation [GO:0030890]; regulation of vitamin metabolic process [GO:0030656]	endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; growth factor activity [GO:0008083]; B cell costimulation [GO:0031296]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; positive regulation of B cell proliferation [GO:0030890]; regulation of vitamin metabolic process [GO:0030656]	calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; growth factor activity [GO:0008083]	GO:0005509; GO:0005783; GO:0005886; GO:0005887; GO:0008083; GO:0009235; GO:0010008; GO:0015889; GO:0016020; GO:0030656; GO:0030890; GO:0031296; GO:0031419; GO:0038024	ESLLLSEQK	16.62000084	0.831818342	0.831818342	0.226095046	1045.643842	15.60067	15.75389	16.4979	15.8475	15.24739	13.93528	15.19004	16.08347	13.96937	16.58089	13.63192	12.38434	14.30182	0	14.72046	15.96495	0	0	0	0	15.83711	18.68246	0	12.73752	0	0	14.99926	0	0	0	0	17.1574	16.46496	15.88246	0	0	0	17.27776	17.45476	16.52354	0	16.67134	15.38393	16.71588	15.94802	16.56219	15.21079	15.74589
Q9NPF2	CHSTB_HUMAN	"Carbohydrate sulfotransferase 11, EC 2.8.2.5 (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1, C4S-1, C4ST-1, C4ST1)"	CHST11	Homo sapiens (Human)	carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]	chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659	NKFTQK	6.5	0.998829722	0.998829722	0.216919241	765.5945963	0	14.41996	0	13.32349	15.39526	0	15.30614	0	0	15.17437	14.95194	8.35033	16.48791	0	0	0	16.94266	13.71977	0	16.13444	0	16.81518	16.56122	16.43425	0	0	0	15.56912	15.97186	14.08969	16.27553	0	0	0	0	0	0	16.73798	0	15.78274	18.91579	14.13038	0	15.69861	0	16.1313	14.47239	14.82923
Q9NPF4	OSGEP_HUMAN	"tRNA N6-adenosine threonylcarbamoyltransferase, EC 2.3.1.234 (N6-L-threonylcarbamoyladenine synthase, t(6)A synthase) (O-sialoglycoprotein endopeptidase, hOSGEP) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP) (tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP)"	OSGEP GCPL1	Homo sapiens (Human)	tRNA threonylcarbamoyladenosine modification [GO:0002949]	cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949]	metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]	GO:0000408; GO:0002949; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0016607; GO:0046872; GO:0061711	LVELPYTVK	10.67000008	0.478656411	0.478656411	0.238866083	1060.75967	0	16.6865	0	0	0	0	0	0	0	15.21087	0	0	0	14.36358	14.41753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.47383	16.17056	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.54052	15.70251
Q9NPG3	UBN1_HUMAN	Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein)	UBN1	Homo sapiens (Human)	DNA replication-independent chromatin assembly [GO:0006336]	bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA replication-independent chromatin assembly [GO:0006336]	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005654; GO:0005923; GO:0006336; GO:0016604; GO:0016605; GO:0034451	VGGVLCTEEK	4.289999962	1	1	0.036410391	1092.515701	0	0	0	0	14.0469	0	0	0	0	0	0	12.06607	9.824705	0	0	0	15.02988	0	13.84159	0	0	15.41368	0	14.73929	0	0	0	15.5778	11.37683	0	0	0	0	0	13.24242	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NPG4	PCD12_HUMAN	"Protocadherin-12 (Vascular cadherin-2) (Vascular endothelial cadherin-2, VE-cad-2, VE-cadherin-2) [Cleaved into: Protocadherin-12, secreted form ]"	PCDH12 UNQ395/PRO731	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; glycogen metabolic process [GO:0005977]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; labyrinthine layer development [GO:0060711]; neuron recognition [GO:0008038]	cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; glycogen metabolic process [GO:0005977]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; labyrinthine layer development [GO:0060711]; neuron recognition [GO:0008038]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0005977; GO:0007155; GO:0007156; GO:0008038; GO:0016339; GO:0060711; GO:0070062	TLRNQGNQGAPAESR	4.059999943	1	1	0.111108363	1597.002431	13.63233	13.56129	15.37464	0	0	14.70697	15.58641	0	13.56142	13.61615	13.72812	13.7416	0	0	0	13.87422	0	0	0	0	0	0	15.47628	0	0	0	16.10589	0	0	0	0	0	0	0	0	0	14.18564	0	0	0	0	0	0	0	0	0	0	0
Q9NPH0	PPA6_HUMAN	"Lysophosphatidic acid phosphatase type 6, EC 3.1.3.2 (Acid phosphatase 6, lysophosphatidic) (Acid phosphatase-like protein 1) (PACPL1)"	ACP6 ACPL1 LPAP UNQ205/PRO231	Homo sapiens (Human)	dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; lysobisphosphatidic acid metabolic process [GO:2001311]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; lysobisphosphatidic acid metabolic process [GO:2001311]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]	acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]	GO:0002244; GO:0003993; GO:0005737; GO:0005739; GO:0005759; GO:0006644; GO:0006654; GO:0016311; GO:0016791; GO:0052642; GO:2001311	LWTPVGVLTSLAYCLHQR	1.330000043	1	1	0.041721072	2112.834883	0	9.407831	12.26564	0	13.42836	13.3625	0	0	13.06061	16.05612	0	0	14.79723	13.62742	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.69535	0	0	14.65866	14.07773	0	0	0	0	0	0	0
Q9NPH3	IL1AP_HUMAN	"Interleukin-1 receptor accessory protein, IL-1 receptor accessory protein, IL-1RAcP, EC 3.2.2.6 (Interleukin-1 receptor 3, IL-1R-3, IL-1R3)"	IL1RAP C3orf13 IL1R3	Homo sapiens (Human)	immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]	extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]"	"interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]"	GO:0002114; GO:0004908; GO:0005149; GO:0005576; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0016020; GO:0032736; GO:0032753; GO:0032754; GO:0032755; GO:0045087; GO:0050135; GO:0051092; GO:0051965; GO:0061809; GO:0065003; GO:0098978; GO:0099151; GO:0099545; GO:0099560; GO:1905606	DLEEPINFR	18.95999908	1	1	0.447352373	1132.110318	0	0	18.19364	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NPH5	NOX4_HUMAN	"NADPH oxidase 4, EC 1.6.3.- (Kidney oxidase-1, KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase)"	NOX4 RENOX	Homo sapiens (Human)	bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell aging [GO:0007569]; cell morphogenesis [GO:0000902]; cellular response to glucose stimulus [GO:0071333]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; reactive oxygen species biosynthetic process [GO:1903409]; reactive oxygen species metabolic process [GO:0072593]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; nucleotide binding [GO:0000166]; oxygen sensor activity [GO:0019826]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell aging [GO:0007569]; cell morphogenesis [GO:0000902]; cellular response to glucose stimulus [GO:0071333]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; reactive oxygen species biosynthetic process [GO:1903409]; reactive oxygen species metabolic process [GO:0072593]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]	electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; nucleotide binding [GO:0000166]; oxygen sensor activity [GO:0019826]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]	GO:0000166; GO:0000902; GO:0003015; GO:0005634; GO:0005730; GO:0005739; GO:0005789; GO:0005886; GO:0005925; GO:0006801; GO:0006952; GO:0006954; GO:0007569; GO:0008285; GO:0009055; GO:0010467; GO:0016021; GO:0016174; GO:0016175; GO:0019826; GO:0020037; GO:0042554; GO:0043020; GO:0043406; GO:0045453; GO:0048471; GO:0050660; GO:0050667; GO:0051897; GO:0055007; GO:0061098; GO:0070374; GO:0071333; GO:0072341; GO:0072593; GO:0097038; GO:1903409; GO:1990782; GO:2000573	LFIGRPR	5.75	1	1	0.052929003	858.0399611	14.81106	15.08927	17.56341	0	14.89842	0	0	0	0	0	15.58791	0	0	12.82921	0	0	0	0	0	0	0	0	11.69494	0	15.54576	0	0	0	0	0	0	15.21601	0	0	14.76698	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NPH6	OBP2B_HUMAN	"Odorant-binding protein 2b (Odorant-binding protein IIb, OBPIIb)"	OBP2B UNQ653/PRO1283	Homo sapiens (Human)	chemosensory behavior [GO:0007635]; sensory perception of smell [GO:0007608]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; odorant binding [GO:0005549]; small molecule binding [GO:0036094]; chemosensory behavior [GO:0007635]; sensory perception of smell [GO:0007608]	odorant binding [GO:0005549]; small molecule binding [GO:0036094]	GO:0005549; GO:0005615; GO:0007608; GO:0007635; GO:0036094	VTALGGGKLEATFTFMR	14.46000004	1	1	0	1812.210287	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.30644	0	0	0
Q9NPI1	BRD7_HUMAN	Bromodomain-containing protein 7 (75 kDa bromodomain protein) (Protein CELTIX-1)	BRD7 BP75 CELTIX1	Homo sapiens (Human)	"cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of histone acetylation [GO:0035066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of histone acetylation [GO:0035066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]"	histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000776; GO:0000785; GO:0000976; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0007049; GO:0008285; GO:0016055; GO:0016363; GO:0016586; GO:0030071; GO:0035066; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0070577; GO:2000045; GO:2000134; GO:2000781; GO:2000819	GGHSR	5.730000019	1	1	0.29036964	513.5491532	0	0	18.42736	17.90824	0	0	17.44805	0	17.85545	0	0	16.1994	0	0	0	0	0	17.68102	21.19622	0	0	0	0	17.25833	0	0	0	17.61188	16.89519	0	0	0	0	0	17.82149	0	0	0	0	16.5547	0	17.9799	0	17.74039	0	0	17.56009	15.99235
Q9NPI6	DCP1A_HUMAN	"mRNA-decapping enzyme 1A, EC 3.6.1.62 (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF)"	DCP1A SMIF	Homo sapiens (Human)	"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; methylguanosine-cap decapping [GO:0110156]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of catalytic activity [GO:0043085]; protein localization to cytoplasmic stress granule [GO:1903608]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; methylguanosine-cap decapping [GO:0110156]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of catalytic activity [GO:0043085]; protein localization to cytoplasmic stress granule [GO:1903608]"	enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; mRNA binding [GO:0003729]	GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0008047; GO:0016020; GO:0016787; GO:0019894; GO:0031087; GO:0036464; GO:0042802; GO:0043085; GO:0110156; GO:1903608	GAMVASFSPAAGQLATPESFIEPPSK	5.989999771	0.835116506	0.835116506	0.084312194	2589.565446	13.15949	12.33273	0	13.21322	11.99691	12.2863	0	0	0	11.54962	11.03277	10.78628	0	0	0	0	0	0	0	11.21247	0	0	11.54804	0	0	0	0	14.95596	0	13.08457	0	0	13.26156	10.85542	0	12.84297	11.20452	0	0	11.29985	11.89662	0	0	0	13.44719	0	0	14.29415
Q9NPI8	FANCF_HUMAN	"Fanconi anemia group F protein, Protein FACF"	FANCF	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]	chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]	chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; cellular response to DNA damage stimulus [GO:0006974]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]		GO:0000785; GO:0005654; GO:0006513; GO:0006974; GO:0036297; GO:0043240	LQEVGK	7.269999981	0.01428822	0.01428822	0.053244363	673.3635559	15.14448	0	0	0	0	0	0	0	15.60194	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.25467	0	0	0	0	0	0	17.78853	16.52022	0	0	0	0	0	0	0	0	0	0	17.31232
Q9NPJ6	MED4_HUMAN	"Mediator of RNA polymerase II transcription subunit 4 (Activator-recruited cofactor 36 kDa component, ARC36) (Mediator complex subunit 4) (TRAP/SMCC/PC2 subunit p36 subunit) (Vitamin D3 receptor-interacting protein complex 36 kDa component, DRIP36)"	MED4 ARC36 DRIP36 VDRIP HSPC126	Homo sapiens (Human)	"positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]"	nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]	GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0016020; GO:0016592; GO:0030374; GO:0032968; GO:0042809; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0070847	LGGGLGVAGGNSTR	2.200000048	1	1	0.069933087	1215.599947	14.13274	0	14.57837	0	15.94186	0	0	0	14.08851	0	0	0	0	0	0	14.66125	0	0	13.80005	0	0	0	0	0	15.09025	0	15.32487	16.15051	0	0	0	15.37734	14.94942	0	0	0	0	0	0	0	0	16.19501	16.14733	0	0	0	0	0
Q9NPR2	SEM4B_HUMAN	Semaphorin-4B (Semaphorin-C)	SEMA4B KIAA1745 SEMAC UNQ749/PRO1480	Homo sapiens (Human)	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0030215; GO:0030335; GO:0045202; GO:0045499; GO:0048843; GO:0050919; GO:0071526	GLLYAASHSGVVQVPMANCSLYR	3.119999886	1	1	0.255027667	2493.634601	0	0	11.4669	13.97992	0	0	0	0	13.07073	0	0	0	0	0	0	0	12.9277	0	0	0	0	15.27493	0	0	0	12.59586	14.83447	0	13.70571	0	14.1844	12.84238	15.96208	15.45578	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NQ11	AT132_HUMAN	"Polyamine-transporting ATPase 13A2, EC 7.6.2.-"	ATP13A2 PARK9	Homo sapiens (Human)	autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]	autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]	"autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; ABC-type polyamine transporter activity [GO:0015417]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; zinc ion homeostasis [GO:0055069]"	"ABC-type polyamine transporter activity [GO:0015417]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]"	GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0008270; GO:0010628; GO:0010821; GO:0015417; GO:0016021; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030003; GO:0030133; GO:0030145; GO:0031902; GO:0031982; GO:0032585; GO:0033157; GO:0034220; GO:0034599; GO:0043005; GO:0043025; GO:0043202; GO:0046777; GO:0050714; GO:0052548; GO:0055069; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0071294; GO:0080025; GO:0097734; GO:1900180; GO:1901215; GO:1902047; GO:1903135; GO:1903146; GO:1903543; GO:1903710; GO:1904714; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1905166; GO:1990938; GO:2000152	FYKHSMK	7.710000038	0.741566062	0.741566062	0.204232663	957.1804736	16.7819	9.741111	13.90876	15.48275	0	0	13.08788	15.59683	0	0	0	0	0	0	0	0	0	14.31573	16.00667	0	0	0	0	14.50028	0	0	0	16.53107	14.43258	0	0	0	0	0	0	0	17.87709	0	0	0	0	14.04114	15.25831	15.08385	14.93472	0	0	14.56101
Q9NQ30	ESM1_HUMAN	"Endothelial cell-specific molecule 1, ESM-1"	ESM1	Homo sapiens (Human)	angiogenesis [GO:0001525]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hepatocyte growth factor receptor signaling pathway [GO:1902204]; sprouting angiogenesis [GO:0002040]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; hepatocyte growth factor receptor binding [GO:0005171]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hepatocyte growth factor receptor signaling pathway [GO:1902204]; sprouting angiogenesis [GO:0002040]	hepatocyte growth factor receptor binding [GO:0005171]; integrin binding [GO:0005178]	GO:0001525; GO:0002040; GO:0005171; GO:0005178; GO:0005576; GO:0008284; GO:1902204	ENAAGSPVMR	8.529999733	1	1	0.060903171	1032.483731	14.28537	0	0	0	0	0	0	0	0	0	0	0	14.41346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.11474	0	0	0	0	0	0	0	0	0	0	0
Q9NQ32	CK016_HUMAN	Uncharacterized protein C11orf16	C11orf16	Homo sapiens (Human)						MESSTGPR	5.96999979	1	1	0.103314421	864.9337387	15.17197	0	15.31242	0	0	0	0	0	0	0	0	0	0	0	0	14.8721	0	15.73883	0	0	0	0	0	0	15.5698	0	0	0	0	0	0	0	0	0	0	14.85026	0	0	0	0	0	0	0	0	0	0	0	14.23999
Q9NQ38	ISK5_HUMAN	"Serine protease inhibitor Kazal-type 5 (Lympho-epithelial Kazal-type-related inhibitor, LEKTI) [Cleaved into: Hemofiltrate peptide HF6478; Hemofiltrate peptide HF7665 ]"	SPINK5	Homo sapiens (Human)	cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; epidermal cell differentiation [GO:0009913]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antibacterial peptide production [GO:0002787]; negative regulation of immune response [GO:0050777]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of serine-type peptidase activity [GO:1902572]; regulation of cell adhesion [GO:0030155]; regulation of T cell differentiation [GO:0045580]; regulation of timing of anagen [GO:0051884]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; epidermal cell differentiation [GO:0009913]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antibacterial peptide production [GO:0002787]; negative regulation of immune response [GO:0050777]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of serine-type peptidase activity [GO:1902572]; regulation of cell adhesion [GO:0030155]; regulation of T cell differentiation [GO:0045580]; regulation of timing of anagen [GO:0051884]	serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002787; GO:0004867; GO:0005576; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005938; GO:0007417; GO:0009913; GO:0016525; GO:0030154; GO:0030155; GO:0030198; GO:0030855; GO:0035315; GO:0043231; GO:0045580; GO:0048471; GO:0050777; GO:0051884; GO:0097209; GO:1900004; GO:1902572	ENDPIRGPDGK	3.440000057	1	1	0.38460608	1196.808356	15.51864	16.21703	15.07778	14.99261	0	14.26977	13.14615	13.11254	0	9.85105	0	0	0	0	0	15.30165	15.25565	0	14.92089	0	12.85254	0	14.14378	0	0	0	16.12572	0	0	0	0	0	0	13.86004	0	0	0	16.91551	0	16.33635	17.2095	0	0	0	0	0	16.49385	0
Q9NQ55	SSF1_HUMAN	"Suppressor of SWI4 1 homolog, Ssf-1 (Brix domain-containing protein 3) (Peter Pan homolog)"	PPAN BXDC3 SSF1	Homo sapiens (Human)	ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	"nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]"	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000027; GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0019843; GO:0030687	DVVSSLRR	14.67000008	1	1	0.29291221	930.0609642	0	17.13071	17.98077	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.04993	0	0	18.20554	0	0	0	0	0	0	0	0	0	0	0	20.01047	0	0	19.26641	0	17.87922	0	0	18.74614	0	0	0	0
Q9NQ66	PLCB1_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1, EC 3.1.4.11 (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I, PLC-I) (Phospholipase C-beta-1, PLC-beta-1)"	PLCB1 KIAA0581	Homo sapiens (Human)	"activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of monocyte extravasation [GO:2000438]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; signal transduction [GO:0007165]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase C activity [GO:0004629]; activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of monocyte extravasation [GO:2000438]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; signal transduction [GO:0007165]"	"calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase C activity [GO:0004629]"	GO:0000086; GO:0000785; GO:0004435; GO:0004629; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007186; GO:0007213; GO:0007215; GO:0007612; GO:0007613; GO:0008277; GO:0016607; GO:0019899; GO:0021987; GO:0031161; GO:0031965; GO:0032735; GO:0032957; GO:0032991; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0060466; GO:0070062; GO:0070498; GO:0080154; GO:0098794; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:2000344; GO:2000438; GO:2000560	SHKSSEGSGK	13.81000042	1	1	0.261976022	1002.285005	0	17.28012	0	0	0	16.09232	0	0	0	0	0	0	0	0	0	0	16.86077	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NQ75	CASS4_HUMAN	"Cas scaffolding protein family member 4 (HEF-like protein) (HEF1-EFS-p130Cas-like protein, HEPL)"	CASS4 C20orf32 HEFL	Homo sapiens (Human)	actin filament reorganization [GO:0090527]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; protein tyrosine kinase binding [GO:1990782]; actin filament reorganization [GO:0090527]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	protein tyrosine kinase binding [GO:1990782]	GO:0005737; GO:0005856; GO:0005925; GO:0007155; GO:0007169; GO:0016477; GO:0030335; GO:0051897; GO:0061098; GO:0090527; GO:1900026; GO:1990782	TTSPSPEPDR	7.769999981	0.613464415	0.613464415	0.235600046	1086.761374	13.12162	15.57501	16.22138	6.556757	0	0	0	0	15.2993	14.66619	14.402	0	0	13.17305	15.32367	0	0	0	0	14.30888	0	0	15.55918	16.24484	16.30618	0	16.43296	0	16.92545	0	14.65612	14.90204	16.81063	0	0	15.77104	0	17.31779	16.45885	0	16.28433	0	16.23536	15.49731	0	0	16.04942	0
Q9NQ76	MEPE_HUMAN	"Matrix extracellular phosphoglycoprotein (Osteoblast/osteocyte factor 45, OF45) (Osteoregulin)"	MEPE	Homo sapiens (Human)	biomineral tissue development [GO:0031214]; skeletal system development [GO:0001501]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix protein binding [GO:1990430]; extracellular matrix structural constituent [GO:0005201]; biomineral tissue development [GO:0031214]; skeletal system development [GO:0001501]	extracellular matrix protein binding [GO:1990430]; extracellular matrix structural constituent [GO:0005201]	GO:0001501; GO:0005201; GO:0005576; GO:0005788; GO:0031012; GO:0031214; GO:1990430	NKGMPQGK	6.840000153	0.900920093	0.900920093	0.232789859	875.2961488	14.07673	15.36639	0	14.03557	15.93688	17.14006	16.1858	16.57567	15.42398	15.50555	15.83513	0	16.22455	0	16.54502	0	15.67154	15.36868	16.09757	0	14.17663	14.75306	15.84036	15.95689	15.03557	0	0	15.04191	0	14.18409	0	0	17.27431	0	16.83775	0	15.37467	16.46173	0	0	13.77004	15.27983	13.82369	0	15.50083	0	16.79506	0
Q9NQ79	CRAC1_HUMAN	"Cartilage acidic protein 1 (68 kDa chondrocyte-expressed protein, CEP-68) (ASPIC)"	CRTAC1 ASPIC1 CEP68	Homo sapiens (Human)	axonal fasciculation [GO:0007413]	extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; axonal fasciculation [GO:0007413]	calcium ion binding [GO:0005509]	GO:0005509; GO:0007413; GO:0070062	KSGAHLR	5.699999809	1	1	0.265262322	768.0979849	16.59992	0	16.36535	18.51672	0	15.76289	0	16.5033	16.47353	0	0	15.14819	13.39462	15.58821	15.77426	14.55508	0	14.63726	17.07017	16.27631	14.25471	18.25881	15.46366	16.43137	16.78538	14.95667	0	16.7886	0	14.49715	16.55934	0	18.64295	0	16.66472	0	0	16.85637	0	0	15.48933	0	14.61817	0	16.96072	14.45275	16.79985	12.53999
Q9NQ86	TRI36_HUMAN	"E3 ubiquitin-protein ligase TRIM36, EC 2.3.2.27 (RING finger protein 98) (RING-type E3 ubiquitin transferase TRIM36) (Tripartite motif-containing protein 36) (Zinc-binding protein Rbcc728)"	TRIM36 RBCC728 RNF98	Homo sapiens (Human)	acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; alpha-tubulin binding [GO:0043014]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051]	alpha-tubulin binding [GO:0043014]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000281; GO:0001669; GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0007051; GO:0007340; GO:0008270; GO:0043014; GO:0051726; GO:0070507	AIDSSK	5.989999771	1	1	0.023567994	620.9084133	0	0	14.16895	0	0	0	12.7486	16.11957	15.35063	14.75574	15.50684	15.21319	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.00044	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NQ87	HEYL_HUMAN	"Hairy/enhancer-of-split related with YRPW motif-like protein, hHeyL (Class B basic helix-loop-helix protein 33, bHLHb33) (Hairy-related transcription factor 3, HRT-3, hHRT3)"	HEYL BHLHB33 HRT3	Homo sapiens (Human)	"anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; atrioventricular valve morphogenesis [GO:0003181]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; glomerulus development [GO:0032835]; mesenchymal cell development [GO:0014031]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; ventricular septum morphogenesis [GO:0060412]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AF-1 domain binding [GO:0050683]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; atrioventricular valve morphogenesis [GO:0003181]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; glomerulus development [GO:0032835]; mesenchymal cell development [GO:0014031]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; ventricular septum morphogenesis [GO:0060412]"	"AF-1 domain binding [GO:0050683]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003151; GO:0003180; GO:0003181; GO:0003184; GO:0003198; GO:0003203; GO:0003208; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007219; GO:0009952; GO:0010629; GO:0014031; GO:0032835; GO:0035914; GO:0042803; GO:0043433; GO:0045666; GO:0045892; GO:0045944; GO:0050683; GO:0050767; GO:0060317; GO:0060412; GO:0060766; GO:0061314; GO:0071773; GO:0072014	ATGIILPARR	1.610000014	1	1	0.137456341	1068.293198	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.78911	0	0	0	0	15.47004	0	0	0	0	0	0	0	0	0	0	0	0	17.43296	0	0	0	0	0	0	0	0	0
Q9NQ89	CL004_HUMAN	Protein C12orf4	C12orf4	Homo sapiens (Human)	regulation of mast cell degranulation [GO:0043304]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; regulation of mast cell degranulation [GO:0043304]		GO:0005737; GO:0043304	ERFCNR	1.169999957	1	1	0.103183547	882.6312388	0	16.34398	16.918	13.88848	14.66531	0	13.05874	0	16.66764	0	14.96344	0	0	0	0	0	0	0	0	0	0	16.07652	14.64921	0	0	0	0	16.26255	12.4531	0	0	15.91115	0	0	0	0	0	18.874	0	0	0	0	0	0	15.01184	0	0	0
Q9NQ90	ANO2_HUMAN	Anoctamin-2 (Transmembrane protein 16B)	ANO2 C12orf3 TMEM16B	Homo sapiens (Human)	chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	chloride channel complex [GO:0034707]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	chloride channel complex [GO:0034707]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]	GO:0005229; GO:0005254; GO:0005654; GO:0005886; GO:0034220; GO:0034707; GO:0046983; GO:0055085; GO:1902476	MATPGPR	2.089999914	1	1	0.044007837	728.5799341	0	14.65241	0	0	0	0	0	13.35465	0	16.27928	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.78462	0	17.71702	0	0	0	0	0	0	0	0	0	0
Q9NQA5	TRPV5_HUMAN	"Transient receptor potential cation channel subfamily V member 5, TrpV5 (Calcium transport protein 2, CaT2) (Epithelial calcium channel 1, ECaC, ECaC1) (Osm-9-like TRP channel 3, OTRPC3)"	TRPV5 ECAC1	Homo sapiens (Human)	calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809]	calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]	GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0016324; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0070588; GO:0098703	AQVVATTVMLERK	4.659999847	0.434091568	0.434091568	0.336441368	1461.371657	16.40131	15.99877	0	16.59711	15.55785	15.05267	15.2805	16.00329	15.29228	14.00258	16.54997	0	14.65145	0	0	14.09465	14.68907	14.52737	13.76738	16.92428	13.54106	0	16.85227	0	0	16.10096	0	0	0	0	0	0	16.71865	0	17.1707	0	0	0	0	0	0	0	0	0	17.45421	16.6147	15.1452	13.03899
Q9NQC3	RTN4_HUMAN	"Reticulon-4 (Foocen) (Neurite outgrowth inhibitor, Nogo protein) (Neuroendocrine-specific protein, NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5)"	RTN4 KIAA0886 NOGO My043 SP1507	Homo sapiens (Human)	apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]	cell junction [GO:0030054]; cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cell junction [GO:0030054]; cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]	cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]	GO:0001825; GO:0002523; GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007029; GO:0007413; GO:0010634; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030176; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042981; GO:0042995; GO:0045296; GO:0045766; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0060907; GO:0061462; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0120078; GO:1902430; GO:1902624; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1990809; GO:2000172; GO:2000347; GO:2001213	DSKEDSDMLAAGGK	2.930000067	1	1	1.38E-12	1439.633999	14.71961	15.13342	11.72665	11.43198	0	0	0	0	13.95151	0	0	15.57677	0	15.29298	0	0	13.57623	0	0	14.19153	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NQC7	CYLD_HUMAN	"Ubiquitin carboxyl-terminal hydrolase CYLD, EC 3.4.19.12 (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)"	CYLD CYLD1 KIAA0849 HSPC057	Homo sapiens (Human)	cell cycle [GO:0007049]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent deubiquitinase [GO:0004843]; zinc ion binding [GO:0008270]	GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006511; GO:0007049; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0031234; GO:0032088; GO:0032480; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070423; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242	SKNTWYIDEVAEDPAK	5.570000172	1	1	0.29682004	1866.418753	0	0	0	0	0	0	0	14.00179	0	0	15.74555	0	15.15852	15.05138	0	0	0	12.31982	0	0	0	14.70877	0	0	0	0	0	0	14.15523	0	0	0	0	0	15.44936	15.53462	0	0	0	14.07341	13.95114	15.63331	13.03775	15.34899	16.99012	15.56172	0	16.43043
Q9NQF3	SERHL_HUMAN	"Serine hydrolase-like protein, SHL, EC 3.1.-.-"	SERHL SERHL2	Homo sapiens (Human)			hydrolase activity [GO:0016787]	hydrolase activity [GO:0016787]	GO:0016787	QRTALTSSAGSCVR	3.460000038	1	1	0.379625192	1491.929957	0	12.9004	0	0	14.99125	14.15625	0	0	0	13.63275	0	0	0	16.43723	0	0	0	13.32393	0	0	0	0	0	15.98669	0	14.83415	0	16.01505	0	0	0	15.48192	0	0	13.39326	0	17.11355	0	0	0	0	0	0	0	0	16.23643	0	0
Q9NQG7	HPS4_HUMAN	Hermansky-Pudlak syndrome 4 protein (Light-ear protein homolog)	HPS4 KIAA1667	Homo sapiens (Human)	blood coagulation [GO:0007596]; hemostasis [GO:0007599]; intracellular transport [GO:0046907]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]	BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; intracellular transport [GO:0046907]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006605; GO:0007040; GO:0007596; GO:0007599; GO:0016020; GO:0016192; GO:0030318; GO:0031085; GO:0031267; GO:0031410; GO:0042470; GO:0042803; GO:0042827; GO:0046907; GO:0046983; GO:0048075; GO:0050821; GO:0060155; GO:1903232; GO:1903955	GEVLGLSSSLGK	5.909999847	1	1	0.260142425	1145.881057	15.84484	11.00163	14.42831	9.531819	14.98245	9.663874	0	14.63686	0	14.59882	0	13.55984	0	0	14.81557	0	0	0	0	14.92316	16.62781	0	0	0	0	8.829999	0	0	0	0	0	15.70812	0	0	14.91125	0	0	0	0	0	0	0	15.03497	14.24578	15.51778	15.22819	0	14.0098
Q9NQH7	XPP3_HUMAN	"Xaa-Pro aminopeptidase 3, X-Pro aminopeptidase 3, EC 3.4.11.9 (Aminopeptidase P3, APP3)"	XPNPEP3	Homo sapiens (Human)	glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]	GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0008233; GO:0016485; GO:0030145; GO:0042803; GO:0070006	DAPEKFR	12.07999992	0.557783961	0.557783961	0.290229335	863.9306704	0	15.606	0	0	0	15.29275	0	14.88804	0	0	0	0	0	16.15985	0	15.8339	0	0	0	0	0	0	0	0	0	0	13.90412	13.29663	15.06272	15.84703	15.8524	14.1626	13.51543	15.03971	15.3289	14.74942	14.95657	0	14.07292	15.34033	15.77424	15.25377	14.63247	0	0	17.17767	0	0
Q9NQI0	DDX4_HUMAN	"Probable ATP-dependent RNA helicase DDX4, EC 3.6.4.13 (DEAD box protein 4) (Vasa homolog)"	DDX4 VASA	Homo sapiens (Human)	cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007276; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0030317; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:1990511	GGRGSFR	7.809999943	0.183660939	0.183660939	0.245502776	736.1524738	16.75053	12.71278	16.17458	16.10722	0	0	0	0	0	0	0	0	17.50576	13.80002	17.78926	0	0	16.19328	17.28356	0	16.19485	16.24807	0	15.56224	0	16.89478	0	15.26341	16.64568	16.20294	0	0	17.18354	0	16.71734	15.75303	18.45914	17.84912	16.88299	0	17.30081	15.9315	17.87038	0	17.46664	0	18.15886	0
Q9NQL9	DMRT3_HUMAN	Doublesex- and mab-3-related transcription factor 3	DMRT3 DMRTA3	Homo sapiens (Human)	adult walking behavior [GO:0007628]; male sex differentiation [GO:0046661]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; transmission of nerve impulse [GO:0019226]; ventral spinal cord interneuron specification [GO:0021521]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult walking behavior [GO:0007628]; male sex differentiation [GO:0046661]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; transmission of nerve impulse [GO:0019226]; ventral spinal cord interneuron specification [GO:0021521]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0007628; GO:0019226; GO:0021521; GO:0042487; GO:0046661; GO:0046872; GO:1990837	YPLMLRNTLAR	7.599999905	1	1	0.340304372	1362.916036	0	0	0	14.53035	0	0	0	14.87335	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.0895	17.89688	14.31118	14.02928	0	12.91465	15.28959	0	15.09803	15.47026	0	0	0	0	16.83417	16.77266	15.86357	0	0	16.44658	17.59327	17.34377	0	0	0	15.50328
Q9NQP4	PFD4_HUMAN	Prefoldin subunit 4 (Protein C-1)	PFDN4 PFD4	Homo sapiens (Human)	negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:1905907	MAATMK	1.559999943	1	1	0.207981019	667.4148702	16.31685	0	15.72966	16.16828	0	16.25573	15.59526	14.81729	17.20662	0	16.65789	0	15.81254	14.9794	13.38973	15.32001	15.58681	17.05327	0	16.28873	0	16.3781	16.32565	15.6076	16.42168	16.07225	0	15.68913	0	15.48061	16.27659	15.48468	16.03412	16.59319	0	16.21509	16.89044	17.17041	15.58315	16.42134	15.42522	15.84306	16.59333	16.71532	16.43589	0	16.1458	16.91979
Q9NQQ7	S35C2_HUMAN	Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein)	SLC35C2 C20orf5 OVCOV1 CGI-15	Homo sapiens (Human)	negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]	cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786]	antiporter activity [GO:0015297]	GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0010629; GO:0015297; GO:0015786; GO:0016021; GO:0033116; GO:0036066; GO:0045747	ALHSRGDGGPK	6.840000153	0.267462254	0.267462254	0.037893628	1095.75439	12.99547	0	0	0	15.4922	12.56493	15.37749	0	0	13.09076	10.16658	14.65866	10.89474	0	12.39602	14.55289	8.401666	8.102065	0	0	0	13.8704	0	14.04302	0	13.49577	0	12.71545	14.68924	14.88165	0	0	0	0	0	0	0	0	0	0	14.68159	13.44807	16.05012	0	0	13.82432	0	0
Q9NQR1	KMT5A_HUMAN	"N-lysine methyltransferase KMT5A, EC 2.1.1.- (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A, EC 2.1.1.361) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07, PR-Set7, PR/SET07) (SET domain-containing protein 8)"	KMT5A PRSET7 SET07 SET8 SETD8	Homo sapiens (Human)	"cell division [GO:0051301]; chromatin organization [GO:0006325]; mitotic chromosome condensation [GO:0007076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]"	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell division [GO:0051301]; chromatin organization [GO:0006325]; mitotic chromosome condensation [GO:0007076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]"	histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0002039; GO:0003714; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0007076; GO:0016278; GO:0016279; GO:0018024; GO:0018026; GO:0042799; GO:0043516; GO:0045892; GO:0051301; GO:1901796	GPGRPRTDGENVFTGQSK	8.960000038	1	1	0.184564362	1903.93746	0	0	0	15.28642	0	0	0	0	12.30334	15.86602	0	0	0	0	0	14.71508	0	0	0	0	0	0	15.51829	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.18017	12.83771	0
Q9NQR7	CC177_HUMAN	Coiled-coil domain-containing protein 177 (Myelin proteolipid protein-like protein)	CCDC177 C14orf162 PLPL	Homo sapiens (Human)						ALADLVR	3.339999914	1	1	0.304711405	757.9771102	0	0	0	0	17.14744	19.06326	16.7434	0	0	17.35831	0	18.26205	15.34914	17.18787	16.77406	0	18.35323	0	16.41357	0	0	17.45442	0	0	0	0	0	0	17.24892	0	19.05997	0	0	17.29662	0	18.54063	0	0	0	0	17.54122	0	0	17.60092	0	0	0	15.1239
Q9NQR9	G6PC2_HUMAN	"Glucose-6-phosphatase 2, G-6-Pase 2, G6Pase 2, EC 3.1.3.9 (Islet-specific glucose-6-phosphatase catalytic subunit-related protein)"	G6PC2 IGRP	Homo sapiens (Human)	gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796]	glucose-6-phosphatase activity [GO:0004346]	GO:0004346; GO:0005789; GO:0006094; GO:0016020; GO:0016021; GO:0042593; GO:0050796; GO:0051156	MDFLHR	1.25	1	1	8.03E-13	835.5289336	14.61529	13.55019	15.21502	0	15.4507	0	14.60455	10.93129	14.38291	0	15.12222	14.81362	0	14.54231	14.83944	0	16.25486	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.38099	0	0	0	0	0	0
Q9NQS1	AVEN_HUMAN	Cell death regulator Aven	AVEN	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]		GO:0005829; GO:0006915; GO:0010972; GO:0012505; GO:0016020; GO:0043066	GRPGGDR	1.220000029	1	1	0.257335457	715.4638764	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59995	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.64219	0	0	0	0	0	0	0	0	0	0	0
Q9NQS5	GPR84_HUMAN	G-protein coupled receptor 84 (Inflammation-related G-protein coupled receptor EX33)	GPR84 EX33	Homo sapiens (Human)	neuropeptide signaling pathway [GO:0007218]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; G protein-coupled peptide receptor activity [GO:0008528]; urotensin II receptor activity [GO:0001604]; neuropeptide signaling pathway [GO:0007218]	G protein-coupled peptide receptor activity [GO:0008528]; urotensin II receptor activity [GO:0001604]	GO:0001604; GO:0005886; GO:0005887; GO:0007218; GO:0008528; GO:0035579; GO:0043235; GO:0070821	QFRQAYGSILK	2.329999924	1	1	0.248381459	1312.213981	0	0	12.97163	0	0	0	0	14.90015	0	0	0	0	0	0	0	0	0	0	0	18.35571	0	0	0	0	0	0	0	0	0	14.33572	17.08554	0	0	15.06783	15.41387	16.58269	0	0	15.33775	0	0	0	0	15.63183	0	0	0	0
Q9NQS7	INCE_HUMAN	Inner centromere protein	INCENP	Homo sapiens (Human)	chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein phosphorylation [GO:0006468]	"central element [GO:0000801]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]"	"central element [GO:0000801]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; protein serine/threonine kinase activator activity [GO:0043539]; chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein phosphorylation [GO:0006468]"	protein serine/threonine kinase activator activity [GO:0043539]	GO:0000278; GO:0000281; GO:0000775; GO:0000776; GO:0000800; GO:0000801; GO:0001934; GO:0005634; GO:0005654; GO:0005721; GO:0005819; GO:0005829; GO:0005874; GO:0006468; GO:0007052; GO:0007059; GO:0010369; GO:0015630; GO:0016572; GO:0016604; GO:0030496; GO:0032133; GO:0032991; GO:0043539; GO:0051256; GO:0051257; GO:0051310; GO:0071902; GO:0090267; GO:1901970; GO:1902425; GO:1903490; GO:1990385	TPSSPCPASK	4.199999809	1	1	0.182322813	1031.182408	0	0	0	0	0	0	15.50736	0	0	0	0	0	16.683	0	0	0	0	15.24361	15.22108	0	15.93412	0	0	0	0	0	0	0	0	15.34659	0	0	0	15.49659	15.52247	15.74436	15.58961	15.01055	16.4778	10.71759	15.77694	0	0	0	0	14.82376	0	0
Q9NQT4	EXOS5_HUMAN	Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B)	EXOSC5 CML28 RRP46	Homo sapiens (Human)	"defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]"	3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000791; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034475; GO:0043928; GO:0045006; GO:0051607; GO:0071028; GO:0071051; GO:0101019	ATLEVILRPK	4.46999979	0.294729412	0.294729412	0.248201804	1138.300693	13.62474	16.12934	0	0	18.64736	15.58811	18.17363	0	16.1542	14.7824	0	0	18.90102	18.2358	16.57124	0	0	18.65028	0	0	0	19.42011	18.93103	16.90025	0	17.07631	0	0	17.37623	0	0	18.61834	0	0	0	17.01474	0	0	0	0	18.86687	16.51994	0	0	16.07211	18.56667	0	18.28688
Q9NQT8	KI13B_HUMAN	Kinesin-like protein KIF13B (Kinesin-like protein GAKIN)	KIF13B GAKIN KIAA0639	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110]	axon [GO:0030424]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	axon [GO:0030424]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]	GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0006605; GO:0007018; GO:0007165; GO:0008017; GO:0016887; GO:0019901; GO:0030424; GO:0042110; GO:0050770; GO:0071889	ATGPVR	13.52000046	0.495361269	0.495361269	0.315521926	600.7697199	0	0	14.52957	15.45135	14.47112	14.66125	15.45707	14.9955	15.89707	16.20624	15.50954	14.498	15.52596	15.89553	15.28715	15.26107	16.5991	15.50157	16.71281	16.33125	0	15.98272	16.79887	16.69148	14.65692	0	0	15.76437	0	15.55765	15.78117	15.20074	0	15.9396	15.37027	14.9459	16.0619	0	17.07576	16.59286	0	0	0	15.71474	0	0	16.08109	15.88779
Q9NQV8	PRDM8_HUMAN	"PR domain zinc finger protein 8, EC 2.1.1.- (PR domain-containing protein 8)"	PRDM8 PFM5	Homo sapiens (Human)	"methylation [GO:0032259]; oligodendrocyte development [GO:0014003]; regulation of transcription, DNA-templated [GO:0006355]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; oligodendrocyte development [GO:0014003]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]	GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0008168; GO:0014003; GO:0016604; GO:0032259; GO:0046872	MEDTGIQR	4.329999924	1	1	0.104154093	965.7347335	15.55154	0	0	0	15.89499	0	13.03908	16.57209	17.04512	17.73634	16.14856	0	16.04125	0	0	16.97896	0	15.73661	0	0	0	0	0	11.61165	0	12.85829	0	16.14654	16.58223	0	0	0	16.08936	0	0	0	0	14.20166	14.94446	0	0	0	0	0	0	0	0	0
Q9NQW5	PRDM7_HUMAN	"Histone-lysine N-methyltransferase PRDM7, EC 2.1.1.- (PR domain zinc finger protein 7) (PR domain-containing protein 7) ([histone H3]-lysine4 N-methyltransferase PRDM7)"	PRDM7 PFM4	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; nucleus [GO:0005634]	"chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; recombination hotspot binding [GO:0010844]; chromatin organization [GO:0006325]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]"	histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; recombination hotspot binding [GO:0010844]	GO:0005634; GO:0005694; GO:0006325; GO:0006355; GO:0010468; GO:0010844; GO:0010845; GO:0042800; GO:0046975; GO:0080182	MNYNALITVGLR	1.330000043	1	1	0.422776031	1365.184159	0	0	0	0	0	0	0	0	0	0	16.18746	0	0	15.8771	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NQW6	ANLN_HUMAN	Anillin	ANLN	Homo sapiens (Human)	actomyosin contractile ring assembly [GO:0000915]; glomerular visceral epithelial cell migration [GO:0090521]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106]	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]	actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; actomyosin contractile ring assembly [GO:0000915]; glomerular visceral epithelial cell migration [GO:0090521]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106]	actin binding [GO:0003779]; cadherin binding [GO:0045296]	GO:0000281; GO:0000915; GO:0000921; GO:0002244; GO:0003779; GO:0005654; GO:0005826; GO:0005829; GO:0005938; GO:0007096; GO:0015629; GO:0030496; GO:0031106; GO:0032059; GO:0045296; GO:0090521; GO:1904172	EFCAR	5.690000057	1	1	0.16536517	684.6151682	16.14546	15.65456	14.66477	0	13.50955	0	0	0	0	0	0	16.1235	0	11.41951	0	0	16.24719	16.40457	14.6599	0	0	0	0	0	0	15.17733	0	0	0	15.73769	16.82118	14.78823	15.93663	0	0	15.8216	0	0	15.62787	0	16.53643	17.33076	0	0	17.0239	0	16.83006	0
Q9NQW7	XPP1_HUMAN	"Xaa-Pro aminopeptidase 1, EC 3.4.11.9 (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P, sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)"	XPNPEP1 XPNPEPL XPNPEPL1	Homo sapiens (Human)	bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	NSAESEGMRR	2.019999981	1	1	0.017597401	1153.595863	13.18818	13.9789	13.25166	0	0	0	0	0	0	0	0	0	14.54922	9.553975	0	0	14.25904	0	0	0	0	0	16.49679	0	0	0	13.52507	0	0	15.27885	14.86127	0	0	16.40248	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NQW8	CNGB3_HUMAN	"Cyclic nucleotide-gated cation channel beta-3 (Cone photoreceptor cGMP-gated channel subunit beta) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-3, CNG channel beta-3)"	CNGB3	Homo sapiens (Human)	cation transport [GO:0006812]; signal transduction [GO:0007165]; visual perception [GO:0007601]	photoreceptor outer segment [GO:0001750]; transmembrane transporter complex [GO:1902495]	photoreceptor outer segment [GO:0001750]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; cation transport [GO:0006812]; signal transduction [GO:0007165]; visual perception [GO:0007601]	cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]	GO:0001750; GO:0005222; GO:0005223; GO:0006812; GO:0007165; GO:0007601; GO:0030553; GO:1902495	DLALLFPPK	27.19000053	1	1	0.202534168	1014.773535	0	22.4609	22.62801	21.6277	22.28582	22.47704	22.50192	22.15231	23.27731	23.08463	19.14362	23.55483	22.65381	22.75433	17.27813	0	21.4515	22.51136	0	21.285	22.03333	0	23.33424	21.80259	18.93256	23.17702	0	21.12999	22.25919	21.41351	22.98337	23.30571	0	22.56099	0	0	23.1891	23.17618	23.51935	0	20.96551	0	22.7763	22.19903	0	20.98258	20.73926	21.45281
Q9NQX0	PRDM6_HUMAN	"Putative histone-lysine N-methyltransferase PRDM6, EC 2.1.1.361 (PR domain zinc finger protein 6) (PR domain-containing protein 6)"	PRDM6 PFM3	Homo sapiens (Human)	chromatin organization [GO:0006325]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]	histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0000122; GO:0005634; GO:0006325; GO:0010468; GO:0022008; GO:0042054; GO:0042802; GO:0046872; GO:0051151	CDMCADNR	5.400000095	1	1	0.081909437	1054.628475	14.82093	17.26646	8.825614	0	16.15304	0	0	0	0	13.85662	0	0	13.8765	8.216123	0	0	0	0	0	0	0	0	0	0	0	0	0	14.26018	0	0	0	0	15.91553	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NQX1	PRDM5_HUMAN	"PR domain zinc finger protein 5, EC 2.1.1.- (PR domain-containing protein 5)"	PRDM5 PFM2	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extracellular matrix organization [GO:1903053]; regulation of gene expression [GO:0010468]"	nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extracellular matrix organization [GO:1903053]; regulation of gene expression [GO:0010468]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000278; GO:0000976; GO:0000977; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0010468; GO:0016575; GO:0016604; GO:0043565; GO:0045892; GO:0045944; GO:0046872; GO:0051567; GO:0140297; GO:1903053; GO:1990830	QSTAGRK	16.56999969	1	1	0.247729762	746.7836053	15.25754	13.49373	15.96051	16.04418	15.15185	15.51435	15.49524	14.87777	0	14.33538	13.16404	15.36234	0	0	14.02817	0	13.2857	15.67514	16.74325	16.74506	15.37671	15.53262	14.64493	13.94906	0	0	0	0	14.58158	14.42128	0	16.00182	15.41379	16.72137	15.3055	0	15.98863	0	0	0	0	14.91156	14.80289	15.35521	16.0363	0	0	14.8012
Q9NQX5	NPDC1_HUMAN	"Neural proliferation differentiation and control protein 1, NPDC-1"	NPDC1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021	KESGHSTPPLPK	14.80000019	1	1	0.452431241	1278.440422	18.9003	19.81351	19.9198	0	0	18.34627	20.89721	20.11361	17.00998	21.27714	18.24357	15.18317	20.70818	0	0	19.87544	0	0	0	0	19.84437	0	19.58823	0	20.23191	0	0	17.90372	19.90029	19.13635	0	21.03735	20.83405	0	20.08969	0	0	21.01581	17.299	19.83541	0	19.3287	20.22477	17.29771	20.29394	0	0	0
Q9NQX6	ZN331_HUMAN	Zinc finger protein 331 (C2H2-like zinc finger protein rearranged in thyroid adenomas) (Zinc finger protein 361) (Zinc finger protein 463)	ZNF331 RITA ZNF361 ZNF463	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0008270	AFICGSSLIQHKR	8.170000076	1	1	0.335813535	1517.728206	0	0	18.06062	0	0	0	0	0	16.77564	0	17.30692	0	18.07383	0	0	0	0	0	0	0	0	0	17.5815	0	0	17.39976	0	0	0	20.49235	17.27921	0	0	0	0	0	19.51045	0	19.67813	0	0	0	0	0	0	0	0	0
Q9NQZ5	STAR7_HUMAN	"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7, StARD7)"	STARD7 GTT1	Homo sapiens (Human)		mitochondrial outer membrane [GO:0005741]	mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]	lipid binding [GO:0008289]	GO:0005741; GO:0008289	FVTGLRVR	6.289999962	0.576822221	0.576822221	0.107062713	950.205914	13.7347	15.07426	14.6441	13.32911	14.50458	0	0	0	0	0	0	14.91562	0	14.18942	13.44688	0	16.0137	15.80301	0	14.84082	16.61076	13.13819	13.83425	0	0	0	17.04622	0	0	0	0	0	0	0	0	16.14625	15.98296	0	0	0	15.59086	14.58578	0	0	0	0	0	0
Q9NQZ6	ZC4H2_HUMAN	Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127)	ZC4H2 HCA127 KIAA1166	Homo sapiens (Human)	nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; noradrenergic neuron development [GO:0003358]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; protein monoubiquitination [GO:0006513]; regulation of transcription regulatory region DNA binding [GO:2000677]; spinal cord motor neuron differentiation [GO:0021522]	cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; noradrenergic neuron development [GO:0003358]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; protein monoubiquitination [GO:0006513]; regulation of transcription regulatory region DNA binding [GO:2000677]; spinal cord motor neuron differentiation [GO:0021522]	metal ion binding [GO:0046872]	GO:0003358; GO:0005634; GO:0005737; GO:0006513; GO:0007399; GO:0007528; GO:0021522; GO:0032991; GO:0043025; GO:0045211; GO:0045666; GO:0046872; GO:0051091; GO:2000677	ADEQEIMCK	3.950000048	1	1	0.123404215	1123.845708	0	14.57976	0	0	0	0	0	0	0	0	0	12.1683	0	15.23296	0	11.46058	0	0	0	14.42732	0	0	0	13.14285	0	0	0	13.25409	15.69622	0	14.67027	0	0	14.20266	0	0	0	0	0	15.15472	14.93099	0	0	0	0	0	0	0
Q9NQZ8	ZNF71_HUMAN	Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71)	ZNF71 EZFIT	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	GACPPVR	5	1	1	0.240283031	755.2349533	13.83944	0	0	14.51143	0	0	15.03904	0	14.05842	14.70928	16.24142	15.63062	0	15.26178	0	15.80234	0	0	16.83771	0	0	0	0	0	15.37509	15.8381	0	0	0	15.96704	0	0	17.37503	16.33313	15.96119	0	16.75309	0	0	0	15.89814	0	0	0	0	0	15.70797	0
Q9NR09	BIRC6_HUMAN	"Baculoviral IAP repeat-containing protein 6, EC 2.3.2.27 (BIR repeat-containing ubiquitin-conjugating enzyme, BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon, APOLLON)"	BIRC6 KIAA1289	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]	cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]	cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237	INQNVAALPVASSVMDR	4.28000021	1	1	0.220074896	1800.432861	0	13.67557	14.93871	15.27043	15.7457	11.96101	14.53093	0	10.46688	15.52278	0	0	0	0	0	0	0	13.11662	0	0	0	0	0	0	0	15.57155	14.27568	0	11.38619	14.31685	0	0	0	0	13.36967	0	14.51616	16.92194	0	17.59248	0	0	11.37968	0	0	0	0	0
Q9NR11	ZN302_HUMAN	Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327)	ZNF302 ZNF135L ZNF140L ZNF327	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	IHSMKK	12.72000027	0.530981421	0.530981421	0.199402423	759.0433071	0	17.75826	15.23872	0	16.70434	0	0	0	18.14154	13.66654	18.79534	0	11.85741	0	18.04284	14.32533	0	0	0	0	15.99894	0	19.07263	0	17.65413	16.43255	16.71067	15.904	16.76882	15.09262	18.52507	19.48767	16.97583	0	17.17862	16.6556	0	17.65526	18.74509	0	10.4441	0	0	14.57473	14.64123	0	0	15.16759
Q9NR16	C163B_HUMAN	Scavenger receptor cysteine-rich type 1 protein M160 (CD163 antigen-like 1) (CD antigen CD163b)	CD163L1 CD163B M160 UNQ6434/PRO23202	Homo sapiens (Human)		external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]	scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005576; GO:0009897; GO:0016021	HKEDAGVICSEFTALR	3.369999886	1	1	0.309324826	1831.72082	14.60703	16.25198	11.67111	0	0	0	0	12.7879	0	0	0	17.24914	0	0	0	12.1962	0	0	0	0	0	0	15.87686	15.05964	0	12.50523	0	0	0	0	0	0	0	0	0	15.75824	0	0	0	0	0	0	0	0	0	0	0	0
Q9NR22	ANM8_HUMAN	"Protein arginine N-methyltransferase 8, EC 2.1.1.319 (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 4)"	PRMT8 HRMT1L3 HRMT1L4	Homo sapiens (Human)	"histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of protein binding [GO:0043393]"	anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; plasma membrane [GO:0005886]	"anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of protein binding [GO:0043393]"	enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0005886; GO:0006479; GO:0008469; GO:0008757; GO:0016571; GO:0018216; GO:0019899; GO:0019919; GO:0035241; GO:0035242; GO:0042802; GO:0042803; GO:0043393; GO:0051260; GO:0098753; GO:1904047	DVAMK	4.440000057	0.133739054	0.133739054	0.139775545	579.9864385	13.15328	15.78306	15.42939	13.8569	7.80643	13.67501	14.91068	18.35588	13.14681	17.14673	14.43096	14.34213	16.00083	13.80368	0	0	16.93651	0	15.68548	15.1996	14.05387	14.67063	15.53573	15.91385	15.86557	15.2488	17.22389	15.39533	0	15.62979	15.89953	0	13.49382	16.04493	18.41979	17.64212	14.33176	17.20953	16.68211	0	16.72772	0	14.92113	13.92254	14.74858	16.51194	16.57809	13.36341
Q9NR28	DBLOH_HUMAN	"Diablo IAP-binding mitochondrial protein (Diablo homolog, mitochondrial) (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase, Smac)"	DIABLO SMAC	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]	CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]		GO:0005739; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0008625; GO:0008631; GO:0008635; GO:0009898; GO:0035631; GO:0043065; GO:0051402; GO:0097193	AESEQEAYLR	13.77000046	1	1	0.518541411	1195.432844	20.6857	0	19.59064	17.41657	18.55227	0	0	0	0	20.31073	18.2364	19.64183	0	18.01053	16.23734	0	0	0	0	0	0	0	0	0	0	0	0	0	19.15308	0	0	0	0	0	18.16822	0	0	0	0	0	0	0	0	18.22461	0	0	0	19.19939
Q9NR30	DDX21_HUMAN	"Nucleolar RNA helicase 2, EC 3.6.4.13 (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)"	DDX21	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of histone acetylation [GO:0035066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop disassembly [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]	B-WICH complex [GO:0110016]; chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	B-WICH complex [GO:0110016]; chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; chromatin remodeling [GO:0006338]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of histone acetylation [GO:0035066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop disassembly [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	GO:0001649; GO:0002735; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005654; GO:0005694; GO:0005730; GO:0005739; GO:0005829; GO:0006338; GO:0006364; GO:0006366; GO:0016020; GO:0016887; GO:0019843; GO:0030515; GO:0035066; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045943; GO:0045944; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016	ELANQVSK	6.429999828	1	1	2.29E-13	888.7060546	0	0	0	14.13008	12.29998	16.19085	14.09953	11.23197	0	0	15.63252	0	12.70632	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.57403	0	0	0	0	0	0	0	0	0	0	0	12.66614	0	0	0	0	0
Q9NR45	SIAS_HUMAN	"Sialic acid synthase (N-acetylneuraminate synthase, EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase, EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase)"	NANS SAS	Homo sapiens (Human)	carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; glycosylation [GO:0070085]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444]; carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; glycosylation [GO:0070085]	N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444]	GO:0005737; GO:0005829; GO:0006055; GO:0008781; GO:0016051; GO:0047444; GO:0050462; GO:0070062; GO:0070085	GRPMVISSGMQSMDTMK	6.739999771	1	1	0.149409415	1903.806786	13.62383	14.43199	17.08955	16.44053	15.60347	0	15.42745	13.97914	14.67523	0	15.79328	0	16.07731	15.23462	0	15.84904	15.78728	0	15.60381	0	0	0	0	0	0	15.72138	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.07877	17.39932	0	0	16.38538	0	16.29801	0
Q9NR46	SHLB2_HUMAN	Endophilin-B2 (SH3 domain-containing GRB2-like protein B2)	SH3GLB2 KIAA1848 PP578	Homo sapiens (Human)	membrane organization [GO:0061024]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; membrane organization [GO:0061024]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]	GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0042802; GO:0045296; GO:0061024	MDFNMKK	3.710000038	1	1	0.259575806	946.2927755	0	0	14.51669	13.37478	0	14.21117	12.42112	12.80811	16.71625	15.89688	15.96675	0	0	0	14.79579	15.58835	15.51932	15.46251	0	15.03253	15.08254	16.47268	0	0	15.33149	0	0	15.09801	0	15.81371	16.527	0	15.41725	0	0	16.414	15.50896	0	0	0	0	0	0	16.64319	0	0	0	0
Q9NR48	ASH1L_HUMAN	"Histone-lysine N-methyltransferase ASH1L, EC 2.1.1.359, EC 2.1.1.367 (ASH1-like protein, huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H)"	ASH1L KIAA1420 KMT2H	Homo sapiens (Human)	chromatin organization [GO:0006325]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]	bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]	GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0006325; GO:0007338; GO:0009791; GO:0018024; GO:0030317; GO:0042800; GO:0043124; GO:0043409; GO:0045944; GO:0046697; GO:0046872; GO:0046974; GO:0046975; GO:0061038; GO:0097676; GO:1903699; GO:1903709	LLNQILSSSVESSNKGK	1.039999962	0.168679968	0.168679968	0.125458194	1802.916917	17.2781	13.28095	18.20789	0	12.61064	0	16.22657	17.18891	0	0	17.26589	15.36414	15.40952	12.94678	17.41343	16.92507	0	0	14.39157	0	0	18.19928	0	0	13.84335	0	15.25938	17.17278	0	0	16.67421	17.57416	16.17207	0	0	0	0	14.21076	13.0929	16.70003	15.48001	0	0	0	16.81886	0	0	15.47144
Q9NR55	BATF3_HUMAN	"Basic leucine zipper transcriptional factor ATF-like 3, B-ATF-3 (21 kDa small nuclear factor isolated from T-cells) (Jun dimerization protein p21SNFT)"	BATF3 SNFT	Homo sapiens (Human)	dendritic cell differentiation [GO:0097028]; integrated stress response signaling [GO:0140467]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; dendritic cell differentiation [GO:0097028]; integrated stress response signaling [GO:0140467]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0009615; GO:0043011; GO:0090575; GO:0097028; GO:0140467; GO:1990837	SQGLPAAGSVLQR	6.300000191	1	1	0.388085026	1283.000318	14.53671	0	14.97906	13.98086	0	0	0	0	15.47198	0	0	14.11272	13.65978	0	0	0	0	15.69241	0	0	13.88528	0	0	0	0	0	0	0	16.87023	0	0	0	13.92269	0	14.50259	0	13.59388	0	0	15.49179	16.35259	0	0	15.32582	0	0	0	0
Q9NR61	DLL4_HUMAN	"Delta-like protein 4 (Drosophila Delta homolog 4, Delta4)"	DLL4 UNQ1895/PRO4341	Homo sapiens (Human)	angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]; visual perception [GO:0007601]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]; visual perception [GO:0007601]	calcium ion binding [GO:0005509]; Notch binding [GO:0005112]	GO:0000122; GO:0001525; GO:0001569; GO:0001974; GO:0003180; GO:0003208; GO:0003209; GO:0003222; GO:0003344; GO:0005112; GO:0005509; GO:0005886; GO:0007165; GO:0007219; GO:0007601; GO:0008015; GO:0008285; GO:0010596; GO:0010628; GO:0010629; GO:0016021; GO:0030217; GO:0035912; GO:0035924; GO:0044344; GO:0045746; GO:0045747; GO:0050767; GO:0060579; GO:0061074; GO:0061314; GO:0072554; GO:0090051; GO:1903588; GO:2000179	GTMPGK	6.619999886	1	1	0.255475463	603.3291845	16.84241	16.76657	16.28549	0	17.4766	17.23699	15.77298	18.90738	16.93597	0	0	0	17.8413	0	0	0	18.43258	0	18.55191	0	0	0	0	0	0	0	0	0	0	0	0	0	19.07574	17.01092	0	0	0	0	19.52554	0	0	0	0	0	16.42081	17.27017	18.05068	0
Q9NR63	CP26B_HUMAN	"Cytochrome P450 26B1, EC 1.14.13.- (Cytochrome P450 26A2) (Cytochrome P450 retinoic acid-inactivating 2, Cytochrome P450RAI-2) (Retinoic acid-metabolizing cytochrome)"	CYP26B1 CYP26A2 P450RAI2	Homo sapiens (Human)	bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]	"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]"	"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]"	GO:0001709; GO:0001768; GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006766; GO:0006805; GO:0006954; GO:0007140; GO:0007283; GO:0008401; GO:0009954; GO:0010628; GO:0016125; GO:0016491; GO:0016709; GO:0020037; GO:0030326; GO:0033189; GO:0034653; GO:0042573; GO:0043587; GO:0045580; GO:0048384; GO:0048387; GO:0060349; GO:0061436; GO:0070268; GO:0071300; GO:2001037	SEDKDGR	10.17000008	1	1	0.199263578	805.2250407	18.4804	17.1377	16.53117	17.41583	17.06182	13.26655	16.38872	0	0	14.82924	0	16.88329	13.32778	15.24849	0	0	18.17789	0	16.38225	0	17.05792	17.42579	14.87316	17.77384	0	16.60373	0	0	13.81086	16.19932	17.77841	18.91982	16.86329	14.8718	0	15.04998	17.82037	15.69729	15.69259	16.15889	16.99388	12.18386	13.88262	0	17.24479	15.40166	16.44403	0
Q9NR77	PXMP2_HUMAN	Peroxisomal membrane protein 2 (22 kDa peroxisomal membrane protein)	PXMP2 PMP22	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991]		GO:0005737; GO:0005739; GO:0005778; GO:0005829; GO:0016020; GO:0016021; GO:0032991	RALAQYLLFLR	11.06000042	1	1	0.19342963	1362.656379	15.2766	15.27747	13.39799	0	0	0	14.67893	15.35241	15.17164	12.51205	15.77302	11.40397	15.55901	15.91576	0	0	0	0	0	16.55634	0	16.69292	0	0	14.92115	14.19076	15.91075	14.22647	15.6561	0	0	17.45015	0	16.72835	0	0	0	0	0	0	0	0	16.11651	0	0	0	0	0
Q9NR81	ARHG3_HUMAN	"Rho guanine nucleotide exchange factor 3 (Exchange factor found in platelets and leukemic and neuronal tissues, XPLN)"	ARHGEF3	Homo sapiens (Human)	positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	cytosol [GO:0005829]	cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005829; GO:0007266; GO:0035025; GO:0051056	VKPLSR	5.46999979	1	1	0.283097025	700.2078263	0	16.91213	0	0	15.44234	0	17.81369	0	16.75667	0	0	17.10495	17.81655	0	0	0	15.83359	17.60886	17.00427	16.15859	17.03793	18.76879	17.00546	0	0	0	0	15.65105	16.56387	0	18.96392	0	0	17.7579	0	0	18.46852	17.77197	17.09279	0	0	0	0	16.99943	0	0	0	0
Q9NR82	KCNQ5_HUMAN	Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5)	KCNQ5	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]	clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]	calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805	EQGEASSSQK	7	1	1	0.203380919	1049.722753	14.88349	15.50919	16.17603	0	0	0	16.05752	0	0	16.18303	0	0	15.86814	0	16.17169	15.41764	14.38536	0	14.72668	15.24765	0	16.00494	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.92828	0	0	0	0	0	0	0	0	0
Q9NR83	S2A4R_HUMAN	"SLC2A4 regulator (GLUT4 enhancer factor, GEF) (Huntington disease gene regulatory region-binding protein 1, HDBP-1)"	SLC2A4RG HDBP1	Homo sapiens (Human)	"regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0016607; GO:0046872	AAGRDPSALR	2.519999981	1	1	0.292333699	1013.729154	0	0	0	15.69624	0	0	17.79881	18.49667	0	17.60239	16.86801	18.02247	0	0	0	0	0	0	0	0	16.38787	0	0	17.70787	0	17.72173	0	17.6166	17.87629	0	17.74506	0	0	0	0	17.96098	18.8913	0	0	0	0	0	0	0	18.11038	0	0	0
Q9NR96	TLR9_HUMAN	Toll-like receptor 9 (CD antigen CD289)	TLR9 UNQ5798/PRO19605	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of gastrointestinal epithelium [GO:0030277]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of B cell activation [GO:0050871]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of B cell differentiation [GO:0045577]; regulation of toll-like receptor 9 signaling pathway [GO:0034163]; response to molecule of bacterial origin [GO:0002237]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endolysosome [GO:0036019]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endolysosome [GO:0036019]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; interleukin-1 receptor binding [GO:0005149]; NAD+ nucleosidase activity [GO:0003953]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]; unmethylated CpG binding [GO:0045322]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of gastrointestinal epithelium [GO:0030277]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of B cell activation [GO:0050871]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of B cell differentiation [GO:0045577]; regulation of toll-like receptor 9 signaling pathway [GO:0034163]; response to molecule of bacterial origin [GO:0002237]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]	interleukin-1 receptor binding [GO:0005149]; NAD+ nucleosidase activity [GO:0003953]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]; unmethylated CpG binding [GO:0045322]	GO:0000139; GO:0002224; GO:0002237; GO:0002639; GO:0002755; GO:0003953; GO:0004888; GO:0005149; GO:0005576; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005886; GO:0006954; GO:0007249; GO:0007252; GO:0010008; GO:0010628; GO:0016021; GO:0016323; GO:0016324; GO:0030277; GO:0030890; GO:0032009; GO:0032088; GO:0032715; GO:0032717; GO:0032722; GO:0032725; GO:0032727; GO:0032728; GO:0032729; GO:0032733; GO:0032735; GO:0032741; GO:0032755; GO:0032757; GO:0032760; GO:0034122; GO:0034123; GO:0034162; GO:0034163; GO:0035197; GO:0036019; GO:0036020; GO:0038187; GO:0042742; GO:0042803; GO:0043123; GO:0043410; GO:0043507; GO:0045087; GO:0045322; GO:0045577; GO:0045944; GO:0046330; GO:0050729; GO:0050829; GO:0050871; GO:0051092; GO:0051607; GO:0051770; GO:1901224; GO:1901895	DNHHFYNR	9.569999695	0.010842936	0.010842936	0.24049032	1102.165445	14.03849	15.60333	16.10532	0	0	0	15.30912	0	0	0	14.72238	0	0	0	0	0	0	0	14.25125	15.78146	0	0	15.97694	0	16.21856	0	15.27616	0	15.33403	0	0	13.84221	15.90153	14.44041	14.10188	0	11.91216	0	16.97441	0	14.29464	11.73781	15.21619	15.07233	13.52764	14.97	0	0
Q9NR99	MXRA5_HUMAN	"Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan, Adlican)"	MXRA5	Homo sapiens (Human)	response to transforming growth factor beta [GO:0071559]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; response to transforming growth factor beta [GO:0071559]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559	ITGTSPRR	8.770000458	0.650428653	0.650428653	0.310850021	886.9924596	19.60335	18.23953	19.0401	18.19287	0	0	0	18.8247	0	18.48898	0	18.88633	0	0	17.92093	0	0	17.89017	18.69013	16.87978	0	0	19.32279	0	19.68728	0	18.24936	19.6667	17.20325	15.56768	21.01644	20.0228	18.62617	19.27841	19.57656	19.98248	19.38321	0	0	0	0	0	18.43853	18.80312	19.00356	18.38569	18.40837	18.96317
Q9NRA2	S17A5_HUMAN	"Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter, AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)"	SLC17A5	Homo sapiens (Human)	amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]	carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]	GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672	ISHYEK	2.470000029	1	1	0.121542702	775.9009271	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.12076	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NRC1	ST7_HUMAN	Suppressor of tumorigenicity 7 protein (Protein FAM4A1) (Protein HELG)	ST7 FAM4A1 HELG RAY1	Homo sapiens (Human)	extracellular matrix organization [GO:0030198]; regulation of cell differentiation [GO:0045595]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; extracellular matrix organization [GO:0030198]; regulation of cell differentiation [GO:0045595]		GO:0016021; GO:0030198; GO:0045595	AVSDK	3.950000048	1.63E-08	1.63E-08	0.299805382	516.0560155	0	0	0	18.71424	0	0	0	19.21645	0	17.25684	17.63291	0	17.76118	18.33571	0	16.823	18.58614	0	0	0	17.91076	17.58686	17.49287	0	0	0	18.34958	0	0	0	0	0	0	0	0	0	0	0	18.8181	0	17.6482	18.31073	0	0	0	19.32662	0	0
Q9NRC6	SPTN5_HUMAN	"Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)"	SPTBN5 BSPECV HUBSPECV HUSPECV	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]	apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]	apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; spectrin binding [GO:0030507]	GO:0002046; GO:0003779; GO:0005737; GO:0005829; GO:0005875; GO:0007030; GO:0007041; GO:0008022; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030507; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0043621; GO:0045179; GO:0045505; GO:0051015; GO:0051693; GO:0097381	AGQPHSPR	6.639999866	1	1	0.142771123	849.9823282	0	0	0	0	0	0	0	0	0	0	0	17.16658	0	0	0	0	0	0	0	0	0	18.5068	0	0	0	0	0	0	0	0	0	0	0	0	19.14677	0	0	0	0	18.05399	0	0	0	0	0	0	0	0
Q9NRD5	PICK1_HUMAN	PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein)	PICK1 PRKCABP	Homo sapiens (Human)	"cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]	GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005543; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006886; GO:0006890; GO:0007205; GO:0008021; GO:0008022; GO:0014069; GO:0015844; GO:0019899; GO:0019904; GO:0021782; GO:0030666; GO:0032588; GO:0034315; GO:0034316; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043045; GO:0043046; GO:0043113; GO:0045161; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0140090	TIKPMLTDLNTYLNKAIPDTR	13.14999962	1	1	0.441517097	2434.597596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NRD9	DUOX1_HUMAN	"Dual oxidase 1, EC 1.11.1.-, EC 1.6.3.1 (Large NOX 1) (Long NOX 1) (NADPH thyroid oxidase 1) (Thyroid oxidase 1)"	DUOX1 DUOX LNOX1 THOX1	Homo sapiens (Human)	cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]	apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH oxidase H202-forming activity [GO:0106293]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590]	calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH oxidase H202-forming activity [GO:0106293]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]	GO:0004601; GO:0005509; GO:0005783; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0009986; GO:0016174; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0031252; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0050661; GO:0050665; GO:0051591; GO:0090303; GO:0106293; GO:0106294; GO:2000147	DGNGYLSFR	1	1	1	0.235444364	1028.217837	0	0	0	0	0	17.10522	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.83819	0	0	0	0	0	0	0	0	0	0	0	0	0	16.95232	0	0	0	0	0	0
Q9NRG1	PRDC1_HUMAN	Phosphoribosyltransferase domain-containing protein 1	PRTFDC1 HHGP	Homo sapiens (Human)	purine ribonucleoside salvage [GO:0006166]		magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; purine ribonucleoside salvage [GO:0006166]	magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]	GO:0000166; GO:0000287; GO:0006166; GO:0042803	MAGSSEEAPDYGR	2.829999924	1	1	0.270324084	1370.526134	13.25	15.66897	13.7447	13.85279	0	14.14901	14.28966	13.36178	13.97996	0	0	0	0	0	15.06576	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.67646	0	0	0	0	0	16.74593	0	0	0	0	0	0	0	0	0	0
Q9NRG4	SMYD2_HUMAN	"N-lysine methyltransferase SMYD2, EC 2.1.1.- (HSKM-B) (Histone methyltransferase SMYD2, EC 2.1.1.354) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2)"	SMYD2 KMT3C	Homo sapiens (Human)	"chromatin organization [GO:0006325]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]"	histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]	GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0007507; GO:0008285; GO:0016278; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975; GO:1901796	QKIHPER	1.320000052	1	1	0.248421394	908.3028201	0	0	0	0	0	0	0	0	0	0	0	17.57229	0	0	0	0	0	0	0	0	0	19.53959	0	0	0	0	16.81353	0	0	16.67715	0	0	0	0	0	0	0	17.23302	0	0	0	0	0	0	0	0	0	0
Q9NRG9	AAAS_HUMAN	Aladin (Adracalin)	AAAS ADRACALA GL003	Homo sapiens (Human)	fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822]	centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822]		GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006913; GO:0007612; GO:0009566; GO:0015031; GO:0016020; GO:0031965; GO:0046822; GO:0051028; GO:0072686; GO:0090307	WPTLSGRCQTGCWSPDGSR	6.139999866	1	1	2.29E-12	2208.008829	0	15.22529	0	0	0	16.02279	11.95866	15.14841	15.30598	0	0	0	0	0	16.30335	14.86647	0	0	0	0	0	0	0	0	0	0	16.15398	15.4017	17.0482	0	16.46132	16.23477	16.93529	0	0	0	15.84185	0	0	0	0	0	0	0	0	17.30891	0	0
Q9NRI5	DISC1_HUMAN	Disrupted in schizophrenia 1 protein	DISC1 KIAA0457	Homo sapiens (Human)	"canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to centrosome [GO:0071539]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of dendritic spine development [GO:0060998]; regulation of synapse maturation [GO:0090128]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to electrical stimulus [GO:0051602]; TOR signaling [GO:0031929]"	cell body [GO:0044297]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; dynein complex [GO:0030286]; endoplasmic reticulum [GO:0005783]; intermediate filament cytoskeleton [GO:0045111]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]	"cell body [GO:0044297]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; dynein complex [GO:0030286]; endoplasmic reticulum [GO:0005783]; intermediate filament cytoskeleton [GO:0045111]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to centrosome [GO:0071539]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of dendritic spine development [GO:0060998]; regulation of synapse maturation [GO:0090128]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to electrical stimulus [GO:0051602]; TOR signaling [GO:0031929]"	identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877]	GO:0000226; GO:0001764; GO:0001954; GO:0002052; GO:0005634; GO:0005739; GO:0005783; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0008021; GO:0010976; GO:0014069; GO:0019894; GO:0021846; GO:0021852; GO:0030177; GO:0030286; GO:0031929; GO:0032091; GO:0036064; GO:0042802; GO:0044297; GO:0044877; GO:0045111; GO:0045773; GO:0048471; GO:0051560; GO:0051602; GO:0051966; GO:0060070; GO:0060090; GO:0060271; GO:0060998; GO:0071539; GO:0090128; GO:0090724; GO:0097546; GO:1905515; GO:2000060	EDYNRLR	4.510000229	1	1	0.119399093	967.9665011	14.31148	0	15.19766	0	15.89425	13.47726	14.20644	0	13.29495	16.29629	14.1221	0	16.08543	0	0	0	0	0	0	0	0	0	0	15.68335	0	16.71163	0	0	0	0	0	0	0	0	0	0	0	0	0	14.46516	0	0	0	0	0	0	12.56499	0
Q9NRJ1	MOST1_HUMAN	Protein MOST-1	C8orf17	Homo sapiens (Human)	negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]		GO:0005634; GO:0005737; GO:0005789; GO:0008284; GO:0043066	MLADLTPGVEMSCR	2.069999933	1	1	2.06E-12	1612.841336	14.59589	15.4007	0	13.85063	15.3291	0	0	0	15.39493	0	14.69954	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.81063	0	16.15141	0	16.08487	16.62812	0	0	0	16.23505	0	0	15.7923	14.70126	0	0	0	0	0	0
Q9NRJ2	GSAS1_HUMAN	Putative uncharacterized protein GSN-AS1 (GSN antisense RNA 1) (GSN antisense gene protein 1) (Protein MOST-2)	GSN-AS1 C9orf31 MOST2	Homo sapiens (Human)						APSPVPASSLQDHSR	7.139999866	0.560663521	0.560663521	0.330907646	1547.657725	0	0	0	0	14.10162	0	14.83744	12.90273	0	0	0	14.83597	15.82327	0	0	0	19.79775	0	12.29665	0	0	0	0	13.36447	0	0	0	0	0	0	0	0	0	0	0	16.75996	0	0	0	0	0	0	0	0	0	0	0	0
Q9NRJ5	PAPOB_HUMAN	"Poly(A) polymerase beta, PAP-beta, EC 2.7.7.19 (Polynucleotide adenylyltransferase beta) (Testis-specific poly(A) polymerase)"	PAPOLB PAPT	Homo sapiens (Human)	mRNA polyadenylation [GO:0006378]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0006378; GO:0046872	GADIDALCVAPSHVDR	5.53000021	1	1	0.367411419	1694.999081	0	0	18.49561	0	18.79643	19.12795	0	0	0	21.78545	0	0	0	19.37993	18.14877	20.33665	0	20.37424	19.03297	0	20.02048	0	0	0	0	19.85605	20.69786	18.92093	0	0	0	0	0	0	0	0	19.25236	22.43432	0	0	0	18.58993	0	19.97611	0	0	20.3594	0
Q9NRK6	ABCBA_HUMAN	"ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein, ABC-me protein) (ATP-binding cassette transporter 10, ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2, M-ABC2)"	ABCB10	Homo sapiens (Human)	erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803]	GO:0005524; GO:0005739; GO:0005743; GO:0006783; GO:0006839; GO:0016887; GO:0032592; GO:0034514; GO:0042803; GO:0045648; GO:0046985; GO:0048821; GO:0070455; GO:0140359	ALLKNPK	12.42000008	0.009131705	0.009131705	0.309499691	782.910276	19.24011	0	0	0	16.56806	17.30601	18.10563	0	17.48677	0	16.78517	16.81962	0	18.56287	17.39517	0	0	0	16.03865	0	0	17.20948	0	0	0	0	19.24403	17.52224	17.75882	0	0	0	0	0	19.42931	0	0	18.90796	0	0	17.68858	0	0	0	0	19.16308	0	0
Q9NRL2	BAZ1A_HUMAN	"Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1, hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180, WCRF180) (hWALp1)"	BAZ1A ACF1 WCRF180 HSPC317	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]	ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; nucleosome mobilization [GO:0042766]; nucleosome positioning [GO:0016584]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]	GO:0000228; GO:0005634; GO:0005721; GO:0006261; GO:0006275; GO:0006334; GO:0006338; GO:0006357; GO:0008623; GO:0016584; GO:0016590; GO:0042766; GO:0045740; GO:0046872	ELPEPTPVK	2.470000029	1	1	0.159626918	1010.585186	15.70509	0	13.81315	0	0	14.26338	15.54934	0	14.18068	16.2548	0	0	15.45046	14.13411	12.68473	0	14.59804	14.53402	14.0133	15.8075	0	0	15.6745	16.31937	14.53495	15.05413	0	0	14.50793	9.825973	16.51927	14.01193	14.79205	16.49784	0	14.66438	0	15.17034	0	15.47298	0	0	14.41577	15.93351	0	14.17406	13.33756	14.76493
Q9NRM1	ENAM_HUMAN	Enamelin	ENAM	Homo sapiens (Human)	ameloblast differentiation [GO:0036305]; amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; positive regulation of enamel mineralization [GO:0070175]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; structural constituent of tooth enamel [GO:0030345]; ameloblast differentiation [GO:0036305]; amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; positive regulation of enamel mineralization [GO:0070175]	structural constituent of tooth enamel [GO:0030345]	GO:0005576; GO:0005788; GO:0030345; GO:0031012; GO:0031214; GO:0036305; GO:0070175; GO:0097186	DIISPTSILPGQR	9.899999619	0.704887867	0.704887867	0.165084845	1398.02126	0	12.41258	9.221328	16.29003	16.01045	16.09251	15.16721	15.90716	17.26097	16.03797	16.79651	0	0	17.17428	15.38485	0	15.40171	15.4941	0	0	16.18633	14.997	0	0	12.69859	0	12.2265	0	16.80961	0	16.43537	0	13.37112	14.50912	13.50546	13.4905	15.13542	16.57164	0	0	18.73409	15.29671	14.21469	0	17.49997	17.3317	17.07283	18.2425
Q9NRM7	LATS2_HUMAN	"Serine/threonine-protein kinase LATS2, EC 2.7.11.1 (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase)"	LATS2 KPM	Homo sapiens (Human)	cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0000922; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0009755; GO:0017015; GO:0018105; GO:0034451; GO:0035329; GO:0035556; GO:0043065; GO:0045736; GO:0046620; GO:0046872; GO:0051301; GO:0090090; GO:0106310; GO:1900181	SKSEQYDLDSLCAGMEQSLR	11.86999989	1	1	0.31366029	2316.097534	18.93689	0	0	0	18.24768	19.0868	0	0	0	0	0	19.91076	0	0	17.36555	16.75728	0	0	0	0	16.80738	0	0	0	19.56558	0	0	0	17.28548	18.86176	0	0	0	0	0	0	0	0	0	0	0	0	17.71331	0	0	18.86509	0	0
Q9NRN5	OLFL3_HUMAN	Olfactomedin-like protein 3 (HNOEL-iso) (hOLF44)	OLFML3 PSEC0035 PSEC0173 PSEC0244 UNQ663/PRO1294	Homo sapiens (Human)	signal transduction [GO:0007165]	extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]	extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; signal transduction [GO:0007165]		GO:0005615; GO:0007165; GO:1903561	ARIQCSFDASGTLTPER	6.619999886	1	1	0.232338664	1907.803226	14.54951	0	12.84432	14.2505	10.17467	0	0	14.52056	0	0	0	14.19121	0	14.53613	0	13.59407	14.07128	0	0	11.85206	0	0	0	0	0	16.2787	0	0	0	0	0	0	0	0	0	0	0	0	0	14.99372	15.97719	0	0	0	0	0	0	0
Q9NRN9	METL5_HUMAN	"rRNA N6-adenosine-methyltransferase METTL5, EC 2.1.1.- (Methyltransferase-like protein 5)"	METTL5 DC3 HSPC133	Homo sapiens (Human)	positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; stem cell differentiation [GO:0048863]	cell projection [GO:0042995]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]	cell projection [GO:0042995]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; stem cell differentiation [GO:0048863]	nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]	GO:0003676; GO:0005634; GO:0008988; GO:0016740; GO:0031167; GO:0042995; GO:0045727; GO:0048863; GO:0098793; GO:0098794; GO:1904047	TALEMARTAVYSLHK	3.329999924	0.997359931	0.997359931	0	1703.26155	0	14.64609	0	15.75027	0	16.04395	0	15.15939	16.39779	14.98254	0	15.38107	0	0	0	13.91426	0	0	15.02939	0	0	0	0	0	14.56277	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NRP2	COXM2_HUMAN	COX assembly mitochondrial protein 2 homolog	CMC2 C16orf61 DC13	Homo sapiens (Human)		mitochondrion [GO:0005739]	mitochondrion [GO:0005739]		GO:0005739	SREHGIAMR	5.820000172	0.226784438	0.226784438	0.156603805	1073.247606	15.86842	17.5616	19.47607	0	0	17.43257	9.926258	13.36495	0	0	16.7458	0	0	0	14.38995	12.66384	13.46228	0	15.09745	9.869217	15.22925	0	14.11829	12.93856	16.32615	0	0	0	0	0	16.42745	15.69105	0	14.70596	13.96608	0	15.55122	16.2673	14.33506	15.85035	0	15.84001	12.17752	12.69598	13.55139	0	0	0
Q9NRP4	SDHF3_HUMAN	"Succinate dehydrogenase assembly factor 3, mitochondrial, SDH assembly factor 3, SDHAF3"	SDHAF3 ACN9 DC11	Homo sapiens (Human)	mitochondrial respiratory chain complex II assembly [GO:0034553]; regulation of gluconeogenesis [GO:0006111]; succinate metabolic process [GO:0006105]	mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]	mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex II assembly [GO:0034553]; regulation of gluconeogenesis [GO:0006111]; succinate metabolic process [GO:0006105]		GO:0005758; GO:0005759; GO:0006105; GO:0006111; GO:0034553	HVSRVR	5.119999886	1	1	0.090959125	754.7481059	14.01426	15.29007	13.35516	13.50108	15.94011	0	15.66919	13.83476	14.14725	12.13481	0	16.37897	14.83706	13.84728	13.67796	0	15.2466	14.34475	0	14.89327	14.04352	15.76384	16.19896	0	0	0	17.12803	0	0	0	0	0	0	0	0	0	0	0	0	15.96483	0	0	0	0	0	0	0	0
Q9NRP7	STK36_HUMAN	"Serine/threonine-protein kinase 36, EC 2.7.11.1 (Fused homolog)"	STK36 KIAA1278	Homo sapiens (Human)	brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription corepressor binding [GO:0001222]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transcription corepressor binding [GO:0001222]	GO:0001222; GO:0003351; GO:0004674; GO:0004712; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007224; GO:0007228; GO:0007420; GO:0009791; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310	KYSAQVVALK	14.40999985	1	1	0.14965567	1107.467836	17.68151	15.07378	15.75307	0	17.64245	16.0936	18.25276	0	0	18.3391	0	17.01341	18.9699	0	18.13184	17.06233	0	0	16.99337	0	17.98024	17.58966	0	0	15.66691	18.12609	18.09975	17.49084	18.29219	0	0	18.14621	0	0	0	17.28257	0	18.45652	18.3117	0	15.43305	0	15.53662	17.95122	18.50514	0	15.48076	17.48971
Q9NRR4	RNC_HUMAN	"Ribonuclease 3, EC 3.1.26.3 (Protein Drosha) (Ribonuclease III, RNase III) (p241)"	DROSHA RN3 RNASE3L RNASEN	Homo sapiens (Human)	defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; ribosome biogenesis [GO:0042254]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]	DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]	GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006396; GO:0010468; GO:0010586; GO:0010628; GO:0014069; GO:0016075; GO:0017151; GO:0031053; GO:0031054; GO:0042254; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628	GPSIQQAEMGAAMDALEK	11.60999966	1	1	0.317191693	1845.831165	0	0	0	0	0	0	0	15.31164	0	0	0	0	0	17.16709	0	16.61399	0	0	0	20.00867	0	0	0	0	19.22111	0	0	0	0	0	0	0	19.5078	0	0	14.80641	19.03179	0	0	0	0	18.12073	0	0	18.20026	0	0	0
Q9NRR5	UBQL4_HUMAN	"Ubiquilin-4 (Ataxin-1 interacting ubiquitin-like protein, A1Up) (Ataxin-1 ubiquitin-like-interacting protein A1U) (Connexin43-interacting protein of 75 kDa, CIP75)"	UBQLN4 C1orf6 CIP75 UBIN	Homo sapiens (Human)	autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]	autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511]	identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005789; GO:0005829; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0031410; GO:0031593; GO:0032434; GO:0032991; GO:0036435; GO:0042802; GO:0048471; GO:0090734; GO:1901097; GO:2000042	NPEISHMLNNPELMR	28.03000069	0.483942926	0.483942926	0.108496721	1811.498868	16.37721	14.34163	0	0	13.65406	0	16.87291	0	0	13.35843	0	0	13.98772	12.60545	11.3564	0	0	0	17.78945	0	13.76747	0	0	0	16.3143	17.74454	14.47928	0	0	0	0	0	0	0	0	0	15.3532	0	0	0	0	0	0	0	0	0	0	0
Q9NRR6	INP5E_HUMAN	"Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase, EC 3.1.3.86)"	INPP5E	Homo sapiens (Human)	inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]	axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	"axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]"	"inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]"	GO:0000139; GO:0001726; GO:0004439; GO:0004445; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0005930; GO:0006661; GO:0014067; GO:0016314; GO:0017148; GO:0032580; GO:0034485; GO:0046855; GO:0046856; GO:1903565	SSAADVTTR	7.46999979	1	1	0.215409113	908.3203596	12.16585	0	0	0	0	15.01511	0	0	12.44804	0	15.01194	12.77996	0	14.54062	0	16.75435	0	0	16.39613	0	15.91891	0	14.16262	0	0	0	0	0	0	16.0437	13.8752	0	15.14285	0	15.43106	0	16.57832	0	0	0	15.1966	0	0	0	0	0	0	0
Q9NRS6	SNX15_HUMAN	Sorting nexin-15	SNX15	Homo sapiens (Human)	intracellular protein transport [GO:0006886]	cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]	phosphatidylinositol binding [GO:0035091]	GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0030659; GO:0035091; GO:0043231	HYTVSDPR	4.570000172	0.931629419	0.931629419	0.018283473	975.5699768	15.03562	14.68188	9.929601	0	14.47651	14.18641	15.47379	15.85955	0	16.22256	0	0	14.42362	0	0	0	0	0	0	0	0	0	13.96852	13.05191	0	0	0	0	0	0	0	15.28469	16.3442	0	0	0	0	16.83737	15.96749	0	0	0	0	15.17682	0	0	0	0
Q9NRW1	RAB6B_HUMAN	"Ras-related protein Rab-6B, EC 3.6.5.2"	RAB6B	Homo sapiens (Human)	"Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]	"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]	GO:0000139; GO:0003924; GO:0005525; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0007030; GO:0012505; GO:0031410; GO:0031489; GO:0042147; GO:0098793	AKELSVMFIETSAK	8.590000153	1	1	0.111986259	1568.420362	17.46401	0	16.85425	0	18.71844	0	14.57591	16.76671	0	0	17.49877	0	16.37867	17.00343	16.74556	0	17.22378	14.75904	0	0	0	0	20.0206	16.67074	0	16.82937	16.91614	0	14.84741	0	13.73768	0	17.44276	0	0	0	16.67695	0	0	0	17.92873	0	15.38975	13.3729	0	17.20093	16.21815	14.73477
Q9NRW4	DUS22_HUMAN	"Dual specificity protein phosphatase 22, EC 3.1.3.16, EC 3.1.3.48 (JNK-stimulatory phosphatase-1, JSP-1) (Low molecular weight dual specificity phosphatase 2, LMW-DSP2) (Mitogen-activated protein kinase phosphatase x, MAP kinase phosphatase x, MKP-x)"	DUSP22 JSP1 LMWDSP2 MKPX	Homo sapiens (Human)	cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903996]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; plasma membrane [GO:0005886]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903996]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; transforming growth factor beta receptor signaling pathway [GO:0007179]	non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]	GO:0000122; GO:0002710; GO:0004722; GO:0004725; GO:0004726; GO:0005737; GO:0005829; GO:0005886; GO:0007179; GO:0008138; GO:0030336; GO:0031941; GO:0035335; GO:0042127; GO:0046330; GO:0050860; GO:0050868; GO:0051895; GO:0061851; GO:0071364; GO:1903996; GO:1990782	DAEQLSKNK	6.110000134	1	1	1.15E-12	1028.836554	0	0	0	0	0	0	12.14701	0	0	0	16.20848	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.50341	0	0	0	0	14.30814	0	0	0	0	0	0	14.93215	0	0	0	0	0	0	0	0	0
Q9NRX1	PNO1_HUMAN	RNA-binding protein PNO1 (Partner of NOB1)	PNO1	Homo sapiens (Human)		cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0005829	GDHLSRAIGR	1.809999943	0.982273936	0.982273936	0.188238581	1078.367649	15.25206	14.61493	15.91367	13.66072	0	0	0	14.69368	0	11.10282	15.81782	0	15.67747	16.74971	13.28482	16.13453	15.51374	15.26567	0	0	0	17.29071	0	0	0	17.2294	0	17.20271	15.75837	0	15.44665	16.04837	0	0	16.84145	15.38423	0	0	0	0	0	0	15.14105	15.4902	0	14.55127	0	0
Q9NRX2	RM17_HUMAN	"39S ribosomal protein L17, mitochondrial, L17mt, MRP-L17 (LYST-interacting protein 2) (Mitochondrial large ribosomal subunit protein bL17m)"	MRPL17 LIP2	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]	protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0015934; GO:0019904; GO:0032543	AKMAVIEYK	2.809999943	1	1	0.646370738	1069.41604	0	0	0	0	0	0	0	0	0	0	18.30019	17.57544	0	0	0	0	0	0	17.52148	17.30674	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NRX3	NUA4L_HUMAN	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 (NADH-ubiquinone oxidoreductase MLRQ subunit homolog, NUOMS)"	NDUFA4L2	Homo sapiens (Human)		mitochondrial respiratory chain complex IV [GO:0005751]	mitochondrial respiratory chain complex IV [GO:0005751]		GO:0005751	AGASLGARFYR	4.380000114	1	1	0.076113264	1168.274223	15.0115	14.8747	15.68844	0	0	0	14.25105	0	15.67875	17.60916	15.75074	15.44155	12.41102	15.48069	14.12117	16.27623	0	16.66022	15.46802	15.81726	0	0	0	0	16.39528	0	0	0	15.53561	0	15.80035	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.3194	0
Q9NRY4	RHG35_HUMAN	"Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1, GRF-1) (Rho GAP p190A, p190-A)"	ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP	Homo sapiens (Human)	"axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; wound healing, spreading of cells [GO:0044319]"	actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; wound healing, spreading of cells [GO:0044319]"	DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]	GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007165; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0031668; GO:0032794; GO:0032956; GO:0035024; GO:0036064; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0044877; GO:0045724; GO:0050770; GO:0051056; GO:0097485	AQSNGSGNGSDSEMDTSSLER	4.960000038	1	1	1.83E-12	2128.118723	0	0	14.75396	0	17.07479	16.15744	12.96723	12.68856	0	13.30935	16.90168	14.92964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NRY5	F1142_HUMAN	Protein FAM114A2	FAM114A2 C5orf3	Homo sapiens (Human)			purine nucleotide binding [GO:0017076]	purine nucleotide binding [GO:0017076]	GO:0017076	GLMNR	1.070000052	1	1	0.250538943	606.1756144	15.78794	14.73436	0	0	0	0	0	16.45798	0	0	0	0	15.67093	16.00715	0	15.07814	0	13.88198	17.2245	16.88599	0	15.67833	0	0	0	0	15.87074	0	0	0	15.64051	15.91645	15.13533	0	14.71874	15.53414	17.07496	16.833	0	15.02934	16.75615	14.9867	16.3647	17.58776	16.83076	17.52925	15.50254	17.1239
Q9NRZ5	PLCD_HUMAN	"1-acyl-sn-glycerol-3-phosphate acyltransferase delta, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 4, 1-AGP acyltransferase 4, 1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta, LPAAT-delta)"	AGPAT4 UNQ499/PRO1016	Homo sapiens (Human)	CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]	GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006654; GO:0008654; GO:0012505; GO:0016021; GO:0016024; GO:0016746	MDLAGLLK	7.510000229	0.305666536	0.305666536	0.108562506	875.1021611	0	0	0	15.79236	0	0	16.16292	0	16.67213	0	14.43673	0	16.05675	0	13.71129	17.54548	0	14.45241	0	15.93541	13.48169	16.24617	12.93023	0	0	16.84634	13.07055	16.00943	12.11172	0	16.39678	0	0	15.08702	0	13.4318	16.96484	15.05642	16.54363	16.58331	0	0	0	0	0	15.37724	15.70901	15.83962
Q9NRZ9	HELLS_HUMAN	"Lymphoid-specific helicase, EC 3.6.4.- (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6)"	HELLS PASG SMARCA6 Nbla10143	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; kidney development [GO:0001822]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; kidney development [GO:0001822]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]"	ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]	GO:0000775; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006346; GO:0007049; GO:0010216; GO:0016787; GO:0031508; GO:0046651; GO:0051301; GO:0140658; GO:1990830; GO:2001243	FLLTKMEQQQLEEQK	1.769999981	1	1	9.20E-13	1893.322877	0	14.8056	13.89563	0	0	15.14548	15.31983	0	16.02099	15.77094	0	0	14.64569	0	14.176	12.12633	15.30569	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NS00	C1GLT_HUMAN	"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, EC 2.4.1.122 (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1, Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1, C1GalT1, Core 1 beta3-Gal-T1)"	C1GALT1	Homo sapiens (Human)	"angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]"	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]"	glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]	GO:0000139; GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872; GO:0060576	CNKVLFMSSEENK	8.649999619	1	1	0.058256071	1601.14782	0	0	16.1368	15.62936	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NS15	LTBP3_HUMAN	"Latent-transforming growth factor beta-binding protein 3, LTBP-3"	LTBP3	Homo sapiens (Human)	bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179]	calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]	GO:0005509; GO:0005576; GO:0007179; GO:0030502; GO:0032331; GO:0036363; GO:0045780; GO:0046849; GO:0048251; GO:0050431; GO:0060349; GO:0060430; GO:0062023; GO:0070062; GO:1902462; GO:2000741	CVNLPGSYR	2.640000105	1	1	0.279616427	1066.561731	0	0	17.19191	0	16.88273	0	0	0	0	16.35667	17.49731	0	16.88595	17.10816	0	0	14.46504	0	0	15.98596	0	0	0	0	0	16.80244	0	0	0	0	18.81183	0	18.89325	17.64126	0	0	0	18.27299	17.00825	0	0	0	0	0	0	0	0	0
Q9NS37	ZHANG_HUMAN	"CREB/ATF bZIP transcription factor (Host cell factor-binding transcription factor Zhangfei, HCF-binding transcription factor Zhangfei)"	CREBZF ZF	Homo sapiens (Human)	"ATF6-mediated unfolded protein response [GO:0036500]; integrated stress response signaling [GO:0140467]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]"	chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]; ATF6-mediated unfolded protein response [GO:0036500]; integrated stress response signaling [GO:0140467]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0009615; GO:0036500; GO:0042802; GO:0045814; GO:0045892; GO:0045944; GO:0051090; GO:0090575; GO:0140467	AVLANETGLARLLSR	12.47000027	1	1	0.299638226	1581.227941	0	16.51334	15.62675	16.12809	0	0	0	17.06399	0	0	0	0	0	16.71142	0	15.63313	0	0	0	0	0	0	0	15.65898	0	0	0	16.05863	0	0	0	15.12078	16.76438	15.57583	0	0	16.29151	0	0	0	0	0	0	0	0	0	0	0
Q9NS40	KCNH7_HUMAN	"Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3, ERG-3, Eag-related protein 3, Ether-a-go-go-related protein 3, hERG-3) (Voltage-gated potassium channel subunit Kv11.3)"	KCNH7 ERG3	Homo sapiens (Human)	circadian rhythm [GO:0007623]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; circadian rhythm [GO:0007623]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	inward rectifier potassium channel activity [GO:0005242]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]	GO:0005242; GO:0005249; GO:0005886; GO:0005887; GO:0007623; GO:0034765; GO:0042391; GO:0044877; GO:0071805; GO:0086011	ESCSPSEADDTK	11.96000004	1	1	0.021824413	1326.336504	11.00633	14.43952	0	0	0	0	0	0	13.77656	0	0	0	0	0	0	0	12.32027	0	14.22335	15.01425	14.27682	15.59473	0	11.77014	15.34256	0	12.87546	0	0	0	0	0	0	0	0	16.19397	0	12.81655	0	0	0	0	0	0	0	0	0	0
Q9NS56	TOPRS_HUMAN	"E3 ubiquitin-protein ligase Topors, EC 2.3.2.27 (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3, p53-binding protein 3, p53BP3)"	TOPORS LUN TP53BPL	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]"	centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]	"centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]"	antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005654; GO:0005814; GO:0006351; GO:0006511; GO:0006513; GO:0006974; GO:0008630; GO:0010842; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0030496; GO:0032391; GO:0034504; GO:0035845; GO:0036064; GO:0042127; GO:0042771; GO:0043066; GO:0043161; GO:0044547; GO:0045893; GO:0046548; GO:0046549; GO:0046872; GO:0051443; GO:0051457; GO:0061630; GO:0070936	DCDMS	22.14999962	0.557988763	0.557988763	0.116842493	627.6446642	14.69895	11.28121	17.43236	0	0	0	0	0	14.80879	8.375754	16.68566	14.58976	10.66175	0	15.00035	15.71733	17.62658	15.50859	0	0	0	14.18324	11.87898	17.53711	15.70381	17.57048	15.50489	0	0	14.57525	16.88239	16.45466	15.94924	15.64426	17.78364	0	16.53686	15.80532	15.80937	15.22637	0	12.42532	14.06241	0	14.66694	16.86999	14.36171	17.0369
Q9NS62	THSD1_HUMAN	Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module)	THSD1 TMTSP UNQ3010/PRO9769	Homo sapiens (Human)	focal adhesion assembly [GO:0048041]	cell periphery [GO:0071944]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]	cell periphery [GO:0071944]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; extracellular matrix binding [GO:0050840]; focal adhesion assembly [GO:0048041]	extracellular matrix binding [GO:0050840]	GO:0005576; GO:0005768; GO:0005829; GO:0005925; GO:0010008; GO:0016021; GO:0048041; GO:0050840; GO:0071944	GPSPSHKSVSR	5.489999771	0.606721163	0.606721163	0.257097671	1138.126865	14.79092	0	13.39311	15.09752	14.4206	14.41164	0	0	0	0	0	13.58374	14.71757	0	0	0	0	16.47614	12.74061	15.95464	14.36011	15.41649	0	0	0	0	15.45388	14.83885	15.23916	13.69553	0	15.96241	13.52106	16.07865	14.96688	0	13.68524	15.79474	15.27856	15.45819	14.7209	0.2015113	15.78156	14.85793	15.73481	14.85742	15.62244	14.3207
Q9NS64	RPRM_HUMAN	Protein reprimo	RPRM	Homo sapiens (Human)	regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]		GO:0005737; GO:0007346; GO:0016021; GO:0051726	SEGMINFLVK	5.460000038	1	1	0.008369389	1152.148689	0	0	14.15397	15.3913	11.11469	13.7604	12.17995	0	0	0	16.28027	15.45365	0	14.29233	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.3152	0	0	0	0	13.43453	0	0	0	0	0	0	0	12.49788	12.40757	13.81499	0	0	0
Q9NS66	GP173_HUMAN	Probable G-protein coupled receptor 173 (Super conserved receptor expressed in brain 3)	GPR173 SREB3	Homo sapiens (Human)	negative regulation of neuron migration [GO:2001223]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; negative regulation of neuron migration [GO:2001223]; signal transduction [GO:0007165]	G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]	GO:0004930; GO:0004968; GO:0005886; GO:0007165; GO:0016021; GO:2001223	YMAIAHHRFYAK	2.140000105	1	1	0.473292852	1522.746674	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.58931	16.86068	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.96166	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NS75	CLTR2_HUMAN	"Cysteinyl leukotriene receptor 2, CysLTR2 (G-protein coupled receptor GPCR21, hGPCR21) (G-protein coupled receptor HG57) (HPN321)"	CYSLTR2 CYSLT2 CYSLT2R PSEC0146	Homo sapiens (Human)	cellular response to glucagon stimulus [GO:0071377]; immune response [GO:0006955]; neuropeptide signaling pathway [GO:0007218]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; guanyl-nucleotide exchange factor activity [GO:0005085]; leukotriene receptor activity [GO:0004974]; cellular response to glucagon stimulus [GO:0071377]; immune response [GO:0006955]; neuropeptide signaling pathway [GO:0007218]	cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; guanyl-nucleotide exchange factor activity [GO:0005085]; leukotriene receptor activity [GO:0004974]	GO:0001631; GO:0004974; GO:0005085; GO:0005886; GO:0005887; GO:0006955; GO:0007218; GO:0008528; GO:0071377	GHPQKAK	1.24000001	0.477744579	0.477744579	0.075901278	764.4578404	17.67916	0	11.33954	0	0	0	0	0	0	14.73757	16.44211	16.1898	0	15.21792	13.58456	0	15.86098	0	0	15.54336	0	15.93566	15.22009	17.75864	14.32995	13.79888	0	0	0	15.21897	16.72915	16.72078	15.69523	0	16.2271	0	0	16.47584	17.22851	0	13.56361	0	0	0	0	0	0	15.67375
Q9NS87	KIF15_HUMAN	"Kinesin-like protein KIF15 (Kinesin-like protein 2, hKLP2) (Kinesin-like protein 7) (Serologically defined breast cancer antigen NY-BR-62)"	KIF15 KLP2 KNSL7	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; regulation of mitotic spindle assembly [GO:1901673]	centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]	centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; regulation of mitotic spindle assembly [GO:1901673]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0000278; GO:0003774; GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0007018; GO:0008017; GO:0016020; GO:0016887; GO:1901673	NAEILRMK	6.010000229	0.448309243	0.448309243	0.29891453	991.3746312	17.87475	0	0	0	0	0	0	0	0	0	0	0	16.12763	0	17.25407	0	16.15104	0	16.95474	0	0	0	0	0	0	17.53124	0	0	0	0	17.8958	0	0	0	0	0	19.94599	0	0	18.11076	0	0	17.38287	0	0	0	16.9574	19.60031
Q9NS91	RAD18_HUMAN	"E3 ubiquitin-protein ligase RAD18, EC 2.3.2.27 (Postreplication repair protein RAD18, hHR18, hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18)"	RAD18 RNF73	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell death [GO:0060548]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell death [GO:0060548]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]	damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]	GO:0000403; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042802; GO:0044877; GO:0046872; GO:0051865; GO:0051984; GO:0060548; GO:0061630; GO:0097505	AAESAEIEPR	4.550000191	1	1	9.19E-13	1069.600854	13.17956	0	0	12.56937	14.8916	0	0	0	0	0	9.763923	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.57718	0	0	0	0	17.0628	0	11.60222	0	0	0
Q9NSA0	S22AB_HUMAN	Solute carrier family 22 member 11 (Organic anion transporter 4)	SLC22A11 OAT4	Homo sapiens (Human)	organic anion transport [GO:0015711]; urate metabolic process [GO:0046415]	apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; organic anion transport [GO:0015711]; urate metabolic process [GO:0046415]	inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005452; GO:0005886; GO:0005887; GO:0008514; GO:0009897; GO:0015347; GO:0015711; GO:0016324; GO:0046415; GO:0070062	NLTIEVLMSSVK	3.710000038	1	1	0	1348.134905	0	15.31756	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NSA2	KCND1_HUMAN	Potassium voltage-gated channel subfamily D member 1 (Voltage-gated potassium channel subunit Kv4.1)	KCND1	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]	dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]	A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005250; GO:0005886; GO:0008076; GO:0014069; GO:0016021; GO:0034765; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805	DPDMFR	7.659999847	0.311023623	0.311023623	0.245142219	781.0398867	0	0	0	0	0	0	0	0	15.15547	0	0	0	0	0	0	0	0	0	0	0	0	0	16.8012	0	15.17771	13.92748	14.61683	15.49244	13.97453	0	0	0	14.33344	16.08269	15.75151	15.66942	15.50521	0	15.96823	0	0	16.5122	16.08168	15.80682	16.63046	15.83486	16.72988	16.83565
Q9NSB4	KRT82_HUMAN	"Keratin, type II cuticular Hb2 (Keratin-82, K82) (Type II hair keratin Hb2) (Type-II keratin Kb22)"	KRT82 KRTHB2	Homo sapiens (Human)		cytosol [GO:0005829]; keratin filament [GO:0045095]	cytosol [GO:0005829]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]	structural constituent of skin epidermis [GO:0030280]	GO:0005829; GO:0030280; GO:0045095	CGGTLPGFGYR	3.99000001	0.908463418	0.908463418	0.349148476	1185.026011	13.17828	0	0	0	0	0	0	0	0	0	0	0	7.756369	0	14.8874	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.9474	0	0	0	0	0	0	0	0	0	0
Q9NSB8	HOME2_HUMAN	"Homer protein homolog 2, Homer-2 (Cupidin)"	HOMER2	Homo sapiens (Human)	behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; synaptic receptor adaptor activity [GO:0030160]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605]	actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; synaptic receptor adaptor activity [GO:0030160]	GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035256; GO:0035584; GO:0043229; GO:0045177; GO:0048148; GO:0048875; GO:0070885; GO:0098978; GO:2001256	IISVDGAK	8.619999886	1	1	0.316864005	801.7803626	13.91539	13.66681	0	14.83423	0	0	0	0	11.73112	0	0	0	12.84963	0	0	0	0	0	0	15.86885	0	0	0	11.94425	17.08817	13.45405	14.59631	0	0	14.26821	0	0	15.23199	15.75792	0	0	0	15.74161	0	0	0	13.68443	15.80545	0	15.01394	0	13.37168	0
Q9NSC2	SALL1_HUMAN	"Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1, HSal1, Sal-1)"	SALL1 SAL1 ZNF794	Homo sapiens (Human)	"adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]"	chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]"	"beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000792; GO:0000978; GO:0000981; GO:0001227; GO:0001657; GO:0001658; GO:0001822; GO:0003281; GO:0003337; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007507; GO:0008013; GO:0008406; GO:0010369; GO:0021553; GO:0021889; GO:0021983; GO:0030177; GO:0030325; GO:0031129; GO:0042733; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048566; GO:0060173; GO:0061034; GO:0072073; GO:0072092	AFTTKGNLK	13	0.831935763	0.831935763	0.135128366	977.6086172	15.46339	15.18764	13.42605	0	0	0	15.58001	0	0	14.54189	15.41138	15.32644	14.92802	14.20282	15.06177	0	0	0	0	0	0	14.7905	0	15.33816	15.24063	16.79006	15.2622	15.34445	16.08706	13.49014	14.59262	0	14.46757	0	15.56109	16.1647	13.94586	16.22472	15.47421	0	13.58371	15.78586	15.04189	15.70044	0	11.18183	0	0
Q9NSC7	SIA7A_HUMAN	"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, EC 2.4.99.3 (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I, ST6GalNAcI) (Sialyltransferase 7A, SIAT7-A)"	ST6GALNAC1 SIAT7A UNQ543/PRO848	Homo sapiens (Human)	oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]"	"alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]"	GO:0000139; GO:0001665; GO:0006486; GO:0008373; GO:0009312; GO:0016021	MLAPTGAVSTR	4.989999771	1	1	0.329288186	1103.020969	16.84158	15.7308	13.90679	0	0	14.6359	15.53208	0	15.05094	0	0	15.26178	0	0	0	0	0	0	0	16.33115	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.68699	16.14816	16.81404	0	0	0	0	0	0
Q9NSD7	RL3R1_HUMAN	"Relaxin-3 receptor 1, RLN3 receptor 1 (G protein-coupled receptor SALPR) (G-protein coupled receptor GPCR135) (Relaxin family peptide receptor 3) (Somatostatin- and angiotensin-like peptide receptor)"	RXFP3 GPCR135 RLN3R1 SALPR	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]	G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0008528; GO:0032467	AMCKIVSMVTSMNMYASVFFLTAMSVTR	2.809999943	0.946467996	0.946467996	0.196784047	3239.617295	0	16.78696	0	0	0	15.45532	14.89849	15.00292	0	0	0	13.41299	15.21089	9.545285	0	0	0	0	0	13.60156	14.00185	0	0	0	0	0	0	16.10488	0	0	0	0	0	0	0	0	0	14.93767	0	0	0	0	0	12.94443	12.48631	0	0	0
Q9NSD9	SYFB_HUMAN	"Phenylalanine--tRNA ligase beta subunit, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase beta subunit, PheRS)"	FARSB FARSLB FRSB HSPC173	Homo sapiens (Human)	phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006412; GO:0006432; GO:0009328; GO:0016020; GO:0051290	NPGFEIIHGLLDRIMQLLDVPPGEDK	12.22999954	1	1	1.84E-12	2932.306464	14.1434	0	0	13.31883	0	0	12.43422	11.35337	0	15.26379	13.47365	12.6012	0	13.80598	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NSE4	SYIM_HUMAN	"Isoleucine--tRNA ligase, mitochondrial, EC 6.1.1.5 (Isoleucyl-tRNA synthetase, IleRS)"	IARS2	Homo sapiens (Human)	isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006428; GO:0032543	ARSFAK	9.909999847	0.469910502	0.469910502	0.198076403	677.2445617	0	0	13.58954	0	0	14.07882	0	16.49541	0	0	0	0	0	16.01089	0	0	0	0	0	0	0	0	16.35921	0	0	0	17.58522	16.61685	0	0	18.00388	11.85546	13.95448	16.44178	18.46707	16.67911	0	0	18.68512	15.15845	0	17.55589	16.4609	0	15.8815	0	0	15.15063
Q9NSI6	BRWD1_HUMAN	Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9)	BRWD1 C21orf107 WDR9	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]		GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007010; GO:0008360	ELSSGNESSSSVR	2.819999933	1	1	0.020063244	1338.544813	0	0	0	0	0	0	10.48819	0	0	14.72497	0	0	14.94863	0	0	0	0	0	0	0	0	0	0	0	15.6413	15.42839	0	0	0	0	0	15.03906	0	0	0	0	0	10.54373	0	0	0	0	0	0	0	16.12624	0	0
Q9NSI8	SAMN1_HUMAN	"SAM domain-containing protein SAMSN-1 (Hematopoietic adaptor containing SH3 and SAM domains 1) (Nash1) (SAM domain, SH3 domain and nuclear localization signals protein 1) (SH3-SAM adaptor protein)"	SAMSN1 HACS1	Homo sapiens (Human)	negative regulation of adaptive immune response [GO:0002820]; negative regulation of B cell activation [GO:0050869]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ruffle [GO:0001726]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ruffle [GO:0001726]; phosphotyrosine residue binding [GO:0001784]; RNA binding [GO:0003723]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of B cell activation [GO:0050869]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]	phosphotyrosine residue binding [GO:0001784]; RNA binding [GO:0003723]	GO:0001726; GO:0001784; GO:0002820; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0050732; GO:0050869	GDIIDIICKTPMGMWTGMLNNK	5.21999979	0.895820737	0.895820737	0.092560268	2559.281319	0	13.02889	14.35634	14.41385	0	0	0	0	16.043	0	0	13.37792	0	0	15.82764	0	0	0	15.17493	0	0	0	0	0	0	0	0	0	0	12.70837	13.89128	0	0	15.44123	0	15.62537	15.5179	0	0	13.65575	0	0	0	16.04478	0	15.77641	0	0
Q9NSJ1	Z355P_HUMAN	Putative zinc finger protein 355P (Zinc finger protein ZnFP01)	ZNF355P ZNF834 PRED65	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	DCGKIFK	7.329999924	1	1	0.161261317	866.4045356	18.88686	14.23134	0	17.76211	0	15.64667	0	17.08147	15.86269	0	17.73649	16.59731	17.16186	0	15.88096	0	16.89148	0	17.38538	16.56761	13.84449	0	16.97186	0	0	0	16.66004	0	14.04128	0	12.66541	17.66936	14.63466	17.64877	17.30572	18.16193	18.38706	0	14.49565	13.60069	0	15.48792	16.44689	17.02921	12.65096	16.7413	0	17.54783
Q9NSK0	KLC4_HUMAN	"Kinesin light chain 4, KLC 4 (Kinesin-like protein 8)"	KLC4 KNSL8	Homo sapiens (Human)		cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]		GO:0005737; GO:0005871; GO:0005874	RSSELLVR	2.849999905	1	1	0.250596728	958.9177755	15.97937	15.54892	15.32644	11.13847	0	14.17516	13.02507	13.64291	9.95682	15.82761	13.9024	15.51395	0	13.97844	15.6478	14.07439	12.89888	14.28142	0	13.60144	6.897024	0	10.98684	13.60278	0	0	14.33337	15.26249	15.39569	16.57829	16.04835	13.27426	0	12.30712	13.96523	13.6223	14.94838	0	16.40445	15.34017	0	0	7.87948	12.9666	14.97948	0	0	0
Q9NSN8	SNTG1_HUMAN	"Gamma-1-syntrophin, G1SYN (Syntrophin-4, SYN4)"	SNTG1	Homo sapiens (Human)	cell communication [GO:0007154]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; syntrophin complex [GO:0016013]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]; cell communication [GO:0007154]	actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005634; GO:0005737; GO:0005856; GO:0007154; GO:0008022; GO:0016010; GO:0016013; GO:0032587	NAGEEVTLTVSFLKR	6.179999828	1	1	0.040504595	1663.256605	0	0	15.13662	0	0	0	0	0	0	0	0	13.45108	0	15.02938	0	13.30036	0	0	14.87888	0	0	0	0	0	15.76614	0	13.68989	0	0	0	17.61677	0	0	0	0	0	0	16.33672	0	0	0	0	15.32924	0	0	0	0	0
Q9NSU2	TREX1_HUMAN	"Three-prime repair exonuclease 1, EC 3.1.11.2 (3'-5' exonuclease TREX1) (Deoxyribonuclease III, DNase III)"	TREX1	Homo sapiens (Human)	"activation of immune response [GO:0002253]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to reactive oxygen species [GO:0034614]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response in brain or nervous system [GO:0002383]; inflammatory response to antigenic stimulus [GO:0002437]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear replication fork [GO:0043596]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear replication fork [GO:0043596]; oligosaccharyltransferase complex [GO:0008250]; protein-DNA complex [GO:0032993]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; metal ion binding [GO:0046872]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]; activation of immune response [GO:0002253]; apoptotic cell clearance [GO:0043277]; atrial cardiac muscle tissue development [GO:0003228]; blood vessel development [GO:0001568]; CD86 biosynthetic process [GO:0035781]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to interferon-beta [GO:0035458]; cellular response to reactive oxygen species [GO:0034614]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; establishment of protein localization [GO:0045184]; generation of precursor metabolites and energy [GO:0006091]; heart morphogenesis [GO:0003007]; heart process [GO:0003015]; immune complex formation [GO:0097281]; immune response in brain or nervous system [GO:0002383]; inflammatory response to antigenic stimulus [GO:0002437]; kidney development [GO:0001822]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage activation involved in immune response [GO:0002281]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein stabilization [GO:0050821]; regulation of catalytic activity [GO:0050790]; regulation of cellular respiration [GO:0043457]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110]; regulation of immunoglobulin production [GO:0002637]; regulation of inflammatory response [GO:0050727]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lysosome organization [GO:1905671]; regulation of protein complex stability [GO:0061635]; regulation of T cell activation [GO:0050863]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type I interferon production [GO:0032479]; T cell antigen processing and presentation [GO:0002457]; transposition, RNA-mediated [GO:0032197]; type I interferon signaling pathway [GO:0060337]"	"3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; adenyl deoxyribonucleotide binding [GO:0032558]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; exodeoxyribonuclease III activity [GO:0008853]; magnesium ion binding [GO:0000287]; metal ion binding [GO:0046872]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]"	GO:0000287; GO:0000738; GO:0001568; GO:0001822; GO:0002253; GO:0002281; GO:0002320; GO:0002383; GO:0002437; GO:0002457; GO:0002637; GO:0003007; GO:0003015; GO:0003228; GO:0003690; GO:0003697; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0006091; GO:0006110; GO:0006259; GO:0006260; GO:0006281; GO:0006298; GO:0006304; GO:0006310; GO:0008250; GO:0008296; GO:0008301; GO:0008340; GO:0008408; GO:0008853; GO:0019217; GO:0031571; GO:0032197; GO:0032405; GO:0032407; GO:0032479; GO:0032508; GO:0032558; GO:0032680; GO:0032993; GO:0034614; GO:0035458; GO:0035781; GO:0042803; GO:0043277; GO:0043457; GO:0043596; GO:0045184; GO:0045824; GO:0046872; GO:0046890; GO:0050699; GO:0050727; GO:0050790; GO:0050821; GO:0050863; GO:0051607; GO:0060337; GO:0060339; GO:0061635; GO:0071480; GO:0072711; GO:0097281; GO:1904161; GO:1905671	NTSPSLGESR	1.24000001	1	1	0.243349187	1048.253794	0	0	14.94815	14.94575	14.94474	14.05409	15.04137	15.02798	0	0	15.9247	0	14.36222	0	0	0	14.44682	16.60538	0	14.5243	15.03393	14.22336	16.64681	0	0	16.27207	0	0	14.07587	14.00369	16.73361	0	0	0	0	0	15.45175	0	15.96432	0	15.21127	0	14.60697	14.90901	0	0	0	15.07661
Q9NT62	ATG3_HUMAN	"Ubiquitin-like-conjugating enzyme ATG3, EC 2.3.2.- (Autophagy-related protein 3, APG3-like, hApg3) (Protein PC3-96)"	ATG3 APG3 APG3L	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular protein modification process [GO:0006464]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]	cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular protein modification process [GO:0006464]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017]	Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787]	GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0006464; GO:0006612; GO:0016567; GO:0019776; GO:0019777; GO:0019787; GO:0019899; GO:0043653; GO:0044804; GO:0050765; GO:1902017	IVEACK	6.03000021	0.563812077	0.563812077	0.229932894	721.0937904	0	14.76621	16.16847	0	0	0	17.02917	0	0	0	0	0	0	0	0	0	16.65565	15.03667	16.73297	0	0	0	0	0	0	14.42651	0	0	17.4027	0	0	0	17.12348	16.19753	17.02244	0	17.99268	16.51388	0	0	0	16.83453	0	16.93349	16.32789	15.40772	0	16.78824
Q9NT99	LRC4B_HUMAN	"Leucine-rich repeat-containing protein 4B (Netrin-G3 ligand, NGL-3)"	LRRC4B LRIG4	Homo sapiens (Human)	positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]	cerebellar mossy fiber [GO:0044300]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	cerebellar mossy fiber [GO:0044300]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; signaling receptor binding [GO:0005102]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005886; GO:0042734; GO:0044300; GO:0051965; GO:0098978; GO:0099061; GO:0099151; GO:0099560; GO:1905606	CRTGTSMTSVNWLTPNGTLMTHGSYR	9.670000076	1	1	2.75E-12	2944.386287	16.17621	0	15.24603	15.51092	16.2732	0	15.05949	14.52906	0	0	0	0	0	15.31817	0	0	0	0	0	0	0	14.51183	0	0	0	0	0	0	0	14.99362	0	12.64116	0	0	14.38252	0	0	10.62949	0	13.35117	10.06491	0	0	0	0	0	0	0
Q9NTG1	PKDRE_HUMAN	Polycystic kidney disease and receptor for egg jelly-related protein (PKD and REJ homolog)	PKDREJ	Homo sapiens (Human)	acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982]	calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]	GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0016021; GO:0050982	MRPGPALLLLGVGLSLSVGR	6.929999828	1	1	0.161320173	2023.056954	14.6311	17.07281	0	0	10.95965	14.19184	13.81717	0	14.19749	0	0	0	0	0	0	15.6138	0	9.942275	0	0	0	0	15.50992	0	0	15.11238	15.03093	13.74378	0	0	0	0	0	0	0	16.13745	0	0	14.74377	0	0	0	0	0	15.44484	0	0	0
Q9NTG7	SIR3_HUMAN	"NAD-dependent protein deacetylase sirtuin-3, mitochondrial, hSIRT3, EC 2.3.1.286 (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3)"	SIRT3 SIR2L3	Homo sapiens (Human)	aerobic respiration [GO:0009060]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003950; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006471; GO:0006476; GO:0008270; GO:0009060; GO:0017136; GO:0032991; GO:0034979; GO:0034983; GO:0043565; GO:0070403; GO:1901671; GO:1902553; GO:2000304	VSGIPASK	10.72000027	0.315258443	0.315258443	0.265123623	759.0925478	16.03393	15.77368	0	10.00897	15.30466	15.80278	16.62234	0	16.1721	15.72205	0	14.11841	16.88664	15.64587	0	0	17.18892	16.36377	15.74357	16.71419	0	0	0	17.29881	16.21416	17.95823	16.06381	16.3192	15.63978	0	0	0	0	16.74776	0	17.37332	0	16.9988	16.65487	15.92919	17.36591	0	16.33383	0	0	0	0	0
Q9NTI5	PDS5B_HUMAN	Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3)	PDS5B APRIN AS3 KIAA0979	Homo sapiens (Human)	cell division [GO:0051301]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127]	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127]"	DNA binding [GO:0003677]	GO:0000775; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0007064; GO:0008283; GO:0008285; GO:0042127; GO:0051301	EAMMGLAQIYK	6.300000191	1	1	0.199914672	1253.498168	15.85244	0	13.48312	13.8115	0	14.8408	13.20621	14.8141	13.11551	15.22171	0	16.23467	0	15.84487	0	0	14.76656	0	0	0	0	14.74265	0	0	0	0	15.0645	16.61365	0	0	16.23683	0	15.6958	0	13.86584	0	0	0	12.03617	16.13916	16.01431	0	0	0	0	0	0	0
Q9NTJ5	SAC1_HUMAN	"Phosphatidylinositol-3-phosphatase SAC1, EC 3.1.3.64 (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein)"	SACM1L KIAA0851 SAC1	Homo sapiens (Human)	phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]	phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]	GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0006661; GO:0016021; GO:0016791; GO:0034596; GO:0043812; GO:0046856; GO:0140268	THLGLIMDGWNSMIR	6.869999886	1	1	1.60E-12	1759.516415	0	0	0	0	10.90954	0	0	0	0	0	0	0	0	15.7075	0	15.37643	15.84529	0	16.48946	16.0353	16.22424	16.89964	15.75931	16.06632	0	14.8405	0	0	15.70324	16.4467	0	0	12.3578	17.04918	14.17922	12.15471	0	0	0	0	0	0	0	0	0	0	0	0
Q9NTN3	S35D1_HUMAN	"UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, UDP-GlcA/UDP-GalNAc transporter (Solute carrier family 35 member D1) (UDP-galactose transporter-related protein 7, UGTrel7)"	SLC35D1 KIAA0260 UGTREL7	Homo sapiens (Human)	carbohydrate transport [GO:0008643]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]	antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]	GO:0005461; GO:0005462; GO:0005463; GO:0005789; GO:0005794; GO:0008643; GO:0015297; GO:0016021	LLAAGFYGVSSFLIVVVNK	3.119999886	1	1	0.726705642	1995.581583	0	0	0	0	0	0	0	17.60942	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NTZ6	RBM12_HUMAN	"RNA-binding protein 12 (RNA-binding motif protein 12) (SH3/WW domain anchor protein in the nucleus, SWAN)"	RBM12 KIAA0765 HRIHFB2091	Homo sapiens (Human)	regulation of RNA splicing [GO:0043484]	nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; regulation of RNA splicing [GO:0043484]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0043484; GO:1990904	NNGNGLVK	16.17000008	1	1	0.277854749	812.0314617	17.16244	16.37928	14.87354	15.53079	0	13.89567	15.50007	0	14.80711	0	15.42966	0	16.65693	15.82967	15.61457	0	0	16.57343	0	15.45323	0	0	0	0	0	0	16.3185	14.89054	15.99128	16.62282	17.81029	16.76402	16.72161	16.08823	14.54039	15.5231	15.63206	13.33401	15.39321	16.22991	16.76261	16.4925	17.3943	0	17.31231	16.18081	12.38263	15.5048
Q9NU02	ANKE1_HUMAN	Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5)	ANKEF1 ANKRD5	Homo sapiens (Human)			calcium ion binding [GO:0005509]	calcium ion binding [GO:0005509]	GO:0005509	GKTPPILK	9.300000191	0.036701348	0.036701348	0.239938011	853.5010655	17.57523	12.76454	13.29642	14.91733	14.68626	15.83161	0	0	0	0	0	15.97503	0	0	0	16.76964	15.98735	0	15.06202	0	0	15.4541	16.2517	0	0	0	0	0	15.60868	0	0	15.16453	17.33807	0	0	0	0	0	0	0	0	0	19.17965	0	0	0	0	0
Q9NU22	MDN1_HUMAN	Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein)	MDN1 KIAA0301	Homo sapiens (Human)	ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0016020; GO:0016887; GO:0030687; GO:0045111	AEFAK	9.260000229	1	1	0.2398098	562.0692249	16.79114	18.83076	0	0	16.9409	0	0	17.75825	17.58134	0	16.31112	0	0	0	0	0	16.7977	0	0	16.84436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.13116	0	0	0	17.61972	0	0	0	0	0	0
Q9NU53	GINM1_HUMAN	Glycoprotein integral membrane protein 1	GINM1 C6orf72 UNQ710/PRO1361	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	MEGAPPGSLALR	3.349999905	1	1	0.270710686	1213.787764	7.897054	12.07675	15.75149	14.45565	14.37351	13.88018	0	9.328765	0	0	16.46012	0	15.37294	12.33416	0	0	0	0	0	0	16.27834	0	0	0	15.66545	14.96767	15.61984	14.14736	0	0	16.24042	0	0	0	0	0	15.90812	0	0	0	0	0	16.5075	16.70987	0	17.12642	0	0
Q9NUB1	ACS2L_HUMAN	"Acetyl-coenzyme A synthetase 2-like, mitochondrial, EC 6.2.1.1 (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2, AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase, EC 6.2.1.17)"	ACSS1 ACAS2L KIAA1846	Homo sapiens (Human)	acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542]	acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]	GO:0003987; GO:0005524; GO:0005759; GO:0006069; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218	YDRSSLR	1.049999952	1	1	0.157802989	898.1322965	0	0	0	0	0	14.21585	0	0	0	0	0	11.15787	15.32216	0	0	0	0	0	0	16.00613	0	0	0	0	0	14.51645	16.21016	15.19414	14.25306	14.46764	0	15.05974	16.42565	0	0	12.83489	0	0	0	0	16.15031	14.72402	15.7534	0	15.93892	0	0	13.59573
Q9NUB4	CT141_HUMAN	Uncharacterized protein C20orf141	C20orf141	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	EDPIPVPPR	20.31999969	1	1	1.03E-12	1015.433307	0	0	14.35519	0	15.6599	14.73361	0	0	15.31648	0	0	0	0	0	0	14.79191	0	13.71023	15.32275	0	0	15.27095	0	0	0	0	0	14.24337	0	0	0	0	15.28739	13.96228	12.21009	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NUD5	ZCHC3_HUMAN	Zinc finger CCHC domain-containing protein 3	ZCCHC3 C20orf99	Homo sapiens (Human)	activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]	double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0002218; GO:0003690; GO:0003723; GO:0005737; GO:0008270; GO:0009597; GO:0032481; GO:0045087; GO:0051607; GO:0071360; GO:1900246	TCFKCGSR	5.130000114	0.88512063	0.88512063	0.146822563	1014.875234	15.46722	0	0	0	0	0	13.78287	13.20283	0	0	0	0	0	0	0	0	14.72012	15.66455	0	0	13.26049	0	0	18.02279	0	0	14.22869	16.2571	13.52845	16.3304	16.46308	13.76398	0	14.73331	10.34484	15.7589	0	0	0	0	0	0	0	0	0	0	14.34192	0
Q9NUD7	CT096_HUMAN	Uncharacterized protein C20orf96	C20orf96	Homo sapiens (Human)						KVLESLSDK	11.61999989	0.462036759	0.462036759	0.293103909	1023.52966	15.76827	15.92924	0	0	0	0	0	0	15.39528	0	0	0	14.58074	12.65809	11.59764	15.76548	12.23518	15.9325	0	0	14.68658	0	14.39486	16.4555	13.77922	14.10658	15.56765	0	14.32616	14.77691	15.92439	15.40806	0	14.81972	15.88076	14.8611	0	10.85561	0	15.63238	14.65218	15.22011	0	0	0	10.89303	11.14974	0
Q9NUE0	ZDH18_HUMAN	"Palmitoyltransferase ZDHHC18, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 18, DHHC-18) (Zinc finger DHHC domain-containing protein 18)"	ZDHHC18	Homo sapiens (Human)	peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706	AKPDASMVGGHP	6.820000172	1	1	0.015501987	1165.727842	0	15.86527	0	0	0	15.81116	0	0	0	0	0	0	16.35606	0	0	14.0072	0	0	16.18892	17.40402	0	0	0	0	0	16.47444	16.74209	14.98289	15.62132	15.90235	15.72946	0	14.89759	0	15.57809	16.60421	16.87073	0	0	15.17198	15.14229	15.60155	0	0	0	0	0	14.7666
Q9NUG4	CCM2L_HUMAN	"Cerebral cavernous malformations 2 protein-like, CCM2-like"	CCM2L C20orf160	Homo sapiens (Human)	heart morphogenesis [GO:0003007]		heart morphogenesis [GO:0003007]		GO:0003007	DNEELILR	4.400000095	1	1	9.14E-13	1001.50434	13.86243	14.89229	0	0	13.69777	14.66937	12.48925	0	0	0	12.59823	11.73012	12.42146	0	0	13.58893	14.41792	13.55682	13.00185	0	0	13.08772	16.24797	0	13.80514	12.55434	0	15.09111	13.92063	12.71724	16.38156	0	0	0	0	0	16.43887	0	0	15.953	15.11154	13.52788	0	0	0	0	0	0
Q9NUG6	PDRG1_HUMAN	p53 and DNA damage-regulated protein 1	PDRG1 C20orf126 PDRG	Homo sapiens (Human)	protein folding [GO:0006457]; protein stabilization [GO:0050821]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	unfolded protein binding [GO:0051082]	GO:0005737; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0101031; GO:1990062	QIVDLDTK	6.980000019	1	1	0.133812781	932.451466	0	0	0	14.6744	0	13.62971	0	0	0	14.76549	15.6679	10.15134	0	15.23159	0	15.63176	0	0	0	17.3742	0	17.78354	0	17.08467	14.6433	0	0	16.8905	0	0	0	0	16.86391	0	16.65001	17.74693	0	19.63428	0	0	13.21658	17.28112	0	0	0	16.81204	16.31523	0
Q9NUL3	STAU2_HUMAN	Double-stranded RNA-binding protein Staufen homolog 2	STAU2	Homo sapiens (Human)	anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; eye morphogenesis [GO:0048592]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468]	axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]	axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; kinesin binding [GO:0019894]; mitogen-activated protein kinase binding [GO:0051019]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; eye morphogenesis [GO:0048592]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468]	double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; kinesin binding [GO:0019894]; mitogen-activated protein kinase binding [GO:0051019]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]	GO:0003723; GO:0003725; GO:0005730; GO:0005783; GO:0005874; GO:0010468; GO:0010494; GO:0016020; GO:0019894; GO:0030424; GO:0030544; GO:0031965; GO:0032839; GO:0032956; GO:0034599; GO:0043022; GO:0043025; GO:0043198; GO:0048592; GO:0051019; GO:0051489; GO:0051965; GO:0061003; GO:0098964; GO:1900454; GO:1990124	EFVMQVKVGNEVATGTGPNK	4.539999962	0.114951849	0.114951849	0.179080198	2120.667365	14.52524	15.17732	10.6627	0	0	15.22077	0	15.55824	0	15.0928	15.17034	0	0	0	10.70747	0	0	0	0	0	13.10772	0	14.73144	0	0	0	15.39453	14.96943	0	0	0	0	0	14.83683	0	0	0	0	13.03754	10.48336	13.35794	0	13.72324	0	0	0	0	0
Q9NUN5	LMBD1_HUMAN	"Lysosomal cobalamin transport escort protein LMBD1, LMBD1 (HDAg-L-interacting protein NESI) (LMBR1 domain-containing protein 1) (Nuclear export signal-interacting protein)"	LMBRD1 C6orf209 NESI BM-021 CD001 MSTP044	Homo sapiens (Human)	clathrin-dependent endocytosis [GO:0072583]; cobalamin metabolic process [GO:0009235]; gastrulation [GO:0007369]; insulin receptor internalization [GO:0038016]; protein localization to lysosome [GO:0061462]; protein localization to vacuole [GO:0072665]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; AP-2 adaptor complex binding [GO:0035612]; clathrin heavy chain binding [GO:0032050]; cobalamin binding [GO:0031419]; insulin receptor binding [GO:0005158]; protein-membrane adaptor activity [GO:0043495]; clathrin-dependent endocytosis [GO:0072583]; cobalamin metabolic process [GO:0009235]; gastrulation [GO:0007369]; insulin receptor internalization [GO:0038016]; protein localization to lysosome [GO:0061462]; protein localization to vacuole [GO:0072665]	AP-2 adaptor complex binding [GO:0035612]; clathrin heavy chain binding [GO:0032050]; cobalamin binding [GO:0031419]; insulin receptor binding [GO:0005158]; protein-membrane adaptor activity [GO:0043495]	GO:0005158; GO:0005765; GO:0005774; GO:0005789; GO:0005886; GO:0007369; GO:0009235; GO:0016020; GO:0016021; GO:0030136; GO:0031419; GO:0032050; GO:0035612; GO:0038016; GO:0043231; GO:0043495; GO:0045334; GO:0061462; GO:0072583; GO:0072665	NQNGTFK	15.23999977	0.731820345	0.731820345	0.169167741	804.2816006	16.72368	16.25911	15.75406	0	17.39984	16.15347	0	0	17.08658	0	15.85551	17.55714	17.1197	0	16.38692	0	15.10338	0	17.32458	0	0	0	16.95963	15.54079	0	15.29765	0	16.15845	0	16.17643	15.13293	0	15.72112	0	0	0	16.23605	13.56617	0	17.56019	16.24822	0	17.89394	16.82689	17.47259	16.14234	16.54551	0
Q9NUN7	ACER3_HUMAN	"Alkaline ceramidase 3, AlkCDase 3, Alkaline CDase 3, EC 3.5.1.-, EC 3.5.1.23 (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase, aPHC)"	ACER3 APHC PHCA	Homo sapiens (Human)	ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]; ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]	calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]	GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016021; GO:0017040; GO:0030148; GO:0030173; GO:0030176; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121	APAADR	4.809999943	0.940635681	0.940635681	0.267448734	601.1163177	16.56249	13.43941	15.34813	14.68367	15.58474	14.87704	15.89092	15.30434	0	0	14.10845	15.40761	0	15.99015	14.20356	0	15.6362	15.30355	15.68528	15.93964	0	0	16.46877	0	0	0	16.22753	15.48507	16.16011	0	15.01083	0	0	16.15393	0	0	16.4063	16.31972	0	15.68623	16.21399	16.27474	16.67387	0	0	0	0	0
Q9NUP7	TRM13_HUMAN	"tRNA:m(4)X modification enzyme TRM13 homolog, EC 2.1.1.225 (Coiled-coil domain-containing protein 76)"	TRMT13 CCDC76	Homo sapiens (Human)	tRNA methylation [GO:0030488]		metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]	metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]	GO:0008175; GO:0030488; GO:0046872; GO:0106050	LLIDQGR	30.87000084	0.675828636	0.675828636	0.220831647	811.7637729	18.7398	18.64668	19.31339	16.75531	17.33627	16.84311	14.70703	16.10649	17.84859	16.6632	16.8067	17.02741	18.61564	20.01256	16.42922	18.33451	16.62983	18.07187	17.58214	17.86728	16.83198	17.19997	16.90356	18.46071	18.82142	17.4726	18.1591	16.38995	17.28246	19.83092	19.79274	19.15107	18.49613	0	18.45069	17.29567	19.33461	0	16.76053	17.52941	19.74576	17.29418	17.72237	16.95134	19.13001	16.6131	17.95639	16.83214
Q9NUQ2	PLCE_HUMAN	"1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 5, 1-AGP acyltransferase 5, 1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon, LPAAT-epsilon)"	AGPAT5	Homo sapiens (Human)	acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]	endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]	GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016021; GO:0016024; GO:0016746	KTLPSMLILSGLTAGMLMTDAGR	13.22999954	1	1	3.20E-12	2392.722037	13.94273	13.89263	0	12.81435	14.43327	0	0	13.5833	0	0	0	15.0239	16.68035	0	12.88763	0	0	0	0	16.18805	0	16.47693	0	15.41788	16.09799	0	0	14.73682	0	0	15.36425	13.52065	14.51469	13.88691	13.64068	8.224022	0	0	0	0	0	14.98771	0	0	15.69644	0	0	15.87004
Q9NUQ6	SPS2L_HUMAN	"SPATS2-like protein (DNA polymerase-transactivated protein 6) (Stress granule and nucleolar protein, SGNP)"	SPATS2L DNAPTP6 SP1224	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0032991	AANPKMVSSLPSTADPSHQTMPANK	3.160000086	1	1	1.83E-12	2612.97705	0	0	0	0	0	0	0	0	12.46673	15.01111	0	13.22742	0	0	0	0	0	0	14.70408	0	0	0	16.95004	13.83513	0	0	15.45307	0	0	0	0	15.30771	0	0	15.1597	0	0	0	0	15.58149	13.58862	14.31496	14.9288	0	0	0	0	0
Q9NUQ7	UFSP2_HUMAN	"Ufm1-specific protease 2, UfSP2, EC 3.4.22.-"	UFSP2 C4orf20	Homo sapiens (Human)	proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]	thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]	GO:0005634; GO:0005737; GO:0005783; GO:0006508; GO:0016790; GO:0033146; GO:0071567	SIPTHR	5.829999924	1	1	0.101183471	709.8308751	0	14.30193	14.48214	0	15.7691	0	0	15.28415	16.42993	13.42864	0	14.13938	13.69787	0	0	15.66197	0	15.07653	0	0	0	0	0	0	0	0	0	0	0	16.10608	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NUQ8	ABCF3_HUMAN	ATP-binding cassette sub-family F member 3	ABCF3	Homo sapiens (Human)	defense response to virus [GO:0051607]	membrane [GO:0016020]	membrane [GO:0016020]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]	GO:0005524; GO:0016020; GO:0045296; GO:0051607	MLEKLPELKPVDK	10.53999996	1	1	0.27478143	1556.480714	15.12784	0	0	0	14.03721	14.38675	0	0	13.97386	16.1431	16.65199	15.0585	14.89208	13.71607	13.91202	0	0	0	0	0	0	0	0	0	0	15.29327	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NUT2	MITOS_HUMAN	"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial, ABCB8) (Mitochondrial ATP-binding cassette 1, M-ABC1) (Mitochondrial sulfonylurea-receptor, MITOSUR)"	ABCB8 MABC1 MITOSUR	Homo sapiens (Human)	cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of membrane [GO:0016021]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of membrane [GO:0016021]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085]	ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]	GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0006884; GO:0016021; GO:0031966; GO:0042626; GO:0043190; GO:0055085; GO:0062157; GO:0071805; GO:0140141; GO:0140359	LTLLLMVATPALMGVGTLMGSGLRK	2.75999999	1	1	0.254609929	2574.524555	0	0	0	0	0	0	16.57747	0	0	0	0	15.62087	15.24482	0	0	0	0	0	19.54025	0	0	0	0	0	0	15.70007	0	0	0	0	17.76977	0	0	0	18.10238	0	17.47549	0	15.39663	0	0	0	0	15.99463	0	0	17.88616	0
Q9NUU7	DD19A_HUMAN	"ATP-dependent RNA helicase DDX19A, EC 3.6.4.13 (DDX19-like protein) (DEAD box protein 19A)"	DDX19A DDX19L	Homo sapiens (Human)	poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016020; GO:0016887; GO:0016973	VEPSDR	8.229999542	1	1	0.212969734	701.6336624	18.95575	15.27395	16.32454	15.7347	13.65798	13.77999	14.74835	12.5639	0	0	0	0	0	12.84623	0	14.63963	13.97335	16.17286	0	0	14.39113	0	0	0	16.43317	17.96107	16.54098	0	0	0	16.46913	14.33565	14.2605	15.47897	17.49848	15.15364	16.53253	15.89696	0	16.48771	15.35183	17.12064	0	0	0	0	0	16.00748
Q9NUV7	SPTC3_HUMAN	"Serine palmitoyltransferase 3, EC 2.3.1.50 (Long chain base biosynthesis protein 2b, LCB2b) (Long chain base biosynthesis protein 3, LCB 3) (Serine-palmitoyl-CoA transferase 3, SPT 3)"	SPTLC3 C20orf38 SPTLC2L	Homo sapiens (Human)	ceramide biosynthetic process [GO:0046513]; sphingoid biosynthetic process [GO:0046520]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; ceramide biosynthetic process [GO:0046513]; sphingoid biosynthetic process [GO:0046520]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]	pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]	GO:0004758; GO:0005789; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046512; GO:0046513; GO:0046520	SLKLIMGLDGTTQGLQR	2.150000095	1	1	0.285659596	1830.446937	0	15.21893	16.75802	15.41412	0	12.68102	14.76243	12.0063	0	12.99347	0	0	0	0	14.83867	13.55753	0	0	17.3054	0	0	15.85713	15.55738	0	0	0	0	15.26257	17.50151	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.269
Q9NUZ1	ACOXL_HUMAN	"Acyl-coenzyme A oxidase-like protein, Acyl-CoA oxidase-like protein, EC 1.3.3.-"	ACOXL	Homo sapiens (Human)	fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]	peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]	acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]	GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0033540; GO:0050660; GO:0055088; GO:0071949	FAMDLPLLK	12.44999981	1	1	0.129813661	1062.572153	16.86642	12.69742	0	0	0	13.29276	16.19119	0	18.31448	14.83242	13.65969	0	15.96574	15.86722	16.85482	16.81483	16.37685	17.95691	17.57129	18.13551	18.35934	16.71058	16.70585	17.10045	0	15.34757	17.87846	17.87738	17.02694	17.26385	14.51007	16.76463	16.48231	18.16328	18.2747	17.24999	18.39426	18.76833	17.60115	18.10086	17.44013	17.40872	17.58771	18.23429	17.15783	17.82804	18.16626	18.71997
Q9NV06	DCA13_HUMAN	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)	DCAF13 WDSOF1 HSPC064	Homo sapiens (Human)	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"	cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	"cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]"	estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]	GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0080008	ANASEK	3.5	1	1	0.007475627	621.178265	0	0	15.87836	0	0	0	0	0	0	0	0	0	0	0	16.55758	0	0	0	0	0	0	15.84764	0	0	0	0	15.81408	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NV29	TM100_HUMAN	Transmembrane protein 100	TMEM100	Homo sapiens (Human)	angiogenesis [GO:0001525]; arterial endothelial cell differentiation [GO:0060842]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; in utero embryonic development [GO:0001701]; Notch signaling pathway [GO:0007219]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of vasculogenesis [GO:2001214]; protein kinase B signaling [GO:0043491]; regulation of calcium-mediated signaling [GO:0050848]; regulation of sensory perception of pain [GO:0051930]; vasculogenesis [GO:0001570]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; arterial endothelial cell differentiation [GO:0060842]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; in utero embryonic development [GO:0001701]; Notch signaling pathway [GO:0007219]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of vasculogenesis [GO:2001214]; protein kinase B signaling [GO:0043491]; regulation of calcium-mediated signaling [GO:0050848]; regulation of sensory perception of pain [GO:0051930]; vasculogenesis [GO:0001570]		GO:0001525; GO:0001570; GO:0001701; GO:0003198; GO:0005783; GO:0005886; GO:0007219; GO:0016021; GO:0030509; GO:0043204; GO:0043491; GO:0045603; GO:0048471; GO:0050848; GO:0051930; GO:0060842; GO:0071773; GO:2001214	AHMAATMEK	5.75	1	1	0.228015776	987.2238578	16.7245	0	0	0	15.13739	0	0	0	0	15.06055	0	14.22153	0	0	0	0	0	0	0	15.46937	12.37713	15.93024	0	0	0	0	17.1771	0	15.60163	0	0	18.0963	16.55045	15.70242	0	0	16.55089	0	0	0	0	0	0	13.7175	0	0	0	0
Q9NV56	MRGBP_HUMAN	"MRG/MORF4L-binding protein (MRG-binding protein) (Up-regulated in colon cancer 4, Urcc4)"	MRGBP C20orf20	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]"	NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	"NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]"		GO:0000786; GO:0005654; GO:0006325; GO:0006357; GO:0016573; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779	ASEKSSK	7.480000019	0.254285157	0.254285157	0.253689599	736.3625042	16.08113	16.14728	16.17389	17.70079	18.80181	0	14.60946	0	16.56509	0	0	0	16.7584	0	15.45467	0	15.58447	0	16.68567	0	18.03817	15.11021	0	15.63482	17.84748	16.85586	16.46161	16.15097	15.59789	17.0171	0	17.47695	16.96235	16.74706	0	16.34618	17.28713	16.68389	17.68324	17.42703	17.77152	16.27317	17.47289	17.68926	17.07955	17.24495	16.65736	17.43117
Q9NV66	TYW1_HUMAN	"S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1, EC 4.1.3.44 (Radical S-adenosyl methionine and flavodoxin domain-containing protein 1) (tRNA wybutosine-synthesizing protein 1 homolog) (tRNA-yW-synthesizing protein)"	TYW1 RSAFD1	Homo sapiens (Human)	wybutosine biosynthetic process [GO:0031591]		"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]; wybutosine biosynthetic process [GO:0031591]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]"	GO:0010181; GO:0031591; GO:0046872; GO:0051539; GO:0102521	EAIENHQNMIK	10.82999992	1	1	0.462113409	1342.094624	0	0	0	17.3494	17.59858	0	0	0	0	0	0	0	0	0	16.77743	0	0	18.27128	17.22836	0	0	0	0	0	0	0	0	18.57099	17.77218	18.04481	0	0	0	0	18.92601	20.17785	0	19.08662	0	17.5262	0	0	17.80783	0	0	0	0	0
Q9NV70	EXOC1_HUMAN	Exocyst complex component 1 (Exocyst complex component Sec3)	EXOC1 SEC3 SEC3L1 BM-012	Homo sapiens (Human)	defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]"	"phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]"	GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048015; GO:0048471; GO:0050714; GO:0051607; GO:0090148; GO:0090522; GO:0090543; GO:0098592	DFFEVAKIK	3.109999895	1	1	0.054937504	1096.725781	16.00388	15.64431	0	0	0	14.40632	12.10709	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.39521	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NV72	ZN701_HUMAN	Zinc finger protein 701	ZNF701	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	KLMSSTER	9.170000076	1	1	4.60E-13	950.4307405	0	16.47157	15.36417	0	0	0	0	0	0	0	0	0	15.7336	0	0	0	0	0	0	0	0	0	14.27445	0	0	0	15.18366	0	0	0	0	0	0	0	0	0	0	14.44827	0	0	0	0	0	0	0	0	0	0
Q9NV79	PCMD2_HUMAN	Protein-L-isoaspartate O-methyltransferase domain-containing protein 2	PCMTD2 C20orf36	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]	GO:0004719; GO:0005737	ITRTGPSAWETK	9.979999542	1	1	0.045453867	1345.298629	0	0	0	15.6728	0	16.15942	0	0	0	0	0	15.06001	0	10.69294	0	0	0	15.44827	0	0	0	0	0	0	16.50218	0	14.52219	0	0	0	0	14.40815	0	14.64385	14.10327	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NVA2	SEP11_HUMAN	Septin-11	SEPTIN11 SEPT11	Homo sapiens (Human)	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]	axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]	axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]	GO:0001725; GO:0003924; GO:0005525; GO:0005940; GO:0015630; GO:0030424; GO:0031105; GO:0032153; GO:0034613; GO:0043197; GO:0060090; GO:0061640	NASFT	3.549999952	0.34733209	0.34733209	0.165430057	539.3084433	15.50145	13.99233	15.18827	0	15.06639	15.20266	0	15.78304	0	0	0	15.20086	15.09047	14.90856	16.50657	15.68993	15.30522	16.46179	14.67029	15.34954	15.26589	16.79847	16.69428	15.84893	12.10161	14.47713	13.46886	13.01886	15.31385	14.92569	15.13808	15.32817	15.15169	15.83296	12.79391	16.06507	15.72287	16.23207	16.44972	14.94463	0	15.79304	16.10254	14.61498	13.8567	16.24103	17.26092	14.82763
Q9NVC6	MED17_HUMAN	"Mediator of RNA polymerase II transcription subunit 17 (Activator-recruited cofactor 77 kDa component, ARC77) (Cofactor required for Sp1 transcriptional activation subunit 6, CRSP complex subunit 6) (Mediator complex subunit 17) (Thyroid hormone receptor-associated protein complex 80 kDa component, Trap80) (Transcriptional coactivator CRSP77) (Vitamin D3 receptor-interacting protein complex 80 kDa component, DRIP80)"	MED17 ARC77 CRSP6 DRIP77 DRIP80 TRAP80	Homo sapiens (Human)	"positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]	GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006367; GO:0016020; GO:0016592; GO:0030374; GO:0032968; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0051123; GO:0060261; GO:0070847	NGPESGSKIMVQFPR	7.039999962	0.502545714	0.502545714	0.085406837	1646.638942	15.97995	0	15.10607	0	0	14.70065	14.85151	0	14.55535	15.6742	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.05355	13.99721	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.22665	16.18073	0	0	0	0	0	0
Q9NVD3	SETD4_HUMAN	"SET domain-containing protein 4, EC 2.1.1.-, EC 2.1.1.364"	SETD4 C21orf18 C21orf27	Homo sapiens (Human)	histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 monomethylation [GO:0097692]; histone H4-K20 trimethylation [GO:0034773]; inflammatory response [GO:0006954]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; protein-lysine N-methyltransferase activity [GO:0016279]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 monomethylation [GO:0097692]; histone H4-K20 trimethylation [GO:0034773]; inflammatory response [GO:0006954]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863]	histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0005634; GO:0005829; GO:0006954; GO:0016279; GO:0018023; GO:0018026; GO:0032755; GO:0032760; GO:0034773; GO:0042799; GO:0042800; GO:0044648; GO:0050729; GO:0071863; GO:0097692	VSHMKDEK	10.23999977	0.605279982	0.605279982	0.016768642	989.5899829	0	0	0	17.22836	0	14.32592	11.05965	8.843022	12.14116	0	15.73499	16.57029	12.89899	0	0	13.28253	14.84568	15.53952	16.94181	0	0	16.09831	13.03466	0	0	13.68645	13.84465	0	13.6732	0	12.96102	14.44277	0	0	15.37845	14.02253	0	14.1196	0	14.56112	15.45686	15.93019	10.74009	13.90699	16.24611	16.17251	0	13.56178
Q9NVD7	PARVA_HUMAN	Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2)	PARVA MXRA2	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; protein kinase inhibitor activity [GO:0004860]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; protein kinase inhibitor activity [GO:0004860]	GO:0002040; GO:0003148; GO:0003779; GO:0004860; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0008360; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0031532; GO:0034113; GO:0034446; GO:0045296; GO:0050821; GO:0060271; GO:0070252; GO:0071670	SPTPKSPPSR	17.84000015	1	1	0.318648607	1053.053719	13.67803	15.0634	13.18401	0	0	0	0	0	0	0	0	0	0	14.47284	0	15.85017	0	0	0	0	0	0	0	0	0	0	0	0	0	13.6584	0	15.30719	13.49851	0	0	15.67109	0	0	0	0	16.05595	0	0	0	0	0	0	0
Q9NVE4	CCD87_HUMAN	Coiled-coil domain-containing protein 87	CCDC87	Homo sapiens (Human)	cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]		cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]		GO:0007283; GO:0007338; GO:0030154; GO:1905516; GO:2000344	NEVVVQAAAVRVSDR	3.730000019	1	1	0.258902547	1613.775803	0	15.76997	0	0	11.064	0	14.10942	0	0	12.0993	13.61186	14.12423	0	0	0	0	0	0	0	0	14.16971	0	15.33516	0	14.20962	14.07462	13.67603	0	0	13.25957	0	14.17755	0	0	0	0	0	14.12861	0	13.42098	0	18.44935	14.36297	0	13.18183	0	0	12.48917
Q9NVE5	UBP40_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 40, EC 3.4.19.12 (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40)"	USP40	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0031647	DGDTIGVK	6.909999847	1	1	0.304271866	801.6082259	0	0	0	17.89689	18.38777	0	17.63207	0	0	17.82825	0	0	16.87981	0	0	18.5498	0	0	16.57242	0	18.46521	17.14602	0	0	0	0	0	0	17.0689	0	0	0	18.71866	18.5924	0	19.80862	0	0	14.4233	17.25419	0	0	18.00927	0	0	0	0	18.5088
Q9NVE7	PANK4_HUMAN	"4'-phosphopantetheine phosphatase, EC 3.1.3.- (Inactive pantothenic acid kinase 4, hPanK4)"	PANK4	Homo sapiens (Human)	coenzyme A biosynthetic process [GO:0015937]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]	GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872	EDMAKSLLHMISNDIGQLACLHAR	5.409999847	1	1	0.055394273	2723.231409	15.63235	15.05834	0	14.04003	0	0	0	0	11.85226	14.37119	18.05038	13.71907	16.99267	8.318459	0	11.45608	0	0	0	14.54459	0	16.74954	0	0	0	16.23413	0	16.88341	15.09759	0	20.06427	14.45842	0	0	0	0	0	15.79309	0	15.36704	13.52428	0	0	13.82146	0	0	0	0
Q9NVF7	FBX28_HUMAN	F-box only protein 28	FBXO28 CENP-30 KIAA0483	Homo sapiens (Human)	protein polyubiquitination [GO:0000209]	kinetochore [GO:0000776]	kinetochore [GO:0000776]; identical protein binding [GO:0042802]; protein polyubiquitination [GO:0000209]	identical protein binding [GO:0042802]	GO:0000209; GO:0000776; GO:0042802	LMGSPPVPGPSAALTTMQLFSK	1.539999962	1	1	0.250525619	2229.221025	9.264452	0	12.09011	0	11.19163	11.50326	0	14.68841	0	11.58895	13.82404	0	13.96504	12.34898	7.798967	0	0	0	0	0	0	0	16.14972	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NVH0	EXD2_HUMAN	"Exonuclease 3'-5' domain-containing protein 2, EC 3.1.11.1 (3'-5' exoribonuclease EXD2, EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2)"	EXD2 C14orf114 EXDL2	Homo sapiens (Human)	DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297]	3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]	GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0008852; GO:0016021; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090305; GO:0090734	RDSYIR	22	0.041855346	0.041855346	0.159506183	809.5952063	20.15615	17.43822	21.35003	16.63366	17.08957	17.75299	16.98936	19.62628	18.3732	18.69303	18.03571	17.36334	18.95545	18.49587	18.3328	16.81831	16.87951	17.52536	17.93804	17.22083	17.87997	18.30485	17.59962	17.7483	19.36512	16.55828	17.77747	16.9124	16.7479	17.78806	16.69891	19.3562	19.63089	18.36249	18.2432	20.74088	20.27849	18.98459	20.02568	17.96132	16.99349	19.57515	19.48256	16.38964	16.11478	17.89557	15.92681	18.10271
Q9NVH2	INT7_HUMAN	"Integrator complex subunit 7, Int7"	INTS7 C1orf73	Homo sapiens (Human)	cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]		GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0016180; GO:0016604; GO:0032039; GO:0034472; GO:0071479	LGMLSVLSTLSGTIAIK	9.260000229	1	1	2.06E-12	1716.74783	14.25696	14.63413	0	0	0	0	0	14.13872	13.53022	0	0	14.49522	15.48972	0	0	10.55533	15.11593	15.10483	11.15732	0	0	0	0	0	0	15.01607	0	16.02484	0	14.59953	0	0	15.56681	14.51159	14.4121	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NVI1	FANCI_HUMAN	"Fanconi anemia group I protein, Protein FACI"	FANCI KIAA1794	Homo sapiens (Human)	cell cycle [GO:0007049]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; cell cycle [GO:0007049]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398]	DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]	GO:0000785; GO:0003677; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0016020; GO:0031398; GO:0036297; GO:0070182; GO:1990391	EGSLVNGK	7.460000038	1	1	0.21985592	803.6176925	15.20528	0	14.61825	17.6234	13.51632	0	15.03643	0	0	0	0	0	0	16.46444	15.82419	0	14.87036	15.81728	0	0	0	16.69874	0	0	15.9118	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.37406	0	0	0	0
Q9NVI7	ATD3A_HUMAN	ATPase family AAA domain-containing protein 3A	ATAD3A	Homo sapiens (Human)	antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]	GO:0001558; GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0016021; GO:0016887; GO:0042645; GO:0042802; GO:0043066; GO:0140374	ATLNAFLYRTGQHSNK	1.629999995	1	1	0.277412036	1821.163411	14.74377	11.17445	11.30814	14.53292	13.90557	0	12.15081	0	0	16.74393	0	15.6486	13.12817	12.72195	0	0	14.23095	13.31882	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.55663	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NVL8	CC198_HUMAN	Uncharacterized protein CCDC198	CCDC198 C14orf105	Homo sapiens (Human)						EVETPSAGR	9.479999542	0.375987202	0.375987202	0.197909059	943.3732294	0	17.51089	0	14.30406	0	17.18246	17.23163	15.38542	15.27466	15.96867	17.50003	17.43292	14.86708	12.45788	14.29495	13.39579	16.09243	16.25035	15.04727	15.8013	13.04168	16.36083	16.78549	0	17.02524	15.44302	14.95886	16.813	17.8369	16.58327	18.17937	18.99738	17.81138	15.97573	16.08892	14.742	16.08978	12.23776	15.06164	16.2885	18.47708	12.44288	13.50623	17.77008	17.51821	16.03079	17.42141	16.30478
Q9NVM9	INT13_HUMAN	Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95)	INTS13 ASUN C12orf11 GCT1	Homo sapiens (Human)	cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]		GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0016604; GO:0030317; GO:0032039; GO:0043231; GO:0051301; GO:0051642; GO:0080154; GO:0090435	EELAEAEIIK	16.05999947	1	1	0.306367572	1145.535268	13.4709	18.30645	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NVN8	GNL3L_HUMAN	Guanine nucleotide-binding protein-like 3-like protein	GNL3L	Homo sapiens (Human)	"negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]"	cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]	"cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]"	GTP binding [GO:0005525]; RNA binding [GO:0003723]	GO:0003723; GO:0005525; GO:0005654; GO:0005697; GO:0005730; GO:0005829; GO:0016020; GO:0031334; GO:0031397; GO:0031647; GO:0032091; GO:0032211; GO:0033234; GO:0042254; GO:1904816	IMETDPLQQGQALASALK	10.81999969	1	1	2.07E-12	1930.247513	0	15.85167	14.41286	0	14.30522	0	0	14.60843	14.56803	0	14.25696	0	13.97872	0	0	0	0	14.2283	0	0	0	0	0	0	0	0	0	0	0	15.43886	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NVP1	DDX18_HUMAN	"ATP-dependent RNA helicase DDX18, EC 3.6.4.13 (DEAD box protein 18) (Myc-regulated DEAD box protein, MrDb)"	DDX18 cPERP-D	Homo sapiens (Human)	"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]	"chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0016020; GO:0016887	STVLTNGEAAMQSSNSESKK	3.869999886	1	1	4.91E-13	2085.997791	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NVP4	DZAN1_HUMAN	Double zinc ribbon and ankyrin repeat-containing protein 1	DZANK1 C20orf12 C20orf84	Homo sapiens (Human)	eye photoreceptor cell development [GO:0042462]		metal ion binding [GO:0046872]; eye photoreceptor cell development [GO:0042462]	metal ion binding [GO:0046872]	GO:0042462; GO:0046872	ACGTGNPAHLR	1.840000033	1	1	0.253079184	1154.866934	0	0	0	0	0	0	0	19.73236	0	0	0	0	18.09765	0	0	0	0	0	0	0	0	19.19272	0	18.59751	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.48612	0	0	0	0	0	0	0
Q9NVR0	KLH11_HUMAN	Kelch-like protein 11	KLHL11	Homo sapiens (Human)		cytosol [GO:0005829]	cytosol [GO:0005829]		GO:0005829	DTEDGLK	10.64000034	0.612073481	0.612073481	0.249378273	777.5188591	16.06075	15.61727	0	0	14.92171	15.63777	14.69435	16.23602	0	17.37817	0	0	15.44762	13.62971	0	0	14.02019	15.09027	0	0	0	17.22514	15.03403	16.70017	14.33908	13.51056	17.05914	16.07536	0	12.39882	0	0	16.89101	0	0	0	0	0	0	14.89515	0	16.32099	0	0	0	0	0	16.36682
Q9NVR2	INT10_HUMAN	"Integrator complex subunit 10, Int10"	INTS10 C8orf35	Homo sapiens (Human)	snRNA processing [GO:0016180]	integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]		GO:0005634; GO:0005654; GO:0016180; GO:0032039	HHTVTR	6.880000114	0.503160536	0.503160536	0.189524818	751.7744486	14.59635	0	15.45879	13.09186	14.45108	14.85932	15.28045	0	9.612368	15.65955	0	0	0	15.79292	0	0	0	0	0	0	0	0	0	16.98633	0	0	0	0	0	0	0	0	0	0	0	0	0	15.09303	0	0	0	0	0	0	16.27122	0	0	0
Q9NVR7	TBCC1_HUMAN	TBCC domain-containing protein 1	TBCCD1	Homo sapiens (Human)	maintenance of centrosome location [GO:0051661]; maintenance of Golgi location [GO:0051684]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]	cytoplasm [GO:0005737]; spindle pole centrosome [GO:0031616]	cytoplasm [GO:0005737]; spindle pole centrosome [GO:0031616]; maintenance of centrosome location [GO:0051661]; maintenance of Golgi location [GO:0051684]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]		GO:0005737; GO:0008360; GO:0030334; GO:0031616; GO:0051661; GO:0051684	SVTIEK	3.00999999	1	1	0.287726002	676.6573454	0	0	0	0	0	0	0	19.39335	0	17.61385	0	0	0	0	0	0	0	0	0	0	18.96116	0	0	0	0	19.40056	18.1744	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.88274	0	0	0
Q9NVS9	PNPO_HUMAN	"Pyridoxine-5'-phosphate oxidase, EC 1.4.3.5 (Pyridoxamine-phosphate oxidase)"	PNPO	Homo sapiens (Human)	pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]	cytosol [GO:0005829]	cytosol [GO:0005829]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]	FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]	GO:0004733; GO:0005829; GO:0008615; GO:0010181; GO:0030170; GO:0042803; GO:0042823	SAAMDLGPMRK	3.180000067	1	1	0.134526577	1204.9921	12.02774	13.18455	0	0	14.13213	14.70443	13.99037	13.5764	13.62469	0	0	0	12.72542	13.76793	13.3539	13.85755	0	0	0	0	0	0	13.96576	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.92746	0	0	0	0	0	0	0	0	0	0
Q9NVU7	SDA1_HUMAN	"Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1, hSDA)"	SDAD1 NUC130	Homo sapiens (Human)	protein transport [GO:0015031]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein transport [GO:0015031]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]		GO:0000055; GO:0005654; GO:0005730; GO:0015031; GO:0042273	NVMMSAR	7.730000019	0.478520751	0.478520751	0.279113926	841.8082551	15.29679	15.43211	14.5169	14.74504	15.97207	16.0001	16.16247	15.30433	0	15.32852	15.21346	15.21366	14.59773	0	16.51511	0	16.68095	15.2531	15.30158	17.44127	0	0	0	0	0	0	16.50514	0	0	16.47895	16.69769	15.72549	16.40787	16.8483	0	16.63822	17.54072	16.67501	17.01259	17.23338	15.64784	15.29451	16.86376	17.49943	17.00238	16.43867	0	16.29628
Q9NVV0	TM38B_HUMAN	"Trimeric intracellular cation channel type B, TRIC-B, TRICB (Transmembrane protein 38B)"	TMEM38B C9orf87	Homo sapiens (Human)	bone development [GO:0060348]; bone mineralization [GO:0030282]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extracellular matrix constituent secretion [GO:0070278]; lung alveolus development [GO:0048286]; lung epithelial cell differentiation [GO:0060487]; phospholipid biosynthetic process [GO:0008654]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; secretion by lung epithelial cell involved in lung growth [GO:0061033]	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sarcoplasmic reticulum membrane [GO:0033017]	integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sarcoplasmic reticulum membrane [GO:0033017]; identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; bone development [GO:0060348]; bone mineralization [GO:0030282]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extracellular matrix constituent secretion [GO:0070278]; lung alveolus development [GO:0048286]; lung epithelial cell differentiation [GO:0060487]; phospholipid biosynthetic process [GO:0008654]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; secretion by lung epithelial cell involved in lung growth [GO:0061033]	identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]	GO:0005267; GO:0005634; GO:0007029; GO:0008654; GO:0010881; GO:0014808; GO:0016021; GO:0030282; GO:0031965; GO:0033017; GO:0042802; GO:0048286; GO:0060348; GO:0060487; GO:0061033; GO:0070278; GO:0071313	MSYPAK	5.829999924	1	1	6.87E-13	711.5059676	14.48459	13.73576	14.60381	14.40362	16.6313	0	0	0	0	0	0	0	0	0	0	15.38246	0	0	0	0	0	0	0	0	0	0	16.57456	0	0	0	15.92175	0	16.07604	16.18564	16.90816	16.94382	17.68995	0	0	0	0	0	0	0	0	0	0	0
Q9NVV4	PAPD1_HUMAN	"Poly(A) RNA polymerase, mitochondrial, PAP, EC 2.7.7.19 (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1, TUTase 1) (mtPAP)"	MTPAP PAPD1	Homo sapiens (Human)	histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005654; GO:0005739; GO:0006378; GO:0016779; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817	VQRPIVR	11.93000031	0.604428828	0.604428828	0.243031322	868.0049929	18.33574	20.04394	14.25892	0	17.52687	20.05507	18.20588	11.92317	0	17.24517	19.34855	14.41083	16.25227	17.60398	18.3067	18.15802	16.90104	18.19427	0	17.27688	0	0	0	0	0	0	20.33858	0	0	15.48135	18.87329	20.30923	20.50332	0	18.5937	17.57533	19.16389	19.1653	0	17.98812	18.59069	0	0	0	18.52135	0	0	21.36174
Q9NW08	RPC2_HUMAN	"DNA-directed RNA polymerase III subunit RPC2, RNA polymerase III subunit C2, EC 2.7.7.6 (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)"	POLR3B	Homo sapiens (Human)	"defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]"	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607	GATDSYIEK	5	1	1	0.135791216	982.3780179	16.21978	15.55576	15.35699	12.83462	15.1959	15.24449	0	0	16.34824	14.57377	0	14.26529	0	0	0	0	0	0	0	0	0	15.00138	0	0	0	0	0	0	0	14.99362	0	0	0	0	0	15.94973	0	0	0	14.26273	0	16.65708	0	0	0	0	0	0
Q9NW13	RBM28_HUMAN	RNA-binding protein 28 (RNA-binding motif protein 28)	RBM28	Homo sapiens (Human)	mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]	nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	RNA binding [GO:0003723]	GO:0003723; GO:0005681; GO:0005730; GO:0006397; GO:0008380	MRSKPATGEPQK	3.109999895	1	1	0.244493482	1328.605585	0	15.44331	14.14099	0	14.07139	15.68847	0	0	15.82283	0	15.0382	0	0	15.38639	0	0	0	13.95751	0	0	15.40356	0	0	0	14.59554	0	0	16.72749	13.78753	0	0	0	0	0	13.83632	17.45421	0	0	0	16.85062	16.22474	0	0	13.97434	0	0	0	0
Q9NW15	ANO10_HUMAN	Anoctamin-10 (Transmembrane protein 16K)	ANO10 TMEM16K	Homo sapiens (Human)	cation transport [GO:0006812]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229]; cation transport [GO:0006812]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]	calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229]	GO:0005227; GO:0005229; GO:0005886; GO:0006812; GO:0006821; GO:0016020; GO:0016021; GO:0034220; GO:0043231; GO:0055085	IRMLLGAEAVGLVK	4.949999809	1	1	0.424204179	1485.794988	0	0	0	0	0	0	0	17.4241	0	0	16.42027	17.4621	18.25677	0	0	0	0	0	18.50271	0	18.65302	0	0	0	0	0	0	0	18.56253	0	0	0	0	19.88247	0	0	0	19.15186	19.02181	0	0	0	0	0	0	0	0	18.78025
Q9NW64	RBM22_HUMAN	Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) (Zinc finger CCCH domain-containing protein 16)	RBM22 ZC3H16 199G4	Homo sapiens (Human)	"cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]"	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]"	calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]	GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0017070; GO:0033120; GO:0036002; GO:0042307; GO:0045292; GO:0046827; GO:0046872; GO:0048306; GO:0071006; GO:0071007; GO:0071013; GO:0071466	TITVVQRQQCAFIQFATR	10.89999962	1	1	0.234459857	2171.788898	0	15.09419	15.15952	0	11.27398	0	0	0	0	15.08806	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NW68	BSDC1_HUMAN	BSD domain-containing protein 1	BSDC1 UNQ2494/PRO5781	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	VLPKDLSQK	4.239999771	1	1	0.016909224	1027.325724	15.48402	0	0	15.69184	0	0	15.58258	15.22255	0	0	15.15815	13.95424	0	0	0	15.35906	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NW75	GPTC2_HUMAN	G patch domain-containing protein 2	GPATCH2 GPATC2	Homo sapiens (Human)		nuclear speck [GO:0016607]; nucleolus [GO:0005730]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0005730; GO:0016607	GLGLGFPLPK	7.510000229	0.348840296	0.348840296	0.229098742	999.3185175	17.46018	17.19318	15.8709	16.33269	0	16.70928	18.32213	16.41389	14.35322	15.83595	17.98985	14.57158	17.49087	12.7032	13.77508	14.90382	15.58814	14.97223	15.68788	16.20315	17.66651	17.15829	17.13423	17.05144	0	14.17395	0	16.09319	0	15.28008	0	16.8872	0	0	15.95131	15.87861	14.62866	16.33066	18.39538	0	13.68261	0	17.99056	15.75191	14.91064	18.39189	15.61938	17.60929
Q9NW97	TMM51_HUMAN	Transmembrane protein 51	TMEM51 C1orf72	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	TEVGGGILK	8.100000381	0.459951639	0.459951639	0.266673014	872.3247571	18.83766	17.60501	18.33649	13.59071	17.96806	17.13865	0	0	0	17.4721	0	18.57297	0	0	0	0	0	0	0	0	16.57128	16.53346	0	0	0	0	0	0	17.40596	0	18.75187	0	18.86792	0	18.87438	0	17.10916	0	17.94691	17.17915	17.8203	16.90401	0	0	0	17.80351	0	17.32847
Q9NWD8	TM248_HUMAN	Transmembrane protein 248	TMEM248 C7orf42	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	LTVIVPDDDR	3.309999943	1	1	0.085404792	1144.68787	15.20556	0	17.13755	0	16.31148	15.06536	13.53184	0	0	8.837421	14.82917	0	0	18.62855	13.45664	0	0	12.28088	0	15.22482	0	0	0	0	0	0	0	0	0	0	16.47716	0	16.16049	0	13.84513	14.9902	15.45785	18.0482	0	0	16.95693	13.14302	15.86635	0	0	0	0	14.24518
Q9NWH9	SLTM_HUMAN	SAFB-like transcription modulator (Modulator of estrogen-induced transcription)	SLTM MET	Homo sapiens (Human)	apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0016604; GO:0043565; GO:0050684	IEGKDEK	14.81000042	1	1	0.254231833	818.0168549	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.24708	0	0	0	16.00192	0	0	0	0	0	0	15.92214	0	0	0	0	0	0	0	15.26885	13.03218	0	15.00467	11.8136	0	0	0	0	16.10665	0	0	0	0
Q9NWL6	ASND1_HUMAN	Asparagine synthetase domain-containing protein 1 (HCV NS3-transactivated protein 1)	ASNSD1 NS3TP1 Nbla00058	Homo sapiens (Human)	asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]		asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]	GO:0004066; GO:0006529; GO:0006541	DENLTANEVLK	10.26000023	1	1	0.333687178	1246.192333	10.40313	0	0	14.72028	11.95935	0	0	0	0	0	11.89276	0	0	14.04791	15.80889	0	0	0	0	0	0	0	15.62144	0	0	0	0	0	15.93803	0	0	0	0	15.62106	0	0	0	0	0	0	0	0	0	16.26882	0	0	0	0
Q9NWM3	CUED1_HUMAN	CUE domain-containing protein 1	CUEDC1	Homo sapiens (Human)			ubiquitin binding [GO:0043130]	ubiquitin binding [GO:0043130]	GO:0043130	RSSSGSGGGGTAGAR	13.78999996	1	1	0.459150803	1263.627135	0	18.22931	19.08217	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.35755	0	0	0	0	0	0	0	0
Q9NWM8	FKB14_HUMAN	"Peptidyl-prolyl cis-trans isomerase FKBP14, PPIase FKBP14, EC 5.2.1.8 (22 kDa FK506-binding protein, 22 kDa FKBP, FKBP-22) (FK506-binding protein 14, FKBP-14) (Rotamase)"	FKBP14 FKBP22 UNQ322/PRO381	Homo sapiens (Human)		endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005509; GO:0005788	IPPESTLIFNIDLLEIRNGPR	1.25999999	1	1	4.58E-12	2408.272499	13.87276	0	12.41849	0	14.81778	11.74617	9.712662	16.69837	13.64477	14.90232	0	14.60371	12.97784	13.61218	0	15.26049	0	15.03494	0	11.7551	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.43551	0	0	0	0	0	14.84717	0
Q9NWQ4	GPT2L_HUMAN	G patch domain-containing protein 2-like	GPATCH2L C14orf118 KIAA1152	Homo sapiens (Human)						EVAPVTNFSDSDDTMVAK	1.450000048	1	1	0.458623017	1941.430733	14.47031	15.4519	0	0	0	0	0	0	0	0	14.46027	13.21943	11.7601	0	15.59254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.81383	0	0	0	15.70401	0	0	0	0	0	0
Q9NWQ8	PHAG1_HUMAN	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp)	PAG1 CBP PAG	Homo sapiens (Human)	adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]	SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]	GO:0002250; GO:0005886; GO:0007165; GO:0016021; GO:0035556; GO:0035591; GO:0042169; GO:0045121; GO:0050863; GO:0050868	GHSGKAK	8.75	1	1	0.142627924	684.4188046	0	15.17554	0	14.12455	0	0	15.04877	0	16.65598	0	0	0	0	0	0	14.94801	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.37996	16.7901	0	0	0	0	0	0	0	16.6304	0	0	0	0	17.46807	0	0
Q9NWV8	BABA1_HUMAN	BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex)	BABAM1 C19orf62 MERIT40 NBA1 HSPC142	Homo sapiens (Human)	cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006302; GO:0006325; GO:0007095; GO:0010212; GO:0016604; GO:0044818; GO:0045739; GO:0051301; GO:0070531; GO:0070536; GO:0070537; GO:0070552	SWQVPPPAPEVQIR	9.170000076	0.606396317	0.606396317	0.069618403	1604.630984	0	0	16.85136	15.39857	15.77447	0	0	0	16.62145	13.33378	15.0943	0	15.05713	16.96803	0	13.21628	14.84158	12.10829	17.44347	0	15.47111	0	11.07167	13.80929	18.78177	0	0	14.9514	0	0	0	0	15.22361	0	10.98324	7.622881	17.18914	12.1422	15.93744	17.92135	12.64455	0	14.21141	0	13.11714	0	0	0
Q9NWW5	CLN6_HUMAN	"Ceroid-lipofuscinosis neuronal protein 6, Protein CLN6"	CLN6	Homo sapiens (Human)	cellular macromolecule catabolic process [GO:0044265]; cholesterol metabolic process [GO:0008203]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; locomotion involved in locomotory behavior [GO:0031987]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; positive regulation of proteolysis [GO:0045862]; protein catabolic process [GO:0030163]; visual perception [GO:0007601]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]	early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; lysophosphatidic acid binding [GO:0035727]; protein homodimerization activity [GO:0042803]; sulfatide binding [GO:0120146]; cellular macromolecule catabolic process [GO:0044265]; cholesterol metabolic process [GO:0008203]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; locomotion involved in locomotory behavior [GO:0031987]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; positive regulation of proteolysis [GO:0045862]; protein catabolic process [GO:0030163]; visual perception [GO:0007601]	lysophosphatidic acid binding [GO:0035727]; protein homodimerization activity [GO:0042803]; sulfatide binding [GO:0120146]	GO:0001573; GO:0005730; GO:0005769; GO:0005783; GO:0005788; GO:0005789; GO:0007040; GO:0007042; GO:0007601; GO:0008203; GO:0016020; GO:0016021; GO:0030163; GO:0030203; GO:0031987; GO:0035727; GO:0042803; GO:0043231; GO:0044265; GO:0045121; GO:0045862; GO:0120146	ENPIIK	1.99000001	2.34E-09	2.34E-09	0.251125143	712.544922	0	0	18.48182	17.91897	0	17.44437	16.46864	0	17.83965	0	0	0	17.83067	17.74791	0	0	0	17.70146	0	0	0	0	16.41697	0	0	0	19.00969	0	0	19.00724	0	0	0	0	20.13637	0	0	0	19.45101	0	0	0	0	16.80709	17.28966	18.2079	16.80436	18.03203
Q9NWW7	CB042_HUMAN	Uncharacterized protein C2orf42	C2orf42	Homo sapiens (Human)		nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654	ISIGSAK	13.88000011	1	1	0.203971452	675.6467601	15.8206	15.81838	14.8976	14.70695	0	15.60249	15.83321	15.18965	0	0	0	0	15.0148	16.21214	17.12955	15.96021	0	16.45934	0	17.61509	0	0	0	0	17.62166	15.62685	16.31936	16.00474	17.34006	16.55	16.013	16.55507	16.05771	16.8878	17.74475	0	17.79833	18.79977	16.90393	17.17888	17.56411	17.43351	17.70635	0	17.30149	17.11676	0	0
Q9NWX5	ASB6_HUMAN	"Ankyrin repeat and SOCS box protein 6, ASB-6"	ASB6	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]	cytosol [GO:0005829]	cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567]		GO:0005829; GO:0016567; GO:0035556	KAETVLDLMVTNSQK	15.80000019	1	1	0.519208008	1693.601872	17.15334	12.88262	0	0	0	0	19.89173	0	18.02927	0	0	0	17.68676	0	0	0	0	0	0	0	17.83519	0	0	0	0	0	0	18.82624	0	0	21.32813	0	20.72377	0	0	0	0	0	18.59461	0	0	0	0	18.70069	0	18.45922	16.7818	0
Q9NWX6	THG1_HUMAN	"Probable tRNA(His) guanylyltransferase, EC 2.7.7.79 (Induced in high glucose-1, IHG-1) (Interphase cytoplasmic foci protein 45) (tRNA-histidine guanylyltransferase)"	THG1L ICF45	Homo sapiens (Human)	mitochondrial fusion [GO:0008053]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; stress-induced mitochondrial fusion [GO:1990046]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]	cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; tRNA guanylyltransferase activity [GO:0008193]; mitochondrial fusion [GO:0008053]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; stress-induced mitochondrial fusion [GO:1990046]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; tRNA guanylyltransferase activity [GO:0008193]	GO:0000049; GO:0000287; GO:0005085; GO:0005524; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006400; GO:0006979; GO:0008033; GO:0008053; GO:0008193; GO:0016779; GO:0042802; GO:0051289; GO:1990046; GO:1990234	SKFEYVR	6.570000172	1	1	1.26E-12	928.610624	13.52283	15.15142	0	0	0	16.38173	0	0	0	0	0	0	0	0	0	0	15.40775	14.44038	0	0	0	0	0	0	0	0	0	0	0	13.99179	0	0	0	0	0	0	16.03147	15.52057	0	0	0	0	0	0	0	0	0	16.53022
Q9NWY4	HPF1_HUMAN	Histone PARylation factor 1	HPF1 C4orf27	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of histone modification [GO:0031056]; regulation of protein ADP-ribosylation [GO:0010835]	chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of histone modification [GO:0031056]; regulation of protein ADP-ribosylation [GO:0010835]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]	GO:0000785; GO:0003682; GO:0005634; GO:0006302; GO:0006974; GO:0010835; GO:0018312; GO:0031056; GO:0042393; GO:0072572; GO:0090734	VGGGGKR	3.130000114	1	1	0.152923565	626.2270203	0	0	0	13.20915	0	0	0	14.49596	14.09282	0	0	0	0	0	14.51069	0	0	0	0	15.62236	0	0	0	0	16.86246	16.28915	14.69949	16.73738	15.21166	0	15.56729	0	0	0	0	0	0	16.19346	16.41413	17.06366	0	0	14.24618	0	0	0	0	0
Q9NX02	NALP2_HUMAN	"NACHT, LRR and PYD domains-containing protein 2 (Nucleotide-binding site protein 1) (PYRIN domain and NACHT domain-containing protein 1) (PYRIN-containing APAF1-like protein 2)"	NLRP2 NALP2 NBS1 PAN1 PYPAF2	Homo sapiens (Human)	apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; Pyrin domain binding [GO:0032090]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]	ATP binding [GO:0005524]; Pyrin domain binding [GO:0032090]	GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006954; GO:0032088; GO:0032090; GO:0032731; GO:0043231; GO:0043280; GO:0045087	KERPPLDVDEMLER	5.059999943	1	1	0.286970597	1746.078337	0	16.85693	12.4768	0	0	0	16.40086	15.70064	0	0	0	15.01688	14.39544	0	15.19704	0	15.22759	0	13.23492	0	0	14.78432	0	15.85409	0	0	12.73285	0	0	13.94008	0	0	0	0	0	16.29612	0	12.001	17.01538	16.0626	14.05129	15.84138	14.35861	0	0	15.81356	0	0
Q9NX04	CA109_HUMAN	Uncharacterized protein C1orf109	C1orf109	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829	QLVAGDIVLDK	1.220000029	0.023968497	0.023968497	0.166955859	1171.540847	14.67176	10.84642	0	0	0	0	14.43288	0	15.12782	0	0	15.78486	14.42995	12.61673	15.33664	14.41139	14.07696	0	15.62279	0	0	14.37101	0	14.0586	15.03118	0	0	13.20793	14.32156	14.87806	14.8415	15.16186	15.0222	12.64358	0	15.55389	12.24017	15.58848	15.88688	14.36452	12.40044	13.05169	15.79637	12.73996	15.0514	15.30998	13.45906	13.81889
Q9NX09	DDIT4_HUMAN	"DNA damage-inducible transcript 4 protein (HIF-1 responsive protein RTP801) (Protein regulated in development and DNA damage response 1, REDD-1)"	DDIT4 REDD1 RTP801	Homo sapiens (Human)	apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; defense response to virus [GO:0051607]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of glycolytic process [GO:0045820]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of TOR signaling [GO:0032007]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron death [GO:1901216]; protein-containing complex disassembly [GO:0032984]; reactive oxygen species metabolic process [GO:0072593]; regulation of TOR signaling [GO:0032006]; response to hypoxia [GO:0001666]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 14-3-3 protein binding [GO:0071889]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; defense response to virus [GO:0051607]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of glycolytic process [GO:0045820]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of TOR signaling [GO:0032007]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron death [GO:1901216]; protein-containing complex disassembly [GO:0032984]; reactive oxygen species metabolic process [GO:0072593]; regulation of TOR signaling [GO:0032006]; response to hypoxia [GO:0001666]	14-3-3 protein binding [GO:0071889]	GO:0001666; GO:0001764; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0007420; GO:0010801; GO:0030182; GO:0032006; GO:0032007; GO:0032984; GO:0033137; GO:0042771; GO:0045820; GO:0048011; GO:0051607; GO:0071549; GO:0071889; GO:0072593; GO:1901216; GO:1902532	LLMPSQLVSQVGKELLR	1.50999999	1	1	0.536070018	1927.432284	0	15.42661	16.15559	0	0	0	17.57508	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.99177	0	0	0	0	0	0	0	16.86217	0	0	0	0	0	0	0	0
Q9NX31	OSER1_HUMAN	Oxidative stress-responsive serine-rich protein 1 (Oxidative stress-responsive protein 1) (Peroxide-inducible transcript 1 protein)	OSER1 C20orf111 BM-038 HSPC168 HSPC207	Homo sapiens (Human)	cellular response to hydrogen peroxide [GO:0070301]		cellular response to hydrogen peroxide [GO:0070301]		GO:0070301	VDASGSVASLSVGEGTGVR	5.039999962	1	1	0.170368884	1747.447489	0	0	0	16.18467	0	0	0	0	0	16.54868	0	15.46722	0	14.266	13.55658	0	0	0	0	0	13.47658	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.96613	0	0	0
Q9NX40	OCAD1_HUMAN	OCIA domain-containing protein 1 (Ovarian cancer immunoreactive antigen domain containing 1) (Ovarian carcinoma immunoreactive antigen)	OCIAD1 ASRIJ OCIA	Homo sapiens (Human)	endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]	endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736]		GO:0005764; GO:0005768; GO:0005794; GO:0006897; GO:0016020; GO:0046427; GO:0061484; GO:2000736	YGSIPK	3.24000001	1	1	0.199369745	665.5600775	19.17444	17.13071	15.09179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NX45	SOLH2_HUMAN	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	SOHLH2 TEB1	Homo sapiens (Human)	cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007283; GO:0009994; GO:0030154; GO:0042803; GO:0046982; GO:1990837	NGNGLELNASLSEFEKNK	4.699999809	1	1	0.493019283	1963.26	0	0	0	16.78646	0	0	0	0	0	0	0	0	18.01881	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.58231	0	19.08706	0	0	0	17.22614	0	0	0	0	16.86346	0	0	18.34709	0	0	0	17.62198
Q9NX58	LYAR_HUMAN	Cell growth-regulating nucleolar protein	LYAR PNAS-5	Homo sapiens (Human)	erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription regulator inhibitor activity [GO:0140416]; erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription regulator inhibitor activity [GO:0140416]	GO:0000122; GO:0001750; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0046872; GO:0048821; GO:0050766; GO:0140297; GO:0140416	GYEGK	3.059999943	1	1	0.103525944	554.2557145	14.80368	14.8535	13.48411	13.6757	15.9499	13.63698	15.23293	0	15.20004	13.2141	16.2143	15.84348	14.28095	0	15.23035	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NX62	IMPA3_HUMAN	"Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase, Golgi-resident PAP phosphatase, gPAPP, EC 3.1.3.7 (3'(2'), 5'-bisphosphate nucleotidase 2) (Inositol monophosphatase domain-containing protein 1) (Myo-inositol monophosphatase A3) (Phosphoadenosine phosphate 3'-nucleotidase)"	BPNT2 IMPA3 IMPAD1	Homo sapiens (Human)	chondrocyte development [GO:0002063]; chondroitin sulfate metabolic process [GO:0030204]; embryonic digit morphogenesis [GO:0042733]; endochondral ossification [GO:0001958]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; post-embryonic development [GO:0009791]; skeletal system development [GO:0001501]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]	"cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; 3',5'-nucleotide bisphosphate phosphatase activity [GO:0097657]; 3'-nucleotidase activity [GO:0008254]; metal ion binding [GO:0046872]; chondrocyte development [GO:0002063]; chondroitin sulfate metabolic process [GO:0030204]; embryonic digit morphogenesis [GO:0042733]; endochondral ossification [GO:0001958]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; post-embryonic development [GO:0009791]; skeletal system development [GO:0001501]"	"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; 3',5'-nucleotide bisphosphate phosphatase activity [GO:0097657]; 3'-nucleotidase activity [GO:0008254]; metal ion binding [GO:0046872]"	GO:0001501; GO:0001958; GO:0002063; GO:0005654; GO:0005794; GO:0005796; GO:0005829; GO:0008254; GO:0008441; GO:0009791; GO:0012505; GO:0016020; GO:0016021; GO:0016604; GO:0030204; GO:0032588; GO:0042733; GO:0046854; GO:0046855; GO:0046872; GO:0097657	SSYNEK	2.329999924	1	1	0.067681924	726.6978534	0	15.57905	12.60982	15.5182	11.95159	14.69297	0	0	0	0	14.77613	0	16.49946	0	0	0	0	0	17.04401	17.17896	0	17.06504	0	0	16.64322	15.31294	0	14.3246	15.79255	0	0	0	0	0	0	0	0	16.74835	0	0	0	0	0	0	0	0	0	0
Q9NX63	MIC19_HUMAN	MICOS complex subunit MIC19 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 3)	CHCHD3 MIC19 MINOS3	Homo sapiens (Human)	cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053]	extracellular exosome [GO:0070062]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; SAM complex [GO:0001401]	extracellular exosome [GO:0070062]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; SAM complex [GO:0001401]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053]	molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]	GO:0001401; GO:0005634; GO:0005739; GO:0005743; GO:0007007; GO:0008053; GO:0019902; GO:0042407; GO:0044284; GO:0060090; GO:0061617; GO:0070062; GO:0140275	AAEEVEAK	7.369999886	1	1	0.209804099	844.7909109	14.18704	15.79249	0	0	16.44113	17.06767	0	16.34192	0	0	0	0	0	14.59651	0	15.34871	0	0	0	0	0	0	15.783	0	15.77312	0	0	0	0	16.68543	15.28543	16.73063	0	0	16.737	0	0	16.76808	0	0	0	0	0	0	0	0	0	0
Q9NX74	DUS2L_HUMAN	"tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, EC 1.3.1.91 (Dihydrouridine synthase 2) (Up-regulated in lung cancer protein 8, URLC8) (tRNA-dihydrouridine synthase 2-like, hDUS2)"	DUS2 DUS2L	Homo sapiens (Human)	negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264]; negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943]	double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264]	GO:0000049; GO:0002943; GO:0003725; GO:0004860; GO:0005737; GO:0005783; GO:0005829; GO:0010181; GO:0017150; GO:0050660; GO:0060548; GO:0070402; GO:0102264	EQLESPQGR	10.85000038	0.647840321	0.647840321	0.077599226	1041.843948	0	0	15.07302	15.63429	0	16.12543	15.86093	13.88706	15.03816	16.97621	16.55026	13.65263	17.79779	18.59445	18.48204	0	18.4351	17.67927	0	16.79782	18.85269	18.43199	17.77526	18.3947	14.50151	16.13799	15.35035	0	17.09277	17.06973	0	15.74677	15.86578	17.15586	16.35178	0	16.78819	17.80168	0	19.23503	17.9103	18.31412	13.82412	0	15.54366	0	16.05273	17.22118
Q9NX76	CKLF6_HUMAN	CKLF-like MARVEL transmembrane domain-containing protein 6 (Chemokine-like factor superfamily member 6)	CMTM6 CKLFSF6	Homo sapiens (Human)	endocytic recycling [GO:0032456]; protein transport [GO:0015031]; regulation of protein stability [GO:0031647]	azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]	azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; regulation of protein stability [GO:0031647]		GO:0005886; GO:0015031; GO:0016020; GO:0016021; GO:0031647; GO:0031901; GO:0032456; GO:0035577; GO:0035579; GO:0055038	MENGAVYSPTTEEDPGPAR	1.99000001	0.19955571	0.19955571	0.157896248	2036.877331	15.03837	0	11.57094	0	0	0	0	14.13932	0	0	0	0	0	0	0	0	0	11.81935	12.94335	0	0	15.45813	15.61151	0	0	13.93641	0	0	0	12.7862	0	0	0	0	0	0	11.99095	13.93595	0	0	0	0	13.002	0	0	0	0	0
Q9NX77	ENK13_HUMAN	"Endogenous retrovirus group K member 13-1 Env polyprotein (Envelope polyprotein) (HERV-K_16p13.3 provirus ancestral Env polyprotein) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]"	ERVK13-1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]	structural molecule activity [GO:0005198]	GO:0005198; GO:0005886; GO:0016021	VPLTTKTNK	6.239999771	0.932772577	0.932772577	0.26836442	1001.307412	15.14525	15.8781	15.78071	0	0	15.8825	15.2221	15.73474	15.28445	0	15.80096	16.02596	14.83177	15.95086	0	0	0	0	16.09787	14.82773	0	16.21471	0	0	0	16.27758	16.54382	0	0	15.64094	0	0	0	15.28166	14.92368	14.82734	0	0	0	15.25264	14.80437	16.19088	15.04392	0	0	17.21207	16.46248	15.05617
Q9NX78	TM260_HUMAN	Transmembrane protein 260	TMEM260 C14orf101	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	MSPHGDGR	4.119999886	1	1	0.245194281	872.6301274	13.84022	15.50635	0	14.58759	15.57219	15.69555	15.65117	0	15.02806	0	16.33161	13.67805	15.5074	16.2508	14.97641	14.96647	14.9696	0	0	15.82899	0	0	15.38771	0	0	0	0	0	0	14.67578	0	0	15.33074	16.19786	0	0	0	0	16.36218	0	0	0	0	0	0	0	0	14.81833
Q9NX95	SYBU_HUMAN	Syntabulin (Golgi-localized syntaphilin-related protein) (Syntaxin-1-binding protein)	SYBU GOLSYN KIAA1472	Homo sapiens (Human)	axonal transport of mitochondrion [GO:0019896]; synapse maturation [GO:0060074]	axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; kinesin binding [GO:0019894]; syntaxin-1 binding [GO:0017075]; axonal transport of mitochondrion [GO:0019896]; synapse maturation [GO:0060074]	kinesin binding [GO:0019894]; syntaxin-1 binding [GO:0017075]	GO:0000139; GO:0005881; GO:0016021; GO:0017075; GO:0019894; GO:0019896; GO:0031410; GO:0043231; GO:0060074; GO:1904115	GSDCSPIMR	4.940000057	0.618527114	0.618527114	0.246481087	1039.390739	16.08941	17.4526	16.24682	15.6086	0	0	15.82293	13.90302	0	15.92216	0	17.48862	0	14.3814	13.51794	13.92078	16.16528	0	0	0	14.611	0	16.50502	0	16.83185	0	16.29395	16.58517	16.43089	0	15.43274	0	16.40932	0	0	0	0	0	0	16.43578	16.30537	15.79298	16.03688	0	16.19795	17.49953	15.61083	16.02331
Q9NXA8	SIR5_HUMAN	"NAD-dependent protein deacylase sirtuin-5, mitochondrial, EC 2.3.1.- (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5)"	SIRT5 SIR2L5	Homo sapiens (Human)	mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]; response to nutrient levels [GO:0031667]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]; response to nutrient levels [GO:0031667]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]	GO:0003950; GO:0005634; GO:0005739; GO:0005758; GO:0005759; GO:0005829; GO:0006471; GO:0006476; GO:0007005; GO:0008270; GO:0010566; GO:0010667; GO:0031667; GO:0034979; GO:0036046; GO:0036047; GO:0036048; GO:0036049; GO:0036054; GO:0036055; GO:0061697; GO:0061698; GO:0070403; GO:2000378	NQICLKMARPSSSMADFR	2.779999971	1	1	0.140065896	2111.969433	12.08937	10.64773	14.71656	0	11.19798	0	15.28156	0	0	0	0	0	0	16.3839	0	0	0	0	0	0	13.87556	0	15.92317	0	0	11.23801	13.18404	0	0	12.47166	0	16.06024	0	0	17.26121	0	0	0	0	14.64532	0	0	12.03952	0	0	0	14.33633	0
Q9NXB0	MKS1_HUMAN	Meckel syndrome type 1 protein	MKS1	Homo sapiens (Human)	"branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]"	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]	"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]"		GO:0001843; GO:0003271; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1901620; GO:1905515; GO:1990403; GO:2000095	IPGSFK	9.510000229	1	1	0.161745554	647.4624082	0	0	0	0	0	0	0	0	0	0	15.01131	14.59423	0	0	12.24119	0	13.0609	0	0	0	0	14.62223	0	0	17.97349	15.48761	0	14.88777	15.17113	14.04144	18.93942	13.75157	17.30643	17.12789	16.86559	0	0	0	19.23569	0	0	0	14.06087	0	0	19.02506	0	0
Q9NXD2	MTMRA_HUMAN	Myotubularin-related protein 10 (Inactive phosphatidylinositol 3-phosphatase 10)	MTMR10	Homo sapiens (Human)	phosphatidylinositol dephosphorylation [GO:0046856]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol dephosphorylation [GO:0046856]	phosphatidylinositol-3-phosphatase activity [GO:0004438]	GO:0004438; GO:0005737; GO:0005829; GO:0046856	LICSNFK	4.559999943	1	1	0.143162123	881.5610162	13.81385	16.13102	0	14.85888	14.71152	11.89809	15.94835	0	0	16.23755	0	0	0	0	0	0	15.70867	0	0	0	16.33666	16.48817	15.88176	16.0296	0	0	0	0	14.6386	14.68169	0	0	0	0	15.92066	0	16.58379	17.32749	18.11557	0	13.91764	16.60397	18.28389	0	16.70976	0	15.70434	0
Q9NXE4	NSMA3_HUMAN	"Sphingomyelin phosphodiesterase 4, EC 3.1.4.12 (Neutral sphingomyelinase 3, nSMase-3, nSMase3) (Neutral sphingomyelinase III)"	SMPD4 KIAA1418 SKNY	Homo sapiens (Human)	cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; sarcolemma [GO:0042383]; trans-Golgi network [GO:0005802]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; sarcolemma [GO:0042383]; trans-Golgi network [GO:0005802]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685]	metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290]	GO:0000139; GO:0004767; GO:0005635; GO:0005640; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0006685; GO:0007029; GO:0016021; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356	GPRLSLR	2.039999962	0.324166417	0.324166417	0.072777299	799.4293601	0	17.38351	15.30179	15.88254	13.51146	0	0	0	0	17.12482	0	0	16.26608	0	0	0	0	16.5053	0	16.05627	13.29931	0	17.62842	0	0	0	0	0	0	17.37962	14.59416	18.2659	16.18862	0	18.02624	13.98012	17.17515	17.63962	16.70226	0	15.66334	15.46173	0	0	16.85583	0	0	0
Q9NXE8	CWC25_HUMAN	Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25)	CWC25 CCDC49	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684]	"nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]"		GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006	SRSPRPSK	6.389999866	0.517953873	0.517953873	0.082420799	914.6104283	16.91208	14.86553	15.86583	15.67567	0	13.89911	0	15.42895	16.3209	15.60213	16.51601	0	14.53026	0	0	0	0	0	0	0	0	0	15.72568	0	0	0	0	0	0	0	0	0	0	0	0	0	15.7358	0	0	15.15589	0	16.47188	0	0	0	0	0	0
Q9NXF1	TEX10_HUMAN	Testis-expressed protein 10	TEX10 L18 Nbla10363	Homo sapiens (Human)		mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0071339	QHDFQK	7.170000076	0.408816963	0.408816963	0.163317458	803.0086597	0	13.74247	0	13.95011	14.2477	14.65408	0	15.07417	11.21175	0	0	0	14.44049	15.69224	0	14.44412	12.41455	14.97628	14.10054	0	0	0	0	0	0	0	0	14.40899	0	15.2492	0	0	0	0	14.46545	0	0	0	0	15.26068	0	0	0	0	0	0	13.12671	0
Q9NXG0	CNTLN_HUMAN	Centlein (Centrosomal protein)	CNTLN C9orf101 C9orf39	Homo sapiens (Human)	centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365]	protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]	GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0033365; GO:0070062	AKSEMATMK	14.82999992	1	1	1.03E-12	1013.674203	16.2403	14.27923	14.61215	13.95644	0	15.35685	0	0	0	15.32508	0	13.17665	15.29781	15.89009	0	0	0	0	0	0	0	0	13.14272	15.82833	15.66198	17.03646	0	0	0	0	0	0	0	0	0	0	0	0	0	16.22861	14.99667	0	0	0	0	0	18.42261	0
Q9NXH8	TOR4A_HUMAN	Torsin-4A (Torsin family 4 member A)	TOR4A C9orf167	Homo sapiens (Human)		endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; platelet alpha granule lumen [GO:0031093]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]	GO:0005524; GO:0005576; GO:0005635; GO:0005788; GO:0016021; GO:0016887; GO:0031093	ASLLAVLSR	13.23999977	1	1	0.396577981	927.8440023	15.07183	16.30099	14.96314	16.02915	0	15.19911	15.88926	0	15.01615	16.03515	14.26156	16.28412	14.64882	15.5867	15.56849	16.1749	15.91105	16.06482	14.59844	14.94557	16.66828	0	0	14.94395	15.81378	15.8014	15.89579	15.18856	16.30434	15.19166	16.43222	0	0	15.10279	16.23222	16.70536	15.78522	17.01784	0	0	0	0	15.60797	16.21966	15.64527	0	16.34939	0
Q9NXL2	ARH38_HUMAN	Rho guanine nucleotide exchange factor 38	ARHGEF38	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005737	LNIHSISK	8.140000343	0.606539845	0.606539845	0.093147133	911.6506894	15.74773	13.32027	13.08369	13.82948	0	0	16.42358	0	0	0	14.16052	0	16.29173	15.19412	17.38147	12.44972	16.33239	13.98794	16.19055	13.63876	16.6248	15.70928	16.25016	15.33851	16.54576	13.06894	0	11.4473	16.18885	15.5124	0	15.31421	16.17358	0	0	15.03263	14.24221	17.93317	15.50172	12.86695	13.39517	17.18613	15.96514	0	0	16.18797	0	0
Q9NXL9	MCM9_HUMAN	"DNA helicase MCM9, hMCM9, EC 3.6.4.12 (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9)"	MCM9 C6orf61 MCMDC1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298]	chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]	chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0003678; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006974; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0032508; GO:0036298; GO:0042555; GO:0044877; GO:0070716; GO:0071168; GO:0097362	IISSFILENKGYPSK	17.45999908	1	1	0.266183798	1693.28001	0	14.03451	14.86384	14.43579	0	14.9307	15.23821	0	0	14.35422	0	0	0	0	0	15.21237	0	13.92433	0	0	14.75036	0	0	0	0	0	0	13.90534	16.5094	0	15.6652	16.65898	0	0	0	0	0	0	0	0	0	0	0	0	15.46642	0	16.54327	0
Q9NXN4	GDAP2_HUMAN	Ganglioside-induced differentiation-associated protein 2	GDAP2	Homo sapiens (Human)	response to retinoic acid [GO:0032526]	lysosomal membrane [GO:0005765]	lysosomal membrane [GO:0005765]; response to retinoic acid [GO:0032526]		GO:0005765; GO:0032526	LLPLYFPRSLK	6.570000172	7.93E-05	7.93E-05	0.187520917	1345.848371	0	17.89472	0	0	0	0	15.77741	16.49878	0	0	0	0	0	0	0	0	17.3468	0	0	0	0	0	0	0	0	0	17.20675	0	0	0	0	0	19.37599	0	17.46054	0	0	18.1093	0	0	17.21761	17.52372	0	0	0	15.7099	0	0
Q9NXP7	GIN1_HUMAN	"Gypsy retrotransposon integrase-like protein 1, GIN-1 (Ty3/Gypsy integrase 1) (Zinc finger H2C2 domain-containing protein)"	GIN1 TGIN1 ZH2C2	Homo sapiens (Human)	DNA integration [GO:0015074]		nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]	nucleic acid binding [GO:0003676]	GO:0003676; GO:0015074	NTPYFQMFSR	11.82999992	1	1	0.188413785	1307.321872	15.81302	0	18.11976	0	0	0	15.96812	0	0	0	0	0	0	0	0	0	0	0	0	0	13.57701	0	0	13.71484	0	0	0	17.31659	13.20658	0	0	0	0	0	0	18.08126	0	0	0	0	0	0	16.99799	0	0	0	16.51501	0
Q9NXR8	ING3_HUMAN	Inhibitor of growth protein 3 (p47ING3)	ING3 HSPC301	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]"	NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]	"NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]"	metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	GO:0000786; GO:0000812; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016573; GO:0032777; GO:0035064; GO:0035267; GO:0040008; GO:0042981; GO:0043065; GO:0043967; GO:0043968; GO:0045893; GO:0046872; GO:0051726; GO:1905168; GO:2000779	WYCPQCTAAMKR	5.760000229	1	1	1.14E-12	1586.539237	15.22044	0	13.81929	13.28836	12.97826	14.8972	0	12.9365	12.88011	0	12.33294	15.08669	0	0	13.51872	14.53991	0	16.12271	12.9592	13.62598	10.20932	0	15.33138	0	0	0	0	0	15.22433	14.69987	15.23897	14.62536	12.68931	13.83193	0	0	16.14409	15.1228	0	0	14.51192	14.88762	0	0	0	0	0	14.38746
Q9NXS2	QPCTL_HUMAN	"Glutaminyl-peptide cyclotransferase-like protein, EC 2.3.2.5 (Golgi-resident glutaminyl-peptide cyclotransferase) (isoQC, gQC)"	QPCTL	Homo sapiens (Human)	"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]"	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]"	glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]	GO:0000139; GO:0005794; GO:0008270; GO:0016020; GO:0016021; GO:0016603; GO:0017186	TPGSPGNLQVRK	6.840000153	1	1	0.455716551	1254.88418	0	10.0461	11.39701	14.13552	14.32598	0	0	14.20047	14.89459	0	14.36716	11.66185	13.67633	0	0	15.48448	0	0	0	14.73228	15.09146	0	0	0	0	16.54766	0	0	15.49631	0	0	16.60458	0	0	16.31689	0	15.53489	17.37549	0	16.03284	0	16.60228	0	0	0	15.72268	16.08059	15.57767
Q9NXS3	KLH28_HUMAN	Kelch-like protein 28 (BTB/POZ domain-containing protein 5)	KLHL28 BTBD5	Homo sapiens (Human)						YDPSKDSWEMVASMADK	5.690000057	1	1	0.397338899	1990.79536	0	0	12.57307	0	0	0	15.52653	0	15.85841	17.70225	0	13.02873	17.99544	9.699737	0	0	0	0	0	0	0	0	16.21224	16.51128	0	16.56298	0	0	0	0	0	0	0	16.4773	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NXV6	CARF_HUMAN	CDKN2A-interacting protein (Collaborator of ARF)	CDKN2AIP CARF	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell growth [GO:0030308]; positive regulation of cell growth [GO:0030307]; positive regulation of signal transduction [GO:0009967]; regulation of protein stability [GO:0031647]	granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell growth [GO:0030308]; positive regulation of cell growth [GO:0030307]; positive regulation of signal transduction [GO:0009967]; regulation of protein stability [GO:0031647]	p53 binding [GO:0002039]; RNA binding [GO:0003723]	GO:0001652; GO:0002039; GO:0003723; GO:0005654; GO:0005730; GO:0006974; GO:0009967; GO:0030307; GO:0030308; GO:0031647	VIEGKNSSAVEQDHAK	5.329999924	1	1	0.455053807	1713.690098	0	0	0	0	0	0	0	0	17.59142	0	0	0	0	0	0	0	0	0	16.28602	0	14.18504	0	0	0	0	18.63862	0	18.86987	0	0	0	0	0	17.84001	19.41148	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NXW2	DJB12_HUMAN	DnaJ homolog subfamily B member 12	DNAJB12	Homo sapiens (Human)	cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433]	Hsp70 protein binding [GO:0030544]	GO:0005783; GO:0005789; GO:0016020; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0036503; GO:0051085; GO:0065003; GO:0071218	AIQSNQPDR	4.599999905	1	1	0.305787773	1027.847343	15.31954	16.65256	16.7157	17.45029	17.88308	17.57013	0	0	17.78685	0	17.43764	0	0	0	16.59119	17.70995	0	0	0	0	0	0	17.9179	0	0	0	0	17.1551	0	0	0	18.3705	0	0	0	19.66573	17.52249	0	0	17.13519	0	18.02545	0	0	0	0	0	0
Q9NXX6	NSE4A_HUMAN	"Non-structural maintenance of chromosomes element 4 homolog A, NS4EA, Non-SMC element 4 homolog A"	NSMCE4A C10orf86 PP4762	Homo sapiens (Human)	DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]	"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]"	"chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]"		GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0006281; GO:0016604; GO:0016925; GO:0030915; GO:0032204; GO:2001022	GPEGR	7.230000019	0.358177215	0.358177215	0.158703041	514.3857853	16.71128	17.6913	0	18.79735	18.23502	17.48314	16.83049	18.25834	16.93355	18.67566	16.42819	16.79083	16.47445	16.57874	16.6436	17.44807	18.21246	16.31924	17.35098	18.24187	17.12984	18.15688	16.60739	17.51784	16.6812	18.17673	17.71077	18.18958	16.36312	16.52656	17.54829	17.09468	17.37688	18.4024	17.62892	16.86392	16.7594	15.5185	17.06115	18.06487	17.06435	17.39232	18.10999	15.57068	15.46781	17.48377	16.78801	16.97256
Q9NXZ1	SAGE1_HUMAN	"Sarcoma antigen 1 (Cancer/testis antigen 14, CT14)"	SAGE1 SAGE	Homo sapiens (Human)	snRNA 3'-end processing [GO:0034472]	integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; snRNA 3'-end processing [GO:0034472]		GO:0005654; GO:0016604; GO:0032039; GO:0034472	EEKMESGKPQTDK	9.329999924	0.452168047	0.452168047	0.395940879	1523.427914	0	14.61101	12.4582	0	14.74887	15.73119	10.55422	0	13.89572	12.84534	16.11352	16.03987	0	14.66656	0	0	0	0	15.86326	0	16.20395	0	0	0	0	0	0	11.10822	0	15.89581	0	16.4232	0	16.86728	15.98278	17.1468	0	0	0	14.91316	18.28745	0	0	0	0	0	0	0
Q9NXZ2	DDX43_HUMAN	"Probable ATP-dependent RNA helicase DDX43, EC 3.6.4.13 (Cancer/testis antigen 13, CT13) (DEAD box protein 43) (DEAD box protein HAGE) (Helical antigen)"	DDX43 HAGE	Homo sapiens (Human)			ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0016887	TGPEGYSVGR	10.82999992	1	1	0.07327418	1022.732006	13.03835	0	0	0	10.59397	0	18.29207	0	0	12.07245	15.9362	15.06842	0	0	16.75615	13.01398	0	14.39959	15.88348	17.08641	13.24697	17.21514	15.45837	9.437531	13.13857	13.14919	17.43315	15.53347	16.03617	0	0	15.84312	15.90085	0	16.80922	0	16.50128	17.46296	0	16.98151	13.16323	16.15724	0	15.7906	0	14.3963	16.61897	15.1303
Q9NY26	S39A1_HUMAN	"Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1, ZIP-1, hZIP1)"	SLC39A1 IRT1 ZIP1 ZIRTL CGI-08 CGI-71	Homo sapiens (Human)	cation transport [GO:0006812]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inorganic cation transmembrane transporter activity [GO:0022890]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385]; cation transport [GO:0006812]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577]	inorganic cation transmembrane transporter activity [GO:0022890]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0001701; GO:0005102; GO:0005385; GO:0005789; GO:0005886; GO:0006812; GO:0016020; GO:0016021; GO:0022890; GO:0048701; GO:0060173; GO:0071577	GILAVSLSLR	5.539999962	0.176186323	0.176186323	0.274700978	1028.441629	17.4429	18.0705	0	0	0	0	0	17.58641	19.5879	16.39036	0	0	16.27297	0	0	0	17.16404	0	0	0	0	0	0	16.23406	17.8175	17.84955	17.00512	16.67721	16.73056	0	19.00777	17.70643	0	17.81708	0	0	17.21563	0	0	17.37041	0	18.21792	0	0	0	0	0	0
Q9NY27	PP4R2_HUMAN	Serine/threonine-protein phosphatase 4 regulatory subunit 2	PPP4R2 SBBI57	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; histone dephosphorylation [GO:0016576]; mRNA processing [GO:0006397]; negative regulation of histone phosphorylation [GO:0033128]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569]; RNA splicing [GO:0008380]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]; cellular protein modification process [GO:0006464]; histone dephosphorylation [GO:0016576]; mRNA processing [GO:0006397]; negative regulation of histone phosphorylation [GO:0033128]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569]; RNA splicing [GO:0008380]	protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]	GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006397; GO:0006464; GO:0006470; GO:0008380; GO:0010569; GO:0016576; GO:0019888; GO:0030289; GO:0030674; GO:0033128; GO:2000779	ETEELVGSNSSK	5.650000095	1	1	0.438458865	1279.34451	19.66337	0	0	17.67187	0	0	0	0	0	0	15.19005	0	0	18.22734	17.55368	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.70162	19.60181	0	0	0	20.01186	0	17.28199	17.71849	0	0	0	0	0	0	0
Q9NY46	SCN3A_HUMAN	Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3)	SCN3A KIAA1356 NAC3	Homo sapiens (Human)	membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; cytoplasm [GO:0005737]; voltage-gated sodium channel complex [GO:0001518]	axon [GO:0030424]; cytoplasm [GO:0005737]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0005737; GO:0006814; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0086010	GRIDLPIK	2.519999981	1	1	0.276952388	912.7723342	18.71524	16.85333	18.11177	0	19.27377	18.20681	17.49203	0	0	0	0	0	16.62707	0	16.8003	0	18.51303	0	0	0	0	0	16.73955	16.66108	18.72208	0	0	0	0	16.79103	19.48291	18.4712	0	0	16.85072	0	0	17.59453	18.3264	0	17.59305	0	0	0	16.76846	18.59675	17.63865	18.09837
Q9NY47	CA2D2_HUMAN	Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2 ]	CACNA2D2 KIAA0558	Homo sapiens (Human)	regulation of ion transmembrane transport [GO:0034765]	plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]	plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765]	metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]	GO:0005245; GO:0005886; GO:0005891; GO:0034765; GO:0046872	INTQEYLDVLGRPMVLAGK	5.320000172	1	1	3.65E-12	2132.842947	0	0	0	17.76766	0	0	0	12.09969	15.74613	12.52888	17.45528	17.0382	0	16.33853	12.81054	10.18856	16.07966	0	0	15.9672	10.97079	0	16.67394	10.53285	14.72213	18.06584	0	0	0	14.41492	0	0	16.67075	12.54577	12.02564	12.4	16.04597	15.78426	0	15.1497	16.09176	12.98086	17.34019	0	14.0771	14.7886	0	17.60296
Q9NY61	AATF_HUMAN	Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1)	AATF CHE1 DED HSPC277	Homo sapiens (Human)	cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]	leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]	GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005794; GO:0006357; GO:0006974; GO:0007155; GO:0007346; GO:0019901; GO:0032929; GO:0040016; GO:0042254; GO:0042985; GO:0043066; GO:0043522; GO:0045944; GO:0048156; GO:2000378; GO:2001234	LEMEDYPSFMAKR	7.599999905	1	1	0.450903688	1633.125459	0	0	0	0	0	0	0	16.56252	0	17.46631	0	0	0	17.43472	0	0	0	17.82034	0	0	0	0	19.9232	0	0	0	0	0	0	0	19.61731	0	18.56644	0	0	19.35596	0	0	0	0	0	0	18.27904	17.39997	0	0	0	0
Q9NY64	GTR8_HUMAN	"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8, GLUT-8) (Glucose transporter type X1)"	SLC2A8 GLUT8 GLUTX1	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666]	clathrin-coated endocytic vesicle membrane [GO:0030669]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]	clathrin-coated endocytic vesicle membrane [GO:0030669]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666]	D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]	GO:0001666; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0030669; GO:0033300; GO:0055056; GO:0070837; GO:1904659	GKTLEQITAHFEGR	3.25999999	1	1	0.042312814	1586.844315	0	0	0	0	0	0	0	0	0	0	0	14.09055	0	0	0	13.88032	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.33926	16.83465	14.69266	0	0	0	14.69751	0	0	0	0	0	0	0	0	0	0
Q9NY74	ETAA1_HUMAN	Ewing's tumor-associated antigen 1 (Ewing's tumor-associated antigen 16)	ETAA1 ETAA16	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]	cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]	protein serine/threonine kinase activator activity [GO:0043539]	GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0031297; GO:0043539; GO:0043596; GO:0071902; GO:2000001	KPIKGNTK	4.170000076	1	1	0.180298193	881.6060336	12.81017	0	16.39709	13.99045	15.9981	15.40448	0	15.93073	0	0	15.80572	0	15.52728	0	15.14709	0	14.45747	0	15.76723	15.71905	16.23949	0	0	0	15.22236	0	15.20013	15.88404	16.59428	0	0	0	15.87812	13.88062	14.51222	14.61001	16.47799	15.24349	15.67145	15.20537	14.67944	15.63071	15.15317	16.59743	16.18965	14.08499	15.63097	15.5551
Q9NY87	SPNXC_HUMAN	"Sperm protein associated with the nucleus on the X chromosome C (Cancer/testis antigen 11.3, CT11.3) (Cancer/testis-associated protein CTp11) (Nuclear-associated protein SPAN-Xc, SPANX-C) (SPANX family member C)"	SPANXC	Homo sapiens (Human)		cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]		GO:0005634; GO:0005737	LKTSESSTILVVR	5.340000153	1	1	0.282859255	1433.266244	0	14.71031	15.5715	13.15042	0	15.17902	0	0	13.28089	15.13754	15.50202	13.35077	0	10.75236	15.91046	14.91619	0	11.95492	14.56781	13.93049	0	13.77114	15.82199	0	0	0	14.98565	0	0	0	0	14.34137	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NY91	SC5A4_HUMAN	Solute carrier family 5 member 4	SLC5A4 SAAT1 SGLT3	Homo sapiens (Human)	sodium ion transport [GO:0006814]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814]	glucose:sodium symporter activity [GO:0005412]	GO:0005412; GO:0005886; GO:0006814; GO:0016021	RFGGER	10.52999973	1	1	0.271740577	720.8061726	14.12651	0	15.2001	14.92449	14.98042	12.68231	14.39845	15.39813	14.22011	0	15.04002	15.37087	16.39467	15.47742	14.30905	16.46466	11.67692	12.94479	14.82118	0	15.26519	0	0	0	16.54659	0	0	15.28865	15.73839	14.14118	14.53676	16.49527	0	15.35588	14.65622	0	0	15.77867	17.38567	16.66633	0	0	16.07337	0	16.01691	0	15.33352	0
Q9NY93	DDX56_HUMAN	"Probable ATP-dependent RNA helicase DDX56, EC 3.6.4.13 (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56)"	DDX56 DDX21 NOH61	Homo sapiens (Human)	positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]	membrane [GO:0016020]; nucleolus [GO:0005730]	membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976; GO:0016020; GO:0016887	ASDPEAGVAR	6.880000114	1	1	1.37E-12	973.2310049	16.50959	14.103	0	12.31629	15.63697	14.75873	15.76616	13.29603	14.89535	15.12329	13.22397	0	14.89518	0	0	0	0	0	15.10005	0	0	0	0	0	16.20956	13.86176	15.01799	12.89849	15.11347	13.5392	0	0	0	0	0	0	0	0	0	0	0	0	11.96052	0	0	0	0	0
Q9NY99	SNTG2_HUMAN	"Gamma-2-syntrophin, G2SYN (Syntrophin-5, SYN5)"	SNTG2	Homo sapiens (Human)	central nervous system development [GO:0007417]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; central nervous system development [GO:0007417]	actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]	GO:0003779; GO:0005198; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0007417; GO:0016010; GO:0016013; GO:0030165; GO:0042383; GO:0097109	ATFMEVQRTGSR	2.819999933	1	1	0.306380552	1382.768876	0	0	14.3264	0	0	0	12.8084	15.33614	14.18078	0	13.57394	13.82849	0	13.74766	0	0	0	0	0	14.16788	0	0	0	0	0	14.05016	0	0	14.98094	0	0	14.10374	0	0	0	0	0	0	0	14.42183	0	0	0	0	13.14575	0	16.76456	0
Q9NYA1	SPHK1_HUMAN	"Sphingosine kinase 1, SK 1, SPK 1, EC 2.7.1.91 (Acetyltransferase SPHK1, EC 2.3.1.-)"	SPHK1 SK1 SPHK SPK	Homo sapiens (Human)	blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]	acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]	GO:0000287; GO:0001568; GO:0001727; GO:0003677; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006473; GO:0006665; GO:0006670; GO:0006954; GO:0007420; GO:0008289; GO:0008481; GO:0010800; GO:0010803; GO:0016020; GO:0016310; GO:0016407; GO:0017050; GO:0019722; GO:0030100; GO:0030139; GO:0030148; GO:0030307; GO:0030335; GO:0031398; GO:0031901; GO:0032651; GO:0032740; GO:0034612; GO:0035556; GO:0035924; GO:0038036; GO:0043066; GO:0043231; GO:0045766; GO:0045840; GO:0045931; GO:0045987; GO:0046512; GO:0046521; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0070301; GO:0071363; GO:0071897; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364	DPAGGPR	1.389999986	0.515886366	0.515886366	0.107625718	670.4773787	0	14.37432	12.97492	0	0	0	0	0	0	0	16.19265	0	0	0	0	0	0	0	0	0	0	0	15.02839	0	0	0	0	15.5177	0	15.94778	0	0	0	0	0	0	0	0	0	15.40006	0	17.41969	0	0	0	16.37382	16.66763	17.59501
Q9NYA3	GOG6A_HUMAN	Golgin subfamily A member 6A (Golgin linked to PML) (Golgin-like protein)	GOLGA6A GLP GOLGA6	Homo sapiens (Human)	Golgi organization [GO:0007030]	cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]	cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030]		GO:0000137; GO:0005801; GO:0007030; GO:0032580	SLSELKNQMAEPPSLAPPAVTSVVEQLQDEAK	2.420000076	1	1	0.181055989	3406.460145	0	0	0	0	11.59542	7.372975	0	7.718947	0	14.3164	13.32394	12.69819	10.78539	13.42327	12.03982	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NYA4	MTMR4_HUMAN	"Myotubularin-related protein 4, EC 3.1.3.48 (FYVE domain-containing dual specificity protein phosphatase 2, FYVE-DSP2) (Zinc finger FYVE domain-containing protein 11)"	MTMR4 KIAA0647 ZFYVE11	Homo sapiens (Human)	negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transforming growth factor beta receptor signaling pathway [GO:0007179]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular space [GO:0005615]	"cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transforming growth factor beta receptor signaling pathway [GO:0007179]"	"metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005615; GO:0005768; GO:0005829; GO:0006470; GO:0006661; GO:0007179; GO:0010506; GO:0019903; GO:0030512; GO:0031901; GO:0046856; GO:0046872; GO:0052629; GO:0060304	IPVVVYR	6.420000076	1	1	0.302450468	845.9043881	15.18071	16.80835	0	0	0	0	14.883	16.14701	0	0	0	13.33806	0	0	16.93423	0	14.19666	0	16.23693	15.29899	0	0	16.67743	0	0	0	17.27858	17.54295	0	15.76499	0	0	16.7754	16.14798	17.2247	17.30234	15.62371	18.19845	0	16.95092	17.55087	16.86134	17.16893	16.89205	17.38086	17.39924	15.31947	15.98064
Q9NYB5	SO1C1_HUMAN	"Solute carrier organic anion transporter family member 1C1 (Organic anion transporter F, OATP-F) (Organic anion transporter polypeptide-related protein 5, OAT-RP-5, OATPRP5) (Organic anion-transporting polypeptide 14, OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter)"	SLCO1C1 OATP14 OATP1C1 OATPF SLC21A14	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; positive regulation of thyroid hormone generation [GO:2000611]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; bile acid and bile salt transport [GO:0015721]; positive regulation of thyroid hormone generation [GO:2000611]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0005886; GO:0005887; GO:0015125; GO:0015347; GO:0015349; GO:0015721; GO:0016323; GO:0043252; GO:0055085; GO:0070327; GO:0150104; GO:2000611	ERTMVSTR	3.890000105	1	1	0.17953601	980.3979273	0	0	0	15.12797	0	0	14.11955	11.59701	15.65919	12.83429	15.91518	16.71349	15.43946	0	14.12417	0	0	14.16242	0	0	0	0	0	0	0	0	0	0	0	15.91766	0	0	16.03123	0	0	0	0	0	0	0	0	0	13.99166	0	0	13.96724	0	0
Q9NYC9	DYH9_HUMAN	Dynein axonemal heavy chain 9 (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9)	DNAH9 DNAH17L DNEL1 KIAA0357	Homo sapiens (Human)	cell projection organization [GO:0030030]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]; mucociliary clearance [GO:0120197]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]	9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cell projection organization [GO:0030030]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]; mucociliary clearance [GO:0120197]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003341; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0031514; GO:0036157; GO:0045505; GO:0051959; GO:0090660; GO:0097729; GO:0120135; GO:0120197	AALAAENADGEPGADR	30.92000008	1	1	0.203814052	1527.97624	24.01407	0	0	0	0	24.04543	0	0	0	0	0	0	23.58134	0	0	23.17624	0	0	0	0	0	23.44995	0	0	0	0	0	0	21.72569	0	0	0	0	23.75042	22.31023	22.71845	0	0	0	0	0	23.54472	0	23.5835	0	0	0	22.23974
Q9NYD6	HXC10_HUMAN	Homeobox protein Hox-C10 (Homeobox protein Hox-3I)	HOXC10 HOX3I	Homo sapiens (Human)	anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuromuscular process [GO:0050905]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; spinal cord motor neuron cell fate specification [GO:0021520]	chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuromuscular process [GO:0050905]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; spinal cord motor neuron cell fate specification [GO:0021520]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0008284; GO:0009952; GO:0009954; GO:0016604; GO:0021520; GO:0030326; GO:0045944; GO:0050905; GO:0120163; GO:1990837	SAGMYMQSGSDFNCGVMRGCGLAPSLSK	5.159999847	1	1	0.219138284	2983.83204	0	0	0	0	0	0	0	0	0	14.61839	0	0	0	0	0	10.80321	0	0	0	0	0	0	0	0	14.66751	0	15.83335	0	0	0	0	0	16.57434	0	18.03187	0	0	0	14.38891	0	0	0	0	0	14.71345	0	0	0
Q9NYF0	DACT1_HUMAN	"Dapper homolog 1, hDPR1 (Dapper antagonist of catenin 1) (Hepatocellular carcinoma novel gene 3 protein)"	DACT1 DPR1 HNG3	Homo sapiens (Human)	"embryonic hindgut morphogenesis [GO:0048619]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube development [GO:0021915]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein stability [GO:0031647]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; beta-catenin binding [GO:0008013]; delta-catenin binding [GO:0070097]; histone deacetylase binding [GO:0042826]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; embryonic hindgut morphogenesis [GO:0048619]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube development [GO:0021915]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein stability [GO:0031647]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]"	beta-catenin binding [GO:0008013]; delta-catenin binding [GO:0070097]; histone deacetylase binding [GO:0042826]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]	GO:0000122; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008013; GO:0016055; GO:0021915; GO:0030177; GO:0030178; GO:0031647; GO:0032091; GO:0032092; GO:0042826; GO:0045202; GO:0045732; GO:0046329; GO:0048619; GO:0051018; GO:0060828; GO:0061629; GO:0070097; GO:0090090; GO:0090263; GO:1903364; GO:1904864; GO:2000095; GO:2000134	GAGGAGAAAPR	5.639999866	1	1	5.48E-05	855.1183712	0	0	0	0	0	0	0	0	0	0	0	0	0	15.55447	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.01735	0	0	14.53571	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NYF3	FA53C_HUMAN	Protein FAM53C	FAM53C C5orf6	Homo sapiens (Human)	protein import into nucleus [GO:0006606]	nucleus [GO:0005634]	nucleus [GO:0005634]; protein import into nucleus [GO:0006606]		GO:0005634; GO:0006606	RLRPSLDFDK	7.989999771	0.752840936	0.752840936	0.196385757	1244.082724	0	0	0	15.45686	0	0	13.27804	15.37746	0	0	0	0	0	0	0	0	0	15.37607	0	0	0	0	16.57456	14.97532	0	0	16.15517	0	0	0	0	0	13.25274	0	0	9.441109	0	0	0	9.521435	0	15.74568	0	0	0	0	0	0
Q9NYF5	FA13B_HUMAN	Protein FAM13B (GAP-like protein N61)	FAM13B C5orf5 FAM13B1	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0051056	NAQKEDR	2.960000038	1	1	0.213658174	861.5099518	0	0	0	12.33483	16.02322	15.76246	0	15.51093	0	14.2672	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.51818	0	17.16806	0	0	15.55267	16.88183	0	0	0	0	0	0	0	0	0	0	0	0
Q9NYF8	BCLF1_HUMAN	"Bcl-2-associated transcription factor 1, Btf (BCLAF1 and THRAP3 family member 1)"	BCLAF1 BTF KIAA0164	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]"	cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]"	DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	GO:0003677; GO:0003712; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0016592; GO:0016607; GO:0043065; GO:0043620; GO:0045892; GO:0045944; GO:1990830; GO:2000144; GO:2001022; GO:2001244	EEDKNSER	8.779999733	0.546656966	0.546656966	0.149666127	1007.665782	14.8294	14.4064	0	14.70451	0	0	11.92997	16.37107	0	13.09965	15.23432	14.49076	0	13.65471	0	0	0	0	0	0	14.13493	0	0	0	0	0	0	0	0	0	0	0	0	14.2912	0	15.25577	13.769	0	15.42486	0	15.53542	0	0	0	0	0	0	0
Q9NYG2	ZDHC3_HUMAN	"Palmitoyltransferase ZDHHC3, EC 2.3.1.225 (Acyltransferase ZDHHC3, EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3, DHHC-3)"	ZDHHC3 HSD49	Homo sapiens (Human)	"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]"	palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]	GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:0140439; GO:1902685; GO:1903546	AMLTDPGAVPKGNATK	9.539999962	1	1	0.513862602	1587.005233	16.95743	17.22629	16.17692	16.31001	0	0	0	19.42845	0	0	0	0	0	0	17.56745	16.64015	0	0	0	0	17.26172	0	0	0	16.88626	18.17931	0	0	17.7977	0	15.19999	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32318	0	0	0
Q9NYH9	UTP6_HUMAN	U3 small nucleolar RNA-associated protein 6 homolog (Hepatocellular carcinoma-associated antigen 66) (Multiple hat domains protein)	UTP6 C17orf40 HCA66 MHAT	Homo sapiens (Human)	"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"	snoRNA binding [GO:0030515]	GO:0000462; GO:0005654; GO:0005694; GO:0005730; GO:0030515; GO:0032040; GO:0034388	MELMHAEK	7.650000095	0.9030689	0.9030689	0.024486727	1003.025568	0	0	0	0	0	0	0	0	13.73898	0	0	0	0	0	11.51977	0	0	0	0	0	0	0	0	0	0	0	0	16.24972	0	0	0	0	0	0	0	0	0	0	0	0	15.07406	0	0	0	0	0	0	0
Q9NYI0	PSD3_HUMAN	"PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D, Exchange factor for ARF6 D) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3)"	PSD3 EFA6D EFA6R HCA67 KIAA0942	Homo sapiens (Human)	regulation of ARF protein signal transduction [GO:0032012]	postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]	postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of ARF protein signal transduction [GO:0032012]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0014069; GO:0032012; GO:0032587	ELLSNDESEAAGLK	2.809999943	1	1	0.372678885	1474.26516	14.7787	13.1108	0	0	0	0	0	14.18996	0	0	0	0	16.12983	0	0	16.4581	0	15.32723	17.01019	0	0	0	15.68651	16.91384	0	15.9102	0	14.9348	17.05712	17.2685	15.81759	16.804	17.13326	17.10044	0	0	0	0	17.934	16.60381	17.03513	17.4213	0	17.07411	17.05399	17.86806	17.52945	0
Q9NYJ8	TAB2_HUMAN	"TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2, TAB-2) (TGF-beta-activated kinase 1-binding protein 2)"	TAB2 KIAA0733 MAP3K7IP2	Homo sapiens (Human)	heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496]	K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]	GO:0005654; GO:0005829; GO:0005886; GO:0007507; GO:0008270; GO:0010008; GO:0010507; GO:0032496; GO:0043123; GO:0043130; GO:0045860; GO:0070530	FNPIMVTLAPNIQTGR	4.619999886	1	1	0.491300909	1771.284201	0	0	14.5046	0	0	0	17.33259	0	17.26667	0	17.5476	0	0	0	0	0	0	0	0	0	16.45412	0	0	0	0	16.32533	0	0	0	0	0	0	0	0	17.34508	0	0	0	17.46226	0	0	0	0	0	0	0	0	0
Q9NYL2	M3K20_HUMAN	"Mitogen-activated protein kinase kinase kinase 20, EC 2.7.11.25 (Human cervical cancer suppressor gene 4 protein, HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase, MLK-related kinase, MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)"	MAP3K20 MLTK ZAK HCCS4	Homo sapiens (Human)	cell cycle [GO:0007049]; cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; JNK cascade [GO:0007254]; limb development [GO:0060173]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; JNK cascade [GO:0007254]; limb development [GO:0060173]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403]	ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA binding [GO:0003723]	GO:0000077; GO:0000287; GO:0003723; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007010; GO:0007049; GO:0007254; GO:0008219; GO:0030154; GO:0038066; GO:0042733; GO:0043065; GO:0051403; GO:0060173; GO:0071480; GO:0106310; GO:1904291	GDSSAEMSVYASLFKENNITGK	4.75	1	1	0.194199872	2364.374358	10.58971	14.79287	8.89582	10.91276	16.61095	12.21367	0	0	0	0	0	0	0	0	0	0	14.4309	11.65063	13.09192	0	0	0	0	0	0	15.01666	0	0	0	15.26205	14.17086	0	0	12.87283	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NYN1	RASLC_HUMAN	"Ras-like protein family member 12, EC 3.6.5.2 (Ras-like protein Ris)"	RASL12 RIS	Homo sapiens (Human)	signal transduction [GO:0007165]	plasma membrane [GO:0005886]	plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165]	G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007165; GO:0019003	SIPALLLGNK	5.880000114	1	1	0.180525725	1025.876512	0	12.37329	14.1942	14.05332	14.66432	13.21139	15.43094	14.96558	15.10446	0	13.9318	15.71967	0	0	0	14.13396	0	14.90747	15.29602	14.60993	0	0	0	0	0	0	0	17.34722	0	0	15.88006	17.03746	0	0	15.9697	15.75362	0	0	0	0	15.351	0	0	15.56435	0	0	0	0
Q9NYP3	DONS_HUMAN	Protein downstream neighbor of Son (B17)	DONSON C21orf60	Homo sapiens (Human)	DNA damage checkpoint signaling [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]	nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]	nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]; DNA damage checkpoint signaling [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478]		GO:0000077; GO:0005634; GO:0005657; GO:0006260; GO:0007095; GO:0030894; GO:0033260; GO:0048478	HEVQMDHRPESVVLVK	7.510000229	2.68E-06	2.68E-06	0.073812607	1903.592919	17.83424	0	0	15.60691	16.38527	15.92617	14.85981	0	0	15.49933	17.19655	17.23438	16.60946	15.74081	0	0	16.01027	14.69024	14.59079	0	14.35936	15.82056	17.29564	18.06737	17.46412	14.94913	15.69071	16.12415	16.12834	17.1029	16.17574	0	16.26933	16.0572	17.03871	16.86864	16.80422	17.04709	15.49137	16.75707	17.53489	16.01216	16.80476	16.66351	16.74474	15.89248	17.12415	17.03436
Q9NYQ6	CELR1_HUMAN	"Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2, hFmi2)"	CELSR1 CDHF9 FMI2	Homo sapiens (Human)	"apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]	GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016021; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609	ETKETHVLR	2.549999952	1	1	0.102283631	1111.327234	0	0	0	15.47287	0	14.11032	15.02981	11.84278	14.92317	14.92321	0	14.89302	14.81132	11.6695	13.19915	14.92689	14.54437	14.79336	15.05973	13.94736	11.56569	12.62792	14.56605	17.3703	0	0	15.17946	0	0	0	0	13.74011	0	0	15.38211	0	15.19995	0	0	0	0	0	0	0	14.84749	0	0	0
Q9NYQ8	FAT2_HUMAN	"Protocadherin Fat 2, hFat2 (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1, Multiple EGF-like domains protein 1)"	FAT2 CDHF8 KIAA0811 MEGF1	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005794; GO:0005886; GO:0005912; GO:0007156; GO:0010631; GO:0016021; GO:0031589; GO:0070062; GO:0098609	DVFNLVAKATDGGGR	3.730000019	1	1	0.16899035	1519.419096	17.46609	17.75826	17.6669	0	0	0	0	12.34297	0	13.66654	14.76153	0	0	16.71544	15.63649	12.93671	17.49389	0	13.33086	10.65874	0	0	0	15.48703	17.91812	13.78864	13.48603	16.4718	0	16.89628	13.96855	15.52423	0	15.12758	11.59059	17.31203	0	14.15481	0	11.80393	15.17625	0	13.08491	14.80429	0	11.42095	0	14.88888
Q9NYS0	KBRS1_HUMAN	"NF-kappa-B inhibitor-interacting Ras-like protein 1 (I-kappa-B-interacting Ras-like protein 1, Kappa B-Ras protein 1, KappaB-Ras1)"	NKIRAS1 KBRAS1	Homo sapiens (Human)	I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lung alveolus development [GO:0048286]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lung alveolus development [GO:0048286]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129]	GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0007249; GO:0010803; GO:0032484; GO:0032794; GO:0043129; GO:0048286	SSFPLPGRK	2.420000076	0.026292294	0.026292294	0.258228674	987.3444056	0	0	0	0	0	0	16.71676	0	15.59363	0	0	17.8597	17.63806	0	0	0	0	0	0	0	0	18.13902	0	0	0	0	18.05052	16.55798	17.11621	0	15.44712	0	0	0	0	0	0	0	0	0	0	0	17.50255	0	16.56483	15.58114	0	0
Q9NYU1	UGGG2_HUMAN	"UDP-glucose:glycoprotein glucosyltransferase 2, UGT2, hUGT2, EC 2.4.1.- (UDP--Glc:glycoprotein glucosyltransferase 2) (UDP-glucose ceramide glucosyltransferase-like 1)"	UGGT2 UGCGL2 UGT2	Homo sapiens (Human)	endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]	UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]	GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0044322; GO:0051082; GO:0071712; GO:1904380	IAVNQHMR	7.119999886	0.309260875	0.309260875	0.203089848	967.5180802	15.44357	16.70886	16.96078	0	0	13.6767	16.69916	15.75046	15.36103	15.61829	14.86828	15.85078	16.37534	16.0615	0	16.54721	16.71692	15.59208	0	17.38947	16.76982	0	0	14.95921	16.70706	15.93986	15.79489	16.22209	0	14.19475	16.30961	16.31173	14.8742	0	15.11317	16.90611	16.3723	12.81009	16.22705	16.86235	15.65385	15.23743	15.12761	13.9043	14.95898	14.25759	0	15.55271
Q9NYU2	UGGG1_HUMAN	"UDP-glucose:glycoprotein glucosyltransferase 1, UGT1, hUGT1, EC 2.4.1.- (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)"	UGGT1 GT UGCGL1 UGGT UGT1 UGTR	Homo sapiens (Human)	'de novo' posttranslational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' posttranslational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279]	UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]	GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0044322; GO:0051082; GO:0051084; GO:0070062; GO:0071712; GO:1904380	GMSSK	2.309999943	1	1	0	507.5161022	16.68126	0	15.87005	0	0	0	0	0	17.17884	16.48905	16.69892	16.9096	16.07887	16.19563	16.99501	0	16.83582	16.07275	17.92881	18.0493	0	0	0	0	0	0	0	0	0	0	0	17.64407	0	0	0	0	0	0	0	0	0	0	0	0	17.09933	0	0	0
Q9NYV4	CDK12_HUMAN	"Cyclin-dependent kinase 12, EC 2.7.11.22, EC 2.7.11.23 (Cdc2-related kinase, arginine/serine-rich, CrkRS) (Cell division cycle 2-related protein kinase 7, CDC2-related protein kinase 7) (Cell division protein kinase 12, hCDK12)"	CDK12 CRK7 CRKRS KIAA0904	Homo sapiens (Human)	mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	GO:0000307; GO:0002944; GO:0004672; GO:0004693; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0006368; GO:0006397; GO:0006468; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0046777; GO:0070816; GO:0106310; GO:2000737	LVSKHK	4.699999809	1	1	0.248500766	712.8158369	0	0	0	0	0	0	0	0	0	0	0	0	16.6387	0	16.68585	16.79485	16.41711	0	0	17.39712	0	0	0	0	0	15.61441	0	0	0	14.16973	14.53121	14.62561	0	0	16.20506	0	17.65359	0	0	0	0	0	17.44293	0	0	0	0	0
Q9NYV6	RRN3_HUMAN	"RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA, TIF-IA)"	RRN3 TIFIA	Homo sapiens (Human)	"cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; cell population proliferation [GO:0008283]; cytoplasm organization [GO:0007028]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]"	RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]	GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005634; GO:0005654; GO:0005730; GO:0006361; GO:0007000; GO:0007028; GO:0008283; GO:0042254; GO:0045893; GO:0048872; GO:1902254; GO:2000142	LPGDAAASSSAVK	3.710000038	0.502729177	0.502729177	0.211472788	1173.751972	16.48701	14.24901	0	0	0	14.86049	12.35151	0	14.24563	15.82946	0	0	0	0	13.17496	0	0	0	0	0	15.93358	0	0	0	0	16.51626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.81666	0	0	0	0
Q9NYW0	T2R10_HUMAN	"Taste receptor type 2 member 10, T2R10 (Taste receptor family B member 2, TRB2)"	TAS2R10	Homo sapiens (Human)	detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]	bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]	GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0033038	HNRQMQSNVTGLR	3.900000095	0.191283569	0.191283569	0.31462119	1557.37912	0	0	0	0	0	0	0	13.782	13.39635	0	0	0	0	0	0	0	16.38348	0	0	0	0	0	0	0	15.22233	0	0	15.72419	16.53782	13.95812	13.9491	13.84105	0	15.54235	15.35947	14.25173	0	13.94435	0	14.07905	14.07556	12.1927	13.55627	14.87444	17.30183	17.47864	0	17.07265
Q9NYW5	TA2R4_HUMAN	"Taste receptor type 2 member 4, T2R4"	TAS2R4	Homo sapiens (Human)	detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; respiratory gaseous exchange by respiratory system [GO:0007585]	ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; respiratory gaseous exchange by respiratory system [GO:0007585]	bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]	GO:0001580; GO:0004930; GO:0005886; GO:0007585; GO:0008527; GO:0016021; GO:0033038; GO:0060170	SHRISSSDR	15.60999966	1	1	0.155313451	1045.175979	0	0	14.79148	0	14.56518	14.08659	8.701708	14.53932	0	15.66593	15.0159	0	0	0	0	14.16883	0	14.43617	0	0	0	0	14.49444	0	0	14.39754	0	0	0	14.01753	14.86163	0	15.74695	0	0	0	0	16.08673	0	0	0	15.63219	0	0	0	0	0	15.3137
Q9NYY8	FAKD2_HUMAN	"FAST kinase domain-containing protein 2, mitochondrial"	FASTKD2 KIAA0971	Homo sapiens (Human)	apoptotic process [GO:0006915]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA processing [GO:0000963]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA processing [GO:0006396]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; apoptotic process [GO:0006915]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA processing [GO:0000963]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA processing [GO:0006396]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0006396; GO:0006915; GO:0019843; GO:0032543; GO:0035770; GO:0042645; GO:0044528; GO:0070131; GO:1902775	GFLAMKMR	4.130000114	0.846710742	0.846710742	0.174586289	985.7605054	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NYZ2	MFRN1_HUMAN	Mitoferrin-1 (Mitochondrial iron transporter 1) (Mitochondrial solute carrier protein) (Solute carrier family 25 member 37)	SLC25A37 MFRN MSCP HT015	Homo sapiens (Human)	iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]; positive regulation of hemoglobin biosynthetic process [GO:0046985]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; iron ion transmembrane transporter activity [GO:0005381]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]; positive regulation of hemoglobin biosynthetic process [GO:0046985]	iron ion transmembrane transporter activity [GO:0005381]	GO:0005381; GO:0005739; GO:0005743; GO:0016021; GO:0046985; GO:0048250; GO:0055072	MDGDSRDGGGGK	4.630000114	1	1	0.403034849	1168.262213	15.84788	14.12554	16.06978	14.74909	16.28392	16.33471	15.40801	0	15.75649	0	14.33333	0	16.01056	0	0	0	0	16.23388	0	14.90233	15.00768	0	15.63869	0	0	0	0	0	16.5625	16.36101	0	0	0	16.23776	0	0	0	16.42491	0	0	0	16.39551	0	16.67443	15.38788	16.92108	16.13746	0
Q9NYZ3	GTSE1_HUMAN	"G2 and S phase-expressed protein 1, GTSE-1 (Protein B99 homolog)"	GTSE1	Homo sapiens (Human)	"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; microtubule-based process [GO:0007017]"	cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]	"cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; microtubule binding [GO:0008017]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; microtubule-based process [GO:0007017]"	microtubule binding [GO:0008017]	GO:0005654; GO:0005829; GO:0005881; GO:0006977; GO:0007017; GO:0008017; GO:0015630; GO:0016020	KNSAMR	8.680000305	1	1	0.066953606	721.7904769	14.25529	0	12.33328	0	0	0	0	0	0	13.53499	0	0	0	0	0	0	0	0	0	0	0	0	0	14.3657	13.90216	0	14.34234	0	0	0	0	0	0	17.85829	0	0	0	0	0	0	0	0	0	0	0	0	0	14.50089
Q9NZ08	ERAP1_HUMAN	"Endoplasmic reticulum aminopeptidase 1, EC 3.4.11.- (ARTS-1) (Adipocyte-derived leucine aminopeptidase, A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase, PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)"	ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154	Homo sapiens (Human)	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]"	"aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]"	GO:0001525; GO:0002250; GO:0002474; GO:0004175; GO:0004177; GO:0005138; GO:0005151; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008235; GO:0008270; GO:0009617; GO:0016020; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0045088; GO:0045444; GO:0045766; GO:0070006; GO:0070062	NVHMKQEHYMK	2.109999895	0.341058552	0.341058552	0.295917238	1461.16328	0	16.15488	14.73721	0	0	17.46703	0	0	14.37207	15.10648	13.89705	16.04917	0	0	0	15.62791	0	0	0	0	13.35274	0	0	0	0	16.15602	0	0	0	0	0	0	0	0	15.09376	0	0	0	0	0	0	0	0	0	14.20958	0	0	0
Q9NZ20	PA2G3_HUMAN	"Group 3 secretory phospholipase A2, EC 3.1.1.4 (Group III secretory phospholipase A2, GIII sPLA2, sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3)"	PLA2G3	Homo sapiens (Human)	acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288]	centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288]	calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]	GO:0001675; GO:0002532; GO:0005576; GO:0005615; GO:0005814; GO:0005886; GO:0006644; GO:0006658; GO:0007288; GO:0010629; GO:0010744; GO:0010976; GO:0019372; GO:0031394; GO:0032308; GO:0034374; GO:0034375; GO:0042116; GO:0043303; GO:0043524; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0046488; GO:0046872; GO:0047498; GO:0048469; GO:0050482; GO:0055037; GO:0060271; GO:0060376; GO:1900017; GO:1900222; GO:1903595; GO:2001135	GPMSFYNQCLQLTQAARRPDR	6.809999943	1	1	0.206125754	2525.987869	0	14.95388	12.78897	0	0	13.45914	0	0	14.89838	0	0	13.79611	18.19402	0	17.63579	0	14.25816	0	16.8584	19.24776	0	17.2463	17.74694	0	15.39443	0	15.96907	0	0	0	16.32818	12.38809	0	15.07132	0	12.11614	15.13782	13.29788	0	14.75996	0	0	0	0	0	0	0	0
Q9NZ38	IDAS1_HUMAN	Uncharacterized protein IDI2-AS1 (IDI2 antisense RNA 1) (IDI2 antisense gene protein 1)	IDI2-AS1 C10orf110 HT009	Homo sapiens (Human)						KSSALGK	8.25	0.89245677	0.89245677	0.247009388	691.1441478	15.99534	17.40773	14.16052	0	12.27563	14.62462	14.10957	15.33883	16.11559	17.1788	16.35	0	14.90406	16.01521	0	16.58494	14.9488	13.7076	16.41883	0	0	16.97729	14.91327	15.24478	14.77358	0	0	0	0	16.35899	12.87911	15.82972	15.24066	0	15.4253	17.31914	0	15.21946	0	15.67879	0	16.08867	16.63004	15.1465	16.07005	16.80394	0	16.49608
Q9NZ43	USE1_HUMAN	Vesicle transport protein USE1 (Putative MAPK-activating protein PM26) (USE1-like protein) (p31)	USE1 USE1L MDS032	Homo sapiens (Human)	"lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]"	SNAP receptor activity [GO:0005484]	GO:0005484; GO:0005783; GO:0005789; GO:0006890; GO:0007041; GO:0015031; GO:0016021; GO:0030163; GO:0031201; GO:0032940	MADQNLEK	6.480000019	1	1	2.17E-12	964.9044803	18.0626	13.7711	0	16.09514	16.22087	0	12.05758	13.55222	0	10.31925	0	10.55308	0	12.68562	14.14823	14.34347	0	11.36199	12.62049	14.97683	13.75992	16.70687	17.41286	17.44069	17.75758	14.5946	13.91146	13.73244	14.41195	14.66427	14.82093	18.22331	14.81014	0	15.026	0	15.64756	0	16.5732	16.22154	0	12.83227	17.20477	13.16339	15.17521	15.88169	14.59081	16.46272
Q9NZ45	CISD1_HUMAN	CDGSH iron-sulfur domain-containing protein 1 (MitoNEET)	CISD1 C10orf70 ZCD1 MDS029	Homo sapiens (Human)	regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	"integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457]"	"2 iron, 2 sulfur cluster binding [GO:0051537]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]"	GO:0005739; GO:0005741; GO:0010506; GO:0016021; GO:0042802; GO:0043457; GO:0046872; GO:0051537	SLTSSSSVR	1.590000033	0.918919504	0.918919504	0.215032829	920.8669604	0	0	12.46421	0	0	0	0	0	14.52771	14.37071	0	12.77609	15.00915	0	0	0	0	16.45287	0	0	0	16.67118	0	16.26406	0	0	0	0	0	0	16.56057	0	15.70013	0	0	0	0	15.34515	0	0	15.72395	15.11332	0	0	0	0	0	16.90623
Q9NZ52	GGA3_HUMAN	"ADP-ribosylation factor-binding protein GGA3 (Golgi-localized, gamma ear-containing, ARF-binding protein 3)"	GGA3 KIAA0154	Homo sapiens (Human)	endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of protein stability [GO:0031647]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of protein stability [GO:0031647]	phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]	GO:0005764; GO:0005794; GO:0005802; GO:0006622; GO:0006886; GO:0010008; GO:0031267; GO:0031647; GO:0031648; GO:0031901; GO:0032456; GO:0032991; GO:0034394; GO:0035091; GO:0043001; GO:0043130; GO:0044877; GO:0045732; GO:0055038; GO:1902430	VIELLYSWTMALPEEAK	5.139999866	1	1	0.110265329	2008.345423	12.92319	0	15.03199	14.10128	0	13.63151	0	15.18003	13.57753	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.52577	13.85503	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NZ71	RTEL1_HUMAN	"Regulator of telomere elongation helicase 1, EC 3.6.4.12 (Novel helicase-like)"	RTEL1 C20orf41 KIAA1088 NHL	Homo sapiens (Human)	DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657]	"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]"	GO:0000723; GO:0000732; GO:0000781; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0010569; GO:0016887; GO:0031297; GO:0032206; GO:0032508; GO:0043247; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1902990; GO:1904355; GO:1904358; GO:1904430; GO:1904506; GO:1904535	GVIVTGLPYPPRMDPR	3.140000105	1	1	0.276166815	1767.553339	0	0	14.53768	0	0	0	0	0	0	15.11573	0	0	0	0	0	16.39679	0	0	0	0	0	0	0	14.34245	0	0	14.70451	0	0	0	15.76107	0	13.92057	8.987556	0	17.19099	0	14.12541	0	0	0	0	0	17.75968	18.58546	0	0	0
Q9NZ72	STMN3_HUMAN	Stathmin-3 (SCG10-like protein)	STMN3 SCLIP	Homo sapiens (Human)	blastocyst hatching [GO:0001835]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; negative regulation of Rac protein signal transduction [GO:0035021]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of microtubule polymerization or depolymerization [GO:0031110]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; blastocyst hatching [GO:0001835]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; negative regulation of Rac protein signal transduction [GO:0035021]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of microtubule polymerization or depolymerization [GO:0031110]	protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]	GO:0001835; GO:0005737; GO:0005794; GO:0005829; GO:0007019; GO:0007399; GO:0015631; GO:0019904; GO:0030426; GO:0031110; GO:0031122; GO:0031175; GO:0035021; GO:0043005; GO:0043087; GO:0051493	ELHAAEVRR	2.529999971	1	1	0.286236469	1080.425001	0	16.24821	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.62527	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NZ94	NLGN3_HUMAN	Neuroligin-3 (Gliotactin homolog)	NLGN3 KIAA1480 NL3	Homo sapiens (Human)	"adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]"	"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]"	cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]	GO:0002087; GO:0005886; GO:0005887; GO:0006898; GO:0007158; GO:0007268; GO:0007416; GO:0007612; GO:0009986; GO:0030139; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0048675; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051968; GO:0060024; GO:0060076; GO:0060080; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098983; GO:0098985; GO:0099054; GO:0099055; GO:0099060; GO:2000463; GO:2000969	WLRLGPPSLSLSPKPTVGR	8.06000042	0.130363926	0.130363926	0.153921112	2056.216986	0	0	19.06583	0	0	18.26541	16.70046	16.33489	19.77423	17.70412	14.627	0	0	13.43707	0	0	0	0	0	0	9.67522	18.11246	16.9531	0	12.65126	0	14.14602	0	0	0	14.9514	17.7162	0	13.23003	16.55253	17.09594	16.38285	17.13453	17.04511	18.52524	17.67441	16.89684	0	11.12316	13.56061	15.35069	15.26912	16.37322
Q9NZB2	F120A_HUMAN	Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)	FAM120A C9orf10 KIAA0183 OSSA	Homo sapiens (Human)		cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0016020	SSAMSSDGSLAENGVMAEEKPAPQMNGSTGDAR	5.28000021	0.885971487	0.885971487	0.183673405	3297.799258	17.97511	14.16435	9.604689	0	0	13.48349	0	14.97966	0	0	12.53002	0	0	11.99256	12.05746	0	0	0	0	0	0	0	0	0	13.87926	14.63396	11.58356	9.259307	0	11.27233	0	0	0	0	14.02331	0	12.98256	12.8237	0	13.11364	0	0	0	0	0	0	0	0
Q9NZB8	MOCS1_HUMAN	"Molybdenum cofactor biosynthesis protein 1 (Cell migration-inducing gene 11 protein) (Molybdenum cofactor synthesis-step 1 protein A-B) [Includes: GTP 3',8-cyclase, EC 4.1.99.22 (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase, EC 4.6.1.17 (Molybdenum cofactor biosynthesis protein C) ]"	MOCS1 MIG11	Homo sapiens (Human)	Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]	cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]	"cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]"	GO:0005525; GO:0005634; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799	ADSDANSK	5.75	0.327375323	0.327375323	0.105395515	806.5477305	0	11.70552	0	13.80173	0	14.80843	0	15.28325	0	15.62005	13.50786	13.68937	14.9907	0	0	0	0	0	0	0	12.93847	0	0	0	0	0	0	0	0	0	0	14.52261	0	0	0	0	0	0	15.77705	0	0	0	0	0	15.98637	0	0	0
Q9NZC2	TREM2_HUMAN	"Triggering receptor expressed on myeloid cells 2, TREM-2 (Triggering receptor expressed on monocytes 2)"	TREM2	Homo sapiens (Human)	"amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; astrocyte activation [GO:0048143]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to lipid [GO:0071396]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptidoglycan [GO:0071224]; complement-mediated synapse pruning [GO:0150062]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; defense response to Gram-negative bacterium [GO:0050829]; dendritic cell differentiation [GO:0097028]; dendritic spine maintenance [GO:0097062]; detection of lipopolysaccharide [GO:0032497]; detection of lipoteichoic acid [GO:0070392]; detection of peptidoglycan [GO:0032499]; excitatory synapse pruning [GO:1905805]; humoral immune response [GO:0006959]; import into cell [GO:0098657]; lipid homeostasis [GO:0055088]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microglial cell activation involved in immune response [GO:0002282]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of autophagy [GO:0010507]; negative regulation of cell activation [GO:0050866]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of tumor necrosis factor production [GO:0032720]; osteoclast differentiation [GO:0030316]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002588]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of C-C chemokine receptor CCR7 signaling pathway [GO:1903082]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of CAMKK-AMPK signaling cascade [GO:1905291]; positive regulation of CD40 signaling pathway [GO:2000350]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of complement activation, classical pathway [GO:0045960]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of gene expression [GO:0010628]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of kinase activity [GO:0033674]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of synapse pruning [GO:1905808]; positive regulation of TOR signaling [GO:0032008]; pyroptosis [GO:0070269]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of gene expression [GO:0010468]; regulation of hippocampal neuron apoptotic process [GO:0110089]; regulation of innate immune response [GO:0045088]; regulation of interleukin-6 production [GO:0032675]; regulation of intracellular signal transduction [GO:1902531]; regulation of lipid metabolic process [GO:0019216]; regulation of macrophage inflammatory protein 1 alpha production [GO:0071640]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of plasma membrane bounded cell projection organization [GO:0120035]; regulation of resting membrane potential [GO:0060075]; regulation of toll-like receptor 6 signaling pathway [GO:0034151]; regulation of TOR signaling [GO:0032006]; respiratory burst after phagocytosis [GO:0045728]; response to axon injury [GO:0048678]; response to ischemia [GO:0002931]; social behavior [GO:0035176]"	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]	"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; kinase activator activity [GO:0019209]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid binding [GO:0070891]; low-density lipoprotein particle binding [GO:0030169]; peptidoglycan binding [GO:0042834]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; sulfatide binding [GO:0120146]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle binding [GO:0034189]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; astrocyte activation [GO:0048143]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to lipid [GO:0071396]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptidoglycan [GO:0071224]; complement-mediated synapse pruning [GO:0150062]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; defense response to Gram-negative bacterium [GO:0050829]; dendritic cell differentiation [GO:0097028]; dendritic spine maintenance [GO:0097062]; detection of lipopolysaccharide [GO:0032497]; detection of lipoteichoic acid [GO:0070392]; detection of peptidoglycan [GO:0032499]; excitatory synapse pruning [GO:1905805]; humoral immune response [GO:0006959]; import into cell [GO:0098657]; lipid homeostasis [GO:0055088]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microglial cell activation involved in immune response [GO:0002282]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of autophagy [GO:0010507]; negative regulation of cell activation [GO:0050866]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of tumor necrosis factor production [GO:0032720]; osteoclast differentiation [GO:0030316]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002588]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of C-C chemokine receptor CCR7 signaling pathway [GO:1903082]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of CAMKK-AMPK signaling cascade [GO:1905291]; positive regulation of CD40 signaling pathway [GO:2000350]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of complement activation, classical pathway [GO:0045960]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of gene expression [GO:0010628]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of kinase activity [GO:0033674]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of synapse pruning [GO:1905808]; positive regulation of TOR signaling [GO:0032008]; pyroptosis [GO:0070269]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of gene expression [GO:0010468]; regulation of hippocampal neuron apoptotic process [GO:0110089]; regulation of innate immune response [GO:0045088]; regulation of interleukin-6 production [GO:0032675]; regulation of intracellular signal transduction [GO:1902531]; regulation of lipid metabolic process [GO:0019216]; regulation of macrophage inflammatory protein 1 alpha production [GO:0071640]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of plasma membrane bounded cell projection organization [GO:0120035]; regulation of resting membrane potential [GO:0060075]; regulation of toll-like receptor 6 signaling pathway [GO:0034151]; regulation of TOR signaling [GO:0032006]; respiratory burst after phagocytosis [GO:0045728]; response to axon injury [GO:0048678]; response to ischemia [GO:0002931]; social behavior [GO:0035176]"	amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; kinase activator activity [GO:0019209]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid binding [GO:0070891]; low-density lipoprotein particle binding [GO:0030169]; peptidoglycan binding [GO:0042834]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; sulfatide binding [GO:0120146]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle binding [GO:0034189]	GO:0001530; GO:0001540; GO:0001774; GO:0001786; GO:0001934; GO:0002282; GO:0002588; GO:0002862; GO:0002931; GO:0004888; GO:0005543; GO:0005576; GO:0005886; GO:0005887; GO:0006910; GO:0006911; GO:0006959; GO:0007613; GO:0008035; GO:0008289; GO:0008429; GO:0010468; GO:0010507; GO:0010628; GO:0010822; GO:0010875; GO:0010887; GO:0010891; GO:0010983; GO:0014067; GO:0014068; GO:0016021; GO:0019209; GO:0019216; GO:0030169; GO:0030316; GO:0031226; GO:0032006; GO:0032008; GO:0032497; GO:0032499; GO:0032675; GO:0032691; GO:0032720; GO:0032733; GO:0033674; GO:0034136; GO:0034144; GO:0034151; GO:0034185; GO:0034186; GO:0034189; GO:0034241; GO:0034351; GO:0035176; GO:0038023; GO:0038160; GO:0042834; GO:0043124; GO:0043277; GO:0044853; GO:0044877; GO:0045088; GO:0045672; GO:0045728; GO:0045960; GO:0048143; GO:0048678; GO:0050714; GO:0050730; GO:0050731; GO:0050766; GO:0050829; GO:0050850; GO:0050866; GO:0050921; GO:0055088; GO:0060075; GO:0060100; GO:0061518; GO:0061889; GO:0070269; GO:0070345; GO:0070374; GO:0070392; GO:0070891; GO:0071223; GO:0071224; GO:0071333; GO:0071396; GO:0071456; GO:0071640; GO:0071813; GO:0097028; GO:0097062; GO:0097110; GO:0098657; GO:0110089; GO:0120035; GO:0120146; GO:0140052; GO:0150062; GO:0150079; GO:0150094; GO:1900015; GO:1900016; GO:1900223; GO:1900226; GO:1901076; GO:1901224; GO:1901800; GO:1901980; GO:1902227; GO:1902531; GO:1903078; GO:1903082; GO:1903376; GO:1903753; GO:1903980; GO:1904093; GO:1904141; GO:1904646; GO:1904951; GO:1905291; GO:1905581; GO:1905805; GO:1905808; GO:1905907; GO:1990782; GO:2000350; GO:2001171	VLVEVLADPLDHR	3.480000019	0.995923638	0.995923638	0.451855244	1475.266614	15.39393	14.4509	0	14.95062	14.74819	14.85292	14.0765	13.1398	14.05753	0	0	0	0	0	0	0	0	16.86267	0	0	0	0	0	0	15.54103	15.43426	0	0	0	0	0	0	16.48221	14.76678	16.45054	0	0	16.71348	0	0	0	0	0	16.56439	15.97706	0	0	0
Q9NZD4	AHSP_HUMAN	Alpha-hemoglobin-stabilizing protein (Erythroid differentiation-related factor) (Erythroid-associated factor)	AHSP EDRF ERAF	Homo sapiens (Human)	erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; hemopoiesis [GO:0030097]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; hemoglobin complex [GO:0005833]	cytoplasm [GO:0005737]; hemoglobin complex [GO:0005833]; hemoglobin binding [GO:0030492]; unfolded protein binding [GO:0051082]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; hemopoiesis [GO:0030097]; protein folding [GO:0006457]; protein stabilization [GO:0050821]	hemoglobin binding [GO:0030492]; unfolded protein binding [GO:0051082]	GO:0005737; GO:0005833; GO:0006457; GO:0020027; GO:0030097; GO:0030218; GO:0030492; GO:0050821; GO:0051082	DLISAGLK	22.82999992	0.902237296	0.902237296	0.230008317	813.0732119	17.55968	17.99547	0	0	0	17.28378	0	0	0	0	18.13705	0	17.62562	0	0	0	0	0	0	0	0	0	18.14349	0	0	0	0	0	0	0	0	18.14896	17.15468	0	17.73574	0	18.80447	0	0	17.9758	18.01772	19.77028	0	0	18.26178	17.60565	0	0
Q9NZH7	IL36B_HUMAN	"Interleukin-36 beta (FIL1 eta) (Interleukin-1 eta, IL-1 eta) (Interleukin-1 family member 8, IL-1F8) (Interleukin-1 homolog 2, IL-1H2)"	IL36B IL1F8 IL1H2	Homo sapiens (Human)	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of T cell differentiation [GO:0045582]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of T cell differentiation [GO:0045582]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	GO:0002437; GO:0005125; GO:0005149; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0006955; GO:0010628; GO:0019221; GO:0045087; GO:0045582; GO:0071222	TNIGMPGRM	8.75	0.754950523	0.754950523	0.242924115	992.8177565	16.42639	14.47585	15.52794	15.53104	14.75961	15.05104	14.45329	14.5497	14.02635	0	15.61167	16.25306	15.84504	14.76899	0	0	0	14.87827	16.16266	14.60631	16.76767	15.50185	0	16.09296	0	0	0	16.33893	0	0	0	0	16.63547	0	14.66933	15.16832	0	16.30169	16.20464	16.67549	14.20233	17.8362	15.95429	15.81316	0	0	0	0
Q9NZI8	IF2B1_HUMAN	"Insulin-like growth factor 2 mRNA-binding protein 1, IGF2 mRNA-binding protein 1, IMP-1, IMP1 (Coding region determinant-binding protein, CRD-BP) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zipcode-binding protein 1, ZBP-1)"	IGF2BP1 CRDBP VICKZ1 ZBP1	Homo sapiens (Human)	"CRD-mediated mRNA stabilization [GO:0070934]; dendrite arborization [GO:0140059]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of mRNA stability involved in response to stress [GO:0010610]; regulation of RNA metabolic process [GO:0051252]"	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]	"CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; dendrite arborization [GO:0140059]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of mRNA stability involved in response to stress [GO:0010610]; regulation of RNA metabolic process [GO:0051252]"	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]	GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007399; GO:0010468; GO:0010494; GO:0010610; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0043025; GO:0043197; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0051252; GO:0070934; GO:0070937; GO:0097150; GO:0140059; GO:1900152; GO:1990247; GO:1990904; GO:2000767	MILEIMHK	11.68999958	0.413794279	0.413794279	0.140433991	1014.642195	17.59263	15.92904	15.09265	14.68942	15.89384	16.83624	15.47521	17.02441	13.99655	16.045	17.21558	17.18142	14.24999	16.7414	15.97308	16.82043	18.16635	0	14.06361	16.8764	17.53153	12.91318	17.40097	16.44302	17.66281	16.68116	15.37896	16.15651	16.30199	12.72927	17.04257	16.13079	17.74074	17.11799	17.1531	15.003	0	16.70909	14.82734	15.33149	13.51071	16.66533	16.35268	16.17162	19.10024	14.87483	0	13.17244
Q9NZJ0	DTL_HUMAN	Denticleless protein homolog (DDB1- and CUL4-associated factor 2) (Lethal(2) denticleless protein homolog) (Retinoic acid-regulated nuclear matrix-associated protein)	DTL CDT2 CDW1 DCAF2 L2DTL RAMP	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]	protein-macromolecule adaptor activity [GO:0030674]	GO:0000209; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005813; GO:0005829; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0007095; GO:0009411; GO:0010971; GO:0019985; GO:0030674; GO:0031464; GO:0031465; GO:0031965; GO:0043161; GO:0045732; GO:0048511; GO:0051726; GO:0080008	IMSPR	3.789999962	0.724496961	0.724496961	0.281911536	619.0016117	17.37346	15.19946	0	16.09346	0	0	18.47053	15.99606	0	0	0	18.37396	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.75493	0	0	17.03086	0	0	0	18.38065	0	0	18.70114	16.81787	0	0	0	0	0	17.62094	0	0
Q9NZJ4	SACS_HUMAN	"Sacsin (DnaJ homolog subfamily C member 29, DNAJC29)"	SACS KIAA0730	Homo sapiens (Human)	negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]	GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084	FSLSESGR	3.339999914	1	1	0.159185035	880.1272968	16.08331	0	14.62752	0	0	13.83341	14.18912	0	16.78953	0	15.66061	0	0	0	0	0	15.90269	11.65007	0	17.2931	16.2844	17.05966	0	0	17.07656	17.06223	17.46513	17.65657	17.4208	16.70541	17.79974	17.41668	18.31852	17.10789	0	0	17.67703	18.23439	16.79192	0	13.26652	13.94122	0	0	0	17.69564	16.18688	16.66525
Q9NZJ5	E2AK3_HUMAN	"Eukaryotic translation initiation factor 2-alpha kinase 3, EC 2.7.11.1 (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase, HsPEK)"	EIF2AK3 PEK PERK	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004712; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006468; GO:0006919; GO:0006983; GO:0007029; GO:0010575; GO:0010628; GO:0010998; GO:0016020; GO:0017148; GO:0018105; GO:0019722; GO:0019899; GO:0019903; GO:0030176; GO:0030282; GO:0030968; GO:0031018; GO:0031642; GO:0032055; GO:0032057; GO:0034198; GO:0034976; GO:0036492; GO:0036499; GO:0042149; GO:0042802; GO:0045943; GO:0046777; GO:0048009; GO:0048471; GO:0051879; GO:0060734; GO:0070417; GO:0106310; GO:1900182; GO:1902235; GO:1990737	IISDVEEQEAAIMDIVIK	9.229999542	1	1	0.2544046	2015.750255	0	0	0	0	0	15.87337	0	0	13.56439	0	0	0	13.43668	0	0	0	0	14.25296	0	0	10.55016	0	0	16.20031	0	12.8358	13.31979	0	13.80661	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.60442
Q9NZL3	ZN224_HUMAN	"Zinc finger protein 224 (Bone marrow zinc finger 2, BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22)"	ZNF224 BMZF2 KOX22 ZNF233 ZNF255 ZNF27	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0017053; GO:0031965; GO:0043565; GO:0045892; GO:0046872	APCLLK	4.789999962	0.12171641	0.12171641	0.226144468	698.5544012	0	0	0	0	15.18019	16.44144	0	0	0	0	0	0	15.41855	9.661558	17.5181	0	0	15.57852	0	13.87272	0	0	0	12.13958	0	0	0	16.52883	16.40701	14.47913	17.07961	0	0	0	16.81629	14.65988	0	0	0	0	0	14.42982	17.11535	0	16.88368	15.01708	0	0
Q9NZM1	MYOF_HUMAN	Myoferlin (Fer-1-like protein 3)	MYOF FER1L3 KIAA1207	Homo sapiens (Human)	blood circulation [GO:0008015]; membrane fusion [GO:0061025]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]	caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; blood circulation [GO:0008015]; membrane fusion [GO:0061025]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]	metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]	GO:0001778; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0006936; GO:0007009; GO:0007520; GO:0008015; GO:0016021; GO:0030659; GO:0031410; GO:0031965; GO:0033292; GO:0043231; GO:0046872; GO:0061025; GO:0070062	KDLTQTASSTAR	1.460000038	1	1	0.236372222	1279.880064	0	0	16.05921	0	0	0	0	0	0	20.25412	16.46227	0	14.4929	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32505	0	0	0	0	16.96557	0	0	0	0
Q9NZM3	ITSN2_HUMAN	Intersectin-2 (SH3 domain-containing protein 1B) (SH3P18) (SH3P18-like WASP-associated protein)	ITSN2 KIAA1256 SH3D1B SWAP	Homo sapiens (Human)	cell differentiation [GO:0030154]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; positive regulation of dendrite extension [GO:1903861]	centrosome [GO:0005813]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; presynapse [GO:0098793]	centrosome [GO:0005813]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; positive regulation of dendrite extension [GO:1903861]	calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]	GO:0005085; GO:0005509; GO:0005813; GO:0005829; GO:0005905; GO:0006897; GO:0016197; GO:0030154; GO:0060090; GO:0070062; GO:0098793; GO:0150007; GO:1903861	NREQEEIVR	11.68000031	0.657192171	0.657192171	0.438679995	1173.412805	13.57393	13.41313	0	0	0	0	0	0	0	0	0	0	0	15.7075	0	16.1806	0	0	0	16.974	15.81126	0	15.35993	0	16.97133	14.88626	16.43463	15.96959	0	0	0	14.82848	0	17.24353	15.52475	15.05599	18.07329	17.36467	17.07821	16.55744	0	17.35715	0	0	16.942	0	17.29878	16.89487
Q9NZN1	IRPL1_HUMAN	"Interleukin-1 receptor accessory protein-like 1, IL-1-RAPL-1, IL-1RAPL-1, IL1RAPL-1, EC 3.2.2.6 (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2, TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1)"	IL1RAPL1 OPHN4	Homo sapiens (Human)	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of exocytosis [GO:0045920]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; signal transduction [GO:0007165]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	"axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor binding [GO:0005102]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of exocytosis [GO:0045920]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; signal transduction [GO:0007165]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]"	"NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor binding [GO:0005102]"	GO:0005102; GO:0005737; GO:0005886; GO:0007157; GO:0007165; GO:0009986; GO:0010975; GO:0016021; GO:0030182; GO:0030424; GO:0030425; GO:0045211; GO:0045920; GO:0050135; GO:0050775; GO:0051965; GO:0061809; GO:0097105; GO:0098978; GO:0099175; GO:0099545; GO:1905606	IEIMLFYR	6.699999809	1	1	0.245958899	1100.065234	0	0	0	0	0	0	0	17.68845	18.06895	0	0	15.99068	0	0	0	16.86026	15.46678	0	0	0	0	0	0	0	0	17.20116	0	0	0	16.0042	0	0	0	0	0	0	0	0	0	0	0	16.83853	0	0	0	0	0	0
Q9NZN4	EHD2_HUMAN	EH domain-containing protein 2 (PAST homolog 2)	EHD2 PAST2	Homo sapiens (Human)	cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]; cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]	GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005769; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0010008; GO:0015630; GO:0016197; GO:0016787; GO:0019898; GO:0019904; GO:0030139; GO:0030866; GO:0032456; GO:0042802; GO:0043231; GO:0045171; GO:0048471; GO:0055038; GO:0060271; GO:0070062; GO:0072659; GO:0097320; GO:1901741; GO:2001137	YDEIFYNLAPADGKLSGSK	6.139999866	1	1	0.172465202	2089.141292	14.23522	14.13874	15.47504	0	15.34093	14.00092	16.85883	0	11.29797	14.41024	15.57142	12.79226	0	0	13.59521	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NZP6	NPAP1_HUMAN	Nuclear pore-associated protein 1	NPAP1 C15orf2	Homo sapiens (Human)	cell differentiation [GO:0030154]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]	intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; cell differentiation [GO:0030154]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283]	nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]	GO:0005637; GO:0005643; GO:0005654; GO:0005886; GO:0006405; GO:0006606; GO:0007283; GO:0008139; GO:0017056; GO:0030154; GO:0043231	HVCFQLP	3.930000067	1	1	0.265975707	900.2594575	13.96253	0	11.59075	0	0	0	0	15.07681	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.56475	0	11.77833	15.73007	0	0	0	0	16.33391	15.5681	14.80875	16.88189	0	0	13.68086	16.23372	15.25371	10.13313	0	0	0	0
Q9NZQ0	DJC27_HUMAN	DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)	DNAJC27 RABJS RBJ	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701]	nucleus [GO:0005634]	nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0070374; GO:0071701	DSWDMLGVKPGASR	2.769999981	1	1	0.341416628	1534.976056	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.26472	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9NZQ3	SPN90_HUMAN	"NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein, VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1, DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein, WISH) (Wiskott-Aldrich syndrome protein-interacting protein)"	NCKIPSD AF3P21 SPIN90	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of neuron projection development [GO:0010976]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]	cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of neuron projection development [GO:0010976]	Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]	GO:0005634; GO:0005829; GO:0005882; GO:0006897; GO:0007010; GO:0008092; GO:0010976; GO:0017124; GO:0071933	LLLLLNR	23.27000046	1	1	0.289359191	854.6514096	14.38436	18.11053	0	17.38409	16.68907	16.54684	0	18.77916	0	0	0	16.89842	16.72647	0	18.35722	0	17.70847	16.82105	0	16.75424	0	0	0	0	0	17.84099	0	0	0	0	20.06638	17.38056	18.4602	17.0577	0	18.25805	16.59568	19.20707	0	0	0	16.74689	17.90757	0	0	0	17.49817	0
Q9NZQ8	TRPM5_HUMAN	"Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5, LTrpC-5, LTrpC5) (MLSN1- and TRP-related gene 1 protein)"	TRPM5 LTRPC5 MTR1	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of taste [GO:0050909]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ligand-gated calcium channel activity [GO:0099604]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of taste [GO:0050909]	calcium activated cation channel activity [GO:0005227]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ligand-gated calcium channel activity [GO:0099604]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]	GO:0005216; GO:0005227; GO:0005244; GO:0005261; GO:0005267; GO:0005272; GO:0005886; GO:0005887; GO:0016021; GO:0030425; GO:0034765; GO:0043025; GO:0050909; GO:0070588; GO:0098655; GO:0099604	DSEGEVLRK	4.059999943	1	1	0.273394083	1032.308848	15.62786	14.64108	0	0	0	16.09164	0	0	13.4809	0	13.59519	0	0	15.80094	0	14.85112	0	0	0	0	0	0	14.68534	0	0	0	0	0	14.15456	0	0	16.39198	0	15.51686	0	15.5736	14.54433	14.78113	0	14.93295	16.13419	15.38645	0	0	13.40529	0	0	0
Q9NZQ9	TMOD4_HUMAN	"Tropomodulin-4 (Skeletal muscle tropomodulin, Sk-Tmod)"	TMOD4	Homo sapiens (Human)	actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]	cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]	cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]	actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]	GO:0005523; GO:0005856; GO:0005865; GO:0006936; GO:0007015; GO:0030016; GO:0030239; GO:0051015; GO:0051694	QWPGDAVEMEMATVLEQCPSIVR	2.130000114	0.064885892	0.064885892	1.38E-12	2662.878072	0	0	0	0	13.90329	14.49693	0	0	0	0	0	0	15.60352	15.37406	0	0	0	14.27025	14.77858	14.50324	0	0	15.41609	0	15.25237	0	0	13.83375	0	15.46193	0	0	14.51528	0	14.9855	0	0	0	0	0	14.92679	12.36987	0	0	0	18.28021	0	0
Q9NZR2	LRP1B_HUMAN	"Low-density lipoprotein receptor-related protein 1B, LRP-1B (Low-density lipoprotein receptor-related protein-deleted in tumor, LRP-DIT)"	LRP1B LRPDIT	Homo sapiens (Human)	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]	GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0016021; GO:0043235	AIAVDPIAGK	8.659999847	1	1	0.169167348	954.3816998	18.79213	14.20839	12.96045	0	15.64927	14.0829	14.00486	14.89961	16.41312	14.51462	15.18097	16.23955	0	13.46367	15.23037	0	0	0	14.30355	13.96221	0	0	0	0	0	0	0	0	16.26729	0	0	0	15.68784	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.86419
Q9NZR4	VSX1_HUMAN	Visual system homeobox 1 (Homeodomain protein RINX) (Retinal inner nuclear layer homeobox protein) (Transcription factor VSX1)	VSX1 RINX	Homo sapiens (Human)	"neuron development [GO:0048666]; neuron maturation [GO:0042551]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; retinal bipolar neuron differentiation [GO:0060040]; visual perception [GO:0007601]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; neuron development [GO:0048666]; neuron maturation [GO:0042551]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; retinal bipolar neuron differentiation [GO:0060040]; visual perception [GO:0007601]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0007601; GO:0042551; GO:0048666; GO:0050896; GO:0060040; GO:1990837	GPEPAAPLAPSRPPPALGRQK	2.019999981	0.102519803	0.102519803	0.141868339	2104.412095	0	15.48969	13.56905	13.78805	0	0	0	0	11.01711	13.08064	11.28725	14.18843	0	15.79114	0	0	16.14196	14.66981	12.4945	0	16.06329	0	0	0	0	0	17.57747	0	13.34206	17.53532	12.97674	13.31001	0	0	0	0	0	17.35735	0	13.97252	17.28445	15.50807	14.82196	0	0	17.45482	0	0
Q9NZS9	BFAR_HUMAN	Bifunctional apoptosis regulator (RING finger protein 47)	BFAR BAR RNF47	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005783; GO:0005887; GO:0006511; GO:0006915; GO:0016020; GO:0030176; GO:0030674; GO:0043066; GO:0043161; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1903895	AILMELER	6.639999866	1	1	0.038843217	975.9468661	16.01867	0	16.65746	13.47842	16.08923	16.14337	0	15.73654	11.50605	0	0	14.84565	0	17.90329	12.92671	0	0	16.06163	0	14.40935	0	14.66064	16.29262	16.069	0	13.52962	0	17.92421	0	0	0	18.08917	12.44672	16.98462	13.1903	15.40817	16.60712	13.67706	0	15.27264	16.86787	16.81021	15.02809	14.12758	0	0	13.4756	15.25106
Q9NZT2	OGFR_HUMAN	"Opioid growth factor receptor, OGFr (Protein 7-60) (Zeta-type opioid receptor)"	OGFR	Homo sapiens (Human)	regulation of cell growth [GO:0001558]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; opioid growth factor receptor activity [GO:0140625]; regulation of cell growth [GO:0001558]	opioid growth factor receptor activity [GO:0140625]	GO:0001558; GO:0005634; GO:0005737; GO:0016020; GO:0140625	ELPGVR	6.539999962	1	1	3.46E-13	669.6351368	0	0	0	0	13.97313	15.25152	0	12.03737	15.77252	13.79138	12.86331	14.66581	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.85216	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.8898	0	0	0	0	0
Q9NZU0	FLRT3_HUMAN	Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3)	FLRT3 KIAA1469 UNQ856/PRO1865	Homo sapiens (Human)	axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]	axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]	chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]	GO:0003345; GO:0005104; GO:0005615; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007411; GO:0007416; GO:0007507; GO:0008543; GO:0014069; GO:0030054; GO:0030674; GO:0031012; GO:0031175; GO:0032584; GO:0042803; GO:0043679; GO:0044295; GO:0045499; GO:0048598; GO:0048678; GO:0051965; GO:0060322; GO:0097060; GO:0098742; GO:0098978; GO:0099055; GO:0099560; GO:1990138	LALPMTALR	6.170000076	0.381557167	0.381557167	0.130672759	1000.546933	17.42138	17.49085	0	14.93841	15.47614	15.93402	16.83933	0	0	15.44961	0	17.13471	17.018	13.95984	15.80286	0	14.2233	16.43961	0	0	15.18376	0	16.59656	0	13.5449	0	0	15.60488	15.6344	14.81693	0	0	17.82386	15.15524	16.89288	0	16.4831	17.75438	0	17.59034	0	16.11149	0	15.72048	16.90675	14.25005	17.6136	12.6656
Q9NZU5	LMCD1_HUMAN	LIM and cysteine-rich domains protein 1 (Dyxin)	LMCD1	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; regulation of cardiac muscle hypertrophy [GO:0010611]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; regulation of cardiac muscle hypertrophy [GO:0010611]	transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0010611; GO:0070886	GTCSGFEPHSWR	4.300000191	0.307219863	0.307219863	0.332423766	1421.702533	16.63616	3.239412	13.51261	14.87944	0	0	0	15.04046	14.88462	15.6741	14.01045	14.42035	0	14.89739	0	0	13.56841	0	15.53648	0	0	0	0	0	15.57179	16.11409	0	0	0	14.77964	0	16.08933	0	0	0	0	0	0	16.55615	0	0	0	0	0	0	0	0	15.59858
Q9NZU7	CABP1_HUMAN	"Calcium-binding protein 1, CaBP1 (Calbrain) (Caldendrin)"	CABP1	Homo sapiens (Human)	negative regulation of protein import into nucleus [GO:0042308]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; enzyme inhibitor activity [GO:0004857]; nuclear localization sequence binding [GO:0008139]; negative regulation of protein import into nucleus [GO:0042308]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; enzyme inhibitor activity [GO:0004857]; nuclear localization sequence binding [GO:0008139]	GO:0000139; GO:0004857; GO:0005509; GO:0005615; GO:0005856; GO:0005886; GO:0005938; GO:0007601; GO:0008139; GO:0014069; GO:0042308; GO:0048306; GO:0048471; GO:0050896	AAAAAASGGSR	1.74000001	1	1	0.291703276	890.3599542	0	18.88798	0	17.16893	0	0	0	19.15009	0	0	0	0	0	0	17.95876	16.87168	0	0	0	0	16.58135	18.3257	17.22978	17.01236	18.9515	0	18.54337	0	17.39021	0	0	0	0	18.36314	18.6331	19.27699	19.03122	0	19.0478	0	0	0	0	18.2966	0	17.60448	0	0
Q9NZW4	DSPP_HUMAN	"Dentin sialophosphoprotein [Cleaved into: Dentin phosphoprotein (Dentin phosphophoryn, DPP); Dentin sialoprotein, DSP ]"	DSPP	Homo sapiens (Human)	biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; multicellular organism development [GO:0007275]; odontoblast differentiation [GO:0071895]; ossification [GO:0001503]; regulation of odontoblast differentiation [GO:1901329]; skeletal system development [GO:0001501]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; multicellular organism development [GO:0007275]; odontoblast differentiation [GO:0071895]; ossification [GO:0001503]; regulation of odontoblast differentiation [GO:1901329]; skeletal system development [GO:0001501]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]	GO:0001501; GO:0001503; GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005634; GO:0005737; GO:0007275; GO:0031012; GO:0031214; GO:0071895; GO:0097187; GO:1901329	SNTNGNTDK	6.760000229	0.932032585	0.932032585	0.217358199	950.969411	0	16.77226	17.03225	18.20391	0	0	12.83571	16.5541	15.46572	18.65567	0	18.11685	14.55214	13.05596	0	0	0	0	0	15.40912	12.43475	16.40123	14.99709	0	17.77102	16.95811	16.58261	16.27191	17.46174	0	16.91188	17.52949	0	17.4226	15.90553	0	0	0	18.95889	18.12799	17.1671	16.43628	8.435129	0	16.6762	16.15602	16.55181	13.89689
Q9P016	THYN1_HUMAN	Thymocyte nuclear protein 1 (Thymocyte protein Thy28)	THYN1 THY28 HSPC144 MDS012 My0054	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]		GO:0005634	TENSGEALAK	7.139999866	0.65807426	0.65807426	0.232224137	1019.713817	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.79327	0	0	0	0	0	0	0	0	0	18.59259	0	0	0	0
Q9P032	NDUF4_HUMAN	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa)	NDUFAF4 C6orf66 HRPAP20 HSPC125 My013	Homo sapiens (Human)	defense response to virus [GO:0051607]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; defense response to virus [GO:0051607]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005739; GO:0005743; GO:0008284; GO:0031966; GO:0032981; GO:0043066; GO:0051607	DPVSSLQVK	4.269999981	0.470404744	0.470404744	0.271304926	973.7052728	15.13079	14.93311	12.58799	14.89041	0	0	0	0	0	16.32153	0	16.04296	14.75959	0	0	0	13.10429	15.7073	16.55596	15.63211	13.2949	0	14.74998	13.83216	0	0	0	0	16.21628	0	15.48673	0	14.86714	15.89662	0	16.33413	0	15.45949	15.78326	16.4745	0	15.18156	16.22348	0	0	14.9562	15.15913	0
Q9P0J0	NDUAD_HUMAN	"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6, CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein, GRIM-19, Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit)"	NDUFA13 GRIM19 CDA016 CGI-39	Homo sapiens (Human)	"aerobic respiration [GO:0009060]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; electron transport chain [GO:0022900]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of peptidase activity [GO:0010952]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]"	cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; aerobic respiration [GO:0009060]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; electron transport chain [GO:0022900]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of peptidase activity [GO:0010952]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593]"	ATP binding [GO:0005524]	GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005746; GO:0005747; GO:0009060; GO:0010952; GO:0022900; GO:0030308; GO:0031966; GO:0032981; GO:0035458; GO:0042776; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243	ENLEEEAIIMK	6.190000057	1	1	0.478465006	1335.710244	0	14.57487	0	21.43639	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.16487	0	0	0	0	19.58813	0	0	0	0	0	0	0	0	0	0	0	0	0	18.8813	0	0	0	0	0	0	0	0	0	0
Q9P0L1	ZKSC7_HUMAN	Zinc finger protein with KRAB and SCAN domains 7 (Zinc finger protein 167) (Zinc finger protein 448) (Zinc finger protein 64)	ZKSCAN7 ZNF167 ZNF448 ZNF64	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	GSELTPKQEFFK	1	1	1	0.527726326	1410.616631	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.419	0	0	0	0	0	0	0	0	0	0	0
Q9P0L2	MARK1_HUMAN	"Serine/threonine-protein kinase MARK1, EC 2.7.11.1, EC 2.7.11.26 (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c, Par-1c, Par1c)"	MARK1 KIAA1477 MARK	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; establishment of mitochondrion localization [GO:0051654]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of neuron projection development [GO:0010975]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; cytoskeleton organization [GO:0007010]; establishment of mitochondrion localization [GO:0051654]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of neuron projection development [GO:0010975]; Wnt signaling pathway [GO:0016055]"	"ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]"	GO:0000226; GO:0000287; GO:0001764; GO:0001786; GO:0004674; GO:0004712; GO:0005524; GO:0005546; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0015630; GO:0016055; GO:0018105; GO:0030425; GO:0035556; GO:0048156; GO:0050321; GO:0050773; GO:0051654; GO:0070300; GO:0106310	EEGKDSKPR	9.359999657	1	1	0.235968507	1045.481989	16.71862	15.09706	15.15933	0	0	0	0	0	14.7829	0	0	0	0	0	0	0	15.27442	0	0	16.72669	0	0	0	0	0	14.80854	0	15.60755	0	15.16698	16.27095	16.74402	0	15.88445	12.95078	0	15.22454	17.0276	16.45078	0	0	15.49186	14.67826	0	0	0	16.1906	16.35943
Q9P0L9	PK2L1_HUMAN	Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog) (Polycystin-2L1) (Polycystin-L) (Polycystin-L1)	PKD2L1 PKD2L PKDL TRPP3	Homo sapiens (Human)	cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]	actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; sour taste receptor activity [GO:0033040]; cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725]	alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; sour taste receptor activity [GO:0033040]	GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0009986; GO:0015269; GO:0015629; GO:0016020; GO:0016021; GO:0031410; GO:0033040; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071468; GO:0071805; GO:0097730; GO:0098662	SGPEAARAGGWVSGEEFYMLTR	3.019999981	1	1	0.063544054	2375.806217	12.85408	11.66457	0	0	13.55104	11.17449	14.16138	10.75669	0	13.25476	0	0	12.36496	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P0M2	AKA7G_HUMAN	"A-kinase anchor protein 7 isoform gamma, AKAP-7 isoform gamma (A-kinase anchor protein 18 kDa, AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma, PRKA7 isoform gamma)"	AKAP7 AKAP18	Homo sapiens (Human)	modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]	cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738]	nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]	GO:0000166; GO:0005634; GO:0005829; GO:0010738; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686	IDPDLYEK	3.470000029	1	1	1.18E-13	992.8151894	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P0M4	IL17C_HUMAN	"Interleukin-17C, IL-17C (Cytokine CX2)"	IL17C UNQ561/PRO1122	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]	cytokine activity [GO:0005125]	GO:0005125; GO:0005576; GO:0005615; GO:0006954; GO:0007166; GO:0007267	GCIDARTGR	8.640000343	1	1	0.178148586	1006.227911	15.00167	17.21359	15.34625	9.172527	13.48187	13.01779	0	0	0	15.56662	15.17134	15.2647	0	0	0	0	0	0	0	0	0	0	0	0	0	15.17078	0	0	0	0	15.32518	17.00219	0	0	0	0	0	0	0	0	0	0	0	10.41374	0	0	0	0
Q9P0M6	H2AW_HUMAN	"Core histone macro-H2A.2, Histone macroH2A2, mH2A2"	MACROH2A2 H2AFY2	Homo sapiens (Human)	"brain development [GO:0007420]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of keratinocyte differentiation [GO:0045618]"	"Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]"	"Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of keratinocyte differentiation [GO:0045618]"	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]	GO:0000122; GO:0000781; GO:0000785; GO:0000786; GO:0000976; GO:0000977; GO:0001740; GO:0003677; GO:0005654; GO:0006334; GO:0007420; GO:0007549; GO:0031490; GO:0045618; GO:0045814; GO:0046982; GO:0070062; GO:0071169; GO:1901837	EGTSNSTSEDGPGDGFTILSSK	4.730000019	1	1	0.457095447	2186.457678	19.61138	19.30319	0	0	0	0	0	19.88379	14.81036	13.65521	12.18744	18.90231	0	0	18.16603	0	0	0	18.191	0	0	19.36431	0	0	0	0	19.78177	0	0	0	0	20.59369	0	0	0	0	0	19.5171	0	0	0	0	17.68525	0	0	0	18.44303	0
Q9P0T4	ZN581_HUMAN	Zinc finger protein 581	ZNF581 HSPC189	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872	RASHLAR	14.93999958	1	1	0.235189783	811.2358516	15.07543	15.78587	15.63928	11.49496	12.31802	0	0	0	0	13.3389	15.48635	14.99494	13.52202	0	14.80941	0	0	0	0	14.93081	0	15.41306	0	0	14.443	0	0	0	0	13.11204	0	16.12954	0	0	13.70971	0	0	0	0	0	15.23737	0	0	16.34177	12.36357	0	0	0
Q9P0T7	TMEM9_HUMAN	"Proton-transporting V-type ATPase complex assembly regulator TMEM9, v-ATPase assembly regulator TMEM9 (Dermal papilla-derived protein 4) (Transmembrane protein 9, Protein TMEM9)"	TMEM9 DERP4 TMEM9A HSPC186 PSEC0012 UNQ631/PRO1248	Homo sapiens (Human)	endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein transport [GO:0015031]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of protein catabolic process [GO:0042176]	integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; multivesicular body membrane [GO:0032585]	integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; multivesicular body membrane [GO:0032585]; endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein transport [GO:0015031]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of protein catabolic process [GO:0042176]		GO:0005764; GO:0005765; GO:0005770; GO:0007042; GO:0015031; GO:0015630; GO:0016021; GO:0032585; GO:0042176; GO:0043231; GO:0045171; GO:0048388; GO:0070070; GO:0072686; GO:0090263	SMAAAAASLGGPRANTVLER	3.390000105	1	1	0.199416704	1942.90919	14.98397	14.34044	0	0	0	0	0	14.69718	0	0	0	12.81299	12.12887	0	0	14.75882	0	0	13.87702	0	15.2689	14.85652	0	0	0	0	13.05903	14.4816	13.36522	0	17.30718	14.90244	12.69534	11.59643	13.16531	13.67556	0	0	0	0	0	0	0	0	0	0	0	0
Q9P0U3	SENP1_HUMAN	"Sentrin-specific protease 1, EC 3.4.22.- (Sentrin/SUMO-specific protease SENP1)"	SENP1	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; SUMO-specific endopeptidase activity [GO:0070139]; SUMO-specific isopeptidase activity [GO:0070140]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508]	endopeptidase activity [GO:0004175]; SUMO-specific endopeptidase activity [GO:0070139]; SUMO-specific isopeptidase activity [GO:0070140]	GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006508; GO:0006919; GO:0016926; GO:0031965; GO:0045944; GO:0070139; GO:0070140; GO:0097190	CLSSSKNTLK	4.730000019	1	1	0.290625331	1137.8709	17.18373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.43863	0	17.70703	0	0	0	19.02468	0	0	0	0	0
Q9P0V3	SH3B4_HUMAN	SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein)	SH3BP4 BOG25 EHB10 TTP	Homo sapiens (Human)	cellular response to amino acid stimulus [GO:0071230]; endocytosis [GO:0006897]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of GTPase activity [GO:0034260]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790]	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; cellular response to amino acid stimulus [GO:0071230]; endocytosis [GO:0006897]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of GTPase activity [GO:0034260]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790]	GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]	GO:0005092; GO:0005634; GO:0005737; GO:0005905; GO:0006897; GO:0008285; GO:0010508; GO:0030136; GO:0030308; GO:0031267; GO:0032007; GO:0034260; GO:0042802; GO:0050790; GO:0061462; GO:0070062; GO:0071230	AANSNGLPR	1.809999943	0.322331935	0.322331935	0.251554261	899.9130864	0	0	0	14.98423	0	0	15.96983	0	0	0	0	0	0	0	15.72867	18.81943	14.36987	13.85146	0	0	0	0	0	14.87415	0	0	16.83394	0	0	12.98502	0	0	15.70666	0	0	0	0	16.85399	0	0	0	0	0	0	0	0	0	0
Q9P0W8	SPAT7_HUMAN	Spermatogenesis-associated protein 7 (HSD-3.1) (Spermatogenesis-associated protein HSD3)	SPATA7 HSD3	Homo sapiens (Human)	microtubule cytoskeleton organization [GO:0000226]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; rod photoreceptor outer segment [GO:0120200]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; rod photoreceptor outer segment [GO:0120200]; microtubule cytoskeleton organization [GO:0000226]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601]		GO:0000226; GO:0005654; GO:0005739; GO:0005829; GO:0005930; GO:0007601; GO:0015630; GO:0032391; GO:0036064; GO:0045494; GO:0050896; GO:0120200; GO:0120206; GO:1903546; GO:1903621	ALDMLLSAPK	5.130000114	1	1	0.152311963	1075.746299	15.89166	16.05599	14.98165	7.333758	0	0	16.50718	0	14.55158	15.26457	18.41745	0	0	15.12002	14.5082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.32578	0	0	0	15.19571	0	0	0	0	16.64024	0	0	0	0
Q9P0X4	CAC1I_HUMAN	"Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3, Ca(v)3.3)"	CACNA1I KIAA1120	Homo sapiens (Human)	calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431]	neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]	neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431]	low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0007165; GO:0008332; GO:0019228; GO:0030317; GO:0030431; GO:0034765; GO:0043005; GO:0045956; GO:0070509; GO:0086010	APLPMGLGPLAPPPQPLPGELEPGDAASKR	3.710000038	1	1	1.83E-12	2970.472778	11.72126	12.19	12.02557	14.42391	12.96986	12.20289	0	0	0	13.4923	0	15.22966	12.1585	11.23272	13.62095	11.28046	0	13.21867	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P107	GMIP_HUMAN	"GEM-interacting protein, GMIP"	GMIP	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056]	GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]	GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046872; GO:0051056; GO:0090630	RMNEAVQALR	7.130000114	0.056887396	0.056887396	0.079410592	1188.429367	14.89983	0	5.148437	12.61457	14.26901	13.1064	0	11.35622	0	14.42889	0	0	0	12.38131	0	10.63806	10.72329	9.987067	15.91536	0	13.38119	0	0	11.61727	0	0	0	0	0	0	0	0	0	0	14.16396	0	0	0	0	0	0	0	0	0	13.0914	0	0	0
Q9P109	GCNT4_HUMAN	"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4, EC 2.4.1.102 (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3, C2GnT3)"	GCNT4	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; homeostasis of number of cells [GO:0048872]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]"	"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]"	GO:0000139; GO:0002121; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0008375; GO:0016021; GO:0016266; GO:0042403; GO:0048729; GO:0048872; GO:0060993	DTYSPDEHFWATLIR	5.429999828	0.170069456	0.170069456	0.168768644	1852.265151	0	17.50234	0	0	0	0	15.55632	15.96271	0	0	14.91814	17.26577	0	13.39903	0	0	0	15.1756	0	0	16.93444	16.13033	16.239	15.03123	16.63699	0	19.41812	0	16.95387	19.11968	0	19.72134	0	0	0	13.70318	0	0	16.98055	18.32005	0	16.48772	14.48244	0	14.32934	14.63383	0	17.92542
Q9P127	LUZP4_HUMAN	"Leucine zipper protein 4 (Cancer/testis antigen 28, CT-28, CT28) (Tumor antigen HOM-TES-85)"	LUZP4	Homo sapiens (Human)	mRNA transport [GO:0051028]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]	RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005737; GO:0051028	DLIATQR	22.29999924	1	1	0.069696885	815.7094272	14.86754	0	0	0	0	0	0	0	0	0	17.75326	0	16.97039	0	0	0	0	0	0	0	0	0	0	0	0	18.05687	0	0	16.57398	0	0	15.92206	0	0	0	0	0	0	0	0	0	0	0	0	0	16.13433	0	16.18794
Q9P1A2	PP4RL_HUMAN	Putative serine/threonine-protein phosphatase 4 regulatory subunit 1-like	PPP4R1L C20orf192 PRO1085	Homo sapiens (Human)	protein dephosphorylation [GO:0006470]		protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]	protein phosphatase regulator activity [GO:0019888]	GO:0006470; GO:0019888	LVSDPCR	8.949999809	1	1	0.193386924	845.323878	0	16.12908	14.1508	14.22075	13.79833	13.81243	18.14921	14.09424	14.44753	13.01959	13.98317	14.5363	0	15.89023	15.44281	15.59365	16.25694	14.86222	0	17.81352	0	0	0	0	15.08504	14.90353	14.6477	13.01673	13.28535	14.212	16.62653	13.87138	15.48714	0	18.74646	15.21178	15.24157	14.87536	14.75879	0	15.16928	15.11951	16.30161	14.86023	0	16.30489	0	15.04822
Q9P1Q0	VPS54_HUMAN	Vacuolar protein sorting-associated protein 54 (Hepatocellular carcinoma protein 8) (Tumor antigen HOM-HCC-8) (Tumor antigen SLP-8p)	VPS54 HCC8	Homo sapiens (Human)	"Golgi to vacuole transport [GO:0006896]; homeostasis of number of cells within a tissue [GO:0048873]; lysosomal transport [GO:0007041]; musculoskeletal movement [GO:0050881]; neurofilament cytoskeleton organization [GO:0060052]; protein transport [GO:0015031]; regulation of growth [GO:0040008]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	"cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; syntaxin binding [GO:0019905]; Golgi to vacuole transport [GO:0006896]; homeostasis of number of cells within a tissue [GO:0048873]; lysosomal transport [GO:0007041]; musculoskeletal movement [GO:0050881]; neurofilament cytoskeleton organization [GO:0060052]; protein transport [GO:0015031]; regulation of growth [GO:0040008]; retrograde transport, endosome to Golgi [GO:0042147]"	syntaxin binding [GO:0019905]	GO:0000938; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006896; GO:0007041; GO:0015031; GO:0016020; GO:0019905; GO:0032588; GO:0040008; GO:0042147; GO:0048471; GO:0048873; GO:0050881; GO:0060052	ASSHSSSPVPQGSSSDVFFK	7.820000172	1	1	0.754186218	2038.668562	0	0	0	0	0	0	0	16.73642	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P1U1	ARP3B_HUMAN	Actin-related protein 3B (ARP3-beta) (Actin-like protein 3B) (Actin-related protein ARP4)	ACTR3B ARP11 ARP4	Homo sapiens (Human)		cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; actin binding [GO:0003779]; ATP binding [GO:0005524]	actin binding [GO:0003779]; ATP binding [GO:0005524]	GO:0003779; GO:0005524; GO:0005737; GO:0005856; GO:0042995; GO:0070062	RPLYKNVVLSGGSTMFR	9.470000267	1	1	0.130853874	1939.995267	15.75152	16.138	15.40132	18.2433	15.2155	16.27804	13.21597	0	14.70755	0	0	15.45736	17.0341	17.79568	17.06066	16.42676	16.10478	0	0	0	17.17146	0	0	17.03353	0	18.28627	0	13.54524	16.64614	0	17.42063	0	16.88341	16.13203	0	15.34423	16.7993	17.20244	0	15.41744	15.31466	0	0	17.61977	0	17.5552	0	0
Q9P1V8	SAM15_HUMAN	"Sterile alpha motif domain-containing protein 15, SAM domain-containing protein 15"	SAMD15 C14orf174 FAM15A	Homo sapiens (Human)						EGEPDSAK	3.369999886	1	1	0.097898127	831.9874346	0	16.83431	0	14.59012	15.93906	13.73367	16.22379	0	13.29194	14.86912	16.93808	15.74921	0	16.48626	14.14381	0	0	16.1061	0	0	0	0	0	0	15.76614	0	15.34774	0	0	0	0	0	0	0	0	15.56661	0	0	0	0	15.79068	0	0	16.10185	0	0	14.63334	0
Q9P1Y5	CAMP3_HUMAN	Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha)	CAMSAP3 KIAA1543	Homo sapiens (Human)	cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell-cell adhesion [GO:0090136]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; in utero embryonic development [GO:0001701]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; protein transport along microtubule [GO:0098840]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; regulation of Golgi organization [GO:1903358]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043]; zonula adherens maintenance [GO:0045218]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule minus-end [GO:0036449]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; zonula adherens [GO:0005915]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule minus-end [GO:0036449]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell-cell adhesion [GO:0090136]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; in utero embryonic development [GO:0001701]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; protein transport along microtubule [GO:0098840]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; regulation of Golgi organization [GO:1903358]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043]; zonula adherens maintenance [GO:0045218]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]	GO:0000226; GO:0001701; GO:0003341; GO:0005516; GO:0005654; GO:0005737; GO:0005813; GO:0005915; GO:0005930; GO:0007026; GO:0009792; GO:0030334; GO:0030507; GO:0030951; GO:0031113; GO:0031122; GO:0031175; GO:0031514; GO:0033043; GO:0034453; GO:0036064; GO:0036449; GO:0045198; GO:0045218; GO:0051011; GO:0051015; GO:0051893; GO:0070507; GO:0090136; GO:0098840; GO:1903358	ANHFLILFR	25.10000038	0.323707312	0.323707312	0.303829434	1131.794321	17.51903	0	17.12425	0	0	0	18.58097	18.61863	18.98189	19.18149	0	0	0	0	0	17.50562	0	18.40018	0	18.30047	16.5747	18.87842	17.77568	18.86465	0	0	0	0	17.70471	0	18.40779	0	18.48519	0	18.3973	0	0	17.7474	0	18.27205	19.03451	18.59302	0	0	18.41178	18.73889	0	18.47058
Q9P1Y6	PHRF1_HUMAN	PHD and RING finger domain-containing protein 1	PHRF1 KIAA1542	Homo sapiens (Human)	mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]	membrane [GO:0016020]	membrane [GO:0016020]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366]	metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]	GO:0006366; GO:0006397; GO:0016020; GO:0019904; GO:0046872; GO:0070063	TPAPR	4.179999828	1	1	0.122705548	541.6738324	13.91273	0	16.06309	0	15.2164	15.70404	0	0	16.13745	0	15.29667	0	15.49989	0	0	0	0	0	0	0	0	0	0	0	15.97395	0	0	0	14.46957	0	16.10623	15.32155	0	16.32241	0	13.67377	15.60506	0	0	0	16.88007	0	0	0	17.99624	0	0	0
Q9P1Z0	ZBTB4_HUMAN	"Zinc finger and BTB domain-containing protein 4 (KAISO-like zinc finger protein 1, KAISO-L1)"	ZBTB4 KIAA1538	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; methyl-CpNpG binding [GO:0010428]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; methyl-CpNpG binding [GO:0010428]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0006974; GO:0008327; GO:0010428; GO:0016604; GO:0019901; GO:0042803; GO:0043565; GO:0045892; GO:0046872	SVLAASSPFFR	10.90999985	1	1	0.483520875	1181.526338	17.66814	18.41112	0	0	0	0	16.87021	0	17.66545	0	0	17.35401	0	19.06581	0	0	0	20.2012	0	17.75188	0	0	0	0	0	18.03907	0	0	0	0	0	0	0	19.77704	0	0	18.37091	0	0	0	0	0	0	0	0	0	20.2205	18.03683
Q9P1Z2	CACO1_HUMAN	Calcium-binding and coiled-coil domain-containing protein 1 (Calphoglin) (Coiled-coil coactivator protein) (Sarcoma antigen NY-SAR-3)	CALCOCO1 KIAA1536 PP13275 UNQ2436/PRO4996	Homo sapiens (Human)	"intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]"	chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]"	armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	GO:0000785; GO:0000976; GO:0000978; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005829; GO:0007165; GO:0008013; GO:0008022; GO:0010628; GO:0016055; GO:0030374; GO:0030518; GO:0043231; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0070016	EQLRGAQELAASSQQK	10.98999977	1	1	0.038991296	1744.308912	0	15.35487	16.78705	17.26218	15.4677	0	0	0	0	14.38486	15.82062	0	16.06265	16.95713	16.73611	17.37833	0	14.55809	0	16.59835	17.09655	11.97316	0	0	15.25353	14.89704	14.6226	13.05893	12.1514	13.06914	16.98486	14.41115	15.21907	17.95544	0	15.60848	0	13.86189	11.47836	13.61302	14.76804	16.50953	17.14419	0	0	0	8.896737	16.8273
Q9P1Z3	HCN3_HUMAN	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	HCN3 KIAA1535	Homo sapiens (Human)	cellular response to cAMP [GO:0071320]; cellular response to dopamine [GO:1903351]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; response to cisplatin [GO:0072718]; sodium ion transmembrane transport [GO:0035725]	cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; cellular response to cAMP [GO:0071320]; cellular response to dopamine [GO:1903351]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; response to cisplatin [GO:0072718]; sodium ion transmembrane transport [GO:0035725]	cAMP binding [GO:0030552]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]	GO:0003254; GO:0005248; GO:0005249; GO:0005886; GO:0005887; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0043025; GO:0044316; GO:0071320; GO:0071805; GO:0072718; GO:0086091; GO:0098907; GO:1903351; GO:2001257	LPADTR	15.32999992	1	1	0.247799248	673.5148137	20.7634	17.62991	0	0	0	18.02054	0	0	0	0	0	0	0	0	0	18.84798	16.44906	0	0	0	18.89314	16.63132	17.01715	16.98351	0	0	0	16.86452	17.32081	0	17.23999	19.21501	18.77029	18.55613	0	17.10773	0	0	0	0	0	0	19.0796	17.7258	0	0	0	0
Q9P1Z9	CC180_HUMAN	Coiled-coil domain-containing protein 180	CCDC180 C9orf174 KIAA1529	Homo sapiens (Human)		extracellular exosome [GO:0070062]	extracellular exosome [GO:0070062]		GO:0070062	MDESKEGSIQGLEEMQVER	10.97999954	1	1	0.44361305	2212.000996	0	0	15.762	21.63359	0	21.17939	20.45022	0	0	0	0	0	18.79833	0	20.91103	0	0	0	19.51412	0	0	0	0	0	0	0	0	0	0	0	0	0	21.75658	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P202	WHRN_HUMAN	Whirlin (Autosomal recessive deafness type 31 protein)	WHRN DFNB31 KIAA1526	Homo sapiens (Human)	auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]	actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]	actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]; identical protein binding [GO:0042802]; auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]	identical protein binding [GO:0042802]	GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0060088; GO:0060122; GO:1990075; GO:1990227; GO:1990696	FDHLVLRR	2.890000105	1	1	0.167292486	1055.648109	0	13.0283	0	0	15.82246	0	0	0	0	15.46375	14.95139	0	0	0	13.39493	0	0	0	0	0	0	13.80381	16.27049	0	15.03923	0	0	0	0	0	0	17.01517	16.68446	0	0	0	0	0	0	0	15.83759	0	0	0	13.66454	0	15.1114	0
Q9P203	BTBD7_HUMAN	BTB/POZ domain-containing protein 7	BTBD7 KIAA1525	Homo sapiens (Human)	morphogenesis of a branching epithelium [GO:0061138]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]	nucleus [GO:0005634]	nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]		GO:0005634; GO:0060693; GO:0061138	AVISAR	3.019999981	1	1	0.305793138	617.0647061	17.26528	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.38954	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P206	K1522_HUMAN	Uncharacterized protein KIAA1522	KIAA1522	Homo sapiens (Human)	cell differentiation [GO:0030154]		cell differentiation [GO:0030154]		GO:0030154	APPPVAR	5.860000134	1	1	0.303633445	706.8655255	15.07693	13.71575	14.74448	17.23053	17.11832	0	17.28497	16.13188	15.33431	15.86016	16.59429	0	0	15.63275	17.03916	16.65781	17.11855	0	0	0	16.94213	18.59289	18.77963	18.82504	0	0	16.75242	17.56623	13.73176	0	15.79653	17.01917	16.61134	16.98347	17.15853	16.92871	0	16.74344	0	16.36381	17.25949	15.137	0	17.92217	16.62756	17.0166	17.34715	0
Q9P209	CEP72_HUMAN	"Centrosomal protein of 72 kDa, Cep72"	CEP72 KIAA1519	Homo sapiens (Human)	centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051]		GO:0005654; GO:0005739; GO:0005813; GO:0005829; GO:0007051; GO:0007099; GO:0033566; GO:0034451; GO:1904779	GCCLEK	10.85000038	1.56E-08	1.56E-08	0.242833951	767.0925943	21.16385	18.22186	21.53113	17.83482	18.83032	21.34146	0	0	21.87488	20.3248	0	0	18.69023	18.72839	21.51521	0	20.2068	20.95661	0	22.50291	0	21.01693	0	21.2215	0	0	18.49804	19.8016	0	19.25577	0	18.71059	17.96253	0	0	0	0	19.50183	20.63803	21.6231	20.82076	0	0	21.21839	0	20.53646	21.55582	0
Q9P212	PLCE1_HUMAN	"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, EC 3.1.4.11 (Pancreas-enriched phospholipase C) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1, PLC-epsilon-1)"	PLCE1 KIAA1516 PLCE PPLC	Homo sapiens (Human)	calcium-mediated signaling [GO:0019722]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate-mediated signaling [GO:0048016]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; regulation of smooth muscle contraction [GO:0006940]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267]; calcium-mediated signaling [GO:0019722]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate-mediated signaling [GO:0048016]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; regulation of smooth muscle contraction [GO:0006940]	enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267]	GO:0000139; GO:0001558; GO:0004435; GO:0004629; GO:0005085; GO:0005829; GO:0005886; GO:0006651; GO:0006940; GO:0007010; GO:0007173; GO:0007200; GO:0007204; GO:0007265; GO:0007507; GO:0008277; GO:0010592; GO:0016042; GO:0019722; GO:0019899; GO:0030027; GO:0031267; GO:0032835; GO:0043410; GO:0045859; GO:0046578; GO:0046872; GO:0048015; GO:0048016	AHQTPVDILK	7.829999924	0.165747449	0.165747449	0.229134035	1121.435246	16.50461	14.16529	0	15.87969	14.83957	13.45167	0	11.5605	0	0	0	15.20795	0	0	0	13.3024	13.12097	13.98758	0	0	11.71726	0	15.6251	0	0	14.76473	14.9051	0	0	0	15.13591	0	0	0	0	15.36976	0	0	15.69338	14.00541	0	0	0	15.47295	13.6943	0	0	15.36062
Q9P215	POGK_HUMAN	Pogo transposable element with KRAB domain	POGK KIAA1513 LST003 SLTP003	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]"	DNA binding [GO:0003677]	GO:0003677; GO:0005634; GO:0005654; GO:0006355	SVLALR	1.019999981	1	1	0.061365074	657.2883573	0	0	20.75601	0	0	0	0	0	18.66389	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.46314	0	0	0	0	0	0	0	0	0	0	0	0	17.60245	0	0	0	0	0	0	0	18.43502	0
Q9P218	COKA1_HUMAN	Collagen alpha-1(XX) chain	COL20A1 KIAA1510	Homo sapiens (Human)		collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]		GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0062023	GEKGDHGLPGLQGHPGHQGIPGR	1.50999999	1	1	0.288360857	2301.439793	0	11.49543	13.11857	12.64398	14.52508	11.50737	14.93774	16.01943	13.12213	9.764253	14.09113	0	0	0	0	13.96761	13.29683	0	0	0	0	14.89124	0	16.22883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P219	DAPLE_HUMAN	"Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues, hDaple) (Hook-related protein 2, HkRP2)"	CCDC88C DAPLE KIAA1509	Homo sapiens (Human)	apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098]	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]	cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098]	dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]	GO:0001932; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005737; GO:0005813; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031098; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043621; GO:0051959; GO:0090090	EAWGPGHK	8.56000042	0.457227826	0.457227826	0.185750835	881.4246296	0	14.5471	14.7731	14.84333	15.97135	15.41182	15.89773	15.89441	16.41201	16.39585	13.0201	11.3174	0	16.94559	16.99789	17.12219	17.29014	15.31154	16.79228	17.73354	13.30855	14.12219	16.02022	13.33768	17.11855	13.56252	17.36599	0	16.07561	0	0	17.17579	0	16.02905	14.93989	0	17.45318	17.20273	18.04231	0	18.39957	17.04008	18.27154	17.14968	17.40955	0	17.32172	0
Q9P225	DYH2_HUMAN	Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) (Dynein heavy chain domain-containing protein 3)	DNAH2 DNAHC2 DNHD3 KIAA1503	Homo sapiens (Human)	cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285	AGSSDR	1.940000057	0.903162897	0.903162897	0.138077525	591.3533397	16.19281	18.32224	17.11423	0	16.53834	16.20697	16.12196	17.24388	17.98284	17.20356	16.41527	16.14841	17.60914	17.84723	18.30987	16.15596	17.05181	17.53951	18.27914	17.03556	16.2637	17.00157	17.74422	17.60432	0	17.35995	0	17.72702	13.71899	17.69624	17.99634	17.41712	16.45543	15.7623	16.69169	18.52774	18.09915	17.48423	16.4926	16.96261	18.13123	17.52093	16.31672	17.15124	18.85561	0	17.45143	17.17333
Q9P227	RHG23_HUMAN	Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23)	ARHGAP23 KIAA1501	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0051056; GO:0070062	DDSAAAPK	5.420000076	0.463811606	0.463811606	0.244346701	774.1580386	15.81987	0	14.64129	13.80179	15.22157	15.29406	11.99105	14.43188	15.38686	15.36807	12.95518	15.42076	17.03459	14.17888	0	0	14.60034	0	15.70744	13.97093	14.45121	13.22048	14.17371	15.27306	0	15.04626	13.91971	0	15.58238	0	0	14.58345	0	0	14.70289	0	16.77497	15.7824	0	16.14615	0	11.69545	0	0	16.51372	15.28417	14.6261	15.98269
Q9P232	CNTN3_HUMAN	"Contactin-3 (Brain-derived immunoglobulin superfamily protein 1, BIG-1) (Plasmacytoma-associated neuronal glycoprotein)"	CNTN3 KIAA1496 PANG	Homo sapiens (Human)	cell adhesion [GO:0007155]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]		GO:0005576; GO:0005886; GO:0007155; GO:0031225; GO:0043005	MKVAGNETSAR	7.110000134	1	1	0.383975728	1181.430132	15.77299	12.99592	0	0	15.83799	0	0	14.93266	14.29788	0	0	13.33802	16.66195	14.75836	15.55375	0	0	0	16.97179	0	17.70753	0	0	0	15.17628	17.33075	0	16.59712	0	15.66493	16.84933	0	15.092	0	0	15.46797	16.30701	18.17677	16.60247	0	0	16.45044	0	13.03387	0	15.92981	0	0
Q9P241	AT10D_HUMAN	"Phospholipid-transporting ATPase VD, EC 7.6.2.1 (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D)"	ATP10D ATPVD KIAA1487	Homo sapiens (Human)	cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006812; GO:0016021; GO:0016887; GO:0034220; GO:0045332; GO:0140326; GO:0140351; GO:1990531	DACGMLMSTILKELQK	2.450000048	1	1	1.37E-12	1832.606472	14.51119	0	14.23036	0	0	13.52541	0	0	0	0	0	10.97461	14.87352	12.86157	0	0	0	0	0	0	14.59622	0	0	12.014	0	0	13.5904	0	14.21942	0	15.22134	12.06753	0	15.24566	0	14.53786	11.00541	0	13.89828	0	0	15.98099	0	0	16.72021	0	0	16.15002
Q9P246	STIM2_HUMAN	Stromal interaction molecule 2	STIM2 KIAA1482	Homo sapiens (Human)	activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of calcium ion transport [GO:0051928]; store-operated calcium entry [GO:0002115]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of calcium ion transport [GO:0051928]; store-operated calcium entry [GO:0002115]	calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]	GO:0002115; GO:0005246; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0015279; GO:0016021; GO:0032237; GO:0051928	HITIEDLWK	31.37000084	1	1	0.207551147	1154.645195	21.06433	18.79942	20.85317	0	0	20.70226	21.02459	0	0	19.38702	22.07417	15.94068	21.46085	0	0	16.12523	19.42249	0	0	0	20.68782	21.64473	0	0	20.63708	21.66145	20.1446	20.97699	20.43883	21.30239	0	21.00567	22.40594	0	20.64938	20.682	21.01907	0	0	21.17075	21.02402	0	0	20.84885	20.62004	0	21.2921	19.97724
Q9P253	VPS18_HUMAN	"Vacuolar protein sorting-associated protein 18 homolog, hVPS18"	VPS18 KIAA1475	Homo sapiens (Human)	autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; protein ubiquitination [GO:0016567]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle exocytosis [GO:2000300]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]; viral entry into host cell [GO:0046718]	actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynapse [GO:0098793]	actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynapse [GO:0098793]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; protein ubiquitination [GO:0016567]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle exocytosis [GO:2000300]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]; viral entry into host cell [GO:0046718]	actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]	GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0007040; GO:0008333; GO:0016567; GO:0019905; GO:0030123; GO:0030136; GO:0030674; GO:0030897; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0035542; GO:0046718; GO:0046872; GO:0048284; GO:0061630; GO:0098793; GO:0098978; GO:2000300	SAPRAFAWMMGDGVLYGALDCGRPDSLLSEER	3.039999962	1	1	1.84E-12	3542.464528	0	0	14.1478	13.90955	11.14579	0	13.21523	13.61084	14.82044	11.51788	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P258	RCC2_HUMAN	Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa)	RCC2 KIAA1470 TD60	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]	"chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]"	"chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]"	guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	GO:0003723; GO:0005085; GO:0005730; GO:0005829; GO:0005874; GO:0005886; GO:0007049; GO:0007229; GO:0008017; GO:0010762; GO:0010971; GO:0019901; GO:0019904; GO:0030334; GO:0030496; GO:0031267; GO:0031901; GO:0034260; GO:0034506; GO:0045184; GO:0048041; GO:0051301; GO:0051895; GO:0051987; GO:0072356; GO:0090630; GO:1900025; GO:1900027; GO:1990023	DEMVPR	15.61999989	1	1	1.16E-13	743.4838745	14.571	0	15.54066	0	14.40553	0	0	13.76061	0	0	0	0	0	0	0	0	0	13.82206	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P260	RELCH_HUMAN	"RAB11-binding protein RELCH (LisH domain and HEAT repeat-containing protein KIAA1468) (RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing) (RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats)"	RELCH KIAA1468	Homo sapiens (Human)	intracellular cholesterol transport [GO:0032367]	recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367]		GO:0005802; GO:0032367; GO:0055037	ECEQK	6.860000134	1	1	0.289082086	692.3147984	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.44064	0	0	0	19.29208	0	0	0	19.68456	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P265	DIP2B_HUMAN	"Disco-interacting protein 2 homolog B, DIP2 homolog B"	DIP2B KIAA1463	Homo sapiens (Human)	negative regulation of axon extension [GO:0030517]; positive regulation of peptidyl-lysine acetylation [GO:2000758]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204]; alpha-tubulin binding [GO:0043014]; negative regulation of axon extension [GO:0030517]; positive regulation of peptidyl-lysine acetylation [GO:2000758]	alpha-tubulin binding [GO:0043014]	GO:0005634; GO:0005737; GO:0016020; GO:0030424; GO:0030425; GO:0030517; GO:0043014; GO:0043204; GO:0070062; GO:2000758	DSFLADQLDPIYVAYNM	10.56999969	1	1	2.06E-12	1991.213459	14.9494	0	0	14.59076	0	14.89775	14.38787	13.1309	13.56379	0	0	0	16.87338	16.06144	0	15.21845	14.35585	0	0	13.78885	0	0	0	17.81947	17.3971	17.50582	16.36903	0	14.44248	0	0	0	16.76498	15.65102	0	16.15351	16.4196	0	0	0	13.75335	0	0	0	0	0	0	0
Q9P266	JCAD_HUMAN	"Junctional protein associated with coronary artery disease, JCAD"	JCAD KIAA1462	Homo sapiens (Human)	cell adhesion [GO:0007155]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]	adherens junction [GO:0005912]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]	adherens junction [GO:0005912]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; cell adhesion [GO:0007155]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]		GO:0005912; GO:0007155; GO:0032587; GO:0043410; GO:0048471; GO:0090050; GO:1900748; GO:1903589; GO:1903672	GNSPEMR	3.49000001	7.23E-06	7.23E-06	0.285140635	790.335264	0	17.07441	18.97816	0	0	0	17.89797	0	0	0	19.62129	0	0	0	0	0	0	0	0	0	0	18.12784	0	0	0	0	0	0	17.35668	0	0	0	0	18.88486	19.30939	0	0	0	0	0	0	0	0	0	0	17.71786	16.32634	0
Q9P267	MBD5_HUMAN	Methyl-CpG-binding domain protein 5 (Methyl-CpG-binding protein MBD5)	MBD5 KIAA1461	Homo sapiens (Human)	glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; regulation of behavior [GO:0050795]; regulation of multicellular organism growth [GO:0040014]	chromocenter [GO:0010369]; chromosome [GO:0005694]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromocenter [GO:0010369]; chromosome [GO:0005694]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; regulation of behavior [GO:0050795]; regulation of multicellular organism growth [GO:0040014]	chromatin binding [GO:0003682]	GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0007399; GO:0010369; GO:0030496; GO:0040014; GO:0042593; GO:0050795; GO:0060399; GO:0070062	LMIGSSNAMGR	1.190000057	0.640215576	0.640215576	0.186250602	1152.957165	0	0	14.60752	11.6736	0	0	0	0	0	0	0	12.4539	0	16.25303	12.14776	15.9667	0	0	16.9906	15.50833	0	16.33264	0	15.09201	0	0	0	14.89359	0	11.41492	15.21645	0	11.80737	17.11187	15.41075	14.24881	15.197	0	0	15.9851	0	14.72032	15.53299	0	15.21223	16.79563	14.00756	16.43566
Q9P273	TEN3_HUMAN	"Teneurin-3, Ten-3 (Protein Odd Oz/ten-m homolog 3) (Tenascin-M3, Ten-m3) (Teneurin transmembrane protein 3)"	TENM3 KIAA1455 ODZ3 TNM3	Homo sapiens (Human)	camera-type eye morphogenesis [GO:0048593]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]; positive regulation of neuron projection development [GO:0010976]; regulation of homophilic cell adhesion [GO:1903385]; signal transduction [GO:0007165]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]	axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; camera-type eye morphogenesis [GO:0048593]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]; positive regulation of neuron projection development [GO:0010976]; regulation of homophilic cell adhesion [GO:1903385]; signal transduction [GO:0007165]	cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005887; GO:0007156; GO:0007157; GO:0007165; GO:0010976; GO:0016020; GO:0030424; GO:0042803; GO:0043005; GO:0046982; GO:0048593; GO:0048666; GO:0050839; GO:1903385	DYITDVNSWLVTFGFHLHNAIPGFPVPK	1.149999976	0.402275771	0.402275771	5.02E-12	3185.030603	16.93383	12.69742	0	0	15.20443	0	0	0	16.16714	9.434449	16.31094	16.28925	17.53751	16.47065	0	17.36691	0	17.90933	17.24439	17.56701	17.07507	16.51586	14.23431	16.44805	13.45943	16.32815	16.73279	0	17.35942	0	15.83429	0	17.08635	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.79814
Q9P275	UBP36_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 36, EC 3.4.19.12 (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36)"	USP36 KIAA1453	Homo sapiens (Human)	histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723]; thiol-dependent deubiquitinase [GO:0004843]; histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723]; thiol-dependent deubiquitinase [GO:0004843]	GO:0003723; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007000; GO:0016242; GO:0016578; GO:0016579; GO:0016607; GO:0031647; GO:0042981; GO:0050821; GO:1903146; GO:1903955; GO:2000232	AVEEDGHLK	19.5	1	1	0.086304433	993.6977149	0	17.68084	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.91328	0	0	0	0	0	0	0	0	0	0	0	0
Q9P278	FNIP2_HUMAN	Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein)	FNIP2 FNIPL KIAA1450 MAPO1	Homo sapiens (Human)	intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]	ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]	GO:0000122; GO:0001932; GO:0005737; GO:0005765; GO:0005829; GO:0006468; GO:0008630; GO:0031334; GO:0033138; GO:0034451; GO:0042030; GO:0051087	APTLLQK	16.32999992	1	1	0.189071555	769.4582774	18.22674	15.8407	20.72528	21.04155	21.193	16.78569	17.8644	19.04345	17.50607	0	17.49303	0	0	0	0	0	0	0	0	0	0	18.13934	18.23573	0	0	0	0	17.04119	0	0	19.73692	0	0	0	18.04437	17.3475	18.35573	0	0	0	0	0	0	0	0	0	17.7979	0
Q9P281	BAHC1_HUMAN	"BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2, BAH domain-containing protein 2)"	BAHCC1 BAHD2 KIAA1447	Homo sapiens (Human)			chromatin binding [GO:0003682]	chromatin binding [GO:0003682]	GO:0003682	AREALFPVHSVATPIFGNGFR	2.930000067	1	1	0.126552273	2286.811581	0	14.06011	14.74664	0	0	12.3952	0	0	0	0	0	0	12.43707	0	0	13.63568	0	15.53661	15.65214	0	0	14.14842	12.39714	14.42275	14.05841	13.39669	0	0	13.06825	15.93452	0	0	0	14.94851	9.35814	11.26103	15.46813	12.38829	0	0	0	0	0	0	0	0	0	0
Q9P283	SEM5B_HUMAN	Semaphorin-5B	SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001	Homo sapiens (Human)	axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	GO:0001755; GO:0007411; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526	TCNPEGCPEVR	15.05000019	0.741288066	0.741288066	0.070994073	1318.441845	14.69956	13.39237	15.56764	11.26797	0	13.4257	14.71744	14.5501	0	0	0	14.82808	12.59592	0	14.00716	15.8052	13.05365	15.76549	0	12.5286	0	0	14.36273	15.05532	0	0	11.14751	0	0	11.94693	15.43961	14.15051	0	0	14.7459	12.52629	0	0	0	0	14.99273	14.53067	11.91544	0	16.4777	14.39233	15.45564	0
Q9P286	PAK5_HUMAN	"Serine/threonine-protein kinase PAK 5, EC 2.7.11.1 (p21-activated kinase 5, PAK-5) (p21-activated kinase 7, PAK-7)"	PAK5 KIAA1264 PAK7	Homo sapiens (Human)	apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001558; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007010; GO:0007165; GO:0007612; GO:0007613; GO:0007626; GO:0008283; GO:0016477; GO:0035556; GO:0043408; GO:0045202; GO:0106310; GO:2001237	HTGKQVAVK	22.71999931	0.138413578	0.138413578	0.274061003	967.6015244	15.4405	14.83614	17.07935	17.27017	15.25723	15.16895	13.94589	16.99176	16.01027	0	14.88344	0	16.26516	14.94925	17.54954	0	17.12946	15.76102	0	17.31301	14.3912	0	0	0	15.19318	0	14.44467	16.04595	16.96165	16.39789	0	14.87632	18.61932	14.66263	0	0	16.51668	0	0	0	13.96661	0	16.82301	0	0	0	0	0
Q9P287	BCCIP_HUMAN	BRCA2 and CDKN1A-interacting protein (P21- and CDK-associated protein 1) (Protein TOK-1)	BCCIP TOK1	Homo sapiens (Human)	DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; neuroendocrine cell differentiation [GO:0061101]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase regulator activity [GO:0019207]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]; DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; neuroendocrine cell differentiation [GO:0061101]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	kinase regulator activity [GO:0019207]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]	GO:0000079; GO:0000132; GO:0000226; GO:0003723; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0007052; GO:0015631; GO:0019207; GO:0019908; GO:0034453; GO:0061101; GO:0090307; GO:0097431	AALMFANAEEEFFYEK	13.05000019	1	1	0.357355158	1905.926035	0	0	0	0	0	0	0	0	0	15.63277	14.37691	12.71497	15.48264	0	0	0	15.14718	0	0	0	17.02246	0	0	14.90418	0	15.14066	0	0	15.44546	15.16219	0	0	0	0	13.9698	0	0	0	0	15.16056	0	0	0	0	0	0	0	0
Q9P2B7	CFA97_HUMAN	Cilia- and flagella-associated protein 97	CFAP97 KIAA1430	Homo sapiens (Human)	spermatogenesis [GO:0007283]		spermatogenesis [GO:0007283]		GO:0007283	QNDDPK	9.319999695	0.706597447	0.706597447	0.189639184	718.1604365	13.52205	14.69211	15.72441	0	13.01019	0	14.45471	15.82894	0	0	15.22327	0	0	15.59209	0	14.52475	14.03942	0	13.622	15.40255	15.65444	0	0	15.89138	16.97081	0	0	0	0	0	0	16.09352	0	16.3278	17.09074	15.89513	0	0	0	15.64437	0	15.07676	0	15.63939	0	0	0	0
Q9P2D0	IBTK_HUMAN	"Inhibitor of Bruton tyrosine kinase, IBtk"	IBTK BTKI KIAA1417	Homo sapiens (Human)	negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209]	protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]	GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209	EAVYTMGLNGGQLGCLLDPNGEKCVTAPR	2.930000067	1	1	0.225202778	3135.975961	16.02003	17.84254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P2D1	CHD7_HUMAN	"Chromodomain-helicase-DNA-binding protein 7, CHD-7, EC 3.6.4.12 (ATP-dependent helicase CHD7)"	CHD7 KIAA1416	Homo sapiens (Human)	"adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	GO:0000978; GO:0001501; GO:0001701; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0006364; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010880; GO:0016887; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042472; GO:0043584; GO:0045944; GO:0048752; GO:0048806; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060173; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:0140658; GO:1990841	KMGGAMAPPMK	15.01000023	1	1	0.28941578	1149.569061	13.23615	0	12.75184	0	15.79199	0	0	15.64209	15.66287	14.29382	14.47738	0	0	15.59269	0	15.69791	0	0	0	16.85966	15.489	0	17.67341	0	14.79678	0	0	16.26581	0	0	0	0	0	15.92259	14.58281	15.70333	15.72354	16.22962	0	0	0	0	0	0	0	0	0	0
Q9P2D3	HTR5B_HUMAN	HEAT repeat-containing protein 5B	HEATR5B KIAA1414 p200 p200a	Homo sapiens (Human)	"endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"	clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]	"clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]"		GO:0005829; GO:0006897; GO:0008104; GO:0015031; GO:0016020; GO:0016607; GO:0030136; GO:0030139; GO:0042147; GO:0043231; GO:0048471	KEAESKPK	10.64999962	0.365611881	0.365611881	0.219076234	914.9931375	14.28581	11.77464	18.72571	15.32215	13.3327	17.16339	15.40022	0	0	0	0	0	15.92108	0	13.1684	16.46183	16.85021	0	16.56823	16.74628	0	17.47521	15.78655	15.82888	15.84686	0	0	19.47881	18.09696	16.13809	15.61567	17.58283	15.53836	18.35591	17.8524	17.16716	16.84228	17.63551	15.76382	18.56504	14.12396	0	15.4198	15.40217	13.90089	16.53278	17.299	17.58302
Q9P2D6	F135A_HUMAN	Protein FAM135A	FAM135A KIAA1411	Homo sapiens (Human)	cellular lipid metabolic process [GO:0044255]		cellular lipid metabolic process [GO:0044255]		GO:0044255	TIEIKPSNK	3.859999895	0.351102591	0.351102591	0.279437252	1027.09195	14.88893	0	0	15.81036	13.8335	0	0	16.44337	0	15.13543	14.26018	0	0	13.40259	13.66369	17.31363	13.98929	0	12.88222	16.13384	14.4915	15.50763	0	15.79668	0	15.91432	0	15.53571	0	0	17.20702	0	0	0	14.26114	0	0	0	0	15.25563	15.82307	0	0	0	0	0	0	17.24438
Q9P2D7	DYH1_HUMAN	"Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1, HSRF-1) (hDHC7)"	DNAH1 DHC7 DNAHC1 KIAA1410	Homo sapiens (Human)	cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285	FGGAPAGPAGTGK	4.21999979	1	1	0.264211315	1087.635902	0	0	0	14.93556	0	0	0	15.08163	0	0	0	0	13.35678	0	16.1159	0	0	0	0	15.87143	0	0	15.65014	15.5049	0	0	14.70614	0	0	0	15.79529	15.24368	12.24998	16.32472	0	0	0	0	0	0	0	0	15.29018	15.56637	0	0	0	0
Q9P2D8	UNC79_HUMAN	Protein unc-79 homolog	UNC79 KIAA1409	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]		GO:0005886; GO:0016021	KNLPAGGAMIR	4.909999847	0.938742042	0.938742042	0.188661474	1127.468752	15.34385	17.7979	0	15.96737	0	18.58219	0	17.81708	0	0	14.2009	12.73959	0	0	0	9.317339	16.31818	0	0	0	15.59994	14.43983	0	0	13.40911	0	14.04018	14.23594	16.88274	13.70569	15.71286	15.73588	0	14.59978	17.25007	13.84644	0	0	17.63987	0	0	0	16.3124	0	13.50663	12.3695	0	16.45909
Q9P2E2	KIF17_HUMAN	Kinesin-like protein KIF17 (KIF3-related motor protein)	KIF17 KIAA1405 KIF3X	Homo sapiens (Human)	anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]	GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0015031; GO:0016192; GO:0016887; GO:0030030; GO:0032391; GO:0032839; GO:0036064; GO:0043005; GO:0098971; GO:1990075	LARLSSTVAR	5.230000019	1	1	0.077918273	1073.411114	17.11192	14.10004	9.497762	16.06072	0	0	0	14.92867	0	0	0	14.59465	0	8.26724	15.17984	0	0	0	0	0	0	0	0	0	10.87493	0	16.06784	14.31507	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P2E3	ZNFX1_HUMAN	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	Homo sapiens (Human)	activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of viral genome replication [GO:0045071]	cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380]	cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; heterochromatin assembly by small RNA [GO:0031048]; negative regulation of viral genome replication [GO:0045071]	helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0051607	KMHVLEEK	11.56999969	0.808172405	0.808172405	0.190067591	1015.639702	16.87572	15.22338	0	0	0	17.02027	17.98281	0	16.59423	16.03368	17.17748	0	15.84281	0	0	0	0	0	17.13864	16.08385	17.10669	17.14367	18.87481	18.45676	0	16.49733	16.56002	0	0	18.39025	0	0	17.84237	0	16.85074	0	17.07896	18.34838	17.32082	17.32215	16.60851	17.56194	0	15.74065	17.44184	17.4823	14.73715	0
Q9P2E7	PCD10_HUMAN	Protocadherin-10	PCDH10 KIAA1400	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156	GNEMNLFR	16.31999969	0.314522445	0.314522445	0.255651808	977.0564115	15.54342	0	13.43264	12.34029	13.56824	14.11751	0	14.84197	15.53882	0	0	0	0	0	0	0	0	0	0	0	0	12.67776	0	15.57446	0	8.479778	13.42916	0	16.16022	15.31959	0	15.6453	16.23212	0	0	0	0	0	0	13.41552	14.03887	0	0	14.29337	10.97624	0	0	15.60407
Q9P2E9	RRBP1_HUMAN	"Ribosome-binding protein 1 (180 kDa ribosome receptor homolog, RRp) (ES/130-related protein) (Ribosome receptor protein)"	RRBP1 KIAA1398	Homo sapiens (Human)	osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; translation [GO:0006412]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ribosome [GO:0005840]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ribosome [GO:0005840]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; translation [GO:0006412]	RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]	GO:0001649; GO:0003723; GO:0005783; GO:0005840; GO:0006412; GO:0015031; GO:0016020; GO:0030176; GO:0038023	AATRLQELLK	24.25	0.658984601	0.658984601	0.201611757	1142.585487	18.76184	19.82567	19.15925	18.74982	16.14837	20.35284	20.07587	19.59157	19.83972	16.60543	21.48353	19.02544	0	16.78077	19.79586	20.97016	17.50271	18.98135	17.12575	16.62362	19.17536	19.98142	18.81076	19.49775	20.91105	20.2406	21.17635	0	18.34849	17.81789	18.00809	17.19913	17.44009	20.47653	17.95038	17.18399	21.57357	20.744	21.343	20.45588	19.2583	20.181	19.75714	15.83385	19.5418	20.40047	19.49288	17.19522
Q9P2F5	STOX2_HUMAN	Storkhead-box protein 2	STOX2 KIAA1392	Homo sapiens (Human)	embryo development ending in birth or egg hatching [GO:0009792]; maternal placenta development [GO:0001893]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; embryo development ending in birth or egg hatching [GO:0009792]; maternal placenta development [GO:0001893]; positive regulation of transcription by RNA polymerase II [GO:0045944]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0001228; GO:0001893; GO:0005634; GO:0005737; GO:0009792; GO:0045944	STVNFSYK	12.60000038	0.701344371	0.701344371	0.145399674	947.6404895	16.26406	15.07064	0	0	0	13.83877	0	15.17116	15.72076	0	15.26758	0	0	0	0	0	14.08297	15.40154	0	15.65264	0	16.3258	0	15.90163	16.05458	0	16.33101	14.40068	11.70899	14.72867	16.21154	16.65887	14.55933	6.36316	16.27146	12.8663	16.54222	0	0	16.87527	0	13.85486	0	0	0	0	0	15.25173
Q9P2F6	RHG20_HUMAN	Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20)	ARHGAP20 KIAA1391	Homo sapiens (Human)	regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005829; GO:0007165; GO:0051056	CSEPNIEDQNR	15.71000004	1	1	6.93E-13	1361.061937	0	16.1456	17.54148	0	0	16.85996	16.01659	0	0	0	0	0	16.40416	0	15.9262	0	16.3202	0	0	0	0	0	0	0	0	0	0	0	17.22733	0	0	0	0	0	0	0	0	0	0	0	16.40524	0	0	0	0	0	0	16.46831
Q9P2F8	SI1L2_HUMAN	"Signal-induced proliferation-associated 1-like protein 2, SIPA1-like protein 2"	SIPA1L2 KIAA1389	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0051056; GO:0090630	TSVTVKVVIIQPHDDGSPR	3.059999943	1	1	0.653599958	2047.769208	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.70627	0	0	0	0	0
Q9P2G1	AKIB1_HUMAN	"Ankyrin repeat and IBR domain-containing protein 1, EC 2.3.2.31"	ANKIB1 KIAA1386	Homo sapiens (Human)	positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]	metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]	GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630	APAVDCGK	6.239999771	0.577537477	0.577537477	0.18030385	814.4966606	0	0	16.9305	0	0	14.16404	14.43658	0	0	0	0	17.68432	16.80381	15.62501	0	0	0	0	0	0	16.00282	15.64255	0	0	0	16.07511	0	0	0	0	0	18.37982	0	17.39741	0	0	18.55029	0	0	0	0	0	0	0	0	16.33064	0	0
Q9P2G4	MAP10_HUMAN	Microtubule-associated protein 10 (Microtubule regulator of 120 KDa)	MAP10 KIAA1383 MTR120	Homo sapiens (Human)	cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]; regulation of microtubule-based process [GO:0032886]	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]	centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; microtubule binding [GO:0008017]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]; regulation of microtubule-based process [GO:0032886]	microtubule binding [GO:0008017]	GO:0005813; GO:0005881; GO:0008017; GO:0030496; GO:0031122; GO:0032467; GO:0032886; GO:0051256; GO:0051301; GO:0097431; GO:1990023	LQPATLHCRLLR	3.579999924	1	1	0.204871907	1477.387735	0	14.38193	0	0	0	13.27792	0	0	0	0	0	14.7823	0	0	0	14.69005	0	11.8623	0	0	0	0	9.777668	0	16.08673	0	13.53998	15.212	14.7818	0	16.46118	14.71859	13.71949	0	0	0	0	0	0	0	0	0	17.01212	0	0	0	0	0
Q9P2H0	CE126_HUMAN	Centrosomal protein of 126 kDa	CEP126 KIAA1377	Homo sapiens (Human)	cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515]	centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; midbody [GO:0030496]	centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; midbody [GO:0030496]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515]		GO:0005737; GO:0005813; GO:0007052; GO:0030496; GO:0031122; GO:0060271; GO:0097546; GO:1905515	INCEKEMNENMR	27.79999924	0.989090204	0.989090204	0.207191476	1587.939686	0	0	0	0	0	0	0	0	12.9789	0	16.3075	15.06484	0	0	15.09545	0	0	0	0	0	0	0	14.60967	0	13.42728	0	15.79052	15.67257	0	0	16.03338	11.90852	0	0	0	15.86559	0	0	0	14.65255	0	0	0	0	0	0	0	15.73954
Q9P2H5	UBP35_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 35, EC 3.4.19.12 (Deubiquitinating enzyme 35) (Ubiquitin thioesterase 35) (Ubiquitin-specific-processing protease 35)"	USP35 KIAA1372 USP34	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579	KHCITEDTPPTSLYIEGLDSK	3.140000105	1	1	0.113851826	2404.660656	0	0	0	0	13.93177	14.84624	14.85293	13.45456	14.23616	14.65721	14.07402	0	13.60514	0	13.5882	0	12.97412	0	0	0	0	0	0	0	0	0	15.12694	0	0	0	0	16.44869	0	0	0	0	0	0	0	0	16.47449	13.88582	0	0	0	0	14.64485	0
Q9P2I0	CPSF2_HUMAN	"Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit, CPSF 100 kDa subunit)"	CPSF2 CPSF100 KIAA1367	Homo sapiens (Human)	mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	RNA binding [GO:0003723]	GO:0003723; GO:0005654; GO:0005847; GO:0006378; GO:0006398; GO:0016020; GO:0098789	SDGDSIK	12.18999958	1	1	0.31167794	721.3581214	0	18.9585	0	0	0	17.4363	0	18.53226	0	0	0	19.02321	0	16.50528	0	0	16.95757	0	0	0	18.85353	17.3074	18.79977	17.93418	0	19.35153	22.70845	16.69209	0	16.12451	18.86603	0	0	21.48662	18.39464	0	18.10499	0	0	20.28368	20.48831	0	17.03853	18.97481	18.53806	0	19.53173	18.01009
Q9P2J2	TUTLA_HUMAN	"Protein turtle homolog A (Immunoglobulin superfamily member 9A, IgSF9A)"	IGSF9 IGSF9A KIAA1355 NRT1	Homo sapiens (Human)	axon guidance [GO:0007411]; dendrite development [GO:0016358]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]	axon [GO:0030424]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	axon [GO:0030424]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]	cell-cell adhesion mediator activity [GO:0098632]	GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0016358; GO:0030424; GO:0030425; GO:0050807; GO:0060077; GO:0070593; GO:0098632	RLDGYVLEGR	9.569999695	0.81708467	0.81708467	0.372876967	1178.378204	0	15.74401	0	14.81937	0	0	0	0	0	0	0	0	15.17858	0	0	16.06635	0	15.8203	0	16.16329	14.94491	13.53694	16.03219	0	15.39593	0	14.82148	0	15.12335	15.06167	15.10393	15.76668	0	13.38997	16.3528	0	0	0	0	0	16.29804	15.82389	0	0	16.23247	0	0	0
Q9P2J5	SYLC_HUMAN	"Leucine--tRNA ligase, cytoplasmic, EC 6.1.1.4 (Leucyl-tRNA synthetase, LeuRS)"	LARS1 KIAA1352 LARS	Homo sapiens (Human)	cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]	GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253	KMIDAGDALIYMEPEK	1.139999986	0.294296801	0.294296801	4.79E-12	1856.0592	0	8.282296	0	0	14.02256	16.06459	0	9.020055	13.43408	12.67265	17.39786	0	14.00239	0	15.03943	13.63464	15.53998	0	13.37664	16.51398	15.66781	12.84997	15.81489	14.14678	13.22262	13.44511	0	14.90235	14.76286	16.26229	11.62786	0	16.84653	0	16.7177	11.68442	15.21868	15.26031	15.13676	0	16.25149	0	15.45214	15.93394	0	15.66271	0	0
Q9P2K1	C2D2A_HUMAN	Coiled-coil and C2 domain-containing protein 2A	CC2D2A KIAA1345	Homo sapiens (Human)	axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]	ciliary transition zone [GO:0035869]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; MKS complex [GO:0036038]	ciliary transition zone [GO:0035869]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; MKS complex [GO:0036038]; axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]		GO:0001822; GO:0001843; GO:0005829; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403	RWFGDDGR	5.119999886	0.400857836	0.400857836	0.081537787	1009.657182	13.9967	0	0	0	15.61464	15.45845	0	0	14.25548	0	0	0	0	0	0	0	16.40714	0	0	0	0	0	0	0	0	0	0	0	0	16.06004	0	0	0	14.52876	0	7.419394	0	0	0	14.35545	8.802118	14.25729	0	0	0	0	0	14.70449
Q9P2K5	MYEF2_HUMAN	"Myelin expression factor 2, MEF-2, MyEF-2 (MST156)"	MYEF2 KIAA1341	Homo sapiens (Human)	myotube differentiation [GO:0014902]; neuron differentiation [GO:0030182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; myotube differentiation [GO:0014902]; neuron differentiation [GO:0030182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]; regulation of transcription by RNA polymerase II [GO:0006357]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006357; GO:0014902; GO:0030182; GO:0071014; GO:1990904; GO:2000815	EKVGEVTYVELFK	2.519999981	1	1	0.37534747	1539.743022	0	15.30756	0	0	0	0	0	0	0	16.01603	0	16.041	0	0	0	14.56938	0	0	16.47288	0	0	16.74349	16.32189	17.78987	0	0	0	0	0	0	0	0	0	14.34547	0	0	15.20796	14.95079	0	0	0	0	0	0	0	14.98852	0	15.66753
Q9P2K8	E2AK4_HUMAN	"eIF-2-alpha kinase GCN2, EC 2.7.11.1 (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein)"	EIF2AK4 GCN2 KIAA1338	Homo sapiens (Human)	adaptive immune response [GO:0002250]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; polysome [GO:0005844]	cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tRNA binding [GO:0000049]; adaptive immune response [GO:0002250]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]	ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tRNA binding [GO:0000049]	GO:0000049; GO:0000077; GO:0001934; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004672; GO:0004674; GO:0004694; GO:0004712; GO:0005524; GO:0005829; GO:0005844; GO:0006446; GO:0006468; GO:0007049; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0036492; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0070417; GO:0071264; GO:0106310; GO:0140469; GO:1900273; GO:1990138; GO:1990253	GDVWR	17.22999954	0.394675702	0.394675702	0.224571009	632.5989945	20.89536	21.41753	21.64488	21.1642	19.93744	13.78859	21.40595	21.42632	22.40633	21.9771	21.10671	20.8324	19.42492	18.04752	21.07396	17.44539	20.7261	20.89015	19.36364	20.57139	20.93245	0	20.99688	18.95401	21.87979	20.20144	19.72116	22.02396	21.48716	0	21.16594	20.04117	22.79646	21.65737	21.40291	22.31737	18.13044	21.42056	22.23656	0	17.77031	17.71255	21.31391	19.70123	20.2858	21.07728	21.85706	21.97009
Q9P2L0	WDR35_HUMAN	WD repeat-containing protein 35 (Intraflagellar transport protein 121 homolog)	WDR35 IFT121 KIAA1336	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]	axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]		GO:0005813; GO:0005929; GO:0005930; GO:0030991; GO:0035721; GO:0036064; GO:0042073; GO:0060271; GO:0061512; GO:0097542; GO:1990830	THVIAASK	7.019999981	1	1	0.098317036	826.175378	14.00789	12.43251	13.21433	11.52889	14.22439	15.34552	0	0	0	0	15.9626	0	13.95447	13.96414	0	0	0	0	0	15.05773	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P2M1	LR2BP_HUMAN	"LRP2-binding protein (Megalin-binding protein, MegBP)"	LRP2BP KIAA1325	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]		GO:0005737	LWLIAADNGNPKASVK	2.480000019	1	1	0.185240634	1696.795784	0	0	11.93378	0	0	15.83143	0	0	0	0	15.42205	0	0	0	0	14.02476	0	0	0	0	0	0	0	0	0	0	0	0	0	15.12494	14.92278	0	0	0	0	0	0	15.08098	0	0	14.61005	0	0	0	0	0	0	0
Q9P2M7	CING_HUMAN	Cingulin	CGN KIAA1319	Homo sapiens (Human)		bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]	bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296]	actin binding [GO:0003779]; cadherin binding [GO:0045296]	GO:0003779; GO:0005886; GO:0005923; GO:0016459; GO:0030054; GO:0045296	HGLETQVMELQNKLK	4.369999886	1	1	0.335901837	1783.635261	14.68121	0	14.04688	13.51033	13.46683	14.6509	14.29812	13.68485	0	13.48896	0	16.08249	0	0	0	0	0	0	0	0	0	0	0	0	15.86626	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.0013	0	0	0	0	0	16.21794	0
Q9P2N2	RHG28_HUMAN	Rho GTPase-activating protein 28 (Rho-type GTPase-activating protein 28)	ARHGAP28 KIAA1314	Homo sapiens (Human)	negative regulation of GTP binding [GO:1904425]; negative regulation of stress fiber assembly [GO:0051497]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; negative regulation of GTP binding [GO:1904425]; negative regulation of stress fiber assembly [GO:0051497]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030833; GO:0051056; GO:0051497; GO:1904425	LMLKYQK	7.269999981	0.578870773	0.578870773	0.216510379	922.5685101	15.47201	14.84501	15.02748	0	14.6783	14.44201	13.87245	15.91587	17.66872	16.29536	14.98619	15.55352	14.75202	0	0	0	15.14158	14.29024	13.07414	15.63561	14.77396	0	15.87341	14.88666	15.96899	16.62689	16.57641	0	0	0	0	0	15.78642	0	15.88192	0	15.04384	14.83192	0	16.52396	0	16.308	0	15.48806	16.28448	16.04783	0	0
Q9P2N4	ATS9_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 9, ADAM-TS 9, ADAM-TS9, ADAMTS-9, EC 3.4.24.-"	ADAMTS9 KIAA1312	Homo sapiens (Human)	aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; glycoprotein catabolic process [GO:0006516]; heart valve morphogenesis [GO:0003179]; multicellular organism development [GO:0007275]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192]	metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0006516; GO:0007275; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671	FYSEEEAELK	9.949999809	1	1	0.447921901	1243.93412	18.76909	0	0	0	0	0	0	0	0	0	0	16.553	0	0	0	0	0	0	0	0	17.80912	0	18.08019	0	0	0	18.30556	16.92705	0	17.82724	0	0	0	19.91138	0	0	19.01867	0	17.32993	0	0	0	0	0	0	0	0	18.51716
Q9P2N6	KANL3_HUMAN	KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) (Serum inhibited-related protein) (Testis development protein PRTD)	KANSL3 KIAA1310 NSL3 PRTD SI1	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]"	histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]	"histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]"		GO:0000123; GO:0005654; GO:0006325; GO:0043231; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0045944; GO:0051571; GO:1900095	QNMLVR	3.769999981	0.980712712	0.980712712	0.062344134	775.4713129	16.22353	16.93986	15.51371	15.79316	0	15.97366	15.2522	17.96847	11.2192	13.70456	16.39417	16.05537	0	17.64204	0	17.59371	0	0	0	15.50536	0	0	16.35957	14.75272	17.38475	16.51008	0	0	16.92912	15.65217	0	19.11562	15.83171	12.54136	18.35646	16.93953	16.66998	0	13.93573	18.41659	17.22469	0	0	13.23712	0	14.98757	0	12.91481
Q9P2P1	NYNRI_HUMAN	Protein NYNRIN (NYN domain and retroviral integrase catalytic domain-containing protein) (Protein cousin of GIN1)	NYNRIN CGIN1 KIAA1305	Homo sapiens (Human)	"DNA integration [GO:0015074]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	cytoplasmic ribonucleoprotein granule [GO:0036464]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	"cytoplasmic ribonucleoprotein granule [GO:0036464]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729]; DNA integration [GO:0015074]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]"	endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729]	GO:0003729; GO:0004521; GO:0005634; GO:0015074; GO:0016021; GO:0036464; GO:0090502	AAEEDDLDSSLASVFR	10.22999954	1	1	0.180332411	1723.908563	15.19091	15.33717	15.74979	15.89899	14.25686	17.49384	15.42745	14.59238	0	11.59141	15.81706	14.41975	14.05599	15.12089	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9P2P6	STAR9_HUMAN	"StAR-related lipid transfer protein 9 (START domain-containing protein 9, StARD9)"	STARD9 KIAA1300	Homo sapiens (Human)	microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225]	centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225]	ATP binding [GO:0005524]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0007018; GO:0008017; GO:0008289; GO:0051225	DEHTASAADTSR	3.519999981	1	1	4.58E-13	1257.818266	16.07404	0	12.80597	17.53685	0	0	0	11.73661	11.97575	13.02985	16.26411	13.34616	0	11.45126	0	0	0	12.99146	0	0	0	0	0	0	0	0	0	0	0	13.28785	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.10875	0	0	0
Q9P2Q2	FRM4A_HUMAN	FERM domain-containing protein 4A	FRMD4A FRMD4 KIAA1294	Homo sapiens (Human)	establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-macromolecule adaptor activity [GO:0030674]; establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714]	protein-macromolecule adaptor activity [GO:0030674]	GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162	DMLAALK	4.670000076	1	1	0.059917364	777.5750885	13.0796	0	0	0	0	0	0	0	14.3051	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.04442	0	0	0	15.69584	0	0	16.61246	0	15.85954	16.21756	16.08996	0	15.77893	12.63239	0	0	0	15.98447	0	0	0	0	0	0
Q9P2R3	ANFY1_HUMAN	"Rabankyrin-5, Rank-5 (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif)"	ANKFY1 ANKHZN KIAA1255	Homo sapiens (Human)	"endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; membrane [GO:0016020]	"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]"	metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]	GO:0005765; GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0031267; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0070062; GO:0090160; GO:1901981	AIVRSGAR	11.88000011	1	1	0.255252073	829.7639347	15.94633	17.61292	17.02612	0	0	0	19.09632	0	0	17.42626	0	0	16.71292	0	0	0	18.55239	0	0	0	16.95407	0	0	0	0	0	0	0	17.27318	0	18.91956	0	0	0	0	18.23372	0	0	19.279	16.50031	0	0	16.54886	0	0	18.35957	0	16.61698
Q9P2R6	RERE_HUMAN	Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein)	RERE ARG ARP ATN1L KIAA0458	Homo sapiens (Human)	branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]	histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0046872; GO:0048755; GO:0048813	DHLLMNVK	5.400000095	1	1	0.2396388	985.403008	0	0	0	0	0	0	0	0	19.2857	0	0	17.27811	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.22303	0	0	0	16.5531	0	0	0	0	0	0	0	0	0	17.64478	0	16.26044
Q9P2S2	NRX2A_HUMAN	Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha)	NRXN2 KIAA0921	Homo sapiens (Human)	adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]	calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005246; GO:0005886; GO:0007158; GO:0007165; GO:0007268; GO:0007269; GO:0007416; GO:0016021; GO:0030534; GO:0032991; GO:0035176; GO:0042297; GO:0046872; GO:0050839; GO:0071625; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0098793	DVVYK	10.59000015	0.465156078	0.465156078	0.166265868	623.479724	15.87369	16.43679	15.7638	16.17604	15.92821	14.73884	15.39155	15.55417	16.2066	15.3709	16.793	14.28353	0	15.71739	16.20883	16.53049	15.96719	16.06635	0	13.86656	0	16.67048	15.84316	0	16.02176	0	16.08111	15.66354	15.18933	14.31635	16.13442	15.64771	16.02266	15.98127	0	15.51365	0	16.47037	16.64107	15.28951	17.51581	16.94599	13.81441	14.29685	15.89232	16.60326	0	15.10547
Q9P2S6	ANKY1_HUMAN	Ankyrin repeat and MYND domain-containing protein 1 (Testis-specific ankyrin-like protein 1) (Zinc finger MYND domain-containing protein 13)	ANKMY1 TSAL1 ZMYND13	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	SGFAPCGPKEQLSMEMILK	3	1	1	0.127954109	2123.485534	17.94551	9.016873	0	15.47414	13.51492	0	17.13899	0	13.67945	0	0	0	0	15.84205	0	0	0	0	0	15.47939	0	0	0	0	0	0	0	15.42923	0	17.47749	0	0	0	0	0	0	0	0	0	0	15.29837	0	0	0	0	0	0	0
Q9P2T0	THEG_HUMAN	"Testicular haploid expressed gene protein (Cancer/testis antigen 56, CT56)"	THEG	Homo sapiens (Human)	cell differentiation [GO:0030154]; chaperone-mediated protein complex assembly [GO:0051131]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]	nucleus [GO:0005634]; cell differentiation [GO:0030154]; chaperone-mediated protein complex assembly [GO:0051131]; spermatogenesis [GO:0007283]		GO:0005634; GO:0007283; GO:0030154; GO:0051131	ELAAPK	5.25	0.241519898	0.241519898	0.274410273	627.8612121	16.01549	14.58188	14.71374	14.53457	15.67752	14.9019	0	0	14.77397	16.07535	15.05748	15.76597	16.2458	15.36721	14.85508	16.05382	15.9488	16.64654	16.67812	16.97216	16.68492	17.58868	15.35558	15.69969	17.81255	16.97493	15.05468	16.06064	17.00221	16.67002	15.24384	15.82019	15.83317	16.62951	17.66518	17.66696	0	17.56105	17.16598	15.68709	15.24457	17.63878	17.58059	17.59457	16.34969	18.19955	18.49858	15.90661
Q9P2T1	GMPR2_HUMAN	"GMP reductase 2, GMPR 2, EC 1.7.1.7 (Guanosine 5'-monophosphate oxidoreductase 2, Guanosine monophosphate reductase 2)"	GMPR2	Homo sapiens (Human)	GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]	cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]	GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]	GO:0003920; GO:0005829; GO:0006144; GO:0046037; GO:0046872; GO:1902560	QTYSGVPIIAANMDTVGTFEMAK	9.369999886	1	1	0.153625159	2459.018776	15.58505	0	14.74618	14.4892	14.18188	13.57005	17.42162	0	0	16.62893	18.29431	15.25739	11.61339	19.81779	0	0	14.39569	15.97121	0	15.49564	0	0	19.86051	15.29169	0	0	18.54099	0	17.0725	18.13498	0	0	0	0	0	0	17.87035	18.37265	14.73936	0	0	16.08459	0	15.91898	0	17.35105	0	0
Q9P2V4	LRIT1_HUMAN	"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1 (Leucine-rich repeat-containing protein 21) (Photoreceptor-associated LRR superfamily protein) (Retina-specific protein PAL)"	LRIT1 LRRC21 PAL	Homo sapiens (Human)		integral component of endoplasmic reticulum membrane [GO:0030176]	integral component of endoplasmic reticulum membrane [GO:0030176]		GO:0030176	SLLGGTALLR	7.610000134	1	1	0.292000614	1000.461932	0	14.46013	15.28277	11.44397	15.16839	15.77329	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.2641	0	14.54544	0	14.77625	0	16.05786	0	15.94718	15.42867	16.37964	14.91515	15.01144	9.226576	0	16.16828	0	14.48238	13.41197	0	0	0	0	0	15.5636	0
Q9P2W9	STX18_HUMAN	Syntaxin-18 (Cell growth-inhibiting gene 9 protein)	STX18 GIG9	Homo sapiens (Human)	"endoplasmic reticulum membrane organization [GO:0090158]; intracellular protein transport [GO:0006886]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of organelle assembly [GO:1902117]; regulation of Golgi organization [GO:1903358]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum membrane organization [GO:0090158]; intracellular protein transport [GO:0006886]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of organelle assembly [GO:1902117]; regulation of Golgi organization [GO:1903358]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]	GO:0000139; GO:0005484; GO:0005783; GO:0005789; GO:0006886; GO:0006890; GO:0016021; GO:0019904; GO:0031201; GO:0090158; GO:1902117; GO:1902953; GO:1903358	LEPEPNTK	12.80000019	1	1	0.181302802	925.384561	12.66101	16.55022	15.8934	15.12611	0	14.7595	16.08624	14.94743	16.08708	15.41105	12.47012	16.34184	14.7186	14.40531	15.74267	0	0	0	0	16.20682	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.59823	0	0	0	0	0	0	0	0	0	0	0
Q9P2Y4	ZN219_HUMAN	Zinc finger protein 219	ZNF219	Homo sapiens (Human)	"limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter levels [GO:0001505]; regulation of transcription, DNA-templated [GO:0006355]"	integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histamine receptor activity [GO:0004969]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter levels [GO:0001505]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histamine receptor activity [GO:0004969]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001505; GO:0003677; GO:0003700; GO:0004969; GO:0005634; GO:0005654; GO:0006355; GO:0016021; GO:0032332; GO:0045892; GO:0045944; GO:0046872; GO:0060174	REPPSLLGYLSLR	1.179999948	0.962314904	0.962314904	0.273995489	1499.781077	13.80186	14.66741	13.79002	15.98014	0	14.36661	15.04799	0	14.58981	14.97182	14.36112	16.05825	15.4416	14.97077	16.12519	13.13371	14.33597	0	14.70907	0	0	0	0	0	0	0	0	14.03051	0	0	0	0	0	0	0	0	0	0	0	0	0	12.14412	0	16.56487	0	0	0	0
Q9UBB4	ATX10_HUMAN	Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein)	ATXN10 SCA10	Homo sapiens (Human)	cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]		GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0016020; GO:0030425; GO:0031175; GO:0043025; GO:0048471; GO:0060271	ALTALFK	9.779999733	1	1	0.069032536	763.5523198	11.92911	13.30606	13.3614	14.70976	0	15.40587	0	0	0	16.17373	15.20919	13.67371	15.02193	0	13.11031	15.36558	0	0	15.55451	0	15.60386	0	0	0	0	0	0	0	15.1397	15.93805	0	0	0	16.31096	0	13.41095	0	0	0	15.32523	0	0	0	0	0	14.20571	14.47836	0
Q9UBB9	TFP11_HUMAN	"Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1, STIP-1)"	TFIP11 STIP HSPC006	Homo sapiens (Human)	"biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]"	"catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]"	"catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; nucleic acid binding [GO:0003676]; biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]"	nucleic acid binding [GO:0003676]	GO:0000390; GO:0000398; GO:0000781; GO:0003676; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0006396; GO:0016607; GO:0031012; GO:0031214; GO:0031333; GO:0031848; GO:0032091; GO:0071008; GO:0071013; GO:1904876; GO:2001033	LLQKMGYVPGR	5.239999771	1	1	4.60E-13	1278.85556	14.8651	13.29296	15.84017	0	0	14.98423	0	0	0	0	0	0	0	0	0	0	0	0	0	13.89806	0	0	0	0	0	14.78647	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.78956
Q9UBC1	IKBL1_HUMAN	"NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein, I-kappa-B-like protein, IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1)"	NFKBIL1 IKBL	Homo sapiens (Human)	cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]		GO:0005634; GO:0005654; GO:0005829; GO:0007249; GO:0031665; GO:0032088; GO:0032720; GO:0034122; GO:0071222	SSMASTSRR	6.019999981	1	1	0.086669995	999.6864383	0	0	0	0	0	0	0	0	0	0	0	0	13.39627	0	15.33024	0	11.62231	15.5839	13.52017	0	0	0	17.29571	0	14.58076	9.411975	0	0	0	0	14.46693	0	0	15.59864	0	15.3271	10.85892	16.8381	0	15.3597	0	0	15.05786	15.37066	14.82758	13.66423	12.38302	0
Q9UBC2	EP15R_HUMAN	"Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein, Eps15R)"	EPS15L1 EPS15R	Homo sapiens (Human)	endocytosis [GO:0006897]; endosomal transport [GO:0016197]	clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0045296	NDPFTSDPFTK	22.85000038	0.809022665	0.809022665	0.260947687	1269.833693	19.13441	21.34546	20.94831	15.98996	20.63829	19.56057	20.41659	20.68687	20.83147	17.46568	21.08999	21.04648	19.07603	20.85315	20.93981	18.88334	0	21.9446	21.18455	19.53051	20.88447	21.82935	0	20.68995	0	15.67854	20.6116	20.12805	20.30459	21.66421	21.63053	20.80388	22.57905	21.78128	21.79339	22.85641	22.02949	22.68282	22.08093	21.32229	20.5391	19.78544	0	21.79883	22.00427	19.22676	21.18769	20.8006
Q9UBC3	DNM3B_HUMAN	"DNA (cytosine-5)-methyltransferase 3B, Dnmt3b, EC 2.1.1.37 (DNA methyltransferase HsaIIIB, DNA MTase HsaIIIB, M.HsaIIIB)"	DNMT3B	Homo sapiens (Human)	C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]	catalytic complex [GO:1902494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"catalytic complex [GO:1902494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [GO:0051718]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]"	"DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [GO:0051718]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]"	GO:0000122; GO:0003677; GO:0003714; GO:0003886; GO:0005634; GO:0005654; GO:0006306; GO:0009008; GO:0010628; GO:0046872; GO:0051571; GO:0051573; GO:0051718; GO:0090116; GO:1902494	EDSILVNGACSDQSSDSPPILEAIRTPEIR	1.809999943	1	1	9.20E-13	3269.888712	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.33967	13.64242	15.38336	0	0	0	0	14.90154	0	0	15.19002	0	0	0	0	0	9.21436	14.3273	0	14.81167	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UBC5	MYO1A_HUMAN	"Unconventional myosin-Ia (Brush border myosin I, BBM-I, BBMI) (Myosin I heavy chain, MIHC)"	MYO1A MYHL	Homo sapiens (Human)	actin filament organization [GO:0007015]; microvillus assembly [GO:0030033]; sensory perception of sound [GO:0007605]; vesicle localization [GO:0051648]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; microvillus assembly [GO:0030033]; sensory perception of sound [GO:0007605]; vesicle localization [GO:0051648]; vesicle transport along actin filament [GO:0030050]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007015; GO:0007605; GO:0015629; GO:0016323; GO:0016324; GO:0016328; GO:0016459; GO:0030033; GO:0030050; GO:0030864; GO:0031941; GO:0031982; GO:0044853; GO:0051015; GO:0051648	AVQSAMAVIGFSEEEIR	8.5	1	1	0.280627323	1854.312393	14.1318	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.53074	13.80806	0	0	0	0	0	0	0	16.25673	0	0	0	0	13.88465	14.63846	0	0	15.81892	16.11548	15.29875	15.10752	0	0	0	16.70139	0	0	0	0	0	0	0
Q9UBF2	COPG2_HUMAN	"Coatomer subunit gamma-2 (Gamma-2-coat protein, Gamma-2-COP)"	COPG2	Homo sapiens (Human)	"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; transport vesicle [GO:0030133]	"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]"	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005783; GO:0005789; GO:0005793; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0009306; GO:0030126; GO:0030133; GO:0030426; GO:0072384	LALADGVTMQVTVRSK	4.789999962	0.241632253	0.241632253	0.467330528	1704.922667	20.3864	0	19.2176	19.5221	0	0	19.46774	19.13946	0	0	0	18.87235	0	19.84942	18.1594	0	0	0	0	0	0	0	0	19.46549	0	0	0	0	17.86534	18.90239	0	0	0	18.73435	0	20.83036	19.52258	0	0	0	0	0	19.13307	0	0	0	0	0
Q9UBG3	CRNN_HUMAN	Cornulin (53 kDa putative calcium-binding protein) (53 kDa squamous epithelial-induced stress protein) (58 kDa heat shock protein) (Squamous epithelial heat shock protein 53) (Tumor-related protein)	CRNN C1orf10 DRC1 PDRC1 SEP53	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of gene expression [GO:0010468]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to heat [GO:0009408]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of gene expression [GO:0010468]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to heat [GO:0009408]	calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914]	GO:0005509; GO:0005737; GO:0009408; GO:0010468; GO:0010838; GO:0014066; GO:0016020; GO:0046914; GO:0048306; GO:0051092; GO:0070062; GO:0071345; GO:0098609; GO:1902808	VAQACFK	16.22999954	0.837097824	0.837097824	0.127628277	822.3967982	16.50371	0	0	17.30147	0	0	16.07876	0	11.07059	15.9325	16.14981	0	0	0	0	10.17637	0	0	0	0	0	0	0	0	15.35252	0	13.37812	15.7412	0	0	0	0	0	0	0	0	14.0031	0	0	0	0	0	0	14.8938	0	0	0	0
Q9UBH0	I36RA_HUMAN	"Interleukin-36 receptor antagonist protein, IL-36Ra (FIL1 delta) (IL-1-related protein 3, IL-1RP3) (Interleukin-1 HY1, IL-1HY1) (Interleukin-1 delta, IL-1 delta) (Interleukin-1 family member 5, IL-1F5) (Interleukin-1 receptor antagonist homolog 1, IL-1ra homolog 1) (Interleukin-1-like protein 1, IL-1L1)"	IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342	Homo sapiens (Human)	antifungal humoral response [GO:0019732]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]; antifungal humoral response [GO:0019732]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]	cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]	GO:0001960; GO:0002437; GO:0005125; GO:0005149; GO:0005152; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0019732; GO:0032689; GO:0032700; GO:0032715; GO:0045087; GO:0071222	GEEISVVPNR	8.350000381	0.506805658	0.506805658	0.236195015	1100.260924	12.36745	13.70313	13.58658	13.93083	14.37646	14.26527	0	0	0	0	14.73716	0	14.22084	17.30987	0	0	0	14.80581	9.630497	0	0	14.87506	14.97294	14.03983	15.80421	0	0	0	15.25006	0	0	0	0	0	0	0	14.96529	0	0	0	0	0	0	0	0	0	15.40204	0
Q9UBH6	XPR1_HUMAN	"Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3, X-receptor)"	XPR1 SYG1 XR	Homo sapiens (Human)	cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615]	efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	GO:0000822; GO:0001618; GO:0004888; GO:0004930; GO:0005737; GO:0005794; GO:0005886; GO:0006817; GO:0007186; GO:0009615; GO:0015114; GO:0015562; GO:0016021; GO:0016036; GO:0030643; GO:0031226; GO:0035435; GO:0038023	MKFAEHLSAHITPEWR	8.399999619	1	1	0.249107355	1968.880683	16.27153	14.57737	14.95917	0	0	0	15.09374	0	0	0	0	0	0	15.48857	12.22467	0	13.77774	0	0	0	0	0	15.17447	16.57404	14.17451	0	0	0	0	0	0	0	0	0	0	0	0	0	17.09891	0	0	0	0	0	0	0	0	0
Q9UBJ2	ABCD2_HUMAN	"ATP-binding cassette sub-family D member 2, EC 3.1.2.-, EC 7.6.2.- (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein, hALDR)"	ABCD2 ALD1 ALDL1 ALDR ALDRP	Homo sapiens (Human)	fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]	ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0007031; GO:0015910; GO:0016021; GO:0016887; GO:0032000; GO:0042626; GO:0042760; GO:0042803; GO:0043217; GO:0046982; GO:0047617; GO:0140359; GO:1900016; GO:1903427; GO:1990535; GO:2001280	THMLNAAADRVK	6.139999866	1	1	0.226129622	1343.437697	15.23245	0	12.97848	0	0	0	0	0	0	0	0	13.18373	0	0	0	14.44963	0	0	0	0	15.54801	14.31226	0	0	16.44754	0	0	0	13.47709	0	14.42863	0	0	0	16.07218	0	0	15.05035	0	0	15.68085	0	0	0	15.27657	0	18.48042	0
Q9UBK7	RBL2A_HUMAN	Rab-like protein 2A	RABL2A	Homo sapiens (Human)	intracellular protein transport [GO:0006886]	endomembrane system [GO:0012505]	endomembrane system [GO:0012505]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0006886; GO:0012505	TKPSELDQGK	4.050000191	0.043489832	0.043489832	0.214255699	1101.590223	0	0	0	0	0	0	18.69328	18.51616	0	0	0	0	0	16.99498	0	0	0	0	0	0	0	0	0	0	17.29566	0	17.54988	17.67687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.55404	0	0	16.28398	0	0
Q9UBK8	MTRR_HUMAN	"Methionine synthase reductase, MSR, EC 1.16.1.8 (Aquacobalamin reductase, AqCbl reductase)"	MTRR	Homo sapiens (Human)	DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; [methionine synthase] reductase activity [GO:0030586]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; S-adenosylmethionine cycle [GO:0033353]"	"[methionine synthase] reductase activity [GO:0030586]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]"	GO:0003958; GO:0005654; GO:0005829; GO:0006306; GO:0009086; GO:0010181; GO:0016491; GO:0016723; GO:0030586; GO:0033353; GO:0043418; GO:0045111; GO:0046655; GO:0050660; GO:0050667; GO:0070402; GO:0071949; GO:1904042	ALAPKISISPR	7.619999886	1	1	0.173824509	1149.183934	15.29271	16.14334	11.09637	0	0	0	0	15.08116	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.75039	0	15.16799	0	0	0	0	0	15.20899	0	0	0	0	0	16.21671	0	15.75239	0	0	13.69102	0	0	0	0	0	0
Q9UBK9	UXT_HUMAN	"Protein UXT (Androgen receptor trapped clone 27 protein, ART-27) (Ubiquitously expressed transcript protein)"	UXT HSPC024	Homo sapiens (Human)	apoptotic process [GO:0006915]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]	centrosome [GO:0005813]; chaperone complex [GO:0101031]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; spindle pole [GO:0000922]	centrosome [GO:0005813]; chaperone complex [GO:0101031]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; spindle pole [GO:0000922]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]	beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000226; GO:0000785; GO:0000922; GO:0003682; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005856; GO:0006357; GO:0006915; GO:0007098; GO:0008017; GO:0047497; GO:0048487; GO:0050821; GO:0101031; GO:1990062	ELQGLQNFPEKPHH	1.460000038	1	1	0.304124221	1673.473022	0	0	14.93381	14.97797	0	0	0	0	0	0	14.43526	0	0	16.11915	14.19712	0	0	16.50887	0	0	0	16.10076	0	0	0	0	0	0	0	15.04171	0	0	0	0	17.09118	0	0	0	0	0	0	0	4.459944	0	0	0	0	0
Q9UBL0	ARP21_HUMAN	"cAMP-regulated phosphoprotein 21, ARPP-21 (Thymocyte cAMP-regulated phosphoprotein)"	ARPP21 TARPP	Homo sapiens (Human)		cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; nucleic acid binding [GO:0003676]	calmodulin binding [GO:0005516]; nucleic acid binding [GO:0003676]	GO:0003676; GO:0005516; GO:0005737	SKSGAGK	8.050000191	1	1	0.118284489	633.2691942	0	16.21292	0	0	14.77635	0	0	17.05282	0	0	0	13.26355	0	0	15.69901	15.7757	0	0	0	16.38266	0	15.74413	15.79529	0	0	0	17.56479	0	0	0	0	0	0	15.68629	0	0	0	0	0	0	0	0	16.56134	15.98892	16.97666	0	18.37066	0
Q9UBL3	ASH2L_HUMAN	Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein)	ASH2L ASH2L1	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627]	euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627]	beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]	GO:0000791; GO:0000976; GO:0005634; GO:0005654; GO:0006325; GO:0006974; GO:0008013; GO:0008284; GO:0030097; GO:0035097; GO:0043627; GO:0044665; GO:0044666; GO:0045944; GO:0046872; GO:0048188; GO:0051568; GO:0071339	ASHGVRK	8.5	1	1	4.60E-13	756.4193508	0	0	15.75746	0	0	0	0	0	0	0	0	0	0	0	0	0	15.97453	0	16.42636	0	0	16.31643	0	0	0	0	0	0	0	16.38398	0	0	16.36396	0	0	17.19092	18.45847	17.36669	0	0	0	17.54426	0	0	0	0	0	18.16014
Q9UBL6	CPNE7_HUMAN	Copine-7 (Copine VII)	CPNE7	Homo sapiens (Human)	cellular response to calcium ion [GO:0071277]; lipid metabolic process [GO:0006629]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; lipid metabolic process [GO:0006629]	calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; transporter activity [GO:0005215]	GO:0005215; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006629; GO:0046872; GO:0070062; GO:0071277	KVTRPLLLK	6.019999981	1	1	0.196543061	1068.646688	0	20.22525	12.85515	0	0	0	18.17085	0	17.72808	0	0	0	16.97559	0	0	18.25965	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.02572	0	18.5888	0	0	0	0	0
Q9UBM1	PEMT_HUMAN	"Phosphatidylethanolamine N-methyltransferase, PEAMT, PEMT, EC 2.1.1.17, EC 2.1.1.71 (PEMT2) (Phospholipid methyltransferase, PLMT)"	PEMT PEMPT PNMT	Homo sapiens (Human)	blastocyst hatching [GO:0001835]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingomyelin biosynthetic process [GO:0006686]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [GO:0080101]; phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608]; blastocyst hatching [GO:0001835]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingomyelin biosynthetic process [GO:0006686]	phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [GO:0080101]; phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608]	GO:0000773; GO:0001835; GO:0004608; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006656; GO:0006686; GO:0016021; GO:0031966; GO:0032259; GO:0043231; GO:0080101; GO:0120162	ASGSHK	2.339999914	0.166615188	0.166615188	0.149459079	585.5601903	0	16.34095	15.97219	0	14.96853	16.93207	11.00055	14.27707	13.58334	0	12.76632	13.98758	14.80084	16.76293	0	0	0	0	0	0	0	0	0	0	0	0	15.54897	0	0	15.10994	0	0	0	0	0	0	16.17122	17.11329	14.40244	0	0	0	0	0	0	0	0	0
Q9UBM4	OPT_HUMAN	Opticin (Oculoglycan)	OPTC OPT	Homo sapiens (Human)	collagen fibril organization [GO:0030199]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; collagen fibril organization [GO:0030199]	extracellular matrix structural constituent [GO:0005201]	GO:0005201; GO:0005576; GO:0030199; GO:0031012	SVHLQNNLIETMQR	6.829999924	1	1	4.60E-13	1692.797653	0	0	15.41932	14.20092	0	0	0	0	13.03303	14.1229	0	0	12.11878	0	0	15.70045	0	0	15.82766	0	0	0	0	0	0	0	0	0	13.38542	0	0	0	0	0	0	0	0	0	0	0	16.06642	0	0	0	0	0	0	0
Q9UBN4	TRPC4_HUMAN	"Short transient receptor potential channel 4, TrpC4 (Trp-related protein 4, hTrp-4, hTrp4)"	TRPC4	Homo sapiens (Human)	calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480]	basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480]"	"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"	GO:0005262; GO:0005886; GO:0005887; GO:0005901; GO:0006816; GO:0006828; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0034703; GO:0034704; GO:0045296; GO:0048709; GO:0051480; GO:0070509; GO:0070588; GO:0070679	ESWDMWHPTLVAEALFAIANIFSSLR	5.900000095	0.627986193	0.627986193	4.12E-12	3004.891477	0	16.80868	0	12.65003	0	15.21079	0	8.593329	0	0	16.32782	0	0	0	0	14.14195	16.03122	14.29985	0	0	0	0	0	15.57224	15.49815	0	12.25381	0	0	0	0	0	16.21822	0	0	0	0	12.47761	0	0	0	0	0	0	0	0	15.61078	0
Q9UBN6	TR10D_HUMAN	"Tumor necrosis factor receptor superfamily member 10D (Decoy receptor 2, DcR2) (TNF-related apoptosis-inducing ligand receptor 4, TRAIL receptor 4, TRAIL-R4) (TRAIL receptor with a truncated death domain) (CD antigen CD264)"	TNFRSF10D DCR2 TRAILR4 TRUNDD UNQ251/PRO288	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]	TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0006915; GO:0007165; GO:0009986; GO:0016021; GO:0043066; GO:0045569	EEECPAGSHR	7.539999962	1	1	0.062989939	1170.13992	16.20007	12.00126	16.21554	14.92276	13.44749	0	0	14.46199	15.44995	0	15.02002	0	0	15.34147	0	0	15.27035	0	15.73746	14.10872	0	15.43458	13.60614	0	0	0	0	0	16.13116	0	0	0	0	16.65056	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UBN7	HDAC6_HUMAN	"Histone deacetylase 6, HD6, EC 3.5.1.98 (Tubulin-lysine deacetylase HDAC6, EC 3.5.1.-)"	HDAC6 KIAA0901 JM21	Homo sapiens (Human)	"aggresome assembly [GO:0070842]; autophagy [GO:0006914]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of signaling receptor activity [GO:2000273]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"	aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]	"aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of signaling receptor activity [GO:2000273]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]"	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	GO:0000118; GO:0000209; GO:0000978; GO:0001222; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051354; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090042; GO:1901300; GO:1903146; GO:1904115; GO:2000273	LVDAVLGAEIR	4.360000134	1	1	2.32E-13	1156.52822	0	16.17609	14.86602	0	0	0	0	0	14.53339	0	0	13.10697	0	0	0	0	0	0	0	0	0	0	0	0	14.17509	0	0	0	0	0	0	0	0	0	0	0	15.70795	0	0	0	0	0	0	0	0	0	0	0
Q9UBP0	SPAST_HUMAN	"Spastin, EC 5.6.1.1 (Spastic paraplegia 4 protein)"	SPAST ADPSP FSP2 KIAA1083 SPG4	Homo sapiens (Human)	anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]	alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]	GO:0000281; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005789; GO:0005811; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0007084; GO:0007409; GO:0008017; GO:0008089; GO:0008152; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0016887; GO:0019896; GO:0030496; GO:0031117; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0044877; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0061640; GO:0070062; GO:0071782; GO:0090148; GO:1904115	EQAVEWYKK	2.579999924	0.544339597	0.544339597	0.217933833	1180.408051	0	0	0	0	0	8.074463	14.84447	0	12.78813	9.952555	0	0	0	15.79981	3.226864	14.89415	0	0	15.99822	0	0	0	0	0	0	0	13.81809	0	0	0	0	0	15.2093	0	0	14.78448	0	0	0	0	0	0	15.67047	0	0	0	0	15.11528
Q9UBP8	KAAG1_HUMAN	Kidney-associated antigen 1 (RU2 antisense gene protein)	KAAG1 RU2AS	Homo sapiens (Human)	immune response [GO:0006955]		immune response [GO:0006955]		GO:0006955	LTNPQVK	10.68999958	1	1	0.316552037	798.8143487	0	0	0	17.86409	0	0	0	16.66565	0	17.86485	0	16.79863	0	0	0	17.48943	0	17.62218	18.61629	17.96586	17.56098	17.77304	0	0	0	18.33268	18.57547	16.94868	0	17.65376	0	0	17.70096	18.37072	15.89291	19.07184	0	0	0	0	0	18.2973	18.467	0	0	17.73886	18.15561	18.49896
Q9UBQ5	EIF3K_HUMAN	"Eukaryotic translation initiation factor 3 subunit K, eIF3k (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28)"	EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001	Homo sapiens (Human)	formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]	ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022	VWMSKYGWSADESGQIFICSQEESIKPK	1.769999981	1	1	4.59E-12	3306.159188	12.06127	0	14.95959	0	0	14.076	14.53191	13.65659	11.45138	13.77843	15.16943	15.30158	11.83811	13.22509	13.74895	12.35791	0	0	0	0	0	0	0	0	0	15.16743	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UBQ6	EXTL2_HUMAN	"Exostosin-like 2, EC 2.4.1.223 (Alpha-1,4-N-acetylhexosaminyltransferase EXTL2) (Alpha-GalNAcT EXTL2) (EXT-related protein 2) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) [Cleaved into: Processed exostosin-like 2 ]"	EXTL2 EXTR2	Homo sapiens (Human)	heparan sulfate proteoglycan biosynthetic process [GO:0015012]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; alpha-1,4-N-acetylgalactosaminyltransferase activity [GO:0035248]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; glycosaminoglycan binding [GO:0005539]; manganese ion binding [GO:0030145]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]"	"alpha-1,4-N-acetylgalactosaminyltransferase activity [GO:0035248]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; glycosaminoglycan binding [GO:0005539]; manganese ion binding [GO:0030145]"	GO:0001888; GO:0005539; GO:0005576; GO:0005654; GO:0005783; GO:0005789; GO:0005829; GO:0006044; GO:0006486; GO:0015012; GO:0016021; GO:0019276; GO:0030145; GO:0035248; GO:0047237	LPGRVMGIR	3.329999924	0.347253948	0.347253948	0.258980973	1014.116024	16.46961	0	13.53891	14.90554	13.81474	14.69084	10.24454	14.25329	15.12364	12.35047	15.26785	0	13.00393	0	0	15.12643	8.115193	14.95231	0	0	0	15.32182	0	0	0	0	0	15.75542	0	0	0	0	15.62852	0	16.97626	15.16875	14.42535	0	0	0	14.88415	0	13.91823	15.49872	0	14.74758	0	0
Q9UBR4	LHX3_HUMAN	"LIM/homeobox protein Lhx3, LIM homeobox protein 3"	LHX3	Homo sapiens (Human)	"animal organ morphogenesis [GO:0009887]; inner ear development [GO:0048839]; lung development [GO:0030324]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; pituitary gland development [GO:0021983]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron cell fate specification [GO:0021520]; ventral spinal cord interneuron specification [GO:0021521]"	chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; inner ear development [GO:0048839]; lung development [GO:0030324]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; pituitary gland development [GO:0021983]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron cell fate specification [GO:0021520]; ventral spinal cord interneuron specification [GO:0021521]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]"	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001890; GO:0005634; GO:0005667; GO:0006357; GO:0008045; GO:0009887; GO:0021520; GO:0021521; GO:0021526; GO:0021527; GO:0021983; GO:0030182; GO:0030324; GO:0043066; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0048839; GO:0061629	SRGGSK	2.190000057	1	1	0.096943565	591.5532473	14.26223	15.05883	0	0	16.18086	14.71671	0	0	0	11.68523	16.30626	0	15.57391	15.30183	12.6544	16.12413	0	0	15.64538	17.44394	0	0	0	0	0	15.69971	0	0	0	0	0	0	0	18.61245	16.19641	0	0	0	0	16.54784	0	0	0	0	0	0	0	0
Q9UBS0	KS6B2_HUMAN	"Ribosomal protein S6 kinase beta-2, S6K-beta-2, S6K2, EC 2.7.11.1 (70 kDa ribosomal protein S6 kinase 2, P70S6K2, p70-S6K 2) (S6 kinase-related kinase, SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta, S6K-beta, p70 S6 kinase beta, p70 S6K-beta, p70 S6KB, p70-beta)"	RPS6KB2 STK14B	Homo sapiens (Human)	peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412]	ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006412; GO:0007165; GO:0018105; GO:0031929; GO:0042277; GO:0043491; GO:0045948; GO:0106310	DLKPENIMLSSQGHIK	17.13999939	0.48070544	0.48070544	0.182398636	1806.498056	0	13.07453	0	13.7522	0	12.92786	13.15435	8.562015	13.60342	13.35116	0	15.64253	0	0	12.64015	0	16.5739	0	0	0	0	0	17.09953	0	13.98014	17.38258	15.80019	15.39574	0	13.09884	0	0	0	0	0	0	14.69166	0	0	14.41668	16.85497	0	0	15.55549	0	0	0	0
Q9UBS8	RNF14_HUMAN	"E3 ubiquitin-protein ligase RNF14, EC 2.3.2.31 (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein)"	RNF14 ARA54 HRIHFB2038	Homo sapiens (Human)	"androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]"	androgen receptor binding [GO:0050681]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]	GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630	LFLCSICFCEKLGSECMYFLECR	1.690000057	1	1	1.40E-12	3038.620051	8.726695	9.95084	0	0	12.74572	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.58503	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UBS9	SUCO_HUMAN	SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1)	SUCO C1orf9 CH1 OPT SLP1	Homo sapiens (Human)	ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850]		GO:0001503; GO:0005737; GO:0005791; GO:0016020; GO:0016021; GO:0030867; GO:0032967; GO:0045669; GO:0046850	LGTFHGRDER	6.380000114	1	1	0.192078629	1188.629767	12.85408	11.66457	0	0	13.55104	0	14.16138	10.75669	15.59687	12.90298	0	0	15.36458	0	14.05481	13.93834	0	0	15.92242	0	0	0	0	0	17.01764	0	0	0	0	0	0	0	0	0	14.44452	0	0	0	0	0	15.38413	0	14.47855	0	0	14.44906	0	0
Q9UBT6	POLK_HUMAN	"DNA polymerase kappa, EC 2.7.7.7 (DINB protein, DINP)"	POLK DINB1	Homo sapiens (Human)	"cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]"	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0034644; GO:0042276; GO:0046872	DKPIAVGSMSMLSTSNYHAR	2.369999886	1	1	0.031423981	2181.762926	16.61298	0	0	0	0	11.29172	0	0	14.6979	15.61714	15.70566	0	0	17.95255	14.66545	0	0	13.0424	0	0	15.19035	0	0	0	18.11998	0	14.33857	0	0	13.71346	18.13495	0	0	0	13.32825	0	15.36787	16.73644	13.44505	13.67017	0	0	13.74279	0	13.72444	13.77452	11.04454	0
Q9UBT7	CTNL1_HUMAN	"Alpha-catulin (Alpha-catenin-related protein, ACRP) (Catenin alpha-like protein 1)"	CTNNAL1	Homo sapiens (Human)	cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]	GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015	LIPLCHQLQTVTK	1.330000043	1	1	0.496516483	1550.224228	0	15.91752	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.47865	11.67195	0	17.34336	19.3092	0	0	0	0	0	0	18.59357	0	0	0	0	0	0	0	0	0	0	0	17.50553	0	0	0	0	0
Q9UBU2	DKK2_HUMAN	"Dickkopf-related protein 2, Dickkopf-2, Dkk-2, hDkk-2"	DKK2 UNQ682/PRO1316	Homo sapiens (Human)	negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]	co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]	GO:0005615; GO:0016055; GO:0039706; GO:0048019; GO:0090090; GO:0090263	MAALMR	2.940000057	1	1	1.14E-13	707.511146	14.00464	15.21648	14.50652	13.90157	14.36969	13.86443	16.28864	15.8433	15.8503	14.04415	14.93043	14.57751	0	16.74233	17.48617	16.52338	15.3386	16.44675	0	17.3382	0	0	0	0	17.14536	14.78405	15.12912	0	15.7775	0	0	0	0	0	0	0	0	0	0	15.45486	15.85801	0	0	0	0	0	0	0
Q9UBU8	MO4L1_HUMAN	Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (Protein MSL3-1) (Transcription factor-like protein MRG15)	MORF4L1 MRG15 FWP006 HSPC008 HSPC061 PP368	Homo sapiens (Human)	"cell population proliferation [GO:0008283]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]"	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Sin3 complex [GO:0016580]	"histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]; cell population proliferation [GO:0008283]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]"	chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]	GO:0000123; GO:0000724; GO:0000786; GO:0003682; GO:0005654; GO:0006325; GO:0008283; GO:0016573; GO:0016575; GO:0016580; GO:0016607; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0047485; GO:0051726; GO:1905168; GO:2000779	SAVRPRR	11.64999962	0.044679906	0.044679906	0.21749708	843.315478	0	0	0	0	0	0	0	15.73847	0	0	0	0	16.82702	18.15516	0	16.97782	15.13947	15.6092	0	0	0	0	0	0	15.73563	0	0	15.44578	0	0	0	0	0	16.61973	0	14.3062	0	0	0	0	0	0	18.35333	0	0	0	0	0
Q9UBU9	NXF1_HUMAN	Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP)	NXF1 TAP	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0010494; GO:0015031; GO:0016607; GO:0016973; GO:0042272; GO:0042405	LKDPTLR	9.279999733	1	1	0.22318514	841.5116643	15.60824	15.57604	16.88325	14.24564	14.26257	15.20044	14.74585	15.93383	15.59235	14.20599	14.47947	17.67536	15.06628	16.80332	0	0	14.38962	15.47213	0	15.50394	0	13.88199	14.60301	16.23329	16.08668	16.08024	15.8507	15.12301	0	0	0	0	0	0	0	16.6922	15.81898	14.95023	16.53979	15.82342	14.78263	0	0	0	0	0	0	15.54982
Q9UBV2	SE1L1_HUMAN	"Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1, Sel-1L)"	SEL1L TSA305 UNQ128/PRO1063	Homo sapiens (Human)	"ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]"	Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]	"Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]"		GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0016021; GO:0030433; GO:0030970; GO:0036503; GO:0036513; GO:0050821	DHTTAGR	5.21999979	0.674760759	0.674760759	0.30250015	756.8031338	15.83849	14.68757	0	14.55443	15.72827	16.4627	0	0	17.09268	16.64077	12.93368	15.70156	17.39451	15.24513	0	0	17.61445	16.585	0	16.67068	16.83401	0	0	16.33694	14.81645	16.73341	15.89469	0	0	0	16.00089	0	17.37526	15.98756	16.47264	0	15.92182	17.67979	15.87238	16.58663	0	16.78355	0	14.63229	16.22841	15.42897	13.92553	15.87868
Q9UBV4	WNT16_HUMAN	Protein Wnt-16	WNT16	Homo sapiens (Human)	bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	GO:0003408; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0010628; GO:0014068; GO:0030182; GO:0030216; GO:0043616; GO:0045165; GO:0046330; GO:0046849; GO:0060070; GO:0060317; GO:0060548; GO:0090399; GO:0090403	QKELCK	6.28000021	0.693529427	0.693529427	0.207672145	805.4628367	0	0	0	15.88432	0	15.95807	0	14.54734	14.84448	0	15.64581	0	16.59522	15.21264	0	15.87609	16.08031	0	17.44318	15.91326	16.9908	15.97259	0	0	15.8916	15.33873	15.97559	16.10252	13.28286	15.84596	15.909	15.99822	15.58233	16.42882	15.8457	16.25222	16.89186	17.28926	17.29863	15.40001	0	16.1305	16.61179	16.49387	0	17.36641	16.72834	0
Q9UBV7	B4GT7_HUMAN	"Beta-1,4-galactosyltransferase 7, Beta-1,4-GalTase 7, Beta4Gal-T7, b4Gal-T7, EC 2.4.1.- (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase, EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)"	B4GALT7 XGALT1 UNQ748/PRO1478	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; glycosylation [GO:0070085]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan biosynthetic process [GO:0030166]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; cellular protein modification process [GO:0006464]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; glycosylation [GO:0070085]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan biosynthetic process [GO:0030166]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]"	"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]"	GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006464; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0030166; GO:0030203; GO:0032580; GO:0046525; GO:0048147; GO:0070085; GO:0097435	EGGLNTVK	6.519999981	0.25079903	0.25079903	0.012754608	817.5387027	16.37927	0	0	15.60536	14.2266	0	0	18.60178	0	0	0	0	15.37722	14.89542	0	0	0	0	16.4061	12.59282	0	16.09179	0	12.92003	18.15022	0	0	0	0	0	0	15.4163	17.11052	0	0	16.25739	14.49226	16.24443	14.44111	12.85552	0	0	0	0	0	0	17.21927	0
Q9UBW5	BIN2_HUMAN	Bridging integrator 2 (Breast cancer-associated protein 1)	BIN2 BRAP1	Homo sapiens (Human)	"cell chemotaxis [GO:0060326]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]"	cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; secretory granule lumen [GO:0034774]	"cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; secretory granule lumen [GO:0034774]; phospholipid binding [GO:0005543]; cell chemotaxis [GO:0060326]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]"	phospholipid binding [GO:0005543]	GO:0001891; GO:0002102; GO:0005543; GO:0005576; GO:0005886; GO:0005938; GO:0006911; GO:0030054; GO:0034774; GO:0042995; GO:0060326; GO:0071800; GO:0097320; GO:1904813	AEEEFNK	12.14000034	1	1	0.241483016	866.5179148	0	15.25393	17.79956	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.35412	0	0	0	0	0	18.49233	0	0	0	19.68995	0	0	0	0	0	0	0	0	0	0	0	19.01393	0	0	17.42639	0	0	0	0
Q9UBW7	ZMYM2_HUMAN	Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198)	ZMYM2 FIM RAMP ZNF198	Homo sapiens (Human)		cytosol [GO:0005829]; PML body [GO:0016605]	cytosol [GO:0005829]; PML body [GO:0016605]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]	ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]	GO:0005829; GO:0008270; GO:0016605; GO:0031624	MFECYLSKSPQNLNQR	16.76000023	1	1	2.29E-12	2031.669956	0	16.23127	16.05548	0	15.6303	0	15.26129	16.8893	16.30178	0	15.96101	16.4207	17.03511	16.1692	16.80974	16.42001	16.23965	0	15.50161	17.30082	0	15.43891	0	0	0	16.68274	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UBX0	HESX1_HUMAN	"Homeobox expressed in ES cells 1 (Homeobox protein ANF, hAnf)"	HESX1 HANF	Homo sapiens (Human)	brain development [GO:0007420]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; cellular response to cadmium ion [GO:0071276]; ERK1 and ERK2 cascade [GO:0070371]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; gonad development [GO:0008406]; leukemia inhibitory factor signaling pathway [GO:0048861]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; otic vesicle formation [GO:0030916]; pituitary gland development [GO:0021983]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; thyroid gland development [GO:0030878]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; cellular response to cadmium ion [GO:0071276]; ERK1 and ERK2 cascade [GO:0070371]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; gonad development [GO:0008406]; leukemia inhibitory factor signaling pathway [GO:0048861]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; otic vesicle formation [GO:0030916]; pituitary gland development [GO:0021983]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; thyroid gland development [GO:0030878]"	"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007420; GO:0008022; GO:0008406; GO:0010467; GO:0019827; GO:0021983; GO:0030878; GO:0030916; GO:0035264; GO:0042803; GO:0043010; GO:0043584; GO:0045995; GO:0047485; GO:0048853; GO:0048861; GO:0048863; GO:0060070; GO:0070371; GO:0071276; GO:1990837	ESQFLMAK	7.519999981	0.595692933	0.595692933	0.206621066	968.38081	14.06353	16.18692	8.437937	18.822	12.29	0	18.56495	14.21705	14.84613	15.8892	0	15.49363	0	15.57345	0	0	14.54929	13.54564	15.47465	0	0	15.05739	16.82813	15.04489	0	0	0	16.47806	14.45693	16.07743	0	0	0	15.00392	0	17.41449	11.40851	14.82691	0	0	15.03821	0	15.27318	0	0	0	0	0
Q9UBX1	CATF_HUMAN	"Cathepsin F, CATSF, EC 3.4.22.41"	CTSF	Homo sapiens (Human)	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cysteine-type endopeptidase activity [GO:0004197]	GO:0004197; GO:0005615; GO:0005764; GO:0005783; GO:0005886; GO:0006508; GO:0019886; GO:0043202; GO:0043231; GO:0051603; GO:0062023; GO:0070062; GO:1903561	AVLGLVRGR	7.010000229	1	1	0.045527551	939.7355424	15.83428	0	13.53564	0	0	0	15.39819	0	0	0	0	15.47563	15.37452	0	0	0	0	0	0	0	0	0	17.14414	0	16.15659	0	0	0	0	0	14.40157	0	0	15.64102	15.32094	0	16.60678	0	0	0	0	0	0	0	0	0	0	0
Q9UBY0	SL9A2_HUMAN	"Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2, NHE-2) (Solute carrier family 9 member 2)"	SLC9A2 NHE2	Homo sapiens (Human)	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0005886; GO:0006811; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719	DMPSTPPTPHSREK	1.059999943	1	1	0.373772372	1596.158557	15.15109	0	15.23557	15.08074	0	13.67397	14.53363	10.75811	13.3922	15.60622	0	0	0	13.83484	0	0	15.40018	0	0	12.80369	0	15.34227	14.67046	0	15.4528	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UBZ4	APEX2_HUMAN	"DNA-(apurinic or apyrimidinic site) endonuclease 2, EC 3.1.11.2 (AP endonuclease XTH2) (APEX nuclease 2) (APEX nuclease-like 2) (Apurinic-apyrimidinic endonuclease 2, AP endonuclease 2)"	APEX2 APE2 APEXL2 XTH2	Homo sapiens (Human)	base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310]	DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]	GO:0001650; GO:0003677; GO:0003906; GO:0004519; GO:0005634; GO:0005654; GO:0005739; GO:0006284; GO:0006310; GO:0007049; GO:0008081; GO:0008270; GO:0008311; GO:0043231	SGYSGVATFCK	13.77999973	1	1	0.045506856	1175.904086	0	14.78088	0	0	0	0	0	0	15.75817	0	13.96198	0	0	13.50061	0	0	16.68991	0	0	0	0	0	0	0	0	0	0	0	16.55813	16.28399	15.28455	0	16.19471	16.44392	0	14.55866	17.43724	0	0	0	0	16.41658	0	16.72972	0	0	18.09379	0
Q9UBZ9	REV1_HUMAN	"DNA repair protein REV1, EC 2.7.7.- (Alpha integrin-binding protein 80, AIBP80) (Rev1-like terminal deoxycytidyl transferase)"	REV1 REV1L	Homo sapiens (Human)	DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411]	damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0003684; GO:0003887; GO:0005654; GO:0006260; GO:0009411; GO:0017125; GO:0042276; GO:0046872; GO:0070987	AADIPDSSLWENPDSAQANGIDSVLSR	2.519999981	1	1	0.080623203	2828.008427	0	0	9.026469	0	0	10.08491	0	0	16.55214	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.33946	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UC06	ZNF70_HUMAN	Zinc finger protein 70 (Zinc finger protein N27C7-1)	ZNF70	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076]	"cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005737; GO:0006357; GO:0043076; GO:0046872	IHSGEKL	3.900000095	1	1	0.195176607	785.8094675	14.50952	13.67721	14.45105	15.49293	0	0	0	0	0	0	14.71333	0	0	0	0	0	14.85548	15.63412	0	15.05819	0	15.56628	0	0	0	13.4218	15.46494	15.14131	0	0	14.72091	15.57154	0	12.85358	16.09339	14.56292	0	0	0	14.63248	16.44191	0	0	0	0	9.502491	13.37977	16.40596
Q9UDR5	AASS_HUMAN	"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase, LKR, LOR, EC 1.5.1.8; Saccharopine dehydrogenase, SDH, EC 1.5.1.9 ]"	AASS	Homo sapiens (Human)	L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; histone binding [GO:0042393]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; transcription corepressor activity [GO:0003714]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]"	"histone binding [GO:0042393]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; transcription corepressor activity [GO:0003714]"	GO:0000122; GO:0003714; GO:0004753; GO:0004754; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006554; GO:0019878; GO:0031061; GO:0033512; GO:0042393; GO:0043231; GO:0047130; GO:0047131	AQEANMGLLDEILKQEIR	3.640000105	1	1	1.38E-12	2087.224383	15.17945	14.87003	15.3873	11.94326	0	15.97311	16.06347	14.77516	15.74926	14.5107	12.20179	0	0	0	0	0	0	0	0	0	0	0	0	0	15.16728	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UDT6	CLIP2_HUMAN	"CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115, CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein)"	CLIP2 CYLN2 KIAA0291 WBSCR3 WBSCR4 WSCR4	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]	cytoplasm [GO:0005737]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cytoplasmic microtubule organization [GO:0031122]	microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]	GO:0005634; GO:0005737; GO:0005875; GO:0008017; GO:0031122; GO:0035371; GO:0051010	ESVLNSSVK	11.17000008	0.525052309	0.525052309	0.170605715	963.8767998	15.8725	18.21701	15.70199	14.20096	17.50051	17.31524	17.31914	19.1596	0	17.41453	14.9269	17.26543	13.37739	0	0	11.04795	17.45233	15.62607	15.19235	14.97595	12.84716	17.26837	16.37676	0	16.00652	13.94039	15.22389	16.10172	14.46047	13.80675	0	15.86781	14.77567	0	15.40531	15.87374	17.21539	16.73281	0	14.06152	0	15.49539	16.27216	12.1862	13.58887	16.05607	0	14.97717
Q9UDW1	QCR9_HUMAN	Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein)	UQCR10 UCRC HSPC119	Homo sapiens (Human)	"cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]	"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]"	ubiquinol-cytochrome-c reductase activity [GO:0008121]	GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0045333	MAAATLTSKLYSLLFR	9.93999958	0.438507199	0.438507199	1.60E-12	1802.574011	15.7923	0	15.64271	16.90008	14.10318	0	0	14.89223	15.6529	13.0147	15.35671	0	0	0	14.93295	12.88003	0	12.68212	14.81155	0	16.87978	16.07837	0	0	0	0	16.28839	0	12.73286	0	13.77964	0	15.31928	0	15.08885	0	17.46982	16.50494	0	14.21727	0	16.64987	0	13.8505	14.80507	13.49047	0	0
Q9UDX4	S14L3_HUMAN	SEC14-like protein 3 (Tocopherol-associated protein 2)	SEC14L3 TAP2	Homo sapiens (Human)		cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; lipid binding [GO:0008289]	lipid binding [GO:0008289]	GO:0005737; GO:0008289; GO:0016607; GO:0070062	LFPVGYNLMKPFLSEDTR	9.590000153	1	1	0.110283107	2141.902773	0	0	0	14.18887	0	0	0	0	15.81889	13.81576	15.57583	17.68718	14.85612	14.91873	17.13572	0	0	0	0	14.55797	0	0	0	12.76239	16.5111	16.56069	0	0	0	0	0	0	0	17.78632	0	0	0	0	20.71998	0	0	0	0	0	0	0	15.01247	0
Q9UDX5	MTFP1_HUMAN	"Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein, MTP18)"	MTFP1 MTP18 HSPC242 My022	Homo sapiens (Human)	apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; response to muscle activity [GO:0014850]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; response to muscle activity [GO:0014850]		GO:0000266; GO:0005739; GO:0005743; GO:0006915; GO:0014850; GO:0016021	SVDFLLDSSLRK	8.899999619	0.412609637	0.412609637	0.057209591	1379.111745	16.59773	0	0	14.34729	16.95317	14.19271	15.86405	0	14.56493	0	15.13636	16.44708	16.32729	0	13.23555	0	14.59105	17.06603	10.60328	0	0	0	12.47306	0	0	9.547702	15.51984	0	14.0217	0	16.87466	14.46669	0	10.36987	14.52141	16.58525	0	15.22244	0	14.16288	0	11.74381	0	0	0	14.39893	17.51343	0
Q9UDY2	ZO2_HUMAN	Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2)	TJP2 X104 ZO2	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; homotypic cell-cell adhesion [GO:0034109]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]; regulation of membrane permeability [GO:0090559]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; guanylate kinase activity [GO:0004385]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; homotypic cell-cell adhesion [GO:0034109]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]; regulation of membrane permeability [GO:0090559]	cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; guanylate kinase activity [GO:0004385]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674]	GO:0004385; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0019904; GO:0030674; GO:0034109; GO:0035633; GO:0044291; GO:0045216; GO:0045296; GO:0050839; GO:0050892; GO:0090557; GO:0090559; GO:0098609; GO:0150105; GO:1905605; GO:1990782	DAGSEK	6.389999866	1	1	0.046721385	606.8709383	14.63149	0	14.88029	0	0	0	15.71827	13.10238	0	0	15.28723	0	0	18.41956	0	17.79053	0	0	16.94692	15.81634	0	0	0	15.95854	17.06616	0	16.80274	15.78286	0	0	11.54255	0	0	14.64428	0	17.75427	0	17.81613	0	0	18.16835	15.93679	16.39103	0	17.87853	15.07125	0	15.94644
Q9UDY4	DNJB4_HUMAN	"DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog, HSP40 homolog, Heat shock protein 40 homolog) (Human liver DnaJ-like protein)"	DNAJB4 DNAJW HLJ1	Homo sapiens (Human)	chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0051082; GO:0051085; GO:0051087	MGGGR	1.789999962	1	1	0.224189687	477.4533241	16.51891	15.41658	15.00052	15.6907	0	14.42252	0	15.2911	0	0	0	0	0	0	16.00674	0	14.93251	16.17798	16.48795	0	14.60319	0	17.34128	0	16.34684	18.78725	0	14.71786	0	0	0	0	18.28657	17.30778	0	13.0103	17.93621	0	0	15.83424	0	0	14.96714	0	0	0	0	0
Q9UDY8	MALT1_HUMAN	"Mucosa-associated lymphoid tissue lymphoma translocation protein 1, EC 3.4.22.- (MALT lymphoma-associated translocation) (Paracaspase)"	MALT1 MLT	Homo sapiens (Human)	activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]	CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]	CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]	cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0007250; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0043621; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321	EIPNGNTSELIFNAVHVK	3.880000114	0.41173473	0.41173473	0.069988227	1982.514912	14.31647	0	0	11.69514	0	0	0	0	14.65752	14.69063	15.6275	0	0	0	0	13.84854	15.25691	0	0	0	0	0	0	0	0	19.2352	12.89265	0	0	0	0	13.56109	13.64638	0	0	0	0	0	14.02609	0	0	0	0	0	0	0	14.03831	0
Q9UEF7	KLOT_HUMAN	"Klotho, EC 3.2.1.31 [Cleaved into: Klotho peptide ]"	KL	Homo sapiens (Human)	acute inflammatory response [GO:0002526]; aging [GO:0007568]; calcium ion homeostasis [GO:0055074]; carbohydrate metabolic process [GO:0005975]; energy reserve metabolic process [GO:0006112]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; negative regulation of systemic arterial blood pressure [GO:0003085]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of bone mineralization [GO:0030501]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to vitamin D [GO:0033280]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; beta-glucuronidase activity [GO:0004566]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hormone activity [GO:0005179]; vitamin D binding [GO:0005499]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; calcium ion homeostasis [GO:0055074]; carbohydrate metabolic process [GO:0005975]; energy reserve metabolic process [GO:0006112]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; negative regulation of systemic arterial blood pressure [GO:0003085]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of bone mineralization [GO:0030501]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to vitamin D [GO:0033280]	beta-glucosidase activity [GO:0008422]; beta-glucuronidase activity [GO:0004566]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hormone activity [GO:0005179]; vitamin D binding [GO:0005499]	GO:0002526; GO:0003085; GO:0004566; GO:0005104; GO:0005179; GO:0005499; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0005975; GO:0006112; GO:0007568; GO:0008286; GO:0008422; GO:0008543; GO:0014823; GO:0016021; GO:0016324; GO:0017134; GO:0030501; GO:0033280; GO:0042421; GO:0055074; GO:0070062; GO:0090080; GO:1990776	VLEFDIGWLAEPIFGSGDYPWVMR	2.069999933	1	1	9.18E-13	2797.831798	0	0	0	0	0	15.03991	0	0	0	0	0	0	0	0	0	0	0	0	0	15.30348	0	0	0	0	0	0	13.36631	0	0	15.03418	0	15.64946	10.7809	13.38032	14.13141	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UEG4	ZN629_HUMAN	Zinc finger protein 629 (Zinc finger protein 65)	ZNF629 KIAA0326 ZNF65	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	GNSYPGAAEGR	1.25	0.000647227	0.000647227	0.120535682	1078.804293	15.34923	16.37795	6.518115	14.80174	17.81077	15.37464	12.3036	9.503556	13.6889	16.65474	11.40253	16.66787	0	15.98829	16.59827	14.18937	17.05389	0	10.4466	0	16.11159	15.03784	18.28152	16.56656	0	16.73657	0	16.64174	11.3222	13.67564	18.51459	14.0601	16.17831	15.2409	9.54968	15.813	16.98575	16.32144	15.48996	17.26843	13.9521	0	16.08815	9.198061	16.37839	0	15.4889	0
Q9UET6	TRM7_HUMAN	"Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase, EC 2.1.1.205 (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1)"	FTSJ1 JM23	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]	RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]	GO:0001510; GO:0002128; GO:0002181; GO:0005737; GO:0005829; GO:0006400; GO:0008173; GO:0008175; GO:0009020; GO:0030488; GO:0052666	EFQLFQGVTR	7.96999979	1	1	1.15E-12	1223.462361	13.27424	0	0	0	0	0	0	0	0	0	0	14.66301	0	0	15.40553	12.84334	0	0	0	14.89515	17.04218	0	0	0	16.59803	0	0	13.19427	0	0	0	0	0	0	0	0	14.55018	0	0	15.60104	0	0	0	0	0	0	0	0
Q9UEY8	ADDG_HUMAN	Gamma-adducin (Adducin-like protein 70)	ADD3 ADDL	Homo sapiens (Human)	barbed-end actin filament capping [GO:0051016]	brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; barbed-end actin filament capping [GO:0051016]	actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]	GO:0000794; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0014069; GO:0016020; GO:0051015; GO:0051016	TPSFLK	5.420000076	0.16387251	0.16387251	0.243067346	694.7684606	0	15.62221	15.39753	0	0	0	0	0	0	0	0	15.1085	16.0095	15.80249	16.6279	0	15.83785	11.71098	15.61012	15.53908	16.82417	0	0	0	15.67916	15.40607	15.3341	0	17.11298	16.65041	16.40035	16.76597	0	17.12756	15.98563	15.78573	17.3176	18.28145	16.22975	18.06994	16.1882	17.10609	15.39272	0	0	15.69583	19.37584	14.64463
Q9UF56	FXL17_HUMAN	F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13)	FBXL17 FBL17 FBX13 FBXO13	Homo sapiens (Human)	entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]		GO:0000086; GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043153; GO:0043161; GO:0051726	ISDEGMIVIAK	6.789999962	0.645940542	0.645940542	0.167005834	1188.372476	16.39212	0	0	0	0	10.08342	12.841	13.24263	0	0	0	0	0	12.70688	0	0	0	0	0	0	0	15.69598	0	0	0	14.16749	0	13.96932	6.547565	0	0	0	0	0	0	0	15.71445	0	0	0	0	14.66981	13.79913	15.50228	13.01107	15.50094	0	14.59557
Q9UF83	YM012_HUMAN	Uncharacterized protein DKFZp434B061		Homo sapiens (Human)		extracellular space [GO:0005615]	extracellular space [GO:0005615]		GO:0005615	ASLTMTPSR	5.360000134	1	1	0.116241395	976.5389688	11.71828	14.8815	16.33085	0	14.73157	13.87944	0	15.18998	13.19649	14.0408	0	0	0	0	0	15.40093	0	0	0	0	0	0	0	13.14278	0	0	0	0	15.68184	14.66172	0	0	0	0	0	0	0	16.10134	16.11456	0	0	0	0	0	0	0	0	0
Q9UFC0	LRWD1_HUMAN	"Leucine-rich repeat and WD repeat-containing protein 1 (Centromere protein 33, CENP-33) (Origin recognition complex-associated protein, ORC-associated protein, ORCA)"	LRWD1 CENP-33 ORCA	Homo sapiens (Human)	chromatin organization [GO:0006325]; DNA replication initiation [GO:0006270]; establishment of protein localization to chromatin [GO:0071169]	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"	"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; DNA replication initiation [GO:0006270]; establishment of protein localization to chromatin [GO:0071169]"	chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]	GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005654; GO:0005664; GO:0005721; GO:0005730; GO:0005737; GO:0005815; GO:0006270; GO:0006325; GO:0008327; GO:0035064; GO:0043231; GO:0071169	QPPLLPAALQAPTQILK	8.680000305	0.647526085	0.647526085	5.02E-12	1799.405916	0	0	11.24265	12.73318	0	15.38708	13.67062	0	0	0	12.22955	14.76812	0	0	16.99943	0	15.36755	0	10.60245	0	15.72736	0	0	0	0	14.6117	0	16.09753	0	13.64099	0	15.64254	16.47399	15.67107	15.92292	0	10.84369	0	17.56317	0	15.84204	16.1824	19.02083	0	0	0	13.03053	17.78287
Q9UFH2	DYH17_HUMAN	Dynein axonemal heavy chain 17 (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein axonemal light chain 2)	DNAH17 DNAHL1 DNEL2	Homo sapiens (Human)	cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]	axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0003341; GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285	EHIPEACLK	1.889999986	1	1	0.166431703	1095.805978	15.41064	13.67126	0	0	14.94602	12.25021	0	14.93567	9.451061	6.06231	0	0	15.07441	0	0	0	0	11.49991	0	0	0	0	0	0	0	0	16.77459	16.09609	0	0	0	0	0	0	0	0	0	0	0	0	0	15.18441	16.17913	0	0	0	0	0
Q9UFP1	GAK1A_HUMAN	Golgi-associated kinase 1A (Protein FAM198A)	GASK1A C3orf41 FAM198A	Homo sapiens (Human)		caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]		GO:0005576; GO:0005783; GO:0005794; GO:0005901; GO:0043231	ESPGGDLR	9	1	1	0.034884198	831.6870304	13.77112	0	15.84404	0	14.38432	0	16.61543	0	0	0	0	14.89098	0	0	15.29678	0	14.14248	0	0	12.97101	14.62189	0	0	0	0	0	0	0	0	0	0	0	0	0	14.32794	0	14.42046	0	0	15.97404	0	0	0	0	0	0	0	0
Q9UFV1	TBC29_HUMAN	Putative TBC1 domain family member 29	TBC1D29P TBC1D29	Homo sapiens (Human)						GPSLLQTPPRVPGQQALSR	3.50999999	1	1	0.645733675	2002.718298	0	18.38125	18.57294	18.63804	0	0	0	0	0	0	0	0	17.7564	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UFW8	CGBP1_HUMAN	"CGG triplet repeat-binding protein 1, CGG-binding protein 1 (20 kDa CGG-binding protein) (p20-CGGBP DNA-binding protein)"	CGGBP1 CGGBP	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]"	DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]	GO:0000122; GO:0003690; GO:0005634; GO:0005654; GO:0010468; GO:0040029; GO:0042802; GO:0140297	HVKNGGSIPK	3.480000019	1	1	0.071884688	1037.149954	13.74299	0	0	16.1484	17.47446	11.63688	0	0	14.65474	0	0	14.41504	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UG01	IF172_HUMAN	Intraflagellar transport protein 172 homolog	IFT172 KIAA1179	Homo sapiens (Human)	bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]		GO:0001843; GO:0001947; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007420; GO:0008544; GO:0009953; GO:0016485; GO:0021522; GO:0030992; GO:0031122; GO:0035720; GO:0036064; GO:0042073; GO:0045879; GO:0045880; GO:0048596; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097542; GO:0097598; GO:1903561; GO:1905515	AGDLFEK	4.929999828	1	1	0.265212754	778.0985474	0	16.9885	0	0	0	16.53642	18.90646	0	0	17.96591	0	0	0	0	0	0	0	0	0	0	16.47972	0	0	0	0	18.11991	0	0	18.90187	0	17.61778	0	22.4734	19.09624	0	0	18.88059	0	19.60472	0	0	0	0	0	16.26812	0	0	0
Q9UG22	GIMA2_HUMAN	"GTPase IMAP family member 2 (Immunity-associated protein 2, hIMAP2)"	GIMAP2 IMAP2	Homo sapiens (Human)		endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]	endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]	GTP binding [GO:0005525]; identical protein binding [GO:0042802]	GO:0005525; GO:0005654; GO:0005783; GO:0005811; GO:0042802	KQAFESK	13.14999962	1	1	0.590670441	839.0374826	0	0	0	0	0	0	0	0	0	19.87562	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.21151	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UG56	PISD_HUMAN	"Phosphatidylserine decarboxylase proenzyme, mitochondrial, EC 4.1.1.65 [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain ]"	PISD	Homo sapiens (Human)	mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821]	phosphatidylserine decarboxylase activity [GO:0004609]	GO:0004609; GO:0005634; GO:0005739; GO:0006646; GO:0010821; GO:0016540; GO:0031305; GO:0035694	DLHTNSPRHSK	11.48999977	1	1	1.37E-12	1291.129979	0	0	14.93514	0	0	15.31627	0	0	0	0	0	16.75612	0	0	16.94457	0	0	0	15.54917	14.56717	16.27188	15.00707	0	0	0	15.49709	0	14.56646	15.55998	0	15.18722	0	0	0	0	0	14.13616	0	0	0	14.99169	0	15.45639	0	14.61111	0	0	0
Q9UG63	ABCF2_HUMAN	ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2)	ABCF2 HUSSY-18	Homo sapiens (Human)		membrane [GO:0016020]	membrane [GO:0016020]; ATP binding [GO:0005524]	ATP binding [GO:0005524]	GO:0005524; GO:0016020	HSHVKIGR	9.109999657	1	1	0.13640048	933.0717836	0	0	0	16.43548	0	0	0	0	16.44249	0	16.71522	14.94954	0	0	15.01382	0	14.21789	0	0	0	0	0	0	0	0	0	0	13.80464	0	0	0	15.21057	15.52132	0	13.55302	0	0	0	0	0	15.10144	18.23189	0	0	0	14.88129	0	0
Q9UGF5	O14J1_HUMAN	Olfactory receptor 14J1 (Hs6M1-28) (Olfactory receptor 5U1) (Olfactory receptor OR6-25)	OR14J1 OR5U1	Homo sapiens (Human)		integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]	GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021	MVNLTSMSGFLLMGFSDER	10.02999973	0.286529928	0.286529928	0.038787262	2167.592707	21.0173	20.1326	21.07408	19.14323	19.69103	19.68236	20.29627	0	0	19.58584	19.5741	0	19.53855	20.24933	18.17401	19.50311	19.69933	0	20.47915	20.25838	17.30772	18.80404	0	0	16.72218	19.04566	0	18.04183	17.53423	16.86197	12.97011	19.30577	18.41567	18.83961	17.24483	18.23355	0	18.15859	0	18.70108	19.47347	17.89269	18.98346	17.11935	0	18.27777	17.56722	0
Q9UGH3	S23A2_HUMAN	"Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2, hSVCT2) (Yolk sac permease-like molecule 2)"	SLC23A2 KIAA0238 NBTL1 SLC23A1 SVCT2 YSPL2	Homo sapiens (Human)	cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904]	L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]	GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0015229; GO:0015882; GO:0016021; GO:0016323; GO:0016324; GO:0019852; GO:0070904; GO:0071361; GO:1901215; GO:1903861	NVKFPLPIYK	9.800000191	0.387836307	0.387836307	0.106530658	1221.679216	0	0	13.22952	0	0	0	0	0	6.989971	16.96663	0	12.5926	12.93472	9.599805	0	0	0	14.58239	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.98237	0	0	14.96786	0	16.44444	15.75071	13.50839	0	0	0	15.38997	15.48581
Q9UGI0	ZRAN1_HUMAN	"Ubiquitin thioesterase ZRANB1, EC 3.4.19.12 (TRAF-binding domain-containing protein, hTrabid) (Zinc finger Ran-binding domain-containing protein 1)"	ZRANB1 TRABID	Homo sapiens (Human)	cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent deubiquitinase [GO:0004843]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055]	deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0031593; GO:0035523; GO:0043231; GO:0046872; GO:0070530; GO:0070536; GO:0071947; GO:0101005; GO:1990168	CTMCRAQRPSGTIITEDPFK	9.710000038	1	1	1.83E-12	2385.02106	14.19776	14.30905	14.2874	0	0	0	0	0	0	0	0	0	0	13.30254	0	14.0431	12.92569	0	0	0	0	0	0	0	8.813399	0	12.89187	0	12.34105	0	0	0	0	0	0	0	0	13.30451	13.45068	0	0	0	14.41264	0	0	0	0	11.6953
Q9UGI6	KCNN3_HUMAN	"Small conductance calcium-activated potassium channel protein 3, SK3, SKCa 3, SKCa3 (KCa2.3)"	KCNN3 K3	Homo sapiens (Human)	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; small conductance calcium-activated potassium channel activity [GO:0016286]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]	calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; small conductance calcium-activated potassium channel activity [GO:0016286]	GO:0005242; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0016021; GO:0016286; GO:0043005; GO:0043025; GO:0071805	SEDLEK	4.53000021	1	1	0.150576802	719.4826149	15.97857	16.45473	16.59027	14.97022	0	15.01418	14.81071	0	13.49618	0	0	0	0	17.15732	0	15.72198	15.60248	16.25713	0	15.51492	14.83637	0	13.8794	16.32902	0	16.00312	17.09272	15.23386	15.06233	0	0	16.18725	0	0	0	0	0	15.9266	16.14998	16.70565	15.39169	0	15.25256	14.94871	16.65484	15.04798	15.46864	15.04711
Q9UGI9	AAKG3_HUMAN	"5'-AMP-activated protein kinase subunit gamma-3, AMPK gamma3, AMPK subunit gamma-3"	PRKAG3 AMPKG3	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen biosynthetic process [GO:0005978]; glycolytic process [GO:0006096]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen biosynthetic process [GO:0005978]; glycolytic process [GO:0006096]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]	AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0004679; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005978; GO:0006096; GO:0006468; GO:0006633; GO:0014873; GO:0016208; GO:0019887; GO:0019901; GO:0031588; GO:0031669; GO:0035556; GO:0042149; GO:0050790; GO:0071900	EPGLEHALR	2.910000086	1	1	0.004231975	1021.813436	0	15.22287	14.5131	0	0	0	13.48875	13.52852	0	14.17809	14.88312	0	0	15.07703	0	13.71704	0	0	16.62915	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UGJ0	AAKG2_HUMAN	"5'-AMP-activated protein kinase subunit gamma-2, AMPK gamma2, AMPK subunit gamma-2 (H91620p)"	PRKAG2	Homo sapiens (Human)	ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126]	ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]	GO:0004679; GO:0004862; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006468; GO:0006469; GO:0006633; GO:0006754; GO:0008603; GO:0008607; GO:0010800; GO:0016126; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0042149; GO:0043531; GO:0045860; GO:0046320; GO:0046324; GO:0050790	AAPLWESK	5.260000229	1	1	0.294341317	900.8494549	0	0	14.86886	17.13531	13.63623	0	15.55969	16.50919	0	16.36519	0	16.08891	0	14.91233	0	0	0	15.00524	16.1335	13.13029	15.26104	0	15.53192	16.54704	14.76606	14.80278	16.0708	15.7986	0	15.01757	16.23665	0	16.10028	0	0	0	0	0	16.28727	0	0	0	14.61163	0	0	0	14.59632	14.11029
Q9UGJ1	GCP4_HUMAN	"Gamma-tubulin complex component 4, GCP-4, hGCP4 (Gamma-ring complex protein 76 kDa, h76p, hGrip76)"	TUBGCP4 76P GCP4	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225]	gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]	GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003	IHGCQILETVYK	5.699999809	1	1	0.29654991	1460.972329	0	0	0	0	0	0	14.74936	0	17.44502	0	16.04483	0	0	0	0	0	0	0	0	0	17.65874	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.89346	0	0	0	0	0	0	0	0	0	0	0
Q9UGL1	KDM5B_HUMAN	"Lysine-specific demethylase 5B, EC 1.14.11.67 (Cancer/testis antigen 31, CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1, RBP2-H1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B)"	KDM5B JARID1B PLU1 RBBP2H1	Homo sapiens (Human)	"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]"	DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034720; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864	AVGSHIR	3.279999971	0.351588517	0.351588517	0.026543663	738.2951282	17.15878	16.15951	0	16.85832	15.24807	0	13.85783	17.54895	14.04485	15.06441	17.13874	17.05388	16.36945	14.57944	15.1648	16.02594	18.76851	16.55921	13.42098	14.73932	15.94041	14.46066	15.08524	14.99787	18.55475	14.68994	17.38886	12.83342	12.05591	12.71033	0	15.60433	14.40129	18.13758	0	15.75803	17.00681	0	16.96351	16.93295	13.55538	17.06117	10.97418	18.28365	0	12.10905	0	16.86253
Q9UGM5	FETUB_HUMAN	Fetuin-B (16G2) (Fetuin-like protein IRL685) (Gugu)	FETUB	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; negative regulation of endopeptidase activity [GO:0010951]; single fertilization [GO:0007338]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of endopeptidase activity [GO:0010951]; single fertilization [GO:0007338]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]	GO:0004866; GO:0004869; GO:0005576; GO:0007338; GO:0007339; GO:0008191; GO:0010951; GO:0070062	VNDAQEYRR	3.680000067	1	1	0.101870666	1151.437525	12.4201	15.61404	15.87224	14.76285	0	0	0	14.78619	0	12.98979	0	12.75722	12.38586	0	13.62935	0	0	0	0	0	0	0	0	0	0	15.76539	0	13.78127	0	0	0	0	0	14.70166	0	0	14.5623	0	15.55071	0	0	0	0	0	0	0	0	0
Q9UGN5	PARP2_HUMAN	"Poly [ADP-ribose] polymerase 2, PARP-2, hPARP-2, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 2, ARTD2) (DNA ADP-ribosyltransferase PARP2, EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2, ADPRT-2) (Poly[ADP-ribose] synthase 2, pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2, EC 2.4.2.-)"	PARP2 ADPRT2 ADPRTL2	Homo sapiens (Human)	base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; histone modification [GO:0016570]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; nucleosome binding [GO:0031491]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; histone modification [GO:0016570]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; nucleosome binding [GO:0031491]; protein ADP-ribosylase activity [GO:1990404]	GO:0003677; GO:0003682; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0006471; GO:0016570; GO:0018312; GO:0030592; GO:0031491; GO:0061051; GO:0070212; GO:0070213; GO:0090734; GO:0097191; GO:0140294; GO:1901215; GO:1990404	KMPVAGGK	1.190000057	1	1	1.19E-13	798.6699265	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.97895	0	0	0	0	0
Q9UGR2	Z3H7B_HUMAN	"Zinc finger CCCH domain-containing protein 7B (Rotavirus 'X'-associated non-structural protein, RoXaN)"	ZC3H7B KIAA1031	Homo sapiens (Human)	posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]	nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]	metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0010608; GO:0035196; GO:0035198; GO:0046872	ASSSMGAPRTHGPSTFDLQMK	5.25	1	1	1.83E-12	2234.235909	0	0	17.00191	0	15.29455	12.0452	0	0	0	0	0	0	0	13.20283	0	0	0	0	0	0	0	14.76416	0	13.28351	0	0	0	0	0	9.390087	13.99098	13.21881	0	13.06384	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UGU0	TCF20_HUMAN	"Transcription factor 20, TCF-20 (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein, SPRE-binding protein)"	TCF20 KIAA0292 SPBP	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0045944; GO:0046872	GMELK	2.25999999	0.467600822	0.467600822	0.146974435	576.5946655	0	0	10.79009	15.2567	15.20979	10.40394	14.70073	15.92674	0	15.53889	0	13.51349	16.16748	0	16.21334	16.17859	17.3772	14.1594	0	0	13.9481	14.54974	15.89297	15.1119	0	17.17833	0	0	15.97464	14.08304	13.67049	16.57202	13.12992	14.03388	17.36705	16.91268	0	18.31259	0	19.06048	18.0844	16.75761	0	16.27137	0	16.76797	17.02983	0
Q9UH03	SEPT3_HUMAN	Neuronal-specific septin-3	SEPTIN3 SEP3 SEPT3	Homo sapiens (Human)	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]	cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]	GO:0003924; GO:0005525; GO:0005940; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0042802; GO:0043005; GO:0060090; GO:0061640; GO:0098793; GO:0099569	QESMPFAVVGSDK	3.609999895	1	1	0.351038717	1410.986995	0	15.93773	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.60261	0	0	0	0	0	0	15.45399	0	15.05443	0	0	0	0	16.10053	0	0	17.68217	16.63894	15.93813	0	16.2438	0	15.87817	15.46714	14.5288	0	0	0
Q9UH36	SRR1L_HUMAN	SRR1-like protein (SRR1 domain-containing protein)	SRRD SRR1L	Homo sapiens (Human)	heme biosynthetic process [GO:0006783]; microtubule-based process [GO:0007017]; regulation of circadian rhythm [GO:0042752]; regulation of heme biosynthetic process [GO:0070453]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; heme biosynthetic process [GO:0006783]; microtubule-based process [GO:0007017]; regulation of circadian rhythm [GO:0042752]; regulation of heme biosynthetic process [GO:0070453]; rhythmic process [GO:0048511]		GO:0005634; GO:0005737; GO:0006783; GO:0007017; GO:0042752; GO:0048511; GO:0070453	GREAAPR	10.89999962	0.190619454	0.190619454	0.280978423	756.0240511	18.20885	0	15.11606	13.81536	0	16.88336	0	16.5404	0	15.49546	13.59563	9.405877	16.85924	14.20101	0	17.02543	15.51858	15.69505	0	0	0	17.47658	0	0	15.67908	16.9742	0	17.29414	16.9997	15.79833	16.96287	16.20247	16.01554	14.96668	0	0	17.53658	18.14402	0	0	14.32928	16.2951	16.46445	0	0	17.50254	0	15.91315
Q9UH64	NSGX_HUMAN	Putative protein CDKN2A-DT (CDKN2A antisense RNA 1) (CDKN2A antisense gene protein 1) (Protein CDKN2A-AS1) (Susceptibility protein NSG-x)	CDKN2A-DT C9orf53 CDKN2A-AS1	Homo sapiens (Human)						SEPRACNNPTVAENR	14.68000031	0.947462797	0.947462797	0.108269057	1715.433109	17.41705	17.45913	0	0	0	0	15.04171	13.022	14.65597	14.68382	0	16.14658	14.47086	16.13354	16.16876	11.16883	14.06705	13.62876	0	0	14.70617	13.92446	14.39941	0	17.20349	17.08807	15.2877	14.73892	15.23187	16.50766	14.80845	13.79151	0	15.72723	16.49399	13.44623	15.49961	15.78282	15.73203	0	0	0	0	0	0	0	0	15.58189
Q9UH99	SUN2_HUMAN	"SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein, Rab5IP) (Sad1/unc-84 protein-like 2)"	SUN2 FRIGG KIAA0668 RAB5IP UNC84B	Homo sapiens (Human)	centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; positive regulation of cell migration [GO:0030335]	endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; positive regulation of cell migration [GO:0030335]	cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495]	GO:0005521; GO:0005635; GO:0005639; GO:0006998; GO:0007052; GO:0007097; GO:0008017; GO:0010008; GO:0030335; GO:0031022; GO:0031965; GO:0034993; GO:0042802; GO:0043495; GO:0051321; GO:0051642; GO:0090292; GO:0140444	RGTGGSESSR	2.640000105	1	1	8.09E-13	993.6755748	0	0	15.87374	16.74435	0	16.51167	0	0	0	16.55555	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UHA3	RLP24_HUMAN	Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) (Ribosomal protein L24-like)	RSL24D1 C15orf15 RPL24L My024	Homo sapiens (Human)	ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005654; GO:0005730; GO:0005840; GO:0006412; GO:0042273	APLAGK	7.21999979	1	1	0.198507866	553.4844695	0	0	0	0	0	0	18.81683	0	0	0	0	18.52665	0	0	0	0	0	0	0	0	19.20697	0	0	0	19.21968	0	0	0	0	18.57482	0	0	0	0	0	0	0	0	0	18.38431	0	0	0	0	0	0	0	0
Q9UHB6	LIMA1_HUMAN	LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm)	LIMA1 EPLIN SREBP3 PP624	Homo sapiens (Human)	actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529]	actin cytoskeleton [GO:0015629]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]	actin cytoskeleton [GO:0015629]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529]	actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]	GO:0001725; GO:0001726; GO:0003785; GO:0005829; GO:0005886; GO:0005925; GO:0008203; GO:0015629; GO:0016477; GO:0030299; GO:0030835; GO:0031526; GO:0031529; GO:0032154; GO:0042632; GO:0045296; GO:0046872; GO:0051015; GO:0051017	KNGNVGK	10.09000015	1	1	0.293423704	717.1188824	17.59724	0	0	17.85416	0	0	0	21.25078	18.07726	0	18.09894	18.18689	18.26114	21.03997	0	0	0	0	17.32454	0	0	18.18744	18.77326	0	0	17.36433	20.45163	0	0	0	0	0	18.95748	22.22595	22.89789	18.66183	0	0	0	0	0	0	0	16.61742	0	0	0	0
Q9UHB7	AFF4_HUMAN	"AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein, Protein AF-5q31) (Major CDK9 elongation factor-associated protein)"	AFF4 AF5Q31 MCEF HSPC092	Homo sapiens (Human)	regulation of gene expression [GO:0010468]; spermatid development [GO:0007286]	euchromatin [GO:0000791]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]	euchromatin [GO:0000791]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; regulation of gene expression [GO:0010468]; spermatid development [GO:0007286]		GO:0000791; GO:0001650; GO:0005654; GO:0007286; GO:0008023; GO:0010468; GO:0032783	AHLTK	4.349999905	0.361173481	0.361173481	0.191055287	569.3542419	15.70402	13.78516	16.08591	14.10088	15.90737	15.04707	15.65914	15.63867	0	0	15.85744	15.58547	15.1269	16.22494	15.53139	15.14929	14.51131	16.00816	14.8665	0	0	14.86437	0	15.87412	9.864925	15.05605	15.26448	0	16.05105	13.78872	16.24084	15.40598	15.49658	15.43894	16.53278	16.23598	0	15.39969	14.49143	0	14.51258	15.58886	16.15931	15.96979	0	16.8546	14.12372	13.71135
Q9UHB9	SRP68_HUMAN	"Signal recognition particle subunit SRP68, SRP68 (Signal recognition particle 68 kDa protein)"	SRP68	Homo sapiens (Human)	response to xenobiotic stimulus [GO:0009410]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to xenobiotic stimulus [GO:0009410]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]"	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]	GO:0003723; GO:0005047; GO:0005730; GO:0005783; GO:0005786; GO:0005829; GO:0005840; GO:0005925; GO:0006614; GO:0008312; GO:0009410; GO:0019904; GO:0030942; GO:0048500	YLLLVLMDAERAWSYAMQLK	1.769999981	1	1	4.12E-12	2430.204703	0	0	0	14.84536	14.32855	0	0	10.83435	0	16.90722	0	14.71969	0	12.89111	15.49438	0	0	14.2151	0	0	0	14.89464	0	0	0	14.91054	14.31894	16.43681	14.35278	15.01498	14.98839	14.74017	0	0	0	0	0	15.54565	0	15.31821	0	16.32782	15.93376	0	0	0	0	0
Q9UHC1	MLH3_HUMAN	DNA mismatch repair protein Mlh3 (MutL protein homolog 3)	MLH3	Homo sapiens (Human)	female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130]	chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696]; female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696]	GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300	STVTKSIVEEFIR	4.590000153	1	1	0.436318771	1508.730436	13.91868	0	14.42827	0	15.23247	0	0	0	0	0	13.35604	0	14.88589	14.22736	0	0	15.19592	0	9.748099	0	0	0	0	0	15.73737	0	0	0	0	0	0	0	0	0	0	16.88342	15.39886	0	16.82044	0	15.96527	0	0	0	0	0	0	0
Q9UHC6	CNTP2_HUMAN	Contactin-associated protein-like 2 (Cell recognition molecule Caspr2)	CNTNAP2 CASPR2 KIAA0868	Homo sapiens (Human)	adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; positive regulation of gap junction assembly [GO:1903598]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]	axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]	axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; positive regulation of gap junction assembly [GO:1903598]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]	enzyme binding [GO:0019899]	GO:0005769; GO:0005794; GO:0007155; GO:0007420; GO:0007612; GO:0008038; GO:0008076; GO:0008283; GO:0009986; GO:0016020; GO:0016021; GO:0019226; GO:0019899; GO:0021756; GO:0021761; GO:0021794; GO:0021987; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0035176; GO:0042297; GO:0043025; GO:0043204; GO:0044224; GO:0045163; GO:0048812; GO:0071109; GO:0071205; GO:0071625; GO:1903598	CVPNHCEHGGK	5.110000134	1	1	0.428137396	1295.033777	0	0	0	0	0	15.10133	0	15.0828	0	0	0	0	0	0	0	0	0	0	16.58261	0	0	0	0	0	0	0	0	14.56025	15.80778	0	15.77425	0	17.62868	16.89591	16.10401	0	0	16.99977	18.07886	17.21095	0	17.08669	14.44745	16.59555	14.7168	17.17143	0	0
Q9UHD2	TBK1_HUMAN	"Serine/threonine-protein kinase TBK1, EC 2.7.11.1 (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)"	TBK1 NAK	Homo sapiens (Human)	activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0002218; GO:0003676; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0033138; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0106310; GO:1901214; GO:1902554; GO:1904417	HTMTPIYPSSNTLVEMTLGMKK	1.340000033	0.084004477	0.084004477	0.035433693	2511.929752	14.56577	0	13.82101	0	13.72668	0	0	0	10.9709	0	0	0	0	0	13.05206	0	0	8.713421	14.80138	13.55746	0	15.77578	0	13.02287	0	0	0	0	0	0	0	12.55659	0	0	0	0	11.71149	0	0	12.65167	0	0	0	15.09848	14.40636	0	0	0
Q9UHD8	SEPT9_HUMAN	"Septin-9 (MLL septin-like fusion protein MSF-A, MLL septin-like fusion protein) (Ovarian/Breast septin, Ov/Br septin) (Septin D1)"	SEPTIN9 KIAA0991 MSF SEPT9	Homo sapiens (Human)	cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]	actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cellular protein localization [GO:0034613]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]	cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]	GO:0001725; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005930; GO:0005940; GO:0015629; GO:0015630; GO:0031105; GO:0032153; GO:0034613; GO:0045296; GO:0048471; GO:0060090; GO:0061640; GO:0097730; GO:1902857	TSSGRLR	7.630000114	1	1	0.105902912	775.9351974	0	0	0	0	15.24828	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.93353	0	16.05951	0	0	17.09468	15.44507	0	0	0	0	0	16.60197	0	0	0	0	0	0	0	0	0	17.9065	0	0	0	0	0
Q9UHE8	STEA1_HUMAN	"Metalloreductase STEAP1, EC 1.16.1.- (Six-transmembrane epithelial antigen of prostate 1)"	STEAP1 PRSS24 STEAP	Homo sapiens (Human)	ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	cell-cell junction [GO:0005911]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cell-cell junction [GO:0005911]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; channel activity [GO:0015267]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transporter activity [GO:0005215]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]	channel activity [GO:0015267]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transporter activity [GO:0005215]	GO:0005215; GO:0005768; GO:0005886; GO:0005887; GO:0005911; GO:0006811; GO:0010008; GO:0015267; GO:0016020; GO:0016491; GO:0046872; GO:0055072	IPILVINK	9.630000114	0.366091937	0.366091937	0.188214651	909.8176029	0	15.57281	15.7889	0	0	0	0	0	0	0	0	15.27855	0	14.0063	17.10433	0	14.90954	16.69245	0	0	0	0	0	0	0	0	0	0	15.63266	0	0	17.57026	17.41411	16.32775	0	0	0	0	0	15.44251	0	0	0	0	0	0	0	0
Q9UHF1	EGFL7_HUMAN	"Epidermal growth factor-like protein 7, EGF-like protein 7 (Multiple epidermal growth factor-like domains protein 7, Multiple EGF-like domains protein 7) (NOTCH4-like protein) (Vascular endothelial statin, VE-statin) (Zneu1)"	EGFL7 MEGF7 UNQ187/PRO1449	Homo sapiens (Human)	anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]	calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]	GO:0001525; GO:0001568; GO:0001570; GO:0001938; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0009986; GO:0045746; GO:0048856; GO:0062023	GGPPR	2.480000019	1	1	0.238360418	484.30083	0	0	17.06537	17.03712	17.76148	0	17.54808	17.32333	0	0	0	0	0	16.21158	0	0	0	0	0	0	0	0	0	16.74813	0	16.25211	0	0	15.73982	0	0	0	17.63939	18.45249	16.95814	16.95655	0	0	0	17.76578	0	0	17.17487	0	18.37525	16.6665	17.17013	15.8128
Q9UHF3	NAT8B_HUMAN	"Putative N-acetyltransferase 8B, EC 2.3.1.- (Acetyltransferase 1, ATase1) (Camello-like protein 2)"	NAT8B CML2	Homo sapiens (Human)	amyloid fibril formation [GO:1990000]; amyloid-beta metabolic process [GO:0050435]; gastrulation with mouth forming second [GO:0001702]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]	endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]	"endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]; amyloid fibril formation [GO:1990000]; amyloid-beta metabolic process [GO:0050435]; gastrulation with mouth forming second [GO:0001702]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]"	"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]"	GO:0001702; GO:0004468; GO:0005789; GO:0005793; GO:0008080; GO:0010628; GO:0016021; GO:0018003; GO:0033116; GO:0043066; GO:0050435; GO:1990000	YVDIALR	6.900000095	1	1	0.103925709	849.7100236	16.97168	0	0	0	0	14.34157	0	0	16.51917	0	0	17.53027	14.51309	0	0	0	15.36276	18.00589	0	0	12.82944	0	0	0	13.48687	0	16.84587	14.83056	0	0	0	0	0	0	16.41555	0	0	16.40297	0	0	0	0	0	0	0	0	14.19518	0
Q9UHF7	TRPS1_HUMAN	Zinc finger transcription factor Trps1 (Tricho-rhino-phalangeal syndrome type I protein) (Zinc finger protein GC79)	TRPS1	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of chondrocyte differentiation [GO:0032330]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of chondrocyte differentiation [GO:0032330]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000785; GO:0000977; GO:0001227; GO:0001501; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0019904; GO:0032330; GO:0032991	SHSAQQPVLVSQTLDIHK	3.400000095	0.516007423	0.516007423	0.059216793	1987.265461	0	0	0	17.68509	12.98058	0	16.22322	14.79282	16.27296	19.06722	17.22526	16.47722	0	0	15.88793	10.06796	16.22021	13.03829	14.89767	0	0	18.29169	18.99592	0	0	0	17.17463	0	15.92398	17.02846	17.43855	17.3152	14.35329	0	16.08157	14.20289	0	15.32941	18.15522	0	9.216983	14.12807	0	0	15.03188	16.07019	15.90792	11.05721
Q9UHG3	PCYOX_HUMAN	"Prenylcysteine oxidase 1, EC 1.8.3.5 (Prenylcysteine lyase)"	PCYOX1 KIAA0908 PCL1 UNQ597/PRO1183	Homo sapiens (Human)	chloride transmembrane transport [GO:1902476]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]	extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; prenylcysteine oxidase activity [GO:0001735]; chloride transmembrane transport [GO:1902476]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]	prenylcysteine oxidase activity [GO:0001735]	GO:0001735; GO:0005764; GO:0005886; GO:0030327; GO:0030328; GO:0034361; GO:0070062; GO:1902476	YTGNPTK	6.449999809	1	1	0.268701772	781.054169	15.58087	0	0	0	0	15.5844	15.35815	0	16.23135	0	14.93802	0	0	0	0	0	0	0	17.20962	0	0	0	16.15093	0	0	0	0	0	0	0	0	16.60315	0	0	16.82108	0	0	0	17.99809	16.83048	0	0	0	0	0	0	0	0
Q9UHI7	S23A1_HUMAN	"Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1, hSVCT1) (Yolk sac permease-like molecule 3)"	SLC23A1 SVCT1 YSPL3	Homo sapiens (Human)	brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]; transepithelial L-ascorbic acid transport [GO:0070904]	dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837; GO:0070904	RVVQYGAAIMLVLGTIGK	3.319999933	0.421392739	0.421392739	0.164062954	1905.559088	15.58518	17.22893	12.64639	17.77681	0	15.74224	0	17.77432	15.00731	13.41651	15.21815	15.98719	15.25583	14.86328	12.57951	17.19013	16.68171	13.99027	17.61512	0	0	0	15.91231	16.73888	17.39884	0	13.29366	0	14.72824	15.33648	16.34213	0	16.2315	13.49745	14.34334	15.77396	15.60899	0	17.52948	15.82353	15.42007	0	0	9.188748	16.16082	0	15.44854	14.08785
Q9UHJ3	SMBT1_HUMAN	"Scm-like with four MBT domains protein 1, hSFMBT (Renal ubiquitous protein 1)"	SFMBT1 RU1	Homo sapiens (Human)	"cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]	GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635	QTLIGACSPPVPLLEGLRNGR	3.869999886	0.008601096	0.008601096	0.12419547	2247.981301	15.3368	15.06086	15.35657	14.27332	0	12.83067	14.66521	14.44619	10.5623	15.13326	16.57916	16.36837	14.10097	0	15.08203	0	0	14.14005	14.90628	15.53067	13.14452	15.68382	13.40171	14.23319	15.9175	0	16.27246	13.58392	16.55193	14.20298	0	13.53482	16.59613	16.20763	0	14.82089	14.67447	12.01124	0	13.68492	0	15.95915	12.04381	14.80066	15.34063	0	0	15.57278
Q9UHL0	DDX25_HUMAN	"ATP-dependent RNA helicase DDX25, EC 3.6.4.13 (DEAD box protein 25) (Gonadotropin-regulated testicular RNA helicase)"	DDX25 GRTH	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006406; GO:0006417; GO:0007286; GO:0010494; GO:0016887; GO:0016973; GO:0033391	QVTIVVNFDLPVK	4.269999981	0.978647232	0.978647232	0.049546627	1471.528708	17.62369	0	0	14.81444	17.35451	16.9801	16.36717	14.37201	0	0	0	0	0	0	15.85426	0	16.23904	0	13.7366	17.74342	16.88974	0	10.64298	14.34109	0	0	0	15.99969	4.804131	13.73575	15.9929	0	17.82184	0	16.67696	13.31798	0	0	16.12758	0	0	0	0	0	15.78189	0	0	14.69374
Q9UHL4	DPP2_HUMAN	"Dipeptidyl peptidase 2, EC 3.4.14.2 (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II, DPP II) (Quiescent cell proline dipeptidase)"	DPP7 DPP2 QPP	Homo sapiens (Human)	lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005576; GO:0005794; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0043231; GO:0070062; GO:1905146	CTQGVREAFR	10.21000004	1	1	0.049611427	1224.316033	9.446607	9.359151	12.82536	12.16312	12.88075	11.58878	13.07702	10.72485	0	14.95174	13.17909	10.64276	16.35632	14.32438	13.49205	14.52626	0	12.51772	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95893	0	0	0	0	0	0	0	0	14.90171	0	14.62161	0	0	15.29222	0	0
Q9UHM6	OPN4_HUMAN	Melanopsin (Opsin-4)	OPN4 MOP	Homo sapiens (Human)	cellular response to light stimulus [GO:0071482]; detection of temperature stimulus involved in thermoception [GO:0050960]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; thermotaxis [GO:0043052]; visual perception [GO:0007601]	axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]	axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; detection of temperature stimulus involved in thermoception [GO:0050960]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; protein-chromophore linkage [GO:0018298]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; thermotaxis [GO:0043052]; visual perception [GO:0007601]	11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]	GO:0005502; GO:0005886; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016021; GO:0018298; GO:0030424; GO:0030425; GO:0042752; GO:0043052; GO:0043204; GO:0048511; GO:0050960; GO:0071482; GO:0097381; GO:1990384; GO:1990913	ALQTFGACK	8.680000305	1	1	0.234030565	995.6883253	17.33678	15.23599	14.69928	12.7857	16.63304	14.22651	17.99811	20.13375	17.49311	16.2497	12.84766	11.23279	0	12.88518	0	16.38276	0	0	0	16.51833	16.98031	0	14.99276	19.50511	0	16.70782	16.47697	17.21336	17.68213	0	16.88214	16.59961	18.9858	0	18.12222	0	0	0	0	0	15.65432	0	14.28998	16.43736	17.59782	18.74103	0	15.88469
Q9UHP6	RSP14_HUMAN	Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1)	RSPH14 RTDR1	Homo sapiens (Human)						DSNSMVR	2.869999886	1	1	0.244714933	823.6315425	0	0	18.73314	0	0	0	0	17.94858	0	0	17.17193	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UHQ1	NARF_HUMAN	"Nuclear prelamin A recognition factor (Iron-only hydrogenase-like protein 2, IOP2)"	NARF	Homo sapiens (Human)		lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; lamin binding [GO:0005521]	lamin binding [GO:0005521]	GO:0005521; GO:0005638; GO:0005652; GO:0005654; GO:0005730; GO:0031981	GADCVLTSGEIAQIMEQGDLSVR	6.920000076	1	1	0.238462585	2448.329757	13.97184	0	14.32874	0	0	14.21975	0	15.89107	14.62689	0	0	14.36924	17.39417	0	0	15.83931	0	16.70423	18.06276	18.89777	0	15.63056	17.65884	16.96302	14.72301	0	0	16.24346	0	0	15.65188	14.66562	14.79283	14.03595	15.22029	0	0	16.58438	0	15.80727	14.89822	16.03962	14.74079	0	15.70056	0	0	13.34391
Q9UHQ7	TCAL9_HUMAN	"Transcription elongation factor A protein-like 9, TCEA-like protein 9 (Transcription elongation factor S-II protein-like 9) (WW domain-binding protein 5, WBP-5)"	TCEAL9 WBP5	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; WW domain binding [GO:0050699]	WW domain binding [GO:0050699]	GO:0005634; GO:0050699	LIQSLQEFK	13.72999954	1	1	0.258002098	1106.235073	19.85511	20.06164	18.02051	0	20.00524	19.92499	19.80005	0	19.92218	0	17.47848	0	0	19.84597	0	18.79727	21.39086	20.90671	16.44168	0	19.21045	0	0	15.87428	0	20.36475	0	18.35965	20.54827	0	21.83213	18.40773	0	0	19.54866	22.25268	21.23687	21.0838	21.61971	20.77051	0	0	16.38667	18.17681	18.29058	17.12475	0	0
Q9UHQ9	NB5R1_HUMAN	"NADH-cytochrome b5 reductase 1, b5R.1, EC 1.6.2.2 (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)"	CYB5R1 NQO3A2 UNQ3049/PRO9865	Homo sapiens (Human)	bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]	endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]	"endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]"	"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]"	GO:0004128; GO:0005739; GO:0005789; GO:0005886; GO:0015701; GO:0016020; GO:0016021; GO:0016126; GO:0031092; GO:0070062; GO:0071949	FKLWFTLDHPPK	7.420000076	1	1	0.537292807	1529.702269	0	17.80631	0	18.21586	0	0	0	0	0	17.88043	0	0	0	0	0	0	0	0	0	0	0	0	19.61935	17.86012	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.77291	0	0	0	0	0
Q9UHR4	BI2L1_HUMAN	"Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1, BAI1-associated protein 2-like protein 1 (Insulin receptor tyrosine kinase substrate)"	BAIAP2L1 IRTKS	Homo sapiens (Human)	actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; regulation of insulin receptor signaling pathway [GO:0046626]; response to bacterium [GO:0009617]	adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; proline-rich region binding [GO:0070064]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; regulation of insulin receptor signaling pathway [GO:0046626]; response to bacterium [GO:0009617]	actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; proline-rich region binding [GO:0070064]	GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0007009; GO:0009617; GO:0030838; GO:0046626; GO:0051017; GO:0051764; GO:0070062; GO:0070064; GO:0098641; GO:2000251	MPPAPSGRAYTSPLIDMFNNPATAAPNSQR	3.809999943	1	1	0.177759127	3205.545605	14.03797	14.05983	0	15.58519	14.33309	0	14.61338	14.71648	14.03672	0	8.506832	14.70494	13.27322	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UHR6	ZNHI2_HUMAN	Zinc finger HIT domain-containing protein 2 (Protein FON)	ZNHIT2 C11orf5	Homo sapiens (Human)			metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0046872	GAMHEVAR	4.199999809	1	1	0.180727847	886.2172492	13.99763	14.37762	0	13.13377	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UHV7	MED13_HUMAN	"Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component, ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component, Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250, DRIP250)"	MED13 ARC250 KIAA0593 THRAP1 TRAP240	Homo sapiens (Human)	"cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328]"	mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328]"	nuclear receptor coactivator activity [GO:0030374]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]	GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0030374; GO:0042632; GO:0042809; GO:0043433; GO:0045893; GO:0045944; GO:0046966; GO:0060261; GO:0070328	QFYPISCCLKEMSEEK	7.809999943	0.121636152	0.121636152	0.13541634	2049.375481	17.4518	0	16.19847	9.126029	9.692772	14.53723	0	0	14.71706	0	0	0	0	0	0	0	0	0	11.48264	0	0	16.42847	19.37605	15.05148	0	16.63886	0	0	0	0	17.39043	8.99017	14.66429	15.25436	0	0	0	15.60982	0	14.34734	0	14.63923	16.75759	0	15.00827	0	16.70252	0
Q9UHW9	S12A6_HUMAN	Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3)	SLC12A6 KCC3	Homo sapiens (Human)	ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]	ammonium transmembrane transporter activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]	GO:0001525; GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0008519; GO:0015079; GO:0015379; GO:0016021; GO:0016323; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:0071476; GO:0071477; GO:0140157; GO:1902476; GO:1990573	LNEVIVNK	2.349999905	0.898612142	0.898612142	0.262967234	929.755191	17.30614	17.8905	17.86655	20.47727	20.09312	18.5407	18.43633	0	18.08238	0	0	16.07279	0	0	0	16.19717	0	16.66291	0	0	15.9484	0	0	0	0	0	19.11026	0	0	0	0	0	0	19.12996	0	19.09601	18.04049	19.54397	17.46308	18.13679	0	18.0557	0	0	0	0	0	0
Q9UHY7	ENOPH_HUMAN	"Enolase-phosphatase E1, EC 3.1.3.77 (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)"	ENOPH1 MASA MSTP145	Homo sapiens (Human)	L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]	cytosol [GO:0005829]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleus [GO:0005634]; 2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]"	"2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]"	GO:0000287; GO:0005634; GO:0005829; GO:0019284; GO:0019509; GO:0043715; GO:0043716; GO:0043874	AAFTAGR	6.039999962	7.47E-05	7.47E-05	0.288659271	692.7042602	18.60652	0	19.67343	15.72041	0	17.20459	0	0	0	0	0	16.68844	0	0	17.78958	0	17.71221	18.84362	0	0	0	0	19.752	0	0	0	0	0	0	18.14482	0	0	0	0	0	18.65472	0	0	18.1626	18.28696	0	19.23873	0	11.41317	0	0	0	0
Q9UI12	VATH_HUMAN	"V-type proton ATPase subunit H, V-ATPase subunit H (Nef-binding protein 1, NBP1) (Protein VMA13 homolog) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)"	ATP6V1H CGI-11	Homo sapiens (Human)	endocytosis [GO:0006897]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]"	"cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; endocytosis [GO:0006897]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]"	"enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000139; GO:0000221; GO:0005765; GO:0005829; GO:0005886; GO:0006897; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0030234; GO:0033176; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:1902600	RVIEQLGGK	3	1	1	0.280286624	1000.334893	0	0	0	14.57539	21.13284	19.73909	0	0	0	0	16.16692	0	0	0	0	0	0	0	0	0	16.86408	0	17.69623	0	17.61707	0	17.82113	0	0	0	0	18.57279	0	0	0	17.96645	0	0	18.29585	0	0	0	0	16.85541	0	0	0	0
Q9UI17	M2GD_HUMAN	"Dimethylglycine dehydrogenase, mitochondrial, EC 1.5.8.4 (ME2GLYDH)"	DMGDH	Homo sapiens (Human)	amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]	dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]	GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865	GLLLRSCPLQGSPGRPR	2.74000001	1	1	0.267280334	1863.515406	0	11.21328	14.49696	13.82059	12.34058	15.39316	14.80235	14.9835	13.05963	0	0	0	14.1222	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.08412	0	0
Q9UI30	TR112_HUMAN	Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog)	TRMT112 AD-001 HSPC152 HSPC170	Homo sapiens (Human)	histone lysine methylation [GO:0034968]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; histone lysine methylation [GO:0034968]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488]	protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]	GO:0005654; GO:0005829; GO:0008276; GO:0018364; GO:0030488; GO:0031167; GO:0032991; GO:0034968; GO:0046982; GO:0048471; GO:0070476; GO:2000234	GVGSRGFPLR	5.309999943	0.175178379	0.175178379	0.247794166	1045.732281	0	17.76738	12.96679	0	0	0	0	0	15.5109	0	0	0	0	15.44386	0	0	0	16.60828	0	0	0	16.77846	0	0	0	0	0	0	0	0	0	18.94695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.90124	0
Q9UI32	GLSL_HUMAN	"Glutaminase liver isoform, mitochondrial, GLS, EC 3.5.1.2 (L-glutaminase) (L-glutamine amidohydrolase)"	GLS2 GA	Homo sapiens (Human)	cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]	glutaminase activity [GO:0004359]	GO:0004359; GO:0005739; GO:0005759; GO:0006520; GO:0006537; GO:0006543; GO:0042981; GO:0072593	AEKFDFVLQYLNK	24.44000053	0.164127469	0.164127469	0.447206058	1614.207493	0	16.27761	0	0	0	0	19.40616	0	0	18.81307	18.21858	0	17.77043	0	0	0	19.95437	0	0	0	17.86095	0	18.94032	0	0	0	0	18.3653	17.08895	0	19.15135	0	18.49601	20.32463	0	19.78615	0	0	19.24129	0	0	17.85993	17.10854	17.6851	18.58368	18.67362	0	0
Q9UI33	SCNBA_HUMAN	"Sodium channel protein type 11 subunit alpha (Peripheral nerve sodium channel 5, PN5) (Sensory neuron sodium channel 2) (Sodium channel protein type XI subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.9) (hNaN)"	SCN11A SCN12A SNS2	Homo sapiens (Human)	membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of sensory perception of pain [GO:0051930]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; C-fiber [GO:0044299]; extracellular exosome [GO:0070062]; voltage-gated sodium channel complex [GO:0001518]	axon [GO:0030424]; C-fiber [GO:0044299]; extracellular exosome [GO:0070062]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of sensory perception of pain [GO:0051930]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0006814; GO:0009410; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0044299; GO:0051930; GO:0070062; GO:0086010	GAAIIQKAFR	8.590000153	1	1	0.189000746	1078.283667	15.64454	0	0	12.32952	0	0	15.70017	0	0	0	0	14.8898	0	14.85092	0	12.79681	0	0	0	0	0	0	0	0	0	15.81816	0	0	17.31376	0	0	0	0	0	0	0	0	0	0	15.60495	0	0	0	0	0	0	0	0
Q9UI42	CBPA4_HUMAN	"Carboxypeptidase A4, EC 3.4.17.- (Carboxypeptidase A3)"	CPA4 CPA3 UNQ694/PRO1339	Homo sapiens (Human)	histone acetylation [GO:0016573]; proteolysis [GO:0006508]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; histone acetylation [GO:0016573]; proteolysis [GO:0006508]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0016573	EWISQATAIWTARK	2.769999981	1	1	0.040938476	1660.843381	0	0	16.80632	0	0	0	0	0	17.91225	0	16.81729	19.14511	18.92604	17.12767	17.75467	0	0	0	0	0	0	0	18.17284	15.70244	0	17.72775	0	0	0	0	0	0	0	17.70234	0	17.50077	0	0	17.98563	0	17.14109	17.88293	0	0	0	0	18.8425	0
Q9UI46	DNAI1_HUMAN	Dynein axonemal intermediate chain 1 (Axonemal dynein intermediate chain 1)	DNAI1	Homo sapiens (Human)	cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]	9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; cytoskeletal motor activity [GO:0003774]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]	cytoskeletal motor activity [GO:0003774]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]	GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005813; GO:0005856; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0097729; GO:0120293	DELVAGSQESVK	13.10000038	1	1	0.255322875	1262.720231	14.40216	0	0	14.90408	14.79463	0	0	0	0	15.4573	0	14.79363	12.64089	0	0	0	0	16.93712	0	0	0	0	0	0	0	16.74913	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UI47	CTNA3_HUMAN	Catenin alpha-3 (Alpha T-catenin) (Cadherin-associated protein)	CTNNA3	Homo sapiens (Human)	actin filament organization [GO:0007015]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]	adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; lamellipodium [GO:0030027]	adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; lamellipodium [GO:0030027]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; actin filament organization [GO:0007015]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]	actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]	GO:0005829; GO:0005856; GO:0005912; GO:0005916; GO:0007015; GO:0008013; GO:0016477; GO:0030027; GO:0045296; GO:0051015; GO:0086073; GO:0086091; GO:0090136; GO:0098609; GO:0098911	NTMEMYK	13.73999977	0.487602025	0.487602025	0.197973835	933.7306806	0	0	0	0	0	15.10378	0	0	14.24201	0	0	0	0	0	0	0	0	0	0	0	0	15.60924	0	16.05333	0	0	0	13.93019	0	0	15.73492	0	0	0	0	0	0	0	17.05202	0	0	0	0	0	0	0	0	0
Q9UIA9	XPO7_HUMAN	"Exportin-7, Exp7 (Ran-binding protein 16)"	XPO7 KIAA0745 RANBP16	Homo sapiens (Human)	protein export from nucleus [GO:0006611]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611]	nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]	GO:0005049; GO:0005634; GO:0005643; GO:0005737; GO:0006611; GO:0031267	TSFMMLFEWIYPSYMPILQR	2.24000001	1	1	0.331462829	2601.423974	14.0714	0	18.36036	0	0	0	0	0	0	0	0	0	0	0	0	18.10822	0	18.27596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UIB8	SLAF5_HUMAN	SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84)	CD84 SLAMF5	Homo sapiens (Human)	adaptive immune response [GO:0002250]; autophagy [GO:0006914]; defense response [GO:0006952]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innate immune response [GO:0045087]; negative regulation of granulocyte macrophage colony-stimulating factor production [GO:0032685]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of macrophage activation [GO:0043030]; regulation of store-operated calcium entry [GO:2001256]; T cell activation [GO:0042110]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; adaptive immune response [GO:0002250]; autophagy [GO:0006914]; defense response [GO:0006952]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innate immune response [GO:0045087]; negative regulation of granulocyte macrophage colony-stimulating factor production [GO:0032685]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of macrophage activation [GO:0043030]; regulation of store-operated calcium entry [GO:2001256]; T cell activation [GO:0042110]	identical protein binding [GO:0042802]	GO:0002250; GO:0005886; GO:0005887; GO:0006914; GO:0006952; GO:0007156; GO:0009897; GO:0032685; GO:0032701; GO:0032715; GO:0032760; GO:0033004; GO:0042110; GO:0042802; GO:0043030; GO:0043231; GO:0043305; GO:0045087; GO:0071639; GO:2001256	YNLQIYR	3.779999971	1	1	0.031292206	971.2983749	0	0	14.58662	11.06332	0	13.16426	0	0	0	13.8004	0	14.28752	0	0	0	14.31287	0	12.51001	0	0	0	0	0	0	15.74436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UIF3	TEKT2_HUMAN	"Tektin-2 (Tektin-t) (Testicular tektin) (Testicular tektin B1-like protein, TEKTB1, Tektin-B1)"	TEKT2	Homo sapiens (Human)	cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]		GO:0005634; GO:0005737; GO:0005815; GO:0005874; GO:0015630; GO:0030317; GO:0031514; GO:0036159; GO:0060271; GO:0060294	VATEFAFR	6.849999905	0.732038677	0.732038677	0.117809651	941.3657342	0	16.73526	16.47447	17.89676	0	14.04694	15.73396	0	16.06369	16.77367	17.43318	13.81032	13.71504	13.68572	16.17175	0	12.00107	17.25269	0	10.11147	14.21764	15.07669	16.53116	14.77714	20.13232	18.5931	17.94861	14.77256	16.06791	16.08133	18.27264	18.31999	0	16.28922	15.7109	0	16.44674	13.55173	16.34256	9.759974	15.67889	17.40185	11.33469	0	14.03361	16.09268	16.26875	0
Q9UIF7	MUTYH_HUMAN	"Adenine DNA glycosylase, EC 3.2.2.31 (MutY homolog, hMYH)"	MUTYH MYH	Homo sapiens (Human)	base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]"	GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539	AEDEMDLDR	8.149999619	1	1	0.306263706	1093.964571	15.36044	0	16.59883	0	0	0	14.34303	15.42917	0	0	16.36791	0	0	0	0	16.0587	16.49755	15.57736	0	14.18588	0	0	0	0	0	16.70206	0	0	0	16.15094	0	17.3527	16.37427	0	0	0	15.66136	0	0	0	16.6035	15.43212	17.4149	0	18.84966	0	0	0
Q9UIF8	BAZ2B_HUMAN	Bromodomain adjacent to zinc finger domain protein 2B (hWALp4)	BAZ2B KIAA1476	Homo sapiens (Human)	chromatin remodeling [GO:0006338]; modulation of age-related behavioral decline [GO:0090647]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; modulation of age-related behavioral decline [GO:0090647]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872; GO:0090647	LIVPSPDVLKAGNK	3.730000019	1	1	1.15E-12	1450.201053	13.86876	0	0	0	0	11.73424	0	0	13.95677	0	0	0	0	0	0	0	0	0	0	0	15.45958	18.3205	0	0	0	0	0	0	0	0	0	0	0	0	14.47725	15.5759	0	0	0	16.01943	0	0	16.79376	0	0	0	0	0
Q9UIF9	BAZ2A_HUMAN	"Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5, TTF-I-interacting protein 5, Tip5) (hWALp3)"	BAZ2A KIAA0314 TIP5	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]"	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; rDNA heterochromatin [GO:0033553]	"chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; rDNA heterochromatin [GO:0033553]; DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]"	DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]	GO:0000183; GO:0001188; GO:0003677; GO:0003723; GO:0005677; GO:0005730; GO:0005829; GO:0006306; GO:0006338; GO:0006351; GO:0006355; GO:0016575; GO:0016607; GO:0016922; GO:0033553; GO:0042393; GO:0046872; GO:0070577	ITELLNKTDNRPLK	4.570000172	0.121650994	0.121650994	0.518935098	1654.989607	0	0	0	20.36927	0	0	19.5931	0	0	19.95505	0	19.46121	18.46165	0	19.84546	0	18.05586	0	16.89819	18.28627	0	0	20.07885	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.7249	17.66628	19.04213	0	0	19.19751	0	0	0	19.33497
Q9UIG0	BAZ1B_HUMAN	"Tyrosine-protein kinase BAZ1B, EC 2.7.10.2 (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2)"	BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF	Homo sapiens (Human)	cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; histone H2A phosphorylation [GO:1990164]; histone phosphorylation [GO:0016572]; negative regulation of mitotic chromosome condensation [GO:1905213]; nucleosome positioning [GO:0016584]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]	B-WICH complex [GO:0110016]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; WICH complex [GO:0090535]	B-WICH complex [GO:0110016]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; WICH complex [GO:0090535]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; histone H2A phosphorylation [GO:1990164]; histone phosphorylation [GO:0016572]; negative regulation of mitotic chromosome condensation [GO:1905213]; nucleosome positioning [GO:0016584]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]	ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]	GO:0000793; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005654; GO:0005721; GO:0005730; GO:0006338; GO:0006357; GO:0006974; GO:0008270; GO:0016572; GO:0016584; GO:0035066; GO:0035173; GO:0042393; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0110016; GO:1905213; GO:1990164; GO:2001020	KPNLGLK	5.320000172	0.303094774	0.303094774	0.221925991	770.2618468	0	0	14.62666	14.67233	13.66676	15.39074	13.89127	14.31985	14.23763	0	15.16144	0	14.42269	0	13.71536	0	15.88707	16.16025	0	15.10643	15.62235	15.22796	14.57897	16.7623	0	0	0	17.17114	14.74391	0	0	0	0	0	0	16.56493	0	0	16.83193	14.82381	15.32861	13.43732	0	15.13482	15.88517	15.92569	15.43771	0
Q9UIG5	PS1C1_HUMAN	Psoriasis susceptibility 1 candidate gene 1 protein (Protein SEEK1)	PSORS1C1 C6orf16 SEEK1	Homo sapiens (Human)						MTCTDQK	2.720000029	0.335555673	0.335555673	0.23182599	900.3169795	0	0	0	12.82332	0	14.28335	15.98365	0	15.03792	16.05884	12.64089	15.92615	11.42414	0	14.29559	15.28682	16.04589	13.67528	13.29943	15.54792	17.13753	0	0	0	15.01997	16.32772	0	15.14211	16.16979	0	15.64162	16.99016	16.60565	0	17.1446	15.51033	15.33927	16.38513	16.38857	0	15.96018	9.086922	0	14.95312	12.87383	15.69019	16.65651	0
Q9UII2	ATIF1_HUMAN	"ATPase inhibitor, mitochondrial (ATP synthase F1 subunit epsilon) (Inhibitor of F(1)F(o)-ATPase, IF(1), IF1)"	ATP5IF1 ATPI ATPIF1	Homo sapiens (Human)	angiogenesis [GO:0001525]; erythrocyte differentiation [GO:0030218]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; mitochondrial depolarization [GO:0051882]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of hydrolase activity [GO:0051346]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; reactive oxygen species metabolic process [GO:0072593]; regulation of ATP metabolic process [GO:1903578]; regulation of protein targeting to mitochondrion [GO:1903214]	cell surface [GO:0009986]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	cell surface [GO:0009986]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; angiostatin binding [GO:0043532]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; mitochondrial proton-transporting ATP synthase complex binding [GO:0140260]; protein homodimerization activity [GO:0042803]; angiogenesis [GO:0001525]; erythrocyte differentiation [GO:0030218]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; mitochondrial depolarization [GO:0051882]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of hydrolase activity [GO:0051346]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; reactive oxygen species metabolic process [GO:0072593]; regulation of ATP metabolic process [GO:1903578]; regulation of protein targeting to mitochondrion [GO:1903214]	angiostatin binding [GO:0043532]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; mitochondrial proton-transporting ATP synthase complex binding [GO:0140260]; protein homodimerization activity [GO:0042803]	GO:0001525; GO:0001937; GO:0004857; GO:0005516; GO:0005739; GO:0006091; GO:0006783; GO:0009986; GO:0019899; GO:0030218; GO:0032780; GO:0032991; GO:0042030; GO:0042802; GO:0042803; GO:0043532; GO:0051117; GO:0051346; GO:0051882; GO:0072593; GO:0140260; GO:1901030; GO:1903052; GO:1903214; GO:1903578; GO:1904925	EAGGAFGKR	2.809999943	1	1	0.310778169	893.234855	0	0	0	18.97997	0	17.86403	18.5771	0	16.43832	16.78789	17.99207	17.10795	0	18.07551	0	18.04263	18.35835	0	18.01473	16.81882	0	0	0	0	0	19.33578	0	0	0	17.55768	17.65882	18.86255	0	0	0	19.35588	0	17.80717	0	19.0095	17.00448	17.60289	0	0	0	17.73299	18.70285	17.5467
Q9UII4	HERC5_HUMAN	"E3 ISG15--protein ligase HERC5, EC 2.3.2.- (Cyclin-E-binding protein 1) (HECT domain and RCC1-like domain-containing protein 5)"	HERC5 CEB1 CEBP1	Homo sapiens (Human)	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; ISG15-protein conjugation [GO:0032020]; protein ubiquitination [GO:0016567]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of defense response to virus [GO:0050688]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cyclin binding [GO:0030332]; ISG15 transferase activity [GO:0042296]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; ISG15-protein conjugation [GO:0032020]; protein ubiquitination [GO:0016567]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of defense response to virus [GO:0050688]	cyclin binding [GO:0030332]; ISG15 transferase activity [GO:0042296]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000079; GO:0003723; GO:0004842; GO:0005737; GO:0005829; GO:0016567; GO:0030332; GO:0032020; GO:0042296; GO:0045087; GO:0048471; GO:0050688; GO:0051607; GO:0061630	FESILQEK	9.390000343	1	1	0.104348069	989.653836	14.84389	0	14.21314	15.76352	0	0	0	14.19499	13.83001	0	0	15.55389	0	13.77644	0	14.18598	0	0	0	0	0	0	15.61569	0	13.1823	0	0	0	0	0	0	0	0	0	0	0	12.79074	0	0	0	0	14.4357	0	0	0	0	0	0
Q9UII5	ZN107_HUMAN	Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25)	ZNF107 ZFD25 ZNF588	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	LTAHKK	9.270000458	0.969270051	0.969270051	0.168517503	696.5443745	16.42463	13.3018	16.17145	16.38054	15.4183	16.22738	0	15.02206	16.30968	15.60043	16.72847	13.55791	16.66373	15.68566	14.85092	15.99515	15.44797	16.33324	16.92815	0	14.89347	0	0	0	17.05823	0	16.56502	0	16.25466	16.995	0	0	0	16.89219	16.4052	0	0	17.39114	0	16.4426	15.90898	0	0	16.2988	0	0	0	0
Q9UIJ7	KAD3_HUMAN	"GTP:AMP phosphotransferase AK3, mitochondrial, EC 2.7.4.10 (Adenylate kinase 3, AK 3) (Adenylate kinase 3 alpha-like 1)"	AK3 AK3L1 AK6 AKL3L	Homo sapiens (Human)	ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051]	ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]	GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899	LIPDDVMTR	4.489999771	1	1	0.184620094	1062.360279	14.32327	16.51337	0	15.57015	15.51178	13.00172	14.71025	17.02784	15.79014	0	14.46854	14.28612	15.09835	14.15719	16.10342	14.71736	11.35842	0	14.35281	0	0	0	0	0	16.16436	0	0	0	0	0	0	0	0	14.66384	0	14.73278	0	0	15.11073	16.32878	15.68812	0	0	15.50406	0	15.44185	0	0
Q9UIL4	KIF25_HUMAN	Kinesin-like protein KIF25 (Kinesin-like protein 3)	KIF25 KNSL3	Homo sapiens (Human)	establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of autophagy [GO:0010507]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; organelle organization [GO:0006996]; protein homotetramerization [GO:0051289]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of autophagy [GO:0010507]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; organelle organization [GO:0006996]; protein homotetramerization [GO:0051289]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]	GO:0000070; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0006996; GO:0007018; GO:0008017; GO:0008569; GO:0010507; GO:0016887; GO:0046603; GO:0051289; GO:0051294; GO:0051647	ARQVQR	2.99000001	1	1	0.140926726	756.8802217	0	0	16.18827	0	16.36752	15.7449	14.37416	0	0	13.84348	0	0	0	0	0	11.26943	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.5769	16.45222	20.14758	0	0	17.31297	0	0	0	0	0	0	0	16.31048	0	0
Q9UIL8	PHF11_HUMAN	PHD finger protein 11 (BRCA1 C-terminus-associated protein) (Renal carcinoma antigen NY-REN-34)	PHF11 BCAP	Homo sapiens (Human)		nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]	metal ion binding [GO:0046872]	GO:0005634; GO:0005654; GO:0031965; GO:0046872	LLCQQHAQFPIIAQSAK	4.5	1	1	1.60E-12	1951.951775	0	0	13.36781	0	0	14.03084	14.22514	0	0	0	0	11.84997	17.31369	0	0	13.61704	0	0	0	0	16.01536	0	14.42426	14.04601	0	0	14.50024	0	0	0	0	0	0	16.8975	14.85786	0	13.22985	0	0	14.74942	0	12.76612	0	0	0	0	0	15.88218
Q9UIQ6	LCAP_HUMAN	"Leucyl-cystinyl aminopeptidase, Cystinyl aminopeptidase, EC 3.4.11.3 (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase, IRAP) (Oxytocinase, OTase) (Placental leucine aminopeptidase, P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form ]"	LNPEP OTASE	Homo sapiens (Human)	"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]"	cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]"	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0002480; GO:0004177; GO:0005576; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006508; GO:0007165; GO:0007267; GO:0007565; GO:0008217; GO:0008237; GO:0008270; GO:0016020; GO:0030163; GO:0030659; GO:0031905; GO:0042277; GO:0043171; GO:0048471; GO:0060395; GO:0070006; GO:0120163	YQSVSLLDK	1.860000014	1	1	0.153201137	1053.553248	0	10.47053	12.38531	14.72265	17.52338	15.54248	15.63458	0	0	17.01611	16.04914	14.53093	0	0	12.69425	0	0	0	0	0	0	15.61582	0	0	0	0	0	0	0	15.56082	0	0	0	0	0	0	0	16.65881	15.99251	0	0	0	0	14.80528	0	16.15396	0	0
Q9UIS9	MBD1_HUMAN	Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1)	MBD1 CXXC3 PCM1	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]; transcription by RNA polymerase II [GO:0006366]"	chromosome [GO:0005694]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromosome [GO:0005694]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription by RNA polymerase II [GO:0006366]"	DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006366; GO:0008270; GO:0008327; GO:0010385; GO:0016363; GO:0016607; GO:0045322; GO:0045892	DLKKPGAR	13.02999973	1	1	0.567373551	883.018078	0	0	0	0	0	16.87712	0	0	0	0	0	0	0	0	0	0	0	0	17.13616	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.26981	0	0	0	0
Q9UIV8	SPB13_HUMAN	"Serpin B13 (HaCaT UV-repressible serpin, Hurpin) (Headpin) (Peptidase inhibitor 13, PI-13) (Proteinase inhibitor 13)"	SERPINB13 PI13	Homo sapiens (Human)	negative regulation of endopeptidase activity [GO:0010951]; negative regulation of keratinocyte apoptotic process [GO:1902173]; regulation of proteolysis [GO:0030162]; response to UV [GO:0009411]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of keratinocyte apoptotic process [GO:1902173]; regulation of proteolysis [GO:0030162]; response to UV [GO:0009411]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]	GO:0002020; GO:0004867; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0009411; GO:0010951; GO:0016607; GO:0030162; GO:0043202; GO:0070062; GO:1902173	YYHASLEPVDFVNAADESRK	7.480000019	1	1	2.75E-12	2311.100354	14.54078	14.67033	14.31453	0	0	9.724477	0	0	0	0	0	0	17.71164	0	0	0	0	0	0	0	16.17358	0	17.62011	13.59723	7.064343	0	16.10019	0	0	0	14.68326	0	12.32867	16.18089	0	0	0	16.40814	0	0	0	0	0	0	11.14879	0	14.28813	0
Q9UIW0	VAX2_HUMAN	Ventral anterior homeobox 2	VAX2	Homo sapiens (Human)	axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic eye morphogenesis [GO:0048048]; forebrain development [GO:0030900]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic eye morphogenesis [GO:0048048]; forebrain development [GO:0030900]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]"	"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001162; GO:0001227; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007398; GO:0007409; GO:0007417; GO:0007601; GO:0009950; GO:0016055; GO:0030182; GO:0030900; GO:0031490; GO:0048048; GO:0060041; GO:1990837	MGDGGAER	5.630000114	1	1	0.266653685	808.1925994	15.35484	15.52076	16.07071	15.81264	15.67008	15.83384	15.04728	16.00706	14.98369	0	15.96399	15.98192	17.29746	16.02864	15.90562	0	15.06454	15.74524	0	15.81491	13.47866	0	0	15.93117	16.42658	12.90529	15.63443	15.80138	16.25636	16.06401	16.55848	15.94914	16.63452	16.41016	14.39105	17.05154	0	16.55029	16.89561	0	16.40891	0	15.1274	16.6557	0	0	15.05818	0
Q9UIW2	PLXA1_HUMAN	Plexin-A1 (Semaphorin receptor NOV)	PLXNA1 NOV PLXN1	Homo sapiens (Human)	dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	semaphorin receptor activity [GO:0017154]	GO:0002116; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0014910; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:0060666; GO:0070062; GO:1902287; GO:1990138	LSPETGPR	6.53000021	1	1	5.71E-13	857.4451762	14.02896	0	15.12558	16.07814	16.30007	0	0	15.09894	13.20086	0	15.3392	0	0	0	13.20694	0	0	0	15.05054	0	0	0	0	0	15.72205	0	14.1049	11.96858	15.34766	0	15.25362	14.5724	9.120336	0	14.40287	13.71443	0	10.5047	0	13.07985	0	12.24688	0	14.05224	0	0	0	16.22971
Q9UIY3	RWD2A_HUMAN	RWD domain-containing protein 2A	RWDD2A RWDD2	Homo sapiens (Human)						HISCKHAESVETEGNGEDLR	2.440000057	1	1	0.249835587	2268.551935	15.90061	0	0	13.10626	15.02766	14.41724	0	12.35549	13.46012	0	0	0	0	0	0	0	0	0	0	14.02958	0	0	0	0	0	16.37526	10.99605	15.2722	0	0	0	0	0	0	0	0	0	0	0	15.97396	0	0	0	17.01742	11.40629	14.15525	0	12.61695
Q9UJ14	GGT7_HUMAN	"Glutathione hydrolase 7, EC 3.4.19.13 (Gamma-glutamyltransferase 7, GGT 7, EC 2.3.2.2) (Gamma-glutamyltransferase-like 3) (Gamma-glutamyltransferase-like 5) (Gamma-glutamyltranspeptidase 7) [Cleaved into: Glutathione hydrolase 7 heavy chain; Glutathione hydrolase 7 light chain ]"	GGT7 GGTL3 GGTL5	Homo sapiens (Human)	glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883]	glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]	GO:0005886; GO:0006750; GO:0006751; GO:0016021; GO:0036374; GO:0102953; GO:0103068; GO:1901750; GO:1902883	ALAEQLPPNMSER	3.779999971	1	1	0	1454.81746	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UJ68	MSRA_HUMAN	"Mitochondrial peptide methionine sulfoxide reductase, EC 1.8.4.11 (Peptide-methionine (S)-S-oxide reductase, Peptide Met(O) reductase) (Protein-methionine-S-oxide reductase, PMSR)"	MSRA	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; cellular response to oxidative stress [GO:0034599]; methionine metabolic process [GO:0006555]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464]; cellular response to oxidative stress [GO:0034599]; methionine metabolic process [GO:0006555]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]	L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]	GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006464; GO:0006555; GO:0006979; GO:0008113; GO:0015629; GO:0030091; GO:0034599; GO:0036456; GO:0070062	TGHAEVVRVVYQPEHMSFEELLK	6.300000191	1	1	3.20E-12	2689.772348	11.96932	14.51812	0	12.80327	0	0	11.27422	12.35155	13.26917	0	0	0	0	0	12.98058	13.43532	0	10.73766	0	13.54381	0	0	0	0	0	0	0	14.5381	11.41813	13.64938	0	0	0	0	0	0	0	0	0	0	0	0	13.55231	0	0	0	0	0
Q9UJ71	CLC4K_HUMAN	C-type lectin domain family 4 member K (Langerin) (CD antigen CD207)	CD207 CLEC4K	Homo sapiens (Human)	defense response to virus [GO:0051607]	clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; defense response to virus [GO:0051607]	carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]	GO:0005537; GO:0005886; GO:0009897; GO:0016021; GO:0030139; GO:0030246; GO:0030669; GO:0031901; GO:0051607	RPYVPSEP	12.44999981	1	1	0.239182592	945.7458204	0	0	16.46585	16.59921	0	13.01335	15.4263	13.10778	16.52369	15.94209	16.99111	15.37173	13.95395	14.66965	14.77284	14.95251	13.41417	15.34293	15.95994	12.78766	16.35482	14.39455	16.41825	16.83595	0	15.02628	17.188	0	0	15.60239	0	0	0	15.87519	16.4621	15.8823	15.30498	0	0	0	0	15.54101	0	0	0	13.75995	15.55336	15.57888
Q9UJ96	KCNG2_HUMAN	Potassium voltage-gated channel subfamily G member 2 (Cardiac potassium channel subunit) (Voltage-gated potassium channel subunit Kv6.2)	KCNG2 KCNF2	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]	delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008016; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0070062; GO:0071805	SPCAFRAIVALLR	9.520000458	0.798262894	0.798262894	0.249087903	1473.02821	17.00921	16.88195	11.16575	0	17.03447	12.637	16.02536	0	15.57944	17.75055	0	13.58562	0	16.74429	0	0	0	18.36816	17.04597	16.48695	15.95187	0	0	16.91451	16.6723	18.62103	17.76755	16.82203	9.083152	0	0	0	18.7036	16.20502	0	16.96409	0	17.885	14.195	0	0	18.32666	16.23187	14.69151	0	0	15.20188	0
Q9UJ98	STAG3_HUMAN	Cohesin subunit SA-3 (SCC3 homolog 3) (Stromal antigen 3) (Stromalin-3)	STAG3	Homo sapiens (Human)	establishment of meiotic sister chromatid cohesion [GO:0034089]; sister chromatid cohesion [GO:0007062]; synaptonemal complex assembly [GO:0007130]	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; extracellular space [GO:0005615]; meiotic cohesin complex [GO:0030893]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]"	"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; extracellular space [GO:0005615]; meiotic cohesin complex [GO:0030893]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; establishment of meiotic sister chromatid cohesion [GO:0034089]; sister chromatid cohesion [GO:0007062]; synaptonemal complex assembly [GO:0007130]"	chromatin binding [GO:0003682]	GO:0000775; GO:0000785; GO:0000795; GO:0003682; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0007062; GO:0007130; GO:0008278; GO:0030893; GO:0034089	EMEEEDGSELDFAQGQPVAGTER	1.049999952	1	1	1.83E-12	2541.080035	14.13772	0	16.11185	0	0	14.51822	13.37711	15.55038	13.18145	15.03818	14.30181	0	0	0	0	0	0	0	0	0	0	0	15.54246	14.63259	0	0	16.05866	0	0	0	0	0	0	0	0	0	0	0	0	0	16.02414	0	0	0	0	0	0	0
Q9UJA3	MCM8_HUMAN	"DNA helicase MCM8, EC 3.6.4.12 (Minichromosome maintenance 8)"	MCM8 C20orf154	Homo sapiens (Human)	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]	chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]	GO:0000724; GO:0003678; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006974; GO:0007049; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0042555; GO:0048232; GO:0050821; GO:0071168; GO:0097362	CMFLLYIEANSISNSKGQK	5.360000134	1	1	0.179720662	2202.06322	14.96599	0	14.69318	0	0	0	0	14.23595	13.81932	0	15.84035	0	0	0	0	0	0	0	0	15.53229	0	0	0	16.08629	0	0	16.16286	14.54031	15.61718	0	15.59884	16.28308	0	0	0	0	17.7669	0	0	0	0	0	0	0	0	0	0	0
Q9UJC3	HOOK1_HUMAN	"Protein Hook homolog 1, h-hook1, hHK1"	HOOK1	Homo sapiens (Human)	cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031]	actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]	GO:0003779; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0007030; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0042802; GO:0042803; GO:0045022; GO:0051959; GO:0070695; GO:1905198; GO:1905719	SEGESSSKLK	3.25999999	1	1	0.212641874	1050.752301	5.77644	15.68179	13.91964	0	13.87957	12.99375	12.02102	14.02566	14.34909	14.60723	13.56393	0	14.86396	0	14.34232	0	0	0	15.77533	15.86118	0	14.70744	0	15.81771	15.42111	0	0	0	16.40965	0	0	0	0	0	0	0	0	16.06793	16.15477	0	0	0	0	0	0	0	0	0
Q9UJF2	NGAP_HUMAN	Ras GTPase-activating protein nGAP (RAS protein activator-like 2)	RASAL2 NGAP	Homo sapiens (Human)	adipose tissue development [GO:0060612]; gene expression [GO:0010467]; multicellular organism growth [GO:0035264]; regulation of GTPase activity [GO:0043087]; regulation of protein activation cascade [GO:2000257]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; adipose tissue development [GO:0060612]; gene expression [GO:0010467]; multicellular organism growth [GO:0035264]; regulation of GTPase activity [GO:0043087]; regulation of protein activation cascade [GO:2000257]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]	GO:0002021; GO:0005096; GO:0005829; GO:0007165; GO:0009749; GO:0010467; GO:0035264; GO:0043087; GO:0060612; GO:2000257	DLAPKK	6.400000095	0.837437212	0.837437212	0.189493177	669.5690146	0	19.33661	18.73635	0	18.70529	0	0	0	0	0	0	0	0	0	0	18.40149	18.99382	0	0	16.02011	0	0	0	19.31005	0	18.81141	0	0	0	0	0	0	0	0	0	0	0	0	18.82658	0	0	0	0	0	0	0	17.24079	0
Q9UJL9	ZF69B_HUMAN	Zinc finger protein 69 homolog B (Zinc finger protein 643)	ZFP69B ZNF643	Homo sapiens (Human)	Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleolus [GO:0005730]; nucleus [GO:0005634]	"nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005730; GO:0006357; GO:0007030; GO:0046872	NTFSNVV	3.140000105	0.240074143	0.240074143	0.233606239	780.7564615	13.86182	14.64548	0	16.25032	0	0	15.79068	0	15.75717	14.58772	0	15.31278	13.62691	14.72482	16.68619	14.61424	15.24822	14.15338	0	15.59075	15.14668	16.37195	16.10504	0	0	0	15.38615	0	0	0	16.03376	0	16.2991	0	17.4153	0	16.35551	15.39726	15.47178	0	0	14.64616	15.00911	15.6807	0	0	0	0
Q9UJM8	HAOX1_HUMAN	"2-Hydroxyacid oxidase 1, HAOX1, EC 1.1.3.15 (Glycolate oxidase, GO, GOX) (Glyoxylate oxidase, EC 1.2.3.5)"	HAO1 GOX1	Homo sapiens (Human)	fatty acid alpha-oxidation [GO:0001561]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969]; fatty acid alpha-oxidation [GO:0001561]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969]	GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0005829; GO:0006979; GO:0010181; GO:0046296; GO:0047969	GTDVLK	6.659999847	0.405790895	0.405790895	0.114650731	632.281268	16.67904	15.63173	18.19731	18.51095	16.5761	13.69027	15.08925	0	15.92469	16.74726	17.71738	16.21161	0	14.01541	14.64317	18.26115	17.06251	14.66809	14.40988	15.27683	15.48111	0	17.02821	15.64911	16.29835	14.99741	13.56982	15.87365	15.78192	16.20108	15.27977	15.47409	16.2503	0	16.4946	15.21946	15.0436	16.26207	16.92183	12.27983	16.60201	14.26716	16.70194	15.7841	19.49898	15.40358	14.84096	0
Q9UJQ1	LAMP5_HUMAN	"Lysosome-associated membrane glycoprotein 5 (Brain and dendritic cell-associated LAMP) (Brain-associated LAMP-like protein, BAD-LAMP) (Lysosome-associated membrane protein 5, LAMP-5)"	LAMP5 C20orf103	Homo sapiens (Human)	establishment of protein localization to organelle [GO:0072594]	cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; growth cone membrane [GO:0032584]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]	cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; growth cone membrane [GO:0032584]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; establishment of protein localization to organelle [GO:0072594]		GO:0005765; GO:0005886; GO:0010008; GO:0016021; GO:0030659; GO:0030672; GO:0031901; GO:0031902; GO:0032584; GO:0032590; GO:0033116; GO:0055038; GO:0072594	SQYKHMG	17.36000061	1	1	0.250235774	866.3056946	0	14.96616	0	16.75066	14.18901	16.40155	0	16.38365	14.79455	0	0	0	0	15.47571	0	0	15.75934	16.60342	0	14.28197	0	18.083	15.55396	0	0	0	18.06045	13.23641	0	0	17.08096	0	15.40303	0	0	0	17.62469	0	0	0	15.10553	0	0	16.00907	0	0	0	0
Q9UJT0	TBE_HUMAN	Tubulin epsilon chain (Epsilon-tubulin)	TUBE1 TUBE	Homo sapiens (Human)	centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]	GO:0000226; GO:0000242; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007098	ARAVLIDMEEGVVNEILQGPLR	10.31000042	1	1	0.104933828	2437.819675	0	0	14.8931	0	0	12.75237	13.16634	14.70653	0	0	0	0	14.90119	15.42723	0	0	0	15.28887	0	14.75154	0	15.76213	0	15.40758	16.69955	0	15.81745	14.5977	0	0	0	0	14.60041	0	0	0	0	0	0	17.78174	0	0	0	0	0	0	0	17.58561
Q9UJU2	LEF1_HUMAN	"Lymphoid enhancer-binding factor 1, LEF-1 (T cell-specific transcription factor 1-alpha, TCF1-alpha)"	LEF1	Homo sapiens (Human)	"anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell proliferation [GO:0042100]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-4 [GO:0071353]; chorio-allantoic fusion [GO:0060710]; dentate gyrus development [GO:0021542]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; face morphogenesis [GO:0060325]; forebrain neuroblast division [GO:0021873]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; histone H3 acetylation [GO:0043966]; histone H3-K56 acetylation [GO:0097043]; histone H4 acetylation [GO:0043967]; mammary gland development [GO:0030879]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; paraxial mesoderm formation [GO:0048341]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary palate development [GO:0062009]; sensory perception of taste [GO:0050909]; somitogenesis [GO:0001756]; sprouting angiogenesis [GO:0002040]; T cell receptor V(D)J recombination [GO:0033153]; T-helper 1 cell differentiation [GO:0045063]; tongue development [GO:0043586]; trachea gland development [GO:0061153]"	beta-catenin-TCF complex [GO:1990907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]	"beta-catenin-TCF complex [GO:1990907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; estrogen receptor binding [GO:0030331]; gamma-catenin binding [GO:0045295]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; transcription regulator inhibitor activity [GO:0140416]; anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell proliferation [GO:0042100]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-4 [GO:0071353]; chorio-allantoic fusion [GO:0060710]; dentate gyrus development [GO:0021542]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; face morphogenesis [GO:0060325]; forebrain neuroblast division [GO:0021873]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; histone H3 acetylation [GO:0043966]; histone H3-K56 acetylation [GO:0097043]; histone H4 acetylation [GO:0043967]; mammary gland development [GO:0030879]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; paraxial mesoderm formation [GO:0048341]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary palate development [GO:0062009]; sensory perception of taste [GO:0050909]; somitogenesis [GO:0001756]; sprouting angiogenesis [GO:0002040]; T cell receptor V(D)J recombination [GO:0033153]; T-helper 1 cell differentiation [GO:0045063]; tongue development [GO:0043586]; trachea gland development [GO:0061153]"	"armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; estrogen receptor binding [GO:0030331]; gamma-catenin binding [GO:0045295]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; transcription regulator inhibitor activity [GO:0140416]"	GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0001228; GO:0001569; GO:0001649; GO:0001756; GO:0001837; GO:0002040; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0008013; GO:0008284; GO:0008301; GO:0010628; GO:0010718; GO:0021542; GO:0021861; GO:0021873; GO:0021943; GO:0022408; GO:0022409; GO:0030177; GO:0030223; GO:0030326; GO:0030331; GO:0030335; GO:0030509; GO:0030854; GO:0030879; GO:0032696; GO:0032713; GO:0032714; GO:0032993; GO:0033153; GO:0042100; GO:0042393; GO:0042475; GO:0042826; GO:0043066; GO:0043392; GO:0043565; GO:0043586; GO:0043923; GO:0043966; GO:0043967; GO:0045063; GO:0045295; GO:0045588; GO:0045597; GO:0045843; GO:0045892; GO:0045893; GO:0045944; GO:0048341; GO:0050767; GO:0050909; GO:0060033; GO:0060070; GO:0060325; GO:0060326; GO:0060710; GO:0061153; GO:0062009; GO:0070016; GO:0070742; GO:0071345; GO:0071353; GO:0071864; GO:0071866; GO:0090068; GO:0097043; GO:0140416; GO:1902262; GO:1902732; GO:1990837; GO:1990907	DNYGK	8.109999657	1	1	0.123169415	597.446982	14.27937	10.4502	13.28453	0	11.58358	0	0	15.54442	15.60734	14.00752	0	0	0	0	16.62248	15.96426	0	15.51997	14.61793	15.44395	0	0	0	14.79673	0	0	0	0	0	0	0	0	0	16.1273	15.99132	0	0	0	0	0	0	16.22018	0	0	0	0	0	0
Q9UJU6	DBNL_HUMAN	"Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa, HIP-55) (SH3 domain-containing protein 7)"	DBNL CMAP SH3P7 PP5423	Homo sapiens (Human)	adaptive immune response [GO:0002250]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; ruffle assembly [GO:0097178]; synapse assembly [GO:0007416]	cell cortex [GO:0005938]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; site of polarized growth [GO:0030427]; tertiary granule lumen [GO:1904724]	cell cortex [GO:0005938]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; site of polarized growth [GO:0030427]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; adaptive immune response [GO:0002250]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; ruffle assembly [GO:0097178]; synapse assembly [GO:0007416]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0000139; GO:0001726; GO:0002102; GO:0002250; GO:0003779; GO:0005576; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0006898; GO:0007416; GO:0008022; GO:0008047; GO:0014069; GO:0016601; GO:0019904; GO:0030027; GO:0030425; GO:0030427; GO:0030665; GO:0030833; GO:0030864; GO:0034774; GO:0043204; GO:0043231; GO:0045211; GO:0045296; GO:0045773; GO:0048812; GO:0051015; GO:0061003; GO:0070062; GO:0071800; GO:0097178; GO:0098974; GO:1904724; GO:1904813	EEENRR	9.170000076	1	1	0.150535826	831.3578377	16.92823	14.24474	14.77518	14.78565	0	0	0	0	14.88411	0	15.51564	14.70042	15.9705	14.39807	13.62125	15.17336	12.96982	14.60209	0	13.59476	0	0	0	0	15.74397	0	0	0	16.90642	0	0	0	0	0	13.83638	15.51765	0	0	17.19445	0	0	17.1882	0	0	0	0	0	0
Q9UJV3	TRIM1_HUMAN	"Probable E3 ubiquitin-protein ligase MID2, EC 2.3.2.27 (Midin-2) (Midline defect 2) (Midline-2) (RING finger protein 60) (RING-type E3 ubiquitin transferase MID2) (Tripartite motif-containing protein 1)"	MID2 FXY2 RNF60 TRIM1	Homo sapiens (Human)	innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to microtubule [GO:0035372]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to microtubule [GO:0035372]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790]	enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	GO:0003713; GO:0005737; GO:0005874; GO:0008017; GO:0008270; GO:0010508; GO:0016567; GO:0016740; GO:0019899; GO:0032897; GO:0035372; GO:0042802; GO:0042803; GO:0043123; GO:0044790; GO:0045087; GO:0046597; GO:0051091; GO:0051092; GO:0051219; GO:0070062	ISNDGLQMEK	7.590000153	0.235700622	0.235700622	2.28E-13	1147.518669	0	16.68944	13.98419	0	0	17.02615	14.54993	0	15.5905	16.58579	14.26765	12.02481	14.29538	13.93429	0	16.64262	17.99939	0	0	0	14.77172	0	0	16.23193	14.03531	16.04566	14.53317	0	0	15.69237	0	0	16.4893	16.39337	16.47391	8.324779	13.81875	13.44298	12.04522	15.86179	14.61005	15.02562	0	12.46172	0	15.21475	15.99947	13.44127
Q9UJV9	DDX41_HUMAN	"Probable ATP-dependent RNA helicase DDX41, EC 3.6.4.13 (DEAD box protein 41) (DEAD box protein abstrakt homolog)"	DDX41 ABS	Homo sapiens (Human)	"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]"	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0006915; GO:0008283; GO:0016020; GO:0016887; GO:0030154; GO:0046872; GO:0071013	EEAKMVYLLECLQK	8.760000229	1.57E-08	1.57E-08	0.272357861	1769.970764	15.40167	0	0	11.24013	14.89383	15.48495	0	0	14.33024	15.95626	16.74834	0	0	15.47913	0	15.81496	0	17.05744	0	11.87596	17.09796	16.74537	16.29847	0	0	0	16.4674	16.486	15.89449	13.13236	16.15384	0	15.79708	15.85631	15.7184	15.05129	18.04801	13.3968	15.46998	0	0	14.76803	0	15.03681	14.56902	15.38325	13.65951	0
Q9UJW0	DCTN4_HUMAN	"Dynactin subunit 4, Dyn4 (Dynactin subunit p62)"	DCTN4	Homo sapiens (Human)		cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]	cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]	protein N-terminus binding [GO:0047485]	GO:0000776; GO:0000922; GO:0001725; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005869; GO:0005925; GO:0005938; GO:0030017; GO:0047485	ELVLAGK	4.980000019	1	1	3.46E-13	729.5762458	15.26465	0	0	0	0	0	0	0	0	0	0	0	0	0	16.84595	16.49339	0	0	0	0	0	0	0	0	0	17.04083	0	15.59445	0	0	0	0	16.96016	17.09754	15.13003	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UJW3	DNM3L_HUMAN	DNA (cytosine-5)-methyltransferase 3-like	DNMT3L	Homo sapiens (Human)	"C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; male meiosis I [GO:0007141]; negative regulation of DNA methylation [GO:1905642]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation [GO:1905643]; regulation of gene expression by genomic imprinting [GO:0006349]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]"	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	"catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; male meiosis I [GO:0007141]; negative regulation of DNA methylation [GO:1905642]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation [GO:1905643]; regulation of gene expression by genomic imprinting [GO:0006349]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]"	enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0005829; GO:0006306; GO:0006349; GO:0007141; GO:0007283; GO:0008047; GO:0019899; GO:0032776; GO:0043046; GO:0045892; GO:0046872; GO:0048863; GO:0090116; GO:1902494; GO:1905642; GO:1905643	VWSNIPAIR	6.53000021	1	1	4.63E-13	1056.264946	0	17.3221	14.75183	0	0	0	15.90897	15.11176	13.71813	0	0	14.85388	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UJW7	ZN229_HUMAN	Zinc finger protein 229	ZNF229	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872	YGSGLLSHK	7.059999943	1	1	0.168517314	963.83955	0	15.90403	0	0	14.95658	0	0	0	15.40372	0	0	15.93287	16.57203	15.93464	0	0	13.9483	14.93678	0	13.84949	0	14.03248	14.28206	16.27305	0	0	0	14.70838	14.39663	11.151	15.46896	12.96337	15.4487	0	0	0	0	0	0	0	0	0	0	0	0	14.99905	0	0
Q9UJW8	ZN180_HUMAN	Zinc finger protein 180 (HHZ168)	ZNF180	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	THTGEKPYRCNQCGK	5.630000114	0.495086253	0.495086253	0.314217297	1836.651135	0	14.4348	14.09049	0	17.4802	0	0	0	14.12948	0	0	15.3997	0	0	0	13.56947	16.07005	0	0	0	0	0	0	0	0	16.52633	0	0	0	0	0	0	0	0	0	0	0	0	0	17.27905	0	0	0	0	0	0	0	0
Q9UJX0	OSGI1_HUMAN	"Oxidative stress-induced growth inhibitor 1 (Bone marrow stromal cell-derived growth inhibitor, BMSC-derived growth inhibitor) (Ovary, kidney and liver protein 38, huOKL38) (Pregnancy-induced growth inhibitor OKL38)"	OSGIN1 BDGI OKL38	Homo sapiens (Human)	cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]		growth factor activity [GO:0008083]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]	growth factor activity [GO:0008083]	GO:0008083; GO:0030154; GO:0030308; GO:0030334; GO:0042127; GO:0042981; GO:0043065	ETRKPP	4.349999905	0.507549584	0.507549584	3.44E-13	727.2409561	0	15.44349	0	13.98406	0	0	12.93885	0	0	0	15.50895	0	0	0	0	0	0	0	14.89565	0	0	0	15.32247	0	14.35531	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.1216	12.24398	0	15.40691	0	15.86252	0	0	0
Q9UJX2	CDC23_HUMAN	"Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8, APC8) (Cyclosome subunit 8)"	CDC23 ANAPC8	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of exit from mitosis [GO:0007096]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of exit from mitosis [GO:0007096]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511]	ubiquitin-protein transferase activity [GO:0004842]	GO:0000278; GO:0004842; GO:0005654; GO:0005680; GO:0005737; GO:0005829; GO:0006511; GO:0007080; GO:0007091; GO:0007096; GO:0007346; GO:0016567; GO:0030071; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979	IENMDTFSNLLYVRSMK	3.859999895	1	1	0.114686311	2077.555539	0	0	0	0	0	0	0	0	13.9536	0	0	0	0	0	0	15.54125	14.45571	0	0	0	0	0	17.60258	0	14.38695	0	14.60906	0	0	0	0	0	0	17.06459	16.50614	0	0	0	0	0	0	0	0	0	15.88517	0	0	0
Q9UJX4	APC5_HUMAN	"Anaphase-promoting complex subunit 5, APC5 (Cyclosome subunit 5)"	ANAPC5 APC5	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	protein phosphatase binding [GO:0019903]	GO:0005634; GO:0005654; GO:0005680; GO:0005819; GO:0005829; GO:0007049; GO:0007346; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979	SDSYVLLEHSVKK	5.170000076	1	1	0.189389746	1508.303774	0	12.3049	16.40583	11.34122	0	14.66531	0	0	13.99972	6.828477	0	0	16.38535	0	0	0	0	0	0	14.13957	0	0	16.21557	0	16.31111	12.89114	0	0	16.2768	15.21727	0	16.34686	0	0	13.77069	0	0	0	0	0	0	0	0	0	12.92782	0	0	0
Q9UJX5	APC4_HUMAN	"Anaphase-promoting complex subunit 4, APC4 (Cyclosome subunit 4)"	ANAPC4 APC4	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0007346; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0051445; GO:0070979	NTTTSVQDEFMHLLLWGK	6.389999866	1	1	2.30E-12	2116.525198	13.87954	12.2747	16.13731	0	14.07547	0	14.98967	0	0	14.02102	0	15.10081	15.01017	15.69325	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UJX6	ANC2_HUMAN	"Anaphase-promoting complex subunit 2, APC2 (Cyclosome subunit 2)"	ANAPC2 APC2 KIAA1406	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of gene expression [GO:0010629]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of gene expression [GO:0010629]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]	ubiquitin protein ligase binding [GO:0031625]	GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0007346; GO:0010629; GO:0031145; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0051445; GO:0070979; GO:0090129	SLLADR	9.720000267	1	1	0.100286572	673.3940374	0	0	0	0	15.0846	13.62692	0	0	15.63351	12.55366	0	14.70202	0	0	0	16.71726	0	0	0	0	0	0	0	0	13.45505	14.02285	0	0	14.17212	16.3582	16.3466	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UJY4	GGA2_HUMAN	"ADP-ribosylation factor-binding protein GGA2 (Gamma-adaptin-related protein 2) (Golgi-localized, gamma ear-containing, ARF-binding protein 2) (VHS domain and ear domain of gamma-adaptin, Vear)"	GGA2 KIAA1080	Homo sapiens (Human)	Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to cell surface [GO:0034394]	clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]	clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to cell surface [GO:0034394]	phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]	GO:0005794; GO:0005802; GO:0006886; GO:0010008; GO:0030136; GO:0031267; GO:0031901; GO:0034394; GO:0035091; GO:0043001; GO:0043130	IRDAYQMLK	6.179999828	0.845697284	0.845697284	0.221092047	1154.768859	15.18919	15.18473	15.5699	14.21607	15.08578	14.99435	14.76458	12.75829	15.2796	15.96954	16.59222	13.54549	0	14.84975	14.67975	13.45418	13.49273	14.26358	0	0	0	0	0	0	14.43334	15.44401	0	16.26987	14.97891	0	16.27602	15.73361	15.11658	0	15.30504	14.25965	0	15.97068	0	14.71106	0	0	14.01955	0	0	0	0	14.69768
Q9UJZ1	STML2_HUMAN	"Stomatin-like protein 2, mitochondrial, SLP-2 (EPB72-like protein 2) (Paraprotein target 7, Paratarg-7)"	STOML2 SLP2 HSPC108	Homo sapiens (Human)	"CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]	"cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]"	cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005743; GO:0005758; GO:0005856; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032743; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046	GTGALLLRGSLLASGR	2.589999914	1	1	0.125316841	1541.393956	0	0	0	0	0	0	0	0	17.64465	0	14.62554	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.81559	0	0	0	0	0	0	0	0	0	19.3679	0	0	17.92627	0	0	0	0	0	0	0	0	0
Q9UK11	ZN223_HUMAN	Zinc finger protein 223	ZNF223	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0046872	SGLDLHHR	12.56999969	1	1	0.262727456	933.9724701	16.52193	0	16.49776	0	13.87633	0	0	0	0	0	0	0	15.86576	15.75682	0	0	16.97037	0	0	0	0	17.79926	11.67541	16.49474	0	17.65058	0	15.02665	18.55483	17.38592	17.02054	0	18.92648	16.75115	15.90162	14.08691	0	0	13.32747	0	0	17.09236	0	0	16.66685	0	15.32139	0
Q9UK12	ZN222_HUMAN	Zinc finger protein 222	ZNF222	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872	DHSGENPSKCEDCGK	21.30999947	1	1	0.00969368	1720.166294	0	14.73535	11.96882	14.57569	16.07217	11.30967	0	11.55167	0	14.74168	0	14.55859	0	0	0	0	0	0	0	0	0	0	0	18.10881	0	13.76166	16.6621	0	0	15.07583	0	17.01698	15.56681	15.11699	14.92858	0	0	0	0	0	0	0	0	0	16.24631	0	0	0
Q9UK13	ZN221_HUMAN	Zinc finger protein 221	ZNF221	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872	SALNSHSMVHIEEKPYK	7.690000057	1	1	0.319374789	1969.483299	12.96556	13.58187	13.5187	0	0	0	0	0	12.96142	0	0	0	13.14182	0	0	0	14.32938	0	0	0	0	0	0	0	0	0	0	0	0	13.77542	0	14.15239	0	0	0	0	0	0	0	14.51554	12.94897	16.10548	0	0	0	0	0	0
Q9UK22	FBX2_HUMAN	F-box only protein 2	FBXO2 FBX2	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]; amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433]	amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]; ubiquitin-protein transferase activity [GO:0004842]	GO:0001540; GO:0004842; GO:0005737; GO:0005783; GO:0005829; GO:0006464; GO:0006508; GO:0006516; GO:0016020; GO:0016567; GO:0019005; GO:0030246; GO:0030433; GO:0031146; GO:0031396; GO:0043197	FVRFEHGGQDSVYWK	4.670000076	0.2996521	0.2996521	0.122881826	1855.332207	14.63629	0	17.52595	0	10.53201	0	15.7952	0	0	0	10.23838	16.45298	12.40469	11.35018	15.69993	0	0	0	0	18.11226	16.97259	12.74267	0	17.18184	17.0238	0	0	17.54145	16.12533	0	16.93708	0	17.19599	0	7.48557	11.57713	17.1287	0	16.15527	14.34066	13.25919	17.71629	15.40577	0	0	18.55408	0	17.92542
Q9UK32	KS6A6_HUMAN	"Ribosomal protein S6 kinase alpha-6, S6K-alpha-6, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 6, p90-RSK 6, p90RSK6) (Ribosomal S6 kinase 4, RSK-4) (pp90RSK4)"	RPS6KA6 RSK4	Homo sapiens (Human)	"central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]"	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]	GO:0000287; GO:0001650; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006978; GO:0007165; GO:0007417; GO:0018105; GO:0045992; GO:0070373; GO:0106310; GO:2000381	DLKPENILLDEIGHIK	5.550000191	0.273547083	0.273547083	0.442302247	1846.591084	15.66183	15.60916	0	0	13.22607	0	15.73279	0	15.40479	0	0	18.01614	0	0	0	0	0	16.25897	0	15.43698	0	0	15.22793	16.95739	0	0	0	0	0	0	0	0	0	0	0	0	0	16.69955	0	17.60195	0	0	0	0	0	0	0	0
Q9UK39	NOCT_HUMAN	"Nocturnin, EC 3.1.3.108 (Carbon catabolite repression 4-like protein)"	NOCT CCR4 CCRN4L NOC	Homo sapiens (Human)	circadian regulation of gene expression [GO:0032922]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; P-body assembly [GO:0033962]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]; transcription by RNA polymerase II [GO:0006366]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; P-body assembly [GO:0033962]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]; transcription by RNA polymerase II [GO:0006366]	3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]	GO:0000175; GO:0000290; GO:0000932; GO:0003729; GO:0004535; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006366; GO:0006739; GO:0009991; GO:0010629; GO:0019178; GO:0032496; GO:0032922; GO:0033962; GO:0042752; GO:0045600; GO:0045668; GO:0045995; GO:0046872; GO:0048255; GO:0048471; GO:0102757	RLPAPGLR	10.06999969	1	1	0.190257257	879.8958806	0	0	13.86803	13.71463	12.32862	0	14.64156	13.7885	12.16701	14.62095	14.68299	11.2909	0	10.35114	0	13.96424	0	0	0	0	0	15.93927	0	0	0	0	0	0	0	0	0	0	0	0	0	16.50508	0	0	0	0	0	0	0	0	0	0	0	0
Q9UK41	VPS28_HUMAN	"Vacuolar protein sorting-associated protein 28 homolog, H-Vps28 (ESCRT-I complex subunit VPS28)"	VPS28	Homo sapiens (Human)	macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]	protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]	GO:0000813; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010008; GO:0016236; GO:0031397; GO:0031902; GO:0036258; GO:0039702; GO:0043130; GO:0043162; GO:0043328; GO:0044877; GO:0045732; GO:0070062; GO:2000397	QVQGSEISSIDEFCR	3.269999981	1	1	0.021835594	1753.902818	15.45051	11.82065	13.05239	13.37026	11.99551	14.29522	14.18693	0	13.60972	0	0	0	13.92944	13.65864	0	0	0	0	0	14.60154	0	14.07648	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UK59	DBR1_HUMAN	"Lariat debranching enzyme, EC 3.1.-.-"	DBR1	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]"	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]	GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008419; GO:0046872	YRHMQTFYR	7.179999828	0.467022717	0.467022717	0.115459904	1319.683632	12.13266	10.76947	10.51485	0	13.39882	0	0	0	14.01101	0	0	0	0	12.11118	0	0	0	0	14.48171	0	11.21594	12.54911	0	0	10.93938	14.15805	0	9.793364	12.43638	0	0	13.44837	0	0	0	15.07257	0	0	0	0	14.90859	0	13.44452	12.6749	15.6086	0	0	11.58832
Q9UK61	TASOR_HUMAN	Protein TASOR (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140) (Transgene activation suppressor protein)	TASOR C3orf63 FAM208A KIAA1105	Homo sapiens (Human)	"anterior/posterior axis specification, embryo [GO:0008595]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]"	heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]	"heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; anterior/posterior axis specification, embryo [GO:0008595]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]"	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	GO:0000792; GO:0003682; GO:0003723; GO:0005654; GO:0008595; GO:0045814; GO:0045869; GO:0060809; GO:0090309; GO:0097355	GFGSGK	5.389999866	0.6695261	0.6695261	0.268614855	554.866946	13.69595	16.06636	0	15.75019	15.19679	14.95752	15.45547	0	15.09513	0	13.31763	15.20425	0	0	0	0	0	0	0	0	15.60091	16.37165	16.15304	0	0	9.768986	15.46844	15.16841	15.33023	0	13.74773	0	0	15.56656	15.26638	0	0	15.67889	0	16.03175	0	0	0	0	15.60764	0	0	15.80609
Q9UK73	FEM1B_HUMAN	"Protein fem-1 homolog B, FEM1b (FEM1-beta) (Fem-1-like death receptor-binding protein alpha) (Fem-1-like in apoptotic pathway protein alpha, F1A-alpha)"	FEM1B F1AA KIAA0396	Homo sapiens (Human)	apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; death receptor binding [GO:0005123]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]	death receptor binding [GO:0005123]; ubiquitin ligase-substrate adaptor activity [GO:1990756]	GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0031462; GO:0043161; GO:0051438; GO:0060442; GO:0060743; GO:0140627; GO:1902041; GO:1990756; GO:2000001	EGLAGYVYKAASEGK	4.949999809	1	1	0.567415386	1542.98863	0	0	0	0	0	0	18.18842	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.03773	0	0	0	0	0	0	0	0	0	0	0	0	0	19.28855	0	0	0	0	0	0	0	16.7789	0	0	0	0
Q9UK76	JUPI1_HUMAN	"Jupiter microtubule associated homolog 1 (Androgen-regulated protein 2) (Hematological and neurological expressed 1 protein) [Cleaved into: Jupiter microtubule associated homolog 1, N-terminally processed ]"	JPT1 ARM2 HN1	Homo sapiens (Human)		cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0031965	EDLESSGLQR	9.760000229	0.699034572	0.699034572	0.266875386	1135.148209	0	0	11.75241	14.55527	14.3098	0	15.58446	0	14.89438	0	0	0	15.14659	0	0	0	0	0	0	0	15.49397	14.62839	0	0	0	0	16.57287	0	0	16.55862	0	15.21543	0	16.19283	0	0	14.62424	0	0	0	14.60477	16.21892	15.8089	0	0	0	0	0
Q9UK96	FBX10_HUMAN	F-box only protein 10	FBXO10 FBX10 PRMT11	Homo sapiens (Human)	apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511]	ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0042981	AKMEGNIFR	2.380000114	1	1	0.22699159	1079.589795	0	15.88712	14.67086	15.66832	14.21262	14.23475	15.0864	12.88117	15.49873	0	0	15.17422	0	0	19.38799	0	0	14.43326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.88154	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UK99	FBX3_HUMAN	F-box only protein 3	FBXO3 FBX3	Homo sapiens (Human)	proteolysis [GO:0006508]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis [GO:0006508]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005654; GO:0005829; GO:0006508	IEMSKDALPEK	6.28000021	1	1	0.12224278	1276.940287	0	12.12297	0	14.69928	0	12.84098	0	0	12.68983	14.58952	0	14.98019	16.61901	0	0	0	12.05119	0	11.47175	12.69609	12.52374	15.53566	15.34567	12.78148	0	17.40544	18.38266	11.49598	0	0	0	14.81953	0	0	13.03067	14.27266	14.42126	0	15.18423	15.24913	17.48879	0	0	14.19965	17.23833	17.26544	0	0
Q9UKA1	FBXL5_HUMAN	F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5) (F-box protein FBL4/FBL5) (p45SKP2-like protein)	FBXL5 FBL4 FBL5 FLR1	Homo sapiens (Human)	iron ion homeostasis [GO:0055072]; positive regulation of cellular protein catabolic process [GO:1903364]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; iron ion binding [GO:0005506]; ubiquitin-protein transferase activity [GO:0004842]; iron ion homeostasis [GO:0055072]; positive regulation of cellular protein catabolic process [GO:1903364]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	iron ion binding [GO:0005506]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0004842; GO:0005506; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0055072; GO:1903364	GLSLWNHAEER	4.130000114	1	1	0.289021882	1312.687396	0	15.38973	0	14.91576	13.9692	0	0	0	0	0	13.22566	12.57761	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.75251	0	0	0	0	0	0	0	0	15.76174	0	0
Q9UKA4	AKA11_HUMAN	"A-kinase anchor protein 11, AKAP-11 (A-kinase anchor protein 220 kDa, AKAP 220, hAKAP220) (Protein kinase A-anchoring protein 11, PRKA11)"	AKAP11 AKAP220 KIAA0629	Homo sapiens (Human)	cortical actin cytoskeleton organization [GO:0030866]; intracellular signal transduction [GO:0035556]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; renal water homeostasis [GO:0003091]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]; cortical actin cytoskeleton organization [GO:0030866]; intracellular signal transduction [GO:0035556]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; renal water homeostasis [GO:0003091]	protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]	GO:0003091; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0008104; GO:0008157; GO:0030866; GO:0034237; GO:0035556; GO:0036010; GO:0051018	EDSGLFSPIR	6.320000172	1	1	0.065723078	1121.72353	14.2293	11.12663	0	14.15182	15.27643	0	0	0	12.27528	0	0	13.09317	14.28125	0	0	0	0	0	0	0	0	15.00189	0	0	8.97318	12.7341	0	10.74524	15.06053	13.68527	0	0	0	0	0	0	0	15.77184	0	14.05267	13.56696	14.84193	0	0	0	0	0	0
Q9UKC9	FBXL2_HUMAN	F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2) (F-box protein FBL2/FBL3)	FBXL2 FBL2 FBL3	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; modulation by host of viral RNA genome replication [GO:0044830]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	cytoplasm [GO:0005737]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]	cytoplasm [GO:0005737]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]; calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; cellular protein modification process [GO:0006464]; modulation by host of viral RNA genome replication [GO:0044830]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]	calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]	GO:0005516; GO:0005737; GO:0006464; GO:0006508; GO:0006513; GO:0010506; GO:0014066; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830	GCIGVGDSSLK	5.550000191	1	1	0.198105643	1093.858062	8.643178	0	14.17504	13.8999	0	11.44458	12.7527	14.75414	0	0	0	0	13.29625	0	15.28588	0	0	0	0	0	0	0	0	0	0	14.51508	0	15.33008	0	0	0	0	0	0	0	0	14.79374	0	0	0	0	0	0	0	0	0	0	0
Q9UKD2	MRT4_HUMAN	mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4)	MRTO4 C1orf33 MRT4	Homo sapiens (Human)	nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"	"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]"	RNA binding [GO:0003723]	GO:0000027; GO:0000956; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273	HSRMFFGK	7.730000019	1	1	0.505770076	1010.69827	0	0	0	19.29384	0	0	18.03397	0	0	0	0	0	0	0	0	0	18.06674	0	0	17.4096	0	0	0	0	18.14914	0	0	0	0	0	0	18.21606	0	19.33069	20.97243	0	18.45213	0	0	0	0	17.34097	0	19.6789	0	0	0	0
Q9UKE5	TNIK_HUMAN	"TRAF2 and NCK-interacting protein kinase, EC 2.7.11.1"	TNIK KIAA0551	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; Wnt signaling pathway [GO:0016055]	"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037]"	"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; actin cytoskeleton reorganization [GO:0031532]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; Wnt signaling pathway [GO:0016055]"	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0001934; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0016055; GO:0016324; GO:0030033; GO:0031532; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048812; GO:0048814; GO:0055037; GO:0070062; GO:0072659; GO:0098793; GO:0098978; GO:0099092; GO:0106310	NHSQRPATEQLMK	3.890000105	1	1	1.38E-12	1540.634917	0	0	0	0	0	9.724477	0	0	0	0	0	0	17.71164	0	0	0	0	0	0	0	0	0	0	0	0	0	16.10019	0	0	0	0	0	0	16.18089	0	0	0	0	0	0	0	0	0	0	11.14879	16.55516	0	0
Q9UKF2	ADA30_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 30, ADAM 30, EC 3.4.24.-"	ADAM30 UNQ2509/PRO5997	Homo sapiens (Human)		external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0031902; GO:1990913	ATISTCMGGLRGVFNIDAK	1.220000029	1	1	0.286501057	2010.820466	0	0	14.94705	15.68753	0	13.73673	15.83019	13.94615	12.85394	15.87465	10.47686	13.7998	0	12.23782	13.89994	0	14.84904	0	14.87731	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.70156	0	13.52033	12.97295	0	0	0	0	0	0	0
Q9UKF5	ADA29_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 29, ADAM 29 (Cancer/testis antigen 73, CT73)"	ADAM29	Homo sapiens (Human)	male gonad development [GO:0008584]; spermatogenesis [GO:0007283]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; male gonad development [GO:0008584]; spermatogenesis [GO:0007283]	metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0005886; GO:0005887; GO:0007283; GO:0008237; GO:0008584; GO:0009897; GO:1990913	IQCENVTEIPNMSDHTTVHWAR	17.04999924	1	1	0.687568989	2655.0549	0	19.01543	17.89908	15.11964	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.53213	0	0	0	0	0	0	0	0	0	0
Q9UKG4	S13A4_HUMAN	Solute carrier family 13 member 4 (Na(+)/sulfate cotransporter SUT-1) (NaS2)	SLC13A4 SUT1	Homo sapiens (Human)	anion transmembrane transport [GO:0098656]; sulfate transport [GO:0008272]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium:sulfate symporter activity [GO:0015382]; anion transmembrane transport [GO:0098656]; sulfate transport [GO:0008272]	sodium:sulfate symporter activity [GO:0015382]	GO:0005886; GO:0005887; GO:0008272; GO:0015382; GO:0016021; GO:0098656	LGDISYPEMVTGFFFILMTVLWFTR	3.710000038	1	1	1.38E-12	2999.832152	0	11.81043	14.95164	13.71478	0	11.83372	16.87991	12.35384	12.88889	11.59587	0	13.64647	0	0	0	13.04975	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKG9	OCTC_HUMAN	"Peroxisomal carnitine O-octanoyltransferase, COT, EC 2.3.1.137"	CROT COT	Homo sapiens (Human)	carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]	carnitine O-octanoyltransferase activity [GO:0008458]	GO:0005777; GO:0005782; GO:0005829; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015908; GO:0015936; GO:0033540; GO:0043231; GO:0051791	GFDRHLLGLLLIAK	5.010000229	0.484945446	0.484945446	4.58E-13	1566.916339	14.59521	0	13.693	0	0	15.16269	0	14.03444	14.98391	14.4202	11.87807	16.13124	0	0	0	15.66874	0	0	18.02761	0	0	0	0	16.47147	15.42417	15.69052	16.88516	0	0	0	0	0	0	0	0	0	17.2146	0	0	0	0	0	0	0	0	0	0	0
Q9UKI8	TLK1_HUMAN	"Serine/threonine-protein kinase tousled-like 1, EC 2.7.11.1 (PKU-beta) (Tousled-like kinase 1)"	TLK1 KIAA0137	Homo sapiens (Human)	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0001672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006468; GO:0006886; GO:0006974; GO:0007049; GO:0007059; GO:0018105; GO:0035556; GO:0106310	FDVHQLANDPYLLPHMR	3.269999981	1	1	0.141384894	2082.90258	13.69896	13.98341	12.67499	0	0	0	13.39632	0	12.3652	0	0	14.07631	0	0	0	0	13.35641	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.63427	13.08893	13.70316	0	0	0	0	0	0	0	0	14.9098
Q9UKI9	PO2F3_HUMAN	"POU domain, class 2, transcription factor 3 (Octamer-binding protein 11, Oct-11) (Octamer-binding transcription factor 11, OTF-11) (Transcription factor PLA-1) (Transcription factor Skn-1)"	POU2F3 OTF11 PLA1	Homo sapiens (Human)	epidermis development [GO:0008544]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epidermis development [GO:0008544]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008544; GO:0016604; GO:0043565; GO:0043922; GO:0045944; GO:1990837	WNHSTYLH	10.81999969	0.653751493	0.653751493	0.376067422	1057.080002	14.0912	12.64927	12.48893	0	0	14.8972	15.17298	0	16.60922	0	0	0	0	0	15.76508	0	0	0	15.18443	0	0	15.5558	0	0	0	0	0	15.19208	0	0	0	14.47221	0	13.83193	15.16993	0	0	14.47059	0	0	14.93227	0	12.88417	0	14.69586	0	0	0
Q9UKJ3	GPTC8_HUMAN	G patch domain-containing protein 8	GPATCH8 GPATC8 KIAA0553	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0046872	DDGRGDDSK	12.88000011	1	1	0.372403383	965.0377678	0	0	15.59715	0	0	0	13.68457	14.41451	0	14.38503	0	14.55287	15.28403	14.85789	15.44747	16.3564	0	16.74018	0	0	0	0	0	0	0	16.54719	0	0	0	0	0	0	0	0	0	16.32795	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKK3	PARP4_HUMAN	"Protein mono-ADP-ribosyltransferase PARP4, EC 2.4.2.- (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4, ARTD4) (PARP-related/IalphaI-related H5/proline-rich, PH5P) (Poly [ADP-ribose] polymerase 4, PARP-4) (Vault poly(ADP-ribose) polymerase, VPARP)"	PARP4 ADPRTL1 KIAA0177 PARPL	Homo sapiens (Human)	cell death [GO:0008219]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; regulation of telomerase activity [GO:0051972]; response to xenobiotic stimulus [GO:0009410]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle microtubule [GO:0005876]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle microtubule [GO:0005876]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; regulation of telomerase activity [GO:0051972]; response to xenobiotic stimulus [GO:0009410]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005876; GO:0006281; GO:0006464; GO:0006471; GO:0006954; GO:0006974; GO:0008219; GO:0009410; GO:0016020; GO:0019899; GO:0051972; GO:0070062; GO:0140289; GO:1990404; GO:1990904	KIPFSK	2.650000095	0.421497077	0.421497077	0.126000951	718.4725501	10.74152	0	16.6656	10.08419	0	12.28421	16.85325	17.38608	15.85667	0	15.9805	15.55349	15.9055	14.84105	0	17.67179	15.28726	0	15.97676	15.79471	14.11494	18.50397	15.07757	14.36991	16.44021	17.74354	0	16.91156	13.53208	0	0	0	17.51515	14.08729	18.33347	14.11872	0	0	16.27427	0	15.78783	0	17.64172	17.41779	0	0	0	14.90162
Q9UKL0	RCOR1_HUMAN	REST corepressor 1 (Protein CoREST)	RCOR1 KIAA0071 RCOR	Homo sapiens (Human)	"chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; histone deacetylation [GO:0016575]; histone H4 deacetylation [GO:0070933]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]"	DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	"DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; histone deacetylation [GO:0016575]; histone H4 deacetylation [GO:0070933]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]	GO:0000118; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0006357; GO:0010629; GO:0016575; GO:0017053; GO:0019899; GO:0030218; GO:0045654; GO:0045892; GO:0070933; GO:1990391	LDGGIEPYR	19.31999969	1	1	0.432183315	1014.200589	13.88925	15.58681	14.14549	13.92526	14.65503	14.96489	15.50424	14.62765	15.03287	14.90332	13.12983	15.91557	0	12.74731	15.90242	0	0	15.68568	0	0	0	0	0	0	0	0	0	0	0	0	0	16.42419	15.35408	16.27925	0	0	0	0	16.49301	0	0	16.04041	0	15.66844	0	0	15.63664	0
Q9UKL2	O52A1_HUMAN	Olfactory receptor 52A1 (HPFH1OR) (Odorant receptor HOR3'beta4) (Olfactory receptor OR11-319)	OR52A1	Homo sapiens (Human)	sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; transmembrane signaling receptor activity [GO:0004888]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0004930; GO:0004984; GO:0005887; GO:0007165; GO:0007608	SLHEPLYIFLGMLGATDIALASSIMPK	3.569999933	0.950863063	0.950863063	4.12E-12	2903.577492	0	15.48519	14.57465	0	11.62606	0	0	13.46894	15.11174	0	13.92532	0	0	0	10.92708	11.50838	0	0	18.89414	0	0	0	16.11883	0	0	0	0	0	0	0	0	0	0	12.63367	9.233723	0	15.71186	0	0	0	14.87573	0	0	0	0	0	0	0
Q9UKL3	C8AP2_HUMAN	CASP8-associated protein 2 (FLICE-associated huge protein)	CASP8AP2 FLASH KIAA1315 RIP25	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cell cycle [GO:0007049]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fas signaling pathway [GO:0036337]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; death receptor binding [GO:0005123]; peptidase activator activity involved in apoptotic process [GO:0016505]; SUMO polymer binding [GO:0032184]; transcription corepressor activity [GO:0003714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cell cycle [GO:0007049]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fas signaling pathway [GO:0036337]; signal transduction [GO:0007165]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; death receptor binding [GO:0005123]; peptidase activator activity involved in apoptotic process [GO:0016505]; SUMO polymer binding [GO:0032184]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006919; GO:0007049; GO:0007165; GO:0008625; GO:0008656; GO:0016505; GO:0016605; GO:0032184; GO:0036337; GO:0071260; GO:0097190	KNGIVDR	6.96999979	0.052647244	0.052647244	0.215311392	802.5007891	0	0	15.78245	0	0	15.75461	0	15.5877	0	0	16.98692	14.71513	15.72396	0	16.06498	0	15.01503	16.39256	0	16.92294	16.51464	15.19096	14.70486	11.67267	16.66872	17.65709	17.68086	0	0	16.46663	0	0	17.57569	0	16.48226	0	17.66978	0	0	0	16.49925	16.52337	16.30338	15.37552	0	0	0	15.90216
Q9UKM7	MA1B1_HUMAN	"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase, EC 3.2.1.113 (ER alpha-1,2-mannosidase) (ER mannosidase 1, ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)"	MAN1B1 UNQ747/PRO1477	Homo sapiens (Human)	"endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral protein processing [GO:0019082]"	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral protein processing [GO:0019082]"	"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]"	GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0006491; GO:0009311; GO:0016020; GO:0016021; GO:0019082; GO:0030433; GO:0031410; GO:0036508; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:1903561; GO:1904380; GO:1904382	EFEEAR	7.440000057	1	1	0.18326565	779.758726	18.02403	0	17.84603	0	17.63232	16.44683	0	15.90435	0	16.56172	16.58888	16.28694	0	16.72077	16.76921	0	15.8588	0	0	16.16451	0	0	16.92451	17.61524	0	0	0	16.89549	15.26408	0	0	0	17.07417	17.2173	0	0	17.38288	18.62484	16.59157	14.8233	16.45399	0	16.26297	17.16226	0	0	0	16.66433
Q9UKN1	MUC12_HUMAN	"Mucin-12, MUC-12 (Mucin-11, MUC-11)"	MUC12 MUC11	Homo sapiens (Human)	regulation of cell growth [GO:0001558]	Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; regulation of cell growth [GO:0001558]		GO:0001558; GO:0005796; GO:0005886; GO:0005887	LACVNKCTK	2.49000001	0.750507891	0.750507891	0.216247352	1092.975143	0	14.93484	16.20674	18.00392	13.30098	0	0	11.87411	0	0	0	0	0	0	0	13.39872	14.0918	0	0	0	0	15.14871	0	15.49518	0	0	0	0	0	0	0	14.43893	16.1293	0	0	15.41676	0	0	0	15.56108	0	15.48171	15.74956	12.77581	15.0814	13.34793	12.21651	13.89991
Q9UKN7	MYO15_HUMAN	Unconventional myosin-XV (Unconventional myosin-15)	MYO15A MYO15	Homo sapiens (Human)	actin filament organization [GO:0007015]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; vesicle [GO:0031982]	actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016459; GO:0030050; GO:0031982; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858	AMLAGRSSK	2.039999962	1	1	0.128587864	936.0972771	16.16564	0	12.96403	13.60923	0	14.52224	16.18849	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.77826	0	0	13.9123	0	0	0	0	0	0	0	0	0	0	0	13.81642	0	0	0	0	0	0	0	0
Q9UKN8	TF3C4_HUMAN	"General transcription factor 3C polypeptide 4, EC 2.3.1.48 (TF3C-delta) (Transcription factor IIIC 90 kDa subunit, TFIIIC 90 kDa subunit, TFIIIC90) (Transcription factor IIIC subunit delta)"	GTF3C4	Homo sapiens (Human)	5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; histone acetyltransferase activity [GO:0004402]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797]	DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; histone acetyltransferase activity [GO:0004402]; RNA polymerase III general transcription initiation factor activity [GO:0000995]	GO:0000127; GO:0000995; GO:0003677; GO:0004402; GO:0005654; GO:0005739; GO:0006383; GO:0006384; GO:0008047; GO:0042791; GO:0042797	MSGLIVGSAFGPIK	6.619999886	1	1	0.333672516	1394.298825	16.30989	0	0	15.63601	14.28059	14.29561	0	0	14.65754	14.71236	14.69659	15.12306	0	16.31775	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.68784	0	14.93641	0	16.88898	0	0	0	15.70267	0	0	0	0	0	0	0
Q9UKP4	ATS7_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 7, ADAM-TS 7, ADAM-TS7, ADAMTS-7, EC 3.4.24.- (COMPase)"	ADAMTS7	Homo sapiens (Human)	cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in cellular protein catabolic process [GO:0051603]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in cellular protein catabolic process [GO:0051603]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773	EIRIQEVAEAANFLALR	4.050000191	1	1	0.48806044	1942.319004	0	0	0	0	0	0	0	17.50187	0	17.88247	0	0	15.94154	0	0	0	0	17.57845	0	0	0	0	0	0	0	0	16.90313	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.90754	0	0	0	0	0	0
Q9UKP5	ATS6_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 6, ADAM-TS 6, ADAM-TS6, ADAMTS-6, EC 3.4.24.-"	ADAMTS6	Homo sapiens (Human)	aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976	NKPCGTLGLASVAGMCEPER	6.090000153	1	1	0.136733696	2147.41822	9.095655	10.6897	0	0	0	0	0	0	12.88789	0	0	14.02411	0	0	0	0	0	12.58277	15.03854	0	0	0	0	0	0	17.72665	0	15.78583	12.75618	12.50337	12.53535	0	0	14.87701	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKQ2	ADA28_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 28, ADAM 28, EC 3.4.24.- (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II, eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L, MDC-L)"	ADAM28 ADAM23 MDCL	Homo sapiens (Human)	spermatogenesis [GO:0007283]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; spermatogenesis [GO:0007283]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004175; GO:0004222; GO:0005576; GO:0005739; GO:0005886; GO:0007283; GO:0008237; GO:0016021; GO:0046872	EPEQQEQFETELKYK	1.929999948	0.300735295	0.300735295	0.108471694	1922.533152	0	16.70222	0	0	0	0	15.19305	13.02215	0	0	0	17.31041	0	14.51268	13.98379	0	0	16.68907	0	0	16.17063	0	0	13.18561	0	0	0	15.12982	15.37952	9.165317	16.20379	16.60653	0	15.45463	17.16637	0	0	17.07099	15.99139	0	15.35633	13.33206	0	14.68556	0	17.79627	0	16.85637
Q9UKR3	KLK13_HUMAN	"Kallikrein-13, EC 3.4.21.- (Kallikrein-like protein 4, KLK-L4)"	KLK13 KLKL4	Homo sapiens (Human)	protein processing [GO:0016485]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; hydrolase activity [GO:0016787]; serine-type endopeptidase activity [GO:0004252]; protein processing [GO:0016485]; proteolysis [GO:0006508]	hydrolase activity [GO:0016787]; serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0006508; GO:0016485; GO:0016787; GO:0030141	MWPLALVIASLTLALSGGVSQESSK	17.02000046	1	1	1.38E-12	2558.368204	14.88152	11.93754	10.03126	13.44717	13.50778	0	15.87314	0	10.90031	13.41704	0	0	0	10.21048	0	14.81719	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKS6	PACN3_HUMAN	Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511)	PACSIN3	Homo sapiens (Human)	cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endocytosis [GO:0030100]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium channel inhibitor activity [GO:0019855]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endocytosis [GO:0030100]	calcium channel inhibitor activity [GO:0019855]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]	GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007010; GO:0008092; GO:0008289; GO:0019855; GO:0030100; GO:0042802; GO:0045806; GO:0051044; GO:0051926; GO:0070062; GO:0097320	GAFHRPVLGGFRESR	2.700000048	1	1	7.03E-13	1683.853009	0	0	13.57196	0	14.64066	0	0	0	0	0	0	0	0	0	0	0	0	0	17.44695	0	0	17.62121	0	0	0	0	0	0	0	0	0	0	14.90091	14.03102	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKT4	FBX5_HUMAN	F-box only protein 5 (Early mitotic inhibitor 1)	FBXO5 EMI1 FBX5	Homo sapiens (Human)	cell division [GO:0051301]; microtubule polymerization [GO:0046785]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of response to DNA damage stimulus [GO:2001021]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; oocyte maturation [GO:0001556]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of osteoblast differentiation [GO:0045669]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly involved in female meiosis I [GO:0007057]; vesicle organization [GO:0016050]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; anaphase-promoting complex binding [GO:0010997]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; ubiquitin ligase inhibitor activity [GO:1990948]; cell division [GO:0051301]; microtubule polymerization [GO:0046785]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of response to DNA damage stimulus [GO:2001021]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; oocyte maturation [GO:0001556]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of osteoblast differentiation [GO:0045669]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly involved in female meiosis I [GO:0007057]; vesicle organization [GO:0016050]	anaphase-promoting complex binding [GO:0010997]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; ubiquitin ligase inhibitor activity [GO:1990948]	GO:0001556; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006275; GO:0007057; GO:0007088; GO:0007346; GO:0008284; GO:0010971; GO:0010997; GO:0016050; GO:0016567; GO:0019901; GO:0032876; GO:0045669; GO:0045835; GO:0045841; GO:0046785; GO:0046872; GO:0051301; GO:0051444; GO:0070169; GO:0072687; GO:1904667; GO:1905322; GO:1990948; GO:2000773; GO:2001021	GAFQLYSKAIQR	2.349999905	1	1	0.490105723	1381.520921	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.22641	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKT5	FBX4_HUMAN	F-box only protein 4	FBXO4 FBX4	Homo sapiens (Human)	aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; posttranscriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; posttranscriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511]	protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000151; GO:0000209; GO:0000723; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007568; GO:0010608; GO:0016567; GO:0019005; GO:0019725; GO:0031146; GO:0031398; GO:0031647; GO:0031648; GO:0032212; GO:0035726; GO:0042803; GO:0048147; GO:0061630; GO:0071479; GO:1900181; GO:1902916; GO:2000001	MAGSEPR	10.89000034	0.109048657	0.109048657	0.232980873	745.0322332	0	15.0323	0	0	14.37282	0	13.90952	17.58898	15.76066	0	16.28426	16.94789	16.63337	0	0	14.37906	14.93381	14.12404	14.39623	16.40178	16.11432	0	0	0	0	15.37993	0	0	15.12056	15.32177	17.85377	15.79951	0	14.95951	12.98186	0	0	0	0	0	17.77933	14.55079	16.89729	0	15.31025	0	0	15.97109
Q9UKU9	ANGL2_HUMAN	Angiopoietin-related protein 2 (Angiopoietin-like protein 2)	ANGPTL2 ARP2 UNQ170/PRO196	Homo sapiens (Human)	multicellular organism development [GO:0007275]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; multicellular organism development [GO:0007275]	signaling receptor binding [GO:0005102]	GO:0005102; GO:0005615; GO:0007275; GO:0062023; GO:0070062	SRYQDGVYWAEFR	1.940000057	0.056773111	0.056773111	0.04316247	1675.940687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKV3	ACINU_HUMAN	"Apoptotic chromatin condensation inducer in the nucleus, Acinus"	ACIN1 ACINUS KIAA0670	Homo sapiens (Human)	"apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]"	ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	"ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]"	ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	GO:0003676; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016607; GO:0016887; GO:0019899; GO:0030218; GO:0030263; GO:0043065; GO:0045657; GO:0048025; GO:0061574	LQPERGSPK	3.279999971	1	1	0.007047341	1012.069274	16.31249	16.30051	14.96397	0	0	0	9.914357	0	13.87129	0	12.83496	0	11.9866	0	13.4542	13.34525	14.56094	13.57968	15.24419	0	0	12.95249	13.9937	12.07785	14.20106	13.48682	14.18548	0	15.52459	0	15.41113	0	13.51027	16.7694	0	13.67126	13.48243	14.83842	17.01795	15.36726	12.8506	15.52312	0	14.88492	0	0	0	13.48045
Q9UKV8	AGO2_HUMAN	"Protein argonaute-2, Argonaute2, hAgo2, EC 3.1.26.n2 (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2, eIF-2C 2, eIF2C 2) (PAZ Piwi domain protein, PPD) (Protein slicer)"	AGO2 EIF2C2	Homo sapiens (Human)	"gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; mRNA destabilization-mediated gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; mRNA destabilization-mediated gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]"	"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]"	GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0016020; GO:0016246; GO:0016442; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0036464; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0045975; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904	EIVEHMVQHFK	2.230000019	1	1	0.478322602	1413.15015	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKW4	VAV3_HUMAN	"Guanine nucleotide exchange factor VAV3, VAV-3"	VAV3	Homo sapiens (Human)	angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cellular response to DNA damage stimulus [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906]	cytosol [GO:0005829]; immunological synapse [GO:0001772]	cytosol [GO:0005829]; immunological synapse [GO:0001772]; epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cellular response to DNA damage stimulus [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906]	epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]	GO:0001525; GO:0001772; GO:0005085; GO:0005096; GO:0005154; GO:0005829; GO:0006906; GO:0006974; GO:0007229; GO:0007264; GO:0008361; GO:0009410; GO:0030032; GO:0030168; GO:0030593; GO:0030890; GO:0038095; GO:0038096; GO:0043087; GO:0043552; GO:0045785; GO:0046872; GO:0050853; GO:0051056	QVDPGLPK	8.710000038	1	1	0.271921947	852.9619273	0	0	0	16.4526	0	0	0	0	17.51083	0	11.81909	0	0	0	17.73709	0	0	0	0	0	0	0	0	17.31616	18.28449	17.36655	17.27311	0	0	0	0	0	0	0	18.33582	17.83706	18.73964	17.38239	21.18607	0	0	0	0	0	0	0	16.07163	0
Q9UKW6	ELF5_HUMAN	"ETS-related transcription factor Elf-5 (E74-like factor 5) (Epithelium-restricted ESE-1-related Ets factor) (Epithelium-specific Ets transcription factor 2, ESE-2)"	ELF5 ESE2	Homo sapiens (Human)	cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:1990837	ALRYYYK	10.71000004	1	1	0.139482929	977.6852161	0	0	14.16153	0	0	14.12915	11.99282	0	14.962	0	0	13.68064	15.07781	0	14.95439	0	0	14.35694	0	0	0	14.0956	13.70434	0	0	14.44828	0	0	15.88282	0	14.75449	0	0	0	0	0	15.66084	0	0	13.66518	0	15.7016	0	0	0	0	16.04677	0
Q9UKX3	MYH13_HUMAN	"Myosin-13 (Myosin heavy chain 13) (Myosin heavy chain, skeletal muscle, extraocular, MyHC-EO) (Myosin heavy chain, skeletal muscle, laryngeal, MyHC-IIL) (Superfast myosin)"	MYH13	Homo sapiens (Human)	cellular response to starvation [GO:0009267]; muscle contraction [GO:0006936]	extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]	extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; cellular response to starvation [GO:0009267]; muscle contraction [GO:0006936]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0009267; GO:0030016; GO:0032982; GO:0051015; GO:0070062	SELKMEIDDMASNIEALSK	12.38000011	1	1	0.139374972	2156.33963	12.97423	0	0	0	0	0	0	15.07695	0	0	0	0	15.41879	0	0	9.974621	14.63327	13.52419	15.14081	0	0	15.28454	0	15.07952	15.86465	0	14.64432	14.15543	15.69098	0	16.00294	0	0	16.61845	0	0	13.5354	0	0	0	14.78457	12.91354	0	0	0	0	0	0
Q9UKY0	PRND_HUMAN	Prion-like protein doppel (PrPLP) (Prion protein 2)	PRND DPL UNQ1830/PRO3443	Homo sapiens (Human)	acrosome reaction [GO:0007340]; cellular copper ion homeostasis [GO:0006878]; protein homooligomerization [GO:0051260]	anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; acrosome reaction [GO:0007340]; cellular copper ion homeostasis [GO:0006878]; protein homooligomerization [GO:0051260]	copper ion binding [GO:0005507]	GO:0005507; GO:0005576; GO:0005886; GO:0006878; GO:0007340; GO:0031362; GO:0051260	KLDIDFGAEGNR	5.710000038	1	1	0.073788204	1334.366168	0	0	0	0	15.25883	0	0	0	15.2608	0	14.95979	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.84057	0	0	0	16.15722	14.4607	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UKZ1	CNO11_HUMAN	CCR4-NOT transcription complex subunit 11	CNOT11 C2orf29 C40	Homo sapiens (Human)	gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]	CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]		GO:0000289; GO:0005634; GO:0005829; GO:0006402; GO:0017148; GO:0030014; GO:0031047	FFLSQLMLAPPR	4.110000134	0.356406838	0.356406838	0.102207663	1435.431642	0	13.2291	15.52903	0	0	11.86627	0	0	13.58266	13.76882	0	11.49736	0	14.60138	0	15.99195	13.94643	16.29243	0	15.75063	13.05304	15.31001	7.106359	15.79074	0	16.68624	0	14.9154	12.13084	15.30187	0	15.84079	13.63299	0	15.62285	0	17.24621	0	16.39753	14.50506	16.17955	17.48713	0	10.26449	15.17769	14.21962	12.90194	0
Q9UKZ4	TEN1_HUMAN	"Teneurin-1, Ten-1 (Protein Odd Oz/ten-m homolog 1) (Tenascin-M1, Ten-m1) (Teneurin transmembrane protein 1) [Cleaved into: Ten-1 intracellular domain, IDten-1, Ten-1 ICD; Teneurin C-terminal-associated peptide, TCPA-1 (Ten-1 extracellular domain, Ten-1 ECD) ]"	TENM1 ODZ1 TNM1	Homo sapiens (Human)	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuropeptide signaling pathway [GO:0007218]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of transcription by RNA polymerase III [GO:0006359]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuropeptide signaling pathway [GO:0007218]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of transcription by RNA polymerase III [GO:0006359]	cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0006359; GO:0006955; GO:0007157; GO:0007218; GO:0007399; GO:0008201; GO:0008285; GO:0016363; GO:0016607; GO:0030838; GO:0033138; GO:0042803; GO:0043005; GO:0043406; GO:0046982; GO:0048471; GO:0048666; GO:0050839; GO:0051491; GO:0090316	HGYQLEMGSDVDTETEGAASPDHALR	7.539999962	1	1	2.75E-12	2785.675175	0	0	0	0	12.74846	0	0	0	11.13788	11.64975	15.01401	0	12.36956	0	0	0	13.69823	16.69257	0	14.68292	0	0	0	0	0	0	0	0	0	0	13.57999	13.8832	0	0	0	0	0	15.57542	13.82383	0	0	0	0	0	13.27944	0	14.12547	0
Q9UKZ9	PCOC2_HUMAN	"Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2, PCPE-2, Procollagen C-proteinase enhancer 2)"	PCOLCE2 PCPE2 UNQ250/PRO287	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830]	collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]	GO:0005518; GO:0005576; GO:0008201; GO:0016504; GO:1990830	ITVPEGK	2.880000114	1	1	0.091616438	743.7107943	0	0	0	0	0	0	0	0	0	16.37306	0	0	0	14.74896	0	0	0	0	0	15.44209	0	0	0	0	0	0	0	0	16.40964	0	0	0	14.76595	0	0	0	16.12138	0	0	13.87792	15.49384	15.57508	0	14.99012	15.47222	0	0	0
Q9UL12	SARDH_HUMAN	"Sarcosine dehydrogenase, mitochondrial, SarDH, EC 1.5.8.3 (BPR-2)"	SARDH DMGDHL1	Homo sapiens (Human)	sarcosine catabolic process [GO:1901053]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; sarcosine catabolic process [GO:1901053]	oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]	GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:1901053	NGQVVGHVR	6.210000038	1	1	0.258162614	964.448926	0	0	0	16.41517	0	16.46025	17.60332	0	18.37118	0	17.46407	0	0	0	16.70905	16.34103	0	0	0	15.88259	15.99925	0	16.13585	0	0	0	18.13865	0	0	17.45134	0	0	0	17.9791	0	0	17.0559	0	0	0	0	0	16.29382	17.27546	0	15.70856	0	17.45053
Q9UL15	BAG5_HUMAN	"BAG family molecular chaperone regulator 5, BAG-5 (Bcl-2-associated athanogene 5)"	BAG5 KIAA0873	Homo sapiens (Human)	Golgi organization [GO:0007030]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein refolding [GO:0061084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neuron death [GO:0070997]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of inclusion body assembly [GO:0090083]; regulation of ubiquitin-protein transferase activity [GO:0051438]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein refolding [GO:0061084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neuron death [GO:0070997]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of inclusion body assembly [GO:0090083]; regulation of ubiquitin-protein transferase activity [GO:0051438]	adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]	GO:0000774; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0007030; GO:0010977; GO:0016020; GO:0016234; GO:0019901; GO:0031397; GO:0031625; GO:0032435; GO:0048471; GO:0050821; GO:0051087; GO:0051438; GO:0051444; GO:0061084; GO:0070997; GO:0090083; GO:1902176	TEIRNYR	11.42000008	1	1	0.215679805	952.499804	12.78805	15.49785	0	15.45061	0	15.15085	17.99137	0	0	15.34365	16.3736	0	0	0	0	0	0	0	13.55026	13.95898	0	0	0	15.61496	0	0	0	0	0	16.21665	15.36173	16.3569	0	0	0	0	0	0	0	0	16.61387	0	0	0	0	16.00713	0	17.12272
Q9UL16	CFA45_HUMAN	Cilia- and flagella-associated protein 45 (Coiled-coil domain-containing protein 19) (Nasopharyngeal epithelium-specific protein 1)	CFAP45 CCDC19 NESG1	Homo sapiens (Human)	cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]	9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AMP binding [GO:0016208]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]	AMP binding [GO:0016208]	GO:0005576; GO:0005634; GO:0005654; GO:0005930; GO:0016208; GO:0030317; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0097729	EATMDAVMTR	4.78000021	1	1	0.095189607	1139.993144	15.03216	12.7237	15.01679	14.54391	13.17153	15.21207	0	0	15.94703	16.0081	13.41852	0	16.58278	0	0	13.50714	15.7447	15.18647	15.10121	16.12577	13.62296	0	13.86685	0	0	15.49942	0	0	0	0	0	0	15.25633	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UL17	TBX21_HUMAN	"T-box transcription factor TBX21, T-box protein 21 (T-cell-specific T-box transcription factor T-bet) (Transcription factor TBLYM)"	TBX21 TBET TBLYM	Homo sapiens (Human)	"cell fate specification [GO:0001708]; cellular response to organic substance [GO:0071310]; lymphocyte migration [GO:0072676]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of T cell differentiation [GO:0045580]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]; T-helper 1 cell lineage commitment [GO:0002296]"	neuronal cell body [GO:0043025]; nucleus [GO:0005634]	"neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell fate specification [GO:0001708]; cellular response to organic substance [GO:0071310]; lymphocyte migration [GO:0072676]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of T cell differentiation [GO:0045580]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]; T-helper 1 cell lineage commitment [GO:0002296]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001708; GO:0002296; GO:0005634; GO:0006357; GO:0009615; GO:0032703; GO:0043025; GO:0043161; GO:0043565; GO:0045580; GO:0045892; GO:0045893; GO:0045944; GO:0048304; GO:0071310; GO:0072676; GO:1990837; GO:2000320; GO:2000329; GO:2000552; GO:2000556	AGLYPGPR	3.269999981	1	1	6.88E-13	831.7198483	0	0	0	0	15.17347	0	0	0	16.48082	0	0	0	0	14.81582	0	0	0	0	0	12.4768	0	15.57133	0	0	0	0	0	0	0	15.45125	0	0	16.07857	15.67459	0	0	0	0	12.96153	0	13.16363	0	0	0	0	0	0	0
Q9UL18	AGO1_HUMAN	"Protein argonaute-1, Argonaute1, hAgo1 (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1, eIF-2C 1, eIF2C 1) (Putative RNA-binding protein Q99)"	AGO1 EIF2C1	Homo sapiens (Human)	miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of angiogenesis [GO:0016525]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of angiogenesis [GO:0016525]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA interference [GO:0016246]; RNA secondary structure unwinding [GO:0010501]	core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]	GO:0000932; GO:0000956; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0010501; GO:0016246; GO:0016442; GO:0016525; GO:0031054; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0036464; GO:0045944; GO:0070578; GO:1990904	NIDEQPKPLTDSQR	8.710000038	1	1	0.32421771	1642.557963	17.97672	0	0	17.1266	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UL25	RAB21_HUMAN	Ras-related protein Rab-21	RAB21 KIAA0118	Homo sapiens (Human)	anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157]	axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]	axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005789; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0008089; GO:0009898; GO:0012505; GO:0012506; GO:0017157; GO:0019003; GO:0030516; GO:0031901; GO:0032154; GO:0032482; GO:0032580; GO:0045202; GO:0048260; GO:0050775; GO:0050821; GO:0070062; GO:0098559; GO:1904115; GO:2000643	RGVQIIDDEPQAQTSGGGCCSSG	3.660000086	0.185496807	0.185496807	0.278187545	2378.387952	14.74213	12.67223	11.9809	0	14.69479	0	13.50354	0	0	11.04643	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.39695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UL26	RB22A_HUMAN	"Ras-related protein Rab-22A, Rab-22"	RAB22A RAB22	Homo sapiens (Human)	endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0010008; GO:0012505; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0070062; GO:0097494	ALAPMYYR	10.22000027	1	1	0.230413247	1000.325971	15.46398	12.37964	0	13.8616	15.9081	16.84504	16.01273	14.28954	0	16.48204	0	13.64647	11.62544	15.07336	14.25124	0	12.92251	14.51659	10.55626	16.76886	0	16.47311	15.82802	16.06013	0	16.19197	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.87965	15.43477	13.52622	0	15.89682	15.19675
Q9UL36	ZN236_HUMAN	Zinc finger protein 236	ZNF236	Homo sapiens (Human)	cellular response to glucose stimulus [GO:0071333]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:0071333	AHIMLHEK	18.30999947	0.51157397	0.51157397	0.095101268	982.3660587	15.98752	0	0	0	0	0	15.11626	0	12.96333	0	18.34697	0	15.91533	0	15.64984	14.03134	0	0	0	0	0	0	0	0	0	15.93656	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.57627	0	0	0
Q9UL41	PNMA3_HUMAN	Paraneoplastic antigen Ma3	PNMA3 MA3	Homo sapiens (Human)	positive regulation of apoptotic process [GO:0043065]	nucleolus [GO:0005730]	nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; positive regulation of apoptotic process [GO:0043065]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005730; GO:0008270; GO:0043065	RTVSDMNR	1.200000048	1	1	5.75E-13	994.5284219	0	0	0	0	13.2376	0	0	0	12.30665	0	0	17.91133	0	0	13.50276	0	0	0	0	14.39903	0	0	0	0	15.14645	15.9648	0	0	0	0	0	0	0	0	0	0	0	17.35662	0	15.79121	0	0	0	0	0	0	0	0
Q9UL51	HCN2_HUMAN	"Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2, BCNG-2)"	HCN2 BCNG2	Homo sapiens (Human)	cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]	cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]	GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0005887; GO:0007267; GO:0008076; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086091; GO:0098719; GO:0098855; GO:0098907; GO:1990573; GO:2001257	APRTSPYGGLPAAPLAGPALPAR	5.289999962	1	1	4.61E-13	2203.379982	0	0	0	0	15.29463	12.38059	14.51957	0	0	0	0	13.83037	12.32827	0	9.446576	0	0	0	12.9143	0	0	0	0	0	0	0	0	0	12.98214	0	0	10.35172	0	0	0	0	0	0	0	14.3189	14.16209	0	0	0	0	0	0	0
Q9UL52	TM11E_HUMAN	"Transmembrane protease serine 11E, EC 3.4.21.- (Serine protease DESC1) (Transmembrane protease serine 11E2) [Cleaved into: Transmembrane protease serine 11E non-catalytic chain; Transmembrane protease serine 11E catalytic chain ]"	TMPRSS11E DESC1 TMPRSS11E2 UNQ742/PRO1461	Homo sapiens (Human)	cognition [GO:0050890]; proteolysis [GO:0006508]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; cognition [GO:0050890]; proteolysis [GO:0006508]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0004252; GO:0005576; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0050890	VDPHSVK	9.729999542	1	1	0.265374381	781.8438987	12.72399	13.82933	0	15.54492	14.24539	15.63466	14.99071	14.40833	16.81142	16.22436	13.72174	0	12.99187	16.18845	17.19869	0	0	15.34333	0	0	0	0	0	15.79624	0	0	0	14.71245	0	15.06968	0	15.2556	16.13505	0	0	0	0	0	0	16.85934	0	16.34448	0	0	0	16.58368	0	0
Q9UL54	TAOK2_HUMAN	"Serine/threonine-protein kinase TAO2, EC 2.7.11.1 (Kinase from chicken homolog C, hKFC-C) (Prostate-derived sterile 20-like kinase 1, PSK-1, PSK1, Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2)"	TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; basal dendrite arborization [GO:0150020]; basal dendrite morphogenesis [GO:0150019]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]; regulation of MAPK cascade [GO:0043408]; stress-activated MAPK cascade [GO:0051403]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; neuropilin binding [GO:0038191]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; basal dendrite arborization [GO:0150020]; basal dendrite morphogenesis [GO:0150019]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]; regulation of MAPK cascade [GO:0043408]; stress-activated MAPK cascade [GO:0051403]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; neuropilin binding [GO:0038191]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]	GO:0000165; GO:0001558; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0006612; GO:0006915; GO:0006974; GO:0007095; GO:0007409; GO:0008360; GO:0015629; GO:0016021; GO:0016477; GO:0030036; GO:0030424; GO:0030659; GO:0031410; GO:0031434; GO:0031954; GO:0032147; GO:0032874; GO:0032956; GO:0035556; GO:0038191; GO:0043005; GO:0043235; GO:0043408; GO:0043410; GO:0043539; GO:0044294; GO:0044295; GO:0046330; GO:0046777; GO:0048041; GO:0048156; GO:0048812; GO:0050321; GO:0051403; GO:0106310; GO:0150019; GO:0150020	ALQGCGAVGDR	1.929999948	0.993469417	0.993469417	0.305540554	1102.951285	16.56859	17.99652	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.2552	0	0	0	0	0	0	17.06755	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UL62	TRPC5_HUMAN	"Short transient receptor potential channel 5, TrpC5 (Transient receptor protein 5, TRP-5, hTRP-5, hTRP5)"	TRPC5 TRP5	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]	calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	"calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]"	"actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]"	GO:0003779; GO:0005262; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007204; GO:0007399; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045121; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:1902630	RPSGEK	6.139999866	0.351259351	0.351259351	0.169622771	674.3204543	0	18.25373	0	0	0	0	0	0	0	18.43267	18.81771	15.72219	0	0	0	18.9135	16.21086	16.51235	0	0	14.05325	17.53454	0	0	17.66441	18.41225	0	0	14.29092	16.13535	16.05303	16.47942	0	17.18909	0	15.56736	17.83713	18.46383	0	17.14921	17.86983	0	17.59291	13.80182	0	15.59019	16.70006	14.56465
Q9UL63	MKLN1_HUMAN	Muskelin	MKLN1	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005737; GO:0005829; GO:0005938; GO:0007160; GO:0007165; GO:0008360; GO:0031532; GO:0042802; GO:0042803; GO:0098794	DSGMVPMTGFTQR	2.089999914	1	1	0.466229982	1460.081214	0	0	16.07223	16.09563	14.73044	16.2774	0	0	0	0	0	0	0	0	0	0	0	0	0	15.54915	0	16.50506	0	0	0	0	0	0	0	15.96042	0	16.30383	0	0	0	0	0	0	17.5994	0	16.71222	0	0	0	0	0	0	0
Q9ULB1	NRX1A_HUMAN	Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha)	NRXN1 KIAA0578	Homo sapiens (Human)	"adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]"	cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]	"cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]"	acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]	GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030534; GO:0031965; GO:0031982; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0042995; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:2000463	DCSQEDNNVEGLAHLMMGDQGKSK	6.849999905	0.463015258	0.463015258	0.174702456	2678.187711	13.0683	14.50428	14.04892	14.96008	0	0	15.96146	13.20844	14.47611	15.30001	15.14274	0	13.30154	15.35004	0	11.83052	0	0	13.06166	0	0	0	0	0	0	10.51671	0	0	0	0	0	0	0	14.70665	14.47498	0	16.11308	0	0	0	18.35183	14.09567	0	0	0	0	14.13153	0
Q9ULC3	RAB23_HUMAN	Ras-related protein Rab-23	RAB23 HSPC137	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]	autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]	autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006886; GO:0006968; GO:0010008; GO:0012505; GO:0030054; GO:0030670; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094	NEEAEALAK	10.90999985	1	1	0.313749557	976.0554034	16.58551	17.20665	0	0	17.38153	0	0	0	0	0	16.50784	0	17.84183	17.45932	15.83138	0	0	0	0	0	16.26685	0	0	0	0	0	17.0528	19.42169	0	0	0	16.97673	0	0	0	0	17.05934	0	17.95468	17.796	0	0	0	0	0	16.63363	0	0
Q9ULC5	ACSL5_HUMAN	"Long-chain-fatty-acid--CoA ligase 5, EC 6.2.1.3 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5, LACS 5)"	ACSL5 ACS5 FACL5 UNQ633/PRO1250	Homo sapiens (Human)	lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0004467; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0008610; GO:0010747; GO:0016020; GO:0016021; GO:0035338; GO:0047676; GO:2001236	LAVSSK	13.47999954	0.979076803	0.979076803	0.260105394	603.8234241	16.23196	13.17335	0	15.68329	16.95616	17.77324	17.30854	17.92989	0	0	0	15.26011	17.4364	17.83859	0	16.8215	0	0	0	17.29968	16.33365	16.04569	15.85956	0	18.91427	16.15154	18.43773	16.34241	17.1534	0	0	18.94058	0	16.68714	16.30046	15.78176	16.42495	14.72862	15.29003	18.6881	16.94594	19.32362	16.97869	15.88581	14.30472	0	15.67814	16.31351
Q9ULD2	MTUS1_HUMAN	Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1)	MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1	Homo sapiens (Human)	regulation of macrophage chemotaxis [GO:0010758]	extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]	extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; microtubule binding [GO:0008017]; regulation of macrophage chemotaxis [GO:0010758]	microtubule binding [GO:0008017]	GO:0005615; GO:0005634; GO:0005730; GO:0005739; GO:0005794; GO:0005815; GO:0005819; GO:0005874; GO:0005886; GO:0008017; GO:0010758; GO:0015630	GKDLGTQNHTSELILSSPPGQK	1.75999999	1	1	0.192818523	2307.266444	16.05795	0	8.964159	0	0	13.60439	0	14.23037	0	0	0	13.62704	0	14.78827	0	0	0	0	0	0	0	0	0	0	14.18945	12.3463	0	0	0	10.47937	0	10.95296	15.27484	15.06084	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULD4	BRPF3_HUMAN	Bromodomain and PHD finger-containing protein 3	BRPF3 KIAA1286	Homo sapiens (Human)	chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; extracellular region [GO:0005576]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]	cytosol [GO:0005829]; extracellular region [GO:0005576]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]	GO:0000123; GO:0005576; GO:0005829; GO:0006325; GO:0006357; GO:0043966; GO:0044154; GO:0045740; GO:0046872; GO:0050793; GO:0070776; GO:1903706	SRGKPALSR	2.369999886	0.476395905	0.476395905	0.102002946	971.8592546	17.30563	16.01906	15.20299	0	0	0	16.38251	20.01913	13.85302	17.53209	12.22841	0	12.79707	14.84614	10.60958	0	17.06859	16.85657	16.54701	0	15.78293	16.8693	18.96759	17.80312	7.04091	15.32882	15.84188	13.82252	17.18513	17.65554	13.1825	18.32911	17.30181	0	15.54864	0	13.91742	0	16.74382	17.75964	15.1231	15.8862	14.39506	13.8049	0	0	16.27998	14.725
Q9ULD6	INTU_HUMAN	Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6)	INTU KIAA1284 PDZD6 PDZK6	Homo sapiens (Human)	cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; intraciliary transport [GO:0042073]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192]	cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]	cell surface [GO:0009986]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; intraciliary transport [GO:0042073]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192]		GO:0001736; GO:0005737; GO:0005929; GO:0007399; GO:0008589; GO:0009986; GO:0010839; GO:0016192; GO:0021513; GO:0021915; GO:0030216; GO:0030278; GO:0031069; GO:0031514; GO:0036064; GO:0042073; GO:0042733; GO:0043587; GO:0044458; GO:0045880; GO:0051782; GO:0060021; GO:0060173; GO:0060271; GO:1902017; GO:1905515	APPVMAYWVVGR	12.47000027	0.499385208	0.499385208	0.46998609	1362.950299	0	20.07532	0	0	0	18.46515	0	0	19.35123	0	0	0	18.40263	0	0	0	0	0	18.01302	0	0	0	0	0	0	19.10335	0	19.71635	18.7836	19.30291	0	0	0	19.35296	21.50333	0	0	19.59108	0	18.78293	17.13795	18.74614	18.66002	0	0	0	0	0
Q9ULD8	KCNH3_HUMAN	"Potassium voltage-gated channel subfamily H member 3 (Brain-specific eag-like channel 1, BEC1) (Ether-a-go-go-like potassium channel 2, ELK channel 2, ELK2) (Voltage-gated potassium channel subunit Kv12.2)"	KCNH3 KIAA1282	Homo sapiens (Human)	potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]	voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0016021; GO:0034765; GO:0042391; GO:0071805	GEVALFLVSHK	5.460000038	1	1	0.275760916	1200.020101	0	0	13.97544	11.96832	0	15.47359	0	15.25397	13.7965	0	0	0	0	0	0	15.05559	0	0	15.26562	0	0	16.58631	14.52104	14.3099	0	0	15.08839	0	0	0	16.46219	16.89554	0	0	16.91426	0	0	0	13.00031	14.7709	16.91034	0	0	0	0	0	0	15.94132
Q9ULD9	ZN608_HUMAN	Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36)	ZNF608 KIAA1281	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	metal ion binding [GO:0046872]	GO:0000122; GO:0005634; GO:0006357; GO:0046872	SAPDSGLMGNSMLVK	5.539999962	1	1	0.443963781	1505.592527	0	0	0	0	15.786	0	0	0	0	0	0	0	0	0	0	0	0	16.59185	0	18.03529	0	0	0	17.86363	0	0	0	16.33963	16.77504	15.7717	0	0	16.71491	0	0	16.26833	15.59406	16.75561	17.13511	16.76373	0	0	17.4987	16.72007	0	0	0	0
Q9ULE0	WWC3_HUMAN	Protein WWC3	WWC3 KIAA1280	Homo sapiens (Human)	"cell migration [GO:0016477]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hippo signaling [GO:0035330]; regulation of transcription, DNA-templated [GO:0006355]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; cell migration [GO:0016477]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hippo signaling [GO:0035330]; regulation of transcription, DNA-templated [GO:0006355]"	kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]	GO:0000122; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0035330; GO:0035331; GO:0046621; GO:0060090	DRLQLIK	3.029999971	1	1	0.097050628	883.886348	17.06943	14.45523	14.72611	0	0	15.2358	0	0	0	14.69033	0	13.135	14.29002	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.82326	16.03219	0	0	0	0
Q9ULE4	F184B_HUMAN	Protein FAM184B	FAM184B KIAA1276	Homo sapiens (Human)						HTVEIK	1.620000005	1	1	0.025602826	725.3008828	15.16405	16.26793	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.93539	0	0	0	0	0
Q9ULE6	PALD_HUMAN	Paladin	PALD1 KIAA1274 PALD	Homo sapiens (Human)		cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein tyrosine phosphatase activity [GO:0004725]	protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005737; GO:0005829	AHLSEPPPGK	6.059999943	1	1	4.63E-13	1032.329741	15.16173	14.63213	0	0	15.02886	0	15.23068	0	0	0	13.32028	13.21588	0	0	0	0	0	0	0	0	0	16.47767	17.06875	0	0	0	0	0	0	14.83516	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULF5	S39AA_HUMAN	"Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10, ZIP-10)"	SLC39A10 KIAA1265 ZIP10	Homo sapiens (Human)	cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578]	zinc ion transmembrane transporter activity [GO:0005385]	GO:0002903; GO:0005385; GO:0005887; GO:0006882; GO:0030890; GO:0050861; GO:0071578; GO:1903615	GEPSNEPSTETNK	7.570000172	1	1	0.546197922	1389.708126	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.98174	0	0	17.47598	0	0	0	0	0	0	0	0	18.9395	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULG1	INO80_HUMAN	"Chromatin-remodeling ATPase INO80, hINO80, EC 3.6.4.- (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80) (INO80 complex subunit A)"	INO80 INO80A INOC1 KIAA1259	Homo sapiens (Human)	"cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"	cytosol [GO:0005829]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	"cytosol [GO:0005829]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; histone binding [GO:0042393]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"	"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; histone binding [GO:0042393]"	GO:0000070; GO:0000723; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0006275; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0033044; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043618; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051225; GO:0051301; GO:0051726; GO:0060382; GO:0070914; GO:0071479; GO:0140658; GO:1904507; GO:2000045	GRPKGSGSTAK	5.179999828	1	1	0.063956355	1044.753116	14.88851	15.88535	16.20744	0	15.56861	0	0	14.9577	15.98861	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.04209	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULH0	KDIS_HUMAN	Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein)	KIDINS220 ARMS KIAA1250	Homo sapiens (Human)	cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]	PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]	GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090	DGNTALMIASK	7.53000021	1	1	0.29489214	1118.889112	15.90491	13.59746	15.51414	12.30526	15.92733	0	0	0	0	0	0	0	15.18566	0	0	0	0	13.26295	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULH4	LRFN2_HUMAN	Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1)	LRFN2 KIAA1246 SALM1	Homo sapiens (Human)	modulation of chemical synaptic transmission [GO:0050804]; regulation of postsynapse organization [GO:0099175]	cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; modulation of chemical synaptic transmission [GO:0050804]; regulation of postsynapse organization [GO:0099175]		GO:0005886; GO:0009986; GO:0050804; GO:0098685; GO:0099061; GO:0099175	VKMYQLQYNCSDDEVLIYR	2.119999886	0.079582669	0.079582669	0.038364302	2454.336337	0	0	17.21491	9.297158	15.32314	12.20938	15.85744	15.27272	0	15.55414	14.80494	14.00546	0	0	14.78388	0	15.81574	0	0	0	14.82717	0	17.49721	17.13482	14.04325	0	13.06751	0	0	0	15.18948	0	15.42809	15.64277	0	0	0	0	16.77007	0	16.38689	15.5294	16.35964	14.19508	0	0	15.69901	16.12451
Q9ULH7	MRTFB_HUMAN	"Myocardin-related transcription factor B, MRTF-B (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2)"	MRTFB KIAA1243 MKL2	Homo sapiens (Human)	muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]	nucleus [GO:0005634]	nucleus [GO:0005634]; cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713]; muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]	cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:1902895	MIDSSK	14.60999966	0.138525173	0.138525173	0.30000099	682.9404535	14.03725	15.43635	13.97882	0	0	0	0	0	0	0	0	14.67139	16.45059	0	14.66235	15.75044	16.36357	16.2236	17.30522	0	16.54754	16.9199	16.43215	0	17.2521	16.04623	0	15.1651	0	0	16.84887	16.66539	15.82897	16.3813	14.78005	16.90023	16.95096	0	19.00624	16.16743	16.35466	16.9273	17.5572	0	16.9263	0	18.51911	17.90126
Q9ULI0	ATD2B_HUMAN	ATPase family AAA domain-containing protein 2B	ATAD2B KIAA1240	Homo sapiens (Human)	positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; positive regulation of transcription by RNA polymerase II [GO:0045944]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]	GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0042393; GO:0045944; GO:0070577	LILEQAK	29.84000015	0.920502365	0.920502365	0.232147443	814.4905355	0	17.42806	17.76413	17.31739	17.43134	17.52003	17.75045	17.88669	17.84785	0	17.61919	17.5297	17.04638	16.74983	17.10517	17.97495	17.73448	17.81405	17.20044	17.83284	17.34978	17.41899	17.48246	18.1158	17.91311	16.9919	17.41122	16.92229	17.74717	17.4949	15.14285	17.85828	16.73168	16.91139	16.88221	17.8601	0	17.49261	0	16.74065	16.95507	17.71784	16.74781	17.82068	16.19625	17.4076	16.95108	16.79239
Q9ULI1	NWD2_HUMAN	NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)	NWD2 KIAA1239	Homo sapiens (Human)						ESTEVFAR	7.210000038	0.222358584	0.222358584	0.187776838	938.7950292	16.67596	0	14.55981	15.97169	17.03849	14.90631	16.11149	15.51171	11.71904	15.85596	14.82305	11.37407	14.94832	14.66394	13.4645	13.51562	15.24267	0	0	13.71114	14.73394	0	0	0	17.59048	16.31247	0	0	14.98017	0	14.62589	17.69328	0	0	0	16.31018	15.90328	16.63289	0	0	15.08365	0	13.45359	0	0	16.27719	15.326	0
Q9ULI3	HEG1_HUMAN	Protein HEG homolog 1	HEG1 KIAA1237	Homo sapiens (Human)	cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222]	cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222]	calcium ion binding [GO:0005509]	GO:0001570; GO:0001701; GO:0001886; GO:0001945; GO:0003017; GO:0003209; GO:0003222; GO:0003281; GO:0005509; GO:0005576; GO:0005911; GO:0007043; GO:0007507; GO:0009791; GO:0009897; GO:0016021; GO:0030324; GO:0035024; GO:0035264; GO:0048845; GO:0050878; GO:0055017; GO:0060039; GO:0090271; GO:1902414; GO:1905709; GO:2000299	GICNLVR	13.75	0.623617113	0.623617113	0.18865461	831.9169701	11.74208	0	0	0	0	14.74113	13.89466	14.46032	14.5548	14.55606	0	14.14642	0	16.60514	14.63975	0	0	0	0	0	0	0	0	0	0	11.3321	0	0	15.21097	0	0	15.86296	0	0	14.46215	0	0	0	0	15.37885	0	0	11.60262	12.49854	0	15.83148	16.75408	0
Q9ULI4	KI26A_HUMAN	Kinesin-like protein KIF26A	KIF26A KIAA1236	Homo sapiens (Human)	enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]	cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]	ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	GO:0001560; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0008017; GO:0009968; GO:0048484	AASKTK	2.440000057	1	1	0.146129652	603.5437373	0	0	0	0	0	0	0	0	15.91395	0	0	0	15.44112	0	0	0	0	0	0	0	0	16.21368	0	0	16.71262	0	0	0	0	15.73612	14.42163	0	16.34484	16.71675	16.2944	16.23353	0	15.1811	15.39649	0	0	17.34012	0	0	0	0	0	0
Q9ULJ1	ODF2L_HUMAN	Protein BCAP (Basal body centriole-associated protein) (Outer dense fiber protein 2-like)	ODF2L BCAP KIAA1229	Homo sapiens (Human)	cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of cilium assembly [GO:1902017]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of cilium assembly [GO:1902017]		GO:0005737; GO:0005813; GO:0005814; GO:0030030; GO:0034451; GO:0036064; GO:1902017; GO:1902018	QLEAALEEGRQK	8.079999924	1	1	6.91E-13	1378.337454	13.57009	0	0	0	16.03209	14.8282	15.12938	0	14.22659	0	11.07645	0	0	0	0	0	0	0	15.5783	16.09601	0	0	16.83314	0	0	0	0	0	14.52562	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.41646	0	0	0
Q9ULJ3	ZBT21_HUMAN	Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295)	ZBTB21 KIAA1227 ZNF295	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; POZ domain binding [GO:0031208]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; POZ domain binding [GO:0031208]; sequence-specific DNA binding [GO:0043565]"	GO:0000122; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008327; GO:0031208; GO:0042802; GO:0043565; GO:0045892; GO:0046872	EVYQCR	2.680000067	1	1	0.055208511	855.3922025	14.78194	15.22561	8.625778	0	16.44314	0	14.18429	16.84867	14.46196	0	15.28539	14.89678	0	14.64093	0	0	0	0	0	12.59215	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULJ7	ANR50_HUMAN	Ankyrin repeat domain-containing protein 50	ANKRD50 KIAA1223	Homo sapiens (Human)	endocytic recycling [GO:0032456]; protein transport [GO:0015031]	endosome [GO:0005768]	endosome [GO:0005768]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]		GO:0005768; GO:0015031; GO:0032456	VAALEGHR	9.970000267	1	1	0.032360753	852.4793409	14.573	14.53737	12.65205	0	0	0	16.54532	0	0	0	0	13.42724	0	14.09442	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.22636	15.98836	0	14.54857	0	0	15.50911	16.37382	0	12.12454	15.95292	0	0	15.78512	0	15.53448	0	0
Q9ULK0	GRID1_HUMAN	"Glutamate receptor ionotropic, delta-1, GluD1, GluR delta-1 subunit"	GRID1 KIAA1220	Homo sapiens (Human)	"modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]"	extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	"extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]"	glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]	GO:0004970; GO:0005886; GO:0008066; GO:0015276; GO:0035176; GO:0035249; GO:0038023; GO:0042802; GO:0045211; GO:0050804; GO:0070062; GO:0098978; GO:0099061; GO:1904315	WHSMASLNCIR	1.769999981	1	1	0.207802996	1373.51464	0	0	0	0	0	0	16.84718	0	0	0	0	0	0	0	0	0	15.57886	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.5744	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULK2	AT7L1_HUMAN	Ataxin-7-like protein 1 (Ataxin-7-like protein 4)	ATXN7L1 ATXN7L4 KIAA1218	Homo sapiens (Human)						VASPAK	2.880000114	1	1	0.112636344	570.1258857	15.14079	14.79283	14.92011	16.06572	15.6547	0	0	0	0	0	0	0	0	0	13.74926	0	0	0	0	15.70402	15.70598	0	0	16.07481	15.40738	0	0	0	0	15.28865	13.22452	15.80943	13.24006	14.01571	15.62094	0	16.88456	0	0	0	0	13.8668	13.10648	0	17.35411	0	0	0
Q9ULK4	MED23_HUMAN	"Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component, ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3, CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog, hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component, DRIP130)"	MED23 ARC130 CRSP3 DRIP130 KIAA1216 SUR2	Homo sapiens (Human)	"positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription coactivator activity [GO:0003713]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]"	transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006367; GO:0010628; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847	LISCLGAFR	7.449999809	1	1	0.160299919	1036.787458	0	0	0	0	15.26013	0	17.00097	0	0	16.98211	15.01523	0	11.26227	0	0	15.30644	0	18.31848	0	0	0	0	0	0	0	0	15.66593	0	10.9352	0	0	0	17.62738	0	0	0	0	17.522	0	0	0	0	0	0	15.83612	0	0	0
Q9ULK5	VANG2_HUMAN	Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2)	VANGL2 KIAA1215 STB1	Homo sapiens (Human)	"apical protein localization [GO:0045176]; cell migration involved in kidney development [GO:0035787]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]	"apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; apical protein localization [GO:0045176]; cell migration involved in kidney development [GO:0035787]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"		GO:0001736; GO:0001843; GO:0001947; GO:0005886; GO:0005911; GO:0016021; GO:0016324; GO:0016328; GO:0035787; GO:0045176; GO:0060071; GO:1905515	KVSGFK	10.47000027	0.264648527	0.264648527	0.206175507	667.3142998	0	15.3617	15.93352	0	0	0	0	0	0	0	12.76138	16.21831	0	0	15.89701	15.67574	17.50039	15.69684	0	17.25106	17.33404	0	16.80212	0	0	0	16.79695	15.58532	16.12635	15.60029	16.97656	16.5511	15.95657	0	15.39897	0	17.09493	15.38313	17.27054	17.12578	15.41134	14.65984	16.16651	15.11647	17.13126	0	0	16.02633
Q9ULL0	K1210_HUMAN	Acrosomal protein KIAA1210	KIAA1210	Homo sapiens (Human)		acrosomal vesicle [GO:0001669]	acrosomal vesicle [GO:0001669]		GO:0001669	APPSQKYK	4.539999962	1	1	0.025240217	917.4843535	0	15.07359	14.50037	13.01789	13.68373	14.42036	13.65611	14.08495	14.7102	0	14.57734	0	0	0	14.46952	13.2389	0	15.12696	16.15462	14.16597	0	14.96147	13.11588	0	11.00087	0	0	0	0	15.03547	14.09716	14.90462	0	12.27142	0	0	0	15.2821	0	15.48148	0	0	0	0	14.53194	14.9052	0	0
Q9ULL4	PLXB3_HUMAN	Plexin-B3	PLXNB3 KIAA1206 PLXN6	Homo sapiens (Human)	cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154]; cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]	cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154]	GO:0001938; GO:0002116; GO:0005886; GO:0005887; GO:0007156; GO:0007162; GO:0008360; GO:0009986; GO:0010593; GO:0010976; GO:0017154; GO:0019904; GO:0030334; GO:0030336; GO:0034260; GO:0043087; GO:0050772; GO:0050918; GO:0051022; GO:0060326; GO:0071526; GO:0098632; GO:1902287	QMVERYYADIR	8.729999542	0.396867156	0.396867156	0.058685581	1444.444048	0	0	0	0	0	0	0	0	10.82415	12.02578	15.70099	17.71244	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.799703	0	11.63472	15.24027	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.00653
Q9ULL8	SHRM4_HUMAN	Protein Shroom4 (Second homolog of apical protein)	SHROOM4 KIAA1202 SHAP	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]	actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; stress fiber [GO:0001725]	actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890]	actin filament binding [GO:0051015]; myosin II binding [GO:0045159]	GO:0001725; GO:0005654; GO:0005737; GO:0005884; GO:0005912; GO:0005925; GO:0007015; GO:0007420; GO:0009898; GO:0009925; GO:0016324; GO:0030036; GO:0030864; GO:0043231; GO:0043296; GO:0045159; GO:0050890; GO:0051015	AVCKSNEFEK	3.420000076	1	1	0.047311131	1213.241536	14.26125	11.44872	11.60855	15.16106	17.98345	11.81343	13.55571	0	0	0	0	12.61277	10.98253	14.85921	13.54804	0	0	0	0	0	0	13.48445	14.55748	0	14.23896	0	0	0	11.23538	9.795198	0	0	0	0	13.72928	0	0	0	0	0	15.82652	0	0	0	0	0	0	0
Q9ULM0	PKHH1_HUMAN	"Pleckstrin homology domain-containing family H member 1, PH domain-containing family H member 1"	PLEKHH1 KIAA1200	Homo sapiens (Human)		cytoskeleton [GO:0005856]	cytoskeleton [GO:0005856]		GO:0005856	EIVAGR	1.320000052	1	1	0.19308048	643.6681643	15.043	16.31499	16.67525	0	15.64161	15.88722	14.6914	14.8517	16.50579	0	0	0	16.39023	16.31333	0	0	15.31827	16.10019	16.09319	13.45018	0	16.60591	13.876	14.51227	15.42311	15.07758	16.32282	16.75834	0	17.0175	15.72343	0	0	0	13.59704	0	16.60365	15.38488	14.5299	16.75431	15.6648	16.37607	15.12338	14.98809	14.33811	16.54694	14.55265	0
Q9ULM6	CNOT6_HUMAN	"CCR4-NOT transcription complex subunit 6, EC 3.1.13.4 (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase)"	CNOT6 CCR4 CCR4a KIAA1194	Homo sapiens (Human)	"exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"	CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	"CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by miRNA [GO:0035195]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]"	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]	GO:0000175; GO:0000289; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0008284; GO:0010606; GO:0016020; GO:0030014; GO:0030374; GO:0035195; GO:0043928; GO:0046872; GO:0070966	NIIDKASR	5.760000229	1	1	0.238851398	915.8880814	15.62935	0	0	16.39994	0	0	15.33822	16.41613	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULN7	PNM8B_HUMAN	Paraneoplastic antigen-like protein 8B (PNMA-like protein 2)	PNMA8B KIAA1183 PNMAL2	Homo sapiens (Human)						GVTPEK	14.44999981	0.841153145	0.841153145	0.232638711	632.6822108	15.25254	15.23229	16.37789	15.08342	14.20313	15.97475	15.0001	13.50865	16.22835	16.33792	15.30525	16.52108	15.06629	15.65042	15.64831	15.89013	16.61872	0	15.59954	16.4737	16.87661	16.48923	0	16.08013	16.14857	0	15.49526	9.701278	15.11802	15.62793	15.71664	16.21354	16.21585	17.76789	0	17.54374	16.18127	0	15.87296	15.5823	16.75279	17.06433	16.48473	17.13552	0	15.90594	0	17.42004
Q9ULP9	TBC24_HUMAN	TBC1 domain family member 24	TBC1D24 KIAA1171	Homo sapiens (Human)	neuron death in response to oxidative stress [GO:0036475]; neuron projection development [GO:0031175]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; neuron death in response to oxidative stress [GO:0036475]; neuron projection development [GO:0031175]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005737; GO:0005886; GO:0030054; GO:0030659; GO:0031175; GO:0031594; GO:0036475; GO:0043195	ILACNDPGR	3.660000086	1	1	0.156845687	1015.560516	12.79702	0	14.15742	0	0	0	11.80882	0	14.64662	0	14.78877	0	12.5866	14.93345	0	15.51207	0	15.07159	13.59779	0	13.82399	0	13.93304	0	0	0	13.51024	0	14.49197	0	0	0	17.13005	0	0	15.72123	0	0	0	15.19404	0	17.6459	14.58514	0	0	0	15.35956	0
Q9ULR5	PAI2B_HUMAN	"Polyadenylate-binding protein-interacting protein 2B, PABP-interacting protein 2B, PAIP-2B, Poly(A)-binding protein-interacting protein 2B"	PAIP2B KIAA1155	Homo sapiens (Human)	negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]	cytoplasm [GO:0005737]	"cytoplasm [GO:0005737]; translation repressor activity [GO:0030371]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]"	"translation repressor activity [GO:0030371]; translation repressor activity, mRNA regulatory element binding [GO:0000900]"	GO:0000900; GO:0005737; GO:0017148; GO:0030371; GO:0045947	NGSNMANTSPSVK	7.170000076	1	1	0.513950343	1321.98831	0	0	0	0	0	0	0	0	0	0	0	0	17.30185	0	0	0	19.30913	0	0	0	0	0	0	18.93746	18.18368	0	0	17.85746	0	0	0	18.36627	0	0	0	0	0	0	0	15.93019	0	19.20589	0	0	0	0	0	0
Q9ULT0	TTC7A_HUMAN	"Tetratricopeptide repeat protein 7A, TPR repeat protein 7A"	TTC7A KIAA1140 TTC7	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; hemopoiesis [GO:0030097]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cellular iron ion homeostasis [GO:0006879]; hemopoiesis [GO:0030097]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659]		GO:0005737; GO:0005886; GO:0006879; GO:0030097; GO:0046854; GO:0072659	GRLAEVK	12.85999966	0.225180238	0.225180238	0.135489435	773.4359812	18.06501	17.26319	17.31932	16.00789	16.17401	16.87964	17.20554	13.95847	16.17934	17.3713	15.93494	17.09696	0	17.24188	0	16.65425	15.50972	17.24032	17.08585	16.61559	16.01607	0	17.12024	17.11605	16.48902	17.14937	17.03003	17.29907	16.89902	16.64697	17.47785	0	14.8589	16.78165	17.06575	15.83314	17.21147	16.75825	18.936	17.0401	14.716	16.60265	16.58802	16.11267	16.56432	17.10862	17.62435	16.04285
Q9ULT6	ZNRF3_HUMAN	"E3 ubiquitin-protein ligase ZNRF3, EC 2.3.2.27 (RING finger protein 203) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3)"	ZNRF3 KIAA1133 RNF203	Homo sapiens (Human)	"limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein ubiquitination [GO:0016567]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]"	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein ubiquitination [GO:0016567]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]"	frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0005109; GO:0005886; GO:0005887; GO:0006511; GO:0016055; GO:0016567; GO:0038018; GO:0046872; GO:0060173; GO:0061630; GO:0072089; GO:0090090; GO:2000051; GO:2000095	GLRCSR	4.360000134	1	1	0.021111481	748.8613216	0	0	0	0	0	0	0	16.333	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.29908	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULT8	HECD1_HUMAN	"E3 ubiquitin-protein ligase HECTD1, EC 2.3.2.26 (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1)"	HECTD1 KIAA1131	Homo sapiens (Human)	anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281]		metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281]	metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]	GO:0001779; GO:0001843; GO:0003170; GO:0003281; GO:0006511; GO:0032436; GO:0035904; GO:0046872; GO:0048856; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:1903077	DGFNK	2.24000001	1	1	0.139073727	580.3649838	0	0	0	13.37488	14.16617	15.65225	13.44389	16.11563	14.26011	15.74556	15.17667	15.95639	16.89532	16.53607	16.04355	16.6371	0	14.24147	0	16.11665	0	0	0	0	15.11939	16.31994	15.67017	15.06607	0	0	0	0	0	0	15.35723	0	0	0	0	0	15.70256	0	15.40227	0	17.41886	0	16.62744	0
Q9ULU4	PKCB1_HUMAN	"Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3, CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)"	ZMYND8 KIAA1125 PRKCBP1 RACK7	Homo sapiens (Human)	negative regulation of cell migration [GO:0030336]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; negative regulation of cell migration [GO:0030336]	DNA-binding transcription factor binding [GO:0140297]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0070577; GO:0140297	DPGSAERTAQK	3.700000048	0.714742184	0.714742184	0.215619238	1160.524089	0	14.72981	0	0	13.76551	0	18.3433	0	13.29878	14.79391	13.71248	0	0	14.2769	15.06554	0	15.02178	15.11119	14.57733	11.69646	0	0	0	14.64723	0	0	0	0	0	0	0	14.87658	0	15.60746	14.37027	0	0	14.67378	0	0	0	0	14.79908	0	0	0	14.77257	0
Q9ULU8	CAPS1_HUMAN	"Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1, CAPS-1)"	CADPS CAPS CAPS1 KIAA1121	Homo sapiens (Human)	dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079]	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal dense core vesicle membrane [GO:0099012]; presynapse [GO:0098793]	cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal dense core vesicle membrane [GO:0099012]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079]	lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]	GO:0005829; GO:0006887; GO:0008289; GO:0015031; GO:0016079; GO:0019901; GO:0045921; GO:0046872; GO:0098793; GO:0098978; GO:0099012; GO:1990504	VARMVQSGGCSANDSR	8.460000038	1	1	0.57186615	1694.420318	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.44114	0	0	18.20063	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULV3	CIZ1_HUMAN	Cip1-interacting zinc finger protein (CDKN1A-interacting zinc finger protein 1) (Nuclear protein NP94) (Zinc finger protein 356)	CIZ1 LSFR1 NP94 ZNF356	Homo sapiens (Human)	maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-dependent DNA replication initiation [GO:0032298]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin binding [GO:0030332]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-dependent DNA replication initiation [GO:0032298]	cyclin binding [GO:0030332]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	GO:0003676; GO:0005634; GO:0005654; GO:0005886; GO:0008270; GO:0030332; GO:0032298; GO:0051457	EPPGQLQVK	4.900000095	1	1	0.21534726	995.9946728	15.96442	13.13546	14.07124	16.05149	0	12.01292	0	0	13.87418	16.35093	0	13.9412	0	0	0	0	13.73096	0	18.47793	0	0	15.98808	15.02123	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.81171	0	14.36383	0	15.01627	0	0
Q9ULV4	COR1C_HUMAN	Coronin-1C (Coronin-3) (hCRNN4)	CORO1C CRN2 CRNN4	Homo sapiens (Human)	actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]; actin filament binding [GO:0051015]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]	actin filament binding [GO:0051015]; small GTPase binding [GO:0031267]	GO:0001755; GO:0001932; GO:0001933; GO:0005925; GO:0005938; GO:0006909; GO:0007015; GO:0007165; GO:0010008; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016197; GO:0016328; GO:0016477; GO:0016600; GO:0030017; GO:0030027; GO:0031267; GO:0032587; GO:0042383; GO:0044387; GO:0045184; GO:0045202; GO:0051015; GO:0051893; GO:0051895; GO:0090148; GO:0090630; GO:0097750; GO:0140285; GO:1900024; GO:1900025; GO:1900027; GO:2000394	KQEIVAEK	3.650000095	0.265378177	0.265378177	0.18520546	945.5378299	0	15.38626	15.27173	0	0	14.22169	0	14.2989	15.70175	0	0	15.47743	15.74772	0	17.14257	14.47645	15.05153	16.42356	16.10483	15.63782	15.35755	15.41242	15.56674	16.51605	16.96124	15.32051	0	14.5018	15.70747	15.62407	16.23472	0	15.40815	0	14.27689	14.08133	15.40025	16.65516	16.00644	16.012	15.52872	16.57665	12.29273	11.21851	16.44376	16.19862	15.56308	14.12624
Q9ULV5	HSF4_HUMAN	"Heat shock factor protein 4, HSF 4, hHSF4 (Heat shock transcription factor 4, HSTF 4)"	HSF4	Homo sapiens (Human)	cell development [GO:0048468]; histone H3-K9 demethylation [GO:0033169]; lens fiber cell differentiation [GO:0070306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; histone H3-K9 demethylation [GO:0033169]; lens fiber cell differentiation [GO:0070306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007601; GO:0008284; GO:0016607; GO:0019903; GO:0033169; GO:0042802; GO:0045597; GO:0045944; GO:0048468; GO:0070306; GO:1990837	LLGEVQALR	5.010000229	1	1	0.22810244	998.5892124	0	0	0	0	0	0	0	0	0	16.04211	14.91485	0	0	0	16.46128	0	0	0	0	0	0	0	0	14.29051	0	11.79568	0	16.31879	0	0	0	0	15.57459	14.31545	0	0	0	0	17.41904	0	0	0	0	0	0	0	0	0
Q9ULW0	TPX2_HUMAN	"Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2, DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Hepatocellular carcinoma-associated antigen 90) (Protein fls353) (Restricted expression proliferation-associated protein 100, p100)"	TPX2 C20orf1 C20orf2 DIL2 HCA519	Homo sapiens (Human)	activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of mitotic spindle organization [GO:0060236]	axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of mitotic spindle organization [GO:0060236]	importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]	GO:0000278; GO:0000922; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005880; GO:0006915; GO:0007020; GO:0007026; GO:0008017; GO:0015630; GO:0019901; GO:0030295; GO:0032147; GO:0043203; GO:0045171; GO:0051301; GO:0060236; GO:0061676; GO:0072686; GO:0090307	ARAVTCK	4.659999847	1	1	0.297471876	805.8492966	0	0	0	0	0	0	0	0	18.18628	17.13767	0	0	16.98481	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.54923	17.72445	0	0	0	0	0	0	0
Q9ULW2	FZD10_HUMAN	"Frizzled-10, Fz-10, hFz10 (FzE7) (CD antigen CD350)"	FZD10	Homo sapiens (Human)	canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; negative regulation of GTPase activity [GO:0034260]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; negative regulation of GTPase activity [GO:0034260]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956]	G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	GO:0004930; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0009986; GO:0016021; GO:0017147; GO:0030182; GO:0032956; GO:0034260; GO:0038031; GO:0042813; GO:0043507; GO:0043547; GO:0060070; GO:0071300	KAQHPQK	9.569999695	1	1	0.161985974	837.1386073	0	14.53441	0	0	11.7601	8.675522	14.45628	0	13.78759	12.66693	0	0	0	14.80836	0	10.92421	0	15.07313	15.71058	12.21284	0	0	13.68897	12.55996	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULW8	PADI3_HUMAN	"Protein-arginine deiminase type-3, EC 3.5.3.15 (Peptidylarginine deiminase III) (Protein-arginine deiminase type III)"	PADI3 PAD3 PDI3	Homo sapiens (Human)	histone citrullination [GO:0036414]; protein citrullination [GO:0018101]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-arginine deiminase activity [GO:0004668]; histone citrullination [GO:0036414]; protein citrullination [GO:0018101]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-arginine deiminase activity [GO:0004668]	GO:0004668; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0018101; GO:0036414; GO:0042802	EYPLGRILIGGNLPGSSGR	11.68999958	1	1	0.656296679	1956.67059	14.56779	17.00159	0	0	0	0	0	0	0	20.94262	0	0	0	0	19.71107	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9ULX5	RN112_HUMAN	"RING finger protein 112, EC 2.3.2.27 (Brain finger protein) (Zinc finger protein 179)"	RNF112 BFP ZNF179	Homo sapiens (Human)	cell death in response to hydrogen peroxide [GO:0036474]; cell death in response to oxidative stress [GO:0036473]; embryonic brain development [GO:1990403]; endoplasmic reticulum organization [GO:0007029]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neuron differentiation [GO:0030182]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of neuron differentiation [GO:0045666]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; regulation of cell cycle [GO:0051726]; response to hydroperoxide [GO:0033194]	cell body [GO:0044297]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]	cell body [GO:0044297]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell death in response to hydrogen peroxide [GO:0036474]; cell death in response to oxidative stress [GO:0036473]; embryonic brain development [GO:1990403]; endoplasmic reticulum organization [GO:0007029]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neuron differentiation [GO:0030182]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of neuron differentiation [GO:0045666]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; regulation of cell cycle [GO:0051726]; response to hydroperoxide [GO:0033194]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0007029; GO:0008021; GO:0008270; GO:0014069; GO:0016021; GO:0016604; GO:0019898; GO:0030182; GO:0033194; GO:0036473; GO:0036474; GO:0043005; GO:0043204; GO:0043621; GO:0044297; GO:0045666; GO:0045687; GO:0051260; GO:0051726; GO:0051865; GO:0061630; GO:0070315; GO:1990403	VLPDTMR	3.700000048	1	1	0.165298988	847.6827336	0	0	16.90958	0	0	0	0	0	0	0	0	0	0	0	0	15.69553	0	0	0	0	0	0	15.9591	0	0	16.36848	0	0	0	0	0	0	15.40357	16.23564	0	0	16.13811	0	0	0	0	0	0	0	16.11316	0	0	0
Q9ULX6	AKP8L_HUMAN	"A-kinase anchor protein 8-like, AKAP8-like protein (Helicase A-binding protein 95, HAP95) (Homologous to AKAP95 protein, HA95) (Neighbor of A-kinase-anchoring protein 95, Neighbor of AKAP95)"	AKAP8L NAKAP NAKAP95 HRIHFB2018	Homo sapiens (Human)	cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear membrane disassembly [GO:0051081]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone phosphorylation [GO:0033127]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear membrane disassembly [GO:0051081]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone phosphorylation [GO:0033127]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380]	DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]	GO:0000785; GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005737; GO:0006397; GO:0007076; GO:0008380; GO:0010793; GO:0016363; GO:0016605; GO:0016607; GO:0017151; GO:0031065; GO:0033127; GO:0034237; GO:0042826; GO:0044839; GO:0045944; GO:0046872; GO:0051081; GO:1990904	TMDHNRNR	6.269999981	1	1	0.157588747	1061.721887	0	13.40572	0	0	0	0	12.3206	15.37147	0	0	0	0	15.96205	0	0	14.3759	15.36094	15.74517	14.09939	12.26084	15.00177	0	17.37865	0	0	0	0	0	0	0	0	0	0	14.3957	0	0	0	0	0	0	0	15.6453	0	0	15.07027	17.18377	0	0
Q9UM00	TMCO1_HUMAN	"Calcium load-activated calcium channel, CLAC channel (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3)"	TMCO1 TMCC4 PNAS-10 PNAS-136 UNQ151/PRO177	Homo sapiens (Human)	calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; ribosome binding [GO:0043022]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]	calcium channel activity [GO:0005262]; ribosome binding [GO:0043022]	GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0006874; GO:0006983; GO:0030176; GO:0032469; GO:0043022; GO:0070588	ILGLAPSR	10.85000038	1	1	0.58615938	830.0607688	16.20416	0	0	0	0	16.42243	0	0	0	0	0	17.4003	0	16.63286	0	0	0	0	0	0	0	0	0	0	15.95739	0	0	0	0	0	17.53714	0	0	0	0	0	0	0	16.97236	0	0	0	0	16.62177	0	0	17.31281	0
Q9UM11	FZR1_HUMAN	"Fizzy-related protein homolog, Fzr (CDC20-like protein 1) (Cdh1/Hct1 homolog, hCDH1)"	FZR1 CDH1 FYR FZR KIAA1242	Homo sapiens (Human)	anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell aging [GO:0090344]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346]	anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]	GO:0005654; GO:0005680; GO:0005829; GO:0006281; GO:0007095; GO:0007346; GO:0008284; GO:0010997; GO:0031145; GO:0031965; GO:0040020; GO:0045732; GO:0051301; GO:0051445; GO:0070306; GO:0070979; GO:0090344; GO:1904668; GO:1905786; GO:1990757	QIVIQNENTMPRVTEMR	1.090000033	0.498589605	0.498589605	0.383746688	2073.891978	0	0	0	0	0	0	15.19933	0	13.95627	0	14.43405	0	15.02108	0	0	0	0	12.06794	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.80406	0	0	0	0	0	0	0	0	0	0	0	0
Q9UM19	HPCL4_HUMAN	"Hippocalcin-like protein 4, HLP4"	HPCAL4	Homo sapiens (Human)	central nervous system development [GO:0007417]; signal transduction [GO:0007165]		calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; central nervous system development [GO:0007417]; signal transduction [GO:0007165]	calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]	GO:0005246; GO:0005509; GO:0007165; GO:0007417; GO:0008022; GO:0019904	MVGTVIMMR	2.720000029	1	1	0.354232688	1070.161604	0	0	14.04988	0	0	0	0	0	0	0	17.22005	0	0	0	0	15.399	0	0	0	0	16.65785	0	16.37515	0	0	0	16.19821	17.33627	15.9098	0	0	15.53638	0	0	14.65109	0	0	0	14.08004	0	0	18.38103	0	0	0	0	0	0
Q9UM21	MGT4A_HUMAN	"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A, EC 2.4.1.145 (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa, GlcNAc-T IVa, GnT-IVa, N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa) [Cleaved into: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form ]"	MGAT4A	Homo sapiens (Human)	glyoxylate metabolic process [GO:0046487]; N-glycan processing [GO:0006491]; positive regulation of protein glycosylation in Golgi [GO:0090284]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; peroxisome [GO:0005777]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; peroxisome [GO:0005777]; acetylglucosaminyltransferase activity [GO:0008375]; alanine-glyoxylate transaminase activity [GO:0008453]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; glyoxylate metabolic process [GO:0046487]; N-glycan processing [GO:0006491]; positive regulation of protein glycosylation in Golgi [GO:0090284]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082]"	"acetylglucosaminyltransferase activity [GO:0008375]; alanine-glyoxylate transaminase activity [GO:0008453]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]"	GO:0000139; GO:0005777; GO:0005783; GO:0005788; GO:0005793; GO:0005795; GO:0006487; GO:0006491; GO:0008375; GO:0008453; GO:0008454; GO:0016021; GO:0019082; GO:0042803; GO:0046487; GO:0046872; GO:0070062; GO:0090284	EFLALK	10.57999992	0.657352448	0.657352448	0.252960408	720.708459	15.58858	14.7796	0	0	0	17.08125	0	0	20.10227	0	0	17.09632	0	0	18.56894	18.88775	0	0	0	0	16.80951	17.42189	0	0	0	0	0	0	0	0	0	0	0	0	18.87454	0	18.18356	0	0	17.42361	0	0	0	0	18.15352	0	0	0
Q9UM47	NOTC3_HUMAN	"Neurogenic locus notch homolog protein 3, Notch 3 [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain ]"	NOTCH3	Homo sapiens (Human)	artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]	GO:0000122; GO:0000139; GO:0005509; GO:0005576; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0015629; GO:0016021; GO:0019899; GO:0030900; GO:0038023; GO:0042802; GO:0043235; GO:0045296; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104	DGINR	10.68999958	0.008318659	0.008318659	0.314008915	574.9325893	17.31965	17.87689	19.25293	0	0	18.99943	0	0	0	0	16.72515	0	0	0	0	18.00766	16.55321	0	0	0	0	0	0	18.08732	0	0	0	0	18.81839	17.59195	0	18.17834	0	18.01764	18.43066	0	0	0	0	0	0	0	17.51582	0	0	0	0	0
Q9UM54	MYO6_HUMAN	Unconventional myosin-VI (Unconventional myosin-6)	MYO6 KIAA0389	Homo sapiens (Human)	"actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]"	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]"	"actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]"	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]	GO:0000146; GO:0001726; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016461; GO:0016591; GO:0030048; GO:0030050; GO:0030139; GO:0030175; GO:0030330; GO:0030665; GO:0031410; GO:0031941; GO:0031965; GO:0031982; GO:0032587; GO:0042472; GO:0042491; GO:0042802; GO:0043531; GO:0045944; GO:0048471; GO:0051015; GO:0051046; GO:0060001; GO:0070062	AEACIKMQK	13.38000011	1	1	0.089597163	1095.448411	15.23687	14.76662	0	11.17212	0	12.67384	11.91678	12.40031	13.51467	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.79756	0	0	0	0	0	0	0
Q9UM73	ALK_HUMAN	"ALK tyrosine kinase receptor, EC 2.7.10.1 (Anaplastic lymphoma kinase) (CD antigen CD246)"	ALK	Homo sapiens (Human)	adult behavior [GO:0030534]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; adult behavior [GO:0030534]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; neuron development [GO:0048666]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	GO:0004704; GO:0004712; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0016310; GO:0021766; GO:0030534; GO:0032991; GO:0033674; GO:0036269; GO:0042127; GO:0042802; GO:0042981; GO:0043235; GO:0043410; GO:0045664; GO:0046777; GO:0048666; GO:0050995; GO:0051092; GO:0060159; GO:0070062; GO:0090648; GO:0097009; GO:1900006	EPHDR	5.909999847	0.318987072	0.318987072	4.59E-13	654.3249877	12.63827	14.60029	14.72887	0	0	15.15186	16.83628	0	15.22341	16.27595	15.77509	15.32827	0	16.42078	15.24589	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.14945
Q9UM82	SPAT2_HUMAN	Spermatogenesis-associated protein 2	SPATA2 KIAA0757 PD1	Homo sapiens (Human)	necroptotic process [GO:0070266]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of inflammatory response [GO:0050727]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin-specific protease binding [GO:1990381]; necroptotic process [GO:0070266]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of inflammatory response [GO:0050727]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]	protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin-specific protease binding [GO:1990381]	GO:0001650; GO:0005654; GO:0005737; GO:0007283; GO:0010803; GO:0030159; GO:0044877; GO:0050727; GO:0060544; GO:0070266; GO:0070536; GO:0072520; GO:1990108; GO:1990381	FMPNNQLNYKSTQLSHLVYR	3.609999895	1	1	1.38E-12	2469.080058	0	0	0	0	15.9585	0	16.6842	0	0	0	0	0	0	16.24333	0	0	0	0	0	0	16.90914	0	0	15.01346	0	0	0	0	0	0	17.12795	0	16.73795	14.19952	0	16.38283	0	0	0	0	0	0	0	0	0	0	0	0
Q9UMD9	COHA1_HUMAN	"Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1, LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen, 97 kDa LAD antigen, 97-LAD) (Linear IgA bullous disease antigen of 97 kDa, LABD97) ]"	COL17A1 BP180 BPAG2	Homo sapiens (Human)	cell-matrix adhesion [GO:0007160]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hemidesmosome [GO:0030056]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hemidesmosome [GO:0030056]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell-matrix adhesion [GO:0007160]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0005886; GO:0005887; GO:0005911; GO:0007160; GO:0008544; GO:0030020; GO:0030056; GO:0030198; GO:0031012; GO:0031581; GO:0062023	GDMGSPGPKGDR	6.449999809	1	1	0.116400238	1175.591697	0	0	6.120511	18.06898	12.20104	12.81892	0	0	7.758375	0	0	0	13.76633	0	0	0	0	0	13.78997	0	0	16.57612	0	0	13.83371	0	15.4173	0	0	0	0	0	0	0	0	0	0	15.71585	0	0	0	0	0	0	0	0	0	14.40189
Q9UMF0	ICAM5_HUMAN	"Intercellular adhesion molecule 5, ICAM-5 (Telencephalin)"	ICAM5 TLCN TLN	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909]	integrin binding [GO:0005178]	GO:0005178; GO:0005886; GO:0005887; GO:0006909; GO:0007155; GO:0098609	GAVLTATVLAR	9.350000381	0.131069973	0.131069973	0.100599232	1070.978391	16.33588	0	14.43421	0	16.00104	0	18.25511	0	0	17.21786	0	13.32529	0	11.56335	0	0	16.03113	10.67189	16.24325	13.46088	14.68766	0	0	16.76598	0	9.199366	15.34602	17.09539	17.57855	14.61391	0	0	17.00903	17.01366	16.76279	16.85986	14.57083	0	8.789617	0	0	0	0	0	13.66492	15.6046	14.62299	17.0899
Q9UMN6	KMT2B_HUMAN	"Histone-lysine N-methyltransferase 2B, Lysine N-methyltransferase 2B, EC 2.1.1.364 (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7, WBP-7)"	KMT2B HRX2 KIAA0304 MLL2 MLL4 TRX2 WBP7	Homo sapiens (Human)	"chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription, DNA-templated [GO:0045893]"	histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription, DNA-templated [GO:0045893]"	histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	GO:0005634; GO:0005654; GO:0006325; GO:0008270; GO:0035097; GO:0042800; GO:0044648; GO:0044665; GO:0045322; GO:0045893; GO:0051568; GO:0097692	FPGRPRGAGGGGGR	5.019999981	1	1	0.089563404	1298.124343	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.97136	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.54009	0	0	0	0	0	0	0	0	0	0	0
Q9UMQ6	CAN11_HUMAN	"Calpain-11, EC 3.4.22.- (Calcium-activated neutral proteinase 11, CANP 11)"	CAPN11	Homo sapiens (Human)	proteolysis [GO:0006508]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]	calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233]	GO:0001669; GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0008233	GFGLDACR	10.52000046	1	1	0.054394062	894.5973911	0	14.66158	17.56929	0	16.47595	15.4291	0	15.85303	0	14.24752	14.38932	0	0	0	0	0	0	0	0	15.62927	14.03755	16.21083	0	16.73777	15.71689	13.54037	0	0	16.04706	0	0	15.08341	15.49656	15.31368	13.18022	0	17.03367	0	16.78419	15.3473	14.81617	0	17.46019	0	16.10776	16.6385	0	0
Q9UMR2	DD19B_HUMAN	"ATP-dependent RNA helicase DDX19B, EC 3.6.4.13 (DEAD box RNA helicase DEAD5) (DEAD box protein 19B)"	DDX19B DBP5 DDX19 TDBP	Homo sapiens (Human)	mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006406; GO:0010494; GO:0016020; GO:0016887; GO:0016973; GO:0070062	HSMNILNRIQEHFNK	6.449999809	1	1	0.157092565	1896.133516	0	18.40107	0	15.13495	0	0	0	9.765998	16.06142	0	0	0	14.13542	15.0844	0	0	13.91686	0	0	0	0	0	0	15.48409	14.0879	0	0	0	0	0	0	0	0	0	16.4977	0	0	0	16.91085	0	0	0	0	0	12.57634	0	0	0
Q9UMR7	CLC4A_HUMAN	C-type lectin domain family 4 member A (C-type lectin DDB27) (C-type lectin superfamily member 6) (Dendritic cell immunoreceptor) (Lectin-like immunoreceptor) (CD antigen CD367)	CLEC4A CLECSF6 DCIR LLIR HDCGC13P	Homo sapiens (Human)	"adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]"	external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	"external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; negative regulation of cytokine production [GO:0001818]; negative regulation of tumor necrosis factor production [GO:0032720]; plasmacytoid dendritic cell antigen processing and presentation [GO:0002470]"	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]	GO:0001818; GO:0002250; GO:0002470; GO:0004888; GO:0005509; GO:0005537; GO:0005886; GO:0005887; GO:0006955; GO:0007155; GO:0007166; GO:0009897; GO:0030246; GO:0032720; GO:0036037; GO:0042590; GO:0061760	SVCEMMK	5.920000076	1	1	0.478271222	915.5299039	0	0	0	0	15.16972	0	0	0	0	16.91997	0	0	15.63249	0	0	0	0	0	0	0	0	16.62449	0	15.96082	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UMS0	NFU1_HUMAN	"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)"	NFU1 HIRIP5 CGI-33	Homo sapiens (Human)	iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]"	"4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]"	GO:0005506; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016226; GO:0051539; GO:0097428	AATARR	8.329999924	1	1	0.273333273	646.9458998	15.51486	0	0	15.92189	0	14.9943	14.98334	0	14.45648	16.19587	15.21488	0	0	0	0	0	14.62108	0	0	0	0	0	0	0	0	0	0	15.69467	0	0	0	0	0	0	0	15.54945	0	0	16.72155	0	0	0	0	0	0	0	0	0
Q9UMS5	PHTF1_HUMAN	Protein PHTF1	PHTF1 PHTF	Homo sapiens (Human)		cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]		GO:0005789; GO:0005801; GO:0016021	DSDSLAESEFESAAFSQGSR	2.5	1	1	4.71E-13	2119.428405	20.34206	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UMS6	SYNP2_HUMAN	Synaptopodin-2 (Genethonin-2) (Myopodin)	SYNPO2	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; vesicle tethering complex [GO:0099023]; Z disc [GO:0030018]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; vesicle tethering complex [GO:0099023]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein-macromolecule adaptor activity [GO:0030674]; autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]	14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein-macromolecule adaptor activity [GO:0030674]	GO:0000045; GO:0001725; GO:0003779; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0015629; GO:0030018; GO:0030335; GO:0030674; GO:0031005; GO:0032233; GO:0043231; GO:0051371; GO:0051393; GO:0061684; GO:0071889; GO:0099023; GO:2000298	EQDAAQTDGLRTTTSYQR	4.769999981	0.994272649	0.994272649	1.38E-12	2040.90062	10.79352	0	0	0	0	14.05468	13.55423	12.32776	0	14.64541	15.95591	0	0	0	0	0	15.3664	0	0	0	0	0	0	0	0	0	0	0	0	0	15.51244	14.73705	0	0	0	16.26236	0	0	0	0	0	0	17.55522	0	0	15.9004	0	0
Q9UMX0	UBQL1_HUMAN	"Ubiquilin-1 (Protein linking IAP with cytoskeleton 1, PLIC-1, hPLIC-1)"	UBQLN1 DA41 PLIC1	Homo sapiens (Human)	aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]	aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]	GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071	QQLPTFLQQMQNPDTLSAMSNPR	5.809999943	1	1	0.411301974	2676.828374	16.26704	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UMX2	OAZ3_HUMAN	"Ornithine decarboxylase antizyme 3, AZ3, ODC-Az 3"	OAZ3	Homo sapiens (Human)	negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283]	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ornithine decarboxylase inhibitor activity [GO:0008073]; negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283]	ornithine decarboxylase inhibitor activity [GO:0008073]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0007283; GO:0008073; GO:0045732; GO:0072562; GO:0090316; GO:1902268	EKMLPR	28.5	2.48E-06	2.48E-06	0.236789712	773.9894025	17.30484	18.51523	19.11555	16.2455	0	17.02968	0	17.61076	18.21541	18.83773	16.74737	0	0	18.11073	0	17.50396	0	0	16.66448	0	19.14628	20.3455	0	20.75012	0	0	19.65654	18.06323	19.02803	16.37726	0	20.85932	21.46069	0	0	0	0	19.21748	18.92096	0	18.29049	18.4529	17.85476	0	20.92485	0	0	17.55114
Q9UMX3	BOK_HUMAN	"Bcl-2-related ovarian killer protein, hBOK (Bcl-2-like protein 9, Bcl2-L-9)"	BOK BCL2L9	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein complex oligomerization [GO:0051259]; regulation of autophagy [GO:0010506]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of granulosa cell apoptotic process [GO:1904708]; release of cytochrome c from mitochondria [GO:0001836]	cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]	cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; BH domain binding [GO:0051400]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein complex oligomerization [GO:0051259]; regulation of autophagy [GO:0010506]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of granulosa cell apoptotic process [GO:1904708]; release of cytochrome c from mitochondria [GO:0001836]	BH domain binding [GO:0051400]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]	GO:0001836; GO:0005102; GO:0005634; GO:0005640; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0006915; GO:0006919; GO:0006921; GO:0007420; GO:0008584; GO:0008630; GO:0008635; GO:0010506; GO:0016020; GO:0016021; GO:0031625; GO:0031901; GO:0031966; GO:0032588; GO:0033106; GO:0042803; GO:0043065; GO:0043524; GO:0044877; GO:0046982; GO:0048709; GO:0051259; GO:0051400; GO:0051402; GO:0051480; GO:0051902; GO:0055038; GO:0060546; GO:0072332; GO:0097192; GO:1900119; GO:1901029; GO:1901030; GO:1901382; GO:1902237; GO:1903899; GO:1904708; GO:2001244	KTLATWLR	3.410000086	0.52885884	0.52885884	0.245278582	989.0486769	0	16.9276	0	0	0	0	17.23323	17.03434	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.14874	16.37233	0	0	0	18.36079	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UMY4	SNX12_HUMAN	Sorting nexin-12	SNX12	Homo sapiens (Human)	endocytic recycling [GO:0032456]; late endosome to Golgi transport [GO:0034499]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; retromer complex [GO:0030904]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; retromer complex [GO:0030904]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endocytic recycling [GO:0032456]; late endosome to Golgi transport [GO:0034499]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]	enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0005769; GO:0010629; GO:0010955; GO:0015031; GO:0019899; GO:0030100; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0034499; GO:0035091; GO:0042177; GO:0051224; GO:2000642	IVVPPLPGKALK	17.63999939	0.270763099	0.270763099	0.161639718	1231.816469	14.36817	13.2467	13.29797	0	13.39685	13.14419	13.66017	12.8486	0	13.42351	12.35251	15.0257	15.55193	0	0	0	0	0	0	0	14.51151	0	15.74144	15.21512	0	0	0	0	0	0	0	16.58966	16.30702	0	12.80665	0	0	14.70863	16.35233	0	0	0	0	0	0	0	0	14.09696
Q9UMZ2	SYNRG_HUMAN	Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin)	SYNRG AP1GBP1 SYNG	Homo sapiens (Human)	endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]	AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]		GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471	SVSTPQSTGSAATMTALAATK	4.139999866	0.273711741	0.273711741	0.004617132	1994.201346	0	0	0	0	17.16629	0	0	0	13.97524	0	0	0	0	0	0	16.17919	0	0	14.4824	0	0	17.05331	14.87331	0	15.0244	15.1969	0	0	0	0	0	0	17.49672	0	14.85076	0	17.32635	0	0	0	16.16516	0	13.72115	0	13.34874	0	15.33207	0
Q9UN30	SCML1_HUMAN	Sex comb on midleg-like protein 1	SCML1	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]	GO:0003682; GO:0005634; GO:0042393; GO:0045892	IQRFHAR	1.00999999	1	1	0.153108775	927.8811818	13.6828	0	0	0	0	0	0	13.82506	15.98586	0	0	0	0	0	15.32456	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.26053	0	0	16.23255	15.48367	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UN36	NDRG2_HUMAN	Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613)	NDRG2 KIAA1248 SYLD	Homo sapiens (Human)	cell differentiation [GO:0030154]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of smooth muscle cell proliferation [GO:0048662]; regulation of platelet-derived growth factor production [GO:0090361]; regulation of vascular endothelial growth factor production [GO:0010574]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of smooth muscle cell proliferation [GO:0048662]; regulation of platelet-derived growth factor production [GO:0090361]; regulation of vascular endothelial growth factor production [GO:0010574]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]; Wnt signaling pathway [GO:0016055]		GO:0001818; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0007165; GO:0010574; GO:0016055; GO:0021762; GO:0030154; GO:0030426; GO:0048471; GO:0048662; GO:0070062; GO:0070373; GO:0090361	GGDITLR	7.679999828	1	1	0.252527109	732.5837234	17.10542	0	16.9087	0	17.50864	0	0	0	0	0	0	0	17.8001	18.83426	0	19.67763	0	18.68984	18.49979	0	17.69657	0	19.5856	17.71226	20.26391	0	0	19.83634	0	0	0	20.01296	0	19.93129	0	18.3205	17.69033	0	0	0	17.55062	0	0	17.65858	0	20.23737	0	0
Q9UN37	VPS4A_HUMAN	"Vacuolar protein sorting-associated protein 4A, EC 3.6.4.6 (Protein SKD2) (VPS4-1, hVPS4)"	VPS4A VPS4	Homo sapiens (Human)	abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear membrane reassembly [GO:0007084]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]	ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein disaggregase activity [GO:0140545]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear membrane reassembly [GO:0007084]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein disaggregase activity [GO:0140545]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]	GO:0000916; GO:0000922; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006914; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0007084; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0043162; GO:0044877; GO:0044878; GO:0046761; GO:0048471; GO:0051301; GO:0060548; GO:0061640; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0072319; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:0140545; GO:1903076; GO:1903543; GO:1903774; GO:1904896; GO:1904903; GO:1904949	TEGYSGADISIIVR	8.850000381	1	1	0.576798015	1479.896959	0	0	0	17.83323	0	0	0	18.31561	0	0	0	0	0	0	0	0	0	18.20216	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.32345	0	0	0	0	0
Q9UN67	PCDBA_HUMAN	"Protocadherin beta-10, PCDH-beta-10"	PCDHB10 UNQ1906/PRO4352	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0045202	SGTSTVR	2.74000001	1	1	0.142519061	706.1626	15.62279	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.95536	0	0	0	0	19.62089	0	0	0	0	16.16381	0	0	0	0	17.16849	16.5078	0	0	0	0	0	16.66065	0	0	16.45975	0	0	0	0
Q9UN70	PCDGK_HUMAN	"Protocadherin gamma-C3, PCDH-gamma-C3 (Protocadherin-2) (Protocadherin-43, PC-43)"	PCDHGC3 PCDH2	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; synapse organization [GO:0050808]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; synapse organization [GO:0050808]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0016020; GO:0016339; GO:0043524; GO:0050808	DAGTPSLSALTIVR	2.140000105	1	1	0.207796636	1400.551057	0	0	0	0	0	0	0	0	15.71675	0	14.64766	16.15551	0	0	0	0	0	15.55478	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UN71	PCDGG_HUMAN	"Protocadherin gamma-B4, PCDH-gamma-B4 (Cadherin-20) (Fibroblast cadherin-2)"	PCDHGB4 CDH20 FIB2	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0016020; GO:0016339	SDGSK	3.329999924	1	1	0.206617124	494.1884193	12.75469	18.5861	19.45498	0	0	16.52596	0	0	17.6535	0	0	17.46032	0	16.18927	17.40602	0	0	15.45501	0	16.40503	0	0	0	18.78952	18.99834	18.93324	18.4885	0	0	17.19111	0	17.34132	0	0	18.8677	19.04335	18.93266	0	0	16.46783	0	0	16.53729	0	0	15.7581	0	0
Q9UN74	PCDA4_HUMAN	"Protocadherin alpha-4, PCDH-alpha-4"	PCDHA4	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0042802	SKFHIDPITGQIIVK	3.200000048	1	1	0.267160323	1692.83256	14.96477	0	13.83203	0	0	0	0	0	15.13642	0	0	0	0	0	0	0	0	0	0	16.14691	14.01503	0	0	0	0	14.665	0	0	0	0	0	0	0	16.78336	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UN79	SOX13_HUMAN	Transcription factor SOX-13 (Islet cell antigen 12) (SRY (Sex determining region Y)-box 13) (Type 1 diabetes autoantigen ICA12)	SOX13	Homo sapiens (Human)	"anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; gamma-delta T cell differentiation [GO:0042492]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord oligodendrocyte cell differentiation [GO:0021529]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; gamma-delta T cell differentiation [GO:0042492]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord oligodendrocyte cell differentiation [GO:0021529]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001217; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0009653; GO:0021529; GO:0042492; GO:0042802; GO:0043565; GO:0045165; GO:0045588; GO:0045892; GO:0090090; GO:0090336	AIQDAR	1.110000014	0.896874666	0.896874666	0.211037531	671.7420387	15.24234	9.059141	14.70912	14.14083	0	14.81212	16.19732	0	0	15.17727	13.82187	15.09904	0	14.85945	14.34008	16.0422	0	15.20936	15.84093	14.52101	16.07605	15.84115	15.0507	0	16.62005	0	0	0	16.00221	0	0	0	0	16.47647	0	16.22013	15.47448	0	0	14.78477	0	0	0	13.29486	16.00571	0	15.69588	0
Q9UN81	LORF1_HUMAN	"LINE-1 retrotransposable element ORF1 protein, L1ORF1p (LINE retrotransposable element 1) (LINE1 retrotransposable element 1)"	L1RE1 LRE1	Homo sapiens (Human)	"transposition, RNA-mediated [GO:0032197]"	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]	"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transposition, RNA-mediated [GO:0032197]"	identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	GO:0000166; GO:0003697; GO:0003727; GO:0005730; GO:0005737; GO:0010494; GO:0032197; GO:0036464; GO:0042802; GO:1990904	QANVQIQEIQR	3.230000019	0.820357144	0.820357144	4.58E-13	1329.825959	14.68614	0	0	14.37305	14.32489	16.05149	14.09545	0	14.68512	13.70883	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.68762	0	0	0	13.86092	0	0	0	0	0	0	0	0	0	0	0	14.65794	0	14.53468	0	11.80919	0	0	0
Q9UNA0	ATS5_HUMAN	"A disintegrin and metalloproteinase with thrombospondin motifs 5, ADAM-TS 5, ADAM-TS5, ADAMTS-5, EC 3.4.24.- (A disintegrin and metalloproteinase with thrombospondin motifs 11, ADAM-TS 11, ADAMTS-11) (ADMP-2) (Aggrecanase-2)"	ADAMTS5 ADAMTS11 ADMP2	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]; negative regulation of cold-induced thermogenesis [GO:0120163]; proteolysis [GO:0006508]; tooth eruption [GO:0044691]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]; negative regulation of cold-induced thermogenesis [GO:0120163]; proteolysis [GO:0006508]; tooth eruption [GO:0044691]	endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004175; GO:0004222; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0006508; GO:0007520; GO:0008201; GO:0008233; GO:0008237; GO:0008270; GO:0022617; GO:0030198; GO:0031012; GO:0042742; GO:0044691; GO:0050840; GO:0062023; GO:0120163	VGYLVYAGGR	6.429999828	1	1	0.151617216	1053.319386	14.36308	0	16.23313	15.36561	0	0	0	0	0	0	13.84579	0	0	0	0	0	0	0	15.79206	0	0	16.60947	14.82424	0	0	0	0	0	0	15.32271	0	0	0	0	0	0	0	0	18.68643	0	0	0	0	13.31188	0	0	0	15.69361
Q9UNA1	RHG26_HUMAN	Rho GTPase-activating protein 26 (GTPase regulator associated with focal adhesion kinase) (Oligophrenin-1-like protein) (Rho-type GTPase-activating protein 26)	ARHGAP26 GRAF KIAA0621 OPHN1L	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]	GO:0005096; GO:0005543; GO:0005829; GO:0005856; GO:0005925; GO:0007165; GO:0007399; GO:0030036; GO:0051056	NLSSAK	4.429999828	0.01598496	0.01598496	0.186621881	621.4921668	15.84844	14.10981	15.93735	14.89983	0	14.69613	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.89216	14.72929	15.16972	0	15.72559	0	15.44386	11.79483	0	0	15.05	16.07615	16.90615	0	14.86685	0	0	16.97209	15.4361	0	0	15.60871	15.39735	15.35789
Q9UND3	NPIA1_HUMAN	"Nuclear pore complex-interacting protein family member A1 (Nuclear pore complex-interacting protein, NPIP)"	NPIPA1 NPIP	Homo sapiens (Human)	mRNA transport [GO:0051028]; protein transport [GO:0015031]	nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; mRNA transport [GO:0051028]; protein transport [GO:0015031]		GO:0005643; GO:0005654; GO:0015031; GO:0031965; GO:0051028	KPLCNR	3.839999914	1	1	0.245915215	786.9774927	0	15.46379	11.74628	0	0	0	15.8984	0	15.63066	0	0	0	0	0	0	0	0	0	0	0	0	16.92183	14.96297	0	15.70024	0	10.70661	15.75836	16.41941	14.77287	15.94284	0	15.80927	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UNE7	CHIP_HUMAN	"E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)"	STUB1 CHIP PP1131	Homo sapiens (Human)	cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]	chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]	chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0038128; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0048156; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031	SPSAQELK	15.40999985	1	1	0.186221744	859.3154386	18.15282	15.33979	12.41994	0	0	0	0	0	15.06563	17.94689	0	0	15.74254	0	0	0	0	0	0	0	0	0	0	16.01669	14.57653	16.10469	0	0	0	15.38157	0	0	0	0	16.54338	0	0	13.75421	0	0	14.7512	0	0	0	16.36068	0	0	0
Q9UNF1	MAGD2_HUMAN	"Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein, BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen)"	MAGED2 BCG1	Homo sapiens (Human)	female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294]	cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]	cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294]		GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294	AQETEAAPSQAPADEPEPESAAAQSQENQDTRPKVK	8.659999847	1	1	0.106747106	3805.697862	0	0	14.51179	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UNH6	SNX7_HUMAN	Sorting nexin-7	SNX7	Homo sapiens (Human)	positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phosphatidylinositol binding [GO:0035091]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]	phosphatidylinositol binding [GO:0035091]	GO:0005769; GO:0015031; GO:0031901; GO:0035091; GO:2000786	QGPGLLSR	10.38000011	1	1	4.59E-13	827.4826892	15.72009	14.89869	0	15.59734	0	16.00737	15.6681	0	15.40972	14.47466	0	15.93905	0	0	0	16.85977	16.40123	0	15.43025	16.13941	16.06376	0	0	0	0	0	14.35206	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UNI1	CELA1_HUMAN	"Chymotrypsin-like elastase family member 1, EC 3.4.21.36 (Elastase-1) (Pancreatic elastase 1)"	CELA1 ELA1	Homo sapiens (Human)	elastin catabolic process [GO:0060309]; exocrine pancreas development [GO:0031017]; inflammatory response [GO:0006954]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas morphogenesis [GO:0061113]; positive regulation of angiogenesis [GO:0045766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proteolysis [GO:0006508]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; tissue remodeling [GO:0048771]; Wnt signaling pathway [GO:0016055]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; elastin catabolic process [GO:0060309]; exocrine pancreas development [GO:0031017]; inflammatory response [GO:0006954]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas morphogenesis [GO:0061113]; positive regulation of angiogenesis [GO:0045766]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proteolysis [GO:0006508]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; tissue remodeling [GO:0048771]; Wnt signaling pathway [GO:0016055]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	GO:0000122; GO:0004252; GO:0005615; GO:0006508; GO:0006954; GO:0009791; GO:0016055; GO:0031017; GO:0035264; GO:0042127; GO:0045595; GO:0045766; GO:0045944; GO:0046872; GO:0048771; GO:0060309; GO:0061113	NTMVCAGGDGVR	9.609999657	1	1	0.53140024	1234.890637	0	0	0	0	0	0	0	0	14.27678	0	0	0	0	0	18.90015	0	0	0	0	0	15.27528	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UNI6	DUS12_HUMAN	"Dual specificity protein phosphatase 12, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity tyrosine phosphatase YVH1)"	DUSP12	Homo sapiens (Human)	cellular protein modification process [GO:0006464]; dephosphorylation [GO:0016311]; positive regulation of glucokinase activity [GO:0033133]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; dephosphorylation [GO:0016311]; positive regulation of glucokinase activity [GO:0033133]; protein dephosphorylation [GO:0006470]	kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]	GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006464; GO:0006470; GO:0008138; GO:0008270; GO:0016311; GO:0016791; GO:0019900; GO:0033133	DEVLYKCR	9.210000038	0.351579577	0.351579577	0.188996152	1081.538737	15.10195	0	13.98946	0	0	0	0	13.38097	0	0	0	0	0	0	0	0	0	15.31151	13.20756	13.10423	13.75909	15.95036	15.95194	15.70996	15.06975	0	14.7072	15.17155	0	0	15.08319	14.28803	14.76666	14.21741	15.2893	0	16.05626	0	0	15.94734	0	15.35901	0	15.38445	0	0	13.21477	0
Q9UNK0	STX8_HUMAN	Syntaxin-8	STX8	Homo sapiens (Human)	cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]	cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]	chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625]	GO:0000149; GO:0005484; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005802; GO:0005829; GO:0005887; GO:0006886; GO:0006906; GO:0008333; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0031201; GO:0031625; GO:0031902; GO:0031982; GO:0045022; GO:0045335; GO:0048278; GO:0048471; GO:0055037; GO:0071346; GO:1903076	RVNMVDR	1	1	1	0.019867079	889.7234266	0	14.68831	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.91005	0	0	15.80582	0	0	0	0	0	0	15.71612	0	0	0	0	15.07524	12.88616	16.30077	0	0	0	13.73723	0	0	0	0	0	0	0	0
Q9UNQ0	ABCG2_HUMAN	"Broad substrate specificity ATP-binding cassette transporter ABCG2, EC 7.6.2.2 (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)"	ABCG2 ABCP BCRP BCRP1 MXR	Homo sapiens (Human)	biotin transport [GO:0015878]; cellular detoxification [GO:1990748]; export across plasma membrane [GO:0140115]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate metabolic process [GO:0046415]; xenobiotic transport across blood-brain barrier [GO:1990962]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; identical protein binding [GO:0042802]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]; biotin transport [GO:0015878]; cellular detoxification [GO:1990748]; export across plasma membrane [GO:0140115]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate metabolic process [GO:0046415]; xenobiotic transport across blood-brain barrier [GO:1990962]	ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; identical protein binding [GO:0042802]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]	GO:0005524; GO:0005654; GO:0005886; GO:0006869; GO:0008514; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015711; GO:0015878; GO:0016021; GO:0016324; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0042802; GO:0042803; GO:0042910; GO:0045121; GO:0046415; GO:0055085; GO:0070633; GO:0097744; GO:0098591; GO:0140115; GO:0150104; GO:1990748; GO:1990962	ATEIIEPSK	1.480000019	0.102700256	0.102700256	0.009223706	988.3656174	14.22317	16.07393	0	0	0	0	0	0	13.8287	13.19478	0	0	15.44454	13.43962	13.55898	0	0	0	0	0	14.70276	0	0	0	16.35199	0	0	0	0	0	0	15.03824	0	0	0	0	0	0	0	15.49513	0	0	0	0	0	0	14.85425	14.3278
Q9UNQ2	DIM1_HUMAN	"Probable dimethyladenosine transferase, EC 2.1.1.183 (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)"	DIMT1 DIMT1L HUSSY-05	Homo sapiens (Human)	positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]"	"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]"	GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005759; GO:0005829; GO:0031167; GO:0052909; GO:2000234	SGAIGR	1.75	1	1	0.244125804	560.2422575	16.13793	15.82531	17.62769	0	0	0	0	0	0	0	0	0	0	17.09431	0	0	0	0	15.81524	16.84324	0	16.48767	16.50143	0	17.72219	17.51619	16.66426	0	0	16.38468	0	0	0	17.62575	0	0	0	18.2874	0	0	0	0	0	0	0	18.46337	16.11657	0
Q9UNS1	TIM_HUMAN	"Protein timeless homolog, hTIM"	TIMELESS TIM TIM1 TIMELESS1	Homo sapiens (Human)	"branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]"	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]	"chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]"	DNA binding [GO:0003677]; identical protein binding [GO:0042802]	GO:0000076; GO:0000122; GO:0000785; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0009582; GO:0030324; GO:0031298; GO:0035861; GO:0042752; GO:0042802; GO:0043111; GO:0044770; GO:0045892; GO:0048478; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781	ALLLAHKK	1.840000033	1	1	0.173442794	893.6910847	16.40143	15.00181	0	0	0	0	15.88997	0	13.42448	15.43954	15.12482	15.95509	16.12831	15.34789	0	0	0	14.44134	0	16.21878	15.63006	0	15.51544	15.22126	16.55914	0	14.84137	0	15.28475	14.43657	14.99929	0	15.51826	12.92204	0	14.35697	16.71393	15.61155	16.92904	15.2658	16.25413	16.29105	15.18362	14.98728	15.14653	16.1859	16.20606	15.30374
Q9UNW1	MINP1_HUMAN	"Multiple inositol polyphosphate phosphatase 1, EC 3.1.3.62 (2,3-bisphosphoglycerate 3-phosphatase, 2,3-BPG phosphatase, EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase, Ins(1,3,4,5)P(4) 3-phosphatase)"	MINPP1 MIPP UNQ900/PRO1917	Homo sapiens (Human)	bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]	"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; protein histidine phosphatase activity [GO:0101006]; bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797]"	"acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; protein histidine phosphatase activity [GO:0101006]"	GO:0001503; GO:0003993; GO:0005783; GO:0005788; GO:0006797; GO:0030282; GO:0030351; GO:0034417; GO:0043647; GO:0051717; GO:0052745; GO:0052826; GO:0070062; GO:0101006	LITSSK	7.059999943	1	1	0.126526489	645.4386984	16.48859	0	0	0	0	0	0	15.0622	15.45089	0	0	14.92737	0	0	0	16.00422	0	0	0	13.91713	0	0	0	0	0	16.37332	0	0	0	0	16.91532	0	15.16583	16.37461	14.85209	0	0	16.97678	15.28037	17.24973	16.62948	16.33892	15.2702	16.04868	15.47759	16.22997	16.94166	16.22773
Q9UNW8	GP132_HUMAN	Probable G-protein coupled receptor 132 (G2 accumulation protein)	GPR132 G2A	Homo sapiens (Human)	G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]	G protein-coupled receptor activity [GO:0004930]	GO:0000082; GO:0004930; GO:0005886; GO:0010972; GO:0016021	CPMLLK	20.25	0.338056982	0.338056982	0.244113432	762.0386162	18.2135	19.09359	18.61115	0	15.28102	0	21.54016	0	21.31044	17.09639	0	16.98907	18.74444	18.24773	18.66063	19.89181	0	18.12315	20.05333	17.44826	0	0	18.06194	18.04852	22.5887	0	21.07516	0	18.1079	19.72703	0	19.78669	19.99442	20.72843	20.72176	21.14278	19.98779	18.65938	19.26265	0	0	0	0	17.2822	18.22805	18.72527	17.78858	18.49927
Q9UNX4	WDR3_HUMAN	WD repeat-containing protein 3	WDR3	Homo sapiens (Human)	maturation of SSU-rRNA [GO:0030490]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490]	RNA binding [GO:0003723]; snoRNA binding [GO:0030515]	GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388	GEKILILQGLK	10.14000034	1	1	0.123921859	1216.053501	0	15.73733	12.13934	0	0	0	0	14.05741	0	0	0	0	13.37043	14.48189	0	0	0	0	0	11.86117	0	0	0	0	0	0	0	0	0	0	0	0	15.91052	0	0	0	0	0	0	10.7468	0	0	0	0	0	0	0	0
Q9UNX9	KCJ14_HUMAN	"ATP-sensitive inward rectifier potassium channel 14 (Inward rectifier K(+) channel Kir2.4, IRK-4) (Potassium channel, inwardly rectifying subfamily J member 14)"	KCNJ14 IRK4	Homo sapiens (Human)	potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]	dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]	inward rectifier potassium channel activity [GO:0005242]	GO:0005242; GO:0005886; GO:0008076; GO:0030425; GO:0034765; GO:0043025; GO:1990573	AEQASHSLK	13.10000038	0.681856096	0.681856096	0.225394651	970.588703	18.7738	15.28839	17.42377	17.08224	0	17.83538	16.1139	15.51214	15.70944	15.28969	16.5275	15.49642	15.21794	14.60408	13.4348	17.00832	16.10935	15.41761	14.01034	13.5376	12.87611	16.68735	15.49108	17.28436	16.09687	10.57179	17.57006	16.43133	16.10639	13.52069	0	17.44712	20.25152	18.25234	15.58538	0	19.1074	0	0	0	16.06866	0	15.83478	14.14821	16.00658	16.28281	16.21722	0
Q9UNY5	ZN232_HUMAN	Zinc finger protein 232 (Zinc finger and SCAN domain-containing protein 11)	ZNF232 ZSCAN11	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0043231; GO:0046872	DHECSECGK	1.580000043	1	1	6.88E-13	1122.233534	14.71566	14.83216	14.06168	0	14.94664	0	13.95397	0	0	0	0	0	0	0	15.52421	0	0	0	17.65455	0	0	0	12.69842	16.34957	0	15.55309	0	0	0	0	15.74057	0	14.89653	0	0	0	0	0	16.95128	15.76791	13.8671	0	0	15.88454	0	0	0	0
Q9UNZ5	L10K_HUMAN	Leydig cell tumor 10 kDa protein homolog	C19orf53 HSPC023	Homo sapiens (Human)						KGAAAATSSK	9.520000458	0.255715698	0.255715698	0.252142104	891.119566	0	0	0	0	0	0	17.42495	0	16.10272	0	0	16.56948	0	0	0	18.07436	0	0	0	0	0	0	0	0	0	0	0	17.09319	17.65432	0	17.42862	0	0	0	0	18.73232	0	18.32891	0	0	0	18.06236	0	17.41539	0	0	0	0
Q9UP52	TFR2_HUMAN	"Transferrin receptor protein 2, TfR2"	TFR2	Homo sapiens (Human)	acute-phase response [GO:0006953]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; endocytic iron import into cell [GO:0140298]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; positive regulation of endocytosis [GO:0045807]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein maturation [GO:1903319]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; response to iron ion [GO:0010039]; transferrin transport [GO:0033572]	cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; co-receptor binding [GO:0039706]; transferrin receptor activity [GO:0004998]; acute-phase response [GO:0006953]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; endocytic iron import into cell [GO:0140298]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; positive regulation of endocytosis [GO:0045807]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein maturation [GO:1903319]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; response to iron ion [GO:0010039]; transferrin transport [GO:0033572]	co-receptor binding [GO:0039706]; transferrin receptor activity [GO:0004998]	GO:0004998; GO:0005886; GO:0005887; GO:0006826; GO:0006879; GO:0006898; GO:0006953; GO:0009897; GO:0010039; GO:0031410; GO:0033572; GO:0039706; GO:0045807; GO:0045944; GO:0055072; GO:0071281; GO:0090277; GO:0140298; GO:1903319; GO:1990712	AVVYVSLDNAVLGDDKFHAK	1.899999976	1	1	0.166476985	2163.960914	0	0	11.25035	0	0	12.31431	14.38055	0	0	13.6413	14.28311	13.24324	13.65509	13.07746	0	0	0	0	15.99821	0	0	0	0	0	0	13.11479	15.24049	0	0	0	0	16.12446	0	0	0	0	16.18086	0	0	0	0	13.84779	0	0	16.27786	0	0	0
Q9UPA5	BSN_HUMAN	Protein bassoon (Zinc finger protein 231)	BSN KIAA0434 ZNF231	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; presynapse to nucleus signaling pathway [GO:0099526]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of synaptic vesicle cycle [GO:0098693]	axon [GO:0030424]; cell surface [GO:0009986]; cytoskeleton of presynaptic active zone [GO:0048788]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	axon [GO:0030424]; cell surface [GO:0009986]; cytoskeleton of presynaptic active zone [GO:0048788]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; metal ion binding [GO:0046872]; structural constituent of presynaptic active zone [GO:0098882]; chemical synaptic transmission [GO:0007268]; presynapse to nucleus signaling pathway [GO:0099526]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of synaptic vesicle cycle [GO:0098693]	metal ion binding [GO:0046872]; structural constituent of presynaptic active zone [GO:0098882]	GO:0005634; GO:0007268; GO:0008021; GO:0009986; GO:0014069; GO:0030424; GO:0030425; GO:0030672; GO:0035418; GO:0044306; GO:0046872; GO:0048786; GO:0048788; GO:0060076; GO:0098685; GO:0098693; GO:0098882; GO:0098978; GO:0098982; GO:0099526; GO:1904071	AAAKPKTMPK	2.559999943	1	1	0.036744763	1041.423982	0	0	16.68959	0	0	0	0	0	0	0	0	14.19448	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.21116	15.44709	0	0	0	0	0	0	0	15.02214	0	14.50072	0	15.04774	0	0	0	0	0	0
Q9UPC5	GPR34_HUMAN	Probable G-protein coupled receptor 34	GPR34	Homo sapiens (Human)	G protein-coupled receptor signaling pathway [GO:0007186]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]	G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]	GO:0004930; GO:0005887; GO:0007186; GO:0045028	IQSSSK	5.659999847	1	1	0.20591168	648.7613196	15.67313	15.35941	0	17.45577	15.77062	0	15.75086	14.50424	15.13085	0	0	14.14102	0	0	0	0	0	18.1931	0	16.28468	0	0	12.96534	0	0	16.10661	0	0	0	0	0	16.46159	0	0	0	16.61611	0	0	0	0	16.0796	0	0	0	0	0	0	0
Q9UPE1	SRPK3_HUMAN	"SRSF protein kinase 3, EC 2.7.11.1 (Muscle-specific serine kinase 1, MSSK-1) (Serine/arginine-rich protein-specific kinase 3, SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23)"	SRPK3 MSSK1 STK23	Homo sapiens (Human)	cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; muscle tissue development [GO:0060537]; regulation of mRNA processing [GO:0050684]; skeletal muscle tissue development [GO:0007519]; spliceosomal complex assembly [GO:0000245]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; muscle tissue development [GO:0060537]; regulation of mRNA processing [GO:0050684]; skeletal muscle tissue development [GO:0007519]; spliceosomal complex assembly [GO:0000245]	ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000245; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0007519; GO:0030154; GO:0035556; GO:0050684; GO:0060537; GO:0106310	GGYHPVK	9.68999958	1	1	0.085552848	756.3696262	0	9.597686	13.7156	0	0	0	0	0	0	0	0	0	0	19.33494	0	18.5276	0	0	19.40611	0	0	0	0	0	14.92064	18.11976	15.99353	16.11229	0	0	0	16.89876	15.0071	14.77176	15.74834	13.3473	14.90608	15.03839	0	0	15.47024	0	0	0	0	0	0	0
Q9UPG8	PLAL2_HUMAN	Zinc finger protein PLAGL2 (Pleiomorphic adenoma-like protein 2)	PLAGL2 KIAA0198	Homo sapiens (Human)	"chylomicron assembly [GO:0034378]; lipid metabolic process [GO:0006629]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; chylomicron assembly [GO:0034378]; lipid metabolic process [GO:0006629]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006351; GO:0006357; GO:0006629; GO:0009791; GO:0034378; GO:0043565; GO:0046872; GO:2001244	DVMGTK	5.409999847	1	1	0.142920001	665.633675	0	0	0	0	0	0	0	0	15.72933	0	0	0	17.05923	0	0	0	15.83592	0	0	0	0	0	16.57907	0	0	16.35096	16.38759	0	0	0	16.11156	16.82872	0	0	15.86542	0	0	16.02576	16.73602	12.812	16.66198	14.13079	16.32155	15.57782	0	0	0	15.69324
Q9UPI3	FLVC2_HUMAN	"Feline leukemia virus subgroup C receptor-related protein 2 (Calcium-chelate transporter, CCT)"	FLVCR2 C14orf58	Homo sapiens (Human)	heme export [GO:0097037]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; heme export [GO:0097037]	heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]	GO:0005886; GO:0015232; GO:0016021; GO:0020037; GO:0097037	ANKETLENK	8.720000267	1	1	0	1046.700924	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UPM6	LHX6_HUMAN	"LIM/homeobox protein Lhx6, LIM homeobox protein 6 (LIM/homeobox protein Lhx6.1)"	LHX6 LHX6.1	Homo sapiens (Human)	cell maturation [GO:0048469]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; forebrain neuron development [GO:0021884]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell maturation [GO:0048469]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; forebrain neuron development [GO:0021884]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0021799; GO:0021800; GO:0021853; GO:0021884; GO:0030182; GO:0046872; GO:0048469; GO:1990837	MAQPGSGCK	4.920000076	1	1	0.233238603	934.8682449	15.8654	0	0	16.37767	15.52898	14.80655	15.15346	16.67403	14.97558	14.206	16.36789	0	0	15.32063	0	0	0	0	0	0	0	16.18985	0	15.67757	15.55462	14.86792	16.00392	14.96014	15.23884	15.42821	0	16.26935	14.60171	15.15178	15.13055	15.41997	14.50206	15.27664	13.32014	15.8417	14.75973	16.15025	14.33624	15.13959	0	16.29271	16.60155	15.1809
Q9UPM8	AP4E1_HUMAN	AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin)	AP4E1	Homo sapiens (Human)	protein localization [GO:0008104]; protein targeting [GO:0006605]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; cargo adaptor activity [GO:0140312]; protein localization [GO:0008104]; protein targeting [GO:0006605]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192]	cargo adaptor activity [GO:0140312]	GO:0005802; GO:0006605; GO:0006898; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0140312	LGSLVRGITALTSK	6.639999866	1	1	0.183992408	1416.730214	0	0	15.69919	13.51847	0	14.89215	0	15.70428	0	13.45239	14.10502	14.86993	0	0	16.55989	0	14.47972	16.15795	0	0	0	16.92056	0	0	14.69958	0	0	0	0	0	0	0	0	0	15.52172	15.52668	14.28247	0	0	15.79475	16.80379	15.71003	15.1543	0	16.49022	0	0	16.13334
Q9UPN3	MACF1_HUMAN	"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein, ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)"	MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251	Homo sapiens (Human)	Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]	GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011	DATER	4.190000057	1	1	0.191398668	590.8592242	0	15.80226	0	0	0	17.14808	16.95716	0	0	0	0	0	0	0	17.33108	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.74647	0	0	0	0
Q9UPN4	CP131_HUMAN	Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1)	CEP131 AZI1 KIAA1118	Homo sapiens (Human)	cell cycle [GO:0007049]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288]	acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212]	acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cell cycle [GO:0007049]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288]	protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]	GO:0001669; GO:0002177; GO:0005813; GO:0005814; GO:0005829; GO:0007049; GO:0007288; GO:0008284; GO:0010824; GO:0015630; GO:0034451; GO:0035735; GO:0035869; GO:0036064; GO:0042803; GO:0043231; GO:0044877; GO:0045171; GO:0060271; GO:0071539; GO:0090316; GO:0120212; GO:1905198; GO:1905515; GO:1990953	AAIQELQQK	12.61999989	0.651562452	0.651562452	0.227673855	1027.60643	0	14.99496	0	0	16.04703	0	0	13.65947	17.32771	0	13.20709	0	15.0084	0	16.9949	0	13.98163	0	0	15.63202	16.39856	15.20571	0	12.91585	14.42016	16.84178	0	0	0	0	15.5163	13.13818	12.68306	0	0	0	0	0	15.77398	13.89977	14.47709	0	18.91684	0	19.01634	0	15.28321	0
Q9UPN6	SCAF8_HUMAN	SR-related and CTD-associated factor 8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16)	SCAF8 CCAP7 KIAA1116 RBM16	Homo sapiens (Human)	"mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]"	cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]"	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]	GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005849; GO:0006369; GO:0006378; GO:0016363; GO:0032786; GO:0043175; GO:1990269; GO:2000805	GLPPIRSK	4.21999979	1	1	0.250939258	869.2531752	15.25778	15.47376	16.96654	14.51502	15.22996	14.86006	0	0	0	15.0221	13.46671	16.63828	15.25592	0	14.37343	16.80894	15.93513	0	15.23785	15.21762	0	16.30502	17.12827	15.17438	0	0	17.3588	0	0	0	0	15.64085	15.46209	0	16.62885	0	17.18039	16.36802	15.47773	12.82344	0	0	15.69887	14.97398	0	16.49182	16.63057	15.73243
Q9UPP1	PHF8_HUMAN	"Histone lysine demethylase PHF8, EC 1.14.11.27, EC 1.14.11.65 (PHD finger protein 8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8)"	PHF8 KIAA1111 ZNF422	Homo sapiens (Human)	"brain development [GO:0007420]; chromatin organization [GO:0006325]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]"	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; chromatin organization [GO:0006325]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]"	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	GO:0000082; GO:0003682; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558; GO:0140680; GO:0140683	KDGLGMTLPSPSFTVR	7.320000172	1	1	0.071800468	1721.617471	0	0	0	0	17.64304	0	0	0	17.36052	14.30794	14.48914	0	13.68916	0	14.63738	13.72708	14.71894	14.4952	16.02324	0	0	0	0	0	14.88286	0	0	0	0	0	0	0	0	0	0	0	13.44153	0	0	0	0	13.53838	0	0	13.47581	0	0	0
Q9UPP2	IQEC3_HUMAN	IQ motif and SEC7 domain-containing protein 3	IQSEC3 KIAA1110	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012]	cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]	cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012]	guanyl-nucleotide exchange factor activity [GO:0005085]	GO:0005085; GO:0005654; GO:0005829; GO:0014069; GO:0030036; GO:0032012; GO:0045211; GO:0060077; GO:0098690; GO:0098982; GO:0099629	AACTIQTAFRQYQLSK	3.5	1	1	2.28E-12	1885.265526	0	14.84967	13.05665	8.86089	14.24058	14.3331	0	14.77984	14.6495	0	0	16.30043	0	14.77941	12.42053	14.54917	0	0	0	13.16782	15.28856	0	0	0	12.95281	15.76359	14.21318	0	12.76401	0	0	14.63848	0	0	13.74044	0	0	17.00599	0	13.61454	13.62648	0	11.47917	14.68912	13.41894	0	14.65673	15.37667
Q9UPP5	K1107_HUMAN	"AP2-interacting clathrin-endocytosis protein, APache"	KIAA1107	Homo sapiens (Human)	clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; neuron projection development [GO:0031175]; synaptic vesicle recycling via endosome [GO:0036466]	axon [GO:0030424]; cell body [GO:0044297]; clathrin-coated vesicle [GO:0030136]; neuron projection terminus [GO:0044306]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]	axon [GO:0030424]; cell body [GO:0044297]; clathrin-coated vesicle [GO:0030136]; neuron projection terminus [GO:0044306]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; neuron projection development [GO:0031175]; synaptic vesicle recycling via endosome [GO:0036466]		GO:0008021; GO:0030136; GO:0030424; GO:0031175; GO:0036466; GO:0044297; GO:0044306; GO:0098793; GO:0150007	VTNGTSNK	3.74000001	0.709868729	0.709868729	1.14E-12	817.4703859	15.57987	16.22122	12.43394	15.28848	15.62984	16.0101	16.47894	17.38835	15.81856	17.88201	0	15.67276	0	0	18.21389	17.70477	15.02728	0	16.44934	0	13.51707	16.80737	16.36838	14.92463	0	0	0	0	0	0	0	19.3985	17.15767	16.77446	0	0	16.85903	12.16116	0	15.85232	0	14.57907	0	0	0	0	17.2032	15.80488
Q9UPQ0	LIMC1_HUMAN	LIM and calponin homology domains-containing protein 1	LIMCH1 KIAA1102	Homo sapiens (Human)	actomyosin structure organization [GO:0031032]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893]	cytoplasm [GO:0005737]; stress fiber [GO:0001725]	cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034]; actomyosin structure organization [GO:0031032]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893]	actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034]	GO:0001725; GO:0001934; GO:0003779; GO:0005737; GO:0030336; GO:0031032; GO:0032034; GO:0046872; GO:0051496; GO:0051893; GO:0060327	EFEGLLAQMR	1.629999995	0.278757811	0.278757811	0.196269282	1210.234613	14.82268	12.50735	13.81033	0	0	0	0	0	0	0	13.8335	15.21284	14.44762	14.19134	0	0	0	12.0879	10.31666	15.78337	0	14.6263	0	0	14.14229	12.81069	13.21172	0	0	14.0241	12.63251	13.50848	0	14.25297	0	0	0	0	0	15.068	14.1428	0	0	0	0	0	0	0
Q9UPQ7	PZRN3_HUMAN	"E3 ubiquitin-protein ligase PDZRN3, EC 2.3.2.27 (Ligand of Numb protein X 3) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3, Protein SEMACAP3)"	PDZRN3 KIAA1095 LNX3 SEMCAP3	Homo sapiens (Human)	neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]	cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005737; GO:0007528; GO:0008270; GO:0016567; GO:0031594; GO:0061630	AHNGALQAR	12.81000042	0.160425663	0.160425663	0.057476001	937.9522723	16.93774	16.53273	0	0	0	0	0	0	16.87691	0	15.94326	0	0	18.08065	15.86958	0	0	17.62692	15.74512	17.63609	0	0	10.8294	11.21413	16.08828	19.15668	16.11801	16.81041	17.20735	14.86294	0	16.72259	15.50678	0	0	16.39321	17.83779	16.89027	19.00737	17.09343	12.98522	0	17.53265	0	17.38034	17.35149	0	16.36048
Q9UPQ9	TNR6B_HUMAN	Trinucleotide repeat-containing gene 6B protein	TNRC6B KIAA1093	Homo sapiens (Human)	"gene silencing by miRNA [GO:0035195]; gene silencing by RNA [GO:0031047]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; gene silencing by RNA [GO:0031047]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of miRNA-mediated gene silencing by inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]"	RNA binding [GO:0003723]	GO:0000932; GO:0003723; GO:0005654; GO:0005829; GO:0031047; GO:0035195; GO:0035278; GO:0060213; GO:1900153; GO:1905618	NGAIVAPGKTR	2.539999962	1	1	0.097110699	1082.980001	12.93057	15.10812	12.58267	11.35616	15.43726	11.27609	14.45525	14.14696	12.41326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.88655	0	0	0	0	0	0	0	0	0	0	0	0	17.10904	0	0	0	0	0	0	0	0	13.45477	0
Q9UPR3	SMG5_HUMAN	"Nonsense-mediated mRNA decay factor SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog, hSMG-5)"	SMG5 EST1B KIAA1089	Homo sapiens (Human)	"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]"	histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]	GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0031625; GO:0032204; GO:0032210; GO:0035303; GO:0042162; GO:0042826; GO:0051721; GO:0070034	KPVSASGK	1.830000043	1	1	6.91E-13	771.4270869	0	0	0	0	0	0	0	0	0	0	0	0	17.15638	0	0	16.32643	0	0	0	0	0	17.33141	0	0	0	0	0	0	15.11995	0	17.2004	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UPR5	NAC2_HUMAN	Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2)	SLC8A2 KIAA1087 NCX2	Homo sapiens (Human)	calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]	axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]	calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]	GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0035725; GO:0042383; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099608; GO:0106056; GO:0150104; GO:1903779; GO:1905060; GO:1990034	RIAEMGKPVLGENCR	2.539999962	0.605351567	0.605351567	0.388844644	1744.940659	13.42933	10.32195	13.73672	16.35418	14.50244	0	14.87558	0	15.03702	0	16.22916	14.63752	0	16.4138	14.86269	13.88145	0	0	0	0	0	0	0	0	0	0	0	16.26452	0	0	0	0	0	15.36996	0	0	0	0	0	0	0	0	0	0	0	0	14.54972	0
Q9UPR6	ZFR2_HUMAN	Zinc finger RNA-binding protein 2	ZFR2 KIAA1086	Homo sapiens (Human)			double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	GO:0003725; GO:0003727; GO:0008270	GGEGLV	25.55999947	0.560828209	0.560828209	0.23396096	531.1346311	0	15.48586	15.25321	0	13.48044	11.45957	15.7011	15.80775	15.48414	17.02103	16.35055	14.1693	15.09814	15.93653	15.30451	16.25779	15.0769	15.54918	15.16781	16.33357	15.18473	16.28672	17.2765	17.21955	15.93	16.35351	14.17916	0	16.24456	0	16.25502	15.98119	16.57516	15.76825	14.70621	16.76543	16.21556	16.89916	16.71739	15.55389	15.54406	14.17797	16.99084	0	15.50443	0	15.51212	14.99945
Q9UPS8	ANR26_HUMAN	Ankyrin repeat domain-containing protein 26	ANKRD26 KIAA1074	Homo sapiens (Human)	negative regulation of fat cell differentiation [GO:0045599]	centrosome [GO:0005813]	centrosome [GO:0005813]; negative regulation of fat cell differentiation [GO:0045599]		GO:0005813; GO:0045599	EYVQVLK	2.309999943	1	1	0.192237394	876.41282	0	14.10347	14.57037	14.50426	0	0	0	0	0	0	0	0	0	0	0	0	15.80294	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.69436	0	0
Q9UPT5	EXOC7_HUMAN	Exocyst complex component 7 (Exocyst complex component Exo70)	EXOC7 EXO70 KIAA1067	Homo sapiens (Human)	exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]		GO:0000145; GO:0000281; GO:0005815; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0032584; GO:0034451; GO:0090148; GO:0090522; GO:0090543; GO:2000535	LFDTSA	7.460000038	1	1	0.235875349	653.1420592	0	15.57815	15.65613	15.66663	0	15.67388	16.13793	0	15.75561	0	15.38295	16.49185	0	15.4513	15.56809	0	0	0	0	16.72391	15.88838	15.53798	16.27483	16.08044	0	0	0	17.18528	15.5582	0	0	0	0	0	0	0	0	0	0	0	14.97012	0	15.75444	0	0	0	0	0
Q9UPT6	JIP3_HUMAN	"C-Jun-amino-terminal kinase-interacting protein 3, JIP-3, JNK-interacting protein 3 (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3)"	MAPK8IP3 JIP3 KIAA1066	Homo sapiens (Human)	anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; negative regulation of apoptotic process [GO:0043066]; positive regulation of JNK cascade [GO:0046330]; protein stabilization [GO:0050821]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; negative regulation of apoptotic process [GO:0043066]; positive regulation of JNK cascade [GO:0046330]; protein stabilization [GO:0050821]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]	JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]	GO:0000139; GO:0005078; GO:0005737; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0031103; GO:0031410; GO:0043066; GO:0044297; GO:0046328; GO:0046330; GO:0048471; GO:0050821; GO:0061564; GO:0099641; GO:1904115	IPMAQRR	7.429999828	0.44592315	0.44592315	0.211417457	888.325397	14.02462	14.09602	0	0	0	0	0	0	0	16.12108	0	0	17.72779	15.67683	17.01066	14.97945	0	15.10966	0	17.96339	16.1258	0	0	15.58915	10.66422	14.5227	16.92628	17.56926	14.97068	17.22601	16.53634	16.5034	14.73204	16.2356	14.42058	14.58358	17.39697	16.34378	18.63066	16.6448	13.55527	15.21765	6.793787	17.37643	16.77799	15.73786	0	17.87576
Q9UPT8	ZC3H4_HUMAN	Zinc finger CCCH domain-containing protein 4	ZC3H4 C19orf7 KIAA1064	Homo sapiens (Human)	"negative regulation of transcription, DNA-templated [GO:0045892]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; negative regulation of transcription, DNA-templated [GO:0045892]"	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0045892; GO:0046872	APTDPR	4.809999943	0.717248261	0.717248261	0.25025356	655.786754	13.901	15.4624	0	0	0	14.68314	15.43774	14.51917	14.98082	15.17982	16.45824	0	0	0	0	15.32948	0	0	16.97718	15.68183	16.20766	0	0	15.53429	16.17291	0	0	0	0	0	0	0	15.96071	16.19155	0	0	0	16.40972	0	14.90014	15.07588	0	0	0	0	0	0	0
Q9UPU5	UBP24_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 24, EC 3.4.19.12 (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)"	USP24 KIAA1057	Homo sapiens (Human)	protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579	GLFVEKMPAR	5.010000229	1	1	0.026309858	1147.858065	8.826991	0	11.68048	13.57148	11.88104	14.48817	12.78766	0	13.74399	13.93684	0	0	0	0	14.46083	9.714729	11.72407	0	0	0	0	0	0	0	0	8.838489	0	0	0	12.41296	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UPU7	TBD2B_HUMAN	TBC1 domain family member 2B	TBC1D2B KIAA1055	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]	cytosol [GO:0005829]; early endosome [GO:0005769]	cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]	GTPase activator activity [GO:0005096]	GO:0005096; GO:0005769; GO:0005829; GO:0006897; GO:0090630	DIIGSYK	10.32999992	0.338932574	0.338932574	0.286293428	798.0291696	16.30049	15.4585	14.997	14.41942	12.79803	13.27527	0	12.95198	14.95323	14.453	15.012	14.83047	16.3509	13.48975	0	15.46647	14.86953	15.1626	15.14233	0	15.84518	0	14.69576	16.84399	14.86745	0	15.67199	0	15.99899	14.46969	0	0	0	14.33886	16.32076	14.26893	15.71513	15.84413	0	0	15.58009	15.34425	0	16.03195	0	15.97868	15.34548	0
Q9UPV0	CE164_HUMAN	"Centrosomal protein of 164 kDa, Cep164"	CEP164 KIAA1052 NPHP15	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]		GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0007049; GO:0051301; GO:0060271; GO:0097539	EHSAELERLCSSLEAK	10.56000042	0.951785147	0.951785147	0.235251324	1859.335735	0	0	15.94611	0	0	0	0	15.46255	0	16.10321	0	0	17.74468	0	0	0	17.48484	0	0	16.43776	0	0	0	14.50862	0	0	0	0	0	0	0	0	0	19.25107	0	0	16.01656	0	0	0	0	0	0	0	17.57971	15.46303	16.65441	0
Q9UPV9	TRAK1_HUMAN	Trafficking kinesin-binding protein 1 (106 kDa O-GlcNAc transferase-interacting protein) (Protein Milton)	TRAK1 KIAA1042 OIP106	Homo sapiens (Human)	anterograde axonal transport of mitochondrion [GO:0098957]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; protein O-linked glycosylation [GO:0006493]; protein targeting [GO:0006605]; regulation of transcription by RNA polymerase II [GO:0006357]; vesicle transport along microtubule [GO:0047496]	axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; anterograde axonal transport of mitochondrion [GO:0098957]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; protein O-linked glycosylation [GO:0006493]; protein targeting [GO:0006605]; regulation of transcription by RNA polymerase II [GO:0006357]; vesicle transport along microtubule [GO:0047496]	GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]	GO:0005102; GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005829; GO:0005938; GO:0006357; GO:0006493; GO:0006605; GO:0008333; GO:0017022; GO:0022008; GO:0030425; GO:0031410; GO:0031966; GO:0047496; GO:0048311; GO:0050811; GO:0098957; GO:1904115	HELSMK	6.019999981	1	1	0.056245088	744.2644138	16.49361	13.45106	15.93364	0	0	15.52338	0	15.75641	13.00913	15.5595	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.64713	0	0	0	0	0	0	0	0	0	0	17.08893	0	15.22985	0
Q9UPW5	CBPC1_HUMAN	"Cytosolic carboxypeptidase 1, EC 3.4.17.-, EC 3.4.17.24 (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog) (Protein deglutamylase CCP1)"	AGTPBP1 CCP1 KIAA1035 NNA1	Homo sapiens (Human)	adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; neurotransmitter metabolic process [GO:0042133]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; neurotransmitter metabolic process [GO:0042133]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958]	metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	GO:0001754; GO:0004181; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0007628; GO:0008270; GO:0008285; GO:0015631; GO:0021702; GO:0021772; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0042133; GO:0043231; GO:0050905; GO:0060041; GO:0098957; GO:0098958; GO:1904115; GO:2000060	IVGLLAQLEK	10.53999996	1	1	0.100981779	1083.095581	0	13.54122	15.08278	14.33298	15.18867	9.869556	0	8.550252	0	0	14.65006	16.18527	12.37927	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UPW6	SATB2_HUMAN	DNA-binding protein SATB2 (Special AT-rich sequence-binding protein 2)	SATB2 KIAA1034	Homo sapiens (Human)	cartilage development [GO:0051216]; cellular response to organic substance [GO:0071310]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]	"chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cartilage development [GO:0051216]; cellular response to organic substance [GO:0071310]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000118; GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001764; GO:0002076; GO:0003682; GO:0005654; GO:0005667; GO:0006338; GO:0006357; GO:0009880; GO:0016363; GO:0021902; GO:0042826; GO:0045944; GO:0048704; GO:0051216; GO:0060021; GO:0071310	KEEDPR	16.57999992	1	1	0.208373244	772.9653235	14.17957	15.1912	0	0	0	0	0	14.01079	0	0	0	13.16519	0	0	0	0	17.24223	17.32805	0	0	0	0	0	21.07186	0	16.03705	0	0	0	0	0	16.26455	21.89251	0	22.33602	0	17.31447	0	0	0	16.33936	0	0	0	0	0	0	0
Q9UPW8	UN13A_HUMAN	Protein unc-13 homolog A (Munc13-1)	UNC13A KIAA1032	Homo sapiens (Human)	"cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"	neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]	"neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]"	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]	GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007269; GO:0007528; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030154; GO:0030672; GO:0031594; GO:0035249; GO:0042734; GO:0043005; GO:0043195; GO:0048786; GO:0051966; GO:0061789; GO:0098831; GO:0099011; GO:0099525; GO:1903861	APVAPTEAPDMAKVAPKPATPDK	10.01000023	1	1	1.84E-12	2318.903334	13.14368	0	13.98195	9.121446	0	11.54666	6.417267	13.45481	13.96936	0	15.95477	13.98696	0	0	13.66795	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UPX6	MNAR1_HUMAN	Major intrinsically disordered Notch2-binding receptor 1 (Membrane integral NOTCH2-associated receptor 1) (Ubiquitination and mTOR signaling protein)	MINAR1 KIAA1024 UBTOR	Homo sapiens (Human)	angiogenesis [GO:0001525]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TOR signaling [GO:0032007]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TOR signaling [GO:0032007]		GO:0001525; GO:0005886; GO:0008285; GO:0010977; GO:0016021; GO:0016525; GO:0030308; GO:0031397; GO:0032007	KIMVAADIVTIFNLIQMNGGAAK	6.480000019	1	1	4.57E-12	2434.14692	16.8261	0	0	0	16.47084	0	0	0	0	0	16.6767	0	0	15.57653	14.67526	16.14067	0	0	0	15.90482	0	15.92346	15.58719	0	0	0	0	0	0	15.91589	0	0	17.13287	15.49118	12.20693	17.73036	17.07442	15.87409	18.95087	0	0	0	16.6909	15.68929	12.38685	0	0	0
Q9UPX8	SHAN2_HUMAN	"SH3 and multiple ankyrin repeat domains protein 2, Shank2 (Cortactin-binding protein 1, CortBP1) (Proline-rich synapse-associated protein 1)"	SHANK2 CORTBP1 KIAA1022 PROSAP1	Homo sapiens (Human)	adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; regulation of synapse organization [GO:0050807]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124]; structural constituent of postsynaptic density [GO:0098919]; synaptic receptor adaptor activity [GO:0030160]; adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; regulation of synapse organization [GO:0050807]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124]; structural constituent of postsynaptic density [GO:0098919]; synaptic receptor adaptor activity [GO:0030160]	GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007420; GO:0007584; GO:0007612; GO:0008022; GO:0008284; GO:0008306; GO:0008344; GO:0009410; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0048786; GO:0050807; GO:0060170; GO:0060291; GO:0060292; GO:0071625; GO:0098686; GO:0098919; GO:0098978	MNIERALK	7.460000038	0.665849626	0.665849626	0.13874797	975.5480951	11.83927	14.35166	15.28221	12.10516	12.23018	8.872895	0	0	0	0	14.55995	14.13236	0	0	0	15.27394	0	0	16.0449	14.13613	0	15.42231	14.39054	16.66542	13.00217	13.86368	14.27112	17.46902	15.27067	14.47906	0	0	0	0	0	0	0	14.81879	0	0	12.71822	0	12.74334	17.95752	16.4329	0	12.38101	14.54332
Q9UPY3	DICER_HUMAN	"Endoribonuclease Dicer, EC 3.1.26.3 (Helicase with RNase motif, Helicase MOI)"	DICER1 DICER HERNA KIAA0928	Homo sapiens (Human)	"apoptotic DNA fragmentation [GO:0006309]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA metabolic process [GO:0010586]; negative regulation of gene expression [GO:0010629]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA catabolic process [GO:0016078]"	ARC complex [GO:0033167]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	"ARC complex [GO:0033167]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; apoptotic DNA fragmentation [GO:0006309]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA metabolic process [GO:0010586]; negative regulation of gene expression [GO:0010629]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA catabolic process [GO:0016078]"	ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]	GO:0000122; GO:0003677; GO:0003723; GO:0003725; GO:0004386; GO:0004521; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006309; GO:0010586; GO:0010626; GO:0010629; GO:0014040; GO:0016078; GO:0016442; GO:0019904; GO:0021675; GO:0030422; GO:0030423; GO:0031054; GO:0031643; GO:0032290; GO:0032720; GO:0033167; GO:0035087; GO:0035196; GO:0035197; GO:0035280; GO:0038061; GO:0046872; GO:0048471; GO:0048812; GO:0070062; GO:0070578; GO:0070883; GO:0090501; GO:0090502	IPPRCMFDHPDADK	3.619999886	1	1	0.087814982	1699.505694	14.72032	0	13.48601	16.00012	0	0	14.92873	0	0	0	0	0	0	0	13.45332	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.44265	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UPY5	XCT_HUMAN	Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT)	SLC7A11	Homo sapiens (Human)	adult behavior [GO:0030534]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]	apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]	apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542]	cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0005791; GO:0005856; GO:0005886; GO:0006749; GO:0008542; GO:0009636; GO:0009986; GO:0014070; GO:0015179; GO:0015327; GO:0016021; GO:0021591; GO:0021756; GO:0030534; GO:0031526; GO:0033029; GO:0034599; GO:0034775; GO:0035094; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070306; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0140206; GO:1901494; GO:1903204; GO:1903786; GO:1904717; GO:2000211	CPDMHRPFK	10.5	1	1	0.792555241	1202.588919	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.64144	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UPY8	MARE3_HUMAN	"Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3, EBF3) (End-binding protein 3, EB3) (RP3)"	MAPRE3	Homo sapiens (Human)	"cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]"	cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]	"cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]"	identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]	GO:0005737; GO:0005815; GO:0008017; GO:0008022; GO:0008104; GO:0015630; GO:0019901; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0042802; GO:0045737; GO:0045860; GO:0045893; GO:0048471; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721	IEQLCSGAAYCQFMDMLFPGCVHLRK	1.49000001	1	1	9.14E-13	3146.246591	13.83479	14.16349	0	14.79567	14.9447	12.23922	0	13.66503	0	0	13.22745	11.36714	10.70705	14.49079	0	12.41309	11.97009	0	10.62625	0	0	0	14.69323	0	14.88239	16.63922	13.05781	0	0	0	0	0	0	0	0	0	0	0	0	12.76239	0	0	0	0	0	0	0	0
Q9UPZ3	HPS5_HUMAN	"Hermansky-Pudlak syndrome 5 protein (Alpha-integrin-binding protein 63) (Ruby-eye protein 2 homolog, Ru2)"	HPS5 AIBP63 KIAA1017	Homo sapiens (Human)	blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]	BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]	BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]		GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232	ESVSSFVRK	14.72000027	1	1	0.041159984	1038.554281	12.0778	12.76331	15.47089	14.46851	13.88684	14.8153	0	14.52793	0	0	11.99011	14.46635	0	0	0	0	0	0	0	0	0	14.39331	0	15.71445	0	12.85801	14.7976	15.0128	14.12931	0	13.34425	0	0	0	0	0	0	14.85736	0	0	0	0	0	0	0	0	0	0
Q9UPZ9	CILK1_HUMAN	"Serine/threonine-protein kinase ICK, EC 2.7.11.1 (Ciliogenesis associated kinase 1) (Intestinal cell kinase, hICK) (Laryngeal cancer kinase 2, LCK2) (MAK-related kinase, MRK)"	CILK1 ICK KIAA0936	Homo sapiens (Human)	cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]	ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0001650; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006468; GO:0007165; GO:0035556; GO:0035720; GO:0035721; GO:0036064; GO:0042073; GO:0060271; GO:0097542; GO:0097546; GO:0106310	ISSRQHQASQPPLHLTYPYK	5.440000057	1	1	1.38E-12	2355.116393	0	0	0	0	12.17714	0	15.65793	0	0	13.54636	10.79052	15.44555	14.15374	0	13.62328	0	0	0	0	0	0	0	0	0	0	0	15.60136	0	14.2318	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.5137	0	0	0	0
Q9UQ10	DHDH_HUMAN	"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase, EC 1.3.1.20 (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase, EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) (Hum2DD)"	DHDH 2DD	Homo sapiens (Human)	D-xylose catabolic process [GO:0042843]		"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; nucleotide binding [GO:0000166]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]"	"D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; nucleotide binding [GO:0000166]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]"	GO:0000166; GO:0042843; GO:0047115; GO:0047837	AEFGK	4.480000019	0.871593058	0.871593058	0.200986064	554.0979432	0	0	0	0	0	0	15.16445	0	0	0	0	0	0	0	0	16.90679	0	0	0	0	0	0	0	0	15.43662	13.22678	0	0	0	0	0	0	0	15.51164	0	13.24081	17.27273	16.11893	0	0	0	0	14.45178	0	0	0	0	0
Q9UQ13	SHOC2_HUMAN	Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog)	SHOC2 KIAA0862	Homo sapiens (Human)	fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]	protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]	GO:0000164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007265; GO:0008157; GO:0008543; GO:0019888; GO:0019903; GO:0046579	DPKVPSAK	9.300000191	1	1	0.382189308	842.1426698	16.04641	16.0865	0	0	16.05729	16.54267	16.49571	16.98161	16.22342	0	15.29213	0	13.81994	16.35318	0	0	16.34861	0	13.92069	16.26351	14.85395	0	15.69436	15.52713	16.82916	15.65774	15.78281	17.07265	11.35056	0	0	0	0	0	16.24568	0	0	0	0	14.73203	15.70367	0	0	13.50111	15.76211	0	0	0
Q9UQ16	DYN3_HUMAN	"Dynamin-3, EC 3.6.5.5 (Dynamin, testicular) (T-dynamin)"	DNM3 KIAA0820	Homo sapiens (Human)	endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; synapse assembly [GO:0007416]; synaptic vesicle endocytosis [GO:0048488]	apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]; endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; synapse assembly [GO:0007416]; synaptic vesicle endocytosis [GO:0048488]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]	GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006897; GO:0007416; GO:0008017; GO:0014069; GO:0016020; GO:0030424; GO:0031623; GO:0031798; GO:0031802; GO:0042802; GO:0043083; GO:0043197; GO:0044327; GO:0045202; GO:0046847; GO:0048471; GO:0048488; GO:0050998; GO:0051491; GO:0061002; GO:0061828; GO:0061829; GO:0070062; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099186; GO:1903423	ASLLRAGVYPDK	5.96999979	1	1	0.027907158	1287.672227	0	10.19253	0	17.71014	15.0024	12.56619	0	0	0	0	0	14.4701	0	0	0	0	0	0	0	0	0	0	13.1214	15.20856	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UQ35	SRRM2_HUMAN	"Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa, SR-related nuclear matrix protein of 300 kDa, Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803, TaxREB803)"	SRRM2 KIAA0324 SRL300 SRM300 HSPC075	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]"	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"	C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0047485; GO:0070742; GO:0071005; GO:0071007; GO:0071013	IPAASAAAMNLASAR	1.330000043	1	1	0.204690616	1410.310975	0	14.58249	0	0	0	0	15.8448	0	0	13.66	0	0	0	0	0	0	0	16.17245	0	0	0	0	0	10.45315	0	15.02236	0	0	0	0	0	14.08579	0	16.14003	0	15.25787	0	15.22474	0	0	0	0	0	0	0	13.87283	0	0
Q9UQ80	PA2G4_HUMAN	"Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog, hG4-1) (ErbB3-binding protein 1)"	PA2G4 EBP1	Homo sapiens (Human)	"negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]"	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]	GO:0003676; GO:0003714; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0045597; GO:0045892; GO:0070062	SLVEASSSGVSVLSLCEKGDAMIMEETGK	4.75	0.477001727	0.477001727	1.83E-12	3045.771372	6.58212	12.2123	0	15.19172	13.45774	0	15.59599	10.5659	0	15.22033	0	11.61389	14.81594	0	15.57751	0	0	0	14.3286	0	0	0	14.98658	0	15.14361	0	13.51024	0	0	0	0	0	0	0	0	0	17.37204	0	0	11.9274	14.79474	0	0	0	0	0	15.23608	0
Q9UQ84	EXO1_HUMAN	"Exonuclease 1, hExo1, EC 3.1.-.- (Exonuclease I, hExoI)"	EXO1 EXOI HEX1	Homo sapiens (Human)	DNA recombination [GO:0006310]; DNA repair [GO:0006281]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446]; t-circle formation [GO:0090656]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0051908]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446]; t-circle formation [GO:0090656]	5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0051908]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]	GO:0002455; GO:0003677; GO:0003682; GO:0004523; GO:0004527; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006298; GO:0006310; GO:0008409; GO:0016446; GO:0016604; GO:0017108; GO:0035312; GO:0045145; GO:0045190; GO:0046872; GO:0048256; GO:0051321; GO:0051908; GO:0090656	KNSSEGNK	3.380000114	0.67318815	0.67318815	0.260303842	864.2353103	16.31292	19.02524	16.29912	0	0	0	0	0	0	18.98547	0	0	16.68718	0	0	0	0	16.76101	15.92561	0	0	0	0	0	0	0	0	0	16.84529	19.16343	0	0	18.60309	16.80683	0	0	18.87158	0	19.70183	0	0	18.32724	17.84488	19.75434	0	0	0	0
Q9UQB3	CTND2_HUMAN	"Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein, NPRAP) (Neurojungin)"	CTNND2 NPRAP	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055]	beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]	GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609	GSSPKQSPSR	7.380000114	0.307271808	0.307271808	0.088534438	1031.817144	0	14.37353	16.95091	16.24373	15.58518	9.243081	15.21653	0	0	14.46178	13.77171	0	14.9374	15.95657	15.00866	13.15155	14.06476	16.87419	8.929984	14.12906	0	16.29297	17.65886	16.42425	17.14421	11.31458	12.96943	0	17.07085	17.76132	15.83991	0	14.25003	11.63552	16.96316	15.74574	15.05635	16.84405	12.99584	0	16.54301	0	16.45594	13.53083	14.24618	13.98077	14.70476	14.64418
Q9UQB8	BAIP2_HUMAN	"Brain-specific angiogenesis inhibitor 1-associated protein 2, BAI-associated protein 2, BAI1-associated protein 2, Protein BAP2 (Fas ligand-associated factor 3, FLAF3) (Insulin receptor substrate p53/p58, IRS-58, IRSp53/58) (Insulin receptor substrate protein of 53 kDa, IRSp53, Insulin receptor substrate p53)"	BAIAP2	Homo sapiens (Human)	"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to L-glutamate [GO:1905232]; dendrite development [GO:0016358]; insulin receptor signaling pathway [GO:0008286]; modification of synaptic structure, modulating synaptic transmission [GO:0099564]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of synaptic plasticity [GO:0048167]; response to bacterium [GO:0009617]"	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine cytoplasm [GO:0061846]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; neuron projection branch point [GO:0061845]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; rough endoplasmic reticulum [GO:0005791]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; synaptic membrane [GO:0097060]"	"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine cytoplasm [GO:0061846]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; neuron projection branch point [GO:0061845]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; rough endoplasmic reticulum [GO:0005791]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; synaptic membrane [GO:0097060]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; scaffold protein binding [GO:0097110]; transcription coregulator binding [GO:0001221]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to L-glutamate [GO:1905232]; dendrite development [GO:0016358]; insulin receptor signaling pathway [GO:0008286]; modification of synaptic structure, modulating synaptic transmission [GO:0099564]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of synaptic plasticity [GO:0048167]; response to bacterium [GO:0009617]"	cadherin binding involved in cell-cell adhesion [GO:0098641]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; scaffold protein binding [GO:0097110]; transcription coregulator binding [GO:0001221]	GO:0001221; GO:0001726; GO:0005654; GO:0005737; GO:0005791; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0007009; GO:0007409; GO:0007420; GO:0008022; GO:0008093; GO:0008286; GO:0008360; GO:0009617; GO:0016358; GO:0030027; GO:0030141; GO:0030165; GO:0030175; GO:0030838; GO:0032956; GO:0035418; GO:0042802; GO:0043025; GO:0043198; GO:0044306; GO:0048167; GO:0051017; GO:0051764; GO:0060076; GO:0061003; GO:0061845; GO:0061846; GO:0070062; GO:0070064; GO:0071364; GO:0097060; GO:0097110; GO:0098641; GO:0098685; GO:0098978; GO:0099092; GO:0099523; GO:0099524; GO:0099564; GO:1905232; GO:1905274; GO:2000251; GO:2000463	QGELENYVSDGYKTALTEER	6.539999962	1	1	0.241813654	2302.432747	0	15.36708	16.85779	15.98249	15.296	0	14.63113	14.81511	1.099677	0	0	17.15529	0	0	0	15.85373	12.83072	0	15.37442	10.73209	0	15.70461	0	9.100988	0	16.75887	0	0	0	19.13865	0	18.4714	0	18.13459	17.78827	0	18.65758	0	18.28657	0	0	0	0	0	0	0	18.43083	0
Q9UQC2	GAB2_HUMAN	GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100)	GAB2 KIAA0571	Homo sapiens (Human)	osteoclast differentiation [GO:0030316]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mast cell degranulation [GO:0043306]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; osteoclast differentiation [GO:0030316]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mast cell degranulation [GO:0043306]"	"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]"	GO:0005068; GO:0005547; GO:0005737; GO:0005829; GO:0005886; GO:0008284; GO:0030316; GO:0043306; GO:0043325; GO:0048015	MSGGGDVVCTGWLR	6.619999886	1	1	0.466780045	1511.512915	0	0	0	14.58131	0	0	0	0	0	0	14.8277	0	0	15.75447	0	16.13647	0	15.32529	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UQD0	SCN8A_HUMAN	Sodium channel protein type 8 subunit alpha (Sodium channel protein type VIII subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.6)	SCN8A MED	Homo sapiens (Human)	membrane depolarization during action potential [GO:0086010]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuronal action potential [GO:0019228]; peripheral nervous system development [GO:0007422]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	axon [GO:0030424]; axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]	axon [GO:0030424]; axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; ATP binding [GO:0005524]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuronal action potential [GO:0019228]; peripheral nervous system development [GO:0007422]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]	ATP binding [GO:0005524]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]	GO:0001518; GO:0005244; GO:0005248; GO:0005524; GO:0005886; GO:0006814; GO:0007399; GO:0007422; GO:0016021; GO:0019228; GO:0030018; GO:0030054; GO:0030424; GO:0031410; GO:0033268; GO:0034765; GO:0035725; GO:0042552; GO:0043194; GO:0086010	NGDFQKNGNGTTSGIGSSVEK	13.57999992	1	1	2.75E-12	2097.191022	13.57893	15.65755	0	13.61236	0	0	0	13.13814	0	0	0	0	14.74825	0	0	0	0	0	0	0	0	0	0	0	12.52954	0	0	0	14.97461	0	16.27444	0	0	0	0	15.43007	0	0	14.3268	0	0	0	0	0	0	0	0	0
Q9UQE7	SMC3_HUMAN	"Structural maintenance of chromosomes protein 3, SMC protein 3, SMC-3 (Basement membrane-associated chondroitin proteoglycan, Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome-associated polypeptide, hCAP)"	SMC3 BAM BMH CSPG6 SMC3L1	Homo sapiens (Human)	cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"	"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cohesin loading activity [GO:0061775]; double-stranded DNA binding [GO:0003690]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]"	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cohesin loading activity [GO:0061775]; double-stranded DNA binding [GO:0003690]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982]	GO:0000278; GO:0000775; GO:0000785; GO:0000800; GO:0003682; GO:0003690; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006275; GO:0006281; GO:0007062; GO:0007064; GO:0008278; GO:0016363; GO:0016887; GO:0019827; GO:0030893; GO:0034089; GO:0034990; GO:0034991; GO:0036033; GO:0046982; GO:0048487; GO:0051301; GO:0051321; GO:0061775; GO:0070840; GO:0090307; GO:0097431	GYKSIMELMNVLELR	7.760000229	1	1	0.116064571	1812.960933	0	0	0	14.45759	13.19679	0	14.92595	0	12.54401	14.4972	15.56328	0	0	0	14.37152	0	14.58884	0	0	0	0	0	0	0	0	15.07413	0	0	0	0	0	0	0	0	0	0	0	0	0	17.49248	15.93817	13.5776	0	0	0	0	0	0
Q9UQF0	SYCY1_HUMAN	"Syncytin-1 (Endogenous retrovirus group W member 1) (Env-W) (Envelope polyprotein gPr73) (Enverin) (HERV-7q Envelope protein) (HERV-W envelope protein) (HERV-W_7q21.2 provirus ancestral Env polyprotein) (Syncytin) [Cleaved into: Surface protein, SU (gp50); Transmembrane protein, TM (gp24) ]"	ERVW-1 ERVWE1	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; myoblast fusion [GO:0007520]; syncytium formation [GO:0006949]; syncytium formation by plasma membrane fusion [GO:0000768]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anatomical structure morphogenesis [GO:0009653]; myoblast fusion [GO:0007520]; syncytium formation [GO:0006949]; syncytium formation by plasma membrane fusion [GO:0000768]		GO:0000768; GO:0005886; GO:0006949; GO:0007520; GO:0009653; GO:0016021	LQMEPK	3.470000029	0.021800254	0.021800254	0.139003697	761.352651	16.5816	0	0	0	0	0	0	0	0	0	16.00552	0	0	0	0	16.11308	0	0	0	0	19.32015	0	0	0	0	0	0	0	0	0	15.25627	17.17527	0	0	0	0	16.53371	0	0	0	0	0	0	0	0	0	0	0
Q9UQF2	JIP1_HUMAN	"C-Jun-amino-terminal kinase-interacting protein 1, JIP-1, JNK-interacting protein 1 (Islet-brain 1, IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1)"	MAPK8IP1 IB1 JIP1 PRKM8IP	Homo sapiens (Human)	"JUN phosphorylation [GO:0007258]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of JNK cascade [GO:0046328]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]"	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]	"cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; JUN phosphorylation [GO:0007258]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of JNK cascade [GO:0046328]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]"	kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]	GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007258; GO:0016192; GO:0019894; GO:0019901; GO:0030425; GO:0031966; GO:0043508; GO:0044297; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243	VSRSSSPLK	4.730000019	0.039545093	0.039545093	0.266556469	961.3734442	0	0	0	0	0	0	0	0	18.02725	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.40167	17.65574	0	0	17.82102	0	0	16.96702	0	0	0	18.07881	0	0	19.02591	0	17.34149	0	17.28272	17.10546	0	0	0
Q9UQL6	HDAC5_HUMAN	"Histone deacetylase 5, HD5, EC 3.5.1.98 (Antigen NY-CO-9)"	HDAC5 KIAA0600	Homo sapiens (Human)	"B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of myotube differentiation [GO:0010830]; regulation of protein binding [GO:0043393]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein deacetylase activity [GO:0033558]; protein kinase C binding [GO:0005080]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor binding [GO:0001222]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of myotube differentiation [GO:0010830]; regulation of protein binding [GO:0043393]"	DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein deacetylase activity [GO:0033558]; protein kinase C binding [GO:0005080]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor binding [GO:0001222]	GO:0000118; GO:0000122; GO:0000978; GO:0001222; GO:0004407; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006338; GO:0006476; GO:0006954; GO:0010830; GO:0010832; GO:0016575; GO:0016607; GO:0030183; GO:0031507; GO:0032869; GO:0033558; GO:0040029; GO:0042113; GO:0042802; GO:0042826; GO:0043393; GO:0045892; GO:0045944; GO:0046872; GO:0051091; GO:0061629; GO:0090051; GO:0140297	QQQLQLGK	6.849999905	0.116762862	0.116762862	0.201417806	943.7788842	14.48042	14.93033	16.03471	0	0	15.66116	14.43364	12.32373	15.00405	0	14.04778	15.71707	0	0	13.52746	16.19203	0	16.14587	0	0	0	0	15.2872	0	0	0	17.57251	16.45427	0	15.44739	15.49658	17.89337	0	0	0	0	16.58626	0	0	0	0	0	0	0	0	0	0	0
Q9UQM7	KCC2A_HUMAN	"Calcium/calmodulin-dependent protein kinase type II subunit alpha, CaM kinase II subunit alpha, CaMK-II subunit alpha, EC 2.7.11.17"	CAMK2A CAMKA KIAA0968	Homo sapiens (Human)	angiotensin-activated signaling pathway [GO:0038166]; calcium ion transport [GO:0006816]; dendritic spine development [GO:0060996]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]; response to ischemia [GO:0002931]	calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; angiotensin-activated signaling pathway [GO:0038166]; calcium ion transport [GO:0006816]; dendritic spine development [GO:0060996]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]; response to ischemia [GO:0002931]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000082; GO:0002931; GO:0004674; GO:0004683; GO:0004712; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005954; GO:0006468; GO:0006816; GO:0010666; GO:0014069; GO:0016301; GO:0018105; GO:0030666; GO:0035254; GO:0038166; GO:0042802; GO:0042803; GO:0043005; GO:0043197; GO:0046777; GO:0046872; GO:0046928; GO:0048168; GO:0051092; GO:0051346; GO:0051928; GO:0060996; GO:0106310; GO:1902108; GO:1990443; GO:2000124; GO:2001222	KSDGVK	14.53999996	0.816178977	0.816178977	0.304915993	633.130085	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.00822	0	0	0	0	18.27126	0	18.61609	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9UQN3	CHM2B_HUMAN	"Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b, CHMP2b) (Vacuolar protein sorting-associated protein 2-2, Vps2-2, hVps2-2)"	CHMP2B CGI-84	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cognition [GO:0050890]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; neuron cellular homeostasis [GO:0070050]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]	amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cognition [GO:0050890]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; neuron cellular homeostasis [GO:0070050]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	cadherin binding [GO:0045296]; protein domain specific binding [GO:0019904]	GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005737; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007032; GO:0007080; GO:0010824; GO:0015031; GO:0016236; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0043162; GO:0045296; GO:0045324; GO:0046761; GO:0050890; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070050; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904903; GO:1904930	MAGAMSTTAK	7.159999847	0.604642332	0.604642332	0.282974487	1003.923744	0	0	15.40511	16.63403	15.09093	16.06322	13.56884	13.46622	0	0	0	0	17.1159	0	15.47462	0	0	17.03814	14.50911	15.86649	12.0924	15.39136	15.08586	15.88526	15.66423	17.44038	16.45533	15.34853	17.06587	17.42054	0	17.04489	0	16.30015	16.43514	15.60813	0	0	0	15.34009	16.02152	15.28121	16.31904	16.53332	17.61652	0	0	15.90371
Q9UQP3	TENN_HUMAN	"Tenascin-N, TN-N (Tenascin-W, TN-W)"	TNN TNW	Homo sapiens (Human)	axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899]	CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733]	CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899]	identical protein binding [GO:0042802]; integrin binding [GO:0005178]	GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0033689; GO:0042802; GO:0043025; GO:0045668; GO:0062023; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905240; GO:1905899; GO:1990026; GO:1990138; GO:2001223	AQTEIDGPK	7.010000229	1	1	0.131258591	959.1899843	14.86892	0	0	0	0	0	0	13.06015	0	16.0402	0	0	0	0	0	0	0	12.65913	0	0	0	0	0	16.49379	0	0	0	15.63902	14.54067	0	14.51767	0	0	14.81635	0	0	14.74973	0	0	0	0	0	0	0	0	0	0	0
Q9UQQ1	NALDL_HUMAN	"Aminopeptidase NAALADL1, EC 3.4.11.- (100 kDa ileum brush border membrane protein, I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein, NAALADase L)"	NAALADL1 NAALADASEL NAALADL	Homo sapiens (Human)	peptide catabolic process [GO:0043171]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]	aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0004177; GO:0004180; GO:0005509; GO:0008233; GO:0008237; GO:0008270; GO:0016021; GO:0016324; GO:0042803; GO:0043171	VLGTLLK	4.440000057	1	1	0.139979011	742.7448495	18.58143	0	0	0	0	0	0	0	0	0	17.82059	16.29396	0	18.61985	0	17.74918	15.8605	0	0	0	15.09767	15.61943	0	18.14429	0	15.12961	0	0	16.37723	13.50892	13.3218	11.02233	0	18.76162	16.92547	12.34073	16.22966	17.83872	13.96672	18.62449	0	16.27384	0	16.08985	16.60083	17.18987	17.0486	14.00297
Q9UQQ2	SH2B3_HUMAN	SH2B adapter protein 3 (Lymphocyte adapter protein) (Lymphocyte-specific adapter protein Lnk) (Signal transduction protein Lnk)	SH2B3 LNK	Homo sapiens (Human)	cellular response to chemokine [GO:1990869]; cellular response to interleukin-3 [GO:0036016]; embryonic hemopoiesis [GO:0035162]; erythrocyte development [GO:0048821]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; monocyte homeostasis [GO:0035702]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; neutrophil homeostasis [GO:0001780]; thrombopoietin-mediated signaling pathway [GO:0038163]	cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; signaling receptor complex adaptor activity [GO:0030159]; stem cell factor receptor binding [GO:0005173]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to chemokine [GO:1990869]; cellular response to interleukin-3 [GO:0036016]; embryonic hemopoiesis [GO:0035162]; erythrocyte development [GO:0048821]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; monocyte homeostasis [GO:0035702]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; neutrophil homeostasis [GO:0001780]; thrombopoietin-mediated signaling pathway [GO:0038163]	protein tyrosine kinase binding [GO:1990782]; signaling receptor complex adaptor activity [GO:0030159]; stem cell factor receptor binding [GO:0005173]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	GO:0001780; GO:0005068; GO:0005173; GO:0005829; GO:0005886; GO:0008285; GO:0030159; GO:0035162; GO:0035556; GO:0035702; GO:0035855; GO:0036016; GO:0038163; GO:0042532; GO:0043407; GO:0046426; GO:0048821; GO:0051898; GO:0060761; GO:0070100; GO:0090331; GO:1900235; GO:1990782; GO:1990869	APGPDGPDR	6.420000076	0.453659087	0.453659087	0.263757693	881.9295041	16.35991	15.38278	15.67826	14.94717	13.83812	15.0436	0	0	0	15.14471	0	16.24554	0	14.24766	0	0	0	14.86963	15.58076	0	0	0	16.31974	0	16.16779	0	16.50498	0	15.23036	0	0	15.86212	0	0	14.53399	0	0	0	0	0	0	14.93677	0	0	15.3756	15.06354	0	0
Q9Y217	MTMR6_HUMAN	"Myotubularin-related protein 6 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)"	MTMR6	Homo sapiens (Human)	endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]"	"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]"	GO:0004438; GO:0004722; GO:0004725; GO:0005635; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0006470; GO:0006661; GO:0006897; GO:0032587; GO:0046856; GO:0048471; GO:0052629; GO:0106018	LNAMANR	18.14999962	0.204302877	0.204302877	0.154482933	801.8288024	13.85283	14.64851	9.699535	11.2973	15.41816	18.135	0	15.29327	0	0	16.68453	16.63647	0	16.76997	15.31125	16.5441	12.99532	0	15.16959	17.77532	16.58711	0	16.85894	15.81656	16.5832	19.68413	17.14353	0	0	0	15.64056	0	0	0	15.04732	15.19562	0	15.49046	12.01017	16.84441	16.02745	0	0	17.27422	0	16.05724	0	0
Q9Y222	DMTF1_HUMAN	"Cyclin-D-binding Myb-like transcription factor 1, hDMTF1 (Cyclin-D-interacting Myb-like protein 1, hDMP1)"	DMTF1 DMP1	Homo sapiens (Human)	"cell cycle [GO:0007049]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; cell cycle [GO:0007049]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007049	SASSVK	10.85999966	0.478698224	0.478698224	0.140156972	578.3271684	0	0	0	0	0	0	14.92179	0	0	0	0	0	14.90294	0	0	20.32049	0	15.48443	0	0	20.28298	0	0	0	0	0	0	0	0	0	17.16752	0	18.80055	0	0	20.21056	0	0	0	0	0	21.16998	0	0	0	21.08749	16.01303	0
Q9Y223	GLCNE_HUMAN	"Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing), EC 3.2.1.183 (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase, EC 2.7.1.60 (ManAc kinase) ]"	GNE GLCNE	Homo sapiens (Human)	cell adhesion [GO:0007155]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate metabolic process [GO:0006054]; UDP-N-acetylglucosamine metabolic process [GO:0006047]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761]; cell adhesion [GO:0007155]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate metabolic process [GO:0006054]; UDP-N-acetylglucosamine metabolic process [GO:0006047]"	"ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761]"	GO:0004553; GO:0005524; GO:0005737; GO:0005829; GO:0006045; GO:0006047; GO:0006054; GO:0007155; GO:0008761; GO:0009384; GO:0046872	EMVRVMR	16.42000008	0.966063976	0.966063976	0.090556926	953.4743576	13.16931	13.41614	12.00164	0	0	0	15.06604	12.68085	14.02887	0	0	0	0	0	15.93708	0	0	14.78089	11.9255	13.99021	15.53588	0	0	0	15.72757	14.70149	13.72448	15.07639	0	13.76884	13.84025	13.44971	0	15.11445	15.96016	15.53295	15.48374	16.36048	17.99529	13.10822	0	17.32655	0	0	0	16.19122	0	16.57021
Q9Y227	ENTP4_HUMAN	"Ectonucleoside triphosphate diphosphohydrolase 4, NTPDase 4, EC 3.6.1.15, EC 3.6.1.6 (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase, UDPase, EC 3.6.1.42)"	ENTPD4 KIAA0392 LALP70 LYSAL1	Homo sapiens (Human)	CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; UDP catabolic process [GO:0006256]	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of autophagosome membrane [GO:0097637]; integral component of Golgi membrane [GO:0030173]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of autophagosome membrane [GO:0097637]; integral component of Golgi membrane [GO:0030173]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; CTPase activity [GO:0043273]; cytidine-diphosphatase activity [GO:0036384]; GTPase activity [GO:0003924]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; UDP catabolic process [GO:0006256]	CTPase activity [GO:0043273]; cytidine-diphosphatase activity [GO:0036384]; GTPase activity [GO:0003924]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]	GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0009134; GO:0016020; GO:0017110; GO:0017111; GO:0030173; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712; GO:0097637	ETIQPFMNK	2.809999943	0.589747131	0.589747131	0.168144511	1122.469068	14.90972	0	13.11306	0	0	11.51118	0	0	0	0	0	0	0	0	0	17.64886	13.50844	15.07474	0	15.07202	0	0	15.59157	0	14.59029	14.81976	14.1332	5.52055	12.38209	14.31738	15.24104	14.49466	14.46256	0	14.38965	13.42927	12.98866	15.49122	14.6638	12.67221	14.98187	15.48677	0	14.94708	15.081	0	13.36588	13.90905
Q9Y233	PDE10_HUMAN	"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A, EC 3.1.4.17"	PDE10A	Homo sapiens (Human)	cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]	cytosol [GO:0005829]	"cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]"	"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]"	GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0007165; GO:0010754; GO:0030552; GO:0030553; GO:0046069; GO:0046872; GO:0047555	FSIEKGIAGQVAR	15.77000046	1	1	0.069421308	1375.400923	0	16.16539	0	16.87621	0	0	0	0	0	16.51861	16.69096	16.02392	0	0	0	16.51542	0	0	0	0	0	0	0	0	0	16.36061	0	0	0	0	0	0	0	0	0	0	17.33272	0	0	16.07067	17.74132	17.25763	16.42777	0	16.10307	0	0	0
Q9Y235	ABEC2_HUMAN	"C->U-editing enzyme APOBEC-2, EC 3.5.4.36 (mRNA(cytosine(6666)) deaminase 2)"	APOBEC2	Homo sapiens (Human)	cytidine to uridine editing [GO:0016554]; DNA demethylation [GO:0080111]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytidine to uridine editing [GO:0016554]; DNA demethylation [GO:0080111]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]	cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0006397; GO:0016554; GO:0016556; GO:0042802; GO:0046872; GO:0080111	GGQVQASR	14.02000046	1.04E-05	1.04E-05	0.282348915	803.0853318	0	19.98106	0	0	0	0	0	16.6156	17.61758	19.05004	0	18.41673	17.80879	0	17.61479	16.85466	0	0	0	0	16.39167	0	0	0	0	0	0	18.10376	17.63376	18.63506	0	0	18.4985	0	0	0	18.96516	0	16.36131	0	17.47888	0	0	17.8974	0	0	0	18.93134
Q9Y238	DLEC1_HUMAN	"Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1, DLC-1)"	DLEC1 DLC1	Homo sapiens (Human)	cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283]	alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]	GO:0002357; GO:0005737; GO:0005829; GO:0007283; GO:0008285; GO:0030154; GO:0043014; GO:0048487	AIAENER	6.139999866	0.464946538	0.464946538	0.192688081	801.7402535	0	14.9446	0	0	0	0	0	0	0	0	0	15.70201	16.32409	0	16.00406	0	0	15.01474	0	17.27712	0	16.84244	17.01294	0	17.21566	0	16.54241	0	15.80349	16.80297	16.47244	16.72375	16.98619	0	0	17.38989	0	17.52885	17.24176	17.37458	16.92657	17.32447	15.98237	17.1831	17.08541	17.92178	16.51447	18.01468
Q9Y240	CLC11_HUMAN	C-type lectin domain family 11 member A (C-type lectin superfamily member 3) (Lymphocyte secreted C-type lectin) (Osteolectin) (Stem cell growth factor) (p47)	CLEC11A CLECSF3 LSLCL SCGF	Homo sapiens (Human)	ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083]; ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284]	carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083]	GO:0001503; GO:0005576; GO:0005615; GO:0005737; GO:0008083; GO:0008284; GO:0030246	DAVQALQEAQGR	4.679999828	1	1	0.011031445	1284.801303	0	0	0	0	0	0	0	0	0	0	0	0	0	12.63976	0	0	0	12.07469	0	0	0	13.56837	0	0	14.58661	0	18.07483	0	0	0	0	11.66109	0	16.59517	0	12.81392	14.12933	0	10.11548	0	14.15573	0	0	0	0	0	0	0
Q9Y248	PSF2_HUMAN	DNA replication complex GINS protein PSF2 (GINS complex subunit 2)	GINS2 PSF2 CGI-122 DC5 HSPC037	Homo sapiens (Human)	DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]		GO:0000727; GO:0000811; GO:0005634; GO:0005654; GO:0006268; GO:0071162; GO:1900264; GO:1903934	LLLNHASDNIPK	6.079999924	1	1	3.42E-12	1332.212781	16.79639	13.65175	0	0	12.77453	16.06224	0	14.16393	0	0	15.33797	16.61985	14.97379	15.02174	15.89272	15.76845	11.81664	14.44455	12.65022	0	13.37591	0	0	15.753	0	0	0	18.10814	17.45044	16.95646	16.17118	18.29792	15.60551	0	15.62975	0	0	15.25168	15.49006	0	0	0	16.75169	0	14.78122	15.26906	15.04894	0
Q9Y250	LZTS1_HUMAN	Leucine zipper putative tumor suppressor 1 (F37/esophageal cancer-related gene-coding leucine-zipper motif) (Fez1)	LZTS1 FEZ1	Homo sapiens (Human)	mitotic cell cycle phase transition [GO:0044772]; negative regulation of macroautophagy [GO:0016242]; regulation of dendrite morphogenesis [GO:0048814]; regulation of synaptic plasticity [GO:0048167]	cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of macroautophagy [GO:0016242]; regulation of dendrite morphogenesis [GO:0048814]; regulation of synaptic plasticity [GO:0048167]	microtubule binding [GO:0008017]	GO:0005737; GO:0005886; GO:0008017; GO:0014069; GO:0016242; GO:0043197; GO:0044772; GO:0048167; GO:0048814	SSSKMGK	6.869999886	0.279031485	0.279031485	0.236933346	740.6336449	15.62994	15.82296	16.03374	0	15.73533	0	0	0	15.17414	16.49238	16.00895	15.69976	15.8744	16.55822	15.43396	18.49052	17.90672	18.28922	15.48893	19.10521	16.95395	16.2699	17.20959	16.76567	18.30661	17.69152	18.16551	18.40401	19.24514	17.56399	18.68411	18.31989	18.32884	18.54501	18.8152	18.51739	19.5331	19.83891	17.14918	16.18796	19.23487	17.31645	16.66424	19.83102	18.26015	17.01081	19.59056	19.89601
Q9Y252	RNF6_HUMAN	"E3 ubiquitin-protein ligase RNF6, EC 2.3.2.27 (RING-type E3 ubiquitin transferase RNF6)"	RNF6 SPG2	Homo sapiens (Human)	"negative regulation of axon extension [GO:0030517]; positive regulation of transcription, DNA-templated [GO:0045893]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	"axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of axon extension [GO:0030517]; positive regulation of transcription, DNA-templated [GO:0045893]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]"	androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006511; GO:0016567; GO:0016605; GO:0030424; GO:0030517; GO:0031965; GO:0043231; GO:0044314; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630; GO:0070936; GO:0085020	LERSGIR	8.229999542	1	1	0.015866517	829.3665933	0	15.77017	17.04413	0	0	0	0	0	16.40311	0	0	0	0	0	16.19872	0	0	16.86099	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y253	POLH_HUMAN	"DNA polymerase eta, EC 2.7.7.7 (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)"	POLH RAD30 RAD30A XPV	Homo sapiens (Human)	cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]	damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]	GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494	LEESSK	2.339999914	1	1	0.213124998	694.2070024	14.96301	16.19202	0	0	0	0	0	0	0	0	16.41505	0	16.80865	15.04899	0	15.8261	16.3732	15.74832	0	16.98639	16.40915	0	0	0	16.7683	0	0	0	0	0	0	17.71907	0	17.12252	17.29086	18.30908	17.24232	17.63576	0	16.72779	17.57724	0	0	16.13201	15.74362	0	0	0
Q9Y255	PRLD1_HUMAN	"PRELI domain-containing protein 1, mitochondrial (25 kDa protein of relevant evolutionary and lymphoid interest) (Px19-like protein)"	PRELID1 PRELI CGI-106 SBBI12	Homo sapiens (Human)	apoptotic process [GO:0006915]; immune response [GO:0006955]; intermembrane lipid transfer [GO:0120009]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of cellular respiration [GO:1901857]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of membrane lipid distribution [GO:0097035]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of T cell differentiation [GO:0045580]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; apoptotic process [GO:0006915]; immune response [GO:0006955]; intermembrane lipid transfer [GO:0120009]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of cellular respiration [GO:1901857]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of membrane lipid distribution [GO:0097035]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of T cell differentiation [GO:0045580]		GO:0005654; GO:0005739; GO:0005758; GO:0006915; GO:0006955; GO:0007275; GO:0010917; GO:0010950; GO:0015914; GO:0032991; GO:0043066; GO:0045580; GO:0051881; GO:0070234; GO:0090201; GO:0097035; GO:0120009; GO:1901857; GO:2001140	LQGEAPSK	6.519999981	1	1	0.301244901	829.3824052	0	0	17.64277	18.59721	0	0	0	0	0	0	0	0	0	0	0	0	18.58764	16.50149	0	15.52308	17.34003	0	16.40268	0	16.29642	0	17.34547	0	18.05156	0	0	0	0	0	0	18.66174	0	0	0	0	0	0	17.3189	0	0	16.96706	0	0
Q9Y256	FACE2_HUMAN	"CAAX prenyl protease 2, EC 3.4.-.- (Farnesylated proteins-converting enzyme 2, FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog, hRCE1)"	RCE1 FACE2 RCE1A RCE1B	Homo sapiens (Human)	CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342]	cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]	GO:0000165; GO:0004175; GO:0004197; GO:0004222; GO:0005789; GO:0005829; GO:0005887; GO:0008238; GO:0016020; GO:0018342; GO:0030176; GO:0071586	AGDSEAPLCS	4.460000038	1	1	0.2127792	1005.54718	14.6677	0	0	0	0	0	0	0	0	0	14.9612	15.84843	16.22495	0	0	15.17452	0	15.46785	0	14.28907	16.50978	13.87136	16.16821	17.56683	0	0	0	0	0	0	0	0	17.48026	13.17041	18.24452	0	0	0	0	0	15.24502	0	0	13.65942	0	16.97947	0	0
Q9Y259	CHKB_HUMAN	"Choline/ethanolamine kinase (Choline kinase beta, CK, CKB, EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase, EK, EC 2.7.1.82) (Ethanolamine kinase beta, EKB) (choline/ethanolamine kinase beta, CKEKB)"	CHKB CHETK CHKL	Homo sapiens (Human)	CDP-choline pathway [GO:0006657]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; CDP-choline pathway [GO:0006657]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]	GO:0004103; GO:0004305; GO:0005524; GO:0005737; GO:0005829; GO:0006646; GO:0006656; GO:0006657; GO:0007517	VYPVSGGLSNLLFR	9.529999733	1	1	1.37E-12	1520.136163	12.86286	15.46862	9.229641	14.46382	13.18043	0	0	0	0	0	0	13.93226	13.25233	15.17275	0	0	0	14.06308	0	0	13.69693	14.35332	16.96453	0	0	16.33735	0	0	13.59542	14.49953	0	13.56322	0	13.36493	0	0	0	0	0	15.37019	0	11.66916	12.71184	0	0	0	0	0
Q9Y261	FOXA2_HUMAN	"Hepatocyte nuclear factor 3-beta, HNF-3-beta, HNF-3B (Forkhead box protein A2) (Transcription factor 3B, TCF-3B)"	FOXA2 HNF3B TCF3B	Homo sapiens (Human)	"adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chromatin organization [GO:0006325]; dopaminergic neuron differentiation [GO:0071542]; endocrine pancreas development [GO:0031018]; negative regulation of detection of glucose [GO:2000971]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of transcription from RNA polymerase II promoter by glucose [GO:0061987]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of blood coagulation [GO:0030193]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-6 [GO:0070741]"	cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chromatin organization [GO:0006325]; dopaminergic neuron differentiation [GO:0071542]; endocrine pancreas development [GO:0031018]; negative regulation of detection of glucose [GO:2000971]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of transcription from RNA polymerase II promoter by glucose [GO:0061987]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of blood coagulation [GO:0030193]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-6 [GO:0070741]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]"	GO:0000432; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001708; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006357; GO:0008344; GO:0009653; GO:0010719; GO:0019904; GO:0030054; GO:0030154; GO:0030193; GO:0031018; GO:0033132; GO:0040019; GO:0043433; GO:0045893; GO:0045944; GO:0061178; GO:0061987; GO:0070741; GO:0071542; GO:0090009; GO:1990837; GO:2000049; GO:2000543; GO:2000971	AYEQVMHYPGYGSPMPGSLAMGPVTNK	1.379999995	1	1	4.57E-12	2899.07105	13.87145	12.95792	15.40725	0	13.56684	13.48268	14.53639	9.934956	0	14.32734	14.7874	0	0	0	9.685966	0	0	0	14.83663	0	0	0	0	12.9432	14.75509	0	16.06993	0	0	0	0	0	0	0	0	0	14.43783	0	0	0	0	13.43995	0	0	11.5309	0	0	0
Q9Y264	ANGP4_HUMAN	"Angiopoietin-4, ANG-4 (Angiopoietin-3, ANG-3)"	ANGPT4 ANG3 ANG4	Homo sapiens (Human)	angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]	receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	GO:0001525; GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007219; GO:0010595; GO:0016525; GO:0030297; GO:0030971; GO:0043066; GO:0043536; GO:0043537; GO:0045766; GO:0050731; GO:0062023; GO:0071456	YKMDGIR	2.799999952	1	1	0.116390566	879.4937295	0	0	0	0	0	0	0	0	0	0	14.90017	16.66872	0	11.66388	0	0	0	0	0	0	0	0	0	0	0	0	17.54995	0	15.81189	0	0	15.32256	0	0	0	0	16.02225	0	16.20788	0	0	0	10.10845	0	0	0	0	0
Q9Y265	RUVB1_HUMAN	"RuvB-like 1, EC 3.6.4.12 (49 kDa TATA box-binding protein-interacting protein, 49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein, ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238, NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha, TAP54-alpha)"	RUVBL1 INO80H NMP238 TIP49 TIP49A	Homo sapiens (Human)	"box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nucleosome mobilization [GO:0042766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]"	chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812]	"chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nucleosome mobilization [GO:0042766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]"	ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	GO:0000492; GO:0000723; GO:0000786; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007049; GO:0007283; GO:0016020; GO:0016363; GO:0016573; GO:0016887; GO:0017025; GO:0031011; GO:0033044; GO:0035267; GO:0040008; GO:0042766; GO:0042981; GO:0043486; GO:0043531; GO:0043967; GO:0043968; GO:0045296; GO:0045893; GO:0045995; GO:0050821; GO:0051117; GO:0051301; GO:0051726; GO:0060382; GO:0070062; GO:0071339; GO:0090263; GO:0097255; GO:0101031; GO:0120293; GO:1904507; GO:1904874; GO:1905168; GO:1990062; GO:1990904; GO:2000779	QAASGLVGQENAR	6.769999981	0.214883953	0.214883953	0.00209374	1300.503734	11.32402	11.79013	14.68325	10.39366	0	0	13.92233	0	0	0	0	10.6351	0	0	0	0	0	0	14.5778	0	0	0	12.10505	0	14.07705	0	0	0	0	0	15.05512	0	0	0	10.83157	0	0	12.84952	0	11.70355	0	0	0	0	0	12.88466	0	12.59906
Q9Y272	RASD1_HUMAN	Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1)	RASD1 AGS1 DEXRAS1	Homo sapiens (Human)	"G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]"	nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]	"nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]"	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005634; GO:0005886; GO:0007165; GO:0007186; GO:0007263; GO:0016529; GO:0045892; GO:0048471	CAYFEISAKK	2.359999895	0.798124194	0.798124194	0.132039989	1216.617107	13.94944	15.41176	0	0	0	0	0	15.17	0	14.28316	0	0	0	0	0	12.33535	0	0	10.43034	0	0	0	0	15.69071	14.38751	0	0	0	0	15.82194	15.71612	12.07137	13.52612	10.89891	0	0	15.50603	0	14.14261	11.69235	14.52537	14.5849	15.10239	0	0	0	0	0
Q9Y275	TN13B_HUMAN	"Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator, BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1, TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form ]"	TNFSF13B BAFF BLYS TALL1 TNFSF20 ZTNF4 UNQ401/PRO738	Homo sapiens (Human)	B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; immune response [GO:0006955]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; immune response [GO:0006955]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	GO:0001782; GO:0002636; GO:0005102; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005925; GO:0006955; GO:0007165; GO:0016021; GO:0030183; GO:0030890; GO:0031295; GO:0031296; GO:0033209; GO:0042102; GO:0043231; GO:0048018; GO:0048471	LKECVSILPR	6.949999809	1	1	0.358115655	1214.070131	0	0	0	14.03781	14.00162	0	0	14.51077	14.44971	13.82295	14.3766	14.66968	15.16288	14.87787	0	15.52536	0	0	13.41025	0	0	12.83928	12.23069	0	0	0	0	0	0	0	14.88341	0	0	0	16.349	0	0	0	0	0	0	16.28777	0	0	15.51872	0	0	0
Q9Y283	INVS_HUMAN	Inversin (Inversion of embryo turning homolog) (Nephrocystin-2)	INVS INV NPHP2	Homo sapiens (Human)	negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]	cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]	cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]	calmodulin binding [GO:0005516]	GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0005929; GO:0016020; GO:0016055; GO:0090090	RPNETAR	11.36999989	0.781433046	0.781433046	0.17905129	841.6234159	15.47292	15.48412	0	15.15419	0	0	14.21069	15.37646	0	14.82987	15.04537	0	16.07235	16.92814	0	0	16.61039	0	0	0	15.99448	16.89921	0	15.27973	16.73663	16.09592	0	14.88434	0	15.7233	17.56488	15.87998	16.15726	15.66206	14.91741	15.99734	17.53574	17.67699	17.17934	15.48345	16.56946	16.99882	14.74285	17.47403	14.24613	13.38389	14.61419	16.99852
Q9Y297	FBW1A_HUMAN	F-box/WD repeat-containing protein 1A (E3RSIkappaB) (Epididymis tissue protein Li 2a) (F-box and WD repeats protein beta-TrCP) (pIkappaBalpha-E3 receptor subunit)	BTRC BTRCP FBW1A FBXW1A	Homo sapiens (Human)	"branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]	"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase activity [GO:0061630]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"	beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase activity [GO:0061630]	GO:0000209; GO:0005654; GO:0005829; GO:0006470; GO:0006511; GO:0007165; GO:0008013; GO:0016055; GO:0016567; GO:0016874; GO:0019005; GO:0031146; GO:0031648; GO:0033598; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0043433; GO:0045309; GO:0045862; GO:0045879; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1904668; GO:1990756; GO:1990757	FMCSMPR	6.75	0.006964582	0.006964582	0.308577076	944.8517638	0	0	15.13143	0	0	0	0	0	0	16.8644	13.12337	0	0	0	16.9836	17.46922	0	0	0	0	0	17.99789	0	0	0	0	16.70745	15.84883	16.14182	0	0	0	0	0	20.90909	0	16.03921	18.37315	0	0	0	16.24125	0	0	0	16.22275	17.97062	0
Q9Y2A9	B3GN3_HUMAN	"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3, EC 2.4.1.149 (Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase, EC 2.4.1.146) (Beta-1,3-galactosyltransferase 8, Beta-1,3-GalTase 8, Beta3Gal-T8, Beta3GalT8, b3Gal-T8) (Beta-3-Gx-T8) (Core 1 extending beta-1,3-N-acetylglucosaminyltransferase) (Core1-beta3GlcNAcT) (Transmembrane protein 3) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, BGnT-3, Beta-1,3-Gn-T3, Beta-1,3-N-acetylglucosaminyltransferase 3, Beta3Gn-T3) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8)"	B3GNT3 B3GALT8 TMEM3 UNQ637/PRO1266	Homo sapiens (Human)	keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]	Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]	"Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]"	"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]"	GO:0000139; GO:0005887; GO:0008194; GO:0008457; GO:0008499; GO:0008532; GO:0016266; GO:0016757; GO:0018146; GO:0030311; GO:0047223	DLLLVHR	8.81000042	1	1	0.246674604	865.1220588	15.43026	16.3111	16.04233	16.1894	0	16.63203	0	0	0	0	0	0	0	0	0	14.64153	15.71926	16.05658	0	16.24231	15.86512	0	17.21808	0	15.63564	0	16.45923	15.81061	16.04022	16.58582	15.32025	12.07778	15.07932	15.52593	0	15.06531	16.45881	14.51178	0	15.82544	0	15.60363	16.77472	14.78742	15.73733	15.73156	17.17507	15.29499
Q9Y2B0	CNPY2_HUMAN	Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4)	CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426	Homo sapiens (Human)	negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; regulation of low-density lipoprotein particle clearance [GO:0010988]	endoplasmic reticulum [GO:0005783]	endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; regulation of low-density lipoprotein particle clearance [GO:0010988]		GO:0005783; GO:0010629; GO:0010988; GO:1905599	TIQMGSFR	3.319999933	0.397486001	0.397486001	0.174283964	941.9276771	13.64237	16.64143	15.05286	14.27117	0	0	15.07237	0	15.59831	16.06214	0	16.10894	14.84638	12.47808	12.96142	0	13.92453	14.34788	15.77066	0	15.26457	0	0	0	15.41012	0	0	0	0	0	0	15.5841	15.71326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.23495
Q9Y2B4	T53G5_HUMAN	TP53-target gene 5 protein (TP53-inducible gene 5 protein)	TP53TG5 C20orf10	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308]		GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0030308; GO:0035556	RPKNSR	7.550000191	1	1	0.228814573	756.4256322	0	0	0	0	0	0	0	18.12603	0	18.46904	0	0	0	0	0	17.10382	0	0	16.67334	17.13419	0	0	0	0	0	17.99424	0	0	0	0	0	18.86753	0	0	0	0	0	0	18.10207	0	16.81048	0	0	0	0	0	0	0
Q9Y2B5	VP9D1_HUMAN	VPS9 domain-containing protein 1 (Protein ATP-BL)	VPS9D1 ATPBL C16orf7	Homo sapiens (Human)	ATP synthesis coupled proton transport [GO:0015986]; vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]	cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; transporter activity [GO:0005215]; ATP synthesis coupled proton transport [GO:0015986]; vesicle-mediated transport [GO:0016192]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; transporter activity [GO:0005215]	GO:0005085; GO:0005096; GO:0005215; GO:0005829; GO:0015986; GO:0016192; GO:0030139; GO:0031267; GO:0042802	MAAAAGDGTVKPLQSAMK	12.63000011	0.96966666	0.96966666	0.128582657	1763.911874	12.55597	0	0	0	14.08782	0	14.70485	0	14.75292	0	0	0	0	0	16.48612	14.06634	0	15.415	0	0	17.19179	0	16.08955	0	14.17705	13.4092	0	0	0	0	0	0	0	14.3299	0	15.09311	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2C3	B3GT5_HUMAN	"Beta-1,3-galactosyltransferase 5, Beta-1,3-GalTase 5, Beta3Gal-T5, Beta3GalT5, b3Gal-T5, EC 2.4.1.- (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)"	B3GALT5	Homo sapiens (Human)	lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]"	"glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]"	GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006629; GO:0008194; GO:0008499; GO:0009312; GO:0016021; GO:0016757	TLLDYWQALENSR	9.229999542	1	1	0.440302638	1608.80916	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.03399	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2C5	S17A4_HUMAN	Probable small intestine urate exporter (Solute carrier family 17 member 4)	SLC17A4	Homo sapiens (Human)	anion transport [GO:0006820]; phosphate-containing compound metabolic process [GO:0006796]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]	apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; phosphate-containing compound metabolic process [GO:0006796]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]	sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]	GO:0005436; GO:0005764; GO:0005887; GO:0006796; GO:0006814; GO:0006820; GO:0015136; GO:0015739; GO:0016020; GO:0016021; GO:0016324; GO:0022857	MSTGPDVK	7.099999905	1	1	0.288996376	833.5841882	0	0	0	0	16.77664	17.76996	18.24331	0	0	0	0	17.96738	0	15.88212	0	0	0	0	0	0	17.47466	16.89587	17.67489	16.31942	20.09294	19.81318	0	0	18.48982	19.58487	0	0	19.15168	19.49291	0	0	0	0	0	18.41772	0	18.0109	0	0	0	0	0	17.40134
Q9Y2D1	ATF5_HUMAN	"Cyclic AMP-dependent transcription factor ATF-5, cAMP-dependent transcription factor ATF-5 (Activating transcription factor 5) (Transcription factor ATFx)"	ATF5 ATFX	Homo sapiens (Human)	"cerebellar granule cell precursor proliferation [GO:0021930]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron development [GO:0021891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of centrosome cycle [GO:0046605]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]; cerebellar granule cell precursor proliferation [GO:0021930]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron development [GO:0021891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of centrosome cycle [GO:0046605]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]"	GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006355; GO:0006357; GO:0007623; GO:0008285; GO:0009791; GO:0015631; GO:0019900; GO:0021891; GO:0021930; GO:0035264; GO:0043066; GO:0043565; GO:0045444; GO:0045892; GO:0045893; GO:0045944; GO:0046605; GO:0090575; GO:1902750	SAALR	12.19999981	0.710302234	0.710302234	0.250833971	518.5201002	18.51149	19.99751	0	0	0	15.69454	0	0	0	17.44268	0	17.10763	0	0	0	17.98351	0	0	0	15.85122	0	0	19.04601	0	0	0	0	0	0	0	0	0	18.07622	17.7809	0	0	18.82071	0	19.32514	0	17.36105	16.37368	16.61396	17.77938	0	0	0	0
Q9Y2D4	EXC6B_HUMAN	Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2)	EXOC6B KIAA0919 SEC15B SEC15L2	Homo sapiens (Human)	exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]	exocyst [GO:0000145]	exocyst [GO:0000145]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]		GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522	NQVTDTNR	14.17000008	0.682269096	0.682269096	0.281717882	948.0320411	20.17649	0	16.05516	15.5482	21.20896	0	21.34869	18.12544	18.22498	15.79095	21.33643	16.83302	17.79489	19.5571	0	17.74449	0	16.65606	17.23376	0	16.77104	19.40074	18.35676	17.40618	17.02521	18.41191	22.44854	0	18.03811	0	0	0	19.69589	0	17.55918	18.56959	18.83976	0	20.03365	20.07396	21.23415	18.23789	17.38971	20.17247	0	20.71255	16.28773	21.72749
Q9Y2D8	ADIP_HUMAN	"Afadin- and alpha-actinin-binding protein, ADIP (Afadin DIL domain-interacting protein) (SSX2-interacting protein)"	SSX2IP KIAA0923	Homo sapiens (Human)	cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020]	adherens junction [GO:0005912]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	adherens junction [GO:0005912]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein domain specific binding [GO:0019904]; cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020]	protein domain specific binding [GO:0019904]	GO:0005634; GO:0005737; GO:0005912; GO:0007098; GO:0007155; GO:0019904; GO:0031252; GO:0032991; GO:0034451; GO:0035020; GO:0035735; GO:0036064; GO:0060271; GO:2000145	NEDEMYK	13.46000004	1	1	0.230439367	930.157504	16.05589	0	0	13.35166	0	0	0	0	0	0	14.60662	16.58383	14.78081	0	0	14.61307	15.1966	0	0	16.28785	16.4205	0	0	0	0	0	15.78724	0	15.4668	0	0	17.81054	0	0	0	0	0	0	0	16.45291	0	0	16.21032	0	15.37573	0	14.23874	15.95261
Q9Y2E4	DIP2C_HUMAN	"Disco-interacting protein 2 homolog C, DIP2 homolog C"	DIP2C KIAA0934	Homo sapiens (Human)						DGSVLGVTVTR	6.570000172	0.012178234	0.012178234	0.053588992	1103.73541	14.56636	14.42918	13.80436	0	0	14.16658	14.54029	13.77831	15.34858	13.57347	0	0	16.14209	15.38878	0	15.55772	14.81358	0	14.55647	15.88648	14.99281	13.08002	16.39601	15.10568	0	16.84228	14.28392	6.275543	12.39358	0	0	0	0	0	0	7.609893	16.17619	14.77703	16.91817	0	12.95911	0	0	8.118203	14.91179	16.95578	0	16.432
Q9Y2E5	MA2B2_HUMAN	"Epididymis-specific alpha-mannosidase, EC 3.2.1.24 (Alpha-1,6-mannosidase) (Mannosidase alpha class 2B member 2)"	MAN2B2 KIAA0935	Homo sapiens (Human)	mannose metabolic process [GO:0006013]	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]	alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0043202; GO:0046872; GO:0070062	QSNRTVR	8.840000153	1	1	0.219228128	859.8914232	16.31276	7.785418	11.17545	14.78358	15.32555	15.36242	0	14.56528	14.57309	14.27924	13.52142	0	14.19369	16.19122	14.03951	13.33627	14.37768	0	0	14.17062	0	0	16.25626	0	16.13661	14.96327	0	14.09619	16.29836	16.72563	16.86159	15.81001	0	13.84177	15.2459	16.58214	0	0	16.3229	16.28895	16.09957	14.66532	0	15.53155	0	15.5346	15.28616	0
Q9Y2E6	DTX4_HUMAN	"E3 ubiquitin-protein ligase DTX4, EC 2.3.2.27 (Protein deltex-4, Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4)"	DTX4 KIAA0937 RNF155	Homo sapiens (Human)	Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]	ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0004842; GO:0005654; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0032479; GO:0061630	NMPPPGVVK	1.5	1	1	0.092431117	950.7435315	0	0	0	16.83365	0	16.06181	0	0	0	0	0	17.59857	0	0	0	0	0	0	15.22121	0	12.43475	16.3548	0	0	0	0	0	0	12.77649	16.82535	13.51463	17.52949	0	0	0	0	16.49092	0	16.84793	0	0	0	0	0	0	14.69966	16.24531	0
Q9Y2E8	SL9A8_HUMAN	"Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8, NHE-8) (Solute carrier family 9 member 8)"	SLC9A8 KIAA0939 NHE8	Homo sapiens (Human)	ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]	potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]	GO:0000139; GO:0005794; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805	KNMSDVSGWQTFLQALDYFLK	2.630000114	0.737768829	0.737768829	0.099435731	2490.621152	15.63083	15.63491	14.68877	13.78977	13.77456	0	0	0	11.07383	15.51503	0	14.26324	0	15.55049	0	13.09212	0	15.49895	0	15.33362	14.23235	0	0	0	0	14.64507	0	15.24359	13.63256	13.49218	15.21599	0	0	0	0	0	0	0	0	15.59223	0	0	14.37103	0	0	0	14.65339	0
Q9Y2F5	ICE1_HUMAN	Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1)	ICE1 KIAA0947	Homo sapiens (Human)	positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	Cajal body [GO:0015030]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]	Cajal body [GO:0015030]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein-macromolecule adaptor activity [GO:0030674]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	protein-macromolecule adaptor activity [GO:0030674]	GO:0000791; GO:0005654; GO:0008023; GO:0015030; GO:0016604; GO:0030674; GO:0031334; GO:0035363; GO:0042795; GO:0042796; GO:0045945; GO:0090316	HWTTASRSMSDR	6.610000134	1	1	0.031808281	1446.562774	15.77086	0	15.20435	0	14.42319	14.07079	0	0	14.28028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.23545	0	0	0	0	15.12716	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2F9	BTBD3_HUMAN	BTB/POZ domain-containing protein 3	BTBD3 KIAA0952	Homo sapiens (Human)	cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008]	identical protein binding [GO:0042802]	GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0042802; GO:0048813	YIVPHLAR	14.28999996	1	1	0.249635648	969.5565719	14.9111	13.25206	0	14.51252	14.69262	14.68438	14.92519	14.05111	13.25851	12.32392	0	10.15303	0	14.73132	0	14.56547	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2G1	MYRF_HUMAN	"Myelin regulatory factor, EC 3.4.-.- (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal ]"	MYRF C11orf9 KIAA0954 MRF	Homo sapiens (Human)	"central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]"	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]; central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]"	GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0008233; GO:0014003; GO:0016021; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0042802; GO:0043565; GO:0045893; GO:0048709	AQVPDTVFHHGRVGINTDRPDEALVVHGNVK	10.98999977	1	1	0.039160701	3376.642551	13.77287	15.79289	0	7.602714	11.47516	0	9.136415	13.82305	12.98897	0	0	13.09384	11.43698	9.390469	10.07404	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2G2	CARD8_HUMAN	"Caspase recruitment domain-containing protein 8, EC 3.4.-.- (CARD-inhibitor of NF-kappa-B-activating ligand, CARDINAL) (Tumor up-regulated CARD-containing antagonist of CASP9, TUCAN) [Cleaved into: Caspase recruitment domain-containing protein 8, C-terminus, CARD8-CT; Caspase recruitment domain-containing protein 8, N-terminus, CARD8-NT ]"	CARD8 DACAR KIAA0955 NDPP1	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; CARD8 inflammasome complex assembly [GO:0140633]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; self proteolysis [GO:0097264]	CARD8 inflammasome complex [GO:0140634]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	CARD8 inflammasome complex [GO:0140634]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; endopeptidase activity [GO:0004175]; NACHT domain binding [GO:0032089]; pattern recognition receptor activity [GO:0038187]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; CARD8 inflammasome complex assembly [GO:0140633]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; self proteolysis [GO:0097264]	CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; endopeptidase activity [GO:0004175]; NACHT domain binding [GO:0032089]; pattern recognition receptor activity [GO:0038187]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006919; GO:0006954; GO:0008233; GO:0008656; GO:0010804; GO:0031665; GO:0032088; GO:0032089; GO:0032691; GO:0032731; GO:0032991; GO:0038187; GO:0042803; GO:0042981; GO:0043122; GO:0043124; GO:0043280; GO:0043621; GO:0050700; GO:0051260; GO:0051607; GO:0061702; GO:0070269; GO:0072559; GO:0097264; GO:0097340; GO:0140374; GO:0140608; GO:0140633; GO:0140634; GO:1900226	EPIQLEITEKR	16.5	1	1	0.601347332	1356.514978	0	0	0	0	0	18.97318	0	0	0	0	0	0	18.58436	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2G3	AT11B_HUMAN	"Phospholipid-transporting ATPase IF, EC 7.6.2.1 (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)"	ATP11B ATPIF ATPIR KIAA0956	Homo sapiens (Human)	aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332]	azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]	azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine floppase activity [GO:0090556]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine floppase activity [GO:0090556]	GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090555; GO:0090556; GO:0140326; GO:1990531	DEIFPADLVLLSSDR	3.799999952	1	1	0.613316861	1690.378474	12.7822	0	17.94111	0	0	0	0	0	17.60929	0	0	0	0	0	0	0	0	0	0	18.32578	0	0	0	0	0	0	0	0	0	0	0	0	19.00997	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.6777
Q9Y2G4	ANKR6_HUMAN	Ankyrin repeat domain-containing protein 6 (Diversin)	ANKRD6 KIAA0957	Homo sapiens (Human)	"negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]"	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]"		GO:0005634; GO:0005737; GO:0043231; GO:0046330; GO:0090090; GO:2000096	AGANVLAKNK	7.5	1	1	2.29E-13	988.0105901	15.34579	12.30548	13.42021	13.44389	15.10933	14.88206	13.74958	12.93134	15.10131	0	12.28588	0	13.56157	14.94008	15.4626	0	14.1814	11.84232	12.89246	0	14.84632	14.29609	0	0	0	0	0	0	0	11.2121	0	0	0	0	0	0	0	0	0	14.80414	0	14.83332	0	0	0	0	0	0
Q9Y2G9	SBNO2_HUMAN	Protein strawberry notch homolog 2	SBNO2 KIAA0963	Homo sapiens (Human)	"bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]; regulation of transcription, DNA-templated [GO:0006355]"	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]	GO:0002281; GO:0005634; GO:0006355; GO:0030282; GO:0030316; GO:0031490; GO:0042393; GO:0045892; GO:0045944; GO:0050727; GO:0061430; GO:0071222; GO:0071348; GO:0071354; GO:0072675; GO:1990830	GVGAMEIVAMDMKVSGMYIAR	3.299999952	0.78609097	0.78609097	0.16739307	2239.41429	0	0	0	12.3138	0	0	12.55447	14.23997	0	0	13.87024	0	0	0	0	8.083526	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.24793	14.24471	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2H0	DLGP4_HUMAN	"Disks large-associated protein 4, DAP-4 (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4, SAPAP-4)"	DLGAP4 DAP4 KIAA0964 SAPAP4	Homo sapiens (Human)	regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052]	cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572]	cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572]; molecular adaptor activity [GO:0060090]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052]	molecular adaptor activity [GO:0060090]	GO:0005886; GO:0023052; GO:0031594; GO:0060090; GO:0098962; GO:0098978; GO:0098981; GO:0099572	SSVPSHSMSSR	5.46999979	0.671241462	0.671241462	0.063679767	1177.011094	13.88868	15.74668	17.2245	0	0	14.12223	0	12.51379	5.912094	0	14.03773	0	13.0741	13.79912	13.86238	0	0	0	0	0	0	0	14.54234	0	15.20555	0	16.56332	0	0	14.63533	17.00485	15.26515	16.43872	0	0	15.46333	0	16.44522	14.91933	0	0	0	14.13488	0	13.68861	0	15.81285	0
Q9Y2H1	ST38L_HUMAN	"Serine/threonine-protein kinase 38-like, EC 2.7.11.1 (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2)"	STK38L KIAA0965 NDR2	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128]	actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0003779; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0015629; GO:0016020; GO:0018105; GO:0035556; GO:0051128; GO:0106310	GSIPTYMKAGK	4.130000114	1	1	0.087773287	1172.401033	0	0	0	0	8.026401	0	0	0	13.20304	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.46447	16.11903	12.71963	14.05857	14.55936	0	0	14.46687	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2H2	SAC2_HUMAN	"Phosphatidylinositide phosphatase SAC2, EC 3.1.3.25 (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2, hSAC2)"	INPP5F KIAA0966 SAC2 MSTP007 MSTP047	Homo sapiens (Human)	adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896]	axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]	axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]	GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0008934; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0033137; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0051896; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135	GQESPLK	7.590000153	1	1	0.035977508	757.0249779	16.70356	15.44586	17.35088	16.78509	12.51892	16.50403	13.96509	0	0	12.89001	16.95177	17.09618	15.06184	13.72722	16.07185	0	0	14.88846	16.17044	16.84572	14.88939	12.41656	12.18998	15.55822	14.57424	13.09781	16.01915	12.38962	14.88094	0	0	0	17.39658	18.20034	0	17.25421	16.71502	11.09944	16.35286	15.96802	0	15.19979	13.3498	16.3572	14.44524	11.82634	14.10608	13.17897
Q9Y2H5	PKHA6_HUMAN	"Pleckstrin homology domain-containing family A member 6, PH domain-containing family A member 6 (Phosphoinositol 3-phosphate-binding protein 3, PEPP-3)"	PLEKHA6 KIAA0969 PEPP3	Homo sapiens (Human)						NPNAPVTK	2.24000001	1	1	6.89E-13	838.2074004	0	12.45944	13.05396	17.95653	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.37081	0	0	14.88266	0	16.84805	0	17.33189	19.11472	0	0	0	0	0	0	0	13.91561	0
Q9Y2H8	ZN510_HUMAN	Zinc finger protein 510	ZNF510 KIAA0972	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872	STLRDHHR	3.309999943	0.987318039	0.987318039	0.151913398	1021.710421	0	15.59993	0	0	0	14.31815	0	0	0	0	0	14.90991	0	0	0	0	0	0	0	15.28509	16.10094	0	0	0	16.10242	15.64846	0	14.52783	14.95191	10.81198	13.79168	14.21467	0	14.19773	17.68265	0	0	0	15.84049	16.48834	0	0	14.71283	10.73879	14.4715	0	0	13.15618
Q9Y2H9	MAST1_HUMAN	"Microtubule-associated serine/threonine-protein kinase 1, EC 2.7.11.1 (Syntrophin-associated serine/threonine-protein kinase)"	MAST1 KIAA0973 SAST	Homo sapiens (Human)	brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0018105; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310	ATTPGGRTLER	11.94999981	1	1	0.307739626	1155.850185	0	0	0	17.65401	0	0	0	0	0	0	0	0	0	0	0	0	16.68361	0	0	0	0	16.44709	0	0	0	0	0	0	19.16787	0	20.01886	0	19.83714	0	0	0	0	18.40836	0	0	16.84986	0	0	0	0	0	16.15294	0
Q9Y2I1	NISCH_HUMAN	"Nischarin (Imidazoline receptor 1, I-1, IR1) (Imidazoline receptor antisera-selected protein, hIRAS) (Imidazoline-1 receptor, I1R) (Imidazoline-1 receptor candidate protein, I-1 receptor candidate protein, I1R candidate protein)"	NISCH IRAS KIAA0975	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601]	identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]	GO:0005178; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006915; GO:0015630; GO:0016020; GO:0016601; GO:0019901; GO:0030036; GO:0030336; GO:0035091; GO:0042802; GO:0043231; GO:0045171; GO:0055037	IDKNLLPPK	28.25	1	1	0.501744995	1036.531993	16.92385	0	20.02929	16.43579	0	17.71218	0	17.38037	0	0	0	0	0	0	17.94275	17.27498	17.33961	0	0	0	0	0	0	0	0	0	0	0	17.36357	0	0	0	0	0	0	20.3242	0	0	0	0	0	0	0	19.7403	0	0	0	0
Q9Y2I6	NINL_HUMAN	Ninein-like protein	NINL KIAA0980 NLP	Homo sapiens (Human)	microtubule anchoring at centrosome [GO:0034454]	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; calcium ion binding [GO:0005509]; microtubule anchoring at centrosome [GO:0034454]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0015630; GO:0034454; GO:0045171	YVNGSKWYGR	2.829999924	1	1	0.013776562	1230.538784	0	0	0	0	17.78853	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2I7	FYV1_HUMAN	"1-phosphatidylinositol 3-phosphate 5-kinase, Phosphatidylinositol 3-phosphate 5-kinase, EC 2.7.1.150 (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III, PIPkin-III, Type III PIP kinase) (Serine-protein kinase PIKFYVE, EC 2.7.11.1)"	PIKFYVE KIAA0981 PIP5K3	Homo sapiens (Human)	"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]	"cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]"	"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]"	GO:0000139; GO:0000285; GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0016308; GO:0016887; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785	ISAMDASPR	4.789999962	0.010998036	0.010998036	0.28854555	963.2755689	18.28327	18.64818	0	17.39513	0	0	0	0	0	0	16.83376	0	0	17.43032	0	0	0	0	0	0	0	0	0	0	17.71485	18.68358	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2I8	WDR37_HUMAN	WD repeat-containing protein 37	WDR37 KIAA0982	Homo sapiens (Human)		"cytoplasm [GO:0005737]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"		GO:0005634; GO:0005737; GO:0030687	TKASHSTSQLSQK	4.800000191	1	1	0.011572846	1402.148325	0	0	0	0	16.13026	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.99487	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.22039	0	0	0	0	0	0
Q9Y2I9	TBC30_HUMAN	TBC1 domain family member 30	TBC1D30 KIAA0984	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547]	GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]	GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0031267; GO:0036064; GO:0043547; GO:0090630; GO:1902018	DRLLHK	9.770000458	0.527321279	0.527321279	0.231013344	780.6266484	14.42197	0	0	0	0	0	15.61973	0	0	0	0	0	0	0	0	0	17.4342	0	16.91495	0	17.80177	0	17.39224	0	16.85903	16.73908	16.94731	16.60826	17.46176	0	16.09521	15.81936	15.61821	16.77975	17.57362	16.30733	0	17.73474	18.59325	16.86407	16.12106	17.43935	17.35747	17.82826	17.81845	0	17.84795	17.96519
Q9Y2J4	AMOL2_HUMAN	"Angiomotin-like protein 2 (Leman coiled-coil protein, LCCP)"	AMOTL2 KIAA0989	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; hippo signaling [GO:0035329]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055]	bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]	bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; hippo signaling [GO:0035329]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055]		GO:0001525; GO:0003365; GO:0005829; GO:0005886; GO:0005923; GO:0016055; GO:0030036; GO:0030334; GO:0031410; GO:0035329; GO:0055037	LKVLHAQILEK	16.01000023	1	1	0.264935972	1288.328947	0	15.92379	8.961805	0	18.00646	16.4265	0	18.44471	0	18.11326	0	0	15.63725	0	0	16.68627	0	14.9406	0	19.1803	16.48282	0	17.60592	0	0	0	15.09482	0	0	0	16.33482	0	0	15.67662	0	0	0	15.65262	0	17.34951	0	0	0	0	0	0	0	0
Q9Y2J8	PADI2_HUMAN	"Protein-arginine deiminase type-2, EC 3.5.3.15 (PAD-H19) (Peptidylarginine deiminase II) (Protein-arginine deiminase type II)"	PADI2 KIAA0994 PAD2 PDI2	Homo sapiens (Human)	cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of lymphocyte chemotaxis [GO:1901624]; protein citrullination [GO:0018101]; regulation of chromatin disassembly [GO:0010848]; substantia nigra development [GO:0021762]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; estrogen receptor binding [GO:0030331]; protein homodimerization activity [GO:0042803]; protein-arginine deiminase activity [GO:0004668]; cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of lymphocyte chemotaxis [GO:1901624]; protein citrullination [GO:0018101]; regulation of chromatin disassembly [GO:0010848]; substantia nigra development [GO:0021762]	calcium ion binding [GO:0005509]; estrogen receptor binding [GO:0030331]; protein homodimerization activity [GO:0042803]; protein-arginine deiminase activity [GO:0004668]	GO:0000791; GO:0004668; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0010848; GO:0018101; GO:0021762; GO:0030331; GO:0030520; GO:0035578; GO:0036413; GO:0036414; GO:0042803; GO:0045815; GO:0070062; GO:0070100; GO:1901624; GO:1990830	QKDGHGEAIMFK	6.039999962	1	1	0.108586124	1376.123935	13.37583	16.07491	15.16219	7.522533	0	12.28604	13.71777	0	13.45173	0	0	13.07724	13.27923	14.53987	0	14.5287	11.51891	0	16.17419	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.6744	0	0	0	0	0	0
Q9Y2K2	SIK3_HUMAN	"Serine/threonine-protein kinase SIK3, EC 2.7.11.1 (Salt-inducible kinase 3, SIK-3) (Serine/threonine-protein kinase QSK)"	SIK3 KIAA0999 QSK L19	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0006468; GO:0035556; GO:0050321; GO:0106310; GO:1904263; GO:1904515	GISISPSAGQMQMQHR	2.710000038	0.116214328	0.116214328	0.156378072	1728.862284	11.20006	0	13.68522	15.48544	12.79468	0	0	0	0	18.67453	0	0	0	0	17.82391	0	17.22365	16.56576	0	16.14488	18.10756	16.99611	13.72579	0	17.17247	18.33138	17.17494	0	12.60345	0	0	0	17.54799	0	0	16.86019	18.11108	0	0	0	0	0	16.47308	10.76013	0	0	0	13.28929
Q9Y2K3	MYH15_HUMAN	Myosin-15 (Myosin heavy chain 15)	MYH15 KIAA1000	Homo sapiens (Human)		cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]	GO:0003774; GO:0005516; GO:0005524; GO:0005829; GO:0016459; GO:0030016; GO:0032982; GO:0043231; GO:0051015	EALINQLSR	8.869999886	1	1	0.494342057	1044.565407	16.41333	16.15016	14.51202	0	0	0	0	14.76678	0	0	0	13.903	16.01078	0	0	0	0	0	0	0	0	0	0	15.52115	0	16.41471	0	0	0	0	0	16.10159	15.40165	0	11.73482	16.98139	13.29814	0	16.30038	15.09591	0	16.30771	16.93216	0	16.25477	0	0	16.60377
Q9Y2K5	R3HD2_HUMAN	R3H domain-containing protein 2	R3HDM2 KIAA1002	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723; GO:0005634	TEADKLFTQLAMSGAK	3.359999895	1	1	0.082202744	1725.980352	0	0	0	0	15.72134	15.47745	15.26653	0	15.46025	0	0	14.05342	0	0	14.98654	0	0	0	0	0	0	16.55797	0	0	0	15.25116	0	0	0	0	15.9717	0	15.49912	0	0	14.90471	0	15.69869	17.04637	15.94636	16.25146	0	0	15.82112	0	0	0	14.38612
Q9Y2K7	KDM2A_HUMAN	"Lysine-specific demethylase 2A, EC 1.14.11.27 (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A)"	KDM2A CXXC8 FBL11 FBL7 FBXL11 JHDM1A KIAA1004	Homo sapiens (Human)	chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription by competitive promoter binding [GO:0010944]; protein demethylation [GO:0006482]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription by competitive promoter binding [GO:0010944]; protein demethylation [GO:0006482]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]	histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	GO:0003712; GO:0005654; GO:0006303; GO:0006325; GO:0006357; GO:0006482; GO:0008270; GO:0010944; GO:0032452; GO:0032922; GO:0042752; GO:0045322; GO:0051864; GO:0070544; GO:0140680	GIEMTMAQWTR	6.849999905	1	1	0.51151735	1354.115279	0	0	0	0	0	0	0	0	19.5288	0	0	0	0	0	0	0	0	16.41331	0	0	0	0	0	0	0	0	0	0	18.07176	0	18.22215	0	0	0	0	0	0	19.16277	0	0	0	18.69802	0	16.2624	0	0	18.25159	0
Q9Y2L1	RRP44_HUMAN	"Exosome complex exonuclease RRP44, EC 3.1.13.-, EC 3.1.26.- (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)"	DIS3 KIAA1008 RRP44	Homo sapiens (Human)	CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0016075; GO:0043928; GO:0071034	TRAGGVMK	6.800000191	1	1	0.020896155	836.4717064	0	0	0	14.18926	0	0	15.6128	0	0	15.00629	16.20719	14.36656	0	0	14.6263	0	0	0	0	0	0	0	0	0	12.19461	12.93476	0	0	0	0	0	0	0	13.60665	0	0	0	0	0	15.52736	0	15.88717	0	0	0	0	15.06737	0
Q9Y2L5	TPPC8_HUMAN	Trafficking protein particle complex subunit 8 (Protein TRS85 homolog)	TRAPPC8 KIAA1012	Homo sapiens (Human)	COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]; vesicle tethering [GO:0099022]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]; vesicle tethering [GO:0099022]		GO:0000407; GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0031410; GO:0034497; GO:0048208; GO:0099022; GO:1990072	EFHIVQVSSSSKHWK	4.889999866	1	1	0.253030737	1799.109594	0	0	0	14.79597	0	0	0	0	0	0	0	0	16.78169	0	0	17.63091	0	13.05823	0	0	0	0	0	0	0	0	15.49675	0	0	0	0	0	0	0	13.908	0	17.1861	16.25543	0	0	0	0	0	0	0	0	0	0
Q9Y2L6	FRM4B_HUMAN	FERM domain-containing protein 4B (GRP1-binding protein GRSP1)	FRMD4B GRSP1 KIAA1013	Homo sapiens (Human)	establishment of epithelial cell polarity [GO:0090162]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; ruffle [GO:0001726]	adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; ruffle [GO:0001726]; establishment of epithelial cell polarity [GO:0090162]		GO:0001726; GO:0005615; GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0090162	VGTAFK	6.03000021	0.598541915	0.598541915	0.259128478	622.716641	0	15.09616	13.31661	14.31911	14.85958	14.45596	0	0	14.88131	0	14.77505	15.55136	0	15.61152	0	15.76838	15.02512	17.04223	17.38297	0	0	15.08	0	15.83253	15.33201	15.53147	15.96261	16.54947	15.7559	15.64797	15.49032	14.67772	0	15.6194	15.11698	13.96125	17.00376	16.77983	16.19297	13.30502	16.31144	15.34535	0	16.05767	15.89531	17.09203	0	15.54744
Q9Y2M0	FAN1_HUMAN	"Fanconi-associated nuclease 1, EC 3.1.21.-, EC 3.1.4.1 (FANCD2/FANCI-associated nuclease 1, hFAN1) (Myotubularin-related protein 15)"	FAN1 KIAA1018 MTMR15	Homo sapiens (Human)	"DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]"	cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; magnesium ion binding [GO:0000287]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]"	5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; magnesium ion binding [GO:0000287]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036]	GO:0000287; GO:0000724; GO:0004528; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006289; GO:0008409; GO:0017108; GO:0033683; GO:0036297; GO:0045171; GO:0070336; GO:0140036	SQSLS	5.360000134	0.958550394	0.958550394	0.264934684	520.2041581	0	16.721	0	19.38605	17.25166	0	0	0	18.44273	0	17.18145	0	17.16455	19.58754	0	20.17541	0	0	0	0	18.05071	0	0	0	0	19.68171	17.24795	0	0	16.99309	0	0	0	18.00298	0	0	0	16.53681	18.46391	20.04513	0	0	17.16366	16.82647	0	17.67023	0	0
Q9Y2P8	RCL1_HUMAN	RNA 3'-terminal phosphate cyclase-like protein	RCL1 RNAC RPC2 RPCL1 RTC2 HSPC338	Homo sapiens (Human)	"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]"	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]"	endoribonuclease activity [GO:0004521]	GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005654; GO:0005730	ITNGSR	8.899999619	1	1	0.195733622	647.641135	0	0	0	0	0	0	0	0	0	16.54755	0	11.70396	0	0	0	16.61087	16.85531	16.30107	0	17.49408	17.39851	0	17.85545	0	0	15.64309	0	16.07698	17.78425	16.01933	17.79968	17.44997	0	16.50056	0	15.83734	17.69904	18.34899	0	16.43567	16.9049	16.46496	17.23171	15.55899	16.96506	16.95323	17.59855	17.23984
Q9Y2Q0	AT8A1_HUMAN	"Phospholipid-transporting ATPase IA, EC 7.6.2.1 (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)"	ATP8A1 ATPIA	Homo sapiens (Human)	aminophospholipid translocation [GO:0140331]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transport across blood-brain barrier [GO:0150104]	azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]	azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; aminophospholipid translocation [GO:0140331]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transport across blood-brain barrier [GO:0150104]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]	GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0030335; GO:0031090; GO:0031410; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0043231; GO:0045332; GO:0061092; GO:0070062; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:0150104; GO:1990531	TPSGK	9.569999695	0.00231286	0.00231286	0.072705621	489.1721272	13.10702	8.546457	14.92136	0	18.11101	0	0	16.77444	16.06807	15.90122	14.46202	15.74714	15.58847	14.18448	14.54647	15.00802	0	0	16.52414	14.8123	15.7118	15.73209	15.14794	0	14.88584	13.71081	11.18283	12.39909	0	18.06446	14.36764	16.08944	15.65703	0	15.39007	0	15.55188	0	0	14.92528	16.46691	14.07111	14.19884	12.72039	14.81795	15.55918	15.83016	14.47619
Q9Y2Q3	GSTK1_HUMAN	"Glutathione S-transferase kappa 1, EC 2.5.1.18 (GST 13-13) (GST class-kappa) (GSTK1-1, hGSTK1) (Glutathione S-transferase subunit 13)"	GSTK1 HDCMD47P	Homo sapiens (Human)	epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]	glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]	GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006749; GO:0016020; GO:0030855; GO:0070062	IATPKVK	12.05000019	1	1	0.259435965	754.1703037	16.13858	13.82595	13.9665	0	15.93192	15.98195	0	0	0	14.51777	0	16.20366	0	15.16371	15.96204	13.94008	0	16.00782	0	15.38014	15.29768	0	0	0	0	15.30328	16.80927	14.33872	15.50126	0	0	16.00227	15.43292	16.72216	16.49163	0	16.75215	0	18.37283	0	0	0	15.30643	16.26653	0	14.41487	14.91366	0
Q9Y2Q9	RT28_HUMAN	"28S ribosomal protein S28, mitochondrial, MRP-S28, S28mt (28S ribosomal protein S35, mitochondrial, MRP-S35, S35mt) (Mitochondrial small ribosomal subunit protein bS1m)"	MRPS28 MRPS35 HSPC007	Homo sapiens (Human)	mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543]	RNA binding [GO:0003723]	GO:0003723; GO:0005739; GO:0005743; GO:0005763; GO:0032543	MAALCR	2.5	1	1	0.290341845	738.1053224	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.2068	0	0	0	0	0	0	0	0	0	18.13764	0	0	0	0	0	0	0	0	0	0	0	0	18.08978	0	0	0	20.16054
Q9Y2R4	DDX52_HUMAN	"Probable ATP-dependent RNA helicase DDX52, EC 3.6.4.13 (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)"	DDX52 ROK1 HUSSY-19	Homo sapiens (Human)	maturation of SSU-rRNA [GO:0030490]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0016020; GO:0016887; GO:0030490	IHMIHKAAVAAK	9.319999695	1	1	0.125605606	1299.379447	14.45726	0	0	0	0	0	0	0	0	0	14.48698	0	0	14.21192	0	0	0	0	0	0	0	15.23664	0	12.70427	0	0	0	0	0	0	16.13068	0	0	16.6196	14.94659	0	0	16.93988	0	0	0	0	0	0	0	0	0	0
Q9Y2R5	RT17_HUMAN	"28S ribosomal protein S17, mitochondrial, MRP-S17, S17mt (Mitochondrial small ribosomal subunit protein uS17m)"	MRPS17 RPMS17 HSPC011	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0019843; GO:0032543	ALPVPR	10.32999992	1	1	0.252918504	653.5446005	0	16.28424	0	0	0	0	17.84544	0	0	0	0	0	0	16.81227	18.1097	18.49446	18.29383	17.28654	0	0	16.83725	0	0	0	16.80082	0	0	17.20293	0	17.91895	20.17747	0	0	0	18.60055	0	18.09048	20.0899	18.91727	16.90323	18.63015	0	19.43924	0	0	0	0	0
Q9Y2R9	RT07_HUMAN	"28S ribosomal protein S7, mitochondrial, MRP-S7, S7mt (Mitochondrial small ribosomal subunit protein uS7m) (bMRP-27a, bMRP27a)"	MRPS7	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	GO:0000028; GO:0003723; GO:0003729; GO:0003735; GO:0005743; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543	FYQVPVPLPDRR	5.570000172	1	1	0.397730711	1485.280399	0	0	14.98171	13.67519	0	0	6.936442	0	0	0	15.1386	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.17435	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2S6	TMA7_HUMAN	Translation machinery-associated protein 7 (Coiled-coil domain-containing protein 72)	TMA7 CCDC72 HSPC016 HSPC330	Homo sapiens (Human)						GPLATGGIKK	6.010000229	0.454527736	0.454527736	0.258934117	941.734051	12.82753	16.24065	15.06506	16.34649	12.97782	16.14915	15.15735	13.95833	15.65813	0	15.94832	15.19717	15.58263	0	0	0	12.84962	0	15.75332	0	0	0	0	0	15.37264	0	15.16034	15.1106	16.45983	0	0	15.55227	15.70217	15.36982	15.60756	0	0	0	0	0	0	0	0	0	14.9259	15.14664	0	14.345
Q9Y2T1	AXIN2_HUMAN	"Axin-2 (Axin-like protein, Axil) (Axis inhibition protein 2) (Conductin)"	AXIN2	Homo sapiens (Human)	bone mineralization [GO:0030282]; cell death [GO:0008219]; cell population proliferation [GO:0008283]; cellular protein localization [GO:0034613]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; intramembranous ossification [GO:0001957]; maintenance of DNA repeat elements [GO:0043570]; mRNA stabilization [GO:0048255]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; odontogenesis [GO:0042476]; positive regulation of cell death [GO:0010942]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chondrocyte development [GO:0061181]; regulation of mismatch repair [GO:0032423]; secondary heart field specification [GO:0003139]; somitogenesis [GO:0001756]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; bone mineralization [GO:0030282]; cell death [GO:0008219]; cell population proliferation [GO:0008283]; cellular protein localization [GO:0034613]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; intramembranous ossification [GO:0001957]; maintenance of DNA repeat elements [GO:0043570]; mRNA stabilization [GO:0048255]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; odontogenesis [GO:0042476]; positive regulation of cell death [GO:0010942]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chondrocyte development [GO:0061181]; regulation of mismatch repair [GO:0032423]; secondary heart field specification [GO:0003139]; somitogenesis [GO:0001756]; Wnt signaling pathway [GO:0016055]	beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]	GO:0001756; GO:0001934; GO:0001957; GO:0003139; GO:0003413; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0008013; GO:0008219; GO:0008283; GO:0008285; GO:0010718; GO:0010942; GO:0016055; GO:0019899; GO:0019901; GO:0030282; GO:0030877; GO:0031625; GO:0032423; GO:0034613; GO:0042476; GO:0043161; GO:0043570; GO:0045668; GO:0045860; GO:0048255; GO:0061181; GO:0070411; GO:0070602; GO:0071407; GO:0090090; GO:2000054	QMNLKDTK	5.559999943	1	1	0.049347989	995.9053531	0	15.6883	16.22296	17.36481	16.61384	0	0	0	16.37674	0	16.18827	0	15.49596	15.22559	0	14.6984	14.92557	0	16.56993	0	0	15.22982	2.274087	0	18.02443	0	0	12.09509	0	15.66638	17.38234	15.23585	14.02565	17.67121	14.80935	0	13.36651	18.00447	17.54805	0	13.42878	0	13.32681	0	13.48911	17.44037	15.03712	0
Q9Y2T2	AP3M1_HUMAN	AP-3 complex subunit mu-1 (AP-3 adaptor complex mu3A subunit) (Adaptor-related protein complex 3 subunit mu-1) (Mu-adaptin 3A) (Mu3A-adaptin)	AP3M1	Homo sapiens (Human)	"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192]"	AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; small GTPase binding [GO:0031267]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192]"	small GTPase binding [GO:0031267]	GO:0005764; GO:0005765; GO:0005769; GO:0005794; GO:0006622; GO:0006897; GO:0008089; GO:0016192; GO:0030123; GO:0030131; GO:0030659; GO:0031267; GO:0031410; GO:0035654; GO:0046907; GO:0048490; GO:0060155; GO:1903232; GO:1904115	YTNNEAYFDVVEEIDAIIDK	3.809999943	1	1	0.034007992	2362.394089	0	14.95634	0	14.17949	14.81227	12.7269	0	12.97096	10.63282	11.76599	12.36366	14.5833	11.8562	0	0	0	0	11.04958	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.39508
Q9Y2T4	2ABG_HUMAN	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (IMYPNO1) (PP2A subunit B isoform B55-gamma) (PP2A subunit B isoform PR55-gamma) (PP2A subunit B isoform R2-gamma) (PP2A subunit B isoform gamma)	PPP2R2C	Homo sapiens (Human)	peptidyl-serine dephosphorylation [GO:0070262]	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]	cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; peptidyl-serine dephosphorylation [GO:0070262]	protein phosphatase regulator activity [GO:0019888]	GO:0000159; GO:0005829; GO:0019888; GO:0070262	GEDTDTR	3.5	1	1	0.256812884	795.0016856	0	17.34315	0	16.74038	17.00693	15.51676	0	0	0	0	0	15.70491	0	0	0	14.91381	0	15.30384	0	0	13.95851	0	14.8699	15.06188	14.44411	0	0	0	16.48022	14.39808	0	0	17.72783	18.38147	0	0	0	0	16.75111	16.73615	0	17.79879	0	0	16.20096	0	0	0
Q9Y2U5	M3K2_HUMAN	"Mitogen-activated protein kinase kinase kinase 2, EC 2.7.11.25 (MAPK/ERK kinase kinase 2, MEK kinase 2, MEKK 2)"	MAP3K2 MAPKKK2 MEKK2	Homo sapiens (Human)	"cellular response to mechanical stimulus [GO:0071260]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to mechanical stimulus [GO:0071260]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]"	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004709; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0019901; GO:0045893; GO:0046872; GO:0071260; GO:0106310	SRMPR	7.309999943	0.399983108	0.399983108	0.181731966	645.3029143	0	15.27942	16.85736	0	15.47969	0	0	14.8772	0	0	0	15.62784	0	15.63282	0	0	0	0	0	16.07265	0	0	0	0	15.7249	0	0	14.29129	0	15.28078	16.77027	0	0	16.56419	15.03927	0	17.51797	17.18714	16.181	0	16.0568	16.10013	16.22072	15.57183	17.32687	0	0	17.60016
Q9Y2W1	TR150_HUMAN	"Thyroid hormone receptor-associated protein 3 (BCLAF1 and THRAP3 family member 2) (Thyroid hormone receptor-associated protein complex 150 kDa component, Trap150)"	THRAP3 BCLAF2 TRAP150	Homo sapiens (Human)	"circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	extracellular exosome [GO:0070062]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"extracellular exosome [GO:0070062]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; phosphoprotein binding [GO:0051219]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"	ATP binding [GO:0005524]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; phosphoprotein binding [GO:0051219]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; vitamin D receptor binding [GO:0042809]	GO:0000381; GO:0000956; GO:0000978; GO:0003677; GO:0003712; GO:0003713; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0006397; GO:0007623; GO:0008380; GO:0016592; GO:0016607; GO:0030374; GO:0042753; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0048026; GO:0048255; GO:0051219; GO:0070062	DLVHSNK	4.039999962	1	1	0.262177173	811.0448247	0	0	0	20.07172	0	0	0	17.30249	0	0	0	18.76218	0	0	0	0	0	0	0	0	0	0	0	18.87099	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2W7	CSEN_HUMAN	"Calsenilin (A-type potassium channel modulatory protein 3) (DRE-antagonist modulator, DREAM) (Kv channel-interacting protein 3, KChIP3)"	KCNIP3 CSEN DREAM KCHIP3	Homo sapiens (Human)	apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; voltage-gated ion channel activity [GO:0005244]; apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]; signal transduction [GO:0007165]"	"calcium ion binding [GO:0005509]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; voltage-gated ion channel activity [GO:0005244]"	GO:0000122; GO:0000978; GO:0001227; GO:0005244; GO:0005267; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0008076; GO:0015459; GO:0072659; GO:1901379	GFKNECPTGLVDEDTFK	5.820000172	1	1	0.469691136	1955.534683	0	0	0	0	0	0	17.45559	0	0	0	0	0	0	0	0	0	18.89623	0	0	0	0	0	0	0	0	0	0	18.09542	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y2X3	NOP58_HUMAN	Nucleolar protein 58 (Nucleolar protein 5)	NOP58 NOL5 NOP5 HSPC120	Homo sapiens (Human)	rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]	box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]	ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]	GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761	LGGVIKEK	8.569999695	1	1	0.433809617	842.0977868	16.44895	16.17461	16.49977	16.77912	16.51725	14.79047	0	15.95356	16.89673	0	0	15.41588	0	0	15.63708	15.53827	0	0	15.37737	0	0	15.52223	0	0	0	0	0	16.54387	0	15.332	0	0	0	15.48	0	0	0	17.33996	17.0225	14.98977	15.82333	0	0	0	15.48756	0	0	0
Q9Y2X7	GIT1_HUMAN	"ARF GTPase-activating protein GIT1, ARF GAP GIT1 (Cool-associated and tyrosine-phosphorylated protein 1, CAT-1, CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1)"	GIT1	Homo sapiens (Human)	brain development [GO:0007420]; cell redox homeostasis [GO:0045454]; cellular response to lipopolysaccharide [GO:0071222]; ephrin receptor signaling pathway [GO:0048013]; intramembranous ossification [GO:0001957]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; negative regulation of glycolytic process [GO:0045820]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of interleukin-1 beta production [GO:0032691]; neuron development [GO:0048666]; positive regulation of microtubule nucleation [GO:0090063]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300]	calyx of Held [GO:0044305]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]	calyx of Held [GO:0044305]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cell redox homeostasis [GO:0045454]; cellular response to lipopolysaccharide [GO:0071222]; ephrin receptor signaling pathway [GO:0048013]; intramembranous ossification [GO:0001957]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; negative regulation of glycolytic process [GO:0045820]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of interleukin-1 beta production [GO:0032691]; neuron development [GO:0048666]; positive regulation of microtubule nucleation [GO:0090063]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300]	gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]	GO:0001957; GO:0005096; GO:0005739; GO:0005813; GO:0005829; GO:0005925; GO:0007420; GO:0007626; GO:0008277; GO:0014069; GO:0016020; GO:0030027; GO:0032465; GO:0032691; GO:0043015; GO:0044305; GO:0044877; GO:0045454; GO:0045820; GO:0046872; GO:0048013; GO:0048666; GO:0061743; GO:0071222; GO:0090063; GO:0097431; GO:0098794; GO:0099171; GO:0106015; GO:2000300	ALATSEAK	8.590000153	0.098288842	0.098288842	0.265435213	789.7879446	0	16.91143	0	0	16.63548	0	18.4415	0	18.68291	16.67593	16.47712	0	0	0	0	0	18.32814	0	0	16.58556	0	16.8922	0	0	0	17.19463	18.34765	18.64874	0	0	19.30519	17.43	0	0	18.27461	0	0	17.64235	0	0	0	0	0	0	0	18.68387	0	0
Q9Y2Y9	KLF13_HUMAN	"Krueppel-like factor 13 (Basic transcription element-binding protein 3, BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1, RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1)"	KLF13 BTEB3 NSLP1	Homo sapiens (Human)	negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0046872; GO:1990837	SDASSPTISPASSP	1.620000005	0.058652677	0.058652677	0.162391134	1299.283067	10.93128	13.34	15.22583	0	0	12.85836	0	0	0	0	0	0	12.67123	11.9655	0	0	0	14.57052	14.48432	0	0	0	0	12.93334	0	14.87847	0	0	0	15.19688	0	0	0	15.97166	13.9366	0	0	0	0	0	0	0	0	0	10.97332	15.06504	16.28674	0
Q9Y2Z0	SGT1_HUMAN	Protein SGT1 homolog (Protein 40-6-3) (Sgt1) (Suppressor of G2 allele of SKP1 homolog)	SUGT1	Homo sapiens (Human)	mitotic cell cycle [GO:0000278]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]	cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; chaperone binding [GO:0051087]; mitotic cell cycle [GO:0000278]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]	chaperone binding [GO:0051087]	GO:0000151; GO:0000278; GO:0000776; GO:0005634; GO:0005829; GO:0031647; GO:0032991; GO:0050821; GO:0051087	LDIETGFHR	9.399999619	0.668629289	0.668629289	0.17247103	1087.80499	0	14.86265	0	0	0	14.21067	0	0	10.6858	0	0	0	0	0	15.76665	15.94928	0	0	15.54653	0	0	0	0	0	0	0	0	13.81153	0	0	0	0	16.24429	0	0	0	0	0	0	0	15.70205	0	0	0	10.58348	0	13.7664	0
Q9Y2Z4	SYYM_HUMAN	"Tyrosine--tRNA ligase, mitochondrial, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS)"	YARS2 CGI-04	Homo sapiens (Human)	mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine binding [GO:0072545]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039]	ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine binding [GO:0072545]; tyrosine-tRNA ligase activity [GO:0004831]	GO:0000049; GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006412; GO:0016604; GO:0042803; GO:0043039; GO:0070184; GO:0072545	AGHNVIALVGGATARLGDPSGR	2.670000076	1	1	0.259065153	2089.668792	0	13.73223	0	0	0	0	0	0	0	0	0	0	0	11.66813	0	0	0	14.43617	0	11.90882	0	0	0	0	0	0	0	13.56177	0	0	16.05172	0	0	15.08863	11.62809	0	15.60987	0	0	0	14.94955	15.06434	0	0	0	0	0	0
Q9Y305	ACOT9_HUMAN	"Acyl-coenzyme A thioesterase 9, mitochondrial, Acyl-CoA thioesterase 9, EC 3.1.2.- (Acyl-CoA thioester hydrolase 9)"	ACOT9 CGI-16	Homo sapiens (Human)	acyl-CoA metabolic process [GO:0006637]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]	acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0016290; GO:0047617; GO:0052689	IDMCKK	22.26000023	1	1	0.245023037	809.446268	20.59136	18.68848	19.85	0	17.98817	18.46602	19.81842	18.62741	19.2213	20.70611	19.76137	19.18641	19.70765	20.41766	20.47234	19.02276	19.98958	18.99682	19.64848	19.69307	19.15107	19.24162	18.5787	17.63925	19.77985	20.18721	18.29279	19.45193	20.59063	19.95731	20.31741	18.68127	18.81521	20.24164	16.5806	19.03548	18.92842	19.43103	0	0	18.33195	20.7099	18.07929	17.26993	0	18.81558	0	0
Q9Y312	AAR2_HUMAN	Protein AAR2 homolog (AAR2 splicing factor homolog)	AAR2 C20orf4 CGI-23 PRO0225	Homo sapiens (Human)	spliceosomal tri-snRNP complex assembly [GO:0000244]	spliceosomal complex [GO:0005681]; U5 snRNP [GO:0005682]	spliceosomal complex [GO:0005681]; U5 snRNP [GO:0005682]; spliceosomal tri-snRNP complex assembly [GO:0000244]		GO:0000244; GO:0005681; GO:0005682	AAVQMDPELAKR	1.179999948	1	1	0.714504458	1345.345665	18.00291	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.18994	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y320	TMX2_HUMAN	Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14)	TMX2 TXNDC14 CGI-31 My009 PIG26 PSEC0045 UNQ237/PRO270	Homo sapiens (Human)	brain development [GO:0007420]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane-bounded organelle [GO:0043227]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane-bounded organelle [GO:0043227]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; brain development [GO:0007420]	disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]	GO:0005739; GO:0005789; GO:0007420; GO:0015036; GO:0016021; GO:0031966; GO:0042802; GO:0043227; GO:0044233	YTDVSTR	5.860000134	1	1	0.277124481	839.9671551	0	0	0	0	0	0	0	14.41465	0	0	0	14.47614	16.62345	0	16.21199	0	0	0	0	0	0	0	0	16.40549	0	0	17.18842	0	0	0	15.72704	0	0	17.17562	16.83007	0	17.64973	0	16.95302	0	0	16.73425	13.74752	16.27697	0	0	16.18117	0
Q9Y371	SHLB1_HUMAN	"Endophilin-B1 (Bax-interacting factor 1, Bif-1) (SH3 domain-containing GRB2-like protein B1)"	SH3GLB1 KIAA0491 CGI-61	Homo sapiens (Human)	apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; membrane fission [GO:0090148]; membrane organization [GO:0061024]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to vacuolar membrane [GO:1903778]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]	autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; protein-containing complex [GO:0032991]	autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; membrane fission [GO:0090148]; membrane organization [GO:0061024]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to vacuolar membrane [GO:1903778]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]	cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0000421; GO:0005737; GO:0005741; GO:0005829; GO:0006914; GO:0006915; GO:0008289; GO:0010508; GO:0016020; GO:0016241; GO:0030496; GO:0031334; GO:0031410; GO:0031647; GO:0032465; GO:0032801; GO:0032991; GO:0034198; GO:0042149; GO:0042802; GO:0042803; GO:0045296; GO:0048102; GO:0061024; GO:0090148; GO:1903527; GO:1903778; GO:1903955; GO:2000786	IMKQTEVLLQPNPNAR	3.849999905	1	1	0.202801599	1851.392161	16.47469	0	0	14.87938	0	0	0	0	16.27335	16.94644	0	0	14.96906	0	15.43372	16.32742	0	0	0	16.14669	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y375	CIA30_HUMAN	"Complex I intermediate-associated protein 30, mitochondrial (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1)"	NDUFAF1 CIA30 CGI-65	Homo sapiens (Human)	"chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; NADH dehydrogenase complex assembly [GO:0010257]; protein-containing complex assembly [GO:0065003]"	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]	"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; NADH dehydrogenase complex assembly [GO:0010257]; protein-containing complex assembly [GO:0065003]"	unfolded protein binding [GO:0051082]	GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0005829; GO:0006120; GO:0010257; GO:0032981; GO:0051082; GO:0051131; GO:0065003	GAFER	10.81000042	0.090243913	0.090243913	0.183001169	578.4657806	0	14.82614	12.48569	11.20731	15.68431	0	14.86257	13.91129	0	15.59521	15.35345	14.87409	14.39978	13.32275	15.55527	0	0	16.54959	0	15.85932	15.59613	0	0	0	15.08494	15.46508	16.10976	16.23368	16.07534	14.24735	13.18232	14.6785	16.17056	15.32217	16.02741	15.20983	15.51659	0	16.57779	15.24396	17.05993	15.65429	16.26022	15.0372	15.60877	0	16.95061	0
Q9Y383	LC7L2_HUMAN	Putative RNA-binding protein Luc7-like 2	LUC7L2 CGI-59 CGI-74	Homo sapiens (Human)	mRNA splice site selection [GO:0006376]	nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]	enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004	SRSMSR	8.340000153	1	1	0.13367591	738.5462437	16.5154	0	16.07612	14.933	0	0	0	16.59363	0	0	15.87631	0	16.18777	15.54882	15.9516	16.53895	0	15.54592	0	0	0	0	0	0	17.14897	16.06961	0	0	0	0	0	0	16.15123	0	0	16.99555	17.61974	0	17.60325	18.80464	17.86788	16.9688	17.52151	16.06705	16.18732	17.59459	16.92345	17.14441
Q9Y385	UB2J1_HUMAN	"Ubiquitin-conjugating enzyme E2 J1, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1, NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E, HsUBC6e)"	UBE2J1 NCUBE1 CGI-76 HSPC153 HSPC205	Homo sapiens (Human)	"negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]"	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]"	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]	GO:0000209; GO:0005524; GO:0005634; GO:0005789; GO:0007286; GO:0016021; GO:0018279; GO:0030433; GO:0031625; GO:0032680; GO:0061631; GO:1904153	NTSMSPRQR	11.80000019	0.208732545	0.208732545	0.291283534	1089.814185	14.75279	15.76251	15.64267	0	0	15.18764	0	13.71635	0	0	0	16.2077	0	0	0	15.82825	0	0	0	0	15.61441	0	16.86315	0	12.42691	14.37928	15.81286	14.81979	15.46025	0	0	16.77499	0	0	0	16.24109	0	16.85961	16.30491	15.52163	16.01376	15.74485	16.41396	15.68055	0	16.31144	16.51885	16.73016
Q9Y397	ZDHC9_HUMAN	"Palmitoyltransferase ZDHHC9, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 9, DHHC-9, DHHC9) (Zinc finger protein 379) (Zinc finger protein 380)"	ZDHHC9 CXorf11 ZDHHC10 ZNF379 ZNF380 CGI-89 UNQ261/PRO298	Homo sapiens (Human)	MAPK cascade [GO:0000165]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; Ras palmitoyltransferase activity [GO:0043849]; MAPK cascade [GO:0000165]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]	palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; Ras palmitoyltransferase activity [GO:0043849]	GO:0000139; GO:0000165; GO:0002178; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0031228; GO:0043849	MSVMVVR	9.930000305	0.581035852	0.581035852	0.173307728	853.9112564	0	0	15.80048	13.91649	14.67968	15.80542	14.73699	16.12508	0	16.19746	0	0	15.72089	0	0	0	0	15.86196	16.31502	10.46976	0	0	0	13.77804	17.05858	0	17.0026	0	0	15.69953	0	14.86971	15.37492	13.20915	0	15.10786	14.83372	14.82115	15.18139	0	15.80926	13.22367	17.51257	16.19128	16.05047	15.08052	0	0
Q9Y399	RT02_HUMAN	"28S ribosomal protein S2, mitochondrial, MRP-S2, S2mt (Mitochondrial small ribosomal subunit protein uS2m)"	MRPS2 CGI-91	Homo sapiens (Human)	mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543]	structural constituent of ribosome [GO:0003735]	GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0061668	MATSSAALPR	7.099999905	1	1	0.520255044	1021.923821	0	0	0	0	0	0	0	0	0	0	0	16.65551	0	0	0	0	0	0	20.05546	0	0	0	18.47408	0	0	0	0	0	0	18.91682	0	19.92627	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y3A2	UTP11_HUMAN	"Probable U3 small nucleolar RNA-associated protein 11, U3 snoRNA-associated protein 11 (UTP11-like protein)"	UTP11 UTP11L CGI-94 HDCMB12P	Homo sapiens (Human)	nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]	GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0007399; GO:0032040; GO:0043065	QQNKHVFFFDTK	2.799999952	1	1	0.03060014	1538.820319	0	0	0	0	0	0	14.35781	0	0	0	0	0	15.3328	0	0	0	0	14.04517	0	0	0	0	16.72472	0	13.73098	0	16.36594	0	15.94913	15.73482	0	0	15.74368	0	15.19745	0	16.11332	0	14.45194	14.86081	0	15.86521	0	0	0	0	0	0
Q9Y3A4	RRP7A_HUMAN	Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14)	RRP7A CGI-96	Homo sapiens (Human)	blastocyst formation [GO:0001825]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]	CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; UTP-C complex [GO:0034456]	CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]	RNA binding [GO:0003723]	GO:0000028; GO:0001825; GO:0003723; GO:0005654; GO:0005737; GO:0006364; GO:0032545; GO:0034456	MEHLAQLR	1.659999967	1	1	0.097340624	999.4357779	13.82347	14.76841	14.14873	12.27171	11.78133	13.68694	15.66347	0	12.78987	13.44301	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.09124	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.3785	0	0	0	0	0	0	0
Q9Y3A5	SBDS_HUMAN	Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein)	SBDS CGI-97	Homo sapiens (Human)	bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364]	microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]	GO:0000922; GO:0001833; GO:0002244; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539	LTNVAVVRMK	3.799999952	0.082400851	0.082400851	0.069577738	1146.145476	16.53108	14.36296	0	0	0	15.61032	11.71959	15.40011	0	16.80748	13.90091	12.77476	15.79278	19.04483	13.61999	0	0	15.08662	14.29373	15.27429	18.07896	0	17.09022	14.65069	0	0	15.97733	0	15.3924	0	0	0	15.13963	0	15.47095	0	15.93983	0	16.48957	0	16.48947	0	10.7205	13.25119	17.87954	0	0	0
Q9Y3B6	EMC9_HUMAN	ER membrane protein complex subunit 9 (Protein FAM158A)	EMC9 C14orf122 FAM158A CGI-112	Homo sapiens (Human)	protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]	cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]		GO:0005737; GO:0005789; GO:0045050; GO:0071816; GO:0072546	LVPQPR	4.809999943	0.452044517	0.452044517	0.128853937	708.9091422	15.29449	14.54113	0	12.23196	15.56555	14.28409	0	15.70563	0	13.87277	0	12.17073	0	13.21445	19.03243	0	0	0	0	16.07255	17.22525	16.12944	15.33728	0	0	14.47863	14.26473	0	17.08572	12.03296	0	14.3663	17.38779	0	0	0	0	14.77058	11.97079	15.88534	0	15.89811	0	0	14.19477	14.03339	12.89916	16.42606
Q9Y3B7	RM11_HUMAN	"39S ribosomal protein L11, mitochondrial, L11mt, MRP-L11 (Mitochondrial large ribosomal subunit protein uL11m)"	MRPL11 CGI-113	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]	large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0015934; GO:0032543; GO:0070180	GVSINQFCK	2.769999981	1	1	0.115051999	1052.001417	0	0	15.31278	11.95428	15.39466	14.72273	14.21605	14.27509	14.73964	0	0	0	11.70055	15.5112	14.7923	15.50857	15.28061	0	12.60775	11.8384	0	14.23725	15.93905	0	0	0	0	0	0	15.50946	0	0	0	0	15.13694	0	0	0	0	15.5451	0	0	0	0	0	14.3219	14.03925	0
Q9Y3C0	WASC3_HUMAN	WASH complex subunit 3 (Coiled-coil domain-containing protein 53)	WASHC3 AD-016 CCDC53 CGI-116 x0009	Homo sapiens (Human)	actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]	early endosome membrane [GO:0031901]; WASH complex [GO:0071203]	early endosome membrane [GO:0031901]; WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]		GO:0006887; GO:0015031; GO:0016197; GO:0030041; GO:0031901; GO:0034315; GO:0071203	MDEDGLPLMGSGIDLTK	12.61999989	1	1	0.202775891	1807.11886	0	14.08897	0	0	16.53664	13.38808	0	0	0	0	0	13.67912	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.05885	15.84367	0	0	0	14.97166	0	14.95716	0	0	12.35264	0	0	0	0	13.71628	0	0	0	15.74901
Q9Y3C6	PPIL1_HUMAN	"Peptidyl-prolyl cis-trans isomerase-like 1, PPIase, EC 5.2.1.8 (Rotamase PPIL1)"	PPIL1 CYPL1 CGI-124 UNQ2425/PRO4984	Homo sapiens (Human)	"embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]"	cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718; GO:1990403	VCQGIGMVNR	2.410000086	1	1	0.067692202	1150.339055	14.39215	14.35892	13.03857	14.0266	11.77891	13.92307	14.26251	13.23816	12.26614	17.50872	12.62027	10.40297	0	0	0	15.47505	0	0	0	13.79934	8.171681	0	17.10051	0	13.72868	0	0	0	0	13.27174	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.16139	0	0	0
Q9Y3E7	CHMP3_HUMAN	"Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24, hVps24)"	CHMP3 CGI149 NEDF VPS24 CGI-149	Homo sapiens (Human)	apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]	amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]	identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; ubiquitin-specific protease binding [GO:1990381]	GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005770; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006915; GO:0006997; GO:0007080; GO:0010824; GO:0015031; GO:0016236; GO:0019076; GO:0030496; GO:0031210; GO:0031410; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0042802; GO:0043162; GO:0044790; GO:0045324; GO:0046761; GO:0051258; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904930; GO:1990381; GO:2000641	AHMNSVLMGMKNQLAVLR	4.599999905	1	1	1.38E-12	2014.73165	0	12.88435	13.24234	14.70451	0	14.69436	0	0	0	13.09965	0	0	0	0	0	0	0	0	0	0	0	0	11.98739	0	14.74723	0	16.40527	0	0	0	0	0	0	0	0	0	0	0	0	14.11482	15.53542	0	0	0	0	0	0	0
Q9Y3M8	STA13_HUMAN	"StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein, DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13, StARD13)"	STARD13 DLC2 GT650	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]	cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]	GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]	GO:0005096; GO:0005811; GO:0005829; GO:0007165; GO:0008289; GO:0030036; GO:0031966; GO:0035023; GO:0043542; GO:0051056; GO:0090051; GO:0097498	KVGDGNPLK	5.449999809	0.093320608	0.093320608	0.272797517	926.2540885	0	0	0	0	0	0	0	18.21742	0	0	0	16.08946	0	0	0	0	16.95183	0	0	16.74264	0	0	15.77812	0	0	19.97767	0	0	0	0	0	18.56634	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y3M9	ZN337_HUMAN	Zinc finger protein 337	ZNF337	Homo sapiens (Human)	negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872	DKSSYNK	9.619999886	0.002333762	0.002333762	0.140607439	840.6188621	0	21.85295	0	0	0	0	0	0	0	0	0	0	17.23573	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.59979	0	0	0	0	0	0	0	0	0	19.01332	0	0	0	0	0	0	0	0
Q9Y3P9	RBGP1_HUMAN	Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)	RABGAP1 HSPC094	Homo sapiens (Human)	activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; regulation of GTPase activity [GO:0043087]	centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]	centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; regulation of GTPase activity [GO:0043087]	GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]	GO:0005096; GO:0005813; GO:0005829; GO:0005875; GO:0007049; GO:0015631; GO:0031267; GO:0043087; GO:0090630	EYHTMR	11	1	1	0.252392756	836.3741555	0	0	0	0	14.40131	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.85853	11.86642	14.30718	0	0	0	0	14.13767	0	0	0	0	0	13.4905	0	0	0	0	16.542	0
Q9Y3Q0	NALD2_HUMAN	"N-acetylated-alpha-linked acidic dipeptidase 2, EC 3.4.17.21 (Glutamate carboxypeptidase III, GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II, NAALADase II)"	NAALAD2	Homo sapiens (Human)	proteolysis [GO:0006508]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]	carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; serine-type peptidase activity [GO:0008236]	GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016021; GO:0016805; GO:0046872	QLSVAQLR	3.940000057	0.750268579	0.750268579	0.252585277	913.7806122	16.32943	15.69425	17.04421	14.90508	15.53456	14.69117	15.31483	0	13.53652	15.84796	15.46468	16.46919	15.72374	16.1468	15.90938	15.91561	14.45082	15.8188	16.54738	17.10127	0	16.42961	13.81975	16.11859	17.42379	0	16.6608	16.40158	16.49691	0	17.04066	15.3205	15.78487	16.13407	16.64948	15.51463	15.59369	16.44292	16.27642	16.17491	16.95267	0	16.32524	16.68469	16.27348	16.15992	15.44594	16.3181
Q9Y3Q7	ADA18_HUMAN	"Disintegrin and metalloproteinase domain-containing protein 18, ADAM 18 (Transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein III, tMDC III)"	ADAM18 TMDC3 UNQ858/PRO1867	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	integral component of membrane [GO:0016021]; membrane [GO:0016020]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]	metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004222; GO:0007155; GO:0007283; GO:0007339; GO:0008237; GO:0016020; GO:0016021; GO:0030154	VPLNSQIK	6.739999771	0.199350864	0.199350864	0.163248564	898.2963459	14.44021	0	0	15.37661	16.78378	0	0	0	17.41113	0	0	0	0	16.63932	0	0	18.08282	0	16.197	18.09101	0	17.06388	14.50974	16.63344	0	0	0	0	0	16.83438	17.15046	0	0	0	16.90377	0	0	13.49807	17.94293	18.35236	18.93794	19.82535	0	0	0	0	18.56819	16.99531
Q9Y3R4	NEUR2_HUMAN	"Sialidase-2, EC 3.2.1.18 (Cytosolic sialidase) (N-acetyl-alpha-neuraminidase 2)"	NEU2	Homo sapiens (Human)	cellular oligosaccharide catabolic process [GO:0051692]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; glycosphingolipid metabolic process [GO:0006687]; oligosaccharide catabolic process [GO:0009313]	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; cellular oligosaccharide catabolic process [GO:0051692]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; glycosphingolipid metabolic process [GO:0006687]; oligosaccharide catabolic process [GO:0009313]	exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]	GO:0004308; GO:0005737; GO:0005829; GO:0006516; GO:0006687; GO:0006689; GO:0009313; GO:0016020; GO:0043231; GO:0051692; GO:0052794; GO:0052795; GO:0052796; GO:1902494	DEHAELIVLRR	21.12000084	1	1	0.139936156	1351.315353	0	15.8861	0	0	0	14.93701	0	0	0	0	0	14.96341	12.19431	0	15.64594	16.08522	0	0	16.68333	0	15.56612	16.17104	17.8735	17.36567	14.95289	16.28784	0	0	14.34491	18.23181	0	17.88914	0	0	14.81472	0	0	15.27297	15.40905	0	17.08926	0	15.7864	0	16.46946	0	0	0
Q9Y3R5	DOP2_HUMAN	Protein dopey-2	DOP1B C21orf5 DOPEY2 KIAA0933	Homo sapiens (Human)	cognition [GO:0050890]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; cognition [GO:0050890]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]		GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0007029; GO:0009880; GO:0015031; GO:0031901; GO:0050890; GO:0070062	ERQEAVEALFK	24.73999977	0.771071017	0.771071017	9.17E-13	1319.668274	9.676688	12.35123	0	15.40638	0	0	0	16.04016	0	15.12881	0	0	0	0	0	0	0	13.59455	0	0	0	0	0	0	0	17.90289	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.04765	17.28169	0
Q9Y3S1	WNK2_HUMAN	"Serine/threonine-protein kinase WNK2, EC 2.7.11.1 (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43)"	WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0008285; GO:0010766; GO:0019869; GO:0019870; GO:0035556; GO:0046777; GO:0050801; GO:0070373; GO:0090263; GO:0106310; GO:1903288; GO:2000651	AARPGPQR	10.47000027	1	1	0.382824992	853.8181909	0	15.39787	0	14.19152	18.21342	0	16.50798	15.77645	13.18957	13.99292	13.36003	14.51539	14.25711	12.74291	13.32634	14.42061	16.97772	0	0	0	0	14.60037	0	0	17.91841	0	0	0	0	17.62446	0	0	16.57555	0	0	16.87729	0	0	0	0	0	15.8917	0	15.86815	0	0	0	0
Q9Y3T6	R3HC1_HUMAN	R3H and coiled-coil domain-containing protein 1	R3HCC1	Homo sapiens (Human)			nucleic acid binding [GO:0003676]	nucleic acid binding [GO:0003676]	GO:0003676	ERPQTNATVAR	16.12000084	1	1	0.345484962	1241.707202	0	0	15.42592	0	14.03372	15.38002	0	14.89944	14.17439	0	0	0	17.17565	15.28967	13.6648	13.67516	15.24383	16.60005	0	15.15545	13.92526	0	16.33284	16.14551	0	16.40639	15.9779	15.59012	0	0	0	0	16.18126	0	15.22026	17.20901	0	0	0	15.16905	16.37793	0	0	14.05812	0	0	16.2983	0
Q9Y3U8	RL36_HUMAN	60S ribosomal protein L36 (Large ribosomal subunit protein eL36)	RPL36	Homo sapiens (Human)	cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788	EELSNVLAAMRK	13.27999973	1	1	0.108262282	1377.803745	15.60529	16.14397	13.47857	0	0	11.62959	0	15.72255	15.65378	0	0	0	0	0	0	0	0	10.84074	0	14.61086	0	0	0	0	14.90866	0	0	0	14.77996	0	16.77652	16.20089	15.25981	14.8265	0	0	13.42307	0	0	0	0	0	0	0	0	0	0	0
Q9Y3X0	CCDC9_HUMAN	Coiled-coil domain-containing protein 9	CCDC9	Homo sapiens (Human)			RNA binding [GO:0003723]	RNA binding [GO:0003723]	GO:0003723	AEASSRR	13.47999954	1	1	0.305701974	777.8658764	16.97478	0	14.93888	16.34007	15.71242	15.78423	0	0	16.69856	16.21685	0	15.99724	0	0	0	15.64367	15.08484	0	0	14.76206	0	16.96318	0	0	0	14.45151	0	15.27715	0	16.50219	0	15.30416	14.97188	16.49268	15.81801	0	16.58578	0	16.21988	16.96839	0	15.79148	0	0	0	16.11922	0	17.58139
Q9Y426	C2CD2_HUMAN	C2 domain-containing protein 2 (Transmembrane protein 24-like)	C2CD2 C21orf25 C21orf258 TMEM24L	Homo sapiens (Human)		cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]		GO:0005634; GO:0005829; GO:0016021	LLSRHR	7.289999962	1	1	0.205588003	780.416796	16.52566	15.44207	15.6425	16.12652	0	0	0	0	0	16.76925	15.97653	14.83136	15.79472	12.89487	15.85849	14.94497	13.06832	15.07333	0	16.55734	0	0	0	0	15.67275	14.88859	16.29209	0	0	0	0	17.50688	0	0	16.03817	16.40044	0	0	0	0	0	0	17.3679	16.01216	0	16.44275	15.05181	17.14435
Q9Y446	PKP3_HUMAN	Plakophilin-3	PKP3	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; desmosome assembly [GO:0002159]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; protein localization to plasma membrane [GO:0072659]	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; desmosome assembly [GO:0002159]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; protein localization to plasma membrane [GO:0072659]	alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]	GO:0001533; GO:0002159; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0010628; GO:0019899; GO:0030054; GO:0030057; GO:0045294; GO:0045296; GO:0050839; GO:0072659; GO:0098609; GO:0098641; GO:1902373; GO:1990124	QASSSSSR	1.720000029	1	1	0.044275945	808.7332628	13.35116	13.83313	13.69518	0	15.72441	13.93542	14.95302	13.2263	0	0	14.30651	15.65297	16.50075	15.24419	15.58568	16.00324	13.64457	0	0	0	0	15.53258	0	0	0	0	0	0	0	0	15.93332	0	15.80071	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y448	SKAP_HUMAN	"Small kinetochore-associated protein, SKAP (Kinetochore-localized astrin-binding protein, Kinastrin) (Kinetochore-localized astrin/SPAG5-binding protein) (TRAF4-associated factor 1)"	KNSTRN C15orf23 SKAP TRAF4AF1 HSD11	Homo sapiens (Human)	cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; chromosome segregation [GO:0007059]; microtubule cytoskeleton organization [GO:0000226]; mitotic sister chromatid segregation [GO:0000070]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; spindle organization [GO:0007051]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; spindle pole [GO:0000922]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; spindle pole [GO:0000922]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; chromosome segregation [GO:0007059]; microtubule cytoskeleton organization [GO:0000226]; mitotic sister chromatid segregation [GO:0000070]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; spindle organization [GO:0007051]	microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]	GO:0000070; GO:0000226; GO:0000776; GO:0000922; GO:0001726; GO:0005634; GO:0005737; GO:0005815; GO:0005886; GO:0007051; GO:0007059; GO:0016477; GO:0034451; GO:0035371; GO:0042803; GO:0051010; GO:0051301; GO:0051988; GO:0071364; GO:0072686	KFLFETQAADLAGGTTVAAGNLLNESEK	6.800000191	1	1	0.053075642	2895.826344	8.803637	0	13.57426	0	0	0	0	15.41345	0	0	0	14.86658	0	12.99569	0	15.33174	8.058535	0	0	0	0	0	0	0	11.89588	0	0	0	13.2288	15.00085	14.57506	0	0	0	13.32683	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y450	HBS1L_HUMAN	HBS1-like protein (ERFS)	HBS1L HBS1 KIAA1038	Homo sapiens (Human)	signal transduction [GO:0007165]; translation [GO:0006412]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; signal transduction [GO:0007165]; translation [GO:0006412]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]	GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0007165; GO:0016020; GO:0070062	GVTMDVGMTKFETTTK	3.410000086	1	1	0.317070236	1745.754747	15.71938	13.80799	16.73316	12.73042	0	15.7628	14.2737	0	0	0	17.52058	0	0	14.11724	0	0	13.94276	13.66361	15.28875	0	0	0	0	16.00628	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.49372	0	0	0	0
Q9Y458	TBX22_HUMAN	"T-box transcription factor TBX22, T-box protein 22"	TBX22 TBOX22	Homo sapiens (Human)	"cell fate specification [GO:0001708]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001708; GO:0003677; GO:0005634; GO:0006357; GO:0045892	LISGSNHLK	10.5	0.423208624	0.423208624	0.237651926	969.352834	0	16.42202	16.01077	11.95461	14.7195	15.53089	14.98572	0	15.07682	13.92902	0	17.54231	13.60169	14.20562	0	13.83798	0	0	0	16.02453	15.55302	0	16.31585	12.44725	0	15.86885	14.05673	0	0	0	15.5845	0	0	0	0	0	15.78101	0	0	14.85912	15.74627	0	0	16.07707	0	0	0	0
Q9Y462	ZN711_HUMAN	Zinc finger protein 711 (Zinc finger protein 6)	ZNF711 CMPX1 ZNF6	Homo sapiens (Human)	"positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]"	chromatin [GO:0000785]; nucleus [GO:0005634]	"chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]"	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0010468; GO:0043565; GO:0045893; GO:0046872	HLDLFQGHK	6.429999828	1	1	0.204288159	1097.938945	13.49682	12.83615	14.29877	12.24319	15.36154	13.82085	15.63047	15.45081	14.32599	0	0	7.903785	14.18184	16.22728	14.99963	13.93162	14.63008	0	14.25632	14.38884	14.20779	15.8952	16.559	14.02837	0	14.02005	0	0	0	0	0	0	0	0	15.08764	0	0	0	0	0	0	0	0	0	0	14.84884	0	14.01467
Q9Y467	SALL2_HUMAN	"Sal-like protein 2 (Zinc finger protein 795) (Zinc finger protein SALL2) (Zinc finger protein Spalt-2, Sal-2, hSal2)"	SALL2 KIAA0360 SAL2 ZNF795	Homo sapiens (Human)	eye development [GO:0001654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; eye development [GO:0001654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0005634; GO:0006357; GO:0045944; GO:0046872	AQNSCPICQK	4.829999924	1	1	4.56E-13	1206.032008	0	16.43204	16.21586	12.7817	13.78864	0	0	0	16.78294	18.31612	12.0412	0	14.78942	15.18707	14.60375	16.65086	16.17968	13.05832	16.20175	0	14.69619	14.79722	16.77931	0	18.36751	17.32168	18.38802	0	16.93764	0	16.50282	0	0	0	0	12.47413	15.14521	15.67705	16.48363	17.05545	14.21331	0	16.96514	15.21206	16.76943	0	16.69514	17.19136
Q9Y468	LMBL1_HUMAN	"Lethal(3)malignant brain tumor-like protein 1, H-l(3)mbt, H-l(3)mbt protein, L(3)mbt-like (L(3)mbt protein homolog) (L3MBTL1)"	L3MBTL1 KIAA0681 L3MBT L3MBTL	Homo sapiens (Human)	"chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitotic nuclear division [GO:0007088]"	chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; condensed chromosome [GO:0000793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; condensed chromosome [GO:0000793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; nucleosome binding [GO:0031491]; SAM domain binding [GO:0032093]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitotic nuclear division [GO:0007088]"	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; nucleosome binding [GO:0031491]; SAM domain binding [GO:0032093]; zinc ion binding [GO:0008270]	GO:0000785; GO:0000793; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0007088; GO:0008270; GO:0030097; GO:0031491; GO:0031507; GO:0032093; GO:0035064; GO:0042393; GO:0042802; GO:0045652; GO:0045892; GO:0051726; GO:0061793	NGFKLGMK	8.600000381	1	1	0.581057539	911.3200823	18.44619	0	0	0	0	0	0	0	17.19201	0	0	0	0	18.64938	17.41696	0	0	17.64207	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.15382	0	0	0	0	0	0	0	0	0	19.26427	17.12749	16.77426	17.31586	0	18.6686
Q9Y473	ZN175_HUMAN	Zinc finger protein 175 (Zinc finger protein OTK18)	ZNF175	Homo sapiens (Human)	defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]	"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]"	GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0045944; GO:0046872; GO:0051607	CSYSVK	3.180000067	1	1	0.181783558	742.7240313	14.75545	15.28547	0	0	0	15.04157	0	0	0	0	0	15.31847	15.70318	0	0	0	0	0	0	13.47366	14.85306	0	15.62548	0	14.514	15.24421	0	15.44667	15.68097	13.3535	0	0	0	0	0	0	13.87286	0	0	16.09955	0	0	0	0	0	0	0	0
Q9Y478	AAKB1_HUMAN	"5'-AMP-activated protein kinase subunit beta-1, AMPK subunit beta-1, AMPKb"	PRKAB1 AMPK	Homo sapiens (Human)	cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; signal transduction [GO:0007165]	protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]	GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0007165; GO:0010628; GO:0019901; GO:0031588; GO:0031669; GO:0035878; GO:0050790; GO:0120162	TDFEVFDALMVDSQK	5.679999828	1	1	0.121219663	1759.916024	13.42579	14.62144	0	15.50293	11.9075	0	15.59966	0	0	0	12.08019	15.06675	12.56621	0	14.18456	13.25399	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.83627	0	0	14.60726	0	0	0	0	0	0	0
Q9Y483	MTF2_HUMAN	"Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2, hPCl2)"	MTF2 PCL2	Homo sapiens (Human)	"cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"	cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]	GO:0000122; GO:0000977; GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006325; GO:0006355; GO:0007379; GO:0019827; GO:0035064; GO:0035098; GO:0045944; GO:0046872; GO:0048863; GO:0061086; GO:0061087; GO:1990830	MRDSTGAGNSLVHK	6.139999866	0.684309185	0.684309185	0.417172739	1471.849631	0	15.22529	15.03178	0	15.27459	15.67155	0	0	0	17.71423	0	0	15.72099	16.56049	14.06345	0	0	0	0	16.11454	0	0	0	0	17.71321	0	17.06196	0	0	0	15.80591	0	0	16.83253	16.57233	0	18.47156	0	16.19587	17.90795	16.56337	18.64159	18.00224	17.05675	0	0	16.96788	0
Q9Y484	WIPI4_HUMAN	"WD repeat domain phosphoinositide-interacting protein 4, WIPI-4 (WD repeat-containing protein 45)"	WDR45 WDRX1 WDRXI4 WIPI4 JM5	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]"	"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]"	GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006497; GO:0006914; GO:0009267; GO:0019898; GO:0019901; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025; GO:1901981; GO:2000786	LVLEFTFTKPVLSVR	4.170000076	1	1	0.186165382	1748.310584	15.14435	15.88737	16.25858	13.7946	14.91908	0	0	0	16.45996	0	0	0	0	13.59274	14.53077	0	14.16435	0	0	14.00979	16.13746	15.84411	15.09305	16.60237	0	0	16.07975	0	0	0	16.22147	0	0	14.64773	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y485	DMXL1_HUMAN	"DmX-like protein 1, X-like 1 protein"	DMXL1 XL1	Homo sapiens (Human)	vacuolar acidification [GO:0007035]	RAVE complex [GO:0043291]	RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035]		GO:0007035; GO:0043291	ERVQNALEVNLR	6.440000057	1	1	1	1439.997549	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.51438	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y487	VPP2_HUMAN	"V-type proton ATPase 116 kDa subunit a 2, V-ATPase 116 kDa subunit a 2 (Lysosomal H(+)-transporting ATPase V0 subunit a 2) (TJ6) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2)"	ATP6V0A2	Homo sapiens (Human)	cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; Golgi lumen acidification [GO:0061795]; immune response [GO:0006955]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]	"acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"	"acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; Golgi lumen acidification [GO:0061795]; immune response [GO:0006955]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]"	"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]"	GO:0000139; GO:0000220; GO:0001669; GO:0005765; GO:0005886; GO:0005925; GO:0006879; GO:0006955; GO:0007035; GO:0010008; GO:0016021; GO:0016241; GO:0016471; GO:0030670; GO:0033176; GO:0036295; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:0061795; GO:1902600	AAESVYSR	5.46999979	1	1	0.370035805	885.1774451	14.19158	0	0	15.35691	14.85897	15.03075	15.81023	14.52876	15.58513	14.87545	0	0	0	15.65571	0	14.95247	0	15.69509	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.64125	0	0	0	0	0	0	0	0	0	0	15.3547
Q9Y490	TLN1_HUMAN	Talin-1	TLN1 KIAA1027 TLN	Homo sapiens (Human)	cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893]	actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]	GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609	ALGDLISATK	11.5	1	1	0.220866489	989.2423302	12.86609	13.85849	16.87616	13.68079	15.47182	14.52152	14.52264	0	14.0949	0	15.64925	0	14.62786	0	0	0	0	15.00683	0	0	14.36131	0	0	16.9057	0	15.83054	0	0	0	0	15.32397	15.18051	14.62601	0	17.51915	0	0	0	0	0	0	0	0	0	0	0	14.94468	14.61483
Q9Y493	ZAN_HUMAN	Zonadhesin	ZAN	Homo sapiens (Human)	binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609]		GO:0005615; GO:0005886; GO:0007339; GO:0016021; GO:0031012; GO:0098609	GSTAYLDIALDALSIRR	1.909999967	1	1	0.273444412	1835.817378	0	0	0	10.07506	12.14594	14.65806	7.602327	0	15.61292	15.6108	14.4359	0	0	0	15.77568	0	0	14.02695	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.44076	0	0	0
Q9Y496	KIF3A_HUMAN	Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)	KIF3A KIF3	Homo sapiens (Human)	anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]	axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]	axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507]; anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507]	GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006996; GO:0007018; GO:0008017; GO:0008089; GO:0008574; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0019903; GO:0030507; GO:0031267; GO:0034454; GO:0060271; GO:0070062; GO:0072383; GO:0097542; GO:1902414; GO:1904115	KVWTMLMAAK	6.679999828	0.626959503	0.626959503	9.15E-13	1201.530728	10.49301	14.05247	15.38796	14.13146	13.9813	15.91091	16.15796	13.31637	0	14.07354	0	14.9533	12.56978	0	0	13.87062	0	13.82127	0	0	13.60891	0	0	0	0	0	14.83393	13.45386	0	0	0	0	0	0	0	0	0	14.60098	0	0	12.22601	0	0	0	13.6412	0	16.28073	11.06306
Q9Y4A5	TRRAP_HUMAN	"Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor, PAF350/400) (STAF40) (Tra1 homolog)"	TRRAP PAF400	Homo sapiens (Human)	"chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]	"Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	transcription coregulator activity [GO:0003712]	GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006282; GO:0006325; GO:0006355; GO:0006357; GO:0016573; GO:0016578; GO:0033276; GO:0035267; GO:0035521; GO:0035522; GO:0042981; GO:0043484; GO:0043966; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779	ALNSTNSELQEAGEACMR	6.260000229	1	1	2.75E-12	1995.723803	13.13734	14.61466	0	0	0	12.43614	0	0	13.48128	0	0	0	15.42495	15.58324	15.65507	0	0	13.59046	16.25857	0	16.15798	14.71685	16.95298	0	0	13.80784	0	14.9079	14.36743	0	15.36485	14.44519	14.49421	16.36524	11.78436	0	0	0	0	0	14.86075	0	0	0	0	0	0	0
Q9Y4A8	NF2L3_HUMAN	"Nuclear factor erythroid 2-related factor 3, NF-E2-related factor 3, NFE2-related factor 3 (Nuclear factor, erythroid derived 2, like 3)"	NFE2L3 NRF3	Homo sapiens (Human)	integrated stress response signaling [GO:0140467]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	"chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; integrated stress response signaling [GO:0140467]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]"	GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0090575; GO:0140467	AINIMK	3.299999952	1	1	0.034838412	705.4726955	14.99299	14.09364	10.50944	14.05414	15.3433	14.10154	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y4B4	ARIP4_HUMAN	"Helicase ARIP4, EC 3.6.4.12 (Androgen receptor-interacting protein 4) (RAD54-like protein 2)"	RAD54L2 ARIP4 KIAA0809	Homo sapiens (Human)		nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]	GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0016887; GO:0140658	GDEKPVASVRPVQSTPIPMMPR	1.580000043	1	1	0.279415303	2408.641583	15.10036	0	0	15.35347	12.73983	13.061	0	0	12.37009	0	0	0	0	0	14.6154	0	0	13.82596	0	0	14.04565	15.56414	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y4B5	MTCL1_HUMAN	Microtubule cross-linking factor 1 (Coiled-coil domain-containing protein 165) (PAR-1-interacting protein) (SOGA family member 2)	MTCL1 CCDC165 KIAA0802 SOGA2	Homo sapiens (Human)	establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922]	apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506]	microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0000922; GO:0001578; GO:0003723; GO:0005615; GO:0005737; GO:0005856; GO:0008017; GO:0010506; GO:0016324; GO:0016327; GO:0016328; GO:0030496; GO:0042803; GO:0045197; GO:0090314; GO:0097427	AEMEDMR	6.039999962	0.358836979	0.358836979	0.123087215	913.3846243	0	0	16.08388	0	0	14.64279	14.43655	0	8.160881	0	0	0	13.20157	15.37017	15.56036	16.08928	15.15802	10.52655	15.23661	15.85348	15.59737	0	0	14.2674	0	0	16.20498	15.60844	14.67431	0	15.18757	14.99547	13.74776	11.34862	17.87825	15.62891	0	16.66032	17.28671	16.49986	16.14232	12.56724	15.32444	0	18.05375	14.71194	18.02796	14.91583
Q9Y4C0	NRX3A_HUMAN	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625]	cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]	GO:0005886; GO:0005887; GO:0007158; GO:0007411; GO:0007612; GO:0030534; GO:0035176; GO:0038023; GO:0046872; GO:0050839; GO:0071625; GO:0097109	VKATQK	12.93000031	1	1	0.095679949	675.3144029	14.60235	14.45543	0	13.66861	14.40735	14.00212	11.97852	0	11.2052	14.0715	14.70498	14.43303	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.31898	0
Q9Y4C1	KDM3A_HUMAN	"Lysine-specific demethylase 3A, EC 1.14.11.65 (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A)"	KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA	Homo sapiens (Human)	"androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]"	chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; iron ion binding [GO:0005506]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]"	androgen receptor binding [GO:0050681]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; iron ion binding [GO:0005506]; transcription coregulator activity [GO:0003712]	GO:0000118; GO:0000785; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006357; GO:0007290; GO:0009755; GO:0016020; GO:0030521; GO:0031490; GO:0032454; GO:0033169; GO:0036123; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0051573; GO:0120162; GO:0140683; GO:1990830; GO:2000036; GO:2000736	AVKGVR	9.359999657	3.63E-07	3.63E-07	0.286186904	630.8900798	0	0	0	0	0	0	0	19.70481	18.37433	0	19.26241	0	0	17.21305	0	0	0	0	0	0	16.19104	0	0	0	0	16.87601	0	0	0	0	19.25202	0	0	17.53158	0	18.59212	21.01391	0	19.45166	0	0	0	0	0	0	0	0	0
Q9Y4C8	RBM19_HUMAN	Probable RNA-binding protein 19 (RNA-binding motif protein 19)	RBM19 KIAA0682	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of embryonic development [GO:0040019]"	chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	"chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of embryonic development [GO:0040019]"	RNA binding [GO:0003723]	GO:0000398; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0016020; GO:0016607; GO:0040019	DGKFR	6.849999905	1	1	0.062132037	621.441397	14.79515	14.31675	0	12.66386	14.16146	0	15.69192	13.98319	15.21355	15.24184	0	10.51384	14.43566	0	0	0	15.24383	16.06408	14.61658	15.68544	0	0	0	15.07926	0	0	0	0	0	17.35757	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.22229	0	15.51194	0
Q9Y4D1	DAAM1_HUMAN	Disheveled-associated activator of morphogenesis 1	DAAM1 KIAA0666	Homo sapiens (Human)	"actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	"ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"	actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]	GO:0001725; GO:0003779; GO:0005829; GO:0005886; GO:0016020; GO:0030036; GO:0031267; GO:0031514; GO:0036064; GO:0042802; GO:0060071	GATSWPEFYIDQLNSMAARK	8.449999809	1	1	0.091120933	2284.203585	0	0	11.46131	14.31314	12.00692	13.79624	8.588158	13.50343	12.35963	13.62503	14.93202	9.180206	12.41034	11.88374	13.82031	13.42919	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.08512	0	9.888877	0	0	0
Q9Y4D2	DGLA_HUMAN	"Diacylglycerol lipase-alpha, DAGL-alpha, DGL-alpha, EC 3.1.1.116 (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)"	DAGLA C11orf11 KIAA0659 NSDDR	Homo sapiens (Human)	arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]	dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; acylglycerol lipase activity [GO:0047372]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	acylglycerol lipase activity [GO:0047372]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0047372; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077	IIVGATK	5.690000057	1	1	0.100056685	698.4063961	14.13506	0	15.10652	11.97114	0	16.7108	13.31975	0	0	16.12101	0	13.8162	0	0	0	13.6648	0	0	0	0	0	14.89716	0	15.91284	0	13.99913	0	0	0	0	0	0	15.11673	16.48483	0	0	0	0	0	0	0	0	0	16.48969	17.96846	18.41909	16.05716	0
Q9Y4D7	PLXD1_HUMAN	Plexin-D1	PLXND1 KIAA0620	Homo sapiens (Human)	angiogenesis [GO:0001525]; aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; synapse assembly [GO:0007416]	integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; synapse assembly [GO:0007416]	protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154]	GO:0001525; GO:0001569; GO:0001822; GO:0002116; GO:0003151; GO:0003279; GO:0005886; GO:0005887; GO:0007162; GO:0007416; GO:0008360; GO:0017154; GO:0019904; GO:0030027; GO:0030334; GO:0031258; GO:0032092; GO:0035904; GO:0043087; GO:0043542; GO:0045765; GO:0050772; GO:0060666; GO:0060976; GO:0071526; GO:1902287	EQDSLGLQSHEYRVK	5.78000021	1	1	0.376382751	1789.880824	12.16237	15.61349	12.21662	0	12.81211	0	14.88474	0	0	16.40122	0	0	13.83624	0	15.02041	0	16.86055	12.99637	0	0	0	0	0	0	0	15.30831	0	0	0	0	0	0	0	0	15.68576	0	0	0	0	0	0	0	0	16.23616	0	0	0	14.80502
Q9Y4D8	HECD4_HUMAN	"Probable E3 ubiquitin-protein ligase HECTD4, EC 2.3.2.26 (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4)"	HECTD4 C12orf51 KIAA0614	Homo sapiens (Human)	glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]	integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]	ubiquitin-protein transferase activity [GO:0004842]	GO:0004842; GO:0006006; GO:0016021; GO:0042593	LVPGAREVLTEIFK	4.880000114	0.9650442	0.9650442	0.229349421	1570.910757	0	0	0	0	15.41808	0	16.498	0	0	17.31366	0	0	14.94615	0	0	0	15.44297	0	0	0	0	0	0	0	15.13883	0	0	0	0	0	0	0	0	0	0	0	0	16.8985	13.28385	0	14.75407	0	0	0	13.3472	0	0	0
Q9Y4E1	WAC2C_HUMAN	"WASH complex subunit 2C (Vaccinia virus penetration factor, VPEF)"	WASHC2C FAM21C KIAA0592 VPEF	Homo sapiens (Human)	"endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; negative regulation of barbed-end actin filament capping [GO:2000813]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; retrograde transport, endosome to Golgi [GO:0042147]"	cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]	"cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; negative regulation of barbed-end actin filament capping [GO:2000813]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; retrograde transport, endosome to Golgi [GO:0042147]"	"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]"	GO:0005546; GO:0005547; GO:0005730; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010314; GO:0015031; GO:0016197; GO:0031901; GO:0032266; GO:0032456; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0043325; GO:0070273; GO:0071203; GO:0080025; GO:1900024; GO:1901981; GO:1905394; GO:2000813	MMNRTTPDQELVPASEPVWERPWSVEEIR	3.279999971	1	1	4.60E-13	3483.817664	14.92091	13.86008	0	13.88476	0	9.991055	13.97623	0	0	0	0	11.43934	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y4E5	ZN451_HUMAN	"E3 SUMO-protein ligase ZNF451, EC 2.3.2.- (Coactivator for steroid receptors) (E3 SUMO-protein transferase ZNF451) (Zinc finger protein 451)"	ZNF451 COASTER KIAA0576 KIAA1702	Homo sapiens (Human)	negative regulation of histone H3-K9 acetylation [GO:2000616]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]; PML body [GO:0016605]	nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; SUMO ligase activity [GO:0061665]; transcription corepressor activity [GO:0003714]; negative regulation of histone H3-K9 acetylation [GO:2000616]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468]	metal ion binding [GO:0046872]; SUMO ligase activity [GO:0061665]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0005634; GO:0010468; GO:0016605; GO:0016925; GO:0030512; GO:0045944; GO:0046872; GO:0060633; GO:0061665; GO:2000616	CVACHK	8.600000381	1	1	0.11464651	774.9404614	13.25414	17.60407	17.68714	0	15.0397	14.43481	16.89667	17.71633	0	0	13.44703	0	16.3251	13.53372	0	0	10.45808	14.33718	16.21906	17.98199	0	18.44757	13.29328	15.8071	11.46485	17.56472	15.79636	0	14.56523	0	15.88015	18.91381	14.28607	15.90339	0	17.11172	17.2526	0	17.44391	7.084331	0	0	0	17.98752	0	0	15.3953	15.99511
Q9Y4E6	WDR7_HUMAN	WD repeat-containing protein 7 (Rabconnectin-3 beta) (TGF-beta resistance-associated protein TRAG)	WDR7 KIAA0541 TRAG	Homo sapiens (Human)	hematopoietic progenitor cell differentiation [GO:0002244]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; hematopoietic progenitor cell differentiation [GO:0002244]		GO:0002244; GO:0005737	LARLIWTSNR	4.659999847	0.527776599	0.527776599	0.253147209	1229.72383	0	0	17.29507	18.19912	0	0	0	0	0	17.81952	18.61673	19.01793	0	16.45903	18.00332	0	20.00439	0	0	0	0	18.40102	18.96476	20.63281	0	0	0	17.33625	0	0	19.46079	0	0	19.46689	20.20044	20.62879	19.6877	0	0	0	0	15.67911	19.22627	0	0	0	19.78435	0
Q9Y4E8	UBP15_HUMAN	"Ubiquitin carboxyl-terminal hydrolase 15, EC 3.4.19.12 (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4)"	USP15 KIAA0529	Homo sapiens (Human)	BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K27-linked deubiquitination [GO:1990167]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; thiol-dependent deubiquitinase [GO:0004843]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K27-linked deubiquitination [GO:1990167]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; thiol-dependent deubiquitinase [GO:0004843]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]	GO:0004197; GO:0004843; GO:0005160; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0007179; GO:0016579; GO:0016604; GO:0030509; GO:0035520; GO:0035616; GO:0042802; GO:0046332; GO:0060389; GO:0061649; GO:1900246; GO:1905035; GO:1990167; GO:1990380	SYAELIK	8.340000153	1	1	0.321041615	822.1474057	17.93997	0	0	0	0	0	0	0	0	0	18.0213	0	0	16.56932	0	16.73462	0	0	0	0	0	0	0	18.06127	0	0	17.72834	0	0	0	0	19.89663	18.34927	0	0	0	0	0	19.63173	0	18.40535	0	0	0	0	17.1278	0	0
Q9Y4F1	FARP1_HUMAN	"FERM, ARHGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (FERM, RhoGEF and pleckstrin domain-containing protein 1) (Pleckstrin homology domain-containing family C member 2, PH domain-containing family C member 2)"	FARP1 CDEP PLEKHC2	Homo sapiens (Human)	dendrite morphogenesis [GO:0048813]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; dendrite morphogenesis [GO:0048813]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416]	cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]	GO:0005085; GO:0005829; GO:0005856; GO:0007416; GO:0008092; GO:0030175; GO:0030425; GO:0031234; GO:0031267; GO:0043197; GO:0048813; GO:0098890; GO:0098942; GO:0098974; GO:0098978; GO:1905606	NIQGMKHLAAHLWK	7.71999979	1	1	0.19749403	1647.468929	0	15.03848	0	0	14.8996	13.40521	0	0	0	0	0	0	0	16.8491	0	0	0	16.32654	0	15.5857	0	0	0	0	0	0	0	0	0	0	15.78809	15.86129	0	0	0	0	0	0	0	0	0	14.86673	0	0	0	0	0	0
Q9Y4F3	MARF1_HUMAN	Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1)	MARF1 KIAA0430 LKAP	Homo sapiens (Human)	double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; ribonuclease activity [GO:0004540]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; posttranscriptional gene silencing [GO:0016441]; regulation of gene expression [GO:0010468]	CCR4-NOT complex binding [GO:1905762]; mRNA binding involved in posttranscriptional gene silencing [GO:1903231]; ribonuclease activity [GO:0004540]	GO:0004540; GO:0005737; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0016020; GO:0016441; GO:0043231; GO:0048477; GO:1903231; GO:1905762	ATPGK	3.420000076	0.672676027	0.672676027	0.33531657	473.5352428	19.69676	16.73134	18.76252	18.26468	16.05733	16.858	19.09678	18.67983	18.65825	19.3771	0	0	18.93333	19.09338	17.39275	18.54369	18.35388	20.51844	0	18.55226	0	17.21455	0	18.05233	20.93638	17.7252	20.93893	18.50109	17.88505	0	19.89604	17.93448	19.83286	20.74278	20.93571	19.20066	17.97674	18.82308	0	0	18.56149	19.09476	0	18.87137	19.13679	20.50505	18.96735	17.57374
Q9Y4F4	TGRM1_HUMAN	TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B)	TOGARAM1 FAM179B KIAA0423	Homo sapiens (Human)	axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]	axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]	microtubule binding [GO:0008017]	GO:0000226; GO:0005815; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0008017; GO:0031116; GO:0035082; GO:0036064; GO:0060271; GO:0072686; GO:0090307; GO:1905515	ADLSTVGHKK	3.24000001	0.83876133	0.83876133	0.222226099	1050.492513	0	16.0304	9.268474	13.37138	0	13.68665	0	0	15.27072	15.56653	15.27225	11.67984	16.02995	0	0	16.02511	14.352	15.05541	14.79005	13.90362	0	0	14.76657	16.40777	0	0	0	0	0	0	15.46567	0	16.52384	0	15.42592	0	0	0	0	0	0	0	0	0	0	0	15.2771	0
Q9Y4F9	RIPR2_HUMAN	Rho family-interacting cell polarization regulator 2	RIPOR2 C6orf32 DIFF48 FAM65B KIAA0386 PL48	Homo sapiens (Human)	cell adhesion [GO:0007155]; cellular response to chemokine [GO:1990869]; chemotaxis [GO:0006935]; negative regulation of cell adhesion [GO:0007162]; negative regulation of establishment of T cell polarity [GO:1903904]; negative regulation of protein localization to cell leading edge [GO:1905872]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T cell migration [GO:2000405]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic spindle assembly [GO:1901673]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; 14-3-3 protein binding [GO:0071889]; cell adhesion [GO:0007155]; cellular response to chemokine [GO:1990869]; chemotaxis [GO:0006935]; negative regulation of cell adhesion [GO:0007162]; negative regulation of establishment of T cell polarity [GO:1903904]; negative regulation of protein localization to cell leading edge [GO:1905872]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T cell migration [GO:2000405]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic spindle assembly [GO:1901673]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]	14-3-3 protein binding [GO:0071889]	GO:0005737; GO:0005856; GO:0006935; GO:0007155; GO:0007162; GO:0007605; GO:0016324; GO:0030175; GO:0032420; GO:0035024; GO:0042130; GO:0045663; GO:0048741; GO:0051491; GO:0051726; GO:0060171; GO:0071889; GO:0090023; GO:1901673; GO:1901741; GO:1903904; GO:1905872; GO:1990869; GO:2000114; GO:2000391; GO:2000405; GO:2001107	AACLALKILEATESIK	5.139999866	1	1	0.373909345	1730.762192	0	16.37183	13.37228	0	0	15.24024	0	0	12.65073	16.35823	0	0	0	0	0	0	0	0	0	0	16.01802	0	15.22875	0	0	0	14.14974	0	16.57567	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.9832	0	0	0	13.95053
Q9Y4G2	PKHM1_HUMAN	"Pleckstrin homology domain-containing family M member 1, PH domain-containing family M member 1 (162 kDa adapter protein, AP162)"	PLEKHM1 KIAA0356	Homo sapiens (Human)	autophagosome-lysosome fusion [GO:0061909]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031]	autolysosome [GO:0044754]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleolus [GO:0005730]	autolysosome [GO:0044754]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; autophagosome-lysosome fusion [GO:0061909]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031]	metal ion binding [GO:0046872]	GO:0005730; GO:0005764; GO:0005765; GO:0015031; GO:0031902; GO:0032418; GO:0043231; GO:0044754; GO:0045780; GO:0046872; GO:0061909; GO:1900029; GO:1902774	KLVGSVK	12.38000011	0.01404978	0.01404978	0.175520498	727.2612889	0	14.72374	14.15012	14.71338	14.25453	12.06255	0	0	14.54739	16.4979	13.04665	13.33825	0	13.36504	0	16.55104	14.19991	0	15.73507	15.67055	15.98935	0	0	0	0	16.20966	15.67928	0	16.20769	0	0	0	0	0	0	0	16.2806	0	0	16.0751	0	15.5043	13.90655	0	16.47413	16.91077	14.4132	14.4273
Q9Y4G6	TLN2_HUMAN	Talin-2	TLN2 KIAA0320	Homo sapiens (Human)	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]	GO:0001726; GO:0003779; GO:0005178; GO:0005198; GO:0005200; GO:0005737; GO:0005886; GO:0005925; GO:0007043; GO:0007155; GO:0015629; GO:0045202; GO:0051015; GO:0098609	AAVPTVSDQAAAMQLSQCAK	4.369999886	0.878194213	0.878194213	0.174808117	2063.96996	0	13.17144	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.31028	0	0	15.18035	0	0	0	0	0	0	15.99325	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y4G8	RPGF2_HUMAN	"Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF, CNrasGEF) (Neural RAP guanine nucleotide exchange protein, nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1, PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1)"	RAPGEF2 KIAA0313 NRAPGEP PDZGEF1	Homo sapiens (Human)	adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; WW domain binding [GO:0050699]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591]	beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; WW domain binding [GO:0050699]	GO:0000165; GO:0001568; GO:0001764; GO:0005085; GO:0005096; GO:0005509; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0007186; GO:0007218; GO:0007264; GO:0007265; GO:0008285; GO:0010976; GO:0016020; GO:0016324; GO:0019933; GO:0019992; GO:0021591; GO:0021884; GO:0030033; GO:0030139; GO:0030165; GO:0030552; GO:0031175; GO:0031547; GO:0031697; GO:0032092; GO:0032486; GO:0032991; GO:0035556; GO:0038180; GO:0043005; GO:0043025; GO:0043547; GO:0043950; GO:0045202; GO:0045860; GO:0048022; GO:0048167; GO:0048471; GO:0050699; GO:0050774; GO:0061028; GO:0070300; GO:0070374; GO:0071320; GO:0071321; GO:0071880; GO:0072659; GO:0090557; GO:1901888; GO:1990090; GO:2000481; GO:2000670; GO:2001214; GO:2001224	KPVKSETSPVAPR	3.789999962	0.570299149	0.570299149	0.280374427	1395.737508	12.25524	12.51386	14.7929	0	0	0	0	0	15.53957	0	16.03883	0	0	15.10418	0	0	13.97672	0	12.69063	10.33905	10.43095	15.30023	0	0	0	0	0	14.99286	0	0	0	0	16.28132	0	14.02469	0	15.04866	0	14.76379	15.59373	0	15.31279	15.26426	16.50047	17.35058	0	0	0
Q9Y4I1	MYO5A_HUMAN	"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)"	MYO5A MYH12	Homo sapiens (Human)	actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; melanosome transport [GO:0032402]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; ruffle [GO:0001726]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; melanosome transport [GO:0032402]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	GO:0000146; GO:0001726; GO:0003723; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006892; GO:0007015; GO:0015031; GO:0015629; GO:0016020; GO:0016192; GO:0016459; GO:0030048; GO:0030050; GO:0030426; GO:0031267; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0042470; GO:0043005; GO:0051015; GO:0070062; GO:0072659	DADSCTIPPK	7.960000038	0.138383225	0.138383225	0.129453731	1102.63693	15.65248	11.33684	15.88735	17.12353	0	0	13.94153	11.34755	10.72821	15.58489	0	0	16.45675	16.67406	14.80866	11.09709	17.01442	12.87152	17.20553	15.22105	10.64249	0	15.7344	15.47691	14.94183	15.31702	14.40111	16.15893	0	12.96788	14.9008	10.75681	17.03265	16.39603	15.18618	15.04897	16.03949	16.1108	13.67126	13.19852	15.41851	15.31969	15.88243	11.45685	15.98449	12.58579	16.36441	0
Q9Y4I5	MTL5_HUMAN	"Tesmin (Metallothionein-like 5, testis-specific) (Testis-specific metallothionein-like protein)"	TESMIN MTL5	Homo sapiens (Human)	"cell differentiation [GO:0030154]; cellular metal ion homeostasis [GO:0006875]; male meiotic nuclear division [GO:0007140]; regulation of transcription, DNA-templated [GO:0006355]; response to metal ion [GO:0010038]; spermatogenesis [GO:0007283]"	cytoplasm [GO:0005737]; nucleus [GO:0005634]	"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; cellular metal ion homeostasis [GO:0006875]; male meiotic nuclear division [GO:0007140]; regulation of transcription, DNA-templated [GO:0006355]; response to metal ion [GO:0010038]; spermatogenesis [GO:0007283]"	metal ion binding [GO:0046872]	GO:0005634; GO:0005737; GO:0006355; GO:0006875; GO:0007140; GO:0007283; GO:0010038; GO:0030154; GO:0046872	EPVLHAFNPALGADCKGQVK	8.670000076	1	1	0.287611009	2152.869939	15.02137	0	10.80174	0	0	0	0	0	0	0	14.46667	0	14.26841	14.84273	0	0	0	0	0	0	0	0	0	0	0	0	16.37969	0	0	0	14.72822	13.6531	0	15.71088	0	0	0	0	0	15.46352	9.138938	0	0	0	0	0	0	13.99766
Q9Y4J8	DTNA_HUMAN	"Dystrobrevin alpha, DTN-A (Alpha-dystrobrevin) (Dystrophin-related protein 3)"	DTNA DRP3	Homo sapiens (Human)	chemical synaptic transmission [GO:0007268]; neuromuscular synaptic transmission [GO:0007274]; signal transduction [GO:0007165]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; neuromuscular synaptic transmission [GO:0007274]; signal transduction [GO:0007165]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536]	zinc ion binding [GO:0008270]	GO:0005654; GO:0005737; GO:0005886; GO:0006941; GO:0007165; GO:0007268; GO:0007274; GO:0008270; GO:0030054; GO:0032991; GO:0045111; GO:0045202; GO:0099536	GNTMAER	3.74000001	1	1	0.227102201	797.125368	0	13.83526	0	0	11.92834	14.56711	14.97906	14.12618	0	12.07793	14.47915	16.08451	0	14.78819	15.13604	13.98689	16.49456	13.76284	14.78322	15.68233	12.85011	15.37446	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.31222	0	0	0	0	15.40549	0	0	0	0	0	0
Q9Y4K0	LOXL2_HUMAN	"Lysyl oxidase homolog 2, EC 1.4.3.13 (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14)"	LOXL2	Homo sapiens (Human)	"aging [GO:0007568]; cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]"	basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; aging [GO:0007568]; cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]"	calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]	GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005044; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005654; GO:0005783; GO:0006464; GO:0007155; GO:0007568; GO:0009055; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0046688; GO:0062023; GO:0070492; GO:0070828; GO:1902455	AILSTYR	5.050000191	1	1	0.230397877	822.4024561	0	0	0	16.00356	15.47861	15.19294	0	0	0	0	0	17.81258	0	0	0	0	0	0	0	0	15.26198	0	16.61814	14.60192	0	15.74009	14.4712	0	16.42003	0	0	16.58568	0	0	0	17.237	18.78018	0	0	17.96503	0	0	0	0	0	0	0	14.65052
Q9Y4K1	CRBG1_HUMAN	Beta/gamma crystallin domain-containing protein 1 (Absent in melanoma 1 protein)	CRYBG1 AIM1	Homo sapiens (Human)			carbohydrate binding [GO:0030246]	carbohydrate binding [GO:0030246]	GO:0030246	QPPPASSPTKR	2.49000001	1	1	0.170752737	1166.47541	0	14.50228	9.24807	0	15.54749	0	0	0	0	0	0	0	15.78252	14.77652	0	12.77287	0	13.82743	0	15.1494	14.49524	0	0	0	14.83136	11.72539	0	0	15.33323	14.64242	14.12835	14.42263	16.29356	0	0	13.17921	0	14.6632	15.52931	0	0	15.93264	13.42848	12.94298	13.69456	0	13.30395	16.41475
Q9Y4K3	TRAF6_HUMAN	"TNF receptor-associated factor 6, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6)"	TRAF6 RNF85	Homo sapiens (Human)	"activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	"CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]"	histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002223; GO:0002637; GO:0002726; GO:0002753; GO:0002755; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006974; GO:0007249; GO:0007250; GO:0008270; GO:0009898; GO:0010008; GO:0019886; GO:0019901; GO:0030316; GO:0031398; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0038095; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0047485; GO:0048468; GO:0048471; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679	FDMGSLR	9.569999695	0.024392799	0.024392799	0.232080104	842.5388156	17.98899	17.67682	15.95797	18.2634	0	0	18.92761	0	17.19401	0	0	17.37456	0	17.46622	0	0	18.85853	0	17.03944	17.4193	18.90724	17.47663	18.73467	0	0	19.5702	0	0	16.97107	0	0	0	0	0	20.07001	0	20.47706	18.61881	19.43097	0	0	18.3431	16.98931	17.78045	0	18.06123	0	18.32519
Q9Y4K4	M4K5_HUMAN	"Mitogen-activated protein kinase kinase kinase kinase 5, EC 2.7.11.1 (Kinase homologous to SPS1/STE20, KHS) (MAPK/ERK kinase kinase kinase 5, MEK kinase kinase 5, MEKKK 5)"	MAP4K5	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0008349; GO:0035556; GO:0106310	ALFLMSK	13.53999996	0.398668647	0.398668647	0.080947752	824.7360205	17.34742	0	0	16.24558	15.44866	17.19619	15.88505	16.6711	0	0	16.48111	0	14.0885	16.15498	17.31969	0	0	15.42603	16.22383	0	0	15.0026	0	17.74282	17.14835	15.50017	0	0	15.53253	15.67771	16.06964	16.64457	15.89972	16.82147	16.84444	18.51074	16.55766	0	16.07751	16.25949	0	16.46608	15.65089	0	0	17.55878	17.24652	14.96193
Q9Y4L1	HYOU1_HUMAN	"Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein, ORP-150) (170 kDa glucose-regulated protein, GRP-170)"	HYOU1 GRP170 ORP150	Homo sapiens (Human)	cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]	endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0016020; GO:0016887; GO:0034663; GO:0034976; GO:0051082; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382	EEISGK	11.18000031	1	1	0.192082549	661.4185406	13.83706	15.60246	14.12632	15.50493	0	13.08471	14.44586	16.27851	16.20733	15.96496	15.7117	14.80734	0	16.70006	14.53661	15.77822	14.68683	15.61774	15.65094	14.27022	14.80208	17.25701	16.07635	16.52839	0	0	0	0	16.35969	0	15.19196	0	0	16.18583	0	15.90931	16.53037	0	0	15.9681	0	0	0	0	15.64018	16.70772	0	0
Q9Y4M8	CH071_HUMAN	Putative uncharacterized protein encoded by LINC00588	LINC00588 C8orf71	Homo sapiens (Human)						AHATSSVKPRAR	5.96999979	1	1	0.211351034	1280.455585	0	10.53448	12.25797	0	15.43994	14.02297	0	0	0	0	0	0	14.75766	0	0	0	15.53806	0	0	15.05517	0	0	0	0	0	16.1811	16.91007	0	0	0	0	0	0	15.02165	15.44856	15.3856	0	15.93186	15.72525	15.45209	16.43418	0	0	15.39359	0	0	14.14831	0
Q9Y4P3	TBL2_HUMAN	"Transducin beta-like protein 2 (WS beta-transducin repeats protein, WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein)"	TBL2 WBSCR13 UNQ563/PRO1125	Homo sapiens (Human)	cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968]	phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]	GO:0003723; GO:0005783; GO:0019901; GO:0030176; GO:0030968; GO:0031369; GO:0042149; GO:0051219; GO:0071456	ANGFPPDKSSGSK	8.399999619	0.8368119	0.8368119	0.028789966	1291.070218	13.72396	0	0	0	15.27835	16.17524	0	14.28364	0	0	0	14.28387	13.83152	14.80937	0	11.97878	0	0	8.737085	13.67605	15.72805	16.09054	0	12.82514	0	0	15.1234	0	14.89087	14.94415	0	16.15002	18.87038	13.88316	0	0	0	15.0183	0	0	18.06972	11.6991	14.21906	0	14.48601	0	13.59657	13.86466
Q9Y4P8	WIPI2_HUMAN	"WD repeat domain phosphoinositide-interacting protein 2, WIPI-2 (WIPI49-like protein 2)"	WIPI2 CGI-50	Homo sapiens (Human)	autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]	cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]	"cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]"	"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]"	GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005829; GO:0006497; GO:0009267; GO:0010314; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0044804; GO:0061739; GO:0080025; GO:0098792	LATASEKGTVIR	5.570000172	1	1	0.107431124	1249.481979	0	0	0	0	0	12.497	15.13149	0	14.84882	15.6191	0	14.85057	15.24737	0	15.39563	0	0	0	0	0	0	0	13.5498	0	0	14.16286	14.80672	0	0	14.72503	0	15.14336	0	0	15.66595	0	0	0	0	0	0	0	0	0	0	0	14.32149	15.06166
Q9Y4P9	SPEF1_HUMAN	Sperm flagellar protein 1	SPEF1 C20orf28	Homo sapiens (Human)	"axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of cell death [GO:0060548]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]"	9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]	"9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of cell death [GO:0060548]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]"	actin binding [GO:0003779]; microtubule binding [GO:0008017]	GO:0001578; GO:0003341; GO:0003779; GO:0005737; GO:0005874; GO:0005902; GO:0005930; GO:0007026; GO:0008017; GO:0016323; GO:0016324; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0046847; GO:0051493; GO:0060548; GO:0097542; GO:0097729; GO:1904158; GO:1990716; GO:2000095	IEDLSRR	1.720000029	1	1	0.287450502	889.8973951	0	0	14.9039	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.34101	0	0	0	17.0019	0	0	0	14.57803	0	0	0	0	0	0	0	0	0	0	0	0	0	15.01672	0	0	0	0	0	15.84957	0
Q9Y4R7	TTLL3_HUMAN	"Tubulin monoglycylase TTLL3, EC 6.3.2.- (HOTTL) (Tubulin--tyrosine ligase-like protein 3)"	TTLL3 PRO0207	Homo sapiens (Human)	axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094]	axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]	"axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094]"	"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]"	GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0030317; GO:0035082; GO:0036126; GO:0046872; GO:0060271; GO:0070735; GO:0070736	QHSKLVGTK	8.270000458	0.210344881	0.210344881	0.315609633	996.1346117	0	12.89188	15.94053	11.32329	16.29495	0	0	0	0	0	0	13.04673	0	15.25747	0	0	0	0	0	0	12.98781	12.33844	0	0	14.59375	0	0	12.56617	0	13.83581	0	14.14043	14.76924	0	0	0	0	16.39539	0	0	14.82021	16.33322	14.04347	0	0	10.42647	11.64658	15.41399
Q9Y4R8	TELO2_HUMAN	"Telomere length regulation protein TEL2 homolog (Protein clk-2 homolog, hCLK2)"	TELO2 KIAA0683	Homo sapiens (Human)	positive regulation of DNA damage checkpoint [GO:2000003]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006]; telomere maintenance via telomerase [GO:0007004]	"ASTRA complex [GO:0070209]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT complex [GO:0110078]"	"ASTRA complex [GO:0070209]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT complex [GO:0110078]; Hsp90 protein binding [GO:0051879]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162]; positive regulation of DNA damage checkpoint [GO:2000003]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006]; telomere maintenance via telomerase [GO:0007004]"	Hsp90 protein binding [GO:0051879]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162]	GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0007004; GO:0016020; GO:0016604; GO:0019901; GO:0031931; GO:0031932; GO:0032006; GO:0034399; GO:0042162; GO:0044877; GO:0050821; GO:0051879; GO:0060090; GO:0070209; GO:0071902; GO:0110078; GO:1904263; GO:1904515; GO:2000003	RLGMIVAEVVSAR	10.39000034	1	1	0.0995216	1416.719305	0	15.41261	18.46648	0	0	15.18752	0	0	0	0	15.54626	16.35331	17.33651	0	0	0	0	0	0	0	16.48828	0	0	0	15.68118	0	0	0	0	0	16.36901	0	0	15.17404	14.92756	15.57186	0	0	16.65627	16.8291	9.741915	0	17.99954	17.72634	19.02589	13.41608	0	16.81875
Q9Y4W6	AFG32_HUMAN	"AFG3-like protein 2, EC 3.4.24.- (Paraplegin-like protein)"	AFG3L2	Homo sapiens (Human)	axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013]	ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0055001; GO:0060013; GO:0065003	DFVNNYLSK	10.60999966	0.438003004	0.438003004	0.164552366	1099.482066	14.45795	15.48475	0	0	13.24036	0	9.751763	14.09644	14.10247	0	15.47773	0	14.60094	0	12.10136	11.31504	0	0	0	0	0	0	0	0	0	14.60254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y4Z0	LSM4_HUMAN	"U6 snRNA-associated Sm-like protein LSm4 (Glycine-rich protein, GRP)"	LSM4	Homo sapiens (Human)	"mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]"	cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	"cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]"	PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]	GO:0000387; GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005829; GO:0008380; GO:0016020; GO:0017070; GO:0032991; GO:0033962; GO:0042731; GO:0046540; GO:0071005; GO:0097526; GO:0120115	GMGGAGRGVFGGR	5.889999866	0.19972685	0.19972685	0.362085296	1194.270503	15.32566	15.16125	14.85748	0	15.38874	0	13.58664	10.88061	0	0	11.56722	14.04123	14.71587	13.049	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.47826	0	0	0	0
Q9Y519	T184B_HUMAN	Transmembrane protein 184B (Putative MAPK-activating protein FM08)	TMEM184B C22orf5 PSEC0108	Homo sapiens (Human)		integral component of membrane [GO:0016021]	integral component of membrane [GO:0016021]		GO:0016021	DNEKTLLLSSDDEF	10.64999962	1	1	0.319488157	1626.095616	0	0	0	0	0	17.2126	0	0	17.09697	0	0	0	0	0	0	0	0	0	18.95908	0	0	0	18.23369	0	0	0	0	0	0	0	0	0	0	0	0	0	17.80233	0	0	0	0	0	0	0	0	0	0	0
Q9Y520	PRC2C_HUMAN	Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C)	PRRC2C BAT2D1 BAT2L2 KIAA1096 XTP2	Homo sapiens (Human)	cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; stress granule assembly [GO:0034063]	protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	GO:0002244; GO:0003723; GO:0005829; GO:0008022; GO:0010494; GO:0016020; GO:0030154; GO:0034063	ISAVESQPSR	6.449999809	0.229372635	0.229372635	0.252586061	1072.066605	14.43154	7.572981	0	15.16848	0	17.4439	0	16.95548	0	15.74354	0	0	0	0	0	11.74674	14.44788	0	13.91678	13.41945	15.47775	0	14.40387	0	13.23845	12.27609	14.14527	14.30887	15.43998	13.98415	0	0	0	0	0	0	11.04997	13.36703	0	15.87247	14.34305	0	15.08102	0	0	0	0	15.00632
Q9Y546	LRC42_HUMAN	Leucine-rich repeat-containing protein 42	LRRC42	Homo sapiens (Human)						ENGQLHMVNLALDGVR	3.299999952	0.576661646	0.576661646	0.20740345	1782.414318	14.84082	14.45747	12.88521	0	14.0002	12.54701	15.74228	0	10.71119	0	0	0	15.48375	15.24098	13.6005	0	0	0	0	0	15.05201	0	0	0	0	0	15.48826	0	13.61696	13.63597	0	0	0	0	11.50478	0	0	0	15.90771	9.042872	0	0	12.74949	0	0	0	0	15.01676
Q9Y548	YIPF1_HUMAN	Protein YIPF1 (YIP1 family member 1)	YIPF1	Homo sapiens (Human)	vesicle-mediated transport [GO:0016192]	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]	Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; small GTPase binding [GO:0031267]; vesicle-mediated transport [GO:0016192]	small GTPase binding [GO:0031267]	GO:0000138; GO:0005654; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0016021; GO:0016192; GO:0030133; GO:0031267; GO:0031902	EEDDELLGNDDSDK	5.929999828	1	1	0.418617484	1592.7416	16.71265	16.16406	14.87461	0	13.69893	13.91358	0	15.41151	15.21336	0	15.96377	0	0	15.74511	0	0	16.89602	0	0	0	0	0	0	0	0	0	0	15.37739	15.09031	15.26265	16.74473	17.18018	0	0	17.2732	16.39122	17.49216	14.31235	14.28891	16.83653	16.0774	15.65331	0	15.70059	17.01224	0	0	0
Q9Y561	LRP12_HUMAN	"Low-density lipoprotein receptor-related protein 12, LDLR-related protein 12, LRP-12 (Suppressor of tumorigenicity 7 protein)"	LRP12 ST7	Homo sapiens (Human)	endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]	clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle receptor activity [GO:0005041]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]	low-density lipoprotein particle receptor activity [GO:0005041]	GO:0001764; GO:0005041; GO:0005887; GO:0005905; GO:0006897; GO:0007165; GO:0016021; GO:0031175; GO:0040008	DMAGASGGVAAPLPQK	1.919999957	1	1	0.129247336	1469.735849	14.25505	15.03069	15.27143	15.40463	0	0	0	17.26991	0	0	14.26435	0	15.93557	14.17419	12.15816	13.39529	0	15.14566	18.02059	0	16.11584	14.21879	0	0	0	16.05951	17.32053	12.8618	15.16254	16.6288	15.43664	8.284001	0	0	13.21928	14.61405	15.8399	0	0	15.8885	16.20214	16.20459	15.02241	17.85743	16.52902	0	0	11.58464
Q9Y572	RIPK3_HUMAN	"Receptor-interacting serine/threonine-protein kinase 3, EC 2.7.11.1 (RIP-like protein kinase 3) (Receptor-interacting protein 3, RIP-3)"	RIPK3 RIP3	Homo sapiens (Human)	"activation of protein kinase activity [GO:0032147]; amyloid fibril formation [GO:1990000]; apoptotic signaling pathway [GO:0097190]; cellular protein modification process [GO:0006464]; cellular response to hydrogen peroxide [GO:0070301]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lymph node development [GO:0048535]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ligase activity [GO:0051351]; positive regulation of necroptotic process [GO:0060545]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; regulation of activated T cell proliferation [GO:0046006]; regulation of activation-induced cell death of T cells [GO:0070235]; regulation of adaptive immune response [GO:0002819]; regulation of apoptotic process [GO:0042981]; regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000452]; regulation of interferon-gamma production [GO:0032649]; regulation of T cell mediated cytotoxicity [GO:0001914]; signal transduction [GO:0007165]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; activation of protein kinase activity [GO:0032147]; amyloid fibril formation [GO:1990000]; apoptotic signaling pathway [GO:0097190]; cellular protein modification process [GO:0006464]; cellular response to hydrogen peroxide [GO:0070301]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lymph node development [GO:0048535]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ligase activity [GO:0051351]; positive regulation of necroptotic process [GO:0060545]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; regulation of activated T cell proliferation [GO:0046006]; regulation of activation-induced cell death of T cells [GO:0070235]; regulation of adaptive immune response [GO:0002819]; regulation of apoptotic process [GO:0042981]; regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000452]; regulation of interferon-gamma production [GO:0032649]; regulation of T cell mediated cytotoxicity [GO:0001914]; signal transduction [GO:0007165]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]"	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]	GO:0001914; GO:0002819; GO:0003713; GO:0004672; GO:0004674; GO:0004704; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0007165; GO:0007249; GO:0010922; GO:0032147; GO:0032649; GO:0032991; GO:0033077; GO:0042802; GO:0042981; GO:0043029; GO:0044877; GO:0046006; GO:0046777; GO:0048535; GO:0048536; GO:0048538; GO:0051092; GO:0051351; GO:0051353; GO:0051607; GO:0060545; GO:0070235; GO:0070266; GO:0070301; GO:0097190; GO:0097300; GO:0097527; GO:0097528; GO:0106310; GO:1990000; GO:2000379; GO:2000452; GO:2001244	LLKEVVLGMFYLHDQNPVLLHR	1.610000014	1	1	1.38E-12	2651.388721	0	0	0	0	0	0	0	0	0	0	0	0	0	15.86338	0	15.69173	0	16.06168	13.31052	16.847	16.86995	14.07266	14.34605	15.44772	16.0203	0	0	0	0	13.81363	15.13218	0	0	14.49258	0	13.24601	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y573	IPP_HUMAN	"Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide, IPP) (Kelch-like protein 27)"	IPP KLHL27	Homo sapiens (Human)		actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]	actin binding [GO:0003779]	GO:0003779; GO:0005737; GO:0015629	WEVVGNMAVSR	3.309999943	1	1	0.264882263	1248.475327	14.07671	13.45633	14.9823	13.31557	0	12.66248	15.52678	15.28887	0	0	13.30385	0	0	7.556188	0	14.48497	0	0	0	0	15.81642	0	0	0	0	0	0	0	0	0	0	15.91288	0	0	0	0	0	0	17.85448	0	0	0	0	0	16.2072	0	0	0
Q9Y586	MB212_HUMAN	Protein mab-21-like 2	MAB21L2	Homo sapiens (Human)	camera-type eye development [GO:0043010]; embryonic body morphogenesis [GO:0010172]; eye development [GO:0001654]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; camera-type eye development [GO:0043010]; embryonic body morphogenesis [GO:0010172]; eye development [GO:0001654]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]		GO:0001654; GO:0005634; GO:0005737; GO:0007399; GO:0008284; GO:0010172; GO:0043010	FISSLSEIDAR	1.480000019	0.153317437	0.153317437	0.192102446	1240.282654	14.93513	15.27519	0	0	15.82437	0	15.4275	0	13.72568	16.08704	16.49717	0	15.70125	0	13.47029	14.16907	0	0	14.71082	0	16.03154	16.32188	14.96589	0	15.26465	0	11.61393	0	14.60779	0	15.06131	0	15.49252	14.92839	14.70313	0	0	15.5317	0	14.7319	0	14.97021	15.69379	14.65039	15.6215	15.26755	13.53817	12.44181
Q9Y5B0	CTDP1_HUMAN	"RNA polymerase II subunit A C-terminal domain phosphatase, EC 3.1.3.16 (TFIIF-associating CTD phosphatase)"	CTDP1 FCP1	Homo sapiens (Human)	cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription elongation from RNA polymerase II promoter [GO:0006368]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription elongation from RNA polymerase II promoter [GO:0006368]	phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]	GO:0000922; GO:0001096; GO:0004721; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006368; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043231; GO:0043923; GO:0051233; GO:0051301; GO:0061052; GO:0070940	DDHTKAQR	4.480000019	1	1	0.089146026	969.4747144	0	13.14618	10.75495	0	0	15.90886	0	0	0	15.92216	0	0	15.25679	0	0	0	14.44437	0	0	0	0	0	0	0	0	13.96041	0	15.17079	0	0	0	14.66055	0	0	11.98794	0	0	15.17122	0	0	0	0	0	0	0	0	0	0
Q9Y5B9	SP16H_HUMAN	"FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16, hSPT16)"	SUPT16H FACT140 FACTP140	Homo sapiens (Human)	"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent chromatin organization [GO:0034724]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent chromatin organization [GO:0034724]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]"	nucleosome binding [GO:0031491]; RNA binding [GO:0003723]	GO:0003723; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006334; GO:0006337; GO:0006366; GO:0006368; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101	LAESVEK	1.399999976	1	1	0.126998431	776.3582068	0	11.68393	0	15.84475	0	0	0	15.28971	14.0767	0	15.96747	0	10.05115	15.38591	0	15.87269	13.50645	0	13.43551	0	12.65329	0	13.70005	0	0	0	0	0	0	0	0	15.50814	14.99629	0	14.9949	0	0	0	0	0	14.52361	0	0	0	0	0	0	0
Q9Y5E4	PCDB5_HUMAN	"Protocadherin beta-5, PCDH-beta-5"	PCDHB5	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0045202	TAEIRLK	6.070000172	1	1	0.266278369	829.9277952	13.81079	15.65218	14.61125	0	14.42079	16.12025	0	15.94995	0	16.78644	17.87324	0	14.93529	0	11.49308	0	0	14.44343	0	13.89959	0	0	0	15.96287	0	0	0	0	0	15.71177	0	0	0	0	16.49409	16.69557	0	0	0	0	0	16.34319	0	0	0	0	0	0
Q9Y5E6	PCDB3_HUMAN	"Protocadherin beta-3, PCDH-beta-3"	PCDHB3	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339; GO:0045202	IIDVNDHSPVFFENEMHLK	4.860000134	1	1	0.245690098	2299.337133	0	13.8018	13.98626	11.79219	12.9467	12.89214	14.62318	13.57672	0	12.73148	14.67172	0	14.15061	14.74837	13.36755	0	14.17655	15.42553	11.43506	0	0	16.23565	15.93307	0	0	0	0	0	0	0	0	16.3493	0	10.61657	0	0	0	0	0	0	14.69603	14.38377	0	0	0	16.04823	14.97744	0
Q9Y5E8	PCDBF_HUMAN	"Protocadherin beta-15, PCDH-beta-15"	PCDHB15	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]	integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0032391	LVTEGALDR	2.900000095	1	1	0.117350278	975.7722096	12.61905	13.88844	13.35897	14.69794	13.1436	14.00902	15.67573	13.146	14.99034	16.33298	15.91231	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.78017	16.61304	0	0	0
Q9Y5F0	PCDBD_HUMAN	"Protocadherin beta-13, PCDH-beta-13"	PCDHB13 UNQ332/PRO531	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; postsynaptic membrane [GO:0045211]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; postsynaptic membrane [GO:0045211]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0032391; GO:0045211; GO:0097381	LHLQLNQETADLLLNEKLDR	15.51000023	1	1	0.252384876	2375.600293	0	18.13452	0	0	0	0	18.5094	0	0	0	0	0	0	0	0	0	0	0	0	0	18.61992	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.91931	0	0	0	0	0	0	0	0	0	17.40653	0
Q9Y5F2	PCDBB_HUMAN	"Protocadherin beta-11, PCDH-beta-11"	PCDHB11	Homo sapiens (Human)	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339; GO:0045202	VVSNDK	17.21999931	1	1	0.231380617	661.706237	6.902163	16.75032	18.31812	0	0	17.89588	17.744	16.90374	0	0	0	0	17.39177	16.63167	0	0	18.93924	17.31768	0	17.37088	0	0	0	0	0	0	17.13724	0	0	0	18.00818	17.62569	0	17.95085	17.41365	17.33529	18.69148	0	0	0	0	0	0	16.65811	17.16433	0	0	0
Q9Y5F6	PCDGM_HUMAN	"Protocadherin gamma-C5, PCDH-gamma-C5"	PCDHGC5	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; synapse organization [GO:0050808]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; synapse organization [GO:0050808]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0043524; GO:0050808	NLFGLDPSSGAIHVLGPIDFEESR	2.920000076	1	1	0.262840625	2570.922111	13.75278	13.16613	14.00223	0	0	0	0	0	0	0	0	15.15502	0	14.48234	0	15.47508	0	0	16.02502	0	0	0	16.39406	16.6513	0	0	0	0	14.88164	0	13.51566	0	0	0	13.44697	0	8.577464	0	0	0	15.6054	0	13.04152	0	0	0	0	0
Q9Y5F9	PCDGI_HUMAN	"Protocadherin gamma-B6, PCDH-gamma-B6"	PCDHGB6	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156	CNIETDIPFK	3.579999924	1	1	0.079965452	1236.336778	0	0	11.1064	0	14.68189	0	8.081136	0	0	17.55612	0	0	0	14.17679	0	0	0	0	0	0	0	0	12.58062	0	0	0	0	14.23724	0	10.71564	0	0	0	0	15.25116	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y5G1	PCDGF_HUMAN	"Protocadherin gamma-B3, PCDH-gamma-B3"	PCDHGB3	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156	IVQDTK	3.559999943	1	1	2.30E-13	703.516161	14.83781	0	15.06946	16.53628	0	14.72491	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.55458	0	0	15.93127	16.12674	0	13.66154	0	0	14.67752	14.64341	0	16.14049	15.69086	0	0	15.45282	0	0	0	0	0	0	0	0	0	0
Q9Y5G3	PCDGD_HUMAN	"Protocadherin gamma-B1, PCDH-gamma-B1"	PCDHGB1	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]	growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426	DLGLSVR	1.950000048	1	1	0.023710388	758.5111544	0	0	0	0	0	0	18.7461	0	0	0	0	0	0	0	0	0	0	0	0	0	16.35974	0	0	0	0	0	0	0	0	0	16.91845	0	0	0	0	0	0	18.10953	0	0	0	0	0	16.83693	0	0	0	0
Q9Y5G4	PCDG9_HUMAN	"Protocadherin gamma-A9, PCDH-gamma-A9"	PCDHGA9	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]; RNA binding [GO:0003723]	GO:0003723; GO:0005509; GO:0005887; GO:0007155; GO:0007156	DLQMQVTASDSGSPPLSSNVSLR	5.079999924	1	1	4.56E-12	2405.125465	12.62187	0	0	16.51516	0	13.19118	17.06355	14.31334	13.89086	0	0	14.41496	14.58674	14.52158	11.25084	0	14.97508	0	0	14.36687	0	0	0	16.6517	0	15.15963	14.7725	14.52652	0	12.08406	0	15.51798	0	0	13.29203	0	17.37303	14.71772	0	0	12.92675	14.38094	14.71367	10.67182	0	11.0759	15.14379	0
Q9Y5H3	PCDGA_HUMAN	"Protocadherin gamma-A10, PCDH-gamma-A10"	PCDHGA10	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156	YTGEIK	5.309999943	0.412464499	0.412464499	0.263502114	709.2185185	0	0	0	0	0	0	0	0	0	0	17.05912	0	0	0	17.85553	0	0	0	16.1886	0	0	0	0	0	0	0	0	0	16.264	0	0	18.50991	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y5H6	PCDA8_HUMAN	"Protocadherin alpha-8, PCDH-alpha-8"	PCDHA8	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399	VGGTGGAASK	4.53000021	1	1	0.227056026	803.8873235	15.70753	15.50099	0	13.78272	14.7021	14.48327	0	14.48993	0	0	15.95474	15.15317	0	0	0	14.98218	15.47304	0	0	0	15.5143	16.15971	0	0	16.73483	14.7456	14.71329	15.23878	15.29838	13.59669	13.98363	16.2669	15.76838	13.12605	15.54479	15.18167	14.78074	16.01621	0	13.83523	15.79063	15.31756	16.0092	0	0	14.98799	12.24595	0
Q9Y5H9	PCDA2_HUMAN	"Protocadherin alpha-2, PCDH-alpha-2"	PCDHA2	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]	endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005634; GO:0005783; GO:0005887; GO:0007155; GO:0007156; GO:0007399	GTPSMSGHCKISLK	9.029999733	1	1	0.588802244	1517.343161	15.24504	0	18.32144	18.56199	19.73227	18.50631	19.67819	0	17.55227	18.74681	18.71629	18.173	17.39467	14.92504	19.12222	19.31905	0	0	18.34953	0	18.77129	20.53798	19.92955	19.75221	0	19.29046	0	20.79044	17.82868	19.28905	20.8856	0	21.66391	20.13654	0	0	20.83261	20.06323	20.92208	19.67869	18.20832	18.20761	0	18.30183	18.87473	0	18.47566	18.8412
Q9Y5I1	PCDAB_HUMAN	"Protocadherin alpha-11, PCDH-alpha-11"	PCDHA11 CNRS7	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	integral component of plasma membrane [GO:0005887]	integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399	TDLMAFSPSLPLGLNK	2.890000105	1	1	0.3433469	1719.627746	0	0	0	14.35095	0	0	0	14.06569	0	0	13.50413	0	0	0	0	15.61636	0	0	0	0	0	0	0	0	16.48168	0	15.89304	0	0	0	0	0	0	0	0	0	15.78546	0	16.96428	0	0	15.82437	0	15.91263	0	0	0	16.79167
Q9Y5I3	PCDA1_HUMAN	"Protocadherin alpha-1, PCDH-alpha-1"	PCDHA1	Homo sapiens (Human)	cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]	calcium ion binding [GO:0005509]	GO:0005509; GO:0005576; GO:0005783; GO:0005887; GO:0007155; GO:0007156; GO:0007399	VASKTHR	5	1	1	0.09963962	799.5824117	15.01624	12.39491	14.20236	13.87108	0	14.41826	0	0	0	0	0	14.58418	0	0	0	0	0	0	0	0	19.10374	17.17796	0	0	16.83056	0	15.41513	16.25986	17.2387	16.00316	16.64731	0	0	0	15.09141	0	17.6306	17.46302	0	0	0	0	0	0	0	0	0	0
Q9Y5I7	CLD16_HUMAN	"Claudin-16 (Paracellin-1, PCLN-1)"	CLDN16 PCLN1	Homo sapiens (Human)	bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular metal ion homeostasis [GO:0006875]; intercellular transport [GO:0010496]; metal ion transport [GO:0030001]	bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular metal ion homeostasis [GO:0006875]; intercellular transport [GO:0010496]; metal ion transport [GO:0030001]	identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; structural molecule activity [GO:0005198]	GO:0005198; GO:0005886; GO:0005923; GO:0006875; GO:0007155; GO:0010496; GO:0015095; GO:0016021; GO:0016338; GO:0030001; GO:0042802; GO:0070830	AYSAAGVSMAK	7.400000095	1	1	0.357698033	1072.135842	0	14.57844	9.763926	15.97151	15.50653	0	12.50485	15.82566	15.13129	14.24357	0	0	15.66096	15.78076	0	0	0	15.65671	0	0	16.39047	0	0	0	0	16.08622	0	0	15.69604	0	15.91165	0	0	0	0	0	0	16.29707	0	0	0	0	0	0	0	0	15.45757	0
Q9Y5J5	PHLA3_HUMAN	Pleckstrin homology-like domain family A member 3 (TDAG51/Ipl homolog 1)	PHLDA3 TIH1	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of apoptotic process [GO:0043065]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-5-phosphate binding [GO:0010314]; anatomical structure morphogenesis [GO:0009653]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of apoptotic process [GO:0043065]"	"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-5-phosphate binding [GO:0010314]"	GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0009653; GO:0010314; GO:0032266; GO:0042771; GO:0043065; GO:0043325; GO:0051898; GO:0080025	AVECVESTGR	5.860000134	1	1	0.137589999	1107.351166	14.43312	14.86782	10.58485	0	0	0	0	13.71595	0	0	0	14.20709	0	0	14.43989	0	0	0	0	12.53022	0	0	0	0	0	0	15.10603	14.59944	0	0	13.91314	10.89453	15.05559	14.84001	15.69617	0	14.05861	14.34677	13.36355	15.78178	13.96423	0	14.22157	13.39133	14.1891	12.67551	12.11566	15.61657
Q9Y5J7	TIM9_HUMAN	Mitochondrial import inner membrane translocase subunit Tim9	TIMM9 TIM9 TIM9A TIMM9A	Homo sapiens (Human)	protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605]	chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005739; GO:0005743; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0051087	AGLLGQPR	6.650000095	1	1	0	811.3341085	0	0	0	13.87727	14.47836	14.19426	13.24046	14.86982	14.99271	0	14.11791	13.04752	15.81025	0	0	16.0071	14.65889	0	16.83182	13.76199	0	14.3536	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.27269	0	0	0	0	0	0	0	0	0
Q9Y5K3	PCY1B_HUMAN	"Choline-phosphate cytidylyltransferase B, EC 2.7.7.15 (CCT-beta) (CTP:phosphocholine cytidylyltransferase B, CCT B, CT B) (Phosphorylcholine transferase B)"	PCYT1B CCTB	Homo sapiens (Human)	CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283]	choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]	GO:0001541; GO:0004105; GO:0005737; GO:0005783; GO:0005789; GO:0006656; GO:0006657; GO:0007283; GO:0031210; GO:0042802	EAGMFVPTQRTEGISTSDIITR	3.619999886	1	1	0.376751753	2423.198318	0	0	19.04167	0	0	0	0	0	20.32679	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.45958	0	0	0	0	0	21.70243	0	19.76553	0	0	0	0	0	0	0	0	0
Q9Y5K6	CD2AP_HUMAN	CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains)	CD2AP	Homo sapiens (Human)	"actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; vesicle organization [GO:0016050]"	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle [GO:0031982]	"actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle [GO:0031982]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]; vascular endothelial growth factor receptor binding [GO:0005172]; actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; vesicle organization [GO:0016050]"	beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]; vascular endothelial growth factor receptor binding [GO:0005172]	GO:0001650; GO:0001726; GO:0005172; GO:0005200; GO:0005737; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007049; GO:0007165; GO:0008013; GO:0008022; GO:0015629; GO:0016050; GO:0016477; GO:0017124; GO:0030139; GO:0030424; GO:0030425; GO:0031252; GO:0031941; GO:0031982; GO:0032911; GO:0034451; GO:0042802; GO:0043161; GO:0044877; GO:0045296; GO:0048259; GO:0048471; GO:0050714; GO:0051058; GO:0051301; GO:0065003; GO:0070062; GO:0098609; GO:1900182; GO:2000249	ERHGNVASLVQR	3.130000114	1	1	0.218905422	1366.65538	16.20355	0	0	0	0	0	0	0	0	14.96374	0	0	0	16.55892	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.80017	13.32662	0	14.90854	0	12.99593	0	0	15.29126	0	0	0	0	0	0	0	0	0
Q9Y5L0	TNPO3_HUMAN	"Transportin-3 (Importin-12, Imp12) (Transportin-SR, TRN-SR)"	TNPO3 IPO12	Homo sapiens (Human)	protein import into nucleus [GO:0006606]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606]	identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267]	GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0031267; GO:0042802; GO:0043231; GO:0061608	IVERCCR	4.630000114	1	1	0.154289512	992.996246	14.52574	0	0	0	0	0	0	15.92783	0	0	0	0	0	0	0	15.04496	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.33221	0	0	0	0	0	0	0	0	0
Q9Y5L4	TIM13_HUMAN	Mitochondrial import inner membrane translocase subunit Tim13	TIMM13 TIM13B TIMM13A TIMM13B	Homo sapiens (Human)	protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605]	fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]	fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605]	zinc ion binding [GO:0008270]	GO:0001650; GO:0005739; GO:0005743; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0042719; GO:0045039	CIAMCMDR	4.650000095	1	1	0.237373147	1088.51321	14.9794	13.42696	14.06071	15.89081	14.07169	15.39181	14.02729	0	0	15.7555	0	0	0	15.56806	0	16.80455	0	0	15.91023	16.11341	0	0	16.99158	0	0	0	0	0	0	15.66738	0	14.38777	16.48185	15.26207	14.50604	0	0	15.44939	15.31069	0	0	15.47577	0	15.08131	0	0	0	0
Q9Y5M1	F215A_HUMAN	"Uncharacterized protein FAM215A (Apoptosis-related protein 2, APR-2)"	FAM215A APR2 C17orf88	Homo sapiens (Human)						GSEPPGRSAGLQGATER	5.46999979	1	1	0.457892346	1670.541954	0	0	0	0	0	0	0	0	0	0	0	17.64535	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y5M8	SRPRB_HUMAN	"Signal recognition particle receptor subunit beta, SR-beta (Protein APMCF1)"	SRPRB PSEC0230	Homo sapiens (Human)	"protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"	cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]"	GTP binding [GO:0005525]	GO:0005525; GO:0005737; GO:0005785; GO:0005789; GO:0005881; GO:0006617; GO:0016020; GO:0016021; GO:0045047	LLTGLYR	1.820000052	1	1	0.192115999	836.612744	14.99999	11.89345	12.73643	15.94813	0	17.07767	0	0	14.66325	16.38624	14.28531	0	0	0	0	14.6804	0	0	0	0	14.80449	0	0	0	0	0	0	0	14.3381	0	0	0	0	0	0	0	0	0	0	16.03226	15.43504	0	0	0	0	0	0	0
Q9Y5Q6	INSL5_HUMAN	"Insulin-like peptide INSL5, Insulin-like peptide 5 [Cleaved into: Insulin-like peptide INSL5 B chain; Insulin-like peptide INSL5 A chain ]"	INSL5 UNQ156/PRO182	Homo sapiens (Human)	positive regulation of feeding behavior [GO:2000253]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; positive regulation of feeding behavior [GO:2000253]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]	GO:0001664; GO:0005179; GO:0005576; GO:2000253	KHSVMSR	8.880000114	1	1	0.094471549	859.4407718	0	14.093	13.50544	16.18599	13.95494	0	12.01252	14.2679	0	16.0251	0	14.01623	0	14.07578	13.77726	14.66205	0	0	0	14.98556	15.07396	0	14.58227	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y5Q9	TF3C3_HUMAN	"General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit, TFIIIC 102 kDa subunit, TFIIIC102) (Transcription factor IIIC subunit gamma, TF3C-gamma)"	GTF3C3	Homo sapiens (Human)	5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]	DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]	GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0031965; GO:0042791; GO:0042797	ELEYFGLSAAILDK	9.710000038	0.865794361	0.865794361	0.320535119	1568.179926	15.67723	17.21292	14.98245	0	0	13.31145	16.96731	14.9803	15.78616	11.97542	16.55356	19.38248	0	0	0	0	13.07506	15.01334	0	14.38033	14.56734	0	0	0	16.26086	16.67874	16.47349	15.6468	0	0	15.46587	0	16.71311	0	17.82483	0	0	0	0	0	16.39621	12.12605	0	0	0	16.81992	13.86876	15.28204
Q9Y5R6	DMRT1_HUMAN	Doublesex- and mab-3-related transcription factor 1 (DM domain expressed in testis protein 1)	DMRT1 DMT1	Homo sapiens (Human)	cell morphogenesis [GO:0000902]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; male germ cell proliferation [GO:0002176]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of male gonad development [GO:2000020]; positive regulation of meiosis I [GO:0060903]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nodal signaling pathway [GO:1900107]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell morphogenesis [GO:0000902]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; male germ cell proliferation [GO:0002176]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of male gonad development [GO:2000020]; positive regulation of meiosis I [GO:0060903]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nodal signaling pathway [GO:1900107]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283]"	"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0002176; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0007281; GO:0007283; GO:0007548; GO:0008354; GO:0030238; GO:0035556; GO:0042802; GO:0045835; GO:0045840; GO:0045944; GO:0046661; GO:0046872; GO:0048599; GO:0060008; GO:0060009; GO:0060903; GO:1900107; GO:1990837; GO:2000020	GGGSGSGASDLGAGSK	17.07999992	1	1	0.354579201	1264.062213	0	21.41183	20.17827	15.08751	0	0	0	20.77694	22.84247	0	0	0	19.4116	0	0	0	19.94022	0	0	20.54494	20.91575	20.12742	0	18.06337	19.84177	21.02511	0	20.04446	0	21.41353	0	21.40062	0	22.04121	21.40291	21.64545	0	0	22.04796	19.48297	0	20.42245	0	0	0	0	21.87025	21.94479
Q9Y5S2	MRCKB_HUMAN	"Serine/threonine-protein kinase MRCK beta, EC 2.7.11.1 (CDC42-binding protein kinase beta, CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta, MRCK beta, Myotonic dystrophy protein kinase-like beta)"	CDC42BPB KIAA1124	Homo sapiens (Human)	actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; establishment or maintenance of cell polarity [GO:0007163]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]	actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; establishment or maintenance of cell polarity [GO:0007163]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]	GO:0000287; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0006468; GO:0007010; GO:0007163; GO:0007165; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031267; GO:0031532; GO:0042641; GO:0044877; GO:0070062; GO:0106310	EELHKQLVEASER	4.53000021	1	1	0.300977802	1568.298515	0	14.04558	14.9604	15.01475	0	0	0	0	0	0	0	0	0	13.62338	0	13.64867	15.39152	14.30122	0	15.30716	0	0	0	15.51686	0	14.07831	0	0	14.59763	0	0	13.97016	16.26755	12.84546	0	0	15.25707	0	0	0	16.14159	15.99684	0	0	15.22659	0	0	0
Q9Y5W5	WIF1_HUMAN	"Wnt inhibitory factor 1, WIF-1"	WIF1 UNQ191/PRO217	Homo sapiens (Human)	anatomical structure development [GO:0048856]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	cell surface [GO:0009986]; extracellular region [GO:0005576]	cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	signaling receptor binding [GO:0005102]; Wnt-protein binding [GO:0017147]	GO:0005102; GO:0005576; GO:0007165; GO:0009986; GO:0016055; GO:0017147; GO:0030178; GO:0045600; GO:0048856	NGGFCNER	6.239999771	1	1	0.221104295	952.7734321	16.27505	0	0	16.91325	10.17467	0	0	16.22644	0	0	16.44457	13.74627	0	14.73213	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.68773	0	0	16.38362	0	0	0	0	0	0	0	0	0	0	0	15.5924	15.99268	16.09759	0
Q9Y5W7	SNX14_HUMAN	Sorting nexin-14	SNX14	Homo sapiens (Human)	autophagosome maturation [GO:0097352]; protein transport [GO:0015031]	cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	"cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; autophagosome maturation [GO:0097352]; protein transport [GO:0015031]"	"phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]"	GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016021; GO:0030425; GO:0031902; GO:0035091; GO:0043231; GO:0080025; GO:0097352	TMGQKLK	14.06000042	1	1	0.22334558	820.4666284	16.22885	0	14.85766	0	15.34319	15.7536	15.32638	14.19366	16.04902	16.27895	15.52899	15.40901	15.24648	16.30006	14.88773	15.83888	16.03429	15.05944	0	15.00325	0	16.18231	16.89731	15.22012	16.03644	16.75473	15.66724	15.4963	16.45128	0	0	15.4989	0	15.3552	16.03946	17.41939	0	16.52686	16.6238	17.251	16.22816	15.45534	0	15.66154	14.60357	15.50229	16.71772	16.35306
Q9Y5W8	SNX13_HUMAN	Sorting nexin-13 (RGS domain- and PHOX domain-containing protein) (RGS-PX1)	SNX13 KIAA0713	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]	early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]	phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]	GO:0005769; GO:0006886; GO:0009968; GO:0031901; GO:0032266; GO:0035091; GO:0043231; GO:0043547	AYSKGK	10.52999973	1	1	0.221586105	653.5347927	15.4862	16.35217	15.70465	16.01523	14.86658	14.89726	15.69779	16.81537	16.338	14.29608	0	15.64591	0	14.77753	15.63565	15.42302	14.96297	16.70078	0	0	15.19794	17.16508	0	15.84582	0	0	0	0	16.60687	0	0	0	16.63661	16.03689	13.97101	16.50255	16.21433	0	17.80231	16.37765	0	0	14.46775	0	0	15.68706	0	0
Q9Y5W9	SNX11_HUMAN	Sorting nexin-11	SNX11	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050]	endosome [GO:0005768]; membrane [GO:0016020]	endosome [GO:0005768]; membrane [GO:0016020]; phosphatidylinositol phosphate binding [GO:1901981]; intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050]	phosphatidylinositol phosphate binding [GO:1901981]	GO:0005768; GO:0006886; GO:0016020; GO:0016050; GO:1901981	SCCFLPR	1.809999943	0.99297899	0.99297899	0.285095536	938.2102751	0	0	0	0	15.70401	13.86932	16.73024	0	0	0	0	15.21351	0	0	15.0585	15.64517	0	0	0	16.29812	16.95504	0	0	0	0	0	0	16.18948	0	0	0	16.12861	0	0	0	16.03396	14.20002	14.92485	16.91126	0	0	0	0	11.05843	17.17427	15.39424	13.73267	12.50935
Q9Y5X1	SNX9_HUMAN	"Sorting nexin-9 (SH3 and PX domain-containing protein 1, Protein SDP1) (SH3 and PX domain-containing protein 3A)"	SNX9 SH3PX1 SH3PXD3A	Homo sapiens (Human)	cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; protein-containing complex assembly [GO:0065003]; receptor-mediated endocytosis [GO:0006898]	clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]	clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; protein-containing complex assembly [GO:0065003]; receptor-mediated endocytosis [GO:0006898]	1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]	GO:0000281; GO:0001726; GO:0005545; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006898; GO:0016197; GO:0030136; GO:0030659; GO:0030838; GO:0031234; GO:0031410; GO:0031625; GO:0032437; GO:0035091; GO:0036089; GO:0042802; GO:0042803; GO:0043547; GO:0045296; GO:0045860; GO:0051044; GO:0060988; GO:0065003; GO:0070062; GO:0071933; GO:0097320	DEKEWK	4.210000038	1	1	0.023572853	833.8002402	0	0	0	17.91569	14.72968	14.28775	0	13.06287	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.63434	18.00243	0	0	15.57011	0	0	17.08464	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y5X2	SNX8_HUMAN	Sorting nexin-8	SNX8	Homo sapiens (Human)	early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]	identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]	GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231	HVEYEVSSQR	4.210000038	1	1	0.19562145	1234.888027	14.00299	15.22866	15.13173	12.63625	0	17.81948	14.14748	12.45371	12.7174	0	10.27737	13.75017	16.33412	12.47483	12.73346	0	14.28187	0	0	0	0	9.948502	0	15.05311	17.76686	16.39025	15.67363	0	0	0	17.73335	0	0	0	0	0	0	0	15.66725	0	0	0	0	0	0	0	0	0
Q9Y5X4	NR2E3_HUMAN	Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor)	NR2E3 PNR RNR	Homo sapiens (Human)	anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000978; GO:0001228; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007165; GO:0007601; GO:0007602; GO:0008270; GO:0008285; GO:0010628; GO:0030154; GO:0042462; GO:0043565; GO:0045944; GO:0048856; GO:0060041	METRPTALMSSTVAAAAPAAGAASRK	3.619999886	1	1	9.21E-13	2532.470976	0	0	13.50672	0	0	0	0	0	0	0	0	0	14.74032	0	0	13.85251	0	0	0	0	0	0	0	0	16.75947	0	15.65386	0	0	0	16.47837	18.54446	0	17.00792	0	0	0	15.23908	0	0	0	0	0	0	0	0	0	0
Q9Y5Y6	ST14_HUMAN	"Suppressor of tumorigenicity 14 protein, EC 3.4.21.109 (Matriptase) (Membrane-type serine protease 1, MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein)"	ST14 PRSS14 SNC19 TADG15	Homo sapiens (Human)	epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; proteolysis [GO:0006508]	basolateral plasma membrane [GO:0016323]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; proteolysis [GO:0006508]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016323; GO:0019897; GO:0030216; GO:0060672	GGGGPK	2.910000086	1	1	0.23016423	471.3419811	0	13.25524	0	0	0	0	15.90334	0	17.00658	0	0	0	0	0	18.27311	0	0	0	0	0	0	0	0	17.71673	0	0	0	0	0	0	18.31598	0	0	0	0	0	0	0	0	0	0	0	0	17.73655	0	0	0	0
Q9Y5Y7	LYVE1_HUMAN	"Lymphatic vessel endothelial hyaluronic acid receptor 1, LYVE-1 (Cell surface retention sequence-binding protein 1, CRSBP-1) (Extracellular link domain-containing protein 1) (Hyaluronic acid receptor)"	LYVE1 CRSBP1 HAR XLKD1 UNQ230/PRO263	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; cell-matrix adhesion [GO:0007160]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cellular extravasation [GO:0002693]; response to wounding [GO:0009611]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; hyaluronic acid binding [GO:0005540]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; anatomical structure morphogenesis [GO:0009653]; cell-matrix adhesion [GO:0007160]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cellular extravasation [GO:0002693]; response to wounding [GO:0009611]	hyaluronic acid binding [GO:0005540]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	GO:0002693; GO:0004888; GO:0005540; GO:0005886; GO:0005887; GO:0006027; GO:0007160; GO:0009611; GO:0009653; GO:0016020; GO:0038023; GO:0070062	AEELSIQVSCR	6.329999924	1	1	0.152517343	1291.305603	0	14.38543	0	12.95989	14.73296	0	15.47124	11.66515	15.29466	14.40664	16.09186	0	0	0	12.81683	0	0	0	0	0	0	0	0	0	0	14.20463	0	0	9.886811	0	0	11.45298	0	0	0	0	10.63596	0	0	0	0	0	0	0	0	13.76654	14.9756	0
Q9Y5Z7	HCFC2_HUMAN	"Host cell factor 2, HCF-2 (C2 factor)"	HCFC2	Homo sapiens (Human)	"chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; viral process [GO:0016032]"	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Set1C/COMPASS complex [GO:0048188]	"cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Set1C/COMPASS complex [GO:0048188]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; viral process [GO:0016032]"	transcription coactivator activity [GO:0003713]	GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0016032; GO:0016604; GO:0035097; GO:0044665; GO:0048188; GO:0051568; GO:0071339	DSGSPKMYVFGGMCGAR	6.039999962	1	1	0.078731045	1836.487203	11.63811	0	10.30529	14.10473	0	0	0	0	0	0	0	12.8667	0	0	0	10.66712	0	0	0	0	0	0	0	14.86492	0	13.65787	0	15.15026	0	13.55413	0	0	0	0	0	14.04021	0	0	0	14.35242	15.79863	0	0	0	0	0	0	0
Q9Y608	LRRF2_HUMAN	"Leucine-rich repeat flightless-interacting protein 2, LRR FLII-interacting protein 2"	LRRFIP2	Homo sapiens (Human)	"regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]"		"LRR domain binding [GO:0030275]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]"	LRR domain binding [GO:0030275]	GO:0006355; GO:0016055; GO:0030275	QISEYK	6.690000057	5.65E-05	5.65E-05	0.175464643	766.4433834	15.72238	0	14.90764	15.22559	14.91917	15.01991	0	15.38569	0	15.56313	0	0	0	0	0	16.35815	0	16.09034	0	14.62243	15.84478	16.03113	17.03236	16.43213	0	0	16.74714	16.3524	16.96585	14.47712	15.21787	15.79198	14.81607	0	15.69167	0	17.36533	16.50055	16.23313	14.81055	15.04043	16.30339	16.784	13.82958	13.74926	16.32285	16.27984	14.8347
Q9Y615	ACL7A_HUMAN	Actin-like protein 7A (Actin-like-7-alpha)	ACTL7A	Homo sapiens (Human)	acrosome assembly [GO:0001675]; fertilization [GO:0009566]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dynactin complex [GO:0005869]; Golgi apparatus [GO:0005794]; male germ cell nucleus [GO:0001673]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dynactin complex [GO:0005869]; Golgi apparatus [GO:0005794]; male germ cell nucleus [GO:0001673]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; structural constituent of cytoskeleton [GO:0005200]; acrosome assembly [GO:0001675]; fertilization [GO:0009566]	structural constituent of cytoskeleton [GO:0005200]	GO:0001669; GO:0001673; GO:0001675; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005856; GO:0005869; GO:0009566; GO:0031514; GO:0032991	SMQLGLHTQTVSCLNKCDIALK	3.049999952	0.266589105	0.266589105	0.124281506	2517.582987	0	14.57768	0	0	14.92993	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.791719	0	0	0	0	0	0	0	0	0	0	0	12.83992	0	16.09186	11.98814	0	0	0	0	0	0	0	0
Q9Y617	SERC_HUMAN	"Phosphoserine aminotransferase, EC 2.6.1.52 (Phosphohydroxythreonine aminotransferase, PSAT)"	PSAT1 PSA	Homo sapiens (Human)	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]	GO:0004648; GO:0005737; GO:0005829; GO:0006564; GO:0008615; GO:0030170; GO:0042802; GO:0070062	AAEEAKK	11.39999962	0.374941915	0.374941915	0.007128286	747.4322578	16.22683	16.00088	0	0	14.724	11.97881	0	15.6445	15.87561	15.96721	17.41046	17.60114	14.09682	16.73914	13.18399	14.7292	17.43863	12.49564	14.51732	0	14.2612	16.4989	16.41363	0	0	0	15.72307	18.95764	14.65042	18.6553	0	12.43915	14.38231	0	0	0	16.20042	0	12.96661	13.89828	12.31501	13.67173	17.93736	17.73848	0	16.20291	0	0
Q9Y618	NCOR2_HUMAN	"Nuclear receptor corepressor 2, N-CoR2 (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor, SMRT) (T3 receptor-associating factor, TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)"	NCOR2 CTG26	Homo sapiens (Human)	"estrous cycle [GO:0044849]; lactation [GO:0007595]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to organonitrogen compound [GO:0010243]"	chromatin [GO:0000785]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	"chromatin [GO:0000785]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; Notch binding [GO:0005112]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoid X receptor binding [GO:0046965]; transcription corepressor activity [GO:0003714]; estrous cycle [GO:0044849]; lactation [GO:0007595]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to organonitrogen compound [GO:0010243]"	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; Notch binding [GO:0005112]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoid X receptor binding [GO:0046965]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0000785; GO:0003677; GO:0003682; GO:0003714; GO:0005112; GO:0005634; GO:0005654; GO:0006357; GO:0007595; GO:0010243; GO:0010565; GO:0016020; GO:0016363; GO:0016604; GO:0017053; GO:0032355; GO:0035259; GO:0042826; GO:0044849; GO:0044877; GO:0045892; GO:0046965; GO:0047485; GO:0060766; GO:1903799	KLILYFK	20.54999924	0.457605153	0.457605153	0.224365133	925.1514715	16.58876	18.09017	16.79501	18.91235	15.83679	17.58625	16.41271	16.81896	18.04949	18.26093	16.7513	15.69362	15.93201	15.68273	15.73721	15.28724	17.42571	16.76704	16.92854	18.82103	15.09943	16.95864	15.97893	16.8774	16.24414	18.20292	16.18748	0	0	14.93856	17.73131	17.93327	17.38583	0	16.96859	16.5758	17.2985	18.82055	16.00034	17.031	16.74421	0	16.76361	0	16.28578	16.28737	14.42316	15.54475
Q9Y620	RA54B_HUMAN	"DNA repair and recombination protein RAD54B, EC 3.6.4.- (RAD54 homolog B)"	RAD54B	Homo sapiens (Human)	determination of adult lifespan [GO:0008340]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410]	nucleus [GO:0005634]	nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; hydrolase activity [GO:0016787]; RNA helicase activity [GO:0003724]; determination of adult lifespan [GO:0008340]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410]	ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; hydrolase activity [GO:0016787]; RNA helicase activity [GO:0003724]	GO:0000724; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005634; GO:0006312; GO:0007131; GO:0008340; GO:0009410; GO:0010212; GO:0015616; GO:0016787; GO:0140658	EGIIFLYECVMGMRMNGR	5.369999886	0.039296336	0.039296336	0.069414616	2191.328716	0	0	0	0	0	0	0	0	0	0	0	15.7914	0	0	0	12.80162	16.94778	0	0	22.08512	0	16.82091	0	0	16.35947	0	0	17.40129	0	0	16.87166	0	0	0	0	0	0	17.81372	0	7.952849	0	0	0	0	18.5981	0	0	0
Q9Y623	MYH4_HUMAN	"Myosin-4 (Myosin heavy chain 2b, MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb, MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal)"	MYH4	Homo sapiens (Human)	actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]	muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]	muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; double-stranded RNA binding [GO:0003725]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; double-stranded RNA binding [GO:0003725]; microfilament motor activity [GO:0000146]	GO:0000146; GO:0003725; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0016887; GO:0030016; GO:0030017; GO:0030048; GO:0030049; GO:0032982; GO:0046034; GO:0051015	DAMVSQLSR	3.980000019	0.012830636	0.012830636	2.17E-12	1006.837327	13.7944	0	10.9374	15.26155	17.72317	0	0	0	0	10.94978	16.35245	14.56955	14.25592	15.44178	16.60944	0	0	14.51563	0	10.98094	0	17.66715	16.461	13.28537	16.80399	15.32341	12.07157	15.53643	16.31738	12.79715	14.92628	17.31333	14.87002	12.56522	16.19589	0	15.79294	0	17.03449	13.42126	0	14.45057	8.392653	9.146929	0	0	15.44099	16.9942
Q9Y657	SPIN1_HUMAN	Spindlin-1 (Ovarian cancer-related protein) (Spindlin1)	SPIN1 OCR SPIN	Homo sapiens (Human)	"chromatin organization [GO:0006325]; gamete generation [GO:0007276]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]; Wnt signaling pathway [GO:0016055]"	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	"cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; gamete generation [GO:0007276]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]; Wnt signaling pathway [GO:0016055]"	methylated histone binding [GO:0035064]	GO:0005634; GO:0005654; GO:0005730; GO:0005819; GO:0005829; GO:0006325; GO:0006355; GO:0007276; GO:0009303; GO:0016055; GO:0030177; GO:0031965; GO:0035064; GO:0045893; GO:0051321	TPGQRSR	2.420000076	1	1	0.220703664	802.328558	15.08268	15.54709	0	0	0	0	0	0	0	0	0	14.59717	0	0	0	16.82557	0	16.50126	0	0	0	0	0	0	0	0	0	0	0	0	16.20472	0	16.21757	16.05812	15.54873	0	0	0	16.10475	0	16.57656	0	0	0	0	0	0	0
Q9Y662	HS3SB_HUMAN	"Heparan sulfate glucosamine 3-O-sulfotransferase 3B1, EC 2.8.2.30 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3B1, 3-OST-3B, Heparan sulfate 3-O-sulfotransferase 3B1, h3-OST-3B)"	HS3ST3B1 3OST3B1 HS3ST3B	Homo sapiens (Human)	"glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; protein sulfation [GO:0006477]"	Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]	"Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; protein sulfation [GO:0006477]"	[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]	GO:0000139; GO:0005887; GO:0006024; GO:0006477; GO:0008467; GO:0015012; GO:0015015; GO:0033872	EAPARISAMSK	3.569999933	0.569760561	0.569760561	0.364549941	1176.04691	15.59787	0	13.06786	15.96705	0	12.29115	0	13.39845	14.82643	0	0	0	16.2923	0	0	0	16.39175	0	0	0	0	0	0	0	0	0	16.01748	0	0	0	0	0	0	0	0	0	0	0	0	0	15.99091	0	0	0	0	0	0	0
Q9Y664	KPTN_HUMAN	KICSTOR complex protein kaptin (Actin-associated protein 2E4)	KPTN	Homo sapiens (Human)	actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]	KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]	KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]	actin filament binding [GO:0051015]	GO:0005765; GO:0007015; GO:0030027; GO:0032420; GO:0034198; GO:0042149; GO:0051015; GO:0061462; GO:0098871; GO:0140007; GO:1904262	MMGEAAVAAGPCPLR	5.409999847	1	1	0.405412904	1562.78067	15.0784	0	14.74888	0	11.87419	0	0	14.51196	0	0	0	13.43396	12.99187	15.97345	14.0407	0	13.29148	13.42957	14.85353	0	0	16.45712	0	0	0	0	0	0	13.82967	0	13.00699	0	13.45274	14.64961	12.45876	15.21241	0	16.3485	0	12.90349	14.16992	16.3007	0	0	0	0	17.57255	16.18361
Q9Y672	ALG6_HUMAN	"Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase, EC 2.4.1.267 (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)"	ALG6 My046	Homo sapiens (Human)	dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]"	"dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527]"	GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016020; GO:0016021; GO:0042281; GO:0046527	GYESQAHK	8.159999847	1	1	0.142214943	919.4272325	0	0	0	0	0	0	0	15.91881	0	0	15.08578	13.24004	15.64382	0	0	0	14.21227	0	15.35127	0	16.50675	0	15.05755	13.84364	0	0	14.24041	14.98613	0	0	14.57189	14.96311	0	14.67459	15.01452	0	12.90869	0	0	0	0	0	0	0	0	14.38483	0	0
Q9Y673	ALG5_HUMAN	"Dolichyl-phosphate beta-glucosyltransferase, DolP-glucosyltransferase, EC 2.4.1.117 (Asparagine-linked glycosylation protein 5 homolog)"	ALG5 HSPC149	Homo sapiens (Human)	determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576]; determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576]	GO:0004576; GO:0004581; GO:0005789; GO:0006486; GO:0006487; GO:0007368; GO:0016020; GO:0016021; GO:0018279	VRVITLVK	5.449999809	0.636579394	0.636579394	0.28993948	929.1400825	15.76882	17.29984	18.60499	18.40427	0	0	17.98145	0	18.35633	17.80478	0	0	0	0	0	0	0	18.87704	18.27943	16.0943	0	0	0	0	0	18.80969	0	17.51279	0	0	0	0	0	19.22286	0	0	18.17503	0	17.55892	0	0	17.6388	0	17.11061	16.03517	17.02166	0	0
Q9Y675	SNURF_HUMAN	SNRPN upstream reading frame protein	SNURF	Homo sapiens (Human)		nuclear speck [GO:0016607]; nucleus [GO:0005634]	nuclear speck [GO:0016607]; nucleus [GO:0005634]		GO:0005634; GO:0016607	QAFLAETPR	5.21999979	0.166018173	0.166018173	0.225240387	1030.106469	15.49221	15.38077	14.2798	11.09179	0	15.57979	15.10213	0	16.16228	14.60476	16.58054	15.01744	0	0	0	0	0	0	17.36106	16.2382	0	15.64018	0	0	14.61907	15.55814	13.43366	0	15.32999	0	14.72341	15.06751	14.24545	0	15.20237	0	0	0	0	14.65448	0	0	0	15.89199	15.15306	15.97635	16.5348	13.88325
Q9Y678	COPG1_HUMAN	"Coatomer subunit gamma-1 (Gamma-1-coat protein, Gamma-1-COP)"	COPG1 COPG	Homo sapiens (Human)	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of Golgi localization [GO:0051683]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]	COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of Golgi localization [GO:0051683]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]	structural molecule activity [GO:0005198]	GO:0000139; GO:0005198; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0009306; GO:0030126; GO:0030133; GO:0051683; GO:0072384	GGHDILVR	5.980000019	1	1	0.168800237	866.1639337	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.89158	0	0	0	18.0191	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y680	FKBP7_HUMAN	"Peptidyl-prolyl cis-trans isomerase FKBP7, PPIase FKBP7, EC 5.2.1.8 (23 kDa FK506-binding protein, 23 kDa FKBP, FKBP-23) (FK506-binding protein 7, FKBP-7) (Rotamase)"	FKBP7 FKBP23 UNQ670/PRO1304	Homo sapiens (Human)	peptidyl-proline modification [GO:0018208]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; peptidyl-proline modification [GO:0018208]	calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0003755; GO:0005509; GO:0005528; GO:0005783; GO:0005788; GO:0018208	VVIPPSFAYGK	4.449999809	0.161932334	0.161932334	0.051738381	1177.260838	13.10334	0	0	14.44156	13.84651	0	0	13.05406	0	0	0	12.80897	0	0	0	18.3156	0	0	14.0815	0	13.99082	0	0	15.06941	17.89391	0	0	15.22214	0	0	0	15.27595	0	0	0	0	12.36018	0	14.83545	0	0	12.49783	11.26146	0	0	0	12.72808	0
Q9Y689	ARL5A_HUMAN	ADP-ribosylation factor-like protein 5A	ARL5A ARFLP5 ARL5	Homo sapiens (Human)	intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192]	trans-Golgi network [GO:0005802]	trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192]	GTP binding [GO:0005525]; GTPase activity [GO:0003924]	GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0016192; GO:1903292	VIIVGLDNAGK	6.300000191	1	1	0.119506436	1097.509701	15.35245	15.16299	0	15.6735	14.36415	13.25539	0	0	0	0	0	0	0	8.442018	0	0	0	0	15.29318	0	0	0	0	0	0	0	0	0	0	0	15.53675	15.71906	0	0	0	0	0	0	0	0	0	0	0	0	0	14.41183	0	0
Q9Y692	GMEB1_HUMAN	"Glucocorticoid modulatory element-binding protein 1, GMEB-1 (DNA-binding protein p96PIF) (Parvovirus initiation factor p96, PIF p96)"	GMEB1	Homo sapiens (Human)	regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp27 protein binding [GO:0051008]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]"	"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp27 protein binding [GO:0051008]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]"	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0042802; GO:0046872; GO:0051008; GO:1990837	AILLWKK	5.889999866	1	1	0.199423288	869.6646452	0	0	15.09731	0	0	16.44444	14.76313	14.85374	12.37638	0	0	13.54873	0	0	0	6.11677	15.9473	16.94487	0	15.91004	17.31589	0	0	0	0	0	0	17.10068	16.11781	0	16.58667	16.07098	15.91293	0	0	0	0	0	0	0	0	15.75624	0	0	0	0	15.8339	0
Q9Y697	NFS1_HUMAN	"Cysteine desulfurase, mitochondrial, EC 2.8.1.7"	NFS1 NIFS HUSSY-08	Homo sapiens (Human)	[2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]	cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0016226; GO:0018283; GO:0030170; GO:0031071; GO:0042803; GO:0044571; GO:0046872; GO:0051536; GO:1990229	LRVGDR	6.619999886	1	1	0.262397161	717.0025243	0	0	0	0	0	0	0	0	0	15.0812	0	0	0	0	0	15.99612	0	0	15.66518	0	0	16.85885	0	14.26494	0	0	16.80681	0	0	16.12399	0	16.13768	0	0	0	16.10881	15.99543	16.85487	16.45117	0	17.40355	17.14602	0	15.74906	17.16448	17.22457	15.6698	17.45543
Q9Y6A5	TACC3_HUMAN	Transforming acidic coiled-coil-containing protein 3 (ERIC-1)	TACC3 ERIC1	Homo sapiens (Human)	cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236]		GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850	KEQMR	6.610000134	1	1	0.270513539	708.0805136	0	0	15.04113	0	0	0	16.45328	0	0	0	0	0	0	16.82745	17.07659	0	0	15.95803	0	0	16.4521	18.52153	18.95917	0	16.19844	16.16252	16.94603	16.6858	15.7644	0	16.56245	16.68758	15.23177	0	16.65545	17.88428	17.45812	17.56767	15.82483	15.67095	16.52991	16.6526	15.84627	0	17.26385	0	0	16.81459
Q9Y6B7	AP4B1_HUMAN	AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin)	AP4B1	Homo sapiens (Human)	protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]	AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192]	clathrin binding [GO:0030276]	GO:0005802; GO:0005829; GO:0006605; GO:0008104; GO:0016192; GO:0019898; GO:0030124; GO:0030131; GO:0030276; GO:0031904; GO:0032588	SSSPGVVMGATK	14.14999962	1	1	0.214309371	1120.734245	13.10032	0	13.14201	12.9357	15.11973	13.86558	11.95413	14.45369	11.43566	0	13.21007	15.25935	0	0	0	0	0	0	12.58417	14.49715	0	15.18614	0	0	0	15.7385	0	0	14.88993	0	16.20266	0	0	0	0	0	0	0	13.99356	14.48524	0	0	0	0	0	16.66061	0	15.02393
Q9Y6C2	EMIL1_HUMAN	"EMILIN-1 (Elastin microfibril interface-located protein 1, Elastin microfibril interfacer 1)"	EMILIN1 EMI	Homo sapiens (Human)	aortic valve morphogenesis [GO:0003180]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell activation [GO:0050866]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage migration [GO:1905522]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; EMILIN complex [GO:1990971]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integrin alpha4-beta1 complex [GO:0034668]	collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; EMILIN complex [GO:1990971]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integrin alpha4-beta1 complex [GO:0034668]; extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802]; integrin binding involved in cell-matrix adhesion [GO:0098640]; aortic valve morphogenesis [GO:0003180]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell activation [GO:0050866]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage migration [GO:1905522]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]	extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802]; integrin binding involved in cell-matrix adhesion [GO:0098640]	GO:0003180; GO:0005576; GO:0005581; GO:0005615; GO:0007155; GO:0007160; GO:0008217; GO:0010628; GO:0010629; GO:0010811; GO:0016477; GO:0016525; GO:0030023; GO:0030194; GO:0030512; GO:0030948; GO:0032966; GO:0033627; GO:0034668; GO:0042127; GO:0042802; GO:0045766; GO:0048251; GO:0050866; GO:0060394; GO:0062023; GO:0070062; GO:0070373; GO:0098640; GO:1900426; GO:1901203; GO:1904027; GO:1905522; GO:1990971	LLASVEER	8.039999962	1	1	0.270156726	915.3409282	16.00098	14.41328	15.5498	14.36411	14.8177	12.74031	13.84753	0	0	10.59768	15.65788	0	15.1196	0	0	15.05162	13.848	0	14.40471	14.37024	0	15.88974	0	0	15.61358	0	14.3866	0	0	0	0	15.70573	0	14.93208	17.38693	0	0	0	16.72566	16.40672	0	0	14.85689	13.8042	0	0	0	14.53137
Q9Y6C5	PTC2_HUMAN	"Protein patched homolog 2, PTC2"	PTCH2 UNQ560/PRO1121/PRO57079	Homo sapiens (Human)	cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224]	hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]	GO:0001558; GO:0001709; GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0009957; GO:0016021; GO:0042633; GO:0043588; GO:0045606; GO:0045879; GO:0097108	GPGPATG	1.470000029	1	1	0.162161803	556.6913859	14.8303	16.51568	12.55479	15.51322	11.55332	14.62196	15.82978	0	0	0	0	0	0	15.65116	0	0	0	0	0	0	12.56826	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.53122	0	16.89701	0	0	0	0	0	0	0	0	0
Q9Y6C9	MTCH2_HUMAN	Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein)	MTCH2 MIMP HSPC032	Homo sapiens (Human)	lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635]		GO:0005634; GO:0005739; GO:0005741; GO:0005743; GO:0010635; GO:0016020; GO:0016021; GO:0043065; GO:0055088; GO:0070585; GO:2000738	MADAASQVLLGSGLTILSQPLMYVK	11.55000019	1	1	0.434928613	2621.436871	0	0	0	0	0	0	0	22.77418	22.64373	0	0	20.56685	0	22.07593	0	22.02778	21.33089	0	0	0	0	0	0	0	0	22.47179	0	0	0	0	0	0	0	0	18.40067	0	0	0	0	22.77899	0	0	0	0	0	0	20.54648	0
Q9Y6D0	SELK_HUMAN	"Selenoprotein K, SelK"	SELENOK SELK HSPC030 HSPC297	Homo sapiens (Human)	calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; protein palmitoylation [GO:0018345]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein transport [GO:0051223]; respiratory burst after phagocytosis [GO:0045728]; response to oxidative stress [GO:0006979]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; protein palmitoylation [GO:0018345]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein transport [GO:0051223]; respiratory burst after phagocytosis [GO:0045728]; response to oxidative stress [GO:0006979]	identical protein binding [GO:0042802]	GO:0002230; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006816; GO:0006979; GO:0010742; GO:0016021; GO:0018345; GO:0032469; GO:0032755; GO:0032760; GO:0042102; GO:0042802; GO:0045728; GO:0050848; GO:0051223; GO:0070059; GO:0071639; GO:2000406	MVYISNGQVLDSR	12.53999996	1	1	0.044233349	1481.914272	10.43584	15.71966	13.90554	0	0	0	14.77292	10.57928	14.92028	11.45274	0	6.695354	0	15.42519	13.33596	8.720258	9.756022	14.49141	0	14.60602	15.44071	14.11716	0	0	0	13.25437	0	0	0	13.08054	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6D5	BIG2_HUMAN	"Brefeldin A-inhibited guanine nucleotide-exchange protein 2, Brefeldin A-inhibited GEP 2 (ADP-ribosylation factor guanine nucleotide-exchange factor 2)"	ARFGEF2 ARFGEP2 BIG2	Homo sapiens (Human)	endomembrane system organization [GO:0010256]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular signal transduction [GO:0035556]; positive regulation of tumor necrosis factor production [GO:0032760]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of ARF protein signal transduction [GO:0032012]	asymmetric synapse [GO:0032279]; axonemal microtubule [GO:0005879]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; symmetric synapse [GO:0032280]; trans-Golgi network [GO:0005802]	asymmetric synapse [GO:0032279]; axonemal microtubule [GO:0005879]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; symmetric synapse [GO:0032280]; trans-Golgi network [GO:0005802]; GABA receptor binding [GO:0050811]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular signal transduction [GO:0035556]; positive regulation of tumor necrosis factor production [GO:0032760]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of ARF protein signal transduction [GO:0032012]	GABA receptor binding [GO:0050811]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0000139; GO:0001881; GO:0005085; GO:0005794; GO:0005802; GO:0005815; GO:0005829; GO:0005879; GO:0006887; GO:0006893; GO:0007032; GO:0010256; GO:0015031; GO:0016020; GO:0017022; GO:0031410; GO:0032012; GO:0032279; GO:0032280; GO:0032760; GO:0034237; GO:0035556; GO:0043197; GO:0043231; GO:0048471; GO:0050811; GO:0055037	DMAIR	4.829999924	1	1	0.38566885	620.6597452	0	0	0	0	0	0	0	0	0	0	0	0	16.54462	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6D6	BIG1_HUMAN	"Brefeldin A-inhibited guanine nucleotide-exchange protein 1, Brefeldin A-inhibited GEP 1 (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1)"	ARFGEF1 ARFGEP1 BIG1	Homo sapiens (Human)	endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]	guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]	GO:0000139; GO:0005085; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0006887; GO:0007030; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0090284; GO:0090303; GO:2000114	FLTSQQLFK	3.220000029	1	1	0.157938465	1110.637611	0	0	0	0	0	14.53574	0	0	0	0	0	12.38327	0	0	0	12.60215	9.956769	0	0	13.65037	0	0	0	0	0	0	0	13.24408	13.44196	0	0	13.84563	10.73436	0	15.47278	14.60126	0	0	14.76247	0	0	0	14.59352	0	0	0	0	15.06771
Q9Y6D9	MD1L1_HUMAN	"Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1, MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog, HsMAD1, hMAD1) (Tax-binding protein 181)"	MAD1L1 MAD1 TXBP181	Homo sapiens (Human)	attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]	identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]	GO:0000776; GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051220; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728	MQEQLER	2.109999895	0.564864159	0.564864159	0.302150636	932.2598341	17.4455	0	0	0	17.15318	0	16.90809	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.73724	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6E0	STK24_HUMAN	"Serine/threonine-protein kinase 24, EC 2.7.11.1 (Mammalian STE20-like protein kinase 3, MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal, MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal, MST3/C) ]"	STK24 MST3 STK3	Homo sapiens (Human)	cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000139; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0008631; GO:0009267; GO:0030336; GO:0042542; GO:0045296; GO:0046777; GO:0046872; GO:0048679; GO:0048680; GO:0070062; GO:0097194; GO:0106310	GEPPHSELHPMK	10.77999973	1	1	0.325699831	1373.710407	0	14.50915	15.37713	0	0	0	0	0	14.91689	0	16.43385	0	0	16.74128	0	15.45542	13.64646	8.388667	0	0	0	0	14.69585	0	17.35413	0	16.83181	14.48262	0	0	14.3776	16.07964	15.0499	0	0	0	16.67278	15.11759	0	15.3915	16.49954	15.35923	0	16.63468	16.17544	0	0	0
Q9Y6E2	5MP1_HUMAN	eIF5-mimic protein 1 (Basic leucine zipper and W2 domain-containing protein 2)	BZW2 5MP1 HSPC028 MSTP017	Homo sapiens (Human)	cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]; membrane [GO:0016020]	cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of translational initiation [GO:0006446]	cadherin binding [GO:0045296]	GO:0005737; GO:0006446; GO:0007399; GO:0016020; GO:0030154; GO:0045296	AFSETEQTK	4.840000153	1	1	0.15805403	1039.766602	0	0	0	0	0	0	0	0	16.52044	0	11.85924	0	12.39255	0	0	0	0	0	0	0	0	0	13.99789	0	0	0	0	16.56343	0	0	0	14.36949	0	0	0	0	0	0	12.96446	0	0	0	0	0	15.88517	0	17.26078	0
Q9Y6F1	PARP3_HUMAN	"Protein mono-ADP-ribosyltransferase PARP3, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 3, ARTD3) (DNA ADP-ribosyltransferase PARP3, EC 2.4.2.-) (IRT1) (NAD(+) ADP-ribosyltransferase 3, ADPRT-3) (Poly [ADP-ribose] polymerase 3, PARP-3, hPARP-3) (Poly[ADP-ribose] synthase 3, pADPRT-3)"	PARP3 ADPRT3 ADPRTL3	Homo sapiens (Human)	DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723]	centriole [GO:0005814]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]	centriole [GO:0005814]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723]	catalytic activity [GO:0003824]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]	GO:0000723; GO:0003824; GO:0003950; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006281; GO:0006302; GO:0006471; GO:0016604; GO:0030592; GO:0035861; GO:0045171; GO:0045829; GO:0051106; GO:0060236; GO:0070212; GO:0070213; GO:0140289; GO:0140294; GO:1905662; GO:1990166; GO:1990404; GO:2001034	TKNNWAER	14.77000046	1	1	0.202442687	1018.499474	0	15.33242	0	19.55828	0	0	16.0839	0	0	17.5614	0	0	18.45893	0	17.6791	17.72541	16.49643	18.70221	19.44079	16.00553	18.86689	0	17.72005	17.05693	0	16.75135	0	17.01131	18.35343	18.98184	17.79688	18.52329	17.97341	17.47662	0	20.39869	18.59522	19.3562	19.4548	19.33569	18.00168	19.61178	20.14456	17.36866	16.99903	18.05934	18.39668	19.24143
Q9Y6F6	IRAG1_HUMAN	"Inositol 1,4,5-triphosphate receptor associated 1 (Inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate) (JAW1-related protein MRVI1) (Protein MRVI1)"	IRAG1 IRAG JAW1L MRVI1	Homo sapiens (Human)	cGMP-mediated signaling [GO:0019934]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; cGMP-mediated signaling [GO:0019934]		GO:0005789; GO:0016021; GO:0016529; GO:0019934; GO:0031095; GO:0048471	SMSLTLGKNMPR	6.849999905	1	1	0.094813595	1350.563446	0	0	0	0	0	0	0	0	0	0	0	0	0	16.54577	0	15.6587	0	0	0	16.89237	0	0	0	0	0	0	15.35151	16.1002	0	0	17.5879	15.05508	0	17.315	0	16.28232	16.47457	16.95515	0	15.91745	0	0	0	0	0	0	0	16.55584
Q9Y6F8	CDY1_HUMAN	"Testis-specific chromodomain protein Y 1, EC 2.3.1.48"	CDY1 CDY1A; CDY1B	Homo sapiens (Human)	spermatogenesis [GO:0007283]	nucleus [GO:0005634]	nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; spermatogenesis [GO:0007283]	histone acetyltransferase activity [GO:0004402]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]	GO:0003714; GO:0004402; GO:0005634; GO:0007283; GO:0035064	TQIHPLMSQMSGSVTASMATGSATRK	6.920000076	1	1	0.247241074	2695.690038	14.35753	0	8.698849	0	0	0	0	14.21272	0	0	14.38312	14.04805	0	14.76837	0	13.23912	0	0	13.27712	0	0	0	15.11647	0	0	0	15.83948	0	13.93643	0	0	0	15.61677	0	0	0	13.87025	0	15.54523	15.79539	0	0	0	16.2218	0	14.37155	0	0
Q9Y6F9	WNT6_HUMAN	Protein Wnt-6	WNT6	Homo sapiens (Human)	"axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]"	cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	"cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]"	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	GO:0001658; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0009798; GO:0009986; GO:0010628; GO:0030182; GO:0030666; GO:0031012; GO:0042475; GO:0045165; GO:0045893; GO:0060070; GO:0060684; GO:0061303; GO:0070062; GO:0070172; GO:0071300; GO:0072079	TGSPGTR	8.239999771	1	1	0.059384729	676.3644826	15.04497	17.22682	18.11264	16.91656	17.63119	17.4706	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6G3	RM42_HUMAN	"39S ribosomal protein L42, mitochondrial, L42mt, MRP-L42 (39S ribosomal protein L31, mitochondrial, L31mt, MRP-L31) (Mitochondrial large ribosomal subunit protein mL42)"	MRPL42 MRPL31 MRPS32 RPML31 HSPC204 PTD007	Homo sapiens (Human)	mitochondrial translation [GO:0032543]; translation [GO:0006412]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0005763; GO:0005886; GO:0006412; GO:0032543	MAVAAVK	28.18000031	0.003396253	0.003396253	0.260129182	706.2236327	16.60982	15.64148	0	15.14011	15.56208	14.85198	16.23172	15.25775	13.51317	0	15.82447	15.16674	0	15.30305	17.23834	15.95302	15.4063	0	16.43427	0	15.65739	0	17.30369	0	16.58382	16.04794	0	15.77054	16.77167	0	15.15831	16.79444	16.27154	0	0	0	0	0	16.83574	15.64571	16.40177	16.04145	0	0	0	16.04285	15.70624	0
Q9Y6G9	DC1L1_HUMAN	"Cytoplasmic dynein 1 light intermediate chain 1, LIC1 (Dynein light chain A, DLC-A) (Dynein light intermediate chain 1, cytosolic)"	DYNC1LI1 DNCLI1	Homo sapiens (Human)	cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]	centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle pole [GO:0000922]	centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]	ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; RNA binding [GO:0003723]	GO:0000226; GO:0000776; GO:0000922; GO:0003723; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005886; GO:0007018; GO:0007049; GO:0016020; GO:0019003; GO:0030667; GO:0045504; GO:0051301; GO:0090267; GO:0101003	AEDNFEDIITKPPVR	4.909999847	1	1	0.172073647	1740.926765	0	0	0	12.20435	15.84778	0	14.99889	0	0	0	0	14.80015	16.61951	0	0	0	0	0	0	0	0	16.2982	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6H1	CHCH2_HUMAN	"Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (Aging-associated gene 10 protein) (HCV NS2 trans-regulated protein, NS2TP)"	CHCHD2 C7orf17 AAG10	Homo sapiens (Human)	cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; sequence-specific DNA binding [GO:0043565]; cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037]	DNA-binding transcription factor binding [GO:0140297]; sequence-specific DNA binding [GO:0043565]	GO:0005634; GO:0005739; GO:0005758; GO:0007005; GO:0034599; GO:0043565; GO:0045944; GO:0140297; GO:1900037; GO:1905448	QCRLANGLA	7.420000076	1	1	0.34485967	1001.350725	15.43884	14.47834	16.39956	14.31274	15.30362	14.8232	0	11.85055	0	12.24584	15.20496	15.10545	15.05971	16.32326	16.08988	0	16.41539	0	0	15.84745	0	16.36655	14.92054	0	0	15.84605	13.88169	15.86944	16.43796	0	0	0	0	0	16.17498	16.25064	17.51308	17.27496	17.11123	15.83925	15.97092	0	15.45464	0	16.88765	0	0	16.00257
Q9Y6H3	ATP23_HUMAN	"Mitochondrial inner membrane protease ATP23 homolog, EC 3.4.24.- (Ku70-binding protein 3) (XRCC6-binding protein 1)"	ATP23 KUB3 XRCC6BP1	Homo sapiens (Human)	double-strand break repair via nonhomologous end joining [GO:0006303]; mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]	cell junction [GO:0030054]; cytosol [GO:0005829]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; extrinsic component of mitochondrial inner membrane [GO:0031314]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cytosol [GO:0005829]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; extrinsic component of mitochondrial inner membrane [GO:0031314]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; DNA-dependent protein kinase activity [GO:0004677]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; double-strand break repair via nonhomologous end joining [GO:0006303]; mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]	DNA-dependent protein kinase activity [GO:0004677]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]	GO:0004222; GO:0004677; GO:0005829; GO:0005886; GO:0005958; GO:0006303; GO:0030054; GO:0031314; GO:0033615; GO:0034982; GO:0043231; GO:0046872	AGAPDERR	4.760000229	1	1	0.12164378	871.6945443	10.40155	0	12.75204	0	14.28196	15.28755	0	13.02291	14.65259	15.66752	0	13.05138	0	0	0	16.03427	0	0	0	0	0	0	0	0	15.97969	13.43084	14.9565	15.01901	14.44439	0	15.14463	0	15.55699	0	0	0	14.63008	0	13.62048	13.81601	0	14.05698	0	0	0	0	0	0
Q9Y6H5	SNCAP_HUMAN	"Synphilin-1, Sph1 (Alpha-synuclein-interacting protein)"	SNCAIP	Homo sapiens (Human)	cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]	identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]	GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083	KIPLEK	7.260000229	8.18E-08	8.18E-08	0.278015588	727.3687949	16.7869	0	0	16.72756	0	0	18.99667	0	0	0	19.13342	0	18.17809	16.38092	0	0	18.05547	0	0	17.43677	0	0	0	17.03344	16.15457	18.06989	0	19.05345	17.61764	18.40074	0	0	19.28929	0	19.68308	0	0	0	0	0	18.74892	19.67353	0	0	0	0	18.49457	0
Q9Y6I3	EPN1_HUMAN	Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1)	EPN1	Homo sapiens (Human)	embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; Notch signaling pathway [GO:0007219]	clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; Notch signaling pathway [GO:0007219]	clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]	GO:0001701; GO:0005543; GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0007219; GO:0007565; GO:0030125; GO:0030276; GO:0048568; GO:1903671	DFQYVDR	13.85000038	0.041990116	0.041990116	0.143659096	942.3207946	0	17.14421	16.44933	15.51157	15.96784	0	18.27243	18.89838	0	16.50344	16.53732	0	0	17.73572	15.68515	16.81247	12.78915	15.4144	0	0	13.84893	17.29442	17.07517	16.48528	17.58125	0	0	16.43205	19.24254	0	18.00874	19.5491	18.13261	10.50985	0	15.97677	15.13444	13.91968	14.58314	10.75593	0	18.14592	0	16.29221	17.0475	0	0	0
Q9Y6I7	WSB1_HUMAN	"WD repeat and SOCS box-containing protein 1, WSB-1 (SOCS box-containing WD protein SWiP-1)"	WSB1 SWIP1	Homo sapiens (Human)	intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314]	cytosol [GO:0005829]	cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314]	ubiquitin protein ligase activity [GO:0061630]	GO:0005829; GO:0035556; GO:0044314; GO:0061630; GO:0140454	LLEFLSYR	4.78000021	1	1	0.103887954	1040.658144	0	0	0	0	15.58231	13.23457	0	13.97699	13.89435	0	15.73593	14.77275	0	13.36651	13.88995	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6I8	PXMP4_HUMAN	Peroxisomal membrane protein 4 (24 kDa peroxisomal intrinsic membrane protein)	PXMP4 PMP24	Homo sapiens (Human)		cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]		GO:0005777; GO:0005778; GO:0005829; GO:0016021	MAAPPQLR	11.78999996	0.297799945	0.297799945	0.280515698	899.9904193	14.00133	0	14.481	13.92586	15.27938	0	0	0	0	0	0	0	11.25672	13.5074	0	0	0	0	14.19973	0	13.67065	16.39481	0	0	10.45886	0	16.44501	13.65156	16.4233	15.76477	0	15.22874	0	0	0	0	0	0	0	0	16.59923	12.16131	15.52976	0	0	0	0	15.94871
Q9Y6J0	CABIN_HUMAN	"Calcineurin-binding protein cabin-1 (Calcineurin inhibitor, CAIN)"	CABIN1 KIAA0330	Homo sapiens (Human)	cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent chromatin assembly [GO:0006336]	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent chromatin assembly [GO:0006336]	protein phosphatase inhibitor activity [GO:0004864]	GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006336; GO:0007166; GO:0016235	FDSWAGMALARASR	5.889999866	1	1	0	1552.161574	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6K5	OAS3_HUMAN	"2'-5'-oligoadenylate synthase 3, (2-5')oligo(A) synthase 3, 2-5A synthase 3, EC 2.7.7.84 (p100 OAS, p100OAS)"	OAS3 P/OKcl.4	Homo sapiens (Human)	defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]	2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]	GO:0001730; GO:0003725; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006139; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0043231; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060339; GO:0060700; GO:0071639; GO:0071650; GO:0071659; GO:2000342	GPGLPR	1.820000052	1	1	0.194542987	596.4755106	0	0	14.72332	0	0	14.12123	15.33075	0	13.72598	15.54329	12.65919	13.82363	15.27038	13.62512	0	15.26601	15.50501	16.70014	16.51414	16.17306	15.64127	0	15.74185	0	0	15.44207	0	0	0	16.52108	0	0	0	0	0	0	0	0	0	0	16.04923	0	0	16.4453	0	0	0	0
Q9Y6L6	SO1B1_HUMAN	"Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1, LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2, OATP-2) (Solute carrier family 21 member 6)"	SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6	Homo sapiens (Human)	bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]	bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]	GO:0005886; GO:0005887; GO:0015125; GO:0015347; GO:0015349; GO:0015711; GO:0015721; GO:0016020; GO:0016323; GO:0042167; GO:0043252	YCNGLKMFLAALSLSFIAK	5.190000057	1	1	0	2146.360359	16.59423	0	15.65295	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6M1	IF2B2_HUMAN	"Insulin-like growth factor 2 mRNA-binding protein 2, IGF2 mRNA-binding protein 2, IMP-2 (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)"	IGF2BP2 IMP2 VICKZ2	Homo sapiens (Human)	anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]	GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007399; GO:0009653; GO:0010468; GO:0010494; GO:0017148; GO:0045182; GO:0048027; GO:0051028; GO:0051252; GO:0070934; GO:1990247	AQGRIFGK	11.57999992	1	1	0.219540654	877.4439363	16.78926	14.43501	0	0	14.6995	14.59869	0	16.3638	0	17.3625	15.54069	14.47462	13.76675	15.22116	15.34435	8.835226	0	14.72966	16.45549	14.63432	15.40671	0	0	0	15.23046	16.24851	0	0	14.78361	0	0	15.40576	16.45945	0	15.91134	0	11.65647	16.80909	15.85197	15.58085	13.94451	0	0	0	0	0	16.4023	15.54721
Q9Y6M5	ZNT1_HUMAN	"Zinc transporter 1, ZnT-1 (Solute carrier family 30 member 1)"	SLC30A1 ZNT1	Homo sapiens (Human)	cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]	calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]	GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0010312; GO:0016021; GO:0019855; GO:0030315; GO:0031965; GO:0046929; GO:0070509; GO:0070574; GO:0071577; GO:0071584; GO:0071585; GO:0090281; GO:0098685; GO:0099061	LLCMLALTFMFMVLEVVVSR	6.699999809	1	1	0.131504163	2417.642721	11.57107	0	0	0	0	13.82104	0	0	0	0	13.00318	0	13.88192	0	0	0	12.14384	13.13124	14.80997	0	0	15.53565	0	12.11275	0	0	0	12.63795	11.68816	0	11.8373	0	0	13.3038	12.313	10.52066	15.3779	0	15.17372	14.51189	14.71277	13.65715	0	0	0	0	0	0
Q9Y6M7	S4A7_HUMAN	"Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b, Bicarbonate transporter) (Solute carrier family 4 member 7)"	SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6	Homo sapiens (Human)	auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]	inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0008510; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0032420; GO:0050801; GO:0051453; GO:0055085; GO:0060117	IEPPK	2.380000114	1	1	0.276795022	582.7145962	14.78164	14.0636	15.82243	0	15.49916	0	0	15.33781	14.50327	0	15.69086	16.10862	0	0	0	0	16.34007	0	16.33498	0	0	0	16.10909	0	0	0	0	0	0	0	0	15.98597	0	0	0	16.48355	0	0	0	16.23441	0	0	0	0	16.10207	0	16.24723	0
Q9Y6N1	COX11_HUMAN	"Cytochrome c oxidase assembly protein COX11, mitochondrial"	COX11	Homo sapiens (Human)	metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132]	integral component of mitochondrial inner membrane [GO:0031305]; intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	integral component of mitochondrial inner membrane [GO:0031305]; intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132]	copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]	GO:0005507; GO:0005739; GO:0009055; GO:0031304; GO:0031305; GO:0032991; GO:0033132; GO:0055065	IENMVPVK	7.329999924	0.7806229	0.7806229	0.284218474	945.6229066	0	16.95193	0	0	16.1885	18.20772	0	0	16.28074	16.9939	16.77389	16.57728	17.76997	0	0	0	0	0	0	0	0	0	0	0	17.90202	0	16.26814	0	0	0	18.94607	18.8646	0	0	0	0	0	0	17.06548	16.13335	0	0	18.11834	17.19925	0	0	0	0
Q9Y6N5	SQOR_HUMAN	"Sulfide:quinone oxidoreductase, mitochondrial, SQOR, EC 1.8.5.8 (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)"	SQOR SQRDL CGI-44	Homo sapiens (Human)	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	"mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]	GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949	VTELNPDK	11.61999989	1	1	1.17E-13	915.4831939	0	0	15.30852	0	14.83873	0	0	0	0	0	0	0	0	0	0	15.99071	0	0	0	0	0	0	0	0	0	14.73948	0	0	0	0	0	0	0	15.70452	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6N7	ROBO1_HUMAN	Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1)	ROBO1 DUTT1	Homo sapiens (Human)	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]	GO:0002042; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005886; GO:0005887; GO:0006919; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035481; GO:0035904; GO:0042802; GO:0043406; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748	DQVVALGR	7.789999962	0.791894078	0.791894078	0.280361033	857.1825833	18.59361	17.65549	17.26996	19.03221	0	0	18.14356	18.74882	0	19.40751	19.49733	20.17259	0	17.60133	0	0	0	0	17.16797	0	0	18.73963	0	18.10185	19.266	0	19.64731	18.00589	16.97838	18.65589	19.24275	0	18.97182	0	0	0	0	18.24213	0	0	0	0	0	0	17.22891	0	19.4771	18.33467
Q9Y6N8	CAD10_HUMAN	Cadherin-10 (T2-cadherin)	CDH10	Homo sapiens (Human)	adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]	adherens junction [GO:0005912]; catenin complex [GO:0016342]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]	GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098609; GO:0098742; GO:0098978; GO:0098982; GO:0099059; GO:0099060	FNKLAEMYGGGESDK	3.220000029	1	1	0.124900376	1645.013024	14.60015	17.74477	16.99985	11.0415	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6Q2	STON1_HUMAN	Stonin-1 (Stoned B-like factor)	STON1 SALF SBLF STN1	Homo sapiens (Human)	regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; synaptic vesicle [GO:0008021]	clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]	clathrin adaptor activity [GO:0035615]	GO:0008021; GO:0016020; GO:0016192; GO:0030100; GO:0030136; GO:0031410; GO:0035615; GO:0048488	CSTNPGK	6.099999905	1	1	0.212444394	759.8245221	15.21263	0	14.16777	0	0	15.94295	0	0	15.06793	0	0	0	15.55469	15.6743	14.58659	16.42109	15.68117	15.4417	0	0	0	0	16.03586	0	0	0	0	15.63463	0	15.4857	0	14.23677	16.36213	0	15.55202	0	16.60418	15.7792	15.44293	15.91021	0	15.75624	7.216362	15.23378	16.87177	14.74633	16.52521	16.3906
Q9Y6Q3	ZFP37_HUMAN	"Zinc finger protein 37 homolog, Zfp-37"	ZFP37	Homo sapiens (Human)	"negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	nucleus [GO:0005634]	"nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]"	"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]"	GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0008270	GEAPWLGK	3.400000095	1	1	0.198963911	857.4064747	17.46112	13.70093	12.69333	15.67854	14.10584	17.85833	15.63637	0	14.35009	14.42903	0	14.40362	0	0	0	0	16.40456	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.23474	0	0	0	0	0	0	0	16.35522	0	15.27454	0	0
Q9Y6Q9	NCOA3_HUMAN	"Nuclear receptor coactivator 3, NCoA-3, EC 2.3.1.48 (ACTR) (Amplified in breast cancer 1 protein, AIB-1) (CBP-interacting protein, pCIP) (Class E basic helix-loop-helix protein 42, bHLHe42) (Receptor-associated coactivator 3, RAC-3) (Steroid receptor coactivator protein 3, SRC-3) (Thyroid hormone receptor activator molecule 1, TRAM-1)"	NCOA3 AIB1 BHLHE42 RAC3 TRAM1	Homo sapiens (Human)	cell dedifferentiation [GO:0043697]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hormone stimulus [GO:0032870]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor transactivation [GO:0035624]; regulation of stem cell division [GO:2000035]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; RNA polymerase II complex binding [GO:0000993]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; cell dedifferentiation [GO:0043697]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hormone stimulus [GO:0032870]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor transactivation [GO:0035624]; regulation of stem cell division [GO:2000035]	disordered domain specific binding [GO:0097718]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; RNA polymerase II complex binding [GO:0000993]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0000785; GO:0000993; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016922; GO:0030374; GO:0032870; GO:0032991; GO:0035624; GO:0043697; GO:0045618; GO:0045944; GO:0046966; GO:0046983; GO:0047485; GO:0070062; GO:0071392; GO:0097718; GO:1902459; GO:2000035	TNTPKQLR	4.96999979	0.50530982	0.50530982	0.293859674	956.9266155	15.17408	13.32865	13.44331	0	0	0	0	0	13.00718	15.12515	0	13.54562	0	0	15.53278	0	13.90558	12.85343	0	15.72636	15.77021	0	0	0	0	0	0	0	13.20373	0	0	0	0	15.97927	0	0	11.9047	15.63284	0	13.08504	0	0	0	0	0	15.68697	0	14.91611
Q9Y6R1	S4A4_HUMAN	"Electrogenic sodium bicarbonate cotransporter 1, Sodium bicarbonate cotransporter (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1)"	SLC4A4 NBC NBC1 NBCE1	Homo sapiens (Human)	bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; positive regulation of glycolytic process [GO:0045821]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; positive regulation of glycolytic process [GO:0045821]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]	identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]	GO:0005452; GO:0005886; GO:0005887; GO:0006814; GO:0008510; GO:0009986; GO:0015293; GO:0015701; GO:0016020; GO:0016323; GO:0022857; GO:0035725; GO:0036376; GO:0042391; GO:0042802; GO:0045821; GO:0050801; GO:0051453; GO:0055085; GO:0070062; GO:0150104	WSKPHVATLSLHSLFELR	3.859999895	1	1	0.533836602	2121.38972	0	17.28586	15.06905	17.77293	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6R4	M3K4_HUMAN	"Mitogen-activated protein kinase kinase kinase 4, EC 2.7.11.25 (MAP three kinase 1) (MAPK/ERK kinase kinase 4, MEK kinase 4, MEKK 4)"	MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1	Homo sapiens (Human)	chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]	ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]	GO:0000165; GO:0001890; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:0106310; GO:1900745; GO:1904355	LSAPVR	7.099999905	0.224038363	0.224038363	0.304680319	641.1128942	0	16.11011	15.72745	15.98333	0	16.99634	0	15.35131	0	15.79152	16.13563	15.50105	0	16.13431	15.36891	0	0	0	0	0	0	15.80296	15.16677	16.57041	16.17844	0	0	0	15.98313	0	15.14317	0	15.92621	0	16.18162	17.73827	0	0	0	16.90778	0	16.01244	0	16.14689	0	0	0	16.71681
Q9Y6R7	FCGBP_HUMAN	"IgGFc-binding protein (Fcgamma-binding protein antigen, FcgammaBP)"	FCGBP	Homo sapiens (Human)		extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]		GO:0005615; GO:0031012; GO:0070062	SRLPVSLSEGR	10.10999966	1	1	0.616342782	1200.263105	0	19.73714	19.74038	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.37688	0	0	0	0	0	18.23367	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Q9Y6W5	WASF2_HUMAN	"Wiskott-Aldrich syndrome protein family member 2, WASP family protein member 2 (Protein WAVE-2) (Verprolin homology domain-containing protein 2)"	WASF2 WAVE2	Homo sapiens (Human)	actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]	actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202]	actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]	actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124]	GO:0001525; GO:0001667; GO:0001726; GO:0003779; GO:0005769; GO:0005829; GO:0005911; GO:0006897; GO:0007188; GO:0010592; GO:0015629; GO:0016323; GO:0016601; GO:0017124; GO:0030027; GO:0030032; GO:0030036; GO:0030048; GO:0031209; GO:0032991; GO:0034237; GO:0035855; GO:0045202; GO:0045296; GO:0051018; GO:0051497; GO:0070062; GO:0071933; GO:0072673; GO:0098974; GO:2000601	QTLPSVR	11.07999992	0.897524118	0.897524118	0.247281129	801.2630932	16.24491	12.87834	15.01839	14.99655	14.18489	14.86078	16.27247	15.85957	14.73585	16.54538	16.28767	14.01832	0	14.95214	0	0	0	0	15.91351	14.88862	0	15.85157	0	16.95613	17.14462	0	16.88041	15.66609	0	16.92807	0	17.88474	0	17.23767	13.14874	0	13.92564	0	16.96222	0	15.97945	0	0	0	14.17909	0	16.57499	16.62327
Q9Y6W6	DUS10_HUMAN	"Dual specificity protein phosphatase 10, EC 3.1.3.16, EC 3.1.3.48 (Mitogen-activated protein kinase phosphatase 5, MAP kinase phosphatase 5, MKP-5)"	DUSP10 MKP5	Homo sapiens (Human)	dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]	JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]	GO:0002819; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0008330; GO:0008432; GO:0010633; GO:0016311; GO:0016607; GO:0016791; GO:0017017; GO:0030336; GO:0032496; GO:0033549; GO:0035970; GO:0043409; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0048715; GO:0050680; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264	ILTPKLMGVETVV	10.14000034	1	1	6.87E-13	1415.684553	0	0	0	15.60251	11.77737	13.78741	0	0	13.76505	0	15.58673	0	16.18667	0	0	0	12.49318	14.54065	14.30507	0	0	0	0	15.27632	0	0	0	0	14.32829	0	13.69917	0	15.9889	14.51328	0	15.05814	15.52647	0	0	0	0	15.29758	0	0	0	0	0	0
Q9Y6X0	SETBP_HUMAN	"SET-binding protein, SEB"	SETBP1 KIAA0437	Homo sapiens (Human)		cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]	DNA binding [GO:0003677]	GO:0003677; GO:0005654; GO:0005829; GO:0016604	HGVHLQGPVSMGLGDMQPSLNPPK	3.910000086	1	1	0.017872799	2527.386466	14.4618	0	15.00071	0	15.57828	12.97269	0	0	0	0	0	13.18105	14.96125	0	0	0	0	14.91343	14.23128	14.05227	0	0	16.46529	0	0	14.22078	15.13651	0	14.68985	0	0	12.67822	16.35683	15.3679	13.94561	0	0	0	0	0	16.51814	0	0	0	0	0	0	0
Q9Y6X6	MYO16_HUMAN	Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16)	MYO16 KIAA0865 MYO16B NYAP3	Homo sapiens (Human)	cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein phosphatase binding [GO:0019903]; cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065]	actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein phosphatase binding [GO:0019903]	GO:0003774; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0008285; GO:0014065; GO:0016459; GO:0019903; GO:0021549; GO:0048471; GO:0048812; GO:0051015; GO:2000134	QMKLQRPMSMLTDVK	13.13000011	1	1	0.392382437	1836.749353	0	0	13.22301	0	0	0	0	0	0	0	15.78143	11.67853	14.15344	0	0	0	14.24282	0	0	0	0	0	16.17241	16.355	0	0	0	13.554	0	0	0	0	16.21925	0	0	0	0	12.70881	0	0	0	0	0	0	12.73151	0	0	0
Q9Y6X8	ZHX2_HUMAN	"Zinc fingers and homeoboxes protein 2 (Alpha-fetoprotein regulator 1, AFP regulator 1) (Regulator of AFP) (Zinc finger and homeodomain protein 2)"	ZHX2 AFR1 KIAA0854 RAF	Homo sapiens (Human)	"mRNA catabolic process [GO:0006402]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019]"	chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	"chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; mRNA catabolic process [GO:0006402]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019]"	"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]"	GO:0000122; GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006402; GO:0035019; GO:0042802; GO:0042803; GO:0045665; GO:0045892; GO:0046872; GO:0046982; GO:0060040	EKTQGQVK	2.880000114	1	1	0.197164136	916.4922423	14.75308	0	15.431	13.38839	14.73796	0	15.13919	15.61448	14.72531	16.03035	0	0	16.32733	14.85077	15.46874	14.5317	15.8731	13.59661	16.10385	8.06818	13.79021	14.29269	15.63629	17.04238	15.58662	17.23202	15.39764	0	0	14.48716	0	0	0	15.69116	15.52218	0	17.2674	0	0	16.06729	13.95353	15.42539	0	15.01591	15.30648	0	15.0431	0
Q9Y6Z5	AFDDT_HUMAN	Putative uncharacterized protein AFDN-DT (AFDN divergent transcript) (Protein HGC6.4)	AFDN-DT AFDN-AS1 C6orf124	Homo sapiens (Human)						AVLGPNGR	2.170000076	0.419846237	0.419846237	0.23530919	783.8488718	12.96674	0	0	0	14.40217	15.18979	13.9373	14.44752	14.29906	15.66283	0	16.03388	15.22985	14.7472	0	0	15.77336	0	0	0	0	0	14.45593	0	0	0	0	15.28781	16.03501	0	15.91274	0	14.85584	14.36902	15.15897	15.47747	14.91598	0	0	15.69415	0	0	0	15.89856	0	13.46905	13.08889	0
Q9Y6Z7	COL10_HUMAN	"Collectin-10 (Collectin liver protein 1, CL-L1) (Collectin-34, CL-34)"	COLEC10 CLL1 UNQ366/PRO702	Homo sapiens (Human)	"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]"	collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; serine-type endopeptidase complex [GO:1905370]	"collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; serine-type endopeptidase complex [GO:1905370]; chemoattractant activity [GO:0042056]; mannose binding [GO:0005537]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]"	chemoattractant activity [GO:0042056]; mannose binding [GO:0005537]	GO:0001867; GO:0002752; GO:0005537; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0005794; GO:0006508; GO:0009897; GO:0042056; GO:1903028; GO:1904888; GO:1905370	FYYIVQEEKNYR	5.239999771	1	1	0.341479824	1652.73675	15.55768	0	0	0	15.29869	0	0	18.94066	0	0	0	0	16.67377	0	0	17.19689	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.29013	0	0	14.46075	0	0	13.02207	16.63237	0	0	0	0	0	15.43489	0	16.53028	0
U3KPV4	A3LT2_HUMAN	"Alpha-1,3-galactosyltransferase 2, EC 2.4.1.87 (Isoglobotriaosylceramide synthase, iGb3 synthase, iGb3S)"	A3GALT2 A3GALT2P IGBS3S	Homo sapiens (Human)	carbohydrate metabolic process [GO:0005975]; cellular response to manganese ion [GO:0071287]; glycosphingolipid biosynthetic process [GO:0006688]; lipid glycosylation [GO:0030259]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; N-acetyllactosaminide 3-alpha-galactosyltransferase activity [GO:0047276]; carbohydrate metabolic process [GO:0005975]; cellular response to manganese ion [GO:0071287]; glycosphingolipid biosynthetic process [GO:0006688]; lipid glycosylation [GO:0030259]	glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; N-acetyllactosaminide 3-alpha-galactosyltransferase activity [GO:0047276]	GO:0005794; GO:0005975; GO:0006688; GO:0016021; GO:0016757; GO:0030259; GO:0031982; GO:0032580; GO:0046872; GO:0047276; GO:0071287	VALGPGRR	7.170000076	0.010038396	0.010038396	0.15590111	826.1869536	14.21528	15.36238	14.25871	0	0	15.01388	0	13.87601	13.90175	16.03965	0	0	14.3816	14.0879	14.55838	0	14.93272	0	0	16.08654	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.60372	0	0	15.48722	0	0	0	13.54496	14.9611	0	0	0
